id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
127869946|NCT02926833|460141590|FG000|Overall Study|Death|1|||
127869947|NCT02926833|460141591|FG001|Overall Study|Death|1|||
127869948|NCT02926833|460141592|FG002|Overall Study|Death|2|||
127869949|NCT02926833|460141593|FG003|Overall Study|Death|13|||
127869950|NCT02926833|460141590|FG000|Overall Study|Lost to Follow-up|1|||
127869951|NCT02926833|460141591|FG001|Overall Study|Lost to Follow-up|2|||
127869952|NCT02926833|460141592|FG002|Overall Study|Lost to Follow-up|0|||
127869953|NCT02926833|460141593|FG003|Overall Study|Lost to Follow-up|3|||
127869954|NCT02926833|460141590|FG000|Overall Study|Full Consent Withdrawal|0|||
127869955|NCT02926833|460141591|FG001|Overall Study|Full Consent Withdrawal|0|||
127869956|NCT02926833|460141592|FG002|Overall Study|Full Consent Withdrawal|0|||
127869957|NCT02926833|460141593|FG003|Overall Study|Full Consent Withdrawal|2|||
127869958|NCT02926833|460141590|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
127869959|NCT02926833|460141591|FG001|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
127869960|NCT02926833|460141592|FG002|Overall Study|Rolled Over to Long-term Follow-up Study|3|||
127869961|NCT02926833|460141593|FG003|Overall Study|Rolled Over to Long-term Follow-up Study|4|||
127869962|NCT02926833|460141590|FG000|Overall Study|Investigator Decision|0|||
127869963|NCT02926833|460141591|FG001|Overall Study|Investigator Decision|1|||
127869964|NCT02926833|460141592|FG002|Overall Study|Investigator Decision|0|||
127869965|NCT02926833|460141593|FG003|Overall Study|Investigator Decision|0|||
127869966|NCT02926833|460141590|FG000|Overall Study|Adverse Event|0|||
127869967|NCT02926833|460141591|FG001|Overall Study|Adverse Event|0|||
127869968|NCT02926833|460141592|FG002|Overall Study|Adverse Event|1|||
127869969|NCT02926833|460141593|FG003|Overall Study|Adverse Event|0|||
127869970|NCT02926833|460141590|FG000|Overall Study|Partial Withdrawal of Consent|0|||
127869971|NCT02926833|460141591|FG001|Overall Study|Partial Withdrawal of Consent|0|||
127869972|NCT02926833|460141592|FG002|Overall Study|Partial Withdrawal of Consent|0|||
127869973|NCT02926833|460141593|FG003|Overall Study|Partial Withdrawal of Consent|1|||
127869974|NCT01189201|460141596|FG000|Overall Study|Adverse Event|1|||
127869975|NCT01277757|460141597|FG000|Overall Study|Disease Progression|1|||
127869976|NCT01277757|460141597|FG000|Overall Study|Withdrawal by Subject|1|||
127869977|NCT04308668|460141598|FG000|Overall Study|Lost to Follow-up|32|||
127869978|NCT04308668|460141599|FG001|Overall Study|Lost to Follow-up|38|||
127869979|NCT04308668|460141598|FG000|Overall Study|Withdrawal by Subject|4|||
127869980|NCT04308668|460141599|FG001|Overall Study|Withdrawal by Subject|4|||
127869981|NCT01945866|460141600|FG000|Overall Study|Eyes did not complete or were dropped|2|||
127869982|NCT01945866|460141601|FG001|Overall Study|Eyes did not complete or were dropped|0|||
127869983|NCT03808298|460141602|FG000|Overall Study|Adverse Event|3|||
127869984|NCT03808298|460141602|FG000|Overall Study|Physician Decision|1|||
127869985|NCT03808298|460141602|FG000|Overall Study|Withdrawal by Subject|1|||
127869986|NCT03808298|460141602|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
127869987|NCT01674010|460141603|FG000|Open Treatment Phase 1|Adverse Event|10|||
127869988|NCT01674010|460141604|FG001|Open Treatment Phase 1|Adverse Event|0|||
127869989|NCT01674010|460141605|FG002|Open Treatment Phase 1|Adverse Event|0|||
127869990|NCT01674010|460141603|FG000|Open Treatment Phase 1|Death|1|||
127869991|NCT01674010|460141604|FG001|Open Treatment Phase 1|Death|0|||
127869992|NCT01674010|460141605|FG002|Open Treatment Phase 1|Death|0|||
127869993|NCT01674010|460141603|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
127869994|NCT01674010|460141604|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
127869995|NCT01674010|460141605|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
127869996|NCT01674010|460141603|FG000|Open Treatment Phase 1|Physician Decision|9|||
127869997|NCT01674010|460141604|FG001|Open Treatment Phase 1|Physician Decision|0|||
127869998|NCT01674010|460141605|FG002|Open Treatment Phase 1|Physician Decision|0|||
127869999|NCT01674010|460141603|FG000|Open Treatment Phase 1|Protocol Violation|7|||
127870000|NCT01674010|460141604|FG001|Open Treatment Phase 1|Protocol Violation|0|||
127870001|NCT01674010|460141605|FG002|Open Treatment Phase 1|Protocol Violation|0|||
127870002|NCT01674010|460141603|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
127870003|NCT01674010|460141604|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
127870004|NCT01674010|460141605|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
127870005|NCT01674010|460141603|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
127870006|NCT01674010|460141604|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
127870007|NCT01674010|460141605|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
127870008|NCT01674010|460141603|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
127870009|NCT01674010|460141604|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
127870010|NCT01674010|460141605|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
127870011|NCT01674010|460141603|FG000|Randomization Phase 2|Adverse Event|0|||
127870012|NCT01674010|460141604|FG001|Randomization Phase 2|Adverse Event|1|||
127870013|NCT01674010|460141605|FG002|Randomization Phase 2|Adverse Event|1|||
127647193|NCT02532179|459328509|FG000|Overall Study|Lost to Follow-up|1|||
127870014|NCT01674010|460141603|FG000|Randomization Phase 2|Lost to Follow-up|0|||
127647194|NCT02532179|459328509|FG000|Overall Study|Pregnancy|1|||
127870015|NCT01674010|460141604|FG001|Randomization Phase 2|Lost to Follow-up|1|||
127870016|NCT01674010|460141605|FG002|Randomization Phase 2|Lost to Follow-up|2|||
127870017|NCT01674010|460141603|FG000|Randomization Phase 2|Mood episode recurrence|0|||
127870018|NCT01674010|460141604|FG001|Randomization Phase 2|Mood episode recurrence|8|||
127870019|NCT01674010|460141605|FG002|Randomization Phase 2|Mood episode recurrence|2|||
127870020|NCT01674010|460141603|FG000|Randomization Phase 2|Physician Decision|0|||
127870021|NCT01674010|460141604|FG001|Randomization Phase 2|Physician Decision|0|||
127870022|NCT01674010|460141605|FG002|Randomization Phase 2|Physician Decision|2|||
127870023|NCT01674010|460141603|FG000|Randomization Phase 2|Pregnancy|0|||
127870024|NCT01674010|460141604|FG001|Randomization Phase 2|Pregnancy|1|||
127870025|NCT01674010|460141605|FG002|Randomization Phase 2|Pregnancy|1|||
127870026|NCT01674010|460141603|FG000|Randomization Phase 2|Protocol Violation|0|||
127870027|NCT01674010|460141604|FG001|Randomization Phase 2|Protocol Violation|1|||
127870028|NCT01674010|460141605|FG002|Randomization Phase 2|Protocol Violation|1|||
127870029|NCT01674010|460141603|FG000|Randomization Phase 2|Sponsor Decision|0|||
127870030|NCT01674010|460141604|FG001|Randomization Phase 2|Sponsor Decision|42|||
127647195|NCT02532179|459328509|FG000|Overall Study|Subject received depot steroid injection|1|||
127647196|NCT04128293|459328518|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
127647197|NCT04128293|459328519|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
127647198|NCT04128293|459328520|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
127647199|NCT04128293|459328521|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
127647200|NCT01357616|459328522|FG000|Overall Study|Adverse Event|1|||
127647201|NCT01357616|459328523|FG001|Overall Study|Adverse Event|1|||
127647202|NCT01357616|459328522|FG000|Overall Study|Lost to Follow-up|4|||
127647203|NCT01357616|459328523|FG001|Overall Study|Lost to Follow-up|3|||
127647204|NCT01357616|459328522|FG000|Overall Study|Protocol Violation|0|||
127647205|NCT01357616|459328523|FG001|Overall Study|Protocol Violation|2|||
127647206|NCT01357616|459328522|FG000|Overall Study|Inadequate Control of IOP|1|||
127647207|NCT01357616|459328523|FG001|Overall Study|Inadequate Control of IOP|2|||
127647208|NCT01357616|459328522|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
127647209|NCT01357616|459328523|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
127647210|NCT01357616|459328522|FG000|Overall Study|Withdrawal by Subject|1|||
127647211|NCT01357616|459328523|FG001|Overall Study|Withdrawal by Subject|0|||
127647212|NCT01699022|459328526|FG000|Overall Study|Early discontinuation from the study|3|||
127647213|NCT02052310|459328527|FG000|Overall Study|Death|64|||
127647214|NCT02052310|459328528|FG001|Overall Study|Death|54|||
127647215|NCT02052310|459328527|FG000|Overall Study|Withdrawal by Subject|37|||
127647216|NCT02052310|459328528|FG001|Overall Study|Withdrawal by Subject|49|||
127647217|NCT02052310|459328527|FG000|Overall Study|Other than specified|32|||
127647218|NCT02052310|459328528|FG001|Overall Study|Other than specified|29|||
127647219|NCT02052310|459328527|FG000|Overall Study|Adverse Event|29|||
127647220|NCT02052310|459328528|FG001|Overall Study|Adverse Event|22|||
127647221|NCT02052310|459328527|FG000|Overall Study|Kidney Transplant|23|||
127647222|NCT02052310|459328528|FG001|Overall Study|Kidney Transplant|29|||
127647223|NCT02052310|459328527|FG000|Overall Study|Physician Decision|14|||
127647224|NCT02052310|459328528|FG001|Overall Study|Physician Decision|7|||
127647225|NCT02052310|459328527|FG000|Overall Study|Lack of Efficacy|6|||
127647226|NCT02052310|459328528|FG001|Overall Study|Lack of Efficacy|1|||
127647227|NCT02052310|459328527|FG000|Overall Study|Site Terminated by Sponsor|5|||
127647228|NCT02052310|459328528|FG001|Overall Study|Site Terminated by Sponsor|13|||
127647229|NCT02052310|459328527|FG000|Overall Study|Lost to Follow-up|4|||
127647230|NCT02052310|459328528|FG001|Overall Study|Lost to Follow-up|2|||
127647231|NCT02052310|459328527|FG000|Overall Study|Protocol Violation|1|||
127647232|NCT02052310|459328528|FG001|Overall Study|Protocol Violation|6|||
127647233|NCT02066402|459328531|FG000|Overall Study|Adverse Event|1|||
127647234|NCT02066402|459328532|FG001|Overall Study|Adverse Event|2|||
127647235|NCT02066402|459328531|FG000|Overall Study|Lost to Follow-up|11|||
127647236|NCT02066402|459328532|FG001|Overall Study|Lost to Follow-up|8|||
127647237|NCT02066402|459328531|FG000|Overall Study|Withdrawal by Subject|14|||
127647238|NCT02066402|459328532|FG001|Overall Study|Withdrawal by Subject|11|||
127647239|NCT02066402|459328531|FG000|Overall Study|Progressive disease-clinical progression|0|||
127647240|NCT02066402|459328532|FG001|Overall Study|Progressive disease-clinical progression|1|||
127647241|NCT02066402|459328531|FG000|Overall Study|Protocol driven decision point|0|||
127647242|NCT02066402|459328532|FG001|Overall Study|Protocol driven decision point|1|||
127647243|NCT01505387|459328533|FG000|Overall Study|Protocol Violation|1|||
127647244|NCT01505387|459328534|FG001|Overall Study|Protocol Violation|0|||
127647245|NCT01505387|459328533|FG000|Overall Study|Withdrawal by Subject|1|||
127647246|NCT01505387|459328534|FG001|Overall Study|Withdrawal by Subject|1|||
127647247|NCT01755702|459328535|FG000|Wash Out Period I|Other Reason|3|||
127647248|NCT01755702|459328535|FG000|Washout Period II|Other Reason|5|||
127647249|NCT00594854|459328536|FG000|Overall Study|Study terminated|7|||
127647250|NCT00594854|459328537|FG001|Overall Study|Study terminated|10|||
127647251|NCT03172702|459328538|FG000|Overall Study|Adverse Event|9|||
127647252|NCT03172702|459328538|FG000|Overall Study|Death|2|||
127647253|NCT03172702|459328538|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
127647254|NCT03172702|459328538|FG000|Overall Study|Withdrawal by Subject|5|||
127758398|NCT04396366|459741938|FG000|Overall Study|Adverse Event|1|||
127870031|NCT01674010|460141605|FG002|Randomization Phase 2|Sponsor Decision|45|||
127870032|NCT01674010|460141603|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
127981283|NCT04240886|460554285|FG000|Treatment Phase|Death|4|||
127647255|NCT03172702|459328538|FG000|Overall Study|Other|2|||
127647256|NCT06134180|459328549|FG000|Overall Study|Lost to Follow-up|4|||
127647257|NCT02152982|459328550|FG000|Overall Study|Ineligible|4|||
127647258|NCT02152982|459328551|FG001|Overall Study|Ineligible|4|||
127647259|NCT02152982|459328550|FG000|Overall Study|Did not start treatment|12|||
127647260|NCT02152982|459328551|FG001|Overall Study|Did not start treatment|6|||
127647261|NCT00569582|459328555|FG000|Overall Study|Withdrawal by Subject|5|||
127870033|NCT01674010|460141604|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
127870034|NCT01674010|460141605|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
127870035|NCT03159455|460141606|FG000|Overall Study|Adverse Event|0|||
127870036|NCT03159455|460141607|FG001|Overall Study|Adverse Event|0|||
127870037|NCT03159455|460141608|FG002|Overall Study|Adverse Event|0|||
127870038|NCT03159455|460141609|FG003|Overall Study|Adverse Event|0|||
127870039|NCT03159455|460141610|FG004|Overall Study|Adverse Event|0|||
127870040|NCT03159455|460141611|FG005|Overall Study|Adverse Event|1|||
127870041|NCT01801475|460141619|FG000|Overall Study|Withdrawal by Subject|0|||
127870042|NCT01801475|460141620|FG001|Overall Study|Withdrawal by Subject|0|||
127870043|NCT01801475|460141621|FG002|Overall Study|Withdrawal by Subject|0|||
127870044|NCT01801475|460141622|FG003|Overall Study|Withdrawal by Subject|0|||
127870045|NCT01801475|460141623|FG004|Overall Study|Withdrawal by Subject|1|||
127870046|NCT00421928|460141624|FG000|Overall Study|Adverse Event|61|||
127534883|NCT01517750|458923296|FG000|Overall Study|Lost to Follow-up|1|||
127534884|NCT01517750|458923297|FG001|Overall Study|Lost to Follow-up|2|||
127534885|NCT01517750|458923298|FG002|Overall Study|Lost to Follow-up|4|||
127534886|NCT01517750|458923299|FG003|Overall Study|Lost to Follow-up|1|||
127534887|NCT01307319|458923300|FG000|Overall Study|Adverse Event|2|||
127534888|NCT01307319|458923301|FG001|Overall Study|Adverse Event|2|||
127534889|NCT01307319|458923302|FG002|Overall Study|Adverse Event|1|||
127534890|NCT01307319|458923300|FG000|Overall Study|Lost to Follow-up|1|||
127534891|NCT01307319|458923301|FG001|Overall Study|Lost to Follow-up|0|||
127534892|NCT01307319|458923302|FG002|Overall Study|Lost to Follow-up|1|||
127534893|NCT01307319|458923300|FG000|Overall Study|Protocol Violation|1|||
127534894|NCT01307319|458923301|FG001|Overall Study|Protocol Violation|1|||
127534895|NCT01307319|458923302|FG002|Overall Study|Protocol Violation|0|||
127534896|NCT01307319|458923300|FG000|Overall Study|Withdrawal by Subject|0|||
127534897|NCT01307319|458923301|FG001|Overall Study|Withdrawal by Subject|1|||
127534898|NCT01307319|458923302|FG002|Overall Study|Withdrawal by Subject|2|||
127534899|NCT01307319|458923300|FG000|Overall Study|Other|0|||
127534900|NCT01307319|458923301|FG001|Overall Study|Other|4|||
127534901|NCT01307319|458923302|FG002|Overall Study|Other|3|||
127534902|NCT03347123|458923304|FG000|Overall Study|Death|1|||
127534903|NCT03347123|458923305|FG001|Overall Study|Death|2|||
127534904|NCT03347123|458923306|FG002|Overall Study|Death|0|||
127534905|NCT03347123|458923307|FG003|Overall Study|Death|0|||
127534906|NCT03347123|458923308|FG004|Overall Study|Death|0|||
127534907|NCT03347123|458923309|FG005|Overall Study|Death|0|||
127534908|NCT03347123|458923310|FG006|Overall Study|Death|0|||
127534909|NCT03347123|458923304|FG000|Overall Study|Withdrawal by Subject|1|||
127534910|NCT03347123|458923305|FG001|Overall Study|Withdrawal by Subject|0|||
127534911|NCT03347123|458923306|FG002|Overall Study|Withdrawal by Subject|0|||
127534912|NCT03347123|458923307|FG003|Overall Study|Withdrawal by Subject|0|||
127534913|NCT03347123|458923308|FG004|Overall Study|Withdrawal by Subject|0|||
127534914|NCT03347123|458923309|FG005|Overall Study|Withdrawal by Subject|0|||
127534915|NCT03347123|458923310|FG006|Overall Study|Withdrawal by Subject|0|||
127534916|NCT03347123|458923304|FG000|Overall Study|Reason not Specified|3|||
127534917|NCT03347123|458923305|FG001|Overall Study|Reason not Specified|4|||
127534918|NCT03347123|458923306|FG002|Overall Study|Reason not Specified|0|||
127534919|NCT03347123|458923307|FG003|Overall Study|Reason not Specified|0|||
127534920|NCT03347123|458923308|FG004|Overall Study|Reason not Specified|0|||
127534921|NCT03347123|458923309|FG005|Overall Study|Reason not Specified|0|||
127534922|NCT03347123|458923310|FG006|Overall Study|Reason not Specified|0|||
127534923|NCT00248495|458923311|FG000|Overall Study|Withdrawal by Subject|1|||
127534924|NCT03812380|458923312|FG000|Overall Study|Protocol Violation|3|||
127534925|NCT03812380|458923313|FG001|Overall Study|Protocol Violation|3|||
127534926|NCT03812380|458923312|FG000|Overall Study|Withdrawal by Subject|5|||
127534927|NCT03812380|458923313|FG001|Overall Study|Withdrawal by Subject|4|||
127534928|NCT03812380|458923312|FG000|Overall Study|Early termination of study|14|||
127534929|NCT03812380|458923313|FG001|Overall Study|Early termination of study|14|||
127647262|NCT00569582|459328555|FG000|Overall Study|Death|2|||
127647263|NCT00569582|459328555|FG000|Overall Study|Adverse Event|7|||
127647264|NCT00569582|459328555|FG000|Overall Study|Subject was too ill to travel.|1|||
127870047|NCT00421928|460141625|FG001|Overall Study|Adverse Event|140|||
127534930|NCT01285401|458923314|FG000|Overall Study|Prematurely withdrawn from the study|17|||
127534931|NCT01285401|458923315|FG001|Overall Study|Prematurely withdrawn from the study|29|||
127534932|NCT02648204|458923316|FG000|Overall Study|Withdrawal by Subject|12|||
127534933|NCT02648204|458923317|FG001|Overall Study|Withdrawal by Subject|8|||
127534934|NCT02648204|458923318|FG002|Overall Study|Withdrawal by Subject|2|||
127534935|NCT02648204|458923319|FG003|Overall Study|Withdrawal by Subject|6|||
127647265|NCT00569582|459328555|FG000|Overall Study|Subject was non-compliant.|1|||
127647266|NCT02782169|459328561|FG000|Overall Study|Lost to Follow-up|1|||
127647267|NCT02782169|459328562|FG001|Overall Study|Lost to Follow-up|2|||
127647268|NCT02975973|459328563|FG000|Overall Study|Adverse Event|1|||
127870048|NCT00421928|460141626|FG002|Overall Study|Adverse Event|22|||
127870049|NCT00421928|460141624|FG000|Overall Study|Lost to Follow-up|5|||
127647269|NCT02975973|459328564|FG001|Overall Study|Adverse Event|1|||
127870050|NCT00421928|460141625|FG001|Overall Study|Lost to Follow-up|0|||
127870051|NCT00421928|460141626|FG002|Overall Study|Lost to Follow-up|3|||
127870052|NCT00421928|460141624|FG000|Overall Study|Withdrawal by Subject|50|||
127647270|NCT02975973|459328565|FG002|Overall Study|Adverse Event|1|||
127647271|NCT02975973|459328566|FG003|Overall Study|Adverse Event|0|||
127647272|NCT00771810|459328567|FG000|Overall Study|Adverse Event|3|||
127647273|NCT00771810|459328568|FG001|Overall Study|Adverse Event|0|||
127647274|NCT00771810|459328569|FG002|Overall Study|Adverse Event|2|||
127647275|NCT00771810|459328567|FG000|Overall Study|Lost to Follow-up|0|||
127647276|NCT00771810|459328568|FG001|Overall Study|Lost to Follow-up|0|||
127647277|NCT00771810|459328569|FG002|Overall Study|Lost to Follow-up|1|||
127647278|NCT00771810|459328567|FG000|Overall Study|Physician Decision|1|||
127647279|NCT00771810|459328568|FG001|Overall Study|Physician Decision|2|||
127870053|NCT00421928|460141625|FG001|Overall Study|Withdrawal by Subject|48|||
127870054|NCT00421928|460141626|FG002|Overall Study|Withdrawal by Subject|43|||
127870055|NCT00421928|460141624|FG000|Overall Study|Lack of Efficacy|15|||
127870056|NCT00421928|460141625|FG001|Overall Study|Lack of Efficacy|7|||
127870057|NCT00421928|460141626|FG002|Overall Study|Lack of Efficacy|35|||
127870058|NCT00421928|460141624|FG000|Overall Study|Study drug non-compliant|6|||
127870059|NCT00421928|460141625|FG001|Overall Study|Study drug non-compliant|7|||
127870060|NCT00421928|460141626|FG002|Overall Study|Study drug non-compliant|4|||
127870061|NCT00421928|460141624|FG000|Overall Study|All other|26|||
127870062|NCT00421928|460141625|FG001|Overall Study|All other|21|||
127870063|NCT00421928|460141626|FG002|Overall Study|All other|27|||
127870064|NCT00421928|460141624|FG000|Overall Study|Death|0|||
127647280|NCT00771810|459328569|FG002|Overall Study|Physician Decision|2|||
127647281|NCT00771810|459328567|FG000|Overall Study|Protocol Violation|0|||
127870065|NCT00421928|460141625|FG001|Overall Study|Death|1|||
127870066|NCT00421928|460141626|FG002|Overall Study|Death|0|||
127870067|NCT05056311|460141633|FG000|Overall Study|Lost to Follow-up|14|||
127870068|NCT05056311|460141633|FG000|Overall Study|Withdrawal by Subject|1|||
127870069|NCT05056311|460141633|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
127870070|NCT03799198|460141634|FG000|Overall Study|Lost to Follow-up|4|||
127870071|NCT03799198|460141635|FG001|Overall Study|Lost to Follow-up|8|||
127870072|NCT03799198|460141634|FG000|Overall Study|Death|0|||
127870073|NCT03799198|460141635|FG001|Overall Study|Death|1|||
127870074|NCT00548340|460141638|FG000|Overall Study|Protocol Violation|2|||
127870075|NCT00548340|460141639|FG001|Overall Study|Protocol Violation|3|||
127870076|NCT00548340|460141640|FG002|Overall Study|Protocol Violation|3|||
127870077|NCT00548340|460141638|FG000|Overall Study|Adverse Event|2|||
127870078|NCT00548340|460141639|FG001|Overall Study|Adverse Event|2|||
127870079|NCT00548340|460141640|FG002|Overall Study|Adverse Event|2|||
127870080|NCT00548340|460141638|FG000|Overall Study|Lost to Follow-up|1|||
127870081|NCT00548340|460141639|FG001|Overall Study|Lost to Follow-up|1|||
127870082|NCT00548340|460141640|FG002|Overall Study|Lost to Follow-up|0|||
127647282|NCT00771810|459328568|FG001|Overall Study|Protocol Violation|1|||
127647283|NCT00771810|459328569|FG002|Overall Study|Protocol Violation|1|||
127647284|NCT00771810|459328567|FG000|Overall Study|Withdrawal by Subject|1|||
127870083|NCT00548340|460141638|FG000|Overall Study|Withdrawal by Subject|2|||
127870084|NCT00548340|460141639|FG001|Overall Study|Withdrawal by Subject|4|||
127870085|NCT00548340|460141640|FG002|Overall Study|Withdrawal by Subject|3|||
127870086|NCT00548340|460141638|FG000|Overall Study|Other|1|||
127870087|NCT00548340|460141639|FG001|Overall Study|Other|1|||
127870088|NCT00548340|460141640|FG002|Overall Study|Other|1|||
127870089|NCT01096017|460141641|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
127870090|NCT01096017|460141642|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
127870091|NCT00351611|460141645|FG000|Overall Study|Adverse Event|11|||
127870092|NCT00351611|460141646|FG001|Overall Study|Adverse Event|3|||
127870093|NCT00351611|460141645|FG000|Overall Study|Death|1|||
127870094|NCT00351611|460141646|FG001|Overall Study|Death|0|||
127647285|NCT00771810|459328568|FG001|Overall Study|Withdrawal by Subject|2|||
127647286|NCT00771810|459328569|FG002|Overall Study|Withdrawal by Subject|0|||
127647287|NCT00771810|459328567|FG000|Overall Study|Other|0|||
127647288|NCT00771810|459328568|FG001|Overall Study|Other|0|||
127647289|NCT00771810|459328569|FG002|Overall Study|Other|1|||
127870095|NCT00351611|460141645|FG000|Overall Study|Lost to Follow-up|1|||
127870096|NCT00351611|460141646|FG001|Overall Study|Lost to Follow-up|0|||
127870097|NCT00351611|460141645|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
127870098|NCT00351611|460141646|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
127870099|NCT00351611|460141645|FG000|Overall Study|Other|1|||
127647290|NCT02660827|459328570|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
127647291|NCT02660827|459328570|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
127870100|NCT00351611|460141646|FG001|Overall Study|Other|0|||
127870101|NCT00351611|460141645|FG000|Overall Study|Protocol Violation|0|||
127870102|NCT00351611|460141646|FG001|Overall Study|Protocol Violation|2|||
127647292|NCT02660827|459328570|FG000|From Study to End of Continued Access|Adverse Event|3|||
127870103|NCT00267202|460141647|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
127870104|NCT00267202|460141648|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
127870105|NCT00267202|460141647|FG000|Overall Study|Withdrawal by Subject|12|||
127870106|NCT00267202|460141648|FG001|Overall Study|Withdrawal by Subject|15|||
127870107|NCT00267202|460141647|FG000|Overall Study|Adverse Event|13|||
127870108|NCT00267202|460141648|FG001|Overall Study|Adverse Event|7|||
127870109|NCT00267202|460141647|FG000|Overall Study|Protocol Violation|2|||
127870110|NCT00267202|460141648|FG001|Overall Study|Protocol Violation|3|||
127870111|NCT00267202|460141647|FG000|Overall Study|Administrative problems|2|||
127870112|NCT00267202|460141648|FG001|Overall Study|Administrative problems|1|||
127870113|NCT00267202|460141647|FG000|Overall Study|Lost to Follow-up|3|||
127870114|NCT00267202|460141648|FG001|Overall Study|Lost to Follow-up|0|||
127870115|NCT03457701|460141651|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
127870116|NCT03457701|460141652|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
127870117|NCT03457701|460141651|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
127870118|NCT03457701|460141652|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
127870119|NCT02243306|460141653|FG000|Overall Study|Adverse Event|0|||
127870120|NCT02243306|460141654|FG001|Overall Study|Adverse Event|1|||
127870121|NCT02243306|460141653|FG000|Overall Study|Other: Reached stopping criteria|0|||
127870122|NCT02243306|460141654|FG001|Overall Study|Other: Reached stopping criteria|1|||
127870123|NCT02243306|460141653|FG000|Overall Study|Physician Decision|0|||
127870124|NCT02243306|460141654|FG001|Overall Study|Physician Decision|1|||
127870125|NCT00496782|460141658|FG000|Overall Study|Protocol Violation|1|||
127870126|NCT00496782|460141659|FG001|Overall Study|Protocol Violation|2|||
127870127|NCT01288911|460141660|FG000|Double-blind Period|Death|11|||
127870128|NCT01288911|460141661|FG001|Double-blind Period|Death|7|||
127870129|NCT01288911|460141660|FG000|Double-blind Period|Lost to Follow-up|0|||
127870130|NCT01288911|460141661|FG001|Double-blind Period|Lost to Follow-up|2|||
127870131|NCT01288911|460141660|FG000|Double-blind Period|Progressive Disease|75|||
127870132|NCT01288911|460141661|FG001|Double-blind Period|Progressive Disease|103|||
127870133|NCT01288911|460141660|FG000|Double-blind Period|Protocol Violation|1|||
127870134|NCT01288911|460141661|FG001|Double-blind Period|Protocol Violation|0|||
127870135|NCT01288911|460141660|FG000|Double-blind Period|Withdrawal by Subject|25|||
127870136|NCT01288911|460141661|FG001|Double-blind Period|Withdrawal by Subject|26|||
127870137|NCT01288911|460141660|FG000|Double-blind Period|Miscellaneous Reason|29|||
127870138|NCT01288911|460141661|FG001|Double-blind Period|Miscellaneous Reason|42|||
127870139|NCT01288911|460141660|FG000|Double-blind Period|Randomized but never received study drug|1|||
127870140|NCT01288911|460141661|FG001|Double-blind Period|Randomized but never received study drug|2|||
127870141|NCT01288911|460141660|FG000|Open-label Period (All Enzalutamide)|Death|0|||
127870142|NCT01288911|460141661|FG001|Open-label Period (All Enzalutamide)|Death|1|||
127870143|NCT01288911|460141660|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
127870144|NCT01288911|460141661|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
127870145|NCT01288911|460141660|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
127870146|NCT01288911|460141661|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
127870147|NCT01288911|460141660|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
127870148|NCT01288911|460141661|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
127870149|NCT01288911|460141660|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
127870150|NCT01288911|460141661|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
127870151|NCT01288911|460141660|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
127870152|NCT01288911|460141661|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
127870153|NCT02431559|460141662|FG000|Overall Study|Adverse Event|0|||
127870154|NCT02431559|460141663|FG001|Overall Study|Adverse Event|1|||
127870155|NCT02431559|460141664|FG002|Overall Study|Adverse Event|0|||
127981284|NCT04240886|460554285|FG000|Treatment Phase|Discontinuation by Subject|1|||
127981285|NCT04240886|460554285|FG000|Treatment Phase|Adverse Event|5|||
127647293|NCT02660827|459328570|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
127647294|NCT02660827|459328570|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
127647295|NCT02660827|459328570|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
127647296|NCT02660827|459328570|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
127647297|NCT02660827|459328570|FG000|Period 2: Continued Access Period|Adverse Event|3|||
127647298|NCT02953938|459328571|FG000|Overall Study|Adverse Event|0|||
127647299|NCT02953938|459328572|FG001|Overall Study|Adverse Event|1|||
127647300|NCT02953938|459328571|FG000|Overall Study|Withdrawal by Subject|1|||
127647301|NCT02953938|459328572|FG001|Overall Study|Withdrawal by Subject|1|||
127647302|NCT00045305|459328579|FG000|Overall Study|Lack of Efficacy|6|||
127758399|NCT04396366|459741939|FG001|Overall Study|Adverse Event|0|||
127870156|NCT02431559|460141665|FG003|Overall Study|Adverse Event|4|||
127870157|NCT02431559|460141662|FG000|Overall Study|Progressive disease|2|||
127870158|NCT02431559|460141663|FG001|Overall Study|Progressive disease|1|||
127870159|NCT02431559|460141664|FG002|Overall Study|Progressive disease|4|||
127870160|NCT02431559|460141665|FG003|Overall Study|Progressive disease|22|||
127870161|NCT02431559|460141662|FG000|Overall Study|Withdrawal by Subject|0|||
127870162|NCT02431559|460141663|FG001|Overall Study|Withdrawal by Subject|1|||
127870163|NCT02431559|460141664|FG002|Overall Study|Withdrawal by Subject|0|||
127870164|NCT02431559|460141665|FG003|Overall Study|Withdrawal by Subject|4|||
127870165|NCT02431559|460141662|FG000|Overall Study|Physician Decision|0|||
127870166|NCT02431559|460141663|FG001|Overall Study|Physician Decision|0|||
127870167|NCT02431559|460141664|FG002|Overall Study|Physician Decision|0|||
127870168|NCT02431559|460141665|FG003|Overall Study|Physician Decision|1|||
127647303|NCT00045305|459328579|FG000|Overall Study|Adverse Event|3|||
127647304|NCT00045305|459328579|FG000|Overall Study|Death|3|||
127647305|NCT00045305|459328579|FG000|Overall Study|site error|2|||
127647306|NCT03848403|459328585|FG000|Period 2 (Day 8)|Adverse Event|1|||
127647307|NCT03848403|459328586|FG001|Period 2 (Day 8)|Adverse Event|2|||
127647308|NCT03848403|459328587|FG002|Period 2 (Day 8)|Adverse Event|2|||
127647309|NCT03848403|459328585|FG000|Period 2 (Day 8)|Physician Decision|0|||
127647310|NCT03848403|459328586|FG001|Period 2 (Day 8)|Physician Decision|1|||
127870169|NCT02543918|460141666|FG000|Overall Study|Never treated|0|||
127870170|NCT02543918|460141667|FG001|Overall Study|Never treated|1|||
127647311|NCT03848403|459328587|FG002|Period 2 (Day 8)|Physician Decision|0|||
127647312|NCT03848403|459328585|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
127647313|NCT03848403|459328586|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
127647314|NCT03848403|459328587|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
127647315|NCT01939548|459328588|FG000|Overall Study|Non compliance|0|||
127870171|NCT02543918|460141666|FG000|Overall Study|Lost to Follow-up|1|||
127870172|NCT02543918|460141667|FG001|Overall Study|Lost to Follow-up|1|||
127870173|NCT02543918|460141666|FG000|Overall Study|Withdrawal by Subject|1|||
127870174|NCT02543918|460141667|FG001|Overall Study|Withdrawal by Subject|1|||
127870175|NCT02543918|460141666|FG000|Overall Study|Adverse Event|1|||
127870176|NCT02543918|460141667|FG001|Overall Study|Adverse Event|1|||
127870177|NCT00606931|460141673|FG000|Overall Study|Withdrawal by Subject|3|||
127870178|NCT02924129|460141687|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
127870179|NCT02924129|460141688|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
127870180|NCT02924129|460141687|FG000|Overall Study|Withdrawal by Subject|2|||
127870181|NCT02924129|460141688|FG001|Overall Study|Withdrawal by Subject|2|||
127870182|NCT02924129|460141687|FG000|Overall Study|Physician Decision|1|||
127870183|NCT02924129|460141688|FG001|Overall Study|Physician Decision|0|||
127870184|NCT02924129|460141687|FG000|Overall Study|Missed Visit|0|||
127870185|NCT02924129|460141688|FG001|Overall Study|Missed Visit|1|||
127870186|NCT01348828|460141693|FG000|Overall Study|Death|20|||
127870187|NCT01348828|460141693|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
127870188|NCT01348828|460141693|FG000|Overall Study|Conversion|2|||
127870189|NCT01348828|460141693|FG000|Overall Study|missed visit|1|||
127870190|NCT00302731|460141696|FG000|Overall Study|Lost to Follow-up|1|||
127870191|NCT00302731|460141697|FG001|Overall Study|Lost to Follow-up|2|||
127870192|NCT00302731|460141698|FG002|Overall Study|Lost to Follow-up|0|||
127870193|NCT00302731|460141699|FG003|Overall Study|Lost to Follow-up|0|||
127870194|NCT00302731|460141696|FG000|Overall Study|Adverse Event|0|||
127870195|NCT00302731|460141697|FG001|Overall Study|Adverse Event|2|||
127870196|NCT00302731|460141698|FG002|Overall Study|Adverse Event|2|||
127870197|NCT00302731|460141699|FG003|Overall Study|Adverse Event|0|||
127870198|NCT00302731|460141696|FG000|Overall Study|Withdrawal by Subject|1|||
127870199|NCT00302731|460141697|FG001|Overall Study|Withdrawal by Subject|1|||
127870200|NCT00302731|460141698|FG002|Overall Study|Withdrawal by Subject|0|||
127870201|NCT00302731|460141699|FG003|Overall Study|Withdrawal by Subject|0|||
127870202|NCT00302731|460141696|FG000|Overall Study|Protocol Violation|1|||
127870203|NCT00302731|460141697|FG001|Overall Study|Protocol Violation|0|||
127534936|NCT02648204|458923316|FG000|Overall Study|Lost to Follow-up|5|||
127534937|NCT02648204|458923317|FG001|Overall Study|Lost to Follow-up|8|||
127647316|NCT01939548|459328589|FG001|Overall Study|Non compliance|2|||
127647317|NCT01939548|459328590|FG002|Overall Study|Non compliance|0|||
127647318|NCT01939548|459328588|FG000|Overall Study|Study Terminated by Sponsor|17|||
127647319|NCT01939548|459328589|FG001|Overall Study|Study Terminated by Sponsor|19|||
127870204|NCT00302731|460141698|FG002|Overall Study|Protocol Violation|0|||
127870205|NCT00302731|460141699|FG003|Overall Study|Protocol Violation|0|||
127870206|NCT00302731|460141696|FG000|Overall Study|cancer unrelated to study discovered|1|||
127647320|NCT01939548|459328590|FG002|Overall Study|Study Terminated by Sponsor|12|||
127647321|NCT01939548|459328588|FG000|Overall Study|Insufficient Clinical Response|1|||
127647322|NCT01939548|459328589|FG001|Overall Study|Insufficient Clinical Response|0|||
127870207|NCT00302731|460141697|FG001|Overall Study|cancer unrelated to study discovered|0|||
127870208|NCT00302731|460141698|FG002|Overall Study|cancer unrelated to study discovered|1|||
127870209|NCT00302731|460141699|FG003|Overall Study|cancer unrelated to study discovered|0|||
127870210|NCT01000311|460141700|FG000|Overall Study|Adverse Event|2|||
127870211|NCT01000311|460141701|FG001|Overall Study|Adverse Event|5|||
127870212|NCT01000311|460141700|FG000|Overall Study|Withdrawal by Subject|16|||
127870213|NCT01000311|460141701|FG001|Overall Study|Withdrawal by Subject|24|||
127870214|NCT01000311|460141700|FG000|Overall Study|Lost to Follow-up|15|||
127870215|NCT01000311|460141701|FG001|Overall Study|Lost to Follow-up|24|||
127870216|NCT01000311|460141700|FG000|Overall Study|Protocol Violation|1|||
127870217|NCT01000311|460141701|FG001|Overall Study|Protocol Violation|2|||
127870218|NCT01000311|460141700|FG000|Overall Study|Inappropriate enrollment|2|||
127870219|NCT01000311|460141701|FG001|Overall Study|Inappropriate enrollment|0|||
127870220|NCT01000311|460141700|FG000|Overall Study|Administrative reason|9|||
127870221|NCT01000311|460141701|FG001|Overall Study|Administrative reason|15|||
127870222|NCT01610752|460141704|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
127870223|NCT01610752|460141705|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
127870224|NCT01610752|460141706|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
127870225|NCT02815670|460141707|FG000|Overall Study|Prematurely discontinued of the trial|1|||
127870226|NCT01411917|460141708|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
127870227|NCT01411917|460141709|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
127870228|NCT02354599|460141715|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
127870229|NCT02354599|460141716|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
127870230|NCT02354599|460141717|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
127870231|NCT02354599|460141718|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
127870232|NCT02354599|460141719|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
127870233|NCT02354599|460141720|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
127870234|NCT02354599|460141715|FG000|Overall Study|Withdrawal by Subject|1|||
127870235|NCT02354599|460141716|FG001|Overall Study|Withdrawal by Subject|1|||
127870236|NCT02354599|460141717|FG002|Overall Study|Withdrawal by Subject|0|||
127870237|NCT02354599|460141718|FG003|Overall Study|Withdrawal by Subject|0|||
127870238|NCT02354599|460141719|FG004|Overall Study|Withdrawal by Subject|0|||
127870239|NCT02354599|460141720|FG005|Overall Study|Withdrawal by Subject|0|||
127870240|NCT01087944|460141740|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
127870241|NCT01087944|460141741|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
127870242|NCT01087944|460141740|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
127870243|NCT01087944|460141741|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
127870244|NCT01159665|460141742|FG000|Overall Study|Withdrawal by Subject|0|||
127870245|NCT01159665|460141743|FG001|Overall Study|Withdrawal by Subject|1|||
127870246|NCT01159665|460141744|FG002|Overall Study|Withdrawal by Subject|0|||
127870247|NCT01159665|460141745|FG003|Overall Study|Withdrawal by Subject|0|||
127870248|NCT01159665|460141746|FG004|Overall Study|Withdrawal by Subject|0|||
127870249|NCT01159665|460141747|FG005|Overall Study|Withdrawal by Subject|0|||
127870250|NCT00540228|460141749|FG000|Overall Study|Adverse Event|2|||
127870251|NCT00540228|460141750|FG001|Overall Study|Adverse Event|0|||
127870252|NCT00540228|460141751|FG002|Overall Study|Adverse Event|0|||
127870253|NCT00540228|460141752|FG003|Overall Study|Adverse Event|0|||
127870254|NCT00540228|460141753|FG004|Overall Study|Adverse Event|0|||
127870255|NCT00540228|460141749|FG000|Overall Study|Lost to Follow-up|1|||
127870256|NCT00540228|460141750|FG001|Overall Study|Lost to Follow-up|1|||
127870257|NCT00540228|460141751|FG002|Overall Study|Lost to Follow-up|0|||
127870258|NCT00540228|460141752|FG003|Overall Study|Lost to Follow-up|0|||
127870259|NCT00540228|460141753|FG004|Overall Study|Lost to Follow-up|0|||
127870260|NCT01377194|460141754|FG000|Overall Study|Adverse Event|3|||
127870261|NCT01377194|460141755|FG001|Overall Study|Adverse Event|12|||
127870262|NCT01377194|460141756|FG002|Overall Study|Adverse Event|19|||
127870263|NCT01377194|460141754|FG000|Overall Study|Lack of Efficacy|3|||
127870264|NCT01377194|460141755|FG001|Overall Study|Lack of Efficacy|3|||
127870265|NCT01377194|460141756|FG002|Overall Study|Lack of Efficacy|3|||
127870266|NCT01377194|460141754|FG000|Overall Study|Protocol Violation|4|||
127870267|NCT01377194|460141755|FG001|Overall Study|Protocol Violation|10|||
127870268|NCT01377194|460141756|FG002|Overall Study|Protocol Violation|6|||
127870269|NCT01377194|460141754|FG000|Overall Study|Withdrawal by Subject|8|||
127870270|NCT01377194|460141755|FG001|Overall Study|Withdrawal by Subject|10|||
127870271|NCT01377194|460141756|FG002|Overall Study|Withdrawal by Subject|7|||
127870272|NCT01377194|460141754|FG000|Overall Study|Lost to Follow-up|14|||
127870273|NCT01377194|460141755|FG001|Overall Study|Lost to Follow-up|8|||
127870274|NCT01377194|460141756|FG002|Overall Study|Lost to Follow-up|11|||
127870275|NCT02451137|460141759|FG000|Overall Study|Randomized but not treated|19|||
127870276|NCT02451137|460141760|FG001|Overall Study|Randomized but not treated|27|||
127870277|NCT02451137|460141759|FG000|Overall Study|Adverse Event|43|||
127870278|NCT02451137|460141760|FG001|Overall Study|Adverse Event|42|||
127870279|NCT02451137|460141759|FG000|Overall Study|Lack of Efficacy|4|||
127870280|NCT02451137|460141760|FG001|Overall Study|Lack of Efficacy|9|||
127870281|NCT02451137|460141759|FG000|Overall Study|Participant decision:discontinue insulin|41|||
127870282|NCT02451137|460141760|FG001|Overall Study|Participant decision:discontinue insulin|43|||
127870283|NCT02451137|460141759|FG000|Overall Study|Hypoglycemia|2|||
127870284|NCT02451137|460141760|FG001|Overall Study|Hypoglycemia|1|||
127870285|NCT02451137|460141759|FG000|Overall Study|Investigator's decision|23|||
127870286|NCT02451137|460141760|FG001|Overall Study|Investigator's decision|19|||
127870287|NCT02451137|460141759|FG000|Overall Study|Lost to Follow-up|53|||
127870288|NCT02451137|460141760|FG001|Overall Study|Lost to Follow-up|61|||
127870289|NCT02451137|460141759|FG000|Overall Study|Physician Decision|6|||
127870290|NCT02451137|460141760|FG001|Overall Study|Physician Decision|5|||
127870291|NCT02451137|460141759|FG000|Overall Study|Sponsor decision|13|||
127870292|NCT02451137|460141760|FG001|Overall Study|Sponsor decision|25|||
127870293|NCT02451137|460141759|FG000|Overall Study|Withdrawal by Subject|40|||
127870294|NCT02451137|460141760|FG001|Overall Study|Withdrawal by Subject|63|||
127870295|NCT02451137|460141759|FG000|Overall Study|Other than specified above|2|||
127870296|NCT02451137|460141760|FG001|Overall Study|Other than specified above|3|||
127870297|NCT01977573|460141763|FG000|Overall Study|Adverse Event|7|||
127870298|NCT01977573|460141764|FG001|Overall Study|Adverse Event|0|||
127870299|NCT01977573|460141765|FG002|Overall Study|Adverse Event|2|||
127870300|NCT01977573|460141766|FG003|Overall Study|Adverse Event|1|||
127870301|NCT01977573|460141763|FG000|Overall Study|Lost to Follow-up|1|||
127870302|NCT01977573|460141764|FG001|Overall Study|Lost to Follow-up|0|||
127870303|NCT01977573|460141765|FG002|Overall Study|Lost to Follow-up|0|||
127870304|NCT01977573|460141766|FG003|Overall Study|Lost to Follow-up|1|||
127870305|NCT01977573|460141763|FG000|Overall Study|Physician Decision|1|||
127870306|NCT01977573|460141764|FG001|Overall Study|Physician Decision|0|||
127870307|NCT01977573|460141765|FG002|Overall Study|Physician Decision|0|||
127870308|NCT01977573|460141766|FG003|Overall Study|Physician Decision|0|||
127870309|NCT01977573|460141763|FG000|Overall Study|Protocol Violation|3|||
127870310|NCT01977573|460141764|FG001|Overall Study|Protocol Violation|1|||
127870311|NCT01977573|460141765|FG002|Overall Study|Protocol Violation|0|||
127870312|NCT01977573|460141766|FG003|Overall Study|Protocol Violation|0|||
127870313|NCT01977573|460141763|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
127870314|NCT01977573|460141764|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
127870315|NCT01977573|460141765|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
127870316|NCT01977573|460141766|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
127870317|NCT01977573|460141763|FG000|Overall Study|Withdrawal by Subject|6|||
127870318|NCT01977573|460141764|FG001|Overall Study|Withdrawal by Subject|1|||
127870319|NCT01977573|460141765|FG002|Overall Study|Withdrawal by Subject|1|||
127870320|NCT01977573|460141766|FG003|Overall Study|Withdrawal by Subject|1|||
127870321|NCT02993731|460141767|FG000|Overall Study|Study Termination|101|||
127870322|NCT02993731|460141768|FG001|Overall Study|Study Termination|105|||
127870323|NCT02545504|460141773|FG000|Overall Study|Death|174|||
127870324|NCT02545504|460141774|FG001|Overall Study|Death|168|||
127870325|NCT02545504|460141773|FG000|Overall Study|Unknown reason|30|||
127870326|NCT02545504|460141774|FG001|Overall Study|Unknown reason|32|||
127870327|NCT02545504|460141773|FG000|Overall Study|Withdrew consent|9|||
127870328|NCT02545504|460141774|FG001|Overall Study|Withdrew consent|11|||
127870329|NCT02545504|460141773|FG000|Overall Study|Investigator's discretion|3|||
127870330|NCT02545504|460141774|FG001|Overall Study|Investigator's discretion|1|||
127870331|NCT02545504|460141773|FG000|Overall Study|Lost to Follow-up|2|||
127870332|NCT02545504|460141774|FG001|Overall Study|Lost to Follow-up|2|||
127870333|NCT00508820|460141775|FG000|Overall Study|Adverse Event|6|||
127870334|NCT00508820|460141776|FG001|Overall Study|Adverse Event|10|||
127870335|NCT00508820|460141775|FG000|Overall Study|Death|6|||
127870336|NCT00508820|460141776|FG001|Overall Study|Death|8|||
127870337|NCT00508820|460141775|FG000|Overall Study|Lost to Follow-up|1|||
127870338|NCT00508820|460141776|FG001|Overall Study|Lost to Follow-up|1|||
127870339|NCT00508820|460141775|FG000|Overall Study|Physician Decision|8|||
127870340|NCT00508820|460141776|FG001|Overall Study|Physician Decision|2|||
127870341|NCT00508820|460141775|FG000|Overall Study|Pregnancy|0|||
127870342|NCT00508820|460141776|FG001|Overall Study|Pregnancy|2|||
127870343|NCT00508820|460141775|FG000|Overall Study|Protocol Violation|2|||
127870344|NCT00508820|460141776|FG001|Overall Study|Protocol Violation|0|||
127870345|NCT00508820|460141775|FG000|Overall Study|Withdrawal by Subject|10|||
127870346|NCT00508820|460141776|FG001|Overall Study|Withdrawal by Subject|12|||
127870347|NCT00508820|460141775|FG000|Overall Study|Other|11|||
127870348|NCT00508820|460141776|FG001|Overall Study|Other|2|||
127870349|NCT00508820|460141775|FG000|Overall Study|Noncompliance|1|||
127870350|NCT00508820|460141776|FG001|Overall Study|Noncompliance|0|||
127870351|NCT00508820|460141775|FG000|Overall Study|Requirement for alternative therapy|7|||
127870352|NCT00508820|460141776|FG001|Overall Study|Requirement for alternative therapy|15|||
127870353|NCT00508820|460141775|FG000|Overall Study|Protocol-specified Criteria|3|||
127870354|NCT00508820|460141776|FG001|Overall Study|Protocol-specified Criteria|12|||
127870355|NCT01266967|460143525|FG000|Overall Study|Death|69|||
127870356|NCT01266967|460143526|FG001|Overall Study|Death|61|||
127870357|NCT01266967|460143525|FG000|Overall Study|Study Closed/Terminated|15|||
127870358|NCT01266967|460143526|FG001|Overall Study|Study Closed/Terminated|17|||
127870359|NCT01266967|460143525|FG000|Overall Study|Lost to Follow-up|2|||
127870360|NCT01266967|460143526|FG001|Overall Study|Lost to Follow-up|1|||
127870361|NCT01266967|460143525|FG000|Overall Study|Physician Decision|0|||
127870362|NCT01266967|460143526|FG001|Overall Study|Physician Decision|1|||
127870363|NCT01266967|460143525|FG000|Overall Study|Withdrawal by Subject|3|||
127870364|NCT01266967|460143526|FG001|Overall Study|Withdrawal by Subject|3|||
127870365|NCT04398030|460143527|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
127870366|NCT04398030|460143528|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
127870367|NCT04398030|460143527|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
127870368|NCT04398030|460143528|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
127870369|NCT02713490|460143533|FG000|Overall Study|Withdrawal by Subject|2|||
127870370|NCT02713490|460143534|FG001|Overall Study|Withdrawal by Subject|1|||
127870371|NCT02713490|460143533|FG000|Overall Study|Did not receive study drug|1|||
127870372|NCT02713490|460143534|FG001|Overall Study|Did not receive study drug|0|||
127870373|NCT02713490|460143533|FG000|Overall Study|Met exclusion criteria|0|||
127870374|NCT02713490|460143534|FG001|Overall Study|Met exclusion criteria|1|||
127870375|NCT00346775|460143535|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
127870376|NCT00346775|460143536|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
127870377|NCT00346775|460143535|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
127870378|NCT00346775|460143536|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
127870379|NCT00346775|460143535|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
127870380|NCT00346775|460143536|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
127870381|NCT02946515|460143537|FG000|Overall Study|Lost to Follow-up|2|||
127870382|NCT02946515|460143538|FG001|Overall Study|Lost to Follow-up|1|||
127870383|NCT00960869|460143542|FG000|Overall Study|Adverse Event|17|||
127870384|NCT00960869|460143543|FG001|Overall Study|Adverse Event|26|||
127870385|NCT00960869|460143542|FG000|Overall Study|Withdrawal by Subject|16|||
127870386|NCT00960869|460143543|FG001|Overall Study|Withdrawal by Subject|14|||
127870387|NCT00960869|460143542|FG000|Overall Study|Lost to Follow-up|1|||
127870388|NCT00960869|460143543|FG001|Overall Study|Lost to Follow-up|4|||
127870389|NCT00960869|460143542|FG000|Overall Study|Misc|19|||
127870390|NCT00960869|460143543|FG001|Overall Study|Misc|18|||
127870391|NCT01714726|460143544|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
127870392|NCT01714726|460143545|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
127870393|NCT01714726|460143546|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
127870394|NCT01714726|460143547|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
127647323|NCT01939548|459328590|FG002|Overall Study|Insufficient Clinical Response|0|||
127647324|NCT01939548|459328588|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
127647325|NCT01939548|459328589|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
127647326|NCT01939548|459328590|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
127647327|NCT01939548|459328588|FG000|Overall Study|Withdrawal by Subject|4|||
127647328|NCT01939548|459328589|FG001|Overall Study|Withdrawal by Subject|4|||
127647329|NCT01939548|459328590|FG002|Overall Study|Withdrawal by Subject|1|||
127647330|NCT01939548|459328588|FG000|Overall Study|Protocol Violation|7|||
127647331|NCT01939548|459328589|FG001|Overall Study|Protocol Violation|6|||
127647332|NCT01939548|459328590|FG002|Overall Study|Protocol Violation|5|||
127647333|NCT01939548|459328588|FG000|Overall Study|Lost to Follow-up|5|||
127647334|NCT01939548|459328589|FG001|Overall Study|Lost to Follow-up|5|||
127647335|NCT01939548|459328590|FG002|Overall Study|Lost to Follow-up|3|||
127647336|NCT01939548|459328588|FG000|Overall Study|Adverse Event|2|||
127647337|NCT01939548|459328589|FG001|Overall Study|Adverse Event|9|||
127647338|NCT01939548|459328590|FG002|Overall Study|Adverse Event|7|||
127647339|NCT01939548|459328588|FG000|Overall Study|Death|0|||
127647340|NCT01939548|459328589|FG001|Overall Study|Death|0|||
127647341|NCT01939548|459328590|FG002|Overall Study|Death|1|||
127647342|NCT01939548|459328588|FG000|Overall Study|Participant dropped|0|||
127647343|NCT01939548|459328589|FG001|Overall Study|Participant dropped|0|||
127647344|NCT01939548|459328590|FG002|Overall Study|Participant dropped|1|||
127647345|NCT01939548|459328588|FG000|Overall Study|Participant unwilling to continue|0|||
127647346|NCT01939548|459328589|FG001|Overall Study|Participant unwilling to continue|1|||
127647347|NCT01939548|459328590|FG002|Overall Study|Participant unwilling to continue|0|||
127647348|NCT01939548|459328588|FG000|Overall Study|Participant withdrew consent|0|||
127647349|NCT01939548|459328589|FG001|Overall Study|Participant withdrew consent|2|||
127647350|NCT01939548|459328590|FG002|Overall Study|Participant withdrew consent|0|||
127647351|NCT01939548|459328588|FG000|Overall Study|Did not complete follow-up|0|||
127647352|NCT01939548|459328589|FG001|Overall Study|Did not complete follow-up|1|||
127647353|NCT01939548|459328590|FG002|Overall Study|Did not complete follow-up|0|||
127647354|NCT02114151|459328598|FG000|Overall Study|Death|1|||
127647355|NCT02114151|459328598|FG000|Overall Study|Lost to Follow-up|1|||
127647356|NCT02114151|459328598|FG000|Overall Study|Withdrawal by Subject|5|||
127647357|NCT01494584|459328599|FG000|Overall Study|Study Closed/Terminated|1|||
127647358|NCT01666808|459328600|FG000|Overall Study|Lost to Follow-up|9|||
127647359|NCT01666808|459328601|FG001|Overall Study|Lost to Follow-up|15|||
127647360|NCT01666808|459328600|FG000|Overall Study|Withdrawal by Subject|3|||
127647361|NCT01666808|459328601|FG001|Overall Study|Withdrawal by Subject|1|||
127647362|NCT01666808|459328600|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
127647363|NCT01666808|459328601|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
127647364|NCT02638948|459328604|FG000|Overall Study|Withdrawal by Subject|4|||
127981286|NCT04240886|460554285|FG000|Follow-up Phase|Withdrawal by Subject|1|||
127647365|NCT02638948|459328605|FG001|Overall Study|Withdrawal by Subject|5|||
127647366|NCT02638948|459328606|FG002|Overall Study|Withdrawal by Subject|3|||
127647367|NCT02638948|459328607|FG003|Overall Study|Withdrawal by Subject|1|||
127647368|NCT02638948|459328604|FG000|Overall Study|Administrative Reason by Sponsor|0|||
127647369|NCT02638948|459328605|FG001|Overall Study|Administrative Reason by Sponsor|1|||
127758400|NCT00166712|459741941|FG000|Overall Study|Death|0|||
127870395|NCT01714726|460143544|FG000|Double-Blinded Induction Period|Adverse Event|0|||
127870396|NCT01714726|460143545|FG001|Double-Blinded Induction Period|Adverse Event|1|||
127870397|NCT01714726|460143546|FG002|Double-Blinded Induction Period|Adverse Event|0|||
127870398|NCT01714726|460143547|FG003|Double-Blinded Induction Period|Adverse Event|0|||
127870399|NCT01714726|460143544|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
127870400|NCT01714726|460143545|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
127870401|NCT01714726|460143546|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
127870402|NCT01714726|460143547|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
127870403|NCT01714726|460143544|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
127647370|NCT02638948|459328606|FG002|Overall Study|Administrative Reason by Sponsor|0|||
127647371|NCT02638948|459328607|FG003|Overall Study|Administrative Reason by Sponsor|4|||
127647372|NCT02638948|459328604|FG000|Overall Study|Adverse Event|0|||
127647373|NCT02638948|459328605|FG001|Overall Study|Adverse Event|0|||
127870404|NCT01714726|460143545|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
127870405|NCT01714726|460143546|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
127870406|NCT01714726|460143547|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
127870407|NCT01714726|460143544|FG000|Open-Label Period|Other|0|||
127981287|NCT04240886|460554285|FG000|Follow-up Phase|Discontinuation by Subject|1|||
127981288|NCT04240886|460554285|FG000|Follow-up Phase|Death|2|||
127981289|NCT01632904|460554286|FG000|Overall Study|Adverse Event|4|||
127981290|NCT01632904|460554287|FG001|Overall Study|Adverse Event|1|||
127870408|NCT01714726|460143545|FG001|Open-Label Period|Other|0|||
127870409|NCT01714726|460143546|FG002|Open-Label Period|Other|1|||
127870410|NCT01714726|460143547|FG003|Open-Label Period|Other|3|||
127870411|NCT01714726|460143544|FG000|Open-Label Period|Adverse Event|0|||
127870412|NCT01714726|460143545|FG001|Open-Label Period|Adverse Event|0|||
127870413|NCT01714726|460143546|FG002|Open-Label Period|Adverse Event|1|||
127870414|NCT01714726|460143547|FG003|Open-Label Period|Adverse Event|0|||
127870415|NCT01714726|460143544|FG000|Open-Label Period|Withdrawal by Subject|0|||
127870416|NCT01714726|460143545|FG001|Open-Label Period|Withdrawal by Subject|0|||
127870417|NCT01714726|460143546|FG002|Open-Label Period|Withdrawal by Subject|9|||
127647374|NCT02638948|459328606|FG002|Overall Study|Adverse Event|1|||
127647375|NCT02638948|459328607|FG003|Overall Study|Adverse Event|1|||
127647376|NCT02638948|459328604|FG000|Overall Study|Lack of Efficacy|1|||
127647377|NCT02638948|459328605|FG001|Overall Study|Lack of Efficacy|1|||
127647378|NCT02638948|459328606|FG002|Overall Study|Lack of Efficacy|0|||
127647379|NCT02638948|459328607|FG003|Overall Study|Lack of Efficacy|0|||
127870418|NCT01714726|460143547|FG003|Open-Label Period|Withdrawal by Subject|19|||
127870419|NCT01714726|460143544|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
127870420|NCT01714726|460143545|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
127870421|NCT01714726|460143546|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
127870422|NCT01714726|460143547|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
127870423|NCT01714726|460143544|FG000|Open-Label Period|Lost to Follow-up|0|||
127870424|NCT01714726|460143545|FG001|Open-Label Period|Lost to Follow-up|0|||
127870425|NCT01714726|460143546|FG002|Open-Label Period|Lost to Follow-up|3|||
127870426|NCT01714726|460143547|FG003|Open-Label Period|Lost to Follow-up|4|||
127870427|NCT02501642|460143548|FG000|Overall Study|Lost to Follow-up|7|||
127647380|NCT02638948|459328604|FG000|Overall Study|Lost to Follow-up|0|||
127647381|NCT02638948|459328605|FG001|Overall Study|Lost to Follow-up|0|||
127647382|NCT02638948|459328606|FG002|Overall Study|Lost to Follow-up|1|||
127647383|NCT02638948|459328607|FG003|Overall Study|Lost to Follow-up|1|||
127647384|NCT02638948|459328604|FG000|Overall Study|Poor/Non-Compliance|0|||
127647385|NCT02638948|459328605|FG001|Overall Study|Poor/Non-Compliance|2|||
127647386|NCT02638948|459328606|FG002|Overall Study|Poor/Non-Compliance|1|||
127647387|NCT02638948|459328607|FG003|Overall Study|Poor/Non-Compliance|0|||
127647388|NCT02638948|459328604|FG000|Overall Study|Participant no longer met study criteria|0|||
127870428|NCT02501642|460143549|FG001|Overall Study|Lost to Follow-up|11|||
127870429|NCT01846442|460143553|FG000|Overall Study|Adverse Event|2|||
127981291|NCT01632904|460554286|FG000|Overall Study|Physician Decision|0|||
127981292|NCT01632904|460554287|FG001|Overall Study|Physician Decision|1|||
127981293|NCT01632904|460554286|FG000|Overall Study|Subject decision|3|||
127981294|NCT01632904|460554287|FG001|Overall Study|Subject decision|2|||
127647389|NCT02638948|459328605|FG001|Overall Study|Participant no longer met study criteria|1|||
127647390|NCT02638948|459328606|FG002|Overall Study|Participant no longer met study criteria|0|||
127981295|NCT01632904|460554286|FG000|Overall Study|Disease Progression|0|||
127981296|NCT01632904|460554287|FG001|Overall Study|Disease Progression|1|||
127981297|NCT01632904|460554286|FG000|Overall Study|Reason for discontinuation not available|0|||
127647391|NCT02638948|459328607|FG003|Overall Study|Participant no longer met study criteria|0|||
127981298|NCT01632904|460554287|FG001|Overall Study|Reason for discontinuation not available|1|||
127981299|NCT01250171|460554288|FG000|Overall Study|Administrative reasons|1|||
127981300|NCT01250171|460554289|FG001|Overall Study|Administrative reasons|0|||
127981301|NCT01250171|460554290|FG002|Overall Study|Administrative reasons|0|||
127981302|NCT04557124|460554295|FG000|Allocation (Baseline)|Withdrawal by Subject|0|||
127981303|NCT04557124|460554296|FG001|Allocation (Baseline)|Withdrawal by Subject|1|||
127981304|NCT04557124|460554295|FG000|Mid-point (1 Month)|Missed testing|5|||
127870430|NCT01846442|460143554|FG001|Overall Study|Adverse Event|4|||
127870431|NCT01846442|460143555|FG002|Overall Study|Adverse Event|2|||
127870432|NCT01846442|460143556|FG003|Overall Study|Adverse Event|1|||
127870433|NCT01846442|460143553|FG000|Overall Study|Lost to Follow-up|0|||
127870434|NCT01846442|460143554|FG001|Overall Study|Lost to Follow-up|0|||
127870435|NCT01846442|460143555|FG002|Overall Study|Lost to Follow-up|1|||
127870436|NCT01846442|460143556|FG003|Overall Study|Lost to Follow-up|0|||
127870437|NCT01846442|460143553|FG000|Overall Study|Withdrawal by Subject|3|||
127870438|NCT01846442|460143554|FG001|Overall Study|Withdrawal by Subject|2|||
127870439|NCT01846442|460143555|FG002|Overall Study|Withdrawal by Subject|0|||
127870440|NCT01846442|460143556|FG003|Overall Study|Withdrawal by Subject|1|||
127870441|NCT01846442|460143553|FG000|Overall Study|Left the city/Lost medication|1|||
127870442|NCT01846442|460143554|FG001|Overall Study|Left the city/Lost medication|0|||
127870443|NCT01846442|460143555|FG002|Overall Study|Left the city/Lost medication|1|||
127870444|NCT01846442|460143556|FG003|Overall Study|Left the city/Lost medication|1|||
127870445|NCT02600559|460143567|FG000|Overall Study|Withdrawal by Subject|3|||
127870446|NCT02600559|460143567|FG000|Overall Study|Lost to Follow-up|20|||
127870447|NCT01153971|460143570|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
127870448|NCT01153971|460143570|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
127870449|NCT01153971|460143570|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
127870450|NCT01153971|460143570|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
127870451|NCT01153971|460143570|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
127870452|NCT01153971|460143570|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
127870453|NCT01153971|460143570|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
127870454|NCT03410693|460143571|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
127870455|NCT03410693|460143572|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
127870456|NCT03410693|460143571|FG000|Overall Study|Disc trt: Lost to follow up|0|||
127870457|NCT03410693|460143572|FG001|Overall Study|Disc trt: Lost to follow up|1|||
127870458|NCT03410693|460143571|FG000|Overall Study|Disc trt: radiological progression|58|||
127870459|NCT03410693|460143572|FG001|Overall Study|Disc trt: radiological progression|50|||
127870460|NCT03410693|460143571|FG000|Overall Study|Disc trt: Other|1|||
127870461|NCT03410693|460143572|FG001|Overall Study|Disc trt: Other|0|||
127870462|NCT03410693|460143571|FG000|Overall Study|Study drug never administered|1|||
127870463|NCT03410693|460143572|FG001|Overall Study|Study drug never administered|6|||
127870464|NCT03410693|460143571|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
127870465|NCT03410693|460143572|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
127870466|NCT03410693|460143571|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
127870467|NCT03410693|460143572|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
127870468|NCT03410693|460143571|FG000|Overall Study|Disc trt: Physician decision|0|||
127870469|NCT03410693|460143572|FG001|Overall Study|Disc trt: Physician decision|5|||
127870470|NCT03410693|460143571|FG000|Overall Study|Disc trt: clinical progression|1|||
127870471|NCT03410693|460143572|FG001|Overall Study|Disc trt: clinical progression|5|||
127870472|NCT03410693|460143571|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
127870473|NCT03410693|460143572|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
127870474|NCT00953576|460143573|FG000|Overall Study|Adverse Event|0|||
127870475|NCT00953576|460143574|FG001|Overall Study|Adverse Event|1|||
127870476|NCT00953576|460143573|FG000|Overall Study|Ineligible after Consent|2|||
127870477|NCT00953576|460143574|FG001|Overall Study|Ineligible after Consent|0|||
127870478|NCT03628781|460143579|FG000|Overall Study|Lost to Follow-up|16|||
127870479|NCT03628781|460143580|FG001|Overall Study|Lost to Follow-up|8|||
127870480|NCT03628781|460143579|FG000|Overall Study|Withdrawal by Subject|16|||
127870481|NCT03628781|460143580|FG001|Overall Study|Withdrawal by Subject|1|||
127870482|NCT01545375|460143583|FG000|Overall Study|Adverse Event|2|||
127870483|NCT01545375|460143584|FG001|Overall Study|Adverse Event|1|||
127870484|NCT01545375|460143583|FG000|Overall Study|Lost to Follow-up|34|||
127870485|NCT01545375|460143584|FG001|Overall Study|Lost to Follow-up|31|||
127870486|NCT01545375|460143583|FG000|Overall Study|Protocol Violation|3|||
127870487|NCT01545375|460143584|FG001|Overall Study|Protocol Violation|3|||
127870488|NCT01545375|460143583|FG000|Overall Study|Withdrawal by Subject|58|||
127870489|NCT01545375|460143584|FG001|Overall Study|Withdrawal by Subject|55|||
127870490|NCT02687815|460143585|FG000|Overall Study|Lost to Follow-up|2|||
127870491|NCT02687815|460143586|FG001|Overall Study|Lost to Follow-up|4|||
127870492|NCT02687815|460143585|FG000|Overall Study|Withdrawal by Subject|2|||
127870493|NCT02687815|460143586|FG001|Overall Study|Withdrawal by Subject|4|||
127870494|NCT01846039|460143587|FG000|Overall Study|Protocol Violation|1|||
127870495|NCT01846039|460143587|FG000|Overall Study|Subject Withdrew Consent|1|||
127870496|NCT04854421|460143588|FG000|Overall Study|Removed from the final analysis due to poor image quality.|2|||
127870497|NCT04854421|460143589|FG001|Overall Study|Removed from the final analysis due to poor image quality.|2|||
127870498|NCT03472586|460143595|FG000|Overall Study|Physician Decision|6|||
127870499|NCT03472586|460143595|FG000|Overall Study|Death|6|||
127870500|NCT03472586|460143595|FG000|Overall Study|Adverse Event|1|||
127870501|NCT02528331|460143596|FG000|Overall Study|Withdrawal by Subject|2|||
127870502|NCT06045026|460143602|FG000|Overall Study|Lost to Follow-up|60|||
127870503|NCT06045026|460143602|FG000|Overall Study|Adverse Event|12|||
127870504|NCT06045026|460143602|FG000|Overall Study|Withdrawal by Subject|3|||
127870505|NCT06045026|460143602|FG000|Overall Study|Enrollment closed|1|||
127870506|NCT01399619|460143603|FG000|Overall Study|Adverse Event|10|||
127870507|NCT01399619|460143604|FG001|Overall Study|Adverse Event|0|||
127870508|NCT01399619|460143605|FG002|Overall Study|Adverse Event|4|||
127870509|NCT01399619|460143606|FG003|Overall Study|Adverse Event|10|||
127870510|NCT01399619|460143603|FG000|Overall Study|Lack of Efficacy|9|||
127870511|NCT01399619|460143604|FG001|Overall Study|Lack of Efficacy|0|||
127870512|NCT01399619|460143605|FG002|Overall Study|Lack of Efficacy|5|||
127870513|NCT01399619|460143606|FG003|Overall Study|Lack of Efficacy|0|||
127870514|NCT01399619|460143603|FG000|Overall Study|Withdrawal by Subject|6|||
127870515|NCT01399619|460143604|FG001|Overall Study|Withdrawal by Subject|0|||
127870516|NCT01399619|460143605|FG002|Overall Study|Withdrawal by Subject|3|||
127870517|NCT01399619|460143606|FG003|Overall Study|Withdrawal by Subject|4|||
127870518|NCT01399619|460143603|FG000|Overall Study|Protocol Violation|0|||
127870519|NCT01399619|460143604|FG001|Overall Study|Protocol Violation|0|||
127870520|NCT01399619|460143605|FG002|Overall Study|Protocol Violation|0|||
127870521|NCT01399619|460143606|FG003|Overall Study|Protocol Violation|1|||
127870522|NCT01399619|460143603|FG000|Overall Study|Not treated|0|||
127870523|NCT01399619|460143604|FG001|Overall Study|Not treated|0|||
127870524|NCT01399619|460143605|FG002|Overall Study|Not treated|0|||
127870525|NCT01399619|460143606|FG003|Overall Study|Not treated|2|||
127870526|NCT01980056|460143607|FG000|Overall Study|Death|1|||
127870527|NCT01980056|460143608|FG001|Overall Study|Death|1|||
127870528|NCT01980056|460143609|FG002|Overall Study|Death|0|||
127870529|NCT00408408|460143610|FG000|Overall Study|No follow up data|2|||
127981305|NCT04557124|460554296|FG001|Mid-point (1 Month)|Missed testing|4|||
127981306|NCT04557124|460554295|FG000|Mid-point (1 Month)|Lost to Follow-up|1|||
127981307|NCT04557124|460554296|FG001|Mid-point (1 Month)|Lost to Follow-up|2|||
127981308|NCT04557124|460554295|FG000|Post-testing (2 Months)|Missed testing|1|||
127981309|NCT04557124|460554296|FG001|Post-testing (2 Months)|Missed testing|5|||
127981310|NCT04557124|460554295|FG000|Post-testing (2 Months)|Lost to Follow-up|2|||
127981311|NCT04557124|460554296|FG001|Post-testing (2 Months)|Lost to Follow-up|3|||
127981312|NCT04557124|460554295|FG000|Follow-up (4 Months)|Lost to Follow-up|2|||
127981313|NCT04557124|460554296|FG001|Follow-up (4 Months)|Lost to Follow-up|1|||
127981314|NCT04550832|460554297|FG000|Overall Study|Adverse Event|0|||
127981315|NCT04550832|460554298|FG001|Overall Study|Adverse Event|0|||
127981316|NCT04550832|460554299|FG002|Overall Study|Adverse Event|2|||
127981317|NCT04550832|460554300|FG003|Overall Study|Adverse Event|0|||
127981318|NCT04550832|460554301|FG004|Overall Study|Adverse Event|1|||
127981319|NCT04823130|460554302|FG000|Overall Study|Withdrawal by Subject|2|||
127981320|NCT04823130|460554303|FG001|Overall Study|Withdrawal by Subject|3|||
127981321|NCT04823130|460554302|FG000|Overall Study|Failure to meet inclusion criteria|6|||
127981322|NCT04823130|460554303|FG001|Overall Study|Failure to meet inclusion criteria|4|||
127981323|NCT04823130|460554302|FG000|Overall Study|Other-unspecified|1|||
127981324|NCT04823130|460554303|FG001|Overall Study|Other-unspecified|0|||
127981325|NCT03315455|460554304|FG000|Overall Study|Ongoing in the Study|13|||
127981326|NCT03315455|460554305|FG001|Overall Study|Ongoing in the Study|24|||
127981327|NCT03315455|460554306|FG002|Overall Study|Ongoing in the Study|17|||
127981328|NCT03315455|460554307|FG003|Overall Study|Ongoing in the Study|15|||
127981329|NCT03315455|460554304|FG000|Overall Study|Withdrawal by Subject|0|||
127981330|NCT03315455|460554305|FG001|Overall Study|Withdrawal by Subject|1|||
127981331|NCT03315455|460554306|FG002|Overall Study|Withdrawal by Subject|0|||
127981332|NCT03315455|460554307|FG003|Overall Study|Withdrawal by Subject|0|||
127981333|NCT03030118|460554311|FG000|Overall Study|Achieved SLE Diagnosis|11|||
127981334|NCT03030118|460554312|FG001|Overall Study|Achieved SLE Diagnosis|10|||
127981335|NCT03030118|460554311|FG000|Overall Study|Adverse Event|1|||
127981336|NCT03030118|460554312|FG001|Overall Study|Adverse Event|1|||
127981337|NCT03030118|460554311|FG000|Overall Study|Pregnancy|2|||
127981338|NCT03030118|460554312|FG001|Overall Study|Pregnancy|2|||
127981339|NCT03030118|460554311|FG000|Overall Study|Lost to Follow-up|5|||
127981340|NCT03030118|460554312|FG001|Overall Study|Lost to Follow-up|6|||
127981341|NCT03030118|460554311|FG000|Overall Study|Concomitant Medications|1|||
127981342|NCT03030118|460554312|FG001|Overall Study|Concomitant Medications|1|||
127981343|NCT03030118|460554311|FG000|Overall Study|Achieved SLE and Concomitant Meds|1|||
127981344|NCT03030118|460554312|FG001|Overall Study|Achieved SLE and Concomitant Meds|0|||
127981345|NCT03030118|460554311|FG000|Overall Study|Other|2|||
127981346|NCT03030118|460554312|FG001|Overall Study|Other|0|||
127981347|NCT03030118|460554311|FG000|Overall Study|Withdrawal by Subject|26|||
127534938|NCT02648204|458923318|FG002|Overall Study|Lost to Follow-up|4|||
127870530|NCT00408408|460143611|FG001|Overall Study|No follow up data|3|||
127870531|NCT00408408|460143612|FG002|Overall Study|No follow up data|0|||
127870532|NCT00408408|460143613|FG003|Overall Study|No follow up data|7|||
127981348|NCT03030118|460554312|FG001|Overall Study|Withdrawal by Subject|21|||
127981349|NCT03030118|460554311|FG000|Overall Study|Protocol Violation|1|||
127981350|NCT03030118|460554312|FG001|Overall Study|Protocol Violation|6|||
127981351|NCT01911780|460554313|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
127981352|NCT01911780|460554314|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
127981353|NCT01911780|460554313|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
127981354|NCT01911780|460554314|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
127981355|NCT01911780|460554313|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
127981356|NCT01911780|460554314|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
127981357|NCT01911780|460554313|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
127981358|NCT01911780|460554314|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
127981359|NCT01911780|460554313|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
127981360|NCT01911780|460554314|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
127981361|NCT01911780|460554313|FG000|Extension Period (52 Weeks)|Personal reason|1|||
127981362|NCT01911780|460554314|FG001|Extension Period (52 Weeks)|Personal reason|1|||
127981363|NCT03385304|460554319|FG000|Overall Study|Death|19|||
127981364|NCT03385304|460554320|FG001|Overall Study|Death|7|||
127981365|NCT03385304|460554319|FG000|Overall Study|Lost to Follow-up|17|||
127981366|NCT03385304|460554320|FG001|Overall Study|Lost to Follow-up|14|||
127981367|NCT03385304|460554319|FG000|Overall Study|Withdrawal by Subject|3|||
127981368|NCT03385304|460554320|FG001|Overall Study|Withdrawal by Subject|2|||
127981369|NCT03385304|460554319|FG000|Overall Study|Incarceration|2|||
127981370|NCT03385304|460554320|FG001|Overall Study|Incarceration|3|||
127981371|NCT02720744|460554321|FG000|Overall Study|Protocol Violation|0|||
127981372|NCT02720744|460554322|FG001|Overall Study|Protocol Violation|2|||
127981373|NCT02720744|460554321|FG000|Overall Study|Pregnancy|2|||
127981374|NCT02720744|460554322|FG001|Overall Study|Pregnancy|0|||
127981375|NCT02720744|460554321|FG000|Overall Study|Lack of Efficacy|2|||
127981376|NCT02720744|460554322|FG001|Overall Study|Lack of Efficacy|8|||
127981377|NCT02720744|460554321|FG000|Overall Study|Adverse Event|21|||
127981378|NCT02720744|460554322|FG001|Overall Study|Adverse Event|3|||
127981379|NCT02720744|460554321|FG000|Overall Study|Withdrawal by Subject|11|||
127981380|NCT02720744|460554322|FG001|Overall Study|Withdrawal by Subject|11|||
127981381|NCT02720744|460554321|FG000|Overall Study|Lost to follow up|2|||
127981382|NCT02720744|460554322|FG001|Overall Study|Lost to follow up|0|||
127981383|NCT02720744|460554321|FG000|Overall Study|Non Compliance with Investigational Product|0|||
127981384|NCT02720744|460554322|FG001|Overall Study|Non Compliance with Investigational Product|1|||
127981385|NCT02720744|460554321|FG000|Overall Study|Excluded Concomitant Medication|0|||
127981386|NCT02720744|460554322|FG001|Overall Study|Excluded Concomitant Medication|1|||
127981387|NCT00550862|460554328|FG000|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
127981388|NCT00550862|460554329|FG001|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
127981389|NCT00550862|460554330|FG002|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|12|||
127981390|NCT00550862|460554331|FG003|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|1|||
127981391|NCT00550862|460554332|FG004|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|0|||
127981392|NCT00550862|460554328|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|1|||
127981393|NCT00550862|460554329|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
127981394|NCT00550862|460554330|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|2|||
127981395|NCT00550862|460554331|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
127981396|NCT00550862|460554332|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
127981397|NCT00550862|460554328|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
127981398|NCT00550862|460554329|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
127981399|NCT00550862|460554330|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|1|||
127981400|NCT00550862|460554331|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
127981401|NCT00550862|460554332|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
127981402|NCT00550862|460554328|FG000|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
127981403|NCT00550862|460554329|FG001|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
127981404|NCT00550862|460554330|FG002|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|1|||
127981405|NCT00550862|460554331|FG003|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
127981406|NCT00550862|460554332|FG004|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
127981407|NCT00550862|460554328|FG000|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
127981408|NCT00550862|460554329|FG001|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|1|||
127981409|NCT00550862|460554330|FG002|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
127981410|NCT00550862|460554331|FG003|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
127981411|NCT00550862|460554332|FG004|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
127981412|NCT00550862|460554328|FG000|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
127981413|NCT00550862|460554329|FG001|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
127870533|NCT00408408|460143614|FG004|Overall Study|No follow up data|5|||
127870534|NCT00408408|460143615|FG005|Overall Study|No follow up data|3|||
127981414|NCT00550862|460554330|FG002|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
127981415|NCT00550862|460554331|FG003|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
127981416|NCT00550862|460554332|FG004|LTSE Phase (Up to 12 Months)|Adverse Event|14|||
127758401|NCT00166712|459741942|FG001|Overall Study|Death|1|||
127981417|NCT00550862|460554328|FG000|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
127981418|NCT00550862|460554329|FG001|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
127981419|NCT00550862|460554330|FG002|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
127981420|NCT00550862|460554331|FG003|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
127981421|NCT00550862|460554332|FG004|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|2|||
127981422|NCT00550862|460554328|FG000|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
127981423|NCT00550862|460554329|FG001|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
127981424|NCT00550862|460554330|FG002|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
127981425|NCT00550862|460554331|FG003|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
127981426|NCT00550862|460554332|FG004|LTSE Phase (Up to 12 Months)|Protocol Violation|1|||
127981427|NCT00550862|460554328|FG000|LTSE Phase (Up to 12 Months)|Other|0|||
127981428|NCT00550862|460554329|FG001|LTSE Phase (Up to 12 Months)|Other|0|||
127981429|NCT00550862|460554330|FG002|LTSE Phase (Up to 12 Months)|Other|0|||
127981430|NCT00550862|460554331|FG003|LTSE Phase (Up to 12 Months)|Other|0|||
127981431|NCT00550862|460554332|FG004|LTSE Phase (Up to 12 Months)|Other|2|||
127981432|NCT00550862|460554328|FG000|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
127981433|NCT00550862|460554329|FG001|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
127981434|NCT00550862|460554330|FG002|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
127981435|NCT00550862|460554331|FG003|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
127981436|NCT00550862|460554332|FG004|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|59|||
127981437|NCT00980174|460554333|FG000|Overall Study|Withdrawal by Subject|1|||
127981438|NCT00980174|460554334|FG001|Overall Study|Withdrawal by Subject|4|||
127981439|NCT00980174|460554333|FG000|Overall Study|Adverse Event|0|||
127981440|NCT00980174|460554334|FG001|Overall Study|Adverse Event|3|||
127981441|NCT00980174|460554333|FG000|Overall Study|Ineligibility determined|2|||
127981442|NCT00980174|460554334|FG001|Overall Study|Ineligibility determined|1|||
127981443|NCT00980174|460554333|FG000|Overall Study|Death|1|||
127981444|NCT00980174|460554334|FG001|Overall Study|Death|1|||
127981445|NCT00980174|460554333|FG000|Overall Study|Other|0|||
127981446|NCT00980174|460554334|FG001|Overall Study|Other|1|||
127981447|NCT03488225|460554336|FG000|Overall Study|Off Protocol Therapy|2|||
127981448|NCT03488225|460554336|FG000|Overall Study|Stem Cell Transplant|2|||
127981449|NCT04631107|460554338|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
127981450|NCT04631107|460554338|FG000|Second Intervention (1 Night)|Adverse Event|1|||
127981451|NCT04631107|460554338|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
127981452|NCT04631107|460554338|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
127981453|NCT05385224|460554340|FG000|Overall Study|Unable to swallow capsule|2|||
127534939|NCT02648204|458923319|FG003|Overall Study|Lost to Follow-up|6|||
127534940|NCT02648204|458923316|FG000|Overall Study|Missing follow-up information|4|||
127534941|NCT02648204|458923317|FG001|Overall Study|Missing follow-up information|4|||
127534942|NCT02648204|458923318|FG002|Overall Study|Missing follow-up information|4|||
127534943|NCT02648204|458923319|FG003|Overall Study|Missing follow-up information|2|||
127534944|NCT02648204|458923316|FG000|Overall Study|Death|1|||
127534945|NCT02648204|458923317|FG001|Overall Study|Death|1|||
127534946|NCT02648204|458923318|FG002|Overall Study|Death|2|||
127534947|NCT02648204|458923319|FG003|Overall Study|Death|2|||
127534948|NCT02648204|458923316|FG000|Overall Study|Adverse Event|0|||
127534949|NCT02648204|458923317|FG001|Overall Study|Adverse Event|0|||
127534950|NCT02648204|458923318|FG002|Overall Study|Adverse Event|1|||
127534951|NCT02648204|458923319|FG003|Overall Study|Adverse Event|0|||
127534952|NCT02366312|458923331|FG000|Overall Study|Lost to Follow-up|0|||
127534953|NCT02366312|458923332|FG001|Overall Study|Lost to Follow-up|1|||
127534954|NCT03719131|458923333|FG000|Overall Study|Death|1|||
127534955|NCT03719131|458923334|FG001|Overall Study|Death|2|||
127534956|NCT03294590|458923335|FG000|Overall Study|Lost to Follow-up|105|||
127534957|NCT03294590|458923336|FG001|Overall Study|Lost to Follow-up|107|||
127534958|NCT01272232|458923340|FG000|Weeks 0-56|Adverse Event|39|||
127534959|NCT01272232|458923341|FG001|Weeks 0-56|Adverse Event|18|||
127534960|NCT01272232|458923342|FG002|Weeks 0-56|Adverse Event|7|||
127534961|NCT01272232|458923340|FG000|Weeks 0-56|Lack of Efficacy|0|||
127758402|NCT00166712|459741941|FG000|Overall Study|Adverse Event|1|||
127534962|NCT01272232|458923341|FG001|Weeks 0-56|Lack of Efficacy|0|||
127534963|NCT01272232|458923342|FG002|Weeks 0-56|Lack of Efficacy|3|||
127534964|NCT01272232|458923340|FG000|Weeks 0-56|Protocol Violation|12|||
127534965|NCT01272232|458923341|FG001|Weeks 0-56|Protocol Violation|8|||
127534966|NCT01272232|458923342|FG002|Weeks 0-56|Protocol Violation|13|||
127534967|NCT01272232|458923340|FG000|Weeks 0-56|Withdrawal criteria|32|||
127534968|NCT01272232|458923341|FG001|Weeks 0-56|Withdrawal criteria|14|||
127534969|NCT01272232|458923342|FG002|Weeks 0-56|Withdrawal criteria|37|||
127534970|NCT01272232|458923340|FG000|Weeks 0-56|Unclassified|16|||
127534971|NCT01272232|458923341|FG001|Weeks 0-56|Unclassified|7|||
127534972|NCT01272232|458923342|FG002|Weeks 0-56|Unclassified|12|||
127534973|NCT01272232|458923340|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
127534974|NCT01272232|458923341|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
127534975|NCT01272232|458923342|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
127534976|NCT01272232|458923340|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
127534977|NCT01272232|458923341|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
127534978|NCT01272232|458923342|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
127534979|NCT01272232|458923340|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
127534980|NCT01272232|458923341|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
127534981|NCT01272232|458923342|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
127534982|NCT01272232|458923340|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
127534983|NCT01272232|458923341|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
127534984|NCT01272232|458923342|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
127534985|NCT01272232|458923340|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
127534986|NCT01272232|458923341|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
127534987|NCT01272232|458923342|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
127534988|NCT00628030|458923345|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
127534989|NCT00628030|458923346|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
127534990|NCT00628030|458923345|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
127534991|NCT00628030|458923346|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
127534992|NCT00628030|458923345|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
127534993|NCT00628030|458923346|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
127534994|NCT01156480|458923348|FG000|Overall Study|change in diagnosis|0|||
127534995|NCT01156480|458923349|FG001|Overall Study|change in diagnosis|1|||
127534996|NCT03367858|458923350|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
127534997|NCT03367858|458923351|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
127534998|NCT03367858|458923350|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
127534999|NCT03367858|458923351|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
127535000|NCT03367858|458923350|FG000|3 Month Follow Up|Lost to Follow-up|8|||
127535001|NCT03367858|458923351|FG001|3 Month Follow Up|Lost to Follow-up|3|||
127535002|NCT03367858|458923350|FG000|3 Month Follow Up|Moved out of study area|2|||
127535003|NCT03367858|458923351|FG001|3 Month Follow Up|Moved out of study area|6|||
127535004|NCT03367858|458923350|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
127535005|NCT03367858|458923351|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
127535006|NCT03367858|458923350|FG000|3 Month Follow Up|MRI contraindication|2|||
127535007|NCT03367858|458923351|FG001|3 Month Follow Up|MRI contraindication|1|||
127535008|NCT03367858|458923350|FG000|3 Month Follow Up|Incarcerated|0|||
127535009|NCT03367858|458923351|FG001|3 Month Follow Up|Incarcerated|1|||
127535010|NCT03367858|458923350|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
127535011|NCT03367858|458923351|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
127535012|NCT03367858|458923350|FG000|6 Month Follow Up|Lost to Follow-up|5|||
127535013|NCT03367858|458923351|FG001|6 Month Follow Up|Lost to Follow-up|2|||
127535014|NCT03367858|458923350|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
127535015|NCT03367858|458923351|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
127535016|NCT03367858|458923350|FG000|12 Month Follow Up|Lost to Follow-up|3|||
127535017|NCT03367858|458923351|FG001|12 Month Follow Up|Lost to Follow-up|3|||
127535018|NCT03367858|458923350|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
127535019|NCT03367858|458923351|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
127535020|NCT04276233|458923352|FG000|Overall Study|Adverse Event|1|||
127535021|NCT04276233|458923352|FG000|Overall Study|Lost to Follow-up|3|||
127535022|NCT04276233|458923352|FG000|Overall Study|Physician Decision|4|||
127535023|NCT04276233|458923352|FG000|Overall Study|Withdrawal by Subject|2|||
127535024|NCT01946139|458923353|FG000|Overall Study|Withdrawal by Subject|8|||
127535025|NCT01946139|458923353|FG000|Overall Study|ineligible|8|||
127535026|NCT01946139|458923353|FG000|Overall Study|Specimens not available|4|||
127535027|NCT03275740|458923360|FG000|Overall Study|Adverse Event|0|||
127535028|NCT03275740|458923361|FG001|Overall Study|Adverse Event|0|||
127535029|NCT03275740|458923362|FG002|Overall Study|Adverse Event|0|||
127535030|NCT03275740|458923363|FG003|Overall Study|Adverse Event|0|||
127535031|NCT03275740|458923364|FG004|Overall Study|Adverse Event|1|||
127535032|NCT03275740|458923365|FG005|Overall Study|Adverse Event|0|||
127535033|NCT03275740|458923366|FG006|Overall Study|Adverse Event|0|||
127535034|NCT03275740|458923367|FG007|Overall Study|Adverse Event|0|||
127535035|NCT03275740|458923368|FG008|Overall Study|Adverse Event|0|||
127535036|NCT03275740|458923369|FG009|Overall Study|Adverse Event|0|||
127535037|NCT03275740|458923370|FG010|Overall Study|Adverse Event|0|||
127535038|NCT03275740|458923371|FG011|Overall Study|Adverse Event|0|||
127535039|NCT03275740|458923360|FG000|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
127535040|NCT03275740|458923361|FG001|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
127535041|NCT03275740|458923362|FG002|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
127535042|NCT03275740|458923363|FG003|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
127535043|NCT03275740|458923364|FG004|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
127535044|NCT03275740|458923365|FG005|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|1|||
127535045|NCT03275740|458923366|FG006|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
127870535|NCT00399542|460143620|FG000|Overall Study|Adverse Event|18|||
127981454|NCT05385224|460554340|FG000|Overall Study|Withdrawal by Subject|2|||
127981455|NCT05385224|460554340|FG000|Overall Study|Did not meet study criteria|1|||
127981456|NCT00551161|460554341|FG000|Overall Study|Withdrawal by Subject|1|||
127981457|NCT01935128|460554342|FG000|Overall Study|Death|1|||
127981458|NCT01935128|460554342|FG000|Overall Study|Adverse Event|6|||
127981459|NCT00096993|460554343|FG000|Overall Study|Death|1|||
127981460|NCT00096993|460554344|FG001|Overall Study|Death|0|||
127981461|NCT00096993|460554343|FG000|Overall Study|Disease progression|56|||
127981462|NCT00096993|460554344|FG001|Overall Study|Disease progression|53|||
127981463|NCT00096993|460554343|FG000|Overall Study|Adverse Event|2|||
127981464|NCT00096993|460554344|FG001|Overall Study|Adverse Event|8|||
127981465|NCT00096993|460554343|FG000|Overall Study|Subject's decision|3|||
127981466|NCT00096993|460554344|FG001|Overall Study|Subject's decision|1|||
127981467|NCT00096993|460554343|FG000|Overall Study|Physician Decision|2|||
127981468|NCT00096993|460554344|FG001|Overall Study|Physician Decision|1|||
127981469|NCT00096993|460554343|FG000|Overall Study|Non-compliance|0|||
127981470|NCT00096993|460554344|FG001|Overall Study|Non-compliance|1|||
127981471|NCT00096993|460554343|FG000|Overall Study|Other unspecified|1|||
127981472|NCT00096993|460554344|FG001|Overall Study|Other unspecified|1|||
127981473|NCT00772005|460554345|FG000|Overall Study|Adverse Event|9|||
127981474|NCT00772005|460554346|FG001|Overall Study|Adverse Event|14|||
127981475|NCT00772005|460554347|FG002|Overall Study|Adverse Event|10|||
127981476|NCT00772005|460554348|FG003|Overall Study|Adverse Event|13|||
127981477|NCT00772005|460554345|FG000|Overall Study|Lack of Efficacy|0|||
127981478|NCT00772005|460554346|FG001|Overall Study|Lack of Efficacy|1|||
127981479|NCT00772005|460554347|FG002|Overall Study|Lack of Efficacy|0|||
127981480|NCT00772005|460554348|FG003|Overall Study|Lack of Efficacy|0|||
127981481|NCT00772005|460554345|FG000|Overall Study|Withdrawal by Subject|3|||
127981482|NCT00772005|460554346|FG001|Overall Study|Withdrawal by Subject|7|||
127981483|NCT00772005|460554347|FG002|Overall Study|Withdrawal by Subject|10|||
127981484|NCT00772005|460554348|FG003|Overall Study|Withdrawal by Subject|2|||
127981485|NCT00772005|460554345|FG000|Overall Study|Protocol Violation|2|||
127981486|NCT00772005|460554346|FG001|Overall Study|Protocol Violation|4|||
127981487|NCT00772005|460554347|FG002|Overall Study|Protocol Violation|1|||
127981488|NCT00772005|460554348|FG003|Overall Study|Protocol Violation|6|||
127981489|NCT00772005|460554345|FG000|Overall Study|Lost to Follow-up|7|||
127981490|NCT00772005|460554346|FG001|Overall Study|Lost to Follow-up|3|||
127981491|NCT00772005|460554347|FG002|Overall Study|Lost to Follow-up|6|||
127981492|NCT00772005|460554348|FG003|Overall Study|Lost to Follow-up|3|||
127981493|NCT00772005|460554345|FG000|Overall Study|Non-compliance with study procedures|1|||
127981494|NCT00772005|460554346|FG001|Overall Study|Non-compliance with study procedures|1|||
127981495|NCT00772005|460554347|FG002|Overall Study|Non-compliance with study procedures|0|||
127981496|NCT00772005|460554348|FG003|Overall Study|Non-compliance with study procedures|1|||
127981497|NCT00772005|460554345|FG000|Overall Study|Non-compliance with drug administration|3|||
127981498|NCT00772005|460554346|FG001|Overall Study|Non-compliance with drug administration|0|||
127981499|NCT00772005|460554347|FG002|Overall Study|Non-compliance with drug administration|1|||
127981500|NCT00772005|460554348|FG003|Overall Study|Non-compliance with drug administration|1|||
127981501|NCT01440569|460554352|FG000|Main Study|Enrolled but not treated|1|||
127981502|NCT01440569|460554353|FG001|Main Study|Enrolled but not treated|0|||
127981503|NCT01440569|460554352|FG000|Main Study|Adverse Event|9|||
127981504|NCT01440569|460554353|FG001|Main Study|Adverse Event|0|||
127981505|NCT01440569|460554352|FG000|Main Study|Pregnancy|1|||
127981506|NCT01440569|460554353|FG001|Main Study|Pregnancy|0|||
127981507|NCT01440569|460554352|FG000|Main Study|Investigator's Discretion|1|||
127981508|NCT01440569|460554353|FG001|Main Study|Investigator's Discretion|1|||
127981509|NCT01440569|460554352|FG000|Main Study|Withdrew Consent|7|||
127981510|NCT01440569|460554353|FG001|Main Study|Withdrew Consent|1|||
127981511|NCT01440569|460554352|FG000|Main Study|Lost to Follow-up|13|||
127981512|NCT01440569|460554353|FG001|Main Study|Lost to Follow-up|2|||
127981513|NCT01440569|460554352|FG000|Main Study|Subject Non-Compliance|3|||
127981514|NCT01440569|460554353|FG001|Main Study|Subject Non-Compliance|0|||
127981515|NCT01440569|460554352|FG000|Main Study|Protocol Violation|1|||
127981516|NCT01440569|460554353|FG001|Main Study|Protocol Violation|0|||
127981517|NCT01440569|460554352|FG000|Open-Label Rollover Phase|Adverse Event|3|||
127981518|NCT01440569|460554353|FG001|Open-Label Rollover Phase|Adverse Event|0|||
127981519|NCT01440569|460554352|FG000|Open-Label Rollover Phase|Pregnancy|1|||
127981520|NCT01440569|460554353|FG001|Open-Label Rollover Phase|Pregnancy|0|||
127981521|NCT01440569|460554352|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
127981522|NCT01440569|460554353|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
127981523|NCT01440569|460554352|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
127870536|NCT00399542|460143621|FG001|Overall Study|Adverse Event|15|||
127981524|NCT01440569|460554353|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
127981525|NCT01440569|460554352|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
127981526|NCT01440569|460554353|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
127981527|NCT01440569|460554352|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
127981528|NCT01440569|460554353|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
127981529|NCT01440569|460554352|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
127981530|NCT01440569|460554353|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
127981531|NCT05020366|460554354|FG000|Overall Study|Lost to Follow-up|2|||
127981532|NCT05020366|460554355|FG001|Overall Study|Lost to Follow-up|0|||
127981533|NCT05020366|460554354|FG000|Overall Study|Withdrawal by Subject|2|||
127981534|NCT05020366|460554355|FG001|Overall Study|Withdrawal by Subject|0|||
127981535|NCT00435487|460554369|FG000|Overall Study|Death|3|||
127981536|NCT00435487|460554370|FG001|Overall Study|Death|4|||
127981537|NCT00435487|460554369|FG000|Overall Study|Adverse Event|0|||
127981538|NCT00435487|460554370|FG001|Overall Study|Adverse Event|3|||
127981539|NCT00435487|460554369|FG000|Overall Study|Lost to Follow-up|2|||
127981540|NCT00435487|460554370|FG001|Overall Study|Lost to Follow-up|2|||
127981541|NCT00435487|460554369|FG000|Overall Study|Other|5|||
127981542|NCT00435487|460554370|FG001|Overall Study|Other|2|||
127981543|NCT00435487|460554369|FG000|Overall Study|Withdrawal by Subject|2|||
127981544|NCT00435487|460554370|FG001|Overall Study|Withdrawal by Subject|1|||
127981545|NCT00435487|460554369|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
127981546|NCT00435487|460554370|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
127981547|NCT00435487|460554369|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
127981548|NCT00435487|460554370|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
127981549|NCT03301844|460554371|FG000|Overall Study|suspected colon cancer|1|||
127981550|NCT03301844|460554372|FG001|Overall Study|suspected colon cancer|1|||
127981551|NCT05087966|460554373|FG000|Overall Study|Lost to Follow-up|1|||
127981552|NCT05087966|460554373|FG000|Overall Study|Withdrawal by Subject|5|||
127981553|NCT01267201|460554374|FG000|First Intervention Period|Withdrawal by Subject|1|||
127981554|NCT01267201|460554375|FG001|First Intervention Period|Withdrawal by Subject|0|||
127981555|NCT01267201|460554376|FG002|First Intervention Period|Withdrawal by Subject|0|||
127981556|NCT01267201|460554377|FG003|First Intervention Period|Withdrawal by Subject|0|||
127981557|NCT01267201|460554378|FG004|First Intervention Period|Withdrawal by Subject|0|||
127981558|NCT01267201|460554379|FG005|First Intervention Period|Withdrawal by Subject|0|||
127981559|NCT01267201|460554374|FG000|Second Intervention Period|Withdrawal by Subject|0|||
127981560|NCT01267201|460554375|FG001|Second Intervention Period|Withdrawal by Subject|1|||
127981561|NCT01267201|460554376|FG002|Second Intervention Period|Withdrawal by Subject|0|||
127981562|NCT01267201|460554377|FG003|Second Intervention Period|Withdrawal by Subject|0|||
127981563|NCT01267201|460554378|FG004|Second Intervention Period|Withdrawal by Subject|0|||
127981564|NCT01267201|460554379|FG005|Second Intervention Period|Withdrawal by Subject|0|||
127981565|NCT00501059|460554380|FG000|Overall Study|Protocol Violation|80|||
127981566|NCT00501059|460554381|FG001|Overall Study|Protocol Violation|69|||
127981567|NCT00501059|460554380|FG000|Overall Study|Death|140|||
127981568|NCT00501059|460554381|FG001|Overall Study|Death|137|||
127981569|NCT00501059|460554380|FG000|Overall Study|Other|236|||
127981570|NCT00501059|460554381|FG001|Overall Study|Other|239|||
127981571|NCT00501059|460554380|FG000|Overall Study|Missing end-of-study page|91|||
127981572|NCT00501059|460554381|FG001|Overall Study|Missing end-of-study page|92|||
127981573|NCT00501059|460554380|FG000|Overall Study|Clinical endpoint reached|110|||
127981574|NCT00501059|460554381|FG001|Overall Study|Clinical endpoint reached|123|||
127981575|NCT00501059|460554380|FG000|Overall Study|Insufficient therapeutic effect|4|||
127981576|NCT00501059|460554381|FG001|Overall Study|Insufficient therapeutic effect|5|||
127981577|NCT00501059|460554380|FG000|Overall Study|Consent withdrawn by subject|817|||
127981578|NCT00501059|460554381|FG001|Overall Study|Consent withdrawn by subject|873|||
127981579|NCT00501059|460554380|FG000|Overall Study|Non-compliant with study treatment|23|||
127981580|NCT00501059|460554381|FG001|Overall Study|Non-compliant with study treatment|16|||
127981581|NCT00501059|460554380|FG000|Overall Study|Reason not given|3|||
127981582|NCT00501059|460554381|FG001|Overall Study|Reason not given|1|||
127981583|NCT00501059|460554380|FG000|Overall Study|Adverse Event|129|||
127981584|NCT00501059|460554381|FG001|Overall Study|Adverse Event|122|||
127981585|NCT00501059|460554380|FG000|Overall Study|Lost to Follow-up|210|||
127981586|NCT00501059|460554381|FG001|Overall Study|Lost to Follow-up|198|||
127981587|NCT00501059|460554380|FG000|Overall Study|Not treated|25|||
127981588|NCT00501059|460554381|FG001|Overall Study|Not treated|17|||
127981589|NCT00955968|460554386|FG000|Overall Study|Death|2|||
127981590|NCT00955968|460554387|FG001|Overall Study|Death|4|||
127981591|NCT00955968|460554386|FG000|Overall Study|Withdrawal by Subject|35|||
127981592|NCT00955968|460554387|FG001|Overall Study|Withdrawal by Subject|31|||
127981593|NCT00955968|460554386|FG000|Overall Study|Lost to Follow-up|45|||
127647392|NCT02638948|459328604|FG000|Overall Study|Other than specified above|4|||
127981594|NCT00955968|460554387|FG001|Overall Study|Lost to Follow-up|39|||
127981595|NCT00955968|460554386|FG000|Overall Study|Site closed|55|||
127981596|NCT00955968|460554387|FG001|Overall Study|Site closed|52|||
127981597|NCT00430352|460554391|FG000|Overall Study|Disease progression|58|||
127981598|NCT00430352|460554391|FG000|Overall Study|Withdrawal by Subject|11|||
127981599|NCT00430352|460554391|FG000|Overall Study|Adverse Event|16|||
127981600|NCT00430352|460554391|FG000|Overall Study|Death|5|||
127981601|NCT00430352|460554391|FG000|Overall Study|Other|48|||
127981602|NCT04326439|460554394|FG000|Overall Study|Withdrawal by Subject|1|||
127981603|NCT04326439|460554395|FG001|Overall Study|Withdrawal by Subject|0|||
127981604|NCT04326439|460554394|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
127535046|NCT03275740|458923367|FG007|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
127535047|NCT03275740|458923368|FG008|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
127535048|NCT03275740|458923369|FG009|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
127535049|NCT03275740|458923370|FG010|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
127535050|NCT03275740|458923371|FG011|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
127535051|NCT03275740|458923360|FG000|Overall Study|Withdrawal by Subject|0|||
127981605|NCT04326439|460554395|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
127981606|NCT04326439|460554394|FG000|Overall Study|Relapse after Induction 2|0|||
127981607|NCT04326439|460554395|FG001|Overall Study|Relapse after Induction 2|1|||
127535052|NCT03275740|458923361|FG001|Overall Study|Withdrawal by Subject|0|||
127535053|NCT03275740|458923362|FG002|Overall Study|Withdrawal by Subject|0|||
127535054|NCT03275740|458923363|FG003|Overall Study|Withdrawal by Subject|0|||
127535055|NCT03275740|458923364|FG004|Overall Study|Withdrawal by Subject|0|||
127535056|NCT03275740|458923365|FG005|Overall Study|Withdrawal by Subject|0|||
127535057|NCT03275740|458923366|FG006|Overall Study|Withdrawal by Subject|0|||
127535058|NCT03275740|458923367|FG007|Overall Study|Withdrawal by Subject|0|||
127535059|NCT03275740|458923368|FG008|Overall Study|Withdrawal by Subject|1|||
127535060|NCT03275740|458923369|FG009|Overall Study|Withdrawal by Subject|1|||
127535061|NCT03275740|458923370|FG010|Overall Study|Withdrawal by Subject|0|||
127535062|NCT03275740|458923371|FG011|Overall Study|Withdrawal by Subject|0|||
127535063|NCT03827655|458923373|FG000|Overall Study|Death|0|||
127535064|NCT03827655|458923374|FG001|Overall Study|Death|0|||
127535065|NCT03827655|458923375|FG002|Overall Study|Death|0|||
127535066|NCT03827655|458923376|FG003|Overall Study|Death|0|||
127535067|NCT03827655|458923377|FG004|Overall Study|Death|1|||
127535068|NCT03827655|458923373|FG000|Overall Study|Protocol Deviation|1|||
127535069|NCT03827655|458923374|FG001|Overall Study|Protocol Deviation|0|||
127535070|NCT03827655|458923375|FG002|Overall Study|Protocol Deviation|1|||
127535071|NCT03827655|458923376|FG003|Overall Study|Protocol Deviation|1|||
127535072|NCT03827655|458923377|FG004|Overall Study|Protocol Deviation|0|||
127535073|NCT03827655|458923373|FG000|Overall Study|Withdrawal by Subject|3|||
127535074|NCT03827655|458923374|FG001|Overall Study|Withdrawal by Subject|2|||
127535075|NCT03827655|458923375|FG002|Overall Study|Withdrawal by Subject|2|||
127535076|NCT03827655|458923376|FG003|Overall Study|Withdrawal by Subject|0|||
127535077|NCT03827655|458923377|FG004|Overall Study|Withdrawal by Subject|1|||
127535078|NCT03827655|458923373|FG000|Overall Study|Reason not Specified|3|||
127535079|NCT03827655|458923374|FG001|Overall Study|Reason not Specified|1|||
127981608|NCT04326439|460554394|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
127981609|NCT04326439|460554395|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
127981610|NCT00204477|460554396|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
127981611|NCT00204477|460554397|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
127981612|NCT00204477|460554396|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
127981613|NCT00204477|460554397|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
127981614|NCT04272606|460554400|FG000|Overall Study|Protocol Violation|1|||
127981615|NCT04272606|460554401|FG001|Overall Study|Protocol Violation|1|||
127981616|NCT04272606|460554400|FG000|Overall Study|Physician Decision|0|||
127981617|NCT04272606|460554401|FG001|Overall Study|Physician Decision|1|||
127981618|NCT00787917|460554408|FG000|Blinded Treatment|Adverse Event|1|||
127981619|NCT00787917|460554409|FG001|Blinded Treatment|Adverse Event|0|||
127981620|NCT00787917|460554408|FG000|Blinded Treatment|Lack of Efficacy|1|||
127981621|NCT00787917|460554409|FG001|Blinded Treatment|Lack of Efficacy|0|||
127981622|NCT00787917|460554408|FG000|Blinded Treatment|Administrative problems|3|||
127981623|NCT00787917|460554409|FG001|Blinded Treatment|Administrative problems|2|||
127981624|NCT00787917|460554408|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
127981625|NCT00787917|460554409|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
127981626|NCT00787917|460554408|FG000|Open Label|Administrative problems|3|||
127981627|NCT00787917|460554409|FG001|Open Label|Administrative problems|0|||
127981628|NCT00778102|460554410|FG000|Overall Study|Adverse Event|8|||
127981629|NCT00778102|460554411|FG001|Overall Study|Adverse Event|5|||
127981630|NCT00778102|460554410|FG000|Overall Study|Death|1|||
127981631|NCT00778102|460554411|FG001|Overall Study|Death|1|||
127981632|NCT00778102|460554410|FG000|Overall Study|Lost to Follow-up|1|||
127981633|NCT00778102|460554411|FG001|Overall Study|Lost to Follow-up|0|||
127981634|NCT00778102|460554410|FG000|Overall Study|Violation of Selection Criteria|1|||
127981635|NCT00778102|460554411|FG001|Overall Study|Violation of Selection Criteria|1|||
127981636|NCT00778102|460554410|FG000|Overall Study|Protocol Violation|0|||
127981637|NCT00778102|460554411|FG001|Overall Study|Protocol Violation|1|||
127981638|NCT00778102|460554410|FG000|Overall Study|Refused Treatment|2|||
127981639|NCT00778102|460554411|FG001|Overall Study|Refused Treatment|3|||
127535080|NCT03827655|458923375|FG002|Overall Study|Reason not Specified|1|||
127535081|NCT03827655|458923376|FG003|Overall Study|Reason not Specified|1|||
127758403|NCT00166712|459741942|FG001|Overall Study|Adverse Event|0|||
127535082|NCT03827655|458923377|FG004|Overall Study|Reason not Specified|1|||
127535083|NCT02336607|458923378|FG000|Overall Study|Physician Decision|1|||
127535084|NCT02336607|458923379|FG001|Overall Study|Physician Decision|4|||
127981640|NCT00778102|460554410|FG000|Overall Study|Withdrawal by Subject|1|||
127981641|NCT00778102|460554411|FG001|Overall Study|Withdrawal by Subject|1|||
127981642|NCT00778102|460554410|FG000|Overall Study|Administrative Reason|7|||
127981643|NCT00778102|460554411|FG001|Overall Study|Administrative Reason|10|||
127981644|NCT01328548|460554412|FG000|Overall Study|Death|3|||
127981645|NCT01328548|460554413|FG001|Overall Study|Death|0|||
127981646|NCT01328548|460554412|FG000|Overall Study|Protocol Violation|1|||
127981647|NCT01328548|460554413|FG001|Overall Study|Protocol Violation|0|||
127981648|NCT00073983|460554414|FG000|Overall Study|not evaluable|1|||
127981649|NCT03800836|460554415|FG000|Overall Study|Other|2|||
127981650|NCT03800836|460554416|FG001|Overall Study|Other|1|||
127981651|NCT03800836|460554417|FG002|Overall Study|Other|0|||
127981652|NCT03800836|460554418|FG003|Overall Study|Other|2|||
127981653|NCT03800836|460554419|FG004|Overall Study|Other|0|||
127981654|NCT03800836|460554420|FG005|Overall Study|Other|1|||
127981655|NCT03800836|460554415|FG000|Overall Study|Lost to Follow-up|2|||
127981656|NCT03800836|460554416|FG001|Overall Study|Lost to Follow-up|0|||
127981657|NCT03800836|460554417|FG002|Overall Study|Lost to Follow-up|1|||
127981658|NCT03800836|460554418|FG003|Overall Study|Lost to Follow-up|1|||
127981659|NCT03800836|460554419|FG004|Overall Study|Lost to Follow-up|3|||
127981660|NCT03800836|460554420|FG005|Overall Study|Lost to Follow-up|0|||
127981661|NCT03800836|460554415|FG000|Overall Study|Withdrawal by Subject|1|||
127981662|NCT03800836|460554416|FG001|Overall Study|Withdrawal by Subject|0|||
127981663|NCT03800836|460554417|FG002|Overall Study|Withdrawal by Subject|0|||
127981664|NCT03800836|460554418|FG003|Overall Study|Withdrawal by Subject|0|||
127981665|NCT03800836|460554419|FG004|Overall Study|Withdrawal by Subject|0|||
127981666|NCT03800836|460554420|FG005|Overall Study|Withdrawal by Subject|0|||
127870537|NCT00399542|460143620|FG000|Overall Study|Protocol Violation|13|||
127870538|NCT00399542|460143621|FG001|Overall Study|Protocol Violation|3|||
127870539|NCT00399542|460143620|FG000|Overall Study|Withdrawal by Subject|28|||
127870540|NCT00399542|460143621|FG001|Overall Study|Withdrawal by Subject|10|||
127870541|NCT00399542|460143620|FG000|Overall Study|Lack of Efficacy|18|||
127870542|NCT00399542|460143621|FG001|Overall Study|Lack of Efficacy|8|||
127870543|NCT00399542|460143620|FG000|Overall Study|Lost to Follow-up|6|||
127870544|NCT00399542|460143621|FG001|Overall Study|Lost to Follow-up|6|||
127870545|NCT00399542|460143620|FG000|Overall Study|Other|1|||
127870546|NCT00399542|460143621|FG001|Overall Study|Other|0|||
127870547|NCT00399542|460143620|FG000|Overall Study|Physician Decision|0|||
127870548|NCT00399542|460143621|FG001|Overall Study|Physician Decision|1|||
127870549|NCT03172026|460143622|FG000|Overall Study|Withdrawal by Subject|1|||
127870550|NCT03172026|460143623|FG001|Overall Study|Withdrawal by Subject|0|||
127870551|NCT03172026|460143622|FG000|Overall Study|COVID restrictions|1|||
127870552|NCT03172026|460143623|FG001|Overall Study|COVID restrictions|0|||
127870553|NCT00265109|460143624|FG000|Overall Study|Withdrawal by Subject|5|||
127870554|NCT00265109|460143624|FG000|Overall Study|Adverse Event|1|||
127870555|NCT02463097|460143625|FG000|Overall Study|Withdrawal by Subject|1|||
127870556|NCT01757821|460143626|FG000|Overall Study|Adverse Event|1|||
127870557|NCT00334893|460143627|FG000|Overall Study|Not Treated|1|||
127870558|NCT00334893|460143628|FG001|Overall Study|Not Treated|0|||
127870559|NCT01552408|460143632|FG000|Overall Study|Lost to Follow-up|2|||
127870560|NCT01552408|460143633|FG001|Overall Study|Lost to Follow-up|0|||
127870561|NCT01552408|460143632|FG000|Overall Study|Relocation|0|||
127870562|NCT01552408|460143633|FG001|Overall Study|Relocation|1|||
127870563|NCT01552408|460143632|FG000|Overall Study|Withdrawal by Subject|2|||
127870564|NCT01552408|460143633|FG001|Overall Study|Withdrawal by Subject|1|||
127870565|NCT00656669|460145036|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
127870566|NCT00656669|460145036|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
127870567|NCT00656669|460145036|FG000|AC (Cycles 6-9)|Adverse Event|1|||
127870568|NCT00656669|460145036|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
127870569|NCT03778021|460145037|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
127870570|NCT03778021|460145038|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
127870571|NCT00679042|460145039|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
127870572|NCT00679042|460145039|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
127870573|NCT00679042|460145039|FG000|5-Year Follow Up|Death|1|||
127981667|NCT03800836|460554415|FG000|Overall Study|Physician Decision|31|||
127981668|NCT03800836|460554416|FG001|Overall Study|Physician Decision|3|||
127647393|NCT02638948|459328605|FG001|Overall Study|Other than specified above|1|||
127647394|NCT02638948|459328606|FG002|Overall Study|Other than specified above|1|||
127981669|NCT03800836|460554417|FG002|Overall Study|Physician Decision|6|||
127981670|NCT03800836|460554418|FG003|Overall Study|Physician Decision|4|||
127647395|NCT02638948|459328607|FG003|Overall Study|Other than specified above|1|||
127870574|NCT00679042|460145039|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
127870575|NCT00679042|460145039|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
127870576|NCT01224171|460145040|FG000|Overall Study|Adverse Event|8|||
127870577|NCT01224171|460145041|FG001|Overall Study|Adverse Event|4|||
127870578|NCT01224171|460145040|FG000|Overall Study|Protocol Violation|0|||
127870579|NCT01224171|460145041|FG001|Overall Study|Protocol Violation|1|||
127870580|NCT01224171|460145040|FG000|Overall Study|Lack of Efficacy|5|||
127981671|NCT03800836|460554419|FG004|Overall Study|Physician Decision|4|||
127870581|NCT01224171|460145041|FG001|Overall Study|Lack of Efficacy|1|||
127870582|NCT01224171|460145040|FG000|Overall Study|Withdrawal of Consent|2|||
127870583|NCT01224171|460145041|FG001|Overall Study|Withdrawal of Consent|4|||
127870584|NCT01224171|460145040|FG000|Overall Study|Lost to Follow-up|0|||
127870585|NCT01224171|460145041|FG001|Overall Study|Lost to Follow-up|3|||
127870586|NCT03737812|460145042|FG000|Overall Study|Withdrawal by Subject|1|||
127870587|NCT03737812|460145043|FG001|Overall Study|Withdrawal by Subject|2|||
127870588|NCT03737812|460145044|FG002|Overall Study|Withdrawal by Subject|1|||
127870589|NCT03737812|460145042|FG000|Overall Study|Sponsor Discontinued the Study|4|||
127981672|NCT03800836|460554420|FG005|Overall Study|Physician Decision|5|||
127535085|NCT02336607|458923380|FG002|Overall Study|Physician Decision|3|||
127535086|NCT02336607|458923381|FG003|Overall Study|Physician Decision|15|||
127535087|NCT02336607|458923378|FG000|Overall Study|Lack of Efficacy|1|||
127535088|NCT02336607|458923379|FG001|Overall Study|Lack of Efficacy|0|||
127535089|NCT02336607|458923380|FG002|Overall Study|Lack of Efficacy|0|||
127647396|NCT00810264|459328611|FG000|Overall Study|Lost to Follow-up|191|||
127647397|NCT00810264|459328611|FG000|Overall Study|Withdrawal by subject or physician|721|||
127647398|NCT00810264|459328611|FG000|Overall Study|Death|641|||
127647399|NCT06213701|459328612|FG000|Overall Study|Withdrawal by Subject|2|||
127647400|NCT06213701|459328613|FG001|Overall Study|Withdrawal by Subject|1|||
127647401|NCT06213701|459328614|FG002|Overall Study|Withdrawal by Subject|0|||
127647402|NCT02495025|459328619|FG000|Overall Study|Lost to Follow-up|21|||
127647403|NCT02495025|459328620|FG001|Overall Study|Lost to Follow-up|14|||
127647404|NCT02495025|459328619|FG000|Overall Study|Withdrawal by Subject|5|||
127647405|NCT02495025|459328620|FG001|Overall Study|Withdrawal by Subject|0|||
127647406|NCT00313820|459328622|FG000|Assigned to Treatment|Other|1|||
127647407|NCT00313820|459328623|FG001|Assigned to Treatment|Other|0|||
127647408|NCT00313820|459328622|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
127647409|NCT00313820|459328623|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
127647410|NCT00313820|459328622|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
127647411|NCT00313820|459328623|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
127647412|NCT00313820|459328622|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
127647413|NCT00313820|459328623|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
127647414|NCT00313820|459328622|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
127647415|NCT00313820|459328623|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
127647416|NCT00313820|459328622|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
127647417|NCT00313820|459328623|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
127647418|NCT00265889|459328629|FG000|Overall Study|Physician Decision|1|||
127647419|NCT00265889|459328629|FG000|Overall Study|Protocol Violation|1|||
127647420|NCT00265889|459328629|FG000|Overall Study|Insurance denied the request|3|||
127647421|NCT02134587|459328630|FG000|Overall Study|Did not completed all meetings|30|||
127647422|NCT01515748|459328634|FG000|Overall Study|Withdrawal by Subject|32|||
127647423|NCT01515748|459328635|FG001|Overall Study|Withdrawal by Subject|41|||
127647424|NCT01515748|459328634|FG000|Overall Study|Lost to Follow-up|2|||
127647425|NCT01515748|459328635|FG001|Overall Study|Lost to Follow-up|4|||
127647426|NCT01515748|459328634|FG000|Overall Study|Other than specified above|5|||
127647427|NCT01515748|459328635|FG001|Overall Study|Other than specified above|10|||
127647428|NCT03221387|459328638|FG000|Overall Study|Lost to Follow-up|1|||
127647429|NCT03221387|459328638|FG000|Overall Study|Lung transplant|1|||
127647430|NCT04102579|459328642|FG000|Overall Study|Withdrawal by Subject|3|||
127647431|NCT04102579|459328643|FG001|Overall Study|Withdrawal by Subject|4|||
127647432|NCT04102579|459328642|FG000|Overall Study|Lost to Follow-up|0|||
127647433|NCT04102579|459328643|FG001|Overall Study|Lost to Follow-up|1|||
127647434|NCT04102579|459328642|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
127647435|NCT04102579|459328643|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
127647436|NCT04102579|459328642|FG000|Overall Study|Other than Specified|1|||
127647437|NCT04102579|459328643|FG001|Overall Study|Other than Specified|0|||
127647438|NCT04102579|459328642|FG000|Overall Study|Not Dosed with Study Drug|0|||
127647439|NCT04102579|459328643|FG001|Overall Study|Not Dosed with Study Drug|1|||
127647440|NCT01525602|459328644|FG000|Overall Study|Adverse Event|1|||
127647441|NCT01525602|459328645|FG001|Overall Study|Adverse Event|0|||
127647442|NCT01525602|459328646|FG002|Overall Study|Adverse Event|1|||
127647443|NCT01525602|459328647|FG003|Overall Study|Adverse Event|1|||
127647444|NCT01525602|459328648|FG004|Overall Study|Adverse Event|3|||
127870590|NCT03737812|460145043|FG001|Overall Study|Sponsor Discontinued the Study|3|||
127870591|NCT03737812|460145044|FG002|Overall Study|Sponsor Discontinued the Study|2|||
127870592|NCT03737812|460145042|FG000|Overall Study|Adverse Event|0|||
127870593|NCT03737812|460145043|FG001|Overall Study|Adverse Event|1|||
127870594|NCT03737812|460145044|FG002|Overall Study|Adverse Event|0|||
127870595|NCT03737812|460145042|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
127870596|NCT03737812|460145043|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
127870597|NCT03737812|460145044|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
127870598|NCT02624713|460145045|FG000|Overall Study|Lost to Follow-up|14|||
127981673|NCT03800836|460554415|FG000|Overall Study|Death|34|||
127535090|NCT02336607|458923381|FG003|Overall Study|Lack of Efficacy|2|||
127647445|NCT01525602|459328649|FG005|Overall Study|Adverse Event|3|||
127647446|NCT01525602|459328650|FG006|Overall Study|Adverse Event|0|||
127647447|NCT01525602|459328651|FG007|Overall Study|Adverse Event|1|||
127647448|NCT01525602|459328644|FG000|Overall Study|Disease progression|6|||
127647449|NCT01525602|459328645|FG001|Overall Study|Disease progression|3|||
127647450|NCT01525602|459328646|FG002|Overall Study|Disease progression|2|||
127870599|NCT02624713|460145046|FG001|Overall Study|Lost to Follow-up|0|||
127870600|NCT00285857|460145050|FG000|Overall Study|Withdrawal by Subject|2|||
127870601|NCT00285857|460145050|FG000|Overall Study|Inadequate initial breast cytology|1|||
127870602|NCT00285857|460145050|FG000|Overall Study|Adverse Event|1|||
127870603|NCT01161173|460145056|FG000|Overall Study|Protocol Violation|13|||
127870604|NCT01161173|460145056|FG000|Overall Study|Lost to Follow-up|7|||
127870605|NCT01161173|460145056|FG000|Overall Study|Progressive Disease|82|||
127981674|NCT03800836|460554416|FG001|Overall Study|Death|16|||
127981675|NCT03800836|460554417|FG002|Overall Study|Death|5|||
127981676|NCT03800836|460554418|FG003|Overall Study|Death|5|||
127981677|NCT03800836|460554419|FG004|Overall Study|Death|10|||
127535091|NCT02336607|458923378|FG000|Overall Study|Lost to Follow-up|2|||
127535092|NCT02336607|458923379|FG001|Overall Study|Lost to Follow-up|1|||
127535093|NCT02336607|458923380|FG002|Overall Study|Lost to Follow-up|0|||
127535094|NCT02336607|458923381|FG003|Overall Study|Lost to Follow-up|21|||
127535095|NCT02336607|458923378|FG000|Overall Study|Protocol Violation|0|||
127535096|NCT02336607|458923379|FG001|Overall Study|Protocol Violation|1|||
127535097|NCT02336607|458923380|FG002|Overall Study|Protocol Violation|1|||
127535098|NCT02336607|458923381|FG003|Overall Study|Protocol Violation|3|||
127535099|NCT02336607|458923378|FG000|Overall Study|Adverse Event|0|||
127535100|NCT02336607|458923379|FG001|Overall Study|Adverse Event|2|||
127535101|NCT02336607|458923380|FG002|Overall Study|Adverse Event|2|||
127535102|NCT02336607|458923381|FG003|Overall Study|Adverse Event|26|||
127535103|NCT02336607|458923378|FG000|Overall Study|Withdrawal by Subject|0|||
127535104|NCT02336607|458923379|FG001|Overall Study|Withdrawal by Subject|2|||
127535105|NCT02336607|458923380|FG002|Overall Study|Withdrawal by Subject|0|||
127535106|NCT02336607|458923381|FG003|Overall Study|Withdrawal by Subject|20|||
127535107|NCT02552966|458923382|FG000|Overall Study|Lost to Follow-up|2|||
127535108|NCT02552966|458923382|FG000|Overall Study|Withdrawal by Subject|3|||
127535109|NCT01721161|458923386|FG000|Overall Study|Adverse Event|2|||
127535110|NCT01721161|458923387|FG001|Overall Study|Adverse Event|3|||
127535111|NCT01721161|458923386|FG000|Overall Study|Lost to Follow-up|1|||
127535112|NCT01721161|458923387|FG001|Overall Study|Lost to Follow-up|2|||
127535113|NCT01721161|458923386|FG000|Overall Study|Withdrawal by Subject|1|||
127535114|NCT01721161|458923387|FG001|Overall Study|Withdrawal by Subject|1|||
127535115|NCT01721161|458923386|FG000|Overall Study|Other|0|||
127535116|NCT01721161|458923387|FG001|Overall Study|Other|1|||
127535117|NCT01091675|458923392|FG000|Overall Study|Adverse Event|7|||
127535118|NCT01091675|458923392|FG000|Overall Study|Lack of Efficacy|27|||
127535119|NCT00614380|458923393|FG000|Overall Study|Adverse Event|14|||
127535120|NCT00614380|458923394|FG001|Overall Study|Adverse Event|4|||
127535121|NCT00614380|458923395|FG002|Overall Study|Adverse Event|0|||
127535122|NCT00614380|458923396|FG003|Overall Study|Adverse Event|0|||
127981678|NCT03800836|460554420|FG005|Overall Study|Death|0|||
127981679|NCT03800836|460554415|FG000|Overall Study|Symptomatic Deterioration|1|||
127981680|NCT03800836|460554416|FG001|Overall Study|Symptomatic Deterioration|0|||
127981681|NCT03800836|460554417|FG002|Overall Study|Symptomatic Deterioration|1|||
127981682|NCT03800836|460554418|FG003|Overall Study|Symptomatic Deterioration|0|||
127981683|NCT03800836|460554419|FG004|Overall Study|Symptomatic Deterioration|0|||
127981684|NCT03800836|460554420|FG005|Overall Study|Symptomatic Deterioration|0|||
127535123|NCT00614380|458923393|FG000|Overall Study|Lost to Follow-up|6|||
127535124|NCT00614380|458923394|FG001|Overall Study|Lost to Follow-up|1|||
127535125|NCT00614380|458923395|FG002|Overall Study|Lost to Follow-up|0|||
127535126|NCT00614380|458923396|FG003|Overall Study|Lost to Follow-up|0|||
127647451|NCT01525602|459328647|FG003|Overall Study|Disease progression|5|||
127647452|NCT01525602|459328648|FG004|Overall Study|Disease progression|22|||
127535127|NCT00614380|458923393|FG000|Overall Study|Non compliant with the protocol|12|||
127535128|NCT00614380|458923394|FG001|Overall Study|Non compliant with the protocol|2|||
127535129|NCT00614380|458923395|FG002|Overall Study|Non compliant with the protocol|1|||
127647453|NCT01525602|459328649|FG005|Overall Study|Disease progression|2|||
127870606|NCT01161173|460145056|FG000|Overall Study|Withdrawal of Consent|5|||
127870607|NCT01161173|460145056|FG000|Overall Study|Unacceptable Toxicity|21|||
127870608|NCT01161173|460145056|FG000|Overall Study|Death|194|||
127535130|NCT00614380|458923396|FG003|Overall Study|Non compliant with the protocol|2|||
127535131|NCT00614380|458923393|FG000|Overall Study|Consent withdrawn|3|||
127535132|NCT00614380|458923394|FG001|Overall Study|Consent withdrawn|1|||
127535133|NCT00614380|458923395|FG002|Overall Study|Consent withdrawn|0|||
127535134|NCT00614380|458923396|FG003|Overall Study|Consent withdrawn|0|||
127535135|NCT02888106|458923399|FG000|Overall Study|Withdrawal by Subject|1|||
127535136|NCT02888106|458923400|FG001|Overall Study|Withdrawal by Subject|2|||
127535137|NCT02888106|458923401|FG002|Overall Study|Withdrawal by Subject|0|||
127535138|NCT02888106|458923402|FG003|Overall Study|Withdrawal by Subject|1|||
127535139|NCT02888106|458923403|FG004|Overall Study|Withdrawal by Subject|0|||
127535140|NCT02888106|458923404|FG005|Overall Study|Withdrawal by Subject|0|||
127535141|NCT02888106|458923399|FG000|Overall Study|Lost to Follow-up|1|||
127647454|NCT01525602|459328650|FG006|Overall Study|Disease progression|3|||
127647455|NCT01525602|459328651|FG007|Overall Study|Disease progression|3|||
127647456|NCT01525602|459328644|FG000|Overall Study|Clinical progression|2|||
127647457|NCT01525602|459328645|FG001|Overall Study|Clinical progression|0|||
127647458|NCT01525602|459328646|FG002|Overall Study|Clinical progression|0|||
127647459|NCT01525602|459328647|FG003|Overall Study|Clinical progression|0|||
127647460|NCT01525602|459328648|FG004|Overall Study|Clinical progression|0|||
127647461|NCT01525602|459328649|FG005|Overall Study|Clinical progression|0|||
127647462|NCT01525602|459328650|FG006|Overall Study|Clinical progression|1|||
127647463|NCT01525602|459328651|FG007|Overall Study|Clinical progression|1|||
127647464|NCT01525602|459328644|FG000|Overall Study|Non-compliance|0|||
127647465|NCT01525602|459328645|FG001|Overall Study|Non-compliance|0|||
127647466|NCT01525602|459328646|FG002|Overall Study|Non-compliance|0|||
127647467|NCT01525602|459328647|FG003|Overall Study|Non-compliance|0|||
127647468|NCT01525602|459328648|FG004|Overall Study|Non-compliance|1|||
127647469|NCT01525602|459328649|FG005|Overall Study|Non-compliance|0|||
127647470|NCT01525602|459328650|FG006|Overall Study|Non-compliance|0|||
127647471|NCT01525602|459328651|FG007|Overall Study|Non-compliance|0|||
127647472|NCT01525602|459328644|FG000|Overall Study|Withdrawal by Subject|0|||
127647473|NCT01525602|459328645|FG001|Overall Study|Withdrawal by Subject|0|||
127647474|NCT01525602|459328646|FG002|Overall Study|Withdrawal by Subject|0|||
127647475|NCT01525602|459328647|FG003|Overall Study|Withdrawal by Subject|0|||
127647476|NCT01525602|459328648|FG004|Overall Study|Withdrawal by Subject|3|||
127647477|NCT01525602|459328649|FG005|Overall Study|Withdrawal by Subject|1|||
127647478|NCT01525602|459328650|FG006|Overall Study|Withdrawal by Subject|0|||
127647479|NCT01525602|459328651|FG007|Overall Study|Withdrawal by Subject|1|||
127647480|NCT01525602|459328644|FG000|Overall Study|Physician Decision|0|||
127647481|NCT01525602|459328645|FG001|Overall Study|Physician Decision|0|||
127647482|NCT01525602|459328646|FG002|Overall Study|Physician Decision|0|||
127647483|NCT01525602|459328647|FG003|Overall Study|Physician Decision|0|||
127647484|NCT01525602|459328648|FG004|Overall Study|Physician Decision|3|||
127647485|NCT01525602|459328649|FG005|Overall Study|Physician Decision|0|||
127647486|NCT01525602|459328650|FG006|Overall Study|Physician Decision|1|||
127647487|NCT01525602|459328651|FG007|Overall Study|Physician Decision|0|||
127647488|NCT01525602|459328644|FG000|Overall Study|Death|0|||
127647489|NCT01525602|459328645|FG001|Overall Study|Death|0|||
127647490|NCT01525602|459328646|FG002|Overall Study|Death|0|||
127647491|NCT01525602|459328647|FG003|Overall Study|Death|0|||
127647492|NCT01525602|459328648|FG004|Overall Study|Death|1|||
127647493|NCT01525602|459328649|FG005|Overall Study|Death|1|||
127647494|NCT01525602|459328650|FG006|Overall Study|Death|0|||
127647495|NCT01525602|459328651|FG007|Overall Study|Death|0|||
127647496|NCT01525602|459328644|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
127647497|NCT01525602|459328645|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
127647498|NCT01525602|459328646|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
127647499|NCT01525602|459328647|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
127647500|NCT01525602|459328648|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
127647501|NCT01525602|459328649|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
127647502|NCT01525602|459328650|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
127647503|NCT01525602|459328651|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
127647504|NCT04349280|459328652|FG000|Main Study (Up to Approx. 95 Weeks)|Ongoing|1|||
127535142|NCT02888106|458923400|FG001|Overall Study|Lost to Follow-up|0|||
127647505|NCT04349280|459328653|FG001|Main Study (Up to Approx. 95 Weeks)|Ongoing|0|||
127647506|NCT04349280|459328652|FG000|Main Study (Up to Approx. 95 Weeks)|Death|12|||
127647507|NCT04349280|459328653|FG001|Main Study (Up to Approx. 95 Weeks)|Death|0|||
127647508|NCT04349280|459328652|FG000|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|0|||
127647509|NCT04349280|459328653|FG001|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|1|||
127647510|NCT01194570|459330154|FG000|Overall Study|Adverse Event|22|||
127981685|NCT05128773|460556014|FG000|Overall Study|Sponsor decision to terminate study|3|||
127535143|NCT02888106|458923401|FG002|Overall Study|Lost to Follow-up|0|||
127647511|NCT01194570|459330155|FG001|Overall Study|Adverse Event|40|||
127647512|NCT01194570|459330154|FG000|Overall Study|Death|6|||
127647513|NCT01194570|459330155|FG001|Overall Study|Death|20|||
127647514|NCT01194570|459330154|FG000|Overall Study|Lack of Efficacy|32|||
127647515|NCT01194570|459330155|FG001|Overall Study|Lack of Efficacy|33|||
127647516|NCT01194570|459330154|FG000|Overall Study|Lost to Follow-up|4|||
127647517|NCT01194570|459330155|FG001|Overall Study|Lost to Follow-up|15|||
127647518|NCT01194570|459330154|FG000|Overall Study|Non-Compliance|2|||
127535144|NCT02888106|458923402|FG003|Overall Study|Lost to Follow-up|1|||
127535145|NCT02888106|458923403|FG004|Overall Study|Lost to Follow-up|0|||
127535146|NCT02888106|458923404|FG005|Overall Study|Lost to Follow-up|1|||
127535147|NCT02888106|458923399|FG000|Overall Study|Adverse Event|2|||
127535148|NCT02888106|458923400|FG001|Overall Study|Adverse Event|0|||
127535149|NCT02888106|458923401|FG002|Overall Study|Adverse Event|0|||
127535150|NCT02888106|458923402|FG003|Overall Study|Adverse Event|0|||
127535151|NCT02888106|458923403|FG004|Overall Study|Adverse Event|0|||
127535152|NCT02888106|458923404|FG005|Overall Study|Adverse Event|0|||
127535153|NCT02888106|458923399|FG000|Overall Study|Withdrawal of consent|0|||
127535154|NCT02888106|458923400|FG001|Overall Study|Withdrawal of consent|0|||
127535155|NCT02888106|458923401|FG002|Overall Study|Withdrawal of consent|0|||
127535156|NCT02888106|458923402|FG003|Overall Study|Withdrawal of consent|0|||
127535157|NCT02888106|458923403|FG004|Overall Study|Withdrawal of consent|1|||
127535158|NCT02888106|458923404|FG005|Overall Study|Withdrawal of consent|0|||
127535159|NCT02888106|458923399|FG000|Overall Study|Pregnancy|1|||
127535160|NCT02888106|458923400|FG001|Overall Study|Pregnancy|0|||
127535161|NCT02888106|458923401|FG002|Overall Study|Pregnancy|0|||
127535162|NCT02888106|458923402|FG003|Overall Study|Pregnancy|0|||
127535163|NCT02888106|458923403|FG004|Overall Study|Pregnancy|0|||
127535164|NCT02888106|458923404|FG005|Overall Study|Pregnancy|0|||
127535165|NCT01188772|458923413|FG000|Overall Study|Randomized but Not Treated|0|||
127535166|NCT01188772|458923414|FG001|Overall Study|Randomized but Not Treated|1|||
127535167|NCT01188772|458923415|FG002|Overall Study|Randomized but Not Treated|0|||
127535168|NCT01188772|458923416|FG003|Overall Study|Randomized but Not Treated|0|||
127535169|NCT01188772|458923413|FG000|Overall Study|Adverse Event|0|||
127981686|NCT04250714|460556015|FG000|Overall Study|Treatment - withdrawal by subject|14|||
127981687|NCT04250714|460556015|FG000|Overall Study|Treatment - Lost to Follow-up|11|||
127981688|NCT04250714|460556015|FG000|Overall Study|Treatment - End of study due to logistical reasons|2|||
127535170|NCT01188772|458923414|FG001|Overall Study|Adverse Event|1|||
127535171|NCT01188772|458923415|FG002|Overall Study|Adverse Event|2|||
127535172|NCT01188772|458923416|FG003|Overall Study|Adverse Event|0|||
127535173|NCT01188772|458923413|FG000|Overall Study|Lost to Follow-up|4|||
127535174|NCT01188772|458923414|FG001|Overall Study|Lost to Follow-up|1|||
127535175|NCT01188772|458923415|FG002|Overall Study|Lost to Follow-up|1|||
127535176|NCT01188772|458923416|FG003|Overall Study|Lost to Follow-up|1|||
127535177|NCT01188772|458923413|FG000|Overall Study|Non-responder|0|||
127535178|NCT01188772|458923414|FG001|Overall Study|Non-responder|0|||
127535179|NCT01188772|458923415|FG002|Overall Study|Non-responder|3|||
127535180|NCT01188772|458923416|FG003|Overall Study|Non-responder|0|||
127647519|NCT01194570|459330155|FG001|Overall Study|Non-Compliance|2|||
127647520|NCT01194570|459330154|FG000|Overall Study|Non-Compliance With Study Drug|2|||
127647521|NCT01194570|459330155|FG001|Overall Study|Non-Compliance With Study Drug|2|||
127647522|NCT01194570|459330154|FG000|Overall Study|Other|18|||
127647523|NCT01194570|459330155|FG001|Overall Study|Other|47|||
127647524|NCT01194570|459330154|FG000|Overall Study|Physician Decision|10|||
127647525|NCT01194570|459330155|FG001|Overall Study|Physician Decision|25|||
127647526|NCT01194570|459330154|FG000|Overall Study|Protocol Violation|1|||
127647527|NCT01194570|459330155|FG001|Overall Study|Protocol Violation|2|||
127647528|NCT01194570|459330154|FG000|Overall Study|Study Terminated By Sponsor|0|||
127647529|NCT01194570|459330155|FG001|Overall Study|Study Terminated By Sponsor|1|||
127647530|NCT01194570|459330154|FG000|Overall Study|Withdrawal by Subject|57|||
127647531|NCT01194570|459330155|FG001|Overall Study|Withdrawal by Subject|82|||
127647532|NCT01194570|459330154|FG000|Overall Study|Pregnancy|1|||
127647533|NCT01194570|459330155|FG001|Overall Study|Pregnancy|1|||
127647534|NCT01337674|459330159|FG000|Treatment Period 1|Adverse Event|0|||
127647535|NCT01337674|459330160|FG001|Treatment Period 1|Adverse Event|1|||
127647536|NCT01337674|459330161|FG002|Treatment Period 1|Adverse Event|0|||
127647537|NCT01337674|459330162|FG003|Treatment Period 1|Adverse Event|0|||
127647538|NCT01337674|459330159|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
127647539|NCT01337674|459330160|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
127647540|NCT01337674|459330161|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
127647541|NCT01337674|459330162|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
127647542|NCT01337674|459330159|FG000|Treatment Period 2|Withdrawal by Subject|0|||
127647543|NCT01337674|459330160|FG001|Treatment Period 2|Withdrawal by Subject|0|||
127647544|NCT01337674|459330161|FG002|Treatment Period 2|Withdrawal by Subject|1|||
127981689|NCT04250714|460556015|FG000|Overall Study|Treatment - End of study due to refusing testing COVID|1|||
127981690|NCT04250714|460556015|FG000|Overall Study|Treatment - Death|1|||
127981691|NCT04250714|460556015|FG000|Overall Study|Treatment - Withdrawn due to unknown reason|2|||
127647545|NCT01337674|459330162|FG003|Treatment Period 2|Withdrawal by Subject|0|||
127535181|NCT01188772|458923413|FG000|Overall Study|Physician Decision|0|||
127535182|NCT01188772|458923414|FG001|Overall Study|Physician Decision|0|||
127535183|NCT01188772|458923415|FG002|Overall Study|Physician Decision|1|||
127535184|NCT01188772|458923416|FG003|Overall Study|Physician Decision|0|||
127535185|NCT01188772|458923413|FG000|Overall Study|Terminated by Sponsor|0|||
127535186|NCT01188772|458923414|FG001|Overall Study|Terminated by Sponsor|0|||
127535187|NCT01188772|458923415|FG002|Overall Study|Terminated by Sponsor|1|||
127535188|NCT01188772|458923416|FG003|Overall Study|Terminated by Sponsor|0|||
127647546|NCT03076970|459330163|FG000|Washout Period 2|Adverse Event|0|||
127647547|NCT03076970|459330164|FG001|Washout Period 2|Adverse Event|0|||
127647548|NCT03076970|459330165|FG002|Washout Period 2|Adverse Event|0|||
127647549|NCT03076970|459330166|FG003|Washout Period 2|Adverse Event|0|||
127647550|NCT03076970|459330167|FG004|Washout Period 2|Adverse Event|1|||
127647551|NCT03076970|459330168|FG005|Washout Period 2|Adverse Event|0|||
127647552|NCT03076970|459330163|FG000|Period 3|Withdrawal by Subject|0|||
127647553|NCT03076970|459330164|FG001|Period 3|Withdrawal by Subject|0|||
127647554|NCT03076970|459330165|FG002|Period 3|Withdrawal by Subject|0|||
127647555|NCT03076970|459330166|FG003|Period 3|Withdrawal by Subject|0|||
127647556|NCT03076970|459330167|FG004|Period 3|Withdrawal by Subject|0|||
127647557|NCT03076970|459330168|FG005|Period 3|Withdrawal by Subject|1|||
127647558|NCT03076970|459330163|FG000|Period 3|Failure to meet I/E criteria|0|||
127647559|NCT03076970|459330164|FG001|Period 3|Failure to meet I/E criteria|0|||
127647560|NCT03076970|459330165|FG002|Period 3|Failure to meet I/E criteria|0|||
127647561|NCT03076970|459330166|FG003|Period 3|Failure to meet I/E criteria|0|||
127647562|NCT03076970|459330167|FG004|Period 3|Failure to meet I/E criteria|1|||
127647563|NCT03076970|459330168|FG005|Period 3|Failure to meet I/E criteria|0|||
127647564|NCT01111123|459330174|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
127870609|NCT01161173|460145056|FG000|Overall Study|End of Study|2|||
127870610|NCT01161173|460145056|FG000|Overall Study|Reasons Not Specified|23|||
127870611|NCT00792467|460145059|FG000|Overall Study|progression of disease|17|||
127870612|NCT00792467|460145059|FG000|Overall Study|Adverse Event|1|||
127870613|NCT00792467|460145059|FG000|Overall Study|patient request|1|||
127870614|NCT00792467|460145059|FG000|Overall Study|Lost to Follow-up|1|||
127870615|NCT00792467|460145059|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
127870616|NCT00792467|460145059|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
127870617|NCT03911401|460145060|FG000|Overall Study|Adverse Event|1|||
127870618|NCT03911401|460145061|FG001|Overall Study|Adverse Event|2|||
127870619|NCT03911401|460145062|FG002|Overall Study|Adverse Event|5|||
127870620|NCT03911401|460145060|FG000|Overall Study|Lack of Efficacy|1|||
127870621|NCT03911401|460145061|FG001|Overall Study|Lack of Efficacy|1|||
127870622|NCT03911401|460145062|FG002|Overall Study|Lack of Efficacy|8|||
127870623|NCT03911401|460145060|FG000|Overall Study|Physician Decision|0|||
127870624|NCT03911401|460145061|FG001|Overall Study|Physician Decision|0|||
127981692|NCT04250714|460556015|FG000|Overall Study|Consent Ineligible - Does not meet eligibility criteria|1|||
127981693|NCT04250714|460556015|FG000|Overall Study|Attempt|2|||
127870625|NCT03911401|460145062|FG002|Overall Study|Physician Decision|1|||
127870626|NCT03911401|460145060|FG000|Overall Study|Withdrawal by Subject|1|||
127870627|NCT03911401|460145061|FG001|Overall Study|Withdrawal by Subject|2|||
127870628|NCT03911401|460145062|FG002|Overall Study|Withdrawal by Subject|0|||
127870629|NCT03911401|460145060|FG000|Overall Study|Withdrawal by parent/guardian|4|||
127870630|NCT03911401|460145061|FG001|Overall Study|Withdrawal by parent/guardian|4|||
127981694|NCT04250714|460556015|FG000|Overall Study|Intent|7|||
127981695|NCT04676412|460556016|FG000|Overall Study|Death|28|||
127981696|NCT04676412|460556017|FG001|Overall Study|Death|31|||
127981697|NCT04676412|460556016|FG000|Overall Study|Lost to Follow-up|1|||
127981698|NCT04676412|460556017|FG001|Overall Study|Lost to Follow-up|2|||
127981699|NCT04676412|460556016|FG000|Overall Study|Sponsor Decision|20|||
127981700|NCT04676412|460556017|FG001|Overall Study|Sponsor Decision|23|||
127981701|NCT04676412|460556016|FG000|Overall Study|Withdrawal by Subject|0|||
127981702|NCT04676412|460556017|FG001|Overall Study|Withdrawal by Subject|2|||
127981703|NCT04697056|460556018|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
127981704|NCT04697056|460556019|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
127981705|NCT04439357|460556021|FG000|Overall Study|Disease Progression|4|||
127981706|NCT05906836|460556027|FG000|Overall Study|Unwilling to Make Travel Arrangements|1|||
127981707|NCT05906836|460556027|FG000|Overall Study|Lost to Follow-up|1|||
127981708|NCT02542293|460556028|FG000|Overall Study|Death|367|||
127981709|NCT02542293|460556029|FG001|Overall Study|Death|377|||
127981710|NCT02542293|460556028|FG000|Overall Study|Withdrawal by Subject|8|||
127981711|NCT02542293|460556029|FG001|Overall Study|Withdrawal by Subject|19|||
127981712|NCT04529850|460556030|FG000|Overall Study|Death|2|||
127981713|NCT04529850|460556030|FG000|Overall Study|Physician Decision|1|||
127981714|NCT04529850|460556030|FG000|Overall Study|Withdrawal by Subject|2|||
127981715|NCT00480493|460556031|FG000|Overall Study|moved|2|||
127981716|NCT00480493|460556032|FG001|Overall Study|moved|7|||
127981717|NCT03747302|460556033|FG000|Overall Study|Withdrawal by Subject|1|||
127981718|NCT03747302|460556034|FG001|Overall Study|Withdrawal by Subject|2|||
127981719|NCT03769675|460556035|FG000|Overall Study|Lost to Follow-up|1|||
127981720|NCT01032070|460556036|FG000|Overall Study|Disease progression|13|||
127647565|NCT01111123|459330175|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
127647566|NCT01111123|459330174|FG000|Maintenance Phase|Lost to Follow-up|0|||
127647567|NCT01111123|459330175|FG001|Maintenance Phase|Lost to Follow-up|2|||
127758404|NCT00166712|459741941|FG000|Overall Study|Withdrawal by Subject|1|||
127981721|NCT01032070|460556037|FG001|Overall Study|Disease progression|8|||
127981722|NCT01032070|460556036|FG000|Overall Study|Medical or ethical reasons|0|||
127647568|NCT00119405|459330176|FG000|Overall Study|Withdrawal by Subject|1|||
127647569|NCT01203930|459330187|FG000|Overall Study|Disease Progression|0|||
127647570|NCT01203930|459330188|FG001|Overall Study|Disease Progression|4|||
127647571|NCT01203930|459330187|FG000|Overall Study|Death|3|||
127647572|NCT01203930|459330188|FG001|Overall Study|Death|1|||
127647573|NCT01203930|459330187|FG000|Overall Study|Withdrew Consent|1|||
127647574|NCT01203930|459330188|FG001|Overall Study|Withdrew Consent|10|||
127647575|NCT01203930|459330187|FG000|Overall Study|Investigator Request|0|||
127647576|NCT01203930|459330188|FG001|Overall Study|Investigator Request|8|||
127647577|NCT01203930|459330187|FG000|Overall Study|Study Terminated by Sponsor|0|||
127647578|NCT01203930|459330188|FG001|Overall Study|Study Terminated by Sponsor|12|||
127647579|NCT01203930|459330187|FG000|Overall Study|Poor tolerance of study drug|0|||
127647580|NCT01203930|459330188|FG001|Overall Study|Poor tolerance of study drug|1|||
127647581|NCT01203930|459330187|FG000|Overall Study|Adverse Event|17|||
127647582|NCT01203930|459330188|FG001|Overall Study|Adverse Event|5|||
127647583|NCT02178059|459330189|FG000|Washout|Physician Decision|1|||
127647584|NCT02178059|459330190|FG001|Washout|Physician Decision|0|||
127647585|NCT05178121|459330191|FG000|Overall Study|Other|4|||
127647586|NCT05178121|459330191|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
127647587|NCT00662857|459330195|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
127647588|NCT00662857|459330196|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
127647589|NCT00662857|459330195|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
127647590|NCT00662857|459330196|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
127647591|NCT00662857|459330195|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
127647592|NCT00662857|459330196|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
127647593|NCT03966053|459330197|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
127647594|NCT00989092|459330198|FG000|Overall Study|Physician Decision|9|||
127647595|NCT00989092|459330199|FG001|Overall Study|Physician Decision|6|||
127647596|NCT00989092|459330198|FG000|Overall Study|Adverse Event|20|||
127647597|NCT00989092|459330199|FG001|Overall Study|Adverse Event|1|||
127647598|NCT00989092|459330198|FG000|Overall Study|Chemotherapy initiated|12|||
127647599|NCT00989092|459330199|FG001|Overall Study|Chemotherapy initiated|4|||
127647600|NCT00989092|459330198|FG000|Overall Study|Withdrawal by Subject|17|||
127647601|NCT00989092|459330199|FG001|Overall Study|Withdrawal by Subject|9|||
127647602|NCT00989092|459330198|FG000|Overall Study|Death|14|||
127647603|NCT00989092|459330199|FG001|Overall Study|Death|2|||
127647604|NCT00989092|459330198|FG000|Overall Study|Ineligibility determined|3|||
127647605|NCT00989092|459330199|FG001|Overall Study|Ineligibility determined|3|||
127647606|NCT00989092|459330198|FG000|Overall Study|Lost to Follow-up|6|||
127647607|NCT00989092|459330199|FG001|Overall Study|Lost to Follow-up|2|||
127647608|NCT00989092|459330198|FG000|Overall Study|Other|3|||
127647609|NCT00989092|459330199|FG001|Overall Study|Other|1|||
127647610|NCT00989092|459330198|FG000|Overall Study|Protocol deviation|2|||
127870631|NCT03911401|460145062|FG002|Overall Study|Withdrawal by parent/guardian|11|||
127870632|NCT00462501|460145063|FG000|Overall Study|Not treated|3|||
127870633|NCT00462501|460145063|FG000|Overall Study|Adverse Event|2|||
127870634|NCT00998166|460145064|FG000|Overall Study|Early Study Termination|8|||
127870635|NCT00933543|460145070|FG000|Overall Study|Adverse Event|2|||
127870636|NCT00933543|460145071|FG001|Overall Study|Adverse Event|1|||
127870637|NCT00933543|460145070|FG000|Overall Study|Lost to Follow-up|0|||
127870638|NCT00933543|460145071|FG001|Overall Study|Lost to Follow-up|1|||
127870639|NCT00933543|460145070|FG000|Overall Study|Withdrawal by Subject|0|||
127870640|NCT00933543|460145071|FG001|Overall Study|Withdrawal by Subject|1|||
127870641|NCT00933543|460145070|FG000|Overall Study|Lack of Efficacy|0|||
127870642|NCT00933543|460145071|FG001|Overall Study|Lack of Efficacy|3|||
127870643|NCT00933543|460145070|FG000|Overall Study|Other|1|||
127870644|NCT00933543|460145071|FG001|Overall Study|Other|1|||
127870645|NCT04988035|460145072|FG000|Overall Study|Death|19|||
127870646|NCT04988035|460145073|FG001|Overall Study|Death|13|||
127870647|NCT04988035|460145072|FG000|Overall Study|Lost to Follow-up|12|||
127870648|NCT04988035|460145073|FG001|Overall Study|Lost to Follow-up|6|||
127870649|NCT04988035|460145072|FG000|Overall Study|Protocol Violation|0|||
127870650|NCT04988035|460145073|FG001|Overall Study|Protocol Violation|1|||
127870651|NCT04988035|460145072|FG000|Overall Study|Withdrawal by Subject|2|||
127870652|NCT04988035|460145073|FG001|Overall Study|Withdrawal by Subject|4|||
127647611|NCT00989092|459330199|FG001|Overall Study|Protocol deviation|0|||
127647612|NCT00989092|459330198|FG000|Overall Study|Erythropoietin therapy initiated|2|||
127647613|NCT00989092|459330199|FG001|Overall Study|Erythropoietin therapy initiated|0|||
127647614|NCT00989092|459330198|FG000|Overall Study|Did not receive study drug|2|||
127647615|NCT00989092|459330199|FG001|Overall Study|Did not receive study drug|0|||
127870653|NCT04988035|460145072|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
127870654|NCT04988035|460145073|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
127647616|NCT01332227|459330201|FG000|Overall Study|Adverse Event|4|||
127647617|NCT01332227|459330202|FG001|Overall Study|Adverse Event|1|||
127647618|NCT01332227|459330201|FG000|Overall Study|Withdrawal by Subject|5|||
127870655|NCT00612456|460145078|FG000|Overall Study|Adverse Event|1|||
127870656|NCT00612456|460145079|FG001|Overall Study|Adverse Event|0|||
127870657|NCT00612456|460145080|FG002|Overall Study|Adverse Event|0|||
127870658|NCT00612456|460145078|FG000|Overall Study|Lack of Efficacy|1|||
127870659|NCT00612456|460145079|FG001|Overall Study|Lack of Efficacy|1|||
127870660|NCT00612456|460145080|FG002|Overall Study|Lack of Efficacy|0|||
127870661|NCT00612456|460145078|FG000|Overall Study|Withdrawal by Subject|0|||
127870662|NCT00612456|460145079|FG001|Overall Study|Withdrawal by Subject|1|||
127870663|NCT00612456|460145080|FG002|Overall Study|Withdrawal by Subject|0|||
127870664|NCT01258803|460145081|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
127870665|NCT01258803|460145082|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
127870666|NCT01258803|460145083|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
127870667|NCT01258803|460145084|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
127981723|NCT01032070|460556037|FG001|Overall Study|Medical or ethical reasons|2|||
127647619|NCT01332227|459330202|FG001|Overall Study|Withdrawal by Subject|1|||
127647620|NCT01332227|459330201|FG000|Overall Study|Lost to Follow-up|2|||
127647621|NCT01332227|459330202|FG001|Overall Study|Lost to Follow-up|0|||
127647622|NCT01332227|459330201|FG000|Overall Study|Lack of Efficacy|3|||
127647623|NCT01332227|459330202|FG001|Overall Study|Lack of Efficacy|1|||
127647624|NCT01332227|459330201|FG000|Overall Study|Poor compliance/noncompliance|1|||
127647625|NCT01332227|459330202|FG001|Overall Study|Poor compliance/noncompliance|1|||
127647626|NCT01332227|459330201|FG000|Overall Study|Patient moved from area|1|||
127647627|NCT01332227|459330202|FG001|Overall Study|Patient moved from area|0|||
127647628|NCT01332227|459330201|FG000|Overall Study|Patient began prohibited medication|0|||
127647629|NCT01332227|459330202|FG001|Overall Study|Patient began prohibited medication|1|||
127647630|NCT00514943|459330203|FG000|Stage 1|Progressive disease|4|||
127647631|NCT00514943|459330204|FG001|Stage 1|Progressive disease|8|||
127647632|NCT00514943|459330203|FG000|Stage 1|Other Adverse Event|16|||
127647633|NCT00514943|459330204|FG001|Stage 1|Other Adverse Event|6|||
127647634|NCT00514943|459330203|FG000|Stage 1|Not treated|1|||
127647635|NCT00514943|459330204|FG001|Stage 1|Not treated|2|||
127647636|NCT00514943|459330203|FG000|Stage 1|Patient refused to continue study meds|8|||
127647637|NCT00514943|459330204|FG001|Stage 1|Patient refused to continue study meds|3|||
127647638|NCT00514943|459330203|FG000|Stage 1|Other than stated above|1|||
127647639|NCT00514943|459330204|FG001|Stage 1|Other than stated above|7|||
127870668|NCT01258803|460145085|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
127870669|NCT01258803|460145086|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
127870670|NCT01258803|460145081|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
127870671|NCT01258803|460145082|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
127870672|NCT01258803|460145083|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
127870673|NCT01258803|460145084|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
127870674|NCT01258803|460145085|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
127870675|NCT01258803|460145086|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
127870676|NCT01258803|460145081|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
127870677|NCT01258803|460145082|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
127870678|NCT01258803|460145083|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
127870679|NCT01258803|460145084|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
127870680|NCT01258803|460145085|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
127870681|NCT01258803|460145086|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
127870682|NCT00920582|460145087|FG000|Overall Study|Lost to Follow-up|5|||
127870683|NCT00920582|460145088|FG001|Overall Study|Lost to Follow-up|1|||
127870684|NCT00920582|460145089|FG002|Overall Study|Lost to Follow-up|2|||
127870685|NCT00920582|460145090|FG003|Overall Study|Lost to Follow-up|0|||
127870686|NCT00920582|460145087|FG000|Overall Study|Withdrawal by Subject|5|||
127870687|NCT00920582|460145088|FG001|Overall Study|Withdrawal by Subject|4|||
127870688|NCT00920582|460145089|FG002|Overall Study|Withdrawal by Subject|6|||
127870689|NCT00920582|460145090|FG003|Overall Study|Withdrawal by Subject|3|||
127870690|NCT00920582|460145087|FG000|Overall Study|Protocol Violation|1|||
127870691|NCT00920582|460145088|FG001|Overall Study|Protocol Violation|0|||
127870692|NCT00920582|460145089|FG002|Overall Study|Protocol Violation|0|||
127870693|NCT00920582|460145090|FG003|Overall Study|Protocol Violation|0|||
127870694|NCT00920582|460145087|FG000|Overall Study|Other|2|||
127870695|NCT00920582|460145088|FG001|Overall Study|Other|1|||
127870696|NCT00920582|460145089|FG002|Overall Study|Other|3|||
127870697|NCT00920582|460145090|FG003|Overall Study|Other|2|||
127981724|NCT01032070|460556036|FG000|Overall Study|Withdrawal by Subject|0|||
127981725|NCT01032070|460556037|FG001|Overall Study|Withdrawal by Subject|2|||
127647640|NCT00514943|459330203|FG000|Stage 2|Progressive disease|27|||
127647641|NCT00514943|459330204|FG001|Stage 2|Progressive disease|24|||
127647642|NCT00514943|459330203|FG000|Stage 2|Other Adverse Event|3|||
127647643|NCT00514943|459330204|FG001|Stage 2|Other Adverse Event|10|||
127647644|NCT00514943|459330203|FG000|Stage 2|Patient refused to continue study meds|2|||
127647645|NCT00514943|459330204|FG001|Stage 2|Patient refused to continue study meds|0|||
127870698|NCT04652245|460145096|FG000|Wash-Out Period|Adverse Event|0|||
127870699|NCT04652245|460145097|FG001|Wash-Out Period|Adverse Event|2|||
127870700|NCT04652245|460145096|FG000|Wash-Out Period|Withdrawal by Subject|0|||
127870701|NCT04652245|460145097|FG001|Wash-Out Period|Withdrawal by Subject|2|||
127647646|NCT00514943|459330203|FG000|Stage 2|Other than stated above|0|||
127647647|NCT00514943|459330204|FG001|Stage 2|Other than stated above|2|||
127647648|NCT02173548|459330207|FG000|Overall Study|Lost to Follow-up|0|||
127647649|NCT02173548|459330208|FG001|Overall Study|Lost to Follow-up|2|||
127647650|NCT02173548|459330207|FG000|Overall Study|Withdrawal by Subject|1|||
127647651|NCT02173548|459330208|FG001|Overall Study|Withdrawal by Subject|0|||
127647652|NCT03040713|459330214|FG000|Overall Study|Positive amyloid scan|3|||
127647653|NCT04539821|459330215|FG000|Overall Study|Withdrawal by Subject|2|||
127647654|NCT04539821|459330215|FG000|Overall Study|continued care with their physician|20|||
127647655|NCT04539821|459330215|FG000|Overall Study|treatment needs outside scope of VCPM|3|||
127647656|NCT02641392|459330216|FG000|Overall Study|Lost to Follow-up|0|||
127647657|NCT02641392|459330217|FG001|Overall Study|Lost to Follow-up|0|||
127647658|NCT02641392|459330218|FG002|Overall Study|Lost to Follow-up|2|||
127647659|NCT02641392|459330216|FG000|Overall Study|Withdrawal by Subject|0|||
127647660|NCT02641392|459330217|FG001|Overall Study|Withdrawal by Subject|0|||
127647661|NCT02641392|459330218|FG002|Overall Study|Withdrawal by Subject|17|||
127647662|NCT02641392|459330216|FG000|Overall Study|Adverse Event|0|||
127647663|NCT02641392|459330217|FG001|Overall Study|Adverse Event|1|||
127647664|NCT02641392|459330218|FG002|Overall Study|Adverse Event|25|||
127647665|NCT02641392|459330216|FG000|Overall Study|Study Terminated by Sponsor|4|||
127647666|NCT02641392|459330217|FG001|Overall Study|Study Terminated by Sponsor|12|||
127647667|NCT02641392|459330218|FG002|Overall Study|Study Terminated by Sponsor|144|||
127647668|NCT02641392|459330216|FG000|Overall Study|Lack of Efficacy|0|||
127647669|NCT02641392|459330217|FG001|Overall Study|Lack of Efficacy|0|||
127647670|NCT02641392|459330218|FG002|Overall Study|Lack of Efficacy|101|||
127647671|NCT02641392|459330216|FG000|Overall Study|Miscellaneous|0|||
127647672|NCT02641392|459330217|FG001|Overall Study|Miscellaneous|0|||
127647673|NCT02641392|459330218|FG002|Overall Study|Miscellaneous|3|||
127647674|NCT02641392|459330216|FG000|Overall Study|Death|0|||
127647675|NCT02641392|459330217|FG001|Overall Study|Death|0|||
127647676|NCT02641392|459330218|FG002|Overall Study|Death|1|||
127647677|NCT02691182|459330219|FG000|Overall Study|Withdrawal by Subject|4|||
127647678|NCT02691182|459330220|FG001|Overall Study|Withdrawal by Subject|7|||
127647679|NCT02691182|459330221|FG002|Overall Study|Withdrawal by Subject|6|||
127647680|NCT02691182|459330222|FG003|Overall Study|Withdrawal by Subject|8|||
127647681|NCT02691182|459330219|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
127647682|NCT02691182|459330220|FG001|Overall Study|Withdrawal by Parent/Guardian|47|||
127647683|NCT02691182|459330221|FG002|Overall Study|Withdrawal by Parent/Guardian|33|||
127870702|NCT04419558|460145100|FG000|DB Period (48 Weeks)|Adverse Event|6|||
127870703|NCT04419558|460145101|FG001|DB Period (48 Weeks)|Adverse Event|6|||
127981726|NCT00738062|460556038|FG000|Open Label Treatment|Lack of Efficacy|5|||
127981727|NCT00738062|460556039|FG001|Open Label Treatment|Lack of Efficacy|0|||
127981728|NCT00738062|460556040|FG002|Open Label Treatment|Lack of Efficacy|0|||
127981729|NCT00738062|460556038|FG000|Open Label Treatment|Adverse Event|11|||
127981730|NCT00738062|460556039|FG001|Open Label Treatment|Adverse Event|0|||
127981731|NCT00738062|460556040|FG002|Open Label Treatment|Adverse Event|0|||
127981732|NCT00738062|460556038|FG000|Open Label Treatment|Protocol Violation|2|||
127981733|NCT00738062|460556039|FG001|Open Label Treatment|Protocol Violation|0|||
127981734|NCT00738062|460556040|FG002|Open Label Treatment|Protocol Violation|0|||
127981735|NCT00738062|460556038|FG000|Open Label Treatment|Withdrawal by Subject|9|||
127981736|NCT00738062|460556039|FG001|Open Label Treatment|Withdrawal by Subject|0|||
127981737|NCT00738062|460556040|FG002|Open Label Treatment|Withdrawal by Subject|0|||
127981738|NCT00738062|460556038|FG000|Open Label Treatment|Investigator Decision|1|||
127981739|NCT00738062|460556039|FG001|Open Label Treatment|Investigator Decision|0|||
127981740|NCT00738062|460556040|FG002|Open Label Treatment|Investigator Decision|0|||
127981741|NCT00738062|460556038|FG000|Open-Label Extension|Adverse Event|5|||
127981742|NCT00738062|460556039|FG001|Open-Label Extension|Adverse Event|0|||
127981743|NCT00738062|460556040|FG002|Open-Label Extension|Adverse Event|0|||
127981744|NCT00738062|460556038|FG000|Open-Label Extension|Physician Decision|1|||
127981745|NCT00738062|460556039|FG001|Open-Label Extension|Physician Decision|0|||
127981746|NCT00738062|460556040|FG002|Open-Label Extension|Physician Decision|0|||
127981747|NCT00738062|460556038|FG000|Open-Label Extension|Lack of Efficacy|2|||
127981748|NCT00738062|460556039|FG001|Open-Label Extension|Lack of Efficacy|0|||
127981749|NCT00738062|460556040|FG002|Open-Label Extension|Lack of Efficacy|0|||
127981750|NCT00738062|460556038|FG000|Open-Label Extension|Withdrawal by Subject|6|||
127981751|NCT00738062|460556039|FG001|Open-Label Extension|Withdrawal by Subject|0|||
127981752|NCT00738062|460556040|FG002|Open-Label Extension|Withdrawal by Subject|0|||
127981753|NCT00738062|460556038|FG000|Open-Label Extension|Protocol Violation|1|||
127981754|NCT00738062|460556039|FG001|Open-Label Extension|Protocol Violation|0|||
127981755|NCT00738062|460556040|FG002|Open-Label Extension|Protocol Violation|0|||
127981756|NCT00738062|460556038|FG000|Open-Label Extension|Study Terminated|2|||
127647684|NCT02691182|459330222|FG003|Overall Study|Withdrawal by Parent/Guardian|38|||
127647685|NCT02691182|459330219|FG000|Overall Study|Lost to Follow-up|8|||
127647686|NCT02691182|459330220|FG001|Overall Study|Lost to Follow-up|33|||
127647687|NCT02691182|459330221|FG002|Overall Study|Lost to Follow-up|19|||
127647688|NCT02691182|459330222|FG003|Overall Study|Lost to Follow-up|22|||
127981757|NCT00738062|460556039|FG001|Open-Label Extension|Study Terminated|0|||
127981758|NCT00738062|460556040|FG002|Open-Label Extension|Study Terminated|0|||
127981759|NCT00426660|460556041|FG000|Overall Study|Death|14|||
127981760|NCT00426660|460556041|FG000|Overall Study|Adverse Event|23|||
127981761|NCT00426660|460556041|FG000|Overall Study|Insufficient Clinical Response|22|||
127981762|NCT00426660|460556041|FG000|Overall Study|Lost to Follow-up|15|||
127981763|NCT00426660|460556041|FG000|Overall Study|Other|23|||
127981764|NCT00426660|460556041|FG000|Overall Study|Withdrawal by Subject|18|||
127981765|NCT00426660|460556041|FG000|Overall Study|Protocol Violation|1|||
127981766|NCT00426660|460556041|FG000|Overall Study|Enrolled Not Treated|15|||
127981767|NCT00894790|460556042|FG000|Overall Study|Protocol Violation|0|||
127981768|NCT00894790|460556043|FG001|Overall Study|Protocol Violation|1|||
127981769|NCT00894790|460556042|FG000|Overall Study|Lost to Follow-up|0|||
127981770|NCT00894790|460556043|FG001|Overall Study|Lost to Follow-up|1|||
127981771|NCT00894790|460556042|FG000|Overall Study|Did not meet entrance criteria|1|||
127981772|NCT00894790|460556043|FG001|Overall Study|Did not meet entrance criteria|0|||
127647689|NCT02691182|459330219|FG000|Overall Study|Adverse Event|3|||
127647690|NCT02691182|459330220|FG001|Overall Study|Adverse Event|10|||
127647691|NCT02691182|459330221|FG002|Overall Study|Adverse Event|10|||
127647692|NCT02691182|459330222|FG003|Overall Study|Adverse Event|11|||
127981773|NCT01432275|460556044|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
127981774|NCT01432275|460556045|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
127981775|NCT01432275|460556044|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
127981776|NCT01432275|460556045|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
127981777|NCT01432275|460556044|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
127981778|NCT01432275|460556045|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
127981779|NCT01432275|460556044|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
127981780|NCT01432275|460556045|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
127981781|NCT01432275|460556044|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
127981782|NCT01432275|460556045|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
127981783|NCT01432275|460556044|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
127981784|NCT01432275|460556045|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
127981785|NCT01432275|460556044|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
127981786|NCT01432275|460556045|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
127981787|NCT01432275|460556044|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
127981788|NCT01432275|460556045|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
127981789|NCT01432275|460556044|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
127981790|NCT01432275|460556045|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
127981791|NCT01935700|460556046|FG000|Overall Study|Withdrawal by Subject|1|||
127981792|NCT01935700|460556047|FG001|Overall Study|Withdrawal by Subject|0|||
127981793|NCT01935700|460556046|FG000|Overall Study|Physician Decision|4|||
127981794|NCT01935700|460556047|FG001|Overall Study|Physician Decision|0|||
127981795|NCT05020899|460556049|FG000|8 Week Follow-up|Lost to Follow-up|3|||
127981796|NCT05020899|460556050|FG001|8 Week Follow-up|Lost to Follow-up|6|||
127981797|NCT05020899|460556049|FG000|12 Week Follow-up|Lost to Follow-up|1|||
127981798|NCT05020899|460556050|FG001|12 Week Follow-up|Lost to Follow-up|0|||
127981799|NCT05020899|460556049|FG000|12 Week Follow-up|Death|0|||
127981800|NCT05020899|460556050|FG001|12 Week Follow-up|Death|1|||
127981801|NCT02124759|460556051|FG000|Overall Study|Withdrawal by Subject|3|||
127981802|NCT02124759|460556052|FG001|Overall Study|Withdrawal by Subject|1|||
127981803|NCT02124759|460556053|FG002|Overall Study|Withdrawal by Subject|1|||
127981804|NCT02124759|460556051|FG000|Overall Study|Screen Fail|2|||
127981805|NCT02124759|460556052|FG001|Overall Study|Screen Fail|2|||
127981806|NCT02124759|460556053|FG002|Overall Study|Screen Fail|3|||
127981807|NCT01068626|460556054|FG000|Overall Study|Adverse Event|3|||
127981808|NCT01068626|460556055|FG001|Overall Study|Adverse Event|0|||
127981809|NCT01068626|460556054|FG000|Overall Study|Withdrawal by Subject|0|||
127981810|NCT01068626|460556055|FG001|Overall Study|Withdrawal by Subject|2|||
127981811|NCT01785849|460556058|FG000|Overall Study|Death|7|||
127981812|NCT01785849|460556059|FG001|Overall Study|Death|9|||
127981813|NCT01785849|460556058|FG000|Overall Study|Protocol Specified Criteria|29|||
127981814|NCT01785849|460556059|FG001|Overall Study|Protocol Specified Criteria|1|||
127981815|NCT01785849|460556058|FG000|Overall Study|Withdrawal by Subject|15|||
127981816|NCT01785849|460556059|FG001|Overall Study|Withdrawal by Subject|12|||
127981817|NCT01785849|460556058|FG000|Overall Study|Sponsor Decision|0|||
127647693|NCT02691182|459330219|FG000|Overall Study|Physician Decision|3|||
127981818|NCT01785849|460556059|FG001|Overall Study|Sponsor Decision|1|||
127981819|NCT01785849|460556058|FG000|Overall Study|Lost to Follow-up|10|||
127981820|NCT01785849|460556059|FG001|Overall Study|Lost to Follow-up|11|||
127981821|NCT04340843|460556060|FG000|Overall Study|Adverse Event|0|||
127981822|NCT04340843|460556061|FG001|Overall Study|Adverse Event|2|||
127981823|NCT04340843|460556060|FG000|Overall Study|Withdrawal by Subject|0|||
127981824|NCT04340843|460556061|FG001|Overall Study|Withdrawal by Subject|2|||
127981825|NCT04249622|460556062|FG000|Overall Study|Withdrawal by Subject|1|||
127981826|NCT04249622|460556063|FG001|Overall Study|Withdrawal by Subject|1|||
127981827|NCT04249622|460556062|FG000|Overall Study|Alternative therapy|1|||
127981828|NCT04249622|460556063|FG001|Overall Study|Alternative therapy|0|||
127981829|NCT04249622|460556062|FG000|Overall Study|Discontinuation of pertuzumab|1|||
127981830|NCT04249622|460556063|FG001|Overall Study|Discontinuation of pertuzumab|0|||
127981831|NCT01634659|460556067|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
127981832|NCT01634659|460556068|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
127981833|NCT01634659|460556067|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
127981834|NCT01634659|460556068|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
127981835|NCT02431806|460556069|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
127981836|NCT02431806|460556070|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
127981837|NCT02431806|460556071|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
127981838|NCT02431806|460556072|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
127981839|NCT02431806|460556069|FG000|Double-blind Treatment Period|Adverse Event|4|||
127981840|NCT02431806|460556070|FG001|Double-blind Treatment Period|Adverse Event|7|||
127981841|NCT02431806|460556071|FG002|Double-blind Treatment Period|Adverse Event|11|||
127981842|NCT02431806|460556072|FG003|Double-blind Treatment Period|Adverse Event|7|||
127981843|NCT02431806|460556069|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
127981844|NCT02431806|460556070|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
127981845|NCT02431806|460556071|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
127981846|NCT02431806|460556072|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
127981847|NCT02431806|460556069|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
127981848|NCT02431806|460556070|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
127981849|NCT02431806|460556071|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
127981850|NCT02431806|460556072|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
127981851|NCT02431806|460556069|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
127981852|NCT02431806|460556070|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
127981853|NCT02431806|460556071|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
127981854|NCT02431806|460556072|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
127981855|NCT02431806|460556069|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
127981856|NCT02431806|460556070|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
127981857|NCT02431806|460556071|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
127981858|NCT02431806|460556072|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
127981859|NCT02431806|460556069|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
127981860|NCT02431806|460556070|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
127981861|NCT02431806|460556071|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
127981862|NCT02431806|460556072|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
127981863|NCT03627416|460556073|FG000|Overall Study|Adverse Event|0|||
127981864|NCT03627416|460556074|FG001|Overall Study|Adverse Event|1|||
127647694|NCT02691182|459330220|FG001|Overall Study|Physician Decision|7|||
127647695|NCT02691182|459330221|FG002|Overall Study|Physician Decision|14|||
127647696|NCT02691182|459330222|FG003|Overall Study|Physician Decision|8|||
127647697|NCT02691182|459330219|FG000|Overall Study|Lack of Efficacy|0|||
127647698|NCT02691182|459330220|FG001|Overall Study|Lack of Efficacy|0|||
127647699|NCT02691182|459330221|FG002|Overall Study|Lack of Efficacy|0|||
127647700|NCT02691182|459330222|FG003|Overall Study|Lack of Efficacy|4|||
127647701|NCT02691182|459330219|FG000|Overall Study|Protocol Violation|2|||
127647702|NCT02691182|459330220|FG001|Overall Study|Protocol Violation|6|||
127647703|NCT02691182|459330221|FG002|Overall Study|Protocol Violation|6|||
127647704|NCT02691182|459330222|FG003|Overall Study|Protocol Violation|8|||
127647705|NCT02691182|459330219|FG000|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|9|||
127647706|NCT02691182|459330220|FG001|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|43|||
127647707|NCT02691182|459330221|FG002|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|40|||
127647708|NCT02691182|459330222|FG003|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|58|||
127647709|NCT02691182|459330219|FG000|Overall Study|Missing|0|||
127647710|NCT02691182|459330220|FG001|Overall Study|Missing|5|||
127647711|NCT02691182|459330221|FG002|Overall Study|Missing|1|||
127981865|NCT01294371|460556075|FG000|Overall Study|Adverse Event|1|||
127981866|NCT01294371|460556075|FG000|Overall Study|Withdrawal by Subject|12|||
127981867|NCT01294371|460556075|FG000|Overall Study|Lost to Follow-up|6|||
127981868|NCT01294371|460556075|FG000|Overall Study|Administrative Reason|1|||
127870704|NCT04419558|460145100|FG000|DB Period (48 Weeks)|Death|14|||
127647712|NCT02691182|459330222|FG003|Overall Study|Missing|5|||
127647713|NCT02563002|459330225|FG000|Overall Study|Death|72|||
127647714|NCT02563002|459330226|FG001|Overall Study|Death|87|||
127647715|NCT02563002|459330225|FG000|Overall Study|Lost to Follow-up|5|||
127647716|NCT02563002|459330226|FG001|Overall Study|Lost to Follow-up|0|||
127647717|NCT02563002|459330225|FG000|Overall Study|Physician Decision|0|||
127647718|NCT02563002|459330226|FG001|Overall Study|Physician Decision|2|||
127647719|NCT02563002|459330225|FG000|Overall Study|Withdrawal by Subject|2|||
127647720|NCT02563002|459330226|FG001|Overall Study|Withdrawal by Subject|10|||
127647721|NCT02563002|459330225|FG000|Overall Study|Sponsor decision|74|||
127647722|NCT02563002|459330226|FG001|Overall Study|Sponsor decision|55|||
127647723|NCT02054806|459330228|FG000|Overall Study|Sponsor Decision|31|||
127647724|NCT02054806|459330228|FG000|Overall Study|Withdrawal by Subject|43|||
127647725|NCT02054806|459330228|FG000|Overall Study|Protocol Violation|2|||
127647726|NCT02054806|459330228|FG000|Overall Study|Lost to Follow-up|10|||
127647727|NCT02054806|459330228|FG000|Overall Study|Death|391|||
127647728|NCT01113502|459330231|FG000|Overall Study|Withdrawal by Subject|1|||
127647729|NCT01113502|459330232|FG001|Overall Study|Withdrawal by Subject|0|||
127647730|NCT01113502|459330233|FG002|Overall Study|Withdrawal by Subject|1|||
127647731|NCT01113502|459330234|FG003|Overall Study|Withdrawal by Subject|1|||
127647732|NCT01113502|459330235|FG004|Overall Study|Withdrawal by Subject|0|||
127647733|NCT01113502|459330231|FG000|Overall Study|Adverse Event|0|||
127647734|NCT01113502|459330232|FG001|Overall Study|Adverse Event|0|||
127647735|NCT01113502|459330233|FG002|Overall Study|Adverse Event|3|||
127647736|NCT01113502|459330234|FG003|Overall Study|Adverse Event|2|||
127647737|NCT01113502|459330235|FG004|Overall Study|Adverse Event|0|||
127647738|NCT03002610|459330244|FG000|Overall Study|Withdrawal by Subject|6|||
127647739|NCT03002610|459330245|FG001|Overall Study|Withdrawal by Subject|25|||
127647740|NCT03002610|459330246|FG002|Overall Study|Withdrawal by Subject|13|||
127647741|NCT01362439|459330249|FG000|Overall Study|Adverse Event|1|||
127647742|NCT01362439|459330249|FG000|Overall Study|Lack of Efficacy|3|||
127647743|NCT01362439|459330249|FG000|Overall Study|Lost to Follow-up|2|||
127647744|NCT01362439|459330249|FG000|Overall Study|Study medication non-compliant|1|||
127647745|NCT01362439|459330249|FG000|Overall Study|Participant who withdrew consent|8|||
127647746|NCT00658567|459330251|FG000|Overall Study|Adverse Event|5|||
127647747|NCT00658567|459330252|FG001|Overall Study|Adverse Event|2|||
127647748|NCT00658567|459330253|FG002|Overall Study|Adverse Event|3|||
127647749|NCT00658567|459330251|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
127647750|NCT00658567|459330252|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
127647751|NCT00658567|459330253|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
127647752|NCT00658567|459330251|FG000|Overall Study|Physician Decision|0|||
127647753|NCT00658567|459330252|FG001|Overall Study|Physician Decision|1|||
127647754|NCT00658567|459330253|FG002|Overall Study|Physician Decision|0|||
127647755|NCT00658567|459330251|FG000|Overall Study|At Discretion of Sponsor|1|||
127647756|NCT00658567|459330252|FG001|Overall Study|At Discretion of Sponsor|1|||
127647757|NCT00658567|459330253|FG002|Overall Study|At Discretion of Sponsor|1|||
127647758|NCT01281644|459330254|FG000|Overall Study|Lost to Follow-up|3|||
127647759|NCT01281644|459330254|FG000|Overall Study|Withdrawal by Subject|2|||
127647760|NCT00691938|459330256|FG000|Overall Study|QTc prolongation|1|||
127647761|NCT00691938|459330257|FG001|Overall Study|QTc prolongation|0|||
127647762|NCT00691938|459330258|FG002|Overall Study|QTc prolongation|0|||
127647763|NCT00691938|459330259|FG003|Overall Study|QTc prolongation|0|||
127647764|NCT00691938|459330260|FG004|Overall Study|QTc prolongation|0|||
127647765|NCT00691938|459330261|FG005|Overall Study|QTc prolongation|0|||
127647766|NCT00691938|459330262|FG006|Overall Study|QTc prolongation|0|||
127647767|NCT04860518|459330264|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
127647768|NCT04860518|459330265|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
127647769|NCT01844284|459330270|FG000|Overall Study|Lost to Follow-up|12|||
127647770|NCT01844284|459330271|FG001|Overall Study|Lost to Follow-up|7|||
127647771|NCT00611858|459330272|FG000|Overall Study|Adverse Event|2|||
127647772|NCT00611858|459330272|FG000|Overall Study|Withdrawal by Subject|2|||
127647773|NCT01058304|459330273|FG000|Overall Study|Withdrawal by Subject|8|||
127647774|NCT01058304|459330274|FG001|Overall Study|Withdrawal by Subject|5|||
127758405|NCT00166712|459741942|FG001|Overall Study|Withdrawal by Subject|2|||
127981869|NCT01294371|460556075|FG000|Overall Study|Other|14|||
127647775|NCT01058304|459330273|FG000|Overall Study|Lost to Follow-up|13|||
127981870|NCT05619536|460556076|FG000|Overall Study|Withdrawal by Subject|0|||
127647776|NCT01058304|459330274|FG001|Overall Study|Lost to Follow-up|16|||
127647777|NCT01058304|459330273|FG000|Overall Study|Developed exclusion criterion|6|||
127981871|NCT05619536|460556077|FG001|Overall Study|Withdrawal by Subject|1|||
127647778|NCT01058304|459330274|FG001|Overall Study|Developed exclusion criterion|12|||
127647779|NCT01820559|459330275|FG000|Overall Study|Adverse Event|4|||
127647780|NCT01820559|459330276|FG001|Overall Study|Adverse Event|6|||
127647781|NCT01820559|459330277|FG002|Overall Study|Adverse Event|13|||
127647782|NCT01820559|459330275|FG000|Overall Study|Withdrawal by Subject|1|||
127647783|NCT01820559|459330276|FG001|Overall Study|Withdrawal by Subject|2|||
127647784|NCT01820559|459330277|FG002|Overall Study|Withdrawal by Subject|5|||
127647785|NCT01820559|459330275|FG000|Overall Study|Protocol Violation|2|||
127647786|NCT01820559|459330276|FG001|Overall Study|Protocol Violation|1|||
127647787|NCT01820559|459330277|FG002|Overall Study|Protocol Violation|3|||
127647788|NCT01820559|459330275|FG000|Overall Study|Subject's non-compliance|1|||
127647789|NCT01820559|459330276|FG001|Overall Study|Subject's non-compliance|0|||
127647790|NCT01820559|459330277|FG002|Overall Study|Subject's non-compliance|2|||
127647791|NCT01820559|459330275|FG000|Overall Study|Lost to Follow-up|3|||
127647792|NCT01820559|459330276|FG001|Overall Study|Lost to Follow-up|2|||
127647793|NCT01820559|459330277|FG002|Overall Study|Lost to Follow-up|2|||
127647794|NCT01820559|459330275|FG000|Overall Study|At sponsor request|0|||
127647795|NCT01820559|459330276|FG001|Overall Study|At sponsor request|0|||
127647796|NCT01820559|459330277|FG002|Overall Study|At sponsor request|1|||
127647797|NCT01820559|459330275|FG000|Overall Study|Lack of Efficacy|3|||
127647798|NCT01820559|459330276|FG001|Overall Study|Lack of Efficacy|2|||
127647799|NCT01820559|459330277|FG002|Overall Study|Lack of Efficacy|3|||
127647800|NCT02755597|459330278|FG000|Overall Study|Withdrew consent|27|||
127647801|NCT02755597|459330279|FG001|Overall Study|Withdrew consent|11|||
127647802|NCT02755597|459330278|FG000|Overall Study|Lost to Follow-up|1|||
127981872|NCT05619536|460556078|FG002|Overall Study|Withdrawal by Subject|0|||
127981873|NCT05619536|460556079|FG003|Overall Study|Withdrawal by Subject|1|||
127647803|NCT02755597|459330279|FG001|Overall Study|Lost to Follow-up|0|||
127647804|NCT02755597|459330278|FG000|Overall Study|Death|78|||
127647805|NCT02755597|459330279|FG001|Overall Study|Death|36|||
127647806|NCT02755597|459330278|FG000|Overall Study|Study terminated by Sponsor|67|||
127647807|NCT02755597|459330279|FG001|Overall Study|Study terminated by Sponsor|47|||
127647808|NCT02755597|459330278|FG000|Overall Study|Other, not specified|20|||
127981874|NCT05619536|460556076|FG000|Overall Study|Lost to Follow-up|0|||
127981875|NCT05619536|460556077|FG001|Overall Study|Lost to Follow-up|1|||
127647809|NCT02755597|459330279|FG001|Overall Study|Other, not specified|3|||
127647810|NCT02755597|459330278|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
127647811|NCT02755597|459330279|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
127647812|NCT04642898|459330281|FG000|Overall Study|Withdrawal by Subject|2|||
127647813|NCT04642898|459330282|FG001|Overall Study|Withdrawal by Subject|4|||
127758406|NCT00166712|459741941|FG000|Overall Study|Physician Decision|0|||
127758407|NCT00166712|459741942|FG001|Overall Study|Physician Decision|2|||
127758408|NCT03986944|459741943|FG000|Overall Study|Adverse Event|1|||
127758409|NCT03986944|459741944|FG001|Overall Study|Adverse Event|2|||
127647814|NCT04642898|459330283|FG002|Overall Study|Withdrawal by Subject|4|||
127647815|NCT04642898|459330284|FG003|Overall Study|Withdrawal by Subject|6|||
127647816|NCT04642898|459330285|FG004|Overall Study|Withdrawal by Subject|2|||
127647817|NCT04642898|459330286|FG005|Overall Study|Withdrawal by Subject|6|||
127647818|NCT04642898|459330281|FG000|Overall Study|Lost to Follow-up|0|||
127758410|NCT03986944|459741945|FG002|Overall Study|Adverse Event|3|||
127758411|NCT03986944|459741943|FG000|Overall Study|Protocol Violation|0|||
127758412|NCT03986944|459741944|FG001|Overall Study|Protocol Violation|1|||
127758413|NCT03986944|459741945|FG002|Overall Study|Protocol Violation|1|||
127758414|NCT03986944|459741943|FG000|Overall Study|Withdrawal by Subject|3|||
127758415|NCT03986944|459741944|FG001|Overall Study|Withdrawal by Subject|5|||
127758416|NCT03986944|459741945|FG002|Overall Study|Withdrawal by Subject|5|||
127758417|NCT03986944|459741943|FG000|Overall Study|Study termination|10|||
127758418|NCT03986944|459741944|FG001|Overall Study|Study termination|10|||
127758419|NCT03986944|459741945|FG002|Overall Study|Study termination|10|||
127758420|NCT03986944|459741943|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|1|||
127758421|NCT03986944|459741944|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
127758422|NCT03986944|459741945|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
127758423|NCT03986944|459741943|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
127758424|NCT03986944|459741944|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|1|||
127758425|NCT03986944|459741945|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
127758426|NCT01015560|459741947|FG000|Overall Study|Adverse Event|1|||
127758427|NCT01015560|459741947|FG000|Overall Study|Not protocol specified|1|||
127758428|NCT01015560|459741947|FG000|Overall Study|Withdrawal by Subject|1|||
127758429|NCT00640133|459741948|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
127758430|NCT00640133|459741949|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
127758431|NCT00640133|459741948|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
127758432|NCT00640133|459741949|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
127758433|NCT00640133|459741948|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
127758434|NCT00640133|459741949|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
127981876|NCT05619536|460556078|FG002|Overall Study|Lost to Follow-up|1|||
127758435|NCT00128102|459741952|FG000|Overall Study|Site Discontinued|3|||
127758436|NCT00128102|459741953|FG001|Overall Study|Site Discontinued|6|||
127758437|NCT00128102|459741952|FG000|Overall Study|Other|0|||
127758438|NCT00128102|459741953|FG001|Overall Study|Other|1|||
127758439|NCT00128102|459741952|FG000|Overall Study|Progressive Disease|255|||
127758440|NCT00128102|459741953|FG001|Overall Study|Progressive Disease|285|||
127758441|NCT00128102|459741952|FG000|Overall Study|Adverse Event|34|||
127981877|NCT05619536|460556079|FG003|Overall Study|Lost to Follow-up|0|||
127647819|NCT04642898|459330282|FG001|Overall Study|Lost to Follow-up|0|||
127647820|NCT04642898|459330283|FG002|Overall Study|Lost to Follow-up|0|||
127647821|NCT04642898|459330284|FG003|Overall Study|Lost to Follow-up|2|||
127647822|NCT04642898|459330285|FG004|Overall Study|Lost to Follow-up|0|||
127647823|NCT04642898|459330286|FG005|Overall Study|Lost to Follow-up|1|||
127647824|NCT04642898|459330281|FG000|Overall Study|Therapist left trial before patient completed treatment|1|||
127647825|NCT04642898|459330282|FG001|Overall Study|Therapist left trial before patient completed treatment|0|||
127647826|NCT04642898|459330283|FG002|Overall Study|Therapist left trial before patient completed treatment|0|||
127647827|NCT04642898|459330284|FG003|Overall Study|Therapist left trial before patient completed treatment|0|||
127647828|NCT04642898|459330285|FG004|Overall Study|Therapist left trial before patient completed treatment|0|||
127647829|NCT04642898|459330286|FG005|Overall Study|Therapist left trial before patient completed treatment|1|||
127647830|NCT04642898|459330281|FG000|Overall Study|Ineligible due to conflict of interest with therapist|0|||
127647831|NCT04642898|459330282|FG001|Overall Study|Ineligible due to conflict of interest with therapist|0|||
127647832|NCT04642898|459330283|FG002|Overall Study|Ineligible due to conflict of interest with therapist|0|||
127647833|NCT04642898|459330284|FG003|Overall Study|Ineligible due to conflict of interest with therapist|0|||
127647834|NCT04642898|459330285|FG004|Overall Study|Ineligible due to conflict of interest with therapist|1|||
127647835|NCT04642898|459330286|FG005|Overall Study|Ineligible due to conflict of interest with therapist|0|||
127647836|NCT03574597|459330287|FG000|Overall Study|Withdrawal by Subject|67|||
127647837|NCT03574597|459330288|FG001|Overall Study|Withdrawal by Subject|96|||
127647838|NCT03574597|459330287|FG000|Overall Study|Lost to Follow-up|192|||
127647839|NCT03574597|459330288|FG001|Overall Study|Lost to Follow-up|188|||
127647840|NCT03434678|459330289|FG000|Overall Study|Withdrawal by Subject|13|||
127647841|NCT03434678|459330290|FG001|Overall Study|Withdrawal by Subject|13|||
127647842|NCT03434678|459330289|FG000|Overall Study|Found to be ineligible post randomization|2|||
127647843|NCT03434678|459330290|FG001|Overall Study|Found to be ineligible post randomization|1|||
127647844|NCT06060457|459330291|FG000|Overall Study|Adverse Event|1|||
127647845|NCT06060457|459330292|FG001|Overall Study|Adverse Event|1|||
127647846|NCT06060457|459330291|FG000|Overall Study|Death|2|||
127647847|NCT06060457|459330292|FG001|Overall Study|Death|2|||
127647848|NCT06060457|459330291|FG000|Overall Study|Lost to Follow-up|17|||
127647849|NCT06060457|459330292|FG001|Overall Study|Lost to Follow-up|19|||
127647850|NCT06060457|459330291|FG000|Overall Study|Physician Decision|0|||
127647851|NCT06060457|459330292|FG001|Overall Study|Physician Decision|1|||
127647852|NCT06060457|459330291|FG000|Overall Study|Protocol Violation|1|||
127647853|NCT06060457|459330292|FG001|Overall Study|Protocol Violation|1|||
127647854|NCT06060457|459330291|FG000|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
127647855|NCT06060457|459330292|FG001|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
127647856|NCT06060457|459330291|FG000|Overall Study|Withdrawal by Subject|12|||
127647857|NCT06060457|459330292|FG001|Overall Study|Withdrawal by Subject|15|||
127647858|NCT06060457|459330291|FG000|Overall Study|Other Than Specified|2|||
127647859|NCT06060457|459330292|FG001|Overall Study|Other Than Specified|1|||
127647860|NCT02061202|459330293|FG000|Overall Study|Lost to Follow-up|1|||
127647861|NCT02061202|459330294|FG001|Overall Study|Lost to Follow-up|1|||
127647862|NCT03419364|459330295|FG000|Overall Study|Delivery due to maternal condition|2|||
127647863|NCT03419364|459330296|FG001|Overall Study|Delivery due to maternal condition|0|||
127647864|NCT03419364|459330297|FG002|Overall Study|Delivery due to maternal condition|0|||
127647865|NCT01338025|459330301|FG000|Overall Study|Unexpected closure of study|10|||
127647866|NCT01338025|459330302|FG001|Overall Study|Unexpected closure of study|9|||
127647867|NCT01338025|459330301|FG000|Overall Study|Withdrawal by Subject|0|||
127647868|NCT01338025|459330302|FG001|Overall Study|Withdrawal by Subject|2|||
127647869|NCT01338025|459330301|FG000|Overall Study|Found ineligible after starting|1|||
127647870|NCT01338025|459330302|FG001|Overall Study|Found ineligible after starting|0|||
127647871|NCT04120233|459330303|FG000|Overall Study|Adverse Event|0|||
127647872|NCT04120233|459330304|FG001|Overall Study|Adverse Event|0|||
127647873|NCT04120233|459330305|FG002|Overall Study|Adverse Event|0|||
127647874|NCT04120233|459330306|FG003|Overall Study|Adverse Event|0|||
127647875|NCT04120233|459330307|FG004|Overall Study|Adverse Event|1|||
127647876|NCT04120233|459330308|FG005|Overall Study|Adverse Event|0|||
127647877|NCT03779906|459330309|FG000|Overall Study|Lost to Follow-up|7|||
127647878|NCT03779906|459330309|FG000|Overall Study|COVID pandemic|1|||
127647879|NCT02543658|459331577|FG000|Overall Study|Lack of Efficacy|0|||
127647880|NCT02543658|459331578|FG001|Overall Study|Lack of Efficacy|4|||
127647881|NCT00789815|459331579|FG000|Overall Study|Protocol Violation|6|||
127647882|NCT00789815|459331580|FG001|Overall Study|Protocol Violation|1|||
127647883|NCT00789815|459331579|FG000|Overall Study|Intubation due to massive bleeding|1|||
127647884|NCT00789815|459331580|FG001|Overall Study|Intubation due to massive bleeding|0|||
127647885|NCT00939484|459331582|FG000|Overall Study|Progression/Relapse|8|||
127647886|NCT00939484|459331583|FG001|Overall Study|Progression/Relapse|20|||
127647887|NCT00939484|459331584|FG002|Overall Study|Progression/Relapse|3|||
127647888|NCT01224925|459331585|FG000|Overall Study|Lost to Follow-up|3|||
127647889|NCT01224925|459331586|FG001|Overall Study|Lost to Follow-up|2|||
127647890|NCT00245102|459331588|FG000|Overall Study|Not Treated|1|||
127647891|NCT00245102|459331589|FG001|Overall Study|Not Treated|0|||
127647892|NCT00245102|459331590|FG002|Overall Study|Not Treated|1|||
127647893|NCT00245102|459331591|FG003|Overall Study|Not Treated|0|||
127647894|NCT00245102|459331592|FG004|Overall Study|Not Treated|0|||
127647895|NCT00245102|459331593|FG005|Overall Study|Not Treated|0|||
127647896|NCT00245102|459331588|FG000|Overall Study|Protocol Violation|1|||
127647897|NCT00245102|459331589|FG001|Overall Study|Protocol Violation|0|||
127647898|NCT00245102|459331590|FG002|Overall Study|Protocol Violation|0|||
127647899|NCT00245102|459331591|FG003|Overall Study|Protocol Violation|0|||
127647900|NCT00245102|459331592|FG004|Overall Study|Protocol Violation|0|||
127647901|NCT00245102|459331593|FG005|Overall Study|Protocol Violation|0|||
127647902|NCT00245102|459331588|FG000|Overall Study|Death|0|||
127647903|NCT00245102|459331589|FG001|Overall Study|Death|0|||
127647904|NCT00245102|459331590|FG002|Overall Study|Death|0|||
127647905|NCT00245102|459331591|FG003|Overall Study|Death|1|||
127647906|NCT00245102|459331592|FG004|Overall Study|Death|0|||
127647907|NCT00245102|459331593|FG005|Overall Study|Death|0|||
127647908|NCT00245102|459331588|FG000|Overall Study|Adverse Event|4|||
127647909|NCT00245102|459331589|FG001|Overall Study|Adverse Event|2|||
127647910|NCT00245102|459331590|FG002|Overall Study|Adverse Event|5|||
127647911|NCT00245102|459331591|FG003|Overall Study|Adverse Event|1|||
127647912|NCT00245102|459331592|FG004|Overall Study|Adverse Event|0|||
127647913|NCT00245102|459331593|FG005|Overall Study|Adverse Event|2|||
127647914|NCT00245102|459331588|FG000|Overall Study|Decline in performance|0|||
127647915|NCT00245102|459331589|FG001|Overall Study|Decline in performance|2|||
127647916|NCT00245102|459331590|FG002|Overall Study|Decline in performance|0|||
127647917|NCT00245102|459331591|FG003|Overall Study|Decline in performance|1|||
127647918|NCT00245102|459331592|FG004|Overall Study|Decline in performance|0|||
127647919|NCT00245102|459331593|FG005|Overall Study|Decline in performance|2|||
127647920|NCT00245102|459331588|FG000|Overall Study|Participant needed surgery|0|||
127647921|NCT00245102|459331589|FG001|Overall Study|Participant needed surgery|0|||
127647922|NCT00245102|459331590|FG002|Overall Study|Participant needed surgery|1|||
127647923|NCT00245102|459331591|FG003|Overall Study|Participant needed surgery|0|||
127647924|NCT00245102|459331592|FG004|Overall Study|Participant needed surgery|0|||
127647925|NCT00245102|459331593|FG005|Overall Study|Participant needed surgery|0|||
127647926|NCT00245102|459331588|FG000|Overall Study|Clinical progression|1|||
127647927|NCT00245102|459331589|FG001|Overall Study|Clinical progression|0|||
127647928|NCT00245102|459331590|FG002|Overall Study|Clinical progression|0|||
127647929|NCT00245102|459331591|FG003|Overall Study|Clinical progression|0|||
127647930|NCT00245102|459331592|FG004|Overall Study|Clinical progression|0|||
127647931|NCT00245102|459331593|FG005|Overall Study|Clinical progression|0|||
127647932|NCT02035332|459331594|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
127647933|NCT00838682|459331595|FG000|Overall Study|Lost to Follow-up|21|||
127647934|NCT00838682|459331596|FG001|Overall Study|Lost to Follow-up|14|||
127647935|NCT00838682|459331595|FG000|Overall Study|detection of exclusion criteria|4|||
127647936|NCT00838682|459331596|FG001|Overall Study|detection of exclusion criteria|3|||
127647937|NCT00838682|459331595|FG000|Overall Study|Protocol Violation|0|||
127647938|NCT00838682|459331596|FG001|Overall Study|Protocol Violation|1|||
127647939|NCT00838682|459331595|FG000|Overall Study|Withdrawal by Subject|0|||
127647940|NCT00838682|459331596|FG001|Overall Study|Withdrawal by Subject|1|||
127647941|NCT04098406|459331601|FG000|Overall Study|Adverse Event|2|||
127647942|NCT04098406|459331602|FG001|Overall Study|Adverse Event|1|||
127647943|NCT04098406|459331601|FG000|Overall Study|Withdrawal by Subject|1|||
127647944|NCT04098406|459331602|FG001|Overall Study|Withdrawal by Subject|0|||
127647945|NCT01783418|459331605|FG000|Overall Study|Withdrawal by Subject|1|||
127647946|NCT01783418|459331606|FG001|Overall Study|Withdrawal by Subject|0|||
127647947|NCT03548207|459331607|FG000|Overall Study|Death|10|||
127647948|NCT03548207|459331608|FG001|Overall Study|Death|23|||
127647949|NCT03548207|459331609|FG002|Overall Study|Death|3|||
127647950|NCT03548207|459331607|FG000|Overall Study|Lost to Follow-up|0|||
127647951|NCT03548207|459331608|FG001|Overall Study|Lost to Follow-up|2|||
127535189|NCT01188772|458923413|FG000|Overall Study|Treatment Failure|0|||
127535190|NCT01188772|458923414|FG001|Overall Study|Treatment Failure|0|||
127535191|NCT01188772|458923415|FG002|Overall Study|Treatment Failure|1|||
127647952|NCT03548207|459331609|FG002|Overall Study|Lost to Follow-up|0|||
127647953|NCT03548207|459331607|FG000|Overall Study|Withdrawal by Subject|0|||
127647954|NCT03548207|459331608|FG001|Overall Study|Withdrawal by Subject|3|||
127981878|NCT03619902|460556080|FG000|Overall Study|Termination of Study by Investigator|1|||
127981879|NCT03619902|460556080|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
127647955|NCT03548207|459331609|FG002|Overall Study|Withdrawal by Subject|0|||
127647956|NCT03548207|459331607|FG000|Overall Study|Sponsor decision|19|||
127647957|NCT03548207|459331608|FG001|Overall Study|Sponsor decision|40|||
127647958|NCT03548207|459331609|FG002|Overall Study|Sponsor decision|6|||
127647959|NCT03548207|459331607|FG000|Overall Study|Randomized but not treated|6|||
127647960|NCT03548207|459331608|FG001|Overall Study|Randomized but not treated|10|||
127647961|NCT03548207|459331609|FG002|Overall Study|Randomized but not treated|4|||
127647962|NCT00415610|459331610|FG000|Overall Study|Death|3|||
127647963|NCT00415610|459331611|FG001|Overall Study|Death|2|||
127647964|NCT00415610|459331612|FG002|Overall Study|Death|5|||
127647965|NCT00999466|459331613|FG000|Main Part|Withdrawal by Subject|0|||
127535192|NCT01188772|458923416|FG003|Overall Study|Treatment Failure|0|||
127535193|NCT01188772|458923413|FG000|Overall Study|Virologic Failure|1|||
127535194|NCT01188772|458923414|FG001|Overall Study|Virologic Failure|0|||
127535195|NCT01188772|458923415|FG002|Overall Study|Virologic Failure|0|||
127535196|NCT01188772|458923416|FG003|Overall Study|Virologic Failure|0|||
127535197|NCT01188772|458923413|FG000|Overall Study|Withdrawal by Subject|0|||
127535198|NCT01188772|458923414|FG001|Overall Study|Withdrawal by Subject|0|||
127535199|NCT01188772|458923415|FG002|Overall Study|Withdrawal by Subject|2|||
127535200|NCT01188772|458923416|FG003|Overall Study|Withdrawal by Subject|0|||
127647966|NCT00999466|459331614|FG001|Main Part|Withdrawal by Subject|0|||
127647967|NCT00999466|459331615|FG002|Main Part|Withdrawal by Subject|2|||
127647968|NCT00999466|459331613|FG000|Main Part|Adverse Event|0|||
127647969|NCT00999466|459331614|FG001|Main Part|Adverse Event|4|||
127647970|NCT00999466|459331615|FG002|Main Part|Adverse Event|2|||
127647971|NCT00645164|459331618|FG000|Overall Study|Lost to Follow-up|2|||
127647972|NCT00645164|459331618|FG000|Overall Study|Withdrawal by Subject|4|||
127647973|NCT00645164|459331618|FG000|Overall Study|Protocol Violation|1|||
127647974|NCT03595332|459331619|FG000|Overall Study|Lost to Follow-up|16|||
127647975|NCT03595332|459331620|FG001|Overall Study|Lost to Follow-up|22|||
127647976|NCT03595332|459331619|FG000|Overall Study|Unable to retrieve ID from school|0|||
127647977|NCT03595332|459331620|FG001|Overall Study|Unable to retrieve ID from school|2|||
127647978|NCT00117676|459331621|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
127647979|NCT00117676|459331622|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
127647980|NCT00117676|459331621|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
127647981|NCT00117676|459331622|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
127647982|NCT00117676|459331621|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
127647983|NCT00117676|459331622|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
127647984|NCT00117676|459331621|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
127647985|NCT00117676|459331622|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
127647986|NCT00117676|459331621|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
127647987|NCT00117676|459331622|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
127647988|NCT00117676|459331621|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
127647989|NCT00117676|459331622|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
127647990|NCT00117676|459331621|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
127647991|NCT00117676|459331622|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
127647992|NCT00117676|459331621|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
127647993|NCT00117676|459331622|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
127647994|NCT00117676|459331621|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
127647995|NCT00117676|459331622|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
127647996|NCT00117676|459331621|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
127647997|NCT00117676|459331622|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
127647998|NCT00117676|459331621|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
127647999|NCT00117676|459331622|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
127648000|NCT00117676|459331621|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
127648001|NCT00117676|459331622|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
127648002|NCT00117676|459331621|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
127758442|NCT00128102|459741953|FG001|Overall Study|Adverse Event|11|||
127758443|NCT00128102|459741952|FG000|Overall Study|Death|12|||
127758444|NCT00128102|459741953|FG001|Overall Study|Death|13|||
127758445|NCT00128102|459741952|FG000|Overall Study|Physician Decision|3|||
127758446|NCT00128102|459741953|FG001|Overall Study|Physician Decision|3|||
127758447|NCT00128102|459741952|FG000|Overall Study|Withdrawal by Subject|19|||
127758448|NCT00128102|459741953|FG001|Overall Study|Withdrawal by Subject|11|||
127758449|NCT00128102|459741952|FG000|Overall Study|Protocol Violation|2|||
127981880|NCT02923245|460556081|FG000|Overall Study|ultrasound order was cancelled|2|||
127981881|NCT02923245|460556082|FG001|Overall Study|ultrasound order was cancelled|1|||
127758450|NCT00128102|459741953|FG001|Overall Study|Protocol Violation|2|||
127758451|NCT01202903|459741954|FG000|Overall Study|Administrative Probelms|1|||
127758452|NCT01202903|459741955|FG001|Overall Study|Administrative Probelms|4|||
127758453|NCT01202903|459741954|FG000|Overall Study|Protocol Violation|0|||
127758454|NCT01202903|459741955|FG001|Overall Study|Protocol Violation|1|||
127758455|NCT01202903|459741954|FG000|Overall Study|Death|1|||
127535201|NCT01894607|458923417|FG000|Overall Study|Ineligible|1|||
127535202|NCT03259555|458923430|FG000|Overall Study|Adverse Event|6|||
127758456|NCT01202903|459741955|FG001|Overall Study|Death|0|||
127758457|NCT01202903|459741954|FG000|Overall Study|Lost to Follow-up|1|||
127758458|NCT01202903|459741955|FG001|Overall Study|Lost to Follow-up|1|||
127758459|NCT01202903|459741954|FG000|Overall Study|Lack of Efficacy|1|||
127981882|NCT02520427|460556083|FG000|Overall Study|Decision by sponsor|0|||
127535203|NCT03259555|458923431|FG001|Overall Study|Adverse Event|4|||
127535204|NCT03259555|458923430|FG000|Overall Study|Lack of Efficacy|6|||
127535205|NCT03259555|458923431|FG001|Overall Study|Lack of Efficacy|4|||
127535206|NCT03259555|458923430|FG000|Overall Study|Lost to Follow-up|0|||
127648003|NCT00117676|459331622|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
127648004|NCT00117676|459331621|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
127648005|NCT00117676|459331622|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
127648006|NCT00117676|459331621|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
127648007|NCT00117676|459331622|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
127648008|NCT00117676|459331621|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
127648009|NCT00117676|459331622|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
127648010|NCT00117676|459331621|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
127648011|NCT00117676|459331622|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
127648012|NCT00117676|459331621|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
127648013|NCT00117676|459331622|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
127648014|NCT00117676|459331621|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
127648015|NCT00117676|459331622|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
127758460|NCT01202903|459741955|FG001|Overall Study|Lack of Efficacy|3|||
127758461|NCT01202903|459741954|FG000|Overall Study|Adverse Event|3|||
127758462|NCT01202903|459741955|FG001|Overall Study|Adverse Event|3|||
127758463|NCT01202903|459741954|FG000|Overall Study|Withdrawal by Subject|4|||
127758464|NCT01202903|459741955|FG001|Overall Study|Withdrawal by Subject|4|||
127758465|NCT03339245|459741956|FG000|Overall Study|Adverse Event|1|||
127758466|NCT03339245|459741957|FG001|Overall Study|Adverse Event|1|||
127758467|NCT03339245|459741956|FG000|Overall Study|Withdrawal by Subject|1|||
127758468|NCT03339245|459741957|FG001|Overall Study|Withdrawal by Subject|0|||
127758469|NCT00837694|459741958|FG000|Overall Study|Lost to Follow-up|2|||
127758470|NCT00837694|459741959|FG001|Overall Study|Lost to Follow-up|0|||
127758471|NCT00837694|459741960|FG002|Overall Study|Lost to Follow-up|2|||
127758472|NCT00837694|459741961|FG003|Overall Study|Lost to Follow-up|1|||
127758473|NCT00837694|459741962|FG004|Overall Study|Lost to Follow-up|1|||
127758474|NCT00837694|459741963|FG005|Overall Study|Lost to Follow-up|1|||
127758475|NCT00306670|459741970|FG000|Overall Study|patients recruited; Genentech, the st|0|||
127758476|NCT00306670|459741971|FG001|Overall Study|patients recruited; Genentech, the st|2|||
127758477|NCT00503139|459741972|FG000|Overall Study|Case Report Forms were not collected|4|||
127758478|NCT00503139|459741972|FG000|Overall Study|Protocol Violation|4|||
127758479|NCT02735577|459741973|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
127758480|NCT02735577|459741973|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
127758481|NCT00833833|459741974|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
127758482|NCT00833833|459741975|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
127758483|NCT00833833|459741976|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
127758484|NCT00833833|459741977|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
127758485|NCT00833833|459741978|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
127758486|NCT00833833|459741979|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
127758487|NCT00833833|459741974|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
127758488|NCT00833833|459741975|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
127758489|NCT00833833|459741976|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
127535207|NCT03259555|458923431|FG001|Overall Study|Lost to Follow-up|2|||
127535208|NCT03259555|458923430|FG000|Overall Study|Non-Compliance With Study Drug|1|||
127535209|NCT03259555|458923431|FG001|Overall Study|Non-Compliance With Study Drug|0|||
127535210|NCT03259555|458923430|FG000|Overall Study|Progressive Disease|0|||
127535211|NCT03259555|458923431|FG001|Overall Study|Progressive Disease|2|||
127535212|NCT03259555|458923430|FG000|Overall Study|Withdrawal by Subject|19|||
127535213|NCT03259555|458923431|FG001|Overall Study|Withdrawal by Subject|16|||
127535214|NCT03259555|458923430|FG000|Overall Study|Physician Decision|1|||
127535215|NCT03259555|458923431|FG001|Overall Study|Physician Decision|2|||
127535216|NCT03259555|458923430|FG000|Overall Study|Other|1|||
127535217|NCT03259555|458923431|FG001|Overall Study|Other|0|||
127535218|NCT04393493|458923432|FG000|First 4 Days of Intervention|Early improvement|5|||
127535219|NCT04393493|458923433|FG001|First 4 Days of Intervention|Early improvement|7|||
127535220|NCT01125800|458923434|FG000|Phase I|Protocol Violation|0|||
127535221|NCT01125800|458923435|FG001|Phase I|Protocol Violation|3|||
127535222|NCT01125800|458923436|FG002|Phase I|Protocol Violation|1|||
127535223|NCT01125800|458923437|FG003|Phase I|Protocol Violation|1|||
127535224|NCT01125800|458923438|FG004|Phase I|Protocol Violation|0|||
127535225|NCT01125800|458923434|FG000|Phase I|Adverse Event|2|||
127535226|NCT01125800|458923435|FG001|Phase I|Adverse Event|2|||
127758490|NCT00833833|459741977|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
127758491|NCT00833833|459741978|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
127758492|NCT00833833|459741979|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
127758493|NCT00833833|459741974|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
127758494|NCT00833833|459741975|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
127535227|NCT01125800|458923436|FG002|Phase I|Adverse Event|1|||
127535228|NCT01125800|458923437|FG003|Phase I|Adverse Event|7|||
127535229|NCT01125800|458923438|FG004|Phase I|Adverse Event|0|||
127535230|NCT01125800|458923434|FG000|Phase I|Administrative problems|1|||
127648016|NCT00117676|459331621|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
127648017|NCT00117676|459331622|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
127648018|NCT00117676|459331621|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
127648019|NCT00117676|459331622|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
127648020|NCT00117676|459331621|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
127648021|NCT00117676|459331622|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
127648022|NCT00117676|459331621|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
127648023|NCT00117676|459331622|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
127648024|NCT00117676|459331621|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
127648025|NCT00117676|459331622|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
127648026|NCT00117676|459331621|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
127648027|NCT00117676|459331622|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
127758495|NCT00833833|459741976|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
127758496|NCT00833833|459741977|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
127758497|NCT00833833|459741978|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
127758498|NCT00833833|459741979|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
127758499|NCT00833833|459741974|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
127758500|NCT00833833|459741975|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
127758501|NCT00833833|459741976|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
127758502|NCT00833833|459741977|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
127758503|NCT00833833|459741978|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
127758504|NCT00833833|459741979|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
127758505|NCT00833833|459741974|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
127758506|NCT00833833|459741975|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
127758507|NCT00833833|459741976|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
127758508|NCT00833833|459741977|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
127758509|NCT00833833|459741978|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
127758510|NCT00833833|459741979|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
127758511|NCT00833833|459741974|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
127981883|NCT02520427|460556084|FG001|Overall Study|Decision by sponsor|0|||
127981884|NCT02520427|460556085|FG002|Overall Study|Decision by sponsor|0|||
127981885|NCT02520427|460556086|FG003|Overall Study|Decision by sponsor|0|||
127981886|NCT02520427|460556087|FG004|Overall Study|Decision by sponsor|0|||
127981887|NCT02520427|460556088|FG005|Overall Study|Decision by sponsor|0|||
127981888|NCT02520427|460556089|FG006|Overall Study|Decision by sponsor|0|||
127758512|NCT00833833|459741975|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
127758513|NCT00833833|459741976|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
127758514|NCT00833833|459741977|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
127758515|NCT00833833|459741978|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
127758516|NCT00833833|459741979|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
127758517|NCT00833833|459741974|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
127758518|NCT00833833|459741975|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
127758519|NCT00833833|459741976|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
127758520|NCT00833833|459741977|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
127758521|NCT00833833|459741978|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
127758522|NCT00833833|459741979|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
127758523|NCT00833833|459741974|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
127758524|NCT00833833|459741975|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
127758525|NCT00833833|459741976|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
127758526|NCT00833833|459741977|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
127758527|NCT00833833|459741978|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
127758528|NCT00833833|459741979|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
127758529|NCT00833833|459741974|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
127758530|NCT00833833|459741975|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
127758531|NCT00833833|459741976|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
127758532|NCT00833833|459741977|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
127758533|NCT00833833|459741978|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
127758534|NCT00833833|459741979|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
127758535|NCT00833833|459741974|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
127758536|NCT00833833|459741975|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
127758537|NCT00833833|459741976|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
127758538|NCT00833833|459741977|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
127758539|NCT00833833|459741978|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
127758540|NCT00833833|459741979|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
127758541|NCT00833833|459741974|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
127758542|NCT00833833|459741975|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
127758543|NCT00833833|459741976|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
127981889|NCT02520427|460556090|FG007|Overall Study|Decision by sponsor|0|||
127981890|NCT02520427|460556091|FG008|Overall Study|Decision by sponsor|1|||
127758544|NCT00833833|459741977|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
127758545|NCT00833833|459741978|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
127758546|NCT00833833|459741979|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
127758547|NCT00833833|459741974|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
127758548|NCT00833833|459741975|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
127758549|NCT00833833|459741976|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
127758550|NCT00833833|459741977|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
127758551|NCT00833833|459741978|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
127758552|NCT00833833|459741979|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
127758553|NCT00833833|459741974|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
127758554|NCT00833833|459741975|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
127758555|NCT00833833|459741976|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
127758556|NCT00833833|459741977|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
127758557|NCT00833833|459741978|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
127758558|NCT00833833|459741979|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
127758559|NCT01994837|459741980|FG000|Overall Study|Progressive disease per protocol|23|||
127981891|NCT02520427|460556092|FG009|Overall Study|Decision by sponsor|1|||
127981892|NCT02520427|460556093|FG010|Overall Study|Decision by sponsor|0|||
127981893|NCT02520427|460556094|FG011|Overall Study|Decision by sponsor|0|||
127981894|NCT02520427|460556095|FG012|Overall Study|Decision by sponsor|0|||
127981895|NCT02520427|460556096|FG013|Overall Study|Decision by sponsor|0|||
127981896|NCT02520427|460556097|FG014|Overall Study|Decision by sponsor|0|||
127981897|NCT02520427|460556098|FG015|Overall Study|Decision by sponsor|0|||
127981898|NCT02520427|460556099|FG016|Overall Study|Decision by sponsor|0|||
127981899|NCT02520427|460556100|FG017|Overall Study|Decision by sponsor|0|||
127981900|NCT02520427|460556101|FG018|Overall Study|Decision by sponsor|0|||
127981901|NCT02520427|460556102|FG019|Overall Study|Decision by sponsor|0|||
127981902|NCT02520427|460556103|FG020|Overall Study|Decision by sponsor|0|||
127981903|NCT02520427|460556104|FG021|Overall Study|Decision by sponsor|0|||
127981904|NCT02520427|460556105|FG022|Overall Study|Decision by sponsor|0|||
127981905|NCT02520427|460556106|FG023|Overall Study|Decision by sponsor|0|||
127981906|NCT02520427|460556107|FG024|Overall Study|Decision by sponsor|0|||
127981907|NCT02520427|460556108|FG025|Overall Study|Decision by sponsor|0|||
127981908|NCT02520427|460556083|FG000|Overall Study|Withdrawal by Subject|0|||
127981909|NCT02520427|460556084|FG001|Overall Study|Withdrawal by Subject|0|||
127981910|NCT02520427|460556085|FG002|Overall Study|Withdrawal by Subject|1|||
127981911|NCT02520427|460556086|FG003|Overall Study|Withdrawal by Subject|0|||
127981912|NCT02520427|460556087|FG004|Overall Study|Withdrawal by Subject|0|||
127981913|NCT02520427|460556088|FG005|Overall Study|Withdrawal by Subject|0|||
127981914|NCT02520427|460556089|FG006|Overall Study|Withdrawal by Subject|0|||
127981915|NCT02520427|460556090|FG007|Overall Study|Withdrawal by Subject|0|||
127981916|NCT02520427|460556091|FG008|Overall Study|Withdrawal by Subject|0|||
127981917|NCT02520427|460556092|FG009|Overall Study|Withdrawal by Subject|0|||
127981918|NCT02520427|460556093|FG010|Overall Study|Withdrawal by Subject|0|||
127981919|NCT02520427|460556094|FG011|Overall Study|Withdrawal by Subject|0|||
127981920|NCT02520427|460556095|FG012|Overall Study|Withdrawal by Subject|1|||
127981921|NCT02520427|460556096|FG013|Overall Study|Withdrawal by Subject|1|||
127981922|NCT02520427|460556097|FG014|Overall Study|Withdrawal by Subject|1|||
127981923|NCT02520427|460556098|FG015|Overall Study|Withdrawal by Subject|0|||
127981924|NCT02520427|460556099|FG016|Overall Study|Withdrawal by Subject|1|||
127981925|NCT02520427|460556100|FG017|Overall Study|Withdrawal by Subject|0|||
127981926|NCT02520427|460556101|FG018|Overall Study|Withdrawal by Subject|0|||
127981927|NCT02520427|460556102|FG019|Overall Study|Withdrawal by Subject|3|||
127981928|NCT02520427|460556103|FG020|Overall Study|Withdrawal by Subject|2|||
127981929|NCT02520427|460556104|FG021|Overall Study|Withdrawal by Subject|0|||
127981930|NCT02520427|460556105|FG022|Overall Study|Withdrawal by Subject|0|||
127981931|NCT02520427|460556106|FG023|Overall Study|Withdrawal by Subject|0|||
127981932|NCT02520427|460556107|FG024|Overall Study|Withdrawal by Subject|0|||
127981933|NCT02520427|460556108|FG025|Overall Study|Withdrawal by Subject|0|||
127981934|NCT02520427|460556083|FG000|Overall Study|Death|1|||
127981935|NCT02520427|460556084|FG001|Overall Study|Death|0|||
127981936|NCT02520427|460556085|FG002|Overall Study|Death|0|||
127981937|NCT02520427|460556086|FG003|Overall Study|Death|0|||
127981938|NCT02520427|460556087|FG004|Overall Study|Death|0|||
127981939|NCT02520427|460556088|FG005|Overall Study|Death|0|||
127981940|NCT02520427|460556089|FG006|Overall Study|Death|0|||
127981941|NCT02520427|460556090|FG007|Overall Study|Death|0|||
127981942|NCT02520427|460556091|FG008|Overall Study|Death|0|||
127981943|NCT02520427|460556092|FG009|Overall Study|Death|0|||
127981944|NCT02520427|460556093|FG010|Overall Study|Death|0|||
127981945|NCT02520427|460556094|FG011|Overall Study|Death|0|||
127981946|NCT02520427|460556095|FG012|Overall Study|Death|0|||
127981947|NCT02520427|460556096|FG013|Overall Study|Death|0|||
127981948|NCT02520427|460556097|FG014|Overall Study|Death|0|||
127981949|NCT02520427|460556098|FG015|Overall Study|Death|0|||
127981950|NCT02520427|460556099|FG016|Overall Study|Death|2|||
127981951|NCT02520427|460556100|FG017|Overall Study|Death|1|||
127981952|NCT02520427|460556101|FG018|Overall Study|Death|3|||
127981953|NCT02520427|460556102|FG019|Overall Study|Death|2|||
127981954|NCT02520427|460556103|FG020|Overall Study|Death|0|||
127981955|NCT02520427|460556104|FG021|Overall Study|Death|0|||
127981956|NCT02520427|460556105|FG022|Overall Study|Death|1|||
127981957|NCT02520427|460556106|FG023|Overall Study|Death|0|||
127981958|NCT02520427|460556107|FG024|Overall Study|Death|1|||
127981959|NCT02520427|460556108|FG025|Overall Study|Death|0|||
127981960|NCT00793624|460556111|FG000|Overall Study|Adverse Event|18|||
127981961|NCT00793624|460556112|FG001|Overall Study|Adverse Event|16|||
127981962|NCT00793624|460556113|FG002|Overall Study|Adverse Event|15|||
127981963|NCT00793624|460556114|FG003|Overall Study|Adverse Event|20|||
127981964|NCT00793624|460556111|FG000|Overall Study|Lost to Follow-up|2|||
127981965|NCT00793624|460556112|FG001|Overall Study|Lost to Follow-up|2|||
127981966|NCT00793624|460556113|FG002|Overall Study|Lost to Follow-up|4|||
127981967|NCT00793624|460556114|FG003|Overall Study|Lost to Follow-up|0|||
127981968|NCT00793624|460556111|FG000|Overall Study|Withdrawal by Subject|20|||
127981969|NCT00793624|460556112|FG001|Overall Study|Withdrawal by Subject|9|||
127981970|NCT00793624|460556113|FG002|Overall Study|Withdrawal by Subject|11|||
127981971|NCT00793624|460556114|FG003|Overall Study|Withdrawal by Subject|14|||
127981972|NCT00793624|460556111|FG000|Overall Study|Lack of Efficacy|9|||
127981973|NCT00793624|460556112|FG001|Overall Study|Lack of Efficacy|2|||
127981974|NCT00793624|460556113|FG002|Overall Study|Lack of Efficacy|1|||
127981975|NCT00793624|460556114|FG003|Overall Study|Lack of Efficacy|3|||
127981976|NCT00793624|460556111|FG000|Overall Study|Non compliance with protocol|2|||
127981977|NCT00793624|460556112|FG001|Overall Study|Non compliance with protocol|3|||
127981978|NCT00793624|460556113|FG002|Overall Study|Non compliance with protocol|2|||
127981979|NCT00793624|460556114|FG003|Overall Study|Non compliance with protocol|3|||
127981980|NCT00793624|460556111|FG000|Overall Study|Other reason not described above|6|||
127981981|NCT00793624|460556112|FG001|Overall Study|Other reason not described above|4|||
127981982|NCT00793624|460556113|FG002|Overall Study|Other reason not described above|6|||
127981983|NCT00793624|460556114|FG003|Overall Study|Other reason not described above|3|||
127981984|NCT00710684|460556115|FG000|Overall Study|Adverse Event|11|||
127981985|NCT00710684|460556116|FG001|Overall Study|Adverse Event|19|||
127981986|NCT00710684|460556117|FG002|Overall Study|Adverse Event|16|||
127981987|NCT00710684|460556115|FG000|Overall Study|Lack of Efficacy|4|||
127981988|NCT00710684|460556116|FG001|Overall Study|Lack of Efficacy|3|||
127981989|NCT00710684|460556117|FG002|Overall Study|Lack of Efficacy|5|||
127981990|NCT00710684|460556115|FG000|Overall Study|Protocol Violation|5|||
127981991|NCT00710684|460556116|FG001|Overall Study|Protocol Violation|5|||
127981992|NCT00710684|460556117|FG002|Overall Study|Protocol Violation|5|||
127981993|NCT00710684|460556115|FG000|Overall Study|Lost to Follow-up|4|||
127981994|NCT00710684|460556116|FG001|Overall Study|Lost to Follow-up|6|||
127981995|NCT00710684|460556117|FG002|Overall Study|Lost to Follow-up|7|||
127981996|NCT00710684|460556115|FG000|Overall Study|Physician Decision|0|||
127981997|NCT00710684|460556116|FG001|Overall Study|Physician Decision|2|||
127981998|NCT00710684|460556117|FG002|Overall Study|Physician Decision|4|||
127981999|NCT00710684|460556115|FG000|Overall Study|Withdrawal by Subject|24|||
127982000|NCT00710684|460556116|FG001|Overall Study|Withdrawal by Subject|18|||
127982001|NCT00710684|460556117|FG002|Overall Study|Withdrawal by Subject|11|||
127982002|NCT00710684|460556115|FG000|Overall Study|Missing|1|||
127982003|NCT00710684|460556116|FG001|Overall Study|Missing|0|||
127982004|NCT00710684|460556117|FG002|Overall Study|Missing|0|||
127982005|NCT00710684|460556115|FG000|Overall Study|Did not continue after week 24|25|||
127982006|NCT00710684|460556116|FG001|Overall Study|Did not continue after week 24|21|||
127982007|NCT00710684|460556117|FG002|Overall Study|Did not continue after week 24|16|||
127982008|NCT04778059|460556118|FG000|Overall Study|Death|2|||
127982009|NCT04778059|460556119|FG001|Overall Study|Death|2|||
127982010|NCT04778059|460556120|FG002|Overall Study|Death|1|||
127982011|NCT04778059|460556121|FG003|Overall Study|Death|1|||
127982012|NCT04778059|460556122|FG004|Overall Study|Death|1|||
127982013|NCT04778059|460556118|FG000|Overall Study|Lost to Follow-up|0|||
127982014|NCT04778059|460556119|FG001|Overall Study|Lost to Follow-up|0|||
127982015|NCT04778059|460556120|FG002|Overall Study|Lost to Follow-up|0|||
127982016|NCT04778059|460556121|FG003|Overall Study|Lost to Follow-up|0|||
127982017|NCT04778059|460556122|FG004|Overall Study|Lost to Follow-up|1|||
127982018|NCT04778059|460556118|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
127982019|NCT04778059|460556119|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
127982020|NCT04778059|460556120|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
127758560|NCT01994837|459741980|FG000|Overall Study|Adv event related to progressive disease|3|||
127982021|NCT04778059|460556121|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
127982022|NCT04778059|460556122|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
127982023|NCT00157248|460556124|FG000|Overall Study|Adverse Event|36|||
127982024|NCT00157248|460556125|FG001|Overall Study|Adverse Event|25|||
127982025|NCT00157248|460556126|FG002|Overall Study|Adverse Event|13|||
127982026|NCT00157248|460556127|FG003|Overall Study|Adverse Event|33|||
127982027|NCT00157248|460556124|FG000|Overall Study|Protocol Violation|4|||
127982028|NCT00157248|460556125|FG001|Overall Study|Protocol Violation|0|||
127982029|NCT00157248|460556126|FG002|Overall Study|Protocol Violation|2|||
127982030|NCT00157248|460556127|FG003|Overall Study|Protocol Violation|2|||
127982031|NCT00157248|460556124|FG000|Overall Study|Lost to Follow-up|0|||
127982032|NCT00157248|460556125|FG001|Overall Study|Lost to Follow-up|1|||
127982033|NCT00157248|460556126|FG002|Overall Study|Lost to Follow-up|0|||
127982034|NCT00157248|460556127|FG003|Overall Study|Lost to Follow-up|0|||
127982035|NCT00157248|460556124|FG000|Overall Study|Withdrawal by Subject|1|||
127982036|NCT00157248|460556125|FG001|Overall Study|Withdrawal by Subject|4|||
127982037|NCT00157248|460556126|FG002|Overall Study|Withdrawal by Subject|3|||
127982038|NCT00157248|460556127|FG003|Overall Study|Withdrawal by Subject|3|||
127982039|NCT00157248|460556124|FG000|Overall Study|site closures, subject moving|7|||
127982040|NCT00157248|460556125|FG001|Overall Study|site closures, subject moving|7|||
127982041|NCT00157248|460556126|FG002|Overall Study|site closures, subject moving|3|||
127982042|NCT00157248|460556127|FG003|Overall Study|site closures, subject moving|9|||
127982043|NCT01306045|460556128|FG000|Met General Eligibility Criteria|Screen failures|193|||
127982044|NCT01306045|460556129|FG001|Met General Eligibility Criteria|Screen failures|11|||
127982045|NCT01306045|460556130|FG002|Met General Eligibility Criteria|Screen failures|8|||
127982046|NCT02987972|460556131|FG000|Overall Study|Adverse Event|1|||
127982047|NCT02987972|460556132|FG001|Overall Study|Adverse Event|1|||
127982048|NCT02987972|460556133|FG002|Overall Study|Adverse Event|0|||
127982049|NCT02987972|460556131|FG000|Overall Study|Death|1|||
127982050|NCT02987972|460556132|FG001|Overall Study|Death|0|||
127982051|NCT02987972|460556133|FG002|Overall Study|Death|0|||
127982052|NCT02987972|460556131|FG000|Overall Study|Lack of Efficacy|9|||
127982053|NCT02987972|460556132|FG001|Overall Study|Lack of Efficacy|12|||
127982054|NCT02987972|460556133|FG002|Overall Study|Lack of Efficacy|12|||
127982055|NCT02987972|460556131|FG000|Overall Study|Lost to Follow-up|7|||
127982056|NCT02987972|460556132|FG001|Overall Study|Lost to Follow-up|8|||
127982057|NCT02987972|460556133|FG002|Overall Study|Lost to Follow-up|4|||
127982058|NCT02987972|460556131|FG000|Overall Study|Physician Decision|1|||
127982059|NCT02987972|460556132|FG001|Overall Study|Physician Decision|6|||
127982060|NCT02987972|460556133|FG002|Overall Study|Physician Decision|0|||
127982061|NCT02987972|460556131|FG000|Overall Study|Protocol Violation|2|||
127982062|NCT02987972|460556132|FG001|Overall Study|Protocol Violation|1|||
127982063|NCT02987972|460556133|FG002|Overall Study|Protocol Violation|5|||
127982064|NCT02987972|460556131|FG000|Overall Study|Withdrawal by Subject|22|||
127982065|NCT02987972|460556132|FG001|Overall Study|Withdrawal by Subject|17|||
127982066|NCT02987972|460556133|FG002|Overall Study|Withdrawal by Subject|21|||
127982067|NCT05072106|460557602|FG000|Overall Study|Progressive disease|3|||
127982068|NCT05072106|460557603|FG001|Overall Study|Progressive disease|3|||
127982069|NCT05072106|460557602|FG000|Overall Study|Compassionate use|3|||
127982070|NCT05072106|460557603|FG001|Overall Study|Compassionate use|1|||
127982071|NCT05072106|460557602|FG000|Overall Study|Withdrawal by Subject|1|||
127982072|NCT05072106|460557603|FG001|Overall Study|Withdrawal by Subject|0|||
127982073|NCT03839459|460557604|FG000|Overall Study|Withdrawal by Subject|2|||
127982074|NCT03839459|460557604|FG000|Overall Study|progression of disease|3|||
127982075|NCT01458951|460557608|FG000|Overall Study|Other|1|||
127982076|NCT01458951|460557609|FG001|Overall Study|Other|0|||
127982077|NCT01458951|460557610|FG002|Overall Study|Other|0|||
127982078|NCT01458951|460557608|FG000|Overall Study|Protocol Violation|5|||
127982079|NCT01458951|460557609|FG001|Overall Study|Protocol Violation|1|||
127982080|NCT01458951|460557610|FG002|Overall Study|Protocol Violation|0|||
127982081|NCT01458951|460557608|FG000|Overall Study|Withdrawal by Subject|2|||
127982082|NCT01458951|460557609|FG001|Overall Study|Withdrawal by Subject|0|||
127982083|NCT01458951|460557610|FG002|Overall Study|Withdrawal by Subject|2|||
127982084|NCT01458951|460557608|FG000|Overall Study|Adverse Event|7|||
127982085|NCT01458951|460557609|FG001|Overall Study|Adverse Event|0|||
127982086|NCT01458951|460557610|FG002|Overall Study|Adverse Event|2|||
127982087|NCT01458951|460557608|FG000|Overall Study|Insufficient Clinical Response|17|||
127982088|NCT01458951|460557609|FG001|Overall Study|Insufficient Clinical Response|0|||
127982089|NCT01458951|460557610|FG002|Overall Study|Insufficient Clinical Response|11|||
127982090|NCT02963558|460557613|FG000|Overall Study|Withdrawn by investigator|1|||
127982091|NCT02963558|460557614|FG001|Overall Study|Withdrawn by investigator|0|||
127982092|NCT02963558|460557613|FG000|Overall Study|Withdrawal by Subject|0|||
127982093|NCT02963558|460557614|FG001|Overall Study|Withdrawal by Subject|1|||
127982094|NCT01573767|460557615|FG000|Overall Study|Adverse Event|0|||
127982095|NCT01573767|460557616|FG001|Overall Study|Adverse Event|1|||
127982096|NCT01573767|460557617|FG002|Overall Study|Adverse Event|0|||
127535231|NCT01125800|458923435|FG001|Phase I|Administrative problems|0|||
127535232|NCT01125800|458923436|FG002|Phase I|Administrative problems|0|||
127982097|NCT01573767|460557618|FG003|Overall Study|Adverse Event|1|||
127982098|NCT01573767|460557615|FG000|Overall Study|Lack of Efficacy|18|||
127535233|NCT01125800|458923437|FG003|Phase I|Administrative problems|0|||
127982099|NCT01573767|460557616|FG001|Overall Study|Lack of Efficacy|15|||
127982100|NCT01573767|460557617|FG002|Overall Study|Lack of Efficacy|12|||
127982101|NCT01573767|460557618|FG003|Overall Study|Lack of Efficacy|17|||
127982102|NCT01573767|460557615|FG000|Overall Study|Protocol Violation|3|||
127982103|NCT01573767|460557616|FG001|Overall Study|Protocol Violation|1|||
127982104|NCT01573767|460557617|FG002|Overall Study|Protocol Violation|1|||
127982105|NCT01573767|460557618|FG003|Overall Study|Protocol Violation|3|||
127535234|NCT01125800|458923438|FG004|Phase I|Administrative problems|0|||
127535235|NCT01125800|458923434|FG000|Phase I|Withdrawal by Subject|0|||
127535236|NCT01125800|458923435|FG001|Phase I|Withdrawal by Subject|0|||
127535237|NCT01125800|458923436|FG002|Phase I|Withdrawal by Subject|1|||
127535238|NCT01125800|458923437|FG003|Phase I|Withdrawal by Subject|0|||
127535239|NCT01125800|458923438|FG004|Phase I|Withdrawal by Subject|0|||
127535240|NCT01125800|458923434|FG000|Phase I|Disease progression|5|||
127982106|NCT01573767|460557615|FG000|Overall Study|Lost to Follow-up|0|||
127982107|NCT01573767|460557616|FG001|Overall Study|Lost to Follow-up|1|||
127982108|NCT01573767|460557617|FG002|Overall Study|Lost to Follow-up|1|||
127982109|NCT01573767|460557618|FG003|Overall Study|Lost to Follow-up|1|||
127982110|NCT01573767|460557615|FG000|Overall Study|Physician Decision|1|||
127535241|NCT01125800|458923435|FG001|Phase I|Disease progression|4|||
127535242|NCT01125800|458923436|FG002|Phase I|Disease progression|1|||
127535243|NCT01125800|458923437|FG003|Phase I|Disease progression|3|||
127535244|NCT01125800|458923438|FG004|Phase I|Disease progression|0|||
127535245|NCT01125800|458923434|FG000|Phase II|Protocol Violation|0|||
127982111|NCT01573767|460557616|FG001|Overall Study|Physician Decision|2|||
127535246|NCT01125800|458923435|FG001|Phase II|Protocol Violation|0|||
127535247|NCT01125800|458923436|FG002|Phase II|Protocol Violation|0|||
127535248|NCT01125800|458923437|FG003|Phase II|Protocol Violation|0|||
127535249|NCT01125800|458923438|FG004|Phase II|Protocol Violation|1|||
127535250|NCT01125800|458923434|FG000|Phase II|Adverse Event|0|||
127535251|NCT01125800|458923435|FG001|Phase II|Adverse Event|0|||
127535252|NCT01125800|458923436|FG002|Phase II|Adverse Event|0|||
127535253|NCT01125800|458923437|FG003|Phase II|Adverse Event|0|||
127535254|NCT01125800|458923438|FG004|Phase II|Adverse Event|2|||
127535255|NCT01125800|458923434|FG000|Phase II|Disease progression|0|||
127535256|NCT01125800|458923435|FG001|Phase II|Disease progression|0|||
127648028|NCT00117676|459331621|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
127648029|NCT00117676|459331622|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
127648030|NCT00117676|459331621|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
127648031|NCT00117676|459331622|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
127982112|NCT01573767|460557617|FG002|Overall Study|Physician Decision|0|||
127982113|NCT01573767|460557618|FG003|Overall Study|Physician Decision|2|||
127982114|NCT01573767|460557615|FG000|Overall Study|Withdrawal by Subject|0|||
127982115|NCT01573767|460557616|FG001|Overall Study|Withdrawal by Subject|1|||
127982116|NCT01573767|460557617|FG002|Overall Study|Withdrawal by Subject|0|||
127982117|NCT01573767|460557618|FG003|Overall Study|Withdrawal by Subject|0|||
127982118|NCT01371877|460557619|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
127982119|NCT01371877|460557620|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
127982122|NCT00869557|460557622|FG000|Randomized Phase|Lost to Follow-up|2|||
127982123|NCT00869557|460557623|FG001|Randomized Phase|Lost to Follow-up|1|||
127982124|NCT00869557|460557622|FG000|Randomized Phase|Investigator's Discretion|1|||
127982125|NCT00869557|460557623|FG001|Randomized Phase|Investigator's Discretion|0|||
127648032|NCT00117676|459331621|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
127648033|NCT00117676|459331622|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
127648034|NCT00117676|459331621|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
127648035|NCT00117676|459331622|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
127648036|NCT00117676|459331621|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
127648037|NCT00117676|459331622|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
127648038|NCT00117676|459331621|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
127648039|NCT00117676|459331622|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
127648040|NCT00117676|459331621|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
127648041|NCT00117676|459331622|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
127648042|NCT00117676|459331621|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
127648043|NCT00117676|459331622|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
127648044|NCT00117676|459331621|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
127648045|NCT00117676|459331622|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
127648046|NCT00117676|459331621|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
127648047|NCT00117676|459331622|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
127648048|NCT00952822|459331623|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
127648049|NCT00952822|459331624|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
127982126|NCT00869557|460557622|FG000|Randomized Phase|Withdrew Consent|0|||
127982127|NCT00869557|460557623|FG001|Randomized Phase|Withdrew Consent|1|||
127982128|NCT00869557|460557622|FG000|Extension Phase|Adverse Event|2|||
127982129|NCT00869557|460557623|FG001|Extension Phase|Adverse Event|2|||
127648050|NCT00952822|459331625|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
127982130|NCT00869557|460557622|FG000|Extension Phase|Lack of Efficacy|1|||
127982131|NCT00869557|460557623|FG001|Extension Phase|Lack of Efficacy|0|||
127535257|NCT01125800|458923436|FG002|Phase II|Disease progression|0|||
127535258|NCT01125800|458923437|FG003|Phase II|Disease progression|1|||
127982132|NCT00869557|460557622|FG000|Extension Phase|Lost to Follow-up|3|||
127982133|NCT00869557|460557623|FG001|Extension Phase|Lost to Follow-up|1|||
127982134|NCT00869557|460557622|FG000|Extension Phase|Investigator's Discretion|2|||
127982135|NCT00869557|460557623|FG001|Extension Phase|Investigator's Discretion|0|||
127982136|NCT00869557|460557622|FG000|Extension Phase|Withdrew Consent|2|||
127982137|NCT00869557|460557623|FG001|Extension Phase|Withdrew Consent|0|||
127982138|NCT02368210|460557624|FG000|Overall Study|Withdrawal by Subject|1|||
127982139|NCT02368210|460557625|FG001|Overall Study|Withdrawal by Subject|0|||
127982140|NCT02368210|460557624|FG000|Overall Study|Adverse Event|0|||
127982141|NCT02368210|460557625|FG001|Overall Study|Adverse Event|1|||
127982142|NCT00078949|460557626|FG000|Overall Study|No treated|4|||
127982143|NCT00078949|460557627|FG001|Overall Study|No treated|5|||
127982144|NCT00078949|460557628|FG002|Overall Study|No treated|3|||
127982145|NCT00078949|460557629|FG003|Overall Study|No treated|3|||
127982146|NCT01143064|460557630|FG000|Overall Study|Death|109|||
127982147|NCT01143064|460557631|FG001|Overall Study|Death|91|||
127982148|NCT01143064|460557630|FG000|Overall Study|Adverse Event|0|||
127982149|NCT01143064|460557631|FG001|Overall Study|Adverse Event|1|||
127982150|NCT01143064|460557630|FG000|Overall Study|Withdrawal by Subject|7|||
127982151|NCT01143064|460557631|FG001|Overall Study|Withdrawal by Subject|5|||
127982152|NCT01143064|460557630|FG000|Overall Study|Lost to Follow-up|17|||
127982153|NCT01143064|460557631|FG001|Overall Study|Lost to Follow-up|14|||
127982154|NCT01143064|460557630|FG000|Overall Study|Physician Decision|0|||
127982155|NCT01143064|460557631|FG001|Overall Study|Physician Decision|4|||
127982156|NCT01199822|460557637|FG000|Overall Study|Investigator discontinued therapy|0|||
127982157|NCT01199822|460557638|FG001|Overall Study|Investigator discontinued therapy|1|||
127982158|NCT01199822|460557639|FG002|Overall Study|Investigator discontinued therapy|0|||
127982159|NCT04027075|460557640|FG000|Overall Study|Lost to Follow-up|41|||
127982160|NCT04027075|460557641|FG001|Overall Study|Lost to Follow-up|22|||
127982161|NCT02772276|460557644|FG000|Overall Study|Lost to Follow-up|0|||
127982162|NCT02772276|460557645|FG001|Overall Study|Lost to Follow-up|0|||
127982163|NCT02772276|460557646|FG002|Overall Study|Lost to Follow-up|0|||
127982164|NCT02772276|460557647|FG003|Overall Study|Lost to Follow-up|0|||
127982165|NCT02772276|460557648|FG004|Overall Study|Lost to Follow-up|0|||
127982166|NCT02772276|460557649|FG005|Overall Study|Lost to Follow-up|0|||
127982167|NCT02772276|460557650|FG006|Overall Study|Lost to Follow-up|1|||
127982168|NCT02772276|460557651|FG007|Overall Study|Lost to Follow-up|0|||
127982169|NCT02772276|460557652|FG008|Overall Study|Lost to Follow-up|0|||
127982170|NCT02772276|460557653|FG009|Overall Study|Lost to Follow-up|0|||
127982171|NCT02772276|460557654|FG010|Overall Study|Lost to Follow-up|0|||
127982172|NCT02772276|460557655|FG011|Overall Study|Lost to Follow-up|0|||
127982173|NCT02772276|460557656|FG012|Overall Study|Lost to Follow-up|0|||
127982174|NCT02772276|460557644|FG000|Overall Study|Withdrew consent|0|||
127982175|NCT02772276|460557645|FG001|Overall Study|Withdrew consent|0|||
127982176|NCT02772276|460557646|FG002|Overall Study|Withdrew consent|0|||
127982177|NCT02772276|460557647|FG003|Overall Study|Withdrew consent|0|||
127982178|NCT02772276|460557648|FG004|Overall Study|Withdrew consent|0|||
127982179|NCT02772276|460557649|FG005|Overall Study|Withdrew consent|0|||
127982180|NCT02772276|460557650|FG006|Overall Study|Withdrew consent|0|||
127982181|NCT02772276|460557651|FG007|Overall Study|Withdrew consent|1|||
127982182|NCT02772276|460557652|FG008|Overall Study|Withdrew consent|0|||
127982183|NCT02772276|460557653|FG009|Overall Study|Withdrew consent|0|||
127982184|NCT02772276|460557654|FG010|Overall Study|Withdrew consent|0|||
127982185|NCT02772276|460557655|FG011|Overall Study|Withdrew consent|0|||
127982186|NCT02772276|460557656|FG012|Overall Study|Withdrew consent|0|||
127982187|NCT00455520|460557658|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
127982188|NCT00455520|460557659|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
127982189|NCT00455520|460557658|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
127982190|NCT00455520|460557659|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
127982191|NCT00455520|460557658|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
127982192|NCT00455520|460557659|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
127982193|NCT00455520|460557658|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
127982194|NCT00455520|460557659|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
127982195|NCT00455520|460557658|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
127982196|NCT00455520|460557659|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
127982197|NCT00455520|460557658|FG000|Open Label Tapentadol Extended Release|All other|33|||
127982198|NCT00455520|460557659|FG001|Open Label Tapentadol Extended Release|All other|0|||
127982199|NCT00455520|460557658|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
127982200|NCT00455520|460557659|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
127982201|NCT00455520|460557658|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
127982202|NCT00455520|460557659|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
127982203|NCT00455520|460557658|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
127982204|NCT00455520|460557659|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
127982205|NCT00455520|460557658|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
127982206|NCT00455520|460557659|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
127982207|NCT00455520|460557658|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
127982208|NCT00455520|460557659|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
127982209|NCT00455520|460557658|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
127982210|NCT00455520|460557659|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
127982211|NCT03448939|460557660|FG000|Overall Study|Adverse Event|5|||
127982212|NCT03448939|460557661|FG001|Overall Study|Adverse Event|1|||
127982213|NCT03448939|460557660|FG000|Overall Study|Lost to Follow-up|6|||
127982214|NCT03448939|460557661|FG001|Overall Study|Lost to Follow-up|6|||
127982215|NCT03448939|460557660|FG000|Overall Study|Pregnancy|1|||
127982216|NCT03448939|460557661|FG001|Overall Study|Pregnancy|1|||
127982217|NCT03448939|460557660|FG000|Overall Study|Withdrawal by Subject|9|||
127982218|NCT03448939|460557661|FG001|Overall Study|Withdrawal by Subject|3|||
127982219|NCT04093492|460557664|FG000|25 Weeks Gestational Age (GA)|Delivered before assessment|1|||
127982220|NCT04093492|460557665|FG001|25 Weeks Gestational Age (GA)|Delivered before assessment|2|||
127982221|NCT04093492|460557666|FG002|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
127982222|NCT04093492|460557667|FG003|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
127982223|NCT04093492|460557664|FG000|25 Weeks Gestational Age (GA)|No response|5|||
127982224|NCT04093492|460557665|FG001|25 Weeks Gestational Age (GA)|No response|5|||
127982225|NCT04093492|460557666|FG002|25 Weeks Gestational Age (GA)|No response|5|||
127982226|NCT04093492|460557667|FG003|25 Weeks Gestational Age (GA)|No response|2|||
127982227|NCT04093492|460557664|FG000|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
127982228|NCT04093492|460557665|FG001|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
127982229|NCT04093492|460557666|FG002|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
127982230|NCT04093492|460557667|FG003|25 Weeks Gestational Age (GA)|Withdrawal by Subject|1|||
127982231|NCT04093492|460557664|FG000|30 Weeks GA|Delivered before assessment|1|||
127982232|NCT04093492|460557665|FG001|30 Weeks GA|Delivered before assessment|2|||
127982233|NCT04093492|460557666|FG002|30 Weeks GA|Delivered before assessment|0|||
127982234|NCT04093492|460557667|FG003|30 Weeks GA|Delivered before assessment|0|||
127982235|NCT04093492|460557664|FG000|30 Weeks GA|No response|7|||
127982236|NCT04093492|460557665|FG001|30 Weeks GA|No response|5|||
127982237|NCT04093492|460557666|FG002|30 Weeks GA|No response|5|||
127982238|NCT04093492|460557667|FG003|30 Weeks GA|No response|2|||
127982239|NCT04093492|460557664|FG000|30 Weeks GA|Lost to Follow-up|0|||
127982240|NCT04093492|460557665|FG001|30 Weeks GA|Lost to Follow-up|1|||
127982241|NCT04093492|460557666|FG002|30 Weeks GA|Lost to Follow-up|0|||
127982242|NCT04093492|460557667|FG003|30 Weeks GA|Lost to Follow-up|0|||
127982243|NCT04093492|460557664|FG000|34 Weeks GA|Delivered before assessment|6|||
127982244|NCT04093492|460557665|FG001|34 Weeks GA|Delivered before assessment|3|||
127982245|NCT04093492|460557666|FG002|34 Weeks GA|Delivered before assessment|0|||
127982246|NCT04093492|460557667|FG003|34 Weeks GA|Delivered before assessment|0|||
127982247|NCT04093492|460557664|FG000|34 Weeks GA|No response|0|||
127982248|NCT04093492|460557665|FG001|34 Weeks GA|No response|7|||
127982249|NCT04093492|460557666|FG002|34 Weeks GA|No response|5|||
127982250|NCT04093492|460557667|FG003|34 Weeks GA|No response|3|||
127982251|NCT04093492|460557664|FG000|34 Weeks GA|Lost to Follow-up|0|||
127982252|NCT04093492|460557665|FG001|34 Weeks GA|Lost to Follow-up|1|||
127982253|NCT04093492|460557666|FG002|34 Weeks GA|Lost to Follow-up|0|||
127982254|NCT04093492|460557667|FG003|34 Weeks GA|Lost to Follow-up|0|||
127982255|NCT01472965|460557668|FG000|Overall Study|Withdrawal by Subject|1|||
127982256|NCT01472965|460557669|FG001|Overall Study|Withdrawal by Subject|0|||
127982257|NCT00628095|460557670|FG000|Overall Study|Adverse Event|5|||
127982258|NCT00628095|460557671|FG001|Overall Study|Adverse Event|3|||
127982259|NCT00628095|460557670|FG000|Overall Study|Lack of Efficacy|0|||
127982260|NCT00628095|460557671|FG001|Overall Study|Lack of Efficacy|3|||
127982261|NCT00628095|460557670|FG000|Overall Study|Withdrawal by Subject|2|||
127982262|NCT00628095|460557671|FG001|Overall Study|Withdrawal by Subject|0|||
127982263|NCT00628095|460557670|FG000|Overall Study|Other|0|||
127982264|NCT00628095|460557671|FG001|Overall Study|Other|1|||
127982265|NCT03235115|460557675|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
127982266|NCT03235115|460557676|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
127982267|NCT03235115|460557677|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
127982268|NCT03235115|460557678|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
127982269|NCT03235115|460557679|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
127982270|NCT03235115|460557680|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
127982271|NCT00006305|460557681|FG000|Overall Study|Withdrawal by Subject|17|||
127982272|NCT00006305|460557682|FG001|Overall Study|Withdrawal by Subject|10|||
127982273|NCT00006305|460557683|FG002|Overall Study|Withdrawal by Subject|15|||
127982274|NCT00006305|460557684|FG003|Overall Study|Withdrawal by Subject|14|||
127982275|NCT00662558|460557687|FG000|Overall Study|Adverse Event|21|||
127982276|NCT00662558|460557688|FG001|Overall Study|Adverse Event|59|||
127982277|NCT00662558|460557687|FG000|Overall Study|Lack of Efficacy|4|||
127982278|NCT00662558|460557688|FG001|Overall Study|Lack of Efficacy|7|||
127982279|NCT00662558|460557687|FG000|Overall Study|Lost to Follow-up|13|||
127982280|NCT00662558|460557688|FG001|Overall Study|Lost to Follow-up|10|||
127982281|NCT00662558|460557687|FG000|Overall Study|Other|9|||
127982282|NCT00662558|460557688|FG001|Overall Study|Other|14|||
127535259|NCT01125800|458923438|FG004|Phase II|Disease progression|8|||
127535260|NCT03370718|458923443|FG000|Overall Study|Withdrawal by Subject|1|||
127535261|NCT01670721|458923444|FG000|Overall Study|Participant's decision|15|||
127535262|NCT01670721|458923444|FG000|Overall Study|Other than specified above|38|||
127535263|NCT04970654|458923447|FG000|Overall Study|Withdrawal by parents/guardian|1|||
127535264|NCT04970654|458923448|FG001|Overall Study|Withdrawal by parents/guardian|2|||
127535265|NCT04970654|458923447|FG000|Overall Study|Unclassified|2|||
127535266|NCT04970654|458923448|FG001|Overall Study|Unclassified|1|||
127535267|NCT04970654|458923447|FG000|Overall Study|Lost to Follow-up|1|||
127535268|NCT04970654|458923448|FG001|Overall Study|Lost to Follow-up|0|||
127535269|NCT01572480|458923451|FG000|Participants Enrolled|Withdrawal by Subject|1|||
127535270|NCT01572480|458923451|FG000|Drug Administration|Discontinued drug/Off Study|1|||
127535271|NCT01572480|458923451|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
127982283|NCT00662558|460557687|FG000|Overall Study|Withdrawal by Subject|7|||
127758561|NCT01994837|459741980|FG000|Overall Study|Fatal progressive disease|2|||
127758562|NCT01994837|459741980|FG000|Overall Study|Adverse event not related to progression|1|||
127758563|NCT01994837|459741980|FG000|Overall Study|Chose palliative care|1|||
127758564|NCT01994837|459741980|FG000|Overall Study|Proceeded to transplant|1|||
127758565|NCT01994837|459741980|FG000|Overall Study|Removed from study due to no response|1|||
127982284|NCT00662558|460557688|FG001|Overall Study|Withdrawal by Subject|12|||
127982285|NCT00662558|460557687|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
127535272|NCT01572480|458923451|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
127535273|NCT06172348|458923452|FG000|Treatment Period 2|Adverse Event|0|||
127535274|NCT06172348|458923453|FG001|Treatment Period 2|Adverse Event|0|||
127535275|NCT06172348|458923454|FG002|Treatment Period 2|Adverse Event|1|||
127535276|NCT06172348|458923455|FG003|Treatment Period 2|Adverse Event|0|||
127535277|NCT06172348|458923456|FG004|Treatment Period 2|Adverse Event|0|||
127535278|NCT06172348|458923457|FG005|Treatment Period 2|Adverse Event|0|||
127535279|NCT00191334|458923458|FG000|Overall Study|Adverse Event|4|||
127535280|NCT00191334|458923458|FG000|Overall Study|Disease Progression or Relapse|8|||
127535281|NCT00191334|458923458|FG000|Overall Study|Physician Decision|1|||
127982286|NCT00662558|460557688|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
127982287|NCT00329641|460557689|FG000|Overall Study|Did not start treatment|1|||
127982288|NCT00329641|460557689|FG000|Overall Study|Not eligible|1|||
127982289|NCT00329641|460557689|FG000|Overall Study|Adverse Event|3|||
127982290|NCT00329641|460557689|FG000|Overall Study|Other reason, not protocol specified|1|||
127982291|NCT00783224|460557690|FG000|Overall Study|Adverse Event|0|||
127982292|NCT00783224|460557691|FG001|Overall Study|Adverse Event|0|||
127982293|NCT00783224|460557692|FG002|Overall Study|Adverse Event|1|||
127982294|NCT00783224|460557693|FG003|Overall Study|Adverse Event|0|||
127982295|NCT00783224|460557690|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
127982296|NCT00783224|460557691|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
127982297|NCT00783224|460557692|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
127535282|NCT00191334|458923458|FG000|Overall Study|Withdrawal by Subject|4|||
127535283|NCT05579977|458923466|FG000|Treatment Phase|Other|0|||
127535284|NCT05579977|458923467|FG001|Treatment Phase|Other|0|||
127535285|NCT05579977|458923468|FG002|Treatment Phase|Other|0|||
127535286|NCT05579977|458923469|FG003|Treatment Phase|Other|2|||
127535287|NCT05579977|458923470|FG004|Treatment Phase|Other|1|||
127535288|NCT05579977|458923471|FG005|Treatment Phase|Other|2|||
127758566|NCT01127893|459741981|FG000|Overall Study|Study Termination by the Sponsor|1|||
127758567|NCT01262677|459741982|FG000|Overall Study|Does not meet entrance criteria|0|||
127758568|NCT01262677|459741983|FG001|Overall Study|Does not meet entrance criteria|2|||
127758569|NCT01262677|459741984|FG002|Overall Study|Does not meet entrance criteria|0|||
127758570|NCT01262677|459741982|FG000|Overall Study|Insufficient clinical response|0|||
127758571|NCT01262677|459741983|FG001|Overall Study|Insufficient clinical response|0|||
127758572|NCT01262677|459741984|FG002|Overall Study|Insufficient clinical response|1|||
127758573|NCT01262677|459741982|FG000|Overall Study|Lost to Follow-up|1|||
127758574|NCT01262677|459741983|FG001|Overall Study|Lost to Follow-up|0|||
127758575|NCT01262677|459741984|FG002|Overall Study|Lost to Follow-up|2|||
127758576|NCT01262677|459741982|FG000|Overall Study|No longer willing to participate|3|||
127758577|NCT01262677|459741983|FG001|Overall Study|No longer willing to participate|3|||
127758578|NCT01262677|459741984|FG002|Overall Study|No longer willing to participate|2|||
127758579|NCT01262677|459741982|FG000|Overall Study|Reason not provided|2|||
127758580|NCT01262677|459741983|FG001|Overall Study|Reason not provided|1|||
127758581|NCT01262677|459741984|FG002|Overall Study|Reason not provided|3|||
127758582|NCT01262677|459741982|FG000|Overall Study|Protocol Violation|0|||
127758583|NCT01262677|459741983|FG001|Overall Study|Protocol Violation|1|||
127758584|NCT01262677|459741984|FG002|Overall Study|Protocol Violation|1|||
127758585|NCT01262677|459741982|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
127758586|NCT01262677|459741983|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
127758587|NCT01262677|459741984|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
127758588|NCT00574873|459741985|FG000|Overall Study|Withdrawal by Subject|18|||
127758589|NCT00574873|459741986|FG001|Overall Study|Withdrawal by Subject|19|||
127535289|NCT05579977|458923472|FG006|Treatment Phase|Other|1|||
127982298|NCT00783224|460557693|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
127982299|NCT00783224|460557690|FG000|Overall Study|Inappropriate as a study subject|0|||
127758590|NCT00574873|459741985|FG000|Overall Study|Investigator request|18|||
127758591|NCT00574873|459741986|FG001|Overall Study|Investigator request|8|||
127758592|NCT00574873|459741985|FG000|Overall Study|Death|15|||
127758593|NCT00574873|459741986|FG001|Overall Study|Death|14|||
127758594|NCT00574873|459741985|FG000|Overall Study|Lost to Follow-up|14|||
127758595|NCT00574873|459741986|FG001|Overall Study|Lost to Follow-up|5|||
127758596|NCT00574873|459741985|FG000|Overall Study|Other|40|||
127758597|NCT00574873|459741986|FG001|Overall Study|Other|4|||
127758598|NCT00574873|459741985|FG000|Overall Study|Discontinuation of study by sponsor|5|||
127758599|NCT00574873|459741986|FG001|Overall Study|Discontinuation of study by sponsor|199|||
127758600|NCT00574873|459741985|FG000|Overall Study|Blank, site closed per local regulations|2|||
127758601|NCT00574873|459741986|FG001|Overall Study|Blank, site closed per local regulations|2|||
127758602|NCT00574873|459741985|FG000|Overall Study|Extension Study|126|||
127758603|NCT00574873|459741986|FG001|Overall Study|Extension Study|0|||
127758604|NCT00201643|459741992|FG000|Overall Study|Withdrawal by Subject|5|||
127758605|NCT00201643|459741993|FG001|Overall Study|Withdrawal by Subject|4|||
127758606|NCT03568318|459742005|FG000|Overall Study|Adverse Event|3|||
127758607|NCT03568318|459742006|FG001|Overall Study|Adverse Event|1|||
127758608|NCT03568318|459742007|FG002|Overall Study|Adverse Event|1|||
127758609|NCT03568318|459742008|FG003|Overall Study|Adverse Event|0|||
127758610|NCT03568318|459742009|FG004|Overall Study|Adverse Event|1|||
127758611|NCT03568318|459742010|FG005|Overall Study|Adverse Event|0|||
127758612|NCT03568318|459742005|FG000|Overall Study|Withdrawal by Subject|6|||
127758613|NCT03568318|459742006|FG001|Overall Study|Withdrawal by Subject|5|||
127758614|NCT03568318|459742007|FG002|Overall Study|Withdrawal by Subject|2|||
127758615|NCT03568318|459742008|FG003|Overall Study|Withdrawal by Subject|1|||
127758616|NCT03568318|459742009|FG004|Overall Study|Withdrawal by Subject|0|||
127758617|NCT03568318|459742010|FG005|Overall Study|Withdrawal by Subject|0|||
127758618|NCT03568318|459742005|FG000|Overall Study|Lost to Follow-up|3|||
127758619|NCT03568318|459742006|FG001|Overall Study|Lost to Follow-up|2|||
127758620|NCT03568318|459742007|FG002|Overall Study|Lost to Follow-up|2|||
127758621|NCT03568318|459742008|FG003|Overall Study|Lost to Follow-up|2|||
127758622|NCT03568318|459742009|FG004|Overall Study|Lost to Follow-up|1|||
127758623|NCT03568318|459742010|FG005|Overall Study|Lost to Follow-up|0|||
127758624|NCT03568318|459742005|FG000|Overall Study|Other|3|||
127758625|NCT03568318|459742006|FG001|Overall Study|Other|1|||
127758626|NCT03568318|459742007|FG002|Overall Study|Other|3|||
127758627|NCT03568318|459742008|FG003|Overall Study|Other|0|||
127758628|NCT03568318|459742009|FG004|Overall Study|Other|0|||
127758629|NCT03568318|459742010|FG005|Overall Study|Other|0|||
127758630|NCT03568318|459742005|FG000|Overall Study|Ongoing at Time of Analysis|5|||
127758631|NCT03568318|459742006|FG001|Overall Study|Ongoing at Time of Analysis|3|||
127758632|NCT03568318|459742007|FG002|Overall Study|Ongoing at Time of Analysis|2|||
127758633|NCT03568318|459742008|FG003|Overall Study|Ongoing at Time of Analysis|1|||
127758634|NCT03568318|459742009|FG004|Overall Study|Ongoing at Time of Analysis|0|||
127648051|NCT00952822|459331626|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
127648052|NCT00952822|459331623|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
127648053|NCT00952822|459331624|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
127648054|NCT00952822|459331625|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
127648055|NCT00952822|459331626|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
127648056|NCT04555096|459331630|FG000|Overall Study|Death|4|||
127648057|NCT04555096|459331631|FG001|Overall Study|Death|4|||
127648058|NCT04555096|459331630|FG000|Overall Study|Withdrawal by Subject|1|||
127648059|NCT04555096|459331631|FG001|Overall Study|Withdrawal by Subject|0|||
127648060|NCT04555096|459331630|FG000|Overall Study|Other|0|||
127648061|NCT04555096|459331631|FG001|Overall Study|Other|1|||
127648062|NCT03641313|459331634|FG000|Overall Study|Death|1|||
127758635|NCT03568318|459742010|FG005|Overall Study|Ongoing at Time of Analysis|0|||
127758636|NCT01638429|459742013|FG000|Overall Study|Withdrawal by Subject|1|||
127758637|NCT03207451|459742014|FG000|Overall Study|scheduling conflict|1|||
127758638|NCT03207451|459742015|FG001|Overall Study|scheduling conflict|0|||
127758639|NCT03207451|459742016|FG002|Overall Study|scheduling conflict|2|||
127758640|NCT03207451|459742017|FG003|Overall Study|scheduling conflict|2|||
127758641|NCT03207451|459742014|FG000|Overall Study|Adverse Event|0|||
127758642|NCT03207451|459742015|FG001|Overall Study|Adverse Event|0|||
127982300|NCT00783224|460557691|FG001|Overall Study|Inappropriate as a study subject|0|||
127982301|NCT00783224|460557692|FG002|Overall Study|Inappropriate as a study subject|0|||
127982302|NCT00783224|460557693|FG003|Overall Study|Inappropriate as a study subject|1|||
127982303|NCT01711619|460557694|FG000|Overall Study|Early study termination|10|||
127982304|NCT01711619|460557695|FG001|Overall Study|Early study termination|14|||
127982305|NCT01711619|460557694|FG000|Overall Study|Withdrawal by Subject|3|||
127982306|NCT01711619|460557695|FG001|Overall Study|Withdrawal by Subject|7|||
127982307|NCT01711619|460557694|FG000|Overall Study|Protocol Violation|2|||
127758643|NCT03207451|459742016|FG002|Overall Study|Adverse Event|0|||
127758644|NCT03207451|459742017|FG003|Overall Study|Adverse Event|1|||
127982308|NCT01711619|460557695|FG001|Overall Study|Protocol Violation|3|||
127758645|NCT00996476|459742019|FG000|Overall Study|Withdrawal by Subject|1|||
127758646|NCT00996476|459742020|FG001|Overall Study|Withdrawal by Subject|2|||
127758647|NCT00996476|459742021|FG002|Overall Study|Withdrawal by Subject|1|||
127758648|NCT00996476|459742022|FG003|Overall Study|Withdrawal by Subject|0|||
127758649|NCT00996476|459742023|FG004|Overall Study|Withdrawal by Subject|1|||
127758650|NCT00996476|459742019|FG000|Overall Study|Adverse Event|0|||
127758651|NCT00996476|459742020|FG001|Overall Study|Adverse Event|1|||
127758652|NCT00996476|459742021|FG002|Overall Study|Adverse Event|0|||
127758653|NCT00996476|459742022|FG003|Overall Study|Adverse Event|0|||
127758654|NCT00996476|459742023|FG004|Overall Study|Adverse Event|1|||
127758655|NCT05540717|459742024|FG000|Overall Study|Lost to Follow-up|2|||
127758656|NCT05540717|459742025|FG001|Overall Study|Lost to Follow-up|5|||
127758657|NCT05540717|459742024|FG000|Overall Study|Withdrawal by Subject|6|||
127758658|NCT05540717|459742025|FG001|Overall Study|Withdrawal by Subject|6|||
127758659|NCT05540717|459742024|FG000|Overall Study|Sponsor request|1|||
127758660|NCT05540717|459742025|FG001|Overall Study|Sponsor request|0|||
127758661|NCT05540717|459742024|FG000|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
127758662|NCT05540717|459742025|FG001|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
127758663|NCT05540717|459742024|FG000|Overall Study|Other|0|||
127648063|NCT03641313|459331634|FG000|Overall Study|Withdrawal by Subject|2|||
127648064|NCT03641313|459331634|FG000|Overall Study|Declining health|1|||
127648065|NCT03641313|459331634|FG000|Overall Study|Adverse Event|1|||
127648066|NCT01533493|459331637|FG000|Overall Study|Adverse Event|2|||
127648067|NCT01533493|459331638|FG001|Overall Study|Adverse Event|1|||
127648068|NCT01533493|459331637|FG000|Overall Study|Withdrawal by Subject|1|||
127648069|NCT01533493|459331638|FG001|Overall Study|Withdrawal by Subject|2|||
127648070|NCT01533493|459331637|FG000|Overall Study|Lost to Follow-up|2|||
127648071|NCT01533493|459331638|FG001|Overall Study|Lost to Follow-up|0|||
127648072|NCT02657031|459331643|FG000|Overall Study|Adverse Event|1|||
127648073|NCT02657031|459331644|FG001|Overall Study|Adverse Event|2|||
127648074|NCT03078816|459331645|FG000|Overall Study|Withdrawal by Subject|1|||
127648075|NCT05007392|459331646|FG000|Overall Study|Randomized but not treated|1|||
127648076|NCT05007392|459331647|FG001|Overall Study|Randomized but not treated|2|||
127648077|NCT05007392|459331646|FG000|Overall Study|Other|5|||
127648078|NCT05007392|459331647|FG001|Overall Study|Other|4|||
127648079|NCT05007392|459331646|FG000|Overall Study|Lost to Follow-up|1|||
127648080|NCT05007392|459331647|FG001|Overall Study|Lost to Follow-up|2|||
127648081|NCT05007392|459331646|FG000|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|0|||
127648082|NCT05007392|459331647|FG001|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|1|||
127648083|NCT05007392|459331646|FG000|Overall Study|Use of prohibited concomitant drug|1|||
127648084|NCT05007392|459331647|FG001|Overall Study|Use of prohibited concomitant drug|1|||
127648085|NCT05007392|459331646|FG000|Overall Study|Inadequate therapeutic effect or progression of disease|1|||
127648086|NCT05007392|459331647|FG001|Overall Study|Inadequate therapeutic effect or progression of disease|0|||
127648087|NCT05007392|459331646|FG000|Overall Study|Adverse Event|10|||
127648088|NCT05007392|459331647|FG001|Overall Study|Adverse Event|6|||
127648089|NCT05007392|459331646|FG000|Overall Study|Participant choice|5|||
127648090|NCT05007392|459331647|FG001|Overall Study|Participant choice|10|||
127758664|NCT05540717|459742025|FG001|Overall Study|Other|1|||
127758665|NCT00473265|459742026|FG000|Overall Study|Unrelated adverse event|5|||
127758666|NCT00473265|459742026|FG000|Overall Study|Off treatment early|15|||
127758667|NCT01940939|459742031|FG000|Overall Study|Withdrawal by Subject|2|||
127758668|NCT01940939|459742032|FG001|Overall Study|Withdrawal by Subject|8|||
127758669|NCT01470001|459742033|FG000|Overall Study|Lost to Follow-up|1|||
127758670|NCT01470001|459742034|FG001|Overall Study|Lost to Follow-up|1|||
127758671|NCT01470001|459742033|FG000|Overall Study|Physician Decision|2|||
127758672|NCT01470001|459742034|FG001|Overall Study|Physician Decision|0|||
127758673|NCT01470001|459742033|FG000|Overall Study|Withdrawal by Subject|2|||
127758674|NCT01470001|459742034|FG001|Overall Study|Withdrawal by Subject|1|||
127758675|NCT01895101|459742035|FG000|Overall Study|OPCAB procedure|1|||
127758676|NCT01895101|459742036|FG001|Overall Study|OPCAB procedure|1|||
127758677|NCT01895101|459742037|FG002|Overall Study|OPCAB procedure|3|||
127758678|NCT01895101|459742035|FG000|Overall Study|Withdrawal by Subject|0|||
127758679|NCT01895101|459742036|FG001|Overall Study|Withdrawal by Subject|1|||
127758680|NCT01895101|459742037|FG002|Overall Study|Withdrawal by Subject|2|||
127758681|NCT01895101|459742035|FG000|Overall Study|another study, enrolled in other study|0|||
127758682|NCT01895101|459742036|FG001|Overall Study|another study, enrolled in other study|1|||
127758683|NCT01895101|459742037|FG002|Overall Study|another study, enrolled in other study|0|||
127758684|NCT01895101|459742035|FG000|Overall Study|Death|0|||
127758685|NCT01895101|459742036|FG001|Overall Study|Death|1|||
127758686|NCT01895101|459742037|FG002|Overall Study|Death|0|||
127758687|NCT01895101|459742035|FG000|Overall Study|coagulation disorder|0|||
127758688|NCT01895101|459742036|FG001|Overall Study|coagulation disorder|1|||
127758689|NCT01895101|459742037|FG002|Overall Study|coagulation disorder|0|||
127758690|NCT03339583|459742038|FG000|First Intervention (14 Days)|Adverse Event|1|||
127758691|NCT03339583|459742039|FG001|First Intervention (14 Days)|Adverse Event|0|||
127758692|NCT03339583|459742038|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
127758693|NCT03339583|459742039|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
127758694|NCT03339583|459742038|FG000|Second Intervention (14 Days)|Adverse Event|0|||
127758695|NCT03339583|459742039|FG001|Second Intervention (14 Days)|Adverse Event|1|||
127758696|NCT03339583|459742038|FG000|Follow-up (14 Days)|Physician Decision|6|||
127758697|NCT03339583|459742039|FG001|Follow-up (14 Days)|Physician Decision|3|||
127758698|NCT00734591|459742040|FG000|Screening for Prospective Period|Site did not participate|1604|||
127758699|NCT00734591|459742041|FG001|Screening for Prospective Period|Site did not participate|1488|||
127758700|NCT00734591|459742040|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
127758701|NCT00734591|459742041|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
127758702|NCT00734591|459742040|FG000|Prospective Period|Withdrawal by Subject|11|||
127758703|NCT00734591|459742041|FG001|Prospective Period|Withdrawal by Subject|9|||
127758704|NCT00734591|459742040|FG000|Prospective Period|Lost to Follow-up|37|||
127758705|NCT00734591|459742041|FG001|Prospective Period|Lost to Follow-up|33|||
127758706|NCT00734591|459742040|FG000|Prospective Period|Study Terminated|1|||
127758707|NCT00734591|459742041|FG001|Prospective Period|Study Terminated|0|||
127758708|NCT00734591|459742040|FG000|Prospective Period|Other|2|||
127758709|NCT00734591|459742041|FG001|Prospective Period|Other|2|||
127758710|NCT00338962|459742044|FG000|Overall Study|Lost to Follow-up|3|||
127758711|NCT00338962|459742045|FG001|Overall Study|Lost to Follow-up|3|||
127758712|NCT00338962|459742046|FG002|Overall Study|Lost to Follow-up|2|||
127758713|NCT00338962|459742047|FG003|Overall Study|Lost to Follow-up|3|||
127758714|NCT00338962|459742044|FG000|Overall Study|Withdrawal by Subject|1|||
127758715|NCT00338962|459742045|FG001|Overall Study|Withdrawal by Subject|0|||
127758716|NCT00338962|459742046|FG002|Overall Study|Withdrawal by Subject|0|||
127758717|NCT00338962|459742047|FG003|Overall Study|Withdrawal by Subject|0|||
127758718|NCT00338962|459742044|FG000|Overall Study|No Transportation|2|||
127758719|NCT00338962|459742045|FG001|Overall Study|No Transportation|0|||
127758720|NCT00338962|459742046|FG002|Overall Study|No Transportation|0|||
127758721|NCT00338962|459742047|FG003|Overall Study|No Transportation|0|||
127758722|NCT00338962|459742044|FG000|Overall Study|Time Constraint|2|||
127758723|NCT00338962|459742045|FG001|Overall Study|Time Constraint|0|||
127758724|NCT00338962|459742046|FG002|Overall Study|Time Constraint|0|||
127758725|NCT00338962|459742047|FG003|Overall Study|Time Constraint|0|||
127758726|NCT00338962|459742044|FG000|Overall Study|Moved|0|||
127982309|NCT01711619|460557694|FG000|Overall Study|Adverse Event|2|||
127982310|NCT01711619|460557695|FG001|Overall Study|Adverse Event|0|||
127982311|NCT01711619|460557694|FG000|Overall Study|Lost to Follow-up|1|||
127982312|NCT01711619|460557695|FG001|Overall Study|Lost to Follow-up|0|||
127982313|NCT00503997|460557701|FG000|Overall Study|disease progression|1|||
127982314|NCT00503997|460557701|FG000|Overall Study|Adverse Event|5|||
127982315|NCT00503997|460557701|FG000|Overall Study|Death|1|||
127982316|NCT00503997|460557701|FG000|Overall Study|Withdrawal by Subject|1|||
127982317|NCT01195844|460557702|FG000|Overall Study|Fecal sample not collected|40|||
127982318|NCT02565706|460557706|FG000|Overall Study|Withdrawal by Subject|5|||
127982319|NCT02565706|460557707|FG001|Overall Study|Withdrawal by Subject|7|||
127982320|NCT02565706|460557708|FG002|Overall Study|Withdrawal by Subject|7|||
127982321|NCT02565706|460557709|FG003|Overall Study|Withdrawal by Subject|11|||
127982322|NCT02565706|460557706|FG000|Overall Study|Lost to Follow-up|72|||
127982323|NCT02565706|460557707|FG001|Overall Study|Lost to Follow-up|75|||
127982324|NCT02565706|460557708|FG002|Overall Study|Lost to Follow-up|82|||
127982325|NCT02565706|460557709|FG003|Overall Study|Lost to Follow-up|74|||
127982326|NCT00401960|460557716|FG000|Overall Study|Lost to Follow-up|3|||
127982327|NCT00401960|460557717|FG001|Overall Study|Lost to Follow-up|0|||
127982328|NCT00401960|460557716|FG000|Overall Study|Death|2|||
127982329|NCT00401960|460557717|FG001|Overall Study|Death|0|||
127982330|NCT02649426|460557718|FG000|Overall Study|Follow-up on going|1|||
127982331|NCT02649426|460557719|FG001|Overall Study|Follow-up on going|26|||
127982332|NCT02649426|460557720|FG002|Overall Study|Follow-up on going|28|||
127982333|NCT02649426|460557721|FG003|Overall Study|Follow-up on going|31|||
127982334|NCT01606202|460557722|FG000|Overall Study|Adverse Event|5|||
127982335|NCT01606202|460557723|FG001|Overall Study|Adverse Event|0|||
127982336|NCT01606202|460557722|FG000|Overall Study|Withdrawal by Subject|2|||
127758727|NCT00338962|459742045|FG001|Overall Study|Moved|1|||
127758728|NCT00338962|459742046|FG002|Overall Study|Moved|0|||
127758729|NCT00338962|459742047|FG003|Overall Study|Moved|0|||
127758730|NCT00338962|459742044|FG000|Overall Study|Adverse Event|0|||
127758731|NCT00338962|459742045|FG001|Overall Study|Adverse Event|0|||
127758732|NCT00338962|459742046|FG002|Overall Study|Adverse Event|2|||
127982337|NCT01606202|460557723|FG001|Overall Study|Withdrawal by Subject|1|||
127982338|NCT01606202|460557722|FG000|Overall Study|Personal problems|0|||
127758733|NCT00338962|459742047|FG003|Overall Study|Adverse Event|0|||
127758734|NCT00338962|459742044|FG000|Overall Study|Poor Compliance|0|||
127758735|NCT00338962|459742045|FG001|Overall Study|Poor Compliance|0|||
127982339|NCT01606202|460557723|FG001|Overall Study|Personal problems|1|||
127982340|NCT01606202|460557722|FG000|Overall Study|Problems with administration|0|||
127982341|NCT01606202|460557723|FG001|Overall Study|Problems with administration|1|||
127758736|NCT00338962|459742046|FG002|Overall Study|Poor Compliance|2|||
127758737|NCT00338962|459742047|FG003|Overall Study|Poor Compliance|0|||
127758738|NCT03214640|459742048|FG000|Overall Study|Protocol Violation|1|||
127982342|NCT02584959|460557724|FG000|Period 1|Withdrawn from study|3|||
127982343|NCT02584959|460557725|FG001|Period 1|Withdrawn from study|4|||
127982344|NCT02584959|460557726|FG002|Period 1|Withdrawn from study|0|||
127982345|NCT02584959|460557724|FG000|Period 2|Withdrawn from study|6|||
127982346|NCT02584959|460557725|FG001|Period 2|Withdrawn from study|1|||
127982347|NCT02584959|460557726|FG002|Period 2|Withdrawn from study|2|||
127982348|NCT00195494|460557729|FG000|Year 1|Adverse Event|0|||
127982349|NCT00195494|460557730|FG001|Year 1|Adverse Event|0|||
127982350|NCT00195494|460557731|FG002|Year 1|Adverse Event|0|||
127982351|NCT00195494|460557732|FG003|Year 1|Adverse Event|0|||
127982352|NCT00195494|460557733|FG004|Year 1|Adverse Event|34|||
127982353|NCT00195494|460557734|FG005|Year 1|Adverse Event|27|||
127982354|NCT00195494|460557729|FG000|Year 1|System Toxicity|0|||
127982355|NCT00195494|460557730|FG001|Year 1|System Toxicity|0|||
127982356|NCT00195494|460557731|FG002|Year 1|System Toxicity|0|||
127982357|NCT00195494|460557732|FG003|Year 1|System Toxicity|0|||
127982358|NCT00195494|460557733|FG004|Year 1|System Toxicity|0|||
127982359|NCT00195494|460557734|FG005|Year 1|System Toxicity|1|||
127982360|NCT00195494|460557729|FG000|Year 1|Lack of Efficacy|0|||
127982361|NCT00195494|460557730|FG001|Year 1|Lack of Efficacy|0|||
127982362|NCT00195494|460557731|FG002|Year 1|Lack of Efficacy|0|||
127982363|NCT00195494|460557732|FG003|Year 1|Lack of Efficacy|0|||
127982364|NCT00195494|460557733|FG004|Year 1|Lack of Efficacy|24|||
127982365|NCT00195494|460557734|FG005|Year 1|Lack of Efficacy|9|||
127982366|NCT00195494|460557729|FG000|Year 1|Compliance|0|||
127982367|NCT00195494|460557730|FG001|Year 1|Compliance|0|||
127982368|NCT00195494|460557731|FG002|Year 1|Compliance|0|||
127982369|NCT00195494|460557732|FG003|Year 1|Compliance|0|||
127982370|NCT00195494|460557733|FG004|Year 1|Compliance|5|||
127982371|NCT00195494|460557734|FG005|Year 1|Compliance|1|||
127982372|NCT00195494|460557729|FG000|Year 1|Lost to Follow-up|0|||
127982373|NCT00195494|460557730|FG001|Year 1|Lost to Follow-up|0|||
127982374|NCT00195494|460557731|FG002|Year 1|Lost to Follow-up|0|||
127982375|NCT00195494|460557732|FG003|Year 1|Lost to Follow-up|0|||
127982376|NCT00195494|460557733|FG004|Year 1|Lost to Follow-up|1|||
127982377|NCT00195494|460557734|FG005|Year 1|Lost to Follow-up|0|||
127982378|NCT00195494|460557729|FG000|Year 1|Missed >4 consecutive doses|0|||
127982379|NCT00195494|460557730|FG001|Year 1|Missed >4 consecutive doses|0|||
127982380|NCT00195494|460557731|FG002|Year 1|Missed >4 consecutive doses|0|||
127982381|NCT00195494|460557732|FG003|Year 1|Missed >4 consecutive doses|0|||
127982382|NCT00195494|460557733|FG004|Year 1|Missed >4 consecutive doses|3|||
127982383|NCT00195494|460557734|FG005|Year 1|Missed >4 consecutive doses|2|||
127982384|NCT00195494|460557729|FG000|Year 1|Protocol deviation|0|||
127758739|NCT03214640|459742049|FG001|Overall Study|Protocol Violation|2|||
127758740|NCT03214640|459742050|FG002|Overall Study|Protocol Violation|1|||
127758741|NCT03214640|459742051|FG003|Overall Study|Protocol Violation|4|||
127758742|NCT01259089|459742052|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
127758743|NCT01259089|459742053|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
127758744|NCT01259089|459742054|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
127758745|NCT01259089|459742055|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
127758746|NCT01259089|459742056|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
127758747|NCT01259089|459742057|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
127758748|NCT01259089|459742052|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
127758749|NCT01259089|459742053|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
127758750|NCT01259089|459742054|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
127758751|NCT01259089|459742055|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
127758752|NCT01259089|459742056|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
127758753|NCT01259089|459742057|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
127982385|NCT00195494|460557730|FG001|Year 1|Protocol deviation|0|||
127758754|NCT01259089|459742052|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
127982386|NCT00195494|460557731|FG002|Year 1|Protocol deviation|0|||
127982387|NCT00195494|460557732|FG003|Year 1|Protocol deviation|0|||
127982388|NCT00195494|460557733|FG004|Year 1|Protocol deviation|2|||
127982389|NCT00195494|460557734|FG005|Year 1|Protocol deviation|3|||
127982390|NCT00195494|460557729|FG000|Year 1|Physician Decision|0|||
127982391|NCT00195494|460557730|FG001|Year 1|Physician Decision|0|||
127982392|NCT00195494|460557731|FG002|Year 1|Physician Decision|0|||
127982393|NCT00195494|460557732|FG003|Year 1|Physician Decision|0|||
127982394|NCT00195494|460557733|FG004|Year 1|Physician Decision|1|||
127982395|NCT00195494|460557734|FG005|Year 1|Physician Decision|0|||
127982396|NCT00195494|460557729|FG000|Year 1|Withdrawal by Subject|0|||
127982397|NCT00195494|460557730|FG001|Year 1|Withdrawal by Subject|0|||
127982398|NCT00195494|460557731|FG002|Year 1|Withdrawal by Subject|0|||
127982399|NCT00195494|460557732|FG003|Year 1|Withdrawal by Subject|0|||
127982400|NCT00195494|460557733|FG004|Year 1|Withdrawal by Subject|8|||
127982401|NCT00195494|460557734|FG005|Year 1|Withdrawal by Subject|9|||
127982402|NCT00195494|460557729|FG000|Year 1|Protocol Violation|0|||
127982403|NCT00195494|460557730|FG001|Year 1|Protocol Violation|0|||
127982404|NCT00195494|460557731|FG002|Year 1|Protocol Violation|0|||
127982405|NCT00195494|460557732|FG003|Year 1|Protocol Violation|0|||
127982406|NCT00195494|460557733|FG004|Year 1|Protocol Violation|1|||
127982407|NCT00195494|460557734|FG005|Year 1|Protocol Violation|1|||
127982408|NCT00195494|460557729|FG000|Year 2|Adverse Event|3|||
127982409|NCT00195494|460557730|FG001|Year 2|Adverse Event|7|||
127982410|NCT00195494|460557731|FG002|Year 2|Adverse Event|5|||
127982411|NCT00195494|460557732|FG003|Year 2|Adverse Event|9|||
127982412|NCT00195494|460557733|FG004|Year 2|Adverse Event|0|||
127982413|NCT00195494|460557734|FG005|Year 2|Adverse Event|0|||
127982414|NCT00195494|460557729|FG000|Year 2|Lack of Efficacy|0|||
127982415|NCT00195494|460557730|FG001|Year 2|Lack of Efficacy|1|||
127982416|NCT00195494|460557731|FG002|Year 2|Lack of Efficacy|7|||
127982417|NCT00195494|460557732|FG003|Year 2|Lack of Efficacy|7|||
127982418|NCT00195494|460557733|FG004|Year 2|Lack of Efficacy|0|||
127982419|NCT00195494|460557734|FG005|Year 2|Lack of Efficacy|0|||
127982420|NCT00195494|460557729|FG000|Year 2|Compliance|1|||
127982421|NCT00195494|460557730|FG001|Year 2|Compliance|0|||
127982422|NCT00195494|460557731|FG002|Year 2|Compliance|0|||
127982423|NCT00195494|460557732|FG003|Year 2|Compliance|2|||
127982424|NCT00195494|460557733|FG004|Year 2|Compliance|0|||
127982425|NCT00195494|460557734|FG005|Year 2|Compliance|0|||
127982426|NCT00195494|460557729|FG000|Year 2|Lost to Follow-up|0|||
127982427|NCT00195494|460557730|FG001|Year 2|Lost to Follow-up|0|||
127982428|NCT00195494|460557731|FG002|Year 2|Lost to Follow-up|1|||
127982429|NCT00195494|460557732|FG003|Year 2|Lost to Follow-up|1|||
127982430|NCT00195494|460557733|FG004|Year 2|Lost to Follow-up|0|||
127982431|NCT00195494|460557734|FG005|Year 2|Lost to Follow-up|0|||
127982432|NCT00195494|460557729|FG000|Year 2|Missed >4 consecutive doses|1|||
127982433|NCT00195494|460557730|FG001|Year 2|Missed >4 consecutive doses|1|||
127982434|NCT00195494|460557731|FG002|Year 2|Missed >4 consecutive doses|1|||
127982435|NCT00195494|460557732|FG003|Year 2|Missed >4 consecutive doses|0|||
127982436|NCT00195494|460557733|FG004|Year 2|Missed >4 consecutive doses|0|||
127982437|NCT00195494|460557734|FG005|Year 2|Missed >4 consecutive doses|0|||
127982438|NCT00195494|460557729|FG000|Year 2|Protocol deviation|0|||
127982439|NCT00195494|460557730|FG001|Year 2|Protocol deviation|1|||
127982440|NCT00195494|460557731|FG002|Year 2|Protocol deviation|0|||
127982441|NCT00195494|460557732|FG003|Year 2|Protocol deviation|0|||
127982442|NCT00195494|460557733|FG004|Year 2|Protocol deviation|0|||
127982443|NCT00195494|460557734|FG005|Year 2|Protocol deviation|0|||
127982444|NCT00195494|460557729|FG000|Year 2|Physician Decision|1|||
127982445|NCT00195494|460557730|FG001|Year 2|Physician Decision|1|||
127982446|NCT00195494|460557731|FG002|Year 2|Physician Decision|0|||
127982447|NCT00195494|460557732|FG003|Year 2|Physician Decision|0|||
127982448|NCT00195494|460557733|FG004|Year 2|Physician Decision|0|||
127982449|NCT00195494|460557734|FG005|Year 2|Physician Decision|0|||
127982450|NCT00195494|460557729|FG000|Year 2|Withdrawal by Subject|1|||
127982451|NCT00195494|460557730|FG001|Year 2|Withdrawal by Subject|5|||
127982452|NCT00195494|460557731|FG002|Year 2|Withdrawal by Subject|4|||
127982453|NCT00195494|460557732|FG003|Year 2|Withdrawal by Subject|3|||
127982454|NCT00195494|460557733|FG004|Year 2|Withdrawal by Subject|0|||
127982455|NCT00195494|460557734|FG005|Year 2|Withdrawal by Subject|0|||
127982456|NCT00195494|460557729|FG000|Year 2|System toxicity|0|||
127982457|NCT00195494|460557730|FG001|Year 2|System toxicity|0|||
127982458|NCT00195494|460557731|FG002|Year 2|System toxicity|0|||
127982459|NCT00195494|460557732|FG003|Year 2|System toxicity|1|||
127982460|NCT00195494|460557733|FG004|Year 2|System toxicity|0|||
127982461|NCT00195494|460557734|FG005|Year 2|System toxicity|0|||
127982462|NCT03802565|460557743|FG000|Overall Study|Adverse Event|0|||
127982463|NCT03802565|460557744|FG001|Overall Study|Adverse Event|1|||
127982464|NCT03802565|460557745|FG002|Overall Study|Adverse Event|2|||
127982465|NCT03802565|460557746|FG003|Overall Study|Adverse Event|1|||
127982466|NCT03802565|460557747|FG004|Overall Study|Adverse Event|1|||
127982467|NCT03802565|460557743|FG000|Overall Study|Withdrawal by Subject|2|||
127982468|NCT03802565|460557744|FG001|Overall Study|Withdrawal by Subject|2|||
127982469|NCT03802565|460557745|FG002|Overall Study|Withdrawal by Subject|2|||
127982470|NCT03802565|460557746|FG003|Overall Study|Withdrawal by Subject|0|||
127982471|NCT03802565|460557747|FG004|Overall Study|Withdrawal by Subject|1|||
127982472|NCT03802565|460557743|FG000|Overall Study|Protocol Violation|2|||
127982473|NCT03802565|460557744|FG001|Overall Study|Protocol Violation|1|||
127982474|NCT03802565|460557745|FG002|Overall Study|Protocol Violation|4|||
127982475|NCT03802565|460557746|FG003|Overall Study|Protocol Violation|5|||
127982476|NCT03802565|460557747|FG004|Overall Study|Protocol Violation|1|||
127982477|NCT03802565|460557743|FG000|Overall Study|Lost to Follow-up|0|||
127982478|NCT03802565|460557744|FG001|Overall Study|Lost to Follow-up|0|||
127982479|NCT03802565|460557745|FG002|Overall Study|Lost to Follow-up|1|||
127982480|NCT03802565|460557746|FG003|Overall Study|Lost to Follow-up|0|||
127982481|NCT03802565|460557747|FG004|Overall Study|Lost to Follow-up|0|||
127982482|NCT03802565|460557743|FG000|Overall Study|Subjects Related to Each Other|1|||
127982483|NCT03802565|460557744|FG001|Overall Study|Subjects Related to Each Other|0|||
127982484|NCT03802565|460557745|FG002|Overall Study|Subjects Related to Each Other|0|||
127982485|NCT03802565|460557746|FG003|Overall Study|Subjects Related to Each Other|2|||
127982486|NCT03802565|460557747|FG004|Overall Study|Subjects Related to Each Other|1|||
127982487|NCT03802565|460557743|FG000|Overall Study|Elevated Enzymes|0|||
127982488|NCT03802565|460557744|FG001|Overall Study|Elevated Enzymes|0|||
127982489|NCT03802565|460557745|FG002|Overall Study|Elevated Enzymes|0|||
127982490|NCT03802565|460557746|FG003|Overall Study|Elevated Enzymes|0|||
127982491|NCT03802565|460557747|FG004|Overall Study|Elevated Enzymes|2|||
127982492|NCT04506905|460557750|FG000|Overall Study|Lost to Follow-up|1|||
127982493|NCT04506905|460557751|FG001|Overall Study|Lost to Follow-up|0|||
127982494|NCT04506905|460557752|FG002|Overall Study|Lost to Follow-up|0|||
127982495|NCT04506905|460557753|FG003|Overall Study|Lost to Follow-up|1|||
127982496|NCT04506905|460557754|FG004|Overall Study|Lost to Follow-up|0|||
127982497|NCT04506905|460557755|FG005|Overall Study|Lost to Follow-up|0|||
127982498|NCT04506905|460557756|FG006|Overall Study|Lost to Follow-up|0|||
127982499|NCT04506905|460557757|FG007|Overall Study|Lost to Follow-up|0|||
127982500|NCT04506905|460557758|FG008|Overall Study|Lost to Follow-up|0|||
127982501|NCT04506905|460557750|FG000|Overall Study|Withdrawal by Subject|0|||
127982502|NCT04506905|460557751|FG001|Overall Study|Withdrawal by Subject|0|||
127982503|NCT04506905|460557752|FG002|Overall Study|Withdrawal by Subject|0|||
127982504|NCT04506905|460557753|FG003|Overall Study|Withdrawal by Subject|2|||
127982505|NCT04506905|460557754|FG004|Overall Study|Withdrawal by Subject|0|||
127982506|NCT04506905|460557755|FG005|Overall Study|Withdrawal by Subject|0|||
127982507|NCT04506905|460557756|FG006|Overall Study|Withdrawal by Subject|0|||
127982508|NCT04506905|460557757|FG007|Overall Study|Withdrawal by Subject|0|||
127982509|NCT04506905|460557758|FG008|Overall Study|Withdrawal by Subject|0|||
127982510|NCT03309696|460558763|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
127982511|NCT03309696|460558764|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
127982512|NCT03309696|460558765|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
127982513|NCT03309696|460558766|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
127982514|NCT05940077|460558769|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
127982515|NCT00328094|460558772|FG000|Overall Study|Physician Decision|3|||
127982516|NCT00328094|460558773|FG001|Overall Study|Physician Decision|3|||
127982517|NCT02309723|460558774|FG000|Overall Study|Withdrawal by Subject|24|||
127982518|NCT02309723|460558775|FG001|Overall Study|Withdrawal by Subject|23|||
127982519|NCT02309723|460558776|FG002|Overall Study|Withdrawal by Subject|24|||
127982520|NCT01565668|460558777|FG000|Overall Study|Death|2|||
127982521|NCT01565668|460558778|FG001|Overall Study|Death|1|||
127982522|NCT01565668|460558777|FG000|Overall Study|Lack of Efficacy|4|||
127982523|NCT01565668|460558778|FG001|Overall Study|Lack of Efficacy|2|||
127982524|NCT01565668|460558777|FG000|Overall Study|Participant went on Hospice Care|1|||
127982525|NCT01565668|460558778|FG001|Overall Study|Participant went on Hospice Care|0|||
127982526|NCT01565668|460558777|FG000|Overall Study|Adverse Event|6|||
127982527|NCT01565668|460558778|FG001|Overall Study|Adverse Event|1|||
127982528|NCT01565668|460558777|FG000|Overall Study|Randomized, but never received drug|0|||
127982529|NCT01565668|460558778|FG001|Overall Study|Randomized, but never received drug|2|||
127982530|NCT01565668|460558777|FG000|Overall Study|Progressive disease|13|||
127982531|NCT01565668|460558778|FG001|Overall Study|Progressive disease|14|||
127982532|NCT01565668|460558777|FG000|Overall Study|Withdrawal by Subject|1|||
127982533|NCT01565668|460558778|FG001|Overall Study|Withdrawal by Subject|3|||
127982534|NCT01565668|460558777|FG000|Overall Study|HSCT Transplant|11|||
127982535|NCT01565668|460558778|FG001|Overall Study|HSCT Transplant|15|||
127982536|NCT02255552|460558779|FG000|Overall Study|Participants enrolled into another study|0|||
127982537|NCT02255552|460558780|FG001|Overall Study|Participants enrolled into another study|11|||
127982538|NCT02255552|460558779|FG000|Overall Study|Withdrawal by Subject|1|||
127982539|NCT02255552|460558780|FG001|Overall Study|Withdrawal by Subject|4|||
127982540|NCT03422159|460558786|FG000|Overall Study|Exclusion due to terminal disease|2|||
127982541|NCT03422159|460558787|FG001|Overall Study|Exclusion due to terminal disease|1|||
127982542|NCT00980018|460558793|FG000|Overall Study|Adverse Event|8|||
127982543|NCT00980018|460558793|FG000|Overall Study|Patient withdrew consent|3|||
127982544|NCT00980018|460558793|FG000|Overall Study|Lost to Follow-up|1|||
127982545|NCT00087126|460558794|FG000|Overall Study|Ineligible - second primary|1|||
127982546|NCT00087126|460558794|FG000|Overall Study|Never treated|1|||
127982547|NCT01832818|460558795|FG000|Overall Study|Lost to Follow-up|6|||
127982548|NCT00934856|460558798|FG000|Feasibility Part|Progressive disease|4|||
127982549|NCT00934856|460558799|FG001|Feasibility Part|Progressive disease|4|||
127982550|NCT00934856|460558800|FG002|Feasibility Part|Progressive disease|2|||
127982551|NCT00934856|460558801|FG003|Feasibility Part|Progressive disease|3|||
127982552|NCT00934856|460558802|FG004|Feasibility Part|Progressive disease|0|||
127982553|NCT00934856|460558803|FG005|Feasibility Part|Progressive disease|0|||
127982554|NCT00934856|460558798|FG000|Feasibility Part|Physician Decision|0|||
127982555|NCT00934856|460558799|FG001|Feasibility Part|Physician Decision|0|||
127982556|NCT00934856|460558800|FG002|Feasibility Part|Physician Decision|1|||
127982557|NCT00934856|460558801|FG003|Feasibility Part|Physician Decision|0|||
127982558|NCT00934856|460558802|FG004|Feasibility Part|Physician Decision|0|||
127982559|NCT00934856|460558803|FG005|Feasibility Part|Physician Decision|0|||
127982560|NCT00934856|460558798|FG000|Feasibility Part|Adverse Event|1|||
127982561|NCT00934856|460558799|FG001|Feasibility Part|Adverse Event|1|||
127982562|NCT00934856|460558800|FG002|Feasibility Part|Adverse Event|0|||
127982563|NCT00934856|460558801|FG003|Feasibility Part|Adverse Event|1|||
127982564|NCT00934856|460558802|FG004|Feasibility Part|Adverse Event|0|||
127982565|NCT00934856|460558803|FG005|Feasibility Part|Adverse Event|2|||
127982566|NCT00934856|460558798|FG000|Feasibility Part|Withdrawal by Subject|0|||
127982567|NCT00934856|460558799|FG001|Feasibility Part|Withdrawal by Subject|0|||
127982568|NCT00934856|460558800|FG002|Feasibility Part|Withdrawal by Subject|0|||
127982569|NCT00934856|460558801|FG003|Feasibility Part|Withdrawal by Subject|1|||
127982570|NCT00934856|460558802|FG004|Feasibility Part|Withdrawal by Subject|0|||
127982571|NCT00934856|460558803|FG005|Feasibility Part|Withdrawal by Subject|1|||
127982572|NCT00934856|460558798|FG000|Extension Part|Adverse Event|0|||
127982573|NCT00934856|460558799|FG001|Extension Part|Adverse Event|0|||
127982574|NCT00934856|460558800|FG002|Extension Part|Adverse Event|0|||
127982575|NCT00934856|460558801|FG003|Extension Part|Adverse Event|1|||
127982576|NCT00934856|460558802|FG004|Extension Part|Adverse Event|4|||
127982577|NCT00934856|460558803|FG005|Extension Part|Adverse Event|4|||
127982578|NCT00934856|460558798|FG000|Extension Part|Progressive disease|0|||
127982579|NCT00934856|460558799|FG001|Extension Part|Progressive disease|0|||
127982580|NCT00934856|460558800|FG002|Extension Part|Progressive disease|0|||
127982581|NCT00934856|460558801|FG003|Extension Part|Progressive disease|1|||
127982582|NCT00934856|460558802|FG004|Extension Part|Progressive disease|0|||
127982583|NCT00934856|460558803|FG005|Extension Part|Progressive disease|0|||
127982584|NCT00934856|460558798|FG000|Extension Part|Non-compliance with drug|0|||
127982585|NCT00934856|460558799|FG001|Extension Part|Non-compliance with drug|0|||
127982586|NCT00934856|460558800|FG002|Extension Part|Non-compliance with drug|0|||
127982587|NCT00934856|460558801|FG003|Extension Part|Non-compliance with drug|0|||
127982588|NCT00934856|460558802|FG004|Extension Part|Non-compliance with drug|0|||
127982589|NCT00934856|460558803|FG005|Extension Part|Non-compliance with drug|1|||
127982590|NCT01256385|460558804|FG000|Overall Study|Physician Decision|1|||
127982591|NCT01256385|460558805|FG001|Overall Study|Physician Decision|1|||
127982592|NCT01256385|460558804|FG000|Overall Study|Withdrawal by Subject|2|||
127982593|NCT01256385|460558805|FG001|Overall Study|Withdrawal by Subject|2|||
127982594|NCT02020512|460558806|FG000|Overall Study|Adverse Event|1|||
127982595|NCT02020512|460558806|FG000|Overall Study|Lost to Follow-up|3|||
127982596|NCT02020512|460558806|FG000|Overall Study|Protocol Violation|4|||
127982597|NCT00835679|460558807|FG000|Overall Study|Withdrawal by Subject|1|||
127982598|NCT00835679|460558808|FG001|Overall Study|Withdrawal by Subject|0|||
127982599|NCT00835679|460558809|FG002|Overall Study|Withdrawal by Subject|0|||
127982600|NCT00835679|460558810|FG003|Overall Study|Withdrawal by Subject|0|||
127982601|NCT04769739|460558813|FG000|Overall Study|Colorectal cancer obstruction|2|||
127982602|NCT04769739|460558814|FG001|Overall Study|Colorectal cancer obstruction|0|||
127982603|NCT04769739|460558815|FG002|Overall Study|Colorectal cancer obstruction|0|||
127982604|NCT04769739|460558816|FG003|Overall Study|Colorectal cancer obstruction|0|||
127982605|NCT04769739|460558813|FG000|Overall Study|Failed cecal intubation|1|||
127982606|NCT04769739|460558814|FG001|Overall Study|Failed cecal intubation|0|||
127982607|NCT04769739|460558815|FG002|Overall Study|Failed cecal intubation|0|||
127982608|NCT04769739|460558816|FG003|Overall Study|Failed cecal intubation|1|||
127982609|NCT04769739|460558813|FG000|Overall Study|Poor bowel preparation|0|||
127982610|NCT04769739|460558814|FG001|Overall Study|Poor bowel preparation|0|||
127982611|NCT04769739|460558815|FG002|Overall Study|Poor bowel preparation|0|||
127982612|NCT04769739|460558816|FG003|Overall Study|Poor bowel preparation|1|||
127982613|NCT03689543|460558817|FG000|Overall Study|Adverse Event|0|||
127982614|NCT03689543|460558818|FG001|Overall Study|Adverse Event|0|||
127982615|NCT03689543|460558819|FG002|Overall Study|Adverse Event|1|||
127982616|NCT00932451|460558820|FG000|Overall Study|Withdrawal by Subject|69|||
127982617|NCT00932451|460558820|FG000|Overall Study|Lost to Follow-up|22|||
127982618|NCT00932451|460558820|FG000|Overall Study|Death|726|||
127982619|NCT00932451|460558820|FG000|Overall Study|Other reasons|5|||
127982620|NCT02968433|460558838|FG000|Overall Study|Withdrawal by Subject|1|||
127982621|NCT02079636|460558839|FG000|Overall Study|Death|2|||
127982622|NCT02079636|460558840|FG001|Overall Study|Death|1|||
127982623|NCT02079636|460558841|FG002|Overall Study|Death|0|||
127982624|NCT02079636|460558842|FG003|Overall Study|Death|5|||
127982625|NCT02079636|460558843|FG004|Overall Study|Death|1|||
127982626|NCT02079636|460558844|FG005|Overall Study|Death|2|||
127982627|NCT02079636|460558845|FG006|Overall Study|Death|1|||
127982628|NCT02079636|460558846|FG007|Overall Study|Death|0|||
127982629|NCT02079636|460558847|FG008|Overall Study|Death|0|||
127982630|NCT02079636|460558848|FG009|Overall Study|Death|0|||
127982631|NCT02079636|460558849|FG010|Overall Study|Death|0|||
127982632|NCT02079636|460558850|FG011|Overall Study|Death|1|||
127982633|NCT02079636|460558851|FG012|Overall Study|Death|1|||
127982634|NCT02079636|460558852|FG013|Overall Study|Death|0|||
127982635|NCT02079636|460558853|FG014|Overall Study|Death|2|||
127982636|NCT02079636|460558839|FG000|Overall Study|Adverse Event|1|||
127982637|NCT02079636|460558840|FG001|Overall Study|Adverse Event|1|||
127982638|NCT02079636|460558841|FG002|Overall Study|Adverse Event|0|||
127982639|NCT02079636|460558842|FG003|Overall Study|Adverse Event|1|||
127982640|NCT02079636|460558843|FG004|Overall Study|Adverse Event|1|||
127982641|NCT02079636|460558844|FG005|Overall Study|Adverse Event|2|||
127982642|NCT02079636|460558845|FG006|Overall Study|Adverse Event|0|||
127982643|NCT02079636|460558846|FG007|Overall Study|Adverse Event|0|||
127982644|NCT02079636|460558847|FG008|Overall Study|Adverse Event|0|||
127982645|NCT02079636|460558848|FG009|Overall Study|Adverse Event|0|||
127982646|NCT02079636|460558849|FG010|Overall Study|Adverse Event|0|||
127982647|NCT02079636|460558850|FG011|Overall Study|Adverse Event|0|||
127982648|NCT02079636|460558851|FG012|Overall Study|Adverse Event|0|||
127982649|NCT02079636|460558852|FG013|Overall Study|Adverse Event|0|||
127982650|NCT02079636|460558853|FG014|Overall Study|Adverse Event|0|||
127982651|NCT02079636|460558839|FG000|Overall Study|Progressive disease|0|||
127982652|NCT02079636|460558840|FG001|Overall Study|Progressive disease|0|||
127982653|NCT02079636|460558841|FG002|Overall Study|Progressive disease|0|||
127982654|NCT02079636|460558842|FG003|Overall Study|Progressive disease|2|||
127982655|NCT02079636|460558843|FG004|Overall Study|Progressive disease|0|||
127982656|NCT02079636|460558844|FG005|Overall Study|Progressive disease|0|||
127982657|NCT02079636|460558845|FG006|Overall Study|Progressive disease|0|||
127982658|NCT02079636|460558846|FG007|Overall Study|Progressive disease|0|||
127982659|NCT02079636|460558847|FG008|Overall Study|Progressive disease|0|||
127982660|NCT02079636|460558848|FG009|Overall Study|Progressive disease|0|||
127982661|NCT02079636|460558849|FG010|Overall Study|Progressive disease|0|||
127982662|NCT02079636|460558850|FG011|Overall Study|Progressive disease|0|||
127982663|NCT02079636|460558851|FG012|Overall Study|Progressive disease|1|||
127982664|NCT02079636|460558852|FG013|Overall Study|Progressive disease|0|||
127982665|NCT02079636|460558853|FG014|Overall Study|Progressive disease|0|||
127982666|NCT02079636|460558839|FG000|Overall Study|Withdrawal by Subject|0|||
127982667|NCT02079636|460558840|FG001|Overall Study|Withdrawal by Subject|0|||
127982668|NCT02079636|460558841|FG002|Overall Study|Withdrawal by Subject|0|||
127982669|NCT02079636|460558842|FG003|Overall Study|Withdrawal by Subject|4|||
127982670|NCT02079636|460558843|FG004|Overall Study|Withdrawal by Subject|0|||
127982671|NCT02079636|460558844|FG005|Overall Study|Withdrawal by Subject|1|||
127982672|NCT02079636|460558845|FG006|Overall Study|Withdrawal by Subject|0|||
127982673|NCT02079636|460558846|FG007|Overall Study|Withdrawal by Subject|0|||
127982674|NCT02079636|460558847|FG008|Overall Study|Withdrawal by Subject|0|||
127982675|NCT02079636|460558848|FG009|Overall Study|Withdrawal by Subject|2|||
127982676|NCT02079636|460558849|FG010|Overall Study|Withdrawal by Subject|1|||
127982677|NCT02079636|460558850|FG011|Overall Study|Withdrawal by Subject|1|||
127982678|NCT02079636|460558851|FG012|Overall Study|Withdrawal by Subject|1|||
127982679|NCT02079636|460558852|FG013|Overall Study|Withdrawal by Subject|0|||
127982680|NCT02079636|460558853|FG014|Overall Study|Withdrawal by Subject|2|||
127982681|NCT02079636|460558839|FG000|Overall Study|Physician Decision|0|||
127982682|NCT02079636|460558840|FG001|Overall Study|Physician Decision|0|||
127982683|NCT02079636|460558841|FG002|Overall Study|Physician Decision|0|||
127982684|NCT02079636|460558842|FG003|Overall Study|Physician Decision|0|||
127982685|NCT02079636|460558843|FG004|Overall Study|Physician Decision|0|||
127982686|NCT02079636|460558844|FG005|Overall Study|Physician Decision|1|||
127982687|NCT02079636|460558845|FG006|Overall Study|Physician Decision|0|||
127982688|NCT02079636|460558846|FG007|Overall Study|Physician Decision|0|||
127982689|NCT02079636|460558847|FG008|Overall Study|Physician Decision|0|||
127982690|NCT02079636|460558848|FG009|Overall Study|Physician Decision|1|||
127982691|NCT02079636|460558849|FG010|Overall Study|Physician Decision|1|||
127982692|NCT02079636|460558850|FG011|Overall Study|Physician Decision|0|||
127982693|NCT02079636|460558851|FG012|Overall Study|Physician Decision|0|||
127982694|NCT02079636|460558852|FG013|Overall Study|Physician Decision|0|||
127982695|NCT02079636|460558853|FG014|Overall Study|Physician Decision|1|||
127982696|NCT02079636|460558839|FG000|Overall Study|Lost to Follow-up|0|||
127982697|NCT02079636|460558840|FG001|Overall Study|Lost to Follow-up|0|||
127982698|NCT02079636|460558841|FG002|Overall Study|Lost to Follow-up|0|||
127982699|NCT02079636|460558842|FG003|Overall Study|Lost to Follow-up|0|||
127982700|NCT02079636|460558843|FG004|Overall Study|Lost to Follow-up|0|||
127982701|NCT02079636|460558844|FG005|Overall Study|Lost to Follow-up|0|||
127982702|NCT02079636|460558845|FG006|Overall Study|Lost to Follow-up|0|||
127982703|NCT02079636|460558846|FG007|Overall Study|Lost to Follow-up|1|||
127982704|NCT02079636|460558847|FG008|Overall Study|Lost to Follow-up|0|||
127982705|NCT02079636|460558848|FG009|Overall Study|Lost to Follow-up|0|||
127982706|NCT02079636|460558849|FG010|Overall Study|Lost to Follow-up|0|||
127982707|NCT02079636|460558850|FG011|Overall Study|Lost to Follow-up|0|||
127982708|NCT02079636|460558851|FG012|Overall Study|Lost to Follow-up|0|||
127982709|NCT02079636|460558852|FG013|Overall Study|Lost to Follow-up|0|||
127982710|NCT02079636|460558853|FG014|Overall Study|Lost to Follow-up|0|||
127982711|NCT00875433|460558854|FG000|Overall Study|Progressive disease|41|||
127982712|NCT00875433|460558854|FG000|Overall Study|Other Adverse Event|14|||
127982713|NCT00875433|460558854|FG000|Overall Study|Withdrawal by Subject|2|||
127982714|NCT00875433|460558854|FG000|Overall Study|Other|3|||
127982715|NCT00637806|460558855|FG000|Double-blind Phase|Study Discontinued|2|||
127982716|NCT00637806|460558856|FG001|Double-blind Phase|Study Discontinued|0|||
127982717|NCT00637806|460558857|FG002|Double-blind Phase|Study Discontinued|1|||
127982718|NCT00637806|460558858|FG003|Double-blind Phase|Study Discontinued|0|||
127982719|NCT00637806|460558855|FG000|Extension Phase|Study Discontinued|0|||
127982720|NCT00637806|460558856|FG001|Extension Phase|Study Discontinued|0|||
127982721|NCT00637806|460558857|FG002|Extension Phase|Study Discontinued|0|||
127982722|NCT00637806|460558858|FG003|Extension Phase|Study Discontinued|1|||
127982723|NCT00725101|460558859|FG000|Overall Study|Death|3|||
127982724|NCT00725101|460558859|FG000|Overall Study|Lost to Follow-up|353|||
127982725|NCT00725101|460558859|FG000|Overall Study|Protocol Violation|1|||
127982726|NCT00725101|460558859|FG000|Overall Study|Withdrawal by Subject|127|||
127982727|NCT00725101|460558859|FG000|Overall Study|not specified/no reason given|11|||
127982728|NCT00622336|460558860|FG000|Treatment Phase|Progression of Disease|181|||
127982729|NCT00622336|460558860|FG000|Treatment Phase|Adverse Event|46|||
127982730|NCT00622336|460558860|FG000|Treatment Phase|Other|40|||
127982731|NCT00622336|460558860|FG000|Treatment Phase|Death|14|||
127982732|NCT00622336|460558860|FG000|Treatment Phase|Lack of therapeutic effect|13|||
127982733|NCT00622336|460558860|FG000|Treatment Phase|Withdrawal by Subject|13|||
127982734|NCT00622336|460558860|FG000|Treatment Phase|Lost to Follow-up|2|||
127982735|NCT00622336|460558860|FG000|Extension Phase|Adverse Event|2|||
127982736|NCT00622336|460558860|FG000|Extension Phase|Progressive Disease|6|||
127982737|NCT00622336|460558860|FG000|Extension Phase|Lack of therapeutic effect|2|||
127982738|NCT00622336|460558860|FG000|Extension Phase|Withdrawal by Subject|1|||
127982739|NCT00622336|460558860|FG000|Extension Phase|Lost to Follow-up|1|||
127982740|NCT00622336|460558860|FG000|Extension Phase|Other|9|||
127982741|NCT04148287|460558862|FG000|Overall Study|Death|2|||
127982742|NCT03164265|460558863|FG000|Overall Study|Physician Decision|3|||
127982743|NCT03912428|460558864|FG000|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
127982744|NCT03912428|460558865|FG001|Phase 2: Whole Body PET/CT Scans|Physician Decision|2|||
127982745|NCT03912428|460558866|FG002|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
127982746|NCT03912428|460558867|FG003|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
127982747|NCT03912428|460558864|FG000|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
127982748|NCT03912428|460558865|FG001|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|3|||
127982749|NCT03912428|460558866|FG002|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|1|||
127982750|NCT03912428|460558867|FG003|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
127982751|NCT03912428|460558864|FG000|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
127982752|NCT03912428|460558865|FG001|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
127982753|NCT03912428|460558866|FG002|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
127982754|NCT03912428|460558867|FG003|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|2|||
127982755|NCT02889835|460558868|FG000|Overall Study|Lost to Follow-up|13|||
127982756|NCT02889835|460558869|FG001|Overall Study|Lost to Follow-up|13|||
127982757|NCT02889835|460558870|FG002|Overall Study|Lost to Follow-up|13|||
127982758|NCT02889835|460558868|FG000|Overall Study|Withdrawal by Subject|2|||
127982759|NCT02889835|460558869|FG001|Overall Study|Withdrawal by Subject|2|||
127982760|NCT02889835|460558870|FG002|Overall Study|Withdrawal by Subject|2|||
127982761|NCT02889835|460558868|FG000|Overall Study|Protocol Violation|1|||
127982762|NCT02889835|460558869|FG001|Overall Study|Protocol Violation|1|||
127982763|NCT02889835|460558870|FG002|Overall Study|Protocol Violation|1|||
127982764|NCT02889835|460558868|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
127982765|NCT02889835|460558869|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
127982766|NCT02889835|460558870|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
127982767|NCT02889835|460558868|FG000|Overall Study|Death|1|||
127982768|NCT02889835|460558869|FG001|Overall Study|Death|1|||
127982769|NCT02889835|460558870|FG002|Overall Study|Death|1|||
127982770|NCT01777139|460560105|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
127982771|NCT01777139|460560106|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
127982772|NCT01777139|460560105|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
127982773|NCT01777139|460560106|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
127982774|NCT01777139|460560105|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
127982775|NCT01777139|460560106|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
127982776|NCT01777139|460560105|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
127982777|NCT01777139|460560106|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
127982778|NCT01777139|460560105|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
127982779|NCT01777139|460560106|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
127982780|NCT01777139|460560105|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
127982781|NCT01777139|460560106|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
127982782|NCT01777139|460560105|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
127982783|NCT01777139|460560106|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
127982784|NCT01777139|460560105|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
127982785|NCT01777139|460560106|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
127982786|NCT05625477|460560107|FG000|Overall Study|Lost to Follow-up|2|||
127982787|NCT05625477|460560108|FG001|Overall Study|Lost to Follow-up|2|||
127982788|NCT05625477|460560109|FG002|Overall Study|Lost to Follow-up|1|||
127982789|NCT05625477|460560110|FG003|Overall Study|Lost to Follow-up|1|||
127982790|NCT05625477|460560111|FG004|Overall Study|Lost to Follow-up|0|||
127982791|NCT05625477|460560107|FG000|Overall Study|Covid quarantine|1|||
127982792|NCT05625477|460560108|FG001|Overall Study|Covid quarantine|0|||
127982793|NCT05625477|460560109|FG002|Overall Study|Covid quarantine|0|||
127982794|NCT05625477|460560110|FG003|Overall Study|Covid quarantine|0|||
127982795|NCT05625477|460560111|FG004|Overall Study|Covid quarantine|0|||
127982796|NCT02502266|460560112|FG000|Overall Study|Adverse Event|0|||
127982797|NCT02502266|460560113|FG001|Overall Study|Adverse Event|0|||
127982798|NCT02502266|460560114|FG002|Overall Study|Adverse Event|0|||
127982799|NCT02502266|460560115|FG003|Overall Study|Adverse Event|0|||
127982800|NCT02502266|460560116|FG004|Overall Study|Adverse Event|1|||
127982801|NCT02502266|460560117|FG005|Overall Study|Adverse Event|1|||
127982802|NCT02502266|460560118|FG006|Overall Study|Adverse Event|1|||
127982803|NCT02502266|460560112|FG000|Overall Study|Withdrawal by Subject|30|||
127982804|NCT02502266|460560113|FG001|Overall Study|Withdrawal by Subject|15|||
127982805|NCT02502266|460560114|FG002|Overall Study|Withdrawal by Subject|16|||
127982806|NCT02502266|460560115|FG003|Overall Study|Withdrawal by Subject|0|||
127982807|NCT02502266|460560116|FG004|Overall Study|Withdrawal by Subject|0|||
127982808|NCT02502266|460560117|FG005|Overall Study|Withdrawal by Subject|0|||
127982809|NCT02502266|460560118|FG006|Overall Study|Withdrawal by Subject|0|||
127982810|NCT02502266|460560112|FG000|Overall Study|Still on Treatment|0|||
127982811|NCT02502266|460560113|FG001|Overall Study|Still on Treatment|0|||
127982812|NCT02502266|460560114|FG002|Overall Study|Still on Treatment|1|||
127982813|NCT02502266|460560115|FG003|Overall Study|Still on Treatment|0|||
127982814|NCT02502266|460560116|FG004|Overall Study|Still on Treatment|0|||
127982815|NCT02502266|460560117|FG005|Overall Study|Still on Treatment|0|||
127982816|NCT02502266|460560118|FG006|Overall Study|Still on Treatment|0|||
127982817|NCT02502266|460560112|FG000|Overall Study|Other Reasons|19|||
127758755|NCT01259089|459742053|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
127982818|NCT02502266|460560113|FG001|Overall Study|Other Reasons|6|||
127982819|NCT02502266|460560114|FG002|Overall Study|Other Reasons|14|||
127982820|NCT02502266|460560115|FG003|Overall Study|Other Reasons|0|||
127982821|NCT02502266|460560116|FG004|Overall Study|Other Reasons|1|||
127982822|NCT02502266|460560117|FG005|Overall Study|Other Reasons|1|||
127982823|NCT02502266|460560118|FG006|Overall Study|Other Reasons|0|||
127982824|NCT02502266|460560112|FG000|Overall Study|Arm 4 Discontinued|0|||
127982825|NCT02502266|460560113|FG001|Overall Study|Arm 4 Discontinued|0|||
127982826|NCT02502266|460560114|FG002|Overall Study|Arm 4 Discontinued|0|||
127982827|NCT02502266|460560115|FG003|Overall Study|Arm 4 Discontinued|52|||
127982828|NCT02502266|460560116|FG004|Overall Study|Arm 4 Discontinued|0|||
127982829|NCT02502266|460560117|FG005|Overall Study|Arm 4 Discontinued|0|||
127982830|NCT02502266|460560118|FG006|Overall Study|Arm 4 Discontinued|0|||
127982831|NCT02502266|460560112|FG000|Overall Study|Never treated|0|||
127982832|NCT02502266|460560113|FG001|Overall Study|Never treated|0|||
127982833|NCT02502266|460560114|FG002|Overall Study|Never treated|0|||
127982834|NCT02502266|460560115|FG003|Overall Study|Never treated|0|||
127982835|NCT02502266|460560116|FG004|Overall Study|Never treated|0|||
127982836|NCT02502266|460560117|FG005|Overall Study|Never treated|1|||
127982837|NCT02502266|460560118|FG006|Overall Study|Never treated|0|||
127982838|NCT02921750|460560119|FG000|Overall Study|Adverse Event|1|||
127982839|NCT02921750|460560120|FG001|Overall Study|Adverse Event|2|||
127982840|NCT02921750|460560119|FG000|Overall Study|Withdrawal by Subject|1|||
127982841|NCT02921750|460560120|FG001|Overall Study|Withdrawal by Subject|1|||
127982842|NCT02921750|460560119|FG000|Overall Study|Lost to Follow-up|3|||
127982843|NCT02921750|460560120|FG001|Overall Study|Lost to Follow-up|3|||
127982844|NCT02921750|460560119|FG000|Overall Study|Wound healed|3|||
127982845|NCT02921750|460560120|FG001|Overall Study|Wound healed|3|||
127982846|NCT02921750|460560119|FG000|Overall Study|Serious Adverse Event|1|||
127982847|NCT02921750|460560120|FG001|Overall Study|Serious Adverse Event|2|||
127982848|NCT03605849|460560121|FG000|Overall Study|Adverse Event|20|||
127982849|NCT03605849|460560122|FG001|Overall Study|Adverse Event|21|||
127982850|NCT03605849|460560123|FG002|Overall Study|Adverse Event|29|||
127982851|NCT03605849|460560124|FG003|Overall Study|Adverse Event|11|||
127982852|NCT03605849|460560121|FG000|Overall Study|Lack of Efficacy|4|||
127982853|NCT03605849|460560122|FG001|Overall Study|Lack of Efficacy|7|||
127982854|NCT03605849|460560123|FG002|Overall Study|Lack of Efficacy|9|||
127982855|NCT03605849|460560124|FG003|Overall Study|Lack of Efficacy|2|||
127982856|NCT03605849|460560121|FG000|Overall Study|Lost to Follow-up|8|||
127982857|NCT03605849|460560122|FG001|Overall Study|Lost to Follow-up|8|||
127982858|NCT03605849|460560123|FG002|Overall Study|Lost to Follow-up|14|||
127982859|NCT03605849|460560124|FG003|Overall Study|Lost to Follow-up|11|||
127982860|NCT03605849|460560121|FG000|Overall Study|Non-compliance With IMP|6|||
127982861|NCT03605849|460560122|FG001|Overall Study|Non-compliance With IMP|5|||
127870705|NCT04419558|460145101|FG001|DB Period (48 Weeks)|Death|11|||
127982862|NCT03605849|460560123|FG002|Overall Study|Non-compliance With IMP|2|||
127982863|NCT03605849|460560124|FG003|Overall Study|Non-compliance With IMP|1|||
127982864|NCT03605849|460560121|FG000|Overall Study|Protocol Deviation|1|||
127982865|NCT03605849|460560122|FG001|Overall Study|Protocol Deviation|2|||
127982866|NCT03605849|460560123|FG002|Overall Study|Protocol Deviation|1|||
127982867|NCT03605849|460560124|FG003|Overall Study|Protocol Deviation|3|||
127982868|NCT03605849|460560121|FG000|Overall Study|Withdrawal by Subject|33|||
127982869|NCT03605849|460560122|FG001|Overall Study|Withdrawal by Subject|28|||
127982870|NCT03605849|460560123|FG002|Overall Study|Withdrawal by Subject|30|||
127982871|NCT03605849|460560124|FG003|Overall Study|Withdrawal by Subject|28|||
127982872|NCT03605849|460560121|FG000|Overall Study|Site Terminated by Sponsor|0|||
127982873|NCT03605849|460560122|FG001|Overall Study|Site Terminated by Sponsor|0|||
127982874|NCT03605849|460560123|FG002|Overall Study|Site Terminated by Sponsor|0|||
127982875|NCT03605849|460560124|FG003|Overall Study|Site Terminated by Sponsor|1|||
127982876|NCT03605849|460560121|FG000|Overall Study|Physician Decision|2|||
127982877|NCT03605849|460560122|FG001|Overall Study|Physician Decision|1|||
127982878|NCT03605849|460560123|FG002|Overall Study|Physician Decision|2|||
127982879|NCT03605849|460560124|FG003|Overall Study|Physician Decision|1|||
127982880|NCT03605849|460560121|FG000|Overall Study|Enrolled, but not Treated|2|||
127982881|NCT03605849|460560122|FG001|Overall Study|Enrolled, but not Treated|2|||
127982882|NCT03605849|460560123|FG002|Overall Study|Enrolled, but not Treated|3|||
127982883|NCT03605849|460560124|FG003|Overall Study|Enrolled, but not Treated|2|||
127982884|NCT03605849|460560121|FG000|Overall Study|Other (COVID-19 Related)|0|||
127982885|NCT03605849|460560122|FG001|Overall Study|Other (COVID-19 Related)|1|||
127982886|NCT03605849|460560123|FG002|Overall Study|Other (COVID-19 Related)|1|||
127982887|NCT03605849|460560124|FG003|Overall Study|Other (COVID-19 Related)|0|||
127982888|NCT03605849|460560121|FG000|Overall Study|Other (Not Related to COVID-19)|2|||
127982889|NCT03605849|460560122|FG001|Overall Study|Other (Not Related to COVID-19)|4|||
127982890|NCT03605849|460560123|FG002|Overall Study|Other (Not Related to COVID-19)|4|||
127982891|NCT03605849|460560124|FG003|Overall Study|Other (Not Related to COVID-19)|5|||
127982892|NCT02304380|460560125|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
127982893|NCT02304380|460560126|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
127982894|NCT02304380|460560127|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
127982895|NCT02304380|460560128|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
127982896|NCT02304380|460560129|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
127982897|NCT02304380|460560130|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
127982898|NCT00590538|460560131|FG000|Overall Study|Study terminated before completed|2|||
127982899|NCT01125813|460560132|FG000|Overall Study|Death|1|||
127982900|NCT01125813|460560132|FG000|Overall Study|Withdrawal by Subject|1|||
127982901|NCT01125813|460560132|FG000|Overall Study|Screen Failures|4|||
127982902|NCT00985426|460560133|FG000|Overall Study|Adverse Event|0|||
127982903|NCT00985426|460560134|FG001|Overall Study|Adverse Event|1|||
127982904|NCT00985426|460560133|FG000|Overall Study|Subject Non-Compliance|3|||
127982905|NCT00985426|460560134|FG001|Overall Study|Subject Non-Compliance|3|||
127982906|NCT00985426|460560133|FG000|Overall Study|Withdrawal by Subject|12|||
127982907|NCT00985426|460560134|FG001|Overall Study|Withdrawal by Subject|16|||
127982908|NCT00985426|460560133|FG000|Overall Study|Lost to Follow-up|8|||
127982909|NCT00985426|460560134|FG001|Overall Study|Lost to Follow-up|10|||
127982910|NCT00985426|460560133|FG000|Overall Study|Death|7|||
127982911|NCT00985426|460560134|FG001|Overall Study|Death|3|||
127982912|NCT00985426|460560133|FG000|Overall Study|Protocol Violation|2|||
127982913|NCT00985426|460560134|FG001|Overall Study|Protocol Violation|0|||
127982914|NCT00985426|460560133|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
127982915|NCT00985426|460560134|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
127982916|NCT04258254|460560135|FG000|Overall Study|Withdrawal by Subject|0|||
127982917|NCT04258254|460560136|FG001|Overall Study|Withdrawal by Subject|1|||
127982918|NCT04258254|460560137|FG002|Overall Study|Withdrawal by Subject|0|||
127982919|NCT04829331|460560138|FG000|Overall Study|Lost to Follow-up|1|||
127982920|NCT04829331|460560139|FG001|Overall Study|Lost to Follow-up|0|||
127982921|NCT01149421|460560140|FG000|Overall Study|Adverse Event|22|||
127982922|NCT01149421|460560141|FG001|Overall Study|Adverse Event|6|||
127982923|NCT01149421|460560142|FG002|Overall Study|Adverse Event|11|||
127982924|NCT01149421|460560140|FG000|Overall Study|Withdrawal by Subject|20|||
127982925|NCT01149421|460560141|FG001|Overall Study|Withdrawal by Subject|12|||
127982926|NCT01149421|460560142|FG002|Overall Study|Withdrawal by Subject|13|||
127982927|NCT01149421|460560140|FG000|Overall Study|Sponsor Decision|0|||
127982928|NCT01149421|460560141|FG001|Overall Study|Sponsor Decision|1|||
127982929|NCT01149421|460560142|FG002|Overall Study|Sponsor Decision|1|||
127982930|NCT01149421|460560140|FG000|Overall Study|Lost to Follow-up|2|||
127982931|NCT01149421|460560141|FG001|Overall Study|Lost to Follow-up|4|||
127982932|NCT01149421|460560142|FG002|Overall Study|Lost to Follow-up|5|||
127982933|NCT01149421|460560140|FG000|Overall Study|Physician Decision|5|||
127982934|NCT01149421|460560141|FG001|Overall Study|Physician Decision|3|||
127982935|NCT01149421|460560142|FG002|Overall Study|Physician Decision|6|||
127982936|NCT01149421|460560140|FG000|Overall Study|Entry Criteria Not Met|1|||
127982937|NCT01149421|460560141|FG001|Overall Study|Entry Criteria Not Met|1|||
127982938|NCT01149421|460560142|FG002|Overall Study|Entry Criteria Not Met|2|||
127982939|NCT01149421|460560140|FG000|Overall Study|Protocol Violation|2|||
127982940|NCT01149421|460560141|FG001|Overall Study|Protocol Violation|2|||
127982941|NCT01149421|460560142|FG002|Overall Study|Protocol Violation|6|||
127982942|NCT03570554|460560145|FG000|Overall Study|Non-compliance with study drug|0|||
127982943|NCT03570554|460560146|FG001|Overall Study|Non-compliance with study drug|0|||
127982944|NCT03570554|460560147|FG002|Overall Study|Non-compliance with study drug|1|||
127982945|NCT03570554|460560148|FG003|Overall Study|Non-compliance with study drug|0|||
127982946|NCT03570554|460560145|FG000|Overall Study|Adverse Event|0|||
127982947|NCT03570554|460560146|FG001|Overall Study|Adverse Event|0|||
127982948|NCT03570554|460560147|FG002|Overall Study|Adverse Event|0|||
127982949|NCT03570554|460560148|FG003|Overall Study|Adverse Event|1|||
127982950|NCT02956057|460560153|FG000|Overall Study|Discontinued intervention|14|||
127982951|NCT02956057|460560154|FG001|Overall Study|Discontinued intervention|10|||
127982952|NCT02956057|460560155|FG002|Overall Study|Discontinued intervention|7|||
127982953|NCT02956057|460560156|FG003|Overall Study|Discontinued intervention|14|||
127982954|NCT02956057|460560157|FG004|Overall Study|Discontinued intervention|4|||
127982955|NCT02956057|460560158|FG005|Overall Study|Discontinued intervention|17|||
127982956|NCT02956057|460560153|FG000|Overall Study|Lost to Follow-up|0|||
127982957|NCT02956057|460560154|FG001|Overall Study|Lost to Follow-up|2|||
127982958|NCT02956057|460560155|FG002|Overall Study|Lost to Follow-up|1|||
127982959|NCT02956057|460560156|FG003|Overall Study|Lost to Follow-up|1|||
127982960|NCT02956057|460560157|FG004|Overall Study|Lost to Follow-up|1|||
127982961|NCT02956057|460560158|FG005|Overall Study|Lost to Follow-up|0|||
127982962|NCT04679051|460560161|FG000|Overall Study|felt tired after restricted time in bed|3|||
127982963|NCT04679051|460560162|FG001|Overall Study|felt tired after restricted time in bed|0|||
127982964|NCT04679051|460560161|FG000|Overall Study|discomfort with blood pressure cuff|2|||
127982965|NCT04679051|460560162|FG001|Overall Study|discomfort with blood pressure cuff|0|||
127982966|NCT04679051|460560161|FG000|Overall Study|scheduling conflict|1|||
127982967|NCT04679051|460560162|FG001|Overall Study|scheduling conflict|1|||
127982968|NCT04679051|460560161|FG000|Overall Study|Protocol Violation|0|||
127982969|NCT04679051|460560162|FG001|Overall Study|Protocol Violation|4|||
127982970|NCT00033657|460560163|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
127982971|NCT00033657|460560164|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
127982972|NCT00033657|460560163|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
127982973|NCT00033657|460560164|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
127982974|NCT00033657|460560163|FG000|Neoadjuvant Chemotherapy|Death|1|||
127982975|NCT00033657|460560164|FG001|Neoadjuvant Chemotherapy|Death|1|||
127982976|NCT00033657|460560163|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
127982977|NCT00033657|460560164|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
127982978|NCT00033657|460560163|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
127982979|NCT00033657|460560164|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
127982980|NCT00033657|460560163|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
127982981|NCT00033657|460560164|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
127982982|NCT00033657|460560163|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
127982983|NCT00033657|460560164|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
127982984|NCT00033657|460560163|FG000|Surgical Resection|not complete resection|0|||
127982985|NCT00033657|460560164|FG001|Surgical Resection|not complete resection|3|||
127982986|NCT00033657|460560163|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
127982987|NCT00033657|460560164|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
127982988|NCT00033657|460560163|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
127982989|NCT00033657|460560164|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
127982990|NCT00033657|460560163|FG000|Adjuvant Chemotherapy|Death|2|||
127982991|NCT00033657|460560164|FG001|Adjuvant Chemotherapy|Death|1|||
127982992|NCT00033657|460560163|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
127982993|NCT00033657|460560164|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
127982994|NCT00033657|460560163|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
127982995|NCT00033657|460560164|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
127982996|NCT00033657|460560163|FG000|Adjuvant Chemotherapy|Other|0|||
127982997|NCT00033657|460560164|FG001|Adjuvant Chemotherapy|Other|2|||
127982998|NCT02945254|460560167|FG000|Overall Study|Lost to Follow-up|1|||
127982999|NCT02945254|460560168|FG001|Overall Study|Lost to Follow-up|0|||
127983000|NCT02945254|460560167|FG000|Overall Study|Withdrawal by Subject|1|||
127983001|NCT02945254|460560168|FG001|Overall Study|Withdrawal by Subject|0|||
127983002|NCT02631070|460560173|FG000|Overall Study|Withdrawal by Subject|35|||
127983003|NCT02631070|460560174|FG001|Overall Study|Withdrawal by Subject|13|||
127983004|NCT02631070|460560173|FG000|Overall Study|Death|45|||
127983005|NCT02631070|460560174|FG001|Overall Study|Death|24|||
127983006|NCT02631070|460560173|FG000|Overall Study|Lost to Follow-up|5|||
127983007|NCT02631070|460560174|FG001|Overall Study|Lost to Follow-up|1|||
127983008|NCT02631070|460560173|FG000|Overall Study|Transition to rollover protocol|52|||
127983009|NCT02631070|460560174|FG001|Overall Study|Transition to rollover protocol|21|||
127983010|NCT02631070|460560173|FG000|Overall Study|Other reasons|12|||
127983011|NCT02631070|460560174|FG001|Overall Study|Other reasons|5|||
127983012|NCT01522235|460560176|FG000|Overall Study|Physician Decision|1|||
127983013|NCT01522235|460560177|FG001|Overall Study|Physician Decision|1|||
127983014|NCT01273155|460560182|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
127983015|NCT01273155|460560183|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
127983016|NCT01273155|460560184|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
127983017|NCT01273155|460560185|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
127983018|NCT01273155|460560186|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
127983019|NCT01273155|460560187|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
127758756|NCT01259089|459742054|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
127983020|NCT01273155|460560188|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
127983021|NCT01273155|460560182|FG000|Overall Study|Change in liver function/no longer eval.|0|||
127758757|NCT01259089|459742055|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
127758758|NCT01259089|459742056|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
127758759|NCT01259089|459742057|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
127983022|NCT01273155|460560183|FG001|Overall Study|Change in liver function/no longer eval.|1|||
127983023|NCT01273155|460560184|FG002|Overall Study|Change in liver function/no longer eval.|0|||
127983024|NCT01273155|460560185|FG003|Overall Study|Change in liver function/no longer eval.|0|||
127983025|NCT01273155|460560186|FG004|Overall Study|Change in liver function/no longer eval.|1|||
127983026|NCT01273155|460560187|FG005|Overall Study|Change in liver function/no longer eval.|0|||
127983027|NCT01273155|460560188|FG006|Overall Study|Change in liver function/no longer eval.|0|||
127983028|NCT01273155|460560182|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
127983029|NCT01273155|460560183|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
127983030|NCT01273155|460560184|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
127983031|NCT01273155|460560185|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
127983032|NCT01273155|460560186|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
127983033|NCT01273155|460560187|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
127983034|NCT01273155|460560188|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
127983035|NCT01273155|460560182|FG000|Overall Study|Died during Cycle 1|0|||
127983036|NCT01273155|460560183|FG001|Overall Study|Died during Cycle 1|0|||
127983037|NCT01273155|460560184|FG002|Overall Study|Died during Cycle 1|1|||
127983038|NCT01273155|460560185|FG003|Overall Study|Died during Cycle 1|1|||
127983039|NCT01273155|460560186|FG004|Overall Study|Died during Cycle 1|0|||
127983040|NCT01273155|460560187|FG005|Overall Study|Died during Cycle 1|2|||
127983041|NCT01273155|460560188|FG006|Overall Study|Died during Cycle 1|2|||
127983042|NCT01273155|460560182|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
127983043|NCT01273155|460560183|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
127983044|NCT01273155|460560184|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
127983045|NCT01273155|460560185|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
127983046|NCT01273155|460560186|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
127983047|NCT01273155|460560187|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
127983048|NCT01273155|460560188|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
127983049|NCT01438814|460560194|FG000|Overall Study|Adverse Event|3|||
127983050|NCT01438814|460560195|FG001|Overall Study|Adverse Event|3|||
127983051|NCT01438814|460560194|FG000|Overall Study|Protocol Violation|1|||
127983052|NCT01438814|460560195|FG001|Overall Study|Protocol Violation|2|||
127983053|NCT01438814|460560194|FG000|Overall Study|Lost to Follow-up|4|||
127983054|NCT01438814|460560195|FG001|Overall Study|Lost to Follow-up|3|||
127983055|NCT01438814|460560194|FG000|Overall Study|Withdrawal by Subject|4|||
127983056|NCT01438814|460560195|FG001|Overall Study|Withdrawal by Subject|2|||
127983057|NCT01438814|460560194|FG000|Overall Study|Other|2|||
127983058|NCT01438814|460560195|FG001|Overall Study|Other|4|||
127983059|NCT01870297|460560200|FG000|Overall Study|Adverse Event|0|||
127983060|NCT01870297|460560201|FG001|Overall Study|Adverse Event|0|||
127983061|NCT01870297|460560202|FG002|Overall Study|Adverse Event|0|||
127983062|NCT01870297|460560203|FG003|Overall Study|Adverse Event|0|||
127983063|NCT01870297|460560204|FG004|Overall Study|Adverse Event|2|||
127983064|NCT01870297|460560205|FG005|Overall Study|Adverse Event|0|||
127983065|NCT01870297|460560206|FG006|Overall Study|Adverse Event|0|||
127983066|NCT01870297|460560200|FG000|Overall Study|Lost to Follow-up|0|||
127983067|NCT01870297|460560201|FG001|Overall Study|Lost to Follow-up|1|||
127983068|NCT01870297|460560202|FG002|Overall Study|Lost to Follow-up|1|||
127983069|NCT01870297|460560203|FG003|Overall Study|Lost to Follow-up|0|||
127983070|NCT01870297|460560204|FG004|Overall Study|Lost to Follow-up|0|||
127983071|NCT01870297|460560205|FG005|Overall Study|Lost to Follow-up|0|||
127983072|NCT01870297|460560206|FG006|Overall Study|Lost to Follow-up|0|||
127983073|NCT01870297|460560200|FG000|Overall Study|Withdrawal by Subject|0|||
127983074|NCT01870297|460560201|FG001|Overall Study|Withdrawal by Subject|0|||
127983075|NCT01870297|460560202|FG002|Overall Study|Withdrawal by Subject|0|||
127983076|NCT01870297|460560203|FG003|Overall Study|Withdrawal by Subject|0|||
127983077|NCT01870297|460560204|FG004|Overall Study|Withdrawal by Subject|1|||
127983078|NCT01870297|460560205|FG005|Overall Study|Withdrawal by Subject|1|||
127983079|NCT01870297|460560206|FG006|Overall Study|Withdrawal by Subject|1|||
127983080|NCT01870297|460560200|FG000|Overall Study|Sponsor Decision|0|||
127983081|NCT01870297|460560201|FG001|Overall Study|Sponsor Decision|6|||
127983082|NCT01870297|460560202|FG002|Overall Study|Sponsor Decision|0|||
127983083|NCT01870297|460560203|FG003|Overall Study|Sponsor Decision|0|||
127983084|NCT01870297|460560204|FG004|Overall Study|Sponsor Decision|0|||
127983085|NCT01870297|460560205|FG005|Overall Study|Sponsor Decision|0|||
127983086|NCT01870297|460560206|FG006|Overall Study|Sponsor Decision|1|||
127983087|NCT00337779|460560207|FG000|Overall Study|Withdrawal by Subject|10|||
127983088|NCT00337779|460560208|FG001|Overall Study|Withdrawal by Subject|12|||
127983089|NCT00337779|460560207|FG000|Overall Study|Sponsor decision|1|||
127983090|NCT00337779|460560208|FG001|Overall Study|Sponsor decision|1|||
127983091|NCT00337779|460560207|FG000|Overall Study|Physician Decision|3|||
127983092|NCT00337779|460560208|FG001|Overall Study|Physician Decision|6|||
127983093|NCT00337779|460560207|FG000|Overall Study|Protocol Violation|1|||
127535290|NCT05579977|458923473|FG007|Treatment Phase|Other|2|||
127983094|NCT00337779|460560208|FG001|Overall Study|Protocol Violation|1|||
127983095|NCT00337779|460560207|FG000|Overall Study|Lost to Follow-up|6|||
127983096|NCT00337779|460560208|FG001|Overall Study|Lost to Follow-up|5|||
127983097|NCT00337779|460560207|FG000|Overall Study|Adverse Event|28|||
127983098|NCT00337779|460560208|FG001|Overall Study|Adverse Event|51|||
127983099|NCT00337779|460560207|FG000|Overall Study|Pregnancy|3|||
127983100|NCT00337779|460560208|FG001|Overall Study|Pregnancy|2|||
127983101|NCT00337779|460560207|FG000|Overall Study|Death|0|||
127983102|NCT00337779|460560208|FG001|Overall Study|Death|1|||
127983103|NCT03008278|460560209|FG000|Overall Study|Progressive Disease|0|||
127983104|NCT03008278|460560210|FG001|Overall Study|Progressive Disease|0|||
127983105|NCT03008278|460560211|FG002|Overall Study|Progressive Disease|32|||
127983106|NCT03008278|460560209|FG000|Overall Study|Adverse Event|0|||
127983107|NCT03008278|460560210|FG001|Overall Study|Adverse Event|0|||
127983108|NCT03008278|460560211|FG002|Overall Study|Adverse Event|4|||
127983109|NCT03008278|460560209|FG000|Overall Study|Withdrawal by Subject|0|||
127983110|NCT03008278|460560210|FG001|Overall Study|Withdrawal by Subject|0|||
127983111|NCT03008278|460560211|FG002|Overall Study|Withdrawal by Subject|3|||
127983112|NCT03008278|460560209|FG000|Overall Study|Physician Decision|0|||
127983113|NCT03008278|460560210|FG001|Overall Study|Physician Decision|2|||
127983114|NCT03008278|460560211|FG002|Overall Study|Physician Decision|0|||
127983115|NCT00513357|460560212|FG000|Overall Study|did not receive allocated placebo|2|||
127983116|NCT00513357|460560213|FG001|Overall Study|did not receive allocated placebo|3|||
127983117|NCT00513357|460560212|FG000|Overall Study|Adverse Event|4|||
127983118|NCT00513357|460560213|FG001|Overall Study|Adverse Event|2|||
127983119|NCT00513357|460560212|FG000|Overall Study|Death|2|||
127983120|NCT00513357|460560213|FG001|Overall Study|Death|0|||
127983121|NCT00513357|460560212|FG000|Overall Study|Withdrawal by Subject|5|||
127983122|NCT00513357|460560213|FG001|Overall Study|Withdrawal by Subject|4|||
127983123|NCT00513357|460560212|FG000|Overall Study|Disease Progression|2|||
127983124|NCT00513357|460560213|FG001|Overall Study|Disease Progression|1|||
127983125|NCT01162122|460560214|FG000|Overall Study|Withdrawal by Subject|52|||
127983126|NCT01162122|460560215|FG001|Overall Study|Withdrawal by Subject|43|||
127983127|NCT01162122|460560214|FG000|Overall Study|Lost to Follow-up|73|||
127983128|NCT01162122|460560215|FG001|Overall Study|Lost to Follow-up|91|||
127983129|NCT01162122|460560214|FG000|Overall Study|Adverse Event|3|||
127983130|NCT01162122|460560215|FG001|Overall Study|Adverse Event|2|||
127983131|NCT01162122|460560214|FG000|Overall Study|Death|51|||
127983132|NCT01162122|460560215|FG001|Overall Study|Death|46|||
127983133|NCT01162122|460560214|FG000|Overall Study|Protocol Violation|2|||
127983134|NCT01162122|460560215|FG001|Overall Study|Protocol Violation|2|||
127983135|NCT01162122|460560214|FG000|Overall Study|Inappropriate enrollment|5|||
127983136|NCT01162122|460560215|FG001|Overall Study|Inappropriate enrollment|4|||
127983137|NCT01162122|460560214|FG000|Overall Study|Administrative reason|1|||
127983138|NCT01162122|460560215|FG001|Overall Study|Administrative reason|1|||
127983139|NCT01162122|460560214|FG000|Overall Study|Unable to classify|3|||
127983140|NCT01162122|460560215|FG001|Overall Study|Unable to classify|7|||
127983141|NCT01162122|460560214|FG000|Overall Study|Missing primary reason|1|||
127983142|NCT01162122|460560215|FG001|Overall Study|Missing primary reason|0|||
127983143|NCT00422422|460560219|FG000|Overall Study|Lack of Efficacy|1|||
127983144|NCT00422422|460560219|FG000|Overall Study|Protocol Violation|1|||
127983145|NCT00422422|460560219|FG000|Overall Study|Withdrawal by Subject|2|||
127983146|NCT00422422|460560219|FG000|Overall Study|SAE, non-fatal|1|||
127983147|NCT00422422|460560219|FG000|Overall Study|AE, non-serious non-fatal|5|||
127983148|NCT03313310|460560220|FG000|Phase 2|Lost to Follow-up|4|||
127983149|NCT03313310|460560221|FG001|Phase 2|Lost to Follow-up|0|||
127983150|NCT03313310|460560220|FG000|Phase 3|Lost to Follow-up|0|||
127983151|NCT03313310|460560221|FG001|Phase 3|Lost to Follow-up|1|||
127983152|NCT01217385|460560222|FG000|Overall Study|Withdrawal by Subject|3|||
127983153|NCT01217385|460560222|FG000|Overall Study|DOSI not performed/not eval|12|||
127983154|NCT01217385|460560222|FG000|Overall Study|Central Path not Available|1|||
127983155|NCT01217385|460560222|FG000|Overall Study|Normal Breast TOI not available|10|||
127983156|NCT00090987|460560223|FG000|Overall Study|Adverse Event|5|||
127983157|NCT00090987|460560223|FG000|Overall Study|Lack of Efficacy|7|||
127983158|NCT00090987|460560223|FG000|Overall Study|Withdrawal by Subject|3|||
127983159|NCT00090987|460560223|FG000|Overall Study|alternative therapy|1|||
127983160|NCT00090987|460560223|FG000|Overall Study|Non-compliance|4|||
127983161|NCT00090987|460560223|FG000|Overall Study|Incarcerated|1|||
127983162|NCT01731470|460560226|FG000|Overall Study|Withdrawal by Subject|1|||
127983163|NCT01731470|460560226|FG000|Overall Study|Did not meet study criteria|1|||
127983164|NCT01592292|460560227|FG000|Overall Study|Follow-up loss|3|||
127983165|NCT01592292|460560228|FG001|Overall Study|Follow-up loss|3|||
127535291|NCT05579977|458923474|FG008|Treatment Phase|Other|2|||
127983166|NCT01592292|460560229|FG002|Overall Study|Follow-up loss|1|||
127983167|NCT01592292|460560230|FG003|Overall Study|Follow-up loss|0|||
127535292|NCT05579977|458923475|FG009|Treatment Phase|Other|1|||
127983168|NCT01592292|460560227|FG000|Overall Study|Withdrew consent|2|||
127983169|NCT01592292|460560228|FG001|Overall Study|Withdrew consent|1|||
127983170|NCT01592292|460560229|FG002|Overall Study|Withdrew consent|0|||
127983171|NCT01592292|460560230|FG003|Overall Study|Withdrew consent|0|||
127983172|NCT01592292|460560227|FG000|Overall Study|Other|1|||
127983173|NCT01592292|460560228|FG001|Overall Study|Other|1|||
127983174|NCT01592292|460560229|FG002|Overall Study|Other|2|||
127983175|NCT01592292|460560230|FG003|Overall Study|Other|1|||
127983176|NCT01876979|460560231|FG000|Overall Study|Physician Decision|2|||
127983177|NCT01876979|460560232|FG001|Overall Study|Physician Decision|3|||
127983178|NCT00948506|460560235|FG000|Overall Study|Withdrawal by Subject|3|||
127983179|NCT00948506|460560236|FG001|Overall Study|Withdrawal by Subject|1|||
127983180|NCT03233204|460560237|FG000|Overall Study|Adverse Event|1|||
127983181|NCT03233204|460560237|FG000|Overall Study|Death|1|||
127983182|NCT03233204|460560237|FG000|Overall Study|Withdrawal by Subject|1|||
127983183|NCT03233204|460560237|FG000|Overall Study|Progressive Disease|3|||
127983184|NCT00721279|460560238|FG000|Overall Study|Lack of Efficacy|6|||
127983185|NCT00721279|460560239|FG001|Overall Study|Lack of Efficacy|3|||
127983186|NCT00721279|460560238|FG000|Overall Study|Tolerability insufficient|5|||
127983187|NCT00721279|460560239|FG001|Overall Study|Tolerability insufficient|2|||
127983188|NCT00721279|460560238|FG000|Overall Study|Withdrawal by Subject|13|||
127983189|NCT00721279|460560239|FG001|Overall Study|Withdrawal by Subject|3|||
127983190|NCT00721279|460560238|FG000|Overall Study|Other|12|||
127983191|NCT00721279|460560239|FG001|Overall Study|Other|16|||
127983192|NCT02680834|460560240|FG000|Overall Study|Physician Decision|5|||
127983193|NCT02680834|460560241|FG001|Overall Study|Physician Decision|2|||
127983194|NCT02680834|460560240|FG000|Overall Study|Withdrawal by Subject|6|||
127983195|NCT02680834|460560241|FG001|Overall Study|Withdrawal by Subject|0|||
127983196|NCT02680834|460560240|FG000|Overall Study|Lost to Follow-up|0|||
127535293|NCT05579977|458923476|FG010|Treatment Phase|Other|0|||
127535294|NCT05579977|458923477|FG011|Treatment Phase|Other|0|||
127535295|NCT05579977|458923478|FG012|Treatment Phase|Other|3|||
127535296|NCT05579977|458923466|FG000|Treatment Phase|Treatment with restricted medication needed|2|||
127535297|NCT05579977|458923467|FG001|Treatment Phase|Treatment with restricted medication needed|0|||
127535298|NCT05579977|458923468|FG002|Treatment Phase|Treatment with restricted medication needed|0|||
127535299|NCT05579977|458923469|FG003|Treatment Phase|Treatment with restricted medication needed|0|||
127535300|NCT05579977|458923470|FG004|Treatment Phase|Treatment with restricted medication needed|0|||
127535301|NCT05579977|458923471|FG005|Treatment Phase|Treatment with restricted medication needed|1|||
127535302|NCT05579977|458923472|FG006|Treatment Phase|Treatment with restricted medication needed|0|||
127535303|NCT05579977|458923473|FG007|Treatment Phase|Treatment with restricted medication needed|0|||
127535304|NCT05579977|458923474|FG008|Treatment Phase|Treatment with restricted medication needed|0|||
127535305|NCT05579977|458923475|FG009|Treatment Phase|Treatment with restricted medication needed|0|||
127535306|NCT05579977|458923476|FG010|Treatment Phase|Treatment with restricted medication needed|0|||
127535307|NCT05579977|458923477|FG011|Treatment Phase|Treatment with restricted medication needed|0|||
127535308|NCT05579977|458923478|FG012|Treatment Phase|Treatment with restricted medication needed|0|||
127535309|NCT05579977|458923466|FG000|Treatment Phase|Withdrawal by Subject|2|||
127535310|NCT05579977|458923467|FG001|Treatment Phase|Withdrawal by Subject|0|||
127535311|NCT05579977|458923468|FG002|Treatment Phase|Withdrawal by Subject|0|||
127535312|NCT05579977|458923469|FG003|Treatment Phase|Withdrawal by Subject|1|||
127535313|NCT05579977|458923470|FG004|Treatment Phase|Withdrawal by Subject|2|||
127535314|NCT05579977|458923471|FG005|Treatment Phase|Withdrawal by Subject|0|||
127535315|NCT05579977|458923472|FG006|Treatment Phase|Withdrawal by Subject|1|||
127535316|NCT05579977|458923473|FG007|Treatment Phase|Withdrawal by Subject|8|||
127535317|NCT05579977|458923474|FG008|Treatment Phase|Withdrawal by Subject|3|||
127535318|NCT05579977|458923475|FG009|Treatment Phase|Withdrawal by Subject|3|||
127535319|NCT05579977|458923476|FG010|Treatment Phase|Withdrawal by Subject|5|||
127535320|NCT05579977|458923477|FG011|Treatment Phase|Withdrawal by Subject|1|||
127535321|NCT05579977|458923478|FG012|Treatment Phase|Withdrawal by Subject|3|||
127535322|NCT05579977|458923466|FG000|Treatment Phase|Study terminated by sponsor|70|||
127535323|NCT05579977|458923467|FG001|Treatment Phase|Study terminated by sponsor|70|||
127535324|NCT05579977|458923468|FG002|Treatment Phase|Study terminated by sponsor|61|||
127535325|NCT05579977|458923469|FG003|Treatment Phase|Study terminated by sponsor|59|||
127535326|NCT05579977|458923470|FG004|Treatment Phase|Study terminated by sponsor|63|||
127535327|NCT05579977|458923471|FG005|Treatment Phase|Study terminated by sponsor|53|||
127535328|NCT05579977|458923472|FG006|Treatment Phase|Study terminated by sponsor|66|||
127535329|NCT05579977|458923473|FG007|Treatment Phase|Study terminated by sponsor|48|||
127535330|NCT05579977|458923474|FG008|Treatment Phase|Study terminated by sponsor|47|||
127535331|NCT05579977|458923475|FG009|Treatment Phase|Study terminated by sponsor|37|||
127535332|NCT05579977|458923476|FG010|Treatment Phase|Study terminated by sponsor|44|||
127535333|NCT05579977|458923477|FG011|Treatment Phase|Study terminated by sponsor|36|||
127535334|NCT05579977|458923478|FG012|Treatment Phase|Study terminated by sponsor|32|||
127535335|NCT05579977|458923466|FG000|Treatment Phase|Pregnancy|0|||
127535336|NCT05579977|458923467|FG001|Treatment Phase|Pregnancy|0|||
127535337|NCT05579977|458923468|FG002|Treatment Phase|Pregnancy|0|||
127535338|NCT05579977|458923469|FG003|Treatment Phase|Pregnancy|0|||
127983197|NCT02680834|460560241|FG001|Overall Study|Lost to Follow-up|1|||
127983198|NCT03467763|460560242|FG000|Overall Study|Lost to Follow-up|1|||
127983199|NCT03467763|460560242|FG000|Overall Study|Protocol Violation|2|||
127983200|NCT04918355|460560243|FG000|Overall Study|no qualifying health encounter|497|||
127983201|NCT04918355|460560244|FG001|Overall Study|no qualifying health encounter|192|||
127983202|NCT04918355|460560245|FG002|Overall Study|no qualifying health encounter|438|||
127983203|NCT04918355|460560246|FG003|Overall Study|no qualifying health encounter|424|||
127983204|NCT02327013|460562397|FG000|Overall Study|Adverse Event|4|||
127983205|NCT02327013|460562398|FG001|Overall Study|Adverse Event|4|||
127983206|NCT02327013|460562399|FG002|Overall Study|Adverse Event|3|||
127983207|NCT02327013|460562400|FG003|Overall Study|Adverse Event|0|||
127983208|NCT02327013|460562401|FG004|Overall Study|Adverse Event|1|||
127983209|NCT02327013|460562397|FG000|Overall Study|Lack of Efficacy|2|||
127983210|NCT02327013|460562398|FG001|Overall Study|Lack of Efficacy|0|||
127983211|NCT02327013|460562399|FG002|Overall Study|Lack of Efficacy|5|||
127983212|NCT02327013|460562400|FG003|Overall Study|Lack of Efficacy|0|||
127983213|NCT02327013|460562401|FG004|Overall Study|Lack of Efficacy|1|||
127983214|NCT02327013|460562397|FG000|Overall Study|Non-compliance with IMP|1|||
127983215|NCT02327013|460562398|FG001|Overall Study|Non-compliance with IMP|2|||
127983216|NCT02327013|460562399|FG002|Overall Study|Non-compliance with IMP|7|||
127983217|NCT02327013|460562400|FG003|Overall Study|Non-compliance with IMP|0|||
127983218|NCT02327013|460562401|FG004|Overall Study|Non-compliance with IMP|0|||
127983219|NCT02327013|460562397|FG000|Overall Study|Withdrawal of Consent|1|||
127983220|NCT02327013|460562398|FG001|Overall Study|Withdrawal of Consent|0|||
127983221|NCT02327013|460562399|FG002|Overall Study|Withdrawal of Consent|3|||
127983222|NCT02327013|460562400|FG003|Overall Study|Withdrawal of Consent|0|||
127983223|NCT02327013|460562401|FG004|Overall Study|Withdrawal of Consent|0|||
127983224|NCT02327013|460562397|FG000|Overall Study|Lost to Follow-up|2|||
127983225|NCT02327013|460562398|FG001|Overall Study|Lost to Follow-up|4|||
127983226|NCT02327013|460562399|FG002|Overall Study|Lost to Follow-up|5|||
127983227|NCT02327013|460562400|FG003|Overall Study|Lost to Follow-up|0|||
127983228|NCT02327013|460562401|FG004|Overall Study|Lost to Follow-up|0|||
127983229|NCT02327013|460562397|FG000|Overall Study|Administrative or other reason(s)|1|||
127983230|NCT02327013|460562398|FG001|Overall Study|Administrative or other reason(s)|5|||
127983231|NCT02327013|460562399|FG002|Overall Study|Administrative or other reason(s)|11|||
127983232|NCT02327013|460562400|FG003|Overall Study|Administrative or other reason(s)|1|||
127983233|NCT02327013|460562401|FG004|Overall Study|Administrative or other reason(s)|1|||
127983234|NCT02327013|460562397|FG000|Overall Study|Protocol Violation|0|||
127983235|NCT02327013|460562398|FG001|Overall Study|Protocol Violation|0|||
127983236|NCT02327013|460562399|FG002|Overall Study|Protocol Violation|3|||
127983237|NCT02327013|460562400|FG003|Overall Study|Protocol Violation|0|||
127983238|NCT02327013|460562401|FG004|Overall Study|Protocol Violation|1|||
127983239|NCT02327013|460562397|FG000|Overall Study|Withdrawal before treatment|2|||
127983240|NCT02327013|460562398|FG001|Overall Study|Withdrawal before treatment|1|||
127983241|NCT02327013|460562399|FG002|Overall Study|Withdrawal before treatment|5|||
127983242|NCT02327013|460562400|FG003|Overall Study|Withdrawal before treatment|0|||
127983243|NCT02327013|460562401|FG004|Overall Study|Withdrawal before treatment|0|||
127983244|NCT00616603|460562403|FG000|Overall Study|Physician Decision|2|||
127983245|NCT00616603|460562404|FG001|Overall Study|Physician Decision|0|||
127983246|NCT00616603|460562405|FG002|Overall Study|Physician Decision|2|||
127983247|NCT03738800|460562407|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
127983248|NCT03738800|460562408|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
127983249|NCT03738800|460562409|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
127983250|NCT03738800|460562407|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
127983251|NCT03738800|460562408|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
127983252|NCT03738800|460562409|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
127983253|NCT03738800|460562407|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
127983254|NCT03738800|460562408|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
127983255|NCT03738800|460562409|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
127983256|NCT00766467|460562419|FG000|Overall Study|Withdrawal by Subject|7|||
127983257|NCT00766467|460562420|FG001|Overall Study|Withdrawal by Subject|2|||
127983258|NCT00766467|460562419|FG000|Overall Study|Adverse Event|1|||
127983259|NCT00766467|460562420|FG001|Overall Study|Adverse Event|1|||
127983260|NCT00766467|460562419|FG000|Overall Study|Protocol Violation|2|||
127983261|NCT00766467|460562420|FG001|Overall Study|Protocol Violation|4|||
127983262|NCT00766467|460562419|FG000|Overall Study|Tumor Progression on Study|0|||
127983263|NCT00766467|460562420|FG001|Overall Study|Tumor Progression on Study|1|||
127983264|NCT00766467|460562419|FG000|Overall Study|Physician Decision|1|||
127983265|NCT00766467|460562420|FG001|Overall Study|Physician Decision|0|||
127983266|NCT03435224|460562423|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
127983267|NCT02604550|460562426|FG000|Overall Study|Lost to Follow-up|7|||
127983268|NCT02604550|460562427|FG001|Overall Study|Lost to Follow-up|6|||
127535339|NCT05579977|458923470|FG004|Treatment Phase|Pregnancy|0|||
127983269|NCT02604550|460562426|FG000|Overall Study|Withdrawal by Subject|0|||
127983270|NCT02604550|460562427|FG001|Overall Study|Withdrawal by Subject|1|||
127983271|NCT02604550|460562426|FG000|Overall Study|Incomplete data using paper journal|18|||
127535340|NCT05579977|458923471|FG005|Treatment Phase|Pregnancy|0|||
127535341|NCT05579977|458923472|FG006|Treatment Phase|Pregnancy|0|||
127535342|NCT05579977|458923473|FG007|Treatment Phase|Pregnancy|0|||
127535343|NCT05579977|458923474|FG008|Treatment Phase|Pregnancy|0|||
127535344|NCT05579977|458923475|FG009|Treatment Phase|Pregnancy|1|||
127535345|NCT05579977|458923476|FG010|Treatment Phase|Pregnancy|0|||
127535346|NCT05579977|458923477|FG011|Treatment Phase|Pregnancy|0|||
127758760|NCT01259089|459742052|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
127758761|NCT01259089|459742053|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
127758762|NCT01259089|459742054|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
127758763|NCT01259089|459742055|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
127535347|NCT05579977|458923478|FG012|Treatment Phase|Pregnancy|0|||
127535348|NCT05579977|458923466|FG000|Treatment Phase|Physician Decision|0|||
127535349|NCT05579977|458923467|FG001|Treatment Phase|Physician Decision|0|||
127535350|NCT05579977|458923468|FG002|Treatment Phase|Physician Decision|0|||
127535351|NCT05579977|458923469|FG003|Treatment Phase|Physician Decision|0|||
127535352|NCT05579977|458923470|FG004|Treatment Phase|Physician Decision|0|||
127535353|NCT05579977|458923471|FG005|Treatment Phase|Physician Decision|0|||
127535354|NCT05579977|458923472|FG006|Treatment Phase|Physician Decision|0|||
127535355|NCT05579977|458923473|FG007|Treatment Phase|Physician Decision|0|||
127535356|NCT05579977|458923474|FG008|Treatment Phase|Physician Decision|0|||
127535357|NCT05579977|458923475|FG009|Treatment Phase|Physician Decision|0|||
127535358|NCT05579977|458923476|FG010|Treatment Phase|Physician Decision|0|||
127535359|NCT05579977|458923477|FG011|Treatment Phase|Physician Decision|1|||
127535360|NCT05579977|458923478|FG012|Treatment Phase|Physician Decision|0|||
127535361|NCT05579977|458923466|FG000|Treatment Phase|Lost to Follow-up|0|||
127535362|NCT05579977|458923467|FG001|Treatment Phase|Lost to Follow-up|0|||
127535363|NCT05579977|458923468|FG002|Treatment Phase|Lost to Follow-up|0|||
127535364|NCT05579977|458923469|FG003|Treatment Phase|Lost to Follow-up|1|||
127535365|NCT05579977|458923470|FG004|Treatment Phase|Lost to Follow-up|1|||
127535366|NCT05579977|458923471|FG005|Treatment Phase|Lost to Follow-up|1|||
127535367|NCT05579977|458923472|FG006|Treatment Phase|Lost to Follow-up|0|||
127535368|NCT05579977|458923473|FG007|Treatment Phase|Lost to Follow-up|1|||
127535369|NCT05579977|458923474|FG008|Treatment Phase|Lost to Follow-up|2|||
127535370|NCT05579977|458923475|FG009|Treatment Phase|Lost to Follow-up|2|||
127535371|NCT05579977|458923476|FG010|Treatment Phase|Lost to Follow-up|1|||
127535372|NCT05579977|458923477|FG011|Treatment Phase|Lost to Follow-up|4|||
127535373|NCT05579977|458923478|FG012|Treatment Phase|Lost to Follow-up|3|||
127535374|NCT05579977|458923466|FG000|Treatment Phase|Death|1|||
127535375|NCT05579977|458923467|FG001|Treatment Phase|Death|0|||
127535376|NCT05579977|458923468|FG002|Treatment Phase|Death|0|||
127535377|NCT05579977|458923469|FG003|Treatment Phase|Death|0|||
127535378|NCT05579977|458923470|FG004|Treatment Phase|Death|0|||
127535379|NCT05579977|458923471|FG005|Treatment Phase|Death|0|||
127535380|NCT05579977|458923472|FG006|Treatment Phase|Death|0|||
127535381|NCT05579977|458923473|FG007|Treatment Phase|Death|0|||
127535382|NCT05579977|458923474|FG008|Treatment Phase|Death|0|||
127535383|NCT05579977|458923475|FG009|Treatment Phase|Death|0|||
127535384|NCT05579977|458923476|FG010|Treatment Phase|Death|0|||
127535385|NCT05579977|458923477|FG011|Treatment Phase|Death|0|||
127535386|NCT05579977|458923478|FG012|Treatment Phase|Death|0|||
127535387|NCT05579977|458923466|FG000|Treatment Phase|Adverse Event|0|||
127535388|NCT05579977|458923467|FG001|Treatment Phase|Adverse Event|3|||
127535389|NCT05579977|458923468|FG002|Treatment Phase|Adverse Event|11|||
127535390|NCT05579977|458923469|FG003|Treatment Phase|Adverse Event|10|||
127535391|NCT05579977|458923470|FG004|Treatment Phase|Adverse Event|5|||
127535392|NCT05579977|458923471|FG005|Treatment Phase|Adverse Event|17|||
127535393|NCT05579977|458923472|FG006|Treatment Phase|Adverse Event|5|||
127535394|NCT05579977|458923473|FG007|Treatment Phase|Adverse Event|5|||
127535395|NCT05579977|458923474|FG008|Treatment Phase|Adverse Event|12|||
127535396|NCT05579977|458923475|FG009|Treatment Phase|Adverse Event|20|||
127535397|NCT05579977|458923476|FG010|Treatment Phase|Adverse Event|15|||
127535398|NCT05579977|458923477|FG011|Treatment Phase|Adverse Event|24|||
127535399|NCT05579977|458923478|FG012|Treatment Phase|Adverse Event|23|||
127535400|NCT05579977|458923466|FG000|Treatment Phase|Randomized not treated|0|||
127535401|NCT05579977|458923467|FG001|Treatment Phase|Randomized not treated|0|||
127535402|NCT05579977|458923468|FG002|Treatment Phase|Randomized not treated|0|||
127535403|NCT05579977|458923469|FG003|Treatment Phase|Randomized not treated|0|||
127535404|NCT05579977|458923470|FG004|Treatment Phase|Randomized not treated|1|||
127535405|NCT05579977|458923471|FG005|Treatment Phase|Randomized not treated|0|||
127535406|NCT05579977|458923472|FG006|Treatment Phase|Randomized not treated|0|||
127535407|NCT05579977|458923473|FG007|Treatment Phase|Randomized not treated|0|||
127535408|NCT05579977|458923474|FG008|Treatment Phase|Randomized not treated|0|||
127535409|NCT05579977|458923475|FG009|Treatment Phase|Randomized not treated|0|||
127535410|NCT05579977|458923476|FG010|Treatment Phase|Randomized not treated|0|||
127535411|NCT05579977|458923477|FG011|Treatment Phase|Randomized not treated|0|||
127535412|NCT05579977|458923478|FG012|Treatment Phase|Randomized not treated|0|||
127535413|NCT05579977|458923466|FG000|Follow up|Death|1|||
127535414|NCT05579977|458923467|FG001|Follow up|Death|0|||
127535415|NCT05579977|458923468|FG002|Follow up|Death|0|||
127535416|NCT05579977|458923469|FG003|Follow up|Death|0|||
127535417|NCT05579977|458923470|FG004|Follow up|Death|0|||
127535418|NCT05579977|458923471|FG005|Follow up|Death|0|||
127535419|NCT05579977|458923472|FG006|Follow up|Death|0|||
127535420|NCT05579977|458923473|FG007|Follow up|Death|0|||
127535421|NCT05579977|458923474|FG008|Follow up|Death|0|||
127535422|NCT05579977|458923475|FG009|Follow up|Death|0|||
127535423|NCT05579977|458923476|FG010|Follow up|Death|0|||
127535424|NCT05579977|458923477|FG011|Follow up|Death|0|||
127535425|NCT05579977|458923478|FG012|Follow up|Death|0|||
127535426|NCT05579977|458923466|FG000|Follow up|Lost to Follow-up|0|||
127535427|NCT05579977|458923467|FG001|Follow up|Lost to Follow-up|0|||
127535428|NCT05579977|458923468|FG002|Follow up|Lost to Follow-up|0|||
127535429|NCT05579977|458923469|FG003|Follow up|Lost to Follow-up|1|||
127535430|NCT05579977|458923470|FG004|Follow up|Lost to Follow-up|1|||
127535431|NCT05579977|458923471|FG005|Follow up|Lost to Follow-up|2|||
127535432|NCT05579977|458923472|FG006|Follow up|Lost to Follow-up|1|||
127535433|NCT05579977|458923473|FG007|Follow up|Lost to Follow-up|1|||
127535434|NCT05579977|458923474|FG008|Follow up|Lost to Follow-up|3|||
127535435|NCT05579977|458923475|FG009|Follow up|Lost to Follow-up|2|||
127535436|NCT05579977|458923476|FG010|Follow up|Lost to Follow-up|2|||
127535437|NCT05579977|458923477|FG011|Follow up|Lost to Follow-up|4|||
127535438|NCT05579977|458923478|FG012|Follow up|Lost to Follow-up|4|||
127535439|NCT05579977|458923466|FG000|Follow up|Withdrawal by Subject|2|||
127535440|NCT05579977|458923467|FG001|Follow up|Withdrawal by Subject|0|||
127535441|NCT05579977|458923468|FG002|Follow up|Withdrawal by Subject|0|||
127535442|NCT05579977|458923469|FG003|Follow up|Withdrawal by Subject|0|||
127535443|NCT05579977|458923470|FG004|Follow up|Withdrawal by Subject|1|||
127535444|NCT05579977|458923471|FG005|Follow up|Withdrawal by Subject|0|||
127535445|NCT05579977|458923472|FG006|Follow up|Withdrawal by Subject|1|||
127535446|NCT05579977|458923473|FG007|Follow up|Withdrawal by Subject|4|||
127535447|NCT05579977|458923474|FG008|Follow up|Withdrawal by Subject|2|||
127535448|NCT05579977|458923475|FG009|Follow up|Withdrawal by Subject|3|||
127535449|NCT05579977|458923476|FG010|Follow up|Withdrawal by Subject|3|||
127535450|NCT05579977|458923477|FG011|Follow up|Withdrawal by Subject|1|||
127535451|NCT05579977|458923478|FG012|Follow up|Withdrawal by Subject|3|||
127535452|NCT00350844|458923481|FG000|Overall Study|Lost to Follow-up|1|||
127535453|NCT01420926|458923482|FG000|Overall Study|Adverse Event|6|||
127535454|NCT01420926|458923483|FG001|Overall Study|Adverse Event|4|||
127535455|NCT01420926|458923482|FG000|Overall Study|Death|18|||
127535456|NCT01420926|458923483|FG001|Overall Study|Death|17|||
127535457|NCT01420926|458923482|FG000|Overall Study|Withdrawal by Subject|11|||
127535458|NCT01420926|458923483|FG001|Overall Study|Withdrawal by Subject|17|||
127535459|NCT01420926|458923482|FG000|Overall Study|Non-protocol treatment|17|||
127535460|NCT01420926|458923483|FG001|Overall Study|Non-protocol treatment|20|||
127535461|NCT01420926|458923482|FG000|Overall Study|Physician Decision|8|||
127535462|NCT01420926|458923483|FG001|Overall Study|Physician Decision|5|||
127535463|NCT02775916|458923486|FG000|Overall Study|Adverse Event|1|||
127535464|NCT02775916|458923487|FG001|Overall Study|Adverse Event|0|||
127535465|NCT02775916|458923486|FG000|Overall Study|Subject/Guardian Decision|2|||
127535466|NCT02775916|458923487|FG001|Overall Study|Subject/Guardian Decision|0|||
127535467|NCT01232868|458925730|FG000|Overall Study|Lost to Follow-up|2|||
127535468|NCT01232868|458925731|FG001|Overall Study|Lost to Follow-up|4|||
127535469|NCT02539797|458925732|FG000|Overall Study|Lost to Follow-up|0|||
127535470|NCT02539797|458925733|FG001|Overall Study|Lost to Follow-up|1|||
127535471|NCT02539797|458925734|FG002|Overall Study|Lost to Follow-up|0|||
127758764|NCT01259089|459742056|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
127758765|NCT01259089|459742057|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
127758766|NCT01259089|459742052|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
127758767|NCT01259089|459742053|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
127758768|NCT01259089|459742054|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
127758769|NCT01259089|459742055|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
127758770|NCT01259089|459742056|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
127758771|NCT01259089|459742057|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
127758772|NCT01259089|459742052|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
127758773|NCT01259089|459742053|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
127758774|NCT01259089|459742054|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
127758775|NCT01259089|459742055|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
127758776|NCT01259089|459742056|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
127758777|NCT01259089|459742057|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
127758778|NCT01259089|459742052|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
127758779|NCT01259089|459742053|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
127758780|NCT01259089|459742054|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
127758781|NCT01259089|459742055|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
127758782|NCT01259089|459742056|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
127758783|NCT01259089|459742057|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
127758784|NCT01259089|459742052|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
127758785|NCT01259089|459742053|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
127535472|NCT04002960|458925736|FG000|Overall Study|Withdrawn prior to Completion|2|||
127535473|NCT00865345|458925739|FG000|Overall Study|Withdrawal by Subject|2|||
127758786|NCT01259089|459742054|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
127758787|NCT01259089|459742055|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
127758788|NCT01259089|459742056|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
127758789|NCT01259089|459742057|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
127758790|NCT01259089|459742052|FG000|Survival Follow up for Two Years|Death|3|||
127758791|NCT01259089|459742053|FG001|Survival Follow up for Two Years|Death|2|||
127758792|NCT01259089|459742054|FG002|Survival Follow up for Two Years|Death|2|||
127758793|NCT01259089|459742055|FG003|Survival Follow up for Two Years|Death|3|||
127758794|NCT01259089|459742056|FG004|Survival Follow up for Two Years|Death|6|||
127758795|NCT01259089|459742057|FG005|Survival Follow up for Two Years|Death|13|||
127758796|NCT01259089|459742052|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
127758797|NCT01259089|459742053|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
127758798|NCT01259089|459742054|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
127758799|NCT01259089|459742055|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
127758800|NCT01259089|459742056|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
127758801|NCT01259089|459742057|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
127535474|NCT00383786|458925740|FG000|Overall Study|Protocol Violation|2|||
127535475|NCT00383786|458925741|FG001|Overall Study|Protocol Violation|6|||
127535476|NCT00383786|458925740|FG000|Overall Study|Withdrawal by Subject|2|||
127535477|NCT00383786|458925741|FG001|Overall Study|Withdrawal by Subject|5|||
127535478|NCT00383786|458925740|FG000|Overall Study|Physician Decision|0|||
127535479|NCT00383786|458925741|FG001|Overall Study|Physician Decision|1|||
127535480|NCT02735239|458925744|FG000|Overall Study|Adverse Event|0|||
127535481|NCT02735239|458925745|FG001|Overall Study|Adverse Event|0|||
127535482|NCT02735239|458925746|FG002|Overall Study|Adverse Event|4|||
127535483|NCT02735239|458925747|FG003|Overall Study|Adverse Event|0|||
127535484|NCT02735239|458925748|FG004|Overall Study|Adverse Event|0|||
127535485|NCT02735239|458925749|FG005|Overall Study|Adverse Event|0|||
127535486|NCT02735239|458925744|FG000|Overall Study|Death|1|||
127535487|NCT02735239|458925745|FG001|Overall Study|Death|1|||
127535488|NCT02735239|458925746|FG002|Overall Study|Death|0|||
127535489|NCT02735239|458925747|FG003|Overall Study|Death|0|||
127535490|NCT02735239|458925748|FG004|Overall Study|Death|0|||
127535491|NCT02735239|458925749|FG005|Overall Study|Death|0|||
127535492|NCT02735239|458925744|FG000|Overall Study|Physician Decision|0|||
127535493|NCT02735239|458925745|FG001|Overall Study|Physician Decision|0|||
127535494|NCT02735239|458925746|FG002|Overall Study|Physician Decision|1|||
127535495|NCT02735239|458925747|FG003|Overall Study|Physician Decision|0|||
127535496|NCT02735239|458925748|FG004|Overall Study|Physician Decision|0|||
127535497|NCT02735239|458925749|FG005|Overall Study|Physician Decision|0|||
127535498|NCT02735239|458925744|FG000|Overall Study|Progressive disease|3|||
127535499|NCT02735239|458925745|FG001|Overall Study|Progressive disease|1|||
127535500|NCT02735239|458925746|FG002|Overall Study|Progressive disease|3|||
127535501|NCT02735239|458925747|FG003|Overall Study|Progressive disease|0|||
127535502|NCT02735239|458925748|FG004|Overall Study|Progressive disease|0|||
127535503|NCT02735239|458925749|FG005|Overall Study|Progressive disease|2|||
127535504|NCT02735239|458925744|FG000|Overall Study|Withdrawal by Subject|0|||
127535505|NCT02735239|458925745|FG001|Overall Study|Withdrawal by Subject|1|||
127535506|NCT02735239|458925746|FG002|Overall Study|Withdrawal by Subject|0|||
127535507|NCT02735239|458925747|FG003|Overall Study|Withdrawal by Subject|0|||
127535508|NCT02735239|458925748|FG004|Overall Study|Withdrawal by Subject|0|||
127535509|NCT02735239|458925749|FG005|Overall Study|Withdrawal by Subject|0|||
127535510|NCT02723773|458925750|FG000|Overall Study|Adverse Event|934|||
127535511|NCT02723773|458925751|FG001|Overall Study|Adverse Event|3|||
127535512|NCT02723773|458925752|FG002|Overall Study|Adverse Event|1|||
127535513|NCT02723773|458925753|FG003|Overall Study|Adverse Event|9|||
127535514|NCT02723773|458925750|FG000|Overall Study|Protocol Violation|1|||
127535515|NCT02723773|458925751|FG001|Overall Study|Protocol Violation|0|||
127535516|NCT02723773|458925752|FG002|Overall Study|Protocol Violation|0|||
127535517|NCT02723773|458925753|FG003|Overall Study|Protocol Violation|0|||
127535518|NCT02723773|458925750|FG000|Overall Study|Withdrawal by Subject|360|||
127535519|NCT02723773|458925751|FG001|Overall Study|Withdrawal by Subject|5|||
127535520|NCT02723773|458925752|FG002|Overall Study|Withdrawal by Subject|6|||
127535521|NCT02723773|458925753|FG003|Overall Study|Withdrawal by Subject|10|||
127535522|NCT02723773|458925750|FG000|Overall Study|Migrated/moved from study area|37|||
127535523|NCT02723773|458925751|FG001|Overall Study|Migrated/moved from study area|0|||
127535524|NCT02723773|458925752|FG002|Overall Study|Migrated/moved from study area|0|||
127535525|NCT02723773|458925753|FG003|Overall Study|Migrated/moved from study area|1|||
127535526|NCT02723773|458925750|FG000|Overall Study|Lost to Follow-up|198|||
127535527|NCT02723773|458925751|FG001|Overall Study|Lost to Follow-up|0|||
127535528|NCT02723773|458925752|FG002|Overall Study|Lost to Follow-up|0|||
127535529|NCT02723773|458925753|FG003|Overall Study|Lost to Follow-up|0|||
127535530|NCT02723773|458925750|FG000|Overall Study|Other|189|||
127535531|NCT02723773|458925751|FG001|Overall Study|Other|1|||
127535532|NCT02723773|458925752|FG002|Overall Study|Other|2|||
127535533|NCT02723773|458925753|FG003|Overall Study|Other|2|||
127535534|NCT00387881|458925757|FG000|Overall Study|Lost to Follow-up|23|||
127535535|NCT00387881|458925758|FG001|Overall Study|Lost to Follow-up|23|||
127535536|NCT00387881|458925757|FG000|Overall Study|Protocol Violation|2|||
127535537|NCT00387881|458925758|FG001|Overall Study|Protocol Violation|12|||
127535538|NCT00387881|458925757|FG000|Overall Study|Withdrawal by Subject|15|||
127535539|NCT00387881|458925758|FG001|Overall Study|Withdrawal by Subject|18|||
127535540|NCT00387881|458925757|FG000|Overall Study|Sponsor terminated Study|0|||
127535541|NCT00387881|458925758|FG001|Overall Study|Sponsor terminated Study|1|||
127535542|NCT00387881|458925757|FG000|Overall Study|Not eligible|6|||
127535543|NCT00387881|458925758|FG001|Overall Study|Not eligible|7|||
127535544|NCT00387881|458925757|FG000|Overall Study|No opportunity to treat headache|32|||
127535545|NCT00387881|458925758|FG001|Overall Study|No opportunity to treat headache|34|||
127535546|NCT00387881|458925757|FG000|Overall Study|Not otherwise specified|11|||
127535547|NCT00387881|458925758|FG001|Overall Study|Not otherwise specified|7|||
127535548|NCT03629886|458925759|FG000|Overall Study|Migrated / moved from the study area|0|||
127535549|NCT03629886|458925760|FG001|Overall Study|Migrated / moved from the study area|55|||
127535550|NCT03629886|458925759|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
127535551|NCT03629886|458925760|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
127535552|NCT03629886|458925759|FG000|Overall Study|Study vaccine not administrated|0|||
127535553|NCT03629886|458925760|FG001|Overall Study|Study vaccine not administrated|3|||
127535554|NCT03629886|458925759|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
127535555|NCT03629886|458925760|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
127535556|NCT03629886|458925759|FG000|Overall Study|Refused vaccination step of the study|0|||
127535557|NCT03629886|458925760|FG001|Overall Study|Refused vaccination step of the study|44|||
127535558|NCT01050634|458925761|FG000|Overall Study|Enrolled, but Not Treated|56|||
127535559|NCT01050634|458925761|FG000|Overall Study|Death|2|||
127535560|NCT01050634|458925761|FG000|Overall Study|Adverse Event|42|||
127535561|NCT01050634|458925761|FG000|Overall Study|Lost to Follow-up|2|||
127535562|NCT01050634|458925761|FG000|Overall Study|Other|21|||
127535563|NCT01050634|458925761|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
127535564|NCT00496015|458925762|FG000|Overall Study|Other|1|||
127535565|NCT00496015|458925763|FG001|Overall Study|Other|0|||
127535566|NCT00496015|458925764|FG002|Overall Study|Other|0|||
127535567|NCT00496015|458925765|FG003|Overall Study|Other|1|||
127535568|NCT00496015|458925766|FG004|Overall Study|Other|0|||
127535569|NCT00527735|458925767|FG000|Overall Study|Disease progression|47|||
127535570|NCT00527735|458925768|FG001|Overall Study|Disease progression|61|||
127535571|NCT00527735|458925769|FG002|Overall Study|Disease progression|53|||
127535572|NCT00527735|458925767|FG000|Overall Study|Death|23|||
127535573|NCT00527735|458925768|FG001|Overall Study|Death|13|||
127535574|NCT00527735|458925769|FG002|Overall Study|Death|15|||
127535575|NCT00527735|458925767|FG000|Overall Study|Completed treatment in treatment phase|14|||
127535576|NCT00527735|458925768|FG001|Overall Study|Completed treatment in treatment phase|13|||
127535577|NCT00527735|458925769|FG002|Overall Study|Completed treatment in treatment phase|18|||
127535578|NCT00527735|458925767|FG000|Overall Study|Adverse Event|10|||
127535579|NCT00527735|458925768|FG001|Overall Study|Adverse Event|6|||
127535580|NCT00527735|458925769|FG002|Overall Study|Adverse Event|7|||
127535581|NCT00527735|458925767|FG000|Overall Study|Not identified|5|||
127535582|NCT00527735|458925768|FG001|Overall Study|Not identified|5|||
127535583|NCT00527735|458925769|FG002|Overall Study|Not identified|5|||
127535584|NCT00527735|458925767|FG000|Overall Study|Withdrawal by Subject|5|||
127535585|NCT00527735|458925768|FG001|Overall Study|Withdrawal by Subject|4|||
127535586|NCT00527735|458925769|FG002|Overall Study|Withdrawal by Subject|3|||
127535587|NCT00527735|458925767|FG000|Overall Study|No longer met study criteria|2|||
127535588|NCT00527735|458925768|FG001|Overall Study|No longer met study criteria|2|||
127535589|NCT00527735|458925769|FG002|Overall Study|No longer met study criteria|1|||
127535590|NCT00527735|458925767|FG000|Overall Study|Lost to Follow-up|0|||
127535591|NCT00527735|458925768|FG001|Overall Study|Lost to Follow-up|0|||
127535592|NCT00527735|458925769|FG002|Overall Study|Lost to Follow-up|3|||
127535593|NCT00527735|458925767|FG000|Overall Study|Poor compliance or noncompliance|0|||
127535594|NCT00527735|458925768|FG001|Overall Study|Poor compliance or noncompliance|1|||
127535595|NCT00527735|458925769|FG002|Overall Study|Poor compliance or noncompliance|1|||
127535596|NCT00527735|458925767|FG000|Overall Study|Completed treatment during maintenance|2|||
127535597|NCT00527735|458925768|FG001|Overall Study|Completed treatment during maintenance|2|||
127535598|NCT00527735|458925769|FG002|Overall Study|Completed treatment during maintenance|1|||
127535599|NCT01535807|458925770|FG000|Overall Study|Withdrawal by Subject|1|||
127535600|NCT01535807|458925771|FG001|Overall Study|Withdrawal by Subject|1|||
127535601|NCT01535807|458925770|FG000|Overall Study|Data collection error|1|||
127535602|NCT01535807|458925771|FG001|Overall Study|Data collection error|1|||
127535603|NCT02730728|458925774|FG000|Overall Study|Withdrawal by Subject|0|||
127535604|NCT02730728|458925775|FG001|Overall Study|Withdrawal by Subject|1|||
127535605|NCT02730728|458925776|FG002|Overall Study|Withdrawal by Subject|0|||
127535606|NCT02730728|458925774|FG000|Overall Study|Lack of Efficacy|0|||
127798467|NCT01789970|459885615|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
127535607|NCT02730728|458925775|FG001|Overall Study|Lack of Efficacy|1|||
127535608|NCT02730728|458925776|FG002|Overall Study|Lack of Efficacy|1|||
127535609|NCT01855412|458925777|FG000|Overall Study|Death|77|||
127535610|NCT01855412|458925778|FG001|Overall Study|Death|123|||
127535611|NCT01855412|458925779|FG002|Overall Study|Death|30|||
127535612|NCT01855412|458925777|FG000|Overall Study|Lost to Follow-up|28|||
127535613|NCT01855412|458925778|FG001|Overall Study|Lost to Follow-up|46|||
127535614|NCT01855412|458925779|FG002|Overall Study|Lost to Follow-up|15|||
127535615|NCT01855412|458925777|FG000|Overall Study|Withdrawal by Subject|77|||
127535616|NCT01855412|458925778|FG001|Overall Study|Withdrawal by Subject|123|||
127535617|NCT01855412|458925779|FG002|Overall Study|Withdrawal by Subject|24|||
127535618|NCT01855412|458925777|FG000|Overall Study|Physician Decision|25|||
127535619|NCT01855412|458925778|FG001|Overall Study|Physician Decision|31|||
127535620|NCT01855412|458925779|FG002|Overall Study|Physician Decision|3|||
127535621|NCT01855412|458925777|FG000|Overall Study|Site Closure|4|||
127535622|NCT01855412|458925778|FG001|Overall Study|Site Closure|18|||
127535623|NCT01855412|458925779|FG002|Overall Study|Site Closure|1|||
127535624|NCT01855412|458925777|FG000|Overall Study|Reason not Specified|1|||
127535625|NCT01855412|458925778|FG001|Overall Study|Reason not Specified|2|||
127535626|NCT01855412|458925779|FG002|Overall Study|Reason not Specified|3|||
127535627|NCT00404651|458925781|FG000|Overall Study|Serious Adverse Event|0|||
127535628|NCT00404651|458925782|FG001|Overall Study|Serious Adverse Event|0|||
127535629|NCT00404651|458925783|FG002|Overall Study|Serious Adverse Event|2|||
127535630|NCT00404651|458925784|FG003|Overall Study|Serious Adverse Event|0|||
127535631|NCT00404651|458925781|FG000|Overall Study|Protocol Violation|10|||
127535632|NCT00404651|458925782|FG001|Overall Study|Protocol Violation|5|||
127535633|NCT00404651|458925783|FG002|Overall Study|Protocol Violation|14|||
127535634|NCT00404651|458925784|FG003|Overall Study|Protocol Violation|5|||
127535635|NCT00404651|458925781|FG000|Overall Study|Lost to Follow-up|15|||
127535636|NCT00404651|458925782|FG001|Overall Study|Lost to Follow-up|11|||
127535637|NCT00404651|458925783|FG002|Overall Study|Lost to Follow-up|13|||
127535638|NCT00404651|458925784|FG003|Overall Study|Lost to Follow-up|10|||
127535639|NCT00404651|458925781|FG000|Overall Study|Withdrawal by Subject|14|||
127535640|NCT00404651|458925782|FG001|Overall Study|Withdrawal by Subject|12|||
127535641|NCT00404651|458925783|FG002|Overall Study|Withdrawal by Subject|16|||
127535642|NCT00404651|458925784|FG003|Overall Study|Withdrawal by Subject|6|||
127535643|NCT01702844|458925799|FG000|Overall Study|Adverse Event|9|||
127535644|NCT01702844|458925799|FG000|Overall Study|Death|1|||
127535645|NCT01702844|458925799|FG000|Overall Study|Withdrawal by Subject|3|||
127535646|NCT01702844|458925799|FG000|Overall Study|Physician Decision|6|||
127535647|NCT02123134|458925800|FG000|Overall Study|Withdrawal of consent|3|||
127535648|NCT02123134|458925801|FG001|Overall Study|Withdrawal of consent|2|||
127535649|NCT02123134|458925800|FG000|Overall Study|Administrative decision|0|||
127535650|NCT02123134|458925801|FG001|Overall Study|Administrative decision|1|||
127535651|NCT03431441|458925802|FG000|Overall Study|Withdrawal by Subject|2|||
127535652|NCT03431441|458925802|FG000|Overall Study|Adverse Event|2|||
127535653|NCT03431441|458925802|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
127535654|NCT00346216|458925803|FG000|Overall Study|Other|181|||
127535655|NCT00346216|458925804|FG001|Overall Study|Other|231|||
127535656|NCT00346216|458925805|FG002|Overall Study|Other|205|||
127535657|NCT00346216|458925803|FG000|Overall Study|No longer willing to participate|600|||
127535658|NCT00346216|458925804|FG001|Overall Study|No longer willing to participate|606|||
127535659|NCT00346216|458925805|FG002|Overall Study|No longer willing to participate|585|||
127535660|NCT00346216|458925803|FG000|Overall Study|Withdrawal by Subject|661|||
127535661|NCT00346216|458925804|FG001|Overall Study|Withdrawal by Subject|692|||
127535662|NCT00346216|458925805|FG002|Overall Study|Withdrawal by Subject|651|||
127535663|NCT00346216|458925803|FG000|Overall Study|Lost to Follow-up|611|||
127535664|NCT00346216|458925804|FG001|Overall Study|Lost to Follow-up|588|||
127535665|NCT00346216|458925805|FG002|Overall Study|Lost to Follow-up|542|||
127535666|NCT00346216|458925803|FG000|Overall Study|Physician Decision|80|||
127535667|NCT00346216|458925804|FG001|Overall Study|Physician Decision|76|||
127535668|NCT00346216|458925805|FG002|Overall Study|Physician Decision|59|||
127535669|NCT00346216|458925803|FG000|Overall Study|Does not meet entrance criteria|13|||
127535670|NCT00346216|458925804|FG001|Overall Study|Does not meet entrance criteria|10|||
127535671|NCT00346216|458925805|FG002|Overall Study|Does not meet entrance criteria|8|||
127535672|NCT00346216|458925803|FG000|Overall Study|Death|189|||
127535673|NCT00346216|458925804|FG001|Overall Study|Death|192|||
127535674|NCT00346216|458925805|FG002|Overall Study|Death|228|||
127535675|NCT00346216|458925803|FG000|Overall Study|Study terminated by sponsor|11|||
127535676|NCT00346216|458925804|FG001|Overall Study|Study terminated by sponsor|4|||
127798468|NCT01789970|459885613|FG000|Open-label Titration Period|Protocol Violation|18|||
127535677|NCT00346216|458925805|FG002|Overall Study|Study terminated by sponsor|8|||
127535678|NCT00346216|458925803|FG000|Overall Study|Missing Subject Summary Status|62|||
127535679|NCT00346216|458925804|FG001|Overall Study|Missing Subject Summary Status|61|||
127535680|NCT00346216|458925805|FG002|Overall Study|Missing Subject Summary Status|62|||
127535681|NCT00764699|458925819|FG000|Overall Study|PI left and study terminated|3|||
127535682|NCT03985761|458925826|FG000|Overall Study|Withdrawal by Subject|2|||
127535683|NCT03985761|458925827|FG001|Overall Study|Withdrawal by Subject|3|||
127535684|NCT01755234|458925828|FG000|Overall Study|Lost to Follow-up|11|||
127535685|NCT01755234|458925829|FG001|Overall Study|Lost to Follow-up|6|||
127535686|NCT01755234|458925828|FG000|Overall Study|Change in surgical case|2|||
127535687|NCT01755234|458925829|FG001|Overall Study|Change in surgical case|1|||
127535688|NCT01755234|458925828|FG000|Overall Study|case cancelled|1|||
127535689|NCT01755234|458925829|FG001|Overall Study|case cancelled|0|||
127535690|NCT01755234|458925828|FG000|Overall Study|Withdrawal by Subject|0|||
127535691|NCT01755234|458925829|FG001|Overall Study|Withdrawal by Subject|1|||
127535692|NCT01755234|458925828|FG000|Overall Study|unblinded|1|||
127535693|NCT01755234|458925829|FG001|Overall Study|unblinded|0|||
127535694|NCT02322281|458925832|FG000|Overall Study|Progressive Disease|42|||
127535695|NCT02322281|458925833|FG001|Overall Study|Progressive Disease|14|||
127535696|NCT02322281|458925834|FG002|Overall Study|Progressive Disease|49|||
127535697|NCT02322281|458925832|FG000|Overall Study|Adverse Event|3|||
127535698|NCT02322281|458925833|FG001|Overall Study|Adverse Event|4|||
127535699|NCT02322281|458925834|FG002|Overall Study|Adverse Event|6|||
127535700|NCT02322281|458925832|FG000|Overall Study|Death|3|||
127535701|NCT02322281|458925833|FG001|Overall Study|Death|3|||
127535702|NCT02322281|458925834|FG002|Overall Study|Death|3|||
127535703|NCT02322281|458925832|FG000|Overall Study|Withdrawal by Subject|1|||
127535704|NCT02322281|458925833|FG001|Overall Study|Withdrawal by Subject|1|||
127535705|NCT02322281|458925834|FG002|Overall Study|Withdrawal by Subject|6|||
127535706|NCT02322281|458925832|FG000|Overall Study|Physician Decision|2|||
127535707|NCT02322281|458925833|FG001|Overall Study|Physician Decision|0|||
127535708|NCT02322281|458925834|FG002|Overall Study|Physician Decision|5|||
127535709|NCT02322281|458925832|FG000|Overall Study|Study Terminated by Sponsor|2|||
127535710|NCT02322281|458925833|FG001|Overall Study|Study Terminated by Sponsor|0|||
127535711|NCT02322281|458925834|FG002|Overall Study|Study Terminated by Sponsor|0|||
127535712|NCT02322281|458925832|FG000|Overall Study|Missing|0|||
127535713|NCT02322281|458925833|FG001|Overall Study|Missing|0|||
127535714|NCT02322281|458925834|FG002|Overall Study|Missing|1|||
127535715|NCT02322281|458925832|FG000|Overall Study|Miscellaneous|0|||
127535716|NCT02322281|458925833|FG001|Overall Study|Miscellaneous|0|||
127535717|NCT02322281|458925834|FG002|Overall Study|Miscellaneous|4|||
127535718|NCT01220167|458925835|FG000|Period 3|Urine positive for substance abuse|0|||
127535719|NCT01220167|458925836|FG001|Period 3|Urine positive for substance abuse|1|||
127535720|NCT01220167|458925837|FG002|Period 3|Urine positive for substance abuse|0|||
127535721|NCT05789745|458925841|FG000|Overall Study|Withdrawal by Subject|0|||
127535722|NCT05789745|458925842|FG001|Overall Study|Withdrawal by Subject|0|||
127535723|NCT05789745|458925843|FG002|Overall Study|Withdrawal by Subject|0|||
127535724|NCT05789745|458925844|FG003|Overall Study|Withdrawal by Subject|0|||
127535725|NCT05789745|458925845|FG004|Overall Study|Withdrawal by Subject|1|||
127535726|NCT00619515|458925846|FG000|Overall Study|Study Termination by IRB|73|||
127535727|NCT04862065|458925852|FG000|Screening|Protocol Violation|54|||
127535728|NCT04862065|458925853|FG001|Screening|Protocol Violation|0|||
127535729|NCT04862065|458925854|FG002|Screening|Protocol Violation|0|||
127535730|NCT04862065|458925852|FG000|Screening|Insufficient Sample|1|||
127535731|NCT04862065|458925853|FG001|Screening|Insufficient Sample|0|||
127535732|NCT04862065|458925854|FG002|Screening|Insufficient Sample|0|||
127535733|NCT04862065|458925852|FG000|Follow-Up|Lost to Follow-up|3|||
127535734|NCT04862065|458925853|FG001|Follow-Up|Lost to Follow-up|0|||
127535735|NCT04862065|458925854|FG002|Follow-Up|Lost to Follow-up|0|||
127535736|NCT02634333|458925855|FG000|Overall Study|Completed out of Window|3|||
127535737|NCT02634333|458925856|FG001|Overall Study|Completed out of Window|2|||
127535738|NCT02634333|458925855|FG000|Overall Study|Missed Visit|5|||
127535739|NCT02634333|458925856|FG001|Overall Study|Missed Visit|2|||
127535740|NCT02634333|458925855|FG000|Overall Study|Lost to Follow-up|12|||
127535741|NCT02634333|458925856|FG001|Overall Study|Lost to Follow-up|7|||
127535742|NCT02634333|458925855|FG000|Overall Study|Withdrawal by Subject|9|||
127535743|NCT02634333|458925856|FG001|Overall Study|Withdrawal by Subject|13|||
127535744|NCT02634333|458925855|FG000|Overall Study|Death|11|||
127535745|NCT02634333|458925856|FG001|Overall Study|Death|8|||
127535746|NCT03001557|458925859|FG000|Core Phase|Randomized but not treated|0|||
127535747|NCT03001557|458925860|FG001|Core Phase|Randomized but not treated|0|||
127535748|NCT03001557|458925861|FG002|Core Phase|Randomized but not treated|1|||
127535749|NCT03001557|458925862|FG003|Core Phase|Randomized but not treated|0|||
127535750|NCT03001557|458925863|FG004|Core Phase|Randomized but not treated|0|||
127535751|NCT03001557|458925864|FG005|Core Phase|Randomized but not treated|0|||
127535752|NCT03001557|458925865|FG006|Core Phase|Randomized but not treated|0|||
127535753|NCT03001557|458925866|FG007|Core Phase|Randomized but not treated|0|||
127535754|NCT03001557|458925859|FG000|Extension Phase|Adverse Event|0|||
127535755|NCT03001557|458925860|FG001|Extension Phase|Adverse Event|0|||
127535756|NCT03001557|458925861|FG002|Extension Phase|Adverse Event|0|||
127535757|NCT03001557|458925862|FG003|Extension Phase|Adverse Event|0|||
127535758|NCT03001557|458925863|FG004|Extension Phase|Adverse Event|0|||
127535759|NCT03001557|458925864|FG005|Extension Phase|Adverse Event|2|||
127535760|NCT03001557|458925865|FG006|Extension Phase|Adverse Event|0|||
127535761|NCT03001557|458925866|FG007|Extension Phase|Adverse Event|0|||
127535762|NCT03001557|458925859|FG000|Extension Phase|Withdrawal by Subject|0|||
127535763|NCT03001557|458925860|FG001|Extension Phase|Withdrawal by Subject|0|||
127535764|NCT03001557|458925861|FG002|Extension Phase|Withdrawal by Subject|0|||
127535765|NCT03001557|458925862|FG003|Extension Phase|Withdrawal by Subject|0|||
127535766|NCT03001557|458925863|FG004|Extension Phase|Withdrawal by Subject|0|||
127535767|NCT03001557|458925864|FG005|Extension Phase|Withdrawal by Subject|1|||
127535768|NCT03001557|458925865|FG006|Extension Phase|Withdrawal by Subject|5|||
127535769|NCT03001557|458925866|FG007|Extension Phase|Withdrawal by Subject|2|||
127535770|NCT03001557|458925859|FG000|Extension Phase|Lost to Follow-up|0|||
127535771|NCT03001557|458925860|FG001|Extension Phase|Lost to Follow-up|0|||
127535772|NCT03001557|458925861|FG002|Extension Phase|Lost to Follow-up|0|||
127535773|NCT03001557|458925862|FG003|Extension Phase|Lost to Follow-up|0|||
127535774|NCT03001557|458925863|FG004|Extension Phase|Lost to Follow-up|0|||
127535775|NCT03001557|458925864|FG005|Extension Phase|Lost to Follow-up|0|||
127535776|NCT03001557|458925865|FG006|Extension Phase|Lost to Follow-up|2|||
127758802|NCT01259089|459742052|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
127758803|NCT01259089|459742053|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
127758804|NCT01259089|459742054|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
127758805|NCT01259089|459742055|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
127758806|NCT01259089|459742056|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
127758807|NCT01259089|459742057|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
127758808|NCT01280357|459742058|FG000|Overall Study|Excluded no internal monitoring|14|||
127758809|NCT01280357|459742058|FG000|Overall Study|IInsufficient data/No data supplied|12|||
127758810|NCT00886795|459742059|FG000|Overall Study|Lack of Efficacy|1|||
127758811|NCT02310100|459742064|FG000|Overall Study|Physician Decision|3|||
127758812|NCT02310100|459742064|FG000|Overall Study|Withdrawal by Subject|10|||
127758813|NCT02310100|459742064|FG000|Overall Study|Enrollment closure|1|||
127758814|NCT02310100|459742064|FG000|Overall Study|Unapproved ablation operator|1|||
127758815|NCT02310100|459742064|FG000|Overall Study|Visit compliance|1|||
127758816|NCT02310100|459742064|FG000|Overall Study|Lost to Follow-up|2|||
127758817|NCT00688870|459742067|FG000|Infant Series|Parent or legal guardian request|4|||
127758818|NCT00688870|459742068|FG001|Infant Series|Parent or legal guardian request|0|||
127758819|NCT01253018|459742079|FG000|Overall Study|Lost to Follow-up|1|||
127758820|NCT01253018|459742080|FG001|Overall Study|Lost to Follow-up|1|||
127758821|NCT01253018|459742079|FG000|Overall Study|Robot Repair Issues|2|||
127758822|NCT01253018|459742080|FG001|Overall Study|Robot Repair Issues|0|||
127758823|NCT01253018|459742079|FG000|Overall Study|Withdrawal by Subject|1|||
127758824|NCT01253018|459742080|FG001|Overall Study|Withdrawal by Subject|1|||
127758825|NCT03449901|459742081|FG000|Overall Study|Progression|57|||
127758826|NCT03449901|459742082|FG001|Overall Study|Progression|12|||
127758827|NCT03449901|459742081|FG000|Overall Study|Adverse Event|3|||
127758828|NCT03449901|459742082|FG001|Overall Study|Adverse Event|0|||
127758829|NCT03449901|459742081|FG000|Overall Study|Death|6|||
127758830|NCT03449901|459742082|FG001|Overall Study|Death|2|||
127758831|NCT03449901|459742081|FG000|Overall Study|Withdrawal by Subject|12|||
127758832|NCT03449901|459742082|FG001|Overall Study|Withdrawal by Subject|1|||
127758833|NCT03449901|459742081|FG000|Overall Study|Physician Decision|1|||
127758834|NCT03449901|459742082|FG001|Overall Study|Physician Decision|0|||
127758835|NCT03449901|459742081|FG000|Overall Study|Patient elected for surgical intervention|1|||
127758836|NCT03449901|459742082|FG001|Overall Study|Patient elected for surgical intervention|0|||
127758837|NCT03449901|459742081|FG000|Overall Study|Patient off for other complicating disease|1|||
127758838|NCT03449901|459742082|FG001|Overall Study|Patient off for other complicating disease|0|||
127758839|NCT03466073|459742083|FG000|Overall Study|Death|1|||
127758840|NCT03466073|459742084|FG001|Overall Study|Death|0|||
127758841|NCT03466073|459742085|FG002|Overall Study|Death|0|||
127758842|NCT03466073|459742086|FG003|Overall Study|Death|0|||
127758843|NCT03466073|459742087|FG004|Overall Study|Death|0|||
127758844|NCT03466073|459742088|FG005|Overall Study|Death|1|||
127758845|NCT00744757|459742089|FG000|Overall Study|Objective disease progression|7|||
127758846|NCT00744757|459742089|FG000|Overall Study|Physician Decision|5|||
127758847|NCT00744757|459742089|FG000|Overall Study|Withdrawal by Subject|1|||
127758848|NCT00744757|459742089|FG000|Overall Study|Death|6|||
127758849|NCT00744757|459742089|FG000|Overall Study|Adverse Event|2|||
127758850|NCT03682302|459742090|FG000|Overall Study|Lost to Follow-up|1|||
127758851|NCT03682302|459742091|FG001|Overall Study|Lost to Follow-up|2|||
127758852|NCT03682302|459742092|FG002|Overall Study|Lost to Follow-up|0|||
127758853|NCT03682302|459742093|FG003|Overall Study|Lost to Follow-up|1|||
127758854|NCT03682302|459742090|FG000|Overall Study|Study drug was not administered|0|||
127758855|NCT03682302|459742091|FG001|Overall Study|Study drug was not administered|0|||
127758856|NCT03682302|459742092|FG002|Overall Study|Study drug was not administered|1|||
127758857|NCT03682302|459742093|FG003|Overall Study|Study drug was not administered|1|||
127758858|NCT05051462|459742094|FG000|Overall Study|Lost to Follow-up|1|||
127758859|NCT05051462|459742095|FG001|Overall Study|Lost to Follow-up|8|||
127535777|NCT03001557|458925866|FG007|Extension Phase|Lost to Follow-up|1|||
127535778|NCT03001557|458925859|FG000|Extension Phase|Administrative Reason|0|||
127758860|NCT05051462|459742094|FG000|Overall Study|Withdrawal by Subject|1|||
127758861|NCT05051462|459742095|FG001|Overall Study|Withdrawal by Subject|0|||
127758862|NCT05051462|459742094|FG000|Overall Study|Protocol Violation|0|||
127535779|NCT03001557|458925860|FG001|Extension Phase|Administrative Reason|0|||
127535780|NCT03001557|458925861|FG002|Extension Phase|Administrative Reason|0|||
127535781|NCT03001557|458925862|FG003|Extension Phase|Administrative Reason|0|||
127535782|NCT03001557|458925863|FG004|Extension Phase|Administrative Reason|0|||
127535783|NCT03001557|458925864|FG005|Extension Phase|Administrative Reason|1|||
127535784|NCT03001557|458925865|FG006|Extension Phase|Administrative Reason|3|||
127535785|NCT03001557|458925866|FG007|Extension Phase|Administrative Reason|3|||
127535786|NCT03001557|458925859|FG000|Extension Phase|Loss of caregiver|0|||
127535787|NCT03001557|458925860|FG001|Extension Phase|Loss of caregiver|0|||
127535788|NCT03001557|458925861|FG002|Extension Phase|Loss of caregiver|0|||
127535789|NCT03001557|458925862|FG003|Extension Phase|Loss of caregiver|0|||
127535790|NCT03001557|458925863|FG004|Extension Phase|Loss of caregiver|0|||
127535791|NCT03001557|458925864|FG005|Extension Phase|Loss of caregiver|0|||
127535792|NCT03001557|458925865|FG006|Extension Phase|Loss of caregiver|1|||
127535793|NCT03001557|458925866|FG007|Extension Phase|Loss of caregiver|0|||
127535794|NCT03001557|458925859|FG000|Extension Phase|Others|0|||
127535795|NCT03001557|458925860|FG001|Extension Phase|Others|0|||
127535796|NCT03001557|458925861|FG002|Extension Phase|Others|0|||
127535797|NCT03001557|458925862|FG003|Extension Phase|Others|0|||
127535798|NCT03001557|458925863|FG004|Extension Phase|Others|0|||
127535799|NCT03001557|458925864|FG005|Extension Phase|Others|1|||
127535800|NCT03001557|458925865|FG006|Extension Phase|Others|3|||
127535801|NCT03001557|458925866|FG007|Extension Phase|Others|0|||
127535802|NCT01794000|458925867|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
127535803|NCT01794000|458925868|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
127535804|NCT01794000|458925867|FG000|Double-Blind Phase (DBP)|Death|1|||
127535805|NCT01794000|458925868|FG001|Double-Blind Phase (DBP)|Death|2|||
127535806|NCT01794000|458925867|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
127535807|NCT01794000|458925868|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
127535808|NCT01794000|458925867|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
127535809|NCT01794000|458925868|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
127535810|NCT01794000|458925867|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
127535811|NCT01794000|458925868|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
127535812|NCT01794000|458925867|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
127535813|NCT01794000|458925868|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
127535814|NCT01794000|458925867|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
127535815|NCT01794000|458925868|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
127535816|NCT01794000|458925867|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
127535817|NCT01794000|458925868|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
127535818|NCT02365649|458925873|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
127535819|NCT02365649|458925874|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
127535820|NCT02365649|458925875|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
127535821|NCT02365649|458925876|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
127535822|NCT02365649|458925877|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
127535823|NCT02365649|458925878|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
127535824|NCT02365649|458925879|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
127535825|NCT02365649|458925880|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
127535826|NCT02365649|458925881|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
127535827|NCT02365649|458925882|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
127535828|NCT02365649|458925873|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
127535829|NCT02365649|458925874|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
127535830|NCT02365649|458925875|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
127535831|NCT02365649|458925876|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
127535832|NCT02365649|458925877|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
127535833|NCT02365649|458925878|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
127535834|NCT02365649|458925879|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
127535835|NCT02365649|458925880|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
127535836|NCT02365649|458925881|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
127535837|NCT02365649|458925882|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
127535838|NCT02365649|458925873|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
127535839|NCT02365649|458925874|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
127535840|NCT02365649|458925875|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
127535841|NCT02365649|458925876|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
127535842|NCT02365649|458925877|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
127535843|NCT02365649|458925878|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
127535844|NCT02365649|458925879|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
127535845|NCT02365649|458925880|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
127535846|NCT02365649|458925881|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
127535847|NCT02365649|458925882|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
127642254|NCT02794285|459310075|FG001|Overall Study|Missing|0|||
127758863|NCT05051462|459742095|FG001|Overall Study|Protocol Violation|2|||
127535848|NCT02365649|458925873|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
127535849|NCT02365649|458925874|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
127535850|NCT02365649|458925875|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
127535851|NCT02365649|458925876|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
127535852|NCT02365649|458925877|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
127535853|NCT02365649|458925878|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
127535854|NCT02365649|458925879|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
127535855|NCT02365649|458925880|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
127535856|NCT02365649|458925881|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
127535857|NCT02365649|458925882|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
127535858|NCT02365649|458925873|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
127535859|NCT02365649|458925874|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
127535860|NCT02365649|458925875|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
127535861|NCT02365649|458925876|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
127535862|NCT02365649|458925877|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
127535863|NCT02365649|458925878|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
127535864|NCT02365649|458925879|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
127535865|NCT02365649|458925880|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
127535866|NCT02365649|458925881|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
127535867|NCT02365649|458925882|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
127535868|NCT02365649|458925873|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
127535869|NCT02365649|458925874|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
127535870|NCT02365649|458925875|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
127535871|NCT02365649|458925876|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
127535872|NCT02365649|458925877|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
127535873|NCT02365649|458925878|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
127535874|NCT02365649|458925879|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
127535875|NCT02365649|458925880|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
127535876|NCT02365649|458925881|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
127535877|NCT02365649|458925882|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
127535878|NCT02365649|458925873|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
127535879|NCT02365649|458925874|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
127535880|NCT02365649|458925875|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
127535881|NCT02365649|458925876|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
127535882|NCT02365649|458925877|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
127535883|NCT02365649|458925878|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
127535884|NCT02365649|458925879|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
127535885|NCT02365649|458925880|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
127535886|NCT02365649|458925881|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
127535887|NCT02365649|458925882|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
127535888|NCT02365649|458925873|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
127535889|NCT02365649|458925874|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
127535890|NCT02365649|458925875|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
127535891|NCT02365649|458925876|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
127535892|NCT02365649|458925877|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
127535893|NCT02365649|458925878|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
127535894|NCT02365649|458925879|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
127535895|NCT02365649|458925880|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
127535896|NCT02365649|458925881|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
127535897|NCT02365649|458925882|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
127535898|NCT02365649|458925873|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
127535899|NCT02365649|458925874|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
127535900|NCT02365649|458925875|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
127535901|NCT02365649|458925876|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
127535902|NCT02365649|458925877|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
127535903|NCT02365649|458925878|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
127535904|NCT02365649|458925879|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
127535905|NCT02365649|458925880|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
127535906|NCT02365649|458925881|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
127535907|NCT02365649|458925882|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
127535908|NCT02365649|458925873|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
127535909|NCT02365649|458925874|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
127535910|NCT02365649|458925875|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
127535911|NCT02365649|458925876|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
127535912|NCT02365649|458925877|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
127642255|NCT02794285|459310076|FG002|Overall Study|Missing|0|||
127535913|NCT02365649|458925878|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
127535914|NCT02365649|458925879|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
127535915|NCT02365649|458925880|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
127535916|NCT02365649|458925881|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
127535917|NCT02365649|458925882|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
127535918|NCT02365649|458925873|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
127535919|NCT02365649|458925874|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
127535920|NCT02365649|458925875|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
127535921|NCT02365649|458925876|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
127535922|NCT02365649|458925877|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
127535923|NCT02365649|458925878|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
127535924|NCT02365649|458925879|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
127535925|NCT02365649|458925880|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
127535926|NCT02365649|458925881|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
127535927|NCT02365649|458925882|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
127535928|NCT02365649|458925873|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
127535929|NCT02365649|458925874|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
127535930|NCT02365649|458925875|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
127535931|NCT02365649|458925876|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
127535932|NCT02365649|458925877|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
127535933|NCT02365649|458925878|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
127535934|NCT02365649|458925879|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
127535935|NCT02365649|458925880|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
127535936|NCT02365649|458925881|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
127535937|NCT02365649|458925882|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
127535938|NCT02910466|458925887|FG000|Overall Study|Adverse Event|1|||
127535939|NCT02910466|458925887|FG000|Overall Study|Withdrawal by Subject|3|||
127535940|NCT02910466|458925887|FG000|Overall Study|Lost to Follow-up|5|||
127535941|NCT02910466|458925887|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
127535942|NCT02910466|458925887|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
127535943|NCT04332107|458925896|FG000|Day 3|Lost to Follow-up|23|||
127535944|NCT04332107|458925897|FG001|Day 3|Lost to Follow-up|14|||
127758864|NCT02425904|459742096|FG000|Overall Study|Lost to Follow-up|1|||
127758865|NCT02425904|459742097|FG001|Overall Study|Lost to Follow-up|0|||
127758866|NCT02425904|459742096|FG000|Overall Study|Withdrawal by Subject|2|||
127758867|NCT02425904|459742097|FG001|Overall Study|Withdrawal by Subject|0|||
127758868|NCT02425904|459742096|FG000|Overall Study|Death|0|||
127758869|NCT02425904|459742097|FG001|Overall Study|Death|3|||
127758870|NCT05260021|459742102|FG000|Double-blind Period (30 Weeks)|Adverse Event|2|||
127758871|NCT05260021|459742103|FG001|Double-blind Period (30 Weeks)|Adverse Event|0|||
127758872|NCT05260021|459742104|FG002|Double-blind Period (30 Weeks)|Adverse Event|0|||
127758873|NCT05260021|459742102|FG000|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
127758874|NCT05260021|459742103|FG001|Double-blind Period (30 Weeks)|Withdrawal by Subject|2|||
127758875|NCT05260021|459742104|FG002|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
127758876|NCT05260021|459742102|FG000|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
127758877|NCT05260021|459742103|FG001|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
127758878|NCT05260021|459742104|FG002|Double-blind Period (30 Weeks)|Lost to Follow-up|1|||
127758879|NCT05260021|459742102|FG000|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
127758880|NCT05260021|459742103|FG001|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|1|||
127758881|NCT05260021|459742104|FG002|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
127758882|NCT05260021|459742102|FG000|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
127758883|NCT05260021|459742103|FG001|Double-blind Period (30 Weeks)|Incorrectly Enrolled|1|||
127758884|NCT05260021|459742104|FG002|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
127758885|NCT03842358|459742106|FG000|Overall Study|Poor DOT probe contact with breast|2|||
127758886|NCT03842358|459742106|FG000|Overall Study|DOT system problem|1|||
127758887|NCT03842358|459742106|FG000|Overall Study|Switched to x-ray guided biopsy|3|||
127758888|NCT03842358|459742106|FG000|Overall Study|No biopsy after physician review|4|||
127758889|NCT03842358|459742106|FG000|Overall Study|Patient withdrew|2|||
127758890|NCT03843554|459743454|FG000|Overall Study|Physician Decision|0|||
127758891|NCT03843554|459743455|FG001|Overall Study|Physician Decision|2|||
127758892|NCT02731690|459743459|FG000|Overall Study|Adverse Event|1|||
127758893|NCT02731690|459743459|FG000|Overall Study|Withdrawal by Subject|3|||
127758894|NCT02731690|459743459|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
127758895|NCT03446781|459743462|FG000|Overall Study|Lost to Follow-up|11|||
127758896|NCT03446781|459743463|FG001|Overall Study|Lost to Follow-up|5|||
127758897|NCT03446781|459743462|FG000|Overall Study|Withdrawal by Subject|9|||
127758898|NCT03446781|459743463|FG001|Overall Study|Withdrawal by Subject|7|||
127535945|NCT04332107|458925896|FG000|Day 3|Missing outcome data|3|||
127535946|NCT04332107|458925897|FG001|Day 3|Missing outcome data|6|||
127535947|NCT04332107|458925896|FG000|Day 14|Lost to Follow-up|13|||
127535948|NCT04332107|458925897|FG001|Day 14|Lost to Follow-up|4|||
127535949|NCT04332107|458925896|FG000|Day 14|Missing outcome data|4|||
127535950|NCT04332107|458925897|FG001|Day 14|Missing outcome data|4|||
127535951|NCT04332107|458925896|FG000|Day 21|Lost to Follow-up|10|||
127535952|NCT04332107|458925897|FG001|Day 21|Lost to Follow-up|2|||
127535953|NCT01808196|458925902|FG000|Overall Study|Lost to Follow-up|1|||
127535954|NCT00479713|458925905|FG000|Overall Study|Adverse Event|8|||
127535955|NCT00479713|458925906|FG001|Overall Study|Adverse Event|6|||
127535956|NCT00479713|458925905|FG000|Overall Study|Death|1|||
127535957|NCT00479713|458925906|FG001|Overall Study|Death|0|||
127535958|NCT00479713|458925905|FG000|Overall Study|Lost to Follow-up|0|||
127535959|NCT00479713|458925906|FG001|Overall Study|Lost to Follow-up|1|||
127535960|NCT00479713|458925905|FG000|Overall Study|Protocol Violation|0|||
127535961|NCT00479713|458925906|FG001|Overall Study|Protocol Violation|1|||
127535962|NCT00479713|458925905|FG000|Overall Study|Withdrawal by Subject|4|||
127535963|NCT00479713|458925906|FG001|Overall Study|Withdrawal by Subject|1|||
127535964|NCT00141102|458925907|FG000|Overall Study|Adverse Event|233|||
127535965|NCT00141102|458925908|FG001|Overall Study|Adverse Event|305|||
127535966|NCT00141102|458925907|FG000|Overall Study|Laboratory Abnormality|9|||
127535967|NCT00141102|458925908|FG001|Overall Study|Laboratory Abnormality|33|||
127535968|NCT00141102|458925907|FG000|Overall Study|Lack of Efficacy|21|||
127535969|NCT00141102|458925908|FG001|Overall Study|Lack of Efficacy|26|||
127535970|NCT00141102|458925907|FG000|Overall Study|Lost to Follow-up|29|||
127535971|NCT00141102|458925908|FG001|Overall Study|Lost to Follow-up|32|||
127535972|NCT00141102|458925907|FG000|Overall Study|Other|87|||
127535973|NCT00141102|458925908|FG001|Overall Study|Other|76|||
127535974|NCT00141102|458925907|FG000|Overall Study|Withdrawal by Subject|112|||
127535975|NCT00141102|458925908|FG001|Overall Study|Withdrawal by Subject|142|||
127535976|NCT00141102|458925907|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
127535977|NCT00141102|458925908|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
127535978|NCT00141102|458925907|FG000|Overall Study|Death|2|||
127535979|NCT00141102|458925908|FG001|Overall Study|Death|2|||
127535980|NCT03863509|458925909|FG000|Overall Study|COVID-19 shutdown period|0|||
127535981|NCT03863509|458925910|FG001|Overall Study|COVID-19 shutdown period|4|||
127535982|NCT03863509|458925911|FG002|Overall Study|COVID-19 shutdown period|0|||
127535983|NCT03863509|458925909|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
127535984|NCT03863509|458925910|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
127535985|NCT03863509|458925911|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
127535986|NCT03863509|458925909|FG000|Overall Study|Lost to Follow-up|8|||
127535987|NCT03863509|458925910|FG001|Overall Study|Lost to Follow-up|0|||
127535988|NCT03863509|458925911|FG002|Overall Study|Lost to Follow-up|2|||
127535989|NCT03863509|458925909|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
127535990|NCT03863509|458925910|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
127535991|NCT03863509|458925911|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
127535992|NCT03863509|458925909|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
127535993|NCT03863509|458925910|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
127535994|NCT03863509|458925911|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
127535995|NCT00866814|458925912|FG000|Overall Study|Lost to Follow-up|12|||
127535996|NCT00866814|458925912|FG000|Overall Study|Adverse Event|2|||
127535997|NCT00866814|458925912|FG000|Overall Study|Physician Decision|1|||
127535998|NCT00866814|458925912|FG000|Overall Study|Death|1|||
127535999|NCT00866814|458925912|FG000|Overall Study|No longer wished to participate|1|||
127536000|NCT00866814|458925912|FG000|Overall Study|Unable to meet follow-up requirements|2|||
127536001|NCT00866814|458925912|FG000|Overall Study|Moved to area without study site|1|||
127536002|NCT01063153|458925914|FG000|Overall Study|Found Ineligible During Screening|2|||
127536003|NCT01063153|458925915|FG001|Overall Study|Found Ineligible During Screening|0|||
127536004|NCT01063153|458925914|FG000|Overall Study|Lost to Follow-up|0|||
127536005|NCT01063153|458925915|FG001|Overall Study|Lost to Follow-up|7|||
127536006|NCT01063153|458925914|FG000|Overall Study|Withdrawal by Subject|0|||
127536007|NCT01063153|458925915|FG001|Overall Study|Withdrawal by Subject|1|||
127536008|NCT01063153|458925914|FG000|Overall Study|Physician Decision|0|||
127536009|NCT01063153|458925915|FG001|Overall Study|Physician Decision|4|||
127642256|NCT02794285|459310077|FG003|Overall Study|Missing|0|||
127642257|NCT02794285|459310074|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
127642258|NCT02794285|459310075|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
127642259|NCT02794285|459310076|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
127642260|NCT02794285|459310077|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
127642261|NCT02794285|459310074|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
127642262|NCT02794285|459310075|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
127642263|NCT02794285|459310076|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
127642264|NCT02794285|459310077|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
127536010|NCT04481243|458927711|FG000|Overall Study|Withdrawal by Subject|4|||
127536011|NCT02831764|458927712|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
127536012|NCT02831764|458927713|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
127536013|NCT02831764|458927714|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
127536014|NCT02831764|458927715|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
127536015|NCT02831764|458927716|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
127536016|NCT02831764|458927712|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
127536017|NCT02831764|458927713|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
127536018|NCT02831764|458927714|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
127536019|NCT02831764|458927715|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
127536020|NCT02831764|458927716|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
127536021|NCT02831764|458927712|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
127536022|NCT02831764|458927713|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
127536023|NCT02831764|458927714|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
127536024|NCT02831764|458927715|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
127536025|NCT02831764|458927716|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
127536026|NCT02831764|458927712|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
127536027|NCT02831764|458927713|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
127536028|NCT02831764|458927714|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
127536029|NCT02831764|458927715|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
127536030|NCT02831764|458927716|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
127536031|NCT02831764|458927712|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
127536032|NCT02831764|458927713|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
127536033|NCT02831764|458927714|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
127536034|NCT02831764|458927715|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
127536035|NCT02831764|458927716|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
127536036|NCT02831764|458927712|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
127536037|NCT02831764|458927713|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
127536038|NCT02831764|458927714|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
127536039|NCT02831764|458927715|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
127536040|NCT02831764|458927716|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
127536041|NCT02831764|458927712|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
127536042|NCT02831764|458927713|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
127536043|NCT02831764|458927714|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
127536044|NCT02831764|458927715|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
127536045|NCT02831764|458927716|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
127536046|NCT02831764|458927712|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
127536047|NCT02831764|458927713|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
127536048|NCT02831764|458927714|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
127536049|NCT02831764|458927715|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
127536050|NCT02831764|458927716|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
127536051|NCT02831764|458927712|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
127536052|NCT02831764|458927713|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
127536053|NCT02831764|458927714|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
127536054|NCT02831764|458927715|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
127536055|NCT02831764|458927716|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
127536056|NCT02831764|458927712|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
127536057|NCT02831764|458927713|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
127536058|NCT02831764|458927714|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
127536059|NCT02831764|458927715|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
127536060|NCT02831764|458927716|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
127536061|NCT02831764|458927712|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
127536062|NCT02831764|458927713|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
127536063|NCT02831764|458927714|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
127536064|NCT02831764|458927715|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
127536065|NCT02831764|458927716|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
127536066|NCT02831764|458927712|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
127536067|NCT02831764|458927713|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
127536068|NCT02831764|458927714|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
127536069|NCT02831764|458927715|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
127536070|NCT02831764|458927716|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
127758899|NCT03446781|459743462|FG000|Overall Study|Adverse Event|8|||
127758900|NCT03446781|459743463|FG001|Overall Study|Adverse Event|2|||
127536071|NCT02831764|458927712|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
127536072|NCT02831764|458927713|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
127536073|NCT02831764|458927714|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
127536074|NCT02831764|458927715|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
127536075|NCT02831764|458927716|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
127536076|NCT02831764|458927712|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
127536077|NCT02831764|458927713|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
127536078|NCT02831764|458927714|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
127536079|NCT02831764|458927715|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
127536080|NCT02831764|458927716|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
127536081|NCT02831764|458927712|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
127536082|NCT02831764|458927713|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
127536083|NCT02831764|458927714|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
127536084|NCT02831764|458927715|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
127536085|NCT02831764|458927716|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
127536086|NCT02831764|458927712|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
127536087|NCT02831764|458927713|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
127536088|NCT02831764|458927714|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
127536089|NCT02831764|458927715|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
127536090|NCT02831764|458927716|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
127536091|NCT02831764|458927712|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
127536092|NCT02831764|458927713|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
127536093|NCT02831764|458927714|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
127536094|NCT02831764|458927715|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
127536095|NCT02831764|458927716|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
127536096|NCT02831764|458927712|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
127536097|NCT02831764|458927713|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
127536098|NCT02831764|458927714|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
127536099|NCT02831764|458927715|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
127536100|NCT02831764|458927716|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
127536101|NCT02831764|458927712|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
127536102|NCT02831764|458927713|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
127536103|NCT02831764|458927714|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
127536104|NCT02831764|458927715|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
127536105|NCT02831764|458927716|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
127536106|NCT04564846|458927717|FG000|Overall Study|Withdrawal by Subject|2|||
127536107|NCT04564846|458927718|FG001|Overall Study|Withdrawal by Subject|1|||
127536108|NCT04564846|458927717|FG000|Overall Study|Physician Decision|0|||
127536109|NCT04564846|458927718|FG001|Overall Study|Physician Decision|1|||
127536110|NCT04564846|458927717|FG000|Overall Study|Lost to Follow-up|0|||
127536111|NCT04564846|458927718|FG001|Overall Study|Lost to Follow-up|1|||
127536112|NCT04564846|458927717|FG000|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
127536113|NCT04564846|458927718|FG001|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
127536114|NCT04564846|458927717|FG000|Overall Study|Subject non-compliance|1|||
127536115|NCT04564846|458927718|FG001|Overall Study|Subject non-compliance|0|||
127536116|NCT03737123|458927719|FG000|Study Treatment|Adverse Event|2|||
127536117|NCT03737123|458927720|FG001|Study Treatment|Adverse Event|0|||
127536118|NCT03737123|458927719|FG000|Study Treatment|Disease Progression|2|||
127536119|NCT03737123|458927720|FG001|Study Treatment|Disease Progression|0|||
127536120|NCT03737123|458927719|FG000|Study Treatment|Withdrawal by Subject|2|||
127536121|NCT03737123|458927720|FG001|Study Treatment|Withdrawal by Subject|0|||
127536122|NCT03737123|458927719|FG000|Follow up|Death|1|||
127536123|NCT03737123|458927720|FG001|Follow up|Death|0|||
127536124|NCT03737123|458927719|FG000|Follow up|Withdrawal by Subject|1|||
127536125|NCT03737123|458927720|FG001|Follow up|Withdrawal by Subject|0|||
127536126|NCT03737123|458927719|FG000|Follow up|Termination of study|4|||
127536127|NCT03737123|458927720|FG001|Follow up|Termination of study|0|||
127536128|NCT02173769|458927721|FG000|Overall Study|Protocol Violation|4|||
127536129|NCT04388111|458927722|FG000|Overall Study|Lost to Follow-up|5|||
127536130|NCT04388111|458927723|FG001|Overall Study|Lost to Follow-up|3|||
127536131|NCT04388111|458927722|FG000|Overall Study|Adverse Event|1|||
127536132|NCT04388111|458927723|FG001|Overall Study|Adverse Event|1|||
127536133|NCT04388111|458927722|FG000|Overall Study|Protocol Violation|2|||
127536134|NCT04388111|458927723|FG001|Overall Study|Protocol Violation|4|||
127536135|NCT04388111|458927722|FG000|Overall Study|Withdrawal by Subject|1|||
127536136|NCT04388111|458927723|FG001|Overall Study|Withdrawal by Subject|0|||
127536137|NCT00453154|458927732|FG000|Double BIind Maintenance|Adverse Event|0|||
127536138|NCT00453154|458927733|FG001|Double BIind Maintenance|Adverse Event|0|||
127536139|NCT00453154|458927734|FG002|Double BIind Maintenance|Adverse Event|3|||
127536140|NCT00453154|458927735|FG003|Double BIind Maintenance|Adverse Event|12|||
127536141|NCT00453154|458927732|FG000|Double BIind Maintenance|Death|0|||
127536142|NCT00453154|458927733|FG001|Double BIind Maintenance|Death|0|||
127536143|NCT00453154|458927734|FG002|Double BIind Maintenance|Death|2|||
127536144|NCT00453154|458927735|FG003|Double BIind Maintenance|Death|1|||
127536145|NCT00453154|458927732|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
127536146|NCT00453154|458927733|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
127536147|NCT00453154|458927734|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
127536148|NCT00453154|458927735|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
127536149|NCT00453154|458927732|FG000|Double BIind Maintenance|Progression|0|||
127536150|NCT00453154|458927733|FG001|Double BIind Maintenance|Progression|0|||
127536151|NCT00453154|458927734|FG002|Double BIind Maintenance|Progression|29|||
127536152|NCT00453154|458927735|FG003|Double BIind Maintenance|Progression|26|||
127536153|NCT00453154|458927732|FG000|Double BIind Maintenance|Medical Issues|0|||
127536154|NCT00453154|458927733|FG001|Double BIind Maintenance|Medical Issues|0|||
127536155|NCT00453154|458927734|FG002|Double BIind Maintenance|Medical Issues|3|||
127536156|NCT00453154|458927735|FG003|Double BIind Maintenance|Medical Issues|1|||
127536157|NCT00453154|458927732|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
127536158|NCT00453154|458927733|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
127536159|NCT00453154|458927734|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
127536160|NCT00453154|458927735|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
127536161|NCT01790594|458927737|FG000|Overall Study|Death|1|||
127536162|NCT01790594|458927738|FG001|Overall Study|Death|0|||
127536163|NCT01790594|458927739|FG002|Overall Study|Death|0|||
127536164|NCT01790594|458927737|FG000|Overall Study|Physician Decision|2|||
127536165|NCT01790594|458927738|FG001|Overall Study|Physician Decision|1|||
127536166|NCT01790594|458927739|FG002|Overall Study|Physician Decision|0|||
127536167|NCT01790594|458927737|FG000|Overall Study|Withdrawal by Subject|2|||
127536168|NCT01790594|458927738|FG001|Overall Study|Withdrawal by Subject|0|||
127536169|NCT01790594|458927739|FG002|Overall Study|Withdrawal by Subject|0|||
127536170|NCT01790594|458927737|FG000|Overall Study|Transplant was not done|0|||
127536171|NCT01790594|458927738|FG001|Overall Study|Transplant was not done|0|||
127536172|NCT01790594|458927739|FG002|Overall Study|Transplant was not done|3|||
127536173|NCT01790594|458927737|FG000|Overall Study|Terminated prior to week 76|0|||
127536174|NCT01790594|458927738|FG001|Overall Study|Terminated prior to week 76|2|||
127536175|NCT01790594|458927739|FG002|Overall Study|Terminated prior to week 76|0|||
127536176|NCT03291067|458927741|FG000|Overall Study|Adverse Event|0|||
127536177|NCT03291067|458927742|FG001|Overall Study|Adverse Event|2|||
127536178|NCT03291067|458927743|FG002|Overall Study|Adverse Event|17|||
127536179|NCT03291067|458927744|FG003|Overall Study|Adverse Event|3|||
127536180|NCT03291067|458927741|FG000|Overall Study|Lost to Follow-up|2|||
127536181|NCT03291067|458927742|FG001|Overall Study|Lost to Follow-up|1|||
127536182|NCT03291067|458927743|FG002|Overall Study|Lost to Follow-up|0|||
127536183|NCT03291067|458927744|FG003|Overall Study|Lost to Follow-up|1|||
127536184|NCT03291067|458927741|FG000|Overall Study|Physician Decision|0|||
127536185|NCT03291067|458927742|FG001|Overall Study|Physician Decision|0|||
127536186|NCT03291067|458927743|FG002|Overall Study|Physician Decision|1|||
127536187|NCT03291067|458927744|FG003|Overall Study|Physician Decision|0|||
127536188|NCT03291067|458927741|FG000|Overall Study|Protocol Violation|5|||
127536189|NCT03291067|458927742|FG001|Overall Study|Protocol Violation|3|||
127536190|NCT03291067|458927743|FG002|Overall Study|Protocol Violation|4|||
127536191|NCT03291067|458927744|FG003|Overall Study|Protocol Violation|2|||
127536192|NCT03291067|458927741|FG000|Overall Study|Withdrawal by Subject|3|||
127536193|NCT03291067|458927742|FG001|Overall Study|Withdrawal by Subject|4|||
127536194|NCT03291067|458927743|FG002|Overall Study|Withdrawal by Subject|7|||
127536195|NCT03291067|458927744|FG003|Overall Study|Withdrawal by Subject|5|||
127536196|NCT03291067|458927741|FG000|Overall Study|Other|0|||
127536197|NCT03291067|458927742|FG001|Overall Study|Other|4|||
127536198|NCT03291067|458927743|FG002|Overall Study|Other|4|||
127536199|NCT03291067|458927744|FG003|Overall Study|Other|6|||
127536200|NCT02038153|458927745|FG000|Overall Study|Withdrawal by Subject|1|||
127536201|NCT03016312|458927746|FG000|Overall Study|discontinued before the treatment started|0|||
127536202|NCT03016312|458927747|FG001|Overall Study|discontinued before the treatment started|1|||
127536203|NCT03016312|458927746|FG000|Overall Study|Withdrawal by Subject|37|||
127536204|NCT03016312|458927747|FG001|Overall Study|Withdrawal by Subject|44|||
127536205|NCT03016312|458927746|FG000|Overall Study|Terminated by the Sponsor's decision|100|||
127536206|NCT03016312|458927747|FG001|Overall Study|Terminated by the Sponsor's decision|126|||
127536207|NCT03016312|458927746|FG000|Overall Study|Physician Decision|1|||
127758901|NCT03446781|459743462|FG000|Overall Study|Protocol Violation|0|||
127536208|NCT03016312|458927747|FG001|Overall Study|Physician Decision|3|||
127536209|NCT03016312|458927746|FG000|Overall Study|Lost to Follow-up|12|||
127536210|NCT03016312|458927747|FG001|Overall Study|Lost to Follow-up|12|||
127536211|NCT03016312|458927746|FG000|Overall Study|Death|210|||
127536212|NCT03016312|458927747|FG001|Overall Study|Death|184|||
127536213|NCT03016312|458927746|FG000|Overall Study|loss to contact|1|||
127536214|NCT03016312|458927747|FG001|Overall Study|loss to contact|0|||
127536215|NCT03016312|458927746|FG000|Overall Study|started a new cancer therapy|1|||
127536216|NCT03016312|458927747|FG001|Overall Study|started a new cancer therapy|0|||
127536217|NCT01884077|458927748|FG000|Overall Study|screen fail|0|||
127536218|NCT01884077|458927749|FG001|Overall Study|screen fail|2|||
127536219|NCT01884077|458927748|FG000|Overall Study|canceled surgery|2|||
127536220|NCT01884077|458927749|FG001|Overall Study|canceled surgery|0|||
127536221|NCT01884077|458927748|FG000|Overall Study|Lost to Follow-up|0|||
127536222|NCT01884077|458927749|FG001|Overall Study|Lost to Follow-up|4|||
127536223|NCT01884077|458927748|FG000|Overall Study|study closed|6|||
127536224|NCT01884077|458927749|FG001|Overall Study|study closed|4|||
127536225|NCT00981149|458927750|FG000|Overall Study|Lost to Follow-up|1|||
127536226|NCT00981149|458927751|FG001|Overall Study|Lost to Follow-up|2|||
127536227|NCT00981149|458927750|FG000|Overall Study|Withdrawal by Subject|1|||
127536228|NCT00981149|458927751|FG001|Overall Study|Withdrawal by Subject|1|||
127536229|NCT02748863|458927753|FG000|Treatment Period 1|Adverse Event|0|||
127536230|NCT02748863|458927754|FG001|Treatment Period 1|Adverse Event|1|||
127536231|NCT02748863|458927755|FG002|Treatment Period 1|Adverse Event|0|||
127536232|NCT02748863|458927756|FG003|Treatment Period 1|Adverse Event|0|||
127536233|NCT02748863|458927757|FG004|Treatment Period 1|Adverse Event|0|||
127536234|NCT02748863|458927753|FG000|Treatment Period 1|Lack of Efficacy|0|||
127536235|NCT02748863|458927754|FG001|Treatment Period 1|Lack of Efficacy|0|||
127536236|NCT02748863|458927755|FG002|Treatment Period 1|Lack of Efficacy|1|||
127536237|NCT02748863|458927756|FG003|Treatment Period 1|Lack of Efficacy|0|||
127536238|NCT02748863|458927757|FG004|Treatment Period 1|Lack of Efficacy|0|||
127536239|NCT02748863|458927753|FG000|Treatment Period 1|Withdrawal by Subject|0|||
127536240|NCT02748863|458927754|FG001|Treatment Period 1|Withdrawal by Subject|1|||
127536241|NCT02748863|458927755|FG002|Treatment Period 1|Withdrawal by Subject|1|||
127536242|NCT02748863|458927756|FG003|Treatment Period 1|Withdrawal by Subject|0|||
127536243|NCT02748863|458927757|FG004|Treatment Period 1|Withdrawal by Subject|0|||
127536244|NCT02748863|458927753|FG000|Treatment Period 2|Lost to Follow-up|2|||
127536245|NCT02748863|458927754|FG001|Treatment Period 2|Lost to Follow-up|0|||
127536246|NCT02748863|458927755|FG002|Treatment Period 2|Lost to Follow-up|0|||
127536247|NCT02748863|458927756|FG003|Treatment Period 2|Lost to Follow-up|0|||
127536248|NCT02748863|458927757|FG004|Treatment Period 2|Lost to Follow-up|0|||
127536249|NCT02748863|458927753|FG000|Treatment Period 2|Adverse Event|3|||
127536250|NCT02748863|458927754|FG001|Treatment Period 2|Adverse Event|2|||
127536251|NCT02748863|458927755|FG002|Treatment Period 2|Adverse Event|0|||
127536252|NCT02748863|458927756|FG003|Treatment Period 2|Adverse Event|2|||
127536253|NCT02748863|458927757|FG004|Treatment Period 2|Adverse Event|0|||
127536254|NCT02748863|458927753|FG000|Treatment Period 2|Lack of Efficacy|0|||
127536255|NCT02748863|458927754|FG001|Treatment Period 2|Lack of Efficacy|1|||
127536256|NCT02748863|458927755|FG002|Treatment Period 2|Lack of Efficacy|0|||
127536257|NCT02748863|458927756|FG003|Treatment Period 2|Lack of Efficacy|0|||
127536258|NCT02748863|458927757|FG004|Treatment Period 2|Lack of Efficacy|0|||
127536259|NCT02748863|458927753|FG000|Treatment Period 2|Pregnancy|0|||
127536260|NCT02748863|458927754|FG001|Treatment Period 2|Pregnancy|0|||
127536261|NCT02748863|458927755|FG002|Treatment Period 2|Pregnancy|0|||
127536262|NCT02748863|458927756|FG003|Treatment Period 2|Pregnancy|0|||
127536263|NCT02748863|458927757|FG004|Treatment Period 2|Pregnancy|1|||
127536264|NCT01960140|458927758|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
127536265|NCT04537793|458927759|FG000|Part B (24 Weeks)|Adverse Event|0|||
127536266|NCT04537793|458927760|FG001|Part B (24 Weeks)|Adverse Event|1|||
127536267|NCT05470387|458927761|FG000|Overall Study|Protocol Violation|0|||
127536268|NCT05470387|458927762|FG001|Overall Study|Protocol Violation|3|||
127536269|NCT01255423|458927763|FG000|Overall Study|Abnormal Laboratory value|3|||
127536270|NCT01255423|458927764|FG001|Overall Study|Abnormal Laboratory value|2|||
127536271|NCT01255423|458927763|FG000|Overall Study|Use of prohibited medications|0|||
127536272|NCT01255423|458927764|FG001|Overall Study|Use of prohibited medications|1|||
127536273|NCT00657046|458927766|FG000|Overall Study|Adverse Event|1|||
127536274|NCT00657046|458927767|FG001|Overall Study|Adverse Event|1|||
127536275|NCT00657046|458927768|FG002|Overall Study|Adverse Event|0|||
127536276|NCT00657046|458927766|FG000|Overall Study|Protocol Violation|2|||
127536277|NCT00657046|458927767|FG001|Overall Study|Protocol Violation|2|||
127536278|NCT00657046|458927768|FG002|Overall Study|Protocol Violation|0|||
127536279|NCT00657046|458927766|FG000|Overall Study|Withdrawal by Subject|1|||
127536280|NCT00657046|458927767|FG001|Overall Study|Withdrawal by Subject|0|||
127536281|NCT00657046|458927768|FG002|Overall Study|Withdrawal by Subject|0|||
127536282|NCT00657046|458927766|FG000|Overall Study|Death|0|||
127536283|NCT00657046|458927767|FG001|Overall Study|Death|0|||
127536284|NCT00657046|458927768|FG002|Overall Study|Death|1|||
127536285|NCT00657046|458927766|FG000|Overall Study|Surgery|0|||
127536286|NCT00657046|458927767|FG001|Overall Study|Surgery|0|||
127536287|NCT00657046|458927768|FG002|Overall Study|Surgery|1|||
127536288|NCT01176058|458927769|FG000|Overall Study|Adverse Event|1|||
127536289|NCT01176058|458927770|FG001|Overall Study|Adverse Event|0|||
127536290|NCT01176058|458927769|FG000|Overall Study|Insufficient clinical response|2|||
127536291|NCT01176058|458927770|FG001|Overall Study|Insufficient clinical response|2|||
127536292|NCT01176058|458927769|FG000|Overall Study|Insufficient mycological response|0|||
127536293|NCT01176058|458927770|FG001|Overall Study|Insufficient mycological response|1|||
127536294|NCT01176058|458927769|FG000|Overall Study|Withdrawal by Subject|1|||
127536295|NCT01176058|458927770|FG001|Overall Study|Withdrawal by Subject|0|||
127536296|NCT01858363|458927771|FG000|Overall Study|Death|35|||
127536297|NCT01858363|458927772|FG001|Overall Study|Death|9|||
127536298|NCT01858363|458927771|FG000|Overall Study|Withdrawal by Subject|28|||
127536299|NCT01858363|458927772|FG001|Overall Study|Withdrawal by Subject|14|||
127536300|NCT01858363|458927771|FG000|Overall Study|Lost to Follow-up|13|||
127536301|NCT01858363|458927772|FG001|Overall Study|Lost to Follow-up|3|||
127536302|NCT03480152|458927782|FG000|Phase I|Signed consent. Died before treatment.|1|||
127536303|NCT03480152|458927783|FG001|Phase I|Signed consent. Died before treatment.|0|||
127536304|NCT03480152|458927784|FG002|Phase I|Signed consent. Died before treatment.|0|||
127536305|NCT00101686|458927785|FG000|Overall Study|Progressive Disease|37|||
127536306|NCT00101686|458927786|FG001|Overall Study|Progressive Disease|28|||
127536307|NCT00101686|458927787|FG002|Overall Study|Progressive Disease|37|||
127536308|NCT00101686|458927788|FG003|Overall Study|Progressive Disease|38|||
127536309|NCT00101686|458927789|FG004|Overall Study|Progressive Disease|28|||
127536310|NCT00101686|458927790|FG005|Overall Study|Progressive Disease|25|||
127536311|NCT00101686|458927791|FG006|Overall Study|Progressive Disease|5|||
127536312|NCT00101686|458927792|FG007|Overall Study|Progressive Disease|7|||
127536313|NCT00101686|458927793|FG008|Overall Study|Progressive Disease|10|||
127536314|NCT00101686|458927794|FG009|Overall Study|Progressive Disease|8|||
127536315|NCT00101686|458927785|FG000|Overall Study|initiation other anti-cancer treatment|4|||
127536316|NCT00101686|458927786|FG001|Overall Study|initiation other anti-cancer treatment|3|||
127536317|NCT00101686|458927787|FG002|Overall Study|initiation other anti-cancer treatment|4|||
127536318|NCT00101686|458927788|FG003|Overall Study|initiation other anti-cancer treatment|3|||
127536319|NCT00101686|458927789|FG004|Overall Study|initiation other anti-cancer treatment|1|||
127536320|NCT00101686|458927790|FG005|Overall Study|initiation other anti-cancer treatment|1|||
127536321|NCT00101686|458927791|FG006|Overall Study|initiation other anti-cancer treatment|2|||
127536322|NCT00101686|458927792|FG007|Overall Study|initiation other anti-cancer treatment|2|||
127536323|NCT00101686|458927793|FG008|Overall Study|initiation other anti-cancer treatment|3|||
127536324|NCT00101686|458927794|FG009|Overall Study|initiation other anti-cancer treatment|3|||
127536325|NCT00101686|458927785|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
127536326|NCT00101686|458927786|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
127536327|NCT00101686|458927787|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
127536328|NCT00101686|458927788|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
127536329|NCT00101686|458927789|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
127536330|NCT00101686|458927790|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
127536331|NCT00101686|458927791|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
127536332|NCT00101686|458927792|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
127536333|NCT00101686|458927793|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
127536334|NCT00101686|458927794|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
127536335|NCT00101686|458927785|FG000|Overall Study|unacceptable toxicity|3|||
127536336|NCT00101686|458927786|FG001|Overall Study|unacceptable toxicity|9|||
127536337|NCT00101686|458927787|FG002|Overall Study|unacceptable toxicity|10|||
127536338|NCT00101686|458927788|FG003|Overall Study|unacceptable toxicity|6|||
127536339|NCT00101686|458927789|FG004|Overall Study|unacceptable toxicity|16|||
127536340|NCT00101686|458927790|FG005|Overall Study|unacceptable toxicity|10|||
127536341|NCT00101686|458927791|FG006|Overall Study|unacceptable toxicity|4|||
127536342|NCT00101686|458927792|FG007|Overall Study|unacceptable toxicity|2|||
127536343|NCT00101686|458927793|FG008|Overall Study|unacceptable toxicity|1|||
127536344|NCT00101686|458927794|FG009|Overall Study|unacceptable toxicity|4|||
127536345|NCT00101686|458927785|FG000|Overall Study|Randomized but did not receive treament|1|||
127536346|NCT00101686|458927786|FG001|Overall Study|Randomized but did not receive treament|6|||
127536347|NCT00101686|458927787|FG002|Overall Study|Randomized but did not receive treament|2|||
127536348|NCT00101686|458927788|FG003|Overall Study|Randomized but did not receive treament|2|||
127536349|NCT00101686|458927789|FG004|Overall Study|Randomized but did not receive treament|2|||
127536350|NCT00101686|458927790|FG005|Overall Study|Randomized but did not receive treament|2|||
127536351|NCT00101686|458927791|FG006|Overall Study|Randomized but did not receive treament|0|||
127536352|NCT00101686|458927792|FG007|Overall Study|Randomized but did not receive treament|1|||
127536353|NCT00101686|458927793|FG008|Overall Study|Randomized but did not receive treament|0|||
127536354|NCT00101686|458927794|FG009|Overall Study|Randomized but did not receive treament|1|||
127536355|NCT00101686|458927785|FG000|Overall Study|intercurrent non-cancer related illness|0|||
127536356|NCT00101686|458927786|FG001|Overall Study|intercurrent non-cancer related illness|0|||
127536357|NCT00101686|458927787|FG002|Overall Study|intercurrent non-cancer related illness|2|||
127536358|NCT00101686|458927788|FG003|Overall Study|intercurrent non-cancer related illness|0|||
127536359|NCT00101686|458927789|FG004|Overall Study|intercurrent non-cancer related illness|1|||
127536360|NCT00101686|458927790|FG005|Overall Study|intercurrent non-cancer related illness|3|||
127536361|NCT00101686|458927791|FG006|Overall Study|intercurrent non-cancer related illness|1|||
127536362|NCT00101686|458927792|FG007|Overall Study|intercurrent non-cancer related illness|0|||
127536363|NCT00101686|458927793|FG008|Overall Study|intercurrent non-cancer related illness|1|||
127536364|NCT00101686|458927794|FG009|Overall Study|intercurrent non-cancer related illness|1|||
127536365|NCT00101686|458927785|FG000|Overall Study|Physician Decision|10|||
127536366|NCT00101686|458927786|FG001|Overall Study|Physician Decision|13|||
127536367|NCT00101686|458927787|FG002|Overall Study|Physician Decision|6|||
127536368|NCT00101686|458927788|FG003|Overall Study|Physician Decision|7|||
127536369|NCT00101686|458927789|FG004|Overall Study|Physician Decision|8|||
127536370|NCT00101686|458927790|FG005|Overall Study|Physician Decision|9|||
127536371|NCT00101686|458927791|FG006|Overall Study|Physician Decision|5|||
127536372|NCT00101686|458927792|FG007|Overall Study|Physician Decision|5|||
127536373|NCT00101686|458927793|FG008|Overall Study|Physician Decision|1|||
127536374|NCT00101686|458927794|FG009|Overall Study|Physician Decision|1|||
127536375|NCT00101686|458927785|FG000|Overall Study|Other|1|||
127536376|NCT00101686|458927786|FG001|Overall Study|Other|4|||
127536377|NCT00101686|458927787|FG002|Overall Study|Other|1|||
127536378|NCT00101686|458927788|FG003|Overall Study|Other|6|||
127536379|NCT00101686|458927789|FG004|Overall Study|Other|2|||
127536380|NCT00101686|458927790|FG005|Overall Study|Other|12|||
127536381|NCT00101686|458927791|FG006|Overall Study|Other|1|||
127536382|NCT00101686|458927792|FG007|Overall Study|Other|5|||
127536383|NCT00101686|458927793|FG008|Overall Study|Other|3|||
127536384|NCT00101686|458927794|FG009|Overall Study|Other|3|||
127536385|NCT00101686|458927785|FG000|Overall Study|Withdrawal by Subject|9|||
127536386|NCT00101686|458927786|FG001|Overall Study|Withdrawal by Subject|8|||
127536387|NCT00101686|458927787|FG002|Overall Study|Withdrawal by Subject|6|||
127536388|NCT00101686|458927788|FG003|Overall Study|Withdrawal by Subject|8|||
127536389|NCT00101686|458927789|FG004|Overall Study|Withdrawal by Subject|8|||
127536390|NCT00101686|458927790|FG005|Overall Study|Withdrawal by Subject|7|||
127536391|NCT00101686|458927791|FG006|Overall Study|Withdrawal by Subject|7|||
127536392|NCT00101686|458927792|FG007|Overall Study|Withdrawal by Subject|7|||
127536393|NCT00101686|458927793|FG008|Overall Study|Withdrawal by Subject|8|||
127536394|NCT00101686|458927794|FG009|Overall Study|Withdrawal by Subject|9|||
127536395|NCT02525471|458927795|FG000|Overall Study|Screen Failure|6|||
127536396|NCT02525471|458927795|FG000|Overall Study|Withdrawal by Subject|4|||
127536397|NCT02525471|458927795|FG000|Overall Study|Death|1|||
127536398|NCT00890825|458927796|FG000|Overall Study|Withdrawal by Subject|1|||
127536399|NCT00890825|458927797|FG001|Overall Study|Withdrawal by Subject|0|||
127536400|NCT00890825|458927796|FG000|Overall Study|Alive at data cut off (DCO)|13|||
127536401|NCT00890825|458927797|FG001|Overall Study|Alive at data cut off (DCO)|14|||
127536402|NCT01054456|458927798|FG000|Overall Study|Other|1|||
127536403|NCT00687401|458927801|FG000|Overall Study|Protocol Violation|7|||
127536404|NCT00687401|458927801|FG000|Overall Study|Adverse Event|6|||
127536405|NCT00687401|458927801|FG000|Overall Study|Lack of Efficacy|6|||
127536406|NCT00687401|458927801|FG000|Overall Study|Withdrawal by Subject|4|||
127536407|NCT00687401|458927801|FG000|Overall Study|Did not return for visit|3|||
127536408|NCT00687401|458927801|FG000|Overall Study|For reasons different from those above|4|||
127536409|NCT02920892|458927802|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
127536410|NCT02920892|458927803|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
127536411|NCT02920892|458927804|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
127536412|NCT02920892|458927802|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
127536413|NCT02920892|458927803|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
127536414|NCT02920892|458927804|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
127536415|NCT02920892|458927802|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
127536416|NCT02920892|458927803|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
127536417|NCT02920892|458927804|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
127536418|NCT02920892|458927802|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
127536419|NCT02920892|458927803|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
127536420|NCT02920892|458927804|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
127536421|NCT02920892|458927802|FG000|Placebo-Controlled Period|Physician Decision|0|||
127536422|NCT02920892|458927803|FG001|Placebo-Controlled Period|Physician Decision|0|||
127536423|NCT02920892|458927804|FG002|Placebo-Controlled Period|Physician Decision|1|||
127536424|NCT02920892|458927802|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
127536425|NCT02920892|458927803|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
127536426|NCT02920892|458927804|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
127536427|NCT02920892|458927802|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
127536428|NCT02920892|458927803|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
127536429|NCT02920892|458927804|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
127642265|NCT03252587|459310078|FG000|Overall Study|Adverse Event|3|||
127648091|NCT05007392|459331646|FG000|Overall Study|Withdrawal of consent|5|||
127648092|NCT05007392|459331647|FG001|Overall Study|Withdrawal of consent|4|||
127648093|NCT01218126|459331648|FG000|Overall Study|Adverse Event|8|||
127648094|NCT01218126|459331649|FG001|Overall Study|Adverse Event|10|||
127648095|NCT01218126|459331650|FG002|Overall Study|Adverse Event|12|||
127648096|NCT01218126|459331651|FG003|Overall Study|Adverse Event|16|||
127648097|NCT01218126|459331648|FG000|Overall Study|Lack of Efficacy|7|||
127648098|NCT01218126|459331649|FG001|Overall Study|Lack of Efficacy|2|||
127648099|NCT01218126|459331650|FG002|Overall Study|Lack of Efficacy|2|||
127648100|NCT01218126|459331651|FG003|Overall Study|Lack of Efficacy|6|||
127648101|NCT01218126|459331648|FG000|Overall Study|Protocol Violation|5|||
127648102|NCT01218126|459331649|FG001|Overall Study|Protocol Violation|2|||
127648103|NCT01218126|459331650|FG002|Overall Study|Protocol Violation|2|||
127648104|NCT01218126|459331651|FG003|Overall Study|Protocol Violation|3|||
127648105|NCT01218126|459331648|FG000|Overall Study|Protocol-defined stopping criteria|1|||
127648106|NCT01218126|459331649|FG001|Overall Study|Protocol-defined stopping criteria|1|||
127648107|NCT01218126|459331650|FG002|Overall Study|Protocol-defined stopping criteria|0|||
127648108|NCT01218126|459331651|FG003|Overall Study|Protocol-defined stopping criteria|0|||
127648109|NCT01218126|459331648|FG000|Overall Study|Lost to Follow-up|0|||
127648110|NCT01218126|459331649|FG001|Overall Study|Lost to Follow-up|0|||
127648111|NCT01218126|459331650|FG002|Overall Study|Lost to Follow-up|0|||
127648112|NCT01218126|459331651|FG003|Overall Study|Lost to Follow-up|2|||
127648113|NCT01218126|459331648|FG000|Overall Study|Physician Decision|1|||
127648114|NCT01218126|459331649|FG001|Overall Study|Physician Decision|2|||
127648115|NCT01218126|459331650|FG002|Overall Study|Physician Decision|4|||
127648116|NCT01218126|459331651|FG003|Overall Study|Physician Decision|2|||
127648117|NCT01218126|459331648|FG000|Overall Study|Withdrawal by Subject|2|||
127648118|NCT01218126|459331649|FG001|Overall Study|Withdrawal by Subject|5|||
127648119|NCT01218126|459331650|FG002|Overall Study|Withdrawal by Subject|4|||
127536430|NCT02920892|458927802|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
127536431|NCT02920892|458927803|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
127536432|NCT02920892|458927804|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
127536433|NCT04486235|458927805|FG000|Overall Study|Pregnancy|1|||
127536434|NCT04486235|458927806|FG001|Overall Study|Pregnancy|0|||
127536435|NCT04486235|458927805|FG000|Overall Study|Lost to Follow-up|1|||
127536436|NCT04486235|458927806|FG001|Overall Study|Lost to Follow-up|0|||
127536437|NCT03935126|458927807|FG000|Overall Study|Study termination by sponsor|3|||
127536438|NCT03649217|458927808|FG000|Overall Study|subject had severe ataxia not initially found|1|||
127536439|NCT03649217|458927808|FG000|Overall Study|subject had cognitive issues not initially found|1|||
127536440|NCT01092728|458927809|FG000|Overall Study|Withdrawal by Subject|2|||
127536441|NCT01092728|458927810|FG001|Overall Study|Withdrawal by Subject|0|||
127536442|NCT01092728|458927809|FG000|Overall Study|Adverse Event|0|||
127536443|NCT01092728|458927810|FG001|Overall Study|Adverse Event|1|||
127536444|NCT01092728|458927809|FG000|Overall Study|Disease Progression|1|||
127536445|NCT01092728|458927810|FG001|Overall Study|Disease Progression|13|||
127536446|NCT01092728|458927809|FG000|Overall Study|Prohibited Concomitant Medications|1|||
127536447|NCT01092728|458927810|FG001|Overall Study|Prohibited Concomitant Medications|0|||
127536448|NCT02520726|458927811|FG000|Overall Study|Lost to Follow-up|3|||
127648120|NCT01218126|459331651|FG003|Overall Study|Withdrawal by Subject|6|||
127648121|NCT00453986|459331652|FG000|Overall Study|Lost to Follow-up|6|||
127648122|NCT00453986|459331653|FG001|Overall Study|Lost to Follow-up|5|||
127648123|NCT00453986|459331654|FG002|Overall Study|Lost to Follow-up|6|||
127648124|NCT00453986|459331655|FG003|Overall Study|Lost to Follow-up|2|||
127648125|NCT00453986|459331656|FG004|Overall Study|Lost to Follow-up|0|||
127648126|NCT00522626|459331659|FG000|Overall Study|Lost to Follow-up|7|||
127648127|NCT02553460|459331661|FG000|Overall Study|Death|3|||
127648128|NCT02553460|459331661|FG000|Overall Study|Withdrawal by Subject|1|||
127648129|NCT02553460|459331661|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
127648130|NCT02553460|459331661|FG000|Overall Study|Relapse or Transplant|14|||
127648131|NCT02553460|459331661|FG000|Overall Study|No response to treatment|2|||
127758902|NCT03446781|459743463|FG001|Overall Study|Protocol Violation|3|||
127758903|NCT04410523|459743467|FG000|Overall Study|Study terminated by sponsor|1|||
127758904|NCT04410523|459743468|FG001|Overall Study|Study terminated by sponsor|3|||
127758905|NCT04410523|459743469|FG002|Overall Study|Study terminated by sponsor|2|||
127758906|NCT04410523|459743470|FG003|Overall Study|Study terminated by sponsor|6|||
127758907|NCT04410523|459743471|FG004|Overall Study|Study terminated by sponsor|3|||
127758908|NCT04410523|459743472|FG005|Overall Study|Study terminated by sponsor|4|||
127758909|NCT04410523|459743467|FG000|Overall Study|Adverse Event|1|||
127648132|NCT02553460|459331661|FG000|Overall Study|CAR T cells|2|||
127758910|NCT04410523|459743468|FG001|Overall Study|Adverse Event|0|||
127758911|NCT04410523|459743469|FG002|Overall Study|Adverse Event|0|||
127758912|NCT04410523|459743470|FG003|Overall Study|Adverse Event|0|||
127648133|NCT04814368|459331662|FG000|Overall Study|Study Terminated by Sponsor|0|||
127648134|NCT04814368|459331663|FG001|Overall Study|Study Terminated by Sponsor|3|||
127648135|NCT04814368|459331664|FG002|Overall Study|Study Terminated by Sponsor|0|||
127648136|NCT04814368|459331665|FG003|Overall Study|Study Terminated by Sponsor|2|||
127758913|NCT04410523|459743471|FG004|Overall Study|Adverse Event|0|||
127758914|NCT04410523|459743472|FG005|Overall Study|Adverse Event|2|||
127758915|NCT04410523|459743467|FG000|Overall Study|Lost to Follow-up|0|||
127758916|NCT04410523|459743468|FG001|Overall Study|Lost to Follow-up|1|||
127758917|NCT04410523|459743469|FG002|Overall Study|Lost to Follow-up|0|||
127758918|NCT04410523|459743470|FG003|Overall Study|Lost to Follow-up|0|||
127758919|NCT04410523|459743471|FG004|Overall Study|Lost to Follow-up|0|||
127758920|NCT04410523|459743472|FG005|Overall Study|Lost to Follow-up|0|||
127758921|NCT04410523|459743467|FG000|Overall Study|Physician Decision|0|||
127758922|NCT04410523|459743468|FG001|Overall Study|Physician Decision|1|||
127758923|NCT04410523|459743469|FG002|Overall Study|Physician Decision|0|||
127758924|NCT04410523|459743470|FG003|Overall Study|Physician Decision|0|||
127758925|NCT04410523|459743471|FG004|Overall Study|Physician Decision|0|||
127758926|NCT04410523|459743472|FG005|Overall Study|Physician Decision|0|||
127758927|NCT04410523|459743467|FG000|Overall Study|Pregnancy|0|||
127758928|NCT04410523|459743468|FG001|Overall Study|Pregnancy|0|||
127758929|NCT04410523|459743469|FG002|Overall Study|Pregnancy|0|||
127758930|NCT04410523|459743470|FG003|Overall Study|Pregnancy|0|||
127758931|NCT04410523|459743471|FG004|Overall Study|Pregnancy|0|||
127758932|NCT04410523|459743472|FG005|Overall Study|Pregnancy|1|||
127758933|NCT04410523|459743467|FG000|Overall Study|Protocol deviation|0|||
127758934|NCT04410523|459743468|FG001|Overall Study|Protocol deviation|0|||
127758935|NCT04410523|459743469|FG002|Overall Study|Protocol deviation|0|||
127758936|NCT04410523|459743470|FG003|Overall Study|Protocol deviation|0|||
127758937|NCT04410523|459743471|FG004|Overall Study|Protocol deviation|0|||
127758938|NCT04410523|459743472|FG005|Overall Study|Protocol deviation|2|||
127758939|NCT04410523|459743467|FG000|Overall Study|Subject decision|2|||
127758940|NCT04410523|459743468|FG001|Overall Study|Subject decision|0|||
127758941|NCT04410523|459743469|FG002|Overall Study|Subject decision|0|||
127758942|NCT04410523|459743470|FG003|Overall Study|Subject decision|1|||
127758943|NCT04410523|459743471|FG004|Overall Study|Subject decision|0|||
127758944|NCT04410523|459743472|FG005|Overall Study|Subject decision|1|||
127758945|NCT00490490|459743473|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
127758946|NCT00490490|459743473|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
127758947|NCT00370682|459743474|FG000|Overall Study|Moved from area|0|||
127758948|NCT00370682|459743475|FG001|Overall Study|Moved from area|2|||
127758949|NCT00370682|459743476|FG002|Overall Study|Moved from area|0|||
127758950|NCT00370682|459743474|FG000|Overall Study|Lost to Follow-up|0|||
127758951|NCT00370682|459743475|FG001|Overall Study|Lost to Follow-up|1|||
127758952|NCT00370682|459743476|FG002|Overall Study|Lost to Follow-up|1|||
127758953|NCT03651622|459743477|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
127758954|NCT03651622|459743478|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
127758955|NCT03651622|459743479|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
127758956|NCT03651622|459743477|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
127758957|NCT03651622|459743478|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
127758958|NCT03651622|459743479|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
127758959|NCT03651622|459743477|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
127758960|NCT03651622|459743478|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
127758961|NCT03651622|459743479|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
127758962|NCT03651622|459743477|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
127758963|NCT03651622|459743478|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
127758964|NCT03651622|459743479|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
127758965|NCT03651622|459743477|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
127758966|NCT03651622|459743478|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
127758967|NCT03651622|459743479|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
127758968|NCT01519089|459743480|FG000|Overall Study|Adverse Event|4|||
127758969|NCT01519089|459743481|FG001|Overall Study|Adverse Event|4|||
127758970|NCT01519089|459743480|FG000|Overall Study|Lack of Efficacy|0|||
127758971|NCT01519089|459743481|FG001|Overall Study|Lack of Efficacy|2|||
127758972|NCT01519089|459743480|FG000|Overall Study|Lost to Follow-up|1|||
127758973|NCT01519089|459743481|FG001|Overall Study|Lost to Follow-up|0|||
127758974|NCT01519089|459743480|FG000|Overall Study|Withdrawal by Subject|0|||
127758975|NCT01519089|459743481|FG001|Overall Study|Withdrawal by Subject|2|||
127758976|NCT01519089|459743480|FG000|Overall Study|Other|2|||
127758977|NCT01519089|459743481|FG001|Overall Study|Other|6|||
127758978|NCT01519089|459743480|FG000|Overall Study|Not received study drug|0|||
127758979|NCT01519089|459743481|FG001|Overall Study|Not received study drug|1|||
127758980|NCT00127205|459743482|FG000|Overall Study|Adverse Event|228|||
127758981|NCT00127205|459743483|FG001|Overall Study|Adverse Event|387|||
127758982|NCT00127205|459743484|FG002|Overall Study|Adverse Event|273|||
127758983|NCT00127205|459743482|FG000|Overall Study|Death|8|||
127758984|NCT00127205|459743483|FG001|Overall Study|Death|6|||
127758985|NCT00127205|459743484|FG002|Overall Study|Death|5|||
127758986|NCT00127205|459743482|FG000|Overall Study|Withdrawal by Subject|318|||
127758987|NCT00127205|459743483|FG001|Overall Study|Withdrawal by Subject|310|||
127758988|NCT00127205|459743484|FG002|Overall Study|Withdrawal by Subject|172|||
127758989|NCT00127205|459743482|FG000|Overall Study|Other-non protocol specified|142|||
127758990|NCT00127205|459743483|FG001|Overall Study|Other-non protocol specified|129|||
127758991|NCT00127205|459743484|FG002|Overall Study|Other-non protocol specified|77|||
127758992|NCT00127205|459743482|FG000|Overall Study|Data not reported|6|||
127758993|NCT00127205|459743483|FG001|Overall Study|Data not reported|10|||
127758994|NCT00127205|459743484|FG002|Overall Study|Data not reported|1|||
127758995|NCT00127205|459743482|FG000|Overall Study|Progression|127|||
127758996|NCT00127205|459743483|FG001|Overall Study|Progression|131|||
127758997|NCT00127205|459743484|FG002|Overall Study|Progression|84|||
127758998|NCT03582943|459743487|FG000|Allocated to Groups|Withdrawal by Subject|1|||
127758999|NCT03582943|459743488|FG001|Allocated to Groups|Withdrawal by Subject|1|||
127759000|NCT03582943|459743487|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
127759001|NCT03582943|459743488|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
127759002|NCT03582943|459743487|FG000|Analyzed|Protocol Violation|4|||
127759003|NCT03582943|459743488|FG001|Analyzed|Protocol Violation|1|||
127759004|NCT05032872|459743495|FG000|Overall Study|Adverse Event|1|||
127759005|NCT05032872|459743496|FG001|Overall Study|Adverse Event|0|||
127759006|NCT05032872|459743495|FG000|Overall Study|Lost to Follow-up|2|||
127759007|NCT05032872|459743496|FG001|Overall Study|Lost to Follow-up|4|||
127759008|NCT05032872|459743495|FG000|Overall Study|Withdrawal by Subject|4|||
127759009|NCT05032872|459743496|FG001|Overall Study|Withdrawal by Subject|3|||
127759010|NCT05870228|459743497|FG000|Overall Study|Lost to Follow-up|2|||
127759011|NCT05870228|459743498|FG001|Overall Study|Lost to Follow-up|0|||
127759012|NCT05870228|459743497|FG000|Overall Study|Withdrawal by Subject|1|||
127759013|NCT05870228|459743498|FG001|Overall Study|Withdrawal by Subject|0|||
127648137|NCT04814368|459331662|FG000|Overall Study|Subject Decision|1|||
127648138|NCT04814368|459331663|FG001|Overall Study|Subject Decision|2|||
127648139|NCT04814368|459331664|FG002|Overall Study|Subject Decision|0|||
127648140|NCT04814368|459331665|FG003|Overall Study|Subject Decision|0|||
127648141|NCT01953003|459333147|FG000|Overall Study|Not treated|0|||
127648142|NCT01953003|459333148|FG001|Overall Study|Not treated|1|||
127759014|NCT00488475|459743499|FG000|Overall Study|Other|1754|||
127759015|NCT04662931|459743518|FG000|Overall Study|Withdrawal by Subject|17|||
127759016|NCT04662931|459743518|FG000|Overall Study|Death|3|||
127759017|NCT04662931|459743518|FG000|Overall Study|Lost to Follow-up|3|||
127759018|NCT04662931|459743518|FG000|Overall Study|Guardian Decision|1|||
127759019|NCT06665919|459743520|FG000|Overall Study|Withdrawal by Subject|4|||
127759020|NCT06665919|459743521|FG001|Overall Study|Withdrawal by Subject|4|||
127759021|NCT06665919|459743522|FG002|Overall Study|Withdrawal by Subject|4|||
127759022|NCT06665919|459743520|FG000|Overall Study|Non-compliance to Treatment|4|||
127759023|NCT06665919|459743521|FG001|Overall Study|Non-compliance to Treatment|1|||
127759024|NCT06665919|459743522|FG002|Overall Study|Non-compliance to Treatment|6|||
127759025|NCT06665919|459743520|FG000|Overall Study|Lost to Follow-up|3|||
127759026|NCT06665919|459743521|FG001|Overall Study|Lost to Follow-up|0|||
127759027|NCT06665919|459743522|FG002|Overall Study|Lost to Follow-up|2|||
127759028|NCT06665919|459743520|FG000|Overall Study|Physician Decision|4|||
127759029|NCT06665919|459743521|FG001|Overall Study|Physician Decision|0|||
127759030|NCT06665919|459743522|FG002|Overall Study|Physician Decision|1|||
127759031|NCT04150068|459743523|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
127759032|NCT04150068|459743524|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
127759033|NCT04150068|459743525|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
127648143|NCT01953003|459333147|FG000|Overall Study|Progressive disease|35|||
127648144|NCT01953003|459333148|FG001|Overall Study|Progressive disease|45|||
127648145|NCT01953003|459333147|FG000|Overall Study|Related Adverse events|7|||
127648146|NCT01953003|459333148|FG001|Overall Study|Related Adverse events|2|||
127648147|NCT01953003|459333147|FG000|Overall Study|Non-related adverse events|0|||
127648148|NCT01953003|459333148|FG001|Overall Study|Non-related adverse events|2|||
127648149|NCT01953003|459333147|FG000|Overall Study|Protocol Violation|0|||
127648150|NCT01953003|459333148|FG001|Overall Study|Protocol Violation|1|||
127648151|NCT01953003|459333147|FG000|Overall Study|Withdrawal by Subject|14|||
127648152|NCT01953003|459333148|FG001|Overall Study|Withdrawal by Subject|4|||
127648153|NCT04791761|459333151|FG000|Overall Study|Lost to Follow-up|8|||
127648154|NCT04791761|459333152|FG001|Overall Study|Lost to Follow-up|6|||
127648155|NCT04791761|459333153|FG002|Overall Study|Lost to Follow-up|10|||
127648156|NCT04791761|459333151|FG000|Overall Study|Withdrawal by Subject|0|||
127648157|NCT04791761|459333152|FG001|Overall Study|Withdrawal by Subject|1|||
127648158|NCT04791761|459333153|FG002|Overall Study|Withdrawal by Subject|1|||
127759034|NCT04150068|459743523|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
127759035|NCT04150068|459743524|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
127759036|NCT04150068|459743525|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
127759037|NCT04625413|459743526|FG000|Overall Study|Hospice|2|||
127759038|NCT04625413|459743526|FG000|Overall Study|Distress|1|||
127759039|NCT04625413|459743526|FG000|Overall Study|Not feeling well|1|||
127759040|NCT04679935|459743527|FG000|Overall Study|Death|0|||
127759041|NCT04679935|459743528|FG001|Overall Study|Death|1|||
127759042|NCT02993146|459743529|FG000|Overall Study|Withdrawal by Subject|0|||
127759043|NCT02993146|459743530|FG001|Overall Study|Withdrawal by Subject|0|||
127759044|NCT02993146|459743531|FG002|Overall Study|Withdrawal by Subject|1|||
127759045|NCT02993146|459743532|FG003|Overall Study|Withdrawal by Subject|1|||
127759046|NCT04349631|459743535|FG000|Overall Study|Lost to Follow-up|3|||
127759047|NCT04349631|459743535|FG000|Overall Study|Withdrawal by Subject|7|||
127759048|NCT01982448|459743536|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
127759049|NCT01982448|459743537|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
127759050|NCT01982448|459743536|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
127759051|NCT01982448|459743537|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
127759052|NCT01982448|459743536|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
127759053|NCT01982448|459743537|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
127759054|NCT01982448|459743536|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
127759055|NCT01982448|459743537|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
127759056|NCT03333876|459745519|FG000|Screening Period|Screen Failure|4|||
127759057|NCT03333876|459745519|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
127759058|NCT03333876|459745519|FG000|Mandibular Advancement|Adverse Event|2|||
127759059|NCT03333876|459745519|FG000|Mandibular Advancement|Product Damage|2|||
127759060|NCT00095498|459745520|FG000|Overall Study|Physician Decision|9|||
127759061|NCT00095498|459745521|FG001|Overall Study|Physician Decision|10|||
127759062|NCT00095498|459745522|FG002|Overall Study|Physician Decision|8|||
127759063|NCT00095498|459745520|FG000|Overall Study|Adverse Event|1|||
127759064|NCT00095498|459745521|FG001|Overall Study|Adverse Event|0|||
127759065|NCT00095498|459745522|FG002|Overall Study|Adverse Event|1|||
127759066|NCT00095498|459745520|FG000|Overall Study|Withdrawal by Subject|15|||
127759067|NCT00095498|459745521|FG001|Overall Study|Withdrawal by Subject|16|||
127759068|NCT00095498|459745522|FG002|Overall Study|Withdrawal by Subject|15|||
127759069|NCT00095498|459745520|FG000|Overall Study|Disease progression|0|||
127759070|NCT00095498|459745521|FG001|Overall Study|Disease progression|1|||
127759071|NCT00095498|459745522|FG002|Overall Study|Disease progression|1|||
127759072|NCT00095498|459745520|FG000|Overall Study|Ineligibility determined|3|||
127759073|NCT00095498|459745521|FG001|Overall Study|Ineligibility determined|0|||
127759074|NCT00095498|459745522|FG002|Overall Study|Ineligibility determined|2|||
127759075|NCT00095498|459745520|FG000|Overall Study|Lost to Follow-up|1|||
127759076|NCT00095498|459745521|FG001|Overall Study|Lost to Follow-up|1|||
127759077|NCT00095498|459745522|FG002|Overall Study|Lost to Follow-up|2|||
127759078|NCT00095498|459745520|FG000|Overall Study|Noncompliance|1|||
127759079|NCT00095498|459745521|FG001|Overall Study|Noncompliance|0|||
127759080|NCT00095498|459745522|FG002|Overall Study|Noncompliance|1|||
127759081|NCT00095498|459745520|FG000|Overall Study|Other|6|||
127759082|NCT00095498|459745521|FG001|Overall Study|Other|7|||
127759083|NCT00095498|459745522|FG002|Overall Study|Other|6|||
127759084|NCT00095498|459745520|FG000|Overall Study|Protocol Violation|0|||
127759085|NCT00095498|459745521|FG001|Overall Study|Protocol Violation|0|||
127759086|NCT00095498|459745522|FG002|Overall Study|Protocol Violation|1|||
127759087|NCT00095498|459745520|FG000|Overall Study|Requirement for alternative therapy|1|||
127759088|NCT00095498|459745521|FG001|Overall Study|Requirement for alternative therapy|0|||
127759089|NCT00095498|459745522|FG002|Overall Study|Requirement for alternative therapy|2|||
127759090|NCT04684394|459745523|FG000|Overall Study|Death|1|||
127759091|NCT04684394|459745524|FG001|Overall Study|Death|2|||
127759092|NCT04684394|459745523|FG000|Overall Study|Lost to Follow-up|1|||
127759093|NCT04684394|459745524|FG001|Overall Study|Lost to Follow-up|0|||
127759094|NCT04684394|459745523|FG000|Overall Study|Withdrawal by Subject|2|||
127759095|NCT04684394|459745524|FG001|Overall Study|Withdrawal by Subject|0|||
127759096|NCT04684394|459745523|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
127759097|NCT04684394|459745524|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
127759098|NCT00591370|459745526|FG000|Overall Study|Not Treated|2|||
127759099|NCT03439254|459745527|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
127759100|NCT03439254|459745528|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
127759101|NCT03439254|459745529|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
127759102|NCT03439254|459745530|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
127759103|NCT03439254|459745531|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
127759104|NCT03439254|459745532|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
127759105|NCT03439254|459745527|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
127759106|NCT03439254|459745528|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
127759107|NCT03439254|459745529|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
127759108|NCT03439254|459745530|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
127759109|NCT03439254|459745531|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
127759110|NCT03439254|459745532|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
127759111|NCT03439254|459745527|FG000|Double-blind Phase (18 Months)|Death|1|||
127759112|NCT03439254|459745528|FG001|Double-blind Phase (18 Months)|Death|2|||
127759113|NCT03439254|459745529|FG002|Double-blind Phase (18 Months)|Death|2|||
127759114|NCT03439254|459745530|FG003|Double-blind Phase (18 Months)|Death|0|||
127759115|NCT03439254|459745531|FG004|Double-blind Phase (18 Months)|Death|0|||
127759116|NCT03439254|459745532|FG005|Double-blind Phase (18 Months)|Death|0|||
127759117|NCT03439254|459745527|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
127759118|NCT03439254|459745528|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
127759119|NCT03439254|459745529|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
127759120|NCT03439254|459745530|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
127759121|NCT03439254|459745531|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
127759122|NCT03439254|459745532|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
127759123|NCT03439254|459745527|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
127759124|NCT03439254|459745528|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
127759125|NCT03439254|459745529|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
127759126|NCT03439254|459745530|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
127759127|NCT03439254|459745531|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
127759128|NCT03439254|459745532|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
127759129|NCT03439254|459745527|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
127759130|NCT03439254|459745528|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
127759131|NCT03439254|459745529|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
127759132|NCT03439254|459745530|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
127759133|NCT03439254|459745531|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
127759134|NCT03439254|459745532|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
127759135|NCT03439254|459745527|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
127759136|NCT03439254|459745528|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
127759137|NCT03439254|459745529|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
127759138|NCT03439254|459745530|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
127759139|NCT03439254|459745531|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
127759140|NCT03439254|459745532|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
127759141|NCT03439254|459745527|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
127759142|NCT03439254|459745528|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
127759143|NCT03439254|459745529|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
127759144|NCT03439254|459745530|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
127759145|NCT03439254|459745531|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
127759146|NCT03439254|459745532|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
127759147|NCT03439254|459745527|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
127759148|NCT03439254|459745528|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
127759149|NCT03439254|459745529|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
127759150|NCT03439254|459745530|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
127759151|NCT03439254|459745531|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
127759152|NCT03439254|459745532|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
127759153|NCT03439254|459745527|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
127759154|NCT03439254|459745528|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
127870706|NCT04419558|460145100|FG000|DB Period (48 Weeks)|Lost to Follow-up|1|||
127870707|NCT04419558|460145101|FG001|DB Period (48 Weeks)|Lost to Follow-up|3|||
127870708|NCT04419558|460145100|FG000|DB Period (48 Weeks)|Investigator Decision|0|||
127870709|NCT04419558|460145101|FG001|DB Period (48 Weeks)|Investigator Decision|1|||
127870710|NCT04419558|460145100|FG000|DB Period (48 Weeks)|Study terminated by sponsor|99|||
127870711|NCT04419558|460145101|FG001|DB Period (48 Weeks)|Study terminated by sponsor|101|||
127870712|NCT04419558|460145100|FG000|DB Period (48 Weeks)|Disease Progression|1|||
127870713|NCT04419558|460145101|FG001|DB Period (48 Weeks)|Disease Progression|0|||
127870714|NCT04419558|460145100|FG000|DB Period (48 Weeks)|Withdrawal by Subject|11|||
127870715|NCT04419558|460145101|FG001|DB Period (48 Weeks)|Withdrawal by Subject|7|||
127870716|NCT04419558|460145100|FG000|DB Period (48 Weeks)|Lung Transplant|1|||
127870717|NCT04419558|460145101|FG001|DB Period (48 Weeks)|Lung Transplant|0|||
127870718|NCT04419558|460145100|FG000|DB Period (48 Weeks)|Participant Decision|4|||
127870719|NCT04419558|460145101|FG001|DB Period (48 Weeks)|Participant Decision|3|||
127870720|NCT04419558|460145100|FG000|OLE Period (48 Weeks)|Adverse Event|3|||
127870721|NCT04419558|460145101|FG001|OLE Period (48 Weeks)|Adverse Event|1|||
127870722|NCT04419558|460145100|FG000|OLE Period (48 Weeks)|Death|4|||
127870723|NCT04419558|460145101|FG001|OLE Period (48 Weeks)|Death|6|||
127870724|NCT04419558|460145100|FG000|OLE Period (48 Weeks)|Study terminated by sponsor|34|||
127870725|NCT04419558|460145101|FG001|OLE Period (48 Weeks)|Study terminated by sponsor|37|||
127870726|NCT04419558|460145100|FG000|OLE Period (48 Weeks)|Withdrawal by Subject|0|||
127870727|NCT04419558|460145101|FG001|OLE Period (48 Weeks)|Withdrawal by Subject|1|||
127870728|NCT00903357|460145102|FG000|First Intervention|Withdrawal by Subject|5|||
127870729|NCT00903357|460145103|FG001|First Intervention|Withdrawal by Subject|3|||
127870730|NCT00903357|460145102|FG000|First Intervention|Flu|0|||
127870731|NCT00903357|460145103|FG001|First Intervention|Flu|1|||
127870732|NCT00903357|460145102|FG000|Wash Out Period of 2 Weeks|Flu|0|||
127870733|NCT00903357|460145103|FG001|Wash Out Period of 2 Weeks|Flu|1|||
127870734|NCT00903357|460145102|FG000|Second Intervention|Lost to Follow-up|1|||
127870735|NCT00903357|460145103|FG001|Second Intervention|Lost to Follow-up|0|||
127870736|NCT05146999|460145105|FG000|Overall Study|Withdrew consent|6|||
127870737|NCT05146999|460145106|FG001|Overall Study|Withdrew consent|1|||
127870738|NCT05146999|460145105|FG000|Overall Study|Lost to Follow-up|3|||
127870739|NCT05146999|460145106|FG001|Overall Study|Lost to Follow-up|2|||
127870740|NCT05146999|460145105|FG000|Overall Study|Other|1|||
127870741|NCT05146999|460145106|FG001|Overall Study|Other|3|||
127870742|NCT04668157|460145107|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|1|||
127870743|NCT04668157|460145108|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
127870744|NCT04668157|460145107|FG000|Treatment Period (52 Weeks)|Other|0|||
127870745|NCT04668157|460145108|FG001|Treatment Period (52 Weeks)|Other|2|||
127870746|NCT00383292|460145109|FG000|Overall Study|Adverse Event|4|||
127870747|NCT00383292|460145110|FG001|Overall Study|Adverse Event|1|||
127870748|NCT00383292|460145111|FG002|Overall Study|Adverse Event|2|||
127870749|NCT00383292|460145109|FG000|Overall Study|Death|3|||
127870750|NCT00383292|460145110|FG001|Overall Study|Death|3|||
127870751|NCT00383292|460145111|FG002|Overall Study|Death|3|||
127870752|NCT00383292|460145109|FG000|Overall Study|Physician Decision|4|||
127870753|NCT00383292|460145110|FG001|Overall Study|Physician Decision|0|||
127870754|NCT00383292|460145111|FG002|Overall Study|Physician Decision|1|||
127870755|NCT00383292|460145109|FG000|Overall Study|Withdrawal by Subject|3|||
127870756|NCT00383292|460145110|FG001|Overall Study|Withdrawal by Subject|2|||
127870757|NCT00383292|460145111|FG002|Overall Study|Withdrawal by Subject|2|||
127870758|NCT00383292|460145109|FG000|Overall Study|Other|1|||
127870759|NCT00383292|460145110|FG001|Overall Study|Other|0|||
127870760|NCT00383292|460145111|FG002|Overall Study|Other|0|||
127870761|NCT03329404|460145112|FG000|Overall Study|The study was suspended.|1|||
127870762|NCT03329404|460145113|FG001|Overall Study|The study was suspended.|4|||
127870763|NCT01016912|460145114|FG000|End of Treatment Period|Lack of Efficacy|0|||
127870764|NCT01016912|460145115|FG001|End of Treatment Period|Lack of Efficacy|1|||
127870765|NCT01016912|460145116|FG002|End of Treatment Period|Lack of Efficacy|0|||
127870766|NCT01016912|460145117|FG003|End of Treatment Period|Lack of Efficacy|4|||
127870767|NCT01016912|460145118|FG004|End of Treatment Period|Lack of Efficacy|4|||
127870768|NCT01016912|460145114|FG000|End of Treatment Period|Adverse Event|0|||
127870769|NCT01016912|460145115|FG001|End of Treatment Period|Adverse Event|1|||
127870770|NCT01016912|460145116|FG002|End of Treatment Period|Adverse Event|1|||
127870771|NCT01016912|460145117|FG003|End of Treatment Period|Adverse Event|0|||
127870772|NCT01016912|460145118|FG004|End of Treatment Period|Adverse Event|0|||
127870773|NCT01016912|460145114|FG000|End of Treatment Period|Completed double-blind period only|0|||
127870774|NCT01016912|460145115|FG001|End of Treatment Period|Completed double-blind period only|1|||
127870775|NCT01016912|460145116|FG002|End of Treatment Period|Completed double-blind period only|0|||
127870776|NCT01016912|460145117|FG003|End of Treatment Period|Completed double-blind period only|0|||
127870777|NCT01016912|460145118|FG004|End of Treatment Period|Completed double-blind period only|0|||
127870778|NCT01016912|460145114|FG000|Follow-up Period|Other reason|0|||
127870779|NCT01016912|460145115|FG001|Follow-up Period|Other reason|0|||
127759155|NCT03439254|459745529|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
127759156|NCT03439254|459745530|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
127759157|NCT03439254|459745531|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
127759158|NCT03439254|459745532|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
127759159|NCT03439254|459745527|FG000|Double-blind Phase (18 Months)|Site closure|0|||
127759160|NCT03439254|459745528|FG001|Double-blind Phase (18 Months)|Site closure|0|||
127759161|NCT03439254|459745529|FG002|Double-blind Phase (18 Months)|Site closure|1|||
127759162|NCT03439254|459745530|FG003|Double-blind Phase (18 Months)|Site closure|0|||
127759163|NCT03439254|459745531|FG004|Double-blind Phase (18 Months)|Site closure|0|||
127759164|NCT03439254|459745532|FG005|Double-blind Phase (18 Months)|Site closure|0|||
127759165|NCT03439254|459745527|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
127759166|NCT03439254|459745528|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
127759167|NCT03439254|459745529|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
127759168|NCT03439254|459745530|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
127759169|NCT03439254|459745531|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
127759170|NCT03439254|459745532|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
127759171|NCT03439254|459745527|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
127759172|NCT03439254|459745528|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
127759173|NCT03439254|459745529|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
127759174|NCT03439254|459745530|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
127759175|NCT03439254|459745531|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
127759176|NCT03439254|459745532|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
127759177|NCT03439254|459745527|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
127759178|NCT03439254|459745528|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
127759179|NCT03439254|459745529|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
127759180|NCT03439254|459745530|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
127759181|NCT03439254|459745531|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
127759182|NCT03439254|459745532|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
127759183|NCT03439254|459745527|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
127759184|NCT03439254|459745528|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
127759185|NCT03439254|459745529|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
127759186|NCT03439254|459745530|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
127759187|NCT03439254|459745531|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
127759188|NCT03439254|459745532|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
127759189|NCT03439254|459745527|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
127759190|NCT03439254|459745528|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
127759191|NCT03439254|459745529|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
127759192|NCT03439254|459745530|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
127759193|NCT03439254|459745531|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
127759194|NCT03439254|459745532|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
127759195|NCT03439254|459745527|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
127759196|NCT03439254|459745528|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
127759197|NCT03439254|459745529|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
127759198|NCT03439254|459745530|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
127759199|NCT03439254|459745531|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
127759200|NCT03439254|459745532|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
127759201|NCT03439254|459745527|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
127759202|NCT03439254|459745528|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
127759203|NCT03439254|459745529|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
127759204|NCT03439254|459745530|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
127759205|NCT03439254|459745531|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
127759206|NCT03439254|459745532|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
127759207|NCT03439254|459745527|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
127759208|NCT03439254|459745528|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
127759209|NCT03439254|459745529|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
127759210|NCT03439254|459745530|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
127759211|NCT03439254|459745531|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
127759212|NCT03439254|459745532|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
127759213|NCT03439254|459745527|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
127759214|NCT03439254|459745528|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
127759215|NCT03439254|459745529|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
127759216|NCT03439254|459745530|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
127759217|NCT03439254|459745531|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
127759218|NCT03439254|459745532|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
127759219|NCT03439254|459745527|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
127759220|NCT03439254|459745528|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
127759221|NCT03439254|459745529|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
127759222|NCT03439254|459745530|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
127759223|NCT03439254|459745531|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
127759224|NCT03439254|459745532|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
127759225|NCT03439254|459745527|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
127759226|NCT03439254|459745528|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
127759227|NCT03439254|459745529|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
127759228|NCT03439254|459745530|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
127648159|NCT04791761|459333151|FG000|Overall Study|Protocol Violation|0|||
127759229|NCT03439254|459745531|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
127759230|NCT03439254|459745532|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
127759231|NCT03439254|459745527|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
127759232|NCT03439254|459745528|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
127759233|NCT03439254|459745529|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
127759234|NCT03439254|459745530|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
127759235|NCT03439254|459745531|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
127759236|NCT03439254|459745532|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
127759237|NCT02075476|459745534|FG000|Overall Study|Death|2|||
127759238|NCT02075476|459745535|FG001|Overall Study|Death|2|||
127759239|NCT02075476|459745534|FG000|Overall Study|Lost to Follow-up|1|||
127759240|NCT02075476|459745535|FG001|Overall Study|Lost to Follow-up|3|||
127759241|NCT02898077|459745541|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
127759242|NCT02898077|459745542|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
127759243|NCT02898077|459745541|FG000|Overall Study|Lost to Follow-up|4|||
127759244|NCT02898077|459745542|FG001|Overall Study|Lost to Follow-up|3|||
127759245|NCT02898077|459745541|FG000|Overall Study|Physician Decision|0|||
127759246|NCT02898077|459745542|FG001|Overall Study|Physician Decision|2|||
127759247|NCT02898077|459745541|FG000|Overall Study|Sponsor Decision|32|||
127759248|NCT02898077|459745542|FG001|Overall Study|Sponsor Decision|13|||
127759249|NCT02898077|459745541|FG000|Overall Study|Withdrawal by Subject|6|||
127759250|NCT02898077|459745542|FG001|Overall Study|Withdrawal by Subject|3|||
127759251|NCT02898077|459745541|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
127759252|NCT02898077|459745542|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
127759253|NCT02898077|459745541|FG000|Overall Study|Ended extension period|3|||
127759254|NCT02898077|459745542|FG001|Overall Study|Ended extension period|0|||
127759255|NCT00621777|459745543|FG000|Open Phase|Adverse Event|20|||
127759256|NCT00621777|459745544|FG001|Open Phase|Adverse Event|0|||
127759257|NCT00621777|459745543|FG000|Open Phase|Did not abstain during open phase|56|||
127759258|NCT00621777|459745544|FG001|Open Phase|Did not abstain during open phase|0|||
127759259|NCT00621777|459745543|FG000|Open Phase|Withdrawal by Subject|17|||
127759260|NCT00621777|459745544|FG001|Open Phase|Withdrawal by Subject|0|||
127759261|NCT00621777|459745543|FG000|Open Phase|administrative|13|||
127759262|NCT00621777|459745544|FG001|Open Phase|administrative|0|||
127759263|NCT00621777|459745543|FG000|Open Phase|Lost to Follow-up|10|||
127759264|NCT00621777|459745544|FG001|Open Phase|Lost to Follow-up|0|||
127759265|NCT00621777|459745543|FG000|Randomized Phase|Adverse Event|3|||
127759266|NCT00621777|459745544|FG001|Randomized Phase|Adverse Event|3|||
127759267|NCT00621777|459745543|FG000|Randomized Phase|Lost to Follow-up|3|||
127759268|NCT00621777|459745544|FG001|Randomized Phase|Lost to Follow-up|3|||
127759269|NCT00621777|459745543|FG000|Randomized Phase|Withdrawal by Subject|1|||
127759270|NCT00621777|459745544|FG001|Randomized Phase|Withdrawal by Subject|9|||
127759271|NCT00621777|459745543|FG000|Randomized Phase|administrative|0|||
127759272|NCT00621777|459745544|FG001|Randomized Phase|administrative|3|||
127759273|NCT00621777|459745543|FG000|Randomized Phase|Death|0|||
127759274|NCT00621777|459745544|FG001|Randomized Phase|Death|1|||
127759275|NCT01239043|459745545|FG000|Overall Study|Protocol Violation|2|||
127759276|NCT01239043|459745546|FG001|Overall Study|Protocol Violation|1|||
127759277|NCT00436852|459745552|FG000|Overall Study|Death|23|||
127759278|NCT00436852|459745553|FG001|Overall Study|Death|34|||
127759279|NCT00436852|459745552|FG000|Overall Study|Lack of Efficacy|9|||
127759280|NCT00436852|459745553|FG001|Overall Study|Lack of Efficacy|7|||
127759281|NCT00436852|459745552|FG000|Overall Study|Withdrawal by Subject|2|||
127759282|NCT00436852|459745553|FG001|Overall Study|Withdrawal by Subject|4|||
127759283|NCT00436852|459745552|FG000|Overall Study|Ineligible|1|||
127759284|NCT00436852|459745553|FG001|Overall Study|Ineligible|0|||
127759285|NCT02141620|459745554|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
127759286|NCT02141620|459745555|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
127759287|NCT00307684|459745556|FG000|Open Label Phase|Lack of Efficacy|0|||
127759288|NCT00307684|459745557|FG001|Open Label Phase|Lack of Efficacy|0|||
127759289|NCT00307684|459745558|FG002|Open Label Phase|Lack of Efficacy|3|||
127759290|NCT00307684|459745556|FG000|Open Label Phase|Adverse Event|0|||
127759291|NCT00307684|459745557|FG001|Open Label Phase|Adverse Event|0|||
127759292|NCT00307684|459745558|FG002|Open Label Phase|Adverse Event|16|||
127759293|NCT00307684|459745556|FG000|Open Label Phase|Withdrawal by Subject|0|||
127759294|NCT00307684|459745557|FG001|Open Label Phase|Withdrawal by Subject|0|||
127759295|NCT00307684|459745558|FG002|Open Label Phase|Withdrawal by Subject|15|||
127759296|NCT00307684|459745556|FG000|Open Label Phase|Lost to Follow-up|0|||
127759297|NCT00307684|459745557|FG001|Open Label Phase|Lost to Follow-up|0|||
127759298|NCT00307684|459745558|FG002|Open Label Phase|Lost to Follow-up|11|||
127759299|NCT00307684|459745556|FG000|Open Label Phase|non compliance|0|||
127759300|NCT00307684|459745557|FG001|Open Label Phase|non compliance|0|||
127759301|NCT00307684|459745558|FG002|Open Label Phase|non compliance|5|||
127759302|NCT00307684|459745556|FG000|Open Label Phase|other|0|||
127759303|NCT00307684|459745557|FG001|Open Label Phase|other|0|||
127759304|NCT00307684|459745558|FG002|Open Label Phase|other|6|||
127759305|NCT00307684|459745556|FG000|Double Blind Phase|Lack of Efficacy|2|||
127759306|NCT00307684|459745557|FG001|Double Blind Phase|Lack of Efficacy|5|||
127759307|NCT00307684|459745558|FG002|Double Blind Phase|Lack of Efficacy|0|||
127759308|NCT03377699|459745562|FG000|Overall Study|Withdrawal by Subject|2|||
127759309|NCT03377699|459745563|FG001|Overall Study|Withdrawal by Subject|9|||
127759310|NCT03377699|459745562|FG000|Overall Study|Lost to Follow-up|1|||
127759311|NCT03377699|459745563|FG001|Overall Study|Lost to Follow-up|1|||
127759312|NCT03377699|459745562|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
127759313|NCT03377699|459745563|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
127759314|NCT03377699|459745562|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
127759315|NCT03377699|459745563|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
127759316|NCT03377699|459745562|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
127759317|NCT03377699|459745563|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
127759318|NCT03377699|459745562|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
127759319|NCT03377699|459745563|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
127759320|NCT02580305|459745564|FG000|Overall Study|Adverse Event|15|||
127759321|NCT02580305|459745565|FG001|Overall Study|Adverse Event|19|||
127759322|NCT02580305|459745566|FG002|Overall Study|Adverse Event|10|||
127759323|NCT02580305|459745564|FG000|Overall Study|Lack of Efficacy|5|||
127759324|NCT02580305|459745565|FG001|Overall Study|Lack of Efficacy|0|||
127759325|NCT02580305|459745566|FG002|Overall Study|Lack of Efficacy|2|||
127759326|NCT02580305|459745564|FG000|Overall Study|Protocol Violation|4|||
127759327|NCT02580305|459745565|FG001|Overall Study|Protocol Violation|9|||
127759328|NCT02580305|459745566|FG002|Overall Study|Protocol Violation|6|||
127759329|NCT02580305|459745564|FG000|Overall Study|Lost to Follow-up|4|||
127759330|NCT02580305|459745565|FG001|Overall Study|Lost to Follow-up|4|||
127759331|NCT02580305|459745566|FG002|Overall Study|Lost to Follow-up|2|||
127759332|NCT02580305|459745564|FG000|Overall Study|Withdrawal by Subject|11|||
127759333|NCT02580305|459745565|FG001|Overall Study|Withdrawal by Subject|9|||
127759334|NCT02580305|459745566|FG002|Overall Study|Withdrawal by Subject|7|||
127759335|NCT02580305|459745564|FG000|Overall Study|Randomized in error and never treated|4|||
127759336|NCT02580305|459745565|FG001|Overall Study|Randomized in error and never treated|8|||
127759337|NCT02580305|459745566|FG002|Overall Study|Randomized in error and never treated|5|||
127759338|NCT00224887|459745567|FG000|Overall Study|Pregnancy|6|||
127759339|NCT00224887|459745568|FG001|Overall Study|Pregnancy|6|||
127759340|NCT00798590|459745571|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
127759341|NCT00798590|459745572|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
127759342|NCT01163292|459745578|FG000|Overall Study|Lack of Efficacy|9|||
127759343|NCT01163292|459745579|FG001|Overall Study|Lack of Efficacy|0|||
127759344|NCT01163292|459745578|FG000|Overall Study|Adverse Event|6|||
127759345|NCT01163292|459745579|FG001|Overall Study|Adverse Event|0|||
127759346|NCT01163292|459745578|FG000|Overall Study|Initiation of biological therapy|0|||
127759347|NCT01163292|459745579|FG001|Overall Study|Initiation of biological therapy|15|||
127759348|NCT01163292|459745578|FG000|Overall Study|Sufficient response to adalimumab|8|||
127759349|NCT01163292|459745579|FG001|Overall Study|Sufficient response to adalimumab|0|||
127759350|NCT01163292|459745578|FG000|Overall Study|Refusal to receive adalimumab|7|||
127759351|NCT01163292|459745579|FG001|Overall Study|Refusal to receive adalimumab|0|||
127759352|NCT01163292|459745578|FG000|Overall Study|Economic reasons|6|||
127759353|NCT01163292|459745579|FG001|Overall Study|Economic reasons|0|||
127759354|NCT01163292|459745578|FG000|Overall Study|No further visits|5|||
127759355|NCT01163292|459745579|FG001|Overall Study|No further visits|7|||
127759356|NCT03223662|459745580|FG000|Overall Study|Physician Decision|1|||
127536449|NCT02520726|458927812|FG001|Overall Study|Lost to Follow-up|2|||
127536450|NCT00721396|458927813|FG000|Overall Study|Adverse Event|4|||
127536451|NCT00721396|458927814|FG001|Overall Study|Adverse Event|7|||
127536452|NCT00721396|458927815|FG002|Overall Study|Adverse Event|2|||
127536453|NCT00721396|458927816|FG003|Overall Study|Adverse Event|0|||
127536454|NCT00721396|458927813|FG000|Overall Study|Withdrawal by Subject|12|||
127536455|NCT00721396|458927814|FG001|Overall Study|Withdrawal by Subject|15|||
127536456|NCT00721396|458927815|FG002|Overall Study|Withdrawal by Subject|3|||
127536457|NCT00721396|458927816|FG003|Overall Study|Withdrawal by Subject|7|||
127536458|NCT00721396|458927813|FG000|Overall Study|Lost to Follow-up|7|||
127536459|NCT00721396|458927814|FG001|Overall Study|Lost to Follow-up|9|||
127536460|NCT00721396|458927815|FG002|Overall Study|Lost to Follow-up|3|||
127536461|NCT00721396|458927816|FG003|Overall Study|Lost to Follow-up|3|||
127536462|NCT00721396|458927813|FG000|Overall Study|Protocol Violation|4|||
127536463|NCT00721396|458927814|FG001|Overall Study|Protocol Violation|3|||
127536464|NCT00721396|458927815|FG002|Overall Study|Protocol Violation|1|||
127536465|NCT00721396|458927816|FG003|Overall Study|Protocol Violation|0|||
127536466|NCT00721396|458927813|FG000|Overall Study|Inappropriate enrollment|0|||
127536467|NCT00721396|458927814|FG001|Overall Study|Inappropriate enrollment|2|||
127536468|NCT00721396|458927815|FG002|Overall Study|Inappropriate enrollment|0|||
127536469|NCT00721396|458927816|FG003|Overall Study|Inappropriate enrollment|0|||
127536470|NCT00721396|458927813|FG000|Overall Study|Administrative reason|3|||
127536471|NCT00721396|458927814|FG001|Overall Study|Administrative reason|0|||
127536472|NCT00721396|458927815|FG002|Overall Study|Administrative reason|1|||
127536473|NCT00721396|458927816|FG003|Overall Study|Administrative reason|0|||
127536474|NCT03546621|458927817|FG000|Overall Study|Withdrawal by Subject|0|||
127536475|NCT03546621|458927818|FG001|Overall Study|Withdrawal by Subject|1|||
127536476|NCT03546621|458927819|FG002|Overall Study|Withdrawal by Subject|2|||
127536477|NCT03546621|458927820|FG003|Overall Study|Withdrawal by Subject|1|||
127536478|NCT03546621|458927817|FG000|Overall Study|Lost to Follow-up|0|||
127536479|NCT03546621|458927818|FG001|Overall Study|Lost to Follow-up|1|||
127536480|NCT03546621|458927819|FG002|Overall Study|Lost to Follow-up|0|||
127536481|NCT03546621|458927820|FG003|Overall Study|Lost to Follow-up|0|||
127536482|NCT03546621|458927817|FG000|Overall Study|Adverse Event|0|||
127536483|NCT03546621|458927818|FG001|Overall Study|Adverse Event|1|||
127536484|NCT03546621|458927819|FG002|Overall Study|Adverse Event|0|||
127536485|NCT03546621|458927820|FG003|Overall Study|Adverse Event|1|||
127536486|NCT03546621|458927817|FG000|Overall Study|Progressive disease|0|||
127536487|NCT03546621|458927818|FG001|Overall Study|Progressive disease|0|||
127536488|NCT03546621|458927819|FG002|Overall Study|Progressive disease|0|||
127536489|NCT03546621|458927820|FG003|Overall Study|Progressive disease|1|||
127536490|NCT02021565|458927827|FG000|Baseline Through Intervention|Death|0|||
127536491|NCT02021565|458927828|FG001|Baseline Through Intervention|Death|1|||
127536492|NCT02021565|458927827|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
127536493|NCT02021565|458927828|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
127536494|NCT02021565|458927827|FG000|Baseline Through Intervention|Protocol Violation|0|||
127536495|NCT02021565|458927828|FG001|Baseline Through Intervention|Protocol Violation|7|||
127536496|NCT02021565|458927827|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
127536497|NCT02021565|458927828|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
127536498|NCT02021565|458927827|FG000|3-month Follow-up|Death|3|||
127536499|NCT02021565|458927828|FG001|3-month Follow-up|Death|0|||
127536500|NCT02021565|458927827|FG000|3-month Follow-up|Withdrawal by Subject|4|||
127536501|NCT02021565|458927828|FG001|3-month Follow-up|Withdrawal by Subject|0|||
127536502|NCT02021565|458927827|FG000|3-month Follow-up|Protocol Violation|3|||
127536503|NCT02021565|458927828|FG001|3-month Follow-up|Protocol Violation|2|||
127536504|NCT03318549|458927829|FG000|Overall Study|Withdrawal by Subject|5|||
127536505|NCT03318549|458927830|FG001|Overall Study|Withdrawal by Subject|19|||
127536506|NCT03318549|458927831|FG002|Overall Study|Withdrawal by Subject|2|||
127536507|NCT03318549|458927832|FG003|Overall Study|Withdrawal by Subject|0|||
127536508|NCT03318549|458927833|FG004|Overall Study|Withdrawal by Subject|0|||
127536509|NCT03318549|458927834|FG005|Overall Study|Withdrawal by Subject|0|||
127536510|NCT03318549|458927835|FG006|Overall Study|Withdrawal by Subject|0|||
127536511|NCT03318549|458927829|FG000|Overall Study|Physician Decision|0|||
127536512|NCT03318549|458927830|FG001|Overall Study|Physician Decision|4|||
127536513|NCT03318549|458927831|FG002|Overall Study|Physician Decision|1|||
127536514|NCT03318549|458927832|FG003|Overall Study|Physician Decision|0|||
127536515|NCT03318549|458927833|FG004|Overall Study|Physician Decision|0|||
127536516|NCT03318549|458927834|FG005|Overall Study|Physician Decision|0|||
127536517|NCT03318549|458927835|FG006|Overall Study|Physician Decision|0|||
127536518|NCT03318549|458927829|FG000|Overall Study|Lost to Follow-up|0|||
127536519|NCT03318549|458927830|FG001|Overall Study|Lost to Follow-up|3|||
127536520|NCT03318549|458927831|FG002|Overall Study|Lost to Follow-up|3|||
127536521|NCT03318549|458927832|FG003|Overall Study|Lost to Follow-up|0|||
127536522|NCT03318549|458927833|FG004|Overall Study|Lost to Follow-up|0|||
127536523|NCT03318549|458927834|FG005|Overall Study|Lost to Follow-up|0|||
127536524|NCT03318549|458927835|FG006|Overall Study|Lost to Follow-up|0|||
127536525|NCT00510835|458927838|FG000|Overall Study|Withdrawal by Subject|6|||
127536526|NCT00510835|458927839|FG001|Overall Study|Withdrawal by Subject|2|||
127536527|NCT00510835|458927840|FG002|Overall Study|Withdrawal by Subject|2|||
127536528|NCT00607087|458927844|FG000|Overall Study|Withdrawal by Subject|9|||
127536529|NCT00607087|458927845|FG001|Overall Study|Withdrawal by Subject|4|||
127536530|NCT00607087|458927846|FG002|Overall Study|Withdrawal by Subject|4|||
127536531|NCT00607087|458927844|FG000|Overall Study|Adverse Event|3|||
127536532|NCT00607087|458927845|FG001|Overall Study|Adverse Event|2|||
127536533|NCT00607087|458927846|FG002|Overall Study|Adverse Event|3|||
127536534|NCT00607087|458927844|FG000|Overall Study|Other reason|1|||
127536535|NCT00607087|458927845|FG001|Overall Study|Other reason|5|||
127536536|NCT00607087|458927846|FG002|Overall Study|Other reason|2|||
127536537|NCT00607087|458927844|FG000|Overall Study|Poor compliance to protocol|1|||
127536538|NCT00607087|458927845|FG001|Overall Study|Poor compliance to protocol|0|||
127536539|NCT00607087|458927846|FG002|Overall Study|Poor compliance to protocol|1|||
127536540|NCT00607087|458927844|FG000|Overall Study|Lost to Follow-up|1|||
127536541|NCT00607087|458927845|FG001|Overall Study|Lost to Follow-up|0|||
127536542|NCT00607087|458927846|FG002|Overall Study|Lost to Follow-up|0|||
127536543|NCT00607087|458927844|FG000|Period 1|Withdrawal by Subject|7|||
127536544|NCT00607087|458927845|FG001|Period 1|Withdrawal by Subject|2|||
127536545|NCT00607087|458927846|FG002|Period 1|Withdrawal by Subject|3|||
127536546|NCT00607087|458927844|FG000|Period 1|Adverse Event|3|||
127536547|NCT00607087|458927845|FG001|Period 1|Adverse Event|0|||
127536548|NCT00607087|458927846|FG002|Period 1|Adverse Event|0|||
127536549|NCT00607087|458927844|FG000|Period 1|Poor compliance to protocol|1|||
127536550|NCT00607087|458927845|FG001|Period 1|Poor compliance to protocol|0|||
127536551|NCT00607087|458927846|FG002|Period 1|Poor compliance to protocol|0|||
127536552|NCT00607087|458927844|FG000|Period 1|Lost to Follow-up|1|||
127536553|NCT00607087|458927845|FG001|Period 1|Lost to Follow-up|0|||
127536554|NCT00607087|458927846|FG002|Period 1|Lost to Follow-up|0|||
127536555|NCT00607087|458927844|FG000|Period 1|Other reason|0|||
127536556|NCT00607087|458927845|FG001|Period 1|Other reason|4|||
127536557|NCT00607087|458927846|FG002|Period 1|Other reason|2|||
127536558|NCT00607087|458927844|FG000|Period 2|Withdrawal by Subject|0|||
127536559|NCT00607087|458927845|FG001|Period 2|Withdrawal by Subject|1|||
127648160|NCT04791761|459333152|FG001|Overall Study|Protocol Violation|1|||
127648161|NCT04791761|459333153|FG002|Overall Study|Protocol Violation|1|||
127536560|NCT00607087|458927846|FG002|Period 2|Withdrawal by Subject|1|||
127536561|NCT00607087|458927844|FG000|Period 2|Other reason|1|||
127536562|NCT00607087|458927845|FG001|Period 2|Other reason|1|||
127536563|NCT00607087|458927846|FG002|Period 2|Other reason|0|||
127536564|NCT00607087|458927844|FG000|Period 2|Adverse Event|0|||
127536565|NCT00607087|458927845|FG001|Period 2|Adverse Event|1|||
127536566|NCT00607087|458927846|FG002|Period 2|Adverse Event|3|||
127536567|NCT00607087|458927844|FG000|Period 2|Poor compliance to protocol|0|||
127536568|NCT00607087|458927845|FG001|Period 2|Poor compliance to protocol|0|||
127536569|NCT00607087|458927846|FG002|Period 2|Poor compliance to protocol|1|||
127536570|NCT00607087|458927844|FG000|Period 3|Withdrawal by Subject|2|||
127536571|NCT00607087|458927845|FG001|Period 3|Withdrawal by Subject|1|||
127536572|NCT00607087|458927846|FG002|Period 3|Withdrawal by Subject|0|||
127536573|NCT00607087|458927844|FG000|Period 3|Adverse Event|0|||
127536574|NCT00607087|458927845|FG001|Period 3|Adverse Event|1|||
127536575|NCT00607087|458927846|FG002|Period 3|Adverse Event|0|||
127536576|NCT00650767|458927847|FG000|Overall Study|Adverse Event|0|||
127536577|NCT00650767|458927848|FG001|Overall Study|Adverse Event|3|||
127536578|NCT00650767|458927849|FG002|Overall Study|Adverse Event|10|||
127536579|NCT00650767|458927850|FG003|Overall Study|Adverse Event|8|||
127536580|NCT00650767|458927847|FG000|Overall Study|Death|1|||
127536581|NCT00650767|458927848|FG001|Overall Study|Death|0|||
127536582|NCT00650767|458927849|FG002|Overall Study|Death|0|||
127536583|NCT00650767|458927850|FG003|Overall Study|Death|0|||
127536584|NCT00650767|458927847|FG000|Overall Study|Withdrawal by Subject|2|||
127536585|NCT00650767|458927848|FG001|Overall Study|Withdrawal by Subject|4|||
127536586|NCT00650767|458927849|FG002|Overall Study|Withdrawal by Subject|3|||
127536587|NCT00650767|458927850|FG003|Overall Study|Withdrawal by Subject|3|||
127536588|NCT00650767|458927847|FG000|Overall Study|Lost to Follow-up|1|||
127536589|NCT00650767|458927848|FG001|Overall Study|Lost to Follow-up|1|||
127536590|NCT00650767|458927849|FG002|Overall Study|Lost to Follow-up|1|||
127536591|NCT00650767|458927850|FG003|Overall Study|Lost to Follow-up|0|||
127536592|NCT00650767|458927847|FG000|Overall Study|Other|1|||
127536593|NCT00650767|458927848|FG001|Overall Study|Other|1|||
127536594|NCT00650767|458927849|FG002|Overall Study|Other|0|||
127536595|NCT00650767|458927850|FG003|Overall Study|Other|0|||
127536596|NCT01774799|458927851|FG000|Overall Study|Lost to Follow-up|1|||
127536597|NCT01774799|458927852|FG001|Overall Study|Lost to Follow-up|1|||
127536598|NCT01774799|458927853|FG002|Overall Study|Lost to Follow-up|0|||
127536599|NCT01774799|458927854|FG003|Overall Study|Lost to Follow-up|0|||
127536600|NCT02586623|458927855|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
127536601|NCT02586623|458927856|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
127536602|NCT02586623|458927857|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
127536603|NCT02586623|458927855|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
127536604|NCT02586623|458927856|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
127536605|NCT02586623|458927857|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
127536606|NCT02586623|458927855|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
127536607|NCT02586623|458927856|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
127536608|NCT02586623|458927857|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
127536609|NCT02586623|458927855|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
127536610|NCT02586623|458927856|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
127536611|NCT02586623|458927857|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
127536612|NCT02586623|458927855|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
127536613|NCT02586623|458927856|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
127536614|NCT02586623|458927857|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
127536615|NCT02586623|458927855|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
127536616|NCT02586623|458927856|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
127536617|NCT02586623|458927857|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
127536618|NCT02586623|458927855|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
127536619|NCT02586623|458927856|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
127536620|NCT02586623|458927857|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
127536621|NCT02586623|458927855|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
127536622|NCT02586623|458927856|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
127536623|NCT02586623|458927857|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
127536624|NCT02586623|458927855|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
127536625|NCT02586623|458927856|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
127536626|NCT02586623|458927857|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
127536627|NCT02586623|458927855|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
127536628|NCT02586623|458927856|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
127536629|NCT02586623|458927857|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
127536630|NCT02586623|458927855|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
127536631|NCT02586623|458927856|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
127536632|NCT02586623|458927857|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
127536633|NCT02586623|458927855|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
127536634|NCT02586623|458927856|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
127536635|NCT02586623|458927857|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
127536636|NCT02586623|458927855|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
127536637|NCT02586623|458927856|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
127536638|NCT02586623|458927857|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
127536639|NCT02586623|458927855|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
127536640|NCT02586623|458927856|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
127536641|NCT02586623|458927857|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
127536642|NCT02586623|458927855|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
127536643|NCT02586623|458927856|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
127536644|NCT02586623|458927857|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
127536645|NCT02586623|458927855|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
127536646|NCT02586623|458927856|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
127536647|NCT02586623|458927857|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
127536648|NCT02586623|458927855|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
127536649|NCT02586623|458927856|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
127648162|NCT01756352|459333154|FG000|Overall Study|moved away and lost to followup|1|||
127648163|NCT03315143|459333155|FG000|Overall Study|Death|240|||
127648164|NCT03315143|459333156|FG001|Overall Study|Death|246|||
127648165|NCT03315143|459333155|FG000|Overall Study|Withdrawal by Subject|57|||
127648166|NCT03315143|459333156|FG001|Overall Study|Withdrawal by Subject|68|||
127648167|NCT03315143|459333155|FG000|Overall Study|Site Terminated by Sponsor|256|||
127648168|NCT03315143|459333156|FG001|Overall Study|Site Terminated by Sponsor|282|||
127648169|NCT03315143|459333155|FG000|Overall Study|Study Terminated by Sponsor|4723|||
127648170|NCT03315143|459333156|FG001|Overall Study|Study Terminated by Sponsor|4664|||
127648171|NCT03315143|459333155|FG000|Overall Study|Reason not Specified|16|||
127648172|NCT03315143|459333156|FG001|Overall Study|Reason not Specified|32|||
127648173|NCT00549757|459333157|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
127648174|NCT00549757|459333158|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
127648175|NCT00549757|459333157|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
127648176|NCT00549757|459333158|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
127648177|NCT00549757|459333157|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
127648178|NCT00549757|459333158|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
127648179|NCT00549757|459333157|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
127648180|NCT00549757|459333158|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
127648181|NCT00549757|459333157|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
127648182|NCT00549757|459333158|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
127648183|NCT00549757|459333157|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
127648184|NCT00549757|459333158|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
127648185|NCT00549757|459333157|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
127648186|NCT00549757|459333158|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
127648187|NCT00549757|459333157|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
127648188|NCT00549757|459333158|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
127648189|NCT00549757|459333157|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
127648190|NCT00549757|459333158|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
127648191|NCT00549757|459333157|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
127648192|NCT00549757|459333158|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
127648193|NCT00549757|459333157|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
127648194|NCT00549757|459333158|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
127648195|NCT00549757|459333157|FG000|Extension Period (in Average 9 Months)|Death|143|||
127648196|NCT00549757|459333158|FG001|Extension Period (in Average 9 Months)|Death|136|||
127648197|NCT00549757|459333157|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
127648198|NCT00549757|459333158|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
127648199|NCT00549757|459333157|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
127648200|NCT00549757|459333158|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
127648201|NCT00549757|459333157|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
127648202|NCT00549757|459333158|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
127648203|NCT00293267|459333159|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
127648204|NCT00293267|459333160|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
127648205|NCT00293267|459333159|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
127648206|NCT00293267|459333160|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
127648207|NCT00293267|459333159|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
127648208|NCT00293267|459333160|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
127648209|NCT00293267|459333159|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
127648210|NCT00293267|459333160|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
127648211|NCT00293267|459333159|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
127536650|NCT02586623|458927857|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
127759357|NCT03223662|459745580|FG000|Overall Study|Study closure|1|||
127759358|NCT02217475|459745581|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
127798469|NCT01789970|459885614|FG001|Open-label Titration Period|Protocol Violation|0|||
127536651|NCT02586623|458927855|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
127536652|NCT02586623|458927856|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
127536653|NCT02586623|458927857|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
127536654|NCT02586623|458927855|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
127536655|NCT02586623|458927856|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
127536656|NCT02586623|458927857|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
127536657|NCT02586623|458927855|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
127536658|NCT02586623|458927856|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
127536659|NCT02586623|458927857|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
127536660|NCT02586623|458927855|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
127536661|NCT02586623|458927856|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
127536662|NCT02586623|458927857|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
127536663|NCT00871871|458927860|FG000|Part I|Adverse Event|0|||
127536664|NCT00871871|458927861|FG001|Part I|Adverse Event|2|||
127536665|NCT00871871|458927862|FG002|Part I|Adverse Event|0|||
127536666|NCT00871871|458927863|FG003|Part I|Adverse Event|0|||
127536667|NCT00871871|458927860|FG000|Part I|Withdrawal by Subject|3|||
127536668|NCT00871871|458927861|FG001|Part I|Withdrawal by Subject|0|||
127536669|NCT00871871|458927862|FG002|Part I|Withdrawal by Subject|0|||
127536670|NCT00871871|458927863|FG003|Part I|Withdrawal by Subject|0|||
127536671|NCT00871871|458927860|FG000|Part I|Laboratory abnormality|0|||
127536672|NCT00871871|458927861|FG001|Part I|Laboratory abnormality|1|||
127536673|NCT00871871|458927862|FG002|Part I|Laboratory abnormality|0|||
127536674|NCT00871871|458927863|FG003|Part I|Laboratory abnormality|0|||
127536675|NCT00871871|458927860|FG000|Part II|Lack of Efficacy|0|||
127536676|NCT00871871|458927861|FG001|Part II|Lack of Efficacy|0|||
127536677|NCT00871871|458927862|FG002|Part II|Lack of Efficacy|1|||
127536678|NCT00871871|458927863|FG003|Part II|Lack of Efficacy|0|||
127536679|NCT00871871|458927860|FG000|Part II|Withdrawal by Subject|0|||
127536680|NCT00871871|458927861|FG001|Part II|Withdrawal by Subject|0|||
127536681|NCT00871871|458927862|FG002|Part II|Withdrawal by Subject|2|||
127536682|NCT00871871|458927863|FG003|Part II|Withdrawal by Subject|1|||
127536683|NCT00871871|458927860|FG000|Part II|Adverse Event|0|||
127536684|NCT00871871|458927861|FG001|Part II|Adverse Event|0|||
127536685|NCT00871871|458927862|FG002|Part II|Adverse Event|1|||
127536686|NCT00871871|458927863|FG003|Part II|Adverse Event|2|||
127536687|NCT00871871|458927860|FG000|Part II|Protocol Violation|0|||
127536688|NCT00871871|458927861|FG001|Part II|Protocol Violation|0|||
127536689|NCT00871871|458927862|FG002|Part II|Protocol Violation|0|||
127536690|NCT00871871|458927863|FG003|Part II|Protocol Violation|1|||
127536691|NCT03064490|458927869|FG000|Overall Study|Physician Decision|5|||
127536692|NCT04233801|458929916|FG000|Overall Study|Other than listed|0|||
127536693|NCT04233801|458929917|FG001|Overall Study|Other than listed|0|||
127536694|NCT04233801|458929918|FG002|Overall Study|Other than listed|1|||
127536695|NCT04233801|458929916|FG000|Overall Study|Withdrawal by Subject|0|||
127536696|NCT04233801|458929917|FG001|Overall Study|Withdrawal by Subject|2|||
127536697|NCT04233801|458929918|FG002|Overall Study|Withdrawal by Subject|3|||
127536698|NCT00928486|458929919|FG000|Overall Study|Adverse Event|2|||
127536699|NCT00928486|458929919|FG000|Overall Study|Disease Progression|7|||
127536700|NCT00928486|458929919|FG000|Overall Study|Withdrawal by Subject|1|||
127536701|NCT01342913|458929920|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
127536702|NCT01342913|458929921|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
127536703|NCT01342913|458929922|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
127536704|NCT01342913|458929920|FG000|2-week Run-in Period|Physician Decision|6|||
127536705|NCT01342913|458929921|FG001|2-week Run-in Period|Physician Decision|0|||
127536706|NCT01342913|458929922|FG002|2-week Run-in Period|Physician Decision|0|||
127536707|NCT01342913|458929920|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
127536708|NCT01342913|458929921|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
127536709|NCT01342913|458929922|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
127536710|NCT01342913|458929920|FG000|2-week Run-in Period|Adverse Event|2|||
127536711|NCT01342913|458929921|FG001|2-week Run-in Period|Adverse Event|0|||
127536712|NCT01342913|458929922|FG002|2-week Run-in Period|Adverse Event|0|||
127536713|NCT01342913|458929920|FG000|2-week Run-in Period|Protocol Violation|5|||
127536714|NCT01342913|458929921|FG001|2-week Run-in Period|Protocol Violation|0|||
127536715|NCT01342913|458929922|FG002|2-week Run-in Period|Protocol Violation|0|||
127536716|NCT01342913|458929920|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
127536717|NCT01342913|458929921|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
127536718|NCT01342913|458929922|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
127536719|NCT01342913|458929920|FG000|Double-Blind Treatment Period|Adverse Event|0|||
127536720|NCT01342913|458929921|FG001|Double-Blind Treatment Period|Adverse Event|3|||
127536721|NCT01342913|458929922|FG002|Double-Blind Treatment Period|Adverse Event|6|||
127642266|NCT03252587|459310079|FG001|Overall Study|Adverse Event|8|||
127536722|NCT01342913|458929920|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
127536723|NCT01342913|458929921|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
127536724|NCT01342913|458929922|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
127536725|NCT01342913|458929920|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
127536726|NCT01342913|458929921|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
127536727|NCT01342913|458929922|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
127536728|NCT01342913|458929920|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
127536729|NCT01342913|458929921|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
127536730|NCT01342913|458929922|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
127536731|NCT01342913|458929920|FG000|Double-Blind Treatment Period|Physician Decision|0|||
127536732|NCT01342913|458929921|FG001|Double-Blind Treatment Period|Physician Decision|2|||
127536733|NCT01342913|458929922|FG002|Double-Blind Treatment Period|Physician Decision|0|||
127536734|NCT01342913|458929920|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
127536735|NCT01342913|458929921|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
127536736|NCT01342913|458929922|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
127536737|NCT04024891|458929923|FG000|Overall Study|Pregnancy|0|||
127536738|NCT04024891|458929924|FG001|Overall Study|Pregnancy|1|||
127536739|NCT01474317|458929926|FG000|Overall Study|Adverse Event|1|||
127536740|NCT01474317|458929926|FG000|Overall Study|Subject ineligible for study|1|||
127536741|NCT02152631|458929929|FG000|Overall Study|Adverse Event|32|||
127536742|NCT02152631|458929930|FG001|Overall Study|Adverse Event|4|||
127536743|NCT02152631|458929929|FG000|Overall Study|Withdrawal by Subject|13|||
127536744|NCT02152631|458929930|FG001|Overall Study|Withdrawal by Subject|16|||
127536745|NCT02152631|458929929|FG000|Overall Study|Noncompliance with study drug|1|||
127536746|NCT02152631|458929930|FG001|Overall Study|Noncompliance with study drug|0|||
127536747|NCT02152631|458929929|FG000|Overall Study|Physician Decision|1|||
127536748|NCT02152631|458929930|FG001|Overall Study|Physician Decision|2|||
127536749|NCT02152631|458929929|FG000|Overall Study|Lost to Follow-up|0|||
127536750|NCT02152631|458929930|FG001|Overall Study|Lost to Follow-up|1|||
127536751|NCT02152631|458929929|FG000|Overall Study|On Treatment|19|||
127536752|NCT02152631|458929930|FG001|Overall Study|On Treatment|3|||
127536753|NCT05473026|458929931|FG000|Overall Study|Lost to Follow-up|5|||
127536754|NCT05473026|458929932|FG001|Overall Study|Lost to Follow-up|2|||
127536755|NCT03683173|458929943|FG000|Completed Follow-up|Unavailable|235|||
127536756|NCT03683173|458929944|FG001|Completed Follow-up|Unavailable|217|||
127536757|NCT03683173|458929943|FG000|Completed Follow-up|Refused|69|||
127536758|NCT03683173|458929944|FG001|Completed Follow-up|Refused|59|||
127536759|NCT03683173|458929943|FG000|Completed Follow-up|Disconnected phone|65|||
127536760|NCT03683173|458929944|FG001|Completed Follow-up|Disconnected phone|95|||
127536761|NCT03683173|458929943|FG000|Completed Follow-up|Health issue/deceased|10|||
127536762|NCT03683173|458929944|FG001|Completed Follow-up|Health issue/deceased|4|||
127536763|NCT03683173|458929943|FG000|Completed Follow-up|Moved away|8|||
127536764|NCT03683173|458929944|FG001|Completed Follow-up|Moved away|1|||
127536765|NCT02647281|458929945|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
127536766|NCT02647281|458929946|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
127536767|NCT02647281|458929947|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
127536768|NCT02647281|458929948|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
127536769|NCT02647281|458929949|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
127536770|NCT02647281|458929950|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
127536771|NCT02647281|458929951|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
127536772|NCT02647281|458929952|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
127536773|NCT02647281|458929953|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
127536774|NCT05801991|458929954|FG000|Overall Study|Lost to Follow-up|1|||
127536775|NCT05801991|458929955|FG001|Overall Study|Lost to Follow-up|0|||
127536776|NCT02210000|458929956|FG000|Overall Study|Study Terminated|11|||
127536777|NCT02210000|458929957|FG001|Overall Study|Study Terminated|12|||
127536778|NCT02210000|458929956|FG000|Overall Study|Withdrawal by Subject|7|||
127536779|NCT02210000|458929957|FG001|Overall Study|Withdrawal by Subject|1|||
127536780|NCT02210000|458929956|FG000|Overall Study|Adverse Event|1|||
127536781|NCT02210000|458929957|FG001|Overall Study|Adverse Event|5|||
127536782|NCT02210000|458929956|FG000|Overall Study|Lost to Follow-up|0|||
127536783|NCT02210000|458929957|FG001|Overall Study|Lost to Follow-up|2|||
127536784|NCT02210000|458929956|FG000|Overall Study|Physician Decision|0|||
127536785|NCT02210000|458929957|FG001|Overall Study|Physician Decision|1|||
127536786|NCT01329263|458929960|FG000|Overall Study|Lost to Follow-up|4|||
127536787|NCT01329263|458929961|FG001|Overall Study|Lost to Follow-up|21|||
127536788|NCT01329263|458929960|FG000|Overall Study|Withdrawal by Subject|1|||
127536789|NCT01329263|458929961|FG001|Overall Study|Withdrawal by Subject|2|||
127536790|NCT01421017|458929963|FG000|Overall Study|Withdrawal by Subject|2|||
127536791|NCT01421017|458929964|FG001|Overall Study|Withdrawal by Subject|0|||
127536792|NCT01421017|458929965|FG002|Overall Study|Withdrawal by Subject|0|||
127536793|NCT01421017|458929963|FG000|Overall Study|POD|0|||
127536794|NCT01421017|458929964|FG001|Overall Study|POD|6|||
127536795|NCT01421017|458929965|FG002|Overall Study|POD|3|||
127536796|NCT00308139|458929966|FG000|Overall Study|Adverse Event|20|||
127536797|NCT00308139|458929967|FG001|Overall Study|Adverse Event|14|||
127536798|NCT00308139|458929966|FG000|Overall Study|Lost to Follow-up|13|||
127536799|NCT00308139|458929967|FG001|Overall Study|Lost to Follow-up|8|||
127536800|NCT00308139|458929966|FG000|Overall Study|Protocol Violation|3|||
127536801|NCT00308139|458929967|FG001|Overall Study|Protocol Violation|2|||
127536802|NCT00308139|458929966|FG000|Overall Study|Withdrawal of Consent|40|||
127536803|NCT00308139|458929967|FG001|Overall Study|Withdrawal of Consent|42|||
127536804|NCT00308139|458929966|FG000|Overall Study|Investigator Decision|11|||
127536805|NCT00308139|458929967|FG001|Overall Study|Investigator Decision|10|||
127536806|NCT00308139|458929966|FG000|Overall Study|Loss of Glucose Control|5|||
127536807|NCT00308139|458929967|FG001|Overall Study|Loss of Glucose Control|7|||
127536808|NCT00308139|458929966|FG000|Overall Study|Administrative|1|||
127536809|NCT00308139|458929967|FG001|Overall Study|Administrative|4|||
127536810|NCT00308139|458929966|FG000|Overall Study|Other|1|||
127536811|NCT00308139|458929967|FG001|Overall Study|Other|0|||
127536812|NCT00833040|458929970|FG000|Overall Study|Adverse Event|0|||
127536813|NCT00833040|458929971|FG001|Overall Study|Adverse Event|0|||
127536814|NCT00833040|458929972|FG002|Overall Study|Adverse Event|0|||
127536815|NCT00833040|458929973|FG003|Overall Study|Adverse Event|0|||
127536816|NCT00833040|458929974|FG004|Overall Study|Adverse Event|0|||
127536817|NCT00833040|458929975|FG005|Overall Study|Adverse Event|1|||
127536818|NCT02313766|458929976|FG000|Overall Study|surgery cancelled|1|||
127536819|NCT02313766|458929977|FG001|Overall Study|surgery cancelled|0|||
127536820|NCT02313766|458929978|FG002|Overall Study|surgery cancelled|0|||
127536821|NCT02313766|458929976|FG000|Overall Study|Lost to Follow-up|0|||
127536822|NCT02313766|458929977|FG001|Overall Study|Lost to Follow-up|2|||
127536823|NCT02313766|458929978|FG002|Overall Study|Lost to Follow-up|0|||
127536824|NCT02313766|458929976|FG000|Overall Study|Adverse Event|0|||
127536825|NCT02313766|458929977|FG001|Overall Study|Adverse Event|1|||
127536826|NCT02313766|458929978|FG002|Overall Study|Adverse Event|0|||
127536827|NCT03489863|458929979|FG000|Overall Study|Withdrawal by Subject|0|||
127536828|NCT03489863|458929980|FG001|Overall Study|Withdrawal by Subject|1|||
127536829|NCT02193776|458929982|FG000|Overall Study|Consent withdrawn|1|||
127536830|NCT02193776|458929983|FG001|Overall Study|Consent withdrawn|0|||
127536831|NCT02193776|458929984|FG002|Overall Study|Consent withdrawn|0|||
127536832|NCT02193776|458929985|FG003|Overall Study|Consent withdrawn|0|||
127536833|NCT02193776|458929982|FG000|Overall Study|Failure to comply with protocol|0|||
127536834|NCT02193776|458929983|FG001|Overall Study|Failure to comply with protocol|1|||
127536835|NCT02193776|458929984|FG002|Overall Study|Failure to comply with protocol|0|||
127536836|NCT02193776|458929985|FG003|Overall Study|Failure to comply with protocol|0|||
127536837|NCT02193776|458929982|FG000|Overall Study|Investigator/Sponsor decision|1|||
127536838|NCT02193776|458929983|FG001|Overall Study|Investigator/Sponsor decision|1|||
127536839|NCT02193776|458929984|FG002|Overall Study|Investigator/Sponsor decision|0|||
127536840|NCT02193776|458929985|FG003|Overall Study|Investigator/Sponsor decision|0|||
127536841|NCT02193776|458929982|FG000|Overall Study|Death|1|||
127536842|NCT02193776|458929983|FG001|Overall Study|Death|0|||
127536843|NCT02193776|458929984|FG002|Overall Study|Death|0|||
127536844|NCT02193776|458929985|FG003|Overall Study|Death|0|||
127536845|NCT02193776|458929982|FG000|Overall Study|Adverse event/Specific toxicity|5|||
127536846|NCT02193776|458929983|FG001|Overall Study|Adverse event/Specific toxicity|5|||
127536847|NCT02193776|458929984|FG002|Overall Study|Adverse event/Specific toxicity|2|||
127536848|NCT02193776|458929985|FG003|Overall Study|Adverse event/Specific toxicity|2|||
127536849|NCT00962208|458929987|FG000|Overall Study|Could not achieve good vision|9|||
127536850|NCT00962208|458929988|FG001|Overall Study|Could not achieve good vision|0|||
127536851|NCT00962208|458929987|FG000|Overall Study|Contraindicated to continue study|5|||
127536852|NCT00962208|458929988|FG001|Overall Study|Contraindicated to continue study|1|||
127536853|NCT00962208|458929987|FG000|Overall Study|Lost to Follow-up|0|||
127536854|NCT00962208|458929988|FG001|Overall Study|Lost to Follow-up|9|||
127536855|NCT00791388|458929989|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
127536856|NCT00791388|458929990|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
127536857|NCT00791388|458929991|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
127536858|NCT00791388|458929992|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
127536859|NCT00791388|458929993|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
127536860|NCT00791388|458929989|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
127536861|NCT00791388|458929990|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
127536862|NCT00791388|458929991|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
127536863|NCT00791388|458929992|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
127536864|NCT00791388|458929993|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
127536865|NCT00791388|458929989|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
127536866|NCT00791388|458929990|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
127536867|NCT00791388|458929991|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
127536868|NCT00791388|458929992|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
127536869|NCT00791388|458929993|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
127536870|NCT01458639|458929994|FG000|Overall Study|Physician Decision|4|||
127536871|NCT01458639|458929994|FG000|Overall Study|Equipment issue|1|||
127642267|NCT03252587|459310080|FG002|Overall Study|Adverse Event|6|||
127536872|NCT01458639|458929994|FG000|Overall Study|Inability to obtain subject blood sample|1|||
127536873|NCT00867165|458929995|FG000|Overall Study|Adverse Event|3|||
127536874|NCT00867165|458929996|FG001|Overall Study|Adverse Event|0|||
127536875|NCT00867165|458929995|FG000|Overall Study|Withdrawal by Subject|1|||
127759359|NCT02217475|459745582|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
127759360|NCT02217475|459745583|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
127759361|NCT02217475|459745581|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
127759362|NCT02217475|459745582|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
127759363|NCT02217475|459745583|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
127759364|NCT02217475|459745581|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
127759365|NCT02217475|459745582|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
127759366|NCT02217475|459745583|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
127759367|NCT02217475|459745581|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
127759368|NCT02217475|459745582|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
127759369|NCT02217475|459745583|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
127759370|NCT02217475|459745581|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
127759371|NCT02217475|459745582|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
127759372|NCT02217475|459745583|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
127759373|NCT02217475|459745581|FG000|Discontinued After Period 1|Adverse Event|1|||
127759374|NCT02217475|459745582|FG001|Discontinued After Period 1|Adverse Event|2|||
127759375|NCT02217475|459745583|FG002|Discontinued After Period 1|Adverse Event|0|||
127759376|NCT02217475|459745581|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
127759377|NCT02217475|459745582|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
127759378|NCT02217475|459745583|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
127759379|NCT02217475|459745581|FG000|Discontinued After Period 1|Physician Decision|0|||
127759380|NCT02217475|459745582|FG001|Discontinued After Period 1|Physician Decision|0|||
127759381|NCT02217475|459745583|FG002|Discontinued After Period 1|Physician Decision|1|||
127759382|NCT02217475|459745581|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
127759383|NCT02217475|459745582|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
127759384|NCT02217475|459745583|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
127536876|NCT00867165|458929996|FG001|Overall Study|Withdrawal by Subject|0|||
127536877|NCT00377520|458930001|FG000|Overall Study|Ineligible (Prior radiation)|1|||
127536878|NCT01506271|458930006|FG000|Overall Study|Progressive disease|0|||
127536879|NCT01506271|458930007|FG001|Overall Study|Progressive disease|1|||
127536880|NCT01506271|458930008|FG002|Overall Study|Progressive disease|0|||
127536881|NCT01506271|458930006|FG000|Overall Study|Protocol Violation|3|||
127536882|NCT01506271|458930007|FG001|Overall Study|Protocol Violation|1|||
127536883|NCT01506271|458930008|FG002|Overall Study|Protocol Violation|0|||
127536884|NCT01506271|458930006|FG000|Overall Study|Death|0|||
127536885|NCT01506271|458930007|FG001|Overall Study|Death|1|||
127536886|NCT01506271|458930008|FG002|Overall Study|Death|0|||
127536887|NCT01506271|458930006|FG000|Overall Study|Adverse Event|0|||
127536888|NCT01506271|458930007|FG001|Overall Study|Adverse Event|2|||
127536889|NCT01506271|458930008|FG002|Overall Study|Adverse Event|0|||
127536890|NCT01506271|458930006|FG000|Overall Study|Insufficient supply of study drug|1|||
127536891|NCT01506271|458930007|FG001|Overall Study|Insufficient supply of study drug|0|||
127536892|NCT01506271|458930008|FG002|Overall Study|Insufficient supply of study drug|0|||
127536893|NCT01506271|458930006|FG000|Overall Study|Withdrawal by Subject|0|||
127536894|NCT01506271|458930007|FG001|Overall Study|Withdrawal by Subject|1|||
127536895|NCT01506271|458930008|FG002|Overall Study|Withdrawal by Subject|1|||
127536896|NCT01506271|458930006|FG000|Overall Study|Lost to Follow-up|0|||
127536897|NCT01506271|458930007|FG001|Overall Study|Lost to Follow-up|1|||
127536898|NCT01506271|458930008|FG002|Overall Study|Lost to Follow-up|2|||
127536899|NCT03040141|458930011|FG000|Overall Study|Death|1|||
127536900|NCT03040141|458930012|FG001|Overall Study|Death|2|||
127536901|NCT03040141|458930013|FG002|Overall Study|Death|3|||
127536902|NCT03040141|458930011|FG000|Overall Study|Withdrawal by Subject|3|||
127536903|NCT03040141|458930012|FG001|Overall Study|Withdrawal by Subject|1|||
127536904|NCT03040141|458930013|FG002|Overall Study|Withdrawal by Subject|1|||
127536905|NCT03040141|458930011|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
127536906|NCT03040141|458930012|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
127536907|NCT03040141|458930013|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
127536908|NCT03040141|458930011|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
127536909|NCT03040141|458930012|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
127536910|NCT03040141|458930013|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
127536911|NCT01391663|458930014|FG000|Overall Study|Withdrawal by Subject|0|||
127536912|NCT01391663|458930015|FG001|Overall Study|Withdrawal by Subject|0|||
127536913|NCT01391663|458930016|FG002|Overall Study|Withdrawal by Subject|1|||
127536914|NCT01391663|458930017|FG003|Overall Study|Withdrawal by Subject|0|||
127536915|NCT00462306|458930018|FG000|Overall Study|insufficient data|0|||
127759385|NCT02217475|459745581|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
127759386|NCT02217475|459745582|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
127536916|NCT00462306|458930019|FG001|Overall Study|insufficient data|13|||
127536917|NCT03515824|458930020|FG000|Overall Study|Death|3|||
127536918|NCT03515824|458930021|FG001|Overall Study|Death|2|||
127536919|NCT03515824|458930022|FG002|Overall Study|Death|6|||
127536920|NCT03515824|458930023|FG003|Overall Study|Death|0|||
127536921|NCT03515824|458930020|FG000|Overall Study|Lost to Follow-up|0|||
127536922|NCT03515824|458930021|FG001|Overall Study|Lost to Follow-up|1|||
127536923|NCT03515824|458930022|FG002|Overall Study|Lost to Follow-up|1|||
127536924|NCT03515824|458930023|FG003|Overall Study|Lost to Follow-up|0|||
127536925|NCT03515824|458930020|FG000|Overall Study|Study terminated by sponsor|0|||
127536926|NCT03515824|458930021|FG001|Overall Study|Study terminated by sponsor|1|||
127536927|NCT03515824|458930022|FG002|Overall Study|Study terminated by sponsor|6|||
127536928|NCT03515824|458930023|FG003|Overall Study|Study terminated by sponsor|0|||
127536929|NCT03515824|458930020|FG000|Overall Study|Status not recorded|0|||
127536930|NCT03515824|458930021|FG001|Overall Study|Status not recorded|0|||
127536931|NCT03515824|458930022|FG002|Overall Study|Status not recorded|2|||
127536932|NCT03515824|458930023|FG003|Overall Study|Status not recorded|0|||
127536933|NCT01384734|458930025|FG000|Overall Study|Adverse Event|0|||
127536934|NCT01384734|458930026|FG001|Overall Study|Adverse Event|3|||
127536935|NCT01384734|458930027|FG002|Overall Study|Adverse Event|0|||
127536936|NCT01384734|458930028|FG003|Overall Study|Adverse Event|2|||
127536937|NCT01384734|458930029|FG004|Overall Study|Adverse Event|7|||
127536938|NCT01384734|458930025|FG000|Overall Study|Death|1|||
127536939|NCT01384734|458930026|FG001|Overall Study|Death|0|||
127536940|NCT01384734|458930027|FG002|Overall Study|Death|1|||
127536941|NCT01384734|458930028|FG003|Overall Study|Death|0|||
127536942|NCT01384734|458930029|FG004|Overall Study|Death|0|||
127536943|NCT01384734|458930025|FG000|Overall Study|Continuation criteria not met|0|||
127536944|NCT01384734|458930026|FG001|Overall Study|Continuation criteria not met|0|||
127536945|NCT01384734|458930027|FG002|Overall Study|Continuation criteria not met|1|||
127536946|NCT01384734|458930028|FG003|Overall Study|Continuation criteria not met|1|||
127648212|NCT00293267|459333160|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
127648213|NCT00293267|459333159|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
127648214|NCT00293267|459333160|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
127648215|NCT00293267|459333159|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
127648216|NCT00293267|459333160|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
127648217|NCT00293267|459333159|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
127648218|NCT00293267|459333160|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
127648219|NCT00293267|459333159|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
127648220|NCT00293267|459333160|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
127648221|NCT00293267|459333159|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
127648222|NCT00293267|459333160|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
127648223|NCT00293267|459333159|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
127648224|NCT00293267|459333160|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
127648225|NCT00293267|459333159|FG000|Extension - Double-Blind Week 49-156|Death|3|||
127648226|NCT00293267|459333160|FG001|Extension - Double-Blind Week 49-156|Death|0|||
127648227|NCT00293267|459333159|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
127648228|NCT00293267|459333160|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
127648229|NCT00293267|459333159|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
127648230|NCT00293267|459333160|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
127648231|NCT00293267|459333159|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
127648232|NCT00293267|459333160|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
127648233|NCT00293267|459333159|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
127648234|NCT00293267|459333160|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
127648235|NCT00293267|459333159|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
127648236|NCT00293267|459333160|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
127648237|NCT00293267|459333159|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
127648238|NCT00293267|459333160|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
127648239|NCT00293267|459333159|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
127648240|NCT00293267|459333160|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
127648241|NCT00293267|459333159|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
127648242|NCT00293267|459333160|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
127648243|NCT00293267|459333159|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
127648244|NCT00293267|459333160|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
127648245|NCT00293267|459333159|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
127648246|NCT00293267|459333160|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
127648247|NCT00293267|459333159|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
127648248|NCT00293267|459333160|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
127648249|NCT00293267|459333159|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
127536947|NCT01384734|458930029|FG004|Overall Study|Continuation criteria not met|0|||
127536948|NCT01384734|458930025|FG000|Overall Study|Lack of Efficacy|3|||
127648250|NCT00293267|459333160|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
127648251|NCT00293267|459333159|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
127648252|NCT00293267|459333160|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
127648253|NCT00293267|459333159|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
127648254|NCT00293267|459333160|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
127648255|NCT00293267|459333159|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
127648256|NCT00293267|459333160|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
127648257|NCT00293267|459333159|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
127648258|NCT00293267|459333160|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
127648259|NCT01477853|459333161|FG000|Phase A|Adverse Event|1|||
127648260|NCT01477853|459333162|FG001|Phase A|Adverse Event|2|||
127648261|NCT01477853|459333163|FG002|Phase A|Adverse Event|2|||
127648262|NCT01477853|459333161|FG000|Phase A|Lost to Follow-up|4|||
127648263|NCT01477853|459333162|FG001|Phase A|Lost to Follow-up|3|||
127648264|NCT01477853|459333163|FG002|Phase A|Lost to Follow-up|2|||
127648265|NCT01477853|459333161|FG000|Phase A|Physician Decision|1|||
127648266|NCT01477853|459333162|FG001|Phase A|Physician Decision|0|||
127648267|NCT01477853|459333163|FG002|Phase A|Physician Decision|1|||
127648268|NCT01477853|459333161|FG000|Phase A|Study terminated by sponsor|37|||
127648269|NCT01477853|459333162|FG001|Phase A|Study terminated by sponsor|40|||
127648270|NCT01477853|459333163|FG002|Phase A|Study terminated by sponsor|39|||
127648271|NCT01477853|459333161|FG000|Phase B|Lost to Follow-up|0|||
127648272|NCT01477853|459333162|FG001|Phase B|Lost to Follow-up|1|||
127648273|NCT01477853|459333163|FG002|Phase B|Lost to Follow-up|0|||
127648274|NCT01477853|459333161|FG000|Phase B|Study terminated by sponsor|12|||
127648275|NCT01477853|459333162|FG001|Phase B|Study terminated by sponsor|10|||
127648276|NCT01477853|459333163|FG002|Phase B|Study terminated by sponsor|11|||
127648277|NCT01050816|459333164|FG000|Overall Study|Lost to Follow-up|2|||
127648278|NCT01050816|459333164|FG000|Overall Study|patient's refusal|2|||
127648279|NCT03086330|459333165|FG000|Overall Study|Withdrawal by Subject|3|||
127648280|NCT03086330|459333166|FG001|Overall Study|Withdrawal by Subject|2|||
127648281|NCT03086330|459333165|FG000|Overall Study|Lost to Follow-up|1|||
127648282|NCT03086330|459333166|FG001|Overall Study|Lost to Follow-up|2|||
127648283|NCT00948974|459333174|FG000|Overall Study|Lost to Follow-up|23|||
127648284|NCT00948974|459333175|FG001|Overall Study|Lost to Follow-up|20|||
127648285|NCT00238433|459333177|FG000|Overall Study|Screen failure|1|||
127648286|NCT00238433|459333177|FG000|Overall Study|Lost to Follow-up|1|||
127648287|NCT00238433|459333177|FG000|Overall Study|Death|1|||
127648288|NCT01814748|459333180|FG000|Overall Study|Lost to Follow-up|1|||
127648289|NCT01814748|459333181|FG001|Overall Study|Lost to Follow-up|2|||
127648290|NCT01814748|459333180|FG000|Overall Study|Study site terminated by sponsor|1|||
127648291|NCT01814748|459333181|FG001|Overall Study|Study site terminated by sponsor|1|||
127648292|NCT01814748|459333180|FG000|Overall Study|Withdrawal by Subject|6|||
127648293|NCT01814748|459333181|FG001|Overall Study|Withdrawal by Subject|4|||
127648294|NCT04044456|459333182|FG000|Overall Study|Lost to Follow-up|4|||
127648295|NCT04044456|459333183|FG001|Overall Study|Lost to Follow-up|1|||
127648296|NCT04044456|459333182|FG000|Overall Study|Withdrawal by Subject|1|||
127648297|NCT04044456|459333183|FG001|Overall Study|Withdrawal by Subject|0|||
127648298|NCT01972529|459333184|FG000|Overall Study|Adverse Event|0|||
127648299|NCT01972529|459333185|FG001|Overall Study|Adverse Event|1|||
127648300|NCT01972529|459333186|FG002|Overall Study|Adverse Event|0|||
127648301|NCT01972529|459333187|FG003|Overall Study|Adverse Event|0|||
127648302|NCT01972529|459333184|FG000|Overall Study|Lost to Follow-up|1|||
127648303|NCT01972529|459333185|FG001|Overall Study|Lost to Follow-up|0|||
127648304|NCT01972529|459333186|FG002|Overall Study|Lost to Follow-up|0|||
127648305|NCT01972529|459333187|FG003|Overall Study|Lost to Follow-up|0|||
127648306|NCT01972529|459333184|FG000|Overall Study|Participant Choice|0|||
127648307|NCT01972529|459333185|FG001|Overall Study|Participant Choice|1|||
127648308|NCT01972529|459333186|FG002|Overall Study|Participant Choice|0|||
127648309|NCT01972529|459333187|FG003|Overall Study|Participant Choice|0|||
127648310|NCT01972529|459333184|FG000|Overall Study|Withdrawl of Consent|1|||
127648311|NCT01972529|459333185|FG001|Overall Study|Withdrawl of Consent|2|||
127648312|NCT01972529|459333186|FG002|Overall Study|Withdrawl of Consent|0|||
127648313|NCT01972529|459333187|FG003|Overall Study|Withdrawl of Consent|1|||
127648314|NCT01972529|459333184|FG000|Overall Study|Other|0|||
127648315|NCT01972529|459333185|FG001|Overall Study|Other|0|||
127648316|NCT01972529|459333186|FG002|Overall Study|Other|0|||
127648317|NCT01972529|459333187|FG003|Overall Study|Other|2|||
127648318|NCT01972529|459333184|FG000|Overall Study|Not treated|0|||
127648319|NCT01972529|459333185|FG001|Overall Study|Not treated|1|||
127648320|NCT01972529|459333186|FG002|Overall Study|Not treated|2|||
127648321|NCT01972529|459333187|FG003|Overall Study|Not treated|1|||
127648322|NCT02274857|459333188|FG000|Overall Study|Adverse Event|1|||
127648323|NCT02274857|459333189|FG001|Overall Study|Adverse Event|0|||
127648324|NCT02274857|459333188|FG000|Overall Study|Death|1|||
127648325|NCT02274857|459333189|FG001|Overall Study|Death|2|||
127648326|NCT02274857|459333188|FG000|Overall Study|Lost to Follow-up|3|||
127648327|NCT02274857|459333189|FG001|Overall Study|Lost to Follow-up|0|||
127648328|NCT02274857|459333188|FG000|Overall Study|Physician Decision|2|||
127648329|NCT02274857|459333189|FG001|Overall Study|Physician Decision|0|||
127648330|NCT02274857|459333188|FG000|Overall Study|Trial screen failure|0|||
127648331|NCT02274857|459333189|FG001|Overall Study|Trial screen failure|2|||
127648332|NCT02274857|459333188|FG000|Overall Study|Withdrawal by Subject|11|||
127648333|NCT02274857|459333189|FG001|Overall Study|Withdrawal by Subject|2|||
127648334|NCT02274857|459333188|FG000|Overall Study|Other|2|||
127648335|NCT02274857|459333189|FG001|Overall Study|Other|0|||
127648336|NCT00330174|459333193|FG000|Overall Study|Withdrawal by Subject|7|||
127648337|NCT00330174|459333194|FG001|Overall Study|Withdrawal by Subject|7|||
127648338|NCT00330174|459333193|FG000|Overall Study|Lost to Follow-up|4|||
127648339|NCT00330174|459333194|FG001|Overall Study|Lost to Follow-up|1|||
127648340|NCT00330174|459333193|FG000|Overall Study|Clinical deterioration|1|||
127648341|NCT00330174|459333194|FG001|Overall Study|Clinical deterioration|2|||
127648342|NCT00330174|459333193|FG000|Overall Study|Excessive missed visits|3|||
127648343|NCT00330174|459333194|FG001|Overall Study|Excessive missed visits|8|||
127536949|NCT01384734|458930026|FG001|Overall Study|Lack of Efficacy|7|||
127536950|NCT01384734|458930027|FG002|Overall Study|Lack of Efficacy|4|||
127536951|NCT01384734|458930028|FG003|Overall Study|Lack of Efficacy|4|||
127536952|NCT01384734|458930029|FG004|Overall Study|Lack of Efficacy|2|||
127536953|NCT01384734|458930025|FG000|Overall Study|Lost to Follow-up|5|||
127536954|NCT01384734|458930026|FG001|Overall Study|Lost to Follow-up|3|||
127536955|NCT01384734|458930027|FG002|Overall Study|Lost to Follow-up|3|||
127536956|NCT01384734|458930028|FG003|Overall Study|Lost to Follow-up|8|||
127536957|NCT01384734|458930029|FG004|Overall Study|Lost to Follow-up|5|||
127536958|NCT01384734|458930025|FG000|Overall Study|Non-compliance with study drug|1|||
127536959|NCT01384734|458930026|FG001|Overall Study|Non-compliance with study drug|2|||
127536960|NCT01384734|458930027|FG002|Overall Study|Non-compliance with study drug|6|||
127536961|NCT01384734|458930028|FG003|Overall Study|Non-compliance with study drug|0|||
127536962|NCT01384734|458930029|FG004|Overall Study|Non-compliance with study drug|2|||
127536963|NCT01384734|458930025|FG000|Overall Study|Pregnancy|0|||
127536964|NCT01384734|458930026|FG001|Overall Study|Pregnancy|1|||
127536965|NCT01384734|458930027|FG002|Overall Study|Pregnancy|0|||
127536966|NCT01384734|458930028|FG003|Overall Study|Pregnancy|0|||
127536967|NCT01384734|458930029|FG004|Overall Study|Pregnancy|1|||
127536968|NCT01384734|458930025|FG000|Overall Study|Sponsor terminated|0|||
127536969|NCT01384734|458930026|FG001|Overall Study|Sponsor terminated|0|||
127536970|NCT01384734|458930027|FG002|Overall Study|Sponsor terminated|0|||
127536971|NCT01384734|458930028|FG003|Overall Study|Sponsor terminated|0|||
127536972|NCT01384734|458930029|FG004|Overall Study|Sponsor terminated|1|||
127536973|NCT01384734|458930025|FG000|Overall Study|Withdrawal by Subject|5|||
127536974|NCT01384734|458930026|FG001|Overall Study|Withdrawal by Subject|5|||
127536975|NCT01384734|458930027|FG002|Overall Study|Withdrawal by Subject|6|||
127536976|NCT01384734|458930028|FG003|Overall Study|Withdrawal by Subject|7|||
127536977|NCT01384734|458930029|FG004|Overall Study|Withdrawal by Subject|9|||
127536978|NCT01384734|458930025|FG000|Overall Study|Investigator relocating|0|||
127536979|NCT01384734|458930026|FG001|Overall Study|Investigator relocating|2|||
127536980|NCT01384734|458930027|FG002|Overall Study|Investigator relocating|0|||
127536981|NCT01384734|458930028|FG003|Overall Study|Investigator relocating|3|||
127536982|NCT01384734|458930029|FG004|Overall Study|Investigator relocating|1|||
127536983|NCT01384734|458930025|FG000|Overall Study|Unable to come back for visit|1|||
127536984|NCT01384734|458930026|FG001|Overall Study|Unable to come back for visit|0|||
127648344|NCT00330174|459333193|FG000|Overall Study|Miscellaneous reasons|7|||
127648345|NCT00330174|459333194|FG001|Overall Study|Miscellaneous reasons|1|||
127648346|NCT00409682|459333197|FG000|Open-label Induction Period|Adverse Event|1|||
127648347|NCT00409682|459333198|FG001|Open-label Induction Period|Adverse Event|0|||
127648348|NCT00409682|459333199|FG002|Open-label Induction Period|Adverse Event|0|||
127648349|NCT00409682|459333197|FG000|Open-label Induction Period|Lack of Efficacy|1|||
127648350|NCT00409682|459333198|FG001|Open-label Induction Period|Lack of Efficacy|0|||
127648351|NCT00409682|459333199|FG002|Open-label Induction Period|Lack of Efficacy|0|||
127648352|NCT00409682|459333197|FG000|Open-label Induction Period|Protocol Violation|1|||
127648353|NCT00409682|459333198|FG001|Open-label Induction Period|Protocol Violation|0|||
127648354|NCT00409682|459333199|FG002|Open-label Induction Period|Protocol Violation|0|||
127648355|NCT00409682|459333197|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
127648356|NCT00409682|459333198|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
127648357|NCT00409682|459333199|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
127648358|NCT00409682|459333197|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
127648359|NCT00409682|459333198|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
127648360|NCT00409682|459333199|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
127648361|NCT00409682|459333197|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
127648362|NCT00409682|459333198|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
127648363|NCT00409682|459333199|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
127648364|NCT00409682|459333197|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
127648365|NCT00409682|459333198|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
127870780|NCT01016912|460145116|FG002|Follow-up Period|Other reason|1|||
127648366|NCT00409682|459333199|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
127648367|NCT00409682|459333197|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
127648368|NCT00409682|459333198|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
127648369|NCT00409682|459333199|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
127648370|NCT00409682|459333197|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
127648371|NCT00409682|459333198|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
127648372|NCT00409682|459333199|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
127648373|NCT00409682|459333197|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
127648374|NCT00409682|459333198|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
127648375|NCT00409682|459333199|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
127648376|NCT02403180|459333201|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
127648377|NCT02403180|459333202|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
127648378|NCT02403180|459333201|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
127648379|NCT02403180|459333202|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
127648380|NCT00118716|459333208|FG000|Overall Study|Adverse Event|2|||
127648381|NCT00118716|459333209|FG001|Overall Study|Adverse Event|7|||
127648382|NCT00118716|459333208|FG000|Overall Study|Protocol Violation|5|||
127648383|NCT00118716|459333209|FG001|Overall Study|Protocol Violation|4|||
127648384|NCT00118716|459333208|FG000|Overall Study|Withdrawal by Subject|0|||
127648385|NCT00118716|459333209|FG001|Overall Study|Withdrawal by Subject|1|||
127648386|NCT00118716|459333208|FG000|Overall Study|Exacerbation|2|||
127648387|NCT00118716|459333209|FG001|Overall Study|Exacerbation|2|||
127648388|NCT00118716|459333208|FG000|Overall Study|Discontinued by sponsor|1|||
127648389|NCT00118716|459333209|FG001|Overall Study|Discontinued by sponsor|1|||
127648390|NCT00118716|459333208|FG000|Overall Study|Non-compliance|1|||
127648391|NCT00118716|459333209|FG001|Overall Study|Non-compliance|3|||
127648392|NCT00118716|459333208|FG000|Overall Study|misrandomized|1|||
127648393|NCT00118716|459333209|FG001|Overall Study|misrandomized|1|||
127648394|NCT00118716|459333208|FG000|Overall Study|Expired drug use|1|||
127648395|NCT00118716|459333209|FG001|Overall Study|Expired drug use|2|||
127648396|NCT00118716|459333208|FG000|Overall Study|Investigator discretion|0|||
127648397|NCT00118716|459333209|FG001|Overall Study|Investigator discretion|1|||
127648398|NCT01445652|459333210|FG000|Overall Study|Not comfortable in lenses|5|||
127648399|NCT01445652|459333211|FG001|Overall Study|Not comfortable in lenses|0|||
127648400|NCT01445652|459333210|FG000|Overall Study|Failed to attend scheduled visit|2|||
127648401|NCT01445652|459333211|FG001|Overall Study|Failed to attend scheduled visit|3|||
127648402|NCT01445652|459333210|FG000|Overall Study|Failed teach session|2|||
127648403|NCT01445652|459333211|FG001|Overall Study|Failed teach session|0|||
127648404|NCT01445652|459333210|FG000|Overall Study|Adverse Event|1|||
127648405|NCT01445652|459333211|FG001|Overall Study|Adverse Event|0|||
127648406|NCT02436811|459333212|FG000|Overall Study|Lost to Follow-up|2|||
127648407|NCT02436811|459333213|FG001|Overall Study|Lost to Follow-up|9|||
127648408|NCT02436811|459333214|FG002|Overall Study|Lost to Follow-up|7|||
127648409|NCT02227875|459333215|FG000|Overall Study|Protocol Violation|10|||
127648410|NCT02227875|459333216|FG001|Overall Study|Protocol Violation|7|||
127648411|NCT02227875|459333215|FG000|Overall Study|Other|1|||
127648412|NCT02227875|459333216|FG001|Overall Study|Other|3|||
127648413|NCT02227875|459333215|FG000|Overall Study|Physician Decision|1|||
127648414|NCT02227875|459333216|FG001|Overall Study|Physician Decision|0|||
127648415|NCT02227875|459333215|FG000|Overall Study|Adverse Event|3|||
127648416|NCT02227875|459333216|FG001|Overall Study|Adverse Event|0|||
127648417|NCT02227875|459333215|FG000|Overall Study|Withdrawal by Subject|12|||
127648418|NCT02227875|459333216|FG001|Overall Study|Withdrawal by Subject|13|||
127759387|NCT02217475|459745583|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
127759388|NCT02217475|459745581|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
127759389|NCT02217475|459745582|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
127759390|NCT02217475|459745583|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
127759391|NCT02217475|459745581|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
127759392|NCT02217475|459745582|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
127648419|NCT02227875|459333215|FG000|Overall Study|Lost to Follow-up|10|||
127648420|NCT02227875|459333216|FG001|Overall Study|Lost to Follow-up|10|||
127648421|NCT04209725|459333217|FG000|Overall Study|Adverse Event|1|||
127648422|NCT05163522|459333231|FG000|Overall Study|Withdrawal by Subject|0|||
127648423|NCT05163522|459333232|FG001|Overall Study|Withdrawal by Subject|0|||
127648424|NCT05163522|459333233|FG002|Overall Study|Withdrawal by Subject|1|||
127648425|NCT05163522|459333234|FG003|Overall Study|Withdrawal by Subject|0|||
127648426|NCT05163522|459333235|FG004|Overall Study|Withdrawal by Subject|0|||
127759393|NCT02217475|459745583|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
127870781|NCT01016912|460145117|FG003|Follow-up Period|Other reason|1|||
127648427|NCT05163522|459333236|FG005|Overall Study|Withdrawal by Subject|0|||
127648428|NCT05163522|459333237|FG006|Overall Study|Withdrawal by Subject|0|||
127648429|NCT05163522|459333238|FG007|Overall Study|Withdrawal by Subject|0|||
127648430|NCT05163522|459333239|FG008|Overall Study|Withdrawal by Subject|0|||
127648431|NCT05163522|459333240|FG009|Overall Study|Withdrawal by Subject|0|||
127648432|NCT05163522|459333241|FG010|Overall Study|Withdrawal by Subject|0|||
127648433|NCT03412396|459333242|FG000|Overall Study|Withdrawal by Subject|2|||
127648434|NCT03412396|459333242|FG000|Overall Study|"stopped apalutamide at <9 weeks after initiation"|1|||
127648435|NCT03412396|459333242|FG000|Overall Study|Did not undergo RP|2|||
127648436|NCT04899245|459333251|FG000|Overall Study|Withdrawal by Subject|3|||
127648437|NCT04899245|459333252|FG001|Overall Study|Withdrawal by Subject|5|||
127648438|NCT04899245|459333253|FG002|Overall Study|Withdrawal by Subject|2|||
127648439|NCT04899245|459333251|FG000|Overall Study|No longer eligible - Left staff position|0|||
127648440|NCT04899245|459333252|FG001|Overall Study|No longer eligible - Left staff position|0|||
127648441|NCT04899245|459333253|FG002|Overall Study|No longer eligible - Left staff position|1|||
127648442|NCT04899245|459333251|FG000|Overall Study|No longer eligible - Child graduated from school program|19|||
127648443|NCT04899245|459333252|FG001|Overall Study|No longer eligible - Child graduated from school program|21|||
127648444|NCT04899245|459333253|FG002|Overall Study|No longer eligible - Child graduated from school program|0|||
127648445|NCT04899245|459333251|FG000|Overall Study|No longer eligible - Moved away from area|2|||
127648446|NCT04899245|459333252|FG001|Overall Study|No longer eligible - Moved away from area|2|||
127648447|NCT04899245|459333253|FG002|Overall Study|No longer eligible - Moved away from area|0|||
127648448|NCT02753595|459333259|FG000|Overall Study|Sponsor termination|2|||
127648449|NCT02753595|459333260|FG001|Overall Study|Sponsor termination|2|||
127648450|NCT01570868|459333261|FG000|Overall Study|Adverse Event|8|||
127648451|NCT01570868|459333262|FG001|Overall Study|Adverse Event|1|||
127648452|NCT01570868|459333261|FG000|Overall Study|FDA Recommendation|23|||
127648453|NCT01570868|459333262|FG001|Overall Study|FDA Recommendation|3|||
127648454|NCT01570868|459333261|FG000|Overall Study|Physician Decision|10|||
127648455|NCT01570868|459333262|FG001|Overall Study|Physician Decision|4|||
127648456|NCT01570868|459333261|FG000|Overall Study|Lost to Follow-up|1|||
127648457|NCT01570868|459333262|FG001|Overall Study|Lost to Follow-up|0|||
127648458|NCT01570868|459333261|FG000|Overall Study|Withdrawal by Subject|1|||
127648459|NCT01570868|459333262|FG001|Overall Study|Withdrawal by Subject|0|||
127648460|NCT02515279|459333266|FG000|Overall Study|Adverse Event|7|||
127648461|NCT02515279|459333266|FG000|Overall Study|Lack of Efficacy|31|||
127648462|NCT02515279|459333266|FG000|Overall Study|Lost to Follow-up|9|||
127648463|NCT02515279|459333266|FG000|Overall Study|Withdrawal by Subject|18|||
127648464|NCT02515279|459333266|FG000|Overall Study|End-of-treatment visit not attended|17|||
127648465|NCT02515279|459333266|FG000|Overall Study|Other|22|||
127648466|NCT01800968|459333268|FG000|Overall Study|Death|23|||
127648467|NCT01800968|459333269|FG001|Overall Study|Death|16|||
127648468|NCT01800968|459333268|FG000|Overall Study|Lost to Follow-up|5|||
127648469|NCT01800968|459333269|FG001|Overall Study|Lost to Follow-up|7|||
127648470|NCT01800968|459333268|FG000|Overall Study|Withdrawal by Subject|7|||
127648471|NCT01800968|459333269|FG001|Overall Study|Withdrawal by Subject|9|||
127648472|NCT01800968|459333268|FG000|Overall Study|Physician Decision|1|||
127648473|NCT01800968|459333269|FG001|Overall Study|Physician Decision|0|||
127648474|NCT01422408|459333273|FG000|Overall Study|Adverse Event|1|||
127648475|NCT01422408|459333273|FG000|Overall Study|Withdrawal by Subject|3|||
127648476|NCT03185481|459333274|FG000|Overall Study|Adverse Event|1|||
127648477|NCT03185481|459333274|FG000|Overall Study|Study Terminated by Sponsor|4|||
127648478|NCT05099926|459333286|FG000|Overall Study|Lost to Follow-up|1|||
127648479|NCT00724152|459333289|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
127648480|NCT00724152|459333290|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
127648481|NCT00724152|459333291|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
127648482|NCT00724152|459333289|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
127648483|NCT00724152|459333290|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
127648484|NCT00724152|459333291|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
127648485|NCT03266770|459333295|FG000|Overall Study|Physician Decision|3|||
127648486|NCT03266770|459333295|FG000|Overall Study|Insufficient study supplies|1|||
127648487|NCT03266770|459333295|FG000|Overall Study|Adverse Event|1|||
127648488|NCT01860703|459333299|FG000|Overall Study|Adverse Event|1|||
127648489|NCT01860703|459333300|FG001|Overall Study|Adverse Event|4|||
127648490|NCT01860703|459333301|FG002|Overall Study|Adverse Event|0|||
127648491|NCT01860703|459333302|FG003|Overall Study|Adverse Event|2|||
127648492|NCT01860703|459333299|FG000|Overall Study|Withdrawal by Subject|0|||
127648493|NCT01860703|459333300|FG001|Overall Study|Withdrawal by Subject|1|||
127648494|NCT01860703|459333301|FG002|Overall Study|Withdrawal by Subject|0|||
127648495|NCT01860703|459333302|FG003|Overall Study|Withdrawal by Subject|0|||
127648496|NCT01860703|459333299|FG000|Overall Study|Personal reason|1|||
127648497|NCT01860703|459333300|FG001|Overall Study|Personal reason|0|||
127648498|NCT01860703|459333301|FG002|Overall Study|Personal reason|1|||
127648499|NCT01860703|459333302|FG003|Overall Study|Personal reason|0|||
127648500|NCT02453685|459333304|FG000|Overall Study|Adverse Event|0|||
127648501|NCT02453685|459333305|FG001|Overall Study|Adverse Event|1|||
127648502|NCT02453685|459333304|FG000|Overall Study|Protocol Violation|7|||
127648503|NCT02453685|459333305|FG001|Overall Study|Protocol Violation|4|||
127648504|NCT02453685|459333304|FG000|Overall Study|Lost to Follow-up|0|||
127648505|NCT02453685|459333305|FG001|Overall Study|Lost to Follow-up|1|||
127648506|NCT02453685|459333304|FG000|Overall Study|Withdrawal by Subject|8|||
127648507|NCT02453685|459333305|FG001|Overall Study|Withdrawal by Subject|4|||
127648508|NCT02453685|459333304|FG000|Overall Study|Unclassified|4|||
127648509|NCT02453685|459333305|FG001|Overall Study|Unclassified|2|||
127648510|NCT02778100|459333307|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
127648511|NCT02778100|459333308|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
127648512|NCT00552084|459333315|FG000|Overall Study|Adverse Event|2|||
127648513|NCT00552084|459333316|FG001|Overall Study|Adverse Event|3|||
127648514|NCT00552084|459333315|FG000|Overall Study|Withdrawal by Subject|4|||
127648515|NCT00552084|459333316|FG001|Overall Study|Withdrawal by Subject|5|||
127648516|NCT00552084|459333315|FG000|Overall Study|Protocol Violation|1|||
127648517|NCT00552084|459333316|FG001|Overall Study|Protocol Violation|0|||
127759394|NCT02217475|459745581|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
127759395|NCT02217475|459745582|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
127648518|NCT00552084|459333315|FG000|Overall Study|change in anti-arrythmic drug|1|||
127648519|NCT00552084|459333316|FG001|Overall Study|change in anti-arrythmic drug|1|||
127648520|NCT00224770|459335179|FG000|Overall Study|Lost to Follow-up|4|||
127648521|NCT00224770|459335180|FG001|Overall Study|Lost to Follow-up|2|||
127648522|NCT00224770|459335181|FG002|Overall Study|Lost to Follow-up|0|||
127648523|NCT01106430|459335182|FG000|Overall Study|Adverse Event|8|||
127648524|NCT01106430|459335183|FG001|Overall Study|Adverse Event|10|||
127648525|NCT01106430|459335182|FG000|Overall Study|Lack of Efficacy|2|||
127648526|NCT01106430|459335183|FG001|Overall Study|Lack of Efficacy|13|||
127648527|NCT01106430|459335182|FG000|Overall Study|Lost to Follow-up|5|||
127648528|NCT01106430|459335183|FG001|Overall Study|Lost to Follow-up|1|||
127648529|NCT01106430|459335182|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
127648530|NCT01106430|459335183|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
127648531|NCT01106430|459335182|FG000|Overall Study|Moved Out Of State|0|||
127648532|NCT01106430|459335183|FG001|Overall Study|Moved Out Of State|1|||
127648533|NCT01106430|459335182|FG000|Overall Study|Refused To Take Medication|0|||
127759396|NCT02217475|459745583|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
127648534|NCT01106430|459335183|FG001|Overall Study|Refused To Take Medication|1|||
127648535|NCT01106430|459335182|FG000|Overall Study|Noncompliance|0|||
127648536|NCT01106430|459335183|FG001|Overall Study|Noncompliance|1|||
127648537|NCT01106430|459335182|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
127648538|NCT01106430|459335183|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
127648539|NCT01106430|459335182|FG000|Overall Study|Previous Use Of Marijuana|1|||
127648540|NCT01106430|459335183|FG001|Overall Study|Previous Use Of Marijuana|0|||
127648541|NCT01106430|459335182|FG000|Overall Study|Protocol Violation|7|||
127648542|NCT01106430|459335183|FG001|Overall Study|Protocol Violation|2|||
127648543|NCT01106430|459335182|FG000|Overall Study|Withdrawal by Subject|8|||
127648544|NCT01106430|459335183|FG001|Overall Study|Withdrawal by Subject|4|||
127648545|NCT00861614|459335186|FG000|Overall Study|Disease Progression|182|||
127648546|NCT00861614|459335187|FG001|Overall Study|Disease Progression|263|||
127648547|NCT00861614|459335186|FG000|Overall Study|Study Drug Toxicity|79|||
127648548|NCT00861614|459335187|FG001|Overall Study|Study Drug Toxicity|6|||
127648549|NCT00861614|459335186|FG000|Overall Study|Death|32|||
127648550|NCT00861614|459335187|FG001|Overall Study|Death|19|||
127648551|NCT00861614|459335186|FG000|Overall Study|Adverse Event|27|||
127648552|NCT00861614|459335187|FG001|Overall Study|Adverse Event|23|||
127648553|NCT00861614|459335186|FG000|Overall Study|Withdrawal by Subject|34|||
127648554|NCT00861614|459335187|FG001|Overall Study|Withdrawal by Subject|35|||
127648555|NCT00861614|459335186|FG000|Overall Study|Other|17|||
127648556|NCT00861614|459335187|FG001|Overall Study|Other|22|||
127648557|NCT03704584|459335189|FG000|Overall Study|Withdrawal by Subject|1|||
127648558|NCT03704584|459335190|FG001|Overall Study|Withdrawal by Subject|0|||
127648559|NCT03439189|459335191|FG000|Overall Study|Protocol Violation|19|||
127648560|NCT03439189|459335191|FG000|Overall Study|Lack of Efficacy|63|||
127648561|NCT00508261|459335197|FG000|Overall Study|Other|0|||
127648562|NCT00508261|459335198|FG001|Overall Study|Other|1|||
127648563|NCT00508261|459335199|FG002|Overall Study|Other|1|||
127648564|NCT00508261|459335200|FG003|Overall Study|Other|0|||
127648565|NCT00508261|459335197|FG000|Overall Study|Serious Adverse Event|0|||
127648566|NCT00508261|459335198|FG001|Overall Study|Serious Adverse Event|1|||
127648567|NCT00508261|459335199|FG002|Overall Study|Serious Adverse Event|0|||
127648568|NCT00508261|459335200|FG003|Overall Study|Serious Adverse Event|0|||
127648569|NCT00508261|459335197|FG000|Overall Study|Withdrawal by Subject|3|||
127648570|NCT00508261|459335198|FG001|Overall Study|Withdrawal by Subject|4|||
127648571|NCT00508261|459335199|FG002|Overall Study|Withdrawal by Subject|4|||
127648572|NCT00508261|459335200|FG003|Overall Study|Withdrawal by Subject|0|||
127648573|NCT00508261|459335197|FG000|Overall Study|Migrated/ moved from study area|0|||
127648574|NCT00508261|459335198|FG001|Overall Study|Migrated/ moved from study area|1|||
127648575|NCT00508261|459335199|FG002|Overall Study|Migrated/ moved from study area|0|||
127648576|NCT00508261|459335200|FG003|Overall Study|Migrated/ moved from study area|0|||
127648577|NCT00508261|459335197|FG000|Overall Study|Lost to Follow-up|0|||
127648578|NCT00508261|459335198|FG001|Overall Study|Lost to Follow-up|1|||
127648579|NCT00508261|459335199|FG002|Overall Study|Lost to Follow-up|1|||
127648580|NCT00508261|459335200|FG003|Overall Study|Lost to Follow-up|1|||
127648581|NCT00180479|459335201|FG000|Overall Study|Death|4|||
127648582|NCT00180479|459335202|FG001|Overall Study|Death|2|||
127759397|NCT02643472|459745584|FG000|Overall Study|Death|2|||
127759398|NCT02643472|459745585|FG001|Overall Study|Death|5|||
127759399|NCT02643472|459745584|FG000|Overall Study|Withdrawal by Subject|3|||
127759400|NCT02643472|459745585|FG001|Overall Study|Withdrawal by Subject|2|||
127759401|NCT02643472|459745584|FG000|Overall Study|Protocol Violation|0|||
127759402|NCT02643472|459745585|FG001|Overall Study|Protocol Violation|1|||
127759403|NCT02643472|459745584|FG000|Overall Study|Lost to Follow-up|22|||
127759404|NCT02643472|459745585|FG001|Overall Study|Lost to Follow-up|26|||
127759405|NCT01215188|459745586|FG000|Overall Study|Lost to Follow-up|22|||
127759406|NCT01215188|459745587|FG001|Overall Study|Lost to Follow-up|22|||
127759407|NCT01215188|459745588|FG002|Overall Study|Lost to Follow-up|16|||
127759408|NCT01215188|459745586|FG000|Overall Study|Adverse Event|1|||
127759409|NCT01215188|459745587|FG001|Overall Study|Adverse Event|1|||
127759410|NCT01215188|459745588|FG002|Overall Study|Adverse Event|3|||
127759411|NCT01215188|459745586|FG000|Overall Study|Physician Decision|2|||
127759412|NCT01215188|459745587|FG001|Overall Study|Physician Decision|1|||
127759413|NCT01215188|459745588|FG002|Overall Study|Physician Decision|0|||
127759414|NCT01215188|459745586|FG000|Overall Study|Lack of Efficacy|0|||
127759415|NCT01215188|459745587|FG001|Overall Study|Lack of Efficacy|0|||
127759416|NCT01215188|459745588|FG002|Overall Study|Lack of Efficacy|1|||
127759417|NCT01215188|459745586|FG000|Overall Study|Protocol Violation|1|||
127759418|NCT01215188|459745587|FG001|Overall Study|Protocol Violation|1|||
127759419|NCT01215188|459745588|FG002|Overall Study|Protocol Violation|1|||
127759420|NCT01215188|459745586|FG000|Overall Study|Withdrawal by Subject|32|||
127759421|NCT01215188|459745587|FG001|Overall Study|Withdrawal by Subject|34|||
127759422|NCT01215188|459745588|FG002|Overall Study|Withdrawal by Subject|31|||
127759423|NCT00506441|459745589|FG000|Period 1; Open-label Period|Adverse Event|21|||
127759424|NCT00506441|459745590|FG001|Period 1; Open-label Period|Adverse Event|0|||
127759425|NCT00506441|459745589|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
127759426|NCT00506441|459745590|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
127759427|NCT00506441|459745589|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
127759428|NCT00506441|459745590|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
127759429|NCT00506441|459745589|FG000|Period 1; Open-label Period|Physician Decision|5|||
127759430|NCT00506441|459745590|FG001|Period 1; Open-label Period|Physician Decision|0|||
127759431|NCT00506441|459745589|FG000|Period 1; Open-label Period|Protocol Violation|9|||
127759432|NCT00506441|459745590|FG001|Period 1; Open-label Period|Protocol Violation|0|||
127759433|NCT00506441|459745589|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
127759434|NCT00506441|459745590|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
127759435|NCT00506441|459745589|FG000|Period 1; Open-label Period|Other Reasons|13|||
127759436|NCT00506441|459745590|FG001|Period 1; Open-label Period|Other Reasons|0|||
127759437|NCT00506441|459745589|FG000|Period 2; Double-blind Period|Adverse Event|0|||
127759438|NCT00506441|459745590|FG001|Period 2; Double-blind Period|Adverse Event|1|||
127759439|NCT00506441|459745589|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
127759440|NCT00506441|459745590|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
127759441|NCT00506441|459745589|FG000|Period 2; Double-blind Period|Physician Decision|1|||
127759442|NCT00506441|459745590|FG001|Period 2; Double-blind Period|Physician Decision|1|||
127759443|NCT00506441|459745589|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
127759444|NCT00506441|459745590|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
127759445|NCT00506441|459745589|FG000|Period 2; Double-blind Period|Other Reason|1|||
127648583|NCT00180479|459335201|FG000|Overall Study|Lost to Follow-up|9|||
127648584|NCT00180479|459335202|FG001|Overall Study|Lost to Follow-up|7|||
127648585|NCT00180479|459335201|FG000|Overall Study|Withdrawal by Subject|3|||
127648586|NCT00180479|459335202|FG001|Overall Study|Withdrawal by Subject|3|||
127648587|NCT00180479|459335201|FG000|Overall Study|Informed consent not signed|0|||
127648588|NCT00180479|459335202|FG001|Overall Study|Informed consent not signed|1|||
127648589|NCT00526630|459335211|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
127648590|NCT00526630|459335212|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
127648591|NCT00526630|459335211|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
127648592|NCT00526630|459335212|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
127648593|NCT02459262|459335213|FG000|Overall Study|Withdrawal by Subject|0|||
127648594|NCT02459262|459335214|FG001|Overall Study|Withdrawal by Subject|0|||
127759446|NCT00506441|459745590|FG001|Period 2; Double-blind Period|Other Reason|1|||
127759447|NCT01012414|459745591|FG000|Overall Study|Withdrawal by Subject|2|||
127759448|NCT01012414|459745591|FG000|Overall Study|Lost to Follow-up|1|||
127648595|NCT02459262|459335215|FG002|Overall Study|Withdrawal by Subject|0|||
127648596|NCT02459262|459335216|FG003|Overall Study|Withdrawal by Subject|0|||
127648597|NCT02459262|459335217|FG004|Overall Study|Withdrawal by Subject|0|||
127648598|NCT02459262|459335218|FG005|Overall Study|Withdrawal by Subject|0|||
127759449|NCT01012414|459745591|FG000|Overall Study|Trial was stopped before completed|7|||
127759450|NCT00528931|459745593|FG000|Overall Study|Lost to Follow-up|1|||
127759451|NCT00291642|459745596|FG000|Overall Study|Adverse Event|1|||
127759452|NCT00291642|459745597|FG001|Overall Study|Adverse Event|0|||
127759453|NCT00291642|459745598|FG002|Overall Study|Adverse Event|1|||
127759454|NCT00291642|459745599|FG003|Overall Study|Adverse Event|0|||
127648599|NCT02459262|459335219|FG006|Overall Study|Withdrawal by Subject|0|||
127648600|NCT02459262|459335220|FG007|Overall Study|Withdrawal by Subject|0|||
127648601|NCT02459262|459335221|FG008|Overall Study|Withdrawal by Subject|0|||
127648602|NCT02459262|459335222|FG009|Overall Study|Withdrawal by Subject|1|||
127648603|NCT02459262|459335223|FG010|Overall Study|Withdrawal by Subject|0|||
127648604|NCT00840801|459335224|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
127648605|NCT00840801|459335225|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
127648606|NCT00840801|459335226|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
127648607|NCT00840801|459335224|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
127648608|NCT00840801|459335225|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
127648609|NCT00840801|459335226|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
127648610|NCT00840801|459335224|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
127648611|NCT00840801|459335225|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
127648612|NCT00840801|459335226|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
127648613|NCT00840801|459335224|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
127648614|NCT00840801|459335225|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
127648615|NCT00840801|459335226|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
127648616|NCT01242748|459335227|FG000|Overall Study|Adverse Event|10|||
127648617|NCT01242748|459335228|FG001|Overall Study|Adverse Event|5|||
127648618|NCT01242748|459335227|FG000|Overall Study|Lost to Follow-up|6|||
127648619|NCT01242748|459335228|FG001|Overall Study|Lost to Follow-up|2|||
127648620|NCT01242748|459335227|FG000|Overall Study|Physician Decision|3|||
127648621|NCT01242748|459335228|FG001|Overall Study|Physician Decision|2|||
127759455|NCT00291642|459745600|FG004|Overall Study|Adverse Event|1|||
127759456|NCT00291642|459745596|FG000|Overall Study|Patient missed visit|0|||
127759457|NCT00291642|459745597|FG001|Overall Study|Patient missed visit|0|||
127759458|NCT00291642|459745598|FG002|Overall Study|Patient missed visit|1|||
127759459|NCT00291642|459745599|FG003|Overall Study|Patient missed visit|0|||
127759460|NCT00291642|459745600|FG004|Overall Study|Patient missed visit|0|||
127759461|NCT00291642|459745596|FG000|Overall Study|Intake of prohibited medication|1|||
127759462|NCT00291642|459745597|FG001|Overall Study|Intake of prohibited medication|0|||
127759463|NCT00291642|459745598|FG002|Overall Study|Intake of prohibited medication|0|||
127759464|NCT00291642|459745599|FG003|Overall Study|Intake of prohibited medication|0|||
127759465|NCT00291642|459745600|FG004|Overall Study|Intake of prohibited medication|0|||
127759466|NCT02576587|459745605|FG000|Baseline|Equipment failure|0|||
127759467|NCT02576587|459745606|FG001|Baseline|Equipment failure|1|||
127759468|NCT02576587|459745605|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
127759469|NCT02576587|459745606|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
127759470|NCT02576587|459745605|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
127759471|NCT02576587|459745606|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
127759472|NCT02576587|459745605|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
127759473|NCT02576587|459745606|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
127759474|NCT00532493|459745607|FG000|Overall Study|Death|1|||
127759475|NCT00532493|459745608|FG001|Overall Study|Death|1|||
127759476|NCT00532493|459745607|FG000|Overall Study|Lost to Follow-up|10|||
127759477|NCT00532493|459745608|FG001|Overall Study|Lost to Follow-up|7|||
127759478|NCT00532493|459745607|FG000|Overall Study|Withdrawal by Subject|7|||
127759479|NCT00532493|459745608|FG001|Overall Study|Withdrawal by Subject|9|||
127759480|NCT00532493|459745607|FG000|Overall Study|Physician Decision|1|||
127759481|NCT00532493|459745608|FG001|Overall Study|Physician Decision|6|||
127759482|NCT00532493|459745607|FG000|Overall Study|Adverse Event|6|||
127759483|NCT00532493|459745608|FG001|Overall Study|Adverse Event|5|||
127759484|NCT00532493|459745607|FG000|Overall Study|Protocol Deviation|1|||
127759485|NCT00532493|459745608|FG001|Overall Study|Protocol Deviation|0|||
127759486|NCT00532493|459745607|FG000|Overall Study|Subject Moved Away|3|||
127759487|NCT00532493|459745608|FG001|Overall Study|Subject Moved Away|1|||
127759488|NCT00532493|459745607|FG000|Overall Study|Contraindicative Medication|1|||
127759489|NCT00532493|459745608|FG001|Overall Study|Contraindicative Medication|0|||
127759490|NCT01769326|459745611|FG000|Overall Study|Lost to Follow-up|1|||
127759491|NCT01769326|459745612|FG001|Overall Study|Lost to Follow-up|2|||
127759492|NCT01769326|459745613|FG002|Overall Study|Lost to Follow-up|0|||
127648622|NCT01242748|459335227|FG000|Overall Study|Protocol Violation|1|||
127648623|NCT01242748|459335228|FG001|Overall Study|Protocol Violation|0|||
127648624|NCT01242748|459335227|FG000|Overall Study|Withdrawal by Subject|10|||
127759493|NCT01769326|459745614|FG003|Overall Study|Lost to Follow-up|0|||
127759494|NCT01769326|459745611|FG000|Overall Study|unrelated injry|1|||
127759495|NCT01769326|459745612|FG001|Overall Study|unrelated injry|1|||
127759496|NCT01769326|459745613|FG002|Overall Study|unrelated injry|0|||
127759497|NCT01769326|459745614|FG003|Overall Study|unrelated injry|0|||
127759498|NCT01769326|459745611|FG000|Overall Study|got a job|0|||
127759499|NCT01769326|459745612|FG001|Overall Study|got a job|1|||
127648625|NCT01242748|459335228|FG001|Overall Study|Withdrawal by Subject|2|||
127648626|NCT01242748|459335227|FG000|Overall Study|Miscellaneous reasons|8|||
127759500|NCT01769326|459745613|FG002|Overall Study|got a job|0|||
127759501|NCT01769326|459745614|FG003|Overall Study|got a job|0|||
127870782|NCT01016912|460145118|FG004|Follow-up Period|Other reason|0|||
127759502|NCT01769326|459745611|FG000|Overall Study|Got sick and could not complete study|0|||
127759503|NCT01769326|459745612|FG001|Overall Study|Got sick and could not complete study|0|||
127759504|NCT01769326|459745613|FG002|Overall Study|Got sick and could not complete study|1|||
127759505|NCT01769326|459745614|FG003|Overall Study|Got sick and could not complete study|0|||
127759506|NCT01278173|459745615|FG000|Overall Study|Lack of Efficacy|13|||
127759507|NCT01278173|459745615|FG000|Overall Study|Adverse Event|8|||
127759508|NCT01278173|459745615|FG000|Overall Study|Administrative or other reason|4|||
127759509|NCT01278173|459745615|FG000|Overall Study|Protocol Violation|1|||
127759510|NCT01278173|459745615|FG000|Overall Study|Withdrawal by Subject|1|||
127759511|NCT00680992|459745620|FG000|Overall Study|Complete Resection (as per protocol)|25|||
127759512|NCT00680992|459745621|FG001|Overall Study|Complete Resection (as per protocol)|121|||
127759513|NCT00680992|459745622|FG002|Overall Study|Complete Resection (as per protocol)|0|||
127759514|NCT00680992|459745620|FG000|Overall Study|Administrative Decision|83|||
127759515|NCT00680992|459745621|FG001|Overall Study|Administrative Decision|42|||
127759516|NCT00680992|459745622|FG002|Overall Study|Administrative Decision|5|||
127759517|NCT00680992|459745620|FG000|Overall Study|End of Trial|32|||
127759518|NCT00680992|459745621|FG001|Overall Study|End of Trial|12|||
127759519|NCT00680992|459745622|FG002|Overall Study|End of Trial|3|||
127759520|NCT00680992|459745620|FG000|Overall Study|Withdrawal by Subject|33|||
127759521|NCT00680992|459745621|FG001|Overall Study|Withdrawal by Subject|11|||
127759522|NCT00680992|459745622|FG002|Overall Study|Withdrawal by Subject|1|||
127759523|NCT00680992|459745620|FG000|Overall Study|Adverse Event|21|||
127759524|NCT00680992|459745621|FG001|Overall Study|Adverse Event|19|||
127759525|NCT00680992|459745622|FG002|Overall Study|Adverse Event|1|||
127759526|NCT00680992|459745620|FG000|Overall Study|Other|19|||
127759527|NCT00680992|459745621|FG001|Overall Study|Other|14|||
127759528|NCT00680992|459745622|FG002|Overall Study|Other|1|||
127759529|NCT00680992|459745620|FG000|Overall Study|Disease Progression|21|||
127759530|NCT00680992|459745621|FG001|Overall Study|Disease Progression|9|||
127759531|NCT00680992|459745622|FG002|Overall Study|Disease Progression|0|||
127759532|NCT00680992|459745620|FG000|Overall Study|Lost to Follow-up|12|||
127759533|NCT00680992|459745621|FG001|Overall Study|Lost to Follow-up|14|||
127759534|NCT00680992|459745622|FG002|Overall Study|Lost to Follow-up|0|||
127759535|NCT00680992|459745620|FG000|Overall Study|Noncompliance|4|||
127759536|NCT00680992|459745621|FG001|Overall Study|Noncompliance|6|||
127759537|NCT00680992|459745622|FG002|Overall Study|Noncompliance|0|||
127759538|NCT00680992|459745620|FG000|Overall Study|Requirement for Alternative Therapy|8|||
127759539|NCT00680992|459745621|FG001|Overall Study|Requirement for Alternative Therapy|2|||
127759540|NCT00680992|459745622|FG002|Overall Study|Requirement for Alternative Therapy|0|||
127759541|NCT00680992|459745620|FG000|Overall Study|Pregnancy|5|||
127759542|NCT00680992|459745621|FG001|Overall Study|Pregnancy|0|||
127759543|NCT00680992|459745622|FG002|Overall Study|Pregnancy|1|||
127759544|NCT00680992|459745620|FG000|Overall Study|Death|5|||
127759545|NCT00680992|459745621|FG001|Overall Study|Death|1|||
127759546|NCT00680992|459745622|FG002|Overall Study|Death|0|||
127759547|NCT00680992|459745620|FG000|Overall Study|Ineligibility Determined|0|||
127759548|NCT00680992|459745621|FG001|Overall Study|Ineligibility Determined|1|||
127759549|NCT00680992|459745622|FG002|Overall Study|Ineligibility Determined|0|||
127759550|NCT01585155|459745623|FG000|Overall Study|Adverse Event|1|||
127759551|NCT01585155|459745623|FG000|Overall Study|Lack of Efficacy|2|||
127759552|NCT01585155|459745623|FG000|Overall Study|Worsening ulcerative colitis|2|||
127759553|NCT01397422|459745628|FG000|Overall Study|Adverse Event|0|||
127759554|NCT01397422|459745629|FG001|Overall Study|Adverse Event|3|||
127759555|NCT01397422|459745630|FG002|Overall Study|Adverse Event|3|||
127759556|NCT01397422|459745631|FG003|Overall Study|Adverse Event|8|||
127759557|NCT01397422|459745628|FG000|Overall Study|Withdrawal by Subject|1|||
127759558|NCT01397422|459745629|FG001|Overall Study|Withdrawal by Subject|0|||
127759559|NCT01397422|459745630|FG002|Overall Study|Withdrawal by Subject|0|||
127759560|NCT01397422|459745631|FG003|Overall Study|Withdrawal by Subject|0|||
127759561|NCT01397422|459745628|FG000|Overall Study|Increased bradykinesia related to PD|1|||
127759562|NCT01397422|459745629|FG001|Overall Study|Increased bradykinesia related to PD|0|||
127759563|NCT01397422|459745630|FG002|Overall Study|Increased bradykinesia related to PD|0|||
127759564|NCT01397422|459745631|FG003|Overall Study|Increased bradykinesia related to PD|0|||
127759565|NCT03772587|459745632|FG000|Overall Study|COVID-19|0|||
127759566|NCT03772587|459745633|FG001|Overall Study|COVID-19|0|||
127648627|NCT01242748|459335228|FG001|Overall Study|Miscellaneous reasons|3|||
127759567|NCT03772587|459745634|FG002|Overall Study|COVID-19|1|||
127759568|NCT03772587|459745635|FG003|Overall Study|COVID-19|1|||
127759569|NCT03772587|459745636|FG004|Overall Study|COVID-19|0|||
127759570|NCT03772587|459745632|FG000|Overall Study|Withdrawal by Subject|1|||
127759571|NCT03772587|459745633|FG001|Overall Study|Withdrawal by Subject|0|||
127759572|NCT03772587|459745634|FG002|Overall Study|Withdrawal by Subject|0|||
127759573|NCT03772587|459745635|FG003|Overall Study|Withdrawal by Subject|0|||
127759574|NCT03772587|459745636|FG004|Overall Study|Withdrawal by Subject|0|||
127759575|NCT00513305|459745637|FG000|Overall Study|Adverse Event|6|||
127759576|NCT00513305|459745638|FG001|Overall Study|Adverse Event|2|||
127759577|NCT00513305|459745637|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
127759578|NCT00513305|459745638|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
127759579|NCT00513305|459745637|FG000|Overall Study|Lack of Efficacy|8|||
127759580|NCT00513305|459745638|FG001|Overall Study|Lack of Efficacy|13|||
127759581|NCT00513305|459745637|FG000|Overall Study|Withdrawal by Subject|1|||
127759582|NCT00513305|459745638|FG001|Overall Study|Withdrawal by Subject|2|||
127759583|NCT00513305|459745637|FG000|Overall Study|Disease progression|8|||
127759584|NCT00513305|459745638|FG001|Overall Study|Disease progression|5|||
127759585|NCT00513305|459745637|FG000|Overall Study|Eligible for stem cell transplant|1|||
127759586|NCT00513305|459745638|FG001|Overall Study|Eligible for stem cell transplant|0|||
127759587|NCT00513305|459745637|FG000|Overall Study|Hematologic counts did not recover|1|||
127759588|NCT00513305|459745638|FG001|Overall Study|Hematologic counts did not recover|0|||
127759589|NCT00513305|459745637|FG000|Overall Study|Physician Decision|1|||
127759590|NCT00513305|459745638|FG001|Overall Study|Physician Decision|0|||
127759591|NCT00513305|459745637|FG000|Overall Study|Persistent hypocellularity|0|||
127759592|NCT00513305|459745638|FG001|Overall Study|Persistent hypocellularity|1|||
127759593|NCT00513305|459745637|FG000|Overall Study|Sponsor Decision|0|||
127759594|NCT00513305|459745638|FG001|Overall Study|Sponsor Decision|2|||
127759595|NCT05148962|459745642|FG000|Overall Study|Withdrawal by Subject|1|||
127759596|NCT05148962|459745643|FG001|Overall Study|Withdrawal by Subject|1|||
127759597|NCT05148962|459745644|FG002|Overall Study|Withdrawal by Subject|0|||
127759598|NCT05148962|459745645|FG003|Overall Study|Withdrawal by Subject|1|||
127759599|NCT05148962|459745646|FG004|Overall Study|Withdrawal by Subject|0|||
127759600|NCT05148962|459745642|FG000|Overall Study|Participant was early terminated per protocol|0|||
127759601|NCT05148962|459745643|FG001|Overall Study|Participant was early terminated per protocol|0|||
127759602|NCT05148962|459745644|FG002|Overall Study|Participant was early terminated per protocol|3|||
127759603|NCT05148962|459745645|FG003|Overall Study|Participant was early terminated per protocol|5|||
127759604|NCT05148962|459745646|FG004|Overall Study|Participant was early terminated per protocol|2|||
127759605|NCT05148962|459745642|FG000|Overall Study|Miscellaneous|0|||
127759606|NCT05148962|459745643|FG001|Overall Study|Miscellaneous|0|||
127759607|NCT05148962|459745644|FG002|Overall Study|Miscellaneous|0|||
127759608|NCT05148962|459745645|FG003|Overall Study|Miscellaneous|1|||
127759609|NCT05148962|459745646|FG004|Overall Study|Miscellaneous|0|||
127759610|NCT01525238|459745647|FG000|Overall Study|Withdrawal by Subject|1|||
127759611|NCT01525238|459745648|FG001|Overall Study|Withdrawal by Subject|0|||
127759612|NCT01525238|459745649|FG002|Overall Study|Withdrawal by Subject|0|||
127759613|NCT00151281|459745650|FG000|Overall Study|Not evaluable|3|||
127759614|NCT01133418|459745651|FG000|Overall Study|Lost to Follow-up|5|||
127759615|NCT01133418|459745652|FG001|Overall Study|Lost to Follow-up|6|||
127759616|NCT05316701|459745653|FG000|Overall Study|Adverse Event|0|||
127759617|NCT05316701|459745654|FG001|Overall Study|Adverse Event|1|||
127759618|NCT05316701|459745653|FG000|Overall Study|Death|3|||
127759619|NCT05316701|459745654|FG001|Overall Study|Death|9|||
127759620|NCT05316701|459745653|FG000|Overall Study|Lost to Follow-up|1|||
127759621|NCT05316701|459745654|FG001|Overall Study|Lost to Follow-up|0|||
127759622|NCT05316701|459745653|FG000|Overall Study|Physician Decision|1|||
127759623|NCT05316701|459745654|FG001|Overall Study|Physician Decision|4|||
127759624|NCT05316701|459745653|FG000|Overall Study|Withdrawal by Subject|3|||
127759625|NCT05316701|459745654|FG001|Overall Study|Withdrawal by Subject|5|||
127759626|NCT05316701|459745653|FG000|Overall Study|Progression/Relapse|14|||
127759627|NCT05316701|459745654|FG001|Overall Study|Progression/Relapse|9|||
127759628|NCT05316701|459745653|FG000|Overall Study|Received Standard of Care|1|||
127759629|NCT05316701|459745654|FG001|Overall Study|Received Standard of Care|0|||
127759630|NCT05316701|459745653|FG000|Overall Study|Ongoing|70|||
127759631|NCT05316701|459745654|FG001|Overall Study|Ongoing|64|||
127759632|NCT04696653|459745655|FG000|Overall Study|left organization|18|||
127759633|NCT04696653|459745655|FG000|Overall Study|Lost to Follow-up|3|||
127759634|NCT04362189|459745656|FG000|Overall Study|Lost to Follow-up|0|||
127759635|NCT04362189|459745657|FG001|Overall Study|Lost to Follow-up|1|||
127759636|NCT04362189|459745656|FG000|Overall Study|Withdrawal by Subject|1|||
127759637|NCT04362189|459745657|FG001|Overall Study|Withdrawal by Subject|0|||
127759638|NCT04362189|459745656|FG000|Overall Study|FDA Clinical Hold|7|||
127759639|NCT04362189|459745657|FG001|Overall Study|FDA Clinical Hold|2|||
127759640|NCT04362189|459745656|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
127759641|NCT04362189|459745657|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
127759642|NCT04362189|459745656|FG000|Overall Study|Adverse Event|0|||
127759643|NCT04362189|459745657|FG001|Overall Study|Adverse Event|2|||
127759644|NCT04362189|459745656|FG000|Overall Study|Death|4|||
127759645|NCT04362189|459745657|FG001|Overall Study|Death|1|||
127759646|NCT02111681|459745658|FG000|Overall Study|Death|5|||
127759647|NCT02111681|459745658|FG000|Overall Study|Lack of Efficacy|2|||
127759648|NCT02111681|459745658|FG000|Overall Study|Progression of disease|4|||
127759649|NCT01077271|459747245|FG000|Overall Study|Parental desire|8|||
127759650|NCT01077271|459747245|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
127759651|NCT01077271|459747245|FG000|Overall Study|Noncompliance|2|||
127759652|NCT01077271|459747245|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
127759653|NCT01077271|459747245|FG000|Overall Study|Changed doctors|2|||
127759654|NCT01077271|459747245|FG000|Overall Study|Parents thought too many injections|2|||
127759655|NCT01077271|459747245|FG000|Overall Study|End of RSV season nearly reached|1|||
127759656|NCT01077271|459747245|FG000|Overall Study|Mother unconvinced of the necessity|1|||
127759657|NCT05020327|459747246|FG000|Overall Study|Physician Decision|3|||
127759658|NCT05020327|459747247|FG001|Overall Study|Physician Decision|0|||
127759659|NCT05020327|459747248|FG002|Overall Study|Physician Decision|0|||
127759660|NCT05020327|459747246|FG000|Overall Study|Withdrawal by Subject|1|||
127759661|NCT05020327|459747247|FG001|Overall Study|Withdrawal by Subject|1|||
127759662|NCT05020327|459747248|FG002|Overall Study|Withdrawal by Subject|0|||
127759663|NCT05020327|459747246|FG000|Overall Study|personal/cultural, ineligible|12|||
127759664|NCT05020327|459747247|FG001|Overall Study|personal/cultural, ineligible|0|||
127759665|NCT05020327|459747248|FG002|Overall Study|personal/cultural, ineligible|0|||
127759666|NCT00095056|459747249|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
127759667|NCT00095056|459747250|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
127759668|NCT00095056|459747249|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
127759669|NCT00095056|459747250|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
127759670|NCT00095056|459747249|FG000|Phase A (Weeks 0-12)|Death|1|||
127759671|NCT00095056|459747250|FG001|Phase A (Weeks 0-12)|Death|0|||
127759672|NCT00095056|459747249|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
127759673|NCT00095056|459747250|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
127759674|NCT00095056|459747249|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
127759675|NCT00095056|459747250|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
127759676|NCT00095056|459747249|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
127759677|NCT00095056|459747250|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
127759678|NCT00095056|459747249|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
127759679|NCT00095056|459747250|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
127759680|NCT00095056|459747249|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
127759681|NCT00095056|459747250|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
127759682|NCT00095056|459747249|FG000|Phase B (Weeks 12-54)|Death|3|||
127759683|NCT00095056|459747250|FG001|Phase B (Weeks 12-54)|Death|1|||
127759684|NCT00095056|459747249|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
127759685|NCT00095056|459747250|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
127759686|NCT00095056|459747249|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
127759687|NCT00095056|459747250|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
127759688|NCT00923260|459747251|FG000|Overall Study|Lost to Follow-up|1|||
127759689|NCT00923260|459747252|FG001|Overall Study|Lost to Follow-up|1|||
127759690|NCT00836745|459747256|FG000|Overall Study|Death|2|||
127759691|NCT00836745|459747256|FG000|Overall Study|Lost to Follow-up|10|||
127759692|NCT00836745|459747256|FG000|Overall Study|Adverse Event|3|||
127759693|NCT00836745|459747256|FG000|Overall Study|Objective progression or relapse|4|||
127759694|NCT00836745|459747256|FG000|Overall Study|Other|2|||
127759695|NCT02121301|459747260|FG000|Overall Study|Protocol Violation|1|||
127759696|NCT02121301|459747261|FG001|Overall Study|Protocol Violation|4|||
127759697|NCT02121301|459747262|FG002|Overall Study|Protocol Violation|1|||
127759698|NCT02663518|459747266|FG000|Part 1: Phase 1a Escalation|Death|0|||
127759699|NCT02663518|459747267|FG001|Part 1: Phase 1a Escalation|Death|0|||
127759700|NCT02663518|459747268|FG002|Part 1: Phase 1a Escalation|Death|1|||
127759701|NCT02663518|459747269|FG003|Part 1: Phase 1a Escalation|Death|0|||
127759702|NCT02663518|459747270|FG004|Part 1: Phase 1a Escalation|Death|0|||
127759703|NCT02663518|459747271|FG005|Part 1: Phase 1a Escalation|Death|0|||
127759704|NCT02663518|459747272|FG006|Part 1: Phase 1a Escalation|Death|0|||
127759705|NCT02663518|459747273|FG007|Part 1: Phase 1a Escalation|Death|0|||
127759706|NCT02663518|459747274|FG008|Part 1: Phase 1a Escalation|Death|0|||
127759707|NCT02663518|459747275|FG009|Part 1: Phase 1a Escalation|Death|0|||
127759708|NCT02663518|459747276|FG010|Part 1: Phase 1a Escalation|Death|0|||
127759709|NCT02663518|459747277|FG011|Part 1: Phase 1a Escalation|Death|0|||
127759710|NCT02663518|459747278|FG012|Part 1: Phase 1a Escalation|Death|0|||
127759711|NCT02663518|459747279|FG013|Part 1: Phase 1a Escalation|Death|0|||
127759712|NCT02663518|459747266|FG000|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
127759713|NCT02663518|459747267|FG001|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
127759714|NCT02663518|459747268|FG002|Part 1: Phase 1a Escalation|Lost to Follow-up|1|||
127759715|NCT02663518|459747269|FG003|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
127759716|NCT02663518|459747270|FG004|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
127759717|NCT02663518|459747271|FG005|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
127759718|NCT02663518|459747272|FG006|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
127759719|NCT02663518|459747273|FG007|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
127759720|NCT02663518|459747274|FG008|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
127759721|NCT02663518|459747275|FG009|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
127759722|NCT02663518|459747276|FG010|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
127759723|NCT02663518|459747277|FG011|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
127759724|NCT02663518|459747278|FG012|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
127759725|NCT02663518|459747279|FG013|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
127536985|NCT01384734|458930027|FG002|Overall Study|Unable to come back for visit|1|||
127536986|NCT01384734|458930028|FG003|Overall Study|Unable to come back for visit|1|||
127642268|NCT03252587|459310081|FG003|Overall Study|Adverse Event|12|||
127759726|NCT02663518|459747266|FG000|Part 1: Phase 1a Escalation|Progressive Disease|2|||
127648628|NCT03518125|459335232|FG000|Overall Study|Lost to Follow-up|0|||
127648629|NCT03518125|459335233|FG001|Overall Study|Lost to Follow-up|2|||
127648630|NCT03518125|459335234|FG002|Overall Study|Lost to Follow-up|0|||
127648631|NCT03518125|459335235|FG003|Overall Study|Lost to Follow-up|0|||
127648632|NCT03518125|459335236|FG004|Overall Study|Lost to Follow-up|3|||
127648633|NCT03518125|459335237|FG005|Overall Study|Lost to Follow-up|5|||
127648634|NCT03518125|459335232|FG000|Overall Study|Physician Decision|0|||
127648635|NCT03518125|459335233|FG001|Overall Study|Physician Decision|1|||
127648636|NCT03518125|459335234|FG002|Overall Study|Physician Decision|0|||
127648637|NCT03518125|459335235|FG003|Overall Study|Physician Decision|0|||
127648638|NCT03518125|459335236|FG004|Overall Study|Physician Decision|0|||
127648639|NCT03518125|459335237|FG005|Overall Study|Physician Decision|0|||
127648640|NCT03518125|459335232|FG000|Overall Study|Withdrawal by Subject|1|||
127648641|NCT03518125|459335233|FG001|Overall Study|Withdrawal by Subject|1|||
127648642|NCT03518125|459335234|FG002|Overall Study|Withdrawal by Subject|0|||
127648643|NCT03518125|459335235|FG003|Overall Study|Withdrawal by Subject|1|||
127648644|NCT03518125|459335236|FG004|Overall Study|Withdrawal by Subject|1|||
127648645|NCT03518125|459335237|FG005|Overall Study|Withdrawal by Subject|3|||
127648646|NCT03518125|459335232|FG000|Overall Study|Missed Day 394 Visit|1|||
127648647|NCT03518125|459335233|FG001|Overall Study|Missed Day 394 Visit|0|||
127648648|NCT03518125|459335234|FG002|Overall Study|Missed Day 394 Visit|0|||
127648649|NCT03518125|459335235|FG003|Overall Study|Missed Day 394 Visit|0|||
127648650|NCT03518125|459335236|FG004|Overall Study|Missed Day 394 Visit|0|||
127648651|NCT03518125|459335237|FG005|Overall Study|Missed Day 394 Visit|0|||
127648652|NCT03286751|459335242|FG000|Washout Period 1|Withdrawal by Subject|0|||
127648653|NCT03286751|459335243|FG001|Washout Period 1|Withdrawal by Subject|0|||
127648654|NCT03286751|459335244|FG002|Washout Period 1|Withdrawal by Subject|0|||
127648655|NCT03286751|459335245|FG003|Washout Period 1|Withdrawal by Subject|0|||
127648656|NCT03286751|459335246|FG004|Washout Period 1|Withdrawal by Subject|1|||
127648657|NCT03286751|459335247|FG005|Washout Period 1|Withdrawal by Subject|0|||
127648658|NCT03286751|459335242|FG000|Washout Period 2|Personal Reasons|0|||
127648659|NCT03286751|459335243|FG001|Washout Period 2|Personal Reasons|1|||
127648660|NCT03286751|459335244|FG002|Washout Period 2|Personal Reasons|0|||
127648661|NCT03286751|459335245|FG003|Washout Period 2|Personal Reasons|0|||
127648662|NCT03286751|459335246|FG004|Washout Period 2|Personal Reasons|0|||
127648663|NCT03286751|459335247|FG005|Washout Period 2|Personal Reasons|0|||
127648664|NCT03286751|459335242|FG000|Washout Period 5|Adverse Event|0|||
127648665|NCT03286751|459335243|FG001|Washout Period 5|Adverse Event|0|||
127648666|NCT03286751|459335244|FG002|Washout Period 5|Adverse Event|0|||
127648667|NCT03286751|459335245|FG003|Washout Period 5|Adverse Event|0|||
127648668|NCT03286751|459335246|FG004|Washout Period 5|Adverse Event|1|||
127648669|NCT03286751|459335247|FG005|Washout Period 5|Adverse Event|0|||
127648670|NCT01078155|459335248|FG000|Overall Study|Adverse Event|7|||
127648671|NCT01078155|459335248|FG000|Overall Study|Lack of Efficacy|16|||
127648672|NCT01078155|459335248|FG000|Overall Study|Participant's Decision|6|||
127648673|NCT01078155|459335248|FG000|Overall Study|Lost to Follow-up|15|||
127648674|NCT01621880|459335249|FG000|Overall Study|Adverse Event|5|||
127648675|NCT01621880|459335250|FG001|Overall Study|Adverse Event|1|||
127648676|NCT01621880|459335249|FG000|Overall Study|Withdrawal by Subject|5|||
127648677|NCT01621880|459335250|FG001|Overall Study|Withdrawal by Subject|4|||
127648678|NCT01127646|459335251|FG000|Overall Study|Entry Criteria Not Met|1|||
127648679|NCT01127646|459335252|FG001|Overall Study|Entry Criteria Not Met|0|||
127648680|NCT01127646|459335251|FG000|Overall Study|Protocol Violation|0|||
127648681|NCT01127646|459335252|FG001|Overall Study|Protocol Violation|1|||
127648682|NCT04067401|459335253|FG000|Overall Study|Withdrawal by Subject|7|||
127648683|NCT04067401|459335254|FG001|Overall Study|Withdrawal by Subject|0|||
127648684|NCT04067401|459335253|FG000|Overall Study|no data provided|1|||
127648685|NCT04067401|459335254|FG001|Overall Study|no data provided|0|||
127648686|NCT01662063|459335257|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
127648687|NCT01662063|459335258|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
127648688|NCT01662063|459335259|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
127648689|NCT01662063|459335257|FG000|Overall Study|Lack of Efficacy|1|||
127648690|NCT01662063|459335258|FG001|Overall Study|Lack of Efficacy|6|||
127648691|NCT01662063|459335259|FG002|Overall Study|Lack of Efficacy|0|||
127648692|NCT01662063|459335257|FG000|Overall Study|Lost to Follow-up|0|||
127648693|NCT01662063|459335258|FG001|Overall Study|Lost to Follow-up|4|||
127648694|NCT01662063|459335259|FG002|Overall Study|Lost to Follow-up|0|||
127648695|NCT01662063|459335257|FG000|Overall Study|Protocol Violation|1|||
127648696|NCT01662063|459335258|FG001|Overall Study|Protocol Violation|0|||
127648697|NCT01662063|459335259|FG002|Overall Study|Protocol Violation|0|||
127648698|NCT01662063|459335257|FG000|Overall Study|Withdrawal by Subject|2|||
127648699|NCT01662063|459335258|FG001|Overall Study|Withdrawal by Subject|4|||
127648700|NCT01662063|459335259|FG002|Overall Study|Withdrawal by Subject|1|||
127648701|NCT01662063|459335257|FG000|Overall Study|Physician Decision|0|||
127648702|NCT01662063|459335258|FG001|Overall Study|Physician Decision|2|||
127648703|NCT01662063|459335259|FG002|Overall Study|Physician Decision|0|||
127648704|NCT01662063|459335257|FG000|Overall Study|Other|0|||
127648705|NCT01662063|459335258|FG001|Overall Study|Other|1|||
127759727|NCT02663518|459747267|FG001|Part 1: Phase 1a Escalation|Progressive Disease|3|||
127759728|NCT02663518|459747268|FG002|Part 1: Phase 1a Escalation|Progressive Disease|2|||
127759729|NCT02663518|459747269|FG003|Part 1: Phase 1a Escalation|Progressive Disease|3|||
127759730|NCT02663518|459747270|FG004|Part 1: Phase 1a Escalation|Progressive Disease|0|||
127759731|NCT02663518|459747271|FG005|Part 1: Phase 1a Escalation|Progressive Disease|0|||
127759732|NCT02663518|459747272|FG006|Part 1: Phase 1a Escalation|Progressive Disease|0|||
127759733|NCT02663518|459747273|FG007|Part 1: Phase 1a Escalation|Progressive Disease|0|||
127759734|NCT02663518|459747274|FG008|Part 1: Phase 1a Escalation|Progressive Disease|0|||
127759735|NCT02663518|459747275|FG009|Part 1: Phase 1a Escalation|Progressive Disease|0|||
127759736|NCT02663518|459747276|FG010|Part 1: Phase 1a Escalation|Progressive Disease|0|||
127759737|NCT02663518|459747277|FG011|Part 1: Phase 1a Escalation|Progressive Disease|0|||
127759738|NCT02663518|459747278|FG012|Part 1: Phase 1a Escalation|Progressive Disease|0|||
127759739|NCT02663518|459747279|FG013|Part 1: Phase 1a Escalation|Progressive Disease|0|||
127759740|NCT02663518|459747266|FG000|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
127759741|NCT02663518|459747267|FG001|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
127759742|NCT02663518|459747268|FG002|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
127759743|NCT02663518|459747269|FG003|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
127759744|NCT02663518|459747270|FG004|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
127759745|NCT02663518|459747271|FG005|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
127759746|NCT02663518|459747272|FG006|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
127759747|NCT02663518|459747273|FG007|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
127759748|NCT02663518|459747274|FG008|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
127759749|NCT02663518|459747275|FG009|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
127759750|NCT02663518|459747276|FG010|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
127759751|NCT02663518|459747277|FG011|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
127759752|NCT02663518|459747278|FG012|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
127759753|NCT02663518|459747279|FG013|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
127759754|NCT02663518|459747266|FG000|Part 1: Phase 1a Escalation|Other|0|||
127759755|NCT02663518|459747267|FG001|Part 1: Phase 1a Escalation|Other|0|||
127759756|NCT02663518|459747268|FG002|Part 1: Phase 1a Escalation|Other|2|||
127759757|NCT02663518|459747269|FG003|Part 1: Phase 1a Escalation|Other|0|||
127759758|NCT02663518|459747270|FG004|Part 1: Phase 1a Escalation|Other|0|||
127759759|NCT02663518|459747271|FG005|Part 1: Phase 1a Escalation|Other|0|||
127759760|NCT02663518|459747272|FG006|Part 1: Phase 1a Escalation|Other|0|||
127759761|NCT02663518|459747273|FG007|Part 1: Phase 1a Escalation|Other|0|||
127759762|NCT02663518|459747274|FG008|Part 1: Phase 1a Escalation|Other|0|||
127759763|NCT02663518|459747275|FG009|Part 1: Phase 1a Escalation|Other|0|||
127759764|NCT02663518|459747276|FG010|Part 1: Phase 1a Escalation|Other|0|||
127759765|NCT02663518|459747277|FG011|Part 1: Phase 1a Escalation|Other|0|||
127759766|NCT02663518|459747278|FG012|Part 1: Phase 1a Escalation|Other|0|||
127759767|NCT02663518|459747279|FG013|Part 1: Phase 1a Escalation|Other|0|||
127759768|NCT02663518|459747266|FG000|Part 2 and 3: Phase 1b Expansion|Death|0|||
127759769|NCT02663518|459747267|FG001|Part 2 and 3: Phase 1b Expansion|Death|0|||
127759770|NCT02663518|459747268|FG002|Part 2 and 3: Phase 1b Expansion|Death|0|||
127759771|NCT02663518|459747269|FG003|Part 2 and 3: Phase 1b Expansion|Death|0|||
127759772|NCT02663518|459747270|FG004|Part 2 and 3: Phase 1b Expansion|Death|50|||
127759773|NCT02663518|459747271|FG005|Part 2 and 3: Phase 1b Expansion|Death|0|||
127759774|NCT02663518|459747272|FG006|Part 2 and 3: Phase 1b Expansion|Death|25|||
127759775|NCT02663518|459747273|FG007|Part 2 and 3: Phase 1b Expansion|Death|16|||
127759776|NCT02663518|459747274|FG008|Part 2 and 3: Phase 1b Expansion|Death|0|||
127759777|NCT02663518|459747275|FG009|Part 2 and 3: Phase 1b Expansion|Death|0|||
127759778|NCT02663518|459747276|FG010|Part 2 and 3: Phase 1b Expansion|Death|0|||
127759779|NCT02663518|459747277|FG011|Part 2 and 3: Phase 1b Expansion|Death|0|||
127759780|NCT02663518|459747278|FG012|Part 2 and 3: Phase 1b Expansion|Death|0|||
127759781|NCT02663518|459747279|FG013|Part 2 and 3: Phase 1b Expansion|Death|0|||
127759782|NCT02663518|459747266|FG000|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
127759783|NCT02663518|459747267|FG001|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
127759784|NCT02663518|459747268|FG002|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
127759785|NCT02663518|459747269|FG003|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
127759786|NCT02663518|459747270|FG004|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|4|||
127759787|NCT02663518|459747271|FG005|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
127759788|NCT02663518|459747272|FG006|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
127759789|NCT02663518|459747273|FG007|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
127648706|NCT01662063|459335259|FG002|Overall Study|Other|0|||
127648707|NCT00106184|459335261|FG000|Overall Study|Withdrawal by Subject|3|||
127648708|NCT00106184|459335262|FG001|Overall Study|Withdrawal by Subject|2|||
127759790|NCT02663518|459747274|FG008|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
127759791|NCT02663518|459747275|FG009|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
127648709|NCT02313909|459335263|FG000|Overall Study|Consent withdrawn by participant|33|||
127648710|NCT02313909|459335264|FG001|Overall Study|Consent withdrawn by participant|33|||
127759792|NCT02663518|459747276|FG010|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
127759793|NCT02663518|459747277|FG011|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
127759794|NCT02663518|459747278|FG012|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
127759795|NCT02663518|459747279|FG013|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
127759796|NCT02663518|459747266|FG000|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
127759797|NCT02663518|459747267|FG001|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
127759798|NCT02663518|459747268|FG002|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
127759799|NCT02663518|459747269|FG003|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
127759800|NCT02663518|459747270|FG004|Part 2 and 3: Phase 1b Expansion|Progressive Disease|2|||
127759801|NCT02663518|459747271|FG005|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
127759802|NCT02663518|459747272|FG006|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
127759803|NCT02663518|459747273|FG007|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
127759804|NCT02663518|459747274|FG008|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
127759805|NCT02663518|459747275|FG009|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
127759806|NCT02663518|459747276|FG010|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
127759807|NCT02663518|459747277|FG011|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
127759808|NCT02663518|459747278|FG012|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
127759809|NCT02663518|459747279|FG013|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
127759810|NCT02663518|459747266|FG000|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
127759811|NCT02663518|459747267|FG001|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
127759812|NCT02663518|459747268|FG002|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
127759813|NCT02663518|459747269|FG003|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
127759814|NCT02663518|459747270|FG004|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|16|||
127759815|NCT02663518|459747271|FG005|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|1|||
127759816|NCT02663518|459747272|FG006|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|3|||
127759817|NCT02663518|459747273|FG007|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|8|||
127759818|NCT02663518|459747274|FG008|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
127759819|NCT02663518|459747275|FG009|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
127759820|NCT02663518|459747276|FG010|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
127759821|NCT02663518|459747277|FG011|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
127759822|NCT02663518|459747278|FG012|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
127759823|NCT02663518|459747279|FG013|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
127759824|NCT02663518|459747266|FG000|Part 2 and 3: Phase 1b Expansion|Other|0|||
127759825|NCT02663518|459747267|FG001|Part 2 and 3: Phase 1b Expansion|Other|0|||
127759826|NCT02663518|459747268|FG002|Part 2 and 3: Phase 1b Expansion|Other|0|||
127759827|NCT02663518|459747269|FG003|Part 2 and 3: Phase 1b Expansion|Other|0|||
127759828|NCT02663518|459747270|FG004|Part 2 and 3: Phase 1b Expansion|Other|6|||
127759829|NCT02663518|459747271|FG005|Part 2 and 3: Phase 1b Expansion|Other|0|||
127759830|NCT02663518|459747272|FG006|Part 2 and 3: Phase 1b Expansion|Other|2|||
127759831|NCT02663518|459747273|FG007|Part 2 and 3: Phase 1b Expansion|Other|0|||
127759832|NCT02663518|459747274|FG008|Part 2 and 3: Phase 1b Expansion|Other|0|||
127759833|NCT02663518|459747275|FG009|Part 2 and 3: Phase 1b Expansion|Other|0|||
127759834|NCT02663518|459747276|FG010|Part 2 and 3: Phase 1b Expansion|Other|0|||
127759835|NCT02663518|459747277|FG011|Part 2 and 3: Phase 1b Expansion|Other|0|||
127759836|NCT02663518|459747278|FG012|Part 2 and 3: Phase 1b Expansion|Other|0|||
127759837|NCT02663518|459747279|FG013|Part 2 and 3: Phase 1b Expansion|Other|0|||
127759838|NCT02663518|459747266|FG000|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
127759839|NCT02663518|459747267|FG001|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
127759840|NCT02663518|459747268|FG002|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
127759841|NCT02663518|459747269|FG003|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
127759842|NCT02663518|459747270|FG004|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
127759843|NCT02663518|459747271|FG005|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
127759844|NCT02663518|459747272|FG006|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|1|||
127759845|NCT02663518|459747273|FG007|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
127759846|NCT02663518|459747274|FG008|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
127759847|NCT02663518|459747275|FG009|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
127759848|NCT02663518|459747276|FG010|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
127759849|NCT02663518|459747277|FG011|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
127759850|NCT02663518|459747278|FG012|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
127759851|NCT02663518|459747279|FG013|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
127759852|NCT02663518|459747266|FG000|Part 4: Phase 1b Dose Optimization|Death|0|||
127759853|NCT02663518|459747267|FG001|Part 4: Phase 1b Dose Optimization|Death|0|||
127759854|NCT02663518|459747268|FG002|Part 4: Phase 1b Dose Optimization|Death|0|||
127759855|NCT02663518|459747269|FG003|Part 4: Phase 1b Dose Optimization|Death|0|||
127759856|NCT02663518|459747270|FG004|Part 4: Phase 1b Dose Optimization|Death|0|||
127759857|NCT02663518|459747271|FG005|Part 4: Phase 1b Dose Optimization|Death|0|||
127759858|NCT02663518|459747272|FG006|Part 4: Phase 1b Dose Optimization|Death|0|||
127759859|NCT02663518|459747273|FG007|Part 4: Phase 1b Dose Optimization|Death|0|||
127759860|NCT02663518|459747274|FG008|Part 4: Phase 1b Dose Optimization|Death|0|||
127759861|NCT02663518|459747275|FG009|Part 4: Phase 1b Dose Optimization|Death|0|||
127759862|NCT02663518|459747276|FG010|Part 4: Phase 1b Dose Optimization|Death|2|||
127759863|NCT02663518|459747277|FG011|Part 4: Phase 1b Dose Optimization|Death|0|||
127759864|NCT02663518|459747278|FG012|Part 4: Phase 1b Dose Optimization|Death|5|||
127759865|NCT02663518|459747279|FG013|Part 4: Phase 1b Dose Optimization|Death|1|||
127759866|NCT02663518|459747266|FG000|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
127759867|NCT02663518|459747267|FG001|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
127759868|NCT02663518|459747268|FG002|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
127759869|NCT02663518|459747269|FG003|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
127759870|NCT02663518|459747270|FG004|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
127759871|NCT02663518|459747271|FG005|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
127759872|NCT02663518|459747272|FG006|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
127759873|NCT02663518|459747273|FG007|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
127759874|NCT02663518|459747274|FG008|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
127759875|NCT02663518|459747275|FG009|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
127759876|NCT02663518|459747276|FG010|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
127759877|NCT02663518|459747277|FG011|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
127759878|NCT02663518|459747278|FG012|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|1|||
127759879|NCT02663518|459747279|FG013|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
127759880|NCT02663518|459747266|FG000|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
127759881|NCT02663518|459747267|FG001|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
127759882|NCT02663518|459747268|FG002|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
127759883|NCT02663518|459747269|FG003|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
127759884|NCT02663518|459747270|FG004|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
127759885|NCT02663518|459747271|FG005|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
127759886|NCT02663518|459747272|FG006|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
127759887|NCT02663518|459747273|FG007|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
127759888|NCT02663518|459747274|FG008|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
127759889|NCT02663518|459747275|FG009|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
127759890|NCT02663518|459747276|FG010|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
127759891|NCT02663518|459747277|FG011|Part 4: Phase 1b Dose Optimization|Progressive Disease|1|||
127759892|NCT02663518|459747278|FG012|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
127759893|NCT02663518|459747279|FG013|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
127759894|NCT02663518|459747266|FG000|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
127759895|NCT02663518|459747267|FG001|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
127759896|NCT02663518|459747268|FG002|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
127759897|NCT02663518|459747269|FG003|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
127759898|NCT02663518|459747270|FG004|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
127759899|NCT02663518|459747271|FG005|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
127759900|NCT02663518|459747272|FG006|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
127759901|NCT02663518|459747273|FG007|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
127759902|NCT02663518|459747274|FG008|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
127759903|NCT02663518|459747275|FG009|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|2|||
127759904|NCT02663518|459747276|FG010|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
127759905|NCT02663518|459747277|FG011|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
127759906|NCT02663518|459747278|FG012|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
127759907|NCT02663518|459747279|FG013|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
127759908|NCT02663518|459747266|FG000|Part 4: Phase 1b Dose Optimization|Other|0|||
127759909|NCT02663518|459747267|FG001|Part 4: Phase 1b Dose Optimization|Other|0|||
127759910|NCT02663518|459747268|FG002|Part 4: Phase 1b Dose Optimization|Other|0|||
127759911|NCT02663518|459747269|FG003|Part 4: Phase 1b Dose Optimization|Other|0|||
127759912|NCT02663518|459747270|FG004|Part 4: Phase 1b Dose Optimization|Other|0|||
127759913|NCT02663518|459747271|FG005|Part 4: Phase 1b Dose Optimization|Other|0|||
127759914|NCT02663518|459747272|FG006|Part 4: Phase 1b Dose Optimization|Other|0|||
127759915|NCT02663518|459747273|FG007|Part 4: Phase 1b Dose Optimization|Other|0|||
127759916|NCT02663518|459747274|FG008|Part 4: Phase 1b Dose Optimization|Other|0|||
127759917|NCT02663518|459747275|FG009|Part 4: Phase 1b Dose Optimization|Other|0|||
127759918|NCT02663518|459747276|FG010|Part 4: Phase 1b Dose Optimization|Other|1|||
127759919|NCT02663518|459747277|FG011|Part 4: Phase 1b Dose Optimization|Other|1|||
127759920|NCT02663518|459747278|FG012|Part 4: Phase 1b Dose Optimization|Other|0|||
127759921|NCT02663518|459747279|FG013|Part 4: Phase 1b Dose Optimization|Other|1|||
127759922|NCT02663518|459747266|FG000|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
127759923|NCT02663518|459747267|FG001|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
127759924|NCT02663518|459747268|FG002|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
127759925|NCT02663518|459747269|FG003|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
127759926|NCT02663518|459747270|FG004|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
127759927|NCT02663518|459747271|FG005|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
127759928|NCT02663518|459747272|FG006|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
127759929|NCT02663518|459747273|FG007|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
127759930|NCT02663518|459747274|FG008|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
127759931|NCT02663518|459747275|FG009|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
127759932|NCT02663518|459747276|FG010|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
127759933|NCT02663518|459747277|FG011|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
127759934|NCT02663518|459747278|FG012|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|1|||
127759935|NCT02663518|459747279|FG013|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
127759936|NCT03896152|459747280|FG000|Overall Study|Patient/guardian decision|1|||
127759937|NCT03896152|459747281|FG001|Overall Study|Patient/guardian decision|1|||
127759938|NCT03896152|459747280|FG000|Overall Study|Adverse Event|0|||
127759939|NCT03896152|459747281|FG001|Overall Study|Adverse Event|1|||
127759940|NCT03896152|459747280|FG000|Overall Study|Physician Decision|1|||
127759941|NCT03896152|459747281|FG001|Overall Study|Physician Decision|0|||
127759942|NCT03896152|459747280|FG000|Overall Study|Technical problems|1|||
127759943|NCT03896152|459747281|FG001|Overall Study|Technical problems|0|||
127759944|NCT00943852|459747282|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
127759945|NCT00943852|459747283|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
127759946|NCT00943852|459747284|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
127759947|NCT00943852|459747285|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
127759948|NCT00943852|459747286|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
127759949|NCT00943852|459747287|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
127759950|NCT00943852|459747288|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
127759951|NCT00943852|459747289|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
127759952|NCT00943852|459747290|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
127759953|NCT00943852|459747291|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
127759954|NCT00943852|459747282|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
127759955|NCT00943852|459747283|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
127759956|NCT00943852|459747284|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
127759957|NCT00943852|459747285|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
127759958|NCT00943852|459747286|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
127759959|NCT00943852|459747287|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
127759960|NCT00943852|459747288|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
127759961|NCT00943852|459747289|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
127759962|NCT00943852|459747290|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
127759963|NCT00943852|459747291|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
127759964|NCT00943852|459747282|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
127759965|NCT00943852|459747283|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
127759966|NCT00943852|459747284|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
127759967|NCT00943852|459747285|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
127759968|NCT00943852|459747286|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
127759969|NCT00943852|459747287|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
127759970|NCT00943852|459747288|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
127759971|NCT00943852|459747289|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
127759972|NCT00943852|459747290|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
127759973|NCT00943852|459747291|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
127759974|NCT00943852|459747282|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
127759975|NCT00943852|459747283|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
127759976|NCT00943852|459747284|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
127759977|NCT00943852|459747285|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
127759978|NCT00943852|459747286|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
127759979|NCT00943852|459747287|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
127759980|NCT00943852|459747288|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
127759981|NCT00943852|459747289|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
127759982|NCT00943852|459747290|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
127759983|NCT00943852|459747291|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
127759984|NCT00943852|459747282|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
127759985|NCT00943852|459747283|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
127759986|NCT00943852|459747284|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
127759987|NCT00943852|459747285|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
127759988|NCT00943852|459747286|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
127759989|NCT00943852|459747287|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
127759990|NCT00943852|459747288|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
127759991|NCT00943852|459747289|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
127759992|NCT00943852|459747290|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
127759993|NCT00943852|459747291|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
127759994|NCT00941070|459747293|FG000|Overall Study|Patient non-compliant|1|||
127759995|NCT04075994|459747294|FG000|Overall Study|Withdrawal by Subject|8|||
127759996|NCT04075994|459747295|FG001|Overall Study|Withdrawal by Subject|9|||
127759997|NCT04075994|459747294|FG000|Overall Study|Adverse Event|2|||
127759998|NCT04075994|459747295|FG001|Overall Study|Adverse Event|2|||
127759999|NCT04075994|459747294|FG000|Overall Study|Investigator withdrew|3|||
127760000|NCT04075994|459747295|FG001|Overall Study|Investigator withdrew|1|||
127760001|NCT01125514|459747303|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
127760002|NCT01125514|459747303|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
127760003|NCT01125514|459747303|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
127760004|NCT01125514|459747303|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
127760005|NCT01125514|459747303|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
127760006|NCT01125514|459747303|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
127648711|NCT02313909|459335263|FG000|Overall Study|Lost to Follow-up|24|||
127648712|NCT02313909|459335264|FG001|Overall Study|Lost to Follow-up|17|||
127648713|NCT01896869|459335276|FG000|Overall Study|Withdrawal by Subject|0|||
127648714|NCT01896869|459335277|FG001|Overall Study|Withdrawal by Subject|6|||
127648715|NCT01896869|459335276|FG000|Overall Study|Lost to Follow-up|1|||
127648716|NCT01896869|459335277|FG001|Overall Study|Lost to Follow-up|0|||
127648717|NCT00454571|459335280|FG000|Overall Study|Adverse Event|2|||
127648718|NCT00454571|459335281|FG001|Overall Study|Adverse Event|0|||
127648719|NCT00454571|459335280|FG000|Overall Study|Physician Decision|0|||
127648720|NCT00454571|459335281|FG001|Overall Study|Physician Decision|1|||
127648721|NCT00454571|459335280|FG000|Overall Study|Protocol Violation|1|||
127648722|NCT00454571|459335281|FG001|Overall Study|Protocol Violation|0|||
127648723|NCT00454571|459335280|FG000|Overall Study|Withdrawal by Subject|10|||
127648724|NCT00454571|459335281|FG001|Overall Study|Withdrawal by Subject|5|||
127648725|NCT02657317|459335282|FG000|Overall Study|Withdrawal by Subject|2|||
127648726|NCT02657317|459335283|FG001|Overall Study|Withdrawal by Subject|0|||
127648727|NCT02657317|459335282|FG000|Overall Study|Lost to Follow-up|3|||
127648728|NCT02657317|459335283|FG001|Overall Study|Lost to Follow-up|3|||
127648729|NCT01201811|459335284|FG000|Overall Study|Adverse Event|6|||
127648730|NCT01201811|459335284|FG000|Overall Study|Disease progression|3|||
127648731|NCT01201811|459335284|FG000|Overall Study|Withdrawal by Subject|3|||
127648732|NCT01201811|459335284|FG000|Overall Study|Death|4|||
127648733|NCT01201811|459335284|FG000|Overall Study|Treatment Failure|2|||
127648734|NCT01201811|459335284|FG000|Overall Study|Physician Decision|1|||
127648735|NCT01089374|459335285|FG000|Overall Study|Lost to Follow-up|3|||
127648736|NCT01089374|459335286|FG001|Overall Study|Lost to Follow-up|0|||
127648737|NCT01089374|459335285|FG000|Overall Study|Withdrawal by Subject|1|||
127648738|NCT01089374|459335286|FG001|Overall Study|Withdrawal by Subject|0|||
127648739|NCT01089374|459335285|FG000|Overall Study|Study closed early - low accrual|6|||
127648740|NCT01089374|459335286|FG001|Overall Study|Study closed early - low accrual|0|||
127648741|NCT02856113|459335287|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
127648742|NCT02856113|459335288|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
127648743|NCT02856113|459335287|FG000|Overall Study|Significant Protocol Deviation|1|||
127648744|NCT02856113|459335288|FG001|Overall Study|Significant Protocol Deviation|0|||
127648745|NCT02856113|459335287|FG000|Overall Study|Lost to Follow-up|3|||
127648746|NCT02856113|459335288|FG001|Overall Study|Lost to Follow-up|5|||
127648747|NCT02856113|459335287|FG000|Overall Study|Voluntary Withdrawal|3|||
127648748|NCT02856113|459335288|FG001|Overall Study|Voluntary Withdrawal|5|||
127648749|NCT02856113|459335287|FG000|Overall Study|Pregnancy|0|||
127648750|NCT02856113|459335288|FG001|Overall Study|Pregnancy|1|||
127648751|NCT02856113|459335287|FG000|Overall Study|Principal Investigator Discretion|2|||
127648752|NCT02856113|459335288|FG001|Overall Study|Principal Investigator Discretion|1|||
127648753|NCT02856113|459335287|FG000|Overall Study|Randomized but not Treated|1|||
127760007|NCT00858364|459747306|FG000|Overall Study|Administrative Decision|3|||
127648754|NCT02856113|459335288|FG001|Overall Study|Randomized but not Treated|0|||
127648755|NCT02856113|459335287|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
127648756|NCT02856113|459335288|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
127648757|NCT03494166|459335289|FG000|Overall Study|Death|0|||
127648758|NCT03494166|459335290|FG001|Overall Study|Death|0|||
127648759|NCT03494166|459335291|FG002|Overall Study|Death|0|||
127648760|NCT03494166|459335292|FG003|Overall Study|Death|1|||
127648761|NCT03494166|459335293|FG004|Overall Study|Death|3|||
127648762|NCT03494166|459335294|FG005|Overall Study|Death|0|||
127760008|NCT00858364|459747307|FG001|Overall Study|Administrative Decision|2|||
127760009|NCT00858364|459747306|FG000|Overall Study|Adverse Event|5|||
127760010|NCT00858364|459747307|FG001|Overall Study|Adverse Event|2|||
127760011|NCT00858364|459747306|FG000|Overall Study|Withdrawal by Subject|44|||
127760012|NCT00858364|459747307|FG001|Overall Study|Withdrawal by Subject|118|||
127760013|NCT00858364|459747306|FG000|Overall Study|Ineligibility Determined|1|||
127760014|NCT00858364|459747307|FG001|Overall Study|Ineligibility Determined|10|||
127760015|NCT00858364|459747306|FG000|Overall Study|Lost to Follow-up|24|||
127760016|NCT00858364|459747307|FG001|Overall Study|Lost to Follow-up|54|||
127760017|NCT00858364|459747306|FG000|Overall Study|Noncompliance|3|||
127760018|NCT00858364|459747307|FG001|Overall Study|Noncompliance|4|||
127760019|NCT00858364|459747306|FG000|Overall Study|Protocol Deviation|0|||
127760020|NCT00858364|459747307|FG001|Overall Study|Protocol Deviation|2|||
127760021|NCT00858364|459747306|FG000|Overall Study|Other|9|||
127760022|NCT00858364|459747307|FG001|Overall Study|Other|17|||
127760023|NCT00858364|459747306|FG000|Overall Study|Missing|1|||
127760024|NCT00858364|459747307|FG001|Overall Study|Missing|1|||
127760025|NCT00858364|459747306|FG000|Overall Study|Still on-study|114|||
127760026|NCT00858364|459747307|FG001|Overall Study|Still on-study|247|||
127760027|NCT02755818|459747308|FG000|Overall Study|Withdrawal by Subject|0|||
127760028|NCT02755818|459747309|FG001|Overall Study|Withdrawal by Subject|0|||
127760029|NCT02755818|459747310|FG002|Overall Study|Withdrawal by Subject|0|||
127760030|NCT02755818|459747311|FG003|Overall Study|Withdrawal by Subject|2|||
127760031|NCT02755818|459747308|FG000|Overall Study|withdrawal by PI|0|||
127760032|NCT02755818|459747309|FG001|Overall Study|withdrawal by PI|0|||
127760033|NCT02755818|459747310|FG002|Overall Study|withdrawal by PI|1|||
127760034|NCT02755818|459747311|FG003|Overall Study|withdrawal by PI|1|||
127760035|NCT02535091|459747314|FG000|Overall Study|Entered Expanded Access Program (EAP)/Navigator|34|||
127760036|NCT02535091|459747315|FG001|Overall Study|Entered Expanded Access Program (EAP)/Navigator|18|||
127760037|NCT02535091|459747316|FG002|Overall Study|Entered Expanded Access Program (EAP)/Navigator|575|||
127760038|NCT02535091|459747314|FG000|Overall Study|Withdrawal by Subject|14|||
127760039|NCT02535091|459747315|FG001|Overall Study|Withdrawal by Subject|5|||
127760040|NCT02535091|459747316|FG002|Overall Study|Withdrawal by Subject|121|||
127760041|NCT02535091|459747314|FG000|Overall Study|Adverse Event|9|||
127760042|NCT02535091|459747315|FG001|Overall Study|Adverse Event|4|||
127760043|NCT02535091|459747316|FG002|Overall Study|Adverse Event|170|||
127760044|NCT02535091|459747314|FG000|Overall Study|Other|4|||
127760045|NCT02535091|459747315|FG001|Overall Study|Other|3|||
127760046|NCT02535091|459747316|FG002|Overall Study|Other|81|||
127760047|NCT02535091|459747314|FG000|Overall Study|Lost to Follow-up|0|||
127760048|NCT02535091|459747315|FG001|Overall Study|Lost to Follow-up|1|||
127760049|NCT02535091|459747316|FG002|Overall Study|Lost to Follow-up|19|||
127760050|NCT02535091|459747314|FG000|Overall Study|Protocol Violation|0|||
127760051|NCT02535091|459747315|FG001|Overall Study|Protocol Violation|1|||
127760052|NCT02535091|459747316|FG002|Overall Study|Protocol Violation|11|||
127760053|NCT02535091|459747314|FG000|Overall Study|Pregnancy|0|||
127760054|NCT02535091|459747315|FG001|Overall Study|Pregnancy|0|||
127760055|NCT02535091|459747316|FG002|Overall Study|Pregnancy|7|||
127760056|NCT02601300|459747317|FG000|Induction Phase|Lack of Efficacy|2|||
127760057|NCT02601300|459747317|FG000|Induction Phase|Protocol Violation|1|||
127760058|NCT02601300|459747317|FG000|Extension Phase|Withdrawal by Subject|3|||
127760059|NCT02601300|459747317|FG000|Extension Phase|Adverse Event|4|||
127760060|NCT02601300|459747317|FG000|Extension Phase|Lack of Efficacy|10|||
127760061|NCT01127763|459747318|FG000|Overall Study|Adverse Event|2|||
127760062|NCT01127763|459747318|FG000|Overall Study|Withdrawal by Subject|1|||
127760063|NCT01127763|459747318|FG000|Overall Study|Physician Decision|2|||
127760064|NCT00992225|459747321|FG000|Overall Study|Entry Criteria Not Met|8|||
127760065|NCT00992225|459747321|FG000|Overall Study|Adverse Event|2|||
127760066|NCT00738894|459747322|FG000|Overall Study|Lost to Follow-up|23|||
127760067|NCT00738894|459747323|FG001|Overall Study|Lost to Follow-up|13|||
127760068|NCT00738894|459747322|FG000|Overall Study|Withdrawal by Subject|10|||
127760069|NCT00738894|459747323|FG001|Overall Study|Withdrawal by Subject|15|||
127760070|NCT00738894|459747322|FG000|Overall Study|Physician Decision|4|||
127870783|NCT02221882|460145119|FG000|Overall Study|Withdrawal by Subject|0|||
127870784|NCT02221882|460145120|FG001|Overall Study|Withdrawal by Subject|0|||
127870785|NCT02221882|460145121|FG002|Overall Study|Withdrawal by Subject|4|||
127760071|NCT00738894|459747323|FG001|Overall Study|Physician Decision|5|||
127760072|NCT00738894|459747322|FG000|Overall Study|Death|2|||
127760073|NCT00738894|459747323|FG001|Overall Study|Death|0|||
127760074|NCT02546921|459747329|FG000|Overall Study|Adverse Event|0|||
127760075|NCT02546921|459747330|FG001|Overall Study|Adverse Event|5|||
127760076|NCT02546921|459747331|FG002|Overall Study|Adverse Event|2|||
127760077|NCT02546921|459747332|FG003|Overall Study|Adverse Event|0|||
127760078|NCT02546921|459747333|FG004|Overall Study|Adverse Event|0|||
127760079|NCT02546921|459747334|FG005|Overall Study|Adverse Event|0|||
127760080|NCT02546921|459747335|FG006|Overall Study|Adverse Event|0|||
127760081|NCT02546921|459747329|FG000|Overall Study|Evidence of Disease Progression|1|||
127760082|NCT02546921|459747330|FG001|Overall Study|Evidence of Disease Progression|0|||
127760083|NCT02546921|459747331|FG002|Overall Study|Evidence of Disease Progression|0|||
127760084|NCT02546921|459747332|FG003|Overall Study|Evidence of Disease Progression|0|||
127760085|NCT02546921|459747333|FG004|Overall Study|Evidence of Disease Progression|1|||
127760086|NCT02546921|459747334|FG005|Overall Study|Evidence of Disease Progression|0|||
127760087|NCT02546921|459747335|FG006|Overall Study|Evidence of Disease Progression|0|||
127760088|NCT02546921|459747329|FG000|Overall Study|Patient Choice|0|||
127760089|NCT02546921|459747330|FG001|Overall Study|Patient Choice|1|||
127760090|NCT02546921|459747331|FG002|Overall Study|Patient Choice|0|||
127760091|NCT02546921|459747332|FG003|Overall Study|Patient Choice|0|||
127760092|NCT02546921|459747333|FG004|Overall Study|Patient Choice|0|||
127760093|NCT02546921|459747334|FG005|Overall Study|Patient Choice|1|||
127760094|NCT02546921|459747335|FG006|Overall Study|Patient Choice|0|||
127760095|NCT03026075|459747339|FG000|Overall Study|Physician Decision|1|||
127760096|NCT01934790|459747347|FG000|Treatment|Adverse Event|3|||
127760097|NCT01934790|459747347|FG000|Treatment|Clinical progression|6|||
127760098|NCT01934790|459747347|FG000|Treatment|Radiological progression|4|||
127760099|NCT01934790|459747347|FG000|Treatment|Withdrawal by Subject|2|||
127760100|NCT01934790|459747347|FG000|Treatment|Study drug never administered|1|||
127760101|NCT01934790|459747347|FG000|Active Follow up|Death|20|||
127760102|NCT01934790|459747347|FG000|Active Follow up|Physician Decision|2|||
127760103|NCT01934790|459747347|FG000|Active Follow up|Progressive disease|1|||
127760104|NCT01934790|459747347|FG000|Active Follow up|Other reason|1|||
127760105|NCT03798691|459747348|FG000|Overall Study|Lost to Follow-up|2|||
127760106|NCT03798691|459747349|FG001|Overall Study|Lost to Follow-up|2|||
127760107|NCT01144377|459747352|FG000|52 Week Treatment Period|Adverse Event|0|||
127760108|NCT01144377|459747353|FG001|52 Week Treatment Period|Adverse Event|0|||
127760109|NCT01144377|459747354|FG002|52 Week Treatment Period|Adverse Event|3|||
127760110|NCT01144377|459747355|FG003|52 Week Treatment Period|Adverse Event|2|||
127760111|NCT01144377|459747356|FG004|52 Week Treatment Period|Adverse Event|1|||
127870786|NCT02221882|460145122|FG003|Overall Study|Withdrawal by Subject|2|||
127870787|NCT02221882|460145123|FG004|Overall Study|Withdrawal by Subject|2|||
127870788|NCT02221882|460145124|FG005|Overall Study|Withdrawal by Subject|2|||
127870789|NCT02221882|460145119|FG000|Overall Study|Death|0|||
127870790|NCT02221882|460145120|FG001|Overall Study|Death|1|||
127870791|NCT02221882|460145121|FG002|Overall Study|Death|0|||
127870792|NCT02221882|460145122|FG003|Overall Study|Death|0|||
127870793|NCT02221882|460145123|FG004|Overall Study|Death|0|||
127870794|NCT02221882|460145124|FG005|Overall Study|Death|0|||
127642269|NCT03252587|459310078|FG000|Overall Study|Lack of Efficacy|7|||
127642270|NCT03252587|459310079|FG001|Overall Study|Lack of Efficacy|2|||
127760112|NCT01144377|459747352|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
127760113|NCT01144377|459747353|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
127760114|NCT01144377|459747354|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
127760115|NCT01144377|459747355|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
127760116|NCT01144377|459747356|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
127760117|NCT01144377|459747352|FG000|52 Week Treatment Period|Protocol Violation|0|||
127760118|NCT01144377|459747353|FG001|52 Week Treatment Period|Protocol Violation|0|||
127760119|NCT01144377|459747354|FG002|52 Week Treatment Period|Protocol Violation|0|||
127760120|NCT01144377|459747355|FG003|52 Week Treatment Period|Protocol Violation|0|||
127760121|NCT01144377|459747356|FG004|52 Week Treatment Period|Protocol Violation|1|||
127760122|NCT01144377|459747352|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
127760123|NCT01144377|459747353|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
127760124|NCT01144377|459747354|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
127760125|NCT01144377|459747355|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
127760126|NCT01144377|459747356|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
127760127|NCT01144377|459747352|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
127760128|NCT01144377|459747353|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
127760129|NCT01144377|459747354|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
127760130|NCT01144377|459747355|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
127760131|NCT01144377|459747356|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
127760132|NCT01144377|459747352|FG000|52 Week Treatment Period|Sponsor Decision|0|||
127760133|NCT01144377|459747353|FG001|52 Week Treatment Period|Sponsor Decision|0|||
127760134|NCT01144377|459747354|FG002|52 Week Treatment Period|Sponsor Decision|0|||
127760135|NCT01144377|459747355|FG003|52 Week Treatment Period|Sponsor Decision|0|||
127760136|NCT01144377|459747356|FG004|52 Week Treatment Period|Sponsor Decision|1|||
127760137|NCT01144377|459747352|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
127760138|NCT01144377|459747353|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
127760139|NCT01144377|459747354|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
127760140|NCT01144377|459747355|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
127760141|NCT01144377|459747356|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
127760142|NCT01144377|459747352|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
127760143|NCT01144377|459747353|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
127760144|NCT01144377|459747354|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
127870795|NCT00796367|460145125|FG000|Overall Study|Adverse Event|6|||
127870796|NCT00796367|460145126|FG001|Overall Study|Adverse Event|4|||
127760145|NCT01144377|459747355|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
127760146|NCT01144377|459747356|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
127760147|NCT01144377|459747352|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
127760148|NCT01144377|459747353|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
127760149|NCT01144377|459747354|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
127760150|NCT01144377|459747355|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
127760151|NCT01144377|459747356|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
127760152|NCT00607724|459747357|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
127760153|NCT00607724|459747358|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
127760154|NCT00607724|459747359|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
127760155|NCT00607724|459747360|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
127760156|NCT00607724|459747361|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
127760157|NCT00607724|459747362|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
127760158|NCT00607724|459747363|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
127760159|NCT00607724|459747357|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
127760160|NCT00607724|459747358|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
127760161|NCT00607724|459747359|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
127760162|NCT00607724|459747360|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
127760163|NCT00607724|459747361|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
127760164|NCT00607724|459747362|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
127760165|NCT00607724|459747363|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
127760166|NCT00607724|459747357|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
127760167|NCT00607724|459747358|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
127760168|NCT00607724|459747359|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
127760169|NCT00607724|459747360|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
127760170|NCT00607724|459747361|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
127760171|NCT00607724|459747362|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
127760172|NCT00607724|459747363|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
127760173|NCT00607724|459747357|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
127760174|NCT00607724|459747358|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
127760175|NCT00607724|459747359|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
127760176|NCT00607724|459747360|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
127760177|NCT00607724|459747361|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
127760178|NCT00607724|459747362|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
127760179|NCT00607724|459747363|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
127760180|NCT00607724|459747357|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
127760181|NCT00607724|459747358|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
127760182|NCT00607724|459747359|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
127760183|NCT00607724|459747360|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
127760184|NCT00607724|459747361|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
127760185|NCT00607724|459747362|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
127760186|NCT00607724|459747363|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
127760187|NCT03738423|459747364|FG000|Overall Study|Withdrawal by Subject|9|||
127760188|NCT03738423|459747365|FG001|Overall Study|Withdrawal by Subject|12|||
127760189|NCT03738423|459747366|FG002|Overall Study|Withdrawal by Subject|9|||
127760190|NCT03738423|459747367|FG003|Overall Study|Withdrawal by Subject|12|||
127760191|NCT03738423|459747368|FG004|Overall Study|Withdrawal by Subject|10|||
127760192|NCT03738423|459747364|FG000|Overall Study|Lack of Efficacy|3|||
127760193|NCT03738423|459747365|FG001|Overall Study|Lack of Efficacy|1|||
127760194|NCT03738423|459747366|FG002|Overall Study|Lack of Efficacy|1|||
127760195|NCT03738423|459747367|FG003|Overall Study|Lack of Efficacy|1|||
127760196|NCT03738423|459747368|FG004|Overall Study|Lack of Efficacy|2|||
127760197|NCT03738423|459747364|FG000|Overall Study|Lost to Follow-up|1|||
127760198|NCT03738423|459747365|FG001|Overall Study|Lost to Follow-up|0|||
127870797|NCT00796367|460145127|FG002|Overall Study|Adverse Event|7|||
127870798|NCT00796367|460145125|FG000|Overall Study|Lost to Follow-up|5|||
127870799|NCT00796367|460145126|FG001|Overall Study|Lost to Follow-up|4|||
127870800|NCT00796367|460145127|FG002|Overall Study|Lost to Follow-up|21|||
127870801|NCT00796367|460145125|FG000|Overall Study|Withdrawal by Subject|9|||
127870802|NCT00796367|460145126|FG001|Overall Study|Withdrawal by Subject|11|||
127870803|NCT00796367|460145127|FG002|Overall Study|Withdrawal by Subject|12|||
127870804|NCT00796367|460145125|FG000|Overall Study|Lack of Efficacy|2|||
127870805|NCT00796367|460145126|FG001|Overall Study|Lack of Efficacy|1|||
127870806|NCT00796367|460145127|FG002|Overall Study|Lack of Efficacy|0|||
127870807|NCT00796367|460145125|FG000|Overall Study|non compliance|3|||
127870808|NCT00796367|460145126|FG001|Overall Study|non compliance|1|||
127870809|NCT00796367|460145127|FG002|Overall Study|non compliance|1|||
127870810|NCT00796367|460145125|FG000|Overall Study|Pregnancy|1|||
127870811|NCT00796367|460145126|FG001|Overall Study|Pregnancy|0|||
127870812|NCT00796367|460145127|FG002|Overall Study|Pregnancy|1|||
127870813|NCT00796367|460145125|FG000|Overall Study|Requirement for restricted medication|2|||
127870814|NCT00796367|460145126|FG001|Overall Study|Requirement for restricted medication|0|||
127870815|NCT00796367|460145127|FG002|Overall Study|Requirement for restricted medication|2|||
127870816|NCT00796367|460145125|FG000|Overall Study|other|2|||
127870817|NCT00796367|460145126|FG001|Overall Study|other|4|||
127870818|NCT00796367|460145127|FG002|Overall Study|other|3|||
127870819|NCT05664672|460145128|FG000|Overall Study|Adverse Event|0|||
127870820|NCT05664672|460145129|FG001|Overall Study|Adverse Event|0|||
127870821|NCT05664672|460145130|FG002|Overall Study|Adverse Event|0|||
127870822|NCT05664672|460145131|FG003|Overall Study|Adverse Event|0|||
127870823|NCT05664672|460145132|FG004|Overall Study|Adverse Event|0|||
127870824|NCT05664672|460145133|FG005|Overall Study|Adverse Event|1|||
127870825|NCT05664672|460145128|FG000|Overall Study|Withdrawal by Subject|0|||
127870826|NCT05664672|460145129|FG001|Overall Study|Withdrawal by Subject|1|||
127870827|NCT05664672|460145130|FG002|Overall Study|Withdrawal by Subject|3|||
127870828|NCT05664672|460145131|FG003|Overall Study|Withdrawal by Subject|0|||
127870829|NCT05664672|460145132|FG004|Overall Study|Withdrawal by Subject|5|||
127870830|NCT05664672|460145133|FG005|Overall Study|Withdrawal by Subject|6|||
127870831|NCT05664672|460145128|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
127870832|NCT05664672|460145129|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
127870833|NCT05664672|460145130|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
127870834|NCT05664672|460145131|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
127870835|NCT05664672|460145132|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
127870836|NCT05664672|460145133|FG005|Overall Study|Failure to Meet Randomization Criteria|0|||
127870837|NCT05664672|460145128|FG000|Overall Study|Met Eligibility Criteria But Not Needed|1|||
127870838|NCT05664672|460145129|FG001|Overall Study|Met Eligibility Criteria But Not Needed|0|||
127870839|NCT05664672|460145130|FG002|Overall Study|Met Eligibility Criteria But Not Needed|0|||
127870840|NCT05664672|460145131|FG003|Overall Study|Met Eligibility Criteria But Not Needed|0|||
127870841|NCT05664672|460145132|FG004|Overall Study|Met Eligibility Criteria But Not Needed|0|||
127870842|NCT05664672|460145133|FG005|Overall Study|Met Eligibility Criteria But Not Needed|0|||
127870843|NCT02370173|460145144|FG000|Overall Study|Protocol Violation|1|||
127870844|NCT02370173|460145145|FG001|Overall Study|Protocol Violation|1|||
127870845|NCT02370173|460145144|FG000|Overall Study|Withdrawal by Subject|2|||
127870846|NCT02370173|460145145|FG001|Overall Study|Withdrawal by Subject|2|||
127870847|NCT04236986|460145146|FG000|Overall Study|Withdrawal by Subject|3|||
127870848|NCT04236986|460145147|FG001|Overall Study|Withdrawal by Subject|1|||
127870849|NCT04034225|460145148|FG000|Overall Study|Death|3|||
127870850|NCT04034225|460145148|FG000|Overall Study|Withdrawal by Subject|2|||
127870851|NCT04034225|460145148|FG000|Overall Study|Study termination by Sponsor|18|||
127870852|NCT04034225|460145148|FG000|Overall Study|Physician Decision|1|||
127870853|NCT04034225|460145148|FG000|Overall Study|Lack of Efficacy|1|||
127870854|NCT01326481|460145154|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
127870855|NCT00307736|460145155|FG000|Overall Study|Adverse Event|0|||
127870856|NCT00307736|460145156|FG001|Overall Study|Adverse Event|0|||
127870857|NCT00307736|460145157|FG002|Overall Study|Adverse Event|1|||
127870858|NCT00307736|460145158|FG003|Overall Study|Adverse Event|3|||
127870859|NCT00307736|460145155|FG000|Overall Study|Withdrawal by Subject|0|||
127870860|NCT00307736|460145156|FG001|Overall Study|Withdrawal by Subject|0|||
127870861|NCT00307736|460145157|FG002|Overall Study|Withdrawal by Subject|2|||
127870862|NCT00307736|460145158|FG003|Overall Study|Withdrawal by Subject|0|||
127870863|NCT02260791|460145161|FG000|Overall Study|Lost to Follow-up|4|||
127870864|NCT02260791|460145162|FG001|Overall Study|Lost to Follow-up|4|||
127870865|NCT02260791|460145161|FG000|Overall Study|Lack of Efficacy|2|||
127870866|NCT02260791|460145162|FG001|Overall Study|Lack of Efficacy|1|||
127870867|NCT02260791|460145161|FG000|Overall Study|Adverse Event|13|||
127870868|NCT02260791|460145162|FG001|Overall Study|Adverse Event|9|||
127870869|NCT02260791|460145161|FG000|Overall Study|Death|1|||
127870870|NCT02260791|460145162|FG001|Overall Study|Death|0|||
127870871|NCT02260791|460145161|FG000|Overall Study|Withdrawal by Subject|11|||
127870872|NCT02260791|460145162|FG001|Overall Study|Withdrawal by Subject|16|||
127870873|NCT02260791|460145161|FG000|Overall Study|Screen failure|0|||
127870874|NCT02260791|460145162|FG001|Overall Study|Screen failure|1|||
127870875|NCT02260791|460145161|FG000|Overall Study|Protocol deviation|2|||
127870876|NCT02260791|460145162|FG001|Overall Study|Protocol deviation|3|||
127870877|NCT04246996|460145164|FG000|Overall Study|Physician Decision|1|||
127870878|NCT04246996|460145165|FG001|Overall Study|Physician Decision|1|||
127870879|NCT04246996|460145164|FG000|Overall Study|Did not meet eligibility criteria|1|||
127870880|NCT04246996|460145165|FG001|Overall Study|Did not meet eligibility criteria|4|||
127870881|NCT02442284|460145166|FG000|Overall Study|Adverse Event|1|||
127870882|NCT02442284|460145166|FG000|Overall Study|Withdrew Consent|2|||
127870883|NCT02442284|460145166|FG000|Overall Study|Lost to Follow-up|3|||
127870884|NCT02442284|460145166|FG000|Overall Study|Other|1|||
127870885|NCT01365182|460145167|FG000|Overall Study|Withdrawal by Subject|10|||
127870886|NCT01365182|460145168|FG001|Overall Study|Withdrawal by Subject|13|||
127870887|NCT01365182|460145169|FG002|Overall Study|Withdrawal by Subject|12|||
127870888|NCT04604015|460145172|FG000|Overall Study|Incomplete Data Collection|33|||
127870889|NCT01231620|460145173|FG000|Overall Study|Physician Decision|3|||
127870890|NCT01231620|460145174|FG001|Overall Study|Physician Decision|5|||
127870891|NCT01231620|460145175|FG002|Overall Study|Physician Decision|10|||
127870892|NCT01231620|460145173|FG000|Overall Study|Death|12|||
127870893|NCT01231620|460145174|FG001|Overall Study|Death|14|||
127870894|NCT01231620|460145175|FG002|Overall Study|Death|11|||
127870895|NCT01231620|460145173|FG000|Overall Study|Adverse Event|2|||
127870896|NCT01231620|460145174|FG001|Overall Study|Adverse Event|2|||
127870897|NCT01231620|460145175|FG002|Overall Study|Adverse Event|1|||
127870898|NCT01231620|460145173|FG000|Overall Study|Withdrawal by Subject|6|||
127870899|NCT01231620|460145174|FG001|Overall Study|Withdrawal by Subject|6|||
127870900|NCT01231620|460145175|FG002|Overall Study|Withdrawal by Subject|8|||
127870901|NCT01231620|460145173|FG000|Overall Study|Lost to Follow-up|3|||
127870902|NCT01231620|460145174|FG001|Overall Study|Lost to Follow-up|4|||
127870903|NCT01231620|460145175|FG002|Overall Study|Lost to Follow-up|9|||
127870904|NCT02576652|460145178|FG000|Overall Study|Withdrawal by Subject|2|||
127870905|NCT02985541|460146754|FG000|Overall Study|Withdrawal by Subject|33|||
127870906|NCT02985541|460146754|FG000|Overall Study|Lost to Follow-up|26|||
127870907|NCT02985541|460146754|FG000|Overall Study|Adverse Event|27|||
127870908|NCT02985541|460146754|FG000|Overall Study|Physician Decision|2|||
127870909|NCT02985541|460146754|FG000|Overall Study|Pregnancy|2|||
127870910|NCT02985541|460146754|FG000|Overall Study|Wish for pregnancy|44|||
127870911|NCT02985541|460146754|FG000|Overall Study|Other reason|5|||
127870912|NCT02985541|460146754|FG000|Overall Study|Not valid for analysis|2|||
127870913|NCT00247416|460146757|FG000|Overall Study|3 patients were found to be ineligible|1|||
127870914|NCT00247416|460146758|FG001|Overall Study|3 patients were found to be ineligible|2|||
127870915|NCT00798161|460146759|FG000|Overall Study|Adverse Event|3|||
127870916|NCT00798161|460146760|FG001|Overall Study|Adverse Event|4|||
127870917|NCT00798161|460146761|FG002|Overall Study|Adverse Event|6|||
127870918|NCT00798161|460146762|FG003|Overall Study|Adverse Event|6|||
127870919|NCT00798161|460146763|FG004|Overall Study|Adverse Event|5|||
127870920|NCT00798161|460146764|FG005|Overall Study|Adverse Event|2|||
127870921|NCT00798161|460146765|FG006|Overall Study|Adverse Event|4|||
127870922|NCT00798161|460146759|FG000|Overall Study|Protocol Violation|2|||
127870923|NCT00798161|460146760|FG001|Overall Study|Protocol Violation|1|||
127870924|NCT00798161|460146761|FG002|Overall Study|Protocol Violation|3|||
127870925|NCT00798161|460146762|FG003|Overall Study|Protocol Violation|3|||
127870926|NCT00798161|460146763|FG004|Overall Study|Protocol Violation|3|||
127870927|NCT00798161|460146764|FG005|Overall Study|Protocol Violation|2|||
127870928|NCT00798161|460146765|FG006|Overall Study|Protocol Violation|0|||
127870929|NCT00798161|460146759|FG000|Overall Study|Lost to Follow-up|1|||
127870930|NCT00798161|460146760|FG001|Overall Study|Lost to Follow-up|3|||
127870931|NCT00798161|460146761|FG002|Overall Study|Lost to Follow-up|4|||
127870932|NCT00798161|460146762|FG003|Overall Study|Lost to Follow-up|3|||
127870933|NCT00798161|460146763|FG004|Overall Study|Lost to Follow-up|4|||
127870934|NCT00798161|460146764|FG005|Overall Study|Lost to Follow-up|0|||
127870935|NCT00798161|460146765|FG006|Overall Study|Lost to Follow-up|0|||
127870936|NCT00798161|460146759|FG000|Overall Study|Withdrawal by Subject|5|||
127870937|NCT00798161|460146760|FG001|Overall Study|Withdrawal by Subject|4|||
127870938|NCT00798161|460146761|FG002|Overall Study|Withdrawal by Subject|5|||
127870939|NCT00798161|460146762|FG003|Overall Study|Withdrawal by Subject|4|||
127870940|NCT00798161|460146763|FG004|Overall Study|Withdrawal by Subject|2|||
127870941|NCT00798161|460146764|FG005|Overall Study|Withdrawal by Subject|3|||
127870942|NCT00798161|460146765|FG006|Overall Study|Withdrawal by Subject|1|||
127870943|NCT00798161|460146759|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
127870944|NCT00798161|460146760|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
127870945|NCT00798161|460146761|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
127870946|NCT00798161|460146762|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
127870947|NCT00798161|460146763|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
127870948|NCT00798161|460146764|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
127870949|NCT00798161|460146765|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
127870950|NCT00761761|460146766|FG000|Overall Study|Lost to Follow-up|3|||
127870951|NCT00761761|460146767|FG001|Overall Study|Lost to Follow-up|1|||
127870952|NCT00761761|460146766|FG000|Overall Study|Withdrawal by Subject|3|||
127870953|NCT00761761|460146767|FG001|Overall Study|Withdrawal by Subject|0|||
127648763|NCT03494166|459335289|FG000|Overall Study|Lost to Follow-up|2|||
127870954|NCT04511533|460146771|FG000|Treatment|Other|2|||
127870955|NCT04511533|460146771|FG000|Treatment|Withdrawal by Subject|11|||
127870956|NCT04511533|460146771|FG000|Treatment|Death|5|||
127870957|NCT04511533|460146771|FG000|Treatment|Physician Decision|1|||
127870958|NCT04511533|460146771|FG000|Treatment|Progressive Disease|61|||
127870959|NCT04511533|460146771|FG000|Follow-Up|Other|7|||
127870960|NCT04511533|460146771|FG000|Follow-Up|Withdrawal by Subject|5|||
127648764|NCT03494166|459335290|FG001|Overall Study|Lost to Follow-up|2|||
127870961|NCT04511533|460146771|FG000|Follow-Up|Lost to Follow-up|2|||
127870962|NCT04511533|460146771|FG000|Follow-Up|Death|4|||
127870963|NCT02918968|460146774|FG000|1st Line AAT|Progressive disease|9|||
127870964|NCT02918968|460146775|FG001|1st Line AAT|Progressive disease|4|||
127870965|NCT02918968|460146774|FG000|1st Line AAT|Adverse Event|12|||
127870966|NCT02918968|460146775|FG001|1st Line AAT|Adverse Event|3|||
127536987|NCT01384734|458930029|FG004|Overall Study|Unable to come back for visit|0|||
127760199|NCT03738423|459747366|FG002|Overall Study|Lost to Follow-up|1|||
127760200|NCT03738423|459747367|FG003|Overall Study|Lost to Follow-up|1|||
127760201|NCT03738423|459747368|FG004|Overall Study|Lost to Follow-up|0|||
127760202|NCT03738423|459747364|FG000|Overall Study|Protocol Violation|1|||
127760203|NCT03738423|459747365|FG001|Overall Study|Protocol Violation|0|||
127760204|NCT03738423|459747366|FG002|Overall Study|Protocol Violation|0|||
127760205|NCT03738423|459747367|FG003|Overall Study|Protocol Violation|0|||
127760206|NCT03738423|459747368|FG004|Overall Study|Protocol Violation|1|||
127760207|NCT03738423|459747364|FG000|Overall Study|Physician Decision|0|||
127760208|NCT03738423|459747365|FG001|Overall Study|Physician Decision|0|||
127760209|NCT03738423|459747366|FG002|Overall Study|Physician Decision|1|||
127760210|NCT03738423|459747367|FG003|Overall Study|Physician Decision|0|||
127760211|NCT03738423|459747368|FG004|Overall Study|Physician Decision|1|||
127760212|NCT03738423|459747364|FG000|Overall Study|Death|0|||
127760213|NCT03738423|459747365|FG001|Overall Study|Death|0|||
127760214|NCT03738423|459747366|FG002|Overall Study|Death|0|||
127760215|NCT03738423|459747367|FG003|Overall Study|Death|0|||
127760216|NCT03738423|459747368|FG004|Overall Study|Death|1|||
127760217|NCT03738423|459747364|FG000|Overall Study|Randomized but never treated|0|||
127760218|NCT03738423|459747365|FG001|Overall Study|Randomized but never treated|0|||
127760219|NCT03738423|459747366|FG002|Overall Study|Randomized but never treated|1|||
127760220|NCT03738423|459747367|FG003|Overall Study|Randomized but never treated|1|||
127760221|NCT03738423|459747368|FG004|Overall Study|Randomized but never treated|0|||
127760222|NCT02592876|459747369|FG000|Overall Study|Withdrawal by Subject|3|||
127760223|NCT02592876|459747370|FG001|Overall Study|Withdrawal by Subject|3|||
127760224|NCT02592876|459747369|FG000|Overall Study|Study Termination by Sponsor|32|||
127760225|NCT02592876|459747370|FG001|Overall Study|Study Termination by Sponsor|27|||
127760226|NCT02592876|459747369|FG000|Overall Study|Lost to Follow-up|0|||
127760227|NCT02592876|459747370|FG001|Overall Study|Lost to Follow-up|1|||
127760228|NCT02592876|459747369|FG000|Overall Study|Death|6|||
127760229|NCT02592876|459747370|FG001|Overall Study|Death|9|||
127760230|NCT00611975|459747373|FG000|Overall Study|Withdrawal by Subject|3|||
127760231|NCT00611975|459747374|FG001|Overall Study|Withdrawal by Subject|7|||
127760232|NCT00611975|459747373|FG000|Overall Study|Pregnancy|2|||
127760233|NCT00611975|459747374|FG001|Overall Study|Pregnancy|1|||
127760234|NCT01198756|459748852|FG000|Overall Study|Adverse Event|0|||
127760235|NCT01198756|459748853|FG001|Overall Study|Adverse Event|0|||
127760236|NCT01198756|459748854|FG002|Overall Study|Adverse Event|0|||
127760237|NCT01198756|459748855|FG003|Overall Study|Adverse Event|1|||
127760238|NCT01198756|459748852|FG000|Overall Study|Protocol Violation|0|||
127760239|NCT01198756|459748853|FG001|Overall Study|Protocol Violation|0|||
127760240|NCT01198756|459748854|FG002|Overall Study|Protocol Violation|0|||
127760241|NCT01198756|459748855|FG003|Overall Study|Protocol Violation|2|||
127760242|NCT01198756|459748852|FG000|Overall Study|Withdrawal by Subject|9|||
127760243|NCT01198756|459748853|FG001|Overall Study|Withdrawal by Subject|4|||
127760244|NCT01198756|459748854|FG002|Overall Study|Withdrawal by Subject|7|||
127760245|NCT01198756|459748855|FG003|Overall Study|Withdrawal by Subject|5|||
127760246|NCT01198756|459748852|FG000|Overall Study|Lost to Follow-up|29|||
127760247|NCT01198756|459748853|FG001|Overall Study|Lost to Follow-up|36|||
127760248|NCT01198756|459748854|FG002|Overall Study|Lost to Follow-up|23|||
127760249|NCT01198756|459748855|FG003|Overall Study|Lost to Follow-up|18|||
127760250|NCT05816330|459748861|FG000|Overall Study|Withdrawal by Subject|4|||
127760251|NCT05816330|459748862|FG001|Overall Study|Withdrawal by Subject|1|||
127760252|NCT01353859|459748863|FG000|Overall Study|Adverse Event|3|||
127760253|NCT01353859|459748863|FG000|Overall Study|Lack of Efficacy|1|||
127760254|NCT00700427|459748864|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
127760255|NCT00700427|459748865|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
127760256|NCT00700427|459748866|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
127760257|NCT00700427|459748867|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
127760258|NCT00700427|459748868|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
127760259|NCT00700427|459748864|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
127760260|NCT00700427|459748865|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
127760261|NCT00700427|459748866|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
127760262|NCT00700427|459748867|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
127760263|NCT00700427|459748868|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
127760264|NCT00700427|459748864|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
127760265|NCT00700427|459748865|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
127760266|NCT00700427|459748866|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
127760267|NCT00700427|459748867|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
127760268|NCT00700427|459748868|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
127760269|NCT00700427|459748864|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
127760270|NCT00700427|459748865|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
127760271|NCT00700427|459748866|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
127870967|NCT02918968|460146774|FG000|1st Line AAT|Physician Decision|4|||
127870968|NCT02918968|460146775|FG001|1st Line AAT|Physician Decision|2|||
127870969|NCT02918968|460146774|FG000|1st Line AAT|Withdrawal by Subject|2|||
127870970|NCT02918968|460146775|FG001|1st Line AAT|Withdrawal by Subject|1|||
127870971|NCT02918968|460146774|FG000|1st Line AAT|Lost to Follow-up|0|||
127870972|NCT02918968|460146775|FG001|1st Line AAT|Lost to Follow-up|1|||
127870973|NCT02918968|460146774|FG000|1st Line AAT|Death|1|||
127870974|NCT02918968|460146775|FG001|1st Line AAT|Death|0|||
127870975|NCT02918968|460146774|FG000|1st Line AAT|Miscellaneous|1|||
127870976|NCT02918968|460146775|FG001|1st Line AAT|Miscellaneous|0|||
127870977|NCT02918968|460146774|FG000|2nd Line AAT|Progressive disease|21|||
127870978|NCT02918968|460146775|FG001|2nd Line AAT|Progressive disease|3|||
127870979|NCT02918968|460146774|FG000|2nd Line AAT|Adverse Event|2|||
127870980|NCT02918968|460146775|FG001|2nd Line AAT|Adverse Event|5|||
127870981|NCT02918968|460146774|FG000|2nd Line AAT|Physician Decision|0|||
127870982|NCT02918968|460146775|FG001|2nd Line AAT|Physician Decision|1|||
127870983|NCT02918968|460146774|FG000|2nd Line AAT|Withdrawal by Subject|2|||
127870984|NCT02918968|460146775|FG001|2nd Line AAT|Withdrawal by Subject|2|||
127870985|NCT02918968|460146774|FG000|2nd Line AAT|Death|0|||
127870986|NCT02918968|460146775|FG001|2nd Line AAT|Death|1|||
127870987|NCT00727246|460146780|FG000|Overall Study|could not complete MRI|0|||
127870988|NCT00727246|460146781|FG001|Overall Study|could not complete MRI|1|||
127870989|NCT00727246|460146782|FG002|Overall Study|could not complete MRI|0|||
127870990|NCT00727246|460146783|FG003|Overall Study|could not complete MRI|1|||
127870991|NCT00727246|460146780|FG000|Overall Study|incidental finding|0|||
127870992|NCT00727246|460146781|FG001|Overall Study|incidental finding|0|||
127870993|NCT00727246|460146782|FG002|Overall Study|incidental finding|0|||
127870994|NCT00727246|460146783|FG003|Overall Study|incidental finding|1|||
127870995|NCT00727246|460146780|FG000|Overall Study|withdrawn|0|||
127870996|NCT00727246|460146781|FG001|Overall Study|withdrawn|0|||
127870997|NCT00727246|460146782|FG002|Overall Study|withdrawn|1|||
127870998|NCT00727246|460146783|FG003|Overall Study|withdrawn|0|||
127870999|NCT02696382|460146785|FG000|Overall Study|Death|7|||
127871000|NCT02696382|460146786|FG001|Overall Study|Death|2|||
127871001|NCT02696382|460146785|FG000|Overall Study|Withdrawal by Subject|5|||
127871002|NCT02696382|460146786|FG001|Overall Study|Withdrawal by Subject|12|||
127871003|NCT02696382|460146785|FG000|Overall Study|Lost to Follow-up|4|||
127871004|NCT02696382|460146786|FG001|Overall Study|Lost to Follow-up|7|||
127871005|NCT03781167|460146793|FG000|Overall Study|Adverse Event|23|||
127871006|NCT03781167|460146794|FG001|Overall Study|Adverse Event|25|||
127871007|NCT03781167|460146793|FG000|Overall Study|Withdrew consent|16|||
127871008|NCT03781167|460146794|FG001|Overall Study|Withdrew consent|12|||
127871009|NCT03781167|460146793|FG000|Overall Study|Lost to Follow-up|0|||
127871010|NCT03781167|460146794|FG001|Overall Study|Lost to Follow-up|1|||
127871011|NCT03781167|460146793|FG000|Overall Study|Lack of Efficacy|4|||
127871012|NCT03781167|460146794|FG001|Overall Study|Lack of Efficacy|5|||
127871013|NCT03781167|460146793|FG000|Overall Study|Difficulty with drug delivery system|2|||
127871014|NCT03781167|460146794|FG001|Overall Study|Difficulty with drug delivery system|3|||
127871015|NCT03781167|460146793|FG000|Overall Study|Other, not specified|2|||
127871016|NCT03781167|460146794|FG001|Overall Study|Other, not specified|2|||
127871017|NCT01590628|460146802|FG000|Overall Study|Death|2|||
127871018|NCT01590628|460146803|FG001|Overall Study|Death|0|||
127871019|NCT00475657|460146804|FG000|Overall Study|Death|1|||
127871020|NCT00475657|460146804|FG000|Overall Study|Sponsor's Decision|3|||
127871021|NCT00761735|460146805|FG000|Overall Study|Lost to Follow-up|6|||
127871022|NCT00761735|460146805|FG000|Overall Study|Withdrawal by Subject|6|||
127871023|NCT00761735|460146805|FG000|Overall Study|Non-compliance with protocol|1|||
127871024|NCT00761735|460146805|FG000|Overall Study|Administrative|1|||
127871025|NCT00381680|460146806|FG000|Overall Study|Adverse Event|9|||
127871026|NCT00381680|460146807|FG001|Overall Study|Adverse Event|3|||
127871027|NCT00381680|460146806|FG000|Overall Study|Death|10|||
127871028|NCT00381680|460146807|FG001|Overall Study|Death|7|||
127871029|NCT00381680|460146806|FG000|Overall Study|Lost to Follow-up|3|||
127871030|NCT00381680|460146807|FG001|Overall Study|Lost to Follow-up|2|||
127871031|NCT00381680|460146806|FG000|Overall Study|Physician Decision|25|||
127871032|NCT00381680|460146807|FG001|Overall Study|Physician Decision|6|||
127871033|NCT00381680|460146806|FG000|Overall Study|Withdrawal by Subject|3|||
127871034|NCT00381680|460146807|FG001|Overall Study|Withdrawal by Subject|1|||
127871035|NCT00381680|460146806|FG000|Overall Study|Entry onto another COG Trial|1|||
127871036|NCT00381680|460146807|FG001|Overall Study|Entry onto another COG Trial|2|||
127871037|NCT00381680|460146806|FG000|Overall Study|Alternative Therapy|11|||
127871038|NCT00381680|460146807|FG001|Overall Study|Alternative Therapy|5|||
127871039|NCT00381680|460146806|FG000|Overall Study|Secondary Malignancy|3|||
127871040|NCT00381680|460146807|FG001|Overall Study|Secondary Malignancy|0|||
127871041|NCT00381680|460146806|FG000|Overall Study|Delay initiation|1|||
127871042|NCT00381680|460146807|FG001|Overall Study|Delay initiation|0|||
127871043|NCT00381680|460146806|FG000|Overall Study|Stem Cell Transplant|26|||
127871044|NCT00381680|460146807|FG001|Overall Study|Stem Cell Transplant|10|||
127871045|NCT00381680|460146806|FG000|Overall Study|Relapse|18|||
127871046|NCT00381680|460146807|FG001|Overall Study|Relapse|9|||
127871047|NCT00381680|460146806|FG000|Overall Study|Induction Failure|4|||
127871048|NCT00381680|460146807|FG001|Overall Study|Induction Failure|1|||
127871049|NCT00381680|460146806|FG000|Overall Study|Progression|1|||
127871050|NCT00381680|460146807|FG001|Overall Study|Progression|1|||
127871051|NCT00381680|460146806|FG000|Overall Study|Other not otherwise specified|7|||
127871052|NCT00381680|460146807|FG001|Overall Study|Other not otherwise specified|2|||
127871053|NCT00381680|460146806|FG000|Overall Study|Ineligible|3|||
127871054|NCT00381680|460146807|FG001|Overall Study|Ineligible|1|||
127871055|NCT03099096|460146812|FG000|Overall Study|Adverse Event|1|||
127871056|NCT03099096|460146812|FG000|Overall Study|Physician Decision|1|||
127871057|NCT04626947|460146826|FG000|Overall Study|Study terminated|14|||
127871058|NCT01428882|460146827|FG000|Overall Study|Lack of Efficacy|2|||
127871059|NCT01428882|460146828|FG001|Overall Study|Lack of Efficacy|7|||
127871060|NCT01428882|460146827|FG000|Overall Study|Protocol Violation|4|||
127871061|NCT01428882|460146828|FG001|Overall Study|Protocol Violation|3|||
127871062|NCT00429026|460146831|FG000|Overall Study|Inevaluable for response.|40|||
127871063|NCT03831282|460146832|FG000|Overall Study|Could not place sensor|1|||
127871064|NCT03556202|460146835|FG000|Extension Treatment Period|Adverse Event|18|||
127871065|NCT03556202|460146836|FG001|Extension Treatment Period|Adverse Event|14|||
127871066|NCT03556202|460146837|FG002|Extension Treatment Period|Adverse Event|9|||
127871067|NCT03556202|460146835|FG000|Extension Treatment Period|Death|2|||
127871068|NCT03556202|460146836|FG001|Extension Treatment Period|Death|6|||
127871069|NCT03556202|460146837|FG002|Extension Treatment Period|Death|0|||
127871070|NCT03556202|460146835|FG000|Extension Treatment Period|Lack of Efficacy|5|||
127871071|NCT03556202|460146836|FG001|Extension Treatment Period|Lack of Efficacy|12|||
127871072|NCT03556202|460146837|FG002|Extension Treatment Period|Lack of Efficacy|18|||
127871073|NCT03556202|460146835|FG000|Extension Treatment Period|Lost to Follow-up|9|||
127871074|NCT03556202|460146836|FG001|Extension Treatment Period|Lost to Follow-up|20|||
127871075|NCT03556202|460146837|FG002|Extension Treatment Period|Lost to Follow-up|2|||
127871076|NCT03556202|460146835|FG000|Extension Treatment Period|Pregnancy|2|||
127871077|NCT03556202|460146836|FG001|Extension Treatment Period|Pregnancy|4|||
127871078|NCT03556202|460146837|FG002|Extension Treatment Period|Pregnancy|3|||
127871079|NCT03556202|460146835|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
127871080|NCT03556202|460146836|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
127871081|NCT03556202|460146837|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
127871082|NCT03556202|460146835|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
127871083|NCT03556202|460146836|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
127871084|NCT03556202|460146837|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
127871085|NCT03556202|460146835|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
127871086|NCT03556202|460146836|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
127871087|NCT03556202|460146837|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
127871088|NCT03556202|460146835|FG000|Extension Treatment Period|Physician Decision|0|||
127871089|NCT03556202|460146836|FG001|Extension Treatment Period|Physician Decision|8|||
127871090|NCT03556202|460146837|FG002|Extension Treatment Period|Physician Decision|2|||
127871091|NCT03556202|460146835|FG000|Extension Treatment Period|Protocol Violation|0|||
127871092|NCT03556202|460146836|FG001|Extension Treatment Period|Protocol Violation|1|||
127871093|NCT03556202|460146837|FG002|Extension Treatment Period|Protocol Violation|1|||
127871094|NCT03556202|460146835|FG000|Extension Treatment Period|Sponsor Decision|0|||
127871095|NCT03556202|460146836|FG001|Extension Treatment Period|Sponsor Decision|1|||
127871096|NCT03556202|460146837|FG002|Extension Treatment Period|Sponsor Decision|0|||
127871097|NCT03556202|460146835|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
127871098|NCT03556202|460146836|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
127871099|NCT03556202|460146837|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
127871100|NCT03556202|460146835|FG000|Follow-Up Period (12 Weeks)|Death|1|||
127871101|NCT03556202|460146836|FG001|Follow-Up Period (12 Weeks)|Death|0|||
127871102|NCT03556202|460146837|FG002|Follow-Up Period (12 Weeks)|Death|0|||
127871103|NCT03556202|460146835|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
127871104|NCT03556202|460146836|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
127871105|NCT03556202|460146837|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
127871106|NCT03556202|460146835|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
127871107|NCT03556202|460146836|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
127871108|NCT03556202|460146837|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
127871109|NCT03556202|460146835|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
127871110|NCT03556202|460146836|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
127871111|NCT03556202|460146837|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
127871112|NCT03556202|460146835|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
127871113|NCT03556202|460146836|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
127871114|NCT03556202|460146837|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
127536988|NCT01384734|458930025|FG000|Overall Study|Prison|0|||
127536989|NCT01384734|458930026|FG001|Overall Study|Prison|0|||
127871115|NCT03556202|460146835|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
127871116|NCT03556202|460146836|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
127871117|NCT03556202|460146837|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
127871118|NCT03556202|460146835|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
127871119|NCT03556202|460146836|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
127871120|NCT03556202|460146837|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
127871121|NCT03556202|460146835|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
127871122|NCT03556202|460146836|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
127871123|NCT03556202|460146837|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
127871124|NCT03556202|460146835|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
127871125|NCT03556202|460146836|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
127871126|NCT03556202|460146837|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
127871127|NCT03556202|460146835|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
127871128|NCT03556202|460146836|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
127871129|NCT03556202|460146837|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
127871130|NCT03556202|460146835|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
127871131|NCT03556202|460146836|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
127871132|NCT03556202|460146837|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
127871133|NCT03556202|460146835|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
127871134|NCT03556202|460146836|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
127871135|NCT03556202|460146837|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
127871136|NCT03556202|460146835|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
127871137|NCT03556202|460146836|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
127871138|NCT03556202|460146837|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
127871139|NCT01539512|460146838|FG000|Overall Study|Adverse Event|9|||
127871140|NCT01539512|460146839|FG001|Overall Study|Adverse Event|7|||
127871141|NCT01539512|460146838|FG000|Overall Study|Physician Decision|1|||
127871142|NCT01539512|460146839|FG001|Overall Study|Physician Decision|1|||
127871143|NCT01539512|460146838|FG000|Overall Study|Withdrawal by Subject|12|||
127871144|NCT01539512|460146839|FG001|Overall Study|Withdrawal by Subject|5|||
127871145|NCT01539512|460146838|FG000|Overall Study|Richter's Transformation|1|||
127871146|NCT01539512|460146839|FG001|Overall Study|Richter's Transformation|0|||
127871147|NCT04479358|460146846|FG000|Overall Study|Withdrawal by Subject|0|||
127871148|NCT04479358|460146847|FG001|Overall Study|Withdrawal by Subject|0|||
127871149|NCT04479358|460146848|FG002|Overall Study|Withdrawal by Subject|1|||
127871150|NCT04479358|460146849|FG003|Overall Study|Withdrawal by Subject|0|||
127871151|NCT04479358|460146850|FG004|Overall Study|Withdrawal by Subject|0|||
127871152|NCT04479358|460146851|FG005|Overall Study|Withdrawal by Subject|1|||
127871153|NCT00764465|460146852|FG000|Overall Study|Adverse Event|2|||
127871154|NCT00764465|460146853|FG001|Overall Study|Adverse Event|0|||
127871155|NCT00764465|460146854|FG002|Overall Study|Adverse Event|0|||
127871156|NCT00764465|460146855|FG003|Overall Study|Adverse Event|1|||
127871157|NCT00764465|460146856|FG004|Overall Study|Adverse Event|1|||
127871158|NCT00764465|460146857|FG005|Overall Study|Adverse Event|1|||
127871159|NCT00764465|460146852|FG000|Overall Study|Withdrawal by Subject|0|||
127871160|NCT00764465|460146853|FG001|Overall Study|Withdrawal by Subject|1|||
127871161|NCT00764465|460146854|FG002|Overall Study|Withdrawal by Subject|1|||
127871162|NCT00764465|460146855|FG003|Overall Study|Withdrawal by Subject|0|||
127871163|NCT00764465|460146856|FG004|Overall Study|Withdrawal by Subject|0|||
127871164|NCT00764465|460146857|FG005|Overall Study|Withdrawal by Subject|0|||
127871165|NCT01333501|460146858|FG000|Overall Study|Adverse Event|3|||
127871166|NCT01333501|460146859|FG001|Overall Study|Adverse Event|1|||
127871167|NCT01333501|460146858|FG000|Overall Study|Abnormal laboratory value|2|||
127871168|NCT01333501|460146859|FG001|Overall Study|Abnormal laboratory value|1|||
127871169|NCT01333501|460146858|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
127871170|NCT01333501|460146859|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
127871171|NCT01333501|460146858|FG000|Overall Study|Withdrawn consent|3|||
127871172|NCT01333501|460146859|FG001|Overall Study|Withdrawn consent|12|||
127871173|NCT00674440|460146860|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
127871174|NCT00674440|460146860|FG000|Overall Study|did not have surgery, so unevaluable|7|||
127871175|NCT00674440|460146860|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
127871176|NCT00914940|460146861|FG000|D0 to D100 Post-transplant|Death|2|||
127871177|NCT00914940|460146861|FG000|D101 to 2 Years Post-transplant|Death|8|||
127871178|NCT00914940|460146861|FG000|2 Years to 5 Years Post-transplant|Death|3|||
127871179|NCT01728194|460146866|FG000|Overall Study|Lost to Follow-up|4|||
127871180|NCT01728194|460146867|FG001|Overall Study|Lost to Follow-up|3|||
127871181|NCT01728194|460146866|FG000|Overall Study|Physician Decision|4|||
127871182|NCT01728194|460146867|FG001|Overall Study|Physician Decision|0|||
127871183|NCT01728194|460146866|FG000|Overall Study|Withdrawal by Subject|7|||
127871184|NCT01728194|460146867|FG001|Overall Study|Withdrawal by Subject|3|||
127871185|NCT01728194|460146866|FG000|Overall Study|Perceived Medication Side Effects|4|||
127871186|NCT01728194|460146867|FG001|Overall Study|Perceived Medication Side Effects|0|||
127871187|NCT01728194|460146866|FG000|Overall Study|Family Member Request|1|||
127871188|NCT01728194|460146867|FG001|Overall Study|Family Member Request|0|||
127871189|NCT02129192|460146869|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
127871190|NCT02129192|460146870|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
127871191|NCT01078974|460146871|FG000|Overall Study|Adverse Event|3|||
127871192|NCT00553319|460146872|FG000|Overall Study|Lost to Follow-up|10|||
127871193|NCT00553319|460146873|FG001|Overall Study|Lost to Follow-up|9|||
127871194|NCT00553319|460146874|FG002|Overall Study|Lost to Follow-up|5|||
127871195|NCT00553319|460146872|FG000|Overall Study|wanted treatment elsewhere|2|||
127871196|NCT00553319|460146873|FG001|Overall Study|wanted treatment elsewhere|1|||
127871197|NCT00553319|460146874|FG002|Overall Study|wanted treatment elsewhere|1|||
127871198|NCT00553319|460146872|FG000|Overall Study|non-compliance|0|||
127871199|NCT00553319|460146873|FG001|Overall Study|non-compliance|0|||
127871200|NCT00553319|460146874|FG002|Overall Study|non-compliance|2|||
127871201|NCT00553319|460146872|FG000|Overall Study|incarceration|1|||
127871202|NCT00553319|460146873|FG001|Overall Study|incarceration|0|||
127871203|NCT00553319|460146874|FG002|Overall Study|incarceration|0|||
127871204|NCT00553319|460146872|FG000|Overall Study|moved|1|||
127871205|NCT00553319|460146873|FG001|Overall Study|moved|0|||
127871206|NCT00553319|460146874|FG002|Overall Study|moved|1|||
127871207|NCT03575975|460146882|FG000|Overall Study|Lost to Follow-up|1|||
127871208|NCT03575975|460146883|FG001|Overall Study|Lost to Follow-up|0|||
127871209|NCT03575975|460146884|FG002|Overall Study|Lost to Follow-up|0|||
127871210|NCT00495794|460146885|FG000|Overall Study|Pharmacist did not activate patient|522|||
127871211|NCT00495794|460146886|FG001|Overall Study|Pharmacist did not activate patient|0|||
127871212|NCT03039699|460146888|FG000|Overall Study|Incorrect inclusion|5|||
127871213|NCT03039699|460146889|FG001|Overall Study|Incorrect inclusion|4|||
127871214|NCT03039699|460146888|FG000|Overall Study|Lack of data to assess study endpoint|5|||
127871215|NCT03039699|460146889|FG001|Overall Study|Lack of data to assess study endpoint|3|||
127871216|NCT03039699|460146888|FG000|Overall Study|Bacterial infection|12|||
127871217|NCT03039699|460146889|FG001|Overall Study|Bacterial infection|28|||
127871218|NCT00129220|460146890|FG000|Study Period II|Adverse Event|9|||
127871219|NCT00129220|460146891|FG001|Study Period II|Adverse Event|5|||
127871220|NCT00129220|460146892|FG002|Study Period II|Adverse Event|7|||
127871221|NCT00129220|460146890|FG000|Study Period II|Lack of Efficacy|15|||
127871222|NCT00129220|460146891|FG001|Study Period II|Lack of Efficacy|1|||
127871223|NCT00129220|460146892|FG002|Study Period II|Lack of Efficacy|28|||
127871224|NCT00129220|460146890|FG000|Study Period II|Entry Criteria Not Met|2|||
127871225|NCT00129220|460146891|FG001|Study Period II|Entry Criteria Not Met|0|||
127871226|NCT00129220|460146892|FG002|Study Period II|Entry Criteria Not Met|2|||
127871227|NCT00129220|460146890|FG000|Study Period II|Protocol Violation|4|||
127871228|NCT00129220|460146891|FG001|Study Period II|Protocol Violation|2|||
127983272|NCT02604550|460562427|FG001|Overall Study|Incomplete data using paper journal|19|||
127983273|NCT01404208|460562428|FG000|Overall Study|Discontinued|3|||
127983274|NCT01404208|460562429|FG001|Overall Study|Discontinued|0|||
127983275|NCT01777295|460562432|FG000|Overall Study|Withdrawal by Subject|2|||
127983276|NCT01777295|460562433|FG001|Overall Study|Withdrawal by Subject|2|||
127983277|NCT01777295|460562432|FG000|Overall Study|Pregnancy|0|||
127983278|NCT01777295|460562433|FG001|Overall Study|Pregnancy|1|||
127983279|NCT01777295|460562432|FG000|Overall Study|Personal problem|1|||
127983280|NCT01777295|460562433|FG001|Overall Study|Personal problem|0|||
127983281|NCT01777295|460562432|FG000|Overall Study|Investigator call for AEs check|1|||
127983282|NCT01777295|460562433|FG001|Overall Study|Investigator call for AEs check|0|||
127983283|NCT01069419|460562434|FG000|Overall Study|Adverse Event|233|||
127983284|NCT01069419|460562434|FG000|Overall Study|Lack of Efficacy|332|||
127983285|NCT01069419|460562434|FG000|Overall Study|Lost to Follow-up|49|||
127983286|NCT01069419|460562434|FG000|Overall Study|Remission of disease|11|||
127983287|NCT01069419|460562434|FG000|Overall Study|Withdrawal by Subject|34|||
127983288|NCT01069419|460562434|FG000|Overall Study|Other Reason|43|||
127983289|NCT01069419|460562434|FG000|Overall Study|Missing termination information|13|||
127983290|NCT00908076|460562435|FG000|Overall Study|Lack of Efficacy|1|||
127983291|NCT00908076|460562436|FG001|Overall Study|Lack of Efficacy|1|||
127983292|NCT02382796|460562437|FG000|Overall Study|Global deterioration of health status|1|||
127983293|NCT02382796|460562437|FG000|Overall Study|Objective progression or relapse|3|||
127983294|NCT02382796|460562437|FG000|Overall Study|Commercial dacomitinib became available|3|||
127983295|NCT04007107|460562444|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
127983296|NCT04007107|460562445|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
127983297|NCT04007107|460562446|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
127983298|NCT04007107|460562447|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
127983299|NCT04068688|460562453|FG000|Overall Study|Lost to Follow-up|1|||
127983300|NCT04068688|460562454|FG001|Overall Study|Lost to Follow-up|1|||
127983301|NCT04068688|460562455|FG002|Overall Study|Lost to Follow-up|0|||
127983302|NCT04068688|460562456|FG003|Overall Study|Lost to Follow-up|0|||
127983303|NCT04068688|460562457|FG004|Overall Study|Lost to Follow-up|5|||
127983304|NCT04068688|460562458|FG005|Overall Study|Lost to Follow-up|5|||
127983305|NCT04068688|460562459|FG006|Overall Study|Lost to Follow-up|0|||
127983306|NCT04068688|460562460|FG007|Overall Study|Lost to Follow-up|0|||
127871229|NCT00129220|460146892|FG002|Study Period II|Protocol Violation|1|||
127871230|NCT00129220|460146890|FG000|Study Period II|Physician Decision|0|||
127983307|NCT04068688|460562461|FG008|Overall Study|Lost to Follow-up|1|||
127983308|NCT04068688|460562462|FG009|Overall Study|Lost to Follow-up|0|||
127983309|NCT04068688|460562453|FG000|Overall Study|Withdrawal by Subject|1|||
127983310|NCT04068688|460562454|FG001|Overall Study|Withdrawal by Subject|1|||
127983311|NCT04068688|460562455|FG002|Overall Study|Withdrawal by Subject|0|||
127871231|NCT00129220|460146891|FG001|Study Period II|Physician Decision|1|||
127871232|NCT00129220|460146892|FG002|Study Period II|Physician Decision|0|||
127871233|NCT00129220|460146890|FG000|Study Period II|Withdrawal by Subject|1|||
127871234|NCT00129220|460146891|FG001|Study Period II|Withdrawal by Subject|3|||
127871235|NCT00129220|460146892|FG002|Study Period II|Withdrawal by Subject|4|||
127871236|NCT00129220|460146890|FG000|Study Period II|Reason Not Specified|2|||
127871237|NCT00129220|460146891|FG001|Study Period II|Reason Not Specified|0|||
127871238|NCT00129220|460146892|FG002|Study Period II|Reason Not Specified|5|||
127871239|NCT00129220|460146890|FG000|Study Period III|Adverse Event|1|||
127871240|NCT00129220|460146891|FG001|Study Period III|Adverse Event|0|||
127871241|NCT00129220|460146892|FG002|Study Period III|Adverse Event|3|||
127871242|NCT00129220|460146890|FG000|Study Period III|Protocol Violation|1|||
127871243|NCT00129220|460146891|FG001|Study Period III|Protocol Violation|1|||
127871244|NCT00129220|460146892|FG002|Study Period III|Protocol Violation|2|||
127871245|NCT00129220|460146890|FG000|Study Period III|Withdrawal by Subject|1|||
127871246|NCT00129220|460146891|FG001|Study Period III|Withdrawal by Subject|0|||
127871247|NCT00129220|460146892|FG002|Study Period III|Withdrawal by Subject|3|||
127871248|NCT00129220|460146890|FG000|Study Period III|Sponsor Decision|1|||
127871249|NCT00129220|460146891|FG001|Study Period III|Sponsor Decision|0|||
127871250|NCT00129220|460146892|FG002|Study Period III|Sponsor Decision|0|||
127871251|NCT00129220|460146890|FG000|Study Period III|Reason Not Specified|9|||
127871252|NCT00129220|460146891|FG001|Study Period III|Reason Not Specified|0|||
127871253|NCT00129220|460146892|FG002|Study Period III|Reason Not Specified|2|||
127871254|NCT01883362|460146893|FG000|Treatment|Adverse Event|1|||
127871255|NCT01883362|460146894|FG001|Treatment|Adverse Event|8|||
127871256|NCT01883362|460146893|FG000|Treatment|Withdrawal by Subject|6|||
127871257|NCT01883362|460146894|FG001|Treatment|Withdrawal by Subject|2|||
127871258|NCT01883362|460146893|FG000|Treatment|Administrative problems|4|||
127871259|NCT01883362|460146894|FG001|Treatment|Administrative problems|1|||
127871260|NCT01883362|460146893|FG000|Treatment|Relapse|4|||
127871261|NCT01883362|460146894|FG001|Treatment|Relapse|2|||
127871262|NCT01883362|460146893|FG000|Treatment|Randomized, not treated|1|||
127871263|NCT01883362|460146894|FG001|Treatment|Randomized, not treated|1|||
127871264|NCT01883362|460146893|FG000|Post Treatment Follow-up|Protocol Violation|0|||
127871265|NCT01883362|460146894|FG001|Post Treatment Follow-up|Protocol Violation|1|||
127871266|NCT01883362|460146893|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
127871267|NCT01883362|460146894|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
127871268|NCT01883362|460146893|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
127871269|NCT01883362|460146894|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
127871270|NCT01883362|460146893|FG000|Post Treatment Follow-up|Administrative problems|2|||
127871271|NCT01883362|460146894|FG001|Post Treatment Follow-up|Administrative problems|0|||
127871272|NCT01883362|460146893|FG000|Post Treatment Follow-up|Death|8|||
127871273|NCT01883362|460146894|FG001|Post Treatment Follow-up|Death|4|||
127871274|NCT01883362|460146893|FG000|Post Treatment Follow-up|Relapse|1|||
127871275|NCT01883362|460146894|FG001|Post Treatment Follow-up|Relapse|2|||
127871276|NCT02911285|460146895|FG000|Overall Study|Lost to Follow-up|8|||
127871277|NCT02911285|460146896|FG001|Overall Study|Lost to Follow-up|5|||
127871278|NCT02911285|460146895|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
127871279|NCT02911285|460146896|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
127871280|NCT01230489|460146897|FG000|Overall Study|Death|2|||
127871281|NCT01230489|460146897|FG000|Overall Study|Adverse Event|2|||
127871282|NCT01230489|460146897|FG000|Overall Study|Treatment modality changed|1|||
127871283|NCT01791543|460146898|FG000|Overall Study|Lost to Follow-up|1|||
127871284|NCT01791543|460146898|FG000|Overall Study|Adverse Event|1|||
127871285|NCT03996694|460148588|FG000|First Washout (7 Days)|positive urine drug screen|0|||
127871286|NCT03996694|460148589|FG001|First Washout (7 Days)|positive urine drug screen|0|||
127871287|NCT03996694|460148590|FG002|First Washout (7 Days)|positive urine drug screen|1|||
127871288|NCT03996694|460148591|FG003|First Washout (7 Days)|positive urine drug screen|0|||
127871289|NCT03996694|460148592|FG004|First Washout (7 Days)|positive urine drug screen|0|||
127871290|NCT03996694|460148593|FG005|First Washout (7 Days)|positive urine drug screen|0|||
127871291|NCT03996694|460148588|FG000|First Washout (7 Days)|Adverse Event|0|||
127871292|NCT03996694|460148589|FG001|First Washout (7 Days)|Adverse Event|1|||
127871293|NCT03996694|460148590|FG002|First Washout (7 Days)|Adverse Event|0|||
127871294|NCT03996694|460148591|FG003|First Washout (7 Days)|Adverse Event|0|||
127871295|NCT03996694|460148592|FG004|First Washout (7 Days)|Adverse Event|0|||
127871296|NCT03996694|460148593|FG005|First Washout (7 Days)|Adverse Event|0|||
127871297|NCT03996694|460148588|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
127871298|NCT03996694|460148589|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
127871299|NCT03996694|460148590|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
127871300|NCT03996694|460148591|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
127871301|NCT03996694|460148592|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
127871302|NCT03996694|460148593|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
127871303|NCT03996694|460148588|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
127871304|NCT03996694|460148589|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
127871305|NCT03996694|460148590|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
127871306|NCT03996694|460148591|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
127871307|NCT03996694|460148592|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
127871308|NCT03996694|460148593|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
127871309|NCT01458535|460148596|FG000|Overall Study|Other|0|||
127871310|NCT01458535|460148597|FG001|Overall Study|Other|0|||
127871311|NCT01458535|460148598|FG002|Overall Study|Other|0|||
127871312|NCT01458535|460148599|FG003|Overall Study|Other|0|||
127871313|NCT01458535|460148600|FG004|Overall Study|Other|1|||
127871314|NCT01458535|460148601|FG005|Overall Study|Other|1|||
127871315|NCT01458535|460148596|FG000|Overall Study|Withdrawal by Subject|0|||
127871316|NCT01458535|460148597|FG001|Overall Study|Withdrawal by Subject|0|||
127871317|NCT01458535|460148598|FG002|Overall Study|Withdrawal by Subject|2|||
127871318|NCT01458535|460148599|FG003|Overall Study|Withdrawal by Subject|0|||
127871319|NCT01458535|460148600|FG004|Overall Study|Withdrawal by Subject|1|||
127871320|NCT01458535|460148601|FG005|Overall Study|Withdrawal by Subject|1|||
127871321|NCT01458535|460148596|FG000|Overall Study|Lost to Follow-up|0|||
127871322|NCT01458535|460148597|FG001|Overall Study|Lost to Follow-up|2|||
127871323|NCT01458535|460148598|FG002|Overall Study|Lost to Follow-up|0|||
127871324|NCT01458535|460148599|FG003|Overall Study|Lost to Follow-up|3|||
127871325|NCT01458535|460148600|FG004|Overall Study|Lost to Follow-up|2|||
127871326|NCT01458535|460148601|FG005|Overall Study|Lost to Follow-up|2|||
127871327|NCT01458535|460148596|FG000|Overall Study|Adverse Event|0|||
127871328|NCT01458535|460148597|FG001|Overall Study|Adverse Event|0|||
127871329|NCT01458535|460148598|FG002|Overall Study|Adverse Event|0|||
127871330|NCT01458535|460148599|FG003|Overall Study|Adverse Event|1|||
127871331|NCT01458535|460148600|FG004|Overall Study|Adverse Event|0|||
127871332|NCT01458535|460148601|FG005|Overall Study|Adverse Event|0|||
127871333|NCT01238861|460148602|FG000|Overall Study|Lost to Follow-up|4|||
127871334|NCT01238861|460148603|FG001|Overall Study|Lost to Follow-up|2|||
127871335|NCT01238861|460148604|FG002|Overall Study|Lost to Follow-up|3|||
127871336|NCT01238861|460148605|FG003|Overall Study|Lost to Follow-up|1|||
127871337|NCT01238861|460148606|FG004|Overall Study|Lost to Follow-up|1|||
127871338|NCT01238861|460148607|FG005|Overall Study|Lost to Follow-up|2|||
127871339|NCT01238861|460148602|FG000|Overall Study|Unplanned surgery|1|||
127871340|NCT01238861|460148603|FG001|Overall Study|Unplanned surgery|0|||
127871341|NCT01238861|460148604|FG002|Overall Study|Unplanned surgery|0|||
127871342|NCT01238861|460148605|FG003|Overall Study|Unplanned surgery|0|||
127871343|NCT01238861|460148606|FG004|Overall Study|Unplanned surgery|0|||
127871344|NCT01238861|460148607|FG005|Overall Study|Unplanned surgery|0|||
127871345|NCT01238861|460148602|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
127871346|NCT01238861|460148603|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
127871347|NCT01238861|460148604|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
127871348|NCT01238861|460148605|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
127871349|NCT01238861|460148606|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
127871350|NCT01238861|460148607|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
127871351|NCT01238861|460148602|FG000|Overall Study|Incorrect enrollment/randomization|0|||
127871352|NCT01238861|460148603|FG001|Overall Study|Incorrect enrollment/randomization|0|||
127871353|NCT01238861|460148604|FG002|Overall Study|Incorrect enrollment/randomization|1|||
127871354|NCT01238861|460148605|FG003|Overall Study|Incorrect enrollment/randomization|0|||
127871355|NCT01238861|460148606|FG004|Overall Study|Incorrect enrollment/randomization|1|||
127871356|NCT01238861|460148607|FG005|Overall Study|Incorrect enrollment/randomization|0|||
127871357|NCT01238861|460148602|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
127871358|NCT01238861|460148603|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
127871359|NCT01238861|460148604|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
127871360|NCT01238861|460148605|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
127871361|NCT01238861|460148606|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
127871362|NCT01238861|460148607|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
127871363|NCT01238861|460148602|FG000|Overall Study|Subject moved out of state/area|0|||
127871364|NCT01238861|460148603|FG001|Overall Study|Subject moved out of state/area|0|||
127871365|NCT01238861|460148604|FG002|Overall Study|Subject moved out of state/area|1|||
127871366|NCT01238861|460148605|FG003|Overall Study|Subject moved out of state/area|1|||
127871367|NCT01238861|460148606|FG004|Overall Study|Subject moved out of state/area|0|||
127871368|NCT01238861|460148607|FG005|Overall Study|Subject moved out of state/area|0|||
127871369|NCT01238861|460148602|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
127871370|NCT01238861|460148603|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
127871371|NCT01238861|460148604|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
127871372|NCT01238861|460148605|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
127871373|NCT01238861|460148606|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
127871374|NCT01238861|460148607|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
127871375|NCT01238861|460148602|FG000|Overall Study|Personal problems|0|||
127871376|NCT01238861|460148603|FG001|Overall Study|Personal problems|0|||
127871377|NCT01238861|460148604|FG002|Overall Study|Personal problems|0|||
127871378|NCT01238861|460148605|FG003|Overall Study|Personal problems|1|||
127871379|NCT01238861|460148606|FG004|Overall Study|Personal problems|0|||
127871380|NCT01238861|460148607|FG005|Overall Study|Personal problems|0|||
127871381|NCT01238861|460148602|FG000|Overall Study|Unable to continue visits|0|||
127871382|NCT01238861|460148603|FG001|Overall Study|Unable to continue visits|0|||
127871383|NCT01238861|460148604|FG002|Overall Study|Unable to continue visits|0|||
127871384|NCT01238861|460148605|FG003|Overall Study|Unable to continue visits|1|||
127871385|NCT01238861|460148606|FG004|Overall Study|Unable to continue visits|0|||
127871386|NCT01238861|460148607|FG005|Overall Study|Unable to continue visits|1|||
127871387|NCT01238861|460148602|FG000|Overall Study|Serious adverse event|0|||
127871388|NCT01238861|460148603|FG001|Overall Study|Serious adverse event|0|||
127871389|NCT01238861|460148604|FG002|Overall Study|Serious adverse event|0|||
127871390|NCT01238861|460148605|FG003|Overall Study|Serious adverse event|0|||
127871391|NCT01238861|460148606|FG004|Overall Study|Serious adverse event|0|||
127871392|NCT01238861|460148607|FG005|Overall Study|Serious adverse event|1|||
127871393|NCT01238861|460148602|FG000|Overall Study|Lack of compliance|0|||
127871394|NCT01238861|460148603|FG001|Overall Study|Lack of compliance|0|||
127871395|NCT01238861|460148604|FG002|Overall Study|Lack of compliance|0|||
127871396|NCT01238861|460148605|FG003|Overall Study|Lack of compliance|0|||
127871397|NCT01238861|460148606|FG004|Overall Study|Lack of compliance|0|||
127871398|NCT01238861|460148607|FG005|Overall Study|Lack of compliance|1|||
127871399|NCT01238861|460148602|FG000|Overall Study|Adverse Event|0|||
127871400|NCT01238861|460148603|FG001|Overall Study|Adverse Event|1|||
127871401|NCT01238861|460148604|FG002|Overall Study|Adverse Event|0|||
127871402|NCT01238861|460148605|FG003|Overall Study|Adverse Event|0|||
127871403|NCT01238861|460148606|FG004|Overall Study|Adverse Event|0|||
127871404|NCT01238861|460148607|FG005|Overall Study|Adverse Event|0|||
127871405|NCT01238861|460148602|FG000|Overall Study|Withdrawal by Subject|6|||
127871406|NCT01238861|460148603|FG001|Overall Study|Withdrawal by Subject|5|||
127871407|NCT01238861|460148604|FG002|Overall Study|Withdrawal by Subject|4|||
127871408|NCT01238861|460148605|FG003|Overall Study|Withdrawal by Subject|8|||
127871409|NCT01238861|460148606|FG004|Overall Study|Withdrawal by Subject|10|||
127871410|NCT01238861|460148607|FG005|Overall Study|Withdrawal by Subject|9|||
127871411|NCT01269346|460148608|FG000|Treatment Phase|Disease progression|3|||
127871412|NCT01269346|460148608|FG000|Treatment Phase|Adverse Event|3|||
127871413|NCT01269346|460148608|FG000|Treatment Phase|Withdrawal by Subject|1|||
127871414|NCT01269346|460148608|FG000|Treatment Phase|Other|2|||
127871415|NCT01269346|460148608|FG000|Extension Phase|Adverse Event|6|||
127871416|NCT01269346|460148608|FG000|Extension Phase|Withdrawal by Subject|4|||
127871417|NCT01269346|460148608|FG000|Extension Phase|Disease progression|22|||
127871418|NCT01269346|460148608|FG000|Extension Phase|Physician decision or participant choice|9|||
127871419|NCT01269346|460148608|FG000|Extension Phase|Clinical progression|1|||
127871420|NCT01269346|460148608|FG000|Extension Phase|Started a prohibited con med|1|||
127871421|NCT01855607|460148609|FG000|Overall Study|Withdrawal by Subject|1|||
127871422|NCT01855607|460148609|FG000|Overall Study|Study was terminated|11|||
127871423|NCT04001790|460148614|FG000|Overall Study|Withdrawal by Subject|1|||
127871424|NCT04001790|460148615|FG001|Overall Study|Withdrawal by Subject|2|||
127871425|NCT02706327|460148616|FG000|Overall Study|Lost to Follow-up|1|||
127871426|NCT02706327|460148617|FG001|Overall Study|Lost to Follow-up|1|||
127871427|NCT02706327|460148618|FG002|Overall Study|Lost to Follow-up|2|||
127871428|NCT04576702|460148623|FG000|Overall Study|Death|1|||
127871429|NCT04576702|460148624|FG001|Overall Study|Death|0|||
127871430|NCT04576702|460148625|FG002|Overall Study|Death|0|||
127871431|NCT04576702|460148626|FG003|Overall Study|Death|0|||
127536990|NCT01384734|458930027|FG002|Overall Study|Prison|1|||
127536991|NCT01384734|458930028|FG003|Overall Study|Prison|0|||
127871432|NCT04576702|460148623|FG000|Overall Study|Withdrawal by Subject|0|||
127871433|NCT04576702|460148624|FG001|Overall Study|Withdrawal by Subject|2|||
127871434|NCT04576702|460148625|FG002|Overall Study|Withdrawal by Subject|1|||
127871435|NCT04576702|460148626|FG003|Overall Study|Withdrawal by Subject|0|||
127871436|NCT04576702|460148623|FG000|Overall Study|Lost to Follow-up|3|||
127871437|NCT04576702|460148624|FG001|Overall Study|Lost to Follow-up|3|||
127871438|NCT04576702|460148625|FG002|Overall Study|Lost to Follow-up|3|||
127871439|NCT04576702|460148626|FG003|Overall Study|Lost to Follow-up|4|||
127871440|NCT01319422|460148629|FG000|Overall Study|Withdrawal by Subject|1|||
127871441|NCT01319422|460148630|FG001|Overall Study|Withdrawal by Subject|0|||
127871442|NCT06104423|460148631|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|3|||
127871443|NCT06104423|460148632|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|6|||
127871444|NCT06104423|460148633|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|0|||
127871445|NCT06104423|460148631|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
127871446|NCT06104423|460148632|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
127871447|NCT06104423|460148633|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|0|||
127871448|NCT03417245|460148634|FG000|Overall Study|Adverse Event|1|||
127871449|NCT03417245|460148635|FG001|Overall Study|Adverse Event|0|||
127648765|NCT03494166|459335291|FG002|Overall Study|Lost to Follow-up|2|||
127871450|NCT03417245|460148634|FG000|Overall Study|Protocol Violation|1|||
127871451|NCT03417245|460148635|FG001|Overall Study|Protocol Violation|0|||
127871452|NCT03417245|460148634|FG000|Overall Study|Withdrawal by Subject|1|||
127871453|NCT03417245|460148635|FG001|Overall Study|Withdrawal by Subject|1|||
127871454|NCT02708524|460148643|FG000|Overall Study|Adverse Event|0|||
127871455|NCT02708524|460148644|FG001|Overall Study|Adverse Event|1|||
127871456|NCT02708524|460148645|FG002|Overall Study|Adverse Event|0|||
127871457|NCT02708524|460148646|FG003|Overall Study|Adverse Event|0|||
127871458|NCT02708524|460148643|FG000|Overall Study|Lens Discomfort|1|||
127871459|NCT02708524|460148644|FG001|Overall Study|Lens Discomfort|0|||
127871460|NCT02708524|460148645|FG002|Overall Study|Lens Discomfort|1|||
127871461|NCT02708524|460148646|FG003|Overall Study|Lens Discomfort|0|||
127871462|NCT02708524|460148643|FG000|Overall Study|Lost to Follow-up|1|||
127871463|NCT02708524|460148644|FG001|Overall Study|Lost to Follow-up|1|||
127871464|NCT02708524|460148645|FG002|Overall Study|Lost to Follow-up|1|||
127871465|NCT02708524|460148646|FG003|Overall Study|Lost to Follow-up|0|||
127871466|NCT02708524|460148643|FG000|Overall Study|Protocol Violation|0|||
127871467|NCT02708524|460148644|FG001|Overall Study|Protocol Violation|1|||
127871468|NCT02708524|460148645|FG002|Overall Study|Protocol Violation|0|||
127871469|NCT02708524|460148646|FG003|Overall Study|Protocol Violation|0|||
127871470|NCT02708524|460148643|FG000|Overall Study|Withdrawal by Subject|1|||
127871471|NCT02708524|460148644|FG001|Overall Study|Withdrawal by Subject|1|||
127871472|NCT02708524|460148645|FG002|Overall Study|Withdrawal by Subject|0|||
127871473|NCT02708524|460148646|FG003|Overall Study|Withdrawal by Subject|0|||
127871474|NCT02708524|460148643|FG000|Overall Study|Dispensed incorrect study lens|0|||
127871475|NCT02708524|460148644|FG001|Overall Study|Dispensed incorrect study lens|1|||
127871476|NCT02708524|460148645|FG002|Overall Study|Dispensed incorrect study lens|1|||
127871477|NCT02708524|460148646|FG003|Overall Study|Dispensed incorrect study lens|0|||
127871478|NCT02708524|460148643|FG000|Overall Study|Did not wear lens at final visit|0|||
127871479|NCT02708524|460148644|FG001|Overall Study|Did not wear lens at final visit|1|||
127648766|NCT03494166|459335292|FG003|Overall Study|Lost to Follow-up|2|||
127648767|NCT03494166|459335293|FG004|Overall Study|Lost to Follow-up|14|||
127648768|NCT03494166|459335294|FG005|Overall Study|Lost to Follow-up|0|||
127871480|NCT02708524|460148645|FG002|Overall Study|Did not wear lens at final visit|0|||
127871481|NCT02708524|460148646|FG003|Overall Study|Did not wear lens at final visit|0|||
127871482|NCT02708524|460148643|FG000|Overall Study|Subject lost study lens|1|||
127871483|NCT02708524|460148644|FG001|Overall Study|Subject lost study lens|0|||
127871484|NCT02708524|460148645|FG002|Overall Study|Subject lost study lens|0|||
127871485|NCT02708524|460148646|FG003|Overall Study|Subject lost study lens|0|||
127871486|NCT00229931|460148647|FG000|Overall Study|Death|1|||
127871487|NCT00229931|460148648|FG001|Overall Study|Death|0|||
127871488|NCT00229931|460148647|FG000|Overall Study|Lost to Follow-up|3|||
127871489|NCT00229931|460148648|FG001|Overall Study|Lost to Follow-up|2|||
127871490|NCT02992743|460148649|FG000|Overall Study|Withdrawal by Subject|1|||
127871491|NCT02992743|460148650|FG001|Overall Study|Withdrawal by Subject|1|||
127871492|NCT02992743|460148649|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
127871493|NCT02992743|460148650|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
127871494|NCT02992743|460148649|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
127871495|NCT02992743|460148650|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
127871496|NCT02992743|460148649|FG000|Overall Study|No measurable disease|1|||
127871497|NCT02992743|460148650|FG001|Overall Study|No measurable disease|0|||
127871498|NCT02992743|460148649|FG000|Overall Study|Lost to Follow-up|0|||
127871499|NCT02992743|460148650|FG001|Overall Study|Lost to Follow-up|1|||
127871500|NCT03290131|460148651|FG000|Overall Study|Adverse Event|22|||
127871501|NCT03290131|460148652|FG001|Overall Study|Adverse Event|57|||
127871502|NCT03290131|460148653|FG002|Overall Study|Adverse Event|11|||
127871503|NCT03290131|460148651|FG000|Overall Study|Withdrawal by Subject|18|||
127871504|NCT03290131|460148652|FG001|Overall Study|Withdrawal by Subject|13|||
127871505|NCT03290131|460148653|FG002|Overall Study|Withdrawal by Subject|8|||
127871506|NCT03290131|460148651|FG000|Overall Study|MS Relapse|2|||
127871507|NCT03290131|460148652|FG001|Overall Study|MS Relapse|1|||
127871508|NCT03290131|460148653|FG002|Overall Study|MS Relapse|0|||
127871509|NCT03290131|460148651|FG000|Overall Study|Unknown reason|0|||
127871510|NCT03290131|460148652|FG001|Overall Study|Unknown reason|1|||
127871511|NCT03290131|460148653|FG002|Overall Study|Unknown reason|0|||
127871512|NCT00465101|460148654|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
127871513|NCT00465101|460148654|FG000|Overall Study|Change in health precluded follow up|4|||
127871514|NCT00465101|460148654|FG000|Overall Study|Did not meet study criteria|4|||
127871515|NCT00465101|460148654|FG000|Overall Study|Lost to Follow-up|5|||
127871516|NCT00465101|460148654|FG000|Overall Study|Other|6|||
127871517|NCT00465101|460148654|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
127871518|NCT00465101|460148654|FG000|Overall Study|Patient postponed procedure|1|||
127871519|NCT00465101|460148654|FG000|Overall Study|Site closed due to IRB expiration|1|||
127871520|NCT00465101|460148654|FG000|Overall Study|Unable to obtain IRB approval|1|||
127871521|NCT00465101|460148654|FG000|Overall Study|Death|3|||
127871522|NCT00465101|460148654|FG000|Overall Study|Withdrawal by Subject|25|||
127871523|NCT00465101|460148654|FG000|Overall Study|Physician Decision|1|||
127871524|NCT00465101|460148654|FG000|Overall Study|Withdrew consent prior to procedure|3|||
127871525|NCT00483574|460148655|FG000|Overall Study|Adverse Event|6|||
127871526|NCT00483574|460148656|FG001|Overall Study|Adverse Event|0|||
127871527|NCT00483574|460148655|FG000|Overall Study|Protocol Violation|28|||
127871528|NCT00483574|460148656|FG001|Overall Study|Protocol Violation|9|||
127871529|NCT00483574|460148655|FG000|Overall Study|Lost to Follow-up|16|||
127871530|NCT00483574|460148656|FG001|Overall Study|Lost to Follow-up|4|||
127871531|NCT00483574|460148655|FG000|Overall Study|Withdrawal by Subject|52|||
127871532|NCT00483574|460148656|FG001|Overall Study|Withdrawal by Subject|0|||
127871533|NCT00361504|460148659|FG000|Overall Study|Withdrawal by Subject|94|||
127871534|NCT00361504|460148660|FG001|Overall Study|Withdrawal by Subject|31|||
127871535|NCT00361504|460148659|FG000|Overall Study|Lost to Follow-up|40|||
127871536|NCT00361504|460148660|FG001|Overall Study|Lost to Follow-up|7|||
127871537|NCT00361504|460148659|FG000|Overall Study|Adverse Event|203|||
127871538|NCT00361504|460148660|FG001|Overall Study|Adverse Event|82|||
127871539|NCT00361504|460148659|FG000|Overall Study|Lack of Efficacy|72|||
127871540|NCT00361504|460148660|FG001|Overall Study|Lack of Efficacy|7|||
127871541|NCT00361504|460148659|FG000|Overall Study|Resolution of Pain|2|||
127871542|NCT00361504|460148660|FG001|Overall Study|Resolution of Pain|0|||
127871543|NCT00361504|460148659|FG000|Overall Study|Study medication non compliant|42|||
127871544|NCT00361504|460148660|FG001|Overall Study|Study medication non compliant|15|||
127871545|NCT00361504|460148659|FG000|Overall Study|All other|28|||
127871546|NCT00361504|460148660|FG001|Overall Study|All other|3|||
127871547|NCT00450814|460148661|FG000|Overall Study|Failed to complete the initial therapy|0|||
127871548|NCT00450814|460148662|FG001|Overall Study|Failed to complete the initial therapy|0|||
127871549|NCT00450814|460148663|FG002|Overall Study|Failed to complete the initial therapy|0|||
127871550|NCT00450814|460148664|FG003|Overall Study|Failed to complete the initial therapy|1|||
127871551|NCT00450814|460148665|FG004|Overall Study|Failed to complete the initial therapy|1|||
127871552|NCT00450814|460148666|FG005|Overall Study|Failed to complete the initial therapy|1|||
127871553|NCT00450814|460148667|FG006|Overall Study|Failed to complete the initial therapy|0|||
127871554|NCT00450814|460148668|FG007|Overall Study|Failed to complete the initial therapy|0|||
127871555|NCT00450814|460148669|FG008|Overall Study|Failed to complete the initial therapy|0|||
127871556|NCT00450814|460148670|FG009|Overall Study|Failed to complete the initial therapy|0|||
127871557|NCT00450814|460148671|FG010|Overall Study|Failed to complete the initial therapy|0|||
127871558|NCT00450814|460148661|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
127871559|NCT00450814|460148662|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
127871560|NCT00450814|460148663|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
127871561|NCT00450814|460148664|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
127871562|NCT00450814|460148665|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
127871563|NCT00450814|460148666|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
127871564|NCT00450814|460148667|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
127871565|NCT00450814|460148668|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
127871566|NCT00450814|460148669|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
127871567|NCT00450814|460148670|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
127871568|NCT00450814|460148671|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
127871569|NCT02067728|460148672|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
127871570|NCT02067728|460148673|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
127871571|NCT02067728|460148672|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
127871572|NCT02067728|460148673|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
127871573|NCT02067728|460148672|FG000|6 Month Measurements|Unable to attend|114|||
127871574|NCT02067728|460148673|FG001|6 Month Measurements|Unable to attend|97|||
127871575|NCT03602976|460148677|FG000|Overall Study|Withdrawal by Subject|1|||
127871576|NCT04837807|460148678|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
127871577|NCT04837807|460148679|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
127871578|NCT02190604|460148680|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
127871579|NCT02190604|460148681|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
127871580|NCT02190604|460148682|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
127871581|NCT02190604|460148683|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
127871582|NCT02190604|460148684|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
127871583|NCT02190604|460148685|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
127871584|NCT02190604|460148686|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
127871585|NCT02190604|460148687|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
127871586|NCT02190604|460148688|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
127871587|NCT02190604|460148689|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
127871588|NCT02190604|460148690|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
127871589|NCT02190604|460148691|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
127871590|NCT02190604|460148692|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
127871591|NCT02190604|460148693|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
127871592|NCT02190604|460148694|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
127871593|NCT02190604|460148695|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
127871594|NCT02190604|460148696|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
127871595|NCT02190604|460148697|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
127871596|NCT02190604|460148698|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
127871597|NCT02190604|460148680|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
127871598|NCT02190604|460148681|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
127871599|NCT02190604|460148682|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
127871600|NCT02190604|460148683|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
127871601|NCT02190604|460148684|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
127871602|NCT02190604|460148685|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
127871603|NCT02190604|460148686|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
127871604|NCT02190604|460148687|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
127871605|NCT02190604|460148688|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
127871606|NCT02190604|460148689|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
127871607|NCT02190604|460148690|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
127871608|NCT02190604|460148691|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
127871609|NCT02190604|460148692|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
127871610|NCT02190604|460148693|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
127871611|NCT02190604|460148694|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
127871612|NCT02190604|460148695|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
127871613|NCT02190604|460148696|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
127871614|NCT02190604|460148697|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
127871615|NCT02190604|460148698|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
127871616|NCT04095039|460148701|FG000|Overall Study|Withdrawal by Subject|2|||
127871617|NCT04095039|460148702|FG001|Overall Study|Withdrawal by Subject|16|||
127871618|NCT04095039|460148701|FG000|Overall Study|Transplanted|21|||
127871619|NCT04095039|460148702|FG001|Overall Study|Transplanted|24|||
127871620|NCT04095039|460148701|FG000|Overall Study|Transferred to Non-study Facility|47|||
127871621|NCT04095039|460148702|FG001|Overall Study|Transferred to Non-study Facility|44|||
127871622|NCT04095039|460148701|FG000|Overall Study|Withdrawal from internvention target|0|||
127871623|NCT04095039|460148702|FG001|Overall Study|Withdrawal from internvention target|2|||
127871624|NCT04095039|460148701|FG000|Overall Study|Switch to peritoneal dialysis or home hemodialysis|2|||
127871625|NCT04095039|460148702|FG001|Overall Study|Switch to peritoneal dialysis or home hemodialysis|4|||
127871626|NCT04095039|460148701|FG000|Overall Study|Cacliphylaxis|0|||
127871627|NCT04095039|460148702|FG001|Overall Study|Cacliphylaxis|1|||
127871628|NCT04095039|460148701|FG000|Overall Study|Pregnancy|1|||
127871629|NCT04095039|460148702|FG001|Overall Study|Pregnancy|0|||
127871630|NCT01990339|460148705|FG000|Overall Study|Data Not Available|49|||
127871631|NCT01990339|460148705|FG000|Overall Study|Voluntary Withdrawal|1402|||
127871632|NCT01990339|460148705|FG000|Overall Study|Lost to Follow-up|861|||
127536992|NCT01384734|458930029|FG004|Overall Study|Prison|0|||
127536993|NCT01384734|458930025|FG000|Overall Study|As per Exclusion criteria|0|||
127871633|NCT01038609|460148706|FG000|Overall Study|Adverse Event|0|||
127871634|NCT01038609|460148707|FG001|Overall Study|Adverse Event|0|||
127871635|NCT01038609|460148708|FG002|Overall Study|Adverse Event|1|||
127871636|NCT01038609|460148709|FG003|Overall Study|Adverse Event|0|||
127871637|NCT01038609|460148710|FG004|Overall Study|Adverse Event|0|||
127871638|NCT01038609|460148706|FG000|Overall Study|Dosing Error|0|||
127536994|NCT01384734|458930026|FG001|Overall Study|As per Exclusion criteria|1|||
127536995|NCT01384734|458930027|FG002|Overall Study|As per Exclusion criteria|0|||
127536996|NCT01384734|458930028|FG003|Overall Study|As per Exclusion criteria|0|||
127536997|NCT01384734|458930029|FG004|Overall Study|As per Exclusion criteria|0|||
127536998|NCT01384734|458930025|FG000|Overall Study|Missed End of treatment visit|0|||
127536999|NCT01384734|458930026|FG001|Overall Study|Missed End of treatment visit|0|||
127537000|NCT01384734|458930027|FG002|Overall Study|Missed End of treatment visit|0|||
127537001|NCT01384734|458930028|FG003|Overall Study|Missed End of treatment visit|1|||
127537002|NCT01384734|458930029|FG004|Overall Study|Missed End of treatment visit|0|||
127537003|NCT01384734|458930025|FG000|Overall Study|Adhesion problem|0|||
127537004|NCT01384734|458930026|FG001|Overall Study|Adhesion problem|0|||
127537005|NCT01384734|458930027|FG002|Overall Study|Adhesion problem|0|||
127537006|NCT01384734|458930028|FG003|Overall Study|Adhesion problem|1|||
127537007|NCT01384734|458930029|FG004|Overall Study|Adhesion problem|0|||
127537008|NCT01384734|458930025|FG000|Overall Study|Early termination|0|||
127537009|NCT01384734|458930026|FG001|Overall Study|Early termination|0|||
127537010|NCT01384734|458930027|FG002|Overall Study|Early termination|0|||
127537011|NCT01384734|458930028|FG003|Overall Study|Early termination|0|||
127871639|NCT01038609|460148707|FG001|Overall Study|Dosing Error|0|||
127871640|NCT01038609|460148708|FG002|Overall Study|Dosing Error|0|||
127871641|NCT01038609|460148709|FG003|Overall Study|Dosing Error|1|||
127871642|NCT01038609|460148710|FG004|Overall Study|Dosing Error|1|||
127871643|NCT01038609|460148706|FG000|Overall Study|Death in the Family|1|||
127871644|NCT01038609|460148707|FG001|Overall Study|Death in the Family|0|||
127871645|NCT01038609|460148708|FG002|Overall Study|Death in the Family|0|||
127871646|NCT01038609|460148709|FG003|Overall Study|Death in the Family|0|||
127871647|NCT01038609|460148710|FG004|Overall Study|Death in the Family|0|||
127871648|NCT01038609|460148706|FG000|Overall Study|Refusal of Blood Draws|0|||
127871649|NCT01038609|460148707|FG001|Overall Study|Refusal of Blood Draws|1|||
127871650|NCT01038609|460148708|FG002|Overall Study|Refusal of Blood Draws|0|||
127871651|NCT01038609|460148709|FG003|Overall Study|Refusal of Blood Draws|0|||
127871652|NCT01038609|460148710|FG004|Overall Study|Refusal of Blood Draws|0|||
127871653|NCT02309372|460148711|FG000|Overall Study|Lost to Follow-up|3|||
127871654|NCT02309372|460148712|FG001|Overall Study|Lost to Follow-up|2|||
127871655|NCT01590810|460148714|FG000|Overall Study|Physician Decision|0|||
127871656|NCT01590810|460148715|FG001|Overall Study|Physician Decision|1|||
127871657|NCT01590810|460148716|FG002|Overall Study|Physician Decision|1|||
127537012|NCT01384734|458930029|FG004|Overall Study|Early termination|1|||
127537013|NCT01384734|458930025|FG000|Overall Study|Physician Decision|1|||
127537014|NCT01384734|458930026|FG001|Overall Study|Physician Decision|0|||
127871658|NCT01590810|460148717|FG003|Overall Study|Physician Decision|0|||
127871659|NCT01590810|460148718|FG004|Overall Study|Physician Decision|0|||
127871660|NCT02400281|460148719|FG000|Overall Study|Adverse Event|0|||
127871661|NCT02400281|460148720|FG001|Overall Study|Adverse Event|0|||
127871662|NCT02400281|460148721|FG002|Overall Study|Adverse Event|1|||
127871663|NCT02400281|460148722|FG003|Overall Study|Adverse Event|0|||
127871664|NCT02400281|460148723|FG004|Overall Study|Adverse Event|1|||
127871665|NCT02400281|460148724|FG005|Overall Study|Adverse Event|0|||
127871666|NCT02400281|460148719|FG000|Overall Study|Physician Decision|0|||
127871667|NCT02400281|460148720|FG001|Overall Study|Physician Decision|0|||
127871668|NCT02400281|460148721|FG002|Overall Study|Physician Decision|1|||
127871669|NCT02400281|460148722|FG003|Overall Study|Physician Decision|0|||
127871670|NCT02400281|460148723|FG004|Overall Study|Physician Decision|0|||
127871671|NCT02400281|460148724|FG005|Overall Study|Physician Decision|0|||
127871672|NCT00412360|460148725|FG000|Overall Study|Lost to Follow-up|0|||
127871673|NCT00412360|460148726|FG001|Overall Study|Lost to Follow-up|1|||
127871674|NCT00412360|460148725|FG000|Overall Study|Not Transplanted|1|||
127871675|NCT00412360|460148726|FG001|Overall Study|Not Transplanted|2|||
127871676|NCT03655951|460148728|FG000|Overall Study|Lost to Follow-up|39|||
127871677|NCT03655951|460148729|FG001|Overall Study|Lost to Follow-up|20|||
127871678|NCT03655951|460148728|FG000|Overall Study|Withdrawal by Subject|0|||
127537015|NCT01384734|458930027|FG002|Overall Study|Physician Decision|0|||
127871679|NCT03655951|460148729|FG001|Overall Study|Withdrawal by Subject|1|||
127871680|NCT02811640|460148730|FG000|Overall Study|Technology malfunction|2|||
127983312|NCT04068688|460562456|FG003|Overall Study|Withdrawal by Subject|0|||
127983313|NCT04068688|460562457|FG004|Overall Study|Withdrawal by Subject|0|||
127983314|NCT04068688|460562458|FG005|Overall Study|Withdrawal by Subject|0|||
127983315|NCT04068688|460562459|FG006|Overall Study|Withdrawal by Subject|0|||
127983316|NCT04068688|460562460|FG007|Overall Study|Withdrawal by Subject|0|||
127983317|NCT04068688|460562461|FG008|Overall Study|Withdrawal by Subject|0|||
127983318|NCT04068688|460562462|FG009|Overall Study|Withdrawal by Subject|0|||
127983319|NCT04068688|460562453|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
127983320|NCT04068688|460562454|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
127983321|NCT04068688|460562455|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
127537016|NCT01384734|458930028|FG003|Overall Study|Physician Decision|0|||
127537017|NCT01384734|458930029|FG004|Overall Study|Physician Decision|0|||
127537018|NCT00920855|458930030|FG000|Overall Study|Adverse Event|1|||
127537019|NCT00920855|458930031|FG001|Overall Study|Adverse Event|1|||
127537020|NCT00920855|458930032|FG002|Overall Study|Adverse Event|4|||
127537021|NCT00920855|458930030|FG000|Overall Study|Withdrawal by Subject|2|||
127983322|NCT04068688|460562456|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
127983323|NCT04068688|460562457|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
127983324|NCT04068688|460562458|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
127983325|NCT04068688|460562459|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
127983326|NCT04068688|460562460|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
127983327|NCT04068688|460562461|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
127983328|NCT04068688|460562462|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
127983329|NCT02554318|460562463|FG000|Overall Study|Withdrawal by Subject|10|||
127983330|NCT02554318|460562464|FG001|Overall Study|Withdrawal by Subject|8|||
127871681|NCT02441517|460148732|FG000|Overall Study|Lost to Follow-up|1|||
127871682|NCT02441517|460148732|FG000|Overall Study|Withdrawal by Subject|2|||
127871683|NCT02441517|460148732|FG000|Overall Study|Study Terminated by Sponsor|1|||
127871684|NCT01393444|460148733|FG000|Overall Study|Withdrawal by Subject|1|||
127871685|NCT01393444|460148733|FG000|Overall Study|Determined ineligible during screening.|2|||
127871686|NCT01349816|460148736|FG000|Overall Study|Withdrawal by Subject|4|||
127871687|NCT01349816|460148736|FG000|Overall Study|Physician Decision|1|||
127537022|NCT00920855|458930031|FG001|Overall Study|Withdrawal by Subject|1|||
127537023|NCT00920855|458930032|FG002|Overall Study|Withdrawal by Subject|6|||
127537024|NCT00920855|458930030|FG000|Overall Study|Disease progression|2|||
127537025|NCT00920855|458930031|FG001|Overall Study|Disease progression|1|||
127537026|NCT00920855|458930032|FG002|Overall Study|Disease progression|10|||
127537027|NCT00920855|458930030|FG000|Overall Study|Noncompliance to study medication|0|||
127537028|NCT00920855|458930031|FG001|Overall Study|Noncompliance to study medication|0|||
127537029|NCT00920855|458930032|FG002|Overall Study|Noncompliance to study medication|1|||
127537030|NCT00920855|458930030|FG000|Overall Study|Response plateau; started maintenance|0|||
127537031|NCT00920855|458930031|FG001|Overall Study|Response plateau; started maintenance|0|||
127537032|NCT00920855|458930032|FG002|Overall Study|Response plateau; started maintenance|1|||
127537033|NCT00539994|458930033|FG000|Overall Study|Lost to Follow-up|2|||
127537034|NCT00539994|458930034|FG001|Overall Study|Lost to Follow-up|1|||
127537035|NCT00539994|458930035|FG002|Overall Study|Lost to Follow-up|0|||
127537036|NCT00539994|458930033|FG000|Overall Study|Withdrawal by Subject|1|||
127537037|NCT00539994|458930034|FG001|Overall Study|Withdrawal by Subject|0|||
127537038|NCT00539994|458930035|FG002|Overall Study|Withdrawal by Subject|1|||
127537039|NCT00539994|458930033|FG000|Overall Study|Physician Decision|0|||
127537040|NCT00539994|458930034|FG001|Overall Study|Physician Decision|0|||
127537041|NCT00539994|458930035|FG002|Overall Study|Physician Decision|1|||
127537042|NCT03071263|458930036|FG000|Overall Study|Adverse Event|1|||
127537043|NCT03071263|458930037|FG001|Overall Study|Adverse Event|3|||
127537044|NCT03071263|458930036|FG000|Overall Study|Withdrawal by Subject|1|||
127537045|NCT03071263|458930037|FG001|Overall Study|Withdrawal by Subject|3|||
127537046|NCT03071263|458930036|FG000|Overall Study|Physician Decision|1|||
127537047|NCT03071263|458930037|FG001|Overall Study|Physician Decision|0|||
127537048|NCT03071263|458930036|FG000|Overall Study|Participant moved to another city|0|||
127537049|NCT03071263|458930037|FG001|Overall Study|Participant moved to another city|1|||
127537050|NCT03084796|458930038|FG000|Overall Study|Adverse Event|4|||
127537051|NCT03084796|458930039|FG001|Overall Study|Adverse Event|5|||
127537052|NCT03084796|458930040|FG002|Overall Study|Adverse Event|6|||
127537053|NCT03084796|458930041|FG003|Overall Study|Adverse Event|2|||
127537054|NCT03084796|458930042|FG004|Overall Study|Adverse Event|3|||
127537055|NCT03084796|458930043|FG005|Overall Study|Adverse Event|5|||
127537056|NCT03084796|458930038|FG000|Overall Study|Withdrawal by Subject|3|||
127537057|NCT03084796|458930039|FG001|Overall Study|Withdrawal by Subject|5|||
127537058|NCT03084796|458930040|FG002|Overall Study|Withdrawal by Subject|2|||
127537059|NCT03084796|458930041|FG003|Overall Study|Withdrawal by Subject|1|||
127537060|NCT03084796|458930042|FG004|Overall Study|Withdrawal by Subject|3|||
127871688|NCT01349816|460148736|FG000|Overall Study|Adverse Event|14|||
127537061|NCT03084796|458930043|FG005|Overall Study|Withdrawal by Subject|0|||
127537062|NCT03084796|458930038|FG000|Overall Study|Protocol Violation|0|||
127537063|NCT03084796|458930039|FG001|Overall Study|Protocol Violation|0|||
127537064|NCT03084796|458930040|FG002|Overall Study|Protocol Violation|1|||
127537065|NCT03084796|458930041|FG003|Overall Study|Protocol Violation|0|||
127537066|NCT03084796|458930042|FG004|Overall Study|Protocol Violation|1|||
127537067|NCT03084796|458930043|FG005|Overall Study|Protocol Violation|1|||
127537068|NCT03084796|458930038|FG000|Overall Study|Lack of Efficacy|0|||
127537069|NCT03084796|458930039|FG001|Overall Study|Lack of Efficacy|0|||
127537070|NCT03084796|458930040|FG002|Overall Study|Lack of Efficacy|1|||
127537071|NCT03084796|458930041|FG003|Overall Study|Lack of Efficacy|0|||
127537072|NCT03084796|458930042|FG004|Overall Study|Lack of Efficacy|1|||
127537073|NCT03084796|458930043|FG005|Overall Study|Lack of Efficacy|0|||
127537074|NCT03084796|458930038|FG000|Overall Study|Lost to Follow-up|0|||
127537075|NCT03084796|458930039|FG001|Overall Study|Lost to Follow-up|0|||
127537076|NCT03084796|458930040|FG002|Overall Study|Lost to Follow-up|1|||
127537077|NCT03084796|458930041|FG003|Overall Study|Lost to Follow-up|1|||
127537078|NCT03084796|458930042|FG004|Overall Study|Lost to Follow-up|3|||
127537079|NCT03084796|458930043|FG005|Overall Study|Lost to Follow-up|1|||
127537080|NCT03084796|458930038|FG000|Overall Study|Randomization error|0|||
127537081|NCT03084796|458930039|FG001|Overall Study|Randomization error|0|||
127537082|NCT03084796|458930040|FG002|Overall Study|Randomization error|1|||
127537083|NCT03084796|458930041|FG003|Overall Study|Randomization error|0|||
127537084|NCT03084796|458930042|FG004|Overall Study|Randomization error|0|||
127537085|NCT03084796|458930043|FG005|Overall Study|Randomization error|0|||
127537086|NCT05470985|458930044|FG000|Double Blind Treatment Period|Study terminated by sponsor|1|||
127537087|NCT05470985|458930045|FG001|Double Blind Treatment Period|Study terminated by sponsor|0|||
127537088|NCT05470985|458930044|FG000|Double Blind Treatment Period|Physician Decision|0|||
127537089|NCT05470985|458930045|FG001|Double Blind Treatment Period|Physician Decision|1|||
127537090|NCT05470985|458930044|FG000|Long Term Extension|Adverse Event|0|||
127537091|NCT05470985|458930045|FG001|Long Term Extension|Adverse Event|1|||
127537092|NCT05470985|458930044|FG000|Long Term Extension|Study terminated by sponsor|2|||
127537093|NCT05470985|458930045|FG001|Long Term Extension|Study terminated by sponsor|0|||
127537094|NCT02741245|458930046|FG000|Overall Study|Adverse Event|0|||
127537095|NCT02741245|458930047|FG001|Overall Study|Adverse Event|0|||
127537096|NCT02741245|458930048|FG002|Overall Study|Adverse Event|0|||
127537097|NCT02741245|458930049|FG003|Overall Study|Adverse Event|2|||
127537098|NCT02741245|458930050|FG004|Overall Study|Adverse Event|2|||
127537099|NCT02741245|458930046|FG000|Overall Study|Protocol Violation|0|||
127537100|NCT02741245|458930047|FG001|Overall Study|Protocol Violation|1|||
127537101|NCT02741245|458930048|FG002|Overall Study|Protocol Violation|0|||
127537102|NCT02741245|458930049|FG003|Overall Study|Protocol Violation|1|||
127537103|NCT02741245|458930050|FG004|Overall Study|Protocol Violation|0|||
127537104|NCT02741245|458930046|FG000|Overall Study|Withdrawal by Subject|0|||
127537105|NCT02741245|458930047|FG001|Overall Study|Withdrawal by Subject|0|||
127537106|NCT02741245|458930048|FG002|Overall Study|Withdrawal by Subject|0|||
127537107|NCT02741245|458930049|FG003|Overall Study|Withdrawal by Subject|1|||
127537108|NCT02741245|458930050|FG004|Overall Study|Withdrawal by Subject|0|||
127537109|NCT00154297|458930053|FG000|Overall Study|Death|5|||
127537110|NCT00154297|458930054|FG001|Overall Study|Death|2|||
127537111|NCT00154297|458930053|FG000|Overall Study|Withdrawal by Subject|0|||
127537112|NCT00154297|458930054|FG001|Overall Study|Withdrawal by Subject|5|||
127537113|NCT00154297|458930053|FG000|Overall Study|Lost to Follow-up|3|||
127537114|NCT00154297|458930054|FG001|Overall Study|Lost to Follow-up|0|||
127537115|NCT00990106|458930055|FG000|Overall Study|"too busy to continue"|1|||
127537116|NCT00990106|458930056|FG001|Overall Study|"too busy to continue"|2|||
127537117|NCT00990106|458930055|FG000|Overall Study|Lost to Follow-up|1|||
127537118|NCT00990106|458930056|FG001|Overall Study|Lost to Follow-up|3|||
127537119|NCT00990106|458930055|FG000|Overall Study|Withdrawal by Subject|2|||
127537120|NCT00990106|458930056|FG001|Overall Study|Withdrawal by Subject|1|||
127537121|NCT00990106|458930055|FG000|Overall Study|opted for open label prazosin|1|||
127537122|NCT00990106|458930056|FG001|Overall Study|opted for open label prazosin|1|||
127537123|NCT00990106|458930055|FG000|Overall Study|relocation/deployment|4|||
127537124|NCT00990106|458930056|FG001|Overall Study|relocation/deployment|1|||
127537125|NCT00990106|458930055|FG000|Overall Study|started exclusionary medication|0|||
127537126|NCT00990106|458930056|FG001|Overall Study|started exclusionary medication|1|||
127537127|NCT00990106|458930055|FG000|Overall Study|planned major surgery|0|||
127537128|NCT00990106|458930056|FG001|Overall Study|planned major surgery|1|||
127537129|NCT00990106|458930055|FG000|Overall Study|scheduling conflicts|0|||
127537130|NCT00990106|458930056|FG001|Overall Study|scheduling conflicts|2|||
127537131|NCT00410956|458930058|FG000|Overall Study|Adverse Event|1|||
127537132|NCT00410956|458930058|FG000|Overall Study|Death|2|||
127537133|NCT00410956|458930058|FG000|Overall Study|Lack of Efficacy|10|||
127648769|NCT03494166|459335289|FG000|Overall Study|Withdrawal by Subject|10|||
127537134|NCT00410956|458930058|FG000|Overall Study|Physician Decision|6|||
127537135|NCT01650194|458930059|FG000|Overall Study|Progressive Disease (PD)|35|||
127537136|NCT01650194|458930059|FG000|Overall Study|Withdrawal by Subject|2|||
127537137|NCT01650194|458930059|FG000|Overall Study|Miscellaneous|10|||
127537138|NCT00880698|458930063|FG000|Overall Study|Death|0|||
127648770|NCT03494166|459335290|FG001|Overall Study|Withdrawal by Subject|7|||
127648771|NCT03494166|459335291|FG002|Overall Study|Withdrawal by Subject|0|||
127648772|NCT03494166|459335292|FG003|Overall Study|Withdrawal by Subject|5|||
127648773|NCT03494166|459335293|FG004|Overall Study|Withdrawal by Subject|3|||
127648774|NCT03494166|459335294|FG005|Overall Study|Withdrawal by Subject|17|||
127648775|NCT03494166|459335289|FG000|Overall Study|Screen failure|1|||
127648776|NCT03494166|459335290|FG001|Overall Study|Screen failure|0|||
127648777|NCT03494166|459335291|FG002|Overall Study|Screen failure|0|||
127648778|NCT03494166|459335292|FG003|Overall Study|Screen failure|0|||
127648779|NCT03494166|459335293|FG004|Overall Study|Screen failure|1|||
127648780|NCT03494166|459335294|FG005|Overall Study|Screen failure|0|||
127648781|NCT03033225|459335300|FG000|Overall Study|Withdrawal by Subject|5|||
127648782|NCT03371940|459335301|FG000|Overall Study|Withdrawal by Subject|8|||
127648783|NCT03371940|459335302|FG001|Overall Study|Withdrawal by Subject|1|||
127648784|NCT03371940|459335303|FG002|Overall Study|Withdrawal by Subject|3|||
127648785|NCT03371940|459335304|FG003|Overall Study|Withdrawal by Subject|4|||
127648786|NCT00031486|459335307|FG000|Overall Study|Adverse Event|1|||
127648787|NCT00031486|459335308|FG001|Overall Study|Adverse Event|0|||
127648788|NCT00031486|459335307|FG000|Overall Study|Lost to Follow-up|0|||
127648789|NCT00031486|459335308|FG001|Overall Study|Lost to Follow-up|1|||
127648790|NCT00031486|459335307|FG000|Overall Study|Withdrawal by Subject|3|||
127648791|NCT00031486|459335308|FG001|Overall Study|Withdrawal by Subject|2|||
127648792|NCT00031486|459335307|FG000|Overall Study|Death|0|||
127648793|NCT00031486|459335308|FG001|Overall Study|Death|3|||
127648794|NCT00031486|459335307|FG000|Overall Study|Non-compliant|0|||
127648795|NCT00031486|459335308|FG001|Overall Study|Non-compliant|4|||
127648796|NCT00031486|459335307|FG000|Overall Study|Did not meet eligibility requirement|2|||
127648797|NCT00031486|459335308|FG001|Overall Study|Did not meet eligibility requirement|1|||
127648798|NCT00031486|459335307|FG000|Overall Study|Other|1|||
127648799|NCT00031486|459335308|FG001|Overall Study|Other|1|||
127648800|NCT03685591|459335309|FG000|Overall Study|Global Deterioration of Health Status|0|||
127648801|NCT03685591|459335310|FG001|Overall Study|Global Deterioration of Health Status|0|||
127648802|NCT03685591|459335311|FG002|Overall Study|Global Deterioration of Health Status|0|||
127648803|NCT03685591|459335312|FG003|Overall Study|Global Deterioration of Health Status|1|||
127648804|NCT03685591|459335313|FG004|Overall Study|Global Deterioration of Health Status|2|||
127648805|NCT03685591|459335314|FG005|Overall Study|Global Deterioration of Health Status|4|||
127648806|NCT03685591|459335315|FG006|Overall Study|Global Deterioration of Health Status|1|||
127648807|NCT03685591|459335316|FG007|Overall Study|Global Deterioration of Health Status|1|||
127648808|NCT03685591|459335317|FG008|Overall Study|Global Deterioration of Health Status|0|||
127648809|NCT03685591|459335309|FG000|Overall Study|Progressive Disease|1|||
127648810|NCT03685591|459335310|FG001|Overall Study|Progressive Disease|1|||
127648811|NCT03685591|459335311|FG002|Overall Study|Progressive Disease|0|||
127648812|NCT03685591|459335312|FG003|Overall Study|Progressive Disease|3|||
127648813|NCT03685591|459335313|FG004|Overall Study|Progressive Disease|5|||
127648814|NCT03685591|459335314|FG005|Overall Study|Progressive Disease|4|||
127648815|NCT03685591|459335315|FG006|Overall Study|Progressive Disease|3|||
127648816|NCT03685591|459335316|FG007|Overall Study|Progressive Disease|2|||
127648817|NCT03685591|459335317|FG008|Overall Study|Progressive Disease|1|||
127648818|NCT03685591|459335309|FG000|Overall Study|Other|0|||
127648819|NCT03685591|459335310|FG001|Overall Study|Other|0|||
127648820|NCT03685591|459335311|FG002|Overall Study|Other|1|||
127648821|NCT03685591|459335312|FG003|Overall Study|Other|0|||
127648822|NCT03685591|459335313|FG004|Overall Study|Other|2|||
127648823|NCT03685591|459335314|FG005|Overall Study|Other|3|||
127648824|NCT03685591|459335315|FG006|Overall Study|Other|0|||
127648825|NCT03685591|459335316|FG007|Overall Study|Other|0|||
127648826|NCT03685591|459335317|FG008|Overall Study|Other|0|||
127648827|NCT03685591|459335309|FG000|Overall Study|Withdrawal by Subject|0|||
127648828|NCT03685591|459335310|FG001|Overall Study|Withdrawal by Subject|0|||
127648829|NCT03685591|459335311|FG002|Overall Study|Withdrawal by Subject|0|||
127648830|NCT03685591|459335312|FG003|Overall Study|Withdrawal by Subject|0|||
127648831|NCT03685591|459335313|FG004|Overall Study|Withdrawal by Subject|3|||
127648832|NCT03685591|459335314|FG005|Overall Study|Withdrawal by Subject|2|||
127648833|NCT03685591|459335315|FG006|Overall Study|Withdrawal by Subject|0|||
127648834|NCT03685591|459335316|FG007|Overall Study|Withdrawal by Subject|0|||
127648835|NCT03685591|459335317|FG008|Overall Study|Withdrawal by Subject|1|||
127648836|NCT03685591|459335309|FG000|Overall Study|Adverse Event|0|||
127648837|NCT03685591|459335310|FG001|Overall Study|Adverse Event|0|||
127648838|NCT03685591|459335311|FG002|Overall Study|Adverse Event|0|||
127648839|NCT03685591|459335312|FG003|Overall Study|Adverse Event|1|||
127648840|NCT03685591|459335313|FG004|Overall Study|Adverse Event|1|||
127648841|NCT03685591|459335314|FG005|Overall Study|Adverse Event|4|||
127648842|NCT03685591|459335315|FG006|Overall Study|Adverse Event|0|||
127648843|NCT03685591|459335316|FG007|Overall Study|Adverse Event|1|||
127648844|NCT03685591|459335317|FG008|Overall Study|Adverse Event|1|||
127648845|NCT02220894|459335318|FG000|Overall Study|Adverse Event|127|||
127648846|NCT02220894|459335319|FG001|Overall Study|Adverse Event|74|||
127648847|NCT02220894|459335318|FG000|Overall Study|Death|418|||
127537139|NCT00880698|458930064|FG001|Overall Study|Death|0|||
127537140|NCT00880698|458930065|FG002|Overall Study|Death|1|||
127537141|NCT00880698|458930066|FG003|Overall Study|Death|2|||
127537142|NCT00880698|458930063|FG000|Overall Study|Lost to Follow-up|1|||
127537143|NCT00880698|458930064|FG001|Overall Study|Lost to Follow-up|3|||
127537144|NCT00880698|458930065|FG002|Overall Study|Lost to Follow-up|0|||
127871689|NCT01349816|460148736|FG000|Overall Study|Lost to Follow-up|2|||
127871690|NCT01349816|460148736|FG000|Overall Study|Protocol Violation|1|||
127537145|NCT00880698|458930066|FG003|Overall Study|Lost to Follow-up|1|||
127537146|NCT04158583|458930068|FG000|Overall Study|Withdrawal by Subject|1|||
127537147|NCT04158583|458930069|FG001|Overall Study|Withdrawal by Subject|1|||
127537148|NCT04158583|458930070|FG002|Overall Study|Withdrawal by Subject|0|||
127537149|NCT04158583|458930071|FG003|Overall Study|Withdrawal by Subject|0|||
127537150|NCT04158583|458930072|FG004|Overall Study|Withdrawal by Subject|1|||
127537151|NCT04158583|458930073|FG005|Overall Study|Withdrawal by Subject|0|||
127537152|NCT04158583|458930074|FG006|Overall Study|Withdrawal by Subject|0|||
127537153|NCT04158583|458930075|FG007|Overall Study|Withdrawal by Subject|0|||
127871691|NCT01349816|460148736|FG000|Overall Study|Protocol-specified criteria|8|||
127871692|NCT02569996|460148737|FG000|Overall Study|Adverse Event|6|||
127871693|NCT02569996|460148737|FG000|Overall Study|Physician Decision|3|||
127871694|NCT02569996|460148737|FG000|Overall Study|Progression of the disease|18|||
127871695|NCT02569996|460148737|FG000|Overall Study|New anti-lymphoma treatment|1|||
127871696|NCT02569996|460148737|FG000|Overall Study|Non-compliance|9|||
127871697|NCT02569996|460148737|FG000|Overall Study|Withdrawal by Subject|5|||
127871698|NCT02569996|460148737|FG000|Overall Study|Lost to Follow-up|5|||
127871699|NCT02569996|460148737|FG000|Overall Study|Complete remission|7|||
127871700|NCT02569996|460148737|FG000|Overall Study|Unknown reason|1|||
127871701|NCT01397409|460148740|FG000|Stage 2|Adverse Event|0|||
127871702|NCT01397409|460148741|FG001|Stage 2|Adverse Event|0|||
127871703|NCT01397409|460148742|FG002|Stage 2|Adverse Event|0|||
127871704|NCT01397409|460148743|FG003|Stage 2|Adverse Event|0|||
127871705|NCT01397409|460148744|FG004|Stage 2|Adverse Event|6|||
127871706|NCT01397409|460148745|FG005|Stage 2|Adverse Event|3|||
127871707|NCT01397409|460148746|FG006|Stage 2|Adverse Event|0|||
127871708|NCT01397409|460148747|FG007|Stage 2|Adverse Event|0|||
127871709|NCT01397409|460148748|FG008|Stage 2|Adverse Event|0|||
127871710|NCT01397409|460148749|FG009|Stage 2|Adverse Event|0|||
127871711|NCT01397409|460148740|FG000|Stage 2|Personal Reasons|0|||
127871712|NCT01397409|460148741|FG001|Stage 2|Personal Reasons|0|||
127871713|NCT01397409|460148742|FG002|Stage 2|Personal Reasons|0|||
127871714|NCT01397409|460148743|FG003|Stage 2|Personal Reasons|0|||
127871715|NCT01397409|460148744|FG004|Stage 2|Personal Reasons|1|||
127871716|NCT01397409|460148745|FG005|Stage 2|Personal Reasons|0|||
127871717|NCT01397409|460148746|FG006|Stage 2|Personal Reasons|0|||
127871718|NCT01397409|460148747|FG007|Stage 2|Personal Reasons|0|||
127871719|NCT01397409|460148748|FG008|Stage 2|Personal Reasons|0|||
127871720|NCT01397409|460148749|FG009|Stage 2|Personal Reasons|0|||
127871721|NCT01397409|460148740|FG000|Stage 2|Other Miscellaneous Reasons|0|||
127871722|NCT01397409|460148741|FG001|Stage 2|Other Miscellaneous Reasons|0|||
127871723|NCT01397409|460148742|FG002|Stage 2|Other Miscellaneous Reasons|0|||
127871724|NCT01397409|460148743|FG003|Stage 2|Other Miscellaneous Reasons|0|||
127871725|NCT01397409|460148744|FG004|Stage 2|Other Miscellaneous Reasons|1|||
127871726|NCT01397409|460148745|FG005|Stage 2|Other Miscellaneous Reasons|1|||
127871727|NCT01397409|460148746|FG006|Stage 2|Other Miscellaneous Reasons|0|||
127871728|NCT01397409|460148747|FG007|Stage 2|Other Miscellaneous Reasons|0|||
127871729|NCT01397409|460148748|FG008|Stage 2|Other Miscellaneous Reasons|0|||
127871730|NCT01397409|460148749|FG009|Stage 2|Other Miscellaneous Reasons|0|||
127983331|NCT02248974|460562465|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
127983332|NCT02248974|460562466|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
127983333|NCT02248974|460562465|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
127983334|NCT02248974|460562466|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
127983335|NCT02248974|460562465|FG000|1-Day Follow-Up|Enrolled in another study|1|||
127983336|NCT02248974|460562466|FG001|1-Day Follow-Up|Enrolled in another study|0|||
127983337|NCT02248974|460562465|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
127983338|NCT02248974|460562466|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
127648848|NCT02220894|459335319|FG001|Overall Study|Death|508|||
127648849|NCT02220894|459335318|FG000|Overall Study|Lost to Follow-up|0|||
127983339|NCT02248974|460562465|FG000|1-Week Follow-Up|Enrolled in another study|1|||
127537154|NCT04158583|458930076|FG008|Overall Study|Withdrawal by Subject|2|||
127537155|NCT04158583|458930077|FG009|Overall Study|Withdrawal by Subject|0|||
127648850|NCT02220894|459335319|FG001|Overall Study|Lost to Follow-up|4|||
127648851|NCT02220894|459335318|FG000|Overall Study|Site Terminated by Sponsor|2|||
127537156|NCT04158583|458930068|FG000|Overall Study|Study Terminated by Sponsor|0|||
127537157|NCT04158583|458930069|FG001|Overall Study|Study Terminated by Sponsor|0|||
127537158|NCT04158583|458930070|FG002|Overall Study|Study Terminated by Sponsor|0|||
127871731|NCT01397409|460148740|FG000|Stage 3|Adverse Event|0|||
127871732|NCT01397409|460148741|FG001|Stage 3|Adverse Event|0|||
127871733|NCT01397409|460148742|FG002|Stage 3|Adverse Event|0|||
127871734|NCT01397409|460148743|FG003|Stage 3|Adverse Event|0|||
127983340|NCT02248974|460562466|FG001|1-Week Follow-Up|Enrolled in another study|1|||
127983341|NCT02248974|460562465|FG000|1-Week Follow-Up|Transferred to another facility|1|||
127983342|NCT02248974|460562466|FG001|1-Week Follow-Up|Transferred to another facility|0|||
127983343|NCT02248974|460562465|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
127983344|NCT02248974|460562466|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
127983345|NCT02248974|460562465|FG000|1-Week Follow-Up|Death|1|||
127983346|NCT02248974|460562466|FG001|1-Week Follow-Up|Death|1|||
127983347|NCT02248974|460562465|FG000|1-Week Follow-Up|Excluded because of age|0|||
127983348|NCT02248974|460562466|FG001|1-Week Follow-Up|Excluded because of age|1|||
127983349|NCT02248974|460562465|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
127983350|NCT02248974|460562466|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
127983351|NCT02248974|460562465|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
127983352|NCT02248974|460562466|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
127983353|NCT02248974|460562465|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
127983354|NCT02248974|460562466|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
127983355|NCT02248974|460562465|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
127983356|NCT02248974|460562466|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
127983357|NCT02248974|460562465|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
127983358|NCT02248974|460562466|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
127983359|NCT02332239|460562467|FG000|Overall Study|Lost to Follow-up|4|||
127983360|NCT02332239|460562468|FG001|Overall Study|Lost to Follow-up|6|||
127983361|NCT00115037|460562469|FG000|Phase1|Lost to Follow-up|16|||
127983362|NCT00115037|460562470|FG001|Phase1|Lost to Follow-up|23|||
127983363|NCT00115037|460562471|FG002|Phase1|Lost to Follow-up|0|||
127983364|NCT00115037|460562472|FG003|Phase1|Lost to Follow-up|0|||
127983365|NCT00115037|460562473|FG004|Phase1|Lost to Follow-up|0|||
127983366|NCT00115037|460562474|FG005|Phase1|Lost to Follow-up|0|||
127983367|NCT00115037|460562469|FG000|Phase1|Withdrawal by Subject|9|||
127983368|NCT00115037|460562470|FG001|Phase1|Withdrawal by Subject|4|||
127983369|NCT00115037|460562471|FG002|Phase1|Withdrawal by Subject|0|||
127983370|NCT00115037|460562472|FG003|Phase1|Withdrawal by Subject|0|||
127983371|NCT00115037|460562473|FG004|Phase1|Withdrawal by Subject|0|||
127983372|NCT00115037|460562474|FG005|Phase1|Withdrawal by Subject|0|||
127983373|NCT00115037|460562469|FG000|Phase2|Death|0|||
127983374|NCT00115037|460562470|FG001|Phase2|Death|0|||
127983375|NCT00115037|460562471|FG002|Phase2|Death|1|||
127983376|NCT00115037|460562472|FG003|Phase2|Death|0|||
127983377|NCT00115037|460562473|FG004|Phase2|Death|0|||
127983378|NCT00115037|460562474|FG005|Phase2|Death|1|||
127983379|NCT00115037|460562469|FG000|Phase2|Withdrawal by Subject|0|||
127983380|NCT00115037|460562470|FG001|Phase2|Withdrawal by Subject|0|||
127983381|NCT00115037|460562471|FG002|Phase2|Withdrawal by Subject|2|||
127983382|NCT00115037|460562472|FG003|Phase2|Withdrawal by Subject|1|||
127983383|NCT00115037|460562473|FG004|Phase2|Withdrawal by Subject|2|||
127983384|NCT00115037|460562474|FG005|Phase2|Withdrawal by Subject|1|||
127983385|NCT00115037|460562469|FG000|Phase2|Lost to Follow-up|0|||
127983386|NCT00115037|460562470|FG001|Phase2|Lost to Follow-up|0|||
127983387|NCT00115037|460562471|FG002|Phase2|Lost to Follow-up|12|||
127983388|NCT00115037|460562472|FG003|Phase2|Lost to Follow-up|14|||
127983389|NCT00115037|460562473|FG004|Phase2|Lost to Follow-up|4|||
127983390|NCT00115037|460562474|FG005|Phase2|Lost to Follow-up|10|||
127983391|NCT00396877|460562475|FG000|Overall Study|Lost to Follow-up|2|||
127983392|NCT00396877|460562476|FG001|Overall Study|Lost to Follow-up|1|||
127983393|NCT00396877|460562475|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
127983394|NCT00396877|460562476|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
127983395|NCT00334802|460562477|FG000|Overall Study|Progressive Disease|2|||
127537159|NCT04158583|458930071|FG003|Overall Study|Study Terminated by Sponsor|1|||
127537160|NCT04158583|458930072|FG004|Overall Study|Study Terminated by Sponsor|0|||
127537161|NCT04158583|458930073|FG005|Overall Study|Study Terminated by Sponsor|0|||
127537162|NCT04158583|458930074|FG006|Overall Study|Study Terminated by Sponsor|0|||
127537163|NCT04158583|458930075|FG007|Overall Study|Study Terminated by Sponsor|0|||
127537164|NCT04158583|458930076|FG008|Overall Study|Study Terminated by Sponsor|0|||
127537165|NCT04158583|458930077|FG009|Overall Study|Study Terminated by Sponsor|0|||
127537166|NCT04158583|458930068|FG000|Overall Study|Progressive Disease|1|||
127537167|NCT04158583|458930069|FG001|Overall Study|Progressive Disease|0|||
127537168|NCT04158583|458930070|FG002|Overall Study|Progressive Disease|3|||
127537169|NCT04158583|458930071|FG003|Overall Study|Progressive Disease|5|||
127537170|NCT04158583|458930072|FG004|Overall Study|Progressive Disease|0|||
127537171|NCT04158583|458930073|FG005|Overall Study|Progressive Disease|1|||
127648852|NCT02220894|459335319|FG001|Overall Study|Site Terminated by Sponsor|0|||
127983396|NCT00334802|460562478|FG001|Overall Study|Progressive Disease|24|||
127983397|NCT00334802|460562477|FG000|Overall Study|Toxicity|1|||
127983398|NCT00334802|460562478|FG001|Overall Study|Toxicity|5|||
127537172|NCT04158583|458930074|FG006|Overall Study|Progressive Disease|6|||
127537173|NCT04158583|458930075|FG007|Overall Study|Progressive Disease|2|||
127537174|NCT04158583|458930076|FG008|Overall Study|Progressive Disease|1|||
127983399|NCT00334802|460562477|FG000|Overall Study|Lack of Efficacy|1|||
127983400|NCT00334802|460562478|FG001|Overall Study|Lack of Efficacy|3|||
127983401|NCT00334802|460562477|FG000|Overall Study|Patient Condition Aggrevated|1|||
127983402|NCT00334802|460562478|FG001|Overall Study|Patient Condition Aggrevated|0|||
127983403|NCT00334802|460562477|FG000|Overall Study|Physician Decision|1|||
127537175|NCT04158583|458930077|FG009|Overall Study|Progressive Disease|2|||
127537176|NCT04158583|458930068|FG000|Overall Study|Lost to Follow-up|0|||
127537177|NCT04158583|458930069|FG001|Overall Study|Lost to Follow-up|0|||
127537178|NCT04158583|458930070|FG002|Overall Study|Lost to Follow-up|1|||
127537179|NCT04158583|458930071|FG003|Overall Study|Lost to Follow-up|1|||
127537180|NCT04158583|458930072|FG004|Overall Study|Lost to Follow-up|1|||
127537181|NCT04158583|458930073|FG005|Overall Study|Lost to Follow-up|0|||
127537182|NCT04158583|458930074|FG006|Overall Study|Lost to Follow-up|0|||
127537183|NCT04158583|458930075|FG007|Overall Study|Lost to Follow-up|0|||
127537184|NCT04158583|458930076|FG008|Overall Study|Lost to Follow-up|0|||
127537185|NCT04158583|458930077|FG009|Overall Study|Lost to Follow-up|0|||
127537186|NCT04158583|458930068|FG000|Overall Study|Due To Patient Status|0|||
127537187|NCT04158583|458930069|FG001|Overall Study|Due To Patient Status|0|||
127537188|NCT04158583|458930070|FG002|Overall Study|Due To Patient Status|0|||
127537189|NCT04158583|458930071|FG003|Overall Study|Due To Patient Status|0|||
127537190|NCT04158583|458930072|FG004|Overall Study|Due To Patient Status|0|||
127537191|NCT04158583|458930073|FG005|Overall Study|Due To Patient Status|0|||
127537192|NCT04158583|458930074|FG006|Overall Study|Due To Patient Status|0|||
127537193|NCT04158583|458930075|FG007|Overall Study|Due To Patient Status|0|||
127537194|NCT04158583|458930076|FG008|Overall Study|Due To Patient Status|1|||
127537195|NCT04158583|458930077|FG009|Overall Study|Due To Patient Status|0|||
127537196|NCT04158583|458930068|FG000|Overall Study|Death|3|||
127537197|NCT04158583|458930069|FG001|Overall Study|Death|4|||
127537198|NCT04158583|458930070|FG002|Overall Study|Death|2|||
127537199|NCT04158583|458930071|FG003|Overall Study|Death|2|||
127537200|NCT04158583|458930072|FG004|Overall Study|Death|4|||
127537201|NCT04158583|458930073|FG005|Overall Study|Death|3|||
127537202|NCT04158583|458930074|FG006|Overall Study|Death|5|||
127537203|NCT04158583|458930075|FG007|Overall Study|Death|2|||
127537204|NCT04158583|458930076|FG008|Overall Study|Death|0|||
127537205|NCT04158583|458930077|FG009|Overall Study|Death|1|||
127537206|NCT04158583|458930068|FG000|Overall Study|Clinical Progression Disease|0|||
127537207|NCT04158583|458930069|FG001|Overall Study|Clinical Progression Disease|0|||
127537208|NCT04158583|458930070|FG002|Overall Study|Clinical Progression Disease|0|||
127537209|NCT04158583|458930071|FG003|Overall Study|Clinical Progression Disease|1|||
127537210|NCT04158583|458930072|FG004|Overall Study|Clinical Progression Disease|0|||
127537211|NCT04158583|458930073|FG005|Overall Study|Clinical Progression Disease|0|||
127537212|NCT04158583|458930074|FG006|Overall Study|Clinical Progression Disease|0|||
127537213|NCT04158583|458930075|FG007|Overall Study|Clinical Progression Disease|0|||
127537214|NCT04158583|458930076|FG008|Overall Study|Clinical Progression Disease|0|||
127537215|NCT04158583|458930077|FG009|Overall Study|Clinical Progression Disease|0|||
127537216|NCT04158583|458930068|FG000|Overall Study|Clinical Progression|0|||
127537217|NCT04158583|458930069|FG001|Overall Study|Clinical Progression|0|||
127537218|NCT04158583|458930070|FG002|Overall Study|Clinical Progression|0|||
127537219|NCT04158583|458930071|FG003|Overall Study|Clinical Progression|0|||
127537220|NCT04158583|458930072|FG004|Overall Study|Clinical Progression|1|||
127537221|NCT04158583|458930073|FG005|Overall Study|Clinical Progression|0|||
127537222|NCT04158583|458930074|FG006|Overall Study|Clinical Progression|2|||
127537223|NCT04158583|458930075|FG007|Overall Study|Clinical Progression|0|||
127537224|NCT04158583|458930076|FG008|Overall Study|Clinical Progression|0|||
127537225|NCT04158583|458930077|FG009|Overall Study|Clinical Progression|0|||
127537226|NCT04158583|458930068|FG000|Overall Study|Clinical Deterioration|0|||
127537227|NCT04158583|458930069|FG001|Overall Study|Clinical Deterioration|0|||
127537228|NCT04158583|458930070|FG002|Overall Study|Clinical Deterioration|0|||
127983404|NCT00334802|460562478|FG001|Overall Study|Physician Decision|0|||
127983405|NCT00334802|460562477|FG000|Overall Study|Withdrawal by Subject|0|||
127983406|NCT00334802|460562478|FG001|Overall Study|Withdrawal by Subject|4|||
127983407|NCT00334802|460562477|FG000|Overall Study|Adverse Event|0|||
127983408|NCT00334802|460562478|FG001|Overall Study|Adverse Event|3|||
127983409|NCT00334802|460562477|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
127983410|NCT00334802|460562478|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
127983411|NCT03436199|460562479|FG000|Overall Study|Adverse Event|15|||
127983412|NCT03436199|460562480|FG001|Overall Study|Adverse Event|40|||
127983413|NCT03436199|460562481|FG002|Overall Study|Adverse Event|7|||
127983414|NCT03436199|460562479|FG000|Overall Study|Withdrawal by Subject|4|||
127983415|NCT03436199|460562480|FG001|Overall Study|Withdrawal by Subject|10|||
127983416|NCT03436199|460562481|FG002|Overall Study|Withdrawal by Subject|3|||
127983417|NCT03436199|460562479|FG000|Overall Study|Lost to Follow-up|1|||
127983418|NCT03436199|460562480|FG001|Overall Study|Lost to Follow-up|0|||
127983419|NCT03436199|460562481|FG002|Overall Study|Lost to Follow-up|2|||
127983420|NCT03436199|460562479|FG000|Overall Study|Protocol Violation|1|||
127537229|NCT04158583|458930071|FG003|Overall Study|Clinical Deterioration|1|||
127537230|NCT04158583|458930072|FG004|Overall Study|Clinical Deterioration|0|||
127537231|NCT04158583|458930073|FG005|Overall Study|Clinical Deterioration|0|||
127537232|NCT04158583|458930074|FG006|Overall Study|Clinical Deterioration|0|||
127537233|NCT04158583|458930075|FG007|Overall Study|Clinical Deterioration|0|||
127983421|NCT03436199|460562480|FG001|Overall Study|Protocol Violation|1|||
127983422|NCT03436199|460562481|FG002|Overall Study|Protocol Violation|0|||
127983423|NCT03436199|460562479|FG000|Overall Study|Physician Decision|0|||
127983424|NCT03436199|460562480|FG001|Overall Study|Physician Decision|1|||
127983425|NCT03436199|460562481|FG002|Overall Study|Physician Decision|0|||
127983426|NCT03436199|460562479|FG000|Overall Study|Could not return to clinic|1|||
127983427|NCT03436199|460562480|FG001|Overall Study|Could not return to clinic|0|||
127537234|NCT04158583|458930076|FG008|Overall Study|Clinical Deterioration|0|||
127537235|NCT04158583|458930077|FG009|Overall Study|Clinical Deterioration|1|||
127537236|NCT01871519|458930078|FG000|Overall Study|Death|26|||
127537237|NCT01871519|458930078|FG000|Overall Study|Lost to Follow-up|15|||
127537238|NCT01871519|458930078|FG000|Overall Study|Withdrawal by Subject|49|||
127537239|NCT00320515|458930079|FG000|Overall Study|Death|33|||
127537240|NCT00320515|458930079|FG000|Overall Study|Lost to Follow-up|6|||
127537241|NCT00320515|458930079|FG000|Overall Study|Physician Decision|2|||
127537242|NCT00320515|458930079|FG000|Overall Study|Withdrawal by Subject|8|||
127983428|NCT03436199|460562481|FG002|Overall Study|Could not return to clinic|0|||
127537243|NCT00794950|458930080|FG000|BCG Induction|Withdrawal by Subject|2|||
127537244|NCT00794950|458930080|FG000|BCG Induction|ineligible|3|||
127537245|NCT00794950|458930080|FG000|BCG Induction|noncompliant w. BCG|1|||
127537246|NCT00794950|458930080|FG000|BCG Induction|Adverse Event|1|||
127537247|NCT00794950|458930080|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
127537248|NCT00794950|458930080|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
127537249|NCT00794950|458930080|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
127537250|NCT00794950|458930080|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
127537251|NCT02485704|458930081|FG000|Overall Study|Lost to Follow-up|4|||
127537252|NCT02485704|458930082|FG001|Overall Study|Lost to Follow-up|5|||
127537253|NCT02485704|458930081|FG000|Overall Study|Withdrawal by Subject|0|||
127537254|NCT02485704|458930082|FG001|Overall Study|Withdrawal by Subject|3|||
127537255|NCT02485704|458930081|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
127537256|NCT02485704|458930082|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
127537257|NCT01777776|458930083|FG000|Overall Study|Adverse Event|2|||
127537258|NCT01777776|458930084|FG001|Overall Study|Adverse Event|4|||
127537259|NCT01777776|458930085|FG002|Overall Study|Adverse Event|0|||
127537260|NCT01777776|458930086|FG003|Overall Study|Adverse Event|0|||
127537261|NCT01777776|458930083|FG000|Overall Study|Disease Progression|4|||
127537262|NCT01777776|458930084|FG001|Overall Study|Disease Progression|8|||
127537263|NCT01777776|458930085|FG002|Overall Study|Disease Progression|6|||
127537264|NCT01777776|458930086|FG003|Overall Study|Disease Progression|3|||
127537265|NCT01777776|458930083|FG000|Overall Study|Withdrawal by Subject|0|||
127537266|NCT01777776|458930084|FG001|Overall Study|Withdrawal by Subject|0|||
127537267|NCT01777776|458930085|FG002|Overall Study|Withdrawal by Subject|0|||
127537268|NCT01777776|458930086|FG003|Overall Study|Withdrawal by Subject|1|||
127537269|NCT00851786|458930087|FG000|Overall Study|Withdrawal by Subject|0|||
127537270|NCT00851786|458930088|FG001|Overall Study|Withdrawal by Subject|1|||
127537271|NCT00851786|458930087|FG000|Overall Study|Protocol Violation|0|||
127537272|NCT00851786|458930088|FG001|Overall Study|Protocol Violation|1|||
127537273|NCT00851786|458930087|FG000|Overall Study|Lost to Follow-up|1|||
127537274|NCT00851786|458930088|FG001|Overall Study|Lost to Follow-up|0|||
127537275|NCT00851786|458930087|FG000|Overall Study|Incarceration|1|||
127537276|NCT00851786|458930088|FG001|Overall Study|Incarceration|0|||
127537277|NCT00851786|458930087|FG000|Overall Study|Site Closure|1|||
127537278|NCT00851786|458930088|FG001|Overall Study|Site Closure|0|||
127537279|NCT00851786|458930087|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
127537280|NCT00851786|458930088|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
127983429|NCT03436199|460562479|FG000|Overall Study|Withdrawn per physician|0|||
127983430|NCT03436199|460562480|FG001|Overall Study|Withdrawn per physician|1|||
127983431|NCT03436199|460562481|FG002|Overall Study|Withdrawn per physician|0|||
127983432|NCT00085098|460562482|FG000|Overall Study|Withdrawal by Subject|0|||
127983433|NCT00085098|460562483|FG001|Overall Study|Withdrawal by Subject|1|||
127983434|NCT00085098|460562482|FG000|Overall Study|Ineligible|1|||
127983435|NCT00085098|460562483|FG001|Overall Study|Ineligible|1|||
127983436|NCT03515629|460562484|FG000|Overall Study|Death|0|||
127983437|NCT03515629|460562485|FG001|Overall Study|Death|1|||
127983438|NCT03515629|460562486|FG002|Overall Study|Death|1|||
127983439|NCT03515629|460562484|FG000|Overall Study|Progressive disease|0|||
127983440|NCT03515629|460562485|FG001|Overall Study|Progressive disease|1|||
127983441|NCT03515629|460562486|FG002|Overall Study|Progressive disease|0|||
127983442|NCT01886781|460562487|FG000|Overall Study|Protocol Violation|5|||
127537281|NCT03858049|458932043|FG000|Overall Study|Adverse Event|16|||
127537282|NCT03858049|458932044|FG001|Overall Study|Adverse Event|9|||
127537283|NCT03858049|458932043|FG000|Overall Study|Other|1|||
127537284|NCT03858049|458932044|FG001|Overall Study|Other|1|||
127537285|NCT04617782|458932045|FG000|Treatment A - 5 mg TDS|Physician Decision|2|||
127537286|NCT04617782|458932045|FG000|Treatment A - 5 mg TDS|failure to follow site rules|1|||
127983443|NCT01886781|460562488|FG001|Overall Study|Protocol Violation|0|||
127983444|NCT01886781|460562487|FG000|Overall Study|Adverse Event|1|||
127983445|NCT01886781|460562488|FG001|Overall Study|Adverse Event|0|||
127983446|NCT01886781|460562487|FG000|Overall Study|Lost to Follow-up|5|||
127983447|NCT01886781|460562488|FG001|Overall Study|Lost to Follow-up|0|||
127537287|NCT04617782|458932045|FG000|Treatment B - 10 mg TDS|Protocol Violation|1|||
127537288|NCT04617782|458932045|FG000|Treatment B - 10 mg TDS|Withdrawal by Subject|1|||
127537289|NCT04617782|458932045|FG000|Treatment C - 10 mg Oral|Protocol Violation|2|||
127537290|NCT04617782|458932045|FG000|Treatment C - 10 mg Oral|failure to follow site rules|1|||
127537291|NCT01690052|458932052|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
127537292|NCT01690052|458932053|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
127537293|NCT02995980|458932059|FG000|Overall Study|Lost to Follow-up|14|||
127537294|NCT00657540|458932061|FG000|Overall Study|Lost to Follow-up|1|||
127537295|NCT00657540|458932062|FG001|Overall Study|Lost to Follow-up|4|||
127537296|NCT01169103|458932064|FG000|Overall Study|Lost to Follow-up|3|||
127537297|NCT01169103|458932065|FG001|Overall Study|Lost to Follow-up|3|||
127537298|NCT01169103|458932064|FG000|Overall Study|Withdrawal by Subject|3|||
127537299|NCT01169103|458932065|FG001|Overall Study|Withdrawal by Subject|1|||
127537300|NCT03010527|458932066|FG000|Overall Study|Death|0|||
127537301|NCT03010527|458932067|FG001|Overall Study|Death|0|||
127537302|NCT03010527|458932068|FG002|Overall Study|Death|1|||
127537303|NCT03010527|458932066|FG000|Overall Study|Adverse Event|0|||
127537304|NCT03010527|458932067|FG001|Overall Study|Adverse Event|4|||
127537305|NCT03010527|458932068|FG002|Overall Study|Adverse Event|2|||
127537306|NCT03010527|458932066|FG000|Overall Study|Protocol Violation|0|||
127537307|NCT03010527|458932067|FG001|Overall Study|Protocol Violation|1|||
127537308|NCT03010527|458932068|FG002|Overall Study|Protocol Violation|0|||
127537309|NCT03010527|458932066|FG000|Overall Study|Lost to Follow-up|0|||
127537310|NCT03010527|458932067|FG001|Overall Study|Lost to Follow-up|2|||
127537311|NCT03010527|458932068|FG002|Overall Study|Lost to Follow-up|1|||
127537312|NCT03010527|458932066|FG000|Overall Study|Withdrawal by Subject|0|||
127537313|NCT03010527|458932067|FG001|Overall Study|Withdrawal by Subject|3|||
127537314|NCT03010527|458932068|FG002|Overall Study|Withdrawal by Subject|4|||
127537315|NCT03010527|458932066|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
127537316|NCT03010527|458932067|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
127537317|NCT03010527|458932068|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
127537318|NCT03010527|458932066|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
127537319|NCT03010527|458932067|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
127537320|NCT03010527|458932068|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
127537321|NCT03010527|458932066|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
127537322|NCT03010527|458932067|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
127537323|NCT03010527|458932068|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
127537324|NCT02656017|458932069|FG000|Overall Study|Study burden|3|||
127537325|NCT02656017|458932070|FG001|Overall Study|Study burden|3|||
127537326|NCT02656017|458932069|FG000|Overall Study|Adverse Event|2|||
127537327|NCT02656017|458932070|FG001|Overall Study|Adverse Event|1|||
127537328|NCT02656017|458932069|FG000|Overall Study|Unable/unwilling to take study medication|2|||
127537329|NCT02656017|458932070|FG001|Overall Study|Unable/unwilling to take study medication|1|||
127537330|NCT02656017|458932069|FG000|Overall Study|Began Tolvaptan|1|||
127537331|NCT02656017|458932070|FG001|Overall Study|Began Tolvaptan|1|||
127537332|NCT02656017|458932069|FG000|Overall Study|Withdrawal by Subject|1|||
127537333|NCT02656017|458932070|FG001|Overall Study|Withdrawal by Subject|0|||
127537334|NCT02792231|458932075|FG000|Overall Study|Patient/guardian decision|32|||
127537335|NCT02792231|458932076|FG001|Overall Study|Patient/guardian decision|42|||
127537336|NCT02792231|458932075|FG000|Overall Study|Adverse Event|15|||
127537337|NCT02792231|458932076|FG001|Overall Study|Adverse Event|11|||
127537338|NCT02792231|458932075|FG000|Overall Study|Physician Decision|14|||
127537339|NCT02792231|458932076|FG001|Overall Study|Physician Decision|12|||
127537340|NCT02792231|458932075|FG000|Overall Study|Lack of Efficacy|7|||
127537341|NCT02792231|458932076|FG001|Overall Study|Lack of Efficacy|9|||
127537342|NCT02792231|458932075|FG000|Overall Study|Lost to Follow-up|9|||
127537343|NCT02792231|458932076|FG001|Overall Study|Lost to Follow-up|5|||
127537344|NCT02792231|458932075|FG000|Overall Study|Pregnancy|1|||
127537345|NCT02792231|458932076|FG001|Overall Study|Pregnancy|3|||
127537346|NCT02792231|458932075|FG000|Overall Study|Non-compliance with study treatment|2|||
127537347|NCT02792231|458932076|FG001|Overall Study|Non-compliance with study treatment|1|||
127537348|NCT02792231|458932075|FG000|Overall Study|Protocol deviation|2|||
127537349|NCT02792231|458932076|FG001|Overall Study|Protocol deviation|0|||
127537350|NCT02792231|458932075|FG000|Overall Study|Technical problems|0|||
127537351|NCT02792231|458932076|FG001|Overall Study|Technical problems|1|||
127537352|NCT05196828|458932077|FG000|Overall Study|Withdrawal by Subject|2|||
127537353|NCT05196828|458932078|FG001|Overall Study|Withdrawal by Subject|0|||
127537354|NCT05196828|458932077|FG000|Overall Study|Lost to Follow-up|0|||
127537355|NCT05196828|458932078|FG001|Overall Study|Lost to Follow-up|4|||
127537356|NCT05196828|458932077|FG000|Overall Study|Adverse Event|1|||
127537357|NCT05196828|458932078|FG001|Overall Study|Adverse Event|0|||
127537358|NCT02469623|458932079|FG000|Overall Study|Not consented for long-term follow-up|4|||
127537359|NCT02469623|458932079|FG000|Overall Study|Lost to Follow-up|4|||
127537360|NCT02469623|458932079|FG000|Overall Study|Withdrawal by Subject|2|||
127537361|NCT02469623|458932079|FG000|Overall Study|Death|3|||
127537362|NCT04073186|458932080|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
127537363|NCT04073186|458932080|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
127537364|NCT04073186|458932080|FG000|First Wearing Cycle|Protocol Violation|1|||
127537365|NCT04073186|458932080|FG000|First Wearing Cycle|Lens Discomfort|2|||
127537366|NCT04073186|458932080|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
127537367|NCT04073186|458932080|FG000|Second Wearing Cycle|Adverse Event|1|||
127537368|NCT03309878|458932081|FG000|Overall Study|Adverse Event|1|||
127537369|NCT03309878|458932082|FG001|Overall Study|Adverse Event|0|||
127537370|NCT03309878|458932083|FG002|Overall Study|Adverse Event|0|||
127537371|NCT03309878|458932084|FG003|Overall Study|Adverse Event|0|||
127537372|NCT03309878|458932081|FG000|Overall Study|Did not maintain eligibility|2|||
127537373|NCT03309878|458932082|FG001|Overall Study|Did not maintain eligibility|1|||
127537374|NCT03309878|458932083|FG002|Overall Study|Did not maintain eligibility|0|||
127537375|NCT03309878|458932084|FG003|Overall Study|Did not maintain eligibility|0|||
127537376|NCT03309878|458932081|FG000|Overall Study|Withdrawal by Subject|0|||
127537377|NCT03309878|458932082|FG001|Overall Study|Withdrawal by Subject|1|||
127537378|NCT03309878|458932083|FG002|Overall Study|Withdrawal by Subject|0|||
127537379|NCT03309878|458932084|FG003|Overall Study|Withdrawal by Subject|0|||
127537380|NCT01096316|458932085|FG000|Overall Study|Lost to Follow-up|15|||
127537381|NCT01096316|458932086|FG001|Overall Study|Lost to Follow-up|9|||
127537382|NCT02763644|458932087|FG000|Overall Study|Patient/guardian decision|1|||
127537383|NCT02763644|458932088|FG001|Overall Study|Patient/guardian decision|0|||
127537384|NCT02763644|458932087|FG000|Overall Study|Death|1|||
127537385|NCT02763644|458932088|FG001|Overall Study|Death|1|||
127537386|NCT02763644|458932087|FG000|Overall Study|Adverse Event|1|||
127537387|NCT02763644|458932088|FG001|Overall Study|Adverse Event|1|||
127537388|NCT02836652|458932089|FG000|Overall Study|Death|3|||
127537389|NCT02836652|458932090|FG001|Overall Study|Death|3|||
127537390|NCT02836652|458932089|FG000|Overall Study|Transplant/Explant|3|||
127537391|NCT02836652|458932090|FG001|Overall Study|Transplant/Explant|4|||
127537392|NCT02836652|458932089|FG000|Overall Study|Withdrawn|9|||
127648853|NCT02220894|459335318|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
127648854|NCT02220894|459335319|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
127648855|NCT02220894|459335318|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
127648856|NCT02220894|459335319|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
127648857|NCT02220894|459335318|FG000|Overall Study|Withdrawal by Subject|10|||
127648858|NCT02220894|459335319|FG001|Overall Study|Withdrawal by Subject|9|||
127648859|NCT00500903|459335320|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
127648860|NCT00500903|459335321|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
127648861|NCT00500903|459335322|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
127648862|NCT00500903|459335320|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
127648863|NCT00500903|459335321|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
127648864|NCT00500903|459335322|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
127648865|NCT00500903|459335320|FG000|Overall Study|Progressive Disease|41|||
127648866|NCT00500903|459335321|FG001|Overall Study|Progressive Disease|2|||
127648867|NCT00500903|459335322|FG002|Overall Study|Progressive Disease|15|||
127648868|NCT00500903|459335320|FG000|Overall Study|Patient Declined Further Treatment|0|||
127648869|NCT00500903|459335321|FG001|Overall Study|Patient Declined Further Treatment|0|||
127648870|NCT00500903|459335322|FG002|Overall Study|Patient Declined Further Treatment|3|||
127648871|NCT00500903|459335320|FG000|Overall Study|Symptomatic Deterioration|2|||
127648872|NCT00500903|459335321|FG001|Overall Study|Symptomatic Deterioration|0|||
127648873|NCT00500903|459335322|FG002|Overall Study|Symptomatic Deterioration|0|||
127648874|NCT00500903|459335320|FG000|Overall Study|Reason Not Specified|10|||
127648875|NCT00500903|459335321|FG001|Overall Study|Reason Not Specified|0|||
127648876|NCT00500903|459335322|FG002|Overall Study|Reason Not Specified|2|||
127648877|NCT00696410|459335325|FG000|Overall Study|Lost to Follow-up|2|||
127648878|NCT00696410|459335326|FG001|Overall Study|Lost to Follow-up|0|||
127648879|NCT00696410|459335325|FG000|Overall Study|Withdrawal by Subject|8|||
127648880|NCT00696410|459335326|FG001|Overall Study|Withdrawal by Subject|0|||
127648881|NCT00696410|459335325|FG000|Overall Study|Physician Decision|3|||
127648882|NCT00696410|459335326|FG001|Overall Study|Physician Decision|0|||
127648883|NCT03017079|459335329|FG000|Overall Study|Physician Decision|1|||
127648884|NCT03017079|459335330|FG001|Overall Study|Physician Decision|1|||
127648885|NCT03017079|459335329|FG000|Overall Study|Death|3|||
127648886|NCT03017079|459335330|FG001|Overall Study|Death|2|||
127648887|NCT03017079|459335329|FG000|Overall Study|Lack of Efficacy|2|||
127648888|NCT03017079|459335330|FG001|Overall Study|Lack of Efficacy|2|||
127648889|NCT03017079|459335329|FG000|Overall Study|Protocol Violation|0|||
127648890|NCT03017079|459335330|FG001|Overall Study|Protocol Violation|1|||
127648891|NCT02240108|459336404|FG000|Overall Study|Other than specified|8|||
127648892|NCT02240108|459336405|FG001|Overall Study|Other than specified|6|||
127648893|NCT02240108|459336404|FG000|Overall Study|Adverse Event|1|||
127648894|NCT02240108|459336405|FG001|Overall Study|Adverse Event|9|||
127537393|NCT02836652|458932090|FG001|Overall Study|Withdrawn|9|||
127537394|NCT02836652|458932089|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
127537395|NCT02836652|458932090|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
127648895|NCT02240108|459336404|FG000|Overall Study|Pregnancy|1|||
127648896|NCT02240108|459336405|FG001|Overall Study|Pregnancy|0|||
127537396|NCT00473434|458932091|FG000|Overall Study|Physician Decision|3|||
127537397|NCT00473434|458932091|FG000|Overall Study|Withdrawal by Subject|9|||
127537398|NCT00473434|458932091|FG000|Overall Study|Compliance|3|||
127537399|NCT00473434|458932091|FG000|Overall Study|Lack of Efficacy|3|||
127537400|NCT00473434|458932091|FG000|Overall Study|Adverse Event|3|||
127537401|NCT00473434|458932091|FG000|Overall Study|Patient was selling medication to others|1|||
127537402|NCT00473434|458932091|FG000|Overall Study|Safety evaluation|1|||
127537403|NCT00473434|458932091|FG000|Overall Study|Reason not specified|6|||
127537404|NCT00473434|458932091|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
127537405|NCT00473434|458932091|FG000|Overall Study|Switching to trial medication|1|||
127537406|NCT00473434|458932091|FG000|Overall Study|No longer required|1|||
127537407|NCT02349633|458932092|FG000|Overall Study|Death|0|||
127537408|NCT02349633|458932093|FG001|Overall Study|Death|1|||
127537409|NCT02349633|458932094|FG002|Overall Study|Death|0|||
127537410|NCT02349633|458932095|FG003|Overall Study|Death|0|||
127537411|NCT02349633|458932096|FG004|Overall Study|Death|0|||
127537412|NCT02349633|458932097|FG005|Overall Study|Death|1|||
127537413|NCT02349633|458932098|FG006|Overall Study|Death|1|||
127537414|NCT02349633|458932099|FG007|Overall Study|Death|1|||
127537415|NCT02349633|458932100|FG008|Overall Study|Death|0|||
127537416|NCT02349633|458932101|FG009|Overall Study|Death|1|||
127537417|NCT02349633|458932102|FG010|Overall Study|Death|0|||
127537418|NCT02349633|458932103|FG011|Overall Study|Death|0|||
127537419|NCT02349633|458932104|FG012|Overall Study|Death|0|||
127537420|NCT02349633|458932105|FG013|Overall Study|Death|0|||
127537421|NCT02349633|458932092|FG000|Overall Study|Withdrawal by Subject|0|||
127537422|NCT02349633|458932093|FG001|Overall Study|Withdrawal by Subject|0|||
127537423|NCT02349633|458932094|FG002|Overall Study|Withdrawal by Subject|0|||
127537424|NCT02349633|458932095|FG003|Overall Study|Withdrawal by Subject|1|||
127537425|NCT02349633|458932096|FG004|Overall Study|Withdrawal by Subject|0|||
127537426|NCT02349633|458932097|FG005|Overall Study|Withdrawal by Subject|0|||
127537427|NCT02349633|458932098|FG006|Overall Study|Withdrawal by Subject|0|||
127537428|NCT02349633|458932099|FG007|Overall Study|Withdrawal by Subject|2|||
127537429|NCT02349633|458932100|FG008|Overall Study|Withdrawal by Subject|2|||
127537430|NCT02349633|458932101|FG009|Overall Study|Withdrawal by Subject|1|||
127537431|NCT02349633|458932102|FG010|Overall Study|Withdrawal by Subject|0|||
127537432|NCT02349633|458932103|FG011|Overall Study|Withdrawal by Subject|0|||
127537433|NCT02349633|458932104|FG012|Overall Study|Withdrawal by Subject|0|||
127537434|NCT02349633|458932105|FG013|Overall Study|Withdrawal by Subject|0|||
127537435|NCT02349633|458932092|FG000|Overall Study|Withdrawal of informed consent|0|||
127537436|NCT02349633|458932093|FG001|Overall Study|Withdrawal of informed consent|0|||
127537437|NCT02349633|458932094|FG002|Overall Study|Withdrawal of informed consent|0|||
127537438|NCT02349633|458932095|FG003|Overall Study|Withdrawal of informed consent|1|||
127537439|NCT02349633|458932096|FG004|Overall Study|Withdrawal of informed consent|1|||
127537440|NCT02349633|458932097|FG005|Overall Study|Withdrawal of informed consent|0|||
127537441|NCT02349633|458932098|FG006|Overall Study|Withdrawal of informed consent|0|||
127537442|NCT02349633|458932099|FG007|Overall Study|Withdrawal of informed consent|3|||
127537443|NCT02349633|458932100|FG008|Overall Study|Withdrawal of informed consent|0|||
127537444|NCT02349633|458932101|FG009|Overall Study|Withdrawal of informed consent|0|||
127537445|NCT02349633|458932102|FG010|Overall Study|Withdrawal of informed consent|0|||
127537446|NCT02349633|458932103|FG011|Overall Study|Withdrawal of informed consent|0|||
127537447|NCT02349633|458932104|FG012|Overall Study|Withdrawal of informed consent|0|||
127537448|NCT02349633|458932105|FG013|Overall Study|Withdrawal of informed consent|0|||
127537449|NCT02349633|458932092|FG000|Overall Study|Transition to compassionate use|0|||
127537450|NCT02349633|458932093|FG001|Overall Study|Transition to compassionate use|0|||
127537451|NCT02349633|458932094|FG002|Overall Study|Transition to compassionate use|0|||
127537452|NCT02349633|458932095|FG003|Overall Study|Transition to compassionate use|0|||
127537453|NCT02349633|458932096|FG004|Overall Study|Transition to compassionate use|1|||
127537454|NCT02349633|458932097|FG005|Overall Study|Transition to compassionate use|0|||
127537455|NCT02349633|458932098|FG006|Overall Study|Transition to compassionate use|0|||
127537456|NCT02349633|458932099|FG007|Overall Study|Transition to compassionate use|3|||
127537457|NCT02349633|458932100|FG008|Overall Study|Transition to compassionate use|0|||
127537458|NCT02349633|458932101|FG009|Overall Study|Transition to compassionate use|1|||
127537459|NCT02349633|458932102|FG010|Overall Study|Transition to compassionate use|0|||
127537460|NCT02349633|458932103|FG011|Overall Study|Transition to compassionate use|0|||
127537461|NCT02349633|458932104|FG012|Overall Study|Transition to compassionate use|0|||
127537462|NCT02349633|458932105|FG013|Overall Study|Transition to compassionate use|0|||
127537463|NCT02349633|458932092|FG000|Overall Study|Early termination of survival follow-up|0|||
127537464|NCT02349633|458932093|FG001|Overall Study|Early termination of survival follow-up|0|||
127537465|NCT02349633|458932094|FG002|Overall Study|Early termination of survival follow-up|0|||
127537466|NCT02349633|458932095|FG003|Overall Study|Early termination of survival follow-up|0|||
127537467|NCT02349633|458932096|FG004|Overall Study|Early termination of survival follow-up|0|||
127537468|NCT02349633|458932097|FG005|Overall Study|Early termination of survival follow-up|0|||
127537469|NCT02349633|458932098|FG006|Overall Study|Early termination of survival follow-up|0|||
127648897|NCT02240108|459336404|FG000|Overall Study|Withdrawal by Subject|4|||
127648898|NCT02240108|459336405|FG001|Overall Study|Withdrawal by Subject|9|||
127648899|NCT02240108|459336404|FG000|Overall Study|StudyTerminated by Sponsor|0|||
127648900|NCT02240108|459336405|FG001|Overall Study|StudyTerminated by Sponsor|1|||
127537470|NCT02349633|458932099|FG007|Overall Study|Early termination of survival follow-up|4|||
127537471|NCT02349633|458932100|FG008|Overall Study|Early termination of survival follow-up|0|||
127537472|NCT02349633|458932101|FG009|Overall Study|Early termination of survival follow-up|0|||
127537473|NCT02349633|458932102|FG010|Overall Study|Early termination of survival follow-up|0|||
127537474|NCT02349633|458932103|FG011|Overall Study|Early termination of survival follow-up|0|||
127537475|NCT02349633|458932104|FG012|Overall Study|Early termination of survival follow-up|0|||
127537476|NCT02349633|458932105|FG013|Overall Study|Early termination of survival follow-up|0|||
127537477|NCT02349633|458932092|FG000|Overall Study|Termination by sponsor|0|||
127537478|NCT02349633|458932093|FG001|Overall Study|Termination by sponsor|0|||
127537479|NCT02349633|458932094|FG002|Overall Study|Termination by sponsor|0|||
127537480|NCT02349633|458932095|FG003|Overall Study|Termination by sponsor|0|||
127537481|NCT02349633|458932096|FG004|Overall Study|Termination by sponsor|0|||
127537482|NCT02349633|458932097|FG005|Overall Study|Termination by sponsor|0|||
127537483|NCT02349633|458932098|FG006|Overall Study|Termination by sponsor|0|||
127537484|NCT02349633|458932099|FG007|Overall Study|Termination by sponsor|1|||
127537485|NCT02349633|458932100|FG008|Overall Study|Termination by sponsor|0|||
127537486|NCT02349633|458932101|FG009|Overall Study|Termination by sponsor|2|||
127537487|NCT02349633|458932102|FG010|Overall Study|Termination by sponsor|0|||
127648901|NCT01345630|459336406|FG000|Overall Study|Adverse Event|22|||
127648902|NCT01345630|459336407|FG001|Overall Study|Adverse Event|23|||
127648903|NCT01345630|459336406|FG000|Overall Study|Lost to Follow-up|17|||
127648904|NCT01345630|459336407|FG001|Overall Study|Lost to Follow-up|16|||
127648905|NCT01345630|459336406|FG000|Overall Study|Protocol Violation|4|||
127648906|NCT01345630|459336407|FG001|Overall Study|Protocol Violation|1|||
127648907|NCT01345630|459336406|FG000|Overall Study|Medication error without associated AE|0|||
127648908|NCT01345630|459336407|FG001|Overall Study|Medication error without associated AE|1|||
127648909|NCT01345630|459336406|FG000|Overall Study|Study terminated by sponsor|254|||
127648910|NCT01345630|459336407|FG001|Overall Study|Study terminated by sponsor|285|||
127648911|NCT01345630|459336406|FG000|Overall Study|Other reasons|6|||
127648912|NCT01345630|459336407|FG001|Overall Study|Other reasons|8|||
127648913|NCT01345630|459336406|FG000|Overall Study|Withdrawn due to pregnancy|1|||
127648914|NCT01345630|459336407|FG001|Overall Study|Withdrawn due to pregnancy|2|||
127648915|NCT01345630|459336406|FG000|Overall Study|No longer willing to participate|9|||
127648916|NCT01345630|459336407|FG001|Overall Study|No longer willing to participate|12|||
127648917|NCT01345630|459336406|FG000|Overall Study|Insufficient clinical response|48|||
127648918|NCT01345630|459336407|FG001|Overall Study|Insufficient clinical response|11|||
127648919|NCT04233372|459336408|FG000|Overall Study|Lost to Follow-up|104|||
127648920|NCT04233372|459336408|FG000|Overall Study|Adverse Event|8|||
127648921|NCT04233372|459336408|FG000|Overall Study|Withdrawal by Subject|2|||
127648922|NCT03938454|459336409|FG000|Overall Study|Protocol Violation|1|||
127648923|NCT03938454|459336409|FG000|Overall Study|Withdrawal by Subject|2|||
127648924|NCT03938454|459336409|FG000|Overall Study|Lost to Follow-up|3|||
127648925|NCT01090310|459336410|FG000|Core Study|Adverse Event|2|||
127648926|NCT01090310|459336411|FG001|Core Study|Adverse Event|2|||
127648927|NCT01090310|459336412|FG002|Core Study|Adverse Event|1|||
127648928|NCT01090310|459336413|FG003|Core Study|Adverse Event|1|||
127648929|NCT01090310|459336410|FG000|Core Study|Subject withdrew consent|0|||
127648930|NCT01090310|459336411|FG001|Core Study|Subject withdrew consent|3|||
127648931|NCT01090310|459336412|FG002|Core Study|Subject withdrew consent|1|||
127648932|NCT01090310|459336413|FG003|Core Study|Subject withdrew consent|1|||
127648933|NCT01090310|459336410|FG000|Core Study|Abnormal test procedure result|0|||
127648934|NCT01090310|459336411|FG001|Core Study|Abnormal test procedure result|0|||
127648935|NCT01090310|459336412|FG002|Core Study|Abnormal test procedure result|1|||
127648936|NCT01090310|459336413|FG003|Core Study|Abnormal test procedure result|0|||
127648937|NCT01090310|459336410|FG000|Core Study|Administrative reasons|5|||
127648938|NCT01090310|459336411|FG001|Core Study|Administrative reasons|6|||
127648939|NCT01090310|459336412|FG002|Core Study|Administrative reasons|4|||
127648940|NCT01090310|459336413|FG003|Core Study|Administrative reasons|4|||
127648941|NCT01090310|459336410|FG000|Core Study|Protocol deviation|1|||
127648942|NCT01090310|459336411|FG001|Core Study|Protocol deviation|0|||
127648943|NCT01090310|459336412|FG002|Core Study|Protocol deviation|0|||
127648944|NCT01090310|459336413|FG003|Core Study|Protocol deviation|1|||
127537488|NCT02349633|458932103|FG011|Overall Study|Termination by sponsor|0|||
127648945|NCT01090310|459336410|FG000|Extension Study|Aministrative problems|13|||
127648946|NCT01090310|459336411|FG001|Extension Study|Aministrative problems|15|||
127648947|NCT01090310|459336412|FG002|Extension Study|Aministrative problems|14|||
127648948|NCT01090310|459336413|FG003|Extension Study|Aministrative problems|18|||
127648949|NCT01090310|459336410|FG000|Extension Study|Adverse Event|0|||
127648950|NCT01090310|459336411|FG001|Extension Study|Adverse Event|0|||
127648951|NCT01090310|459336412|FG002|Extension Study|Adverse Event|0|||
127648952|NCT01090310|459336413|FG003|Extension Study|Adverse Event|1|||
127648953|NCT01090310|459336410|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
127537489|NCT02349633|458932104|FG012|Overall Study|Termination by sponsor|0|||
127537490|NCT02349633|458932105|FG013|Overall Study|Termination by sponsor|0|||
127537491|NCT02349633|458932092|FG000|Overall Study|Other|0|||
127537492|NCT02349633|458932093|FG001|Overall Study|Other|0|||
127537493|NCT02349633|458932094|FG002|Overall Study|Other|0|||
127537494|NCT02349633|458932095|FG003|Overall Study|Other|0|||
127537495|NCT02349633|458932096|FG004|Overall Study|Other|0|||
127537496|NCT02349633|458932097|FG005|Overall Study|Other|0|||
127537497|NCT02349633|458932098|FG006|Overall Study|Other|0|||
127537498|NCT02349633|458932099|FG007|Overall Study|Other|2|||
127537499|NCT02349633|458932100|FG008|Overall Study|Other|0|||
127537500|NCT02349633|458932101|FG009|Overall Study|Other|0|||
127537501|NCT02349633|458932102|FG010|Overall Study|Other|0|||
127537502|NCT02349633|458932103|FG011|Overall Study|Other|0|||
127537503|NCT02349633|458932104|FG012|Overall Study|Other|0|||
127537504|NCT02349633|458932105|FG013|Overall Study|Other|0|||
127537505|NCT01008943|458932108|FG000|Overall Study|Withdrawal by Subject|1|||
127537506|NCT04244253|458932109|FG000|Overall Study|Adverse Event|2|||
127537507|NCT04244253|458932110|FG001|Overall Study|Adverse Event|2|||
127537508|NCT04244253|458932111|FG002|Overall Study|Adverse Event|4|||
127537509|NCT04244253|458932109|FG000|Overall Study|Protocol Violation|1|||
127537510|NCT04244253|458932110|FG001|Overall Study|Protocol Violation|2|||
127537511|NCT04244253|458932111|FG002|Overall Study|Protocol Violation|1|||
127537512|NCT04244253|458932109|FG000|Overall Study|Withdrawal by Subject|0|||
127537513|NCT04244253|458932110|FG001|Overall Study|Withdrawal by Subject|1|||
127537514|NCT04244253|458932111|FG002|Overall Study|Withdrawal by Subject|6|||
127537515|NCT04244253|458932109|FG000|Overall Study|Non-Compliance With Study Drug|0|||
127537516|NCT04244253|458932110|FG001|Overall Study|Non-Compliance With Study Drug|0|||
127537517|NCT04244253|458932111|FG002|Overall Study|Non-Compliance With Study Drug|1|||
127537518|NCT04663321|458932112|FG000|Overall Study|Study terminated by Sponsor|2|||
127537519|NCT04663321|458932113|FG001|Overall Study|Study terminated by Sponsor|1|||
127537520|NCT04663321|458932114|FG002|Overall Study|Study terminated by Sponsor|2|||
127537521|NCT04663321|458932112|FG000|Overall Study|Withdrawal by Subject|10|||
127537522|NCT04663321|458932113|FG001|Overall Study|Withdrawal by Subject|3|||
127537523|NCT04663321|458932114|FG002|Overall Study|Withdrawal by Subject|2|||
127537524|NCT04663321|458932112|FG000|Overall Study|Not provided|0|||
127537525|NCT04663321|458932113|FG001|Overall Study|Not provided|0|||
127537526|NCT04663321|458932114|FG002|Overall Study|Not provided|1|||
127537527|NCT01453140|458932115|FG000|Overall Study|Adverse Event|3|||
127537528|NCT02611479|458932116|FG000|Baseline Enrollment|Exited study|13|||
127537529|NCT02611479|458932116|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
127537530|NCT02611479|458932116|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
127537531|NCT02611479|458932116|FG000|Data Cleaning|No baseline function or pain metrics|2|||
127537532|NCT02653326|458932121|FG000|Overall Study|Lost to Follow-up|10|||
127537533|NCT02653326|458932122|FG001|Overall Study|Lost to Follow-up|7|||
127537534|NCT02422498|458932123|FG000|Overall Study|Inevaluable|4|||
127537535|NCT03206216|458932124|FG000|Overall Study|Withdrawal by Subject|0|||
127537536|NCT03206216|458932125|FG001|Overall Study|Withdrawal by Subject|1|||
127537537|NCT05767021|458932128|FG000|Overall Study|Adverse Event|2|||
127537538|NCT05767021|458932128|FG000|Overall Study|Protocol Deviation|1|||
127537539|NCT05767021|458932128|FG000|Overall Study|Withdrawal by Subject|1|||
127537540|NCT05767021|458932128|FG000|Overall Study|Physician Decision|1|||
127537541|NCT05767021|458932128|FG000|Overall Study|Lack of Efficacy|11|||
127537542|NCT05767021|458932128|FG000|Overall Study|Assigned Treatment by Mistake|1|||
127537543|NCT04154943|458932132|FG000|Overall Study|Study Ongoing|68|||
127537544|NCT04154943|458932132|FG000|Overall Study|Lost to Follow-up|1|||
127537545|NCT04154943|458932132|FG000|Overall Study|Decision by the Investigator|1|||
127537546|NCT04154943|458932132|FG000|Overall Study|Death|5|||
127537547|NCT04154943|458932132|FG000|Overall Study|Withdrawal by Subject|4|||
127537548|NCT02738008|458932133|FG000|Overall Study|Study Terminated by Sponsor|1|||
127537549|NCT02738008|458932134|FG001|Overall Study|Study Terminated by Sponsor|5|||
127537550|NCT02738008|458932135|FG002|Overall Study|Study Terminated by Sponsor|3|||
127537551|NCT02738008|458932133|FG000|Overall Study|Adverse Event|0|||
127537552|NCT02738008|458932134|FG001|Overall Study|Adverse Event|1|||
127537553|NCT02738008|458932135|FG002|Overall Study|Adverse Event|2|||
127537554|NCT04621448|458932136|FG000|Baseline to 12 Weeks|Withdrawal by Subject|6|||
127537555|NCT04621448|458932137|FG001|Baseline to 12 Weeks|Withdrawal by Subject|8|||
127537556|NCT04621448|458932138|FG002|Baseline to 12 Weeks|Withdrawal by Subject|6|||
127537557|NCT04621448|458932139|FG003|Baseline to 12 Weeks|Withdrawal by Subject|8|||
127537558|NCT04621448|458932136|FG000|Baseline to 12 Weeks|Lost to Follow-up|0|||
127537559|NCT04621448|458932137|FG001|Baseline to 12 Weeks|Lost to Follow-up|1|||
127537560|NCT04621448|458932138|FG002|Baseline to 12 Weeks|Lost to Follow-up|0|||
127642271|NCT03252587|459310080|FG002|Overall Study|Lack of Efficacy|2|||
127642272|NCT03252587|459310081|FG003|Overall Study|Lack of Efficacy|4|||
127642273|NCT03252587|459310078|FG000|Overall Study|Lost to Follow-up|2|||
127642274|NCT03252587|459310079|FG001|Overall Study|Lost to Follow-up|0|||
127642275|NCT03252587|459310080|FG002|Overall Study|Lost to Follow-up|0|||
127642276|NCT03252587|459310081|FG003|Overall Study|Lost to Follow-up|2|||
127537561|NCT04621448|458932139|FG003|Baseline to 12 Weeks|Lost to Follow-up|1|||
127537562|NCT04621448|458932136|FG000|12 to 24 Weeks|Lost to Follow-up|1|||
127537563|NCT04621448|458932137|FG001|12 to 24 Weeks|Lost to Follow-up|0|||
127537564|NCT04621448|458932138|FG002|12 to 24 Weeks|Lost to Follow-up|1|||
127537565|NCT04621448|458932139|FG003|12 to 24 Weeks|Lost to Follow-up|0|||
127537566|NCT04621448|458932136|FG000|12 to 24 Weeks|Withdrawal by Subject|3|||
127537567|NCT04621448|458932137|FG001|12 to 24 Weeks|Withdrawal by Subject|2|||
127537568|NCT04621448|458932138|FG002|12 to 24 Weeks|Withdrawal by Subject|3|||
127537569|NCT04621448|458932139|FG003|12 to 24 Weeks|Withdrawal by Subject|2|||
127537570|NCT03550378|458932140|FG000|Overall Study|Death|0|||
127537571|NCT03550378|458932141|FG001|Overall Study|Death|1|||
127537572|NCT04590014|458932144|FG000|Overall Study|Withdrawal by Subject|1|||
127537573|NCT04590014|458932145|FG001|Overall Study|Withdrawal by Subject|0|||
127537574|NCT00468299|458932146|FG000|Overall Study|Withdrawal by Subject|0|||
127537575|NCT00468299|458932147|FG001|Overall Study|Withdrawal by Subject|1|||
127537576|NCT01290523|458932148|FG000|Overall Study|Death|3|||
127537577|NCT01917747|458932149|FG000|Overall Study|Withdrawal by Subject|1|||
127537578|NCT01917747|458932150|FG001|Overall Study|Withdrawal by Subject|2|||
127537579|NCT01917747|458932149|FG000|Overall Study|Lost to Follow-up|18|||
127537580|NCT01917747|458932150|FG001|Overall Study|Lost to Follow-up|9|||
127537581|NCT00152503|458932152|FG000|Overall Study|Adverse Event|4|||
127537582|NCT02922725|458932153|FG000|Overall Study|Withdrawal by Subject|1|||
127537583|NCT02922725|458932154|FG001|Overall Study|Withdrawal by Subject|0|||
127537584|NCT02922725|458932155|FG002|Overall Study|Withdrawal by Subject|0|||
127537585|NCT01300234|458932156|FG000|Overall Study|Adverse Event|1|||
127537586|NCT01300234|458932157|FG001|Overall Study|Adverse Event|1|||
127537587|NCT01300234|458932156|FG000|Overall Study|Protocol Violation|2|||
127537588|NCT01300234|458932157|FG001|Overall Study|Protocol Violation|3|||
127537589|NCT01300234|458932156|FG000|Overall Study|Withdrawal by Subject|5|||
127537590|NCT01300234|458932157|FG001|Overall Study|Withdrawal by Subject|9|||
127537591|NCT01300234|458932156|FG000|Overall Study|Lost to Follow-up|14|||
127537592|NCT01300234|458932157|FG001|Overall Study|Lost to Follow-up|12|||
127537593|NCT01300234|458932156|FG000|Overall Study|Pregnancy|2|||
127537594|NCT01300234|458932157|FG001|Overall Study|Pregnancy|1|||
127537595|NCT01300234|458932156|FG000|Overall Study|Participant reached stopping critera|2|||
127537596|NCT01300234|458932157|FG001|Overall Study|Participant reached stopping critera|0|||
127537597|NCT01300234|458932156|FG000|Overall Study|Participant stopped medication|1|||
127537598|NCT01300234|458932157|FG001|Overall Study|Participant stopped medication|1|||
127537599|NCT01300234|458932156|FG000|Overall Study|Participant refused return to hospital|1|||
127537600|NCT01300234|458932157|FG001|Overall Study|Participant refused return to hospital|0|||
127537601|NCT03253679|458932158|FG000|Overall Study|Screen Failure|1|||
127537602|NCT04816214|458932160|FG000|Overall Study|Progressive Disease|4|||
127537603|NCT04816214|458932161|FG001|Overall Study|Progressive Disease|0|||
127537604|NCT04816214|458932162|FG002|Overall Study|Progressive Disease|0|||
127537605|NCT04816214|458932160|FG000|Overall Study|Death|1|||
127537606|NCT04816214|458932161|FG001|Overall Study|Death|0|||
127537607|NCT04816214|458932162|FG002|Overall Study|Death|0|||
127537608|NCT04816214|458932160|FG000|Overall Study|Study Terminated by Sponsor|1|||
127537609|NCT04816214|458932161|FG001|Overall Study|Study Terminated by Sponsor|0|||
127537610|NCT04816214|458932162|FG002|Overall Study|Study Terminated by Sponsor|0|||
127537611|NCT00550407|458932163|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
127537612|NCT00550407|458932164|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
127537613|NCT00550407|458932165|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
127537614|NCT00550407|458932163|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
127537615|NCT00550407|458932164|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
127537616|NCT00550407|458932165|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
127537617|NCT00550407|458932163|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
127537618|NCT00550407|458932164|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
127537619|NCT00550407|458932165|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
127537620|NCT00550407|458932163|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
127537621|NCT00550407|458932164|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
127537622|NCT00550407|458932165|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
127537623|NCT00550407|458932163|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
127537624|NCT00550407|458932164|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
127537625|NCT00550407|458932165|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
127537626|NCT00550407|458932163|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
127537627|NCT00550407|458932164|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
127537628|NCT00550407|458932165|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
127537629|NCT00550407|458932163|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
127537630|NCT00550407|458932164|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
127537631|NCT00550407|458932165|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
127537632|NCT00550407|458932163|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
127648954|NCT01090310|459336411|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
127648955|NCT01090310|459336412|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
127648956|NCT01090310|459336413|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
127648957|NCT01090310|459336410|FG000|Extension Study|Subject withdrew consent|0|||
127648958|NCT01090310|459336411|FG001|Extension Study|Subject withdrew consent|1|||
127648959|NCT01090310|459336412|FG002|Extension Study|Subject withdrew consent|0|||
127648960|NCT01090310|459336413|FG003|Extension Study|Subject withdrew consent|0|||
127648961|NCT00949884|459336417|FG000|Overall Study|Adverse Event|14|||
127648962|NCT00949884|459336418|FG001|Overall Study|Adverse Event|3|||
127537633|NCT00550407|458932164|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
127648963|NCT00949884|459336419|FG002|Overall Study|Adverse Event|12|||
127648964|NCT00949884|459336417|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
127648965|NCT00949884|459336418|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
127648966|NCT00949884|459336419|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
127648967|NCT00949884|459336417|FG000|Overall Study|Lost to Follow-up|7|||
127648968|NCT00949884|459336418|FG001|Overall Study|Lost to Follow-up|5|||
127648969|NCT00949884|459336419|FG002|Overall Study|Lost to Follow-up|5|||
127648970|NCT00949884|459336417|FG000|Overall Study|Physician Decision|5|||
127648971|NCT00949884|459336418|FG001|Overall Study|Physician Decision|0|||
127648972|NCT00949884|459336419|FG002|Overall Study|Physician Decision|6|||
127648973|NCT00949884|459336417|FG000|Overall Study|Treatment non-compliance|5|||
127648974|NCT00949884|459336418|FG001|Overall Study|Treatment non-compliance|0|||
127648975|NCT00949884|459336419|FG002|Overall Study|Treatment non-compliance|8|||
127648976|NCT00949884|459336417|FG000|Overall Study|Withdrawal by Subject|13|||
127648977|NCT00949884|459336418|FG001|Overall Study|Withdrawal by Subject|4|||
127648978|NCT00949884|459336419|FG002|Overall Study|Withdrawal by Subject|16|||
127537634|NCT00550407|458932165|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
127537635|NCT00550407|458932163|FG000|26-Week Randomized Phase|Adverse Event|0|||
127537636|NCT00550407|458932164|FG001|26-Week Randomized Phase|Adverse Event|5|||
127537637|NCT00550407|458932165|FG002|26-Week Randomized Phase|Adverse Event|2|||
127537638|NCT00550407|458932163|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
127537639|NCT00550407|458932164|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
127537640|NCT00550407|458932165|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
127537641|NCT00550407|458932163|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
127537642|NCT00550407|458932164|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
127537643|NCT00550407|458932165|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
127537644|NCT00550407|458932163|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
127537645|NCT00550407|458932164|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
127537646|NCT00550407|458932165|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
127537647|NCT00584415|458932166|FG000|Overall Study|Adverse Event|7|||
127537648|NCT05051579|458932167|FG000|Overall Study|Withdrawal by Subject|3|||
127537649|NCT05051579|458932168|FG001|Overall Study|Withdrawal by Subject|5|||
127537650|NCT05051579|458932169|FG002|Overall Study|Withdrawal by Subject|2|||
127537651|NCT05051579|458932170|FG003|Overall Study|Withdrawal by Subject|1|||
127537652|NCT05051579|458932171|FG004|Overall Study|Withdrawal by Subject|4|||
127537653|NCT05051579|458932172|FG005|Overall Study|Withdrawal by Subject|0|||
127537654|NCT05051579|458932173|FG006|Overall Study|Withdrawal by Subject|4|||
127537655|NCT05051579|458932167|FG000|Overall Study|Lost to Follow-up|1|||
127537656|NCT05051579|458932168|FG001|Overall Study|Lost to Follow-up|0|||
127537657|NCT05051579|458932169|FG002|Overall Study|Lost to Follow-up|0|||
127537658|NCT05051579|458932170|FG003|Overall Study|Lost to Follow-up|0|||
127537659|NCT05051579|458932171|FG004|Overall Study|Lost to Follow-up|1|||
127537660|NCT05051579|458932172|FG005|Overall Study|Lost to Follow-up|0|||
127537661|NCT05051579|458932173|FG006|Overall Study|Lost to Follow-up|1|||
127537662|NCT05051579|458932167|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
127537663|NCT05051579|458932168|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
127537664|NCT05051579|458932169|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
127537665|NCT05051579|458932170|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
127537666|NCT05051579|458932171|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
127537667|NCT05051579|458932172|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
127537668|NCT05051579|458932173|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
127648979|NCT00949884|459336417|FG000|Overall Study|Lack of Efficacy|4|||
127648980|NCT00949884|459336418|FG001|Overall Study|Lack of Efficacy|2|||
127648981|NCT00949884|459336419|FG002|Overall Study|Lack of Efficacy|7|||
127648982|NCT00949884|459336417|FG000|Overall Study|Study terminated by sponsor|0|||
127537669|NCT05051579|458932167|FG000|Overall Study|Adverse Event|2|||
127537670|NCT05051579|458932168|FG001|Overall Study|Adverse Event|1|||
127537671|NCT05051579|458932169|FG002|Overall Study|Adverse Event|0|||
127537672|NCT05051579|458932170|FG003|Overall Study|Adverse Event|4|||
127537673|NCT05051579|458932171|FG004|Overall Study|Adverse Event|1|||
127537674|NCT05051579|458932172|FG005|Overall Study|Adverse Event|2|||
127537675|NCT05051579|458932173|FG006|Overall Study|Adverse Event|0|||
127537676|NCT05051579|458932167|FG000|Overall Study|Inadvertent Enrollment|0|||
127537677|NCT05051579|458932168|FG001|Overall Study|Inadvertent Enrollment|0|||
127537678|NCT05051579|458932169|FG002|Overall Study|Inadvertent Enrollment|0|||
127537679|NCT05051579|458932170|FG003|Overall Study|Inadvertent Enrollment|0|||
127537680|NCT05051579|458932171|FG004|Overall Study|Inadvertent Enrollment|0|||
127537681|NCT05051579|458932172|FG005|Overall Study|Inadvertent Enrollment|0|||
127537682|NCT05051579|458932173|FG006|Overall Study|Inadvertent Enrollment|1|||
127537683|NCT05051579|458932167|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
127537684|NCT05051579|458932168|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
127537685|NCT05051579|458932169|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
127537686|NCT05051579|458932170|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
127537687|NCT05051579|458932171|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
127537688|NCT05051579|458932172|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
127537689|NCT05051579|458932173|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
127537690|NCT05051579|458932167|FG000|Overall Study|Sponsor Decision|0|||
127537691|NCT05051579|458932168|FG001|Overall Study|Sponsor Decision|0|||
127537692|NCT05051579|458932169|FG002|Overall Study|Sponsor Decision|0|||
127537693|NCT05051579|458932170|FG003|Overall Study|Sponsor Decision|0|||
127537694|NCT05051579|458932171|FG004|Overall Study|Sponsor Decision|1|||
127537695|NCT05051579|458932172|FG005|Overall Study|Sponsor Decision|0|||
127537696|NCT05051579|458932173|FG006|Overall Study|Sponsor Decision|0|||
127537697|NCT05051579|458932167|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
127537698|NCT05051579|458932168|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
127537699|NCT05051579|458932169|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
127537700|NCT05051579|458932170|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
127537701|NCT05051579|458932171|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
127537702|NCT05051579|458932172|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
127537703|NCT05051579|458932173|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
127537704|NCT00717249|458932174|FG000|Overall Study|Lens Discomfort|4|||
127537705|NCT00717249|458932175|FG001|Overall Study|Lens Discomfort|1|||
127537706|NCT00717249|458932174|FG000|Overall Study|Unsatisfactory visual Response|0|||
127537707|NCT00717249|458932175|FG001|Overall Study|Unsatisfactory visual Response|2|||
127537708|NCT00717249|458932174|FG000|Overall Study|Adverse Event|4|||
127537709|NCT00717249|458932175|FG001|Overall Study|Adverse Event|2|||
127537710|NCT00717249|458932174|FG000|Overall Study|Lost to Follow-up|2|||
127537711|NCT00717249|458932175|FG001|Overall Study|Lost to Follow-up|0|||
127537712|NCT00717249|458932174|FG000|Overall Study|Withdrawal by Subject|1|||
127537713|NCT00717249|458932175|FG001|Overall Study|Withdrawal by Subject|2|||
127537714|NCT00717249|458932174|FG000|Overall Study|Pregnancy|6|||
127537715|NCT00717249|458932175|FG001|Overall Study|Pregnancy|3|||
127537716|NCT00717249|458932174|FG000|Overall Study|Protocol Violation|0|||
127537717|NCT00717249|458932175|FG001|Overall Study|Protocol Violation|2|||
127537718|NCT00717249|458932174|FG000|Overall Study|Subject became Ineligible|1|||
127537719|NCT00717249|458932175|FG001|Overall Study|Subject became Ineligible|1|||
127537720|NCT00717249|458932174|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
127537721|NCT00717249|458932175|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
127537722|NCT00717249|458932174|FG000|Overall Study|Gastric Surgery|0|||
127537723|NCT00717249|458932175|FG001|Overall Study|Gastric Surgery|1|||
127537724|NCT00717249|458932174|FG000|Overall Study|Diagnosed with Diabetes|1|||
127537725|NCT00717249|458932175|FG001|Overall Study|Diagnosed with Diabetes|0|||
127537726|NCT00717249|458932174|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
127537727|NCT00717249|458932175|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
127537728|NCT00717249|458932174|FG000|Overall Study|Subject relocated|1|||
127537729|NCT00717249|458932175|FG001|Overall Study|Subject relocated|0|||
127537730|NCT00717249|458932174|FG000|Overall Study|Headaches|1|||
127537731|NCT00717249|458932175|FG001|Overall Study|Headaches|0|||
127537732|NCT00360412|458932176|FG000|Overall Study|Adverse Event|37|||
127537733|NCT00360412|458932177|FG001|Overall Study|Adverse Event|65|||
127537734|NCT00360412|458932176|FG000|Overall Study|Protocol Violation|2|||
127537735|NCT00360412|458932177|FG001|Overall Study|Protocol Violation|5|||
127537736|NCT00360412|458932176|FG000|Overall Study|Patient withdrew consent|27|||
127537737|NCT00360412|458932177|FG001|Overall Study|Patient withdrew consent|52|||
127537738|NCT00360412|458932176|FG000|Overall Study|Lack of therapeutic efficacy|46|||
127537739|NCT00360412|458932177|FG001|Overall Study|Lack of therapeutic efficacy|61|||
127648983|NCT00949884|459336418|FG001|Overall Study|Study terminated by sponsor|0|||
127537740|NCT00360412|458932176|FG000|Overall Study|Physician Decision|2|||
127537741|NCT00360412|458932177|FG001|Overall Study|Physician Decision|4|||
127537742|NCT00360412|458932176|FG000|Overall Study|Other|5|||
127537743|NCT00360412|458932177|FG001|Overall Study|Other|6|||
127537744|NCT00360412|458932176|FG000|Overall Study|Study termination by Sponsor|214|||
127537745|NCT00360412|458932177|FG001|Overall Study|Study termination by Sponsor|469|||
127537746|NCT05148234|458932178|FG000|Phase I|Ineligible|0|||
127648984|NCT00949884|459336419|FG002|Overall Study|Study terminated by sponsor|1|||
127648985|NCT03092375|459336420|FG000|Overall Study|Lack of Efficacy|0|||
127648986|NCT03092375|459336421|FG001|Overall Study|Lack of Efficacy|1|||
127648987|NCT03092375|459336422|FG002|Overall Study|Lack of Efficacy|1|||
127648988|NCT03092375|459336423|FG003|Overall Study|Lack of Efficacy|0|||
127648989|NCT01255592|459336424|FG000|Overall Study|Adverse Event|5|||
127648990|NCT01255592|459336425|FG001|Overall Study|Adverse Event|0|||
127648991|NCT01255592|459336424|FG000|Overall Study|Withdrawal by Subject|1|||
127648992|NCT01255592|459336425|FG001|Overall Study|Withdrawal by Subject|0|||
127648993|NCT01255592|459336424|FG000|Overall Study|Other|0|||
127648994|NCT01255592|459336425|FG001|Overall Study|Other|1|||
127648995|NCT01083641|459336426|FG000|Overall Study|Withdrawal by Subject|2|||
127648996|NCT01777321|459336427|FG000|Overall Study|Withdrawal by Subject|0|||
127648997|NCT01777321|459336428|FG001|Overall Study|Withdrawal by Subject|1|||
127648998|NCT00089141|459336431|FG000|Overall Study|Termination of trial|18|||
127648999|NCT00089141|459336432|FG001|Overall Study|Termination of trial|24|||
127649000|NCT05131165|459336433|FG000|Overall Study|Death|1|||
127649001|NCT05131165|459336434|FG001|Overall Study|Death|1|||
127649002|NCT05131165|459336435|FG002|Overall Study|Death|0|||
127649003|NCT05131165|459336433|FG000|Overall Study|Lost to Follow-up|2|||
127649004|NCT05131165|459336434|FG001|Overall Study|Lost to Follow-up|2|||
127649005|NCT05131165|459336435|FG002|Overall Study|Lost to Follow-up|5|||
127649006|NCT05131165|459336433|FG000|Overall Study|Transferred out of clinic|1|||
127649007|NCT05131165|459336434|FG001|Overall Study|Transferred out of clinic|0|||
127649008|NCT05131165|459336435|FG002|Overall Study|Transferred out of clinic|3|||
127649009|NCT05131165|459336433|FG000|Overall Study|Dropped out|1|||
127649010|NCT05131165|459336434|FG001|Overall Study|Dropped out|2|||
127649011|NCT05131165|459336435|FG002|Overall Study|Dropped out|0|||
127649012|NCT05168579|459336441|FG000|Overall Study|Lack of Consent|1|||
127649013|NCT05168579|459336442|FG001|Overall Study|Lack of Consent|0|||
127649014|NCT05168579|459336441|FG000|Overall Study|Conflicts with time|2|||
127649015|NCT05168579|459336442|FG001|Overall Study|Conflicts with time|0|||
127649016|NCT05168579|459336441|FG000|Overall Study|Time slots were full|3|||
127649017|NCT05168579|459336442|FG001|Overall Study|Time slots were full|0|||
127649018|NCT05168579|459336441|FG000|Overall Study|Lost to Follow-up|0|||
127649019|NCT05168579|459336442|FG001|Overall Study|Lost to Follow-up|15|||
127649020|NCT01424930|459336445|FG000|Overall Study|Adverse Event|0|||
127649021|NCT01424930|459336446|FG001|Overall Study|Adverse Event|1|||
127649022|NCT01424930|459336445|FG000|Overall Study|Death|1|||
127649023|NCT01424930|459336446|FG001|Overall Study|Death|0|||
127649024|NCT01424930|459336445|FG000|Overall Study|Progressive Disease|3|||
127649025|NCT01424930|459336446|FG001|Overall Study|Progressive Disease|6|||
127649026|NCT01424930|459336445|FG000|Overall Study|Screen Failure|0|||
127649027|NCT01424930|459336446|FG001|Overall Study|Screen Failure|1|||
127649028|NCT01424930|459336445|FG000|Overall Study|Reason not specified|0|||
127649029|NCT01424930|459336446|FG001|Overall Study|Reason not specified|6|||
127649030|NCT02857426|459336450|FG000|Overall Study|Disease progression|34|||
127649031|NCT02857426|459336451|FG001|Overall Study|Disease progression|13|||
127537747|NCT05148234|458932179|FG001|Phase I|Ineligible|0|||
127537748|NCT05148234|458932180|FG002|Phase I|Ineligible|0|||
127537749|NCT05148234|458932181|FG003|Phase I|Ineligible|0|||
127537750|NCT05148234|458932182|FG004|Phase I|Ineligible|0|||
127537751|NCT05148234|458932183|FG005|Phase I|Ineligible|0|||
127537752|NCT05148234|458932184|FG006|Phase I|Ineligible|0|||
127537753|NCT05148234|458932185|FG007|Phase I|Ineligible|1|||
127537754|NCT05148234|458932178|FG000|Phase I|Company closed the trial.|0|||
127649032|NCT02857426|459336450|FG000|Overall Study|Study drug toxicity|4|||
127649033|NCT02857426|459336451|FG001|Overall Study|Study drug toxicity|1|||
127649034|NCT02857426|459336450|FG000|Overall Study|Death|1|||
127649035|NCT02857426|459336451|FG001|Overall Study|Death|0|||
127649036|NCT02857426|459336450|FG000|Overall Study|Adverse event unrelated to study drug|6|||
127649037|NCT02857426|459336451|FG001|Overall Study|Adverse event unrelated to study drug|2|||
127649038|NCT02857426|459336450|FG000|Overall Study|Participant withdrew consent|1|||
127649039|NCT02857426|459336451|FG001|Overall Study|Participant withdrew consent|1|||
127649040|NCT02857426|459336450|FG000|Overall Study|Maximum clinical benefit|1|||
127649041|NCT02857426|459336451|FG001|Overall Study|Maximum clinical benefit|0|||
127649042|NCT02857426|459336450|FG000|Overall Study|Completed treatment|0|||
127649043|NCT02857426|459336451|FG001|Overall Study|Completed treatment|2|||
127649044|NCT02110901|459336455|FG000|Overall Study|Death|6|||
127649045|NCT02110901|459336456|FG001|Overall Study|Death|3|||
127649046|NCT02110901|459336455|FG000|Overall Study|Lost to Follow-up|12|||
127649047|NCT02110901|459336456|FG001|Overall Study|Lost to Follow-up|8|||
127649048|NCT02110901|459336455|FG000|Overall Study|Withdrawal by Subject|7|||
127649049|NCT02110901|459336456|FG001|Overall Study|Withdrawal by Subject|3|||
127649050|NCT02110901|459336455|FG000|Overall Study|received a kidney transplant|5|||
127537755|NCT05148234|458932179|FG001|Phase I|Company closed the trial.|1|||
127537756|NCT05148234|458932180|FG002|Phase I|Company closed the trial.|0|||
127537757|NCT05148234|458932181|FG003|Phase I|Company closed the trial.|0|||
127649051|NCT02110901|459336456|FG001|Overall Study|received a kidney transplant|0|||
127649052|NCT01780935|459336458|FG000|Overall Study|Admin problems due to early termination|321|||
127537758|NCT05148234|458932182|FG004|Phase I|Company closed the trial.|0|||
127537759|NCT05148234|458932183|FG005|Phase I|Company closed the trial.|0|||
127537760|NCT05148234|458932184|FG006|Phase I|Company closed the trial.|0|||
127537761|NCT05148234|458932185|FG007|Phase I|Company closed the trial.|0|||
127537762|NCT03061201|458932186|FG000|Overall Study|Participants Terminated at Month 36|0|||
127537763|NCT03061201|458932187|FG001|Overall Study|Participants Terminated at Month 36|1|||
127537764|NCT03061201|458932188|FG002|Overall Study|Participants Terminated at Month 36|0|||
127537765|NCT03061201|458932189|FG003|Overall Study|Participants Terminated at Month 36|1|||
127537766|NCT03061201|458932186|FG000|Overall Study|Lost to Follow-up|1|||
127537767|NCT03061201|458932187|FG001|Overall Study|Lost to Follow-up|0|||
127537768|NCT03061201|458932188|FG002|Overall Study|Lost to Follow-up|0|||
127537769|NCT03061201|458932189|FG003|Overall Study|Lost to Follow-up|0|||
127537770|NCT03062358|458932190|FG000|Overall Study|Death|269|||
127537771|NCT03062358|458932191|FG001|Overall Study|Death|145|||
127537772|NCT03062358|458932190|FG000|Overall Study|Withdrawal by Subject|2|||
127537773|NCT03062358|458932191|FG001|Overall Study|Withdrawal by Subject|1|||
127537774|NCT03062358|458932190|FG000|Overall Study|Sponsor Decision|29|||
127537775|NCT03062358|458932191|FG001|Overall Study|Sponsor Decision|7|||
127537776|NCT03861273|458932192|FG000|Screening Phase (3 Weeks)|Other|1|||
127537777|NCT03861273|458932192|FG000|Screening Phase (3 Weeks)|Screen failure|5|||
127537778|NCT03861273|458932192|FG000|Follow-up Phase (Year 1)|Ongoing|2|||
127537779|NCT03861273|458932192|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Ongoing|42|||
127537780|NCT03861273|458932192|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Withdrawal by Subject|1|||
127537781|NCT03799341|458932193|FG000|12-Week Treatment Interval|Withdrawal by Investigator|0|||
127537782|NCT03799341|458932194|FG001|12-Week Treatment Interval|Withdrawal by Investigator|0|||
127537783|NCT03799341|458932195|FG002|12-Week Treatment Interval|Withdrawal by Investigator|1|||
127537784|NCT03799341|458932193|FG000|12-Week Treatment Interval|Withdrawal by Subject|0|||
127537785|NCT03799341|458932194|FG001|12-Week Treatment Interval|Withdrawal by Subject|0|||
127537786|NCT03799341|458932195|FG002|12-Week Treatment Interval|Withdrawal by Subject|1|||
127537787|NCT03799341|458932193|FG000|Post-Tx Evaluation Session|Lost to Follow-up|4|||
127537788|NCT03799341|458932194|FG001|Post-Tx Evaluation Session|Lost to Follow-up|4|||
127537789|NCT03799341|458932195|FG002|Post-Tx Evaluation Session|Lost to Follow-up|0|||
127537790|NCT03799341|458932193|FG000|Post-Tx Evaluation Session|Declined or Unavailable|1|||
127537791|NCT03799341|458932194|FG001|Post-Tx Evaluation Session|Declined or Unavailable|2|||
127537792|NCT03799341|458932195|FG002|Post-Tx Evaluation Session|Declined or Unavailable|0|||
127537793|NCT03799341|458932193|FG000|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|12|||
127537794|NCT03799341|458932194|FG001|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|10|||
127537795|NCT03799341|458932195|FG002|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|0|||
127537796|NCT03799341|458932193|FG000|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|1|||
127537797|NCT03799341|458932194|FG001|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
127537798|NCT03799341|458932195|FG002|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
127537799|NCT01116648|458932196|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
127537800|NCT01116648|458932197|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
127537801|NCT01116648|458932198|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
127537802|NCT01116648|458932199|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
127537803|NCT01116648|458932200|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
127537804|NCT01116648|458932201|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
127537805|NCT01116648|458932202|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
127537806|NCT01116648|458932203|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
127537807|NCT01116648|458932204|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
127537808|NCT01116648|458932205|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
127537809|NCT01116648|458932206|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
127537810|NCT01116648|458932207|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
127537811|NCT01116648|458932208|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
127537812|NCT01116648|458932209|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
127537813|NCT01116648|458932210|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
127537814|NCT04539938|458932211|FG000|Overall Study|Death|30|||
127537815|NCT04539938|458932211|FG000|Overall Study|Withdrawal by Subject|4|||
127537816|NCT01928927|458932212|FG000|Overall Study|Lost to Follow-up|1|||
127537817|NCT01928927|458932213|FG001|Overall Study|Lost to Follow-up|0|||
127537818|NCT01928927|458932212|FG000|Overall Study|Withdrawal by Subject|1|||
127537819|NCT01928927|458932213|FG001|Overall Study|Withdrawal by Subject|1|||
127537820|NCT02079740|458933043|FG000|Phase 1b: Dose Escalation|Adverse Event|0|||
127537821|NCT02079740|458933044|FG001|Phase 1b: Dose Escalation|Adverse Event|0|||
127871735|NCT01397409|460148744|FG004|Stage 3|Adverse Event|0|||
127537822|NCT02079740|458933045|FG002|Phase 1b: Dose Escalation|Adverse Event|0|||
127537823|NCT02079740|458933046|FG003|Phase 1b: Dose Escalation|Adverse Event|0|||
127537824|NCT02079740|458933047|FG004|Phase 1b: Dose Escalation|Adverse Event|1|||
127537825|NCT02079740|458933048|FG005|Phase 1b: Dose Escalation|Adverse Event|0|||
127537826|NCT02079740|458933049|FG006|Phase 1b: Dose Escalation|Adverse Event|0|||
127537827|NCT02079740|458933050|FG007|Phase 1b: Dose Escalation|Adverse Event|0|||
127537828|NCT02079740|458933051|FG008|Phase 1b: Dose Escalation|Adverse Event|0|||
127537829|NCT02079740|458933052|FG009|Phase 1b: Dose Escalation|Adverse Event|0|||
127537830|NCT02079740|458933053|FG010|Phase 1b: Dose Escalation|Adverse Event|0|||
127649053|NCT01780935|459336459|FG001|Overall Study|Admin problems due to early termination|309|||
127760272|NCT00700427|459748867|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
127537831|NCT02079740|458933054|FG011|Phase 1b: Dose Escalation|Adverse Event|0|||
127537832|NCT02079740|458933055|FG012|Phase 1b: Dose Escalation|Adverse Event|0|||
127537833|NCT02079740|458933043|FG000|Phase 1b: Dose Escalation|Physician Decision|0|||
127537834|NCT02079740|458933044|FG001|Phase 1b: Dose Escalation|Physician Decision|0|||
127537835|NCT02079740|458933045|FG002|Phase 1b: Dose Escalation|Physician Decision|0|||
127537836|NCT02079740|458933046|FG003|Phase 1b: Dose Escalation|Physician Decision|0|||
127537837|NCT02079740|458933047|FG004|Phase 1b: Dose Escalation|Physician Decision|1|||
127537838|NCT02079740|458933048|FG005|Phase 1b: Dose Escalation|Physician Decision|0|||
127537839|NCT02079740|458933049|FG006|Phase 1b: Dose Escalation|Physician Decision|0|||
127537840|NCT02079740|458933050|FG007|Phase 1b: Dose Escalation|Physician Decision|0|||
127537841|NCT02079740|458933051|FG008|Phase 1b: Dose Escalation|Physician Decision|0|||
127537842|NCT02079740|458933052|FG009|Phase 1b: Dose Escalation|Physician Decision|0|||
127537843|NCT02079740|458933053|FG010|Phase 1b: Dose Escalation|Physician Decision|0|||
127537844|NCT02079740|458933054|FG011|Phase 1b: Dose Escalation|Physician Decision|0|||
127871736|NCT01397409|460148745|FG005|Stage 3|Adverse Event|0|||
127537845|NCT02079740|458933055|FG012|Phase 1b: Dose Escalation|Physician Decision|0|||
127537846|NCT02079740|458933043|FG000|Phase 1b: Dose Escalation|Clinical Progression|0|||
127537847|NCT02079740|458933044|FG001|Phase 1b: Dose Escalation|Clinical Progression|0|||
127537848|NCT02079740|458933045|FG002|Phase 1b: Dose Escalation|Clinical Progression|0|||
127537849|NCT02079740|458933046|FG003|Phase 1b: Dose Escalation|Clinical Progression|0|||
127537850|NCT02079740|458933047|FG004|Phase 1b: Dose Escalation|Clinical Progression|0|||
127537851|NCT02079740|458933048|FG005|Phase 1b: Dose Escalation|Clinical Progression|0|||
127537852|NCT02079740|458933049|FG006|Phase 1b: Dose Escalation|Clinical Progression|0|||
127537853|NCT02079740|458933050|FG007|Phase 1b: Dose Escalation|Clinical Progression|1|||
127537854|NCT02079740|458933051|FG008|Phase 1b: Dose Escalation|Clinical Progression|0|||
127537855|NCT02079740|458933052|FG009|Phase 1b: Dose Escalation|Clinical Progression|0|||
127537856|NCT02079740|458933053|FG010|Phase 1b: Dose Escalation|Clinical Progression|0|||
127537857|NCT02079740|458933054|FG011|Phase 1b: Dose Escalation|Clinical Progression|0|||
127649054|NCT01780935|459336458|FG000|Overall Study|Adverse Event|2|||
127649055|NCT01780935|459336459|FG001|Overall Study|Adverse Event|4|||
127649056|NCT01780935|459336458|FG000|Overall Study|Death|1|||
127649057|NCT01780935|459336459|FG001|Overall Study|Death|6|||
127649058|NCT01780935|459336458|FG000|Overall Study|Lost to Follow-up|2|||
127649059|NCT01780935|459336459|FG001|Overall Study|Lost to Follow-up|6|||
127649060|NCT01780935|459336458|FG000|Overall Study|Physician Decision|1|||
127649061|NCT01780935|459336459|FG001|Overall Study|Physician Decision|1|||
127649062|NCT01780935|459336458|FG000|Overall Study|Protocol deviation|0|||
127649063|NCT01780935|459336459|FG001|Overall Study|Protocol deviation|1|||
127649064|NCT01780935|459336458|FG000|Overall Study|Patient withdrew consent|8|||
127649065|NCT01780935|459336459|FG001|Overall Study|Patient withdrew consent|9|||
127649066|NCT00855595|459336460|FG000|Overall Study|Withdrawal by Subject|1|||
127649067|NCT00855595|459336461|FG001|Overall Study|Withdrawal by Subject|2|||
127649068|NCT00855595|459336460|FG000|Overall Study|Lost to Follow-up|3|||
127649069|NCT00855595|459336461|FG001|Overall Study|Lost to Follow-up|3|||
127649070|NCT00855595|459336460|FG000|Overall Study|Adverse Event|1|||
127649071|NCT00855595|459336461|FG001|Overall Study|Adverse Event|1|||
127649072|NCT00855595|459336460|FG000|Overall Study|patient moved out of state|1|||
127649073|NCT00855595|459336461|FG001|Overall Study|patient moved out of state|0|||
127649074|NCT00855595|459336460|FG000|Overall Study|patient left country|0|||
127649075|NCT00855595|459336461|FG001|Overall Study|patient left country|1|||
127649076|NCT02831257|459336462|FG000|Overall Study|Lack of Efficacy|3|||
127649077|NCT02831257|459336462|FG000|Overall Study|Adverse Event|2|||
127649078|NCT02831257|459336462|FG000|Overall Study|Physician Decision|1|||
127649079|NCT02831257|459336462|FG000|Overall Study|Withdrawal by Subject|6|||
127649080|NCT00166296|459336463|FG000|Overall Study|Withdrawal by Subject|1|||
127649081|NCT00166296|459336464|FG001|Overall Study|Withdrawal by Subject|3|||
127649082|NCT00166296|459336463|FG000|Overall Study|Adverse Event|2|||
127649083|NCT00166296|459336464|FG001|Overall Study|Adverse Event|4|||
127649084|NCT00166296|459336463|FG000|Overall Study|Lost to Follow-up|4|||
127649085|NCT00166296|459336464|FG001|Overall Study|Lost to Follow-up|2|||
127649086|NCT04035200|459336465|FG000|Overall Study|Lost to Follow-up|0|||
127649087|NCT04035200|459336466|FG001|Overall Study|Lost to Follow-up|1|||
127649088|NCT04035200|459336467|FG002|Overall Study|Lost to Follow-up|0|||
127649089|NCT04035200|459336465|FG000|Overall Study|Withdrawal by Subject|1|||
127649090|NCT04035200|459336466|FG001|Overall Study|Withdrawal by Subject|4|||
127649091|NCT04035200|459336467|FG002|Overall Study|Withdrawal by Subject|4|||
127649092|NCT04035200|459336465|FG000|Overall Study|COVID-19|1|||
127649093|NCT04035200|459336466|FG001|Overall Study|COVID-19|0|||
127649094|NCT04035200|459336467|FG002|Overall Study|COVID-19|0|||
127649095|NCT04035200|459336465|FG000|Overall Study|Early Termination|0|||
127649096|NCT04035200|459336466|FG001|Overall Study|Early Termination|1|||
127649097|NCT04035200|459336467|FG002|Overall Study|Early Termination|0|||
127649098|NCT04035200|459336465|FG000|Overall Study|Non-compliance|0|||
127871737|NCT01397409|460148746|FG006|Stage 3|Adverse Event|0|||
127760273|NCT00700427|459748868|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
127537858|NCT02079740|458933055|FG012|Phase 1b: Dose Escalation|Clinical Progression|0|||
127537859|NCT02079740|458933043|FG000|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
127537860|NCT02079740|458933044|FG001|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
127537861|NCT02079740|458933045|FG002|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
127537862|NCT02079740|458933046|FG003|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
127537863|NCT02079740|458933047|FG004|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
127537864|NCT02079740|458933048|FG005|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
127537865|NCT02079740|458933049|FG006|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
127537866|NCT02079740|458933050|FG007|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|1|||
127537867|NCT02079740|458933051|FG008|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
127537868|NCT02079740|458933052|FG009|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
127537869|NCT02079740|458933053|FG010|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
127537870|NCT02079740|458933054|FG011|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
127537871|NCT02079740|458933055|FG012|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
127537872|NCT02079740|458933043|FG000|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
127537873|NCT02079740|458933044|FG001|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
127537874|NCT02079740|458933045|FG002|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
127537875|NCT02079740|458933046|FG003|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
127537876|NCT02079740|458933047|FG004|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
127537877|NCT02079740|458933048|FG005|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
127537878|NCT02079740|458933049|FG006|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
127537879|NCT02079740|458933050|FG007|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
127537880|NCT02079740|458933051|FG008|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
127537881|NCT02079740|458933052|FG009|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
127537882|NCT02079740|458933053|FG010|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
127537883|NCT02079740|458933054|FG011|Phase 2: Expansion Cohorts|Withdrawal by Subject|1|||
127537884|NCT02079740|458933055|FG012|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
127537885|NCT03493945|458933056|FG000|Phase I Dose Escalation|Ineligible|0|||
127537886|NCT03493945|458933057|FG001|Phase I Dose Escalation|Ineligible|0|||
127537887|NCT03493945|458933058|FG002|Phase I Dose Escalation|Ineligible|1|||
127537888|NCT03493945|458933059|FG003|Phase I Dose Escalation|Ineligible|0|||
127537889|NCT03493945|458933060|FG004|Phase I Dose Escalation|Ineligible|0|||
127537890|NCT03493945|458933061|FG005|Phase I Dose Escalation|Ineligible|0|||
127537891|NCT03493945|458933062|FG006|Phase I Dose Escalation|Ineligible|0|||
127537892|NCT03493945|458933056|FG000|Phase I Dose Escalation|New therapy|0|||
127537893|NCT03493945|458933057|FG001|Phase I Dose Escalation|New therapy|1|||
127537894|NCT03493945|458933058|FG002|Phase I Dose Escalation|New therapy|0|||
127537895|NCT03493945|458933059|FG003|Phase I Dose Escalation|New therapy|0|||
127537896|NCT03493945|458933060|FG004|Phase I Dose Escalation|New therapy|0|||
127537897|NCT03493945|458933061|FG005|Phase I Dose Escalation|New therapy|0|||
127537898|NCT03493945|458933062|FG006|Phase I Dose Escalation|New therapy|0|||
127537899|NCT03493945|458933056|FG000|Phase II Dose Expansion|Refused further treatment|0|||
127537900|NCT03493945|458933057|FG001|Phase II Dose Expansion|Refused further treatment|0|||
127537901|NCT03493945|458933058|FG002|Phase II Dose Expansion|Refused further treatment|0|||
127537902|NCT03493945|458933059|FG003|Phase II Dose Expansion|Refused further treatment|0|||
127537903|NCT03493945|458933060|FG004|Phase II Dose Expansion|Refused further treatment|1|||
127537904|NCT03493945|458933061|FG005|Phase II Dose Expansion|Refused further treatment|1|||
127537905|NCT03493945|458933062|FG006|Phase II Dose Expansion|Refused further treatment|0|||
127537906|NCT03493945|458933056|FG000|Phase II Dose Expansion|Switched to alternative therapy|0|||
127537907|NCT03493945|458933057|FG001|Phase II Dose Expansion|Switched to alternative therapy|0|||
127537908|NCT03493945|458933058|FG002|Phase II Dose Expansion|Switched to alternative therapy|0|||
127537909|NCT03493945|458933059|FG003|Phase II Dose Expansion|Switched to alternative therapy|3|||
127537910|NCT03493945|458933060|FG004|Phase II Dose Expansion|Switched to alternative therapy|0|||
127537911|NCT03493945|458933061|FG005|Phase II Dose Expansion|Switched to alternative therapy|0|||
127537912|NCT03493945|458933062|FG006|Phase II Dose Expansion|Switched to alternative therapy|0|||
127537913|NCT02421172|458933067|FG000|Period 1|Adverse Event|1|||
127537914|NCT02421172|458933068|FG001|Period 1|Adverse Event|0|||
127537915|NCT02421172|458933069|FG002|Period 1|Adverse Event|0|||
127537916|NCT02421172|458933070|FG003|Period 1|Adverse Event|0|||
127537917|NCT02421172|458933071|FG004|Period 1|Adverse Event|0|||
127537918|NCT02421172|458933067|FG000|Period 1|Lost to Follow-up|3|||
127537919|NCT02421172|458933068|FG001|Period 1|Lost to Follow-up|1|||
127537920|NCT02421172|458933069|FG002|Period 1|Lost to Follow-up|0|||
127537921|NCT02421172|458933070|FG003|Period 1|Lost to Follow-up|0|||
127537922|NCT02421172|458933071|FG004|Period 1|Lost to Follow-up|0|||
127537923|NCT02421172|458933067|FG000|Period 1|Patient/guardian decision|0|||
127871738|NCT01397409|460148747|FG007|Stage 3|Adverse Event|1|||
127537924|NCT02421172|458933068|FG001|Period 1|Patient/guardian decision|1|||
127537925|NCT02421172|458933069|FG002|Period 1|Patient/guardian decision|0|||
127760274|NCT00700427|459748864|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
127760275|NCT00700427|459748865|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
127760276|NCT00700427|459748866|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
127760277|NCT00700427|459748867|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
127760278|NCT00700427|459748868|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
127760279|NCT00700427|459748864|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
127760280|NCT00700427|459748865|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
127760281|NCT00700427|459748866|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
127760282|NCT00700427|459748867|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
127760283|NCT00700427|459748868|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
127760284|NCT00700427|459748864|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
127760285|NCT00700427|459748865|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
127760286|NCT00700427|459748866|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
127760287|NCT00700427|459748867|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
127760288|NCT00700427|459748868|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
127760289|NCT00700427|459748864|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
127760290|NCT00700427|459748865|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
127760291|NCT00700427|459748866|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
127760292|NCT00700427|459748867|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
127760293|NCT00700427|459748868|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
127760294|NCT00700427|459748864|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
127760295|NCT00700427|459748865|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
127760296|NCT00700427|459748866|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
127760297|NCT00700427|459748867|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
127760298|NCT00700427|459748868|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
127760299|NCT00700427|459748864|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
127760300|NCT00700427|459748865|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
127760301|NCT00700427|459748866|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
127760302|NCT00700427|459748867|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
127760303|NCT00700427|459748868|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
127760304|NCT00700427|459748864|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
127760305|NCT00700427|459748865|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
127760306|NCT00700427|459748866|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
127760307|NCT00700427|459748867|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
127760308|NCT00700427|459748868|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
127760309|NCT00700427|459748864|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
127760310|NCT00700427|459748865|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
127760311|NCT00700427|459748866|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
127760312|NCT00700427|459748867|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
127760313|NCT00700427|459748868|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
127760314|NCT00700427|459748864|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
127760315|NCT00700427|459748865|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
127760316|NCT00700427|459748866|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
127760317|NCT00700427|459748867|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
127760318|NCT00700427|459748868|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
127537926|NCT02421172|458933070|FG003|Period 1|Patient/guardian decision|0|||
127537927|NCT02421172|458933071|FG004|Period 1|Patient/guardian decision|0|||
127537928|NCT02421172|458933067|FG000|Period 2|Adverse Event|0|||
127537929|NCT02421172|458933068|FG001|Period 2|Adverse Event|0|||
127537930|NCT02421172|458933069|FG002|Period 2|Adverse Event|4|||
127537931|NCT02421172|458933070|FG003|Period 2|Adverse Event|0|||
127537932|NCT02421172|458933071|FG004|Period 2|Adverse Event|0|||
127537933|NCT02421172|458933067|FG000|Period 2|Lost to Follow-up|0|||
127537934|NCT02421172|458933068|FG001|Period 2|Lost to Follow-up|0|||
127537935|NCT02421172|458933069|FG002|Period 2|Lost to Follow-up|0|||
127537936|NCT02421172|458933070|FG003|Period 2|Lost to Follow-up|1|||
127537937|NCT02421172|458933071|FG004|Period 2|Lost to Follow-up|0|||
127537938|NCT02421172|458933067|FG000|Period 2|Patient/guardian decision|0|||
127537939|NCT02421172|458933068|FG001|Period 2|Patient/guardian decision|0|||
127537940|NCT02421172|458933069|FG002|Period 2|Patient/guardian decision|3|||
127537941|NCT02421172|458933070|FG003|Period 2|Patient/guardian decision|2|||
127537942|NCT02421172|458933071|FG004|Period 2|Patient/guardian decision|1|||
127537943|NCT00683878|458933072|FG000|Overall Study|Lack of Efficacy|3|||
127537944|NCT00683878|458933073|FG001|Overall Study|Lack of Efficacy|0|||
127537945|NCT00683878|458933074|FG002|Overall Study|Lack of Efficacy|1|||
127537946|NCT00683878|458933072|FG000|Overall Study|Adverse Event|4|||
127537947|NCT00683878|458933073|FG001|Overall Study|Adverse Event|3|||
127537948|NCT00683878|458933074|FG002|Overall Study|Adverse Event|3|||
127537949|NCT00683878|458933072|FG000|Overall Study|Withdrawal by Subject|9|||
127537950|NCT00683878|458933073|FG001|Overall Study|Withdrawal by Subject|8|||
127537951|NCT00683878|458933074|FG002|Overall Study|Withdrawal by Subject|6|||
127537952|NCT00683878|458933072|FG000|Overall Study|Death|0|||
127537953|NCT00683878|458933073|FG001|Overall Study|Death|1|||
127537954|NCT00683878|458933074|FG002|Overall Study|Death|0|||
127537955|NCT00683878|458933072|FG000|Overall Study|Lost to Follow-up|4|||
127537956|NCT00683878|458933073|FG001|Overall Study|Lost to Follow-up|2|||
127537957|NCT00683878|458933074|FG002|Overall Study|Lost to Follow-up|4|||
127537958|NCT00683878|458933072|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
127537959|NCT00683878|458933073|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
127537960|NCT00683878|458933074|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
127537961|NCT02869633|458933075|FG000|Overall Study|Death|2|||
127537962|NCT02869633|458933076|FG001|Overall Study|Death|1|||
127537963|NCT02869633|458933075|FG000|Overall Study|Patient refused follow-up|1|||
127537964|NCT02869633|458933076|FG001|Overall Study|Patient refused follow-up|0|||
127537965|NCT02869633|458933075|FG000|Overall Study|Provider discretion|1|||
127537966|NCT02869633|458933076|FG001|Overall Study|Provider discretion|0|||
127537967|NCT02869633|458933075|FG000|Overall Study|Investigator decision|1|||
127537968|NCT02869633|458933076|FG001|Overall Study|Investigator decision|0|||
127537969|NCT02869633|458933075|FG000|Overall Study|Lost to Follow-up|0|||
127537970|NCT02869633|458933076|FG001|Overall Study|Lost to Follow-up|1|||
127537971|NCT02869633|458933075|FG000|Overall Study|Not eligible|6|||
127537972|NCT02869633|458933076|FG001|Overall Study|Not eligible|1|||
127537973|NCT02869633|458933075|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
127537974|NCT02869633|458933076|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
127537975|NCT02869633|458933075|FG000|Overall Study|Withdrawal by Subject|0|||
127537976|NCT02869633|458933076|FG001|Overall Study|Withdrawal by Subject|1|||
127537977|NCT04319198|458933079|FG000|Overall Study|Adverse Events Resolution or Stabilization|3|||
127537978|NCT04319198|458933080|FG001|Overall Study|Adverse Events Resolution or Stabilization|4|||
127537979|NCT04319198|458933081|FG002|Overall Study|Adverse Events Resolution or Stabilization|0|||
127537980|NCT04319198|458933079|FG000|Overall Study|Death|0|||
127537981|NCT04319198|458933080|FG001|Overall Study|Death|3|||
127537982|NCT04319198|458933081|FG002|Overall Study|Death|3|||
127537983|NCT04319198|458933079|FG000|Overall Study|Reason Not Specified|0|||
127537984|NCT04319198|458933080|FG001|Overall Study|Reason Not Specified|2|||
127537985|NCT04319198|458933081|FG002|Overall Study|Reason Not Specified|4|||
127537986|NCT04319198|458933079|FG000|Overall Study|Withdrawal of Consent|0|||
127537987|NCT04319198|458933080|FG001|Overall Study|Withdrawal of Consent|0|||
127537988|NCT04319198|458933081|FG002|Overall Study|Withdrawal of Consent|5|||
127537989|NCT04319198|458933079|FG000|Overall Study|Site Terminated by Sponsor|0|||
127537990|NCT04319198|458933080|FG001|Overall Study|Site Terminated by Sponsor|1|||
127537991|NCT04319198|458933081|FG002|Overall Study|Site Terminated by Sponsor|0|||
127537992|NCT01693029|458933082|FG000|Overall Study|Withdrawal by Subject|15|||
127537993|NCT01693029|458933083|FG001|Overall Study|Withdrawal by Subject|22|||
127537994|NCT01693029|458933082|FG000|Overall Study|Kidney transplantation|7|||
127537995|NCT01693029|458933083|FG001|Overall Study|Kidney transplantation|7|||
127537996|NCT01693029|458933082|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
127537997|NCT01693029|458933083|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
127537998|NCT01693029|458933082|FG000|Overall Study|Protocol Violation|6|||
127537999|NCT01693029|458933083|FG001|Overall Study|Protocol Violation|7|||
127538000|NCT01693029|458933082|FG000|Overall Study|Change in dialysis modality|2|||
127538001|NCT01693029|458933083|FG001|Overall Study|Change in dialysis modality|1|||
127538002|NCT01693029|458933082|FG000|Overall Study|Physician Decision|0|||
127538003|NCT01693029|458933083|FG001|Overall Study|Physician Decision|2|||
127538004|NCT01693029|458933082|FG000|Overall Study|Lost to Follow-up|0|||
127538005|NCT01693029|458933083|FG001|Overall Study|Lost to Follow-up|1|||
127538006|NCT01693029|458933082|FG000|Overall Study|Adverse Event|1|||
127538007|NCT01693029|458933083|FG001|Overall Study|Adverse Event|6|||
127538008|NCT01693029|458933082|FG000|Overall Study|Death|5|||
127538009|NCT01693029|458933083|FG001|Overall Study|Death|8|||
127538010|NCT01693029|458933082|FG000|Overall Study|Non-compliance|2|||
127538011|NCT01693029|458933083|FG001|Overall Study|Non-compliance|1|||
127538012|NCT06039579|458933086|FG000|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
127538013|NCT06039579|458933087|FG001|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
127538014|NCT06039579|458933088|FG002|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
127538015|NCT06039579|458933089|FG003|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
127538016|NCT06039579|458933090|FG004|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
127538017|NCT06039579|458933091|FG005|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
127538018|NCT06039579|458933092|FG006|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
127538019|NCT06039579|458933093|FG007|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|1|||
127538020|NCT02356159|458933099|FG000|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
127538021|NCT02356159|458933100|FG001|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
127538022|NCT02356159|458933101|FG002|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
127538023|NCT02356159|458933102|FG003|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
127538024|NCT02356159|458933103|FG004|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
127538025|NCT02356159|458933104|FG005|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|1|||
127538026|NCT00861705|458933105|FG000|Overall Study|Never Began Treatment|7|||
127538027|NCT00861705|458933106|FG001|Overall Study|Never Began Treatment|3|||
127538028|NCT00861705|458933107|FG002|Overall Study|Never Began Treatment|0|||
127538029|NCT00861705|458933108|FG003|Overall Study|Never Began Treatment|1|||
127538030|NCT06418152|458933109|FG000|Overall Study|Frequent DBS setting changes|1|||
127538031|NCT06418152|458933109|FG000|Overall Study|Withdrawal by Subject|2|||
127538032|NCT00667628|458933110|FG000|Overall Study|Lost to Follow-up|1|||
127538033|NCT00667628|458933111|FG001|Overall Study|Lost to Follow-up|0|||
127538034|NCT00667628|458933110|FG000|Overall Study|Death|6|||
127538035|NCT00667628|458933111|FG001|Overall Study|Death|6|||
127538036|NCT00667628|458933110|FG000|Overall Study|Investigator Considers in Best Interest|1|||
127538037|NCT00667628|458933111|FG001|Overall Study|Investigator Considers in Best Interest|0|||
127538038|NCT00667628|458933110|FG000|Overall Study|Sponsor Terminated Study|17|||
127538039|NCT00667628|458933111|FG001|Overall Study|Sponsor Terminated Study|21|||
127538040|NCT03360682|458933112|FG000|Overall Study|Adverse Event|3|||
127538041|NCT00743249|458933115|FG000|Overall Study|Adverse Event|0|||
127538042|NCT00743249|458933116|FG001|Overall Study|Adverse Event|4|||
127538043|NCT00743249|458933115|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
127538044|NCT00743249|458933116|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
127538045|NCT00743249|458933115|FG000|Overall Study|Unsuccessful insertion of stent|2|||
127760319|NCT00700427|459748864|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
127760320|NCT00700427|459748865|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
127760321|NCT00700427|459748866|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
127760322|NCT00700427|459748867|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
127760323|NCT00700427|459748868|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
127760324|NCT00700427|459748864|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
127760325|NCT00700427|459748865|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
127760326|NCT00700427|459748866|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
127760327|NCT00700427|459748867|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
127760328|NCT00700427|459748868|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
127760329|NCT00700427|459748864|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
127760330|NCT00700427|459748865|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
127760331|NCT00700427|459748866|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
127760332|NCT00700427|459748867|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
127760333|NCT00700427|459748868|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
127760334|NCT00700427|459748864|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
127538046|NCT00743249|458933116|FG001|Overall Study|Unsuccessful insertion of stent|1|||
127538047|NCT00423657|458933119|FG000|Overall Study|Withdrew consent|10|||
127538048|NCT00423657|458933120|FG001|Overall Study|Withdrew consent|8|||
127538049|NCT00423657|458933119|FG000|Overall Study|Non-compliance|0|||
127538050|NCT00423657|458933120|FG001|Overall Study|Non-compliance|1|||
127538051|NCT00423657|458933119|FG000|Overall Study|Other|15|||
127538052|NCT00423657|458933120|FG001|Overall Study|Other|16|||
127538053|NCT00423657|458933119|FG000|Overall Study|Request of sponsor/investigator|1|||
127538054|NCT00423657|458933120|FG001|Overall Study|Request of sponsor/investigator|0|||
127538055|NCT01239381|458933121|FG000|Overall Study|Protocol Violation|1|||
127538056|NCT01239381|458933121|FG000|Overall Study|Withdrawal by Subject|1|||
127538057|NCT06237049|458933122|FG000|Overall Study|Death|0|||
127538058|NCT06237049|458933123|FG001|Overall Study|Death|0|||
127538059|NCT06237049|458933124|FG002|Overall Study|Death|0|||
127538060|NCT06237049|458933125|FG003|Overall Study|Death|1|||
127538061|NCT06237049|458933122|FG000|Overall Study|Lost to Follow-up|11|||
127538062|NCT06237049|458933123|FG001|Overall Study|Lost to Follow-up|5|||
127538063|NCT06237049|458933124|FG002|Overall Study|Lost to Follow-up|8|||
127760335|NCT00700427|459748865|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
127760336|NCT00700427|459748866|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
127760337|NCT00700427|459748867|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
127760338|NCT00700427|459748868|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
127538064|NCT06237049|458933125|FG003|Overall Study|Lost to Follow-up|8|||
127538065|NCT06237049|458933122|FG000|Overall Study|Protocol Violation|0|||
127760339|NCT00700427|459748864|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
127760340|NCT00700427|459748865|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
127760341|NCT00700427|459748866|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
127760342|NCT00700427|459748867|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
127538066|NCT06237049|458933123|FG001|Overall Study|Protocol Violation|1|||
127538067|NCT06237049|458933124|FG002|Overall Study|Protocol Violation|0|||
127538068|NCT06237049|458933125|FG003|Overall Study|Protocol Violation|1|||
127538069|NCT06237049|458933122|FG000|Overall Study|Withdrawal by Subject|4|||
127538070|NCT06237049|458933123|FG001|Overall Study|Withdrawal by Subject|2|||
127538071|NCT06237049|458933124|FG002|Overall Study|Withdrawal by Subject|1|||
127538072|NCT06237049|458933125|FG003|Overall Study|Withdrawal by Subject|0|||
127538073|NCT04908397|458933126|FG000|Overall Study|Withdrawal by Subject|2|||
127538074|NCT04264442|458933127|FG000|Overall Study|Lack of Efficacy|6|||
127538075|NCT04264442|458933127|FG000|Overall Study|Lost to Follow-up|2|||
127538076|NCT04264442|458933127|FG000|Overall Study|Sponsor Decision|23|||
127538077|NCT04264442|458933127|FG000|Overall Study|Withdrawal by Subject|11|||
127538078|NCT04264442|458933127|FG000|Overall Study|Study Termination|5|||
127538079|NCT04879628|458933131|FG000|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
127538080|NCT04879628|458933132|FG001|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
127538081|NCT04879628|458933133|FG002|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|1|||
127538082|NCT04879628|458933134|FG003|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
127538083|NCT04879628|458933131|FG000|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
127538084|NCT04879628|458933132|FG001|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
127538085|NCT04879628|458933133|FG002|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|1|||
127760343|NCT00700427|459748868|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
127760344|NCT00700427|459748864|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
127760345|NCT00700427|459748865|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
127760346|NCT00700427|459748866|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
127760347|NCT00700427|459748867|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
127760348|NCT00700427|459748868|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
127760349|NCT00700427|459748864|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
127760350|NCT00700427|459748865|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
127760351|NCT00700427|459748866|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
127760352|NCT00700427|459748867|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
127760353|NCT00700427|459748868|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
127760354|NCT00700427|459748864|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
127760355|NCT00700427|459748865|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
127760356|NCT00700427|459748866|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
127760357|NCT00700427|459748867|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
127760358|NCT00700427|459748868|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
127760359|NCT00700427|459748864|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
127760360|NCT00700427|459748865|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
127760361|NCT00700427|459748866|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
127760362|NCT00700427|459748867|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
127760363|NCT00700427|459748868|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
127760364|NCT00700427|459748864|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
127760365|NCT00700427|459748865|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
127760366|NCT00700427|459748866|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
127760367|NCT00700427|459748867|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
127760368|NCT00700427|459748868|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
127760369|NCT00700427|459748864|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
127760370|NCT00700427|459748865|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
127760371|NCT00700427|459748866|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
127760372|NCT00700427|459748867|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
127760373|NCT00700427|459748868|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
127760374|NCT00700427|459748864|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
127760375|NCT00700427|459748865|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
127760376|NCT00700427|459748866|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
127760377|NCT00700427|459748867|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
127760378|NCT00700427|459748868|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
127760379|NCT00700427|459748864|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
127760380|NCT00700427|459748865|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
127760381|NCT00700427|459748866|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
127760382|NCT00700427|459748867|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
127760383|NCT00700427|459748868|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
127760384|NCT00700427|459748864|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
127760385|NCT00700427|459748865|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
127760386|NCT00700427|459748866|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
127760387|NCT00700427|459748867|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
127760388|NCT00700427|459748868|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
127760389|NCT00700427|459748864|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
127760390|NCT00700427|459748865|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
127871739|NCT01397409|460148748|FG008|Stage 3|Adverse Event|0|||
127538086|NCT04879628|458933134|FG003|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
127538087|NCT04879628|458933131|FG000|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
127538088|NCT04879628|458933132|FG001|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
127538089|NCT04879628|458933133|FG002|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
127538090|NCT04879628|458933134|FG003|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|2|||
127538091|NCT04879628|458933131|FG000|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
127538092|NCT04879628|458933132|FG001|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
127538093|NCT04879628|458933133|FG002|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|63|||
127760391|NCT00700427|459748866|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
127760392|NCT00700427|459748867|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
127760393|NCT00700427|459748868|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
127760394|NCT00700427|459748864|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
127760395|NCT00700427|459748865|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
127760396|NCT00700427|459748866|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
127760397|NCT00700427|459748867|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
127760398|NCT00700427|459748868|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
127760399|NCT00700427|459748864|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
127760400|NCT00700427|459748865|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
127760401|NCT00700427|459748866|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
127760402|NCT00700427|459748867|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
127760403|NCT00700427|459748868|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
127760404|NCT00700427|459748864|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
127760405|NCT00700427|459748865|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
127760406|NCT00700427|459748866|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
127760407|NCT00700427|459748867|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
127760408|NCT00700427|459748868|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
127760409|NCT00700427|459748864|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
127760410|NCT00700427|459748865|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
127760411|NCT00700427|459748866|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
127760412|NCT00700427|459748867|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
127760413|NCT00700427|459748868|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
127760414|NCT00700427|459748864|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
127760415|NCT00700427|459748865|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
127760416|NCT00700427|459748866|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
127760417|NCT00700427|459748867|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
127760418|NCT00700427|459748868|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
127760419|NCT00700427|459748864|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
127760420|NCT00700427|459748865|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
127760421|NCT00700427|459748866|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
127760422|NCT00700427|459748867|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
127760423|NCT00700427|459748868|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
127760424|NCT00700427|459748864|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
127760425|NCT00700427|459748865|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
127760426|NCT00700427|459748866|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
127760427|NCT00700427|459748867|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
127760428|NCT00700427|459748868|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
127760429|NCT00700427|459748864|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
127760430|NCT00700427|459748865|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
127760431|NCT00700427|459748866|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
127760432|NCT00700427|459748867|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
127760433|NCT00700427|459748868|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
127760434|NCT00700427|459748864|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
127760435|NCT00700427|459748865|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
127760436|NCT00700427|459748866|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
127538094|NCT04879628|458933134|FG003|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|62|||
127538095|NCT01962441|458933625|FG000|Randomized Period|Randomized but Never Treated|4|||
127538096|NCT01962441|458933626|FG001|Randomized Period|Randomized but Never Treated|2|||
127538097|NCT01962441|458933627|FG002|Randomized Period|Randomized but Never Treated|3|||
127538098|NCT01962441|458933625|FG000|Randomized Period|Lost to Follow-up|2|||
127538099|NCT01962441|458933626|FG001|Randomized Period|Lost to Follow-up|4|||
127538100|NCT01962441|458933627|FG002|Randomized Period|Lost to Follow-up|4|||
127538101|NCT01962441|458933625|FG000|Randomized Period|Withdrew Consent|3|||
127760437|NCT00700427|459748867|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
127760438|NCT00700427|459748868|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
127760439|NCT00700427|459748864|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
127760440|NCT00700427|459748865|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
127538102|NCT01962441|458933626|FG001|Randomized Period|Withdrew Consent|3|||
127538103|NCT01962441|458933627|FG002|Randomized Period|Withdrew Consent|2|||
127538104|NCT01962441|458933625|FG000|Randomized Period|Adverse Event|1|||
127538105|NCT01962441|458933626|FG001|Randomized Period|Adverse Event|1|||
127538106|NCT01962441|458933627|FG002|Randomized Period|Adverse Event|0|||
127538107|NCT01962441|458933625|FG000|Randomized Period|Death|0|||
127538108|NCT01962441|458933626|FG001|Randomized Period|Death|0|||
127538109|NCT01962441|458933627|FG002|Randomized Period|Death|2|||
127538110|NCT01962441|458933625|FG000|Randomized Period|Protocol Violation|0|||
127538111|NCT01962441|458933626|FG001|Randomized Period|Protocol Violation|1|||
127538112|NCT01962441|458933627|FG002|Randomized Period|Protocol Violation|0|||
127538113|NCT01962441|458933625|FG000|Retreatment Substudy|Lack of Efficacy|1|||
127538114|NCT01962441|458933626|FG001|Retreatment Substudy|Lack of Efficacy|0|||
127538115|NCT01962441|458933627|FG002|Retreatment Substudy|Lack of Efficacy|0|||
127538116|NCT01962441|458933625|FG000|Retreatment Substudy|Lost to Follow-up|1|||
127538117|NCT01962441|458933626|FG001|Retreatment Substudy|Lost to Follow-up|0|||
127538118|NCT01962441|458933627|FG002|Retreatment Substudy|Lost to Follow-up|0|||
127538119|NCT02055898|458933628|FG000|First Intervention (5 Days)|Physician Decision|2|||
127538120|NCT02055898|458933629|FG001|First Intervention (5 Days)|Physician Decision|0|||
127538121|NCT02055898|458933628|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
127538122|NCT02055898|458933629|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
127538123|NCT04551989|458933633|FG000|Overall Study|Adverse Event|4|||
127538124|NCT04551989|458933633|FG000|Overall Study|Protocol Violation|3|||
127538125|NCT04551989|458933633|FG000|Overall Study|Lost to Follow-up|1|||
127538126|NCT04551989|458933633|FG000|Overall Study|Physician Decision|3|||
127538127|NCT00088530|458933634|FG000|Overall Study|Progressive/Relapsed Disease|28|||
127538128|NCT00088530|458933635|FG001|Overall Study|Progressive/Relapsed Disease|39|||
127538129|NCT00088530|458933634|FG000|Overall Study|Adverse Event|15|||
127538130|NCT00088530|458933635|FG001|Overall Study|Adverse Event|9|||
127538131|NCT00088530|458933634|FG000|Overall Study|Withdrawal by Subject|2|||
127538132|NCT00088530|458933635|FG001|Overall Study|Withdrawal by Subject|5|||
127538133|NCT00088530|458933634|FG000|Overall Study|Lost to Follow-up|2|||
127538134|NCT00088530|458933635|FG001|Overall Study|Lost to Follow-up|0|||
127538135|NCT00088530|458933634|FG000|Overall Study|Physician Decision|2|||
127538136|NCT00088530|458933635|FG001|Overall Study|Physician Decision|0|||
127538137|NCT00088530|458933634|FG000|Overall Study|Sponsor decision|0|||
127538138|NCT00088530|458933635|FG001|Overall Study|Sponsor decision|1|||
127538139|NCT00088530|458933634|FG000|Overall Study|Patient never treated|1|||
127538140|NCT00088530|458933635|FG001|Overall Study|Patient never treated|0|||
127538141|NCT03649074|458933638|FG000|Overall Study|Lost to Follow-up|2|||
127538142|NCT03649074|458933639|FG001|Overall Study|Lost to Follow-up|1|||
127538143|NCT03649074|458933638|FG000|Overall Study|Adverse Event|1|||
127538144|NCT03649074|458933639|FG001|Overall Study|Adverse Event|0|||
127538145|NCT03649074|458933638|FG000|Overall Study|Physician Decision|1|||
127538146|NCT03649074|458933639|FG001|Overall Study|Physician Decision|0|||
127538147|NCT03649074|458933638|FG000|Overall Study|Withdrawal by Subject|0|||
127538148|NCT03649074|458933639|FG001|Overall Study|Withdrawal by Subject|2|||
127538149|NCT03649074|458933638|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
127538150|NCT03649074|458933639|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
127538151|NCT03649074|458933638|FG000|Overall Study|Other|1|||
127538152|NCT03649074|458933639|FG001|Overall Study|Other|0|||
127538153|NCT00556894|458933640|FG000|Overall Study|Adverse Event|2|||
127538154|NCT00556894|458933641|FG001|Overall Study|Adverse Event|3|||
127538155|NCT00556894|458933642|FG002|Overall Study|Adverse Event|3|||
127538156|NCT00556894|458933640|FG000|Overall Study|Death|1|||
127538157|NCT00556894|458933641|FG001|Overall Study|Death|0|||
127538158|NCT00556894|458933642|FG002|Overall Study|Death|0|||
127538159|NCT00556894|458933640|FG000|Overall Study|regulatory decision in Bulgaria|10|||
127538160|NCT00556894|458933641|FG001|Overall Study|regulatory decision in Bulgaria|14|||
127538161|NCT00556894|458933642|FG002|Overall Study|regulatory decision in Bulgaria|13|||
127538162|NCT00556894|458933640|FG000|Overall Study|Change in therapy|2|||
127538163|NCT00556894|458933641|FG001|Overall Study|Change in therapy|1|||
127538164|NCT00556894|458933642|FG002|Overall Study|Change in therapy|2|||
127538165|NCT00556894|458933640|FG000|Overall Study|Withdrawal by Subject|1|||
127538166|NCT00556894|458933641|FG001|Overall Study|Withdrawal by Subject|1|||
127538167|NCT00556894|458933642|FG002|Overall Study|Withdrawal by Subject|1|||
127760441|NCT00700427|459748866|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
127538168|NCT04875195|458933645|FG000|Overall Study|Death|9|||
127538169|NCT04875195|458933646|FG001|Overall Study|Death|3|||
127538170|NCT04875195|458933645|FG000|Overall Study|Withdrawal by Subject|2|||
127538171|NCT04875195|458933646|FG001|Overall Study|Withdrawal by Subject|1|||
127538172|NCT04875195|458933645|FG000|Overall Study|Ongoing in study|49|||
127538173|NCT04875195|458933646|FG001|Overall Study|Ongoing in study|2|||
127538174|NCT05190120|458933647|FG000|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
127538175|NCT05190120|458933648|FG001|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
127538176|NCT05190120|458933649|FG002|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
127538177|NCT05190120|458933650|FG003|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|3|||
127760442|NCT00700427|459748867|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
127760443|NCT00700427|459748868|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
127760444|NCT01941719|459748869|FG000|Overall Study|Lost to Follow-up|20|||
127760445|NCT01941719|459748870|FG001|Overall Study|Lost to Follow-up|19|||
127760446|NCT01744392|459748873|FG000|Overall Study|Physician Decision|1|||
127760447|NCT01416389|459748874|FG000|Overall Study|Lost to Follow-up|1|||
127760448|NCT01416389|459748875|FG001|Overall Study|Lost to Follow-up|0|||
127760449|NCT01416389|459748874|FG000|Overall Study|Started New Therapy|2|||
127760450|NCT01416389|459748875|FG001|Overall Study|Started New Therapy|0|||
127760451|NCT03980808|459748882|FG000|Overall Study|Lost to Follow-up|2|||
127760452|NCT03980808|459748883|FG001|Overall Study|Lost to Follow-up|2|||
127760453|NCT01655693|459748884|FG000|Overall Study|Progression of Disease|92|||
127760454|NCT01655693|459748885|FG001|Overall Study|Progression of Disease|76|||
127760455|NCT01655693|459748886|FG002|Overall Study|Progression of Disease|58|||
127760456|NCT01655693|459748884|FG000|Overall Study|Death|8|||
127760457|NCT01655693|459748885|FG001|Overall Study|Death|9|||
127760458|NCT01655693|459748886|FG002|Overall Study|Death|12|||
127760459|NCT01655693|459748884|FG000|Overall Study|Serious Adverse Event|3|||
127760460|NCT01655693|459748885|FG001|Overall Study|Serious Adverse Event|15|||
127760461|NCT01655693|459748886|FG002|Overall Study|Serious Adverse Event|11|||
127760462|NCT01655693|459748884|FG000|Overall Study|Withdrawal by Subject|3|||
127760463|NCT01655693|459748885|FG001|Overall Study|Withdrawal by Subject|2|||
127760464|NCT01655693|459748886|FG002|Overall Study|Withdrawal by Subject|20|||
127760465|NCT01655693|459748884|FG000|Overall Study|Adverse Event|3|||
127760466|NCT01655693|459748885|FG001|Overall Study|Adverse Event|11|||
127760467|NCT01655693|459748886|FG002|Overall Study|Adverse Event|3|||
127760468|NCT01655693|459748884|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
127760469|NCT01655693|459748885|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
127760470|NCT01655693|459748886|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
127760471|NCT01655693|459748884|FG000|Overall Study|Non-Compliance|0|||
127760472|NCT01655693|459748885|FG001|Overall Study|Non-Compliance|0|||
127760473|NCT01655693|459748886|FG002|Overall Study|Non-Compliance|7|||
127760474|NCT01655693|459748884|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
127760475|NCT01655693|459748885|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
127760476|NCT01655693|459748886|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
127760477|NCT01655693|459748884|FG000|Overall Study|Protocol Violation|1|||
127760478|NCT01655693|459748885|FG001|Overall Study|Protocol Violation|0|||
127760479|NCT01655693|459748886|FG002|Overall Study|Protocol Violation|3|||
127760480|NCT01655693|459748884|FG000|Overall Study|Lost to Follow-up|1|||
127760481|NCT01655693|459748885|FG001|Overall Study|Lost to Follow-up|0|||
127760482|NCT01655693|459748886|FG002|Overall Study|Lost to Follow-up|1|||
127760483|NCT01655693|459748884|FG000|Overall Study|Screening Failure|1|||
127760484|NCT01655693|459748885|FG001|Overall Study|Screening Failure|0|||
127760485|NCT01655693|459748886|FG002|Overall Study|Screening Failure|0|||
127760486|NCT01655693|459748884|FG000|Overall Study|Other|8|||
127760487|NCT01655693|459748885|FG001|Overall Study|Other|6|||
127760488|NCT01655693|459748886|FG002|Overall Study|Other|15|||
127760489|NCT00929110|459748889|FG000|Overall Study|Adverse Event|40|||
127760490|NCT00929110|459748890|FG001|Overall Study|Adverse Event|29|||
127760491|NCT00929110|459748891|FG002|Overall Study|Adverse Event|18|||
127760492|NCT00929110|459748889|FG000|Overall Study|Subject withdrew consent|40|||
127760493|NCT00929110|459748890|FG001|Overall Study|Subject withdrew consent|23|||
127760494|NCT00929110|459748891|FG002|Overall Study|Subject withdrew consent|26|||
127760495|NCT00929110|459748889|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
127760496|NCT00929110|459748890|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
127760497|NCT00929110|459748891|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
127760498|NCT00929110|459748889|FG000|Overall Study|Lost to Follow-up|7|||
127760499|NCT00929110|459748890|FG001|Overall Study|Lost to Follow-up|7|||
127760500|NCT00929110|459748891|FG002|Overall Study|Lost to Follow-up|3|||
127760501|NCT00929110|459748889|FG000|Overall Study|Protocol deviation|5|||
127760502|NCT00929110|459748890|FG001|Overall Study|Protocol deviation|2|||
127760503|NCT00929110|459748891|FG002|Overall Study|Protocol deviation|4|||
127760504|NCT00929110|459748889|FG000|Overall Study|Administrative problems|4|||
127760505|NCT00929110|459748890|FG001|Overall Study|Administrative problems|1|||
127760506|NCT00929110|459748891|FG002|Overall Study|Administrative problems|2|||
127760507|NCT00929110|459748889|FG000|Overall Study|Death|2|||
127760508|NCT00929110|459748890|FG001|Overall Study|Death|2|||
127760509|NCT00929110|459748891|FG002|Overall Study|Death|2|||
127760510|NCT00929110|459748889|FG000|Overall Study|Abnormal laboratory value(s)|0|||
127760511|NCT00929110|459748890|FG001|Overall Study|Abnormal laboratory value(s)|1|||
127760512|NCT00929110|459748891|FG002|Overall Study|Abnormal laboratory value(s)|0|||
127760513|NCT00929110|459748889|FG000|Overall Study|Abnormal test procedure result(s)|0|||
127760514|NCT00929110|459748890|FG001|Overall Study|Abnormal test procedure result(s)|1|||
127760515|NCT00929110|459748891|FG002|Overall Study|Abnormal test procedure result(s)|1|||
127760516|NCT00929110|459748889|FG000|Overall Study|Patient inability to use the device|0|||
127538178|NCT05190120|458933647|FG000|Overall Study|Lost to Follow-up|5|||
127538179|NCT05190120|458933648|FG001|Overall Study|Lost to Follow-up|0|||
127538180|NCT05190120|458933649|FG002|Overall Study|Lost to Follow-up|2|||
127538181|NCT05190120|458933650|FG003|Overall Study|Lost to Follow-up|3|||
127538182|NCT03069352|458933651|FG000|Overall Study|Ongoing|12|||
127538183|NCT03069352|458933652|FG001|Overall Study|Ongoing|40|||
127538184|NCT02621424|458933653|FG000|Overall Study|Withdrawal by Subject|1|||
127538185|NCT02621424|458933654|FG001|Overall Study|Withdrawal by Subject|2|||
127538186|NCT04750642|458933658|FG000|Overall Study|Adverse Event|1|||
127538187|NCT04750642|458933659|FG001|Overall Study|Adverse Event|0|||
127538188|NCT04750642|458933658|FG000|Overall Study|Withdrawal by Subject|0|||
127538189|NCT04750642|458933659|FG001|Overall Study|Withdrawal by Subject|1|||
127538190|NCT04750642|458933658|FG000|Overall Study|Protocol Violation|0|||
127538191|NCT04750642|458933659|FG001|Overall Study|Protocol Violation|1|||
127538192|NCT03100149|458933660|FG000|Overall Study|Adverse Event|0|||
127538193|NCT03100149|458933661|FG001|Overall Study|Adverse Event|1|||
127538194|NCT03100149|458933662|FG002|Overall Study|Adverse Event|0|||
127538195|NCT03100149|458933660|FG000|Overall Study|Participant Moved out of Country|0|||
127538196|NCT03100149|458933661|FG001|Overall Study|Participant Moved out of Country|0|||
127538197|NCT03100149|458933662|FG002|Overall Study|Participant Moved out of Country|1|||
127760517|NCT00929110|459748890|FG001|Overall Study|Patient inability to use the device|1|||
127760518|NCT00929110|459748891|FG002|Overall Study|Patient inability to use the device|0|||
127760519|NCT02703259|459748892|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
127760520|NCT02703259|459748893|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
127760521|NCT02703259|459748892|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
127760522|NCT02703259|459748893|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
127760523|NCT02703259|459748892|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
127760524|NCT02703259|459748893|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
127760525|NCT02544451|459748898|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
127760526|NCT02544451|459748899|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
127760527|NCT02544451|459748900|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
127760528|NCT02544451|459748901|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
127760529|NCT02544451|459748898|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
127760530|NCT02544451|459748899|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
127760531|NCT02544451|459748900|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
127760532|NCT02544451|459748901|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
127760533|NCT02544451|459748898|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
127760534|NCT02544451|459748899|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
127760535|NCT02544451|459748900|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
127760536|NCT02544451|459748901|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
127760537|NCT02544451|459748898|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
127760538|NCT02544451|459748899|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
127760539|NCT02544451|459748900|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
127760540|NCT02544451|459748901|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
127760541|NCT02544451|459748898|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
127760542|NCT02544451|459748899|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
127760543|NCT02544451|459748900|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
127760544|NCT02544451|459748901|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
127760545|NCT02544451|459748898|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
127760546|NCT02544451|459748899|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
127760547|NCT02544451|459748900|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
127760548|NCT02544451|459748901|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
127760549|NCT03001076|459748902|FG000|Overall Study|Withdrawal by patient|2|||
127760550|NCT03001076|459748903|FG001|Overall Study|Withdrawal by patient|0|||
127760551|NCT03001076|459748902|FG000|Overall Study|Other|1|||
127760552|NCT03001076|459748903|FG001|Overall Study|Other|0|||
127760553|NCT03001076|459748902|FG000|Overall Study|Adverse Event|3|||
127760554|NCT03001076|459748903|FG001|Overall Study|Adverse Event|3|||
127760555|NCT03001076|459748902|FG000|Overall Study|Sponsor decision|1|||
127760556|NCT03001076|459748903|FG001|Overall Study|Sponsor decision|0|||
127760557|NCT03001076|459748902|FG000|Overall Study|Lost to Follow-up|0|||
127760558|NCT03001076|459748903|FG001|Overall Study|Lost to Follow-up|2|||
127760559|NCT00948766|459748904|FG000|Core Study|Adverse Event|73|||
127760560|NCT00948766|459748905|FG001|Core Study|Adverse Event|51|||
127760561|NCT00948766|459748904|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
127760562|NCT00948766|459748905|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
127538198|NCT03100149|458933660|FG000|Overall Study|Withdrawal by Subject|0|||
127538199|NCT03100149|458933661|FG001|Overall Study|Withdrawal by Subject|3|||
127538200|NCT03100149|458933662|FG002|Overall Study|Withdrawal by Subject|1|||
127538201|NCT04972162|458933664|FG000|Washout Period (5 Days)|Withdrawal by Subject|1|||
127538202|NCT04972162|458933665|FG001|Washout Period (5 Days)|Withdrawal by Subject|1|||
127538203|NCT00336024|458933666|FG000|Overall Study|Death|2|||
127760563|NCT00948766|459748904|FG000|Core Study|Patient Withdrew Consent|27|||
127760564|NCT00948766|459748905|FG001|Core Study|Patient Withdrew Consent|46|||
127760565|NCT00948766|459748904|FG000|Core Study|Lost to Follow-up|3|||
127760566|NCT00948766|459748905|FG001|Core Study|Lost to Follow-up|2|||
127760567|NCT00948766|459748904|FG000|Core Study|Administrative Problems|2|||
127760568|NCT00948766|459748905|FG001|Core Study|Administrative Problems|2|||
127760569|NCT00948766|459748904|FG000|Core Study|Death|1|||
127760570|NCT00948766|459748905|FG001|Core Study|Death|1|||
127760571|NCT00948766|459748904|FG000|Core Study|Protocol Deviation|8|||
127760572|NCT00948766|459748905|FG001|Core Study|Protocol Deviation|10|||
127760573|NCT00948766|459748904|FG000|Extension Study|Adverse Event|43|||
127538204|NCT00336024|458933667|FG001|Overall Study|Death|1|||
127538205|NCT00336024|458933666|FG000|Overall Study|Physician Decision|4|||
127760574|NCT00948766|459748905|FG001|Extension Study|Adverse Event|0|||
127760575|NCT00948766|459748904|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
127760576|NCT00948766|459748905|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
127538206|NCT00336024|458933667|FG001|Overall Study|Physician Decision|1|||
127760577|NCT00948766|459748904|FG000|Extension Study|Study Drug No Longer Required|1|||
127760578|NCT00948766|459748905|FG001|Extension Study|Study Drug No Longer Required|0|||
127760579|NCT00948766|459748904|FG000|Extension Study|Patient Withdrew Consent|32|||
127760580|NCT00948766|459748905|FG001|Extension Study|Patient Withdrew Consent|0|||
127760581|NCT00948766|459748904|FG000|Extension Study|Lost to Follow-up|8|||
127760582|NCT00948766|459748905|FG001|Extension Study|Lost to Follow-up|0|||
127760583|NCT00948766|459748904|FG000|Extension Study|Administrative Problems|1|||
127760584|NCT00948766|459748905|FG001|Extension Study|Administrative Problems|0|||
127760585|NCT00948766|459748904|FG000|Extension Study|Death|4|||
127760586|NCT00948766|459748905|FG001|Extension Study|Death|0|||
127760587|NCT01036438|459748909|FG000|Overall Study|Adverse Event|7|||
127760588|NCT01036438|459748910|FG001|Overall Study|Adverse Event|8|||
127760589|NCT01036438|459748909|FG000|Overall Study|Death|0|||
127760590|NCT01036438|459748910|FG001|Overall Study|Death|1|||
127760591|NCT01036438|459748909|FG000|Overall Study|No effect of study treatment|3|||
127760592|NCT01036438|459748910|FG001|Overall Study|No effect of study treatment|1|||
127760593|NCT02153073|459748911|FG000|Overall Study|Case Report Forms Uncollected|230|||
127760594|NCT02153073|459748911|FG000|Overall Study|Protocol Deviation|68|||
127760595|NCT03702231|459748912|FG000|Overall Study|Withdrawal by Subject|1|||
127760596|NCT03702231|459748913|FG001|Overall Study|Withdrawal by Subject|0|||
127538207|NCT00336024|458933666|FG000|Overall Study|Protocol Violation|1|||
127538208|NCT00336024|458933667|FG001|Overall Study|Protocol Violation|0|||
127538209|NCT00336024|458933666|FG000|Overall Study|Withdrawal by Subject|1|||
127538210|NCT00336024|458933667|FG001|Overall Study|Withdrawal by Subject|2|||
127538211|NCT00336024|458933666|FG000|Overall Study|Failure to fulfill consolidation|1|||
127538212|NCT00336024|458933667|FG001|Overall Study|Failure to fulfill consolidation|1|||
127538213|NCT00336024|458933666|FG000|Overall Study|Progressive Disease|4|||
127538214|NCT00336024|458933667|FG001|Overall Study|Progressive Disease|7|||
127538215|NCT00336024|458933666|FG000|Overall Study|Ineligible|7|||
127538216|NCT00336024|458933667|FG001|Overall Study|Ineligible|7|||
127538217|NCT01519323|458935071|FG000|Overall Study|Death|3|||
127538218|NCT01519323|458935072|FG001|Overall Study|Death|2|||
127538219|NCT01519323|458935071|FG000|Overall Study|Study terminated by sponsor|0|||
127538220|NCT01519323|458935072|FG001|Overall Study|Study terminated by sponsor|1|||
127538221|NCT00445549|458935073|FG000|Overall Study|progressive disease|12|||
127538222|NCT00383552|458935076|FG000|Overall Study|Adverse Event|7|||
127538223|NCT00383552|458935077|FG001|Overall Study|Adverse Event|6|||
127538224|NCT00383552|458935078|FG002|Overall Study|Adverse Event|9|||
127538225|NCT00383552|458935079|FG003|Overall Study|Adverse Event|6|||
127538226|NCT00383552|458935076|FG000|Overall Study|Lack of Efficacy|4|||
127538227|NCT00383552|458935077|FG001|Overall Study|Lack of Efficacy|13|||
127538228|NCT00383552|458935078|FG002|Overall Study|Lack of Efficacy|29|||
127538229|NCT00383552|458935079|FG003|Overall Study|Lack of Efficacy|42|||
127538230|NCT00383552|458935076|FG000|Overall Study|Lost to Follow-up|0|||
127538231|NCT00383552|458935077|FG001|Overall Study|Lost to Follow-up|1|||
127538232|NCT00383552|458935078|FG002|Overall Study|Lost to Follow-up|5|||
127538233|NCT00383552|458935079|FG003|Overall Study|Lost to Follow-up|1|||
127760597|NCT03702231|459748914|FG002|Overall Study|Withdrawal by Subject|0|||
127760598|NCT03702231|459748912|FG000|Overall Study|Protocol Violation|0|||
127760599|NCT03702231|459748913|FG001|Overall Study|Protocol Violation|0|||
127760600|NCT03702231|459748914|FG002|Overall Study|Protocol Violation|1|||
127760601|NCT03702231|459748912|FG000|Overall Study|Change in CLL Treatment|0|||
127760602|NCT03702231|459748913|FG001|Overall Study|Change in CLL Treatment|0|||
127760603|NCT03702231|459748914|FG002|Overall Study|Change in CLL Treatment|1|||
127760604|NCT03702231|459748912|FG000|Overall Study|COVID Pandemic|1|||
127760605|NCT03702231|459748913|FG001|Overall Study|COVID Pandemic|4|||
127538234|NCT00383552|458935076|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
127538235|NCT00383552|458935077|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
127538236|NCT00383552|458935078|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
127538237|NCT00383552|458935079|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
127538238|NCT00383552|458935076|FG000|Overall Study|Did not wish to continue (related)|1|||
127538239|NCT00383552|458935077|FG001|Overall Study|Did not wish to continue (related)|0|||
127538240|NCT00383552|458935078|FG002|Overall Study|Did not wish to continue (related)|2|||
127538241|NCT00383552|458935079|FG003|Overall Study|Did not wish to continue (related)|3|||
127538242|NCT00383552|458935076|FG000|Overall Study|Noncompliance with the protocol|11|||
127538243|NCT00383552|458935077|FG001|Overall Study|Noncompliance with the protocol|6|||
127538244|NCT00383552|458935078|FG002|Overall Study|Noncompliance with the protocol|8|||
127538245|NCT00383552|458935079|FG003|Overall Study|Noncompliance with the protocol|10|||
127538246|NCT00383552|458935076|FG000|Overall Study|Did not meet protocol eligibility|8|||
127760606|NCT03702231|459748914|FG002|Overall Study|COVID Pandemic|1|||
127760607|NCT03702231|459748912|FG000|Overall Study|Non-compliance|0|||
127760608|NCT03702231|459748913|FG001|Overall Study|Non-compliance|0|||
127760609|NCT03702231|459748914|FG002|Overall Study|Non-compliance|1|||
127760610|NCT03590366|459748915|FG000|Overall Study|Adverse Event|0|||
127760611|NCT03590366|459748916|FG001|Overall Study|Adverse Event|3|||
127760612|NCT03590366|459748915|FG000|Overall Study|Lost to Follow-up|3|||
127760613|NCT03590366|459748916|FG001|Overall Study|Lost to Follow-up|3|||
127760614|NCT03590366|459748915|FG000|Overall Study|Withdrawal by Subject|0|||
127760615|NCT03590366|459748916|FG001|Overall Study|Withdrawal by Subject|2|||
127760616|NCT01081665|459748917|FG000|Overall Study|Death|41|||
127760617|NCT01081665|459748917|FG000|Overall Study|Lost to Follow-up|18|||
127760618|NCT01081665|459748917|FG000|Overall Study|Withdrawal by Subject|17|||
127760619|NCT01081665|459748917|FG000|Overall Study|Change of dialysis unit|10|||
127760620|NCT01081665|459748917|FG000|Overall Study|Regulation of iPTH|5|||
127760621|NCT01081665|459748917|FG000|Overall Study|Change in renal replacement therapy|2|||
127760622|NCT01081665|459748917|FG000|Overall Study|Adverse Event|1|||
127760623|NCT01081665|459748917|FG000|Overall Study|Lack of Efficacy|1|||
127760624|NCT01413503|459748922|FG000|Overall Study|Lost to Follow-up|1|||
127760625|NCT01373151|459748923|FG000|Period 1|Lack of Efficacy|3|||
127760626|NCT01373151|459748924|FG001|Period 1|Lack of Efficacy|0|||
127760627|NCT01373151|459748925|FG002|Period 1|Lack of Efficacy|0|||
127760628|NCT01373151|459748926|FG003|Period 1|Lack of Efficacy|0|||
127760629|NCT01373151|459748927|FG004|Period 1|Lack of Efficacy|1|||
127760630|NCT01373151|459748928|FG005|Period 1|Lack of Efficacy|0|||
127760631|NCT01373151|459748929|FG006|Period 1|Lack of Efficacy|0|||
127760632|NCT01373151|459748923|FG000|Period 1|Adverse Event|0|||
127760633|NCT01373151|459748924|FG001|Period 1|Adverse Event|0|||
127760634|NCT01373151|459748925|FG002|Period 1|Adverse Event|1|||
127760635|NCT01373151|459748926|FG003|Period 1|Adverse Event|0|||
127760636|NCT01373151|459748927|FG004|Period 1|Adverse Event|4|||
127760637|NCT01373151|459748928|FG005|Period 1|Adverse Event|3|||
127760638|NCT01373151|459748929|FG006|Period 1|Adverse Event|0|||
127760639|NCT01373151|459748923|FG000|Period 1|Withdrawal by Subject|2|||
127760640|NCT01373151|459748924|FG001|Period 1|Withdrawal by Subject|0|||
127760641|NCT01373151|459748925|FG002|Period 1|Withdrawal by Subject|3|||
127760642|NCT01373151|459748926|FG003|Period 1|Withdrawal by Subject|1|||
127760643|NCT01373151|459748927|FG004|Period 1|Withdrawal by Subject|0|||
127760644|NCT01373151|459748928|FG005|Period 1|Withdrawal by Subject|1|||
127760645|NCT01373151|459748929|FG006|Period 1|Withdrawal by Subject|0|||
127760646|NCT01373151|459748923|FG000|Period 2|Lack of Efficacy|9|||
127760647|NCT01373151|459748924|FG001|Period 2|Lack of Efficacy|0|||
127760648|NCT01373151|459748925|FG002|Period 2|Lack of Efficacy|0|||
127760649|NCT01373151|459748926|FG003|Period 2|Lack of Efficacy|1|||
127760650|NCT01373151|459748927|FG004|Period 2|Lack of Efficacy|2|||
127760651|NCT01373151|459748928|FG005|Period 2|Lack of Efficacy|0|||
127760652|NCT01373151|459748929|FG006|Period 2|Lack of Efficacy|3|||
127760653|NCT01373151|459748923|FG000|Period 2|Adverse Event|0|||
127760654|NCT01373151|459748924|FG001|Period 2|Adverse Event|0|||
127760655|NCT01373151|459748925|FG002|Period 2|Adverse Event|3|||
127760656|NCT01373151|459748926|FG003|Period 2|Adverse Event|3|||
127760657|NCT01373151|459748927|FG004|Period 2|Adverse Event|0|||
127760658|NCT01373151|459748928|FG005|Period 2|Adverse Event|0|||
127760659|NCT01373151|459748929|FG006|Period 2|Adverse Event|1|||
127760660|NCT01373151|459748923|FG000|Period 2|subject request to discontinue|0|||
127760661|NCT01373151|459748924|FG001|Period 2|subject request to discontinue|1|||
127760662|NCT01373151|459748925|FG002|Period 2|subject request to discontinue|0|||
127983448|NCT01886781|460562487|FG000|Overall Study|Withdrawal by Subject|2|||
127538247|NCT00383552|458935077|FG001|Overall Study|Did not meet protocol eligibility|6|||
127538248|NCT00383552|458935078|FG002|Overall Study|Did not meet protocol eligibility|2|||
127538249|NCT00383552|458935079|FG003|Overall Study|Did not meet protocol eligibility|3|||
127760663|NCT01373151|459748926|FG003|Period 2|subject request to discontinue|0|||
127760664|NCT01373151|459748927|FG004|Period 2|subject request to discontinue|0|||
127760665|NCT01373151|459748928|FG005|Period 2|subject request to discontinue|0|||
127760666|NCT01373151|459748929|FG006|Period 2|subject request to discontinue|0|||
127760667|NCT01373151|459748923|FG000|Period 2|Withdrawal by Subject|0|||
127760668|NCT01373151|459748924|FG001|Period 2|Withdrawal by Subject|0|||
127760669|NCT01373151|459748925|FG002|Period 2|Withdrawal by Subject|0|||
127760670|NCT01373151|459748926|FG003|Period 2|Withdrawal by Subject|1|||
127760671|NCT01373151|459748927|FG004|Period 2|Withdrawal by Subject|0|||
127760672|NCT01373151|459748928|FG005|Period 2|Withdrawal by Subject|0|||
127760673|NCT01373151|459748929|FG006|Period 2|Withdrawal by Subject|0|||
127760674|NCT01373151|459748923|FG000|Period 2|Other|0|||
127538250|NCT00383552|458935076|FG000|Overall Study|Administrative|1|||
127538251|NCT00383552|458935077|FG001|Overall Study|Administrative|0|||
127538252|NCT00383552|458935078|FG002|Overall Study|Administrative|1|||
127538253|NCT00383552|458935079|FG003|Overall Study|Administrative|1|||
127538254|NCT03096834|458935080|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
127538255|NCT03096834|458935081|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
127538256|NCT03096834|458935082|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
127538257|NCT03096834|458935083|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
127538258|NCT03096834|458935080|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
127538259|NCT03096834|458935081|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
127538260|NCT03096834|458935082|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
127538261|NCT03096834|458935083|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
127538262|NCT03096834|458935080|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
127538263|NCT03096834|458935081|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
127538264|NCT03096834|458935082|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
127538265|NCT03096834|458935083|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
127538266|NCT03096834|458935080|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
127538267|NCT03096834|458935081|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
127538268|NCT03096834|458935082|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
127538269|NCT03096834|458935083|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
127538270|NCT03096834|458935080|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
127538271|NCT03096834|458935081|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
127538272|NCT03096834|458935082|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
127538273|NCT03096834|458935083|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
127538274|NCT03096834|458935080|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
127538275|NCT03096834|458935081|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
127538276|NCT03096834|458935082|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
127538277|NCT03096834|458935083|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
127538278|NCT03096834|458935080|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
127538279|NCT03096834|458935081|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
127538280|NCT03096834|458935082|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
127538281|NCT03096834|458935083|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
127538282|NCT03096834|458935080|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
127538283|NCT03096834|458935081|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
127538284|NCT03096834|458935082|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
127538285|NCT03096834|458935083|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
127538286|NCT03096834|458935080|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
127538287|NCT03096834|458935081|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
127538288|NCT03096834|458935082|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
127538289|NCT03096834|458935083|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
127538290|NCT03096834|458935080|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
127538291|NCT03096834|458935081|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
127538292|NCT03096834|458935082|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
127538293|NCT03096834|458935083|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
127538294|NCT03096834|458935080|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
127538295|NCT03096834|458935081|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
127538296|NCT03096834|458935082|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
127538297|NCT03096834|458935083|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
127538298|NCT03096834|458935080|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
127538299|NCT03096834|458935081|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
127538300|NCT03096834|458935082|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
127538301|NCT03096834|458935083|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
127538302|NCT00966654|458935084|FG000|Overall Study|Study was terminated,PI left institution|12|||
127538303|NCT04416204|458935087|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
127538304|NCT04416204|458935088|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
127538305|NCT04416204|458935089|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
127538306|NCT04416204|458935090|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
127538307|NCT04456504|458935091|FG000|Overall Study|Lost to Follow-up|2|||
127538308|NCT01405768|458935092|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
127538309|NCT01405768|458935093|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
127538310|NCT01381016|458935098|FG000|Overall Study|Lost to Follow-up|1|||
127538311|NCT01381016|458935099|FG001|Overall Study|Lost to Follow-up|1|||
127538312|NCT01381016|458935098|FG000|Overall Study|Screen Failure|2|||
127538313|NCT01381016|458935099|FG001|Overall Study|Screen Failure|2|||
127760675|NCT01373151|459748924|FG001|Period 2|Other|0|||
127760676|NCT01373151|459748925|FG002|Period 2|Other|1|||
127760677|NCT01373151|459748926|FG003|Period 2|Other|0|||
127538314|NCT01381016|458935098|FG000|Overall Study|Withdrawal by Subject|0|||
127538315|NCT01381016|458935099|FG001|Overall Study|Withdrawal by Subject|1|||
127538316|NCT01381016|458935098|FG000|Overall Study|Physician Decision|0|||
127538317|NCT01381016|458935099|FG001|Overall Study|Physician Decision|2|||
127538318|NCT01451723|458935101|FG000|Overall Study|study halted|6|||
127760678|NCT01373151|459748927|FG004|Period 2|Other|0|||
127538319|NCT01451723|458935102|FG001|Overall Study|study halted|5|||
127538320|NCT01631435|458935103|FG000|Overall Study|Adverse Event|2|||
127538321|NCT01631435|458935103|FG000|Overall Study|Withdrawal by Subject|2|||
127538322|NCT01631435|458935103|FG000|Overall Study|incomplete study procedure|5|||
127538323|NCT04245111|458935104|FG000|Overall Study|Lost to Follow-up|5|||
127538324|NCT04245111|458935105|FG001|Overall Study|Lost to Follow-up|1|||
127538325|NCT04245111|458935106|FG002|Overall Study|Lost to Follow-up|1|||
127538326|NCT03192176|458935107|FG000|Overall Study|Adverse Event|1|||
127538327|NCT03192176|458935108|FG001|Overall Study|Adverse Event|0|||
127538328|NCT03192176|458935109|FG002|Overall Study|Adverse Event|4|||
127538329|NCT03192176|458935110|FG003|Overall Study|Adverse Event|5|||
127538330|NCT03192176|458935111|FG004|Overall Study|Adverse Event|3|||
127538331|NCT03192176|458935112|FG005|Overall Study|Adverse Event|2|||
127538332|NCT03192176|458935113|FG006|Overall Study|Adverse Event|3|||
127538333|NCT03192176|458935114|FG007|Overall Study|Adverse Event|3|||
127538334|NCT03192176|458935107|FG000|Overall Study|Lost to Follow-up|0|||
127538335|NCT03192176|458935108|FG001|Overall Study|Lost to Follow-up|0|||
127538336|NCT03192176|458935109|FG002|Overall Study|Lost to Follow-up|1|||
127538337|NCT03192176|458935110|FG003|Overall Study|Lost to Follow-up|2|||
127538338|NCT03192176|458935111|FG004|Overall Study|Lost to Follow-up|3|||
127538339|NCT03192176|458935112|FG005|Overall Study|Lost to Follow-up|1|||
127538340|NCT03192176|458935113|FG006|Overall Study|Lost to Follow-up|1|||
127538341|NCT03192176|458935114|FG007|Overall Study|Lost to Follow-up|1|||
127538342|NCT03192176|458935107|FG000|Overall Study|Physician Decision|1|||
127538343|NCT03192176|458935108|FG001|Overall Study|Physician Decision|0|||
127538344|NCT03192176|458935109|FG002|Overall Study|Physician Decision|0|||
127538345|NCT03192176|458935110|FG003|Overall Study|Physician Decision|0|||
127538346|NCT03192176|458935111|FG004|Overall Study|Physician Decision|0|||
127538347|NCT03192176|458935112|FG005|Overall Study|Physician Decision|2|||
127538348|NCT03192176|458935113|FG006|Overall Study|Physician Decision|1|||
127538349|NCT03192176|458935114|FG007|Overall Study|Physician Decision|0|||
127538350|NCT03192176|458935107|FG000|Overall Study|Protocol Deviation|1|||
127538351|NCT03192176|458935108|FG001|Overall Study|Protocol Deviation|1|||
127538352|NCT03192176|458935109|FG002|Overall Study|Protocol Deviation|0|||
127538353|NCT03192176|458935110|FG003|Overall Study|Protocol Deviation|0|||
127538354|NCT03192176|458935111|FG004|Overall Study|Protocol Deviation|2|||
127538355|NCT03192176|458935112|FG005|Overall Study|Protocol Deviation|0|||
127538356|NCT03192176|458935113|FG006|Overall Study|Protocol Deviation|0|||
127538357|NCT03192176|458935114|FG007|Overall Study|Protocol Deviation|0|||
127538358|NCT03192176|458935107|FG000|Overall Study|Withdrawal by Subject|3|||
127538359|NCT03192176|458935108|FG001|Overall Study|Withdrawal by Subject|4|||
127538360|NCT03192176|458935109|FG002|Overall Study|Withdrawal by Subject|0|||
127538361|NCT03192176|458935110|FG003|Overall Study|Withdrawal by Subject|4|||
127538362|NCT03192176|458935111|FG004|Overall Study|Withdrawal by Subject|3|||
127538363|NCT03192176|458935112|FG005|Overall Study|Withdrawal by Subject|4|||
127538364|NCT03192176|458935113|FG006|Overall Study|Withdrawal by Subject|4|||
127538365|NCT03192176|458935114|FG007|Overall Study|Withdrawal by Subject|2|||
127538366|NCT03192176|458935107|FG000|Overall Study|Miscellaneous|1|||
127538367|NCT03192176|458935108|FG001|Overall Study|Miscellaneous|0|||
127538368|NCT03192176|458935109|FG002|Overall Study|Miscellaneous|1|||
127538369|NCT03192176|458935110|FG003|Overall Study|Miscellaneous|1|||
127538370|NCT03192176|458935111|FG004|Overall Study|Miscellaneous|1|||
127538371|NCT03192176|458935112|FG005|Overall Study|Miscellaneous|2|||
127538372|NCT03192176|458935113|FG006|Overall Study|Miscellaneous|0|||
127538373|NCT03192176|458935114|FG007|Overall Study|Miscellaneous|1|||
127538374|NCT03532542|458935117|FG000|Overall Study|Death|1|||
127538375|NCT03532542|458935118|FG001|Overall Study|Death|0|||
127538376|NCT03532542|458935117|FG000|Overall Study|Study Terminated by Sponsor|41|||
127538377|NCT03532542|458935118|FG001|Overall Study|Study Terminated by Sponsor|65|||
127538378|NCT03532542|458935117|FG000|Overall Study|Withdrawal by Subject|6|||
127538379|NCT03532542|458935118|FG001|Overall Study|Withdrawal by Subject|5|||
127538380|NCT02314052|458935119|FG000|Cycle One|Adverse Event|0|||
127538381|NCT02314052|458935120|FG001|Cycle One|Adverse Event|0|||
127538382|NCT02314052|458935121|FG002|Cycle One|Adverse Event|0|||
127538383|NCT02314052|458935122|FG003|Cycle One|Adverse Event|1|||
127538384|NCT02314052|458935123|FG004|Cycle One|Adverse Event|0|||
127538385|NCT02314052|458935124|FG005|Cycle One|Adverse Event|0|||
127538386|NCT00117637|458935125|FG000|First Intervention (Period 1)|Adverse Event|11|||
127538387|NCT00117637|458935126|FG001|First Intervention (Period 1)|Adverse Event|16|||
127538388|NCT00117637|458935125|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
127538389|NCT00117637|458935126|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
127538390|NCT00117637|458935125|FG000|First Intervention (Period 1)|Protocol Violation|1|||
127538391|NCT00117637|458935126|FG001|First Intervention (Period 1)|Protocol Violation|0|||
127538392|NCT00117637|458935125|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
127538393|NCT00117637|458935126|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
127538394|NCT00117637|458935125|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
127538395|NCT00117637|458935126|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
127538396|NCT00117637|458935125|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
127538397|NCT00117637|458935126|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
127538398|NCT00117637|458935125|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
127538399|NCT00117637|458935126|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
127538400|NCT00117637|458935125|FG000|First Intervention (Period 1)|reason not reported|0|||
127538401|NCT00117637|458935126|FG001|First Intervention (Period 1)|reason not reported|1|||
127538402|NCT00117637|458935125|FG000|Second Intervention (Period 2)|Adverse Event|0|||
127538403|NCT00117637|458935126|FG001|Second Intervention (Period 2)|Adverse Event|9|||
127538404|NCT00117637|458935125|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
127538405|NCT00117637|458935126|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
127538406|NCT00117637|458935125|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
127538407|NCT00117637|458935126|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
127538408|NCT00117637|458935125|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
127538409|NCT00117637|458935126|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
127538410|NCT00117637|458935125|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
127538411|NCT00117637|458935126|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
127538412|NCT00117637|458935125|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
127538413|NCT00117637|458935126|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
127538414|NCT00117637|458935125|FG000|Second Intervention (Period 2)|reason not reported|1|||
127538415|NCT00117637|458935126|FG001|Second Intervention (Period 2)|reason not reported|0|||
127538416|NCT01620060|458935127|FG000|Overall Study|Adverse Event|9|||
127538417|NCT01620060|458935127|FG000|Overall Study|Protocol Violation|1|||
127538418|NCT01620060|458935127|FG000|Overall Study|Withdrawal by Subject|1|||
127538419|NCT01620060|458935127|FG000|Overall Study|Did not comply with Study Produre|1|||
127538420|NCT01620060|458935127|FG000|Overall Study|Family emergency|1|||
127538421|NCT01620060|458935127|FG000|Overall Study|Per Sponsor Decision|2|||
127538422|NCT01582061|458935128|FG000|Overall Study|Lack of Efficacy|3|||
127538423|NCT01582061|458935129|FG001|Overall Study|Lack of Efficacy|23|||
127538424|NCT01582061|458935128|FG000|Overall Study|Adverse Event|12|||
127538425|NCT01582061|458935129|FG001|Overall Study|Adverse Event|8|||
127538426|NCT01582061|458935128|FG000|Overall Study|Withdrawal by Subject|10|||
127538427|NCT01582061|458935129|FG001|Overall Study|Withdrawal by Subject|4|||
127538428|NCT01582061|458935128|FG000|Overall Study|Abnormal laboratory value(s)|1|||
127538429|NCT01582061|458935129|FG001|Overall Study|Abnormal laboratory value(s)|0|||
127538430|NCT01582061|458935128|FG000|Overall Study|Death|0|||
127538431|NCT01582061|458935129|FG001|Overall Study|Death|1|||
127538432|NCT01582061|458935128|FG000|Overall Study|condition no longer requires study drug|1|||
127538433|NCT01582061|458935129|FG001|Overall Study|condition no longer requires study drug|0|||
127538434|NCT01582061|458935128|FG000|Overall Study|Lost to Follow-up|1|||
127538435|NCT01582061|458935129|FG001|Overall Study|Lost to Follow-up|0|||
127538436|NCT00231777|458935130|FG000|Overall Study|Lost to Follow-up|3|||
127538437|NCT00231777|458935131|FG001|Overall Study|Lost to Follow-up|0|||
127538438|NCT00231777|458935130|FG000|Overall Study|Other|3|||
127538439|NCT00231777|458935131|FG001|Overall Study|Other|2|||
127538440|NCT04698343|458935134|FG000|Overall Study|Withdrawal by Subject|6|||
127538441|NCT04698343|458935134|FG000|Overall Study|Physician Decision|2|||
127538442|NCT04698343|458935134|FG000|Overall Study|Failed to meet the required reduction in opioid dosage due to increased RLS symptoms|4|||
127538443|NCT04698343|458935134|FG000|Overall Study|1 was discontinued based on CGI-I score exceeding 5|1|||
127538444|NCT04698343|458935134|FG000|Overall Study|Personal reasons|3|||
127538445|NCT04698343|458935134|FG000|Overall Study|1 withdrew due to non-RLS opioid withdrawal symptoms|1|||
127538446|NCT02756338|458935135|FG000|Overall Study|Withdrawn by Investigator|1|||
127538447|NCT02756338|458935135|FG000|Overall Study|Device Replaced with Pacemaker|4|||
127538448|NCT00300755|458935138|FG000|Overall Study|Adverse Event|1|||
127538449|NCT00300755|458935139|FG001|Overall Study|Adverse Event|2|||
127538450|NCT00300755|458935140|FG002|Overall Study|Adverse Event|1|||
127538451|NCT00300755|458935138|FG000|Overall Study|Withdrawal by Subject|0|||
127538452|NCT00300755|458935139|FG001|Overall Study|Withdrawal by Subject|2|||
127538453|NCT00300755|458935140|FG002|Overall Study|Withdrawal by Subject|0|||
127538454|NCT00300755|458935138|FG000|Overall Study|Protocol Violation|0|||
127538455|NCT00300755|458935139|FG001|Overall Study|Protocol Violation|0|||
127538456|NCT00300755|458935140|FG002|Overall Study|Protocol Violation|1|||
127538457|NCT02694744|458935144|FG000|Overall Study|Adverse Event|2|||
127538458|NCT02694744|458935145|FG001|Overall Study|Adverse Event|1|||
127538459|NCT02694744|458935144|FG000|Overall Study|Withdrawal by Subject|2|||
127538460|NCT02694744|458935145|FG001|Overall Study|Withdrawal by Subject|1|||
127538461|NCT02694744|458935144|FG000|Overall Study|Physician Decision|1|||
127538462|NCT02694744|458935145|FG001|Overall Study|Physician Decision|2|||
127538463|NCT02694744|458935144|FG000|Overall Study|Lost to Follow-up|1|||
127538464|NCT02694744|458935145|FG001|Overall Study|Lost to Follow-up|0|||
127538465|NCT02694744|458935144|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
127538466|NCT02694744|458935145|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
127538467|NCT00686777|458935146|FG000|Overall Study|Adverse Event|2|||
127538468|NCT00686777|458935146|FG000|Overall Study|Pregnancy|1|||
127538469|NCT00686777|458935146|FG000|Overall Study|Withdrawal by Subject|2|||
127538470|NCT00686777|458935146|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
127538471|NCT00686777|458935146|FG000|Overall Study|No Visit|1|||
127538472|NCT01945021|458935147|FG000|Overall Study|Adverse Event|1|||
127538473|NCT01945021|458935147|FG000|Overall Study|Withdrawal of consent|12|||
127538474|NCT01945021|458935147|FG000|Overall Study|Lost to Follow-up|5|||
127538475|NCT01945021|458935147|FG000|Overall Study|Death|65|||
127538476|NCT03582215|458935148|FG000|Overall Study|Adverse Event|1|||
127538477|NCT03582215|458935149|FG001|Overall Study|Adverse Event|0|||
127538478|NCT03582215|458935150|FG002|Overall Study|Adverse Event|0|||
127538479|NCT03582215|458935151|FG003|Overall Study|Adverse Event|0|||
127538480|NCT03582215|458935152|FG004|Overall Study|Adverse Event|0|||
127538481|NCT03582215|458935153|FG005|Overall Study|Adverse Event|0|||
127538482|NCT03582215|458935154|FG006|Overall Study|Adverse Event|2|||
127538483|NCT03582215|458935155|FG007|Overall Study|Adverse Event|2|||
127538484|NCT02163902|458935156|FG000|Overall Study|Subject's Request|3|||
127538485|NCT02163902|458935157|FG001|Overall Study|Subject's Request|4|||
127538486|NCT02163902|458935156|FG000|Overall Study|Lost to Follow-up|6|||
127538487|NCT02163902|458935157|FG001|Overall Study|Lost to Follow-up|7|||
127538488|NCT02163902|458935156|FG000|Overall Study|Administrative Decision|2|||
127538489|NCT02163902|458935157|FG001|Overall Study|Administrative Decision|2|||
127538490|NCT02174731|458935158|FG000|Overall Study|Participant decision|67|||
127538491|NCT02174731|458935159|FG001|Overall Study|Participant decision|64|||
127538492|NCT02174731|458935158|FG000|Overall Study|Incorrect enrolment before randomization|0|||
127538493|NCT02174731|458935159|FG001|Overall Study|Incorrect enrolment before randomization|1|||
127538494|NCT02174731|458935158|FG000|Overall Study|Missing|2|||
127538495|NCT02174731|458935159|FG001|Overall Study|Missing|0|||
127538496|NCT03119259|458935160|FG000|Overall Study|Withdrawn as no longer eligible|1|||
127538497|NCT03119259|458935161|FG001|Overall Study|Withdrawn as no longer eligible|0|||
127538498|NCT03119259|458935160|FG000|Overall Study|Withdrawal by Subject|4|||
127538499|NCT03119259|458935161|FG001|Overall Study|Withdrawal by Subject|2|||
127538500|NCT03119259|458935160|FG000|Overall Study|Lost to Follow-up|0|||
127538501|NCT03119259|458935161|FG001|Overall Study|Lost to Follow-up|1|||
127538502|NCT00739401|458935166|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
127538503|NCT00739401|458935166|FG000|Overall Study|Death|3|||
127538504|NCT00739401|458935166|FG000|Overall Study|Withdrawal by Subject|4|||
127538505|NCT04575155|458935167|FG000|2 Month|Withdrawal by Subject|1|||
127538506|NCT04575155|458935168|FG001|2 Month|Withdrawal by Subject|1|||
127538507|NCT04575155|458935167|FG000|2 Month|Lost to Follow-up|5|||
127538508|NCT04575155|458935168|FG001|2 Month|Lost to Follow-up|3|||
127538509|NCT04575155|458935167|FG000|2 Month|Ineligible|1|||
127538510|NCT04575155|458935168|FG001|2 Month|Ineligible|0|||
127538511|NCT00660192|458935171|FG000|Overall Study|Lost to Follow-up|2|||
127538512|NCT00660192|458935172|FG001|Overall Study|Lost to Follow-up|3|||
127538513|NCT00982735|458935173|FG000|Overall Study|Lost to Follow-up|6|||
127538514|NCT00982735|458935173|FG000|Overall Study|Patient ineligible for trial|224|||
127538515|NCT02734693|458935174|FG000|Overall Study|Adverse Event|1|||
127538516|NCT02734693|458935175|FG001|Overall Study|Adverse Event|3|||
127538517|NCT02734693|458935176|FG002|Overall Study|Adverse Event|3|||
127538518|NCT02734693|458935174|FG000|Overall Study|Lack of Efficacy|1|||
127538519|NCT02734693|458935175|FG001|Overall Study|Lack of Efficacy|0|||
127538520|NCT02734693|458935176|FG002|Overall Study|Lack of Efficacy|0|||
127538521|NCT02734693|458935174|FG000|Overall Study|Lost to Follow-up|2|||
127538522|NCT02734693|458935175|FG001|Overall Study|Lost to Follow-up|0|||
127538523|NCT02734693|458935176|FG002|Overall Study|Lost to Follow-up|0|||
127538524|NCT02734693|458935174|FG000|Overall Study|Protocol Violation|1|||
127538525|NCT02734693|458935175|FG001|Overall Study|Protocol Violation|0|||
127538526|NCT02734693|458935176|FG002|Overall Study|Protocol Violation|0|||
127538527|NCT02734693|458935174|FG000|Overall Study|Withdrawal by Subject|1|||
127760679|NCT01373151|459748928|FG005|Period 2|Other|0|||
127760680|NCT01373151|459748929|FG006|Period 2|Other|1|||
127538528|NCT02734693|458935175|FG001|Overall Study|Withdrawal by Subject|0|||
127538529|NCT02734693|458935176|FG002|Overall Study|Withdrawal by Subject|0|||
127538530|NCT02898454|458935184|FG000|Overall Study|Adverse Event|4|||
127538531|NCT02898454|458935185|FG001|Overall Study|Adverse Event|1|||
127538532|NCT02898454|458935186|FG002|Overall Study|Adverse Event|2|||
127538533|NCT02898454|458935184|FG000|Overall Study|Protocol Violation|1|||
127538534|NCT02898454|458935185|FG001|Overall Study|Protocol Violation|0|||
127538535|NCT02898454|458935186|FG002|Overall Study|Protocol Violation|1|||
127538536|NCT02898454|458935184|FG000|Overall Study|Lack of Efficacy|4|||
127538537|NCT02898454|458935185|FG001|Overall Study|Lack of Efficacy|1|||
127538538|NCT02898454|458935186|FG002|Overall Study|Lack of Efficacy|0|||
127538539|NCT02898454|458935184|FG000|Overall Study|Withdrawal by Subject|6|||
127538540|NCT02898454|458935185|FG001|Overall Study|Withdrawal by Subject|3|||
127538541|NCT02898454|458935186|FG002|Overall Study|Withdrawal by Subject|3|||
127538542|NCT02898454|458935184|FG000|Overall Study|Lost to Follow-up|1|||
127538543|NCT02898454|458935185|FG001|Overall Study|Lost to Follow-up|0|||
127538544|NCT02898454|458935186|FG002|Overall Study|Lost to Follow-up|0|||
127538545|NCT02898454|458935184|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
127760681|NCT00293059|459748930|FG000|Overall Study|Adverse Event|12|||
127538546|NCT02898454|458935185|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
127538547|NCT02898454|458935186|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
127538548|NCT01601535|458935187|FG000|Phase 1|Adverse Event|1|||
127538549|NCT01601535|458935188|FG001|Phase 1|Adverse Event|0|||
127538550|NCT01601535|458935189|FG002|Phase 1|Adverse Event|2|||
127538551|NCT01601535|458935190|FG003|Phase 1|Adverse Event|1|||
127538552|NCT01601535|458935191|FG004|Phase 1|Adverse Event|0|||
127538553|NCT01601535|458935192|FG005|Phase 1|Adverse Event|0|||
127538554|NCT01601535|458935187|FG000|Phase 1|Withdrawal by Subject|2|||
127538555|NCT01601535|458935188|FG001|Phase 1|Withdrawal by Subject|1|||
127538556|NCT01601535|458935189|FG002|Phase 1|Withdrawal by Subject|1|||
127538557|NCT01601535|458935190|FG003|Phase 1|Withdrawal by Subject|2|||
127538558|NCT01601535|458935191|FG004|Phase 1|Withdrawal by Subject|0|||
127538559|NCT01601535|458935192|FG005|Phase 1|Withdrawal by Subject|0|||
127538560|NCT01601535|458935187|FG000|Phase 1|Progressive Disease|2|||
127649099|NCT04035200|459336466|FG001|Overall Study|Non-compliance|1|||
127649100|NCT04035200|459336467|FG002|Overall Study|Non-compliance|0|||
127649101|NCT00386022|459336473|FG000|Plus Estrogen|Lost to Follow-up|2|||
127649102|NCT00386022|459336474|FG001|Plus Estrogen|Lost to Follow-up|0|||
127649103|NCT00386022|459336473|FG000|Plus Estrogen|Adverse Event|0|||
127649104|NCT00386022|459336474|FG001|Plus Estrogen|Adverse Event|1|||
127649105|NCT00168038|459336481|FG000|Overall Study|Adverse Event|1|||
127649106|NCT00168038|459336481|FG000|Overall Study|Therapy failure|1|||
127649107|NCT01685138|459336484|FG000|Overall Study|Lost to Follow-up|1|||
127649108|NCT01685138|459336484|FG000|Overall Study|Protocol Violation|1|||
127649109|NCT01685138|459336484|FG000|Overall Study|No longer requires treatment|1|||
127649110|NCT01685138|459336484|FG000|Overall Study|Subject/guardian decision|2|||
127649111|NCT01685138|459336484|FG000|Overall Study|Physician Decision|6|||
127649112|NCT01685138|459336484|FG000|Overall Study|Death|10|||
127649113|NCT01685138|459336484|FG000|Overall Study|Adverse Event|18|||
127649114|NCT01685138|459336484|FG000|Overall Study|Progressive disease|53|||
127649115|NCT02068495|459336489|FG000|Overall Study|Case Report Forms Uncollected|60|||
127649116|NCT02068495|459336489|FG000|Overall Study|Protocol Deviation|49|||
127649117|NCT00689026|459336490|FG000|Overall Study|Withdrawal by Subject|13|||
127649118|NCT00689026|459336491|FG001|Overall Study|Withdrawal by Subject|6|||
127649119|NCT02703922|459336495|FG000|Overall Study|Death|5|||
127649120|NCT02703922|459336496|FG001|Overall Study|Death|8|||
127649121|NCT02703922|459336495|FG000|Overall Study|Lost to Follow-up|10|||
127649122|NCT02703922|459336496|FG001|Overall Study|Lost to Follow-up|10|||
127649123|NCT00394355|459336498|FG000|Overall Study|Adverse Event|10|||
127649124|NCT00394355|459336499|FG001|Overall Study|Adverse Event|6|||
127649125|NCT00394355|459336500|FG002|Overall Study|Adverse Event|7|||
127649126|NCT00394355|459336501|FG003|Overall Study|Adverse Event|8|||
127649127|NCT00394355|459336498|FG000|Overall Study|Did not meet protocol eligibility|1|||
127649128|NCT00394355|459336499|FG001|Overall Study|Did not meet protocol eligibility|5|||
127649129|NCT00394355|459336500|FG002|Overall Study|Did not meet protocol eligibility|4|||
127649130|NCT00394355|459336501|FG003|Overall Study|Did not meet protocol eligibility|2|||
127649131|NCT00394355|459336498|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
127649132|NCT00394355|459336499|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
127649133|NCT00394355|459336500|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
127649134|NCT00394355|459336501|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
127649135|NCT00394355|459336498|FG000|Overall Study|Subject withdrawal - related to drug|1|||
127649136|NCT00394355|459336499|FG001|Overall Study|Subject withdrawal - related to drug|0|||
127649137|NCT00394355|459336500|FG002|Overall Study|Subject withdrawal - related to drug|0|||
127649138|NCT00394355|459336501|FG003|Overall Study|Subject withdrawal - related to drug|0|||
127649139|NCT00394355|459336498|FG000|Overall Study|Lost to Follow-up|7|||
127649140|NCT00394355|459336499|FG001|Overall Study|Lost to Follow-up|5|||
127649141|NCT00394355|459336500|FG002|Overall Study|Lost to Follow-up|4|||
127649142|NCT00394355|459336501|FG003|Overall Study|Lost to Follow-up|3|||
127649143|NCT00394355|459336498|FG000|Overall Study|Noncompliance with protocol|4|||
127649144|NCT00394355|459336499|FG001|Overall Study|Noncompliance with protocol|3|||
127649145|NCT00394355|459336500|FG002|Overall Study|Noncompliance with protocol|10|||
127649146|NCT00394355|459336501|FG003|Overall Study|Noncompliance with protocol|8|||
127649147|NCT00394355|459336498|FG000|Overall Study|Administrative|0|||
127649148|NCT00394355|459336499|FG001|Overall Study|Administrative|1|||
127649149|NCT00394355|459336500|FG002|Overall Study|Administrative|1|||
127649150|NCT00394355|459336501|FG003|Overall Study|Administrative|1|||
127649151|NCT00394355|459336498|FG000|Overall Study|Lack of Efficacy|0|||
127649152|NCT00394355|459336499|FG001|Overall Study|Lack of Efficacy|0|||
127649153|NCT00394355|459336500|FG002|Overall Study|Lack of Efficacy|2|||
127538561|NCT01601535|458935188|FG001|Phase 1|Progressive Disease|3|||
127538562|NCT01601535|458935189|FG002|Phase 1|Progressive Disease|2|||
127538563|NCT01601535|458935190|FG003|Phase 1|Progressive Disease|1|||
127538564|NCT01601535|458935191|FG004|Phase 1|Progressive Disease|0|||
127649154|NCT00394355|459336501|FG003|Overall Study|Lack of Efficacy|3|||
127538565|NCT01601535|458935192|FG005|Phase 1|Progressive Disease|0|||
127649155|NCT01648348|459336504|FG000|Overall Study|Cancel|1|||
127649156|NCT01648348|459336505|FG001|Overall Study|Cancel|0|||
127538566|NCT01601535|458935187|FG000|Phase 1|Started Another Treatment|1|||
127538567|NCT01601535|458935188|FG001|Phase 1|Started Another Treatment|2|||
127538568|NCT01601535|458935189|FG002|Phase 1|Started Another Treatment|0|||
127538569|NCT01601535|458935190|FG003|Phase 1|Started Another Treatment|0|||
127538570|NCT01601535|458935191|FG004|Phase 1|Started Another Treatment|0|||
127538571|NCT01601535|458935192|FG005|Phase 1|Started Another Treatment|0|||
127538572|NCT01601535|458935187|FG000|Phase 2|Adverse Event|0|||
127538573|NCT01601535|458935188|FG001|Phase 2|Adverse Event|0|||
127538574|NCT01601535|458935189|FG002|Phase 2|Adverse Event|0|||
127538575|NCT01601535|458935190|FG003|Phase 2|Adverse Event|0|||
127538576|NCT01601535|458935191|FG004|Phase 2|Adverse Event|5|||
127538577|NCT01601535|458935192|FG005|Phase 2|Adverse Event|1|||
127538578|NCT01601535|458935187|FG000|Phase 2|Withdrawal by Subject|0|||
127538579|NCT01601535|458935188|FG001|Phase 2|Withdrawal by Subject|0|||
127538580|NCT01601535|458935189|FG002|Phase 2|Withdrawal by Subject|0|||
127538581|NCT01601535|458935190|FG003|Phase 2|Withdrawal by Subject|0|||
127538582|NCT01601535|458935191|FG004|Phase 2|Withdrawal by Subject|8|||
127538583|NCT01601535|458935192|FG005|Phase 2|Withdrawal by Subject|2|||
127538584|NCT01601535|458935187|FG000|Phase 2|Progressive Disease|0|||
127538585|NCT01601535|458935188|FG001|Phase 2|Progressive Disease|0|||
127538586|NCT01601535|458935189|FG002|Phase 2|Progressive Disease|0|||
127538587|NCT01601535|458935190|FG003|Phase 2|Progressive Disease|0|||
127538588|NCT01601535|458935191|FG004|Phase 2|Progressive Disease|5|||
127538589|NCT01601535|458935192|FG005|Phase 2|Progressive Disease|7|||
127538590|NCT01601535|458935187|FG000|Phase 2|Started Another Treatment|0|||
127538591|NCT01601535|458935188|FG001|Phase 2|Started Another Treatment|0|||
127538592|NCT01601535|458935189|FG002|Phase 2|Started Another Treatment|0|||
127538593|NCT01601535|458935190|FG003|Phase 2|Started Another Treatment|0|||
127538594|NCT01601535|458935191|FG004|Phase 2|Started Another Treatment|1|||
127538595|NCT01601535|458935192|FG005|Phase 2|Started Another Treatment|2|||
127538596|NCT00647296|458935193|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
127538597|NCT00647296|458935194|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
127538598|NCT00647296|458935195|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
127538599|NCT00647296|458935196|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
127538600|NCT00647296|458935193|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
127538601|NCT00647296|458935194|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
127538602|NCT00647296|458935195|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
127538603|NCT00647296|458935196|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
127538604|NCT00647296|458935193|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
127538605|NCT00647296|458935194|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
127538606|NCT00647296|458935195|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
127538607|NCT00647296|458935196|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
127538608|NCT00647296|458935193|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
127538609|NCT00647296|458935194|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
127538610|NCT00647296|458935195|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
127538611|NCT00647296|458935196|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
127538612|NCT00647296|458935193|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
127538613|NCT00647296|458935194|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
127538614|NCT00647296|458935195|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
127538615|NCT00647296|458935196|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
127538616|NCT00647296|458935193|FG000|Part 2: 4-week Placebo Washout|Death|3|||
127538617|NCT00647296|458935194|FG001|Part 2: 4-week Placebo Washout|Death|0|||
127538618|NCT00647296|458935195|FG002|Part 2: 4-week Placebo Washout|Death|0|||
127538619|NCT00647296|458935196|FG003|Part 2: 4-week Placebo Washout|Death|0|||
127538620|NCT00647296|458935193|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
127538621|NCT00647296|458935194|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
127538622|NCT00647296|458935195|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
127538623|NCT00647296|458935196|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
127538624|NCT00647296|458935193|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
127538625|NCT00647296|458935194|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
127538626|NCT00647296|458935195|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
127538627|NCT00647296|458935196|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
127538628|NCT00647296|458935193|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
127538629|NCT00647296|458935194|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
127538630|NCT00647296|458935195|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
127538631|NCT00647296|458935196|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
127538632|NCT00647296|458935193|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
127538633|NCT00647296|458935194|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
127538634|NCT00647296|458935195|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
127538635|NCT00647296|458935196|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
127538636|NCT00647296|458935193|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
127538637|NCT00647296|458935194|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
127538638|NCT00647296|458935195|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
127538639|NCT00647296|458935196|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
127538640|NCT01787461|458935197|FG000|Overall Study|Adverse Event|4|||
127538641|NCT01787461|458935198|FG001|Overall Study|Adverse Event|3|||
127538642|NCT01787461|458935197|FG000|Overall Study|Lost to Follow-up|3|||
127538643|NCT01787461|458935198|FG001|Overall Study|Lost to Follow-up|2|||
127538644|NCT01787461|458935197|FG000|Overall Study|No longer met eligibility criteria|1|||
127538645|NCT01787461|458935198|FG001|Overall Study|No longer met eligibility criteria|0|||
127538646|NCT01787461|458935197|FG000|Overall Study|Withdrawal by Subject|3|||
127538647|NCT01787461|458935198|FG001|Overall Study|Withdrawal by Subject|4|||
127538648|NCT01787461|458935197|FG000|Overall Study|Protocol Violation|3|||
127538649|NCT01787461|458935198|FG001|Overall Study|Protocol Violation|0|||
127538650|NCT03883581|458935199|FG000|Overall Study|Withdrawal by Subject|4|||
127538651|NCT04612725|458935200|FG000|Overall Study|Adverse Event|1|||
127538652|NCT04612725|458935201|FG001|Overall Study|Adverse Event|3|||
127538653|NCT04612725|458935202|FG002|Overall Study|Adverse Event|1|||
127538654|NCT04612725|458935203|FG003|Overall Study|Adverse Event|0|||
127538655|NCT04612725|458935204|FG004|Overall Study|Adverse Event|1|||
127538656|NCT04612725|458935200|FG000|Overall Study|Lost to Follow-up|0|||
127538657|NCT04612725|458935201|FG001|Overall Study|Lost to Follow-up|1|||
127538658|NCT04612725|458935202|FG002|Overall Study|Lost to Follow-up|0|||
127538659|NCT04612725|458935203|FG003|Overall Study|Lost to Follow-up|0|||
127538660|NCT04612725|458935204|FG004|Overall Study|Lost to Follow-up|0|||
127538661|NCT04612725|458935200|FG000|Overall Study|Physician Decision|2|||
127538662|NCT04612725|458935201|FG001|Overall Study|Physician Decision|0|||
127538663|NCT04612725|458935202|FG002|Overall Study|Physician Decision|0|||
127538664|NCT04612725|458935203|FG003|Overall Study|Physician Decision|0|||
127538665|NCT04612725|458935204|FG004|Overall Study|Physician Decision|0|||
127538666|NCT04612725|458935200|FG000|Overall Study|Study terminated by sponsor|3|||
127538667|NCT04612725|458935201|FG001|Overall Study|Study terminated by sponsor|1|||
127538668|NCT04612725|458935202|FG002|Overall Study|Study terminated by sponsor|2|||
127538669|NCT04612725|458935203|FG003|Overall Study|Study terminated by sponsor|4|||
127538670|NCT04612725|458935204|FG004|Overall Study|Study terminated by sponsor|5|||
127538671|NCT04612725|458935200|FG000|Overall Study|Withdrawal by Subject|8|||
127538672|NCT04612725|458935201|FG001|Overall Study|Withdrawal by Subject|3|||
127538673|NCT04612725|458935202|FG002|Overall Study|Withdrawal by Subject|5|||
127538674|NCT04612725|458935203|FG003|Overall Study|Withdrawal by Subject|1|||
127538675|NCT04612725|458935204|FG004|Overall Study|Withdrawal by Subject|9|||
127538676|NCT04612725|458935200|FG000|Overall Study|Other|0|||
127538677|NCT04612725|458935201|FG001|Overall Study|Other|0|||
127538678|NCT04612725|458935202|FG002|Overall Study|Other|0|||
127538679|NCT04612725|458935203|FG003|Overall Study|Other|0|||
127538680|NCT04612725|458935204|FG004|Overall Study|Other|1|||
127538681|NCT02354235|458935205|FG000|Overall Study|Adverse Event|2|||
127538682|NCT02354235|458935206|FG001|Overall Study|Adverse Event|2|||
127538683|NCT02354235|458935205|FG000|Overall Study|Physician Decision|0|||
127538684|NCT02354235|458935206|FG001|Overall Study|Physician Decision|1|||
127538685|NCT02354235|458935205|FG000|Overall Study|Withdrawal by Subject|1|||
127538686|NCT02354235|458935206|FG001|Overall Study|Withdrawal by Subject|3|||
127538687|NCT02354235|458935205|FG000|Overall Study|Conflict with the stopping criteria|0|||
127538688|NCT02354235|458935206|FG001|Overall Study|Conflict with the stopping criteria|1|||
127538689|NCT02926638|458935209|FG000|Overall Study|Progression|2|||
127538690|NCT02926638|458935210|FG001|Overall Study|Progression|5|||
127538691|NCT02926638|458935209|FG000|Overall Study|Ineligible|1|||
127538692|NCT02926638|458935210|FG001|Overall Study|Ineligible|0|||
127538693|NCT02926638|458935209|FG000|Overall Study|Not protocol specified|1|||
127538694|NCT02926638|458935210|FG001|Overall Study|Not protocol specified|0|||
127538695|NCT00644423|458937020|FG000|Overall Study|Lost to Follow-up|1|||
127538696|NCT00644423|458937021|FG001|Overall Study|Lost to Follow-up|1|||
127538697|NCT01908426|458937022|FG000|Overall Study|Adverse Event|98|||
127538698|NCT01908426|458937023|FG001|Overall Study|Adverse Event|11|||
127538699|NCT01908426|458937022|FG000|Overall Study|Clinical Deterioration|72|||
127538700|NCT01908426|458937023|FG001|Overall Study|Clinical Deterioration|38|||
127538701|NCT01908426|458937022|FG000|Overall Study|Lack of Efficacy|3|||
127538702|NCT01908426|458937023|FG001|Overall Study|Lack of Efficacy|0|||
127538703|NCT01908426|458937022|FG000|Overall Study|Lost to Follow-up|0|||
127538704|NCT01908426|458937023|FG001|Overall Study|Lost to Follow-up|1|||
127760682|NCT00293059|459748931|FG001|Overall Study|Adverse Event|4|||
127760683|NCT00293059|459748930|FG000|Overall Study|Lack of Efficacy|2|||
127760684|NCT00293059|459748931|FG001|Overall Study|Lack of Efficacy|0|||
127760685|NCT00293059|459748930|FG000|Overall Study|Lost to Follow-up|2|||
127538705|NCT01908426|458937022|FG000|Overall Study|Physician Decision|3|||
127538706|NCT01908426|458937023|FG001|Overall Study|Physician Decision|3|||
127538707|NCT01908426|458937022|FG000|Overall Study|Withdrawal by Subject|11|||
127538708|NCT01908426|458937023|FG001|Overall Study|Withdrawal by Subject|6|||
127538709|NCT01908426|458937022|FG000|Overall Study|Progressive Disease|206|||
127538710|NCT01908426|458937023|FG001|Overall Study|Progressive Disease|152|||
127538711|NCT01908426|458937022|FG000|Overall Study|Protocol Violation|1|||
127760686|NCT00293059|459748931|FG001|Overall Study|Lost to Follow-up|3|||
127538712|NCT01908426|458937023|FG001|Overall Study|Protocol Violation|0|||
127538713|NCT01908426|458937022|FG000|Overall Study|No Study Treatment Given|3|||
127538714|NCT01908426|458937023|FG001|Overall Study|No Study Treatment Given|0|||
127538715|NCT01005251|458937034|FG000|Overall Study|Withdrawal by Subject|2|||
127538716|NCT01005251|458937035|FG001|Overall Study|Withdrawal by Subject|5|||
127538717|NCT01005251|458937036|FG002|Overall Study|Withdrawal by Subject|3|||
127538718|NCT01005251|458937037|FG003|Overall Study|Withdrawal by Subject|4|||
127538719|NCT01005251|458937038|FG004|Overall Study|Withdrawal by Subject|9|||
127538720|NCT01005251|458937034|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
127538721|NCT01005251|458937035|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
127538722|NCT01005251|458937036|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
127538723|NCT01005251|458937037|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
127538724|NCT01005251|458937038|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
127538725|NCT01005251|458937034|FG000|Overall Study|Adverse Event|2|||
127538726|NCT01005251|458937035|FG001|Overall Study|Adverse Event|6|||
127538727|NCT01005251|458937036|FG002|Overall Study|Adverse Event|8|||
127538728|NCT01005251|458937037|FG003|Overall Study|Adverse Event|5|||
127538729|NCT01005251|458937038|FG004|Overall Study|Adverse Event|4|||
127538730|NCT01005251|458937034|FG000|Overall Study|Protocol Violation|1|||
127538731|NCT01005251|458937035|FG001|Overall Study|Protocol Violation|0|||
127538732|NCT01005251|458937036|FG002|Overall Study|Protocol Violation|0|||
127538733|NCT01005251|458937037|FG003|Overall Study|Protocol Violation|0|||
127538734|NCT01005251|458937038|FG004|Overall Study|Protocol Violation|2|||
127538735|NCT01005251|458937034|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
127538736|NCT01005251|458937035|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
127538737|NCT01005251|458937036|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
127538738|NCT01005251|458937037|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
127538739|NCT01005251|458937038|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
127538740|NCT01005251|458937034|FG000|Overall Study|Lost to Follow-up|1|||
127538741|NCT01005251|458937035|FG001|Overall Study|Lost to Follow-up|4|||
127538742|NCT01005251|458937036|FG002|Overall Study|Lost to Follow-up|2|||
127538743|NCT01005251|458937037|FG003|Overall Study|Lost to Follow-up|0|||
127538744|NCT01005251|458937038|FG004|Overall Study|Lost to Follow-up|0|||
127538745|NCT01005251|458937034|FG000|Overall Study|Physician Decision|0|||
127538746|NCT01005251|458937035|FG001|Overall Study|Physician Decision|0|||
127538747|NCT01005251|458937036|FG002|Overall Study|Physician Decision|0|||
127538748|NCT01005251|458937037|FG003|Overall Study|Physician Decision|0|||
127538749|NCT01005251|458937038|FG004|Overall Study|Physician Decision|2|||
127538750|NCT01005251|458937034|FG000|Overall Study|Patient moved|1|||
127538751|NCT01005251|458937035|FG001|Overall Study|Patient moved|0|||
127538752|NCT01005251|458937036|FG002|Overall Study|Patient moved|0|||
127538753|NCT01005251|458937037|FG003|Overall Study|Patient moved|0|||
127538754|NCT01005251|458937038|FG004|Overall Study|Patient moved|0|||
127538755|NCT01005251|458937034|FG000|Overall Study|Wrong drug dispensed|0|||
127538756|NCT01005251|458937035|FG001|Overall Study|Wrong drug dispensed|1|||
127538757|NCT01005251|458937036|FG002|Overall Study|Wrong drug dispensed|0|||
127538758|NCT01005251|458937037|FG003|Overall Study|Wrong drug dispensed|0|||
127538759|NCT01005251|458937038|FG004|Overall Study|Wrong drug dispensed|0|||
127538760|NCT01005251|458937034|FG000|Overall Study|Randomized in error|0|||
127538761|NCT01005251|458937035|FG001|Overall Study|Randomized in error|0|||
127538762|NCT01005251|458937036|FG002|Overall Study|Randomized in error|1|||
127538763|NCT01005251|458937037|FG003|Overall Study|Randomized in error|1|||
127538764|NCT01005251|458937038|FG004|Overall Study|Randomized in error|0|||
127538765|NCT01005251|458937034|FG000|Overall Study|Lack of Efficacy|0|||
127538766|NCT01005251|458937035|FG001|Overall Study|Lack of Efficacy|0|||
127538767|NCT01005251|458937036|FG002|Overall Study|Lack of Efficacy|1|||
127538768|NCT01005251|458937037|FG003|Overall Study|Lack of Efficacy|1|||
127538769|NCT01005251|458937038|FG004|Overall Study|Lack of Efficacy|0|||
127538770|NCT00141453|458937045|FG000|Overall Study|Protocol Violation|6|||
127538771|NCT00141453|458937046|FG001|Overall Study|Protocol Violation|5|||
127538772|NCT00443040|458937049|FG000|Overall Study|Withdrawal by Subject|1|||
127538773|NCT00443040|458937050|FG001|Overall Study|Withdrawal by Subject|0|||
127538774|NCT00443040|458937051|FG002|Overall Study|Withdrawal by Subject|0|||
127538775|NCT00443040|458937049|FG000|Overall Study|Converted to an open laparotomy|3|||
127538776|NCT00443040|458937050|FG001|Overall Study|Converted to an open laparotomy|0|||
127538777|NCT00443040|458937051|FG002|Overall Study|Converted to an open laparotomy|1|||
127760687|NCT00293059|459748930|FG000|Overall Study|Pregnancy|1|||
127760688|NCT00293059|459748931|FG001|Overall Study|Pregnancy|1|||
127538778|NCT03661723|458937060|FG000|Overall Study|Disease Progression|4|||
127538779|NCT03661723|458937061|FG001|Overall Study|Disease Progression|24|||
127538780|NCT03661723|458937062|FG002|Overall Study|Disease Progression|4|||
127760689|NCT00293059|459748930|FG000|Overall Study|Protocol Violation|2|||
127538781|NCT03661723|458937063|FG003|Overall Study|Disease Progression|19|||
127538782|NCT03661723|458937060|FG000|Overall Study|Withdrawal by Subject|1|||
127538783|NCT03661723|458937061|FG001|Overall Study|Withdrawal by Subject|0|||
127538784|NCT03661723|458937062|FG002|Overall Study|Withdrawal by Subject|2|||
127760690|NCT00293059|459748931|FG001|Overall Study|Protocol Violation|0|||
127760691|NCT00293059|459748930|FG000|Overall Study|Withdrawal by Subject|11|||
127760692|NCT00293059|459748931|FG001|Overall Study|Withdrawal by Subject|5|||
127760693|NCT00293059|459748930|FG000|Overall Study|Participant moved out of state|1|||
127760694|NCT00293059|459748931|FG001|Overall Study|Participant moved out of state|0|||
127871740|NCT01397409|460148749|FG009|Stage 3|Adverse Event|0|||
127871741|NCT01397409|460148740|FG000|Stage 3|Other Miscellaneous Reasons|0|||
127871742|NCT01397409|460148741|FG001|Stage 3|Other Miscellaneous Reasons|0|||
127871743|NCT01397409|460148742|FG002|Stage 3|Other Miscellaneous Reasons|0|||
127871744|NCT01397409|460148743|FG003|Stage 3|Other Miscellaneous Reasons|0|||
127871745|NCT01397409|460148744|FG004|Stage 3|Other Miscellaneous Reasons|0|||
127871746|NCT01397409|460148745|FG005|Stage 3|Other Miscellaneous Reasons|0|||
127871747|NCT01397409|460148746|FG006|Stage 3|Other Miscellaneous Reasons|0|||
127871748|NCT01397409|460148747|FG007|Stage 3|Other Miscellaneous Reasons|1|||
127871749|NCT01397409|460148748|FG008|Stage 3|Other Miscellaneous Reasons|0|||
127871750|NCT01397409|460148749|FG009|Stage 3|Other Miscellaneous Reasons|0|||
127871751|NCT01207427|460148750|FG000|Double-blind Treatment Period|Adverse Event|0|||
127871752|NCT01207427|460148751|FG001|Double-blind Treatment Period|Adverse Event|1|||
127871753|NCT01207427|460148752|FG002|Double-blind Treatment Period|Adverse Event|0|||
127871754|NCT01207427|460148750|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
127871755|NCT01207427|460148751|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
127871756|NCT01207427|460148752|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
127871757|NCT01207427|460148750|FG000|Double-blind Treatment Period|Protocol Violation|2|||
127871758|NCT01207427|460148751|FG001|Double-blind Treatment Period|Protocol Violation|1|||
127871759|NCT01207427|460148752|FG002|Double-blind Treatment Period|Protocol Violation|1|||
127871760|NCT01207427|460148750|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
127871761|NCT01207427|460148751|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
127871762|NCT01207427|460148752|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
127871763|NCT01790633|460148753|FG000|Overall Study|Protocol Violation|1|||
127871764|NCT01790633|460148754|FG001|Overall Study|Protocol Violation|2|||
127871765|NCT01790633|460148753|FG000|Overall Study|Did not have serology performed|47|||
127871766|NCT01790633|460148754|FG001|Overall Study|Did not have serology performed|0|||
127871767|NCT01790633|460148753|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
127871768|NCT01790633|460148754|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
127871769|NCT00157157|460148755|FG000|Overall Study|Withdrawal by Subject|6|||
127871770|NCT00157157|460148755|FG000|Overall Study|Physician Decision|1|||
127871771|NCT00157157|460148755|FG000|Overall Study|Lost to Follow-up|1|||
127871772|NCT00157157|460148755|FG000|Overall Study|Enrolled in another study|1|||
127871773|NCT00157157|460148755|FG000|Overall Study|Met exclusion criteria|1|||
127871774|NCT00157157|460148755|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
127871775|NCT02930889|460149882|FG000|Overall Study|Lost to Follow-up|2|||
127871776|NCT02930889|460149882|FG000|Overall Study|Withdrawal by Subject|6|||
127871777|NCT02930889|460149882|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
127871778|NCT00198107|460149888|FG000|Double-Blind Period|Adverse Event|1|||
127871779|NCT00198107|460149889|FG001|Double-Blind Period|Adverse Event|1|||
127871780|NCT00198107|460149890|FG002|Double-Blind Period|Adverse Event|0|||
127871781|NCT00198107|460149888|FG000|Double-Blind Period|Lack of Efficacy|2|||
127871782|NCT00198107|460149889|FG001|Double-Blind Period|Lack of Efficacy|0|||
127871783|NCT00198107|460149890|FG002|Double-Blind Period|Lack of Efficacy|0|||
127871784|NCT00198107|460149888|FG000|Double-Blind Period|Lost to Follow-up|2|||
127871785|NCT00198107|460149889|FG001|Double-Blind Period|Lost to Follow-up|1|||
127871786|NCT00198107|460149890|FG002|Double-Blind Period|Lost to Follow-up|0|||
127871787|NCT00198107|460149888|FG000|Double-Blind Period|Physician Decision|1|||
127871788|NCT00198107|460149889|FG001|Double-Blind Period|Physician Decision|0|||
127871789|NCT00198107|460149890|FG002|Double-Blind Period|Physician Decision|0|||
127871790|NCT00198107|460149888|FG000|Double-Blind Period|Withdrawal by Subject|0|||
127871791|NCT00198107|460149889|FG001|Double-Blind Period|Withdrawal by Subject|1|||
127871792|NCT00198107|460149890|FG002|Double-Blind Period|Withdrawal by Subject|0|||
127871793|NCT00198107|460149888|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
127871794|NCT00198107|460149889|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
127871795|NCT00198107|460149890|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
127871796|NCT02383966|460149896|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
127871797|NCT02383966|460149897|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
127871798|NCT02383966|460149896|FG000|Overall Study|Randomized, but not treated|1|||
127871799|NCT02383966|460149897|FG001|Overall Study|Randomized, but not treated|3|||
127871800|NCT02163759|460149898|FG000|Overall Study|Withdrawal by Subject|1|||
127871801|NCT02163759|460149899|FG001|Overall Study|Withdrawal by Subject|5|||
127871802|NCT02163759|460149900|FG002|Overall Study|Withdrawal by Subject|1|||
127871803|NCT02163759|460149898|FG000|Overall Study|Adverse Event|0|||
127871804|NCT02163759|460149899|FG001|Overall Study|Adverse Event|0|||
127871805|NCT02163759|460149900|FG002|Overall Study|Adverse Event|1|||
127871806|NCT02163759|460149898|FG000|Overall Study|Death|0|||
127538785|NCT03661723|458937063|FG003|Overall Study|Withdrawal by Subject|4|||
127538786|NCT03661723|458937060|FG000|Overall Study|Physician Decision|1|||
127538787|NCT03661723|458937061|FG001|Overall Study|Physician Decision|0|||
127538788|NCT03661723|458937062|FG002|Overall Study|Physician Decision|0|||
127538789|NCT03661723|458937063|FG003|Overall Study|Physician Decision|0|||
127538790|NCT03661723|458937060|FG000|Overall Study|Clinical Deterioration|0|||
127538791|NCT03661723|458937061|FG001|Overall Study|Clinical Deterioration|0|||
127538792|NCT03661723|458937062|FG002|Overall Study|Clinical Deterioration|0|||
127538793|NCT03661723|458937063|FG003|Overall Study|Clinical Deterioration|1|||
127538794|NCT00718510|458937066|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
127538795|NCT00718510|458937067|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
127538796|NCT00718510|458937066|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
127538797|NCT00718510|458937067|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
127538798|NCT00467740|458937070|FG000|Overall Study|Adverse Event|0|||
127538799|NCT00467740|458937071|FG001|Overall Study|Adverse Event|0|||
127538800|NCT00467740|458937072|FG002|Overall Study|Adverse Event|1|||
127538801|NCT00467740|458937073|FG003|Overall Study|Adverse Event|0|||
127538802|NCT00467740|458937074|FG004|Overall Study|Adverse Event|0|||
127538803|NCT00467740|458937070|FG000|Overall Study|Protocol Violation|0|||
127538804|NCT00467740|458937071|FG001|Overall Study|Protocol Violation|0|||
127538805|NCT00467740|458937072|FG002|Overall Study|Protocol Violation|1|||
127538806|NCT00467740|458937073|FG003|Overall Study|Protocol Violation|0|||
127538807|NCT00467740|458937074|FG004|Overall Study|Protocol Violation|0|||
127538808|NCT00467740|458937070|FG000|Overall Study|Lost to Follow-up|0|||
127538809|NCT00467740|458937071|FG001|Overall Study|Lost to Follow-up|1|||
127538810|NCT00467740|458937072|FG002|Overall Study|Lost to Follow-up|0|||
127538811|NCT00467740|458937073|FG003|Overall Study|Lost to Follow-up|0|||
127538812|NCT00467740|458937074|FG004|Overall Study|Lost to Follow-up|0|||
127538813|NCT00467740|458937070|FG000|Overall Study|Withdrawal by Subject|1|||
127538814|NCT00467740|458937071|FG001|Overall Study|Withdrawal by Subject|1|||
127538815|NCT00467740|458937072|FG002|Overall Study|Withdrawal by Subject|0|||
127538816|NCT00467740|458937073|FG003|Overall Study|Withdrawal by Subject|1|||
127538817|NCT00467740|458937074|FG004|Overall Study|Withdrawal by Subject|0|||
127538818|NCT00467740|458937070|FG000|Overall Study|Lack of Efficacy|0|||
127538819|NCT00467740|458937071|FG001|Overall Study|Lack of Efficacy|1|||
127538820|NCT00467740|458937072|FG002|Overall Study|Lack of Efficacy|0|||
127538821|NCT00467740|458937073|FG003|Overall Study|Lack of Efficacy|0|||
127538822|NCT00467740|458937074|FG004|Overall Study|Lack of Efficacy|0|||
127538823|NCT02903160|458937075|FG000|Overall Study|Adverse Event|2|||
127538824|NCT02903160|458937075|FG000|Overall Study|Death|1|||
127538825|NCT02903160|458937075|FG000|Overall Study|Lost to Follow-up|2|||
127538826|NCT02903160|458937075|FG000|Overall Study|Withdrawal by Subject|1|||
127538827|NCT02903160|458937075|FG000|Overall Study|Medical Insurance Barriers|1|||
127538828|NCT01664910|458937078|FG000|Overall Study|Adverse Event|0|||
127538829|NCT01664910|458937079|FG001|Overall Study|Adverse Event|0|||
127538830|NCT01664910|458937080|FG002|Overall Study|Adverse Event|1|||
127538831|NCT00730158|458937085|FG000|Overall Study|Withdrawal by Subject|1|||
127538832|NCT00730158|458937086|FG001|Overall Study|Withdrawal by Subject|1|||
127538833|NCT04678115|458937087|FG000|Overall Study|Lost to Follow-up|1|||
127538834|NCT04678115|458937088|FG001|Overall Study|Lost to Follow-up|0|||
127538835|NCT01168349|458937089|FG000|Overall Study|Death|157|||
127538836|NCT01168349|458937089|FG000|Overall Study|Lost to Follow-up|34|||
127538837|NCT01168349|458937089|FG000|Overall Study|Withdrawal by Subject|9|||
127538838|NCT01168349|458937089|FG000|Overall Study|Kidney transplantation|3|||
127538839|NCT01168349|458937089|FG000|Overall Study|Other|22|||
127538840|NCT01168349|458937089|FG000|Overall Study|Protocol Violation|76|||
127538841|NCT03535974|458937090|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
127538842|NCT03535974|458937091|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
127538843|NCT03535974|458937092|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
127538844|NCT03535974|458937090|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
127538845|NCT03535974|458937091|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
127538846|NCT03535974|458937092|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
127538847|NCT00844376|458937093|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
127538848|NCT00844376|458937094|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
127538849|NCT04059549|458937095|FG000|Overall Study|Withdrawal by Subject|2|||
127538850|NCT04059549|458937096|FG001|Overall Study|Withdrawal by Subject|0|||
127538851|NCT02678351|458937098|FG000|Overall Study|Withdrawal by Subject|1|||
127538852|NCT00988884|458937099|FG000|Overall Study|Adverse Event|0|||
127538853|NCT00988884|458937100|FG001|Overall Study|Adverse Event|1|||
127538854|NCT00988884|458937099|FG000|Overall Study|Lost to Follow-up|20|||
127538855|NCT00988884|458937100|FG001|Overall Study|Lost to Follow-up|16|||
127538856|NCT00988884|458937099|FG000|Overall Study|Protocol Violation|0|||
127538857|NCT00988884|458937100|FG001|Overall Study|Protocol Violation|1|||
127538858|NCT00988884|458937099|FG000|Overall Study|Withdrawal by Subject|15|||
127538859|NCT00988884|458937100|FG001|Overall Study|Withdrawal by Subject|18|||
127538860|NCT01919229|458937101|FG000|Overall Study|Subject/guardian decision|0|||
127642277|NCT03252587|459310078|FG000|Overall Study|Pregnancy|2|||
127538861|NCT01919229|458937102|FG001|Overall Study|Subject/guardian decision|0|||
127538862|NCT01919229|458937103|FG002|Overall Study|Subject/guardian decision|1|||
127538863|NCT01632020|458937104|FG000|Overall Study|Withdrawal by Subject|1|||
127538864|NCT01632020|458937105|FG001|Overall Study|Withdrawal by Subject|0|||
127538865|NCT01632020|458937104|FG000|Overall Study|Adverse Event|1|||
127538866|NCT01632020|458937105|FG001|Overall Study|Adverse Event|0|||
127538867|NCT00549640|458937107|FG000|Overall Study|Withdrawal by Subject|6|||
127538868|NCT00549640|458937108|FG001|Overall Study|Withdrawal by Subject|12|||
127538869|NCT00549640|458937107|FG000|Overall Study|Adverse Event|5|||
127538870|NCT00549640|458937108|FG001|Overall Study|Adverse Event|0|||
127538871|NCT00549640|458937107|FG000|Overall Study|Lost to Follow-up|7|||
127538872|NCT00549640|458937108|FG001|Overall Study|Lost to Follow-up|4|||
127538873|NCT04999839|458937117|FG000|Overall Study|Adverse Event|1|||
127538874|NCT04999839|458937118|FG001|Overall Study|Adverse Event|1|||
127538875|NCT04999839|458937119|FG002|Overall Study|Adverse Event|1|||
127538876|NCT04999839|458937120|FG003|Overall Study|Adverse Event|1|||
127538877|NCT04999839|458937121|FG004|Overall Study|Adverse Event|1|||
127538878|NCT04999839|458937117|FG000|Overall Study|Lost to Follow-up|2|||
127538879|NCT04999839|458937118|FG001|Overall Study|Lost to Follow-up|0|||
127538880|NCT04999839|458937119|FG002|Overall Study|Lost to Follow-up|2|||
127538881|NCT04999839|458937120|FG003|Overall Study|Lost to Follow-up|4|||
127538882|NCT04999839|458937121|FG004|Overall Study|Lost to Follow-up|1|||
127538883|NCT04999839|458937117|FG000|Overall Study|Withdrawal by Subject|6|||
127538884|NCT04999839|458937118|FG001|Overall Study|Withdrawal by Subject|5|||
127538885|NCT04999839|458937119|FG002|Overall Study|Withdrawal by Subject|3|||
127538886|NCT04999839|458937120|FG003|Overall Study|Withdrawal by Subject|2|||
127538887|NCT04999839|458937121|FG004|Overall Study|Withdrawal by Subject|2|||
127538888|NCT04999839|458937117|FG000|Overall Study|Lack of Efficacy|0|||
127538889|NCT04999839|458937118|FG001|Overall Study|Lack of Efficacy|1|||
127538890|NCT04999839|458937119|FG002|Overall Study|Lack of Efficacy|0|||
127538891|NCT04999839|458937120|FG003|Overall Study|Lack of Efficacy|0|||
127538892|NCT04999839|458937121|FG004|Overall Study|Lack of Efficacy|0|||
127538893|NCT04999839|458937117|FG000|Overall Study|Physician Decision|0|||
127538894|NCT04999839|458937118|FG001|Overall Study|Physician Decision|0|||
127538895|NCT04999839|458937119|FG002|Overall Study|Physician Decision|0|||
127538896|NCT04999839|458937120|FG003|Overall Study|Physician Decision|0|||
127538897|NCT04999839|458937121|FG004|Overall Study|Physician Decision|1|||
127538898|NCT04999839|458937117|FG000|Overall Study|Sponsor request|0|||
127538899|NCT04999839|458937118|FG001|Overall Study|Sponsor request|1|||
127538900|NCT04999839|458937119|FG002|Overall Study|Sponsor request|0|||
127538901|NCT04999839|458937120|FG003|Overall Study|Sponsor request|0|||
127538902|NCT04999839|458937121|FG004|Overall Study|Sponsor request|0|||
127538903|NCT04999839|458937117|FG000|Overall Study|Other|0|||
127538904|NCT04999839|458937118|FG001|Overall Study|Other|0|||
127538905|NCT04999839|458937119|FG002|Overall Study|Other|1|||
127538906|NCT04999839|458937120|FG003|Overall Study|Other|0|||
127538907|NCT04999839|458937121|FG004|Overall Study|Other|0|||
127538908|NCT01362348|458937122|FG000|Overall Study|Protocol-defined stopping criteria|9|||
127538909|NCT01362348|458937122|FG000|Overall Study|Study closed/terminated|5|||
127538910|NCT00399516|458937123|FG000|Overall Study|Lost to Follow-up|2|||
127538911|NCT02675907|458937126|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
127538912|NCT02675907|458937127|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
127538913|NCT02675907|458937126|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
127538914|NCT02675907|458937127|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
127538915|NCT02675907|458937126|FG000|Study Overall|Lack of Efficacy|1|||
127538916|NCT02675907|458937127|FG001|Study Overall|Lack of Efficacy|0|||
127538917|NCT02675907|458937126|FG000|Study Overall|Withdrawal by Subject|2|||
127538918|NCT02675907|458937127|FG001|Study Overall|Withdrawal by Subject|2|||
127538919|NCT02675907|458937126|FG000|Study Overall|Lost to Follow-up|0|||
127538920|NCT02675907|458937127|FG001|Study Overall|Lost to Follow-up|2|||
127538921|NCT00539981|458937128|FG000|Overall Study|Adverse events (AE)|3|||
127538922|NCT00539981|458937129|FG001|Overall Study|Adverse events (AE)|3|||
127538923|NCT00539981|458937128|FG000|Overall Study|Lost to Follow-up|260|||
127538924|NCT00539981|458937129|FG001|Overall Study|Lost to Follow-up|251|||
127538925|NCT00539981|458937128|FG000|Overall Study|Withdrew consent|22|||
127538926|NCT00539981|458937129|FG001|Overall Study|Withdrew consent|14|||
127538927|NCT00539981|458937128|FG000|Overall Study|Death|1|||
127538928|NCT00539981|458937129|FG001|Overall Study|Death|1|||
127538929|NCT00539981|458937128|FG000|Overall Study|Other reason-unspecified|9|||
127538930|NCT00539981|458937129|FG001|Overall Study|Other reason-unspecified|13|||
127538931|NCT01611792|458937130|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
127538932|NCT01611792|458937131|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
127538933|NCT01611792|458937130|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
127538934|NCT01611792|458937131|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
127538935|NCT00525512|458937137|FG000|Double-Blind Phase|Adverse Event|48|||
127983449|NCT01886781|460562488|FG001|Overall Study|Withdrawal by Subject|1|||
127538936|NCT00525512|458937138|FG001|Double-Blind Phase|Adverse Event|28|||
127538937|NCT00525512|458937139|FG002|Double-Blind Phase|Adverse Event|0|||
127760695|NCT00293059|459748930|FG000|Overall Study|Participant stopped study drug|1|||
127760696|NCT00293059|459748931|FG001|Overall Study|Participant stopped study drug|0|||
127983450|NCT01886781|460562487|FG000|Overall Study|Worsening of symptoms|1|||
127983451|NCT01886781|460562488|FG001|Overall Study|Worsening of symptoms|1|||
127983452|NCT03769194|460562489|FG000|Overall Study|Withdrawal by Subject|0|||
127983453|NCT03769194|460562490|FG001|Overall Study|Withdrawal by Subject|7|||
127983454|NCT03769194|460562491|FG002|Overall Study|Withdrawal by Subject|4|||
127983455|NCT03769194|460562492|FG003|Overall Study|Withdrawal by Subject|1|||
127983456|NCT03769194|460562489|FG000|Overall Study|moved from study area|0|||
127983457|NCT03769194|460562490|FG001|Overall Study|moved from study area|2|||
127983458|NCT03769194|460562491|FG002|Overall Study|moved from study area|1|||
127983459|NCT03769194|460562492|FG003|Overall Study|moved from study area|1|||
127983460|NCT03769194|460562489|FG000|Overall Study|Lost to Follow-up|3|||
127983461|NCT03769194|460562490|FG001|Overall Study|Lost to Follow-up|6|||
127983462|NCT03769194|460562491|FG002|Overall Study|Lost to Follow-up|3|||
127983463|NCT03769194|460562492|FG003|Overall Study|Lost to Follow-up|6|||
127983464|NCT03769194|460562489|FG000|Overall Study|other|1|||
127983465|NCT03769194|460562490|FG001|Overall Study|other|3|||
127983466|NCT03769194|460562491|FG002|Overall Study|other|0|||
127983467|NCT03769194|460562492|FG003|Overall Study|other|1|||
127983468|NCT01672294|460562496|FG000|Overall Study|Withdrawal by Subject|4|||
127983469|NCT01672294|460562497|FG001|Overall Study|Withdrawal by Subject|4|||
127983470|NCT01672294|460562498|FG002|Overall Study|Withdrawal by Subject|4|||
127983471|NCT01672294|460562499|FG003|Overall Study|Withdrawal by Subject|4|||
127983472|NCT01672294|460562496|FG000|Overall Study|Excluded by study|1|||
127983473|NCT01672294|460562497|FG001|Overall Study|Excluded by study|1|||
127983474|NCT01672294|460562498|FG002|Overall Study|Excluded by study|0|||
127983475|NCT01672294|460562499|FG003|Overall Study|Excluded by study|0|||
127983476|NCT01672294|460562496|FG000|Overall Study|Lost to Follow-up|1|||
127983477|NCT01672294|460562497|FG001|Overall Study|Lost to Follow-up|16|||
127983478|NCT01672294|460562498|FG002|Overall Study|Lost to Follow-up|7|||
127983479|NCT01672294|460562499|FG003|Overall Study|Lost to Follow-up|9|||
127983480|NCT03887117|460562500|FG000|Overall Study|Discontinued prematurely|0|||
127983481|NCT03887117|460562501|FG001|Overall Study|Discontinued prematurely|1|||
127983482|NCT03887117|460562502|FG002|Overall Study|Discontinued prematurely|1|||
127983483|NCT03887117|460562503|FG003|Overall Study|Discontinued prematurely|2|||
127983484|NCT01739764|460562504|FG000|Overall Study|Adverse Event|0|||
127983485|NCT01739764|460562505|FG001|Overall Study|Adverse Event|3|||
127983486|NCT01739764|460562506|FG002|Overall Study|Adverse Event|4|||
127983487|NCT01739764|460562504|FG000|Overall Study|Death|4|||
127983488|NCT01739764|460562505|FG001|Overall Study|Death|6|||
127983489|NCT01739764|460562506|FG002|Overall Study|Death|38|||
127983490|NCT01739764|460562504|FG000|Overall Study|Lost to Follow-up|0|||
127983491|NCT01739764|460562505|FG001|Overall Study|Lost to Follow-up|0|||
127983492|NCT01739764|460562506|FG002|Overall Study|Lost to Follow-up|5|||
127983493|NCT01739764|460562504|FG000|Overall Study|Non-Compliance|0|||
127983494|NCT01739764|460562505|FG001|Overall Study|Non-Compliance|0|||
127983495|NCT01739764|460562506|FG002|Overall Study|Non-Compliance|1|||
127983496|NCT01739764|460562504|FG000|Overall Study|Multiple Reasons|3|||
127983497|NCT01739764|460562505|FG001|Overall Study|Multiple Reasons|2|||
127983498|NCT01739764|460562506|FG002|Overall Study|Multiple Reasons|3|||
127983499|NCT01739764|460562504|FG000|Overall Study|Physician Decision|2|||
127983500|NCT01739764|460562505|FG001|Overall Study|Physician Decision|2|||
127983501|NCT01739764|460562506|FG002|Overall Study|Physician Decision|4|||
127983502|NCT01739764|460562504|FG000|Overall Study|Progressive Disease|3|||
127983503|NCT01739764|460562505|FG001|Overall Study|Progressive Disease|5|||
127983504|NCT01739764|460562506|FG002|Overall Study|Progressive Disease|16|||
127983505|NCT01739764|460562504|FG000|Overall Study|Protocol Violation|0|||
127983506|NCT01739764|460562505|FG001|Overall Study|Protocol Violation|0|||
127983507|NCT01739764|460562506|FG002|Overall Study|Protocol Violation|2|||
127983508|NCT01739764|460562504|FG000|Overall Study|Study Terminated by Sponsor|8|||
127983509|NCT01739764|460562505|FG001|Overall Study|Study Terminated by Sponsor|13|||
127983510|NCT01739764|460562506|FG002|Overall Study|Study Terminated by Sponsor|26|||
127983511|NCT01739764|460562504|FG000|Overall Study|Withdrawal by Subject|6|||
127983512|NCT01739764|460562505|FG001|Overall Study|Withdrawal by Subject|5|||
127983513|NCT01739764|460562506|FG002|Overall Study|Withdrawal by Subject|27|||
127983514|NCT01389258|460562507|FG000|Overall Study|Lost to Follow-up|5|||
127983515|NCT00926536|460562508|FG000|Overall Study|Physician Decision|1|||
127983516|NCT00926536|460562509|FG001|Overall Study|Physician Decision|2|||
127983517|NCT00990665|460562510|FG000|Overall Study|Unsuccessful Implant|8|||
127983518|NCT00990665|460562510|FG000|Overall Study|Death|29|||
127983519|NCT00990665|460562510|FG000|Overall Study|Heart Transplant|1|||
127983520|NCT00990665|460562510|FG000|Overall Study|Withdrawal by Subject|6|||
127983521|NCT00990665|460562510|FG000|Overall Study|Lost to Follow-up|1|||
127983522|NCT00990665|460562510|FG000|Overall Study|System Explant|3|||
127983523|NCT01080391|460562511|FG000|Overall Study|Randomized but not treated|7|||
127538938|NCT00525512|458937140|FG003|Double-Blind Phase|Adverse Event|0|||
127538939|NCT00525512|458937137|FG000|Double-Blind Phase|Protocol Violation|3|||
127538940|NCT00525512|458937138|FG001|Double-Blind Phase|Protocol Violation|1|||
127538941|NCT00525512|458937139|FG002|Double-Blind Phase|Protocol Violation|0|||
127538942|NCT00525512|458937140|FG003|Double-Blind Phase|Protocol Violation|0|||
127538943|NCT00525512|458937137|FG000|Double-Blind Phase|Lost to Follow-up|3|||
127538944|NCT00525512|458937138|FG001|Double-Blind Phase|Lost to Follow-up|7|||
127538945|NCT00525512|458937139|FG002|Double-Blind Phase|Lost to Follow-up|0|||
127538946|NCT00525512|458937140|FG003|Double-Blind Phase|Lost to Follow-up|0|||
127538947|NCT00525512|458937137|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
127538948|NCT00525512|458937138|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
127538949|NCT00525512|458937139|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
127538950|NCT00525512|458937140|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
127538951|NCT00525512|458937137|FG000|Double-Blind Phase|Lack of Efficacy|13|||
127538952|NCT00525512|458937138|FG001|Double-Blind Phase|Lack of Efficacy|5|||
127538953|NCT00525512|458937139|FG002|Double-Blind Phase|Lack of Efficacy|0|||
127538954|NCT00525512|458937140|FG003|Double-Blind Phase|Lack of Efficacy|0|||
127538955|NCT00525512|458937137|FG000|Double-Blind Phase|Other reason (not specified)|12|||
127538956|NCT00525512|458937138|FG001|Double-Blind Phase|Other reason (not specified)|13|||
127538957|NCT00525512|458937139|FG002|Double-Blind Phase|Other reason (not specified)|0|||
127538958|NCT00525512|458937140|FG003|Double-Blind Phase|Other reason (not specified)|0|||
127538959|NCT00525512|458937137|FG000|Open-Label Phase|Adverse Event|0|||
127538960|NCT00525512|458937138|FG001|Open-Label Phase|Adverse Event|0|||
127538961|NCT00525512|458937139|FG002|Open-Label Phase|Adverse Event|1|||
127538962|NCT00525512|458937140|FG003|Open-Label Phase|Adverse Event|0|||
127538963|NCT00525512|458937137|FG000|Open-Label Phase|Lost to Follow-up|0|||
127538964|NCT00525512|458937138|FG001|Open-Label Phase|Lost to Follow-up|0|||
127538965|NCT00525512|458937139|FG002|Open-Label Phase|Lost to Follow-up|1|||
127538966|NCT00525512|458937140|FG003|Open-Label Phase|Lost to Follow-up|0|||
127538967|NCT00525512|458937137|FG000|Open-Label Phase|Other reason (not specified)|0|||
127538968|NCT00525512|458937138|FG001|Open-Label Phase|Other reason (not specified)|0|||
127538969|NCT00525512|458937139|FG002|Open-Label Phase|Other reason (not specified)|4|||
127538970|NCT00525512|458937140|FG003|Open-Label Phase|Other reason (not specified)|5|||
127538971|NCT03289208|458937145|FG000|Overall Study|Adverse Event|1|||
127538972|NCT03289208|458937146|FG001|Overall Study|Adverse Event|0|||
127538973|NCT03289208|458937147|FG002|Overall Study|Adverse Event|0|||
127538974|NCT03353675|458937151|FG000|Overall Study|Adverse Event|4|||
127538975|NCT02362724|458937154|FG000|Overall Study|Withdrawal by Subject|3|||
127538976|NCT02362724|458937155|FG001|Overall Study|Withdrawal by Subject|1|||
127538977|NCT02362724|458937154|FG000|Overall Study|Adverse Event|3|||
127538978|NCT02362724|458937155|FG001|Overall Study|Adverse Event|0|||
127538979|NCT02025179|458937156|FG000|Overall Study|Lost to Follow-up|0|||
127538980|NCT02025179|458937157|FG001|Overall Study|Lost to Follow-up|0|||
127538981|NCT02025179|458937158|FG002|Overall Study|Lost to Follow-up|1|||
127538982|NCT00402168|458937159|FG000|Randomized|Lost to Follow-up|1|||
127538983|NCT00402168|458937160|FG001|Randomized|Lost to Follow-up|0|||
127538984|NCT00402168|458937159|FG000|Randomized|Withdrawal by Subject|0|||
127538985|NCT00402168|458937160|FG001|Randomized|Withdrawal by Subject|1|||
127538986|NCT00402168|458937159|FG000|Treatment (up to 12 Months)|Death|0|||
127538987|NCT00402168|458937160|FG001|Treatment (up to 12 Months)|Death|1|||
127538988|NCT00402168|458937159|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
127538989|NCT00402168|458937160|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
127538990|NCT00402168|458937159|FG000|Treatment (up to 12 Months)|non-specified|0|||
127538991|NCT00402168|458937160|FG001|Treatment (up to 12 Months)|non-specified|1|||
127538992|NCT00402168|458937159|FG000|Long Term (LT)|Adverse Event|1|||
127538993|NCT00402168|458937160|FG001|Long Term (LT)|Adverse Event|5|||
127538994|NCT00402168|458937159|FG000|Long Term (LT)|Withdrawal by Subject|4|||
127538995|NCT00402168|458937160|FG001|Long Term (LT)|Withdrawal by Subject|7|||
127538996|NCT00402168|458937159|FG000|Long Term (LT)|Pregnancy|0|||
127538997|NCT00402168|458937160|FG001|Long Term (LT)|Pregnancy|1|||
127538998|NCT00402168|458937159|FG000|Long Term (LT)|Lost to Follow-up|1|||
127538999|NCT00402168|458937160|FG001|Long Term (LT)|Lost to Follow-up|0|||
127539000|NCT00402168|458937159|FG000|Long Term (LT)|Death|4|||
127539001|NCT00402168|458937160|FG001|Long Term (LT)|Death|0|||
127539002|NCT00402168|458937159|FG000|Long Term (LT)|Lack of Efficacy|0|||
127539003|NCT00402168|458937160|FG001|Long Term (LT)|Lack of Efficacy|2|||
127539004|NCT00402168|458937159|FG000|Long Term (LT)|non-specified|1|||
127539005|NCT00402168|458937160|FG001|Long Term (LT)|non-specified|2|||
127539006|NCT00402168|458937159|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
127539007|NCT00402168|458937160|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
127539008|NCT00402168|458937159|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
127539009|NCT00402168|458937160|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
127539010|NCT00395746|458937166|FG000|Overall Study|Adverse Event|5|||
127539011|NCT00395746|458937167|FG001|Overall Study|Adverse Event|2|||
127539012|NCT00395746|458937168|FG002|Overall Study|Adverse Event|2|||
127539013|NCT00395746|458937166|FG000|Overall Study|Protocol Violation|0|||
127539014|NCT00395746|458937167|FG001|Overall Study|Protocol Violation|1|||
127539015|NCT00395746|458937168|FG002|Overall Study|Protocol Violation|0|||
127539016|NCT00395746|458937166|FG000|Overall Study|Lack of Efficacy|2|||
127539017|NCT00395746|458937167|FG001|Overall Study|Lack of Efficacy|0|||
127539018|NCT00395746|458937168|FG002|Overall Study|Lack of Efficacy|17|||
127539019|NCT00395746|458937166|FG000|Overall Study|Hypoglycaemia|2|||
127539020|NCT00395746|458937167|FG001|Overall Study|Hypoglycaemia|1|||
127539021|NCT00395746|458937168|FG002|Overall Study|Hypoglycaemia|0|||
127539022|NCT00395746|458937166|FG000|Overall Study|Subject decision|0|||
127539023|NCT00395746|458937167|FG001|Overall Study|Subject decision|0|||
127539024|NCT00395746|458937168|FG002|Overall Study|Subject decision|1|||
127539025|NCT00395746|458937166|FG000|Overall Study|Withdrawal of consent|0|||
127539026|NCT00395746|458937167|FG001|Overall Study|Withdrawal of consent|0|||
127539027|NCT00395746|458937168|FG002|Overall Study|Withdrawal of consent|1|||
127539028|NCT00395746|458937166|FG000|Overall Study|Difficultulty in use of device|0|||
127539029|NCT00395746|458937167|FG001|Overall Study|Difficultulty in use of device|0|||
127539030|NCT00395746|458937168|FG002|Overall Study|Difficultulty in use of device|1|||
127539031|NCT00395746|458937166|FG000|Overall Study|Unable to visit site on schedule|1|||
127539032|NCT00395746|458937167|FG001|Overall Study|Unable to visit site on schedule|0|||
127539033|NCT00395746|458937168|FG002|Overall Study|Unable to visit site on schedule|0|||
127539034|NCT03137992|458937173|FG000|Washout Period 1|Adverse Event|1|||
127539035|NCT03137992|458937174|FG001|Washout Period 1|Adverse Event|1|||
127539036|NCT03137992|458937175|FG002|Washout Period 1|Adverse Event|0|||
127539037|NCT03137992|458937176|FG003|Washout Period 1|Adverse Event|0|||
127539038|NCT03137992|458937177|FG004|Washout Period 1|Adverse Event|0|||
127539039|NCT03137992|458937178|FG005|Washout Period 1|Adverse Event|1|||
127539040|NCT03137992|458937173|FG000|Washout Period 1|Withdrawal by Subject|0|||
127539041|NCT03137992|458937174|FG001|Washout Period 1|Withdrawal by Subject|1|||
127539042|NCT03137992|458937175|FG002|Washout Period 1|Withdrawal by Subject|1|||
127539043|NCT03137992|458937176|FG003|Washout Period 1|Withdrawal by Subject|0|||
127539044|NCT03137992|458937177|FG004|Washout Period 1|Withdrawal by Subject|0|||
127539045|NCT03137992|458937178|FG005|Washout Period 1|Withdrawal by Subject|0|||
127539046|NCT03137992|458937173|FG000|Washout Period 1|Principal Investigator Discretion|0|||
127539047|NCT03137992|458937174|FG001|Washout Period 1|Principal Investigator Discretion|1|||
127539048|NCT03137992|458937175|FG002|Washout Period 1|Principal Investigator Discretion|0|||
127539049|NCT03137992|458937176|FG003|Washout Period 1|Principal Investigator Discretion|0|||
127539050|NCT03137992|458937177|FG004|Washout Period 1|Principal Investigator Discretion|0|||
127539051|NCT03137992|458937178|FG005|Washout Period 1|Principal Investigator Discretion|0|||
127539052|NCT03137992|458937173|FG000|Washout Period 1|COPD Exacerbation|1|||
127539053|NCT03137992|458937174|FG001|Washout Period 1|COPD Exacerbation|1|||
127539054|NCT03137992|458937175|FG002|Washout Period 1|COPD Exacerbation|1|||
127539055|NCT03137992|458937176|FG003|Washout Period 1|COPD Exacerbation|0|||
127539056|NCT03137992|458937177|FG004|Washout Period 1|COPD Exacerbation|1|||
127539057|NCT03137992|458937178|FG005|Washout Period 1|COPD Exacerbation|1|||
127539058|NCT03137992|458937173|FG000|Washout Period 1|Subject Noncompliance|1|||
127539059|NCT03137992|458937174|FG001|Washout Period 1|Subject Noncompliance|0|||
127539060|NCT03137992|458937175|FG002|Washout Period 1|Subject Noncompliance|0|||
127539061|NCT03137992|458937176|FG003|Washout Period 1|Subject Noncompliance|0|||
127539062|NCT03137992|458937177|FG004|Washout Period 1|Subject Noncompliance|1|||
127539063|NCT03137992|458937178|FG005|Washout Period 1|Subject Noncompliance|0|||
127539064|NCT03137992|458937173|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
127539065|NCT03137992|458937174|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
127539066|NCT03137992|458937175|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
127539067|NCT03137992|458937176|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
127539068|NCT03137992|458937177|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
127539069|NCT03137992|458937178|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
127539070|NCT03137992|458937173|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
127539071|NCT03137992|458937174|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
127539072|NCT03137992|458937175|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
127539073|NCT03137992|458937176|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
127539074|NCT03137992|458937177|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
127539075|NCT03137992|458937178|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
127539076|NCT03137992|458937173|FG000|Period 2 (Visit 3)|Adverse Event|0|||
127539077|NCT03137992|458937174|FG001|Period 2 (Visit 3)|Adverse Event|1|||
127539078|NCT03137992|458937175|FG002|Period 2 (Visit 3)|Adverse Event|0|||
127539079|NCT03137992|458937176|FG003|Period 2 (Visit 3)|Adverse Event|0|||
127539080|NCT03137992|458937177|FG004|Period 2 (Visit 3)|Adverse Event|0|||
127539081|NCT03137992|458937178|FG005|Period 2 (Visit 3)|Adverse Event|0|||
127539082|NCT03137992|458937173|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
127539083|NCT03137992|458937174|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
127539084|NCT03137992|458937175|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
127539085|NCT03137992|458937176|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
127539086|NCT03137992|458937177|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
127539087|NCT03137992|458937178|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
127539088|NCT03137992|458937173|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
127539089|NCT03137992|458937174|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
127539090|NCT03137992|458937175|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
127539091|NCT03137992|458937176|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
127539092|NCT03137992|458937177|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
127539093|NCT03137992|458937178|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
127539094|NCT03137992|458937173|FG000|Washout Period 2|COPD Exacerbation|1|||
127539095|NCT03137992|458937174|FG001|Washout Period 2|COPD Exacerbation|1|||
127539096|NCT03137992|458937175|FG002|Washout Period 2|COPD Exacerbation|0|||
127539097|NCT03137992|458937176|FG003|Washout Period 2|COPD Exacerbation|0|||
127539098|NCT03137992|458937177|FG004|Washout Period 2|COPD Exacerbation|1|||
127539099|NCT03137992|458937178|FG005|Washout Period 2|COPD Exacerbation|0|||
127539100|NCT03137992|458937173|FG000|Washout Period 2|Subject Non-compliance|0|||
127539101|NCT03137992|458937174|FG001|Washout Period 2|Subject Non-compliance|1|||
127539102|NCT03137992|458937175|FG002|Washout Period 2|Subject Non-compliance|0|||
127539103|NCT03137992|458937176|FG003|Washout Period 2|Subject Non-compliance|0|||
127539104|NCT03137992|458937177|FG004|Washout Period 2|Subject Non-compliance|0|||
127539105|NCT03137992|458937178|FG005|Washout Period 2|Subject Non-compliance|0|||
127539106|NCT03137992|458937173|FG000|Washout Period 2|Adverse Event|0|||
127539107|NCT03137992|458937174|FG001|Washout Period 2|Adverse Event|0|||
127539108|NCT03137992|458937175|FG002|Washout Period 2|Adverse Event|0|||
127539109|NCT03137992|458937176|FG003|Washout Period 2|Adverse Event|1|||
127539110|NCT03137992|458937177|FG004|Washout Period 2|Adverse Event|1|||
127539111|NCT03137992|458937178|FG005|Washout Period 2|Adverse Event|0|||
127539112|NCT03137992|458937173|FG000|Washout Period 2|Withdrawal by Subject|1|||
127539113|NCT03137992|458937174|FG001|Washout Period 2|Withdrawal by Subject|0|||
127539114|NCT03137992|458937175|FG002|Washout Period 2|Withdrawal by Subject|0|||
127539115|NCT03137992|458937176|FG003|Washout Period 2|Withdrawal by Subject|0|||
127539116|NCT03137992|458937177|FG004|Washout Period 2|Withdrawal by Subject|1|||
127539117|NCT03137992|458937178|FG005|Washout Period 2|Withdrawal by Subject|0|||
127539118|NCT03137992|458937173|FG000|Washout Period 2|Sponsor Decision|0|||
127539119|NCT03137992|458937174|FG001|Washout Period 2|Sponsor Decision|0|||
127539120|NCT03137992|458937175|FG002|Washout Period 2|Sponsor Decision|0|||
127539121|NCT03137992|458937176|FG003|Washout Period 2|Sponsor Decision|0|||
127539122|NCT03137992|458937177|FG004|Washout Period 2|Sponsor Decision|0|||
127539123|NCT03137992|458937178|FG005|Washout Period 2|Sponsor Decision|1|||
127539124|NCT03137992|458937173|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
127539125|NCT03137992|458937174|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
127539126|NCT03137992|458937175|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
127539127|NCT03137992|458937176|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
127539128|NCT03137992|458937177|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
127539129|NCT03137992|458937178|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
127539130|NCT03137992|458937173|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
127539131|NCT03137992|458937174|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
127539132|NCT03137992|458937175|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
127539133|NCT03137992|458937176|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
127539134|NCT03137992|458937177|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
127539135|NCT03137992|458937178|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
127539136|NCT03137992|458937173|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
127539137|NCT03137992|458937174|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
127539138|NCT03137992|458937175|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
127539139|NCT03137992|458937176|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
127539140|NCT03137992|458937177|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
127539141|NCT03137992|458937178|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
127539142|NCT03137992|458937173|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
127539143|NCT03137992|458937174|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
127539144|NCT03137992|458937175|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
127539145|NCT03137992|458937176|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
127539146|NCT03137992|458937177|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
127539147|NCT03137992|458937178|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
127539148|NCT03137992|458937173|FG000|Part 2 (Open-label Extension)|Per study team|1|||
127539149|NCT03137992|458937174|FG001|Part 2 (Open-label Extension)|Per study team|0|||
127539150|NCT03137992|458937175|FG002|Part 2 (Open-label Extension)|Per study team|0|||
127539151|NCT03137992|458937176|FG003|Part 2 (Open-label Extension)|Per study team|0|||
127539152|NCT03137992|458937177|FG004|Part 2 (Open-label Extension)|Per study team|0|||
127539153|NCT03137992|458937178|FG005|Part 2 (Open-label Extension)|Per study team|0|||
127539154|NCT03137992|458937173|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
127539155|NCT03137992|458937174|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
127539156|NCT03137992|458937175|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
127539157|NCT03137992|458937176|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
127539158|NCT03137992|458937177|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
127539159|NCT03137992|458937178|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
127539160|NCT02370420|458937179|FG000|Overall Study|Physician Decision|3|||
127539161|NCT02370420|458937180|FG001|Overall Study|Physician Decision|3|||
127539162|NCT02370420|458937179|FG000|Overall Study|Lost to Follow-up|11|||
127539163|NCT02370420|458937180|FG001|Overall Study|Lost to Follow-up|9|||
127539164|NCT03077542|458937181|FG000|Overall Study|Death|4|||
127539165|NCT03077542|458937182|FG001|Overall Study|Death|0|||
127539166|NCT03077542|458937181|FG000|Overall Study|Physician Decision|6|||
127539167|NCT03077542|458937182|FG001|Overall Study|Physician Decision|1|||
127539168|NCT03077542|458937181|FG000|Overall Study|Withdrawal by Subject|0|||
127539169|NCT03077542|458937182|FG001|Overall Study|Withdrawal by Subject|1|||
127539170|NCT00795704|458937183|FG000|Overall Study|Withdrawal by Subject|3|||
127539171|NCT00795704|458937184|FG001|Overall Study|Withdrawal by Subject|2|||
127539172|NCT00795704|458937183|FG000|Overall Study|Adverse Event|1|||
127539173|NCT00795704|458937184|FG001|Overall Study|Adverse Event|1|||
127539174|NCT03980730|458937185|FG000|Overall Study|Study Terminated by Sponsor|0|||
127539175|NCT03980730|458937186|FG001|Overall Study|Study Terminated by Sponsor|3|||
127539176|NCT03980730|458937185|FG000|Overall Study|Adverse Event|2|||
127539177|NCT03980730|458937186|FG001|Overall Study|Adverse Event|0|||
127539178|NCT03980730|458937185|FG000|Overall Study|Sponsor Request|0|||
127539179|NCT03980730|458937186|FG001|Overall Study|Sponsor Request|1|||
127539180|NCT01300728|458937187|FG000|Overall Study|Withdrawal by Subject|1|||
127539181|NCT01300728|458937188|FG001|Overall Study|Withdrawal by Subject|1|||
127539182|NCT01300728|458937187|FG000|Overall Study|Physician Decision|1|||
127539183|NCT01300728|458937188|FG001|Overall Study|Physician Decision|0|||
127539184|NCT00880620|458937191|FG000|Overall Study|Adverse Event|4|||
127539185|NCT00880620|458937192|FG001|Overall Study|Adverse Event|5|||
127539186|NCT00880620|458937193|FG002|Overall Study|Adverse Event|15|||
127539187|NCT00880620|458937194|FG003|Overall Study|Adverse Event|15|||
127539188|NCT00880620|458937191|FG000|Overall Study|Death|0|||
127539189|NCT00880620|458937192|FG001|Overall Study|Death|0|||
127539190|NCT00880620|458937193|FG002|Overall Study|Death|1|||
127539191|NCT00880620|458937194|FG003|Overall Study|Death|0|||
127539192|NCT00880620|458937191|FG000|Overall Study|Lack of Efficacy|12|||
127539193|NCT00880620|458937192|FG001|Overall Study|Lack of Efficacy|4|||
127539194|NCT00880620|458937193|FG002|Overall Study|Lack of Efficacy|0|||
127539195|NCT00880620|458937194|FG003|Overall Study|Lack of Efficacy|1|||
127539196|NCT00880620|458937191|FG000|Overall Study|Lost to Follow-up|0|||
127539197|NCT00880620|458937192|FG001|Overall Study|Lost to Follow-up|1|||
127539198|NCT00880620|458937193|FG002|Overall Study|Lost to Follow-up|1|||
127539199|NCT00880620|458937194|FG003|Overall Study|Lost to Follow-up|0|||
127539200|NCT00880620|458937191|FG000|Overall Study|Protocol Violation|0|||
127539201|NCT00880620|458937192|FG001|Overall Study|Protocol Violation|1|||
127539202|NCT00880620|458937193|FG002|Overall Study|Protocol Violation|0|||
127539203|NCT00880620|458937194|FG003|Overall Study|Protocol Violation|2|||
127539204|NCT00880620|458937191|FG000|Overall Study|Withdrawal by Subject|4|||
127539205|NCT00880620|458937192|FG001|Overall Study|Withdrawal by Subject|3|||
127539206|NCT00880620|458937193|FG002|Overall Study|Withdrawal by Subject|1|||
127539207|NCT00880620|458937194|FG003|Overall Study|Withdrawal by Subject|3|||
127539208|NCT00880620|458937191|FG000|Overall Study|Noncompliance|0|||
127539209|NCT00880620|458937192|FG001|Overall Study|Noncompliance|0|||
127539210|NCT00880620|458937193|FG002|Overall Study|Noncompliance|1|||
127539211|NCT00880620|458937194|FG003|Overall Study|Noncompliance|1|||
127539212|NCT00880620|458937191|FG000|Overall Study|Other|1|||
127539213|NCT00880620|458937192|FG001|Overall Study|Other|1|||
127539214|NCT00880620|458937193|FG002|Overall Study|Other|2|||
127539215|NCT00880620|458937194|FG003|Overall Study|Other|2|||
127539216|NCT00301808|458937196|FG000|Overall Study|Adverse Event|5|||
127539217|NCT00301808|458937196|FG000|Overall Study|Death|3|||
127539218|NCT00301808|458937196|FG000|Overall Study|Lack of Efficacy|4|||
127539219|NCT05893862|458937200|FG000|Overall Study|Physician Decision|0|||
127539220|NCT05893862|458937201|FG001|Overall Study|Physician Decision|1|||
127539221|NCT05893862|458937202|FG002|Overall Study|Physician Decision|0|||
127539222|NCT05893862|458937203|FG003|Overall Study|Physician Decision|0|||
127539223|NCT05893862|458937204|FG004|Overall Study|Physician Decision|1|||
127539224|NCT05893862|458937205|FG005|Overall Study|Physician Decision|0|||
127539225|NCT05893862|458937200|FG000|Overall Study|Withdrawal by Subject|1|||
127539226|NCT05893862|458937201|FG001|Overall Study|Withdrawal by Subject|7|||
127539227|NCT05893862|458937202|FG002|Overall Study|Withdrawal by Subject|1|||
127539228|NCT05893862|458937203|FG003|Overall Study|Withdrawal by Subject|3|||
127539229|NCT05893862|458937204|FG004|Overall Study|Withdrawal by Subject|3|||
127539230|NCT05893862|458937205|FG005|Overall Study|Withdrawal by Subject|2|||
127539231|NCT05893862|458937200|FG000|Overall Study|Adverse Event|1|||
127539232|NCT05893862|458937201|FG001|Overall Study|Adverse Event|4|||
127539233|NCT05893862|458937202|FG002|Overall Study|Adverse Event|2|||
127539234|NCT05893862|458937203|FG003|Overall Study|Adverse Event|2|||
127539235|NCT05893862|458937204|FG004|Overall Study|Adverse Event|1|||
127539236|NCT05893862|458937205|FG005|Overall Study|Adverse Event|0|||
127539237|NCT02429830|458937206|FG000|Overall Study|Lost to Follow-up|1|||
127539238|NCT02429830|458937206|FG000|Overall Study|Device Explant|2|||
127539239|NCT02426580|458938741|FG000|Overall Study|Death|2|||
127539240|NCT02426580|458938742|FG001|Overall Study|Death|2|||
127539241|NCT02426580|458938741|FG000|Overall Study|Lost to Follow-up|0|||
127539242|NCT02426580|458938742|FG001|Overall Study|Lost to Follow-up|9|||
127539243|NCT02426580|458938741|FG000|Overall Study|transfer to hemodialysis|5|||
127539244|NCT02426580|458938742|FG001|Overall Study|transfer to hemodialysis|5|||
127539245|NCT02426580|458938741|FG000|Overall Study|Kidney transplant|3|||
127539246|NCT02426580|458938742|FG001|Overall Study|Kidney transplant|0|||
127539247|NCT02426580|458938741|FG000|Overall Study|Allergic to egg white|1|||
127539248|NCT02426580|458938742|FG001|Overall Study|Allergic to egg white|0|||
127539249|NCT05482308|458938754|FG000|Overall Study|Withdrawal by Subject|1|||
127539250|NCT05482308|458938755|FG001|Overall Study|Withdrawal by Subject|0|||
127539251|NCT05482308|458938754|FG000|Overall Study|No longer meets eligibility criteria|0|||
127539252|NCT05482308|458938755|FG001|Overall Study|No longer meets eligibility criteria|1|||
127539253|NCT00416624|458938761|FG000|Overall Study|Withdrawal by Subject|1|||
127539254|NCT00416624|458938762|FG001|Overall Study|Withdrawal by Subject|6|||
127539255|NCT00416624|458938763|FG002|Overall Study|Withdrawal by Subject|4|||
127539256|NCT00416624|458938764|FG003|Overall Study|Withdrawal by Subject|9|||
127539257|NCT00416624|458938761|FG000|Overall Study|Death|4|||
127539258|NCT00416624|458938762|FG001|Overall Study|Death|7|||
127539259|NCT00416624|458938763|FG002|Overall Study|Death|7|||
127539260|NCT00416624|458938764|FG003|Overall Study|Death|1|||
127539261|NCT00416624|458938761|FG000|Overall Study|Adverse Event|8|||
127539262|NCT00416624|458938762|FG001|Overall Study|Adverse Event|3|||
127539263|NCT00416624|458938763|FG002|Overall Study|Adverse Event|2|||
127539264|NCT00416624|458938764|FG003|Overall Study|Adverse Event|2|||
127539265|NCT00416624|458938761|FG000|Overall Study|Other|8|||
127539266|NCT00416624|458938762|FG001|Overall Study|Other|11|||
127539267|NCT00416624|458938763|FG002|Overall Study|Other|5|||
127539268|NCT00416624|458938764|FG003|Overall Study|Other|5|||
127539269|NCT00416624|458938761|FG000|Overall Study|Cancel|1|||
127539270|NCT00416624|458938762|FG001|Overall Study|Cancel|0|||
127539271|NCT00416624|458938763|FG002|Overall Study|Cancel|0|||
127539272|NCT00416624|458938764|FG003|Overall Study|Cancel|0|||
127539273|NCT00768989|458938767|FG000|Prior to Week 24|Withdrawal by Subject|1|||
127539274|NCT00768989|458938768|FG001|Prior to Week 24|Withdrawal by Subject|0|||
127539275|NCT00768989|458938767|FG000|Prior to Week 24|Adverse Event|3|||
127539276|NCT00768989|458938768|FG001|Prior to Week 24|Adverse Event|0|||
127539277|NCT00768989|458938767|FG000|Prior to Week 24|Lost to Follow-up|0|||
127539278|NCT00768989|458938768|FG001|Prior to Week 24|Lost to Follow-up|1|||
127539279|NCT00768989|458938767|FG000|Prior to Week 24|Protocol Violation|0|||
127539280|NCT00768989|458938768|FG001|Prior to Week 24|Protocol Violation|2|||
127539281|NCT00768989|458938767|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
127539282|NCT00768989|458938768|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
127539283|NCT00768989|458938767|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
127539284|NCT00768989|458938768|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
127539285|NCT00768989|458938767|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
127539286|NCT00768989|458938768|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
127539287|NCT00768989|458938767|FG000|On or After Week 36|Lack of Efficacy|1|||
127539288|NCT00768989|458938768|FG001|On or After Week 36|Lack of Efficacy|0|||
127539289|NCT00768989|458938767|FG000|On or After Week 36|Adverse Event|0|||
127539290|NCT00768989|458938768|FG001|On or After Week 36|Adverse Event|1|||
127539291|NCT00768989|458938767|FG000|On or After Week 36|Lost to Follow-up|1|||
127539292|NCT00768989|458938768|FG001|On or After Week 36|Lost to Follow-up|0|||
127539293|NCT00768989|458938767|FG000|On or After Week 36|Poor Compliance|1|||
127539294|NCT00768989|458938768|FG001|On or After Week 36|Poor Compliance|0|||
127539295|NCT00768989|458938767|FG000|On or After Week 36|Protocol Violation|1|||
127539296|NCT00768989|458938768|FG001|On or After Week 36|Protocol Violation|0|||
127539297|NCT00768989|458938767|FG000|On or After Week 36|Did not attend termination visit|2|||
127539298|NCT00768989|458938768|FG001|On or After Week 36|Did not attend termination visit|0|||
127539299|NCT00768989|458938767|FG000|On or After Week 36|Sponsor Termination|45|||
127539300|NCT00768989|458938768|FG001|On or After Week 36|Sponsor Termination|26|||
127539301|NCT03585660|458938769|FG000|Overall Study|operator error|1|||
127539302|NCT03585660|458938769|FG000|Overall Study|technical error|2|||
127539303|NCT03585660|458938769|FG000|Overall Study|hip prosthesis|2|||
127539304|NCT03585660|458938769|FG000|Overall Study|did not undergo biopsy|8|||
127539305|NCT03585660|458938769|FG000|Overall Study|scanner problem|2|||
127539306|NCT00435409|458938770|FG000|Overall Study|Protocol Violation|1|||
127539307|NCT00435409|458938771|FG001|Overall Study|Protocol Violation|2|||
127539308|NCT00435409|458938772|FG002|Overall Study|Protocol Violation|0|||
127539309|NCT00435409|458938770|FG000|Overall Study|Lost to Follow-up|1|||
127539310|NCT00435409|458938771|FG001|Overall Study|Lost to Follow-up|2|||
127539311|NCT00435409|458938772|FG002|Overall Study|Lost to Follow-up|0|||
127539312|NCT00435409|458938770|FG000|Overall Study|Death|8|||
127539313|NCT00435409|458938771|FG001|Overall Study|Death|6|||
127539314|NCT00435409|458938772|FG002|Overall Study|Death|6|||
127539315|NCT00435409|458938770|FG000|Overall Study|Objective progression or relapse|158|||
127539316|NCT00435409|458938771|FG001|Overall Study|Objective progression or relapse|93|||
127539317|NCT00435409|458938772|FG002|Overall Study|Objective progression or relapse|58|||
127539318|NCT00435409|458938770|FG000|Overall Study|Global deterioration of health status|0|||
127539319|NCT00435409|458938771|FG001|Overall Study|Global deterioration of health status|0|||
127539320|NCT00435409|458938772|FG002|Overall Study|Global deterioration of health status|4|||
127539321|NCT00435409|458938770|FG000|Overall Study|Withdrawal by Subject|8|||
127539322|NCT00435409|458938771|FG001|Overall Study|Withdrawal by Subject|7|||
127539323|NCT00435409|458938772|FG002|Overall Study|Withdrawal by Subject|1|||
127539324|NCT00435409|458938770|FG000|Overall Study|Other|45|||
127539325|NCT00435409|458938771|FG001|Overall Study|Other|30|||
127539326|NCT00435409|458938772|FG002|Overall Study|Other|1|||
127539327|NCT00435409|458938770|FG000|Overall Study|Adverse Event|0|||
127539328|NCT00435409|458938771|FG001|Overall Study|Adverse Event|0|||
127539329|NCT00435409|458938772|FG002|Overall Study|Adverse Event|8|||
127539330|NCT00435409|458938770|FG000|Overall Study|Sponsor decision|0|||
127539331|NCT00435409|458938771|FG001|Overall Study|Sponsor decision|3|||
127539332|NCT00435409|458938772|FG002|Overall Study|Sponsor decision|0|||
127539333|NCT05635461|458938775|FG000|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
127539334|NCT05635461|458938776|FG001|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
127539335|NCT05635461|458938777|FG002|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
127539336|NCT05635461|458938778|FG003|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
127539337|NCT05635461|458938779|FG004|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|1|||
127539338|NCT05635461|458938780|FG005|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
127539339|NCT05635461|458938775|FG000|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
127539340|NCT05635461|458938776|FG001|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|1|||
127539341|NCT05635461|458938777|FG002|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
127539342|NCT05635461|458938778|FG003|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
127539343|NCT05635461|458938779|FG004|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
127539344|NCT05635461|458938780|FG005|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
127539345|NCT05635461|458938775|FG000|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
127539346|NCT05635461|458938776|FG001|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
127539347|NCT05635461|458938777|FG002|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
127539348|NCT05635461|458938778|FG003|Period 3: Dosing 3 (Day 1)|Adverse Event|1|||
127539349|NCT05635461|458938779|FG004|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
127539350|NCT05635461|458938780|FG005|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
127539351|NCT03760029|458938783|FG000|Overall Study|Death|1|||
127539352|NCT03760029|458938784|FG001|Overall Study|Death|0|||
127539353|NCT03760029|458938785|FG002|Overall Study|Death|0|||
127539354|NCT03760029|458938783|FG000|Overall Study|Lost to Follow-up|0|||
127539355|NCT03760029|458938784|FG001|Overall Study|Lost to Follow-up|2|||
127539356|NCT03760029|458938785|FG002|Overall Study|Lost to Follow-up|1|||
127539357|NCT03760029|458938783|FG000|Overall Study|Withdrawal by Subject|1|||
127539358|NCT03760029|458938784|FG001|Overall Study|Withdrawal by Subject|4|||
127539359|NCT03760029|458938785|FG002|Overall Study|Withdrawal by Subject|1|||
127539360|NCT03760029|458938783|FG000|Overall Study|Withdrawal by parent/guardian|4|||
127539361|NCT03760029|458938784|FG001|Overall Study|Withdrawal by parent/guardian|4|||
127539362|NCT03760029|458938785|FG002|Overall Study|Withdrawal by parent/guardian|1|||
127539363|NCT03760029|458938783|FG000|Overall Study|Other|2|||
127539364|NCT03760029|458938784|FG001|Overall Study|Other|1|||
127539365|NCT03760029|458938785|FG002|Overall Study|Other|0|||
127539366|NCT04890652|458938789|FG000|Overall Study|Withdrawal by Subject|2|||
127539367|NCT02269124|458938792|FG000|Overall Study|Lost to Follow-up|1|||
127539368|NCT02269124|458938793|FG001|Overall Study|Lost to Follow-up|0|||
127539369|NCT02269124|458938792|FG000|Overall Study|Withdrawal by Subject|0|||
127539370|NCT02269124|458938793|FG001|Overall Study|Withdrawal by Subject|2|||
127539371|NCT01045460|458938796|FG000|Overall Study|Physician Decision|3|||
127539372|NCT01045460|458938797|FG001|Overall Study|Physician Decision|2|||
127539373|NCT01045460|458938796|FG000|Overall Study|Lost to Follow-up|0|||
127539374|NCT01045460|458938797|FG001|Overall Study|Lost to Follow-up|1|||
127539375|NCT01045460|458938796|FG000|Overall Study|Lack of Efficacy|3|||
127539376|NCT01045460|458938797|FG001|Overall Study|Lack of Efficacy|0|||
127539377|NCT01600885|458938798|FG000|First Period|Adverse Event|1|||
127539378|NCT01600885|458938799|FG001|First Period|Adverse Event|1|||
127539379|NCT01600885|458938798|FG000|First Period|moved out of area|1|||
127539380|NCT01600885|458938799|FG001|First Period|moved out of area|0|||
127539381|NCT00436332|458938800|FG000|Overall Study|Adverse Event|9|||
127539382|NCT00436332|458938800|FG000|Overall Study|Withdrawal by Subject|2|||
127539383|NCT00436332|458938800|FG000|Overall Study|Progression|59|||
127539384|NCT00436332|458938800|FG000|Overall Study|Death|2|||
127539385|NCT00436332|458938800|FG000|Overall Study|Not Protocol Specified|6|||
127539386|NCT00436332|458938800|FG000|Overall Study|Ineligible|2|||
127539387|NCT00436332|458938800|FG000|Overall Study|Never Received Treatment|3|||
127539388|NCT00005906|458938809|FG000|Overall Study|Lack of Efficacy|3|||
127539389|NCT00667888|458938810|FG000|Overall Study|Death|1|||
127539390|NCT00667888|458938811|FG001|Overall Study|Death|1|||
127539391|NCT00667888|458938810|FG000|Overall Study|Withdrawal by Subject|6|||
127539392|NCT00667888|458938811|FG001|Overall Study|Withdrawal by Subject|3|||
127539393|NCT00667888|458938810|FG000|Overall Study|Proceed with other treatment|3|||
127539394|NCT00667888|458938811|FG001|Overall Study|Proceed with other treatment|3|||
127539395|NCT00667888|458938810|FG000|Overall Study|Ineligible after SIM|0|||
127539396|NCT00667888|458938811|FG001|Overall Study|Ineligible after SIM|2|||
127539397|NCT02140047|458938812|FG000|Overall Study|Withdrawal by parent/guardian|1|||
127539398|NCT02140047|458938813|FG001|Overall Study|Withdrawal by parent/guardian|1|||
127539399|NCT02140047|458938814|FG002|Overall Study|Withdrawal by parent/guardian|0|||
127539400|NCT00883779|458938815|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
127539401|NCT00883779|458938816|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
127539402|NCT00883779|458938815|FG000|Primary Study Treatment Phase|Disease progression|75|||
127539403|NCT00883779|458938816|FG001|Primary Study Treatment Phase|Disease progression|59|||
127539404|NCT00883779|458938815|FG000|Primary Study Treatment Phase|Adverse Event|16|||
127539405|NCT00883779|458938816|FG001|Primary Study Treatment Phase|Adverse Event|16|||
127539406|NCT00883779|458938815|FG000|Primary Study Treatment Phase|Death|2|||
127539407|NCT00883779|458938816|FG001|Primary Study Treatment Phase|Death|3|||
127539408|NCT00883779|458938815|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
127539409|NCT00883779|458938816|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
127539410|NCT00883779|458938815|FG000|Primary Study Treatment Phase|Other|3|||
127539411|NCT00883779|458938816|FG001|Primary Study Treatment Phase|Other|0|||
127539412|NCT00883779|458938815|FG000|Post-Study Treatment Phase|Adverse Event|2|||
127539413|NCT00883779|458938816|FG001|Post-Study Treatment Phase|Adverse Event|3|||
127539414|NCT00883779|458938815|FG000|Post-Study Treatment Phase|Death|1|||
127539415|NCT00883779|458938816|FG001|Post-Study Treatment Phase|Death|3|||
127539416|NCT00883779|458938815|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
127539417|NCT00883779|458938816|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
127539418|NCT00883779|458938815|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
127539419|NCT00883779|458938816|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
127539420|NCT00883779|458938815|FG000|Post-Study Treatment Phase|Disease progression|103|||
127539421|NCT00883779|458938816|FG001|Post-Study Treatment Phase|Disease progression|122|||
127539422|NCT00883779|458938815|FG000|Post-Study Treatment Phase|Other|3|||
127539423|NCT00883779|458938816|FG001|Post-Study Treatment Phase|Other|0|||
127539424|NCT00883779|458938815|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
127539425|NCT00883779|458938816|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
127539426|NCT00883779|458938815|FG000|Off-study Phase|Death|185|||
127539427|NCT00883779|458938816|FG001|Off-study Phase|Death|174|||
127539428|NCT00883779|458938815|FG000|Off-study Phase|Refused treatment|1|||
127539429|NCT00883779|458938816|FG001|Off-study Phase|Refused treatment|1|||
127539430|NCT00883779|458938815|FG000|Off-study Phase|Failure to return|5|||
127539431|NCT00883779|458938816|FG001|Off-study Phase|Failure to return|6|||
127539432|NCT00883779|458938815|FG000|Off-study Phase|Other|18|||
127539433|NCT00883779|458938816|FG001|Off-study Phase|Other|21|||
127539434|NCT00499681|458938817|FG000|Overall Study|toxicity|0|||
127539435|NCT00499681|458938818|FG001|Overall Study|toxicity|1|||
127539436|NCT00499681|458938817|FG000|Overall Study|disease progression|0|||
127539437|NCT00499681|458938818|FG001|Overall Study|disease progression|1|||
127760697|NCT00293059|459748930|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
127539438|NCT00659061|458938819|FG000|Overall Study|Migration due to political unrest|21|||
127983524|NCT01080391|460562512|FG001|Overall Study|Randomized but not treated|4|||
127983525|NCT00672841|460562513|FG000|Overall Study|Comfort care|1|||
127983526|NCT00672841|460562514|FG001|Overall Study|Comfort care|4|||
127983527|NCT00672841|460562513|FG000|Overall Study|icteric specimens|0|||
127983528|NCT00672841|460562514|FG001|Overall Study|icteric specimens|3|||
127983529|NCT00672841|460562513|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
127983530|NCT00672841|460562514|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
127983531|NCT00672841|460562513|FG000|Overall Study|Adverse Event|0|||
127983532|NCT00672841|460562514|FG001|Overall Study|Adverse Event|3|||
127983533|NCT00672841|460562513|FG000|Overall Study|Pregnancy|0|||
127983534|NCT00672841|460562514|FG001|Overall Study|Pregnancy|1|||
127983535|NCT03578146|460562515|FG000|Overall Study|Did Not Receive Treatment|1|||
127983536|NCT03578146|460562516|FG001|Overall Study|Did Not Receive Treatment|0|||
127983537|NCT03578146|460562517|FG002|Overall Study|Did Not Receive Treatment|0|||
127983538|NCT03578146|460562518|FG003|Overall Study|Did Not Receive Treatment|0|||
127983539|NCT03578146|460562519|FG004|Overall Study|Did Not Receive Treatment|0|||
127983540|NCT03578146|460562520|FG005|Overall Study|Did Not Receive Treatment|2|||
127983541|NCT03578146|460562515|FG000|Overall Study|Lost to Follow-up|0|||
127983542|NCT03578146|460562516|FG001|Overall Study|Lost to Follow-up|1|||
127983543|NCT03578146|460562517|FG002|Overall Study|Lost to Follow-up|1|||
127983544|NCT03578146|460562518|FG003|Overall Study|Lost to Follow-up|0|||
127983545|NCT03578146|460562519|FG004|Overall Study|Lost to Follow-up|0|||
127983546|NCT03578146|460562520|FG005|Overall Study|Lost to Follow-up|1|||
127983547|NCT01717391|460562521|FG000|Overall Study|Withdrawal by Subject|5|||
127983548|NCT01717391|460562521|FG000|Overall Study|Physician Decision|1|||
127983549|NCT01717391|460562521|FG000|Overall Study|FLT technical failure|3|||
127983550|NCT03677934|460562522|FG000|Overall Study|Adverse Event|1|||
127983551|NCT03677934|460562523|FG001|Overall Study|Adverse Event|1|||
127983552|NCT03677934|460562522|FG000|Overall Study|Death|8|||
127983553|NCT03677934|460562523|FG001|Overall Study|Death|4|||
127983554|NCT03677934|460562522|FG000|Overall Study|Lost to Follow-up|3|||
127983555|NCT03677934|460562523|FG001|Overall Study|Lost to Follow-up|0|||
127983556|NCT03677934|460562522|FG000|Overall Study|Non-Compliance With Study Drug|1|||
127983557|NCT03677934|460562523|FG001|Overall Study|Non-Compliance With Study Drug|0|||
127983558|NCT03677934|460562522|FG000|Overall Study|Physician Decision|0|||
127983559|NCT03677934|460562523|FG001|Overall Study|Physician Decision|1|||
127983560|NCT03677934|460562522|FG000|Overall Study|Withdrawal by Subject|1|||
127983561|NCT03677934|460562523|FG001|Overall Study|Withdrawal by Subject|7|||
127983562|NCT01260584|460562524|FG000|Period 1|Protocol Violation|0|||
127983563|NCT01260584|460562525|FG001|Period 1|Protocol Violation|0|||
127983564|NCT01260584|460562526|FG002|Period 1|Protocol Violation|1|||
127983565|NCT01260584|460562527|FG003|Period 1|Protocol Violation|1|||
127983566|NCT01260584|460562524|FG000|Period 1|Adverse Event|0|||
127983567|NCT01260584|460562525|FG001|Period 1|Adverse Event|0|||
127983568|NCT01260584|460562526|FG002|Period 1|Adverse Event|1|||
127983569|NCT01260584|460562527|FG003|Period 1|Adverse Event|0|||
127983570|NCT01260584|460562524|FG000|Period 2|Protocol Violation|0|||
127983571|NCT01260584|460562525|FG001|Period 2|Protocol Violation|2|||
127983572|NCT01260584|460562526|FG002|Period 2|Protocol Violation|3|||
127983573|NCT01260584|460562527|FG003|Period 2|Protocol Violation|1|||
127983574|NCT01260584|460562524|FG000|Period 2|Adverse Event|1|||
127983575|NCT01260584|460562525|FG001|Period 2|Adverse Event|0|||
127983576|NCT01260584|460562526|FG002|Period 2|Adverse Event|2|||
127983577|NCT01260584|460562527|FG003|Period 2|Adverse Event|0|||
127983578|NCT01260584|460562524|FG000|Period 2|Withdrawal by Subject|0|||
127983579|NCT01260584|460562525|FG001|Period 2|Withdrawal by Subject|1|||
127983580|NCT01260584|460562526|FG002|Period 2|Withdrawal by Subject|0|||
127983581|NCT01260584|460562527|FG003|Period 2|Withdrawal by Subject|0|||
127983582|NCT03434249|460562530|FG000|Overall Study|Adverse Event|1|||
127983583|NCT03434249|460562531|FG001|Overall Study|Adverse Event|0|||
127983584|NCT03434249|460562530|FG000|Overall Study|Lost to Follow-up|0|||
127983585|NCT03434249|460562531|FG001|Overall Study|Lost to Follow-up|1|||
127983586|NCT03434249|460562530|FG000|Overall Study|Non-compliance of family|2|||
127983587|NCT03434249|460562531|FG001|Overall Study|Non-compliance of family|1|||
127983588|NCT03434249|460562530|FG000|Overall Study|Difficulties in completing daily diary|2|||
127983589|NCT03434249|460562531|FG001|Overall Study|Difficulties in completing daily diary|1|||
127983590|NCT00561470|460562532|FG000|Overall Study|Adverse Event|74|||
127983591|NCT00561470|460562533|FG001|Overall Study|Adverse Event|163|||
127983592|NCT00561470|460562532|FG000|Overall Study|Disease progression|437|||
127983593|NCT00561470|460562533|FG001|Overall Study|Disease progression|305|||
127983594|NCT00561470|460562532|FG000|Overall Study|poor compliance to protocol|4|||
127983595|NCT00561470|460562533|FG001|Overall Study|poor compliance to protocol|4|||
127983596|NCT00561470|460562532|FG000|Overall Study|Lost to Follow-up|2|||
127983597|NCT00561470|460562533|FG001|Overall Study|Lost to Follow-up|0|||
127983598|NCT00561470|460562532|FG000|Overall Study|Physician Decision|21|||
127983599|NCT00561470|460562533|FG001|Overall Study|Physician Decision|20|||
127983600|NCT00561470|460562532|FG000|Overall Study|Consent Withdrawn|2|||
127983601|NCT00561470|460562533|FG001|Overall Study|Consent Withdrawn|6|||
127983602|NCT00561470|460562532|FG000|Overall Study|Subject request|43|||
127983603|NCT00561470|460562533|FG001|Overall Study|Subject request|77|||
127539439|NCT00659061|458938820|FG001|Overall Study|Migration due to political unrest|15|||
127539440|NCT00079040|458938821|FG000|Overall Study|Withdrew before treatment|1|||
127539441|NCT00079040|458938821|FG000|Overall Study|Ineligible|1|||
127539442|NCT01277744|458938822|FG000|Overall Study|Physician Decision|2|||
127539443|NCT00325897|458938823|FG000|Overall Study|Lost to Follow-up|12|||
127539444|NCT00325897|458938824|FG001|Overall Study|Lost to Follow-up|13|||
127539445|NCT03915717|458938825|FG000|Overall Study|EchoMark Not Implanted|6|||
127539446|NCT03748823|458938827|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
127539447|NCT03748823|458938828|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
127539448|NCT03748823|458938827|FG000|Randomized Treatment Period|Site Source Document Deviations|1|||
127539449|NCT03748823|458938828|FG001|Randomized Treatment Period|Site Source Document Deviations|6|||
127539450|NCT03748823|458938827|FG000|Extension Period|Withdrawal by Subject|9|||
127539451|NCT03748823|458938828|FG001|Extension Period|Withdrawal by Subject|12|||
127539452|NCT03748823|458938827|FG000|Extension Period|Death|2|||
127539453|NCT03748823|458938828|FG001|Extension Period|Death|2|||
127539454|NCT03748823|458938827|FG000|Extension Period|Other than Specified|0|||
127539455|NCT03748823|458938828|FG001|Extension Period|Other than Specified|1|||
127539456|NCT03748823|458938827|FG000|Extension Period|Protocol Violation|1|||
127539457|NCT03748823|458938828|FG001|Extension Period|Protocol Violation|0|||
127539458|NCT03748823|458938827|FG000|Extension Period|Lost to Follow-up|0|||
127539459|NCT03748823|458938828|FG001|Extension Period|Lost to Follow-up|1|||
127539460|NCT03748823|458938827|FG000|Extension Period|Lack of Efficacy|0|||
127539461|NCT03748823|458938828|FG001|Extension Period|Lack of Efficacy|1|||
127539462|NCT03748823|458938827|FG000|Extension Period|Physician Decision|1|||
127539463|NCT03748823|458938828|FG001|Extension Period|Physician Decision|2|||
127539464|NCT01011673|458938832|FG000|Randomized|Secondary headache|2|||
127539465|NCT01011673|458938833|FG001|Randomized|Secondary headache|1|||
127539466|NCT01011673|458938832|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
127539467|NCT01011673|458938833|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
127539468|NCT00626275|458938834|FG000|Part A - Treatment Period 1|Adverse Event|1|||
127539469|NCT00626275|458938835|FG001|Part A - Treatment Period 1|Adverse Event|0|||
127539470|NCT00626275|458938836|FG002|Part A - Treatment Period 1|Adverse Event|0|||
127539471|NCT00626275|458938837|FG003|Part A - Treatment Period 1|Adverse Event|0|||
127539472|NCT00626275|458938838|FG004|Part A - Treatment Period 1|Adverse Event|0|||
127539473|NCT00626275|458938839|FG005|Part A - Treatment Period 1|Adverse Event|0|||
127539474|NCT00626275|458938840|FG006|Part A - Treatment Period 1|Adverse Event|0|||
127539475|NCT00626275|458938841|FG007|Part A - Treatment Period 1|Adverse Event|0|||
127539476|NCT00626275|458938834|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
127539477|NCT00626275|458938835|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
127539478|NCT00626275|458938836|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
127539479|NCT00626275|458938837|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
127539480|NCT00626275|458938838|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
127539481|NCT00626275|458938839|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
127539482|NCT00626275|458938840|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
127539483|NCT00626275|458938841|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
127539484|NCT00626275|458938834|FG000|Part B|Lost to Follow-up|0|||
127539485|NCT00626275|458938835|FG001|Part B|Lost to Follow-up|0|||
127539486|NCT00626275|458938836|FG002|Part B|Lost to Follow-up|0|||
127539487|NCT00626275|458938837|FG003|Part B|Lost to Follow-up|0|||
127539488|NCT00626275|458938838|FG004|Part B|Lost to Follow-up|0|||
127539489|NCT00626275|458938839|FG005|Part B|Lost to Follow-up|0|||
127539490|NCT00626275|458938840|FG006|Part B|Lost to Follow-up|1|||
127539491|NCT00626275|458938841|FG007|Part B|Lost to Follow-up|0|||
127539492|NCT00626275|458938834|FG000|Part B|Withdrawal by Subject|0|||
127539493|NCT00626275|458938835|FG001|Part B|Withdrawal by Subject|0|||
127539494|NCT00626275|458938836|FG002|Part B|Withdrawal by Subject|0|||
127539495|NCT00626275|458938837|FG003|Part B|Withdrawal by Subject|0|||
127539496|NCT00626275|458938838|FG004|Part B|Withdrawal by Subject|0|||
127539497|NCT00626275|458938839|FG005|Part B|Withdrawal by Subject|0|||
127539498|NCT00626275|458938840|FG006|Part B|Withdrawal by Subject|0|||
127539499|NCT00626275|458938841|FG007|Part B|Withdrawal by Subject|1|||
127539500|NCT03740048|458938843|FG000|Overall Study|Withdrawal by Subject|1|||
127539501|NCT03740048|458938844|FG001|Overall Study|Withdrawal by Subject|1|||
127539502|NCT03740048|458938843|FG000|Overall Study|Death|1|||
127539503|NCT03740048|458938844|FG001|Overall Study|Death|6|||
127539504|NCT03740048|458938843|FG000|Overall Study|Switched to thrice-weekly HD|2|||
127539505|NCT03740048|458938844|FG001|Overall Study|Switched to thrice-weekly HD|0|||
127539506|NCT03740048|458938843|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
127539507|NCT03740048|458938844|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
127539508|NCT03740048|458938843|FG000|Overall Study|Lost to Follow-up|0|||
127539509|NCT03740048|458938844|FG001|Overall Study|Lost to Follow-up|1|||
127649157|NCT01648348|459336506|FG002|Overall Study|Cancel|0|||
127539510|NCT03740048|458938843|FG000|Overall Study|Non-compliance with HD|0|||
127539511|NCT03740048|458938844|FG001|Overall Study|Non-compliance with HD|1|||
127649158|NCT01648348|459336507|FG003|Overall Study|Cancel|0|||
127539512|NCT00292942|458938845|FG000|Overall Study|Withdrawal by Subject|0|||
127539513|NCT00292942|458938846|FG001|Overall Study|Withdrawal by Subject|0|||
127539514|NCT00292942|458938847|FG002|Overall Study|Withdrawal by Subject|1|||
127539515|NCT00292942|458938848|FG003|Overall Study|Withdrawal by Subject|0|||
127539516|NCT00292942|458938845|FG000|Overall Study|Adverse Event|0|||
127539517|NCT00292942|458938846|FG001|Overall Study|Adverse Event|0|||
127539518|NCT00292942|458938847|FG002|Overall Study|Adverse Event|0|||
127539519|NCT00292942|458938848|FG003|Overall Study|Adverse Event|1|||
127539520|NCT00644358|458938849|FG000|Overall Study|Adverse Event|124|||
127539521|NCT00644358|458938849|FG000|Overall Study|Lost to Follow-up|105|||
127539522|NCT00644358|458938849|FG000|Overall Study|Consent Withdrawal|64|||
127539523|NCT00644358|458938849|FG000|Overall Study|Lack of Effectiveness|39|||
127539524|NCT00644358|458938849|FG000|Overall Study|Protocol Violation|5|||
127539525|NCT00644358|458938849|FG000|Overall Study|Noncompliance|14|||
127539526|NCT00644358|458938849|FG000|Overall Study|Other Unspecified|11|||
127539527|NCT00651924|458938850|FG000|Overall Study|Withdrawal by PI|0|||
127539528|NCT00651924|458938851|FG001|Overall Study|Withdrawal by PI|2|||
127539529|NCT00651924|458938850|FG000|Overall Study|Withdrawal by Subject|0|||
127539530|NCT00651924|458938851|FG001|Overall Study|Withdrawal by Subject|5|||
127539531|NCT00960063|458938852|FG000|Overall Study|Adverse Event|1|||
127539532|NCT00960063|458938853|FG001|Overall Study|Adverse Event|0|||
127539533|NCT00960063|458938854|FG002|Overall Study|Adverse Event|0|||
127539534|NCT00960063|458938852|FG000|Overall Study|Progression of Disease|0|||
127539535|NCT00960063|458938853|FG001|Overall Study|Progression of Disease|0|||
127539536|NCT00960063|458938854|FG002|Overall Study|Progression of Disease|3|||
127539537|NCT05083351|458938858|FG000|Overall Study|Adverse Event|3|||
127539538|NCT05083351|458938858|FG000|Overall Study|Did not meet data inclusion criteria|8|||
127539539|NCT05083351|458938858|FG000|Overall Study|Did not meet eligibility criteria|19|||
127539540|NCT05083351|458938858|FG000|Overall Study|Study Staff Decision|19|||
127539541|NCT01759420|458938860|FG000|Overall Study|Screen failure|5|||
127539542|NCT01759420|458938860|FG000|Overall Study|Inaccurate EKG machine readings|1|||
127539543|NCT01129622|458938863|FG000|Overall Study|Withdrawal by Subject|2|||
127539544|NCT00591006|458938864|FG000|Overall Study|Withdrawal by Subject|0|||
127539545|NCT00591006|458938865|FG001|Overall Study|Withdrawal by Subject|0|||
127539546|NCT00591006|458938866|FG002|Overall Study|Withdrawal by Subject|0|||
127539547|NCT00591006|458938867|FG003|Overall Study|Withdrawal by Subject|0|||
127539548|NCT00591006|458938868|FG004|Overall Study|Withdrawal by Subject|0|||
127539549|NCT00591006|458938869|FG005|Overall Study|Withdrawal by Subject|0|||
127539550|NCT00591006|458938870|FG006|Overall Study|Withdrawal by Subject|0|||
127539551|NCT00591006|458938871|FG007|Overall Study|Withdrawal by Subject|0|||
127539552|NCT00591006|458938872|FG008|Overall Study|Withdrawal by Subject|0|||
127539553|NCT00591006|458938873|FG009|Overall Study|Withdrawal by Subject|0|||
127539554|NCT00591006|458938874|FG010|Overall Study|Withdrawal by Subject|0|||
127539555|NCT00591006|458938875|FG011|Overall Study|Withdrawal by Subject|0|||
127539556|NCT00591006|458938876|FG012|Overall Study|Withdrawal by Subject|0|||
127539557|NCT00591006|458938877|FG013|Overall Study|Withdrawal by Subject|0|||
127539558|NCT00591006|458938878|FG014|Overall Study|Withdrawal by Subject|0|||
127539559|NCT00591006|458938879|FG015|Overall Study|Withdrawal by Subject|1|||
127539560|NCT00591006|458938880|FG016|Overall Study|Withdrawal by Subject|0|||
127539561|NCT00591006|458938881|FG017|Overall Study|Withdrawal by Subject|0|||
127539562|NCT00591006|458938882|FG018|Overall Study|Withdrawal by Subject|0|||
127539563|NCT00591006|458938883|FG019|Overall Study|Withdrawal by Subject|0|||
127760698|NCT00293059|459748931|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
127760699|NCT00293059|459748930|FG000|Overall Study|missing|3|||
127760700|NCT00293059|459748931|FG001|Overall Study|missing|5|||
127539564|NCT00591006|458938884|FG020|Overall Study|Withdrawal by Subject|0|||
127539565|NCT00591006|458938885|FG021|Overall Study|Withdrawal by Subject|0|||
127539566|NCT00591006|458938886|FG022|Overall Study|Withdrawal by Subject|0|||
127539567|NCT00591006|458938887|FG023|Overall Study|Withdrawal by Subject|1|||
127539568|NCT00591006|458938864|FG000|Overall Study|Adverse Event|0|||
127539569|NCT00591006|458938865|FG001|Overall Study|Adverse Event|0|||
127539570|NCT00591006|458938866|FG002|Overall Study|Adverse Event|0|||
127539571|NCT00591006|458938867|FG003|Overall Study|Adverse Event|0|||
127539572|NCT00591006|458938868|FG004|Overall Study|Adverse Event|0|||
127539573|NCT00591006|458938869|FG005|Overall Study|Adverse Event|0|||
127539574|NCT00591006|458938870|FG006|Overall Study|Adverse Event|0|||
127539575|NCT00591006|458938871|FG007|Overall Study|Adverse Event|0|||
127539576|NCT00591006|458938872|FG008|Overall Study|Adverse Event|0|||
127539577|NCT00591006|458938873|FG009|Overall Study|Adverse Event|0|||
127539578|NCT00591006|458938874|FG010|Overall Study|Adverse Event|0|||
127539579|NCT00591006|458938875|FG011|Overall Study|Adverse Event|0|||
127539580|NCT00591006|458938876|FG012|Overall Study|Adverse Event|0|||
127760701|NCT01468181|459748936|FG000|Overall Study|Adverse Event|8|||
127539581|NCT00591006|458938877|FG013|Overall Study|Adverse Event|0|||
127539582|NCT00591006|458938878|FG014|Overall Study|Adverse Event|0|||
127539583|NCT00591006|458938879|FG015|Overall Study|Adverse Event|0|||
127539584|NCT00591006|458938880|FG016|Overall Study|Adverse Event|0|||
127539585|NCT00591006|458938881|FG017|Overall Study|Adverse Event|0|||
127539586|NCT00591006|458938882|FG018|Overall Study|Adverse Event|0|||
127760702|NCT01468181|459748937|FG001|Overall Study|Adverse Event|1|||
127539587|NCT00591006|458938883|FG019|Overall Study|Adverse Event|0|||
127539588|NCT00591006|458938884|FG020|Overall Study|Adverse Event|0|||
127539589|NCT00591006|458938885|FG021|Overall Study|Adverse Event|0|||
127539590|NCT00591006|458938886|FG022|Overall Study|Adverse Event|1|||
127539591|NCT00591006|458938887|FG023|Overall Study|Adverse Event|0|||
127539592|NCT00689390|458938888|FG000|Overall Study|Adverse Event|19|||
127539593|NCT00689390|458938889|FG001|Overall Study|Adverse Event|0|||
127539594|NCT00689390|458938888|FG000|Overall Study|Lost to Follow-up|179|||
127539595|NCT00689390|458938889|FG001|Overall Study|Lost to Follow-up|7|||
127539596|NCT00689390|458938888|FG000|Overall Study|Withdrawal by Subject|117|||
127539597|NCT00689390|458938889|FG001|Overall Study|Withdrawal by Subject|3|||
127649159|NCT01648348|459336508|FG004|Overall Study|Cancel|3|||
127649160|NCT01648348|459336509|FG005|Overall Study|Cancel|6|||
127649161|NCT01648348|459336504|FG000|Overall Study|Replaced for MTD analysis|1|||
127649162|NCT01648348|459336505|FG001|Overall Study|Replaced for MTD analysis|0|||
127649163|NCT01648348|459336506|FG002|Overall Study|Replaced for MTD analysis|1|||
127649164|NCT01648348|459336507|FG003|Overall Study|Replaced for MTD analysis|0|||
127649165|NCT01648348|459336508|FG004|Overall Study|Replaced for MTD analysis|0|||
127649166|NCT01648348|459336509|FG005|Overall Study|Replaced for MTD analysis|0|||
127649167|NCT01951638|459336510|FG000|Treatment Period|Protocol Violation|0|||
127649168|NCT01951638|459336511|FG001|Treatment Period|Protocol Violation|0|||
127649169|NCT01951638|459336512|FG002|Treatment Period|Protocol Violation|0|||
127649170|NCT01951638|459336513|FG003|Treatment Period|Protocol Violation|2|||
127649171|NCT01951638|459336514|FG004|Treatment Period|Protocol Violation|0|||
127649172|NCT01951638|459336510|FG000|Treatment Period|Protocol-driven decision point|1|||
127649173|NCT01951638|459336511|FG001|Treatment Period|Protocol-driven decision point|3|||
127649174|NCT01951638|459336512|FG002|Treatment Period|Protocol-driven decision point|0|||
127649175|NCT01951638|459336513|FG003|Treatment Period|Protocol-driven decision point|0|||
127649176|NCT01951638|459336514|FG004|Treatment Period|Protocol-driven decision point|0|||
127649177|NCT01951638|459336510|FG000|Treatment Period|Logistical difficulties|0|||
127649178|NCT01951638|459336511|FG001|Treatment Period|Logistical difficulties|1|||
127649179|NCT01951638|459336512|FG002|Treatment Period|Logistical difficulties|1|||
127649180|NCT01951638|459336513|FG003|Treatment Period|Logistical difficulties|0|||
127649181|NCT01951638|459336514|FG004|Treatment Period|Logistical difficulties|0|||
127649182|NCT01951638|459336510|FG000|Treatment Period|Withdrawal by Subject|9|||
127649183|NCT01951638|459336511|FG001|Treatment Period|Withdrawal by Subject|6|||
127649184|NCT01951638|459336512|FG002|Treatment Period|Withdrawal by Subject|4|||
127649185|NCT01951638|459336513|FG003|Treatment Period|Withdrawal by Subject|5|||
127649186|NCT01951638|459336514|FG004|Treatment Period|Withdrawal by Subject|4|||
127649187|NCT01951638|459336510|FG000|Treatment Period|Death|0|||
127649188|NCT01951638|459336511|FG001|Treatment Period|Death|0|||
127649189|NCT01951638|459336512|FG002|Treatment Period|Death|0|||
127649190|NCT01951638|459336513|FG003|Treatment Period|Death|3|||
127649191|NCT01951638|459336514|FG004|Treatment Period|Death|1|||
127649192|NCT01951638|459336510|FG000|Treatment Period|Adverse Event|3|||
127649193|NCT01951638|459336511|FG001|Treatment Period|Adverse Event|4|||
127649194|NCT01951638|459336512|FG002|Treatment Period|Adverse Event|8|||
127649195|NCT01951638|459336513|FG003|Treatment Period|Adverse Event|6|||
127649196|NCT01951638|459336514|FG004|Treatment Period|Adverse Event|5|||
127649197|NCT01951638|459336510|FG000|Follow-up Period|Protocol Violation|0|||
127649198|NCT01951638|459336511|FG001|Follow-up Period|Protocol Violation|0|||
127649199|NCT01951638|459336512|FG002|Follow-up Period|Protocol Violation|0|||
127649200|NCT01951638|459336513|FG003|Follow-up Period|Protocol Violation|1|||
127649201|NCT01951638|459336514|FG004|Follow-up Period|Protocol Violation|0|||
127649202|NCT01951638|459336510|FG000|Follow-up Period|Logistical difficulties|0|||
127649203|NCT01951638|459336511|FG001|Follow-up Period|Logistical difficulties|2|||
127649204|NCT01951638|459336512|FG002|Follow-up Period|Logistical difficulties|0|||
127649205|NCT01951638|459336513|FG003|Follow-up Period|Logistical difficulties|0|||
127649206|NCT01951638|459336514|FG004|Follow-up Period|Logistical difficulties|1|||
127649207|NCT01951638|459336510|FG000|Follow-up Period|Withdrawal by Subject|1|||
127649208|NCT01951638|459336511|FG001|Follow-up Period|Withdrawal by Subject|5|||
127649209|NCT01951638|459336512|FG002|Follow-up Period|Withdrawal by Subject|2|||
127649210|NCT01951638|459336513|FG003|Follow-up Period|Withdrawal by Subject|1|||
127649211|NCT01951638|459336514|FG004|Follow-up Period|Withdrawal by Subject|2|||
127649212|NCT01951638|459336510|FG000|Follow-up Period|Lost to Follow-up|0|||
127649213|NCT01951638|459336511|FG001|Follow-up Period|Lost to Follow-up|1|||
127649214|NCT01951638|459336512|FG002|Follow-up Period|Lost to Follow-up|0|||
127649215|NCT01951638|459336513|FG003|Follow-up Period|Lost to Follow-up|1|||
127539598|NCT00689390|458938888|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
127649216|NCT01951638|459336514|FG004|Follow-up Period|Lost to Follow-up|0|||
127649217|NCT01951638|459336510|FG000|Follow-up Period|Death|1|||
127649218|NCT01951638|459336511|FG001|Follow-up Period|Death|0|||
127649219|NCT01951638|459336512|FG002|Follow-up Period|Death|1|||
127649220|NCT01951638|459336513|FG003|Follow-up Period|Death|4|||
127649221|NCT01951638|459336514|FG004|Follow-up Period|Death|1|||
127649222|NCT01951638|459336510|FG000|Follow-up Period|Adverse Event|0|||
127649223|NCT01951638|459336511|FG001|Follow-up Period|Adverse Event|1|||
127649224|NCT01951638|459336512|FG002|Follow-up Period|Adverse Event|2|||
127539599|NCT00689390|458938889|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
127539600|NCT00689390|458938888|FG000|Overall Study|Non-Compliance With Protocol|21|||
127539601|NCT00689390|458938889|FG001|Overall Study|Non-Compliance With Protocol|0|||
127539602|NCT00689390|458938888|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
127539603|NCT00689390|458938889|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
127539604|NCT00689390|458938888|FG000|Overall Study|Administrative|37|||
127539605|NCT00689390|458938889|FG001|Overall Study|Administrative|0|||
127539606|NCT02343263|458938890|FG000|Overall Study|Physician Decision|5|||
127539607|NCT02343263|458938891|FG001|Overall Study|Physician Decision|3|||
127539608|NCT02343263|458938892|FG002|Overall Study|Physician Decision|1|||
127539609|NCT04258423|458938903|FG000|Overall Study|Study Closure|2|||
127539610|NCT04258423|458938904|FG001|Overall Study|Study Closure|2|||
127539611|NCT03346434|458940422|FG000|Overall Study|Randomized in Error|0|||
127539612|NCT03346434|458940423|FG001|Overall Study|Randomized in Error|0|||
127539613|NCT03346434|458940424|FG002|Overall Study|Randomized in Error|0|||
127539614|NCT03346434|458940425|FG003|Overall Study|Randomized in Error|0|||
127539615|NCT03346434|458940426|FG004|Overall Study|Randomized in Error|1|||
127539616|NCT03346434|458940427|FG005|Overall Study|Randomized in Error|0|||
127539617|NCT03346434|458940422|FG000|Overall Study|Withdrawal by Subject|0|||
127539618|NCT03346434|458940423|FG001|Overall Study|Withdrawal by Subject|0|||
127539619|NCT03346434|458940424|FG002|Overall Study|Withdrawal by Subject|1|||
127539620|NCT03346434|458940425|FG003|Overall Study|Withdrawal by Subject|0|||
127539621|NCT03346434|458940426|FG004|Overall Study|Withdrawal by Subject|1|||
127539622|NCT03346434|458940427|FG005|Overall Study|Withdrawal by Subject|0|||
127539623|NCT03346434|458940422|FG000|Overall Study|Lost to Follow-up|0|||
127539624|NCT03346434|458940423|FG001|Overall Study|Lost to Follow-up|0|||
127539625|NCT03346434|458940424|FG002|Overall Study|Lost to Follow-up|0|||
127539626|NCT03346434|458940425|FG003|Overall Study|Lost to Follow-up|0|||
127539627|NCT03346434|458940426|FG004|Overall Study|Lost to Follow-up|1|||
127539628|NCT03346434|458940427|FG005|Overall Study|Lost to Follow-up|1|||
127539629|NCT03346434|458940422|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
127539630|NCT03346434|458940423|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
127539631|NCT03346434|458940424|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
127539632|NCT03346434|458940425|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
127539633|NCT03346434|458940426|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
127539634|NCT03346434|458940427|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
127539635|NCT03525444|458940428|FG000|Overall Study|Adverse Event|0|||
127539636|NCT03525444|458940429|FG001|Overall Study|Adverse Event|1|||
127539637|NCT03525444|458940428|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
127539638|NCT03525444|458940429|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
127539639|NCT03525444|458940428|FG000|Overall Study|Other|0|||
127539640|NCT03525444|458940429|FG001|Overall Study|Other|1|||
127539641|NCT01419236|458940433|FG000|Overall Study|Adverse Event|1|||
127539642|NCT01419236|458940434|FG001|Overall Study|Adverse Event|0|||
127539643|NCT01419236|458940433|FG000|Overall Study|Lack of Efficacy|0|||
127539644|NCT01419236|458940434|FG001|Overall Study|Lack of Efficacy|1|||
127539645|NCT01419236|458940433|FG000|Overall Study|Lost to Follow-up|1|||
127539646|NCT01419236|458940434|FG001|Overall Study|Lost to Follow-up|0|||
127539647|NCT01419236|458940433|FG000|Overall Study|Physician Decision|1|||
127539648|NCT01419236|458940434|FG001|Overall Study|Physician Decision|0|||
127539649|NCT01419236|458940433|FG000|Overall Study|Withdrawal by Subject|1|||
127539650|NCT01419236|458940434|FG001|Overall Study|Withdrawal by Subject|4|||
127539651|NCT01419236|458940433|FG000|Overall Study|Entry Criteria Not Met|1|||
127539652|NCT01419236|458940434|FG001|Overall Study|Entry Criteria Not Met|0|||
127539653|NCT01131507|458940435|FG000|Overall Study|Adverse Event|1|||
127539654|NCT01131507|458940435|FG000|Overall Study|Lost to Follow-up|1|||
127539655|NCT01131507|458940435|FG000|Overall Study|Withdrawal by Subject|1|||
127539656|NCT01393158|458940442|FG000|Overall Study|Adverse Event|1|||
127539657|NCT01393158|458940443|FG001|Overall Study|Adverse Event|0|||
127539658|NCT00762359|458940444|FG000|Overall Study|Adverse Event|20|||
127539659|NCT00762359|458940445|FG001|Overall Study|Adverse Event|23|||
127539660|NCT00762359|458940444|FG000|Overall Study|Protocol Violation|21|||
127539661|NCT00762359|458940445|FG001|Overall Study|Protocol Violation|13|||
127539662|NCT00762359|458940444|FG000|Overall Study|Withdrawal by Subject|13|||
127539663|NCT00762359|458940445|FG001|Overall Study|Withdrawal by Subject|10|||
127539664|NCT00762359|458940444|FG000|Overall Study|Lack of Efficacy|0|||
127539665|NCT00762359|458940445|FG001|Overall Study|Lack of Efficacy|4|||
127539666|NCT00762359|458940444|FG000|Overall Study|Institution closed|2|||
127539667|NCT00762359|458940445|FG001|Overall Study|Institution closed|3|||
127539668|NCT00762359|458940444|FG000|Overall Study|Physician Decision|2|||
127539669|NCT00762359|458940445|FG001|Overall Study|Physician Decision|3|||
127539670|NCT00762359|458940444|FG000|Overall Study|Removal|0|||
127539671|NCT00762359|458940445|FG001|Overall Study|Removal|1|||
127539672|NCT00762359|458940444|FG000|Overall Study|Withdrew consent|1|||
127539673|NCT00762359|458940445|FG001|Overall Study|Withdrew consent|0|||
127539674|NCT01453049|458940446|FG000|Overall Study|Protocol Violation|2|||
127539675|NCT01453049|458940447|FG001|Overall Study|Protocol Violation|5|||
127539676|NCT01453049|458940446|FG000|Overall Study|Lost to Follow-up|2|||
127539677|NCT01453049|458940447|FG001|Overall Study|Lost to Follow-up|1|||
127539678|NCT01453049|458940446|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
127539679|NCT01453049|458940447|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
127539680|NCT01453049|458940446|FG000|Overall Study|Withdrawal by Subject|1|||
127539681|NCT01453049|458940447|FG001|Overall Study|Withdrawal by Subject|0|||
127539682|NCT01453049|458940446|FG000|Overall Study|Randomized in Error|1|||
127539683|NCT01453049|458940447|FG001|Overall Study|Randomized in Error|0|||
127539684|NCT00882440|458940448|FG000|Overall Study|Adverse Event|2|||
127539685|NCT00882440|458940449|FG001|Overall Study|Adverse Event|2|||
127539686|NCT00882440|458940450|FG002|Overall Study|Adverse Event|2|||
127539687|NCT00882440|458940451|FG003|Overall Study|Adverse Event|1|||
127539688|NCT00882440|458940452|FG004|Overall Study|Adverse Event|1|||
127539689|NCT00882440|458940453|FG005|Overall Study|Adverse Event|4|||
127539690|NCT00882440|458940454|FG006|Overall Study|Adverse Event|2|||
127539691|NCT00882440|458940448|FG000|Overall Study|Lack of Efficacy|3|||
127539692|NCT00882440|458940449|FG001|Overall Study|Lack of Efficacy|5|||
127539693|NCT00882440|458940450|FG002|Overall Study|Lack of Efficacy|2|||
127539694|NCT00882440|458940451|FG003|Overall Study|Lack of Efficacy|0|||
127539695|NCT00882440|458940452|FG004|Overall Study|Lack of Efficacy|0|||
127539696|NCT00882440|458940453|FG005|Overall Study|Lack of Efficacy|3|||
127539697|NCT00882440|458940454|FG006|Overall Study|Lack of Efficacy|0|||
127539698|NCT00882440|458940448|FG000|Overall Study|Lost to Follow-up|2|||
127539699|NCT00882440|458940449|FG001|Overall Study|Lost to Follow-up|0|||
127539700|NCT00882440|458940450|FG002|Overall Study|Lost to Follow-up|1|||
127539701|NCT00882440|458940451|FG003|Overall Study|Lost to Follow-up|1|||
127539702|NCT00882440|458940452|FG004|Overall Study|Lost to Follow-up|1|||
127539703|NCT00882440|458940453|FG005|Overall Study|Lost to Follow-up|0|||
127539704|NCT00882440|458940454|FG006|Overall Study|Lost to Follow-up|1|||
127539705|NCT00882440|458940448|FG000|Overall Study|Protocol Violation|0|||
127539706|NCT00882440|458940449|FG001|Overall Study|Protocol Violation|0|||
127539707|NCT00882440|458940450|FG002|Overall Study|Protocol Violation|1|||
127539708|NCT00882440|458940451|FG003|Overall Study|Protocol Violation|1|||
127539709|NCT00882440|458940452|FG004|Overall Study|Protocol Violation|1|||
127539710|NCT00882440|458940453|FG005|Overall Study|Protocol Violation|0|||
127539711|NCT00882440|458940454|FG006|Overall Study|Protocol Violation|0|||
127539712|NCT00882440|458940448|FG000|Overall Study|Withdrawal by Subject|2|||
127539713|NCT00882440|458940449|FG001|Overall Study|Withdrawal by Subject|1|||
127539714|NCT00882440|458940450|FG002|Overall Study|Withdrawal by Subject|1|||
127539715|NCT00882440|458940451|FG003|Overall Study|Withdrawal by Subject|0|||
127539716|NCT00882440|458940452|FG004|Overall Study|Withdrawal by Subject|6|||
127539717|NCT00882440|458940453|FG005|Overall Study|Withdrawal by Subject|0|||
127539718|NCT00882440|458940454|FG006|Overall Study|Withdrawal by Subject|1|||
127539719|NCT00882440|458940448|FG000|Overall Study|Patient Uncooperative|2|||
127539720|NCT00882440|458940449|FG001|Overall Study|Patient Uncooperative|0|||
127539721|NCT00882440|458940450|FG002|Overall Study|Patient Uncooperative|0|||
127539722|NCT00882440|458940451|FG003|Overall Study|Patient Uncooperative|0|||
127539723|NCT00882440|458940452|FG004|Overall Study|Patient Uncooperative|1|||
127539724|NCT00882440|458940453|FG005|Overall Study|Patient Uncooperative|0|||
127539725|NCT00882440|458940454|FG006|Overall Study|Patient Uncooperative|0|||
127539726|NCT03287791|458940455|FG000|Overall Study|Insufficient Therapeutic Response|0|||
127539727|NCT03287791|458940456|FG001|Overall Study|Insufficient Therapeutic Response|0|||
127539728|NCT03287791|458940457|FG002|Overall Study|Insufficient Therapeutic Response|1|||
127539729|NCT03287791|458940455|FG000|Overall Study|Adverse Event|0|||
127539730|NCT03287791|458940456|FG001|Overall Study|Adverse Event|4|||
127539731|NCT03287791|458940457|FG002|Overall Study|Adverse Event|3|||
127539732|NCT03287791|458940455|FG000|Overall Study|Withdrawal by Subject|12|||
127539733|NCT03287791|458940456|FG001|Overall Study|Withdrawal by Subject|12|||
127539734|NCT03287791|458940457|FG002|Overall Study|Withdrawal by Subject|17|||
127539735|NCT03287791|458940455|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
127539736|NCT03287791|458940456|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
127539737|NCT03287791|458940457|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
127539738|NCT03287791|458940455|FG000|Overall Study|Lost to Follow-up|8|||
127539739|NCT03287791|458940456|FG001|Overall Study|Lost to Follow-up|14|||
127539740|NCT03287791|458940457|FG002|Overall Study|Lost to Follow-up|11|||
127539741|NCT03287791|458940455|FG000|Overall Study|Protocol Violation|7|||
127539742|NCT03287791|458940456|FG001|Overall Study|Protocol Violation|2|||
127539743|NCT03287791|458940457|FG002|Overall Study|Protocol Violation|1|||
127539744|NCT03287791|458940455|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
127539745|NCT03287791|458940456|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
127539746|NCT03287791|458940457|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
127539747|NCT03287791|458940455|FG000|Overall Study|Too much time between 2 visits|0|||
127539748|NCT03287791|458940456|FG001|Overall Study|Too much time between 2 visits|1|||
127539749|NCT03287791|458940457|FG002|Overall Study|Too much time between 2 visits|0|||
127539750|NCT03287791|458940455|FG000|Overall Study|Non-compliance|0|||
127539751|NCT03287791|458940456|FG001|Overall Study|Non-compliance|1|||
127539752|NCT03287791|458940457|FG002|Overall Study|Non-compliance|0|||
127983604|NCT00561470|460562532|FG000|Overall Study|Metastatic surgery|10|||
127983605|NCT00561470|460562533|FG001|Overall Study|Metastatic surgery|12|||
127983606|NCT00561470|460562532|FG000|Overall Study|Unauthorized procedure|3|||
127983607|NCT00561470|460562533|FG001|Overall Study|Unauthorized procedure|1|||
127983608|NCT00561470|460562532|FG000|Overall Study|Randomized but not treated|5|||
127983609|NCT00561470|460562533|FG001|Overall Study|Randomized but not treated|5|||
127983610|NCT00561470|460562532|FG000|Overall Study|Missed visit window|1|||
127983611|NCT00561470|460562533|FG001|Overall Study|Missed visit window|4|||
127983612|NCT00561470|460562532|FG000|Overall Study|Planning surgery|1|||
127983613|NCT00561470|460562533|FG001|Overall Study|Planning surgery|1|||
127983614|NCT00561470|460562532|FG000|Overall Study|Ongoing Treatment|11|||
127983615|NCT00561470|460562533|FG001|Overall Study|Ongoing Treatment|14|||
127983616|NCT02918552|460562534|FG000|Overall Study|Failed Pharmacokinetics|1|||
127983617|NCT02918552|460562535|FG001|Overall Study|Failed Pharmacokinetics|0|||
127983618|NCT02918552|460562534|FG000|Overall Study|Withdrawal by Subject|0|||
127983619|NCT02918552|460562535|FG001|Overall Study|Withdrawal by Subject|1|||
127983620|NCT02918552|460562534|FG000|Overall Study|Lost to Follow-up|0|||
127983621|NCT02918552|460562535|FG001|Overall Study|Lost to Follow-up|1|||
127983622|NCT03325894|460562536|FG000|Overall Study|Adverse Event|2|||
127983623|NCT03325894|460562537|FG001|Overall Study|Adverse Event|3|||
127983624|NCT03325894|460562536|FG000|Overall Study|Protocol Violation|1|||
127983625|NCT03325894|460562537|FG001|Overall Study|Protocol Violation|2|||
127983626|NCT03325894|460562536|FG000|Overall Study|Withdrawal by Subject|10|||
127983627|NCT03325894|460562537|FG001|Overall Study|Withdrawal by Subject|6|||
127983628|NCT03325894|460562536|FG000|Overall Study|Lost to Follow-up|4|||
127983629|NCT03325894|460562537|FG001|Overall Study|Lost to Follow-up|9|||
127983630|NCT03325894|460562536|FG000|Overall Study|Lack of Efficacy|8|||
127983631|NCT03325894|460562537|FG001|Overall Study|Lack of Efficacy|14|||
127983632|NCT03325894|460562536|FG000|Overall Study|Study Terminated by Sponsor|38|||
127983633|NCT03325894|460562537|FG001|Overall Study|Study Terminated by Sponsor|43|||
127983634|NCT03325894|460562536|FG000|Overall Study|Other (Not received Treatment)|1|||
127983635|NCT03325894|460562537|FG001|Overall Study|Other (Not received Treatment)|0|||
127983636|NCT04395274|460562538|FG000|Overall Study|Lost to Follow-up|20|||
127983637|NCT04395274|460562539|FG001|Overall Study|Lost to Follow-up|11|||
127983638|NCT04395274|460562538|FG000|Overall Study|Withdrawal by Subject|13|||
127983639|NCT04395274|460562539|FG001|Overall Study|Withdrawal by Subject|10|||
127983640|NCT04395274|460562538|FG000|Overall Study|Moved Abroad|0|||
127983641|NCT04395274|460562539|FG001|Overall Study|Moved Abroad|1|||
127983642|NCT00335959|460562542|FG000|Overall Study|Adverse Event|2|||
127983643|NCT00335959|460562542|FG000|Overall Study|Ineligible|1|||
127983644|NCT02450552|460562543|FG000|Overall Study|Withdrawal by Subject|4|||
127983645|NCT02450552|460562544|FG001|Overall Study|Withdrawal by Subject|0|||
127983646|NCT02450552|460562545|FG002|Overall Study|Withdrawal by Subject|4|||
127983647|NCT02450552|460562543|FG000|Overall Study|Physician Decision|1|||
127983648|NCT02450552|460562544|FG001|Overall Study|Physician Decision|0|||
127983649|NCT02450552|460562545|FG002|Overall Study|Physician Decision|1|||
127983650|NCT00824382|460562549|FG000|Overall Study|Adverse Event|4|||
127983651|NCT00824382|460562550|FG001|Overall Study|Adverse Event|1|||
127983652|NCT00824382|460562551|FG002|Overall Study|Adverse Event|1|||
127983653|NCT00824382|460562552|FG003|Overall Study|Adverse Event|4|||
127983654|NCT00824382|460562549|FG000|Overall Study|Protocol Violation|1|||
127983655|NCT00824382|460562550|FG001|Overall Study|Protocol Violation|0|||
127983656|NCT00824382|460562551|FG002|Overall Study|Protocol Violation|0|||
127983657|NCT00824382|460562552|FG003|Overall Study|Protocol Violation|1|||
127983658|NCT00824382|460562549|FG000|Overall Study|Investigator's decision|0|||
127983659|NCT00824382|460562550|FG001|Overall Study|Investigator's decision|1|||
127983660|NCT00824382|460562551|FG002|Overall Study|Investigator's decision|2|||
127983661|NCT00824382|460562552|FG003|Overall Study|Investigator's decision|0|||
127983662|NCT02407054|460562553|FG000|Overall Study|Adverse Event|1|||
127983663|NCT02407054|460562554|FG001|Overall Study|Adverse Event|4|||
127983664|NCT02407054|460562555|FG002|Overall Study|Adverse Event|1|||
127983665|NCT02407054|460562553|FG000|Overall Study|Non-compliance with Study|0|||
127983666|NCT02407054|460562554|FG001|Overall Study|Non-compliance with Study|2|||
127983667|NCT02407054|460562555|FG002|Overall Study|Non-compliance with Study|1|||
127983668|NCT02407054|460562553|FG000|Overall Study|Physician Decision|1|||
127983669|NCT02407054|460562554|FG001|Overall Study|Physician Decision|3|||
127983670|NCT02407054|460562555|FG002|Overall Study|Physician Decision|3|||
127983671|NCT02407054|460562553|FG000|Overall Study|Withdrawal by Subject|5|||
127983672|NCT02407054|460562554|FG001|Overall Study|Withdrawal by Subject|9|||
127983673|NCT02407054|460562555|FG002|Overall Study|Withdrawal by Subject|2|||
127983674|NCT00131365|460562556|FG000|Overall Study|Withdrawal by Subject|1|||
127983675|NCT00131365|460562556|FG000|Overall Study|Alternative treatment|3|||
127983676|NCT04608344|460562557|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
127983677|NCT04608344|460562558|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
127983678|NCT04608344|460562557|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
127983679|NCT04608344|460562558|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
127983680|NCT02044874|460562559|FG000|Overall Study|Adverse Event|5|||
127983681|NCT02044874|460562560|FG001|Overall Study|Adverse Event|6|||
127760703|NCT01468181|459748938|FG002|Overall Study|Adverse Event|6|||
127760704|NCT01468181|459748939|FG003|Overall Study|Adverse Event|2|||
127760705|NCT01468181|459748940|FG004|Overall Study|Adverse Event|2|||
127760706|NCT01468181|459748936|FG000|Overall Study|Protocol Violation|2|||
127760707|NCT01468181|459748937|FG001|Overall Study|Protocol Violation|0|||
127760708|NCT01468181|459748938|FG002|Overall Study|Protocol Violation|1|||
127539753|NCT03287791|458940455|FG000|Overall Study|Did not meet inclusion criteria|1|||
127539754|NCT03287791|458940456|FG001|Overall Study|Did not meet inclusion criteria|0|||
127539755|NCT03287791|458940457|FG002|Overall Study|Did not meet inclusion criteria|0|||
127539756|NCT03095651|458940459|FG000|Overall Study|Lost to Follow-up|1|||
127539757|NCT03095651|458940460|FG001|Overall Study|Lost to Follow-up|1|||
127539758|NCT03095651|458940461|FG002|Overall Study|Lost to Follow-up|0|||
127539759|NCT03095651|458940462|FG003|Overall Study|Lost to Follow-up|1|||
127539760|NCT03095651|458940463|FG004|Overall Study|Lost to Follow-up|0|||
127539761|NCT03095651|458940464|FG005|Overall Study|Lost to Follow-up|0|||
127539762|NCT03095651|458940465|FG006|Overall Study|Lost to Follow-up|0|||
127539763|NCT03095651|458940466|FG007|Overall Study|Lost to Follow-up|0|||
127539764|NCT03095651|458940459|FG000|Overall Study|Withdrawal by Subject|0|||
127539765|NCT03095651|458940460|FG001|Overall Study|Withdrawal by Subject|0|||
127539766|NCT03095651|458940461|FG002|Overall Study|Withdrawal by Subject|0|||
127539767|NCT03095651|458940462|FG003|Overall Study|Withdrawal by Subject|0|||
127539768|NCT03095651|458940463|FG004|Overall Study|Withdrawal by Subject|0|||
127539769|NCT03095651|458940464|FG005|Overall Study|Withdrawal by Subject|1|||
127539770|NCT03095651|458940465|FG006|Overall Study|Withdrawal by Subject|0|||
127539771|NCT03095651|458940466|FG007|Overall Study|Withdrawal by Subject|0|||
127539772|NCT02250326|458940467|FG000|Treatment|Death|1|||
127539773|NCT02250326|458940468|FG001|Treatment|Death|13|||
127539774|NCT02250326|458940469|FG002|Treatment|Death|2|||
127539775|NCT02250326|458940467|FG000|Treatment|Adverse Event|8|||
127539776|NCT02250326|458940468|FG001|Treatment|Adverse Event|8|||
127539777|NCT02250326|458940469|FG002|Treatment|Adverse Event|9|||
127539778|NCT02250326|458940467|FG000|Treatment|Progressive Disease|42|||
127539779|NCT02250326|458940468|FG001|Treatment|Progressive Disease|40|||
127539780|NCT02250326|458940469|FG002|Treatment|Progressive Disease|47|||
127539781|NCT02250326|458940467|FG000|Treatment|Symptomatic Deterioration|9|||
127539782|NCT02250326|458940468|FG001|Treatment|Symptomatic Deterioration|4|||
127539783|NCT02250326|458940469|FG002|Treatment|Symptomatic Deterioration|10|||
127539784|NCT02250326|458940467|FG000|Treatment|Withdrawal by Subject|11|||
127539785|NCT02250326|458940468|FG001|Treatment|Withdrawal by Subject|6|||
127539786|NCT02250326|458940469|FG002|Treatment|Withdrawal by Subject|4|||
127539787|NCT02250326|458940467|FG000|Treatment|Other reasons|8|||
127539788|NCT02250326|458940468|FG001|Treatment|Other reasons|7|||
127539789|NCT02250326|458940469|FG002|Treatment|Other reasons|7|||
127539790|NCT02250326|458940467|FG000|Extension Period|Progressive Disease|0|||
127539791|NCT02250326|458940468|FG001|Extension Period|Progressive Disease|2|||
127539792|NCT02250326|458940469|FG002|Extension Period|Progressive Disease|0|||
127539793|NCT02250326|458940467|FG000|Extension Period|Withdrawal by Subject|0|||
127539794|NCT02250326|458940468|FG001|Extension Period|Withdrawal by Subject|1|||
127539795|NCT02250326|458940469|FG002|Extension Period|Withdrawal by Subject|0|||
127539796|NCT02250326|458940467|FG000|Extension Period|Withdrawal by investigator|0|||
127539797|NCT02250326|458940468|FG001|Extension Period|Withdrawal by investigator|1|||
127539798|NCT02250326|458940469|FG002|Extension Period|Withdrawal by investigator|0|||
127539799|NCT00866177|458940474|FG000|Overall Study|Withdrawal by Subject|1|||
127539800|NCT00866177|458940474|FG000|Overall Study|Not Treated|151|||
127539801|NCT02529852|458940475|FG000|Overall Study|Withdrawal by Subject|2|||
127539802|NCT00614575|458940481|FG000|Overall Study|Adverse Event|106|||
127539803|NCT00614575|458940481|FG000|Overall Study|Lost to Follow-up|55|||
127539804|NCT00614575|458940481|FG000|Overall Study|Lack of Efficacy|14|||
127539805|NCT00614575|458940481|FG000|Overall Study|Withdrawal by Subject|6|||
127539806|NCT00614575|458940481|FG000|Overall Study|Death|3|||
127539807|NCT00614575|458940481|FG000|Overall Study|Physician Decision|2|||
127539808|NCT00614575|458940481|FG000|Overall Study|No data were collected.|18|||
127539809|NCT00614575|458940481|FG000|Overall Study|Irregularly enrolled patients|23|||
127539810|NCT00614575|458940481|FG000|Overall Study|No treatment|1|||
127539811|NCT03452540|458940482|FG000|Overall Study|Adverse Event|1|||
127539812|NCT03452540|458940482|FG000|Overall Study|Withdrawal by Subject|1|||
127539813|NCT03452540|458940482|FG000|Overall Study|Other SAE and AE|2|||
127539814|NCT00524485|458940483|FG000|Overall Study|Withdrawal by Subject|5|||
127539815|NCT00472108|458940484|FG000|Overall Study|Lost to Follow-up|0|||
127539816|NCT00472108|458940485|FG001|Overall Study|Lost to Follow-up|1|||
127539817|NCT01339689|458940486|FG000|Overall Study|Adverse Event|1|||
127539818|NCT01339689|458940487|FG001|Overall Study|Adverse Event|2|||
127539819|NCT01339689|458940486|FG000|Overall Study|Lost to Follow-up|9|||
127539820|NCT01339689|458940487|FG001|Overall Study|Lost to Follow-up|3|||
127539821|NCT01339689|458940486|FG000|Overall Study|Withdrawal by Subject|3|||
127539822|NCT01339689|458940487|FG001|Overall Study|Withdrawal by Subject|0|||
127539823|NCT01339689|458940486|FG000|Overall Study|Noncompliance|1|||
127539824|NCT01339689|458940487|FG001|Overall Study|Noncompliance|0|||
127760709|NCT01468181|459748939|FG003|Overall Study|Protocol Violation|0|||
127539825|NCT01339689|458940486|FG000|Overall Study|Relocated out of area|0|||
127539826|NCT01339689|458940487|FG001|Overall Study|Relocated out of area|1|||
127539827|NCT01339689|458940486|FG000|Overall Study|Other|2|||
127539828|NCT01339689|458940487|FG001|Overall Study|Other|2|||
127539829|NCT01339689|458940486|FG000|Overall Study|multiple reasons|1|||
127539830|NCT01339689|458940487|FG001|Overall Study|multiple reasons|1|||
127539831|NCT04571944|458940488|FG000|Overall Study|Death|1|||
127539832|NCT04571944|458940489|FG001|Overall Study|Death|0|||
127539833|NCT04571944|458940488|FG000|Overall Study|Withdrawal by Subject|3|||
127539834|NCT04571944|458940489|FG001|Overall Study|Withdrawal by Subject|0|||
127539835|NCT04571944|458940488|FG000|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|2|||
127539836|NCT04571944|458940489|FG001|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|0|||
127539837|NCT01650558|458940492|FG000|Overall Study|Migration out of study area|61|||
127539838|NCT01650558|458940493|FG001|Overall Study|Migration out of study area|71|||
127539839|NCT01650558|458940494|FG002|Overall Study|Migration out of study area|56|||
127539840|NCT01650558|458940492|FG000|Overall Study|Lost to Follow-up|10|||
127539841|NCT01650558|458940493|FG001|Overall Study|Lost to Follow-up|13|||
127539842|NCT01650558|458940494|FG002|Overall Study|Lost to Follow-up|6|||
127539843|NCT01650558|458940492|FG000|Overall Study|Death|10|||
127539844|NCT01650558|458940493|FG001|Overall Study|Death|6|||
127539845|NCT01650558|458940494|FG002|Overall Study|Death|8|||
127539846|NCT01650558|458940492|FG000|Overall Study|Withdrawal by Subject|1|||
127539847|NCT01650558|458940493|FG001|Overall Study|Withdrawal by Subject|1|||
127539848|NCT01650558|458940494|FG002|Overall Study|Withdrawal by Subject|3|||
127539849|NCT01650558|458940492|FG000|Overall Study|Non-compliant participant|1|||
127539850|NCT01650558|458940493|FG001|Overall Study|Non-compliant participant|0|||
127539851|NCT01650558|458940494|FG002|Overall Study|Non-compliant participant|2|||
127539852|NCT01650558|458940492|FG000|Overall Study|Physician Decision|0|||
127539853|NCT01650558|458940493|FG001|Overall Study|Physician Decision|1|||
127539854|NCT01650558|458940494|FG002|Overall Study|Physician Decision|0|||
127539855|NCT01476722|458940495|FG000|Overall Study|Adverse Event|1|||
127539856|NCT03261336|458940496|FG000|Overall Study|Adverse Event|1|||
127539857|NCT01069484|458940498|FG000|Overall Study|Death-in-near-family|1|||
127539858|NCT01069484|458940499|FG001|Overall Study|Death-in-near-family|0|||
127539859|NCT01069484|458940498|FG000|Overall Study|No specific reason|8|||
127539860|NCT01069484|458940499|FG001|Overall Study|No specific reason|2|||
127539861|NCT01069484|458940498|FG000|Overall Study|Illness mother or child|3|||
127539862|NCT01069484|458940499|FG001|Overall Study|Illness mother or child|1|||
127539863|NCT00758771|458940509|FG000|Overall Study|Withdrawal by Subject|1|||
127539864|NCT00758771|458940510|FG001|Overall Study|Withdrawal by Subject|1|||
127539865|NCT00758771|458940509|FG000|Overall Study|Did not meet eligibility criteria|2|||
127539866|NCT00758771|458940510|FG001|Overall Study|Did not meet eligibility criteria|4|||
127539867|NCT00528957|458940511|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
127539868|NCT00528957|458940512|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
127539869|NCT00528957|458940511|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
127539870|NCT00528957|458940512|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
127539871|NCT00528957|458940511|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
127539872|NCT00528957|458940512|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
127539873|NCT00528957|458940511|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
127539874|NCT00528957|458940512|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
127539875|NCT00528957|458940511|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
127539876|NCT00528957|458940512|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
127539877|NCT00528957|458940511|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
127539878|NCT00528957|458940512|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
127539879|NCT00528957|458940511|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
127539880|NCT00528957|458940512|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
127539881|NCT00528957|458940511|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
127539882|NCT00528957|458940512|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
127539883|NCT00528957|458940511|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
127539884|NCT00528957|458940512|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
127539885|NCT00528957|458940511|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
127539886|NCT00528957|458940512|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
127539887|NCT00528957|458940511|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
127539888|NCT00528957|458940512|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
127539889|NCT00528957|458940511|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
127649225|NCT01951638|459336513|FG003|Follow-up Period|Adverse Event|1|||
127649226|NCT01951638|459336514|FG004|Follow-up Period|Adverse Event|1|||
127649227|NCT00459342|459336516|FG000|Overall Study|Not eligible|1|||
127649228|NCT02686034|459336517|FG000|Run-In Period 1|Eligibility|12|||
127649229|NCT02686034|459336518|FG001|Run-In Period 1|Eligibility|10|||
127539890|NCT00528957|458940512|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
127539891|NCT00528957|458940511|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
127539892|NCT00528957|458940512|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
127539893|NCT00528957|458940511|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
127539894|NCT00528957|458940512|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
127539895|NCT00528957|458940511|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
127539896|NCT00528957|458940512|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
127539897|NCT00528957|458940511|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
127539898|NCT00528957|458940512|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
127539899|NCT00771914|458940513|FG000|Overall Study|Physician Decision|0|||
127539900|NCT00771914|458940514|FG001|Overall Study|Physician Decision|0|||
127539901|NCT00771914|458940515|FG002|Overall Study|Physician Decision|0|||
127539902|NCT00771914|458940516|FG003|Overall Study|Physician Decision|1|||
127539903|NCT00771914|458940513|FG000|Overall Study|Lost to Follow-up|0|||
127539904|NCT00771914|458940514|FG001|Overall Study|Lost to Follow-up|0|||
127539905|NCT00771914|458940515|FG002|Overall Study|Lost to Follow-up|0|||
127539906|NCT00771914|458940516|FG003|Overall Study|Lost to Follow-up|1|||
127539907|NCT02978417|458940519|FG000|Overall Study|Lost to Follow-up|2|||
127539908|NCT02978417|458940520|FG001|Overall Study|Lost to Follow-up|2|||
127539909|NCT01323582|458940530|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
127539910|NCT01323582|458940531|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
127539911|NCT01323582|458940530|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
127539912|NCT01323582|458940531|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
127539913|NCT01323582|458940530|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
127539914|NCT01323582|458940531|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
127539915|NCT00960375|458940536|FG000|Overall Study|Lost to Follow-up|20|||
127539916|NCT00960375|458940537|FG001|Overall Study|Lost to Follow-up|22|||
127539917|NCT02051764|458940538|FG000|Overall Study|Study terminated by sponsor|0|||
127539918|NCT02051764|458940539|FG001|Overall Study|Study terminated by sponsor|7|||
127539919|NCT03155724|458940542|FG000|Overall Study|Death|3|||
127539920|NCT03155724|458940542|FG000|Overall Study|Physician Decision|1|||
127539921|NCT03155724|458940542|FG000|Overall Study|Study closure|7|||
127539922|NCT00321789|458940544|FG000|Overall Study|Lost to Follow-up|4|||
127539923|NCT00321789|458940545|FG001|Overall Study|Lost to Follow-up|7|||
127539924|NCT00321789|458940544|FG000|Overall Study|Withdrawal by Subject|6|||
127539925|NCT00321789|458940545|FG001|Overall Study|Withdrawal by Subject|6|||
127539926|NCT00321789|458940544|FG000|Overall Study|Protocol Violation|5|||
127539927|NCT00321789|458940545|FG001|Overall Study|Protocol Violation|3|||
127539928|NCT03309020|458940546|FG000|Overall Study|Death|1|||
127539929|NCT03309020|458940547|FG001|Overall Study|Death|0|||
127539930|NCT03309020|458940546|FG000|Overall Study|Did not undergo surgery|2|||
127539931|NCT03309020|458940547|FG001|Overall Study|Did not undergo surgery|1|||
127539932|NCT02919761|458940550|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
127539933|NCT02919761|458940551|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
127539934|NCT02919761|458940552|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
127539935|NCT02919761|458940550|FG000|Part 1: Open Label|Adverse Event|1|||
127539936|NCT02919761|458940551|FG001|Part 1: Open Label|Adverse Event|0|||
127539937|NCT02919761|458940552|FG002|Part 1: Open Label|Adverse Event|0|||
127539938|NCT02919761|458940550|FG000|Part 1: Open Label|Lost to Follow-up|1|||
127539939|NCT02919761|458940551|FG001|Part 1: Open Label|Lost to Follow-up|0|||
127539940|NCT02919761|458940552|FG002|Part 1: Open Label|Lost to Follow-up|0|||
127539941|NCT02919761|458940550|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
127539942|NCT02919761|458940551|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
127760710|NCT01468181|459748940|FG004|Overall Study|Protocol Violation|1|||
127760711|NCT01468181|459748936|FG000|Overall Study|Physician Decision|0|||
127760712|NCT01468181|459748937|FG001|Overall Study|Physician Decision|0|||
127760713|NCT01468181|459748938|FG002|Overall Study|Physician Decision|0|||
127760714|NCT01468181|459748939|FG003|Overall Study|Physician Decision|1|||
127760715|NCT01468181|459748940|FG004|Overall Study|Physician Decision|1|||
127760716|NCT01468181|459748936|FG000|Overall Study|Lost to Follow-up|0|||
127760717|NCT01468181|459748937|FG001|Overall Study|Lost to Follow-up|0|||
127760718|NCT01468181|459748938|FG002|Overall Study|Lost to Follow-up|1|||
127760719|NCT01468181|459748939|FG003|Overall Study|Lost to Follow-up|0|||
127760720|NCT01468181|459748940|FG004|Overall Study|Lost to Follow-up|1|||
127760721|NCT01468181|459748936|FG000|Overall Study|Withdrawal by Subject|0|||
127760722|NCT01468181|459748937|FG001|Overall Study|Withdrawal by Subject|1|||
127760723|NCT01468181|459748938|FG002|Overall Study|Withdrawal by Subject|0|||
127760724|NCT01468181|459748939|FG003|Overall Study|Withdrawal by Subject|0|||
127983682|NCT02044874|460562561|FG002|Overall Study|Adverse Event|6|||
127539943|NCT02919761|458940552|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
127539944|NCT02919761|458940550|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
127642278|NCT03252587|459310079|FG001|Overall Study|Pregnancy|1|||
127760725|NCT01468181|459748940|FG004|Overall Study|Withdrawal by Subject|0|||
127760726|NCT04828837|459748941|FG000|Overall Study|Stay-at-home during a COVID-19 outbreak|1|||
127760727|NCT04828837|459748942|FG001|Overall Study|Stay-at-home during a COVID-19 outbreak|3|||
127760728|NCT04828837|459748941|FG000|Overall Study|Lost to Follow-up|2|||
127760729|NCT04828837|459748942|FG001|Overall Study|Lost to Follow-up|6|||
127760730|NCT04828837|459748941|FG000|Overall Study|Lack of Efficacy|1|||
127760731|NCT04828837|459748942|FG001|Overall Study|Lack of Efficacy|0|||
127760732|NCT04828837|459748941|FG000|Overall Study|Admitted due to pneumothorax.|1|||
127760733|NCT04828837|459748942|FG001|Overall Study|Admitted due to pneumothorax.|0|||
127760734|NCT04828837|459748941|FG000|Overall Study|Admitted due to HIVD for operation.|0|||
127760735|NCT04828837|459748942|FG001|Overall Study|Admitted due to HIVD for operation.|1|||
127760736|NCT00545753|459748943|FG000|Overall Study|Withdrawal by Subject|0|||
127760737|NCT00545753|459748944|FG001|Overall Study|Withdrawal by Subject|1|||
127760738|NCT00545753|459748945|FG002|Overall Study|Withdrawal by Subject|10|||
127760739|NCT00545753|459748943|FG000|Overall Study|Lost to Follow-up|13|||
127760740|NCT00545753|459748944|FG001|Overall Study|Lost to Follow-up|3|||
127760741|NCT00545753|459748945|FG002|Overall Study|Lost to Follow-up|12|||
127760742|NCT00545753|459748943|FG000|Overall Study|Protocol Violation|3|||
127760743|NCT00545753|459748944|FG001|Overall Study|Protocol Violation|1|||
127760744|NCT00545753|459748945|FG002|Overall Study|Protocol Violation|4|||
127760745|NCT02297139|459748946|FG000|Overall Study|Disease progression|0|||
127760746|NCT02297139|459748947|FG001|Overall Study|Disease progression|1|||
127760747|NCT02297139|459748946|FG000|Overall Study|Study drug toxicity|0|||
127760748|NCT02297139|459748947|FG001|Overall Study|Study drug toxicity|4|||
127760749|NCT02297139|459748946|FG000|Overall Study|Participant request to discontinue study treatment|0|||
127760750|NCT02297139|459748947|FG001|Overall Study|Participant request to discontinue study treatment|1|||
127760751|NCT02297139|459748946|FG000|Overall Study|Maximum clinical benefit|1|||
127760752|NCT02297139|459748947|FG001|Overall Study|Maximum clinical benefit|0|||
127760753|NCT02297139|459748946|FG000|Overall Study|Administrative reason by sponsor|0|||
127760754|NCT02297139|459748947|FG001|Overall Study|Administrative reason by sponsor|2|||
127760755|NCT02297139|459748946|FG000|Overall Study|Other reasons|0|||
127760756|NCT02297139|459748947|FG001|Overall Study|Other reasons|8|||
127760757|NCT01942785|459748951|FG000|Overall Study|Adverse Event|2|||
127760758|NCT01942785|459748951|FG000|Overall Study|Withdrawal by Subject|1|||
127760759|NCT01942785|459748951|FG000|Overall Study|Protocol Violation|1|||
127760760|NCT02227199|459748952|FG000|Overall Study|Physician Decision|0|||
127760761|NCT02227199|459748953|FG001|Overall Study|Physician Decision|0|||
127760762|NCT02227199|459748954|FG002|Overall Study|Physician Decision|1|||
127760763|NCT02227199|459748952|FG000|Overall Study|Adverse Event|0|||
127760764|NCT02227199|459748953|FG001|Overall Study|Adverse Event|0|||
127760765|NCT02227199|459748954|FG002|Overall Study|Adverse Event|3|||
127760766|NCT05597787|459748955|FG000|Overall Study|Withdrawal by Subject|0|||
127760767|NCT05597787|459748956|FG001|Overall Study|Withdrawal by Subject|0|||
127760768|NCT05597787|459748957|FG002|Overall Study|Withdrawal by Subject|1|||
127760769|NCT05453201|459748959|FG000|Overall Study|Withdrawal by Subject|1|||
127760770|NCT00552929|459748964|FG000|Overall Study|Lost to Follow-up|0|||
127760771|NCT00552929|459748965|FG001|Overall Study|Lost to Follow-up|0|||
127760772|NCT00552929|459748966|FG002|Overall Study|Lost to Follow-up|0|||
127760773|NCT00552929|459748967|FG003|Overall Study|Lost to Follow-up|0|||
127760774|NCT00552929|459748968|FG004|Overall Study|Lost to Follow-up|0|||
127760775|NCT00552929|459748969|FG005|Overall Study|Lost to Follow-up|0|||
127760776|NCT00552929|459748970|FG006|Overall Study|Lost to Follow-up|0|||
127760777|NCT00552929|459748971|FG007|Overall Study|Lost to Follow-up|0|||
127760778|NCT00552929|459748972|FG008|Overall Study|Lost to Follow-up|1|||
127760779|NCT00552929|459748973|FG009|Overall Study|Lost to Follow-up|0|||
127760780|NCT00552929|459748964|FG000|Overall Study|Not Eligible|0|||
127760781|NCT00552929|459748965|FG001|Overall Study|Not Eligible|0|||
127760782|NCT00552929|459748966|FG002|Overall Study|Not Eligible|0|||
127760783|NCT00552929|459748967|FG003|Overall Study|Not Eligible|0|||
127760784|NCT00552929|459748968|FG004|Overall Study|Not Eligible|0|||
127760785|NCT00552929|459748969|FG005|Overall Study|Not Eligible|1|||
127760786|NCT00552929|459748970|FG006|Overall Study|Not Eligible|0|||
127760787|NCT00552929|459748971|FG007|Overall Study|Not Eligible|0|||
127760788|NCT00552929|459748972|FG008|Overall Study|Not Eligible|0|||
127760789|NCT00552929|459748973|FG009|Overall Study|Not Eligible|0|||
127760790|NCT01200290|459748974|FG000|Treatment Period|Adverse Event|1|||
127760791|NCT01200290|459748974|FG000|Post-Treatment Follow-Up Period|Death|2|||
127760792|NCT01147536|459748983|FG000|Overall Study|Administrative study close|2|||
127760793|NCT01147536|459748983|FG000|Overall Study|Death|1|||
127760794|NCT02489968|459748984|FG000|Open-label Treatment Period|Adverse Event|14|||
127760795|NCT02489968|459748985|FG001|Open-label Treatment Period|Adverse Event|7|||
127760796|NCT02489968|459748986|FG002|Open-label Treatment Period|Adverse Event|0|||
127760797|NCT02489968|459748987|FG003|Open-label Treatment Period|Adverse Event|0|||
127760798|NCT02489968|459748988|FG004|Open-label Treatment Period|Adverse Event|0|||
127760799|NCT02489968|459748989|FG005|Open-label Treatment Period|Adverse Event|0|||
127760800|NCT02489968|459748984|FG000|Open-label Treatment Period|Protocol Violation|2|||
127760801|NCT02489968|459748985|FG001|Open-label Treatment Period|Protocol Violation|2|||
127760802|NCT02489968|459748986|FG002|Open-label Treatment Period|Protocol Violation|0|||
127760803|NCT02489968|459748987|FG003|Open-label Treatment Period|Protocol Violation|0|||
127871807|NCT02163759|460149899|FG001|Overall Study|Death|0|||
127871808|NCT02163759|460149900|FG002|Overall Study|Death|1|||
127760804|NCT02489968|459748988|FG004|Open-label Treatment Period|Protocol Violation|0|||
127760805|NCT02489968|459748989|FG005|Open-label Treatment Period|Protocol Violation|0|||
127760806|NCT02489968|459748984|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
127760807|NCT02489968|459748985|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
127760808|NCT02489968|459748986|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
127760809|NCT02489968|459748987|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
127760810|NCT02489968|459748988|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
127760811|NCT02489968|459748989|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
127760812|NCT02489968|459748984|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
127760813|NCT02489968|459748985|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
127760814|NCT02489968|459748986|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
127760815|NCT02489968|459748987|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
127760816|NCT02489968|459748988|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
127760817|NCT02489968|459748989|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
127760818|NCT02489968|459748984|FG000|Open-label Treatment Period|Other than specified above|204|||
127760819|NCT02489968|459748985|FG001|Open-label Treatment Period|Other than specified above|189|||
127760820|NCT02489968|459748986|FG002|Open-label Treatment Period|Other than specified above|0|||
127760821|NCT02489968|459748987|FG003|Open-label Treatment Period|Other than specified above|0|||
127760822|NCT02489968|459748988|FG004|Open-label Treatment Period|Other than specified above|0|||
127760823|NCT02489968|459748989|FG005|Open-label Treatment Period|Other than specified above|0|||
127760824|NCT02489968|459748984|FG000|Double-blind Treatment Period|Adverse Event|0|||
127760825|NCT02489968|459748985|FG001|Double-blind Treatment Period|Adverse Event|0|||
127760826|NCT02489968|459748986|FG002|Double-blind Treatment Period|Adverse Event|2|||
127760827|NCT02489968|459748987|FG003|Double-blind Treatment Period|Adverse Event|6|||
127760828|NCT02489968|459748988|FG004|Double-blind Treatment Period|Adverse Event|4|||
127760829|NCT02489968|459748989|FG005|Double-blind Treatment Period|Adverse Event|5|||
127760830|NCT02489968|459748984|FG000|Double-blind Treatment Period|Protocol Violation|0|||
127760831|NCT02489968|459748985|FG001|Double-blind Treatment Period|Protocol Violation|0|||
127760832|NCT02489968|459748986|FG002|Double-blind Treatment Period|Protocol Violation|0|||
127760833|NCT02489968|459748987|FG003|Double-blind Treatment Period|Protocol Violation|0|||
127760834|NCT02489968|459748988|FG004|Double-blind Treatment Period|Protocol Violation|1|||
127760835|NCT02489968|459748989|FG005|Double-blind Treatment Period|Protocol Violation|1|||
127760836|NCT02489968|459748984|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
127760837|NCT02489968|459748985|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
127760838|NCT02489968|459748986|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
127760839|NCT02489968|459748987|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
127760840|NCT02489968|459748988|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
127760841|NCT02489968|459748989|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
127760842|NCT02489968|459748984|FG000|Double-blind Treatment Period|Other than specified above|0|||
127760843|NCT02489968|459748985|FG001|Double-blind Treatment Period|Other than specified above|0|||
127760844|NCT02489968|459748986|FG002|Double-blind Treatment Period|Other than specified above|0|||
127760845|NCT02489968|459748987|FG003|Double-blind Treatment Period|Other than specified above|0|||
127760846|NCT02489968|459748988|FG004|Double-blind Treatment Period|Other than specified above|1|||
127760847|NCT02489968|459748989|FG005|Double-blind Treatment Period|Other than specified above|0|||
127760848|NCT04577001|459748991|FG000|Overall Study|Subject became ineligible|0|||
127760849|NCT04577001|459748992|FG001|Overall Study|Subject became ineligible|1|||
127760850|NCT01241604|459748993|FG000|Screening Period|Screen Failure|3|||
127760851|NCT01241604|459748994|FG001|Screening Period|Screen Failure|0|||
127760852|NCT01241604|459748995|FG002|Screening Period|Screen Failure|0|||
127760853|NCT01593787|459748996|FG000|Overall Study|Adverse Event|1|||
127760854|NCT01593787|459748997|FG001|Overall Study|Adverse Event|0|||
127760855|NCT01593787|459748998|FG002|Overall Study|Adverse Event|0|||
127760856|NCT01865747|459749000|FG000|Overall Study (ITT)|Adverse Event|32|||
127760857|NCT01865747|459749001|FG001|Overall Study (ITT)|Adverse Event|31|||
127760858|NCT01865747|459749000|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
127760859|NCT01865747|459749001|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
127760860|NCT01865747|459749000|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
127760861|NCT01865747|459749001|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
127760862|NCT01865747|459749000|FG000|Overall Study (ITT)|Protocol Violation|1|||
127760863|NCT01865747|459749001|FG001|Overall Study (ITT)|Protocol Violation|1|||
127760864|NCT01865747|459749000|FG000|Overall Study (ITT)|Physician Decision|5|||
127760865|NCT01865747|459749001|FG001|Overall Study (ITT)|Physician Decision|2|||
127760866|NCT01865747|459749000|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
127760867|NCT01865747|459749001|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
127760868|NCT01865747|459749000|FG000|Overall Study (ITT)|Sponsor Decision|0|||
127760869|NCT01865747|459749001|FG001|Overall Study (ITT)|Sponsor Decision|1|||
127760870|NCT01865747|459749000|FG000|Overall Study (ITT)|Progressive Disease|122|||
127760871|NCT01865747|459749001|FG001|Overall Study (ITT)|Progressive Disease|158|||
127760872|NCT01865747|459749000|FG000|Overall Study (ITT)|Reason Not Provided|0|||
127760873|NCT01865747|459749001|FG001|Overall Study (ITT)|Reason Not Provided|1|||
127760874|NCT01865747|459749000|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
127760875|NCT01865747|459749001|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
127760876|NCT01865747|459749000|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
127760877|NCT01865747|459749001|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
127760878|NCT01865747|459749000|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
127760879|NCT01865747|459749001|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
127760880|NCT01865747|459749000|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
127760881|NCT01865747|459749001|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
127760882|NCT01865747|459749000|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
127760883|NCT01865747|459749001|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
127760884|NCT01865747|459749000|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
127760885|NCT01865747|459749001|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
127760886|NCT01865747|459749000|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
127760887|NCT01865747|459749001|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
127760888|NCT01865747|459749000|FG000|Primary Intent to Treat (PITT)|Other|0|||
127760889|NCT01865747|459749001|FG001|Primary Intent to Treat (PITT)|Other|1|||
127760890|NCT03465904|459749004|FG000|Overall Study|Withdrawal by Subject|9|||
127760891|NCT03465904|459749005|FG001|Overall Study|Withdrawal by Subject|5|||
127760892|NCT03465904|459749004|FG000|Overall Study|Lost to Follow-up|11|||
127760893|NCT03465904|459749005|FG001|Overall Study|Lost to Follow-up|9|||
127760894|NCT03465904|459749004|FG000|Overall Study|Protocol Violation|20|||
127760895|NCT03465904|459749005|FG001|Overall Study|Protocol Violation|15|||
127760896|NCT01305200|459749007|FG000|Overall Study|Physician Decision|4|||
127760897|NCT01305200|459749008|FG001|Overall Study|Physician Decision|6|||
127760898|NCT01305200|459749009|FG002|Overall Study|Physician Decision|1|||
127760899|NCT01305200|459749007|FG000|Overall Study|Withdrawal by Subject|24|||
127760900|NCT01305200|459749008|FG001|Overall Study|Withdrawal by Subject|21|||
127760901|NCT01305200|459749009|FG002|Overall Study|Withdrawal by Subject|1|||
127760902|NCT01305200|459749007|FG000|Overall Study|Ineligible|1|||
127760903|NCT01305200|459749008|FG001|Overall Study|Ineligible|2|||
127760904|NCT01305200|459749009|FG002|Overall Study|Ineligible|1|||
127760905|NCT01305200|459749007|FG000|Overall Study|Death|0|||
127760906|NCT01305200|459749008|FG001|Overall Study|Death|2|||
127760907|NCT01305200|459749009|FG002|Overall Study|Death|0|||
127760908|NCT01290315|459750401|FG000|Overall Study|Adverse Event|0|||
127760909|NCT01290315|459750402|FG001|Overall Study|Adverse Event|0|||
127760910|NCT01290315|459750403|FG002|Overall Study|Adverse Event|0|||
127760911|NCT01290315|459750404|FG003|Overall Study|Adverse Event|3|||
127760912|NCT01290315|459750401|FG000|Overall Study|Selection criteria/compliance|2|||
127760913|NCT01290315|459750402|FG001|Overall Study|Selection criteria/compliance|1|||
127760914|NCT01290315|459750403|FG002|Overall Study|Selection criteria/compliance|0|||
127760915|NCT01290315|459750404|FG003|Overall Study|Selection criteria/compliance|2|||
127760916|NCT01290315|459750401|FG000|Overall Study|Lost to Follow-up|0|||
127760917|NCT01290315|459750402|FG001|Overall Study|Lost to Follow-up|1|||
127760918|NCT01290315|459750403|FG002|Overall Study|Lost to Follow-up|0|||
127760919|NCT01290315|459750404|FG003|Overall Study|Lost to Follow-up|0|||
127760920|NCT01290315|459750401|FG000|Overall Study|Withdrawal by Subject|1|||
127760921|NCT01290315|459750402|FG001|Overall Study|Withdrawal by Subject|1|||
127760922|NCT01290315|459750403|FG002|Overall Study|Withdrawal by Subject|0|||
127760923|NCT01290315|459750404|FG003|Overall Study|Withdrawal by Subject|0|||
127760924|NCT00591721|459750405|FG000|Overall Study|Withdrawal by Subject|10|||
127760925|NCT00591721|459750406|FG001|Overall Study|Withdrawal by Subject|10|||
127760926|NCT00591721|459750405|FG000|Overall Study|Lost to Follow-up|1|||
127760927|NCT00591721|459750406|FG001|Overall Study|Lost to Follow-up|4|||
127760928|NCT00591721|459750405|FG000|Overall Study|Intervention not received|10|||
127760929|NCT00591721|459750406|FG001|Overall Study|Intervention not received|8|||
127760930|NCT00901186|459750409|FG000|Overall Study|Lack of Efficacy|0|||
127760931|NCT00901186|459750410|FG001|Overall Study|Lack of Efficacy|1|||
127760932|NCT00901186|459750409|FG000|Overall Study|Abnormal laboratory values|0|||
127760933|NCT00901186|459750410|FG001|Overall Study|Abnormal laboratory values|1|||
127760934|NCT00901186|459750409|FG000|Overall Study|Lost to Follow-up|2|||
127760935|NCT00901186|459750410|FG001|Overall Study|Lost to Follow-up|0|||
127760936|NCT00901186|459750409|FG000|Overall Study|Adverse Event|2|||
127760937|NCT00901186|459750410|FG001|Overall Study|Adverse Event|4|||
127760938|NCT00901186|459750409|FG000|Overall Study|Administration problems|0|||
127760939|NCT00901186|459750410|FG001|Overall Study|Administration problems|1|||
127760940|NCT00901186|459750409|FG000|Overall Study|Protocol deviations|5|||
127760941|NCT00901186|459750410|FG001|Overall Study|Protocol deviations|4|||
127760942|NCT00581555|459750411|FG000|Overall Study|Adverse Event|4|||
127760943|NCT00581555|459750412|FG001|Overall Study|Adverse Event|3|||
127760944|NCT00581555|459750411|FG000|Overall Study|Physician Decision|3|||
127760945|NCT00581555|459750412|FG001|Overall Study|Physician Decision|2|||
127760946|NCT00581555|459750411|FG000|Overall Study|Withdrawal by Subject|18|||
127760947|NCT00581555|459750412|FG001|Overall Study|Withdrawal by Subject|9|||
127760948|NCT00581555|459750411|FG000|Overall Study|Lost to Follow-up|2|||
127760949|NCT00581555|459750412|FG001|Overall Study|Lost to Follow-up|2|||
127760950|NCT00581555|459750411|FG000|Overall Study|Other reasons|16|||
127760951|NCT00581555|459750412|FG001|Overall Study|Other reasons|4|||
127760952|NCT03828747|459750413|FG000|Double-Blind Treatment Period|Adverse Event|6|||
127760953|NCT03828747|459750414|FG001|Double-Blind Treatment Period|Adverse Event|6|||
127760954|NCT03828747|459750413|FG000|Double-Blind Treatment Period|Death|1|||
127760955|NCT03828747|459750414|FG001|Double-Blind Treatment Period|Death|1|||
127760956|NCT03828747|459750413|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
127760957|NCT03828747|459750414|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
127760958|NCT03828747|459750413|FG000|Double-Blind Treatment Period|Withdrawal by Subject|17|||
127760959|NCT03828747|459750414|FG001|Double-Blind Treatment Period|Withdrawal by Subject|19|||
127760960|NCT03828747|459750413|FG000|Double-Blind Treatment Period|Physician Decision|1|||
127760961|NCT03828747|459750414|FG001|Double-Blind Treatment Period|Physician Decision|4|||
127760962|NCT03828747|459750413|FG000|Double-Blind Treatment Period|Various reasons|5|||
127760963|NCT03828747|459750414|FG001|Double-Blind Treatment Period|Various reasons|3|||
127760964|NCT03828747|459750413|FG000|Open-Label Extension|Adverse Event|9|||
127760965|NCT03828747|459750414|FG001|Open-Label Extension|Adverse Event|7|||
127760966|NCT03828747|459750413|FG000|Open-Label Extension|Death|0|||
127760967|NCT03828747|459750414|FG001|Open-Label Extension|Death|2|||
127760968|NCT03828747|459750413|FG000|Open-Label Extension|Lost to Follow-up|4|||
127760969|NCT03828747|459750414|FG001|Open-Label Extension|Lost to Follow-up|0|||
127760970|NCT03828747|459750413|FG000|Open-Label Extension|Withdrawal by Subject|31|||
127760971|NCT03828747|459750414|FG001|Open-Label Extension|Withdrawal by Subject|30|||
127760972|NCT03828747|459750413|FG000|Open-Label Extension|Various reasons|4|||
127760973|NCT03828747|459750414|FG001|Open-Label Extension|Various reasons|4|||
127760974|NCT03828747|459750413|FG000|Open-Label Extension|Physician Decision|6|||
127760975|NCT03828747|459750414|FG001|Open-Label Extension|Physician Decision|2|||
127760976|NCT03900416|459750415|FG000|Six Week Follow-up|Lost to Follow-up|1|||
127760977|NCT03900416|459750416|FG001|Six Week Follow-up|Lost to Follow-up|0|||
127760978|NCT03900416|459750415|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
127760979|NCT03900416|459750416|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
127760980|NCT03900416|459750415|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
127760981|NCT03900416|459750416|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
127760982|NCT03900416|459750415|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
127760983|NCT03900416|459750416|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
127760984|NCT03900416|459750415|FG000|Twelve Week Follow-up|Adverse Event|1|||
127760985|NCT03900416|459750416|FG001|Twelve Week Follow-up|Adverse Event|1|||
127760986|NCT03900416|459750415|FG000|Six Month Follow-up|Lost to Follow-up|4|||
127760987|NCT03900416|459750416|FG001|Six Month Follow-up|Lost to Follow-up|3|||
127760988|NCT03900416|459750415|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
127760989|NCT03900416|459750416|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
127760990|NCT00772330|459750417|FG000|Overall Study|Lost to Follow-up|3|||
127760991|NCT00424385|459750418|FG000|Cohort 0|Withdrawal by Subject|5|||
127760992|NCT00424385|459750418|FG000|Cohort 0|Physician Decision|1|||
127760993|NCT00424385|459750418|FG000|Cohort 1|Withdrawal by Subject|1|||
127760994|NCT02683876|459750419|FG000|Overall Study|samples damaged during shipping|2|||
127760995|NCT02683876|459750420|FG001|Overall Study|samples damaged during shipping|0|||
127760996|NCT03231800|459750427|FG000|Overall Study|Lost to Follow-up|0|||
127760997|NCT03231800|459750428|FG001|Overall Study|Lost to Follow-up|2|||
127760998|NCT03231800|459750427|FG000|Overall Study|Protocol Violation|1|||
127760999|NCT03231800|459750428|FG001|Overall Study|Protocol Violation|1|||
127761000|NCT03231800|459750427|FG000|Overall Study|reason not provided|2|||
127761001|NCT03231800|459750428|FG001|Overall Study|reason not provided|0|||
127761002|NCT00859222|459750429|FG000|Overall Study|Adverse Event|2|||
127761003|NCT00859222|459750430|FG001|Overall Study|Adverse Event|3|||
127761004|NCT00859222|459750431|FG002|Overall Study|Adverse Event|6|||
127761005|NCT00859222|459750432|FG003|Overall Study|Adverse Event|24|||
127761006|NCT00859222|459750433|FG004|Overall Study|Adverse Event|15|||
127761007|NCT00859222|459750429|FG000|Overall Study|DLT|1|||
127761008|NCT00859222|459750430|FG001|Overall Study|DLT|0|||
127761009|NCT00859222|459750431|FG002|Overall Study|DLT|0|||
127761010|NCT00859222|459750432|FG003|Overall Study|DLT|0|||
127761011|NCT00859222|459750433|FG004|Overall Study|DLT|0|||
127761012|NCT00400725|459750444|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
127761013|NCT00400725|459750445|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
127761014|NCT00400725|459750446|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
127761015|NCT00400725|459750444|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
127761016|NCT00400725|459750445|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
127761017|NCT00400725|459750446|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
127761018|NCT00400725|459750444|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
127761019|NCT00400725|459750445|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
127761020|NCT00400725|459750446|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
127761021|NCT00400725|459750444|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
127761022|NCT00400725|459750445|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
127761023|NCT00400725|459750446|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
127761024|NCT00400725|459750444|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
127761025|NCT00400725|459750445|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
127761026|NCT00400725|459750446|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
127761027|NCT00400725|459750444|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
127761028|NCT00400725|459750445|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
127761029|NCT00400725|459750446|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
127761030|NCT00400725|459750444|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
127761031|NCT00400725|459750445|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
127761032|NCT00400725|459750446|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
127761033|NCT00400725|459750444|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
127761034|NCT00400725|459750445|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
127761035|NCT00400725|459750446|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
127761036|NCT00400725|459750444|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
127761037|NCT00400725|459750445|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
127761038|NCT00400725|459750446|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
127761039|NCT00252577|459750447|FG000|Overall Study|Lost to Follow-up|20|||
127761040|NCT00560066|459750449|FG000|Overall Study|Death|2|||
127761041|NCT00560066|459750450|FG001|Overall Study|Death|1|||
127761042|NCT00560066|459750449|FG000|Overall Study|Withdrawal by Subject|0|||
127761043|NCT00560066|459750450|FG001|Overall Study|Withdrawal by Subject|3|||
127761044|NCT00560066|459750449|FG000|Overall Study|Lost to Follow-up|4|||
127761045|NCT00560066|459750450|FG001|Overall Study|Lost to Follow-up|10|||
127761046|NCT00560066|459750449|FG000|Overall Study|Protocol Violation|0|||
127761047|NCT00560066|459750450|FG001|Overall Study|Protocol Violation|1|||
127761048|NCT00560066|459750449|FG000|Overall Study|Administrative reason|0|||
127761049|NCT00560066|459750450|FG001|Overall Study|Administrative reason|5|||
127761050|NCT00560066|459750449|FG000|Overall Study|Missing primary reason|0|||
127761051|NCT00560066|459750450|FG001|Overall Study|Missing primary reason|2|||
127761052|NCT00620282|459750457|FG000|Overall Study|Adverse Event|0|||
127761053|NCT00620282|459750458|FG001|Overall Study|Adverse Event|1|||
127761054|NCT00620282|459750459|FG002|Overall Study|Adverse Event|0|||
127761055|NCT00620282|459750457|FG000|Overall Study|Arterial line unable to be placed|0|||
127761056|NCT00620282|459750458|FG001|Overall Study|Arterial line unable to be placed|0|||
127761057|NCT00620282|459750459|FG002|Overall Study|Arterial line unable to be placed|1|||
127761058|NCT00620282|459750457|FG000|Overall Study|Withdrawal by Subject|0|||
127761059|NCT00620282|459750458|FG001|Overall Study|Withdrawal by Subject|1|||
127761060|NCT00620282|459750459|FG002|Overall Study|Withdrawal by Subject|0|||
127761061|NCT01258595|459750460|FG000|Overall Study|Lost to Follow-up|1|||
127761062|NCT01258595|459750461|FG001|Overall Study|Lost to Follow-up|0|||
127761063|NCT01258595|459750460|FG000|Overall Study|Withdrawal by Subject|0|||
127761064|NCT01258595|459750461|FG001|Overall Study|Withdrawal by Subject|1|||
127761065|NCT02285153|459750463|FG000|Overall Study|Adverse Event|1|||
127761066|NCT02285153|459750464|FG001|Overall Study|Adverse Event|0|||
127761067|NCT01489891|459750468|FG000|Overall Study|Endoscopy failure|1|||
127761068|NCT01489891|459750469|FG001|Overall Study|Endoscopy failure|0|||
127761069|NCT00998790|459750470|FG000|Overall Study|Withdrawal by Subject|21|||
127761070|NCT00888927|459750471|FG000|Overall Study|Adverse Event|0|||
127761071|NCT00888927|459750472|FG001|Overall Study|Adverse Event|0|||
127761072|NCT00888927|459750473|FG002|Overall Study|Adverse Event|0|||
127761073|NCT00888927|459750474|FG003|Overall Study|Adverse Event|1|||
127761074|NCT00888927|459750471|FG000|Overall Study|Withdrawal of consent|0|||
127761075|NCT00888927|459750472|FG001|Overall Study|Withdrawal of consent|0|||
127761076|NCT00888927|459750473|FG002|Overall Study|Withdrawal of consent|0|||
127761077|NCT00888927|459750474|FG003|Overall Study|Withdrawal of consent|1|||
127761078|NCT03459443|459750475|FG000|Overall Study|Lack of Efficacy|3|||
127761079|NCT03459443|459750475|FG000|Overall Study|Adverse Event|1|||
127761080|NCT03459443|459750475|FG000|Overall Study|Sponsor's decision to close the study|18|||
127761081|NCT03189745|459750476|FG000|Overall Study|Conflict in work schedule of participant|1|||
127761082|NCT03189745|459750477|FG001|Overall Study|Conflict in work schedule of participant|1|||
127761083|NCT01056718|459750478|FG000|Overall Study|Withdrawal by Subject|2|||
127761084|NCT01056718|459750478|FG000|Overall Study|Ischemia on baseline stress test|1|||
127761085|NCT05086276|459750479|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
127761086|NCT05086276|459750480|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
127761087|NCT00777088|459750481|FG000|Overall Study|PED Treatment not attempted|1|||
127761088|NCT03592745|459750482|FG000|Overall Study|Adverse Event|0|||
127761089|NCT03592745|459750483|FG001|Overall Study|Adverse Event|2|||
127761090|NCT03592745|459750482|FG000|Overall Study|Lost to Follow-up|2|||
127761091|NCT03592745|459750483|FG001|Overall Study|Lost to Follow-up|0|||
127761092|NCT03592745|459750482|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
127761093|NCT03592745|459750483|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
127761094|NCT03381339|459750485|FG000|Overall Study|Protocol Violation|4|||
127761095|NCT03381339|459750486|FG001|Overall Study|Protocol Violation|3|||
127761096|NCT03381339|459750485|FG000|Overall Study|Lost to Follow-up|0|||
127761097|NCT03381339|459750486|FG001|Overall Study|Lost to Follow-up|1|||
127761098|NCT03117998|459750490|FG000|Overall Study|Adverse Event|1|||
127761099|NCT03117998|459750491|FG001|Overall Study|Adverse Event|0|||
127761100|NCT03117998|459750492|FG002|Overall Study|Adverse Event|0|||
127761101|NCT03117998|459750493|FG003|Overall Study|Adverse Event|0|||
127761102|NCT03117998|459750494|FG004|Overall Study|Adverse Event|0|||
127761103|NCT03117998|459750495|FG005|Overall Study|Adverse Event|0|||
127761104|NCT03117998|459750490|FG000|Overall Study|Withdrawal by Subject|0|||
127761105|NCT03117998|459750491|FG001|Overall Study|Withdrawal by Subject|0|||
127761106|NCT03117998|459750492|FG002|Overall Study|Withdrawal by Subject|2|||
127761107|NCT03117998|459750493|FG003|Overall Study|Withdrawal by Subject|3|||
127761108|NCT03117998|459750494|FG004|Overall Study|Withdrawal by Subject|3|||
127761109|NCT03117998|459750495|FG005|Overall Study|Withdrawal by Subject|0|||
127761110|NCT03117998|459750490|FG000|Overall Study|Physician Decision|0|||
127761111|NCT03117998|459750491|FG001|Overall Study|Physician Decision|1|||
127761112|NCT03117998|459750492|FG002|Overall Study|Physician Decision|1|||
127761113|NCT03117998|459750493|FG003|Overall Study|Physician Decision|0|||
127761114|NCT03117998|459750494|FG004|Overall Study|Physician Decision|0|||
127761115|NCT03117998|459750495|FG005|Overall Study|Physician Decision|0|||
127761116|NCT03117998|459750490|FG000|Overall Study|Lost to Follow-up|0|||
127761117|NCT03117998|459750491|FG001|Overall Study|Lost to Follow-up|0|||
127761118|NCT03117998|459750492|FG002|Overall Study|Lost to Follow-up|0|||
127761119|NCT03117998|459750493|FG003|Overall Study|Lost to Follow-up|1|||
127761120|NCT03117998|459750494|FG004|Overall Study|Lost to Follow-up|4|||
127761121|NCT03117998|459750495|FG005|Overall Study|Lost to Follow-up|0|||
127761122|NCT03117998|459750490|FG000|Overall Study|Subject noncompliance|0|||
127761123|NCT03117998|459750491|FG001|Overall Study|Subject noncompliance|0|||
127761124|NCT03117998|459750492|FG002|Overall Study|Subject noncompliance|1|||
127761125|NCT03117998|459750493|FG003|Overall Study|Subject noncompliance|0|||
127761126|NCT03117998|459750494|FG004|Overall Study|Subject noncompliance|0|||
127761127|NCT03117998|459750495|FG005|Overall Study|Subject noncompliance|2|||
127761128|NCT03117998|459750490|FG000|Overall Study|Protocol Violation|0|||
127761129|NCT03117998|459750491|FG001|Overall Study|Protocol Violation|0|||
127761130|NCT03117998|459750492|FG002|Overall Study|Protocol Violation|0|||
127761131|NCT03117998|459750493|FG003|Overall Study|Protocol Violation|0|||
127761132|NCT03117998|459750494|FG004|Overall Study|Protocol Violation|0|||
127761133|NCT03117998|459750495|FG005|Overall Study|Protocol Violation|1|||
127761134|NCT04927247|459750496|FG000|Overall Study|Other|2|||
127761135|NCT04927247|459750497|FG001|Overall Study|Other|1|||
127761136|NCT04927247|459750496|FG000|Overall Study|Physician Decision|0|||
127761137|NCT04927247|459750497|FG001|Overall Study|Physician Decision|1|||
127761138|NCT04927247|459750496|FG000|Overall Study|Adverse Event|1|||
127761139|NCT04927247|459750497|FG001|Overall Study|Adverse Event|0|||
127761140|NCT00438672|459750501|FG000|Overall Study|Lost to Follow-up|7|||
127761141|NCT00438672|459750502|FG001|Overall Study|Lost to Follow-up|9|||
127761142|NCT02712905|459750503|FG000|Monotherapy|Death|2|||
127761143|NCT02712905|459750504|FG001|Monotherapy|Death|5|||
127761144|NCT02712905|459750505|FG002|Monotherapy|Death|0|||
127761145|NCT02712905|459750506|FG003|Monotherapy|Death|3|||
127761146|NCT02712905|459750507|FG004|Monotherapy|Death|15|||
127761147|NCT02712905|459750508|FG005|Monotherapy|Death|1|||
127761148|NCT02712905|459750509|FG006|Monotherapy|Death|3|||
127761149|NCT02712905|459750510|FG007|Monotherapy|Death|3|||
127761150|NCT02712905|459750511|FG008|Monotherapy|Death|0|||
127761151|NCT02712905|459750512|FG009|Monotherapy|Death|27|||
127761152|NCT02712905|459750513|FG010|Monotherapy|Death|2|||
127761153|NCT02712905|459750514|FG011|Monotherapy|Death|5|||
127761154|NCT02712905|459750515|FG012|Monotherapy|Death|0|||
127761155|NCT02712905|459750516|FG013|Monotherapy|Death|0|||
127761156|NCT02712905|459750517|FG014|Monotherapy|Death|0|||
127761157|NCT02712905|459750518|FG015|Monotherapy|Death|0|||
127761158|NCT02712905|459750519|FG016|Monotherapy|Death|0|||
127761159|NCT02712905|459750520|FG017|Monotherapy|Death|0|||
127761160|NCT02712905|459750503|FG000|Monotherapy|Lost to Follow-up|0|||
127761161|NCT02712905|459750504|FG001|Monotherapy|Lost to Follow-up|1|||
127761162|NCT02712905|459750505|FG002|Monotherapy|Lost to Follow-up|0|||
127761163|NCT02712905|459750506|FG003|Monotherapy|Lost to Follow-up|1|||
127761164|NCT02712905|459750507|FG004|Monotherapy|Lost to Follow-up|0|||
127761165|NCT02712905|459750508|FG005|Monotherapy|Lost to Follow-up|0|||
127761166|NCT02712905|459750509|FG006|Monotherapy|Lost to Follow-up|0|||
127761167|NCT02712905|459750510|FG007|Monotherapy|Lost to Follow-up|0|||
127761168|NCT02712905|459750511|FG008|Monotherapy|Lost to Follow-up|0|||
127761169|NCT02712905|459750512|FG009|Monotherapy|Lost to Follow-up|2|||
127761170|NCT02712905|459750513|FG010|Monotherapy|Lost to Follow-up|0|||
127761171|NCT02712905|459750514|FG011|Monotherapy|Lost to Follow-up|0|||
127761172|NCT02712905|459750515|FG012|Monotherapy|Lost to Follow-up|0|||
127761173|NCT02712905|459750516|FG013|Monotherapy|Lost to Follow-up|0|||
127761174|NCT02712905|459750517|FG014|Monotherapy|Lost to Follow-up|0|||
127761175|NCT02712905|459750518|FG015|Monotherapy|Lost to Follow-up|0|||
127761176|NCT02712905|459750519|FG016|Monotherapy|Lost to Follow-up|0|||
127761177|NCT02712905|459750520|FG017|Monotherapy|Lost to Follow-up|0|||
127761178|NCT02712905|459750503|FG000|Monotherapy|Physician Decision|1|||
127761179|NCT02712905|459750504|FG001|Monotherapy|Physician Decision|0|||
127761180|NCT02712905|459750505|FG002|Monotherapy|Physician Decision|0|||
127761181|NCT02712905|459750506|FG003|Monotherapy|Physician Decision|1|||
127761182|NCT02712905|459750507|FG004|Monotherapy|Physician Decision|0|||
127761183|NCT02712905|459750508|FG005|Monotherapy|Physician Decision|0|||
127761184|NCT02712905|459750509|FG006|Monotherapy|Physician Decision|0|||
127761185|NCT02712905|459750510|FG007|Monotherapy|Physician Decision|0|||
127761186|NCT02712905|459750511|FG008|Monotherapy|Physician Decision|0|||
127761187|NCT02712905|459750512|FG009|Monotherapy|Physician Decision|1|||
127761188|NCT02712905|459750513|FG010|Monotherapy|Physician Decision|0|||
127761189|NCT02712905|459750514|FG011|Monotherapy|Physician Decision|0|||
127761190|NCT02712905|459750515|FG012|Monotherapy|Physician Decision|0|||
127761191|NCT02712905|459750516|FG013|Monotherapy|Physician Decision|0|||
127761192|NCT02712905|459750517|FG014|Monotherapy|Physician Decision|0|||
127761193|NCT02712905|459750518|FG015|Monotherapy|Physician Decision|0|||
127761194|NCT02712905|459750519|FG016|Monotherapy|Physician Decision|0|||
127761195|NCT02712905|459750520|FG017|Monotherapy|Physician Decision|0|||
127761196|NCT02712905|459750503|FG000|Monotherapy|Study Terminated by Sponsor|0|||
127761197|NCT02712905|459750504|FG001|Monotherapy|Study Terminated by Sponsor|0|||
127761198|NCT02712905|459750505|FG002|Monotherapy|Study Terminated by Sponsor|0|||
127761199|NCT02712905|459750506|FG003|Monotherapy|Study Terminated by Sponsor|0|||
127761200|NCT02712905|459750507|FG004|Monotherapy|Study Terminated by Sponsor|1|||
127761201|NCT02712905|459750508|FG005|Monotherapy|Study Terminated by Sponsor|0|||
127761202|NCT02712905|459750509|FG006|Monotherapy|Study Terminated by Sponsor|0|||
127761203|NCT02712905|459750510|FG007|Monotherapy|Study Terminated by Sponsor|0|||
127761204|NCT02712905|459750511|FG008|Monotherapy|Study Terminated by Sponsor|0|||
127761205|NCT02712905|459750512|FG009|Monotherapy|Study Terminated by Sponsor|2|||
127761206|NCT02712905|459750513|FG010|Monotherapy|Study Terminated by Sponsor|0|||
127761207|NCT02712905|459750514|FG011|Monotherapy|Study Terminated by Sponsor|0|||
127761208|NCT02712905|459750515|FG012|Monotherapy|Study Terminated by Sponsor|0|||
127761209|NCT02712905|459750516|FG013|Monotherapy|Study Terminated by Sponsor|0|||
127761210|NCT02712905|459750517|FG014|Monotherapy|Study Terminated by Sponsor|0|||
127761211|NCT02712905|459750518|FG015|Monotherapy|Study Terminated by Sponsor|0|||
127761212|NCT02712905|459750519|FG016|Monotherapy|Study Terminated by Sponsor|0|||
127761213|NCT02712905|459750520|FG017|Monotherapy|Study Terminated by Sponsor|0|||
127761214|NCT02712905|459750503|FG000|Monotherapy|Withdrawal by Subject|0|||
127761215|NCT02712905|459750504|FG001|Monotherapy|Withdrawal by Subject|0|||
127761216|NCT02712905|459750505|FG002|Monotherapy|Withdrawal by Subject|1|||
127761217|NCT02712905|459750506|FG003|Monotherapy|Withdrawal by Subject|0|||
127761218|NCT02712905|459750507|FG004|Monotherapy|Withdrawal by Subject|2|||
127761219|NCT02712905|459750508|FG005|Monotherapy|Withdrawal by Subject|0|||
127761220|NCT02712905|459750509|FG006|Monotherapy|Withdrawal by Subject|0|||
127761221|NCT02712905|459750510|FG007|Monotherapy|Withdrawal by Subject|0|||
127761222|NCT02712905|459750511|FG008|Monotherapy|Withdrawal by Subject|0|||
127761223|NCT02712905|459750512|FG009|Monotherapy|Withdrawal by Subject|4|||
127761224|NCT02712905|459750513|FG010|Monotherapy|Withdrawal by Subject|1|||
127761225|NCT02712905|459750514|FG011|Monotherapy|Withdrawal by Subject|2|||
127761226|NCT02712905|459750515|FG012|Monotherapy|Withdrawal by Subject|0|||
127761227|NCT02712905|459750516|FG013|Monotherapy|Withdrawal by Subject|0|||
127761228|NCT02712905|459750517|FG014|Monotherapy|Withdrawal by Subject|0|||
127761229|NCT02712905|459750518|FG015|Monotherapy|Withdrawal by Subject|0|||
127761230|NCT02712905|459750519|FG016|Monotherapy|Withdrawal by Subject|0|||
127761231|NCT02712905|459750520|FG017|Monotherapy|Withdrawal by Subject|0|||
127761232|NCT02712905|459750503|FG000|Monotherapy|Started New Cancer Drug|0|||
127761233|NCT02712905|459750504|FG001|Monotherapy|Started New Cancer Drug|0|||
127761234|NCT02712905|459750505|FG002|Monotherapy|Started New Cancer Drug|0|||
127761235|NCT02712905|459750506|FG003|Monotherapy|Started New Cancer Drug|0|||
127761236|NCT02712905|459750507|FG004|Monotherapy|Started New Cancer Drug|0|||
127761237|NCT02712905|459750508|FG005|Monotherapy|Started New Cancer Drug|1|||
127761238|NCT02712905|459750509|FG006|Monotherapy|Started New Cancer Drug|0|||
127761239|NCT02712905|459750510|FG007|Monotherapy|Started New Cancer Drug|0|||
127761240|NCT02712905|459750511|FG008|Monotherapy|Started New Cancer Drug|0|||
127761241|NCT02712905|459750512|FG009|Monotherapy|Started New Cancer Drug|0|||
127761242|NCT02712905|459750513|FG010|Monotherapy|Started New Cancer Drug|0|||
127761243|NCT02712905|459750514|FG011|Monotherapy|Started New Cancer Drug|0|||
127761244|NCT02712905|459750515|FG012|Monotherapy|Started New Cancer Drug|0|||
127761245|NCT02712905|459750516|FG013|Monotherapy|Started New Cancer Drug|0|||
127761246|NCT02712905|459750517|FG014|Monotherapy|Started New Cancer Drug|0|||
127761247|NCT02712905|459750518|FG015|Monotherapy|Started New Cancer Drug|0|||
127761248|NCT02712905|459750519|FG016|Monotherapy|Started New Cancer Drug|0|||
127761249|NCT02712905|459750520|FG017|Monotherapy|Started New Cancer Drug|0|||
127761250|NCT02712905|459750503|FG000|Monotherapy|Adverse Event|0|||
127761251|NCT02712905|459750504|FG001|Monotherapy|Adverse Event|0|||
127761252|NCT02712905|459750505|FG002|Monotherapy|Adverse Event|0|||
127761253|NCT02712905|459750506|FG003|Monotherapy|Adverse Event|0|||
127761254|NCT02712905|459750507|FG004|Monotherapy|Adverse Event|0|||
127761255|NCT02712905|459750508|FG005|Monotherapy|Adverse Event|0|||
127761256|NCT02712905|459750509|FG006|Monotherapy|Adverse Event|0|||
127761257|NCT02712905|459750510|FG007|Monotherapy|Adverse Event|0|||
127761258|NCT02712905|459750511|FG008|Monotherapy|Adverse Event|1|||
127761259|NCT02712905|459750512|FG009|Monotherapy|Adverse Event|0|||
127761260|NCT02712905|459750513|FG010|Monotherapy|Adverse Event|0|||
127761261|NCT02712905|459750514|FG011|Monotherapy|Adverse Event|0|||
127761262|NCT02712905|459750515|FG012|Monotherapy|Adverse Event|0|||
127761263|NCT02712905|459750516|FG013|Monotherapy|Adverse Event|0|||
127761264|NCT02712905|459750517|FG014|Monotherapy|Adverse Event|0|||
127761265|NCT02712905|459750518|FG015|Monotherapy|Adverse Event|0|||
127761266|NCT02712905|459750519|FG016|Monotherapy|Adverse Event|0|||
127761267|NCT02712905|459750520|FG017|Monotherapy|Adverse Event|0|||
127761268|NCT02712905|459750503|FG000|Combination Therapy|Death|0|||
127761269|NCT02712905|459750504|FG001|Combination Therapy|Death|0|||
127761270|NCT02712905|459750505|FG002|Combination Therapy|Death|0|||
127761271|NCT02712905|459750506|FG003|Combination Therapy|Death|0|||
127761272|NCT02712905|459750507|FG004|Combination Therapy|Death|0|||
127761273|NCT02712905|459750508|FG005|Combination Therapy|Death|0|||
127761274|NCT02712905|459750509|FG006|Combination Therapy|Death|0|||
127761275|NCT02712905|459750510|FG007|Combination Therapy|Death|0|||
127761276|NCT02712905|459750511|FG008|Combination Therapy|Death|0|||
127761277|NCT02712905|459750512|FG009|Combination Therapy|Death|0|||
127761278|NCT02712905|459750513|FG010|Combination Therapy|Death|0|||
127761279|NCT02712905|459750514|FG011|Combination Therapy|Death|0|||
127761280|NCT02712905|459750515|FG012|Combination Therapy|Death|5|||
127761281|NCT02712905|459750516|FG013|Combination Therapy|Death|6|||
127761282|NCT02712905|459750517|FG014|Combination Therapy|Death|1|||
127761283|NCT02712905|459750518|FG015|Combination Therapy|Death|3|||
127761284|NCT02712905|459750519|FG016|Combination Therapy|Death|1|||
127761285|NCT02712905|459750520|FG017|Combination Therapy|Death|3|||
127761286|NCT02712905|459750503|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
127761287|NCT02712905|459750504|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
127761288|NCT02712905|459750505|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
127761289|NCT02712905|459750506|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
127761290|NCT02712905|459750507|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
127761291|NCT02712905|459750508|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
127761292|NCT02712905|459750509|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
127761293|NCT02712905|459750510|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
127761294|NCT02712905|459750511|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
127761295|NCT02712905|459750512|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
127761296|NCT02712905|459750513|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
127761297|NCT02712905|459750514|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
127761298|NCT02712905|459750515|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
127761299|NCT02712905|459750516|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
127761300|NCT02712905|459750517|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
127761301|NCT02712905|459750518|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
127761302|NCT02712905|459750519|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
127761303|NCT02712905|459750520|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
127761304|NCT02712905|459750503|FG000|Combination Therapy|Withdrawal by Subject|0|||
127761305|NCT02712905|459750504|FG001|Combination Therapy|Withdrawal by Subject|0|||
127761306|NCT02712905|459750505|FG002|Combination Therapy|Withdrawal by Subject|0|||
127761307|NCT02712905|459750506|FG003|Combination Therapy|Withdrawal by Subject|0|||
127761308|NCT02712905|459750507|FG004|Combination Therapy|Withdrawal by Subject|0|||
127761309|NCT02712905|459750508|FG005|Combination Therapy|Withdrawal by Subject|0|||
127761310|NCT02712905|459750509|FG006|Combination Therapy|Withdrawal by Subject|0|||
127761311|NCT02712905|459750510|FG007|Combination Therapy|Withdrawal by Subject|0|||
127761312|NCT02712905|459750511|FG008|Combination Therapy|Withdrawal by Subject|0|||
127761313|NCT02712905|459750512|FG009|Combination Therapy|Withdrawal by Subject|0|||
127761314|NCT02712905|459750513|FG010|Combination Therapy|Withdrawal by Subject|0|||
127761315|NCT02712905|459750514|FG011|Combination Therapy|Withdrawal by Subject|0|||
127761316|NCT02712905|459750515|FG012|Combination Therapy|Withdrawal by Subject|0|||
127761317|NCT02712905|459750516|FG013|Combination Therapy|Withdrawal by Subject|0|||
127761318|NCT02712905|459750517|FG014|Combination Therapy|Withdrawal by Subject|0|||
127761319|NCT02712905|459750518|FG015|Combination Therapy|Withdrawal by Subject|1|||
127761320|NCT02712905|459750519|FG016|Combination Therapy|Withdrawal by Subject|0|||
127761321|NCT02712905|459750520|FG017|Combination Therapy|Withdrawal by Subject|2|||
127761322|NCT02712905|459750503|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
127761323|NCT02712905|459750504|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
127761324|NCT02712905|459750505|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
127761325|NCT02712905|459750506|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
127761326|NCT02712905|459750507|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
127761327|NCT02712905|459750508|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
127761328|NCT02712905|459750509|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
127761329|NCT02712905|459750510|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
127761330|NCT02712905|459750511|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
127761331|NCT02712905|459750512|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
127761332|NCT02712905|459750513|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
127761333|NCT02712905|459750514|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
127983683|NCT02044874|460562559|FG000|Overall Study|Withdrawal by Subject|8|||
127983684|NCT02044874|460562560|FG001|Overall Study|Withdrawal by Subject|16|||
127761334|NCT02712905|459750515|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
127761335|NCT02712905|459750516|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
127761336|NCT02712905|459750517|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
127761337|NCT02712905|459750518|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
127761338|NCT02712905|459750519|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
127761339|NCT02712905|459750520|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
127761340|NCT00320528|459750521|FG000|Study Period II|Adverse Event|3|||
127761341|NCT00320528|459750522|FG001|Study Period II|Adverse Event|4|||
127761342|NCT00320528|459750523|FG002|Study Period II|Adverse Event|8|||
127761343|NCT00320528|459750521|FG000|Study Period II|Parent/Caregiver Decision|8|||
127761344|NCT00320528|459750522|FG001|Study Period II|Parent/Caregiver Decision|3|||
127761345|NCT00320528|459750523|FG002|Study Period II|Parent/Caregiver Decision|11|||
127761346|NCT00320528|459750521|FG000|Study Period II|Withdrawal by Subject|0|||
127761347|NCT00320528|459750522|FG001|Study Period II|Withdrawal by Subject|1|||
127761348|NCT00320528|459750523|FG002|Study Period II|Withdrawal by Subject|1|||
127761349|NCT00320528|459750521|FG000|Study Period II|Entry Criteria Exclusion|0|||
127761350|NCT00320528|459750522|FG001|Study Period II|Entry Criteria Exclusion|2|||
127761351|NCT00320528|459750523|FG002|Study Period II|Entry Criteria Exclusion|2|||
127761352|NCT00320528|459750521|FG000|Study Period III|Adverse Event|1|||
127761353|NCT00320528|459750522|FG001|Study Period III|Adverse Event|0|||
127761354|NCT00320528|459750523|FG002|Study Period III|Adverse Event|0|||
127761355|NCT00320528|459750521|FG000|Study Period III|Lost to Follow-up|1|||
127761356|NCT00320528|459750522|FG001|Study Period III|Lost to Follow-up|0|||
127761357|NCT00320528|459750523|FG002|Study Period III|Lost to Follow-up|0|||
127761358|NCT00320528|459750521|FG000|Study Period III|Withdrawal by Subject|1|||
127761359|NCT00320528|459750522|FG001|Study Period III|Withdrawal by Subject|1|||
127761360|NCT00320528|459750523|FG002|Study Period III|Withdrawal by Subject|2|||
127761361|NCT00320528|459750521|FG000|Study Period III|Lack of Efficacy|2|||
127761362|NCT00320528|459750522|FG001|Study Period III|Lack of Efficacy|0|||
127761363|NCT00320528|459750523|FG002|Study Period III|Lack of Efficacy|0|||
127761364|NCT00320528|459750521|FG000|Study Period III|Parent/Caregiver Decision|14|||
127761365|NCT00320528|459750522|FG001|Study Period III|Parent/Caregiver Decision|3|||
127761366|NCT00320528|459750523|FG002|Study Period III|Parent/Caregiver Decision|11|||
127761367|NCT00320528|459750521|FG000|Study Period III|Protocol Violation|0|||
127761368|NCT00320528|459750522|FG001|Study Period III|Protocol Violation|1|||
127761369|NCT00320528|459750523|FG002|Study Period III|Protocol Violation|0|||
127761370|NCT00320528|459750521|FG000|Study Period III|Physician Decision|0|||
127761371|NCT00320528|459750522|FG001|Study Period III|Physician Decision|1|||
127761372|NCT00320528|459750523|FG002|Study Period III|Physician Decision|2|||
127761373|NCT00320528|459750521|FG000|Study Period III|Sponsor Decision|0|||
127761374|NCT00320528|459750522|FG001|Study Period III|Sponsor Decision|0|||
127761375|NCT00320528|459750523|FG002|Study Period III|Sponsor Decision|1|||
127761376|NCT00320528|459750521|FG000|Study Period III|Atomoxetine Commercially Available|68|||
127761377|NCT00320528|459750522|FG001|Study Period III|Atomoxetine Commercially Available|25|||
127761378|NCT00320528|459750523|FG002|Study Period III|Atomoxetine Commercially Available|90|||
127761379|NCT04664400|459750524|FG000|Overall Study|Withdrawal by Subject|2|||
127761380|NCT01081132|459750534|FG000|Overall Study|Lack of Efficacy|25|||
127761381|NCT01081132|459750535|FG001|Overall Study|Lack of Efficacy|9|||
127761382|NCT01081132|459750534|FG000|Overall Study|Withdrawal by Subject|13|||
127761383|NCT01081132|459750535|FG001|Overall Study|Withdrawal by Subject|16|||
127761384|NCT01081132|459750534|FG000|Overall Study|Lost to Follow-up|4|||
127761385|NCT01081132|459750535|FG001|Overall Study|Lost to Follow-up|11|||
127761386|NCT01081132|459750534|FG000|Overall Study|Adverse Event|3|||
127761387|NCT01081132|459750535|FG001|Overall Study|Adverse Event|9|||
127761388|NCT01081132|459750534|FG000|Overall Study|Non Compliance|4|||
127761389|NCT01081132|459750535|FG001|Overall Study|Non Compliance|2|||
127761390|NCT01081132|459750534|FG000|Overall Study|Lack Of Compliance|0|||
127761391|NCT01081132|459750535|FG001|Overall Study|Lack Of Compliance|1|||
127761392|NCT01081132|459750534|FG000|Overall Study|Missed Visits|1|||
127761393|NCT01081132|459750535|FG001|Overall Study|Missed Visits|1|||
127761394|NCT01081132|459750534|FG000|Overall Study|Stopped Taking Meds|2|||
127761395|NCT01081132|459750535|FG001|Overall Study|Stopped Taking Meds|0|||
127761396|NCT01081132|459750534|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
127761397|NCT01081132|459750535|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
127761398|NCT01081132|459750534|FG000|Overall Study|Declined Taper Phase|0|||
127761399|NCT01081132|459750535|FG001|Overall Study|Declined Taper Phase|1|||
127761400|NCT01081132|459750534|FG000|Overall Study|Protocol Violation|3|||
127761401|NCT01081132|459750535|FG001|Overall Study|Protocol Violation|1|||
127761402|NCT02019667|459750536|FG000|First Intervention (6 Months)|Adverse Event|0|||
127761403|NCT02019667|459750537|FG001|First Intervention (6 Months)|Adverse Event|1|||
127761404|NCT02019667|459750536|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
127761405|NCT02019667|459750537|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
127761406|NCT02019667|459750536|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
127761407|NCT02019667|459750537|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
127761408|NCT02101385|459750540|FG000|Study Treatment|Disease Progression|9|||
127761409|NCT02101385|459750541|FG001|Study Treatment|Disease Progression|3|||
127761410|NCT02101385|459750540|FG000|Study Treatment|Alternative therapy|0|||
127761411|NCT02101385|459750541|FG001|Study Treatment|Alternative therapy|1|||
127761412|NCT02101385|459750540|FG000|Study Treatment|No treatment, per protocol criteria|0|||
127761413|NCT02101385|459750541|FG001|Study Treatment|No treatment, per protocol criteria|4|||
127761414|NCT02101385|459750540|FG000|Study Treatment|Patient Non compliance|0|||
127761415|NCT02101385|459750541|FG001|Study Treatment|Patient Non compliance|2|||
127761416|NCT02101385|459750540|FG000|Study Treatment|Withdrawal by Subject|5|||
127761417|NCT02101385|459750541|FG001|Study Treatment|Withdrawal by Subject|2|||
127761418|NCT02101385|459750540|FG000|Study Treatment|screen failure|1|||
127761419|NCT02101385|459750541|FG001|Study Treatment|screen failure|0|||
127761420|NCT02101385|459750540|FG000|Study Treatment|AE/Side Effects/Complications|8|||
127761421|NCT02101385|459750541|FG001|Study Treatment|AE/Side Effects/Complications|0|||
127761422|NCT02101385|459750540|FG000|Study Treatment|Lost to Follow-up|1|||
127761423|NCT02101385|459750541|FG001|Study Treatment|Lost to Follow-up|0|||
127761424|NCT02101385|459750540|FG000|Study Treatment|Disease Progression before treatment|1|||
127761425|NCT02101385|459750541|FG001|Study Treatment|Disease Progression before treatment|0|||
127761426|NCT02101385|459750540|FG000|Study Treatment|Death|1|||
127761427|NCT02101385|459750541|FG001|Study Treatment|Death|0|||
127761428|NCT02101385|459750540|FG000|Follow up|Lost to Follow-up|4|||
127761429|NCT02101385|459750541|FG001|Follow up|Lost to Follow-up|9|||
127761430|NCT02101385|459750540|FG000|Follow up|Refused to follow up|5|||
127761431|NCT02101385|459750541|FG001|Follow up|Refused to follow up|4|||
127761432|NCT02101385|459750540|FG000|Follow up|Death|21|||
127761433|NCT02101385|459750541|FG001|Follow up|Death|39|||
127761434|NCT02101385|459750540|FG000|Follow up|study completed|33|||
127761435|NCT02101385|459750541|FG001|Follow up|study completed|52|||
127761436|NCT02101385|459750540|FG000|Follow up|screen failure|2|||
127761437|NCT02101385|459750541|FG001|Follow up|screen failure|0|||
127761438|NCT02101385|459750540|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
127761439|NCT02101385|459750541|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
127761440|NCT02101385|459750540|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
127761441|NCT02101385|459750541|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
127761442|NCT02101385|459750540|FG000|Follow up|Withdrawal by Subject|2|||
127761443|NCT02101385|459750541|FG001|Follow up|Withdrawal by Subject|2|||
127761444|NCT02101385|459750540|FG000|Follow up|PI requested closure of site|0|||
127761445|NCT02101385|459750541|FG001|Follow up|PI requested closure of site|5|||
127761446|NCT02432196|459750542|FG000|Overall Study|Exit - did not receive study device|1|||
127761447|NCT02432196|459750542|FG000|Overall Study|Death|2|||
127761448|NCT02432196|459750542|FG000|Overall Study|Reoperation|3|||
127761449|NCT05038163|459750543|FG000|Stage 1|Did not complete survey|374|||
127761450|NCT05038163|459750544|FG001|Stage 1|Did not complete survey|0|||
127761451|NCT05038163|459750545|FG002|Stage 1|Did not complete survey|0|||
127761452|NCT05038163|459750546|FG003|Stage 1|Did not complete survey|0|||
127761453|NCT05038163|459750547|FG004|Stage 1|Did not complete survey|0|||
127761454|NCT05038163|459750548|FG005|Stage 1|Did not complete survey|0|||
127761455|NCT05038163|459750543|FG000|Stage 2|Did not complete Stage 2 survey|0|||
127761456|NCT05038163|459750544|FG001|Stage 2|Did not complete Stage 2 survey|29|||
127761457|NCT05038163|459750545|FG002|Stage 2|Did not complete Stage 2 survey|30|||
127761458|NCT05038163|459750546|FG003|Stage 2|Did not complete Stage 2 survey|24|||
127761459|NCT05038163|459750547|FG004|Stage 2|Did not complete Stage 2 survey|21|||
127761460|NCT05038163|459750548|FG005|Stage 2|Did not complete Stage 2 survey|100|||
127761461|NCT01905150|459750549|FG000|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|2|||
127761462|NCT01905150|459750550|FG001|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|0|||
127761463|NCT03762200|459750553|FG000|Overall Study|Death|2|||
127761464|NCT05110690|459750554|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
127761465|NCT05110690|459750554|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
127761466|NCT05110690|459750554|FG000|Completion of Intervention|Lost to Follow-up|1|||
127761467|NCT05110690|459750554|FG000|Completion of Intervention|Death|1|||
127761468|NCT05110690|459750554|FG000|Completion of Intervention|Withdrawal by Subject|2|||
127761469|NCT03973931|459750555|FG000|Overall Study|Lost to Follow-up|47|||
127761470|NCT03973931|459750556|FG001|Overall Study|Lost to Follow-up|63|||
127761471|NCT03973931|459750557|FG002|Overall Study|Lost to Follow-up|51|||
127761472|NCT03973931|459750558|FG003|Overall Study|Lost to Follow-up|54|||
127761473|NCT03973931|459750555|FG000|Overall Study|opted out|6|||
127983685|NCT02044874|460562561|FG002|Overall Study|Withdrawal by Subject|23|||
127761474|NCT03973931|459750556|FG001|Overall Study|opted out|5|||
127761475|NCT03973931|459750557|FG002|Overall Study|opted out|5|||
127761476|NCT03973931|459750558|FG003|Overall Study|opted out|1|||
127761477|NCT01022112|459750559|FG000|Overall Study|Adverse Event|1|||
127761478|NCT01022112|459750560|FG001|Overall Study|Adverse Event|2|||
127761479|NCT01022112|459750561|FG002|Overall Study|Adverse Event|0|||
127761480|NCT01022112|459750562|FG003|Overall Study|Adverse Event|1|||
127761481|NCT01022112|459750563|FG004|Overall Study|Adverse Event|0|||
127761482|NCT01022112|459750559|FG000|Overall Study|Lack of Efficacy|1|||
127761483|NCT01022112|459750560|FG001|Overall Study|Lack of Efficacy|0|||
127761484|NCT01022112|459750561|FG002|Overall Study|Lack of Efficacy|0|||
127761485|NCT01022112|459750562|FG003|Overall Study|Lack of Efficacy|0|||
127761486|NCT01022112|459750563|FG004|Overall Study|Lack of Efficacy|1|||
127761487|NCT01022112|459750559|FG000|Overall Study|Physician Decision|0|||
127761488|NCT01022112|459750560|FG001|Overall Study|Physician Decision|0|||
127761489|NCT01022112|459750561|FG002|Overall Study|Physician Decision|1|||
127761490|NCT01022112|459750562|FG003|Overall Study|Physician Decision|0|||
127761491|NCT01022112|459750563|FG004|Overall Study|Physician Decision|1|||
127761492|NCT01022112|459750559|FG000|Overall Study|Withdrawal by Subject|0|||
127761493|NCT01022112|459750560|FG001|Overall Study|Withdrawal by Subject|1|||
127761494|NCT01022112|459750561|FG002|Overall Study|Withdrawal by Subject|2|||
127761495|NCT01022112|459750562|FG003|Overall Study|Withdrawal by Subject|2|||
127761496|NCT01022112|459750563|FG004|Overall Study|Withdrawal by Subject|1|||
127761497|NCT01022112|459750559|FG000|Overall Study|Fasting plasma glucose level increased|1|||
127761498|NCT01022112|459750560|FG001|Overall Study|Fasting plasma glucose level increased|0|||
127761499|NCT01022112|459750561|FG002|Overall Study|Fasting plasma glucose level increased|0|||
127761500|NCT01022112|459750562|FG003|Overall Study|Fasting plasma glucose level increased|0|||
127761501|NCT01022112|459750563|FG004|Overall Study|Fasting plasma glucose level increased|7|||
127761502|NCT00925353|459750564|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
127761503|NCT02980731|459752010|FG000|Overall Study|Death|63|||
127761504|NCT02980731|459752010|FG000|Overall Study|Withdrawal by Subject|6|||
127761505|NCT02980731|459752010|FG000|Overall Study|Lost to Follow-up|5|||
127761506|NCT02980731|459752010|FG000|Overall Study|Study terminated by Sponsor|4|||
127761507|NCT02980731|459752010|FG000|Overall Study|Completed survival follow-up period|65|||
127761508|NCT02980731|459752010|FG000|Overall Study|COVID-19 infection|1|||
127761509|NCT02980731|459752010|FG000|Overall Study|Other, not specified|66|||
127761510|NCT03037931|459752011|FG000|Overall Study|Death|354|||
127761511|NCT03037931|459752012|FG001|Overall Study|Death|367|||
127761512|NCT03037931|459752011|FG000|Overall Study|Lost to Follow-up|7|||
127761513|NCT03037931|459752012|FG001|Overall Study|Lost to Follow-up|4|||
127761514|NCT03037931|459752011|FG000|Overall Study|Withdrawal by Subject|48|||
127761515|NCT03037931|459752012|FG001|Overall Study|Withdrawal by Subject|41|||
127761516|NCT00605215|459752013|FG000|Overall Study|Death|0|||
127761517|NCT00605215|459752014|FG001|Overall Study|Death|0|||
127761518|NCT00605215|459752015|FG002|Overall Study|Death|1|||
127761519|NCT00605215|459752013|FG000|Overall Study|Adverse Event|19|||
127761520|NCT00605215|459752014|FG001|Overall Study|Adverse Event|21|||
127761521|NCT00605215|459752015|FG002|Overall Study|Adverse Event|26|||
127761522|NCT00605215|459752013|FG000|Overall Study|Refusal to sign the re-consent form|8|||
127761523|NCT00605215|459752014|FG001|Overall Study|Refusal to sign the re-consent form|3|||
127761524|NCT00605215|459752015|FG002|Overall Study|Refusal to sign the re-consent form|3|||
127761525|NCT00605215|459752013|FG000|Overall Study|Withdrawal by Subject|39|||
127761526|NCT00605215|459752014|FG001|Overall Study|Withdrawal by Subject|37|||
127761527|NCT00605215|459752015|FG002|Overall Study|Withdrawal by Subject|27|||
127761528|NCT00605215|459752013|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
127761529|NCT00605215|459752014|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
127761530|NCT00605215|459752015|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
127761531|NCT00605215|459752013|FG000|Overall Study|Protocol Violation|3|||
127761532|NCT00605215|459752014|FG001|Overall Study|Protocol Violation|4|||
127761533|NCT00605215|459752015|FG002|Overall Study|Protocol Violation|1|||
127761534|NCT00605215|459752013|FG000|Overall Study|Pregnancy|8|||
127761535|NCT00605215|459752014|FG001|Overall Study|Pregnancy|5|||
127761536|NCT00605215|459752015|FG002|Overall Study|Pregnancy|4|||
127761537|NCT00605215|459752013|FG000|Overall Study|Lost to Follow-up|8|||
127761538|NCT00605215|459752014|FG001|Overall Study|Lost to Follow-up|5|||
127761539|NCT00605215|459752015|FG002|Overall Study|Lost to Follow-up|2|||
127761540|NCT00605215|459752013|FG000|Overall Study|Other than specified|0|||
127761541|NCT00605215|459752014|FG001|Overall Study|Other than specified|2|||
127761542|NCT00605215|459752015|FG002|Overall Study|Other than specified|1|||
127761543|NCT02914275|459752018|FG000|Overall Study|Lost to Follow-up|84|||
127761544|NCT02914275|459752019|FG001|Overall Study|Lost to Follow-up|29|||
127761545|NCT02914275|459752018|FG000|Overall Study|Withdrawal by Subject|26|||
127983686|NCT02044874|460562559|FG000|Overall Study|Physician Decision|0|||
127761546|NCT02914275|459752019|FG001|Overall Study|Withdrawal by Subject|10|||
127761547|NCT02914275|459752018|FG000|Overall Study|Protocol Violation|1|||
127761548|NCT02914275|459752019|FG001|Overall Study|Protocol Violation|1|||
127761549|NCT02914275|459752018|FG000|Overall Study|Physician Decision|3|||
127761550|NCT02914275|459752019|FG001|Overall Study|Physician Decision|1|||
127761551|NCT02914275|459752018|FG000|Overall Study|Other|4|||
127761552|NCT02914275|459752019|FG001|Overall Study|Other|1|||
127761553|NCT02914275|459752018|FG000|Overall Study|Excluded due to invalid informed consent|3|||
127761554|NCT02914275|459752019|FG001|Overall Study|Excluded due to invalid informed consent|0|||
127983687|NCT02044874|460562560|FG001|Overall Study|Physician Decision|2|||
127761555|NCT01302067|459752024|FG000|Overall Study|Death|0|||
127761556|NCT01302067|459752025|FG001|Overall Study|Death|0|||
127761557|NCT01302067|459752026|FG002|Overall Study|Death|1|||
127761558|NCT01302067|459752024|FG000|Overall Study|Physician Decision|9|||
127761559|NCT01302067|459752025|FG001|Overall Study|Physician Decision|5|||
127761560|NCT01302067|459752026|FG002|Overall Study|Physician Decision|14|||
127761561|NCT01302067|459752024|FG000|Overall Study|Lack of Efficacy|8|||
127761562|NCT01302067|459752025|FG001|Overall Study|Lack of Efficacy|4|||
127761563|NCT01302067|459752026|FG002|Overall Study|Lack of Efficacy|2|||
127761564|NCT01302067|459752024|FG000|Overall Study|Lost to Follow-up|9|||
127761565|NCT01302067|459752025|FG001|Overall Study|Lost to Follow-up|4|||
127761566|NCT01302067|459752026|FG002|Overall Study|Lost to Follow-up|15|||
127761567|NCT01302067|459752024|FG000|Overall Study|Withdrawal by Subject|13|||
127761568|NCT01302067|459752025|FG001|Overall Study|Withdrawal by Subject|6|||
127761569|NCT01302067|459752026|FG002|Overall Study|Withdrawal by Subject|10|||
127761570|NCT01302067|459752024|FG000|Overall Study|Other|1|||
127761571|NCT01302067|459752025|FG001|Overall Study|Other|1|||
127761572|NCT01302067|459752026|FG002|Overall Study|Other|3|||
127761573|NCT01302067|459752024|FG000|Overall Study|Protocol Violation|11|||
127761574|NCT01302067|459752025|FG001|Overall Study|Protocol Violation|0|||
127761575|NCT01302067|459752026|FG002|Overall Study|Protocol Violation|8|||
127761576|NCT01302067|459752024|FG000|Overall Study|Adverse Event|27|||
127761577|NCT01302067|459752025|FG001|Overall Study|Adverse Event|14|||
127761578|NCT01302067|459752026|FG002|Overall Study|Adverse Event|45|||
127761579|NCT02738203|459752028|FG000|Overall Study|Failed IUD Insertion|2|||
127761580|NCT02738203|459752029|FG001|Overall Study|Failed IUD Insertion|2|||
127761581|NCT02738203|459752028|FG000|Overall Study|Protocol Violation|0|||
127761582|NCT02738203|459752029|FG001|Overall Study|Protocol Violation|1|||
127761583|NCT03241927|459752030|FG000|Overall Study|study terminated|1|||
127761584|NCT03241927|459752031|FG001|Overall Study|study terminated|0|||
127761585|NCT02704754|459752032|FG000|Overall Study|Lost to Follow-up|1|||
127761586|NCT02704754|459752033|FG001|Overall Study|Lost to Follow-up|1|||
127761587|NCT02704754|459752032|FG000|Overall Study|Lack of Efficacy|1|||
127761588|NCT02704754|459752033|FG001|Overall Study|Lack of Efficacy|0|||
127761589|NCT02704754|459752032|FG000|Overall Study|Withdrawal by Subject|1|||
127761590|NCT02704754|459752033|FG001|Overall Study|Withdrawal by Subject|0|||
127871809|NCT00451191|460149912|FG000|Overall Study|withdrawal or received alternate tx|15|||
127871810|NCT00451191|460149913|FG001|Overall Study|withdrawal or received alternate tx|11|||
127871811|NCT03575806|460149925|FG000|Overall Study|Withdrawal by Subject|0|||
127871812|NCT03575806|460149926|FG001|Overall Study|Withdrawal by Subject|2|||
127871813|NCT03575806|460149925|FG000|Overall Study|Protocol Violation|0|||
127871814|NCT03575806|460149926|FG001|Overall Study|Protocol Violation|2|||
127871815|NCT04963231|460149927|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|43|||
127871816|NCT04963231|460149928|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
127871817|NCT04963231|460149929|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
127871818|NCT04963231|460149927|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|3|||
127871819|NCT04963231|460149928|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
127871820|NCT04963231|460149929|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
127871821|NCT04963231|460149927|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|16|||
127871822|NCT04963231|460149928|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
127871823|NCT04963231|460149929|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
127871824|NCT04963231|460149927|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|2|||
127871825|NCT04963231|460149928|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
127871826|NCT04963231|460149929|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
127871827|NCT04963231|460149927|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
127871828|NCT04963231|460149928|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
127871829|NCT04963231|460149929|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|1|||
127871830|NCT04963231|460149927|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|0|||
127871831|NCT04963231|460149928|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
127871832|NCT04963231|460149929|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
127871833|NCT04963231|460149927|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|0|||
127871834|NCT04963231|460149928|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|1|||
127871835|NCT04963231|460149929|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|4|||
127871836|NCT01982942|460149930|FG000|Overall Study|Adverse Event|10|||
127871837|NCT01982942|460149931|FG001|Overall Study|Adverse Event|5|||
127871838|NCT01982942|460149930|FG000|Overall Study|Lost to Follow-up|4|||
127871839|NCT01982942|460149931|FG001|Overall Study|Lost to Follow-up|3|||
127983688|NCT02044874|460562561|FG002|Overall Study|Physician Decision|1|||
127871840|NCT01982942|460149930|FG000|Overall Study|Multiple sclerosis progression|3|||
127983689|NCT02044874|460562559|FG000|Overall Study|Lost to Follow-up|10|||
127983690|NCT02044874|460562560|FG001|Overall Study|Lost to Follow-up|27|||
127761591|NCT00423943|459752034|FG000|Overall Study|Withdrawal by Subject|3|||
127761592|NCT00423943|459752035|FG001|Overall Study|Withdrawal by Subject|1|||
127761593|NCT03809429|459752039|FG000|Overall Study|Withdrawal by Subject|7|||
127871841|NCT01982942|460149931|FG001|Overall Study|Multiple sclerosis progression|2|||
127871842|NCT01982942|460149930|FG000|Overall Study|Wanted to try therapy not permitted|1|||
127871843|NCT01982942|460149931|FG001|Overall Study|Wanted to try therapy not permitted|0|||
127871844|NCT01982942|460149930|FG000|Overall Study|Subject declined future visits|0|||
127871845|NCT01982942|460149931|FG001|Overall Study|Subject declined future visits|1|||
127871846|NCT01982942|460149930|FG000|Overall Study|Left geographical area|2|||
127871847|NCT01982942|460149931|FG001|Overall Study|Left geographical area|0|||
127871848|NCT01982942|460149930|FG000|Overall Study|Too many pills|1|||
127871849|NCT01982942|460149931|FG001|Overall Study|Too many pills|0|||
127871850|NCT01982942|460149930|FG000|Overall Study|MS Relapse|0|||
127871851|NCT01982942|460149931|FG001|Overall Study|MS Relapse|1|||
127871852|NCT01982942|460149930|FG000|Overall Study|Chose to join a stem cell trial|0|||
127871853|NCT01982942|460149931|FG001|Overall Study|Chose to join a stem cell trial|1|||
127871854|NCT01982942|460149930|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
127871855|NCT01982942|460149931|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
127871856|NCT03471507|460149932|FG000|Overall Study|Lost to Follow-up|1|||
127871857|NCT03471507|460149933|FG001|Overall Study|Lost to Follow-up|3|||
127871858|NCT03471507|460149932|FG000|Overall Study|Physician Decision|0|||
127871859|NCT03471507|460149933|FG001|Overall Study|Physician Decision|1|||
127871860|NCT03471507|460149932|FG000|Overall Study|Withdrawal by Subject|2|||
127871861|NCT03471507|460149933|FG001|Overall Study|Withdrawal by Subject|1|||
127871862|NCT02213666|460149934|FG000|Overall Study|Withdrawal by Subject|1|||
127871863|NCT00750061|460149938|FG000|Overall Study|Adverse Event|2|||
127871864|NCT00750061|460149939|FG001|Overall Study|Adverse Event|0|||
127871865|NCT00750061|460149938|FG000|Overall Study|Withdrawal by Subject|0|||
127871866|NCT00750061|460149939|FG001|Overall Study|Withdrawal by Subject|1|||
127871867|NCT00750061|460149938|FG000|Overall Study|Physician Decision|0|||
127871868|NCT00750061|460149939|FG001|Overall Study|Physician Decision|1|||
127871869|NCT03246152|460149940|FG000|Overall Study|Lost to Follow-up|2|||
127871870|NCT03246152|460149940|FG000|Overall Study|Protocol Violation|1|||
127871871|NCT01374516|460149943|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
127871872|NCT01374516|460149944|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
127871873|NCT01374516|460149943|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
127871874|NCT01374516|460149944|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
127871875|NCT01374516|460149943|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
127871876|NCT01374516|460149944|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
127871877|NCT01374516|460149943|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
127871878|NCT01374516|460149944|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
127871879|NCT01374516|460149943|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
127871880|NCT01374516|460149944|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
127871881|NCT01374516|460149943|FG000|Surveillance Expansion Period|Protocol Violation|386|||
127871882|NCT01374516|460149944|FG001|Surveillance Expansion Period|Protocol Violation|217|||
127871883|NCT01374516|460149943|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
127871884|NCT01374516|460149944|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
127871885|NCT01374516|460149943|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
127871886|NCT01374516|460149944|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
127871887|NCT01374516|460149943|FG000|Surveillance Expansion Period|Serious adverse event|20|||
127871888|NCT01374516|460149944|FG001|Surveillance Expansion Period|Serious adverse event|5|||
127871889|NCT03219372|460149947|FG000|Overall Study|Withdrawal by Subject|1|||
127871890|NCT03219372|460149948|FG001|Overall Study|Withdrawal by Subject|0|||
127871891|NCT04145531|460149952|FG000|Part A|Adverse Event|2|||
127871892|NCT04145531|460149953|FG001|Part A|Adverse Event|12|||
127871893|NCT04145531|460149954|FG002|Part A|Adverse Event|6|||
127871894|NCT04145531|460149955|FG003|Part A|Adverse Event|0|||
127871895|NCT04145531|460149952|FG000|Part A|Death|1|||
127871896|NCT04145531|460149953|FG001|Part A|Death|2|||
127871897|NCT04145531|460149954|FG002|Part A|Death|0|||
127871898|NCT04145531|460149955|FG003|Part A|Death|0|||
127871899|NCT04145531|460149952|FG000|Part A|Physician Decision|2|||
127871900|NCT04145531|460149953|FG001|Part A|Physician Decision|5|||
127871901|NCT04145531|460149954|FG002|Part A|Physician Decision|2|||
127871902|NCT04145531|460149955|FG003|Part A|Physician Decision|0|||
127871903|NCT04145531|460149952|FG000|Part A|Progressive disease|0|||
127871904|NCT04145531|460149953|FG001|Part A|Progressive disease|2|||
127871905|NCT04145531|460149954|FG002|Part A|Progressive disease|1|||
127871906|NCT04145531|460149955|FG003|Part A|Progressive disease|0|||
127871907|NCT04145531|460149952|FG000|Part A|Protocol deviation|0|||
127871908|NCT04145531|460149953|FG001|Part A|Protocol deviation|0|||
127871909|NCT04145531|460149954|FG002|Part A|Protocol deviation|1|||
127871910|NCT04145531|460149955|FG003|Part A|Protocol deviation|0|||
127871911|NCT04145531|460149952|FG000|Part A|Withdrawal by parent or guardian|1|||
127871912|NCT04145531|460149953|FG001|Part A|Withdrawal by parent or guardian|0|||
127871913|NCT04145531|460149954|FG002|Part A|Withdrawal by parent or guardian|0|||
127871914|NCT04145531|460149955|FG003|Part A|Withdrawal by parent or guardian|0|||
127871915|NCT04145531|460149952|FG000|Part A|Withdrawal by participant|0|||
127871916|NCT04145531|460149953|FG001|Part A|Withdrawal by participant|0|||
127871917|NCT04145531|460149954|FG002|Part A|Withdrawal by participant|1|||
127871918|NCT04145531|460149955|FG003|Part A|Withdrawal by participant|0|||
127871919|NCT04145531|460149952|FG000|Part A|Other|0|||
127871920|NCT04145531|460149953|FG001|Part A|Other|0|||
127871921|NCT04145531|460149954|FG002|Part A|Other|1|||
127871922|NCT04145531|460149955|FG003|Part A|Other|0|||
127871923|NCT04145531|460149952|FG000|Part B|Adverse Event|0|||
127871924|NCT04145531|460149953|FG001|Part B|Adverse Event|0|||
127871925|NCT04145531|460149954|FG002|Part B|Adverse Event|0|||
127871926|NCT04145531|460149955|FG003|Part B|Adverse Event|21|||
127871927|NCT04145531|460149952|FG000|Part B|Physician Decision|0|||
127871928|NCT04145531|460149953|FG001|Part B|Physician Decision|0|||
127871929|NCT04145531|460149954|FG002|Part B|Physician Decision|0|||
127871930|NCT04145531|460149955|FG003|Part B|Physician Decision|7|||
127871931|NCT04145531|460149952|FG000|Part B|Progressive disease|0|||
127871932|NCT04145531|460149953|FG001|Part B|Progressive disease|0|||
127871933|NCT04145531|460149954|FG002|Part B|Progressive disease|0|||
127871934|NCT04145531|460149955|FG003|Part B|Progressive disease|1|||
127871935|NCT04145531|460149952|FG000|Part B|Recurrent disease|0|||
127871936|NCT04145531|460149953|FG001|Part B|Recurrent disease|0|||
127871937|NCT04145531|460149954|FG002|Part B|Recurrent disease|0|||
127871938|NCT04145531|460149955|FG003|Part B|Recurrent disease|1|||
127871939|NCT04145531|460149952|FG000|Part B|Withdrawal by parent or guardian|0|||
127871940|NCT04145531|460149953|FG001|Part B|Withdrawal by parent or guardian|0|||
127871941|NCT04145531|460149954|FG002|Part B|Withdrawal by parent or guardian|0|||
127871942|NCT04145531|460149955|FG003|Part B|Withdrawal by parent or guardian|3|||
127871943|NCT04145531|460149952|FG000|Part B|Withdrawal by participant|0|||
127871944|NCT04145531|460149953|FG001|Part B|Withdrawal by participant|0|||
127871945|NCT04145531|460149954|FG002|Part B|Withdrawal by participant|0|||
127871946|NCT04145531|460149955|FG003|Part B|Withdrawal by participant|1|||
127871947|NCT04145531|460149952|FG000|Part B|Other|0|||
127871948|NCT04145531|460149953|FG001|Part B|Other|0|||
127871949|NCT04145531|460149954|FG002|Part B|Other|0|||
127871950|NCT04145531|460149955|FG003|Part B|Other|1|||
127871951|NCT04629534|460149956|FG000|Overall Study|Physician Decision|1|||
127871952|NCT04629534|460149957|FG001|Overall Study|Physician Decision|0|||
127871953|NCT04629534|460149956|FG000|Overall Study|Protocol Violation|0|||
127871954|NCT04629534|460149957|FG001|Overall Study|Protocol Violation|2|||
127871955|NCT02797951|460149958|FG000|Overall Study|Adverse Event|4|||
127871956|NCT02797951|460149958|FG000|Overall Study|Death|1|||
127871957|NCT02797951|460149958|FG000|Overall Study|Lack of Efficacy|19|||
127871958|NCT02797951|460149958|FG000|Overall Study|Lost to Follow-up|4|||
127871959|NCT02797951|460149958|FG000|Overall Study|Physician Decision|6|||
127871960|NCT02797951|460149958|FG000|Overall Study|Withdrawal by Subject|15|||
127871961|NCT00814502|460149959|FG000|Overall Study|Adverse Event|1|||
127871962|NCT00814502|460149960|FG001|Overall Study|Adverse Event|0|||
127871963|NCT00814502|460149959|FG000|Overall Study|Withdrawal by Subject|0|||
127871964|NCT00814502|460149960|FG001|Overall Study|Withdrawal by Subject|2|||
127871965|NCT00234533|460149968|FG000|Overall Study|Withdrawal by Subject|6|||
127871966|NCT00234533|460149968|FG000|Overall Study|Adverse Event|2|||
127871967|NCT00234533|460149968|FG000|Overall Study|Enrolled but not treated|3|||
127871968|NCT01484691|460149969|FG000|Overall Study|Withdrawal by Subject|1|||
127871969|NCT01484691|460149970|FG001|Overall Study|Withdrawal by Subject|1|||
127871970|NCT01484691|460149971|FG002|Overall Study|Withdrawal by Subject|1|||
127871971|NCT01484691|460149969|FG000|Overall Study|Physician Decision|0|||
127871972|NCT01484691|460149970|FG001|Overall Study|Physician Decision|2|||
127871973|NCT01484691|460149971|FG002|Overall Study|Physician Decision|1|||
127871974|NCT03205605|460149976|FG000|Overall Study|Withdrawal by Subject|1|||
127871975|NCT03328325|460149977|FG000|Overall Study|Lost to Follow-up|4|||
127871976|NCT03328325|460149977|FG000|Overall Study|Physician Decision|1|||
127871977|NCT03328325|460149977|FG000|Overall Study|Withdrawal by Subject|3|||
127871978|NCT03328325|460149977|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
127871979|NCT00736840|460149979|FG000|Overall Study|Lost to Follow-up|13|||
127871980|NCT00945815|460149980|FG000|Overall Study|Death|3|||
127871981|NCT00945815|460149980|FG000|Overall Study|Not protocol specified|1|||
127871982|NCT00945815|460149980|FG000|Overall Study|Ineligible|3|||
127871983|NCT00945815|460149980|FG000|Overall Study|Did not begin protocol therapy|1|||
127871984|NCT01314261|460149983|FG000|Overall Study|Adverse Event|1|||
127871985|NCT01314261|460149984|FG001|Overall Study|Adverse Event|0|||
127871986|NCT01314261|460149985|FG002|Overall Study|Adverse Event|0|||
127871987|NCT01314261|460149986|FG003|Overall Study|Adverse Event|0|||
127871988|NCT01314261|460149983|FG000|Overall Study|Withdrawal by Subject|0|||
127871989|NCT01314261|460149984|FG001|Overall Study|Withdrawal by Subject|3|||
127871990|NCT01314261|460149985|FG002|Overall Study|Withdrawal by Subject|1|||
127871991|NCT01314261|460149986|FG003|Overall Study|Withdrawal by Subject|0|||
127871992|NCT01314261|460149983|FG000|Overall Study|Lost to Follow-up|1|||
127871993|NCT01314261|460149984|FG001|Overall Study|Lost to Follow-up|0|||
127871994|NCT01314261|460149985|FG002|Overall Study|Lost to Follow-up|2|||
127871995|NCT01314261|460149986|FG003|Overall Study|Lost to Follow-up|2|||
127871996|NCT01314261|460149983|FG000|Overall Study|Virologic Failure|0|||
127871997|NCT01314261|460149984|FG001|Overall Study|Virologic Failure|1|||
127871998|NCT01314261|460149985|FG002|Overall Study|Virologic Failure|0|||
127871999|NCT01314261|460149986|FG003|Overall Study|Virologic Failure|1|||
127872000|NCT04524507|460149987|FG000|Overall Study|Lost to Follow-up|2|||
127872001|NCT04524507|460149988|FG001|Overall Study|Lost to Follow-up|4|||
127872002|NCT04524507|460149987|FG000|Overall Study|Withdrawal by Subject|2|||
127872003|NCT04524507|460149988|FG001|Overall Study|Withdrawal by Subject|9|||
127872004|NCT04524507|460149987|FG000|Overall Study|Death|2|||
127872005|NCT04524507|460149988|FG001|Overall Study|Death|10|||
127872006|NCT01383317|460149989|FG000|Overall Study|Lost to Follow-up|2|||
127872007|NCT01383317|460149990|FG001|Overall Study|Lost to Follow-up|1|||
127872008|NCT01383317|460149989|FG000|Overall Study|Death|1|||
127872009|NCT01383317|460149990|FG001|Overall Study|Death|0|||
127872010|NCT01383317|460149989|FG000|Overall Study|Adverse Event|0|||
127872011|NCT01383317|460149990|FG001|Overall Study|Adverse Event|1|||
127872012|NCT00422227|460149991|FG000|Overall Study|Adverse Event|3|||
127872013|NCT00422227|460149992|FG001|Overall Study|Adverse Event|8|||
127872014|NCT00422227|460149991|FG000|Overall Study|Lost to Follow-up|1|||
127872015|NCT00422227|460149992|FG001|Overall Study|Lost to Follow-up|3|||
127872016|NCT00422227|460149991|FG000|Overall Study|Withdrawal by Subject|0|||
127872017|NCT00422227|460149992|FG001|Overall Study|Withdrawal by Subject|4|||
127872018|NCT02260804|460149999|FG000|Induction Study Period|Protocol Violation|2|||
127872019|NCT02260804|460150000|FG001|Induction Study Period|Protocol Violation|0|||
127872020|NCT02260804|460149999|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
127649230|NCT02686034|459336517|FG000|Run-In Period 1|Withdrawal by Subject|4|||
127649231|NCT02686034|459336518|FG001|Run-In Period 1|Withdrawal by Subject|3|||
127649232|NCT02686034|459336517|FG000|Run-In Period 1|Lost to Follow-up|4|||
127649233|NCT02686034|459336518|FG001|Run-In Period 1|Lost to Follow-up|4|||
127649234|NCT02686034|459336517|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
127649235|NCT02686034|459336518|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
127649236|NCT02686034|459336517|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
127649237|NCT02686034|459336518|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
127649238|NCT02686034|459336517|FG000|Randomized Controlled Period 2|Adverse Event|0|||
127649239|NCT02686034|459336518|FG001|Randomized Controlled Period 2|Adverse Event|2|||
127649240|NCT02686034|459336517|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
127649241|NCT02686034|459336518|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
127649242|NCT02686034|459336517|FG000|Open Label Period 3|Lost to Follow-up|0|||
127649243|NCT02686034|459336518|FG001|Open Label Period 3|Lost to Follow-up|1|||
127649244|NCT03538951|459336521|FG000|Overall Study|Withdrawal by Subject|1|||
127649245|NCT03538951|459336522|FG001|Overall Study|Withdrawal by Subject|2|||
127649246|NCT01142388|459337724|FG000|Overall Study|Lack of Efficacy|21|||
127649247|NCT01142388|459337725|FG001|Overall Study|Lack of Efficacy|31|||
127649248|NCT01142388|459337724|FG000|Overall Study|Adverse Event|9|||
127649249|NCT01142388|459337725|FG001|Overall Study|Adverse Event|5|||
127649250|NCT01142388|459337724|FG000|Overall Study|Death|3|||
127649251|NCT01142388|459337725|FG001|Overall Study|Death|2|||
127649252|NCT01142388|459337724|FG000|Overall Study|Withdrawal by Subject|5|||
127649253|NCT01142388|459337725|FG001|Overall Study|Withdrawal by Subject|3|||
127649254|NCT01142388|459337724|FG000|Overall Study|Alternative therapy|1|||
127649255|NCT01142388|459337725|FG001|Overall Study|Alternative therapy|0|||
127649256|NCT01142388|459337724|FG000|Overall Study|Other complications|0|||
127649257|NCT01142388|459337725|FG001|Overall Study|Other complications|2|||
127649258|NCT01142388|459337724|FG000|Overall Study|Other|1|||
127649259|NCT01142388|459337725|FG001|Overall Study|Other|1|||
127649260|NCT01142388|459337724|FG000|Overall Study|Never started therapy|7|||
127649261|NCT01142388|459337725|FG001|Overall Study|Never started therapy|3|||
127649262|NCT00695786|459337726|FG000|Overall Study|Adverse Event|0|||
127649263|NCT00695786|459337727|FG001|Overall Study|Adverse Event|3|||
127649264|NCT00695786|459337728|FG002|Overall Study|Adverse Event|4|||
127649265|NCT00695786|459337729|FG003|Overall Study|Adverse Event|2|||
127649266|NCT00695786|459337726|FG000|Overall Study|Lost to Follow-up|0|||
127649267|NCT00695786|459337727|FG001|Overall Study|Lost to Follow-up|5|||
127649268|NCT00695786|459337728|FG002|Overall Study|Lost to Follow-up|1|||
127649269|NCT00695786|459337729|FG003|Overall Study|Lost to Follow-up|1|||
127649270|NCT00695786|459337726|FG000|Overall Study|Withdrawal by Subject|0|||
127649271|NCT00695786|459337727|FG001|Overall Study|Withdrawal by Subject|4|||
127649272|NCT00695786|459337728|FG002|Overall Study|Withdrawal by Subject|3|||
127649273|NCT00695786|459337729|FG003|Overall Study|Withdrawal by Subject|1|||
127649274|NCT00695786|459337726|FG000|Overall Study|Deemed Ineligible|1|||
127649275|NCT00695786|459337727|FG001|Overall Study|Deemed Ineligible|0|||
127649276|NCT00695786|459337728|FG002|Overall Study|Deemed Ineligible|0|||
127649277|NCT00695786|459337729|FG003|Overall Study|Deemed Ineligible|0|||
127649278|NCT00695786|459337726|FG000|Overall Study|Lack of Efficacy|0|||
127872021|NCT02260804|460150000|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
127872022|NCT02260804|460149999|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
127649279|NCT00695786|459337727|FG001|Overall Study|Lack of Efficacy|0|||
127872023|NCT02260804|460150000|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
127872024|NCT02260804|460149999|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
127872025|NCT02260804|460150000|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
127872026|NCT02260804|460149999|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
127872027|NCT02260804|460150000|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
127872028|NCT02260804|460149999|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
127872029|NCT02260804|460150000|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
127872030|NCT02260804|460149999|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
127872031|NCT02260804|460150000|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
127872032|NCT02260804|460149999|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
127872033|NCT02260804|460150000|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
127872034|NCT02260804|460149999|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
127872035|NCT02260804|460150000|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
127872036|NCT02260804|460149999|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
127872037|NCT02260804|460150000|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
127872038|NCT02260804|460149999|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
127872039|NCT02260804|460150000|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
127872040|NCT01018680|460151994|FG000|Overall Study|Adverse Event|23|||
127872041|NCT01018680|460151995|FG001|Overall Study|Adverse Event|40|||
127872042|NCT01018680|460151994|FG000|Overall Study|Withdrawal by Subject|10|||
127872043|NCT01018680|460151995|FG001|Overall Study|Withdrawal by Subject|10|||
127872044|NCT01018680|460151994|FG000|Overall Study|Protocol Violation|5|||
127872045|NCT01018680|460151995|FG001|Overall Study|Protocol Violation|8|||
127872046|NCT01018680|460151994|FG000|Overall Study|Sponsor Decision|6|||
127872047|NCT01018680|460151995|FG001|Overall Study|Sponsor Decision|7|||
127872048|NCT01018680|460151994|FG000|Overall Study|Lack of Efficacy|8|||
127872049|NCT01018680|460151995|FG001|Overall Study|Lack of Efficacy|2|||
127872050|NCT01018680|460151994|FG000|Overall Study|Lost to Follow-up|5|||
127872051|NCT01018680|460151995|FG001|Overall Study|Lost to Follow-up|3|||
127872052|NCT01018680|460151994|FG000|Overall Study|Entry Criteria Not Met|1|||
127872053|NCT01018680|460151995|FG001|Overall Study|Entry Criteria Not Met|4|||
127872054|NCT01018680|460151994|FG000|Overall Study|Physician Decision|3|||
127872055|NCT01018680|460151995|FG001|Overall Study|Physician Decision|1|||
127872056|NCT00219349|460151996|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
127872057|NCT00219349|460151996|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
127872058|NCT00219349|460151996|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
127872059|NCT00219349|460151996|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
127872060|NCT02777554|460151998|FG000|Overall Study|Adverse Event|4|||
127872061|NCT02777554|460151999|FG001|Overall Study|Adverse Event|4|||
127872062|NCT02777554|460152000|FG002|Overall Study|Adverse Event|0|||
127872063|NCT02777554|460152001|FG003|Overall Study|Adverse Event|1|||
127872064|NCT02777554|460152002|FG004|Overall Study|Adverse Event|0|||
127872065|NCT02777554|460152003|FG005|Overall Study|Adverse Event|0|||
127872066|NCT02777554|460151998|FG000|Overall Study|Withdrawal by Subject|3|||
127872067|NCT02777554|460151999|FG001|Overall Study|Withdrawal by Subject|1|||
127872068|NCT02777554|460152000|FG002|Overall Study|Withdrawal by Subject|1|||
127872069|NCT02777554|460152001|FG003|Overall Study|Withdrawal by Subject|0|||
127872070|NCT02777554|460152002|FG004|Overall Study|Withdrawal by Subject|0|||
127872071|NCT02777554|460152003|FG005|Overall Study|Withdrawal by Subject|0|||
127872072|NCT02777554|460151998|FG000|Overall Study|Discharged early due to hurricane|22|||
127872073|NCT02777554|460151999|FG001|Overall Study|Discharged early due to hurricane|20|||
127872074|NCT02777554|460152000|FG002|Overall Study|Discharged early due to hurricane|0|||
127872075|NCT02777554|460152001|FG003|Overall Study|Discharged early due to hurricane|0|||
127872076|NCT02777554|460152002|FG004|Overall Study|Discharged early due to hurricane|0|||
127872077|NCT02777554|460152003|FG005|Overall Study|Discharged early due to hurricane|0|||
127872078|NCT02777554|460151998|FG000|Overall Study|Other - Miscellaneous|1|||
127983691|NCT02044874|460562561|FG002|Overall Study|Lost to Follow-up|21|||
127761594|NCT03809429|459752040|FG001|Overall Study|Withdrawal by Subject|3|||
127761595|NCT03809429|459752039|FG000|Overall Study|Adverse Event|6|||
127761596|NCT03809429|459752040|FG001|Overall Study|Adverse Event|9|||
127761597|NCT03809429|459752039|FG000|Overall Study|COVID-19|3|||
127761598|NCT03809429|459752040|FG001|Overall Study|COVID-19|1|||
127761599|NCT03809429|459752039|FG000|Overall Study|Participant was discontinued by investigator|12|||
127761600|NCT03809429|459752040|FG001|Overall Study|Participant was discontinued by investigator|7|||
127761601|NCT02383056|459752042|FG000|Overall Study|Adverse Event|1|||
127761602|NCT02383056|459752043|FG001|Overall Study|Adverse Event|0|||
127761603|NCT02383056|459752042|FG000|Overall Study|Lost to Follow-up|0|||
127761604|NCT02383056|459752043|FG001|Overall Study|Lost to Follow-up|2|||
127761605|NCT04214600|459752044|FG000|Overall Study|Lost to Follow-up|9|||
127761606|NCT04214600|459752045|FG001|Overall Study|Lost to Follow-up|14|||
127761607|NCT03245151|459752046|FG000|Overall Study|Withdrawal by Subject|2|||
127761608|NCT03245151|459752047|FG001|Overall Study|Withdrawal by Subject|0|||
127761609|NCT03245151|459752048|FG002|Overall Study|Withdrawal by Subject|0|||
127761610|NCT03245151|459752049|FG003|Overall Study|Withdrawal by Subject|2|||
127761611|NCT03245151|459752050|FG004|Overall Study|Withdrawal by Subject|1|||
127761612|NCT03245151|459752046|FG000|Overall Study|Death|3|||
127761613|NCT03245151|459752047|FG001|Overall Study|Death|14|||
127761614|NCT03245151|459752048|FG002|Overall Study|Death|9|||
127761615|NCT03245151|459752049|FG003|Overall Study|Death|16|||
127761616|NCT03245151|459752050|FG004|Overall Study|Death|7|||
127761617|NCT03245151|459752046|FG000|Overall Study|Sponsor's decision|0|||
127872079|NCT02777554|460151999|FG001|Overall Study|Other - Miscellaneous|0|||
127872080|NCT02777554|460152000|FG002|Overall Study|Other - Miscellaneous|0|||
127872081|NCT02777554|460152001|FG003|Overall Study|Other - Miscellaneous|0|||
127872082|NCT02777554|460152002|FG004|Overall Study|Other - Miscellaneous|0|||
127872083|NCT02777554|460152003|FG005|Overall Study|Other - Miscellaneous|0|||
127872084|NCT00270205|460152004|FG000|Overall Study|Lost to Follow-up|1|||
127872085|NCT00270205|460152005|FG001|Overall Study|Lost to Follow-up|0|||
127872086|NCT00270205|460152006|FG002|Overall Study|Lost to Follow-up|0|||
127872087|NCT00270205|460152007|FG003|Overall Study|Lost to Follow-up|1|||
127872088|NCT00066573|460152008|FG000|Overall Study|Did not received protocol treatment|28|||
127872089|NCT00066573|460152009|FG001|Overall Study|Did not received protocol treatment|28|||
127872090|NCT00869362|460152010|FG000|Overall Study|Death|0|||
127872091|NCT00869362|460152011|FG001|Overall Study|Death|2|||
127872092|NCT00869362|460152010|FG000|Overall Study|Lost to Follow-up|1|||
127872093|NCT00869362|460152011|FG001|Overall Study|Lost to Follow-up|3|||
127872094|NCT03053102|460152012|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
127872095|NCT03053102|460152012|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
127872096|NCT03323034|460152013|FG000|Overall Study|Lack of Efficacy|5|||
127872097|NCT03323034|460152014|FG001|Overall Study|Lack of Efficacy|5|||
127872098|NCT03323034|460152015|FG002|Overall Study|Lack of Efficacy|6|||
127872099|NCT03323034|460152016|FG003|Overall Study|Lack of Efficacy|5|||
127872100|NCT03323034|460152017|FG004|Overall Study|Lack of Efficacy|5|||
127872101|NCT03323034|460152013|FG000|Overall Study|Physician Decision|0|||
127872102|NCT03323034|460152014|FG001|Overall Study|Physician Decision|0|||
127872103|NCT03323034|460152015|FG002|Overall Study|Physician Decision|0|||
127872104|NCT03323034|460152016|FG003|Overall Study|Physician Decision|0|||
127872105|NCT03323034|460152017|FG004|Overall Study|Physician Decision|1|||
127872106|NCT03323034|460152013|FG000|Overall Study|Withdrawal by Subject|1|||
127872107|NCT03323034|460152014|FG001|Overall Study|Withdrawal by Subject|1|||
127872108|NCT03323034|460152015|FG002|Overall Study|Withdrawal by Subject|0|||
127872109|NCT03323034|460152016|FG003|Overall Study|Withdrawal by Subject|1|||
127761618|NCT03245151|459752047|FG001|Overall Study|Sponsor's decision|1|||
127761619|NCT03245151|459752048|FG002|Overall Study|Sponsor's decision|0|||
127761620|NCT03245151|459752049|FG003|Overall Study|Sponsor's decision|0|||
127761621|NCT03245151|459752050|FG004|Overall Study|Sponsor's decision|0|||
127761622|NCT03507777|459752051|FG000|Overall Study|Lost to Follow-up|5|||
127761623|NCT03507777|459752052|FG001|Overall Study|Lost to Follow-up|7|||
127761624|NCT03507777|459752051|FG000|Overall Study|Withdrawal by Subject|6|||
127761625|NCT03507777|459752052|FG001|Overall Study|Withdrawal by Subject|11|||
127761626|NCT03507777|459752051|FG000|Overall Study|Death|30|||
127761627|NCT03507777|459752052|FG001|Overall Study|Death|44|||
127761628|NCT03507777|459752051|FG000|Overall Study|Other Reasons|3|||
127761629|NCT03507777|459752052|FG001|Overall Study|Other Reasons|8|||
127761630|NCT00006011|459752053|FG000|Overall Study|Disease progression|13|||
127761631|NCT00006011|459752054|FG001|Overall Study|Disease progression|6|||
127761632|NCT00006011|459752055|FG002|Overall Study|Disease progression|26|||
127761633|NCT00006011|459752053|FG000|Overall Study|Refused further treatment|15|||
127761634|NCT00006011|459752054|FG001|Overall Study|Refused further treatment|13|||
127761635|NCT00006011|459752055|FG002|Overall Study|Refused further treatment|26|||
127761636|NCT00006011|459752053|FG000|Overall Study|Adverse Event|15|||
127761637|NCT00006011|459752054|FG001|Overall Study|Adverse Event|39|||
127761638|NCT00006011|459752055|FG002|Overall Study|Adverse Event|5|||
127761639|NCT00006011|459752053|FG000|Overall Study|Death|0|||
127761640|NCT00006011|459752054|FG001|Overall Study|Death|1|||
127761641|NCT00006011|459752055|FG002|Overall Study|Death|2|||
127761642|NCT00006011|459752053|FG000|Overall Study|Other|4|||
127761643|NCT00006011|459752054|FG001|Overall Study|Other|2|||
127761644|NCT00006011|459752055|FG002|Overall Study|Other|5|||
127761645|NCT00006011|459752053|FG000|Overall Study|Ineligible|18|||
127761646|NCT00006011|459752054|FG001|Overall Study|Ineligible|16|||
127761647|NCT00006011|459752055|FG002|Overall Study|Ineligible|9|||
127761648|NCT00774930|459752059|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
127761649|NCT00774930|459752060|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
127761650|NCT00774930|459752059|FG000|DB Phase|Adverse Event|1|||
127761651|NCT00774930|459752060|FG001|DB Phase|Adverse Event|2|||
127761652|NCT00774930|459752059|FG000|DB Phase|Subject Decision|1|||
127761653|NCT00774930|459752060|FG001|DB Phase|Subject Decision|5|||
127761654|NCT00774930|459752059|FG000|DB Phase|Sponsor Decision|0|||
127761655|NCT00774930|459752060|FG001|DB Phase|Sponsor Decision|1|||
127761656|NCT00774930|459752059|FG000|DB Phase|Disease Progression|1|||
127761657|NCT00774930|459752060|FG001|DB Phase|Disease Progression|1|||
127761658|NCT00774930|459752059|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
127761659|NCT00774930|459752060|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
127761660|NCT00774930|459752059|FG000|IOL Phase|Adverse Event|1|||
127761661|NCT00774930|459752060|FG001|IOL Phase|Adverse Event|1|||
127761662|NCT00774930|459752059|FG000|IOL Phase|Subject Decision|4|||
127761663|NCT00774930|459752060|FG001|IOL Phase|Subject Decision|3|||
127761664|NCT00774930|459752059|FG000|IOL Phase|Physician Decision|3|||
127761665|NCT00774930|459752060|FG001|IOL Phase|Physician Decision|2|||
127761666|NCT00774930|459752059|FG000|IOL Phase|Sponsor Decision|1|||
127761667|NCT00774930|459752060|FG001|IOL Phase|Sponsor Decision|0|||
127761668|NCT00774930|459752059|FG000|IOL Phase|Disease Progression|2|||
127761669|NCT00774930|459752060|FG001|IOL Phase|Disease Progression|1|||
127761670|NCT00774930|459752059|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
127761671|NCT00774930|459752060|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
127761672|NCT00774930|459752059|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
127761673|NCT00774930|459752060|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
127761674|NCT00774930|459752059|FG000|IOL Phase|Other|1|||
127761675|NCT00774930|459752060|FG001|IOL Phase|Other|0|||
127761676|NCT00774930|459752059|FG000|IOL Phase|Brain radiation|0|||
127761677|NCT00774930|459752060|FG001|IOL Phase|Brain radiation|1|||
127761678|NCT00774930|459752059|FG000|LTOLE Phase|Adverse Event|7|||
127761679|NCT00774930|459752060|FG001|LTOLE Phase|Adverse Event|3|||
127761680|NCT00774930|459752059|FG000|LTOLE Phase|Subject decision|0|||
127761681|NCT00774930|459752060|FG001|LTOLE Phase|Subject decision|5|||
127761682|NCT00774930|459752059|FG000|LTOLE Phase|Physician Decision|4|||
127761683|NCT00774930|459752060|FG001|LTOLE Phase|Physician Decision|1|||
127761684|NCT00774930|459752059|FG000|LTOLE Phase|Sponsor decision|2|||
127761685|NCT00774930|459752060|FG001|LTOLE Phase|Sponsor decision|1|||
127761686|NCT00774930|459752059|FG000|LTOLE Phase|Disease Progression|2|||
127761687|NCT00774930|459752060|FG001|LTOLE Phase|Disease Progression|5|||
127761688|NCT00774930|459752059|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
127761689|NCT00774930|459752060|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
127761690|NCT00774930|459752059|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
127761691|NCT00774930|459752060|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
127761692|NCT01153321|459752061|FG000|Overall Study|Development of study withdrawal criteria|0|||
127761693|NCT01153321|459752062|FG001|Overall Study|Development of study withdrawal criteria|1|||
127761694|NCT01153321|459752061|FG000|Overall Study|Withdrawal by Subject|0|||
127761695|NCT01153321|459752062|FG001|Overall Study|Withdrawal by Subject|1|||
127761696|NCT01153321|459752061|FG000|Overall Study|Adverse Event|1|||
127761697|NCT01153321|459752062|FG001|Overall Study|Adverse Event|1|||
127761698|NCT01498679|459752064|FG000|Overall Study|Adverse Event|1|||
127761699|NCT01498679|459752065|FG001|Overall Study|Adverse Event|4|||
127761700|NCT01498679|459752064|FG000|Overall Study|Lack of Efficacy|72|||
127761701|NCT01498679|459752065|FG001|Overall Study|Lack of Efficacy|12|||
127761702|NCT01498679|459752064|FG000|Overall Study|Protocol Violation|4|||
127761703|NCT01498679|459752065|FG001|Overall Study|Protocol Violation|0|||
127761704|NCT01498679|459752064|FG000|Overall Study|Physician Decision|0|||
127761705|NCT01498679|459752065|FG001|Overall Study|Physician Decision|2|||
127761706|NCT01498679|459752064|FG000|Overall Study|Withdrawal by Subject|12|||
127761707|NCT01498679|459752065|FG001|Overall Study|Withdrawal by Subject|4|||
127761708|NCT03212989|459752066|FG000|Overall Study|Physician Decision|8|||
127761709|NCT04738292|459752069|FG000|Overall Study|Death|1|||
127761710|NCT03122223|459752070|FG000|Overall Study|Withdrawal by Subject|2|||
127761711|NCT03122223|459752071|FG001|Overall Study|Withdrawal by Subject|2|||
127761712|NCT03122223|459752072|FG002|Overall Study|Withdrawal by Subject|1|||
127761713|NCT03122223|459752073|FG003|Overall Study|Withdrawal by Subject|0|||
127761714|NCT03122223|459752070|FG000|Overall Study|Lost to Follow-up|0|||
127761715|NCT03122223|459752071|FG001|Overall Study|Lost to Follow-up|2|||
127761716|NCT03122223|459752072|FG002|Overall Study|Lost to Follow-up|2|||
127761717|NCT03122223|459752073|FG003|Overall Study|Lost to Follow-up|0|||
127761718|NCT03122223|459752070|FG000|Overall Study|Participant unable to adhere|1|||
127761719|NCT03122223|459752071|FG001|Overall Study|Participant unable to adhere|1|||
127872110|NCT03323034|460152017|FG004|Overall Study|Withdrawal by Subject|0|||
127872111|NCT02646566|460152018|FG000|Overall Study|Lost to Follow-up|5|||
127872112|NCT02646566|460152019|FG001|Overall Study|Lost to Follow-up|4|||
127872113|NCT02646566|460152020|FG002|Overall Study|Lost to Follow-up|5|||
127872114|NCT02646566|460152018|FG000|Overall Study|Treatment failure|1|||
127872115|NCT02646566|460152019|FG001|Overall Study|Treatment failure|0|||
127872116|NCT02646566|460152020|FG002|Overall Study|Treatment failure|0|||
127872117|NCT02222246|460152021|FG000|Overall Study|No Emergency Department Visits|27|||
127872118|NCT02222246|460152022|FG001|Overall Study|No Emergency Department Visits|26|||
127872119|NCT02222246|460152021|FG000|Overall Study|Physician Decision|0|||
127872120|NCT02222246|460152022|FG001|Overall Study|Physician Decision|1|||
127872121|NCT02660489|460152023|FG000|Overall Study|Lost to Follow-up|1|||
127872122|NCT02660489|460152024|FG001|Overall Study|Lost to Follow-up|1|||
127872123|NCT02660489|460152023|FG000|Overall Study|Adverse Event|1|||
127872124|NCT02660489|460152024|FG001|Overall Study|Adverse Event|3|||
127872125|NCT02660489|460152023|FG000|Overall Study|no rhinovirus infection|4|||
127872126|NCT02660489|460152024|FG001|Overall Study|no rhinovirus infection|4|||
127872127|NCT02064231|460152025|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
127872128|NCT02064231|460152026|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
127872129|NCT02064231|460152027|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
127872130|NCT02064231|460152028|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
127983692|NCT02044874|460562559|FG000|Overall Study|Sponsor Decision|0|||
127872131|NCT02064231|460152025|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
127872132|NCT02064231|460152026|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
127872133|NCT02064231|460152027|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
127872134|NCT02064231|460152028|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
127872135|NCT02064231|460152025|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
127872136|NCT02064231|460152026|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
127872137|NCT02064231|460152027|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
127872138|NCT02064231|460152028|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
127872139|NCT02064231|460152025|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
127872140|NCT02064231|460152026|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
127872141|NCT02064231|460152027|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
127872142|NCT02064231|460152028|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
127872143|NCT04887922|460152029|FG000|1st Randomization|Decided not to have surgery|0|||
127872144|NCT04887922|460152030|FG001|1st Randomization|Decided not to have surgery|1|||
127872145|NCT04887922|460152031|FG002|1st Randomization|Decided not to have surgery|0|||
127872146|NCT04887922|460152032|FG003|1st Randomization|Decided not to have surgery|0|||
127872147|NCT04887922|460152033|FG004|1st Randomization|Decided not to have surgery|0|||
127872148|NCT02985996|460152034|FG000|Overall Study|Withdrawal by Subject|0|||
127872149|NCT02985996|460152035|FG001|Overall Study|Withdrawal by Subject|0|||
127872150|NCT02985996|460152036|FG002|Overall Study|Withdrawal by Subject|1|||
127872151|NCT02985996|460152037|FG003|Overall Study|Withdrawal by Subject|0|||
127872152|NCT02985996|460152038|FG004|Overall Study|Withdrawal by Subject|0|||
127872153|NCT02985996|460152034|FG000|Overall Study|Protocol Violation|0|||
127872154|NCT02985996|460152035|FG001|Overall Study|Protocol Violation|1|||
127872155|NCT02985996|460152036|FG002|Overall Study|Protocol Violation|0|||
127872156|NCT02985996|460152037|FG003|Overall Study|Protocol Violation|0|||
127872157|NCT02985996|460152038|FG004|Overall Study|Protocol Violation|0|||
127872158|NCT00401726|460152039|FG000|Overall Study|Adverse Event|34|||
127872159|NCT00401726|460152040|FG001|Overall Study|Adverse Event|45|||
127872160|NCT00401726|460152039|FG000|Overall Study|Death|0|||
127872161|NCT00401726|460152040|FG001|Overall Study|Death|3|||
127872162|NCT00401726|460152039|FG000|Overall Study|Sponsor Request|0|||
127872163|NCT00401726|460152040|FG001|Overall Study|Sponsor Request|1|||
127872164|NCT00401726|460152039|FG000|Overall Study|Physician Decision|3|||
127872165|NCT00401726|460152040|FG001|Overall Study|Physician Decision|6|||
127872166|NCT00401726|460152039|FG000|Overall Study|Lost to Follow-up|23|||
127872167|NCT00401726|460152040|FG001|Overall Study|Lost to Follow-up|20|||
127872168|NCT00401726|460152039|FG000|Overall Study|Protocol Violation|6|||
127872169|NCT00401726|460152040|FG001|Overall Study|Protocol Violation|3|||
127872170|NCT00401726|460152039|FG000|Overall Study|Withdrawal by Subject|18|||
127872171|NCT00401726|460152040|FG001|Overall Study|Withdrawal by Subject|24|||
127872172|NCT00401726|460152039|FG000|Overall Study|Lack of Efficacy|4|||
127872173|NCT00401726|460152040|FG001|Overall Study|Lack of Efficacy|6|||
127872174|NCT00401726|460152039|FG000|Overall Study|Protocol Deviation|9|||
127872175|NCT00401726|460152040|FG001|Overall Study|Protocol Deviation|4|||
127872176|NCT00442572|460152041|FG000|Overall Study|Relapse|8|||
127872177|NCT00442572|460152042|FG001|Overall Study|Relapse|1|||
127872178|NCT00442572|460152041|FG000|Overall Study|Lost to Follow-up|0|||
127872179|NCT00442572|460152042|FG001|Overall Study|Lost to Follow-up|1|||
127872180|NCT00442572|460152041|FG000|Overall Study|Withdrawal by Subject|0|||
127872181|NCT00442572|460152042|FG001|Overall Study|Withdrawal by Subject|1|||
127872182|NCT03732534|460152043|FG000|Overall Study|Study terminated by Sponsor|6|||
127872183|NCT03735849|460152047|FG000|Overall Study|Lost to Follow-up|1|||
127872184|NCT03735849|460152048|FG001|Overall Study|Lost to Follow-up|0|||
127872185|NCT03735849|460152049|FG002|Overall Study|Lost to Follow-up|0|||
127872186|NCT03735849|460152047|FG000|Overall Study|Participant unable to adhere to visit|1|||
127872187|NCT03735849|460152048|FG001|Overall Study|Participant unable to adhere to visit|0|||
127872188|NCT03735849|460152049|FG002|Overall Study|Participant unable to adhere to visit|0|||
127872189|NCT03735849|460152047|FG000|Overall Study|Not Randomized|0|||
127872190|NCT03735849|460152048|FG001|Overall Study|Not Randomized|0|||
127872191|NCT03735849|460152049|FG002|Overall Study|Not Randomized|4|||
127872192|NCT04585906|460152050|FG000|Overall Study|Lost to Follow-up|8|||
127872193|NCT04585906|460152051|FG001|Overall Study|Lost to Follow-up|5|||
127872194|NCT01050998|460152053|FG000|Overall Study|Adverse Event|1|||
127872195|NCT01050998|460152054|FG001|Overall Study|Adverse Event|0|||
127872196|NCT01050998|460152055|FG002|Overall Study|Adverse Event|1|||
127872197|NCT01050998|460152056|FG003|Overall Study|Adverse Event|0|||
127872198|NCT01050998|460152057|FG004|Overall Study|Adverse Event|2|||
127872199|NCT01050998|460152053|FG000|Overall Study|Withdrawal by Subject|0|||
127872200|NCT01050998|460152054|FG001|Overall Study|Withdrawal by Subject|0|||
127872201|NCT01050998|460152055|FG002|Overall Study|Withdrawal by Subject|0|||
127872202|NCT01050998|460152056|FG003|Overall Study|Withdrawal by Subject|1|||
127872203|NCT01050998|460152057|FG004|Overall Study|Withdrawal by Subject|3|||
127872204|NCT01050998|460152053|FG000|Overall Study|Other|3|||
127872205|NCT01050998|460152054|FG001|Overall Study|Other|2|||
127872206|NCT01050998|460152055|FG002|Overall Study|Other|1|||
127872207|NCT01050998|460152056|FG003|Overall Study|Other|1|||
127872208|NCT01050998|460152057|FG004|Overall Study|Other|5|||
127872209|NCT01050998|460152053|FG000|Overall Study|Data integrity issues|0|||
127872210|NCT01050998|460152054|FG001|Overall Study|Data integrity issues|0|||
127872211|NCT01050998|460152055|FG002|Overall Study|Data integrity issues|1|||
127872212|NCT01050998|460152056|FG003|Overall Study|Data integrity issues|1|||
127872213|NCT01050998|460152057|FG004|Overall Study|Data integrity issues|4|||
127872214|NCT04246593|460152064|FG000|Overall Study|Withdrawal by Subject|14|||
127872215|NCT04246593|460152065|FG001|Overall Study|Withdrawal by Subject|13|||
127872216|NCT04246593|460152064|FG000|Overall Study|Lost to Follow-up|124|||
127872217|NCT04246593|460152065|FG001|Overall Study|Lost to Follow-up|71|||
127872218|NCT04246593|460152064|FG000|Overall Study|Moved out of area/became ineligible|3|||
127872219|NCT04246593|460152065|FG001|Overall Study|Moved out of area/became ineligible|1|||
127872220|NCT04246593|460152064|FG000|Overall Study|Reason unknown|4|||
127872221|NCT04246593|460152065|FG001|Overall Study|Reason unknown|2|||
127872222|NCT02369874|460152067|FG000|Overall Study|Lost to Follow-up|2|||
127872223|NCT02369874|460152068|FG001|Overall Study|Lost to Follow-up|2|||
127872224|NCT02369874|460152069|FG002|Overall Study|Lost to Follow-up|2|||
127872225|NCT02369874|460152067|FG000|Overall Study|Withdrawal by Subject|7|||
127872226|NCT02369874|460152068|FG001|Overall Study|Withdrawal by Subject|9|||
127872227|NCT02369874|460152069|FG002|Overall Study|Withdrawal by Subject|27|||
127872228|NCT02369874|460152067|FG000|Overall Study|Miscellaneous|1|||
127872229|NCT02369874|460152068|FG001|Overall Study|Miscellaneous|1|||
127872230|NCT02369874|460152069|FG002|Overall Study|Miscellaneous|0|||
127872231|NCT02369874|460152067|FG000|Overall Study|On Treatment/Off Study|34|||
127872232|NCT02369874|460152068|FG001|Overall Study|On Treatment/Off Study|45|||
127872233|NCT02369874|460152069|FG002|Overall Study|On Treatment/Off Study|32|||
127872234|NCT00634933|460152072|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
127872235|NCT00634933|460152073|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
127872236|NCT00634933|460152074|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
127872237|NCT00634933|460152075|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
127872238|NCT00634933|460152076|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
127872239|NCT00634933|460152072|FG000|Part A: Baseline to Week 24|Death|1|||
127872240|NCT00634933|460152073|FG001|Part A: Baseline to Week 24|Death|0|||
127872241|NCT00634933|460152074|FG002|Part A: Baseline to Week 24|Death|0|||
127872242|NCT00634933|460152075|FG003|Part A: Baseline to Week 24|Death|0|||
127872243|NCT00634933|460152076|FG004|Part A: Baseline to Week 24|Death|0|||
127872244|NCT00634933|460152072|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
127872245|NCT00634933|460152073|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
127872246|NCT00634933|460152074|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
127872247|NCT00634933|460152075|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
127872248|NCT00634933|460152076|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
127872249|NCT00634933|460152072|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
127872250|NCT00634933|460152073|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
127872251|NCT00634933|460152074|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
127872252|NCT00634933|460152075|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
127872253|NCT00634933|460152076|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
127872254|NCT00634933|460152072|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
127872255|NCT00634933|460152073|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
127872256|NCT00634933|460152074|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
127872257|NCT00634933|460152075|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
127872258|NCT00634933|460152076|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
127872259|NCT00634933|460152072|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
127872260|NCT00634933|460152073|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
127872261|NCT00634933|460152074|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
127872262|NCT00634933|460152075|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
127872263|NCT00634933|460152076|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
127872264|NCT00634933|460152072|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
127872265|NCT00634933|460152073|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
127872266|NCT00634933|460152074|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
127872267|NCT00634933|460152075|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
127872268|NCT00634933|460152076|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
127872269|NCT00634933|460152072|FG000|Part A: Baseline to Week 24|Other|1|||
127872270|NCT00634933|460152073|FG001|Part A: Baseline to Week 24|Other|8|||
127872271|NCT00634933|460152074|FG002|Part A: Baseline to Week 24|Other|5|||
127872272|NCT00634933|460152075|FG003|Part A: Baseline to Week 24|Other|0|||
127872273|NCT00634933|460152076|FG004|Part A: Baseline to Week 24|Other|0|||
127872274|NCT00634933|460152072|FG000|Between Part A and Part B|Physician Decision|0|||
127872275|NCT00634933|460152073|FG001|Between Part A and Part B|Physician Decision|1|||
127872276|NCT00634933|460152074|FG002|Between Part A and Part B|Physician Decision|0|||
127872277|NCT00634933|460152075|FG003|Between Part A and Part B|Physician Decision|0|||
127872278|NCT00634933|460152076|FG004|Between Part A and Part B|Physician Decision|0|||
127872279|NCT00634933|460152072|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
127872280|NCT00634933|460152073|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
127872281|NCT00634933|460152074|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
127872282|NCT00634933|460152075|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
127872283|NCT00634933|460152076|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
127872284|NCT00634933|460152072|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
127872285|NCT00634933|460152073|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
127872286|NCT00634933|460152074|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
127872287|NCT00634933|460152075|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
127872288|NCT00634933|460152076|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
127872289|NCT00634933|460152072|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
127872290|NCT00634933|460152073|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
127872291|NCT00634933|460152074|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
127872292|NCT00634933|460152075|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
127872293|NCT00634933|460152076|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
127872294|NCT00634933|460152072|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
127872295|NCT00634933|460152073|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
127872296|NCT00634933|460152074|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
127872297|NCT00634933|460152075|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
127872298|NCT00634933|460152076|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
127872299|NCT00634933|460152072|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
127872300|NCT00634933|460152073|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
127872301|NCT00634933|460152074|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
127872302|NCT00634933|460152075|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
127872303|NCT00634933|460152076|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
127872304|NCT00634933|460152072|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
127872305|NCT00634933|460152073|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
127872306|NCT00634933|460152074|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
127872307|NCT00634933|460152075|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
127872308|NCT00634933|460152076|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
127872309|NCT00634933|460152072|FG000|Part B: Week 24 to Week 52|Other|0|||
127872310|NCT00634933|460152073|FG001|Part B: Week 24 to Week 52|Other|0|||
127872311|NCT00634933|460152074|FG002|Part B: Week 24 to Week 52|Other|5|||
127872312|NCT00634933|460152075|FG003|Part B: Week 24 to Week 52|Other|0|||
127872313|NCT00634933|460152076|FG004|Part B: Week 24 to Week 52|Other|1|||
127872314|NCT01049360|460152077|FG000|Period 1|Adverse Event|0|||
127872315|NCT01049360|460152078|FG001|Period 1|Adverse Event|1|||
127872316|NCT01049360|460152079|FG002|Period 1|Adverse Event|0|||
127872317|NCT01049360|460152080|FG003|Period 1|Adverse Event|1|||
127872318|NCT01049360|460152081|FG004|Period 1|Adverse Event|0|||
127872319|NCT01049360|460152082|FG005|Period 1|Adverse Event|0|||
127872320|NCT01049360|460152083|FG006|Period 1|Adverse Event|0|||
127872321|NCT01049360|460152084|FG007|Period 1|Adverse Event|1|||
127872322|NCT01049360|460152085|FG008|Period 1|Adverse Event|0|||
127872323|NCT01049360|460152086|FG009|Period 1|Adverse Event|0|||
127872324|NCT01049360|460152087|FG010|Period 1|Adverse Event|0|||
127872325|NCT01049360|460152088|FG011|Period 1|Adverse Event|0|||
127872326|NCT01049360|460152089|FG012|Period 1|Adverse Event|1|||
127872327|NCT01049360|460152090|FG013|Period 1|Adverse Event|1|||
127872328|NCT01049360|460152091|FG014|Period 1|Adverse Event|0|||
127872329|NCT01049360|460152092|FG015|Period 1|Adverse Event|0|||
127872330|NCT01049360|460152093|FG016|Period 1|Adverse Event|1|||
127872331|NCT01049360|460152094|FG017|Period 1|Adverse Event|0|||
127872332|NCT01049360|460152095|FG018|Period 1|Adverse Event|1|||
127872333|NCT01049360|460152096|FG019|Period 1|Adverse Event|0|||
127872334|NCT01049360|460152077|FG000|Period 1|Did not meet inc/exc criteria|0|||
127872335|NCT01049360|460152078|FG001|Period 1|Did not meet inc/exc criteria|0|||
127872336|NCT01049360|460152079|FG002|Period 1|Did not meet inc/exc criteria|0|||
127872337|NCT01049360|460152080|FG003|Period 1|Did not meet inc/exc criteria|0|||
127872338|NCT01049360|460152081|FG004|Period 1|Did not meet inc/exc criteria|0|||
127872339|NCT01049360|460152082|FG005|Period 1|Did not meet inc/exc criteria|0|||
127872340|NCT01049360|460152083|FG006|Period 1|Did not meet inc/exc criteria|0|||
127872341|NCT01049360|460152084|FG007|Period 1|Did not meet inc/exc criteria|1|||
127872342|NCT01049360|460152085|FG008|Period 1|Did not meet inc/exc criteria|1|||
127872343|NCT01049360|460152086|FG009|Period 1|Did not meet inc/exc criteria|0|||
127872344|NCT01049360|460152087|FG010|Period 1|Did not meet inc/exc criteria|0|||
127872345|NCT01049360|460152088|FG011|Period 1|Did not meet inc/exc criteria|0|||
127872346|NCT01049360|460152089|FG012|Period 1|Did not meet inc/exc criteria|0|||
127872347|NCT01049360|460152090|FG013|Period 1|Did not meet inc/exc criteria|0|||
127872348|NCT01049360|460152091|FG014|Period 1|Did not meet inc/exc criteria|0|||
127872349|NCT01049360|460152092|FG015|Period 1|Did not meet inc/exc criteria|0|||
127872350|NCT01049360|460152093|FG016|Period 1|Did not meet inc/exc criteria|0|||
127872351|NCT01049360|460152094|FG017|Period 1|Did not meet inc/exc criteria|0|||
127872352|NCT01049360|460152095|FG018|Period 1|Did not meet inc/exc criteria|0|||
127872353|NCT01049360|460152096|FG019|Period 1|Did not meet inc/exc criteria|0|||
127872354|NCT01049360|460152077|FG000|Period 1|Withdrawal by Subject|0|||
127872355|NCT01049360|460152078|FG001|Period 1|Withdrawal by Subject|0|||
127872356|NCT01049360|460152079|FG002|Period 1|Withdrawal by Subject|0|||
127872357|NCT01049360|460152080|FG003|Period 1|Withdrawal by Subject|0|||
127872358|NCT01049360|460152081|FG004|Period 1|Withdrawal by Subject|0|||
127872359|NCT01049360|460152082|FG005|Period 1|Withdrawal by Subject|0|||
127872360|NCT01049360|460152083|FG006|Period 1|Withdrawal by Subject|0|||
127872361|NCT01049360|460152084|FG007|Period 1|Withdrawal by Subject|0|||
127872362|NCT01049360|460152085|FG008|Period 1|Withdrawal by Subject|1|||
127872363|NCT01049360|460152086|FG009|Period 1|Withdrawal by Subject|0|||
127872364|NCT01049360|460152087|FG010|Period 1|Withdrawal by Subject|1|||
127872365|NCT01049360|460152088|FG011|Period 1|Withdrawal by Subject|0|||
127872366|NCT01049360|460152089|FG012|Period 1|Withdrawal by Subject|1|||
127872367|NCT01049360|460152090|FG013|Period 1|Withdrawal by Subject|0|||
127872368|NCT01049360|460152091|FG014|Period 1|Withdrawal by Subject|0|||
127872369|NCT01049360|460152092|FG015|Period 1|Withdrawal by Subject|0|||
127872370|NCT01049360|460152093|FG016|Period 1|Withdrawal by Subject|0|||
127872371|NCT01049360|460152094|FG017|Period 1|Withdrawal by Subject|0|||
127872372|NCT01049360|460152095|FG018|Period 1|Withdrawal by Subject|0|||
127872373|NCT01049360|460152096|FG019|Period 1|Withdrawal by Subject|0|||
127872374|NCT01049360|460152077|FG000|Period 2|Protocol Violation|0|||
127872375|NCT01049360|460152078|FG001|Period 2|Protocol Violation|0|||
127872376|NCT01049360|460152079|FG002|Period 2|Protocol Violation|0|||
127872377|NCT01049360|460152080|FG003|Period 2|Protocol Violation|1|||
127872378|NCT01049360|460152081|FG004|Period 2|Protocol Violation|0|||
127872379|NCT01049360|460152082|FG005|Period 2|Protocol Violation|0|||
127872380|NCT01049360|460152083|FG006|Period 2|Protocol Violation|0|||
127872381|NCT01049360|460152084|FG007|Period 2|Protocol Violation|0|||
127872382|NCT01049360|460152085|FG008|Period 2|Protocol Violation|0|||
127872383|NCT01049360|460152086|FG009|Period 2|Protocol Violation|0|||
127872384|NCT01049360|460152087|FG010|Period 2|Protocol Violation|0|||
127872385|NCT01049360|460152088|FG011|Period 2|Protocol Violation|0|||
127872386|NCT01049360|460152089|FG012|Period 2|Protocol Violation|0|||
127872387|NCT01049360|460152090|FG013|Period 2|Protocol Violation|0|||
127872388|NCT01049360|460152091|FG014|Period 2|Protocol Violation|1|||
127872389|NCT01049360|460152092|FG015|Period 2|Protocol Violation|1|||
127872390|NCT01049360|460152093|FG016|Period 2|Protocol Violation|0|||
127872391|NCT01049360|460152094|FG017|Period 2|Protocol Violation|0|||
127872392|NCT01049360|460152095|FG018|Period 2|Protocol Violation|0|||
127872393|NCT01049360|460152096|FG019|Period 2|Protocol Violation|0|||
127872394|NCT01049360|460152077|FG000|Period 2|Adverse Event|0|||
127872395|NCT01049360|460152078|FG001|Period 2|Adverse Event|1|||
127872396|NCT01049360|460152079|FG002|Period 2|Adverse Event|0|||
127872397|NCT01049360|460152080|FG003|Period 2|Adverse Event|0|||
127872398|NCT01049360|460152081|FG004|Period 2|Adverse Event|0|||
127872399|NCT01049360|460152082|FG005|Period 2|Adverse Event|0|||
127872400|NCT01049360|460152083|FG006|Period 2|Adverse Event|0|||
127872401|NCT01049360|460152084|FG007|Period 2|Adverse Event|0|||
127872402|NCT01049360|460152085|FG008|Period 2|Adverse Event|1|||
127872403|NCT01049360|460152086|FG009|Period 2|Adverse Event|0|||
127872404|NCT01049360|460152087|FG010|Period 2|Adverse Event|0|||
127872405|NCT01049360|460152088|FG011|Period 2|Adverse Event|0|||
127872406|NCT01049360|460152089|FG012|Period 2|Adverse Event|0|||
127872407|NCT01049360|460152090|FG013|Period 2|Adverse Event|0|||
127872408|NCT01049360|460152091|FG014|Period 2|Adverse Event|0|||
127872409|NCT01049360|460152092|FG015|Period 2|Adverse Event|0|||
127872410|NCT01049360|460152093|FG016|Period 2|Adverse Event|0|||
127872411|NCT01049360|460152094|FG017|Period 2|Adverse Event|0|||
127872412|NCT01049360|460152095|FG018|Period 2|Adverse Event|0|||
127872413|NCT01049360|460152096|FG019|Period 2|Adverse Event|1|||
127872414|NCT01049360|460152077|FG000|Period 2|Withdrawal by Subject|0|||
127872415|NCT01049360|460152078|FG001|Period 2|Withdrawal by Subject|0|||
127872416|NCT01049360|460152079|FG002|Period 2|Withdrawal by Subject|0|||
127872417|NCT01049360|460152080|FG003|Period 2|Withdrawal by Subject|1|||
127872418|NCT01049360|460152081|FG004|Period 2|Withdrawal by Subject|0|||
127872419|NCT01049360|460152082|FG005|Period 2|Withdrawal by Subject|0|||
127872420|NCT01049360|460152083|FG006|Period 2|Withdrawal by Subject|0|||
127872421|NCT01049360|460152084|FG007|Period 2|Withdrawal by Subject|0|||
127872422|NCT01049360|460152085|FG008|Period 2|Withdrawal by Subject|0|||
127872423|NCT01049360|460152086|FG009|Period 2|Withdrawal by Subject|0|||
127872424|NCT01049360|460152087|FG010|Period 2|Withdrawal by Subject|0|||
127872425|NCT01049360|460152088|FG011|Period 2|Withdrawal by Subject|0|||
127872426|NCT01049360|460152089|FG012|Period 2|Withdrawal by Subject|0|||
127872427|NCT01049360|460152090|FG013|Period 2|Withdrawal by Subject|0|||
127872428|NCT01049360|460152091|FG014|Period 2|Withdrawal by Subject|1|||
127872429|NCT01049360|460152092|FG015|Period 2|Withdrawal by Subject|0|||
127872430|NCT01049360|460152093|FG016|Period 2|Withdrawal by Subject|0|||
127983693|NCT02044874|460562560|FG001|Overall Study|Sponsor Decision|1|||
127983694|NCT02044874|460562561|FG002|Overall Study|Sponsor Decision|1|||
127983695|NCT02044874|460562559|FG000|Overall Study|Other|7|||
127983696|NCT02044874|460562560|FG001|Overall Study|Other|3|||
127872431|NCT01049360|460152094|FG017|Period 2|Withdrawal by Subject|0|||
127872432|NCT01049360|460152095|FG018|Period 2|Withdrawal by Subject|0|||
127872433|NCT01049360|460152096|FG019|Period 2|Withdrawal by Subject|1|||
127872434|NCT01049360|460152077|FG000|Period 2|Lack of Efficacy|0|||
127872435|NCT01049360|460152078|FG001|Period 2|Lack of Efficacy|0|||
127872436|NCT01049360|460152079|FG002|Period 2|Lack of Efficacy|0|||
127872437|NCT01049360|460152080|FG003|Period 2|Lack of Efficacy|0|||
127872438|NCT01049360|460152081|FG004|Period 2|Lack of Efficacy|0|||
127872439|NCT01049360|460152082|FG005|Period 2|Lack of Efficacy|1|||
127872440|NCT01049360|460152083|FG006|Period 2|Lack of Efficacy|0|||
127872441|NCT01049360|460152084|FG007|Period 2|Lack of Efficacy|0|||
127872442|NCT01049360|460152085|FG008|Period 2|Lack of Efficacy|0|||
127872443|NCT01049360|460152086|FG009|Period 2|Lack of Efficacy|0|||
127872444|NCT01049360|460152087|FG010|Period 2|Lack of Efficacy|0|||
127872445|NCT01049360|460152088|FG011|Period 2|Lack of Efficacy|0|||
127872446|NCT01049360|460152089|FG012|Period 2|Lack of Efficacy|0|||
127872447|NCT01049360|460152090|FG013|Period 2|Lack of Efficacy|0|||
127872448|NCT01049360|460152091|FG014|Period 2|Lack of Efficacy|0|||
127872449|NCT01049360|460152092|FG015|Period 2|Lack of Efficacy|0|||
127872450|NCT01049360|460152093|FG016|Period 2|Lack of Efficacy|0|||
127872451|NCT01049360|460152094|FG017|Period 2|Lack of Efficacy|0|||
127872452|NCT01049360|460152095|FG018|Period 2|Lack of Efficacy|0|||
127872453|NCT01049360|460152096|FG019|Period 2|Lack of Efficacy|0|||
127872454|NCT01049360|460152077|FG000|Period 4|Protocol Violation|0|||
127872455|NCT01049360|460152078|FG001|Period 4|Protocol Violation|0|||
127872456|NCT01049360|460152079|FG002|Period 4|Protocol Violation|0|||
127872457|NCT01049360|460152080|FG003|Period 4|Protocol Violation|0|||
127872458|NCT01049360|460152081|FG004|Period 4|Protocol Violation|0|||
127872459|NCT01049360|460152082|FG005|Period 4|Protocol Violation|0|||
127872460|NCT01049360|460152083|FG006|Period 4|Protocol Violation|0|||
127872461|NCT01049360|460152084|FG007|Period 4|Protocol Violation|0|||
127872462|NCT01049360|460152085|FG008|Period 4|Protocol Violation|0|||
127872463|NCT01049360|460152086|FG009|Period 4|Protocol Violation|0|||
127872464|NCT01049360|460152087|FG010|Period 4|Protocol Violation|0|||
127872465|NCT01049360|460152088|FG011|Period 4|Protocol Violation|0|||
127872466|NCT01049360|460152089|FG012|Period 4|Protocol Violation|0|||
127539945|NCT02919761|458940551|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
127539946|NCT02919761|458940552|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
127539947|NCT02919761|458940550|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
127539948|NCT02919761|458940551|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
127539949|NCT02919761|458940552|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
127539950|NCT02919761|458940550|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
127539951|NCT02919761|458940551|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
127539952|NCT02919761|458940552|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
127539953|NCT02919761|458940550|FG000|Part 1: Open Label|Termination by Sponsor|1|||
127539954|NCT02919761|458940551|FG001|Part 1: Open Label|Termination by Sponsor|0|||
127539955|NCT02919761|458940552|FG002|Part 1: Open Label|Termination by Sponsor|0|||
127539956|NCT02919761|458940550|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
127539957|NCT02919761|458940551|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
127539958|NCT02919761|458940552|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
127539959|NCT02919761|458940550|FG000|Part 2: Double-blind|Adverse Event|0|||
127539960|NCT02919761|458940551|FG001|Part 2: Double-blind|Adverse Event|1|||
127539961|NCT02919761|458940552|FG002|Part 2: Double-blind|Adverse Event|0|||
127649280|NCT00695786|459337728|FG002|Overall Study|Lack of Efficacy|0|||
127872467|NCT01049360|460152090|FG013|Period 4|Protocol Violation|0|||
127872468|NCT01049360|460152091|FG014|Period 4|Protocol Violation|0|||
127872469|NCT01049360|460152092|FG015|Period 4|Protocol Violation|0|||
127872470|NCT01049360|460152093|FG016|Period 4|Protocol Violation|0|||
127872471|NCT01049360|460152094|FG017|Period 4|Protocol Violation|1|||
127872472|NCT01049360|460152095|FG018|Period 4|Protocol Violation|0|||
127872473|NCT01049360|460152096|FG019|Period 4|Protocol Violation|0|||
127872474|NCT01049360|460152077|FG000|Period 4|Withdrawal by Subject|0|||
127872475|NCT01049360|460152078|FG001|Period 4|Withdrawal by Subject|0|||
127872476|NCT01049360|460152079|FG002|Period 4|Withdrawal by Subject|0|||
127872477|NCT01049360|460152080|FG003|Period 4|Withdrawal by Subject|1|||
127872478|NCT01049360|460152081|FG004|Period 4|Withdrawal by Subject|0|||
127872479|NCT01049360|460152082|FG005|Period 4|Withdrawal by Subject|0|||
127983697|NCT02044874|460562561|FG002|Overall Study|Other|8|||
127983698|NCT00415597|460562562|FG000|Enrollment|Withdrawal by Subject|1|||
127983699|NCT00415597|460562562|FG000|Enrollment|Protocol Violation|1|||
127983700|NCT00415597|460562562|FG000|Treatment|Adverse Event|110|||
127983701|NCT00415597|460562562|FG000|Treatment|Lack of Efficacy|39|||
127983702|NCT00415597|460562562|FG000|Treatment|Protocol Violation|67|||
127983703|NCT00415597|460562562|FG000|Treatment|Physician Decision|3|||
127983704|NCT00415597|460562562|FG000|Treatment|Withdrawal by Subject|51|||
127983705|NCT00415597|460562562|FG000|Treatment|Lost to Follow-up|28|||
127983706|NCT00415597|460562562|FG000|Treatment|Drug Screen|2|||
127983707|NCT00415597|460562562|FG000|Treatment|Administrative|3|||
127983708|NCT00415597|460562562|FG000|Treatment|Sponsor Decision|1|||
127983709|NCT00415597|460562562|FG000|Treatment|Multiple Reasons|1|||
127983710|NCT01447927|460562563|FG000|Overall Study|Adverse Event|4|||
127983711|NCT01447927|460562564|FG001|Overall Study|Adverse Event|3|||
127983712|NCT01447927|460562563|FG000|Overall Study|Withdrawal by Subject|1|||
127872480|NCT01049360|460152083|FG006|Period 4|Withdrawal by Subject|0|||
127872481|NCT01049360|460152084|FG007|Period 4|Withdrawal by Subject|0|||
127872482|NCT01049360|460152085|FG008|Period 4|Withdrawal by Subject|0|||
127539962|NCT02919761|458940550|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
127539963|NCT02919761|458940551|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
127539964|NCT02919761|458940552|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
127539965|NCT02919761|458940550|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
127539966|NCT02919761|458940551|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
127539967|NCT02919761|458940552|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
127539968|NCT02919761|458940550|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
127539969|NCT02919761|458940551|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
127539970|NCT02919761|458940552|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
127539971|NCT02919761|458940550|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
127539972|NCT02919761|458940551|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
127539973|NCT02919761|458940552|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
127539974|NCT02919761|458940550|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
127539975|NCT02919761|458940551|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
127539976|NCT02919761|458940552|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
127539977|NCT02919761|458940550|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
127539978|NCT02919761|458940551|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
127539979|NCT02919761|458940552|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
127539980|NCT00948064|458942394|FG000|Phase I|No treatment received|1|||
127539981|NCT00948064|458942395|FG001|Phase I|No treatment received|0|||
127539982|NCT00948064|458942396|FG002|Phase I|No treatment received|0|||
127539983|NCT00948064|458942394|FG000|Phase II|Physician Decision|0|||
127539984|NCT00948064|458942395|FG001|Phase II|Physician Decision|0|||
127539985|NCT00948064|458942396|FG002|Phase II|Physician Decision|1|||
127539986|NCT00948064|458942394|FG000|Phase II|Withdrawal by Subject|0|||
127539987|NCT00948064|458942395|FG001|Phase II|Withdrawal by Subject|1|||
127539988|NCT00948064|458942396|FG002|Phase II|Withdrawal by Subject|0|||
127539989|NCT02741128|458942407|FG000|Overall Study|Protocol Violation|4|||
127539990|NCT02741128|458942408|FG001|Overall Study|Protocol Violation|1|||
127539991|NCT02741128|458942407|FG000|Overall Study|Withdrawal by Subject|2|||
127539992|NCT02741128|458942408|FG001|Overall Study|Withdrawal by Subject|0|||
127539993|NCT02741128|458942407|FG000|Overall Study|Lost to Follow-up|1|||
127539994|NCT02741128|458942408|FG001|Overall Study|Lost to Follow-up|0|||
127539995|NCT02973100|458942409|FG000|Overall Study|Adverse Event|1|||
127539996|NCT02973100|458942410|FG001|Overall Study|Adverse Event|2|||
127539997|NCT02973100|458942411|FG002|Overall Study|Adverse Event|1|||
127539998|NCT02973100|458942412|FG003|Overall Study|Adverse Event|2|||
127539999|NCT02973100|458942409|FG000|Overall Study|Lost to Follow-up|3|||
127540000|NCT02973100|458942410|FG001|Overall Study|Lost to Follow-up|1|||
127540001|NCT02973100|458942411|FG002|Overall Study|Lost to Follow-up|1|||
127540002|NCT02973100|458942412|FG003|Overall Study|Lost to Follow-up|0|||
127540003|NCT02973100|458942409|FG000|Overall Study|Withdrawal by Subject|3|||
127540004|NCT02973100|458942410|FG001|Overall Study|Withdrawal by Subject|5|||
127540005|NCT02973100|458942411|FG002|Overall Study|Withdrawal by Subject|1|||
127540006|NCT02973100|458942412|FG003|Overall Study|Withdrawal by Subject|4|||
127540007|NCT02973100|458942409|FG000|Overall Study|Notification of change in address|0|||
127540008|NCT02973100|458942410|FG001|Overall Study|Notification of change in address|0|||
127540009|NCT02973100|458942411|FG002|Overall Study|Notification of change in address|0|||
127540010|NCT02973100|458942412|FG003|Overall Study|Notification of change in address|1|||
127540011|NCT02973100|458942409|FG000|Overall Study|Failed to attend Safety followup period|0|||
127540012|NCT02973100|458942410|FG001|Overall Study|Failed to attend Safety followup period|0|||
127540013|NCT02973100|458942411|FG002|Overall Study|Failed to attend Safety followup period|1|||
127540014|NCT02973100|458942412|FG003|Overall Study|Failed to attend Safety followup period|0|||
127540015|NCT01419769|458942413|FG000|Overall Study|Did not receive the AXIOS stent|3|||
127540016|NCT01419769|458942413|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
127540017|NCT00878501|458942414|FG000|Overall Study|Adverse Event|11|||
127540018|NCT00878501|458942415|FG001|Overall Study|Adverse Event|3|||
127540019|NCT00878501|458942416|FG002|Overall Study|Adverse Event|3|||
127540020|NCT00878501|458942414|FG000|Overall Study|Lack of Efficacy|2|||
127540021|NCT00878501|458942415|FG001|Overall Study|Lack of Efficacy|1|||
127540022|NCT00878501|458942416|FG002|Overall Study|Lack of Efficacy|0|||
127872483|NCT01049360|460152086|FG009|Period 4|Withdrawal by Subject|0|||
127872484|NCT01049360|460152087|FG010|Period 4|Withdrawal by Subject|0|||
127872485|NCT01049360|460152088|FG011|Period 4|Withdrawal by Subject|0|||
127540023|NCT00878501|458942414|FG000|Overall Study|Withdrawal by Subject|2|||
127540024|NCT00878501|458942415|FG001|Overall Study|Withdrawal by Subject|1|||
127540025|NCT00878501|458942416|FG002|Overall Study|Withdrawal by Subject|2|||
127540026|NCT00878501|458942414|FG000|Overall Study|Protocol Violation|0|||
127540027|NCT00878501|458942415|FG001|Overall Study|Protocol Violation|0|||
127540028|NCT00878501|458942416|FG002|Overall Study|Protocol Violation|1|||
127540029|NCT00878501|458942414|FG000|Overall Study|Incorrect enrolment|1|||
127540030|NCT00878501|458942415|FG001|Overall Study|Incorrect enrolment|2|||
127540031|NCT00878501|458942416|FG002|Overall Study|Incorrect enrolment|0|||
127540032|NCT00878501|458942414|FG000|Overall Study|Intake of prohibited concom. medication|0|||
127872486|NCT01049360|460152089|FG012|Period 4|Withdrawal by Subject|0|||
127540033|NCT00878501|458942415|FG001|Overall Study|Intake of prohibited concom. medication|0|||
127540034|NCT00878501|458942416|FG002|Overall Study|Intake of prohibited concom. medication|1|||
127540035|NCT00878501|458942414|FG000|Overall Study|Mis-randomisation of patient|1|||
127540036|NCT00878501|458942415|FG001|Overall Study|Mis-randomisation of patient|0|||
127540037|NCT00878501|458942416|FG002|Overall Study|Mis-randomisation of patient|0|||
127540038|NCT00878501|458942414|FG000|Overall Study|Administrative|0|||
127540039|NCT00878501|458942415|FG001|Overall Study|Administrative|0|||
127540040|NCT00878501|458942416|FG002|Overall Study|Administrative|1|||
127540041|NCT00812708|458942419|FG000|Overall Study|Device could not be implanted|2|||
127540042|NCT00812708|458942419|FG000|Overall Study|Lack of medical insurance|1|||
127540043|NCT00812708|458942419|FG000|Overall Study|Switched to another study|1|||
127540044|NCT00812708|458942419|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
127540045|NCT00812708|458942419|FG000|Overall Study|Signed consent but later withdrew|3|||
127540046|NCT01959503|458942420|FG000|Overall Study|Death|2|||
127540047|NCT01959503|458942421|FG001|Overall Study|Death|1|||
127540048|NCT01959503|458942420|FG000|Overall Study|Randomized but not treated|1|||
127540049|NCT01959503|458942421|FG001|Overall Study|Randomized but not treated|1|||
127540050|NCT01600326|458942422|FG000|Overall Study|Lost to Follow-up|1|||
127540051|NCT01600326|458942423|FG001|Overall Study|Lost to Follow-up|1|||
127540052|NCT03224130|458942424|FG000|Overall Study|consent issue|0|||
127540053|NCT03224130|458942425|FG001|Overall Study|consent issue|1|||
127540054|NCT02587520|458942433|FG000|Overall Study|Protocol Violation|2|||
127540055|NCT02587520|458942434|FG001|Overall Study|Protocol Violation|0|||
127540056|NCT02587520|458942435|FG002|Overall Study|Protocol Violation|0|||
127540057|NCT02587520|458942436|FG003|Overall Study|Protocol Violation|2|||
127540058|NCT02587520|458942437|FG004|Overall Study|Protocol Violation|0|||
127540059|NCT02587520|458942438|FG005|Overall Study|Protocol Violation|1|||
127540060|NCT02587520|458942439|FG006|Overall Study|Protocol Violation|1|||
127540061|NCT02587520|458942440|FG007|Overall Study|Protocol Violation|1|||
127540062|NCT02587520|458942441|FG008|Overall Study|Protocol Violation|3|||
127540063|NCT02587520|458942442|FG009|Overall Study|Protocol Violation|3|||
127540064|NCT02587520|458942443|FG010|Overall Study|Protocol Violation|1|||
127540065|NCT02587520|458942444|FG011|Overall Study|Protocol Violation|2|||
127540066|NCT02587520|458942445|FG012|Overall Study|Protocol Violation|0|||
127540067|NCT02587520|458942446|FG013|Overall Study|Protocol Violation|0|||
127540068|NCT02587520|458942447|FG014|Overall Study|Protocol Violation|0|||
127540069|NCT02587520|458942448|FG015|Overall Study|Protocol Violation|0|||
127540070|NCT02587520|458942449|FG016|Overall Study|Protocol Violation|0|||
127540071|NCT02587520|458942450|FG017|Overall Study|Protocol Violation|0|||
127540072|NCT02587520|458942433|FG000|Overall Study|Adverse Event|0|||
127540073|NCT02587520|458942434|FG001|Overall Study|Adverse Event|0|||
127540074|NCT02587520|458942435|FG002|Overall Study|Adverse Event|0|||
127540075|NCT02587520|458942436|FG003|Overall Study|Adverse Event|0|||
127540076|NCT02587520|458942437|FG004|Overall Study|Adverse Event|0|||
127540077|NCT02587520|458942438|FG005|Overall Study|Adverse Event|0|||
127540078|NCT02587520|458942439|FG006|Overall Study|Adverse Event|0|||
127540079|NCT02587520|458942440|FG007|Overall Study|Adverse Event|0|||
127540080|NCT02587520|458942441|FG008|Overall Study|Adverse Event|0|||
127540081|NCT02587520|458942442|FG009|Overall Study|Adverse Event|0|||
127540082|NCT02587520|458942443|FG010|Overall Study|Adverse Event|0|||
127540083|NCT02587520|458942444|FG011|Overall Study|Adverse Event|1|||
127540084|NCT02587520|458942445|FG012|Overall Study|Adverse Event|0|||
127540085|NCT02587520|458942446|FG013|Overall Study|Adverse Event|0|||
127540086|NCT02587520|458942447|FG014|Overall Study|Adverse Event|0|||
127540087|NCT02587520|458942448|FG015|Overall Study|Adverse Event|0|||
127540088|NCT02587520|458942449|FG016|Overall Study|Adverse Event|0|||
127540089|NCT02587520|458942450|FG017|Overall Study|Adverse Event|0|||
127540090|NCT02587520|458942433|FG000|Overall Study|Withdrawal by Subject|0|||
127540091|NCT02587520|458942434|FG001|Overall Study|Withdrawal by Subject|0|||
127540092|NCT02587520|458942435|FG002|Overall Study|Withdrawal by Subject|1|||
127540093|NCT02587520|458942436|FG003|Overall Study|Withdrawal by Subject|1|||
127540094|NCT02587520|458942437|FG004|Overall Study|Withdrawal by Subject|0|||
127540095|NCT02587520|458942438|FG005|Overall Study|Withdrawal by Subject|1|||
127540096|NCT02587520|458942439|FG006|Overall Study|Withdrawal by Subject|1|||
127540097|NCT02587520|458942440|FG007|Overall Study|Withdrawal by Subject|0|||
127540098|NCT02587520|458942441|FG008|Overall Study|Withdrawal by Subject|0|||
127540099|NCT02587520|458942442|FG009|Overall Study|Withdrawal by Subject|0|||
127540100|NCT02587520|458942443|FG010|Overall Study|Withdrawal by Subject|0|||
127540101|NCT02587520|458942444|FG011|Overall Study|Withdrawal by Subject|0|||
127540102|NCT02587520|458942445|FG012|Overall Study|Withdrawal by Subject|0|||
127649281|NCT00695786|459337729|FG003|Overall Study|Lack of Efficacy|4|||
127540103|NCT02587520|458942446|FG013|Overall Study|Withdrawal by Subject|1|||
127540104|NCT02587520|458942447|FG014|Overall Study|Withdrawal by Subject|0|||
127540105|NCT02587520|458942448|FG015|Overall Study|Withdrawal by Subject|0|||
127540106|NCT02587520|458942449|FG016|Overall Study|Withdrawal by Subject|0|||
127540107|NCT02587520|458942450|FG017|Overall Study|Withdrawal by Subject|0|||
127540108|NCT02587520|458942433|FG000|Overall Study|Lost to Follow-up|0|||
127540109|NCT02587520|458942434|FG001|Overall Study|Lost to Follow-up|2|||
127540110|NCT02587520|458942435|FG002|Overall Study|Lost to Follow-up|0|||
127540111|NCT02587520|458942436|FG003|Overall Study|Lost to Follow-up|2|||
127540112|NCT02587520|458942437|FG004|Overall Study|Lost to Follow-up|0|||
127540113|NCT02587520|458942438|FG005|Overall Study|Lost to Follow-up|1|||
127540114|NCT02587520|458942439|FG006|Overall Study|Lost to Follow-up|1|||
127540115|NCT02587520|458942440|FG007|Overall Study|Lost to Follow-up|1|||
127540116|NCT02587520|458942441|FG008|Overall Study|Lost to Follow-up|0|||
127540117|NCT02587520|458942442|FG009|Overall Study|Lost to Follow-up|2|||
127540118|NCT02587520|458942443|FG010|Overall Study|Lost to Follow-up|2|||
127540119|NCT02587520|458942444|FG011|Overall Study|Lost to Follow-up|1|||
127540120|NCT02587520|458942445|FG012|Overall Study|Lost to Follow-up|0|||
127540121|NCT02587520|458942446|FG013|Overall Study|Lost to Follow-up|0|||
127540122|NCT02587520|458942447|FG014|Overall Study|Lost to Follow-up|0|||
127540123|NCT02587520|458942448|FG015|Overall Study|Lost to Follow-up|0|||
127540124|NCT02587520|458942449|FG016|Overall Study|Lost to Follow-up|0|||
127540125|NCT02587520|458942450|FG017|Overall Study|Lost to Follow-up|0|||
127540126|NCT03924622|458942451|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
127540127|NCT03924622|458942452|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
127540128|NCT03924622|458942453|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
127540129|NCT03924622|458942454|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
127540130|NCT03924622|458942455|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
127540131|NCT03924622|458942456|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
127540132|NCT02412306|458942458|FG000|Overall Study|Lost to Follow-up|0|||
127540133|NCT02412306|458942459|FG001|Overall Study|Lost to Follow-up|1|||
127540134|NCT02412306|458942460|FG002|Overall Study|Lost to Follow-up|0|||
127540135|NCT02412306|458942461|FG003|Overall Study|Lost to Follow-up|0|||
127540136|NCT02412306|458942462|FG004|Overall Study|Lost to Follow-up|0|||
127540137|NCT02412306|458942458|FG000|Overall Study|Withdrawal by Subject|0|||
127540138|NCT02412306|458942459|FG001|Overall Study|Withdrawal by Subject|0|||
127540139|NCT02412306|458942460|FG002|Overall Study|Withdrawal by Subject|1|||
127540140|NCT02412306|458942461|FG003|Overall Study|Withdrawal by Subject|0|||
127540141|NCT02412306|458942462|FG004|Overall Study|Withdrawal by Subject|0|||
127540142|NCT02412306|458942458|FG000|Overall Study|Death|5|||
127540143|NCT02412306|458942459|FG001|Overall Study|Death|7|||
127540144|NCT02412306|458942460|FG002|Overall Study|Death|15|||
127540145|NCT02412306|458942461|FG003|Overall Study|Death|0|||
127540146|NCT02412306|458942462|FG004|Overall Study|Death|2|||
127540147|NCT04349891|458942470|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
127540148|NCT04349891|458942471|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
127540149|NCT04349891|458942470|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
127540150|NCT04349891|458942471|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
127540151|NCT04349891|458942470|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
127540152|NCT04349891|458942471|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
127540153|NCT04349891|458942470|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
127540154|NCT04349891|458942471|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
127540155|NCT02927301|458942474|FG000|Overall Study|Death|39|||
127540156|NCT02927301|458942474|FG000|Overall Study|Lost to Follow-up|8|||
127540157|NCT02927301|458942474|FG000|Overall Study|Physician Decision|2|||
127540158|NCT02927301|458942474|FG000|Overall Study|Withdrawal by Subject|12|||
127540159|NCT02927301|458942474|FG000|Overall Study|Study Ended By Sponsor While in Survival Follow-Up|5|||
127540160|NCT04247347|458942479|FG000|Overall Study|Withdrawal by Subject|2|||
127540161|NCT04247347|458942480|FG001|Overall Study|Withdrawal by Subject|3|||
127540162|NCT04247347|458942481|FG002|Overall Study|Withdrawal by Subject|3|||
127540163|NCT04247347|458942479|FG000|Overall Study|Lost to Follow-up|1|||
127540164|NCT04247347|458942480|FG001|Overall Study|Lost to Follow-up|1|||
127540165|NCT04247347|458942481|FG002|Overall Study|Lost to Follow-up|1|||
127540166|NCT03562195|458942482|FG000|Overall Study|Adverse Event|0|||
127540167|NCT03562195|458942483|FG001|Overall Study|Adverse Event|6|||
127540168|NCT03562195|458942482|FG000|Overall Study|Lack of Efficacy|0|||
127540169|NCT03562195|458942483|FG001|Overall Study|Lack of Efficacy|5|||
127540170|NCT03562195|458942482|FG000|Overall Study|Protocol Violation|0|||
127540171|NCT03562195|458942483|FG001|Overall Study|Protocol Violation|1|||
127540172|NCT03562195|458942482|FG000|Overall Study|Lost to Follow-up|0|||
127540173|NCT03562195|458942483|FG001|Overall Study|Lost to Follow-up|1|||
127540174|NCT03562195|458942482|FG000|Overall Study|Physician Decision|1|||
127540175|NCT03562195|458942483|FG001|Overall Study|Physician Decision|0|||
127872487|NCT01049360|460152090|FG013|Period 4|Withdrawal by Subject|0|||
127872488|NCT01049360|460152091|FG014|Period 4|Withdrawal by Subject|0|||
127872489|NCT01049360|460152092|FG015|Period 4|Withdrawal by Subject|0|||
127540176|NCT03562195|458942482|FG000|Overall Study|Withdrawal by Subject|3|||
127540177|NCT03562195|458942483|FG001|Overall Study|Withdrawal by Subject|0|||
127540178|NCT04664153|458942484|FG000|Overall Study|Lack of Efficacy|0|||
127540179|NCT04664153|458942485|FG001|Overall Study|Lack of Efficacy|0|||
127540180|NCT04664153|458942486|FG002|Overall Study|Lack of Efficacy|1|||
127872490|NCT01049360|460152093|FG016|Period 4|Withdrawal by Subject|0|||
127872491|NCT01049360|460152094|FG017|Period 4|Withdrawal by Subject|0|||
127540181|NCT04664153|458942487|FG003|Overall Study|Lack of Efficacy|0|||
127540182|NCT04664153|458942484|FG000|Overall Study|Physician Decision|0|||
127540183|NCT04664153|458942485|FG001|Overall Study|Physician Decision|0|||
127540184|NCT04664153|458942486|FG002|Overall Study|Physician Decision|1|||
127540185|NCT04664153|458942487|FG003|Overall Study|Physician Decision|0|||
127540186|NCT04664153|458942484|FG000|Overall Study|Withdrawal by Subject|3|||
127540187|NCT04664153|458942485|FG001|Overall Study|Withdrawal by Subject|2|||
127540188|NCT04664153|458942486|FG002|Overall Study|Withdrawal by Subject|1|||
127540189|NCT04664153|458942487|FG003|Overall Study|Withdrawal by Subject|2|||
127540190|NCT04664153|458942484|FG000|Overall Study|Other|0|||
127540191|NCT04664153|458942485|FG001|Overall Study|Other|1|||
127540192|NCT04664153|458942486|FG002|Overall Study|Other|0|||
127540193|NCT04664153|458942487|FG003|Overall Study|Other|0|||
127540194|NCT04664153|458942484|FG000|Overall Study|Adverse Event|4|||
127540195|NCT04664153|458942485|FG001|Overall Study|Adverse Event|0|||
127540196|NCT04664153|458942486|FG002|Overall Study|Adverse Event|1|||
127540197|NCT04664153|458942487|FG003|Overall Study|Adverse Event|0|||
127540198|NCT00097500|458942488|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
127540199|NCT00097500|458942489|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
127540200|NCT00097500|458942488|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
127540201|NCT00097500|458942489|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
127540202|NCT00097500|458942488|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
127540203|NCT00097500|458942489|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
127540204|NCT00097500|458942488|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
127540205|NCT00097500|458942489|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
127540206|NCT00097500|458942488|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
127540207|NCT00097500|458942489|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
127540208|NCT00097500|458942488|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
127540209|NCT00097500|458942489|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
127540210|NCT00097500|458942488|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
127540211|NCT00097500|458942489|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
127540212|NCT00642356|458942495|FG000|Overall Study|Adverse Event|1|||
127540213|NCT00642356|458942496|FG001|Overall Study|Adverse Event|0|||
127540214|NCT00642356|458942495|FG000|Overall Study|Protocol Violation|0|||
127540215|NCT00642356|458942496|FG001|Overall Study|Protocol Violation|3|||
127540216|NCT00642356|458942495|FG000|Overall Study|Lack of Efficacy|1|||
127540217|NCT00642356|458942496|FG001|Overall Study|Lack of Efficacy|0|||
127540218|NCT01009060|458942497|FG000|Overall Study|Adverse Event|1|||
127540219|NCT01009060|458942498|FG001|Overall Study|Adverse Event|2|||
127540220|NCT01009060|458942497|FG000|Overall Study|Protocol Violation|0|||
127540221|NCT01009060|458942498|FG001|Overall Study|Protocol Violation|1|||
127540222|NCT01009060|458942497|FG000|Overall Study|Lost to Follow-up|1|||
127540223|NCT01009060|458942498|FG001|Overall Study|Lost to Follow-up|0|||
127540224|NCT01009060|458942497|FG000|Overall Study|Physician Decision|1|||
127540225|NCT01009060|458942498|FG001|Overall Study|Physician Decision|1|||
127540226|NCT01009060|458942497|FG000|Overall Study|Withdrawal by Subject|1|||
127540227|NCT01009060|458942498|FG001|Overall Study|Withdrawal by Subject|1|||
127540228|NCT04602390|458942499|FG000|Overall Study|Withdrawal by Subject|0|||
127540229|NCT04602390|458942500|FG001|Overall Study|Withdrawal by Subject|0|||
127540230|NCT04602390|458942501|FG002|Overall Study|Withdrawal by Subject|0|||
127540231|NCT04602390|458942502|FG003|Overall Study|Withdrawal by Subject|0|||
127540232|NCT04602390|458942503|FG004|Overall Study|Withdrawal by Subject|1|||
127540233|NCT04602390|458942504|FG005|Overall Study|Withdrawal by Subject|0|||
127540234|NCT04602390|458942499|FG000|Overall Study|Adverse Event|0|||
127540235|NCT04602390|458942500|FG001|Overall Study|Adverse Event|0|||
127540236|NCT04602390|458942501|FG002|Overall Study|Adverse Event|0|||
127540237|NCT04602390|458942502|FG003|Overall Study|Adverse Event|0|||
127540238|NCT04602390|458942503|FG004|Overall Study|Adverse Event|0|||
127540239|NCT04602390|458942504|FG005|Overall Study|Adverse Event|1|||
127540240|NCT00265564|458942509|FG000|Overall Study|Lost to Follow-up|5|||
127540241|NCT00265564|458942510|FG001|Overall Study|Lost to Follow-up|7|||
127540242|NCT00265564|458942509|FG000|Overall Study|met exclusion criteria|5|||
127540243|NCT00265564|458942510|FG001|Overall Study|met exclusion criteria|2|||
127540244|NCT00286442|458942511|FG000|Overall Study|Hyperglycemic Rescue|19|||
127540245|NCT00286442|458942512|FG001|Overall Study|Hyperglycemic Rescue|17|||
127540246|NCT00286442|458942513|FG002|Overall Study|Hyperglycemic Rescue|25|||
127540247|NCT00286442|458942511|FG000|Overall Study|Adverse Event|7|||
127540248|NCT00286442|458942512|FG001|Overall Study|Adverse Event|6|||
127540249|NCT00286442|458942513|FG002|Overall Study|Adverse Event|1|||
127540250|NCT00286442|458942511|FG000|Overall Study|Protocol Violation|2|||
127540251|NCT00286442|458942512|FG001|Overall Study|Protocol Violation|4|||
127540252|NCT00286442|458942513|FG002|Overall Study|Protocol Violation|2|||
127540253|NCT00286442|458942511|FG000|Overall Study|Lost to Follow-up|5|||
127540254|NCT00286442|458942512|FG001|Overall Study|Lost to Follow-up|2|||
127540255|NCT00286442|458942513|FG002|Overall Study|Lost to Follow-up|1|||
127540256|NCT00286442|458942511|FG000|Overall Study|Physician Decision|1|||
127540257|NCT00286442|458942512|FG001|Overall Study|Physician Decision|1|||
127540258|NCT00286442|458942513|FG002|Overall Study|Physician Decision|1|||
127540259|NCT00286442|458942511|FG000|Overall Study|Administrative Error|1|||
127540260|NCT00286442|458942512|FG001|Overall Study|Administrative Error|1|||
127540261|NCT00286442|458942513|FG002|Overall Study|Administrative Error|0|||
127540262|NCT00286442|458942511|FG000|Overall Study|Withdrawal by Subject|2|||
127540263|NCT00286442|458942512|FG001|Overall Study|Withdrawal by Subject|14|||
127540264|NCT00286442|458942513|FG002|Overall Study|Withdrawal by Subject|2|||
127540265|NCT02542865|458942516|FG000|Overall Study|Identified as screen failure|1|||
127540266|NCT02542865|458942517|FG001|Overall Study|Identified as screen failure|0|||
127540267|NCT02542865|458942516|FG000|Overall Study|Withdrawal by Subject|16|||
127540268|NCT02542865|458942517|FG001|Overall Study|Withdrawal by Subject|0|||
127540269|NCT04913610|458942520|FG000|Randomized Participants|Did Not Receive Treatment|0|||
127540270|NCT04913610|458942521|FG001|Randomized Participants|Did Not Receive Treatment|0|||
127540271|NCT04913610|458942522|FG002|Randomized Participants|Did Not Receive Treatment|1|||
127540272|NCT04913610|458942523|FG003|Randomized Participants|Did Not Receive Treatment|1|||
127540273|NCT04913610|458942524|FG004|Randomized Participants|Did Not Receive Treatment|0|||
127540274|NCT04913610|458942520|FG000|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
127540275|NCT04913610|458942521|FG001|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
127540276|NCT04913610|458942522|FG002|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
127540277|NCT04913610|458942523|FG003|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
127540278|NCT04913610|458942524|FG004|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
127540279|NCT02358473|458942529|FG000|Overall Study|Disease Progession|6|||
127540280|NCT02358473|458942529|FG000|Overall Study|Adverse Event|3|||
127540281|NCT02358473|458942529|FG000|Overall Study|Withdrawal by Subject|2|||
127540282|NCT02358473|458942529|FG000|Overall Study|Physician Decision|2|||
127540283|NCT02240485|458942530|FG000|3 Months Post-admission|Lost to Follow-up|1|||
127540284|NCT02240485|458942531|FG001|3 Months Post-admission|Lost to Follow-up|5|||
127540285|NCT02240485|458942530|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
127540286|NCT02240485|458942531|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
127540287|NCT02240485|458942530|FG000|9 Months Post-admission|Lost to Follow-up|3|||
127540288|NCT02240485|458942531|FG001|9 Months Post-admission|Lost to Follow-up|1|||
127540289|NCT02240485|458942530|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
127540290|NCT02240485|458942531|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
127540291|NCT02240485|458942530|FG000|18 Months Post-admission|Lost to Follow-up|1|||
127540292|NCT02240485|458942531|FG001|18 Months Post-admission|Lost to Follow-up|1|||
127540293|NCT02240485|458942530|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
127540294|NCT02240485|458942531|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
127540295|NCT00953667|458942532|FG000|Overall Study|Lost to Follow-up|11|||
127540296|NCT00953667|458942532|FG000|Overall Study|Physician Decision|35|||
127540297|NCT00953667|458942532|FG000|Overall Study|Withdrawal by Subject|63|||
127540298|NCT00953667|458942532|FG000|Overall Study|Adverse Event|10|||
127540299|NCT00953667|458942532|FG000|Overall Study|poor venous access,unable to draw blood|4|||
127540300|NCT04819945|458942533|FG000|Overall Study|Lost to Follow-up|1|||
127540301|NCT00475670|458942534|FG000|Overall Study|Death|0|||
127540302|NCT00475670|458942535|FG001|Overall Study|Death|1|||
127540303|NCT00475670|458942534|FG000|Overall Study|Lack of Efficacy|3|||
127540304|NCT00475670|458942535|FG001|Overall Study|Lack of Efficacy|34|||
127540305|NCT00475670|458942534|FG000|Overall Study|Refused treatment|0|||
127540306|NCT00475670|458942535|FG001|Overall Study|Refused treatment|2|||
127540307|NCT00475670|458942534|FG000|Overall Study|Failure to Return|0|||
127540308|NCT00475670|458942535|FG001|Overall Study|Failure to Return|1|||
127540309|NCT00475670|458942534|FG000|Overall Study|Other|0|||
127540310|NCT00475670|458942535|FG001|Overall Study|Other|3|||
127540311|NCT04949191|458942536|FG000|Overall Study|Non-compliance with Study Drug|1|||
127540312|NCT04949191|458942537|FG001|Overall Study|Non-compliance with Study Drug|0|||
127540313|NCT04949191|458942538|FG002|Overall Study|Non-compliance with Study Drug|0|||
127540314|NCT04949191|458942539|FG003|Overall Study|Non-compliance with Study Drug|0|||
127540315|NCT04949191|458942536|FG000|Overall Study|Progressive Disease|0|||
127540316|NCT04949191|458942537|FG001|Overall Study|Progressive Disease|1|||
127540317|NCT04949191|458942538|FG002|Overall Study|Progressive Disease|0|||
127540318|NCT04949191|458942539|FG003|Overall Study|Progressive Disease|0|||
127540319|NCT04949191|458942536|FG000|Overall Study|Transitioned to Commercial Pemigatinib|0|||
127540320|NCT04949191|458942537|FG001|Overall Study|Transitioned to Commercial Pemigatinib|1|||
127540321|NCT04949191|458942538|FG002|Overall Study|Transitioned to Commercial Pemigatinib|0|||
127540322|NCT04949191|458942539|FG003|Overall Study|Transitioned to Commercial Pemigatinib|0|||
127540323|NCT04949191|458942536|FG000|Overall Study|Sponsor Terminated Study|0|||
127540324|NCT04949191|458942537|FG001|Overall Study|Sponsor Terminated Study|0|||
127540325|NCT04949191|458942538|FG002|Overall Study|Sponsor Terminated Study|1|||
127540326|NCT04949191|458942539|FG003|Overall Study|Sponsor Terminated Study|1|||
127540327|NCT02913482|458942540|FG000|Overall Study|Death|0|||
127540328|NCT02913482|458942541|FG001|Overall Study|Death|2|||
127540329|NCT02913482|458942542|FG002|Overall Study|Death|2|||
127540330|NCT02913482|458942540|FG000|Overall Study|Progressive Disease|1|||
127540331|NCT02913482|458942541|FG001|Overall Study|Progressive Disease|1|||
127540332|NCT02913482|458942542|FG002|Overall Study|Progressive Disease|1|||
127540333|NCT02913482|458942540|FG000|Overall Study|Reason not specified|0|||
127540334|NCT02913482|458942541|FG001|Overall Study|Reason not specified|0|||
127540335|NCT02913482|458942542|FG002|Overall Study|Reason not specified|1|||
127540336|NCT02913482|458942540|FG000|Overall Study|Withdrawal by Subject|0|||
127540337|NCT02913482|458942541|FG001|Overall Study|Withdrawal by Subject|1|||
127540338|NCT02913482|458942542|FG002|Overall Study|Withdrawal by Subject|1|||
127540339|NCT01046565|458942545|FG000|Overall Study|Adverse Event|2|||
127540340|NCT01046565|458942545|FG000|Overall Study|Withdrawal by Subject|7|||
127540341|NCT00918385|458942546|FG000|Monotherapy|Adverse Event|1|||
127540342|NCT00918385|458942547|FG001|Monotherapy|Adverse Event|6|||
127540343|NCT00918385|458942546|FG000|Monotherapy|Complicating illness|1|||
127540344|NCT00918385|458942547|FG001|Monotherapy|Complicating illness|0|||
127540345|NCT00918385|458942546|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
127540346|NCT00918385|458942547|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
127540347|NCT00918385|458942546|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
127540348|NCT00918385|458942547|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
127540349|NCT00918385|458942546|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
127540350|NCT00918385|458942547|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
127540351|NCT00918385|458942546|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
127540352|NCT00918385|458942547|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
127540353|NCT00083889|458942549|FG000|Overall Study|Adverse Event|76|||
127540354|NCT00083889|458942550|FG001|Overall Study|Adverse Event|86|||
127540355|NCT00083889|458942549|FG000|Overall Study|Protocol Violation|2|||
127540356|NCT00083889|458942550|FG001|Overall Study|Protocol Violation|2|||
127540357|NCT00083889|458942549|FG000|Overall Study|Withdrawal by Subject|22|||
127540358|NCT00083889|458942550|FG001|Overall Study|Withdrawal by Subject|24|||
127540359|NCT00083889|458942549|FG000|Overall Study|Lack of Efficacy|240|||
127540360|NCT00083889|458942550|FG001|Overall Study|Lack of Efficacy|219|||
127540361|NCT00083889|458942549|FG000|Overall Study|Decision of sponsor|32|||
127540362|NCT00083889|458942550|FG001|Overall Study|Decision of sponsor|4|||
127540363|NCT00083889|458942549|FG000|Overall Study|Randomized: did not take study drug|0|||
127540364|NCT00083889|458942550|FG001|Overall Study|Randomized: did not take study drug|15|||
127540365|NCT00083889|458942549|FG000|Overall Study|Completed on marketed sunitinub|3|||
127540366|NCT00083889|458942550|FG001|Overall Study|Completed on marketed sunitinub|0|||
127540367|NCT00083889|458942549|FG000|Overall Study|Crossover to SU011248|0|||
127540368|NCT00083889|458942550|FG001|Overall Study|Crossover to SU011248|25|||
127540369|NCT03624881|458942551|FG000|Overall Study|Screen Failure|14|||
127540370|NCT03624881|458942552|FG001|Overall Study|Screen Failure|0|||
127540371|NCT03624881|458942551|FG000|Overall Study|No Catheter Inserted|6|||
127540372|NCT03624881|458942552|FG001|Overall Study|No Catheter Inserted|1|||
127540373|NCT03624881|458942551|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
127540374|NCT03624881|458942552|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
127540375|NCT03624881|458942551|FG000|Overall Study|Death|2|||
127540376|NCT03624881|458942552|FG001|Overall Study|Death|0|||
127540377|NCT03624881|458942551|FG000|Overall Study|Lost to Follow-up|10|||
127540378|NCT03624881|458942552|FG001|Overall Study|Lost to Follow-up|4|||
127540379|NCT03624881|458942551|FG000|Overall Study|Withdrawal by Subject|12|||
127540380|NCT03624881|458942552|FG001|Overall Study|Withdrawal by Subject|1|||
127540381|NCT03557970|458942553|FG000|Overall Study|Study closure|1|||
127540382|NCT03557970|458942554|FG001|Overall Study|Study closure|0|||
127540383|NCT03557970|458942553|FG000|Overall Study|Physician Decision|0|||
127540384|NCT03557970|458942554|FG001|Overall Study|Physician Decision|1|||
127540385|NCT03557970|458942553|FG000|Overall Study|Death|0|||
127540386|NCT03557970|458942554|FG001|Overall Study|Death|1|||
127540387|NCT00112736|458942555|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
127540388|NCT00112736|458942556|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
127540389|NCT03473236|458942558|FG000|Overall Study|Withdrawal by Subject|0|||
127540390|NCT03473236|458942559|FG001|Overall Study|Withdrawal by Subject|0|||
127540391|NCT03473236|458942560|FG002|Overall Study|Withdrawal by Subject|0|||
127540392|NCT03473236|458942561|FG003|Overall Study|Withdrawal by Subject|0|||
127540393|NCT03473236|458942562|FG004|Overall Study|Withdrawal by Subject|0|||
127540394|NCT03473236|458942563|FG005|Overall Study|Withdrawal by Subject|1|||
127540395|NCT03473236|458942564|FG006|Overall Study|Withdrawal by Subject|0|||
127540396|NCT03473236|458942565|FG007|Overall Study|Withdrawal by Subject|0|||
127540397|NCT03473236|458942566|FG008|Overall Study|Withdrawal by Subject|1|||
127540398|NCT03473236|458942567|FG009|Overall Study|Withdrawal by Subject|0|||
127540399|NCT00849940|458942568|FG000|Overall Study|Physician Decision|4|||
127540400|NCT01400698|458942575|FG000|Overall Study|Lost to Follow-up|2|||
127540401|NCT01400698|458942576|FG001|Overall Study|Lost to Follow-up|5|||
127540402|NCT01400698|458942577|FG002|Overall Study|Lost to Follow-up|2|||
127540403|NCT01400698|458942578|FG003|Overall Study|Lost to Follow-up|1|||
127540404|NCT01400698|458942579|FG004|Overall Study|Lost to Follow-up|4|||
127540405|NCT01400698|458942580|FG005|Overall Study|Lost to Follow-up|3|||
127540406|NCT01400698|458942575|FG000|Overall Study|Withdrawal by Subject|8|||
127540407|NCT01400698|458942576|FG001|Overall Study|Withdrawal by Subject|2|||
127540408|NCT01400698|458942577|FG002|Overall Study|Withdrawal by Subject|0|||
127540409|NCT01400698|458942578|FG003|Overall Study|Withdrawal by Subject|4|||
127540410|NCT01400698|458942579|FG004|Overall Study|Withdrawal by Subject|1|||
127540411|NCT01400698|458942580|FG005|Overall Study|Withdrawal by Subject|3|||
127540412|NCT01400698|458942575|FG000|Overall Study|Protocol Violation|0|||
127540413|NCT01400698|458942576|FG001|Overall Study|Protocol Violation|1|||
127540414|NCT01400698|458942577|FG002|Overall Study|Protocol Violation|0|||
127540415|NCT01400698|458942578|FG003|Overall Study|Protocol Violation|0|||
127540416|NCT01400698|458942579|FG004|Overall Study|Protocol Violation|1|||
127540417|NCT01400698|458942580|FG005|Overall Study|Protocol Violation|0|||
127540418|NCT01400698|458942575|FG000|Overall Study|Non-compliance|0|||
127540419|NCT01400698|458942576|FG001|Overall Study|Non-compliance|1|||
127540420|NCT01400698|458942577|FG002|Overall Study|Non-compliance|0|||
127540421|NCT01400698|458942578|FG003|Overall Study|Non-compliance|1|||
127540422|NCT01400698|458942579|FG004|Overall Study|Non-compliance|0|||
127540423|NCT01400698|458942580|FG005|Overall Study|Non-compliance|0|||
127540424|NCT01400698|458942575|FG000|Overall Study|Adverse Event|1|||
127540425|NCT01400698|458942576|FG001|Overall Study|Adverse Event|0|||
127540426|NCT01400698|458942577|FG002|Overall Study|Adverse Event|0|||
127540427|NCT01400698|458942578|FG003|Overall Study|Adverse Event|0|||
127540428|NCT01400698|458942579|FG004|Overall Study|Adverse Event|0|||
127540429|NCT01400698|458942580|FG005|Overall Study|Adverse Event|0|||
127540430|NCT01400698|458942575|FG000|Overall Study|Other|4|||
127540431|NCT01400698|458942576|FG001|Overall Study|Other|2|||
127540432|NCT01400698|458942577|FG002|Overall Study|Other|0|||
127540433|NCT01400698|458942578|FG003|Overall Study|Other|2|||
127540434|NCT01400698|458942579|FG004|Overall Study|Other|1|||
127540435|NCT01400698|458942580|FG005|Overall Study|Other|0|||
127540436|NCT03409796|458944422|FG000|Overall Study|Adverse Event|2|||
127540437|NCT03409796|458944423|FG001|Overall Study|Adverse Event|0|||
127540438|NCT03409796|458944422|FG000|Overall Study|Other|0|||
127540439|NCT03409796|458944423|FG001|Overall Study|Other|1|||
127540440|NCT00740220|458944424|FG000|Overall Study|screen failures (non-COPD patients)|9|||
127540441|NCT01602224|458944425|FG000|Overall Study|Adverse Event|0|||
127540442|NCT01602224|458944426|FG001|Overall Study|Adverse Event|1|||
127540443|NCT01602224|458944427|FG002|Overall Study|Adverse Event|0|||
127540444|NCT01602224|458944425|FG000|Overall Study|Investigator Decison|1|||
127540445|NCT01602224|458944426|FG001|Overall Study|Investigator Decison|0|||
127540446|NCT01602224|458944427|FG002|Overall Study|Investigator Decison|0|||
127540447|NCT01602224|458944425|FG000|Overall Study|Lost to Follow-up|0|||
127540448|NCT01602224|458944426|FG001|Overall Study|Lost to Follow-up|0|||
127540449|NCT01602224|458944427|FG002|Overall Study|Lost to Follow-up|1|||
127540450|NCT01602224|458944425|FG000|Overall Study|Protocol Violation|0|||
127540451|NCT01602224|458944426|FG001|Overall Study|Protocol Violation|1|||
127540452|NCT01602224|458944427|FG002|Overall Study|Protocol Violation|0|||
127540453|NCT01602224|458944425|FG000|Overall Study|Sponsor Decision|2|||
127540454|NCT01602224|458944426|FG001|Overall Study|Sponsor Decision|3|||
127540455|NCT01602224|458944427|FG002|Overall Study|Sponsor Decision|2|||
127540456|NCT01602224|458944425|FG000|Overall Study|Withdrawal by Subject|5|||
127540457|NCT01602224|458944426|FG001|Overall Study|Withdrawal by Subject|3|||
127540458|NCT01602224|458944427|FG002|Overall Study|Withdrawal by Subject|3|||
127540459|NCT01352117|458944428|FG000|Overall Study|Death|15|||
127540460|NCT01352117|458944429|FG001|Overall Study|Death|16|||
127540461|NCT01352117|458944428|FG000|Overall Study|Withdrawal by Subject|1|||
127540462|NCT01352117|458944429|FG001|Overall Study|Withdrawal by Subject|0|||
127540463|NCT01352117|458944428|FG000|Overall Study|Lost to Follow-up|2|||
127540464|NCT01352117|458944429|FG001|Overall Study|Lost to Follow-up|7|||
127540465|NCT01352117|458944428|FG000|Overall Study|Non-adherent to study requirements|1|||
127540466|NCT01352117|458944429|FG001|Overall Study|Non-adherent to study requirements|1|||
127540467|NCT01352117|458944428|FG000|Overall Study|Did not initiate study treatment|1|||
127540468|NCT01352117|458944429|FG001|Overall Study|Did not initiate study treatment|0|||
127649282|NCT01364922|459337733|FG000|Open-label (OL) Period|Adverse Event|7|||
127872492|NCT01049360|460152095|FG018|Period 4|Withdrawal by Subject|0|||
127872493|NCT01049360|460152096|FG019|Period 4|Withdrawal by Subject|0|||
127872494|NCT02058849|460152097|FG000|Overall Study|Hospitalization|1|||
127540469|NCT01352117|458944428|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
127540470|NCT01352117|458944429|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
127540471|NCT00633477|458944430|FG000|Overall Study|Death|1|||
127540472|NCT00633477|458944431|FG001|Overall Study|Death|0|||
127540473|NCT00633477|458944430|FG000|Overall Study|Randomized but not treated|1|||
127540474|NCT00633477|458944431|FG001|Overall Study|Randomized but not treated|0|||
127540475|NCT00770653|458944435|FG000|Overall Study|Adverse Event|13|||
127540476|NCT00770653|458944436|FG001|Overall Study|Adverse Event|5|||
127540477|NCT00770653|458944435|FG000|Overall Study|Protocol Violation|8|||
127540478|NCT00770653|458944436|FG001|Overall Study|Protocol Violation|6|||
127540479|NCT00770653|458944435|FG000|Overall Study|Withdrawal by Subject|4|||
127540480|NCT00770653|458944436|FG001|Overall Study|Withdrawal by Subject|7|||
127540481|NCT00770653|458944435|FG000|Overall Study|Lack of Compliance|1|||
127540482|NCT00770653|458944436|FG001|Overall Study|Lack of Compliance|4|||
127872495|NCT02058849|460152098|FG001|Overall Study|Hospitalization|1|||
127872496|NCT02058849|460152097|FG000|Overall Study|Death|1|||
127540483|NCT00770653|458944435|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
127540484|NCT00770653|458944436|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
127540485|NCT00770653|458944435|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
127540486|NCT00770653|458944436|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
127540487|NCT00770653|458944435|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
127540488|NCT00770653|458944436|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
127540489|NCT00770653|458944435|FG000|Overall Study|Lost to Follow-up|1|||
127540490|NCT00770653|458944436|FG001|Overall Study|Lost to Follow-up|2|||
127540491|NCT00770653|458944435|FG000|Overall Study|Physician Decision|1|||
127540492|NCT00770653|458944436|FG001|Overall Study|Physician Decision|0|||
127540493|NCT04906499|458944442|FG000|Overall Study|Lack of time|1|||
127540494|NCT00179621|458944443|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
127540495|NCT00179621|458944444|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
127540496|NCT00179621|458944445|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
127540497|NCT00179621|458944446|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
127540498|NCT00179621|458944443|FG000|Double-Blind Period|Adverse Event|2|||
127540499|NCT00179621|458944444|FG001|Double-Blind Period|Adverse Event|7|||
127540500|NCT00179621|458944445|FG002|Double-Blind Period|Adverse Event|4|||
127540501|NCT00179621|458944446|FG003|Double-Blind Period|Adverse Event|0|||
127540502|NCT00179621|458944443|FG000|Double-Blind Period|Withdrawal by Subject|2|||
127540503|NCT00179621|458944444|FG001|Double-Blind Period|Withdrawal by Subject|1|||
127540504|NCT00179621|458944445|FG002|Double-Blind Period|Withdrawal by Subject|3|||
127540505|NCT00179621|458944446|FG003|Double-Blind Period|Withdrawal by Subject|0|||
127540506|NCT00179621|458944443|FG000|Double-Blind Period|Death|0|||
127540507|NCT00179621|458944444|FG001|Double-Blind Period|Death|1|||
127540508|NCT00179621|458944445|FG002|Double-Blind Period|Death|2|||
127540509|NCT00179621|458944446|FG003|Double-Blind Period|Death|0|||
127540510|NCT00179621|458944443|FG000|Double-Blind Period|Protocol Violation|1|||
127540511|NCT00179621|458944444|FG001|Double-Blind Period|Protocol Violation|0|||
127540512|NCT00179621|458944445|FG002|Double-Blind Period|Protocol Violation|0|||
127540513|NCT00179621|458944446|FG003|Double-Blind Period|Protocol Violation|0|||
127540514|NCT00179621|458944443|FG000|Double-Blind Period|Other|0|||
127540515|NCT00179621|458944444|FG001|Double-Blind Period|Other|2|||
127540516|NCT00179621|458944445|FG002|Double-Blind Period|Other|2|||
127540517|NCT00179621|458944446|FG003|Double-Blind Period|Other|0|||
127540518|NCT00179621|458944443|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
127540519|NCT00179621|458944444|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
127540520|NCT00179621|458944445|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
127540521|NCT00179621|458944446|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
127540522|NCT00179621|458944443|FG000|Open-Label Period|Adverse Event|0|||
127540523|NCT00179621|458944444|FG001|Open-Label Period|Adverse Event|6|||
127540524|NCT00179621|458944445|FG002|Open-Label Period|Adverse Event|5|||
127540525|NCT00179621|458944446|FG003|Open-Label Period|Adverse Event|6|||
127540526|NCT00179621|458944443|FG000|Open-Label Period|Withdrawal by Subject|0|||
127540527|NCT00179621|458944444|FG001|Open-Label Period|Withdrawal by Subject|2|||
127540528|NCT00179621|458944445|FG002|Open-Label Period|Withdrawal by Subject|2|||
127540529|NCT00179621|458944446|FG003|Open-Label Period|Withdrawal by Subject|2|||
127540530|NCT00179621|458944443|FG000|Open-Label Period|Death|0|||
127540531|NCT00179621|458944444|FG001|Open-Label Period|Death|0|||
127540532|NCT00179621|458944445|FG002|Open-Label Period|Death|1|||
127540533|NCT00179621|458944446|FG003|Open-Label Period|Death|2|||
127540534|NCT00179621|458944443|FG000|Open-Label Period|Other|0|||
127540535|NCT00179621|458944444|FG001|Open-Label Period|Other|1|||
127540536|NCT00179621|458944445|FG002|Open-Label Period|Other|1|||
127540537|NCT00179621|458944446|FG003|Open-Label Period|Other|2|||
127540538|NCT00262860|458944453|FG000|Overall Study|Adverse Event|2|||
127540539|NCT01751061|458944455|FG000|Overall Study|Death|1|||
127540540|NCT01751061|458944456|FG001|Overall Study|Death|0|||
127540541|NCT01751061|458944455|FG000|Overall Study|patient death|5|||
127540542|NCT01751061|458944456|FG001|Overall Study|patient death|0|||
127540543|NCT01751061|458944455|FG000|Overall Study|Lost to Follow-up|40|||
127540544|NCT01751061|458944456|FG001|Overall Study|Lost to Follow-up|25|||
127540545|NCT01751061|458944455|FG000|Overall Study|patient regained decisional capacity|4|||
127540546|NCT01751061|458944456|FG001|Overall Study|patient regained decisional capacity|8|||
127540547|NCT01751061|458944455|FG000|Overall Study|Withdrawal by Subject|4|||
127872497|NCT02058849|460152098|FG001|Overall Study|Death|0|||
127872498|NCT02058849|460152097|FG000|Overall Study|Lost to Follow-up|1|||
127540548|NCT01751061|458944456|FG001|Overall Study|Withdrawal by Subject|1|||
127540549|NCT01751061|458944455|FG000|Overall Study|Physician Decision|2|||
127540550|NCT01751061|458944456|FG001|Overall Study|Physician Decision|0|||
127540551|NCT01194830|458944458|FG000|Overall Study|Adverse Event|3|||
127540552|NCT01194830|458944459|FG001|Overall Study|Adverse Event|2|||
127540553|NCT01194830|458944458|FG000|Overall Study|Protocol Violation|5|||
127540554|NCT01194830|458944459|FG001|Overall Study|Protocol Violation|4|||
127540555|NCT01194830|458944458|FG000|Overall Study|Lost to Follow-up|9|||
127540556|NCT01194830|458944459|FG001|Overall Study|Lost to Follow-up|7|||
127540557|NCT01194830|458944458|FG000|Overall Study|Withdrawal by Subject|2|||
127642279|NCT03252587|459310080|FG002|Overall Study|Pregnancy|0|||
127872499|NCT02058849|460152098|FG001|Overall Study|Lost to Follow-up|0|||
127872500|NCT02058849|460152097|FG000|Overall Study|Withdrawal by Subject|4|||
127872501|NCT02058849|460152098|FG001|Overall Study|Withdrawal by Subject|0|||
127872502|NCT01694849|460152099|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
127872503|NCT01694849|460152100|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
127872504|NCT01694849|460152101|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
127872505|NCT01694849|460152099|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
127872506|NCT01694849|460152100|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
127872507|NCT01694849|460152101|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
127872508|NCT01694849|460152099|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
127872509|NCT01694849|460152100|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
127872510|NCT01694849|460152101|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
127872511|NCT01694849|460152099|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
127872512|NCT01694849|460152100|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
127872513|NCT01694849|460152101|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
127872514|NCT01694849|460152099|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
127872515|NCT01694849|460152100|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
127872516|NCT01694849|460152101|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
127872517|NCT01694849|460152099|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
127872518|NCT01694849|460152100|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
127872519|NCT01694849|460152101|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
127872520|NCT01694849|460152099|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
127872521|NCT01694849|460152100|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
127872522|NCT01694849|460152101|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
127872523|NCT01694849|460152099|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
127872524|NCT01694849|460152100|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
127872525|NCT01694849|460152101|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
127872526|NCT01012765|460152102|FG000|Treatment Period 1|Adverse Event|1|||
127872527|NCT01012765|460152103|FG001|Treatment Period 1|Adverse Event|0|||
127872528|NCT01012765|460152104|FG002|Treatment Period 1|Adverse Event|1|||
127872529|NCT01012765|460152105|FG003|Treatment Period 1|Adverse Event|0|||
127872530|NCT01012765|460152106|FG004|Treatment Period 1|Adverse Event|0|||
127872531|NCT01012765|460152107|FG005|Treatment Period 1|Adverse Event|0|||
127872532|NCT01012765|460152102|FG000|Treatment Period 1|Withdrawal by Subject|2|||
127872533|NCT01012765|460152103|FG001|Treatment Period 1|Withdrawal by Subject|0|||
127872534|NCT01012765|460152104|FG002|Treatment Period 1|Withdrawal by Subject|0|||
127872535|NCT01012765|460152105|FG003|Treatment Period 1|Withdrawal by Subject|0|||
127872536|NCT01012765|460152106|FG004|Treatment Period 1|Withdrawal by Subject|0|||
127872537|NCT01012765|460152107|FG005|Treatment Period 1|Withdrawal by Subject|0|||
127872538|NCT01012765|460152102|FG000|Treatment Period 1|Administrative problems|0|||
127872539|NCT01012765|460152103|FG001|Treatment Period 1|Administrative problems|0|||
127872540|NCT01012765|460152104|FG002|Treatment Period 1|Administrative problems|1|||
127872541|NCT01012765|460152105|FG003|Treatment Period 1|Administrative problems|1|||
127872542|NCT01012765|460152106|FG004|Treatment Period 1|Administrative problems|1|||
127872543|NCT01012765|460152107|FG005|Treatment Period 1|Administrative problems|0|||
127872544|NCT01012765|460152102|FG000|Treatment Period 1|Protocol Violation|0|||
127872545|NCT01012765|460152103|FG001|Treatment Period 1|Protocol Violation|0|||
127872546|NCT01012765|460152104|FG002|Treatment Period 1|Protocol Violation|0|||
127872547|NCT01012765|460152105|FG003|Treatment Period 1|Protocol Violation|2|||
127872548|NCT01012765|460152106|FG004|Treatment Period 1|Protocol Violation|1|||
127872549|NCT01012765|460152107|FG005|Treatment Period 1|Protocol Violation|0|||
127872550|NCT01012765|460152102|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
127872551|NCT01012765|460152103|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
127872552|NCT01012765|460152104|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
127872553|NCT01012765|460152105|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
127872554|NCT01012765|460152106|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
127872555|NCT01012765|460152107|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
127872556|NCT01012765|460152102|FG000|Treatment Period 2|Withdrawal by Subject|1|||
127872557|NCT01012765|460152103|FG001|Treatment Period 2|Withdrawal by Subject|0|||
127872558|NCT01012765|460152104|FG002|Treatment Period 2|Withdrawal by Subject|1|||
127872559|NCT01012765|460152105|FG003|Treatment Period 2|Withdrawal by Subject|0|||
127872560|NCT01012765|460152106|FG004|Treatment Period 2|Withdrawal by Subject|1|||
127872561|NCT01012765|460152107|FG005|Treatment Period 2|Withdrawal by Subject|0|||
127872562|NCT01012765|460152102|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
127872563|NCT01012765|460152103|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
127872564|NCT01012765|460152104|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
127872565|NCT01012765|460152105|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
127872566|NCT01012765|460152106|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
127872567|NCT01012765|460152107|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
127872568|NCT01012765|460152102|FG000|Treatment Period 2|Adverse Event|0|||
127540558|NCT01194830|458944459|FG001|Overall Study|Withdrawal by Subject|1|||
127540559|NCT01194830|458944458|FG000|Overall Study|Lack of Efficacy|1|||
127540560|NCT01194830|458944459|FG001|Overall Study|Lack of Efficacy|1|||
127540561|NCT01194830|458944458|FG000|Overall Study|Non-compliance issues|4|||
127540562|NCT01194830|458944459|FG001|Overall Study|Non-compliance issues|4|||
127540563|NCT01194830|458944458|FG000|Overall Study|Other Reason|12|||
127540564|NCT01194830|458944459|FG001|Overall Study|Other Reason|8|||
127540565|NCT01815918|458944462|FG000|Overall Study|Patient samples not analyzable|3|||
127540566|NCT01815918|458944463|FG001|Overall Study|Patient samples not analyzable|4|||
127540567|NCT01815918|458944462|FG000|Overall Study|Lack of Efficacy|15|||
127540568|NCT01815918|458944463|FG001|Overall Study|Lack of Efficacy|15|||
127540569|NCT03284710|458944466|FG000|Overall Study|Withdrawal by Subject|1|||
127540570|NCT03284710|458944467|FG001|Overall Study|Withdrawal by Subject|0|||
127540571|NCT03284710|458944468|FG002|Overall Study|Withdrawal by Subject|1|||
127540572|NCT03284710|458944469|FG003|Overall Study|Withdrawal by Subject|6|||
127540573|NCT03284710|458944466|FG000|Overall Study|Lost to Follow-up|3|||
127540574|NCT03284710|458944467|FG001|Overall Study|Lost to Follow-up|3|||
127540575|NCT03284710|458944468|FG002|Overall Study|Lost to Follow-up|1|||
127540576|NCT03284710|458944469|FG003|Overall Study|Lost to Follow-up|0|||
127540577|NCT03284710|458944466|FG000|Overall Study|Physician Decision|1|||
127540578|NCT03284710|458944467|FG001|Overall Study|Physician Decision|0|||
127540579|NCT03284710|458944468|FG002|Overall Study|Physician Decision|0|||
127540580|NCT03284710|458944469|FG003|Overall Study|Physician Decision|0|||
127540581|NCT03284710|458944466|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
127540582|NCT03284710|458944467|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
127540583|NCT03284710|458944468|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
127540584|NCT03284710|458944469|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
127540585|NCT03284710|458944466|FG000|Overall Study|HIV Infection|0|||
127540586|NCT03284710|458944467|FG001|Overall Study|HIV Infection|2|||
127540587|NCT03284710|458944468|FG002|Overall Study|HIV Infection|2|||
127540588|NCT03284710|458944469|FG003|Overall Study|HIV Infection|1|||
127540589|NCT02814916|458944471|FG000|Overall Study|Withdrawal of consent|0|||
127540590|NCT02814916|458944472|FG001|Overall Study|Withdrawal of consent|2|||
127540591|NCT02814916|458944473|FG002|Overall Study|Withdrawal of consent|0|||
127540592|NCT02814916|458944471|FG000|Overall Study|Lost to Follow-up|0|||
127540593|NCT02814916|458944472|FG001|Overall Study|Lost to Follow-up|1|||
127540594|NCT02814916|458944473|FG002|Overall Study|Lost to Follow-up|0|||
127540595|NCT02814916|458944471|FG000|Overall Study|Other, not specified|0|||
127540596|NCT02814916|458944472|FG001|Overall Study|Other, not specified|1|||
127540597|NCT02814916|458944473|FG002|Overall Study|Other, not specified|0|||
127540598|NCT01706458|458944486|FG000|Overall Study|Physician Decision|3|||
127540599|NCT01706458|458944487|FG001|Overall Study|Physician Decision|4|||
127540600|NCT03547518|458944491|FG000|Overall Study|Lost to Follow-up|2|||
127540601|NCT03547518|458944492|FG001|Overall Study|Lost to Follow-up|0|||
127540602|NCT04742556|458944493|FG000|Overall Study|Withdrawal by Subject|0|||
127540603|NCT04742556|458944494|FG001|Overall Study|Withdrawal by Subject|1|||
127540604|NCT04742556|458944495|FG002|Overall Study|Withdrawal by Subject|0|||
127540605|NCT04742556|458944493|FG000|Overall Study|Adverse Event|0|||
127540606|NCT04742556|458944494|FG001|Overall Study|Adverse Event|0|||
127540607|NCT04742556|458944495|FG002|Overall Study|Adverse Event|2|||
127540608|NCT04742556|458944493|FG000|Overall Study|Clinical disease progression|0|||
127540609|NCT04742556|458944494|FG001|Overall Study|Clinical disease progression|1|||
127540610|NCT04742556|458944495|FG002|Overall Study|Clinical disease progression|2|||
127540611|NCT04742556|458944493|FG000|Overall Study|Objective disease progression|3|||
127540612|NCT04742556|458944494|FG001|Overall Study|Objective disease progression|2|||
127540613|NCT04742556|458944495|FG002|Overall Study|Objective disease progression|4|||
127540614|NCT02201524|458944498|FG000|Overall Study|Adverse Event|0|||
127540615|NCT02201524|458944499|FG001|Overall Study|Adverse Event|2|||
127540616|NCT02201524|458944500|FG002|Overall Study|Adverse Event|1|||
127540617|NCT02201524|458944501|FG003|Overall Study|Adverse Event|0|||
127540618|NCT02201524|458944498|FG000|Overall Study|Insufficient clinical response|1|||
127540619|NCT02201524|458944499|FG001|Overall Study|Insufficient clinical response|0|||
127540620|NCT02201524|458944500|FG002|Overall Study|Insufficient clinical response|0|||
127540621|NCT02201524|458944501|FG003|Overall Study|Insufficient clinical response|0|||
127540622|NCT02201524|458944498|FG000|Overall Study|Lost to Follow-up|0|||
127540623|NCT02201524|458944499|FG001|Overall Study|Lost to Follow-up|0|||
127540624|NCT02201524|458944500|FG002|Overall Study|Lost to Follow-up|2|||
127540625|NCT02201524|458944501|FG003|Overall Study|Lost to Follow-up|0|||
127540626|NCT02201524|458944498|FG000|Overall Study|No longer meets eligibility criteria|0|||
127983713|NCT01447927|460562564|FG001|Overall Study|Withdrawal by Subject|0|||
127983714|NCT04102865|460562566|FG000|Overall Study|Adverse Event|4|||
127540627|NCT02201524|458944499|FG001|Overall Study|No longer meets eligibility criteria|0|||
127540628|NCT02201524|458944500|FG002|Overall Study|No longer meets eligibility criteria|0|||
127540629|NCT02201524|458944501|FG003|Overall Study|No longer meets eligibility criteria|2|||
127540630|NCT02201524|458944498|FG000|Overall Study|Protocol Violation|0|||
127983715|NCT04102865|460562567|FG001|Overall Study|Adverse Event|0|||
127540631|NCT02201524|458944499|FG001|Overall Study|Protocol Violation|0|||
127540632|NCT02201524|458944500|FG002|Overall Study|Protocol Violation|0|||
127540633|NCT02201524|458944501|FG003|Overall Study|Protocol Violation|1|||
127540634|NCT02201524|458944498|FG000|Overall Study|Withdrawal by Subject|0|||
127540635|NCT02201524|458944499|FG001|Overall Study|Withdrawal by Subject|0|||
127540636|NCT02201524|458944500|FG002|Overall Study|Withdrawal by Subject|1|||
127540637|NCT02201524|458944501|FG003|Overall Study|Withdrawal by Subject|1|||
127540638|NCT02201524|458944498|FG000|Overall Study|Other|1|||
127540639|NCT02201524|458944499|FG001|Overall Study|Other|1|||
127540640|NCT02201524|458944500|FG002|Overall Study|Other|0|||
127540641|NCT02201524|458944501|FG003|Overall Study|Other|0|||
127540642|NCT02914639|458944502|FG000|Overall Study|Withdrawal by Subject|0|||
127540643|NCT02914639|458944503|FG001|Overall Study|Withdrawal by Subject|2|||
127540644|NCT01018030|458944505|FG000|Overall Study|Adverse Event|10|||
127540645|NCT01018030|458944506|FG001|Overall Study|Adverse Event|5|||
127540646|NCT01018030|458944507|FG002|Overall Study|Adverse Event|5|||
127540647|NCT01018030|458944505|FG000|Overall Study|Withdrawal by Subject|2|||
127540648|NCT01018030|458944506|FG001|Overall Study|Withdrawal by Subject|2|||
127540649|NCT01018030|458944507|FG002|Overall Study|Withdrawal by Subject|4|||
127540650|NCT01018030|458944505|FG000|Overall Study|Lost to Follow-up|2|||
127540651|NCT01018030|458944506|FG001|Overall Study|Lost to Follow-up|0|||
127540652|NCT01018030|458944507|FG002|Overall Study|Lost to Follow-up|3|||
127540653|NCT01018030|458944505|FG000|Overall Study|Protocol Violation|2|||
127540654|NCT01018030|458944506|FG001|Overall Study|Protocol Violation|1|||
127540655|NCT01018030|458944507|FG002|Overall Study|Protocol Violation|0|||
127540656|NCT01018030|458944505|FG000|Overall Study|Physician Decision|1|||
127540657|NCT01018030|458944506|FG001|Overall Study|Physician Decision|0|||
127540658|NCT01018030|458944507|FG002|Overall Study|Physician Decision|1|||
127540659|NCT01018030|458944505|FG000|Overall Study|Lack of Efficacy|1|||
127540660|NCT01018030|458944506|FG001|Overall Study|Lack of Efficacy|0|||
127540661|NCT01018030|458944507|FG002|Overall Study|Lack of Efficacy|0|||
127540662|NCT01018030|458944505|FG000|Overall Study|Did Not Receive Study Drug|1|||
127540663|NCT01018030|458944506|FG001|Overall Study|Did Not Receive Study Drug|3|||
127540664|NCT01018030|458944507|FG002|Overall Study|Did Not Receive Study Drug|0|||
127540665|NCT03617172|458944508|FG000|Overall Study|Lost to Follow-up|1|||
127540666|NCT03617172|458944509|FG001|Overall Study|Lost to Follow-up|0|||
127540667|NCT00189540|458944510|FG000|Overall Study|Withdrawal by Subject|3|||
127540668|NCT00189540|458944511|FG001|Overall Study|Withdrawal by Subject|0|||
127540669|NCT00189540|458944510|FG000|Overall Study|Death|4|||
127540670|NCT00189540|458944511|FG001|Overall Study|Death|1|||
127540671|NCT01089504|458944512|FG000|Overall Study|Lost to Follow-up|1|||
127540672|NCT01089504|458944513|FG001|Overall Study|Lost to Follow-up|1|||
127540673|NCT01089504|458944512|FG000|Overall Study|Withdrawal by Subject|2|||
127540674|NCT01089504|458944513|FG001|Overall Study|Withdrawal by Subject|0|||
127872569|NCT01012765|460152103|FG001|Treatment Period 2|Adverse Event|1|||
127872570|NCT01012765|460152104|FG002|Treatment Period 2|Adverse Event|1|||
127872571|NCT01012765|460152105|FG003|Treatment Period 2|Adverse Event|0|||
127872572|NCT01012765|460152106|FG004|Treatment Period 2|Adverse Event|0|||
127872573|NCT01012765|460152107|FG005|Treatment Period 2|Adverse Event|0|||
127872574|NCT01012765|460152102|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
127540675|NCT00062439|458944514|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
127540676|NCT00062439|458944514|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
127540677|NCT00062439|458944514|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
127540678|NCT00062439|458944514|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
127540679|NCT00062439|458944514|FG000|Post Chemoradiation Assessment|Death|1|||
127540680|NCT00062439|458944514|FG000|Post Chemoradiation Assessment|Disease progression|2|||
127540681|NCT00062439|458944514|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
127540682|NCT00062439|458944514|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
127540683|NCT00062439|458944514|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
127872575|NCT01012765|460152103|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
127872576|NCT01012765|460152104|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
127872577|NCT01012765|460152105|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
127872578|NCT01012765|460152106|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
127872579|NCT01012765|460152107|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
127983716|NCT04102865|460562566|FG000|Overall Study|Lost to Follow-up|1|||
127540684|NCT00062439|458944514|FG000|Surgery|Physician Decision|4|||
127540685|NCT00062439|458944514|FG000|Surgery|Death|1|||
127540686|NCT00062439|458944514|FG000|Surgery|Adverse Event|2|||
127540687|NCT00062439|458944514|FG000|Consolidation Chemotherapy|Adverse Event|2|||
127540688|NCT01924845|458944515|FG000|Overall Study|Adverse Event|3|||
127540689|NCT01924845|458944515|FG000|Overall Study|Withdrawal by Subject|2|||
127540690|NCT01924845|458944515|FG000|Overall Study|Protocol Violation|1|||
127540691|NCT00001832|458944519|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
127540692|NCT00001832|458944520|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
127540693|NCT00001832|458944521|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
127642280|NCT03252587|459310081|FG003|Overall Study|Pregnancy|1|||
127540694|NCT00001832|458944522|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
127540695|NCT00001832|458944523|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
127540696|NCT00001832|458944524|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
127540697|NCT00001832|458944525|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
127540698|NCT00001832|458944526|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
127540699|NCT00001832|458944527|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
127540700|NCT00001832|458944528|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
127540701|NCT00001832|458944529|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
127540702|NCT00001832|458944530|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
127540703|NCT00001832|458944531|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
127540704|NCT00001832|458944532|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
127540705|NCT00001832|458944533|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
127540706|NCT00001832|458944519|FG000|Treatment Period|Death during treatment|0|||
127540707|NCT00001832|458944520|FG001|Treatment Period|Death during treatment|0|||
127540708|NCT00001832|458944521|FG002|Treatment Period|Death during treatment|0|||
127540709|NCT00001832|458944522|FG003|Treatment Period|Death during treatment|0|||
127540710|NCT00001832|458944523|FG004|Treatment Period|Death during treatment|0|||
127540711|NCT00001832|458944524|FG005|Treatment Period|Death during treatment|1|||
127540712|NCT00001832|458944525|FG006|Treatment Period|Death during treatment|0|||
127540713|NCT00001832|458944526|FG007|Treatment Period|Death during treatment|0|||
127540714|NCT00001832|458944527|FG008|Treatment Period|Death during treatment|0|||
127540715|NCT00001832|458944528|FG009|Treatment Period|Death during treatment|0|||
127540716|NCT00001832|458944529|FG010|Treatment Period|Death during treatment|0|||
127540717|NCT00001832|458944530|FG011|Treatment Period|Death during treatment|0|||
127540718|NCT00001832|458944531|FG012|Treatment Period|Death during treatment|0|||
127540719|NCT00001832|458944532|FG013|Treatment Period|Death during treatment|0|||
127540720|NCT00001832|458944533|FG014|Treatment Period|Death during treatment|0|||
127540721|NCT00001832|458944519|FG000|Treatment Period|Not treated|0|||
127540722|NCT00001832|458944520|FG001|Treatment Period|Not treated|0|||
127540723|NCT00001832|458944521|FG002|Treatment Period|Not treated|0|||
127540724|NCT00001832|458944522|FG003|Treatment Period|Not treated|0|||
127540725|NCT00001832|458944523|FG004|Treatment Period|Not treated|0|||
127540726|NCT00001832|458944524|FG005|Treatment Period|Not treated|0|||
127540727|NCT00001832|458944525|FG006|Treatment Period|Not treated|0|||
127540728|NCT00001832|458944526|FG007|Treatment Period|Not treated|1|||
127540729|NCT00001832|458944527|FG008|Treatment Period|Not treated|0|||
127540730|NCT00001832|458944528|FG009|Treatment Period|Not treated|0|||
127540731|NCT00001832|458944529|FG010|Treatment Period|Not treated|0|||
127540732|NCT00001832|458944530|FG011|Treatment Period|Not treated|0|||
127540733|NCT00001832|458944531|FG012|Treatment Period|Not treated|0|||
127540734|NCT00001832|458944532|FG013|Treatment Period|Not treated|0|||
127540735|NCT00001832|458944533|FG014|Treatment Period|Not treated|0|||
127540736|NCT02546609|458944534|FG000|Overall Study|Withdrawal by Subject|0|||
127540737|NCT02546609|458944535|FG001|Overall Study|Withdrawal by Subject|1|||
127540738|NCT02546609|458944536|FG002|Overall Study|Withdrawal by Subject|2|||
127540739|NCT02546609|458944534|FG000|Overall Study|Adverse Event|0|||
127540740|NCT02546609|458944535|FG001|Overall Study|Adverse Event|6|||
127540741|NCT02546609|458944536|FG002|Overall Study|Adverse Event|1|||
127540742|NCT02546609|458944534|FG000|Overall Study|Protocol Violation|0|||
127540743|NCT02546609|458944535|FG001|Overall Study|Protocol Violation|1|||
127540744|NCT02546609|458944536|FG002|Overall Study|Protocol Violation|1|||
127540745|NCT02546609|458944534|FG000|Overall Study|Lost to Follow-up|2|||
127540746|NCT02546609|458944535|FG001|Overall Study|Lost to Follow-up|3|||
127540747|NCT02546609|458944536|FG002|Overall Study|Lost to Follow-up|1|||
127540748|NCT02546609|458944534|FG000|Overall Study|travel or work schedule restriction|0|||
127540749|NCT02546609|458944535|FG001|Overall Study|travel or work schedule restriction|0|||
127540750|NCT02546609|458944536|FG002|Overall Study|travel or work schedule restriction|2|||
127540751|NCT00914849|458944537|FG000|Overall Study|Withdrawal by Subject|1|||
127540752|NCT00914849|458944538|FG001|Overall Study|Withdrawal by Subject|0|||
127540753|NCT00914849|458944537|FG000|Overall Study|Not eligible|0|||
127540754|NCT00914849|458944538|FG001|Overall Study|Not eligible|1|||
127540755|NCT05106959|458944539|FG000|Overall Study|Lost to Follow-up|1|||
127540756|NCT01292486|458944540|FG000|Overall Study|Protocol Violation|2|||
127872580|NCT01326312|460152108|FG000|Overall Study|Adverse Event|11|||
127872581|NCT01326312|460152109|FG001|Overall Study|Adverse Event|11|||
127540757|NCT01292486|458944540|FG000|Overall Study|Did not meet screening criteria|2|||
127540758|NCT01292486|458944540|FG000|Overall Study|Adverse Event|1|||
127540759|NCT01292486|458944540|FG000|Overall Study|Physician Decision|1|||
127540760|NCT01553084|458944545|FG000|Overall Study|Withdrawal by Subject|15|||
127540761|NCT01553084|458944546|FG001|Overall Study|Withdrawal by Subject|13|||
127540762|NCT01553084|458944547|FG002|Overall Study|Withdrawal by Subject|35|||
127540763|NCT03988400|458944548|FG000|Overall Study|Adverse Event|1|||
127540764|NCT03988400|458944549|FG001|Overall Study|Adverse Event|0|||
127540765|NCT03988400|458944548|FG000|Overall Study|Macular degeneration, unrelated to study procedures.|1|||
127872582|NCT01326312|460152110|FG002|Overall Study|Adverse Event|1|||
127540766|NCT03988400|458944549|FG001|Overall Study|Macular degeneration, unrelated to study procedures.|0|||
127540767|NCT03988400|458944548|FG000|Overall Study|Lost to Follow-up|0|||
127540768|NCT03988400|458944549|FG001|Overall Study|Lost to Follow-up|1|||
127540769|NCT04201431|458944551|FG000|Vaccinations and Primary CHMI|Withdrawal by Subject|6|||
127540770|NCT04201431|458944552|FG001|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
127540771|NCT04201431|458944553|FG002|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
127540772|NCT01546857|458944554|FG000|Overall Study|Withdrawal by Subject|2|||
127540773|NCT01546857|458944555|FG001|Overall Study|Withdrawal by Subject|3|||
127540774|NCT00317473|458944558|FG000|Overall Study|Withdrawal by Subject|2|||
127540775|NCT00317473|458944559|FG001|Overall Study|Withdrawal by Subject|1|||
127540776|NCT00317473|458944560|FG002|Overall Study|Withdrawal by Subject|2|||
127540777|NCT00317473|458944561|FG003|Overall Study|Withdrawal by Subject|1|||
127540778|NCT00317473|458944562|FG004|Overall Study|Withdrawal by Subject|3|||
127540779|NCT00317473|458944563|FG005|Overall Study|Withdrawal by Subject|1|||
127540780|NCT00317473|458944558|FG000|Overall Study|Relocation|1|||
127540781|NCT00317473|458944559|FG001|Overall Study|Relocation|0|||
127540782|NCT00317473|458944560|FG002|Overall Study|Relocation|1|||
127540783|NCT00317473|458944561|FG003|Overall Study|Relocation|1|||
127540784|NCT00317473|458944562|FG004|Overall Study|Relocation|5|||
127540785|NCT00317473|458944563|FG005|Overall Study|Relocation|2|||
127540786|NCT00317473|458944558|FG000|Overall Study|Death|1|||
127540787|NCT00317473|458944559|FG001|Overall Study|Death|0|||
127540788|NCT00317473|458944560|FG002|Overall Study|Death|0|||
127540789|NCT00317473|458944561|FG003|Overall Study|Death|0|||
127540790|NCT00317473|458944562|FG004|Overall Study|Death|0|||
127540791|NCT00317473|458944563|FG005|Overall Study|Death|0|||
127540792|NCT00317473|458944558|FG000|Overall Study|Other|0|||
127540793|NCT00317473|458944559|FG001|Overall Study|Other|2|||
127540794|NCT00317473|458944560|FG002|Overall Study|Other|0|||
127540795|NCT00317473|458944561|FG003|Overall Study|Other|0|||
127540796|NCT00317473|458944562|FG004|Overall Study|Other|0|||
127540797|NCT00317473|458944563|FG005|Overall Study|Other|0|||
127540798|NCT03416868|458944564|FG000|Overall Study|Withdrawal by Subject|2|||
127540799|NCT03416868|458944564|FG000|Overall Study|Lost to Follow-up|1|||
127540800|NCT05435339|458944565|FG000|Overall Study|Death|1|||
127540801|NCT05435339|458944566|FG001|Overall Study|Death|0|||
127540802|NCT05435339|458944567|FG002|Overall Study|Death|3|||
127540803|NCT05435339|458944568|FG003|Overall Study|Death|1|||
127540804|NCT05435339|458944569|FG004|Overall Study|Death|3|||
127540805|NCT05435339|458944570|FG005|Overall Study|Death|2|||
127540806|NCT05435339|458944571|FG006|Overall Study|Death|4|||
127540807|NCT05435339|458944572|FG007|Overall Study|Death|6|||
127540808|NCT05435339|458944565|FG000|Overall Study|Sponsor Decision|0|||
127540809|NCT05435339|458944566|FG001|Overall Study|Sponsor Decision|1|||
127540810|NCT05435339|458944567|FG002|Overall Study|Sponsor Decision|0|||
127540811|NCT05435339|458944568|FG003|Overall Study|Sponsor Decision|0|||
127540812|NCT05435339|458944569|FG004|Overall Study|Sponsor Decision|2|||
127540813|NCT05435339|458944570|FG005|Overall Study|Sponsor Decision|1|||
127540814|NCT05435339|458944571|FG006|Overall Study|Sponsor Decision|2|||
127540815|NCT05435339|458944572|FG007|Overall Study|Sponsor Decision|2|||
127540816|NCT05435339|458944565|FG000|Overall Study|Withdrawal by Subject|0|||
127540817|NCT05435339|458944566|FG001|Overall Study|Withdrawal by Subject|0|||
127540818|NCT05435339|458944567|FG002|Overall Study|Withdrawal by Subject|0|||
127540819|NCT05435339|458944568|FG003|Overall Study|Withdrawal by Subject|0|||
127540820|NCT05435339|458944569|FG004|Overall Study|Withdrawal by Subject|1|||
127540821|NCT05435339|458944570|FG005|Overall Study|Withdrawal by Subject|0|||
127540822|NCT05435339|458944571|FG006|Overall Study|Withdrawal by Subject|1|||
127540823|NCT05435339|458944572|FG007|Overall Study|Withdrawal by Subject|1|||
127540824|NCT00601835|458944578|FG000|Overall Study|Withdrawal by Subject|9|||
127540825|NCT00601835|458944579|FG001|Overall Study|Withdrawal by Subject|6|||
127540826|NCT00601835|458944578|FG000|Overall Study|Physician Decision|1|||
127540827|NCT00601835|458944579|FG001|Overall Study|Physician Decision|0|||
127540828|NCT00601835|458944578|FG000|Overall Study|Lost to Follow-up|37|||
127540829|NCT00601835|458944579|FG001|Overall Study|Lost to Follow-up|5|||
127540830|NCT00601835|458944578|FG000|Overall Study|Adverse Event|1|||
127540831|NCT00601835|458944579|FG001|Overall Study|Adverse Event|1|||
127540832|NCT00601835|458944578|FG000|Overall Study|Relocate|12|||
127649283|NCT01364922|459337734|FG001|Open-label (OL) Period|Adverse Event|0|||
127540833|NCT00601835|458944579|FG001|Overall Study|Relocate|2|||
127540834|NCT01927497|458944580|FG000|Overall Study|Death|0|||
127540835|NCT01927497|458944581|FG001|Overall Study|Death|1|||
127540836|NCT01927497|458944580|FG000|Overall Study|Protocol Violation|2|||
127540837|NCT01927497|458944581|FG001|Overall Study|Protocol Violation|0|||
127540838|NCT03914417|458944582|FG000|Overall Study|Withdrawal by Subject|2|||
127540839|NCT03361137|458944585|FG000|Overall Study|Reason not specified|1|||
127540840|NCT03361137|458944586|FG001|Overall Study|Reason not specified|0|||
127540841|NCT03361137|458944587|FG002|Overall Study|Reason not specified|0|||
127540842|NCT03361137|458944588|FG003|Overall Study|Reason not specified|0|||
127540843|NCT03361137|458944589|FG004|Overall Study|Reason not specified|0|||
127540844|NCT03009058|458944590|FG000|Overall Study|Study terminated soon after initiation for commercial reasons|2|||
127540845|NCT01486966|458944593|FG000|Overall Study|Adverse Event|0|||
127540846|NCT01486966|458944594|FG001|Overall Study|Adverse Event|1|||
127540847|NCT01486966|458944593|FG000|Overall Study|Withdrawal by Subject|0|||
127540848|NCT01486966|458944594|FG001|Overall Study|Withdrawal by Subject|1|||
127540849|NCT02891174|458947014|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
127540850|NCT02891174|458947015|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
127540851|NCT02891174|458947014|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
127540852|NCT02891174|458947015|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
127540853|NCT02891174|458947014|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
127540854|NCT02891174|458947015|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
127540855|NCT02891174|458947014|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
127540856|NCT02891174|458947015|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
127540857|NCT02891174|458947014|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
127540858|NCT02891174|458947015|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
127540859|NCT02891174|458947014|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
127540860|NCT02891174|458947015|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
127540861|NCT02891174|458947014|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
127540862|NCT02891174|458947015|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
127540863|NCT04124939|458947016|FG000|Overall Study|Lost to Follow-up|1|||
127540864|NCT04124939|458947017|FG001|Overall Study|Lost to Follow-up|3|||
127540865|NCT04235140|458947018|FG000|Overall Study|Adverse Event|2|||
127540866|NCT04235140|458947018|FG000|Overall Study|Lost to Follow-up|1|||
127540867|NCT04235140|458947018|FG000|Overall Study|Withdrawal of consent (not due to AE)|4|||
127540868|NCT04235140|458947018|FG000|Overall Study|Commercial drug is available for participants|7|||
127540869|NCT00419393|458947020|FG000|Overall Study|Adverse Event|5|||
127540870|NCT00419393|458947020|FG000|Overall Study|Protocol Violation|5|||
127540871|NCT00419393|458947020|FG000|Overall Study|Withdrawal by Subject|7|||
127540872|NCT00419393|458947020|FG000|Overall Study|Other: Sponsor request|3|||
127540873|NCT00419393|458947020|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
127540874|NCT00419393|458947020|FG000|Overall Study|Other: Site closure|1|||
127540875|NCT00419393|458947020|FG000|Overall Study|Other: Other health problems|1|||
127540876|NCT00419393|458947020|FG000|Overall Study|Other: Investigator decision|1|||
127540877|NCT04516746|458947023|FG000|Overall Study|Randomized but not Treated|51|||
127540878|NCT04516746|458947024|FG001|Overall Study|Randomized but not Treated|19|||
127540879|NCT04516746|458947023|FG000|Overall Study|Adverse Event|0|||
127540880|NCT04516746|458947024|FG001|Overall Study|Adverse Event|1|||
127540881|NCT04516746|458947023|FG000|Overall Study|Death|62|||
127540882|NCT04516746|458947024|FG001|Overall Study|Death|32|||
127540883|NCT04516746|458947023|FG000|Overall Study|Lost to Follow-up|3431|||
127540884|NCT04516746|458947024|FG001|Overall Study|Lost to Follow-up|1831|||
127540885|NCT04516746|458947023|FG000|Overall Study|Withdrawal by Subject|1946|||
127540886|NCT04516746|458947024|FG001|Overall Study|Withdrawal by Subject|1696|||
127540887|NCT04516746|458947023|FG000|Overall Study|Physician Decision|10|||
127540888|NCT04516746|458947024|FG001|Overall Study|Physician Decision|8|||
127540889|NCT04516746|458947023|FG000|Overall Study|Other|35|||
127540890|NCT04516746|458947024|FG001|Overall Study|Other|16|||
127540891|NCT00446849|458947027|FG000|Acute Phase|Lack of Efficacy|64|||
127540892|NCT00446849|458947027|FG000|Acute Phase|Protocol Violation|10|||
127540893|NCT00446849|458947027|FG000|Acute Phase|Consent withdrawn|4|||
127540894|NCT00446849|458947027|FG000|Acute Phase|Lost to Follow-up|2|||
127540895|NCT00446849|458947027|FG000|Acute Phase|Physician Decision|1|||
127540896|NCT00446849|458947027|FG000|Acute Phase|noncompliance|1|||
127540897|NCT00446849|458947027|FG000|Maintenance Phase|Lack of Efficacy|40|||
127540898|NCT00446849|458947027|FG000|Maintenance Phase|Protocol Violation|7|||
127540899|NCT00446849|458947027|FG000|Maintenance Phase|Adverse Event|6|||
127540900|NCT00446849|458947027|FG000|Maintenance Phase|Consent withdrawn|5|||
127540901|NCT00446849|458947027|FG000|Maintenance Phase|Lost to Follow-up|3|||
127540902|NCT00446849|458947027|FG000|Maintenance Phase|Pregnancy|1|||
127540903|NCT00446849|458947027|FG000|Maintenance Phase|noncompliance|2|||
127540904|NCT00446849|458947027|FG000|Maintenance Phase|prohibited medication use|2|||
127540905|NCT00446849|458947027|FG000|Maintenance Phase|antibiotic use|1|||
127540906|NCT00446849|458947027|FG000|Maintenance Phase|study closure|1|||
127540907|NCT00446849|458947027|FG000|Maintenance Phase|hydrocodone use|1|||
127540908|NCT00446849|458947027|FG000|Maintenance Phase|concomitant medication use|1|||
127540909|NCT03115359|458947030|FG000|Overall Study|Withdrawal by Subject|29|||
127540910|NCT03115359|458947031|FG001|Overall Study|Withdrawal by Subject|39|||
127540911|NCT03115359|458947030|FG000|Overall Study|Scheduling conflict|25|||
127540912|NCT03115359|458947031|FG001|Overall Study|Scheduling conflict|23|||
127540913|NCT03115359|458947030|FG000|Overall Study|Personal reasons including health|12|||
127540914|NCT03115359|458947031|FG001|Overall Study|Personal reasons including health|9|||
127540915|NCT03115359|458947030|FG000|Overall Study|Transportation barriers|3|||
127540916|NCT03115359|458947031|FG001|Overall Study|Transportation barriers|0|||
127540917|NCT03115359|458947030|FG000|Overall Study|No longer interested|5|||
127540918|NCT03115359|458947031|FG001|Overall Study|No longer interested|4|||
127540919|NCT03115359|458947030|FG000|Overall Study|No reason provided|45|||
127540920|NCT03115359|458947031|FG001|Overall Study|No reason provided|47|||
127540921|NCT05543265|458947042|FG000|Overall Study|Lost to Follow-up|3|||
127540922|NCT05543265|458947043|FG001|Overall Study|Lost to Follow-up|3|||
127540923|NCT05543265|458947042|FG000|Overall Study|Withdrawal by Subject|0|||
127540924|NCT05543265|458947043|FG001|Overall Study|Withdrawal by Subject|1|||
127540925|NCT05316597|458947044|FG000|First Session|Withdrawal by Subject|0|||
127540926|NCT05316597|458947045|FG001|First Session|Withdrawal by Subject|1|||
127540927|NCT05316597|458947044|FG000|Washout Period|Lost to Follow-up|1|||
127540928|NCT05316597|458947045|FG001|Washout Period|Lost to Follow-up|2|||
127540929|NCT05316597|458947044|FG000|Washout Period|Physician Decision|1|||
127540930|NCT05316597|458947045|FG001|Washout Period|Physician Decision|1|||
127540931|NCT05316597|458947044|FG000|Washout Period|Excluded before second session|1|||
127540932|NCT05316597|458947045|FG001|Washout Period|Excluded before second session|1|||
127540933|NCT05316597|458947044|FG000|Washout Period|Withdrawal by Subject|0|||
127540934|NCT05316597|458947045|FG001|Washout Period|Withdrawal by Subject|4|||
127540935|NCT05526716|458947046|FG000|Overall Study|Death|1|||
127540936|NCT05526716|458947047|FG001|Overall Study|Death|2|||
127540937|NCT05526716|458947046|FG000|Overall Study|Lost to Follow-up|17|||
127540938|NCT05526716|458947047|FG001|Overall Study|Lost to Follow-up|15|||
127540939|NCT05526716|458947046|FG000|Overall Study|Physician Decision|0|||
127540940|NCT05526716|458947047|FG001|Overall Study|Physician Decision|1|||
127540941|NCT05526716|458947046|FG000|Overall Study|Randomized by mistake without study treatment|0|||
127540942|NCT05526716|458947047|FG001|Overall Study|Randomized by mistake without study treatment|1|||
127540943|NCT05526716|458947046|FG000|Overall Study|Withdrawal by Subject|12|||
127540944|NCT05526716|458947047|FG001|Overall Study|Withdrawal by Subject|12|||
127540945|NCT05526716|458947046|FG000|Overall Study|Not reported|0|||
127540946|NCT05526716|458947047|FG001|Overall Study|Not reported|2|||
127540947|NCT04750824|458947048|FG000|Overall Study|Toxicity/intolerability|3|||
127540948|NCT04750824|458947049|FG001|Overall Study|Toxicity/intolerability|1|||
127540949|NCT04750824|458947048|FG000|Overall Study|Death|1|||
127540950|NCT04750824|458947049|FG001|Overall Study|Death|3|||
127540951|NCT04750824|458947048|FG000|Overall Study|Scheduled duration of therapy complete|1|||
127540952|NCT04750824|458947049|FG001|Overall Study|Scheduled duration of therapy complete|9|||
127540953|NCT04750824|458947048|FG000|Overall Study|Disease progression (confirmed with scan)|57|||
127540954|NCT04750824|458947049|FG001|Overall Study|Disease progression (confirmed with scan)|11|||
127540955|NCT00807911|458947050|FG000|Overall Study|Withdrawal by Subject|12|||
127540956|NCT00807911|458947051|FG001|Overall Study|Withdrawal by Subject|10|||
127540957|NCT00807911|458947050|FG000|Overall Study|Ineligible|0|||
127540958|NCT00807911|458947051|FG001|Overall Study|Ineligible|4|||
127540959|NCT01176032|458947054|FG000|Overall Study|Adverse Event|1|||
127540960|NCT01176032|458947055|FG001|Overall Study|Adverse Event|0|||
127540961|NCT01176032|458947054|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
127540962|NCT01176032|458947055|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
127540963|NCT01176032|458947054|FG000|Overall Study|Protocol Violation|1|||
127540964|NCT01176032|458947055|FG001|Overall Study|Protocol Violation|0|||
127540965|NCT01176032|458947054|FG000|Overall Study|Informed consent withdrawn|3|||
127540966|NCT01176032|458947055|FG001|Overall Study|Informed consent withdrawn|0|||
127540967|NCT01176032|458947054|FG000|Overall Study|Other|1|||
127540968|NCT01176032|458947055|FG001|Overall Study|Other|0|||
127540969|NCT01469221|458947056|FG000|Double Blind Phase|Protocol Violation|1|||
127540970|NCT01469221|458947057|FG001|Double Blind Phase|Protocol Violation|0|||
127540971|NCT01469221|458947058|FG002|Double Blind Phase|Protocol Violation|0|||
127540972|NCT01469221|458947056|FG000|Double Blind Phase|Physician Decision|1|||
127540973|NCT01469221|458947057|FG001|Double Blind Phase|Physician Decision|1|||
127540974|NCT01469221|458947058|FG002|Double Blind Phase|Physician Decision|0|||
127540975|NCT01469221|458947056|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
127540976|NCT01469221|458947057|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
127540977|NCT01469221|458947058|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
127540978|NCT04739982|458947069|FG000|Overall Study|Lost to Follow-up|176|||
127540979|NCT04739982|458947070|FG001|Overall Study|Lost to Follow-up|65|||
127540980|NCT04739982|458947069|FG000|Overall Study|Withdrawal by Subject|19|||
127540981|NCT04739982|458947070|FG001|Overall Study|Withdrawal by Subject|0|||
127540982|NCT04739982|458947069|FG000|Overall Study|Protocol Violation|0|||
127540983|NCT04739982|458947070|FG001|Overall Study|Protocol Violation|5|||
127540984|NCT04079296|458947071|FG000|Dose Escalation Phase (56 Days)|Progressive disease|1|||
127540985|NCT04079296|458947072|FG001|Dose Escalation Phase (56 Days)|Progressive disease|1|||
127540986|NCT04079296|458947073|FG002|Dose Escalation Phase (56 Days)|Progressive disease|1|||
127540987|NCT04079296|458947074|FG003|Dose Escalation Phase (56 Days)|Progressive disease|0|||
127540988|NCT04079296|458947075|FG004|Dose Escalation Phase (56 Days)|Progressive disease|0|||
127540989|NCT04079296|458947071|FG000|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
127540990|NCT04079296|458947072|FG001|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
127540991|NCT04079296|458947073|FG002|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
127540992|NCT04079296|458947074|FG003|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
127540993|NCT04079296|458947075|FG004|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
127540994|NCT04079296|458947071|FG000|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
127540995|NCT04079296|458947072|FG001|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
127540996|NCT04079296|458947073|FG002|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
127540997|NCT04079296|458947074|FG003|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
127540998|NCT04079296|458947075|FG004|Dose Expansion Phase (168 Days)|Miscellaneous|1|||
127540999|NCT04079296|458947071|FG000|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
127541000|NCT04079296|458947072|FG001|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
127541001|NCT04079296|458947073|FG002|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
127541002|NCT04079296|458947074|FG003|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
127541003|NCT04079296|458947075|FG004|Dose Expansion Phase (168 Days)|Withdrawal by Subject|1|||
127541004|NCT04079296|458947071|FG000|Dose Expansion Phase (168 Days)|Physician Decision|0|||
127541005|NCT04079296|458947072|FG001|Dose Expansion Phase (168 Days)|Physician Decision|0|||
127541006|NCT04079296|458947073|FG002|Dose Expansion Phase (168 Days)|Physician Decision|0|||
127541007|NCT04079296|458947074|FG003|Dose Expansion Phase (168 Days)|Physician Decision|1|||
127541008|NCT04079296|458947075|FG004|Dose Expansion Phase (168 Days)|Physician Decision|0|||
127541009|NCT04079296|458947071|FG000|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
127541010|NCT04079296|458947072|FG001|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
127541011|NCT04079296|458947073|FG002|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
127541012|NCT04079296|458947074|FG003|Dose Expansion Phase (168 Days)|Progressive Disease|6|||
127541013|NCT04079296|458947075|FG004|Dose Expansion Phase (168 Days)|Progressive Disease|5|||
127541014|NCT04079296|458947071|FG000|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
127541015|NCT04079296|458947072|FG001|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
127541016|NCT04079296|458947073|FG002|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
127541017|NCT04079296|458947074|FG003|Dose Expansion Phase (168 Days)|Lack of Efficacy|3|||
127541018|NCT04079296|458947075|FG004|Dose Expansion Phase (168 Days)|Lack of Efficacy|2|||
127541019|NCT04079296|458947071|FG000|Dose Expansion Phase (168 Days)|Death|0|||
127541020|NCT04079296|458947072|FG001|Dose Expansion Phase (168 Days)|Death|0|||
127541021|NCT04079296|458947073|FG002|Dose Expansion Phase (168 Days)|Death|0|||
127541022|NCT04079296|458947074|FG003|Dose Expansion Phase (168 Days)|Death|1|||
127541023|NCT04079296|458947075|FG004|Dose Expansion Phase (168 Days)|Death|0|||
127541024|NCT01346358|458947088|FG000|Overall Study|Withdrawal by Subject|1|||
127541025|NCT01346358|458947089|FG001|Overall Study|Withdrawal by Subject|0|||
127541026|NCT01346358|458947090|FG002|Overall Study|Withdrawal by Subject|1|||
127541027|NCT01346358|458947091|FG003|Overall Study|Withdrawal by Subject|1|||
127541028|NCT01346358|458947092|FG004|Overall Study|Withdrawal by Subject|0|||
127541029|NCT01346358|458947093|FG005|Overall Study|Withdrawal by Subject|2|||
127541030|NCT01346358|458947094|FG006|Overall Study|Withdrawal by Subject|1|||
127541031|NCT01346358|458947095|FG007|Overall Study|Withdrawal by Subject|1|||
127541032|NCT01346358|458947096|FG008|Overall Study|Withdrawal by Subject|1|||
127541033|NCT01346358|458947088|FG000|Overall Study|Adverse Event|1|||
127541034|NCT01346358|458947089|FG001|Overall Study|Adverse Event|0|||
127541035|NCT01346358|458947090|FG002|Overall Study|Adverse Event|0|||
127541036|NCT01346358|458947091|FG003|Overall Study|Adverse Event|0|||
127541037|NCT01346358|458947092|FG004|Overall Study|Adverse Event|1|||
127541038|NCT01346358|458947093|FG005|Overall Study|Adverse Event|0|||
127541039|NCT01346358|458947094|FG006|Overall Study|Adverse Event|0|||
127541040|NCT01346358|458947095|FG007|Overall Study|Adverse Event|0|||
127541041|NCT01346358|458947096|FG008|Overall Study|Adverse Event|1|||
127541042|NCT01346358|458947088|FG000|Overall Study|Non-Compliance|0|||
127541043|NCT01346358|458947089|FG001|Overall Study|Non-Compliance|0|||
127541044|NCT01346358|458947090|FG002|Overall Study|Non-Compliance|0|||
127541045|NCT01346358|458947091|FG003|Overall Study|Non-Compliance|0|||
127541046|NCT01346358|458947092|FG004|Overall Study|Non-Compliance|0|||
127541047|NCT01346358|458947093|FG005|Overall Study|Non-Compliance|0|||
127541048|NCT01346358|458947094|FG006|Overall Study|Non-Compliance|0|||
127541049|NCT01346358|458947095|FG007|Overall Study|Non-Compliance|2|||
127541050|NCT01346358|458947096|FG008|Overall Study|Non-Compliance|0|||
127541051|NCT01346358|458947088|FG000|Overall Study|Physician Decision|0|||
127541052|NCT01346358|458947089|FG001|Overall Study|Physician Decision|1|||
127541053|NCT01346358|458947090|FG002|Overall Study|Physician Decision|0|||
127541054|NCT01346358|458947091|FG003|Overall Study|Physician Decision|0|||
127541055|NCT01346358|458947092|FG004|Overall Study|Physician Decision|0|||
127541056|NCT01346358|458947093|FG005|Overall Study|Physician Decision|0|||
127541057|NCT01346358|458947094|FG006|Overall Study|Physician Decision|0|||
127541058|NCT01346358|458947095|FG007|Overall Study|Physician Decision|1|||
127541059|NCT01346358|458947096|FG008|Overall Study|Physician Decision|1|||
127541060|NCT00702702|458947099|FG000|Overall Study|Study prematurely terminated|56|||
127541061|NCT02004236|458947100|FG000|Overall Study|Lack of Efficacy|0|||
127541062|NCT02004236|458947101|FG001|Overall Study|Lack of Efficacy|0|||
127541063|NCT02004236|458947102|FG002|Overall Study|Lack of Efficacy|16|||
127541064|NCT05121766|458947103|FG000|Overall Study|Covid reinfection|3|||
127541065|NCT05121766|458947104|FG001|Overall Study|Covid reinfection|0|||
127541066|NCT05121766|458947103|FG000|Overall Study|Withdrawal by Subject|3|||
127541067|NCT05121766|458947104|FG001|Overall Study|Withdrawal by Subject|1|||
127541068|NCT05121766|458947103|FG000|Overall Study|Adverse Event|2|||
127541069|NCT05121766|458947104|FG001|Overall Study|Adverse Event|4|||
127541070|NCT05121766|458947103|FG000|Overall Study|Lost to Follow-up|0|||
127541071|NCT05121766|458947104|FG001|Overall Study|Lost to Follow-up|1|||
127541072|NCT02960217|458947106|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
127541073|NCT02960217|458947107|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
127541074|NCT02960217|458947106|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
127541075|NCT02960217|458947107|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
127541076|NCT02960217|458947106|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
127541077|NCT02960217|458947107|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
127541078|NCT02960217|458947106|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
127541079|NCT02960217|458947107|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
127541080|NCT02960217|458947106|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
127541081|NCT02960217|458947107|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
127541082|NCT02960217|458947106|FG000|Open-Label Extension Phase|Adverse Event|1|||
127541083|NCT02960217|458947107|FG001|Open-Label Extension Phase|Adverse Event|0|||
127541084|NCT02960217|458947106|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
127541085|NCT02960217|458947107|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
127541086|NCT02960217|458947106|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
127541087|NCT02960217|458947107|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
127541088|NCT02960217|458947106|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
127541089|NCT02960217|458947107|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
127541090|NCT00918281|458947110|FG000|Overall Study|Physician Decision|29|||
127541091|NCT01743469|458947111|FG000|Active Treatment Phase|Adverse Event|10|||
127541092|NCT01743469|458947112|FG001|Active Treatment Phase|Adverse Event|5|||
127541093|NCT01743469|458947113|FG002|Active Treatment Phase|Adverse Event|8|||
127541094|NCT01743469|458947114|FG003|Active Treatment Phase|Adverse Event|1|||
127541095|NCT01743469|458947111|FG000|Active Treatment Phase|Disease Progression|40|||
127541096|NCT01743469|458947112|FG001|Active Treatment Phase|Disease Progression|47|||
127541097|NCT01743469|458947113|FG002|Active Treatment Phase|Disease Progression|30|||
127541098|NCT01743469|458947114|FG003|Active Treatment Phase|Disease Progression|20|||
127541099|NCT01743469|458947111|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
127541100|NCT01743469|458947112|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
127541101|NCT01743469|458947113|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
127541102|NCT01743469|458947114|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
127541103|NCT01743469|458947111|FG000|Active Treatment Phase|Missing|1|||
127541104|NCT01743469|458947112|FG001|Active Treatment Phase|Missing|0|||
127541105|NCT01743469|458947113|FG002|Active Treatment Phase|Missing|0|||
127541106|NCT01743469|458947114|FG003|Active Treatment Phase|Missing|0|||
127541107|NCT01743469|458947111|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
127541108|NCT01743469|458947112|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
127541109|NCT01743469|458947113|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
127541110|NCT01743469|458947114|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
127541111|NCT01743469|458947111|FG000|Follow-up Period - Post-Treatment|Death|43|||
127541112|NCT01743469|458947112|FG001|Follow-up Period - Post-Treatment|Death|47|||
127541113|NCT01743469|458947113|FG002|Follow-up Period - Post-Treatment|Death|22|||
127541114|NCT01743469|458947114|FG003|Follow-up Period - Post-Treatment|Death|16|||
127541115|NCT01743469|458947111|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
127541116|NCT01743469|458947112|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
127541117|NCT01743469|458947113|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
127541118|NCT01743469|458947114|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
127541119|NCT00388349|458947115|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
127541120|NCT00388349|458947116|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
127541121|NCT00168844|458947117|FG000|Overall Study|Adverse Event|31|||
127541122|NCT00168844|458947118|FG001|Overall Study|Adverse Event|32|||
127541123|NCT00168844|458947119|FG002|Overall Study|Adverse Event|48|||
127541124|NCT00168844|458947117|FG000|Overall Study|Lost to Follow-up|4|||
127541125|NCT00168844|458947118|FG001|Overall Study|Lost to Follow-up|5|||
127541126|NCT00168844|458947119|FG002|Overall Study|Lost to Follow-up|11|||
127541127|NCT00168844|458947117|FG000|Overall Study|Withdrawal by Subject|12|||
127541128|NCT00168844|458947118|FG001|Overall Study|Withdrawal by Subject|9|||
127541129|NCT00168844|458947119|FG002|Overall Study|Withdrawal by Subject|19|||
127541130|NCT00168844|458947117|FG000|Overall Study|Protocol Violation|2|||
127541131|NCT00168844|458947118|FG001|Overall Study|Protocol Violation|2|||
127541132|NCT00168844|458947119|FG002|Overall Study|Protocol Violation|4|||
127541133|NCT00168844|458947117|FG000|Overall Study|Other|6|||
127541134|NCT00168844|458947118|FG001|Overall Study|Other|7|||
127541135|NCT00168844|458947119|FG002|Overall Study|Other|9|||
127541136|NCT02138890|458947120|FG000|Overall Study|Adverse Event|1|||
127541137|NCT02138890|458947121|FG001|Overall Study|Adverse Event|0|||
127872583|NCT01326312|460152108|FG000|Overall Study|Withdrawal by Subject|1|||
127872584|NCT01326312|460152109|FG001|Overall Study|Withdrawal by Subject|2|||
127872585|NCT01326312|460152110|FG002|Overall Study|Withdrawal by Subject|1|||
127541138|NCT00537394|458947122|FG000|First Year of Follow-up|Death|7|||
127541139|NCT00537394|458947123|FG001|First Year of Follow-up|Death|0|||
127541140|NCT00537394|458947124|FG002|First Year of Follow-up|Death|0|||
127541141|NCT00537394|458947122|FG000|First Year of Follow-up|Severe debilitation|1|||
127541142|NCT00537394|458947123|FG001|First Year of Follow-up|Severe debilitation|0|||
127541143|NCT00537394|458947124|FG002|First Year of Follow-up|Severe debilitation|1|||
127541144|NCT00537394|458947122|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
127541145|NCT00537394|458947123|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
127541146|NCT00537394|458947124|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
127541147|NCT00537394|458947122|FG000|First Year of Follow-up|Lost to Follow-up|1|||
127541148|NCT00537394|458947123|FG001|First Year of Follow-up|Lost to Follow-up|5|||
127541149|NCT00537394|458947124|FG002|First Year of Follow-up|Lost to Follow-up|1|||
127541150|NCT00537394|458947122|FG000|2nd Year of Follow-up|Death|4|||
127541151|NCT00537394|458947123|FG001|2nd Year of Follow-up|Death|1|||
127541152|NCT00537394|458947124|FG002|2nd Year of Follow-up|Death|2|||
127541153|NCT00537394|458947122|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
127541154|NCT00537394|458947123|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
127541155|NCT00537394|458947124|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
127541156|NCT00537394|458947122|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
127541157|NCT00537394|458947123|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
127541158|NCT00537394|458947124|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
127541159|NCT00537394|458947122|FG000|2nd Year of Follow-up|Clinic site closure|1|||
127541160|NCT00537394|458947123|FG001|2nd Year of Follow-up|Clinic site closure|0|||
127541161|NCT00537394|458947124|FG002|2nd Year of Follow-up|Clinic site closure|0|||
127541162|NCT00685165|458947126|FG000|Washout Period of 14 Days|Adverse Event|1|||
127541163|NCT00685165|458947127|FG001|Washout Period of 14 Days|Adverse Event|0|||
127541164|NCT05135871|458947135|FG000|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|1|||
127541165|NCT05135871|458947136|FG001|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
127541166|NCT05135871|458947137|FG002|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
127541167|NCT05135871|458947138|FG003|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
127541168|NCT01420861|458947139|FG000|Overall Study|Adverse Event|2|||
127541169|NCT01420861|458947139|FG000|Overall Study|Study terminated by Sponsor|7|||
127541170|NCT01420861|458947139|FG000|Overall Study|Screen failure|7|||
127541171|NCT01420861|458947139|FG000|Overall Study|Randomized not Treated|2|||
127541172|NCT01247324|458947140|FG000|Overall Study|Death|6|||
127541173|NCT01247324|458947141|FG001|Overall Study|Death|10|||
127541174|NCT01247324|458947140|FG000|Overall Study|Physician Decision|2|||
127541175|NCT01247324|458947141|FG001|Overall Study|Physician Decision|3|||
127541176|NCT01247324|458947140|FG000|Overall Study|Non-compliance with study drug|3|||
127541177|NCT01247324|458947141|FG001|Overall Study|Non-compliance with study drug|0|||
127541178|NCT01247324|458947140|FG000|Overall Study|Lack of Efficacy|24|||
127541179|NCT01247324|458947141|FG001|Overall Study|Lack of Efficacy|14|||
127541180|NCT01247324|458947140|FG000|Overall Study|Non-compliance|3|||
127541181|NCT01247324|458947141|FG001|Overall Study|Non-compliance|2|||
127541182|NCT01247324|458947140|FG000|Overall Study|Pregnancy|5|||
127541183|NCT01247324|458947141|FG001|Overall Study|Pregnancy|10|||
127541184|NCT01247324|458947140|FG000|Overall Study|Protocol Violation|1|||
127541185|NCT01247324|458947141|FG001|Overall Study|Protocol Violation|1|||
127541186|NCT01247324|458947140|FG000|Overall Study|Reason not specified|42|||
127541187|NCT01247324|458947141|FG001|Overall Study|Reason not specified|32|||
127541188|NCT01247324|458947140|FG000|Overall Study|Consent withdrawn by participant|41|||
127541189|NCT01247324|458947141|FG001|Overall Study|Consent withdrawn by participant|56|||
127541190|NCT01247324|458947140|FG000|Overall Study|Adverse Event|49|||
127541191|NCT01247324|458947141|FG001|Overall Study|Adverse Event|35|||
127541192|NCT01247324|458947140|FG000|Overall Study|Lost to Follow-up|3|||
127541193|NCT01247324|458947141|FG001|Overall Study|Lost to Follow-up|6|||
127541194|NCT01247324|458947140|FG000|Overall Study|Study Terminated by Sponsor|4|||
127541195|NCT01247324|458947141|FG001|Overall Study|Study Terminated by Sponsor|1|||
127541196|NCT01247324|458947140|FG000|Overall Study|Missing|2|||
127541197|NCT01247324|458947141|FG001|Overall Study|Missing|1|||
127541198|NCT00506350|458947142|FG000|Overall Study|Serious Adverse Event|1|||
127541199|NCT00506350|458947143|FG001|Overall Study|Serious Adverse Event|0|||
127541200|NCT00506350|458947144|FG002|Overall Study|Serious Adverse Event|0|||
127541201|NCT00506350|458947145|FG003|Overall Study|Serious Adverse Event|0|||
127541202|NCT00506350|458947146|FG004|Overall Study|Serious Adverse Event|0|||
127541203|NCT00506350|458947147|FG005|Overall Study|Serious Adverse Event|0|||
127541204|NCT00506350|458947148|FG006|Overall Study|Serious Adverse Event|0|||
127541205|NCT00506350|458947149|FG007|Overall Study|Serious Adverse Event|0|||
127541206|NCT00506350|458947150|FG008|Overall Study|Serious Adverse Event|0|||
127541207|NCT00506350|458947142|FG000|Overall Study|Adverse Event|0|||
127541208|NCT00506350|458947143|FG001|Overall Study|Adverse Event|0|||
127541209|NCT00506350|458947144|FG002|Overall Study|Adverse Event|0|||
127541210|NCT00506350|458947145|FG003|Overall Study|Adverse Event|0|||
127541211|NCT00506350|458947146|FG004|Overall Study|Adverse Event|0|||
127541212|NCT00506350|458947147|FG005|Overall Study|Adverse Event|0|||
127541213|NCT00506350|458947148|FG006|Overall Study|Adverse Event|0|||
127541214|NCT00506350|458947149|FG007|Overall Study|Adverse Event|1|||
127541215|NCT00506350|458947150|FG008|Overall Study|Adverse Event|1|||
127541216|NCT00506350|458947142|FG000|Overall Study|Protocol Violation|0|||
127541217|NCT00506350|458947143|FG001|Overall Study|Protocol Violation|0|||
127541218|NCT00506350|458947144|FG002|Overall Study|Protocol Violation|1|||
127541219|NCT00506350|458947145|FG003|Overall Study|Protocol Violation|0|||
127541220|NCT00506350|458947146|FG004|Overall Study|Protocol Violation|0|||
127541221|NCT00506350|458947147|FG005|Overall Study|Protocol Violation|0|||
127541222|NCT00506350|458947148|FG006|Overall Study|Protocol Violation|1|||
127541223|NCT00506350|458947149|FG007|Overall Study|Protocol Violation|0|||
127541224|NCT00506350|458947150|FG008|Overall Study|Protocol Violation|0|||
127541225|NCT00506350|458947142|FG000|Overall Study|Withdrawal by Subject|0|||
127541226|NCT00506350|458947143|FG001|Overall Study|Withdrawal by Subject|1|||
127541227|NCT00506350|458947144|FG002|Overall Study|Withdrawal by Subject|1|||
127541228|NCT00506350|458947145|FG003|Overall Study|Withdrawal by Subject|1|||
127541229|NCT00506350|458947146|FG004|Overall Study|Withdrawal by Subject|4|||
127541230|NCT00506350|458947147|FG005|Overall Study|Withdrawal by Subject|1|||
127541231|NCT00506350|458947148|FG006|Overall Study|Withdrawal by Subject|1|||
127541232|NCT00506350|458947149|FG007|Overall Study|Withdrawal by Subject|2|||
127541233|NCT00506350|458947150|FG008|Overall Study|Withdrawal by Subject|0|||
127541234|NCT00506350|458947142|FG000|Overall Study|Lost to Follow-up|1|||
127541235|NCT00506350|458947143|FG001|Overall Study|Lost to Follow-up|1|||
127541236|NCT00506350|458947144|FG002|Overall Study|Lost to Follow-up|1|||
127541237|NCT00506350|458947145|FG003|Overall Study|Lost to Follow-up|1|||
127541238|NCT00506350|458947146|FG004|Overall Study|Lost to Follow-up|2|||
127541239|NCT00506350|458947147|FG005|Overall Study|Lost to Follow-up|1|||
127541240|NCT00506350|458947148|FG006|Overall Study|Lost to Follow-up|0|||
127541241|NCT00506350|458947149|FG007|Overall Study|Lost to Follow-up|0|||
127541242|NCT00506350|458947150|FG008|Overall Study|Lost to Follow-up|2|||
127541243|NCT00506350|458947142|FG000|Overall Study|Medical Reason|0|||
127541244|NCT00506350|458947143|FG001|Overall Study|Medical Reason|0|||
127541245|NCT00506350|458947144|FG002|Overall Study|Medical Reason|0|||
127541246|NCT00506350|458947145|FG003|Overall Study|Medical Reason|0|||
127541247|NCT00506350|458947146|FG004|Overall Study|Medical Reason|1|||
127541248|NCT00506350|458947147|FG005|Overall Study|Medical Reason|0|||
127541249|NCT00506350|458947148|FG006|Overall Study|Medical Reason|0|||
127541250|NCT00506350|458947149|FG007|Overall Study|Medical Reason|0|||
127541251|NCT00506350|458947150|FG008|Overall Study|Medical Reason|0|||
127541252|NCT00506350|458947142|FG000|Overall Study|Other|1|||
127541253|NCT00506350|458947143|FG001|Overall Study|Other|1|||
127541254|NCT00506350|458947144|FG002|Overall Study|Other|3|||
127541255|NCT00506350|458947145|FG003|Overall Study|Other|0|||
127541256|NCT00506350|458947146|FG004|Overall Study|Other|3|||
127541257|NCT00506350|458947147|FG005|Overall Study|Other|0|||
127541258|NCT00506350|458947148|FG006|Overall Study|Other|0|||
127541259|NCT00506350|458947149|FG007|Overall Study|Other|2|||
127541260|NCT00506350|458947150|FG008|Overall Study|Other|2|||
127541261|NCT01691794|458947151|FG000|Overall Study|Poor/Non-Compliance|1|||
127541262|NCT01691794|458947152|FG001|Overall Study|Poor/Non-Compliance|4|||
127541263|NCT01691794|458947153|FG002|Overall Study|Poor/Non-Compliance|1|||
127541264|NCT01691794|458947151|FG000|Overall Study|Death|0|||
127541265|NCT01691794|458947152|FG001|Overall Study|Death|0|||
127541266|NCT01691794|458947153|FG002|Overall Study|Death|1|||
127541267|NCT01691794|458947151|FG000|Overall Study|Lack of Efficacy|0|||
127541268|NCT01691794|458947152|FG001|Overall Study|Lack of Efficacy|7|||
127541269|NCT01691794|458947153|FG002|Overall Study|Lack of Efficacy|1|||
127541270|NCT01691794|458947151|FG000|Overall Study|Participant request to discontinue|0|||
127541271|NCT01691794|458947152|FG001|Overall Study|Participant request to discontinue|1|||
127541272|NCT01691794|458947153|FG002|Overall Study|Participant request to discontinue|0|||
127541273|NCT01691794|458947151|FG000|Overall Study|Adverse Event|0|||
127541274|NCT01691794|458947152|FG001|Overall Study|Adverse Event|1|||
127541275|NCT01691794|458947153|FG002|Overall Study|Adverse Event|1|||
127541276|NCT01691794|458947151|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
127541277|NCT01691794|458947152|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
127541278|NCT01691794|458947153|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
127541279|NCT01691794|458947151|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
127541280|NCT01691794|458947152|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
127541281|NCT01691794|458947153|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
127541282|NCT04972786|458947154|FG000|First Intervention (1 Day)|Adverse Event|1|||
127541283|NCT04972786|458947155|FG001|First Intervention (1 Day)|Adverse Event|0|||
127541284|NCT00844844|458947156|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
127541285|NCT00844844|458947156|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
127541286|NCT00844844|458947156|FG000|Extension Treatment Period|Adverse Event|2|||
127541287|NCT00844844|458947156|FG000|Post Treatment Period|Withdrawal by Subject|1|||
127541288|NCT04886154|458947158|FG000|Overall Study|Adverse Event|0|||
127541289|NCT04886154|458947159|FG001|Overall Study|Adverse Event|0|||
127541290|NCT04886154|458947160|FG002|Overall Study|Adverse Event|0|||
127541291|NCT04886154|458947161|FG003|Overall Study|Adverse Event|0|||
127541292|NCT04886154|458947162|FG004|Overall Study|Adverse Event|1|||
127541293|NCT04886154|458947163|FG005|Overall Study|Adverse Event|0|||
127541294|NCT04886154|458947164|FG006|Overall Study|Adverse Event|0|||
127541295|NCT04886154|458947165|FG007|Overall Study|Adverse Event|1|||
127541296|NCT04886154|458947166|FG008|Overall Study|Adverse Event|1|||
127541297|NCT04886154|458947167|FG009|Overall Study|Adverse Event|0|||
127541298|NCT04886154|458947168|FG010|Overall Study|Adverse Event|0|||
127541299|NCT04886154|458947169|FG011|Overall Study|Adverse Event|1|||
127541300|NCT04886154|458947170|FG012|Overall Study|Adverse Event|0|||
127541301|NCT04886154|458947171|FG013|Overall Study|Adverse Event|0|||
127541302|NCT04886154|458947172|FG014|Overall Study|Adverse Event|3|||
127541303|NCT04886154|458947158|FG000|Overall Study|Lost to Follow-up|1|||
127541304|NCT04886154|458947159|FG001|Overall Study|Lost to Follow-up|0|||
127541305|NCT04886154|458947160|FG002|Overall Study|Lost to Follow-up|2|||
127541306|NCT04886154|458947161|FG003|Overall Study|Lost to Follow-up|0|||
127541307|NCT04886154|458947162|FG004|Overall Study|Lost to Follow-up|17|||
127541308|NCT04886154|458947163|FG005|Overall Study|Lost to Follow-up|7|||
127541309|NCT04886154|458947164|FG006|Overall Study|Lost to Follow-up|8|||
127541310|NCT04886154|458947165|FG007|Overall Study|Lost to Follow-up|7|||
127541311|NCT04886154|458947166|FG008|Overall Study|Lost to Follow-up|8|||
127541312|NCT04886154|458947167|FG009|Overall Study|Lost to Follow-up|0|||
127541313|NCT04886154|458947168|FG010|Overall Study|Lost to Follow-up|2|||
127541314|NCT04886154|458947169|FG011|Overall Study|Lost to Follow-up|0|||
127541315|NCT04886154|458947170|FG012|Overall Study|Lost to Follow-up|0|||
127541316|NCT04886154|458947171|FG013|Overall Study|Lost to Follow-up|0|||
127541317|NCT04886154|458947172|FG014|Overall Study|Lost to Follow-up|0|||
127541318|NCT04886154|458947158|FG000|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
127541319|NCT04886154|458947159|FG001|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
127541320|NCT04886154|458947160|FG002|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
127541321|NCT04886154|458947161|FG003|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
127541322|NCT04886154|458947162|FG004|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
127541323|NCT04886154|458947163|FG005|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
127541324|NCT04886154|458947164|FG006|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|1|||
127541325|NCT04886154|458947165|FG007|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
127541326|NCT04886154|458947166|FG008|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
127541327|NCT04886154|458947167|FG009|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
127541328|NCT04886154|458947168|FG010|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
127541329|NCT04886154|458947169|FG011|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
127541330|NCT04886154|458947170|FG012|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
127541331|NCT04886154|458947171|FG013|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
127541332|NCT04886154|458947172|FG014|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
127541333|NCT04886154|458947158|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127541334|NCT04886154|458947159|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127541335|NCT04886154|458947160|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127541336|NCT04886154|458947161|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127541337|NCT04886154|458947162|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
127541338|NCT04886154|458947163|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127541339|NCT04886154|458947164|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
127541340|NCT04886154|458947165|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
127541341|NCT04886154|458947166|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127541342|NCT04886154|458947167|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127541343|NCT04886154|458947168|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127541344|NCT04886154|458947169|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127541345|NCT04886154|458947170|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127541346|NCT04886154|458947171|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127541347|NCT04886154|458947172|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
127541348|NCT04886154|458947158|FG000|Overall Study|Other, Not Specified|0|||
127541349|NCT04886154|458947159|FG001|Overall Study|Other, Not Specified|0|||
127541350|NCT04886154|458947160|FG002|Overall Study|Other, Not Specified|0|||
127541351|NCT04886154|458947161|FG003|Overall Study|Other, Not Specified|0|||
127541352|NCT04886154|458947162|FG004|Overall Study|Other, Not Specified|11|||
127541353|NCT04886154|458947163|FG005|Overall Study|Other, Not Specified|8|||
127541354|NCT04886154|458947164|FG006|Overall Study|Other, Not Specified|9|||
127872586|NCT01326312|460152108|FG000|Overall Study|Protocol Violation|0|||
127872587|NCT01326312|460152109|FG001|Overall Study|Protocol Violation|1|||
127541355|NCT04886154|458947165|FG007|Overall Study|Other, Not Specified|10|||
127541356|NCT04886154|458947166|FG008|Overall Study|Other, Not Specified|6|||
127541357|NCT04886154|458947167|FG009|Overall Study|Other, Not Specified|1|||
127541358|NCT04886154|458947168|FG010|Overall Study|Other, Not Specified|1|||
127541359|NCT04886154|458947169|FG011|Overall Study|Other, Not Specified|2|||
127541360|NCT04886154|458947170|FG012|Overall Study|Other, Not Specified|1|||
127541361|NCT04886154|458947171|FG013|Overall Study|Other, Not Specified|2|||
127541362|NCT04886154|458947172|FG014|Overall Study|Other, Not Specified|3|||
127541363|NCT00668148|458947190|FG000|Overall Study|Adverse Event|5|||
127541364|NCT00668148|458947190|FG000|Overall Study|Subject Non-compliance|1|||
127541365|NCT00668148|458947190|FG000|Overall Study|Progressive Disease Before Treatment|2|||
127541366|NCT00668148|458947190|FG000|Overall Study|Withdrawal of Consent|2|||
127541367|NCT05472090|458947191|FG000|Overall Study|Adverse Event|2|||
127541368|NCT05472090|458947192|FG001|Overall Study|Adverse Event|3|||
127541369|NCT05472090|458947191|FG000|Overall Study|Lack of Efficacy|1|||
127541370|NCT05472090|458947192|FG001|Overall Study|Lack of Efficacy|0|||
127541371|NCT05472090|458947191|FG000|Overall Study|Physician Decision|1|||
127541372|NCT05472090|458947192|FG001|Overall Study|Physician Decision|0|||
127541373|NCT05472090|458947191|FG000|Overall Study|Withdrawal by Subject|2|||
127541374|NCT05472090|458947192|FG001|Overall Study|Withdrawal by Subject|0|||
127541375|NCT05472090|458947191|FG000|Overall Study|Lost to Follow-up|0|||
127541376|NCT05472090|458947192|FG001|Overall Study|Lost to Follow-up|3|||
127541377|NCT01350999|458947194|FG000|Overall Study|Adverse Event|4|||
127541378|NCT01350999|458947195|FG001|Overall Study|Adverse Event|9|||
127541379|NCT01350999|458947196|FG002|Overall Study|Adverse Event|10|||
127541380|NCT01350999|458947194|FG000|Overall Study|Voluntary withdrawal|3|||
127541381|NCT01350999|458947195|FG001|Overall Study|Voluntary withdrawal|4|||
127541382|NCT01350999|458947196|FG002|Overall Study|Voluntary withdrawal|6|||
127541383|NCT01350999|458947194|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
127541384|NCT01350999|458947195|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
127541385|NCT01350999|458947196|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
127541386|NCT00672555|458948760|FG000|Overall Study|Lost to Follow-up|4|||
127541387|NCT00672555|458948760|FG000|Overall Study|Did not want to answer questionnaire|2|||
127541388|NCT02384551|458948761|FG000|Overall Study|Lost to Follow-up|13|||
127541389|NCT02384551|458948762|FG001|Overall Study|Lost to Follow-up|14|||
127541390|NCT02384551|458948763|FG002|Overall Study|Lost to Follow-up|14|||
127541391|NCT02384551|458948764|FG003|Overall Study|Lost to Follow-up|14|||
127541392|NCT03035032|458948769|FG000|Overall Study|Adverse Event|2|||
127541393|NCT03035032|458948769|FG000|Overall Study|Death|9|||
127541394|NCT03035032|458948769|FG000|Overall Study|Lost to Follow-up|1|||
127541395|NCT03035032|458948769|FG000|Overall Study|Progressive Disease|22|||
127541396|NCT03035032|458948769|FG000|Overall Study|Protocol Violation|2|||
127541397|NCT03035032|458948769|FG000|Overall Study|Withdrawal by Subject|2|||
127541398|NCT03035032|458948769|FG000|Overall Study|Physician Decision|5|||
127541399|NCT00836589|458948770|FG000|Overall Study|Lost to Follow-up|246|||
127541400|NCT00836589|458948770|FG000|Overall Study|Death|429|||
127541401|NCT00836589|458948770|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
127541402|NCT02399215|458948792|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
127541403|NCT02399215|458948792|FG000|Overall Study|Withdrawal by Subject|1|||
127541404|NCT00772538|458948793|FG000|Overall Study|Adverse Event|6|||
127541405|NCT00772538|458948794|FG001|Overall Study|Adverse Event|6|||
127541406|NCT00772538|458948793|FG000|Overall Study|Protocol Violation|3|||
127541407|NCT00772538|458948794|FG001|Overall Study|Protocol Violation|3|||
127541408|NCT00772538|458948793|FG000|Overall Study|Lost to Follow-up|1|||
127541409|NCT00772538|458948794|FG001|Overall Study|Lost to Follow-up|1|||
127541410|NCT00772538|458948793|FG000|Overall Study|Withdrawal by Subject|3|||
127541411|NCT00772538|458948794|FG001|Overall Study|Withdrawal by Subject|8|||
127541412|NCT00772538|458948793|FG000|Overall Study|Lack of Efficacy|0|||
127541413|NCT00772538|458948794|FG001|Overall Study|Lack of Efficacy|1|||
127541414|NCT00772538|458948793|FG000|Overall Study|Other|7|||
127541415|NCT00772538|458948794|FG001|Overall Study|Other|7|||
127541416|NCT00713609|458948797|FG000|Overall Study|Adverse Event|2|||
127541417|NCT00713609|458948798|FG001|Overall Study|Adverse Event|0|||
127541418|NCT00713609|458948799|FG002|Overall Study|Adverse Event|2|||
127541419|NCT00713609|458948800|FG003|Overall Study|Adverse Event|2|||
127541420|NCT00713609|458948801|FG004|Overall Study|Adverse Event|3|||
127541421|NCT00713609|458948802|FG005|Overall Study|Adverse Event|1|||
127541422|NCT00713609|458948797|FG000|Overall Study|Lost to Follow-up|5|||
127541423|NCT00713609|458948798|FG001|Overall Study|Lost to Follow-up|7|||
127541424|NCT00713609|458948799|FG002|Overall Study|Lost to Follow-up|5|||
127541425|NCT00713609|458948800|FG003|Overall Study|Lost to Follow-up|5|||
127541426|NCT00713609|458948801|FG004|Overall Study|Lost to Follow-up|7|||
127541427|NCT00713609|458948802|FG005|Overall Study|Lost to Follow-up|0|||
127541428|NCT00713609|458948797|FG000|Overall Study|Lack of Efficacy|1|||
127872588|NCT01326312|460152110|FG002|Overall Study|Protocol Violation|0|||
127541429|NCT00713609|458948798|FG001|Overall Study|Lack of Efficacy|3|||
127541430|NCT00713609|458948799|FG002|Overall Study|Lack of Efficacy|0|||
127541431|NCT00713609|458948800|FG003|Overall Study|Lack of Efficacy|0|||
127541432|NCT00713609|458948801|FG004|Overall Study|Lack of Efficacy|1|||
127541433|NCT00713609|458948802|FG005|Overall Study|Lack of Efficacy|0|||
127541434|NCT00713609|458948797|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
127541435|NCT00713609|458948798|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
127541436|NCT00713609|458948799|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
127541437|NCT00713609|458948800|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
127541438|NCT00713609|458948801|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
127541439|NCT00713609|458948802|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
127541440|NCT00713609|458948797|FG000|Overall Study|Withdrawal by Subject|6|||
127541441|NCT00713609|458948798|FG001|Overall Study|Withdrawal by Subject|1|||
127541442|NCT00713609|458948799|FG002|Overall Study|Withdrawal by Subject|5|||
127541443|NCT00713609|458948800|FG003|Overall Study|Withdrawal by Subject|1|||
127541444|NCT00713609|458948801|FG004|Overall Study|Withdrawal by Subject|5|||
127541445|NCT00713609|458948802|FG005|Overall Study|Withdrawal by Subject|7|||
127541446|NCT00713609|458948797|FG000|Overall Study|Protocol Violation|6|||
127541447|NCT00713609|458948798|FG001|Overall Study|Protocol Violation|3|||
127541448|NCT00713609|458948799|FG002|Overall Study|Protocol Violation|1|||
127541449|NCT00713609|458948800|FG003|Overall Study|Protocol Violation|1|||
127541450|NCT00713609|458948801|FG004|Overall Study|Protocol Violation|2|||
127541451|NCT00713609|458948802|FG005|Overall Study|Protocol Violation|0|||
127541452|NCT01903356|458948803|FG000|Overall Study|Lost to Follow-up|7|||
127541453|NCT01903356|458948803|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
127872589|NCT01326312|460152108|FG000|Overall Study|Lack of Efficacy|13|||
127872590|NCT01326312|460152109|FG001|Overall Study|Lack of Efficacy|7|||
127872591|NCT01326312|460152110|FG002|Overall Study|Lack of Efficacy|1|||
127872592|NCT01326312|460152108|FG000|Overall Study|Death|1|||
127872593|NCT01326312|460152109|FG001|Overall Study|Death|0|||
127872594|NCT01326312|460152110|FG002|Overall Study|Death|1|||
127872595|NCT01326312|460152108|FG000|Overall Study|progressive disease|0|||
127872596|NCT01326312|460152109|FG001|Overall Study|progressive disease|1|||
127872597|NCT01326312|460152110|FG002|Overall Study|progressive disease|1|||
127872598|NCT01326312|460152108|FG000|Overall Study|Study terminated by Sponsor|8|||
127872599|NCT01326312|460152109|FG001|Overall Study|Study terminated by Sponsor|32|||
127541454|NCT01903356|458948803|FG000|Overall Study|Violated the dosage and administration|3|||
127541455|NCT04529083|458948804|FG000|Overall Study|Withdrawal by Subject|3|||
127541456|NCT03305666|458948805|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
127541457|NCT03305666|458948806|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
127541458|NCT02587221|458948808|FG000|Overall Study|Adverse Event|3|||
127541459|NCT02587221|458948809|FG001|Overall Study|Adverse Event|3|||
127541460|NCT02587221|458948808|FG000|Overall Study|Death|33|||
127541461|NCT02587221|458948809|FG001|Overall Study|Death|34|||
127541462|NCT02587221|458948808|FG000|Overall Study|Withdrawal by Subject|66|||
127541463|NCT02587221|458948809|FG001|Overall Study|Withdrawal by Subject|61|||
127541464|NCT02587221|458948808|FG000|Overall Study|Lost to Follow-up|21|||
127541465|NCT02587221|458948809|FG001|Overall Study|Lost to Follow-up|19|||
127541466|NCT02587221|458948808|FG000|Overall Study|Protocol Violation|6|||
127541467|NCT02587221|458948809|FG001|Overall Study|Protocol Violation|5|||
127541468|NCT02587221|458948808|FG000|Overall Study|Other Reason or Unspecified|2|||
127541469|NCT02587221|458948809|FG001|Overall Study|Other Reason or Unspecified|1|||
127541470|NCT01791244|458948811|FG000|Overall Study|Adverse Event|5|||
127541471|NCT01791244|458948812|FG001|Overall Study|Adverse Event|7|||
127541472|NCT01791244|458948811|FG000|Overall Study|Insufficient clinical response|10|||
127541473|NCT01791244|458948812|FG001|Overall Study|Insufficient clinical response|10|||
127541474|NCT01791244|458948811|FG000|Overall Study|Laboratory Abnormality|0|||
127541475|NCT01791244|458948812|FG001|Overall Study|Laboratory Abnormality|1|||
127541476|NCT01149096|458948814|FG000|Overall Study|Lost to Follow-up|0|||
127541477|NCT01149096|458948815|FG001|Overall Study|Lost to Follow-up|1|||
127541478|NCT03651765|458948819|FG000|Overall Study|Adverse Event|6|||
127541479|NCT03651765|458948819|FG000|Overall Study|Lack of Efficacy|18|||
127541480|NCT03651765|458948819|FG000|Overall Study|Lost to Follow-up|5|||
127541481|NCT03651765|458948819|FG000|Overall Study|Non-Compliance with Study Drug|4|||
127541482|NCT03651765|458948819|FG000|Overall Study|Physician Decision|6|||
127541483|NCT03651765|458948819|FG000|Overall Study|Pregnancy|1|||
127541484|NCT03651765|458948819|FG000|Overall Study|Discontinued by Sponsor|40|||
127541485|NCT03651765|458948819|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
127541486|NCT03651765|458948819|FG000|Overall Study|Withdrawal by Subject|24|||
127541487|NCT03651765|458948819|FG000|Overall Study|Miscellaneous|6|||
127541488|NCT05058365|458948820|FG000|Overall Study|Migration|1|||
127541489|NCT05058365|458948821|FG001|Overall Study|Migration|1|||
127541490|NCT04038359|458948822|FG000|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|1|||
127541491|NCT04038359|458948823|FG001|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|0|||
127541492|NCT04038359|458948822|FG000|Overall Study|Death|8|||
127872600|NCT01326312|460152110|FG002|Overall Study|Study terminated by Sponsor|46|||
127872601|NCT01326312|460152108|FG000|Overall Study|Treatment arm terminated|19|||
127872602|NCT01326312|460152109|FG001|Overall Study|Treatment arm terminated|0|||
127541493|NCT04038359|458948823|FG001|Overall Study|Death|7|||
127541494|NCT04038359|458948822|FG000|Overall Study|Lost to Follow-up|3|||
127541495|NCT04038359|458948823|FG001|Overall Study|Lost to Follow-up|0|||
127541496|NCT04038359|458948822|FG000|Overall Study|Participant Moved|1|||
127541497|NCT04038359|458948823|FG001|Overall Study|Participant Moved|0|||
127541498|NCT04038359|458948822|FG000|Overall Study|Withdrawal by Subject|4|||
127541499|NCT04038359|458948823|FG001|Overall Study|Withdrawal by Subject|3|||
127541500|NCT04038359|458948822|FG000|Overall Study|Physician Decision|3|||
127872603|NCT01326312|460152110|FG002|Overall Study|Treatment arm terminated|0|||
127872604|NCT01326312|460152108|FG000|Overall Study|QTc > 500|0|||
127541501|NCT04038359|458948823|FG001|Overall Study|Physician Decision|2|||
127541502|NCT04038359|458948822|FG000|Overall Study|Adverse Event|0|||
127541503|NCT04038359|458948823|FG001|Overall Study|Adverse Event|2|||
127541504|NCT04038359|458948822|FG000|Overall Study|Progressive Disease|0|||
127541505|NCT04038359|458948823|FG001|Overall Study|Progressive Disease|1|||
127541506|NCT00703014|458948824|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
127541507|NCT00703014|458948825|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
127541508|NCT00703014|458948826|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
127541509|NCT00703014|458948827|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
127541510|NCT00703014|458948824|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
127541511|NCT00703014|458948825|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
127541512|NCT00703014|458948826|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
127541513|NCT00703014|458948827|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
127541514|NCT01033240|458948831|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
127541515|NCT01033240|458948832|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
127541516|NCT01033240|458948833|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
127541517|NCT01033240|458948831|FG000|Overall Study|Death|2|||
127541518|NCT01033240|458948832|FG001|Overall Study|Death|0|||
127541519|NCT01033240|458948833|FG002|Overall Study|Death|0|||
127541520|NCT01033240|458948831|FG000|Overall Study|Withdrew Consent|2|||
127541521|NCT01033240|458948832|FG001|Overall Study|Withdrew Consent|9|||
127541522|NCT01033240|458948833|FG002|Overall Study|Withdrew Consent|2|||
127541523|NCT01033240|458948831|FG000|Overall Study|Disease Progression|35|||
127541524|NCT01033240|458948832|FG001|Overall Study|Disease Progression|32|||
127541525|NCT01033240|458948833|FG002|Overall Study|Disease Progression|41|||
127541526|NCT01033240|458948831|FG000|Overall Study|Investigator Discretion|0|||
127541527|NCT01033240|458948832|FG001|Overall Study|Investigator Discretion|0|||
127541528|NCT01033240|458948833|FG002|Overall Study|Investigator Discretion|2|||
127541529|NCT01033240|458948831|FG000|Overall Study|Other|0|||
127541530|NCT01033240|458948832|FG001|Overall Study|Other|1|||
127541531|NCT01033240|458948833|FG002|Overall Study|Other|2|||
127541532|NCT05468814|458948834|FG000|Overall Study|Lost to Follow-up|5|||
127541533|NCT05468814|458948835|FG001|Overall Study|Lost to Follow-up|6|||
127541534|NCT04716426|458948836|FG000|Overall Study|Vaccination|1|||
127541535|NCT04716426|458948837|FG001|Overall Study|Vaccination|1|||
127541536|NCT04716426|458948836|FG000|Overall Study|Contamination|1|||
127541537|NCT04716426|458948837|FG001|Overall Study|Contamination|0|||
127541538|NCT00551759|458948838|FG000|Overall Study|Adverse Event|7|||
127541539|NCT00551759|458948838|FG000|Overall Study|Death|5|||
127541540|NCT00551759|458948838|FG000|Overall Study|Ineligible|1|||
127541541|NCT00625131|458948841|FG000|Overall Study|Lost to Follow-up|3|||
127541542|NCT00625131|458948842|FG001|Overall Study|Lost to Follow-up|2|||
127541543|NCT00625131|458948843|FG002|Overall Study|Lost to Follow-up|0|||
127541544|NCT00625131|458948841|FG000|Overall Study|Withdrawal by Subject|1|||
127541545|NCT00625131|458948842|FG001|Overall Study|Withdrawal by Subject|0|||
127541546|NCT00625131|458948843|FG002|Overall Study|Withdrawal by Subject|5|||
127541547|NCT01446159|458948853|FG000|Overall Study|Withdrawal by Subject|1|||
127541548|NCT01446159|458948854|FG001|Overall Study|Withdrawal by Subject|0|||
127541549|NCT01446159|458948855|FG002|Overall Study|Withdrawal by Subject|14|||
127541550|NCT01446159|458948856|FG003|Overall Study|Withdrawal by Subject|11|||
127541551|NCT01446159|458948853|FG000|Overall Study|Lost to Follow-up|0|||
127541552|NCT01446159|458948854|FG001|Overall Study|Lost to Follow-up|0|||
127541553|NCT01446159|458948855|FG002|Overall Study|Lost to Follow-up|1|||
127541554|NCT01446159|458948856|FG003|Overall Study|Lost to Follow-up|2|||
127541555|NCT01446159|458948853|FG000|Overall Study|Death|2|||
127541556|NCT01446159|458948854|FG001|Overall Study|Death|3|||
127541557|NCT01446159|458948855|FG002|Overall Study|Death|43|||
127541558|NCT01446159|458948856|FG003|Overall Study|Death|36|||
127541559|NCT01446159|458948853|FG000|Overall Study|Other|0|||
127541560|NCT01446159|458948854|FG001|Overall Study|Other|0|||
127541561|NCT01446159|458948855|FG002|Overall Study|Other|13|||
127541562|NCT01446159|458948856|FG003|Overall Study|Other|13|||
127541563|NCT00795535|458948858|FG000|Overall Study|incomplete data and technical problems|20|||
127541564|NCT00556075|458948859|FG000|Overall Study|Lost to Follow-up|3|||
127541565|NCT00556075|458948860|FG001|Overall Study|Lost to Follow-up|0|||
127541566|NCT00556075|458948861|FG002|Overall Study|Lost to Follow-up|3|||
127541567|NCT00556075|458948859|FG000|Overall Study|Withdrawal by Subject|3|||
127541568|NCT00556075|458948860|FG001|Overall Study|Withdrawal by Subject|3|||
127541569|NCT00556075|458948861|FG002|Overall Study|Withdrawal by Subject|0|||
127541570|NCT00556075|458948859|FG000|Overall Study|Protocol Violation|1|||
127541571|NCT00556075|458948860|FG001|Overall Study|Protocol Violation|1|||
127541572|NCT00556075|458948861|FG002|Overall Study|Protocol Violation|3|||
127541573|NCT00556075|458948859|FG000|Overall Study|Not eligible|1|||
127541574|NCT00556075|458948860|FG001|Overall Study|Not eligible|1|||
127541575|NCT00556075|458948861|FG002|Overall Study|Not eligible|2|||
127541576|NCT00556075|458948859|FG000|Overall Study|Adverse Event|1|||
127541577|NCT00556075|458948860|FG001|Overall Study|Adverse Event|2|||
127541578|NCT00556075|458948861|FG002|Overall Study|Adverse Event|0|||
127541579|NCT00556075|458948859|FG000|Overall Study|Personal issues|4|||
127541580|NCT00556075|458948860|FG001|Overall Study|Personal issues|1|||
127541581|NCT00556075|458948861|FG002|Overall Study|Personal issues|0|||
127541582|NCT00556075|458948859|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
127541583|NCT00556075|458948860|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
127541584|NCT00556075|458948861|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
127541585|NCT02485691|458948862|FG000|Overall Study|Adverse Event|25|||
127541586|NCT02485691|458948863|FG001|Overall Study|Adverse Event|11|||
127541587|NCT02485691|458948862|FG000|Overall Study|Poor compliance to protocol|0|||
127541588|NCT02485691|458948863|FG001|Overall Study|Poor compliance to protocol|1|||
127541589|NCT02485691|458948862|FG000|Overall Study|Disease progression|57|||
127541590|NCT02485691|458948863|FG001|Overall Study|Disease progression|92|||
127541591|NCT02485691|458948862|FG000|Overall Study|Investigator's decision|23|||
127541592|NCT02485691|458948863|FG001|Overall Study|Investigator's decision|5|||
127541593|NCT02485691|458948862|FG000|Overall Study|Participant's request|13|||
127541594|NCT02485691|458948863|FG001|Overall Study|Participant's request|6|||
127541595|NCT02485691|458948862|FG000|Overall Study|Other reason|8|||
127541596|NCT02485691|458948863|FG001|Overall Study|Other reason|9|||
127541597|NCT02485691|458948862|FG000|Overall Study|Randomized and not treated|3|||
127541598|NCT02485691|458948863|FG001|Overall Study|Randomized and not treated|2|||
127541599|NCT00604565|458948864|FG000|Overall Study|Study terminated|0|||
127541600|NCT00604565|458948865|FG001|Overall Study|Study terminated|3|||
127541601|NCT04292535|458948866|FG000|Overall Study|Withdrawal by Subject|0|||
127541602|NCT04292535|458948867|FG001|Overall Study|Withdrawal by Subject|0|||
127541603|NCT04292535|458948868|FG002|Overall Study|Withdrawal by Subject|0|||
127541604|NCT04292535|458948869|FG003|Overall Study|Withdrawal by Subject|0|||
127541605|NCT04292535|458948870|FG004|Overall Study|Withdrawal by Subject|0|||
127541606|NCT04292535|458948871|FG005|Overall Study|Withdrawal by Subject|0|||
127541607|NCT04292535|458948872|FG006|Overall Study|Withdrawal by Subject|0|||
127541608|NCT04292535|458948873|FG007|Overall Study|Withdrawal by Subject|1|||
127541609|NCT04292535|458948874|FG008|Overall Study|Withdrawal by Subject|0|||
127541610|NCT04292535|458948875|FG009|Overall Study|Withdrawal by Subject|0|||
127541611|NCT04292535|458948876|FG010|Overall Study|Withdrawal by Subject|0|||
127541612|NCT04292535|458948877|FG011|Overall Study|Withdrawal by Subject|0|||
127541613|NCT04292535|458948878|FG012|Overall Study|Withdrawal by Subject|0|||
127541614|NCT04292535|458948879|FG013|Overall Study|Withdrawal by Subject|0|||
127541615|NCT04292535|458948866|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
127541616|NCT04292535|458948867|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
127541617|NCT04292535|458948868|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
127541618|NCT04292535|458948869|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
127541619|NCT04292535|458948870|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
127541620|NCT04292535|458948871|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
127541621|NCT04292535|458948872|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
127541622|NCT04292535|458948873|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
127541623|NCT04292535|458948874|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
127541624|NCT04292535|458948875|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
127541625|NCT04292535|458948876|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
127541626|NCT04292535|458948877|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
127541627|NCT04292535|458948878|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
127541628|NCT04292535|458948879|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
127541629|NCT04292535|458948866|FG000|Overall Study|Report of Dizziness|0|||
127541630|NCT04292535|458948867|FG001|Overall Study|Report of Dizziness|0|||
127541631|NCT04292535|458948868|FG002|Overall Study|Report of Dizziness|0|||
127541632|NCT04292535|458948869|FG003|Overall Study|Report of Dizziness|0|||
127541633|NCT04292535|458948870|FG004|Overall Study|Report of Dizziness|0|||
127541634|NCT04292535|458948871|FG005|Overall Study|Report of Dizziness|0|||
127541635|NCT04292535|458948872|FG006|Overall Study|Report of Dizziness|0|||
127541636|NCT04292535|458948873|FG007|Overall Study|Report of Dizziness|0|||
127541637|NCT04292535|458948874|FG008|Overall Study|Report of Dizziness|0|||
127541638|NCT04292535|458948875|FG009|Overall Study|Report of Dizziness|0|||
127872605|NCT01326312|460152109|FG001|Overall Study|QTc > 500|1|||
127872606|NCT01326312|460152110|FG002|Overall Study|QTc > 500|0|||
127541639|NCT04292535|458948876|FG010|Overall Study|Report of Dizziness|0|||
127541640|NCT04292535|458948877|FG011|Overall Study|Report of Dizziness|0|||
127541641|NCT04292535|458948878|FG012|Overall Study|Report of Dizziness|0|||
127541642|NCT04292535|458948879|FG013|Overall Study|Report of Dizziness|1|||
127541643|NCT04292535|458948866|FG000|Overall Study|Equipment Failure|0|||
127541644|NCT04292535|458948867|FG001|Overall Study|Equipment Failure|0|||
127541645|NCT04292535|458948868|FG002|Overall Study|Equipment Failure|0|||
127541646|NCT04292535|458948869|FG003|Overall Study|Equipment Failure|0|||
127541647|NCT04292535|458948870|FG004|Overall Study|Equipment Failure|0|||
127541648|NCT04292535|458948871|FG005|Overall Study|Equipment Failure|0|||
127872607|NCT02219477|460152111|FG000|Overall Study|Adverse Event|0|||
127541649|NCT04292535|458948872|FG006|Overall Study|Equipment Failure|0|||
127541650|NCT04292535|458948873|FG007|Overall Study|Equipment Failure|0|||
127541651|NCT04292535|458948874|FG008|Overall Study|Equipment Failure|0|||
127541652|NCT04292535|458948875|FG009|Overall Study|Equipment Failure|0|||
127541653|NCT04292535|458948876|FG010|Overall Study|Equipment Failure|0|||
127541654|NCT04292535|458948877|FG011|Overall Study|Equipment Failure|1|||
127541655|NCT04292535|458948878|FG012|Overall Study|Equipment Failure|0|||
127541656|NCT04292535|458948879|FG013|Overall Study|Equipment Failure|0|||
127541657|NCT03836625|458948882|FG000|Overall Study|Lost to Follow-up|9|||
127541658|NCT03836625|458948883|FG001|Overall Study|Lost to Follow-up|9|||
127541659|NCT03836625|458948882|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
127541660|NCT03836625|458948883|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
127541661|NCT03836625|458948882|FG000|Overall Study|Death|0|||
127541662|NCT03836625|458948883|FG001|Overall Study|Death|1|||
127541663|NCT03836625|458948882|FG000|Overall Study|Refused follow-up|0|||
127649284|NCT01364922|459337735|FG002|Open-label (OL) Period|Adverse Event|0|||
127649285|NCT01364922|459337733|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
127649286|NCT01364922|459337734|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
127649287|NCT01364922|459337735|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
127649288|NCT01364922|459337733|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
127649289|NCT01364922|459337734|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
127649290|NCT01364922|459337735|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
127649291|NCT01364922|459337733|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
127649292|NCT01364922|459337734|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
127649293|NCT01364922|459337735|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
127649294|NCT01364922|459337733|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
127649295|NCT01364922|459337734|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
127649296|NCT01364922|459337735|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
127649297|NCT01364922|459337733|FG000|Open-label (OL) Period|Other, Unspecified|1|||
127649298|NCT01364922|459337734|FG001|Open-label (OL) Period|Other, Unspecified|0|||
127649299|NCT01364922|459337735|FG002|Open-label (OL) Period|Other, Unspecified|0|||
127649300|NCT01364922|459337733|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
127649301|NCT01364922|459337734|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
127649302|NCT01364922|459337735|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
127649303|NCT01364922|459337733|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
127649304|NCT01364922|459337734|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
127649305|NCT01364922|459337735|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
127649306|NCT01364922|459337733|FG000|Double-Blind (DB) Period|Adverse Event|0|||
127649307|NCT01364922|459337734|FG001|Double-Blind (DB) Period|Adverse Event|0|||
127649308|NCT01364922|459337735|FG002|Double-Blind (DB) Period|Adverse Event|1|||
127649309|NCT01364922|459337733|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
127649310|NCT01364922|459337734|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
127649311|NCT01364922|459337735|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
127649312|NCT04244396|459337736|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|1|||
127649313|NCT04244396|459337736|FG000|Overall Study|Withdrawal by Subject|2|||
127649314|NCT04244396|459337736|FG000|Overall Study|Study termination|37|||
127983717|NCT04102865|460562567|FG001|Overall Study|Lost to Follow-up|0|||
127541664|NCT03836625|458948883|FG001|Overall Study|Refused follow-up|1|||
127541665|NCT04764162|458948884|FG000|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|0|||
127541666|NCT04764162|458948885|FG001|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|1|||
127541667|NCT03413891|458948886|FG000|Overall Study|Lost to Follow-up|2|||
127541668|NCT03413891|458948887|FG001|Overall Study|Lost to Follow-up|1|||
127541669|NCT03413891|458948886|FG000|Overall Study|Protocol Violation|0|||
127541670|NCT03413891|458948887|FG001|Overall Study|Protocol Violation|1|||
127541671|NCT04905134|458948890|FG000|Exam With Standard Nasopharyngoscope|Study device not available|2|||
127541672|NCT04905134|458948890|FG000|Exam With Standard Nasopharyngoscope|Withdrawal by Subject|1|||
127541673|NCT05556265|458948891|FG000|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
127541674|NCT05556265|458948892|FG001|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|1|||
127541675|NCT05556265|458948893|FG002|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
127541676|NCT05556265|458948894|FG003|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
127541677|NCT05556265|458948895|FG004|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
127541678|NCT05556265|458948891|FG000|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
127541679|NCT05556265|458948892|FG001|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|2|||
127541680|NCT05556265|458948893|FG002|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
127541681|NCT05556265|458948894|FG003|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
127541682|NCT05556265|458948895|FG004|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
127649315|NCT01787097|459337737|FG000|Overall Study|Withdrawal by Subject|1|||
127649316|NCT01787097|459337738|FG001|Overall Study|Withdrawal by Subject|0|||
127649317|NCT01787097|459337739|FG002|Overall Study|Withdrawal by Subject|0|||
127649318|NCT01787097|459337740|FG003|Overall Study|Withdrawal by Subject|0|||
127541683|NCT05556265|458948891|FG000|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
127541684|NCT05556265|458948892|FG001|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|2|||
127541685|NCT05556265|458948893|FG002|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
127541686|NCT05556265|458948894|FG003|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
127541687|NCT05556265|458948895|FG004|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
127541688|NCT05556265|458948891|FG000|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
127541689|NCT05556265|458948892|FG001|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
127541690|NCT05556265|458948893|FG002|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|0|||
127541691|NCT05556265|458948894|FG003|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|3|||
127541692|NCT05556265|458948895|FG004|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|1|||
127541693|NCT05556265|458948891|FG000|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
127541694|NCT05556265|458948892|FG001|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|3|||
127541695|NCT05556265|458948893|FG002|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
127541696|NCT05556265|458948894|FG003|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
127541697|NCT05556265|458948895|FG004|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
127541698|NCT05556265|458948891|FG000|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|19|||
127541699|NCT05556265|458948892|FG001|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|12|||
127541700|NCT05556265|458948893|FG002|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|0|||
127541701|NCT05556265|458948894|FG003|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|6|||
127541702|NCT05556265|458948895|FG004|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|9|||
127541703|NCT05556265|458948891|FG000|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
127541704|NCT05556265|458948892|FG001|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|2|||
127541705|NCT05556265|458948893|FG002|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
127541706|NCT05556265|458948894|FG003|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
127541707|NCT05556265|458948895|FG004|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|1|||
127541708|NCT05556265|458948891|FG000|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
127541709|NCT05556265|458948892|FG001|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
127541710|NCT05556265|458948893|FG002|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
127541711|NCT05556265|458948894|FG003|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
127541712|NCT05556265|458948895|FG004|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
127541713|NCT05556265|458948891|FG000|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
127541714|NCT05556265|458948892|FG001|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
127541715|NCT05556265|458948893|FG002|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
127541716|NCT05556265|458948894|FG003|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
127541717|NCT05556265|458948895|FG004|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
127541718|NCT03221556|458948898|FG000|Allocation|post-randomization exclusion|0|||
127541719|NCT03221556|458948899|FG001|Allocation|post-randomization exclusion|1|||
127541720|NCT03221556|458948898|FG000|Follow-Up|Withdrawal by Subject|0|||
127541721|NCT03221556|458948899|FG001|Follow-Up|Withdrawal by Subject|1|||
127541722|NCT02336282|458948900|FG000|Overall Study|Unrelated illness|1|||
127541723|NCT02336282|458948900|FG000|Overall Study|Uncomfortable with technology|1|||
127541724|NCT02336282|458948900|FG000|Overall Study|Lost to Follow-up|1|||
127541725|NCT02336282|458948900|FG000|Overall Study|Not enough time to complete sessions|2|||
127541726|NCT03724942|458948902|FG000|Overall Study|Adverse Event|20|||
127541727|NCT03724942|458948903|FG001|Overall Study|Adverse Event|14|||
127541728|NCT03724942|458948902|FG000|Overall Study|Lack of Efficacy|0|||
127541729|NCT03724942|458948903|FG001|Overall Study|Lack of Efficacy|1|||
127541730|NCT03724942|458948902|FG000|Overall Study|Physician Decision|5|||
127541731|NCT03724942|458948903|FG001|Overall Study|Physician Decision|2|||
127541732|NCT03724942|458948902|FG000|Overall Study|Protocol Violation|1|||
127541733|NCT03724942|458948903|FG001|Overall Study|Protocol Violation|0|||
127541734|NCT03724942|458948902|FG000|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|0|||
127541735|NCT03724942|458948903|FG001|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|1|||
127541736|NCT03724942|458948902|FG000|Overall Study|Withdrawal by Legal Representative|3|||
127541737|NCT03724942|458948903|FG001|Overall Study|Withdrawal by Legal Representative|0|||
127541738|NCT01766050|458951002|FG000|Overall Study|Adverse Event|1|||
127541739|NCT01766050|458951002|FG000|Overall Study|Lost to Follow-up|1|||
127541740|NCT01766050|458951002|FG000|Overall Study|Withdrawal by Subject|2|||
127541741|NCT00089297|458951004|FG000|Overall Study|Adverse Event|9|||
127541742|NCT00089297|458951004|FG000|Overall Study|Death|1|||
127541743|NCT00089297|458951004|FG000|Overall Study|Withdrawal by Subject|12|||
127541744|NCT00089297|458951004|FG000|Overall Study|Disease progression|2|||
127541745|NCT00089297|458951004|FG000|Overall Study|Ineligible|11|||
127541746|NCT00089297|458951004|FG000|Overall Study|Secondary malignancy|1|||
127541747|NCT00089297|458951004|FG000|Overall Study|IRB approval not ready|1|||
127541748|NCT00089297|458951004|FG000|Overall Study|Non-compliance|1|||
127541749|NCT01910298|458951007|FG000|Overall Study|Adverse Event|1|||
127541750|NCT01910298|458951008|FG001|Overall Study|Adverse Event|0|||
127541751|NCT01910298|458951007|FG000|Overall Study|Withdrawal by Subject|2|||
127541752|NCT01910298|458951008|FG001|Overall Study|Withdrawal by Subject|7|||
127541753|NCT01910298|458951007|FG000|Overall Study|Protocol Deviation|0|||
127541754|NCT01910298|458951008|FG001|Overall Study|Protocol Deviation|5|||
127541755|NCT01910298|458951007|FG000|Overall Study|Lost to Follow-up|1|||
127541756|NCT01910298|458951008|FG001|Overall Study|Lost to Follow-up|1|||
127541757|NCT01910298|458951007|FG000|Overall Study|Study Terminated by Sponsor|1|||
127541758|NCT01910298|458951008|FG001|Overall Study|Study Terminated by Sponsor|17|||
127541759|NCT01910298|458951007|FG000|Overall Study|Other Miscellaneous Reasons|0|||
127649319|NCT00553501|459337747|FG000|Overall Study|Adverse Event|2|||
127649320|NCT00553501|459337747|FG000|Overall Study|Death|1|||
127649321|NCT00553501|459337747|FG000|Overall Study|Progression|1|||
127649322|NCT02293395|459337748|FG000|Overall Study|Lost to Follow-up|1|||
127649323|NCT02293395|459337749|FG001|Overall Study|Lost to Follow-up|0|||
127649324|NCT02293395|459337748|FG000|Overall Study|Withdrawal by Subject|8|||
127649325|NCT02293395|459337749|FG001|Overall Study|Withdrawal by Subject|7|||
127649326|NCT01464021|459337750|FG000|Overall Study|Withdrawal by Subject|13|||
127649327|NCT01464021|459337750|FG000|Overall Study|Lost to Follow-up|1|||
127649328|NCT01464021|459337750|FG000|Overall Study|Lack of Efficacy|1|||
127649329|NCT01464021|459337750|FG000|Overall Study|various|11|||
127649330|NCT03391765|459337751|FG000|Overall Study|Adverse Event|2|||
127649331|NCT03391765|459337752|FG001|Overall Study|Adverse Event|0|||
127649332|NCT03391765|459337753|FG002|Overall Study|Adverse Event|0|||
127541760|NCT01910298|458951008|FG001|Overall Study|Other Miscellaneous Reasons|2|||
127541761|NCT03037385|458951011|FG000|Overall Study|Adverse Event|0|||
127541762|NCT03037385|458951012|FG001|Overall Study|Adverse Event|0|||
127541763|NCT03037385|458951013|FG002|Overall Study|Adverse Event|1|||
127541764|NCT03037385|458951014|FG003|Overall Study|Adverse Event|0|||
127541765|NCT03037385|458951015|FG004|Overall Study|Adverse Event|0|||
127541766|NCT03037385|458951016|FG005|Overall Study|Adverse Event|0|||
127541767|NCT03037385|458951017|FG006|Overall Study|Adverse Event|0|||
127541768|NCT03037385|458951018|FG007|Overall Study|Adverse Event|0|||
127541769|NCT03037385|458951019|FG008|Overall Study|Adverse Event|0|||
127541770|NCT03037385|458951020|FG009|Overall Study|Adverse Event|6|||
127541771|NCT03037385|458951011|FG000|Overall Study|Death|1|||
127649333|NCT03391765|459337754|FG003|Overall Study|Adverse Event|2|||
127649334|NCT03391765|459337751|FG000|Overall Study|Withdrew consent|5|||
127649335|NCT03391765|459337752|FG001|Overall Study|Withdrew consent|7|||
127649336|NCT03391765|459337753|FG002|Overall Study|Withdrew consent|2|||
127649337|NCT03391765|459337754|FG003|Overall Study|Withdrew consent|5|||
127649338|NCT03391765|459337751|FG000|Overall Study|Other, not specified|44|||
127649339|NCT03391765|459337752|FG001|Overall Study|Other, not specified|38|||
127872608|NCT02219477|460152112|FG001|Overall Study|Adverse Event|1|||
127872609|NCT02219477|460152113|FG002|Overall Study|Adverse Event|1|||
127541772|NCT03037385|458951012|FG001|Overall Study|Death|4|||
127541773|NCT03037385|458951013|FG002|Overall Study|Death|2|||
127541774|NCT03037385|458951014|FG003|Overall Study|Death|2|||
127541775|NCT03037385|458951015|FG004|Overall Study|Death|5|||
127541776|NCT03037385|458951016|FG005|Overall Study|Death|2|||
127541777|NCT03037385|458951017|FG006|Overall Study|Death|1|||
127541778|NCT03037385|458951018|FG007|Overall Study|Death|4|||
127541779|NCT03037385|458951019|FG008|Overall Study|Death|3|||
127541780|NCT03037385|458951020|FG009|Overall Study|Death|240|||
127541781|NCT03037385|458951011|FG000|Overall Study|Initiation of Another Therapy|1|||
127541782|NCT03037385|458951012|FG001|Overall Study|Initiation of Another Therapy|0|||
127541783|NCT03037385|458951013|FG002|Overall Study|Initiation of Another Therapy|0|||
127541784|NCT03037385|458951014|FG003|Overall Study|Initiation of Another Therapy|0|||
127541785|NCT03037385|458951015|FG004|Overall Study|Initiation of Another Therapy|0|||
127541786|NCT03037385|458951016|FG005|Overall Study|Initiation of Another Therapy|0|||
127541787|NCT03037385|458951017|FG006|Overall Study|Initiation of Another Therapy|0|||
127541788|NCT03037385|458951018|FG007|Overall Study|Initiation of Another Therapy|1|||
127872610|NCT02219477|460152111|FG000|Overall Study|Withdrawal by Subject|0|||
127872611|NCT02219477|460152112|FG001|Overall Study|Withdrawal by Subject|1|||
127872612|NCT02219477|460152113|FG002|Overall Study|Withdrawal by Subject|0|||
127541789|NCT03037385|458951019|FG008|Overall Study|Initiation of Another Therapy|0|||
127541790|NCT03037385|458951020|FG009|Overall Study|Initiation of Another Therapy|2|||
127541791|NCT03037385|458951011|FG000|Overall Study|Lost to Follow-up|0|||
127541792|NCT03037385|458951012|FG001|Overall Study|Lost to Follow-up|0|||
127541793|NCT03037385|458951013|FG002|Overall Study|Lost to Follow-up|0|||
127541794|NCT03037385|458951014|FG003|Overall Study|Lost to Follow-up|0|||
127541795|NCT03037385|458951015|FG004|Overall Study|Lost to Follow-up|0|||
127541796|NCT03037385|458951016|FG005|Overall Study|Lost to Follow-up|1|||
127649340|NCT03391765|459337753|FG002|Overall Study|Other, not specified|21|||
127649341|NCT03391765|459337754|FG003|Overall Study|Other, not specified|16|||
127649342|NCT00944658|459337755|FG000|Treatment 12 Weeks|Adverse Event|0|||
127541797|NCT03037385|458951017|FG006|Overall Study|Lost to Follow-up|0|||
127541798|NCT03037385|458951018|FG007|Overall Study|Lost to Follow-up|0|||
127541799|NCT03037385|458951019|FG008|Overall Study|Lost to Follow-up|0|||
127541800|NCT03037385|458951020|FG009|Overall Study|Lost to Follow-up|16|||
127541801|NCT03037385|458951011|FG000|Overall Study|Physician Decision|0|||
127541802|NCT03037385|458951012|FG001|Overall Study|Physician Decision|0|||
127541803|NCT03037385|458951013|FG002|Overall Study|Physician Decision|0|||
127541804|NCT03037385|458951014|FG003|Overall Study|Physician Decision|0|||
127541805|NCT03037385|458951015|FG004|Overall Study|Physician Decision|0|||
127541806|NCT03037385|458951016|FG005|Overall Study|Physician Decision|0|||
127541807|NCT03037385|458951017|FG006|Overall Study|Physician Decision|0|||
127541808|NCT03037385|458951018|FG007|Overall Study|Physician Decision|0|||
127541809|NCT03037385|458951019|FG008|Overall Study|Physician Decision|0|||
127541810|NCT03037385|458951020|FG009|Overall Study|Physician Decision|1|||
127541811|NCT03037385|458951011|FG000|Overall Study|Progressive Disease|0|||
127541812|NCT03037385|458951012|FG001|Overall Study|Progressive Disease|1|||
127541813|NCT03037385|458951013|FG002|Overall Study|Progressive Disease|1|||
127541814|NCT03037385|458951014|FG003|Overall Study|Progressive Disease|5|||
127541815|NCT03037385|458951015|FG004|Overall Study|Progressive Disease|2|||
127541816|NCT03037385|458951016|FG005|Overall Study|Progressive Disease|0|||
127541817|NCT03037385|458951017|FG006|Overall Study|Progressive Disease|1|||
127541818|NCT03037385|458951018|FG007|Overall Study|Progressive Disease|0|||
127541819|NCT03037385|458951019|FG008|Overall Study|Progressive Disease|0|||
127541820|NCT03037385|458951020|FG009|Overall Study|Progressive Disease|30|||
127541821|NCT03037385|458951011|FG000|Overall Study|Withdrawal by Subject|0|||
127541822|NCT03037385|458951012|FG001|Overall Study|Withdrawal by Subject|0|||
127541823|NCT03037385|458951013|FG002|Overall Study|Withdrawal by Subject|1|||
127541824|NCT03037385|458951014|FG003|Overall Study|Withdrawal by Subject|2|||
127541825|NCT03037385|458951015|FG004|Overall Study|Withdrawal by Subject|1|||
127541826|NCT03037385|458951016|FG005|Overall Study|Withdrawal by Subject|3|||
127541827|NCT03037385|458951017|FG006|Overall Study|Withdrawal by Subject|0|||
127541828|NCT03037385|458951018|FG007|Overall Study|Withdrawal by Subject|0|||
127541829|NCT03037385|458951019|FG008|Overall Study|Withdrawal by Subject|0|||
127541830|NCT03037385|458951020|FG009|Overall Study|Withdrawal by Subject|52|||
127541831|NCT03037385|458951011|FG000|Overall Study|Reason Not Specified|0|||
127541832|NCT03037385|458951012|FG001|Overall Study|Reason Not Specified|1|||
127541833|NCT03037385|458951013|FG002|Overall Study|Reason Not Specified|0|||
127541834|NCT03037385|458951014|FG003|Overall Study|Reason Not Specified|4|||
127541835|NCT03037385|458951015|FG004|Overall Study|Reason Not Specified|3|||
127541836|NCT03037385|458951016|FG005|Overall Study|Reason Not Specified|6|||
127541837|NCT03037385|458951017|FG006|Overall Study|Reason Not Specified|2|||
127541838|NCT03037385|458951018|FG007|Overall Study|Reason Not Specified|0|||
127541839|NCT03037385|458951019|FG008|Overall Study|Reason Not Specified|1|||
127541840|NCT03037385|458951020|FG009|Overall Study|Reason Not Specified|181|||
127541841|NCT04607668|458951026|FG000|Overall Study|Death|49|||
127541842|NCT04607668|458951027|FG001|Overall Study|Death|26|||
127541843|NCT04607668|458951026|FG000|Overall Study|Lost to Follow-up|3|||
127541844|NCT04607668|458951027|FG001|Overall Study|Lost to Follow-up|4|||
127541845|NCT04607668|458951026|FG000|Overall Study|Study terminated by Sponsor|92|||
127649343|NCT00944658|459337756|FG001|Treatment 12 Weeks|Adverse Event|2|||
127649344|NCT02832622|459337762|FG000|Overall Study|MPP not programmed|1259|||
127649345|NCT02832622|459337762|FG000|Overall Study|Withdrawal by Subject|123|||
127649346|NCT02832622|459337762|FG000|Overall Study|Death|119|||
127649347|NCT02832622|459337762|FG000|Overall Study|Unsuccessful CRT implant|93|||
127649348|NCT02832622|459337762|FG000|Overall Study|Lost to Follow-up|45|||
127649349|NCT02832622|459337762|FG000|Overall Study|Patient non-compliance|42|||
127649350|NCT02832622|459337762|FG000|Overall Study|Withdrawal by other reasons|25|||
127649351|NCT02832622|459337762|FG000|Overall Study|System explant|24|||
127649352|NCT02832622|459337762|FG000|Overall Study|Physician Decision|6|||
127649353|NCT02243280|459337763|FG000|Treated|Adverse Event|1|||
127649354|NCT02243280|459337764|FG001|Treated|Adverse Event|0|||
127649355|NCT02243280|459337765|FG002|Treated|Adverse Event|0|||
127649356|NCT02243280|459337766|FG003|Treated|Adverse Event|0|||
127649357|NCT02243280|459337767|FG004|Treated|Adverse Event|0|||
127649358|NCT02243280|459337768|FG005|Treated|Adverse Event|0|||
127649359|NCT02243280|459337769|FG006|Treated|Adverse Event|0|||
127649360|NCT02243280|459337770|FG007|Treated|Adverse Event|0|||
127872613|NCT00499694|460152120|FG000|Overall Study|Patient never received treatment.|1|||
127872614|NCT02304484|460152121|FG000|Overall Study|Death|9|||
127541846|NCT04607668|458951027|FG001|Overall Study|Study terminated by Sponsor|114|||
127541847|NCT04607668|458951026|FG000|Overall Study|Withdrawal by Subject|12|||
127541848|NCT04607668|458951027|FG001|Overall Study|Withdrawal by Subject|11|||
127541849|NCT04607668|458951026|FG000|Overall Study|Other, unspecified|8|||
127541850|NCT04607668|458951027|FG001|Overall Study|Other, unspecified|7|||
127541851|NCT01838694|458951028|FG000|Overall Study|Adverse Event|0|||
127541852|NCT01838694|458951029|FG001|Overall Study|Adverse Event|1|||
127541853|NCT03623243|458951030|FG000|Overall Study|Adverse Event|15|||
127541854|NCT03623243|458951030|FG000|Overall Study|Guardian Decision|1|||
127541855|NCT03623243|458951030|FG000|Overall Study|New Therapy for Study Indication|1|||
127649361|NCT02243280|459337771|FG008|Treated|Adverse Event|0|||
127649362|NCT02243280|459337772|FG009|Treated|Adverse Event|0|||
127541856|NCT03623243|458951030|FG000|Overall Study|Protocol Deviation|3|||
127649363|NCT02243280|459337773|FG010|Treated|Adverse Event|1|||
127649364|NCT02243280|459337763|FG000|Treated|Lost to Follow-up|0|||
127541857|NCT03623243|458951030|FG000|Overall Study|Physician Decision|4|||
127541858|NCT03623243|458951030|FG000|Overall Study|Patient Decision|15|||
127541859|NCT02177695|458951031|FG000|ITT Analysis|Ineligible|5|||
127541860|NCT02177695|458951032|FG001|ITT Analysis|Ineligible|5|||
127541861|NCT02177695|458951031|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
127541862|NCT02177695|458951032|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
127541863|NCT02177695|458951031|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
127541864|NCT02177695|458951032|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
127541865|NCT02177695|458951031|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
127541866|NCT02177695|458951032|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
127541867|NCT00979901|458951033|FG000|Overall Study|Adverse Event|1|||
127541868|NCT00979901|458951034|FG001|Overall Study|Adverse Event|3|||
127541869|NCT00979901|458951035|FG002|Overall Study|Adverse Event|9|||
127541870|NCT00979901|458951036|FG003|Overall Study|Adverse Event|2|||
127541871|NCT00979901|458951033|FG000|Overall Study|Lack of Efficacy|8|||
127541872|NCT00979901|458951034|FG001|Overall Study|Lack of Efficacy|4|||
127541873|NCT00979901|458951035|FG002|Overall Study|Lack of Efficacy|9|||
127541874|NCT00979901|458951036|FG003|Overall Study|Lack of Efficacy|0|||
127541875|NCT00979901|458951033|FG000|Overall Study|Lost to Follow-up|1|||
127541876|NCT00979901|458951034|FG001|Overall Study|Lost to Follow-up|1|||
127541877|NCT00979901|458951035|FG002|Overall Study|Lost to Follow-up|2|||
127541878|NCT00979901|458951036|FG003|Overall Study|Lost to Follow-up|0|||
127541879|NCT00979901|458951033|FG000|Overall Study|Protocol Violation|2|||
127541880|NCT00979901|458951034|FG001|Overall Study|Protocol Violation|2|||
127541881|NCT00979901|458951035|FG002|Overall Study|Protocol Violation|7|||
127541882|NCT00979901|458951036|FG003|Overall Study|Protocol Violation|1|||
127649365|NCT02243280|459337764|FG001|Treated|Lost to Follow-up|0|||
127649366|NCT02243280|459337765|FG002|Treated|Lost to Follow-up|0|||
127649367|NCT02243280|459337766|FG003|Treated|Lost to Follow-up|0|||
127649368|NCT02243280|459337767|FG004|Treated|Lost to Follow-up|0|||
127649369|NCT02243280|459337768|FG005|Treated|Lost to Follow-up|0|||
127649370|NCT02243280|459337769|FG006|Treated|Lost to Follow-up|0|||
127649371|NCT02243280|459337770|FG007|Treated|Lost to Follow-up|0|||
127649372|NCT02243280|459337771|FG008|Treated|Lost to Follow-up|1|||
127649373|NCT02243280|459337772|FG009|Treated|Lost to Follow-up|0|||
127649374|NCT02243280|459337773|FG010|Treated|Lost to Follow-up|2|||
127649375|NCT02472652|459337774|FG000|Overall Study|Lost to Follow-up|1|||
127649376|NCT00998400|459337779|FG000|Overall Study|Lack of interest/motivation|1|||
127649377|NCT00998400|459337780|FG001|Overall Study|Lack of interest/motivation|2|||
127649378|NCT00998400|459337779|FG000|Overall Study|Logistical problems|1|||
127649379|NCT00998400|459337780|FG001|Overall Study|Logistical problems|0|||
127649380|NCT03185832|459337781|FG000|Overall Study|Death|9|||
127649381|NCT03185832|459337782|FG001|Overall Study|Death|14|||
127649382|NCT03185832|459337783|FG002|Overall Study|Death|9|||
127649383|NCT03185832|459337784|FG003|Overall Study|Death|7|||
127649384|NCT03185832|459337781|FG000|Overall Study|Withdrawn - vital status available|0|||
127649385|NCT03185832|459337782|FG001|Overall Study|Withdrawn - vital status available|1|||
127649386|NCT03185832|459337783|FG002|Overall Study|Withdrawn - vital status available|1|||
127649387|NCT03185832|459337784|FG003|Overall Study|Withdrawn - vital status available|4|||
127649388|NCT01807156|459337785|FG000|Overall Study|Physician Decision|1|||
127649389|NCT03122119|459337788|FG000|Overall Study|Did not meet eligibility critria|1|||
127649390|NCT01493687|459337790|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
127649391|NCT01493687|459337791|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
127649392|NCT01493687|459337790|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
127649393|NCT01493687|459337791|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
127649394|NCT01493687|459337790|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
127649395|NCT01493687|459337791|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
127649396|NCT01493687|459337790|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
127649397|NCT01493687|459337791|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
127649398|NCT01493687|459337790|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
127649399|NCT01493687|459337791|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
127649400|NCT01493687|459337790|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
127649401|NCT01493687|459337791|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
127649402|NCT01493687|459337790|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
127649403|NCT01493687|459337791|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
127649404|NCT01493687|459337790|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
127649405|NCT01493687|459337791|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
127649406|NCT01493687|459337790|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
127649407|NCT01493687|459337791|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
127541883|NCT00979901|458951033|FG000|Overall Study|Withdrawal by Subject|2|||
127541884|NCT00979901|458951034|FG001|Overall Study|Withdrawal by Subject|1|||
127541885|NCT00979901|458951035|FG002|Overall Study|Withdrawal by Subject|1|||
127541886|NCT00979901|458951036|FG003|Overall Study|Withdrawal by Subject|1|||
127541887|NCT00979901|458951033|FG000|Overall Study|Noncompliance|1|||
127649408|NCT01493687|459337790|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
127649409|NCT01493687|459337791|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
127649410|NCT01493687|459337790|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
127649411|NCT01493687|459337791|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
127649412|NCT01493687|459337790|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
127649413|NCT01493687|459337791|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
127649414|NCT01493687|459337790|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
127649415|NCT01493687|459337791|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
127649416|NCT01493687|459337790|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
127649417|NCT01493687|459337791|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
127649418|NCT01493687|459337790|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
127649419|NCT01493687|459337791|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
127649420|NCT02364180|459337795|FG000|Overall Study|Screen Fail|1|||
127649421|NCT02323646|459337796|FG000|Treatment Course 1|Adverse Event|1|||
127649422|NCT02323646|459337797|FG001|Treatment Course 1|Adverse Event|0|||
127649423|NCT02323646|459337798|FG002|Treatment Course 1|Adverse Event|1|||
127541888|NCT00979901|458951034|FG001|Overall Study|Noncompliance|0|||
127541889|NCT00979901|458951035|FG002|Overall Study|Noncompliance|0|||
127541890|NCT00979901|458951036|FG003|Overall Study|Noncompliance|0|||
127541891|NCT00979901|458951033|FG000|Overall Study|out-of-state|1|||
127541892|NCT00979901|458951034|FG001|Overall Study|out-of-state|0|||
127541893|NCT00979901|458951035|FG002|Overall Study|out-of-state|0|||
127541894|NCT00979901|458951036|FG003|Overall Study|out-of-state|0|||
127541895|NCT00979901|458951033|FG000|Overall Study|vacation|1|||
127541896|NCT00979901|458951034|FG001|Overall Study|vacation|0|||
127541897|NCT00979901|458951035|FG002|Overall Study|vacation|0|||
127649424|NCT02323646|459337796|FG000|Treatment Course 1|Heavy Bleeding|1|||
127649425|NCT02323646|459337797|FG001|Treatment Course 1|Heavy Bleeding|1|||
127649426|NCT02323646|459337798|FG002|Treatment Course 1|Heavy Bleeding|0|||
127649427|NCT02323646|459337796|FG000|Treatment Course 1|Lost to Follow-up|1|||
127649428|NCT02323646|459337797|FG001|Treatment Course 1|Lost to Follow-up|0|||
127649429|NCT02323646|459337798|FG002|Treatment Course 1|Lost to Follow-up|2|||
127649430|NCT02323646|459337796|FG000|Treatment Course 1|Withdrawal by Subject|0|||
127649431|NCT02323646|459337797|FG001|Treatment Course 1|Withdrawal by Subject|2|||
127649432|NCT02323646|459337798|FG002|Treatment Course 1|Withdrawal by Subject|0|||
127649433|NCT02323646|459337796|FG000|Treatment Course 2|Adverse Event|1|||
127649434|NCT02323646|459337797|FG001|Treatment Course 2|Adverse Event|0|||
127649435|NCT02323646|459337798|FG002|Treatment Course 2|Adverse Event|1|||
127649436|NCT02323646|459337796|FG000|Treatment Course 2|Lost to Follow-up|0|||
127649437|NCT02323646|459337797|FG001|Treatment Course 2|Lost to Follow-up|0|||
127649438|NCT02323646|459337798|FG002|Treatment Course 2|Lost to Follow-up|1|||
127649439|NCT02323646|459337796|FG000|Treatment Course 2|Non-compliance|0|||
127649440|NCT02323646|459337797|FG001|Treatment Course 2|Non-compliance|1|||
127649441|NCT02323646|459337798|FG002|Treatment Course 2|Non-compliance|1|||
127649442|NCT00521144|459337799|FG000|Overall Study|Not Treated|0|||
127649443|NCT00521144|459337800|FG001|Overall Study|Not Treated|0|||
127649444|NCT00521144|459337801|FG002|Overall Study|Not Treated|0|||
127649445|NCT00521144|459337802|FG003|Overall Study|Not Treated|1|||
127649446|NCT00521144|459337803|FG004|Overall Study|Not Treated|0|||
127649447|NCT00521144|459337799|FG000|Overall Study|Adverse Event|0|||
127649448|NCT00521144|459337800|FG001|Overall Study|Adverse Event|1|||
127649449|NCT00521144|459337801|FG002|Overall Study|Adverse Event|0|||
127649450|NCT00521144|459337802|FG003|Overall Study|Adverse Event|0|||
127649451|NCT00521144|459337803|FG004|Overall Study|Adverse Event|1|||
127649452|NCT00521144|459337799|FG000|Overall Study|Progressive Disease|4|||
127649453|NCT00521144|459337800|FG001|Overall Study|Progressive Disease|2|||
127649454|NCT00521144|459337801|FG002|Overall Study|Progressive Disease|2|||
127649455|NCT00521144|459337802|FG003|Overall Study|Progressive Disease|0|||
127649456|NCT00521144|459337803|FG004|Overall Study|Progressive Disease|6|||
127649457|NCT01370525|459337804|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
127649458|NCT01370525|459337805|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
127649459|NCT01370525|459337804|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
127649460|NCT01370525|459337805|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
127649461|NCT01370525|459337804|FG000|Overall Study|Adverse Event|0|||
127649462|NCT01370525|459337805|FG001|Overall Study|Adverse Event|1|||
127649463|NCT01370525|459337804|FG000|Overall Study|Protocol Violation|2|||
127649464|NCT01370525|459337805|FG001|Overall Study|Protocol Violation|1|||
127649465|NCT01370525|459337804|FG000|Overall Study|Lost to follow up|2|||
127649466|NCT01370525|459337805|FG001|Overall Study|Lost to follow up|6|||
127649467|NCT00335452|459337808|FG000|Overall Study|Death|156|||
127541898|NCT00979901|458951036|FG003|Overall Study|vacation|0|||
127541899|NCT00979901|458951033|FG000|Overall Study|elevated lab values pre-randomization|1|||
127541900|NCT00979901|458951034|FG001|Overall Study|elevated lab values pre-randomization|0|||
127649468|NCT00335452|459337809|FG001|Overall Study|Death|144|||
127649469|NCT00335452|459337810|FG002|Overall Study|Death|158|||
127649470|NCT00335452|459337811|FG003|Overall Study|Death|129|||
127649471|NCT00335452|459337808|FG000|Overall Study|Lost to Follow-up|2|||
127983718|NCT04102865|460562566|FG000|Overall Study|Withdrawal by Subject|2|||
127872615|NCT02304484|460152121|FG000|Overall Study|Withdrawal by Subject|14|||
127872616|NCT02304484|460152121|FG000|Overall Study|Lost to Follow-up|2|||
127872617|NCT04338685|460152122|FG000|Overall Study|Death|3|||
127872618|NCT04338685|460152123|FG001|Overall Study|Death|4|||
127872619|NCT04338685|460152124|FG002|Overall Study|Death|2|||
127872620|NCT04338685|460152125|FG003|Overall Study|Death|4|||
127872621|NCT04338685|460152126|FG004|Overall Study|Death|4|||
127872622|NCT04338685|460152127|FG005|Overall Study|Death|8|||
127872623|NCT04338685|460152128|FG006|Overall Study|Death|1|||
127872624|NCT04338685|460152129|FG007|Overall Study|Death|0|||
127872625|NCT04338685|460152130|FG008|Overall Study|Death|0|||
127872626|NCT04338685|460152122|FG000|Overall Study|Study terminated by Sponsor|0|||
127872627|NCT04338685|460152123|FG001|Overall Study|Study terminated by Sponsor|0|||
127872628|NCT04338685|460152124|FG002|Overall Study|Study terminated by Sponsor|1|||
127872629|NCT04338685|460152125|FG003|Overall Study|Study terminated by Sponsor|4|||
127872630|NCT04338685|460152126|FG004|Overall Study|Study terminated by Sponsor|0|||
127872631|NCT04338685|460152127|FG005|Overall Study|Study terminated by Sponsor|5|||
127872632|NCT04338685|460152128|FG006|Overall Study|Study terminated by Sponsor|2|||
127872633|NCT04338685|460152129|FG007|Overall Study|Study terminated by Sponsor|4|||
127872634|NCT04338685|460152130|FG008|Overall Study|Study terminated by Sponsor|1|||
127872635|NCT04338685|460152122|FG000|Overall Study|Withdrawal by Subject|1|||
127872636|NCT04338685|460152123|FG001|Overall Study|Withdrawal by Subject|2|||
127872637|NCT04338685|460152124|FG002|Overall Study|Withdrawal by Subject|0|||
127872638|NCT04338685|460152125|FG003|Overall Study|Withdrawal by Subject|2|||
127872639|NCT04338685|460152126|FG004|Overall Study|Withdrawal by Subject|0|||
127872640|NCT04338685|460152127|FG005|Overall Study|Withdrawal by Subject|5|||
127872641|NCT04338685|460152128|FG006|Overall Study|Withdrawal by Subject|1|||
127872642|NCT04338685|460152129|FG007|Overall Study|Withdrawal by Subject|1|||
127872643|NCT04338685|460152130|FG008|Overall Study|Withdrawal by Subject|0|||
127872644|NCT02967055|460152131|FG000|Overall Study|Excluded|40|||
127872645|NCT02967055|460152131|FG000|Overall Study|Screen fail|3|||
127872646|NCT02967055|460152131|FG000|Overall Study|Lost to Follow-up|2|||
127872647|NCT02967055|460152131|FG000|Overall Study|Stopped due to side effects|3|||
127872648|NCT02967055|460152131|FG000|Overall Study|Stopped due to drug cost|1|||
127872649|NCT00145795|460152132|FG000|Overall Study|Adverse Event|1|||
127872650|NCT00145795|460152133|FG001|Overall Study|Adverse Event|0|||
127872651|NCT00570492|460152134|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
127872652|NCT00570492|460152135|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
127872653|NCT00570492|460152136|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
127872654|NCT00570492|460152134|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
127872655|NCT00570492|460152135|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
127872656|NCT00570492|460152136|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
127872657|NCT00570492|460152134|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
127872658|NCT00570492|460152135|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
127872659|NCT00570492|460152136|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
127872660|NCT00570492|460152134|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
127872661|NCT00570492|460152135|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
127872662|NCT00570492|460152136|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
127872663|NCT00570492|460152134|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
127541901|NCT00979901|458951035|FG002|Overall Study|elevated lab values pre-randomization|0|||
127541902|NCT00979901|458951036|FG003|Overall Study|elevated lab values pre-randomization|0|||
127541903|NCT00979901|458951033|FG000|Overall Study|Discontinued in Error|0|||
127541904|NCT00979901|458951034|FG001|Overall Study|Discontinued in Error|1|||
127541905|NCT00979901|458951035|FG002|Overall Study|Discontinued in Error|0|||
127541906|NCT00979901|458951036|FG003|Overall Study|Discontinued in Error|0|||
127541907|NCT00979901|458951033|FG000|Overall Study|Left Country|0|||
127541908|NCT00979901|458951034|FG001|Overall Study|Left Country|0|||
127541909|NCT00979901|458951035|FG002|Overall Study|Left Country|1|||
127541910|NCT00979901|458951036|FG003|Overall Study|Left Country|0|||
127541911|NCT00979901|458951033|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
127541912|NCT00979901|458951034|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
127541913|NCT00979901|458951035|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
127541914|NCT00979901|458951036|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
127541915|NCT02153086|458951040|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
127541916|NCT02153086|458951040|FG000|Overall Study|Other|2|||
127541917|NCT01317472|458951041|FG000|Overall Study|Withdrawal by Subject|1|||
127541918|NCT01317472|458951042|FG001|Overall Study|Withdrawal by Subject|0|||
127541919|NCT01317472|458951041|FG000|Overall Study|Unrelated hospitalization|1|||
127541920|NCT01317472|458951042|FG001|Overall Study|Unrelated hospitalization|0|||
127541921|NCT05546476|458951043|FG000|Period 1: Part A|Adverse Event|2|||
127872664|NCT00570492|460152135|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
127872665|NCT00570492|460152136|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
127872666|NCT00570492|460152134|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
127872667|NCT00570492|460152135|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
127872668|NCT00570492|460152136|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
127872669|NCT00570492|460152134|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
127872670|NCT00570492|460152135|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
127872671|NCT00570492|460152136|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
127872672|NCT00570492|460152134|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
127872673|NCT00570492|460152135|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
127872674|NCT00570492|460152136|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
127872675|NCT00570492|460152134|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
127872676|NCT00570492|460152135|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
127872677|NCT00570492|460152136|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
127872678|NCT00570492|460152134|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
127872679|NCT00570492|460152135|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
127872680|NCT00570492|460152136|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
127872681|NCT00570492|460152134|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
127872682|NCT00570492|460152135|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
127872683|NCT00570492|460152136|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
127872684|NCT00570492|460152134|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
127872685|NCT00570492|460152135|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
127872686|NCT00570492|460152136|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
127872687|NCT00570492|460152134|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
127872688|NCT00570492|460152135|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
127872689|NCT00570492|460152136|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
127872690|NCT00570492|460152134|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
127872691|NCT00570492|460152135|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
127872692|NCT00570492|460152136|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
127872693|NCT00976989|460152137|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
127872694|NCT00976989|460152138|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
127872695|NCT00976989|460152139|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
127872696|NCT00976989|460152137|FG000|Overall Study|Death|5|||
127872697|NCT00976989|460152138|FG001|Overall Study|Death|7|||
127872698|NCT00976989|460152139|FG002|Overall Study|Death|10|||
127872699|NCT00976989|460152137|FG000|Overall Study|Refused Treatment|4|||
127872700|NCT00976989|460152138|FG001|Overall Study|Refused Treatment|3|||
127872701|NCT00976989|460152139|FG002|Overall Study|Refused Treatment|5|||
127872702|NCT00976989|460152137|FG000|Overall Study|Failure to Return|2|||
127872703|NCT00976989|460152138|FG001|Overall Study|Failure to Return|1|||
127872704|NCT00976989|460152139|FG002|Overall Study|Failure to Return|0|||
127872705|NCT00976989|460152137|FG000|Overall Study|Recurrence of Disease|0|||
127872706|NCT00976989|460152138|FG001|Overall Study|Recurrence of Disease|1|||
127872707|NCT00976989|460152139|FG002|Overall Study|Recurrence of Disease|0|||
127872708|NCT00976989|460152137|FG000|Overall Study|Other|1|||
127872709|NCT00976989|460152138|FG001|Overall Study|Other|0|||
127872710|NCT00976989|460152139|FG002|Overall Study|Other|1|||
127872711|NCT00752206|460152141|FG000|Overall Study|Disease progression|8|||
127872712|NCT00752206|460152142|FG001|Overall Study|Disease progression|11|||
127872713|NCT00752206|460152141|FG000|Overall Study|Pregnancy|1|||
127872714|NCT00752206|460152142|FG001|Overall Study|Pregnancy|0|||
127872715|NCT00678652|460152143|FG000|Overall Study|Protocol Violation|2|||
127872716|NCT00678652|460152144|FG001|Overall Study|Protocol Violation|0|||
127872717|NCT00678652|460152145|FG002|Overall Study|Protocol Violation|0|||
127872718|NCT00678652|460152146|FG003|Overall Study|Protocol Violation|0|||
127872719|NCT00678652|460152143|FG000|Overall Study|Pregnancy|0|||
127872720|NCT00678652|460152144|FG001|Overall Study|Pregnancy|0|||
127872721|NCT00678652|460152145|FG002|Overall Study|Pregnancy|1|||
127872722|NCT00678652|460152146|FG003|Overall Study|Pregnancy|0|||
127872723|NCT00678652|460152143|FG000|Overall Study|Relocation|1|||
127872724|NCT00678652|460152144|FG001|Overall Study|Relocation|0|||
127872725|NCT00678652|460152145|FG002|Overall Study|Relocation|0|||
127872726|NCT00678652|460152146|FG003|Overall Study|Relocation|0|||
127872727|NCT03958045|460152147|FG000|Overall Study|Withdrawal by Subject|1|||
127872728|NCT02283411|460152148|FG000|Overall Study|Withdrawal by Subject|3|||
127872729|NCT02283411|460152148|FG000|Overall Study|Screen Failed|28|||
127872730|NCT04409262|460152150|FG000|Overall Study|Adverse Event|0|||
127649472|NCT00335452|459337809|FG001|Overall Study|Lost to Follow-up|3|||
127872731|NCT04409262|460152151|FG001|Overall Study|Adverse Event|2|||
127872732|NCT04409262|460152150|FG000|Overall Study|Death|55|||
127872733|NCT04409262|460152151|FG001|Overall Study|Death|97|||
127872734|NCT04409262|460152150|FG000|Overall Study|Lost to Follow-up|12|||
127872735|NCT04409262|460152151|FG001|Overall Study|Lost to Follow-up|23|||
127872736|NCT04409262|460152150|FG000|Overall Study|Lack of Staff|0|||
127872737|NCT04409262|460152151|FG001|Overall Study|Lack of Staff|1|||
127872738|NCT04409262|460152150|FG000|Overall Study|Protocol Violation|3|||
127872739|NCT04409262|460152151|FG001|Overall Study|Protocol Violation|1|||
127872740|NCT04409262|460152150|FG000|Overall Study|Withdrawal by Subject|5|||
127872741|NCT04409262|460152151|FG001|Overall Study|Withdrawal by Subject|10|||
127872742|NCT02500732|460152152|FG000|Overall Study|Physician Decision|0|||
127872743|NCT02500732|460152153|FG001|Overall Study|Physician Decision|1|||
127872744|NCT03759340|460152154|FG000|Overall Study|Adverse Event|2|||
127872745|NCT03759340|460152154|FG000|Overall Study|Lost to Follow-up|1|||
127872746|NCT03759340|460152154|FG000|Overall Study|Withdrawal by Subject|15|||
127872747|NCT03759340|460152154|FG000|Overall Study|Study Terminated by Sponsor|38|||
127872748|NCT03289676|460152155|FG000|Overall Study|Withdrawal by Subject|2|||
127872749|NCT03289676|460152156|FG001|Overall Study|Withdrawal by Subject|0|||
127872750|NCT03289676|460152155|FG000|Overall Study|Protocol Violation|2|||
127872751|NCT03289676|460152156|FG001|Overall Study|Protocol Violation|0|||
127872752|NCT03289676|460152155|FG000|Overall Study|Lost to Follow-up|0|||
127872753|NCT03289676|460152156|FG001|Overall Study|Lost to Follow-up|1|||
127872754|NCT02711306|460152157|FG000|Overall Study|Withdrawal by Subject|2|||
127872755|NCT02711306|460152158|FG001|Overall Study|Withdrawal by Subject|2|||
127872756|NCT01396434|460152159|FG000|Overall Study|Lost to Follow-up|1|||
127872757|NCT01396434|460152160|FG001|Overall Study|Lost to Follow-up|0|||
127872758|NCT01396434|460152161|FG002|Overall Study|Lost to Follow-up|0|||
127872759|NCT01396434|460152159|FG000|Overall Study|Other|10|||
127872760|NCT01396434|460152160|FG001|Overall Study|Other|0|||
127872761|NCT01396434|460152161|FG002|Overall Study|Other|0|||
127872762|NCT02207413|460152162|FG000|Overall Study|Withdrawal by Subject|1|||
127872763|NCT02207413|460152163|FG001|Overall Study|Withdrawal by Subject|0|||
127872764|NCT02207413|460152164|FG002|Overall Study|Withdrawal by Subject|0|||
127872765|NCT02207413|460152165|FG003|Overall Study|Withdrawal by Subject|0|||
127872766|NCT02207413|460152166|FG004|Overall Study|Withdrawal by Subject|3|||
127872767|NCT02207413|460152167|FG005|Overall Study|Withdrawal by Subject|7|||
127872768|NCT02207413|460152162|FG000|Overall Study|Lost to Follow-up|0|||
127872769|NCT02207413|460152163|FG001|Overall Study|Lost to Follow-up|0|||
127872770|NCT02207413|460152164|FG002|Overall Study|Lost to Follow-up|0|||
127872771|NCT02207413|460152165|FG003|Overall Study|Lost to Follow-up|1|||
127872772|NCT02207413|460152166|FG004|Overall Study|Lost to Follow-up|1|||
127872773|NCT02207413|460152167|FG005|Overall Study|Lost to Follow-up|5|||
127872774|NCT02207413|460152162|FG000|Overall Study|Adverse Event|0|||
127872775|NCT02207413|460152163|FG001|Overall Study|Adverse Event|0|||
127872776|NCT02207413|460152164|FG002|Overall Study|Adverse Event|0|||
127872777|NCT02207413|460152165|FG003|Overall Study|Adverse Event|0|||
127872778|NCT02207413|460152166|FG004|Overall Study|Adverse Event|2|||
127872779|NCT02207413|460152167|FG005|Overall Study|Adverse Event|1|||
127872780|NCT02207413|460152162|FG000|Overall Study|Migrated/moved from study area|0|||
127872781|NCT02207413|460152163|FG001|Overall Study|Migrated/moved from study area|0|||
127872782|NCT02207413|460152164|FG002|Overall Study|Migrated/moved from study area|0|||
127872783|NCT02207413|460152165|FG003|Overall Study|Migrated/moved from study area|0|||
127872784|NCT02207413|460152166|FG004|Overall Study|Migrated/moved from study area|1|||
127872785|NCT02207413|460152167|FG005|Overall Study|Migrated/moved from study area|0|||
127872786|NCT01241591|460153602|FG000|Overall Study|Lack of Efficacy|5|||
127872787|NCT01241591|460153603|FG001|Overall Study|Lack of Efficacy|2|||
127872788|NCT01241591|460153604|FG002|Overall Study|Lack of Efficacy|2|||
127872789|NCT01241591|460153605|FG003|Overall Study|Lack of Efficacy|3|||
127872790|NCT01241591|460153602|FG000|Overall Study|Protocol Violation|5|||
127872791|NCT01241591|460153603|FG001|Overall Study|Protocol Violation|2|||
127649473|NCT00335452|459337810|FG002|Overall Study|Lost to Follow-up|1|||
127649474|NCT00335452|459337811|FG003|Overall Study|Lost to Follow-up|2|||
127649475|NCT01750879|459337827|FG000|Overall Study|Adverse Event|8|||
127649476|NCT01750879|459337828|FG001|Overall Study|Adverse Event|0|||
127649477|NCT01750879|459337827|FG000|Overall Study|Lack of Efficacy|1|||
127649478|NCT01750879|459337828|FG001|Overall Study|Lack of Efficacy|0|||
127649479|NCT01750879|459337827|FG000|Overall Study|Withdrawal by Subject|1|||
127649480|NCT01750879|459337828|FG001|Overall Study|Withdrawal by Subject|0|||
127649481|NCT01750879|459337827|FG000|Overall Study|Did not complete per protocol|0|||
127649482|NCT01750879|459337828|FG001|Overall Study|Did not complete per protocol|3|||
127649483|NCT02421666|459337829|FG000|6-month Follow-up|Lost to Follow-up|8|||
127649484|NCT02421666|459337830|FG001|6-month Follow-up|Lost to Follow-up|7|||
127649485|NCT02421666|459337829|FG000|6-month Follow-up|Withdrawal by Subject|5|||
127872792|NCT01241591|460153604|FG002|Overall Study|Protocol Violation|3|||
127872793|NCT01241591|460153605|FG003|Overall Study|Protocol Violation|0|||
127872794|NCT01241591|460153602|FG000|Overall Study|Lost to Follow-up|1|||
127872795|NCT01241591|460153603|FG001|Overall Study|Lost to Follow-up|2|||
127872796|NCT01241591|460153604|FG002|Overall Study|Lost to Follow-up|2|||
127872797|NCT01241591|460153605|FG003|Overall Study|Lost to Follow-up|2|||
127872798|NCT01241591|460153602|FG000|Overall Study|Screen Failure|3|||
127872799|NCT01241591|460153603|FG001|Overall Study|Screen Failure|2|||
127872800|NCT01241591|460153604|FG002|Overall Study|Screen Failure|1|||
127872801|NCT01241591|460153605|FG003|Overall Study|Screen Failure|0|||
127649486|NCT02421666|459337830|FG001|6-month Follow-up|Withdrawal by Subject|6|||
127649487|NCT02421666|459337829|FG000|12-month Follow-up|Lost to Follow-up|5|||
127872802|NCT01241591|460153602|FG000|Overall Study|Withdrawal by Subject|6|||
127649488|NCT02421666|459337830|FG001|12-month Follow-up|Lost to Follow-up|5|||
127649489|NCT02421666|459337829|FG000|12-month Follow-up|Withdrawal by Subject|6|||
127649490|NCT02421666|459337830|FG001|12-month Follow-up|Withdrawal by Subject|11|||
127872803|NCT01241591|460153603|FG001|Overall Study|Withdrawal by Subject|4|||
127872804|NCT01241591|460153604|FG002|Overall Study|Withdrawal by Subject|2|||
127872805|NCT01241591|460153605|FG003|Overall Study|Withdrawal by Subject|2|||
127872806|NCT01241591|460153602|FG000|Overall Study|Other|0|||
127872807|NCT01241591|460153603|FG001|Overall Study|Other|1|||
127872808|NCT01241591|460153604|FG002|Overall Study|Other|0|||
127872809|NCT01241591|460153605|FG003|Overall Study|Other|1|||
127872810|NCT01241591|460153602|FG000|Overall Study|Adverse Event|3|||
127872811|NCT01241591|460153603|FG001|Overall Study|Adverse Event|11|||
127872812|NCT01241591|460153604|FG002|Overall Study|Adverse Event|12|||
127872813|NCT01241591|460153605|FG003|Overall Study|Adverse Event|4|||
127872814|NCT01945034|460153606|FG000|Overall Study|Medication Error|0|||
127872815|NCT01945034|460153607|FG001|Overall Study|Medication Error|1|||
127872816|NCT01945034|460153608|FG002|Overall Study|Medication Error|0|||
127872817|NCT01945034|460153606|FG000|Overall Study|Withdrawal by Subject|0|||
127872818|NCT01945034|460153607|FG001|Overall Study|Withdrawal by Subject|3|||
127872819|NCT01945034|460153608|FG002|Overall Study|Withdrawal by Subject|1|||
127872820|NCT01945034|460153606|FG000|Overall Study|Other|0|||
127872821|NCT01945034|460153607|FG001|Overall Study|Other|1|||
127872822|NCT01945034|460153608|FG002|Overall Study|Other|3|||
127872823|NCT01945034|460153606|FG000|Overall Study|Lost to Follow-up|0|||
127872824|NCT01945034|460153607|FG001|Overall Study|Lost to Follow-up|0|||
127872825|NCT01945034|460153608|FG002|Overall Study|Lost to Follow-up|2|||
127872826|NCT01945034|460153606|FG000|Overall Study|Protocol Violation|1|||
127872827|NCT01945034|460153607|FG001|Overall Study|Protocol Violation|0|||
127872828|NCT01945034|460153608|FG002|Overall Study|Protocol Violation|1|||
127872829|NCT01798056|460153609|FG000|Overall Study|Serious Adverse Event|13|||
127872830|NCT01798056|460153610|FG001|Overall Study|Serious Adverse Event|12|||
127872831|NCT01798056|460153609|FG000|Overall Study|Withdrawal by Subject|12|||
127872832|NCT01798056|460153610|FG001|Overall Study|Withdrawal by Subject|9|||
127872833|NCT01798056|460153609|FG000|Overall Study|Migrated/moved from study area|1|||
127872834|NCT01798056|460153610|FG001|Overall Study|Migrated/moved from study area|1|||
127872835|NCT01798056|460153609|FG000|Overall Study|Lost to Follow-up|1|||
127872836|NCT01798056|460153610|FG001|Overall Study|Lost to Follow-up|1|||
127872837|NCT01798056|460153609|FG000|Overall Study|Other|0|||
127872838|NCT01798056|460153610|FG001|Overall Study|Other|2|||
127872839|NCT02147132|460153611|FG000|Overall Study|Lost to Follow-up|1|||
127872840|NCT02147132|460153612|FG001|Overall Study|Lost to Follow-up|0|||
127872841|NCT02147132|460153613|FG002|Overall Study|Lost to Follow-up|0|||
127872842|NCT02147132|460153614|FG003|Overall Study|Lost to Follow-up|0|||
127872843|NCT02842736|460153617|FG000|Overall Study|Lost to Follow-up|13|||
127872844|NCT02842736|460153617|FG000|Overall Study|Intervention for menstrual bleeding|17|||
127649491|NCT02093663|459337835|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
127649492|NCT02093663|459337836|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
127649493|NCT02093663|459337837|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
127649494|NCT02093663|459337838|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
127649495|NCT02093663|459337839|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
127649496|NCT02093663|459337835|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
127649497|NCT02093663|459337836|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
127649498|NCT02093663|459337837|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
127649499|NCT02093663|459337838|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
127649500|NCT02093663|459337839|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
127649501|NCT02093663|459337835|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
127649502|NCT02093663|459337836|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
127649503|NCT02093663|459337837|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
127649504|NCT02093663|459337838|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
127649505|NCT02093663|459337839|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
127649506|NCT02093663|459337835|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
127649507|NCT02093663|459337836|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
127649508|NCT02093663|459337837|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
127872845|NCT02842736|460153617|FG000|Overall Study|Withdrawal by Subject|4|||
127872846|NCT02842736|460153617|FG000|Overall Study|Pregnancy|3|||
127872847|NCT02842736|460153617|FG000|Overall Study|Hysterectomy for fibroids|2|||
127872848|NCT02842736|460153617|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
127872849|NCT02842736|460153617|FG000|Overall Study|IUD: Mirena|1|||
127872850|NCT02815540|460153621|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
127872851|NCT00536991|460153622|FG000|Overall Study|Withdrawal by Subject|10|||
127872852|NCT00536991|460153622|FG000|Overall Study|Physician Decision|1|||
127872853|NCT00536991|460153622|FG000|Overall Study|patient ineligible|2|||
127872854|NCT04621227|460153623|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
127872855|NCT04621227|460153623|FG000|Period 3 (29 Days)|Adverse Event|1|||
127872856|NCT04621227|460153623|FG000|Period 8 (2 Days)|Adverse Event|1|||
127872857|NCT02204449|460153626|FG000|Overall Study|Lost to Follow-up|7|||
127872858|NCT02204449|460153627|FG001|Overall Study|Lost to Follow-up|9|||
127872859|NCT02204449|460153626|FG000|Overall Study|Death|0|||
127872860|NCT02204449|460153627|FG001|Overall Study|Death|1|||
127872861|NCT02204449|460153626|FG000|Overall Study|Withdrawal by Subject|0|||
127872862|NCT02204449|460153627|FG001|Overall Study|Withdrawal by Subject|1|||
127872863|NCT01342445|460153628|FG000|Overall Study|Experienced side effects|0|||
127983719|NCT04102865|460562567|FG001|Overall Study|Withdrawal by Subject|0|||
127649509|NCT02093663|459337838|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
127649510|NCT02093663|459337839|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
127649511|NCT02093663|459337835|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
127649512|NCT02093663|459337836|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
127649513|NCT02093663|459337837|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
127649514|NCT02093663|459337838|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
127649515|NCT02093663|459337839|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
127649516|NCT02093663|459337835|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
127649517|NCT02093663|459337836|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
127649518|NCT02093663|459337837|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
127649519|NCT02093663|459337838|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
127649520|NCT02093663|459337839|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
127649521|NCT02093663|459337835|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
127649522|NCT02093663|459337836|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
127649523|NCT02093663|459337837|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
127649524|NCT02093663|459337838|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
127649525|NCT02093663|459337839|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
127649526|NCT02093663|459337835|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
127649527|NCT02093663|459337836|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
127649528|NCT02093663|459337837|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
127649529|NCT02093663|459337838|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
127649530|NCT02093663|459337839|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
127649531|NCT02093663|459337835|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
127649532|NCT02093663|459337836|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
127649533|NCT02093663|459337837|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
127649534|NCT02093663|459337838|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
127649535|NCT02093663|459337839|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
127649536|NCT00508404|459337840|FG000|Overall Study|Ongoing at Data Cut-off|12|||
127649537|NCT00508404|459337840|FG000|Overall Study|Adverse Event|2|||
127649538|NCT00508404|459337840|FG000|Overall Study|Death|16|||
127649539|NCT00508404|459337840|FG000|Overall Study|Physician Decision|2|||
127649540|NCT00508404|459337840|FG000|Overall Study|Withdrawal by Subject|3|||
127649541|NCT00508404|459337840|FG000|Overall Study|Protocol-specified Criteria|2|||
127649542|NCT00508404|459337840|FG000|Overall Study|Lost to Follow-up|2|||
127649543|NCT00508404|459337840|FG000|Overall Study|Other - Not Specified|3|||
127649544|NCT01059643|459337846|FG000|Overall Study|Adverse Event|3|||
127649545|NCT01059643|459337846|FG000|Overall Study|Withdrawal by Subject|2|||
127649546|NCT01059643|459337846|FG000|Overall Study|Physician Decision|1|||
127649547|NCT00643123|459337856|FG000|Overall Study|Lost to Follow-up|4|||
127649548|NCT00643123|459337857|FG001|Overall Study|Lost to Follow-up|0|||
127649549|NCT00643123|459337856|FG000|Overall Study|Withdrawal by Subject|1|||
127649550|NCT00643123|459337857|FG001|Overall Study|Withdrawal by Subject|1|||
127649551|NCT01591382|459337860|FG000|Overall Study|Discharged Prior to Study Completion|2|||
127649552|NCT01591382|459337861|FG001|Overall Study|Discharged Prior to Study Completion|1|||
127649553|NCT01591382|459337860|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
127649554|NCT01591382|459337861|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
127649555|NCT00855062|459337869|FG000|Step1|Early Study Closure|5|||
127649556|NCT00855062|459337870|FG001|Step1|Early Study Closure|7|||
127649557|NCT00855062|459337869|FG000|Step1|Adverse Event|1|||
127649558|NCT00855062|459337870|FG001|Step1|Adverse Event|1|||
127649559|NCT00855062|459337869|FG000|Step1|Protocol Violation|1|||
127649560|NCT00855062|459337870|FG001|Step1|Protocol Violation|0|||
127649561|NCT00855062|459337869|FG000|Step1|Pregnancy|1|||
127649562|NCT00855062|459337870|FG001|Step1|Pregnancy|0|||
127649563|NCT00855062|459337869|FG000|Step1|Withdrawal by Subject|2|||
127649564|NCT00855062|459337870|FG001|Step1|Withdrawal by Subject|3|||
127649565|NCT00855062|459337869|FG000|Step2|Early Study Closure|6|||
127649566|NCT00855062|459337870|FG001|Step2|Early Study Closure|2|||
127649567|NCT00855062|459337869|FG000|Step2|Adverse Event|0|||
127649568|NCT00855062|459337870|FG001|Step2|Adverse Event|3|||
127649569|NCT00855062|459337869|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
127649570|NCT00855062|459337870|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
127872864|NCT01342445|460153629|FG001|Overall Study|Experienced side effects|2|||
127872865|NCT05299359|460153630|FG000|Main Part: Day 1 up to Day 366|Participants moved to extension part|129|||
127649571|NCT01960725|459337873|FG000|Overall Study|Lost to Follow-up|4|||
127872866|NCT05299359|460153631|FG001|Main Part: Day 1 up to Day 366|Participants moved to extension part|0|||
127872867|NCT05299359|460153630|FG000|Main Part: Day 1 up to Day 366|Other|2|||
127872868|NCT05299359|460153631|FG001|Main Part: Day 1 up to Day 366|Other|0|||
127872869|NCT05299359|460153630|FG000|Main Part: Day 1 up to Day 366|Withdrawal by Subject|1|||
127872870|NCT05299359|460153631|FG001|Main Part: Day 1 up to Day 366|Withdrawal by Subject|0|||
127872871|NCT05299359|460153630|FG000|Main Part: Day 1 up to Day 366|Lost to Follow-up|1|||
127872872|NCT05299359|460153631|FG001|Main Part: Day 1 up to Day 366|Lost to Follow-up|0|||
127872873|NCT05299359|460153630|FG000|Extension Part: Day 1 to Day 366|Lost to Follow-up|0|||
127872874|NCT05299359|460153631|FG001|Extension Part: Day 1 to Day 366|Lost to Follow-up|2|||
127872875|NCT05299359|460153630|FG000|Extension Part: Day 1 to Day 366|Withdrawal by Subject|0|||
127872876|NCT05299359|460153631|FG001|Extension Part: Day 1 to Day 366|Withdrawal by Subject|5|||
127872877|NCT05299359|460153630|FG000|Extension Part: Day 1 to Day 366|Other|0|||
127872878|NCT05299359|460153631|FG001|Extension Part: Day 1 to Day 366|Other|1|||
127872879|NCT02392078|460153632|FG000|Overall Study|Did not have procedure|32|||
127872880|NCT02392078|460153633|FG001|Overall Study|Did not have procedure|43|||
127872881|NCT02392078|460153634|FG002|Overall Study|Did not have procedure|20|||
127872882|NCT02392078|460153635|FG003|Overall Study|Did not have procedure|1|||
127872883|NCT02652793|460153638|FG000|Overall Study|Adverse Event|1|||
127872884|NCT02652793|460153638|FG000|Overall Study|Lost to Follow-up|2|||
127872885|NCT02652793|460153638|FG000|Overall Study|Withdrawal by Subject|1|||
127872886|NCT03868410|460153639|FG000|Overall Study|Physician Decision|0|||
127872887|NCT03868410|460153640|FG001|Overall Study|Physician Decision|1|||
127872888|NCT01059175|460153641|FG000|Overall Study|Death|17|||
127872889|NCT01059175|460153642|FG001|Overall Study|Death|17|||
127872890|NCT01059175|460153641|FG000|Overall Study|Adverse Event|4|||
127872891|NCT01059175|460153642|FG001|Overall Study|Adverse Event|2|||
127872892|NCT01059175|460153641|FG000|Overall Study|Lost to Follow-up|0|||
127872893|NCT01059175|460153642|FG001|Overall Study|Lost to Follow-up|1|||
127872894|NCT04579666|460153643|FG000|RTP (Up to Week 52)|Adverse Event|4|||
127872895|NCT04579666|460153644|FG001|RTP (Up to Week 52)|Adverse Event|3|||
127872896|NCT04579666|460153645|FG002|RTP (Up to Week 52)|Adverse Event|0|||
127872897|NCT04579666|460153646|FG003|RTP (Up to Week 52)|Adverse Event|0|||
127872898|NCT04579666|460153643|FG000|RTP (Up to Week 52)|Death|24|||
127872899|NCT04579666|460153644|FG001|RTP (Up to Week 52)|Death|9|||
127872900|NCT04579666|460153645|FG002|RTP (Up to Week 52)|Death|0|||
127872901|NCT04579666|460153646|FG003|RTP (Up to Week 52)|Death|0|||
127872902|NCT04579666|460153643|FG000|RTP (Up to Week 52)|Lost to Follow-up|1|||
127872903|NCT04579666|460153644|FG001|RTP (Up to Week 52)|Lost to Follow-up|0|||
127872904|NCT04579666|460153645|FG002|RTP (Up to Week 52)|Lost to Follow-up|0|||
127872905|NCT04579666|460153646|FG003|RTP (Up to Week 52)|Lost to Follow-up|0|||
127872906|NCT04579666|460153643|FG000|RTP (Up to Week 52)|Physician Decision|4|||
127649572|NCT01960725|459337874|FG001|Overall Study|Lost to Follow-up|3|||
127649573|NCT01960725|459337873|FG000|Overall Study|Withdrawal by Subject|1|||
127649574|NCT01960725|459337874|FG001|Overall Study|Withdrawal by Subject|0|||
127649575|NCT01960725|459337873|FG000|Overall Study|unable to obtain blood sample|1|||
127649576|NCT01960725|459337874|FG001|Overall Study|unable to obtain blood sample|2|||
127649577|NCT00758459|459337875|FG000|Overall Study|Adverse Event|3|||
127649578|NCT00758459|459337876|FG001|Overall Study|Adverse Event|2|||
127649579|NCT00758459|459337875|FG000|Overall Study|Protocol Violation|0|||
127649580|NCT00758459|459337876|FG001|Overall Study|Protocol Violation|1|||
127649581|NCT00758459|459337875|FG000|Overall Study|Withdrawal by Subject|0|||
127649582|NCT00758459|459337876|FG001|Overall Study|Withdrawal by Subject|1|||
127649583|NCT01281202|459337879|FG000|Overall Study|Adverse Event|2|||
127649584|NCT01281202|459337880|FG001|Overall Study|Adverse Event|0|||
127649585|NCT01281202|459337879|FG000|Overall Study|Withdrawal by Subject|2|||
127649586|NCT01281202|459337880|FG001|Overall Study|Withdrawal by Subject|2|||
127649587|NCT01281202|459337879|FG000|Overall Study|Protocol Violation|11|||
127649588|NCT01281202|459337880|FG001|Overall Study|Protocol Violation|10|||
127649589|NCT01281202|459337879|FG000|Overall Study|Administrative|2|||
127649590|NCT01281202|459337880|FG001|Overall Study|Administrative|8|||
127649591|NCT01281202|459337879|FG000|Overall Study|Lost to Follow-up|11|||
127649592|NCT01281202|459337880|FG001|Overall Study|Lost to Follow-up|13|||
127649593|NCT01281202|459337879|FG000|Overall Study|Incarceration|0|||
127649594|NCT01281202|459337880|FG001|Overall Study|Incarceration|3|||
127649595|NCT04252742|459337885|FG000|Overall Study|Decision by sponsor|0|||
127649596|NCT04252742|459337886|FG001|Overall Study|Decision by sponsor|2|||
127649597|NCT04252742|459337885|FG000|Overall Study|Withdrawal by Subject|15|||
127872907|NCT04579666|460153644|FG001|RTP (Up to Week 52)|Physician Decision|1|||
127872908|NCT04579666|460153645|FG002|RTP (Up to Week 52)|Physician Decision|0|||
127872909|NCT04579666|460153646|FG003|RTP (Up to Week 52)|Physician Decision|0|||
127649598|NCT04252742|459337886|FG001|Overall Study|Withdrawal by Subject|9|||
127872910|NCT04579666|460153643|FG000|RTP (Up to Week 52)|Progressive disease|1|||
127872911|NCT04579666|460153644|FG001|RTP (Up to Week 52)|Progressive disease|0|||
127872912|NCT04579666|460153645|FG002|RTP (Up to Week 52)|Progressive disease|0|||
127872913|NCT04579666|460153646|FG003|RTP (Up to Week 52)|Progressive disease|0|||
127872914|NCT04579666|460153643|FG000|RTP (Up to Week 52)|Site terminated by sponsor|7|||
127872915|NCT04579666|460153644|FG001|RTP (Up to Week 52)|Site terminated by sponsor|5|||
127872916|NCT04579666|460153645|FG002|RTP (Up to Week 52)|Site terminated by sponsor|0|||
127872917|NCT04579666|460153646|FG003|RTP (Up to Week 52)|Site terminated by sponsor|0|||
127872918|NCT04579666|460153643|FG000|RTP (Up to Week 52)|Study terminated by sponsor|2|||
127872919|NCT04579666|460153644|FG001|RTP (Up to Week 52)|Study terminated by sponsor|0|||
127872920|NCT04579666|460153645|FG002|RTP (Up to Week 52)|Study terminated by sponsor|0|||
127872921|NCT04579666|460153646|FG003|RTP (Up to Week 52)|Study terminated by sponsor|0|||
127872922|NCT04579666|460153643|FG000|RTP (Up to Week 52)|Withdrawal by Subject|25|||
127872923|NCT04579666|460153644|FG001|RTP (Up to Week 52)|Withdrawal by Subject|11|||
127872924|NCT04579666|460153645|FG002|RTP (Up to Week 52)|Withdrawal by Subject|0|||
127872925|NCT04579666|460153646|FG003|RTP (Up to Week 52)|Withdrawal by Subject|0|||
127872926|NCT04579666|460153643|FG000|RTP (Up to Week 52)|Other|2|||
127872927|NCT04579666|460153644|FG001|RTP (Up to Week 52)|Other|0|||
127872928|NCT04579666|460153645|FG002|RTP (Up to Week 52)|Other|0|||
127872929|NCT04579666|460153646|FG003|RTP (Up to Week 52)|Other|0|||
127872930|NCT04579666|460153643|FG000|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
127872931|NCT04579666|460153644|FG001|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
127872932|NCT04579666|460153645|FG002|OLP (From Week 52 up to Week 104)|Adverse Event|2|||
127872933|NCT04579666|460153646|FG003|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
127872934|NCT04579666|460153643|FG000|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
127872935|NCT04579666|460153644|FG001|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
127872936|NCT04579666|460153645|FG002|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|19|||
127872937|NCT04579666|460153646|FG003|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|12|||
127872938|NCT04579666|460153643|FG000|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
127872939|NCT04579666|460153644|FG001|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
127872940|NCT04579666|460153645|FG002|OLP (From Week 52 up to Week 104)|Sponsor request|63|||
127872941|NCT04579666|460153646|FG003|OLP (From Week 52 up to Week 104)|Sponsor request|31|||
127872942|NCT04579666|460153643|FG000|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
127872943|NCT04579666|460153644|FG001|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
127872944|NCT04579666|460153645|FG002|OLP (From Week 52 up to Week 104)|Physician Decision|3|||
127872945|NCT04579666|460153646|FG003|OLP (From Week 52 up to Week 104)|Physician Decision|1|||
127872946|NCT04579666|460153643|FG000|OLP (From Week 52 up to Week 104)|Death|0|||
127872947|NCT04579666|460153644|FG001|OLP (From Week 52 up to Week 104)|Death|0|||
127872948|NCT04579666|460153645|FG002|OLP (From Week 52 up to Week 104)|Death|10|||
127872949|NCT04579666|460153646|FG003|OLP (From Week 52 up to Week 104)|Death|6|||
127872950|NCT05450198|460153647|FG000|Overall Study|Withdrawal by Subject|1|||
127872951|NCT05450198|460153648|FG001|Overall Study|Withdrawal by Subject|1|||
127872952|NCT05450198|460153649|FG002|Overall Study|Withdrawal by Subject|2|||
127872953|NCT05450198|460153650|FG003|Overall Study|Withdrawal by Subject|0|||
127872954|NCT05450198|460153647|FG000|Overall Study|Lost to Follow-up|1|||
127872955|NCT05450198|460153648|FG001|Overall Study|Lost to Follow-up|0|||
127872956|NCT05450198|460153649|FG002|Overall Study|Lost to Follow-up|2|||
127872957|NCT05450198|460153650|FG003|Overall Study|Lost to Follow-up|1|||
127872958|NCT00643006|460153654|FG000|Overall Study|Lost to Follow-up|5|||
127872959|NCT00643006|460153655|FG001|Overall Study|Lost to Follow-up|4|||
127872960|NCT01151085|460153657|FG000|Overall Study|Lost to Follow-up|31|||
127872961|NCT01151085|460153657|FG000|Overall Study|Protocol Violation|25|||
127872962|NCT01308476|460153658|FG000|Overall Study|Lost to Follow-up|2|||
127872963|NCT01308476|460153659|FG001|Overall Study|Lost to Follow-up|2|||
127872964|NCT01308476|460153658|FG000|Overall Study|Other|1|||
127872965|NCT01308476|460153659|FG001|Overall Study|Other|0|||
127872966|NCT00812968|460153660|FG000|Overall Study|Relapse after erythroid response|6|||
127872967|NCT00812968|460153660|FG000|Overall Study|Disease progression|1|||
127872968|NCT00812968|460153660|FG000|Overall Study|No further treatment required|1|||
127872969|NCT00812968|460153660|FG000|Overall Study|Study closed due to marketing approval|3|||
127872970|NCT01243762|460153668|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
127872971|NCT01243762|460153669|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
127872972|NCT01243762|460153670|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
127872973|NCT01243762|460153671|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
127872974|NCT01243762|460153672|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
127872975|NCT01243762|460153673|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
127983720|NCT01764997|460562568|FG000|Run-in Period|Adverse Event|15|||
127872976|NCT01243762|460153674|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
127872977|NCT01243762|460153668|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
127872978|NCT01243762|460153669|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
127872979|NCT01243762|460153670|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
127872980|NCT01243762|460153671|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
127872981|NCT01243762|460153672|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
127872982|NCT01243762|460153673|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
127872983|NCT01243762|460153674|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
127872984|NCT01243762|460153668|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
127872985|NCT01243762|460153669|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
127872986|NCT01243762|460153670|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
127872987|NCT01243762|460153671|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
127872988|NCT01243762|460153672|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
127872989|NCT01243762|460153673|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
127872990|NCT01243762|460153674|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
127872991|NCT01243762|460153668|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
127872992|NCT01243762|460153669|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
127872993|NCT01243762|460153670|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
127872994|NCT01243762|460153671|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
127872995|NCT01243762|460153672|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
127872996|NCT01243762|460153673|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
127872997|NCT01243762|460153674|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
127872998|NCT01243762|460153668|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
127872999|NCT01243762|460153669|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
127873000|NCT01243762|460153670|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
127873001|NCT01243762|460153671|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
127873002|NCT01243762|460153672|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
127873003|NCT01243762|460153673|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
127873004|NCT01243762|460153674|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
127873005|NCT01243762|460153668|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
127873006|NCT01243762|460153669|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
127873007|NCT01243762|460153670|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
127873008|NCT01243762|460153671|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
127873009|NCT01243762|460153672|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
127873010|NCT01243762|460153673|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
127873011|NCT01243762|460153674|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
127873012|NCT01243762|460153668|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
127873013|NCT01243762|460153669|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
127873014|NCT01243762|460153670|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
127873015|NCT01243762|460153671|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
127873016|NCT01243762|460153672|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
127873017|NCT01243762|460153673|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
127873018|NCT01243762|460153674|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
127873019|NCT01243762|460153668|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
127873020|NCT01243762|460153669|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
127873021|NCT01243762|460153670|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
127873022|NCT01243762|460153671|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
127873023|NCT01243762|460153672|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
127873024|NCT01243762|460153673|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
127873025|NCT01243762|460153674|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
127873026|NCT02059265|460153675|FG000|Overall Study|Ineligible|4|||
127873027|NCT04196023|460153676|FG000|Overall Study|Withdrawal by Subject|0|||
127873028|NCT04196023|460153677|FG001|Overall Study|Withdrawal by Subject|1|||
127873029|NCT04196023|460153676|FG000|Overall Study|Adverse Event|3|||
127873030|NCT04196023|460153677|FG001|Overall Study|Adverse Event|1|||
127873031|NCT04196023|460153676|FG000|Overall Study|Lost to Follow-up|0|||
127873032|NCT04196023|460153677|FG001|Overall Study|Lost to Follow-up|1|||
127873033|NCT04359758|460153682|FG000|Overall Study|Protocol Violation|3|||
127873034|NCT04359758|460153683|FG001|Overall Study|Protocol Violation|2|||
127873035|NCT03605758|460153684|FG000|Overall Study|Lost to Follow-up|2|||
127873036|NCT03605758|460153685|FG001|Overall Study|Lost to Follow-up|1|||
127873037|NCT03605758|460153684|FG000|Overall Study|Illness|0|||
127873038|NCT03605758|460153685|FG001|Overall Study|Illness|1|||
127873039|NCT03605758|460153684|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
127873040|NCT03605758|460153685|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
127873041|NCT04753606|460153686|FG000|Overall Study|Adverse Event|1|||
127873042|NCT04753606|460153687|FG001|Overall Study|Adverse Event|0|||
127873043|NCT04753606|460153688|FG002|Overall Study|Adverse Event|0|||
127873044|NCT00489411|460153689|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
127873045|NCT00489411|460153690|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
127873046|NCT00489411|460153689|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
127649599|NCT04252742|459337885|FG000|Overall Study|Lost to Follow-up|0|||
127649600|NCT04252742|459337886|FG001|Overall Study|Lost to Follow-up|1|||
127873047|NCT00489411|460153690|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
127873048|NCT00489411|460153689|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
127873049|NCT00489411|460153690|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
127873050|NCT00489411|460153689|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
127873051|NCT00489411|460153690|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
127873052|NCT00489411|460153689|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
127873053|NCT00489411|460153690|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
127873054|NCT01748162|460153691|FG000|Overall Study|no additional croup episodes to evaluate|2|||
127649601|NCT01784068|459337889|FG000|NTCS Phase|Adverse Event|5|||
127649602|NCT01784068|459337890|FG001|NTCS Phase|Adverse Event|0|||
127649603|NCT01784068|459337889|FG000|NTCS Phase|Physician Decision|2|||
127649604|NCT01784068|459337890|FG001|NTCS Phase|Physician Decision|0|||
127649605|NCT01784068|459337889|FG000|NTCS Phase|Patient/guardian decision|3|||
127649606|NCT01784068|459337890|FG001|NTCS Phase|Patient/guardian decision|0|||
127649607|NCT01784068|459337889|FG000|NTCS Phase|Death|2|||
127649608|NCT01784068|459337890|FG001|NTCS Phase|Death|0|||
127649609|NCT01784068|459337889|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
127649610|NCT01784068|459337890|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
127649611|NCT01784068|459337889|FG000|TFR Phase|Physician Decision|0|||
127649612|NCT01784068|459337890|FG001|TFR Phase|Physician Decision|1|||
127649613|NCT01784068|459337889|FG000|TFR Phase|Patient/guardian decision|0|||
127649614|NCT01784068|459337890|FG001|TFR Phase|Patient/guardian decision|3|||
127649615|NCT01784068|459337889|FG000|TFR Phase|Death|0|||
127649616|NCT01784068|459337890|FG001|TFR Phase|Death|1|||
127649617|NCT01784068|459337889|FG000|TFR Phase|Lack of Efficacy|0|||
127649618|NCT01784068|459337890|FG001|TFR Phase|Lack of Efficacy|88|||
127649619|NCT00946296|459337891|FG000|Overall Study|Physician Decision|3|||
127649620|NCT00946296|459337892|FG001|Overall Study|Physician Decision|0|||
127649621|NCT00701038|459337896|FG000|Overall Study|study amended pilot group of patients|4|||
127649622|NCT00701038|459337897|FG001|Overall Study|study amended pilot group of patients|4|||
127649623|NCT01064297|459337900|FG000|Overall Study|Lost to Follow-up|791|||
127649624|NCT01064297|459337901|FG001|Overall Study|Lost to Follow-up|48|||
127649625|NCT01064297|459337902|FG002|Overall Study|Lost to Follow-up|133|||
127649626|NCT00766675|459339434|FG000|Overall Study|Adverse Event|16|||
127649627|NCT00766675|459339434|FG000|Overall Study|Lost to Follow-up|2|||
127649628|NCT00766675|459339434|FG000|Overall Study|Withdrawal by Subject|11|||
127649629|NCT00766675|459339434|FG000|Overall Study|Protocol Violation|8|||
127649630|NCT00766675|459339434|FG000|Overall Study|Participant took prohibited medication|1|||
127649631|NCT00766675|459339434|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
127649632|NCT00766675|459339434|FG000|Overall Study|Insufficient therapy|1|||
127649633|NCT01289418|459339438|FG000|Day 8 Survey|email address invalid|283|||
127649634|NCT01289418|459339438|FG000|Day 8 Survey|participants did not complete the survey|1935|||
127649635|NCT01289418|459339438|FG000|Day 29 Survey|email address invalid|283|||
127649636|NCT01289418|459339438|FG000|Day 29 Survey|participants did not complete the survey|2185|||
127649637|NCT05050578|459339442|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
127649638|NCT05050578|459339443|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
127649639|NCT05050578|459339442|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
127649640|NCT05050578|459339443|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
127649641|NCT05050578|459339442|FG000|Period 2, 30 Days|Protocol Violation|0|||
127649642|NCT05050578|459339443|FG001|Period 2, 30 Days|Protocol Violation|1|||
127649643|NCT03386032|459339450|FG000|Overall Study|Lack of Efficacy|6|||
127649644|NCT03386032|459339451|FG001|Overall Study|Lack of Efficacy|2|||
127649645|NCT03386032|459339452|FG002|Overall Study|Lack of Efficacy|0|||
127649646|NCT03386032|459339450|FG000|Overall Study|Adverse Event|2|||
127649647|NCT03386032|459339451|FG001|Overall Study|Adverse Event|2|||
127649648|NCT03386032|459339452|FG002|Overall Study|Adverse Event|0|||
127649649|NCT03386032|459339450|FG000|Overall Study|Withdrawal by Subject|1|||
127649650|NCT03386032|459339451|FG001|Overall Study|Withdrawal by Subject|0|||
127649651|NCT03386032|459339452|FG002|Overall Study|Withdrawal by Subject|0|||
127649652|NCT03386032|459339450|FG000|Overall Study|Lost to Follow-up|9|||
127649653|NCT03386032|459339451|FG001|Overall Study|Lost to Follow-up|3|||
127649654|NCT03386032|459339452|FG002|Overall Study|Lost to Follow-up|0|||
127649655|NCT02940574|459339467|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
127649656|NCT02940574|459339468|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
127649657|NCT02940574|459339467|FG000|1-year Follow-up|Lost to Follow-up|3|||
127649658|NCT02940574|459339468|FG001|1-year Follow-up|Lost to Follow-up|4|||
127649659|NCT00387894|459339469|FG000|Overall Study|Withdrawal by Subject|1|||
127649660|NCT01119768|459339470|FG000|Treatment Period|Lack of Efficacy|18|||
127649661|NCT01119768|459339471|FG001|Treatment Period|Lack of Efficacy|25|||
127649662|NCT02923739|459339478|FG000|Overall Study|Withdrawal by Subject|2|||
127649663|NCT02923739|459339479|FG001|Overall Study|Withdrawal by Subject|0|||
127649664|NCT02923739|459339480|FG002|Overall Study|Withdrawal by Subject|0|||
127649665|NCT02923739|459339481|FG003|Overall Study|Withdrawal by Subject|0|||
127649666|NCT02923739|459339478|FG000|Overall Study|Failed Screening|3|||
127649667|NCT02923739|459339479|FG001|Overall Study|Failed Screening|0|||
127649668|NCT02923739|459339480|FG002|Overall Study|Failed Screening|0|||
127649669|NCT02923739|459339481|FG003|Overall Study|Failed Screening|0|||
127649670|NCT02634788|459339484|FG000|Overall Study|Adverse Event|0|||
127649671|NCT02634788|459339485|FG001|Overall Study|Adverse Event|8|||
127649672|NCT02634788|459339486|FG002|Overall Study|Adverse Event|3|||
127649673|NCT02634788|459339487|FG003|Overall Study|Adverse Event|1|||
127649674|NCT02634788|459339484|FG000|Overall Study|Lack of Efficacy|4|||
127649675|NCT02634788|459339485|FG001|Overall Study|Lack of Efficacy|0|||
127649676|NCT02634788|459339486|FG002|Overall Study|Lack of Efficacy|1|||
127649677|NCT02634788|459339487|FG003|Overall Study|Lack of Efficacy|4|||
127873055|NCT01748162|460153692|FG001|Overall Study|no additional croup episodes to evaluate|2|||
127873056|NCT01748162|460153691|FG000|Overall Study|participant consented but did not begin|0|||
127873057|NCT01748162|460153692|FG001|Overall Study|participant consented but did not begin|1|||
127873058|NCT01748162|460153691|FG000|Overall Study|reasons not available|3|||
127873059|NCT01748162|460153692|FG001|Overall Study|reasons not available|2|||
127873060|NCT03841331|460153693|FG000|Overall Study|Withdrawal by Subject|4|||
127873061|NCT03841331|460153694|FG001|Overall Study|Withdrawal by Subject|9|||
127873062|NCT03841331|460153693|FG000|Overall Study|Lost to Follow-up|5|||
127873063|NCT03841331|460153694|FG001|Overall Study|Lost to Follow-up|1|||
127873064|NCT02743117|460153695|FG000|Overall Study|Lost to Follow-up|0|||
127873065|NCT02743117|460153696|FG001|Overall Study|Lost to Follow-up|1|||
127873066|NCT02743117|460153695|FG000|Overall Study|Other|1|||
127873067|NCT02743117|460153696|FG001|Overall Study|Other|0|||
127873068|NCT01207219|460153697|FG000|Overall Study|changed diagnosis during study period|5|||
127873069|NCT01207219|460153698|FG001|Overall Study|changed diagnosis during study period|3|||
127873070|NCT01207219|460153699|FG002|Overall Study|changed diagnosis during study period|1|||
127873071|NCT01207219|460153697|FG000|Overall Study|Lost to Follow-up|6|||
127873072|NCT01207219|460153698|FG001|Overall Study|Lost to Follow-up|8|||
127873073|NCT01207219|460153699|FG002|Overall Study|Lost to Follow-up|6|||
127873074|NCT03532048|460153702|FG000|Overall Study|Lost to Follow-up|12|||
127873075|NCT03532048|460153703|FG001|Overall Study|Lost to Follow-up|17|||
127873076|NCT03532048|460153702|FG000|Overall Study|Withdrawal by Subject|7|||
127873077|NCT03532048|460153703|FG001|Overall Study|Withdrawal by Subject|0|||
127873078|NCT01901393|460153706|FG000|Overall Study|Adverse Event|1|||
127873079|NCT01901393|460153707|FG001|Overall Study|Adverse Event|0|||
127873080|NCT00596466|460153712|FG000|Overall Study|Lack of Efficacy|5|||
127873081|NCT00596466|460153712|FG000|Overall Study|Adverse Event|4|||
127873082|NCT00596466|460153712|FG000|Overall Study|Withdrawal by Subject|2|||
127873083|NCT00596466|460153712|FG000|Overall Study|Protocol Violation|2|||
127873084|NCT00596466|460153712|FG000|Overall Study|Unpecified|2|||
127873085|NCT00596466|460153712|FG000|Overall Study|Enrolled, not treated|2|||
127873086|NCT00908375|460153713|FG000|Overall Study|Withdrawal by Subject|2|||
127873087|NCT00908375|460153714|FG001|Overall Study|Withdrawal by Subject|4|||
127873088|NCT00908375|460153713|FG000|Overall Study|Lost to Follow-up|8|||
127873089|NCT00908375|460153714|FG001|Overall Study|Lost to Follow-up|6|||
127873090|NCT01298323|460153718|FG000|Overall Study|Adverse Event|2|||
127873091|NCT01298323|460153719|FG001|Overall Study|Adverse Event|4|||
127873092|NCT01298323|460153718|FG000|Overall Study|Death|11|||
127873093|NCT01298323|460153719|FG001|Overall Study|Death|16|||
127873094|NCT01298323|460153718|FG000|Overall Study|Lost to Follow-up|1|||
127873095|NCT01298323|460153719|FG001|Overall Study|Lost to Follow-up|0|||
127873096|NCT01298323|460153718|FG000|Overall Study|Withdrawal by Subject|6|||
127873097|NCT01298323|460153719|FG001|Overall Study|Withdrawal by Subject|3|||
127873098|NCT01298323|460153718|FG000|Overall Study|Protocol Violation|1|||
127873099|NCT01298323|460153719|FG001|Overall Study|Protocol Violation|0|||
127873100|NCT01298323|460153718|FG000|Overall Study|Other|10|||
127873101|NCT01298323|460153719|FG001|Overall Study|Other|9|||
127873102|NCT01298323|460153718|FG000|Overall Study|Ongoing|55|||
127873103|NCT01298323|460153719|FG001|Overall Study|Ongoing|55|||
127873104|NCT01298323|460153718|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
127873105|NCT01298323|460153719|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
127873106|NCT02396849|460153720|FG000|Overall Study|Lost to Follow-up|1|||
127873107|NCT02396849|460153721|FG001|Overall Study|Lost to Follow-up|1|||
127873108|NCT02396849|460153720|FG000|Overall Study|Did not tolerate intervention|1|||
127873109|NCT02396849|460153721|FG001|Overall Study|Did not tolerate intervention|1|||
127873110|NCT04794491|460153726|FG000|Overall Study|Adverse Event|1|||
127873111|NCT04794491|460153726|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
127873112|NCT04794491|460153726|FG000|Overall Study|Noncompliance With Study Intervention|1|||
127873113|NCT04794491|460153726|FG000|Overall Study|Withdrawal by Subject|2|||
127873114|NCT00931515|460153727|FG000|Overall Study|Lost to Follow-up|2|||
127873115|NCT00931515|460153728|FG001|Overall Study|Lost to Follow-up|5|||
127873116|NCT02950831|460153729|FG000|Overall Study|Lost to Follow-up|1|||
127873117|NCT02950831|460153729|FG000|Overall Study|Withdrawal by Subject|3|||
127873118|NCT02950831|460153729|FG000|Overall Study|stimulation trail failure|5|||
127873119|NCT01965600|460153730|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
127873120|NCT01965600|460153731|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
127873121|NCT01965600|460153732|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
127873122|NCT01965600|460153733|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
127873123|NCT01965600|460153730|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
127873124|NCT01965600|460153731|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
127873125|NCT01965600|460153732|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
127873126|NCT01965600|460153733|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
127873127|NCT01965600|460153730|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
127873128|NCT01965600|460153731|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
127873129|NCT01965600|460153732|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
127873130|NCT01965600|460153733|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
127873131|NCT01965600|460153730|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
127873132|NCT01965600|460153731|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
127873133|NCT01965600|460153732|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
127873134|NCT01965600|460153733|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
127873135|NCT01965600|460153730|FG000|Second Intervention|Study terminated by Sponsor|0|||
127873136|NCT01965600|460153731|FG001|Second Intervention|Study terminated by Sponsor|0|||
127873137|NCT01965600|460153732|FG002|Second Intervention|Study terminated by Sponsor|2|||
127873138|NCT01965600|460153733|FG003|Second Intervention|Study terminated by Sponsor|2|||
127873139|NCT03418727|460153741|FG000|Overall Study|Adverse Event|1|||
127873140|NCT03418727|460153742|FG001|Overall Study|Adverse Event|2|||
127873141|NCT03418727|460153743|FG002|Overall Study|Adverse Event|0|||
127873142|NCT03418727|460153741|FG000|Overall Study|Withdrawal by Subject|0|||
127873143|NCT03418727|460153742|FG001|Overall Study|Withdrawal by Subject|0|||
127873144|NCT03418727|460153743|FG002|Overall Study|Withdrawal by Subject|2|||
127873145|NCT00686894|460153748|FG000|Overall Study|Relapse|2|||
127873146|NCT00686894|460153748|FG000|Overall Study|Protocol Violation|4|||
127873147|NCT04678557|460153749|FG000|Overall Study|Withdrawal by Subject|1|||
127873148|NCT04678557|460153750|FG001|Overall Study|Withdrawal by Subject|0|||
127873149|NCT04678557|460153749|FG000|Overall Study|Lack of Efficacy|0|||
127873150|NCT04678557|460153750|FG001|Overall Study|Lack of Efficacy|13|||
127873151|NCT04678557|460153749|FG000|Overall Study|Safety Evaluation|0|||
127873152|NCT04678557|460153750|FG001|Overall Study|Safety Evaluation|1|||
127873153|NCT01013207|460155606|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
127873154|NCT00953017|460155621|FG000|Overall Study|DId not show up for colonoscopy|4|||
127873155|NCT00953017|460155622|FG001|Overall Study|DId not show up for colonoscopy|4|||
127873156|NCT00953017|460155623|FG002|Overall Study|DId not show up for colonoscopy|5|||
127873157|NCT00953017|460155624|FG003|Overall Study|DId not show up for colonoscopy|4|||
127873158|NCT00953017|460155621|FG000|Overall Study|Incomplete data|1|||
127873159|NCT00953017|460155622|FG001|Overall Study|Incomplete data|1|||
127873160|NCT00953017|460155623|FG002|Overall Study|Incomplete data|0|||
127873161|NCT00953017|460155624|FG003|Overall Study|Incomplete data|0|||
127873162|NCT00953017|460155621|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
127873163|NCT00953017|460155622|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
127873164|NCT00953017|460155623|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
127873165|NCT00953017|460155624|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
127873166|NCT00953017|460155621|FG000|Overall Study|Brown stool prior to procedure|0|||
127873167|NCT00953017|460155622|FG001|Overall Study|Brown stool prior to procedure|0|||
127873168|NCT00953017|460155623|FG002|Overall Study|Brown stool prior to procedure|1|||
127873169|NCT00953017|460155624|FG003|Overall Study|Brown stool prior to procedure|0|||
127873170|NCT00718809|460155627|FG000|Overall Study|Disease progression|9|||
127873171|NCT00718809|460155628|FG001|Overall Study|Disease progression|7|||
127873172|NCT00718809|460155627|FG000|Overall Study|Adverse Event|1|||
127873173|NCT00718809|460155628|FG001|Overall Study|Adverse Event|1|||
127873174|NCT00718809|460155627|FG000|Overall Study|Withdrawal by Subject|0|||
127873175|NCT00718809|460155628|FG001|Overall Study|Withdrawal by Subject|1|||
127873176|NCT00718809|460155627|FG000|Overall Study|Lost to Follow-up|1|||
127873177|NCT00718809|460155628|FG001|Overall Study|Lost to Follow-up|0|||
127873178|NCT00718809|460155627|FG000|Overall Study|Noncompliance|1|||
127873179|NCT00718809|460155628|FG001|Overall Study|Noncompliance|0|||
127873180|NCT00463385|460155629|FG000|Overall Study|Other|4|||
127873181|NCT00463385|460155630|FG001|Overall Study|Other|3|||
127873182|NCT00463385|460155631|FG002|Overall Study|Other|6|||
127873183|NCT00463385|460155632|FG003|Overall Study|Other|4|||
127873184|NCT00463385|460155629|FG000|Overall Study|Adverse Event|5|||
127873185|NCT00463385|460155630|FG001|Overall Study|Adverse Event|8|||
127873186|NCT00463385|460155631|FG002|Overall Study|Adverse Event|4|||
127873187|NCT00463385|460155632|FG003|Overall Study|Adverse Event|2|||
127873188|NCT00463385|460155629|FG000|Overall Study|Lack of Efficacy|6|||
127873189|NCT00463385|460155630|FG001|Overall Study|Lack of Efficacy|6|||
127873190|NCT00463385|460155631|FG002|Overall Study|Lack of Efficacy|7|||
127873191|NCT00463385|460155632|FG003|Overall Study|Lack of Efficacy|9|||
127873192|NCT00463385|460155629|FG000|Overall Study|Withdrawal by Subject|3|||
127873193|NCT00463385|460155630|FG001|Overall Study|Withdrawal by Subject|3|||
127873194|NCT00463385|460155631|FG002|Overall Study|Withdrawal by Subject|3|||
127873195|NCT00463385|460155632|FG003|Overall Study|Withdrawal by Subject|4|||
127873196|NCT00463385|460155629|FG000|Overall Study|Lost to Follow-up|0|||
127873197|NCT00463385|460155630|FG001|Overall Study|Lost to Follow-up|0|||
127873198|NCT00463385|460155631|FG002|Overall Study|Lost to Follow-up|0|||
127873199|NCT00463385|460155632|FG003|Overall Study|Lost to Follow-up|1|||
127873200|NCT00463385|460155629|FG000|Overall Study|Death|2|||
127873201|NCT00463385|460155630|FG001|Overall Study|Death|1|||
127873202|NCT00463385|460155631|FG002|Overall Study|Death|2|||
127873203|NCT00463385|460155632|FG003|Overall Study|Death|0|||
127873204|NCT00463385|460155629|FG000|Overall Study|Missing|2|||
127649678|NCT02634788|459339484|FG000|Overall Study|Lost to Follow-up|0|||
127649679|NCT02634788|459339485|FG001|Overall Study|Lost to Follow-up|1|||
127649680|NCT02634788|459339486|FG002|Overall Study|Lost to Follow-up|0|||
127649681|NCT02634788|459339487|FG003|Overall Study|Lost to Follow-up|0|||
127649682|NCT02634788|459339484|FG000|Overall Study|Withdrawal by Subject|0|||
127649683|NCT02634788|459339485|FG001|Overall Study|Withdrawal by Subject|1|||
127649684|NCT02634788|459339486|FG002|Overall Study|Withdrawal by Subject|1|||
127649685|NCT02634788|459339487|FG003|Overall Study|Withdrawal by Subject|0|||
127649686|NCT02496767|459339499|FG000|Open-label Lead-in Phase|Adverse Event|176|||
127649687|NCT02496767|459339500|FG001|Open-label Lead-in Phase|Adverse Event|0|||
127649688|NCT02496767|459339501|FG002|Open-label Lead-in Phase|Adverse Event|0|||
127649689|NCT02496767|459339502|FG003|Open-label Lead-in Phase|Adverse Event|0|||
127649690|NCT02496767|459339503|FG004|Open-label Lead-in Phase|Adverse Event|0|||
127649691|NCT02496767|459339504|FG005|Open-label Lead-in Phase|Adverse Event|0|||
127649692|NCT02496767|459339505|FG006|Open-label Lead-in Phase|Adverse Event|0|||
127649693|NCT02496767|459339506|FG007|Open-label Lead-in Phase|Adverse Event|0|||
127649694|NCT02496767|459339499|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
127649695|NCT02496767|459339500|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
127649696|NCT02496767|459339501|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
127649697|NCT02496767|459339502|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
127649698|NCT02496767|459339503|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
127649699|NCT02496767|459339504|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
127649700|NCT02496767|459339505|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
127649701|NCT02496767|459339506|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
127649702|NCT02496767|459339499|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
127649703|NCT02496767|459339500|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
127649704|NCT02496767|459339501|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
127649705|NCT02496767|459339502|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
127649706|NCT02496767|459339503|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
127649707|NCT02496767|459339504|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
127649708|NCT02496767|459339505|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
127649709|NCT02496767|459339506|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
127649710|NCT02496767|459339499|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
127649711|NCT02496767|459339500|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
127649712|NCT02496767|459339501|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
127649713|NCT02496767|459339502|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
127649714|NCT02496767|459339503|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
127649715|NCT02496767|459339504|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
127649716|NCT02496767|459339505|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
127649717|NCT02496767|459339506|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
127649718|NCT02496767|459339499|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
127649719|NCT02496767|459339500|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
127649720|NCT02496767|459339501|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
127649721|NCT02496767|459339502|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
127649722|NCT02496767|459339503|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
127649723|NCT02496767|459339504|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
127649724|NCT02496767|459339505|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
127649725|NCT02496767|459339506|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
127649726|NCT02496767|459339499|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
127649727|NCT02496767|459339500|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
127649728|NCT02496767|459339501|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
127649729|NCT02496767|459339502|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
127649730|NCT02496767|459339503|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
127649731|NCT02496767|459339504|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
127649732|NCT02496767|459339505|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
127649733|NCT02496767|459339506|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
127649734|NCT02496767|459339499|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
127649735|NCT02496767|459339500|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
127649736|NCT02496767|459339501|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
127649737|NCT02496767|459339502|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
127649738|NCT02496767|459339503|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
127649739|NCT02496767|459339504|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
127649740|NCT02496767|459339505|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
127649741|NCT02496767|459339506|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
127649742|NCT02496767|459339499|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
127649743|NCT02496767|459339500|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
127649744|NCT02496767|459339501|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
127649745|NCT02496767|459339502|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
127649746|NCT02496767|459339503|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
127873205|NCT00463385|460155630|FG001|Overall Study|Missing|0|||
127873206|NCT00463385|460155631|FG002|Overall Study|Missing|0|||
127873207|NCT00463385|460155632|FG003|Overall Study|Missing|2|||
127873208|NCT00463385|460155629|FG000|Overall Study|1 participant received commercial drug|0|||
127873209|NCT00463385|460155630|FG001|Overall Study|1 participant received commercial drug|1|||
127873210|NCT00463385|460155631|FG002|Overall Study|1 participant received commercial drug|0|||
127873211|NCT00463385|460155632|FG003|Overall Study|1 participant received commercial drug|0|||
127873212|NCT00449761|460155633|FG000|Overall Study|Disease progression|12|||
127873213|NCT00449761|460155633|FG000|Overall Study|Death|5|||
127873214|NCT00449761|460155633|FG000|Overall Study|New cancer therapy|1|||
127873215|NCT00344968|460155636|FG000|Overall Study|Adverse Event|5|||
127873216|NCT00344968|460155637|FG001|Overall Study|Adverse Event|4|||
127873217|NCT00344968|460155638|FG002|Overall Study|Adverse Event|15|||
127873218|NCT00344968|460155636|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
127873219|NCT00344968|460155637|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
127873220|NCT00344968|460155638|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
127873221|NCT00344968|460155636|FG000|Overall Study|Protocol Violation|2|||
127873222|NCT00344968|460155637|FG001|Overall Study|Protocol Violation|2|||
127873223|NCT00344968|460155638|FG002|Overall Study|Protocol Violation|5|||
127873224|NCT00344968|460155636|FG000|Overall Study|Withdrawal by Subject|14|||
127873225|NCT00344968|460155637|FG001|Overall Study|Withdrawal by Subject|31|||
127873226|NCT00344968|460155638|FG002|Overall Study|Withdrawal by Subject|27|||
127873227|NCT00344968|460155636|FG000|Overall Study|Lost to Follow-up|24|||
127873228|NCT00344968|460155637|FG001|Overall Study|Lost to Follow-up|37|||
127873229|NCT00344968|460155638|FG002|Overall Study|Lost to Follow-up|37|||
127873230|NCT00344968|460155636|FG000|Overall Study|Death|11|||
127873231|NCT00344968|460155637|FG001|Overall Study|Death|27|||
127873232|NCT00344968|460155638|FG002|Overall Study|Death|31|||
127873233|NCT00344968|460155636|FG000|Overall Study|Other|0|||
127873234|NCT00344968|460155637|FG001|Overall Study|Other|1|||
127873235|NCT00344968|460155638|FG002|Overall Study|Other|0|||
127873236|NCT03735680|460155639|FG000|Overall Study|Withdrawal by Subject|0|||
127873237|NCT03735680|460155640|FG001|Overall Study|Withdrawal by Subject|1|||
127873238|NCT03735680|460155641|FG002|Overall Study|Withdrawal by Subject|0|||
127873239|NCT03735680|460155642|FG003|Overall Study|Withdrawal by Subject|0|||
127873240|NCT03735680|460155643|FG004|Overall Study|Withdrawal by Subject|0|||
127873241|NCT03735680|460155644|FG005|Overall Study|Withdrawal by Subject|1|||
127873242|NCT03735680|460155639|FG000|Overall Study|Patient unable or unwilling to continue|0|||
127873243|NCT03735680|460155640|FG001|Overall Study|Patient unable or unwilling to continue|0|||
127873244|NCT03735680|460155641|FG002|Overall Study|Patient unable or unwilling to continue|1|||
127873245|NCT03735680|460155642|FG003|Overall Study|Patient unable or unwilling to continue|0|||
127873246|NCT03735680|460155643|FG004|Overall Study|Patient unable or unwilling to continue|0|||
127873247|NCT03735680|460155644|FG005|Overall Study|Patient unable or unwilling to continue|0|||
127873248|NCT01422876|460155646|FG000|Week 24|Lost to Follow-up|1|||
127873249|NCT01422876|460155647|FG001|Week 24|Lost to Follow-up|1|||
127873250|NCT01422876|460155648|FG002|Week 24|Lost to Follow-up|2|||
127873251|NCT01422876|460155649|FG003|Week 24|Lost to Follow-up|4|||
127873252|NCT01422876|460155650|FG004|Week 24|Lost to Follow-up|2|||
127873253|NCT01422876|460155651|FG005|Week 24|Lost to Follow-up|0|||
127873254|NCT01422876|460155652|FG006|Week 24|Lost to Follow-up|1|||
127873255|NCT01422876|460155653|FG007|Week 24|Lost to Follow-up|3|||
127873256|NCT01422876|460155654|FG008|Week 24|Lost to Follow-up|3|||
127873257|NCT01422876|460155655|FG009|Week 24|Lost to Follow-up|4|||
127873258|NCT01422876|460155646|FG000|Week 24|Consent withdrawn|5|||
127873259|NCT01422876|460155647|FG001|Week 24|Consent withdrawn|1|||
127873260|NCT01422876|460155648|FG002|Week 24|Consent withdrawn|3|||
127873261|NCT01422876|460155649|FG003|Week 24|Consent withdrawn|4|||
127873262|NCT01422876|460155650|FG004|Week 24|Consent withdrawn|5|||
127873263|NCT01422876|460155651|FG005|Week 24|Consent withdrawn|6|||
127873264|NCT01422876|460155652|FG006|Week 24|Consent withdrawn|5|||
127873265|NCT01422876|460155653|FG007|Week 24|Consent withdrawn|4|||
127873266|NCT01422876|460155654|FG008|Week 24|Consent withdrawn|3|||
127873267|NCT01422876|460155655|FG009|Week 24|Consent withdrawn|6|||
127873268|NCT01422876|460155646|FG000|Week 24|Death|0|||
127873269|NCT01422876|460155647|FG001|Week 24|Death|1|||
127873270|NCT01422876|460155648|FG002|Week 24|Death|0|||
127873271|NCT01422876|460155649|FG003|Week 24|Death|0|||
127873272|NCT01422876|460155650|FG004|Week 24|Death|0|||
127873273|NCT01422876|460155651|FG005|Week 24|Death|0|||
127873274|NCT01422876|460155652|FG006|Week 24|Death|0|||
127873275|NCT01422876|460155653|FG007|Week 24|Death|0|||
127873276|NCT01422876|460155654|FG008|Week 24|Death|0|||
127873277|NCT01422876|460155655|FG009|Week 24|Death|0|||
127873278|NCT01422876|460155646|FG000|Week 52|Lost to Follow-up|3|||
127873279|NCT01422876|460155647|FG001|Week 52|Lost to Follow-up|5|||
127873280|NCT01422876|460155648|FG002|Week 52|Lost to Follow-up|7|||
127873281|NCT01422876|460155649|FG003|Week 52|Lost to Follow-up|5|||
127873282|NCT01422876|460155650|FG004|Week 52|Lost to Follow-up|8|||
127873283|NCT01422876|460155651|FG005|Week 52|Lost to Follow-up|5|||
127873284|NCT01422876|460155652|FG006|Week 52|Lost to Follow-up|5|||
127873285|NCT01422876|460155653|FG007|Week 52|Lost to Follow-up|8|||
127873286|NCT01422876|460155654|FG008|Week 52|Lost to Follow-up|7|||
127873287|NCT01422876|460155655|FG009|Week 52|Lost to Follow-up|8|||
127873288|NCT01422876|460155646|FG000|Week 52|Consent withdrawn|9|||
127873289|NCT01422876|460155647|FG001|Week 52|Consent withdrawn|4|||
127873290|NCT01422876|460155648|FG002|Week 52|Consent withdrawn|6|||
127873291|NCT01422876|460155649|FG003|Week 52|Consent withdrawn|12|||
127873292|NCT01422876|460155650|FG004|Week 52|Consent withdrawn|7|||
127873293|NCT01422876|460155651|FG005|Week 52|Consent withdrawn|12|||
127873294|NCT01422876|460155652|FG006|Week 52|Consent withdrawn|10|||
127873295|NCT01422876|460155653|FG007|Week 52|Consent withdrawn|12|||
127873296|NCT01422876|460155654|FG008|Week 52|Consent withdrawn|13|||
127873297|NCT01422876|460155655|FG009|Week 52|Consent withdrawn|9|||
127873298|NCT01422876|460155646|FG000|Week 52|Death|0|||
127873299|NCT01422876|460155647|FG001|Week 52|Death|1|||
127873300|NCT01422876|460155648|FG002|Week 52|Death|0|||
127873301|NCT01422876|460155649|FG003|Week 52|Death|1|||
127873302|NCT01422876|460155650|FG004|Week 52|Death|0|||
127873303|NCT01422876|460155651|FG005|Week 52|Death|0|||
127873304|NCT01422876|460155652|FG006|Week 52|Death|1|||
127873305|NCT01422876|460155653|FG007|Week 52|Death|3|||
127873306|NCT01422876|460155654|FG008|Week 52|Death|1|||
127873307|NCT01422876|460155655|FG009|Week 52|Death|0|||
127873308|NCT00054639|460155667|FG000|Overall Study|Lack of Efficacy|1|||
127873309|NCT00054639|460155667|FG000|Overall Study|Physician Decision|1|||
127873310|NCT01600755|460155668|FG000|Overall Study|Withdrawal by Subject|6|||
127873311|NCT01548573|460155677|FG000|Overall Study|Death|3|||
127873312|NCT01548573|460155677|FG000|Overall Study|Withdrawal by Subject|2|||
127873313|NCT01366846|460155678|FG000|Overall Study|Withdrawal by Subject|2|||
127873314|NCT01366846|460155679|FG001|Overall Study|Withdrawal by Subject|0|||
127873315|NCT01366846|460155680|FG002|Overall Study|Withdrawal by Subject|0|||
127873316|NCT01366846|460155681|FG003|Overall Study|Withdrawal by Subject|0|||
127873317|NCT01366846|460155678|FG000|Overall Study|Communication Difficulties|1|||
127873318|NCT01366846|460155679|FG001|Overall Study|Communication Difficulties|4|||
127873319|NCT01366846|460155680|FG002|Overall Study|Communication Difficulties|0|||
127873320|NCT01366846|460155681|FG003|Overall Study|Communication Difficulties|1|||
127873321|NCT01366846|460155678|FG000|Overall Study|Scheduling Conflicts|0|||
127873322|NCT01366846|460155679|FG001|Overall Study|Scheduling Conflicts|0|||
127873323|NCT01366846|460155680|FG002|Overall Study|Scheduling Conflicts|1|||
127873324|NCT01366846|460155681|FG003|Overall Study|Scheduling Conflicts|0|||
127873325|NCT00558831|460155687|FG000|Overall Study|Lost to Follow-up|1|||
127873326|NCT00447265|460155688|FG000|Overall Study|Physician Decision|1|||
127873327|NCT00447265|460155689|FG001|Overall Study|Physician Decision|0|||
127873328|NCT00503035|460155692|FG000|Overall Study|Lost to Follow-up|2|||
127873329|NCT00503035|460155692|FG000|Overall Study|Physician Decision|3|||
127873330|NCT00503035|460155692|FG000|Overall Study|Ineligible|15|||
127873331|NCT05028816|460155695|FG000|Overall Study|Lost to Follow-up|5|||
127873332|NCT05028816|460155696|FG001|Overall Study|Lost to Follow-up|3|||
127873333|NCT05028816|460155695|FG000|Overall Study|Withdrawal by Subject|4|||
127873334|NCT05028816|460155696|FG001|Overall Study|Withdrawal by Subject|1|||
127873335|NCT05028816|460155695|FG000|Overall Study|Physician Decision|1|||
127873336|NCT05028816|460155696|FG001|Overall Study|Physician Decision|0|||
127873337|NCT05064436|460155697|FG000|Overall Study|Other Reasons|1|||
127873338|NCT05064436|460155698|FG001|Overall Study|Other Reasons|0|||
127873339|NCT01711736|460155700|FG000|Overall Study|Lost to Follow-up|4|||
127873340|NCT01711736|460155701|FG001|Overall Study|Lost to Follow-up|1|||
127873341|NCT01711736|460155700|FG000|Overall Study|Withdrawal by Subject|6|||
127873342|NCT01711736|460155701|FG001|Overall Study|Withdrawal by Subject|6|||
127873343|NCT01711736|460155700|FG000|Overall Study|Migrated/moved from study area|2|||
127873344|NCT01711736|460155701|FG001|Overall Study|Migrated/moved from study area|1|||
127873345|NCT02957149|460155702|FG000|Overall Study|Withdrawal by Subject|5|||
127873346|NCT02506101|460155703|FG000|Overall Study|Transportation issues|1|||
127873347|NCT02506101|460155704|FG001|Overall Study|Transportation issues|0|||
127873348|NCT02506101|460155703|FG000|Overall Study|No enrollment and staff unavailability|1|||
127873349|NCT02506101|460155704|FG001|Overall Study|No enrollment and staff unavailability|0|||
127873350|NCT03358407|460155705|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
127873351|NCT03358407|460155706|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
127873352|NCT03358407|460155707|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
127873353|NCT03358407|460155708|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
127873354|NCT03358407|460155709|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
127873355|NCT03358407|460155710|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
127873356|NCT03358407|460155711|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
127873357|NCT03358407|460155712|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
127873358|NCT03358407|460155713|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
127873359|NCT03358407|460155714|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
127873360|NCT03358407|460155705|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
127873361|NCT03358407|460155706|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
127873362|NCT03358407|460155707|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
127873363|NCT03358407|460155708|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
127983721|NCT01764997|460562569|FG001|Run-in Period|Adverse Event|0|||
127873364|NCT03358407|460155709|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
127873365|NCT03358407|460155710|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
127873366|NCT03358407|460155711|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
127873367|NCT03358407|460155712|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
127873368|NCT03358407|460155713|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
127873369|NCT03358407|460155714|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
127873370|NCT03358407|460155705|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
127873371|NCT03358407|460155706|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
127873372|NCT03358407|460155707|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
127873373|NCT03358407|460155708|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
127873374|NCT03358407|460155709|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
127873375|NCT03358407|460155710|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
127873376|NCT03358407|460155711|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
127873377|NCT03358407|460155712|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
127873378|NCT03358407|460155713|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
127873379|NCT03358407|460155714|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
127873380|NCT03358407|460155705|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
127873381|NCT03358407|460155706|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
127873382|NCT03358407|460155707|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
127873383|NCT03358407|460155708|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
127873384|NCT03358407|460155709|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
127873385|NCT03358407|460155710|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
127873386|NCT03358407|460155711|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
127873387|NCT03358407|460155712|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
127873388|NCT03358407|460155713|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
127873389|NCT03358407|460155714|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
127873390|NCT03358407|460155705|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
127873391|NCT03358407|460155706|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
127873392|NCT03358407|460155707|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
127873393|NCT03358407|460155708|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
127873394|NCT03358407|460155709|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
127873395|NCT03358407|460155710|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
127873396|NCT03358407|460155711|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
127873397|NCT03358407|460155712|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
127873398|NCT03358407|460155713|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
127873399|NCT03358407|460155714|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
127873400|NCT03358407|460155705|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
127873401|NCT03358407|460155706|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
127873402|NCT03358407|460155707|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
127873403|NCT03358407|460155708|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
127873404|NCT03358407|460155709|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
127873405|NCT03358407|460155710|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
127873406|NCT03358407|460155711|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
127873407|NCT03358407|460155712|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
127873408|NCT03358407|460155713|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
127873409|NCT03358407|460155714|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
127873410|NCT01283009|460155715|FG000|Overall Study|Death|83|||
127873411|NCT01283009|460155716|FG001|Overall Study|Death|78|||
127873412|NCT01283009|460155715|FG000|Overall Study|Study ended early|23|||
127873413|NCT01283009|460155716|FG001|Overall Study|Study ended early|26|||
127649747|NCT02496767|459339504|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
127873414|NCT01283009|460155715|FG000|Overall Study|Withdrawal by Subject|10|||
127873415|NCT01283009|460155716|FG001|Overall Study|Withdrawal by Subject|8|||
127873416|NCT01283009|460155715|FG000|Overall Study|Physician Decision|1|||
127873417|NCT01283009|460155716|FG001|Overall Study|Physician Decision|1|||
127873418|NCT01283009|460155715|FG000|Overall Study|Lost to Follow-up|1|||
127873419|NCT01283009|460155716|FG001|Overall Study|Lost to Follow-up|0|||
127873420|NCT01283009|460155715|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
127873421|NCT01283009|460155716|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
127873422|NCT00505765|460155719|FG000|Overall Study|Withdrawal by Subject|1|||
127649748|NCT02496767|459339505|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
127649749|NCT02496767|459339506|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
127649750|NCT02496767|459339499|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
127873423|NCT00505765|460155720|FG001|Overall Study|Withdrawal by Subject|0|||
127873424|NCT00505765|460155721|FG002|Overall Study|Withdrawal by Subject|0|||
127873425|NCT00505765|460155719|FG000|Overall Study|Adverse Event|1|||
127873426|NCT00505765|460155720|FG001|Overall Study|Adverse Event|2|||
127873427|NCT00505765|460155721|FG002|Overall Study|Adverse Event|0|||
127873428|NCT00505765|460155719|FG000|Overall Study|Noncompliance|0|||
127873429|NCT00505765|460155720|FG001|Overall Study|Noncompliance|1|||
127873430|NCT00505765|460155721|FG002|Overall Study|Noncompliance|3|||
127873431|NCT04640168|460155722|FG000|Overall Study|Withdrawal by Subject|8|||
127873432|NCT04640168|460155723|FG001|Overall Study|Withdrawal by Subject|7|||
127873433|NCT04640168|460155722|FG000|Overall Study|Lost to Follow-up|1|||
127873434|NCT04640168|460155723|FG001|Overall Study|Lost to Follow-up|0|||
127873435|NCT04640168|460155722|FG000|Overall Study|Enrolled but not treated|12|||
127873436|NCT04640168|460155723|FG001|Overall Study|Enrolled but not treated|12|||
127873437|NCT04366258|460155731|FG000|Baseline Assessments|Screen Failure|21|||
127873438|NCT04366258|460155731|FG000|Baseline Assessments|Early Termination|3|||
127873439|NCT01725217|460155732|FG000|Overall Study|Withdrawal by Subject|1|||
127873440|NCT01725217|460155733|FG001|Overall Study|Withdrawal by Subject|0|||
127873441|NCT01725217|460155734|FG002|Overall Study|Withdrawal by Subject|0|||
127873442|NCT00308555|460155735|FG000|Overall Study|Withdrawal by Subject|1|||
127873443|NCT00308555|460155736|FG001|Overall Study|Withdrawal by Subject|0|||
127873444|NCT00308555|460155735|FG000|Overall Study|Physician Decision|2|||
127873445|NCT00308555|460155736|FG001|Overall Study|Physician Decision|0|||
127873446|NCT00276458|460155737|FG000|Overall Study|Adverse Event|0|||
127873447|NCT00276458|460155738|FG001|Overall Study|Adverse Event|2|||
127873448|NCT00276458|460155737|FG000|Overall Study|Lost to Follow-up|2|||
127873449|NCT00276458|460155738|FG001|Overall Study|Lost to Follow-up|2|||
127873450|NCT00276458|460155737|FG000|Overall Study|Protocol Violation|4|||
127873451|NCT00276458|460155738|FG001|Overall Study|Protocol Violation|3|||
127873452|NCT02940392|460155741|FG000|Overall Study|Lost to Follow-up|3|||
127873453|NCT02940392|460155741|FG000|Overall Study|Retreatment|3|||
127873454|NCT02940392|460155741|FG000|Overall Study|Death|2|||
127873455|NCT00480077|460155742|FG000|Overall Study|Death|19|||
127873456|NCT00480077|460155743|FG001|Overall Study|Death|15|||
127873457|NCT00480077|460155742|FG000|Overall Study|early exit|12|||
127873458|NCT00480077|460155743|FG001|Overall Study|early exit|11|||
127873459|NCT04298229|460155748|FG000|Overall Study|Physician Decision|1|||
127873460|NCT04298229|460155749|FG001|Overall Study|Physician Decision|1|||
127873461|NCT04298229|460155748|FG000|Overall Study|Withdrawal by Subject|1|||
127873462|NCT04298229|460155749|FG001|Overall Study|Withdrawal by Subject|1|||
127873463|NCT04298229|460155748|FG000|Overall Study|Did not receive IV loop diuretics|2|||
127873464|NCT04298229|460155749|FG001|Overall Study|Did not receive IV loop diuretics|0|||
127873465|NCT00262119|460155751|FG000|Overall Study|Lost to Follow-up|38|||
127873466|NCT00262119|460155752|FG001|Overall Study|Lost to Follow-up|51|||
127873467|NCT00262119|460155753|FG002|Overall Study|Lost to Follow-up|42|||
127873468|NCT00262119|460155751|FG000|Overall Study|Death|20|||
127873469|NCT00262119|460155752|FG001|Overall Study|Death|19|||
127873470|NCT00262119|460155753|FG002|Overall Study|Death|16|||
127873471|NCT01683565|460155754|FG000|Overall Study|Lost to Follow-up|2|||
127873472|NCT01683565|460155755|FG001|Overall Study|Lost to Follow-up|0|||
127873473|NCT01683565|460155754|FG000|Overall Study|Discontinued Intervention|1|||
127873474|NCT01683565|460155755|FG001|Overall Study|Discontinued Intervention|1|||
127873475|NCT00071006|460155756|FG000|Overall Study|Lack of Efficacy|7|||
127873476|NCT00071006|460155756|FG000|Overall Study|Adverse Event|1|||
127873477|NCT00071006|460155756|FG000|Overall Study|Withdrawal by Subject|1|||
127873478|NCT00071006|460155756|FG000|Overall Study|Other|3|||
127873479|NCT00859313|460155757|FG000|Overall Study|Lack of Efficacy|2|||
127873480|NCT00859313|460155757|FG000|Overall Study|Adverse Event|1|||
127873481|NCT00859313|460155757|FG000|Overall Study|staff error|1|||
127873482|NCT05261126|460155758|FG000|Overall Study|Death|0|||
127873483|NCT05261126|460155759|FG001|Overall Study|Death|0|||
127873484|NCT05261126|460155760|FG002|Overall Study|Death|1|||
127873485|NCT05261126|460155761|FG003|Overall Study|Death|0|||
127873486|NCT05261126|460155762|FG004|Overall Study|Death|0|||
127873487|NCT05261126|460155758|FG000|Overall Study|Lost to Follow-up|0|||
127873488|NCT05261126|460155759|FG001|Overall Study|Lost to Follow-up|0|||
127873489|NCT05261126|460155760|FG002|Overall Study|Lost to Follow-up|0|||
127873490|NCT05261126|460155761|FG003|Overall Study|Lost to Follow-up|0|||
127873491|NCT05261126|460155762|FG004|Overall Study|Lost to Follow-up|1|||
127873492|NCT05261126|460155758|FG000|Overall Study|Physician Decision|1|||
127873493|NCT05261126|460155759|FG001|Overall Study|Physician Decision|0|||
127873494|NCT05261126|460155760|FG002|Overall Study|Physician Decision|0|||
127873495|NCT05261126|460155761|FG003|Overall Study|Physician Decision|0|||
127873496|NCT05261126|460155762|FG004|Overall Study|Physician Decision|0|||
127873497|NCT05261126|460155758|FG000|Overall Study|Screen Failure|0|||
127873498|NCT05261126|460155759|FG001|Overall Study|Screen Failure|0|||
127873499|NCT05261126|460155760|FG002|Overall Study|Screen Failure|0|||
127873500|NCT05261126|460155761|FG003|Overall Study|Screen Failure|0|||
127873501|NCT05261126|460155762|FG004|Overall Study|Screen Failure|1|||
127873502|NCT05261126|460155758|FG000|Overall Study|Withdrawal by Subject|1|||
127873503|NCT05261126|460155759|FG001|Overall Study|Withdrawal by Subject|0|||
127873504|NCT05261126|460155760|FG002|Overall Study|Withdrawal by Subject|1|||
127873505|NCT05261126|460155761|FG003|Overall Study|Withdrawal by Subject|1|||
127983722|NCT01764997|460562570|FG002|Run-in Period|Adverse Event|0|||
127873506|NCT05261126|460155762|FG004|Overall Study|Withdrawal by Subject|0|||
127873507|NCT05261126|460155758|FG000|Overall Study|Not Recorded|0|||
127873508|NCT05261126|460155759|FG001|Overall Study|Not Recorded|0|||
127873509|NCT05261126|460155760|FG002|Overall Study|Not Recorded|0|||
127873510|NCT05261126|460155761|FG003|Overall Study|Not Recorded|1|||
127873511|NCT05261126|460155762|FG004|Overall Study|Not Recorded|0|||
127873512|NCT03901274|460155763|FG000|Overall Study|Lost to Follow-up|120|||
127873513|NCT03901274|460155764|FG001|Overall Study|Lost to Follow-up|124|||
127873514|NCT03901274|460155763|FG000|Overall Study|Withdrawal by Subject|0|||
127873515|NCT03901274|460155764|FG001|Overall Study|Withdrawal by Subject|6|||
127873516|NCT05570604|460155765|FG000|Overall Study|Lost to Follow-up|1|||
127873517|NCT05570604|460155766|FG001|Overall Study|Lost to Follow-up|5|||
127873518|NCT05570604|460155765|FG000|Overall Study|Illness|2|||
127873519|NCT05570604|460155766|FG001|Overall Study|Illness|2|||
127873520|NCT00145119|460155769|FG000|Overall Study|Death|45|||
127873521|NCT04527380|460155770|FG000|Overall Study|Lack of Efficacy|0|||
127873522|NCT04527380|460155771|FG001|Overall Study|Lack of Efficacy|1|||
127873523|NCT04527380|460155770|FG000|Overall Study|Withdrawal by Subject|1|||
127873524|NCT04527380|460155771|FG001|Overall Study|Withdrawal by Subject|0|||
127873525|NCT05437211|460155778|FG000|Overall Study|Patient's decision|1|||
127873526|NCT05437211|460155779|FG001|Overall Study|Patient's decision|1|||
127873527|NCT04410991|460155781|FG000|Overall Study|Poor compliance to protocol|5|||
127873528|NCT04410991|460155782|FG001|Overall Study|Poor compliance to protocol|4|||
127873529|NCT04410991|460155781|FG000|Overall Study|Withdrawal by Subject|59|||
127873530|NCT04410991|460155782|FG001|Overall Study|Withdrawal by Subject|55|||
127873531|NCT04410991|460155781|FG000|Overall Study|Other|10|||
127873532|NCT04410991|460155782|FG001|Overall Study|Other|4|||
127873533|NCT01463631|460155792|FG000|Overall Study|Withdrawal by Subject|0|||
127873534|NCT01463631|460155793|FG001|Overall Study|Withdrawal by Subject|0|||
127873535|NCT01463631|460155794|FG002|Overall Study|Withdrawal by Subject|0|||
127873536|NCT01463631|460155795|FG003|Overall Study|Withdrawal by Subject|1|||
127873537|NCT01463631|460155792|FG000|Overall Study|Death|0|||
127873538|NCT01463631|460155793|FG001|Overall Study|Death|0|||
127873539|NCT01463631|460155794|FG002|Overall Study|Death|1|||
127873540|NCT01463631|460155795|FG003|Overall Study|Death|0|||
127873541|NCT01463631|460155792|FG000|Overall Study|Progressive Disease|0|||
127873542|NCT01463631|460155793|FG001|Overall Study|Progressive Disease|0|||
127873543|NCT01463631|460155794|FG002|Overall Study|Progressive Disease|0|||
127873544|NCT01463631|460155795|FG003|Overall Study|Progressive Disease|5|||
127873545|NCT05966129|460155796|FG000|Overall Study|Death|1|||
127873546|NCT05966129|460155797|FG001|Overall Study|Death|2|||
127873547|NCT05966129|460155796|FG000|Overall Study|Lost to Follow-up|63|||
127873548|NCT05966129|460155797|FG001|Overall Study|Lost to Follow-up|66|||
127873549|NCT05966129|460155796|FG000|Overall Study|Protocol Violation|1|||
127873550|NCT05966129|460155797|FG001|Overall Study|Protocol Violation|0|||
127873551|NCT05966129|460155796|FG000|Overall Study|Withdrawal by Subject|26|||
127873552|NCT05966129|460155797|FG001|Overall Study|Withdrawal by Subject|25|||
127873553|NCT05966129|460155796|FG000|Overall Study|Surgery not completed|63|||
127873554|NCT05966129|460155797|FG001|Overall Study|Surgery not completed|69|||
127873555|NCT05966129|460155796|FG000|Overall Study|Surgery logistics issue|2|||
127873556|NCT05966129|460155797|FG001|Overall Study|Surgery logistics issue|1|||
127873557|NCT03145207|460155798|FG000|Overall Study|volunteer started taking allergy shots|1|||
127873558|NCT03145207|460155798|FG000|Overall Study|baseline blood pressure high|1|||
127873559|NCT02513732|460157877|FG000|Overall Study|Lost to Follow-up|11|||
127873560|NCT02513732|460157877|FG000|Overall Study|Death|9|||
127873561|NCT02513732|460157877|FG000|Overall Study|Changing hospital|2|||
127873562|NCT01740297|460157878|FG000|Overall Study|Withdrawal by Subject|4|||
127873563|NCT01740297|460157879|FG001|Overall Study|Withdrawal by Subject|16|||
127873564|NCT01740297|460157880|FG002|Overall Study|Withdrawal by Subject|17|||
127873565|NCT01740297|460157878|FG000|Overall Study|Death|8|||
127873566|NCT01740297|460157879|FG001|Overall Study|Death|46|||
127873567|NCT01740297|460157880|FG002|Overall Study|Death|40|||
127873568|NCT01740297|460157878|FG000|Overall Study|Lost to Follow-up|1|||
127873569|NCT01740297|460157879|FG001|Overall Study|Lost to Follow-up|2|||
127873570|NCT01740297|460157880|FG002|Overall Study|Lost to Follow-up|4|||
127873571|NCT00761462|460157884|FG000|Treatment|Subjects never received study medication|23|||
127873572|NCT00761462|460157885|FG001|Treatment|Subjects never received study medication|12|||
127873573|NCT00761462|460157884|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
127873574|NCT00761462|460157885|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
127873575|NCT00761462|460157884|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
127873576|NCT00761462|460157885|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
127873577|NCT00761462|460157884|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
127873578|NCT00761462|460157885|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
127873579|NCT01479777|460157886|FG000|Overall Study|Physician Decision|2|||
127873580|NCT01541644|460157892|FG000|Overall Study|Withdrawal by Subject|3|||
127873581|NCT02389621|460157895|FG000|Treatment Period|Withdrawal by Subject|1|||
127873582|NCT02389621|460157896|FG001|Treatment Period|Withdrawal by Subject|1|||
127873583|NCT02389621|460157895|FG000|Posttreatment Period|Adverse Event|3|||
127873584|NCT02389621|460157896|FG001|Posttreatment Period|Adverse Event|1|||
127873585|NCT02389621|460157895|FG000|Posttreatment Period|Withdrawal by Subject|3|||
127873586|NCT02389621|460157896|FG001|Posttreatment Period|Withdrawal by Subject|2|||
127873587|NCT02389621|460157895|FG000|Posttreatment Period|Lost to Follow-up|1|||
127873588|NCT02389621|460157896|FG001|Posttreatment Period|Lost to Follow-up|1|||
127873589|NCT02389621|460157895|FG000|Posttreatment Period|Other - Miscellaneous|2|||
127873590|NCT02389621|460157896|FG001|Posttreatment Period|Other - Miscellaneous|0|||
127873591|NCT00779857|460157902|FG000|Overall Study|Death|1|||
127873592|NCT00779857|460157902|FG000|Overall Study|Withdrawal by Subject|3|||
127873593|NCT00779857|460157902|FG000|Overall Study|Missed Visit|2|||
127873594|NCT00620776|460157903|FG000|Overall Study|Did not receive treatment|3|||
127873595|NCT00620776|460157904|FG001|Overall Study|Did not receive treatment|5|||
127873596|NCT00620776|460157903|FG000|Overall Study|Adverse Event|2|||
127873597|NCT00620776|460157904|FG001|Overall Study|Adverse Event|3|||
127873598|NCT00620776|460157903|FG000|Overall Study|Lack of Efficacy|2|||
127873599|NCT00620776|460157904|FG001|Overall Study|Lack of Efficacy|1|||
127873600|NCT00620776|460157903|FG000|Overall Study|Lost to Follow-up|2|||
127873601|NCT00620776|460157904|FG001|Overall Study|Lost to Follow-up|5|||
127873602|NCT00620776|460157903|FG000|Overall Study|Withdrawal by Subject|3|||
127873603|NCT00620776|460157904|FG001|Overall Study|Withdrawal by Subject|2|||
127873604|NCT03205046|460157906|FG000|Overall Study|Death|10|||
127873605|NCT03205046|460157907|FG001|Overall Study|Death|6|||
127873606|NCT03205046|460157906|FG000|Overall Study|Withdrawal by Subject|1|||
127873607|NCT03205046|460157907|FG001|Overall Study|Withdrawal by Subject|2|||
127873608|NCT03205046|460157906|FG000|Overall Study|Lost to Follow-up|0|||
127873609|NCT03205046|460157907|FG001|Overall Study|Lost to Follow-up|1|||
127873610|NCT03205046|460157906|FG000|Overall Study|Study terminated by sponsor|2|||
127873611|NCT03205046|460157907|FG001|Overall Study|Study terminated by sponsor|1|||
127873612|NCT01023815|460157908|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
127873613|NCT01023815|460157909|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
127873614|NCT01023815|460157910|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
127873615|NCT01023815|460157911|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
127873616|NCT01023815|460157908|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
127873617|NCT01023815|460157909|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
127873618|NCT01023815|460157910|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
127873619|NCT01023815|460157911|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
127873620|NCT01023815|460157908|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
127873621|NCT01023815|460157909|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
127873622|NCT01023815|460157910|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
127873623|NCT01023815|460157911|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
127873624|NCT01023815|460157908|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
127873625|NCT01023815|460157909|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
127873626|NCT01023815|460157910|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
127873627|NCT01023815|460157911|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
127873628|NCT01023815|460157908|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
127873629|NCT01023815|460157909|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
127873630|NCT01023815|460157910|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
127873631|NCT01023815|460157911|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
127873632|NCT03253809|460157916|FG000|Overall Study|Unable to obtain study related data|14|||
127873633|NCT03992456|460157917|FG000|Overall Study|Withdrawal by Subject|1|||
127873634|NCT03992456|460157918|FG001|Overall Study|Withdrawal by Subject|0|||
127873635|NCT03992456|460157917|FG000|Overall Study|Disease progression|4|||
127873636|NCT03992456|460157918|FG001|Overall Study|Disease progression|5|||
127873637|NCT03992456|460157917|FG000|Overall Study|Emergency surgery unrelated to treatment|0|||
127873638|NCT03992456|460157918|FG001|Overall Study|Emergency surgery unrelated to treatment|1|||
127873639|NCT00910000|460157922|FG000|Overall Study|Adverse Event|0|||
127873640|NCT00910000|460157923|FG001|Overall Study|Adverse Event|3|||
127873641|NCT00910000|460157924|FG002|Overall Study|Adverse Event|2|||
127873642|NCT00910000|460157925|FG003|Overall Study|Adverse Event|2|||
127873643|NCT00910000|460157926|FG004|Overall Study|Adverse Event|0|||
127873644|NCT00910000|460157927|FG005|Overall Study|Adverse Event|1|||
127873645|NCT00910000|460157922|FG000|Overall Study|Withdrawal by Subject|0|||
127873646|NCT00910000|460157923|FG001|Overall Study|Withdrawal by Subject|0|||
127873647|NCT00910000|460157924|FG002|Overall Study|Withdrawal by Subject|1|||
127873648|NCT00910000|460157925|FG003|Overall Study|Withdrawal by Subject|0|||
127873649|NCT00910000|460157926|FG004|Overall Study|Withdrawal by Subject|1|||
127873650|NCT00910000|460157927|FG005|Overall Study|Withdrawal by Subject|0|||
127873651|NCT04113746|460157928|FG000|Overall Study|Lost to Follow-up|4|||
127873652|NCT04113746|460157929|FG001|Overall Study|Lost to Follow-up|4|||
127873653|NCT01977625|460157930|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
127873654|NCT01977625|460157931|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
127873655|NCT01977625|460157930|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
127873656|NCT01977625|460157931|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
127873657|NCT02594384|460157932|FG000|Overall Study|Disease Progression|3|||
127873658|NCT02594384|460157933|FG001|Overall Study|Disease Progression|7|||
127873659|NCT02594384|460157934|FG002|Overall Study|Disease Progression|0|||
127873660|NCT02594384|460157935|FG003|Overall Study|Disease Progression|2|||
127873661|NCT02594384|460157936|FG004|Overall Study|Disease Progression|2|||
127873662|NCT02594384|460157937|FG005|Overall Study|Disease Progression|12|||
127873663|NCT02594384|460157938|FG006|Overall Study|Disease Progression|5|||
127873664|NCT02594384|460157939|FG007|Overall Study|Disease Progression|5|||
127873665|NCT02594384|460157932|FG000|Overall Study|Adverse Event|0|||
127873666|NCT02594384|460157933|FG001|Overall Study|Adverse Event|1|||
127873667|NCT02594384|460157934|FG002|Overall Study|Adverse Event|4|||
127873668|NCT02594384|460157935|FG003|Overall Study|Adverse Event|1|||
127873669|NCT02594384|460157936|FG004|Overall Study|Adverse Event|0|||
127873670|NCT02594384|460157937|FG005|Overall Study|Adverse Event|6|||
127873671|NCT02594384|460157938|FG006|Overall Study|Adverse Event|1|||
127873672|NCT02594384|460157939|FG007|Overall Study|Adverse Event|1|||
127873673|NCT02594384|460157932|FG000|Overall Study|Withdrawal by Subject|0|||
127873674|NCT02594384|460157933|FG001|Overall Study|Withdrawal by Subject|0|||
127873675|NCT02594384|460157934|FG002|Overall Study|Withdrawal by Subject|0|||
127873676|NCT02594384|460157935|FG003|Overall Study|Withdrawal by Subject|1|||
127873677|NCT02594384|460157936|FG004|Overall Study|Withdrawal by Subject|0|||
127873678|NCT02594384|460157937|FG005|Overall Study|Withdrawal by Subject|0|||
127873679|NCT02594384|460157938|FG006|Overall Study|Withdrawal by Subject|0|||
127873680|NCT02594384|460157939|FG007|Overall Study|Withdrawal by Subject|1|||
127873681|NCT02594384|460157932|FG000|Overall Study|Physician Decision|0|||
127873682|NCT02594384|460157933|FG001|Overall Study|Physician Decision|0|||
127873683|NCT02594384|460157934|FG002|Overall Study|Physician Decision|0|||
127873684|NCT02594384|460157935|FG003|Overall Study|Physician Decision|0|||
127873685|NCT02594384|460157936|FG004|Overall Study|Physician Decision|0|||
127873686|NCT02594384|460157937|FG005|Overall Study|Physician Decision|1|||
127873687|NCT02594384|460157938|FG006|Overall Study|Physician Decision|2|||
127873688|NCT02594384|460157939|FG007|Overall Study|Physician Decision|0|||
127873689|NCT02594384|460157932|FG000|Overall Study|Progressive Leukocytosis|0|||
127873690|NCT02594384|460157933|FG001|Overall Study|Progressive Leukocytosis|0|||
127873691|NCT02594384|460157934|FG002|Overall Study|Progressive Leukocytosis|1|||
127873692|NCT02594384|460157935|FG003|Overall Study|Progressive Leukocytosis|0|||
127873693|NCT02594384|460157936|FG004|Overall Study|Progressive Leukocytosis|0|||
127873694|NCT02594384|460157937|FG005|Overall Study|Progressive Leukocytosis|0|||
127873695|NCT02594384|460157938|FG006|Overall Study|Progressive Leukocytosis|0|||
127873696|NCT02594384|460157939|FG007|Overall Study|Progressive Leukocytosis|0|||
127873697|NCT02594384|460157932|FG000|Overall Study|Lack of Efficacy|0|||
127873698|NCT02594384|460157933|FG001|Overall Study|Lack of Efficacy|0|||
127873699|NCT02594384|460157934|FG002|Overall Study|Lack of Efficacy|0|||
127873700|NCT02594384|460157935|FG003|Overall Study|Lack of Efficacy|0|||
127873701|NCT02594384|460157936|FG004|Overall Study|Lack of Efficacy|1|||
127873702|NCT02594384|460157937|FG005|Overall Study|Lack of Efficacy|0|||
127873703|NCT02594384|460157938|FG006|Overall Study|Lack of Efficacy|0|||
127873704|NCT02594384|460157939|FG007|Overall Study|Lack of Efficacy|0|||
127873705|NCT02594384|460157932|FG000|Overall Study|Substantial noncompliance|0|||
127873706|NCT02594384|460157933|FG001|Overall Study|Substantial noncompliance|0|||
127873707|NCT02594384|460157934|FG002|Overall Study|Substantial noncompliance|0|||
127873708|NCT02594384|460157935|FG003|Overall Study|Substantial noncompliance|0|||
127873709|NCT02594384|460157936|FG004|Overall Study|Substantial noncompliance|0|||
127873710|NCT02594384|460157937|FG005|Overall Study|Substantial noncompliance|0|||
127873711|NCT02594384|460157938|FG006|Overall Study|Substantial noncompliance|1|||
127873712|NCT02594384|460157939|FG007|Overall Study|Substantial noncompliance|0|||
127873713|NCT03919669|460157942|FG000|Overall Study|Withdrawal by Subject|1|||
127873714|NCT03919669|460157943|FG001|Overall Study|Withdrawal by Subject|0|||
127873715|NCT03919669|460157944|FG002|Overall Study|Withdrawal by Subject|0|||
127873716|NCT03125382|460157945|FG000|Randomization|screening failure|1|||
127873717|NCT03125382|460157946|FG001|Randomization|screening failure|4|||
127873718|NCT03125382|460157947|FG002|Randomization|screening failure|2|||
127873719|NCT03125382|460157948|FG003|Randomization|screening failure|0|||
127873720|NCT03125382|460157945|FG000|Follow-up|Death|1|||
127873721|NCT03125382|460157946|FG001|Follow-up|Death|2|||
127873722|NCT03125382|460157947|FG002|Follow-up|Death|1|||
127873723|NCT03125382|460157948|FG003|Follow-up|Death|2|||
127873724|NCT03125382|460157945|FG000|Follow-up|Lost to Follow-up|1|||
127873725|NCT03125382|460157946|FG001|Follow-up|Lost to Follow-up|4|||
127873726|NCT03125382|460157947|FG002|Follow-up|Lost to Follow-up|3|||
127873727|NCT03125382|460157948|FG003|Follow-up|Lost to Follow-up|1|||
127873728|NCT04964960|460157949|FG000|Overall Study|Withdrawal by Subject|1|||
127873729|NCT02686749|460157950|FG000|Overall Study|terminated for poor enrollment|2|||
127873730|NCT02686749|460157951|FG001|Overall Study|terminated for poor enrollment|2|||
127873731|NCT02319642|460157952|FG000|Overall Study|Adverse Event|2|||
127873732|NCT02319642|460157953|FG001|Overall Study|Adverse Event|4|||
127873733|NCT02319642|460157952|FG000|Overall Study|Lack of Efficacy|1|||
127873734|NCT02319642|460157953|FG001|Overall Study|Lack of Efficacy|1|||
127649751|NCT02496767|459339500|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
127649752|NCT02496767|459339501|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
127649753|NCT02496767|459339502|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
127649754|NCT02496767|459339503|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
127649755|NCT02496767|459339504|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
127649756|NCT02496767|459339505|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
127649757|NCT02496767|459339506|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
127649758|NCT02496767|459339499|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
127649759|NCT02496767|459339500|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
127649760|NCT02496767|459339501|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
127649761|NCT02496767|459339502|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
127649762|NCT02496767|459339503|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
127649763|NCT02496767|459339504|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
127649764|NCT02496767|459339505|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
127649765|NCT02496767|459339506|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
127649766|NCT02496767|459339499|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
127649767|NCT02496767|459339500|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
127649768|NCT02496767|459339501|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
127649769|NCT02496767|459339502|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
127649770|NCT02496767|459339503|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
127649771|NCT02496767|459339504|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
127649772|NCT02496767|459339505|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
127649773|NCT02496767|459339506|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
127649774|NCT02496767|459339499|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
127649775|NCT02496767|459339500|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
127649776|NCT02496767|459339501|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
127649777|NCT02496767|459339502|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
127649778|NCT02496767|459339503|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
127649779|NCT02496767|459339504|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
127649780|NCT02496767|459339505|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
127649781|NCT02496767|459339506|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
127649782|NCT02496767|459339499|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
127649783|NCT02496767|459339500|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
127649784|NCT02496767|459339501|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
127649785|NCT02496767|459339502|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
127649786|NCT02496767|459339503|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
127649787|NCT02496767|459339504|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
127649788|NCT02496767|459339505|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
127649789|NCT02496767|459339506|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
127649790|NCT02496767|459339499|FG000|Double-blind, Withdrawal Phase|Death|0|||
127649791|NCT02496767|459339500|FG001|Double-blind, Withdrawal Phase|Death|0|||
127873735|NCT02319642|460157952|FG000|Overall Study|Withdrawal by Subject|1|||
127873736|NCT02319642|460157953|FG001|Overall Study|Withdrawal by Subject|1|||
127873737|NCT04668066|460157954|FG000|Part 1: Treatment Phase|Adverse Event|0|||
127873738|NCT04668066|460157955|FG001|Part 1: Treatment Phase|Adverse Event|0|||
127649792|NCT02496767|459339501|FG002|Double-blind, Withdrawal Phase|Death|0|||
127649793|NCT02496767|459339502|FG003|Double-blind, Withdrawal Phase|Death|0|||
127649794|NCT02496767|459339503|FG004|Double-blind, Withdrawal Phase|Death|0|||
127649795|NCT02496767|459339504|FG005|Double-blind, Withdrawal Phase|Death|0|||
127649796|NCT02496767|459339505|FG006|Double-blind, Withdrawal Phase|Death|1|||
127649797|NCT02496767|459339506|FG007|Double-blind, Withdrawal Phase|Death|2|||
127649798|NCT02496767|459339499|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
127649799|NCT02496767|459339500|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
127649800|NCT02496767|459339501|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
127649801|NCT02496767|459339502|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
127649802|NCT02496767|459339503|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
127649803|NCT02496767|459339504|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
127649804|NCT02496767|459339505|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
127649805|NCT02496767|459339506|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
127649806|NCT02277990|459339507|FG000|Overall Study|Death|170|||
127649807|NCT02277990|459339508|FG001|Overall Study|Death|188|||
127649808|NCT02277990|459339507|FG000|Overall Study|Withdrawal by Subject|64|||
127649809|NCT02277990|459339508|FG001|Overall Study|Withdrawal by Subject|53|||
127649810|NCT02277990|459339507|FG000|Overall Study|Physician Decision|40|||
127873739|NCT04668066|460157956|FG002|Part 1: Treatment Phase|Adverse Event|0|||
127873740|NCT04668066|460157957|FG003|Part 1: Treatment Phase|Adverse Event|0|||
127873741|NCT04668066|460157958|FG004|Part 1: Treatment Phase|Adverse Event|0|||
127873742|NCT04668066|460157959|FG005|Part 1: Treatment Phase|Adverse Event|0|||
127873743|NCT04668066|460157960|FG006|Part 1: Treatment Phase|Adverse Event|0|||
127873744|NCT04668066|460157961|FG007|Part 1: Treatment Phase|Adverse Event|0|||
127873745|NCT04668066|460157962|FG008|Part 1: Treatment Phase|Adverse Event|0|||
127873746|NCT04668066|460157963|FG009|Part 1: Treatment Phase|Adverse Event|0|||
127873747|NCT04668066|460157964|FG010|Part 1: Treatment Phase|Adverse Event|0|||
127873748|NCT04668066|460157965|FG011|Part 1: Treatment Phase|Adverse Event|1|||
127873749|NCT04668066|460157966|FG012|Part 1: Treatment Phase|Adverse Event|1|||
127873750|NCT04668066|460157967|FG013|Part 1: Treatment Phase|Adverse Event|0|||
127873751|NCT04668066|460157968|FG014|Part 1: Treatment Phase|Adverse Event|0|||
127873752|NCT04668066|460157969|FG015|Part 1: Treatment Phase|Adverse Event|0|||
127873753|NCT04668066|460157970|FG016|Part 1: Treatment Phase|Adverse Event|0|||
127873754|NCT04668066|460157971|FG017|Part 1: Treatment Phase|Adverse Event|0|||
127873755|NCT04668066|460157972|FG018|Part 1: Treatment Phase|Adverse Event|0|||
127873756|NCT04668066|460157954|FG000|Part 1: Treatment Phase|Lost to Follow-up|0|||
127873757|NCT04668066|460157955|FG001|Part 1: Treatment Phase|Lost to Follow-up|0|||
127873758|NCT04668066|460157956|FG002|Part 1: Treatment Phase|Lost to Follow-up|1|||
127873759|NCT04668066|460157957|FG003|Part 1: Treatment Phase|Lost to Follow-up|0|||
127873760|NCT04668066|460157958|FG004|Part 1: Treatment Phase|Lost to Follow-up|0|||
127873761|NCT04668066|460157959|FG005|Part 1: Treatment Phase|Lost to Follow-up|0|||
127873762|NCT04668066|460157960|FG006|Part 1: Treatment Phase|Lost to Follow-up|0|||
127873763|NCT04668066|460157961|FG007|Part 1: Treatment Phase|Lost to Follow-up|0|||
127873764|NCT04668066|460157962|FG008|Part 1: Treatment Phase|Lost to Follow-up|0|||
127873765|NCT04668066|460157963|FG009|Part 1: Treatment Phase|Lost to Follow-up|0|||
127873766|NCT04668066|460157964|FG010|Part 1: Treatment Phase|Lost to Follow-up|0|||
127873767|NCT04668066|460157965|FG011|Part 1: Treatment Phase|Lost to Follow-up|0|||
127873768|NCT04668066|460157966|FG012|Part 1: Treatment Phase|Lost to Follow-up|0|||
127873769|NCT04668066|460157967|FG013|Part 1: Treatment Phase|Lost to Follow-up|0|||
127873770|NCT04668066|460157968|FG014|Part 1: Treatment Phase|Lost to Follow-up|0|||
127873771|NCT04668066|460157969|FG015|Part 1: Treatment Phase|Lost to Follow-up|0|||
127873772|NCT04668066|460157970|FG016|Part 1: Treatment Phase|Lost to Follow-up|0|||
127873773|NCT04668066|460157971|FG017|Part 1: Treatment Phase|Lost to Follow-up|0|||
127873774|NCT04668066|460157972|FG018|Part 1: Treatment Phase|Lost to Follow-up|0|||
127873775|NCT04668066|460157954|FG000|Part 1: Treatment Phase|Other|0|||
127873776|NCT04668066|460157955|FG001|Part 1: Treatment Phase|Other|0|||
127873777|NCT04668066|460157956|FG002|Part 1: Treatment Phase|Other|0|||
127873778|NCT04668066|460157957|FG003|Part 1: Treatment Phase|Other|0|||
127873779|NCT04668066|460157958|FG004|Part 1: Treatment Phase|Other|0|||
127873780|NCT04668066|460157959|FG005|Part 1: Treatment Phase|Other|0|||
127873781|NCT04668066|460157960|FG006|Part 1: Treatment Phase|Other|0|||
127873782|NCT04668066|460157961|FG007|Part 1: Treatment Phase|Other|0|||
127873783|NCT04668066|460157962|FG008|Part 1: Treatment Phase|Other|0|||
127873784|NCT04668066|460157963|FG009|Part 1: Treatment Phase|Other|0|||
127873785|NCT04668066|460157964|FG010|Part 1: Treatment Phase|Other|0|||
127873786|NCT04668066|460157965|FG011|Part 1: Treatment Phase|Other|1|||
127873787|NCT04668066|460157966|FG012|Part 1: Treatment Phase|Other|0|||
127873788|NCT04668066|460157967|FG013|Part 1: Treatment Phase|Other|0|||
127873789|NCT04668066|460157968|FG014|Part 1: Treatment Phase|Other|0|||
127873790|NCT04668066|460157969|FG015|Part 1: Treatment Phase|Other|0|||
127873791|NCT04668066|460157970|FG016|Part 1: Treatment Phase|Other|0|||
127873792|NCT04668066|460157971|FG017|Part 1: Treatment Phase|Other|0|||
127873793|NCT04668066|460157972|FG018|Part 1: Treatment Phase|Other|0|||
127873794|NCT04668066|460157954|FG000|Part 1: Treatment Phase|Withdrawal by Subject|0|||
127873795|NCT04668066|460157955|FG001|Part 1: Treatment Phase|Withdrawal by Subject|0|||
127873796|NCT04668066|460157956|FG002|Part 1: Treatment Phase|Withdrawal by Subject|0|||
127873797|NCT04668066|460157957|FG003|Part 1: Treatment Phase|Withdrawal by Subject|0|||
127873798|NCT04668066|460157958|FG004|Part 1: Treatment Phase|Withdrawal by Subject|0|||
127873799|NCT04668066|460157959|FG005|Part 1: Treatment Phase|Withdrawal by Subject|0|||
127873800|NCT04668066|460157960|FG006|Part 1: Treatment Phase|Withdrawal by Subject|0|||
127873801|NCT04668066|460157961|FG007|Part 1: Treatment Phase|Withdrawal by Subject|0|||
127873802|NCT04668066|460157962|FG008|Part 1: Treatment Phase|Withdrawal by Subject|0|||
127873803|NCT04668066|460157963|FG009|Part 1: Treatment Phase|Withdrawal by Subject|0|||
127873804|NCT04668066|460157964|FG010|Part 1: Treatment Phase|Withdrawal by Subject|0|||
127873805|NCT04668066|460157965|FG011|Part 1: Treatment Phase|Withdrawal by Subject|0|||
127873806|NCT04668066|460157966|FG012|Part 1: Treatment Phase|Withdrawal by Subject|1|||
127873807|NCT04668066|460157967|FG013|Part 1: Treatment Phase|Withdrawal by Subject|0|||
127873808|NCT04668066|460157968|FG014|Part 1: Treatment Phase|Withdrawal by Subject|0|||
127873809|NCT04668066|460157969|FG015|Part 1: Treatment Phase|Withdrawal by Subject|2|||
127873810|NCT04668066|460157970|FG016|Part 1: Treatment Phase|Withdrawal by Subject|0|||
127873811|NCT04668066|460157971|FG017|Part 1: Treatment Phase|Withdrawal by Subject|0|||
127873812|NCT04668066|460157972|FG018|Part 1: Treatment Phase|Withdrawal by Subject|0|||
127873813|NCT04668066|460157954|FG000|Part 1: Follow-Up|Adverse Event|0|||
127873814|NCT04668066|460157955|FG001|Part 1: Follow-Up|Adverse Event|0|||
127873815|NCT04668066|460157956|FG002|Part 1: Follow-Up|Adverse Event|0|||
127873816|NCT04668066|460157957|FG003|Part 1: Follow-Up|Adverse Event|0|||
127873817|NCT04668066|460157958|FG004|Part 1: Follow-Up|Adverse Event|0|||
127873818|NCT04668066|460157959|FG005|Part 1: Follow-Up|Adverse Event|0|||
127873819|NCT04668066|460157960|FG006|Part 1: Follow-Up|Adverse Event|0|||
127873820|NCT04668066|460157961|FG007|Part 1: Follow-Up|Adverse Event|0|||
127873821|NCT04668066|460157962|FG008|Part 1: Follow-Up|Adverse Event|0|||
127873822|NCT04668066|460157963|FG009|Part 1: Follow-Up|Adverse Event|0|||
127873823|NCT04668066|460157964|FG010|Part 1: Follow-Up|Adverse Event|0|||
127873824|NCT04668066|460157965|FG011|Part 1: Follow-Up|Adverse Event|1|||
127873825|NCT04668066|460157966|FG012|Part 1: Follow-Up|Adverse Event|0|||
127873826|NCT04668066|460157967|FG013|Part 1: Follow-Up|Adverse Event|0|||
127873827|NCT04668066|460157968|FG014|Part 1: Follow-Up|Adverse Event|0|||
127873828|NCT04668066|460157969|FG015|Part 1: Follow-Up|Adverse Event|0|||
127873829|NCT04668066|460157970|FG016|Part 1: Follow-Up|Adverse Event|0|||
127873830|NCT04668066|460157971|FG017|Part 1: Follow-Up|Adverse Event|0|||
127873831|NCT04668066|460157972|FG018|Part 1: Follow-Up|Adverse Event|0|||
127873832|NCT04668066|460157954|FG000|Part 1: Follow-Up|Other|0|||
127873833|NCT04668066|460157955|FG001|Part 1: Follow-Up|Other|0|||
127873834|NCT04668066|460157956|FG002|Part 1: Follow-Up|Other|0|||
127873835|NCT04668066|460157957|FG003|Part 1: Follow-Up|Other|0|||
127873836|NCT04668066|460157958|FG004|Part 1: Follow-Up|Other|0|||
127873837|NCT04668066|460157959|FG005|Part 1: Follow-Up|Other|0|||
127873838|NCT04668066|460157960|FG006|Part 1: Follow-Up|Other|0|||
127873839|NCT04668066|460157961|FG007|Part 1: Follow-Up|Other|0|||
127873840|NCT04668066|460157962|FG008|Part 1: Follow-Up|Other|0|||
127873841|NCT04668066|460157963|FG009|Part 1: Follow-Up|Other|0|||
127873842|NCT04668066|460157964|FG010|Part 1: Follow-Up|Other|0|||
127873843|NCT04668066|460157965|FG011|Part 1: Follow-Up|Other|1|||
127873844|NCT04668066|460157966|FG012|Part 1: Follow-Up|Other|1|||
127873845|NCT04668066|460157967|FG013|Part 1: Follow-Up|Other|0|||
127873846|NCT04668066|460157968|FG014|Part 1: Follow-Up|Other|0|||
127873847|NCT04668066|460157969|FG015|Part 1: Follow-Up|Other|0|||
127873848|NCT04668066|460157970|FG016|Part 1: Follow-Up|Other|0|||
127873849|NCT04668066|460157971|FG017|Part 1: Follow-Up|Other|0|||
127873850|NCT04668066|460157972|FG018|Part 1: Follow-Up|Other|0|||
127873851|NCT04668066|460157954|FG000|Part 1: Follow-Up|Withdrawal by Subject|0|||
127873852|NCT04668066|460157955|FG001|Part 1: Follow-Up|Withdrawal by Subject|0|||
127873853|NCT04668066|460157956|FG002|Part 1: Follow-Up|Withdrawal by Subject|0|||
127873854|NCT04668066|460157957|FG003|Part 1: Follow-Up|Withdrawal by Subject|0|||
127873855|NCT04668066|460157958|FG004|Part 1: Follow-Up|Withdrawal by Subject|0|||
127873856|NCT04668066|460157959|FG005|Part 1: Follow-Up|Withdrawal by Subject|0|||
127873857|NCT04668066|460157960|FG006|Part 1: Follow-Up|Withdrawal by Subject|0|||
127873858|NCT04668066|460157961|FG007|Part 1: Follow-Up|Withdrawal by Subject|0|||
127873859|NCT04668066|460157962|FG008|Part 1: Follow-Up|Withdrawal by Subject|0|||
127873860|NCT04668066|460157963|FG009|Part 1: Follow-Up|Withdrawal by Subject|0|||
127873861|NCT04668066|460157964|FG010|Part 1: Follow-Up|Withdrawal by Subject|0|||
127873862|NCT04668066|460157965|FG011|Part 1: Follow-Up|Withdrawal by Subject|0|||
127873863|NCT04668066|460157966|FG012|Part 1: Follow-Up|Withdrawal by Subject|1|||
127873864|NCT04668066|460157967|FG013|Part 1: Follow-Up|Withdrawal by Subject|0|||
127873865|NCT04668066|460157968|FG014|Part 1: Follow-Up|Withdrawal by Subject|0|||
127873866|NCT04668066|460157969|FG015|Part 1: Follow-Up|Withdrawal by Subject|2|||
127873867|NCT04668066|460157970|FG016|Part 1: Follow-Up|Withdrawal by Subject|0|||
127873868|NCT04668066|460157971|FG017|Part 1: Follow-Up|Withdrawal by Subject|0|||
127873869|NCT04668066|460157972|FG018|Part 1: Follow-Up|Withdrawal by Subject|0|||
127873870|NCT04668066|460157954|FG000|Part 2: Treatment Phase|Withdrawal by Subject|0|||
127873871|NCT04668066|460157955|FG001|Part 2: Treatment Phase|Withdrawal by Subject|0|||
127873872|NCT04668066|460157956|FG002|Part 2: Treatment Phase|Withdrawal by Subject|0|||
127873873|NCT04668066|460157957|FG003|Part 2: Treatment Phase|Withdrawal by Subject|0|||
127873874|NCT04668066|460157958|FG004|Part 2: Treatment Phase|Withdrawal by Subject|0|||
127873875|NCT04668066|460157959|FG005|Part 2: Treatment Phase|Withdrawal by Subject|0|||
127873876|NCT04668066|460157960|FG006|Part 2: Treatment Phase|Withdrawal by Subject|0|||
127873877|NCT04668066|460157961|FG007|Part 2: Treatment Phase|Withdrawal by Subject|0|||
127873878|NCT04668066|460157962|FG008|Part 2: Treatment Phase|Withdrawal by Subject|0|||
127873879|NCT04668066|460157963|FG009|Part 2: Treatment Phase|Withdrawal by Subject|0|||
127873880|NCT04668066|460157964|FG010|Part 2: Treatment Phase|Withdrawal by Subject|0|||
127873881|NCT04668066|460157965|FG011|Part 2: Treatment Phase|Withdrawal by Subject|0|||
127873882|NCT04668066|460157966|FG012|Part 2: Treatment Phase|Withdrawal by Subject|0|||
127873883|NCT04668066|460157967|FG013|Part 2: Treatment Phase|Withdrawal by Subject|0|||
127873884|NCT04668066|460157968|FG014|Part 2: Treatment Phase|Withdrawal by Subject|0|||
127873885|NCT04668066|460157969|FG015|Part 2: Treatment Phase|Withdrawal by Subject|0|||
127873886|NCT04668066|460157970|FG016|Part 2: Treatment Phase|Withdrawal by Subject|0|||
127873887|NCT04668066|460157971|FG017|Part 2: Treatment Phase|Withdrawal by Subject|0|||
127873888|NCT04668066|460157972|FG018|Part 2: Treatment Phase|Withdrawal by Subject|1|||
127873889|NCT04668066|460157954|FG000|Part 2: Treatment Phase|Lost to Follow-up|0|||
127873890|NCT04668066|460157955|FG001|Part 2: Treatment Phase|Lost to Follow-up|0|||
127873891|NCT04668066|460157956|FG002|Part 2: Treatment Phase|Lost to Follow-up|0|||
127873892|NCT04668066|460157957|FG003|Part 2: Treatment Phase|Lost to Follow-up|0|||
127873893|NCT04668066|460157958|FG004|Part 2: Treatment Phase|Lost to Follow-up|0|||
127873894|NCT04668066|460157959|FG005|Part 2: Treatment Phase|Lost to Follow-up|0|||
127873895|NCT04668066|460157960|FG006|Part 2: Treatment Phase|Lost to Follow-up|0|||
127873896|NCT04668066|460157961|FG007|Part 2: Treatment Phase|Lost to Follow-up|0|||
127983723|NCT01764997|460562571|FG003|Run-in Period|Adverse Event|0|||
127873897|NCT04668066|460157962|FG008|Part 2: Treatment Phase|Lost to Follow-up|0|||
127873898|NCT04668066|460157963|FG009|Part 2: Treatment Phase|Lost to Follow-up|0|||
127873899|NCT04668066|460157964|FG010|Part 2: Treatment Phase|Lost to Follow-up|0|||
127873900|NCT04668066|460157965|FG011|Part 2: Treatment Phase|Lost to Follow-up|0|||
127873901|NCT04668066|460157966|FG012|Part 2: Treatment Phase|Lost to Follow-up|0|||
127873902|NCT04668066|460157967|FG013|Part 2: Treatment Phase|Lost to Follow-up|0|||
127873903|NCT04668066|460157968|FG014|Part 2: Treatment Phase|Lost to Follow-up|0|||
127873904|NCT04668066|460157969|FG015|Part 2: Treatment Phase|Lost to Follow-up|0|||
127873905|NCT04668066|460157970|FG016|Part 2: Treatment Phase|Lost to Follow-up|0|||
127873906|NCT04668066|460157971|FG017|Part 2: Treatment Phase|Lost to Follow-up|0|||
127873907|NCT04668066|460157972|FG018|Part 2: Treatment Phase|Lost to Follow-up|1|||
127873908|NCT04668066|460157954|FG000|Part 2: Treatment Phase|Other|0|||
127873909|NCT04668066|460157955|FG001|Part 2: Treatment Phase|Other|0|||
127873910|NCT04668066|460157956|FG002|Part 2: Treatment Phase|Other|0|||
127873911|NCT04668066|460157957|FG003|Part 2: Treatment Phase|Other|0|||
127873912|NCT04668066|460157958|FG004|Part 2: Treatment Phase|Other|0|||
127873913|NCT04668066|460157959|FG005|Part 2: Treatment Phase|Other|0|||
127873914|NCT04668066|460157960|FG006|Part 2: Treatment Phase|Other|0|||
127873915|NCT04668066|460157961|FG007|Part 2: Treatment Phase|Other|0|||
127873916|NCT04668066|460157962|FG008|Part 2: Treatment Phase|Other|0|||
127873917|NCT04668066|460157963|FG009|Part 2: Treatment Phase|Other|0|||
127873918|NCT04668066|460157964|FG010|Part 2: Treatment Phase|Other|0|||
127873919|NCT04668066|460157965|FG011|Part 2: Treatment Phase|Other|0|||
127873920|NCT04668066|460157966|FG012|Part 2: Treatment Phase|Other|0|||
127873921|NCT04668066|460157967|FG013|Part 2: Treatment Phase|Other|0|||
127873922|NCT04668066|460157968|FG014|Part 2: Treatment Phase|Other|0|||
127873923|NCT04668066|460157969|FG015|Part 2: Treatment Phase|Other|0|||
127873924|NCT04668066|460157970|FG016|Part 2: Treatment Phase|Other|0|||
127873925|NCT04668066|460157971|FG017|Part 2: Treatment Phase|Other|0|||
127873926|NCT04668066|460157972|FG018|Part 2: Treatment Phase|Other|1|||
127873927|NCT04668066|460157954|FG000|Part 2: Follow-Up|Withdrawal by Subject|0|||
127873928|NCT04668066|460157955|FG001|Part 2: Follow-Up|Withdrawal by Subject|0|||
127873929|NCT04668066|460157956|FG002|Part 2: Follow-Up|Withdrawal by Subject|0|||
127873930|NCT04668066|460157957|FG003|Part 2: Follow-Up|Withdrawal by Subject|0|||
127873931|NCT04668066|460157958|FG004|Part 2: Follow-Up|Withdrawal by Subject|0|||
127873932|NCT04668066|460157959|FG005|Part 2: Follow-Up|Withdrawal by Subject|0|||
127873933|NCT04668066|460157960|FG006|Part 2: Follow-Up|Withdrawal by Subject|0|||
127873934|NCT04668066|460157961|FG007|Part 2: Follow-Up|Withdrawal by Subject|0|||
127873935|NCT04668066|460157962|FG008|Part 2: Follow-Up|Withdrawal by Subject|0|||
127873936|NCT04668066|460157963|FG009|Part 2: Follow-Up|Withdrawal by Subject|0|||
127873937|NCT04668066|460157964|FG010|Part 2: Follow-Up|Withdrawal by Subject|0|||
127873938|NCT04668066|460157965|FG011|Part 2: Follow-Up|Withdrawal by Subject|0|||
127873939|NCT04668066|460157966|FG012|Part 2: Follow-Up|Withdrawal by Subject|0|||
127873940|NCT04668066|460157967|FG013|Part 2: Follow-Up|Withdrawal by Subject|0|||
127873941|NCT04668066|460157968|FG014|Part 2: Follow-Up|Withdrawal by Subject|0|||
127873942|NCT04668066|460157969|FG015|Part 2: Follow-Up|Withdrawal by Subject|0|||
127873943|NCT04668066|460157970|FG016|Part 2: Follow-Up|Withdrawal by Subject|0|||
127873944|NCT04668066|460157971|FG017|Part 2: Follow-Up|Withdrawal by Subject|0|||
127873945|NCT04668066|460157972|FG018|Part 2: Follow-Up|Withdrawal by Subject|1|||
127873946|NCT05147311|460157975|FG000|Overall Study|Did not complete survey|2|||
127873947|NCT05147311|460157976|FG001|Overall Study|Did not complete survey|1|||
127873948|NCT05147311|460157975|FG000|Overall Study|Patient too sick|1|||
127873949|NCT05147311|460157976|FG001|Overall Study|Patient too sick|2|||
127873950|NCT05147311|460157975|FG000|Overall Study|Death|0|||
127873951|NCT05147311|460157976|FG001|Overall Study|Death|1|||
127873952|NCT05147311|460157975|FG000|Overall Study|Declined survey|1|||
127873953|NCT05147311|460157976|FG001|Overall Study|Declined survey|0|||
127873954|NCT04505592|460157978|FG000|Overall Study|Death|2|||
127873955|NCT04505592|460157979|FG001|Overall Study|Death|1|||
127873956|NCT01015118|460157984|FG000|Overall Study|Protocol Violation|5|||
127873957|NCT01015118|460157985|FG001|Overall Study|Protocol Violation|6|||
127873958|NCT01015118|460157984|FG000|Overall Study|Withdrawal by Subject|103|||
127873959|NCT01015118|460157985|FG001|Overall Study|Withdrawal by Subject|27|||
127873960|NCT01015118|460157984|FG000|Overall Study|Other Adverse Event (AE)|141|||
127873961|NCT01015118|460157985|FG001|Overall Study|Other Adverse Event (AE)|33|||
127873962|NCT01015118|460157984|FG000|Overall Study|Worsening or AE of underlying disease|5|||
127873963|NCT01015118|460157985|FG001|Overall Study|Worsening or AE of underlying disease|4|||
127873964|NCT01015118|460157984|FG000|Overall Study|Progressive disease|364|||
127873965|NCT01015118|460157985|FG001|Overall Study|Progressive disease|229|||
127873966|NCT01015118|460157984|FG000|Overall Study|Not treated|9|||
127873967|NCT01015118|460157985|FG001|Overall Study|Not treated|5|||
127873968|NCT01015118|460157984|FG000|Overall Study|Other than stated above|42|||
127873969|NCT01015118|460157985|FG001|Overall Study|Other than stated above|23|||
127873970|NCT03522506|460157986|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
127873971|NCT03522506|460157987|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
127873972|NCT03522506|460157988|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
127873973|NCT03522506|460157989|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
127983724|NCT01764997|460562572|FG004|Run-in Period|Adverse Event|0|||
127873974|NCT03522506|460157986|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
127873975|NCT03522506|460157987|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
127873976|NCT03522506|460157988|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
127873977|NCT03522506|460157989|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
127873978|NCT03480243|460157990|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
127873979|NCT03480243|460157990|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
127873980|NCT02388906|460157999|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
127873981|NCT02388906|460158000|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
127873982|NCT02388906|460157999|FG000|Treatment Period|Disease progression|121|||
127873983|NCT02388906|460158000|FG001|Treatment Period|Disease progression|100|||
127873984|NCT02388906|460157999|FG000|Treatment Period|Study drug toxicity|41|||
127873985|NCT02388906|460158000|FG001|Treatment Period|Study drug toxicity|208|||
127873986|NCT02388906|460157999|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
127873987|NCT02388906|460158000|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
127873988|NCT02388906|460157999|FG000|Treatment Period|Participant request to stop treatment|5|||
127873989|NCT02388906|460158000|FG001|Treatment Period|Participant request to stop treatment|9|||
127873990|NCT02388906|460157999|FG000|Treatment Period|Participant withdrew consent|2|||
127873991|NCT02388906|460158000|FG001|Treatment Period|Participant withdrew consent|3|||
127873992|NCT02388906|460157999|FG000|Treatment Period|Poor/non-compliance|0|||
127873993|NCT02388906|460158000|FG001|Treatment Period|Poor/non-compliance|1|||
127873994|NCT02388906|460157999|FG000|Treatment Period|Participant no longer meets study criteria|0|||
127873995|NCT02388906|460158000|FG001|Treatment Period|Participant no longer meets study criteria|1|||
127873996|NCT02388906|460157999|FG000|Treatment Period|Other reasons|3|||
127873997|NCT02388906|460158000|FG001|Treatment Period|Other reasons|3|||
127873998|NCT04365387|460158001|FG000|Overall Study|Adverse Event|4|||
127873999|NCT04365387|460158002|FG001|Overall Study|Adverse Event|2|||
127874000|NCT04365387|460158001|FG000|Overall Study|Participants request|14|||
127874001|NCT04365387|460158002|FG001|Overall Study|Participants request|14|||
127874002|NCT04365387|460158001|FG000|Overall Study|Lost to Follow-up|8|||
127874003|NCT04365387|460158002|FG001|Overall Study|Lost to Follow-up|5|||
127874004|NCT04365387|460158001|FG000|Overall Study|Protocol deviation|3|||
127874005|NCT04365387|460158002|FG001|Overall Study|Protocol deviation|4|||
127874006|NCT04365387|460158001|FG000|Overall Study|Participant compliance with visit schedule|1|||
127874007|NCT04365387|460158002|FG001|Overall Study|Participant compliance with visit schedule|0|||
127874008|NCT04365387|460158001|FG000|Overall Study|Participant incarcerated|1|||
127874009|NCT04365387|460158002|FG001|Overall Study|Participant incarcerated|0|||
127874010|NCT04365387|460158001|FG000|Overall Study|Participant moved out of town (relocated)|0|||
127874011|NCT04365387|460158002|FG001|Overall Study|Participant moved out of town (relocated)|1|||
127874012|NCT04365387|460158001|FG000|Overall Study|Participant PEF not eligible per sponsor|1|||
127874013|NCT04365387|460158002|FG001|Overall Study|Participant PEF not eligible per sponsor|0|||
127874014|NCT04365387|460158001|FG000|Overall Study|Due to working hours, could not return to other visits|1|||
127874015|NCT04365387|460158002|FG001|Overall Study|Due to working hours, could not return to other visits|0|||
127874016|NCT05770401|460158011|FG000|Overall Study|Lost to Follow-up|5|||
127874017|NCT05770401|460158012|FG001|Overall Study|Lost to Follow-up|4|||
127874018|NCT00402298|460158013|FG000|Overall Study|Withdrawal by Subject|1|||
127874019|NCT00402298|460158014|FG001|Overall Study|Withdrawal by Subject|0|||
127649811|NCT02277990|459339508|FG001|Overall Study|Physician Decision|34|||
127874020|NCT04784455|460158015|FG000|Overall Study|Death|4|||
127874021|NCT05048875|460158018|FG000|Overall Study|Withdrawal by Subject|1|||
127874022|NCT05048875|460158019|FG001|Overall Study|Withdrawal by Subject|0|||
127874023|NCT05048875|460158020|FG002|Overall Study|Withdrawal by Subject|0|||
127874024|NCT05048875|460158021|FG003|Overall Study|Withdrawal by Subject|0|||
127874025|NCT05048875|460158022|FG004|Overall Study|Withdrawal by Subject|0|||
127874026|NCT05048875|460158023|FG005|Overall Study|Withdrawal by Subject|0|||
127874027|NCT05048875|460158024|FG006|Overall Study|Withdrawal by Subject|0|||
127874028|NCT05048875|460158025|FG007|Overall Study|Withdrawal by Subject|0|||
127874029|NCT05048875|460158018|FG000|Overall Study|Adverse Event|0|||
127874030|NCT05048875|460158019|FG001|Overall Study|Adverse Event|0|||
127874031|NCT05048875|460158020|FG002|Overall Study|Adverse Event|0|||
127874032|NCT05048875|460158021|FG003|Overall Study|Adverse Event|1|||
127874033|NCT05048875|460158022|FG004|Overall Study|Adverse Event|0|||
127874034|NCT05048875|460158023|FG005|Overall Study|Adverse Event|0|||
127649812|NCT02277990|459339507|FG000|Overall Study|Lost to Follow-up|66|||
127649813|NCT02277990|459339508|FG001|Overall Study|Lost to Follow-up|69|||
127874035|NCT05048875|460158024|FG006|Overall Study|Adverse Event|0|||
127874036|NCT05048875|460158025|FG007|Overall Study|Adverse Event|0|||
127874037|NCT02255422|460158030|FG000|Overall Study|Withdrawal by Subject|0|||
127874038|NCT02255422|460158031|FG001|Overall Study|Withdrawal by Subject|0|||
127874039|NCT02255422|460158032|FG002|Overall Study|Withdrawal by Subject|0|||
127874040|NCT02255422|460158033|FG003|Overall Study|Withdrawal by Subject|0|||
127874041|NCT02255422|460158034|FG004|Overall Study|Withdrawal by Subject|0|||
127874042|NCT02255422|460158035|FG005|Overall Study|Withdrawal by Subject|0|||
127649814|NCT02277990|459339507|FG000|Overall Study|Had other reason|26|||
127874043|NCT02255422|460158036|FG006|Overall Study|Withdrawal by Subject|2|||
127874044|NCT02255422|460158030|FG000|Overall Study|Lost to Follow-up|0|||
127874045|NCT02255422|460158031|FG001|Overall Study|Lost to Follow-up|0|||
127874046|NCT02255422|460158032|FG002|Overall Study|Lost to Follow-up|1|||
127874047|NCT02255422|460158033|FG003|Overall Study|Lost to Follow-up|0|||
127874048|NCT02255422|460158034|FG004|Overall Study|Lost to Follow-up|0|||
127874049|NCT02255422|460158035|FG005|Overall Study|Lost to Follow-up|0|||
127874050|NCT02255422|460158036|FG006|Overall Study|Lost to Follow-up|0|||
127874051|NCT04411641|460158037|FG000|DB Period|Other|7|||
127874052|NCT04411641|460158038|FG001|DB Period|Other|27|||
127874053|NCT04411641|460158039|FG002|DB Period|Other|0|||
127874054|NCT04411641|460158040|FG003|DB Period|Other|0|||
127874055|NCT04411641|460158037|FG000|DB Period|Withdrawal by Subject|67|||
127874056|NCT04411641|460158038|FG001|DB Period|Withdrawal by Subject|122|||
127874057|NCT04411641|460158039|FG002|DB Period|Withdrawal by Subject|0|||
127874058|NCT04411641|460158040|FG003|DB Period|Withdrawal by Subject|0|||
127874059|NCT04411641|460158037|FG000|DB Period|Progressive disease|76|||
127874060|NCT04411641|460158038|FG001|DB Period|Progressive disease|116|||
127874061|NCT04411641|460158039|FG002|DB Period|Progressive disease|0|||
127874062|NCT04411641|460158040|FG003|DB Period|Progressive disease|0|||
127874063|NCT04411641|460158037|FG000|DB Period|Poor compliance to protocol|1|||
127874064|NCT04411641|460158038|FG001|DB Period|Poor compliance to protocol|5|||
127874065|NCT04411641|460158039|FG002|DB Period|Poor compliance to protocol|0|||
127874066|NCT04411641|460158040|FG003|DB Period|Poor compliance to protocol|0|||
127874067|NCT04411641|460158037|FG000|DB Period|Lack of Efficacy|19|||
127874068|NCT04411641|460158038|FG001|DB Period|Lack of Efficacy|19|||
127874069|NCT04411641|460158039|FG002|DB Period|Lack of Efficacy|0|||
127874070|NCT04411641|460158040|FG003|DB Period|Lack of Efficacy|0|||
127874071|NCT04411641|460158037|FG000|DB Period|Adverse Event|13|||
127874072|NCT04411641|460158038|FG001|DB Period|Adverse Event|29|||
127874073|NCT04411641|460158039|FG002|DB Period|Adverse Event|0|||
127874074|NCT04411641|460158040|FG003|DB Period|Adverse Event|0|||
127874075|NCT04411641|460158037|FG000|DB Period|Randomized and not treated|2|||
127874076|NCT04411641|460158038|FG001|DB Period|Randomized and not treated|2|||
127874077|NCT04411641|460158039|FG002|DB Period|Randomized and not treated|0|||
127874078|NCT04411641|460158040|FG003|DB Period|Randomized and not treated|0|||
127874079|NCT04411641|460158037|FG000|OL|Withdrawal by Subject|0|||
127874080|NCT04411641|460158038|FG001|OL|Withdrawal by Subject|0|||
127874081|NCT04411641|460158039|FG002|OL|Withdrawal by Subject|6|||
127874082|NCT04411641|460158040|FG003|OL|Withdrawal by Subject|17|||
127874083|NCT04411641|460158037|FG000|OL|Progressive disease|0|||
127874084|NCT04411641|460158038|FG001|OL|Progressive disease|0|||
127874085|NCT04411641|460158039|FG002|OL|Progressive disease|1|||
127874086|NCT04411641|460158040|FG003|OL|Progressive disease|2|||
127874087|NCT04411641|460158037|FG000|OL|Poor compliance to protocol|0|||
127874088|NCT04411641|460158038|FG001|OL|Poor compliance to protocol|0|||
127874089|NCT04411641|460158039|FG002|OL|Poor compliance to protocol|1|||
127874090|NCT04411641|460158040|FG003|OL|Poor compliance to protocol|0|||
127874091|NCT04411641|460158037|FG000|OL|Adverse Event|0|||
127874092|NCT04411641|460158038|FG001|OL|Adverse Event|0|||
127874093|NCT04411641|460158039|FG002|OL|Adverse Event|1|||
127874094|NCT04411641|460158040|FG003|OL|Adverse Event|0|||
127874095|NCT04411641|460158037|FG000|OL|Other|0|||
127874096|NCT04411641|460158038|FG001|OL|Other|0|||
127874097|NCT04411641|460158039|FG002|OL|Other|0|||
127874098|NCT04411641|460158040|FG003|OL|Other|6|||
127874099|NCT03282123|460158045|FG000|Overall Study|Withdrawal by Subject|5|||
127874100|NCT01195662|460158046|FG000|Double Blind Treatment Period|Adverse Event|4|||
127874101|NCT01195662|460158047|FG001|Double Blind Treatment Period|Adverse Event|1|||
127874102|NCT01195662|460158048|FG002|Double Blind Treatment Period|Adverse Event|2|||
127874103|NCT01195662|460158046|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
127874104|NCT01195662|460158047|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
127874105|NCT01195662|460158048|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
127874106|NCT01195662|460158046|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
127874107|NCT01195662|460158047|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
127874108|NCT01195662|460158048|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
127874109|NCT01195662|460158046|FG000|Double Blind Treatment Period|Administrative reason|2|||
127874110|NCT01195662|460158047|FG001|Double Blind Treatment Period|Administrative reason|1|||
127983725|NCT01764997|460562568|FG000|Run-in Period|Lack of Efficacy|5|||
127874111|NCT01195662|460158048|FG002|Double Blind Treatment Period|Administrative reason|1|||
127874112|NCT01195662|460158046|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
127874113|NCT01195662|460158047|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
127874114|NCT01195662|460158048|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
127874115|NCT01195662|460158046|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
127874116|NCT01195662|460158047|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
127874117|NCT01195662|460158048|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
127874118|NCT01195662|460158046|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
127874119|NCT01195662|460158047|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
127874120|NCT01195662|460158048|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
127874121|NCT01195662|460158046|FG000|Double Blind Treatment Period|Non-specified|3|||
127874122|NCT01195662|460158047|FG001|Double Blind Treatment Period|Non-specified|0|||
127874123|NCT01195662|460158048|FG002|Double Blind Treatment Period|Non-specified|0|||
127874124|NCT01195662|460158046|FG000|Double Blind Treatment Period|Missing disposition information|0|||
127874125|NCT01195662|460158047|FG001|Double Blind Treatment Period|Missing disposition information|1|||
127874126|NCT01195662|460158048|FG002|Double Blind Treatment Period|Missing disposition information|1|||
127874127|NCT01195662|460158046|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
127874128|NCT01195662|460158047|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
127874129|NCT01195662|460158048|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
127874130|NCT01195662|460158046|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
127874131|NCT01195662|460158047|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
127874132|NCT01195662|460158048|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
127874133|NCT01215968|460158049|FG000|Overall Study|Adverse Event|0|||
127874134|NCT01215968|460158050|FG001|Overall Study|Adverse Event|2|||
127874135|NCT01215968|460158049|FG000|Overall Study|Protocol Violation|2|||
127874136|NCT01215968|460158050|FG001|Overall Study|Protocol Violation|4|||
127874137|NCT01215968|460158049|FG000|Overall Study|Not received study drug|0|||
127874138|NCT01215968|460158050|FG001|Overall Study|Not received study drug|1|||
127874139|NCT05643573|460158052|FG000|Overall Study|Adverse Event|117|||
127874140|NCT05643573|460158053|FG001|Overall Study|Adverse Event|90|||
127874141|NCT05643573|460158052|FG000|Overall Study|Death|53|||
127874142|NCT05643573|460158053|FG001|Overall Study|Death|57|||
127874143|NCT05643573|460158052|FG000|Overall Study|Lost to Follow-up|6|||
127874144|NCT05643573|460158053|FG001|Overall Study|Lost to Follow-up|3|||
127874145|NCT05643573|460158052|FG000|Overall Study|Other|18|||
127874146|NCT05643573|460158053|FG001|Overall Study|Other|15|||
127874147|NCT05643573|460158052|FG000|Overall Study|Outcome event|64|||
127874148|NCT05643573|460158053|FG001|Overall Study|Outcome event|36|||
127874149|NCT05643573|460158052|FG000|Overall Study|Physician Decision|33|||
127874150|NCT05643573|460158053|FG001|Overall Study|Physician Decision|19|||
127874151|NCT05643573|460158052|FG000|Overall Study|Protocol-specified withdrawal criterion met|2|||
127874152|NCT05643573|460158053|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
127874153|NCT05643573|460158052|FG000|Overall Study|Site terminated by sponsor|10|||
127874154|NCT05643573|460158053|FG001|Overall Study|Site terminated by sponsor|10|||
127874155|NCT05643573|460158052|FG000|Overall Study|Study terminated by sponsor|1|||
127874156|NCT05643573|460158053|FG001|Overall Study|Study terminated by sponsor|0|||
127874157|NCT05643573|460158052|FG000|Overall Study|Withdrawal by Subject|178|||
127874158|NCT05643573|460158053|FG001|Overall Study|Withdrawal by Subject|130|||
127874159|NCT04768881|460158056|FG000|Overall Study|Completed Study Follow-up|0|||
127874160|NCT04768881|460158057|FG001|Overall Study|Completed Study Follow-up|2|||
127874161|NCT04768881|460158056|FG000|Overall Study|Death|3|||
127874162|NCT04768881|460158057|FG001|Overall Study|Death|2|||
127874163|NCT04768881|460158056|FG000|Overall Study|Study Terminated by Sponsor|2|||
127874164|NCT04768881|460158057|FG001|Overall Study|Study Terminated by Sponsor|2|||
127874165|NCT04768881|460158056|FG000|Overall Study|Withdrawal by Subject|2|||
127874166|NCT04768881|460158057|FG001|Overall Study|Withdrawal by Subject|0|||
127874167|NCT04768881|460158056|FG000|Overall Study|Other|2|||
127874168|NCT04768881|460158057|FG001|Overall Study|Other|0|||
127874169|NCT04089566|460158059|FG000|Overall Study|Death|0|||
127874170|NCT04089566|460158060|FG001|Overall Study|Death|6|||
127874171|NCT04089566|460158061|FG002|Overall Study|Death|10|||
127874172|NCT04089566|460158062|FG003|Overall Study|Death|0|||
127874173|NCT04089566|460158063|FG004|Overall Study|Death|0|||
127874174|NCT04089566|460158064|FG005|Overall Study|Death|0|||
127874175|NCT04089566|460158059|FG000|Overall Study|Withdrawal by Parent or Guardian|0|||
127874176|NCT04089566|460158060|FG001|Overall Study|Withdrawal by Parent or Guardian|2|||
127874177|NCT04089566|460158061|FG002|Overall Study|Withdrawal by Parent or Guardian|1|||
127874178|NCT04089566|460158062|FG003|Overall Study|Withdrawal by Parent or Guardian|0|||
127874179|NCT04089566|460158063|FG004|Overall Study|Withdrawal by Parent or Guardian|0|||
127874180|NCT04089566|460158064|FG005|Overall Study|Withdrawal by Parent or Guardian|0|||
127874181|NCT04089566|460158059|FG000|Overall Study|Reason not Specified|0|||
127874182|NCT04089566|460158060|FG001|Overall Study|Reason not Specified|4|||
127874183|NCT04089566|460158061|FG002|Overall Study|Reason not Specified|4|||
127874184|NCT04089566|460158062|FG003|Overall Study|Reason not Specified|1|||
127874185|NCT04089566|460158063|FG004|Overall Study|Reason not Specified|0|||
127874186|NCT04089566|460158064|FG005|Overall Study|Reason not Specified|0|||
127874187|NCT01875731|460158072|FG000|Overall Study|Fail to obtain lab sample|1|||
127874188|NCT01875731|460158073|FG001|Overall Study|Fail to obtain lab sample|0|||
127874189|NCT00223990|460158076|FG000|Overall Study|Moved from area|2|||
127874190|NCT00223990|460158077|FG001|Overall Study|Moved from area|1|||
127874191|NCT00223990|460158076|FG000|Overall Study|Withdrawal by Subject|4|||
127874192|NCT00223990|460158077|FG001|Overall Study|Withdrawal by Subject|8|||
127874193|NCT00223990|460158076|FG000|Overall Study|Lost to Follow-up|1|||
127874194|NCT00223990|460158077|FG001|Overall Study|Lost to Follow-up|0|||
127874195|NCT01473602|460159532|FG000|Overall Study|Adverse Event|1|||
127874196|NCT01473602|460159533|FG001|Overall Study|Adverse Event|2|||
127874197|NCT01473602|460159532|FG000|Overall Study|Death|0|||
127874198|NCT01473602|460159533|FG001|Overall Study|Death|1|||
127874199|NCT01473602|460159532|FG000|Overall Study|Lost to Follow-up|1|||
127874200|NCT01473602|460159533|FG001|Overall Study|Lost to Follow-up|1|||
127874201|NCT01473602|460159532|FG000|Overall Study|Withdrawal by Subject|5|||
127874202|NCT01473602|460159533|FG001|Overall Study|Withdrawal by Subject|4|||
127874203|NCT01473602|460159532|FG000|Overall Study|Physician Decision|1|||
127874204|NCT01473602|460159533|FG001|Overall Study|Physician Decision|0|||
127874205|NCT03526549|460159534|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
127874206|NCT03526549|460159535|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
127874207|NCT03526549|460159534|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
127874208|NCT03526549|460159535|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
127874209|NCT03526549|460159534|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
127874210|NCT03526549|460159535|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
127874211|NCT03526549|460159534|FG000|Open-label Phase|Adverse Event|4|||
127874212|NCT03526549|460159535|FG001|Open-label Phase|Adverse Event|0|||
127874213|NCT03526549|460159534|FG000|Open-label Phase|Withdrawal by Subject|54|||
127874214|NCT03526549|460159535|FG001|Open-label Phase|Withdrawal by Subject|0|||
127874215|NCT03526549|460159534|FG000|Open-label Phase|Lost to Follow-up|35|||
127874216|NCT03526549|460159535|FG001|Open-label Phase|Lost to Follow-up|0|||
127874217|NCT03526549|460159534|FG000|Open-label Phase|Other than Specified|5|||
127874218|NCT03526549|460159535|FG001|Open-label Phase|Other than Specified|0|||
127874219|NCT05981365|460159542|FG000|Period 1|Adverse Event|1|||
127874220|NCT05981365|460159543|FG001|Period 1|Adverse Event|0|||
127874221|NCT04780776|460159544|FG000|Titration Week 1-5|Lost to Follow-up|2|||
127874222|NCT04780776|460159545|FG001|Titration Week 1-5|Lost to Follow-up|8|||
127874223|NCT04780776|460159544|FG000|Treatment Week 6-21|Lost to Follow-up|4|||
127874224|NCT04780776|460159545|FG001|Treatment Week 6-21|Lost to Follow-up|4|||
127874225|NCT04780776|460159544|FG000|Follow up Week 22-25|Lost to Follow-up|2|||
127874226|NCT04780776|460159545|FG001|Follow up Week 22-25|Lost to Follow-up|2|||
127874227|NCT03113760|460159546|FG000|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|2|||
127874228|NCT03113760|460159547|FG001|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
127874229|NCT03113760|460159548|FG002|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
127874230|NCT03113760|460159549|FG003|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
127874231|NCT03113760|460159546|FG000|Initial 18 Weeks Treatment Phase|Adverse Event|1|||
127874232|NCT03113760|460159547|FG001|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
127874233|NCT03113760|460159548|FG002|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
127874234|NCT03113760|460159549|FG003|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
127874235|NCT03113760|460159546|FG000|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
127874236|NCT03113760|460159547|FG001|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
127874237|NCT03113760|460159548|FG002|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
127874238|NCT03113760|460159549|FG003|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
127874239|NCT03927989|460159550|FG000|Overall Study|Withdrawal by Subject|0|||
127874240|NCT03927989|460159551|FG001|Overall Study|Withdrawal by Subject|1|||
127874241|NCT00003526|460159552|FG000|Overall Study|Not evaluable|6|||
127874242|NCT01453296|460159555|FG000|Treatment Period 1|Adverse Event|0|||
127874243|NCT01453296|460159556|FG001|Treatment Period 1|Adverse Event|1|||
127874244|NCT01453296|460159555|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
127874245|NCT01453296|460159556|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
127874246|NCT01453296|460159555|FG000|Treatment Period 2|Adverse Event|1|||
127874247|NCT01453296|460159556|FG001|Treatment Period 2|Adverse Event|0|||
127874248|NCT01453296|460159555|FG000|Treatment Period 2|Withdrawal by Subject|1|||
127874249|NCT01453296|460159556|FG001|Treatment Period 2|Withdrawal by Subject|0|||
127874250|NCT03557775|460159557|FG000|Overall Study|Withdrawal by Subject|1|||
127874251|NCT03557775|460159558|FG001|Overall Study|Withdrawal by Subject|2|||
127874252|NCT03557775|460159559|FG002|Overall Study|Withdrawal by Subject|4|||
127874253|NCT03557775|460159557|FG000|Overall Study|Physician Decision|0|||
127874254|NCT03557775|460159558|FG001|Overall Study|Physician Decision|1|||
127874255|NCT03557775|460159559|FG002|Overall Study|Physician Decision|0|||
127874256|NCT00938366|460159567|FG000|Overall Study|Withdrawal by Subject|1|||
127874257|NCT00938366|460159568|FG001|Overall Study|Withdrawal by Subject|0|||
127874258|NCT01250418|460159575|FG000|Overall Study|monitor data failure|1|||
127874259|NCT01250418|460159576|FG001|Overall Study|monitor data failure|1|||
127874260|NCT01761565|460159577|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
127874261|NCT05182840|460159579|FG000|Run-in Period|Not treated|0|||
127874262|NCT05182840|460159580|FG001|Run-in Period|Not treated|1|||
127874263|NCT05182840|460159581|FG002|Run-in Period|Not treated|0|||
127874264|NCT05182840|460159582|FG003|Run-in Period|Not treated|0|||
127874265|NCT05182840|460159583|FG004|Run-in Period|Not treated|0|||
127874266|NCT05182840|460159584|FG005|Run-in Period|Not treated|0|||
127874267|NCT05182840|460159585|FG006|Run-in Period|Not treated|0|||
127874268|NCT05182840|460159586|FG007|Run-in Period|Not treated|0|||
127874269|NCT05182840|460159587|FG008|Run-in Period|Not treated|0|||
127541922|NCT05546476|458951044|FG001|Period 1: Part A|Adverse Event|0|||
127541923|NCT05546476|458951045|FG002|Period 1: Part A|Adverse Event|0|||
127874270|NCT05182840|460159588|FG009|Run-in Period|Not treated|0|||
127874271|NCT05182840|460159579|FG000|Run-in Period|Other reason but not sponsor termination|14|||
127874272|NCT05182840|460159580|FG001|Run-in Period|Other reason but not sponsor termination|18|||
127874273|NCT05182840|460159581|FG002|Run-in Period|Other reason but not sponsor termination|0|||
127874274|NCT05182840|460159582|FG003|Run-in Period|Other reason but not sponsor termination|0|||
127874275|NCT05182840|460159583|FG004|Run-in Period|Other reason but not sponsor termination|0|||
127874276|NCT05182840|460159584|FG005|Run-in Period|Other reason but not sponsor termination|0|||
127874277|NCT05182840|460159585|FG006|Run-in Period|Other reason but not sponsor termination|0|||
127874278|NCT05182840|460159586|FG007|Run-in Period|Other reason but not sponsor termination|0|||
127874279|NCT05182840|460159587|FG008|Run-in Period|Other reason but not sponsor termination|0|||
127874280|NCT05182840|460159588|FG009|Run-in Period|Other reason but not sponsor termination|0|||
127874281|NCT05182840|460159579|FG000|Run-in Period|No reason available|2|||
127874282|NCT05182840|460159580|FG001|Run-in Period|No reason available|2|||
127874283|NCT05182840|460159581|FG002|Run-in Period|No reason available|0|||
127874284|NCT05182840|460159582|FG003|Run-in Period|No reason available|0|||
127874285|NCT05182840|460159583|FG004|Run-in Period|No reason available|0|||
127874286|NCT05182840|460159584|FG005|Run-in Period|No reason available|0|||
127874287|NCT05182840|460159585|FG006|Run-in Period|No reason available|0|||
127874288|NCT05182840|460159586|FG007|Run-in Period|No reason available|0|||
127874289|NCT05182840|460159587|FG008|Run-in Period|No reason available|0|||
127874290|NCT05182840|460159588|FG009|Run-in Period|No reason available|0|||
127874291|NCT05182840|460159579|FG000|Run-in Period|Burden of study procedures|2|||
127874292|NCT05182840|460159580|FG001|Run-in Period|Burden of study procedures|2|||
127874293|NCT05182840|460159581|FG002|Run-in Period|Burden of study procedures|0|||
127874294|NCT05182840|460159582|FG003|Run-in Period|Burden of study procedures|0|||
127874295|NCT05182840|460159583|FG004|Run-in Period|Burden of study procedures|0|||
127874296|NCT05182840|460159584|FG005|Run-in Period|Burden of study procedures|0|||
127874297|NCT05182840|460159585|FG006|Run-in Period|Burden of study procedures|0|||
127874298|NCT05182840|460159586|FG007|Run-in Period|Burden of study procedures|0|||
127874299|NCT05182840|460159587|FG008|Run-in Period|Burden of study procedures|0|||
127874300|NCT05182840|460159588|FG009|Run-in Period|Burden of study procedures|0|||
127874301|NCT05182840|460159579|FG000|Run-in Period|Change of residence|1|||
127874302|NCT05182840|460159580|FG001|Run-in Period|Change of residence|0|||
127874303|NCT05182840|460159581|FG002|Run-in Period|Change of residence|0|||
127874304|NCT05182840|460159582|FG003|Run-in Period|Change of residence|0|||
127874305|NCT05182840|460159583|FG004|Run-in Period|Change of residence|0|||
127874306|NCT05182840|460159584|FG005|Run-in Period|Change of residence|0|||
127874307|NCT05182840|460159585|FG006|Run-in Period|Change of residence|0|||
127874308|NCT05182840|460159586|FG007|Run-in Period|Change of residence|0|||
127874309|NCT05182840|460159587|FG008|Run-in Period|Change of residence|0|||
127874310|NCT05182840|460159588|FG009|Run-in Period|Change of residence|0|||
127874311|NCT05182840|460159579|FG000|Run-in Period|Adverse Event|5|||
127874312|NCT05182840|460159580|FG001|Run-in Period|Adverse Event|5|||
127874313|NCT05182840|460159581|FG002|Run-in Period|Adverse Event|0|||
127874314|NCT05182840|460159582|FG003|Run-in Period|Adverse Event|0|||
127874315|NCT05182840|460159583|FG004|Run-in Period|Adverse Event|0|||
127874316|NCT05182840|460159584|FG005|Run-in Period|Adverse Event|0|||
127874317|NCT05182840|460159585|FG006|Run-in Period|Adverse Event|0|||
127874318|NCT05182840|460159586|FG007|Run-in Period|Adverse Event|0|||
127874319|NCT05182840|460159587|FG008|Run-in Period|Adverse Event|0|||
127874320|NCT05182840|460159588|FG009|Run-in Period|Adverse Event|0|||
127874321|NCT05182840|460159579|FG000|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|34|||
127874322|NCT05182840|460159580|FG001|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|44|||
127874323|NCT05182840|460159581|FG002|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
127874324|NCT05182840|460159582|FG003|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
127649815|NCT02277990|459339508|FG001|Overall Study|Had other reason|32|||
127874325|NCT05182840|460159583|FG004|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
127649816|NCT04711603|459339509|FG000|Double-blind Period (6 Weeks)|Adverse Event|4|||
127649817|NCT04711603|459339510|FG001|Double-blind Period (6 Weeks)|Adverse Event|3|||
127649818|NCT04711603|459339511|FG002|Double-blind Period (6 Weeks)|Adverse Event|0|||
127649819|NCT04711603|459339512|FG003|Double-blind Period (6 Weeks)|Adverse Event|0|||
127874326|NCT05182840|460159584|FG005|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
127649820|NCT04711603|459339509|FG000|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
127649821|NCT04711603|459339510|FG001|Double-blind Period (6 Weeks)|Lack of Efficacy|1|||
127874327|NCT05182840|460159585|FG006|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
127649822|NCT04711603|459339511|FG002|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
127874328|NCT05182840|460159586|FG007|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
127874329|NCT05182840|460159587|FG008|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
127874330|NCT05182840|460159588|FG009|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
127874331|NCT05182840|460159579|FG000|Treatment Period|Reason missing|0|||
127874332|NCT05182840|460159580|FG001|Treatment Period|Reason missing|0|||
127874333|NCT05182840|460159581|FG002|Treatment Period|Reason missing|1|||
127649823|NCT04711603|459339512|FG003|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
127649824|NCT04711603|459339509|FG000|Double-blind Period (6 Weeks)|Protocol Violation|0|||
127649825|NCT04711603|459339510|FG001|Double-blind Period (6 Weeks)|Protocol Violation|1|||
127649826|NCT04711603|459339511|FG002|Double-blind Period (6 Weeks)|Protocol Violation|0|||
127649827|NCT04711603|459339512|FG003|Double-blind Period (6 Weeks)|Protocol Violation|0|||
127649828|NCT04711603|459339509|FG000|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
127649829|NCT04711603|459339510|FG001|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|1|||
127649830|NCT04711603|459339511|FG002|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
127649831|NCT04711603|459339512|FG003|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
127649832|NCT04711603|459339509|FG000|Extension Period (52 Weeks)|Adverse Event|0|||
127649833|NCT04711603|459339510|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
127649834|NCT04711603|459339511|FG002|Extension Period (52 Weeks)|Adverse Event|6|||
127649835|NCT04711603|459339512|FG003|Extension Period (52 Weeks)|Adverse Event|18|||
127649836|NCT04711603|459339509|FG000|Extension Period (52 Weeks)|Lack of Efficacy|0|||
127649837|NCT04711603|459339510|FG001|Extension Period (52 Weeks)|Lack of Efficacy|0|||
127649838|NCT04711603|459339511|FG002|Extension Period (52 Weeks)|Lack of Efficacy|0|||
127649839|NCT04711603|459339512|FG003|Extension Period (52 Weeks)|Lack of Efficacy|1|||
127649840|NCT04711603|459339509|FG000|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
127649841|NCT04711603|459339510|FG001|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
127649842|NCT04711603|459339511|FG002|Extension Period (52 Weeks)|Withdrawal by Subject|4|||
127649843|NCT04711603|459339512|FG003|Extension Period (52 Weeks)|Withdrawal by Subject|5|||
127649844|NCT04711603|459339509|FG000|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
127649845|NCT04711603|459339510|FG001|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
127649846|NCT04711603|459339511|FG002|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|5|||
127649847|NCT04711603|459339512|FG003|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|2|||
127649848|NCT04711603|459339509|FG000|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
127649849|NCT04711603|459339510|FG001|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
127649850|NCT04711603|459339511|FG002|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
127649851|NCT04711603|459339512|FG003|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|1|||
127649852|NCT04711603|459339509|FG000|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
127649853|NCT04711603|459339510|FG001|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
127874334|NCT05182840|460159582|FG003|Treatment Period|Reason missing|0|||
127874335|NCT05182840|460159583|FG004|Treatment Period|Reason missing|0|||
127874336|NCT05182840|460159584|FG005|Treatment Period|Reason missing|0|||
127874337|NCT05182840|460159585|FG006|Treatment Period|Reason missing|0|||
127874338|NCT05182840|460159586|FG007|Treatment Period|Reason missing|0|||
127874339|NCT05182840|460159587|FG008|Treatment Period|Reason missing|0|||
127874340|NCT05182840|460159588|FG009|Treatment Period|Reason missing|0|||
127874341|NCT05182840|460159579|FG000|Treatment Period|Other but not sponsor termination|0|||
127874342|NCT05182840|460159580|FG001|Treatment Period|Other but not sponsor termination|0|||
127649854|NCT04711603|459339511|FG002|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
127649855|NCT04711603|459339512|FG003|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|1|||
127649856|NCT04711603|459339509|FG000|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
127649857|NCT04711603|459339510|FG001|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
127649858|NCT04711603|459339511|FG002|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
127649859|NCT04711603|459339512|FG003|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|1|||
127649860|NCT04711603|459339509|FG000|Extension Period (52 Weeks)|Transferred to another hospital|0|||
127649861|NCT04711603|459339510|FG001|Extension Period (52 Weeks)|Transferred to another hospital|0|||
127649862|NCT04711603|459339511|FG002|Extension Period (52 Weeks)|Transferred to another hospital|2|||
127649863|NCT04711603|459339512|FG003|Extension Period (52 Weeks)|Transferred to another hospital|0|||
127649864|NCT04270747|459339517|FG000|Through Week 16|Adverse Event|1|||
127649865|NCT04270747|459339518|FG001|Through Week 16|Adverse Event|2|||
127649866|NCT04270747|459339519|FG002|Through Week 16|Adverse Event|0|||
127649867|NCT04270747|459339517|FG000|Through Week 16|Death|0|||
127649868|NCT04270747|459339518|FG001|Through Week 16|Death|2|||
127649869|NCT04270747|459339519|FG002|Through Week 16|Death|0|||
127649870|NCT04270747|459339517|FG000|Through Week 16|Consent Withdrawn|3|||
127649871|NCT04270747|459339518|FG001|Through Week 16|Consent Withdrawn|3|||
127649872|NCT04270747|459339519|FG002|Through Week 16|Consent Withdrawn|0|||
127874343|NCT05182840|460159581|FG002|Treatment Period|Other but not sponsor termination|8|||
127874344|NCT05182840|460159582|FG003|Treatment Period|Other but not sponsor termination|6|||
127874345|NCT05182840|460159583|FG004|Treatment Period|Other but not sponsor termination|6|||
127874346|NCT05182840|460159584|FG005|Treatment Period|Other but not sponsor termination|7|||
127649873|NCT04270747|459339517|FG000|Through Week 16|Physician Decision|1|||
127649874|NCT04270747|459339518|FG001|Through Week 16|Physician Decision|1|||
127649875|NCT04270747|459339519|FG002|Through Week 16|Physician Decision|0|||
127649876|NCT04270747|459339517|FG000|Through Week 16|Lost to Follow-up|2|||
127649877|NCT04270747|459339518|FG001|Through Week 16|Lost to Follow-up|0|||
127649878|NCT04270747|459339519|FG002|Through Week 16|Lost to Follow-up|0|||
127649879|NCT04270747|459339517|FG000|Through Week 16|Protocol Violation|1|||
127649880|NCT04270747|459339518|FG001|Through Week 16|Protocol Violation|2|||
127649881|NCT04270747|459339519|FG002|Through Week 16|Protocol Violation|0|||
127649882|NCT04270747|459339517|FG000|Through Week 16|Protocol Specified Criteria|6|||
127649883|NCT04270747|459339518|FG001|Through Week 16|Protocol Specified Criteria|7|||
127649884|NCT04270747|459339519|FG002|Through Week 16|Protocol Specified Criteria|0|||
127649885|NCT04270747|459339517|FG000|Through Week 16|Miscellaneous|1|||
127649886|NCT04270747|459339518|FG001|Through Week 16|Miscellaneous|1|||
127649887|NCT04270747|459339519|FG002|Through Week 16|Miscellaneous|0|||
127649888|NCT04270747|459339517|FG000|Post Week 16|Adverse Event|7|||
127649889|NCT04270747|459339518|FG001|Post Week 16|Adverse Event|5|||
127649890|NCT04270747|459339519|FG002|Post Week 16|Adverse Event|1|||
127649891|NCT04270747|459339517|FG000|Post Week 16|Death|2|||
127649892|NCT04270747|459339518|FG001|Post Week 16|Death|0|||
127649893|NCT04270747|459339519|FG002|Post Week 16|Death|2|||
127649894|NCT04270747|459339517|FG000|Post Week 16|Consent Withdrawn|4|||
127649895|NCT04270747|459339518|FG001|Post Week 16|Consent Withdrawn|3|||
127649896|NCT04270747|459339519|FG002|Post Week 16|Consent Withdrawn|6|||
127649897|NCT04270747|459339517|FG000|Post Week 16|Physician Decision|3|||
127649898|NCT04270747|459339518|FG001|Post Week 16|Physician Decision|1|||
127649899|NCT04270747|459339519|FG002|Post Week 16|Physician Decision|1|||
127649900|NCT04270747|459339517|FG000|Post Week 16|Lost to Follow-up|2|||
127649901|NCT04270747|459339518|FG001|Post Week 16|Lost to Follow-up|1|||
127649902|NCT04270747|459339519|FG002|Post Week 16|Lost to Follow-up|0|||
127649903|NCT04270747|459339517|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
127649904|NCT04270747|459339518|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
127649905|NCT04270747|459339519|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
127649906|NCT04270747|459339517|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
127649907|NCT04270747|459339518|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
127649908|NCT04270747|459339519|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
127649909|NCT04270747|459339517|FG000|Post Week 16|Miscellaneous|1|||
127649910|NCT04270747|459339518|FG001|Post Week 16|Miscellaneous|0|||
127649911|NCT04270747|459339519|FG002|Post Week 16|Miscellaneous|1|||
127649912|NCT05614089|459339521|FG000|Overall Study|Pregnancy|5|||
127649913|NCT05614089|459339522|FG001|Overall Study|Pregnancy|2|||
127649914|NCT05614089|459339521|FG000|Overall Study|Lost to Follow-up|5|||
127649915|NCT05614089|459339522|FG001|Overall Study|Lost to Follow-up|1|||
127649916|NCT05614089|459339521|FG000|Overall Study|Death|0|||
127649917|NCT05614089|459339522|FG001|Overall Study|Death|1|||
127649918|NCT05614089|459339521|FG000|Overall Study|Adverse Event|1|||
127649919|NCT05614089|459339522|FG001|Overall Study|Adverse Event|0|||
127649920|NCT04992546|459339536|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
127649921|NCT04992546|459339536|FG000|Double-Blinded Treatment Period|Doses missed due to Covid-19 pandemic circumstances at the site|1|||
127649922|NCT04992546|459339536|FG000|Open-Label Treatment Period|Adverse Event|3|||
127649923|NCT04992546|459339536|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
127649924|NCT00717860|459339538|FG000|Overall Study|Clinical adverse experience|5|||
127649925|NCT00717860|459339539|FG001|Overall Study|Clinical adverse experience|9|||
127649926|NCT00717860|459339538|FG000|Overall Study|Laboratory adverse experience|2|||
127649927|NCT00717860|459339539|FG001|Overall Study|Laboratory adverse experience|2|||
127649928|NCT00717860|459339538|FG000|Overall Study|Lack of Efficacy|7|||
127649929|NCT00717860|459339539|FG001|Overall Study|Lack of Efficacy|13|||
127649930|NCT00717860|459339538|FG000|Overall Study|Discontinued for other reason|6|||
127649931|NCT00717860|459339539|FG001|Overall Study|Discontinued for other reason|1|||
127649932|NCT00717860|459339538|FG000|Overall Study|Withdrew consent|7|||
127649933|NCT00717860|459339539|FG001|Overall Study|Withdrew consent|3|||
127649934|NCT04058353|459339543|FG000|Overall Study|Adverse Event|2|||
127874347|NCT05182840|460159585|FG006|Treatment Period|Other but not sponsor termination|5|||
127649935|NCT04058353|459339544|FG001|Overall Study|Adverse Event|1|||
127874348|NCT05182840|460159586|FG007|Treatment Period|Other but not sponsor termination|8|||
127649936|NCT04058353|459339543|FG000|Overall Study|Physician Decision|1|||
127649937|NCT04058353|459339544|FG001|Overall Study|Physician Decision|0|||
127649938|NCT04058353|459339543|FG000|Overall Study|Other|1|||
127649939|NCT04058353|459339544|FG001|Overall Study|Other|0|||
127649940|NCT00698646|459339545|FG000|Overall Study|Adverse Event|8|||
127649941|NCT00698646|459339546|FG001|Overall Study|Adverse Event|7|||
127649942|NCT00698646|459339547|FG002|Overall Study|Adverse Event|8|||
127649943|NCT00698646|459339545|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
127649944|NCT00698646|459339546|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
127649945|NCT00698646|459339547|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
127649946|NCT00698646|459339545|FG000|Overall Study|Protocol Deviation|6|||
127649947|NCT00698646|459339546|FG001|Overall Study|Protocol Deviation|2|||
127649948|NCT00698646|459339547|FG002|Overall Study|Protocol Deviation|3|||
127649949|NCT00698646|459339545|FG000|Overall Study|Withdrawal by Subject|10|||
127649950|NCT00698646|459339546|FG001|Overall Study|Withdrawal by Subject|11|||
127649951|NCT00698646|459339547|FG002|Overall Study|Withdrawal by Subject|8|||
127649952|NCT00698646|459339545|FG000|Overall Study|Lost to Follow-up|0|||
127649953|NCT00698646|459339546|FG001|Overall Study|Lost to Follow-up|0|||
127649954|NCT00698646|459339547|FG002|Overall Study|Lost to Follow-up|2|||
127649955|NCT00698646|459339545|FG000|Overall Study|Administrative problems|1|||
127649956|NCT00698646|459339546|FG001|Overall Study|Administrative problems|0|||
127649957|NCT00698646|459339547|FG002|Overall Study|Administrative problems|1|||
127649958|NCT00279201|459339548|FG000|Initiation|Death|1|||
127649959|NCT00279201|459339549|FG001|Initiation|Death|5|||
127649960|NCT00279201|459339550|FG002|Initiation|Death|0|||
127649961|NCT00279201|459339551|FG003|Initiation|Death|0|||
127649962|NCT00279201|459339552|FG004|Initiation|Death|0|||
127649963|NCT00279201|459339553|FG005|Initiation|Death|0|||
127649964|NCT00279201|459339548|FG000|Initiation|Adverse Event|6|||
127649965|NCT00279201|459339549|FG001|Initiation|Adverse Event|15|||
127649966|NCT00279201|459339550|FG002|Initiation|Adverse Event|0|||
127649967|NCT00279201|459339551|FG003|Initiation|Adverse Event|0|||
127649968|NCT00279201|459339552|FG004|Initiation|Adverse Event|0|||
127649969|NCT00279201|459339553|FG005|Initiation|Adverse Event|0|||
127649970|NCT00279201|459339548|FG000|Initiation|Lost to Follow-up|42|||
127649971|NCT00279201|459339549|FG001|Initiation|Lost to Follow-up|41|||
127649972|NCT00279201|459339550|FG002|Initiation|Lost to Follow-up|0|||
127649973|NCT00279201|459339551|FG003|Initiation|Lost to Follow-up|0|||
127649974|NCT00279201|459339552|FG004|Initiation|Lost to Follow-up|0|||
127649975|NCT00279201|459339553|FG005|Initiation|Lost to Follow-up|0|||
127649976|NCT00279201|459339548|FG000|Initiation|Entry Criteria Exclusion|7|||
127649977|NCT00279201|459339549|FG001|Initiation|Entry Criteria Exclusion|9|||
127649978|NCT00279201|459339550|FG002|Initiation|Entry Criteria Exclusion|0|||
127649979|NCT00279201|459339551|FG003|Initiation|Entry Criteria Exclusion|0|||
127649980|NCT00279201|459339552|FG004|Initiation|Entry Criteria Exclusion|0|||
127649981|NCT00279201|459339553|FG005|Initiation|Entry Criteria Exclusion|0|||
127649982|NCT00279201|459339548|FG000|Initiation|Protocol Violation|9|||
127649983|NCT00279201|459339549|FG001|Initiation|Protocol Violation|10|||
127649984|NCT00279201|459339550|FG002|Initiation|Protocol Violation|0|||
127649985|NCT00279201|459339551|FG003|Initiation|Protocol Violation|0|||
127649986|NCT00279201|459339552|FG004|Initiation|Protocol Violation|0|||
127649987|NCT00279201|459339553|FG005|Initiation|Protocol Violation|0|||
127649988|NCT00279201|459339548|FG000|Initiation|Withdrawal by Subject|35|||
127649989|NCT00279201|459339549|FG001|Initiation|Withdrawal by Subject|41|||
127649990|NCT00279201|459339550|FG002|Initiation|Withdrawal by Subject|0|||
127649991|NCT00279201|459339551|FG003|Initiation|Withdrawal by Subject|0|||
127649992|NCT00279201|459339552|FG004|Initiation|Withdrawal by Subject|0|||
127649993|NCT00279201|459339553|FG005|Initiation|Withdrawal by Subject|0|||
127649994|NCT00279201|459339548|FG000|Initiation|Physician Decision|15|||
127649995|NCT00279201|459339549|FG001|Initiation|Physician Decision|18|||
127649996|NCT00279201|459339550|FG002|Initiation|Physician Decision|0|||
127649997|NCT00279201|459339551|FG003|Initiation|Physician Decision|0|||
127649998|NCT00279201|459339552|FG004|Initiation|Physician Decision|0|||
127649999|NCT00279201|459339553|FG005|Initiation|Physician Decision|0|||
127650000|NCT00279201|459339548|FG000|Initiation|Sponsor Decision|13|||
127650001|NCT00279201|459339549|FG001|Initiation|Sponsor Decision|5|||
127650002|NCT00279201|459339550|FG002|Initiation|Sponsor Decision|0|||
127650003|NCT00279201|459339551|FG003|Initiation|Sponsor Decision|0|||
127650004|NCT00279201|459339552|FG004|Initiation|Sponsor Decision|0|||
127650005|NCT00279201|459339553|FG005|Initiation|Sponsor Decision|0|||
127650006|NCT00279201|459339548|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
127650007|NCT00279201|459339549|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
127650008|NCT00279201|459339550|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
127650009|NCT00279201|459339551|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
127650010|NCT00279201|459339552|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
127650011|NCT00279201|459339553|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
127650012|NCT00279201|459339548|FG000|Maintenance|Lack of Efficacy|32|||
127650013|NCT00279201|459339549|FG001|Maintenance|Lack of Efficacy|30|||
127650014|NCT00279201|459339550|FG002|Maintenance|Lack of Efficacy|0|||
127650015|NCT00279201|459339551|FG003|Maintenance|Lack of Efficacy|0|||
127650016|NCT00279201|459339552|FG004|Maintenance|Lack of Efficacy|0|||
127650017|NCT00279201|459339553|FG005|Maintenance|Lack of Efficacy|0|||
127650018|NCT00279201|459339548|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
127650019|NCT00279201|459339549|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
127650020|NCT00279201|459339550|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
127650021|NCT00279201|459339551|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
127650022|NCT00279201|459339552|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
127650023|NCT00279201|459339553|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
127650024|NCT00279201|459339548|FG000|Maintenance|Adverse Event|4|||
127650025|NCT00279201|459339549|FG001|Maintenance|Adverse Event|4|||
127650026|NCT00279201|459339550|FG002|Maintenance|Adverse Event|0|||
127650027|NCT00279201|459339551|FG003|Maintenance|Adverse Event|0|||
127650028|NCT00279201|459339552|FG004|Maintenance|Adverse Event|0|||
127650029|NCT00279201|459339553|FG005|Maintenance|Adverse Event|0|||
127650030|NCT00279201|459339548|FG000|Maintenance|Death|4|||
127650031|NCT00279201|459339549|FG001|Maintenance|Death|4|||
127650032|NCT00279201|459339550|FG002|Maintenance|Death|0|||
127650033|NCT00279201|459339551|FG003|Maintenance|Death|0|||
127650034|NCT00279201|459339552|FG004|Maintenance|Death|0|||
127650035|NCT00279201|459339553|FG005|Maintenance|Death|0|||
127650036|NCT00279201|459339548|FG000|Maintenance|Lost to Follow-up|17|||
127650037|NCT00279201|459339549|FG001|Maintenance|Lost to Follow-up|13|||
127650038|NCT00279201|459339550|FG002|Maintenance|Lost to Follow-up|0|||
127650039|NCT00279201|459339551|FG003|Maintenance|Lost to Follow-up|0|||
127650040|NCT00279201|459339552|FG004|Maintenance|Lost to Follow-up|0|||
127650041|NCT00279201|459339553|FG005|Maintenance|Lost to Follow-up|0|||
127650042|NCT00279201|459339548|FG000|Maintenance|Entry Criteria Exclusion|1|||
127650043|NCT00279201|459339549|FG001|Maintenance|Entry Criteria Exclusion|4|||
127650044|NCT00279201|459339550|FG002|Maintenance|Entry Criteria Exclusion|0|||
127650045|NCT00279201|459339551|FG003|Maintenance|Entry Criteria Exclusion|0|||
127650046|NCT00279201|459339552|FG004|Maintenance|Entry Criteria Exclusion|0|||
127650047|NCT00279201|459339553|FG005|Maintenance|Entry Criteria Exclusion|0|||
127650048|NCT00279201|459339548|FG000|Maintenance|Protocol Violation|16|||
127650049|NCT00279201|459339549|FG001|Maintenance|Protocol Violation|24|||
127650050|NCT00279201|459339550|FG002|Maintenance|Protocol Violation|0|||
127650051|NCT00279201|459339551|FG003|Maintenance|Protocol Violation|0|||
127650052|NCT00279201|459339552|FG004|Maintenance|Protocol Violation|0|||
127650053|NCT00279201|459339553|FG005|Maintenance|Protocol Violation|0|||
127650054|NCT00279201|459339548|FG000|Maintenance|Withdrawal by Subject|18|||
127650055|NCT00279201|459339549|FG001|Maintenance|Withdrawal by Subject|18|||
127650056|NCT00279201|459339550|FG002|Maintenance|Withdrawal by Subject|0|||
127650057|NCT00279201|459339551|FG003|Maintenance|Withdrawal by Subject|0|||
127650058|NCT00279201|459339552|FG004|Maintenance|Withdrawal by Subject|0|||
127650059|NCT00279201|459339553|FG005|Maintenance|Withdrawal by Subject|0|||
127650060|NCT00279201|459339548|FG000|Maintenance|Physician Decision|9|||
127650061|NCT00279201|459339549|FG001|Maintenance|Physician Decision|9|||
127650062|NCT00279201|459339550|FG002|Maintenance|Physician Decision|0|||
127650063|NCT00279201|459339551|FG003|Maintenance|Physician Decision|0|||
127650064|NCT00279201|459339552|FG004|Maintenance|Physician Decision|0|||
127650065|NCT00279201|459339553|FG005|Maintenance|Physician Decision|0|||
127650066|NCT00279201|459339548|FG000|Maintenance|Sponsor Decision|4|||
127650067|NCT00279201|459339549|FG001|Maintenance|Sponsor Decision|0|||
127650068|NCT00279201|459339550|FG002|Maintenance|Sponsor Decision|0|||
127650069|NCT00279201|459339551|FG003|Maintenance|Sponsor Decision|0|||
127650070|NCT00279201|459339552|FG004|Maintenance|Sponsor Decision|0|||
127650071|NCT00279201|459339553|FG005|Maintenance|Sponsor Decision|0|||
127650072|NCT00279201|459339548|FG000|Maintenance|HbA1c>7.5%|123|||
127650073|NCT00279201|459339549|FG001|Maintenance|HbA1c>7.5%|126|||
127650074|NCT00279201|459339550|FG002|Maintenance|HbA1c>7.5%|0|||
127650075|NCT00279201|459339551|FG003|Maintenance|HbA1c>7.5%|0|||
127650076|NCT00279201|459339552|FG004|Maintenance|HbA1c>7.5%|0|||
127650077|NCT00279201|459339553|FG005|Maintenance|HbA1c>7.5%|0|||
127650078|NCT00279201|459339548|FG000|Intensification Addendum|Withdrawal by Subject|0|||
127650079|NCT00279201|459339549|FG001|Intensification Addendum|Withdrawal by Subject|0|||
127650080|NCT00279201|459339550|FG002|Intensification Addendum|Withdrawal by Subject|12|||
127650081|NCT00279201|459339551|FG003|Intensification Addendum|Withdrawal by Subject|14|||
127650082|NCT00279201|459339552|FG004|Intensification Addendum|Withdrawal by Subject|9|||
127650083|NCT00279201|459339553|FG005|Intensification Addendum|Withdrawal by Subject|18|||
127650084|NCT00279201|459339548|FG000|Intensification Addendum|Lost to Follow-up|0|||
127650085|NCT00279201|459339549|FG001|Intensification Addendum|Lost to Follow-up|0|||
127650086|NCT00279201|459339550|FG002|Intensification Addendum|Lost to Follow-up|4|||
127650087|NCT00279201|459339551|FG003|Intensification Addendum|Lost to Follow-up|6|||
127650088|NCT00279201|459339552|FG004|Intensification Addendum|Lost to Follow-up|7|||
127874349|NCT05182840|460159587|FG008|Treatment Period|Other but not sponsor termination|7|||
127874350|NCT05182840|460159588|FG009|Treatment Period|Other but not sponsor termination|2|||
127650089|NCT00279201|459339553|FG005|Intensification Addendum|Lost to Follow-up|7|||
127650090|NCT00279201|459339548|FG000|Intensification Addendum|Protocol Violation|0|||
127650091|NCT00279201|459339549|FG001|Intensification Addendum|Protocol Violation|0|||
127650092|NCT00279201|459339550|FG002|Intensification Addendum|Protocol Violation|2|||
127650093|NCT00279201|459339551|FG003|Intensification Addendum|Protocol Violation|2|||
127650094|NCT00279201|459339552|FG004|Intensification Addendum|Protocol Violation|6|||
127650095|NCT00279201|459339553|FG005|Intensification Addendum|Protocol Violation|6|||
127650096|NCT00279201|459339548|FG000|Intensification Addendum|Adverse Event|0|||
127650097|NCT00279201|459339549|FG001|Intensification Addendum|Adverse Event|0|||
127650098|NCT00279201|459339550|FG002|Intensification Addendum|Adverse Event|0|||
127874351|NCT05182840|460159579|FG000|Treatment Period|Protocol deviation|0|||
127650099|NCT00279201|459339551|FG003|Intensification Addendum|Adverse Event|4|||
127650100|NCT00279201|459339552|FG004|Intensification Addendum|Adverse Event|1|||
127650101|NCT00279201|459339553|FG005|Intensification Addendum|Adverse Event|3|||
127650102|NCT00279201|459339548|FG000|Intensification Addendum|Physician Decision|0|||
127650103|NCT00279201|459339549|FG001|Intensification Addendum|Physician Decision|0|||
127650104|NCT00279201|459339550|FG002|Intensification Addendum|Physician Decision|4|||
127650105|NCT00279201|459339551|FG003|Intensification Addendum|Physician Decision|1|||
127650106|NCT00279201|459339552|FG004|Intensification Addendum|Physician Decision|3|||
127650107|NCT00279201|459339553|FG005|Intensification Addendum|Physician Decision|2|||
127650108|NCT00279201|459339548|FG000|Intensification Addendum|Sponsor Decision|0|||
127650109|NCT00279201|459339549|FG001|Intensification Addendum|Sponsor Decision|0|||
127650110|NCT00279201|459339550|FG002|Intensification Addendum|Sponsor Decision|0|||
127650111|NCT00279201|459339551|FG003|Intensification Addendum|Sponsor Decision|0|||
127650112|NCT00279201|459339552|FG004|Intensification Addendum|Sponsor Decision|1|||
127650113|NCT00279201|459339553|FG005|Intensification Addendum|Sponsor Decision|1|||
127650114|NCT00279201|459339548|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
127650115|NCT00279201|459339549|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
127650116|NCT00279201|459339550|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
127650117|NCT00279201|459339551|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
127650118|NCT00279201|459339552|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
127650119|NCT00279201|459339553|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
127650120|NCT00279201|459339548|FG000|Intensification Addendum|Lack of Efficacy|0|||
127650121|NCT00279201|459339549|FG001|Intensification Addendum|Lack of Efficacy|0|||
127650122|NCT00279201|459339550|FG002|Intensification Addendum|Lack of Efficacy|0|||
127650123|NCT00279201|459339551|FG003|Intensification Addendum|Lack of Efficacy|1|||
127650124|NCT00279201|459339552|FG004|Intensification Addendum|Lack of Efficacy|1|||
127650125|NCT00279201|459339553|FG005|Intensification Addendum|Lack of Efficacy|0|||
127650126|NCT00279201|459339548|FG000|Intensification Addendum|Death|0|||
127650127|NCT00279201|459339549|FG001|Intensification Addendum|Death|0|||
127650128|NCT00279201|459339550|FG002|Intensification Addendum|Death|0|||
127650129|NCT00279201|459339551|FG003|Intensification Addendum|Death|0|||
127650130|NCT00279201|459339552|FG004|Intensification Addendum|Death|1|||
127650131|NCT00279201|459339553|FG005|Intensification Addendum|Death|0|||
127650132|NCT00316173|459339554|FG000|Run-in Phase|Adverse Event|1|||
127650133|NCT00316173|459339555|FG001|Run-in Phase|Adverse Event|0|||
127650134|NCT00316173|459339554|FG000|Run-in Phase|Protocol Violation|1|||
127650135|NCT00316173|459339555|FG001|Run-in Phase|Protocol Violation|0|||
127650136|NCT00316173|459339554|FG000|Run-in Phase|Study Follow-up Stopped|5|||
127650137|NCT00316173|459339555|FG001|Run-in Phase|Study Follow-up Stopped|0|||
127650138|NCT00316173|459339554|FG000|Treatment Phase|Adverse Event|0|||
127650139|NCT00316173|459339555|FG001|Treatment Phase|Adverse Event|1|||
127650140|NCT00316173|459339554|FG000|Treatment Phase|Lack of Efficacy|0|||
127650141|NCT00316173|459339555|FG001|Treatment Phase|Lack of Efficacy|3|||
127650142|NCT00316173|459339554|FG000|Treatment Phase|Lost to Follow-up|0|||
127650143|NCT00316173|459339555|FG001|Treatment Phase|Lost to Follow-up|3|||
127650144|NCT00316173|459339554|FG000|Treatment Phase|Withdrawal by Subject|0|||
127650145|NCT00316173|459339555|FG001|Treatment Phase|Withdrawal by Subject|1|||
127650146|NCT00316173|459339554|FG000|Treatment Phase|Study Follow-up Stopped|0|||
127650147|NCT00316173|459339555|FG001|Treatment Phase|Study Follow-up Stopped|34|||
127650148|NCT02390531|459339556|FG000|Overall Study|Death|0|||
127650149|NCT02390531|459339557|FG001|Overall Study|Death|2|||
127650150|NCT02390531|459339558|FG002|Overall Study|Death|0|||
127650151|NCT02390531|459339559|FG003|Overall Study|Death|1|||
127650152|NCT02390531|459339560|FG004|Overall Study|Death|0|||
127650153|NCT02390531|459339561|FG005|Overall Study|Death|0|||
127650154|NCT02390531|459339562|FG006|Overall Study|Death|0|||
127650155|NCT02390531|459339563|FG007|Overall Study|Death|1|||
127650156|NCT02390531|459339556|FG000|Overall Study|Protocol Violation|0|||
127650157|NCT02390531|459339557|FG001|Overall Study|Protocol Violation|0|||
127650158|NCT02390531|459339558|FG002|Overall Study|Protocol Violation|0|||
127650159|NCT02390531|459339559|FG003|Overall Study|Protocol Violation|0|||
127650160|NCT02390531|459339560|FG004|Overall Study|Protocol Violation|1|||
127650161|NCT02390531|459339561|FG005|Overall Study|Protocol Violation|0|||
127650162|NCT02390531|459339562|FG006|Overall Study|Protocol Violation|2|||
127650163|NCT02390531|459339563|FG007|Overall Study|Protocol Violation|0|||
127650164|NCT00511875|459339564|FG000|Overall Study|Lost to Follow-up|4|||
127650165|NCT00511875|459339565|FG001|Overall Study|Lost to Follow-up|0|||
127650166|NCT00511875|459339564|FG000|Overall Study|Missing variables|1|||
127650167|NCT00511875|459339565|FG001|Overall Study|Missing variables|0|||
127650168|NCT02618616|459339566|FG000|Overall Study|Lack of Efficacy|4|||
127650169|NCT02618616|459339567|FG001|Overall Study|Lack of Efficacy|0|||
127650170|NCT02618616|459339566|FG000|Overall Study|Pregnancy|0|||
127650171|NCT02618616|459339567|FG001|Overall Study|Pregnancy|1|||
127650172|NCT02618616|459339566|FG000|Overall Study|Adverse Event|8|||
127650173|NCT02618616|459339567|FG001|Overall Study|Adverse Event|0|||
127650174|NCT02618616|459339566|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
127983726|NCT01764997|460562569|FG001|Run-in Period|Lack of Efficacy|0|||
127650175|NCT02618616|459339567|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
127650176|NCT02618616|459339566|FG000|Overall Study|Consent withdrawn by subject|8|||
127650177|NCT02618616|459339567|FG001|Overall Study|Consent withdrawn by subject|5|||
127650178|NCT02618616|459339566|FG000|Overall Study|Lost to Follow-up|0|||
127650179|NCT02618616|459339567|FG001|Overall Study|Lost to Follow-up|1|||
127650180|NCT00542880|459339569|FG000|Period 1|Eligibility criteria not fulfilled|2|||
127650181|NCT00542880|459339570|FG001|Period 1|Eligibility criteria not fulfilled|6|||
127650182|NCT00542880|459339569|FG000|Period 1|Adverse Event|2|||
127650183|NCT00542880|459339570|FG001|Period 1|Adverse Event|2|||
127650184|NCT00542880|459339569|FG000|Period 1|Development of study-specific criteria|1|||
127650185|NCT00542880|459339570|FG001|Period 1|Development of study-specific criteria|2|||
127650186|NCT00542880|459339569|FG000|Period 1|Withdrawal by Subject|1|||
127650187|NCT00542880|459339570|FG001|Period 1|Withdrawal by Subject|1|||
127650188|NCT00542880|459339569|FG000|Period 1|Protocol Violation|0|||
127650189|NCT00542880|459339570|FG001|Period 1|Protocol Violation|1|||
127650190|NCT00542880|459339569|FG000|Period 2|Adverse Event|5|||
127650191|NCT00542880|459339570|FG001|Period 2|Adverse Event|7|||
127650192|NCT00542880|459339569|FG000|Period 2|Eligibility not fulfilled|0|||
127650193|NCT00542880|459339570|FG001|Period 2|Eligibility not fulfilled|1|||
127650194|NCT00542880|459339569|FG000|Period 2|Discontinuation criteria|2|||
127650195|NCT00542880|459339570|FG001|Period 2|Discontinuation criteria|0|||
127650196|NCT00542880|459339569|FG000|Period 2|Severe non-compliance|0|||
127650197|NCT00542880|459339570|FG001|Period 2|Severe non-compliance|1|||
127650198|NCT00542880|459339569|FG000|Period 2|Other|0|||
127650199|NCT00542880|459339570|FG001|Period 2|Other|1|||
127650200|NCT00542880|459339569|FG000|Period 3|Adverse Event|0|||
127650201|NCT00542880|459339570|FG001|Period 3|Adverse Event|2|||
127650202|NCT00696384|459339571|FG000|Open Label Phase|Adverse Event|27|||
127650203|NCT00696384|459339572|FG001|Open Label Phase|Adverse Event|0|||
127650204|NCT00696384|459339573|FG002|Open Label Phase|Adverse Event|0|||
127650205|NCT00696384|459339571|FG000|Open Label Phase|Protocol Violation|18|||
127650206|NCT00696384|459339572|FG001|Open Label Phase|Protocol Violation|0|||
127650207|NCT00696384|459339573|FG002|Open Label Phase|Protocol Violation|0|||
127650208|NCT00696384|459339571|FG000|Open Label Phase|Lost to Follow-up|24|||
127650209|NCT00696384|459339572|FG001|Open Label Phase|Lost to Follow-up|0|||
127650210|NCT00696384|459339573|FG002|Open Label Phase|Lost to Follow-up|0|||
127650211|NCT00696384|459339571|FG000|Open Label Phase|Withdrawal by Subject|37|||
127650212|NCT00696384|459339572|FG001|Open Label Phase|Withdrawal by Subject|0|||
127650213|NCT00696384|459339573|FG002|Open Label Phase|Withdrawal by Subject|0|||
127650214|NCT00696384|459339571|FG000|Open Label Phase|Other|6|||
127650215|NCT00696384|459339572|FG001|Open Label Phase|Other|0|||
127650216|NCT00696384|459339573|FG002|Open Label Phase|Other|0|||
127650217|NCT00696384|459339571|FG000|Open Label Phase|Lack of Efficacy|3|||
127650218|NCT00696384|459339572|FG001|Open Label Phase|Lack of Efficacy|0|||
127650219|NCT00696384|459339573|FG002|Open Label Phase|Lack of Efficacy|0|||
127650220|NCT00696384|459339571|FG000|Open Label Phase|Physician Decision|4|||
127650221|NCT00696384|459339572|FG001|Open Label Phase|Physician Decision|0|||
127650222|NCT00696384|459339573|FG002|Open Label Phase|Physician Decision|0|||
127650223|NCT00696384|459339571|FG000|Double Blind Phase|Adverse Event|0|||
127650224|NCT00696384|459339572|FG001|Double Blind Phase|Adverse Event|2|||
127650225|NCT00696384|459339573|FG002|Double Blind Phase|Adverse Event|2|||
127650226|NCT00696384|459339571|FG000|Double Blind Phase|Lost to Follow-up|0|||
127650227|NCT00696384|459339572|FG001|Double Blind Phase|Lost to Follow-up|2|||
127650228|NCT00696384|459339573|FG002|Double Blind Phase|Lost to Follow-up|1|||
127650229|NCT00696384|459339571|FG000|Double Blind Phase|Withdrawal by Subject|0|||
127650230|NCT00696384|459339572|FG001|Double Blind Phase|Withdrawal by Subject|4|||
127650231|NCT00696384|459339573|FG002|Double Blind Phase|Withdrawal by Subject|3|||
127650232|NCT00696384|459339571|FG000|Double Blind Phase|Lack of Efficacy|0|||
127650233|NCT00696384|459339572|FG001|Double Blind Phase|Lack of Efficacy|1|||
127650234|NCT00696384|459339573|FG002|Double Blind Phase|Lack of Efficacy|0|||
127650235|NCT00696384|459339571|FG000|Double Blind Phase|Physician Decision|0|||
127650236|NCT00696384|459339572|FG001|Double Blind Phase|Physician Decision|2|||
127650237|NCT00696384|459339573|FG002|Double Blind Phase|Physician Decision|0|||
127650238|NCT02027402|459339575|FG000|Overall Study|Withdrawal by Subject|4|||
127650239|NCT02027402|459339576|FG001|Overall Study|Withdrawal by Subject|1|||
127650240|NCT04179721|459339582|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
127650241|NCT04179721|459339583|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
127650242|NCT04179721|459339582|FG000|Overall Study|Lost to Follow-up|0|||
127650243|NCT04179721|459339583|FG001|Overall Study|Lost to Follow-up|1|||
127650244|NCT04225988|459339584|FG000|Overall Study|Withdrawal by Subject|2|||
127650245|NCT04225988|459339585|FG001|Overall Study|Withdrawal by Subject|0|||
127650246|NCT03444376|459339592|FG000|Part A|Disease relapse or Progression|1|||
127650247|NCT03444376|459339592|FG000|Part A|Withdrawal by Subject|2|||
127650248|NCT03444376|459339592|FG000|Part A|Adverse Event|1|||
127650249|NCT03444376|459339592|FG000|Part B|Disease relapse or Progression|18|||
127650250|NCT03444376|459339592|FG000|Part B|Withdrawal by Subject|2|||
127650251|NCT03444376|459339592|FG000|Part B|Adverse Event|2|||
127650252|NCT03444376|459339592|FG000|Part B|Physician Decision|1|||
127650253|NCT03444376|459339592|FG000|Part C|Disease relapse or Progression|43|||
127650254|NCT03444376|459339592|FG000|Part C|Withdrawal by Subject|5|||
127650255|NCT03444376|459339592|FG000|Part C|Adverse Event|2|||
127650256|NCT03444376|459339592|FG000|Part C|Physician Decision|2|||
127650257|NCT03444376|459339592|FG000|Part C|Death|1|||
127650258|NCT01984697|459341416|FG000|Overall Study|Adverse Event|0|||
127650259|NCT01984697|459341417|FG001|Overall Study|Adverse Event|0|||
127650260|NCT01984697|459341418|FG002|Overall Study|Adverse Event|2|||
127650261|NCT01984697|459341419|FG003|Overall Study|Adverse Event|0|||
127650262|NCT01984697|459341420|FG004|Overall Study|Adverse Event|0|||
127650263|NCT01984697|459341416|FG000|Overall Study|Lost to Follow-up|14|||
127650264|NCT01984697|459341417|FG001|Overall Study|Lost to Follow-up|5|||
127650265|NCT01984697|459341418|FG002|Overall Study|Lost to Follow-up|10|||
127650266|NCT01984697|459341419|FG003|Overall Study|Lost to Follow-up|6|||
127650267|NCT01984697|459341420|FG004|Overall Study|Lost to Follow-up|21|||
127650268|NCT01984697|459341416|FG000|Overall Study|Physician Decision|3|||
127650269|NCT01984697|459341417|FG001|Overall Study|Physician Decision|0|||
127650270|NCT01984697|459341418|FG002|Overall Study|Physician Decision|0|||
127650271|NCT01984697|459341419|FG003|Overall Study|Physician Decision|1|||
127650272|NCT01984697|459341420|FG004|Overall Study|Physician Decision|0|||
127650273|NCT01984697|459341416|FG000|Overall Study|Protocol Violation|8|||
127650274|NCT01984697|459341417|FG001|Overall Study|Protocol Violation|5|||
127650275|NCT01984697|459341418|FG002|Overall Study|Protocol Violation|3|||
127650276|NCT01984697|459341419|FG003|Overall Study|Protocol Violation|2|||
127650277|NCT01984697|459341420|FG004|Overall Study|Protocol Violation|0|||
127650278|NCT01984697|459341416|FG000|Overall Study|Withdrawal by Subject|15|||
127650279|NCT01984697|459341417|FG001|Overall Study|Withdrawal by Subject|21|||
127650280|NCT01984697|459341418|FG002|Overall Study|Withdrawal by Subject|13|||
127650281|NCT01984697|459341419|FG003|Overall Study|Withdrawal by Subject|11|||
127650282|NCT01984697|459341420|FG004|Overall Study|Withdrawal by Subject|13|||
127650283|NCT01984697|459341416|FG000|Overall Study|Missed last follow-up visit|1|||
127650284|NCT01984697|459341417|FG001|Overall Study|Missed last follow-up visit|0|||
127650285|NCT01984697|459341418|FG002|Overall Study|Missed last follow-up visit|0|||
127650286|NCT01984697|459341419|FG003|Overall Study|Missed last follow-up visit|0|||
127650287|NCT01984697|459341420|FG004|Overall Study|Missed last follow-up visit|0|||
127650288|NCT01984697|459341416|FG000|Overall Study|Death|0|||
127650289|NCT01984697|459341417|FG001|Overall Study|Death|0|||
127650290|NCT01984697|459341418|FG002|Overall Study|Death|0|||
127650291|NCT01984697|459341419|FG003|Overall Study|Death|1|||
127650292|NCT01984697|459341420|FG004|Overall Study|Death|0|||
127650293|NCT01984697|459341416|FG000|Overall Study|Pregnancy|2|||
127650294|NCT01984697|459341417|FG001|Overall Study|Pregnancy|0|||
127650295|NCT01984697|459341418|FG002|Overall Study|Pregnancy|1|||
127650296|NCT01984697|459341419|FG003|Overall Study|Pregnancy|0|||
127650297|NCT01984697|459341420|FG004|Overall Study|Pregnancy|1|||
127650298|NCT03308825|459341421|FG000|Overall Study|Lost to Follow-up|2|||
127650299|NCT03308825|459341422|FG001|Overall Study|Lost to Follow-up|2|||
127650300|NCT03308825|459341423|FG002|Overall Study|Lost to Follow-up|1|||
127650301|NCT03308825|459341424|FG003|Overall Study|Lost to Follow-up|0|||
127650302|NCT03308825|459341421|FG000|Overall Study|Protocol Violation|0|||
127650303|NCT03308825|459341422|FG001|Overall Study|Protocol Violation|2|||
127650304|NCT03308825|459341423|FG002|Overall Study|Protocol Violation|0|||
127650305|NCT03308825|459341424|FG003|Overall Study|Protocol Violation|0|||
127650306|NCT00847405|459341425|FG000|First Intervention|Adverse Event|0|||
127650307|NCT00847405|459341426|FG001|First Intervention|Adverse Event|1|||
127650308|NCT00847405|459341425|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
127650309|NCT00847405|459341426|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
127650310|NCT04737109|459341427|FG000|Study Treatment|Disease Progression|5|||
127650311|NCT04737109|459341428|FG001|Study Treatment|Disease Progression|0|||
127650312|NCT04737109|459341429|FG002|Study Treatment|Disease Progression|0|||
127650313|NCT04737109|459341430|FG003|Study Treatment|Disease Progression|0|||
127874352|NCT05182840|460159580|FG001|Treatment Period|Protocol deviation|0|||
127874353|NCT05182840|460159581|FG002|Treatment Period|Protocol deviation|0|||
127874354|NCT05182840|460159582|FG003|Treatment Period|Protocol deviation|0|||
127874355|NCT05182840|460159583|FG004|Treatment Period|Protocol deviation|0|||
127874356|NCT05182840|460159584|FG005|Treatment Period|Protocol deviation|0|||
127874357|NCT05182840|460159585|FG006|Treatment Period|Protocol deviation|0|||
127874358|NCT05182840|460159586|FG007|Treatment Period|Protocol deviation|0|||
127874359|NCT05182840|460159587|FG008|Treatment Period|Protocol deviation|1|||
127983727|NCT01764997|460562570|FG002|Run-in Period|Lack of Efficacy|0|||
127650314|NCT04737109|459341427|FG000|Study Treatment|Death on study|1|||
127650315|NCT04737109|459341428|FG001|Study Treatment|Death on study|0|||
127650316|NCT04737109|459341429|FG002|Study Treatment|Death on study|0|||
127650317|NCT04737109|459341430|FG003|Study Treatment|Death on study|0|||
127650318|NCT00949715|459341431|FG000|Overall Study|Physician Decision|1|||
127650319|NCT00949715|459341432|FG001|Overall Study|Physician Decision|0|||
127650320|NCT00949715|459341431|FG000|Overall Study|Lost to Follow-up|1|||
127650321|NCT00949715|459341432|FG001|Overall Study|Lost to Follow-up|0|||
127650322|NCT00949715|459341431|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
127650323|NCT00949715|459341432|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
127650324|NCT02259517|459341434|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
127650325|NCT02259517|459341435|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
127650326|NCT02259517|459341436|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
127874360|NCT05182840|460159588|FG009|Treatment Period|Protocol deviation|0|||
127874361|NCT05182840|460159579|FG000|Treatment Period|No reason available|0|||
127874362|NCT05182840|460159580|FG001|Treatment Period|No reason available|0|||
127874363|NCT05182840|460159581|FG002|Treatment Period|No reason available|0|||
127874364|NCT05182840|460159582|FG003|Treatment Period|No reason available|1|||
127874365|NCT05182840|460159583|FG004|Treatment Period|No reason available|0|||
127874366|NCT05182840|460159584|FG005|Treatment Period|No reason available|2|||
127874367|NCT05182840|460159585|FG006|Treatment Period|No reason available|0|||
127874368|NCT05182840|460159586|FG007|Treatment Period|No reason available|1|||
127650327|NCT02259517|459341434|FG000|Overall Study|Withdrawal by Subject|0|||
127650328|NCT02259517|459341435|FG001|Overall Study|Withdrawal by Subject|0|||
127650329|NCT02259517|459341436|FG002|Overall Study|Withdrawal by Subject|3|||
127650330|NCT01352585|459341437|FG000|Overall Study|Adverse Event|2|||
127650331|NCT01352585|459341438|FG001|Overall Study|Adverse Event|1|||
127650332|NCT01352585|459341437|FG000|Overall Study|Lost to Follow-up|1|||
127650333|NCT01352585|459341438|FG001|Overall Study|Lost to Follow-up|0|||
127650334|NCT01352585|459341437|FG000|Overall Study|Other|5|||
127650335|NCT01352585|459341438|FG001|Overall Study|Other|2|||
127874369|NCT05182840|460159587|FG008|Treatment Period|No reason available|0|||
127874370|NCT05182840|460159588|FG009|Treatment Period|No reason available|0|||
127874371|NCT05182840|460159579|FG000|Treatment Period|Burden of study procedures|0|||
127874372|NCT05182840|460159580|FG001|Treatment Period|Burden of study procedures|0|||
127650336|NCT02276066|459341441|FG000|Overall Study|Lost to Follow-up|21|||
127650337|NCT02276066|459341442|FG001|Overall Study|Lost to Follow-up|11|||
127650338|NCT03928028|459341443|FG000|Overall Study|Physician Decision|9|||
127650339|NCT03928028|459341444|FG001|Overall Study|Physician Decision|6|||
127650340|NCT03928028|459341445|FG002|Overall Study|Physician Decision|3|||
127650341|NCT03928028|459341443|FG000|Overall Study|Withdrawal by Subject|12|||
127650342|NCT03928028|459341444|FG001|Overall Study|Withdrawal by Subject|3|||
127650343|NCT03928028|459341445|FG002|Overall Study|Withdrawal by Subject|3|||
127650344|NCT02710292|459341446|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
127650345|NCT02710292|459341447|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
127650346|NCT02710292|459341446|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
127650347|NCT02710292|459341447|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
127650348|NCT04525547|459341448|FG000|Overall Study|Not treated with Ofev|2|||
127650349|NCT04525547|459341448|FG000|Overall Study|Off-label use|2|||
127650350|NCT04525547|459341448|FG000|Overall Study|Lost to Follow-up|1|||
127650351|NCT00800202|459341449|FG000|Overall Study|Adverse Event|7|||
127650352|NCT00800202|459341450|FG001|Overall Study|Adverse Event|6|||
127650353|NCT00800202|459341449|FG000|Overall Study|Death|1|||
127650354|NCT00800202|459341450|FG001|Overall Study|Death|0|||
127650355|NCT00800202|459341449|FG000|Overall Study|Other|5|||
127650356|NCT00800202|459341450|FG001|Overall Study|Other|0|||
127650357|NCT00800202|459341449|FG000|Overall Study|Disease Progression|54|||
127650358|NCT00800202|459341450|FG001|Overall Study|Disease Progression|18|||
127650359|NCT04425902|459341451|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
127650360|NCT02901626|459341457|FG000|Overall Study|Lost to Follow-up|1|||
127650361|NCT02901626|459341458|FG001|Overall Study|Lost to Follow-up|1|||
127650362|NCT00331344|459341459|FG000|Phase I|Adverse Event|0|||
127650363|NCT00331344|459341460|FG001|Phase I|Adverse Event|0|||
127650364|NCT00331344|459341461|FG002|Phase I|Adverse Event|0|||
127650365|NCT00331344|459341462|FG003|Phase I|Adverse Event|1|||
127650366|NCT00331344|459341463|FG004|Phase I|Adverse Event|2|||
127650367|NCT00331344|459341464|FG005|Phase I|Adverse Event|2|||
127650368|NCT00331344|459341465|FG006|Phase I|Adverse Event|0|||
127650369|NCT00331344|459341466|FG007|Phase I|Adverse Event|1|||
127650370|NCT00331344|459341467|FG008|Phase I|Adverse Event|0|||
127650371|NCT00331344|459341459|FG000|Phase II|Death|0|||
127650372|NCT00331344|459341460|FG001|Phase II|Death|0|||
127650373|NCT00331344|459341461|FG002|Phase II|Death|0|||
127650374|NCT00331344|459341462|FG003|Phase II|Death|0|||
127650375|NCT00331344|459341463|FG004|Phase II|Death|0|||
127874373|NCT05182840|460159581|FG002|Treatment Period|Burden of study procedures|0|||
127874374|NCT05182840|460159582|FG003|Treatment Period|Burden of study procedures|0|||
127983728|NCT01764997|460562571|FG003|Run-in Period|Lack of Efficacy|0|||
127983729|NCT01764997|460562572|FG004|Run-in Period|Lack of Efficacy|0|||
127650376|NCT00331344|459341464|FG005|Phase II|Death|0|||
127650377|NCT00331344|459341465|FG006|Phase II|Death|0|||
127650378|NCT00331344|459341466|FG007|Phase II|Death|0|||
127650379|NCT00331344|459341467|FG008|Phase II|Death|4|||
127650380|NCT01373931|459341468|FG000|Lead-in Period|Adverse Event|2|||
127650381|NCT01373931|459341469|FG001|Lead-in Period|Adverse Event|0|||
127650382|NCT01373931|459341468|FG000|Period 1|Adverse Event|2|||
127650383|NCT01373931|459341469|FG001|Period 1|Adverse Event|0|||
127650384|NCT01373931|459341468|FG000|Period 1|Withdrawal by Subject|0|||
127650385|NCT01373931|459341469|FG001|Period 1|Withdrawal by Subject|2|||
127650386|NCT04857034|459341470|FG000|Placebo-Controlled Period|Request to discontinue|2|||
127650387|NCT04857034|459341471|FG001|Placebo-Controlled Period|Request to discontinue|2|||
127650388|NCT04857034|459341472|FG002|Placebo-Controlled Period|Request to discontinue|0|||
127874375|NCT05182840|460159583|FG004|Treatment Period|Burden of study procedures|1|||
127874376|NCT05182840|460159584|FG005|Treatment Period|Burden of study procedures|0|||
127650389|NCT04857034|459341473|FG003|Placebo-Controlled Period|Request to discontinue|0|||
127650390|NCT04857034|459341474|FG004|Placebo-Controlled Period|Request to discontinue|0|||
127650391|NCT04857034|459341470|FG000|Placebo-Controlled Period|withdrew consent|1|||
127650392|NCT04857034|459341471|FG001|Placebo-Controlled Period|withdrew consent|1|||
127650393|NCT04857034|459341472|FG002|Placebo-Controlled Period|withdrew consent|2|||
127650394|NCT04857034|459341473|FG003|Placebo-Controlled Period|withdrew consent|0|||
127650395|NCT04857034|459341474|FG004|Placebo-Controlled Period|withdrew consent|0|||
127650396|NCT04857034|459341470|FG000|Placebo-Controlled Period|Pregnancy|1|||
127650397|NCT04857034|459341471|FG001|Placebo-Controlled Period|Pregnancy|1|||
127650398|NCT04857034|459341472|FG002|Placebo-Controlled Period|Pregnancy|0|||
127650399|NCT04857034|459341473|FG003|Placebo-Controlled Period|Pregnancy|0|||
127650400|NCT04857034|459341474|FG004|Placebo-Controlled Period|Pregnancy|0|||
127650401|NCT04857034|459341470|FG000|Placebo-Controlled Period|Ongoing study period|0|||
127650402|NCT04857034|459341471|FG001|Placebo-Controlled Period|Ongoing study period|1|||
127650403|NCT04857034|459341472|FG002|Placebo-Controlled Period|Ongoing study period|0|||
127650404|NCT04857034|459341473|FG003|Placebo-Controlled Period|Ongoing study period|0|||
127650405|NCT04857034|459341474|FG004|Placebo-Controlled Period|Ongoing study period|0|||
127650406|NCT04857034|459341470|FG000|Active Treatment Period|Lack of Efficacy|1|||
127650407|NCT04857034|459341471|FG001|Active Treatment Period|Lack of Efficacy|0|||
127650408|NCT04857034|459341472|FG002|Active Treatment Period|Lack of Efficacy|0|||
127650409|NCT04857034|459341473|FG003|Active Treatment Period|Lack of Efficacy|0|||
127650410|NCT04857034|459341474|FG004|Active Treatment Period|Lack of Efficacy|0|||
127650411|NCT04857034|459341470|FG000|Active Treatment Period|request to discontinue|0|||
127650412|NCT04857034|459341471|FG001|Active Treatment Period|request to discontinue|1|||
127650413|NCT04857034|459341472|FG002|Active Treatment Period|request to discontinue|0|||
127650414|NCT04857034|459341473|FG003|Active Treatment Period|request to discontinue|1|||
127650415|NCT04857034|459341474|FG004|Active Treatment Period|request to discontinue|0|||
127650416|NCT04857034|459341470|FG000|Active Treatment Period|administrative reason by sponsor|1|||
127650417|NCT04857034|459341471|FG001|Active Treatment Period|administrative reason by sponsor|5|||
127650418|NCT04857034|459341472|FG002|Active Treatment Period|administrative reason by sponsor|0|||
127650419|NCT04857034|459341473|FG003|Active Treatment Period|administrative reason by sponsor|2|||
127650420|NCT04857034|459341474|FG004|Active Treatment Period|administrative reason by sponsor|2|||
127650421|NCT04857034|459341470|FG000|Active Treatment Period|other reasons|1|||
127650422|NCT04857034|459341471|FG001|Active Treatment Period|other reasons|1|||
127650423|NCT04857034|459341472|FG002|Active Treatment Period|other reasons|0|||
127650424|NCT04857034|459341473|FG003|Active Treatment Period|other reasons|0|||
127650425|NCT04857034|459341474|FG004|Active Treatment Period|other reasons|1|||
127650426|NCT04857034|459341470|FG000|Active Treatment Period|Ongoing Study Period|2|||
127650427|NCT04857034|459341471|FG001|Active Treatment Period|Ongoing Study Period|4|||
127650428|NCT04857034|459341472|FG002|Active Treatment Period|Ongoing Study Period|0|||
127650429|NCT04857034|459341473|FG003|Active Treatment Period|Ongoing Study Period|1|||
127650430|NCT04857034|459341474|FG004|Active Treatment Period|Ongoing Study Period|0|||
127650431|NCT00659490|459341475|FG000|Overall Study|Lost to Follow-up|2|||
127650432|NCT00659490|459341476|FG001|Overall Study|Lost to Follow-up|0|||
127650433|NCT00659490|459341477|FG002|Overall Study|Lost to Follow-up|1|||
127650434|NCT00827541|459341478|FG000|Overall Study|Exitus|1|||
127650435|NCT00827541|459341479|FG001|Overall Study|Exitus|8|||
127650436|NCT00827541|459341478|FG000|Overall Study|Other|1|||
127650437|NCT00827541|459341479|FG001|Overall Study|Other|3|||
127650438|NCT00827541|459341478|FG000|Overall Study|Pathogen not susceptible|1|||
127650439|NCT00827541|459341479|FG001|Overall Study|Pathogen not susceptible|0|||
127650440|NCT00827541|459341478|FG000|Overall Study|Lack of effectiveness|1|||
127650441|NCT00827541|459341479|FG001|Overall Study|Lack of effectiveness|0|||
127650442|NCT01649232|459341480|FG000|Overall Study|Physician Decision|2|||
127650443|NCT01649232|459341481|FG001|Overall Study|Physician Decision|0|||
127650444|NCT02228967|459341482|FG000|Overall Study|Lost to Follow-up|146|||
127650445|NCT02228967|459341483|FG001|Overall Study|Lost to Follow-up|142|||
127650446|NCT02228967|459341482|FG000|Overall Study|Withdrawal by Subject|13|||
127650447|NCT02228967|459341483|FG001|Overall Study|Withdrawal by Subject|18|||
127650448|NCT01964326|459341484|FG000|Overall Study|Adverse Event|48|||
127650449|NCT01964326|459341484|FG000|Overall Study|Death|2|||
127650450|NCT01964326|459341484|FG000|Overall Study|Protocol Violation|4|||
127650451|NCT01964326|459341484|FG000|Overall Study|Lost to Follow-up|88|||
127650452|NCT01964326|459341484|FG000|Overall Study|Withdrawal by Subject|87|||
127650453|NCT01964326|459341484|FG000|Overall Study|Pregnancy|1|||
127650454|NCT01964326|459341484|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
127650455|NCT01964326|459341484|FG000|Overall Study|Physician Decision|55|||
127650456|NCT01964326|459341484|FG000|Overall Study|Investigator Discretion|1|||
127650457|NCT01964326|459341484|FG000|Overall Study|Other|9|||
127650458|NCT01964326|459341484|FG000|Overall Study|Did not meet eligibility criteria|1|||
127650459|NCT02347657|459341485|FG000|Overall Study|Physician Decision|0|||
127650460|NCT02347657|459341486|FG001|Overall Study|Physician Decision|1|||
127650461|NCT02347657|459341485|FG000|Overall Study|Adverse Event|8|||
127650462|NCT02347657|459341486|FG001|Overall Study|Adverse Event|4|||
127650463|NCT02347657|459341485|FG000|Overall Study|Withdrawal by Subject|6|||
127650464|NCT02347657|459341486|FG001|Overall Study|Withdrawal by Subject|7|||
127650465|NCT02347657|459341485|FG000|Overall Study|Randomized but not treated|1|||
127650466|NCT02347657|459341486|FG001|Overall Study|Randomized but not treated|0|||
127650467|NCT02347657|459341485|FG000|Overall Study|Other|3|||
127650468|NCT02347657|459341486|FG001|Overall Study|Other|3|||
127650469|NCT00261495|459341487|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
127650470|NCT00261495|459341488|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
127650471|NCT00261495|459341487|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
127650472|NCT00261495|459341488|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
127650473|NCT00261495|459341487|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
127650474|NCT00261495|459341488|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
127650475|NCT00261495|459341487|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
127650476|NCT00261495|459341488|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
127650477|NCT00261495|459341487|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
127650478|NCT00261495|459341488|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
127650479|NCT00261495|459341487|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
127650480|NCT00261495|459341488|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
127650481|NCT00261495|459341487|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
127650482|NCT00261495|459341488|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
127650483|NCT00261495|459341487|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
127650484|NCT00261495|459341488|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
127650485|NCT00261495|459341487|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
127650486|NCT00261495|459341488|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
127650487|NCT00261495|459341487|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
127650488|NCT00261495|459341488|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
127650489|NCT00261495|459341487|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
127650490|NCT00261495|459341488|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
127650491|NCT00261495|459341487|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
127650492|NCT00261495|459341488|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
127650493|NCT00261495|459341487|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
127650494|NCT00261495|459341488|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
127650495|NCT00261495|459341487|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
127650496|NCT00261495|459341488|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
127650497|NCT00261495|459341487|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
127650498|NCT00261495|459341488|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
127650499|NCT00261495|459341487|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
127650500|NCT00261495|459341488|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
127650501|NCT00261495|459341487|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
127650502|NCT00261495|459341488|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
127650503|NCT00261495|459341487|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
127650504|NCT00261495|459341488|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
127650505|NCT00261495|459341487|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
127650506|NCT00261495|459341488|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
127650507|NCT00261495|459341487|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
127650508|NCT00261495|459341488|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
127650509|NCT00261495|459341487|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
127650510|NCT00261495|459341488|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
127650511|NCT03953898|459341489|FG000|Overall Study|Lack of Efficacy|8|||
127650512|NCT03953898|459341489|FG000|Overall Study|Death|3|||
127650513|NCT03953898|459341489|FG000|Overall Study|Withdrawal by Subject|2|||
127650514|NCT03953898|459341489|FG000|Overall Study|Adverse Event|1|||
127650515|NCT01538472|459341490|FG000|Overall Study|Disease Progression|3|||
127650516|NCT01538472|459341490|FG000|Overall Study|Death|1|||
127650517|NCT01059630|459341491|FG000|Overall Study|Death|100|||
127650518|NCT01059630|459341492|FG001|Overall Study|Death|84|||
127650519|NCT01059630|459341491|FG000|Overall Study|Lost to Follow-up|4|||
127650520|NCT01059630|459341492|FG001|Overall Study|Lost to Follow-up|1|||
127650521|NCT01059630|459341491|FG000|Overall Study|Physician Decision|2|||
127650522|NCT01059630|459341492|FG001|Overall Study|Physician Decision|4|||
127650523|NCT01059630|459341491|FG000|Overall Study|Withdrawal by Subject|21|||
127650524|NCT01059630|459341492|FG001|Overall Study|Withdrawal by Subject|14|||
127650525|NCT03170375|459341493|FG000|Phase 1 - 4 Weeks|Withdrawal by Subject|5|||
127650526|NCT03170375|459341494|FG001|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
127650527|NCT03170375|459341495|FG002|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
127650528|NCT03170375|459341493|FG000|Phase 2 - 6 Months|Withdrawal by Subject|0|||
127650529|NCT03170375|459341494|FG001|Phase 2 - 6 Months|Withdrawal by Subject|3|||
127650530|NCT03170375|459341495|FG002|Phase 2 - 6 Months|Withdrawal by Subject|2|||
127650531|NCT00763958|459341496|FG000|Overall Study|did not meet final criteria|4|||
127650532|NCT00763958|459341497|FG001|Overall Study|did not meet final criteria|4|||
127650533|NCT00763958|459341496|FG000|Overall Study|Lost to Follow-up|10|||
127650534|NCT00763958|459341497|FG001|Overall Study|Lost to Follow-up|2|||
127650535|NCT00763958|459341496|FG000|Overall Study|Believed they were receiving placebo|0|||
127650536|NCT00763958|459341497|FG001|Overall Study|Believed they were receiving placebo|5|||
127650537|NCT01376323|459341499|FG000|Overall Study|Adverse Event|1|||
127650538|NCT01376323|459341500|FG001|Overall Study|Adverse Event|0|||
127650539|NCT01376323|459341501|FG002|Overall Study|Adverse Event|0|||
127650540|NCT01376323|459341502|FG003|Overall Study|Adverse Event|2|||
127650541|NCT01376323|459341503|FG004|Overall Study|Adverse Event|0|||
127650542|NCT01376323|459341499|FG000|Overall Study|Lost to Follow-up|0|||
127650543|NCT01376323|459341500|FG001|Overall Study|Lost to Follow-up|0|||
127650544|NCT01376323|459341501|FG002|Overall Study|Lost to Follow-up|0|||
127650545|NCT01376323|459341502|FG003|Overall Study|Lost to Follow-up|2|||
127650546|NCT01376323|459341503|FG004|Overall Study|Lost to Follow-up|0|||
127650547|NCT01376323|459341499|FG000|Overall Study|Physician Decision|1|||
127650548|NCT01376323|459341500|FG001|Overall Study|Physician Decision|0|||
127650549|NCT01376323|459341501|FG002|Overall Study|Physician Decision|2|||
127650550|NCT01376323|459341502|FG003|Overall Study|Physician Decision|1|||
127650551|NCT01376323|459341503|FG004|Overall Study|Physician Decision|1|||
127650552|NCT01376323|459341499|FG000|Overall Study|Withdrawal by Subject|0|||
127650553|NCT01376323|459341500|FG001|Overall Study|Withdrawal by Subject|1|||
127650554|NCT01376323|459341501|FG002|Overall Study|Withdrawal by Subject|1|||
127650555|NCT01376323|459341502|FG003|Overall Study|Withdrawal by Subject|0|||
127650556|NCT01376323|459341503|FG004|Overall Study|Withdrawal by Subject|0|||
127650557|NCT04681729|459341504|FG000|Overall Study|Lack of Efficacy|2|||
127650558|NCT04681729|459341505|FG001|Overall Study|Lack of Efficacy|2|||
127650559|NCT04681729|459341504|FG000|Overall Study|Withdrawal by Subject|8|||
127650560|NCT04681729|459341505|FG001|Overall Study|Withdrawal by Subject|9|||
127650561|NCT02535364|459341507|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
127650562|NCT02535364|459341507|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
127650563|NCT02535364|459341507|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
127650564|NCT02535364|459341507|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
127650565|NCT02535364|459341507|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
127650566|NCT02535364|459341507|FG000|Part B Screening|Death|2|||
127650567|NCT02535364|459341507|FG000|Part B Screening|Physician Decision|1|||
127650568|NCT02535364|459341507|FG000|Part B Screening|Withdrawal by Subject|1|||
127650569|NCT02535364|459341507|FG000|Part B Screening|Adverse Event|1|||
127650570|NCT02535364|459341507|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
127650571|NCT02535364|459341507|FG000|Study Treatment|Death|1|||
127650572|NCT02535364|459341507|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
127650573|NCT02535364|459341507|FG000|12-Month Follow-up Period|Disease progression|22|||
127650574|NCT02535364|459341507|FG000|12-Month Follow-up Period|Death|5|||
127650575|NCT02535364|459341507|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
127650576|NCT02535364|459341507|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
127650577|NCT02535364|459341507|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
127650578|NCT04766086|459341510|FG000|Overall Study|Lost to Follow-up|3|||
127650579|NCT04766086|459341511|FG001|Overall Study|Lost to Follow-up|5|||
127650580|NCT04766086|459341512|FG002|Overall Study|Lost to Follow-up|3|||
127650581|NCT04766086|459341510|FG000|Overall Study|Withdrawal by Subject|1|||
127650582|NCT04766086|459341511|FG001|Overall Study|Withdrawal by Subject|1|||
127650583|NCT04766086|459341512|FG002|Overall Study|Withdrawal by Subject|2|||
127650584|NCT04766086|459341510|FG000|Overall Study|Other|0|||
127650585|NCT04766086|459341511|FG001|Overall Study|Other|0|||
127650586|NCT04766086|459341512|FG002|Overall Study|Other|1|||
127650587|NCT02889133|459341513|FG000|Completed Primary Outcome|Lost to Follow-up|1|||
127650588|NCT02889133|459341514|FG001|Completed Primary Outcome|Lost to Follow-up|1|||
127650589|NCT02889133|459341513|FG000|Completed Primary Outcome|Manufacturing error|3|||
127650590|NCT02889133|459341514|FG001|Completed Primary Outcome|Manufacturing error|8|||
127650591|NCT02889133|459341513|FG000|Completed Primary Outcome|Chromium labeling failure|1|||
127650592|NCT02889133|459341514|FG001|Completed Primary Outcome|Chromium labeling failure|0|||
127650593|NCT02889133|459341513|FG000|Completed Primary Outcome|COVID-19/Illness|4|||
127650594|NCT02889133|459341514|FG001|Completed Primary Outcome|COVID-19/Illness|2|||
127650595|NCT02889133|459341513|FG000|Completed Primary Outcome|Protocol Violation|1|||
127650596|NCT02889133|459341514|FG001|Completed Primary Outcome|Protocol Violation|0|||
127650597|NCT02889133|459341513|FG000|Completed Primary Outcome|Subject did not meet donor criteria|0|||
127650598|NCT02889133|459341514|FG001|Completed Primary Outcome|Subject did not meet donor criteria|1|||
127650599|NCT02889133|459341513|FG000|Completed Secondary Outcomes|Lost to Follow-up|1|||
127874377|NCT05182840|460159585|FG006|Treatment Period|Burden of study procedures|0|||
127650600|NCT02889133|459341514|FG001|Completed Secondary Outcomes|Lost to Follow-up|1|||
127650601|NCT02889133|459341513|FG000|Completed Secondary Outcomes|COVID-19/illness|4|||
127650602|NCT02889133|459341514|FG001|Completed Secondary Outcomes|COVID-19/illness|2|||
127650603|NCT02889133|459341513|FG000|Completed Secondary Outcomes|Subject could not donate blood after randomization|0|||
127650604|NCT02889133|459341514|FG001|Completed Secondary Outcomes|Subject could not donate blood after randomization|2|||
127650605|NCT02889133|459341513|FG000|Completed Secondary Outcomes|Protocol Violation|1|||
127650606|NCT02889133|459341514|FG001|Completed Secondary Outcomes|Protocol Violation|0|||
127874378|NCT05182840|460159586|FG007|Treatment Period|Burden of study procedures|0|||
127650607|NCT03351738|459341515|FG000|Overall Study|Withdrawal by Subject|0|||
127650608|NCT03351738|459341516|FG001|Overall Study|Withdrawal by Subject|1|||
127650609|NCT03351738|459341517|FG002|Overall Study|Withdrawal by Subject|0|||
127650610|NCT03351738|459341518|FG003|Overall Study|Withdrawal by Subject|1|||
127650611|NCT03351738|459341519|FG004|Overall Study|Withdrawal by Subject|0|||
127650612|NCT03351738|459341520|FG005|Overall Study|Withdrawal by Subject|0|||
127650613|NCT01375205|459341523|FG000|Overall Study|Lost to Follow-up|15|||
127650614|NCT01375205|459341524|FG001|Overall Study|Lost to Follow-up|12|||
127650615|NCT01375205|459341523|FG000|Overall Study|Withdrawal by Subject|6|||
127650616|NCT01375205|459341524|FG001|Overall Study|Withdrawal by Subject|1|||
127650617|NCT05687032|459341525|FG000|Treatment Phase|Adverse Event|13|||
127650618|NCT05687032|459341525|FG000|Treatment Phase|Death|1|||
127650619|NCT05687032|459341525|FG000|Treatment Phase|Physician Decision|3|||
127650620|NCT05687032|459341525|FG000|Treatment Phase|Progressive disease|9|||
127650621|NCT05687032|459341525|FG000|Treatment Phase|Withdrawal by Subject|5|||
127650622|NCT05687032|459341525|FG000|Follow-Up Phase|Death|16|||
127650623|NCT05687032|459341525|FG000|Follow-Up Phase|Ongoing|26|||
127650624|NCT05479604|459341528|FG000|Overall Study|Lost to Follow-up|1|||
127650625|NCT05479604|459341529|FG001|Overall Study|Lost to Follow-up|5|||
127650626|NCT03138733|459341530|FG000|Overall Study|Death|17|||
127650627|NCT03138733|459341531|FG001|Overall Study|Death|18|||
127650628|NCT03138733|459341530|FG000|Overall Study|Withdrawal by Subject|11|||
127650629|NCT03138733|459341531|FG001|Overall Study|Withdrawal by Subject|6|||
127650630|NCT03138733|459341530|FG000|Overall Study|Lost to Follow-up|3|||
127650631|NCT03138733|459341531|FG001|Overall Study|Lost to Follow-up|2|||
127650632|NCT03138733|459341530|FG000|Overall Study|Adverse Event|1|||
127650633|NCT03138733|459341531|FG001|Overall Study|Adverse Event|0|||
127650634|NCT03138733|459341530|FG000|Overall Study|Protocol Violation|1|||
127650635|NCT03138733|459341531|FG001|Overall Study|Protocol Violation|3|||
127650636|NCT03138733|459341530|FG000|Overall Study|Administrative or logistical reason|1|||
127650637|NCT03138733|459341531|FG001|Overall Study|Administrative or logistical reason|0|||
127650638|NCT03138733|459341530|FG000|Overall Study|The patient was transferred to another hospital|1|||
127650639|NCT03138733|459341531|FG001|Overall Study|The patient was transferred to another hospital|0|||
127650640|NCT00504426|459341536|FG000|Overall Study|Adverse Event|0|||
127650641|NCT00504426|459341537|FG001|Overall Study|Adverse Event|0|||
127650642|NCT00504426|459341538|FG002|Overall Study|Adverse Event|2|||
127650643|NCT00504426|459341539|FG003|Overall Study|Adverse Event|0|||
127650644|NCT00504426|459341536|FG000|Overall Study|Protocol Violation|1|||
127650645|NCT00504426|459341537|FG001|Overall Study|Protocol Violation|1|||
127650646|NCT00504426|459341538|FG002|Overall Study|Protocol Violation|2|||
127650647|NCT00504426|459341539|FG003|Overall Study|Protocol Violation|0|||
127650648|NCT00504426|459341536|FG000|Overall Study|Withdrawal by Subject|2|||
127650649|NCT00504426|459341537|FG001|Overall Study|Withdrawal by Subject|0|||
127650650|NCT00504426|459341538|FG002|Overall Study|Withdrawal by Subject|0|||
127650651|NCT00504426|459341539|FG003|Overall Study|Withdrawal by Subject|0|||
127650652|NCT00633464|459341541|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
127650653|NCT00633464|459341542|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
127650654|NCT00633464|459341541|FG000|Overall Study|Never Treated (Randomized in error)|0|||
127650655|NCT00633464|459341542|FG001|Overall Study|Never Treated (Randomized in error)|1|||
127650656|NCT02612064|459341543|FG000|Overall Study|Withdrawal by Subject|1|||
127650657|NCT02612064|459341544|FG001|Overall Study|Withdrawal by Subject|1|||
127650658|NCT02612064|459341543|FG000|Overall Study|Other|0|||
127650659|NCT02612064|459341544|FG001|Overall Study|Other|2|||
127650660|NCT01669798|459341545|FG000|Overall Study|Physician Decision|5|||
127650661|NCT01678131|459341548|FG000|Overall Study|Adverse Event|0|||
127650662|NCT01678131|459341549|FG001|Overall Study|Adverse Event|1|||
127650663|NCT01678131|459341550|FG002|Overall Study|Adverse Event|0|||
127650664|NCT01678131|459341548|FG000|Overall Study|Withdrawal by Subject|0|||
127650665|NCT01678131|459341549|FG001|Overall Study|Withdrawal by Subject|0|||
127650666|NCT01678131|459341550|FG002|Overall Study|Withdrawal by Subject|2|||
127650667|NCT00941798|459341551|FG000|Overall Study|Withdrawal by Subject|72|||
127650668|NCT00941798|459341552|FG001|Overall Study|Withdrawal by Subject|74|||
127650669|NCT00941798|459341551|FG000|Overall Study|Adverse Event|43|||
127874379|NCT05182840|460159587|FG008|Treatment Period|Burden of study procedures|0|||
127874380|NCT05182840|460159588|FG009|Treatment Period|Burden of study procedures|0|||
127650670|NCT00941798|459341552|FG001|Overall Study|Adverse Event|23|||
127650671|NCT00941798|459341551|FG000|Overall Study|Lost to Follow-up|29|||
127650672|NCT00941798|459341552|FG001|Overall Study|Lost to Follow-up|23|||
127650673|NCT00941798|459341551|FG000|Overall Study|Protocol Violation|17|||
127650674|NCT00941798|459341552|FG001|Overall Study|Protocol Violation|20|||
127650675|NCT00941798|459341551|FG000|Overall Study|Administrative problems|13|||
127650676|NCT00941798|459341552|FG001|Overall Study|Administrative problems|23|||
127650677|NCT00941798|459341551|FG000|Overall Study|Lack of Efficacy|10|||
127650678|NCT00941798|459341552|FG001|Overall Study|Lack of Efficacy|17|||
127650679|NCT00941798|459341551|FG000|Overall Study|Patient's inability to use device|6|||
127650680|NCT00941798|459341552|FG001|Overall Study|Patient's inability to use device|1|||
127650681|NCT00941798|459341551|FG000|Overall Study|Abnormal test procedure results|3|||
127650682|NCT00941798|459341552|FG001|Overall Study|Abnormal test procedure results|1|||
127650683|NCT00941798|459341551|FG000|Overall Study|Abnormal laboratory values|1|||
127650684|NCT00941798|459341552|FG001|Overall Study|Abnormal laboratory values|2|||
127650685|NCT00941798|459341551|FG000|Overall Study|Death|0|||
127650686|NCT00941798|459341552|FG001|Overall Study|Death|1|||
127650687|NCT00112580|459341553|FG000|Overall Study|Adverse Event|1|||
127650688|NCT00112580|459341554|FG001|Overall Study|Adverse Event|2|||
127650689|NCT00112580|459341553|FG000|Overall Study|Disease progression|5|||
127650690|NCT00112580|459341554|FG001|Overall Study|Disease progression|16|||
127650691|NCT00112580|459341553|FG000|Overall Study|Participant withdrew consent|2|||
127650692|NCT00112580|459341554|FG001|Overall Study|Participant withdrew consent|1|||
127650693|NCT05619003|459341555|FG000|Overall Study|Adverse Event|1|||
127650694|NCT00685945|459342800|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
127650695|NCT03183388|459342801|FG000|Overall Study|Lost to Follow-up|3|||
127650696|NCT03183388|459342802|FG001|Overall Study|Lost to Follow-up|5|||
127650697|NCT03183388|459342801|FG000|Overall Study|Physician Decision|1|||
127650698|NCT03183388|459342802|FG001|Overall Study|Physician Decision|4|||
127650699|NCT03183388|459342801|FG000|Overall Study|Withdrawal by Subject|4|||
127650700|NCT03183388|459342802|FG001|Overall Study|Withdrawal by Subject|1|||
127650701|NCT03183388|459342801|FG000|Overall Study|Moved|1|||
127650702|NCT03183388|459342802|FG001|Overall Study|Moved|0|||
127650703|NCT03183388|459342801|FG000|Overall Study|Met Exclusion Criteria|2|||
127650704|NCT03183388|459342802|FG001|Overall Study|Met Exclusion Criteria|2|||
127650705|NCT03183388|459342801|FG000|Overall Study|COVID Pandemic Related|2|||
127650706|NCT03183388|459342802|FG001|Overall Study|COVID Pandemic Related|4|||
127650707|NCT01728792|459342803|FG000|Overall Study|Withdrawal of Consent|1|||
127650708|NCT01728792|459342804|FG001|Overall Study|Withdrawal of Consent|1|||
127650709|NCT01728792|459342805|FG002|Overall Study|Withdrawal of Consent|0|||
127650710|NCT01728792|459342806|FG003|Overall Study|Withdrawal of Consent|1|||
127650711|NCT01728792|459342807|FG004|Overall Study|Withdrawal of Consent|0|||
127650712|NCT01728792|459342803|FG000|Overall Study|Lost to Follow-up|2|||
127650713|NCT01728792|459342804|FG001|Overall Study|Lost to Follow-up|1|||
127650714|NCT01728792|459342805|FG002|Overall Study|Lost to Follow-up|4|||
127650715|NCT01728792|459342806|FG003|Overall Study|Lost to Follow-up|2|||
127650716|NCT01728792|459342807|FG004|Overall Study|Lost to Follow-up|0|||
127650717|NCT04277455|459342810|FG000|Overall Study|Lost to Follow-up|1|||
127650718|NCT04669600|459342818|FG000|Overall Study|Withdrawal by Subject|1|||
127650719|NCT04669600|459342818|FG000|Overall Study|Other|6|||
127650720|NCT00710606|459342821|FG000|Overall Study|Adverse Event|0|||
127650721|NCT00710606|459342822|FG001|Overall Study|Adverse Event|2|||
127650722|NCT00514683|459342823|FG000|Overall Study|Not treated|2|||
127650723|NCT00514683|459342824|FG001|Overall Study|Not treated|1|||
127650724|NCT00514683|459342825|FG002|Overall Study|Not treated|0|||
127650725|NCT00514683|459342826|FG003|Overall Study|Not treated|0|||
127650726|NCT00514683|459342827|FG004|Overall Study|Not treated|1|||
127650727|NCT00514683|459342823|FG000|Overall Study|Adverse Event|21|||
127650728|NCT00514683|459342824|FG001|Overall Study|Adverse Event|20|||
127650729|NCT00514683|459342825|FG002|Overall Study|Adverse Event|15|||
127650730|NCT00514683|459342826|FG003|Overall Study|Adverse Event|13|||
127650731|NCT00514683|459342827|FG004|Overall Study|Adverse Event|27|||
127650732|NCT00514683|459342823|FG000|Overall Study|Protocol Violation|1|||
127650733|NCT00514683|459342824|FG001|Overall Study|Protocol Violation|1|||
127650734|NCT00514683|459342825|FG002|Overall Study|Protocol Violation|0|||
127650735|NCT00514683|459342826|FG003|Overall Study|Protocol Violation|1|||
127650736|NCT00514683|459342827|FG004|Overall Study|Protocol Violation|0|||
127650737|NCT00514683|459342823|FG000|Overall Study|Withdrawal by Subject|2|||
127650738|NCT00514683|459342824|FG001|Overall Study|Withdrawal by Subject|2|||
127650739|NCT00514683|459342825|FG002|Overall Study|Withdrawal by Subject|1|||
127650740|NCT00514683|459342826|FG003|Overall Study|Withdrawal by Subject|0|||
127650741|NCT00514683|459342827|FG004|Overall Study|Withdrawal by Subject|4|||
127650742|NCT00514683|459342823|FG000|Overall Study|Reason other than listed above|0|||
127650743|NCT00514683|459342824|FG001|Overall Study|Reason other than listed above|1|||
127650744|NCT00514683|459342825|FG002|Overall Study|Reason other than listed above|2|||
127650745|NCT00514683|459342826|FG003|Overall Study|Reason other than listed above|0|||
127650746|NCT00514683|459342827|FG004|Overall Study|Reason other than listed above|1|||
127874381|NCT05182840|460159579|FG000|Treatment Period|Change of residence|0|||
127650747|NCT02736825|459342828|FG000|Overall Study|Lost to Follow-up|10|||
127650748|NCT02736825|459342829|FG001|Overall Study|Lost to Follow-up|11|||
127650749|NCT02736825|459342828|FG000|Overall Study|Early Termination|0|||
127650750|NCT02736825|459342829|FG001|Overall Study|Early Termination|1|||
127650751|NCT00790452|459342830|FG000|Overall Study|Drug supply issue|1|||
127650752|NCT00790452|459342831|FG001|Overall Study|Drug supply issue|0|||
127650753|NCT01564368|459342832|FG000|Overall Study|Ineligible|18|||
127650754|NCT01564368|459342832|FG000|Overall Study|Not Randomized in Parent study|116|||
127650755|NCT01564368|459342832|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
127650756|NCT01564368|459342832|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
127650757|NCT04082884|459342833|FG000|Overall Study|Withdrawal by Subject|1|||
127650758|NCT05674890|459342838|FG000|Overall Study|5 eyes were excluded due to poor reliability indices|2|||
127650759|NCT05674890|459342839|FG001|Overall Study|5 eyes were excluded due to poor reliability indices|3|||
127650760|NCT05674890|459342838|FG000|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
127650761|NCT05674890|459342839|FG001|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
127650762|NCT05674890|459342838|FG000|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|3|||
127650763|NCT05674890|459342839|FG001|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|5|||
127650764|NCT00520975|459342840|FG000|Overall Study|Disease progression|31|||
127650765|NCT00520975|459342841|FG001|Overall Study|Disease progression|23|||
127650766|NCT00520975|459342840|FG000|Overall Study|Adverse Event|7|||
127650767|NCT00520975|459342841|FG001|Overall Study|Adverse Event|10|||
127650768|NCT00520975|459342840|FG000|Overall Study|Death|0|||
127650769|NCT00520975|459342841|FG001|Overall Study|Death|2|||
127650770|NCT00520975|459342840|FG000|Overall Study|Withdrawal by Subject|3|||
127650771|NCT00520975|459342841|FG001|Overall Study|Withdrawal by Subject|5|||
127650772|NCT00520975|459342840|FG000|Overall Study|Other therapy|2|||
127650773|NCT00520975|459342841|FG001|Overall Study|Other therapy|4|||
127650774|NCT00520975|459342840|FG000|Overall Study|Other reasons|4|||
127650775|NCT00520975|459342841|FG001|Overall Study|Other reasons|2|||
127650776|NCT00520975|459342840|FG000|Overall Study|Not start protocol therapy|1|||
127650777|NCT00520975|459342841|FG001|Overall Study|Not start protocol therapy|2|||
127650778|NCT04810221|459342842|FG000|Overall Study|Physician Decision|3|||
127650779|NCT03642938|459342843|FG000|Overall Study|Withdrawal by Subject|0|||
127650780|NCT03642938|459342844|FG001|Overall Study|Withdrawal by Subject|0|||
127650781|NCT03642938|459342845|FG002|Overall Study|Withdrawal by Subject|0|||
127650782|NCT03642938|459342846|FG003|Overall Study|Withdrawal by Subject|1|||
127650783|NCT00105235|459342847|FG000|Overall Study|Death|4|||
127650784|NCT00105235|459342847|FG000|Overall Study|Physician Decision|1|||
127650785|NCT00105235|459342847|FG000|Overall Study|Withdrawal by Subject|2|||
127650786|NCT01995539|459342848|FG000|Overall Study|Screening Failure|1|||
127650787|NCT01995539|459342848|FG000|Overall Study|Withdrawal by Investigator|15|||
127650788|NCT01995539|459342848|FG000|Overall Study|Withdrawal by Subject|11|||
127650789|NCT01995539|459342848|FG000|Overall Study|Lost to Follow-up|5|||
127650790|NCT01995539|459342848|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
127650791|NCT00642902|459342849|FG000|Overall Study|Adverse Event|0|||
127650792|NCT00642902|459342850|FG001|Overall Study|Adverse Event|1|||
127650793|NCT00642902|459342851|FG002|Overall Study|Adverse Event|3|||
127650794|NCT00642902|459342852|FG003|Overall Study|Adverse Event|1|||
127650795|NCT00642902|459342849|FG000|Overall Study|Lost to Follow-up|1|||
127650796|NCT00642902|459342850|FG001|Overall Study|Lost to Follow-up|1|||
127650797|NCT00642902|459342851|FG002|Overall Study|Lost to Follow-up|0|||
127650798|NCT00642902|459342852|FG003|Overall Study|Lost to Follow-up|0|||
127650799|NCT00642902|459342849|FG000|Overall Study|Lack of Efficacy|0|||
127650800|NCT00642902|459342850|FG001|Overall Study|Lack of Efficacy|3|||
127650801|NCT00642902|459342851|FG002|Overall Study|Lack of Efficacy|3|||
127650802|NCT00642902|459342852|FG003|Overall Study|Lack of Efficacy|0|||
127650803|NCT00642902|459342849|FG000|Overall Study|Death|1|||
127650804|NCT00642902|459342850|FG001|Overall Study|Death|0|||
127650805|NCT00642902|459342851|FG002|Overall Study|Death|0|||
127650806|NCT00642902|459342852|FG003|Overall Study|Death|0|||
127650807|NCT00642902|459342849|FG000|Overall Study|Premature termination of clinical trial|37|||
127650808|NCT00642902|459342850|FG001|Overall Study|Premature termination of clinical trial|32|||
127650809|NCT00642902|459342851|FG002|Overall Study|Premature termination of clinical trial|35|||
127650810|NCT00642902|459342852|FG003|Overall Study|Premature termination of clinical trial|35|||
127650811|NCT00642902|459342849|FG000|Overall Study|Randomized, but not treated|0|||
127650812|NCT00642902|459342850|FG001|Overall Study|Randomized, but not treated|0|||
127650813|NCT00642902|459342851|FG002|Overall Study|Randomized, but not treated|1|||
127650814|NCT00642902|459342852|FG003|Overall Study|Randomized, but not treated|0|||
127650815|NCT00642902|459342849|FG000|Overall Study|Other|1|||
127650816|NCT00642902|459342850|FG001|Overall Study|Other|5|||
127650817|NCT00642902|459342851|FG002|Overall Study|Other|1|||
127650818|NCT00642902|459342852|FG003|Overall Study|Other|4|||
127650819|NCT02309112|459342854|FG000|Overall Study|Withdrawal by Subject|1|||
127650820|NCT02309112|459342855|FG001|Overall Study|Withdrawal by Subject|0|||
127650821|NCT02309112|459342856|FG002|Overall Study|Withdrawal by Subject|1|||
127650822|NCT02309112|459342854|FG000|Overall Study|Lost to Follow-up|0|||
127650823|NCT02309112|459342855|FG001|Overall Study|Lost to Follow-up|1|||
127650824|NCT02309112|459342856|FG002|Overall Study|Lost to Follow-up|0|||
127650825|NCT00499863|459342859|FG000|Overall Study|Lack of Efficacy|21|||
127650826|NCT00499863|459342860|FG001|Overall Study|Lack of Efficacy|27|||
127650827|NCT00499863|459342859|FG000|Overall Study|Protocol Violation|12|||
127650828|NCT00499863|459342860|FG001|Overall Study|Protocol Violation|7|||
127650829|NCT00499863|459342859|FG000|Overall Study|Withdrawal by Subject|6|||
127650830|NCT00499863|459342860|FG001|Overall Study|Withdrawal by Subject|4|||
127874382|NCT05182840|460159580|FG001|Treatment Period|Change of residence|0|||
127874383|NCT05182840|460159581|FG002|Treatment Period|Change of residence|0|||
127874384|NCT05182840|460159582|FG003|Treatment Period|Change of residence|0|||
127874385|NCT05182840|460159583|FG004|Treatment Period|Change of residence|0|||
127650831|NCT00499863|459342859|FG000|Overall Study|Adverse Event|8|||
127650832|NCT00499863|459342860|FG001|Overall Study|Adverse Event|2|||
127650833|NCT00499863|459342859|FG000|Overall Study|Sponsor decision|2|||
127650834|NCT00499863|459342860|FG001|Overall Study|Sponsor decision|2|||
127650835|NCT00499863|459342859|FG000|Overall Study|Lost to Follow-up|1|||
127650836|NCT00499863|459342860|FG001|Overall Study|Lost to Follow-up|1|||
127650837|NCT00571701|459342861|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
127650838|NCT00571701|459342862|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
127650839|NCT00571701|459342861|FG000|First Intervention 12 Months|Death|1|||
127650840|NCT00571701|459342862|FG001|First Intervention 12 Months|Death|0|||
127650841|NCT00571701|459342861|FG000|Second Intervention 12 Months|Adverse Event|0|||
127650842|NCT00571701|459342862|FG001|Second Intervention 12 Months|Adverse Event|1|||
127650843|NCT00571701|459342861|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
127650844|NCT00571701|459342862|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
127650845|NCT03759834|459342864|FG000|Overall Study|Withdrawal by Subject|1|||
127650846|NCT05701995|459342865|FG000|Pre-Treatment|Randomization Error|1|||
127650847|NCT05701995|459342866|FG001|Pre-Treatment|Randomization Error|1|||
127650848|NCT05701995|459342865|FG000|Treatment|Withdrawal by Subject|8|||
127650849|NCT05701995|459342866|FG001|Treatment|Withdrawal by Subject|4|||
127650850|NCT05701995|459342865|FG000|Treatment|Lost to Follow-up|2|||
127650851|NCT05701995|459342866|FG001|Treatment|Lost to Follow-up|3|||
127650852|NCT05701995|459342865|FG000|Treatment|Adverse Event|3|||
127650853|NCT05701995|459342866|FG001|Treatment|Adverse Event|1|||
127650854|NCT05701995|459342865|FG000|Treatment|Other Reason|1|||
127650855|NCT05701995|459342866|FG001|Treatment|Other Reason|1|||
127650856|NCT05701995|459342865|FG000|Treatment|Death|1|||
127650857|NCT05701995|459342866|FG001|Treatment|Death|0|||
127650858|NCT05701995|459342865|FG000|Treatment|Physician Decision|0|||
127650859|NCT05701995|459342866|FG001|Treatment|Physician Decision|1|||
127650860|NCT04987762|459342867|FG000|Overall Study|Study was Terminated by Sponsor|103|||
127650861|NCT04803214|459342870|FG000|Overall Study|Adverse Event|1|||
127650862|NCT04803214|459342871|FG001|Overall Study|Adverse Event|0|||
127650863|NCT04803214|459342870|FG000|Overall Study|Withdrawal by Subject|1|||
127650864|NCT04803214|459342871|FG001|Overall Study|Withdrawal by Subject|2|||
127650865|NCT04803214|459342870|FG000|Overall Study|Lost to Follow-up|2|||
127650866|NCT04803214|459342871|FG001|Overall Study|Lost to Follow-up|4|||
127650867|NCT04803214|459342870|FG000|Overall Study|Physician Decision|1|||
127650868|NCT04803214|459342871|FG001|Overall Study|Physician Decision|1|||
127650869|NCT04803214|459342870|FG000|Overall Study|Missed 12 month visit|0|||
127650870|NCT04803214|459342871|FG001|Overall Study|Missed 12 month visit|3|||
127650871|NCT03988166|459342874|FG000|Overall Study|Lost to Follow-up|2|||
127650872|NCT03988166|459342874|FG000|Overall Study|Death|1|||
127650873|NCT03248375|459342875|FG000|Overall Study|Lost to Follow-up|5|||
127650874|NCT03764072|459342880|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
127650875|NCT03764072|459342881|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
127650876|NCT03764072|459342882|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
127650877|NCT03764072|459342883|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
127650878|NCT03764072|459342884|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
127650879|NCT03764072|459342885|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
127650880|NCT03764072|459342880|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
127650881|NCT03764072|459342881|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
127650882|NCT03764072|459342882|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
127650883|NCT03764072|459342883|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
127650884|NCT03764072|459342884|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
127650885|NCT03764072|459342885|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
127650886|NCT03764072|459342880|FG000|Overall Study|Lost to Follow-up|0|||
127650887|NCT03764072|459342881|FG001|Overall Study|Lost to Follow-up|0|||
127650888|NCT03764072|459342882|FG002|Overall Study|Lost to Follow-up|0|||
127650889|NCT03764072|459342883|FG003|Overall Study|Lost to Follow-up|0|||
127650890|NCT03764072|459342884|FG004|Overall Study|Lost to Follow-up|1|||
127650891|NCT03764072|459342885|FG005|Overall Study|Lost to Follow-up|0|||
127650892|NCT00558064|459342886|FG000|Overall Study|Adverse Event|3|||
127650893|NCT00558064|459342887|FG001|Overall Study|Adverse Event|2|||
127650894|NCT00558064|459342886|FG000|Overall Study|Lack of Efficacy|0|||
127650895|NCT00558064|459342887|FG001|Overall Study|Lack of Efficacy|1|||
127650896|NCT00558064|459342886|FG000|Overall Study|Protocol Violation|1|||
127650897|NCT00558064|459342887|FG001|Overall Study|Protocol Violation|0|||
127650898|NCT00558064|459342886|FG000|Overall Study|Lost to Follow-up|0|||
127650899|NCT00558064|459342887|FG001|Overall Study|Lost to Follow-up|1|||
127650900|NCT00558064|459342886|FG000|Overall Study|Withdrawal by Subject|0|||
127650901|NCT00558064|459342887|FG001|Overall Study|Withdrawal by Subject|1|||
127650902|NCT00558064|459342886|FG000|Overall Study|No visit within allowance period|1|||
127650903|NCT00558064|459342887|FG001|Overall Study|No visit within allowance period|0|||
127650904|NCT00982930|459342890|FG000|Overall Study|Adverse Event|1|||
127650905|NCT00982930|459342890|FG000|Overall Study|Withdrawal by Subject|1|||
127650906|NCT00982930|459342890|FG000|Overall Study|Administrative Problems|2|||
127650907|NCT01489189|459342891|FG000|Overall Study|Withdrawal by Subject|20|||
127650908|NCT01489189|459342892|FG001|Overall Study|Withdrawal by Subject|23|||
127650909|NCT01489189|459342891|FG000|Overall Study|Death|10|||
127650910|NCT01489189|459342892|FG001|Overall Study|Death|8|||
127650911|NCT01489189|459342891|FG000|Overall Study|Missed Visit|1|||
127650912|NCT01489189|459342892|FG001|Overall Study|Missed Visit|4|||
127650913|NCT05597722|459342893|FG000|Overall Study|Study was terminated|6|||
127650914|NCT05597722|459342894|FG001|Overall Study|Study was terminated|1|||
127650915|NCT04108000|459342895|FG000|Overall Study|Death of patient|1|||
127650916|NCT04108000|459342896|FG001|Overall Study|Death of patient|0|||
127650917|NCT04108000|459342897|FG002|Overall Study|Death of patient|1|||
127650918|NCT04108000|459342898|FG003|Overall Study|Death of patient|0|||
127650919|NCT04108000|459342895|FG000|Overall Study|Withdrawal by Subject|2|||
127650920|NCT04108000|459342896|FG001|Overall Study|Withdrawal by Subject|2|||
127650921|NCT04108000|459342897|FG002|Overall Study|Withdrawal by Subject|0|||
127650922|NCT04108000|459342898|FG003|Overall Study|Withdrawal by Subject|0|||
127650923|NCT04108000|459342895|FG000|Overall Study|Death of surrogate partner|0|||
127650924|NCT04108000|459342896|FG001|Overall Study|Death of surrogate partner|1|||
127650925|NCT04108000|459342897|FG002|Overall Study|Death of surrogate partner|0|||
127650926|NCT04108000|459342898|FG003|Overall Study|Death of surrogate partner|1|||
127650927|NCT03881696|459342906|FG000|Overall Study|Adverse Event|2|||
127650928|NCT03881696|459342907|FG001|Overall Study|Adverse Event|0|||
127650929|NCT03881696|459342906|FG000|Overall Study|Withdrawal by Subject|2|||
127650930|NCT03881696|459342907|FG001|Overall Study|Withdrawal by Subject|0|||
127650931|NCT03881696|459342906|FG000|Overall Study|Subject withdrawal by parent or guardian|1|||
127650932|NCT03881696|459342907|FG001|Overall Study|Subject withdrawal by parent or guardian|0|||
127650933|NCT03881696|459342906|FG000|Overall Study|Failure to meet continuation criteria|1|||
127874386|NCT05182840|460159584|FG005|Treatment Period|Change of residence|1|||
127874387|NCT05182840|460159585|FG006|Treatment Period|Change of residence|0|||
127874388|NCT05182840|460159586|FG007|Treatment Period|Change of residence|0|||
127874389|NCT05182840|460159587|FG008|Treatment Period|Change of residence|0|||
127874390|NCT05182840|460159588|FG009|Treatment Period|Change of residence|0|||
127874391|NCT05182840|460159579|FG000|Treatment Period|Adverse Event|0|||
127874392|NCT05182840|460159580|FG001|Treatment Period|Adverse Event|0|||
127874393|NCT05182840|460159581|FG002|Treatment Period|Adverse Event|4|||
127874394|NCT05182840|460159582|FG003|Treatment Period|Adverse Event|16|||
127874395|NCT05182840|460159583|FG004|Treatment Period|Adverse Event|12|||
127874396|NCT05182840|460159584|FG005|Treatment Period|Adverse Event|6|||
127874397|NCT05182840|460159585|FG006|Treatment Period|Adverse Event|4|||
127541924|NCT05546476|458951046|FG003|Period 1: Part A|Adverse Event|1|||
127541925|NCT05546476|458951043|FG000|Period 1: Part A|Death|4|||
127541926|NCT05546476|458951044|FG001|Period 1: Part A|Death|4|||
127541927|NCT05546476|458951045|FG002|Period 1: Part A|Death|5|||
127541928|NCT05546476|458951046|FG003|Period 1: Part A|Death|6|||
127541929|NCT05546476|458951043|FG000|Period 1: Part A|Lack of Efficacy|0|||
127541930|NCT05546476|458951044|FG001|Period 1: Part A|Lack of Efficacy|0|||
127541931|NCT05546476|458951045|FG002|Period 1: Part A|Lack of Efficacy|0|||
127541932|NCT05546476|458951046|FG003|Period 1: Part A|Lack of Efficacy|1|||
127541933|NCT05546476|458951043|FG000|Period 1: Part A|Lost to Follow-up|0|||
127541934|NCT05546476|458951044|FG001|Period 1: Part A|Lost to Follow-up|0|||
127541935|NCT05546476|458951045|FG002|Period 1: Part A|Lost to Follow-up|0|||
127541936|NCT05546476|458951046|FG003|Period 1: Part A|Lost to Follow-up|1|||
127541937|NCT05546476|458951043|FG000|Period 1: Part A|Physician Decision|1|||
127541938|NCT05546476|458951044|FG001|Period 1: Part A|Physician Decision|0|||
127541939|NCT05546476|458951045|FG002|Period 1: Part A|Physician Decision|0|||
127541940|NCT05546476|458951046|FG003|Period 1: Part A|Physician Decision|0|||
127541941|NCT05546476|458951043|FG000|Period 1: Part A|Progressive disease|3|||
127541942|NCT05546476|458951044|FG001|Period 1: Part A|Progressive disease|5|||
127541943|NCT05546476|458951045|FG002|Period 1: Part A|Progressive disease|0|||
127541944|NCT05546476|458951046|FG003|Period 1: Part A|Progressive disease|1|||
127541945|NCT05546476|458951043|FG000|Period 1: Part A|Withdrawal by Subject|1|||
127541946|NCT05546476|458951044|FG001|Period 1: Part A|Withdrawal by Subject|1|||
127541947|NCT05546476|458951045|FG002|Period 1: Part A|Withdrawal by Subject|1|||
127541948|NCT05546476|458951046|FG003|Period 1: Part A|Withdrawal by Subject|2|||
127541949|NCT05546476|458951043|FG000|Period 1: Part A|Global deterioration of health status|2|||
127541950|NCT05546476|458951044|FG001|Period 1: Part A|Global deterioration of health status|2|||
127541951|NCT05546476|458951045|FG002|Period 1: Part A|Global deterioration of health status|1|||
127541952|NCT05546476|458951046|FG003|Period 1: Part A|Global deterioration of health status|4|||
127650934|NCT03881696|459342907|FG001|Overall Study|Failure to meet continuation criteria|0|||
127650935|NCT01582789|459344076|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
127650936|NCT01582789|459344077|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
127650937|NCT01191840|459344085|FG000|Overall Study|withdrew consent|2|||
127650938|NCT01191840|459344086|FG001|Overall Study|withdrew consent|1|||
127874398|NCT05182840|460159586|FG007|Treatment Period|Adverse Event|8|||
127874399|NCT05182840|460159587|FG008|Treatment Period|Adverse Event|16|||
127874400|NCT05182840|460159588|FG009|Treatment Period|Adverse Event|5|||
127650939|NCT01191840|459344085|FG000|Overall Study|Subject discontinued treatment|1|||
127650940|NCT01191840|459344086|FG001|Overall Study|Subject discontinued treatment|2|||
127650941|NCT01191840|459344085|FG000|Overall Study|Lost to Follow-up|4|||
127650942|NCT01191840|459344086|FG001|Overall Study|Lost to Follow-up|6|||
127650943|NCT01191840|459344085|FG000|Overall Study|Non Staph Infection|4|||
127650944|NCT01191840|459344086|FG001|Overall Study|Non Staph Infection|3|||
127650945|NCT01191840|459344085|FG000|Overall Study|ineligible at enrollment|1|||
127650946|NCT01191840|459344086|FG001|Overall Study|ineligible at enrollment|0|||
127650947|NCT01191840|459344085|FG000|Overall Study|IRB approval lapse|0|||
127650948|NCT01191840|459344086|FG001|Overall Study|IRB approval lapse|2|||
127650949|NCT01191840|459344085|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
127650950|NCT01191840|459344086|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
127650951|NCT01191840|459344085|FG000|Overall Study|Withdrawal by Subject|2|||
127650952|NCT01191840|459344086|FG001|Overall Study|Withdrawal by Subject|0|||
127650953|NCT01392300|459344087|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
127650954|NCT01392300|459344088|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
127650955|NCT01392300|459344089|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
127650956|NCT01392300|459344087|FG000|Main Period (MP)|Withdrawal by Subject|5|||
127650957|NCT01392300|459344088|FG001|Main Period (MP)|Withdrawal by Subject|1|||
127650958|NCT01392300|459344089|FG002|Main Period (MP)|Withdrawal by Subject|0|||
127650959|NCT01392300|459344087|FG000|Main Period (MP)|Lost to Follow-up|3|||
127650960|NCT01392300|459344088|FG001|Main Period (MP)|Lost to Follow-up|3|||
127650961|NCT01392300|459344089|FG002|Main Period (MP)|Lost to Follow-up|0|||
127650962|NCT01392300|459344087|FG000|Main Period (MP)|Non-compliance|1|||
127650963|NCT01392300|459344088|FG001|Main Period (MP)|Non-compliance|0|||
127650964|NCT01392300|459344089|FG002|Main Period (MP)|Non-compliance|0|||
127650965|NCT01392300|459344087|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
127650966|NCT01392300|459344088|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
127650967|NCT01392300|459344089|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
127650968|NCT01392300|459344087|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
127650969|NCT01392300|459344088|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
127650970|NCT01392300|459344089|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
127650971|NCT01392300|459344087|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
127650972|NCT01392300|459344088|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
127650973|NCT01392300|459344089|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
127650974|NCT01392300|459344087|FG000|Open Label Extension (OLEX) Period|Death|0|||
127650975|NCT01392300|459344088|FG001|Open Label Extension (OLEX) Period|Death|0|||
127650976|NCT01392300|459344089|FG002|Open Label Extension (OLEX) Period|Death|4|||
127650977|NCT01392300|459344087|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
127650978|NCT01392300|459344088|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
127650979|NCT01392300|459344089|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
127650980|NCT01392300|459344087|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
127650981|NCT01392300|459344088|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
127650982|NCT01392300|459344089|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
127650983|NCT01392300|459344087|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
127650984|NCT01392300|459344088|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
127650985|NCT01392300|459344089|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
127650986|NCT01802437|459344094|FG000|Overall Study|Lost to Follow-up|1|||
127650987|NCT01802437|459344095|FG001|Overall Study|Lost to Follow-up|0|||
127650988|NCT01802437|459344094|FG000|Overall Study|Withdrawal by Subject|3|||
127650989|NCT01802437|459344095|FG001|Overall Study|Withdrawal by Subject|4|||
127650990|NCT01682213|459344103|FG000|Overall Study|Withdrawal by Subject|2|||
127650991|NCT00742079|459344104|FG000|Overall Study|Lost to Follow-up|0|||
127650992|NCT00742079|459344105|FG001|Overall Study|Lost to Follow-up|1|||
127650993|NCT01181726|459344106|FG000|First Intervention|Adverse Event|1|||
127650994|NCT01181726|459344107|FG001|First Intervention|Adverse Event|0|||
127650995|NCT01264380|459344108|FG000|Period C|Disease Progression|0|||
127650996|NCT01264380|459344109|FG001|Period C|Disease Progression|0|||
127650997|NCT01264380|459344110|FG002|Period C|Disease Progression|4|||
127650998|NCT01264380|459344108|FG000|Period C|Death|0|||
127874401|NCT05182840|460159579|FG000|Treatment Period|Not treated with study drug|0|||
127874402|NCT05182840|460159580|FG001|Treatment Period|Not treated with study drug|0|||
127650999|NCT01264380|459344109|FG001|Period C|Death|0|||
127874403|NCT05182840|460159581|FG002|Treatment Period|Not treated with study drug|0|||
127874404|NCT05182840|460159582|FG003|Treatment Period|Not treated with study drug|1|||
127874405|NCT05182840|460159583|FG004|Treatment Period|Not treated with study drug|0|||
127651000|NCT01264380|459344110|FG002|Period C|Death|2|||
127651001|NCT01264380|459344108|FG000|Period C|Follow-up for survival status|0|||
127651002|NCT01264380|459344109|FG001|Period C|Follow-up for survival status|0|||
127651003|NCT01264380|459344110|FG002|Period C|Follow-up for survival status|6|||
127651004|NCT01264380|459344108|FG000|Period C|Withdrawal by Subject|0|||
127651005|NCT01264380|459344109|FG001|Period C|Withdrawal by Subject|0|||
127651006|NCT01264380|459344110|FG002|Period C|Withdrawal by Subject|1|||
127651007|NCT01264380|459344108|FG000|Period C|Adverse Event|0|||
127651008|NCT01264380|459344109|FG001|Period C|Adverse Event|0|||
127651009|NCT01264380|459344110|FG002|Period C|Adverse Event|1|||
127651010|NCT01147822|459344111|FG000|Overall Study|Lost to Follow-up|14|||
127651011|NCT01147822|459344112|FG001|Overall Study|Lost to Follow-up|6|||
127651012|NCT01147822|459344111|FG000|Overall Study|Withdrawal by Subject|10|||
127651013|NCT01147822|459344112|FG001|Overall Study|Withdrawal by Subject|16|||
127651014|NCT01147822|459344111|FG000|Overall Study|Physician Decision|9|||
127651015|NCT01147822|459344112|FG001|Overall Study|Physician Decision|8|||
127651016|NCT01147822|459344111|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|4|||
127651017|NCT01147822|459344112|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|5|||
127651018|NCT01147822|459344111|FG000|Overall Study|Protocol Violation|1|||
127651019|NCT01147822|459344112|FG001|Overall Study|Protocol Violation|1|||
127651020|NCT00429663|459344115|FG000|Overall Study|Lost to Follow-up|24|||
127651021|NCT00429663|459344116|FG001|Overall Study|Lost to Follow-up|31|||
127651022|NCT00429663|459344115|FG000|Overall Study|Physician Decision|6|||
127651023|NCT00429663|459344116|FG001|Overall Study|Physician Decision|3|||
127651024|NCT00429663|459344115|FG000|Overall Study|Withdrawal by Subject|2|||
127651025|NCT00429663|459344116|FG001|Overall Study|Withdrawal by Subject|5|||
127651026|NCT00429663|459344115|FG000|Overall Study|Death|4|||
127651027|NCT00429663|459344116|FG001|Overall Study|Death|0|||
127651028|NCT01932697|459344119|FG000|Overall Study|Received a different amount of tx|1|||
127651029|NCT01932697|459344120|FG001|Overall Study|Received a different amount of tx|0|||
127874406|NCT05182840|460159584|FG005|Treatment Period|Not treated with study drug|0|||
127874407|NCT05182840|460159585|FG006|Treatment Period|Not treated with study drug|1|||
127874408|NCT05182840|460159586|FG007|Treatment Period|Not treated with study drug|1|||
127874409|NCT05182840|460159587|FG008|Treatment Period|Not treated with study drug|0|||
127874410|NCT05182840|460159588|FG009|Treatment Period|Not treated with study drug|0|||
127874411|NCT02161380|460159589|FG000|Overall Study|Lost to Follow-up|0|||
127874412|NCT02161380|460159590|FG001|Overall Study|Lost to Follow-up|1|||
127874413|NCT02161380|460159591|FG002|Overall Study|Lost to Follow-up|0|||
127874414|NCT02161380|460159592|FG003|Overall Study|Lost to Follow-up|0|||
127874415|NCT02268214|460159599|FG000|Overall Study|Subject no longer meets study criteria|0|||
127874416|NCT02268214|460159600|FG001|Overall Study|Subject no longer meets study criteria|2|||
127874417|NCT02268214|460159601|FG002|Overall Study|Subject no longer meets study criteria|0|||
127874418|NCT02268214|460159599|FG000|Overall Study|Pregnancy|2|||
127874419|NCT02268214|460159600|FG001|Overall Study|Pregnancy|2|||
127874420|NCT02268214|460159601|FG002|Overall Study|Pregnancy|1|||
127874421|NCT02268214|460159599|FG000|Overall Study|Lost to Follow-up|3|||
127874422|NCT02268214|460159600|FG001|Overall Study|Lost to Follow-up|3|||
127541953|NCT05546476|458951043|FG000|Period 1: Part A|Other: Unspecified|0|||
127541954|NCT05546476|458951044|FG001|Period 1: Part A|Other: Unspecified|2|||
127541955|NCT05546476|458951045|FG002|Period 1: Part A|Other: Unspecified|0|||
127541956|NCT05546476|458951046|FG003|Period 1: Part A|Other: Unspecified|0|||
127541957|NCT05546476|458951043|FG000|Period 2: Part B|Ongoing|26|||
127541958|NCT05546476|458951044|FG001|Period 2: Part B|Ongoing|27|||
127541959|NCT05546476|458951045|FG002|Period 2: Part B|Ongoing|35|||
127541960|NCT05546476|458951046|FG003|Period 2: Part B|Ongoing|29|||
127541961|NCT02182895|458951047|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
127541962|NCT02182895|458951048|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
127541963|NCT02953652|458951049|FG000|Overall Study|Adverse Event|18|||
127541964|NCT02953652|458951049|FG000|Overall Study|Withdrawal by Subject|6|||
127541965|NCT02953652|458951049|FG000|Overall Study|Protocol Violation|1|||
127541966|NCT02953652|458951049|FG000|Overall Study|Disease Progression|27|||
127541967|NCT02230410|458951054|FG000|Overall Study|Screen Failure|3|||
127541968|NCT04196686|458951055|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
127541969|NCT04196686|458951056|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
127541970|NCT03780452|458951067|FG000|Overall Study|Screening failure|2|||
127541971|NCT01001221|458951070|FG000|Overall Study|Adverse Event|1|||
127541972|NCT01001221|458951071|FG001|Overall Study|Adverse Event|2|||
127541973|NCT01001221|458951072|FG002|Overall Study|Adverse Event|0|||
127541974|NCT01001221|458951073|FG003|Overall Study|Adverse Event|2|||
127541975|NCT01001221|458951074|FG004|Overall Study|Adverse Event|0|||
127541976|NCT01001221|458951070|FG000|Overall Study|Disease progression|3|||
127541977|NCT01001221|458951071|FG001|Overall Study|Disease progression|2|||
127541978|NCT01001221|458951072|FG002|Overall Study|Disease progression|2|||
127541979|NCT01001221|458951073|FG003|Overall Study|Disease progression|4|||
127541980|NCT01001221|458951074|FG004|Overall Study|Disease progression|0|||
127541981|NCT01001221|458951070|FG000|Overall Study|Other|1|||
127541982|NCT01001221|458951071|FG001|Overall Study|Other|1|||
127541983|NCT01001221|458951072|FG002|Overall Study|Other|0|||
127651030|NCT01932697|459344119|FG000|Overall Study|Ineligible|1|||
127651031|NCT01932697|459344120|FG001|Overall Study|Ineligible|0|||
127651032|NCT01226511|459344121|FG000|Acute Treatment Period|Adverse Event|7|||
127651033|NCT01226511|459344122|FG001|Acute Treatment Period|Adverse Event|6|||
127874423|NCT02268214|460159601|FG002|Overall Study|Lost to Follow-up|4|||
127874424|NCT02268214|460159599|FG000|Overall Study|Lack of Efficacy|1|||
127874425|NCT02268214|460159600|FG001|Overall Study|Lack of Efficacy|0|||
127651034|NCT01226511|459344121|FG000|Acute Treatment Period|Lack of Efficacy|2|||
127651035|NCT01226511|459344122|FG001|Acute Treatment Period|Lack of Efficacy|1|||
127651036|NCT01226511|459344121|FG000|Acute Treatment Period|Lost to Follow-up|3|||
127651037|NCT01226511|459344122|FG001|Acute Treatment Period|Lost to Follow-up|6|||
127651038|NCT01226511|459344121|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
127651039|NCT01226511|459344122|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
127651040|NCT01226511|459344121|FG000|Acute Treatment Period|Protocol Violation|5|||
127651041|NCT01226511|459344122|FG001|Acute Treatment Period|Protocol Violation|5|||
127651042|NCT01226511|459344121|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
127651043|NCT01226511|459344122|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
127651044|NCT01226511|459344121|FG000|Extension Treatment Period|Adverse Event|8|||
127874426|NCT02268214|460159601|FG002|Overall Study|Lack of Efficacy|2|||
127874427|NCT02268214|460159599|FG000|Overall Study|Adverse Event|11|||
127874428|NCT02268214|460159600|FG001|Overall Study|Adverse Event|14|||
127874429|NCT02268214|460159601|FG002|Overall Study|Adverse Event|9|||
127874430|NCT02268214|460159599|FG000|Overall Study|Withdrawal by Subject|4|||
127874431|NCT02268214|460159600|FG001|Overall Study|Withdrawal by Subject|5|||
127874432|NCT02268214|460159601|FG002|Overall Study|Withdrawal by Subject|10|||
127874433|NCT02268214|460159599|FG000|Overall Study|Subject request to discontinue treatment|10|||
127874434|NCT02268214|460159600|FG001|Overall Study|Subject request to discontinue treatment|8|||
127874435|NCT02268214|460159601|FG002|Overall Study|Subject request to discontinue treatment|6|||
127874436|NCT02268214|460159599|FG000|Overall Study|Poor/non-compliance|2|||
127874437|NCT02268214|460159600|FG001|Overall Study|Poor/non-compliance|1|||
127874438|NCT02268214|460159601|FG002|Overall Study|Poor/non-compliance|2|||
127874439|NCT02268214|460159599|FG000|Overall Study|Other reasons|7|||
127874440|NCT02268214|460159600|FG001|Overall Study|Other reasons|3|||
127874441|NCT02268214|460159601|FG002|Overall Study|Other reasons|3|||
127874442|NCT02268214|460159599|FG000|Overall Study|Not entering long-term period|2|||
127874443|NCT02268214|460159600|FG001|Overall Study|Not entering long-term period|3|||
127874444|NCT02268214|460159601|FG002|Overall Study|Not entering long-term period|5|||
127874445|NCT04342390|460159602|FG000|Overall Study|Lost to Follow-up|3|||
127874446|NCT04342390|460159603|FG001|Overall Study|Lost to Follow-up|0|||
127874447|NCT01083121|460159615|FG000|Overall Study|Use of Humira outside the approved label|81|||
127874448|NCT01958619|460159618|FG000|Overall Study|Protocol Violation|2|||
127874449|NCT01958619|460159619|FG001|Overall Study|Protocol Violation|0|||
127874450|NCT01958619|460159620|FG002|Overall Study|Protocol Violation|1|||
127874451|NCT01958619|460159621|FG003|Overall Study|Protocol Violation|0|||
127874452|NCT05403502|460159622|FG000|Humalog Lead-In Period|Withdrawal by Subject|1|||
127874453|NCT05403502|460159622|FG000|Humalog Lead-In Period|Physician Decision|2|||
127874454|NCT05403502|460159622|FG000|Humalog Lead-In Period|Protocol Violation|1|||
127874455|NCT05403502|460159622|FG000|Lyumjev Treatment Period|Withdrawal by Subject|4|||
127874456|NCT05403502|460159622|FG000|Lyumjev Treatment Period|Physician Decision|2|||
127874457|NCT01054443|460159623|FG000|Overall Study|Withdrawal by Subject|0|||
127874458|NCT01054443|460159624|FG001|Overall Study|Withdrawal by Subject|0|||
127874459|NCT01054443|460159625|FG002|Overall Study|Withdrawal by Subject|0|||
127874460|NCT01054443|460159626|FG003|Overall Study|Withdrawal by Subject|1|||
127874461|NCT00985114|460159627|FG000|Overall Study|Adverse Event|1|||
127874462|NCT00985114|460159628|FG001|Overall Study|Adverse Event|0|||
127874463|NCT00985114|460159627|FG000|Overall Study|Withdrawal by Subject|0|||
127874464|NCT00985114|460159628|FG001|Overall Study|Withdrawal by Subject|2|||
127874465|NCT01119118|460159629|FG000|Overall Study|Adverse Event|1|||
127874466|NCT01003691|460159630|FG000|Overall Study|Adverse Event|0|||
127874467|NCT01003691|460159631|FG001|Overall Study|Adverse Event|0|||
127874468|NCT01003691|460159632|FG002|Overall Study|Adverse Event|0|||
127874469|NCT01003691|460159633|FG003|Overall Study|Adverse Event|1|||
127874470|NCT00167414|460159635|FG000|Overall Study|Death|10|||
127874471|NCT01593761|460159638|FG000|Overall Study|Lost to Follow-up|1|||
127874472|NCT01593761|460159638|FG000|Overall Study|culture negative for MRSA at baseline|5|||
127874473|NCT01593761|460159638|FG000|Overall Study|positive for hepatitis C virus|1|||
127874474|NCT01593761|460159638|FG000|Overall Study|secondary cellulitis|1|||
127874475|NCT00157820|460159644|FG000|Randomized|Physician Decision|4|||
127874476|NCT00157820|460159645|FG001|Randomized|Physician Decision|2|||
127874477|NCT00157820|460159646|FG002|Randomized|Physician Decision|3|||
127651045|NCT01226511|459344122|FG001|Extension Treatment Period|Adverse Event|8|||
127651046|NCT01226511|459344121|FG000|Extension Treatment Period|Lack of Efficacy|3|||
127651047|NCT01226511|459344122|FG001|Extension Treatment Period|Lack of Efficacy|2|||
127651048|NCT01226511|459344121|FG000|Extension Treatment Period|Lost to Follow-up|4|||
127874478|NCT00157820|460159644|FG000|Randomized|Withdrawal by Subject|1|||
127874479|NCT00157820|460159645|FG001|Randomized|Withdrawal by Subject|2|||
127874480|NCT00157820|460159646|FG002|Randomized|Withdrawal by Subject|3|||
127874481|NCT00157820|460159644|FG000|Randomized|Protocol Violation|2|||
127874482|NCT00157820|460159645|FG001|Randomized|Protocol Violation|1|||
127874483|NCT00157820|460159646|FG002|Randomized|Protocol Violation|2|||
127874484|NCT00157820|460159644|FG000|1st 8 Month|Death|7|||
127874485|NCT00157820|460159645|FG001|1st 8 Month|Death|8|||
127874486|NCT00157820|460159646|FG002|1st 8 Month|Death|3|||
127874487|NCT00157820|460159644|FG000|1st 8 Month|Lost to Follow-up|1|||
127874488|NCT00157820|460159645|FG001|1st 8 Month|Lost to Follow-up|2|||
127874489|NCT00157820|460159646|FG002|1st 8 Month|Lost to Follow-up|1|||
127874490|NCT00157820|460159644|FG000|1st 8 Month|Premature cross-over|0|||
127874491|NCT00157820|460159645|FG001|1st 8 Month|Premature cross-over|2|||
127874492|NCT00157820|460159646|FG002|1st 8 Month|Premature cross-over|2|||
127874493|NCT00157820|460159644|FG000|2nd 8 Months|Death|3|||
127874494|NCT00157820|460159645|FG001|2nd 8 Months|Death|1|||
127874495|NCT00157820|460159646|FG002|2nd 8 Months|Death|3|||
127651049|NCT01226511|459344122|FG001|Extension Treatment Period|Lost to Follow-up|3|||
127651050|NCT01226511|459344121|FG000|Extension Treatment Period|Protocol Violation|2|||
127651051|NCT01226511|459344122|FG001|Extension Treatment Period|Protocol Violation|2|||
127651052|NCT01226511|459344121|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
127651053|NCT01226511|459344122|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
127651054|NCT01226511|459344121|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
127651055|NCT01226511|459344122|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
127651056|NCT01226511|459344121|FG000|Extension Treatment Period|Sponsor Decision|1|||
127651057|NCT01226511|459344122|FG001|Extension Treatment Period|Sponsor Decision|1|||
127651058|NCT01226511|459344121|FG000|Taper Period|Adverse Event|1|||
127651059|NCT01226511|459344122|FG001|Taper Period|Adverse Event|0|||
127651060|NCT01226511|459344121|FG000|Taper Period|Lost to Follow-up|2|||
127651061|NCT01226511|459344122|FG001|Taper Period|Lost to Follow-up|2|||
127651062|NCT01226511|459344121|FG000|Taper Period|Protocol Violation|1|||
127651063|NCT01226511|459344122|FG001|Taper Period|Protocol Violation|0|||
127651064|NCT01226511|459344121|FG000|Taper Period|Parent/Caregiver Decision|1|||
127651065|NCT01226511|459344122|FG001|Taper Period|Parent/Caregiver Decision|1|||
127651066|NCT01337986|459344123|FG000|Overall Study|Adverse Event|2|||
127651067|NCT01337986|459344124|FG001|Overall Study|Adverse Event|2|||
127651068|NCT01337986|459344123|FG000|Overall Study|Lost to Follow-up|1|||
127651069|NCT01337986|459344124|FG001|Overall Study|Lost to Follow-up|0|||
127651070|NCT01337986|459344123|FG000|Overall Study|Protocol Violation|0|||
127651071|NCT01337986|459344124|FG001|Overall Study|Protocol Violation|3|||
127651072|NCT01520402|459344127|FG000|Overall Study|Withdrawal by Subject|2|||
127651073|NCT01520402|459344127|FG000|Overall Study|Physician Decision|3|||
127651074|NCT01722162|459344129|FG000|Overall Study|Withdrawal by Subject|1|||
127651075|NCT01722162|459344130|FG001|Overall Study|Withdrawal by Subject|1|||
127651076|NCT01722162|459344129|FG000|Overall Study|Found ineligible|1|||
127651077|NCT01722162|459344130|FG001|Overall Study|Found ineligible|0|||
127651078|NCT01722162|459344129|FG000|Overall Study|Unrelated to study adverse event|2|||
127651079|NCT01722162|459344130|FG001|Overall Study|Unrelated to study adverse event|2|||
127651080|NCT01722162|459344129|FG000|Overall Study|Adverse Event|1|||
127651081|NCT01722162|459344130|FG001|Overall Study|Adverse Event|1|||
127651082|NCT01722162|459344129|FG000|Overall Study|Insurance denial post enrollment|0|||
127651083|NCT01722162|459344130|FG001|Overall Study|Insurance denial post enrollment|1|||
127651084|NCT01722162|459344129|FG000|Overall Study|Noncompliance|0|||
127651085|NCT01722162|459344130|FG001|Overall Study|Noncompliance|1|||
127651086|NCT03124199|459344131|FG000|Overall Study|Lost to Follow-up|4|||
127651087|NCT03086018|459344132|FG000|Final Testing for End of Trial|Adverse Event|1|||
127651088|NCT03086018|459344132|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
127651089|NCT02748694|459344133|FG000|Overall Study|Voluntary Withdrawal|0|||
127651090|NCT02748694|459344134|FG001|Overall Study|Voluntary Withdrawal|0|||
127651091|NCT02748694|459344135|FG002|Overall Study|Voluntary Withdrawal|0|||
127651092|NCT02748694|459344136|FG003|Overall Study|Voluntary Withdrawal|0|||
127651093|NCT02748694|459344137|FG004|Overall Study|Voluntary Withdrawal|0|||
127651094|NCT02748694|459344138|FG005|Overall Study|Voluntary Withdrawal|0|||
127651095|NCT02748694|459344139|FG006|Overall Study|Voluntary Withdrawal|0|||
127651096|NCT02748694|459344140|FG007|Overall Study|Voluntary Withdrawal|0|||
127651097|NCT02748694|459344141|FG008|Overall Study|Voluntary Withdrawal|0|||
127651098|NCT02748694|459344142|FG009|Overall Study|Voluntary Withdrawal|0|||
127651099|NCT02748694|459344143|FG010|Overall Study|Voluntary Withdrawal|0|||
127651100|NCT02748694|459344144|FG011|Overall Study|Voluntary Withdrawal|0|||
127651101|NCT02748694|459344145|FG012|Overall Study|Voluntary Withdrawal|0|||
127651102|NCT02748694|459344146|FG013|Overall Study|Voluntary Withdrawal|0|||
127651103|NCT02748694|459344147|FG014|Overall Study|Voluntary Withdrawal|2|||
127651104|NCT00077064|459344148|FG000|Overall Study|Adverse Event|0|||
127651105|NCT00077064|459344149|FG001|Overall Study|Adverse Event|4|||
127874496|NCT00157820|460159644|FG000|2nd 8 Months|Lost to Follow-up|1|||
127651106|NCT00077064|459344148|FG000|Overall Study|Patient refusal|0|||
127651107|NCT00077064|459344149|FG001|Overall Study|Patient refusal|2|||
127651108|NCT00621543|459344150|FG000|Overall Study|Lost to Follow-up|23|||
127651109|NCT03056534|459344163|FG000|Overall Study|Participant withdrew consent|8|||
127651110|NCT03056534|459344163|FG000|Overall Study|Participant not able to return|6|||
127651111|NCT03056534|459344163|FG000|Overall Study|Lost to Follow-up|37|||
127651112|NCT03056534|459344163|FG000|Overall Study|Investigator judgment|1|||
127651113|NCT03056534|459344163|FG000|Overall Study|Death|4|||
127651114|NCT03056534|459344163|FG000|Overall Study|Adverse Event|1|||
127874497|NCT00157820|460159645|FG001|2nd 8 Months|Lost to Follow-up|5|||
127874498|NCT00157820|460159646|FG002|2nd 8 Months|Lost to Follow-up|2|||
127651115|NCT03056534|459344163|FG000|Overall Study|Screen fail due to femoral stem implanted not being allowed per protocol|1|||
127651116|NCT03815019|459344164|FG000|Overall Study|Withdrawal by Subject|6|||
127651117|NCT03815019|459344165|FG001|Overall Study|Withdrawal by Subject|8|||
127651118|NCT00532155|459344166|FG000|Overall Study|Adverse Event|66|||
127651119|NCT00532155|459344167|FG001|Overall Study|Adverse Event|123|||
127651120|NCT00532155|459344166|FG000|Overall Study|Lack of Efficacy|332|||
127651121|NCT00532155|459344167|FG001|Overall Study|Lack of Efficacy|255|||
127651122|NCT00532155|459344166|FG000|Overall Study|Protocol Violation|1|||
127651123|NCT00532155|459344167|FG001|Overall Study|Protocol Violation|3|||
127651124|NCT00532155|459344166|FG000|Overall Study|Lost to Follow-up|2|||
127651125|NCT00532155|459344167|FG001|Overall Study|Lost to Follow-up|0|||
127651126|NCT00532155|459344166|FG000|Overall Study|Physician Decision|16|||
127651127|NCT00532155|459344167|FG001|Overall Study|Physician Decision|15|||
127651128|NCT00532155|459344166|FG000|Overall Study|Withdrawal by Subject|23|||
127651129|NCT00532155|459344167|FG001|Overall Study|Withdrawal by Subject|44|||
127651130|NCT00532155|459344166|FG000|Overall Study|Consent withdrawn|5|||
127651131|NCT00532155|459344167|FG001|Overall Study|Consent withdrawn|7|||
127651132|NCT00532155|459344166|FG000|Overall Study|Moved|1|||
127651133|NCT00532155|459344167|FG001|Overall Study|Moved|0|||
127651134|NCT00532155|459344166|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
127651135|NCT00532155|459344167|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
127651136|NCT00532155|459344166|FG000|Overall Study|Occurence of a second cancer|0|||
127651137|NCT00532155|459344167|FG001|Overall Study|Occurence of a second cancer|1|||
127651138|NCT00532155|459344166|FG000|Overall Study|Occurence of a secondary cancer|0|||
127651139|NCT00532155|459344167|FG001|Overall Study|Occurence of a secondary cancer|1|||
127651140|NCT00532155|459344166|FG000|Overall Study|Promotor ended study|1|||
127651141|NCT00532155|459344167|FG001|Overall Study|Promotor ended study|0|||
127651142|NCT00532155|459344166|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
127651143|NCT00532155|459344167|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
127651144|NCT00532155|459344166|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
127651145|NCT00532155|459344167|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
127651146|NCT00532155|459344166|FG000|Overall Study|Study stopped|1|||
127651147|NCT00532155|459344167|FG001|Overall Study|Study stopped|0|||
127651148|NCT00532155|459344166|FG000|Overall Study|Study terminated by sponsor|1|||
127651149|NCT00532155|459344167|FG001|Overall Study|Study terminated by sponsor|0|||
127651150|NCT00532155|459344166|FG000|Overall Study|Study termination stop further treatment|4|||
127651151|NCT00532155|459344167|FG001|Overall Study|Study termination stop further treatment|0|||
127651152|NCT00532155|459344166|FG000|Overall Study|Did not receive study medication|2|||
127651153|NCT00532155|459344167|FG001|Overall Study|Did not receive study medication|6|||
127651154|NCT02134925|459344168|FG000|Overall Study|Withdrawal by Subject|1|||
127651155|NCT02134925|459344169|FG001|Overall Study|Withdrawal by Subject|0|||
127651156|NCT02134925|459344168|FG000|Overall Study|Cancel|1|||
127651157|NCT02134925|459344169|FG001|Overall Study|Cancel|6|||
127651158|NCT00654901|459344172|FG000|Overall Study|Lost to Follow-up|1|||
127874499|NCT00157820|460159644|FG000|2nd 8 Months|Premature cross-over|1|||
127874500|NCT00157820|460159645|FG001|2nd 8 Months|Premature cross-over|7|||
127874501|NCT00157820|460159646|FG002|2nd 8 Months|Premature cross-over|9|||
127874502|NCT01302366|460161812|FG000|Overall Study|patient choice or noncompliance|5|||
127874503|NCT00509223|460161813|FG000|Overall Study|Lost to Follow-up|1|||
127874504|NCT00509223|460161814|FG001|Overall Study|Lost to Follow-up|1|||
127874505|NCT00509223|460161813|FG000|Overall Study|Adverse Event|1|||
127874506|NCT00509223|460161814|FG001|Overall Study|Adverse Event|1|||
127874507|NCT00509223|460161813|FG000|Overall Study|Withdrawal by Subject|25|||
127874508|NCT00509223|460161814|FG001|Overall Study|Withdrawal by Subject|6|||
127874509|NCT00509223|460161813|FG000|Overall Study|Including: subject change of address|5|||
127874510|NCT00509223|460161814|FG001|Overall Study|Including: subject change of address|2|||
127874511|NCT00509223|460161813|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
127874512|NCT00509223|460161814|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
127651159|NCT00654901|459344173|FG001|Overall Study|Lost to Follow-up|0|||
127651160|NCT00654901|459344174|FG002|Overall Study|Lost to Follow-up|1|||
127651161|NCT00654901|459344175|FG003|Overall Study|Lost to Follow-up|0|||
127651162|NCT00654901|459344172|FG000|Overall Study|Withdrawal by Subject|3|||
127874513|NCT00934661|460161815|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
127874514|NCT00934661|460161816|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
127651163|NCT00654901|459344173|FG001|Overall Study|Withdrawal by Subject|0|||
127651164|NCT00654901|459344174|FG002|Overall Study|Withdrawal by Subject|1|||
127651165|NCT00654901|459344175|FG003|Overall Study|Withdrawal by Subject|0|||
127651166|NCT04241094|459344179|FG000|Overall Study|Dropped out of treatment|4|||
127874515|NCT00467051|460161817|FG000|Overall Study|Adverse Event|2|||
127874516|NCT00437294|460161820|FG000|Overall Study|Adverse Event|5|||
127874517|NCT00437294|460161821|FG001|Overall Study|Adverse Event|4|||
127651167|NCT04241094|459344179|FG000|Overall Study|Ineligible after clinical assessment|2|||
127651168|NCT04241094|459344179|FG000|Overall Study|Lost to Follow-up|2|||
127651169|NCT02332590|459344180|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
127651170|NCT02332590|459344181|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
127651171|NCT02332590|459344180|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
127651172|NCT02332590|459344181|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
127651173|NCT02332590|459344180|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
127651174|NCT02332590|459344181|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
127874518|NCT00437294|460161820|FG000|Overall Study|Death|5|||
127874519|NCT00437294|460161821|FG001|Overall Study|Death|2|||
127874520|NCT00437294|460161820|FG000|Overall Study|Physician Decision|0|||
127874521|NCT00437294|460161821|FG001|Overall Study|Physician Decision|3|||
127651175|NCT02332590|459344180|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
127651176|NCT02332590|459344181|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
127651177|NCT02332590|459344180|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
127651178|NCT02332590|459344181|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
127651179|NCT02332590|459344180|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
127651180|NCT02332590|459344181|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
127651181|NCT02332590|459344180|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
127651182|NCT02332590|459344181|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
127651183|NCT02332590|459344180|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
127651184|NCT02332590|459344181|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
127651185|NCT02332590|459344180|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
127651186|NCT02332590|459344181|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
127651187|NCT02044848|459345332|FG000|Overall Study|Administrative Problems|2|||
127651188|NCT02044848|459345333|FG001|Overall Study|Administrative Problems|3|||
127651189|NCT01160484|459345334|FG000|Overall Study|Lack of Efficacy|9|||
127651190|NCT01160484|459345334|FG000|Overall Study|Adverse Event|6|||
127651191|NCT01160484|459345334|FG000|Overall Study|Withdrawal by Subject|2|||
127651192|NCT01160484|459345334|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
127874522|NCT00437294|460161820|FG000|Overall Study|Withdrawal by Subject|5|||
127874523|NCT00437294|460161821|FG001|Overall Study|Withdrawal by Subject|0|||
127874524|NCT00437294|460161820|FG000|Overall Study|Progressive Disease|19|||
127874525|NCT00437294|460161821|FG001|Overall Study|Progressive Disease|23|||
127874526|NCT00437294|460161820|FG000|Overall Study|Sponsor Decision|8|||
127874527|NCT00437294|460161821|FG001|Overall Study|Sponsor Decision|9|||
127874528|NCT00437294|460161820|FG000|Overall Study|Protocol Violation|0|||
127874529|NCT00437294|460161821|FG001|Overall Study|Protocol Violation|1|||
127874530|NCT00437294|460161820|FG000|Overall Study|Entry criteria not met|1|||
127874531|NCT00437294|460161821|FG001|Overall Study|Entry criteria not met|1|||
127874532|NCT02674568|460161827|FG000|Overall Study|Withdrawal by Subject|5|||
127874533|NCT02674568|460161827|FG000|Overall Study|Death|303|||
127874534|NCT02674568|460161827|FG000|Overall Study|Physician Decision|2|||
127874535|NCT02674568|460161827|FG000|Overall Study|Lost to Follow-up|9|||
127874536|NCT02674568|460161827|FG000|Overall Study|Other, Not Specified|20|||
127874537|NCT00968539|460161828|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
127874538|NCT00968539|460161829|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
127874539|NCT00457249|460161830|FG000|Overall Study|Lost to Follow-up|3|||
127874540|NCT00457249|460161831|FG001|Overall Study|Lost to Follow-up|0|||
127874541|NCT00457249|460161830|FG000|Overall Study|Protocol Violation|4|||
127874542|NCT00457249|460161831|FG001|Overall Study|Protocol Violation|1|||
127874543|NCT00457249|460161830|FG000|Overall Study|Withdrawal by Subject|3|||
127874544|NCT00457249|460161831|FG001|Overall Study|Withdrawal by Subject|1|||
127874545|NCT00457249|460161830|FG000|Overall Study|Serious Adverse Events|2|||
127874546|NCT00457249|460161831|FG001|Overall Study|Serious Adverse Events|0|||
127874547|NCT00396318|460161832|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
127874548|NCT00326118|460161833|FG000|Active Phase|Withdrawal by Subject|4|||
127874549|NCT00326118|460161834|FG001|Active Phase|Withdrawal by Subject|1|||
127874550|NCT00938392|460161835|FG000|Overall Study|Adverse Event|0|||
127874551|NCT00938392|460161836|FG001|Overall Study|Adverse Event|1|||
127874552|NCT00938392|460161835|FG000|Overall Study|Withdrawal by Subject|0|||
127874553|NCT00938392|460161836|FG001|Overall Study|Withdrawal by Subject|1|||
127874554|NCT00938392|460161835|FG000|Overall Study|Lost to Follow-up|2|||
127874555|NCT00938392|460161836|FG001|Overall Study|Lost to Follow-up|2|||
127874556|NCT02916056|460161837|FG000|Overall Study|Adverse Event|6|||
127874557|NCT02916056|460161837|FG000|Overall Study|Lost to Follow-up|1|||
127874558|NCT02916056|460161837|FG000|Overall Study|Other|12|||
127874559|NCT02916056|460161837|FG000|Overall Study|Protocol Violation|1|||
127651193|NCT00803101|459345335|FG000|Overall Study|Death / Serious Adverse Event|4|||
127874560|NCT02916056|460161837|FG000|Overall Study|Withdrawal by Subject|8|||
127874561|NCT02916056|460161837|FG000|Overall Study|Study Terminated by Sponsor|269|||
127874562|NCT00290511|460161838|FG000|Overall Study|Adverse Event|1|||
127874563|NCT00290511|460161838|FG000|Overall Study|Death|1|||
127874564|NCT00290511|460161838|FG000|Overall Study|Physician Decision|1|||
127874565|NCT00290511|460161838|FG000|Overall Study|Withdrawal by Subject|1|||
127874566|NCT00124709|460161839|FG000|Overall Study|Randomized but did not take medication|3|||
127874567|NCT00124709|460161840|FG001|Overall Study|Randomized but did not take medication|1|||
127874568|NCT00124709|460161839|FG000|Overall Study|Adverse Event|3|||
127874569|NCT00124709|460161840|FG001|Overall Study|Adverse Event|0|||
127874570|NCT00124709|460161839|FG000|Overall Study|Lack of Efficacy|5|||
127874571|NCT00124709|460161840|FG001|Overall Study|Lack of Efficacy|10|||
127874572|NCT00124709|460161839|FG000|Overall Study|Protocol Violation|3|||
127874573|NCT00124709|460161840|FG001|Overall Study|Protocol Violation|5|||
127874574|NCT00124709|460161839|FG000|Overall Study|Withdrawal by Subject|127|||
127874575|NCT00124709|460161840|FG001|Overall Study|Withdrawal by Subject|136|||
127874576|NCT00124709|460161839|FG000|Overall Study|Lost to Follow-up|114|||
127874577|NCT00124709|460161840|FG001|Overall Study|Lost to Follow-up|120|||
127874578|NCT00122954|460161841|FG000|Overall Study|Withdrawal by Subject|2|||
127874579|NCT00122954|460161842|FG001|Overall Study|Withdrawal by Subject|2|||
127874580|NCT00122954|460161841|FG000|Overall Study|Protocol Violation|0|||
127874581|NCT00122954|460161842|FG001|Overall Study|Protocol Violation|1|||
127651194|NCT00803101|459345336|FG001|Overall Study|Death / Serious Adverse Event|6|||
127651195|NCT00803101|459345335|FG000|Overall Study|Withdrawal by Subject|6|||
127651196|NCT00803101|459345336|FG001|Overall Study|Withdrawal by Subject|4|||
127651197|NCT00803101|459345335|FG000|Overall Study|Lost to Follow-up|2|||
127651198|NCT00803101|459345336|FG001|Overall Study|Lost to Follow-up|2|||
127651199|NCT00803101|459345335|FG000|Overall Study|Protocol Violation|1|||
127651200|NCT00803101|459345336|FG001|Overall Study|Protocol Violation|7|||
127651201|NCT00803101|459345335|FG000|Overall Study|Surgery finished outside protocol window|1|||
127651202|NCT00803101|459345336|FG001|Overall Study|Surgery finished outside protocol window|1|||
127874582|NCT01728376|460161843|FG000|Overall Study|Adverse Event|1|||
127874583|NCT01728376|460161844|FG001|Overall Study|Adverse Event|1|||
127651203|NCT00803101|459345335|FG000|Overall Study|Patient died outside SAE report period|1|||
127874584|NCT01728376|460161845|FG002|Overall Study|Adverse Event|1|||
127874585|NCT01728376|460161846|FG003|Overall Study|Adverse Event|1|||
127651204|NCT00803101|459345336|FG001|Overall Study|Patient died outside SAE report period|0|||
127651205|NCT00803101|459345335|FG000|Overall Study|Patient did not attend scheduled visit|2|||
127651206|NCT00803101|459345336|FG001|Overall Study|Patient did not attend scheduled visit|1|||
127651207|NCT00803101|459345335|FG000|Overall Study|Patient did not have surgery|1|||
127651208|NCT00803101|459345336|FG001|Overall Study|Patient did not have surgery|1|||
127651209|NCT01679301|459345339|FG000|Screening Period|screen failure|3|||
127651210|NCT01679301|459345340|FG001|Screening Period|screen failure|0|||
127651211|NCT01679301|459345341|FG002|Screening Period|screen failure|0|||
127651212|NCT04858802|459345342|FG000|Overall Study|Lost to Follow-up|1|||
127651213|NCT04858802|459345343|FG001|Overall Study|Lost to Follow-up|1|||
127651214|NCT04858802|459345342|FG000|Overall Study|Withdrawal by Subject|1|||
127651215|NCT04858802|459345343|FG001|Overall Study|Withdrawal by Subject|1|||
127651216|NCT02026232|459345344|FG000|Overall Study|incomplete visit/missing data|3|||
127651217|NCT02026232|459345345|FG001|Overall Study|incomplete visit/missing data|2|||
127651218|NCT01529008|459345346|FG000|Bone Marrow Harvesting|Physician Decision|1|||
127651219|NCT01529008|459345347|FG001|Bone Marrow Harvesting|Physician Decision|1|||
127874586|NCT01728376|460161847|FG004|Overall Study|Adverse Event|1|||
127874587|NCT01728376|460161848|FG005|Overall Study|Adverse Event|0|||
127874588|NCT01728376|460161843|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
127874589|NCT01728376|460161844|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
127651220|NCT01529008|459345346|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
127651221|NCT01529008|459345347|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
127651222|NCT01529008|459345346|FG000|Treatment|Adverse Event|6|||
127651223|NCT01529008|459345347|FG001|Treatment|Adverse Event|0|||
127651224|NCT01529008|459345346|FG000|Treatment|Other|3|||
127651225|NCT01529008|459345347|FG001|Treatment|Other|1|||
127874590|NCT01728376|460161845|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
127874591|NCT01728376|460161846|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
127874592|NCT01728376|460161847|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
127874593|NCT01728376|460161848|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
127874594|NCT01728376|460161843|FG000|Overall Study|No relevant bacteria|2|||
127874595|NCT01728376|460161844|FG001|Overall Study|No relevant bacteria|0|||
127874596|NCT01728376|460161845|FG002|Overall Study|No relevant bacteria|0|||
127874597|NCT01728376|460161846|FG003|Overall Study|No relevant bacteria|0|||
127874598|NCT01728376|460161847|FG004|Overall Study|No relevant bacteria|1|||
127874599|NCT01728376|460161848|FG005|Overall Study|No relevant bacteria|1|||
127874600|NCT01728376|460161843|FG000|Overall Study|Did not receive treatment|0|||
127874601|NCT01728376|460161844|FG001|Overall Study|Did not receive treatment|1|||
127874602|NCT01728376|460161845|FG002|Overall Study|Did not receive treatment|0|||
127874603|NCT01728376|460161846|FG003|Overall Study|Did not receive treatment|0|||
127651226|NCT01529008|459345346|FG000|Efficacy Analysis|Protocol Violation|2|||
127651227|NCT01529008|459345347|FG001|Efficacy Analysis|Protocol Violation|0|||
127651228|NCT01529008|459345346|FG000|Efficacy Analysis|Physician Decision|0|||
127651229|NCT01529008|459345347|FG001|Efficacy Analysis|Physician Decision|1|||
127874604|NCT01728376|460161847|FG004|Overall Study|Did not receive treatment|0|||
127874605|NCT01728376|460161848|FG005|Overall Study|Did not receive treatment|0|||
127874606|NCT01728376|460161843|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
127651230|NCT01529008|459345346|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
127651231|NCT01529008|459345347|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
127651232|NCT05056870|459345350|FG000|Period 1|Site COVID-19 Related|3|||
127874607|NCT01728376|460161844|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
127874608|NCT01728376|460161845|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
127874609|NCT01728376|460161846|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
127874610|NCT01728376|460161847|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
127874611|NCT01728376|460161848|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
127874612|NCT04341727|460161863|FG000|Overall Study|Withdrawal by Subject|0|||
127651233|NCT05056870|459345351|FG001|Period 1|Site COVID-19 Related|3|||
127651234|NCT05056870|459345350|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
127874613|NCT04341727|460161864|FG001|Overall Study|Withdrawal by Subject|0|||
127874614|NCT04341727|460161865|FG002|Overall Study|Withdrawal by Subject|1|||
127874615|NCT04341727|460161866|FG003|Overall Study|Withdrawal by Subject|0|||
127874616|NCT04341727|460161863|FG000|Overall Study|Lost to Follow-up|0|||
127651235|NCT05056870|459345351|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
127651236|NCT05056870|459345350|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
127651237|NCT05056870|459345351|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
127651238|NCT05056870|459345350|FG000|Period 2|COVID-19 Related|1|||
127651239|NCT05056870|459345351|FG001|Period 2|COVID-19 Related|0|||
127651240|NCT05056870|459345350|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
127651241|NCT05056870|459345351|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
127651242|NCT04207840|459345359|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
127651243|NCT04207840|459345360|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
127651244|NCT04207840|459345361|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
127651245|NCT04207840|459345359|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
127651246|NCT04207840|459345360|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
127651247|NCT04207840|459345361|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
127651248|NCT03261271|459345365|FG000|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
127651249|NCT03261271|459345366|FG001|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
127651250|NCT01114204|459345367|FG000|Overall Study|Adverse Event|3|||
127651251|NCT01114204|459345368|FG001|Overall Study|Adverse Event|2|||
127651252|NCT01114204|459345367|FG000|Overall Study|Lost to Follow-up|1|||
127651253|NCT01114204|459345368|FG001|Overall Study|Lost to Follow-up|0|||
127651254|NCT01114204|459345367|FG000|Overall Study|Withdrawal by Subject|10|||
127651255|NCT01114204|459345368|FG001|Overall Study|Withdrawal by Subject|6|||
127651256|NCT01114204|459345367|FG000|Overall Study|Death|1|||
127651257|NCT01114204|459345368|FG001|Overall Study|Death|0|||
127874617|NCT04341727|460161864|FG001|Overall Study|Lost to Follow-up|0|||
127874618|NCT04341727|460161865|FG002|Overall Study|Lost to Follow-up|0|||
127874619|NCT04341727|460161866|FG003|Overall Study|Lost to Follow-up|1|||
127874620|NCT05604521|460161867|FG000|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|23|||
127874621|NCT05604521|460161868|FG001|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|7|||
127874622|NCT05604521|460161867|FG000|Overall Study|Adverse Event|1|||
127874623|NCT05604521|460161868|FG001|Overall Study|Adverse Event|0|||
127874624|NCT01491737|460161872|FG000|Overall Study|Withdrawal by Subject|20|||
127874625|NCT01491737|460161873|FG001|Overall Study|Withdrawal by Subject|17|||
127874626|NCT01491737|460161872|FG000|Overall Study|Lost to Follow-up|2|||
127874627|NCT01491737|460161873|FG001|Overall Study|Lost to Follow-up|10|||
127874628|NCT01491737|460161872|FG000|Overall Study|Death|63|||
127874629|NCT01491737|460161873|FG001|Overall Study|Death|57|||
127874630|NCT01491737|460161872|FG000|Overall Study|Study Termination by Sponsor|36|||
127874631|NCT01491737|460161873|FG001|Overall Study|Study Termination by Sponsor|36|||
127874632|NCT01491737|460161872|FG000|Overall Study|Reason Not Specified|8|||
127874633|NCT01491737|460161873|FG001|Overall Study|Reason Not Specified|9|||
127874634|NCT01976663|460161874|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
127874635|NCT01976663|460161874|FG000|Overall Study|Personal Reasons|6|||
127874636|NCT01976663|460161874|FG000|Overall Study|Withdrawal by Subject|4|||
127651258|NCT01114204|459345367|FG000|Overall Study|Other-Personal reasons|2|||
127651259|NCT01114204|459345368|FG001|Overall Study|Other-Personal reasons|0|||
127651260|NCT01114204|459345367|FG000|Overall Study|Other-Medical monitor request|1|||
127651261|NCT01114204|459345368|FG001|Overall Study|Other-Medical monitor request|0|||
127651262|NCT01114204|459345367|FG000|Overall Study|Other-Participant request|2|||
127651263|NCT01114204|459345368|FG001|Overall Study|Other-Participant request|0|||
127874637|NCT01976663|460161874|FG000|Overall Study|Screen Failure|3|||
127874638|NCT01976663|460161874|FG000|Overall Study|Adverse Event|2|||
127874639|NCT01976663|460161874|FG000|Overall Study|Lost to Follow-up|3|||
127651264|NCT01114204|459345367|FG000|Overall Study|Other-Protocol Violation|1|||
127651265|NCT01114204|459345368|FG001|Overall Study|Other-Protocol Violation|0|||
127651266|NCT03420781|459345369|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
127651267|NCT03420781|459345370|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
127874640|NCT05279807|460161875|FG000|Overall Study|Withdrawal by Subject|1|||
127874641|NCT05279807|460161876|FG001|Overall Study|Withdrawal by Subject|0|||
127874642|NCT05279807|460161875|FG000|Overall Study|Adverse Event|0|||
127874643|NCT05279807|460161876|FG001|Overall Study|Adverse Event|1|||
127651268|NCT03420781|459345371|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
127651269|NCT03420781|459345372|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
127651270|NCT03420781|459345373|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
127651271|NCT03420781|459345369|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
127651272|NCT03420781|459345370|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
127651273|NCT03420781|459345371|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
127651274|NCT03420781|459345372|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
127651275|NCT03420781|459345373|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
127651276|NCT03420781|459345369|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
127651277|NCT03420781|459345370|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
127651278|NCT03420781|459345371|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
127651279|NCT03420781|459345372|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
127651280|NCT03420781|459345373|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
127651281|NCT03420781|459345369|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
127651282|NCT03420781|459345370|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
127651283|NCT03420781|459345371|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
127651284|NCT03420781|459345372|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
127651285|NCT03420781|459345373|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
127651286|NCT03420781|459345369|FG000|Treatment Period (40 Weeks)|Death|2|||
127651287|NCT03420781|459345370|FG001|Treatment Period (40 Weeks)|Death|2|||
127651288|NCT03420781|459345371|FG002|Treatment Period (40 Weeks)|Death|0|||
127651289|NCT03420781|459345372|FG003|Treatment Period (40 Weeks)|Death|0|||
127651290|NCT03420781|459345373|FG004|Treatment Period (40 Weeks)|Death|0|||
127651291|NCT03420781|459345369|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
127651292|NCT03420781|459345370|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
127651293|NCT03420781|459345371|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
127651294|NCT03420781|459345372|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
127651295|NCT03420781|459345373|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
127651296|NCT03420781|459345369|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
127651297|NCT03420781|459345370|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
127651298|NCT03420781|459345371|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
127651299|NCT03420781|459345372|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
127651300|NCT03420781|459345373|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
127651301|NCT03420781|459345369|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
127651302|NCT03420781|459345370|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
127651303|NCT03420781|459345371|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
127651304|NCT03420781|459345372|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
127651305|NCT03420781|459345373|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
127651306|NCT03420781|459345369|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
127651307|NCT03420781|459345370|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
127651308|NCT03420781|459345371|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
127651309|NCT03420781|459345372|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
127651310|NCT03420781|459345373|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
127651311|NCT03420781|459345369|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
127651312|NCT03420781|459345370|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
127651313|NCT03420781|459345371|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
127651314|NCT03420781|459345372|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
127651315|NCT03420781|459345373|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
127651316|NCT03420781|459345369|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
127651317|NCT03420781|459345370|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
127651318|NCT03420781|459345371|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
127651319|NCT03420781|459345372|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
127651320|NCT03420781|459345373|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
127651321|NCT03420781|459345369|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
127651322|NCT03420781|459345370|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
127651323|NCT03420781|459345371|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
127651324|NCT03420781|459345372|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
127651325|NCT03420781|459345373|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
127651326|NCT03420781|459345369|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
127651327|NCT03420781|459345370|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
127651328|NCT03420781|459345371|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
127651329|NCT03420781|459345372|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
127651330|NCT03420781|459345373|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
127651331|NCT00246337|459345374|FG000|Overall Study|Lost to Follow-up|3|||
127651332|NCT00246337|459345375|FG001|Overall Study|Lost to Follow-up|0|||
127651333|NCT00246337|459345376|FG002|Overall Study|Lost to Follow-up|0|||
127651334|NCT00246337|459345377|FG003|Overall Study|Lost to Follow-up|0|||
127651335|NCT00246337|459345378|FG004|Overall Study|Lost to Follow-up|2|||
127651336|NCT00246337|459345379|FG005|Overall Study|Lost to Follow-up|2|||
127651337|NCT00246337|459345380|FG006|Overall Study|Lost to Follow-up|1|||
127651338|NCT00246337|459345381|FG007|Overall Study|Lost to Follow-up|2|||
127651339|NCT00246337|459345382|FG008|Overall Study|Lost to Follow-up|0|||
127651340|NCT00246337|459345374|FG000|Overall Study|Protocol Violation|1|||
127651341|NCT00246337|459345375|FG001|Overall Study|Protocol Violation|0|||
127651342|NCT00246337|459345376|FG002|Overall Study|Protocol Violation|0|||
127651343|NCT00246337|459345377|FG003|Overall Study|Protocol Violation|0|||
127651344|NCT00246337|459345378|FG004|Overall Study|Protocol Violation|1|||
127651345|NCT00246337|459345379|FG005|Overall Study|Protocol Violation|0|||
127651346|NCT00246337|459345380|FG006|Overall Study|Protocol Violation|1|||
127651347|NCT00246337|459345381|FG007|Overall Study|Protocol Violation|1|||
127651348|NCT00246337|459345382|FG008|Overall Study|Protocol Violation|0|||
127651349|NCT00246337|459345374|FG000|Overall Study|Withdrawal by Subject|2|||
127651350|NCT00246337|459345375|FG001|Overall Study|Withdrawal by Subject|0|||
127651351|NCT00246337|459345376|FG002|Overall Study|Withdrawal by Subject|0|||
127651352|NCT00246337|459345377|FG003|Overall Study|Withdrawal by Subject|0|||
127651353|NCT00246337|459345378|FG004|Overall Study|Withdrawal by Subject|0|||
127651354|NCT00246337|459345379|FG005|Overall Study|Withdrawal by Subject|0|||
127651355|NCT00246337|459345380|FG006|Overall Study|Withdrawal by Subject|1|||
127651356|NCT00246337|459345381|FG007|Overall Study|Withdrawal by Subject|1|||
127651357|NCT00246337|459345382|FG008|Overall Study|Withdrawal by Subject|0|||
127651358|NCT00246337|459345374|FG000|Overall Study|Lack of Qualifying Event|8|||
127651359|NCT00246337|459345375|FG001|Overall Study|Lack of Qualifying Event|2|||
127651360|NCT00246337|459345376|FG002|Overall Study|Lack of Qualifying Event|1|||
127651361|NCT00246337|459345377|FG003|Overall Study|Lack of Qualifying Event|1|||
127651362|NCT00246337|459345378|FG004|Overall Study|Lack of Qualifying Event|1|||
127651363|NCT00246337|459345379|FG005|Overall Study|Lack of Qualifying Event|3|||
127651364|NCT00246337|459345380|FG006|Overall Study|Lack of Qualifying Event|3|||
127651365|NCT00246337|459345381|FG007|Overall Study|Lack of Qualifying Event|2|||
127651366|NCT00246337|459345382|FG008|Overall Study|Lack of Qualifying Event|5|||
127651367|NCT00246337|459345374|FG000|Overall Study|Site Terminated|10|||
127651368|NCT00246337|459345375|FG001|Overall Study|Site Terminated|0|||
127651369|NCT00246337|459345376|FG002|Overall Study|Site Terminated|0|||
127651370|NCT00246337|459345377|FG003|Overall Study|Site Terminated|0|||
127651371|NCT00246337|459345378|FG004|Overall Study|Site Terminated|0|||
127651372|NCT00246337|459345379|FG005|Overall Study|Site Terminated|7|||
127651373|NCT00246337|459345380|FG006|Overall Study|Site Terminated|1|||
127651374|NCT00246337|459345381|FG007|Overall Study|Site Terminated|6|||
127651375|NCT00246337|459345382|FG008|Overall Study|Site Terminated|2|||
127651376|NCT00246337|459345374|FG000|Overall Study|Abnormal baseline lab values|7|||
127651377|NCT00246337|459345375|FG001|Overall Study|Abnormal baseline lab values|0|||
127651378|NCT00246337|459345376|FG002|Overall Study|Abnormal baseline lab values|2|||
127651379|NCT00246337|459345377|FG003|Overall Study|Abnormal baseline lab values|0|||
127651380|NCT00246337|459345378|FG004|Overall Study|Abnormal baseline lab values|0|||
127651381|NCT00246337|459345379|FG005|Overall Study|Abnormal baseline lab values|2|||
127651382|NCT00246337|459345380|FG006|Overall Study|Abnormal baseline lab values|2|||
127651383|NCT00246337|459345381|FG007|Overall Study|Abnormal baseline lab values|0|||
127651384|NCT00246337|459345382|FG008|Overall Study|Abnormal baseline lab values|4|||
127651385|NCT00246337|459345374|FG000|Overall Study|Overwhelmed|0|||
127651386|NCT00246337|459345375|FG001|Overall Study|Overwhelmed|0|||
127651387|NCT00246337|459345376|FG002|Overall Study|Overwhelmed|0|||
127651388|NCT00246337|459345377|FG003|Overall Study|Overwhelmed|0|||
127651389|NCT00246337|459345378|FG004|Overall Study|Overwhelmed|0|||
127651390|NCT00246337|459345379|FG005|Overall Study|Overwhelmed|1|||
127651391|NCT00246337|459345380|FG006|Overall Study|Overwhelmed|0|||
127651392|NCT00246337|459345381|FG007|Overall Study|Overwhelmed|0|||
127651393|NCT00246337|459345382|FG008|Overall Study|Overwhelmed|0|||
127651394|NCT00246337|459345374|FG000|Overall Study|Protocol Violator|1|||
127651395|NCT00246337|459345375|FG001|Overall Study|Protocol Violator|0|||
127651396|NCT00246337|459345376|FG002|Overall Study|Protocol Violator|0|||
127651397|NCT00246337|459345377|FG003|Overall Study|Protocol Violator|0|||
127651398|NCT00246337|459345378|FG004|Overall Study|Protocol Violator|0|||
127874644|NCT05279807|460161875|FG000|Overall Study|Laboratory Abnormal Results|1|||
127874645|NCT05279807|460161876|FG001|Overall Study|Laboratory Abnormal Results|0|||
127651399|NCT00246337|459345379|FG005|Overall Study|Protocol Violator|0|||
127651400|NCT00246337|459345380|FG006|Overall Study|Protocol Violator|0|||
127651401|NCT00246337|459345381|FG007|Overall Study|Protocol Violator|0|||
127651402|NCT00246337|459345382|FG008|Overall Study|Protocol Violator|0|||
127651403|NCT00246337|459345374|FG000|Overall Study|Reported as completing trial in error|0|||
127651404|NCT00246337|459345375|FG001|Overall Study|Reported as completing trial in error|0|||
127651405|NCT00246337|459345376|FG002|Overall Study|Reported as completing trial in error|0|||
127651406|NCT00246337|459345377|FG003|Overall Study|Reported as completing trial in error|0|||
127651407|NCT00246337|459345378|FG004|Overall Study|Reported as completing trial in error|0|||
127651408|NCT00246337|459345379|FG005|Overall Study|Reported as completing trial in error|0|||
127651409|NCT00246337|459345380|FG006|Overall Study|Reported as completing trial in error|0|||
127651410|NCT00246337|459345381|FG007|Overall Study|Reported as completing trial in error|1|||
127651411|NCT00246337|459345382|FG008|Overall Study|Reported as completing trial in error|0|||
127651412|NCT00185640|459345386|FG000|Overall Study|Not Eligible|4|||
127651413|NCT00185640|459345386|FG000|Overall Study|Withdrawal by Subject|3|||
127651414|NCT00185640|459345386|FG000|Overall Study|Death|138|||
127651415|NCT00058422|459345387|FG000|Overall Study|Not treated|2|||
127651416|NCT02192970|459345390|FG000|Overall Study|Lost to Follow-up|6|||
127651417|NCT02192970|459345391|FG001|Overall Study|Lost to Follow-up|0|||
127651418|NCT04074590|459345392|FG000|Overall Study|Adverse Event|1|||
127651419|NCT04074590|459345393|FG001|Overall Study|Adverse Event|0|||
127651420|NCT04074590|459345392|FG000|Overall Study|Physician Decision|1|||
127651421|NCT04074590|459345393|FG001|Overall Study|Physician Decision|0|||
127651422|NCT04074590|459345392|FG000|Overall Study|Withdrawal by Subject|2|||
127651423|NCT04074590|459345393|FG001|Overall Study|Withdrawal by Subject|0|||
127651424|NCT00691132|459345394|FG000|Overall Study|Adverse Event|2|||
127651425|NCT00691132|459345395|FG001|Overall Study|Adverse Event|3|||
127651426|NCT00691132|459345394|FG000|Overall Study|Withdrawal by Subject|10|||
127651427|NCT00691132|459345395|FG001|Overall Study|Withdrawal by Subject|10|||
127651428|NCT03954743|459345396|FG000|Overall Study|Adverse Event|1|||
127651429|NCT03954743|459345397|FG001|Overall Study|Adverse Event|0|||
127651430|NCT03954743|459345396|FG000|Overall Study|Lost to Follow-up|6|||
127651431|NCT03954743|459345397|FG001|Overall Study|Lost to Follow-up|4|||
127651432|NCT03954743|459345396|FG000|Overall Study|Protocol Violation|1|||
127651433|NCT03954743|459345397|FG001|Overall Study|Protocol Violation|0|||
127651434|NCT03954743|459345396|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
127651435|NCT03954743|459345397|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
127651436|NCT03954743|459345396|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
127651437|NCT03954743|459345397|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
127651438|NCT02387996|459345402|FG000|Overall Study|Disease Progression|167|||
127651439|NCT02387996|459345402|FG000|Overall Study|Study Drug Toxicity|31|||
127651440|NCT02387996|459345402|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
127651441|NCT02387996|459345402|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
127651442|NCT02387996|459345402|FG000|Overall Study|Subject Withdrew Consent|5|||
127651443|NCT02387996|459345402|FG000|Overall Study|Lost to Follow-up|1|||
127651444|NCT02387996|459345402|FG000|Overall Study|Poor/Non-Compliance|1|||
127651445|NCT02387996|459345402|FG000|Overall Study|Other Reasons|5|||
127651446|NCT02387996|459345402|FG000|Overall Study|Death|1|||
127651447|NCT05375955|459345411|FG000|Treatment (12 Weeks)|Lost to Follow-up|0|||
127651448|NCT05375955|459345412|FG001|Treatment (12 Weeks)|Lost to Follow-up|2|||
127651449|NCT05375955|459345413|FG002|Treatment (12 Weeks)|Lost to Follow-up|2|||
127651450|NCT05375955|459345414|FG003|Treatment (12 Weeks)|Lost to Follow-up|1|||
127651451|NCT05375955|459345415|FG004|Treatment (12 Weeks)|Lost to Follow-up|1|||
127651452|NCT05375955|459345416|FG005|Treatment (12 Weeks)|Lost to Follow-up|1|||
127651453|NCT05375955|459345417|FG006|Treatment (12 Weeks)|Lost to Follow-up|0|||
127651454|NCT05375955|459345411|FG000|Treatment (12 Weeks)|Physician Decision|4|||
127651455|NCT05375955|459345412|FG001|Treatment (12 Weeks)|Physician Decision|1|||
127651456|NCT05375955|459345413|FG002|Treatment (12 Weeks)|Physician Decision|3|||
127651457|NCT05375955|459345414|FG003|Treatment (12 Weeks)|Physician Decision|0|||
127651458|NCT05375955|459345415|FG004|Treatment (12 Weeks)|Physician Decision|0|||
127651459|NCT05375955|459345416|FG005|Treatment (12 Weeks)|Physician Decision|1|||
127651460|NCT05375955|459345417|FG006|Treatment (12 Weeks)|Physician Decision|0|||
127651461|NCT05375955|459345411|FG000|Treatment (12 Weeks)|Other|0|||
127651462|NCT05375955|459345412|FG001|Treatment (12 Weeks)|Other|1|||
127651463|NCT05375955|459345413|FG002|Treatment (12 Weeks)|Other|0|||
127651464|NCT05375955|459345414|FG003|Treatment (12 Weeks)|Other|0|||
127651465|NCT05375955|459345415|FG004|Treatment (12 Weeks)|Other|0|||
127651466|NCT05375955|459345416|FG005|Treatment (12 Weeks)|Other|0|||
127651467|NCT05375955|459345417|FG006|Treatment (12 Weeks)|Other|0|||
127651468|NCT05375955|459345411|FG000|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
127651469|NCT05375955|459345412|FG001|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
127651470|NCT05375955|459345413|FG002|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
127651471|NCT05375955|459345414|FG003|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
127651472|NCT05375955|459345415|FG004|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
127874646|NCT03110107|460161877|FG000|Treatment Period|Disease Progression|3|||
127651473|NCT05375955|459345416|FG005|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
127651474|NCT05375955|459345417|FG006|Treatment (12 Weeks)|Withdrawal by parent/guardian|1|||
127651475|NCT05375955|459345411|FG000|Treatment (12 Weeks)|Withdrawal by Subject|8|||
127651476|NCT05375955|459345412|FG001|Treatment (12 Weeks)|Withdrawal by Subject|4|||
127651477|NCT05375955|459345413|FG002|Treatment (12 Weeks)|Withdrawal by Subject|7|||
127651478|NCT05375955|459345414|FG003|Treatment (12 Weeks)|Withdrawal by Subject|8|||
127651479|NCT05375955|459345415|FG004|Treatment (12 Weeks)|Withdrawal by Subject|4|||
127651480|NCT05375955|459345416|FG005|Treatment (12 Weeks)|Withdrawal by Subject|3|||
127651481|NCT05375955|459345417|FG006|Treatment (12 Weeks)|Withdrawal by Subject|3|||
127651482|NCT05375955|459345411|FG000|Treatment (12 Weeks)|Pregnancy|0|||
127651483|NCT05375955|459345412|FG001|Treatment (12 Weeks)|Pregnancy|0|||
127874647|NCT03110107|460161878|FG001|Treatment Period|Disease Progression|9|||
127651484|NCT05375955|459345413|FG002|Treatment (12 Weeks)|Pregnancy|1|||
127651485|NCT05375955|459345414|FG003|Treatment (12 Weeks)|Pregnancy|0|||
127874648|NCT03110107|460161879|FG002|Treatment Period|Disease Progression|8|||
127874649|NCT03110107|460161880|FG003|Treatment Period|Disease Progression|11|||
127874650|NCT03110107|460161881|FG004|Treatment Period|Disease Progression|8|||
127874651|NCT03110107|460161882|FG005|Treatment Period|Disease Progression|4|||
127874652|NCT03110107|460161883|FG006|Treatment Period|Disease Progression|6|||
127874653|NCT03110107|460161884|FG007|Treatment Period|Disease Progression|7|||
127874654|NCT03110107|460161885|FG008|Treatment Period|Disease Progression|2|||
127874655|NCT03110107|460161886|FG009|Treatment Period|Disease Progression|10|||
127874656|NCT03110107|460161887|FG010|Treatment Period|Disease Progression|5|||
127874657|NCT03110107|460161888|FG011|Treatment Period|Disease Progression|2|||
127874658|NCT03110107|460161889|FG012|Treatment Period|Disease Progression|0|||
127874659|NCT03110107|460161890|FG013|Treatment Period|Disease Progression|5|||
127874660|NCT03110107|460161891|FG014|Treatment Period|Disease Progression|14|||
127874661|NCT03110107|460161892|FG015|Treatment Period|Disease Progression|14|||
127651486|NCT05375955|459345415|FG004|Treatment (12 Weeks)|Pregnancy|0|||
127651487|NCT05375955|459345416|FG005|Treatment (12 Weeks)|Pregnancy|0|||
127651488|NCT05375955|459345417|FG006|Treatment (12 Weeks)|Pregnancy|0|||
127651489|NCT05375955|459345411|FG000|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
127651490|NCT05375955|459345412|FG001|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
127651491|NCT05375955|459345413|FG002|Follow-up (up to 5 Weeks)|Protocol Violation|1|||
127651492|NCT05375955|459345414|FG003|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
127651493|NCT05375955|459345415|FG004|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
127651494|NCT05375955|459345416|FG005|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
127651495|NCT05375955|459345417|FG006|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
127651496|NCT05375955|459345411|FG000|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
127651497|NCT05375955|459345412|FG001|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
127651498|NCT05375955|459345413|FG002|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
127651499|NCT05375955|459345414|FG003|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
127651500|NCT05375955|459345415|FG004|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
127651501|NCT05375955|459345416|FG005|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
127651502|NCT05375955|459345417|FG006|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
127651503|NCT05375955|459345411|FG000|Follow-up (up to 5 Weeks)|Other|0|||
127651504|NCT05375955|459345412|FG001|Follow-up (up to 5 Weeks)|Other|1|||
127651505|NCT05375955|459345413|FG002|Follow-up (up to 5 Weeks)|Other|0|||
127651506|NCT05375955|459345414|FG003|Follow-up (up to 5 Weeks)|Other|0|||
127651507|NCT05375955|459345415|FG004|Follow-up (up to 5 Weeks)|Other|0|||
127651508|NCT05375955|459345416|FG005|Follow-up (up to 5 Weeks)|Other|0|||
127651509|NCT05375955|459345417|FG006|Follow-up (up to 5 Weeks)|Other|0|||
127651510|NCT05375955|459345411|FG000|Follow-up (up to 5 Weeks)|Physician's decision|2|||
127651511|NCT05375955|459345412|FG001|Follow-up (up to 5 Weeks)|Physician's decision|0|||
127651512|NCT05375955|459345413|FG002|Follow-up (up to 5 Weeks)|Physician's decision|2|||
127651513|NCT05375955|459345414|FG003|Follow-up (up to 5 Weeks)|Physician's decision|0|||
127651514|NCT05375955|459345415|FG004|Follow-up (up to 5 Weeks)|Physician's decision|0|||
127651515|NCT05375955|459345416|FG005|Follow-up (up to 5 Weeks)|Physician's decision|0|||
127651516|NCT05375955|459345417|FG006|Follow-up (up to 5 Weeks)|Physician's decision|0|||
127651517|NCT05375955|459345411|FG000|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
127651518|NCT05375955|459345412|FG001|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
127651519|NCT05375955|459345413|FG002|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
127651520|NCT05375955|459345414|FG003|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
127651521|NCT05375955|459345415|FG004|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
127651522|NCT05375955|459345416|FG005|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
127874662|NCT03110107|460161893|FG016|Treatment Period|Disease Progression|4|||
127874663|NCT03110107|460161894|FG017|Treatment Period|Disease Progression|3|||
127874664|NCT03110107|460161895|FG018|Treatment Period|Disease Progression|16|||
127874665|NCT03110107|460161896|FG019|Treatment Period|Disease Progression|14|||
127874666|NCT03110107|460161897|FG020|Treatment Period|Disease Progression|12|||
127874667|NCT03110107|460161898|FG021|Treatment Period|Disease Progression|16|||
127874668|NCT03110107|460161899|FG022|Treatment Period|Disease Progression|18|||
127874669|NCT03110107|460161900|FG023|Treatment Period|Disease Progression|13|||
127874670|NCT03110107|460161901|FG024|Treatment Period|Disease Progression|16|||
127874671|NCT03110107|460161902|FG025|Treatment Period|Disease Progression|31|||
127874672|NCT03110107|460161877|FG000|Treatment Period|Study drug toxicity|1|||
127874673|NCT03110107|460161878|FG001|Treatment Period|Study drug toxicity|0|||
127874674|NCT03110107|460161879|FG002|Treatment Period|Study drug toxicity|1|||
127874675|NCT03110107|460161880|FG003|Treatment Period|Study drug toxicity|2|||
127651523|NCT05375955|459345417|FG006|Follow-up (up to 5 Weeks)|Lost to Follow-up|2|||
127651524|NCT01320943|459345418|FG000|Overall Study|Lost to Follow-up|1|||
127651525|NCT01320943|459345419|FG001|Overall Study|Lost to Follow-up|0|||
127874676|NCT03110107|460161881|FG004|Treatment Period|Study drug toxicity|0|||
127874677|NCT03110107|460161882|FG005|Treatment Period|Study drug toxicity|3|||
127874678|NCT03110107|460161883|FG006|Treatment Period|Study drug toxicity|1|||
127874679|NCT03110107|460161884|FG007|Treatment Period|Study drug toxicity|1|||
127651526|NCT01320943|459345418|FG000|Overall Study|Physician Decision|0|||
127651527|NCT01320943|459345419|FG001|Overall Study|Physician Decision|1|||
127651528|NCT01320943|459345418|FG000|Overall Study|Randomized but not Treated|0|||
127651529|NCT01320943|459345419|FG001|Overall Study|Randomized but not Treated|1|||
127651530|NCT02063828|459345422|FG000|Overall Study|Withdrawal by Subject|4|||
127651531|NCT02063828|459345423|FG001|Overall Study|Withdrawal by Subject|6|||
127651532|NCT02063828|459345424|FG002|Overall Study|Withdrawal by Subject|3|||
127651533|NCT02063828|459345422|FG000|Overall Study|Death|0|||
127651534|NCT02063828|459345423|FG001|Overall Study|Death|0|||
127651535|NCT02063828|459345424|FG002|Overall Study|Death|1|||
127651536|NCT03937219|459345425|FG000|Overall Study|Death|223|||
127651537|NCT03937219|459345426|FG001|Overall Study|Death|211|||
127651538|NCT03937219|459345425|FG000|Overall Study|Withdrawal by Subject|17|||
127651539|NCT03937219|459345426|FG001|Overall Study|Withdrawal by Subject|25|||
127651540|NCT03937219|459345425|FG000|Overall Study|Lost to Follow-up|3|||
127651541|NCT03937219|459345426|FG001|Overall Study|Lost to Follow-up|4|||
127651542|NCT03483038|459345427|FG000|Overall Study|Subjects still in follow-up|18|||
127651543|NCT02158884|459345430|FG000|Baseline Assessment|Missed performance assessment|3|||
127651544|NCT02158884|459345430|FG000|Baseline Assessment|Missed SMFA|1|||
127651545|NCT02158884|459345430|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
127651546|NCT02158884|459345430|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
127651547|NCT02158884|459345430|FG000|6 Month Assessment|Missed SMFA|20|||
127651548|NCT02158884|459345430|FG000|12 Month Assessment|Missed SMFA|17|||
127651549|NCT01313286|459345435|FG000|Period 1|Withdrawal by Subject|2|||
127651550|NCT01313286|459345436|FG001|Period 1|Withdrawal by Subject|0|||
127651551|NCT00733980|459345439|FG000|Overall Study|Adverse Event|5|||
127651552|NCT00733980|459345440|FG001|Overall Study|Adverse Event|2|||
127651553|NCT00733980|459345439|FG000|Overall Study|Lack of Efficacy|0|||
127651554|NCT00733980|459345440|FG001|Overall Study|Lack of Efficacy|1|||
127651555|NCT00733980|459345439|FG000|Overall Study|Protocol Violation|2|||
127651556|NCT00733980|459345440|FG001|Overall Study|Protocol Violation|1|||
127651557|NCT00733980|459345439|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
127651558|NCT00733980|459345440|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
127651559|NCT00733980|459345439|FG000|Overall Study|Lost to Follow-up|6|||
127651560|NCT00733980|459345440|FG001|Overall Study|Lost to Follow-up|11|||
127651561|NCT00733980|459345439|FG000|Overall Study|Physician Decision|2|||
127651562|NCT00733980|459345440|FG001|Overall Study|Physician Decision|3|||
127651563|NCT00733980|459345439|FG000|Overall Study|Withdrawal by Subject|6|||
127651564|NCT00733980|459345440|FG001|Overall Study|Withdrawal by Subject|2|||
127651565|NCT02010632|459345441|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
127651566|NCT02010632|459345442|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
127651567|NCT00404495|459345448|FG000|Overall Study|Death|37|||
127651568|NCT00404495|459345449|FG001|Overall Study|Death|11|||
127651569|NCT00404495|459345448|FG000|Overall Study|Lost to Follow-up|5|||
127651570|NCT00404495|459345449|FG001|Overall Study|Lost to Follow-up|0|||
127651571|NCT00404495|459345448|FG000|Overall Study|Other|1|||
127651572|NCT00404495|459345449|FG001|Overall Study|Other|0|||
127651573|NCT00404495|459345448|FG000|Overall Study|Withdrawal by Subject|1|||
127651574|NCT00404495|459345449|FG001|Overall Study|Withdrawal by Subject|0|||
127651575|NCT03750006|459345452|FG000|Overall Study|Withdrawal by Subject|8|||
127651576|NCT03750006|459345452|FG000|Overall Study|COVID PANDEMIC|11|||
127651577|NCT04739761|459345454|FG000|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|167|||
127651578|NCT04739761|459345455|FG001|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|189|||
127651579|NCT04739761|459345454|FG000|Overall Study|By complete response from the participant|1|||
127651580|NCT04739761|459345455|FG001|Overall Study|By complete response from the participant|0|||
127651581|NCT04739761|459345454|FG000|Overall Study|Lost to Follow-up|3|||
127651582|NCT04739761|459345455|FG001|Overall Study|Lost to Follow-up|3|||
127651583|NCT04739761|459345454|FG000|Overall Study|Death|13|||
127651584|NCT04739761|459345455|FG001|Overall Study|Death|13|||
127651585|NCT04739761|459345454|FG000|Overall Study|Participant reports worsening of the general critical condition and will not continue|0|||
127651586|NCT04739761|459345455|FG001|Overall Study|Participant reports worsening of the general critical condition and will not continue|1|||
127651587|NCT04739761|459345454|FG000|Overall Study|Participant is in poor health and will not come to the study site|0|||
127651588|NCT04739761|459345455|FG001|Overall Study|Participant is in poor health and will not come to the study site|1|||
127651589|NCT04739761|459345454|FG000|Overall Study|Progression confirmed in magnetic resonance imaging|0|||
127874680|NCT03110107|460161885|FG008|Treatment Period|Study drug toxicity|3|||
127651590|NCT04739761|459345455|FG001|Overall Study|Progression confirmed in magnetic resonance imaging|1|||
127651591|NCT04739761|459345454|FG000|Overall Study|Adverse Event|0|||
127651592|NCT04739761|459345455|FG001|Overall Study|Adverse Event|3|||
127651593|NCT04739761|459345454|FG000|Overall Study|Participant decision|1|||
127651594|NCT04739761|459345455|FG001|Overall Study|Participant decision|0|||
127651595|NCT04739761|459345454|FG000|Overall Study|Sub investigator decision approved by medical monitor|1|||
127651596|NCT04739761|459345455|FG001|Overall Study|Sub investigator decision approved by medical monitor|0|||
127651597|NCT04739761|459345454|FG000|Overall Study|Participant immediately started next line of treatment|1|||
127651598|NCT04739761|459345455|FG001|Overall Study|Participant immediately started next line of treatment|0|||
127651599|NCT04739761|459345454|FG000|Overall Study|Participant's decision because the treatment makes them anxious|1|||
127651600|NCT04739761|459345455|FG001|Overall Study|Participant's decision because the treatment makes them anxious|0|||
127651601|NCT04739761|459345454|FG000|Overall Study|Lack of clinical benefit|1|||
127651602|NCT04739761|459345455|FG001|Overall Study|Lack of clinical benefit|0|||
127651603|NCT04739761|459345454|FG000|Overall Study|Disease progression|5|||
127651604|NCT04739761|459345455|FG001|Overall Study|Disease progression|5|||
127651605|NCT04739761|459345454|FG000|Overall Study|Withdrawal by Subject|14|||
127651606|NCT04739761|459345455|FG001|Overall Study|Withdrawal by Subject|13|||
127651607|NCT04739761|459345454|FG000|Overall Study|Protocol Violation|1|||
127651608|NCT04739761|459345455|FG001|Overall Study|Protocol Violation|0|||
127651609|NCT04739761|459345454|FG000|Overall Study|Physician Decision|2|||
127651610|NCT04739761|459345455|FG001|Overall Study|Physician Decision|0|||
127651611|NCT01061333|459345459|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
127651612|NCT01061333|459345460|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
127651613|NCT01493960|459347398|FG000|Overall Study|Adverse Event|0|||
127651614|NCT01493960|459347399|FG001|Overall Study|Adverse Event|1|||
127651615|NCT01493960|459347398|FG000|Overall Study|Lack of Efficacy|15|||
127651616|NCT01493960|459347399|FG001|Overall Study|Lack of Efficacy|9|||
127651617|NCT01493960|459347398|FG000|Overall Study|Protocol Violation|3|||
127651618|NCT01493960|459347399|FG001|Overall Study|Protocol Violation|0|||
127651619|NCT01493960|459347398|FG000|Overall Study|Withdrawal by Subject|10|||
127651620|NCT01493960|459347399|FG001|Overall Study|Withdrawal by Subject|4|||
127651621|NCT01493960|459347398|FG000|Overall Study|Non-specified|4|||
127651622|NCT01493960|459347399|FG001|Overall Study|Non-specified|4|||
127651623|NCT01679236|459347404|FG000|Overall Study|Lost to Follow-up|15|||
127651624|NCT01679236|459347405|FG001|Overall Study|Lost to Follow-up|15|||
127651625|NCT03559218|459347408|FG000|Overall Study|Withdrawal by Subject|1|||
127651626|NCT03559218|459347409|FG001|Overall Study|Withdrawal by Subject|0|||
127651627|NCT03237858|459347410|FG000|Overall Study|Death|19|||
127651628|NCT03237858|459347410|FG000|Overall Study|Withdrawal by Subject|37|||
127651629|NCT01782742|459347411|FG000|Double-blind Treatment Phase|Adverse Event|1|||
127651630|NCT01782742|459347412|FG001|Double-blind Treatment Phase|Adverse Event|0|||
127651631|NCT01382602|459347413|FG000|Overall Study|Protocol Violation|0|||
127651632|NCT01382602|459347414|FG001|Overall Study|Protocol Violation|3|||
127651633|NCT01382602|459347413|FG000|Overall Study|Withdrawal by Subject|0|||
127651634|NCT01382602|459347414|FG001|Overall Study|Withdrawal by Subject|1|||
127651635|NCT02305381|459347415|FG000|Overall Study|Unclassified|5|||
127651636|NCT02305381|459347416|FG001|Overall Study|Unclassified|5|||
127651637|NCT02305381|459347417|FG002|Overall Study|Unclassified|7|||
127651638|NCT02487498|459347421|FG000|Period: Period 1|Adverse Event|2|||
127651639|NCT02487498|459347422|FG001|Period: Period 1|Adverse Event|4|||
127651640|NCT02487498|459347421|FG000|Period: Period 1|Subject/guardian decision|2|||
127651641|NCT02487498|459347422|FG001|Period: Period 1|Subject/guardian decision|4|||
127651642|NCT02487498|459347421|FG000|Period: Period 1|Lost to Follow-up|0|||
127651643|NCT02487498|459347422|FG001|Period: Period 1|Lost to Follow-up|2|||
127651644|NCT02487498|459347421|FG000|Period: Period 1|Lack of Efficacy|1|||
127651645|NCT02487498|459347422|FG001|Period: Period 1|Lack of Efficacy|0|||
127651646|NCT02487498|459347421|FG000|Period: Period 1|Physician Decision|0|||
127651647|NCT02487498|459347422|FG001|Period: Period 1|Physician Decision|1|||
127651648|NCT02487498|459347421|FG000|Period: Period 1|Protocol deviation|1|||
127651649|NCT02487498|459347422|FG001|Period: Period 1|Protocol deviation|0|||
127651650|NCT02487498|459347421|FG000|Period: Washout|Subject/guardian decision|0|||
127651651|NCT02487498|459347422|FG001|Period: Washout|Subject/guardian decision|5|||
127651652|NCT02487498|459347421|FG000|Period: Washout|Lack of Efficacy|1|||
127651653|NCT02487498|459347422|FG001|Period: Washout|Lack of Efficacy|1|||
127651654|NCT02487498|459347421|FG000|Period: Washout|Physician Decision|1|||
127651655|NCT02487498|459347422|FG001|Period: Washout|Physician Decision|0|||
127651656|NCT02487498|459347421|FG000|Period: Washout|Non-compliance with study treatment|0|||
127651657|NCT02487498|459347422|FG001|Period: Washout|Non-compliance with study treatment|1|||
127651658|NCT02487498|459347421|FG000|Period: Period 2|Adverse Event|2|||
127651659|NCT02487498|459347422|FG001|Period: Period 2|Adverse Event|2|||
127651660|NCT02487498|459347421|FG000|Period: Period 2|Subject/guardian decision|2|||
127651661|NCT02487498|459347422|FG001|Period: Period 2|Subject/guardian decision|1|||
127651662|NCT02487498|459347421|FG000|Period: Period 2|Lost to Follow-up|1|||
127651663|NCT02487498|459347422|FG001|Period: Period 2|Lost to Follow-up|1|||
127651664|NCT02487498|459347421|FG000|Period: Period 2|Death|0|||
127651665|NCT02487498|459347422|FG001|Period: Period 2|Death|1|||
127651666|NCT02487498|459347421|FG000|Period: Period 2|Physician Decision|1|||
127651667|NCT02487498|459347422|FG001|Period: Period 2|Physician Decision|0|||
127651668|NCT00676130|459347423|FG000|Overall Study|Lost to Follow-up|0|||
127651669|NCT00676130|459347424|FG001|Overall Study|Lost to Follow-up|1|||
127651670|NCT00676130|459347423|FG000|Overall Study|Found ineligible|3|||
127651671|NCT00676130|459347424|FG001|Overall Study|Found ineligible|2|||
127651672|NCT00676130|459347423|FG000|Overall Study|Withdrawal by Subject|0|||
127651673|NCT00676130|459347424|FG001|Overall Study|Withdrawal by Subject|1|||
127651674|NCT05044325|459347425|FG000|Part A:Treatment Period 1|Adverse Event|0|||
127651675|NCT05044325|459347426|FG001|Part A:Treatment Period 1|Adverse Event|0|||
127651676|NCT05044325|459347427|FG002|Part A:Treatment Period 1|Adverse Event|0|||
127651677|NCT05044325|459347428|FG003|Part A:Treatment Period 1|Adverse Event|0|||
127874681|NCT03110107|460161886|FG009|Treatment Period|Study drug toxicity|2|||
127874682|NCT03110107|460161887|FG010|Treatment Period|Study drug toxicity|0|||
127874683|NCT03110107|460161888|FG011|Treatment Period|Study drug toxicity|2|||
127874684|NCT03110107|460161889|FG012|Treatment Period|Study drug toxicity|0|||
127874685|NCT03110107|460161890|FG013|Treatment Period|Study drug toxicity|0|||
127874686|NCT03110107|460161891|FG014|Treatment Period|Study drug toxicity|2|||
127874687|NCT03110107|460161892|FG015|Treatment Period|Study drug toxicity|3|||
127874688|NCT03110107|460161893|FG016|Treatment Period|Study drug toxicity|3|||
127874689|NCT03110107|460161894|FG017|Treatment Period|Study drug toxicity|3|||
127874690|NCT03110107|460161895|FG018|Treatment Period|Study drug toxicity|1|||
127874691|NCT03110107|460161896|FG019|Treatment Period|Study drug toxicity|2|||
127874692|NCT03110107|460161897|FG020|Treatment Period|Study drug toxicity|2|||
127651678|NCT05044325|459347429|FG004|Part A:Treatment Period 1|Adverse Event|0|||
127651679|NCT05044325|459347430|FG005|Part A:Treatment Period 1|Adverse Event|1|||
127651680|NCT05044325|459347431|FG006|Part A:Treatment Period 1|Adverse Event|0|||
127651681|NCT05044325|459347432|FG007|Part A:Treatment Period 1|Adverse Event|1|||
127651682|NCT05044325|459347433|FG008|Part A:Treatment Period 1|Adverse Event|0|||
127651683|NCT05044325|459347434|FG009|Part A:Treatment Period 1|Adverse Event|0|||
127651684|NCT05044325|459347425|FG000|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
127651685|NCT05044325|459347426|FG001|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
127651686|NCT05044325|459347427|FG002|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
127651687|NCT05044325|459347428|FG003|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
127651688|NCT05044325|459347429|FG004|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
127651689|NCT05044325|459347430|FG005|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
127651690|NCT05044325|459347431|FG006|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
127651691|NCT05044325|459347432|FG007|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
127651692|NCT05044325|459347433|FG008|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
127651693|NCT05044325|459347434|FG009|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
127651694|NCT05044325|459347425|FG000|Part A:Treatment Period 1|Physician Decision|0|||
127651695|NCT05044325|459347426|FG001|Part A:Treatment Period 1|Physician Decision|0|||
127651696|NCT05044325|459347427|FG002|Part A:Treatment Period 1|Physician Decision|0|||
127651697|NCT05044325|459347428|FG003|Part A:Treatment Period 1|Physician Decision|0|||
127651698|NCT05044325|459347429|FG004|Part A:Treatment Period 1|Physician Decision|0|||
127651699|NCT05044325|459347430|FG005|Part A:Treatment Period 1|Physician Decision|0|||
127651700|NCT05044325|459347431|FG006|Part A:Treatment Period 1|Physician Decision|1|||
127651701|NCT05044325|459347432|FG007|Part A:Treatment Period 1|Physician Decision|0|||
127651702|NCT05044325|459347433|FG008|Part A:Treatment Period 1|Physician Decision|0|||
127651703|NCT05044325|459347434|FG009|Part A:Treatment Period 1|Physician Decision|0|||
127651704|NCT05044325|459347425|FG000|Part A:Treatment Period 1|Withdrawal by Subject|0|||
127651705|NCT05044325|459347426|FG001|Part A:Treatment Period 1|Withdrawal by Subject|0|||
127651706|NCT05044325|459347427|FG002|Part A:Treatment Period 1|Withdrawal by Subject|1|||
127651707|NCT05044325|459347428|FG003|Part A:Treatment Period 1|Withdrawal by Subject|0|||
127651708|NCT05044325|459347429|FG004|Part A:Treatment Period 1|Withdrawal by Subject|0|||
127651709|NCT05044325|459347430|FG005|Part A:Treatment Period 1|Withdrawal by Subject|0|||
127651710|NCT05044325|459347431|FG006|Part A:Treatment Period 1|Withdrawal by Subject|0|||
127651711|NCT05044325|459347432|FG007|Part A:Treatment Period 1|Withdrawal by Subject|0|||
127651712|NCT05044325|459347433|FG008|Part A:Treatment Period 1|Withdrawal by Subject|0|||
127651713|NCT05044325|459347434|FG009|Part A:Treatment Period 1|Withdrawal by Subject|0|||
127651714|NCT05044325|459347425|FG000|Part A:Treatment Period 2|Adverse Event|0|||
127651715|NCT05044325|459347426|FG001|Part A:Treatment Period 2|Adverse Event|1|||
127651716|NCT05044325|459347427|FG002|Part A:Treatment Period 2|Adverse Event|0|||
127651717|NCT05044325|459347428|FG003|Part A:Treatment Period 2|Adverse Event|0|||
127651718|NCT05044325|459347429|FG004|Part A:Treatment Period 2|Adverse Event|1|||
127651719|NCT05044325|459347430|FG005|Part A:Treatment Period 2|Adverse Event|1|||
127651720|NCT05044325|459347431|FG006|Part A:Treatment Period 2|Adverse Event|0|||
127874693|NCT03110107|460161898|FG021|Treatment Period|Study drug toxicity|0|||
127651721|NCT05044325|459347432|FG007|Part A:Treatment Period 2|Adverse Event|0|||
127651722|NCT05044325|459347433|FG008|Part A:Treatment Period 2|Adverse Event|0|||
127651723|NCT05044325|459347434|FG009|Part A:Treatment Period 2|Adverse Event|0|||
127651724|NCT05044325|459347425|FG000|Part A:Treatment Period 2|Physician Decision|0|||
127651725|NCT05044325|459347426|FG001|Part A:Treatment Period 2|Physician Decision|0|||
127651726|NCT05044325|459347427|FG002|Part A:Treatment Period 2|Physician Decision|0|||
127651727|NCT05044325|459347428|FG003|Part A:Treatment Period 2|Physician Decision|0|||
127651728|NCT05044325|459347429|FG004|Part A:Treatment Period 2|Physician Decision|0|||
127874694|NCT03110107|460161899|FG022|Treatment Period|Study drug toxicity|2|||
127874695|NCT03110107|460161900|FG023|Treatment Period|Study drug toxicity|6|||
127874696|NCT03110107|460161901|FG024|Treatment Period|Study drug toxicity|7|||
127651729|NCT05044325|459347430|FG005|Part A:Treatment Period 2|Physician Decision|1|||
127651730|NCT05044325|459347431|FG006|Part A:Treatment Period 2|Physician Decision|0|||
127651731|NCT05044325|459347432|FG007|Part A:Treatment Period 2|Physician Decision|0|||
127651732|NCT05044325|459347433|FG008|Part A:Treatment Period 2|Physician Decision|0|||
127651733|NCT05044325|459347434|FG009|Part A:Treatment Period 2|Physician Decision|0|||
127651734|NCT05044325|459347425|FG000|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
127651735|NCT05044325|459347426|FG001|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
127651736|NCT05044325|459347427|FG002|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
127651737|NCT05044325|459347428|FG003|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
127651738|NCT05044325|459347429|FG004|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
127651739|NCT05044325|459347430|FG005|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
127651740|NCT05044325|459347431|FG006|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
127651741|NCT05044325|459347432|FG007|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
127651742|NCT05044325|459347433|FG008|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
127651743|NCT05044325|459347434|FG009|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
127651744|NCT00755222|459347435|FG000|Overall Study|Withdrawal by Subject|4|||
127651745|NCT00755222|459347436|FG001|Overall Study|Withdrawal by Subject|2|||
127651746|NCT00755222|459347435|FG000|Overall Study|Adverse Event|2|||
127651747|NCT00755222|459347436|FG001|Overall Study|Adverse Event|0|||
127651748|NCT00755222|459347435|FG000|Overall Study|Protocol Violation|2|||
127651749|NCT00755222|459347436|FG001|Overall Study|Protocol Violation|0|||
127651750|NCT04382924|459347440|FG000|Overall Study|Death|2|||
127651751|NCT04382924|459347441|FG001|Overall Study|Death|5|||
127651752|NCT04382924|459347442|FG002|Overall Study|Death|4|||
127651753|NCT04382924|459347440|FG000|Overall Study|Protocol Violation|0|||
127651754|NCT04382924|459347441|FG001|Overall Study|Protocol Violation|1|||
127651755|NCT04382924|459347442|FG002|Overall Study|Protocol Violation|1|||
127651756|NCT04382924|459347440|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
127651757|NCT04382924|459347441|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
127651758|NCT04382924|459347442|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
127651759|NCT04382924|459347440|FG000|Overall Study|Withdrawal by Subject|6|||
127651760|NCT04382924|459347441|FG001|Overall Study|Withdrawal by Subject|3|||
127651761|NCT04382924|459347442|FG002|Overall Study|Withdrawal by Subject|6|||
127651762|NCT01559454|459347443|FG000|Overall Study|Lost to Follow-up|3|||
127651763|NCT01559454|459347444|FG001|Overall Study|Lost to Follow-up|2|||
127651764|NCT01559454|459347443|FG000|Overall Study|Withdrawal by Subject|0|||
127651765|NCT01559454|459347444|FG001|Overall Study|Withdrawal by Subject|1|||
127651766|NCT01559454|459347443|FG000|Overall Study|Physician Decision|0|||
127651767|NCT01559454|459347444|FG001|Overall Study|Physician Decision|1|||
127651768|NCT01559454|459347443|FG000|Overall Study|Protocol Violation|0|||
127651769|NCT01559454|459347444|FG001|Overall Study|Protocol Violation|1|||
127651770|NCT01559454|459347443|FG000|Overall Study|Lack of Efficacy|0|||
127651771|NCT01559454|459347444|FG001|Overall Study|Lack of Efficacy|1|||
127651772|NCT00991341|459347451|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
127651773|NCT00991341|459347452|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
127651774|NCT00991341|459347451|FG000|Overall Study|Death|3|||
127651775|NCT00991341|459347452|FG001|Overall Study|Death|0|||
127651776|NCT00991341|459347451|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
127651777|NCT00991341|459347452|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
127651778|NCT00991341|459347451|FG000|Overall Study|Physician Decision|1|||
127651779|NCT00991341|459347452|FG001|Overall Study|Physician Decision|2|||
127651780|NCT00991341|459347451|FG000|Overall Study|Withdrawal by Subject|3|||
127651781|NCT00991341|459347452|FG001|Overall Study|Withdrawal by Subject|4|||
127651782|NCT00215540|459347453|FG000|Overall Study|Withdrew from study medication|1|||
127651783|NCT00215540|459347454|FG001|Overall Study|Withdrew from study medication|0|||
127874697|NCT03110107|460161902|FG025|Treatment Period|Study drug toxicity|6|||
127651784|NCT00215540|459347455|FG002|Overall Study|Withdrew from study medication|0|||
127651785|NCT03010462|459347456|FG000|Overall Study|Withdrawal by Subject|3|||
127651786|NCT03010462|459347457|FG001|Overall Study|Withdrawal by Subject|1|||
127651787|NCT02207725|459347460|FG000|Overall Study|Did Not Receive Treatment|0|||
127651788|NCT02207725|459347461|FG001|Overall Study|Did Not Receive Treatment|1|||
127651789|NCT02207725|459347462|FG002|Overall Study|Did Not Receive Treatment|1|||
127651790|NCT02207725|459347463|FG003|Overall Study|Did Not Receive Treatment|1|||
127651791|NCT03145766|459347464|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
127651792|NCT03145766|459347465|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
127651793|NCT03145766|459347466|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
127651794|NCT03145766|459347467|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
127651795|NCT03145766|459347468|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
127651796|NCT03145766|459347464|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
127651797|NCT03145766|459347465|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
127651798|NCT03145766|459347466|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
127651799|NCT03145766|459347467|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
127651800|NCT03145766|459347468|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
127651801|NCT03145766|459347464|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
127651802|NCT03145766|459347465|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
127651803|NCT03145766|459347466|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
127651804|NCT03145766|459347467|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
127651805|NCT03145766|459347468|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
127651806|NCT03145766|459347464|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
127651807|NCT03145766|459347465|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
127651808|NCT03145766|459347466|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
127651809|NCT03145766|459347467|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
127651810|NCT03145766|459347468|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
127651811|NCT03145766|459347464|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
127651812|NCT03145766|459347465|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
127651813|NCT03145766|459347466|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
127651814|NCT03145766|459347467|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
127651815|NCT03145766|459347468|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
127651816|NCT03145766|459347464|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
127651817|NCT03145766|459347465|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
127651818|NCT03145766|459347466|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
127651819|NCT03145766|459347467|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
127651820|NCT03145766|459347468|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
127651821|NCT03145766|459347464|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
127651822|NCT03145766|459347465|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
127651823|NCT03145766|459347466|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
127651824|NCT03145766|459347467|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
127651825|NCT03145766|459347468|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
127651826|NCT02799472|459347474|FG000|Overall Study|Withdrawal by Subject|2|||
127651827|NCT02799472|459347475|FG001|Overall Study|Withdrawal by Subject|4|||
127651828|NCT02799472|459347474|FG000|Overall Study|Lack of Efficacy|2|||
127651829|NCT02799472|459347475|FG001|Overall Study|Lack of Efficacy|0|||
127651830|NCT02799472|459347474|FG000|Overall Study|Lost to Follow-up|0|||
127651831|NCT02799472|459347475|FG001|Overall Study|Lost to Follow-up|1|||
127651832|NCT00674570|459347476|FG000|Overall Study|Withdrawal by Subject|0|||
127651833|NCT00674570|459347477|FG001|Overall Study|Withdrawal by Subject|2|||
127651834|NCT00674570|459347478|FG002|Overall Study|Withdrawal by Subject|0|||
127651835|NCT02801669|459347479|FG000|Overall Study|Death|66|||
127874698|NCT03110107|460161877|FG000|Treatment Period|Death|0|||
127874699|NCT03110107|460161878|FG001|Treatment Period|Death|0|||
127874700|NCT03110107|460161879|FG002|Treatment Period|Death|0|||
127874701|NCT03110107|460161880|FG003|Treatment Period|Death|0|||
127874702|NCT03110107|460161881|FG004|Treatment Period|Death|0|||
127874703|NCT03110107|460161882|FG005|Treatment Period|Death|0|||
127874704|NCT03110107|460161883|FG006|Treatment Period|Death|0|||
127874705|NCT03110107|460161884|FG007|Treatment Period|Death|0|||
127874706|NCT03110107|460161885|FG008|Treatment Period|Death|0|||
127874707|NCT03110107|460161886|FG009|Treatment Period|Death|0|||
127874708|NCT03110107|460161887|FG010|Treatment Period|Death|0|||
127874709|NCT03110107|460161888|FG011|Treatment Period|Death|0|||
127874710|NCT03110107|460161889|FG012|Treatment Period|Death|1|||
127874711|NCT03110107|460161890|FG013|Treatment Period|Death|0|||
127874712|NCT03110107|460161891|FG014|Treatment Period|Death|0|||
127874713|NCT03110107|460161892|FG015|Treatment Period|Death|0|||
127874714|NCT03110107|460161893|FG016|Treatment Period|Death|0|||
127874715|NCT03110107|460161894|FG017|Treatment Period|Death|0|||
127874716|NCT03110107|460161895|FG018|Treatment Period|Death|0|||
127874717|NCT03110107|460161896|FG019|Treatment Period|Death|0|||
127874718|NCT03110107|460161897|FG020|Treatment Period|Death|0|||
127874719|NCT03110107|460161898|FG021|Treatment Period|Death|0|||
127874720|NCT03110107|460161899|FG022|Treatment Period|Death|0|||
127874721|NCT03110107|460161900|FG023|Treatment Period|Death|0|||
127874722|NCT03110107|460161901|FG024|Treatment Period|Death|0|||
127874723|NCT03110107|460161902|FG025|Treatment Period|Death|0|||
127874724|NCT03110107|460161877|FG000|Treatment Period|Adverse Event|0|||
127874725|NCT03110107|460161878|FG001|Treatment Period|Adverse Event|0|||
127874726|NCT03110107|460161879|FG002|Treatment Period|Adverse Event|1|||
127874727|NCT03110107|460161880|FG003|Treatment Period|Adverse Event|0|||
127874728|NCT03110107|460161881|FG004|Treatment Period|Adverse Event|0|||
127874729|NCT03110107|460161882|FG005|Treatment Period|Adverse Event|2|||
127874730|NCT03110107|460161883|FG006|Treatment Period|Adverse Event|0|||
127874731|NCT03110107|460161884|FG007|Treatment Period|Adverse Event|2|||
127874732|NCT03110107|460161885|FG008|Treatment Period|Adverse Event|0|||
127874733|NCT03110107|460161886|FG009|Treatment Period|Adverse Event|1|||
127874734|NCT03110107|460161887|FG010|Treatment Period|Adverse Event|0|||
127874735|NCT03110107|460161888|FG011|Treatment Period|Adverse Event|0|||
127874736|NCT03110107|460161889|FG012|Treatment Period|Adverse Event|0|||
127874737|NCT03110107|460161890|FG013|Treatment Period|Adverse Event|0|||
127874738|NCT03110107|460161891|FG014|Treatment Period|Adverse Event|0|||
127874739|NCT03110107|460161892|FG015|Treatment Period|Adverse Event|2|||
127874740|NCT03110107|460161893|FG016|Treatment Period|Adverse Event|0|||
127874741|NCT03110107|460161894|FG017|Treatment Period|Adverse Event|1|||
127874742|NCT03110107|460161895|FG018|Treatment Period|Adverse Event|2|||
127874743|NCT03110107|460161896|FG019|Treatment Period|Adverse Event|1|||
127874744|NCT03110107|460161897|FG020|Treatment Period|Adverse Event|4|||
127874745|NCT03110107|460161898|FG021|Treatment Period|Adverse Event|2|||
127874746|NCT03110107|460161899|FG022|Treatment Period|Adverse Event|2|||
127874747|NCT03110107|460161900|FG023|Treatment Period|Adverse Event|2|||
127874748|NCT03110107|460161901|FG024|Treatment Period|Adverse Event|2|||
127874749|NCT03110107|460161902|FG025|Treatment Period|Adverse Event|4|||
127874750|NCT03110107|460161877|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
127874751|NCT03110107|460161878|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
127874752|NCT03110107|460161879|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
127874753|NCT03110107|460161880|FG003|Treatment Period|Participant request to discontinue study treatment|0|||
127874754|NCT03110107|460161881|FG004|Treatment Period|Participant request to discontinue study treatment|0|||
127874755|NCT03110107|460161882|FG005|Treatment Period|Participant request to discontinue study treatment|0|||
127874756|NCT03110107|460161883|FG006|Treatment Period|Participant request to discontinue study treatment|0|||
127874757|NCT03110107|460161884|FG007|Treatment Period|Participant request to discontinue study treatment|1|||
127874758|NCT03110107|460161885|FG008|Treatment Period|Participant request to discontinue study treatment|0|||
127874759|NCT03110107|460161886|FG009|Treatment Period|Participant request to discontinue study treatment|0|||
127874760|NCT03110107|460161887|FG010|Treatment Period|Participant request to discontinue study treatment|1|||
127874761|NCT03110107|460161888|FG011|Treatment Period|Participant request to discontinue study treatment|0|||
127874762|NCT03110107|460161889|FG012|Treatment Period|Participant request to discontinue study treatment|0|||
127874763|NCT03110107|460161890|FG013|Treatment Period|Participant request to discontinue study treatment|0|||
127874764|NCT03110107|460161891|FG014|Treatment Period|Participant request to discontinue study treatment|0|||
127874765|NCT03110107|460161892|FG015|Treatment Period|Participant request to discontinue study treatment|0|||
127874766|NCT03110107|460161893|FG016|Treatment Period|Participant request to discontinue study treatment|0|||
127874767|NCT03110107|460161894|FG017|Treatment Period|Participant request to discontinue study treatment|0|||
127874768|NCT03110107|460161895|FG018|Treatment Period|Participant request to discontinue study treatment|0|||
127874769|NCT03110107|460161896|FG019|Treatment Period|Participant request to discontinue study treatment|0|||
127874770|NCT03110107|460161897|FG020|Treatment Period|Participant request to discontinue study treatment|0|||
127874771|NCT03110107|460161898|FG021|Treatment Period|Participant request to discontinue study treatment|0|||
127541984|NCT01001221|458951073|FG003|Overall Study|Other|0|||
127541985|NCT01001221|458951074|FG004|Overall Study|Other|0|||
127541986|NCT01001221|458951070|FG000|Overall Study|Not treated; protocol exclusion|0|||
127541987|NCT01001221|458951071|FG001|Overall Study|Not treated; protocol exclusion|0|||
127541988|NCT01001221|458951072|FG002|Overall Study|Not treated; protocol exclusion|1|||
127541989|NCT01001221|458951073|FG003|Overall Study|Not treated; protocol exclusion|0|||
127541990|NCT01001221|458951074|FG004|Overall Study|Not treated; protocol exclusion|0|||
127541991|NCT02388269|458951075|FG000|Overall Study|Adverse Event|2|||
127541992|NCT02388269|458951076|FG001|Overall Study|Adverse Event|0|||
127541993|NCT02388269|458951077|FG002|Overall Study|Adverse Event|0|||
127541994|NCT02388269|458951075|FG000|Overall Study|Withdrawal by Subject|1|||
127541995|NCT02388269|458951076|FG001|Overall Study|Withdrawal by Subject|2|||
127541996|NCT02388269|458951077|FG002|Overall Study|Withdrawal by Subject|0|||
127541997|NCT02388269|458951075|FG000|Overall Study|less than 50% stimulations|1|||
127541998|NCT02388269|458951076|FG001|Overall Study|less than 50% stimulations|0|||
127541999|NCT02388269|458951077|FG002|Overall Study|less than 50% stimulations|0|||
127542000|NCT02388269|458951075|FG000|Overall Study|no diary data|3|||
127542001|NCT02388269|458951076|FG001|Overall Study|no diary data|0|||
127542002|NCT02388269|458951077|FG002|Overall Study|no diary data|0|||
127542003|NCT02388269|458951075|FG000|Overall Study|Protocol Violation|2|||
127542004|NCT02388269|458951076|FG001|Overall Study|Protocol Violation|0|||
127542005|NCT02388269|458951077|FG002|Overall Study|Protocol Violation|0|||
127542006|NCT02388269|458951075|FG000|Overall Study|Screen Failure|0|||
127542007|NCT02388269|458951076|FG001|Overall Study|Screen Failure|0|||
127542008|NCT02388269|458951077|FG002|Overall Study|Screen Failure|10|||
127542009|NCT03448406|458951078|FG000|Overall Study|Noncompliance of scheduled visits|1|||
127542010|NCT03448406|458951079|FG001|Overall Study|Noncompliance of scheduled visits|2|||
127542011|NCT03448406|458951078|FG000|Overall Study|Withdrawal by Subject|1|||
127542012|NCT03448406|458951079|FG001|Overall Study|Withdrawal by Subject|2|||
127542013|NCT03448406|458951078|FG000|Overall Study|Protocol Violation|1|||
127542014|NCT03448406|458951079|FG001|Overall Study|Protocol Violation|0|||
127542015|NCT03448406|458951078|FG000|Overall Study|Adverse Event|8|||
127651836|NCT02801669|459347480|FG001|Overall Study|Death|69|||
127651837|NCT02801669|459347479|FG000|Overall Study|Withdrawal by Subject|81|||
127651838|NCT02801669|459347480|FG001|Overall Study|Withdrawal by Subject|77|||
127651839|NCT02801669|459347479|FG000|Overall Study|Other|4|||
127651840|NCT02801669|459347480|FG001|Overall Study|Other|6|||
127651841|NCT01966003|459347481|FG000|Overall Study|Death|43|||
127651842|NCT01966003|459347482|FG001|Overall Study|Death|36|||
127651843|NCT01966003|459347481|FG000|Overall Study|Protocol Violation|6|||
127651844|NCT01966003|459347482|FG001|Overall Study|Protocol Violation|4|||
127651845|NCT01966003|459347481|FG000|Overall Study|Lost to Follow-up|4|||
127651846|NCT01966003|459347482|FG001|Overall Study|Lost to Follow-up|3|||
127651847|NCT01966003|459347481|FG000|Overall Study|Physician Decision|12|||
127651848|NCT01966003|459347482|FG001|Overall Study|Physician Decision|13|||
127651849|NCT01966003|459347481|FG000|Overall Study|Withdrawal by Subject|29|||
127651850|NCT01966003|459347482|FG001|Overall Study|Withdrawal by Subject|19|||
127651851|NCT01966003|459347481|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
127651852|NCT01966003|459347482|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
127651853|NCT01966003|459347481|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
127651854|NCT01966003|459347482|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
127651855|NCT01966003|459347481|FG000|Overall Study|Other|1|||
127651856|NCT01966003|459347482|FG001|Overall Study|Other|1|||
127651857|NCT02696564|459347483|FG000|Overall Study|Death|1|||
127651858|NCT02696564|459347484|FG001|Overall Study|Death|2|||
127651859|NCT02696564|459347483|FG000|Overall Study|Withdrawal by Subject|3|||
127651860|NCT02696564|459347484|FG001|Overall Study|Withdrawal by Subject|2|||
127651861|NCT02696564|459347483|FG000|Overall Study|Lost to Follow-up|3|||
127651862|NCT02696564|459347484|FG001|Overall Study|Lost to Follow-up|3|||
127651863|NCT02696564|459347483|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
127651864|NCT02696564|459347484|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
127651865|NCT02696564|459347483|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
127651866|NCT02696564|459347484|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
127651867|NCT02696564|459347483|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
127651868|NCT02696564|459347484|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
127651869|NCT02696564|459347483|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
127651870|NCT02696564|459347484|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
127651871|NCT02696564|459347483|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
127651872|NCT02696564|459347484|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
127651873|NCT03633929|459347486|FG000|Overall Study|Lost to Follow-up|1|||
127651874|NCT03633929|459347486|FG000|Overall Study|Did not login to software. Did not participate|3|||
127651875|NCT04461795|459347487|FG000|Overall Study|Lost to Follow-up|2|||
127651876|NCT04461795|459347487|FG000|Overall Study|Withdrawal by Subject|2|||
127651877|NCT04461795|459347487|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
127651878|NCT02287584|459347488|FG000|the Double-blind Phase|Adverse Event|17|||
127651879|NCT02287584|459347489|FG001|the Double-blind Phase|Adverse Event|17|||
127651880|NCT02287584|459347490|FG002|the Double-blind Phase|Adverse Event|12|||
127651881|NCT02287584|459347491|FG003|the Double-blind Phase|Adverse Event|0|||
127651882|NCT02287584|459347492|FG004|the Double-blind Phase|Adverse Event|0|||
127651883|NCT02287584|459347493|FG005|the Double-blind Phase|Adverse Event|0|||
127651884|NCT02287584|459347488|FG000|the Double-blind Phase|Lack of Efficacy|18|||
127651885|NCT02287584|459347489|FG001|the Double-blind Phase|Lack of Efficacy|8|||
127651886|NCT02287584|459347490|FG002|the Double-blind Phase|Lack of Efficacy|8|||
127651887|NCT02287584|459347491|FG003|the Double-blind Phase|Lack of Efficacy|0|||
127651888|NCT02287584|459347492|FG004|the Double-blind Phase|Lack of Efficacy|0|||
127651889|NCT02287584|459347493|FG005|the Double-blind Phase|Lack of Efficacy|0|||
127651890|NCT02287584|459347488|FG000|the Double-blind Phase|Lost to Follow-up|0|||
127651891|NCT02287584|459347489|FG001|the Double-blind Phase|Lost to Follow-up|1|||
127651892|NCT02287584|459347490|FG002|the Double-blind Phase|Lost to Follow-up|1|||
127651893|NCT02287584|459347491|FG003|the Double-blind Phase|Lost to Follow-up|0|||
127651894|NCT02287584|459347492|FG004|the Double-blind Phase|Lost to Follow-up|0|||
127651895|NCT02287584|459347493|FG005|the Double-blind Phase|Lost to Follow-up|0|||
127651896|NCT02287584|459347488|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
127651897|NCT02287584|459347489|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
127651898|NCT02287584|459347490|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
127651899|NCT02287584|459347491|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
127651900|NCT02287584|459347492|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
127651901|NCT02287584|459347493|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
127651902|NCT02287584|459347488|FG000|the Double-blind Phase|Pregnancy|0|||
127651903|NCT02287584|459347489|FG001|the Double-blind Phase|Pregnancy|1|||
127651904|NCT02287584|459347490|FG002|the Double-blind Phase|Pregnancy|0|||
127651905|NCT02287584|459347491|FG003|the Double-blind Phase|Pregnancy|0|||
127651906|NCT02287584|459347492|FG004|the Double-blind Phase|Pregnancy|0|||
127651907|NCT02287584|459347493|FG005|the Double-blind Phase|Pregnancy|0|||
127651908|NCT02287584|459347488|FG000|the Double-blind Phase|Protocol Violation|0|||
127651909|NCT02287584|459347489|FG001|the Double-blind Phase|Protocol Violation|3|||
127651910|NCT02287584|459347490|FG002|the Double-blind Phase|Protocol Violation|0|||
127651911|NCT02287584|459347491|FG003|the Double-blind Phase|Protocol Violation|0|||
127651912|NCT02287584|459347492|FG004|the Double-blind Phase|Protocol Violation|0|||
127542016|NCT03448406|458951079|FG001|Overall Study|Adverse Event|9|||
127542017|NCT03186209|458951084|FG000|Overall Study|Withdrawal by Subject|11|||
127542018|NCT03186209|458951085|FG001|Overall Study|Withdrawal by Subject|22|||
127542019|NCT03186209|458951084|FG000|Overall Study|Pregnancy|1|||
127542020|NCT03186209|458951085|FG001|Overall Study|Pregnancy|0|||
127542021|NCT03186209|458951084|FG000|Overall Study|Adverse Event|4|||
127542022|NCT03186209|458951085|FG001|Overall Study|Adverse Event|0|||
127542023|NCT03186209|458951084|FG000|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|1|||
127542024|NCT03186209|458951085|FG001|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|0|||
127542025|NCT03186209|458951084|FG000|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|0|||
127542026|NCT03186209|458951085|FG001|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|2|||
127542027|NCT03186209|458951084|FG000|Overall Study|Fail to meet randomization criteria|0|||
127542028|NCT03186209|458951085|FG001|Overall Study|Fail to meet randomization criteria|1|||
127542029|NCT03186209|458951084|FG000|Overall Study|Lost to Follow-up|0|||
127542030|NCT03186209|458951085|FG001|Overall Study|Lost to Follow-up|1|||
127542031|NCT03796728|458951087|FG000|Overall Study|Lost to Follow-up|8|||
127542032|NCT03796728|458951087|FG000|Overall Study|Reason not Specified|16|||
127542033|NCT00333775|458951088|FG000|Overall Study|Death|144|||
127542034|NCT00333775|458951089|FG001|Overall Study|Death|149|||
127542035|NCT00333775|458951090|FG002|Overall Study|Death|143|||
127542036|NCT00333775|458951088|FG000|Overall Study|In Follow-up When Study Stopped|87|||
127542037|NCT00333775|458951089|FG001|Overall Study|In Follow-up When Study Stopped|92|||
127542038|NCT00333775|458951090|FG002|Overall Study|In Follow-up When Study Stopped|96|||
127542039|NCT00333775|458951088|FG000|Overall Study|Lost to Follow-up|10|||
127542040|NCT00333775|458951089|FG001|Overall Study|Lost to Follow-up|7|||
127542041|NCT00333775|458951090|FG002|Overall Study|Lost to Follow-up|8|||
127542042|NCT01383928|458951094|FG000|Overall Study|Initiation of ASCT|2|||
127542043|NCT01383928|458951095|FG001|Overall Study|Initiation of ASCT|1|||
127542044|NCT01383928|458951096|FG002|Overall Study|Initiation of ASCT|18|||
127542045|NCT01383928|458951094|FG000|Overall Study|Adverse Event|1|||
127542046|NCT01383928|458951095|FG001|Overall Study|Adverse Event|2|||
127542047|NCT01383928|458951096|FG002|Overall Study|Adverse Event|8|||
127542048|NCT01383928|458951094|FG000|Overall Study|Other|1|||
127542049|NCT01383928|458951095|FG001|Overall Study|Other|3|||
127542050|NCT01383928|458951096|FG002|Overall Study|Other|4|||
127542051|NCT01383928|458951094|FG000|Overall Study|Progressive Disease|1|||
127542052|NCT01383928|458951095|FG001|Overall Study|Progressive Disease|1|||
127542053|NCT01383928|458951096|FG002|Overall Study|Progressive Disease|5|||
127542054|NCT01383928|458951094|FG000|Overall Study|Withdrawal by Subject|0|||
127542055|NCT01383928|458951095|FG001|Overall Study|Withdrawal by Subject|0|||
127542056|NCT01383928|458951096|FG002|Overall Study|Withdrawal by Subject|4|||
127542057|NCT01383928|458951094|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
127542058|NCT01383928|458951095|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
127542059|NCT01383928|458951096|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
127542060|NCT02242942|458951104|FG000|Overall Study|Death|17|||
127542061|NCT02242942|458951105|FG001|Overall Study|Death|20|||
127542062|NCT02242942|458951106|FG002|Overall Study|Death|2|||
127542063|NCT02242942|458951104|FG000|Overall Study|Physician Decision|1|||
127542064|NCT02242942|458951105|FG001|Overall Study|Physician Decision|0|||
127542065|NCT02242942|458951106|FG002|Overall Study|Physician Decision|0|||
127542066|NCT02242942|458951104|FG000|Overall Study|Withdrawal by Subject|8|||
127542067|NCT02242942|458951105|FG001|Overall Study|Withdrawal by Subject|10|||
127542068|NCT02242942|458951106|FG002|Overall Study|Withdrawal by Subject|0|||
127542069|NCT02242942|458951104|FG000|Overall Study|On-going in Study|190|||
127542070|NCT02242942|458951105|FG001|Overall Study|On-going in Study|186|||
127542071|NCT02242942|458951106|FG002|Overall Study|On-going in Study|11|||
127542072|NCT03259230|458951107|FG000|Overall Study|Excluded from the Malignancy Analysis Set|1|||
127542073|NCT03259230|458951108|FG001|Overall Study|Excluded from the Malignancy Analysis Set|0|||
127542074|NCT04842747|458951111|FG000|Overall Study|Withdrawal by Subject|6|||
127542075|NCT04842747|458951112|FG001|Overall Study|Withdrawal by Subject|2|||
127542076|NCT04842747|458951111|FG000|Overall Study|Lost to Follow-up|1|||
127542077|NCT04842747|458951112|FG001|Overall Study|Lost to Follow-up|2|||
127542078|NCT04842747|458951111|FG000|Overall Study|Physician Decision|1|||
127542079|NCT04842747|458951112|FG001|Overall Study|Physician Decision|0|||
127542080|NCT04842747|458951111|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
127542081|NCT04842747|458951112|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
127874772|NCT03110107|460161899|FG022|Treatment Period|Participant request to discontinue study treatment|0|||
127542082|NCT01451606|458951115|FG000|Overall Study|Withdrawal by Subject|4|||
127542083|NCT01451606|458951116|FG001|Overall Study|Withdrawal by Subject|3|||
127542084|NCT02559622|458951119|FG000|Overall Study|Progressive disease|0|||
127651913|NCT02287584|459347493|FG005|the Double-blind Phase|Protocol Violation|0|||
127651914|NCT02287584|459347488|FG000|the Double-blind Phase|other reasons|0|||
127651915|NCT02287584|459347489|FG001|the Double-blind Phase|other reasons|0|||
127651916|NCT02287584|459347490|FG002|the Double-blind Phase|other reasons|1|||
127651917|NCT02287584|459347491|FG003|the Double-blind Phase|other reasons|0|||
127651918|NCT02287584|459347492|FG004|the Double-blind Phase|other reasons|0|||
127651919|NCT02287584|459347493|FG005|the Double-blind Phase|other reasons|0|||
127874773|NCT03110107|460161900|FG023|Treatment Period|Participant request to discontinue study treatment|0|||
127874774|NCT03110107|460161901|FG024|Treatment Period|Participant request to discontinue study treatment|3|||
127874775|NCT03110107|460161902|FG025|Treatment Period|Participant request to discontinue study treatment|0|||
127874776|NCT03110107|460161877|FG000|Treatment Period|Participant withdrew consent|0|||
127874777|NCT03110107|460161878|FG001|Treatment Period|Participant withdrew consent|0|||
127874778|NCT03110107|460161879|FG002|Treatment Period|Participant withdrew consent|1|||
127874779|NCT03110107|460161880|FG003|Treatment Period|Participant withdrew consent|0|||
127874780|NCT03110107|460161881|FG004|Treatment Period|Participant withdrew consent|4|||
127874781|NCT03110107|460161882|FG005|Treatment Period|Participant withdrew consent|3|||
127874782|NCT03110107|460161883|FG006|Treatment Period|Participant withdrew consent|0|||
127874783|NCT03110107|460161884|FG007|Treatment Period|Participant withdrew consent|0|||
127874784|NCT03110107|460161885|FG008|Treatment Period|Participant withdrew consent|0|||
127874785|NCT03110107|460161886|FG009|Treatment Period|Participant withdrew consent|1|||
127874786|NCT03110107|460161887|FG010|Treatment Period|Participant withdrew consent|0|||
127874787|NCT03110107|460161888|FG011|Treatment Period|Participant withdrew consent|0|||
127874788|NCT03110107|460161889|FG012|Treatment Period|Participant withdrew consent|0|||
127874789|NCT03110107|460161890|FG013|Treatment Period|Participant withdrew consent|0|||
127874790|NCT03110107|460161891|FG014|Treatment Period|Participant withdrew consent|0|||
127874791|NCT03110107|460161892|FG015|Treatment Period|Participant withdrew consent|0|||
127874792|NCT03110107|460161893|FG016|Treatment Period|Participant withdrew consent|0|||
127874793|NCT03110107|460161894|FG017|Treatment Period|Participant withdrew consent|0|||
127874794|NCT03110107|460161895|FG018|Treatment Period|Participant withdrew consent|0|||
127874795|NCT03110107|460161896|FG019|Treatment Period|Participant withdrew consent|1|||
127874796|NCT03110107|460161897|FG020|Treatment Period|Participant withdrew consent|0|||
127874797|NCT03110107|460161898|FG021|Treatment Period|Participant withdrew consent|2|||
127874798|NCT03110107|460161899|FG022|Treatment Period|Participant withdrew consent|0|||
127874799|NCT03110107|460161900|FG023|Treatment Period|Participant withdrew consent|0|||
127874800|NCT03110107|460161901|FG024|Treatment Period|Participant withdrew consent|0|||
127874801|NCT03110107|460161902|FG025|Treatment Period|Participant withdrew consent|2|||
127874802|NCT03110107|460161877|FG000|Treatment Period|Participants no longer meets study criteria|0|||
127874803|NCT03110107|460161878|FG001|Treatment Period|Participants no longer meets study criteria|0|||
127874804|NCT03110107|460161879|FG002|Treatment Period|Participants no longer meets study criteria|0|||
127874805|NCT03110107|460161880|FG003|Treatment Period|Participants no longer meets study criteria|0|||
127874806|NCT03110107|460161881|FG004|Treatment Period|Participants no longer meets study criteria|0|||
127874807|NCT03110107|460161882|FG005|Treatment Period|Participants no longer meets study criteria|0|||
127874808|NCT03110107|460161883|FG006|Treatment Period|Participants no longer meets study criteria|0|||
127874809|NCT03110107|460161884|FG007|Treatment Period|Participants no longer meets study criteria|0|||
127874810|NCT03110107|460161885|FG008|Treatment Period|Participants no longer meets study criteria|0|||
127874811|NCT03110107|460161886|FG009|Treatment Period|Participants no longer meets study criteria|0|||
127874812|NCT03110107|460161887|FG010|Treatment Period|Participants no longer meets study criteria|0|||
127874813|NCT03110107|460161888|FG011|Treatment Period|Participants no longer meets study criteria|0|||
127874814|NCT03110107|460161889|FG012|Treatment Period|Participants no longer meets study criteria|0|||
127874815|NCT03110107|460161890|FG013|Treatment Period|Participants no longer meets study criteria|0|||
127874816|NCT03110107|460161891|FG014|Treatment Period|Participants no longer meets study criteria|0|||
127874817|NCT03110107|460161892|FG015|Treatment Period|Participants no longer meets study criteria|0|||
127651920|NCT02287584|459347488|FG000|the Open-label Phase|Did not receive drug|0|||
127651921|NCT02287584|459347489|FG001|the Open-label Phase|Did not receive drug|0|||
127651922|NCT02287584|459347490|FG002|the Open-label Phase|Did not receive drug|0|||
127651923|NCT02287584|459347491|FG003|the Open-label Phase|Did not receive drug|7|||
127651924|NCT02287584|459347492|FG004|the Open-label Phase|Did not receive drug|6|||
127651925|NCT02287584|459347493|FG005|the Open-label Phase|Did not receive drug|4|||
127651926|NCT02287584|459347488|FG000|the Open-label Phase|Adverse Event|0|||
127651927|NCT02287584|459347489|FG001|the Open-label Phase|Adverse Event|0|||
127651928|NCT02287584|459347490|FG002|the Open-label Phase|Adverse Event|0|||
127651929|NCT02287584|459347491|FG003|the Open-label Phase|Adverse Event|15|||
127651930|NCT02287584|459347492|FG004|the Open-label Phase|Adverse Event|12|||
127651931|NCT02287584|459347493|FG005|the Open-label Phase|Adverse Event|16|||
127651932|NCT02287584|459347488|FG000|the Open-label Phase|Lack of Efficacy|0|||
127874818|NCT03110107|460161893|FG016|Treatment Period|Participants no longer meets study criteria|0|||
127874819|NCT03110107|460161894|FG017|Treatment Period|Participants no longer meets study criteria|0|||
127874820|NCT03110107|460161895|FG018|Treatment Period|Participants no longer meets study criteria|0|||
127874821|NCT03110107|460161896|FG019|Treatment Period|Participants no longer meets study criteria|0|||
127874822|NCT03110107|460161897|FG020|Treatment Period|Participants no longer meets study criteria|0|||
127874823|NCT03110107|460161898|FG021|Treatment Period|Participants no longer meets study criteria|0|||
127874824|NCT03110107|460161899|FG022|Treatment Period|Participants no longer meets study criteria|0|||
127874825|NCT03110107|460161900|FG023|Treatment Period|Participants no longer meets study criteria|1|||
127874826|NCT03110107|460161901|FG024|Treatment Period|Participants no longer meets study criteria|0|||
127874827|NCT03110107|460161902|FG025|Treatment Period|Participants no longer meets study criteria|0|||
127874828|NCT03110107|460161877|FG000|Treatment Period|Other Reasons|0|||
127874829|NCT03110107|460161878|FG001|Treatment Period|Other Reasons|0|||
127874830|NCT03110107|460161879|FG002|Treatment Period|Other Reasons|1|||
127874831|NCT03110107|460161880|FG003|Treatment Period|Other Reasons|1|||
127874832|NCT03110107|460161881|FG004|Treatment Period|Other Reasons|0|||
127874833|NCT03110107|460161882|FG005|Treatment Period|Other Reasons|1|||
127874834|NCT03110107|460161883|FG006|Treatment Period|Other Reasons|0|||
127874835|NCT03110107|460161884|FG007|Treatment Period|Other Reasons|0|||
127874836|NCT03110107|460161885|FG008|Treatment Period|Other Reasons|0|||
127874837|NCT03110107|460161886|FG009|Treatment Period|Other Reasons|0|||
127874838|NCT03110107|460161887|FG010|Treatment Period|Other Reasons|0|||
127874839|NCT03110107|460161888|FG011|Treatment Period|Other Reasons|0|||
127874840|NCT03110107|460161889|FG012|Treatment Period|Other Reasons|0|||
127874841|NCT03110107|460161890|FG013|Treatment Period|Other Reasons|0|||
127874842|NCT03110107|460161891|FG014|Treatment Period|Other Reasons|0|||
127874843|NCT03110107|460161892|FG015|Treatment Period|Other Reasons|0|||
127874844|NCT03110107|460161893|FG016|Treatment Period|Other Reasons|0|||
127874845|NCT03110107|460161894|FG017|Treatment Period|Other Reasons|0|||
127874846|NCT03110107|460161895|FG018|Treatment Period|Other Reasons|0|||
127874847|NCT03110107|460161896|FG019|Treatment Period|Other Reasons|0|||
127874848|NCT03110107|460161897|FG020|Treatment Period|Other Reasons|0|||
127874849|NCT03110107|460161898|FG021|Treatment Period|Other Reasons|0|||
127874850|NCT03110107|460161899|FG022|Treatment Period|Other Reasons|0|||
127874851|NCT03110107|460161900|FG023|Treatment Period|Other Reasons|0|||
127874852|NCT03110107|460161901|FG024|Treatment Period|Other Reasons|1|||
127874853|NCT03110107|460161902|FG025|Treatment Period|Other Reasons|0|||
127874854|NCT03586427|460161909|FG000|Overall Study|Lost to Follow-up|0|||
127874855|NCT03586427|460161910|FG001|Overall Study|Lost to Follow-up|3|||
127874856|NCT03586427|460161911|FG002|Overall Study|Lost to Follow-up|1|||
127874857|NCT03586427|460161912|FG003|Overall Study|Lost to Follow-up|3|||
127874858|NCT03586427|460161913|FG004|Overall Study|Lost to Follow-up|3|||
127874859|NCT03586427|460161909|FG000|Overall Study|Withdrawal by Subject|0|||
127874860|NCT03586427|460161910|FG001|Overall Study|Withdrawal by Subject|1|||
127874861|NCT03586427|460161911|FG002|Overall Study|Withdrawal by Subject|2|||
127874862|NCT03586427|460161912|FG003|Overall Study|Withdrawal by Subject|1|||
127874863|NCT03586427|460161913|FG004|Overall Study|Withdrawal by Subject|1|||
127874864|NCT03586427|460161909|FG000|Overall Study|Adverse Event|0|||
127874865|NCT03586427|460161910|FG001|Overall Study|Adverse Event|0|||
127874866|NCT03586427|460161911|FG002|Overall Study|Adverse Event|1|||
127874867|NCT03586427|460161912|FG003|Overall Study|Adverse Event|0|||
127874868|NCT03586427|460161913|FG004|Overall Study|Adverse Event|0|||
127874869|NCT03586427|460161909|FG000|Overall Study|Protocol Violation|0|||
127874870|NCT03586427|460161910|FG001|Overall Study|Protocol Violation|0|||
127874871|NCT03586427|460161911|FG002|Overall Study|Protocol Violation|1|||
127874872|NCT03586427|460161912|FG003|Overall Study|Protocol Violation|0|||
127874873|NCT03586427|460161913|FG004|Overall Study|Protocol Violation|1|||
127874874|NCT03586427|460161909|FG000|Overall Study|Noncompliance with study drug|0|||
127874875|NCT03586427|460161910|FG001|Overall Study|Noncompliance with study drug|0|||
127874876|NCT03586427|460161911|FG002|Overall Study|Noncompliance with study drug|1|||
127874877|NCT03586427|460161912|FG003|Overall Study|Noncompliance with study drug|0|||
127874878|NCT03586427|460161913|FG004|Overall Study|Noncompliance with study drug|0|||
127874879|NCT03193996|460161914|FG000|Overall Study|Withdrawal by Subject|4|||
127874880|NCT03193996|460161914|FG000|Overall Study|Lost to Follow-up|4|||
127874881|NCT03193996|460161914|FG000|Overall Study|Physician Decision|2|||
127874882|NCT03193996|460161914|FG000|Overall Study|Pregnancy|1|||
127542085|NCT02559622|458951120|FG001|Overall Study|Progressive disease|1|||
127542086|NCT02559622|458951121|FG002|Overall Study|Progressive disease|0|||
127874883|NCT03193996|460161914|FG000|Overall Study|Subject did not proceed to reconstructive surgery.|1|||
127874884|NCT03193996|460161914|FG000|Overall Study|Complicating disease|1|||
127874885|NCT00494234|460161915|FG000|Overall Study|Withdrawal by Subject|1|||
127874886|NCT00494234|460161916|FG001|Overall Study|Withdrawal by Subject|0|||
127874887|NCT00494234|460161915|FG000|Overall Study|Disease progression|11|||
127874888|NCT00494234|460161916|FG001|Overall Study|Disease progression|8|||
127874889|NCT00494234|460161915|FG000|Overall Study|Death|2|||
127874890|NCT00494234|460161916|FG001|Overall Study|Death|1|||
127874891|NCT00423137|460161917|FG000|Overall Study|Lost to Follow-up|0|||
127874892|NCT00423137|460161918|FG001|Overall Study|Lost to Follow-up|0|||
127874893|NCT00423137|460161919|FG002|Overall Study|Lost to Follow-up|1|||
127874894|NCT00423137|460161920|FG003|Overall Study|Lost to Follow-up|0|||
127542087|NCT02559622|458951122|FG003|Overall Study|Progressive disease|0|||
127874895|NCT00423137|460161917|FG000|Overall Study|Protocol Violation|0|||
127874896|NCT00423137|460161918|FG001|Overall Study|Protocol Violation|0|||
127874897|NCT00423137|460161919|FG002|Overall Study|Protocol Violation|0|||
127874898|NCT00423137|460161920|FG003|Overall Study|Protocol Violation|1|||
127874899|NCT00423137|460161917|FG000|Overall Study|Adverse Event Study disease worse|1|||
127874900|NCT00423137|460161918|FG001|Overall Study|Adverse Event Study disease worse|0|||
127874901|NCT00423137|460161919|FG002|Overall Study|Adverse Event Study disease worse|3|||
127874902|NCT00423137|460161920|FG003|Overall Study|Adverse Event Study disease worse|1|||
127874903|NCT00423137|460161917|FG000|Overall Study|Adverse Event Other|0|||
127874904|NCT00423137|460161918|FG001|Overall Study|Adverse Event Other|0|||
127874905|NCT00423137|460161919|FG002|Overall Study|Adverse Event Other|2|||
127874906|NCT00423137|460161920|FG003|Overall Study|Adverse Event Other|0|||
127874907|NCT00593385|460161922|FG000|Overall Study|Death|14|||
127874908|NCT00593385|460161922|FG000|Overall Study|Lost to Follow-up|17|||
127874909|NCT00593385|460161922|FG000|Overall Study|Withdrawal by Subject|9|||
127874910|NCT01471197|460161923|FG000|Overall Study|Disease Progression|4|||
127874911|NCT01471197|460161924|FG001|Overall Study|Disease Progression|2|||
127874912|NCT01471197|460161923|FG000|Overall Study|Death|1|||
127874913|NCT01471197|460161924|FG001|Overall Study|Death|0|||
127874914|NCT01471197|460161923|FG000|Overall Study|Study Drug Toxicity|1|||
127874915|NCT01471197|460161924|FG001|Overall Study|Study Drug Toxicity|0|||
127874916|NCT00924313|460161930|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
127874917|NCT01012609|460161931|FG000|Overall Study|Withdrawal by Subject|1|||
127874918|NCT01012609|460161932|FG001|Overall Study|Withdrawal by Subject|1|||
127874919|NCT00483119|460161933|FG000|Overall Study|Adverse Event|0|||
127874920|NCT00483119|460161934|FG001|Overall Study|Adverse Event|1|||
127874921|NCT00483119|460161933|FG000|Overall Study|Physician Decision|1|||
127874922|NCT00483119|460161934|FG001|Overall Study|Physician Decision|0|||
127874923|NCT03426995|460161935|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
127874924|NCT03426995|460161936|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
127874925|NCT03426995|460161937|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
127874926|NCT03426995|460161938|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
127874927|NCT03426995|460161939|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
127874928|NCT03426995|460161940|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
127874929|NCT03426995|460161941|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
127874930|NCT03426995|460161942|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
127874931|NCT03426995|460161943|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
127874932|NCT03426995|460161944|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
127874933|NCT03426995|460161945|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
127874934|NCT03426995|460161946|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
127874935|NCT03426995|460161947|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
127874936|NCT03426995|460161948|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
127874937|NCT03426995|460161949|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
127874938|NCT03426995|460161950|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
127874939|NCT03426995|460161951|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
127874940|NCT03426995|460161952|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
127874941|NCT03426995|460161953|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
127874942|NCT03426995|460161935|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
127874943|NCT03426995|460161936|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
127874944|NCT03426995|460161937|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
127874945|NCT03426995|460161938|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
127874946|NCT03426995|460161939|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
127874947|NCT03426995|460161940|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
127874948|NCT03426995|460161941|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
127874949|NCT03426995|460161942|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
127874950|NCT03426995|460161943|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
127874951|NCT03426995|460161944|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
127874952|NCT03426995|460161945|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
127874953|NCT03426995|460161946|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
127874954|NCT03426995|460161947|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
127874955|NCT03426995|460161948|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
127874956|NCT03426995|460161949|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
127874957|NCT03426995|460161950|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
127874958|NCT03426995|460161951|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
127874959|NCT03426995|460161952|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
127874960|NCT03426995|460161953|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
127874961|NCT03426995|460161935|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
127651933|NCT02287584|459347489|FG001|the Open-label Phase|Lack of Efficacy|0|||
127874962|NCT03426995|460161936|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
127874963|NCT03426995|460161937|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
127874964|NCT03426995|460161938|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
127874965|NCT03426995|460161939|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
127874966|NCT03426995|460161940|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
127874967|NCT03426995|460161941|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
127874968|NCT03426995|460161942|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
127874969|NCT03426995|460161943|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
127874970|NCT03426995|460161944|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
127874971|NCT03426995|460161945|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
127874972|NCT03426995|460161946|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
127874973|NCT03426995|460161947|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
127874974|NCT03426995|460161948|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
127874975|NCT03426995|460161949|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
127874976|NCT03426995|460161950|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
127874977|NCT03426995|460161951|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
127874978|NCT03426995|460161952|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
127874979|NCT03426995|460161953|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
127874980|NCT03426995|460161935|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
127874981|NCT03426995|460161936|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
127874982|NCT03426995|460161937|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
127874983|NCT03426995|460161938|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
127874984|NCT03426995|460161939|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
127874985|NCT03426995|460161940|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
127874986|NCT03426995|460161941|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
127874987|NCT03426995|460161942|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
127874988|NCT03426995|460161943|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
127874989|NCT03426995|460161944|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
127874990|NCT03426995|460161945|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
127874991|NCT03426995|460161946|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
127874992|NCT03426995|460161947|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
127874993|NCT03426995|460161948|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
127874994|NCT03426995|460161949|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
127874995|NCT03426995|460161950|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
127874996|NCT03426995|460161951|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
127874997|NCT03426995|460161952|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
127874998|NCT03426995|460161953|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
127874999|NCT03426995|460161935|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
127875000|NCT03426995|460161936|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
127875001|NCT03426995|460161937|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
127875002|NCT03426995|460161938|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
127875003|NCT03426995|460161939|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
127875004|NCT03426995|460161940|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
127875005|NCT03426995|460161941|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
127875006|NCT03426995|460161942|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
127875007|NCT03426995|460161943|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
127875008|NCT03426995|460161944|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
127875009|NCT03426995|460161945|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
127875010|NCT03426995|460161946|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
127875011|NCT03426995|460161947|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
127875012|NCT03426995|460161948|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
127875013|NCT03426995|460161949|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
127875014|NCT03426995|460161950|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
127875015|NCT03426995|460161951|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
127875016|NCT03426995|460161952|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
127875017|NCT03426995|460161953|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
127875018|NCT03426995|460161935|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
127875019|NCT03426995|460161936|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
127875020|NCT03426995|460161937|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
127875021|NCT03426995|460161938|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
127875022|NCT03426995|460161939|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
127875023|NCT03426995|460161940|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
127875024|NCT03426995|460161941|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
127875025|NCT03426995|460161942|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
127875026|NCT03426995|460161943|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
127983730|NCT01764997|460562568|FG000|Run-in Period|Poor compliance to protocol|1|||
127875027|NCT03426995|460161944|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
127875028|NCT03426995|460161945|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
127875029|NCT03426995|460161946|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
127875030|NCT03426995|460161947|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
127875031|NCT03426995|460161948|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
127875032|NCT03426995|460161949|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
127875033|NCT03426995|460161950|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
127875034|NCT03426995|460161951|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
127875035|NCT03426995|460161952|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
127875036|NCT03426995|460161953|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
127875037|NCT03426995|460161935|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
127875038|NCT03426995|460161936|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
127875039|NCT03426995|460161937|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
127875040|NCT03426995|460161938|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
127875041|NCT03426995|460161939|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
127875042|NCT03426995|460161940|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
127875043|NCT03426995|460161941|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
127875044|NCT03426995|460161942|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
127875045|NCT03426995|460161943|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
127875046|NCT03426995|460161944|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
127875047|NCT03426995|460161945|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
127875048|NCT03426995|460161946|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
127875049|NCT03426995|460161947|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
127875050|NCT03426995|460161948|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
127875051|NCT03426995|460161949|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
127875052|NCT03426995|460161950|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
127875053|NCT03426995|460161951|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
127875054|NCT03426995|460161952|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
127875055|NCT03426995|460161953|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
127875056|NCT05939388|460161954|FG000|Overall Study|Lost to Follow-up|1|||
127875057|NCT00885677|460161960|FG000|Overall Study|Death|40|||
127875058|NCT00885677|460161961|FG001|Overall Study|Death|34|||
127875059|NCT00885677|460161960|FG000|Overall Study|Lost to Follow-up|15|||
127875060|NCT00885677|460161961|FG001|Overall Study|Lost to Follow-up|13|||
127875061|NCT00885677|460161960|FG000|Overall Study|Protocol Violation|54|||
127875062|NCT00885677|460161961|FG001|Overall Study|Protocol Violation|54|||
127875063|NCT00885677|460161960|FG000|Overall Study|premature study closure|41|||
127875064|NCT00885677|460161961|FG001|Overall Study|premature study closure|44|||
127875065|NCT00885677|460161960|FG000|Overall Study|device/lead revision or replacement|7|||
127875066|NCT00885677|460161961|FG001|Overall Study|device/lead revision or replacement|6|||
127875067|NCT00885677|460161960|FG000|Overall Study|Heart transplantation|1|||
127875068|NCT00885677|460161961|FG001|Overall Study|Heart transplantation|0|||
127875069|NCT00885677|460161960|FG000|Overall Study|Inclusion/exclusion not met|25|||
127875070|NCT00885677|460161961|FG001|Overall Study|Inclusion/exclusion not met|27|||
127875071|NCT00972309|460161962|FG000|Overall Study|Switched to alternative treatment|0|||
127875072|NCT00972309|460161963|FG001|Overall Study|Switched to alternative treatment|2|||
127875073|NCT00972309|460161962|FG000|Overall Study|Refused further treatment|0|||
127875074|NCT00972309|460161963|FG001|Overall Study|Refused further treatment|1|||
127875075|NCT00972309|460161962|FG000|Overall Study|Late determination of ineligibility|0|||
127875076|NCT00972309|460161963|FG001|Overall Study|Late determination of ineligibility|1|||
127875077|NCT00972309|460161962|FG000|Overall Study|Second malignancy|1|||
127875078|NCT00972309|460161963|FG001|Overall Study|Second malignancy|1|||
127875079|NCT00972309|460161962|FG000|Overall Study|Visa issues|0|||
127875080|NCT00972309|460161963|FG001|Overall Study|Visa issues|1|||
127875081|NCT00972309|460161962|FG000|Overall Study|Secondary cancer (SCC)|0|||
127875082|NCT00972309|460161963|FG001|Overall Study|Secondary cancer (SCC)|1|||
127875083|NCT00972309|460161962|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
127875084|NCT00972309|460161963|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
127875085|NCT00972309|460161962|FG000|Overall Study|Lost to Follow-up|1|||
127875086|NCT00972309|460161963|FG001|Overall Study|Lost to Follow-up|1|||
127542088|NCT02559622|458951119|FG000|Overall Study|Adverse Event|0|||
127542089|NCT02559622|458951120|FG001|Overall Study|Adverse Event|2|||
127542090|NCT02559622|458951121|FG002|Overall Study|Adverse Event|2|||
127542091|NCT02559622|458951122|FG003|Overall Study|Adverse Event|2|||
127542092|NCT02559622|458951119|FG000|Overall Study|Patient/guardian decision|1|||
127542093|NCT02559622|458951120|FG001|Overall Study|Patient/guardian decision|2|||
127542094|NCT02559622|458951121|FG002|Overall Study|Patient/guardian decision|0|||
127875087|NCT00972309|460161962|FG000|Overall Study|Disease progression on study|10|||
127875088|NCT00972309|460161963|FG001|Overall Study|Disease progression on study|4|||
127542095|NCT02559622|458951122|FG003|Overall Study|Patient/guardian decision|1|||
127542096|NCT02163538|458951123|FG000|Overall Study|Protocol Violation|1|||
127875089|NCT00948896|460161964|FG000|Randomization to 24 Months of Age|Death|1|||
127875090|NCT00948896|460161965|FG001|Randomization to 24 Months of Age|Death|0|||
127875091|NCT00948896|460161966|FG002|Randomization to 24 Months of Age|Death|0|||
127875092|NCT00948896|460161967|FG003|Randomization to 24 Months of Age|Death|0|||
127875093|NCT00948896|460161968|FG004|Randomization to 24 Months of Age|Death|2|||
127875094|NCT00948896|460161969|FG005|Randomization to 24 Months of Age|Death|1|||
127875095|NCT00948896|460161970|FG006|Randomization to 24 Months of Age|Death|2|||
127875096|NCT00948896|460161971|FG007|Randomization to 24 Months of Age|Death|1|||
127875097|NCT00948896|460161964|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
127875098|NCT00948896|460161965|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
127875099|NCT00948896|460161966|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
127875100|NCT00948896|460161967|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
127875101|NCT00948896|460161968|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
127875102|NCT00948896|460161969|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
127875103|NCT00948896|460161970|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
127875104|NCT00948896|460161971|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
127875105|NCT00948896|460161964|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
127875106|NCT00948896|460161965|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
127875107|NCT00948896|460161966|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
127875108|NCT00948896|460161967|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
127875109|NCT00948896|460161968|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
127875110|NCT00948896|460161969|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
127875111|NCT00948896|460161970|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
127875112|NCT00948896|460161971|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
127875113|NCT00948896|460161964|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
127875114|NCT00948896|460161965|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
127875115|NCT00948896|460161966|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
127875116|NCT00948896|460161967|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
127875117|NCT00948896|460161968|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
127875118|NCT00948896|460161969|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
127875119|NCT00948896|460161970|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
127875120|NCT00948896|460161971|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
127875121|NCT00948896|460161964|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
127875122|NCT00948896|460161965|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
127875123|NCT00948896|460161966|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
127875124|NCT00948896|460161967|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
127875125|NCT00948896|460161968|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
127875126|NCT00948896|460161969|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
127875127|NCT00948896|460161970|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
127875128|NCT00948896|460161971|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
127875129|NCT00948896|460161964|FG000|24 Months of Age to 36 Months of Age|Death|0|||
127875130|NCT00948896|460161965|FG001|24 Months of Age to 36 Months of Age|Death|2|||
127875131|NCT00948896|460161966|FG002|24 Months of Age to 36 Months of Age|Death|2|||
127875132|NCT00948896|460161967|FG003|24 Months of Age to 36 Months of Age|Death|0|||
127875133|NCT00948896|460161968|FG004|24 Months of Age to 36 Months of Age|Death|0|||
127875134|NCT00948896|460161969|FG005|24 Months of Age to 36 Months of Age|Death|1|||
127875135|NCT00948896|460161970|FG006|24 Months of Age to 36 Months of Age|Death|0|||
127875136|NCT00948896|460161971|FG007|24 Months of Age to 36 Months of Age|Death|0|||
127875137|NCT00948896|460161964|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
127875138|NCT00948896|460161965|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
127875139|NCT00948896|460161966|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
127875140|NCT00948896|460161967|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
127875141|NCT00948896|460161968|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
127875142|NCT00948896|460161969|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
127875143|NCT00948896|460161970|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
127875144|NCT00948896|460161971|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
127875145|NCT00948896|460161964|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
127875146|NCT00948896|460161965|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
127875147|NCT00948896|460161966|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
127875148|NCT00948896|460161967|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
127875149|NCT00948896|460161968|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
127875150|NCT00948896|460161969|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
127875151|NCT00948896|460161970|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
127875152|NCT00948896|460161971|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
127875153|NCT00948896|460161964|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
127875154|NCT00948896|460161965|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
127875155|NCT00948896|460161966|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
127875156|NCT00948896|460161967|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
127875157|NCT00948896|460161968|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
127875158|NCT00948896|460161969|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
127875159|NCT00948896|460161970|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
127875160|NCT00948896|460161971|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
127875161|NCT00948896|460161964|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
127875162|NCT00948896|460161965|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
127875163|NCT00948896|460161966|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
127875164|NCT00948896|460161967|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
127875165|NCT00948896|460161968|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
127875166|NCT00948896|460161969|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
127875167|NCT00948896|460161970|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
127875168|NCT00948896|460161971|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
127875169|NCT03795233|460161972|FG000|Overall Study|Withdrawal by Subject|2|||
127875170|NCT03795233|460161973|FG001|Overall Study|Withdrawal by Subject|1|||
127875171|NCT03795233|460161972|FG000|Overall Study|Lost to Follow-up|1|||
127875172|NCT03795233|460161973|FG001|Overall Study|Lost to Follow-up|0|||
127875173|NCT03795233|460161972|FG000|Overall Study|Death|1|||
127875174|NCT03795233|460161973|FG001|Overall Study|Death|0|||
127875175|NCT01869959|460161977|FG000|Randomization Period|Physician Decision|0|||
127875176|NCT01869959|460161978|FG001|Randomization Period|Physician Decision|0|||
127875177|NCT01869959|460161979|FG002|Randomization Period|Physician Decision|0|||
127875178|NCT01869959|460161980|FG003|Randomization Period|Physician Decision|0|||
127875179|NCT01869959|460161981|FG004|Randomization Period|Physician Decision|1|||
127875180|NCT01869959|460161977|FG000|Treatment Period|Adverse Event|1|||
127875181|NCT01869959|460161978|FG001|Treatment Period|Adverse Event|0|||
127875182|NCT01869959|460161979|FG002|Treatment Period|Adverse Event|3|||
127875183|NCT01869959|460161980|FG003|Treatment Period|Adverse Event|1|||
127875184|NCT01869959|460161981|FG004|Treatment Period|Adverse Event|0|||
127875185|NCT01869959|460161977|FG000|Treatment Period|Sponsor decision|0|||
127875186|NCT01869959|460161978|FG001|Treatment Period|Sponsor decision|1|||
127875187|NCT01869959|460161979|FG002|Treatment Period|Sponsor decision|0|||
127875188|NCT01869959|460161980|FG003|Treatment Period|Sponsor decision|1|||
127875189|NCT01869959|460161981|FG004|Treatment Period|Sponsor decision|0|||
127875190|NCT01869959|460161977|FG000|Treatment Period|Withdrawal by Subject|0|||
127875191|NCT01869959|460161978|FG001|Treatment Period|Withdrawal by Subject|1|||
127875192|NCT01869959|460161979|FG002|Treatment Period|Withdrawal by Subject|0|||
127875193|NCT01869959|460161980|FG003|Treatment Period|Withdrawal by Subject|0|||
127875194|NCT01869959|460161981|FG004|Treatment Period|Withdrawal by Subject|0|||
127875195|NCT00828009|460161982|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
127875196|NCT00828009|460161982|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
127875197|NCT00828009|460161982|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
127875198|NCT00828009|460161982|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
127875199|NCT00828009|460161982|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
127875200|NCT00828009|460161982|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
127875201|NCT00828009|460161982|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
127875202|NCT00828009|460161982|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
127875203|NCT00828009|460161982|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
127875204|NCT00828009|460161982|FG000|Step 2 - Maintenance Therapy|Death|1|||
127875205|NCT00828009|460161982|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
127875206|NCT00828009|460161982|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
127875207|NCT00828009|460161982|FG000|Step 2 - Maintenance Therapy|Other|1|||
127875208|NCT00563706|460163645|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
127875209|NCT00563706|460163646|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
127875210|NCT00563706|460163647|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
127875211|NCT00563706|460163648|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
127875212|NCT00563706|460163649|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
127875213|NCT00563706|460163650|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
127875214|NCT00563706|460163651|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
127875215|NCT00563706|460163652|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
127875216|NCT00563706|460163653|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
127875217|NCT00563706|460163645|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
127875218|NCT00563706|460163646|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
127651934|NCT02287584|459347490|FG002|the Open-label Phase|Lack of Efficacy|0|||
127651935|NCT02287584|459347491|FG003|the Open-label Phase|Lack of Efficacy|8|||
127875219|NCT00563706|460163647|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
127875220|NCT00563706|460163648|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
127875221|NCT00563706|460163649|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
127875222|NCT00563706|460163650|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
127875223|NCT00563706|460163651|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
127875224|NCT00563706|460163652|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
127875225|NCT00563706|460163653|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
127875226|NCT00563706|460163645|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
127875227|NCT00563706|460163646|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
127875228|NCT00563706|460163647|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
127875229|NCT00563706|460163648|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
127875230|NCT00563706|460163649|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
127875231|NCT00563706|460163650|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
127875232|NCT00563706|460163651|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
127875233|NCT00563706|460163652|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
127875234|NCT00563706|460163653|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
127875235|NCT00563706|460163645|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
127875236|NCT00563706|460163646|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
127875237|NCT00563706|460163647|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
127875238|NCT00563706|460163648|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
127875239|NCT00563706|460163649|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
127875240|NCT00563706|460163650|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
127875241|NCT00563706|460163651|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
127875242|NCT00563706|460163652|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
127875243|NCT00563706|460163653|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
127875244|NCT00563706|460163645|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
127875245|NCT00563706|460163646|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
127875246|NCT00563706|460163647|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
127875247|NCT00563706|460163648|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
127875248|NCT00563706|460163649|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
127875249|NCT00563706|460163650|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
127875250|NCT00563706|460163651|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
127875251|NCT00563706|460163652|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
127875252|NCT00563706|460163653|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
127875253|NCT00700115|460163654|FG000|Overall Study|Withdrawal by Subject|1|||
127875254|NCT00700115|460163655|FG001|Overall Study|Withdrawal by Subject|0|||
127875255|NCT00700115|460163654|FG000|Overall Study|Lost to Follow-up|0|||
127875256|NCT00700115|460163655|FG001|Overall Study|Lost to Follow-up|1|||
127875257|NCT02983305|460163660|FG000|Overall Study|incomplete data|2|||
127875258|NCT02983305|460163661|FG001|Overall Study|incomplete data|0|||
127875259|NCT00822237|460163662|FG000|Dose 1 Vaccination|Not vaccinated|3|||
127875260|NCT00822237|460163663|FG001|Dose 1 Vaccination|Not vaccinated|0|||
127875261|NCT00822237|460163662|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
127875262|NCT00822237|460163663|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
127875263|NCT00822237|460163662|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
127875264|NCT00822237|460163663|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
127875265|NCT00822237|460163662|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
127875266|NCT00822237|460163663|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
127875267|NCT00822237|460163662|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
127875268|NCT00822237|460163663|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
127875269|NCT01646268|460163664|FG000|Overall Study|Adverse Event|6|||
127875270|NCT01646268|460163665|FG001|Overall Study|Adverse Event|7|||
127875271|NCT01646268|460163664|FG000|Overall Study|Lack of Efficacy|1|||
127875272|NCT01646268|460163665|FG001|Overall Study|Lack of Efficacy|3|||
127875273|NCT01646268|460163664|FG000|Overall Study|Protocol Violation|0|||
127875274|NCT01646268|460163665|FG001|Overall Study|Protocol Violation|1|||
127875275|NCT01646268|460163664|FG000|Overall Study|Withdrawal by Subject|2|||
127875276|NCT01646268|460163665|FG001|Overall Study|Withdrawal by Subject|5|||
127875277|NCT01646268|460163664|FG000|Overall Study|Other|2|||
127875278|NCT01646268|460163665|FG001|Overall Study|Other|0|||
127875279|NCT01519635|460163670|FG000|Overall Study|Withdrawal by Subject|0|||
127875280|NCT01519635|460163671|FG001|Overall Study|Withdrawal by Subject|1|||
127875281|NCT01519635|460163670|FG000|Overall Study|No possibility to put a catheter|1|||
127875282|NCT01519635|460163671|FG001|Overall Study|No possibility to put a catheter|2|||
127875283|NCT02325414|460163672|FG000|Overall Study|Withdrawal by Subject|3|||
127875284|NCT02325414|460163673|FG001|Overall Study|Withdrawal by Subject|1|||
127875285|NCT02325414|460163672|FG000|Overall Study|Lost to Follow-up|5|||
127875286|NCT02325414|460163673|FG001|Overall Study|Lost to Follow-up|5|||
127875287|NCT01339273|460163675|FG000|Overall Study|Lost to Follow-up|8|||
127875288|NCT01339273|460163676|FG001|Overall Study|Lost to Follow-up|8|||
127875289|NCT00726882|460163677|FG000|Overall Study|Withdrawal by Subject|5|||
127875290|NCT00726882|460163677|FG000|Overall Study|Lost to Follow-up|7|||
127875291|NCT00726882|460163677|FG000|Overall Study|Other|10|||
127875292|NCT00560573|460163678|FG000|Overall Study|Death|4|||
127875293|NCT00560573|460163679|FG001|Overall Study|Death|1|||
127875294|NCT00560573|460163680|FG002|Overall Study|Death|4|||
127875295|NCT00560573|460163681|FG003|Overall Study|Death|5|||
127875296|NCT00560573|460163682|FG004|Overall Study|Death|1|||
127875297|NCT00560573|460163683|FG005|Overall Study|Death|10|||
127875298|NCT00560573|460163678|FG000|Overall Study|Lost to Follow-up|0|||
127875299|NCT00560573|460163679|FG001|Overall Study|Lost to Follow-up|0|||
127875300|NCT00560573|460163680|FG002|Overall Study|Lost to Follow-up|0|||
127875301|NCT00560573|460163681|FG003|Overall Study|Lost to Follow-up|1|||
127875302|NCT00560573|460163682|FG004|Overall Study|Lost to Follow-up|1|||
127875303|NCT00560573|460163683|FG005|Overall Study|Lost to Follow-up|0|||
127875304|NCT00560573|460163678|FG000|Overall Study|Withdrawal by Subject|0|||
127875305|NCT00560573|460163679|FG001|Overall Study|Withdrawal by Subject|0|||
127875306|NCT00560573|460163680|FG002|Overall Study|Withdrawal by Subject|0|||
127875307|NCT00560573|460163681|FG003|Overall Study|Withdrawal by Subject|1|||
127875308|NCT00560573|460163682|FG004|Overall Study|Withdrawal by Subject|1|||
127875309|NCT00560573|460163683|FG005|Overall Study|Withdrawal by Subject|0|||
127875310|NCT00560573|460163678|FG000|Overall Study|Other|2|||
127875311|NCT00560573|460163679|FG001|Overall Study|Other|2|||
127875312|NCT00560573|460163680|FG002|Overall Study|Other|2|||
127875313|NCT00560573|460163681|FG003|Overall Study|Other|3|||
127875314|NCT00560573|460163682|FG004|Overall Study|Other|3|||
127875315|NCT00560573|460163683|FG005|Overall Study|Other|3|||
127875316|NCT00560573|460163678|FG000|Overall Study|Enrolled, not treated|0|||
127875317|NCT00560573|460163679|FG001|Overall Study|Enrolled, not treated|0|||
127875318|NCT00560573|460163680|FG002|Overall Study|Enrolled, not treated|0|||
127875319|NCT00560573|460163681|FG003|Overall Study|Enrolled, not treated|0|||
127875320|NCT00560573|460163682|FG004|Overall Study|Enrolled, not treated|1|||
127875321|NCT00560573|460163683|FG005|Overall Study|Enrolled, not treated|0|||
127875322|NCT00347776|460163684|FG000|1.5 Month Follow-up|Death|2|||
127875323|NCT00347776|460163685|FG001|1.5 Month Follow-up|Death|0|||
127875324|NCT00347776|460163686|FG002|1.5 Month Follow-up|Death|0|||
127875325|NCT00347776|460163684|FG000|1.5 Month Follow-up|reached the endpoint|12|||
127875326|NCT00347776|460163685|FG001|1.5 Month Follow-up|reached the endpoint|8|||
127875327|NCT00347776|460163686|FG002|1.5 Month Follow-up|reached the endpoint|12|||
127875328|NCT00347776|460163684|FG000|6 Month Follow-up|Death|2|||
127875329|NCT00347776|460163685|FG001|6 Month Follow-up|Death|1|||
127875330|NCT00347776|460163686|FG002|6 Month Follow-up|Death|3|||
127875331|NCT00347776|460163684|FG000|6 Month Follow-up|reached endpont|20|||
127875332|NCT00347776|460163685|FG001|6 Month Follow-up|reached endpont|12|||
127875333|NCT00347776|460163686|FG002|6 Month Follow-up|reached endpont|15|||
127875334|NCT00347776|460163684|FG000|12 Month Follow-up|Lost to Follow-up|7|||
127875335|NCT00347776|460163685|FG001|12 Month Follow-up|Lost to Follow-up|6|||
127875336|NCT00347776|460163686|FG002|12 Month Follow-up|Lost to Follow-up|6|||
127875337|NCT00347776|460163684|FG000|12 Month Follow-up|Death|3|||
127875338|NCT00347776|460163685|FG001|12 Month Follow-up|Death|4|||
127875339|NCT00347776|460163686|FG002|12 Month Follow-up|Death|4|||
127875340|NCT00347776|460163684|FG000|12 Month Follow-up|Reached endpoint|13|||
127875341|NCT00347776|460163685|FG001|12 Month Follow-up|Reached endpoint|6|||
127875342|NCT00347776|460163686|FG002|12 Month Follow-up|Reached endpoint|9|||
127875343|NCT00299546|460163687|FG000|Overall Study|Death|3|||
127875344|NCT00299546|460163688|FG001|Overall Study|Death|2|||
127875345|NCT00299546|460163689|FG002|Overall Study|Death|0|||
127875346|NCT00299546|460163687|FG000|Overall Study|Lost to Follow-up|2|||
127875347|NCT00299546|460163688|FG001|Overall Study|Lost to Follow-up|2|||
127875348|NCT00299546|460163689|FG002|Overall Study|Lost to Follow-up|5|||
127875349|NCT00299546|460163687|FG000|Overall Study|Adverse Event|37|||
127875350|NCT00299546|460163688|FG001|Overall Study|Adverse Event|22|||
127875351|NCT00299546|460163689|FG002|Overall Study|Adverse Event|27|||
127875352|NCT00299546|460163687|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
127875353|NCT00299546|460163688|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
127875354|NCT00299546|460163689|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
127875355|NCT00299546|460163687|FG000|Overall Study|Other|24|||
127875356|NCT00299546|460163688|FG001|Overall Study|Other|26|||
127875357|NCT00299546|460163689|FG002|Overall Study|Other|19|||
127875358|NCT00299546|460163687|FG000|Overall Study|Not treated|0|||
127875359|NCT00299546|460163688|FG001|Overall Study|Not treated|1|||
127983731|NCT01764997|460562569|FG001|Run-in Period|Poor compliance to protocol|0|||
127875360|NCT00299546|460163689|FG002|Overall Study|Not treated|1|||
127875361|NCT03099265|460163690|FG000|Overall Study|Adverse Event|1|||
127875362|NCT02526017|460163694|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
127875363|NCT02526017|460163695|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
127875364|NCT02526017|460163696|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
127875365|NCT02526017|460163697|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
127875366|NCT02526017|460163698|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
127875367|NCT02526017|460163699|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
127875368|NCT02526017|460163700|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
127875369|NCT02526017|460163701|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
127875370|NCT02526017|460163702|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
127875371|NCT00518531|460163704|FG000|Treatment Period 1|Adverse Event|5|||
127875372|NCT00518531|460163705|FG001|Treatment Period 1|Adverse Event|0|||
127875373|NCT00518531|460163704|FG000|Treatment Period 1|Lost to Follow-up|5|||
127875374|NCT00518531|460163705|FG001|Treatment Period 1|Lost to Follow-up|3|||
127875375|NCT00518531|460163704|FG000|Treatment Period 1|Physician Decision|1|||
127875376|NCT00518531|460163705|FG001|Treatment Period 1|Physician Decision|0|||
127875377|NCT00518531|460163704|FG000|Treatment Period 1|Protocol Violation|2|||
127875378|NCT00518531|460163705|FG001|Treatment Period 1|Protocol Violation|0|||
127875379|NCT00518531|460163704|FG000|Treatment Period 1|Withdrawal by Subject|4|||
127875380|NCT00518531|460163705|FG001|Treatment Period 1|Withdrawal by Subject|6|||
127875381|NCT00518531|460163704|FG000|Treatment Period 1|Early crossover|1|||
127875382|NCT00518531|460163705|FG001|Treatment Period 1|Early crossover|3|||
127875383|NCT00518531|460163704|FG000|Treatment Period 2|Withdrawal by Subject|0|||
127875384|NCT00518531|460163705|FG001|Treatment Period 2|Withdrawal by Subject|8|||
127875385|NCT00518531|460163704|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
127875386|NCT00518531|460163705|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
127875387|NCT00518531|460163704|FG000|Treatment Period 2|Adverse Event|1|||
127875388|NCT00518531|460163705|FG001|Treatment Period 2|Adverse Event|7|||
127875389|NCT00518531|460163704|FG000|Treatment Period 2|Protocol-specified criteria|0|||
127875390|NCT00518531|460163705|FG001|Treatment Period 2|Protocol-specified criteria|1|||
127875391|NCT00518531|460163704|FG000|Treatment Period 2|Non-compliance|1|||
127875392|NCT00518531|460163705|FG001|Treatment Period 2|Non-compliance|2|||
127875393|NCT00602927|460163708|FG000|Period 1: 13 Days|Protocol Violation|2|||
127875394|NCT00602927|460163709|FG001|Period 1: 13 Days|Protocol Violation|4|||
127875395|NCT00602927|460163708|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
127875396|NCT00602927|460163709|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
127875397|NCT00602927|460163708|FG000|Period 1: 13 Days|Time|1|||
127875398|NCT00602927|460163709|FG001|Period 1: 13 Days|Time|0|||
127875399|NCT00602927|460163708|FG000|Period 1: 13 Days|Claustrophobia|0|||
127875400|NCT00602927|460163709|FG001|Period 1: 13 Days|Claustrophobia|1|||
127875401|NCT00602927|460163708|FG000|Period 2: 14 Days|Protocol Violation|0|||
127875402|NCT00602927|460163709|FG001|Period 2: 14 Days|Protocol Violation|2|||
127875403|NCT00602927|460163708|FG000|Period 3: 13 Days|Protocol Violation|0|||
127875404|NCT00602927|460163709|FG001|Period 3: 13 Days|Protocol Violation|1|||
127875405|NCT00602927|460163708|FG000|Period 3: 13 Days|MRI data quality|2|||
127875406|NCT00602927|460163709|FG001|Period 3: 13 Days|MRI data quality|2|||
127875407|NCT01817764|460163712|FG000|Overall Study|Adverse Event|7|||
127875408|NCT01817764|460163713|FG001|Overall Study|Adverse Event|10|||
127875409|NCT01817764|460163712|FG000|Overall Study|Lack of Efficacy|9|||
127875410|NCT01817764|460163713|FG001|Overall Study|Lack of Efficacy|7|||
127875411|NCT01817764|460163712|FG000|Overall Study|Protocol Violation|7|||
127875412|NCT01817764|460163713|FG001|Overall Study|Protocol Violation|5|||
127875413|NCT01817764|460163712|FG000|Overall Study|Lost to Follow-up|1|||
127875414|NCT01817764|460163713|FG001|Overall Study|Lost to Follow-up|4|||
127875415|NCT01817764|460163712|FG000|Overall Study|Withdrawal by Subject|10|||
127875416|NCT01817764|460163713|FG001|Overall Study|Withdrawal by Subject|12|||
127875417|NCT04888377|460163714|FG000|Overall Study|Incomplete Follow-up or No Study Data|1|||
127875418|NCT04888377|460163715|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
127875419|NCT04888377|460163714|FG000|Overall Study|Physician Decision|6|||
127875420|NCT04888377|460163715|FG001|Overall Study|Physician Decision|6|||
127875421|NCT04888377|460163714|FG000|Overall Study|Withdrawal by Subject|7|||
127875422|NCT04888377|460163715|FG001|Overall Study|Withdrawal by Subject|3|||
127875423|NCT00526162|460163716|FG000|Overall Study|Device not implanted|3|||
127875424|NCT05993299|460163717|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
127875425|NCT05993299|460163717|FG000|Overall Study|Ongoing|4|||
127875426|NCT00478933|460163722|FG000|Overall Study|Protocol Violation|22|||
127875427|NCT00478933|460163722|FG000|Overall Study|Informed consent not verified|3|||
127875428|NCT00478933|460163722|FG000|Overall Study|Inadequate data available|53|||
127875429|NCT03772574|460163723|FG000|Overall Study|Protocol Violation|2|||
127875430|NCT03772574|460163724|FG001|Overall Study|Protocol Violation|0|||
127875431|NCT03772574|460163725|FG002|Overall Study|Protocol Violation|0|||
127875432|NCT03772574|460163723|FG000|Overall Study|Discomfort|0|||
127875433|NCT03772574|460163724|FG001|Overall Study|Discomfort|5|||
127875434|NCT03772574|460163725|FG002|Overall Study|Discomfort|4|||
127875435|NCT01298362|460163726|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
127875436|NCT01298362|460163727|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
127875437|NCT00762073|460163736|FG000|Overall Study|Lack of Efficacy|1|||
127875438|NCT00762073|460163737|FG001|Overall Study|Lack of Efficacy|1|||
127875439|NCT00762073|460163738|FG002|Overall Study|Lack of Efficacy|0|||
127875440|NCT00762073|460163739|FG003|Overall Study|Lack of Efficacy|0|||
127875441|NCT00762073|460163736|FG000|Overall Study|Adverse Event|1|||
127875442|NCT00762073|460163737|FG001|Overall Study|Adverse Event|0|||
127875443|NCT00762073|460163738|FG002|Overall Study|Adverse Event|1|||
127875444|NCT00762073|460163739|FG003|Overall Study|Adverse Event|1|||
127875445|NCT00762073|460163736|FG000|Overall Study|Significant Subject Noncompliance|0|||
127875446|NCT00762073|460163737|FG001|Overall Study|Significant Subject Noncompliance|1|||
127875447|NCT00762073|460163738|FG002|Overall Study|Significant Subject Noncompliance|0|||
127875448|NCT00762073|460163739|FG003|Overall Study|Significant Subject Noncompliance|1|||
127875449|NCT00762073|460163736|FG000|Overall Study|Withdrawal by Subject|1|||
127875450|NCT00762073|460163737|FG001|Overall Study|Withdrawal by Subject|2|||
127875451|NCT00762073|460163738|FG002|Overall Study|Withdrawal by Subject|1|||
127875452|NCT00762073|460163739|FG003|Overall Study|Withdrawal by Subject|1|||
127875453|NCT00762073|460163736|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
127875454|NCT00762073|460163737|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
127875455|NCT00762073|460163738|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
127875456|NCT00762073|460163739|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
127875457|NCT00491322|460163741|FG000|Overall Study|Protocol Violation|1|||
127875458|NCT00491322|460163742|FG001|Overall Study|Protocol Violation|0|||
127875459|NCT00491322|460163741|FG000|Overall Study|Pregnancy|0|||
127875460|NCT00491322|460163742|FG001|Overall Study|Pregnancy|1|||
127875461|NCT02331680|460163743|FG000|Overall Study|Adverse Event|3|||
127875462|NCT02331680|460163744|FG001|Overall Study|Adverse Event|0|||
127875463|NCT02331680|460163745|FG002|Overall Study|Adverse Event|2|||
127875464|NCT02331680|460163743|FG000|Overall Study|Physician Decision|1|||
127875465|NCT02331680|460163744|FG001|Overall Study|Physician Decision|1|||
127875466|NCT02331680|460163745|FG002|Overall Study|Physician Decision|2|||
127875467|NCT02331680|460163743|FG000|Overall Study|Withdrawal by Subject|0|||
127875468|NCT02331680|460163744|FG001|Overall Study|Withdrawal by Subject|1|||
127875469|NCT02331680|460163745|FG002|Overall Study|Withdrawal by Subject|2|||
127875470|NCT02331680|460163743|FG000|Overall Study|Met withdrawal criteria|2|||
127875471|NCT02331680|460163744|FG001|Overall Study|Met withdrawal criteria|2|||
127875472|NCT02331680|460163745|FG002|Overall Study|Met withdrawal criteria|5|||
127875473|NCT02331680|460163743|FG000|Overall Study|Non-compliance with study drug|0|||
127875474|NCT02331680|460163744|FG001|Overall Study|Non-compliance with study drug|0|||
127875475|NCT02331680|460163745|FG002|Overall Study|Non-compliance with study drug|1|||
127875476|NCT02331680|460163743|FG000|Overall Study|Protocol Violation|0|||
127875477|NCT02331680|460163744|FG001|Overall Study|Protocol Violation|0|||
127875478|NCT02331680|460163745|FG002|Overall Study|Protocol Violation|3|||
127875479|NCT00602667|460163746|FG000|Overall Study|Still on Therapy|0|||
127875480|NCT00602667|460163747|FG001|Overall Study|Still on Therapy|2|||
127875481|NCT00602667|460163748|FG002|Overall Study|Still on Therapy|2|||
127875482|NCT00602667|460163746|FG000|Overall Study|Death|0|||
127875483|NCT00602667|460163747|FG001|Overall Study|Death|1|||
127875484|NCT00602667|460163748|FG002|Overall Study|Death|1|||
127875485|NCT00602667|460163746|FG000|Overall Study|Family request|3|||
127875486|NCT00602667|460163747|FG001|Overall Study|Family request|25|||
127875487|NCT00602667|460163748|FG002|Overall Study|Family request|6|||
127875488|NCT00602667|460163746|FG000|Overall Study|Excessive toxicity|1|||
127875489|NCT00602667|460163747|FG001|Overall Study|Excessive toxicity|1|||
127875490|NCT00602667|460163748|FG002|Overall Study|Excessive toxicity|0|||
127875491|NCT00602667|460163746|FG000|Overall Study|Second malignancy|0|||
127875492|NCT00602667|460163747|FG001|Overall Study|Second malignancy|1|||
127875493|NCT00602667|460163748|FG002|Overall Study|Second malignancy|0|||
127875494|NCT00602667|460163746|FG000|Overall Study|Physician Decision|2|||
127875495|NCT00602667|460163747|FG001|Overall Study|Physician Decision|3|||
127875496|NCT00602667|460163748|FG002|Overall Study|Physician Decision|8|||
127875497|NCT00602667|460163746|FG000|Overall Study|Progressive disease|13|||
127875498|NCT00602667|460163747|FG001|Overall Study|Progressive disease|48|||
127542097|NCT02163538|458951124|FG001|Overall Study|Protocol Violation|0|||
127542098|NCT02163538|458951123|FG000|Overall Study|Physician Decision|0|||
127542099|NCT02163538|458951124|FG001|Overall Study|Physician Decision|1|||
127542100|NCT03668873|458951127|FG000|Overall Study|Lost to Follow-up|6|||
127542101|NCT03668873|458951128|FG001|Overall Study|Lost to Follow-up|3|||
127542102|NCT02183675|458951129|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
127542103|NCT02183675|458951130|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
127542104|NCT02183675|458951131|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
127542105|NCT02183675|458951132|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
127542106|NCT02183675|458951133|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
127542107|NCT02183675|458951134|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
127542108|NCT01521117|458951135|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
127542109|NCT01521117|458951136|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
127542110|NCT01521117|458951135|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
127542111|NCT01521117|458951136|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
127542112|NCT01521117|458951135|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
127875499|NCT00602667|460163748|FG002|Overall Study|Progressive disease|45|||
127875500|NCT00602667|460163746|FG000|Overall Study|Progressive disease prior to therapy|0|||
127875501|NCT00602667|460163747|FG001|Overall Study|Progressive disease prior to therapy|0|||
127875502|NCT00602667|460163748|FG002|Overall Study|Progressive disease prior to therapy|1|||
127875503|NCT04410978|460163754|FG000|Overall Study|Poor compliance to protocol|2|||
127875504|NCT04410978|460163755|FG001|Overall Study|Poor compliance to protocol|4|||
127875505|NCT04410978|460163754|FG000|Overall Study|Withdrawal by Subject|64|||
127875506|NCT04410978|460163755|FG001|Overall Study|Withdrawal by Subject|66|||
127875507|NCT04410978|460163754|FG000|Overall Study|Other|6|||
127875508|NCT04410978|460163755|FG001|Overall Study|Other|7|||
127875509|NCT04410978|460163754|FG000|Overall Study|Missing study status|1|||
127875510|NCT04410978|460163755|FG001|Overall Study|Missing study status|0|||
127875511|NCT05153629|460163757|FG000|Overall Study|Withdrawal by Subject|0|||
127875512|NCT05153629|460163758|FG001|Overall Study|Withdrawal by Subject|2|||
127875513|NCT03743571|460163761|FG000|Overall Study|Withdrawal by Subject|1|||
127875514|NCT03743571|460163762|FG001|Overall Study|Withdrawal by Subject|1|||
127875515|NCT03743571|460163761|FG000|Overall Study|Lost to Follow-up|1|||
127875516|NCT03743571|460163762|FG001|Overall Study|Lost to Follow-up|2|||
127875517|NCT04115488|460163763|FG000|Overall Study|Adverse Event|8|||
127875518|NCT04115488|460163764|FG001|Overall Study|Adverse Event|4|||
127875519|NCT04115488|460163763|FG000|Overall Study|Withdrawal by Subject|3|||
127875520|NCT04115488|460163764|FG001|Overall Study|Withdrawal by Subject|6|||
127875521|NCT04115488|460163763|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
127875522|NCT04115488|460163764|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
127875523|NCT04115488|460163763|FG000|Overall Study|Patient 's location change|1|||
127875524|NCT04115488|460163764|FG001|Overall Study|Patient 's location change|0|||
127875525|NCT04115488|460163763|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
127875526|NCT04115488|460163764|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
127875527|NCT02576951|460163780|FG000|Overall Study|Lost to Follow-up|0|||
127875528|NCT02576951|460163781|FG001|Overall Study|Lost to Follow-up|0|||
127651936|NCT02287584|459347492|FG004|the Open-label Phase|Lack of Efficacy|3|||
127875529|NCT02576951|460163782|FG002|Overall Study|Lost to Follow-up|2|||
127875530|NCT02576951|460163783|FG003|Overall Study|Lost to Follow-up|2|||
127875531|NCT02576951|460163780|FG000|Overall Study|Withdrawal by Subject|1|||
127875532|NCT02576951|460163781|FG001|Overall Study|Withdrawal by Subject|0|||
127875533|NCT02576951|460163782|FG002|Overall Study|Withdrawal by Subject|0|||
127875534|NCT02576951|460163783|FG003|Overall Study|Withdrawal by Subject|2|||
127875535|NCT02576951|460163780|FG000|Overall Study|Protocol Violation|0|||
127875536|NCT02576951|460163781|FG001|Overall Study|Protocol Violation|0|||
127875537|NCT02576951|460163782|FG002|Overall Study|Protocol Violation|0|||
127875538|NCT02576951|460163783|FG003|Overall Study|Protocol Violation|1|||
127875539|NCT01721369|460163787|FG000|Overall Study|Not initial etiological diagnosis|12|||
127875540|NCT03280628|460165519|FG000|Overall Study|Lost to Follow-up|8|||
127875541|NCT03280628|460165520|FG001|Overall Study|Lost to Follow-up|6|||
127875542|NCT03280628|460165521|FG002|Overall Study|Lost to Follow-up|11|||
127875543|NCT01361308|460165524|FG000|Overall Study|Withdrawal by Subject|9|||
127875544|NCT01361308|460165525|FG001|Overall Study|Withdrawal by Subject|13|||
127875545|NCT01361308|460165524|FG000|Overall Study|Physician Decision|3|||
127875546|NCT01361308|460165525|FG001|Overall Study|Physician Decision|3|||
127875547|NCT01361308|460165524|FG000|Overall Study|Lack of Efficacy|2|||
127875548|NCT01361308|460165525|FG001|Overall Study|Lack of Efficacy|0|||
127875549|NCT01361308|460165524|FG000|Overall Study|Protocol Violation|1|||
127875550|NCT01361308|460165525|FG001|Overall Study|Protocol Violation|0|||
127875551|NCT01361308|460165524|FG000|Overall Study|Lost to Follow-up|5|||
127875552|NCT01361308|460165525|FG001|Overall Study|Lost to Follow-up|4|||
127875553|NCT01361308|460165524|FG000|Overall Study|Adverse Event|8|||
127875554|NCT01361308|460165525|FG001|Overall Study|Adverse Event|4|||
127875555|NCT01361308|460165524|FG000|Overall Study|Eligibility Criteria Not Met|2|||
127875556|NCT01361308|460165525|FG001|Overall Study|Eligibility Criteria Not Met|3|||
127875557|NCT01361308|460165524|FG000|Overall Study|Failed C-SSRS|5|||
127875558|NCT01361308|460165525|FG001|Overall Study|Failed C-SSRS|2|||
127875559|NCT01361308|460165524|FG000|Overall Study|Other|0|||
127875560|NCT01361308|460165525|FG001|Overall Study|Other|1|||
127875561|NCT03839693|460165530|FG000|Overall Study|Lost to Follow-up|0|||
127875562|NCT03839693|460165531|FG001|Overall Study|Lost to Follow-up|2|||
127875563|NCT03839693|460165532|FG002|Overall Study|Lost to Follow-up|2|||
127875564|NCT03839693|460165530|FG000|Overall Study|Withdrawal by Subject|1|||
127875565|NCT03839693|460165531|FG001|Overall Study|Withdrawal by Subject|0|||
127875566|NCT03839693|460165532|FG002|Overall Study|Withdrawal by Subject|2|||
127875567|NCT03839693|460165530|FG000|Overall Study|subject moved out of the area|1|||
127875568|NCT03839693|460165531|FG001|Overall Study|subject moved out of the area|0|||
127875569|NCT03839693|460165532|FG002|Overall Study|subject moved out of the area|0|||
127875570|NCT02503215|460165541|FG000|Overall Study|Unable to wear compression stockings|1|||
127875571|NCT02503215|460165541|FG000|Overall Study|Unable to use positive airway pressure|2|||
127875572|NCT03433482|460165542|FG000|Overall Study|Lost to Follow-up|1|||
127875573|NCT03433482|460165543|FG001|Overall Study|Lost to Follow-up|0|||
127875574|NCT03433482|460165544|FG002|Overall Study|Lost to Follow-up|1|||
127875575|NCT03433482|460165545|FG003|Overall Study|Lost to Follow-up|1|||
127875576|NCT03433482|460165542|FG000|Overall Study|Withdrawal by Subject|0|||
127875577|NCT03433482|460165543|FG001|Overall Study|Withdrawal by Subject|0|||
127875578|NCT03433482|460165544|FG002|Overall Study|Withdrawal by Subject|1|||
127875579|NCT03433482|460165545|FG003|Overall Study|Withdrawal by Subject|0|||
127875580|NCT03433482|460165542|FG000|Overall Study|Unknown reason|0|||
127875581|NCT03433482|460165543|FG001|Overall Study|Unknown reason|0|||
127875582|NCT03433482|460165544|FG002|Overall Study|Unknown reason|2|||
127983732|NCT01764997|460562570|FG002|Run-in Period|Poor compliance to protocol|0|||
127875583|NCT03433482|460165545|FG003|Overall Study|Unknown reason|0|||
127875584|NCT01300741|460165546|FG000|Overall Study|Lens deposits|1|||
127875585|NCT01300741|460165546|FG000|Overall Study|Lost to Follow-up|1|||
127875586|NCT01300741|460165546|FG000|Overall Study|Discomfort|1|||
127875587|NCT00594568|460165547|FG000|Initial Treatment|Adverse Event|51|||
127875588|NCT00594568|460165548|FG001|Initial Treatment|Adverse Event|121|||
127875589|NCT00594568|460165549|FG002|Initial Treatment|Adverse Event|144|||
127875590|NCT00594568|460165547|FG000|Initial Treatment|Death|6|||
127875591|NCT00594568|460165548|FG001|Initial Treatment|Death|11|||
127875592|NCT00594568|460165549|FG002|Initial Treatment|Death|15|||
127875593|NCT00594568|460165547|FG000|Initial Treatment|Lost to Follow-up|4|||
127875594|NCT00594568|460165548|FG001|Initial Treatment|Lost to Follow-up|1|||
127875595|NCT00594568|460165549|FG002|Initial Treatment|Lost to Follow-up|4|||
127875596|NCT00594568|460165547|FG000|Initial Treatment|Physician Decision|3|||
127875597|NCT00594568|460165548|FG001|Initial Treatment|Physician Decision|2|||
127875598|NCT00594568|460165549|FG002|Initial Treatment|Physician Decision|4|||
127875599|NCT00594568|460165547|FG000|Initial Treatment|Protocol Violation|2|||
127875600|NCT00594568|460165548|FG001|Initial Treatment|Protocol Violation|2|||
127875601|NCT00594568|460165549|FG002|Initial Treatment|Protocol Violation|5|||
127875602|NCT00594568|460165547|FG000|Initial Treatment|Withdrawal by Subject|25|||
127875603|NCT00594568|460165548|FG001|Initial Treatment|Withdrawal by Subject|31|||
127875604|NCT00594568|460165549|FG002|Initial Treatment|Withdrawal by Subject|46|||
127875605|NCT00594568|460165547|FG000|Initial Treatment|Sponsor decision|193|||
127875606|NCT00594568|460165548|FG001|Initial Treatment|Sponsor decision|142|||
127875607|NCT00594568|460165549|FG002|Initial Treatment|Sponsor decision|147|||
127875608|NCT00594568|460165547|FG000|Initial Treatment|Caregiver decision|21|||
127875609|NCT00594568|460165548|FG001|Initial Treatment|Caregiver decision|36|||
127875610|NCT00594568|460165549|FG002|Initial Treatment|Caregiver decision|36|||
127875611|NCT00594568|460165547|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
127875612|NCT00594568|460165548|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
127875613|NCT00594568|460165549|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
127875614|NCT00594568|460165547|FG000|Initial Treatment|Entry criteria exclusion|0|||
127875615|NCT00594568|460165548|FG001|Initial Treatment|Entry criteria exclusion|1|||
127875616|NCT00594568|460165549|FG002|Initial Treatment|Entry criteria exclusion|1|||
127875617|NCT00594568|460165547|FG000|Delayed Start|Death|0|||
127875618|NCT00594568|460165548|FG001|Delayed Start|Death|0|||
127875619|NCT00594568|460165549|FG002|Delayed Start|Death|1|||
127875620|NCT00594568|460165547|FG000|Delayed Start|Adverse Event|12|||
127875621|NCT00594568|460165548|FG001|Delayed Start|Adverse Event|2|||
127875622|NCT00594568|460165549|FG002|Delayed Start|Adverse Event|2|||
127875623|NCT00594568|460165547|FG000|Delayed Start|Withdrawal by Subject|4|||
127875624|NCT00594568|460165548|FG001|Delayed Start|Withdrawal by Subject|3|||
127875625|NCT00594568|460165549|FG002|Delayed Start|Withdrawal by Subject|0|||
127875626|NCT00594568|460165547|FG000|Delayed Start|Physician Decision|0|||
127875627|NCT00594568|460165548|FG001|Delayed Start|Physician Decision|0|||
127875628|NCT00594568|460165549|FG002|Delayed Start|Physician Decision|1|||
127875629|NCT00594568|460165547|FG000|Delayed Start|Lost to Follow-up|0|||
127875630|NCT00594568|460165548|FG001|Delayed Start|Lost to Follow-up|0|||
127875631|NCT00594568|460165549|FG002|Delayed Start|Lost to Follow-up|1|||
127875632|NCT00594568|460165547|FG000|Delayed Start|Caregiver Decision|5|||
127875633|NCT00594568|460165548|FG001|Delayed Start|Caregiver Decision|6|||
127875634|NCT00594568|460165549|FG002|Delayed Start|Caregiver Decision|2|||
127875635|NCT00594568|460165547|FG000|Delayed Start|Sponsor Decision|77|||
127875636|NCT00594568|460165548|FG001|Delayed Start|Sponsor Decision|66|||
127875637|NCT00594568|460165549|FG002|Delayed Start|Sponsor Decision|59|||
127875638|NCT00594568|460165547|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
127875639|NCT00594568|460165548|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
127875640|NCT00594568|460165549|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
127875641|NCT00594568|460165547|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
127875642|NCT00594568|460165548|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
127875643|NCT00594568|460165549|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
127875644|NCT00594568|460165547|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
127875645|NCT00594568|460165548|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
127875646|NCT00594568|460165549|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
127875647|NCT00594568|460165547|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
127875648|NCT00594568|460165548|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
127875649|NCT00594568|460165549|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
127875650|NCT00594568|460165547|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
127875651|NCT00594568|460165548|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
127983733|NCT01764997|460562571|FG003|Run-in Period|Poor compliance to protocol|0|||
127875652|NCT00594568|460165549|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
127875653|NCT00594568|460165547|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
127875654|NCT00594568|460165548|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
127875655|NCT00594568|460165549|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
127875656|NCT04311411|460165550|FG000|Overall Study|Adverse Event|2|||
127875657|NCT04311411|460165551|FG001|Overall Study|Adverse Event|3|||
127875658|NCT04311411|460165552|FG002|Overall Study|Adverse Event|2|||
127875659|NCT04311411|460165550|FG000|Overall Study|Withdrawal by Subject|3|||
127875660|NCT04311411|460165551|FG001|Overall Study|Withdrawal by Subject|3|||
127875661|NCT04311411|460165552|FG002|Overall Study|Withdrawal by Subject|0|||
127875662|NCT03722849|460165560|FG000|Overall Study|Withdrawal by Subject|1|||
127875663|NCT03722849|460165561|FG001|Overall Study|Withdrawal by Subject|1|||
127875664|NCT05644756|460165562|FG000|Aim 1 Activities (Ethnography)|Withdrawal by Subject|1|||
127875665|NCT05644756|460165562|FG000|Aim 2 Activities (Fidelity to MBC)|Lost to Follow-up|5|||
127875666|NCT03985982|460165563|FG000|Double-Blind Phase|Lost to Follow-up|4|||
127875667|NCT03985982|460165564|FG001|Double-Blind Phase|Lost to Follow-up|3|||
127875668|NCT03985982|460165565|FG002|Double-Blind Phase|Lost to Follow-up|0|||
127875669|NCT03985982|460165563|FG000|Double-Blind Phase|Physician Decision|1|||
127651937|NCT02287584|459347493|FG005|the Open-label Phase|Lack of Efficacy|7|||
127875670|NCT03985982|460165564|FG001|Double-Blind Phase|Physician Decision|0|||
127875671|NCT03985982|460165565|FG002|Double-Blind Phase|Physician Decision|0|||
127875672|NCT03985982|460165563|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
127875673|NCT03985982|460165564|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
127875674|NCT03985982|460165565|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
127875675|NCT03985982|460165563|FG000|Double-Blind Phase|COVID-19|1|||
127875676|NCT03985982|460165564|FG001|Double-Blind Phase|COVID-19|0|||
127875677|NCT03985982|460165565|FG002|Double-Blind Phase|COVID-19|0|||
127875678|NCT03985982|460165563|FG000|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|1|||
127875679|NCT03985982|460165564|FG001|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
127875680|NCT03985982|460165565|FG002|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
127875681|NCT03985982|460165563|FG000|Open-Label Phase|Lost to Follow-up|0|||
127875682|NCT03985982|460165564|FG001|Open-Label Phase|Lost to Follow-up|0|||
127875683|NCT03985982|460165565|FG002|Open-Label Phase|Lost to Follow-up|13|||
127875684|NCT03985982|460165563|FG000|Open-Label Phase|Physician Decision|0|||
127875685|NCT03985982|460165564|FG001|Open-Label Phase|Physician Decision|0|||
127875686|NCT03985982|460165565|FG002|Open-Label Phase|Physician Decision|2|||
127875687|NCT03985982|460165563|FG000|Open-Label Phase|Withdrawal by Subject|0|||
127875688|NCT03985982|460165564|FG001|Open-Label Phase|Withdrawal by Subject|0|||
127875689|NCT03985982|460165565|FG002|Open-Label Phase|Withdrawal by Subject|11|||
127875690|NCT00348348|460165570|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
127875691|NCT00348348|460165571|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
127875692|NCT00348348|460165570|FG000|Overall Study|Lack of Efficacy|1|||
127875693|NCT00348348|460165571|FG001|Overall Study|Lack of Efficacy|1|||
127875694|NCT00348348|460165570|FG000|Overall Study|Lost to Follow-up|8|||
127875695|NCT00348348|460165571|FG001|Overall Study|Lost to Follow-up|10|||
127875696|NCT00348348|460165570|FG000|Overall Study|Withdrawal by Subject|4|||
127875697|NCT00348348|460165571|FG001|Overall Study|Withdrawal by Subject|1|||
127875698|NCT00348348|460165570|FG000|Overall Study|Other|7|||
127875699|NCT00348348|460165571|FG001|Overall Study|Other|4|||
127875700|NCT00348348|460165570|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
127875701|NCT00348348|460165571|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
127875702|NCT00348348|460165570|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
127875703|NCT00348348|460165571|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
127875704|NCT00348348|460165570|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
127875705|NCT00348348|460165571|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
127875706|NCT00348348|460165570|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
127875707|NCT00348348|460165571|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
127875708|NCT00348348|460165570|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
127875709|NCT00348348|460165571|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
127875710|NCT00348348|460165570|FG000|Overall Study|Adverse event probably related to study|1|||
127875711|NCT00348348|460165571|FG001|Overall Study|Adverse event probably related to study|0|||
127875712|NCT00943826|460165574|FG000|Concurrent Phase|Adverse Event|50|||
127875713|NCT00943826|460165575|FG001|Concurrent Phase|Adverse Event|27|||
127875714|NCT00943826|460165574|FG000|Concurrent Phase|Withdrew consent|3|||
127875715|NCT00943826|460165575|FG001|Concurrent Phase|Withdrew consent|7|||
127875716|NCT00943826|460165574|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
127875717|NCT00943826|460165575|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
127875718|NCT00943826|460165574|FG000|Concurrent Phase|Administrative reasons|2|||
127875719|NCT00943826|460165575|FG001|Concurrent Phase|Administrative reasons|1|||
127875720|NCT00943826|460165574|FG000|Concurrent Phase|Protocol Violation|1|||
127875721|NCT00943826|460165575|FG001|Concurrent Phase|Protocol Violation|0|||
127875722|NCT00943826|460165574|FG000|Maintenance Phase|Adverse Event|31|||
127875723|NCT00943826|460165575|FG001|Maintenance Phase|Adverse Event|30|||
127875724|NCT00943826|460165574|FG000|Maintenance Phase|Withdrew consent|2|||
127875725|NCT00943826|460165575|FG001|Maintenance Phase|Withdrew consent|4|||
127875726|NCT00943826|460165574|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
127875727|NCT00943826|460165575|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
127875728|NCT00943826|460165574|FG000|Maintenance Phase|Administrative reasons|4|||
127875729|NCT00943826|460165575|FG001|Maintenance Phase|Administrative reasons|1|||
127875730|NCT00943826|460165574|FG000|Maintenance Phase|Failure to return|0|||
127875731|NCT00943826|460165575|FG001|Maintenance Phase|Failure to return|1|||
127875732|NCT00943826|460165574|FG000|Monotherapy Phase|Adverse Event|42|||
127875733|NCT00943826|460165575|FG001|Monotherapy Phase|Adverse Event|5|||
127875734|NCT00943826|460165574|FG000|Monotherapy Phase|Administrative reasons|11|||
127875735|NCT00943826|460165575|FG001|Monotherapy Phase|Administrative reasons|5|||
127875736|NCT00943826|460165574|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
127875737|NCT00943826|460165575|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
127875738|NCT00943826|460165574|FG000|Monotherapy Phase|Withdrew Consent|2|||
127875739|NCT00943826|460165575|FG001|Monotherapy Phase|Withdrew Consent|3|||
127875740|NCT00943826|460165574|FG000|Monotherapy Phase|Failure to return|2|||
127875741|NCT00943826|460165575|FG001|Monotherapy Phase|Failure to return|1|||
127875742|NCT00943826|460165574|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
127875743|NCT00943826|460165575|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
127875744|NCT00943826|460165574|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
127875745|NCT00943826|460165575|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
127875746|NCT00943826|460165574|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
127875747|NCT00943826|460165575|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
127875748|NCT00943826|460165574|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
127875749|NCT00943826|460165575|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
127875750|NCT00326625|460165576|FG000|Overall Study|Adverse Event|20|||
127875751|NCT00326625|460165577|FG001|Overall Study|Adverse Event|9|||
127875752|NCT00326625|460165576|FG000|Overall Study|Withdrawal by Subject|15|||
127875753|NCT00326625|460165577|FG001|Overall Study|Withdrawal by Subject|12|||
127875754|NCT00326625|460165576|FG000|Overall Study|Death|18|||
127875755|NCT00326625|460165577|FG001|Overall Study|Death|16|||
127875756|NCT00326625|460165576|FG000|Overall Study|Lost to Follow-up|1|||
127875757|NCT00326625|460165577|FG001|Overall Study|Lost to Follow-up|0|||
127875758|NCT00326625|460165576|FG000|Overall Study|prescheduled medical intervention|0|||
127875759|NCT00326625|460165577|FG001|Overall Study|prescheduled medical intervention|1|||
127875760|NCT00455923|460165582|FG000|Overall Study|Pregnancy|0|||
127875761|NCT00455923|460165583|FG001|Overall Study|Pregnancy|2|||
127875762|NCT00455923|460165582|FG000|Overall Study|Other|3|||
127875763|NCT00455923|460165583|FG001|Overall Study|Other|1|||
127875764|NCT01265875|460165585|FG000|Overall Study|Uncooperative/unreliable|1|||
127875765|NCT05275673|460165586|FG000|Overall Study|Study Termination by Sponsor|2|||
127875766|NCT05275673|460165587|FG001|Overall Study|Study Termination by Sponsor|3|||
127875767|NCT05275673|460165586|FG000|Overall Study|Death|1|||
127875768|NCT05275673|460165587|FG001|Overall Study|Death|0|||
127875769|NCT05275673|460165586|FG000|Overall Study|Withdrawal by Subject|1|||
127875770|NCT05275673|460165587|FG001|Overall Study|Withdrawal by Subject|0|||
127875771|NCT02279888|460165590|FG000|Overall Study|Death|326|||
127875772|NCT02279888|460165590|FG000|Overall Study|Withdrawal by Subject|38|||
127875773|NCT02279888|460165590|FG000|Overall Study|Lost to Follow-up|21|||
127875774|NCT02279888|460165590|FG000|Overall Study|Physician Decision|62|||
127875775|NCT02279888|460165590|FG000|Overall Study|Subject Non-compliance|43|||
127875776|NCT02279888|460165590|FG000|Overall Study|Not implanted|14|||
127875777|NCT02279888|460165590|FG000|Overall Study|Visit not performed|26|||
127875778|NCT02335411|460165591|FG000|Overall Study|Death|223|||
127875779|NCT02335411|460165592|FG001|Overall Study|Death|22|||
127875780|NCT02335411|460165593|FG002|Overall Study|Death|26|||
127875781|NCT02335411|460165591|FG000|Overall Study|Physician Decision|3|||
127875782|NCT02335411|460165592|FG001|Overall Study|Physician Decision|0|||
127875783|NCT02335411|460165593|FG002|Overall Study|Physician Decision|0|||
127875784|NCT02335411|460165591|FG000|Overall Study|Protocol Violation|1|||
127875785|NCT02335411|460165592|FG001|Overall Study|Protocol Violation|0|||
127875786|NCT02335411|460165593|FG002|Overall Study|Protocol Violation|0|||
127875787|NCT02335411|460165591|FG000|Overall Study|Withdrawal by Subject|11|||
127875788|NCT02335411|460165592|FG001|Overall Study|Withdrawal by Subject|0|||
127875789|NCT02335411|460165593|FG002|Overall Study|Withdrawal by Subject|3|||
127875790|NCT02335411|460165591|FG000|Overall Study|Sponsor Decision|12|||
127875791|NCT02335411|460165592|FG001|Overall Study|Sponsor Decision|3|||
127875792|NCT02335411|460165593|FG002|Overall Study|Sponsor Decision|2|||
127875793|NCT02335411|460165591|FG000|Overall Study|Adverse Event|9|||
127875794|NCT02335411|460165592|FG001|Overall Study|Adverse Event|0|||
127875795|NCT02335411|460165593|FG002|Overall Study|Adverse Event|0|||
127875796|NCT01891669|460165594|FG000|Overall Study|Death|0|||
127651938|NCT02287584|459347488|FG000|the Open-label Phase|Lost to Follow-up|0|||
127875797|NCT01891669|460165595|FG001|Overall Study|Death|0|||
127875798|NCT01891669|460165596|FG002|Overall Study|Death|0|||
127875799|NCT01891669|460165597|FG003|Overall Study|Death|0|||
127875800|NCT01891669|460165598|FG004|Overall Study|Death|0|||
127875801|NCT01891669|460165599|FG005|Overall Study|Death|0|||
127875802|NCT01891669|460165600|FG006|Overall Study|Death|0|||
127875803|NCT01891669|460165601|FG007|Overall Study|Death|1|||
127875804|NCT01891669|460165602|FG008|Overall Study|Death|0|||
127875805|NCT01891669|460165603|FG009|Overall Study|Death|1|||
127651939|NCT02287584|459347489|FG001|the Open-label Phase|Lost to Follow-up|0|||
127651940|NCT02287584|459347490|FG002|the Open-label Phase|Lost to Follow-up|0|||
127651941|NCT02287584|459347491|FG003|the Open-label Phase|Lost to Follow-up|4|||
127651942|NCT02287584|459347492|FG004|the Open-label Phase|Lost to Follow-up|1|||
127651943|NCT02287584|459347493|FG005|the Open-label Phase|Lost to Follow-up|2|||
127651944|NCT02287584|459347488|FG000|the Open-label Phase|Withdrawal by Subject|0|||
127651945|NCT02287584|459347489|FG001|the Open-label Phase|Withdrawal by Subject|0|||
127651946|NCT02287584|459347490|FG002|the Open-label Phase|Withdrawal by Subject|0|||
127651947|NCT02287584|459347491|FG003|the Open-label Phase|Withdrawal by Subject|18|||
127651948|NCT02287584|459347492|FG004|the Open-label Phase|Withdrawal by Subject|29|||
127651949|NCT02287584|459347493|FG005|the Open-label Phase|Withdrawal by Subject|21|||
127651950|NCT02287584|459347488|FG000|the Open-label Phase|non-compliance|0|||
127651951|NCT02287584|459347489|FG001|the Open-label Phase|non-compliance|0|||
127651952|NCT02287584|459347490|FG002|the Open-label Phase|non-compliance|0|||
127651953|NCT02287584|459347491|FG003|the Open-label Phase|non-compliance|2|||
127651954|NCT02287584|459347492|FG004|the Open-label Phase|non-compliance|5|||
127651955|NCT02287584|459347493|FG005|the Open-label Phase|non-compliance|1|||
127651956|NCT02287584|459347488|FG000|the Open-label Phase|other reasons|0|||
127651957|NCT02287584|459347489|FG001|the Open-label Phase|other reasons|0|||
127651958|NCT02287584|459347490|FG002|the Open-label Phase|other reasons|0|||
127651959|NCT02287584|459347491|FG003|the Open-label Phase|other reasons|3|||
127651960|NCT02287584|459347492|FG004|the Open-label Phase|other reasons|6|||
127651961|NCT02287584|459347493|FG005|the Open-label Phase|other reasons|6|||
127651962|NCT03430063|459347498|FG000|Overall Study|Adverse Event|0|||
127651963|NCT03430063|459347499|FG001|Overall Study|Adverse Event|1|||
127651964|NCT03430063|459347500|FG002|Overall Study|Adverse Event|0|||
127651965|NCT03430063|459347498|FG000|Overall Study|Death|3|||
127651966|NCT03430063|459347499|FG001|Overall Study|Death|2|||
127651967|NCT03430063|459347500|FG002|Overall Study|Death|3|||
127651968|NCT03430063|459347498|FG000|Overall Study|Lost to Follow-up|0|||
127651969|NCT03430063|459347499|FG001|Overall Study|Lost to Follow-up|1|||
127651970|NCT03430063|459347500|FG002|Overall Study|Lost to Follow-up|0|||
127651971|NCT03430063|459347498|FG000|Overall Study|Withdrawal by Subject|0|||
127651972|NCT03430063|459347499|FG001|Overall Study|Withdrawal by Subject|0|||
127651973|NCT03430063|459347500|FG002|Overall Study|Withdrawal by Subject|1|||
127651974|NCT03430063|459347498|FG000|Overall Study|Withdrawal of consent|3|||
127651975|NCT03430063|459347499|FG001|Overall Study|Withdrawal of consent|1|||
127651976|NCT03430063|459347500|FG002|Overall Study|Withdrawal of consent|2|||
127651977|NCT03430063|459347498|FG000|Overall Study|Progressive disease|1|||
127651978|NCT03430063|459347499|FG001|Overall Study|Progressive disease|2|||
127651979|NCT03430063|459347500|FG002|Overall Study|Progressive disease|1|||
127651980|NCT03430063|459347498|FG000|Overall Study|Other un-specified|1|||
127651981|NCT03430063|459347499|FG001|Overall Study|Other un-specified|1|||
127651982|NCT03430063|459347500|FG002|Overall Study|Other un-specified|0|||
127651983|NCT03430063|459347498|FG000|Overall Study|Randomized, but never treated|0|||
127651984|NCT03430063|459347499|FG001|Overall Study|Randomized, but never treated|0|||
127651985|NCT03430063|459347500|FG002|Overall Study|Randomized, but never treated|1|||
127651986|NCT02798211|459347501|FG000|Period 1|Adverse Event|1|||
127651987|NCT02798211|459347502|FG001|Period 1|Adverse Event|1|||
127651988|NCT02798211|459347503|FG002|Period 1|Adverse Event|0|||
127651989|NCT02798211|459347504|FG003|Period 1|Adverse Event|0|||
127651990|NCT02798211|459347505|FG004|Period 1|Adverse Event|0|||
127651991|NCT02798211|459347506|FG005|Period 1|Adverse Event|0|||
127651992|NCT02798211|459347501|FG000|Period 1|Lost to Follow-up|2|||
127651993|NCT02798211|459347502|FG001|Period 1|Lost to Follow-up|1|||
127651994|NCT02798211|459347503|FG002|Period 1|Lost to Follow-up|0|||
127651995|NCT02798211|459347504|FG003|Period 1|Lost to Follow-up|0|||
127651996|NCT02798211|459347505|FG004|Period 1|Lost to Follow-up|0|||
127651997|NCT02798211|459347506|FG005|Period 1|Lost to Follow-up|0|||
127651998|NCT02798211|459347501|FG000|Period 1|Protocol Violation|0|||
127651999|NCT02798211|459347502|FG001|Period 1|Protocol Violation|0|||
127652000|NCT02798211|459347503|FG002|Period 1|Protocol Violation|2|||
127652001|NCT02798211|459347504|FG003|Period 1|Protocol Violation|0|||
127652002|NCT02798211|459347505|FG004|Period 1|Protocol Violation|0|||
127652003|NCT02798211|459347506|FG005|Period 1|Protocol Violation|0|||
127652004|NCT02798211|459347501|FG000|Period 1|Withdrawal by Subject|1|||
127652005|NCT02798211|459347502|FG001|Period 1|Withdrawal by Subject|1|||
127652006|NCT02798211|459347503|FG002|Period 1|Withdrawal by Subject|0|||
127652007|NCT02798211|459347504|FG003|Period 1|Withdrawal by Subject|0|||
127652008|NCT02798211|459347505|FG004|Period 1|Withdrawal by Subject|0|||
127652009|NCT02798211|459347506|FG005|Period 1|Withdrawal by Subject|0|||
127652010|NCT02798211|459347501|FG000|Period 1|Death|0|||
127652011|NCT02798211|459347502|FG001|Period 1|Death|0|||
127652012|NCT02798211|459347503|FG002|Period 1|Death|1|||
127652013|NCT02798211|459347504|FG003|Period 1|Death|0|||
127983734|NCT01764997|460562572|FG004|Run-in Period|Poor compliance to protocol|0|||
127983735|NCT01764997|460562568|FG000|Run-in Period|Other than specified above|17|||
127652014|NCT02798211|459347505|FG004|Period 1|Death|0|||
127652015|NCT02798211|459347506|FG005|Period 1|Death|0|||
127875806|NCT01891669|460165594|FG000|Overall Study|Withdrawal by Subject|1|||
127875807|NCT01891669|460165595|FG001|Overall Study|Withdrawal by Subject|1|||
127875808|NCT01891669|460165596|FG002|Overall Study|Withdrawal by Subject|0|||
127875809|NCT01891669|460165597|FG003|Overall Study|Withdrawal by Subject|0|||
127875810|NCT01891669|460165598|FG004|Overall Study|Withdrawal by Subject|0|||
127875811|NCT01891669|460165599|FG005|Overall Study|Withdrawal by Subject|0|||
127875812|NCT01891669|460165600|FG006|Overall Study|Withdrawal by Subject|1|||
127875813|NCT01891669|460165601|FG007|Overall Study|Withdrawal by Subject|2|||
127875814|NCT01891669|460165602|FG008|Overall Study|Withdrawal by Subject|1|||
127875815|NCT01891669|460165603|FG009|Overall Study|Withdrawal by Subject|1|||
127875816|NCT01891669|460165594|FG000|Overall Study|Other|1|||
127875817|NCT01891669|460165595|FG001|Overall Study|Other|0|||
127875818|NCT01891669|460165596|FG002|Overall Study|Other|0|||
127875819|NCT01891669|460165597|FG003|Overall Study|Other|0|||
127875820|NCT01891669|460165598|FG004|Overall Study|Other|0|||
127875821|NCT01891669|460165599|FG005|Overall Study|Other|0|||
127875822|NCT01891669|460165600|FG006|Overall Study|Other|0|||
127875823|NCT01891669|460165601|FG007|Overall Study|Other|1|||
127875824|NCT01891669|460165602|FG008|Overall Study|Other|0|||
127875825|NCT01891669|460165603|FG009|Overall Study|Other|0|||
127875826|NCT03075826|460165605|FG000|Overall Study|Withdrawal by Subject|1|||
127875827|NCT03075826|460165605|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
127875828|NCT00650806|460165606|FG000|Overall Study|Adverse Event|0|||
127875829|NCT00650806|460165607|FG001|Overall Study|Adverse Event|5|||
127875830|NCT00650806|460165608|FG002|Overall Study|Adverse Event|3|||
127875831|NCT00650806|460165609|FG003|Overall Study|Adverse Event|4|||
127875832|NCT00650806|460165606|FG000|Overall Study|Lost to Follow-up|7|||
127875833|NCT00650806|460165607|FG001|Overall Study|Lost to Follow-up|6|||
127875834|NCT00650806|460165608|FG002|Overall Study|Lost to Follow-up|11|||
127875835|NCT00650806|460165609|FG003|Overall Study|Lost to Follow-up|10|||
127875836|NCT00650806|460165606|FG000|Overall Study|Protocol Violation|0|||
127875837|NCT00650806|460165607|FG001|Overall Study|Protocol Violation|0|||
127875838|NCT00650806|460165608|FG002|Overall Study|Protocol Violation|0|||
127875839|NCT00650806|460165609|FG003|Overall Study|Protocol Violation|1|||
127875840|NCT00650806|460165606|FG000|Overall Study|Pregnancy|0|||
127875841|NCT00650806|460165607|FG001|Overall Study|Pregnancy|0|||
127875842|NCT00650806|460165608|FG002|Overall Study|Pregnancy|0|||
127875843|NCT00650806|460165609|FG003|Overall Study|Pregnancy|1|||
127875844|NCT00650806|460165606|FG000|Overall Study|Withdrawal by Subject|7|||
127875845|NCT00650806|460165607|FG001|Overall Study|Withdrawal by Subject|5|||
127875846|NCT00650806|460165608|FG002|Overall Study|Withdrawal by Subject|8|||
127875847|NCT00650806|460165609|FG003|Overall Study|Withdrawal by Subject|6|||
127875848|NCT00650806|460165606|FG000|Overall Study|Noncompliance with study drug regimen|1|||
127875849|NCT00650806|460165607|FG001|Overall Study|Noncompliance with study drug regimen|1|||
127875850|NCT00650806|460165608|FG002|Overall Study|Noncompliance with study drug regimen|0|||
127875851|NCT00650806|460165609|FG003|Overall Study|Noncompliance with study drug regimen|0|||
127875852|NCT00650806|460165606|FG000|Overall Study|Study terminated by sponsor|2|||
127875853|NCT00650806|460165607|FG001|Overall Study|Study terminated by sponsor|3|||
127875854|NCT00650806|460165608|FG002|Overall Study|Study terminated by sponsor|5|||
127875855|NCT00650806|460165609|FG003|Overall Study|Study terminated by sponsor|4|||
127875856|NCT00650806|460165606|FG000|Overall Study|Other|1|||
127875857|NCT00650806|460165607|FG001|Overall Study|Other|1|||
127875858|NCT00650806|460165608|FG002|Overall Study|Other|2|||
127875859|NCT00650806|460165609|FG003|Overall Study|Other|0|||
127875860|NCT04456998|460165610|FG000|Overall Study|Adverse Event|0|||
127875861|NCT04456998|460165611|FG001|Overall Study|Adverse Event|4|||
127875862|NCT04456998|460165610|FG000|Overall Study|Protocol Deviation|0|||
127875863|NCT04456998|460165611|FG001|Overall Study|Protocol Deviation|1|||
127875864|NCT04456998|460165610|FG000|Overall Study|Withdrawal by Subject|0|||
127875865|NCT04456998|460165611|FG001|Overall Study|Withdrawal by Subject|1|||
127875866|NCT04882085|460165615|FG000|Overall Study|Death|6|||
127875867|NCT04882085|460165616|FG001|Overall Study|Death|9|||
127875868|NCT04882085|460165615|FG000|Overall Study|Withdrawal by Subject|0|||
127875869|NCT04882085|460165616|FG001|Overall Study|Withdrawal by Subject|3|||
127875870|NCT04882085|460165615|FG000|Overall Study|Randomized not treated|1|||
127875871|NCT04882085|460165616|FG001|Overall Study|Randomized not treated|0|||
127875872|NCT00400985|460165617|FG000|Overall Study|Withdrawal by Subject|5|||
127875873|NCT00400985|460165617|FG000|Overall Study|system modification|8|||
127875874|NCT00400985|460165617|FG000|Overall Study|Death|30|||
127875875|NCT00400985|460165617|FG000|Overall Study|Lost to Follow-up|9|||
127875876|NCT00965562|460165618|FG000|Overall Study|Lost to Follow-up|1|||
127875877|NCT00965562|460165619|FG001|Overall Study|Lost to Follow-up|2|||
127875878|NCT00965562|460165620|FG002|Overall Study|Lost to Follow-up|3|||
127875879|NCT00965562|460165618|FG000|Overall Study|Withdrawal by Subject|2|||
127875880|NCT00965562|460165619|FG001|Overall Study|Withdrawal by Subject|2|||
127875881|NCT00965562|460165620|FG002|Overall Study|Withdrawal by Subject|0|||
127875882|NCT03792633|460165625|FG000|Overall Study|Alternative Treatment|17|||
127875883|NCT03792633|460165626|FG001|Overall Study|Alternative Treatment|19|||
127875884|NCT03792633|460165625|FG000|Overall Study|Death|2|||
127875885|NCT03792633|460165626|FG001|Overall Study|Death|0|||
127875886|NCT03792633|460165625|FG000|Overall Study|Disease progression|8|||
127875887|NCT03792633|460165626|FG001|Overall Study|Disease progression|9|||
127875888|NCT03792633|460165625|FG000|Overall Study|Lost to Follow-up|1|||
127875889|NCT03792633|460165626|FG001|Overall Study|Lost to Follow-up|1|||
127875890|NCT03792633|460165625|FG000|Overall Study|Screen fail|1|||
127875891|NCT03792633|460165626|FG001|Overall Study|Screen fail|0|||
127875892|NCT03792633|460165625|FG000|Overall Study|Second malignancy|0|||
127875893|NCT03792633|460165626|FG001|Overall Study|Second malignancy|1|||
127875894|NCT03179462|460165629|FG000|Overall Study|screening failure|1|||
127875895|NCT03179462|460165630|FG001|Overall Study|screening failure|2|||
127875896|NCT03179462|460165631|FG002|Overall Study|screening failure|0|||
127875897|NCT04636437|460165632|FG000|Overall Study|Eligibility failure discovered after study entry|2|||
127875898|NCT04636437|460165633|FG001|Overall Study|Eligibility failure discovered after study entry|1|||
127875899|NCT04636437|460165634|FG002|Overall Study|Eligibility failure discovered after study entry|0|||
127875900|NCT04636437|460165632|FG000|Overall Study|Started weight loss drug/program|2|||
127875901|NCT04636437|460165633|FG001|Overall Study|Started weight loss drug/program|1|||
127875902|NCT04636437|460165634|FG002|Overall Study|Started weight loss drug/program|1|||
127875903|NCT04636437|460165632|FG000|Overall Study|Lost to Follow-up|3|||
127875904|NCT04636437|460165633|FG001|Overall Study|Lost to Follow-up|1|||
127875905|NCT04636437|460165634|FG002|Overall Study|Lost to Follow-up|4|||
127875906|NCT04636437|460165632|FG000|Overall Study|Participant or physician decision|3|||
127875907|NCT04636437|460165633|FG001|Overall Study|Participant or physician decision|1|||
127875908|NCT04636437|460165634|FG002|Overall Study|Participant or physician decision|1|||
127875909|NCT00816166|460165635|FG000|Overall Study|Lost to Follow-up|6|||
127875910|NCT00816166|460165636|FG001|Overall Study|Lost to Follow-up|10|||
127875911|NCT00816166|460165635|FG000|Overall Study|Death|4|||
127875912|NCT00816166|460165636|FG001|Overall Study|Death|2|||
127875913|NCT00352664|460165637|FG000|Overall Study|Withdrawal by Subject|7|||
127875914|NCT00352664|460165638|FG001|Overall Study|Withdrawal by Subject|0|||
127875915|NCT01233284|460165639|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
127875916|NCT01233284|460165640|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
127875917|NCT01233284|460165641|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
127875918|NCT01233284|460165642|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
127875919|NCT01233284|460165643|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
127875920|NCT01233284|460165639|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
127875921|NCT01233284|460165640|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
127875922|NCT01233284|460165641|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
127875923|NCT01233284|460165642|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
127875924|NCT01233284|460165643|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
127875925|NCT01233284|460165639|FG000|Period 1 (4 Weeks)|Other|0|||
127875926|NCT01233284|460165640|FG001|Period 1 (4 Weeks)|Other|0|||
127875927|NCT01233284|460165641|FG002|Period 1 (4 Weeks)|Other|1|||
127875928|NCT01233284|460165642|FG003|Period 1 (4 Weeks)|Other|0|||
127875929|NCT01233284|460165643|FG004|Period 1 (4 Weeks)|Other|0|||
127875930|NCT01233284|460165639|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
127875931|NCT01233284|460165640|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
127875932|NCT01233284|460165641|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
127875933|NCT01233284|460165642|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
127875934|NCT01233284|460165643|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
127875935|NCT01233284|460165639|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
127875936|NCT01233284|460165640|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
127875937|NCT01233284|460165641|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
127875938|NCT01233284|460165642|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
127875939|NCT01233284|460165643|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
127875940|NCT01233284|460165639|FG000|Period 3 (4 Weeks)|Other|0|||
127875941|NCT01233284|460165640|FG001|Period 3 (4 Weeks)|Other|0|||
127875942|NCT01233284|460165641|FG002|Period 3 (4 Weeks)|Other|0|||
127875943|NCT01233284|460165642|FG003|Period 3 (4 Weeks)|Other|1|||
127875944|NCT01233284|460165643|FG004|Period 3 (4 Weeks)|Other|0|||
127875945|NCT01233284|460165639|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
127875946|NCT01233284|460165640|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
127875947|NCT01233284|460165641|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
127875948|NCT01233284|460165642|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
127875949|NCT01233284|460165643|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
127875950|NCT01233284|460165639|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
127875951|NCT01233284|460165640|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
127875952|NCT01233284|460165641|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
127875953|NCT01233284|460165642|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
127875954|NCT01233284|460165643|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
127875955|NCT01058707|460165645|FG000|Overall Study|Disease Progression|15|||
127875956|NCT01058707|460165646|FG001|Overall Study|Disease Progression|20|||
127875957|NCT01058707|460165647|FG002|Overall Study|Disease Progression|20|||
127875958|NCT01058707|460165648|FG003|Overall Study|Disease Progression|15|||
127875959|NCT01058707|460165649|FG004|Overall Study|Disease Progression|23|||
127875960|NCT01058707|460165650|FG005|Overall Study|Disease Progression|10|||
127875961|NCT01058707|460165651|FG006|Overall Study|Disease Progression|12|||
127875962|NCT01058707|460165645|FG000|Overall Study|Adverse Event|11|||
127875963|NCT01058707|460165646|FG001|Overall Study|Adverse Event|4|||
127875964|NCT01058707|460165647|FG002|Overall Study|Adverse Event|7|||
127875965|NCT01058707|460165648|FG003|Overall Study|Adverse Event|6|||
127875966|NCT01058707|460165649|FG004|Overall Study|Adverse Event|7|||
127875967|NCT01058707|460165650|FG005|Overall Study|Adverse Event|3|||
127875968|NCT01058707|460165651|FG006|Overall Study|Adverse Event|1|||
127875969|NCT01058707|460165645|FG000|Overall Study|Subject Decision|5|||
127875970|NCT01058707|460165646|FG001|Overall Study|Subject Decision|3|||
127875971|NCT01058707|460165647|FG002|Overall Study|Subject Decision|3|||
127875972|NCT01058707|460165648|FG003|Overall Study|Subject Decision|1|||
127875973|NCT01058707|460165649|FG004|Overall Study|Subject Decision|2|||
127875974|NCT01058707|460165650|FG005|Overall Study|Subject Decision|3|||
127875975|NCT01058707|460165651|FG006|Overall Study|Subject Decision|6|||
127875976|NCT01058707|460165645|FG000|Overall Study|Lost to Follow-up|0|||
127875977|NCT01058707|460165646|FG001|Overall Study|Lost to Follow-up|0|||
127875978|NCT01058707|460165647|FG002|Overall Study|Lost to Follow-up|1|||
127875979|NCT01058707|460165648|FG003|Overall Study|Lost to Follow-up|0|||
127875980|NCT01058707|460165649|FG004|Overall Study|Lost to Follow-up|0|||
127875981|NCT01058707|460165650|FG005|Overall Study|Lost to Follow-up|0|||
127875982|NCT01058707|460165651|FG006|Overall Study|Lost to Follow-up|0|||
127875983|NCT01058707|460165645|FG000|Overall Study|Reason Not Specified|0|||
127875984|NCT01058707|460165646|FG001|Overall Study|Reason Not Specified|3|||
127875985|NCT01058707|460165647|FG002|Overall Study|Reason Not Specified|2|||
127875986|NCT01058707|460165648|FG003|Overall Study|Reason Not Specified|0|||
127875987|NCT01058707|460165649|FG004|Overall Study|Reason Not Specified|7|||
127875988|NCT01058707|460165650|FG005|Overall Study|Reason Not Specified|1|||
127875989|NCT01058707|460165651|FG006|Overall Study|Reason Not Specified|7|||
127875990|NCT01821391|460165652|FG000|Overall Study|Adverse Event|1|||
127875991|NCT01821391|460165653|FG001|Overall Study|Adverse Event|0|||
127875992|NCT04880850|460165662|FG000|Overall Study|Death|2|||
127875993|NCT04880850|460165663|FG001|Overall Study|Death|1|||
127875994|NCT04880850|460165662|FG000|Overall Study|Lost to Follow-up|3|||
127875995|NCT04880850|460165663|FG001|Overall Study|Lost to Follow-up|6|||
127875996|NCT04880850|460165662|FG000|Overall Study|Physician Decision|2|||
127875997|NCT04880850|460165663|FG001|Overall Study|Physician Decision|1|||
127875998|NCT04880850|460165662|FG000|Overall Study|Withdrawal by Subject|9|||
127875999|NCT04880850|460165663|FG001|Overall Study|Withdrawal by Subject|10|||
127876000|NCT01608321|460165664|FG000|Overall Study|Withdrawal by Subject|1|||
127876001|NCT01608321|460165665|FG001|Overall Study|Withdrawal by Subject|0|||
127876002|NCT03417102|460165666|FG000|Overall Study|Adverse Event|0|||
127876003|NCT03417102|460165667|FG001|Overall Study|Adverse Event|1|||
127876004|NCT03417102|460165666|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
127876005|NCT03417102|460165667|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
127876006|NCT03417102|460165666|FG000|Overall Study|Other|0|||
127876007|NCT03417102|460165667|FG001|Overall Study|Other|1|||
127876008|NCT02062385|460165668|FG000|Overall Study|Adverse Event|19|||
127876009|NCT02062385|460165669|FG001|Overall Study|Adverse Event|13|||
127876010|NCT02062385|460165670|FG002|Overall Study|Adverse Event|1|||
127876011|NCT02062385|460165671|FG003|Overall Study|Adverse Event|0|||
127876012|NCT02062385|460165668|FG000|Overall Study|Protocol Violation|1|||
127876013|NCT02062385|460165669|FG001|Overall Study|Protocol Violation|0|||
127876014|NCT02062385|460165670|FG002|Overall Study|Protocol Violation|0|||
127876015|NCT02062385|460165671|FG003|Overall Study|Protocol Violation|0|||
127876016|NCT02062385|460165668|FG000|Overall Study|Incomplete EPI by database lock|2|||
127876017|NCT02062385|460165669|FG001|Overall Study|Incomplete EPI by database lock|0|||
127876018|NCT02062385|460165670|FG002|Overall Study|Incomplete EPI by database lock|0|||
127876019|NCT02062385|460165671|FG003|Overall Study|Incomplete EPI by database lock|0|||
127876020|NCT02062385|460165668|FG000|Overall Study|Moved|10|||
127876021|NCT02062385|460165669|FG001|Overall Study|Moved|11|||
127876022|NCT02062385|460165670|FG002|Overall Study|Moved|1|||
127876023|NCT02062385|460165671|FG003|Overall Study|Moved|0|||
127876024|NCT02062385|460165668|FG000|Overall Study|Withdrawn by parent/guardian|46|||
127876025|NCT02062385|460165669|FG001|Overall Study|Withdrawn by parent/guardian|41|||
127876026|NCT02062385|460165670|FG002|Overall Study|Withdrawn by parent/guardian|9|||
127876027|NCT02062385|460165671|FG003|Overall Study|Withdrawn by parent/guardian|8|||
127542113|NCT01521117|458951136|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
127542114|NCT00784563|458951137|FG000|Years 1 & 2|Withdrawal by Subject|3|||
127542115|NCT00784563|458951138|FG001|Years 1 & 2|Withdrawal by Subject|2|||
127542116|NCT00784563|458951139|FG002|Years 1 & 2|Withdrawal by Subject|0|||
127542117|NCT00784563|458951137|FG000|Years 1 & 2|Adverse Event|0|||
127542118|NCT00784563|458951138|FG001|Years 1 & 2|Adverse Event|3|||
127542119|NCT00784563|458951139|FG002|Years 1 & 2|Adverse Event|0|||
127542120|NCT00784563|458951137|FG000|Year 3|Withdrawal by Subject|0|||
127542121|NCT00784563|458951138|FG001|Year 3|Withdrawal by Subject|0|||
127542122|NCT00784563|458951139|FG002|Year 3|Withdrawal by Subject|2|||
127876028|NCT02062385|460165668|FG000|Overall Study|Death|0|||
127876029|NCT02062385|460165669|FG001|Overall Study|Death|0|||
127876030|NCT02062385|460165670|FG002|Overall Study|Death|0|||
127876031|NCT02062385|460165671|FG003|Overall Study|Death|1|||
127876032|NCT02062385|460165668|FG000|Overall Study|Lost to Follow-up|0|||
127876033|NCT02062385|460165669|FG001|Overall Study|Lost to Follow-up|0|||
127876034|NCT02062385|460165670|FG002|Overall Study|Lost to Follow-up|1|||
127876035|NCT02062385|460165671|FG003|Overall Study|Lost to Follow-up|0|||
127876036|NCT00526227|460165672|FG000|Overall Study|Device not implanted|1|||
127876037|NCT00526227|460165672|FG000|Overall Study|Death|1|||
127876038|NCT03222856|460165675|FG000|Overall Study|Adverse Event|6|||
127876039|NCT03222856|460165675|FG000|Overall Study|Death|1|||
127876040|NCT00706901|460166985|FG000|Overall Study|Lost to Follow-up|2|||
127876041|NCT00706901|460166986|FG001|Overall Study|Lost to Follow-up|3|||
127876042|NCT00706901|460166987|FG002|Overall Study|Lost to Follow-up|2|||
127876043|NCT00706901|460166985|FG000|Overall Study|Withdrawal by Subject|4|||
127876044|NCT00706901|460166986|FG001|Overall Study|Withdrawal by Subject|2|||
127876045|NCT00706901|460166987|FG002|Overall Study|Withdrawal by Subject|5|||
127876046|NCT00706901|460166985|FG000|Overall Study|In Jail|1|||
127876047|NCT00706901|460166986|FG001|Overall Study|In Jail|0|||
127876048|NCT00706901|460166987|FG002|Overall Study|In Jail|1|||
127876049|NCT00706901|460166985|FG000|Overall Study|Death|1|||
127876050|NCT00706901|460166986|FG001|Overall Study|Death|0|||
127876051|NCT00706901|460166987|FG002|Overall Study|Death|0|||
127876052|NCT04478994|460166988|FG000|Overall Study|Withdrawal by Subject|1|||
127876053|NCT04478994|460166989|FG001|Overall Study|Withdrawal by Subject|1|||
127876054|NCT01100073|460166990|FG000|Overall Study|Lack of Efficacy|4|||
127876055|NCT01100073|460166990|FG000|Overall Study|Insufficient Tolerability|21|||
127876056|NCT01100073|460166990|FG000|Overall Study|Withdrawal by Subject|13|||
127876057|NCT01100073|460166990|FG000|Overall Study|Lost to Follow-up|39|||
127876058|NCT01100073|460166990|FG000|Overall Study|Lack of effect + patient's wish|2|||
127876059|NCT01100073|460166990|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
127876060|NCT01100073|460166990|FG000|Overall Study|Other|8|||
127876061|NCT01100073|460166990|FG000|Overall Study|Missing|5|||
127876062|NCT01656850|460166991|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
127876063|NCT01656850|460166992|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
127876064|NCT01741259|460166998|FG000|Overall Study|Protocol Violation|6|||
127876065|NCT01741259|460166999|FG001|Overall Study|Protocol Violation|4|||
127876066|NCT01741259|460166998|FG000|Overall Study|Withdrawal by Subject|0|||
127876067|NCT01741259|460166999|FG001|Overall Study|Withdrawal by Subject|2|||
127876068|NCT00057330|460167005|FG000|Overall Study|Adverse Event|9|||
127876069|NCT00057330|460167006|FG001|Overall Study|Adverse Event|12|||
127876070|NCT00057330|460167005|FG000|Overall Study|Death|1|||
127876071|NCT00057330|460167006|FG001|Overall Study|Death|0|||
127876072|NCT00057330|460167005|FG000|Overall Study|Protocol Violation|1|||
127876073|NCT00057330|460167006|FG001|Overall Study|Protocol Violation|1|||
127876074|NCT00057330|460167005|FG000|Overall Study|Withdrawal by Subject|115|||
127876075|NCT00057330|460167006|FG001|Overall Study|Withdrawal by Subject|84|||
127876076|NCT00057330|460167005|FG000|Overall Study|Lost to Follow-up|745|||
127876077|NCT00057330|460167006|FG001|Overall Study|Lost to Follow-up|617|||
127876078|NCT00057330|460167005|FG000|Overall Study|Physician Decision|1|||
127876079|NCT00057330|460167006|FG001|Overall Study|Physician Decision|0|||
127876080|NCT00057330|460167005|FG000|Overall Study|Other|260|||
127876081|NCT00057330|460167006|FG001|Overall Study|Other|206|||
127876082|NCT04633434|460167009|FG000|Overall Study|Lost to Follow-up|32|||
127876083|NCT04633434|460167010|FG001|Overall Study|Lost to Follow-up|32|||
127876084|NCT01605370|460167018|FG000|Overall Study|Adverse Event|1|||
127876085|NCT01605370|460167019|FG001|Overall Study|Adverse Event|0|||
127876086|NCT00183170|460167024|FG000|First Intervention|Did not complete study|1|||
127876087|NCT00183170|460167025|FG001|First Intervention|Did not complete study|0|||
127876088|NCT00183170|460167024|FG000|First Intervention|Did not meet targeted BrAC|1|||
127876089|NCT00183170|460167025|FG001|First Intervention|Did not meet targeted BrAC|0|||
127876090|NCT00183170|460167024|FG000|Washout 1 Week|Did not complete study|6|||
127876091|NCT00183170|460167025|FG001|Washout 1 Week|Did not complete study|8|||
127876092|NCT00183170|460167024|FG000|Second Intervention|Did not complete study|1|||
127876093|NCT00183170|460167025|FG001|Second Intervention|Did not complete study|0|||
127876094|NCT00183170|460167024|FG000|Second Intervention|Did not meet targeted BrAC|0|||
127876095|NCT00183170|460167025|FG001|Second Intervention|Did not meet targeted BrAC|2|||
127876096|NCT04983589|460167026|FG000|Overall Study|Withdrawal by Subject|0|||
127876097|NCT04983589|460167027|FG001|Overall Study|Withdrawal by Subject|3|||
127876098|NCT04983589|460167026|FG000|Overall Study|COVID-19 Infection|1|||
127876099|NCT04983589|460167027|FG001|Overall Study|COVID-19 Infection|0|||
127876100|NCT04983589|460167026|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
127876101|NCT04983589|460167027|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
127876102|NCT00924820|460167028|FG000|Overall Study|Death|2|||
127876103|NCT00924820|460167028|FG000|Overall Study|Ineligible, Screen Failure|5|||
127876104|NCT00761969|460167029|FG000|Overall Study|Death|112|||
127876105|NCT00761969|460167030|FG001|Overall Study|Death|47|||
127876106|NCT00761969|460167029|FG000|Overall Study|Lost to Follow-up|88|||
127876107|NCT00761969|460167030|FG001|Overall Study|Lost to Follow-up|93|||
127876108|NCT00585468|460167033|FG000|First Intervention|Withdrawal by Subject|1|||
127876109|NCT00585468|460167034|FG001|First Intervention|Withdrawal by Subject|1|||
127876110|NCT01353586|460167035|FG000|Overall Study|Procedure terminated prior to ablation|3|||
127876111|NCT01353586|460167036|FG001|Overall Study|Procedure terminated prior to ablation|0|||
127876112|NCT01353586|460167035|FG000|Overall Study|Never had insertion of study catheter|4|||
127876113|NCT01353586|460167036|FG001|Overall Study|Never had insertion of study catheter|1|||
127876114|NCT01353586|460167035|FG000|Overall Study|Neurological exam not done|0|||
127876115|NCT01353586|460167036|FG001|Overall Study|Neurological exam not done|1|||
127876116|NCT00978120|460167037|FG000|Overall Study|Death|0|||
127876117|NCT00978120|460167038|FG001|Overall Study|Death|0|||
127876118|NCT00978120|460167039|FG002|Overall Study|Death|0|||
127876119|NCT00978120|460167040|FG003|Overall Study|Death|1|||
127876120|NCT00978120|460167037|FG000|Overall Study|Lost to Follow-up|0|||
127876121|NCT00978120|460167038|FG001|Overall Study|Lost to Follow-up|0|||
127876122|NCT00978120|460167039|FG002|Overall Study|Lost to Follow-up|3|||
127876123|NCT00978120|460167040|FG003|Overall Study|Lost to Follow-up|0|||
127876124|NCT00978120|460167037|FG000|Overall Study|Withdrawal by Subject|2|||
127876125|NCT00978120|460167038|FG001|Overall Study|Withdrawal by Subject|0|||
127876126|NCT00978120|460167039|FG002|Overall Study|Withdrawal by Subject|0|||
127876127|NCT00978120|460167040|FG003|Overall Study|Withdrawal by Subject|0|||
127876128|NCT00978120|460167037|FG000|Overall Study|Moved out of state|0|||
127876129|NCT00978120|460167038|FG001|Overall Study|Moved out of state|0|||
127876130|NCT00978120|460167039|FG002|Overall Study|Moved out of state|0|||
127876131|NCT00978120|460167040|FG003|Overall Study|Moved out of state|1|||
127876132|NCT01068418|460167043|FG000|Overall Study|Physician Decision|12|||
127876133|NCT03155269|460167050|FG000|Overall Study|Withdrawal by Subject|4|||
127876134|NCT03155269|460167051|FG001|Overall Study|Withdrawal by Subject|5|||
127876135|NCT03155269|460167050|FG000|Overall Study|Lost to Follow-up|1|||
127876136|NCT03155269|460167051|FG001|Overall Study|Lost to Follow-up|2|||
127876137|NCT03733301|460167058|FG000|Overall Study|Screen Fail|1|||
127876138|NCT03733301|460167059|FG001|Overall Study|Screen Fail|0|||
127876139|NCT03733301|460167060|FG002|Overall Study|Screen Fail|0|||
127876140|NCT03733301|460167058|FG000|Overall Study|Non-compliance|1|||
127876141|NCT03733301|460167059|FG001|Overall Study|Non-compliance|0|||
127876142|NCT03733301|460167060|FG002|Overall Study|Non-compliance|0|||
127876143|NCT03733301|460167058|FG000|Overall Study|Lack of Efficacy|2|||
127876144|NCT03733301|460167059|FG001|Overall Study|Lack of Efficacy|3|||
127876145|NCT03733301|460167060|FG002|Overall Study|Lack of Efficacy|0|||
127876146|NCT03733301|460167058|FG000|Overall Study|Adverse Event|0|||
127876147|NCT03733301|460167059|FG001|Overall Study|Adverse Event|1|||
127876148|NCT03733301|460167060|FG002|Overall Study|Adverse Event|3|||
127876149|NCT03733301|460167058|FG000|Overall Study|Withdrawal by Subject|3|||
127876150|NCT03733301|460167059|FG001|Overall Study|Withdrawal by Subject|5|||
127876151|NCT03733301|460167060|FG002|Overall Study|Withdrawal by Subject|1|||
127876152|NCT03707145|460167062|FG000|Overall Study|Lost to Follow-up|0|||
127876153|NCT03707145|460167063|FG001|Overall Study|Lost to Follow-up|1|||
127876154|NCT03707145|460167064|FG002|Overall Study|Lost to Follow-up|1|||
127876155|NCT03707145|460167065|FG003|Overall Study|Lost to Follow-up|0|||
127876156|NCT04455620|460167069|FG000|Overall Study|Withdrawal by Subject|0|||
127876157|NCT04455620|460167070|FG001|Overall Study|Withdrawal by Subject|0|||
127876158|NCT04455620|460167071|FG002|Overall Study|Withdrawal by Subject|2|||
127876159|NCT04455620|460167072|FG003|Overall Study|Withdrawal by Subject|0|||
127876160|NCT04455620|460167073|FG004|Overall Study|Withdrawal by Subject|1|||
127876161|NCT04455620|460167069|FG000|Overall Study|Lost to Follow-up|0|||
127876162|NCT04455620|460167070|FG001|Overall Study|Lost to Follow-up|0|||
127876163|NCT04455620|460167071|FG002|Overall Study|Lost to Follow-up|1|||
127876164|NCT04455620|460167072|FG003|Overall Study|Lost to Follow-up|1|||
127876165|NCT04455620|460167073|FG004|Overall Study|Lost to Follow-up|0|||
127876166|NCT04455620|460167069|FG000|Overall Study|Death|1|||
127876167|NCT04455620|460167070|FG001|Overall Study|Death|6|||
127876168|NCT04455620|460167071|FG002|Overall Study|Death|20|||
127876169|NCT04455620|460167072|FG003|Overall Study|Death|1|||
127876170|NCT04455620|460167073|FG004|Overall Study|Death|7|||
127876171|NCT04455620|460167069|FG000|Overall Study|Study Termination|0|||
127876172|NCT04455620|460167070|FG001|Overall Study|Study Termination|2|||
127876173|NCT04455620|460167071|FG002|Overall Study|Study Termination|1|||
127876174|NCT04455620|460167072|FG003|Overall Study|Study Termination|0|||
127876175|NCT04455620|460167073|FG004|Overall Study|Study Termination|6|||
127876176|NCT02851069|460167075|FG000|Overall Study|Failure to Return|3|||
127876177|NCT02851069|460167075|FG000|Overall Study|Other|3|||
127876178|NCT03539952|460167084|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
127876179|NCT03539952|460167085|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
127876180|NCT03539952|460167084|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
127876181|NCT03539952|460167085|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
127876182|NCT03539952|460167084|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
127876183|NCT03539952|460167085|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
127876184|NCT03539952|460167084|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
127542123|NCT00784563|458951137|FG000|Year 3|Adverse Event|0|||
127876185|NCT03539952|460167085|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
127876186|NCT03539952|460167084|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
127876187|NCT03539952|460167085|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
127876188|NCT03539952|460167084|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
127876189|NCT03539952|460167085|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
127876190|NCT03539952|460167084|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
127876191|NCT03539952|460167085|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
127876192|NCT01843660|460167086|FG000|Overall Study|Other|30|||
127876193|NCT01977482|460167087|FG000|Overall Study|Adverse Event|0|||
127876194|NCT01977482|460167088|FG001|Overall Study|Adverse Event|1|||
127876195|NCT01977482|460167089|FG002|Overall Study|Adverse Event|1|||
127876196|NCT01977482|460167090|FG003|Overall Study|Adverse Event|0|||
127876197|NCT01977482|460167091|FG004|Overall Study|Adverse Event|2|||
127876198|NCT01977482|460167092|FG005|Overall Study|Adverse Event|0|||
127876199|NCT01977482|460167087|FG000|Overall Study|Lost to Follow-up|1|||
127876200|NCT01977482|460167088|FG001|Overall Study|Lost to Follow-up|0|||
127876201|NCT01977482|460167089|FG002|Overall Study|Lost to Follow-up|0|||
127876202|NCT01977482|460167090|FG003|Overall Study|Lost to Follow-up|0|||
127876203|NCT01977482|460167091|FG004|Overall Study|Lost to Follow-up|0|||
127876204|NCT01977482|460167092|FG005|Overall Study|Lost to Follow-up|0|||
127876205|NCT01977482|460167087|FG000|Overall Study|Physician Decision|0|||
127876206|NCT01977482|460167088|FG001|Overall Study|Physician Decision|1|||
127876207|NCT01977482|460167089|FG002|Overall Study|Physician Decision|0|||
127876208|NCT01977482|460167090|FG003|Overall Study|Physician Decision|0|||
127876209|NCT01977482|460167091|FG004|Overall Study|Physician Decision|0|||
127876210|NCT01977482|460167092|FG005|Overall Study|Physician Decision|0|||
127876211|NCT01977482|460167087|FG000|Overall Study|Protocol Violation|0|||
127876212|NCT01977482|460167088|FG001|Overall Study|Protocol Violation|0|||
127876213|NCT01977482|460167089|FG002|Overall Study|Protocol Violation|1|||
127876214|NCT01977482|460167090|FG003|Overall Study|Protocol Violation|0|||
127876215|NCT01977482|460167091|FG004|Overall Study|Protocol Violation|0|||
127876216|NCT01977482|460167092|FG005|Overall Study|Protocol Violation|0|||
127876217|NCT01977482|460167087|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
127876218|NCT01977482|460167088|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
127876219|NCT01977482|460167089|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
127876220|NCT01977482|460167090|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
127876221|NCT01977482|460167091|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
127876222|NCT01977482|460167092|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
127876223|NCT01977482|460167087|FG000|Overall Study|Withdrawal by Subject|2|||
127876224|NCT01977482|460167088|FG001|Overall Study|Withdrawal by Subject|4|||
127876225|NCT01977482|460167089|FG002|Overall Study|Withdrawal by Subject|1|||
127876226|NCT01977482|460167090|FG003|Overall Study|Withdrawal by Subject|3|||
127876227|NCT01977482|460167091|FG004|Overall Study|Withdrawal by Subject|1|||
127876228|NCT01977482|460167092|FG005|Overall Study|Withdrawal by Subject|5|||
127876229|NCT00795886|460167093|FG000|Overall Study|Death|10|||
127876230|NCT05554471|460167103|FG000|Overall Study|Physician Decision|2|||
127876231|NCT05554471|460167104|FG001|Overall Study|Physician Decision|1|||
127876232|NCT05554471|460167103|FG000|Overall Study|Lost to Follow-up|2|||
127876233|NCT05554471|460167104|FG001|Overall Study|Lost to Follow-up|1|||
127876234|NCT05554471|460167103|FG000|Overall Study|Death|0|||
127876235|NCT05554471|460167104|FG001|Overall Study|Death|1|||
127876236|NCT01319994|460168340|FG000|Overall Study|Protocol Violation|7|||
127876237|NCT01319994|460168341|FG001|Overall Study|Protocol Violation|6|||
127876238|NCT01340794|460168342|FG000|Overall Study|Withdrawal by Subject|0|||
127876239|NCT01340794|460168343|FG001|Overall Study|Withdrawal by Subject|1|||
127876240|NCT01118949|460168346|FG000|Overall Study|Adverse Event|5|||
127876241|NCT01118949|460168346|FG000|Overall Study|Withdrawal by Subject|4|||
127876242|NCT00685763|460168351|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
127876243|NCT00685763|460168351|FG000|Overall Study|Protocol Violation|1|||
127876244|NCT00698009|460168352|FG000|Overall Study|Withdrawal by Subject|1|||
127876245|NCT02856282|460168353|FG000|Overall Study|Withdrawal by Subject|1|||
127876246|NCT02074982|460168354|FG000|Overall Study|Adverse Event|15|||
127876247|NCT02074982|460168355|FG001|Overall Study|Adverse Event|7|||
127876248|NCT02074982|460168354|FG000|Overall Study|Lack of Efficacy|6|||
127876249|NCT02074982|460168355|FG001|Overall Study|Lack of Efficacy|1|||
127876250|NCT02074982|460168354|FG000|Overall Study|Lost to Follow-up|9|||
127876251|NCT02074982|460168355|FG001|Overall Study|Lost to Follow-up|10|||
127876252|NCT02074982|460168354|FG000|Overall Study|Non-compliance with study treatment|0|||
127876253|NCT02074982|460168355|FG001|Overall Study|Non-compliance with study treatment|2|||
127876254|NCT02074982|460168354|FG000|Overall Study|Physician Decision|1|||
127876255|NCT02074982|460168355|FG001|Overall Study|Physician Decision|1|||
127876256|NCT02074982|460168354|FG000|Overall Study|Pregnancy|1|||
127876257|NCT02074982|460168355|FG001|Overall Study|Pregnancy|2|||
127876258|NCT02074982|460168354|FG000|Overall Study|Protocol deviation|4|||
127876259|NCT02074982|460168355|FG001|Overall Study|Protocol deviation|3|||
127876260|NCT02074982|460168354|FG000|Overall Study|Technical problems|0|||
127876261|NCT02074982|460168355|FG001|Overall Study|Technical problems|2|||
127876262|NCT02074982|460168354|FG000|Overall Study|Subject/guardian decision|15|||
127876263|NCT02074982|460168355|FG001|Overall Study|Subject/guardian decision|24|||
127876264|NCT02074982|460168354|FG000|Overall Study|Death|0|||
127876265|NCT02074982|460168355|FG001|Overall Study|Death|2|||
127876266|NCT02094573|460168358|FG000|Overall Study|Adverse Event|4|||
127876267|NCT02094573|460168359|FG001|Overall Study|Adverse Event|14|||
127876268|NCT02094573|460168358|FG000|Overall Study|Clinical Progressive Disease|9|||
127876269|NCT02094573|460168359|FG001|Overall Study|Clinical Progressive Disease|13|||
127876270|NCT02094573|460168358|FG000|Overall Study|Death|11|||
127876271|NCT02094573|460168359|FG001|Overall Study|Death|3|||
127876272|NCT02094573|460168358|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
127876273|NCT02094573|460168359|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
127876274|NCT02094573|460168358|FG000|Overall Study|Non-compliance with Study Drug|1|||
127876275|NCT02094573|460168359|FG001|Overall Study|Non-compliance with Study Drug|1|||
127876276|NCT02094573|460168358|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
127876277|NCT02094573|460168359|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
127876278|NCT02094573|460168358|FG000|Overall Study|Physician Decision|4|||
127876279|NCT02094573|460168359|FG001|Overall Study|Physician Decision|4|||
127652016|NCT02798211|459347501|FG000|Period 1|Withdrawal of Informed Consent|2|||
127652017|NCT02798211|459347502|FG001|Period 1|Withdrawal of Informed Consent|7|||
127652018|NCT02798211|459347503|FG002|Period 1|Withdrawal of Informed Consent|3|||
127652019|NCT02798211|459347504|FG003|Period 1|Withdrawal of Informed Consent|0|||
127652020|NCT02798211|459347505|FG004|Period 1|Withdrawal of Informed Consent|0|||
127652021|NCT02798211|459347506|FG005|Period 1|Withdrawal of Informed Consent|0|||
127652022|NCT02798211|459347501|FG000|Period 2|Withdrawal by Subject|2|||
127876280|NCT02094573|460168358|FG000|Overall Study|Site Terminated by Sponsor|10|||
127876281|NCT02094573|460168359|FG001|Overall Study|Site Terminated by Sponsor|17|||
127876282|NCT02094573|460168358|FG000|Overall Study|Withdrawal by Subject|6|||
127876283|NCT02094573|460168359|FG001|Overall Study|Withdrawal by Subject|8|||
127876284|NCT02094573|460168358|FG000|Overall Study|Randomized but not Treated|3|||
127876285|NCT02094573|460168359|FG001|Overall Study|Randomized but not Treated|0|||
127876286|NCT00471237|460168364|FG000|Overall Study|Adverse Event|6|||
127876287|NCT00471237|460168365|FG001|Overall Study|Adverse Event|5|||
127876288|NCT00471237|460168366|FG002|Overall Study|Adverse Event|4|||
127876289|NCT00471237|460168367|FG003|Overall Study|Adverse Event|8|||
127876290|NCT00471237|460168368|FG004|Overall Study|Adverse Event|7|||
127876291|NCT00471237|460168369|FG005|Overall Study|Adverse Event|5|||
127876292|NCT00471237|460168370|FG006|Overall Study|Adverse Event|0|||
127876293|NCT00471237|460168364|FG000|Overall Study|Lost to Follow-up|1|||
127876294|NCT00471237|460168365|FG001|Overall Study|Lost to Follow-up|1|||
127876295|NCT00471237|460168366|FG002|Overall Study|Lost to Follow-up|0|||
127876296|NCT00471237|460168367|FG003|Overall Study|Lost to Follow-up|2|||
127876297|NCT00471237|460168368|FG004|Overall Study|Lost to Follow-up|3|||
127876298|NCT00471237|460168369|FG005|Overall Study|Lost to Follow-up|0|||
127876299|NCT00471237|460168370|FG006|Overall Study|Lost to Follow-up|0|||
127876300|NCT00471237|460168364|FG000|Overall Study|Protocol Violation|3|||
127876301|NCT00471237|460168365|FG001|Overall Study|Protocol Violation|6|||
127876302|NCT00471237|460168366|FG002|Overall Study|Protocol Violation|3|||
127876303|NCT00471237|460168367|FG003|Overall Study|Protocol Violation|2|||
127876304|NCT00471237|460168368|FG004|Overall Study|Protocol Violation|2|||
127876305|NCT00471237|460168369|FG005|Overall Study|Protocol Violation|4|||
127876306|NCT00471237|460168370|FG006|Overall Study|Protocol Violation|1|||
127876307|NCT00471237|460168364|FG000|Overall Study|Withdrawal by Subject|8|||
127876308|NCT00471237|460168365|FG001|Overall Study|Withdrawal by Subject|6|||
127876309|NCT00471237|460168366|FG002|Overall Study|Withdrawal by Subject|5|||
127876310|NCT00471237|460168367|FG003|Overall Study|Withdrawal by Subject|8|||
127876311|NCT00471237|460168368|FG004|Overall Study|Withdrawal by Subject|7|||
127876312|NCT00471237|460168369|FG005|Overall Study|Withdrawal by Subject|4|||
127876313|NCT00471237|460168370|FG006|Overall Study|Withdrawal by Subject|2|||
127876314|NCT00471237|460168364|FG000|Overall Study|Sponsor terminated study|20|||
127876315|NCT00471237|460168365|FG001|Overall Study|Sponsor terminated study|23|||
127876316|NCT00471237|460168366|FG002|Overall Study|Sponsor terminated study|19|||
127876317|NCT00471237|460168367|FG003|Overall Study|Sponsor terminated study|22|||
127876318|NCT00471237|460168368|FG004|Overall Study|Sponsor terminated study|18|||
127876319|NCT00471237|460168369|FG005|Overall Study|Sponsor terminated study|24|||
127876320|NCT00471237|460168370|FG006|Overall Study|Sponsor terminated study|0|||
127876321|NCT00471237|460168364|FG000|Overall Study|Non-compliance|0|||
127876322|NCT00471237|460168365|FG001|Overall Study|Non-compliance|1|||
127876323|NCT00471237|460168366|FG002|Overall Study|Non-compliance|0|||
127876324|NCT00471237|460168367|FG003|Overall Study|Non-compliance|1|||
127652023|NCT02798211|459347502|FG001|Period 2|Withdrawal by Subject|0|||
127652024|NCT02798211|459347503|FG002|Period 2|Withdrawal by Subject|0|||
127876325|NCT00471237|460168368|FG004|Overall Study|Non-compliance|0|||
127652025|NCT02798211|459347504|FG003|Period 2|Withdrawal by Subject|0|||
127876326|NCT00471237|460168369|FG005|Overall Study|Non-compliance|0|||
127876327|NCT00471237|460168370|FG006|Overall Study|Non-compliance|0|||
127876328|NCT00471237|460168364|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
127876329|NCT00471237|460168365|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
127876330|NCT00471237|460168366|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
127652026|NCT02798211|459347505|FG004|Period 2|Withdrawal by Subject|2|||
127876331|NCT00471237|460168367|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
127876332|NCT00471237|460168368|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
127876333|NCT00471237|460168369|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
127876334|NCT00471237|460168370|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
127876335|NCT00471237|460168364|FG000|Overall Study|Early stopping due to non-efficacy|1|||
127876336|NCT00471237|460168365|FG001|Overall Study|Early stopping due to non-efficacy|0|||
127876337|NCT00471237|460168366|FG002|Overall Study|Early stopping due to non-efficacy|0|||
127876338|NCT00471237|460168367|FG003|Overall Study|Early stopping due to non-efficacy|0|||
127876339|NCT00471237|460168368|FG004|Overall Study|Early stopping due to non-efficacy|1|||
127876340|NCT00471237|460168369|FG005|Overall Study|Early stopping due to non-efficacy|0|||
127876341|NCT00471237|460168370|FG006|Overall Study|Early stopping due to non-efficacy|0|||
127876342|NCT00471237|460168364|FG000|Overall Study|Participant planned to travel to abraod|1|||
127876343|NCT00471237|460168365|FG001|Overall Study|Participant planned to travel to abraod|0|||
127876344|NCT00471237|460168366|FG002|Overall Study|Participant planned to travel to abraod|0|||
127876345|NCT00471237|460168367|FG003|Overall Study|Participant planned to travel to abraod|0|||
127876346|NCT00471237|460168368|FG004|Overall Study|Participant planned to travel to abraod|0|||
127876347|NCT00471237|460168369|FG005|Overall Study|Participant planned to travel to abraod|1|||
127876348|NCT00471237|460168370|FG006|Overall Study|Participant planned to travel to abraod|0|||
127876349|NCT00471237|460168364|FG000|Overall Study|High parathyroid hormone|0|||
127876350|NCT00471237|460168365|FG001|Overall Study|High parathyroid hormone|0|||
127876351|NCT00471237|460168366|FG002|Overall Study|High parathyroid hormone|1|||
127876352|NCT00471237|460168367|FG003|Overall Study|High parathyroid hormone|0|||
127876353|NCT00471237|460168368|FG004|Overall Study|High parathyroid hormone|0|||
127876354|NCT00471237|460168369|FG005|Overall Study|High parathyroid hormone|0|||
127876355|NCT00471237|460168370|FG006|Overall Study|High parathyroid hormone|0|||
127876356|NCT00471237|460168364|FG000|Overall Study|Participant lost medication|0|||
127876357|NCT00471237|460168365|FG001|Overall Study|Participant lost medication|0|||
127876358|NCT00471237|460168366|FG002|Overall Study|Participant lost medication|0|||
127876359|NCT00471237|460168367|FG003|Overall Study|Participant lost medication|0|||
127876360|NCT00471237|460168368|FG004|Overall Study|Participant lost medication|1|||
127876361|NCT00471237|460168369|FG005|Overall Study|Participant lost medication|0|||
127876362|NCT00471237|460168370|FG006|Overall Study|Participant lost medication|0|||
127876363|NCT00471237|460168364|FG000|Overall Study|Administration of prohibited medicine|0|||
127876364|NCT00471237|460168365|FG001|Overall Study|Administration of prohibited medicine|0|||
127876365|NCT00471237|460168366|FG002|Overall Study|Administration of prohibited medicine|0|||
127876366|NCT00471237|460168367|FG003|Overall Study|Administration of prohibited medicine|0|||
127876367|NCT00471237|460168368|FG004|Overall Study|Administration of prohibited medicine|1|||
127876368|NCT00471237|460168369|FG005|Overall Study|Administration of prohibited medicine|0|||
127876369|NCT00471237|460168370|FG006|Overall Study|Administration of prohibited medicine|0|||
127876370|NCT00471237|460168364|FG000|Overall Study|Participant shifted residence|0|||
127876371|NCT00471237|460168365|FG001|Overall Study|Participant shifted residence|0|||
127876372|NCT00471237|460168366|FG002|Overall Study|Participant shifted residence|0|||
127876373|NCT00471237|460168367|FG003|Overall Study|Participant shifted residence|0|||
127876374|NCT00471237|460168368|FG004|Overall Study|Participant shifted residence|1|||
127876375|NCT00471237|460168369|FG005|Overall Study|Participant shifted residence|0|||
127876376|NCT00471237|460168370|FG006|Overall Study|Participant shifted residence|0|||
127876377|NCT00471237|460168364|FG000|Overall Study|Participant's decision|0|||
127876378|NCT00471237|460168365|FG001|Overall Study|Participant's decision|0|||
127876379|NCT00471237|460168366|FG002|Overall Study|Participant's decision|0|||
127876380|NCT00471237|460168367|FG003|Overall Study|Participant's decision|0|||
127876381|NCT00471237|460168368|FG004|Overall Study|Participant's decision|0|||
127876382|NCT00471237|460168369|FG005|Overall Study|Participant's decision|1|||
127876383|NCT00471237|460168370|FG006|Overall Study|Participant's decision|0|||
127876384|NCT02684370|460168374|FG000|Part A|Adverse Event|2|||
127876385|NCT02684370|460168375|FG001|Part A|Adverse Event|0|||
127876386|NCT02684370|460168376|FG002|Part A|Adverse Event|1|||
127876387|NCT02684370|460168377|FG003|Part A|Adverse Event|0|||
127876388|NCT02684370|460168378|FG004|Part A|Adverse Event|0|||
127876389|NCT02684370|460168379|FG005|Part A|Adverse Event|0|||
127876390|NCT02684370|460168374|FG000|Part A|Lost to Follow-up|1|||
127876391|NCT02684370|460168375|FG001|Part A|Lost to Follow-up|1|||
127652027|NCT02798211|459347506|FG005|Period 2|Withdrawal by Subject|2|||
127652028|NCT02798211|459347501|FG000|Period 2|Adverse Event|5|||
127652029|NCT02798211|459347502|FG001|Period 2|Adverse Event|0|||
127652030|NCT02798211|459347503|FG002|Period 2|Adverse Event|0|||
127876392|NCT02684370|460168376|FG002|Part A|Lost to Follow-up|0|||
127876393|NCT02684370|460168377|FG003|Part A|Lost to Follow-up|0|||
127876394|NCT02684370|460168378|FG004|Part A|Lost to Follow-up|0|||
127876395|NCT02684370|460168379|FG005|Part A|Lost to Follow-up|0|||
127876396|NCT02684370|460168374|FG000|Part A|Subject Withdrawal|1|||
127876397|NCT02684370|460168375|FG001|Part A|Subject Withdrawal|0|||
127876398|NCT02684370|460168376|FG002|Part A|Subject Withdrawal|3|||
127876399|NCT02684370|460168377|FG003|Part A|Subject Withdrawal|0|||
127983736|NCT01764997|460562569|FG001|Run-in Period|Other than specified above|0|||
127652031|NCT02798211|459347504|FG003|Period 2|Adverse Event|0|||
127652032|NCT02798211|459347505|FG004|Period 2|Adverse Event|1|||
127876400|NCT02684370|460168378|FG004|Part A|Subject Withdrawal|0|||
127876401|NCT02684370|460168379|FG005|Part A|Subject Withdrawal|0|||
127876402|NCT02684370|460168374|FG000|Part A|Other|0|||
127876403|NCT02684370|460168375|FG001|Part A|Other|0|||
127876404|NCT02684370|460168376|FG002|Part A|Other|1|||
127876405|NCT02684370|460168377|FG003|Part A|Other|0|||
127876406|NCT02684370|460168378|FG004|Part A|Other|0|||
127876407|NCT02684370|460168379|FG005|Part A|Other|0|||
127876408|NCT02684370|460168374|FG000|Part B|Adverse Event|0|||
127876409|NCT02684370|460168375|FG001|Part B|Adverse Event|0|||
127876410|NCT02684370|460168376|FG002|Part B|Adverse Event|0|||
127876411|NCT02684370|460168377|FG003|Part B|Adverse Event|0|||
127876412|NCT02684370|460168378|FG004|Part B|Adverse Event|2|||
127876413|NCT02684370|460168379|FG005|Part B|Adverse Event|1|||
127876414|NCT02684370|460168374|FG000|Part B|Lost to Follow-up|0|||
127876415|NCT02684370|460168375|FG001|Part B|Lost to Follow-up|0|||
127876416|NCT02684370|460168376|FG002|Part B|Lost to Follow-up|0|||
127876417|NCT02684370|460168377|FG003|Part B|Lost to Follow-up|1|||
127876418|NCT02684370|460168378|FG004|Part B|Lost to Follow-up|2|||
127876419|NCT02684370|460168379|FG005|Part B|Lost to Follow-up|5|||
127876420|NCT02684370|460168374|FG000|Part B|Subject Withdrawal|0|||
127876421|NCT02684370|460168375|FG001|Part B|Subject Withdrawal|0|||
127876422|NCT02684370|460168376|FG002|Part B|Subject Withdrawal|0|||
127876423|NCT02684370|460168377|FG003|Part B|Subject Withdrawal|1|||
127876424|NCT02684370|460168378|FG004|Part B|Subject Withdrawal|1|||
127876425|NCT02684370|460168379|FG005|Part B|Subject Withdrawal|2|||
127876426|NCT04221373|460168380|FG000|Overall Study|Physician Decision|4|||
127876427|NCT04221373|460168381|FG001|Overall Study|Physician Decision|0|||
127876428|NCT00627094|460168387|FG000|Overall Study|Adverse Event|8|||
127876429|NCT00627094|460168388|FG001|Overall Study|Adverse Event|7|||
127876430|NCT00627094|460168387|FG000|Overall Study|Lost to Follow-up|1|||
127876431|NCT00627094|460168388|FG001|Overall Study|Lost to Follow-up|0|||
127876432|NCT00627094|460168387|FG000|Overall Study|Withdrawal by Subject|1|||
127876433|NCT00627094|460168388|FG001|Overall Study|Withdrawal by Subject|1|||
127876434|NCT00627094|460168387|FG000|Overall Study|ulcer healed|1|||
127876435|NCT00627094|460168388|FG001|Overall Study|ulcer healed|7|||
127876436|NCT00627094|460168387|FG000|Overall Study|Other reason|1|||
127876437|NCT00627094|460168388|FG001|Overall Study|Other reason|0|||
127876438|NCT00138658|460168389|FG000|Overall Study|Adverse Event|23|||
127876439|NCT00138658|460168389|FG000|Overall Study|Death|1|||
127876440|NCT00138658|460168389|FG000|Overall Study|Disease Progression|21|||
127876441|NCT00138658|460168389|FG000|Overall Study|Physician Decision|11|||
127876442|NCT00138658|460168389|FG000|Overall Study|Withdrawal by Subject|5|||
127876443|NCT04637815|460168394|FG000|Overall Study|Death|1|||
127876444|NCT04637815|460168395|FG001|Overall Study|Death|0|||
127876445|NCT04637815|460168394|FG000|Overall Study|Lost to Follow-up|5|||
127876446|NCT04637815|460168395|FG001|Overall Study|Lost to Follow-up|2|||
127876447|NCT00337727|460168396|FG000|Overall Study|Adverse Event|5|||
127876448|NCT00337727|460168397|FG001|Overall Study|Adverse Event|3|||
127876449|NCT00337727|460168396|FG000|Overall Study|Lost to Follow-up|5|||
127876450|NCT00337727|460168397|FG001|Overall Study|Lost to Follow-up|4|||
127876451|NCT00337727|460168396|FG000|Overall Study|Physician Decision|1|||
127876452|NCT00337727|460168397|FG001|Overall Study|Physician Decision|0|||
127876453|NCT00337727|460168396|FG000|Overall Study|Protocol Violation|4|||
127876454|NCT00337727|460168397|FG001|Overall Study|Protocol Violation|0|||
127876455|NCT00337727|460168396|FG000|Overall Study|Withdrawal by Subject|3|||
127876456|NCT00337727|460168397|FG001|Overall Study|Withdrawal by Subject|5|||
127876457|NCT00577031|460168398|FG000|Overall Study|Adverse Event|52|||
127876458|NCT00577031|460168398|FG000|Overall Study|Progression of disease|93|||
127876459|NCT00577031|460168398|FG000|Overall Study|Protocol Violation|5|||
127876460|NCT00577031|460168398|FG000|Overall Study|Participant withdrew consent|13|||
127876461|NCT00577031|460168398|FG000|Overall Study|Participant non-compliance|5|||
127876462|NCT00577031|460168398|FG000|Overall Study|Need for surgery|17|||
127876463|NCT00577031|460168398|FG000|Overall Study|Medical decision|14|||
127876464|NCT00577031|460168398|FG000|Overall Study|Death|6|||
127876465|NCT06067191|460168399|FG000|Overall Study|Withdrawal by Subject|0|||
127876466|NCT06067191|460168400|FG001|Overall Study|Withdrawal by Subject|1|||
127876467|NCT00625846|460168402|FG000|Overall Study|Withdrawal by Subject|2|||
127876468|NCT00625846|460168403|FG001|Overall Study|Withdrawal by Subject|0|||
127876469|NCT00625846|460168404|FG002|Overall Study|Withdrawal by Subject|1|||
127876470|NCT00625846|460168405|FG003|Overall Study|Withdrawal by Subject|2|||
127876471|NCT00807040|460168406|FG000|Overall Study|Death|24|||
127876472|NCT00807040|460168407|FG001|Overall Study|Death|29|||
127876473|NCT00807040|460168406|FG000|Overall Study|Withdrawal by Subject|8|||
127876474|NCT00807040|460168407|FG001|Overall Study|Withdrawal by Subject|6|||
127876475|NCT00807040|460168406|FG000|Overall Study|Lost to Follow-up|4|||
127876476|NCT00807040|460168407|FG001|Overall Study|Lost to Follow-up|6|||
127876477|NCT00890409|460168412|FG000|Overall Study|Lost to Follow-up|20|||
127876478|NCT00890409|460168413|FG001|Overall Study|Lost to Follow-up|21|||
127876479|NCT00769132|460168415|FG000|Period 1|Adverse Event|1|||
127876480|NCT00769132|460168416|FG001|Period 1|Adverse Event|0|||
127876481|NCT00769132|460168417|FG002|Period 1|Adverse Event|0|||
127876482|NCT00769132|460168418|FG003|Period 1|Adverse Event|1|||
127876483|NCT00769132|460168415|FG000|Period 2|Withdrawal by Subject|0|||
127876484|NCT00769132|460168416|FG001|Period 2|Withdrawal by Subject|0|||
127876485|NCT00769132|460168417|FG002|Period 2|Withdrawal by Subject|0|||
127876486|NCT00769132|460168418|FG003|Period 2|Withdrawal by Subject|1|||
127876487|NCT00769132|460168415|FG000|Period 3|Withdrawal by Subject|1|||
127876488|NCT00769132|460168416|FG001|Period 3|Withdrawal by Subject|0|||
127876489|NCT00769132|460168417|FG002|Period 3|Withdrawal by Subject|0|||
127876490|NCT00769132|460168418|FG003|Period 3|Withdrawal by Subject|0|||
127876491|NCT00769132|460168415|FG000|Period 4|Withdrawal by Subject|0|||
127876492|NCT00769132|460168416|FG001|Period 4|Withdrawal by Subject|1|||
127876493|NCT00769132|460168417|FG002|Period 4|Withdrawal by Subject|0|||
127876494|NCT00769132|460168418|FG003|Period 4|Withdrawal by Subject|0|||
127876495|NCT00877799|460168420|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
127876496|NCT00877799|460168421|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
127876497|NCT00877799|460168422|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
127876498|NCT00877799|460168423|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
127876499|NCT00877799|460168424|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
127876500|NCT00877799|460168420|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
127876501|NCT00877799|460168421|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
127876502|NCT00877799|460168422|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
127876503|NCT00877799|460168423|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
127876504|NCT00877799|460168424|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
127876505|NCT00877799|460168420|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
127876506|NCT00877799|460168421|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
127876507|NCT00877799|460168422|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
127876508|NCT00877799|460168423|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
127876509|NCT00877799|460168424|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
127876510|NCT00877799|460168420|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
127876511|NCT00877799|460168421|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
127876512|NCT00877799|460168422|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
127876513|NCT00877799|460168423|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
127876514|NCT00877799|460168424|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
127876515|NCT00877799|460168420|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
127876516|NCT00877799|460168421|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
127876517|NCT00877799|460168422|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
127876518|NCT00877799|460168423|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
127876519|NCT00877799|460168424|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
127876520|NCT04054011|460168425|FG000|Overall Study|COVID|3|||
127876521|NCT00557830|460168429|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
127876522|NCT00557830|460168430|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
127876523|NCT00557830|460168431|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
127876524|NCT00557830|460168429|FG000|Screening Treatment Phase|Adverse Event|2|||
127876525|NCT00557830|460168430|FG001|Screening Treatment Phase|Adverse Event|0|||
127876526|NCT00557830|460168431|FG002|Screening Treatment Phase|Adverse Event|0|||
127876527|NCT00557830|460168429|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
127876528|NCT00557830|460168430|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
127876529|NCT00557830|460168431|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
127876530|NCT00538473|460168432|FG000|Overall Study|Adverse Event|1|||
127876531|NCT00538473|460168433|FG001|Overall Study|Adverse Event|0|||
127876532|NCT01833897|460168434|FG000|Overall Study|Lack of Efficacy|1|||
127876533|NCT00669110|460168435|FG000|Overall Study|Adverse Event|4|||
127876534|NCT00669110|460168436|FG001|Overall Study|Adverse Event|3|||
127876535|NCT00669110|460168435|FG000|Overall Study|Caregiver request|3|||
127876536|NCT00669110|460168436|FG001|Overall Study|Caregiver request|2|||
127876537|NCT00669110|460168435|FG000|Overall Study|Physician Decision|0|||
127876538|NCT00669110|460168436|FG001|Overall Study|Physician Decision|1|||
127876539|NCT00669110|460168435|FG000|Overall Study|Lost to Follow-up|1|||
127876540|NCT00669110|460168436|FG001|Overall Study|Lost to Follow-up|0|||
127876541|NCT00669110|460168435|FG000|Overall Study|Protocol Violation|0|||
127876542|NCT00669110|460168436|FG001|Overall Study|Protocol Violation|5|||
127876543|NCT00669110|460168435|FG000|Overall Study|Withdrawal by Subject|0|||
127876544|NCT00669110|460168436|FG001|Overall Study|Withdrawal by Subject|2|||
127876545|NCT00127192|460168437|FG000|Overall Study|Adverse Event|0|||
127876546|NCT00127192|460168438|FG001|Overall Study|Adverse Event|1|||
127876547|NCT00127192|460168439|FG002|Overall Study|Adverse Event|1|||
127876548|NCT00127192|460168440|FG003|Overall Study|Adverse Event|1|||
127876549|NCT00127192|460168441|FG004|Overall Study|Adverse Event|0|||
127876550|NCT00127192|460168437|FG000|Overall Study|Lack of Efficacy|2|||
127876551|NCT00127192|460168438|FG001|Overall Study|Lack of Efficacy|0|||
127876552|NCT00127192|460168439|FG002|Overall Study|Lack of Efficacy|0|||
127876553|NCT00127192|460168440|FG003|Overall Study|Lack of Efficacy|0|||
127876554|NCT00127192|460168441|FG004|Overall Study|Lack of Efficacy|2|||
127876555|NCT00127192|460168437|FG000|Overall Study|Withdrawal by Subject|0|||
127876556|NCT00127192|460168438|FG001|Overall Study|Withdrawal by Subject|0|||
127876557|NCT00127192|460168439|FG002|Overall Study|Withdrawal by Subject|1|||
127876558|NCT00127192|460168440|FG003|Overall Study|Withdrawal by Subject|0|||
127876559|NCT00127192|460168441|FG004|Overall Study|Withdrawal by Subject|3|||
127876560|NCT00127192|460168437|FG000|Overall Study|Adverse event in pre-treatment period|1|||
127876561|NCT00127192|460168438|FG001|Overall Study|Adverse event in pre-treatment period|0|||
127876562|NCT00127192|460168439|FG002|Overall Study|Adverse event in pre-treatment period|0|||
127876563|NCT00127192|460168440|FG003|Overall Study|Adverse event in pre-treatment period|0|||
127876564|NCT00127192|460168441|FG004|Overall Study|Adverse event in pre-treatment period|0|||
127876565|NCT01870921|460168442|FG000|Overall Study|Subject decision|80|||
127876566|NCT01870921|460168442|FG000|Overall Study|Severe non-compliance to protocol|7|||
127876567|NCT01870921|460168442|FG000|Overall Study|Subject Lost to Follow up|2|||
127876568|NCT01870921|460168442|FG000|Overall Study|Other|1|||
127876569|NCT04409509|460168443|FG000|Overall Study|Failure to meet randomization requirement|1|||
127876570|NCT04409509|460168444|FG001|Overall Study|Failure to meet randomization requirement|0|||
127876571|NCT04409509|460168443|FG000|Overall Study|Adverse Event|0|||
127876572|NCT04409509|460168444|FG001|Overall Study|Adverse Event|1|||
127876573|NCT04409509|460168443|FG000|Overall Study|Death|11|||
127876574|NCT04409509|460168444|FG001|Overall Study|Death|10|||
127876575|NCT04409509|460168443|FG000|Overall Study|Non-compliance with study drug|0|||
127876576|NCT04409509|460168444|FG001|Overall Study|Non-compliance with study drug|1|||
127876577|NCT04409509|460168443|FG000|Overall Study|Lost to Follow-up|0|||
127876578|NCT04409509|460168444|FG001|Overall Study|Lost to Follow-up|3|||
127876579|NCT04409509|460168443|FG000|Overall Study|Withdrawal by Subject|0|||
127876580|NCT04409509|460168444|FG001|Overall Study|Withdrawal by Subject|3|||
127876581|NCT04409509|460168443|FG000|Overall Study|Randomized by mistake|0|||
127876582|NCT04409509|460168444|FG001|Overall Study|Randomized by mistake|1|||
127876583|NCT04409509|460168443|FG000|Overall Study|Other|1|||
127876584|NCT04409509|460168444|FG001|Overall Study|Other|1|||
127876585|NCT00077766|460168445|FG000|Overall Study|Adverse Event|1|||
127876586|NCT00077766|460168446|FG001|Overall Study|Adverse Event|1|||
127876587|NCT00077766|460168445|FG000|Overall Study|Withdrawal by Subject|4|||
127876588|NCT00077766|460168446|FG001|Overall Study|Withdrawal by Subject|3|||
127876589|NCT00077766|460168445|FG000|Overall Study|Death|12|||
127876590|NCT00077766|460168446|FG001|Overall Study|Death|10|||
127876591|NCT00077766|460168445|FG000|Overall Study|Lost to Follow-up|2|||
127876592|NCT00077766|460168446|FG001|Overall Study|Lost to Follow-up|0|||
127876593|NCT00077766|460168445|FG000|Overall Study|Protocol Violation|1|||
127876594|NCT00077766|460168446|FG001|Overall Study|Protocol Violation|0|||
127876595|NCT00077766|460168445|FG000|Overall Study|Kidney Transplantation|9|||
127876596|NCT00077766|460168446|FG001|Overall Study|Kidney Transplantation|5|||
127876597|NCT00077766|460168445|FG000|Overall Study|Transplantation|5|||
127876598|NCT00077766|460168446|FG001|Overall Study|Transplantation|1|||
127876599|NCT00077766|460168445|FG000|Overall Study|Investigators Discretion|1|||
127876600|NCT00077766|460168446|FG001|Overall Study|Investigators Discretion|0|||
127876601|NCT00077766|460168445|FG000|Overall Study|Participant's decision|1|||
127876602|NCT00077766|460168446|FG001|Overall Study|Participant's decision|0|||
127876603|NCT00077766|460168445|FG000|Overall Study|Dialysis Discontinued|1|||
127876604|NCT00077766|460168446|FG001|Overall Study|Dialysis Discontinued|0|||
127876605|NCT00077766|460168445|FG000|Overall Study|Dialysis|0|||
127876606|NCT00077766|460168446|FG001|Overall Study|Dialysis|1|||
127876607|NCT00077766|460168445|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
127876608|NCT00077766|460168446|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
127876609|NCT00077766|460168445|FG000|Overall Study|Started Nocturnal Dialysis|0|||
127876610|NCT00077766|460168446|FG001|Overall Study|Started Nocturnal Dialysis|1|||
127876611|NCT00077766|460168445|FG000|Overall Study|Stop Dialysis|0|||
127876612|NCT00077766|460168446|FG001|Overall Study|Stop Dialysis|1|||
127876613|NCT00077766|460168445|FG000|Overall Study|Participants Vacation|2|||
127876614|NCT00077766|460168446|FG001|Overall Study|Participants Vacation|1|||
127876615|NCT03843775|460168447|FG000|Overall Study|Adverse Event|1|||
127876616|NCT03843775|460168448|FG001|Overall Study|Adverse Event|1|||
127876617|NCT03843775|460168447|FG000|Overall Study|Lack of Efficacy|2|||
127876618|NCT03843775|460168448|FG001|Overall Study|Lack of Efficacy|6|||
127876619|NCT03843775|460168447|FG000|Overall Study|Withdrawal by Subject|0|||
127876620|NCT03843775|460168448|FG001|Overall Study|Withdrawal by Subject|1|||
127876621|NCT04150107|460168451|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
127876622|NCT04150107|460168452|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
127876623|NCT04150107|460168451|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
127876624|NCT04150107|460168452|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
127876625|NCT02184988|460168460|FG000|Overall Study|Pregnancy|2|||
127876626|NCT02184988|460168460|FG000|Overall Study|Adverse Event|2|||
127876627|NCT02184988|460168460|FG000|Overall Study|moving away/travelling/unable to complet|6|||
127876628|NCT02184988|460168460|FG000|Overall Study|work scheduling issues|4|||
127876629|NCT02184988|460168460|FG000|Overall Study|various other reasons|9|||
127876630|NCT02184988|460168460|FG000|Overall Study|Lost to Follow-up|32|||
127876631|NCT03075215|460168461|FG000|12-Month Primary Endpoint|Death|152|||
127876632|NCT03075215|460168461|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
127876633|NCT03075215|460168461|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
127876634|NCT03075215|460168461|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
127876635|NCT02756182|460168462|FG000|Overall Study|StudyTechnical Difficulties|4|||
127876636|NCT02146365|460168463|FG000|Overall Study|Lost to Follow-up|2|||
127876637|NCT02146365|460168464|FG001|Overall Study|Lost to Follow-up|1|||
127876638|NCT02146365|460168465|FG002|Overall Study|Lost to Follow-up|3|||
127876639|NCT02146365|460168466|FG003|Overall Study|Lost to Follow-up|3|||
127876640|NCT02146365|460168467|FG004|Overall Study|Lost to Follow-up|1|||
127876641|NCT02146365|460168468|FG005|Overall Study|Lost to Follow-up|1|||
127876642|NCT02146365|460168469|FG006|Overall Study|Lost to Follow-up|0|||
127876643|NCT02146365|460168470|FG007|Overall Study|Lost to Follow-up|1|||
127876644|NCT02146365|460168463|FG000|Overall Study|Withdrawal by Subject|1|||
127876645|NCT02146365|460168464|FG001|Overall Study|Withdrawal by Subject|2|||
127876646|NCT02146365|460168465|FG002|Overall Study|Withdrawal by Subject|1|||
127876647|NCT02146365|460168466|FG003|Overall Study|Withdrawal by Subject|5|||
127876648|NCT02146365|460168467|FG004|Overall Study|Withdrawal by Subject|1|||
127876649|NCT02146365|460168468|FG005|Overall Study|Withdrawal by Subject|0|||
127876650|NCT02146365|460168469|FG006|Overall Study|Withdrawal by Subject|0|||
127876651|NCT02146365|460168470|FG007|Overall Study|Withdrawal by Subject|0|||
127876652|NCT02146365|460168463|FG000|Overall Study|Unable to Comply with Protocol|0|||
127876653|NCT02146365|460168464|FG001|Overall Study|Unable to Comply with Protocol|1|||
127876654|NCT02146365|460168465|FG002|Overall Study|Unable to Comply with Protocol|1|||
127876655|NCT02146365|460168466|FG003|Overall Study|Unable to Comply with Protocol|0|||
127876656|NCT02146365|460168467|FG004|Overall Study|Unable to Comply with Protocol|0|||
127876657|NCT02146365|460168468|FG005|Overall Study|Unable to Comply with Protocol|0|||
127876658|NCT02146365|460168469|FG006|Overall Study|Unable to Comply with Protocol|0|||
127876659|NCT02146365|460168470|FG007|Overall Study|Unable to Comply with Protocol|0|||
127876660|NCT02146365|460168463|FG000|Overall Study|Other|1|||
127876661|NCT02146365|460168464|FG001|Overall Study|Other|0|||
127876662|NCT02146365|460168465|FG002|Overall Study|Other|2|||
127876663|NCT02146365|460168466|FG003|Overall Study|Other|1|||
127876664|NCT02146365|460168467|FG004|Overall Study|Other|0|||
127876665|NCT02146365|460168468|FG005|Overall Study|Other|0|||
127876666|NCT02146365|460168469|FG006|Overall Study|Other|0|||
127876667|NCT02146365|460168470|FG007|Overall Study|Other|0|||
127876668|NCT00209560|460168471|FG000|Overall Study|Lack of Efficacy|1|||
127876669|NCT00209560|460168472|FG001|Overall Study|Lack of Efficacy|0|||
127876670|NCT03188991|460168473|FG000|Overall Study|Withdrawal by Subject|0|||
127876671|NCT03188991|460168474|FG001|Overall Study|Withdrawal by Subject|0|||
127876672|NCT03188991|460168475|FG002|Overall Study|Withdrawal by Subject|0|||
127876673|NCT03188991|460168476|FG003|Overall Study|Withdrawal by Subject|1|||
127876674|NCT00798707|460170173|FG000|Overall Study|Adverse Event|6|||
127876675|NCT00798707|460170174|FG001|Overall Study|Adverse Event|8|||
127876676|NCT00798707|460170175|FG002|Overall Study|Adverse Event|8|||
127876677|NCT00798707|460170173|FG000|Overall Study|Failed to return|2|||
127876678|NCT00798707|460170174|FG001|Overall Study|Failed to return|2|||
127876679|NCT00798707|460170175|FG002|Overall Study|Failed to return|0|||
127876680|NCT00798707|460170173|FG000|Overall Study|Investigator|0|||
127876681|NCT00798707|460170174|FG001|Overall Study|Investigator|1|||
127876682|NCT00798707|460170175|FG002|Overall Study|Investigator|2|||
127876683|NCT00798707|460170173|FG000|Overall Study|Lack of Efficacy|2|||
127876684|NCT00798707|460170174|FG001|Overall Study|Lack of Efficacy|2|||
127876685|NCT00798707|460170175|FG002|Overall Study|Lack of Efficacy|1|||
127876686|NCT00798707|460170173|FG000|Overall Study|Lost to Follow-up|5|||
127876687|NCT00798707|460170174|FG001|Overall Study|Lost to Follow-up|6|||
127876688|NCT00798707|460170175|FG002|Overall Study|Lost to Follow-up|6|||
127876689|NCT00798707|460170173|FG000|Overall Study|Other|0|||
127876690|NCT00798707|460170174|FG001|Overall Study|Other|1|||
127876691|NCT00798707|460170175|FG002|Overall Study|Other|0|||
127876692|NCT00798707|460170173|FG000|Overall Study|Protocol Violation|4|||
127876693|NCT00798707|460170174|FG001|Overall Study|Protocol Violation|0|||
127876694|NCT00798707|460170175|FG002|Overall Study|Protocol Violation|2|||
127876695|NCT00798707|460170173|FG000|Overall Study|Withdrawal by Subject|3|||
127876696|NCT00798707|460170174|FG001|Overall Study|Withdrawal by Subject|8|||
127876697|NCT00798707|460170175|FG002|Overall Study|Withdrawal by Subject|2|||
127876698|NCT00798707|460170173|FG000|Overall Study|Randomized not treated|4|||
127876699|NCT00798707|460170174|FG001|Overall Study|Randomized not treated|5|||
127876700|NCT00798707|460170175|FG002|Overall Study|Randomized not treated|1|||
127876701|NCT01160770|460170178|FG000|Overall Study|Adverse Event|10|||
127876702|NCT01160770|460170178|FG000|Overall Study|Protocol Violation|2|||
127876703|NCT01160770|460170178|FG000|Overall Study|Subject/parent/caregiver request|33|||
127876704|NCT01160770|460170178|FG000|Overall Study|Physician Decision|1|||
127876705|NCT01160770|460170178|FG000|Overall Study|Lost to Follow-up|7|||
127876706|NCT01160770|460170178|FG000|Overall Study|Study termination or sponsor request|1|||
127876707|NCT01160770|460170178|FG000|Overall Study|Death|9|||
127876708|NCT01160770|460170178|FG000|Overall Study|Lack of Efficacy|15|||
127876709|NCT01160770|460170178|FG000|Overall Study|Other Reasons|1|||
127876710|NCT03457727|460170179|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
127876711|NCT03457727|460170180|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
127876712|NCT03457727|460170181|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
127876713|NCT03457727|460170182|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
127876714|NCT00929201|460170183|FG000|Period 1|Withdrawal by Subject|0|||
127876715|NCT00929201|460170184|FG001|Period 1|Withdrawal by Subject|1|||
127876716|NCT01299272|460170187|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
127876717|NCT01299272|460170188|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
127876718|NCT01299272|460170189|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
127876719|NCT01299272|460170190|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
127876720|NCT01299272|460170187|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
127876721|NCT01299272|460170188|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
127876722|NCT01299272|460170189|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
127876723|NCT01299272|460170190|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
127876724|NCT01299272|460170187|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
127876725|NCT01299272|460170188|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
127876726|NCT01299272|460170189|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
127876727|NCT01299272|460170190|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
127876728|NCT01299272|460170187|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
127876729|NCT01299272|460170188|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
127876730|NCT01299272|460170189|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
127876731|NCT01299272|460170190|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
127876732|NCT01299272|460170187|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
127876733|NCT01299272|460170188|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
127876734|NCT01299272|460170189|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
127876735|NCT01299272|460170190|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
127876736|NCT01299272|460170187|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
127876737|NCT01299272|460170188|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
127876738|NCT01299272|460170189|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
127876739|NCT01299272|460170190|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
127876740|NCT01299272|460170187|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
127876741|NCT01299272|460170188|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
127876742|NCT01299272|460170189|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
127876743|NCT01299272|460170190|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
127876744|NCT01299272|460170187|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
127876745|NCT01299272|460170188|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
127876746|NCT01299272|460170189|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
127876747|NCT01299272|460170190|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
127876748|NCT01299272|460170187|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
127876749|NCT01299272|460170188|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
127876750|NCT01299272|460170189|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
127876751|NCT01299272|460170190|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
127876752|NCT01299272|460170187|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
127876753|NCT01299272|460170188|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
127876754|NCT01299272|460170189|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
127876755|NCT01299272|460170190|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
127876756|NCT01299272|460170187|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
127876757|NCT01299272|460170188|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
127876758|NCT01299272|460170189|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
127876759|NCT01299272|460170190|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
127876760|NCT01299272|460170187|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
127876761|NCT01299272|460170188|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
127876762|NCT01299272|460170189|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
127876763|NCT01299272|460170190|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
127876764|NCT01299272|460170187|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
127876765|NCT01299272|460170188|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
127876766|NCT01299272|460170189|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
127876767|NCT01299272|460170190|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
127876768|NCT01299272|460170187|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
127876769|NCT01299272|460170188|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
127876770|NCT01299272|460170189|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
127876771|NCT01299272|460170190|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
127876772|NCT01299272|460170187|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
127876773|NCT01299272|460170188|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
127876774|NCT01299272|460170189|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
127876775|NCT01299272|460170190|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
127876776|NCT01299272|460170187|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
127876777|NCT01299272|460170188|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
127876778|NCT01299272|460170189|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
127876779|NCT01299272|460170190|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
127876780|NCT01299272|460170187|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
127876781|NCT01299272|460170188|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
127876782|NCT01299272|460170189|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
127876783|NCT01299272|460170190|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
127876784|NCT01299272|460170187|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
127876785|NCT01299272|460170188|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
127876786|NCT01299272|460170189|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
127876787|NCT01299272|460170190|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
127876788|NCT01299272|460170187|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
127876789|NCT01299272|460170188|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
127876790|NCT01299272|460170189|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
127876791|NCT01299272|460170190|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
127876792|NCT01299272|460170187|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
127876793|NCT01299272|460170188|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
127876794|NCT01299272|460170189|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
127876795|NCT01299272|460170190|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
127876796|NCT01299272|460170187|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
127876797|NCT01299272|460170188|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
127876798|NCT01299272|460170189|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
127876799|NCT01299272|460170190|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
127876800|NCT01299272|460170187|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
127876801|NCT01299272|460170188|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
127876802|NCT01299272|460170189|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
127876803|NCT01299272|460170190|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
127876804|NCT01299272|460170187|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
127876805|NCT01299272|460170188|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
127876806|NCT01299272|460170189|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
127876807|NCT01299272|460170190|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
127876808|NCT01299272|460170187|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
127876809|NCT01299272|460170188|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
127876810|NCT01299272|460170189|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
127876811|NCT01299272|460170190|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
127876812|NCT01299272|460170187|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
127876813|NCT01299272|460170188|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
127876814|NCT01299272|460170189|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
127876815|NCT01299272|460170190|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
127876816|NCT00464308|460170191|FG000|Overall Study|Adverse Event|22|||
127876817|NCT00464308|460170192|FG001|Overall Study|Adverse Event|27|||
127876818|NCT00464308|460170193|FG002|Overall Study|Adverse Event|16|||
127876819|NCT00464308|460170191|FG000|Overall Study|Lost to Follow-up|29|||
127876820|NCT00464308|460170192|FG001|Overall Study|Lost to Follow-up|19|||
127876821|NCT00464308|460170193|FG002|Overall Study|Lost to Follow-up|20|||
127876822|NCT00464308|460170191|FG000|Overall Study|Patient discontinued and other reasons|17|||
127876823|NCT00464308|460170192|FG001|Overall Study|Patient discontinued and other reasons|17|||
127876824|NCT00464308|460170193|FG002|Overall Study|Patient discontinued and other reasons|23|||
127876825|NCT00464308|460170191|FG000|Overall Study|Physician Decision|1|||
127876826|NCT00464308|460170192|FG001|Overall Study|Physician Decision|0|||
127876827|NCT00464308|460170193|FG002|Overall Study|Physician Decision|0|||
127876828|NCT01513759|460170194|FG000|Overall Study|Protocol Violation|4|||
127876829|NCT01513759|460170194|FG000|Overall Study|Death during catheter placement|1|||
127876830|NCT03606109|460170195|FG000|Overall Study|Lost to Follow-up|2|||
127876831|NCT03606109|460170196|FG001|Overall Study|Lost to Follow-up|1|||
127876832|NCT00630994|460170197|FG000|Overall Study|Adverse Event|1|||
127876833|NCT00630994|460170197|FG000|Overall Study|Disease Progression|1|||
127876834|NCT00630994|460170197|FG000|Overall Study|Lack of Efficacy|1|||
127876835|NCT00630994|460170197|FG000|Overall Study|Other|1|||
127876836|NCT03669640|460170198|FG000|Overall Study|Study Terminated by Sponsor|0|||
127876837|NCT03669640|460170199|FG001|Overall Study|Study Terminated by Sponsor|0|||
127876838|NCT03669640|460170200|FG002|Overall Study|Study Terminated by Sponsor|0|||
127876839|NCT03669640|460170201|FG003|Overall Study|Study Terminated by Sponsor|0|||
127876840|NCT03669640|460170202|FG004|Overall Study|Study Terminated by Sponsor|1|||
127876841|NCT03669640|460170203|FG005|Overall Study|Study Terminated by Sponsor|0|||
127652033|NCT02798211|459347506|FG005|Period 2|Adverse Event|0|||
127652034|NCT02798211|459347501|FG000|Period 2|Lack of Efficacy|1|||
127876842|NCT03669640|460170198|FG000|Overall Study|Lost to Follow-up|0|||
127652035|NCT02798211|459347502|FG001|Period 2|Lack of Efficacy|0|||
127876843|NCT03669640|460170199|FG001|Overall Study|Lost to Follow-up|0|||
127876844|NCT03669640|460170200|FG002|Overall Study|Lost to Follow-up|2|||
127876845|NCT03669640|460170201|FG003|Overall Study|Lost to Follow-up|0|||
127876846|NCT03669640|460170202|FG004|Overall Study|Lost to Follow-up|0|||
127876847|NCT03669640|460170203|FG005|Overall Study|Lost to Follow-up|0|||
127876848|NCT03669640|460170198|FG000|Overall Study|Death|0|||
127876849|NCT03669640|460170199|FG001|Overall Study|Death|0|||
127876850|NCT03669640|460170200|FG002|Overall Study|Death|1|||
127876851|NCT03669640|460170201|FG003|Overall Study|Death|0|||
127876852|NCT03669640|460170202|FG004|Overall Study|Death|0|||
127876853|NCT03669640|460170203|FG005|Overall Study|Death|0|||
127876854|NCT03669640|460170198|FG000|Overall Study|Withdrawal by Subject|1|||
127876855|NCT03669640|460170199|FG001|Overall Study|Withdrawal by Subject|2|||
127876856|NCT03669640|460170200|FG002|Overall Study|Withdrawal by Subject|1|||
127876857|NCT03669640|460170201|FG003|Overall Study|Withdrawal by Subject|0|||
127876858|NCT03669640|460170202|FG004|Overall Study|Withdrawal by Subject|1|||
127876859|NCT03669640|460170203|FG005|Overall Study|Withdrawal by Subject|3|||
127876860|NCT03669640|460170198|FG000|Overall Study|Protocol Violation|1|||
127876861|NCT03669640|460170199|FG001|Overall Study|Protocol Violation|0|||
127876862|NCT03669640|460170200|FG002|Overall Study|Protocol Violation|0|||
127876863|NCT03669640|460170201|FG003|Overall Study|Protocol Violation|0|||
127876864|NCT03669640|460170202|FG004|Overall Study|Protocol Violation|0|||
127876865|NCT03669640|460170203|FG005|Overall Study|Protocol Violation|0|||
127876866|NCT03669640|460170198|FG000|Overall Study|Physician Decision|0|||
127876867|NCT03669640|460170199|FG001|Overall Study|Physician Decision|2|||
127876868|NCT03669640|460170200|FG002|Overall Study|Physician Decision|0|||
127876869|NCT03669640|460170201|FG003|Overall Study|Physician Decision|0|||
127876870|NCT03669640|460170202|FG004|Overall Study|Physician Decision|0|||
127876871|NCT03669640|460170203|FG005|Overall Study|Physician Decision|0|||
127876872|NCT03669640|460170198|FG000|Overall Study|Disease Relapse|1|||
127876873|NCT03669640|460170199|FG001|Overall Study|Disease Relapse|0|||
127876874|NCT03669640|460170200|FG002|Overall Study|Disease Relapse|0|||
127876875|NCT03669640|460170201|FG003|Overall Study|Disease Relapse|0|||
127876876|NCT03669640|460170202|FG004|Overall Study|Disease Relapse|0|||
127876877|NCT03669640|460170203|FG005|Overall Study|Disease Relapse|0|||
127876878|NCT03669640|460170198|FG000|Overall Study|Adverse Event|2|||
127876879|NCT03669640|460170199|FG001|Overall Study|Adverse Event|1|||
127876880|NCT03669640|460170200|FG002|Overall Study|Adverse Event|0|||
127876881|NCT03669640|460170201|FG003|Overall Study|Adverse Event|0|||
127876882|NCT03669640|460170202|FG004|Overall Study|Adverse Event|1|||
127876883|NCT03669640|460170203|FG005|Overall Study|Adverse Event|0|||
127876884|NCT03533608|460170204|FG000|Overall Study|Withdrawal by Subject|3|||
127876885|NCT03533608|460170204|FG000|Overall Study|Physician Decision|2|||
127876886|NCT03286426|460170205|FG000|Overall Study|Physician Decision|3|||
127876887|NCT03514121|460170206|FG000|Overall Study|Withdrawal by Subject|0|||
127876888|NCT03514121|460170207|FG001|Overall Study|Withdrawal by Subject|0|||
127876889|NCT03514121|460170208|FG002|Overall Study|Withdrawal by Subject|0|||
127876890|NCT03514121|460170209|FG003|Overall Study|Withdrawal by Subject|0|||
127876891|NCT03514121|460170210|FG004|Overall Study|Withdrawal by Subject|1|||
127876892|NCT03514121|460170211|FG005|Overall Study|Withdrawal by Subject|2|||
127876893|NCT03514121|460170212|FG006|Overall Study|Withdrawal by Subject|1|||
127876894|NCT03514121|460170213|FG007|Overall Study|Withdrawal by Subject|1|||
127876895|NCT03514121|460170214|FG008|Overall Study|Withdrawal by Subject|7|||
127876896|NCT03514121|460170215|FG009|Overall Study|Withdrawal by Subject|2|||
127876897|NCT03514121|460170206|FG000|Overall Study|Death|0|||
127876898|NCT03514121|460170207|FG001|Overall Study|Death|0|||
127876899|NCT03514121|460170208|FG002|Overall Study|Death|0|||
127876900|NCT03514121|460170209|FG003|Overall Study|Death|0|||
127876901|NCT03514121|460170210|FG004|Overall Study|Death|0|||
127876902|NCT03514121|460170211|FG005|Overall Study|Death|3|||
127876903|NCT03514121|460170212|FG006|Overall Study|Death|2|||
127876904|NCT03514121|460170213|FG007|Overall Study|Death|1|||
127876905|NCT03514121|460170214|FG008|Overall Study|Death|26|||
127876906|NCT03514121|460170215|FG009|Overall Study|Death|3|||
127876907|NCT03514121|460170206|FG000|Overall Study|Lost to Follow-up|0|||
127876908|NCT03514121|460170207|FG001|Overall Study|Lost to Follow-up|0|||
127876909|NCT03514121|460170208|FG002|Overall Study|Lost to Follow-up|1|||
127876910|NCT03514121|460170209|FG003|Overall Study|Lost to Follow-up|0|||
127876911|NCT03514121|460170210|FG004|Overall Study|Lost to Follow-up|0|||
127876912|NCT03514121|460170211|FG005|Overall Study|Lost to Follow-up|0|||
127876913|NCT03514121|460170212|FG006|Overall Study|Lost to Follow-up|0|||
127876914|NCT03514121|460170213|FG007|Overall Study|Lost to Follow-up|0|||
127876915|NCT03514121|460170214|FG008|Overall Study|Lost to Follow-up|1|||
127876916|NCT03514121|460170215|FG009|Overall Study|Lost to Follow-up|0|||
127876917|NCT03514121|460170206|FG000|Overall Study|Adverse Event|0|||
127876918|NCT03514121|460170207|FG001|Overall Study|Adverse Event|0|||
127876919|NCT03514121|460170208|FG002|Overall Study|Adverse Event|0|||
127876920|NCT03514121|460170209|FG003|Overall Study|Adverse Event|0|||
127876921|NCT03514121|460170210|FG004|Overall Study|Adverse Event|0|||
127876922|NCT03514121|460170211|FG005|Overall Study|Adverse Event|0|||
127876923|NCT03514121|460170212|FG006|Overall Study|Adverse Event|1|||
127876924|NCT03514121|460170213|FG007|Overall Study|Adverse Event|0|||
127876925|NCT03514121|460170214|FG008|Overall Study|Adverse Event|0|||
127876926|NCT03514121|460170215|FG009|Overall Study|Adverse Event|0|||
127876927|NCT03514121|460170206|FG000|Overall Study|Other|0|||
127876928|NCT03514121|460170207|FG001|Overall Study|Other|1|||
127876929|NCT03514121|460170208|FG002|Overall Study|Other|1|||
127876930|NCT03514121|460170209|FG003|Overall Study|Other|0|||
127876931|NCT03514121|460170210|FG004|Overall Study|Other|1|||
127876932|NCT03514121|460170211|FG005|Overall Study|Other|2|||
127876933|NCT03514121|460170212|FG006|Overall Study|Other|3|||
127876934|NCT03514121|460170213|FG007|Overall Study|Other|2|||
127876935|NCT03514121|460170214|FG008|Overall Study|Other|7|||
127876936|NCT03514121|460170215|FG009|Overall Study|Other|3|||
127876937|NCT03514121|460170206|FG000|Overall Study|Study termination by Sponsor|0|||
127876938|NCT03514121|460170207|FG001|Overall Study|Study termination by Sponsor|0|||
127876939|NCT03514121|460170208|FG002|Overall Study|Study termination by Sponsor|0|||
127876940|NCT03514121|460170209|FG003|Overall Study|Study termination by Sponsor|0|||
127876941|NCT03514121|460170210|FG004|Overall Study|Study termination by Sponsor|0|||
127876942|NCT03514121|460170211|FG005|Overall Study|Study termination by Sponsor|0|||
127876943|NCT03514121|460170212|FG006|Overall Study|Study termination by Sponsor|0|||
127876944|NCT03514121|460170213|FG007|Overall Study|Study termination by Sponsor|0|||
127876945|NCT03514121|460170214|FG008|Overall Study|Study termination by Sponsor|11|||
127876946|NCT03514121|460170215|FG009|Overall Study|Study termination by Sponsor|3|||
127876947|NCT03514121|460170206|FG000|Overall Study|Investigator decision|0|||
127876948|NCT03514121|460170207|FG001|Overall Study|Investigator decision|0|||
127876949|NCT03514121|460170208|FG002|Overall Study|Investigator decision|0|||
127876950|NCT03514121|460170209|FG003|Overall Study|Investigator decision|0|||
127876951|NCT03514121|460170210|FG004|Overall Study|Investigator decision|0|||
127876952|NCT03514121|460170211|FG005|Overall Study|Investigator decision|0|||
127876953|NCT03514121|460170212|FG006|Overall Study|Investigator decision|0|||
127876954|NCT03514121|460170213|FG007|Overall Study|Investigator decision|0|||
127876955|NCT03514121|460170214|FG008|Overall Study|Investigator decision|1|||
127876956|NCT03514121|460170215|FG009|Overall Study|Investigator decision|0|||
127876957|NCT05553600|460170216|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
127876958|NCT05553600|460170217|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
127876959|NCT05553600|460170218|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
127876960|NCT05553600|460170219|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
127876961|NCT05553600|460170216|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
127876962|NCT05553600|460170217|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
127876963|NCT05553600|460170218|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
127876964|NCT05553600|460170219|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
127876965|NCT05553600|460170216|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
127876966|NCT05553600|460170217|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
127876967|NCT05553600|460170218|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
127876968|NCT05553600|460170219|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
127876969|NCT05553600|460170216|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
127876970|NCT05553600|460170217|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
127876971|NCT05553600|460170218|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
127876972|NCT05553600|460170219|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
127876973|NCT05553600|460170216|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
127876974|NCT05553600|460170217|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
127876975|NCT05553600|460170218|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
127876976|NCT05553600|460170219|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
127876977|NCT05553600|460170216|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
127876978|NCT05553600|460170217|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
127876979|NCT05553600|460170218|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
127876980|NCT05553600|460170219|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
127876981|NCT05553600|460170216|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
127876982|NCT05553600|460170217|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
127876983|NCT05553600|460170218|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
127876984|NCT05553600|460170219|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
127876985|NCT05553600|460170216|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
127876986|NCT05553600|460170217|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
127876987|NCT05553600|460170218|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
127876988|NCT05553600|460170219|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
127876989|NCT05553600|460170216|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
127876990|NCT05553600|460170217|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
127876991|NCT05553600|460170218|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
127876992|NCT05553600|460170219|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
127876993|NCT05553600|460170216|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
127876994|NCT05553600|460170217|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
127876995|NCT05553600|460170218|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
127876996|NCT05553600|460170219|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
127876997|NCT05553600|460170216|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
127876998|NCT05553600|460170217|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
127876999|NCT05553600|460170218|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
127877000|NCT05553600|460170219|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
127877001|NCT05553600|460170216|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
127877002|NCT05553600|460170217|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
127877003|NCT05553600|460170218|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
127877004|NCT05553600|460170219|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
127877005|NCT03286400|460170223|FG000|Overall Study|Death|10|||
127877006|NCT03286400|460170223|FG000|Overall Study|Lost to Follow-up|10|||
127877007|NCT03286400|460170223|FG000|Overall Study|Physician Decision|1|||
127877008|NCT03286400|460170223|FG000|Overall Study|Scheduling difficulty|4|||
127877009|NCT00826176|460170224|FG000|Overall Study|Lost to Follow-up|1|||
127877010|NCT00826176|460170225|FG001|Overall Study|Lost to Follow-up|0|||
127877011|NCT00826176|460170224|FG000|Overall Study|Subject Withdrew Consent|3|||
127877012|NCT00826176|460170225|FG001|Overall Study|Subject Withdrew Consent|0|||
127877013|NCT00826176|460170224|FG000|Overall Study|Administrative|9|||
127877014|NCT00826176|460170225|FG001|Overall Study|Administrative|0|||
127877015|NCT00297882|460170231|FG000|Day 14|Lack of Efficacy|12|||
127877016|NCT00297882|460170232|FG001|Day 14|Lack of Efficacy|49|||
127877017|NCT00297882|460170231|FG000|Day 28|Lost to Follow-up|13|||
127877018|NCT00297882|460170232|FG001|Day 28|Lost to Follow-up|23|||
127877019|NCT00297882|460170231|FG000|Day 28|Lack of Efficacy|3|||
127877020|NCT00297882|460170232|FG001|Day 28|Lack of Efficacy|0|||
127877021|NCT04484805|460170233|FG000|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|1|||
127877022|NCT04484805|460170234|FG001|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|0|||
127877023|NCT04484805|460170233|FG000|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|1|||
127877024|NCT04484805|460170234|FG001|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|0|||
127877025|NCT04242264|460170235|FG000|Overall Study|Lost to Follow-up|2|||
127877026|NCT04242264|460170236|FG001|Overall Study|Lost to Follow-up|2|||
127877027|NCT04242264|460170237|FG002|Overall Study|Lost to Follow-up|1|||
127877028|NCT04242264|460170238|FG003|Overall Study|Lost to Follow-up|1|||
127877029|NCT04242264|460170235|FG000|Overall Study|Withdrawal by Subject|1|||
127877030|NCT04242264|460170236|FG001|Overall Study|Withdrawal by Subject|0|||
127877031|NCT04242264|460170237|FG002|Overall Study|Withdrawal by Subject|0|||
127877032|NCT04242264|460170238|FG003|Overall Study|Withdrawal by Subject|0|||
127877033|NCT02116309|460170242|FG000|Overall Study|Lost to Follow-up|0|||
127877034|NCT02116309|460170243|FG001|Overall Study|Lost to Follow-up|1|||
127877035|NCT00848965|460170244|FG000|Overall Study|Adverse Event|1|||
127877036|NCT00848965|460170244|FG000|Overall Study|Withdrawal by Subject|1|||
127877037|NCT03710824|460170245|FG000|Overall Study|Withdrawal by Subject|1|||
127877038|NCT03710824|460170245|FG000|Overall Study|Lost to Follow-up|3|||
127877039|NCT03710824|460170245|FG000|Overall Study|Adverse Event|25|||
127877040|NCT03710824|460170245|FG000|Overall Study|Treatment discontinuation|2|||
127877041|NCT02329834|460170246|FG000|Overall Study|Physician Decision|1|||
127877042|NCT02329834|460170247|FG001|Overall Study|Physician Decision|0|||
127877043|NCT00578448|460170248|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
127877044|NCT00578448|460170248|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
127877045|NCT00578448|460170248|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
127877046|NCT00578448|460170248|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
127877047|NCT01976104|460170249|FG000|Overall Study|Adverse Event|0|||
127877048|NCT01976104|460170250|FG001|Overall Study|Adverse Event|0|||
127877049|NCT01976104|460170251|FG002|Overall Study|Adverse Event|1|||
127877050|NCT01976104|460170252|FG003|Overall Study|Adverse Event|0|||
127877051|NCT01976104|460170249|FG000|Overall Study|Lost to Follow-up|3|||
127652036|NCT02798211|459347503|FG002|Period 2|Lack of Efficacy|0|||
127652037|NCT02798211|459347504|FG003|Period 2|Lack of Efficacy|1|||
127877052|NCT01976104|460170250|FG001|Overall Study|Lost to Follow-up|0|||
127877053|NCT01976104|460170251|FG002|Overall Study|Lost to Follow-up|1|||
127877054|NCT01976104|460170252|FG003|Overall Study|Lost to Follow-up|1|||
127877055|NCT01976104|460170249|FG000|Overall Study|Subject Choice|0|||
127877056|NCT01976104|460170250|FG001|Overall Study|Subject Choice|1|||
127877057|NCT01976104|460170251|FG002|Overall Study|Subject Choice|0|||
127877058|NCT01976104|460170252|FG003|Overall Study|Subject Choice|1|||
127877059|NCT01976104|460170249|FG000|Overall Study|Withdrawal by Subject|3|||
127877060|NCT01976104|460170250|FG001|Overall Study|Withdrawal by Subject|0|||
127877061|NCT01976104|460170251|FG002|Overall Study|Withdrawal by Subject|0|||
127877062|NCT01976104|460170252|FG003|Overall Study|Withdrawal by Subject|1|||
127877063|NCT01976104|460170249|FG000|Overall Study|Other|0|||
127877064|NCT01976104|460170250|FG001|Overall Study|Other|1|||
127877065|NCT01976104|460170251|FG002|Overall Study|Other|0|||
127877066|NCT01976104|460170252|FG003|Overall Study|Other|0|||
127877067|NCT01317199|460170253|FG000|Dose-escalation Phase 1|Physician Decision|5|||
127877068|NCT01317199|460170254|FG001|Dose-escalation Phase 1|Physician Decision|0|||
127877069|NCT01317199|460170255|FG002|Dose-escalation Phase 1|Physician Decision|0|||
127877070|NCT01317199|460170256|FG003|Dose-escalation Phase 1|Physician Decision|0|||
127877071|NCT01317199|460170253|FG000|Dose-escalation Phase 1|Disease progression|1|||
127877072|NCT01317199|460170254|FG001|Dose-escalation Phase 1|Disease progression|0|||
127877073|NCT01317199|460170255|FG002|Dose-escalation Phase 1|Disease progression|0|||
127877074|NCT01317199|460170256|FG003|Dose-escalation Phase 1|Disease progression|0|||
127877075|NCT01317199|460170253|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
127877076|NCT01317199|460170254|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
127877077|NCT01317199|460170255|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
127877078|NCT01317199|460170256|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
127877079|NCT01317199|460170253|FG000|Randomized Phase 2|Disease progression|0|||
127877080|NCT01317199|460170254|FG001|Randomized Phase 2|Disease progression|3|||
127877081|NCT01317199|460170255|FG002|Randomized Phase 2|Disease progression|7|||
127877082|NCT01317199|460170256|FG003|Randomized Phase 2|Disease progression|5|||
127877083|NCT01317199|460170253|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
127877084|NCT01317199|460170254|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
127877085|NCT01317199|460170255|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
127877086|NCT01317199|460170256|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
127877087|NCT01317199|460170253|FG000|Randomized Phase 2|Adverse Event|0|||
127877088|NCT01317199|460170254|FG001|Randomized Phase 2|Adverse Event|0|||
127877089|NCT01317199|460170255|FG002|Randomized Phase 2|Adverse Event|0|||
127877090|NCT01317199|460170256|FG003|Randomized Phase 2|Adverse Event|1|||
127877091|NCT01317199|460170253|FG000|Randomized Phase 2|Comorbidities|0|||
127877092|NCT01317199|460170254|FG001|Randomized Phase 2|Comorbidities|2|||
127877093|NCT01317199|460170255|FG002|Randomized Phase 2|Comorbidities|2|||
127877094|NCT01317199|460170256|FG003|Randomized Phase 2|Comorbidities|2|||
127877095|NCT01317199|460170253|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
127877096|NCT01317199|460170254|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
127877097|NCT01317199|460170255|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
127877098|NCT01317199|460170256|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
127877099|NCT01317199|460170253|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
127877100|NCT01317199|460170254|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
127877101|NCT01317199|460170255|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
127877102|NCT01317199|460170256|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
127877103|NCT01317199|460170253|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
127877104|NCT01317199|460170254|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
127877105|NCT01317199|460170255|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
127877106|NCT01317199|460170256|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
127877107|NCT01317199|460170253|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
127877108|NCT01317199|460170254|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
127877109|NCT01317199|460170255|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
127877110|NCT01317199|460170256|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
127877111|NCT01353209|460170257|FG000|Overall Study|Adverse Event|1|||
127877112|NCT01353209|460170258|FG001|Overall Study|Adverse Event|1|||
127877113|NCT01301625|460170270|FG000|Overall Study|Death|5|||
127877114|NCT01301625|460170270|FG000|Overall Study|Not Due|21|||
127877115|NCT01301625|460170270|FG000|Overall Study|Expected|8|||
127877116|NCT01301625|460170270|FG000|Overall Study|Lost to Follow-up|1|||
127877117|NCT03237325|460170274|FG000|Overall Study|Lost to Follow-up|3|||
127877118|NCT03237325|460170275|FG001|Overall Study|Lost to Follow-up|5|||
127877119|NCT03237325|460170274|FG000|Overall Study|Physician Decision|2|||
127877120|NCT03237325|460170275|FG001|Overall Study|Physician Decision|4|||
127652038|NCT02798211|459347505|FG004|Period 2|Lack of Efficacy|0|||
127652039|NCT02798211|459347506|FG005|Period 2|Lack of Efficacy|1|||
127652040|NCT02798211|459347501|FG000|Period 2|Lost to Follow-up|3|||
127652041|NCT02798211|459347502|FG001|Period 2|Lost to Follow-up|0|||
127652042|NCT02798211|459347503|FG002|Period 2|Lost to Follow-up|0|||
127652043|NCT02798211|459347504|FG003|Period 2|Lost to Follow-up|0|||
127877121|NCT03237325|460170274|FG000|Overall Study|Withdrawal by Subject|9|||
127877122|NCT03237325|460170275|FG001|Overall Study|Withdrawal by Subject|12|||
127877123|NCT03237325|460170274|FG000|Overall Study|Noncompliance with Study Procedures|1|||
127877124|NCT03237325|460170275|FG001|Overall Study|Noncompliance with Study Procedures|1|||
127877125|NCT03237325|460170274|FG000|Overall Study|Termination by Sponsor|0|||
127877126|NCT03237325|460170275|FG001|Overall Study|Termination by Sponsor|1|||
127877127|NCT03237325|460170274|FG000|Overall Study|Reason other than described|0|||
127877128|NCT03237325|460170275|FG001|Overall Study|Reason other than described|2|||
127877129|NCT05102162|460170279|FG000|Overall Study|Withdrawal by Subject|3|||
127877130|NCT05102162|460170280|FG001|Overall Study|Withdrawal by Subject|0|||
127652044|NCT02798211|459347505|FG004|Period 2|Lost to Follow-up|2|||
127652045|NCT02798211|459347506|FG005|Period 2|Lost to Follow-up|0|||
127877131|NCT05102162|460170279|FG000|Overall Study|Baseline cultures negative|4|||
127877132|NCT05102162|460170280|FG001|Overall Study|Baseline cultures negative|2|||
127877133|NCT05102162|460170279|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
127877134|NCT05102162|460170280|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
127877135|NCT05102162|460170279|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
127877136|NCT05102162|460170280|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
127877137|NCT01165424|460170281|FG000|Overall Study|Clinical adverse experiences|1|||
127877138|NCT01165424|460170281|FG000|Overall Study|Laboratory adverse experiences|1|||
127877139|NCT01165424|460170281|FG000|Overall Study|Did not meet entry criteria|1|||
127877140|NCT01165424|460170281|FG000|Overall Study|Participant moved (relocated)|1|||
127877141|NCT02181673|460170282|FG000|Up to Week 24|Adverse Event|2|||
127877142|NCT02181673|460170283|FG001|Up to Week 24|Adverse Event|0|||
127877143|NCT02181673|460170284|FG002|Up to Week 24|Adverse Event|3|||
127877144|NCT02181673|460170282|FG000|Up to Week 24|Death|1|||
127877145|NCT02181673|460170283|FG001|Up to Week 24|Death|0|||
127877146|NCT02181673|460170284|FG002|Up to Week 24|Death|0|||
127877147|NCT02181673|460170282|FG000|Up to Week 24|Lack of Efficacy|1|||
127877148|NCT02181673|460170283|FG001|Up to Week 24|Lack of Efficacy|0|||
127877149|NCT02181673|460170284|FG002|Up to Week 24|Lack of Efficacy|0|||
127877150|NCT02181673|460170282|FG000|Up to Week 24|Lost to Follow-up|1|||
127877151|NCT02181673|460170283|FG001|Up to Week 24|Lost to Follow-up|0|||
127877152|NCT02181673|460170284|FG002|Up to Week 24|Lost to Follow-up|0|||
127877153|NCT02181673|460170282|FG000|Up to Week 24|Physician Decision|0|||
127877154|NCT02181673|460170283|FG001|Up to Week 24|Physician Decision|0|||
127877155|NCT02181673|460170284|FG002|Up to Week 24|Physician Decision|3|||
127877156|NCT02181673|460170282|FG000|Up to Week 24|Withdrawal by Subject|10|||
127877157|NCT02181673|460170283|FG001|Up to Week 24|Withdrawal by Subject|0|||
127877158|NCT02181673|460170284|FG002|Up to Week 24|Withdrawal by Subject|1|||
127877159|NCT02181673|460170282|FG000|Up to Week 24|Other|2|||
127877160|NCT02181673|460170283|FG001|Up to Week 24|Other|0|||
127877161|NCT02181673|460170284|FG002|Up to Week 24|Other|3|||
127877162|NCT02181673|460170282|FG000|Up to Week 24|Randomized not Treated|0|||
127877163|NCT02181673|460170283|FG001|Up to Week 24|Randomized not Treated|0|||
127877164|NCT02181673|460170284|FG002|Up to Week 24|Randomized not Treated|1|||
127877165|NCT02181673|460170282|FG000|Week 24-Week 60|Adverse Event|0|||
127877166|NCT02181673|460170283|FG001|Week 24-Week 60|Adverse Event|4|||
127877167|NCT02181673|460170284|FG002|Week 24-Week 60|Adverse Event|10|||
127877168|NCT02181673|460170282|FG000|Week 24-Week 60|Other|0|||
127877169|NCT02181673|460170283|FG001|Week 24-Week 60|Other|2|||
127877170|NCT02181673|460170284|FG002|Week 24-Week 60|Other|1|||
127877171|NCT02181673|460170282|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
127877172|NCT02181673|460170283|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
127877173|NCT02181673|460170284|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
127877174|NCT02181673|460170282|FG000|Week 24-Week 60|Pregnancy|0|||
127877175|NCT02181673|460170283|FG001|Week 24-Week 60|Pregnancy|0|||
127877176|NCT02181673|460170284|FG002|Week 24-Week 60|Pregnancy|1|||
127877177|NCT02181673|460170282|FG000|Week 24-Week 60|Lack of Efficacy|0|||
127877178|NCT02181673|460170283|FG001|Week 24-Week 60|Lack of Efficacy|0|||
127877179|NCT02181673|460170284|FG002|Week 24-Week 60|Lack of Efficacy|1|||
127877180|NCT02181673|460170282|FG000|Week 24-Week 60|Lost to Follow-up|0|||
127877181|NCT02181673|460170283|FG001|Week 24-Week 60|Lost to Follow-up|0|||
127877182|NCT02181673|460170284|FG002|Week 24-Week 60|Lost to Follow-up|1|||
127877183|NCT02181673|460170282|FG000|Week 24-Week 60|Physician Decision|0|||
127877184|NCT02181673|460170283|FG001|Week 24-Week 60|Physician Decision|0|||
127877185|NCT02181673|460170284|FG002|Week 24-Week 60|Physician Decision|1|||
127877186|NCT00320801|460170285|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
127877187|NCT00320801|460170286|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
127877188|NCT00320801|460170287|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
127877189|NCT00320801|460170288|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
127877190|NCT00320801|460170285|FG000|Open-label Run-in Period|Adverse Event|33|||
127877191|NCT00320801|460170286|FG001|Open-label Run-in Period|Adverse Event|0|||
127877192|NCT00320801|460170287|FG002|Open-label Run-in Period|Adverse Event|0|||
127877193|NCT00320801|460170288|FG003|Open-label Run-in Period|Adverse Event|0|||
127877194|NCT00320801|460170285|FG000|Open-label Run-in Period|Administrative|10|||
127877195|NCT00320801|460170286|FG001|Open-label Run-in Period|Administrative|0|||
127652046|NCT02798211|459347501|FG000|Period 2|Physician Decision|1|||
127877196|NCT00320801|460170287|FG002|Open-label Run-in Period|Administrative|0|||
127877197|NCT00320801|460170288|FG003|Open-label Run-in Period|Administrative|0|||
127877198|NCT00320801|460170285|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
127877199|NCT00320801|460170286|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
127877200|NCT00320801|460170287|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
127877201|NCT00320801|460170288|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
127877202|NCT00320801|460170285|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
127877203|NCT00320801|460170286|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
127877204|NCT00320801|460170287|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
127877205|NCT00320801|460170288|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
127983737|NCT01764997|460562570|FG002|Run-in Period|Other than specified above|0|||
127877206|NCT00320801|460170285|FG000|Open-label Run-in Period|Did not qualify|1|||
127877207|NCT00320801|460170286|FG001|Open-label Run-in Period|Did not qualify|0|||
127877208|NCT00320801|460170287|FG002|Open-label Run-in Period|Did not qualify|0|||
127877209|NCT00320801|460170288|FG003|Open-label Run-in Period|Did not qualify|0|||
127877210|NCT00320801|460170285|FG000|Double-blind Phase|Withdrawal by Subject|0|||
127877211|NCT00320801|460170286|FG001|Double-blind Phase|Withdrawal by Subject|0|||
127877212|NCT00320801|460170287|FG002|Double-blind Phase|Withdrawal by Subject|1|||
127877213|NCT00320801|460170288|FG003|Double-blind Phase|Withdrawal by Subject|0|||
127877214|NCT00320801|460170285|FG000|Double-blind Phase|Adverse Event|0|||
127877215|NCT00320801|460170286|FG001|Double-blind Phase|Adverse Event|2|||
127877216|NCT00320801|460170287|FG002|Double-blind Phase|Adverse Event|8|||
127877217|NCT00320801|460170288|FG003|Double-blind Phase|Adverse Event|0|||
127877218|NCT00320801|460170285|FG000|Double-blind Phase|Administrative|0|||
127877219|NCT00320801|460170286|FG001|Double-blind Phase|Administrative|0|||
127877220|NCT00320801|460170287|FG002|Double-blind Phase|Administrative|4|||
127877221|NCT00320801|460170288|FG003|Double-blind Phase|Administrative|0|||
127877222|NCT00320801|460170285|FG000|Double-blind Phase|Lack of Efficacy|0|||
127877223|NCT00320801|460170286|FG001|Double-blind Phase|Lack of Efficacy|9|||
127877224|NCT00320801|460170287|FG002|Double-blind Phase|Lack of Efficacy|1|||
127877225|NCT00320801|460170288|FG003|Double-blind Phase|Lack of Efficacy|0|||
127877226|NCT00320801|460170285|FG000|Extension Phase|Withdrawal by Subject|0|||
127877227|NCT00320801|460170286|FG001|Extension Phase|Withdrawal by Subject|0|||
127877228|NCT00320801|460170287|FG002|Extension Phase|Withdrawal by Subject|0|||
127877229|NCT00320801|460170288|FG003|Extension Phase|Withdrawal by Subject|6|||
127877230|NCT00320801|460170285|FG000|Extension Phase|Adverse Event|0|||
127877231|NCT00320801|460170286|FG001|Extension Phase|Adverse Event|0|||
127877232|NCT00320801|460170287|FG002|Extension Phase|Adverse Event|0|||
127877233|NCT00320801|460170288|FG003|Extension Phase|Adverse Event|8|||
127877234|NCT00320801|460170285|FG000|Extension Phase|Administrative|0|||
127877235|NCT00320801|460170286|FG001|Extension Phase|Administrative|0|||
127877236|NCT00320801|460170287|FG002|Extension Phase|Administrative|0|||
127877237|NCT00320801|460170288|FG003|Extension Phase|Administrative|29|||
127877238|NCT00320801|460170285|FG000|Extension Phase|Lack of Efficacy|0|||
127877239|NCT00320801|460170286|FG001|Extension Phase|Lack of Efficacy|0|||
127877240|NCT00320801|460170287|FG002|Extension Phase|Lack of Efficacy|0|||
127877241|NCT00320801|460170288|FG003|Extension Phase|Lack of Efficacy|2|||
127877242|NCT00320801|460170285|FG000|Extension Phase|Lost to Follow-up|0|||
127877243|NCT00320801|460170286|FG001|Extension Phase|Lost to Follow-up|0|||
127877244|NCT00320801|460170287|FG002|Extension Phase|Lost to Follow-up|0|||
127877245|NCT00320801|460170288|FG003|Extension Phase|Lost to Follow-up|3|||
127877246|NCT04764669|460170289|FG000|Overall Study|Adverse Event|1|||
127877247|NCT04764669|460170290|FG001|Overall Study|Adverse Event|0|||
127877248|NCT04764669|460170291|FG002|Overall Study|Adverse Event|1|||
127877249|NCT04764669|460170292|FG003|Overall Study|Adverse Event|0|||
127877250|NCT04764669|460170289|FG000|Overall Study|Subject Choice|0|||
127877251|NCT04764669|460170290|FG001|Overall Study|Subject Choice|0|||
127877252|NCT04764669|460170291|FG002|Overall Study|Subject Choice|1|||
127877253|NCT04764669|460170292|FG003|Overall Study|Subject Choice|0|||
127877254|NCT04764669|460170289|FG000|Overall Study|Withdrawal by Subject|2|||
127877255|NCT04764669|460170290|FG001|Overall Study|Withdrawal by Subject|0|||
127877256|NCT04764669|460170291|FG002|Overall Study|Withdrawal by Subject|0|||
127877257|NCT04764669|460170292|FG003|Overall Study|Withdrawal by Subject|0|||
127877258|NCT01067339|460170295|FG000|Overall Study|Withdrawal by Subject|6|||
127877259|NCT01067339|460170296|FG001|Overall Study|Withdrawal by Subject|5|||
127877260|NCT00227591|460170299|FG000|Overall Study|Withdrawal by Subject|1|||
127877261|NCT01886105|460170300|FG000|Overall Study|Lack of Efficacy|3|||
127877262|NCT00690573|460170311|FG000|Overall Study|Lack of Efficacy|8|||
127877263|NCT00690573|460170311|FG000|Overall Study|Withdrawal by Subject|1|||
127877264|NCT04502862|460170312|FG000|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|4|||
127877265|NCT04502862|460170313|FG001|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|6|||
127877266|NCT04502862|460170312|FG000|Overall Study|Withdrawal by Subject|1|||
127877267|NCT04502862|460170313|FG001|Overall Study|Withdrawal by Subject|0|||
127877268|NCT04502862|460170312|FG000|Overall Study|Adverse Event|1|||
127877269|NCT04502862|460170313|FG001|Overall Study|Adverse Event|1|||
127877270|NCT03505606|460171469|FG000|Overall Study|Unable to complete testing / poor co-operation|0|||
127877271|NCT03505606|460171470|FG001|Overall Study|Unable to complete testing / poor co-operation|1|||
127877272|NCT03505606|460171471|FG002|Overall Study|Unable to complete testing / poor co-operation|0|||
127877273|NCT03505606|460171469|FG000|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|1|||
127877274|NCT03505606|460171470|FG001|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
127877275|NCT03505606|460171471|FG002|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
127877276|NCT03505606|460171469|FG000|Overall Study|Stimulus deprivation / previous haemangioma|0|||
127877277|NCT03505606|460171470|FG001|Overall Study|Stimulus deprivation / previous haemangioma|1|||
127877278|NCT03505606|460171471|FG002|Overall Study|Stimulus deprivation / previous haemangioma|0|||
127877279|NCT03505606|460171469|FG000|Overall Study|Poor compliance with refractive correction|0|||
127877280|NCT03505606|460171470|FG001|Overall Study|Poor compliance with refractive correction|0|||
127877281|NCT03505606|460171471|FG002|Overall Study|Poor compliance with refractive correction|1|||
127877282|NCT03505606|460171469|FG000|Overall Study|Insufficient anisometropia|0|||
127877283|NCT03505606|460171470|FG001|Overall Study|Insufficient anisometropia|0|||
127877284|NCT03505606|460171471|FG002|Overall Study|Insufficient anisometropia|2|||
127877285|NCT03505606|460171469|FG000|Overall Study|Ectopia Lentis|0|||
127877286|NCT03505606|460171470|FG001|Overall Study|Ectopia Lentis|0|||
127877287|NCT03505606|460171471|FG002|Overall Study|Ectopia Lentis|1|||
127877288|NCT03505606|460171469|FG000|Overall Study|alternation of amblyopic eye|0|||
127877289|NCT03505606|460171470|FG001|Overall Study|alternation of amblyopic eye|1|||
127877290|NCT03505606|460171471|FG002|Overall Study|alternation of amblyopic eye|0|||
127877291|NCT02087865|460171476|FG000|Overall Study|Withdrawal by Subject|6|||
127877292|NCT02087865|460171477|FG001|Overall Study|Withdrawal by Subject|0|||
127877293|NCT02087865|460171478|FG002|Overall Study|Withdrawal by Subject|1|||
127877294|NCT02087865|460171476|FG000|Overall Study|Lost to Follow-up|0|||
127877295|NCT02087865|460171477|FG001|Overall Study|Lost to Follow-up|0|||
127877296|NCT02087865|460171478|FG002|Overall Study|Lost to Follow-up|1|||
127877297|NCT02087865|460171476|FG000|Overall Study|Drug Non-compliance|0|||
127877298|NCT02087865|460171477|FG001|Overall Study|Drug Non-compliance|2|||
127877299|NCT02087865|460171478|FG002|Overall Study|Drug Non-compliance|0|||
127877300|NCT02087865|460171476|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
127877301|NCT02087865|460171477|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
127877302|NCT02087865|460171478|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
127877303|NCT01392469|460171484|FG000|Overall Study|Adverse Event|2|||
127877304|NCT01392469|460171484|FG000|Overall Study|Withdrawal by Subject|1|||
127877305|NCT01392469|460171484|FG000|Overall Study|Protocol Violation|1|||
127877306|NCT03255226|460171490|FG000|Overall Study|Adverse Event|2|||
127877307|NCT03255226|460171490|FG000|Overall Study|Physician Decision|3|||
127877308|NCT03255226|460171490|FG000|Overall Study|Withdrawal by Subject|1|||
127877309|NCT03255226|460171490|FG000|Overall Study|Serum or blood sodium increased|4|||
127877310|NCT03255226|460171490|FG000|Overall Study|Serum or blood potassium increased|4|||
127652047|NCT02798211|459347502|FG001|Period 2|Physician Decision|0|||
127877311|NCT01035229|460171491|FG000|Overall Study|Adverse Event|61|||
127877312|NCT01035229|460171492|FG001|Overall Study|Adverse Event|14|||
127877313|NCT01035229|460171491|FG000|Overall Study|Withdrawal by Subject|20|||
127877314|NCT01035229|460171492|FG001|Overall Study|Withdrawal by Subject|7|||
127877315|NCT01035229|460171491|FG000|Overall Study|Lost to Follow-up|1|||
127877316|NCT01035229|460171492|FG001|Overall Study|Lost to Follow-up|0|||
127877317|NCT01035229|460171491|FG000|Overall Study|Administrative problems|1|||
127877318|NCT01035229|460171492|FG001|Overall Study|Administrative problems|1|||
127877319|NCT01035229|460171491|FG000|Overall Study|Death|13|||
127877320|NCT01035229|460171492|FG001|Overall Study|Death|5|||
127877321|NCT01035229|460171491|FG000|Overall Study|New cancer therapy|2|||
127877322|NCT01035229|460171492|FG001|Overall Study|New cancer therapy|0|||
127877323|NCT01035229|460171491|FG000|Overall Study|Protocol Violation|0|||
127877324|NCT01035229|460171492|FG001|Overall Study|Protocol Violation|2|||
127877325|NCT01035229|460171491|FG000|Overall Study|Sponsor's decision to end study|3|||
127877326|NCT01035229|460171492|FG001|Overall Study|Sponsor's decision to end study|3|||
127877327|NCT01035229|460171491|FG000|Overall Study|Disease Progression|261|||
127877328|NCT01035229|460171492|FG001|Overall Study|Disease Progression|152|||
127877329|NCT00648739|460171494|FG000|Overall Study|Adverse Event|1|||
127877330|NCT00648739|460171495|FG001|Overall Study|Adverse Event|0|||
127877331|NCT00648739|460171496|FG002|Overall Study|Adverse Event|1|||
127877332|NCT00648739|460171497|FG003|Overall Study|Adverse Event|2|||
127877333|NCT00648739|460171498|FG004|Overall Study|Adverse Event|1|||
127877334|NCT00648739|460171499|FG005|Overall Study|Adverse Event|0|||
127877335|NCT00648739|460171500|FG006|Overall Study|Adverse Event|0|||
127877336|NCT00648739|460171494|FG000|Overall Study|Withdrawal by Subject|1|||
127877337|NCT00648739|460171495|FG001|Overall Study|Withdrawal by Subject|0|||
127877338|NCT00648739|460171496|FG002|Overall Study|Withdrawal by Subject|1|||
127877339|NCT00648739|460171497|FG003|Overall Study|Withdrawal by Subject|0|||
127877340|NCT00648739|460171498|FG004|Overall Study|Withdrawal by Subject|0|||
127877341|NCT00648739|460171499|FG005|Overall Study|Withdrawal by Subject|2|||
127877342|NCT00648739|460171500|FG006|Overall Study|Withdrawal by Subject|0|||
127877343|NCT00648739|460171494|FG000|Overall Study|Lack of Efficacy|0|||
127877344|NCT00648739|460171495|FG001|Overall Study|Lack of Efficacy|0|||
127877345|NCT00648739|460171496|FG002|Overall Study|Lack of Efficacy|0|||
127877346|NCT00648739|460171497|FG003|Overall Study|Lack of Efficacy|0|||
127877347|NCT00648739|460171498|FG004|Overall Study|Lack of Efficacy|1|||
127877348|NCT00648739|460171499|FG005|Overall Study|Lack of Efficacy|2|||
127877349|NCT00648739|460171500|FG006|Overall Study|Lack of Efficacy|0|||
127877350|NCT00648739|460171494|FG000|Overall Study|Investigator Considered it Advisable|0|||
127877351|NCT00648739|460171495|FG001|Overall Study|Investigator Considered it Advisable|0|||
127877352|NCT00648739|460171496|FG002|Overall Study|Investigator Considered it Advisable|0|||
127877353|NCT00648739|460171497|FG003|Overall Study|Investigator Considered it Advisable|0|||
127877354|NCT00648739|460171498|FG004|Overall Study|Investigator Considered it Advisable|0|||
127877355|NCT00648739|460171499|FG005|Overall Study|Investigator Considered it Advisable|1|||
127877356|NCT00648739|460171500|FG006|Overall Study|Investigator Considered it Advisable|1|||
127877357|NCT00648739|460171494|FG000|Overall Study|Death|0|||
127877358|NCT00648739|460171495|FG001|Overall Study|Death|1|||
127877359|NCT00648739|460171496|FG002|Overall Study|Death|0|||
127877360|NCT00648739|460171497|FG003|Overall Study|Death|0|||
127877361|NCT00648739|460171498|FG004|Overall Study|Death|0|||
127877362|NCT00648739|460171499|FG005|Overall Study|Death|0|||
127877363|NCT00648739|460171500|FG006|Overall Study|Death|0|||
127877364|NCT00648739|460171494|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
127877365|NCT00648739|460171495|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
127877366|NCT00648739|460171496|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
127877367|NCT00648739|460171497|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
127877368|NCT00648739|460171498|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
127877369|NCT00648739|460171499|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
127877370|NCT00648739|460171500|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
127877371|NCT00648739|460171494|FG000|Overall Study|Follow-up Visits Not Completed|0|||
127877372|NCT00648739|460171495|FG001|Overall Study|Follow-up Visits Not Completed|1|||
127877373|NCT00648739|460171496|FG002|Overall Study|Follow-up Visits Not Completed|0|||
127877374|NCT00648739|460171497|FG003|Overall Study|Follow-up Visits Not Completed|0|||
127877375|NCT00648739|460171498|FG004|Overall Study|Follow-up Visits Not Completed|0|||
127877376|NCT00648739|460171499|FG005|Overall Study|Follow-up Visits Not Completed|0|||
127877377|NCT00648739|460171500|FG006|Overall Study|Follow-up Visits Not Completed|0|||
127877378|NCT00564486|460171505|FG000|Overall Study|Adverse Event|0|||
127877379|NCT00564486|460171506|FG001|Overall Study|Adverse Event|1|||
127877380|NCT00564486|460171507|FG002|Overall Study|Adverse Event|0|||
127877381|NCT00564486|460171508|FG003|Overall Study|Adverse Event|0|||
127877382|NCT00564486|460171505|FG000|Overall Study|Withdrawal by Subject|4|||
127877383|NCT00564486|460171506|FG001|Overall Study|Withdrawal by Subject|0|||
127877384|NCT00564486|460171507|FG002|Overall Study|Withdrawal by Subject|0|||
127877385|NCT00564486|460171508|FG003|Overall Study|Withdrawal by Subject|5|||
127877386|NCT00564486|460171505|FG000|Overall Study|Subject refused to have blood drawn|0|||
127877387|NCT00564486|460171506|FG001|Overall Study|Subject refused to have blood drawn|0|||
127877388|NCT00564486|460171507|FG002|Overall Study|Subject refused to have blood drawn|1|||
127877389|NCT00564486|460171508|FG003|Overall Study|Subject refused to have blood drawn|0|||
127877390|NCT00564486|460171505|FG000|Overall Study|Lost to Follow-up|3|||
127877391|NCT00564486|460171506|FG001|Overall Study|Lost to Follow-up|0|||
127877392|NCT00564486|460171507|FG002|Overall Study|Lost to Follow-up|2|||
127877393|NCT00564486|460171508|FG003|Overall Study|Lost to Follow-up|2|||
127877394|NCT03862807|460171513|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
127877395|NCT04362761|460171514|FG000|Part A (48 Weeks)|Adverse Event|2|||
127877396|NCT04362761|460171514|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
127877397|NCT04362761|460171514|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
127877398|NCT04362761|460171514|FG000|Part A (48 Weeks)|Other|5|||
127877399|NCT04362761|460171514|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
127877400|NCT04362761|460171514|FG000|Part B (86 Weeks)|Other|4|||
127877401|NCT00684645|460171515|FG000|Overall Study|Death|2|||
127877402|NCT00684645|460171515|FG000|Overall Study|Progressive disease|67|||
127877403|NCT00684645|460171515|FG000|Overall Study|Adverse Event|27|||
127877404|NCT00684645|460171515|FG000|Overall Study|Lost to Follow-up|3|||
127877405|NCT00684645|460171515|FG000|Overall Study|Other|15|||
127877406|NCT02525627|460171529|FG000|Overall Study|Revision|1|||
127877407|NCT02525627|460171530|FG001|Overall Study|Revision|1|||
127877408|NCT02525627|460171529|FG000|Overall Study|Withdrawal by Subject|1|||
127877409|NCT02525627|460171530|FG001|Overall Study|Withdrawal by Subject|2|||
127877410|NCT02525627|460171529|FG000|Overall Study|Death|1|||
127877411|NCT02525627|460171530|FG001|Overall Study|Death|0|||
127877412|NCT02525627|460171529|FG000|Overall Study|Site terminated|11|||
127877413|NCT02525627|460171530|FG001|Overall Study|Site terminated|10|||
127877414|NCT03746080|460171531|FG000|Overall Study|In follow up|2|||
127877415|NCT03746080|460171531|FG000|Overall Study|Death|15|||
127877416|NCT01473589|460171532|FG000|Overall Study|Adverse Event|1|||
127877417|NCT01473589|460171533|FG001|Overall Study|Adverse Event|1|||
127877418|NCT01473589|460171532|FG000|Overall Study|Death|2|||
127877419|NCT01473589|460171533|FG001|Overall Study|Death|0|||
127877420|NCT01473589|460171532|FG000|Overall Study|Lost to Follow-up|2|||
127877421|NCT01473589|460171533|FG001|Overall Study|Lost to Follow-up|2|||
127877422|NCT01473589|460171532|FG000|Overall Study|Protocol Violation|1|||
127877423|NCT01473589|460171533|FG001|Overall Study|Protocol Violation|0|||
127877424|NCT01473589|460171532|FG000|Overall Study|Withdrawal by Subject|5|||
127877425|NCT01473589|460171533|FG001|Overall Study|Withdrawal by Subject|11|||
127877426|NCT01473589|460171532|FG000|Overall Study|Physician Decision|0|||
127652048|NCT02798211|459347503|FG002|Period 2|Physician Decision|0|||
127877427|NCT01473589|460171533|FG001|Overall Study|Physician Decision|1|||
127877428|NCT01473589|460171532|FG000|Overall Study|Entry criteria not met|0|||
127877429|NCT01473589|460171533|FG001|Overall Study|Entry criteria not met|1|||
127877430|NCT01819467|460171534|FG000|Overall Study|Physician Decision|20|||
127877431|NCT01819467|460171535|FG001|Overall Study|Physician Decision|9|||
127877432|NCT03256526|460171537|FG000|Overall Study|Adverse Event|1|||
127877433|NCT03256526|460171538|FG001|Overall Study|Adverse Event|0|||
127877434|NCT03256526|460171539|FG002|Overall Study|Adverse Event|1|||
127877435|NCT03256526|460171537|FG000|Overall Study|Lost to Follow-up|1|||
127877436|NCT03256526|460171538|FG001|Overall Study|Lost to Follow-up|0|||
127877437|NCT03256526|460171539|FG002|Overall Study|Lost to Follow-up|2|||
127877438|NCT02875340|460171540|FG000|Overall Study|Death|2|||
127877439|NCT02875340|460171540|FG000|Overall Study|Withdrawal by Subject|2|||
127877440|NCT02875340|460171540|FG000|Overall Study|Physician Decision|3|||
127877441|NCT02875340|460171540|FG000|Overall Study|Adverse Event|1|||
127877442|NCT01607398|460171543|FG000|Overall Study|Adverse Event|0|||
127877443|NCT01607398|460171544|FG001|Overall Study|Adverse Event|2|||
127877444|NCT01607398|460171543|FG000|Overall Study|Severe COPD|2|||
127877445|NCT01607398|460171544|FG001|Overall Study|Severe COPD|0|||
127877446|NCT04930536|460171547|FG000|Overall Study|Adverse Event|1|||
127877447|NCT04930536|460171548|FG001|Overall Study|Adverse Event|0|||
127877448|NCT04930536|460171547|FG000|Overall Study|Disease Progression|2|||
127877449|NCT04930536|460171548|FG001|Overall Study|Disease Progression|0|||
127877450|NCT04930536|460171547|FG000|Overall Study|Patient Decision|4|||
127877451|NCT04930536|460171548|FG001|Overall Study|Patient Decision|2|||
127877452|NCT04930536|460171547|FG000|Overall Study|Death, Serious Adverse Event, Screen Failure|1|||
127877453|NCT04930536|460171548|FG001|Overall Study|Death, Serious Adverse Event, Screen Failure|3|||
127877454|NCT01432600|460171549|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
127877455|NCT01432600|460171550|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
127877456|NCT01432600|460171551|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
127877457|NCT04139642|460171554|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
127877458|NCT04139642|460171555|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
127877459|NCT00433771|460171557|FG000|Overall Study|screen fail|14|||
127877460|NCT00433771|460171557|FG000|Overall Study|Treated and later found to be ineligible|2|||
127877461|NCT00433771|460171557|FG000|Overall Study|Death|2|||
127877462|NCT00433771|460171557|FG000|Overall Study|Failure to deploy stent|1|||
127877463|NCT00539006|460171561|FG000|Pre-treatment|Other|0|||
127877464|NCT00539006|460171562|FG001|Pre-treatment|Other|1|||
127877465|NCT00539006|460171563|FG002|Pre-treatment|Other|0|||
127877466|NCT00539006|460171564|FG003|Pre-treatment|Other|0|||
127877467|NCT00539006|460171561|FG000|Treatment Period 1|Lost to Follow-up|0|||
127877468|NCT00539006|460171562|FG001|Treatment Period 1|Lost to Follow-up|0|||
127877469|NCT00539006|460171563|FG002|Treatment Period 1|Lost to Follow-up|1|||
127877470|NCT00539006|460171564|FG003|Treatment Period 1|Lost to Follow-up|0|||
127877471|NCT00539006|460171561|FG000|Treatment Period 1|Protocol Violation|0|||
127877472|NCT00539006|460171562|FG001|Treatment Period 1|Protocol Violation|0|||
127877473|NCT00539006|460171563|FG002|Treatment Period 1|Protocol Violation|1|||
127877474|NCT00539006|460171564|FG003|Treatment Period 1|Protocol Violation|0|||
127877475|NCT00539006|460171561|FG000|Treatment Period 1|Lack of Efficacy|0|||
127877476|NCT00539006|460171562|FG001|Treatment Period 1|Lack of Efficacy|0|||
127877477|NCT00539006|460171563|FG002|Treatment Period 1|Lack of Efficacy|0|||
127877478|NCT00539006|460171564|FG003|Treatment Period 1|Lack of Efficacy|1|||
127877479|NCT00539006|460171561|FG000|Washout|Adverse Event|2|||
127877480|NCT00539006|460171562|FG001|Washout|Adverse Event|1|||
127877481|NCT00539006|460171563|FG002|Washout|Adverse Event|0|||
127877482|NCT00539006|460171564|FG003|Washout|Adverse Event|0|||
127877483|NCT00539006|460171561|FG000|Washout|Protocol Violation|1|||
127877484|NCT00539006|460171562|FG001|Washout|Protocol Violation|1|||
127877485|NCT00539006|460171563|FG002|Washout|Protocol Violation|0|||
127877486|NCT00539006|460171564|FG003|Washout|Protocol Violation|0|||
127877487|NCT00539006|460171561|FG000|Washout|Withdrawal by Subject|0|||
127877488|NCT00539006|460171562|FG001|Washout|Withdrawal by Subject|2|||
127877489|NCT00539006|460171563|FG002|Washout|Withdrawal by Subject|0|||
127877490|NCT00539006|460171564|FG003|Washout|Withdrawal by Subject|0|||
127877491|NCT00539006|460171561|FG000|Washout|Failed to meet continuation criteria|16|||
127877492|NCT00539006|460171562|FG001|Washout|Failed to meet continuation criteria|5|||
127877493|NCT00539006|460171563|FG002|Washout|Failed to meet continuation criteria|14|||
127877494|NCT00539006|460171564|FG003|Washout|Failed to meet continuation criteria|6|||
127877495|NCT00539006|460171561|FG000|Washout|Other|1|||
127877496|NCT00539006|460171562|FG001|Washout|Other|1|||
127877497|NCT00539006|460171563|FG002|Washout|Other|2|||
127877498|NCT00539006|460171564|FG003|Washout|Other|3|||
127877499|NCT00539006|460171561|FG000|Treatment Period 2|Protocol Violation|1|||
127877500|NCT00539006|460171562|FG001|Treatment Period 2|Protocol Violation|0|||
127877501|NCT00539006|460171563|FG002|Treatment Period 2|Protocol Violation|0|||
127877502|NCT00539006|460171564|FG003|Treatment Period 2|Protocol Violation|0|||
127877503|NCT00539006|460171561|FG000|Treatment Period 2|Other|0|||
127877504|NCT00539006|460171562|FG001|Treatment Period 2|Other|1|||
127877505|NCT00539006|460171563|FG002|Treatment Period 2|Other|0|||
127877506|NCT00539006|460171564|FG003|Treatment Period 2|Other|0|||
127877507|NCT02353572|460171565|FG000|Overall Study|Withdrawal by Subject|1|||
127877508|NCT02353572|460171565|FG000|Overall Study|Study terminated|2|||
127877509|NCT02230332|460171573|FG000|Overall Study|Adverse Event|2|||
127877510|NCT02230332|460171574|FG001|Overall Study|Adverse Event|1|||
127877511|NCT02230332|460171573|FG000|Overall Study|Lost to Follow-up|1|||
127877512|NCT02230332|460171574|FG001|Overall Study|Lost to Follow-up|0|||
127877513|NCT02230332|460171573|FG000|Overall Study|Protocol Violation|1|||
127877514|NCT02230332|460171574|FG001|Overall Study|Protocol Violation|0|||
127877515|NCT01036594|460171578|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
127877516|NCT01036594|460171579|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
127877517|NCT01036594|460171578|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
127877518|NCT01036594|460171579|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
127877519|NCT01036594|460171578|FG000|Week 12 Evaluation|Adverse Event|5|||
127877520|NCT01036594|460171579|FG001|Week 12 Evaluation|Adverse Event|0|||
127877521|NCT01036594|460171578|FG000|Week 12 Evaluation|Physician Decision|1|||
127877522|NCT01036594|460171579|FG001|Week 12 Evaluation|Physician Decision|0|||
127877523|NCT01036594|460171578|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
127877524|NCT01036594|460171579|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
127877525|NCT01036594|460171578|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
127877526|NCT01036594|460171579|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
127877527|NCT01036594|460171578|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
127877528|NCT01036594|460171579|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
127877529|NCT01036594|460171578|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
127877530|NCT01036594|460171579|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
127877531|NCT01036594|460171578|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
127877532|NCT01036594|460171579|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
127877533|NCT00244881|460171584|FG000|Overall Study|Withdrawal by Subject|3|||
127877534|NCT03664024|460171585|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
127877535|NCT03664024|460171585|FG000|Overall Study|Lost to Follow-up|2|||
127877536|NCT03664024|460171585|FG000|Overall Study|Withdrawal by Subject|2|||
127877537|NCT03664024|460171585|FG000|Overall Study|Death|80|||
127877538|NCT03159611|460171586|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
127877539|NCT03159611|460171587|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
127877540|NCT03159611|460171586|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
127877541|NCT03159611|460171587|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
127877542|NCT03159611|460171586|FG000|Overall Study|Protocol Violation|7|||
127877543|NCT03159611|460171587|FG001|Overall Study|Protocol Violation|4|||
127877544|NCT03159611|460171586|FG000|Overall Study|Adverse Event|1|||
127877545|NCT03159611|460171587|FG001|Overall Study|Adverse Event|0|||
127877546|NCT03159611|460171586|FG000|Overall Study|Withdrawal by Subject|1|||
127877547|NCT03159611|460171587|FG001|Overall Study|Withdrawal by Subject|1|||
127877548|NCT03159611|460171586|FG000|Overall Study|Non-compliance with protocol requirement|3|||
127877549|NCT03159611|460171587|FG001|Overall Study|Non-compliance with protocol requirement|2|||
127877550|NCT03159611|460171586|FG000|Overall Study|Inability to perform procedures|1|||
127877551|NCT03159611|460171587|FG001|Overall Study|Inability to perform procedures|0|||
127877552|NCT02057549|460171589|FG000|Overall Study|Lost to Follow-up|1|||
127877553|NCT02057549|460171590|FG001|Overall Study|Lost to Follow-up|0|||
127877554|NCT02057549|460171589|FG000|Overall Study|Physician Decision|1|||
127877555|NCT02057549|460171590|FG001|Overall Study|Physician Decision|0|||
127877556|NCT02057549|460171589|FG000|Overall Study|Withdrawal by Subject|1|||
127877557|NCT02057549|460171590|FG001|Overall Study|Withdrawal by Subject|0|||
127877558|NCT01418365|460171591|FG000|First Intervention|Withdrawal by Subject|0|||
127877559|NCT01418365|460171592|FG001|First Intervention|Withdrawal by Subject|1|||
127877560|NCT01418365|460171591|FG000|First Intervention|Non-compliance|1|||
127877561|NCT01418365|460171592|FG001|First Intervention|Non-compliance|0|||
127877562|NCT01418365|460171591|FG000|Second Intervention|Withdrawal by Subject|0|||
127877563|NCT01418365|460171592|FG001|Second Intervention|Withdrawal by Subject|1|||
127877564|NCT01283282|460171595|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
127877565|NCT01283282|460171596|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
127877566|NCT01283282|460171595|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
127877567|NCT01283282|460171596|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
127877568|NCT01283282|460171595|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
127877569|NCT01283282|460171596|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
127877570|NCT00777920|460171597|FG000|Overall Study|Adverse Event|39|||
127652049|NCT02798211|459347504|FG003|Period 2|Physician Decision|1|||
127652050|NCT02798211|459347505|FG004|Period 2|Physician Decision|1|||
127877571|NCT00777920|460171597|FG000|Overall Study|Withdrawal of Consent|4|||
127877572|NCT00777920|460171597|FG000|Overall Study|Lost to Follow-up|1|||
127877573|NCT00777920|460171597|FG000|Overall Study|Investigator's discretion|1|||
127877574|NCT00777920|460171597|FG000|Overall Study|Clinical status did not improve|1|||
127877575|NCT00777920|460171597|FG000|Overall Study|Other, not specified|4|||
127877576|NCT00483717|460171598|FG000|Overall Study|Protocol Violation|5|||
127877577|NCT00483717|460171599|FG001|Overall Study|Protocol Violation|7|||
127877578|NCT00483717|460171598|FG000|Overall Study|Time of dosing missing|1|||
127877579|NCT00483717|460171599|FG001|Overall Study|Time of dosing missing|1|||
127877580|NCT00483717|460171598|FG000|Overall Study|No treatment for migraine|16|||
127877581|NCT00483717|460171599|FG001|Overall Study|No treatment for migraine|13|||
127877582|NCT00483717|460171598|FG000|Overall Study|Lost to Follow-up|1|||
127877583|NCT00483717|460171599|FG001|Overall Study|Lost to Follow-up|0|||
127877584|NCT00483717|460171598|FG000|Overall Study|Withdrawal by Subject|1|||
127877585|NCT00483717|460171599|FG001|Overall Study|Withdrawal by Subject|0|||
127877586|NCT01525407|460171600|FG000|Overall Study|Change in recipient treatment plan|2|||
127877587|NCT01525407|460171601|FG001|Overall Study|Change in recipient treatment plan|2|||
127877588|NCT01525407|460171600|FG000|Overall Study|Withdrawal by Subject|0|||
127877589|NCT01525407|460171601|FG001|Overall Study|Withdrawal by Subject|1|||
127877590|NCT01525407|460171600|FG000|Overall Study|Transplant was delayed|0|||
127877591|NCT01525407|460171601|FG001|Overall Study|Transplant was delayed|1|||
127877592|NCT01525407|460171600|FG000|Overall Study|Delay in Transplant|1|||
127877593|NCT01525407|460171601|FG001|Overall Study|Delay in Transplant|0|||
127877594|NCT03319368|460172953|FG000|Overall Study|Discharge swabs not collected from resident|57|||
127877595|NCT03319368|460172954|FG001|Overall Study|Discharge swabs not collected from resident|46|||
127877596|NCT03000075|460172955|FG000|Part A|Adverse Event|4|||
127877597|NCT03000075|460172956|FG001|Part A|Adverse Event|0|||
127877598|NCT03000075|460172957|FG002|Part A|Adverse Event|0|||
127877599|NCT03000075|460172958|FG003|Part A|Adverse Event|0|||
127877600|NCT03000075|460172959|FG004|Part A|Adverse Event|0|||
127877601|NCT03000075|460172960|FG005|Part A|Adverse Event|0|||
127877602|NCT03000075|460172961|FG006|Part A|Adverse Event|0|||
127877603|NCT03000075|460172955|FG000|Part B|Not dosed due to AE|0|||
127877604|NCT03000075|460172956|FG001|Part B|Not dosed due to AE|0|||
127877605|NCT03000075|460172957|FG002|Part B|Not dosed due to AE|0|||
127877606|NCT03000075|460172958|FG003|Part B|Not dosed due to AE|0|||
127877607|NCT03000075|460172959|FG004|Part B|Not dosed due to AE|0|||
127877608|NCT03000075|460172960|FG005|Part B|Not dosed due to AE|2|||
127877609|NCT03000075|460172961|FG006|Part B|Not dosed due to AE|1|||
127877610|NCT03000075|460172955|FG000|Part B|Adverse Event|0|||
127877611|NCT03000075|460172956|FG001|Part B|Adverse Event|0|||
127877612|NCT03000075|460172957|FG002|Part B|Adverse Event|0|||
127877613|NCT03000075|460172958|FG003|Part B|Adverse Event|0|||
127877614|NCT03000075|460172959|FG004|Part B|Adverse Event|1|||
127877615|NCT03000075|460172960|FG005|Part B|Adverse Event|0|||
127877616|NCT03000075|460172961|FG006|Part B|Adverse Event|0|||
127877617|NCT00440193|460172966|FG000|Treatment Period|Adverse Event|74|||
127877618|NCT00440193|460172967|FG001|Treatment Period|Adverse Event|67|||
127877619|NCT00440193|460172966|FG000|Treatment Period|Death|19|||
127877620|NCT00440193|460172967|FG001|Treatment Period|Death|22|||
127877621|NCT00440193|460172966|FG000|Treatment Period|Lack of Efficacy|0|||
127877622|NCT00440193|460172967|FG001|Treatment Period|Lack of Efficacy|1|||
127877623|NCT00440193|460172966|FG000|Treatment Period|Lost to Follow-up|12|||
127877624|NCT00440193|460172967|FG001|Treatment Period|Lost to Follow-up|18|||
127877625|NCT00440193|460172966|FG000|Treatment Period|Physician Decision|3|||
127877626|NCT00440193|460172967|FG001|Treatment Period|Physician Decision|6|||
127877627|NCT00440193|460172966|FG000|Treatment Period|Protocol Violation|16|||
127877628|NCT00440193|460172967|FG001|Treatment Period|Protocol Violation|19|||
127877629|NCT00440193|460172966|FG000|Treatment Period|Withdrawal by Subject|36|||
127877630|NCT00440193|460172967|FG001|Treatment Period|Withdrawal by Subject|77|||
127877631|NCT00440193|460172966|FG000|Treatment Period|Clinical endpoint reached|28|||
127877632|NCT00440193|460172967|FG001|Treatment Period|Clinical endpoint reached|25|||
127877633|NCT00440193|460172966|FG000|Treatment Period|Study terminated by sponsor|102|||
127877634|NCT00440193|460172967|FG001|Treatment Period|Study terminated by sponsor|94|||
127877635|NCT00440193|460172966|FG000|Treatment Period|Protocol driven decision point|2|||
127877636|NCT00440193|460172967|FG001|Treatment Period|Protocol driven decision point|2|||
127877637|NCT00440193|460172966|FG000|Treatment Period|Switch to commercial drug|0|||
127877638|NCT00440193|460172967|FG001|Treatment Period|Switch to commercial drug|2|||
127877639|NCT00440193|460172966|FG000|Treatment Period|Technical problems|1|||
127877640|NCT00440193|460172967|FG001|Treatment Period|Technical problems|1|||
127877641|NCT00440193|460172966|FG000|Treatment Period|Participant convenience|5|||
127877642|NCT00440193|460172967|FG001|Treatment Period|Participant convenience|2|||
127877643|NCT00440193|460172966|FG000|Treatment Period|Participant did not receive treatment|7|||
127877644|NCT00440193|460172967|FG001|Treatment Period|Participant did not receive treatment|13|||
127877645|NCT00440193|460172966|FG000|Treatment Period|Site closed by investigator|0|||
127877646|NCT00440193|460172967|FG001|Treatment Period|Site closed by investigator|2|||
127877647|NCT00440193|460172966|FG000|Observational Period|Adverse Event|2|||
127877648|NCT00440193|460172967|FG001|Observational Period|Adverse Event|2|||
127877649|NCT00440193|460172966|FG000|Observational Period|Death|15|||
127877650|NCT00440193|460172967|FG001|Observational Period|Death|20|||
127877651|NCT00440193|460172966|FG000|Observational Period|Lost to Follow-up|12|||
127877652|NCT00440193|460172967|FG001|Observational Period|Lost to Follow-up|8|||
127877653|NCT00440193|460172966|FG000|Observational Period|Protocol Violation|1|||
127877654|NCT00440193|460172967|FG001|Observational Period|Protocol Violation|0|||
127877655|NCT00440193|460172966|FG000|Observational Period|Withdrawal by Subject|11|||
127877656|NCT00440193|460172967|FG001|Observational Period|Withdrawal by Subject|8|||
127877657|NCT00440193|460172966|FG000|Observational Period|Physician Decision|1|||
127877658|NCT00440193|460172967|FG001|Observational Period|Physician Decision|0|||
127877659|NCT00440193|460172966|FG000|Observational Period|Clinical endpoint reached|1|||
127877660|NCT00440193|460172967|FG001|Observational Period|Clinical endpoint reached|0|||
127877661|NCT00440193|460172966|FG000|Observational Period|Participant convenience|2|||
127877662|NCT00440193|460172967|FG001|Observational Period|Participant convenience|0|||
127877663|NCT00824993|460172968|FG000|Overall Study|Withdrawal by Subject|1|||
127877664|NCT00824993|460172969|FG001|Overall Study|Withdrawal by Subject|1|||
127877665|NCT00824993|460172968|FG000|Overall Study|Malignancy Relapse|9|||
127877666|NCT00824993|460172969|FG001|Overall Study|Malignancy Relapse|10|||
127877667|NCT00824993|460172968|FG000|Overall Study|Rapid Bone Loss|0|||
127877668|NCT00824993|460172969|FG001|Overall Study|Rapid Bone Loss|1|||
127877669|NCT00824993|460172968|FG000|Overall Study|Non-Compliant|2|||
127877670|NCT00824993|460172969|FG001|Overall Study|Non-Compliant|1|||
127877671|NCT00824993|460172968|FG000|Overall Study|Insurance Issue|2|||
127877672|NCT00824993|460172969|FG001|Overall Study|Insurance Issue|1|||
127877673|NCT00824993|460172968|FG000|Overall Study|Death|0|||
127877674|NCT00824993|460172969|FG001|Overall Study|Death|3|||
127877675|NCT00530621|460172975|FG000|Overall Study|Adverse Event|11|||
127877676|NCT00530621|460172976|FG001|Overall Study|Adverse Event|8|||
127877677|NCT00530621|460172975|FG000|Overall Study|Physician Decision|2|||
127877678|NCT00530621|460172976|FG001|Overall Study|Physician Decision|4|||
127877679|NCT00530621|460172975|FG000|Overall Study|Progressive Disease (PD)|47|||
127877680|NCT00530621|460172976|FG001|Overall Study|Progressive Disease (PD)|40|||
127877681|NCT00530621|460172975|FG000|Overall Study|Sponsor Decision|12|||
127877682|NCT00530621|460172976|FG001|Overall Study|Sponsor Decision|15|||
127877683|NCT00530621|460172975|FG000|Overall Study|Subject Decision|4|||
127877684|NCT00530621|460172976|FG001|Overall Study|Subject Decision|7|||
127877685|NCT00530621|460172975|FG000|Overall Study|Death|3|||
127877686|NCT00530621|460172976|FG001|Overall Study|Death|6|||
127877687|NCT00530621|460172975|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
127877688|NCT00530621|460172976|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
127877689|NCT02596009|460172977|FG000|Overall Study|Administrative problems|0|||
127877690|NCT02596009|460172978|FG001|Overall Study|Administrative problems|1|||
127877691|NCT02596009|460172979|FG002|Overall Study|Administrative problems|0|||
127877692|NCT02596009|460172980|FG003|Overall Study|Administrative problems|0|||
127877693|NCT02596009|460172981|FG004|Overall Study|Administrative problems|0|||
127877694|NCT02596009|460172982|FG005|Overall Study|Administrative problems|0|||
127877695|NCT03409328|460172983|FG000|Overall Study|Lost to Follow-up|6|||
127877696|NCT03409328|460172984|FG001|Overall Study|Lost to Follow-up|3|||
127877697|NCT00518011|460172985|FG000|Overall Study|Death|1|||
127877698|NCT00518011|460172986|FG001|Overall Study|Death|1|||
127877699|NCT00518011|460172985|FG000|Overall Study|Adverse Event|2|||
127877700|NCT00518011|460172986|FG001|Overall Study|Adverse Event|3|||
127877701|NCT00518011|460172985|FG000|Overall Study|Disease Progression|2|||
127877702|NCT00518011|460172986|FG001|Overall Study|Disease Progression|2|||
127877703|NCT00518011|460172985|FG000|Overall Study|Other Reasons|3|||
127877704|NCT00518011|460172986|FG001|Overall Study|Other Reasons|2|||
127877705|NCT00518011|460172985|FG000|Overall Study|Withdrawal by Subject|1|||
127877706|NCT00518011|460172986|FG001|Overall Study|Withdrawal by Subject|0|||
127877707|NCT02998645|460172987|FG000|Treatment Period 1|Adverse Event|6|||
127877708|NCT02998645|460172987|FG000|Treatment Period 1|Death|5|||
127877709|NCT02998645|460172987|FG000|Treatment Period 1|Technical Problems|4|||
127877710|NCT02998645|460172987|FG000|Treatment Period 1|Lack of Efficacy|2|||
127877711|NCT02998645|460172987|FG000|Treatment Period 1|Progressive disease|1|||
127877712|NCT02998645|460172987|FG000|Treatment Period 1|Subject/guardian decision|1|||
127877713|NCT02998645|460172987|FG000|Treatment Period 2|Lack of Efficacy|5|||
127877714|NCT02998645|460172987|FG000|Treatment Period 2|Adverse Event|2|||
127877715|NCT02998645|460172987|FG000|Treatment Period 2|Progressive disease|2|||
127877716|NCT02998645|460172987|FG000|Treatment Period 2|Physician Decision|1|||
127877717|NCT03930615|460172988|FG000|Overall Study|Death|9|||
127877718|NCT03930615|460172989|FG001|Overall Study|Death|3|||
127877719|NCT03930615|460172988|FG000|Overall Study|Lost to Follow-up|1|||
127877720|NCT03930615|460172989|FG001|Overall Study|Lost to Follow-up|2|||
127877721|NCT03930615|460172988|FG000|Overall Study|Physician Decision|3|||
127877722|NCT03930615|460172989|FG001|Overall Study|Physician Decision|4|||
127877723|NCT03930615|460172988|FG000|Overall Study|Withdrawal by Subject|13|||
127877724|NCT03930615|460172989|FG001|Overall Study|Withdrawal by Subject|2|||
127877725|NCT03930615|460172988|FG000|Overall Study|Not treated|1|||
127877726|NCT03930615|460172989|FG001|Overall Study|Not treated|1|||
127877727|NCT04611152|460172995|FG000|Overall Study|Adverse Event|9|||
127877728|NCT04611152|460172996|FG001|Overall Study|Adverse Event|8|||
127877729|NCT04611152|460172995|FG000|Overall Study|Non-compliance with study schedule|1|||
127877730|NCT04611152|460172996|FG001|Overall Study|Non-compliance with study schedule|3|||
127877731|NCT04611152|460172995|FG000|Overall Study|Withdrawal by Subject|5|||
127877732|NCT04611152|460172996|FG001|Overall Study|Withdrawal by Subject|6|||
127877733|NCT04611152|460172995|FG000|Overall Study|Lost to Follow-up|11|||
127877734|NCT04611152|460172996|FG001|Overall Study|Lost to Follow-up|2|||
127877735|NCT03644927|460172997|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
127887237|NCT00373685|460210515|FG001|Overall Study|Randomized, not treated|77|||
127877736|NCT03644927|460172998|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
127877737|NCT00956813|460173002|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
127877738|NCT00956813|460173003|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
127877739|NCT00956813|460173002|FG000|Flaxseed and Placebo|Ineligible|3|||
127877740|NCT00956813|460173003|FG001|Flaxseed and Placebo|Ineligible|1|||
127877741|NCT04797637|460173004|FG000|Overall Study|Lost to Follow-up|23|||
127877742|NCT04797637|460173005|FG001|Overall Study|Lost to Follow-up|32|||
127877743|NCT04797637|460173004|FG000|Overall Study|Withdrawal by Subject|0|||
127877744|NCT04797637|460173005|FG001|Overall Study|Withdrawal by Subject|1|||
127877745|NCT01023022|460173012|FG000|Overall Study|Death|5|||
127877746|NCT01023022|460173012|FG000|Overall Study|Lost to Follow-up|7|||
127877747|NCT01023022|460173012|FG000|Overall Study|due to technical issues|2|||
127877748|NCT03917654|460173013|FG000|Year 1|Withdrawal by Subject|1|||
127877749|NCT03917654|460173014|FG001|Year 1|Withdrawal by Subject|0|||
127877750|NCT03917654|460173015|FG002|Year 1|Withdrawal by Subject|0|||
127877751|NCT03917654|460173016|FG003|Year 1|Withdrawal by Subject|0|||
127877752|NCT03917654|460173017|FG004|Year 1|Withdrawal by Subject|0|||
127877753|NCT03917654|460173018|FG005|Year 1|Withdrawal by Subject|1|||
127877754|NCT03917654|460173019|FG006|Year 1|Withdrawal by Subject|6|||
127877755|NCT03917654|460173020|FG007|Year 1|Withdrawal by Subject|2|||
127877756|NCT03917654|460173021|FG008|Year 1|Withdrawal by Subject|5|||
127877757|NCT03917654|460173022|FG009|Year 1|Withdrawal by Subject|3|||
127877758|NCT03917654|460173023|FG010|Year 1|Withdrawal by Subject|1|||
127877759|NCT03917654|460173024|FG011|Year 1|Withdrawal by Subject|0|||
127877760|NCT03917654|460173013|FG000|Year 1|Travel|0|||
127877761|NCT03917654|460173014|FG001|Year 1|Travel|1|||
127652051|NCT02798211|459347506|FG005|Period 2|Physician Decision|0|||
127652052|NCT02798211|459347501|FG000|Period 2|Pregnancy|0|||
127652053|NCT02798211|459347502|FG001|Period 2|Pregnancy|0|||
127652054|NCT02798211|459347503|FG002|Period 2|Pregnancy|0|||
127652055|NCT02798211|459347504|FG003|Period 2|Pregnancy|2|||
127652056|NCT02798211|459347505|FG004|Period 2|Pregnancy|0|||
127877762|NCT03917654|460173015|FG002|Year 1|Travel|1|||
127877763|NCT03917654|460173016|FG003|Year 1|Travel|0|||
127877764|NCT03917654|460173017|FG004|Year 1|Travel|4|||
127877765|NCT03917654|460173018|FG005|Year 1|Travel|4|||
127877766|NCT03917654|460173019|FG006|Year 1|Travel|10|||
127877767|NCT03917654|460173020|FG007|Year 1|Travel|8|||
127877768|NCT03917654|460173021|FG008|Year 1|Travel|2|||
127877769|NCT03917654|460173022|FG009|Year 1|Travel|5|||
127877770|NCT03917654|460173023|FG010|Year 1|Travel|3|||
127877771|NCT03917654|460173024|FG011|Year 1|Travel|3|||
127877772|NCT03917654|460173013|FG000|Year 1|Subject moved away from site|0|||
127877773|NCT03917654|460173014|FG001|Year 1|Subject moved away from site|1|||
127877774|NCT03917654|460173015|FG002|Year 1|Subject moved away from site|0|||
127877775|NCT03917654|460173016|FG003|Year 1|Subject moved away from site|0|||
127877776|NCT03917654|460173017|FG004|Year 1|Subject moved away from site|0|||
127877777|NCT03917654|460173018|FG005|Year 1|Subject moved away from site|0|||
127877778|NCT03917654|460173019|FG006|Year 1|Subject moved away from site|1|||
127877779|NCT03917654|460173020|FG007|Year 1|Subject moved away from site|2|||
127877780|NCT03917654|460173021|FG008|Year 1|Subject moved away from site|1|||
127877781|NCT03917654|460173022|FG009|Year 1|Subject moved away from site|0|||
127877782|NCT03917654|460173023|FG010|Year 1|Subject moved away from site|0|||
127877783|NCT03917654|460173024|FG011|Year 1|Subject moved away from site|3|||
127877784|NCT03917654|460173013|FG000|Year 1|Spouse/Family member request|0|||
127877785|NCT03917654|460173014|FG001|Year 1|Spouse/Family member request|0|||
127877786|NCT03917654|460173015|FG002|Year 1|Spouse/Family member request|1|||
127877787|NCT03917654|460173016|FG003|Year 1|Spouse/Family member request|0|||
127877788|NCT03917654|460173017|FG004|Year 1|Spouse/Family member request|1|||
127877789|NCT03917654|460173018|FG005|Year 1|Spouse/Family member request|0|||
127877790|NCT03917654|460173019|FG006|Year 1|Spouse/Family member request|0|||
127877791|NCT03917654|460173020|FG007|Year 1|Spouse/Family member request|2|||
127877792|NCT03917654|460173021|FG008|Year 1|Spouse/Family member request|0|||
127877793|NCT03917654|460173022|FG009|Year 1|Spouse/Family member request|0|||
127877794|NCT03917654|460173023|FG010|Year 1|Spouse/Family member request|0|||
127877795|NCT03917654|460173024|FG011|Year 1|Spouse/Family member request|1|||
127877796|NCT03917654|460173013|FG000|Year 1|Death|0|||
127877797|NCT03917654|460173014|FG001|Year 1|Death|0|||
127652057|NCT02798211|459347506|FG005|Period 2|Pregnancy|0|||
127652058|NCT02798211|459347501|FG000|Period 2|Technical problems|1|||
127652059|NCT02798211|459347502|FG001|Period 2|Technical problems|0|||
127652060|NCT02798211|459347503|FG002|Period 2|Technical problems|0|||
127652061|NCT02798211|459347504|FG003|Period 2|Technical problems|1|||
127877798|NCT03917654|460173015|FG002|Year 1|Death|0|||
127877799|NCT03917654|460173016|FG003|Year 1|Death|0|||
127877800|NCT03917654|460173017|FG004|Year 1|Death|0|||
127652062|NCT02798211|459347505|FG004|Period 2|Technical problems|0|||
127877801|NCT03917654|460173018|FG005|Year 1|Death|0|||
127877802|NCT03917654|460173019|FG006|Year 1|Death|0|||
127652063|NCT02798211|459347506|FG005|Period 2|Technical problems|0|||
127877803|NCT03917654|460173020|FG007|Year 1|Death|0|||
127877804|NCT03917654|460173021|FG008|Year 1|Death|1|||
127877805|NCT03917654|460173022|FG009|Year 1|Death|1|||
127877806|NCT03917654|460173023|FG010|Year 1|Death|0|||
127877807|NCT03917654|460173024|FG011|Year 1|Death|0|||
127877808|NCT03917654|460173013|FG000|Year 1|Lost to Follow-up|0|||
127877809|NCT03917654|460173014|FG001|Year 1|Lost to Follow-up|0|||
127877810|NCT03917654|460173015|FG002|Year 1|Lost to Follow-up|0|||
127877811|NCT03917654|460173016|FG003|Year 1|Lost to Follow-up|0|||
127877812|NCT03917654|460173017|FG004|Year 1|Lost to Follow-up|0|||
127877813|NCT03917654|460173018|FG005|Year 1|Lost to Follow-up|0|||
127877814|NCT03917654|460173019|FG006|Year 1|Lost to Follow-up|2|||
127877815|NCT03917654|460173020|FG007|Year 1|Lost to Follow-up|0|||
127877816|NCT03917654|460173021|FG008|Year 1|Lost to Follow-up|0|||
127877817|NCT03917654|460173022|FG009|Year 1|Lost to Follow-up|0|||
127877818|NCT03917654|460173023|FG010|Year 1|Lost to Follow-up|0|||
127877819|NCT03917654|460173024|FG011|Year 1|Lost to Follow-up|0|||
127877820|NCT03917654|460173013|FG000|Year 1|Missed visits|0|||
127877821|NCT03917654|460173014|FG001|Year 1|Missed visits|0|||
127877822|NCT03917654|460173015|FG002|Year 1|Missed visits|0|||
127877823|NCT03917654|460173016|FG003|Year 1|Missed visits|0|||
127877824|NCT03917654|460173017|FG004|Year 1|Missed visits|0|||
127877825|NCT03917654|460173018|FG005|Year 1|Missed visits|0|||
127877826|NCT03917654|460173019|FG006|Year 1|Missed visits|0|||
127877827|NCT03917654|460173020|FG007|Year 1|Missed visits|0|||
127877828|NCT03917654|460173021|FG008|Year 1|Missed visits|0|||
127877829|NCT03917654|460173022|FG009|Year 1|Missed visits|0|||
127877830|NCT03917654|460173023|FG010|Year 1|Missed visits|1|||
127877831|NCT03917654|460173024|FG011|Year 1|Missed visits|1|||
127877832|NCT03917654|460173013|FG000|Year 1|Pregnancy|0|||
127877833|NCT03917654|460173014|FG001|Year 1|Pregnancy|0|||
127877834|NCT03917654|460173015|FG002|Year 1|Pregnancy|0|||
127877835|NCT03917654|460173016|FG003|Year 1|Pregnancy|0|||
127877836|NCT03917654|460173017|FG004|Year 1|Pregnancy|0|||
127877837|NCT03917654|460173018|FG005|Year 1|Pregnancy|0|||
127877838|NCT03917654|460173019|FG006|Year 1|Pregnancy|0|||
127877839|NCT03917654|460173020|FG007|Year 1|Pregnancy|1|||
127877840|NCT03917654|460173021|FG008|Year 1|Pregnancy|0|||
127877841|NCT03917654|460173022|FG009|Year 1|Pregnancy|1|||
127877842|NCT03917654|460173023|FG010|Year 1|Pregnancy|0|||
127877843|NCT03917654|460173024|FG011|Year 1|Pregnancy|0|||
127877844|NCT03917654|460173013|FG000|Year 2|Travel|1|||
127877845|NCT03917654|460173014|FG001|Year 2|Travel|0|||
127877846|NCT03917654|460173015|FG002|Year 2|Travel|0|||
127877847|NCT03917654|460173016|FG003|Year 2|Travel|0|||
127877848|NCT03917654|460173017|FG004|Year 2|Travel|1|||
127877849|NCT03917654|460173018|FG005|Year 2|Travel|1|||
127877850|NCT03917654|460173019|FG006|Year 2|Travel|2|||
127877851|NCT03917654|460173020|FG007|Year 2|Travel|1|||
127877852|NCT03917654|460173021|FG008|Year 2|Travel|0|||
127877853|NCT03917654|460173022|FG009|Year 2|Travel|1|||
127877854|NCT03917654|460173023|FG010|Year 2|Travel|0|||
127877855|NCT03917654|460173024|FG011|Year 2|Travel|1|||
127877856|NCT03917654|460173013|FG000|Year 2|Married|1|||
127877857|NCT03917654|460173014|FG001|Year 2|Married|0|||
127877858|NCT03917654|460173015|FG002|Year 2|Married|0|||
127877859|NCT03917654|460173016|FG003|Year 2|Married|0|||
127877860|NCT03917654|460173017|FG004|Year 2|Married|0|||
127877861|NCT03917654|460173018|FG005|Year 2|Married|0|||
127877862|NCT03917654|460173019|FG006|Year 2|Married|1|||
127877863|NCT03917654|460173020|FG007|Year 2|Married|1|||
127877864|NCT03917654|460173021|FG008|Year 2|Married|0|||
127877865|NCT03917654|460173022|FG009|Year 2|Married|0|||
127877866|NCT03917654|460173023|FG010|Year 2|Married|0|||
127877867|NCT03917654|460173024|FG011|Year 2|Married|0|||
127877868|NCT03917654|460173013|FG000|Year 2|Subject moved away from site|1|||
127877869|NCT03917654|460173014|FG001|Year 2|Subject moved away from site|0|||
127877870|NCT03917654|460173015|FG002|Year 2|Subject moved away from site|0|||
127877871|NCT03917654|460173016|FG003|Year 2|Subject moved away from site|0|||
127877872|NCT03917654|460173017|FG004|Year 2|Subject moved away from site|1|||
127877873|NCT03917654|460173018|FG005|Year 2|Subject moved away from site|0|||
127877874|NCT03917654|460173019|FG006|Year 2|Subject moved away from site|2|||
127877875|NCT03917654|460173020|FG007|Year 2|Subject moved away from site|3|||
127877876|NCT03917654|460173021|FG008|Year 2|Subject moved away from site|0|||
127877877|NCT03917654|460173022|FG009|Year 2|Subject moved away from site|2|||
127877878|NCT03917654|460173023|FG010|Year 2|Subject moved away from site|0|||
127877879|NCT03917654|460173024|FG011|Year 2|Subject moved away from site|1|||
127877880|NCT03917654|460173013|FG000|Year 2|Year 2 Screening failure|0|||
127877881|NCT03917654|460173014|FG001|Year 2|Year 2 Screening failure|1|||
127877882|NCT03917654|460173015|FG002|Year 2|Year 2 Screening failure|0|||
127877883|NCT03917654|460173016|FG003|Year 2|Year 2 Screening failure|0|||
127877884|NCT03917654|460173017|FG004|Year 2|Year 2 Screening failure|2|||
127877885|NCT03917654|460173018|FG005|Year 2|Year 2 Screening failure|0|||
127877886|NCT03917654|460173019|FG006|Year 2|Year 2 Screening failure|4|||
127877887|NCT03917654|460173020|FG007|Year 2|Year 2 Screening failure|3|||
127877888|NCT03917654|460173021|FG008|Year 2|Year 2 Screening failure|10|||
127877889|NCT03917654|460173022|FG009|Year 2|Year 2 Screening failure|2|||
127877890|NCT03917654|460173023|FG010|Year 2|Year 2 Screening failure|1|||
127877891|NCT03917654|460173024|FG011|Year 2|Year 2 Screening failure|1|||
127877892|NCT03917654|460173013|FG000|Year 2|Death|0|||
127877893|NCT03917654|460173014|FG001|Year 2|Death|0|||
127877894|NCT03917654|460173015|FG002|Year 2|Death|0|||
127877895|NCT03917654|460173016|FG003|Year 2|Death|0|||
127877896|NCT03917654|460173017|FG004|Year 2|Death|0|||
127877897|NCT03917654|460173018|FG005|Year 2|Death|1|||
127877898|NCT03917654|460173019|FG006|Year 2|Death|0|||
127877899|NCT03917654|460173020|FG007|Year 2|Death|0|||
127877900|NCT03917654|460173021|FG008|Year 2|Death|1|||
127877901|NCT03917654|460173022|FG009|Year 2|Death|1|||
127877902|NCT03917654|460173023|FG010|Year 2|Death|0|||
127877903|NCT03917654|460173024|FG011|Year 2|Death|0|||
127877904|NCT03917654|460173013|FG000|Year 2|Withdrawal by Subject|0|||
127877905|NCT03917654|460173014|FG001|Year 2|Withdrawal by Subject|0|||
127877906|NCT03917654|460173015|FG002|Year 2|Withdrawal by Subject|0|||
127877907|NCT03917654|460173016|FG003|Year 2|Withdrawal by Subject|0|||
127877908|NCT03917654|460173017|FG004|Year 2|Withdrawal by Subject|0|||
127877909|NCT03917654|460173018|FG005|Year 2|Withdrawal by Subject|0|||
127877910|NCT03917654|460173019|FG006|Year 2|Withdrawal by Subject|3|||
127877911|NCT03917654|460173020|FG007|Year 2|Withdrawal by Subject|0|||
127877912|NCT03917654|460173021|FG008|Year 2|Withdrawal by Subject|2|||
127877913|NCT03917654|460173022|FG009|Year 2|Withdrawal by Subject|5|||
127877914|NCT03917654|460173023|FG010|Year 2|Withdrawal by Subject|0|||
127877915|NCT03917654|460173024|FG011|Year 2|Withdrawal by Subject|0|||
127877916|NCT03917654|460173013|FG000|Year 2|Spouse/family member request|0|||
127877917|NCT03917654|460173014|FG001|Year 2|Spouse/family member request|0|||
127877918|NCT03917654|460173015|FG002|Year 2|Spouse/family member request|0|||
127877919|NCT03917654|460173016|FG003|Year 2|Spouse/family member request|0|||
127877920|NCT03917654|460173017|FG004|Year 2|Spouse/family member request|0|||
127877921|NCT03917654|460173018|FG005|Year 2|Spouse/family member request|0|||
127877922|NCT03917654|460173019|FG006|Year 2|Spouse/family member request|1|||
127877923|NCT03917654|460173020|FG007|Year 2|Spouse/family member request|0|||
127877924|NCT03917654|460173021|FG008|Year 2|Spouse/family member request|0|||
127877925|NCT03917654|460173022|FG009|Year 2|Spouse/family member request|0|||
127877926|NCT03917654|460173023|FG010|Year 2|Spouse/family member request|0|||
127877927|NCT03917654|460173024|FG011|Year 2|Spouse/family member request|0|||
127877928|NCT03917654|460173013|FG000|Year 2|Lost to Follow-up|0|||
127877929|NCT03917654|460173014|FG001|Year 2|Lost to Follow-up|0|||
127877930|NCT03917654|460173015|FG002|Year 2|Lost to Follow-up|0|||
127877931|NCT03917654|460173016|FG003|Year 2|Lost to Follow-up|0|||
127877932|NCT03917654|460173017|FG004|Year 2|Lost to Follow-up|0|||
127877933|NCT03917654|460173018|FG005|Year 2|Lost to Follow-up|0|||
127877934|NCT03917654|460173019|FG006|Year 2|Lost to Follow-up|1|||
127877935|NCT03917654|460173020|FG007|Year 2|Lost to Follow-up|0|||
127877936|NCT03917654|460173021|FG008|Year 2|Lost to Follow-up|1|||
127877937|NCT03917654|460173022|FG009|Year 2|Lost to Follow-up|0|||
127877938|NCT03917654|460173023|FG010|Year 2|Lost to Follow-up|0|||
127877939|NCT03917654|460173024|FG011|Year 2|Lost to Follow-up|1|||
127877940|NCT03917654|460173013|FG000|Year 2|Adverse Event|0|||
127877941|NCT03917654|460173014|FG001|Year 2|Adverse Event|0|||
127877942|NCT03917654|460173015|FG002|Year 2|Adverse Event|0|||
127877943|NCT03917654|460173016|FG003|Year 2|Adverse Event|0|||
127877944|NCT03917654|460173017|FG004|Year 2|Adverse Event|0|||
127877945|NCT03917654|460173018|FG005|Year 2|Adverse Event|0|||
127877946|NCT03917654|460173019|FG006|Year 2|Adverse Event|0|||
127877947|NCT03917654|460173020|FG007|Year 2|Adverse Event|0|||
127877948|NCT03917654|460173021|FG008|Year 2|Adverse Event|0|||
127877949|NCT03917654|460173022|FG009|Year 2|Adverse Event|1|||
127877950|NCT03917654|460173023|FG010|Year 2|Adverse Event|0|||
127877951|NCT03917654|460173024|FG011|Year 2|Adverse Event|0|||
127877952|NCT00905437|460173027|FG000|Overall Study|Adverse Event|3|||
127877953|NCT00905437|460173028|FG001|Overall Study|Adverse Event|2|||
127877954|NCT00905437|460173027|FG000|Overall Study|Lost to Follow-up|0|||
127877955|NCT00905437|460173028|FG001|Overall Study|Lost to Follow-up|1|||
127877956|NCT00905437|460173027|FG000|Overall Study|Withdrawal by Subject|0|||
127877957|NCT00905437|460173028|FG001|Overall Study|Withdrawal by Subject|1|||
127877958|NCT00905437|460173027|FG000|Overall Study|Other|5|||
127877959|NCT00905437|460173028|FG001|Overall Study|Other|6|||
127877960|NCT01306968|460173031|FG000|Overall Study|Lost to Follow-up|1|||
127877961|NCT01306968|460173032|FG001|Overall Study|Lost to Follow-up|1|||
127877962|NCT01306968|460173033|FG002|Overall Study|Lost to Follow-up|0|||
127877963|NCT01306968|460173034|FG003|Overall Study|Lost to Follow-up|0|||
127877964|NCT01306968|460173031|FG000|Overall Study|Physician Decision|0|||
127877965|NCT01306968|460173032|FG001|Overall Study|Physician Decision|1|||
127877966|NCT01306968|460173033|FG002|Overall Study|Physician Decision|0|||
127877967|NCT01306968|460173034|FG003|Overall Study|Physician Decision|0|||
127877968|NCT01306968|460173031|FG000|Overall Study|Relocated and left active duty|0|||
127877969|NCT01306968|460173032|FG001|Overall Study|Relocated and left active duty|1|||
127877970|NCT01306968|460173033|FG002|Overall Study|Relocated and left active duty|1|||
127877971|NCT01306968|460173034|FG003|Overall Study|Relocated and left active duty|1|||
127877972|NCT01306968|460173031|FG000|Overall Study|Withdrew - time commitment|0|||
127877973|NCT01306968|460173032|FG001|Overall Study|Withdrew - time commitment|0|||
127877974|NCT01306968|460173033|FG002|Overall Study|Withdrew - time commitment|0|||
127877975|NCT01306968|460173034|FG003|Overall Study|Withdrew - time commitment|2|||
127877976|NCT01306968|460173031|FG000|Overall Study|Withdrew over privacy concerns|0|||
127877977|NCT01306968|460173032|FG001|Overall Study|Withdrew over privacy concerns|0|||
127877978|NCT01306968|460173033|FG002|Overall Study|Withdrew over privacy concerns|0|||
127877979|NCT01306968|460173034|FG003|Overall Study|Withdrew over privacy concerns|1|||
127877980|NCT01329562|460173037|FG000|Overall Study|Protocol Violation|5|||
127877981|NCT01329562|460173038|FG001|Overall Study|Protocol Violation|3|||
127877982|NCT01329562|460173037|FG000|Overall Study|Lost to Follow-up|1|||
127877983|NCT01329562|460173038|FG001|Overall Study|Lost to Follow-up|1|||
127877984|NCT01329562|460173037|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
127877985|NCT01329562|460173038|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
127877986|NCT01329562|460173037|FG000|Overall Study|Physician Decision|0|||
127877987|NCT01329562|460173038|FG001|Overall Study|Physician Decision|1|||
127877988|NCT03128931|460173039|FG000|Overall Study|Physician Decision|1|||
127877989|NCT03128931|460173039|FG000|Overall Study|Equipment Issues|3|||
127877990|NCT03252015|460173040|FG000|Overall Study|Withdrawal by Subject|0|||
127877991|NCT03252015|460173041|FG001|Overall Study|Withdrawal by Subject|1|||
127877992|NCT03252015|460173042|FG002|Overall Study|Withdrawal by Subject|1|||
127877993|NCT03252015|460173043|FG003|Overall Study|Withdrawal by Subject|0|||
127877994|NCT03252015|460173040|FG000|Overall Study|Adverse Event|1|||
127877995|NCT03252015|460173041|FG001|Overall Study|Adverse Event|0|||
127877996|NCT03252015|460173042|FG002|Overall Study|Adverse Event|0|||
127877997|NCT03252015|460173043|FG003|Overall Study|Adverse Event|1|||
127877998|NCT00061568|460173046|FG000|Overall Study|Lost to Follow-up|12|||
127877999|NCT00061568|460173047|FG001|Overall Study|Lost to Follow-up|0|||
127878000|NCT00061568|460173046|FG000|Overall Study|Death|6|||
127878001|NCT00061568|460173047|FG001|Overall Study|Death|0|||
127878002|NCT00061568|460173046|FG000|Overall Study|Withdrawal by Subject|1|||
127878003|NCT00061568|460173047|FG001|Overall Study|Withdrawal by Subject|0|||
127878004|NCT01071278|460173051|FG000|Overall Study|Premature Discontinuation|254|||
127878005|NCT01071278|460173051|FG000|Overall Study|Completion Status Unknown|459|||
127878006|NCT00903409|460173052|FG000|Overall Study|Adverse Event|11|||
127878007|NCT00903409|460173053|FG001|Overall Study|Adverse Event|9|||
127878008|NCT00903409|460173052|FG000|Overall Study|Non-compliance with Protocol|1|||
127878009|NCT00903409|460173053|FG001|Overall Study|Non-compliance with Protocol|1|||
127878010|NCT00903409|460173052|FG000|Overall Study|Laboratory Abnormality|2|||
127878011|NCT00903409|460173053|FG001|Overall Study|Laboratory Abnormality|0|||
127878012|NCT00903409|460173052|FG000|Overall Study|Withdrawal by Subject|8|||
127878013|NCT00903409|460173053|FG001|Overall Study|Withdrawal by Subject|8|||
127878014|NCT00903409|460173052|FG000|Overall Study|Other|2|||
127878015|NCT00903409|460173053|FG001|Overall Study|Other|3|||
127878016|NCT00903409|460173052|FG000|Overall Study|Lost to Follow-up|2|||
127878017|NCT00903409|460173053|FG001|Overall Study|Lost to Follow-up|6|||
127878018|NCT00797316|460173054|FG000|Overall Study|Administrative problems|1|||
127878019|NCT00797316|460173055|FG001|Overall Study|Administrative problems|0|||
127878020|NCT00797316|460173054|FG000|Overall Study|Adverse Event|5|||
127878021|NCT00797316|460173055|FG001|Overall Study|Adverse Event|3|||
127878022|NCT00797316|460173054|FG000|Overall Study|Lost to Follow-up|4|||
127878023|NCT00797316|460173055|FG001|Overall Study|Lost to Follow-up|8|||
127878024|NCT00797316|460173054|FG000|Overall Study|Protocol Deviation|1|||
127878025|NCT00797316|460173055|FG001|Overall Study|Protocol Deviation|2|||
127878026|NCT00797316|460173054|FG000|Overall Study|Patient withdrew consent|12|||
127878027|NCT00797316|460173055|FG001|Overall Study|Patient withdrew consent|6|||
127878028|NCT00797316|460173054|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
127878029|NCT00797316|460173055|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
127878030|NCT03239340|460173058|FG000|Overall Study|Other|26|||
127878031|NCT03239340|460173058|FG000|Overall Study|Patients who are ongoing in the study at DCO|10|||
127878032|NCT03239340|460173058|FG000|Overall Study|Death|40|||
127878033|NCT03239340|460173058|FG000|Overall Study|Lost to Follow-up|2|||
127878034|NCT03239340|460173058|FG000|Overall Study|Physician Decision|16|||
127878035|NCT03239340|460173058|FG000|Overall Study|Withdrawal by Subject|27|||
127878036|NCT03868059|460173062|FG000|Overall Study|Adverse Event|3|||
127878037|NCT03868059|460173062|FG000|Overall Study|Lost to Follow-up|3|||
127878038|NCT03868059|460173062|FG000|Overall Study|Withdrawal by Subject|6|||
127878039|NCT02061293|460173063|FG000|Overall Study|Elevated Blood Pressure|1|||
127878040|NCT02061293|460173064|FG001|Overall Study|Elevated Blood Pressure|1|||
127878041|NCT04066894|460173066|FG000|Overall Study|Lack of Efficacy|1|||
127878042|NCT04066894|460173066|FG000|Overall Study|Screen Failure|1|||
127878043|NCT03494816|460173067|FG000|Overall Study|Protocol Violation|2|||
127878044|NCT03494816|460173067|FG000|Overall Study|Physician Decision|2|||
127878045|NCT03494816|460173067|FG000|Overall Study|Did not start trial treatment|1|||
127878046|NCT03494816|460173067|FG000|Overall Study|Adverse Event|1|||
127878047|NCT03878108|460173068|FG000|Overall Study|Adverse Event|1|||
127878048|NCT03878108|460173069|FG001|Overall Study|Adverse Event|0|||
127878049|NCT01682681|460173070|FG000|Overall Study|Lack of Efficacy|62|||
127878050|NCT01682681|460173070|FG000|Overall Study|Withdrawal by Subject|1|||
127878051|NCT01682681|460173070|FG000|Overall Study|Moved to other hospital|10|||
127878052|NCT01682681|460173070|FG000|Overall Study|Lost to Follow-up|174|||
127878053|NCT01682681|460173070|FG000|Overall Study|Adverse Event|46|||
127878054|NCT01682681|460173070|FG000|Overall Study|tapering of topiramate|5|||
127878055|NCT01682681|460173070|FG000|Overall Study|Other|21|||
127878056|NCT01682681|460173070|FG000|Overall Study|Low compliance|13|||
127878057|NCT00975000|460173071|FG000|Overall Study|Other|1|||
127878058|NCT00975000|460173072|FG001|Overall Study|Other|0|||
127878059|NCT00975000|460173071|FG000|Overall Study|Adverse Event|1|||
127878060|NCT00975000|460173072|FG001|Overall Study|Adverse Event|1|||
127878061|NCT00975000|460173071|FG000|Overall Study|Withdrawal by Subject|2|||
127878062|NCT00975000|460173072|FG001|Overall Study|Withdrawal by Subject|2|||
127878063|NCT00975000|460173071|FG000|Overall Study|Lost to Follow-up|0|||
127878064|NCT00975000|460173072|FG001|Overall Study|Lost to Follow-up|1|||
127878065|NCT00975000|460173071|FG000|Overall Study|Protocol-specified Criteria|1|||
127878066|NCT00975000|460173072|FG001|Overall Study|Protocol-specified Criteria|0|||
127878067|NCT00975000|460173071|FG000|Overall Study|Non-compliance|0|||
127878068|NCT00975000|460173072|FG001|Overall Study|Non-compliance|1|||
127878069|NCT01126359|460173073|FG000|First Intervention (20-minutes)|Physician Decision|0|||
127878070|NCT01126359|460173074|FG001|First Intervention (20-minutes)|Physician Decision|1|||
127878071|NCT00902486|460173075|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
127878072|NCT00902486|460173076|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
127878073|NCT00902486|460173077|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
127878074|NCT00902486|460173078|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
127878075|NCT00902486|460173079|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
127878076|NCT00902486|460173080|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
127878077|NCT00902486|460173075|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
127878078|NCT00902486|460173076|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
127878079|NCT00902486|460173077|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
127878080|NCT00902486|460173078|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
127878081|NCT00902486|460173079|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
127878082|NCT00902486|460173080|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
127878083|NCT00902486|460173075|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
127878084|NCT00902486|460173076|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
127878085|NCT00902486|460173077|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
127878086|NCT00902486|460173078|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
127878087|NCT00902486|460173079|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
127878088|NCT00902486|460173080|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
127878089|NCT00902486|460173075|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
127878090|NCT00902486|460173076|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
127878091|NCT00902486|460173077|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
127878092|NCT00902486|460173078|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
127878093|NCT00902486|460173079|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
127878094|NCT00902486|460173080|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
127878095|NCT00902486|460173075|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
127878096|NCT00902486|460173076|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
127878097|NCT00902486|460173077|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
127878098|NCT00902486|460173078|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
127878099|NCT00902486|460173079|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
127878100|NCT00902486|460173080|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
127878101|NCT00902486|460173075|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
127878102|NCT00902486|460173076|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
127878103|NCT00902486|460173077|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
127878104|NCT00902486|460173078|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
127878105|NCT00902486|460173079|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
127878106|NCT00902486|460173080|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
127878107|NCT00902486|460173075|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
127878108|NCT00902486|460173076|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
127878109|NCT00902486|460173077|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
127878110|NCT00902486|460173078|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
127878111|NCT00902486|460173079|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
127878112|NCT00902486|460173080|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
127878113|NCT00902486|460173075|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
127878114|NCT00902486|460173076|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
127878115|NCT00902486|460173077|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
127878116|NCT00902486|460173078|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
127878117|NCT00902486|460173079|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
127878118|NCT00902486|460173080|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
127652064|NCT02798211|459347501|FG000|Period 2|Withdrawal of Informed Consent|1|||
127878119|NCT00902486|460173075|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
127652065|NCT02798211|459347502|FG001|Period 2|Withdrawal of Informed Consent|0|||
127878120|NCT00902486|460173076|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
127878121|NCT00902486|460173077|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
127878122|NCT00902486|460173078|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
127878123|NCT00902486|460173079|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
127878124|NCT00902486|460173080|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
127878125|NCT00902486|460173075|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
127878126|NCT00902486|460173076|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
127878127|NCT00902486|460173077|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
127878128|NCT00902486|460173078|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
127878129|NCT00902486|460173079|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
127878130|NCT00902486|460173080|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
127878131|NCT00902486|460173075|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
127878132|NCT00902486|460173076|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
127878133|NCT00902486|460173077|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
127878134|NCT00902486|460173078|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
127878135|NCT00902486|460173079|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
127878136|NCT00902486|460173080|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
127878137|NCT02332655|460173081|FG000|Overall Study|Lack of Efficacy|1|||
127878138|NCT01298661|460173082|FG000|Overall Study|Withdrawal by Subject|2|||
127878139|NCT01298661|460173083|FG001|Overall Study|Withdrawal by Subject|0|||
127878140|NCT01298661|460173084|FG002|Overall Study|Withdrawal by Subject|2|||
127878141|NCT01808508|460175272|FG000|Overall Study|Lost to Follow-up|1|||
127878142|NCT01808508|460175273|FG001|Overall Study|Lost to Follow-up|0|||
127878143|NCT01808508|460175274|FG002|Overall Study|Lost to Follow-up|0|||
127878144|NCT01017731|460175275|FG000|Overall Study|Lost to Follow-up|2|||
127878145|NCT01017731|460175275|FG000|Overall Study|Withdrawal by Subject|3|||
127878146|NCT01017731|460175275|FG000|Overall Study|Physician Decision|2|||
127878147|NCT01017731|460175275|FG000|Overall Study|Adverse Event|1|||
127878148|NCT00242567|460175278|FG000|Overall Study|Adverse Event|70|||
127878149|NCT00242567|460175279|FG001|Overall Study|Adverse Event|43|||
127878150|NCT00242567|460175278|FG000|Overall Study|Disease Progression|17|||
127878151|NCT00242567|460175279|FG001|Overall Study|Disease Progression|22|||
127878152|NCT00242567|460175278|FG000|Overall Study|Symptomatic deterioration|9|||
127878153|NCT00242567|460175279|FG001|Overall Study|Symptomatic deterioration|3|||
127878154|NCT00242567|460175278|FG000|Overall Study|Lack of Efficacy|2|||
127878155|NCT00242567|460175279|FG001|Overall Study|Lack of Efficacy|2|||
127878156|NCT00242567|460175278|FG000|Overall Study|Lost to Follow-up|9|||
127878157|NCT00242567|460175279|FG001|Overall Study|Lost to Follow-up|19|||
127878158|NCT00242567|460175278|FG000|Overall Study|Withdrawal by Subject|33|||
127878159|NCT00242567|460175279|FG001|Overall Study|Withdrawal by Subject|28|||
127878160|NCT00242567|460175278|FG000|Overall Study|Protocol Violation|12|||
127878161|NCT00242567|460175279|FG001|Overall Study|Protocol Violation|12|||
127878162|NCT00242567|460175278|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
127878163|NCT00242567|460175279|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
127878164|NCT00242567|460175278|FG000|Overall Study|Other|14|||
127878165|NCT00242567|460175279|FG001|Overall Study|Other|9|||
127878166|NCT02729545|460175282|FG000|Overall Study|Pregnancy|1|||
127878167|NCT02729545|460175283|FG001|Overall Study|Pregnancy|1|||
127878168|NCT02729545|460175282|FG000|Overall Study|Lost to Follow-up|0|||
127878169|NCT02729545|460175283|FG001|Overall Study|Lost to Follow-up|1|||
127878170|NCT02729545|460175282|FG000|Overall Study|Withdrawal by Subject|2|||
127878171|NCT02729545|460175283|FG001|Overall Study|Withdrawal by Subject|3|||
127878172|NCT03079869|460175292|FG000|Overall Study|Adverse Event|6|||
127878173|NCT03079869|460175293|FG001|Overall Study|Adverse Event|8|||
127878174|NCT03079869|460175292|FG000|Overall Study|Withdrawal by Subject|4|||
127878175|NCT03079869|460175293|FG001|Overall Study|Withdrawal by Subject|1|||
127878176|NCT03079869|460175292|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
127878177|NCT03079869|460175293|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
127878178|NCT02411110|460175294|FG000|Treatment Period 1|Adverse Event|4|||
127878179|NCT02411110|460175295|FG001|Treatment Period 1|Adverse Event|2|||
127878180|NCT02411110|460175294|FG000|Treatment Period 1|Lost to Follow-up|1|||
127878181|NCT02411110|460175295|FG001|Treatment Period 1|Lost to Follow-up|0|||
127878182|NCT02411110|460175294|FG000|Treatment Period 1|Personal Reasons|2|||
127878183|NCT02411110|460175295|FG001|Treatment Period 1|Personal Reasons|5|||
127878184|NCT02411110|460175294|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
127878185|NCT02411110|460175295|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
127878186|NCT02411110|460175294|FG000|Treatment Period 2|Adverse Event|1|||
127878187|NCT02411110|460175295|FG001|Treatment Period 2|Adverse Event|0|||
127878188|NCT02411110|460175294|FG000|Treatment Period 2|Lost to Follow-up|0|||
127878189|NCT02411110|460175295|FG001|Treatment Period 2|Lost to Follow-up|2|||
127878190|NCT02411110|460175294|FG000|Treatment Period 2|Personal Reasons|0|||
127878191|NCT02411110|460175295|FG001|Treatment Period 2|Personal Reasons|2|||
127878192|NCT02871921|460175306|FG000|Overall Study|Withdrawal by Subject|34|||
127878193|NCT02871921|460175307|FG001|Overall Study|Withdrawal by Subject|27|||
127652066|NCT02798211|459347503|FG002|Period 2|Withdrawal of Informed Consent|0|||
127652067|NCT02798211|459347504|FG003|Period 2|Withdrawal of Informed Consent|2|||
127652068|NCT02798211|459347505|FG004|Period 2|Withdrawal of Informed Consent|2|||
127652069|NCT02798211|459347506|FG005|Period 2|Withdrawal of Informed Consent|3|||
127652070|NCT01982435|459347507|FG000|Overall Study|Adverse Event|1|||
127652071|NCT01982435|459347508|FG001|Overall Study|Adverse Event|0|||
127652072|NCT05292534|459347509|FG000|Overall Study|Protocol Violation|3|||
127652073|NCT05292534|459347510|FG001|Overall Study|Protocol Violation|4|||
127652074|NCT05292534|459347509|FG000|Overall Study|Withdrawal by Subject|0|||
127652075|NCT05292534|459347510|FG001|Overall Study|Withdrawal by Subject|1|||
127878194|NCT02871921|460175308|FG002|Overall Study|Withdrawal by Subject|27|||
127652076|NCT01782872|459347512|FG000|Overall Study|Protocol Violation|0|||
127652077|NCT01782872|459347513|FG001|Overall Study|Protocol Violation|0|||
127652078|NCT01782872|459347514|FG002|Overall Study|Protocol Violation|0|||
127652079|NCT01782872|459347515|FG003|Overall Study|Protocol Violation|1|||
127652080|NCT01782872|459347512|FG000|Overall Study|Withdrawal by Subject|0|||
127652081|NCT01782872|459347513|FG001|Overall Study|Withdrawal by Subject|1|||
127652082|NCT01782872|459347514|FG002|Overall Study|Withdrawal by Subject|0|||
127652083|NCT01782872|459347515|FG003|Overall Study|Withdrawal by Subject|0|||
127652084|NCT01892345|459347516|FG000|Overall Study|Adverse Event|0|||
127652085|NCT01892345|459347517|FG001|Overall Study|Adverse Event|2|||
127652086|NCT01892345|459347516|FG000|Overall Study|Death|1|||
127652087|NCT01892345|459347517|FG001|Overall Study|Death|0|||
127652088|NCT01892345|459347516|FG000|Overall Study|Lost to Follow-up|3|||
127652089|NCT01892345|459347517|FG001|Overall Study|Lost to Follow-up|0|||
127652090|NCT01892345|459347516|FG000|Overall Study|Withdrawal by Subject|12|||
127652091|NCT01892345|459347517|FG001|Overall Study|Withdrawal by Subject|1|||
127652092|NCT01473381|459347518|FG000|Overall Study|Adverse Event|8|||
127652093|NCT01473381|459347519|FG001|Overall Study|Adverse Event|20|||
127652094|NCT01473381|459347520|FG002|Overall Study|Adverse Event|25|||
127652095|NCT01473381|459347521|FG003|Overall Study|Adverse Event|17|||
127652096|NCT01473381|459347518|FG000|Overall Study|Insufficient Therapeutic Response|10|||
127652097|NCT01473381|459347519|FG001|Overall Study|Insufficient Therapeutic Response|1|||
127652098|NCT01473381|459347520|FG002|Overall Study|Insufficient Therapeutic Response|2|||
127652099|NCT01473381|459347521|FG003|Overall Study|Insufficient Therapeutic Response|3|||
127652100|NCT01473381|459347518|FG000|Overall Study|Protocol Violation|17|||
127652101|NCT01473381|459347519|FG001|Overall Study|Protocol Violation|23|||
127652102|NCT01473381|459347520|FG002|Overall Study|Protocol Violation|19|||
127652103|NCT01473381|459347521|FG003|Overall Study|Protocol Violation|17|||
127652104|NCT01473381|459347518|FG000|Overall Study|Withdrawal of Consent|20|||
127652105|NCT01473381|459347519|FG001|Overall Study|Withdrawal of Consent|21|||
127652106|NCT01473381|459347520|FG002|Overall Study|Withdrawal of Consent|20|||
127652107|NCT01473381|459347521|FG003|Overall Study|Withdrawal of Consent|26|||
127652108|NCT01473381|459347518|FG000|Overall Study|Lost to Follow-up|25|||
127652109|NCT01473381|459347519|FG001|Overall Study|Lost to Follow-up|28|||
127652110|NCT01473381|459347520|FG002|Overall Study|Lost to Follow-up|35|||
127652111|NCT01473381|459347521|FG003|Overall Study|Lost to Follow-up|23|||
127652112|NCT01473381|459347518|FG000|Overall Study|Other Reasons|0|||
127652113|NCT01473381|459347519|FG001|Overall Study|Other Reasons|0|||
127652114|NCT01473381|459347520|FG002|Overall Study|Other Reasons|1|||
127652115|NCT01473381|459347521|FG003|Overall Study|Other Reasons|3|||
127652116|NCT04026165|459347525|FG000|Run-in Placebo Period|Enrollment Error|13|||
127652117|NCT04026165|459347526|FG001|Run-in Placebo Period|Enrollment Error|0|||
127652118|NCT04026165|459347527|FG002|Run-in Placebo Period|Enrollment Error|0|||
127652119|NCT04026165|459347528|FG003|Run-in Placebo Period|Enrollment Error|0|||
127652120|NCT04026165|459347525|FG000|Run-in Placebo Period|Run-in Failure|4|||
127878195|NCT02871921|460175309|FG003|Overall Study|Withdrawal by Subject|30|||
127878196|NCT01803464|460175312|FG000|Overall Study|Incomplete data|0|||
127878197|NCT01803464|460175313|FG001|Overall Study|Incomplete data|0|||
127878198|NCT01803464|460175314|FG002|Overall Study|Incomplete data|4|||
127878199|NCT01803464|460175315|FG003|Overall Study|Incomplete data|0|||
127878200|NCT01803464|460175312|FG000|Overall Study|Withdrawal by Subject|1|||
127878201|NCT01803464|460175313|FG001|Overall Study|Withdrawal by Subject|0|||
127878202|NCT01803464|460175314|FG002|Overall Study|Withdrawal by Subject|0|||
127878203|NCT01803464|460175315|FG003|Overall Study|Withdrawal by Subject|0|||
127878204|NCT02860039|460175321|FG000|Overall Study|Death|4|||
127878205|NCT02860039|460175322|FG001|Overall Study|Death|0|||
127652121|NCT04026165|459347526|FG001|Run-in Placebo Period|Run-in Failure|0|||
127652122|NCT04026165|459347527|FG002|Run-in Placebo Period|Run-in Failure|0|||
127878206|NCT02860039|460175321|FG000|Overall Study|Lost to Follow-up|2|||
127878207|NCT02860039|460175322|FG001|Overall Study|Lost to Follow-up|2|||
127878208|NCT02860039|460175321|FG000|Overall Study|Protocol Violation|3|||
127652123|NCT04026165|459347528|FG003|Run-in Placebo Period|Run-in Failure|0|||
127652124|NCT04026165|459347525|FG000|Run-in Placebo Period|Protocol Violation|2|||
127652125|NCT04026165|459347526|FG001|Run-in Placebo Period|Protocol Violation|0|||
127652126|NCT04026165|459347527|FG002|Run-in Placebo Period|Protocol Violation|0|||
127652127|NCT04026165|459347528|FG003|Run-in Placebo Period|Protocol Violation|0|||
127652128|NCT04026165|459347525|FG000|Run-in Placebo Period|Withdrew Consent|2|||
127878209|NCT02860039|460175322|FG001|Overall Study|Protocol Violation|1|||
127878210|NCT02860039|460175321|FG000|Overall Study|Withdrawal by Subject|1|||
127878211|NCT02860039|460175322|FG001|Overall Study|Withdrawal by Subject|0|||
127878212|NCT02860039|460175321|FG000|Overall Study|Not otherwise eligible|1|||
127878213|NCT02860039|460175322|FG001|Overall Study|Not otherwise eligible|1|||
127878214|NCT01360021|460175323|FG000|Overall Study|Eligibility criteria + other|2|||
127878215|NCT01360021|460175324|FG001|Overall Study|Eligibility criteria + other|1|||
127878216|NCT01360021|460175325|FG002|Overall Study|Eligibility criteria + other|1|||
127878217|NCT01360021|460175323|FG000|Overall Study|Protocol Violation|0|||
127878218|NCT01360021|460175324|FG001|Overall Study|Protocol Violation|0|||
127878219|NCT01360021|460175325|FG002|Overall Study|Protocol Violation|1|||
127878220|NCT01360021|460175323|FG000|Overall Study|Withdrawal by Subject|4|||
127878221|NCT01360021|460175324|FG001|Overall Study|Withdrawal by Subject|0|||
127878222|NCT01360021|460175325|FG002|Overall Study|Withdrawal by Subject|2|||
127878223|NCT01360021|460175323|FG000|Overall Study|Adverse Event|2|||
127878224|NCT01360021|460175324|FG001|Overall Study|Adverse Event|3|||
127878225|NCT01360021|460175325|FG002|Overall Study|Adverse Event|3|||
127878226|NCT01257737|460175327|FG000|Overall Study|Lost to Follow-up|1|||
127878227|NCT01257737|460175328|FG001|Overall Study|Lost to Follow-up|2|||
127878228|NCT01257737|460175327|FG000|Overall Study|Liver transplant|1|||
127878229|NCT01257737|460175328|FG001|Overall Study|Liver transplant|0|||
127878230|NCT01257737|460175327|FG000|Overall Study|Relocation out of the country|0|||
127878231|NCT01257737|460175328|FG001|Overall Study|Relocation out of the country|1|||
127878232|NCT01257737|460175327|FG000|Overall Study|Withdrew from study|0|||
127878233|NCT01257737|460175328|FG001|Overall Study|Withdrew from study|1|||
127878234|NCT03170271|460175332|FG000|Overall Study|Adverse Event|7|||
127878235|NCT03170271|460175333|FG001|Overall Study|Adverse Event|2|||
127878236|NCT03170271|460175332|FG000|Overall Study|Lost to Follow-up|0|||
127878237|NCT03170271|460175333|FG001|Overall Study|Lost to Follow-up|1|||
127878238|NCT03170271|460175332|FG000|Overall Study|Physician Decision|1|||
127878239|NCT03170271|460175333|FG001|Overall Study|Physician Decision|0|||
127878240|NCT03170271|460175332|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
127878241|NCT03170271|460175333|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
127878242|NCT03170271|460175332|FG000|Overall Study|Withdrawal by Subject|17|||
127878243|NCT03170271|460175333|FG001|Overall Study|Withdrawal by Subject|5|||
127878244|NCT03170271|460175332|FG000|Overall Study|Other|2|||
127878245|NCT03170271|460175333|FG001|Overall Study|Other|2|||
127878246|NCT03170271|460175332|FG000|Overall Study|Randomized in error|4|||
127878247|NCT03170271|460175333|FG001|Overall Study|Randomized in error|0|||
127878248|NCT01244516|460175340|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
127878249|NCT01244516|460175341|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
127878250|NCT01244516|460175342|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
127878251|NCT01244516|460175340|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
127878252|NCT01244516|460175341|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
127878253|NCT01244516|460175342|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
127878254|NCT01244516|460175340|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
127878255|NCT01244516|460175341|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
127878256|NCT01244516|460175342|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
127878257|NCT01244516|460175340|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
127878258|NCT01244516|460175341|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
127878259|NCT01244516|460175342|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
127878260|NCT01244516|460175340|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
127878261|NCT01244516|460175341|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
127878262|NCT01244516|460175342|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
127878263|NCT01244516|460175340|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
127878264|NCT01244516|460175341|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
127878265|NCT01244516|460175342|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
127878266|NCT01244516|460175340|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
127878267|NCT01244516|460175341|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
127878268|NCT01244516|460175342|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
127878269|NCT03345485|460175345|FG000|Overall Study|Do not have a post-dose tumour assessment|0|||
127878270|NCT03345485|460175346|FG001|Overall Study|Do not have a post-dose tumour assessment|0|||
127878271|NCT03345485|460175347|FG002|Overall Study|Do not have a post-dose tumour assessment|0|||
127878272|NCT03345485|460175348|FG003|Overall Study|Do not have a post-dose tumour assessment|0|||
127878273|NCT03345485|460175349|FG004|Overall Study|Do not have a post-dose tumour assessment|0|||
127878274|NCT03345485|460175350|FG005|Overall Study|Do not have a post-dose tumour assessment|0|||
127878275|NCT03345485|460175351|FG006|Overall Study|Do not have a post-dose tumour assessment|1|||
127878276|NCT03345485|460175352|FG007|Overall Study|Do not have a post-dose tumour assessment|2|||
127878277|NCT03345485|460175353|FG008|Overall Study|Do not have a post-dose tumour assessment|0|||
127878278|NCT03345485|460175354|FG009|Overall Study|Do not have a post-dose tumour assessment|0|||
127878279|NCT03345485|460175355|FG010|Overall Study|Do not have a post-dose tumour assessment|2|||
127887238|NCT01864525|460210521|FG000|Overall Study|Adverse Event|1|||
127887239|NCT01864525|460210522|FG001|Overall Study|Adverse Event|0|||
127878280|NCT03345485|460175356|FG011|Overall Study|Do not have a post-dose tumour assessment|3|||
127878281|NCT03345485|460175357|FG012|Overall Study|Do not have a post-dose tumour assessment|3|||
127878282|NCT03359473|460175358|FG000|Overall Study|Adverse Event|0|||
127878283|NCT03359473|460175359|FG001|Overall Study|Adverse Event|2|||
127878284|NCT03359473|460175360|FG002|Overall Study|Adverse Event|5|||
127878285|NCT03359473|460175361|FG003|Overall Study|Adverse Event|3|||
127878286|NCT03359473|460175358|FG000|Overall Study|Lost to Follow-up|0|||
127878287|NCT03359473|460175359|FG001|Overall Study|Lost to Follow-up|1|||
127652129|NCT04026165|459347526|FG001|Run-in Placebo Period|Withdrew Consent|0|||
127652130|NCT04026165|459347527|FG002|Run-in Placebo Period|Withdrew Consent|0|||
127652131|NCT04026165|459347528|FG003|Run-in Placebo Period|Withdrew Consent|0|||
127652132|NCT04026165|459347525|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
127652133|NCT04026165|459347526|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
127652134|NCT04026165|459347527|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
127652135|NCT04026165|459347528|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
127652136|NCT04026165|459347525|FG000|Run-in SEL Period|Run-in Failure|0|||
127652137|NCT04026165|459347526|FG001|Run-in SEL Period|Run-in Failure|26|||
127652138|NCT04026165|459347527|FG002|Run-in SEL Period|Run-in Failure|0|||
127652139|NCT04026165|459347528|FG003|Run-in SEL Period|Run-in Failure|0|||
127652140|NCT04026165|459347525|FG000|Run-in SEL Period|Withdrew Consent|0|||
127652141|NCT04026165|459347526|FG001|Run-in SEL Period|Withdrew Consent|10|||
127652142|NCT04026165|459347527|FG002|Run-in SEL Period|Withdrew Consent|0|||
127652143|NCT04026165|459347528|FG003|Run-in SEL Period|Withdrew Consent|0|||
127652144|NCT04026165|459347525|FG000|Run-in SEL Period|Enrollment Error|0|||
127652145|NCT04026165|459347526|FG001|Run-in SEL Period|Enrollment Error|4|||
127652146|NCT04026165|459347527|FG002|Run-in SEL Period|Enrollment Error|0|||
127652147|NCT04026165|459347528|FG003|Run-in SEL Period|Enrollment Error|0|||
127652148|NCT04026165|459347525|FG000|Run-in SEL Period|Protocol Violation|0|||
127652149|NCT04026165|459347526|FG001|Run-in SEL Period|Protocol Violation|3|||
127652150|NCT04026165|459347527|FG002|Run-in SEL Period|Protocol Violation|0|||
127652151|NCT04026165|459347528|FG003|Run-in SEL Period|Protocol Violation|0|||
127652152|NCT04026165|459347525|FG000|Run-in SEL Period|Investigator's Discretion|0|||
127652153|NCT04026165|459347526|FG001|Run-in SEL Period|Investigator's Discretion|2|||
127652154|NCT04026165|459347527|FG002|Run-in SEL Period|Investigator's Discretion|0|||
127652155|NCT04026165|459347528|FG003|Run-in SEL Period|Investigator's Discretion|0|||
127652156|NCT04026165|459347525|FG000|Run-in SEL Period|Death|0|||
127652157|NCT04026165|459347526|FG001|Run-in SEL Period|Death|1|||
127652158|NCT04026165|459347527|FG002|Run-in SEL Period|Death|0|||
127652159|NCT04026165|459347528|FG003|Run-in SEL Period|Death|0|||
127652160|NCT04026165|459347525|FG000|Randomized Period|Withdrew Consent|0|||
127652161|NCT04026165|459347526|FG001|Randomized Period|Withdrew Consent|0|||
127652162|NCT04026165|459347527|FG002|Randomized Period|Withdrew Consent|5|||
127652163|NCT04026165|459347528|FG003|Randomized Period|Withdrew Consent|8|||
127652164|NCT04026165|459347525|FG000|Randomized Period|Death|0|||
127652165|NCT04026165|459347526|FG001|Randomized Period|Death|0|||
127652166|NCT04026165|459347527|FG002|Randomized Period|Death|5|||
127652167|NCT04026165|459347528|FG003|Randomized Period|Death|7|||
127652168|NCT04026165|459347525|FG000|Randomized Period|Investigator's Discretion|0|||
127652169|NCT04026165|459347526|FG001|Randomized Period|Investigator's Discretion|0|||
127652170|NCT04026165|459347527|FG002|Randomized Period|Investigator's Discretion|2|||
127652171|NCT04026165|459347528|FG003|Randomized Period|Investigator's Discretion|2|||
127652172|NCT04026165|459347525|FG000|Randomized Period|Lost to Follow-up|0|||
127652173|NCT04026165|459347526|FG001|Randomized Period|Lost to Follow-up|0|||
127652174|NCT04026165|459347527|FG002|Randomized Period|Lost to Follow-up|2|||
127652175|NCT04026165|459347528|FG003|Randomized Period|Lost to Follow-up|2|||
127878288|NCT03359473|460175360|FG002|Overall Study|Lost to Follow-up|0|||
127878289|NCT03359473|460175361|FG003|Overall Study|Lost to Follow-up|0|||
127878290|NCT03359473|460175358|FG000|Overall Study|Physician Decision|0|||
127878291|NCT03359473|460175359|FG001|Overall Study|Physician Decision|1|||
127878292|NCT03359473|460175360|FG002|Overall Study|Physician Decision|0|||
127878293|NCT03359473|460175361|FG003|Overall Study|Physician Decision|1|||
127878294|NCT03359473|460175358|FG000|Overall Study|Withdrawal by Subject|1|||
127878295|NCT03359473|460175359|FG001|Overall Study|Withdrawal by Subject|2|||
127878296|NCT03359473|460175360|FG002|Overall Study|Withdrawal by Subject|1|||
127878297|NCT03359473|460175361|FG003|Overall Study|Withdrawal by Subject|0|||
127878298|NCT03359473|460175358|FG000|Overall Study|Protocol-defined stopping criteria|1|||
127878299|NCT03359473|460175359|FG001|Overall Study|Protocol-defined stopping criteria|0|||
127878300|NCT03359473|460175360|FG002|Overall Study|Protocol-defined stopping criteria|0|||
127652176|NCT02487810|459347529|FG000|Overall Study|Withdrawal by Subject|1|||
127652177|NCT02487810|459347530|FG001|Overall Study|Withdrawal by Subject|0|||
127652178|NCT01889186|459347531|FG000|Overall Study|Adverse event- not related to progression|18|||
127652179|NCT01889186|459347532|FG001|Overall Study|Adverse event- not related to progression|5|||
127878301|NCT03359473|460175361|FG003|Overall Study|Protocol-defined stopping criteria|1|||
127878302|NCT05302414|460175362|FG000|Pretest to Posttest|Lost to Follow-up|12|||
127878303|NCT05302414|460175363|FG001|Pretest to Posttest|Lost to Follow-up|8|||
127878304|NCT05302414|460175364|FG002|Pretest to Posttest|Lost to Follow-up|8|||
127878305|NCT05302414|460175362|FG000|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
127878306|NCT05302414|460175363|FG001|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
127878307|NCT05302414|460175364|FG002|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
127878308|NCT01102972|460175365|FG000|Overall Study|Adverse Event|8|||
127878309|NCT01102972|460175366|FG001|Overall Study|Adverse Event|2|||
127878310|NCT01102972|460175365|FG000|Overall Study|Lack of Efficacy|2|||
127878311|NCT01102972|460175366|FG001|Overall Study|Lack of Efficacy|1|||
127878312|NCT01102972|460175365|FG000|Overall Study|Protocol Violation|1|||
127878313|NCT01102972|460175366|FG001|Overall Study|Protocol Violation|0|||
127878314|NCT01102972|460175365|FG000|Overall Study|Lost to Follow-up|10|||
127878315|NCT01102972|460175366|FG001|Overall Study|Lost to Follow-up|5|||
127878316|NCT01102972|460175365|FG000|Overall Study|Investigator Discretion|2|||
127878317|NCT01102972|460175366|FG001|Overall Study|Investigator Discretion|0|||
127878318|NCT01102972|460175365|FG000|Overall Study|Withdrawal by Subject|6|||
127878319|NCT01102972|460175366|FG001|Overall Study|Withdrawal by Subject|6|||
127878320|NCT05168657|460175370|FG000|Overall Study|Adverse Event|0|||
127878321|NCT05168657|460175371|FG001|Overall Study|Adverse Event|0|||
127878322|NCT05168657|460175372|FG002|Overall Study|Adverse Event|1|||
127878323|NCT05168657|460175373|FG003|Overall Study|Adverse Event|0|||
127878324|NCT05168657|460175374|FG004|Overall Study|Adverse Event|0|||
127878325|NCT05168657|460175375|FG005|Overall Study|Adverse Event|0|||
127878326|NCT05168657|460175376|FG006|Overall Study|Adverse Event|0|||
127878327|NCT05168657|460175377|FG007|Overall Study|Adverse Event|0|||
127878328|NCT04935931|460175378|FG000|Overall Study|Withdrawal by Subject|1|||
127878329|NCT00424632|460175381|FG000|Overall Study|Death|0|||
127878330|NCT00424632|460175382|FG001|Overall Study|Death|0|||
127878331|NCT00424632|460175383|FG002|Overall Study|Death|0|||
127878332|NCT00424632|460175384|FG003|Overall Study|Death|0|||
127878333|NCT00424632|460175385|FG004|Overall Study|Death|0|||
127878334|NCT00424632|460175386|FG005|Overall Study|Death|2|||
127878335|NCT00424632|460175387|FG006|Overall Study|Death|0|||
127878336|NCT00424632|460175388|FG007|Overall Study|Death|0|||
127878337|NCT00424632|460175389|FG008|Overall Study|Death|0|||
127878338|NCT00424632|460175390|FG009|Overall Study|Death|0|||
127878339|NCT00424632|460175381|FG000|Overall Study|Adverse Event|0|||
127878340|NCT00424632|460175382|FG001|Overall Study|Adverse Event|0|||
127878341|NCT00424632|460175383|FG002|Overall Study|Adverse Event|0|||
127878342|NCT00424632|460175384|FG003|Overall Study|Adverse Event|0|||
127878343|NCT00424632|460175385|FG004|Overall Study|Adverse Event|0|||
127878344|NCT00424632|460175386|FG005|Overall Study|Adverse Event|0|||
127878345|NCT00424632|460175387|FG006|Overall Study|Adverse Event|0|||
127878346|NCT00424632|460175388|FG007|Overall Study|Adverse Event|0|||
127878347|NCT00424632|460175389|FG008|Overall Study|Adverse Event|3|||
127878348|NCT00424632|460175390|FG009|Overall Study|Adverse Event|2|||
127878349|NCT00424632|460175381|FG000|Overall Study|Global deterioration of health status|0|||
127878350|NCT00424632|460175382|FG001|Overall Study|Global deterioration of health status|0|||
127878351|NCT00424632|460175383|FG002|Overall Study|Global deterioration of health status|0|||
127878352|NCT00424632|460175384|FG003|Overall Study|Global deterioration of health status|1|||
127878353|NCT00424632|460175385|FG004|Overall Study|Global deterioration of health status|1|||
127878354|NCT00424632|460175386|FG005|Overall Study|Global deterioration of health status|0|||
127878355|NCT00424632|460175387|FG006|Overall Study|Global deterioration of health status|0|||
127878356|NCT00424632|460175388|FG007|Overall Study|Global deterioration of health status|0|||
127878357|NCT00424632|460175389|FG008|Overall Study|Global deterioration of health status|0|||
127878358|NCT00424632|460175390|FG009|Overall Study|Global deterioration of health status|0|||
127878359|NCT00424632|460175381|FG000|Overall Study|Objective progression or relapse|1|||
127878360|NCT00424632|460175382|FG001|Overall Study|Objective progression or relapse|1|||
127878361|NCT00424632|460175383|FG002|Overall Study|Objective progression or relapse|1|||
127878362|NCT00424632|460175384|FG003|Overall Study|Objective progression or relapse|2|||
127878363|NCT00424632|460175385|FG004|Overall Study|Objective progression or relapse|2|||
127878364|NCT00424632|460175386|FG005|Overall Study|Objective progression or relapse|13|||
127878365|NCT00424632|460175387|FG006|Overall Study|Objective progression or relapse|7|||
127878366|NCT00424632|460175388|FG007|Overall Study|Objective progression or relapse|3|||
127878367|NCT00424632|460175389|FG008|Overall Study|Objective progression or relapse|12|||
127878368|NCT00424632|460175390|FG009|Overall Study|Objective progression or relapse|4|||
127878369|NCT00424632|460175381|FG000|Overall Study|Other|0|||
127878370|NCT00424632|460175382|FG001|Overall Study|Other|0|||
127878371|NCT00424632|460175383|FG002|Overall Study|Other|0|||
127878372|NCT00424632|460175384|FG003|Overall Study|Other|1|||
127878373|NCT00424632|460175385|FG004|Overall Study|Other|0|||
127878374|NCT00424632|460175386|FG005|Overall Study|Other|0|||
127878375|NCT00424632|460175387|FG006|Overall Study|Other|0|||
127652180|NCT01889186|459347531|FG000|Overall Study|Adverse event- related to progression|7|||
127878376|NCT00424632|460175388|FG007|Overall Study|Other|0|||
127878377|NCT00424632|460175389|FG008|Overall Study|Other|1|||
127878378|NCT00424632|460175390|FG009|Overall Study|Other|0|||
127878379|NCT00445458|460175395|FG000|Overall Study|Disease Progression|3|||
127878380|NCT00445458|460175396|FG001|Overall Study|Disease Progression|4|||
127878381|NCT00445458|460175397|FG002|Overall Study|Disease Progression|54|||
127878382|NCT00445458|460175398|FG003|Overall Study|Disease Progression|27|||
127878383|NCT00445458|460175395|FG000|Overall Study|Withdrawal by Subject|0|||
127878384|NCT00445458|460175396|FG001|Overall Study|Withdrawal by Subject|0|||
127878385|NCT00445458|460175397|FG002|Overall Study|Withdrawal by Subject|7|||
127878386|NCT00445458|460175398|FG003|Overall Study|Withdrawal by Subject|0|||
127878387|NCT00445458|460175395|FG000|Overall Study|Adverse Event|0|||
127878388|NCT00445458|460175396|FG001|Overall Study|Adverse Event|0|||
127878389|NCT00445458|460175397|FG002|Overall Study|Adverse Event|3|||
127878390|NCT00445458|460175398|FG003|Overall Study|Adverse Event|0|||
127878391|NCT00445458|460175395|FG000|Overall Study|Death|0|||
127878392|NCT00445458|460175396|FG001|Overall Study|Death|1|||
127878393|NCT00445458|460175397|FG002|Overall Study|Death|2|||
127878394|NCT00445458|460175398|FG003|Overall Study|Death|0|||
127878395|NCT00445458|460175395|FG000|Overall Study|Physician Decision|0|||
127878396|NCT00445458|460175396|FG001|Overall Study|Physician Decision|0|||
127878397|NCT00445458|460175397|FG002|Overall Study|Physician Decision|1|||
127878398|NCT00445458|460175398|FG003|Overall Study|Physician Decision|1|||
127878399|NCT00445458|460175395|FG000|Overall Study|Surgery|0|||
127878400|NCT00445458|460175396|FG001|Overall Study|Surgery|0|||
127878401|NCT00445458|460175397|FG002|Overall Study|Surgery|1|||
127878402|NCT00445458|460175398|FG003|Overall Study|Surgery|0|||
127878403|NCT00728988|460175403|FG000|Overall Study|Not Treated|2|||
127878404|NCT00728988|460175404|FG001|Overall Study|Not Treated|2|||
127878405|NCT00728988|460175403|FG000|Overall Study|Death|1|||
127878406|NCT00728988|460175404|FG001|Overall Study|Death|1|||
127878407|NCT00728988|460175403|FG000|Overall Study|Adverse Event|3|||
127878408|NCT00728988|460175404|FG001|Overall Study|Adverse Event|2|||
127878409|NCT00728988|460175403|FG000|Overall Study|Other|85|||
127878410|NCT00728988|460175404|FG001|Overall Study|Other|77|||
127878411|NCT00728988|460175403|FG000|Overall Study|Withdrawal by Subject|2|||
127878412|NCT00728988|460175404|FG001|Overall Study|Withdrawal by Subject|6|||
127878413|NCT01984229|460175405|FG000|Safety Follow-up Period|Adverse Event|1|||
127878414|NCT01984229|460175406|FG001|Safety Follow-up Period|Adverse Event|1|||
127878415|NCT01984229|460175405|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
127878416|NCT01984229|460175406|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
127878417|NCT02325739|460175409|FG000|Phase I Part|Adverse Event|1|||
127878418|NCT02325739|460175410|FG001|Phase I Part|Adverse Event|0|||
127878419|NCT02325739|460175411|FG002|Phase I Part|Adverse Event|1|||
127878420|NCT02325739|460175412|FG003|Phase I Part|Adverse Event|2|||
127878421|NCT02325739|460175413|FG004|Phase I Part|Adverse Event|3|||
127878422|NCT02325739|460175414|FG005|Phase I Part|Adverse Event|1|||
127878423|NCT02325739|460175415|FG006|Phase I Part|Adverse Event|0|||
127878424|NCT02325739|460175416|FG007|Phase I Part|Adverse Event|2|||
127878425|NCT02325739|460175417|FG008|Phase I Part|Adverse Event|0|||
127878426|NCT02325739|460175418|FG009|Phase I Part|Adverse Event|0|||
127878427|NCT02325739|460175419|FG010|Phase I Part|Adverse Event|0|||
127878428|NCT02325739|460175409|FG000|Phase I Part|Progressive disease|9|||
127878429|NCT02325739|460175410|FG001|Phase I Part|Progressive disease|6|||
127878430|NCT02325739|460175411|FG002|Phase I Part|Progressive disease|3|||
127878431|NCT02325739|460175412|FG003|Phase I Part|Progressive disease|23|||
127878432|NCT02325739|460175413|FG004|Phase I Part|Progressive disease|14|||
127878433|NCT02325739|460175414|FG005|Phase I Part|Progressive disease|6|||
127878434|NCT02325739|460175415|FG006|Phase I Part|Progressive disease|6|||
127878435|NCT02325739|460175416|FG007|Phase I Part|Progressive disease|3|||
127878436|NCT02325739|460175417|FG008|Phase I Part|Progressive disease|0|||
127878437|NCT02325739|460175418|FG009|Phase I Part|Progressive disease|0|||
127878438|NCT02325739|460175419|FG010|Phase I Part|Progressive disease|0|||
127878439|NCT02325739|460175409|FG000|Phase I Part|Subject/guardian decision|1|||
127878440|NCT02325739|460175410|FG001|Phase I Part|Subject/guardian decision|0|||
127878441|NCT02325739|460175411|FG002|Phase I Part|Subject/guardian decision|1|||
127878442|NCT02325739|460175412|FG003|Phase I Part|Subject/guardian decision|1|||
127878443|NCT02325739|460175413|FG004|Phase I Part|Subject/guardian decision|0|||
127878444|NCT02325739|460175414|FG005|Phase I Part|Subject/guardian decision|0|||
127542124|NCT00784563|458951138|FG001|Year 3|Adverse Event|0|||
127878445|NCT02325739|460175415|FG006|Phase I Part|Subject/guardian decision|0|||
127878446|NCT02325739|460175416|FG007|Phase I Part|Subject/guardian decision|1|||
127878447|NCT02325739|460175417|FG008|Phase I Part|Subject/guardian decision|0|||
127878448|NCT02325739|460175418|FG009|Phase I Part|Subject/guardian decision|0|||
127878449|NCT02325739|460175419|FG010|Phase I Part|Subject/guardian decision|0|||
127878450|NCT02325739|460175409|FG000|Phase I Part|Death|0|||
127878451|NCT02325739|460175410|FG001|Phase I Part|Death|0|||
127878452|NCT02325739|460175411|FG002|Phase I Part|Death|0|||
127878453|NCT02325739|460175412|FG003|Phase I Part|Death|0|||
127878454|NCT02325739|460175413|FG004|Phase I Part|Death|2|||
127878455|NCT02325739|460175414|FG005|Phase I Part|Death|0|||
127878456|NCT02325739|460175415|FG006|Phase I Part|Death|0|||
127878457|NCT02325739|460175416|FG007|Phase I Part|Death|0|||
127878458|NCT02325739|460175417|FG008|Phase I Part|Death|0|||
127878459|NCT02325739|460175418|FG009|Phase I Part|Death|0|||
127878460|NCT02325739|460175419|FG010|Phase I Part|Death|0|||
127878461|NCT02325739|460175409|FG000|Phase II Part|Adverse Event|0|||
127878462|NCT02325739|460175410|FG001|Phase II Part|Adverse Event|0|||
127878463|NCT02325739|460175411|FG002|Phase II Part|Adverse Event|0|||
127878464|NCT02325739|460175412|FG003|Phase II Part|Adverse Event|0|||
127878465|NCT02325739|460175413|FG004|Phase II Part|Adverse Event|0|||
127878466|NCT02325739|460175414|FG005|Phase II Part|Adverse Event|0|||
127878467|NCT02325739|460175415|FG006|Phase II Part|Adverse Event|0|||
127878468|NCT02325739|460175416|FG007|Phase II Part|Adverse Event|0|||
127878469|NCT02325739|460175417|FG008|Phase II Part|Adverse Event|4|||
127878470|NCT02325739|460175418|FG009|Phase II Part|Adverse Event|5|||
127878471|NCT02325739|460175419|FG010|Phase II Part|Adverse Event|1|||
127878472|NCT02325739|460175409|FG000|Phase II Part|Physician Decision|0|||
127878473|NCT02325739|460175410|FG001|Phase II Part|Physician Decision|0|||
127878474|NCT02325739|460175411|FG002|Phase II Part|Physician Decision|0|||
127878475|NCT02325739|460175412|FG003|Phase II Part|Physician Decision|0|||
127878476|NCT02325739|460175413|FG004|Phase II Part|Physician Decision|0|||
127878477|NCT02325739|460175414|FG005|Phase II Part|Physician Decision|0|||
127878478|NCT02325739|460175415|FG006|Phase II Part|Physician Decision|0|||
127878479|NCT02325739|460175416|FG007|Phase II Part|Physician Decision|0|||
127878480|NCT02325739|460175417|FG008|Phase II Part|Physician Decision|0|||
127878481|NCT02325739|460175418|FG009|Phase II Part|Physician Decision|1|||
127878482|NCT02325739|460175419|FG010|Phase II Part|Physician Decision|0|||
127878483|NCT02325739|460175409|FG000|Phase II Part|Progressive disease|0|||
127878484|NCT02325739|460175410|FG001|Phase II Part|Progressive disease|0|||
127878485|NCT02325739|460175411|FG002|Phase II Part|Progressive disease|0|||
127878486|NCT02325739|460175412|FG003|Phase II Part|Progressive disease|0|||
127878487|NCT02325739|460175413|FG004|Phase II Part|Progressive disease|0|||
127878488|NCT02325739|460175414|FG005|Phase II Part|Progressive disease|0|||
127878489|NCT02325739|460175415|FG006|Phase II Part|Progressive disease|0|||
127878490|NCT02325739|460175416|FG007|Phase II Part|Progressive disease|0|||
127878491|NCT02325739|460175417|FG008|Phase II Part|Progressive disease|22|||
127878492|NCT02325739|460175418|FG009|Phase II Part|Progressive disease|29|||
127878493|NCT02325739|460175419|FG010|Phase II Part|Progressive disease|18|||
127878494|NCT02325739|460175409|FG000|Phase II Part|Subject/guardian decision|0|||
127878495|NCT02325739|460175410|FG001|Phase II Part|Subject/guardian decision|0|||
127878496|NCT02325739|460175411|FG002|Phase II Part|Subject/guardian decision|0|||
127878497|NCT02325739|460175412|FG003|Phase II Part|Subject/guardian decision|0|||
127878498|NCT02325739|460175413|FG004|Phase II Part|Subject/guardian decision|0|||
127878499|NCT02325739|460175414|FG005|Phase II Part|Subject/guardian decision|0|||
127878500|NCT02325739|460175415|FG006|Phase II Part|Subject/guardian decision|0|||
127878501|NCT02325739|460175416|FG007|Phase II Part|Subject/guardian decision|0|||
127878502|NCT02325739|460175417|FG008|Phase II Part|Subject/guardian decision|4|||
127878503|NCT02325739|460175418|FG009|Phase II Part|Subject/guardian decision|1|||
127878504|NCT02325739|460175419|FG010|Phase II Part|Subject/guardian decision|1|||
127878505|NCT03186794|460175421|FG000|Overall Study|Physician Decision|2|||
127878506|NCT03186794|460175421|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
127878507|NCT00111007|460175423|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
127878508|NCT00111007|460175424|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
127878509|NCT00111007|460175423|FG000|Double-blind (DB) Treatment|Death|5|||
127878510|NCT00111007|460175424|FG001|Double-blind (DB) Treatment|Death|2|||
127878511|NCT00111007|460175423|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
127878512|NCT00111007|460175424|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
127878513|NCT00111007|460175423|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
127878514|NCT00111007|460175424|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
127878515|NCT00111007|460175423|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
127878516|NCT00111007|460175424|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
127878517|NCT00111007|460175423|FG000|Double-blind (DB) Treatment|Relapse|1|||
127878518|NCT00111007|460175424|FG001|Double-blind (DB) Treatment|Relapse|0|||
127878519|NCT00111007|460175423|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
127878520|NCT00111007|460175424|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
127878521|NCT00111007|460175423|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
127878522|NCT00111007|460175424|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
127878523|NCT00111007|460175423|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
127878524|NCT00111007|460175424|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
127878525|NCT00111007|460175423|FG000|Active Follow-up|Adverse Event|1|||
127878526|NCT00111007|460175424|FG001|Active Follow-up|Adverse Event|0|||
127878527|NCT00111007|460175423|FG000|Active Follow-up|Death|2|||
127878528|NCT00111007|460175424|FG001|Active Follow-up|Death|0|||
127878529|NCT00111007|460175423|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
127878530|NCT00111007|460175424|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
127878531|NCT00111007|460175423|FG000|Long Term Follow-up|Death|34|||
127878532|NCT00111007|460175424|FG001|Long Term Follow-up|Death|39|||
127878533|NCT00111007|460175423|FG000|Long Term Follow-up|Lost to Follow-up|1|||
127878534|NCT00111007|460175424|FG001|Long Term Follow-up|Lost to Follow-up|1|||
127878535|NCT00111007|460175423|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
127878536|NCT00111007|460175424|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
127878537|NCT00111007|460175423|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
127878538|NCT00111007|460175424|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
127652181|NCT01889186|459347532|FG001|Overall Study|Adverse event- related to progression|2|||
127652182|NCT01889186|459347531|FG000|Overall Study|COVID-19 logistical restrictions|1|||
127652183|NCT01889186|459347532|FG001|Overall Study|COVID-19 logistical restrictions|0|||
127652184|NCT01889186|459347531|FG000|Overall Study|Investigator request|1|||
127652185|NCT01889186|459347532|FG001|Overall Study|Investigator request|1|||
127652186|NCT01889186|459347531|FG000|Overall Study|Progressive disease- Richter's|12|||
127652187|NCT01889186|459347532|FG001|Overall Study|Progressive disease- Richter's|7|||
127652188|NCT01889186|459347531|FG000|Overall Study|Progressive disease per protocol|46|||
127652189|NCT01889186|459347532|FG001|Overall Study|Progressive disease per protocol|17|||
127652190|NCT01889186|459347531|FG000|Overall Study|Stem cell transplant|2|||
127652191|NCT01889186|459347532|FG001|Overall Study|Stem cell transplant|1|||
127652192|NCT01889186|459347531|FG000|Overall Study|Withdrew consent|2|||
127652193|NCT01889186|459347532|FG001|Overall Study|Withdrew consent|3|||
127652194|NCT01889186|459347531|FG000|Overall Study|Other, not specified|18|||
127652195|NCT01889186|459347532|FG001|Overall Study|Other, not specified|15|||
127652196|NCT00441701|459347535|FG000|Overall Study|Adverse Event|3|||
127652197|NCT00441701|459347536|FG001|Overall Study|Adverse Event|2|||
127652198|NCT00441701|459347537|FG002|Overall Study|Adverse Event|1|||
127652199|NCT00441701|459347538|FG003|Overall Study|Adverse Event|0|||
127652200|NCT00441701|459347539|FG004|Overall Study|Adverse Event|2|||
127652201|NCT00441701|459347540|FG005|Overall Study|Adverse Event|2|||
127652202|NCT00441701|459347541|FG006|Overall Study|Adverse Event|0|||
127652203|NCT00441701|459347542|FG007|Overall Study|Adverse Event|0|||
127652204|NCT00441701|459347543|FG008|Overall Study|Adverse Event|0|||
127652205|NCT00441701|459347544|FG009|Overall Study|Adverse Event|0|||
127652206|NCT00441701|459347535|FG000|Overall Study|Lack of Efficacy|2|||
127652207|NCT00441701|459347536|FG001|Overall Study|Lack of Efficacy|0|||
127652208|NCT00441701|459347537|FG002|Overall Study|Lack of Efficacy|2|||
127652209|NCT00441701|459347538|FG003|Overall Study|Lack of Efficacy|2|||
127652210|NCT00441701|459347539|FG004|Overall Study|Lack of Efficacy|0|||
127652211|NCT00441701|459347540|FG005|Overall Study|Lack of Efficacy|1|||
127652212|NCT00441701|459347541|FG006|Overall Study|Lack of Efficacy|0|||
127652213|NCT00441701|459347542|FG007|Overall Study|Lack of Efficacy|0|||
127652214|NCT00441701|459347543|FG008|Overall Study|Lack of Efficacy|0|||
127652215|NCT00441701|459347544|FG009|Overall Study|Lack of Efficacy|0|||
127652216|NCT00441701|459347535|FG000|Overall Study|Withdrawal by Subject|0|||
127652217|NCT00441701|459347536|FG001|Overall Study|Withdrawal by Subject|2|||
127652218|NCT00441701|459347537|FG002|Overall Study|Withdrawal by Subject|1|||
127652219|NCT00441701|459347538|FG003|Overall Study|Withdrawal by Subject|1|||
127652220|NCT00441701|459347539|FG004|Overall Study|Withdrawal by Subject|0|||
127652221|NCT00441701|459347540|FG005|Overall Study|Withdrawal by Subject|0|||
127652222|NCT00441701|459347541|FG006|Overall Study|Withdrawal by Subject|0|||
127542125|NCT00784563|458951139|FG002|Year 3|Adverse Event|1|||
127542126|NCT02761330|458951146|FG000|Treatment Week 1|Withdrawal by Subject|0|||
127542127|NCT02761330|458951147|FG001|Treatment Week 1|Withdrawal by Subject|0|||
127542128|NCT02761330|458951148|FG002|Treatment Week 1|Withdrawal by Subject|0|||
127542129|NCT02761330|458951149|FG003|Treatment Week 1|Withdrawal by Subject|1|||
127542130|NCT02761330|458951150|FG004|Treatment Week 1|Withdrawal by Subject|0|||
127542131|NCT02761330|458951151|FG005|Treatment Week 1|Withdrawal by Subject|1|||
127542132|NCT00374140|458951152|FG000|Overall Study|Lost to Follow-up|1|||
127542133|NCT00374140|458951152|FG000|Overall Study|Protocol Violation|1|||
127542134|NCT04576988|458951153|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
127542135|NCT04576988|458951154|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
127542136|NCT04576988|458951153|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
127542137|NCT04576988|458951154|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
127542138|NCT04576988|458951153|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
127542139|NCT04576988|458951154|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
127542140|NCT04576988|458951153|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
127542141|NCT04576988|458951154|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
127542142|NCT04576988|458951153|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
127542143|NCT04576988|458951154|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
127542144|NCT04576988|458951153|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
127542145|NCT04576988|458951154|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
127542146|NCT04576988|458951153|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
127652223|NCT00441701|459347542|FG007|Overall Study|Withdrawal by Subject|0|||
127652224|NCT00441701|459347543|FG008|Overall Study|Withdrawal by Subject|0|||
127652225|NCT00441701|459347544|FG009|Overall Study|Withdrawal by Subject|0|||
127652226|NCT04710927|459347545|FG000|Overall Study|Lost to Follow-up|7|||
127652227|NCT04710927|459347546|FG001|Overall Study|Lost to Follow-up|6|||
127652228|NCT04710927|459347547|FG002|Overall Study|Lost to Follow-up|5|||
127652229|NCT02007434|459347549|FG000|Overall Study|Lost to Follow-up|0|||
127652230|NCT02007434|459347550|FG001|Overall Study|Lost to Follow-up|1|||
127652231|NCT02007434|459347551|FG002|Overall Study|Lost to Follow-up|0|||
127652232|NCT02007434|459347552|FG003|Overall Study|Lost to Follow-up|0|||
127652233|NCT02007434|459347553|FG004|Overall Study|Lost to Follow-up|0|||
127652234|NCT02007434|459347554|FG005|Overall Study|Lost to Follow-up|0|||
127652235|NCT02007434|459347555|FG006|Overall Study|Lost to Follow-up|0|||
127652236|NCT02007434|459347556|FG007|Overall Study|Lost to Follow-up|0|||
127652237|NCT02007434|459347549|FG000|Overall Study|Non-compliance|1|||
127652238|NCT02007434|459347550|FG001|Overall Study|Non-compliance|0|||
127652239|NCT02007434|459347551|FG002|Overall Study|Non-compliance|1|||
127652240|NCT02007434|459347552|FG003|Overall Study|Non-compliance|0|||
127652241|NCT02007434|459347553|FG004|Overall Study|Non-compliance|0|||
127652242|NCT02007434|459347554|FG005|Overall Study|Non-compliance|0|||
127652243|NCT02007434|459347555|FG006|Overall Study|Non-compliance|0|||
127652244|NCT02007434|459347556|FG007|Overall Study|Non-compliance|0|||
127652245|NCT01287611|459347557|FG000|Overall Study|Lost to Follow-up|29|||
127652246|NCT01287611|459347558|FG001|Overall Study|Lost to Follow-up|16|||
127652247|NCT01287611|459347557|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
127652248|NCT01287611|459347558|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
127652249|NCT03745222|459347571|FG000|Overall Study|Withdrawal by Subject|0|||
127652250|NCT03745222|459347572|FG001|Overall Study|Withdrawal by Subject|1|||
127652251|NCT03745222|459347573|FG002|Overall Study|Withdrawal by Subject|0|||
127652252|NCT03299686|459347574|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
127652253|NCT03299686|459347575|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
127652254|NCT03299686|459347574|FG000|Treatment Epoch|Physician Decision|1|||
127652255|NCT03299686|459347575|FG001|Treatment Epoch|Physician Decision|0|||
127652256|NCT03299686|459347574|FG000|Treatment Epoch|Adverse Event|8|||
127652257|NCT03299686|459347575|FG001|Treatment Epoch|Adverse Event|4|||
127652258|NCT03299686|459347574|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
127652259|NCT03299686|459347575|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
127652260|NCT02709005|459347576|FG000|Overall Study|Lost to Follow-up|1|||
127652261|NCT02709005|459347577|FG001|Overall Study|Lost to Follow-up|1|||
127652262|NCT02709005|459347576|FG000|Overall Study|Withdrawal by Subject|3|||
127652263|NCT02709005|459347577|FG001|Overall Study|Withdrawal by Subject|0|||
127652264|NCT01959347|459347578|FG000|Overall Study|Protocol Violation|9|||
127652265|NCT01959347|459347579|FG001|Overall Study|Protocol Violation|7|||
127652266|NCT00860067|459347580|FG000|Overall Study|Lost to Follow-up|46|||
127652267|NCT00860067|459347581|FG001|Overall Study|Lost to Follow-up|9|||
127652268|NCT00860067|459347582|FG002|Overall Study|Lost to Follow-up|9|||
127652269|NCT00860067|459347580|FG000|Overall Study|Withdrawal by Subject|4|||
127652270|NCT00860067|459347581|FG001|Overall Study|Withdrawal by Subject|0|||
127652271|NCT00860067|459347582|FG002|Overall Study|Withdrawal by Subject|0|||
127652272|NCT00860067|459347580|FG000|Overall Study|Pregnancy|1|||
127652273|NCT00860067|459347581|FG001|Overall Study|Pregnancy|0|||
127652274|NCT00860067|459347582|FG002|Overall Study|Pregnancy|0|||
127652275|NCT01282801|459347583|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
127652276|NCT01282801|459347584|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
127652277|NCT01060553|459347587|FG000|Overall Study|Lost to Follow-up|3|||
127652278|NCT01060553|459347588|FG001|Overall Study|Lost to Follow-up|5|||
127652279|NCT01060553|459347587|FG000|Overall Study|Withdrawal by Subject|5|||
127652280|NCT01060553|459347588|FG001|Overall Study|Withdrawal by Subject|5|||
127652281|NCT01060553|459347587|FG000|Overall Study|Lack of Efficacy|1|||
127652282|NCT01060553|459347588|FG001|Overall Study|Lack of Efficacy|0|||
127652283|NCT04707196|459347590|FG000|Overall Study|Withdrawal by Subject|9|||
127652284|NCT04707196|459347591|FG001|Overall Study|Withdrawal by Subject|6|||
127652285|NCT04707196|459347590|FG000|Overall Study|Lost to Follow-up|1|||
127652286|NCT04707196|459347591|FG001|Overall Study|Lost to Follow-up|0|||
127652287|NCT04707196|459347590|FG000|Overall Study|Protocol Violation|4|||
127652288|NCT04707196|459347591|FG001|Overall Study|Protocol Violation|1|||
127652289|NCT04707196|459347590|FG000|Overall Study|Adverse Event|2|||
127652290|NCT04707196|459347591|FG001|Overall Study|Adverse Event|2|||
127652291|NCT04707196|459347590|FG000|Overall Study|Death|3|||
127652292|NCT04707196|459347591|FG001|Overall Study|Death|1|||
127652293|NCT04707196|459347590|FG000|Overall Study|Non-compliance with study drug|1|||
127652294|NCT04707196|459347591|FG001|Overall Study|Non-compliance with study drug|0|||
127652295|NCT04707196|459347590|FG000|Overall Study|Progressive disease|9|||
127652296|NCT04707196|459347591|FG001|Overall Study|Progressive disease|10|||
127652297|NCT01862796|459347592|FG000|Overall Study|Prohibited medications|0|||
127652298|NCT01862796|459347593|FG001|Overall Study|Prohibited medications|0|||
127652299|NCT01862796|459347594|FG002|Overall Study|Prohibited medications|1|||
127652300|NCT02034708|459347599|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
127652301|NCT02034708|459347600|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
127652302|NCT02034708|459347599|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
127652303|NCT02034708|459347600|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
127652304|NCT02034708|459347599|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
127652305|NCT02034708|459347600|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
127652306|NCT02034708|459347599|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
127652307|NCT02034708|459347600|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
127652308|NCT00779779|459347601|FG000|Overall Study|Adverse Event|1|||
127652309|NCT00779779|459347601|FG000|Overall Study|Protocol Violation|14|||
127652310|NCT00779779|459347601|FG000|Overall Study|Withdrawal by Subject|4|||
127652311|NCT00779779|459347601|FG000|Overall Study|Lost to Follow-up|5|||
127652312|NCT02719990|459347602|FG000|Overall Study|Physician Decision|2|||
127652313|NCT02719990|459347602|FG000|Overall Study|Withdrawal by Subject|2|||
127652314|NCT02719990|459347602|FG000|Overall Study|Study Terminated By Sponsor|32|||
127652315|NCT06387472|459347606|FG000|Overall Study|Withdrawal by Subject|1|||
127652316|NCT06387472|459347606|FG000|Overall Study|Lost to Follow-up|2|||
127652317|NCT06387472|459347606|FG000|Overall Study|Physician Decision|1|||
127652318|NCT03935217|459349634|FG000|Overall Study|Adverse Event|1|||
127652319|NCT03935217|459349635|FG001|Overall Study|Adverse Event|0|||
127652320|NCT03935217|459349634|FG000|Overall Study|Lost to Follow-up|0|||
127652321|NCT03935217|459349635|FG001|Overall Study|Lost to Follow-up|1|||
127652322|NCT03935217|459349634|FG000|Overall Study|Withdrawal by Subject|0|||
127652323|NCT03935217|459349635|FG001|Overall Study|Withdrawal by Subject|2|||
127652324|NCT01862991|459349643|FG000|Overall Study|Lost to Follow-up|2|||
127652325|NCT01862991|459349644|FG001|Overall Study|Lost to Follow-up|1|||
127652326|NCT01862991|459349645|FG002|Overall Study|Lost to Follow-up|1|||
127652327|NCT01862991|459349643|FG000|Overall Study|Protocol Violation|1|||
127652328|NCT01862991|459349644|FG001|Overall Study|Protocol Violation|0|||
127652329|NCT01862991|459349645|FG002|Overall Study|Protocol Violation|0|||
127652330|NCT00332332|459349646|FG000|Overall Study|Adverse Event|13|||
127652331|NCT00332332|459349646|FG000|Overall Study|Death|1|||
127652332|NCT00332332|459349646|FG000|Overall Study|Withdrawal by Subject|8|||
127652333|NCT00332332|459349646|FG000|Overall Study|Physician Decision|1|||
127652334|NCT00332332|459349646|FG000|Overall Study|Lost to Follow-up|3|||
127652335|NCT00332332|459349646|FG000|Overall Study|Protocol deviation|4|||
127652336|NCT00332332|459349646|FG000|Overall Study|Noncompliance|2|||
127652337|NCT00332332|459349646|FG000|Overall Study|Disease progression|2|||
127652338|NCT00332332|459349646|FG000|Overall Study|Other|18|||
127652339|NCT00332332|459349646|FG000|Overall Study|Did not receive study treatment|16|||
127652340|NCT01108458|459349647|FG000|Overall Study|Withdrawal by Subject|1|||
127652341|NCT02790073|459349648|FG000|Overall Study|Death|1|||
127652342|NCT02790073|459349648|FG000|Overall Study|Withdrawal from HD|1|||
127652343|NCT02790073|459349648|FG000|Overall Study|Withdrawal by Subject|1|||
127652344|NCT04170686|459349649|FG000|Screening|Physician Decision|12|||
127652345|NCT04170686|459349650|FG001|Screening|Physician Decision|13|||
127652346|NCT04170686|459349649|FG000|Randomization and Treatment|Lost to Follow-up|26|||
127652347|NCT04170686|459349650|FG001|Randomization and Treatment|Lost to Follow-up|15|||
127652348|NCT03328143|459349651|FG000|Overall Study|Declined|3|||
127652349|NCT03328143|459349651|FG000|Overall Study|Required increased sedation|4|||
127652350|NCT03328143|459349651|FG000|Overall Study|Couldn't smell the lavender in the OR|1|||
127652351|NCT03328143|459349651|FG000|Overall Study|Surgery cancelled|1|||
127652352|NCT02243202|459349653|FG000|Overall Study|Adverse Event|5|||
127652353|NCT02243202|459349654|FG001|Overall Study|Adverse Event|6|||
127652354|NCT02243202|459349655|FG002|Overall Study|Adverse Event|10|||
127652355|NCT02243202|459349656|FG003|Overall Study|Adverse Event|4|||
127652356|NCT02243202|459349653|FG000|Overall Study|Lost to Follow-up|9|||
127652357|NCT02243202|459349654|FG001|Overall Study|Lost to Follow-up|9|||
127878539|NCT00111007|460175423|FG000|Long Term Follow-up|Missing|10|||
127878540|NCT00111007|460175424|FG001|Long Term Follow-up|Missing|3|||
127878541|NCT02380248|460175426|FG000|Overall Study|Lost to Follow-up|11|||
127878542|NCT02380248|460175426|FG000|Overall Study|Withdrawal by Subject|3|||
127878543|NCT01275170|460175427|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
127878544|NCT01275170|460175428|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
127878545|NCT01275170|460175429|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
127878546|NCT01275170|460175430|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
127878547|NCT01275170|460175431|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
127878548|NCT01275170|460175432|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
127878549|NCT01275170|460175433|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
127878550|NCT01275170|460175434|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
127878551|NCT00605839|460175435|FG000|Overall Study|Protocol Violation|1|||
127878552|NCT00605839|460175436|FG001|Overall Study|Protocol Violation|0|||
127878553|NCT00605839|460175437|FG002|Overall Study|Protocol Violation|0|||
127878554|NCT02864953|460175438|FG000|Overall Study|Adverse Event|22|||
127878555|NCT02864953|460175439|FG001|Overall Study|Adverse Event|19|||
127878556|NCT02864953|460175438|FG000|Overall Study|Withdrawal by Subject|1|||
127878557|NCT02864953|460175439|FG001|Overall Study|Withdrawal by Subject|0|||
127878558|NCT02864953|460175438|FG000|Overall Study|Physician Decision|4|||
127878559|NCT02864953|460175439|FG001|Overall Study|Physician Decision|2|||
127878560|NCT02864953|460175438|FG000|Overall Study|Death|3|||
127652358|NCT02243202|459349655|FG002|Overall Study|Lost to Follow-up|14|||
127652359|NCT02243202|459349656|FG003|Overall Study|Lost to Follow-up|11|||
127652360|NCT02243202|459349653|FG000|Overall Study|Protocol Violation|3|||
127652361|NCT02243202|459349654|FG001|Overall Study|Protocol Violation|1|||
127652362|NCT02243202|459349655|FG002|Overall Study|Protocol Violation|2|||
127652363|NCT02243202|459349656|FG003|Overall Study|Protocol Violation|1|||
127652364|NCT02243202|459349653|FG000|Overall Study|Withdrawal by Subject|7|||
127652365|NCT02243202|459349654|FG001|Overall Study|Withdrawal by Subject|6|||
127652366|NCT02243202|459349655|FG002|Overall Study|Withdrawal by Subject|4|||
127652367|NCT02243202|459349656|FG003|Overall Study|Withdrawal by Subject|4|||
127652368|NCT02243202|459349653|FG000|Overall Study|Other|1|||
127652369|NCT02243202|459349654|FG001|Overall Study|Other|3|||
127652370|NCT02243202|459349655|FG002|Overall Study|Other|1|||
127652371|NCT02243202|459349656|FG003|Overall Study|Other|2|||
127652372|NCT02243202|459349653|FG000|Overall Study|Randomized but not received treatment|0|||
127652373|NCT02243202|459349654|FG001|Overall Study|Randomized but not received treatment|0|||
127652374|NCT02243202|459349655|FG002|Overall Study|Randomized but not received treatment|0|||
127652375|NCT02243202|459349656|FG003|Overall Study|Randomized but not received treatment|1|||
127652376|NCT02013388|459349660|FG000|Overall Study|work emergency|1|||
127652377|NCT02013388|459349661|FG001|Overall Study|work emergency|0|||
127652378|NCT02013388|459349662|FG002|Overall Study|work emergency|0|||
127652379|NCT02013388|459349663|FG003|Overall Study|work emergency|0|||
127652380|NCT02013388|459349664|FG004|Overall Study|work emergency|1|||
127652381|NCT02013388|459349665|FG005|Overall Study|work emergency|0|||
127652382|NCT02013388|459349666|FG006|Overall Study|work emergency|0|||
127652383|NCT02013388|459349667|FG007|Overall Study|work emergency|0|||
127652384|NCT03243422|459349668|FG000|Overall Study|Death|20|||
127652385|NCT03243422|459349669|FG001|Overall Study|Death|21|||
127652386|NCT03243422|459349668|FG000|Overall Study|Lost to Follow-up|9|||
127652387|NCT03243422|459349669|FG001|Overall Study|Lost to Follow-up|21|||
127652388|NCT03243422|459349668|FG000|Overall Study|Withdrawal by Subject|22|||
127652389|NCT03243422|459349669|FG001|Overall Study|Withdrawal by Subject|8|||
127652390|NCT02173054|459349670|FG000|Overall Study|lack of compliance|1|||
127652391|NCT02173054|459349671|FG001|Overall Study|lack of compliance|0|||
127652392|NCT02173054|459349672|FG002|Overall Study|lack of compliance|0|||
127652393|NCT02173054|459349670|FG000|Overall Study|Withdrawal by Subject|0|||
127652394|NCT02173054|459349671|FG001|Overall Study|Withdrawal by Subject|0|||
127652395|NCT02173054|459349672|FG002|Overall Study|Withdrawal by Subject|1|||
127652396|NCT01330316|459349691|FG000|Overall Study|Adverse Event|2|||
127652397|NCT01330316|459349692|FG001|Overall Study|Adverse Event|2|||
127652398|NCT01330316|459349691|FG000|Overall Study|Lack of Efficacy|0|||
127652399|NCT01330316|459349692|FG001|Overall Study|Lack of Efficacy|10|||
127652400|NCT01330316|459349691|FG000|Overall Study|Lost to Follow-up|0|||
127652401|NCT01330316|459349692|FG001|Overall Study|Lost to Follow-up|1|||
127652402|NCT01330316|459349691|FG000|Overall Study|Withdrawal by Subject|0|||
127878561|NCT02864953|460175439|FG001|Overall Study|Death|13|||
127878562|NCT02864953|460175438|FG000|Overall Study|Reason not specified|14|||
127878563|NCT02864953|460175439|FG001|Overall Study|Reason not specified|12|||
127878564|NCT02864953|460175438|FG000|Overall Study|Withdrew Prior to Dosing|9|||
127878565|NCT02864953|460175439|FG001|Overall Study|Withdrew Prior to Dosing|8|||
127878566|NCT03728257|460175440|FG000|Overall Study|Death|3|||
127878567|NCT03728257|460175441|FG001|Overall Study|Death|0|||
127878568|NCT00621309|460175442|FG000|Overall Study|Withdrawal by Subject|2|||
127878569|NCT00621309|460175443|FG001|Overall Study|Withdrawal by Subject|0|||
127878570|NCT00621309|460175444|FG002|Overall Study|Withdrawal by Subject|1|||
127878571|NCT00621309|460175445|FG003|Overall Study|Withdrawal by Subject|1|||
127878572|NCT00621309|460175446|FG004|Overall Study|Withdrawal by Subject|1|||
127878573|NCT00621309|460175447|FG005|Overall Study|Withdrawal by Subject|1|||
127878574|NCT04993339|460175448|FG000|Overall Study|Lost to Follow-up|0|||
127878575|NCT04993339|460175449|FG001|Overall Study|Lost to Follow-up|1|||
127878576|NCT04993339|460175448|FG000|Overall Study|no MRI scan|3|||
127878577|NCT04993339|460175449|FG001|Overall Study|no MRI scan|1|||
127878578|NCT01381068|460175450|FG000|Overall Study|Death|1|||
127878579|NCT01381068|460175451|FG001|Overall Study|Death|0|||
127878580|NCT02949219|460175457|FG000|Overall Study|Withdrawal by Subject|1|||
127878581|NCT00314262|460175468|FG000|Overall Study|Adverse Event|2|||
127878582|NCT00314262|460175468|FG000|Overall Study|Withdrawal by Subject|2|||
127878583|NCT00314262|460175468|FG000|Overall Study|Physician Decision|1|||
127652403|NCT01330316|459349692|FG001|Overall Study|Withdrawal by Subject|1|||
127652404|NCT01330316|459349691|FG000|Overall Study|other than above|0|||
127652405|NCT01330316|459349692|FG001|Overall Study|other than above|1|||
127652406|NCT00615264|459349695|FG000|Overall Study|Withdrawal by Subject|17|||
127652407|NCT00615264|459349696|FG001|Overall Study|Withdrawal by Subject|19|||
127652408|NCT00615264|459349695|FG000|Overall Study|Lost to Follow-up|6|||
127652409|NCT00615264|459349696|FG001|Overall Study|Lost to Follow-up|13|||
127652410|NCT00615264|459349695|FG000|Overall Study|Adverse Event|8|||
127878584|NCT00083226|460175469|FG000|Overall Study|Lack of Efficacy|19|||
127878585|NCT00083226|460175469|FG000|Overall Study|Adverse Event|9|||
127878586|NCT00083226|460175469|FG000|Overall Study|Death|4|||
127652411|NCT00615264|459349696|FG001|Overall Study|Adverse Event|5|||
127652412|NCT00615264|459349695|FG000|Overall Study|Death|1|||
127652413|NCT00615264|459349696|FG001|Overall Study|Death|1|||
127652414|NCT00615264|459349695|FG000|Overall Study|Protocol Violation|11|||
127652415|NCT00615264|459349696|FG001|Overall Study|Protocol Violation|7|||
127878587|NCT00083226|460175469|FG000|Overall Study|Withdrawal by Subject|4|||
127878588|NCT00083226|460175469|FG000|Overall Study|Other|2|||
127652416|NCT00615264|459349695|FG000|Overall Study|Not defined|7|||
127652417|NCT00615264|459349696|FG001|Overall Study|Not defined|4|||
127652418|NCT00615264|459349695|FG000|Overall Study|Dermal Hypersensitivity|0|||
127652419|NCT00615264|459349696|FG001|Overall Study|Dermal Hypersensitivity|3|||
127652420|NCT04887948|459349704|FG000|Overall Study|Death|1|||
127652421|NCT04887948|459349705|FG001|Overall Study|Death|0|||
127652422|NCT04887948|459349706|FG002|Overall Study|Death|0|||
127652423|NCT04887948|459349704|FG000|Overall Study|Lost to Follow-up|1|||
127652424|NCT04887948|459349705|FG001|Overall Study|Lost to Follow-up|0|||
127652425|NCT04887948|459349706|FG002|Overall Study|Lost to Follow-up|3|||
127652426|NCT04887948|459349704|FG000|Overall Study|Physician Decision|0|||
127652427|NCT04887948|459349705|FG001|Overall Study|Physician Decision|4|||
127652428|NCT04887948|459349706|FG002|Overall Study|Physician Decision|1|||
127652429|NCT04887948|459349704|FG000|Overall Study|Protocol Violation|1|||
127652430|NCT04887948|459349705|FG001|Overall Study|Protocol Violation|1|||
127652431|NCT04887948|459349706|FG002|Overall Study|Protocol Violation|0|||
127652432|NCT04887948|459349704|FG000|Overall Study|Withdrawal by Subject|0|||
127652433|NCT04887948|459349705|FG001|Overall Study|Withdrawal by Subject|6|||
127652434|NCT04887948|459349706|FG002|Overall Study|Withdrawal by Subject|1|||
127652435|NCT04887948|459349704|FG000|Overall Study|No longer met eligibility criteria|1|||
127652436|NCT04887948|459349705|FG001|Overall Study|No longer met eligibility criteria|2|||
127652437|NCT04887948|459349706|FG002|Overall Study|No longer met eligibility criteria|1|||
127652438|NCT04887948|459349704|FG000|Overall Study|Other|2|||
127652439|NCT04887948|459349705|FG001|Overall Study|Other|1|||
127652440|NCT04887948|459349706|FG002|Overall Study|Other|1|||
127652441|NCT00638235|459349710|FG000|Overall Study|Lost to Follow-up|31|||
127652442|NCT00638235|459349711|FG001|Overall Study|Lost to Follow-up|3|||
127652443|NCT00638235|459349712|FG002|Overall Study|Lost to Follow-up|18|||
127652444|NCT00638235|459349713|FG003|Overall Study|Lost to Follow-up|10|||
127652445|NCT00638235|459349714|FG004|Overall Study|Lost to Follow-up|13|||
127652446|NCT00638235|459349715|FG005|Overall Study|Lost to Follow-up|26|||
127652447|NCT00638235|459349716|FG006|Overall Study|Lost to Follow-up|0|||
127652448|NCT00638235|459349717|FG007|Overall Study|Lost to Follow-up|1|||
127652449|NCT00638235|459349718|FG008|Overall Study|Lost to Follow-up|18|||
127652450|NCT02569437|459349725|FG000|Overall Study|Lost to Follow-up|12|||
127652451|NCT02569437|459349726|FG001|Overall Study|Lost to Follow-up|14|||
127652452|NCT00708435|459349730|FG000|Overall Study|Death / Serious Adverse Event|10|||
127652453|NCT00708435|459349731|FG001|Overall Study|Death / Serious Adverse Event|5|||
127652454|NCT00708435|459349730|FG000|Overall Study|Lost to Follow-up|9|||
127652455|NCT00708435|459349731|FG001|Overall Study|Lost to Follow-up|4|||
127652456|NCT00708435|459349730|FG000|Overall Study|Withdrawal by Subject|3|||
127652457|NCT00708435|459349731|FG001|Overall Study|Withdrawal by Subject|7|||
127652458|NCT00708435|459349730|FG000|Overall Study|Adverse Event|1|||
127652459|NCT00708435|459349731|FG001|Overall Study|Adverse Event|0|||
127652460|NCT00708435|459349730|FG000|Overall Study|Protocol Violation|0|||
127652461|NCT00708435|459349731|FG001|Overall Study|Protocol Violation|1|||
127652462|NCT00708435|459349730|FG000|Overall Study|Intervention by primary care physician|1|||
127652463|NCT00708435|459349731|FG001|Overall Study|Intervention by primary care physician|0|||
127652464|NCT00708435|459349730|FG000|Overall Study|Refused hospitalization|1|||
127652465|NCT00708435|459349731|FG001|Overall Study|Refused hospitalization|0|||
127652466|NCT02756832|459349734|FG000|Overall Study|Lost for Observation after Baseline|6|||
127652467|NCT02756832|459349734|FG000|Overall Study|Lost for Observation|13|||
127652468|NCT02756832|459349734|FG000|Overall Study|Patient's Unwillingness|12|||
127652469|NCT02756832|459349734|FG000|Overall Study|Insufficient Efficacy|2|||
127652470|NCT02756832|459349734|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
127652471|NCT02756832|459349734|FG000|Overall Study|Reason not Specified|9|||
127652472|NCT02756832|459349734|FG000|Overall Study|Protocol Deviation|10|||
127652473|NCT01364597|459349735|FG000|Overall Study|Adverse Event|4|||
127652474|NCT01364597|459349736|FG001|Overall Study|Adverse Event|5|||
127652475|NCT01364597|459349737|FG002|Overall Study|Adverse Event|16|||
127652476|NCT01364597|459349738|FG003|Overall Study|Adverse Event|7|||
127652477|NCT01364597|459349735|FG000|Overall Study|Lack of Efficacy|4|||
127652478|NCT01364597|459349736|FG001|Overall Study|Lack of Efficacy|4|||
127652479|NCT01364597|459349737|FG002|Overall Study|Lack of Efficacy|23|||
127652480|NCT01364597|459349738|FG003|Overall Study|Lack of Efficacy|8|||
127652481|NCT01364597|459349735|FG000|Overall Study|Protocol Violation|0|||
127652482|NCT01364597|459349736|FG001|Overall Study|Protocol Violation|0|||
127652483|NCT01364597|459349737|FG002|Overall Study|Protocol Violation|2|||
127652484|NCT01364597|459349738|FG003|Overall Study|Protocol Violation|0|||
127652485|NCT01364597|459349735|FG000|Overall Study|Lost to Follow-up|0|||
127652486|NCT01364597|459349736|FG001|Overall Study|Lost to Follow-up|0|||
127652487|NCT01364597|459349737|FG002|Overall Study|Lost to Follow-up|5|||
127652488|NCT01364597|459349738|FG003|Overall Study|Lost to Follow-up|3|||
127652489|NCT01364597|459349735|FG000|Overall Study|Withdrawal by Subject|4|||
127652490|NCT01364597|459349736|FG001|Overall Study|Withdrawal by Subject|1|||
127652491|NCT01364597|459349737|FG002|Overall Study|Withdrawal by Subject|18|||
127652492|NCT01364597|459349738|FG003|Overall Study|Withdrawal by Subject|6|||
127652493|NCT01364597|459349735|FG000|Overall Study|Non compliance|1|||
127652494|NCT01364597|459349736|FG001|Overall Study|Non compliance|0|||
127652495|NCT01364597|459349737|FG002|Overall Study|Non compliance|1|||
127652496|NCT01364597|459349738|FG003|Overall Study|Non compliance|0|||
127652497|NCT01364597|459349735|FG000|Overall Study|Lack of compliance|1|||
127652498|NCT01364597|459349736|FG001|Overall Study|Lack of compliance|0|||
127652499|NCT01364597|459349737|FG002|Overall Study|Lack of compliance|0|||
127652500|NCT01364597|459349738|FG003|Overall Study|Lack of compliance|0|||
127652501|NCT01364597|459349735|FG000|Overall Study|End of treatment epilepsy|1|||
127652502|NCT01364597|459349736|FG001|Overall Study|End of treatment epilepsy|0|||
127652503|NCT01364597|459349737|FG002|Overall Study|End of treatment epilepsy|0|||
127652504|NCT01364597|459349738|FG003|Overall Study|End of treatment epilepsy|0|||
127652505|NCT01364597|459349735|FG000|Overall Study|No Seizures|1|||
127652506|NCT01364597|459349736|FG001|Overall Study|No Seizures|0|||
127652507|NCT01364597|459349737|FG002|Overall Study|No Seizures|0|||
127652508|NCT01364597|459349738|FG003|Overall Study|No Seizures|0|||
127652509|NCT01364597|459349735|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
127652510|NCT01364597|459349736|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
127652511|NCT01364597|459349737|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
127652512|NCT01364597|459349738|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
127652513|NCT01364597|459349735|FG000|Overall Study|Cure|1|||
127652514|NCT01364597|459349736|FG001|Overall Study|Cure|0|||
127652515|NCT01364597|459349737|FG002|Overall Study|Cure|0|||
127652516|NCT01364597|459349738|FG003|Overall Study|Cure|0|||
127652517|NCT01364597|459349735|FG000|Overall Study|Patient was moving|0|||
127652518|NCT01364597|459349736|FG001|Overall Study|Patient was moving|1|||
127652519|NCT01364597|459349737|FG002|Overall Study|Patient was moving|0|||
127652520|NCT01364597|459349738|FG003|Overall Study|Patient was moving|0|||
127652521|NCT01364597|459349735|FG000|Overall Study|Seizures resolved|0|||
127652522|NCT01364597|459349736|FG001|Overall Study|Seizures resolved|0|||
127652523|NCT01364597|459349737|FG002|Overall Study|Seizures resolved|1|||
127652524|NCT01364597|459349738|FG003|Overall Study|Seizures resolved|0|||
127652525|NCT01364597|459349735|FG000|Overall Study|Patient became seizure-free after surgery|0|||
127652526|NCT01364597|459349736|FG001|Overall Study|Patient became seizure-free after surgery|0|||
127652527|NCT01364597|459349737|FG002|Overall Study|Patient became seizure-free after surgery|1|||
127652528|NCT01364597|459349738|FG003|Overall Study|Patient became seizure-free after surgery|0|||
127652529|NCT01364597|459349735|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
127652530|NCT01364597|459349736|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
127652531|NCT01364597|459349737|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
127652532|NCT01364597|459349738|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
127652533|NCT01364597|459349735|FG000|Overall Study|Patient cured from Epilepsy|0|||
127652534|NCT01364597|459349736|FG001|Overall Study|Patient cured from Epilepsy|0|||
127652535|NCT01364597|459349737|FG002|Overall Study|Patient cured from Epilepsy|1|||
127652536|NCT01364597|459349738|FG003|Overall Study|Patient cured from Epilepsy|0|||
127652537|NCT01364597|459349735|FG000|Overall Study|Investigator decision|0|||
127652538|NCT01364597|459349736|FG001|Overall Study|Investigator decision|0|||
127652539|NCT01364597|459349737|FG002|Overall Study|Investigator decision|1|||
127652540|NCT01364597|459349738|FG003|Overall Study|Investigator decision|0|||
127652541|NCT01364597|459349735|FG000|Overall Study|Sponsor recommended discontinuation|0|||
127652542|NCT01364597|459349736|FG001|Overall Study|Sponsor recommended discontinuation|0|||
127652543|NCT01364597|459349737|FG002|Overall Study|Sponsor recommended discontinuation|0|||
127652544|NCT01364597|459349738|FG003|Overall Study|Sponsor recommended discontinuation|1|||
127652545|NCT01364597|459349735|FG000|Overall Study|Parents went abroad with the patient|0|||
127652546|NCT01364597|459349736|FG001|Overall Study|Parents went abroad with the patient|0|||
127652547|NCT01364597|459349737|FG002|Overall Study|Parents went abroad with the patient|1|||
127652548|NCT01364597|459349738|FG003|Overall Study|Parents went abroad with the patient|0|||
127652549|NCT01364597|459349735|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
127652550|NCT01364597|459349736|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
127652551|NCT01364597|459349737|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
127652552|NCT01364597|459349738|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
127652553|NCT01364597|459349735|FG000|Overall Study|BRV administration dropout|0|||
127652554|NCT01364597|459349736|FG001|Overall Study|BRV administration dropout|0|||
127652555|NCT01364597|459349737|FG002|Overall Study|BRV administration dropout|1|||
127652556|NCT01364597|459349738|FG003|Overall Study|BRV administration dropout|0|||
127652557|NCT01364597|459349735|FG000|Overall Study|Dropout|0|||
127652558|NCT01364597|459349736|FG001|Overall Study|Dropout|0|||
127652559|NCT01364597|459349737|FG002|Overall Study|Dropout|3|||
127652560|NCT01364597|459349738|FG003|Overall Study|Dropout|1|||
127652561|NCT01364597|459349735|FG000|Overall Study|Unreliable subject|0|||
127878589|NCT00083226|460175469|FG000|Overall Study|ineligible or not receiving treatment|4|||
127878590|NCT00909857|460175470|FG000|Overall Study|Withdrawal by Subject|6|||
127878591|NCT00909857|460175471|FG001|Overall Study|Withdrawal by Subject|10|||
127652562|NCT01364597|459349736|FG001|Overall Study|Unreliable subject|0|||
127652563|NCT01364597|459349737|FG002|Overall Study|Unreliable subject|0|||
127652564|NCT01364597|459349738|FG003|Overall Study|Unreliable subject|1|||
127878592|NCT00909857|460175470|FG000|Overall Study|Adverse Event|5|||
127652565|NCT01364597|459349735|FG000|Overall Study|Other|0|||
127652566|NCT01364597|459349736|FG001|Overall Study|Other|0|||
127652567|NCT01364597|459349737|FG002|Overall Study|Other|0|||
127652568|NCT01364597|459349738|FG003|Overall Study|Other|1|||
127652569|NCT01498822|459349739|FG000|Overall Study|Protocol Violation|8|||
127652570|NCT01498822|459349740|FG001|Overall Study|Protocol Violation|4|||
127652571|NCT01498822|459349739|FG000|Overall Study|Other Reason|5|||
127652572|NCT01498822|459349740|FG001|Overall Study|Other Reason|2|||
127652573|NCT01498822|459349739|FG000|Overall Study|Lack of Efficacy|7|||
127652574|NCT01498822|459349740|FG001|Overall Study|Lack of Efficacy|2|||
127652575|NCT01498822|459349739|FG000|Overall Study|AE, non-serious non-fatal|8|||
127652576|NCT01498822|459349740|FG001|Overall Study|AE, non-serious non-fatal|17|||
127652577|NCT01498822|459349739|FG000|Overall Study|SAE, non-fatal|2|||
127652578|NCT01498822|459349740|FG001|Overall Study|SAE, non-fatal|2|||
127652579|NCT01498822|459349739|FG000|Overall Study|Adverse Event, serious fatal|1|||
127652580|NCT01498822|459349740|FG001|Overall Study|Adverse Event, serious fatal|1|||
127652581|NCT01498822|459349739|FG000|Overall Study|Withdrawal by Subject|15|||
127652582|NCT01498822|459349740|FG001|Overall Study|Withdrawal by Subject|25|||
127652583|NCT01498822|459349739|FG000|Overall Study|Lost to Follow-up|8|||
127652584|NCT01498822|459349740|FG001|Overall Study|Lost to Follow-up|3|||
127652585|NCT03579290|459349743|FG000|Overall Study|Lost to Follow-up|9|||
127652586|NCT03131960|459349744|FG000|Overall Study|Adverse Event|0|||
127652587|NCT03131960|459349745|FG001|Overall Study|Adverse Event|1|||
127652588|NCT01674621|459349750|FG000|Overall Study|Adverse Event|3|||
127652589|NCT01674621|459349751|FG001|Overall Study|Adverse Event|2|||
127652590|NCT01674621|459349752|FG002|Overall Study|Adverse Event|5|||
127652591|NCT01674621|459349753|FG003|Overall Study|Adverse Event|5|||
127652592|NCT01674621|459349754|FG004|Overall Study|Adverse Event|1|||
127652593|NCT01674621|459349750|FG000|Overall Study|Inability to Complete Study Procedures|0|||
127652594|NCT01674621|459349751|FG001|Overall Study|Inability to Complete Study Procedures|0|||
127652595|NCT01674621|459349752|FG002|Overall Study|Inability to Complete Study Procedures|0|||
127652596|NCT01674621|459349753|FG003|Overall Study|Inability to Complete Study Procedures|0|||
127652597|NCT01674621|459349754|FG004|Overall Study|Inability to Complete Study Procedures|2|||
127652598|NCT01674621|459349750|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
127652599|NCT01674621|459349751|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
127652600|NCT01674621|459349752|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
127652601|NCT01674621|459349753|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
127652602|NCT01674621|459349754|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
127652603|NCT01674621|459349750|FG000|Overall Study|Withdrawal by Subject|2|||
127652604|NCT01674621|459349751|FG001|Overall Study|Withdrawal by Subject|5|||
127652605|NCT01674621|459349752|FG002|Overall Study|Withdrawal by Subject|2|||
127652606|NCT01674621|459349753|FG003|Overall Study|Withdrawal by Subject|0|||
127652607|NCT01674621|459349754|FG004|Overall Study|Withdrawal by Subject|1|||
127652608|NCT01674621|459349750|FG000|Overall Study|Other than specified|0|||
127652609|NCT01674621|459349751|FG001|Overall Study|Other than specified|1|||
127652610|NCT01674621|459349752|FG002|Overall Study|Other than specified|0|||
127652611|NCT01674621|459349753|FG003|Overall Study|Other than specified|0|||
127652612|NCT01674621|459349754|FG004|Overall Study|Other than specified|2|||
127652613|NCT01148862|459349755|FG000|Second Intervention|Withdrawal by Subject|0|||
127652614|NCT01148862|459349756|FG001|Second Intervention|Withdrawal by Subject|2|||
127652615|NCT00895622|459349757|FG000|Overall Study|Protocol Violation|5|||
127652616|NCT00895622|459349758|FG001|Overall Study|Protocol Violation|4|||
127652617|NCT00895622|459349759|FG002|Overall Study|Protocol Violation|4|||
127652618|NCT03724396|459349760|FG000|Overall Study|Lost to Follow-up|1|||
127652619|NCT03724396|459349761|FG001|Overall Study|Lost to Follow-up|1|||
127652620|NCT03724396|459349760|FG000|Overall Study|Withdrawal by Subject|1|||
127652621|NCT03724396|459349761|FG001|Overall Study|Withdrawal by Subject|0|||
127878593|NCT00909857|460175471|FG001|Overall Study|Adverse Event|5|||
127878594|NCT00909857|460175470|FG000|Overall Study|Lost to Follow-up|2|||
127652622|NCT01490125|459349762|FG000|Period I|Adverse Event|4|||
127652623|NCT01490125|459349763|FG001|Period I|Adverse Event|1|||
127878595|NCT00909857|460175471|FG001|Overall Study|Lost to Follow-up|5|||
127652624|NCT01490125|459349764|FG002|Period I|Adverse Event|1|||
127652625|NCT01490125|459349765|FG003|Period I|Adverse Event|3|||
127878596|NCT00909857|460175470|FG000|Overall Study|Protocol Violation|2|||
127878597|NCT00909857|460175471|FG001|Overall Study|Protocol Violation|1|||
127878598|NCT00909857|460175470|FG000|Overall Study|Pregnancy|1|||
127652626|NCT01490125|459349766|FG004|Period I|Adverse Event|2|||
127652627|NCT01490125|459349767|FG005|Period I|Adverse Event|4|||
127652628|NCT01490125|459349762|FG000|Period I|Protocol Violation|1|||
127652629|NCT01490125|459349763|FG001|Period I|Protocol Violation|1|||
127878599|NCT00909857|460175471|FG001|Overall Study|Pregnancy|0|||
127652630|NCT01490125|459349764|FG002|Period I|Protocol Violation|1|||
127652631|NCT01490125|459349765|FG003|Period I|Protocol Violation|1|||
127652632|NCT01490125|459349766|FG004|Period I|Protocol Violation|0|||
127878600|NCT00909857|460175470|FG000|Overall Study|Other|1|||
127878601|NCT00909857|460175471|FG001|Overall Study|Other|0|||
127878602|NCT00909857|460175470|FG000|Overall Study|Did not receive study medication|19|||
127878603|NCT00909857|460175471|FG001|Overall Study|Did not receive study medication|24|||
127878604|NCT00604175|460175478|FG000|Entry Through Week 28|Death|2|||
127878605|NCT00604175|460175479|FG001|Entry Through Week 28|Death|0|||
127878606|NCT00604175|460175480|FG002|Entry Through Week 28|Death|0|||
127878607|NCT00604175|460175478|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
127878608|NCT00604175|460175479|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
127878609|NCT00604175|460175480|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
127878610|NCT00604175|460175478|FG000|Entry Through Week 28|Lost to Follow-up|4|||
127878611|NCT00604175|460175479|FG001|Entry Through Week 28|Lost to Follow-up|3|||
127878612|NCT00604175|460175480|FG002|Entry Through Week 28|Lost to Follow-up|0|||
127878613|NCT00604175|460175478|FG000|Entry Through Week 28|Ineligible|1|||
127878614|NCT00604175|460175479|FG001|Entry Through Week 28|Ineligible|0|||
127878615|NCT00604175|460175480|FG002|Entry Through Week 28|Ineligible|0|||
127878616|NCT00604175|460175478|FG000|Entry Through Week 28|Did not start intervention|2|||
127878617|NCT00604175|460175479|FG001|Entry Through Week 28|Did not start intervention|0|||
127878618|NCT00604175|460175480|FG002|Entry Through Week 28|Did not start intervention|1|||
127878619|NCT00604175|460175478|FG000|Week 29 Through Week 72|Death|0|||
127878620|NCT00604175|460175479|FG001|Week 29 Through Week 72|Death|0|||
127878621|NCT00604175|460175480|FG002|Week 29 Through Week 72|Death|1|||
127878622|NCT00604175|460175478|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
127878623|NCT00604175|460175479|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
127878624|NCT00604175|460175480|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
127878625|NCT00604175|460175478|FG000|Week 29 Through Week 72|Site closure|0|||
127878626|NCT00604175|460175479|FG001|Week 29 Through Week 72|Site closure|1|||
127878627|NCT00604175|460175480|FG002|Week 29 Through Week 72|Site closure|0|||
127878628|NCT00604175|460175478|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
127878629|NCT00604175|460175479|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
127878630|NCT00604175|460175480|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
127878631|NCT02044094|460175481|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
127878632|NCT02044094|460175481|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
127878633|NCT02044094|460175481|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
127878634|NCT02044094|460175481|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
127878635|NCT02044094|460175481|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
127878636|NCT02044094|460175481|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
127878637|NCT02044094|460175481|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
127878638|NCT02044094|460175481|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
127878639|NCT03353415|460175484|FG000|Masked CGM Wear|Lost to Follow-up|2|||
127878640|NCT03353415|460175484|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
127878641|NCT05378269|460177340|FG000|Overall Study|Protocol Violation|1|||
127878642|NCT05378269|460177341|FG001|Overall Study|Protocol Violation|0|||
127878643|NCT05378269|460177342|FG002|Overall Study|Protocol Violation|2|||
127878644|NCT05378269|460177343|FG003|Overall Study|Protocol Violation|0|||
127878645|NCT05378269|460177344|FG004|Overall Study|Protocol Violation|0|||
127878646|NCT01721200|460177345|FG000|Overall Study|Lost to Follow-up|3|||
127542147|NCT04576988|458951154|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
127542148|NCT04576988|458951153|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
127878647|NCT01721200|460177346|FG001|Overall Study|Lost to Follow-up|5|||
127878648|NCT03926728|460177347|FG000|Overall Study|Withdrawal by Subject|0|||
127878649|NCT03926728|460177348|FG001|Overall Study|Withdrawal by Subject|1|||
127878650|NCT03926728|460177349|FG002|Overall Study|Withdrawal by Subject|1|||
127878651|NCT03926728|460177350|FG003|Overall Study|Withdrawal by Subject|0|||
127878652|NCT03926728|460177351|FG004|Overall Study|Withdrawal by Subject|0|||
127878653|NCT03926728|460177352|FG005|Overall Study|Withdrawal by Subject|1|||
127878654|NCT03926728|460177353|FG006|Overall Study|Withdrawal by Subject|1|||
127878655|NCT03926728|460177354|FG007|Overall Study|Withdrawal by Subject|0|||
127878656|NCT03926728|460177355|FG008|Overall Study|Withdrawal by Subject|0|||
127878657|NCT03926728|460177356|FG009|Overall Study|Withdrawal by Subject|1|||
127878658|NCT03926728|460177357|FG010|Overall Study|Withdrawal by Subject|0|||
127878659|NCT03926728|460177358|FG011|Overall Study|Withdrawal by Subject|0|||
127878660|NCT01956123|460177359|FG000|COS Cycle 2|Protocol Violation|8|||
127878661|NCT01956123|460177360|FG001|COS Cycle 2|Protocol Violation|3|||
127878662|NCT01956123|460177361|FG002|COS Cycle 2|Protocol Violation|0|||
127878663|NCT01956123|460177362|FG003|COS Cycle 2|Protocol Violation|0|||
127878664|NCT01956123|460177359|FG000|COS Cycle 2|Adverse Event|3|||
127878665|NCT01956123|460177360|FG001|COS Cycle 2|Adverse Event|4|||
127878666|NCT01956123|460177361|FG002|COS Cycle 2|Adverse Event|0|||
127878667|NCT01956123|460177362|FG003|COS Cycle 2|Adverse Event|0|||
127878668|NCT01956123|460177359|FG000|COS Cycle 2|Personal Reasons|2|||
127878669|NCT01956123|460177360|FG001|COS Cycle 2|Personal Reasons|0|||
127878670|NCT01956123|460177361|FG002|COS Cycle 2|Personal Reasons|0|||
127878671|NCT01956123|460177362|FG003|COS Cycle 2|Personal Reasons|0|||
127878672|NCT01956123|460177359|FG000|COS Cycle 2|Withdrawal by Subject|1|||
127542149|NCT04576988|458951154|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
127878673|NCT01956123|460177360|FG001|COS Cycle 2|Withdrawal by Subject|0|||
127878674|NCT01956123|460177361|FG002|COS Cycle 2|Withdrawal by Subject|0|||
127878675|NCT01956123|460177362|FG003|COS Cycle 2|Withdrawal by Subject|0|||
127878676|NCT01956123|460177359|FG000|COS Cycle 3|Protocol Violation|0|||
127878677|NCT01956123|460177360|FG001|COS Cycle 3|Protocol Violation|0|||
127878678|NCT01956123|460177361|FG002|COS Cycle 3|Protocol Violation|2|||
127878679|NCT01956123|460177362|FG003|COS Cycle 3|Protocol Violation|1|||
127878680|NCT01956123|460177359|FG000|COS Cycle 3|Adverse Event|0|||
127878681|NCT01956123|460177360|FG001|COS Cycle 3|Adverse Event|0|||
127878682|NCT01956123|460177361|FG002|COS Cycle 3|Adverse Event|3|||
127878683|NCT01956123|460177362|FG003|COS Cycle 3|Adverse Event|0|||
127878684|NCT01956123|460177359|FG000|COS Cycle 3|Personal Reasons|0|||
127878685|NCT01956123|460177360|FG001|COS Cycle 3|Personal Reasons|0|||
127878686|NCT01956123|460177361|FG002|COS Cycle 3|Personal Reasons|1|||
127878687|NCT01956123|460177362|FG003|COS Cycle 3|Personal Reasons|0|||
127878688|NCT01956123|460177359|FG000|COS Cycle 3|Withdrawal by Subject|0|||
127878689|NCT01956123|460177360|FG001|COS Cycle 3|Withdrawal by Subject|0|||
127878690|NCT01956123|460177361|FG002|COS Cycle 3|Withdrawal by Subject|0|||
127878691|NCT01956123|460177362|FG003|COS Cycle 3|Withdrawal by Subject|1|||
127878692|NCT00398632|460177363|FG000|Overall Study|Withdrawal by Subject|1|||
127878693|NCT00398632|460177363|FG000|Overall Study|Lack of Efficacy|1|||
127878694|NCT01325701|460177364|FG000|Overall Study|Adverse Event|12|||
127878695|NCT01325701|460177365|FG001|Overall Study|Adverse Event|0|||
127878696|NCT01325701|460177364|FG000|Overall Study|Protocol Violation|1|||
127878697|NCT01325701|460177365|FG001|Overall Study|Protocol Violation|0|||
127878698|NCT01325701|460177364|FG000|Overall Study|Physician Decision|2|||
127878699|NCT01325701|460177365|FG001|Overall Study|Physician Decision|2|||
127878700|NCT01325701|460177364|FG000|Overall Study|Withdrawal by Subject|2|||
127878701|NCT01325701|460177365|FG001|Overall Study|Withdrawal by Subject|1|||
127878702|NCT01325701|460177364|FG000|Overall Study|Rollerover Extension Study|4|||
127878703|NCT01325701|460177365|FG001|Overall Study|Rollerover Extension Study|0|||
127878704|NCT00388674|460177370|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
127878705|NCT00388674|460177371|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
127878706|NCT00388674|460177370|FG000|Initial Treatment|Adverse Event|22|||
127878707|NCT00388674|460177371|FG001|Initial Treatment|Adverse Event|87|||
127878708|NCT00388674|460177370|FG000|Initial Treatment|Death|215|||
127878709|NCT00388674|460177371|FG001|Initial Treatment|Death|216|||
127878710|NCT00388674|460177370|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
127878711|NCT00388674|460177371|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
127878712|NCT00388674|460177370|FG000|Initial Treatment|HCC|12|||
127878713|NCT00388674|460177371|FG001|Initial Treatment|HCC|20|||
127878714|NCT00388674|460177370|FG000|Initial Treatment|Lost to Follow-up|526|||
127878715|NCT00388674|460177371|FG001|Initial Treatment|Lost to Follow-up|624|||
127878716|NCT00388674|460177370|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
127878717|NCT00388674|460177371|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
127878718|NCT00388674|460177370|FG000|Initial Treatment|Never Treated with Study Medication|1|||
127878719|NCT00388674|460177371|FG001|Initial Treatment|Never Treated with Study Medication|7|||
127878720|NCT00388674|460177370|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
127878721|NCT00388674|460177371|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
127878722|NCT00388674|460177370|FG000|Initial Treatment|Not Defined|125|||
127878723|NCT00388674|460177371|FG001|Initial Treatment|Not Defined|172|||
127878724|NCT00388674|460177370|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
127878725|NCT00388674|460177371|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
127878726|NCT00388674|460177370|FG000|Initial Treatment|Pregnancy|26|||
127878727|NCT00388674|460177371|FG001|Initial Treatment|Pregnancy|16|||
127878728|NCT00388674|460177370|FG000|Initial Treatment|Study Drug Toxicity|5|||
127878729|NCT00388674|460177371|FG001|Initial Treatment|Study Drug Toxicity|92|||
127878730|NCT00388674|460177370|FG000|Initial Treatment|Participant Request|501|||
127878731|NCT00388674|460177371|FG001|Initial Treatment|Participant Request|673|||
127878732|NCT00388674|460177370|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
127878733|NCT00388674|460177371|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
127878734|NCT00388674|460177370|FG000|Initial Treatment|Not Reported|10|||
127878735|NCT00388674|460177371|FG001|Initial Treatment|Not Reported|12|||
127878736|NCT00388674|460177370|FG000|End of Study|Administrative Reason By Sponsor|299|||
127878737|NCT00388674|460177371|FG001|End of Study|Administrative Reason By Sponsor|253|||
127878738|NCT00388674|460177370|FG000|End of Study|Death|239|||
127878739|NCT00388674|460177371|FG001|End of Study|Death|262|||
127878740|NCT00388674|460177370|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
127878741|NCT00388674|460177371|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
127878742|NCT00388674|460177370|FG000|End of Study|HCC|8|||
127878743|NCT00388674|460177371|FG001|End of Study|HCC|7|||
127878744|NCT00388674|460177370|FG000|End of Study|Lost to Follow-up|587|||
127878745|NCT00388674|460177371|FG001|End of Study|Lost to Follow-up|715|||
127878746|NCT00388674|460177370|FG000|End of Study|Malignancy (Non-HCC)|1|||
127878747|NCT00388674|460177371|FG001|End of Study|Malignancy (Non-HCC)|1|||
127878748|NCT00388674|460177370|FG000|End of Study|Non-Study Related Comorbidities|3|||
127878749|NCT00388674|460177371|FG001|End of Study|Non-Study Related Comorbidities|4|||
127878750|NCT00388674|460177370|FG000|End of Study|Not Defined|135|||
127878751|NCT00388674|460177371|FG001|End of Study|Not Defined|214|||
127878752|NCT00388674|460177370|FG000|End of Study|Participant Withdrew Consent|437|||
127652633|NCT01490125|459349767|FG005|Period I|Protocol Violation|0|||
127652634|NCT01490125|459349762|FG000|Period I|Withdrawal by Subject|1|||
127652635|NCT01490125|459349763|FG001|Period I|Withdrawal by Subject|3|||
127652636|NCT01490125|459349764|FG002|Period I|Withdrawal by Subject|2|||
127652637|NCT01490125|459349765|FG003|Period I|Withdrawal by Subject|1|||
127652638|NCT01490125|459349766|FG004|Period I|Withdrawal by Subject|2|||
127878753|NCT00388674|460177371|FG001|End of Study|Participant Withdrew Consent|673|||
127878754|NCT00388674|460177370|FG000|End of Study|No Off-Treatment Status Data|22|||
127878755|NCT00388674|460177371|FG001|End of Study|No Off-Treatment Status Data|30|||
127878756|NCT00388674|460177370|FG000|End of Study|Not Reported|0|||
127878757|NCT00388674|460177371|FG001|End of Study|Not Reported|1|||
127878758|NCT00568776|460177372|FG000|Overall Study|Adverse Event|8|||
127878759|NCT00568776|460177373|FG001|Overall Study|Adverse Event|8|||
127878760|NCT00568776|460177374|FG002|Overall Study|Adverse Event|10|||
127878761|NCT00568776|460177375|FG003|Overall Study|Adverse Event|8|||
127878762|NCT00568776|460177372|FG000|Overall Study|Death|0|||
127878763|NCT00568776|460177373|FG001|Overall Study|Death|1|||
127878764|NCT00568776|460177374|FG002|Overall Study|Death|4|||
127878765|NCT00568776|460177375|FG003|Overall Study|Death|3|||
127878766|NCT00568776|460177372|FG000|Overall Study|Physician Decision|0|||
127878767|NCT00568776|460177373|FG001|Overall Study|Physician Decision|2|||
127878768|NCT00568776|460177374|FG002|Overall Study|Physician Decision|0|||
127878769|NCT00568776|460177375|FG003|Overall Study|Physician Decision|0|||
127878770|NCT00568776|460177372|FG000|Overall Study|Lack of Efficacy|2|||
127878771|NCT00568776|460177373|FG001|Overall Study|Lack of Efficacy|2|||
127878772|NCT00568776|460177374|FG002|Overall Study|Lack of Efficacy|2|||
127878773|NCT00568776|460177375|FG003|Overall Study|Lack of Efficacy|4|||
127878774|NCT00568776|460177372|FG000|Overall Study|Lost to Follow-up|1|||
127878775|NCT00568776|460177373|FG001|Overall Study|Lost to Follow-up|1|||
127878776|NCT00568776|460177374|FG002|Overall Study|Lost to Follow-up|1|||
127878777|NCT00568776|460177375|FG003|Overall Study|Lost to Follow-up|1|||
127878778|NCT00568776|460177372|FG000|Overall Study|Protocol Violation|1|||
127878779|NCT00568776|460177373|FG001|Overall Study|Protocol Violation|0|||
127878780|NCT00568776|460177374|FG002|Overall Study|Protocol Violation|1|||
127878781|NCT00568776|460177375|FG003|Overall Study|Protocol Violation|1|||
127878782|NCT00568776|460177372|FG000|Overall Study|Withdrawal by Subject|13|||
127878783|NCT00568776|460177373|FG001|Overall Study|Withdrawal by Subject|15|||
127878784|NCT00568776|460177374|FG002|Overall Study|Withdrawal by Subject|13|||
127878785|NCT00568776|460177375|FG003|Overall Study|Withdrawal by Subject|7|||
127878786|NCT00568776|460177372|FG000|Overall Study|Loss of Caregiver|0|||
127878787|NCT00568776|460177373|FG001|Overall Study|Loss of Caregiver|2|||
127878788|NCT00568776|460177374|FG002|Overall Study|Loss of Caregiver|1|||
127878789|NCT00568776|460177375|FG003|Overall Study|Loss of Caregiver|2|||
127878790|NCT00568776|460177372|FG000|Overall Study|Sponsor Decision|2|||
127878791|NCT00568776|460177373|FG001|Overall Study|Sponsor Decision|2|||
127878792|NCT00568776|460177374|FG002|Overall Study|Sponsor Decision|41|||
127878793|NCT00568776|460177375|FG003|Overall Study|Sponsor Decision|42|||
127878794|NCT00568776|460177372|FG000|Overall Study|Miscellaeneous|3|||
127878795|NCT00568776|460177373|FG001|Overall Study|Miscellaeneous|3|||
127878796|NCT00568776|460177374|FG002|Overall Study|Miscellaeneous|1|||
127878797|NCT00568776|460177375|FG003|Overall Study|Miscellaeneous|4|||
127878798|NCT02118896|460177386|FG000|Overall Study|Death|4|||
127878799|NCT02118896|460177387|FG001|Overall Study|Death|0|||
127878800|NCT02118896|460177388|FG002|Overall Study|Death|4|||
127878801|NCT02118896|460177389|FG003|Overall Study|Death|6|||
127878802|NCT02118896|460177390|FG004|Overall Study|Death|3|||
127878803|NCT02118896|460177391|FG005|Overall Study|Death|1|||
127878804|NCT02118896|460177392|FG006|Overall Study|Death|0|||
127878805|NCT02118896|460177393|FG007|Overall Study|Death|0|||
127878806|NCT02118896|460177394|FG008|Overall Study|Death|0|||
127878807|NCT02118896|460177395|FG009|Overall Study|Death|0|||
127878808|NCT02118896|460177386|FG000|Overall Study|Adverse Event|5|||
127878809|NCT02118896|460177387|FG001|Overall Study|Adverse Event|4|||
127878810|NCT02118896|460177388|FG002|Overall Study|Adverse Event|4|||
127878811|NCT02118896|460177389|FG003|Overall Study|Adverse Event|5|||
127878812|NCT02118896|460177390|FG004|Overall Study|Adverse Event|5|||
127652639|NCT01490125|459349767|FG005|Period I|Withdrawal by Subject|1|||
127652640|NCT01490125|459349762|FG000|Period II|Adverse Event|2|||
127652641|NCT01490125|459349763|FG001|Period II|Adverse Event|3|||
127652642|NCT01490125|459349764|FG002|Period II|Adverse Event|2|||
127878813|NCT02118896|460177391|FG005|Overall Study|Adverse Event|9|||
127878814|NCT02118896|460177392|FG006|Overall Study|Adverse Event|1|||
127878815|NCT02118896|460177393|FG007|Overall Study|Adverse Event|1|||
127878816|NCT02118896|460177394|FG008|Overall Study|Adverse Event|4|||
127878817|NCT02118896|460177395|FG009|Overall Study|Adverse Event|0|||
127878818|NCT02118896|460177386|FG000|Overall Study|Consent withdrawn|2|||
127878819|NCT02118896|460177387|FG001|Overall Study|Consent withdrawn|0|||
127878820|NCT02118896|460177388|FG002|Overall Study|Consent withdrawn|3|||
127878821|NCT02118896|460177389|FG003|Overall Study|Consent withdrawn|4|||
127878822|NCT02118896|460177390|FG004|Overall Study|Consent withdrawn|1|||
127878823|NCT02118896|460177391|FG005|Overall Study|Consent withdrawn|4|||
127878824|NCT02118896|460177392|FG006|Overall Study|Consent withdrawn|0|||
127878825|NCT02118896|460177393|FG007|Overall Study|Consent withdrawn|0|||
127878826|NCT02118896|460177394|FG008|Overall Study|Consent withdrawn|0|||
127878827|NCT02118896|460177395|FG009|Overall Study|Consent withdrawn|0|||
127878828|NCT02118896|460177386|FG000|Overall Study|Non-compliance|2|||
127878829|NCT02118896|460177387|FG001|Overall Study|Non-compliance|1|||
127878830|NCT02118896|460177388|FG002|Overall Study|Non-compliance|1|||
127878831|NCT02118896|460177389|FG003|Overall Study|Non-compliance|5|||
127878832|NCT02118896|460177390|FG004|Overall Study|Non-compliance|0|||
127878833|NCT02118896|460177391|FG005|Overall Study|Non-compliance|1|||
127878834|NCT02118896|460177392|FG006|Overall Study|Non-compliance|0|||
127878835|NCT02118896|460177393|FG007|Overall Study|Non-compliance|1|||
127878836|NCT02118896|460177394|FG008|Overall Study|Non-compliance|0|||
127878837|NCT02118896|460177395|FG009|Overall Study|Non-compliance|0|||
127878838|NCT02118896|460177386|FG000|Overall Study|Pregnancy|1|||
127878839|NCT02118896|460177387|FG001|Overall Study|Pregnancy|1|||
127878840|NCT02118896|460177388|FG002|Overall Study|Pregnancy|0|||
127878841|NCT02118896|460177389|FG003|Overall Study|Pregnancy|0|||
127878842|NCT02118896|460177390|FG004|Overall Study|Pregnancy|1|||
127878843|NCT02118896|460177391|FG005|Overall Study|Pregnancy|3|||
127878844|NCT02118896|460177392|FG006|Overall Study|Pregnancy|1|||
127878845|NCT02118896|460177393|FG007|Overall Study|Pregnancy|0|||
127878846|NCT02118896|460177394|FG008|Overall Study|Pregnancy|0|||
127878847|NCT02118896|460177395|FG009|Overall Study|Pregnancy|0|||
127878848|NCT02118896|460177386|FG000|Overall Study|Lost to Follow-up|1|||
127878849|NCT02118896|460177387|FG001|Overall Study|Lost to Follow-up|2|||
127878850|NCT02118896|460177388|FG002|Overall Study|Lost to Follow-up|1|||
127878851|NCT02118896|460177389|FG003|Overall Study|Lost to Follow-up|0|||
127878852|NCT02118896|460177390|FG004|Overall Study|Lost to Follow-up|2|||
127878853|NCT02118896|460177391|FG005|Overall Study|Lost to Follow-up|1|||
127878854|NCT02118896|460177392|FG006|Overall Study|Lost to Follow-up|0|||
127878855|NCT02118896|460177393|FG007|Overall Study|Lost to Follow-up|0|||
127878856|NCT02118896|460177394|FG008|Overall Study|Lost to Follow-up|0|||
127878857|NCT02118896|460177395|FG009|Overall Study|Lost to Follow-up|0|||
127878858|NCT02118896|460177386|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
127878859|NCT02118896|460177387|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
127878860|NCT02118896|460177388|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
127878861|NCT02118896|460177389|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
127878862|NCT02118896|460177390|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
127652643|NCT01490125|459349765|FG003|Period II|Adverse Event|2|||
127652644|NCT01490125|459349766|FG004|Period II|Adverse Event|4|||
127652645|NCT01490125|459349767|FG005|Period II|Adverse Event|2|||
127878863|NCT02118896|460177391|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
127878864|NCT02118896|460177392|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
127652646|NCT01490125|459349762|FG000|Period II|Protocol Violation|0|||
127652647|NCT01490125|459349763|FG001|Period II|Protocol Violation|0|||
127878865|NCT02118896|460177393|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
127878866|NCT02118896|460177394|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
127878867|NCT02118896|460177395|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
127878868|NCT02118896|460177386|FG000|Overall Study|Prohibited medication|0|||
127878869|NCT02118896|460177387|FG001|Overall Study|Prohibited medication|0|||
127878870|NCT02118896|460177388|FG002|Overall Study|Prohibited medication|0|||
127878871|NCT02118896|460177389|FG003|Overall Study|Prohibited medication|0|||
127878872|NCT02118896|460177390|FG004|Overall Study|Prohibited medication|1|||
127878873|NCT02118896|460177391|FG005|Overall Study|Prohibited medication|3|||
127878874|NCT02118896|460177392|FG006|Overall Study|Prohibited medication|0|||
127878875|NCT02118896|460177393|FG007|Overall Study|Prohibited medication|0|||
127652648|NCT01490125|459349764|FG002|Period II|Protocol Violation|1|||
127652649|NCT01490125|459349765|FG003|Period II|Protocol Violation|1|||
127652650|NCT01490125|459349766|FG004|Period II|Protocol Violation|0|||
127652651|NCT01490125|459349767|FG005|Period II|Protocol Violation|0|||
127652652|NCT01490125|459349762|FG000|Period II|Lost to Follow-up|0|||
127652653|NCT01490125|459349763|FG001|Period II|Lost to Follow-up|1|||
127878876|NCT02118896|460177394|FG008|Overall Study|Prohibited medication|0|||
127878877|NCT02118896|460177395|FG009|Overall Study|Prohibited medication|0|||
127652654|NCT01490125|459349764|FG002|Period II|Lost to Follow-up|0|||
127652655|NCT01490125|459349765|FG003|Period II|Lost to Follow-up|0|||
127652656|NCT01490125|459349766|FG004|Period II|Lost to Follow-up|0|||
127878878|NCT02118896|460177386|FG000|Overall Study|Miscellaneous|1|||
127878879|NCT02118896|460177387|FG001|Overall Study|Miscellaneous|2|||
127878880|NCT02118896|460177388|FG002|Overall Study|Miscellaneous|0|||
127878881|NCT02118896|460177389|FG003|Overall Study|Miscellaneous|2|||
127878882|NCT02118896|460177390|FG004|Overall Study|Miscellaneous|0|||
127878883|NCT02118896|460177391|FG005|Overall Study|Miscellaneous|4|||
127878884|NCT02118896|460177392|FG006|Overall Study|Miscellaneous|0|||
127878885|NCT02118896|460177393|FG007|Overall Study|Miscellaneous|0|||
127878886|NCT02118896|460177394|FG008|Overall Study|Miscellaneous|0|||
127878887|NCT02118896|460177395|FG009|Overall Study|Miscellaneous|0|||
127878888|NCT03292731|460177396|FG000|Overall Study|Protocol Violation|4|||
127878889|NCT03292731|460177397|FG001|Overall Study|Protocol Violation|11|||
127878890|NCT03292731|460177398|FG002|Overall Study|Protocol Violation|1|||
127878891|NCT03901352|460177399|FG000|Double-blind Phase|Adverse Event|6|||
127878892|NCT03901352|460177400|FG001|Double-blind Phase|Adverse Event|4|||
127878893|NCT03901352|460177399|FG000|Double-blind Phase|Death|1|||
127878894|NCT03901352|460177400|FG001|Double-blind Phase|Death|0|||
127878895|NCT03901352|460177399|FG000|Double-blind Phase|Lack of Efficacy|0|||
127878896|NCT03901352|460177400|FG001|Double-blind Phase|Lack of Efficacy|1|||
127878897|NCT03901352|460177399|FG000|Double-blind Phase|Protocol Violation|0|||
127878898|NCT03901352|460177400|FG001|Double-blind Phase|Protocol Violation|1|||
127878899|NCT03901352|460177399|FG000|Double-blind Phase|Withdrawal by Subject|10|||
127878900|NCT03901352|460177400|FG001|Double-blind Phase|Withdrawal by Subject|8|||
127878901|NCT03901352|460177399|FG000|Open-label Extension Phase|Adverse Event|24|||
127878902|NCT03901352|460177400|FG001|Open-label Extension Phase|Adverse Event|0|||
127878903|NCT03901352|460177399|FG000|Open-label Extension Phase|Lack of Efficacy|1|||
127878904|NCT03901352|460177400|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
127878905|NCT03901352|460177399|FG000|Open-label Extension Phase|Withdrawal by Subject|14|||
127878906|NCT03901352|460177400|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
127878907|NCT03901352|460177399|FG000|Open-label Extension Phase|Other|1|||
127878908|NCT03901352|460177400|FG001|Open-label Extension Phase|Other|0|||
127878909|NCT01965431|460177401|FG000|Overall Study|Adverse Event|0|||
127878910|NCT01965431|460177402|FG001|Overall Study|Adverse Event|1|||
127878911|NCT01965431|460177403|FG002|Overall Study|Adverse Event|0|||
127878912|NCT01965431|460177404|FG003|Overall Study|Adverse Event|0|||
127878913|NCT01965431|460177405|FG004|Overall Study|Adverse Event|0|||
127878914|NCT01965431|460177406|FG005|Overall Study|Adverse Event|0|||
127878915|NCT01965431|460177401|FG000|Overall Study|Other than stated above|6|||
127878916|NCT01965431|460177402|FG001|Overall Study|Other than stated above|5|||
127878917|NCT01965431|460177403|FG002|Overall Study|Other than stated above|6|||
127542150|NCT04576988|458951153|FG000|Long Term Double Blind (LTDB)|Death|2|||
127542151|NCT04576988|458951154|FG001|Long Term Double Blind (LTDB)|Death|1|||
127542152|NCT04576988|458951153|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
127542153|NCT04576988|458951154|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
127542154|NCT01576341|458951155|FG000|Overall Study|Withdrawal by Subject|24|||
127542155|NCT01576341|458951155|FG000|Overall Study|Adverse Event|10|||
127542156|NCT01576341|458951155|FG000|Overall Study|Death|21|||
127542157|NCT01576341|458951155|FG000|Overall Study|Physician Decision|2|||
127542158|NCT01576341|458951155|FG000|Overall Study|Lost to Follow-up|2|||
127542159|NCT01576341|458951155|FG000|Overall Study|Kidney transplantation|10|||
127542160|NCT01576341|458951155|FG000|Overall Study|Protocol Violation|12|||
127542161|NCT01576341|458951155|FG000|Overall Study|Other|12|||
127542162|NCT00617734|458951156|FG000|Overall Study|Withdrew Consent|2|||
127542163|NCT00617734|458951157|FG001|Overall Study|Withdrew Consent|0|||
127542164|NCT00617734|458951156|FG000|Overall Study|Adverse Event|4|||
127542165|NCT00617734|458951157|FG001|Overall Study|Adverse Event|1|||
127542166|NCT00617734|458951156|FG000|Overall Study|Protocol Violation|1|||
127542167|NCT00617734|458951157|FG001|Overall Study|Protocol Violation|0|||
127542168|NCT00617734|458951156|FG000|Overall Study|Found Ineligible After Randomization|1|||
127542169|NCT00617734|458951157|FG001|Overall Study|Found Ineligible After Randomization|4|||
127542170|NCT00617734|458951156|FG000|Overall Study|Lost to Follow-up|0|||
127542171|NCT00617734|458951157|FG001|Overall Study|Lost to Follow-up|1|||
127542172|NCT01844765|458951158|FG000|Overall Study|Adverse Event|6|||
127542173|NCT01844765|458951159|FG001|Overall Study|Adverse Event|8|||
127542174|NCT01844765|458951158|FG000|Overall Study|Withdrawal by Subject|2|||
127542175|NCT01844765|458951159|FG001|Overall Study|Withdrawal by Subject|3|||
127542176|NCT01844765|458951158|FG000|Overall Study|Disease progression|1|||
127542177|NCT01844765|458951159|FG001|Overall Study|Disease progression|0|||
127542178|NCT01844765|458951158|FG000|Overall Study|Administrative problems|3|||
127542179|NCT01844765|458951159|FG001|Overall Study|Administrative problems|4|||
127542180|NCT01844765|458951158|FG000|Overall Study|Protocol deviation|2|||
127542181|NCT01844765|458951159|FG001|Overall Study|Protocol deviation|0|||
127542182|NCT01844765|458951158|FG000|Overall Study|Untreated|1|||
127542183|NCT01844765|458951159|FG001|Overall Study|Untreated|0|||
127542184|NCT01253291|458951168|FG000|Overall Study|Withdrawal by Subject|1|||
127542185|NCT01253291|458951169|FG001|Overall Study|Withdrawal by Subject|1|||
127542186|NCT01253291|458951170|FG002|Overall Study|Withdrawal by Subject|0|||
127542187|NCT01253291|458951171|FG003|Overall Study|Withdrawal by Subject|0|||
127542188|NCT01253291|458951172|FG004|Overall Study|Withdrawal by Subject|0|||
127542189|NCT01253291|458951168|FG000|Overall Study|Adverse Event|0|||
127542190|NCT01253291|458951169|FG001|Overall Study|Adverse Event|1|||
127878918|NCT01965431|460177404|FG003|Overall Study|Other than stated above|6|||
127878919|NCT01965431|460177405|FG004|Overall Study|Other than stated above|6|||
127878920|NCT01965431|460177406|FG005|Overall Study|Other than stated above|6|||
127878921|NCT04635631|460177407|FG000|Overall Study|Adverse Event|1|||
127542191|NCT01253291|458951170|FG002|Overall Study|Adverse Event|0|||
127542192|NCT01253291|458951171|FG003|Overall Study|Adverse Event|0|||
127878922|NCT04635631|460177407|FG000|Overall Study|Progressive disease|13|||
127878923|NCT04635631|460177407|FG000|Overall Study|Withdrawal by Subject|1|||
127878924|NCT02050373|460177408|FG000|Overall Study|Adverse Event|4|||
127878925|NCT02050373|460177409|FG001|Overall Study|Adverse Event|7|||
127878926|NCT02050373|460177408|FG000|Overall Study|Death|3|||
127878927|NCT02050373|460177409|FG001|Overall Study|Death|3|||
127878928|NCT03901339|460177410|FG000|Overall Study|Death|220|||
127878929|NCT03901339|460177411|FG001|Overall Study|Death|192|||
127878930|NCT03901339|460177410|FG000|Overall Study|Informed consent withdrawn|13|||
127878931|NCT03901339|460177411|FG001|Overall Study|Informed consent withdrawn|40|||
127878932|NCT03901339|460177410|FG000|Overall Study|Sponsor request|30|||
127878933|NCT03901339|460177411|FG001|Overall Study|Sponsor request|23|||
127878934|NCT03901339|460177410|FG000|Overall Study|Reason not specified|5|||
127878935|NCT03901339|460177411|FG001|Overall Study|Reason not specified|7|||
127878936|NCT03901339|460177410|FG000|Overall Study|Lost to Follow-up|4|||
127878937|NCT03901339|460177411|FG001|Overall Study|Lost to Follow-up|7|||
127878938|NCT03901339|460177410|FG000|Overall Study|Covid19|0|||
127878939|NCT03901339|460177411|FG001|Overall Study|Covid19|2|||
127878940|NCT00572910|460177414|FG000|Overall Study|Adverse Event|1|||
127878941|NCT00572910|460177415|FG001|Overall Study|Adverse Event|2|||
127878942|NCT00572910|460177416|FG002|Overall Study|Adverse Event|0|||
127878943|NCT00572910|460177417|FG003|Overall Study|Adverse Event|2|||
127878944|NCT00572910|460177418|FG004|Overall Study|Adverse Event|0|||
127878945|NCT00572910|460177419|FG005|Overall Study|Adverse Event|0|||
127878946|NCT00572910|460177420|FG006|Overall Study|Adverse Event|4|||
127878947|NCT00572910|460177421|FG007|Overall Study|Adverse Event|2|||
127878948|NCT00572910|460177422|FG008|Overall Study|Adverse Event|1|||
127878949|NCT00572910|460177423|FG009|Overall Study|Adverse Event|3|||
127878950|NCT00572910|460177424|FG010|Overall Study|Adverse Event|2|||
127878951|NCT00572910|460177414|FG000|Overall Study|Lost to Follow-up|0|||
127878952|NCT00572910|460177415|FG001|Overall Study|Lost to Follow-up|1|||
127878953|NCT00572910|460177416|FG002|Overall Study|Lost to Follow-up|1|||
127878954|NCT00572910|460177417|FG003|Overall Study|Lost to Follow-up|2|||
127878955|NCT00572910|460177418|FG004|Overall Study|Lost to Follow-up|1|||
127878956|NCT00572910|460177419|FG005|Overall Study|Lost to Follow-up|0|||
127878957|NCT00572910|460177420|FG006|Overall Study|Lost to Follow-up|0|||
127878958|NCT00572910|460177421|FG007|Overall Study|Lost to Follow-up|0|||
127878959|NCT00572910|460177422|FG008|Overall Study|Lost to Follow-up|0|||
127878960|NCT00572910|460177423|FG009|Overall Study|Lost to Follow-up|1|||
127878961|NCT00572910|460177424|FG010|Overall Study|Lost to Follow-up|0|||
127878962|NCT00572910|460177414|FG000|Overall Study|Withdrawal by Subject|3|||
127878963|NCT00572910|460177415|FG001|Overall Study|Withdrawal by Subject|0|||
127878964|NCT00572910|460177416|FG002|Overall Study|Withdrawal by Subject|1|||
127878965|NCT00572910|460177417|FG003|Overall Study|Withdrawal by Subject|0|||
127878966|NCT00572910|460177418|FG004|Overall Study|Withdrawal by Subject|1|||
127878967|NCT00572910|460177419|FG005|Overall Study|Withdrawal by Subject|3|||
127878968|NCT00572910|460177420|FG006|Overall Study|Withdrawal by Subject|0|||
127878969|NCT00572910|460177421|FG007|Overall Study|Withdrawal by Subject|2|||
127878970|NCT00572910|460177422|FG008|Overall Study|Withdrawal by Subject|2|||
127878971|NCT00572910|460177423|FG009|Overall Study|Withdrawal by Subject|2|||
127878972|NCT00572910|460177424|FG010|Overall Study|Withdrawal by Subject|1|||
127878973|NCT00592007|460177429|FG000|Overall Study|Withdrawal by Subject|1|||
127878974|NCT00592007|460177429|FG000|Overall Study|patient ineligible (out of lab range)|1|||
127878975|NCT00457418|460177430|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
127878976|NCT00457418|460177430|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
127878977|NCT00457418|460177430|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
127878978|NCT00457418|460177430|FG000|Post PK Maintenance|Adverse Event|10|||
127878979|NCT00457418|460177430|FG000|Post PK Maintenance|Progression of Disease|6|||
127878980|NCT00457418|460177430|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
127878981|NCT00457418|460177430|FG000|Post PK Maintenance|Lost to Follow-up|1|||
127878982|NCT00595127|460177431|FG000|Overall Study|Death|6|||
127878983|NCT00595127|460177431|FG000|Overall Study|Relapsed|3|||
127878984|NCT00595127|460177431|FG000|Overall Study|joined another trial|1|||
127878985|NCT02086968|460177433|FG000|Overall Study|Adverse Event|1|||
127878986|NCT02086968|460177434|FG001|Overall Study|Adverse Event|5|||
127878987|NCT02086968|460177433|FG000|Overall Study|Lost to Follow-up|2|||
127878988|NCT02086968|460177434|FG001|Overall Study|Lost to Follow-up|3|||
127878989|NCT02086968|460177433|FG000|Overall Study|Study drug received outside protocol|0|||
127878990|NCT02086968|460177434|FG001|Overall Study|Study drug received outside protocol|1|||
127878991|NCT02086968|460177433|FG000|Overall Study|Physician Decision|4|||
127878992|NCT02086968|460177434|FG001|Overall Study|Physician Decision|0|||
127878993|NCT02086968|460177433|FG000|Overall Study|Withdrawal by Subject|1|||
127878994|NCT02086968|460177434|FG001|Overall Study|Withdrawal by Subject|4|||
127878995|NCT01569074|460177435|FG000|Overall Study|Study stopped|6|||
127878996|NCT01569074|460177436|FG001|Overall Study|Study stopped|6|||
127878997|NCT01569074|460177437|FG002|Overall Study|Study stopped|8|||
127878998|NCT01569074|460177438|FG003|Overall Study|Study stopped|7|||
127878999|NCT01569074|460177439|FG004|Overall Study|Study stopped|7|||
127879000|NCT01569074|460177435|FG000|Overall Study|Study-specific discontinuation criteria|0|||
127879001|NCT01569074|460177436|FG001|Overall Study|Study-specific discontinuation criteria|1|||
127879002|NCT01569074|460177437|FG002|Overall Study|Study-specific discontinuation criteria|0|||
127879003|NCT01569074|460177438|FG003|Overall Study|Study-specific discontinuation criteria|0|||
127879004|NCT01569074|460177439|FG004|Overall Study|Study-specific discontinuation criteria|0|||
127879005|NCT01569074|460177435|FG000|Overall Study|Severe non-compliance to protocol|0|||
127879006|NCT01569074|460177436|FG001|Overall Study|Severe non-compliance to protocol|0|||
127879007|NCT01569074|460177437|FG002|Overall Study|Severe non-compliance to protocol|1|||
127879008|NCT01569074|460177438|FG003|Overall Study|Severe non-compliance to protocol|0|||
127879009|NCT01569074|460177439|FG004|Overall Study|Severe non-compliance to protocol|0|||
127879010|NCT01569074|460177435|FG000|Overall Study|eg change in circumstances|0|||
127879011|NCT01569074|460177436|FG001|Overall Study|eg change in circumstances|2|||
127879012|NCT01569074|460177437|FG002|Overall Study|eg change in circumstances|0|||
127879013|NCT01569074|460177438|FG003|Overall Study|eg change in circumstances|1|||
127879014|NCT01569074|460177439|FG004|Overall Study|eg change in circumstances|1|||
127879015|NCT01569074|460177435|FG000|Overall Study|Adverse Event|1|||
127879016|NCT01569074|460177436|FG001|Overall Study|Adverse Event|0|||
127879017|NCT01569074|460177437|FG002|Overall Study|Adverse Event|3|||
127879018|NCT01569074|460177438|FG003|Overall Study|Adverse Event|0|||
127879019|NCT01569074|460177439|FG004|Overall Study|Adverse Event|0|||
127879020|NCT02723786|460177440|FG000|Overall Study|Lost to Follow-up|1|||
127879021|NCT03123120|460177441|FG000|Overall Study|Lost to Follow-up|0|||
127879022|NCT03123120|460177442|FG001|Overall Study|Lost to Follow-up|1|||
127879023|NCT03123120|460177441|FG000|Overall Study|Withdrawal by Subject|0|||
127879024|NCT03123120|460177442|FG001|Overall Study|Withdrawal by Subject|1|||
127879025|NCT00203892|460177443|FG000|Overall Study|Physician Decision|1|||
127879026|NCT00203892|460177444|FG001|Overall Study|Physician Decision|2|||
127879027|NCT00203892|460177445|FG002|Overall Study|Physician Decision|0|||
127879028|NCT00203892|460177443|FG000|Overall Study|Death|1|||
127879029|NCT00203892|460177444|FG001|Overall Study|Death|0|||
127879030|NCT00203892|460177445|FG002|Overall Study|Death|0|||
127879031|NCT00806416|460177446|FG000|Period 1 - Part I|Adverse Event|0|||
127879032|NCT00806416|460177447|FG001|Period 1 - Part I|Adverse Event|1|||
127879033|NCT00806416|460177448|FG002|Period 1 - Part I|Adverse Event|0|||
127879034|NCT00806416|460177449|FG003|Period 1 - Part I|Adverse Event|0|||
127879035|NCT00806416|460177446|FG000|Period 1 - Part I|Lost to Follow-up|0|||
127879036|NCT00806416|460177447|FG001|Period 1 - Part I|Lost to Follow-up|2|||
127879037|NCT00806416|460177448|FG002|Period 1 - Part I|Lost to Follow-up|0|||
127879038|NCT00806416|460177449|FG003|Period 1 - Part I|Lost to Follow-up|0|||
127879039|NCT00806416|460177446|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
127879040|NCT00806416|460177447|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
127879041|NCT00806416|460177448|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
127879042|NCT00806416|460177449|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
127879043|NCT00806416|460177446|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
127879044|NCT00806416|460177447|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
127879045|NCT00806416|460177448|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
127879046|NCT00806416|460177449|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
127879047|NCT01610284|460177462|FG000|Randomization Phase|Adverse Event|1|||
127879048|NCT01610284|460177463|FG001|Randomization Phase|Adverse Event|0|||
127879049|NCT01610284|460177462|FG000|Randomization Phase|Physician Decision|1|||
127879050|NCT01610284|460177463|FG001|Randomization Phase|Physician Decision|1|||
127879051|NCT01610284|460177462|FG000|Randomization Phase|Death|0|||
127879052|NCT01610284|460177463|FG001|Randomization Phase|Death|1|||
127879053|NCT01610284|460177462|FG000|Treatment Phase|Adverse Event|80|||
127879054|NCT01610284|460177463|FG001|Treatment Phase|Adverse Event|12|||
127879055|NCT01610284|460177462|FG000|Treatment Phase|Lost to Follow-up|1|||
127879056|NCT01610284|460177463|FG001|Treatment Phase|Lost to Follow-up|0|||
127879057|NCT01610284|460177462|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
127879058|NCT01610284|460177463|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
127879059|NCT01610284|460177462|FG000|Treatment Phase|Physician Decision|27|||
127879060|NCT01610284|460177463|FG001|Treatment Phase|Physician Decision|24|||
127879061|NCT01610284|460177462|FG000|Treatment Phase|Progressive Disease|377|||
127879062|NCT01610284|460177463|FG001|Treatment Phase|Progressive Disease|486|||
127879063|NCT01610284|460177462|FG000|Treatment Phase|Protocol Deviation|2|||
127879064|NCT01610284|460177463|FG001|Treatment Phase|Protocol Deviation|3|||
127879065|NCT01610284|460177462|FG000|Treatment Phase|Study terminated by Sponsor|18|||
127879066|NCT01610284|460177463|FG001|Treatment Phase|Study terminated by Sponsor|15|||
127879067|NCT01610284|460177462|FG000|Treatment Phase|Subject/Guardian Decision|55|||
127879068|NCT01610284|460177463|FG001|Treatment Phase|Subject/Guardian Decision|23|||
127879069|NCT01610284|460177462|FG000|Treatment Phase|Death|6|||
127879070|NCT01610284|460177463|FG001|Treatment Phase|Death|5|||
127879071|NCT01610284|460177462|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
127879072|NCT01610284|460177463|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
127879073|NCT01610284|460177462|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
127879074|NCT01610284|460177463|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
127879075|NCT01610284|460177462|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
127879076|NCT01610284|460177463|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
127879077|NCT01610284|460177462|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
127652657|NCT01490125|459349767|FG005|Period II|Lost to Follow-up|0|||
127879078|NCT01610284|460177463|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
127879079|NCT01610284|460177462|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
127879080|NCT01610284|460177463|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
127879081|NCT01610284|460177462|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
127879082|NCT01610284|460177463|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
127879083|NCT01856257|460177466|FG000|Overall Study|Death|2|||
127879084|NCT01856257|460177467|FG001|Overall Study|Death|0|||
127879085|NCT01856257|460177468|FG002|Overall Study|Death|0|||
127879086|NCT01856257|460177469|FG003|Overall Study|Death|0|||
127879087|NCT01856257|460177466|FG000|Overall Study|Physician Decision|0|||
127879088|NCT01856257|460177467|FG001|Overall Study|Physician Decision|0|||
127879089|NCT01856257|460177468|FG002|Overall Study|Physician Decision|0|||
127879090|NCT01856257|460177469|FG003|Overall Study|Physician Decision|1|||
127879091|NCT01856257|460177466|FG000|Overall Study|Withdrawal by Subject|1|||
127879092|NCT01856257|460177467|FG001|Overall Study|Withdrawal by Subject|1|||
127879093|NCT01856257|460177468|FG002|Overall Study|Withdrawal by Subject|0|||
127879094|NCT01856257|460177469|FG003|Overall Study|Withdrawal by Subject|0|||
127879095|NCT01856257|460177466|FG000|Overall Study|Donor complication|0|||
127879096|NCT01856257|460177467|FG001|Overall Study|Donor complication|0|||
127879097|NCT01856257|460177468|FG002|Overall Study|Donor complication|0|||
127879098|NCT01856257|460177469|FG003|Overall Study|Donor complication|1|||
127879099|NCT01125358|460177473|FG000|Overall Study|Adverse Event|3|||
127879100|NCT01125358|460177474|FG001|Overall Study|Adverse Event|0|||
127879101|NCT01125358|460177475|FG002|Overall Study|Adverse Event|0|||
127879102|NCT01125358|460177476|FG003|Overall Study|Adverse Event|2|||
127879103|NCT01125358|460177473|FG000|Overall Study|Perceived Lack of Efficacy|6|||
127879104|NCT01125358|460177474|FG001|Overall Study|Perceived Lack of Efficacy|3|||
127879105|NCT01125358|460177475|FG002|Overall Study|Perceived Lack of Efficacy|7|||
127879106|NCT01125358|460177476|FG003|Overall Study|Perceived Lack of Efficacy|4|||
127879107|NCT01125358|460177473|FG000|Overall Study|Protocol Violation|1|||
127879108|NCT01125358|460177474|FG001|Overall Study|Protocol Violation|0|||
127879109|NCT01125358|460177475|FG002|Overall Study|Protocol Violation|0|||
127879110|NCT01125358|460177476|FG003|Overall Study|Protocol Violation|0|||
127879111|NCT01125358|460177473|FG000|Overall Study|Sponsor Decision|0|||
127879112|NCT01125358|460177474|FG001|Overall Study|Sponsor Decision|0|||
127879113|NCT01125358|460177475|FG002|Overall Study|Sponsor Decision|1|||
127879114|NCT01125358|460177476|FG003|Overall Study|Sponsor Decision|1|||
127879115|NCT01125358|460177473|FG000|Overall Study|Withdrawal by Subject|2|||
127879116|NCT01125358|460177474|FG001|Overall Study|Withdrawal by Subject|1|||
127879117|NCT01125358|460177475|FG002|Overall Study|Withdrawal by Subject|1|||
127879118|NCT01125358|460177476|FG003|Overall Study|Withdrawal by Subject|1|||
127879119|NCT01157065|460177477|FG000|Overall Study|Death|0|||
127879120|NCT01157065|460177478|FG001|Overall Study|Death|1|||
127879121|NCT01060007|460177481|FG000|Overall Study|Withdrawal by Subject|1|||
127879122|NCT01060007|460177481|FG000|Overall Study|Inevaluable for response at surgery|3|||
127879123|NCT00742859|460177484|FG000|Overall Study|Adverse Event|5|||
127879124|NCT00742859|460177485|FG001|Overall Study|Adverse Event|6|||
127879125|NCT00742859|460177486|FG002|Overall Study|Adverse Event|3|||
127879126|NCT00742859|460177487|FG003|Overall Study|Adverse Event|1|||
127879127|NCT00742859|460177484|FG000|Overall Study|Death|1|||
127879128|NCT00742859|460177485|FG001|Overall Study|Death|0|||
127879129|NCT00742859|460177486|FG002|Overall Study|Death|0|||
127879130|NCT00742859|460177487|FG003|Overall Study|Death|1|||
127879131|NCT00742859|460177484|FG000|Overall Study|Physician Decision|1|||
127879132|NCT00742859|460177485|FG001|Overall Study|Physician Decision|2|||
127879133|NCT00742859|460177486|FG002|Overall Study|Physician Decision|0|||
127879134|NCT00742859|460177487|FG003|Overall Study|Physician Decision|0|||
127879135|NCT00742859|460177484|FG000|Overall Study|Withdrawal by Subject|4|||
127652658|NCT01490125|459349762|FG000|Period II|Withdrawal by Subject|1|||
127652659|NCT01490125|459349763|FG001|Period II|Withdrawal by Subject|0|||
127652660|NCT01490125|459349764|FG002|Period II|Withdrawal by Subject|0|||
127879136|NCT00742859|460177485|FG001|Overall Study|Withdrawal by Subject|2|||
127652661|NCT01490125|459349765|FG003|Period II|Withdrawal by Subject|0|||
127652662|NCT01490125|459349766|FG004|Period II|Withdrawal by Subject|0|||
127879137|NCT00742859|460177486|FG002|Overall Study|Withdrawal by Subject|4|||
127879138|NCT00742859|460177487|FG003|Overall Study|Withdrawal by Subject|1|||
127879139|NCT00742859|460177484|FG000|Overall Study|Endpoint|0|||
127879140|NCT00742859|460177485|FG001|Overall Study|Endpoint|1|||
127879141|NCT00742859|460177486|FG002|Overall Study|Endpoint|1|||
127652663|NCT01490125|459349767|FG005|Period II|Withdrawal by Subject|0|||
127879142|NCT00742859|460177487|FG003|Overall Study|Endpoint|2|||
127879143|NCT00742859|460177484|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
127879144|NCT00742859|460177485|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
127879145|NCT00742859|460177486|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
127879146|NCT00742859|460177487|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
127879147|NCT00742859|460177484|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
127652664|NCT01490125|459349762|FG000|Period III|Adverse Event|3|||
127879148|NCT00742859|460177485|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
127879149|NCT00742859|460177486|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
127879150|NCT00742859|460177487|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
127879151|NCT00742859|460177484|FG000|Overall Study|Sponsor request patient out of town|0|||
127879152|NCT00742859|460177485|FG001|Overall Study|Sponsor request patient out of town|0|||
127879153|NCT00742859|460177486|FG002|Overall Study|Sponsor request patient out of town|1|||
127879154|NCT00742859|460177487|FG003|Overall Study|Sponsor request patient out of town|1|||
127879155|NCT00742859|460177484|FG000|Overall Study|Site error|0|||
127879156|NCT00742859|460177485|FG001|Overall Study|Site error|0|||
127879157|NCT00742859|460177486|FG002|Overall Study|Site error|1|||
127879158|NCT00742859|460177487|FG003|Overall Study|Site error|1|||
127879159|NCT00962013|460177490|FG000|Overall Study|Did not have surgery|1|||
127879160|NCT00962013|460177490|FG000|Overall Study|Death|8|||
127879161|NCT00962013|460177490|FG000|Overall Study|Lost to Follow-up|12|||
127879162|NCT00962013|460177490|FG000|Overall Study|Unable/Unwilling to return|6|||
127879163|NCT00962013|460177490|FG000|Overall Study|Withdrawal by Subject|8|||
127879164|NCT00962013|460177490|FG000|Overall Study|Removal of study device|3|||
127879165|NCT00962013|460177490|FG000|Overall Study|Site Termination|24|||
127879166|NCT00962013|460177490|FG000|Overall Study|No 5 year evaluation|6|||
127879167|NCT04527549|460177491|FG000|Overall Study|Withdrawal by Subject|1|||
127879168|NCT04527549|460177492|FG001|Overall Study|Withdrawal by Subject|1|||
127879169|NCT03972709|460177501|FG000|Overall Study|Withdrawal by Subject|18|||
127879170|NCT03972709|460177502|FG001|Overall Study|Withdrawal by Subject|7|||
127879171|NCT03972709|460177503|FG002|Overall Study|Withdrawal by Subject|14|||
127879172|NCT03972709|460177501|FG000|Overall Study|Study Terminated by Sponsor|48|||
127879173|NCT03972709|460177502|FG001|Overall Study|Study Terminated by Sponsor|25|||
127879174|NCT03972709|460177503|FG002|Overall Study|Study Terminated by Sponsor|50|||
127879175|NCT03972709|460177501|FG000|Overall Study|Physician Decision|1|||
127879176|NCT03972709|460177502|FG001|Overall Study|Physician Decision|0|||
127879177|NCT03972709|460177503|FG002|Overall Study|Physician Decision|0|||
127879178|NCT03972709|460177501|FG000|Overall Study|COVID-19|0|||
127879179|NCT03972709|460177502|FG001|Overall Study|COVID-19|1|||
127879180|NCT03972709|460177503|FG002|Overall Study|COVID-19|1|||
127879181|NCT03972709|460177501|FG000|Overall Study|Lost to Follow-up|6|||
127879182|NCT03972709|460177502|FG001|Overall Study|Lost to Follow-up|1|||
127879183|NCT03972709|460177503|FG002|Overall Study|Lost to Follow-up|2|||
127879184|NCT03972709|460177501|FG000|Overall Study|Death|5|||
127879185|NCT03972709|460177502|FG001|Overall Study|Death|1|||
127879186|NCT03972709|460177503|FG002|Overall Study|Death|4|||
127879187|NCT03972709|460177501|FG000|Overall Study|Adverse Event|3|||
127879188|NCT03972709|460177502|FG001|Overall Study|Adverse Event|1|||
127879189|NCT03972709|460177503|FG002|Overall Study|Adverse Event|4|||
127879190|NCT03972709|460177501|FG000|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
127879191|NCT03972709|460177502|FG001|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|1|||
127879192|NCT03972709|460177503|FG002|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
127879193|NCT03972709|460177501|FG000|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
127879194|NCT03972709|460177502|FG001|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
127879195|NCT03972709|460177503|FG002|Overall Study|Subject in Nursing Home, Unable to Attend Visit|1|||
127879196|NCT03972709|460177501|FG000|Overall Study|Subject Unable to be Contacted|0|||
127879197|NCT03972709|460177502|FG001|Overall Study|Subject Unable to be Contacted|1|||
127879198|NCT03972709|460177503|FG002|Overall Study|Subject Unable to be Contacted|0|||
127879199|NCT03972709|460177501|FG000|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
127879200|NCT03972709|460177502|FG001|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|1|||
127879201|NCT03972709|460177503|FG002|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
127879202|NCT03972709|460177501|FG000|Overall Study|Subject Moved|0|||
127879203|NCT03972709|460177502|FG001|Overall Study|Subject Moved|1|||
127879204|NCT03972709|460177503|FG002|Overall Study|Subject Moved|0|||
127879205|NCT03972709|460177501|FG000|Overall Study|Missed Study Visits|1|||
127879206|NCT03972709|460177502|FG001|Overall Study|Missed Study Visits|0|||
127879207|NCT03972709|460177503|FG002|Overall Study|Missed Study Visits|0|||
127879208|NCT02873195|460177508|FG000|Overall Study|Ineligible|5|||
127879209|NCT02873195|460177509|FG001|Overall Study|Ineligible|0|||
127879210|NCT04278872|460177510|FG000|Overall Study|Adverse Event|1|||
127879211|NCT04278872|460177511|FG001|Overall Study|Adverse Event|0|||
127879212|NCT04278872|460177510|FG000|Overall Study|Protocol Violation|0|||
127879213|NCT04278872|460177511|FG001|Overall Study|Protocol Violation|1|||
127879214|NCT04278872|460177510|FG000|Overall Study|Study Termination|2|||
127879215|NCT04278872|460177511|FG001|Overall Study|Study Termination|0|||
127879216|NCT00752895|460177512|FG000|Overall Study|Withdrawal by Subject|8|||
127879217|NCT00752895|460177513|FG001|Overall Study|Withdrawal by Subject|3|||
127879218|NCT00096031|460177514|FG000|Overall Study|Adverse Event|3|||
127879219|NCT00096031|460177514|FG000|Overall Study|Lack of Efficacy|42|||
127879220|NCT00096031|460177514|FG000|Overall Study|Death|4|||
127879221|NCT00096031|460177514|FG000|Overall Study|Withdrawal by Subject|1|||
127879222|NCT00096031|460177514|FG000|Overall Study|Ineligible|8|||
127879223|NCT00096031|460177514|FG000|Overall Study|Not protocol specified|5|||
127879224|NCT02392377|460177515|FG000|Overall Study|Withdrawal by Subject|0|||
127879225|NCT02392377|460177516|FG001|Overall Study|Withdrawal by Subject|1|||
127879226|NCT03205163|460177519|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
127879227|NCT03205163|460177520|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
127879228|NCT05257109|460177521|FG000|Overall Study|Withdrawal by Subject|1|||
127879229|NCT05257109|460177522|FG001|Overall Study|Withdrawal by Subject|0|||
127879230|NCT05257109|460177523|FG002|Overall Study|Withdrawal by Subject|0|||
127879231|NCT05257109|460177524|FG003|Overall Study|Withdrawal by Subject|0|||
127879232|NCT00359073|460179594|FG000|Overall Study|Withdrawal by Subject|1|||
127879233|NCT00359073|460179595|FG001|Overall Study|Withdrawal by Subject|1|||
127879234|NCT00359073|460179594|FG000|Overall Study|Eligibility criteria no longer met|3|||
127879235|NCT00359073|460179595|FG001|Overall Study|Eligibility criteria no longer met|0|||
127879236|NCT00359073|460179594|FG000|Overall Study|developed RV16 antibody|0|||
127879237|NCT00359073|460179595|FG001|Overall Study|developed RV16 antibody|1|||
127879238|NCT03387423|460179596|FG000|Overall Study|Lost to Follow-up|16|||
127879239|NCT03387423|460179597|FG001|Overall Study|Lost to Follow-up|12|||
127879240|NCT03387423|460179598|FG002|Overall Study|Lost to Follow-up|1|||
127879241|NCT03387423|460179599|FG003|Overall Study|Lost to Follow-up|0|||
127879242|NCT03387423|460179596|FG000|Overall Study|Other|0|||
127879243|NCT03387423|460179597|FG001|Overall Study|Other|3|||
127879244|NCT03387423|460179598|FG002|Overall Study|Other|0|||
127879245|NCT03387423|460179599|FG003|Overall Study|Other|0|||
127652665|NCT01490125|459349763|FG001|Period III|Adverse Event|1|||
127879246|NCT03387423|460179596|FG000|Overall Study|Administrative Reason|166|||
127879247|NCT03387423|460179597|FG001|Overall Study|Administrative Reason|89|||
127879248|NCT03387423|460179598|FG002|Overall Study|Administrative Reason|17|||
127879249|NCT03387423|460179599|FG003|Overall Study|Administrative Reason|19|||
127879250|NCT03387423|460179596|FG000|Overall Study|Revocation Consent|76|||
127879251|NCT03387423|460179597|FG001|Overall Study|Revocation Consent|32|||
127879252|NCT03387423|460179598|FG002|Overall Study|Revocation Consent|3|||
127879253|NCT03387423|460179599|FG003|Overall Study|Revocation Consent|5|||
127879254|NCT01371006|460179600|FG000|Overall Study|Adverse Event|1|||
127879255|NCT01371006|460179601|FG001|Overall Study|Adverse Event|0|||
127879256|NCT00915473|460179602|FG000|Screening|Withdrawal by Subject|1|||
127879257|NCT00915473|460179603|FG001|Screening|Withdrawal by Subject|0|||
127879258|NCT00915473|460179602|FG000|4-week Follow Up|Lost to Follow-up|1|||
127879259|NCT00915473|460179603|FG001|4-week Follow Up|Lost to Follow-up|5|||
127879260|NCT03515837|460179604|FG000|Overall Study|Death|219|||
127879261|NCT03515837|460179605|FG001|Overall Study|Death|227|||
127879262|NCT03515837|460179604|FG000|Overall Study|Lost to Follow-up|0|||
127879263|NCT03515837|460179605|FG001|Overall Study|Lost to Follow-up|1|||
127879264|NCT03515837|460179604|FG000|Overall Study|Withdrawal by Subject|0|||
127879265|NCT03515837|460179605|FG001|Overall Study|Withdrawal by Subject|4|||
127879266|NCT03515837|460179604|FG000|Overall Study|Participation Was Terminated By Sponsor|26|||
127879267|NCT03515837|460179605|FG001|Overall Study|Participation Was Terminated By Sponsor|15|||
127879268|NCT01964898|460179606|FG000|Overall Study|ineligible post-randomization|1|||
127879269|NCT01964898|460179607|FG001|Overall Study|ineligible post-randomization|1|||
127879270|NCT01964898|460179606|FG000|Overall Study|did not receive the allocated interventi|2|||
127879271|NCT01964898|460179607|FG001|Overall Study|did not receive the allocated interventi|1|||
127879272|NCT01964898|460179606|FG000|Overall Study|Lost to Follow-up|3|||
127879273|NCT01964898|460179607|FG001|Overall Study|Lost to Follow-up|5|||
127879274|NCT01964898|460179606|FG000|Overall Study|Withdrawal by Subject|1|||
127879275|NCT01964898|460179607|FG001|Overall Study|Withdrawal by Subject|0|||
127879276|NCT02325401|460179610|FG000|Overall Study|Withdrawal by Subject|0|||
127879277|NCT02325401|460179611|FG001|Overall Study|Withdrawal by Subject|1|||
127879278|NCT02325401|460179612|FG002|Overall Study|Withdrawal by Subject|1|||
127879279|NCT03526679|460179613|FG000|Overall Study|still under treatment|2|||
127879280|NCT03443973|460179614|FG000|Double-blind Treatment Period|Adverse Event|5|||
127879281|NCT03443973|460179615|FG001|Double-blind Treatment Period|Adverse Event|19|||
127879282|NCT03443973|460179616|FG002|Double-blind Treatment Period|Adverse Event|0|||
127879283|NCT03443973|460179617|FG003|Double-blind Treatment Period|Adverse Event|0|||
127879284|NCT03443973|460179614|FG000|Double-blind Treatment Period|Death|5|||
127879285|NCT03443973|460179615|FG001|Double-blind Treatment Period|Death|7|||
127879286|NCT03443973|460179616|FG002|Double-blind Treatment Period|Death|0|||
127879287|NCT03443973|460179617|FG003|Double-blind Treatment Period|Death|0|||
127879288|NCT03443973|460179614|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
127879289|NCT03443973|460179615|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
127879290|NCT03443973|460179616|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
127879291|NCT03443973|460179617|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
127879292|NCT03443973|460179614|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
127879293|NCT03443973|460179615|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
127879294|NCT03443973|460179616|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
127879295|NCT03443973|460179617|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
127879296|NCT03443973|460179614|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
127879297|NCT03443973|460179615|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
127879298|NCT03443973|460179616|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
127879299|NCT03443973|460179617|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
127879300|NCT03443973|460179614|FG000|Double-blind Treatment Period|Physician Decision|5|||
127879301|NCT03443973|460179615|FG001|Double-blind Treatment Period|Physician Decision|6|||
127879302|NCT03443973|460179616|FG002|Double-blind Treatment Period|Physician Decision|0|||
127879303|NCT03443973|460179617|FG003|Double-blind Treatment Period|Physician Decision|0|||
127879304|NCT03443973|460179614|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
127879305|NCT03443973|460179615|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
127879306|NCT03443973|460179616|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
127879307|NCT03443973|460179617|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
127879308|NCT03443973|460179614|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
127879309|NCT03443973|460179615|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
127879310|NCT03443973|460179616|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
127879311|NCT03443973|460179617|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
127879312|NCT03443973|460179614|FG000|Open-label Extension Period|Reason Not Specified|0|||
127879313|NCT03443973|460179615|FG001|Open-label Extension Period|Reason Not Specified|0|||
127879314|NCT03443973|460179616|FG002|Open-label Extension Period|Reason Not Specified|3|||
127879315|NCT03443973|460179617|FG003|Open-label Extension Period|Reason Not Specified|0|||
127879316|NCT03443973|460179614|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
127879317|NCT03443973|460179615|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
127879318|NCT03443973|460179616|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
127879319|NCT03443973|460179617|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
127879320|NCT02209454|460179623|FG000|Second Period|Adverse Event|1|||
127879321|NCT02209454|460179624|FG001|Second Period|Adverse Event|0|||
127879322|NCT00366678|460179629|FG000|Infant Series|Withdrawal by Subject|8|||
127879323|NCT00366678|460179630|FG001|Infant Series|Withdrawal by Subject|6|||
127879324|NCT00366678|460179631|FG002|Infant Series|Withdrawal by Subject|0|||
127879325|NCT00366678|460179629|FG000|Infant Series|Protocol Violation|4|||
127879326|NCT00366678|460179630|FG001|Infant Series|Protocol Violation|3|||
127879327|NCT00366678|460179631|FG002|Infant Series|Protocol Violation|0|||
127879328|NCT00366678|460179629|FG000|Infant Series|Failed to return|1|||
127879329|NCT00366678|460179630|FG001|Infant Series|Failed to return|1|||
127879330|NCT00366678|460179631|FG002|Infant Series|Failed to return|0|||
127879331|NCT00366678|460179629|FG000|Infant Series|Adverse Event|1|||
127879332|NCT00366678|460179630|FG001|Infant Series|Adverse Event|0|||
127879333|NCT00366678|460179631|FG002|Infant Series|Adverse Event|0|||
127879334|NCT00366678|460179629|FG000|After Infant|Withdrawal by Subject|8|||
127879335|NCT00366678|460179630|FG001|After Infant|Withdrawal by Subject|4|||
127879336|NCT00366678|460179631|FG002|After Infant|Withdrawal by Subject|0|||
127879337|NCT00366678|460179629|FG000|After Infant|Lost to Follow-up|2|||
127879338|NCT00366678|460179630|FG001|After Infant|Lost to Follow-up|1|||
127879339|NCT00366678|460179631|FG002|After Infant|Lost to Follow-up|0|||
127879340|NCT00366678|460179629|FG000|After Infant|Failed to return|5|||
127879341|NCT00366678|460179630|FG001|After Infant|Failed to return|5|||
127879342|NCT00366678|460179631|FG002|After Infant|Failed to return|0|||
127879343|NCT00366678|460179629|FG000|After Infant|Adverse Event|1|||
127879344|NCT00366678|460179630|FG001|After Infant|Adverse Event|0|||
127879345|NCT00366678|460179631|FG002|After Infant|Adverse Event|0|||
127879346|NCT00366678|460179629|FG000|After Infant|Protocol Violation|1|||
127879347|NCT00366678|460179630|FG001|After Infant|Protocol Violation|0|||
127879348|NCT00366678|460179631|FG002|After Infant|Protocol Violation|0|||
127879349|NCT00366678|460179629|FG000|Toddler Dose|Protocol Violation|2|||
127879350|NCT00366678|460179630|FG001|Toddler Dose|Protocol Violation|1|||
127879351|NCT00366678|460179631|FG002|Toddler Dose|Protocol Violation|0|||
127879352|NCT00366678|460179629|FG000|Toddler Dose|Failed to return|1|||
127879353|NCT00366678|460179630|FG001|Toddler Dose|Failed to return|0|||
127879354|NCT00366678|460179631|FG002|Toddler Dose|Failed to return|0|||
127879355|NCT00366678|460179629|FG000|Toddler Dose|Withdrawal by Subject|1|||
127879356|NCT00366678|460179630|FG001|Toddler Dose|Withdrawal by Subject|0|||
127879357|NCT00366678|460179631|FG002|Toddler Dose|Withdrawal by Subject|0|||
127879358|NCT00366678|460179629|FG000|Toddler Dose|protocol deviation|1|||
127879359|NCT00366678|460179630|FG001|Toddler Dose|protocol deviation|0|||
127879360|NCT00366678|460179631|FG002|Toddler Dose|protocol deviation|0|||
127879361|NCT04292171|460179632|FG000|Overall Study|Pharmacy error|2|||
127542193|NCT01253291|458951172|FG004|Overall Study|Adverse Event|0|||
127879362|NCT04292171|460179633|FG001|Overall Study|Pharmacy error|0|||
127879363|NCT04292171|460179632|FG000|Overall Study|Delivered prior to procedure|0|||
127879364|NCT04292171|460179633|FG001|Overall Study|Delivered prior to procedure|1|||
127879365|NCT02545868|460179634|FG000|Overall Study|Lack of Efficacy|1|||
127879366|NCT02545868|460179635|FG001|Overall Study|Lack of Efficacy|1|||
127879367|NCT02545868|460179636|FG002|Overall Study|Lack of Efficacy|0|||
127879368|NCT02545868|460179634|FG000|Overall Study|Lost to Follow-up|1|||
127879369|NCT02545868|460179635|FG001|Overall Study|Lost to Follow-up|5|||
127879370|NCT02545868|460179636|FG002|Overall Study|Lost to Follow-up|1|||
127879371|NCT02545868|460179634|FG000|Overall Study|Non-compliance|1|||
127652666|NCT01490125|459349764|FG002|Period III|Adverse Event|0|||
127652667|NCT01490125|459349765|FG003|Period III|Adverse Event|1|||
127652668|NCT01490125|459349766|FG004|Period III|Adverse Event|0|||
127652669|NCT01490125|459349767|FG005|Period III|Adverse Event|0|||
127652670|NCT01490125|459349762|FG000|Period III|Death|0|||
127652671|NCT01490125|459349763|FG001|Period III|Death|0|||
127652672|NCT01490125|459349764|FG002|Period III|Death|0|||
127652673|NCT01490125|459349765|FG003|Period III|Death|1|||
127652674|NCT01490125|459349766|FG004|Period III|Death|0|||
127652675|NCT01490125|459349767|FG005|Period III|Death|0|||
127652676|NCT01490125|459349762|FG000|Period III|Lack of Efficacy|0|||
127652677|NCT01490125|459349763|FG001|Period III|Lack of Efficacy|0|||
127652678|NCT01490125|459349764|FG002|Period III|Lack of Efficacy|0|||
127652679|NCT01490125|459349765|FG003|Period III|Lack of Efficacy|0|||
127652680|NCT01490125|459349766|FG004|Period III|Lack of Efficacy|1|||
127652681|NCT01490125|459349767|FG005|Period III|Lack of Efficacy|0|||
127652682|NCT02237508|459349769|FG000|Overall Study|Withdrawal by Subject|0|||
127652683|NCT02237508|459349770|FG001|Overall Study|Withdrawal by Subject|2|||
127652684|NCT02237508|459349771|FG002|Overall Study|Withdrawal by Subject|0|||
127652685|NCT02237508|459349772|FG003|Overall Study|Withdrawal by Subject|1|||
127652686|NCT02237508|459349773|FG004|Overall Study|Withdrawal by Subject|0|||
127652687|NCT02237508|459349774|FG005|Overall Study|Withdrawal by Subject|1|||
127652688|NCT02237508|459349775|FG006|Overall Study|Withdrawal by Subject|1|||
127652689|NCT02237508|459349776|FG007|Overall Study|Withdrawal by Subject|0|||
127652690|NCT02237508|459349777|FG008|Overall Study|Withdrawal by Subject|1|||
127652691|NCT02237508|459349778|FG009|Overall Study|Withdrawal by Subject|0|||
127652692|NCT02237508|459349769|FG000|Overall Study|Physician Decision|0|||
127652693|NCT02237508|459349770|FG001|Overall Study|Physician Decision|1|||
127652694|NCT02237508|459349771|FG002|Overall Study|Physician Decision|0|||
127652695|NCT02237508|459349772|FG003|Overall Study|Physician Decision|0|||
127652696|NCT02237508|459349773|FG004|Overall Study|Physician Decision|0|||
127652697|NCT02237508|459349774|FG005|Overall Study|Physician Decision|0|||
127652698|NCT02237508|459349775|FG006|Overall Study|Physician Decision|0|||
127652699|NCT02237508|459349776|FG007|Overall Study|Physician Decision|0|||
127652700|NCT02237508|459349777|FG008|Overall Study|Physician Decision|0|||
127652701|NCT02237508|459349778|FG009|Overall Study|Physician Decision|0|||
127652702|NCT02237508|459349769|FG000|Overall Study|Protocol Violation|0|||
127652703|NCT02237508|459349770|FG001|Overall Study|Protocol Violation|0|||
127652704|NCT02237508|459349771|FG002|Overall Study|Protocol Violation|1|||
127652705|NCT02237508|459349772|FG003|Overall Study|Protocol Violation|0|||
127652706|NCT02237508|459349773|FG004|Overall Study|Protocol Violation|0|||
127652707|NCT02237508|459349774|FG005|Overall Study|Protocol Violation|0|||
127652708|NCT02237508|459349775|FG006|Overall Study|Protocol Violation|0|||
127652709|NCT02237508|459349776|FG007|Overall Study|Protocol Violation|0|||
127652710|NCT02237508|459349777|FG008|Overall Study|Protocol Violation|0|||
127879372|NCT02545868|460179635|FG001|Overall Study|Non-compliance|1|||
127879373|NCT02545868|460179636|FG002|Overall Study|Non-compliance|1|||
127879374|NCT02545868|460179634|FG000|Overall Study|Treatment change|21|||
127879375|NCT02545868|460179635|FG001|Overall Study|Treatment change|19|||
127879376|NCT02545868|460179636|FG002|Overall Study|Treatment change|22|||
127879377|NCT02545868|460179634|FG000|Overall Study|Physician Decision|1|||
127879378|NCT02545868|460179635|FG001|Overall Study|Physician Decision|1|||
127879379|NCT02545868|460179636|FG002|Overall Study|Physician Decision|1|||
127879380|NCT02545868|460179634|FG000|Overall Study|Withdrawal by Subject|6|||
127879381|NCT02545868|460179635|FG001|Overall Study|Withdrawal by Subject|7|||
127879382|NCT02545868|460179636|FG002|Overall Study|Withdrawal by Subject|9|||
127879383|NCT01777191|460179637|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
127879384|NCT01777191|460179638|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
127879385|NCT01777191|460179637|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
127879386|NCT01777191|460179638|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
127879387|NCT01777191|460179637|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
127879388|NCT01777191|460179638|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
127879389|NCT01777191|460179637|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
127879390|NCT01777191|460179638|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
127879391|NCT01777191|460179637|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
127879392|NCT01777191|460179638|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
127879393|NCT01777191|460179637|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
127879394|NCT01777191|460179638|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
127879395|NCT01777191|460179637|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
127652711|NCT02237508|459349778|FG009|Overall Study|Protocol Violation|0|||
127652712|NCT04954586|459349779|FG000|Overall Study|Withdrawal by Subject|5|||
127652713|NCT04000594|459349780|FG000|Overall Study|Withdrawal by Subject|1|||
127652714|NCT04000594|459349781|FG001|Overall Study|Withdrawal by Subject|0|||
127652715|NCT04000594|459349782|FG002|Overall Study|Withdrawal by Subject|0|||
127652716|NCT04522180|459349783|FG000|Overall Study|Investigator judgement|3|||
127652717|NCT04522180|459349784|FG001|Overall Study|Investigator judgement|4|||
127879396|NCT01777191|460179638|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
127879397|NCT01777191|460179637|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
127879398|NCT01777191|460179638|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
127879399|NCT01777191|460179637|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
127879400|NCT01777191|460179638|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
127879401|NCT01777191|460179637|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
127879402|NCT01777191|460179638|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
127879403|NCT01777191|460179637|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
127879404|NCT01777191|460179638|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
127879405|NCT04465916|460179643|FG000|Overall Study|Withdrawal by Subject|0|||
127879406|NCT04465916|460179644|FG001|Overall Study|Withdrawal by Subject|1|||
127879407|NCT00468312|460179650|FG000|Overall Study|Adverse Event|2|||
127879408|NCT00468312|460179651|FG001|Overall Study|Adverse Event|1|||
127879409|NCT00468312|460179650|FG000|Overall Study|Lack of Efficacy|0|||
127879410|NCT00468312|460179651|FG001|Overall Study|Lack of Efficacy|1|||
127879411|NCT00468312|460179650|FG000|Overall Study|Withdrawal by Subject|0|||
127879412|NCT00468312|460179651|FG001|Overall Study|Withdrawal by Subject|1|||
127879413|NCT00468312|460179650|FG000|Overall Study|Protocol Violation|2|||
127879414|NCT00468312|460179651|FG001|Overall Study|Protocol Violation|1|||
127879415|NCT00468312|460179650|FG000|Overall Study|Did not meet protocol eligibility|0|||
127879416|NCT00468312|460179651|FG001|Overall Study|Did not meet protocol eligibility|1|||
127879417|NCT01052038|460179652|FG000|Overall Study|Lost to Follow-up|2|||
127879418|NCT01052038|460179653|FG001|Overall Study|Lost to Follow-up|3|||
127879419|NCT01052038|460179654|FG002|Overall Study|Lost to Follow-up|1|||
127879420|NCT01052038|460179652|FG000|Overall Study|Protocol Violation|2|||
127879421|NCT01052038|460179653|FG001|Overall Study|Protocol Violation|3|||
127879422|NCT01052038|460179654|FG002|Overall Study|Protocol Violation|3|||
127879423|NCT03976076|460179655|FG000|Overall Study|Withdrawal by Subject|2|||
127879424|NCT00734617|460179656|FG000|Overall Study|Adverse Event|4|||
127879425|NCT00734617|460179657|FG001|Overall Study|Adverse Event|7|||
127879426|NCT00734617|460179656|FG000|Overall Study|Withdrawal by Subject|103|||
127879427|NCT00734617|460179657|FG001|Overall Study|Withdrawal by Subject|95|||
127879428|NCT02367729|460179663|FG000|Overall Study|Organic disorder diagnosed|2|||
127879429|NCT02367729|460179664|FG001|Overall Study|Organic disorder diagnosed|1|||
127879430|NCT02367729|460179663|FG000|Overall Study|Adverse Event|1|||
127879431|NCT02367729|460179664|FG001|Overall Study|Adverse Event|2|||
127879432|NCT02367729|460179663|FG000|Overall Study|Withdrawal by Subject|0|||
127542194|NCT01253291|458951168|FG000|Overall Study|Lack of Efficacy|1|||
127542195|NCT01253291|458951169|FG001|Overall Study|Lack of Efficacy|0|||
127542196|NCT01253291|458951170|FG002|Overall Study|Lack of Efficacy|0|||
127542197|NCT01253291|458951171|FG003|Overall Study|Lack of Efficacy|0|||
127542198|NCT01253291|458951172|FG004|Overall Study|Lack of Efficacy|0|||
127542199|NCT01253291|458951168|FG000|Overall Study|Physician Decision|2|||
127542200|NCT01253291|458951169|FG001|Overall Study|Physician Decision|0|||
127542201|NCT01253291|458951170|FG002|Overall Study|Physician Decision|0|||
127542202|NCT01253291|458951171|FG003|Overall Study|Physician Decision|0|||
127542203|NCT01253291|458951172|FG004|Overall Study|Physician Decision|2|||
127542204|NCT03905096|458951173|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
127542205|NCT03905096|458951174|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
127542206|NCT02016781|458951175|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
127542207|NCT02016781|458951176|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
127542208|NCT02016781|458951175|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
127542209|NCT02016781|458951176|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
127542210|NCT02016781|458951175|FG000|Final Database Lock|Withdrawal by Subject|2|||
127542211|NCT02016781|458951176|FG001|Final Database Lock|Withdrawal by Subject|1|||
127542212|NCT02016781|458951175|FG000|Final Database Lock|Lost to Follow-up|11|||
127542213|NCT02016781|458951176|FG001|Final Database Lock|Lost to Follow-up|4|||
127542214|NCT02016781|458951175|FG000|Final Database Lock|Missing data|0|||
127542215|NCT02016781|458951176|FG001|Final Database Lock|Missing data|3|||
127542216|NCT04515771|458952670|FG000|Period 1: 6 Month Randomized Period|Lost to Follow-up|9|||
127542217|NCT04515771|458952671|FG001|Period 1: 6 Month Randomized Period|Lost to Follow-up|1|||
127542218|NCT04515771|458952670|FG000|Period 1: 6 Month Randomized Period|Withdrawal by Subject|3|||
127542219|NCT04515771|458952671|FG001|Period 1: 6 Month Randomized Period|Withdrawal by Subject|1|||
127542220|NCT04515771|458952670|FG000|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|0|||
127542221|NCT04515771|458952671|FG001|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|5|||
127542222|NCT01021020|458952673|FG000|Period I|Protocol Violation|1|||
127542223|NCT01021020|458952673|FG000|Period I|Withdrawal by Subject|1|||
127542224|NCT01021020|458952673|FG000|14 Day Washout Period A|Physician Decision|1|||
127542225|NCT00948246|458952674|FG000|Overall Study|Lost to Follow-up|11|||
127542226|NCT00948246|458952674|FG000|Overall Study|Adverse Event|11|||
127879433|NCT02367729|460179664|FG001|Overall Study|Withdrawal by Subject|5|||
127879434|NCT00759174|460179669|FG000|Overall Study|Other|0|||
127879435|NCT00759174|460179670|FG001|Overall Study|Other|2|||
127879436|NCT01890109|460179671|FG000|Overall Study|Withdrawal by Subject|0|||
127879437|NCT01890109|460179672|FG001|Overall Study|Withdrawal by Subject|3|||
127879438|NCT01890109|460179671|FG000|Overall Study|Lost to Follow-up|1|||
127879439|NCT01890109|460179672|FG001|Overall Study|Lost to Follow-up|2|||
127879440|NCT01643928|460179675|FG000|Overall Study|Lost to Follow-up|1|||
127879441|NCT01643928|460179676|FG001|Overall Study|Lost to Follow-up|0|||
127879442|NCT01643928|460179677|FG002|Overall Study|Lost to Follow-up|2|||
127879443|NCT01643928|460179678|FG003|Overall Study|Lost to Follow-up|0|||
127879444|NCT01643928|460179679|FG004|Overall Study|Lost to Follow-up|0|||
127879445|NCT01643928|460179675|FG000|Overall Study|Withdrawal by Subject|2|||
127879446|NCT01643928|460179676|FG001|Overall Study|Withdrawal by Subject|0|||
127879447|NCT01643928|460179677|FG002|Overall Study|Withdrawal by Subject|0|||
127879448|NCT01643928|460179678|FG003|Overall Study|Withdrawal by Subject|1|||
127879449|NCT01643928|460179679|FG004|Overall Study|Withdrawal by Subject|0|||
127879450|NCT01643928|460179675|FG000|Overall Study|Pregnancy|0|||
127879451|NCT01643928|460179676|FG001|Overall Study|Pregnancy|0|||
127879452|NCT01643928|460179677|FG002|Overall Study|Pregnancy|0|||
127879453|NCT01643928|460179678|FG003|Overall Study|Pregnancy|1|||
127879454|NCT01643928|460179679|FG004|Overall Study|Pregnancy|0|||
127879455|NCT01643928|460179675|FG000|Overall Study|Other|5|||
127879456|NCT01643928|460179676|FG001|Overall Study|Other|1|||
127879457|NCT01643928|460179677|FG002|Overall Study|Other|1|||
127879458|NCT01643928|460179678|FG003|Overall Study|Other|0|||
127879459|NCT01643928|460179679|FG004|Overall Study|Other|0|||
127879460|NCT01643928|460179675|FG000|Overall Study|Adverse Event|2|||
127879461|NCT01643928|460179676|FG001|Overall Study|Adverse Event|1|||
127879462|NCT01643928|460179677|FG002|Overall Study|Adverse Event|0|||
127879463|NCT01643928|460179678|FG003|Overall Study|Adverse Event|1|||
127879464|NCT01643928|460179679|FG004|Overall Study|Adverse Event|2|||
127879465|NCT03692078|460179680|FG000|Overall Study|Adverse Event|0|||
127879466|NCT03692078|460179681|FG001|Overall Study|Adverse Event|0|||
127879467|NCT03692078|460179682|FG002|Overall Study|Adverse Event|0|||
127879468|NCT03692078|460179683|FG003|Overall Study|Adverse Event|0|||
127879469|NCT03692078|460179684|FG004|Overall Study|Adverse Event|0|||
127879470|NCT03692078|460179685|FG005|Overall Study|Adverse Event|1|||
127879471|NCT03692078|460179686|FG006|Overall Study|Adverse Event|0|||
127879472|NCT03692078|460179680|FG000|Overall Study|Enrollment Closed|5|||
127879473|NCT03692078|460179681|FG001|Overall Study|Enrollment Closed|0|||
127879474|NCT03692078|460179682|FG002|Overall Study|Enrollment Closed|0|||
127879475|NCT03692078|460179683|FG003|Overall Study|Enrollment Closed|0|||
127879476|NCT03692078|460179684|FG004|Overall Study|Enrollment Closed|0|||
127879477|NCT03692078|460179685|FG005|Overall Study|Enrollment Closed|0|||
127879478|NCT03692078|460179686|FG006|Overall Study|Enrollment Closed|0|||
127879479|NCT03692078|460179680|FG000|Overall Study|Failure To Meet Randomization Criteria|13|||
127879480|NCT03692078|460179681|FG001|Overall Study|Failure To Meet Randomization Criteria|0|||
127879481|NCT03692078|460179682|FG002|Overall Study|Failure To Meet Randomization Criteria|0|||
127879482|NCT03692078|460179683|FG003|Overall Study|Failure To Meet Randomization Criteria|0|||
127879483|NCT03692078|460179684|FG004|Overall Study|Failure To Meet Randomization Criteria|0|||
127879484|NCT03692078|460179685|FG005|Overall Study|Failure To Meet Randomization Criteria|0|||
127879485|NCT03692078|460179686|FG006|Overall Study|Failure To Meet Randomization Criteria|0|||
127879486|NCT03692078|460179680|FG000|Overall Study|Withdrawal by Subject|0|||
127879487|NCT03692078|460179681|FG001|Overall Study|Withdrawal by Subject|2|||
127879488|NCT03692078|460179682|FG002|Overall Study|Withdrawal by Subject|0|||
127879489|NCT03692078|460179683|FG003|Overall Study|Withdrawal by Subject|1|||
127879490|NCT03692078|460179684|FG004|Overall Study|Withdrawal by Subject|5|||
127879491|NCT03692078|460179685|FG005|Overall Study|Withdrawal by Subject|3|||
127879492|NCT03692078|460179686|FG006|Overall Study|Withdrawal by Subject|3|||
127879493|NCT01005680|460179687|FG000|Overall Study|Lost to Follow-up|4|||
127879494|NCT01005680|460179688|FG001|Overall Study|Lost to Follow-up|6|||
127879495|NCT01005680|460179687|FG000|Overall Study|Withdrawal by Subject|1|||
127879496|NCT01005680|460179688|FG001|Overall Study|Withdrawal by Subject|4|||
127879497|NCT01005680|460179687|FG000|Overall Study|Physician Decision|1|||
127879498|NCT01005680|460179688|FG001|Overall Study|Physician Decision|1|||
127879499|NCT03576131|460179689|FG000|Overall Study|Investigator decision|0|||
127879500|NCT03576131|460179690|FG001|Overall Study|Investigator decision|0|||
127879501|NCT03576131|460179691|FG002|Overall Study|Investigator decision|0|||
127879502|NCT03576131|460179692|FG003|Overall Study|Investigator decision|1|||
127652718|NCT04522180|459349783|FG000|Overall Study|Voluntary withdrawal|1|||
127879503|NCT03576131|460179693|FG004|Overall Study|Investigator decision|0|||
127879504|NCT03576131|460179694|FG005|Overall Study|Investigator decision|1|||
127879505|NCT03576131|460179695|FG006|Overall Study|Investigator decision|0|||
127879506|NCT03576131|460179696|FG007|Overall Study|Investigator decision|0|||
127879507|NCT03576131|460179689|FG000|Overall Study|Withdrawal by Subject|1|||
127879508|NCT03576131|460179690|FG001|Overall Study|Withdrawal by Subject|1|||
127879509|NCT03576131|460179691|FG002|Overall Study|Withdrawal by Subject|0|||
127879510|NCT03576131|460179692|FG003|Overall Study|Withdrawal by Subject|1|||
127879511|NCT03576131|460179693|FG004|Overall Study|Withdrawal by Subject|2|||
127879512|NCT03576131|460179694|FG005|Overall Study|Withdrawal by Subject|3|||
127879513|NCT03576131|460179695|FG006|Overall Study|Withdrawal by Subject|1|||
127879514|NCT03576131|460179696|FG007|Overall Study|Withdrawal by Subject|0|||
127879515|NCT03576131|460179689|FG000|Overall Study|Death|3|||
127879516|NCT03576131|460179690|FG001|Overall Study|Death|3|||
127879517|NCT03576131|460179691|FG002|Overall Study|Death|1|||
127879518|NCT03576131|460179692|FG003|Overall Study|Death|5|||
127879519|NCT03576131|460179693|FG004|Overall Study|Death|4|||
127879520|NCT03576131|460179694|FG005|Overall Study|Death|1|||
127879521|NCT03576131|460179695|FG006|Overall Study|Death|0|||
127879522|NCT03576131|460179696|FG007|Overall Study|Death|1|||
127879523|NCT03576131|460179689|FG000|Overall Study|New anti-cancer treatment|5|||
127879524|NCT03576131|460179690|FG001|Overall Study|New anti-cancer treatment|1|||
127879525|NCT03576131|460179691|FG002|Overall Study|New anti-cancer treatment|2|||
127879526|NCT03576131|460179692|FG003|Overall Study|New anti-cancer treatment|3|||
127879527|NCT03576131|460179693|FG004|Overall Study|New anti-cancer treatment|0|||
127879528|NCT03576131|460179694|FG005|Overall Study|New anti-cancer treatment|0|||
127879529|NCT03576131|460179695|FG006|Overall Study|New anti-cancer treatment|0|||
127879530|NCT03576131|460179696|FG007|Overall Study|New anti-cancer treatment|0|||
127879531|NCT03576131|460179689|FG000|Overall Study|Unspecified reason|0|||
127879532|NCT03576131|460179690|FG001|Overall Study|Unspecified reason|0|||
127652719|NCT04522180|459349784|FG001|Overall Study|Voluntary withdrawal|0|||
127879533|NCT03576131|460179691|FG002|Overall Study|Unspecified reason|1|||
127879534|NCT03576131|460179692|FG003|Overall Study|Unspecified reason|1|||
127879535|NCT03576131|460179693|FG004|Overall Study|Unspecified reason|1|||
127879536|NCT03576131|460179694|FG005|Overall Study|Unspecified reason|1|||
127879537|NCT03576131|460179695|FG006|Overall Study|Unspecified reason|0|||
127879538|NCT03576131|460179696|FG007|Overall Study|Unspecified reason|0|||
127879539|NCT03576131|460179689|FG000|Overall Study|Subject non-compliance|0|||
127879540|NCT03576131|460179690|FG001|Overall Study|Subject non-compliance|0|||
127879541|NCT03576131|460179691|FG002|Overall Study|Subject non-compliance|0|||
127879542|NCT03576131|460179692|FG003|Overall Study|Subject non-compliance|0|||
127879543|NCT03576131|460179693|FG004|Overall Study|Subject non-compliance|0|||
127879544|NCT03576131|460179694|FG005|Overall Study|Subject non-compliance|1|||
127879545|NCT03576131|460179695|FG006|Overall Study|Subject non-compliance|0|||
127879546|NCT03576131|460179696|FG007|Overall Study|Subject non-compliance|0|||
127879547|NCT00996632|460179701|FG000|Overall Study|Physician Decision|0|||
127879548|NCT00996632|460179702|FG001|Overall Study|Physician Decision|0|||
127879549|NCT03069365|460179709|FG000|Overall Study|Adverse Event|1|||
127879550|NCT02886494|460179711|FG000|Overall Study|Adverse Event|1|||
127879551|NCT02886494|460179712|FG001|Overall Study|Adverse Event|0|||
127879552|NCT02886494|460179711|FG000|Overall Study|Withdrawal by Subject|12|||
127879553|NCT02886494|460179712|FG001|Overall Study|Withdrawal by Subject|3|||
127879554|NCT02886494|460179711|FG000|Overall Study|Protocol Violation|4|||
127879555|NCT02886494|460179712|FG001|Overall Study|Protocol Violation|1|||
127879556|NCT03099161|460179714|FG000|Overall Study|Adverse Event|0|||
127879557|NCT03099161|460179715|FG001|Overall Study|Adverse Event|0|||
127879558|NCT03099161|460179716|FG002|Overall Study|Adverse Event|2|||
127879559|NCT03099161|460179714|FG000|Overall Study|Physician Decision|2|||
127879560|NCT03099161|460179715|FG001|Overall Study|Physician Decision|0|||
127879561|NCT03099161|460179716|FG002|Overall Study|Physician Decision|0|||
127879562|NCT03099161|460179714|FG000|Overall Study|Progressive Disease|1|||
127879563|NCT03099161|460179715|FG001|Overall Study|Progressive Disease|4|||
127652720|NCT04522180|459349783|FG000|Overall Study|Pregnancy|0|||
127652721|NCT04522180|459349784|FG001|Overall Study|Pregnancy|1|||
127652722|NCT04522180|459349783|FG000|Overall Study|Adverse Event or Serious Adverse event|1|||
127652723|NCT04522180|459349784|FG001|Overall Study|Adverse Event or Serious Adverse event|3|||
127652724|NCT04522180|459349783|FG000|Overall Study|Reason not specified|8|||
127652725|NCT04522180|459349784|FG001|Overall Study|Reason not specified|5|||
127652726|NCT01905046|459349785|FG000|Months 13-24|Withdrawal by Subject|10|||
127652727|NCT01905046|459349786|FG001|Months 13-24|Withdrawal by Subject|10|||
127652728|NCT01905046|459349785|FG000|Months 13-24|Adverse Event|3|||
127652729|NCT01905046|459349786|FG001|Months 13-24|Adverse Event|2|||
127652730|NCT01905046|459349785|FG000|Months 13-24|Protocol Violation|3|||
127652731|NCT01905046|459349786|FG001|Months 13-24|Protocol Violation|3|||
127652732|NCT01905046|459349785|FG000|Months 13-24|Physician Decision|1|||
127879564|NCT03099161|460179716|FG002|Overall Study|Progressive Disease|1|||
127879565|NCT00834366|460179718|FG000|Treatment Period 1|Adverse Event|1|||
127879566|NCT00834366|460179719|FG001|Treatment Period 1|Adverse Event|1|||
127879567|NCT00090259|460179720|FG000|Overall Study|Lost to Follow-up|30|||
127879568|NCT00090259|460179721|FG001|Overall Study|Lost to Follow-up|26|||
127879569|NCT00090259|460179720|FG000|Overall Study|Withdrawal by Subject|21|||
127879570|NCT00090259|460179721|FG001|Overall Study|Withdrawal by Subject|15|||
127879571|NCT00090259|460179720|FG000|Overall Study|Investigator site closed|11|||
127879572|NCT00090259|460179721|FG001|Overall Study|Investigator site closed|7|||
127879573|NCT00960687|460179722|FG000|Washout Period of 7 Days|Adverse Event|3|||
127879574|NCT00960687|460179723|FG001|Washout Period of 7 Days|Adverse Event|2|||
127879575|NCT00960687|460179722|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
127879576|NCT00960687|460179723|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
127652733|NCT01905046|459349786|FG001|Months 13-24|Physician Decision|0|||
127652734|NCT03489057|459349791|FG000|Overall Study|Lost to Follow-up|16|||
127879577|NCT02704130|460179724|FG000|Overall Study|Physician Decision|5|||
127879578|NCT02704130|460179725|FG001|Overall Study|Physician Decision|3|||
127879579|NCT02666768|460179726|FG000|Overall Study|Withdrawal by Subject|4|||
127879580|NCT00285012|460179729|FG000|Assigned to Study Treatment (Tx)|Other|2|||
127879581|NCT00285012|460179730|FG001|Assigned to Study Treatment (Tx)|Other|3|||
127879582|NCT00285012|460179729|FG000|Received Study Tx|Death|2|||
127879583|NCT00285012|460179730|FG001|Received Study Tx|Death|1|||
127879584|NCT00285012|460179729|FG000|Received Study Tx|Adverse Event|5|||
127879585|NCT00285012|460179730|FG001|Received Study Tx|Adverse Event|11|||
127879586|NCT00285012|460179729|FG000|Received Study Tx|Lack of Efficacy|0|||
127879587|NCT00285012|460179730|FG001|Received Study Tx|Lack of Efficacy|3|||
127879588|NCT00285012|460179729|FG000|Received Study Tx|Lost to Follow-up|29|||
127879589|NCT00285012|460179730|FG001|Received Study Tx|Lost to Follow-up|31|||
127879590|NCT00285012|460179729|FG000|Received Study Tx|Withdrawal by Subject|31|||
127879591|NCT00285012|460179730|FG001|Received Study Tx|Withdrawal by Subject|43|||
127879592|NCT00285012|460179729|FG000|Received Study Tx|Other|5|||
127879593|NCT00285012|460179730|FG001|Received Study Tx|Other|5|||
127879594|NCT05004181|460179731|FG000|Overall Study|Withdrawal of consent|0|||
127879595|NCT05004181|460179732|FG001|Overall Study|Withdrawal of consent|0|||
127879596|NCT05004181|460179733|FG002|Overall Study|Withdrawal of consent|1|||
127879597|NCT05004181|460179734|FG003|Overall Study|Withdrawal of consent|3|||
127879598|NCT05004181|460179735|FG004|Overall Study|Withdrawal of consent|3|||
127879599|NCT05004181|460179736|FG005|Overall Study|Withdrawal of consent|0|||
127879600|NCT05004181|460179737|FG006|Overall Study|Withdrawal of consent|30|||
127879601|NCT05004181|460179738|FG007|Overall Study|Withdrawal of consent|9|||
127879602|NCT05004181|460179739|FG008|Overall Study|Withdrawal of consent|3|||
127879603|NCT05004181|460179740|FG009|Overall Study|Withdrawal of consent|2|||
127879604|NCT05004181|460179741|FG010|Overall Study|Withdrawal of consent|5|||
127652735|NCT03489057|459349792|FG001|Overall Study|Lost to Follow-up|16|||
127652736|NCT03489057|459349793|FG002|Overall Study|Lost to Follow-up|14|||
127652737|NCT03489057|459349794|FG003|Overall Study|Lost to Follow-up|14|||
127652738|NCT03489057|459349791|FG000|Overall Study|Withdrawal by Subject|12|||
127652739|NCT03489057|459349792|FG001|Overall Study|Withdrawal by Subject|12|||
127652740|NCT03489057|459349793|FG002|Overall Study|Withdrawal by Subject|8|||
127652741|NCT03489057|459349794|FG003|Overall Study|Withdrawal by Subject|8|||
127652742|NCT03489057|459349791|FG000|Overall Study|Protocol Violation|7|||
127652743|NCT03489057|459349792|FG001|Overall Study|Protocol Violation|7|||
127652744|NCT03489057|459349793|FG002|Overall Study|Protocol Violation|2|||
127879605|NCT05004181|460179742|FG011|Overall Study|Withdrawal of consent|1|||
127879606|NCT05004181|460179731|FG000|Overall Study|Lost to Follow-up|2|||
127879607|NCT05004181|460179732|FG001|Overall Study|Lost to Follow-up|4|||
127879608|NCT05004181|460179733|FG002|Overall Study|Lost to Follow-up|2|||
127879609|NCT05004181|460179734|FG003|Overall Study|Lost to Follow-up|3|||
127879610|NCT05004181|460179735|FG004|Overall Study|Lost to Follow-up|5|||
127879611|NCT05004181|460179736|FG005|Overall Study|Lost to Follow-up|2|||
127879612|NCT05004181|460179737|FG006|Overall Study|Lost to Follow-up|15|||
127879613|NCT05004181|460179738|FG007|Overall Study|Lost to Follow-up|12|||
127879614|NCT05004181|460179739|FG008|Overall Study|Lost to Follow-up|38|||
127879615|NCT05004181|460179740|FG009|Overall Study|Lost to Follow-up|6|||
127879616|NCT05004181|460179741|FG010|Overall Study|Lost to Follow-up|6|||
127879617|NCT05004181|460179742|FG011|Overall Study|Lost to Follow-up|0|||
127879618|NCT05004181|460179731|FG000|Overall Study|Death|0|||
127879619|NCT05004181|460179732|FG001|Overall Study|Death|0|||
127879620|NCT05004181|460179733|FG002|Overall Study|Death|0|||
127879621|NCT05004181|460179734|FG003|Overall Study|Death|0|||
127879622|NCT05004181|460179735|FG004|Overall Study|Death|0|||
127879623|NCT05004181|460179736|FG005|Overall Study|Death|0|||
127879624|NCT05004181|460179737|FG006|Overall Study|Death|1|||
127879625|NCT05004181|460179738|FG007|Overall Study|Death|0|||
127879626|NCT05004181|460179739|FG008|Overall Study|Death|2|||
127879627|NCT05004181|460179740|FG009|Overall Study|Death|0|||
127879628|NCT05004181|460179741|FG010|Overall Study|Death|0|||
127879629|NCT05004181|460179742|FG011|Overall Study|Death|0|||
127879630|NCT05004181|460179731|FG000|Overall Study|Physician Decision|0|||
127879631|NCT05004181|460179732|FG001|Overall Study|Physician Decision|0|||
127879632|NCT05004181|460179733|FG002|Overall Study|Physician Decision|0|||
127879633|NCT05004181|460179734|FG003|Overall Study|Physician Decision|0|||
127879634|NCT05004181|460179735|FG004|Overall Study|Physician Decision|0|||
127983738|NCT01764997|460562571|FG003|Run-in Period|Other than specified above|0|||
127983739|NCT01764997|460562572|FG004|Run-in Period|Other than specified above|0|||
127652745|NCT03489057|459349794|FG003|Overall Study|Protocol Violation|2|||
127652746|NCT01368900|459349797|FG000|Overall Study|Lost to Follow-up|7|||
127652747|NCT04027348|459349800|FG000|Overall Study|Adverse Event|2|||
127652748|NCT01552954|459349801|FG000|Overall Study|Adverse Event|1|||
127879635|NCT05004181|460179736|FG005|Overall Study|Physician Decision|0|||
127879636|NCT05004181|460179737|FG006|Overall Study|Physician Decision|2|||
127879637|NCT05004181|460179738|FG007|Overall Study|Physician Decision|0|||
127879638|NCT05004181|460179739|FG008|Overall Study|Physician Decision|7|||
127879639|NCT05004181|460179740|FG009|Overall Study|Physician Decision|0|||
127879640|NCT05004181|460179741|FG010|Overall Study|Physician Decision|0|||
127879641|NCT05004181|460179742|FG011|Overall Study|Physician Decision|0|||
127652749|NCT01552954|459349802|FG001|Overall Study|Adverse Event|2|||
127652750|NCT01552954|459349801|FG000|Overall Study|Lost to Follow-up|1|||
127652751|NCT01552954|459349802|FG001|Overall Study|Lost to Follow-up|1|||
127652752|NCT01552954|459349801|FG000|Overall Study|Withdrawal by Subject|1|||
127652753|NCT01552954|459349802|FG001|Overall Study|Withdrawal by Subject|1|||
127652754|NCT01552954|459349801|FG000|Overall Study|Protocol Violation|1|||
127652755|NCT01552954|459349802|FG001|Overall Study|Protocol Violation|2|||
127652756|NCT01552954|459349801|FG000|Overall Study|diagnosed DM|1|||
127652757|NCT01552954|459349802|FG001|Overall Study|diagnosed DM|0|||
127652758|NCT04843930|459349803|FG000|Randomization|Withdrawal by Subject|6|||
127652759|NCT04843930|459349804|FG001|Randomization|Withdrawal by Subject|6|||
127652760|NCT04843930|459349805|FG002|Randomization|Withdrawal by Subject|0|||
127652761|NCT04843930|459349806|FG003|Randomization|Withdrawal by Subject|0|||
127652762|NCT04843930|459349803|FG000|Week 6 Assessment|Adverse Event|3|||
127652763|NCT04843930|459349804|FG001|Week 6 Assessment|Adverse Event|0|||
127652764|NCT04843930|459349805|FG002|Week 6 Assessment|Adverse Event|0|||
127652765|NCT04843930|459349806|FG003|Week 6 Assessment|Adverse Event|0|||
127652766|NCT04843930|459349803|FG000|Week 6 Assessment|Withdrawal by Subject|2|||
127652767|NCT04843930|459349804|FG001|Week 6 Assessment|Withdrawal by Subject|1|||
127879642|NCT05004181|460179731|FG000|Overall Study|Withdrawal by Subject|2|||
127879643|NCT05004181|460179732|FG001|Overall Study|Withdrawal by Subject|3|||
127879644|NCT05004181|460179733|FG002|Overall Study|Withdrawal by Subject|2|||
127879645|NCT05004181|460179734|FG003|Overall Study|Withdrawal by Subject|2|||
127879646|NCT05004181|460179735|FG004|Overall Study|Withdrawal by Subject|4|||
127879647|NCT05004181|460179736|FG005|Overall Study|Withdrawal by Subject|2|||
127879648|NCT05004181|460179737|FG006|Overall Study|Withdrawal by Subject|4|||
127879649|NCT05004181|460179738|FG007|Overall Study|Withdrawal by Subject|22|||
127879650|NCT05004181|460179739|FG008|Overall Study|Withdrawal by Subject|8|||
127879651|NCT05004181|460179740|FG009|Overall Study|Withdrawal by Subject|1|||
127879652|NCT05004181|460179741|FG010|Overall Study|Withdrawal by Subject|3|||
127879653|NCT05004181|460179742|FG011|Overall Study|Withdrawal by Subject|2|||
127879654|NCT05004181|460179731|FG000|Overall Study|Protocol Violation|2|||
127879655|NCT05004181|460179732|FG001|Overall Study|Protocol Violation|3|||
127879656|NCT05004181|460179733|FG002|Overall Study|Protocol Violation|0|||
127879657|NCT05004181|460179734|FG003|Overall Study|Protocol Violation|0|||
127879658|NCT05004181|460179735|FG004|Overall Study|Protocol Violation|1|||
127879659|NCT05004181|460179736|FG005|Overall Study|Protocol Violation|0|||
127879660|NCT05004181|460179737|FG006|Overall Study|Protocol Violation|16|||
127879661|NCT05004181|460179738|FG007|Overall Study|Protocol Violation|18|||
127879662|NCT05004181|460179739|FG008|Overall Study|Protocol Violation|2|||
127879663|NCT05004181|460179740|FG009|Overall Study|Protocol Violation|2|||
127879664|NCT05004181|460179741|FG010|Overall Study|Protocol Violation|2|||
127879665|NCT05004181|460179742|FG011|Overall Study|Protocol Violation|1|||
127879666|NCT05004181|460179731|FG000|Overall Study|Not further specified|1|||
127879667|NCT05004181|460179732|FG001|Overall Study|Not further specified|0|||
127879668|NCT05004181|460179733|FG002|Overall Study|Not further specified|0|||
127879669|NCT05004181|460179734|FG003|Overall Study|Not further specified|0|||
127879670|NCT05004181|460179735|FG004|Overall Study|Not further specified|0|||
127879671|NCT05004181|460179736|FG005|Overall Study|Not further specified|0|||
127879672|NCT05004181|460179737|FG006|Overall Study|Not further specified|1|||
127879673|NCT05004181|460179738|FG007|Overall Study|Not further specified|0|||
127879674|NCT05004181|460179739|FG008|Overall Study|Not further specified|2|||
127879675|NCT05004181|460179740|FG009|Overall Study|Not further specified|1|||
127879676|NCT05004181|460179741|FG010|Overall Study|Not further specified|0|||
127879677|NCT05004181|460179742|FG011|Overall Study|Not further specified|1|||
127879678|NCT03993288|460180970|FG000|Overall Study|Lost to Follow-up|2|||
127879679|NCT03993288|460180971|FG001|Overall Study|Lost to Follow-up|1|||
127879680|NCT03993288|460180970|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
127879681|NCT03993288|460180971|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
127879682|NCT03993288|460180970|FG000|Overall Study|wrong randomization|0|||
127879683|NCT03993288|460180971|FG001|Overall Study|wrong randomization|1|||
127879684|NCT03993288|460180970|FG000|Overall Study|improper enrollment|0|||
127879685|NCT03993288|460180971|FG001|Overall Study|improper enrollment|1|||
127879686|NCT03993288|460180970|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
127879687|NCT03993288|460180971|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
127879688|NCT03993288|460180970|FG000|Overall Study|developed SAE|2|||
127879689|NCT03993288|460180971|FG001|Overall Study|developed SAE|0|||
127879690|NCT03993288|460180970|FG000|Overall Study|consent withdrawal|1|||
127879691|NCT03993288|460180971|FG001|Overall Study|consent withdrawal|0|||
127879692|NCT03993288|460180970|FG000|Overall Study|did not follow the treatment schedule|1|||
127879693|NCT03993288|460180971|FG001|Overall Study|did not follow the treatment schedule|0|||
127652768|NCT04843930|459349805|FG002|Week 6 Assessment|Withdrawal by Subject|0|||
127652769|NCT04843930|459349806|FG003|Week 6 Assessment|Withdrawal by Subject|0|||
127652770|NCT04843930|459349803|FG000|Week 16 Follow-Up|Lost to Follow-up|0|||
127652771|NCT04843930|459349804|FG001|Week 16 Follow-Up|Lost to Follow-up|0|||
127652772|NCT04843930|459349805|FG002|Week 16 Follow-Up|Lost to Follow-up|2|||
127652773|NCT04843930|459349806|FG003|Week 16 Follow-Up|Lost to Follow-up|0|||
127652774|NCT01547299|459349810|FG000|Overall Study|Withdrawal by Subject|2|||
127652775|NCT01547299|459349811|FG001|Overall Study|Withdrawal by Subject|2|||
127652776|NCT01576718|459349812|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
127652777|NCT01576718|459349813|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
127652778|NCT01576718|459349814|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
127652779|NCT01576718|459349815|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
127652780|NCT01576718|459349816|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
127652781|NCT01576718|459349817|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
127652782|NCT01576718|459349818|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
127652783|NCT01576718|459349812|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
127652784|NCT01576718|459349813|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
127652785|NCT01576718|459349814|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
127652786|NCT01576718|459349815|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
127652787|NCT01576718|459349816|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
127652788|NCT01576718|459349817|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
127652789|NCT01576718|459349818|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
127652790|NCT01576718|459349812|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
127652791|NCT01576718|459349813|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
127652792|NCT01576718|459349814|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
127652793|NCT01576718|459349815|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
127652794|NCT01576718|459349816|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
127652795|NCT01576718|459349817|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
127652796|NCT01576718|459349818|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
127652797|NCT01576718|459349812|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
127652798|NCT01576718|459349813|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
127652799|NCT01576718|459349814|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
127652800|NCT01576718|459349815|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
127652801|NCT01576718|459349816|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
127652802|NCT01576718|459349817|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
127652803|NCT01576718|459349818|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
127652804|NCT01576718|459349812|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
127652805|NCT01576718|459349813|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
127652806|NCT01576718|459349814|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
127652807|NCT01576718|459349815|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
127652808|NCT01576718|459349816|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
127652809|NCT01576718|459349817|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
127652810|NCT01576718|459349818|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
127652811|NCT01576718|459349812|FG000|Treatment Period|Adverse Event|0|||
127652812|NCT01576718|459349813|FG001|Treatment Period|Adverse Event|1|||
127652813|NCT01576718|459349814|FG002|Treatment Period|Adverse Event|1|||
127652814|NCT01576718|459349815|FG003|Treatment Period|Adverse Event|1|||
127652815|NCT01576718|459349816|FG004|Treatment Period|Adverse Event|1|||
127652816|NCT01576718|459349817|FG005|Treatment Period|Adverse Event|1|||
127652817|NCT01576718|459349818|FG006|Treatment Period|Adverse Event|0|||
127652818|NCT01576718|459349812|FG000|Treatment Period|Withdrawal by Subject|0|||
127652819|NCT01576718|459349813|FG001|Treatment Period|Withdrawal by Subject|1|||
127652820|NCT01576718|459349814|FG002|Treatment Period|Withdrawal by Subject|1|||
127652821|NCT01576718|459349815|FG003|Treatment Period|Withdrawal by Subject|0|||
127652822|NCT01576718|459349816|FG004|Treatment Period|Withdrawal by Subject|2|||
127652823|NCT01576718|459349817|FG005|Treatment Period|Withdrawal by Subject|4|||
127652824|NCT01576718|459349818|FG006|Treatment Period|Withdrawal by Subject|2|||
127652825|NCT01576718|459349812|FG000|Treatment Period|Physician Decision|0|||
127652826|NCT01576718|459349813|FG001|Treatment Period|Physician Decision|1|||
127652827|NCT01576718|459349814|FG002|Treatment Period|Physician Decision|1|||
127652828|NCT01576718|459349815|FG003|Treatment Period|Physician Decision|1|||
127652829|NCT01576718|459349816|FG004|Treatment Period|Physician Decision|1|||
127652830|NCT01576718|459349817|FG005|Treatment Period|Physician Decision|0|||
127652831|NCT01576718|459349818|FG006|Treatment Period|Physician Decision|0|||
127652832|NCT01576718|459349812|FG000|Treatment Period|Protocol Violation|0|||
127652833|NCT01576718|459349813|FG001|Treatment Period|Protocol Violation|5|||
127652834|NCT01576718|459349814|FG002|Treatment Period|Protocol Violation|4|||
127652835|NCT01576718|459349815|FG003|Treatment Period|Protocol Violation|10|||
127652836|NCT01576718|459349816|FG004|Treatment Period|Protocol Violation|6|||
127652837|NCT01576718|459349817|FG005|Treatment Period|Protocol Violation|8|||
127652838|NCT01576718|459349818|FG006|Treatment Period|Protocol Violation|12|||
127652839|NCT01576718|459349812|FG000|Treatment Period|Sponsor request|0|||
127652840|NCT01576718|459349813|FG001|Treatment Period|Sponsor request|1|||
127652841|NCT01576718|459349814|FG002|Treatment Period|Sponsor request|0|||
127879694|NCT03993288|460180970|FG000|Overall Study|did not follow the treatment regimen|1|||
127879695|NCT03993288|460180971|FG001|Overall Study|did not follow the treatment regimen|0|||
127879696|NCT03993288|460180970|FG000|Overall Study|Adverse Event|1|||
127879697|NCT03993288|460180971|FG001|Overall Study|Adverse Event|0|||
127879698|NCT03993288|460180970|FG000|Overall Study|Withdrawal by Subject|1|||
127879699|NCT03993288|460180971|FG001|Overall Study|Withdrawal by Subject|1|||
127879700|NCT01569594|460180977|FG000|Overall Study|Physician Decision|4|||
127879701|NCT01569594|460180977|FG000|Overall Study|Death|13|||
127879702|NCT01569594|460180977|FG000|Overall Study|Lost to Follow-up|22|||
127879703|NCT01569594|460180977|FG000|Overall Study|Adverse Event|2|||
127879704|NCT01569594|460180977|FG000|Overall Study|Withdrawal by Subject|13|||
127879705|NCT01569594|460180977|FG000|Overall Study|Other|4|||
127879706|NCT01569594|460180977|FG000|Overall Study|No ECM used|9|||
127879707|NCT02861534|460180980|FG000|Overall Study|Death|541|||
127879708|NCT02861534|460180981|FG001|Overall Study|Death|552|||
127879709|NCT02861534|460180980|FG000|Overall Study|Lost to Follow-up|14|||
127879710|NCT02861534|460180981|FG001|Overall Study|Lost to Follow-up|14|||
127879711|NCT02861534|460180980|FG000|Overall Study|Site Terminated by Sponsor|4|||
127879712|NCT02861534|460180981|FG001|Overall Study|Site Terminated by Sponsor|3|||
127879713|NCT02861534|460180980|FG000|Overall Study|Withdrawal by Subject|15|||
127879714|NCT02861534|460180981|FG001|Overall Study|Withdrawal by Subject|18|||
127879715|NCT02780115|460180984|FG000|Overall Study|Withdrawal by Subject|0|||
127879716|NCT02780115|460180985|FG001|Overall Study|Withdrawal by Subject|1|||
127879717|NCT02780115|460180986|FG002|Overall Study|Withdrawal by Subject|1|||
127879718|NCT02780115|460180987|FG003|Overall Study|Withdrawal by Subject|0|||
127879719|NCT02780115|460180988|FG004|Overall Study|Withdrawal by Subject|0|||
127879720|NCT02780115|460180984|FG000|Overall Study|Adverse Event|0|||
127879721|NCT02780115|460180985|FG001|Overall Study|Adverse Event|0|||
127879722|NCT02780115|460180986|FG002|Overall Study|Adverse Event|0|||
127879723|NCT02780115|460180987|FG003|Overall Study|Adverse Event|1|||
127879724|NCT02780115|460180988|FG004|Overall Study|Adverse Event|1|||
127879725|NCT01179191|460180989|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
127879726|NCT01179191|460180989|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
127879727|NCT01179191|460180989|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
127879728|NCT01179191|460180989|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
127879729|NCT01179191|460180989|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
127879730|NCT01179191|460180989|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
127879731|NCT01179191|460180989|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
127879732|NCT01179191|460180989|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
127879733|NCT01179191|460180989|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
127879734|NCT01179191|460180989|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
127879735|NCT01179191|460180989|FG000|Maintenance Phase (8 Weeks)|Other|66|||
127879736|NCT00916617|460180993|FG000|Overall Study|Adverse Event|3|||
127879737|NCT00916617|460180994|FG001|Overall Study|Adverse Event|2|||
127879738|NCT00916617|460180995|FG002|Overall Study|Adverse Event|6|||
127542227|NCT00948246|458952674|FG000|Overall Study|Death|1|||
127542228|NCT00948246|458952674|FG000|Overall Study|Withdrawal by Subject|1|||
127542229|NCT03598036|458952675|FG000|Overall Study|Withdrawal by Subject|1|||
127542230|NCT03598036|458952676|FG001|Overall Study|Withdrawal by Subject|0|||
127542231|NCT04199351|458952679|FG000|Overall Study|Decision by sponsor|0|||
127542232|NCT04199351|458952680|FG001|Overall Study|Decision by sponsor|0|||
127542233|NCT04199351|458952681|FG002|Overall Study|Decision by sponsor|0|||
127542234|NCT04199351|458952682|FG003|Overall Study|Decision by sponsor|2|||
127542235|NCT04199351|458952683|FG004|Overall Study|Decision by sponsor|0|||
127542236|NCT04199351|458952684|FG005|Overall Study|Decision by sponsor|0|||
127542237|NCT04199351|458952685|FG006|Overall Study|Decision by sponsor|0|||
127542238|NCT04199351|458952686|FG007|Overall Study|Decision by sponsor|0|||
127542239|NCT04199351|458952687|FG008|Overall Study|Decision by sponsor|0|||
127542240|NCT04199351|458952688|FG009|Overall Study|Decision by sponsor|6|||
127542241|NCT04199351|458952679|FG000|Overall Study|Lost to Follow-up|0|||
127542242|NCT04199351|458952680|FG001|Overall Study|Lost to Follow-up|0|||
127542243|NCT04199351|458952681|FG002|Overall Study|Lost to Follow-up|1|||
127542244|NCT04199351|458952682|FG003|Overall Study|Lost to Follow-up|0|||
127542245|NCT04199351|458952683|FG004|Overall Study|Lost to Follow-up|0|||
127542246|NCT04199351|458952684|FG005|Overall Study|Lost to Follow-up|1|||
127542247|NCT04199351|458952685|FG006|Overall Study|Lost to Follow-up|0|||
127542248|NCT04199351|458952686|FG007|Overall Study|Lost to Follow-up|0|||
127879739|NCT00916617|460180996|FG003|Overall Study|Adverse Event|3|||
127879740|NCT00916617|460180993|FG000|Overall Study|Withdrawal by Subject|3|||
127879741|NCT00916617|460180994|FG001|Overall Study|Withdrawal by Subject|2|||
127879742|NCT00916617|460180995|FG002|Overall Study|Withdrawal by Subject|0|||
127879743|NCT00916617|460180996|FG003|Overall Study|Withdrawal by Subject|1|||
127879744|NCT00916617|460180993|FG000|Overall Study|Caregiver Request|3|||
127879745|NCT00916617|460180994|FG001|Overall Study|Caregiver Request|2|||
127542249|NCT04199351|458952687|FG008|Overall Study|Lost to Follow-up|0|||
127879746|NCT00916617|460180995|FG002|Overall Study|Caregiver Request|1|||
127879747|NCT00916617|460180996|FG003|Overall Study|Caregiver Request|0|||
127879748|NCT00916617|460180993|FG000|Overall Study|Physician Decision|1|||
127879749|NCT00916617|460180994|FG001|Overall Study|Physician Decision|1|||
127652842|NCT01576718|459349815|FG003|Treatment Period|Sponsor request|0|||
127652843|NCT01576718|459349816|FG004|Treatment Period|Sponsor request|0|||
127652844|NCT01576718|459349817|FG005|Treatment Period|Sponsor request|1|||
127652845|NCT01576718|459349818|FG006|Treatment Period|Sponsor request|0|||
127879750|NCT00916617|460180995|FG002|Overall Study|Physician Decision|0|||
127879751|NCT00916617|460180996|FG003|Overall Study|Physician Decision|0|||
127879752|NCT00916617|460180993|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
127879753|NCT00916617|460180994|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
127879754|NCT00916617|460180995|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
127879755|NCT00916617|460180996|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
127879756|NCT00916617|460180993|FG000|Overall Study|Lost to Follow-up|2|||
127879757|NCT00916617|460180994|FG001|Overall Study|Lost to Follow-up|1|||
127879758|NCT00916617|460180995|FG002|Overall Study|Lost to Follow-up|0|||
127879759|NCT00916617|460180996|FG003|Overall Study|Lost to Follow-up|0|||
127879760|NCT00916617|460180993|FG000|Overall Study|Lack of Efficacy|1|||
127879761|NCT00916617|460180994|FG001|Overall Study|Lack of Efficacy|0|||
127879762|NCT00916617|460180995|FG002|Overall Study|Lack of Efficacy|0|||
127879763|NCT00916617|460180996|FG003|Overall Study|Lack of Efficacy|0|||
127879764|NCT00916617|460180993|FG000|Overall Study|Other|2|||
127879765|NCT00916617|460180994|FG001|Overall Study|Other|0|||
127879766|NCT00916617|460180995|FG002|Overall Study|Other|0|||
127879767|NCT00916617|460180996|FG003|Overall Study|Other|2|||
127879768|NCT01988337|460180999|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
127879769|NCT02742818|460181000|FG000|Overall Study|Adverse Event|0|||
127879770|NCT02742818|460181001|FG001|Overall Study|Adverse Event|1|||
127879771|NCT02742818|460181000|FG000|Overall Study|Protocol Violation|0|||
127879772|NCT02742818|460181001|FG001|Overall Study|Protocol Violation|1|||
127879773|NCT01260194|460181003|FG000|Overall Study|Withdrawal of Consent|1|||
127879774|NCT01785472|460181004|FG000|Overall Study|Adverse Event|5|||
127879775|NCT01785472|460181005|FG001|Overall Study|Adverse Event|4|||
127879776|NCT01785472|460181006|FG002|Overall Study|Adverse Event|6|||
127879777|NCT01785472|460181004|FG000|Overall Study|Lack of Efficacy|2|||
127879778|NCT01785472|460181005|FG001|Overall Study|Lack of Efficacy|0|||
127879779|NCT01785472|460181006|FG002|Overall Study|Lack of Efficacy|1|||
127879780|NCT01785472|460181004|FG000|Overall Study|Lost to Follow-up|1|||
127879781|NCT01785472|460181005|FG001|Overall Study|Lost to Follow-up|2|||
127879782|NCT01785472|460181006|FG002|Overall Study|Lost to Follow-up|0|||
127879783|NCT01785472|460181004|FG000|Overall Study|Physician Decision|1|||
127879784|NCT01785472|460181005|FG001|Overall Study|Physician Decision|1|||
127879785|NCT01785472|460181006|FG002|Overall Study|Physician Decision|1|||
127879786|NCT01785472|460181004|FG000|Overall Study|Protocol deviation|0|||
127879787|NCT01785472|460181005|FG001|Overall Study|Protocol deviation|2|||
127879788|NCT01785472|460181006|FG002|Overall Study|Protocol deviation|2|||
127879789|NCT01785472|460181004|FG000|Overall Study|Subject/guardian decision|15|||
127879790|NCT01785472|460181005|FG001|Overall Study|Subject/guardian decision|10|||
127879791|NCT01785472|460181006|FG002|Overall Study|Subject/guardian decision|11|||
127879792|NCT01785472|460181004|FG000|Overall Study|Technical problems|0|||
127879793|NCT01785472|460181005|FG001|Overall Study|Technical problems|0|||
127879794|NCT01785472|460181006|FG002|Overall Study|Technical problems|1|||
127879795|NCT01612780|460181019|FG000|Overall Study|Treatment not completed|1|||
127879796|NCT01612780|460181019|FG000|Overall Study|Withdrawal by Subject|5|||
127652846|NCT01576718|459349812|FG000|Treatment Period|Met stopping criteria|0|||
127652847|NCT01576718|459349813|FG001|Treatment Period|Met stopping criteria|16|||
127652848|NCT01576718|459349814|FG002|Treatment Period|Met stopping criteria|13|||
127652849|NCT01576718|459349815|FG003|Treatment Period|Met stopping criteria|19|||
127652850|NCT01576718|459349816|FG004|Treatment Period|Met stopping criteria|16|||
127652851|NCT01576718|459349817|FG005|Treatment Period|Met stopping criteria|33|||
127652852|NCT01576718|459349818|FG006|Treatment Period|Met stopping criteria|15|||
127652853|NCT01576718|459349812|FG000|Treatment Period|Lost to Follow-up|0|||
127652854|NCT01576718|459349813|FG001|Treatment Period|Lost to Follow-up|0|||
127652855|NCT01576718|459349814|FG002|Treatment Period|Lost to Follow-up|0|||
127652856|NCT01576718|459349815|FG003|Treatment Period|Lost to Follow-up|0|||
127652857|NCT01576718|459349816|FG004|Treatment Period|Lost to Follow-up|1|||
127652858|NCT01576718|459349817|FG005|Treatment Period|Lost to Follow-up|0|||
127652859|NCT01576718|459349818|FG006|Treatment Period|Lost to Follow-up|0|||
127652860|NCT01576718|459349812|FG000|Treatment Period|Noncompliance to study medication|0|||
127652861|NCT01576718|459349813|FG001|Treatment Period|Noncompliance to study medication|0|||
127879797|NCT00556166|460181020|FG000|Overall Study|Withdrawal by Subject|1|||
127879798|NCT03466060|460181021|FG000|Period 1|Test Lens Damage|0|||
127652862|NCT01576718|459349814|FG002|Treatment Period|Noncompliance to study medication|0|||
127879799|NCT03466060|460181022|FG001|Period 1|Test Lens Damage|2|||
127879800|NCT03466060|460181023|FG002|Period 1|Test Lens Damage|0|||
127879801|NCT03466060|460181024|FG003|Period 1|Test Lens Damage|0|||
127879802|NCT03466060|460181025|FG004|Period 1|Test Lens Damage|0|||
127879803|NCT03466060|460181026|FG005|Period 1|Test Lens Damage|0|||
127879804|NCT03466060|460181021|FG000|Period 1|Withdrawal by Subject|0|||
127879805|NCT03466060|460181022|FG001|Period 1|Withdrawal by Subject|0|||
127652863|NCT01576718|459349815|FG003|Treatment Period|Noncompliance to study medication|0|||
127652864|NCT01576718|459349816|FG004|Treatment Period|Noncompliance to study medication|0|||
127652865|NCT01576718|459349817|FG005|Treatment Period|Noncompliance to study medication|1|||
127652866|NCT01576718|459349818|FG006|Treatment Period|Noncompliance to study medication|1|||
127652867|NCT01833143|459349823|FG000|Overall Study|Not Treated|1|||
127652868|NCT03995784|459349824|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
127652869|NCT00045708|459352191|FG000|Phase 1|early progressive disease|0|||
127652870|NCT00045708|459352192|FG001|Phase 1|early progressive disease|1|||
127652871|NCT00045708|459352193|FG002|Phase 1|early progressive disease|0|||
127652872|NCT00284141|459352195|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
127652873|NCT00284141|459352195|FG000|Overall Study|Adverse Event|19|||
127652874|NCT00284141|459352195|FG000|Overall Study|Participant's request|9|||
127652875|NCT00284141|459352195|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
127652876|NCT00284141|459352195|FG000|Overall Study|Clinical deterioration / death|2|||
127652877|NCT00284141|459352195|FG000|Overall Study|General decline|1|||
127652878|NCT00284141|459352195|FG000|Overall Study|Pneumonia|1|||
127652879|NCT00284141|459352195|FG000|Overall Study|Did not take study medication|2|||
127652880|NCT00284141|459352195|FG000|Overall Study|Ongoing treatment|2|||
127652881|NCT00975221|459352197|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
127652882|NCT00975221|459352198|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
127652883|NCT00975221|459352197|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
127652884|NCT00975221|459352198|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
127652885|NCT00975221|459352197|FG000|Titration Phase (Weeks 1-12)|Other|0|||
127652886|NCT00975221|459352198|FG001|Titration Phase (Weeks 1-12)|Other|1|||
127652887|NCT00975221|459352197|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
127652888|NCT00975221|459352198|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
127652889|NCT00975221|459352197|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
127652890|NCT00975221|459352198|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
127652891|NCT00975221|459352197|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
127652892|NCT00975221|459352198|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
127652893|NCT01492686|459352203|FG000|Double-blind Phase|Adverse Event|0|||
127652894|NCT01492686|459352204|FG001|Double-blind Phase|Adverse Event|2|||
127652895|NCT01492686|459352203|FG000|Double-blind Phase|Physician Decision|0|||
127652896|NCT01492686|459352204|FG001|Double-blind Phase|Physician Decision|1|||
127652897|NCT01492686|459352203|FG000|Double-blind Phase|Withdrawal by Subject|0|||
127652898|NCT01492686|459352204|FG001|Double-blind Phase|Withdrawal by Subject|2|||
127652899|NCT01492686|459352203|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
127652900|NCT01492686|459352204|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
127652901|NCT01492686|459352203|FG000|Open-label Phase|Adverse Event|1|||
127652902|NCT01492686|459352204|FG001|Open-label Phase|Adverse Event|2|||
127652903|NCT01492686|459352203|FG000|Open-label Phase|Physician Decision|1|||
127652904|NCT01492686|459352204|FG001|Open-label Phase|Physician Decision|0|||
127652905|NCT01492686|459352203|FG000|Open-label Phase|Withdrawal by Subject|6|||
127652906|NCT01492686|459352204|FG001|Open-label Phase|Withdrawal by Subject|7|||
127879806|NCT03466060|460181023|FG002|Period 1|Withdrawal by Subject|2|||
127879807|NCT03466060|460181024|FG003|Period 1|Withdrawal by Subject|0|||
127879808|NCT03466060|460181025|FG004|Period 1|Withdrawal by Subject|0|||
127879809|NCT03466060|460181026|FG005|Period 1|Withdrawal by Subject|0|||
127879810|NCT03466060|460181021|FG000|Period 1|Lost to Follow-up|0|||
127879811|NCT03466060|460181022|FG001|Period 1|Lost to Follow-up|0|||
127879812|NCT03466060|460181023|FG002|Period 1|Lost to Follow-up|0|||
127879813|NCT03466060|460181024|FG003|Period 1|Lost to Follow-up|1|||
127879814|NCT03466060|460181025|FG004|Period 1|Lost to Follow-up|0|||
127879815|NCT03466060|460181026|FG005|Period 1|Lost to Follow-up|0|||
127879816|NCT03466060|460181021|FG000|Period 1|Grade 2 Conjunctivitis|0|||
127879817|NCT03466060|460181022|FG001|Period 1|Grade 2 Conjunctivitis|0|||
127879818|NCT03466060|460181023|FG002|Period 1|Grade 2 Conjunctivitis|1|||
127879819|NCT03466060|460181024|FG003|Period 1|Grade 2 Conjunctivitis|0|||
127879820|NCT03466060|460181025|FG004|Period 1|Grade 2 Conjunctivitis|0|||
127879821|NCT03466060|460181026|FG005|Period 1|Grade 2 Conjunctivitis|0|||
127879822|NCT03466060|460181021|FG000|Period 2|Lens Handling Difficulties|0|||
127879823|NCT03466060|460181022|FG001|Period 2|Lens Handling Difficulties|0|||
127879824|NCT03466060|460181023|FG002|Period 2|Lens Handling Difficulties|1|||
127879825|NCT03466060|460181024|FG003|Period 2|Lens Handling Difficulties|0|||
127879826|NCT03466060|460181025|FG004|Period 2|Lens Handling Difficulties|0|||
127879827|NCT03466060|460181026|FG005|Period 2|Lens Handling Difficulties|0|||
127879828|NCT02985515|460181029|FG000|Olfaction Testing|Lost to Follow-up|0|||
127879829|NCT02985515|460181030|FG001|Olfaction Testing|Lost to Follow-up|5|||
127879830|NCT02985515|460181029|FG000|Olfaction Testing|Protocol Violation|0|||
127879831|NCT02985515|460181030|FG001|Olfaction Testing|Protocol Violation|3|||
127879832|NCT01071083|460181036|FG000|Overall Study|Adverse Event|1|||
127879833|NCT01071083|460181037|FG001|Overall Study|Adverse Event|0|||
127879834|NCT01071083|460181038|FG002|Overall Study|Adverse Event|1|||
127879835|NCT01071083|460181039|FG003|Overall Study|Adverse Event|0|||
127879836|NCT01071083|460181040|FG004|Overall Study|Adverse Event|1|||
127879837|NCT01071083|460181036|FG000|Overall Study|Withdrawal by Subject|3|||
127879838|NCT01071083|460181037|FG001|Overall Study|Withdrawal by Subject|0|||
127879839|NCT01071083|460181038|FG002|Overall Study|Withdrawal by Subject|2|||
127879840|NCT01071083|460181039|FG003|Overall Study|Withdrawal by Subject|0|||
127879841|NCT01071083|460181040|FG004|Overall Study|Withdrawal by Subject|3|||
127879842|NCT01071083|460181036|FG000|Overall Study|Physician Decision|1|||
127879843|NCT01071083|460181037|FG001|Overall Study|Physician Decision|0|||
127879844|NCT01071083|460181038|FG002|Overall Study|Physician Decision|0|||
127879845|NCT01071083|460181039|FG003|Overall Study|Physician Decision|1|||
127879846|NCT01071083|460181040|FG004|Overall Study|Physician Decision|1|||
127879847|NCT01071083|460181036|FG000|Overall Study|Early Rescue|1|||
127879848|NCT01071083|460181037|FG001|Overall Study|Early Rescue|0|||
127879849|NCT01071083|460181038|FG002|Overall Study|Early Rescue|0|||
127879850|NCT01071083|460181039|FG003|Overall Study|Early Rescue|0|||
127879851|NCT01071083|460181040|FG004|Overall Study|Early Rescue|1|||
127879852|NCT01071083|460181036|FG000|Overall Study|Subject Moved|0|||
127879853|NCT01071083|460181037|FG001|Overall Study|Subject Moved|1|||
127879854|NCT01071083|460181038|FG002|Overall Study|Subject Moved|0|||
127879855|NCT01071083|460181039|FG003|Overall Study|Subject Moved|0|||
127879856|NCT01071083|460181040|FG004|Overall Study|Subject Moved|0|||
127879857|NCT01071083|460181036|FG000|Overall Study|Images Not Usable (Motion)|0|||
127879858|NCT01071083|460181037|FG001|Overall Study|Images Not Usable (Motion)|1|||
127879859|NCT01071083|460181038|FG002|Overall Study|Images Not Usable (Motion)|0|||
127879860|NCT01071083|460181039|FG003|Overall Study|Images Not Usable (Motion)|0|||
127879861|NCT01071083|460181040|FG004|Overall Study|Images Not Usable (Motion)|0|||
127879862|NCT01071083|460181036|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
127879863|NCT01071083|460181037|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
127879864|NCT01071083|460181038|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
127879865|NCT01071083|460181039|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
127879866|NCT01071083|460181040|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
127879867|NCT01071083|460181036|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
127879868|NCT01071083|460181037|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
127879869|NCT01071083|460181038|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
127879870|NCT01071083|460181039|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
127879871|NCT01071083|460181040|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
127879872|NCT01071083|460181036|FG000|Overall Study|Subject Refused to Continue|1|||
127879873|NCT01071083|460181037|FG001|Overall Study|Subject Refused to Continue|0|||
127879874|NCT01071083|460181038|FG002|Overall Study|Subject Refused to Continue|0|||
127879875|NCT01071083|460181039|FG003|Overall Study|Subject Refused to Continue|0|||
127879876|NCT01071083|460181040|FG004|Overall Study|Subject Refused to Continue|0|||
127879877|NCT04732728|460181041|FG000|Overall Study|Death|12|||
127879878|NCT04732728|460181041|FG000|Overall Study|Withdrawn|136|||
127879879|NCT01339000|460181044|FG000|Overall Study|study closed due to lack of drug supply|1|||
127879880|NCT01339000|460181045|FG001|Overall Study|study closed due to lack of drug supply|0|||
127879881|NCT02072174|460181046|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
127879882|NCT02072174|460181047|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
127879883|NCT02072174|460181046|FG000|Overall Study|Protocol Violation|16|||
127879884|NCT02072174|460181047|FG001|Overall Study|Protocol Violation|23|||
127879885|NCT02072174|460181046|FG000|Overall Study|Physician Decision|0|||
127879886|NCT02072174|460181047|FG001|Overall Study|Physician Decision|1|||
127879887|NCT02072174|460181046|FG000|Overall Study|Non-compliance with protocol requirement|2|||
127879888|NCT02072174|460181047|FG001|Overall Study|Non-compliance with protocol requirement|0|||
127879889|NCT05674721|460181049|FG000|Washout Period (Up to 7 Days)|Adverse Event|0|||
127879890|NCT05674721|460181050|FG001|Washout Period (Up to 7 Days)|Adverse Event|1|||
127879891|NCT05674721|460181049|FG000|Washout Period (Up to 7 Days)|Withdrawal by Subject|0|||
127879892|NCT05674721|460181050|FG001|Washout Period (Up to 7 Days)|Withdrawal by Subject|1|||
127879893|NCT05013749|460181062|FG000|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|7|||
127879894|NCT05013749|460181063|FG001|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|2|||
127879895|NCT05013749|460181062|FG000|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|0|||
127879896|NCT05013749|460181063|FG001|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|9|||
127879897|NCT02017535|460181066|FG000|Overall Study|Withdrawal by Subject|1|||
127879898|NCT02017535|460181067|FG001|Overall Study|Withdrawal by Subject|0|||
127879899|NCT02017535|460181068|FG002|Overall Study|Withdrawal by Subject|0|||
127879900|NCT02017535|460181069|FG003|Overall Study|Withdrawal by Subject|0|||
127879901|NCT01393626|460181070|FG000|Overall Study|Adverse Event|2|||
127879902|NCT01393626|460181071|FG001|Overall Study|Adverse Event|1|||
127879903|NCT01393626|460181072|FG002|Overall Study|Adverse Event|5|||
127879904|NCT01393626|460181073|FG003|Overall Study|Adverse Event|0|||
127879905|NCT01393626|460181070|FG000|Overall Study|Did not meet entrance criteria|1|||
127879906|NCT01393626|460181071|FG001|Overall Study|Did not meet entrance criteria|0|||
127879907|NCT01393626|460181072|FG002|Overall Study|Did not meet entrance criteria|0|||
127879908|NCT01393626|460181073|FG003|Overall Study|Did not meet entrance criteria|0|||
127879909|NCT01393626|460181070|FG000|Overall Study|Lack of Efficacy|6|||
127879910|NCT01393626|460181071|FG001|Overall Study|Lack of Efficacy|6|||
127879911|NCT01393626|460181072|FG002|Overall Study|Lack of Efficacy|4|||
127879912|NCT01393626|460181073|FG003|Overall Study|Lack of Efficacy|1|||
127879913|NCT01393626|460181070|FG000|Overall Study|Lost to Follow-up|1|||
127879914|NCT01393626|460181071|FG001|Overall Study|Lost to Follow-up|1|||
127879915|NCT01393626|460181072|FG002|Overall Study|Lost to Follow-up|1|||
127879916|NCT01393626|460181073|FG003|Overall Study|Lost to Follow-up|0|||
127652907|NCT01492686|459352203|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
127652908|NCT01492686|459352204|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
127652909|NCT02228395|459352208|FG000|First Intervention Period|No longer willing to participate|1|||
127652910|NCT02228395|459352209|FG001|First Intervention Period|No longer willing to participate|0|||
127652911|NCT02228395|459352210|FG002|First Intervention Period|No longer willing to participate|0|||
127652912|NCT02228395|459352208|FG000|First Intervention Period|Unable to comply with study dates|0|||
127652913|NCT02228395|459352209|FG001|First Intervention Period|Unable to comply with study dates|1|||
127652914|NCT02228395|459352210|FG002|First Intervention Period|Unable to comply with study dates|1|||
127652915|NCT00985985|459352211|FG000|Overall Study|Adverse Event|4|||
127652916|NCT00985985|459352212|FG001|Overall Study|Adverse Event|2|||
127652917|NCT00985985|459352213|FG002|Overall Study|Adverse Event|2|||
127652918|NCT00985985|459352214|FG003|Overall Study|Adverse Event|2|||
127652919|NCT00985985|459352211|FG000|Overall Study|Lost to Follow-up|4|||
127652920|NCT00985985|459352212|FG001|Overall Study|Lost to Follow-up|11|||
127652921|NCT00985985|459352213|FG002|Overall Study|Lost to Follow-up|2|||
127652922|NCT00985985|459352214|FG003|Overall Study|Lost to Follow-up|3|||
127652923|NCT00985985|459352211|FG000|Overall Study|Protocol Violation|1|||
127652924|NCT00985985|459352212|FG001|Overall Study|Protocol Violation|2|||
127652925|NCT00985985|459352213|FG002|Overall Study|Protocol Violation|0|||
127652926|NCT00985985|459352214|FG003|Overall Study|Protocol Violation|1|||
127652927|NCT00985985|459352211|FG000|Overall Study|Lack of Efficacy|5|||
127652928|NCT00985985|459352212|FG001|Overall Study|Lack of Efficacy|6|||
127652929|NCT00985985|459352213|FG002|Overall Study|Lack of Efficacy|1|||
127652930|NCT00985985|459352214|FG003|Overall Study|Lack of Efficacy|3|||
127652931|NCT00985985|459352211|FG000|Overall Study|Withdrawal by Subject|4|||
127652932|NCT00985985|459352212|FG001|Overall Study|Withdrawal by Subject|2|||
127652933|NCT00985985|459352213|FG002|Overall Study|Withdrawal by Subject|2|||
127652934|NCT00985985|459352214|FG003|Overall Study|Withdrawal by Subject|2|||
127652935|NCT00985985|459352211|FG000|Overall Study|Other Reason|6|||
127652936|NCT00985985|459352212|FG001|Overall Study|Other Reason|1|||
127652937|NCT00985985|459352213|FG002|Overall Study|Other Reason|4|||
127652938|NCT00985985|459352214|FG003|Overall Study|Other Reason|2|||
127652939|NCT02255357|459352215|FG000|Overall Study|Physician Decision|10|||
127652940|NCT02255357|459352216|FG001|Overall Study|Physician Decision|24|||
127652941|NCT00509236|459352217|FG000|Overall Study|Adverse Event|7|||
127652942|NCT00509236|459352218|FG001|Overall Study|Adverse Event|9|||
127652943|NCT00509236|459352217|FG000|Overall Study|Withdrawal by Subject|5|||
127652944|NCT00509236|459352218|FG001|Overall Study|Withdrawal by Subject|10|||
127652945|NCT00509236|459352217|FG000|Overall Study|Protocol Violation|3|||
127652946|NCT00509236|459352218|FG001|Overall Study|Protocol Violation|0|||
127652947|NCT00509236|459352217|FG000|Overall Study|Excluded Medication|1|||
127652948|NCT00509236|459352218|FG001|Overall Study|Excluded Medication|1|||
127652949|NCT00509236|459352217|FG000|Overall Study|Scheduled Kidney Transplant|1|||
127652950|NCT00509236|459352218|FG001|Overall Study|Scheduled Kidney Transplant|0|||
127652951|NCT00792103|459352219|FG000|Overall Study|Enrolled, not treated|15|||
127652952|NCT00792103|459352219|FG000|Overall Study|Lost to Follow-up|17|||
127652953|NCT00792103|459352219|FG000|Overall Study|Adverse Event|25|||
127652954|NCT00792103|459352219|FG000|Overall Study|Withdrawal by Subject|52|||
127652955|NCT00792103|459352219|FG000|Overall Study|Protocol Violation|10|||
127652956|NCT00792103|459352219|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
127652957|NCT01572389|459352221|FG000|Overall Study|Death|1|||
127652958|NCT01572389|459352222|FG001|Overall Study|Death|3|||
127652959|NCT01572389|459352221|FG000|Overall Study|Withdrawal by Subject|14|||
127879917|NCT01393626|460181070|FG000|Overall Study|Withdrawal by Subject|6|||
127879918|NCT01393626|460181071|FG001|Overall Study|Withdrawal by Subject|4|||
127652960|NCT01572389|459352222|FG001|Overall Study|Withdrawal by Subject|2|||
127652961|NCT01572389|459352221|FG000|Overall Study|Lost to Follow-up|25|||
127652962|NCT01572389|459352222|FG001|Overall Study|Lost to Follow-up|14|||
127652963|NCT01572389|459352221|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
127652964|NCT01572389|459352222|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
127652965|NCT01287520|459352223|FG000|Overall Study|Adverse Event|2|||
127652966|NCT01287520|459352224|FG001|Overall Study|Adverse Event|2|||
127652967|NCT01287520|459352225|FG002|Overall Study|Adverse Event|2|||
127652968|NCT01287520|459352226|FG003|Overall Study|Adverse Event|1|||
127652969|NCT01287520|459352227|FG004|Overall Study|Adverse Event|1|||
127652970|NCT01287520|459352228|FG005|Overall Study|Adverse Event|2|||
127879919|NCT01393626|460181072|FG002|Overall Study|Withdrawal by Subject|0|||
127879920|NCT01393626|460181073|FG003|Overall Study|Withdrawal by Subject|0|||
127879921|NCT01393626|460181070|FG000|Overall Study|Other|1|||
127879922|NCT01393626|460181071|FG001|Overall Study|Other|0|||
127879923|NCT01393626|460181072|FG002|Overall Study|Other|0|||
127879924|NCT01393626|460181073|FG003|Overall Study|Other|0|||
127879925|NCT01393626|460181070|FG000|Overall Study|Protocol Violation|1|||
127879926|NCT01393626|460181071|FG001|Overall Study|Protocol Violation|0|||
127879927|NCT01393626|460181072|FG002|Overall Study|Protocol Violation|2|||
127879928|NCT01393626|460181073|FG003|Overall Study|Protocol Violation|0|||
127879929|NCT02858076|460181074|FG000|Overall Study|Death|6|||
127879930|NCT02858076|460181075|FG001|Overall Study|Death|3|||
127879931|NCT02858076|460181074|FG000|Overall Study|Withdrawal by Subject|1|||
127879932|NCT02858076|460181075|FG001|Overall Study|Withdrawal by Subject|5|||
127879933|NCT02858076|460181074|FG000|Overall Study|Lost to Follow-up|2|||
127879934|NCT02858076|460181075|FG001|Overall Study|Lost to Follow-up|7|||
127879935|NCT02858076|460181074|FG000|Overall Study|Completed Out of Window|1|||
127879936|NCT02858076|460181075|FG001|Overall Study|Completed Out of Window|3|||
127879937|NCT03506425|460181076|FG000|Overall Study|Adverse Event|1|||
127879938|NCT03506425|460181077|FG001|Overall Study|Adverse Event|3|||
127879939|NCT03506425|460181078|FG002|Overall Study|Adverse Event|0|||
127879940|NCT03506425|460181076|FG000|Overall Study|Death|1|||
127879941|NCT03506425|460181077|FG001|Overall Study|Death|0|||
127879942|NCT03506425|460181078|FG002|Overall Study|Death|0|||
127879943|NCT03506425|460181076|FG000|Overall Study|Withdrawal by Subject|0|||
127879944|NCT03506425|460181077|FG001|Overall Study|Withdrawal by Subject|0|||
127879945|NCT03506425|460181078|FG002|Overall Study|Withdrawal by Subject|1|||
127879946|NCT02643394|460181081|FG000|Overall Study|Protocol Violation|4|||
127879947|NCT02643394|460181082|FG001|Overall Study|Protocol Violation|5|||
127879948|NCT04088734|460181083|FG000|Overall Study|Other, Not Specified|5|||
127879949|NCT00096200|460181084|FG000|Overall Study|Adverse Event|0|||
127879950|NCT00096200|460181085|FG001|Overall Study|Adverse Event|4|||
127879951|NCT00096200|460181086|FG002|Overall Study|Adverse Event|0|||
127879952|NCT00096200|460181084|FG000|Overall Study|Withdrawal by Subject|1|||
127879953|NCT00096200|460181085|FG001|Overall Study|Withdrawal by Subject|2|||
127879954|NCT00096200|460181086|FG002|Overall Study|Withdrawal by Subject|0|||
127879955|NCT00096200|460181084|FG000|Overall Study|Ineligible pathology|0|||
127879956|NCT00096200|460181085|FG001|Overall Study|Ineligible pathology|1|||
127879957|NCT00096200|460181086|FG002|Overall Study|Ineligible pathology|0|||
127879958|NCT00938015|460181090|FG000|Overall Study|Death|2|||
127879959|NCT00938015|460181090|FG000|Overall Study|Lost to Follow-up|32|||
127879960|NCT00938015|460181090|FG000|Overall Study|Adverse Event|32|||
127879961|NCT00938015|460181090|FG000|Overall Study|Non-responder|52|||
127879962|NCT00938015|460181090|FG000|Overall Study|Reason not related to Etanercept|29|||
127879963|NCT02341482|460181091|FG000|Overall Study|Adverse Event|1|||
127879964|NCT03083639|460181095|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
127879965|NCT03083639|460181096|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
127983740|NCT01764997|460562568|FG000|Study Drug Treatment Period|Adverse Event|0|||
127542250|NCT04199351|458952688|FG009|Overall Study|Lost to Follow-up|0|||
127879966|NCT03083639|460181095|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
127879967|NCT03083639|460181096|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
127879968|NCT01591499|460181097|FG000|Baseline Visit|Withdrawal by Subject|0|||
127879969|NCT01591499|460181098|FG001|Baseline Visit|Withdrawal by Subject|2|||
127879970|NCT01591499|460181099|FG002|Baseline Visit|Withdrawal by Subject|0|||
127542251|NCT04199351|458952679|FG000|Overall Study|Withdrawal by Subject|0|||
127542252|NCT04199351|458952680|FG001|Overall Study|Withdrawal by Subject|1|||
127542253|NCT04199351|458952681|FG002|Overall Study|Withdrawal by Subject|0|||
127542254|NCT04199351|458952682|FG003|Overall Study|Withdrawal by Subject|0|||
127542255|NCT04199351|458952683|FG004|Overall Study|Withdrawal by Subject|1|||
127542256|NCT04199351|458952684|FG005|Overall Study|Withdrawal by Subject|4|||
127542257|NCT04199351|458952685|FG006|Overall Study|Withdrawal by Subject|2|||
127542258|NCT04199351|458952686|FG007|Overall Study|Withdrawal by Subject|0|||
127542259|NCT04199351|458952687|FG008|Overall Study|Withdrawal by Subject|3|||
127542260|NCT04199351|458952688|FG009|Overall Study|Withdrawal by Subject|0|||
127542261|NCT00474487|458952692|FG000|Overall Study|Withdrawal by Subject|6|||
127542262|NCT00474487|458952693|FG001|Overall Study|Withdrawal by Subject|0|||
127542263|NCT00474487|458952694|FG002|Overall Study|Withdrawal by Subject|0|||
127542264|NCT00474487|458952695|FG003|Overall Study|Withdrawal by Subject|0|||
127542265|NCT00474487|458952692|FG000|Overall Study|Lost to Follow-up|20|||
127542266|NCT00474487|458952693|FG001|Overall Study|Lost to Follow-up|1|||
127542267|NCT00474487|458952694|FG002|Overall Study|Lost to Follow-up|7|||
127542268|NCT00474487|458952695|FG003|Overall Study|Lost to Follow-up|0|||
127542269|NCT00474487|458952692|FG000|Overall Study|Inappropriate enrollment|4|||
127542270|NCT00474487|458952693|FG001|Overall Study|Inappropriate enrollment|0|||
127542271|NCT00474487|458952694|FG002|Overall Study|Inappropriate enrollment|7|||
127542272|NCT00474487|458952695|FG003|Overall Study|Inappropriate enrollment|0|||
127542273|NCT00474487|458952692|FG000|Overall Study|Death|0|||
127542274|NCT00474487|458952693|FG001|Overall Study|Death|1|||
127542275|NCT00474487|458952694|FG002|Overall Study|Death|0|||
127879971|NCT01591499|460181100|FG003|Baseline Visit|Withdrawal by Subject|2|||
127879972|NCT01591499|460181097|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
127879973|NCT01591499|460181098|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
127879974|NCT01591499|460181099|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
127879975|NCT01591499|460181100|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
127879976|NCT01591499|460181097|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
127879977|NCT01591499|460181098|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
127879978|NCT01591499|460181099|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
127879979|NCT01591499|460181100|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
127879980|NCT00981019|460181101|FG000|Overall Study|Did not respond|65|||
127879981|NCT00981019|460181101|FG000|Overall Study|Did not match target population|94|||
127879982|NCT00981019|460181101|FG000|Overall Study|Inadvertent exclusion|239|||
127879983|NCT00981019|460181101|FG000|Overall Study|Hit the survey after closure|79|||
127879984|NCT00358670|460181102|FG000|Overall Study|Adverse Event|26|||
127879985|NCT00358670|460181103|FG001|Overall Study|Adverse Event|29|||
127879986|NCT00358670|460181102|FG000|Overall Study|Lack of Efficacy|20|||
127879987|NCT00358670|460181103|FG001|Overall Study|Lack of Efficacy|23|||
127879988|NCT00358670|460181102|FG000|Overall Study|Protocol Violation|6|||
127879989|NCT00358670|460181103|FG001|Overall Study|Protocol Violation|9|||
127879990|NCT00358670|460181102|FG000|Overall Study|Lost to Follow-up|4|||
127652971|NCT01287520|459352229|FG006|Overall Study|Adverse Event|0|||
127652972|NCT01287520|459352230|FG007|Overall Study|Adverse Event|2|||
127652973|NCT01287520|459352231|FG008|Overall Study|Adverse Event|0|||
127652974|NCT01287520|459352223|FG000|Overall Study|Physician Decision|1|||
127652975|NCT01287520|459352224|FG001|Overall Study|Physician Decision|1|||
127652976|NCT01287520|459352225|FG002|Overall Study|Physician Decision|2|||
127652977|NCT01287520|459352226|FG003|Overall Study|Physician Decision|0|||
127652978|NCT01287520|459352227|FG004|Overall Study|Physician Decision|1|||
127652979|NCT01287520|459352228|FG005|Overall Study|Physician Decision|1|||
127652980|NCT01287520|459352229|FG006|Overall Study|Physician Decision|0|||
127652981|NCT01287520|459352230|FG007|Overall Study|Physician Decision|1|||
127652982|NCT01287520|459352231|FG008|Overall Study|Physician Decision|0|||
127652983|NCT01287520|459352223|FG000|Overall Study|Progressive disease|0|||
127652984|NCT01287520|459352224|FG001|Overall Study|Progressive disease|4|||
127652985|NCT01287520|459352225|FG002|Overall Study|Progressive disease|1|||
127652986|NCT01287520|459352226|FG003|Overall Study|Progressive disease|6|||
127652987|NCT01287520|459352227|FG004|Overall Study|Progressive disease|1|||
127652988|NCT01287520|459352228|FG005|Overall Study|Progressive disease|0|||
127652989|NCT01287520|459352229|FG006|Overall Study|Progressive disease|2|||
127652990|NCT01287520|459352230|FG007|Overall Study|Progressive disease|2|||
127652991|NCT01287520|459352231|FG008|Overall Study|Progressive disease|4|||
127652992|NCT01287520|459352223|FG000|Overall Study|Withdrawal by Subject|0|||
127652993|NCT01287520|459352224|FG001|Overall Study|Withdrawal by Subject|0|||
127652994|NCT01287520|459352225|FG002|Overall Study|Withdrawal by Subject|0|||
127652995|NCT01287520|459352226|FG003|Overall Study|Withdrawal by Subject|0|||
127652996|NCT01287520|459352227|FG004|Overall Study|Withdrawal by Subject|0|||
127652997|NCT01287520|459352228|FG005|Overall Study|Withdrawal by Subject|1|||
127652998|NCT01287520|459352229|FG006|Overall Study|Withdrawal by Subject|0|||
127652999|NCT01287520|459352230|FG007|Overall Study|Withdrawal by Subject|0|||
127653000|NCT01287520|459352231|FG008|Overall Study|Withdrawal by Subject|1|||
127653001|NCT03587142|459352232|FG000|Overall Study|Lost to Follow-up|5|||
127653002|NCT03587142|459352233|FG001|Overall Study|Lost to Follow-up|3|||
127653003|NCT03587142|459352232|FG000|Overall Study|Did not complete the f4 visit|3|||
127653004|NCT03587142|459352233|FG001|Overall Study|Did not complete the f4 visit|7|||
127653005|NCT02768662|459352234|FG000|Overall Study|Adverse Event|1|||
127653006|NCT02768662|459352234|FG000|Overall Study|Lost to Follow-up|4|||
127653007|NCT02768662|459352234|FG000|Overall Study|Withdrawal by Subject|3|||
127653008|NCT02768662|459352234|FG000|Overall Study|Study terminated by Sponsor|78|||
127653009|NCT03673462|459352235|FG000|Overall Study|Adverse Event|11|||
127653010|NCT03673462|459352236|FG001|Overall Study|Adverse Event|1|||
127653011|NCT03673462|459352235|FG000|Overall Study|Protocol Violation|25|||
127653012|NCT03673462|459352236|FG001|Overall Study|Protocol Violation|11|||
127653013|NCT03673462|459352235|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
127653014|NCT03673462|459352236|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
127653015|NCT03673462|459352235|FG000|Overall Study|Lost to Follow-up|102|||
127653016|NCT03673462|459352236|FG001|Overall Study|Lost to Follow-up|19|||
127653017|NCT05061537|459352239|FG000|Treatment Phase|Progressive disease|0|||
127653018|NCT05061537|459352240|FG001|Treatment Phase|Progressive disease|1|||
127653019|NCT05061537|459352241|FG002|Treatment Phase|Progressive disease|2|||
127653020|NCT05061537|459352242|FG003|Treatment Phase|Progressive disease|0|||
127879991|NCT00358670|460181103|FG001|Overall Study|Lost to Follow-up|5|||
127879992|NCT00358670|460181102|FG000|Overall Study|Withdrawal by Subject|13|||
127879993|NCT00358670|460181103|FG001|Overall Study|Withdrawal by Subject|24|||
127879994|NCT00358670|460181102|FG000|Overall Study|Protocol Defined Clinical Event|0|||
127653021|NCT05061537|459352243|FG004|Treatment Phase|Progressive disease|0|||
127653022|NCT05061537|459352239|FG000|Treatment Phase|Adverse Event|0|||
127653023|NCT05061537|459352240|FG001|Treatment Phase|Adverse Event|0|||
127653024|NCT05061537|459352241|FG002|Treatment Phase|Adverse Event|2|||
127653025|NCT05061537|459352242|FG003|Treatment Phase|Adverse Event|0|||
127879995|NCT00358670|460181103|FG001|Overall Study|Protocol Defined Clinical Event|1|||
127879996|NCT00358670|460181102|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
127879997|NCT00358670|460181103|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
127879998|NCT00358670|460181102|FG000|Overall Study|Administrative|153|||
127879999|NCT00358670|460181103|FG001|Overall Study|Administrative|125|||
127880000|NCT03940742|460181104|FG000|Overall Study|Lost to Follow-up|0|||
127880001|NCT03940742|460181105|FG001|Overall Study|Lost to Follow-up|0|||
127880002|NCT03940742|460181106|FG002|Overall Study|Lost to Follow-up|0|||
127880003|NCT03940742|460181107|FG003|Overall Study|Lost to Follow-up|1|||
127880004|NCT02032823|460181108|FG000|Overall Study|Death|75|||
127880005|NCT02032823|460181109|FG001|Overall Study|Death|109|||
127880006|NCT02032823|460181108|FG000|Overall Study|Lost to Follow-up|18|||
127880007|NCT02032823|460181109|FG001|Overall Study|Lost to Follow-up|17|||
127880008|NCT02032823|460181108|FG000|Overall Study|Withdrawal by Subject|70|||
127880009|NCT02032823|460181109|FG001|Overall Study|Withdrawal by Subject|53|||
127880010|NCT02032823|460181108|FG000|Overall Study|Ongoing study at data cut-off|755|||
127880011|NCT02032823|460181109|FG001|Overall Study|Ongoing study at data cut-off|731|||
127880012|NCT02032823|460181108|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
127880013|NCT02032823|460181109|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
127880014|NCT03428217|460181110|FG000|Overall Study|Death|89|||
127880015|NCT03428217|460181111|FG001|Overall Study|Death|93|||
127880016|NCT03428217|460181110|FG000|Overall Study|Withdrawal by Subject|8|||
127880017|NCT03428217|460181111|FG001|Overall Study|Withdrawal by Subject|7|||
127880018|NCT03428217|460181110|FG000|Overall Study|Lost to Follow-up|1|||
127880019|NCT03428217|460181111|FG001|Overall Study|Lost to Follow-up|3|||
127880020|NCT03428217|460181110|FG000|Overall Study|Study terminated by sponsor|124|||
127880021|NCT03428217|460181111|FG001|Overall Study|Study terminated by sponsor|118|||
127880022|NCT03428217|460181110|FG000|Overall Study|Other, Not Specified|1|||
127880023|NCT03428217|460181111|FG001|Overall Study|Other, Not Specified|0|||
127880024|NCT03889197|460181112|FG000|Overall Study|Withdrawal by Subject|1|||
127880025|NCT03889197|460181113|FG001|Overall Study|Withdrawal by Subject|0|||
127880026|NCT03889197|460181112|FG000|Overall Study|Physician Decision|0|||
127880027|NCT03889197|460181113|FG001|Overall Study|Physician Decision|1|||
127880028|NCT03889197|460181112|FG000|Overall Study|met exclusion criteria|0|||
127880029|NCT03889197|460181113|FG001|Overall Study|met exclusion criteria|1|||
127880030|NCT03889197|460181112|FG000|Overall Study|Protocol Violation|1|||
127880031|NCT03889197|460181113|FG001|Overall Study|Protocol Violation|0|||
127880032|NCT05899218|460181114|FG000|Overall Study|Lost to Follow-up|2|||
127880033|NCT05899218|460181115|FG001|Overall Study|Lost to Follow-up|2|||
127880034|NCT05899218|460181114|FG000|Overall Study|deemed ineligible out of country|1|||
127880035|NCT05899218|460181115|FG001|Overall Study|deemed ineligible out of country|0|||
127880036|NCT00391118|460181116|FG000|Overall Study|Adverse Event|3|||
127880037|NCT00391118|460181117|FG001|Overall Study|Adverse Event|10|||
127880038|NCT00391118|460181118|FG002|Overall Study|Adverse Event|7|||
127880039|NCT00391118|460181116|FG000|Overall Study|Lost to Follow-up|0|||
127880040|NCT00391118|460181117|FG001|Overall Study|Lost to Follow-up|2|||
127880041|NCT00391118|460181118|FG002|Overall Study|Lost to Follow-up|3|||
127880042|NCT00391118|460181116|FG000|Overall Study|Withdrawal by Subject|0|||
127880043|NCT00391118|460181117|FG001|Overall Study|Withdrawal by Subject|9|||
127880044|NCT00391118|460181118|FG002|Overall Study|Withdrawal by Subject|1|||
127880045|NCT00391118|460181116|FG000|Overall Study|Death|0|||
127880046|NCT00391118|460181117|FG001|Overall Study|Death|1|||
127880047|NCT00391118|460181118|FG002|Overall Study|Death|0|||
127880048|NCT00391118|460181116|FG000|Overall Study|Physician Decision|0|||
127880049|NCT00391118|460181117|FG001|Overall Study|Physician Decision|3|||
127983741|NCT01764997|460562569|FG001|Study Drug Treatment Period|Adverse Event|1|||
127983742|NCT01764997|460562570|FG002|Study Drug Treatment Period|Adverse Event|0|||
127983743|NCT01764997|460562571|FG003|Study Drug Treatment Period|Adverse Event|0|||
127983744|NCT01764997|460562572|FG004|Study Drug Treatment Period|Adverse Event|24|||
127983745|NCT01764997|460562568|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
127983746|NCT01764997|460562569|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
127983747|NCT01764997|460562570|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
127983748|NCT01764997|460562571|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
127983749|NCT01764997|460562572|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
127542276|NCT00474487|458952695|FG003|Overall Study|Death|0|||
127542277|NCT01488045|458952696|FG000|Overall Study|Withdrawal by Subject|6|||
127542278|NCT01488045|458952697|FG001|Overall Study|Withdrawal by Subject|11|||
127542279|NCT01488045|458952696|FG000|Overall Study|Failure to present for colonoscopy|3|||
127880050|NCT00391118|460181118|FG002|Overall Study|Physician Decision|0|||
127880051|NCT00391118|460181116|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
127880052|NCT00391118|460181117|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
127880053|NCT00391118|460181118|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
127880054|NCT00391118|460181116|FG000|Overall Study|Progressive Disease|7|||
127880055|NCT00391118|460181117|FG001|Overall Study|Progressive Disease|26|||
127880056|NCT00391118|460181118|FG002|Overall Study|Progressive Disease|43|||
127880057|NCT00391118|460181116|FG000|Overall Study|Sponsor Decision|0|||
127653026|NCT05061537|459352243|FG004|Treatment Phase|Adverse Event|0|||
127880058|NCT00391118|460181117|FG001|Overall Study|Sponsor Decision|1|||
127880059|NCT00391118|460181118|FG002|Overall Study|Sponsor Decision|3|||
127542280|NCT01488045|458952697|FG001|Overall Study|Failure to present for colonoscopy|6|||
127542281|NCT01488045|458952696|FG000|Overall Study|Failure to report exclusion criteria|0|||
127542282|NCT01488045|458952697|FG001|Overall Study|Failure to report exclusion criteria|1|||
127542283|NCT03405792|458952700|FG000|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|4|||
127542284|NCT03405792|458952701|FG001|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|0|||
127542285|NCT03405792|458952700|FG000|Overall Study|o Did not receive pembrolizumab|1|||
127542286|NCT03405792|458952701|FG001|Overall Study|o Did not receive pembrolizumab|0|||
127542287|NCT03962491|458952702|FG000|Overall Study|Lost to Follow-up|4|||
127542288|NCT03962491|458952703|FG001|Overall Study|Lost to Follow-up|5|||
127542289|NCT03882021|458952704|FG000|Enrollment|Procedure aborted/cancelled|2|||
127542290|NCT03882021|458952704|FG000|Enrollment|HD Grid catheter not introduced into patient|1|||
127542291|NCT03882021|458952704|FG000|Enrollment to 3-Month|Death|1|||
127542292|NCT03882021|458952704|FG000|Enrollment to 3-Month|Operator not able to achieve PVI|4|||
127542293|NCT03882021|458952704|FG000|Enrollment to 3-Month|Missed Visit|4|||
127542294|NCT03882021|458952704|FG000|3-Month to 6-Month Visit|Missed Visit|1|||
127542295|NCT03882021|458952704|FG000|6-Month to 12-Month Visit|Death|1|||
127542296|NCT03882021|458952704|FG000|6-Month to 12-Month Visit|Missed Visit|7|||
127542297|NCT02476617|458952705|FG000|Overall Study|Adverse Event|1|||
127542298|NCT02476617|458952705|FG000|Overall Study|Lost to Follow-up|1|||
127542299|NCT03486912|458952706|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
127542300|NCT03486912|458952707|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
127542301|NCT03486912|458952708|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
127542302|NCT03486912|458952709|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
127542303|NCT03486912|458952706|FG000|Treatment Period|Withdrawal by Subject|3|||
127542304|NCT03486912|458952707|FG001|Treatment Period|Withdrawal by Subject|3|||
127542305|NCT03486912|458952708|FG002|Treatment Period|Withdrawal by Subject|3|||
127542306|NCT03486912|458952709|FG003|Treatment Period|Withdrawal by Subject|2|||
127542307|NCT03486912|458952706|FG000|Treatment Period|Other Reasons|0|||
127542308|NCT03486912|458952707|FG001|Treatment Period|Other Reasons|2|||
127542309|NCT03486912|458952708|FG002|Treatment Period|Other Reasons|1|||
127542310|NCT03486912|458952709|FG003|Treatment Period|Other Reasons|1|||
127542311|NCT03486912|458952706|FG000|Treatment Period|Adverse Event|0|||
127542312|NCT03486912|458952707|FG001|Treatment Period|Adverse Event|1|||
127542313|NCT03486912|458952708|FG002|Treatment Period|Adverse Event|1|||
127542314|NCT03486912|458952709|FG003|Treatment Period|Adverse Event|0|||
127542315|NCT03486912|458952706|FG000|Treatment Period|Lost to Follow-up|1|||
127542316|NCT03486912|458952707|FG001|Treatment Period|Lost to Follow-up|0|||
127542317|NCT03486912|458952708|FG002|Treatment Period|Lost to Follow-up|0|||
127542318|NCT03486912|458952709|FG003|Treatment Period|Lost to Follow-up|2|||
127542319|NCT02491684|458952710|FG000|Treatment Phase|Adverse Event|2|||
127542320|NCT02491684|458952711|FG001|Treatment Phase|Adverse Event|2|||
127542321|NCT02491684|458952710|FG000|Treatment Phase|Incorrect randomisation|1|||
127542322|NCT02491684|458952711|FG001|Treatment Phase|Incorrect randomisation|0|||
127542323|NCT02491684|458952710|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
127542324|NCT02491684|458952711|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
127542325|NCT01263769|458952712|FG000|Overall Study|Non-Compliant with treatment|1|||
127542326|NCT04011540|458952718|FG000|Overall Study|Lost to Follow-up|9|||
127542327|NCT04011540|458952719|FG001|Overall Study|Lost to Follow-up|6|||
127542328|NCT03019406|458952720|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
127542329|NCT03019406|458952721|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
127542330|NCT03019406|458952722|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
127542331|NCT03019406|458952723|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
127542332|NCT01339832|458952726|FG000|Overall Study|Lost to Follow-up|3|||
127542333|NCT01339832|458952726|FG000|Overall Study|Death|11|||
127542334|NCT00468169|458952727|FG000|Overall Study|Withdrawal by Subject|1|||
127542335|NCT00468169|458952728|FG001|Overall Study|Withdrawal by Subject|0|||
127542336|NCT00231816|458952729|FG000|Overall Study|Adverse Event|1|||
127542337|NCT00231816|458952730|FG001|Overall Study|Adverse Event|0|||
127542338|NCT00231816|458952729|FG000|Overall Study|Lost to Follow-up|8|||
127542339|NCT00231816|458952730|FG001|Overall Study|Lost to Follow-up|5|||
127542340|NCT00231816|458952729|FG000|Overall Study|Protocol Violation|2|||
127542341|NCT00231816|458952730|FG001|Overall Study|Protocol Violation|3|||
127542342|NCT00231816|458952729|FG000|Overall Study|Withdrawal by Subject|3|||
127542343|NCT00231816|458952730|FG001|Overall Study|Withdrawal by Subject|3|||
127542344|NCT00231816|458952729|FG000|Overall Study|Other|2|||
127542345|NCT00231816|458952730|FG001|Overall Study|Other|1|||
127542346|NCT01126749|458952735|FG000|Phase 1b|Other|0|||
127542347|NCT01126749|458952736|FG001|Phase 1b|Other|1|||
127542348|NCT01126749|458952737|FG002|Phase 1b|Other|0|||
127542349|NCT01126749|458952738|FG003|Phase 1b|Other|0|||
127542350|NCT01126749|458952735|FG000|Phase 1b|Withdrawal by Subject|0|||
127542351|NCT01126749|458952736|FG001|Phase 1b|Withdrawal by Subject|1|||
127542352|NCT01126749|458952737|FG002|Phase 1b|Withdrawal by Subject|0|||
127542353|NCT01126749|458952738|FG003|Phase 1b|Withdrawal by Subject|0|||
127653027|NCT05061537|459352239|FG000|Treatment Phase|Global deterioration of health status|0|||
127653028|NCT05061537|459352240|FG001|Treatment Phase|Global deterioration of health status|1|||
127653029|NCT05061537|459352241|FG002|Treatment Phase|Global deterioration of health status|0|||
127653030|NCT05061537|459352242|FG003|Treatment Phase|Global deterioration of health status|0|||
127653031|NCT05061537|459352243|FG004|Treatment Phase|Global deterioration of health status|0|||
127653032|NCT05061537|459352239|FG000|Follow up|Other|2|||
127653033|NCT05061537|459352240|FG001|Follow up|Other|0|||
127653034|NCT05061537|459352241|FG002|Follow up|Other|2|||
127653035|NCT05061537|459352242|FG003|Follow up|Other|0|||
127653036|NCT05061537|459352243|FG004|Follow up|Other|0|||
127653037|NCT05061537|459352239|FG000|Follow up|Study terminated by sponsor|0|||
127653038|NCT05061537|459352240|FG001|Follow up|Study terminated by sponsor|0|||
127653039|NCT05061537|459352241|FG002|Follow up|Study terminated by sponsor|2|||
127653040|NCT05061537|459352242|FG003|Follow up|Study terminated by sponsor|0|||
127653041|NCT05061537|459352243|FG004|Follow up|Study terminated by sponsor|0|||
127653042|NCT05061537|459352239|FG000|Long-term Follow-up|Study terminated by sponsor|2|||
127653043|NCT05061537|459352240|FG001|Long-term Follow-up|Study terminated by sponsor|2|||
127653044|NCT05061537|459352241|FG002|Long-term Follow-up|Study terminated by sponsor|2|||
127653045|NCT05061537|459352242|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
127653046|NCT05061537|459352243|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
127653047|NCT05061537|459352239|FG000|Long-term Follow-up|Death|0|||
127653048|NCT05061537|459352240|FG001|Long-term Follow-up|Death|1|||
127653049|NCT05061537|459352241|FG002|Long-term Follow-up|Death|0|||
127653050|NCT05061537|459352242|FG003|Long-term Follow-up|Death|0|||
127653051|NCT05061537|459352243|FG004|Long-term Follow-up|Death|0|||
127653052|NCT03502616|459352244|FG000|Up to Week 16|Withdrawal by Subject|1|||
127653053|NCT03502616|459352245|FG001|Up to Week 16|Withdrawal by Subject|2|||
127653054|NCT03502616|459352244|FG000|Up to Week 16|Lost to Follow-up|0|||
127653055|NCT03502616|459352245|FG001|Up to Week 16|Lost to Follow-up|1|||
127653056|NCT03502616|459352244|FG000|Up to Week 16|Randomized, but not treated|1|||
127653057|NCT03502616|459352245|FG001|Up to Week 16|Randomized, but not treated|0|||
127653058|NCT03502616|459352244|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
127653059|NCT03502616|459352245|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
127653060|NCT03502616|459352244|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
127653061|NCT03502616|459352245|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
127653062|NCT00770432|459352258|FG000|Overall Study|Other|4|||
127653063|NCT00770432|459352259|FG001|Overall Study|Other|6|||
127653064|NCT00770432|459352258|FG000|Overall Study|Non-compliance|0|||
127653065|NCT00770432|459352259|FG001|Overall Study|Non-compliance|1|||
127653066|NCT00988221|459352262|FG000|Part I|Adverse Event|0|||
127653067|NCT00988221|459352263|FG001|Part I|Adverse Event|1|||
127653068|NCT00988221|459352264|FG002|Part I|Adverse Event|2|||
127653069|NCT00988221|459352265|FG003|Part I|Adverse Event|0|||
127653070|NCT00988221|459352262|FG000|Part I|Insufficient Therapeutic Response|4|||
127653071|NCT00988221|459352263|FG001|Part I|Insufficient Therapeutic Response|6|||
127653072|NCT00988221|459352264|FG002|Part I|Insufficient Therapeutic Response|5|||
127653073|NCT00988221|459352265|FG003|Part I|Insufficient Therapeutic Response|0|||
127653074|NCT00988221|459352262|FG000|Part I|Refused Treatment|0|||
127653075|NCT00988221|459352263|FG001|Part I|Refused Treatment|2|||
127653076|NCT00988221|459352264|FG002|Part I|Refused Treatment|1|||
127653077|NCT00988221|459352265|FG003|Part I|Refused Treatment|0|||
127653078|NCT00988221|459352262|FG000|Part I|Lost to Follow-up|0|||
127653079|NCT00988221|459352263|FG001|Part I|Lost to Follow-up|1|||
127653080|NCT00988221|459352264|FG002|Part I|Lost to Follow-up|0|||
127653081|NCT00988221|459352265|FG003|Part I|Lost to Follow-up|0|||
127653082|NCT00988221|459352262|FG000|Part II|Adverse Event|1|||
127653083|NCT00988221|459352263|FG001|Part II|Adverse Event|0|||
127653084|NCT00988221|459352264|FG002|Part II|Adverse Event|0|||
127653085|NCT00988221|459352265|FG003|Part II|Adverse Event|1|||
127653086|NCT00988221|459352262|FG000|Part II|Withdrawal by Subject|0|||
127653087|NCT00988221|459352263|FG001|Part II|Withdrawal by Subject|0|||
127653088|NCT00988221|459352264|FG002|Part II|Withdrawal by Subject|2|||
127653089|NCT00988221|459352265|FG003|Part II|Withdrawal by Subject|2|||
127880060|NCT00391118|460181116|FG000|Overall Study|Protocol Violation|1|||
127880061|NCT00391118|460181117|FG001|Overall Study|Protocol Violation|0|||
127653090|NCT00988221|459352262|FG000|Part II|Reason not Specified|0|||
127653091|NCT00988221|459352263|FG001|Part II|Reason not Specified|0|||
127653092|NCT00988221|459352264|FG002|Part II|Reason not Specified|1|||
127880062|NCT00391118|460181118|FG002|Overall Study|Protocol Violation|0|||
127653093|NCT00988221|459352265|FG003|Part II|Reason not Specified|0|||
127653094|NCT00988221|459352262|FG000|Part III|Adverse Event|1|||
127653095|NCT00988221|459352263|FG001|Part III|Adverse Event|0|||
127653096|NCT00988221|459352264|FG002|Part III|Adverse Event|1|||
127653097|NCT00988221|459352265|FG003|Part III|Adverse Event|0|||
127653098|NCT00988221|459352262|FG000|Part III|Insufficient Therapeutic Response|0|||
127653099|NCT00988221|459352263|FG001|Part III|Insufficient Therapeutic Response|1|||
127653100|NCT00988221|459352264|FG002|Part III|Insufficient Therapeutic Response|1|||
127880063|NCT03078192|460181120|FG000|Overall Study|Withdrawal by Subject|2|||
127653101|NCT00988221|459352265|FG003|Part III|Insufficient Therapeutic Response|0|||
127653102|NCT00988221|459352262|FG000|Part III|Refused Treatment|0|||
127880064|NCT03078192|460181121|FG001|Overall Study|Withdrawal by Subject|1|||
127880065|NCT03078192|460181120|FG000|Overall Study|screen failure|0|||
127880066|NCT03078192|460181121|FG001|Overall Study|screen failure|3|||
127880067|NCT00891527|460183390|FG000|Overall Study|Withdrawal by Subject|2|||
127880068|NCT01186744|460183391|FG000|Overall Study|Lack of Efficacy|156|||
127880069|NCT01186744|460183392|FG001|Overall Study|Lack of Efficacy|99|||
127880070|NCT01186744|460183393|FG002|Overall Study|Lack of Efficacy|0|||
127880071|NCT01186744|460183394|FG003|Overall Study|Lack of Efficacy|2|||
127880072|NCT01186744|460183395|FG004|Overall Study|Lack of Efficacy|2|||
127880073|NCT01186744|460183396|FG005|Overall Study|Lack of Efficacy|5|||
127880074|NCT01186744|460183391|FG000|Overall Study|Protocol Violation|1|||
127880075|NCT01186744|460183392|FG001|Overall Study|Protocol Violation|2|||
127880076|NCT01186744|460183393|FG002|Overall Study|Protocol Violation|0|||
127880077|NCT01186744|460183394|FG003|Overall Study|Protocol Violation|1|||
127880078|NCT01186744|460183395|FG004|Overall Study|Protocol Violation|1|||
127653103|NCT00988221|459352263|FG001|Part III|Refused Treatment|0|||
127653104|NCT00988221|459352264|FG002|Part III|Refused Treatment|1|||
127653105|NCT00988221|459352265|FG003|Part III|Refused Treatment|0|||
127880079|NCT01186744|460183396|FG005|Overall Study|Protocol Violation|2|||
127880080|NCT01186744|460183391|FG000|Overall Study|Lost to Follow-up|15|||
127880081|NCT01186744|460183392|FG001|Overall Study|Lost to Follow-up|16|||
127880082|NCT01186744|460183393|FG002|Overall Study|Lost to Follow-up|2|||
127880083|NCT01186744|460183394|FG003|Overall Study|Lost to Follow-up|1|||
127880084|NCT01186744|460183395|FG004|Overall Study|Lost to Follow-up|1|||
127880085|NCT01186744|460183396|FG005|Overall Study|Lost to Follow-up|4|||
127880086|NCT01186744|460183391|FG000|Overall Study|Screen failure|1|||
127880087|NCT01186744|460183392|FG001|Overall Study|Screen failure|1|||
127880088|NCT01186744|460183393|FG002|Overall Study|Screen failure|0|||
127880089|NCT01186744|460183394|FG003|Overall Study|Screen failure|1|||
127880090|NCT01186744|460183395|FG004|Overall Study|Screen failure|0|||
127880091|NCT01186744|460183396|FG005|Overall Study|Screen failure|0|||
127880092|NCT01186744|460183391|FG000|Overall Study|Withdrawal by Subject|14|||
127880093|NCT01186744|460183392|FG001|Overall Study|Withdrawal by Subject|10|||
127880094|NCT01186744|460183393|FG002|Overall Study|Withdrawal by Subject|2|||
127880095|NCT01186744|460183394|FG003|Overall Study|Withdrawal by Subject|5|||
127880096|NCT01186744|460183395|FG004|Overall Study|Withdrawal by Subject|0|||
127880097|NCT01186744|460183396|FG005|Overall Study|Withdrawal by Subject|6|||
127880098|NCT01186744|460183391|FG000|Overall Study|Study terminated by Sponsor|1|||
127880099|NCT01186744|460183392|FG001|Overall Study|Study terminated by Sponsor|0|||
127880100|NCT01186744|460183393|FG002|Overall Study|Study terminated by Sponsor|0|||
127880101|NCT01186744|460183394|FG003|Overall Study|Study terminated by Sponsor|0|||
127880102|NCT01186744|460183395|FG004|Overall Study|Study terminated by Sponsor|0|||
127880103|NCT01186744|460183396|FG005|Overall Study|Study terminated by Sponsor|0|||
127880104|NCT01186744|460183391|FG000|Overall Study|Other|9|||
127880105|NCT01186744|460183392|FG001|Overall Study|Other|10|||
127880106|NCT01186744|460183393|FG002|Overall Study|Other|1|||
127880107|NCT01186744|460183394|FG003|Overall Study|Other|2|||
127880108|NCT01186744|460183395|FG004|Overall Study|Other|1|||
127880109|NCT01186744|460183396|FG005|Overall Study|Other|5|||
127880110|NCT01186744|460183391|FG000|Overall Study|Adverse Event|10|||
127880111|NCT01186744|460183392|FG001|Overall Study|Adverse Event|14|||
127880112|NCT01186744|460183393|FG002|Overall Study|Adverse Event|1|||
127653106|NCT04581200|459352277|FG000|Overall Study|Lost to Follow-up|6|||
127653107|NCT04581200|459352278|FG001|Overall Study|Lost to Follow-up|5|||
127653108|NCT01781390|459352279|FG000|Overall Study|Withdrawal of Consent|0|||
127653109|NCT01781390|459352280|FG001|Overall Study|Withdrawal of Consent|3|||
127653110|NCT01781390|459352281|FG002|Overall Study|Withdrawal of Consent|1|||
127653111|NCT01781390|459352279|FG000|Overall Study|Lost to Follow-up|1|||
127653112|NCT01781390|459352280|FG001|Overall Study|Lost to Follow-up|1|||
127653113|NCT01781390|459352281|FG002|Overall Study|Lost to Follow-up|1|||
127653114|NCT01781390|459352279|FG000|Overall Study|Adverse Event|1|||
127653115|NCT01781390|459352280|FG001|Overall Study|Adverse Event|2|||
127653116|NCT01781390|459352281|FG002|Overall Study|Adverse Event|1|||
127653117|NCT01781390|459352279|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
127880113|NCT01186744|460183394|FG003|Overall Study|Adverse Event|0|||
127653118|NCT01781390|459352280|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
127653119|NCT01781390|459352281|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
127653120|NCT04404478|459352283|FG000|Overall Study|Withdrawal by Subject|1|||
127880114|NCT01186744|460183395|FG004|Overall Study|Adverse Event|1|||
127880115|NCT01186744|460183396|FG005|Overall Study|Adverse Event|4|||
127880116|NCT01186744|460183391|FG000|Overall Study|Death|1|||
127880117|NCT01186744|460183392|FG001|Overall Study|Death|0|||
127880118|NCT01186744|460183393|FG002|Overall Study|Death|0|||
127880119|NCT01186744|460183394|FG003|Overall Study|Death|0|||
127880120|NCT01186744|460183395|FG004|Overall Study|Death|0|||
127880121|NCT01186744|460183396|FG005|Overall Study|Death|0|||
127880122|NCT01020773|460183399|FG000|Overall Study|Withdrawal by Subject|4|||
127880123|NCT01020773|460183400|FG001|Overall Study|Withdrawal by Subject|3|||
127653121|NCT04404478|459352284|FG001|Overall Study|Withdrawal by Subject|3|||
127880124|NCT01389024|460183401|FG000|Overall Study|Withdrawal by Subject|0|||
127880125|NCT01389024|460183402|FG001|Overall Study|Withdrawal by Subject|1|||
127880126|NCT01389024|460183401|FG000|Overall Study|Lost to Follow-up|1|||
127880127|NCT01389024|460183402|FG001|Overall Study|Lost to Follow-up|0|||
127880128|NCT00819091|460183403|FG000|Overall Study|Adverse Event|3|||
127880129|NCT00819091|460183404|FG001|Overall Study|Adverse Event|5|||
127880130|NCT00819091|460183403|FG000|Overall Study|Protocol Violation|0|||
127880131|NCT00819091|460183404|FG001|Overall Study|Protocol Violation|1|||
127880132|NCT00819091|460183403|FG000|Overall Study|Lost to Follow-up|2|||
127880133|NCT00819091|460183404|FG001|Overall Study|Lost to Follow-up|0|||
127880134|NCT00819091|460183403|FG000|Overall Study|Withdrawal by Subject|1|||
127880135|NCT00819091|460183404|FG001|Overall Study|Withdrawal by Subject|2|||
127880136|NCT00819091|460183403|FG000|Overall Study|Other|1|||
127880137|NCT00819091|460183404|FG001|Overall Study|Other|2|||
127880138|NCT02675426|460183406|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
127880139|NCT02675426|460183407|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
127880140|NCT02675426|460183408|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
127880141|NCT02675426|460183409|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
127880142|NCT02675426|460183406|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
127880143|NCT02675426|460183407|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
127880144|NCT02675426|460183408|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
127880145|NCT02675426|460183409|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
127880146|NCT02675426|460183406|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
127880147|NCT02675426|460183407|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
127880148|NCT02675426|460183408|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
127880149|NCT02675426|460183409|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
127880150|NCT02675426|460183406|FG000|Period 1: Week 1 to Week 12|Other|2|||
127880151|NCT02675426|460183407|FG001|Period 1: Week 1 to Week 12|Other|1|||
127880152|NCT02675426|460183408|FG002|Period 1: Week 1 to Week 12|Other|0|||
127880153|NCT02675426|460183409|FG003|Period 1: Week 1 to Week 12|Other|2|||
127880154|NCT02675426|460183406|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
127880155|NCT02675426|460183407|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
127880156|NCT02675426|460183408|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
127880157|NCT02675426|460183409|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
127880158|NCT02675426|460183406|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
127880159|NCT02675426|460183407|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
127880160|NCT02675426|460183408|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
127880161|NCT02675426|460183409|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
127880162|NCT02675426|460183406|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
127880163|NCT02675426|460183407|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
127880164|NCT02675426|460183408|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
127880165|NCT02675426|460183409|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
127880166|NCT02675426|460183406|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
127880167|NCT02675426|460183407|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
127880168|NCT02675426|460183408|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
127880169|NCT02675426|460183409|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
127880170|NCT02675426|460183406|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
127880171|NCT02675426|460183407|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
127880172|NCT02675426|460183408|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
127880173|NCT02675426|460183409|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
127880174|NCT02675426|460183406|FG000|Period 2: Week 12 to Week 260|Other|8|||
127880175|NCT02675426|460183407|FG001|Period 2: Week 12 to Week 260|Other|12|||
127880176|NCT02675426|460183408|FG002|Period 2: Week 12 to Week 260|Other|23|||
127880177|NCT02675426|460183409|FG003|Period 2: Week 12 to Week 260|Other|15|||
127880178|NCT00953927|460183410|FG000|Overall Study|Lost to Follow-up|61|||
127880179|NCT00953927|460183411|FG001|Overall Study|Lost to Follow-up|65|||
127880180|NCT00953927|460183410|FG000|Overall Study|Withdrawal by Subject|36|||
127880181|NCT00953927|460183411|FG001|Overall Study|Withdrawal by Subject|25|||
127880182|NCT00953927|460183410|FG000|Overall Study|Death|7|||
127880183|NCT00953927|460183411|FG001|Overall Study|Death|4|||
127880184|NCT00953927|460183410|FG000|Overall Study|Other study discontinuation|1|||
127880185|NCT00953927|460183411|FG001|Overall Study|Other study discontinuation|1|||
127880186|NCT02953262|460183412|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
127880187|NCT02953262|460183413|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
127880188|NCT02953262|460183414|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
127880189|NCT02953262|460183415|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
127880190|NCT01652573|460183416|FG000|Overall Study|Adverse Event|0|||
127880191|NCT01652573|460183417|FG001|Overall Study|Adverse Event|1|||
127983750|NCT01764997|460562568|FG000|Study Drug Treatment Period|Other than specified above|0|||
127880192|NCT00740480|460183418|FG000|Overall Study|Adverse Event|1|||
127880193|NCT00740480|460183418|FG000|Overall Study|Physician Decision|1|||
127983751|NCT01764997|460562569|FG001|Study Drug Treatment Period|Other than specified above|0|||
127653122|NCT01859793|459352285|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
127653123|NCT01859793|459352286|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
127653124|NCT01859793|459352285|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
127653125|NCT01859793|459352286|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
127653126|NCT01859793|459352285|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
127653127|NCT01859793|459352286|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
127880194|NCT00934622|460183419|FG000|Overall Study|Lost to Follow-up|7|||
127880195|NCT00934622|460183419|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
127880196|NCT01856686|460183424|FG000|Overall Study|Lost to Follow-up|5|||
127880197|NCT01856686|460183425|FG001|Overall Study|Lost to Follow-up|11|||
127880198|NCT03284424|460183426|FG000|Overall Study|Death|70|||
127880199|NCT03284424|460183427|FG001|Overall Study|Death|24|||
127880200|NCT03284424|460183426|FG000|Overall Study|Lost to Follow-up|3|||
127880201|NCT03284424|460183427|FG001|Overall Study|Lost to Follow-up|1|||
127880202|NCT03284424|460183426|FG000|Overall Study|Physician Decision|1|||
127880203|NCT03284424|460183427|FG001|Overall Study|Physician Decision|2|||
127880204|NCT03284424|460183426|FG000|Overall Study|Withdrawal by Subject|4|||
127880205|NCT03284424|460183427|FG001|Overall Study|Withdrawal by Subject|5|||
127983752|NCT01764997|460562570|FG002|Study Drug Treatment Period|Other than specified above|0|||
127983753|NCT01764997|460562571|FG003|Study Drug Treatment Period|Other than specified above|0|||
127983754|NCT01764997|460562572|FG004|Study Drug Treatment Period|Other than specified above|10|||
127983755|NCT04438499|460562581|FG000|Overall Study|Lack of Efficacy|3|||
127983756|NCT04683939|460562582|FG000|Overall Study|Study termination by the sponsor|0|||
127983757|NCT04683939|460562583|FG001|Overall Study|Study termination by the sponsor|1|||
127983758|NCT04683939|460562584|FG002|Overall Study|Study termination by the sponsor|2|||
127983759|NCT04683939|460562585|FG003|Overall Study|Study termination by the sponsor|2|||
127983760|NCT04683939|460562582|FG000|Overall Study|Death|1|||
127983761|NCT04683939|460562583|FG001|Overall Study|Death|1|||
127983762|NCT04683939|460562584|FG002|Overall Study|Death|2|||
127983763|NCT04683939|460562585|FG003|Overall Study|Death|1|||
127983764|NCT04683939|460562582|FG000|Overall Study|Withdrawal by Subject|1|||
127983765|NCT04683939|460562583|FG001|Overall Study|Withdrawal by Subject|0|||
127983766|NCT04683939|460562584|FG002|Overall Study|Withdrawal by Subject|0|||
127983767|NCT04683939|460562585|FG003|Overall Study|Withdrawal by Subject|0|||
127983768|NCT04683939|460562582|FG000|Overall Study|Physician Decision|1|||
127983769|NCT04683939|460562583|FG001|Overall Study|Physician Decision|0|||
127983770|NCT04683939|460562584|FG002|Overall Study|Physician Decision|0|||
127983771|NCT04683939|460562585|FG003|Overall Study|Physician Decision|0|||
127983772|NCT04683939|460562582|FG000|Overall Study|Lost to Follow-up|0|||
127983773|NCT04683939|460562583|FG001|Overall Study|Lost to Follow-up|1|||
127983774|NCT04683939|460562584|FG002|Overall Study|Lost to Follow-up|0|||
127983775|NCT04683939|460562585|FG003|Overall Study|Lost to Follow-up|0|||
127983776|NCT00224406|460564126|FG000|Overall Study|Re-transplant|0|||
127983777|NCT00224406|460564127|FG001|Overall Study|Re-transplant|2|||
127983778|NCT00224406|460564126|FG000|Overall Study|Death|0|||
127983779|NCT00224406|460564127|FG001|Overall Study|Death|1|||
127983780|NCT00224406|460564126|FG000|Overall Study|Transplant cancelled|0|||
127983781|NCT00224406|460564127|FG001|Overall Study|Transplant cancelled|4|||
127983782|NCT00224406|460564126|FG000|Overall Study|Drug not delivered|2|||
127983783|NCT00224406|460564127|FG001|Overall Study|Drug not delivered|0|||
127983784|NCT00224406|460564126|FG000|Overall Study|Other|4|||
127983785|NCT00224406|460564127|FG001|Overall Study|Other|0|||
127983786|NCT00224406|460564126|FG000|Overall Study|Transplant cancelled|3|||
127983787|NCT00224406|460564127|FG001|Overall Study|Transplant cancelled|0|||
127983788|NCT01556997|460564128|FG000|Overall Study|Adverse Event|10|||
127983789|NCT01556997|460564129|FG001|Overall Study|Adverse Event|12|||
127983790|NCT01556997|460564130|FG002|Overall Study|Adverse Event|12|||
127983791|NCT01556997|460564128|FG000|Overall Study|Lost to Follow-up|6|||
127983792|NCT01556997|460564129|FG001|Overall Study|Lost to Follow-up|6|||
127983793|NCT01556997|460564130|FG002|Overall Study|Lost to Follow-up|4|||
127983794|NCT01556997|460564128|FG000|Overall Study|Physician Decision|1|||
127983795|NCT01556997|460564129|FG001|Overall Study|Physician Decision|1|||
127542354|NCT01126749|458952735|FG000|Phase 1b|Death|3|||
127542355|NCT01126749|458952736|FG001|Phase 1b|Death|4|||
127542356|NCT01126749|458952737|FG002|Phase 1b|Death|0|||
127542357|NCT01126749|458952738|FG003|Phase 1b|Death|0|||
127542358|NCT01126749|458952735|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
127542359|NCT01126749|458952736|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
127542360|NCT01126749|458952737|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
127542361|NCT01126749|458952738|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
127542362|NCT01126749|458952735|FG000|Phase 2|Study Termination by Sponsor|0|||
127542363|NCT01126749|458952736|FG001|Phase 2|Study Termination by Sponsor|0|||
127542364|NCT01126749|458952737|FG002|Phase 2|Study Termination by Sponsor|12|||
127542365|NCT01126749|458952738|FG003|Phase 2|Study Termination by Sponsor|6|||
127542366|NCT01126749|458952735|FG000|Phase 2|Other|0|||
127542367|NCT01126749|458952736|FG001|Phase 2|Other|0|||
127542368|NCT01126749|458952737|FG002|Phase 2|Other|4|||
127542369|NCT01126749|458952738|FG003|Phase 2|Other|2|||
127983796|NCT01556997|460564130|FG002|Overall Study|Physician Decision|1|||
127983797|NCT01556997|460564128|FG000|Overall Study|Withdrawal by Subject|7|||
127983798|NCT01556997|460564129|FG001|Overall Study|Withdrawal by Subject|6|||
127880206|NCT03284424|460183426|FG000|Overall Study|Sponsor's decision|27|||
127880207|NCT03284424|460183427|FG001|Overall Study|Sponsor's decision|22|||
127880208|NCT00602979|460183432|FG000|Overall Study|Lost to Follow-up|3|||
127880209|NCT00602979|460183433|FG001|Overall Study|Lost to Follow-up|2|||
127880210|NCT00602979|460183434|FG002|Overall Study|Lost to Follow-up|3|||
127880211|NCT00602979|460183435|FG003|Overall Study|Lost to Follow-up|2|||
127880212|NCT00602979|460183436|FG004|Overall Study|Lost to Follow-up|3|||
127880213|NCT00602979|460183432|FG000|Overall Study|Failed Intubation|0|||
127880214|NCT00602979|460183433|FG001|Overall Study|Failed Intubation|1|||
127880215|NCT00602979|460183434|FG002|Overall Study|Failed Intubation|0|||
127880216|NCT00602979|460183435|FG003|Overall Study|Failed Intubation|1|||
127983799|NCT01556997|460564130|FG002|Overall Study|Withdrawal by Subject|8|||
127983800|NCT01556997|460564128|FG000|Overall Study|Other|2|||
127880217|NCT00602979|460183436|FG004|Overall Study|Failed Intubation|0|||
127880218|NCT03349437|460183437|FG000|Screening|Screen Fail|4|||
127880219|NCT03349437|460183438|FG001|Screening|Screen Fail|0|||
127880220|NCT03349437|460183439|FG002|Screening|Screen Fail|0|||
127880221|NCT03349437|460183437|FG000|Screening|Withdrawn|1|||
127880222|NCT03349437|460183438|FG001|Screening|Withdrawn|0|||
127880223|NCT03349437|460183439|FG002|Screening|Withdrawn|0|||
127880224|NCT01461369|460183440|FG000|Overall Study|Lack of Efficacy|2|||
127880225|NCT01461369|460183441|FG001|Overall Study|Lack of Efficacy|0|||
127880226|NCT01461369|460183442|FG002|Overall Study|Lack of Efficacy|6|||
127880227|NCT01461369|460183440|FG000|Overall Study|Lost to Follow-up|0|||
127880228|NCT01461369|460183441|FG001|Overall Study|Lost to Follow-up|0|||
127880229|NCT01461369|460183442|FG002|Overall Study|Lost to Follow-up|3|||
127880230|NCT01461369|460183440|FG000|Overall Study|Adverse Event|9|||
127880231|NCT01461369|460183441|FG001|Overall Study|Adverse Event|12|||
127880232|NCT01461369|460183442|FG002|Overall Study|Adverse Event|4|||
127880233|NCT01461369|460183440|FG000|Overall Study|Protocol Violation|1|||
127880234|NCT01461369|460183441|FG001|Overall Study|Protocol Violation|2|||
127880235|NCT01461369|460183442|FG002|Overall Study|Protocol Violation|2|||
127880236|NCT01461369|460183440|FG000|Overall Study|Withdrawal by Subject|1|||
127880237|NCT01461369|460183441|FG001|Overall Study|Withdrawal by Subject|3|||
127880238|NCT01461369|460183442|FG002|Overall Study|Withdrawal by Subject|2|||
127880239|NCT02962739|460183447|FG000|Overall Study|Withdrawal by Subject|0|||
127880240|NCT02962739|460183448|FG001|Overall Study|Withdrawal by Subject|1|||
127880241|NCT02962739|460183449|FG002|Overall Study|Withdrawal by Subject|0|||
127880242|NCT02962739|460183450|FG003|Overall Study|Withdrawal by Subject|0|||
127880243|NCT02962739|460183451|FG004|Overall Study|Withdrawal by Subject|0|||
127880244|NCT02962739|460183452|FG005|Overall Study|Withdrawal by Subject|0|||
127880245|NCT02962739|460183447|FG000|Overall Study|Protocol Violation|0|||
127880246|NCT02962739|460183448|FG001|Overall Study|Protocol Violation|0|||
127880247|NCT02962739|460183449|FG002|Overall Study|Protocol Violation|1|||
127880248|NCT02962739|460183450|FG003|Overall Study|Protocol Violation|0|||
127880249|NCT02962739|460183451|FG004|Overall Study|Protocol Violation|1|||
127880250|NCT02962739|460183452|FG005|Overall Study|Protocol Violation|0|||
127880251|NCT02406742|460183453|FG000|Overall Study|Progression of Disease|5|||
127880252|NCT02406742|460183454|FG001|Overall Study|Progression of Disease|1|||
127880253|NCT02406742|460183455|FG002|Overall Study|Progression of Disease|6|||
127880254|NCT02406742|460183453|FG000|Overall Study|Adverse Event|3|||
127983801|NCT01556997|460564129|FG001|Overall Study|Other|3|||
127983802|NCT01556997|460564130|FG002|Overall Study|Other|7|||
127542370|NCT01126749|458952735|FG000|Phase 2|Withdrawal by Subject|0|||
127542371|NCT01126749|458952736|FG001|Phase 2|Withdrawal by Subject|0|||
127542372|NCT01126749|458952737|FG002|Phase 2|Withdrawal by Subject|0|||
127542373|NCT01126749|458952738|FG003|Phase 2|Withdrawal by Subject|2|||
127542374|NCT01126749|458952735|FG000|Phase 2|Lost to Follow-up|0|||
127542375|NCT01126749|458952736|FG001|Phase 2|Lost to Follow-up|0|||
127542376|NCT01126749|458952737|FG002|Phase 2|Lost to Follow-up|0|||
127542377|NCT01126749|458952738|FG003|Phase 2|Lost to Follow-up|1|||
127542378|NCT01126749|458952735|FG000|Phase 2|Death|0|||
127880255|NCT02406742|460183454|FG001|Overall Study|Adverse Event|0|||
127880256|NCT02406742|460183455|FG002|Overall Study|Adverse Event|2|||
127880257|NCT02406742|460183453|FG000|Overall Study|Death|1|||
127880258|NCT02406742|460183454|FG001|Overall Study|Death|0|||
127880259|NCT02406742|460183455|FG002|Overall Study|Death|0|||
127880260|NCT02406742|460183453|FG000|Overall Study|Lack of Efficacy|0|||
127880261|NCT02406742|460183454|FG001|Overall Study|Lack of Efficacy|0|||
127880262|NCT02406742|460183455|FG002|Overall Study|Lack of Efficacy|1|||
127880263|NCT02406742|460183453|FG000|Overall Study|Withdrawal by Participant|1|||
127880264|NCT02406742|460183454|FG001|Overall Study|Withdrawal by Participant|2|||
127880265|NCT02406742|460183455|FG002|Overall Study|Withdrawal by Participant|0|||
127983803|NCT05459558|460564142|FG000|Overall Study|Adverse Event|1|||
127542379|NCT01126749|458952736|FG001|Phase 2|Death|0|||
127542380|NCT01126749|458952737|FG002|Phase 2|Death|22|||
127542381|NCT01126749|458952738|FG003|Phase 2|Death|22|||
127880266|NCT02406742|460183453|FG000|Overall Study|Physician Decision|1|||
127880267|NCT02406742|460183454|FG001|Overall Study|Physician Decision|2|||
127983804|NCT05459558|460564143|FG001|Overall Study|Adverse Event|0|||
127880268|NCT02406742|460183455|FG002|Overall Study|Physician Decision|1|||
127880269|NCT02406742|460183453|FG000|Overall Study|Transition to other treatment|2|||
127880270|NCT02406742|460183454|FG001|Overall Study|Transition to other treatment|0|||
127880271|NCT02406742|460183455|FG002|Overall Study|Transition to other treatment|1|||
127880272|NCT02406742|460183453|FG000|Overall Study|Other Reasons|1|||
127880273|NCT02406742|460183454|FG001|Overall Study|Other Reasons|11|||
127880274|NCT02406742|460183455|FG002|Overall Study|Other Reasons|5|||
127880275|NCT01563029|460183459|FG000|Overall Study|Adverse Event|1|||
127880276|NCT01563029|460183460|FG001|Overall Study|Adverse Event|0|||
127880277|NCT01563029|460183461|FG002|Overall Study|Adverse Event|1|||
127880278|NCT01563029|460183462|FG003|Overall Study|Adverse Event|2|||
127880279|NCT01563029|460183463|FG004|Overall Study|Adverse Event|1|||
127880280|NCT01563029|460183459|FG000|Overall Study|Lack of Efficacy|42|||
127880281|NCT01563029|460183460|FG001|Overall Study|Lack of Efficacy|16|||
127880282|NCT01563029|460183461|FG002|Overall Study|Lack of Efficacy|23|||
127880283|NCT01563029|460183462|FG003|Overall Study|Lack of Efficacy|21|||
127880284|NCT01563029|460183463|FG004|Overall Study|Lack of Efficacy|19|||
127880285|NCT01563029|460183459|FG000|Overall Study|Protocol Violation|1|||
127880286|NCT01563029|460183460|FG001|Overall Study|Protocol Violation|2|||
127880287|NCT01563029|460183461|FG002|Overall Study|Protocol Violation|3|||
127880288|NCT01563029|460183462|FG003|Overall Study|Protocol Violation|1|||
127880289|NCT01563029|460183463|FG004|Overall Study|Protocol Violation|3|||
127880290|NCT01563029|460183459|FG000|Overall Study|Protocol defined stopping criteria|1|||
127880291|NCT01563029|460183460|FG001|Overall Study|Protocol defined stopping criteria|0|||
127880292|NCT01563029|460183461|FG002|Overall Study|Protocol defined stopping criteria|0|||
127880293|NCT01563029|460183462|FG003|Overall Study|Protocol defined stopping criteria|0|||
127880294|NCT01563029|460183463|FG004|Overall Study|Protocol defined stopping criteria|0|||
127880295|NCT01563029|460183459|FG000|Overall Study|Lost to Follow-up|1|||
127880296|NCT01563029|460183460|FG001|Overall Study|Lost to Follow-up|0|||
127880297|NCT01563029|460183461|FG002|Overall Study|Lost to Follow-up|1|||
127880298|NCT01563029|460183462|FG003|Overall Study|Lost to Follow-up|1|||
127880299|NCT01563029|460183463|FG004|Overall Study|Lost to Follow-up|1|||
127880300|NCT01563029|460183459|FG000|Overall Study|Physician Decision|3|||
127880301|NCT01563029|460183460|FG001|Overall Study|Physician Decision|5|||
127880302|NCT01563029|460183461|FG002|Overall Study|Physician Decision|2|||
127880303|NCT01563029|460183462|FG003|Overall Study|Physician Decision|4|||
127880304|NCT01563029|460183463|FG004|Overall Study|Physician Decision|2|||
127880305|NCT01563029|460183459|FG000|Overall Study|Withdrawal by Subject|4|||
127880306|NCT01563029|460183460|FG001|Overall Study|Withdrawal by Subject|1|||
127880307|NCT01563029|460183461|FG002|Overall Study|Withdrawal by Subject|3|||
127880308|NCT01563029|460183462|FG003|Overall Study|Withdrawal by Subject|4|||
127880309|NCT01563029|460183463|FG004|Overall Study|Withdrawal by Subject|3|||
127983805|NCT05459558|460564144|FG002|Overall Study|Adverse Event|0|||
127983806|NCT05459558|460564142|FG000|Overall Study|Scheduling issue|0|||
127983807|NCT05459558|460564143|FG001|Overall Study|Scheduling issue|1|||
127983808|NCT05459558|460564144|FG002|Overall Study|Scheduling issue|3|||
127983809|NCT05459558|460564142|FG000|Overall Study|Withdrawal by Subject|0|||
127983810|NCT05459558|460564143|FG001|Overall Study|Withdrawal by Subject|0|||
127983811|NCT05459558|460564144|FG002|Overall Study|Withdrawal by Subject|2|||
127983812|NCT01092637|460564145|FG000|Overall Study|Death|47|||
127983813|NCT01092637|460564146|FG001|Overall Study|Death|49|||
127983814|NCT03292458|460564148|FG000|Period 1|Adverse Event|2|||
127983815|NCT03292458|460564149|FG001|Period 1|Adverse Event|0|||
127983816|NCT00593606|460564150|FG000|Overall Study|Adverse Event|13|||
127983817|NCT00593606|460564150|FG000|Overall Study|Withdrawal by Subject|1|||
127983818|NCT00593606|460564150|FG000|Overall Study|Protocol Violation|3|||
127983819|NCT00593606|460564150|FG000|Overall Study|Lost to Follow-up|2|||
127983820|NCT00593606|460564150|FG000|Overall Study|Run-In Failure|5|||
127983821|NCT00593606|460564150|FG000|Overall Study|Screen Failure|3|||
127983822|NCT02278367|460564151|FG000|Overall Study|Physician Decision|5|||
127983823|NCT02278367|460564152|FG001|Overall Study|Physician Decision|0|||
127983824|NCT02278367|460564151|FG000|Overall Study|Withdrawal by Subject|5|||
127983825|NCT02278367|460564152|FG001|Overall Study|Withdrawal by Subject|0|||
127983826|NCT04643964|460564153|FG000|Overall Study|Lost to Follow-up|55|||
127983827|NCT04643964|460564154|FG001|Overall Study|Lost to Follow-up|59|||
127983828|NCT04643964|460564155|FG002|Overall Study|Lost to Follow-up|54|||
127983829|NCT04643964|460564156|FG003|Overall Study|Lost to Follow-up|129|||
127880310|NCT01826201|460183464|FG000|Overall Study|Non compliance with protocol|4|||
127880311|NCT01615822|460183465|FG000|Period 1|Withdrawal by Subject|0|||
127880312|NCT01615822|460183466|FG001|Period 1|Withdrawal by Subject|1|||
127983830|NCT04643964|460564157|FG004|Overall Study|Lost to Follow-up|48|||
127880313|NCT01615822|460183467|FG002|Period 1|Withdrawal by Subject|0|||
127880314|NCT01615822|460183465|FG000|Period 1|Adverse Event|1|||
127880315|NCT01615822|460183466|FG001|Period 1|Adverse Event|1|||
127983831|NCT04643964|460564153|FG000|Overall Study|Failed attention check|1|||
127880316|NCT01615822|460183467|FG002|Period 1|Adverse Event|0|||
127983832|NCT04643964|460564154|FG001|Overall Study|Failed attention check|8|||
127983833|NCT04643964|460564155|FG002|Overall Study|Failed attention check|2|||
127880317|NCT01615822|460183465|FG000|Period 2|Lost to Follow-up|0|||
127880318|NCT01615822|460183466|FG001|Period 2|Lost to Follow-up|1|||
127880319|NCT01615822|460183467|FG002|Period 2|Lost to Follow-up|2|||
127880320|NCT04854707|460183468|FG000|Overall Study|Lack of Efficacy|78|||
127880321|NCT04854707|460183469|FG001|Overall Study|Lack of Efficacy|59|||
127880322|NCT04854707|460183470|FG002|Overall Study|Lack of Efficacy|30|||
127880323|NCT03891875|460183471|FG000|Overall Study|Withdrawal by Subject|20|||
127880324|NCT03891875|460183472|FG001|Overall Study|Withdrawal by Subject|3|||
127880325|NCT03891875|460183471|FG000|Overall Study|Adverse Event|10|||
127880326|NCT03891875|460183472|FG001|Overall Study|Adverse Event|4|||
127880327|NCT03891875|460183471|FG000|Overall Study|Physician Decision|1|||
127880328|NCT03891875|460183472|FG001|Overall Study|Physician Decision|1|||
127880329|NCT03891875|460183471|FG000|Overall Study|Protocol Violation|1|||
127880330|NCT03891875|460183472|FG001|Overall Study|Protocol Violation|0|||
127880331|NCT03891875|460183471|FG000|Overall Study|Lost to Follow-up|1|||
127880332|NCT03891875|460183472|FG001|Overall Study|Lost to Follow-up|0|||
127880333|NCT03891875|460183471|FG000|Overall Study|COVID-19 infection|1|||
127880334|NCT03891875|460183472|FG001|Overall Study|COVID-19 infection|0|||
127880335|NCT02426125|460183475|FG000|Overall Study|Lost to Follow-up|14|||
127880336|NCT02426125|460183476|FG001|Overall Study|Lost to Follow-up|12|||
127880337|NCT02426125|460183475|FG000|Overall Study|Withdrawal by Subject|13|||
127880338|NCT02426125|460183476|FG001|Overall Study|Withdrawal by Subject|14|||
127880339|NCT02426125|460183475|FG000|Overall Study|Death|185|||
127880340|NCT02426125|460183476|FG001|Overall Study|Death|200|||
127880341|NCT02426125|460183475|FG000|Overall Study|Randomized, But Never Treated|5|||
127880342|NCT02426125|460183476|FG001|Overall Study|Randomized, But Never Treated|2|||
127880343|NCT00664066|460183479|FG000|Overall Study|Study terminated|3|||
127880344|NCT01495793|460183480|FG000|Overall Study|Lost to Follow-up|1|||
127880345|NCT01495793|460183480|FG000|Overall Study|Violation of inclusion criteria|1|||
127880346|NCT00478673|460183481|FG000|30-Days Post-Procedure|Death|2|||
127880347|NCT00478673|460183481|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
127880348|NCT00478673|460183481|FG000|30-Days Post-Procedure|Missed Visit|7|||
127880349|NCT00478673|460183481|FG000|12-Months Post-Procedure|Death|23|||
127880350|NCT00478673|460183481|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
127880351|NCT00478673|460183481|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
127880352|NCT00478673|460183481|FG000|12-Months Post-Procedure|Missed Visit|25|||
127880353|NCT00478673|460183481|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
127880354|NCT03701516|460183482|FG000|Period 1|Lost to Follow-up|0|||
127880355|NCT03701516|460183483|FG001|Period 1|Lost to Follow-up|1|||
127880356|NCT03701516|460183482|FG000|Period 1|Adverse Event|0|||
127880357|NCT03701516|460183483|FG001|Period 1|Adverse Event|2|||
127880358|NCT03701516|460183482|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
127880359|NCT03701516|460183483|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
127880360|NCT03701516|460183482|FG000|Period 1|Non Compliance to Protocol|2|||
127880361|NCT03701516|460183483|FG001|Period 1|Non Compliance to Protocol|1|||
127880362|NCT03701516|460183482|FG000|Period 1|Withdrawal by Subject|0|||
127880363|NCT03701516|460183483|FG001|Period 1|Withdrawal by Subject|1|||
127880364|NCT03701516|460183482|FG000|Period 2|failed to meet all eligibility creiteria|1|||
127880365|NCT03701516|460183483|FG001|Period 2|failed to meet all eligibility creiteria|0|||
127880366|NCT03701516|460183482|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
127880367|NCT03701516|460183483|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
127880368|NCT02125734|460183487|FG000|Period 2|Adverse Event|0|||
127880369|NCT02125734|460183488|FG001|Period 2|Adverse Event|1|||
127880370|NCT05083559|460183489|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
127880371|NCT05083559|460183490|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
127880372|NCT05083559|460183489|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
127880373|NCT05083559|460183490|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
127880374|NCT05083559|460183489|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
127880375|NCT05083559|460183490|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
127880376|NCT05246111|460183492|FG000|Period 01|NOT ELIGIBLE IC5|1|||
127880377|NCT05246111|460183493|FG001|Period 01|NOT ELIGIBLE IC5|0|||
127880378|NCT03151226|460183494|FG000|Overall Study|Withdrawal by Subject|2|||
127880379|NCT03151226|460183494|FG000|Overall Study|not wear device correctly|1|||
127880380|NCT02304302|460183497|FG000|Overall Study|Adverse Event|2|||
127880381|NCT02304302|460183498|FG001|Overall Study|Adverse Event|3|||
127880382|NCT02304302|460183497|FG000|Overall Study|Lost to Follow-up|1|||
127880383|NCT02304302|460183498|FG001|Overall Study|Lost to Follow-up|4|||
127880384|NCT02304302|460183497|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
127880385|NCT02304302|460183498|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
127880386|NCT02508649|460183501|FG000|Overall Study|Withdrawal by Subject|4|||
127880387|NCT02508649|460183502|FG001|Overall Study|Withdrawal by Subject|6|||
127880388|NCT02508649|460183503|FG002|Overall Study|Withdrawal by Subject|5|||
127880389|NCT02508649|460183504|FG003|Overall Study|Withdrawal by Subject|6|||
127880390|NCT02508649|460183501|FG000|Overall Study|Investigator withdrew the subject|1|||
127880391|NCT02508649|460183502|FG001|Overall Study|Investigator withdrew the subject|2|||
127880392|NCT02508649|460183503|FG002|Overall Study|Investigator withdrew the subject|1|||
127880393|NCT02508649|460183504|FG003|Overall Study|Investigator withdrew the subject|0|||
127880394|NCT02508649|460183501|FG000|Overall Study|Post randomization screening failure|12|||
127880395|NCT02508649|460183502|FG001|Overall Study|Post randomization screening failure|4|||
127880396|NCT02508649|460183503|FG002|Overall Study|Post randomization screening failure|9|||
127880397|NCT02508649|460183504|FG003|Overall Study|Post randomization screening failure|3|||
127880398|NCT02508649|460183501|FG000|Overall Study|Lost to Follow-up|1|||
127880399|NCT02508649|460183502|FG001|Overall Study|Lost to Follow-up|1|||
127880400|NCT02508649|460183503|FG002|Overall Study|Lost to Follow-up|0|||
127880401|NCT02508649|460183504|FG003|Overall Study|Lost to Follow-up|1|||
127880402|NCT03107715|460183505|FG000|Overall Study|did not deliver at the home hospital|4|||
127880403|NCT03107715|460183506|FG001|Overall Study|did not deliver at the home hospital|6|||
127880404|NCT03107715|460183505|FG000|Overall Study|infant stillborn|0|||
127880405|NCT03107715|460183506|FG001|Overall Study|infant stillborn|1|||
127880406|NCT03594175|460183514|FG000|Overall Study|Not treated|8|||
127880407|NCT03594175|460183515|FG001|Overall Study|Not treated|1|||
127880408|NCT03594175|460183516|FG002|Overall Study|Not treated|5|||
127880409|NCT03594175|460183514|FG000|Overall Study|Adverse Event|3|||
127880410|NCT03594175|460183515|FG001|Overall Study|Adverse Event|0|||
127880411|NCT03594175|460183516|FG002|Overall Study|Adverse Event|0|||
127880412|NCT03594175|460183514|FG000|Overall Study|Withdrawal by Subject|3|||
127880413|NCT03594175|460183515|FG001|Overall Study|Withdrawal by Subject|0|||
127880414|NCT03594175|460183516|FG002|Overall Study|Withdrawal by Subject|0|||
127880415|NCT03594175|460183514|FG000|Overall Study|Protocol Violation|2|||
127880416|NCT03594175|460183515|FG001|Overall Study|Protocol Violation|2|||
127880417|NCT03594175|460183516|FG002|Overall Study|Protocol Violation|2|||
127880418|NCT01915498|460183517|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
127880419|NCT01915498|460183518|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
127880420|NCT01915498|460183519|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
127880421|NCT01915498|460183520|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
127880422|NCT01915498|460183521|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
127880423|NCT01915498|460183522|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
127880424|NCT01915498|460183523|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
127880425|NCT01915498|460183524|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
127880426|NCT01915498|460183525|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
127880427|NCT01915498|460183526|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
127880428|NCT01915498|460183527|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
127880429|NCT01915498|460183528|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
127880430|NCT01915498|460183529|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
127880431|NCT01915498|460183530|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
127880432|NCT01915498|460183531|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
127880433|NCT01915498|460183532|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
127880434|NCT01915498|460183533|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
127880435|NCT01915498|460183534|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
127880436|NCT01915498|460183535|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
127880437|NCT01915498|460183517|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
127880438|NCT01915498|460183518|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
127880439|NCT01915498|460183519|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
127880440|NCT01915498|460183520|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
127880441|NCT01915498|460183521|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
127880442|NCT01915498|460183522|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
127880443|NCT01915498|460183523|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
127880444|NCT01915498|460183524|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
127880445|NCT01915498|460183525|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
127880446|NCT01915498|460183526|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
127880447|NCT01915498|460183527|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
127880448|NCT01915498|460183528|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
127880449|NCT01915498|460183529|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
127880450|NCT01915498|460183530|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
127880451|NCT01915498|460183531|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
127880452|NCT01915498|460183532|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
127880453|NCT01915498|460183533|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
127880454|NCT01915498|460183534|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
127880455|NCT01915498|460183535|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
127880456|NCT01915498|460183517|FG000|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
127880457|NCT01915498|460183518|FG001|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
127880458|NCT01915498|460183519|FG002|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
127880459|NCT01915498|460183520|FG003|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
127983834|NCT04643964|460564156|FG003|Overall Study|Failed attention check|14|||
127880460|NCT01915498|460183521|FG004|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
127880461|NCT01915498|460183522|FG005|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
127880462|NCT01915498|460183523|FG006|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
127880463|NCT01915498|460183524|FG007|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
127880464|NCT01915498|460183525|FG008|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
127880465|NCT01915498|460183526|FG009|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
127880466|NCT01915498|460183527|FG010|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
127880467|NCT01915498|460183528|FG011|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
127880468|NCT01915498|460183529|FG012|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
127880469|NCT01915498|460183530|FG013|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
127880470|NCT01915498|460183531|FG014|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
127880471|NCT01915498|460183532|FG015|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
127880472|NCT01915498|460183533|FG016|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
127880473|NCT01915498|460183534|FG017|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|2|||
127880474|NCT01915498|460183535|FG018|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
127880475|NCT01915498|460183517|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
127880476|NCT01915498|460183518|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
127880477|NCT01915498|460183519|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
127880478|NCT01915498|460183520|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
127880479|NCT01915498|460183521|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
127880480|NCT01915498|460183522|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
127880481|NCT01915498|460183523|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
127880482|NCT01915498|460183524|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
127880483|NCT01915498|460183525|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
127880484|NCT01915498|460183526|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
127880485|NCT01915498|460183527|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
127880486|NCT01915498|460183528|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
127880487|NCT01915498|460183529|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
127880488|NCT01915498|460183530|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
127880489|NCT01915498|460183531|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
127983835|NCT04643964|460564157|FG004|Overall Study|Failed attention check|11|||
127542382|NCT01126749|458952735|FG000|Phase 2|Adverse Event|0|||
127542383|NCT01126749|458952736|FG001|Phase 2|Adverse Event|0|||
127542384|NCT01126749|458952737|FG002|Phase 2|Adverse Event|0|||
127542385|NCT01126749|458952738|FG003|Phase 2|Adverse Event|1|||
127542386|NCT01283139|458952740|FG000|Overall Study|Lost to Follow-up|5|||
127542387|NCT01283139|458952741|FG001|Overall Study|Lost to Follow-up|2|||
127542388|NCT01283139|458952742|FG002|Overall Study|Lost to Follow-up|3|||
127542389|NCT01283139|458952743|FG003|Overall Study|Lost to Follow-up|1|||
127542390|NCT01283139|458952740|FG000|Overall Study|Withdrawal by Subject|8|||
127542391|NCT01283139|458952741|FG001|Overall Study|Withdrawal by Subject|8|||
127542392|NCT01283139|458952742|FG002|Overall Study|Withdrawal by Subject|6|||
127542393|NCT01283139|458952743|FG003|Overall Study|Withdrawal by Subject|8|||
127542394|NCT01283139|458952740|FG000|Overall Study|Death|2|||
127542395|NCT01283139|458952741|FG001|Overall Study|Death|0|||
127542396|NCT01283139|458952742|FG002|Overall Study|Death|2|||
127542397|NCT01283139|458952743|FG003|Overall Study|Death|2|||
127542398|NCT01283139|458952740|FG000|Overall Study|Lack of Efficacy|1|||
127542399|NCT01283139|458952741|FG001|Overall Study|Lack of Efficacy|2|||
127542400|NCT01283139|458952742|FG002|Overall Study|Lack of Efficacy|2|||
127542401|NCT01283139|458952743|FG003|Overall Study|Lack of Efficacy|1|||
127542402|NCT01283139|458952740|FG000|Overall Study|Early termination due to AE/SAE|1|||
127542403|NCT01283139|458952741|FG001|Overall Study|Early termination due to AE/SAE|1|||
127542404|NCT01283139|458952742|FG002|Overall Study|Early termination due to AE/SAE|0|||
127542405|NCT01283139|458952743|FG003|Overall Study|Early termination due to AE/SAE|0|||
127542406|NCT01283139|458952740|FG000|Overall Study|Participant's refusal to continue|0|||
127542407|NCT01283139|458952741|FG001|Overall Study|Participant's refusal to continue|3|||
127542408|NCT01283139|458952742|FG002|Overall Study|Participant's refusal to continue|1|||
127542409|NCT01283139|458952743|FG003|Overall Study|Participant's refusal to continue|1|||
127542410|NCT01283139|458952740|FG000|Overall Study|Pregnancy|0|||
127542411|NCT01283139|458952741|FG001|Overall Study|Pregnancy|1|||
127542412|NCT01283139|458952742|FG002|Overall Study|Pregnancy|1|||
127542413|NCT01283139|458952743|FG003|Overall Study|Pregnancy|0|||
127542414|NCT01283139|458952740|FG000|Overall Study|Missed follow-up visit|0|||
127542415|NCT01283139|458952741|FG001|Overall Study|Missed follow-up visit|1|||
127542416|NCT01283139|458952742|FG002|Overall Study|Missed follow-up visit|2|||
127542417|NCT01283139|458952743|FG003|Overall Study|Missed follow-up visit|2|||
127542418|NCT01283139|458952740|FG000|Overall Study|Participant randomized in error|0|||
127880490|NCT01915498|460183532|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
127880491|NCT01915498|460183533|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
127880492|NCT01915498|460183534|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
127880493|NCT01915498|460183535|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
127880494|NCT01915498|460183517|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
127880495|NCT01915498|460183518|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
127880496|NCT01915498|460183519|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
127880497|NCT01915498|460183520|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
127880498|NCT01915498|460183521|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
127880499|NCT01915498|460183522|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
127880500|NCT01915498|460183523|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
127880501|NCT01915498|460183524|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
127880502|NCT01915498|460183525|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
127880503|NCT01915498|460183526|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
127880504|NCT01915498|460183527|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
127880505|NCT01915498|460183528|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
127880506|NCT01915498|460183529|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
127880507|NCT01915498|460183530|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
127880508|NCT01915498|460183531|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
127880509|NCT01915498|460183532|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
127880510|NCT01915498|460183533|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
127880511|NCT01915498|460183534|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
127880512|NCT01915498|460183535|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
127880513|NCT01915498|460183517|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
127880514|NCT01915498|460183518|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
127880515|NCT01915498|460183519|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
127880516|NCT01915498|460183520|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
127880517|NCT01915498|460183521|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
127880518|NCT01915498|460183522|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
127880519|NCT01915498|460183523|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
127880520|NCT01915498|460183524|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
127880521|NCT01915498|460183525|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
127880522|NCT01915498|460183526|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
127880523|NCT01915498|460183527|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
127880524|NCT01915498|460183528|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
127880525|NCT01915498|460183529|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
127880526|NCT01915498|460183530|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
127880527|NCT01915498|460183531|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
127880528|NCT01915498|460183532|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
127880529|NCT01915498|460183533|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
127880530|NCT01915498|460183534|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
127880531|NCT01915498|460183535|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
127880532|NCT01915498|460183517|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
127880533|NCT01915498|460183518|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
127880534|NCT01915498|460183519|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
127880535|NCT01915498|460183520|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
127880536|NCT01915498|460183521|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
127880537|NCT01915498|460183522|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
127880538|NCT01915498|460183523|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
127880539|NCT01915498|460183524|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
127880540|NCT01915498|460183525|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
127880541|NCT01915498|460183526|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
127880542|NCT01915498|460183527|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
127880543|NCT01915498|460183528|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
127983836|NCT05932225|460564158|FG000|Overall Study|Lost to Follow-up|0|||
127983837|NCT05932225|460564159|FG001|Overall Study|Lost to Follow-up|1|||
127983838|NCT05932225|460564160|FG002|Overall Study|Lost to Follow-up|0|||
127983839|NCT05932225|460564158|FG000|Overall Study|Withdrawal by Subject|1|||
127983840|NCT05932225|460564159|FG001|Overall Study|Withdrawal by Subject|0|||
127983841|NCT05932225|460564160|FG002|Overall Study|Withdrawal by Subject|0|||
127983842|NCT05932225|460564158|FG000|Overall Study|As detailed in the Clinical Study Report|0|||
127983843|NCT05932225|460564159|FG001|Overall Study|As detailed in the Clinical Study Report|2|||
127983844|NCT05932225|460564160|FG002|Overall Study|As detailed in the Clinical Study Report|0|||
127983845|NCT02638129|460564161|FG000|Overall Study|Study terminated|28|||
127983846|NCT02638129|460564162|FG001|Overall Study|Study terminated|30|||
127983847|NCT02949908|460564163|FG000|Overall Study|Study termination|2|||
127983848|NCT01472939|460564164|FG000|Overall Study|Adverse Event|3|||
127983849|NCT01472939|460564165|FG001|Overall Study|Adverse Event|7|||
127983850|NCT01472939|460564166|FG002|Overall Study|Adverse Event|7|||
127983851|NCT01472939|460564167|FG003|Overall Study|Adverse Event|14|||
127983852|NCT01472939|460564164|FG000|Overall Study|Lack of Efficacy|1|||
127983853|NCT01472939|460564165|FG001|Overall Study|Lack of Efficacy|0|||
127983854|NCT01472939|460564166|FG002|Overall Study|Lack of Efficacy|0|||
127983855|NCT01472939|460564167|FG003|Overall Study|Lack of Efficacy|1|||
127983856|NCT01472939|460564164|FG000|Overall Study|Lost to Follow-up|3|||
127983857|NCT01472939|460564165|FG001|Overall Study|Lost to Follow-up|0|||
127983858|NCT01472939|460564166|FG002|Overall Study|Lost to Follow-up|2|||
127983859|NCT01472939|460564167|FG003|Overall Study|Lost to Follow-up|0|||
127983860|NCT01472939|460564164|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
127983861|NCT01472939|460564165|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
127983862|NCT01472939|460564166|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
127983863|NCT01472939|460564167|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
127983864|NCT01472939|460564164|FG000|Overall Study|Prohibited Medication|0|||
127983865|NCT01472939|460564165|FG001|Overall Study|Prohibited Medication|1|||
127983866|NCT01472939|460564166|FG002|Overall Study|Prohibited Medication|0|||
127983867|NCT01472939|460564167|FG003|Overall Study|Prohibited Medication|0|||
127983868|NCT01472939|460564164|FG000|Overall Study|Withdrawal By PI|1|||
127983869|NCT01472939|460564165|FG001|Overall Study|Withdrawal By PI|0|||
127983870|NCT01472939|460564166|FG002|Overall Study|Withdrawal By PI|0|||
127983871|NCT01472939|460564167|FG003|Overall Study|Withdrawal By PI|0|||
127983872|NCT01472939|460564164|FG000|Overall Study|Protocol Violation|3|||
127983873|NCT01472939|460564165|FG001|Overall Study|Protocol Violation|3|||
127983874|NCT01472939|460564166|FG002|Overall Study|Protocol Violation|0|||
127983875|NCT01472939|460564167|FG003|Overall Study|Protocol Violation|1|||
127983876|NCT01472939|460564164|FG000|Overall Study|Withdrawal by Subject|9|||
127983877|NCT01472939|460564165|FG001|Overall Study|Withdrawal by Subject|3|||
127983878|NCT01472939|460564166|FG002|Overall Study|Withdrawal by Subject|1|||
127983879|NCT01472939|460564167|FG003|Overall Study|Withdrawal by Subject|4|||
127983880|NCT00114738|460564168|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
127983881|NCT00114738|460564169|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
127983882|NCT00114738|460564170|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
127983883|NCT00114738|460564168|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
127983884|NCT00114738|460564169|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
127983885|NCT00114738|460564170|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
127983886|NCT00114738|460564168|FG000|Screening for Randomization|Neuropathy|17|||
127983887|NCT00114738|460564169|FG001|Screening for Randomization|Neuropathy|0|||
127983888|NCT00114738|460564170|FG002|Screening for Randomization|Neuropathy|0|||
127983889|NCT00114738|460564168|FG000|Screening for Randomization|Progressive disease|2|||
127983890|NCT00114738|460564169|FG001|Screening for Randomization|Progressive disease|0|||
127983891|NCT00114738|460564170|FG002|Screening for Randomization|Progressive disease|0|||
127983892|NCT00114738|460564168|FG000|Screening for Randomization|CNS Hemorrhage|1|||
127983893|NCT00114738|460564169|FG001|Screening for Randomization|CNS Hemorrhage|0|||
127983894|NCT00114738|460564170|FG002|Screening for Randomization|CNS Hemorrhage|0|||
127983895|NCT00114738|460564168|FG000|Screening for Randomization|Other|1|||
127983896|NCT00114738|460564169|FG001|Screening for Randomization|Other|0|||
127983897|NCT00114738|460564170|FG002|Screening for Randomization|Other|0|||
127983898|NCT00308750|460564175|FG000|Overall Study|Adverse Event|9|||
127983899|NCT00308750|460564176|FG001|Overall Study|Adverse Event|9|||
127983900|NCT00308750|460564177|FG002|Overall Study|Adverse Event|13|||
127983901|NCT00308750|460564175|FG000|Overall Study|Withdrawal by Subject|6|||
127983902|NCT00308750|460564176|FG001|Overall Study|Withdrawal by Subject|2|||
127983903|NCT00308750|460564177|FG002|Overall Study|Withdrawal by Subject|3|||
127983904|NCT00308750|460564175|FG000|Overall Study|Physician Decision|3|||
127983905|NCT00308750|460564176|FG001|Overall Study|Physician Decision|4|||
127983906|NCT00308750|460564177|FG002|Overall Study|Physician Decision|3|||
127983907|NCT00308750|460564175|FG000|Overall Study|Sponsor Decision|1|||
127983908|NCT00308750|460564176|FG001|Overall Study|Sponsor Decision|0|||
127983909|NCT00308750|460564177|FG002|Overall Study|Sponsor Decision|0|||
127983910|NCT00308750|460564175|FG000|Overall Study|Disease Progression|47|||
127983911|NCT00308750|460564176|FG001|Overall Study|Disease Progression|24|||
127983912|NCT00308750|460564177|FG002|Overall Study|Disease Progression|28|||
127983913|NCT00308750|460564175|FG000|Overall Study|Unrelated Complication|3|||
127983914|NCT00308750|460564176|FG001|Overall Study|Unrelated Complication|0|||
127983915|NCT00308750|460564177|FG002|Overall Study|Unrelated Complication|1|||
127983916|NCT00308750|460564175|FG000|Overall Study|Death|1|||
127983917|NCT00308750|460564176|FG001|Overall Study|Death|0|||
127983918|NCT00308750|460564177|FG002|Overall Study|Death|1|||
127983919|NCT00308750|460564175|FG000|Overall Study|Protocol Violation|1|||
127983920|NCT00308750|460564176|FG001|Overall Study|Protocol Violation|0|||
127983921|NCT00308750|460564177|FG002|Overall Study|Protocol Violation|0|||
127542419|NCT01283139|458952741|FG001|Overall Study|Participant randomized in error|0|||
127542420|NCT01283139|458952742|FG002|Overall Study|Participant randomized in error|1|||
127542421|NCT01283139|458952743|FG003|Overall Study|Participant randomized in error|0|||
127542422|NCT01614249|458952744|FG000|Overall Study|Lost to Follow-up|11|||
127542423|NCT01614249|458952745|FG001|Overall Study|Lost to Follow-up|23|||
127983922|NCT00308750|460564175|FG000|Overall Study|New Primary Disease Identified|1|||
127542424|NCT02954536|458952746|FG000|Overall Study|Adverse Event|2|||
127542425|NCT02954536|458952746|FG000|Overall Study|Death|12|||
127542426|NCT05498649|458952747|FG000|Overall Study|Lost to Follow-up|1|||
127542427|NCT02946580|458952751|FG000|Overall Study|Withdrawal by Subject|1|||
127542428|NCT02946580|458952752|FG001|Overall Study|Withdrawal by Subject|2|||
127542429|NCT02946580|458952751|FG000|Overall Study|Adverse Event|0|||
127542430|NCT02946580|458952752|FG001|Overall Study|Adverse Event|2|||
127542431|NCT02946580|458952751|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
127542432|NCT02946580|458952752|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
127542433|NCT03043313|458952755|FG000|Overall Study|Withdrawal by Subject|5|||
127542434|NCT03043313|458952756|FG001|Overall Study|Withdrawal by Subject|1|||
127542435|NCT03043313|458952757|FG002|Overall Study|Withdrawal by Subject|1|||
127542436|NCT03043313|458952755|FG000|Overall Study|Lost to Follow-up|1|||
127542437|NCT03043313|458952756|FG001|Overall Study|Lost to Follow-up|1|||
127542438|NCT03043313|458952757|FG002|Overall Study|Lost to Follow-up|0|||
127542439|NCT03043313|458952755|FG000|Overall Study|Death|28|||
127542440|NCT03043313|458952756|FG001|Overall Study|Death|26|||
127542441|NCT03043313|458952757|FG002|Overall Study|Death|17|||
127542442|NCT03043313|458952755|FG000|Overall Study|Participation terminated by sponsor|11|||
127542443|NCT03043313|458952756|FG001|Overall Study|Participation terminated by sponsor|13|||
127542444|NCT03043313|458952757|FG002|Overall Study|Participation terminated by sponsor|13|||
127542445|NCT00980954|458952758|FG000|Overall Study|Protocol Violation|9|||
127542446|NCT00980954|458952759|FG001|Overall Study|Protocol Violation|15|||
127542447|NCT02657889|458952760|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
127542448|NCT02657889|458952761|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
127542449|NCT02657889|458952762|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
127542450|NCT02657889|458952763|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
127542451|NCT02657889|458952760|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
127542452|NCT02657889|458952761|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
127542453|NCT02657889|458952762|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
127542454|NCT02657889|458952763|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
127542455|NCT02657889|458952760|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
127542456|NCT02657889|458952761|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
127542457|NCT02657889|458952762|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
127542458|NCT02657889|458952763|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
127542459|NCT02657889|458952760|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
127542460|NCT02657889|458952761|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
127542461|NCT02657889|458952762|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
127542462|NCT02657889|458952763|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
127542463|NCT02657889|458952760|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
127542464|NCT02657889|458952761|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
127542465|NCT02657889|458952762|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
127542466|NCT02657889|458952763|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
127542467|NCT02657889|458952760|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
127542468|NCT02657889|458952761|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
127542469|NCT02657889|458952762|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
127542470|NCT02657889|458952763|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
127542471|NCT02657889|458952760|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
127542472|NCT02657889|458952761|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
127542473|NCT02657889|458952762|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
127542474|NCT02657889|458952763|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
127542475|NCT02657889|458952760|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
127542476|NCT02657889|458952761|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
127542477|NCT02657889|458952762|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
127542478|NCT02657889|458952763|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
127542479|NCT02657889|458952760|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
127542480|NCT02657889|458952761|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
127653128|NCT01859793|459352285|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
127983923|NCT00308750|460564176|FG001|Overall Study|New Primary Disease Identified|1|||
127983924|NCT00308750|460564177|FG002|Overall Study|New Primary Disease Identified|0|||
127983925|NCT01358578|460564178|FG000|Induction Period|Adverse Event|2|||
127983926|NCT01358578|460564179|FG001|Induction Period|Adverse Event|4|||
127983927|NCT01358578|460564180|FG002|Induction Period|Adverse Event|2|||
127983928|NCT01358578|460564181|FG003|Induction Period|Adverse Event|6|||
127983929|NCT01358578|460564182|FG004|Induction Period|Adverse Event|0|||
127983930|NCT01358578|460564183|FG005|Induction Period|Adverse Event|0|||
127983931|NCT01358578|460564178|FG000|Induction Period|Lack of Efficacy|0|||
127983932|NCT01358578|460564179|FG001|Induction Period|Lack of Efficacy|0|||
127983933|NCT01358578|460564180|FG002|Induction Period|Lack of Efficacy|9|||
127983934|NCT01358578|460564181|FG003|Induction Period|Lack of Efficacy|1|||
127983935|NCT01358578|460564182|FG004|Induction Period|Lack of Efficacy|0|||
127983936|NCT01358578|460564183|FG005|Induction Period|Lack of Efficacy|0|||
127983937|NCT01358578|460564178|FG000|Induction Period|Lost to Follow-up|0|||
127983938|NCT01358578|460564179|FG001|Induction Period|Lost to Follow-up|0|||
127983939|NCT01358578|460564180|FG002|Induction Period|Lost to Follow-up|1|||
127983940|NCT01358578|460564181|FG003|Induction Period|Lost to Follow-up|4|||
127983941|NCT01358578|460564182|FG004|Induction Period|Lost to Follow-up|0|||
127983942|NCT01358578|460564183|FG005|Induction Period|Lost to Follow-up|0|||
127983943|NCT01358578|460564178|FG000|Induction Period|Physician Decision|2|||
127983944|NCT01358578|460564179|FG001|Induction Period|Physician Decision|1|||
127983945|NCT01358578|460564180|FG002|Induction Period|Physician Decision|2|||
127983946|NCT01358578|460564181|FG003|Induction Period|Physician Decision|0|||
127983947|NCT01358578|460564182|FG004|Induction Period|Physician Decision|0|||
127983948|NCT01358578|460564183|FG005|Induction Period|Physician Decision|0|||
127983949|NCT01358578|460564178|FG000|Induction Period|Protocol Deviation|3|||
127983950|NCT01358578|460564179|FG001|Induction Period|Protocol Deviation|5|||
127983951|NCT01358578|460564180|FG002|Induction Period|Protocol Deviation|0|||
127983952|NCT01358578|460564181|FG003|Induction Period|Protocol Deviation|3|||
127542481|NCT02657889|458952762|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
127542482|NCT02657889|458952763|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
127542483|NCT02657889|458952760|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
127542484|NCT02657889|458952761|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
127542485|NCT02657889|458952762|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
127542486|NCT02657889|458952763|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
127542487|NCT02657889|458952760|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
127542488|NCT02657889|458952761|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
127542489|NCT02657889|458952762|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
127542490|NCT02657889|458952763|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
127542491|NCT02657889|458952760|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
127542492|NCT02657889|458952761|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
127542493|NCT02657889|458952762|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
127542494|NCT02657889|458952763|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
127542495|NCT00517296|458952764|FG000|Overall Study|Withdrawal by Subject|1|||
127542496|NCT00517296|458952765|FG001|Overall Study|Withdrawal by Subject|0|||
127542497|NCT00791934|458952766|FG000|Overall Study|Withdrawal by Subject|2|||
127542498|NCT00791934|458952766|FG000|Overall Study|Did not consent for extended follow-up|13|||
127542499|NCT03642873|458952768|FG000|Third Intervention (1 Day)|Screen failure|0|||
127542500|NCT03642873|458952769|FG001|Third Intervention (1 Day)|Screen failure|0|||
127542501|NCT03642873|458952770|FG002|Third Intervention (1 Day)|Screen failure|0|||
127542502|NCT03642873|458952771|FG003|Third Intervention (1 Day)|Screen failure|0|||
127542503|NCT03642873|458952772|FG004|Third Intervention (1 Day)|Screen failure|1|||
127542504|NCT03642873|458952773|FG005|Third Intervention (1 Day)|Screen failure|0|||
127542505|NCT02234843|458952784|FG000|Overall Study|Death|1|||
127542506|NCT02234843|458952785|FG001|Overall Study|Death|0|||
127542507|NCT02234843|458952786|FG002|Overall Study|Death|0|||
127542508|NCT02234843|458952787|FG003|Overall Study|Death|0|||
127542509|NCT02234843|458952788|FG004|Overall Study|Death|0|||
127542510|NCT02234843|458952789|FG005|Overall Study|Death|0|||
127542511|NCT02234843|458952790|FG006|Overall Study|Death|0|||
127542512|NCT02234843|458952791|FG007|Overall Study|Death|0|||
127542513|NCT02234843|458952792|FG008|Overall Study|Death|0|||
127542514|NCT02234843|458952793|FG009|Overall Study|Death|0|||
127542515|NCT02234843|458952784|FG000|Overall Study|Protocol Violation|1|||
127542516|NCT02234843|458952785|FG001|Overall Study|Protocol Violation|0|||
127542517|NCT02234843|458952786|FG002|Overall Study|Protocol Violation|1|||
127542518|NCT02234843|458952787|FG003|Overall Study|Protocol Violation|0|||
127542519|NCT02234843|458952788|FG004|Overall Study|Protocol Violation|0|||
127542520|NCT02234843|458952789|FG005|Overall Study|Protocol Violation|0|||
127542521|NCT02234843|458952790|FG006|Overall Study|Protocol Violation|0|||
127542522|NCT02234843|458952791|FG007|Overall Study|Protocol Violation|0|||
127542523|NCT02234843|458952792|FG008|Overall Study|Protocol Violation|0|||
127542524|NCT02234843|458952793|FG009|Overall Study|Protocol Violation|0|||
127983953|NCT01358578|460564182|FG004|Induction Period|Protocol Deviation|0|||
127983954|NCT01358578|460564183|FG005|Induction Period|Protocol Deviation|0|||
127983955|NCT01358578|460564178|FG000|Induction Period|technical problems|0|||
127983956|NCT01358578|460564179|FG001|Induction Period|technical problems|0|||
127983957|NCT01358578|460564180|FG002|Induction Period|technical problems|1|||
127983958|NCT01358578|460564181|FG003|Induction Period|technical problems|1|||
127983959|NCT01358578|460564182|FG004|Induction Period|technical problems|0|||
127983960|NCT01358578|460564183|FG005|Induction Period|technical problems|0|||
127983961|NCT01358578|460564178|FG000|Induction Period|Withdrawal by Subject|5|||
127983962|NCT01358578|460564179|FG001|Induction Period|Withdrawal by Subject|5|||
127983963|NCT01358578|460564180|FG002|Induction Period|Withdrawal by Subject|10|||
127983964|NCT01358578|460564181|FG003|Induction Period|Withdrawal by Subject|6|||
127983965|NCT01358578|460564182|FG004|Induction Period|Withdrawal by Subject|0|||
127983966|NCT01358578|460564183|FG005|Induction Period|Withdrawal by Subject|0|||
127983967|NCT01358578|460564178|FG000|Maintenance Period|Adverse Event|2|||
127983968|NCT01358578|460564179|FG001|Maintenance Period|Adverse Event|7|||
127983969|NCT01358578|460564180|FG002|Maintenance Period|Adverse Event|0|||
127983970|NCT01358578|460564181|FG003|Maintenance Period|Adverse Event|6|||
127983971|NCT01358578|460564182|FG004|Maintenance Period|Adverse Event|4|||
127983972|NCT01358578|460564183|FG005|Maintenance Period|Adverse Event|3|||
127983973|NCT01358578|460564178|FG000|Maintenance Period|Lack of Efficacy|10|||
127983974|NCT01358578|460564179|FG001|Maintenance Period|Lack of Efficacy|2|||
127983975|NCT01358578|460564180|FG002|Maintenance Period|Lack of Efficacy|0|||
127983976|NCT01358578|460564181|FG003|Maintenance Period|Lack of Efficacy|11|||
127983977|NCT01358578|460564182|FG004|Maintenance Period|Lack of Efficacy|3|||
127983978|NCT01358578|460564183|FG005|Maintenance Period|Lack of Efficacy|0|||
127983979|NCT01358578|460564178|FG000|Maintenance Period|Lost to Follow-up|4|||
127983980|NCT01358578|460564179|FG001|Maintenance Period|Lost to Follow-up|0|||
127983981|NCT01358578|460564180|FG002|Maintenance Period|Lost to Follow-up|0|||
127983982|NCT01358578|460564181|FG003|Maintenance Period|Lost to Follow-up|5|||
127983983|NCT01358578|460564182|FG004|Maintenance Period|Lost to Follow-up|1|||
127983984|NCT01358578|460564183|FG005|Maintenance Period|Lost to Follow-up|1|||
127983985|NCT01358578|460564178|FG000|Maintenance Period|Non-compliance with study treatment|3|||
127983986|NCT01358578|460564179|FG001|Maintenance Period|Non-compliance with study treatment|1|||
127983987|NCT01358578|460564180|FG002|Maintenance Period|Non-compliance with study treatment|0|||
127983988|NCT01358578|460564181|FG003|Maintenance Period|Non-compliance with study treatment|2|||
127983989|NCT01358578|460564182|FG004|Maintenance Period|Non-compliance with study treatment|1|||
127983990|NCT01358578|460564183|FG005|Maintenance Period|Non-compliance with study treatment|2|||
127983991|NCT01358578|460564178|FG000|Maintenance Period|Physician Decision|0|||
127983992|NCT01358578|460564179|FG001|Maintenance Period|Physician Decision|1|||
127983993|NCT01358578|460564180|FG002|Maintenance Period|Physician Decision|0|||
127983994|NCT01358578|460564181|FG003|Maintenance Period|Physician Decision|1|||
127983995|NCT01358578|460564182|FG004|Maintenance Period|Physician Decision|0|||
127983996|NCT01358578|460564183|FG005|Maintenance Period|Physician Decision|0|||
127983997|NCT01358578|460564178|FG000|Maintenance Period|Pregnancy|1|||
127983998|NCT01358578|460564179|FG001|Maintenance Period|Pregnancy|0|||
127983999|NCT01358578|460564180|FG002|Maintenance Period|Pregnancy|0|||
127984000|NCT01358578|460564181|FG003|Maintenance Period|Pregnancy|0|||
127984001|NCT01358578|460564182|FG004|Maintenance Period|Pregnancy|0|||
127984002|NCT01358578|460564183|FG005|Maintenance Period|Pregnancy|0|||
127984003|NCT01358578|460564178|FG000|Maintenance Period|Protocol deviation|7|||
127984004|NCT01358578|460564179|FG001|Maintenance Period|Protocol deviation|4|||
127984005|NCT01358578|460564180|FG002|Maintenance Period|Protocol deviation|0|||
127984006|NCT01358578|460564181|FG003|Maintenance Period|Protocol deviation|2|||
127984007|NCT01358578|460564182|FG004|Maintenance Period|Protocol deviation|2|||
127984008|NCT01358578|460564183|FG005|Maintenance Period|Protocol deviation|2|||
127984009|NCT01358578|460564178|FG000|Maintenance Period|Withdrawal by Subject|12|||
127984010|NCT01358578|460564179|FG001|Maintenance Period|Withdrawal by Subject|7|||
127984011|NCT01358578|460564180|FG002|Maintenance Period|Withdrawal by Subject|2|||
127984012|NCT01358578|460564181|FG003|Maintenance Period|Withdrawal by Subject|15|||
127984013|NCT01358578|460564182|FG004|Maintenance Period|Withdrawal by Subject|6|||
127984014|NCT01358578|460564183|FG005|Maintenance Period|Withdrawal by Subject|3|||
127984015|NCT01358578|460564178|FG000|Follow-up Period|Adverse Event|1|||
127984016|NCT01358578|460564179|FG001|Follow-up Period|Adverse Event|1|||
127984017|NCT01358578|460564180|FG002|Follow-up Period|Adverse Event|0|||
127984018|NCT01358578|460564181|FG003|Follow-up Period|Adverse Event|0|||
127984019|NCT01358578|460564182|FG004|Follow-up Period|Adverse Event|0|||
127984020|NCT01358578|460564183|FG005|Follow-up Period|Adverse Event|0|||
127984021|NCT01358578|460564178|FG000|Follow-up Period|Lack of Efficacy|3|||
127984022|NCT01358578|460564179|FG001|Follow-up Period|Lack of Efficacy|0|||
127984023|NCT01358578|460564180|FG002|Follow-up Period|Lack of Efficacy|4|||
127984024|NCT01358578|460564181|FG003|Follow-up Period|Lack of Efficacy|1|||
127984025|NCT01358578|460564182|FG004|Follow-up Period|Lack of Efficacy|0|||
127984026|NCT01358578|460564183|FG005|Follow-up Period|Lack of Efficacy|0|||
127984027|NCT01358578|460564178|FG000|Follow-up Period|Lost to Follow-up|0|||
127984028|NCT01358578|460564179|FG001|Follow-up Period|Lost to Follow-up|1|||
127984029|NCT01358578|460564180|FG002|Follow-up Period|Lost to Follow-up|0|||
127984030|NCT01358578|460564181|FG003|Follow-up Period|Lost to Follow-up|4|||
127984031|NCT01358578|460564182|FG004|Follow-up Period|Lost to Follow-up|0|||
127984032|NCT01358578|460564183|FG005|Follow-up Period|Lost to Follow-up|0|||
127984033|NCT01358578|460564178|FG000|Follow-up Period|non- compliance with study treatment|1|||
127984034|NCT01358578|460564179|FG001|Follow-up Period|non- compliance with study treatment|0|||
127984035|NCT01358578|460564180|FG002|Follow-up Period|non- compliance with study treatment|0|||
127984036|NCT01358578|460564181|FG003|Follow-up Period|non- compliance with study treatment|0|||
127984037|NCT01358578|460564182|FG004|Follow-up Period|non- compliance with study treatment|0|||
127984038|NCT01358578|460564183|FG005|Follow-up Period|non- compliance with study treatment|0|||
127984039|NCT01358578|460564178|FG000|Follow-up Period|Pregnancy|1|||
127984040|NCT01358578|460564179|FG001|Follow-up Period|Pregnancy|0|||
127984041|NCT01358578|460564180|FG002|Follow-up Period|Pregnancy|0|||
127984042|NCT01358578|460564181|FG003|Follow-up Period|Pregnancy|0|||
127984043|NCT01358578|460564182|FG004|Follow-up Period|Pregnancy|0|||
127984044|NCT01358578|460564183|FG005|Follow-up Period|Pregnancy|0|||
127984045|NCT01358578|460564178|FG000|Follow-up Period|Withdrawal by Subject|3|||
127984046|NCT01358578|460564179|FG001|Follow-up Period|Withdrawal by Subject|3|||
127984047|NCT01358578|460564180|FG002|Follow-up Period|Withdrawal by Subject|1|||
127984048|NCT01358578|460564181|FG003|Follow-up Period|Withdrawal by Subject|12|||
127984049|NCT01358578|460564182|FG004|Follow-up Period|Withdrawal by Subject|0|||
127984050|NCT01358578|460564183|FG005|Follow-up Period|Withdrawal by Subject|0|||
127984051|NCT01358578|460564178|FG000|Follow-up Period|Physician Decision|1|||
127984052|NCT01358578|460564179|FG001|Follow-up Period|Physician Decision|1|||
127984053|NCT01358578|460564180|FG002|Follow-up Period|Physician Decision|0|||
127984054|NCT01358578|460564181|FG003|Follow-up Period|Physician Decision|2|||
127984055|NCT01358578|460564182|FG004|Follow-up Period|Physician Decision|0|||
127984056|NCT01358578|460564183|FG005|Follow-up Period|Physician Decision|0|||
127984057|NCT00388297|460564184|FG000|Overall Study|Lost to Follow-up|16|||
127984058|NCT00388297|460564185|FG001|Overall Study|Lost to Follow-up|12|||
127984059|NCT00388297|460564186|FG002|Overall Study|Lost to Follow-up|11|||
127984060|NCT00388297|460564187|FG003|Overall Study|Lost to Follow-up|8|||
127984061|NCT02607280|460564188|FG000|Overall Study|Adverse Event|4|||
127984062|NCT02607280|460564189|FG001|Overall Study|Adverse Event|0|||
127984063|NCT02607280|460564188|FG000|Overall Study|Decrease in CrCl <15|0|||
127984064|NCT02607280|460564189|FG001|Overall Study|Decrease in CrCl <15|1|||
127984065|NCT00577005|460564190|FG000|Overall Study|Lost to Follow-up|3|||
127984066|NCT00577005|460564191|FG001|Overall Study|Lost to Follow-up|2|||
127984067|NCT00577005|460564190|FG000|Overall Study|Withdrawal by Subject|2|||
127984068|NCT00577005|460564191|FG001|Overall Study|Withdrawal by Subject|1|||
127984069|NCT01004432|460564192|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
127984070|NCT01004432|460564193|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
127984071|NCT01004432|460564194|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
127984072|NCT01004432|460564195|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
127984073|NCT01004432|460564196|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
127984074|NCT01004432|460564192|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
127984075|NCT01004432|460564193|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
127984076|NCT01004432|460564194|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
127984077|NCT01004432|460564195|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
127984078|NCT01004432|460564196|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
127984079|NCT01004432|460564192|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
127984080|NCT01004432|460564193|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
127984081|NCT01004432|460564194|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
127984082|NCT01004432|460564195|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
127984083|NCT01004432|460564196|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
127984084|NCT01004432|460564192|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
127984085|NCT01004432|460564193|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
127984086|NCT01004432|460564194|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
127984087|NCT01004432|460564195|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
127984088|NCT01004432|460564196|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
127984089|NCT01004432|460564192|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
127984090|NCT01004432|460564193|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
127984091|NCT01004432|460564194|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
127984092|NCT01004432|460564195|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
127984093|NCT01004432|460564196|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
127984094|NCT01004432|460564192|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
127984095|NCT01004432|460564193|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
127984096|NCT01004432|460564194|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
127984097|NCT01004432|460564195|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
127984098|NCT01004432|460564196|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
127984099|NCT01004432|460564192|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
127984100|NCT01004432|460564193|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
127542525|NCT02234843|458952784|FG000|Overall Study|Efficacy outcome reached|2|||
127542526|NCT02234843|458952785|FG001|Overall Study|Efficacy outcome reached|0|||
127542527|NCT02234843|458952786|FG002|Overall Study|Efficacy outcome reached|0|||
127542528|NCT02234843|458952787|FG003|Overall Study|Efficacy outcome reached|0|||
127984101|NCT01004432|460564194|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
127984102|NCT01004432|460564195|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
127984103|NCT01004432|460564196|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
127984104|NCT01004432|460564192|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
127984105|NCT01004432|460564193|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
127984106|NCT01004432|460564194|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
127984107|NCT01004432|460564195|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
127984108|NCT01004432|460564196|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
127984109|NCT01004432|460564192|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
127984110|NCT01004432|460564193|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
127984111|NCT01004432|460564194|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
127984112|NCT01004432|460564195|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
127984113|NCT01004432|460564196|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
127984114|NCT01004432|460564192|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
127984115|NCT01004432|460564193|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
127984116|NCT01004432|460564194|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
127984117|NCT01004432|460564195|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
127984118|NCT01004432|460564196|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
127984119|NCT01004432|460564192|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
127984120|NCT01004432|460564193|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
127984121|NCT01004432|460564194|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
127984122|NCT01004432|460564195|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
127984123|NCT01004432|460564196|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
127984124|NCT01004432|460564192|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
127984125|NCT01004432|460564193|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
127984126|NCT01004432|460564194|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
127984127|NCT01004432|460564195|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
127984128|NCT01004432|460564196|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
127984129|NCT01004432|460564192|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
127984130|NCT01004432|460564193|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
127984131|NCT01004432|460564194|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
127984132|NCT01004432|460564195|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
127984133|NCT01004432|460564196|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
127984134|NCT01004432|460564192|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
127984135|NCT01004432|460564193|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
127984136|NCT01004432|460564194|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
127984137|NCT01004432|460564195|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
127984138|NCT01004432|460564196|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
127984139|NCT01004432|460564192|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
127984140|NCT01004432|460564193|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
127984141|NCT01004432|460564194|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
127984142|NCT01004432|460564195|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
127984143|NCT01004432|460564196|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
127984144|NCT02667626|460564197|FG000|Overall Study|Withdrawal by Subject|0|||
127984145|NCT02667626|460564198|FG001|Overall Study|Withdrawal by Subject|1|||
127984146|NCT02696434|460564200|FG000|Overall Study|Adverse Event|3|||
127984147|NCT02696434|460564201|FG001|Overall Study|Adverse Event|1|||
127984148|NCT02696434|460564200|FG000|Overall Study|Lost to Follow-up|5|||
127984149|NCT02696434|460564201|FG001|Overall Study|Lost to Follow-up|4|||
127984150|NCT02696434|460564200|FG000|Overall Study|Withdrawal by Subject|14|||
127984151|NCT02696434|460564201|FG001|Overall Study|Withdrawal by Subject|12|||
127984152|NCT02696434|460564200|FG000|Overall Study|Physician Decision|0|||
127984153|NCT02696434|460564201|FG001|Overall Study|Physician Decision|1|||
127984154|NCT02539134|460564202|FG000|Overall Study|Lost to Follow-up|1|||
127984155|NCT02539134|460564203|FG001|Overall Study|Lost to Follow-up|0|||
127984156|NCT02539134|460564204|FG002|Overall Study|Lost to Follow-up|0|||
127984157|NCT02539134|460564205|FG003|Overall Study|Lost to Follow-up|0|||
127984158|NCT02539134|460564206|FG004|Overall Study|Lost to Follow-up|0|||
127984159|NCT02539134|460564207|FG005|Overall Study|Lost to Follow-up|0|||
127984160|NCT02971800|460564210|FG000|Overall Study|Protocol Violation|1|||
127984161|NCT02971800|460564210|FG000|Overall Study|Withdrawal by Subject|1|||
127984162|NCT02971800|460564210|FG000|Overall Study|Exclusion criteria prior intervention|1|||
127984163|NCT02971800|460564210|FG000|Overall Study|Number evaluable participant already reached|4|||
127984164|NCT05323994|460564211|FG000|Overall Study|Protocol Violation|1|||
127984165|NCT02223819|460564214|FG000|Overall Study|Lost to Follow-up|2|||
127984166|NCT00367484|460564222|FG000|Overall Study|Adverse Event|7|||
127984167|NCT00367484|460564222|FG000|Overall Study|Withdrew informed consent|5|||
127984168|NCT00367484|460564222|FG000|Overall Study|Travel to USA|1|||
127984169|NCT00367484|460564222|FG000|Overall Study|Lost to Follow-up|1|||
127984170|NCT00367484|460564222|FG000|Overall Study|Protocol Violation|1|||
127653129|NCT01859793|459352286|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
127653130|NCT01735396|459352289|FG000|Overall Study|not evaluable|1|||
127653131|NCT02002182|459352290|FG000|Overall Study|Withdraw from study|3|||
127653132|NCT02002182|459352291|FG001|Overall Study|Withdraw from study|1|||
127984171|NCT00367484|460564222|FG000|Overall Study|The choice of the patient|1|||
127984172|NCT00367484|460564222|FG000|Overall Study|Lack of Efficacy|1|||
127984173|NCT01420679|460564223|FG000|Overall Study|Disease Progression|3|||
127984174|NCT01420679|460564224|FG001|Overall Study|Disease Progression|2|||
127653133|NCT02002182|459352290|FG000|Overall Study|Health Reasons|1|||
127653134|NCT02002182|459352291|FG001|Overall Study|Health Reasons|0|||
127653135|NCT02002182|459352290|FG000|Overall Study|Death|1|||
127653136|NCT02002182|459352291|FG001|Overall Study|Death|0|||
127653137|NCT01597505|459352295|FG000|Overall Study|Physician Decision|5|||
127653138|NCT01597505|459352296|FG001|Overall Study|Physician Decision|0|||
127653139|NCT01597505|459352295|FG000|Overall Study|Adverse Event|19|||
127653140|NCT01597505|459352296|FG001|Overall Study|Adverse Event|7|||
127653141|NCT01597505|459352295|FG000|Overall Study|Lost to Follow-up|4|||
127653142|NCT01597505|459352296|FG001|Overall Study|Lost to Follow-up|2|||
127653143|NCT01597505|459352295|FG000|Overall Study|Withdrawal by Subject|10|||
127653144|NCT01597505|459352296|FG001|Overall Study|Withdrawal by Subject|18|||
127653145|NCT01597505|459352295|FG000|Overall Study|Other|5|||
127653146|NCT01597505|459352296|FG001|Overall Study|Other|6|||
127653147|NCT01597505|459352295|FG000|Overall Study|Missing|1|||
127653148|NCT01597505|459352296|FG001|Overall Study|Missing|0|||
127653149|NCT05454410|459352297|FG000|Overall Study|Withdrawal by Subject|0|||
127653150|NCT05454410|459352298|FG001|Overall Study|Withdrawal by Subject|0|||
127984175|NCT01420679|460564223|FG000|Overall Study|Adverse Event|4|||
127984176|NCT01420679|460564224|FG001|Overall Study|Adverse Event|0|||
127984177|NCT01420679|460564223|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
127984178|NCT01420679|460564224|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
127984179|NCT01420679|460564223|FG000|Overall Study|Patient Decision|1|||
127984180|NCT01420679|460564224|FG001|Overall Study|Patient Decision|0|||
127984181|NCT01420679|460564223|FG000|Overall Study|Investigator Decision|1|||
127984182|NCT01420679|460564224|FG001|Overall Study|Investigator Decision|2|||
127984183|NCT01420679|460564223|FG000|Overall Study|Sponsor Decision|3|||
127984184|NCT01420679|460564224|FG001|Overall Study|Sponsor Decision|3|||
127653151|NCT05454410|459352299|FG002|Overall Study|Withdrawal by Subject|1|||
127653152|NCT05454410|459352300|FG003|Overall Study|Withdrawal by Subject|1|||
127653153|NCT05004688|459352311|FG000|Overall Study|Protocol Violation|7|||
127653154|NCT05004688|459352311|FG000|Overall Study|Physician Decision|2|||
127653155|NCT05004688|459352311|FG000|Overall Study|Withdrawal by Subject|2|||
127653156|NCT03879408|459352312|FG000|Overall Study|Lost to Follow-up|0|||
127653157|NCT03879408|459352313|FG001|Overall Study|Lost to Follow-up|3|||
127984185|NCT01420679|460564223|FG000|Overall Study|Other|1|||
127984186|NCT01420679|460564224|FG001|Overall Study|Other|0|||
127984187|NCT00943670|460564225|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
127984188|NCT00943670|460564225|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
127984189|NCT00943670|460564225|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
127984190|NCT00943670|460564225|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
127984191|NCT00943670|460564225|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
127984192|NCT00943670|460564225|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
127984193|NCT00943670|460564225|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
127984194|NCT00943670|460564225|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
127984195|NCT00943670|460564225|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
127984196|NCT00943670|460564225|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
127984197|NCT03956615|460564226|FG000|Overall Study|No multiple myeloma confirmed|2|||
127984198|NCT03956615|460564226|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
127984199|NCT03956615|460564226|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
127984200|NCT03956615|460564226|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
127984201|NCT04472026|460564227|FG000|Overall Study|Lost to Follow-up|5|||
127984202|NCT04526574|460564232|FG000|Overall Study|Protocol Violation|3|||
127984203|NCT04526574|460564233|FG001|Overall Study|Protocol Violation|1|||
127984204|NCT04526574|460564232|FG000|Overall Study|Withdrawal by Subject|12|||
127984205|NCT04526574|460564233|FG001|Overall Study|Withdrawal by Subject|9|||
127984206|NCT04526574|460564232|FG000|Overall Study|Other|1|||
127984207|NCT04526574|460564233|FG001|Overall Study|Other|2|||
127984208|NCT04526574|460564232|FG000|Overall Study|Adverse Event|1|||
127984209|NCT04526574|460564233|FG001|Overall Study|Adverse Event|1|||
127984210|NCT04526574|460564232|FG000|Overall Study|Death|2|||
127984211|NCT04526574|460564233|FG001|Overall Study|Death|3|||
127984212|NCT04526574|460564232|FG000|Overall Study|Lost to Follow-up|9|||
127984213|NCT04526574|460564233|FG001|Overall Study|Lost to Follow-up|9|||
127984214|NCT04526574|460564232|FG000|Overall Study|No longer meets eligibility criteria|8|||
127984215|NCT04526574|460564233|FG001|Overall Study|No longer meets eligibility criteria|8|||
127653158|NCT03879408|459352314|FG002|Overall Study|Lost to Follow-up|2|||
127653159|NCT03879408|459352315|FG003|Overall Study|Lost to Follow-up|1|||
127984216|NCT00424021|460564236|FG000|NCT00046319 Study Period|Adverse Event|1|||
127984217|NCT00424021|460564237|FG001|NCT00046319 Study Period|Adverse Event|0|||
127984218|NCT00424021|460564238|FG002|NCT00046319 Study Period|Adverse Event|1|||
127984219|NCT00424021|460564239|FG003|NCT00046319 Study Period|Adverse Event|1|||
127984220|NCT00424021|460564236|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
127984221|NCT00424021|460564237|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
127984222|NCT00424021|460564238|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
127984223|NCT00424021|460564239|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
127984224|NCT00424021|460564236|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
127984225|NCT00424021|460564237|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
127984226|NCT00424021|460564238|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
127984227|NCT00424021|460564239|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
127984228|NCT00424021|460564236|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
127984229|NCT00424021|460564237|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
127984230|NCT00424021|460564238|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
127984231|NCT00424021|460564239|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
127984232|NCT00424021|460564236|FG000|AMB-220-E Study Period|Adverse Event|1|||
127984233|NCT00424021|460564237|FG001|AMB-220-E Study Period|Adverse Event|1|||
127984234|NCT00424021|460564238|FG002|AMB-220-E Study Period|Adverse Event|3|||
127984235|NCT00424021|460564239|FG003|AMB-220-E Study Period|Adverse Event|7|||
127984236|NCT00424021|460564236|FG000|AMB-220-E Study Period|Death|0|||
127984237|NCT00424021|460564237|FG001|AMB-220-E Study Period|Death|0|||
127984238|NCT00424021|460564238|FG002|AMB-220-E Study Period|Death|1|||
127984239|NCT00424021|460564239|FG003|AMB-220-E Study Period|Death|1|||
127984240|NCT00424021|460564236|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
127984241|NCT00424021|460564237|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
127984242|NCT00424021|460564238|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
127984243|NCT00424021|460564239|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
127984244|NCT00424021|460564236|FG000|AMB-220-E Study Period|Physician Decision|0|||
127984245|NCT00424021|460564237|FG001|AMB-220-E Study Period|Physician Decision|0|||
127984246|NCT00424021|460564238|FG002|AMB-220-E Study Period|Physician Decision|0|||
127984247|NCT00424021|460564239|FG003|AMB-220-E Study Period|Physician Decision|1|||
127984248|NCT03597022|460564240|FG000|Overall Study|Premature termination of the study|7|||
127984249|NCT03597022|460564241|FG001|Overall Study|Premature termination of the study|7|||
127984250|NCT03597022|460564242|FG002|Overall Study|Premature termination of the study|8|||
127984251|NCT03597022|460564240|FG000|Overall Study|Serious adverse event|1|||
127984252|NCT03597022|460564241|FG001|Overall Study|Serious adverse event|1|||
127984253|NCT03597022|460564242|FG002|Overall Study|Serious adverse event|0|||
127984254|NCT01534208|460564243|FG000|Overall Study|Lost to Follow-up|19|||
127984255|NCT01534208|460564244|FG001|Overall Study|Lost to Follow-up|14|||
127984256|NCT01534208|460564243|FG000|Overall Study|Withdrawal by Subject|6|||
127984257|NCT01534208|460564244|FG001|Overall Study|Withdrawal by Subject|20|||
127984258|NCT01534208|460564243|FG000|Overall Study|Adverse Event|15|||
127984259|NCT01534208|460564244|FG001|Overall Study|Adverse Event|8|||
127984260|NCT01534208|460564243|FG000|Overall Study|Physician Decision|2|||
127984261|NCT01534208|460564244|FG001|Overall Study|Physician Decision|0|||
127984262|NCT01534208|460564243|FG000|Overall Study|Lack of Efficacy|0|||
127984263|NCT01534208|460564244|FG001|Overall Study|Lack of Efficacy|3|||
127984264|NCT01534208|460564243|FG000|Overall Study|Protocol Violation|2|||
127984265|NCT01534208|460564244|FG001|Overall Study|Protocol Violation|2|||
127984266|NCT01534208|460564243|FG000|Overall Study|Sponsor decision|4|||
127984267|NCT01534208|460564244|FG001|Overall Study|Sponsor decision|1|||
127984268|NCT01534208|460564243|FG000|Overall Study|Subject relocation|2|||
127984269|NCT01534208|460564244|FG001|Overall Study|Subject relocation|0|||
127984270|NCT01534208|460564243|FG000|Overall Study|Lab assessment|2|||
127984271|NCT01534208|460564244|FG001|Overall Study|Lab assessment|1|||
127984272|NCT01534208|460564243|FG000|Overall Study|Eligibility error|3|||
127984273|NCT01534208|460564244|FG001|Overall Study|Eligibility error|0|||
127984274|NCT01534208|460564243|FG000|Overall Study|PCP decision|1|||
127984275|NCT01534208|460564244|FG001|Overall Study|PCP decision|0|||
127984276|NCT01534208|460564243|FG000|Overall Study|Needed prohibited meds|1|||
127984277|NCT01534208|460564244|FG001|Overall Study|Needed prohibited meds|0|||
127984278|NCT01904903|460564245|FG000|Overall Study|Withdrawal by Subject|1|||
127984279|NCT00045734|460564246|FG000|Overall Study|Protocol Violation|1|||
127984280|NCT03482167|460564247|FG000|Allocated to Intervention|Physician Decision|1|||
127984281|NCT03482167|460564248|FG001|Allocated to Intervention|Physician Decision|2|||
127984282|NCT03482167|460564247|FG000|Received Intervention|Adverse Event|3|||
127984283|NCT03482167|460564248|FG001|Received Intervention|Adverse Event|1|||
127984284|NCT03482167|460564247|FG000|Received Intervention|Physician Decision|1|||
127984285|NCT03482167|460564248|FG001|Received Intervention|Physician Decision|1|||
127984286|NCT03482167|460564247|FG000|Received Intervention|Withdrawal by Subject|1|||
127984287|NCT03482167|460564248|FG001|Received Intervention|Withdrawal by Subject|0|||
127984288|NCT01001598|460564250|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
127984289|NCT01001598|460564250|FG000|Overall Study|Adverse Event|1|||
127984290|NCT05079230|460564265|FG000|Overall Study|Study Terminated by Sponsor|101|||
127984291|NCT05079230|460564266|FG001|Overall Study|Study Terminated by Sponsor|102|||
127984292|NCT05079230|460564265|FG000|Overall Study|Death|72|||
127984293|NCT05079230|460564266|FG001|Overall Study|Death|66|||
127984294|NCT05079230|460564265|FG000|Overall Study|Withdrew Consent|16|||
127984295|NCT05079230|460564266|FG001|Overall Study|Withdrew Consent|18|||
127984296|NCT05079230|460564265|FG000|Overall Study|Lost to Follow-up|0|||
127984297|NCT05079230|460564266|FG001|Overall Study|Lost to Follow-up|3|||
127984298|NCT01524783|460564267|FG000|Blinded Period|Adverse Event|64|||
127984299|NCT01524783|460564268|FG001|Blinded Period|Adverse Event|7|||
127984300|NCT01524783|460564269|FG002|Blinded Period|Adverse Event|0|||
127984301|NCT01524783|460564267|FG000|Blinded Period|Disease Progression|89|||
127984302|NCT01524783|460564268|FG001|Blinded Period|Disease Progression|75|||
127984303|NCT01524783|460564269|FG002|Blinded Period|Disease Progression|0|||
127984304|NCT01524783|460564267|FG000|Blinded Period|Withdrawal by Subject|19|||
127984305|NCT01524783|460564268|FG001|Blinded Period|Withdrawal by Subject|6|||
127984306|NCT01524783|460564269|FG002|Blinded Period|Withdrawal by Subject|0|||
127984307|NCT01524783|460564267|FG000|Blinded Period|Protocol deviation|2|||
127984308|NCT01524783|460564268|FG001|Blinded Period|Protocol deviation|1|||
127984309|NCT01524783|460564269|FG002|Blinded Period|Protocol deviation|0|||
127984310|NCT01524783|460564267|FG000|Blinded Period|Death|5|||
127984311|NCT01524783|460564268|FG001|Blinded Period|Death|2|||
127984312|NCT01524783|460564269|FG002|Blinded Period|Death|0|||
127984313|NCT01524783|460564267|FG000|Open-label Period|Disease progression|13|||
127984314|NCT01524783|460564268|FG001|Open-label Period|Disease progression|0|||
127984315|NCT01524783|460564269|FG002|Open-label Period|Disease progression|2|||
127984316|NCT01524783|460564267|FG000|Open-label Period|Administrative problems|5|||
127984317|NCT01524783|460564268|FG001|Open-label Period|Administrative problems|0|||
127984318|NCT01524783|460564269|FG002|Open-label Period|Administrative problems|2|||
127984319|NCT01524783|460564267|FG000|Open-label Period|Adverse Event|5|||
127984320|NCT01524783|460564268|FG001|Open-label Period|Adverse Event|0|||
127984321|NCT01524783|460564269|FG002|Open-label Period|Adverse Event|1|||
127984322|NCT01524783|460564267|FG000|Open-label Period|Withdrawal by Subject|2|||
127984323|NCT01524783|460564268|FG001|Open-label Period|Withdrawal by Subject|0|||
127984324|NCT01524783|460564269|FG002|Open-label Period|Withdrawal by Subject|1|||
127984325|NCT01524783|460564267|FG000|Open-label Period|Protocol deviation|1|||
127984326|NCT01524783|460564268|FG001|Open-label Period|Protocol deviation|0|||
127984327|NCT01524783|460564269|FG002|Open-label Period|Protocol deviation|0|||
127984328|NCT02920177|460564271|FG000|Overall Study|Withdrawal by Subject|1|||
127984329|NCT02920177|460564272|FG001|Overall Study|Withdrawal by Subject|1|||
127984330|NCT02920177|460564271|FG000|Overall Study|Physician Decision|1|||
127984331|NCT02920177|460564272|FG001|Overall Study|Physician Decision|0|||
127984332|NCT02920177|460564271|FG000|Overall Study|Lost to Follow-up|0|||
127984333|NCT02920177|460564272|FG001|Overall Study|Lost to Follow-up|1|||
127984334|NCT02054910|460564273|FG000|Overall Study|Lost to Follow-up|4|||
127984335|NCT02054910|460564274|FG001|Overall Study|Lost to Follow-up|1|||
127984336|NCT01096589|460564276|FG000|Overall Study|Adverse Event|2|||
127653160|NCT03879408|459352316|FG004|Overall Study|Lost to Follow-up|0|||
127653161|NCT03879408|459352312|FG000|Overall Study|Withdrawal by Subject|2|||
127653162|NCT03879408|459352313|FG001|Overall Study|Withdrawal by Subject|1|||
127653163|NCT03879408|459352314|FG002|Overall Study|Withdrawal by Subject|1|||
127984337|NCT01096589|460564277|FG001|Overall Study|Adverse Event|1|||
127984338|NCT01096589|460564278|FG002|Overall Study|Adverse Event|2|||
127984339|NCT01096589|460564279|FG003|Overall Study|Adverse Event|1|||
127542529|NCT02234843|458952788|FG004|Overall Study|Efficacy outcome reached|0|||
127542530|NCT02234843|458952789|FG005|Overall Study|Efficacy outcome reached|2|||
127542531|NCT02234843|458952790|FG006|Overall Study|Efficacy outcome reached|0|||
127542532|NCT02234843|458952791|FG007|Overall Study|Efficacy outcome reached|0|||
127542533|NCT02234843|458952792|FG008|Overall Study|Efficacy outcome reached|0|||
127542534|NCT02234843|458952793|FG009|Overall Study|Efficacy outcome reached|0|||
127542535|NCT02234843|458952784|FG000|Overall Study|Patient convenience|2|||
127542536|NCT02234843|458952785|FG001|Overall Study|Patient convenience|0|||
127542537|NCT02234843|458952786|FG002|Overall Study|Patient convenience|0|||
127542538|NCT02234843|458952787|FG003|Overall Study|Patient convenience|0|||
127542539|NCT02234843|458952788|FG004|Overall Study|Patient convenience|0|||
127542540|NCT02234843|458952789|FG005|Overall Study|Patient convenience|1|||
127542541|NCT02234843|458952790|FG006|Overall Study|Patient convenience|0|||
127542542|NCT02234843|458952791|FG007|Overall Study|Patient convenience|0|||
127984340|NCT01096589|460564276|FG000|Overall Study|Withdrawal by Subject|2|||
127984341|NCT01096589|460564277|FG001|Overall Study|Withdrawal by Subject|1|||
127984342|NCT01096589|460564278|FG002|Overall Study|Withdrawal by Subject|1|||
127984343|NCT01096589|460564279|FG003|Overall Study|Withdrawal by Subject|1|||
127984344|NCT01096589|460564276|FG000|Overall Study|Compliance with protocol|0|||
127542543|NCT02234843|458952792|FG008|Overall Study|Patient convenience|0|||
127542544|NCT02234843|458952793|FG009|Overall Study|Patient convenience|0|||
127542545|NCT02234843|458952784|FG000|Overall Study|Withdrawal by Subject|5|||
127984345|NCT01096589|460564277|FG001|Overall Study|Compliance with protocol|0|||
127984346|NCT01096589|460564278|FG002|Overall Study|Compliance with protocol|1|||
127984347|NCT01096589|460564279|FG003|Overall Study|Compliance with protocol|0|||
127984348|NCT01096589|460564276|FG000|Overall Study|found treatment exhausting|0|||
127653164|NCT03879408|459352315|FG003|Overall Study|Withdrawal by Subject|0|||
127653165|NCT03879408|459352316|FG004|Overall Study|Withdrawal by Subject|1|||
127653166|NCT00728962|459352320|FG000|Implant Placement Surgery|Adverse Event|8|||
127653167|NCT00728962|459352320|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
127653168|NCT00728962|459352320|FG000|Implant Placement Surgery|Protocol Violation|1|||
127653169|NCT00728962|459352320|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
127653170|NCT00728962|459352320|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
127653171|NCT05807919|459352321|FG000|Overall Study|Received antibiotics - excluded|0|||
127653172|NCT05807919|459352322|FG001|Overall Study|Received antibiotics - excluded|1|||
127653173|NCT05807919|459352321|FG000|Overall Study|Withdrawal by Subject|0|||
127653174|NCT05807919|459352322|FG001|Overall Study|Withdrawal by Subject|3|||
127653175|NCT05807919|459352321|FG000|Overall Study|Adverse Event|1|||
127653176|NCT05807919|459352322|FG001|Overall Study|Adverse Event|1|||
127653177|NCT02487472|459352323|FG000|Overall Study|Did not complete telephonic interviews|9|||
127653178|NCT02487472|459352323|FG000|Overall Study|Other|2|||
127653179|NCT01931735|459352326|FG000|Randomized Phase|Lost to Follow-up|2|||
127653180|NCT01931735|459352327|FG001|Randomized Phase|Lost to Follow-up|2|||
127653181|NCT01931735|459352328|FG002|Randomized Phase|Lost to Follow-up|5|||
127653182|NCT01931735|459352329|FG003|Randomized Phase|Lost to Follow-up|0|||
127653183|NCT01931735|459352326|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
127653184|NCT01931735|459352327|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
127653185|NCT01931735|459352328|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
127653186|NCT01931735|459352329|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
127653187|NCT01931735|459352326|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
127653188|NCT01931735|459352327|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
127653189|NCT01931735|459352328|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
127653190|NCT01931735|459352329|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
127653191|NCT02552238|459352332|FG000|Overall Study|Withdrawal by Subject|2|||
127653192|NCT02552238|459352332|FG000|Overall Study|Adverse Event|2|||
127653193|NCT05158296|459352335|FG000|Overall Study|Sponsor Decision|2|||
127653194|NCT05158296|459352336|FG001|Overall Study|Sponsor Decision|3|||
127653195|NCT05158296|459352337|FG002|Overall Study|Sponsor Decision|2|||
127653196|NCT02036645|459352340|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
127653197|NCT02036645|459352341|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
127653198|NCT02036645|459352342|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
127653199|NCT02036645|459352343|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
127653200|NCT02036645|459352344|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
127653201|NCT02036645|459352345|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
127653202|NCT02036645|459352346|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
127653203|NCT02036645|459352347|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
127653204|NCT02036645|459352348|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
127653205|NCT02036645|459352349|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
127653206|NCT02036645|459352350|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
127653207|NCT02036645|459352351|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
127653208|NCT02036645|459352340|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
127653209|NCT02036645|459352341|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
127653210|NCT02036645|459352342|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
127653211|NCT02036645|459352343|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
127653212|NCT02036645|459352344|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
127653213|NCT02036645|459352345|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
127653214|NCT02036645|459352346|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
127653215|NCT02036645|459352347|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
127653216|NCT02036645|459352348|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
127653217|NCT02036645|459352349|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
127984349|NCT01096589|460564277|FG001|Overall Study|found treatment exhausting|0|||
127984350|NCT01096589|460564278|FG002|Overall Study|found treatment exhausting|0|||
127653218|NCT02036645|459352350|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
127653219|NCT02036645|459352351|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
127653220|NCT02404389|459352355|FG000|Overall Study|Adverse Event|1|||
127653221|NCT02404389|459352356|FG001|Overall Study|Adverse Event|0|||
127653222|NCT02404389|459352357|FG002|Overall Study|Adverse Event|1|||
127653223|NCT02404389|459352358|FG003|Overall Study|Adverse Event|0|||
127984351|NCT01096589|460564279|FG003|Overall Study|found treatment exhausting|1|||
127984352|NCT03673345|460564282|FG000|Overall Study|Lost to Follow-up|1|||
127984353|NCT03673345|460564283|FG001|Overall Study|Lost to Follow-up|0|||
127984354|NCT03673345|460564284|FG002|Overall Study|Lost to Follow-up|3|||
127984355|NCT03673345|460564285|FG003|Overall Study|Lost to Follow-up|3|||
127984356|NCT03673345|460564286|FG004|Overall Study|Lost to Follow-up|2|||
127984357|NCT03673345|460564287|FG005|Overall Study|Lost to Follow-up|1|||
127984358|NCT03673345|460564288|FG006|Overall Study|Lost to Follow-up|0|||
127984359|NCT03673345|460564289|FG007|Overall Study|Lost to Follow-up|0|||
127984360|NCT03673345|460564282|FG000|Overall Study|Withdrawal by Subject|1|||
127984361|NCT03673345|460564283|FG001|Overall Study|Withdrawal by Subject|0|||
127984362|NCT03673345|460564284|FG002|Overall Study|Withdrawal by Subject|4|||
127984363|NCT03673345|460564285|FG003|Overall Study|Withdrawal by Subject|2|||
127984364|NCT03673345|460564286|FG004|Overall Study|Withdrawal by Subject|0|||
127984365|NCT03673345|460564287|FG005|Overall Study|Withdrawal by Subject|0|||
127984366|NCT03673345|460564288|FG006|Overall Study|Withdrawal by Subject|0|||
127984367|NCT03673345|460564289|FG007|Overall Study|Withdrawal by Subject|0|||
127984368|NCT03673345|460564282|FG000|Overall Study|Physician Decision|0|||
127984369|NCT03673345|460564283|FG001|Overall Study|Physician Decision|0|||
127984370|NCT03673345|460564284|FG002|Overall Study|Physician Decision|2|||
127984371|NCT03673345|460564285|FG003|Overall Study|Physician Decision|0|||
127984372|NCT03673345|460564286|FG004|Overall Study|Physician Decision|0|||
127984373|NCT03673345|460564287|FG005|Overall Study|Physician Decision|0|||
127984374|NCT03673345|460564288|FG006|Overall Study|Physician Decision|0|||
127984375|NCT03673345|460564289|FG007|Overall Study|Physician Decision|0|||
127984376|NCT01362244|460564290|FG000|Overall Study|Adverse Event|3|||
127984377|NCT01362244|460564291|FG001|Overall Study|Adverse Event|5|||
127984378|NCT01362244|460564290|FG000|Overall Study|Lack of Efficacy|5|||
127984379|NCT01362244|460564291|FG001|Overall Study|Lack of Efficacy|11|||
127984380|NCT01362244|460564290|FG000|Overall Study|Lost to Follow-up|0|||
127984381|NCT01362244|460564291|FG001|Overall Study|Lost to Follow-up|2|||
127542546|NCT02234843|458952785|FG001|Overall Study|Withdrawal by Subject|1|||
127542547|NCT02234843|458952786|FG002|Overall Study|Withdrawal by Subject|1|||
127542548|NCT02234843|458952787|FG003|Overall Study|Withdrawal by Subject|0|||
127542549|NCT02234843|458952788|FG004|Overall Study|Withdrawal by Subject|0|||
127542550|NCT02234843|458952789|FG005|Overall Study|Withdrawal by Subject|7|||
127542551|NCT02234843|458952790|FG006|Overall Study|Withdrawal by Subject|0|||
127542552|NCT02234843|458952791|FG007|Overall Study|Withdrawal by Subject|0|||
127542553|NCT02234843|458952792|FG008|Overall Study|Withdrawal by Subject|0|||
127542554|NCT02234843|458952793|FG009|Overall Study|Withdrawal by Subject|0|||
127542555|NCT02234843|458952784|FG000|Overall Study|Recovery|1|||
127542556|NCT02234843|458952785|FG001|Overall Study|Recovery|0|||
127542557|NCT02234843|458952786|FG002|Overall Study|Recovery|0|||
127542558|NCT02234843|458952787|FG003|Overall Study|Recovery|0|||
127542559|NCT02234843|458952788|FG004|Overall Study|Recovery|0|||
127542560|NCT02234843|458952789|FG005|Overall Study|Recovery|0|||
127542561|NCT02234843|458952790|FG006|Overall Study|Recovery|0|||
127542562|NCT02234843|458952791|FG007|Overall Study|Recovery|0|||
127542563|NCT02234843|458952792|FG008|Overall Study|Recovery|0|||
127542564|NCT02234843|458952793|FG009|Overall Study|Recovery|0|||
127542565|NCT02234843|458952784|FG000|Overall Study|Other|0|||
127542566|NCT02234843|458952785|FG001|Overall Study|Other|2|||
127542567|NCT02234843|458952786|FG002|Overall Study|Other|0|||
127542568|NCT02234843|458952787|FG003|Overall Study|Other|1|||
127542569|NCT02234843|458952788|FG004|Overall Study|Other|0|||
127542570|NCT02234843|458952789|FG005|Overall Study|Other|1|||
127542571|NCT02234843|458952790|FG006|Overall Study|Other|0|||
127542572|NCT02234843|458952791|FG007|Overall Study|Other|1|||
127542573|NCT02234843|458952792|FG008|Overall Study|Other|0|||
127542574|NCT02234843|458952793|FG009|Overall Study|Other|0|||
127542575|NCT02234843|458952784|FG000|Overall Study|Physician Decision|4|||
127542576|NCT02234843|458952785|FG001|Overall Study|Physician Decision|1|||
127542577|NCT02234843|458952786|FG002|Overall Study|Physician Decision|0|||
127542578|NCT02234843|458952787|FG003|Overall Study|Physician Decision|1|||
127542579|NCT02234843|458952788|FG004|Overall Study|Physician Decision|0|||
127542580|NCT02234843|458952789|FG005|Overall Study|Physician Decision|0|||
127542581|NCT02234843|458952790|FG006|Overall Study|Physician Decision|0|||
127542582|NCT02234843|458952791|FG007|Overall Study|Physician Decision|1|||
127542583|NCT02234843|458952792|FG008|Overall Study|Physician Decision|0|||
127542584|NCT02234843|458952793|FG009|Overall Study|Physician Decision|0|||
127542585|NCT02234843|458952784|FG000|Overall Study|Adverse Event|5|||
127542586|NCT02234843|458952785|FG001|Overall Study|Adverse Event|1|||
127542587|NCT02234843|458952786|FG002|Overall Study|Adverse Event|1|||
127542588|NCT02234843|458952787|FG003|Overall Study|Adverse Event|3|||
127542589|NCT02234843|458952788|FG004|Overall Study|Adverse Event|2|||
127542590|NCT02234843|458952789|FG005|Overall Study|Adverse Event|1|||
127542591|NCT02234843|458952790|FG006|Overall Study|Adverse Event|0|||
127542592|NCT02234843|458952791|FG007|Overall Study|Adverse Event|0|||
127542593|NCT02234843|458952792|FG008|Overall Study|Adverse Event|1|||
127542594|NCT02234843|458952793|FG009|Overall Study|Adverse Event|0|||
127542595|NCT02234843|458952784|FG000|Overall Study|Non-compliance with study drug|1|||
127542596|NCT02234843|458952785|FG001|Overall Study|Non-compliance with study drug|0|||
127542597|NCT02234843|458952786|FG002|Overall Study|Non-compliance with study drug|0|||
127542598|NCT02234843|458952787|FG003|Overall Study|Non-compliance with study drug|0|||
127542599|NCT02234843|458952788|FG004|Overall Study|Non-compliance with study drug|0|||
127542600|NCT02234843|458952789|FG005|Overall Study|Non-compliance with study drug|1|||
127542601|NCT02234843|458952790|FG006|Overall Study|Non-compliance with study drug|1|||
127542602|NCT02234843|458952791|FG007|Overall Study|Non-compliance with study drug|0|||
127542603|NCT02234843|458952792|FG008|Overall Study|Non-compliance with study drug|0|||
127542604|NCT02234843|458952793|FG009|Overall Study|Non-compliance with study drug|0|||
127542605|NCT02234843|458952784|FG000|Overall Study|Lost to Follow-up|0|||
127984382|NCT01362244|460564290|FG000|Overall Study|Protocol Violation|5|||
127984383|NCT01362244|460564291|FG001|Overall Study|Protocol Violation|1|||
127984384|NCT01362244|460564290|FG000|Overall Study|Withdrawal by Subject|2|||
127984385|NCT01362244|460564291|FG001|Overall Study|Withdrawal by Subject|1|||
127984386|NCT01362244|460564290|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
127984387|NCT01362244|460564291|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
127984388|NCT01362244|460564290|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
127984389|NCT01362244|460564291|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
127984390|NCT02000882|460566228|FG000|Overall Study|Adverse Event|3|||
127984391|NCT02000882|460566228|FG000|Overall Study|Physician Decision|2|||
127984392|NCT02000882|460566228|FG000|Overall Study|Withdrawal by Subject|1|||
127984393|NCT00549601|460566229|FG000|Randomized|Protocol Violation|0|||
127984394|NCT00549601|460566230|FG001|Randomized|Protocol Violation|0|||
127984395|NCT00549601|460566231|FG002|Randomized|Protocol Violation|1|||
127984396|NCT00549601|460566229|FG000|Randomized|Withdrawal by Subject|0|||
127984397|NCT00549601|460566230|FG001|Randomized|Withdrawal by Subject|1|||
127984398|NCT00549601|460566231|FG002|Randomized|Withdrawal by Subject|1|||
127984399|NCT00549601|460566229|FG000|Received Study Drug|Adverse Event|2|||
127984400|NCT00549601|460566230|FG001|Received Study Drug|Adverse Event|5|||
127984401|NCT00549601|460566231|FG002|Received Study Drug|Adverse Event|1|||
127984402|NCT00549601|460566229|FG000|Received Study Drug|Death|0|||
127984403|NCT00549601|460566230|FG001|Received Study Drug|Death|1|||
127984404|NCT00549601|460566231|FG002|Received Study Drug|Death|0|||
127984405|NCT00549601|460566229|FG000|Received Study Drug|Lost to Follow-up|0|||
127984406|NCT00549601|460566230|FG001|Received Study Drug|Lost to Follow-up|1|||
127984407|NCT00549601|460566231|FG002|Received Study Drug|Lost to Follow-up|1|||
127984408|NCT00549601|460566229|FG000|Received Study Drug|Protocol Violation|3|||
127984409|NCT00549601|460566230|FG001|Received Study Drug|Protocol Violation|4|||
127984410|NCT00549601|460566231|FG002|Received Study Drug|Protocol Violation|1|||
127984411|NCT00549601|460566229|FG000|Received Study Drug|Withdrawal by Subject|2|||
127984412|NCT00549601|460566230|FG001|Received Study Drug|Withdrawal by Subject|0|||
127984413|NCT00549601|460566231|FG002|Received Study Drug|Withdrawal by Subject|1|||
127984414|NCT00908596|460566235|FG000|Overall Study|Other reasons|46|||
127984415|NCT00908596|460566236|FG001|Overall Study|Other reasons|6|||
127984416|NCT00908596|460566237|FG002|Overall Study|Other reasons|2|||
127984417|NCT00908596|460566238|FG003|Overall Study|Other reasons|0|||
127984418|NCT00908596|460566235|FG000|Overall Study|Lost to Follow-up|0|||
127984419|NCT00908596|460566236|FG001|Overall Study|Lost to Follow-up|1|||
127984420|NCT00908596|460566237|FG002|Overall Study|Lost to Follow-up|12|||
127984421|NCT00908596|460566238|FG003|Overall Study|Lost to Follow-up|4|||
127984422|NCT00908596|460566235|FG000|Overall Study|Death|0|||
127984423|NCT00908596|460566236|FG001|Overall Study|Death|5|||
127984424|NCT00908596|460566237|FG002|Overall Study|Death|57|||
127984425|NCT00908596|460566238|FG003|Overall Study|Death|32|||
127984426|NCT00908596|460566235|FG000|Overall Study|Protocol Violation|1|||
127984427|NCT00908596|460566236|FG001|Overall Study|Protocol Violation|0|||
127984428|NCT00908596|460566237|FG002|Overall Study|Protocol Violation|0|||
127984429|NCT00908596|460566238|FG003|Overall Study|Protocol Violation|0|||
127984430|NCT00908596|460566235|FG000|Overall Study|Withdrawal by Subject|0|||
127984431|NCT00908596|460566236|FG001|Overall Study|Withdrawal by Subject|1|||
127984432|NCT00908596|460566237|FG002|Overall Study|Withdrawal by Subject|3|||
127984433|NCT00908596|460566238|FG003|Overall Study|Withdrawal by Subject|1|||
127984434|NCT02437188|460566241|FG000|Overall Study|Randomized but did not receive surgery|4|||
127984435|NCT02437188|460566242|FG001|Overall Study|Randomized but did not receive surgery|8|||
127984436|NCT02437188|460566241|FG000|Overall Study|Adverse Event|0|||
127984437|NCT02437188|460566242|FG001|Overall Study|Adverse Event|1|||
127984438|NCT01172808|460566245|FG000|Overall Study|Adverse Event|8|||
127984439|NCT01172808|460566246|FG001|Overall Study|Adverse Event|4|||
127984440|NCT01172808|460566247|FG002|Overall Study|Adverse Event|8|||
127984441|NCT01172808|460566248|FG003|Overall Study|Adverse Event|3|||
127984442|NCT01172808|460566245|FG000|Overall Study|Lack of Efficacy|1|||
127984443|NCT01172808|460566246|FG001|Overall Study|Lack of Efficacy|0|||
127984444|NCT01172808|460566247|FG002|Overall Study|Lack of Efficacy|0|||
127984445|NCT01172808|460566248|FG003|Overall Study|Lack of Efficacy|0|||
127984446|NCT01172808|460566245|FG000|Overall Study|Protocol Violation|2|||
127984447|NCT01172808|460566246|FG001|Overall Study|Protocol Violation|2|||
127984448|NCT01172808|460566247|FG002|Overall Study|Protocol Violation|2|||
127984449|NCT01172808|460566248|FG003|Overall Study|Protocol Violation|0|||
127984450|NCT01172808|460566245|FG000|Overall Study|Lost to Follow-up|0|||
127984451|NCT01172808|460566246|FG001|Overall Study|Lost to Follow-up|1|||
127984452|NCT01172808|460566247|FG002|Overall Study|Lost to Follow-up|1|||
127984453|NCT01172808|460566248|FG003|Overall Study|Lost to Follow-up|3|||
127984454|NCT01172808|460566245|FG000|Overall Study|Withdrawal by Subject|4|||
127984455|NCT01172808|460566246|FG001|Overall Study|Withdrawal by Subject|1|||
127984456|NCT01172808|460566247|FG002|Overall Study|Withdrawal by Subject|3|||
127984457|NCT01172808|460566248|FG003|Overall Study|Withdrawal by Subject|2|||
127984458|NCT01172808|460566245|FG000|Overall Study|Other|6|||
127984459|NCT01172808|460566246|FG001|Overall Study|Other|5|||
127984460|NCT01172808|460566247|FG002|Overall Study|Other|9|||
127984461|NCT01172808|460566248|FG003|Overall Study|Other|7|||
127984462|NCT02661061|460566249|FG000|Overall Study|Lack of Efficacy|1|||
127984463|NCT02661061|460566250|FG001|Overall Study|Lack of Efficacy|1|||
127984464|NCT02661061|460566249|FG000|Overall Study|Withdrawal by Subject|1|||
127984465|NCT02661061|460566250|FG001|Overall Study|Withdrawal by Subject|1|||
127984466|NCT03246061|460566251|FG000|Overall Study|Still in follow-up|15|||
127984467|NCT03246061|460566252|FG001|Overall Study|Still in follow-up|21|||
127984468|NCT01937715|460566253|FG000|Overall Study|Death|0|||
127984469|NCT01937715|460566254|FG001|Overall Study|Death|0|||
127984470|NCT01937715|460566255|FG002|Overall Study|Death|0|||
127984471|NCT01937715|460566256|FG003|Overall Study|Death|1|||
127984472|NCT01937715|460566257|FG004|Overall Study|Death|0|||
127984473|NCT01937715|460566253|FG000|Overall Study|Withdrawal by Subject|0|||
127984474|NCT01937715|460566254|FG001|Overall Study|Withdrawal by Subject|1|||
127984475|NCT01937715|460566255|FG002|Overall Study|Withdrawal by Subject|0|||
127984476|NCT01937715|460566256|FG003|Overall Study|Withdrawal by Subject|0|||
127984477|NCT01937715|460566257|FG004|Overall Study|Withdrawal by Subject|2|||
127984478|NCT01937715|460566253|FG000|Overall Study|Other|0|||
127984479|NCT01937715|460566254|FG001|Overall Study|Other|0|||
127984480|NCT01937715|460566255|FG002|Overall Study|Other|0|||
127984481|NCT01937715|460566256|FG003|Overall Study|Other|3|||
127984482|NCT01937715|460566257|FG004|Overall Study|Other|0|||
127984483|NCT01492101|460566260|FG000|Overall Study|Death|323|||
127984484|NCT01492101|460566261|FG001|Overall Study|Death|322|||
127984485|NCT01492101|460566260|FG000|Overall Study|Withdrawal by Subject|14|||
127984486|NCT01492101|460566261|FG001|Overall Study|Withdrawal by Subject|18|||
127984487|NCT01492101|460566260|FG000|Overall Study|Lost to Follow-up|0|||
127984488|NCT01492101|460566261|FG001|Overall Study|Lost to Follow-up|2|||
127984489|NCT00316914|460566280|FG000|Overall Study|Withdrawal by Subject|5|||
127984490|NCT00316914|460566281|FG001|Overall Study|Withdrawal by Subject|3|||
127984491|NCT00316914|460566280|FG000|Overall Study|Adverse Event|8|||
127984492|NCT00316914|460566281|FG001|Overall Study|Adverse Event|7|||
127984493|NCT00316914|460566280|FG000|Overall Study|Other Problems|6|||
127984494|NCT00316914|460566281|FG001|Overall Study|Other Problems|11|||
127984495|NCT00316914|460566280|FG000|Overall Study|Missing end of treatment documentation|14|||
127984496|NCT00316914|460566281|FG001|Overall Study|Missing end of treatment documentation|15|||
127984497|NCT04105010|460566282|FG000|Overall Study|Death|3|||
127984498|NCT04105010|460566283|FG001|Overall Study|Death|1|||
127984499|NCT04105010|460566284|FG002|Overall Study|Death|1|||
127984500|NCT04105010|460566285|FG003|Overall Study|Death|54|||
127984501|NCT04105010|460566282|FG000|Overall Study|Lost to Follow-up|0|||
127984502|NCT04105010|460566283|FG001|Overall Study|Lost to Follow-up|0|||
127984503|NCT04105010|460566284|FG002|Overall Study|Lost to Follow-up|0|||
127984504|NCT04105010|460566285|FG003|Overall Study|Lost to Follow-up|4|||
127984505|NCT04105010|460566282|FG000|Overall Study|Withdrawal by Subject|8|||
127984506|NCT04105010|460566283|FG001|Overall Study|Withdrawal by Subject|1|||
127984507|NCT04105010|460566284|FG002|Overall Study|Withdrawal by Subject|1|||
127984508|NCT04105010|460566285|FG003|Overall Study|Withdrawal by Subject|4|||
127984509|NCT04105010|460566282|FG000|Overall Study|Other reason|4|||
127984510|NCT04105010|460566283|FG001|Overall Study|Other reason|7|||
127984511|NCT04105010|460566284|FG002|Overall Study|Other reason|0|||
127984512|NCT04105010|460566285|FG003|Overall Study|Other reason|19|||
127984513|NCT01675154|460566286|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
127984514|NCT01675154|460566287|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
127984515|NCT01675154|460566288|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
127984516|NCT01675154|460566289|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
127653224|NCT02404389|459352359|FG004|Overall Study|Adverse Event|2|||
127653225|NCT02404389|459352355|FG000|Overall Study|Subject/guardian decision|1|||
127984517|NCT00427999|460566290|FG000|Overall Study|Adverse Event|6|||
127984518|NCT00427999|460566290|FG000|Overall Study|Abnormal laboratory values|1|||
127984519|NCT00427999|460566290|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
127984520|NCT00427999|460566290|FG000|Overall Study|Protocol Violation|2|||
127653226|NCT02404389|459352356|FG001|Overall Study|Subject/guardian decision|0|||
127653227|NCT02404389|459352357|FG002|Overall Study|Subject/guardian decision|0|||
127653228|NCT02404389|459352358|FG003|Overall Study|Subject/guardian decision|1|||
127653229|NCT02404389|459352359|FG004|Overall Study|Subject/guardian decision|1|||
127653230|NCT00652938|459352360|FG000|Overall Study|Adverse Event|1|||
127653231|NCT00652938|459352361|FG001|Overall Study|Adverse Event|0|||
127653232|NCT00652938|459352362|FG002|Overall Study|Adverse Event|2|||
127653233|NCT00652938|459352360|FG000|Overall Study|Withdrawal by Subject|0|||
127984521|NCT00427999|460566290|FG000|Overall Study|Withdrawal by Subject|9|||
127984522|NCT00427999|460566290|FG000|Overall Study|Death|1|||
127653234|NCT00652938|459352361|FG001|Overall Study|Withdrawal by Subject|6|||
127653235|NCT00652938|459352362|FG002|Overall Study|Withdrawal by Subject|1|||
127984523|NCT02380859|460566291|FG000|Overall Study|Withdrawal by Subject|2|||
127984524|NCT02380859|460566292|FG001|Overall Study|Withdrawal by Subject|0|||
127984525|NCT02284568|460566293|FG000|Overall Study|Adverse Event|2|||
127984526|NCT02284568|460566294|FG001|Overall Study|Adverse Event|9|||
127653236|NCT00652938|459352360|FG000|Overall Study|Lost to Follow-up|0|||
127984527|NCT02284568|460566295|FG002|Overall Study|Adverse Event|4|||
127984528|NCT02284568|460566293|FG000|Overall Study|Withdrawal by Subject|22|||
127984529|NCT02284568|460566294|FG001|Overall Study|Withdrawal by Subject|21|||
127984530|NCT02284568|460566295|FG002|Overall Study|Withdrawal by Subject|1|||
127984531|NCT02284568|460566293|FG000|Overall Study|Noncompliance with study drug admin|1|||
127984532|NCT02284568|460566294|FG001|Overall Study|Noncompliance with study drug admin|2|||
127984533|NCT02284568|460566295|FG002|Overall Study|Noncompliance with study drug admin|0|||
127984534|NCT02284568|460566293|FG000|Overall Study|Noncompliance|1|||
127984535|NCT02284568|460566294|FG001|Overall Study|Noncompliance|0|||
127984536|NCT02284568|460566295|FG002|Overall Study|Noncompliance|0|||
127984537|NCT02284568|460566293|FG000|Overall Study|Protocol Violation|0|||
127984538|NCT02284568|460566294|FG001|Overall Study|Protocol Violation|1|||
127984539|NCT02284568|460566295|FG002|Overall Study|Protocol Violation|0|||
127984540|NCT02284568|460566293|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
127984541|NCT02284568|460566294|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
127984542|NCT02284568|460566295|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
127984543|NCT02284568|460566293|FG000|Overall Study|Lost to Follow-up|0|||
127984544|NCT02284568|460566294|FG001|Overall Study|Lost to Follow-up|3|||
127984545|NCT02284568|460566295|FG002|Overall Study|Lost to Follow-up|0|||
127984546|NCT02284568|460566293|FG000|Overall Study|Lack of Efficacy|4|||
127984547|NCT02284568|460566294|FG001|Overall Study|Lack of Efficacy|7|||
127984548|NCT02284568|460566295|FG002|Overall Study|Lack of Efficacy|0|||
127984549|NCT02284568|460566293|FG000|Overall Study|Other|1|||
127984550|NCT02284568|460566294|FG001|Overall Study|Other|2|||
127984551|NCT02284568|460566295|FG002|Overall Study|Other|0|||
127984552|NCT02284568|460566293|FG000|Overall Study|Withdrew before taking study drug|0|||
127984553|NCT02284568|460566294|FG001|Overall Study|Withdrew before taking study drug|1|||
127984554|NCT02284568|460566295|FG002|Overall Study|Withdrew before taking study drug|0|||
127984555|NCT03000530|460566301|FG000|Overall Study|Adverse Event|0|||
127984556|NCT03000530|460566302|FG001|Overall Study|Adverse Event|0|||
127984557|NCT03000530|460566303|FG002|Overall Study|Adverse Event|2|||
127984558|NCT03000530|460566301|FG000|Overall Study|Lost to Follow-up|0|||
127984559|NCT03000530|460566302|FG001|Overall Study|Lost to Follow-up|3|||
127653237|NCT00652938|459352361|FG001|Overall Study|Lost to Follow-up|0|||
127653238|NCT00652938|459352362|FG002|Overall Study|Lost to Follow-up|2|||
127653239|NCT00652938|459352360|FG000|Overall Study|fear of blood sampling|0|||
127653240|NCT00652938|459352361|FG001|Overall Study|fear of blood sampling|1|||
127653241|NCT00652938|459352362|FG002|Overall Study|fear of blood sampling|0|||
127653242|NCT03324880|459352363|FG000|Overall Study|Adverse Event|0|||
127653243|NCT03324880|459352364|FG001|Overall Study|Adverse Event|2|||
127653244|NCT03324880|459352363|FG000|Overall Study|Withdrawal by Subject|2|||
127653245|NCT03324880|459352364|FG001|Overall Study|Withdrawal by Subject|2|||
127653246|NCT03324880|459352363|FG000|Overall Study|Lost to Follow-up|0|||
127653247|NCT03324880|459352364|FG001|Overall Study|Lost to Follow-up|1|||
127653248|NCT03324880|459352363|FG000|Overall Study|Product Recall|0|||
127653249|NCT03324880|459352364|FG001|Overall Study|Product Recall|1|||
127653250|NCT01412801|459352365|FG000|Overall Study|Death|0|||
127653251|NCT01412801|459352366|FG001|Overall Study|Death|1|||
127653252|NCT01412801|459352367|FG002|Overall Study|Death|0|||
127653253|NCT01412801|459352368|FG003|Overall Study|Death|4|||
127653254|NCT01412801|459352369|FG004|Overall Study|Death|2|||
127653255|NCT01412801|459352370|FG005|Overall Study|Death|2|||
127653256|NCT01412801|459352365|FG000|Overall Study|Lost to Follow-up|1|||
127653257|NCT01412801|459352366|FG001|Overall Study|Lost to Follow-up|2|||
127653258|NCT01412801|459352367|FG002|Overall Study|Lost to Follow-up|4|||
127653259|NCT01412801|459352368|FG003|Overall Study|Lost to Follow-up|0|||
127653260|NCT01412801|459352369|FG004|Overall Study|Lost to Follow-up|1|||
127984560|NCT03000530|460566303|FG002|Overall Study|Lost to Follow-up|1|||
127984561|NCT03000530|460566301|FG000|Overall Study|Withdrawal by Subject|0|||
127984562|NCT03000530|460566302|FG001|Overall Study|Withdrawal by Subject|2|||
127984563|NCT03000530|460566303|FG002|Overall Study|Withdrawal by Subject|1|||
127984564|NCT00312572|460566304|FG000|Overall Study|Adverse Event|10|||
127984565|NCT00312572|460566305|FG001|Overall Study|Adverse Event|16|||
127984566|NCT00312572|460566304|FG000|Overall Study|Lost to Follow-up|1|||
127984567|NCT00312572|460566305|FG001|Overall Study|Lost to Follow-up|1|||
127984568|NCT00312572|460566304|FG000|Overall Study|Administrative|4|||
127984569|NCT00312572|460566305|FG001|Overall Study|Administrative|2|||
127984570|NCT00312572|460566304|FG000|Overall Study|Lack of Efficacy|1|||
127984571|NCT00312572|460566305|FG001|Overall Study|Lack of Efficacy|2|||
127984572|NCT02614131|460566306|FG000|Overall Study|Withdrawal by Subject|1|||
127984573|NCT02614131|460566307|FG001|Overall Study|Withdrawal by Subject|0|||
127984574|NCT02614131|460566308|FG002|Overall Study|Withdrawal by Subject|0|||
127984575|NCT02614131|460566309|FG003|Overall Study|Withdrawal by Subject|0|||
127984576|NCT02614131|460566310|FG004|Overall Study|Withdrawal by Subject|0|||
127984577|NCT02614131|460566311|FG005|Overall Study|Withdrawal by Subject|0|||
127984578|NCT02614131|460566312|FG006|Overall Study|Withdrawal by Subject|0|||
127653261|NCT01412801|459352370|FG005|Overall Study|Lost to Follow-up|1|||
127653262|NCT01412801|459352365|FG000|Overall Study|Withdrawal by Subject|3|||
127984579|NCT02614131|460566306|FG000|Overall Study|Adverse Event|0|||
127984580|NCT02614131|460566307|FG001|Overall Study|Adverse Event|0|||
127984581|NCT02614131|460566308|FG002|Overall Study|Adverse Event|0|||
127542606|NCT02234843|458952785|FG001|Overall Study|Lost to Follow-up|1|||
127542607|NCT02234843|458952786|FG002|Overall Study|Lost to Follow-up|0|||
127542608|NCT02234843|458952787|FG003|Overall Study|Lost to Follow-up|0|||
127542609|NCT02234843|458952788|FG004|Overall Study|Lost to Follow-up|0|||
127542610|NCT02234843|458952789|FG005|Overall Study|Lost to Follow-up|0|||
127542611|NCT02234843|458952790|FG006|Overall Study|Lost to Follow-up|1|||
127542612|NCT02234843|458952791|FG007|Overall Study|Lost to Follow-up|0|||
127542613|NCT02234843|458952792|FG008|Overall Study|Lost to Follow-up|0|||
127542614|NCT02234843|458952793|FG009|Overall Study|Lost to Follow-up|0|||
127542615|NCT04875975|458952812|FG000|Overall Study|Adverse Event|1|||
127542616|NCT04875975|458952813|FG001|Overall Study|Adverse Event|2|||
127542617|NCT04875975|458952812|FG000|Overall Study|Lack of Efficacy|2|||
127542618|NCT04875975|458952813|FG001|Overall Study|Lack of Efficacy|2|||
127542619|NCT04875975|458952812|FG000|Overall Study|Permanently left due to seizure recurrence|1|||
127542620|NCT04875975|458952813|FG001|Overall Study|Permanently left due to seizure recurrence|0|||
127542621|NCT04875975|458952812|FG000|Overall Study|Relapse With Insults|0|||
127542622|NCT04875975|458952813|FG001|Overall Study|Relapse With Insults|1|||
127542623|NCT04875975|458952812|FG000|Overall Study|Permanently left due to new seizure recurrence|0|||
127542624|NCT04875975|458952813|FG001|Overall Study|Permanently left due to new seizure recurrence|1|||
127542625|NCT02994108|458954568|FG000|Intervention Messages|Withdrawal by Subject|2|||
127542626|NCT02994108|458954569|FG001|Intervention Messages|Withdrawal by Subject|0|||
127542627|NCT02994108|458954568|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
127542628|NCT02994108|458954569|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
127542629|NCT02994108|458954568|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
127542630|NCT02994108|458954569|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
127542631|NCT02994108|458954568|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
127542632|NCT02994108|458954569|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
127542633|NCT02081677|458954570|FG000|Overall Study|Adverse Event|0|||
127542634|NCT02081677|458954571|FG001|Overall Study|Adverse Event|0|||
127542635|NCT02081677|458954572|FG002|Overall Study|Adverse Event|1|||
127542636|NCT02081677|458954573|FG003|Overall Study|Adverse Event|0|||
127542637|NCT02081677|458954570|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
127542638|NCT02081677|458954571|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
127542639|NCT02081677|458954572|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
127542640|NCT02081677|458954573|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
127542641|NCT02081677|458954570|FG000|Overall Study|Not comfortable with lens care system|1|||
127542642|NCT02081677|458954571|FG001|Overall Study|Not comfortable with lens care system|0|||
127542643|NCT02081677|458954572|FG002|Overall Study|Not comfortable with lens care system|0|||
127542644|NCT02081677|458954573|FG003|Overall Study|Not comfortable with lens care system|0|||
127542645|NCT02081677|458954570|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
127542646|NCT02081677|458954571|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
127542647|NCT02081677|458954572|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
127542648|NCT02081677|458954573|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
127542649|NCT01097668|458954574|FG000|Overall Study|Withdrawal by Subject|1|||
127542650|NCT01097668|458954575|FG001|Overall Study|Withdrawal by Subject|2|||
127542651|NCT01097668|458954574|FG000|Overall Study|Lost to Follow-up|1|||
127542652|NCT01097668|458954575|FG001|Overall Study|Lost to Follow-up|0|||
127542653|NCT02443688|458954578|FG000|Overall Study|Adverse Event|2|||
127542654|NCT02443688|458954579|FG001|Overall Study|Adverse Event|3|||
127542655|NCT02443688|458954580|FG002|Overall Study|Adverse Event|2|||
127542656|NCT02443688|458954578|FG000|Overall Study|Lost to Follow-up|1|||
127542657|NCT02443688|458954579|FG001|Overall Study|Lost to Follow-up|0|||
127542658|NCT02443688|458954580|FG002|Overall Study|Lost to Follow-up|0|||
127542659|NCT02443688|458954578|FG000|Overall Study|Physician Decision|3|||
127542660|NCT02443688|458954579|FG001|Overall Study|Physician Decision|0|||
127542661|NCT02443688|458954580|FG002|Overall Study|Physician Decision|1|||
127542662|NCT02443688|458954578|FG000|Overall Study|Pregnancy|0|||
127542663|NCT02443688|458954579|FG001|Overall Study|Pregnancy|0|||
127542664|NCT02443688|458954580|FG002|Overall Study|Pregnancy|1|||
127984582|NCT02614131|460566309|FG003|Overall Study|Adverse Event|0|||
127542665|NCT02443688|458954578|FG000|Overall Study|Withdrawal by Subject|3|||
127542666|NCT02443688|458954579|FG001|Overall Study|Withdrawal by Subject|3|||
127542667|NCT02443688|458954580|FG002|Overall Study|Withdrawal by Subject|4|||
127542668|NCT02443688|458954578|FG000|Overall Study|Non-compliance with study drug|1|||
127542669|NCT02443688|458954579|FG001|Overall Study|Non-compliance with study drug|2|||
127542670|NCT02443688|458954580|FG002|Overall Study|Non-compliance with study drug|4|||
127542671|NCT02443688|458954578|FG000|Overall Study|Sponsor Request|2|||
127542672|NCT02443688|458954579|FG001|Overall Study|Sponsor Request|1|||
127542673|NCT02443688|458954580|FG002|Overall Study|Sponsor Request|0|||
127542674|NCT00616759|458954588|FG000|Overall Study|Physician Decision|2|||
127542675|NCT00616759|458954589|FG001|Overall Study|Physician Decision|0|||
127542676|NCT00616759|458954588|FG000|Overall Study|Withdrawal by Subject|1|||
127984583|NCT02614131|460566310|FG004|Overall Study|Adverse Event|0|||
127984584|NCT02614131|460566311|FG005|Overall Study|Adverse Event|0|||
127984585|NCT02614131|460566312|FG006|Overall Study|Adverse Event|1|||
127984586|NCT01285492|460566317|FG000|Overall Study|Adverse Event|11|||
127984587|NCT01285492|460566318|FG001|Overall Study|Adverse Event|0|||
127984588|NCT01285492|460566317|FG000|Overall Study|Protocol Violation|3|||
127984589|NCT01285492|460566318|FG001|Overall Study|Protocol Violation|0|||
127984590|NCT01285492|460566317|FG000|Overall Study|Withdrawal by Subject|2|||
127653263|NCT01412801|459352366|FG001|Overall Study|Withdrawal by Subject|2|||
127653264|NCT01412801|459352367|FG002|Overall Study|Withdrawal by Subject|1|||
127984591|NCT01285492|460566318|FG001|Overall Study|Withdrawal by Subject|1|||
127984592|NCT01285492|460566317|FG000|Overall Study|Death|1|||
127984593|NCT01285492|460566318|FG001|Overall Study|Death|0|||
127984594|NCT01797094|460566319|FG000|Overall Study|Adverse Event|1|||
127984595|NCT01797094|460566320|FG001|Overall Study|Adverse Event|1|||
127984596|NCT01797094|460566319|FG000|Overall Study|Personal Reasons|4|||
127984597|NCT01797094|460566320|FG001|Overall Study|Personal Reasons|0|||
127984598|NCT01797094|460566319|FG000|Overall Study|Protocol Violation|0|||
127984599|NCT01797094|460566320|FG001|Overall Study|Protocol Violation|1|||
127984600|NCT01797094|460566319|FG000|Overall Study|Other Miscellaneous Reasons|1|||
127984601|NCT01797094|460566320|FG001|Overall Study|Other Miscellaneous Reasons|0|||
127984602|NCT03217968|460566323|FG000|Overall Study|Withdrawal by Subject|4|||
127984603|NCT03217968|460566323|FG000|Overall Study|Lost to Follow-up|1|||
127984604|NCT03217968|460566323|FG000|Overall Study|Protocol Violation|6|||
127984605|NCT01887678|460566329|FG000|Overall Study|Adverse Event|4|||
127984606|NCT01887678|460566330|FG001|Overall Study|Adverse Event|6|||
127984607|NCT01887678|460566329|FG000|Overall Study|Exceeded rescue medication dosage|4|||
127984608|NCT01887678|460566330|FG001|Overall Study|Exceeded rescue medication dosage|5|||
127984609|NCT01887678|460566329|FG000|Overall Study|Withdrawal of consent|3|||
127984610|NCT01887678|460566330|FG001|Overall Study|Withdrawal of consent|4|||
127984611|NCT01887678|460566329|FG000|Overall Study|Lost to Follow-up|4|||
127984612|NCT01887678|460566330|FG001|Overall Study|Lost to Follow-up|2|||
127984613|NCT01887678|460566329|FG000|Overall Study|Deterioration of clinical condition|0|||
127984614|NCT01887678|460566330|FG001|Overall Study|Deterioration of clinical condition|4|||
127984615|NCT01887678|460566329|FG000|Overall Study|Lack of Efficacy|1|||
127984616|NCT01887678|460566330|FG001|Overall Study|Lack of Efficacy|2|||
127984617|NCT01887678|460566329|FG000|Overall Study|Non-compliance|0|||
127984618|NCT01887678|460566330|FG001|Overall Study|Non-compliance|3|||
127984619|NCT01887678|460566329|FG000|Overall Study|Specified|1|||
127984620|NCT01887678|460566330|FG001|Overall Study|Specified|2|||
127984621|NCT03013985|460566331|FG000|Overall Study|Protocol Violation|2|||
127984622|NCT03013985|460566332|FG001|Overall Study|Protocol Violation|2|||
127984623|NCT03013985|460566331|FG000|Overall Study|Withdrawal by Subject|14|||
127984624|NCT03013985|460566332|FG001|Overall Study|Withdrawal by Subject|17|||
127984625|NCT00791492|460566335|FG000|Overall Study|Withdrawal by Subject|1|||
127984626|NCT00791492|460566336|FG001|Overall Study|Withdrawal by Subject|2|||
127984627|NCT00791492|460566335|FG000|Overall Study|Liver transplantation|5|||
127984628|NCT00791492|460566336|FG001|Overall Study|Liver transplantation|1|||
127984629|NCT00634049|460566351|FG000|Overall Study|Never received study drug|1|||
127984630|NCT00634049|460566351|FG000|Overall Study|Died prior to receiving study drug|1|||
127984631|NCT00634049|460566351|FG000|Overall Study|Screening failure|1|||
127984632|NCT00314132|460566353|FG000|Overall Study|Lost to Follow-up|3|||
127984633|NCT00314132|460566354|FG001|Overall Study|Lost to Follow-up|13|||
127653265|NCT01412801|459352368|FG003|Overall Study|Withdrawal by Subject|0|||
127653266|NCT01412801|459352369|FG004|Overall Study|Withdrawal by Subject|0|||
127653267|NCT01412801|459352370|FG005|Overall Study|Withdrawal by Subject|0|||
127653268|NCT01412801|459352365|FG000|Overall Study|Relocated to another area|0|||
127653269|NCT01412801|459352366|FG001|Overall Study|Relocated to another area|0|||
127653270|NCT01412801|459352367|FG002|Overall Study|Relocated to another area|2|||
127653271|NCT01412801|459352368|FG003|Overall Study|Relocated to another area|0|||
127653272|NCT01412801|459352369|FG004|Overall Study|Relocated to another area|0|||
127653273|NCT01412801|459352370|FG005|Overall Study|Relocated to another area|0|||
127653274|NCT00116272|459352371|FG000|Overall Study|Lost to Follow-up|11|||
127984634|NCT00314132|460566353|FG000|Overall Study|Withdrawal by Subject|3|||
127984635|NCT00314132|460566354|FG001|Overall Study|Withdrawal by Subject|5|||
127984636|NCT00314132|460566353|FG000|Overall Study|Adverse Event|1|||
127984637|NCT00314132|460566354|FG001|Overall Study|Adverse Event|0|||
127984638|NCT00314132|460566353|FG000|Overall Study|Physician Decision|1|||
127984639|NCT00314132|460566354|FG001|Overall Study|Physician Decision|0|||
127984640|NCT01380691|460566356|FG000|Washout (7 Days)|Protocol Violation|0|||
127984641|NCT01380691|460566357|FG001|Washout (7 Days)|Protocol Violation|0|||
127984642|NCT01380691|460566358|FG002|Washout (7 Days)|Protocol Violation|0|||
127984643|NCT01380691|460566359|FG003|Washout (7 Days)|Protocol Violation|1|||
127984644|NCT01380691|460566356|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
127984645|NCT01380691|460566357|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
127984646|NCT01380691|460566358|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
127984647|NCT01380691|460566359|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
127984648|NCT01987232|460566362|FG000|Overall Study|Ongoing in Study|0|||
127984649|NCT01987232|460566363|FG001|Overall Study|Ongoing in Study|0|||
127653275|NCT00116272|459352372|FG001|Overall Study|Lost to Follow-up|6|||
127653276|NCT00782496|459352375|FG000|Overall Study|Lost to Follow-up|14|||
127653277|NCT00782496|459352376|FG001|Overall Study|Lost to Follow-up|15|||
127653278|NCT00990340|459352380|FG000|First 14-day Treatment|Not Compliant|2|||
127653279|NCT00990340|459352381|FG001|First 14-day Treatment|Not Compliant|1|||
127653280|NCT00990340|459352380|FG000|First 14-day Treatment|Lost to Follow-up|2|||
127653281|NCT00990340|459352381|FG001|First 14-day Treatment|Lost to Follow-up|1|||
127984650|NCT01987232|460566364|FG002|Overall Study|Ongoing in Study|0|||
127984651|NCT01987232|460566365|FG003|Overall Study|Ongoing in Study|1|||
127984652|NCT01987232|460566366|FG004|Overall Study|Ongoing in Study|0|||
127984653|NCT00586508|460566367|FG000|Overall Study|Progressive disease|52|||
127984654|NCT00586508|460566368|FG001|Overall Study|Progressive disease|8|||
127984655|NCT00586508|460566367|FG000|Overall Study|Death|0|||
127984656|NCT00586508|460566368|FG001|Overall Study|Death|1|||
127984657|NCT00586508|460566367|FG000|Overall Study|Adverse Event|12|||
127984658|NCT00586508|460566368|FG001|Overall Study|Adverse Event|4|||
127984659|NCT00586508|460566367|FG000|Overall Study|Withdrawal by Subject|4|||
127984660|NCT00586508|460566368|FG001|Overall Study|Withdrawal by Subject|0|||
127984661|NCT05153148|460566372|FG000|Overall Study|Adverse Event|1|||
127984662|NCT05153148|460566373|FG001|Overall Study|Adverse Event|0|||
127984663|NCT05153148|460566374|FG002|Overall Study|Adverse Event|3|||
127984664|NCT05153148|460566375|FG003|Overall Study|Adverse Event|5|||
127984665|NCT05153148|460566372|FG000|Overall Study|Lost to Follow-up|1|||
127984666|NCT05153148|460566373|FG001|Overall Study|Lost to Follow-up|1|||
127984667|NCT05153148|460566374|FG002|Overall Study|Lost to Follow-up|2|||
127984668|NCT05153148|460566375|FG003|Overall Study|Lost to Follow-up|0|||
127984669|NCT05153148|460566372|FG000|Overall Study|Withdrawal by Subject|6|||
127984670|NCT05153148|460566373|FG001|Overall Study|Withdrawal by Subject|8|||
127984671|NCT05153148|460566374|FG002|Overall Study|Withdrawal by Subject|6|||
127984672|NCT05153148|460566375|FG003|Overall Study|Withdrawal by Subject|8|||
127984673|NCT05153148|460566372|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
127984674|NCT05153148|460566373|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
127984675|NCT05153148|460566374|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
127984676|NCT05153148|460566375|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
127984677|NCT05153148|460566372|FG000|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
127984678|NCT05153148|460566373|FG001|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
127984679|NCT05153148|460566374|FG002|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
127984680|NCT05153148|460566375|FG003|Overall Study|Randomized Without Dosing due to Ineligibility|2|||
127984681|NCT05153148|460566372|FG000|Overall Study|Reason not Specified|1|||
127984682|NCT05153148|460566373|FG001|Overall Study|Reason not Specified|1|||
127984683|NCT05153148|460566374|FG002|Overall Study|Reason not Specified|1|||
127984684|NCT05153148|460566375|FG003|Overall Study|Reason not Specified|1|||
127984685|NCT01732471|460566376|FG000|Overall Study|Withdrawal by Subject|1|||
127984686|NCT00232596|460566377|FG000|6-Week Titration Phase|Adverse Event|6|||
127984687|NCT00232596|460566378|FG001|6-Week Titration Phase|Adverse Event|19|||
127984688|NCT00232596|460566377|FG000|6-Week Titration Phase|Failed to Return|2|||
127984689|NCT00232596|460566378|FG001|6-Week Titration Phase|Failed to Return|1|||
127984690|NCT00232596|460566377|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
127984691|NCT00232596|460566378|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
127984692|NCT00232596|460566377|FG000|6-Week Titration Phase|Protocol Violation|1|||
127984693|NCT00232596|460566378|FG001|6-Week Titration Phase|Protocol Violation|3|||
127984694|NCT00232596|460566377|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
127984695|NCT00232596|460566378|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
127984696|NCT00232596|460566377|FG000|6-Week Titration Phase|Other|3|||
127984697|NCT00232596|460566378|FG001|6-Week Titration Phase|Other|3|||
127984698|NCT00232596|460566377|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
127984699|NCT00232596|460566378|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
127984700|NCT00232596|460566377|FG000|12-Week Maintenance Phase|Adverse Event|7|||
127984701|NCT00232596|460566378|FG001|12-Week Maintenance Phase|Adverse Event|22|||
127984702|NCT00232596|460566377|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
127984703|NCT00232596|460566378|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
127984704|NCT00232596|460566377|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
127984705|NCT00232596|460566378|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
127984706|NCT00232596|460566377|FG000|12-Week Maintenance Phase|Other|1|||
127653282|NCT00990340|459352380|FG000|First 14-day Treatment|Protocol Violation|2|||
127984707|NCT00232596|460566378|FG001|12-Week Maintenance Phase|Other|3|||
127984708|NCT01712334|460566379|FG000|Treatment Period 1|Randomized in Error|0|||
127984709|NCT01712334|460566380|FG001|Treatment Period 1|Randomized in Error|2|||
127984710|NCT01253174|460566383|FG000|Period 1|Randomized but not treated|0|||
127984711|NCT01253174|460566384|FG001|Period 1|Randomized but not treated|1|||
127984712|NCT01253174|460566385|FG002|Period 1|Randomized but not treated|1|||
127984713|NCT01253174|460566386|FG003|Period 1|Randomized but not treated|0|||
127984714|NCT01253174|460566387|FG004|Period 1|Randomized but not treated|1|||
127984715|NCT01253174|460566388|FG005|Period 1|Randomized but not treated|0|||
127984716|NCT01253174|460566383|FG000|Period 2|Adverse Event|0|||
127984717|NCT01253174|460566384|FG001|Period 2|Adverse Event|0|||
127984718|NCT01253174|460566385|FG002|Period 2|Adverse Event|1|||
127984719|NCT01253174|460566386|FG003|Period 2|Adverse Event|0|||
127984720|NCT01253174|460566387|FG004|Period 2|Adverse Event|0|||
127984721|NCT01253174|460566388|FG005|Period 2|Adverse Event|0|||
127984722|NCT01253174|460566383|FG000|Period 3|Withdrawal by Subject|0|||
127984723|NCT01253174|460566384|FG001|Period 3|Withdrawal by Subject|1|||
127984724|NCT01253174|460566385|FG002|Period 3|Withdrawal by Subject|0|||
127984725|NCT01253174|460566386|FG003|Period 3|Withdrawal by Subject|0|||
127984726|NCT01253174|460566387|FG004|Period 3|Withdrawal by Subject|1|||
127984727|NCT01253174|460566388|FG005|Period 3|Withdrawal by Subject|0|||
127984728|NCT01253174|460566383|FG000|Period 3|Pregnancy|0|||
127984729|NCT01253174|460566384|FG001|Period 3|Pregnancy|0|||
127984730|NCT01253174|460566385|FG002|Period 3|Pregnancy|1|||
127984731|NCT01253174|460566386|FG003|Period 3|Pregnancy|0|||
127984732|NCT01253174|460566387|FG004|Period 3|Pregnancy|0|||
127984733|NCT01253174|460566388|FG005|Period 3|Pregnancy|0|||
127984734|NCT03426436|460566389|FG000|Overall Study|Incorrect lead placement|12|||
127984735|NCT03426436|460566389|FG000|Overall Study|Withdrawal by Subject|2|||
127984736|NCT03426436|460566389|FG000|Overall Study|Consent issue|1|||
127984737|NCT03426436|460566389|FG000|Overall Study|ECGs not saved|4|||
127984738|NCT02267135|460566390|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
127984739|NCT02267135|460566391|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
127984740|NCT02267135|460566390|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
127984741|NCT02267135|460566391|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
127984742|NCT02267135|460566390|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
127984743|NCT02267135|460566391|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
127984744|NCT02267135|460566390|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
127984745|NCT02267135|460566391|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
127984746|NCT02267135|460566390|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
127984747|NCT02267135|460566391|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
127984748|NCT02892513|460566392|FG000|Overall Study|Withdrawal by Subject|0|||
127984749|NCT02892513|460566393|FG001|Overall Study|Withdrawal by Subject|1|||
127984750|NCT00900731|460566394|FG000|Overall Study|Adverse Event|31|||
127653283|NCT00990340|459352381|FG001|First 14-day Treatment|Protocol Violation|2|||
127653284|NCT01987817|459352382|FG000|Overall Study|Adverse Event|4|||
127653285|NCT01987817|459352383|FG001|Overall Study|Adverse Event|0|||
127984751|NCT00900731|460566395|FG001|Overall Study|Adverse Event|27|||
127984752|NCT00900731|460566394|FG000|Overall Study|Withdrawal by Subject|8|||
127984753|NCT00900731|460566395|FG001|Overall Study|Withdrawal by Subject|7|||
127984754|NCT00900731|460566394|FG000|Overall Study|Protocol Deviation|8|||
127984755|NCT00900731|460566395|FG001|Overall Study|Protocol Deviation|11|||
127984756|NCT00900731|460566394|FG000|Overall Study|Administrative Problems|5|||
127984757|NCT00900731|460566395|FG001|Overall Study|Administrative Problems|4|||
127984758|NCT00900731|460566394|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
127984759|NCT00900731|460566395|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
127984760|NCT00900731|460566394|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
127984761|NCT00900731|460566395|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
127984762|NCT00900731|460566394|FG000|Overall Study|Lost to Follow-up|2|||
127984763|NCT00900731|460566395|FG001|Overall Study|Lost to Follow-up|3|||
127984764|NCT00900731|460566394|FG000|Overall Study|Lack of Efficacy|1|||
127984765|NCT00900731|460566395|FG001|Overall Study|Lack of Efficacy|3|||
127984766|NCT00900731|460566394|FG000|Overall Study|Death|0|||
127984767|NCT00900731|460566395|FG001|Overall Study|Death|2|||
127984768|NCT03806231|460566396|FG000|Overall Study|Physician Decision|1|||
127984769|NCT03806231|460566397|FG001|Overall Study|Physician Decision|0|||
127984770|NCT03806231|460566396|FG000|Overall Study|Withdrawal by Subject|1|||
127984771|NCT03806231|460566397|FG001|Overall Study|Withdrawal by Subject|0|||
127653286|NCT01987817|459352382|FG000|Overall Study|Withdrawal by Subject|1|||
127984772|NCT02919267|460566398|FG000|Overall Study|Protocol Violation|0|||
127984773|NCT02919267|460566399|FG001|Overall Study|Protocol Violation|3|||
127984774|NCT02919267|460566400|FG002|Overall Study|Protocol Violation|3|||
127984775|NCT02919267|460566401|FG003|Overall Study|Protocol Violation|4|||
127984776|NCT00394433|460566402|FG000|Overall Study|Adverse Event|2|||
127653287|NCT01987817|459352383|FG001|Overall Study|Withdrawal by Subject|1|||
127653288|NCT01987817|459352382|FG000|Overall Study|Physician Decision|1|||
127653289|NCT01987817|459352383|FG001|Overall Study|Physician Decision|0|||
127653290|NCT02070484|459352384|FG000|Overall Study|Withdrawal by Subject|1|||
127653291|NCT02070484|459352385|FG001|Overall Study|Withdrawal by Subject|0|||
127653292|NCT00682643|459352386|FG000|Overall Study|Adverse Event|12|||
127653293|NCT00682643|459352387|FG001|Overall Study|Adverse Event|23|||
127653294|NCT00682643|459352386|FG000|Overall Study|Lack of Efficacy|2|||
127653295|NCT00682643|459352387|FG001|Overall Study|Lack of Efficacy|0|||
127653296|NCT00682643|459352386|FG000|Overall Study|Protocol Violation|38|||
127653297|NCT00682643|459352387|FG001|Overall Study|Protocol Violation|76|||
127653298|NCT00682643|459352386|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
127653299|NCT00682643|459352387|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
127653300|NCT00682643|459352386|FG000|Overall Study|Lost to Follow-up|1|||
127653301|NCT00682643|459352387|FG001|Overall Study|Lost to Follow-up|6|||
127653302|NCT00682643|459352386|FG000|Overall Study|Physician Decision|2|||
127653303|NCT00682643|459352387|FG001|Overall Study|Physician Decision|6|||
127653304|NCT00682643|459352386|FG000|Overall Study|Withdrawal by Subject|19|||
127653305|NCT00682643|459352387|FG001|Overall Study|Withdrawal by Subject|53|||
127653306|NCT00682643|459352386|FG000|Overall Study|Did Not Receive Study Drug|1|||
127653307|NCT00682643|459352387|FG001|Overall Study|Did Not Receive Study Drug|1|||
127653308|NCT01852058|459352390|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
127653309|NCT01852058|459352391|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
127653310|NCT01852058|459352392|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
127653311|NCT01852058|459352393|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
127653312|NCT01852058|459352394|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
127653313|NCT01852058|459352395|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
127653314|NCT01852058|459352396|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
127653315|NCT01852058|459352397|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
127653316|NCT01852058|459352398|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
127984777|NCT00394433|460566402|FG000|Overall Study|Alternative Therapy|1|||
127984778|NCT01554176|460566403|FG000|Treatment Phase|Protocol Violation|1|||
127653317|NCT01852058|459352399|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
127653318|NCT01852058|459352400|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
127653319|NCT01852058|459352401|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
127653320|NCT01852058|459352390|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
127653321|NCT01852058|459352391|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
127653322|NCT01852058|459352392|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
127653323|NCT01852058|459352393|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
127653324|NCT01852058|459352394|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
127653325|NCT01852058|459352395|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
127653326|NCT01852058|459352396|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
127653327|NCT01852058|459352397|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
127653328|NCT01852058|459352398|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
127653329|NCT01852058|459352399|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
127653330|NCT01852058|459352400|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
127653331|NCT01852058|459352401|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
127653332|NCT01852058|459352390|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
127653333|NCT01852058|459352391|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
127984779|NCT01554176|460566404|FG001|Treatment Phase|Protocol Violation|2|||
127984780|NCT01554176|460566405|FG002|Treatment Phase|Protocol Violation|0|||
127984781|NCT01554176|460566406|FG003|Treatment Phase|Protocol Violation|0|||
127984782|NCT01554176|460566407|FG004|Treatment Phase|Protocol Violation|0|||
127984783|NCT01554176|460566403|FG000|Treatment Phase|Physician Decision|1|||
127653334|NCT01852058|459352392|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
127653335|NCT01852058|459352393|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
127653336|NCT01852058|459352394|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
127653337|NCT01852058|459352395|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
127653338|NCT01852058|459352396|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
127653339|NCT01852058|459352397|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
127653340|NCT01852058|459352398|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
127984784|NCT01554176|460566404|FG001|Treatment Phase|Physician Decision|1|||
127984785|NCT01554176|460566405|FG002|Treatment Phase|Physician Decision|0|||
127984786|NCT01554176|460566406|FG003|Treatment Phase|Physician Decision|0|||
127984787|NCT01554176|460566407|FG004|Treatment Phase|Physician Decision|0|||
127984788|NCT01554176|460566403|FG000|Treatment Phase|Lack of Efficacy|0|||
127984789|NCT01554176|460566404|FG001|Treatment Phase|Lack of Efficacy|1|||
127984790|NCT01554176|460566405|FG002|Treatment Phase|Lack of Efficacy|0|||
127984791|NCT01554176|460566406|FG003|Treatment Phase|Lack of Efficacy|0|||
127984792|NCT01554176|460566407|FG004|Treatment Phase|Lack of Efficacy|0|||
127984793|NCT01554176|460566403|FG000|Treatment Phase|Adverse event, non-fatal|1|||
127984794|NCT01554176|460566404|FG001|Treatment Phase|Adverse event, non-fatal|1|||
127984795|NCT01554176|460566405|FG002|Treatment Phase|Adverse event, non-fatal|0|||
127984796|NCT01554176|460566406|FG003|Treatment Phase|Adverse event, non-fatal|0|||
127984797|NCT01554176|460566407|FG004|Treatment Phase|Adverse event, non-fatal|0|||
127984798|NCT01554176|460566403|FG000|Treatment Phase|Non-compliance with study drug|1|||
127984799|NCT01554176|460566404|FG001|Treatment Phase|Non-compliance with study drug|0|||
127984800|NCT01554176|460566405|FG002|Treatment Phase|Non-compliance with study drug|0|||
127984801|NCT01554176|460566406|FG003|Treatment Phase|Non-compliance with study drug|0|||
127984802|NCT01554176|460566407|FG004|Treatment Phase|Non-compliance with study drug|0|||
127984803|NCT01554176|460566403|FG000|Treatment Phase|Withdrawal by Subject|1|||
127984804|NCT01554176|460566404|FG001|Treatment Phase|Withdrawal by Subject|0|||
127984805|NCT01554176|460566405|FG002|Treatment Phase|Withdrawal by Subject|0|||
127984806|NCT01554176|460566406|FG003|Treatment Phase|Withdrawal by Subject|0|||
127984807|NCT01554176|460566407|FG004|Treatment Phase|Withdrawal by Subject|0|||
127984808|NCT01554176|460566403|FG000|Treatment Phase|Lost to Follow-up|3|||
127984809|NCT01554176|460566404|FG001|Treatment Phase|Lost to Follow-up|0|||
127984810|NCT01554176|460566405|FG002|Treatment Phase|Lost to Follow-up|0|||
127984811|NCT01554176|460566406|FG003|Treatment Phase|Lost to Follow-up|0|||
127984812|NCT01554176|460566407|FG004|Treatment Phase|Lost to Follow-up|0|||
127984813|NCT01554176|460566403|FG000|Run-out Phase|Protocol Violation|0|||
127984814|NCT01554176|460566404|FG001|Run-out Phase|Protocol Violation|0|||
127984815|NCT01554176|460566405|FG002|Run-out Phase|Protocol Violation|0|||
127984816|NCT01554176|460566406|FG003|Run-out Phase|Protocol Violation|1|||
127984817|NCT01554176|460566407|FG004|Run-out Phase|Protocol Violation|0|||
127984818|NCT00628927|460566408|FG000|Overall Study|Problems performing blood draw|6|||
127542677|NCT00616759|458954589|FG001|Overall Study|Withdrawal by Subject|2|||
127542678|NCT01231984|458954590|FG000|Study Period 1|Withdrawal by Subject|0|||
127542679|NCT01231984|458954591|FG001|Study Period 1|Withdrawal by Subject|0|||
127542680|NCT01231984|458954592|FG002|Study Period 1|Withdrawal by Subject|0|||
127542681|NCT01231984|458954593|FG003|Study Period 1|Withdrawal by Subject|1|||
127542682|NCT01231984|458954590|FG000|Study Period 1|Lost to Follow-up|1|||
127542683|NCT01231984|458954591|FG001|Study Period 1|Lost to Follow-up|1|||
127542684|NCT01231984|458954592|FG002|Study Period 1|Lost to Follow-up|1|||
127542685|NCT01231984|458954593|FG003|Study Period 1|Lost to Follow-up|0|||
127542686|NCT01231984|458954590|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
127542687|NCT01231984|458954591|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
127542688|NCT01231984|458954592|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
127542689|NCT01231984|458954593|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
127542690|NCT01231984|458954590|FG000|Study Period 1|Screen Failure|0|||
127542691|NCT01231984|458954591|FG001|Study Period 1|Screen Failure|0|||
127542692|NCT01231984|458954592|FG002|Study Period 1|Screen Failure|0|||
127542693|NCT01231984|458954593|FG003|Study Period 1|Screen Failure|1|||
127542694|NCT01231984|458954590|FG000|Study Period 1|Non-compliance with study requirements|5|||
127542695|NCT01231984|458954591|FG001|Study Period 1|Non-compliance with study requirements|0|||
127542696|NCT01231984|458954592|FG002|Study Period 1|Non-compliance with study requirements|2|||
127542697|NCT01231984|458954593|FG003|Study Period 1|Non-compliance with study requirements|1|||
127542698|NCT01231984|458954590|FG000|Study Period 1|Protocol Violation|3|||
127542699|NCT01231984|458954591|FG001|Study Period 1|Protocol Violation|4|||
127542700|NCT01231984|458954592|FG002|Study Period 1|Protocol Violation|2|||
127542701|NCT01231984|458954593|FG003|Study Period 1|Protocol Violation|3|||
127542702|NCT01231984|458954590|FG000|Study Period 1|Adverse Event|1|||
127542703|NCT01231984|458954591|FG001|Study Period 1|Adverse Event|0|||
127542704|NCT01231984|458954592|FG002|Study Period 1|Adverse Event|0|||
127542705|NCT01231984|458954593|FG003|Study Period 1|Adverse Event|0|||
127542706|NCT01231984|458954590|FG000|Study Period 1|Other|0|||
127542707|NCT01231984|458954591|FG001|Study Period 1|Other|0|||
127542708|NCT01231984|458954592|FG002|Study Period 1|Other|0|||
127984819|NCT00628927|460566409|FG001|Overall Study|Problems performing blood draw|0|||
127984820|NCT00628927|460566408|FG000|Overall Study|Lost to Follow-up|1|||
127984821|NCT00628927|460566409|FG001|Overall Study|Lost to Follow-up|0|||
127984822|NCT00628927|460566408|FG000|Overall Study|Equipment failure|1|||
127984823|NCT00628927|460566409|FG001|Overall Study|Equipment failure|0|||
127984824|NCT02093390|460566413|FG000|Overall Study|Withdrawal by Subject|0|||
127984825|NCT02093390|460566414|FG001|Overall Study|Withdrawal by Subject|1|||
127984826|NCT01887288|460568063|FG000|Overall Study|The study was terminated and the PI has|16|||
127984827|NCT00460265|460568069|FG000|Overall Study|Lost to Follow-up|14|||
127984828|NCT00460265|460568070|FG001|Overall Study|Lost to Follow-up|15|||
127984829|NCT00460265|460568069|FG000|Overall Study|Physician Decision|1|||
127984830|NCT00460265|460568070|FG001|Overall Study|Physician Decision|2|||
127542709|NCT01231984|458954593|FG003|Study Period 1|Other|1|||
127542710|NCT01231984|458954590|FG000|Study Period 2|Withdrawal by Subject|1|||
127984831|NCT00460265|460568069|FG000|Overall Study|Withdrawal by Subject|10|||
127984832|NCT00460265|460568070|FG001|Overall Study|Withdrawal by Subject|25|||
127984833|NCT00460265|460568069|FG000|Overall Study|Ongoing|60|||
127984834|NCT00460265|460568070|FG001|Overall Study|Ongoing|47|||
127984835|NCT02719353|460568071|FG000|First Intervention|Physician Decision|0|||
127984836|NCT02719353|460568072|FG001|First Intervention|Physician Decision|1|||
127984837|NCT01917344|460568074|FG000|Overall Study|Withdrawal by Subject|1|||
127984838|NCT00412217|460568075|FG000|Overall Study|Insufficient Data Available|8|||
127984839|NCT00412217|460568076|FG001|Overall Study|Insufficient Data Available|3|||
127984840|NCT00412217|460568075|FG000|Overall Study|Death|5|||
127984841|NCT00412217|460568076|FG001|Overall Study|Death|4|||
127984842|NCT00412217|460568075|FG000|Overall Study|Disease Progression|2|||
127984843|NCT00412217|460568076|FG001|Overall Study|Disease Progression|3|||
127984844|NCT00412217|460568075|FG000|Overall Study|Investigator Decision|1|||
127984845|NCT00412217|460568076|FG001|Overall Study|Investigator Decision|0|||
127984846|NCT00412217|460568075|FG000|Overall Study|Withdrawal by Subject|2|||
127984847|NCT00412217|460568076|FG001|Overall Study|Withdrawal by Subject|0|||
127984848|NCT00412217|460568075|FG000|Overall Study|Lost to Follow-up|1|||
127984849|NCT00412217|460568076|FG001|Overall Study|Lost to Follow-up|4|||
127984850|NCT00412217|460568075|FG000|Overall Study|Study Terminated by Sponsor|26|||
127984851|NCT00412217|460568076|FG001|Overall Study|Study Terminated by Sponsor|33|||
127653341|NCT01852058|459352399|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
127653342|NCT01852058|459352400|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
127653343|NCT01852058|459352401|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
127653344|NCT01852058|459352390|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
127653345|NCT01852058|459352391|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
127653346|NCT01852058|459352392|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
127653347|NCT01852058|459352393|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
127653348|NCT01852058|459352394|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
127653349|NCT01852058|459352395|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
127653350|NCT01852058|459352396|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
127653351|NCT01852058|459352397|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
127653352|NCT01852058|459352398|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
127653353|NCT01852058|459352399|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
127653354|NCT01852058|459352400|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
127653355|NCT01852058|459352401|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
127653356|NCT01852058|459352390|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
127653357|NCT01852058|459352391|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
127653358|NCT01852058|459352392|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
127653359|NCT01852058|459352393|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
127653360|NCT01852058|459352394|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
127653361|NCT01852058|459352395|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
127653362|NCT01852058|459352396|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
127653363|NCT01852058|459352397|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
127653364|NCT01852058|459352398|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
127653365|NCT01852058|459352399|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
127653366|NCT01852058|459352400|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
127653367|NCT01852058|459352401|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
127653368|NCT01852058|459352390|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
127653369|NCT01852058|459352391|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
127653370|NCT01852058|459352392|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
127653371|NCT01852058|459352393|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
127653372|NCT01852058|459352394|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
127653373|NCT01852058|459352395|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
127653374|NCT01852058|459352396|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
127653375|NCT01852058|459352397|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
127653376|NCT01852058|459352398|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
127653377|NCT01852058|459352399|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
127653378|NCT01852058|459352400|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
127653379|NCT01852058|459352401|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
127653380|NCT01852058|459352390|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
127984852|NCT00412217|460568075|FG000|Overall Study|Other|1|||
127984853|NCT00412217|460568076|FG001|Overall Study|Other|1|||
127984854|NCT03114657|460568078|FG000|Overall Study|Adverse Event|9|||
127984855|NCT03114657|460568079|FG001|Overall Study|Adverse Event|6|||
127984856|NCT03114657|460568078|FG000|Overall Study|Death|4|||
127984857|NCT03114657|460568079|FG001|Overall Study|Death|0|||
127984858|NCT03114657|460568078|FG000|Overall Study|Multiple Reasons|1|||
127984859|NCT03114657|460568079|FG001|Overall Study|Multiple Reasons|2|||
127984860|NCT03114657|460568078|FG000|Overall Study|Physician Decision|2|||
127984861|NCT03114657|460568079|FG001|Overall Study|Physician Decision|2|||
127984862|NCT03114657|460568078|FG000|Overall Study|Study Terminated By Sponsor|355|||
127984863|NCT03114657|460568079|FG001|Overall Study|Study Terminated By Sponsor|374|||
127984864|NCT03114657|460568078|FG000|Overall Study|Symptomatic Deterioration|0|||
127984865|NCT03114657|460568079|FG001|Overall Study|Symptomatic Deterioration|1|||
127984866|NCT03114657|460568078|FG000|Overall Study|Withdrawal by Subject|28|||
127984867|NCT03114657|460568079|FG001|Overall Study|Withdrawal by Subject|22|||
127984868|NCT01179737|460568081|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
127984869|NCT01179737|460568082|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
127984870|NCT01179737|460568083|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
127984871|NCT01179737|460568084|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
127984872|NCT01179737|460568081|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
127984873|NCT01179737|460568082|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
127984874|NCT01179737|460568083|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
127984875|NCT01179737|460568084|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
127984876|NCT01179737|460568081|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
127984877|NCT01179737|460568082|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
127984878|NCT01179737|460568083|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
127984879|NCT01179737|460568084|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
127984880|NCT01179737|460568081|FG000|Cohort 1 & Cohort 2|Death|0|||
127984881|NCT01179737|460568082|FG001|Cohort 1 & Cohort 2|Death|0|||
127984882|NCT01179737|460568083|FG002|Cohort 1 & Cohort 2|Death|1|||
127984883|NCT01179737|460568084|FG003|Cohort 1 & Cohort 2|Death|0|||
127984884|NCT01179737|460568081|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
127984885|NCT01179737|460568082|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
127984886|NCT01179737|460568083|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
127984887|NCT01179737|460568084|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
127984888|NCT01179737|460568081|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
127984889|NCT01179737|460568082|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
127984890|NCT01179737|460568083|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
127984891|NCT01179737|460568084|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
127984892|NCT01179737|460568081|FG000|Extension|The study was terminated|3|||
127984893|NCT01179737|460568082|FG001|Extension|The study was terminated|0|||
127984894|NCT01179737|460568083|FG002|Extension|The study was terminated|0|||
127984895|NCT01179737|460568084|FG003|Extension|The study was terminated|0|||
127984896|NCT01546038|460568085|FG000|Overall Study|Death|15|||
127984897|NCT01546038|460568086|FG001|Overall Study|Death|6|||
127984898|NCT01546038|460568087|FG002|Overall Study|Death|4|||
127984899|NCT01546038|460568088|FG003|Overall Study|Death|2|||
127984900|NCT01546038|460568089|FG004|Overall Study|Death|9|||
127984901|NCT01546038|460568090|FG005|Overall Study|Death|3|||
127984902|NCT01546038|460568091|FG006|Overall Study|Death|46|||
127984903|NCT01546038|460568092|FG007|Overall Study|Death|76|||
127984904|NCT01546038|460568093|FG008|Overall Study|Death|39|||
127984905|NCT01546038|460568085|FG000|Overall Study|Lost to Follow-up|0|||
127984906|NCT01546038|460568086|FG001|Overall Study|Lost to Follow-up|0|||
127984907|NCT01546038|460568087|FG002|Overall Study|Lost to Follow-up|0|||
127984908|NCT01546038|460568088|FG003|Overall Study|Lost to Follow-up|0|||
127984909|NCT01546038|460568089|FG004|Overall Study|Lost to Follow-up|1|||
127984910|NCT01546038|460568090|FG005|Overall Study|Lost to Follow-up|0|||
127984911|NCT01546038|460568091|FG006|Overall Study|Lost to Follow-up|2|||
127984912|NCT01546038|460568092|FG007|Overall Study|Lost to Follow-up|1|||
127984913|NCT01546038|460568093|FG008|Overall Study|Lost to Follow-up|0|||
127984914|NCT01546038|460568085|FG000|Overall Study|Withdrawal by Subject|1|||
127984915|NCT01546038|460568086|FG001|Overall Study|Withdrawal by Subject|0|||
127984916|NCT01546038|460568087|FG002|Overall Study|Withdrawal by Subject|0|||
127984917|NCT01546038|460568088|FG003|Overall Study|Withdrawal by Subject|1|||
127984918|NCT01546038|460568089|FG004|Overall Study|Withdrawal by Subject|0|||
127984919|NCT01546038|460568090|FG005|Overall Study|Withdrawal by Subject|1|||
127984920|NCT01546038|460568091|FG006|Overall Study|Withdrawal by Subject|3|||
127984921|NCT01546038|460568092|FG007|Overall Study|Withdrawal by Subject|3|||
127984922|NCT01546038|460568093|FG008|Overall Study|Withdrawal by Subject|1|||
127984923|NCT01546038|460568085|FG000|Overall Study|: Randomized, not treated|0|||
127984924|NCT01546038|460568086|FG001|Overall Study|: Randomized, not treated|0|||
127984925|NCT01546038|460568087|FG002|Overall Study|: Randomized, not treated|0|||
127984926|NCT01546038|460568088|FG003|Overall Study|: Randomized, not treated|0|||
127984927|NCT01546038|460568089|FG004|Overall Study|: Randomized, not treated|0|||
127984928|NCT01546038|460568090|FG005|Overall Study|: Randomized, not treated|0|||
127984929|NCT01546038|460568091|FG006|Overall Study|: Randomized, not treated|2|||
127984930|NCT01546038|460568092|FG007|Overall Study|: Randomized, not treated|4|||
127984931|NCT01546038|460568093|FG008|Overall Study|: Randomized, not treated|3|||
127984932|NCT04245202|460568094|FG000|Overall Study|Lack of Efficacy|10|||
127984933|NCT04245202|460568095|FG001|Overall Study|Lack of Efficacy|1|||
127984934|NCT00717275|460568099|FG000|Overall Study|Premature study termination.|3|||
127984935|NCT03329248|460568102|FG000|Overall Study|Progressive Disease|6|||
127984936|NCT01254721|460568107|FG000|Overall Study|Lost to Follow-up|0|||
127984937|NCT01254721|460568108|FG001|Overall Study|Lost to Follow-up|4|||
127984938|NCT01254721|460568107|FG000|Overall Study|Lack of Efficacy|4|||
127984939|NCT01254721|460568108|FG001|Overall Study|Lack of Efficacy|2|||
127984940|NCT01254721|460568107|FG000|Overall Study|Death|0|||
127984941|NCT01254721|460568108|FG001|Overall Study|Death|1|||
127984942|NCT01254721|460568107|FG000|Overall Study|technical problum|1|||
127984943|NCT01254721|460568108|FG001|Overall Study|technical problum|0|||
127984944|NCT01254721|460568107|FG000|Overall Study|Adverse Event|2|||
127984945|NCT01254721|460568108|FG001|Overall Study|Adverse Event|3|||
127984946|NCT01254721|460568107|FG000|Overall Study|Withdrawal by Subject|8|||
127984947|NCT01254721|460568108|FG001|Overall Study|Withdrawal by Subject|11|||
127984948|NCT01254721|460568107|FG000|Overall Study|Wrongly randomization|0|||
127984949|NCT01254721|460568108|FG001|Overall Study|Wrongly randomization|1|||
127984950|NCT00987402|460568109|FG000|Overall Study|Insufficient data entry|86|||
127984951|NCT00987402|460568110|FG001|Overall Study|Insufficient data entry|98|||
127984952|NCT01430624|460568111|FG000|Overall Study|Lost to Follow-up|23|||
127984953|NCT01430624|460568112|FG001|Overall Study|Lost to Follow-up|29|||
127984954|NCT01430624|460568113|FG002|Overall Study|Lost to Follow-up|27|||
127984955|NCT01430624|460568111|FG000|Overall Study|technical or eligibility|5|||
127984956|NCT01430624|460568112|FG001|Overall Study|technical or eligibility|5|||
127984957|NCT01430624|460568113|FG002|Overall Study|technical or eligibility|2|||
127984958|NCT01362517|460568118|FG000|Overall Study|Protocol Violation|1|||
127984959|NCT01362517|460568118|FG000|Overall Study|Lost to Follow-up|1|||
127984960|NCT03209518|460568121|FG000|Overall Study|Case Report Forms Uncollected|1|||
127984961|NCT03209518|460568121|FG000|Overall Study|Protocol Deviation|1|||
127984962|NCT00236899|460568122|FG000|Overall Study|Adverse Event (Study Related)|1|||
127984963|NCT00236899|460568123|FG001|Overall Study|Adverse Event (Study Related)|1|||
127984964|NCT00236899|460568124|FG002|Overall Study|Adverse Event (Study Related)|2|||
127984965|NCT00236899|460568125|FG003|Overall Study|Adverse Event (Study Related)|1|||
127984966|NCT00236899|460568122|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
127984967|NCT00236899|460568123|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
127984968|NCT00236899|460568124|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
127984969|NCT00236899|460568125|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
127984970|NCT00236899|460568122|FG000|Overall Study|Death (Study Disease)|1|||
127984971|NCT00236899|460568123|FG001|Overall Study|Death (Study Disease)|4|||
127984972|NCT00236899|460568124|FG002|Overall Study|Death (Study Disease)|0|||
127984973|NCT00236899|460568125|FG003|Overall Study|Death (Study Disease)|0|||
127984974|NCT00236899|460568122|FG000|Overall Study|Death (Not Study Related)|2|||
127984975|NCT00236899|460568123|FG001|Overall Study|Death (Not Study Related)|0|||
127984976|NCT00236899|460568124|FG002|Overall Study|Death (Not Study Related)|0|||
127984977|NCT00236899|460568125|FG003|Overall Study|Death (Not Study Related)|0|||
127984978|NCT00236899|460568122|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
127984979|NCT00236899|460568123|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
127984980|NCT00236899|460568124|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
127984981|NCT00236899|460568125|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
127984982|NCT00236899|460568122|FG000|Overall Study|Lost to Follow-up|0|||
127984983|NCT00236899|460568123|FG001|Overall Study|Lost to Follow-up|1|||
127984984|NCT00236899|460568124|FG002|Overall Study|Lost to Follow-up|0|||
127984985|NCT00236899|460568125|FG003|Overall Study|Lost to Follow-up|0|||
127984986|NCT00236899|460568122|FG000|Overall Study|Entry Criteria Exclusion|0|||
127984987|NCT00236899|460568123|FG001|Overall Study|Entry Criteria Exclusion|1|||
127984988|NCT00236899|460568124|FG002|Overall Study|Entry Criteria Exclusion|1|||
127984989|NCT00236899|460568125|FG003|Overall Study|Entry Criteria Exclusion|0|||
127984990|NCT00236899|460568122|FG000|Overall Study|Protocol Violation|1|||
127984991|NCT00236899|460568123|FG001|Overall Study|Protocol Violation|0|||
127984992|NCT00236899|460568124|FG002|Overall Study|Protocol Violation|0|||
127984993|NCT00236899|460568125|FG003|Overall Study|Protocol Violation|0|||
127984994|NCT00236899|460568122|FG000|Overall Study|Withdrawal by Subject|6|||
127984995|NCT00236899|460568123|FG001|Overall Study|Withdrawal by Subject|4|||
127984996|NCT00236899|460568124|FG002|Overall Study|Withdrawal by Subject|5|||
127984997|NCT00236899|460568125|FG003|Overall Study|Withdrawal by Subject|2|||
127984998|NCT00236899|460568122|FG000|Overall Study|Physician Decision|7|||
127984999|NCT00236899|460568123|FG001|Overall Study|Physician Decision|8|||
127985000|NCT00236899|460568124|FG002|Overall Study|Physician Decision|7|||
127985001|NCT00236899|460568125|FG003|Overall Study|Physician Decision|6|||
127985002|NCT00236899|460568122|FG000|Overall Study|Satisfactory Response|2|||
127985003|NCT00236899|460568123|FG001|Overall Study|Satisfactory Response|0|||
127985004|NCT00236899|460568124|FG002|Overall Study|Satisfactory Response|0|||
127985005|NCT00236899|460568125|FG003|Overall Study|Satisfactory Response|1|||
127985006|NCT00236899|460568122|FG000|Overall Study|Lack of Efficacy|18|||
127985007|NCT00236899|460568123|FG001|Overall Study|Lack of Efficacy|18|||
127985008|NCT00236899|460568124|FG002|Overall Study|Lack of Efficacy|25|||
127985009|NCT00236899|460568125|FG003|Overall Study|Lack of Efficacy|23|||
127985010|NCT03379792|460568127|FG000|Overall Study|Physician Decision|0|||
127985011|NCT03379792|460568128|FG001|Overall Study|Physician Decision|0|||
127985012|NCT03379792|460568129|FG002|Overall Study|Physician Decision|0|||
127985013|NCT03379792|460568130|FG003|Overall Study|Physician Decision|1|||
127985014|NCT03379792|460568131|FG004|Overall Study|Physician Decision|0|||
127985015|NCT03379792|460568132|FG005|Overall Study|Physician Decision|0|||
127985016|NCT03379792|460568127|FG000|Overall Study|Withdrawal by Subject|0|||
127985017|NCT03379792|460568128|FG001|Overall Study|Withdrawal by Subject|0|||
127985018|NCT03379792|460568129|FG002|Overall Study|Withdrawal by Subject|0|||
127985019|NCT03379792|460568130|FG003|Overall Study|Withdrawal by Subject|0|||
127985020|NCT03379792|460568131|FG004|Overall Study|Withdrawal by Subject|1|||
127985021|NCT03379792|460568132|FG005|Overall Study|Withdrawal by Subject|1|||
127985022|NCT01121536|460568133|FG000|Overall Study|Adverse Event|63|||
127985023|NCT01121536|460568133|FG000|Overall Study|Lack of Efficacy|35|||
127985024|NCT01121536|460568133|FG000|Overall Study|Withdrawal by Subject|65|||
127985025|NCT01121536|460568133|FG000|Overall Study|Protocol Violation|20|||
127985026|NCT01121536|460568133|FG000|Overall Study|Noncompliance with study medication|12|||
127985027|NCT01121536|460568133|FG000|Overall Study|Noncompliance with study procedures|9|||
127985028|NCT01121536|460568133|FG000|Overall Study|Lost to Follow-up|39|||
127985029|NCT01121536|460568133|FG000|Overall Study|Other|118|||
127985030|NCT02854605|460568136|FG000|Overall Study|Adverse Event|1|||
127985031|NCT02854605|460568137|FG001|Overall Study|Adverse Event|5|||
127985032|NCT02854605|460568138|FG002|Overall Study|Adverse Event|2|||
127985033|NCT02854605|460568136|FG000|Overall Study|Lost to Follow-up|0|||
127985034|NCT02854605|460568137|FG001|Overall Study|Lost to Follow-up|2|||
127985035|NCT02854605|460568138|FG002|Overall Study|Lost to Follow-up|0|||
127985036|NCT02854605|460568136|FG000|Overall Study|Withdrew Consent|1|||
127985037|NCT02854605|460568137|FG001|Overall Study|Withdrew Consent|0|||
127985038|NCT02854605|460568138|FG002|Overall Study|Withdrew Consent|1|||
127985039|NCT02854605|460568136|FG000|Overall Study|Investigator's Discretion|1|||
127985040|NCT02854605|460568137|FG001|Overall Study|Investigator's Discretion|0|||
127985041|NCT02854605|460568138|FG002|Overall Study|Investigator's Discretion|0|||
127985042|NCT02854605|460568136|FG000|Overall Study|Protocol Violation|0|||
127985043|NCT02854605|460568137|FG001|Overall Study|Protocol Violation|0|||
127985044|NCT02854605|460568138|FG002|Overall Study|Protocol Violation|1|||
127985045|NCT00568334|460568141|FG000|Overall Study|Withdrawal by Subject|0|||
127653381|NCT01852058|459352391|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
127653382|NCT01852058|459352392|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
127653383|NCT01852058|459352393|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
127653384|NCT01852058|459352394|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
127653385|NCT01852058|459352395|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
127653386|NCT01852058|459352396|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
127653387|NCT01852058|459352397|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
127985046|NCT00568334|460568142|FG001|Overall Study|Withdrawal by Subject|1|||
127985047|NCT00568334|460568141|FG000|Overall Study|Lost to Follow-up|1|||
127985048|NCT00568334|460568142|FG001|Overall Study|Lost to Follow-up|0|||
127985049|NCT01897571|460568143|FG000|Overall Study|Lost to Follow-up|3|||
127985050|NCT01897571|460568144|FG001|Overall Study|Lost to Follow-up|0|||
127985051|NCT01897571|460568145|FG002|Overall Study|Lost to Follow-up|0|||
127985052|NCT01897571|460568146|FG003|Overall Study|Lost to Follow-up|0|||
127985053|NCT01897571|460568147|FG004|Overall Study|Lost to Follow-up|2|||
127985054|NCT01897571|460568148|FG005|Overall Study|Lost to Follow-up|0|||
127985055|NCT01897571|460568149|FG006|Overall Study|Lost to Follow-up|0|||
127985056|NCT01897571|460568150|FG007|Overall Study|Lost to Follow-up|0|||
127985057|NCT01897571|460568151|FG008|Overall Study|Lost to Follow-up|1|||
127985058|NCT01897571|460568152|FG009|Overall Study|Lost to Follow-up|2|||
127985059|NCT01897571|460568153|FG010|Overall Study|Lost to Follow-up|4|||
127985060|NCT01897571|460568143|FG000|Overall Study|Withdrawal by Subject|0|||
127985061|NCT01897571|460568144|FG001|Overall Study|Withdrawal by Subject|0|||
127985062|NCT01897571|460568145|FG002|Overall Study|Withdrawal by Subject|0|||
127653388|NCT01852058|459352398|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
127653389|NCT01852058|459352399|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
127653390|NCT01852058|459352400|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
127653391|NCT01852058|459352401|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
127985063|NCT01897571|460568146|FG003|Overall Study|Withdrawal by Subject|0|||
127985064|NCT01897571|460568147|FG004|Overall Study|Withdrawal by Subject|0|||
127985065|NCT01897571|460568148|FG005|Overall Study|Withdrawal by Subject|0|||
127985066|NCT01897571|460568149|FG006|Overall Study|Withdrawal by Subject|0|||
127985067|NCT01897571|460568150|FG007|Overall Study|Withdrawal by Subject|1|||
127985068|NCT01897571|460568151|FG008|Overall Study|Withdrawal by Subject|4|||
127985069|NCT01897571|460568152|FG009|Overall Study|Withdrawal by Subject|3|||
127985070|NCT01897571|460568153|FG010|Overall Study|Withdrawal by Subject|1|||
127653392|NCT01852058|459352390|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
127985071|NCT01897571|460568143|FG000|Overall Study|Other|1|||
127985072|NCT01897571|460568144|FG001|Overall Study|Other|0|||
127985073|NCT01897571|460568145|FG002|Overall Study|Other|0|||
127985074|NCT01897571|460568146|FG003|Overall Study|Other|3|||
127985075|NCT01897571|460568147|FG004|Overall Study|Other|3|||
127985076|NCT01897571|460568148|FG005|Overall Study|Other|4|||
127985077|NCT01897571|460568149|FG006|Overall Study|Other|7|||
127653393|NCT01852058|459352391|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
127653394|NCT01852058|459352392|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
127653395|NCT01852058|459352393|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
127653396|NCT01852058|459352394|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
127653397|NCT01852058|459352395|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
127653398|NCT01852058|459352396|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
127653399|NCT01852058|459352397|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
127653400|NCT01852058|459352398|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
127653401|NCT01852058|459352399|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
127653402|NCT01852058|459352400|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
127653403|NCT01852058|459352401|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
127653404|NCT01852058|459352390|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
127653405|NCT01852058|459352391|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
127653406|NCT01852058|459352392|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
127653407|NCT01852058|459352393|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
127653408|NCT01852058|459352394|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
127653409|NCT01852058|459352395|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
127653410|NCT01852058|459352396|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
127653411|NCT01852058|459352397|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
127653412|NCT01852058|459352398|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
127653413|NCT01852058|459352399|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
127653414|NCT01852058|459352400|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
127653415|NCT01852058|459352401|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
127653416|NCT00622180|459352402|FG000|Overall Study|Lost to Follow-up|1|||
127653417|NCT00622180|459352403|FG001|Overall Study|Lost to Follow-up|2|||
127653418|NCT01353222|459352408|FG000|Overall Study|Death|30|||
127653419|NCT01353222|459352409|FG001|Overall Study|Death|30|||
127653420|NCT01353222|459352408|FG000|Overall Study|Withdrawal by Subject|8|||
127653421|NCT01353222|459352409|FG001|Overall Study|Withdrawal by Subject|5|||
127653422|NCT01353222|459352408|FG000|Overall Study|Study Terminated|31|||
127653423|NCT01353222|459352409|FG001|Overall Study|Study Terminated|37|||
127653424|NCT01353222|459352408|FG000|Overall Study|Site closed research department|1|||
127653425|NCT01353222|459352409|FG001|Overall Study|Site closed research department|0|||
127653426|NCT02636270|459352410|FG000|Overall Study|Adverse Event|1|||
127653427|NCT02636270|459352411|FG001|Overall Study|Adverse Event|0|||
127653428|NCT02636270|459352412|FG002|Overall Study|Adverse Event|0|||
127653429|NCT02636270|459352410|FG000|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|1|||
127653430|NCT02636270|459352411|FG001|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
127653431|NCT02636270|459352412|FG002|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
127653432|NCT01119898|459352413|FG000|Overall Study|Adverse Event|4|||
127653433|NCT01119898|459352414|FG001|Overall Study|Adverse Event|5|||
127653434|NCT01119898|459352413|FG000|Overall Study|Withdrawal by Subject|1|||
127653435|NCT01119898|459352414|FG001|Overall Study|Withdrawal by Subject|4|||
127653436|NCT01119898|459352413|FG000|Overall Study|Lack of Efficacy|0|||
127653437|NCT01119898|459352414|FG001|Overall Study|Lack of Efficacy|2|||
127653438|NCT01119898|459352413|FG000|Overall Study|Protocol Violation|1|||
127653439|NCT01119898|459352414|FG001|Overall Study|Protocol Violation|1|||
127653440|NCT01119898|459352413|FG000|Overall Study|Medical procedure|1|||
127653441|NCT01119898|459352414|FG001|Overall Study|Medical procedure|0|||
127653442|NCT01119898|459352413|FG000|Overall Study|Randomized in error did not participate|1|||
127653443|NCT01119898|459352414|FG001|Overall Study|Randomized in error did not participate|0|||
127653444|NCT01806584|459352415|FG000|Overall Study|Adverse Event|2|||
127653445|NCT01806584|459352416|FG001|Overall Study|Adverse Event|1|||
127653446|NCT01806584|459352415|FG000|Overall Study|Death|1|||
127653447|NCT01806584|459352416|FG001|Overall Study|Death|0|||
127653448|NCT01806584|459352415|FG000|Overall Study|Lost to Follow-up|0|||
127653449|NCT01806584|459352416|FG001|Overall Study|Lost to Follow-up|2|||
127653450|NCT01806584|459352415|FG000|Overall Study|Study terminated by sponsor|9|||
127653451|NCT01806584|459352416|FG001|Overall Study|Study terminated by sponsor|14|||
127653452|NCT01806584|459352415|FG000|Overall Study|Withdrawal by Subject|1|||
127653453|NCT01806584|459352416|FG001|Overall Study|Withdrawal by Subject|1|||
127653454|NCT01806584|459352415|FG000|Overall Study|Other unspecified|1|||
127653455|NCT01806584|459352416|FG001|Overall Study|Other unspecified|0|||
127653456|NCT04398537|459352423|FG000|Overall Study|Physician Decision|10|||
127653457|NCT04398537|459352424|FG001|Overall Study|Physician Decision|15|||
127653458|NCT03610737|459354786|FG000|Overall Study|Withdrawal by Subject|1|||
127653459|NCT03610737|459354787|FG001|Overall Study|Withdrawal by Subject|5|||
127653460|NCT03610737|459354786|FG000|Overall Study|Death|1|||
127653461|NCT03610737|459354787|FG001|Overall Study|Death|0|||
127653462|NCT03610737|459354786|FG000|Overall Study|Not treated|5|||
127653463|NCT03610737|459354787|FG001|Overall Study|Not treated|2|||
127985078|NCT01897571|460568150|FG007|Overall Study|Other|0|||
127985079|NCT01897571|460568151|FG008|Overall Study|Other|0|||
127985080|NCT01897571|460568152|FG009|Overall Study|Other|0|||
127985081|NCT01897571|460568153|FG010|Overall Study|Other|0|||
127985082|NCT01897571|460568143|FG000|Overall Study|Enrolled in rollover study|0|||
127985083|NCT01897571|460568144|FG001|Overall Study|Enrolled in rollover study|0|||
127985084|NCT01897571|460568145|FG002|Overall Study|Enrolled in rollover study|0|||
127985085|NCT01897571|460568146|FG003|Overall Study|Enrolled in rollover study|0|||
127985086|NCT01897571|460568147|FG004|Overall Study|Enrolled in rollover study|0|||
127985087|NCT01897571|460568148|FG005|Overall Study|Enrolled in rollover study|0|||
127985088|NCT01897571|460568149|FG006|Overall Study|Enrolled in rollover study|0|||
127985089|NCT01897571|460568150|FG007|Overall Study|Enrolled in rollover study|9|||
127985090|NCT01897571|460568151|FG008|Overall Study|Enrolled in rollover study|7|||
127985091|NCT01897571|460568152|FG009|Overall Study|Enrolled in rollover study|9|||
127985092|NCT01897571|460568153|FG010|Overall Study|Enrolled in rollover study|1|||
127985093|NCT01897571|460568143|FG000|Overall Study|Death|2|||
127985094|NCT01897571|460568144|FG001|Overall Study|Death|2|||
127985095|NCT01897571|460568145|FG002|Overall Study|Death|3|||
127985096|NCT01897571|460568146|FG003|Overall Study|Death|6|||
127985097|NCT01897571|460568147|FG004|Overall Study|Death|7|||
127985098|NCT01897571|460568148|FG005|Overall Study|Death|9|||
127985099|NCT01897571|460568149|FG006|Overall Study|Death|5|||
127985100|NCT01897571|460568150|FG007|Overall Study|Death|22|||
127985101|NCT01897571|460568151|FG008|Overall Study|Death|23|||
127985102|NCT01897571|460568152|FG009|Overall Study|Death|129|||
127985103|NCT01897571|460568153|FG010|Overall Study|Death|59|||
127985104|NCT00306787|460568155|FG000|Overall Study|Discontinued without taking study drug|208|||
127985105|NCT00306787|460568156|FG001|Overall Study|Discontinued without taking study drug|215|||
127985106|NCT00306787|460568155|FG000|Overall Study|Adverse Event|1|||
127985107|NCT00306787|460568156|FG001|Overall Study|Adverse Event|1|||
127985108|NCT00306787|460568155|FG000|Overall Study|Lack of Efficacy|1|||
127985109|NCT00306787|460568156|FG001|Overall Study|Lack of Efficacy|0|||
127985110|NCT00306787|460568155|FG000|Overall Study|Protocol Violation|8|||
127985111|NCT00306787|460568156|FG001|Overall Study|Protocol Violation|10|||
127985112|NCT00306787|460568155|FG000|Overall Study|Withdrawal by Subject|2|||
127985113|NCT00306787|460568156|FG001|Overall Study|Withdrawal by Subject|9|||
127985114|NCT00306787|460568155|FG000|Overall Study|Lost to Follow-up|9|||
127985115|NCT00306787|460568156|FG001|Overall Study|Lost to Follow-up|6|||
127985116|NCT00306787|460568155|FG000|Overall Study|Administrative problems|4|||
127985117|NCT00306787|460568156|FG001|Overall Study|Administrative problems|0|||
127985118|NCT00306787|460568155|FG000|Overall Study|Abnormal laboratory value(s)|1|||
127985119|NCT00306787|460568156|FG001|Overall Study|Abnormal laboratory value(s)|0|||
127985120|NCT02273908|460568157|FG000|Overall Study|Adverse Event|16|||
127985121|NCT02273908|460568158|FG001|Overall Study|Adverse Event|0|||
127985122|NCT02273908|460568157|FG000|Overall Study|Lost to Follow-up|10|||
127985123|NCT02273908|460568158|FG001|Overall Study|Lost to Follow-up|1|||
127985124|NCT02273908|460568157|FG000|Overall Study|Did not meet entrance criteria|3|||
127985125|NCT02273908|460568158|FG001|Overall Study|Did not meet entrance criteria|2|||
127985126|NCT02273908|460568157|FG000|Overall Study|Withdrawal by Subject|4|||
127985127|NCT02273908|460568158|FG001|Overall Study|Withdrawal by Subject|2|||
127985128|NCT04908475|460568159|FG000|Period A (Baseline to Week 16)|Lost to Follow-up|3|||
127985129|NCT04908475|460568160|FG001|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
127985130|NCT04908475|460568161|FG002|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
127985131|NCT04908475|460568162|FG003|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
127985132|NCT04908475|460568163|FG004|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
127985133|NCT04908475|460568164|FG005|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
127985134|NCT04908475|460568159|FG000|Period A (Baseline to Week 16)|Withdrawal by Subject|9|||
127985135|NCT04908475|460568160|FG001|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
127985136|NCT04908475|460568161|FG002|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
127985137|NCT04908475|460568162|FG003|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
127985138|NCT04908475|460568163|FG004|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
127985139|NCT04908475|460568164|FG005|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
127985140|NCT04908475|460568159|FG000|Period A (Baseline to Week 16)|Other, Not Specified|6|||
127985141|NCT04908475|460568160|FG001|Period A (Baseline to Week 16)|Other, Not Specified|0|||
127985142|NCT04908475|460568161|FG002|Period A (Baseline to Week 16)|Other, Not Specified|0|||
127985143|NCT04908475|460568162|FG003|Period A (Baseline to Week 16)|Other, Not Specified|0|||
127985144|NCT04908475|460568163|FG004|Period A (Baseline to Week 16)|Other, Not Specified|0|||
127985145|NCT04908475|460568164|FG005|Period A (Baseline to Week 16)|Other, Not Specified|0|||
127985146|NCT04908475|460568159|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
127985147|NCT04908475|460568160|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
127985148|NCT04908475|460568161|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|4|||
127985149|NCT04908475|460568162|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
127985150|NCT04908475|460568163|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
127985151|NCT04908475|460568164|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
127985152|NCT04908475|460568159|FG000|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
127985153|NCT04908475|460568160|FG001|Period B (Week 16 to Week 52)|Withdrawal by Subject|5|||
127985154|NCT04908475|460568161|FG002|Period B (Week 16 to Week 52)|Withdrawal by Subject|13|||
127985155|NCT04908475|460568162|FG003|Period B (Week 16 to Week 52)|Withdrawal by Subject|2|||
127985156|NCT04908475|460568163|FG004|Period B (Week 16 to Week 52)|Withdrawal by Subject|3|||
127985157|NCT04908475|460568164|FG005|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
127985158|NCT04908475|460568159|FG000|Period B (Week 16 to Week 52)|Other, Not Specified|0|||
127985159|NCT04908475|460568160|FG001|Period B (Week 16 to Week 52)|Other, Not Specified|38|||
127985160|NCT04908475|460568161|FG002|Period B (Week 16 to Week 52)|Other, Not Specified|19|||
127985161|NCT04908475|460568162|FG003|Period B (Week 16 to Week 52)|Other, Not Specified|18|||
127985162|NCT04908475|460568163|FG004|Period B (Week 16 to Week 52)|Other, Not Specified|4|||
127985163|NCT04908475|460568164|FG005|Period B (Week 16 to Week 52)|Other, Not Specified|7|||
127985164|NCT03913104|460568167|FG000|Overall Study|Lost to Follow-up|20|||
127985165|NCT03913104|460568167|FG000|Overall Study|Did Not Take Mifepristone or Misoprostol|8|||
127985166|NCT03913104|460568167|FG000|Overall Study|Withdrawal by Subject|2|||
127985167|NCT00089635|460568168|FG000|Overall Study|Adverse Event|2|||
127985168|NCT00089635|460568168|FG000|Overall Study|Death|17|||
127985169|NCT00089635|460568168|FG000|Overall Study|Disease Progression|12|||
127985170|NCT00089635|460568168|FG000|Overall Study|Lost to Follow-up|3|||
127985171|NCT00089635|460568168|FG000|Overall Study|Withdrawal by Subject|6|||
127985172|NCT00089635|460568168|FG000|Overall Study|Ineligibility determined|1|||
127985173|NCT00089635|460568168|FG000|Overall Study|Other|2|||
127985174|NCT01593254|460568172|FG000|Overall Study|Disease progression|2|||
127985175|NCT01593254|460568173|FG001|Overall Study|Disease progression|7|||
127985176|NCT01593254|460568172|FG000|Overall Study|Study drug toxicity|6|||
127985177|NCT01593254|460568173|FG001|Overall Study|Study drug toxicity|20|||
127985178|NCT01593254|460568172|FG000|Overall Study|Death|3|||
127985179|NCT01593254|460568173|FG001|Overall Study|Death|3|||
127985180|NCT01593254|460568172|FG000|Overall Study|AE unrelated to study drug|0|||
127985181|NCT01593254|460568173|FG001|Overall Study|AE unrelated to study drug|1|||
127985182|NCT01593254|460568172|FG000|Overall Study|participant request to discontinue study treatment|1|||
127985183|NCT01593254|460568173|FG001|Overall Study|participant request to discontinue study treatment|3|||
127985184|NCT01593254|460568172|FG000|Overall Study|participant withdrew consent|0|||
127985185|NCT01593254|460568173|FG001|Overall Study|participant withdrew consent|9|||
127985186|NCT01593254|460568172|FG000|Overall Study|lost to follow up|1|||
127985187|NCT01593254|460568173|FG001|Overall Study|lost to follow up|6|||
127985188|NCT01593254|460568172|FG000|Overall Study|maximum clinical benefit|1|||
127985189|NCT01593254|460568173|FG001|Overall Study|maximum clinical benefit|2|||
127985190|NCT01593254|460568172|FG000|Overall Study|Poor/non compliance|1|||
127985191|NCT01593254|460568173|FG001|Overall Study|Poor/non compliance|1|||
127985192|NCT01593254|460568172|FG000|Overall Study|Pregnancy|0|||
127985193|NCT01593254|460568173|FG001|Overall Study|Pregnancy|3|||
127985194|NCT01593254|460568172|FG000|Overall Study|participant no longer meets study criteria|1|||
127985195|NCT01593254|460568173|FG001|Overall Study|participant no longer meets study criteria|1|||
127985196|NCT01593254|460568172|FG000|Overall Study|Admin reason by sponsor|7|||
127985197|NCT01593254|460568173|FG001|Overall Study|Admin reason by sponsor|3|||
127985198|NCT01593254|460568172|FG000|Overall Study|Imatinib treatment failure|2|||
127985199|NCT01593254|460568173|FG001|Overall Study|Imatinib treatment failure|0|||
127985200|NCT01593254|460568172|FG000|Overall Study|Other Reasons|61|||
127985201|NCT01593254|460568173|FG001|Overall Study|Other Reasons|115|||
127985202|NCT00076999|460568174|FG000|Overall Study|Adverse Event|2|||
127985203|NCT00076999|460568175|FG001|Overall Study|Adverse Event|8|||
127985204|NCT00076999|460568176|FG002|Overall Study|Adverse Event|6|||
127985205|NCT00076999|460568177|FG003|Overall Study|Adverse Event|0|||
127985206|NCT00076999|460568178|FG004|Overall Study|Adverse Event|2|||
127985207|NCT00076999|460568174|FG000|Overall Study|Protocol Violation|0|||
127985208|NCT00076999|460568175|FG001|Overall Study|Protocol Violation|3|||
127985209|NCT00076999|460568176|FG002|Overall Study|Protocol Violation|4|||
127985210|NCT00076999|460568177|FG003|Overall Study|Protocol Violation|0|||
127985211|NCT00076999|460568178|FG004|Overall Study|Protocol Violation|9|||
127985212|NCT00076999|460568174|FG000|Overall Study|Lost to Follow-up|2|||
127985213|NCT00076999|460568175|FG001|Overall Study|Lost to Follow-up|1|||
127985214|NCT00076999|460568176|FG002|Overall Study|Lost to Follow-up|0|||
127985215|NCT00076999|460568177|FG003|Overall Study|Lost to Follow-up|0|||
127985216|NCT00076999|460568178|FG004|Overall Study|Lost to Follow-up|0|||
127985217|NCT00076999|460568174|FG000|Overall Study|Withdrawal by Subject|0|||
127985218|NCT00076999|460568175|FG001|Overall Study|Withdrawal by Subject|4|||
127985219|NCT00076999|460568176|FG002|Overall Study|Withdrawal by Subject|3|||
127985220|NCT00076999|460568177|FG003|Overall Study|Withdrawal by Subject|0|||
127985221|NCT00076999|460568178|FG004|Overall Study|Withdrawal by Subject|1|||
127985222|NCT00076999|460568174|FG000|Overall Study|Other reason (not specified)|8|||
127985223|NCT00076999|460568175|FG001|Overall Study|Other reason (not specified)|8|||
127985224|NCT00076999|460568176|FG002|Overall Study|Other reason (not specified)|4|||
127985225|NCT00076999|460568177|FG003|Overall Study|Other reason (not specified)|1|||
127985226|NCT00076999|460568178|FG004|Overall Study|Other reason (not specified)|13|||
127985227|NCT02603562|460568183|FG000|Overall Study|Lost to Follow-up|1|||
127985228|NCT00932698|460568198|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
127985229|NCT00932698|460568199|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
127985230|NCT00932698|460568200|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
127653464|NCT03610737|459354786|FG000|Overall Study|Missed Visit|1|||
127985231|NCT00932698|460568201|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
127985232|NCT00932698|460568202|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
127985233|NCT00932698|460568203|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
127985234|NCT00932698|460568204|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
127985235|NCT00932698|460568205|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
127985236|NCT00932698|460568206|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
127985237|NCT00932698|460568207|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
127985238|NCT00932698|460568208|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
127985239|NCT00932698|460568198|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
127653465|NCT03610737|459354787|FG001|Overall Study|Missed Visit|2|||
127653466|NCT02991482|459354788|FG000|Overall Study|Disease progression|56|||
127653467|NCT02991482|459354789|FG001|Overall Study|Disease progression|47|||
127653468|NCT02991482|459354788|FG000|Overall Study|Death|4|||
127653469|NCT02991482|459354789|FG001|Overall Study|Death|4|||
127653470|NCT02991482|459354788|FG000|Overall Study|Adverse Event|1|||
127653471|NCT02991482|459354789|FG001|Overall Study|Adverse Event|6|||
127653472|NCT02991482|459354788|FG000|Overall Study|Patient decision|1|||
127653473|NCT02991482|459354789|FG001|Overall Study|Patient decision|1|||
127653474|NCT02991482|459354788|FG000|Overall Study|Physician Decision|0|||
127653475|NCT02991482|459354789|FG001|Overall Study|Physician Decision|6|||
127653476|NCT02991482|459354788|FG000|Overall Study|Clinical deterioration|1|||
127653477|NCT02991482|459354789|FG001|Overall Study|Clinical deterioration|0|||
127653478|NCT02991482|459354788|FG000|Overall Study|Patient feeling too unwell|1|||
127653479|NCT02991482|459354789|FG001|Overall Study|Patient feeling too unwell|0|||
127653480|NCT02991482|459354788|FG000|Overall Study|Worsening of performance status|0|||
127653481|NCT02991482|459354789|FG001|Overall Study|Worsening of performance status|1|||
127653482|NCT02991482|459354788|FG000|Overall Study|Death prior to study drug initiation|1|||
127653483|NCT02991482|459354789|FG001|Overall Study|Death prior to study drug initiation|0|||
127653484|NCT02991482|459354788|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
127653485|NCT02991482|459354789|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
127653486|NCT02396537|459354792|FG000|Overall Study|Protocol Violation|0|||
127653487|NCT02396537|459354793|FG001|Overall Study|Protocol Violation|1|||
127653488|NCT00871403|459354794|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
127653489|NCT00871403|459354795|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
127653490|NCT00871403|459354796|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
127653491|NCT00871403|459354794|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
127653492|NCT00871403|459354795|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
127653493|NCT00871403|459354796|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
127653494|NCT00871403|459354794|FG000|Combination Treatment Phase|Adverse Event|0|||
127653495|NCT00871403|459354795|FG001|Combination Treatment Phase|Adverse Event|17|||
127653496|NCT00871403|459354796|FG002|Combination Treatment Phase|Adverse Event|2|||
127653497|NCT00871403|459354794|FG000|Combination Treatment Phase|Disease Progression|0|||
127653498|NCT00871403|459354795|FG001|Combination Treatment Phase|Disease Progression|8|||
127653499|NCT00871403|459354796|FG002|Combination Treatment Phase|Disease Progression|5|||
127653500|NCT00871403|459354794|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
127880544|NCT01915498|460183529|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
127880545|NCT01915498|460183530|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
127880546|NCT01915498|460183531|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
127880547|NCT01915498|460183532|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
127880548|NCT01915498|460183533|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
127880549|NCT01915498|460183534|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
127880550|NCT01915498|460183535|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
127880551|NCT01915498|460183517|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
127880552|NCT01915498|460183518|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
127653501|NCT00871403|459354795|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
127653502|NCT00871403|459354796|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
127653503|NCT00871403|459354794|FG000|Combination Treatment Phase|Physician Decision|0|||
127653504|NCT00871403|459354795|FG001|Combination Treatment Phase|Physician Decision|1|||
127653505|NCT00871403|459354796|FG002|Combination Treatment Phase|Physician Decision|3|||
127653506|NCT00871403|459354794|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
127653507|NCT00871403|459354795|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
127653508|NCT00871403|459354796|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
127653509|NCT00871403|459354794|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
127653510|NCT00871403|459354795|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
127653511|NCT00871403|459354796|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
127653512|NCT00787319|459354797|FG000|Overall Study|Lost to Follow-up|2|||
127653513|NCT00787319|459354797|FG000|Overall Study|Withdrawal by Subject|15|||
127985240|NCT00932698|460568199|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
127985241|NCT00932698|460568200|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
127985242|NCT00932698|460568201|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
127985243|NCT00932698|460568202|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
127985244|NCT00932698|460568203|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
127985245|NCT00932698|460568204|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
127985246|NCT00932698|460568205|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
127985247|NCT00932698|460568206|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
127985248|NCT00932698|460568207|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
127985249|NCT00932698|460568208|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
127985250|NCT00932698|460568198|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
127985251|NCT00932698|460568199|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
127985252|NCT00932698|460568200|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
127985253|NCT00932698|460568201|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
127985254|NCT00932698|460568202|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
127985255|NCT00932698|460568203|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
127985256|NCT00932698|460568204|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
127985257|NCT00932698|460568205|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
127985258|NCT00932698|460568206|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
127985259|NCT00932698|460568207|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
127985260|NCT00932698|460568208|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
127985261|NCT00932698|460568198|FG000|Part 1 (Dose Escalation)|Other|0|||
127985262|NCT00932698|460568199|FG001|Part 1 (Dose Escalation)|Other|0|||
127985263|NCT00932698|460568200|FG002|Part 1 (Dose Escalation)|Other|1|||
127985264|NCT00932698|460568201|FG003|Part 1 (Dose Escalation)|Other|0|||
127985265|NCT00932698|460568202|FG004|Part 1 (Dose Escalation)|Other|0|||
127985266|NCT00932698|460568203|FG005|Part 1 (Dose Escalation)|Other|0|||
127985267|NCT00932698|460568204|FG006|Part 1 (Dose Escalation)|Other|1|||
127985268|NCT00932698|460568205|FG007|Part 1 (Dose Escalation)|Other|0|||
127985269|NCT00932698|460568206|FG008|Part 1 (Dose Escalation)|Other|0|||
127985270|NCT00932698|460568207|FG009|Part 1 (Dose Escalation)|Other|0|||
127985271|NCT00932698|460568208|FG010|Part 1 (Dose Escalation)|Other|0|||
127985272|NCT00932698|460568198|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
127985273|NCT00932698|460568199|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
127985274|NCT00932698|460568200|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
127985275|NCT00932698|460568201|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
127985276|NCT00932698|460568202|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
127985277|NCT00932698|460568203|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
127985278|NCT00932698|460568204|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
127985279|NCT00932698|460568205|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
127985280|NCT00932698|460568206|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
127985281|NCT00932698|460568207|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
127985282|NCT00932698|460568208|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
127985283|NCT00932698|460568198|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
127985284|NCT00932698|460568199|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
127985285|NCT00932698|460568200|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
127985286|NCT00932698|460568201|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
127985287|NCT00932698|460568202|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
127985288|NCT00932698|460568203|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
127985289|NCT00932698|460568204|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
127985290|NCT00932698|460568205|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
127985291|NCT00932698|460568206|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
127985292|NCT00932698|460568207|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
127985293|NCT00932698|460568208|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
127985294|NCT00932698|460568198|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
127985295|NCT00932698|460568199|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
127985296|NCT00932698|460568200|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
127985297|NCT00932698|460568201|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
127985298|NCT00932698|460568202|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
127985299|NCT00932698|460568203|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
127985300|NCT00932698|460568204|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
127542711|NCT01231984|458954591|FG001|Study Period 2|Withdrawal by Subject|1|||
127542712|NCT01231984|458954592|FG002|Study Period 2|Withdrawal by Subject|0|||
127542713|NCT01231984|458954593|FG003|Study Period 2|Withdrawal by Subject|0|||
127542714|NCT01231984|458954590|FG000|Study Period 2|Lost to Follow-up|1|||
127542715|NCT01231984|458954591|FG001|Study Period 2|Lost to Follow-up|0|||
127542716|NCT01231984|458954592|FG002|Study Period 2|Lost to Follow-up|0|||
127542717|NCT01231984|458954593|FG003|Study Period 2|Lost to Follow-up|3|||
127542718|NCT01231984|458954590|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
127542719|NCT01231984|458954591|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
127542720|NCT01231984|458954592|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
127985301|NCT00932698|460568205|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
127985302|NCT00932698|460568206|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
127653514|NCT00787319|459354797|FG000|Overall Study|Adverse Event|3|||
127653515|NCT00787319|459354797|FG000|Overall Study|Objective progression or relapse|30|||
127653516|NCT00787319|459354797|FG000|Overall Study|Lack of Efficacy|1|||
127653517|NCT00787319|459354797|FG000|Overall Study|Budget exhausted/exceeded|1|||
127653518|NCT00787319|459354797|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
127653519|NCT00787319|459354797|FG000|Overall Study|No health insurance reimbursement|2|||
127653520|NCT00787319|459354797|FG000|Overall Study|Stabilized disease findings|3|||
127653521|NCT00787319|459354797|FG000|Overall Study|Inactive disease|5|||
127653522|NCT02312856|459354798|FG000|Overall Study|Death|1|||
127653523|NCT02312856|459354798|FG000|Overall Study|Lost to Follow-up|3|||
127653524|NCT01932294|459354799|FG000|Overall Study|Death|43|||
127653525|NCT01932294|459354799|FG000|Overall Study|Lost to Follow-up|8|||
127653526|NCT01932294|459354799|FG000|Overall Study|VAD Implantation|20|||
127653527|NCT01932294|459354799|FG000|Overall Study|Heart Transplantation|16|||
127653528|NCT01932294|459354799|FG000|Overall Study|Transferred to other hospitals|12|||
127653529|NCT04415151|459354800|FG000|Overall Study|Death|1|||
127653530|NCT04415151|459354801|FG001|Overall Study|Death|1|||
127653531|NCT04415151|459354800|FG000|Overall Study|Withdrawal by Subject|1|||
127653532|NCT04415151|459354801|FG001|Overall Study|Withdrawal by Subject|0|||
127653533|NCT00659984|459354810|FG000|Overall Study|Adverse Event|1|||
127653534|NCT00927355|459354811|FG000|Overall Study|Adverse Event|1|||
127653535|NCT00927355|459354812|FG001|Overall Study|Adverse Event|1|||
127653536|NCT01800201|459354813|FG000|Overall Study|Withdrawal by Subject|2|||
127653537|NCT01800201|459354814|FG001|Overall Study|Withdrawal by Subject|0|||
127653538|NCT01800201|459354813|FG000|Overall Study|patient privacy concerns|1|||
127653539|NCT01800201|459354814|FG001|Overall Study|patient privacy concerns|1|||
127653540|NCT01800201|459354813|FG000|Overall Study|did not want to use device|0|||
127653541|NCT01800201|459354814|FG001|Overall Study|did not want to use device|1|||
127653542|NCT01800201|459354813|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
127653543|NCT01800201|459354814|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
127653544|NCT01691521|459354818|FG000|Overall Study|Adverse Event|4|||
127653545|NCT01691521|459354819|FG001|Overall Study|Adverse Event|0|||
127653546|NCT01691521|459354820|FG002|Overall Study|Adverse Event|1|||
127653547|NCT01691521|459354818|FG000|Overall Study|Lack of Efficacy|1|||
127653548|NCT01691521|459354819|FG001|Overall Study|Lack of Efficacy|1|||
127653549|NCT01691521|459354820|FG002|Overall Study|Lack of Efficacy|2|||
127653550|NCT01691521|459354818|FG000|Overall Study|Protocol Violation|0|||
127653551|NCT01691521|459354819|FG001|Overall Study|Protocol Violation|3|||
127985303|NCT00932698|460568207|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
127985304|NCT00932698|460568208|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
127985305|NCT00655681|460568209|FG000|Overall Study|Lost to Follow-up|1|||
127985306|NCT00655681|460568210|FG001|Overall Study|Lost to Follow-up|1|||
127985307|NCT02429310|460568211|FG000|Overall Study|Lost to Follow-up|1|||
127985308|NCT02429310|460568212|FG001|Overall Study|Lost to Follow-up|2|||
127985309|NCT02429310|460568211|FG000|Overall Study|Protocol Violation|1|||
127985310|NCT02429310|460568212|FG001|Overall Study|Protocol Violation|1|||
127985311|NCT01085136|460568213|FG000|Part A|Other Adverse event|223|||
127985312|NCT01085136|460568214|FG001|Part A|Other Adverse event|0|||
127985313|NCT01085136|460568215|FG002|Part A|Other Adverse event|0|||
127985314|NCT01085136|460568213|FG000|Part A|Protocol Violation|3|||
127985315|NCT01085136|460568214|FG001|Part A|Protocol Violation|0|||
127985316|NCT01085136|460568215|FG002|Part A|Protocol Violation|0|||
127985317|NCT01085136|460568213|FG000|Part A|Lost to Follow-up|3|||
127985318|NCT01085136|460568214|FG001|Part A|Lost to Follow-up|0|||
127985319|NCT01085136|460568215|FG002|Part A|Lost to Follow-up|0|||
127985320|NCT01085136|460568213|FG000|Part A|Refusal to continue trial medication|64|||
127985321|NCT01085136|460568214|FG001|Part A|Refusal to continue trial medication|0|||
127985322|NCT01085136|460568215|FG002|Part A|Refusal to continue trial medication|0|||
127985323|NCT01085136|460568213|FG000|Part A|Other reason not defined above|30|||
127985324|NCT01085136|460568214|FG001|Part A|Other reason not defined above|0|||
127985325|NCT01085136|460568215|FG002|Part A|Other reason not defined above|0|||
127985326|NCT01085136|460568213|FG000|Part B|Other AE|0|||
127985327|NCT01085136|460568214|FG001|Part B|Other AE|29|||
127985328|NCT01085136|460568215|FG002|Part B|Other AE|8|||
127985329|NCT01085136|460568213|FG000|Part B|Refusal to continue trial medication|0|||
127985330|NCT01085136|460568214|FG001|Part B|Refusal to continue trial medication|12|||
127653552|NCT01691521|459354820|FG002|Overall Study|Protocol Violation|0|||
127653553|NCT01691521|459354818|FG000|Overall Study|Lost to Follow-up|0|||
127653554|NCT01691521|459354819|FG001|Overall Study|Lost to Follow-up|2|||
127653555|NCT01691521|459354820|FG002|Overall Study|Lost to Follow-up|2|||
127653556|NCT01691521|459354818|FG000|Overall Study|Physician Decision|2|||
127653557|NCT01691521|459354819|FG001|Overall Study|Physician Decision|1|||
127653558|NCT01691521|459354820|FG002|Overall Study|Physician Decision|0|||
127653559|NCT01691521|459354818|FG000|Overall Study|Withdrawal by Subject|5|||
127985331|NCT01085136|460568215|FG002|Part B|Refusal to continue trial medication|7|||
127985332|NCT01085136|460568213|FG000|Part B|Not treated|0|||
127985333|NCT01085136|460568214|FG001|Part B|Not treated|4|||
127985334|NCT01085136|460568215|FG002|Part B|Not treated|8|||
127985335|NCT01085136|460568213|FG000|Part B|Other reason not defined above|0|||
127985336|NCT01085136|460568214|FG001|Part B|Other reason not defined above|6|||
127985337|NCT01085136|460568215|FG002|Part B|Other reason not defined above|3|||
127985338|NCT01764659|460568218|FG000|Overall Study|Death|1|||
127985339|NCT01764659|460568218|FG000|Overall Study|Physician Decision|1|||
127985340|NCT01210352|460568219|FG000|Overall Study|Adverse Event|0|||
127985341|NCT01210352|460568220|FG001|Overall Study|Adverse Event|0|||
127985342|NCT01210352|460568221|FG002|Overall Study|Adverse Event|0|||
127985343|NCT01210352|460568222|FG003|Overall Study|Adverse Event|0|||
127985344|NCT01210352|460568223|FG004|Overall Study|Adverse Event|0|||
127985345|NCT01210352|460568224|FG005|Overall Study|Adverse Event|0|||
127985346|NCT01210352|460568225|FG006|Overall Study|Adverse Event|0|||
127985347|NCT01210352|460568226|FG007|Overall Study|Adverse Event|2|||
127985348|NCT01210352|460568227|FG008|Overall Study|Adverse Event|1|||
127985349|NCT01210352|460568219|FG000|Overall Study|Lack of Efficacy|0|||
127985350|NCT01210352|460568220|FG001|Overall Study|Lack of Efficacy|0|||
127985351|NCT01210352|460568221|FG002|Overall Study|Lack of Efficacy|0|||
127985352|NCT01210352|460568222|FG003|Overall Study|Lack of Efficacy|0|||
127985353|NCT01210352|460568223|FG004|Overall Study|Lack of Efficacy|0|||
127985354|NCT01210352|460568224|FG005|Overall Study|Lack of Efficacy|0|||
127985355|NCT01210352|460568225|FG006|Overall Study|Lack of Efficacy|1|||
127985356|NCT01210352|460568226|FG007|Overall Study|Lack of Efficacy|0|||
127985357|NCT01210352|460568227|FG008|Overall Study|Lack of Efficacy|0|||
127985358|NCT01210352|460568219|FG000|Overall Study|Physician Decision|0|||
127985359|NCT01210352|460568220|FG001|Overall Study|Physician Decision|0|||
127985360|NCT01210352|460568221|FG002|Overall Study|Physician Decision|0|||
127985361|NCT01210352|460568222|FG003|Overall Study|Physician Decision|0|||
127985362|NCT01210352|460568223|FG004|Overall Study|Physician Decision|0|||
127985363|NCT01210352|460568224|FG005|Overall Study|Physician Decision|0|||
127985364|NCT01210352|460568225|FG006|Overall Study|Physician Decision|0|||
127985365|NCT01210352|460568226|FG007|Overall Study|Physician Decision|1|||
127985366|NCT01210352|460568227|FG008|Overall Study|Physician Decision|2|||
127985367|NCT01210352|460568219|FG000|Overall Study|Withdrawal by Subject|0|||
127985368|NCT01210352|460568220|FG001|Overall Study|Withdrawal by Subject|0|||
127985369|NCT01210352|460568221|FG002|Overall Study|Withdrawal by Subject|1|||
127985370|NCT01210352|460568222|FG003|Overall Study|Withdrawal by Subject|0|||
127985371|NCT01210352|460568223|FG004|Overall Study|Withdrawal by Subject|0|||
127985372|NCT01210352|460568224|FG005|Overall Study|Withdrawal by Subject|0|||
127985373|NCT01210352|460568225|FG006|Overall Study|Withdrawal by Subject|1|||
127985374|NCT01210352|460568226|FG007|Overall Study|Withdrawal by Subject|0|||
127985375|NCT01210352|460568227|FG008|Overall Study|Withdrawal by Subject|1|||
127985376|NCT01210352|460568219|FG000|Overall Study|Patient Discharged Early|0|||
127985377|NCT01210352|460568220|FG001|Overall Study|Patient Discharged Early|0|||
127985378|NCT01210352|460568221|FG002|Overall Study|Patient Discharged Early|1|||
127985379|NCT01210352|460568222|FG003|Overall Study|Patient Discharged Early|0|||
127985380|NCT01210352|460568223|FG004|Overall Study|Patient Discharged Early|0|||
127985381|NCT01210352|460568224|FG005|Overall Study|Patient Discharged Early|0|||
127985382|NCT01210352|460568225|FG006|Overall Study|Patient Discharged Early|0|||
127985383|NCT01210352|460568226|FG007|Overall Study|Patient Discharged Early|0|||
127985384|NCT01210352|460568227|FG008|Overall Study|Patient Discharged Early|0|||
127985385|NCT01298141|460568228|FG000|Overall Study|Adverse Event|3|||
127985386|NCT01298141|460568228|FG000|Overall Study|Refusal of Required Study Procedures|1|||
127985387|NCT01298141|460568228|FG000|Overall Study|Withdrawal by Subject|6|||
127985388|NCT01298141|460568228|FG000|Overall Study|Termination of Study by the Investigator|5|||
127985389|NCT01298141|460568228|FG000|Overall Study|Other|5|||
127985390|NCT01298141|460568228|FG000|Overall Study|Lost to Follow-up|1|||
127985391|NCT01298141|460568228|FG000|Overall Study|Death|6|||
127985392|NCT01298141|460568228|FG000|Overall Study|Not treated|4|||
127985393|NCT01854879|460568229|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
127985394|NCT01854879|460568229|FG000|Overall Study|screen fail|3|||
127985395|NCT01854879|460568229|FG000|Overall Study|incomplete data set|1|||
127985396|NCT02824562|460570466|FG000|Overall Study|Lost to Follow-up|3|||
127985397|NCT02824562|460570467|FG001|Overall Study|Lost to Follow-up|4|||
127985398|NCT02824562|460570466|FG000|Overall Study|Death|0|||
127985399|NCT02824562|460570467|FG001|Overall Study|Death|1|||
127985400|NCT01709864|460570468|FG000|Overall Study|Physician Decision|0|||
127985401|NCT01709864|460570469|FG001|Overall Study|Physician Decision|1|||
127985402|NCT01709864|460570468|FG000|Overall Study|subject/guardian decision|5|||
127985403|NCT01709864|460570469|FG001|Overall Study|subject/guardian decision|6|||
127985404|NCT01709864|460570468|FG000|Overall Study|Lost to Follow-up|1|||
127985405|NCT01709864|460570469|FG001|Overall Study|Lost to Follow-up|0|||
127985406|NCT01709864|460570468|FG000|Overall Study|non-compliance with study treatment|1|||
127985407|NCT01709864|460570469|FG001|Overall Study|non-compliance with study treatment|1|||
127985408|NCT01709864|460570468|FG000|Overall Study|Adverse Event|0|||
127985409|NCT01709864|460570469|FG001|Overall Study|Adverse Event|2|||
127985410|NCT01709864|460570468|FG000|Overall Study|Death|0|||
127985411|NCT01709864|460570469|FG001|Overall Study|Death|1|||
127985412|NCT02864316|460570472|FG000|Overall Study|Progressive Disease|2|||
127985413|NCT02864316|460570473|FG001|Overall Study|Progressive Disease|1|||
127985414|NCT02864316|460570472|FG000|Overall Study|Adverse Event|0|||
127985415|NCT02864316|460570473|FG001|Overall Study|Adverse Event|1|||
127985416|NCT00298363|460570474|FG000|Overall Study|Lost to Follow-up|0|||
127985417|NCT00298363|460570475|FG001|Overall Study|Lost to Follow-up|0|||
127985418|NCT00298363|460570476|FG002|Overall Study|Lost to Follow-up|1|||
127985419|NCT00298363|460570474|FG000|Overall Study|Physician Decision|4|||
127985420|NCT00298363|460570475|FG001|Overall Study|Physician Decision|1|||
127985421|NCT00298363|460570476|FG002|Overall Study|Physician Decision|0|||
127985422|NCT00298363|460570474|FG000|Overall Study|Protocol Violation|1|||
127985423|NCT00298363|460570475|FG001|Overall Study|Protocol Violation|1|||
127985424|NCT00298363|460570476|FG002|Overall Study|Protocol Violation|0|||
127985425|NCT00298363|460570474|FG000|Overall Study|Withdrawal by Subject|5|||
127985426|NCT00298363|460570475|FG001|Overall Study|Withdrawal by Subject|1|||
127985427|NCT00298363|460570476|FG002|Overall Study|Withdrawal by Subject|3|||
127985428|NCT00298363|460570474|FG000|Overall Study|Adverse Event|5|||
127985429|NCT00298363|460570475|FG001|Overall Study|Adverse Event|2|||
127985430|NCT00298363|460570476|FG002|Overall Study|Adverse Event|2|||
127985431|NCT00298363|460570474|FG000|Overall Study|Lack of Efficacy|2|||
127985432|NCT00298363|460570475|FG001|Overall Study|Lack of Efficacy|3|||
127985433|NCT00298363|460570476|FG002|Overall Study|Lack of Efficacy|0|||
127985434|NCT04710368|460570477|FG000|Overall Study|Withdrawal by Subject|9|||
127985435|NCT04710368|460570477|FG000|Overall Study|Lost to Follow-up|4|||
127985436|NCT04710368|460570477|FG000|Overall Study|Death|2|||
127985437|NCT04710368|460570477|FG000|Overall Study|Patient preference|11|||
127985438|NCT04710368|460570477|FG000|Overall Study|Treatment discontinuation|1|||
127985439|NCT00135356|460570478|FG000|Overall Study|Adverse Event|6|||
127985440|NCT00135356|460570479|FG001|Overall Study|Adverse Event|2|||
127985441|NCT00135356|460570478|FG000|Overall Study|Lack of Efficacy|2|||
127985442|NCT00135356|460570479|FG001|Overall Study|Lack of Efficacy|0|||
127985443|NCT00135356|460570478|FG000|Overall Study|Lost to Follow-up|3|||
127985444|NCT00135356|460570479|FG001|Overall Study|Lost to Follow-up|1|||
127985445|NCT00135356|460570478|FG000|Overall Study|Surgery for abdominal fat|1|||
127985446|NCT00135356|460570479|FG001|Overall Study|Surgery for abdominal fat|0|||
127985447|NCT00135356|460570478|FG000|Overall Study|Change in antiviral regimen|0|||
127985448|NCT00135356|460570479|FG001|Overall Study|Change in antiviral regimen|1|||
127985449|NCT00135356|460570478|FG000|Overall Study|Poor/noncompliance|1|||
127985450|NCT00135356|460570479|FG001|Overall Study|Poor/noncompliance|1|||
127985451|NCT00135356|460570478|FG000|Overall Study|No longer meets study criteria|2|||
127985452|NCT00135356|460570479|FG001|Overall Study|No longer meets study criteria|0|||
127985453|NCT00135356|460570478|FG000|Overall Study|Withdrawal by Subject|2|||
127985454|NCT00135356|460570479|FG001|Overall Study|Withdrawal by Subject|4|||
127985455|NCT00153816|460570480|FG000|Overall Study|Death|6|||
127985456|NCT00153816|460570481|FG001|Overall Study|Death|5|||
127985457|NCT00153816|460570482|FG002|Overall Study|Death|4|||
127985458|NCT00153816|460570483|FG003|Overall Study|Death|6|||
127985459|NCT00153816|460570484|FG004|Overall Study|Death|0|||
127985460|NCT00153816|460570485|FG005|Overall Study|Death|2|||
127985461|NCT00153816|460570480|FG000|Overall Study|Lost to Follow-up|7|||
127985462|NCT00153816|460570481|FG001|Overall Study|Lost to Follow-up|8|||
127985463|NCT00153816|460570482|FG002|Overall Study|Lost to Follow-up|5|||
127985464|NCT00153816|460570483|FG003|Overall Study|Lost to Follow-up|8|||
127985465|NCT00153816|460570484|FG004|Overall Study|Lost to Follow-up|7|||
127985466|NCT00153816|460570485|FG005|Overall Study|Lost to Follow-up|9|||
127985467|NCT00153816|460570480|FG000|Overall Study|Withdrawal by Subject|9|||
127985468|NCT00153816|460570481|FG001|Overall Study|Withdrawal by Subject|9|||
127985469|NCT00153816|460570482|FG002|Overall Study|Withdrawal by Subject|9|||
127985470|NCT00153816|460570483|FG003|Overall Study|Withdrawal by Subject|4|||
127985471|NCT00153816|460570484|FG004|Overall Study|Withdrawal by Subject|1|||
127985472|NCT00153816|460570485|FG005|Overall Study|Withdrawal by Subject|5|||
127985473|NCT00153816|460570480|FG000|Overall Study|Follow-up exam not done|8|||
127985474|NCT00153816|460570481|FG001|Overall Study|Follow-up exam not done|7|||
127985475|NCT00153816|460570482|FG002|Overall Study|Follow-up exam not done|11|||
127985476|NCT00153816|460570483|FG003|Overall Study|Follow-up exam not done|10|||
127985477|NCT00153816|460570484|FG004|Overall Study|Follow-up exam not done|8|||
127985478|NCT00153816|460570485|FG005|Overall Study|Follow-up exam not done|9|||
127985479|NCT00153816|460570480|FG000|Overall Study|Follow-up exam done, histology missing|2|||
127985480|NCT00153816|460570481|FG001|Overall Study|Follow-up exam done, histology missing|3|||
127985481|NCT00153816|460570482|FG002|Overall Study|Follow-up exam done, histology missing|3|||
127985482|NCT00153816|460570483|FG003|Overall Study|Follow-up exam done, histology missing|3|||
127985483|NCT00153816|460570484|FG004|Overall Study|Follow-up exam done, histology missing|1|||
127985484|NCT00153816|460570485|FG005|Overall Study|Follow-up exam done, histology missing|2|||
127985485|NCT00253370|460570486|FG000|Overall Study|Adverse Event|18|||
127985486|NCT00253370|460570486|FG000|Overall Study|Disease progression|13|||
127653560|NCT01691521|459354819|FG001|Overall Study|Withdrawal by Subject|9|||
127985487|NCT00253370|460570486|FG000|Overall Study|Death|2|||
127985488|NCT00253370|460570486|FG000|Overall Study|Withdrawal by Subject|6|||
127985489|NCT00253370|460570486|FG000|Overall Study|Non-protocol therapy|1|||
127985490|NCT00253370|460570486|FG000|Overall Study|Physician Decision|1|||
127985491|NCT00253370|460570486|FG000|Overall Study|Protocol Violation|1|||
127985492|NCT00253370|460570486|FG000|Overall Study|Abdominal pain due to disease|1|||
127985493|NCT01211483|460570491|FG000|Phase 1b|Death|6|||
127985494|NCT01211483|460570492|FG001|Phase 1b|Death|0|||
127985495|NCT01211483|460570493|FG002|Phase 1b|Death|0|||
127985496|NCT01211483|460570494|FG003|Phase 1b|Death|0|||
127985497|NCT01211483|460570491|FG000|Phase 1b|Withdrawal by Subject|1|||
127985498|NCT01211483|460570492|FG001|Phase 1b|Withdrawal by Subject|0|||
127985499|NCT01211483|460570493|FG002|Phase 1b|Withdrawal by Subject|0|||
127985500|NCT01211483|460570494|FG003|Phase 1b|Withdrawal by Subject|0|||
127985501|NCT01211483|460570491|FG000|Phase 2|Lost to Follow-up|0|||
127985502|NCT01211483|460570492|FG001|Phase 2|Lost to Follow-up|1|||
127985503|NCT01211483|460570493|FG002|Phase 2|Lost to Follow-up|1|||
127985504|NCT01211483|460570494|FG003|Phase 2|Lost to Follow-up|2|||
127985505|NCT01211483|460570491|FG000|Phase 2|Death|0|||
127985506|NCT01211483|460570492|FG001|Phase 2|Death|64|||
127985507|NCT01211483|460570493|FG002|Phase 2|Death|53|||
127985508|NCT01211483|460570494|FG003|Phase 2|Death|53|||
127985509|NCT01211483|460570491|FG000|Phase 2|Withdrawal by Subject|0|||
127985510|NCT01211483|460570492|FG001|Phase 2|Withdrawal by Subject|1|||
127985511|NCT01211483|460570493|FG002|Phase 2|Withdrawal by Subject|10|||
127985512|NCT01211483|460570494|FG003|Phase 2|Withdrawal by Subject|5|||
127985513|NCT01211483|460570491|FG000|Phase 2|Study terminated by Sponsor|0|||
127985514|NCT01211483|460570492|FG001|Phase 2|Study terminated by Sponsor|6|||
127985515|NCT01211483|460570493|FG002|Phase 2|Study terminated by Sponsor|8|||
127985516|NCT01211483|460570494|FG003|Phase 2|Study terminated by Sponsor|11|||
127985517|NCT01398410|460570496|FG000|Overall Study|Adverse Event|12|||
127985518|NCT01398410|460570497|FG001|Overall Study|Adverse Event|16|||
127985519|NCT01398410|460570496|FG000|Overall Study|Participants Choice|8|||
127985520|NCT01398410|460570497|FG001|Overall Study|Participants Choice|11|||
127985521|NCT01398410|460570496|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
127985522|NCT01398410|460570497|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
127985523|NCT01398410|460570496|FG000|Overall Study|Other|36|||
127985524|NCT01398410|460570497|FG001|Overall Study|Other|29|||
127985525|NCT02470403|460570498|FG000|Overall Study|Adverse Event|1|||
127985526|NCT02470403|460570499|FG001|Overall Study|Adverse Event|0|||
127985527|NCT02470403|460570500|FG002|Overall Study|Adverse Event|0|||
127985528|NCT02470403|460570501|FG003|Overall Study|Adverse Event|0|||
127985529|NCT02470403|460570502|FG004|Overall Study|Adverse Event|0|||
127985530|NCT02470403|460570498|FG000|Overall Study|Lost to Follow-up|0|||
127985531|NCT02470403|460570499|FG001|Overall Study|Lost to Follow-up|1|||
127985532|NCT02470403|460570500|FG002|Overall Study|Lost to Follow-up|0|||
127985533|NCT02470403|460570501|FG003|Overall Study|Lost to Follow-up|0|||
127985534|NCT02470403|460570502|FG004|Overall Study|Lost to Follow-up|0|||
127985535|NCT02470403|460570498|FG000|Overall Study|Subject/guardian decision|1|||
127985536|NCT02470403|460570499|FG001|Overall Study|Subject/guardian decision|0|||
127985537|NCT02470403|460570500|FG002|Overall Study|Subject/guardian decision|0|||
127985538|NCT02470403|460570501|FG003|Overall Study|Subject/guardian decision|4|||
127985539|NCT02470403|460570502|FG004|Overall Study|Subject/guardian decision|0|||
127985540|NCT00904839|460570503|FG000|Overall Study|Adverse Event|0|||
127985541|NCT00904839|460570504|FG001|Overall Study|Adverse Event|5|||
127985542|NCT00904839|460570505|FG002|Overall Study|Adverse Event|4|||
127985543|NCT00904839|460570503|FG000|Overall Study|Protocol Violation|0|||
127985544|NCT00904839|460570504|FG001|Overall Study|Protocol Violation|1|||
127985545|NCT00904839|460570505|FG002|Overall Study|Protocol Violation|1|||
127985546|NCT00904839|460570503|FG000|Overall Study|Lost to Follow-up|0|||
127985547|NCT00904839|460570504|FG001|Overall Study|Lost to Follow-up|1|||
127985548|NCT00904839|460570505|FG002|Overall Study|Lost to Follow-up|2|||
127985549|NCT00904839|460570503|FG000|Overall Study|Withdrawal by Subject|0|||
127985550|NCT00904839|460570504|FG001|Overall Study|Withdrawal by Subject|2|||
127985551|NCT00904839|460570505|FG002|Overall Study|Withdrawal by Subject|0|||
127985552|NCT00904839|460570503|FG000|Overall Study|Not treated|1|||
127985553|NCT00904839|460570504|FG001|Overall Study|Not treated|0|||
127985554|NCT00904839|460570505|FG002|Overall Study|Not treated|1|||
127985555|NCT00904839|460570503|FG000|Overall Study|Other than above|0|||
127985556|NCT00904839|460570504|FG001|Overall Study|Other than above|9|||
127985557|NCT00904839|460570505|FG002|Overall Study|Other than above|7|||
127985558|NCT00553358|460570508|FG000|Overall Study|Randomized but did not receive treatment|3|||
127985559|NCT00553358|460570509|FG001|Overall Study|Randomized but did not receive treatment|3|||
127985560|NCT00553358|460570510|FG002|Overall Study|Randomized but did not receive treatment|1|||
127985561|NCT00553358|460570508|FG000|Overall Study|Lost to Follow-up|22|||
127985562|NCT00553358|460570509|FG001|Overall Study|Lost to Follow-up|26|||
127985563|NCT00553358|460570510|FG002|Overall Study|Lost to Follow-up|18|||
127985564|NCT00553358|460570508|FG000|Overall Study|Withdrew completely|23|||
127985565|NCT00553358|460570509|FG001|Overall Study|Withdrew completely|33|||
127985566|NCT00553358|460570510|FG002|Overall Study|Withdrew completely|34|||
127985567|NCT00553358|460570508|FG000|Overall Study|Died during clinical follow-up|25|||
127985568|NCT00553358|460570509|FG001|Overall Study|Died during clinical follow-up|29|||
127985569|NCT00553358|460570510|FG002|Overall Study|Died during clinical follow-up|32|||
127985570|NCT00553358|460570508|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
127985571|NCT00553358|460570509|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
127985572|NCT00553358|460570510|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
127985573|NCT00553358|460570508|FG000|Overall Study|Died after clinical follow-up ended|1|||
127985574|NCT00553358|460570509|FG001|Overall Study|Died after clinical follow-up ended|2|||
127985575|NCT00553358|460570510|FG002|Overall Study|Died after clinical follow-up ended|0|||
127985576|NCT00553358|460570508|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
127985577|NCT00553358|460570509|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
127985578|NCT00553358|460570510|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
127985579|NCT05268016|460570512|FG000|Overall Study|Unacceptable toxicity or AE|2|||
127985580|NCT05268016|460570513|FG001|Overall Study|Unacceptable toxicity or AE|2|||
127985581|NCT05268016|460570514|FG002|Overall Study|Unacceptable toxicity or AE|4|||
127985582|NCT05268016|460570515|FG003|Overall Study|Unacceptable toxicity or AE|3|||
127985583|NCT05268016|460570516|FG004|Overall Study|Unacceptable toxicity or AE|1|||
127985584|NCT05268016|460570512|FG000|Overall Study|Withdrawal by Subject|1|||
127985585|NCT05268016|460570513|FG001|Overall Study|Withdrawal by Subject|3|||
127985586|NCT05268016|460570514|FG002|Overall Study|Withdrawal by Subject|2|||
127985587|NCT05268016|460570515|FG003|Overall Study|Withdrawal by Subject|2|||
127985588|NCT05268016|460570516|FG004|Overall Study|Withdrawal by Subject|1|||
127985589|NCT05268016|460570512|FG000|Overall Study|Lost to Follow-up|4|||
127985590|NCT05268016|460570513|FG001|Overall Study|Lost to Follow-up|7|||
127985591|NCT05268016|460570514|FG002|Overall Study|Lost to Follow-up|1|||
127985592|NCT05268016|460570515|FG003|Overall Study|Lost to Follow-up|3|||
127985593|NCT05268016|460570516|FG004|Overall Study|Lost to Follow-up|5|||
127985594|NCT05268016|460570512|FG000|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
127985595|NCT05268016|460570513|FG001|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
127985596|NCT05268016|460570514|FG002|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
127985597|NCT05268016|460570515|FG003|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
127985598|NCT05268016|460570516|FG004|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
127985599|NCT05268016|460570512|FG000|Overall Study|Lack of Efficacy|0|||
127985600|NCT05268016|460570513|FG001|Overall Study|Lack of Efficacy|0|||
127985601|NCT05268016|460570514|FG002|Overall Study|Lack of Efficacy|0|||
127985602|NCT05268016|460570515|FG003|Overall Study|Lack of Efficacy|0|||
127985603|NCT05268016|460570516|FG004|Overall Study|Lack of Efficacy|4|||
127985604|NCT05268016|460570512|FG000|Overall Study|Physician Decision|0|||
127985605|NCT05268016|460570513|FG001|Overall Study|Physician Decision|0|||
127985606|NCT05268016|460570514|FG002|Overall Study|Physician Decision|0|||
127985607|NCT05268016|460570515|FG003|Overall Study|Physician Decision|1|||
127985608|NCT05268016|460570516|FG004|Overall Study|Physician Decision|0|||
127985609|NCT05268016|460570512|FG000|Overall Study|Other|1|||
127985610|NCT05268016|460570513|FG001|Overall Study|Other|0|||
127985611|NCT05268016|460570514|FG002|Overall Study|Other|1|||
127985612|NCT05268016|460570515|FG003|Overall Study|Other|2|||
127985613|NCT05268016|460570516|FG004|Overall Study|Other|0|||
127985614|NCT00404924|460570517|FG000|Overall Study|Adverse Event|75|||
127985615|NCT00404924|460570518|FG001|Overall Study|Adverse Event|16|||
127985616|NCT00404924|460570517|FG000|Overall Study|Condition under investigation worsened|475|||
127985617|NCT00404924|460570518|FG001|Overall Study|Condition under investigation worsened|264|||
127985618|NCT00404924|460570517|FG000|Overall Study|Lost to Follow-up|1|||
127985619|NCT00404924|460570518|FG001|Overall Study|Lost to Follow-up|1|||
127985620|NCT00404924|460570517|FG000|Overall Study|Withdrawal by Subject|26|||
127985621|NCT00404924|460570518|FG001|Overall Study|Withdrawal by Subject|13|||
127985622|NCT00404924|460570517|FG000|Overall Study|Other|25|||
127985623|NCT00404924|460570518|FG001|Overall Study|Other|11|||
127985624|NCT00404924|460570517|FG000|Overall Study|Randomised but not received treatment|1|||
127985625|NCT00404924|460570518|FG001|Overall Study|Randomised but not received treatment|1|||
127985626|NCT01074255|460570523|FG000|Overall Study|Did not receive EMEND|2|||
127985627|NCT02943785|460570525|FG000|Overall Study|Adverse Event|112|||
127985628|NCT02943785|460570526|FG001|Overall Study|Adverse Event|97|||
127985629|NCT02943785|460570525|FG000|Overall Study|Withdrawal by Subject|63|||
127985630|NCT02943785|460570526|FG001|Overall Study|Withdrawal by Subject|126|||
127985631|NCT02943785|460570525|FG000|Overall Study|Physician Decision|23|||
127985632|NCT02943785|460570526|FG001|Overall Study|Physician Decision|47|||
127985633|NCT02943785|460570525|FG000|Overall Study|Death|46|||
127985634|NCT02943785|460570526|FG001|Overall Study|Death|46|||
127985635|NCT02943785|460570525|FG000|Overall Study|Lost to Follow-up|1|||
127985636|NCT02943785|460570526|FG001|Overall Study|Lost to Follow-up|0|||
127985637|NCT02943785|460570525|FG000|Overall Study|Other|16|||
127985638|NCT02943785|460570526|FG001|Overall Study|Other|19|||
127985639|NCT02943785|460570525|FG000|Overall Study|Did not receive any study medication|21|||
127985640|NCT02943785|460570526|FG001|Overall Study|Did not receive any study medication|28|||
127985641|NCT00821015|460570529|FG000|Overall Study|Lost to Follow-up|12|||
127985642|NCT01281956|460570530|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
127985643|NCT01281956|460570531|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
127985644|NCT03170609|460570532|FG000|Overall Study|Death|0|||
127985645|NCT03170609|460570533|FG001|Overall Study|Death|0|||
127985646|NCT03170609|460570534|FG002|Overall Study|Death|1|||
127985647|NCT03170609|460570535|FG003|Overall Study|Death|0|||
127985648|NCT03170609|460570536|FG004|Overall Study|Death|0|||
127985649|NCT03170609|460570537|FG005|Overall Study|Death|0|||
127985650|NCT03170609|460570538|FG006|Overall Study|Death|0|||
127985651|NCT03170609|460570532|FG000|Overall Study|Withdrawal by Subject|1|||
127985652|NCT03170609|460570533|FG001|Overall Study|Withdrawal by Subject|2|||
127985653|NCT03170609|460570534|FG002|Overall Study|Withdrawal by Subject|0|||
127985654|NCT03170609|460570535|FG003|Overall Study|Withdrawal by Subject|0|||
127985655|NCT03170609|460570536|FG004|Overall Study|Withdrawal by Subject|0|||
127985656|NCT03170609|460570537|FG005|Overall Study|Withdrawal by Subject|0|||
127985657|NCT03170609|460570538|FG006|Overall Study|Withdrawal by Subject|1|||
127985658|NCT03170609|460570532|FG000|Overall Study|Lost to Follow-up|1|||
127985659|NCT03170609|460570533|FG001|Overall Study|Lost to Follow-up|0|||
127985660|NCT03170609|460570534|FG002|Overall Study|Lost to Follow-up|5|||
127985661|NCT03170609|460570535|FG003|Overall Study|Lost to Follow-up|2|||
127985662|NCT03170609|460570536|FG004|Overall Study|Lost to Follow-up|1|||
127985663|NCT03170609|460570537|FG005|Overall Study|Lost to Follow-up|1|||
127985664|NCT03170609|460570538|FG006|Overall Study|Lost to Follow-up|0|||
127985665|NCT03170609|460570532|FG000|Overall Study|Other|1|||
127985666|NCT03170609|460570533|FG001|Overall Study|Other|0|||
127985667|NCT03170609|460570534|FG002|Overall Study|Other|0|||
127985668|NCT03170609|460570535|FG003|Overall Study|Other|0|||
127985669|NCT03170609|460570536|FG004|Overall Study|Other|0|||
127985670|NCT03170609|460570537|FG005|Overall Study|Other|1|||
127985671|NCT03170609|460570538|FG006|Overall Study|Other|0|||
127985672|NCT01857102|460570548|FG000|Period 1|No longer meets Eligibility Criteria|0|||
127985673|NCT01857102|460570549|FG001|Period 1|No longer meets Eligibility Criteria|2|||
127985674|NCT01857102|460570548|FG000|Period 1|Lost to Follow-up|0|||
127985675|NCT01857102|460570549|FG001|Period 1|Lost to Follow-up|3|||
127985676|NCT01857102|460570548|FG000|Period 1|Unsatisfactory Lens Fit|1|||
127985677|NCT01857102|460570549|FG001|Period 1|Unsatisfactory Lens Fit|0|||
127985678|NCT01857102|460570548|FG000|Period 1|Unsatisfactory Visual Response|1|||
127985679|NCT01857102|460570549|FG001|Period 1|Unsatisfactory Visual Response|0|||
127985680|NCT01857102|460570548|FG000|Period 1|Physician Decision|1|||
127985681|NCT01857102|460570549|FG001|Period 1|Physician Decision|0|||
127985682|NCT01857102|460570548|FG000|Period 2|Lens Discomfort|1|||
127985683|NCT01857102|460570549|FG001|Period 2|Lens Discomfort|0|||
127985684|NCT01857102|460570548|FG000|Period 2|Unsatisfactory Lens Fit|1|||
127985685|NCT01857102|460570549|FG001|Period 2|Unsatisfactory Lens Fit|0|||
127985686|NCT01490697|460570550|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
127985687|NCT01490697|460570551|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
127985688|NCT00090584|460570552|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
127985689|NCT00090584|460570553|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
127985690|NCT00090584|460570552|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
127985691|NCT00090584|460570553|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
127985692|NCT02117713|460570562|FG000|Week 48|Adverse Event|4|||
127985693|NCT02117713|460570562|FG000|Week 48|Withdrawal by caregiver|2|||
127985694|NCT02117713|460570562|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
127985695|NCT02117713|460570562|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
127985696|NCT02117713|460570562|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
127985697|NCT02117713|460570562|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
127985698|NCT02028169|460570563|FG000|Overall Study|Lost to Follow-up|21|||
127985699|NCT02028169|460570563|FG000|Overall Study|Lack of Efficacy|2|||
127985700|NCT02028169|460570563|FG000|Overall Study|Withdrawal by Subject|2|||
127985701|NCT02028169|460570563|FG000|Overall Study|Adverse Event|1|||
127985702|NCT02028169|460570563|FG000|Overall Study|Cessation of Drug|1|||
127985703|NCT02028169|460570563|FG000|Overall Study|Concomitant Medication Usage|1|||
127985704|NCT03564795|460570564|FG000|Overall Study|Withdrawal by Subject|3|||
127985705|NCT03564795|460570564|FG000|Overall Study|Lost to Follow-up|6|||
127985706|NCT03564795|460570564|FG000|Overall Study|Physician Decision|2|||
127985707|NCT02906033|460570569|FG000|Baseline|Protocol Violation|37|||
127985708|NCT02906033|460570570|FG001|Baseline|Protocol Violation|33|||
127985709|NCT02906033|460570569|FG000|Follow-up|Lost to Follow-up|46|||
127985710|NCT02906033|460570570|FG001|Follow-up|Lost to Follow-up|62|||
127985711|NCT03646305|460570573|FG000|Overall Study|Lost to Follow-up|4|||
127985712|NCT03646305|460570574|FG001|Overall Study|Lost to Follow-up|2|||
127985713|NCT03646305|460570575|FG002|Overall Study|Lost to Follow-up|2|||
127985714|NCT03646305|460570576|FG003|Overall Study|Lost to Follow-up|1|||
127985715|NCT03646305|460570573|FG000|Overall Study|Withdrawal by Subject|1|||
127985716|NCT03646305|460570574|FG001|Overall Study|Withdrawal by Subject|0|||
127985717|NCT03646305|460570575|FG002|Overall Study|Withdrawal by Subject|0|||
127985718|NCT03646305|460570576|FG003|Overall Study|Withdrawal by Subject|1|||
127985719|NCT03168919|460570577|FG000|Overall Study|Withdrawal by Subject|2|||
127985720|NCT00386425|460570579|FG000|Overall Study|Physician Decision|3|||
127985721|NCT00386425|460570580|FG001|Overall Study|Physician Decision|0|||
127985722|NCT00386425|460570581|FG002|Overall Study|Physician Decision|0|||
127985723|NCT00386425|460570579|FG000|Overall Study|Withdrawal by Subject|0|||
127985724|NCT00386425|460570580|FG001|Overall Study|Withdrawal by Subject|1|||
127985725|NCT00386425|460570581|FG002|Overall Study|Withdrawal by Subject|0|||
127985726|NCT02678000|460570582|FG000|PART 2|Adverse Event|0|||
127985727|NCT02678000|460570583|FG001|PART 2|Adverse Event|0|||
127985728|NCT02678000|460570584|FG002|PART 2|Adverse Event|2|||
127985729|NCT02678000|460570585|FG003|PART 2|Adverse Event|1|||
127985730|NCT02678000|460570586|FG004|PART 2|Adverse Event|0|||
127985731|NCT02678000|460570582|FG000|PART 2|Withdrawal by Subject|0|||
127985732|NCT02678000|460570583|FG001|PART 2|Withdrawal by Subject|0|||
127985733|NCT02678000|460570584|FG002|PART 2|Withdrawal by Subject|1|||
127985734|NCT02678000|460570585|FG003|PART 2|Withdrawal by Subject|0|||
127985735|NCT02678000|460570586|FG004|PART 2|Withdrawal by Subject|0|||
127985736|NCT03053427|460570587|FG000|Overall Study|Adverse Event|4|||
127985737|NCT03053427|460570588|FG001|Overall Study|Adverse Event|4|||
127985738|NCT03053427|460570587|FG000|Overall Study|Lack of Efficacy|1|||
127985739|NCT03053427|460570588|FG001|Overall Study|Lack of Efficacy|3|||
127985740|NCT03053427|460570587|FG000|Overall Study|Lost to Follow-up|2|||
127985741|NCT03053427|460570588|FG001|Overall Study|Lost to Follow-up|2|||
127985742|NCT03053427|460570587|FG000|Overall Study|Worsening of the target disease|0|||
127985743|NCT03053427|460570588|FG001|Overall Study|Worsening of the target disease|1|||
127985744|NCT03053427|460570587|FG000|Overall Study|Protocol Deviation|3|||
127985745|NCT03053427|460570588|FG001|Overall Study|Protocol Deviation|3|||
127985746|NCT03053427|460570587|FG000|Overall Study|Withdrawal by Subject|3|||
127985747|NCT03053427|460570588|FG001|Overall Study|Withdrawal by Subject|2|||
127985748|NCT03053427|460570587|FG000|Overall Study|Miscellaneous|0|||
127985749|NCT03053427|460570588|FG001|Overall Study|Miscellaneous|1|||
127985750|NCT02172040|460570593|FG000|Overall Study|Adverse Event|0|||
127985751|NCT02172040|460570594|FG001|Overall Study|Adverse Event|2|||
127985752|NCT02172040|460570595|FG002|Overall Study|Adverse Event|0|||
127985753|NCT02172040|460570596|FG003|Overall Study|Adverse Event|0|||
127985754|NCT02172040|460570593|FG000|Overall Study|Protocol Violation|0|||
127985755|NCT02172040|460570594|FG001|Overall Study|Protocol Violation|1|||
127985756|NCT02172040|460570595|FG002|Overall Study|Protocol Violation|0|||
127985757|NCT02172040|460570596|FG003|Overall Study|Protocol Violation|0|||
127985758|NCT02172040|460570593|FG000|Overall Study|Withdrawal by Subject|0|||
127985759|NCT02172040|460570594|FG001|Overall Study|Withdrawal by Subject|0|||
127985760|NCT02172040|460570595|FG002|Overall Study|Withdrawal by Subject|1|||
127985761|NCT02172040|460570596|FG003|Overall Study|Withdrawal by Subject|0|||
127985762|NCT02172040|460570593|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
127985763|NCT02172040|460570594|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
127985764|NCT02172040|460570595|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
127985765|NCT02172040|460570596|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
127985766|NCT02172040|460570593|FG000|Overall Study|Family emergency abroad|0|||
127985767|NCT02172040|460570594|FG001|Overall Study|Family emergency abroad|0|||
127985768|NCT02172040|460570595|FG002|Overall Study|Family emergency abroad|0|||
127985769|NCT02172040|460570596|FG003|Overall Study|Family emergency abroad|1|||
127985770|NCT02607306|460570603|FG000|Overall Study|Adverse Event|8|||
127985771|NCT02607306|460570604|FG001|Overall Study|Adverse Event|6|||
127985772|NCT02607306|460570605|FG002|Overall Study|Adverse Event|6|||
127985773|NCT02607306|460570603|FG000|Overall Study|Unclassified|1|||
127985774|NCT02607306|460570604|FG001|Overall Study|Unclassified|4|||
127985775|NCT02607306|460570605|FG002|Overall Study|Unclassified|0|||
127985776|NCT02607306|460570603|FG000|Overall Study|Withdrawal by Subject|8|||
127985777|NCT02607306|460570604|FG001|Overall Study|Withdrawal by Subject|10|||
127985778|NCT02607306|460570605|FG002|Overall Study|Withdrawal by Subject|2|||
127985779|NCT02607306|460570603|FG000|Overall Study|Lack of Efficacy|0|||
127985780|NCT02607306|460570604|FG001|Overall Study|Lack of Efficacy|1|||
127985781|NCT02607306|460570605|FG002|Overall Study|Lack of Efficacy|1|||
127985782|NCT02607306|460570603|FG000|Overall Study|Protocol Violation|4|||
127985783|NCT02607306|460570604|FG001|Overall Study|Protocol Violation|2|||
127985784|NCT02607306|460570605|FG002|Overall Study|Protocol Violation|1|||
127985785|NCT01324570|460570606|FG000|Overall Study|Adverse Event|4|||
127985786|NCT01324570|460570607|FG001|Overall Study|Adverse Event|7|||
127985787|NCT01324570|460570606|FG000|Overall Study|Withdrawal by Subject|0|||
127985788|NCT01324570|460570607|FG001|Overall Study|Withdrawal by Subject|3|||
127985789|NCT01324570|460570606|FG000|Overall Study|Lack of Efficacy|0|||
127985790|NCT01324570|460570607|FG001|Overall Study|Lack of Efficacy|1|||
127985791|NCT01324570|460570606|FG000|Overall Study|Confirmed or suspected diversion|0|||
127985792|NCT01324570|460570607|FG001|Overall Study|Confirmed or suspected diversion|1|||
127985793|NCT01324570|460570606|FG000|Overall Study|Administrative|0|||
127985794|NCT01324570|460570607|FG001|Overall Study|Administrative|2|||
127985795|NCT02360475|460570610|FG000|Overall Study|Lost to Follow-up|4|||
127985796|NCT02360475|460570611|FG001|Overall Study|Lost to Follow-up|12|||
127985797|NCT02360475|460570612|FG002|Overall Study|Lost to Follow-up|6|||
127985798|NCT02360475|460570613|FG003|Overall Study|Lost to Follow-up|4|||
127985799|NCT02360475|460570610|FG000|Overall Study|Withdrawal by Subject|0|||
127985800|NCT02360475|460570611|FG001|Overall Study|Withdrawal by Subject|1|||
127985801|NCT02360475|460570612|FG002|Overall Study|Withdrawal by Subject|2|||
127653561|NCT01691521|459354820|FG002|Overall Study|Withdrawal by Subject|4|||
127653562|NCT01153269|459354822|FG000|Overall Study|Withdrawal by Subject|1|||
127653563|NCT01153269|459354822|FG000|Overall Study|Antiretroviral therapy break|1|||
127653564|NCT03541044|459354823|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
127653565|NCT03541044|459354824|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
127653566|NCT03541044|459354823|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
127653567|NCT03541044|459354824|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
127985802|NCT02360475|460570613|FG003|Overall Study|Withdrawal by Subject|0|||
127985803|NCT02360475|460570610|FG000|Overall Study|Migrated/moved from study area|0|||
127985804|NCT02360475|460570611|FG001|Overall Study|Migrated/moved from study area|0|||
127985805|NCT02360475|460570612|FG002|Overall Study|Migrated/moved from study area|0|||
127985806|NCT02360475|460570613|FG003|Overall Study|Migrated/moved from study area|1|||
127985807|NCT00207727|460570615|FG000|Overall Study|Withdrawal by Subject|0|||
127985808|NCT00207727|460570616|FG001|Overall Study|Withdrawal by Subject|0|||
127985809|NCT00207727|460570617|FG002|Overall Study|Withdrawal by Subject|0|||
127985810|NCT00207727|460570618|FG003|Overall Study|Withdrawal by Subject|0|||
127985811|NCT00207727|460570619|FG004|Overall Study|Withdrawal by Subject|1|||
127985812|NCT00207727|460570615|FG000|Overall Study|Lost to Follow-up|0|||
127985813|NCT00207727|460570616|FG001|Overall Study|Lost to Follow-up|1|||
127985814|NCT00207727|460570617|FG002|Overall Study|Lost to Follow-up|0|||
127985815|NCT00207727|460570618|FG003|Overall Study|Lost to Follow-up|0|||
127985816|NCT00207727|460570619|FG004|Overall Study|Lost to Follow-up|0|||
127985817|NCT00207727|460570615|FG000|Overall Study|Other|38|||
127985818|NCT00207727|460570616|FG001|Overall Study|Other|41|||
127985819|NCT00207727|460570617|FG002|Overall Study|Other|41|||
127985820|NCT00207727|460570618|FG003|Overall Study|Other|37|||
127985821|NCT00207727|460570619|FG004|Overall Study|Other|33|||
127985822|NCT03759366|460570620|FG000|Primary Evaluation Period (26 Weeks)|Physician Decision|1|||
127985823|NCT03759366|460570620|FG000|Extension Period (Up to 208 Weeks)|Physician Decision|1|||
127985824|NCT03759366|460570620|FG000|Extension Period (Up to 208 Weeks)|Lost to Follow-up|1|||
127985825|NCT03759366|460570620|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Ultomiris|2|||
127985826|NCT03759366|460570620|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Soliris|1|||
127985827|NCT03759366|460570620|FG000|Extension Period (Up to 208 Weeks)|Participant transferred to another study|1|||
127985828|NCT03759366|460570620|FG000|Extension Period (Up to 208 Weeks)|Withdrawal by Subject|2|||
127985829|NCT04226495|460570621|FG000|Overall Study|Withdrawal by Subject|3|||
127985830|NCT04226495|460570622|FG001|Overall Study|Withdrawal by Subject|3|||
127985831|NCT04226495|460570621|FG000|Overall Study|PI discretion|3|||
127985832|NCT04226495|460570622|FG001|Overall Study|PI discretion|4|||
127985833|NCT00539032|460570626|FG000|Overall Study|Withdrawal by Subject|2|||
127985834|NCT00539032|460570627|FG001|Overall Study|Withdrawal by Subject|1|||
127985835|NCT00435019|460570628|FG000|Overall Study|Adverse Event|1|||
127985836|NCT00435019|460570629|FG001|Overall Study|Adverse Event|0|||
127985837|NCT00435019|460570628|FG000|Overall Study|Lack of Efficacy|1|||
127985838|NCT00435019|460570629|FG001|Overall Study|Lack of Efficacy|2|||
127985839|NCT00435019|460570628|FG000|Overall Study|Protocol Violation|3|||
127985840|NCT00435019|460570629|FG001|Overall Study|Protocol Violation|1|||
127985841|NCT00435019|460570628|FG000|Overall Study|Personal reasons for withdrawal|8|||
127985842|NCT00435019|460570629|FG001|Overall Study|Personal reasons for withdrawal|7|||
127985843|NCT00422292|460570637|FG000|Overall Study|Serious adverse events|1|||
127985844|NCT00422292|460570638|FG001|Overall Study|Serious adverse events|4|||
127985845|NCT00422292|460570639|FG002|Overall Study|Serious adverse events|0|||
127985846|NCT00422292|460570640|FG003|Overall Study|Serious adverse events|0|||
127985847|NCT00422292|460570637|FG000|Overall Study|Adverse Event|1|||
127985848|NCT00422292|460570638|FG001|Overall Study|Adverse Event|0|||
127985849|NCT00422292|460570639|FG002|Overall Study|Adverse Event|1|||
127985850|NCT00422292|460570640|FG003|Overall Study|Adverse Event|0|||
127985851|NCT00422292|460570637|FG000|Overall Study|Protocol Violation|4|||
127985852|NCT00422292|460570638|FG001|Overall Study|Protocol Violation|25|||
127985853|NCT00422292|460570639|FG002|Overall Study|Protocol Violation|8|||
127985854|NCT00422292|460570640|FG003|Overall Study|Protocol Violation|5|||
127985855|NCT00422292|460570637|FG000|Overall Study|Lost to Follow-up|6|||
127985856|NCT00422292|460570638|FG001|Overall Study|Lost to Follow-up|12|||
127985857|NCT00422292|460570639|FG002|Overall Study|Lost to Follow-up|6|||
127985858|NCT00422292|460570640|FG003|Overall Study|Lost to Follow-up|6|||
127985859|NCT00422292|460570637|FG000|Overall Study|Withdrawal by Subject|6|||
127985860|NCT00422292|460570638|FG001|Overall Study|Withdrawal by Subject|25|||
127985861|NCT00422292|460570639|FG002|Overall Study|Withdrawal by Subject|7|||
127985862|NCT00422292|460570640|FG003|Overall Study|Withdrawal by Subject|13|||
127985863|NCT02440854|460570641|FG000|Overall Study|Relocation of patient|1|||
127985864|NCT02440854|460570641|FG000|Overall Study|Death|6|||
127985865|NCT02440854|460570641|FG000|Overall Study|Lost to Follow-up|10|||
127985866|NCT02440854|460570641|FG000|Overall Study|Afatinib discontinuation|46|||
127985867|NCT02440854|460570641|FG000|Overall Study|stopped study at earlier timepoint|14|||
127985868|NCT02440854|460570641|FG000|Overall Study|Study medication not received|1|||
127985869|NCT02440854|460570641|FG000|Overall Study|Violation of inclusion criteria|2|||
127985870|NCT03338569|460570642|FG000|Overall Study|Physician Decision|8|||
127985871|NCT03338569|460570643|FG001|Overall Study|Physician Decision|3|||
127985872|NCT03338569|460570642|FG000|Overall Study|Withdrawal by Subject|0|||
127985873|NCT03338569|460570643|FG001|Overall Study|Withdrawal by Subject|1|||
127985874|NCT03338569|460570642|FG000|Overall Study|Lost to Follow-up|0|||
127653568|NCT02635724|459354825|FG000|Overall Study|Withdrawal by Subject|0|||
127653569|NCT02635724|459354826|FG001|Overall Study|Withdrawal by Subject|1|||
127653570|NCT02635724|459354827|FG002|Overall Study|Withdrawal by Subject|0|||
127653571|NCT02424591|459354830|FG000|Overall Study|Protocol Violation|2|||
127653572|NCT02424591|459354831|FG001|Overall Study|Protocol Violation|3|||
127653573|NCT01446796|459354832|FG000|Overall Study|Withdrawal by Subject|1|||
127653574|NCT01446796|459354833|FG001|Overall Study|Withdrawal by Subject|0|||
127653575|NCT00312702|459354834|FG000|Immunization Phase|Lost to Follow-up|0|||
127653576|NCT00312702|459354835|FG001|Immunization Phase|Lost to Follow-up|1|||
127653577|NCT00312702|459354836|FG002|Immunization Phase|Lost to Follow-up|0|||
127653578|NCT02277743|459354839|FG000|Overall Study|Protocol Violation|1|||
127653579|NCT02277743|459354840|FG001|Overall Study|Protocol Violation|1|||
127653580|NCT02277743|459354841|FG002|Overall Study|Protocol Violation|1|||
127653581|NCT02277743|459354839|FG000|Overall Study|Adverse Event|10|||
127653582|NCT02277743|459354840|FG001|Overall Study|Adverse Event|6|||
127653583|NCT02277743|459354841|FG002|Overall Study|Adverse Event|6|||
127653584|NCT02277743|459354839|FG000|Overall Study|Lack of Efficacy|11|||
127653585|NCT02277743|459354840|FG001|Overall Study|Lack of Efficacy|4|||
127653586|NCT02277743|459354841|FG002|Overall Study|Lack of Efficacy|3|||
127653587|NCT02277743|459354839|FG000|Overall Study|Other than specified above|18|||
127653588|NCT02277743|459354840|FG001|Overall Study|Other than specified above|5|||
127653589|NCT02277743|459354841|FG002|Overall Study|Other than specified above|16|||
127653590|NCT01224158|459354842|FG000|Overall Study|Withdrawal by Subject|1|||
127653591|NCT01224158|459354843|FG001|Overall Study|Withdrawal by Subject|0|||
127653592|NCT02055157|459354844|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
127653593|NCT02055157|459354845|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
127653594|NCT02055157|459354846|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
127653595|NCT02055157|459354847|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
127653596|NCT02055157|459354844|FG000|Initial 6 Months|Adverse Event|0|||
127653597|NCT02055157|459354845|FG001|Initial 6 Months|Adverse Event|0|||
127653598|NCT02055157|459354846|FG002|Initial 6 Months|Adverse Event|0|||
127653599|NCT02055157|459354847|FG003|Initial 6 Months|Adverse Event|1|||
127653600|NCT02055157|459354844|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
127653601|NCT02055157|459354845|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
127653602|NCT02055157|459354846|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
127653603|NCT02055157|459354847|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
127653604|NCT02055157|459354844|FG000|18-month Extension|Investigator decision|0|||
127653605|NCT02055157|459354845|FG001|18-month Extension|Investigator decision|1|||
127653606|NCT02055157|459354846|FG002|18-month Extension|Investigator decision|0|||
127653607|NCT02055157|459354847|FG003|18-month Extension|Investigator decision|0|||
127653608|NCT02055157|459354844|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
127653609|NCT02055157|459354845|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
127653610|NCT02055157|459354846|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
127653611|NCT02055157|459354847|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
127653612|NCT03976466|459354848|FG000|Overall Study|Lost to Follow-up|1|||
127653613|NCT03976466|459354849|FG001|Overall Study|Lost to Follow-up|3|||
127653614|NCT00733499|459354854|FG000|Pre-operative|Protocol Violation|0|||
127653615|NCT00733499|459354855|FG001|Pre-operative|Protocol Violation|1|||
127653616|NCT00733499|459354854|FG000|3 Months Follow-up|Death|1|||
127653617|NCT00733499|459354855|FG001|3 Months Follow-up|Death|2|||
127653618|NCT00733499|459354854|FG000|6 Months Follow-up|Death|0|||
127653619|NCT00733499|459354855|FG001|6 Months Follow-up|Death|2|||
127985875|NCT03338569|460570643|FG001|Overall Study|Lost to Follow-up|1|||
127985876|NCT02243046|460570644|FG000|Overall Study|Lost to Follow-up|1|||
127985877|NCT02243046|460570645|FG001|Overall Study|Lost to Follow-up|1|||
127653620|NCT00733499|459354854|FG000|6 Months Follow-up|Adverse Event|0|||
127653621|NCT00733499|459354855|FG001|6 Months Follow-up|Adverse Event|1|||
127653622|NCT00733499|459354854|FG000|12 Months Follow-up|Death|2|||
127653623|NCT00733499|459354855|FG001|12 Months Follow-up|Death|1|||
127653624|NCT00733499|459354854|FG000|24 Months Follow-up|Death|0|||
127653625|NCT00733499|459354855|FG001|24 Months Follow-up|Death|1|||
127653626|NCT00733499|459354854|FG000|5 Year Followup|Adverse Event|2|||
127985878|NCT02243046|460570646|FG002|Overall Study|Lost to Follow-up|4|||
127985879|NCT02669082|460570647|FG000|Overall Study|Adverse Event|1|||
127985880|NCT04852276|460570648|FG000|Overall Study|Death|2|||
127653627|NCT00733499|459354855|FG001|5 Year Followup|Adverse Event|2|||
127653628|NCT00733499|459354854|FG000|5 Year Followup|Non device related AE|0|||
127653629|NCT00733499|459354855|FG001|5 Year Followup|Non device related AE|1|||
127653630|NCT00733499|459354854|FG000|5 Year Followup|Revision of Study Implant|0|||
127653631|NCT00733499|459354855|FG001|5 Year Followup|Revision of Study Implant|1|||
127985881|NCT04852276|460570649|FG001|Overall Study|Death|0|||
127985882|NCT04852276|460570648|FG000|Overall Study|Lost to Follow-up|15|||
127985883|NCT04852276|460570649|FG001|Overall Study|Lost to Follow-up|9|||
127985884|NCT04852276|460570648|FG000|Overall Study|Withdrawal by Subject|26|||
127985885|NCT04852276|460570649|FG001|Overall Study|Withdrawal by Subject|6|||
127985886|NCT02168777|460572267|FG000|Overall Study|Withdrawal by Subject|1|||
127985887|NCT02168777|460572268|FG001|Overall Study|Withdrawal by Subject|0|||
127985888|NCT02168777|460572269|FG002|Overall Study|Withdrawal by Subject|2|||
127985889|NCT02168777|460572267|FG000|Overall Study|Adverse Event|1|||
127985890|NCT02168777|460572268|FG001|Overall Study|Adverse Event|0|||
127985891|NCT02168777|460572269|FG002|Overall Study|Adverse Event|1|||
127985892|NCT02168777|460572267|FG000|Overall Study|Disease recurrence|0|||
127985893|NCT02168777|460572268|FG001|Overall Study|Disease recurrence|0|||
127985894|NCT02168777|460572269|FG002|Overall Study|Disease recurrence|1|||
127985895|NCT02168777|460572267|FG000|Overall Study|Radiological disease progression|0|||
127985896|NCT02168777|460572268|FG001|Overall Study|Radiological disease progression|5|||
127985897|NCT02168777|460572269|FG002|Overall Study|Radiological disease progression|5|||
127985898|NCT02168777|460572267|FG000|Overall Study|Clinical disease progression|0|||
127985899|NCT02168777|460572268|FG001|Overall Study|Clinical disease progression|1|||
127985900|NCT02168777|460572269|FG002|Overall Study|Clinical disease progression|2|||
127985901|NCT02168777|460572267|FG000|Overall Study|Other reason|0|||
127985902|NCT02168777|460572268|FG001|Overall Study|Other reason|1|||
127985903|NCT02168777|460572269|FG002|Overall Study|Other reason|0|||
127985904|NCT05243563|460572270|FG000|Overall Study|Withdrawal by Subject|1|||
127985905|NCT05243563|460572271|FG001|Overall Study|Withdrawal by Subject|0|||
127985906|NCT05243563|460572270|FG000|Overall Study|Physician Decision|1|||
127985907|NCT05243563|460572271|FG001|Overall Study|Physician Decision|0|||
127985908|NCT01698268|460572273|FG000|Overall Study|Physician Decision|2|||
127985909|NCT01698268|460572274|FG001|Overall Study|Physician Decision|1|||
127985910|NCT01533688|460572275|FG000|Overall Study|Withdrawal by Subject|5|||
127985911|NCT01533688|460572276|FG001|Overall Study|Withdrawal by Subject|4|||
127985912|NCT01533688|460572277|FG002|Overall Study|Withdrawal by Subject|3|||
127985913|NCT01533688|460572275|FG000|Overall Study|Medically unstable|1|||
127985914|NCT01533688|460572276|FG001|Overall Study|Medically unstable|3|||
127985915|NCT01533688|460572277|FG002|Overall Study|Medically unstable|3|||
127985916|NCT01533688|460572275|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
127985917|NCT01533688|460572276|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
127985918|NCT01533688|460572277|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
127985919|NCT02509078|460572282|FG000|Overall Study|Protocol Violation|1|||
127985920|NCT02509078|460572283|FG001|Overall Study|Protocol Violation|1|||
127985921|NCT05916131|460572284|FG000|Overall Study|Lost to Follow-up|0|||
127985922|NCT05916131|460572285|FG001|Overall Study|Lost to Follow-up|0|||
127985923|NCT05916131|460572286|FG002|Overall Study|Lost to Follow-up|1|||
127985924|NCT05916131|460572287|FG003|Overall Study|Lost to Follow-up|0|||
127985925|NCT01167634|460572294|FG000|Overall Study|Lost to Follow-up|1|||
127985926|NCT01167634|460572295|FG001|Overall Study|Lost to Follow-up|3|||
127985927|NCT01167634|460572296|FG002|Overall Study|Lost to Follow-up|3|||
127985928|NCT01167634|460572297|FG003|Overall Study|Lost to Follow-up|4|||
127985929|NCT01167634|460572294|FG000|Overall Study|Withdrawal by Subject|1|||
127985930|NCT01167634|460572295|FG001|Overall Study|Withdrawal by Subject|1|||
127985931|NCT01167634|460572296|FG002|Overall Study|Withdrawal by Subject|0|||
127985932|NCT01167634|460572297|FG003|Overall Study|Withdrawal by Subject|0|||
127985933|NCT02603107|460572298|FG000|Randomized Phase|Withdrew consent|8|||
127985934|NCT02603107|460572299|FG001|Randomized Phase|Withdrew consent|15|||
127985935|NCT02603107|460572298|FG000|Randomized Phase|Lost to Follow-up|1|||
127985936|NCT02603107|460572299|FG001|Randomized Phase|Lost to Follow-up|3|||
127985937|NCT02603107|460572298|FG000|Randomized Phase|Adverse Event|2|||
127985938|NCT02603107|460572299|FG001|Randomized Phase|Adverse Event|0|||
127985939|NCT02603107|460572298|FG000|Randomized Phase|Death|1|||
127985940|NCT02603107|460572299|FG001|Randomized Phase|Death|1|||
127985941|NCT02603107|460572298|FG000|Randomized Phase|Non-compliance with study drug|1|||
127985942|NCT02603107|460572299|FG001|Randomized Phase|Non-compliance with study drug|1|||
127985943|NCT02603107|460572298|FG000|Randomized Phase|Investigator's discretion|0|||
127985944|NCT02603107|460572299|FG001|Randomized Phase|Investigator's discretion|1|||
127985945|NCT02603107|460572298|FG000|Randomized Phase|Lack of Efficacy|1|||
127985946|NCT02603107|460572299|FG001|Randomized Phase|Lack of Efficacy|0|||
127985947|NCT02603107|460572298|FG000|Randomized Phase|Protocol Violation|1|||
127985948|NCT02603107|460572299|FG001|Randomized Phase|Protocol Violation|0|||
127985949|NCT02603107|460572298|FG000|Optional Extension Phase|Lost to Follow-up|3|||
127985950|NCT02603107|460572299|FG001|Optional Extension Phase|Lost to Follow-up|3|||
127985951|NCT02603107|460572298|FG000|Optional Extension Phase|Withdrew consent|3|||
127985952|NCT02603107|460572299|FG001|Optional Extension Phase|Withdrew consent|2|||
127985953|NCT02603107|460572298|FG000|Optional Extension Phase|Investigator's discretion|2|||
127985954|NCT02603107|460572299|FG001|Optional Extension Phase|Investigator's discretion|2|||
127985955|NCT02603107|460572298|FG000|Optional Extension Phase|Pregnancy|0|||
127985956|NCT02603107|460572299|FG001|Optional Extension Phase|Pregnancy|3|||
127985957|NCT02603107|460572298|FG000|Optional Extension Phase|Adverse Event|0|||
127985958|NCT02603107|460572299|FG001|Optional Extension Phase|Adverse Event|2|||
127985959|NCT02603107|460572298|FG000|Optional Extension Phase|Not treated in extension phase|0|||
127985960|NCT02603107|460572299|FG001|Optional Extension Phase|Not treated in extension phase|1|||
127985961|NCT02603107|460572298|FG000|Optional Extension Phase|Protocol Violation|1|||
127985962|NCT02603107|460572299|FG001|Optional Extension Phase|Protocol Violation|0|||
127985963|NCT03411902|460572300|FG000|Overall Study|Lost to Follow-up|3|||
127985964|NCT03411902|460572301|FG001|Overall Study|Lost to Follow-up|0|||
127985965|NCT00419159|460572304|FG000|Overall Study|Adverse Event|7|||
127985966|NCT00419159|460572305|FG001|Overall Study|Adverse Event|15|||
127985967|NCT00419159|460572304|FG000|Overall Study|Abnormal laboratory value(s)|0|||
127985968|NCT00419159|460572305|FG001|Overall Study|Abnormal laboratory value(s)|2|||
127985969|NCT00419159|460572304|FG000|Overall Study|Subject's no longer requires study drug|0|||
127985970|NCT00419159|460572305|FG001|Overall Study|Subject's no longer requires study drug|1|||
127985971|NCT00419159|460572304|FG000|Overall Study|Protocol Violation|1|||
127985972|NCT00419159|460572305|FG001|Overall Study|Protocol Violation|0|||
127985973|NCT00419159|460572304|FG000|Overall Study|Withdrawal by Subject|10|||
127985974|NCT00419159|460572305|FG001|Overall Study|Withdrawal by Subject|3|||
127985975|NCT00419159|460572304|FG000|Overall Study|Lost to Follow-up|0|||
127985976|NCT00419159|460572305|FG001|Overall Study|Lost to Follow-up|1|||
127985977|NCT00419159|460572304|FG000|Overall Study|Death|2|||
127985978|NCT00419159|460572305|FG001|Overall Study|Death|2|||
127985979|NCT00419159|460572304|FG000|Overall Study|Disease progression|79|||
127985980|NCT00419159|460572305|FG001|Overall Study|Disease progression|76|||
127985981|NCT00187278|460572306|FG000|Overall Study|Protocol Violation|10|||
127985982|NCT00187278|460572307|FG001|Overall Study|Protocol Violation|13|||
127985983|NCT00803205|460572308|FG000|Overall Study|Adverse Event|7|||
127985984|NCT00803205|460572309|FG001|Overall Study|Adverse Event|2|||
127985985|NCT00803205|460572308|FG000|Overall Study|Lost to Follow-up|1|||
127985986|NCT00803205|460572309|FG001|Overall Study|Lost to Follow-up|0|||
127985987|NCT00803205|460572308|FG000|Overall Study|Withdrawal by Subject|9|||
127985988|NCT00803205|460572309|FG001|Overall Study|Withdrawal by Subject|9|||
127985989|NCT00803205|460572308|FG000|Overall Study|Physician Decision|1|||
127985990|NCT00803205|460572309|FG001|Overall Study|Physician Decision|0|||
127985991|NCT00803205|460572308|FG000|Overall Study|Protocol Violation|1|||
127985992|NCT00803205|460572309|FG001|Overall Study|Protocol Violation|1|||
127985993|NCT00803205|460572308|FG000|Overall Study|Medical Monitor Decision|1|||
127985994|NCT00803205|460572309|FG001|Overall Study|Medical Monitor Decision|0|||
127985995|NCT00803205|460572308|FG000|Overall Study|Acquired a Lung Infection|0|||
127985996|NCT00803205|460572309|FG001|Overall Study|Acquired a Lung Infection|1|||
127985997|NCT00803205|460572308|FG000|Overall Study|Sponsor Decision|0|||
127985998|NCT00803205|460572309|FG001|Overall Study|Sponsor Decision|1|||
127985999|NCT00270231|460572311|FG000|First Intervention|Lost to Follow-up|1|||
127986000|NCT00270231|460572312|FG001|First Intervention|Lost to Follow-up|1|||
127986001|NCT00270231|460572311|FG000|Washout Period|Lost to Follow-up|1|||
127986002|NCT00270231|460572312|FG001|Washout Period|Lost to Follow-up|0|||
127986003|NCT00270231|460572311|FG000|Second Intervention|Lost to Follow-up|0|||
127986004|NCT00270231|460572312|FG001|Second Intervention|Lost to Follow-up|1|||
127986005|NCT02735096|460572313|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
127986006|NCT00379808|460572314|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
127986007|NCT00379808|460572315|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
127986008|NCT04299048|460572321|FG000|Overall Study|Death|1|||
127986009|NCT04299048|460572321|FG000|Overall Study|Global deterioration of health status|2|||
127986010|NCT04299048|460572321|FG000|Overall Study|Enrolled and not treated|1|||
127986011|NCT03423147|460572323|FG000|Overall Study|Lost to Follow-up|5|||
127986012|NCT03423147|460572324|FG001|Overall Study|Lost to Follow-up|8|||
127986013|NCT03423147|460572323|FG000|Overall Study|Withdrawal by Subject|1|||
127986014|NCT03423147|460572324|FG001|Overall Study|Withdrawal by Subject|0|||
127986015|NCT03423147|460572323|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
127986016|NCT03423147|460572324|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
127986017|NCT03423147|460572323|FG000|Overall Study|Age < 18|1|||
127986018|NCT03423147|460572324|FG001|Overall Study|Age < 18|0|||
127986019|NCT03423147|460572323|FG000|Overall Study|No Trial of Labor|0|||
127986020|NCT03423147|460572324|FG001|Overall Study|No Trial of Labor|1|||
127986021|NCT00508157|460572325|FG000|Overall Study|Adverse Event|0|||
127986022|NCT00508157|460572326|FG001|Overall Study|Adverse Event|1|||
127986023|NCT00508157|460572325|FG000|Overall Study|Subject Withdrew Consent|1|||
127986024|NCT00508157|460572326|FG001|Overall Study|Subject Withdrew Consent|0|||
127986025|NCT00508157|460572325|FG000|Overall Study|Lost to Follow-up|1|||
127986026|NCT00508157|460572326|FG001|Overall Study|Lost to Follow-up|0|||
127986027|NCT00508157|460572325|FG000|Overall Study|Subject no longer met study criteria|0|||
127986028|NCT00508157|460572326|FG001|Overall Study|Subject no longer met study criteria|1|||
127986029|NCT00508157|460572325|FG000|Overall Study|Other known cause|0|||
127986030|NCT00508157|460572326|FG001|Overall Study|Other known cause|1|||
127986031|NCT02069093|460572327|FG000|Overall Study|Disease progression|14|||
127986032|NCT02069093|460572327|FG000|Overall Study|New cancer therapy|1|||
127986033|NCT02069093|460572327|FG000|Overall Study|Death|1|||
127986034|NCT02069093|460572327|FG000|Overall Study|Administrative problems|1|||
127986035|NCT02069093|460572327|FG000|Overall Study|Withdrawal by Subject|2|||
127653632|NCT00733499|459354854|FG000|5 Year Followup|Lost to Follow-up|2|||
127653633|NCT00733499|459354855|FG001|5 Year Followup|Lost to Follow-up|0|||
127653634|NCT00733499|459354854|FG000|5 Year Followup|Death|13|||
127653635|NCT00733499|459354855|FG001|5 Year Followup|Death|19|||
127653636|NCT00733499|459354854|FG000|5 Year Followup|missing, unable to locate|0|||
127653637|NCT00733499|459354855|FG001|5 Year Followup|missing, unable to locate|1|||
127653638|NCT00733499|459354854|FG000|5 Year Followup|Withdrawal by Subject|4|||
127653639|NCT00733499|459354855|FG001|5 Year Followup|Withdrawal by Subject|1|||
127986036|NCT02069093|460572327|FG000|Overall Study|Abnormal laboratory values|1|||
127986037|NCT02069093|460572327|FG000|Overall Study|Adverse Event|10|||
127986038|NCT02258334|460572329|FG000|Overall Study|Adverse Event|1|||
127986039|NCT02258334|460572330|FG001|Overall Study|Adverse Event|0|||
127986040|NCT02258334|460572331|FG002|Overall Study|Adverse Event|0|||
127986041|NCT02258334|460572332|FG003|Overall Study|Adverse Event|0|||
127986042|NCT00862459|460572333|FG000|Overall Study|Lost to Follow-up|1|||
127986043|NCT00862459|460572334|FG001|Overall Study|Lost to Follow-up|2|||
127986044|NCT00862459|460572335|FG002|Overall Study|Lost to Follow-up|2|||
127986045|NCT00862459|460572333|FG000|Overall Study|Protocol Violation|1|||
127986046|NCT00862459|460572334|FG001|Overall Study|Protocol Violation|0|||
127986047|NCT00862459|460572335|FG002|Overall Study|Protocol Violation|0|||
127986048|NCT00862459|460572333|FG000|Overall Study|Withdrawal by Subject|1|||
127986049|NCT00862459|460572334|FG001|Overall Study|Withdrawal by Subject|1|||
127986050|NCT00862459|460572335|FG002|Overall Study|Withdrawal by Subject|3|||
127986051|NCT00862459|460572333|FG000|Overall Study|Adverse Event|0|||
127986052|NCT00862459|460572334|FG001|Overall Study|Adverse Event|1|||
127986053|NCT00862459|460572335|FG002|Overall Study|Adverse Event|0|||
127986054|NCT00862459|460572333|FG000|Overall Study|Personal reasons|1|||
127986055|NCT00862459|460572334|FG001|Overall Study|Personal reasons|0|||
127986056|NCT00862459|460572335|FG002|Overall Study|Personal reasons|0|||
127986057|NCT00862459|460572333|FG000|Overall Study|Operation|1|||
127986058|NCT00862459|460572334|FG001|Overall Study|Operation|1|||
127986059|NCT00862459|460572335|FG002|Overall Study|Operation|0|||
127986060|NCT00862459|460572333|FG000|Overall Study|Intravenous (IV) site problems|1|||
127986061|NCT00862459|460572334|FG001|Overall Study|Intravenous (IV) site problems|0|||
127986062|NCT00862459|460572335|FG002|Overall Study|Intravenous (IV) site problems|1|||
127986063|NCT00862459|460572333|FG000|Overall Study|Unable to hold still for imaging|0|||
127986064|NCT00862459|460572334|FG001|Overall Study|Unable to hold still for imaging|1|||
127986065|NCT00862459|460572335|FG002|Overall Study|Unable to hold still for imaging|0|||
127986066|NCT00862459|460572333|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
127986067|NCT00862459|460572334|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
127986068|NCT00862459|460572335|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
127986069|NCT00862459|460572333|FG000|Overall Study|Administrative problems|0|||
127986070|NCT00862459|460572334|FG001|Overall Study|Administrative problems|1|||
127986071|NCT00862459|460572335|FG002|Overall Study|Administrative problems|0|||
127986072|NCT01333956|460572346|FG000|Overall Study|Lost to Follow-up|1|||
127986073|NCT01333956|460572347|FG001|Overall Study|Lost to Follow-up|2|||
127986074|NCT01333956|460572348|FG002|Overall Study|Lost to Follow-up|0|||
127986075|NCT01333956|460572349|FG003|Overall Study|Lost to Follow-up|1|||
127986076|NCT01333956|460572346|FG000|Overall Study|Unable to complete study procedure|1|||
127986077|NCT01333956|460572347|FG001|Overall Study|Unable to complete study procedure|0|||
127986078|NCT01333956|460572348|FG002|Overall Study|Unable to complete study procedure|0|||
127986079|NCT01333956|460572349|FG003|Overall Study|Unable to complete study procedure|1|||
127986080|NCT01333956|460572346|FG000|Overall Study|Withdrawal by Subject|0|||
127986081|NCT01333956|460572347|FG001|Overall Study|Withdrawal by Subject|2|||
127986082|NCT01333956|460572348|FG002|Overall Study|Withdrawal by Subject|1|||
127986083|NCT01333956|460572349|FG003|Overall Study|Withdrawal by Subject|0|||
127986084|NCT02240069|460572350|FG000|Overall Study|Withdrawal by Subject|5|||
127986085|NCT02240069|460572351|FG001|Overall Study|Withdrawal by Subject|5|||
127986086|NCT02240069|460572352|FG002|Overall Study|Withdrawal by Subject|2|||
127653640|NCT00733499|459354854|FG000|10 Year Followup|Death|9|||
127653641|NCT00733499|459354855|FG001|10 Year Followup|Death|7|||
127653642|NCT00733499|459354854|FG000|10 Year Followup|Adverse Event|3|||
127986087|NCT04907227|460572353|FG000|Overall Study|Death|12|||
127986088|NCT04907227|460572354|FG001|Overall Study|Death|8|||
127653643|NCT00733499|459354855|FG001|10 Year Followup|Adverse Event|3|||
127986089|NCT04907227|460572353|FG000|Overall Study|Withdrawal by Subject|2|||
127653644|NCT00733499|459354854|FG000|10 Year Followup|Lost to Follow-up|3|||
127653645|NCT00733499|459354855|FG001|10 Year Followup|Lost to Follow-up|2|||
127986090|NCT04907227|460572354|FG001|Overall Study|Withdrawal by Subject|2|||
127986091|NCT04907227|460572353|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
127986092|NCT04907227|460572354|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
127986093|NCT04907227|460572353|FG000|Overall Study|Sponsor Decision|25|||
127986094|NCT04907227|460572354|FG001|Overall Study|Sponsor Decision|30|||
127986095|NCT04907227|460572353|FG000|Overall Study|Physician Decision|1|||
127986096|NCT04907227|460572354|FG001|Overall Study|Physician Decision|0|||
127986097|NCT03723070|460572355|FG000|Overall Study|Lost to Follow-up|2|||
127986098|NCT03723070|460572355|FG000|Overall Study|Physician Decision|1|||
127986099|NCT03723070|460572355|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
127986100|NCT02208050|460572356|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
127986101|NCT02208050|460572357|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
127986102|NCT00474786|460572359|FG000|Overall Study|Not Meeting Study Criteria|0|||
127986103|NCT00474786|460572360|FG001|Overall Study|Not Meeting Study Criteria|1|||
127986104|NCT00474786|460572359|FG000|Overall Study|Investigator Request|2|||
127986105|NCT00474786|460572360|FG001|Overall Study|Investigator Request|1|||
127986106|NCT00474786|460572359|FG000|Overall Study|Death|189|||
127986107|NCT00474786|460572360|FG001|Overall Study|Death|170|||
127986108|NCT00474786|460572359|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
127986109|NCT00474786|460572360|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
127986110|NCT00474786|460572359|FG000|Overall Study|Lost to Follow-up|4|||
127986111|NCT00474786|460572360|FG001|Overall Study|Lost to Follow-up|7|||
127986112|NCT00474786|460572359|FG000|Overall Study|Protocol Violation|2|||
127986113|NCT00474786|460572360|FG001|Overall Study|Protocol Violation|0|||
127986114|NCT00474786|460572359|FG000|Overall Study|Withdrawal by Subject|15|||
127986115|NCT00474786|460572360|FG001|Overall Study|Withdrawal by Subject|15|||
127986116|NCT00474786|460572359|FG000|Overall Study|Other|5|||
127986117|NCT00474786|460572360|FG001|Overall Study|Other|0|||
127986118|NCT00432276|460572361|FG000|Overall Study|Hyperglycemic Rescue|44|||
127986119|NCT00432276|460572362|FG001|Overall Study|Hyperglycemic Rescue|87|||
127986120|NCT00432276|460572361|FG000|Overall Study|Adverse Event|13|||
127986121|NCT00432276|460572362|FG001|Overall Study|Adverse Event|16|||
127986122|NCT00432276|460572361|FG000|Overall Study|Protocol Violation|25|||
127986123|NCT00432276|460572362|FG001|Overall Study|Protocol Violation|20|||
127986124|NCT00432276|460572361|FG000|Overall Study|Lost to Follow-up|6|||
127986125|NCT00432276|460572362|FG001|Overall Study|Lost to Follow-up|2|||
127986126|NCT00432276|460572361|FG000|Overall Study|Withdrawal by Subject|25|||
127986127|NCT00432276|460572362|FG001|Overall Study|Withdrawal by Subject|20|||
127986128|NCT00432276|460572361|FG000|Overall Study|Physician Decision|6|||
127986129|NCT00432276|460572362|FG001|Overall Study|Physician Decision|8|||
127986130|NCT00432276|460572361|FG000|Overall Study|Other|2|||
127986131|NCT00432276|460572362|FG001|Overall Study|Other|3|||
127986132|NCT00467961|460572363|FG000|Overall Study|Technical Failures|5|||
127986133|NCT00467961|460572363|FG000|Overall Study|Disease Progression|2|||
127986134|NCT05249127|460572364|FG000|Overall Study|Protocol Violation|13|||
127986135|NCT05249127|460572364|FG000|Overall Study|Physician Decision|4|||
127986136|NCT05249127|460572364|FG000|Overall Study|Withdrawal by Subject|2|||
127986137|NCT05249127|460572364|FG000|Overall Study|Participant Non-compliance|1|||
127986138|NCT02073565|460572366|FG000|Cohort A|Withdrawal by Subject|1|||
127986139|NCT02073565|460572367|FG001|Cohort A|Withdrawal by Subject|0|||
127986140|NCT02073565|460572366|FG000|Cohort B|Withdrawal by Subject|1|||
127986141|NCT02073565|460572367|FG001|Cohort B|Withdrawal by Subject|2|||
127986142|NCT02073565|460572366|FG000|Cohort C|Withdrawal by Subject|0|||
127986143|NCT02073565|460572367|FG001|Cohort C|Withdrawal by Subject|2|||
127986144|NCT02073565|460572366|FG000|Cohort C|Lost to Follow-up|0|||
127986145|NCT02073565|460572367|FG001|Cohort C|Lost to Follow-up|2|||
127986146|NCT03417024|460572370|FG000|Overall Study|Study Termination prior to follow-up|11|||
127986147|NCT03417024|460572370|FG000|Overall Study|Physician Decision|2|||
127986148|NCT04015518|460572371|FG000|Overall Study|Adverse Event|6|||
127986149|NCT04015518|460572372|FG001|Overall Study|Adverse Event|1|||
127986150|NCT04015518|460572373|FG002|Overall Study|Adverse Event|1|||
127986151|NCT04015518|460572374|FG003|Overall Study|Adverse Event|3|||
127986152|NCT04015518|460572375|FG004|Overall Study|Adverse Event|3|||
127986153|NCT04015518|460572371|FG000|Overall Study|Lack of Efficacy|1|||
127986154|NCT04015518|460572372|FG001|Overall Study|Lack of Efficacy|0|||
127986155|NCT04015518|460572373|FG002|Overall Study|Lack of Efficacy|1|||
127986156|NCT04015518|460572374|FG003|Overall Study|Lack of Efficacy|0|||
127986157|NCT04015518|460572375|FG004|Overall Study|Lack of Efficacy|4|||
127986158|NCT04015518|460572371|FG000|Overall Study|Lost to Follow-up|0|||
127986159|NCT04015518|460572372|FG001|Overall Study|Lost to Follow-up|0|||
127986160|NCT04015518|460572373|FG002|Overall Study|Lost to Follow-up|0|||
127986161|NCT04015518|460572374|FG003|Overall Study|Lost to Follow-up|0|||
127986162|NCT04015518|460572375|FG004|Overall Study|Lost to Follow-up|1|||
127986163|NCT04015518|460572371|FG000|Overall Study|Withdrawal by Subject|0|||
127986164|NCT04015518|460572372|FG001|Overall Study|Withdrawal by Subject|1|||
127986165|NCT04015518|460572373|FG002|Overall Study|Withdrawal by Subject|0|||
127986166|NCT04015518|460572374|FG003|Overall Study|Withdrawal by Subject|1|||
127986167|NCT04015518|460572375|FG004|Overall Study|Withdrawal by Subject|1|||
127986168|NCT04015518|460572371|FG000|Overall Study|Patient did not come for consecutive visits|0|||
127986169|NCT04015518|460572372|FG001|Overall Study|Patient did not come for consecutive visits|1|||
127986170|NCT04015518|460572373|FG002|Overall Study|Patient did not come for consecutive visits|0|||
127986171|NCT04015518|460572374|FG003|Overall Study|Patient did not come for consecutive visits|0|||
127986172|NCT04015518|460572375|FG004|Overall Study|Patient did not come for consecutive visits|0|||
127986173|NCT04015518|460572371|FG000|Overall Study|not willing to travel due to Covid-19|0|||
127986174|NCT04015518|460572372|FG001|Overall Study|not willing to travel due to Covid-19|0|||
127986175|NCT04015518|460572373|FG002|Overall Study|not willing to travel due to Covid-19|1|||
127653646|NCT00733499|459354854|FG000|10 Year Followup|Withdrawal by Subject|5|||
127653647|NCT00733499|459354855|FG001|10 Year Followup|Withdrawal by Subject|5|||
127653648|NCT00733499|459354854|FG000|10 Year Followup|missing, unable to locate|0|||
127653649|NCT00733499|459354855|FG001|10 Year Followup|missing, unable to locate|2|||
127653650|NCT02739347|459354856|FG000|Overall Study|Adverse Event|3|||
127986176|NCT04015518|460572374|FG003|Overall Study|not willing to travel due to Covid-19|0|||
127986177|NCT04015518|460572375|FG004|Overall Study|not willing to travel due to Covid-19|0|||
127653651|NCT02739347|459354857|FG001|Overall Study|Adverse Event|0|||
127653652|NCT02739347|459354856|FG000|Overall Study|Protocol Violation|0|||
127653653|NCT02739347|459354857|FG001|Overall Study|Protocol Violation|1|||
127653654|NCT02739347|459354856|FG000|Overall Study|Lost to Follow-up|0|||
127653655|NCT02739347|459354857|FG001|Overall Study|Lost to Follow-up|2|||
127653656|NCT03929562|459354858|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
127653657|NCT03929562|459354859|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
127653658|NCT03929562|459354858|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
127653659|NCT03929562|459354859|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
127653660|NCT03929562|459354858|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
127653661|NCT03929562|459354859|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
127653662|NCT01778556|459354860|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
127653663|NCT01778556|459354861|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
127653664|NCT01778556|459354860|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
127653665|NCT01778556|459354861|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
127653666|NCT01778556|459354860|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
127653667|NCT01778556|459354861|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
127653668|NCT01778556|459354860|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
127653669|NCT01778556|459354861|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
127653670|NCT03682705|459354865|FG000|Overall Study|Adverse Event|1|||
127653671|NCT03682705|459354866|FG001|Overall Study|Adverse Event|1|||
127653672|NCT03682705|459354867|FG002|Overall Study|Adverse Event|1|||
127653673|NCT03682705|459354868|FG003|Overall Study|Adverse Event|0|||
127653674|NCT03682705|459354869|FG004|Overall Study|Adverse Event|1|||
127653675|NCT03682705|459354870|FG005|Overall Study|Adverse Event|1|||
127653676|NCT03682705|459354865|FG000|Overall Study|Withdrawal by Subject|1|||
127653677|NCT03682705|459354866|FG001|Overall Study|Withdrawal by Subject|3|||
127653678|NCT03682705|459354867|FG002|Overall Study|Withdrawal by Subject|2|||
127653679|NCT03682705|459354868|FG003|Overall Study|Withdrawal by Subject|4|||
127653680|NCT03682705|459354869|FG004|Overall Study|Withdrawal by Subject|0|||
127653681|NCT03682705|459354870|FG005|Overall Study|Withdrawal by Subject|1|||
127653682|NCT03682705|459354865|FG000|Overall Study|Other, not specified|0|||
127653683|NCT03682705|459354866|FG001|Overall Study|Other, not specified|0|||
127653684|NCT03682705|459354867|FG002|Overall Study|Other, not specified|0|||
127653685|NCT03682705|459354868|FG003|Overall Study|Other, not specified|1|||
127653686|NCT03682705|459354869|FG004|Overall Study|Other, not specified|2|||
127653687|NCT03682705|459354870|FG005|Overall Study|Other, not specified|0|||
127653688|NCT03682705|459354865|FG000|Overall Study|Lost to Follow-up|0|||
127653689|NCT03682705|459354866|FG001|Overall Study|Lost to Follow-up|0|||
127653690|NCT03682705|459354867|FG002|Overall Study|Lost to Follow-up|0|||
127653691|NCT03682705|459354868|FG003|Overall Study|Lost to Follow-up|0|||
127653692|NCT03682705|459354869|FG004|Overall Study|Lost to Follow-up|3|||
127653693|NCT03682705|459354870|FG005|Overall Study|Lost to Follow-up|0|||
127653694|NCT01919970|459354872|FG000|Overall Study|Withdrawal by Subject|3|||
127653695|NCT01919970|459354873|FG001|Overall Study|Withdrawal by Subject|0|||
127653696|NCT04043962|459354874|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
127653697|NCT04043962|459354874|FG000|Post-Treatment|Withdrawal by Subject|5|||
127653698|NCT04043962|459354874|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
127653699|NCT04615182|459354875|FG000|Overall Study|Re-transplanted|2|||
127653700|NCT04615182|459354875|FG000|Overall Study|Protocol Violation|6|||
127653701|NCT04615182|459354875|FG000|Overall Study|Death|6|||
127653702|NCT04615182|459354875|FG000|Overall Study|Death and protocol violation|1|||
127653703|NCT01336621|459354876|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
127653704|NCT01336621|459354876|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
127653705|NCT01336621|459354876|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
127653706|NCT01336621|459354876|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
127986178|NCT04015518|460572371|FG000|Overall Study|Patient wants to discontinue treatment|0|||
127653707|NCT01336621|459354876|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
127653708|NCT01336621|459354876|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
127653709|NCT01336621|459354876|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
127653710|NCT01336621|459354876|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
127653711|NCT01336621|459354876|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
127653712|NCT01336621|459354876|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
127653713|NCT01336621|459354876|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
127986179|NCT04015518|460572372|FG001|Overall Study|Patient wants to discontinue treatment|0|||
127653714|NCT01336621|459354876|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
127653715|NCT01336621|459354876|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
127653716|NCT01336621|459354876|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
127653717|NCT01126060|459354879|FG000|Overall Study|Protocol Violation|0|||
127653718|NCT01126060|459354880|FG001|Overall Study|Protocol Violation|2|||
127653719|NCT01874145|459354881|FG000|Core Period|Non-compliance|1|||
127653720|NCT01874145|459354882|FG001|Core Period|Non-compliance|0|||
127653721|NCT01874145|459354881|FG000|Core Period|Protocol Violation|1|||
127653722|NCT01874145|459354882|FG001|Core Period|Protocol Violation|1|||
127653723|NCT01874145|459354881|FG000|Core Period|Physician Decision|1|||
127653724|NCT01874145|459354882|FG001|Core Period|Physician Decision|1|||
127653725|NCT01874145|459354881|FG000|Core Period|Adverse Event|0|||
127653726|NCT01874145|459354882|FG001|Core Period|Adverse Event|1|||
127653727|NCT01874145|459354881|FG000|Core Period|Withdrawal by Subject|0|||
127653728|NCT01874145|459354882|FG001|Core Period|Withdrawal by Subject|4|||
127653729|NCT01874145|459354881|FG000|Extension Period|Adverse Event|3|||
127653730|NCT01874145|459354882|FG001|Extension Period|Adverse Event|2|||
127653731|NCT01874145|459354881|FG000|Extension Period|Withdrawal by Subject|2|||
127653732|NCT01874145|459354882|FG001|Extension Period|Withdrawal by Subject|1|||
127653733|NCT01874145|459354881|FG000|Extension Period|Lost to Follow-up|1|||
127653734|NCT01874145|459354882|FG001|Extension Period|Lost to Follow-up|1|||
127653735|NCT00402337|459354887|FG000|Overall Study|Adverse Event|0|||
127653736|NCT00402337|459354888|FG001|Overall Study|Adverse Event|2|||
127653737|NCT00402337|459354889|FG002|Overall Study|Adverse Event|2|||
127653738|NCT00402337|459354890|FG003|Overall Study|Adverse Event|3|||
127653739|NCT00402337|459354891|FG004|Overall Study|Adverse Event|2|||
127653740|NCT00402337|459354887|FG000|Overall Study|Noncompliance|0|||
127653741|NCT00402337|459354888|FG001|Overall Study|Noncompliance|0|||
127653742|NCT00402337|459354889|FG002|Overall Study|Noncompliance|0|||
127653743|NCT00402337|459354890|FG003|Overall Study|Noncompliance|0|||
127653744|NCT00402337|459354891|FG004|Overall Study|Noncompliance|2|||
127653745|NCT00402337|459354887|FG000|Overall Study|Withdrawal by Subject|5|||
127653746|NCT00402337|459354888|FG001|Overall Study|Withdrawal by Subject|3|||
127653747|NCT00402337|459354889|FG002|Overall Study|Withdrawal by Subject|1|||
127653748|NCT00402337|459354890|FG003|Overall Study|Withdrawal by Subject|6|||
127653749|NCT00402337|459354891|FG004|Overall Study|Withdrawal by Subject|4|||
127653750|NCT00402337|459354887|FG000|Overall Study|Lost to Follow-up|0|||
127653751|NCT00402337|459354888|FG001|Overall Study|Lost to Follow-up|0|||
127653752|NCT00402337|459354889|FG002|Overall Study|Lost to Follow-up|1|||
127653753|NCT00402337|459354890|FG003|Overall Study|Lost to Follow-up|2|||
127653754|NCT00402337|459354891|FG004|Overall Study|Lost to Follow-up|0|||
127653755|NCT00402337|459354887|FG000|Overall Study|Physician Decision|0|||
127653756|NCT00402337|459354888|FG001|Overall Study|Physician Decision|0|||
127653757|NCT00402337|459354889|FG002|Overall Study|Physician Decision|0|||
127653758|NCT00402337|459354890|FG003|Overall Study|Physician Decision|1|||
127653759|NCT00402337|459354891|FG004|Overall Study|Physician Decision|0|||
127986180|NCT04015518|460572373|FG002|Overall Study|Patient wants to discontinue treatment|0|||
127986181|NCT04015518|460572374|FG003|Overall Study|Patient wants to discontinue treatment|1|||
127986182|NCT04015518|460572375|FG004|Overall Study|Patient wants to discontinue treatment|0|||
127986183|NCT04015518|460572371|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
127986184|NCT04015518|460572372|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
127986185|NCT04015518|460572373|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
127986186|NCT04015518|460572374|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
127986187|NCT04015518|460572375|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
127986188|NCT04015518|460572371|FG000|Overall Study|Pregnancy|0|||
127986189|NCT04015518|460572372|FG001|Overall Study|Pregnancy|0|||
127986190|NCT04015518|460572373|FG002|Overall Study|Pregnancy|0|||
127986191|NCT04015518|460572374|FG003|Overall Study|Pregnancy|0|||
127986192|NCT04015518|460572375|FG004|Overall Study|Pregnancy|1|||
127986193|NCT04015518|460572371|FG000|Overall Study|Personal reasons|1|||
127986194|NCT04015518|460572372|FG001|Overall Study|Personal reasons|0|||
127653760|NCT00402337|459354887|FG000|Overall Study|Other Reason|0|||
127653761|NCT00402337|459354888|FG001|Overall Study|Other Reason|1|||
127653762|NCT00402337|459354889|FG002|Overall Study|Other Reason|0|||
127653763|NCT00402337|459354890|FG003|Overall Study|Other Reason|0|||
127653764|NCT00402337|459354891|FG004|Overall Study|Other Reason|0|||
127653765|NCT02178566|459354892|FG000|Overall Study|patient did not complete due to noncompliance|0|||
127986195|NCT04015518|460572373|FG002|Overall Study|Personal reasons|0|||
127986196|NCT04015518|460572374|FG003|Overall Study|Personal reasons|0|||
127986197|NCT04015518|460572375|FG004|Overall Study|Personal reasons|1|||
127653766|NCT02178566|459354893|FG001|Overall Study|patient did not complete due to noncompliance|1|||
127653767|NCT02658630|459354898|FG000|Overall Study|Withdrawal by Subject|4|||
127653768|NCT02821819|459354900|FG000|Overall Study|Protocol Violation|1|||
127653769|NCT03565068|459354901|FG000|Overall Study|Protocol Violation|0|||
127653770|NCT03565068|459354902|FG001|Overall Study|Protocol Violation|0|||
127653771|NCT03565068|459354903|FG002|Overall Study|Protocol Violation|0|||
127653772|NCT03565068|459354904|FG003|Overall Study|Protocol Violation|0|||
127653773|NCT03565068|459354905|FG004|Overall Study|Protocol Violation|1|||
127653774|NCT03565068|459354906|FG005|Overall Study|Protocol Violation|0|||
127653775|NCT03565068|459354907|FG006|Overall Study|Protocol Violation|0|||
127653776|NCT03565068|459354908|FG007|Overall Study|Protocol Violation|1|||
127653777|NCT03565068|459354909|FG008|Overall Study|Protocol Violation|0|||
127653778|NCT03565068|459354901|FG000|Overall Study|Sponsor decision|0|||
127653779|NCT03565068|459354902|FG001|Overall Study|Sponsor decision|0|||
127653780|NCT03565068|459354903|FG002|Overall Study|Sponsor decision|0|||
127653781|NCT03565068|459354904|FG003|Overall Study|Sponsor decision|0|||
127653782|NCT03565068|459354905|FG004|Overall Study|Sponsor decision|1|||
127653783|NCT03565068|459354906|FG005|Overall Study|Sponsor decision|1|||
127653784|NCT03565068|459354907|FG006|Overall Study|Sponsor decision|0|||
127653785|NCT03565068|459354908|FG007|Overall Study|Sponsor decision|0|||
127653786|NCT03565068|459354909|FG008|Overall Study|Sponsor decision|0|||
127653787|NCT03565068|459354901|FG000|Overall Study|Withdrawal by Subject|0|||
127653788|NCT03565068|459354902|FG001|Overall Study|Withdrawal by Subject|0|||
127653789|NCT03565068|459354903|FG002|Overall Study|Withdrawal by Subject|1|||
127653790|NCT03565068|459354904|FG003|Overall Study|Withdrawal by Subject|0|||
127653791|NCT03565068|459354905|FG004|Overall Study|Withdrawal by Subject|2|||
127653792|NCT03565068|459354906|FG005|Overall Study|Withdrawal by Subject|0|||
127653793|NCT03565068|459354907|FG006|Overall Study|Withdrawal by Subject|1|||
127986198|NCT04015518|460572371|FG000|Overall Study|Withdrew consent|1|||
127986199|NCT04015518|460572372|FG001|Overall Study|Withdrew consent|0|||
127986200|NCT04015518|460572373|FG002|Overall Study|Withdrew consent|0|||
127986201|NCT04015518|460572374|FG003|Overall Study|Withdrew consent|0|||
127986202|NCT04015518|460572375|FG004|Overall Study|Withdrew consent|0|||
127986203|NCT04015518|460572371|FG000|Overall Study|Prostate carcinoma|1|||
127986204|NCT04015518|460572372|FG001|Overall Study|Prostate carcinoma|0|||
127986205|NCT04015518|460572373|FG002|Overall Study|Prostate carcinoma|0|||
127986206|NCT04015518|460572374|FG003|Overall Study|Prostate carcinoma|0|||
127986207|NCT04015518|460572375|FG004|Overall Study|Prostate carcinoma|0|||
127986208|NCT04015518|460572371|FG000|Overall Study|Could not keep appointments due to work|1|||
127986209|NCT04015518|460572372|FG001|Overall Study|Could not keep appointments due to work|0|||
127986210|NCT04015518|460572373|FG002|Overall Study|Could not keep appointments due to work|0|||
127986211|NCT04015518|460572374|FG003|Overall Study|Could not keep appointments due to work|0|||
127653794|NCT03565068|459354908|FG007|Overall Study|Withdrawal by Subject|5|||
127653795|NCT03565068|459354909|FG008|Overall Study|Withdrawal by Subject|1|||
127653796|NCT03565068|459354901|FG000|Overall Study|Physician Decision|0|||
127653797|NCT03565068|459354902|FG001|Overall Study|Physician Decision|0|||
127653798|NCT03565068|459354903|FG002|Overall Study|Physician Decision|0|||
127653799|NCT03565068|459354904|FG003|Overall Study|Physician Decision|0|||
127986212|NCT04015518|460572375|FG004|Overall Study|Could not keep appointments due to work|0|||
127986213|NCT02195427|460572376|FG000|Overall Study|Did not consent to study extension|13|||
127986214|NCT02195427|460572377|FG001|Overall Study|Did not consent to study extension|9|||
127986215|NCT02195427|460572376|FG000|Overall Study|Withdrawal by Subject|4|||
127653800|NCT03565068|459354905|FG004|Overall Study|Physician Decision|0|||
127880553|NCT01915498|460183519|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
127880554|NCT01915498|460183520|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
127880555|NCT01915498|460183521|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
127880556|NCT01915498|460183522|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
127880557|NCT01915498|460183523|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
127880558|NCT01915498|460183524|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
127880559|NCT01915498|460183525|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
127880560|NCT01915498|460183526|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
127880561|NCT01915498|460183527|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
127880562|NCT01915498|460183528|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
127880563|NCT01915498|460183529|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
127880564|NCT01915498|460183530|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
127880565|NCT01915498|460183531|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
127880566|NCT01915498|460183532|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
127880567|NCT01915498|460183533|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
127880568|NCT01915498|460183534|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
127880569|NCT01915498|460183535|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
127986216|NCT02195427|460572377|FG001|Overall Study|Withdrawal by Subject|2|||
127986217|NCT02195427|460572376|FG000|Overall Study|Lost to Follow-up|0|||
127986218|NCT02195427|460572377|FG001|Overall Study|Lost to Follow-up|1|||
127880570|NCT01915498|460183517|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
127880571|NCT01915498|460183518|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
127986219|NCT02195427|460572376|FG000|Overall Study|Protocol Violation|7|||
127986220|NCT02195427|460572377|FG001|Overall Study|Protocol Violation|14|||
127986221|NCT02195427|460572376|FG000|Overall Study|Conditional re-treatment at W52|2|||
127986222|NCT02195427|460572377|FG001|Overall Study|Conditional re-treatment at W52|1|||
127653801|NCT03565068|459354906|FG005|Overall Study|Physician Decision|0|||
127653802|NCT03565068|459354907|FG006|Overall Study|Physician Decision|0|||
127653803|NCT03565068|459354908|FG007|Overall Study|Physician Decision|1|||
127986223|NCT02655419|460572378|FG000|Overall Study|Enrolled but not treated|1|||
127986224|NCT02655419|460572379|FG001|Overall Study|Enrolled but not treated|5|||
127986225|NCT02655419|460572378|FG000|Overall Study|Withdrawal by Subject|4|||
127986226|NCT02655419|460572379|FG001|Overall Study|Withdrawal by Subject|1|||
127986227|NCT02655419|460572378|FG000|Overall Study|Other|0|||
127986228|NCT02655419|460572379|FG001|Overall Study|Other|1|||
127986229|NCT00505661|460572380|FG000|Overall Study|Not Eligible|4|||
127986230|NCT00463840|460572381|FG000|Overall Study|Disease progression|7|||
127986231|NCT00463840|460572381|FG000|Overall Study|Withdrawal by Subject|2|||
127986232|NCT00463840|460572381|FG000|Overall Study|Adverse Event|3|||
127986233|NCT01653327|460572382|FG000|Overall Study|Withdrawal by Subject|1|||
127986234|NCT01738191|460572383|FG000|Overall Study|Withdrawal by Subject|4|||
127986235|NCT01738191|460572384|FG001|Overall Study|Withdrawal by Subject|1|||
127986236|NCT04607980|460572385|FG000|Overall Study|Adverse Event|3|||
127986237|NCT04607980|460572386|FG001|Overall Study|Adverse Event|4|||
127986238|NCT04607980|460572385|FG000|Overall Study|Death|0|||
127986239|NCT04607980|460572386|FG001|Overall Study|Death|1|||
127986240|NCT04607980|460572385|FG000|Overall Study|Withdrawal by Subject|2|||
127986241|NCT04607980|460572386|FG001|Overall Study|Withdrawal by Subject|5|||
127986242|NCT04607980|460572385|FG000|Overall Study|Lost to Follow-up|4|||
127986243|NCT04607980|460572386|FG001|Overall Study|Lost to Follow-up|8|||
127986244|NCT04607980|460572385|FG000|Overall Study|Protocol Violation|0|||
127986245|NCT04607980|460572386|FG001|Overall Study|Protocol Violation|3|||
127986246|NCT04607980|460572385|FG000|Overall Study|Other|3|||
127986247|NCT04607980|460572386|FG001|Overall Study|Other|0|||
127986248|NCT02109445|460572389|FG000|Overall Study|Symptomatic deterioration|2|||
127986249|NCT02109445|460572389|FG000|Overall Study|Adverse Event|1|||
127986250|NCT02474355|460574082|FG000|Overall Study|Other|43|||
127986251|NCT02474355|460574082|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
127986252|NCT02474355|460574082|FG000|Overall Study|Lost to Follow-up|98|||
127986253|NCT02474355|460574082|FG000|Overall Study|Withdrawal by Subject|124|||
127986254|NCT02474355|460574082|FG000|Overall Study|Death|1361|||
127986255|NCT01066793|460574083|FG000|Overall Study|Death|4|||
127986256|NCT01066793|460574084|FG001|Overall Study|Death|1|||
127986257|NCT01066793|460574085|FG002|Overall Study|Death|1|||
127986258|NCT01066793|460574086|FG003|Overall Study|Death|0|||
127986259|NCT01066793|460574087|FG004|Overall Study|Death|0|||
127986260|NCT01066793|460574088|FG005|Overall Study|Death|0|||
127986261|NCT01066793|460574083|FG000|Overall Study|Lack of Efficacy|2|||
127986262|NCT01066793|460574084|FG001|Overall Study|Lack of Efficacy|1|||
127986263|NCT01066793|460574085|FG002|Overall Study|Lack of Efficacy|0|||
127986264|NCT01066793|460574086|FG003|Overall Study|Lack of Efficacy|0|||
127986265|NCT01066793|460574087|FG004|Overall Study|Lack of Efficacy|0|||
127986266|NCT01066793|460574088|FG005|Overall Study|Lack of Efficacy|0|||
127986267|NCT01066793|460574083|FG000|Overall Study|Lost to Follow-up|180|||
127986268|NCT01066793|460574084|FG001|Overall Study|Lost to Follow-up|39|||
127986269|NCT01066793|460574085|FG002|Overall Study|Lost to Follow-up|82|||
127986270|NCT01066793|460574086|FG003|Overall Study|Lost to Follow-up|16|||
127986271|NCT01066793|460574087|FG004|Overall Study|Lost to Follow-up|0|||
127986272|NCT01066793|460574088|FG005|Overall Study|Lost to Follow-up|1|||
127986273|NCT01066793|460574083|FG000|Overall Study|Physician Decision|3|||
127986274|NCT01066793|460574084|FG001|Overall Study|Physician Decision|0|||
127986275|NCT01066793|460574085|FG002|Overall Study|Physician Decision|0|||
127986276|NCT01066793|460574086|FG003|Overall Study|Physician Decision|0|||
127986277|NCT01066793|460574087|FG004|Overall Study|Physician Decision|0|||
127986278|NCT01066793|460574088|FG005|Overall Study|Physician Decision|0|||
127986279|NCT01066793|460574083|FG000|Overall Study|Protocol Violation|3|||
127986280|NCT01066793|460574084|FG001|Overall Study|Protocol Violation|2|||
127986281|NCT01066793|460574085|FG002|Overall Study|Protocol Violation|2|||
127986282|NCT01066793|460574086|FG003|Overall Study|Protocol Violation|0|||
127986283|NCT01066793|460574087|FG004|Overall Study|Protocol Violation|0|||
127986284|NCT01066793|460574088|FG005|Overall Study|Protocol Violation|0|||
127986285|NCT01066793|460574083|FG000|Overall Study|Withdrawal by Subject|7|||
127986286|NCT01066793|460574084|FG001|Overall Study|Withdrawal by Subject|4|||
127986287|NCT01066793|460574085|FG002|Overall Study|Withdrawal by Subject|1|||
127986288|NCT01066793|460574086|FG003|Overall Study|Withdrawal by Subject|0|||
127986289|NCT01066793|460574087|FG004|Overall Study|Withdrawal by Subject|0|||
127986290|NCT01066793|460574088|FG005|Overall Study|Withdrawal by Subject|0|||
127986291|NCT01066793|460574083|FG000|Overall Study|Early Termination|3|||
127986292|NCT01066793|460574084|FG001|Overall Study|Early Termination|0|||
127986293|NCT01066793|460574085|FG002|Overall Study|Early Termination|0|||
127986294|NCT01066793|460574086|FG003|Overall Study|Early Termination|0|||
127986295|NCT01066793|460574087|FG004|Overall Study|Early Termination|0|||
127986296|NCT01066793|460574088|FG005|Overall Study|Early Termination|0|||
127986297|NCT01066793|460574083|FG000|Overall Study|Lab test not done|7|||
127986298|NCT01066793|460574084|FG001|Overall Study|Lab test not done|0|||
127986299|NCT01066793|460574085|FG002|Overall Study|Lab test not done|0|||
127986300|NCT01066793|460574086|FG003|Overall Study|Lab test not done|1|||
127986301|NCT01066793|460574087|FG004|Overall Study|Lab test not done|0|||
127986302|NCT01066793|460574088|FG005|Overall Study|Lab test not done|0|||
127986303|NCT01066793|460574083|FG000|Overall Study|Miscellaneous|4|||
127653804|NCT03565068|459354909|FG008|Overall Study|Physician Decision|0|||
127653805|NCT03565068|459354901|FG000|Overall Study|Lost to Follow-up|0|||
127653806|NCT03565068|459354902|FG001|Overall Study|Lost to Follow-up|0|||
127653807|NCT03565068|459354903|FG002|Overall Study|Lost to Follow-up|0|||
127653808|NCT03565068|459354904|FG003|Overall Study|Lost to Follow-up|0|||
127653809|NCT03565068|459354905|FG004|Overall Study|Lost to Follow-up|0|||
127653810|NCT03565068|459354906|FG005|Overall Study|Lost to Follow-up|0|||
127653811|NCT03565068|459354907|FG006|Overall Study|Lost to Follow-up|0|||
127653812|NCT03565068|459354908|FG007|Overall Study|Lost to Follow-up|1|||
127653813|NCT03565068|459354909|FG008|Overall Study|Lost to Follow-up|0|||
127653814|NCT00085202|459354910|FG000|Overall Study|Still on therapy|2|||
127653815|NCT00085202|459354911|FG001|Overall Study|Still on therapy|0|||
127653816|NCT00085202|459354910|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
127653817|NCT00085202|459354911|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
127653818|NCT00085202|459354910|FG000|Overall Study|Excessive toxicity|6|||
127653819|NCT00085202|459354911|FG001|Overall Study|Excessive toxicity|5|||
127653820|NCT00085202|459354910|FG000|Overall Study|Non-specified|3|||
127653821|NCT00085202|459354911|FG001|Overall Study|Non-specified|5|||
127653822|NCT00085202|459354910|FG000|Overall Study|Withdrawal by Subject|2|||
127653823|NCT00085202|459354911|FG001|Overall Study|Withdrawal by Subject|1|||
127653824|NCT00085202|459354910|FG000|Overall Study|Physician Decision|4|||
127653825|NCT00085202|459354911|FG001|Overall Study|Physician Decision|1|||
127653826|NCT00085202|459354910|FG000|Overall Study|Progressive disease|1|||
127653827|NCT00085202|459354911|FG001|Overall Study|Progressive disease|11|||
127653828|NCT01436201|459354916|FG000|Overall Study|Adverse Event|2|||
127653829|NCT01436201|459354916|FG000|Overall Study|Withdrawal by Subject|1|||
127653830|NCT01436201|459354916|FG000|Overall Study|Protocol Violation|1|||
127653831|NCT00110890|459354918|FG000|Overall Study|Adverse Event|30|||
127986304|NCT01066793|460574084|FG001|Overall Study|Miscellaneous|5|||
127986305|NCT01066793|460574085|FG002|Overall Study|Miscellaneous|6|||
127986306|NCT01066793|460574086|FG003|Overall Study|Miscellaneous|0|||
127986307|NCT01066793|460574087|FG004|Overall Study|Miscellaneous|0|||
127986308|NCT01066793|460574088|FG005|Overall Study|Miscellaneous|0|||
127986309|NCT01066793|460574083|FG000|Overall Study|Non-responders|104|||
127986310|NCT01066793|460574084|FG001|Overall Study|Non-responders|5|||
127986311|NCT01066793|460574085|FG002|Overall Study|Non-responders|11|||
127986312|NCT01066793|460574086|FG003|Overall Study|Non-responders|25|||
127986313|NCT01066793|460574087|FG004|Overall Study|Non-responders|0|||
127986314|NCT01066793|460574088|FG005|Overall Study|Non-responders|0|||
127986315|NCT01066793|460574083|FG000|Overall Study|Other|15|||
127986316|NCT01066793|460574084|FG001|Overall Study|Other|5|||
127986317|NCT01066793|460574085|FG002|Overall Study|Other|6|||
127986318|NCT01066793|460574086|FG003|Overall Study|Other|2|||
127986319|NCT01066793|460574087|FG004|Overall Study|Other|0|||
127986320|NCT01066793|460574088|FG005|Overall Study|Other|0|||
127986321|NCT01066793|460574083|FG000|Overall Study|Relapse|20|||
127986322|NCT01066793|460574084|FG001|Overall Study|Relapse|8|||
127986323|NCT01066793|460574085|FG002|Overall Study|Relapse|2|||
127986324|NCT01066793|460574086|FG003|Overall Study|Relapse|3|||
127986325|NCT01066793|460574087|FG004|Overall Study|Relapse|0|||
127986326|NCT01066793|460574088|FG005|Overall Study|Relapse|0|||
127986327|NCT01066793|460574083|FG000|Overall Study|Result Not Available|1|||
127986328|NCT01066793|460574084|FG001|Overall Study|Result Not Available|0|||
127986329|NCT01066793|460574085|FG002|Overall Study|Result Not Available|0|||
127986330|NCT01066793|460574086|FG003|Overall Study|Result Not Available|0|||
127986331|NCT01066793|460574087|FG004|Overall Study|Result Not Available|0|||
127986332|NCT01066793|460574088|FG005|Overall Study|Result Not Available|0|||
127986333|NCT01066793|460574083|FG000|Overall Study|Treatment Interrupted|1|||
127986334|NCT01066793|460574084|FG001|Overall Study|Treatment Interrupted|1|||
127986335|NCT01066793|460574085|FG002|Overall Study|Treatment Interrupted|0|||
127986336|NCT01066793|460574086|FG003|Overall Study|Treatment Interrupted|0|||
127986337|NCT01066793|460574087|FG004|Overall Study|Treatment Interrupted|0|||
127986338|NCT01066793|460574088|FG005|Overall Study|Treatment Interrupted|0|||
127986339|NCT01066793|460574083|FG000|Overall Study|Treatment Never Started|18|||
127653832|NCT00110890|459354919|FG001|Overall Study|Adverse Event|7|||
127986340|NCT01066793|460574084|FG001|Overall Study|Treatment Never Started|5|||
127653833|NCT00110890|459354918|FG000|Overall Study|Death|16|||
127653834|NCT00110890|459354919|FG001|Overall Study|Death|9|||
127653835|NCT00110890|459354918|FG000|Overall Study|Lost to Follow-up|3|||
127986341|NCT01066793|460574085|FG002|Overall Study|Treatment Never Started|4|||
127986342|NCT01066793|460574086|FG003|Overall Study|Treatment Never Started|1|||
127986343|NCT01066793|460574087|FG004|Overall Study|Treatment Never Started|0|||
127986344|NCT01066793|460574088|FG005|Overall Study|Treatment Never Started|0|||
127986345|NCT01066793|460574083|FG000|Overall Study|Treatment Stopped|2|||
127986346|NCT01066793|460574084|FG001|Overall Study|Treatment Stopped|1|||
127986347|NCT01066793|460574085|FG002|Overall Study|Treatment Stopped|0|||
127653836|NCT00110890|459354919|FG001|Overall Study|Lost to Follow-up|1|||
127653837|NCT00110890|459354918|FG000|Overall Study|Physician Decision|4|||
127653838|NCT00110890|459354919|FG001|Overall Study|Physician Decision|5|||
127986348|NCT01066793|460574086|FG003|Overall Study|Treatment Stopped|1|||
127653839|NCT00110890|459354918|FG000|Overall Study|Withdrawal by Subject|17|||
127653840|NCT00110890|459354919|FG001|Overall Study|Withdrawal by Subject|5|||
127653841|NCT00110890|459354918|FG000|Overall Study|Protocol Deviation|1|||
127653842|NCT00110890|459354919|FG001|Overall Study|Protocol Deviation|0|||
127653843|NCT00110890|459354918|FG000|Overall Study|Noncompliance|10|||
127653844|NCT00110890|459354919|FG001|Overall Study|Noncompliance|0|||
127653845|NCT00110890|459354918|FG000|Overall Study|Kidney Transplant|16|||
127653846|NCT00110890|459354919|FG001|Overall Study|Kidney Transplant|12|||
127653847|NCT00110890|459354918|FG000|Overall Study|Invest. Product Commercially Available|217|||
127653848|NCT00110890|459354919|FG001|Overall Study|Invest. Product Commercially Available|110|||
127653849|NCT00110890|459354918|FG000|Overall Study|Other|34|||
127653850|NCT00110890|459354919|FG001|Overall Study|Other|23|||
127653851|NCT00110890|459354918|FG000|Overall Study|Ineligibility determined|3|||
127653852|NCT00110890|459354919|FG001|Overall Study|Ineligibility determined|0|||
127653853|NCT00110890|459354918|FG000|Overall Study|Requirement for alternative therapy|0|||
127653854|NCT00110890|459354919|FG001|Overall Study|Requirement for alternative therapy|1|||
127653855|NCT00110890|459354918|FG000|Overall Study|Disease progression|0|||
127653856|NCT00110890|459354919|FG001|Overall Study|Disease progression|1|||
127653857|NCT00110890|459354918|FG000|Overall Study|Parathyroidectomy|0|||
127653858|NCT00110890|459354919|FG001|Overall Study|Parathyroidectomy|1|||
127653859|NCT00110890|459354918|FG000|Overall Study|Did not enter follow-up phase|10|||
127653860|NCT00110890|459354919|FG001|Overall Study|Did not enter follow-up phase|4|||
127653861|NCT00263328|459354920|FG000|Overall Study|Death|0|||
127986349|NCT01066793|460574087|FG004|Overall Study|Treatment Stopped|0|||
127986350|NCT01066793|460574088|FG005|Overall Study|Treatment Stopped|0|||
127986351|NCT01911793|460574089|FG000|Overall Study|Physician Decision|1|||
127986352|NCT01911793|460574090|FG001|Overall Study|Physician Decision|5|||
127986353|NCT03774394|460574091|FG000|Overall Study|Withdrawal by Subject|2|||
127986354|NCT03774394|460574092|FG001|Overall Study|Withdrawal by Subject|0|||
127986355|NCT03334422|460574093|FG000|Overall Study|Adverse Event|1|||
127986356|NCT03334422|460574094|FG001|Overall Study|Adverse Event|3|||
127986357|NCT03334422|460574095|FG002|Overall Study|Adverse Event|2|||
127986358|NCT03334422|460574096|FG003|Overall Study|Adverse Event|2|||
127986359|NCT03334422|460574093|FG000|Overall Study|Lack of Efficacy|10|||
127986360|NCT03334422|460574094|FG001|Overall Study|Lack of Efficacy|2|||
127986361|NCT03334422|460574095|FG002|Overall Study|Lack of Efficacy|7|||
127986362|NCT03334422|460574096|FG003|Overall Study|Lack of Efficacy|3|||
127986363|NCT03334422|460574093|FG000|Overall Study|Withdrawal by Subject|8|||
127986364|NCT03334422|460574094|FG001|Overall Study|Withdrawal by Subject|3|||
127986365|NCT03334422|460574095|FG002|Overall Study|Withdrawal by Subject|1|||
127986366|NCT03334422|460574096|FG003|Overall Study|Withdrawal by Subject|0|||
127986367|NCT03334422|460574093|FG000|Overall Study|Lost to Follow-up|0|||
127986368|NCT03334422|460574094|FG001|Overall Study|Lost to Follow-up|0|||
127986369|NCT03334422|460574095|FG002|Overall Study|Lost to Follow-up|0|||
127986370|NCT03334422|460574096|FG003|Overall Study|Lost to Follow-up|1|||
127986371|NCT03334422|460574093|FG000|Overall Study|Inability to obtain laboratory samples|0|||
127986372|NCT03334422|460574094|FG001|Overall Study|Inability to obtain laboratory samples|1|||
127986373|NCT03334422|460574095|FG002|Overall Study|Inability to obtain laboratory samples|0|||
127986374|NCT03334422|460574096|FG003|Overall Study|Inability to obtain laboratory samples|0|||
127986375|NCT03334422|460574093|FG000|Overall Study|Pregnancy|0|||
127986376|NCT03334422|460574094|FG001|Overall Study|Pregnancy|1|||
127986377|NCT03334422|460574095|FG002|Overall Study|Pregnancy|0|||
127986378|NCT03334422|460574096|FG003|Overall Study|Pregnancy|0|||
127986379|NCT02697916|460574097|FG000|Overall Study|Death|357|||
127986380|NCT02697916|460574098|FG001|Overall Study|Death|315|||
127986381|NCT02697916|460574097|FG000|Overall Study|Withdrawal by Subject|221|||
127653862|NCT00263328|459354921|FG001|Overall Study|Death|0|||
127653863|NCT00263328|459354922|FG002|Overall Study|Death|1|||
127986382|NCT02697916|460574098|FG001|Overall Study|Withdrawal by Subject|393|||
127986383|NCT01313221|460574101|FG000|Overall Study|Protocol Violation|0|||
127986384|NCT01313221|460574102|FG001|Overall Study|Protocol Violation|1|||
127986385|NCT01313221|460574103|FG002|Overall Study|Protocol Violation|1|||
127986386|NCT01313221|460574101|FG000|Overall Study|Non-compliance|3|||
127653864|NCT00263328|459354920|FG000|Overall Study|Lost to Follow-up|1|||
127986387|NCT01313221|460574102|FG001|Overall Study|Non-compliance|0|||
127653865|NCT00263328|459354921|FG001|Overall Study|Lost to Follow-up|1|||
127653866|NCT00263328|459354922|FG002|Overall Study|Lost to Follow-up|0|||
127986388|NCT01313221|460574103|FG002|Overall Study|Non-compliance|2|||
127986389|NCT01313221|460574101|FG000|Overall Study|Withdrawal by Subject|2|||
127986390|NCT01313221|460574102|FG001|Overall Study|Withdrawal by Subject|3|||
127986391|NCT01313221|460574103|FG002|Overall Study|Withdrawal by Subject|5|||
127986392|NCT01313221|460574101|FG000|Overall Study|Requirement for alternative therapy|0|||
127653867|NCT00263328|459354920|FG000|Overall Study|Withdrawal by Subject|3|||
127653868|NCT00263328|459354921|FG001|Overall Study|Withdrawal by Subject|0|||
127653869|NCT00263328|459354922|FG002|Overall Study|Withdrawal by Subject|1|||
127653870|NCT00263328|459354920|FG000|Overall Study|Other|3|||
127986393|NCT01313221|460574102|FG001|Overall Study|Requirement for alternative therapy|1|||
127986394|NCT01313221|460574103|FG002|Overall Study|Requirement for alternative therapy|1|||
127653871|NCT00263328|459354921|FG001|Overall Study|Other|0|||
127653872|NCT00263328|459354922|FG002|Overall Study|Other|1|||
127653873|NCT00263328|459354920|FG000|Overall Study|Adverse Event|1|||
127653874|NCT00263328|459354921|FG001|Overall Study|Adverse Event|1|||
127653875|NCT00263328|459354922|FG002|Overall Study|Adverse Event|4|||
127653876|NCT01301274|459354926|FG000|Overall Study|Physician Decision|2|||
127653877|NCT01301274|459354927|FG001|Overall Study|Physician Decision|1|||
127653878|NCT04512066|459354928|FG000|Double-blind Treatment Period|Adverse Event|6|||
127653879|NCT04512066|459354929|FG001|Double-blind Treatment Period|Adverse Event|4|||
127653880|NCT04512066|459354930|FG002|Double-blind Treatment Period|Adverse Event|5|||
127653881|NCT04512066|459354931|FG003|Double-blind Treatment Period|Adverse Event|1|||
127653882|NCT04512066|459354932|FG004|Double-blind Treatment Period|Adverse Event|0|||
127653883|NCT04512066|459354933|FG005|Double-blind Treatment Period|Adverse Event|0|||
127653884|NCT04512066|459354928|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
127653885|NCT04512066|459354929|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
127653886|NCT04512066|459354930|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
127653887|NCT04512066|459354931|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
127653888|NCT04512066|459354932|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
127653889|NCT04512066|459354933|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
127653890|NCT04512066|459354928|FG000|Double-blind Treatment Period|Physician Decision|1|||
127653891|NCT04512066|459354929|FG001|Double-blind Treatment Period|Physician Decision|0|||
127653892|NCT04512066|459354930|FG002|Double-blind Treatment Period|Physician Decision|1|||
127653893|NCT04512066|459354931|FG003|Double-blind Treatment Period|Physician Decision|0|||
127653894|NCT04512066|459354932|FG004|Double-blind Treatment Period|Physician Decision|0|||
127653895|NCT04512066|459354933|FG005|Double-blind Treatment Period|Physician Decision|0|||
127653896|NCT04512066|459354928|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
127653897|NCT04512066|459354929|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
127653898|NCT04512066|459354930|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
127653899|NCT04512066|459354931|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
127653900|NCT04512066|459354932|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
127653901|NCT04512066|459354933|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
127653902|NCT04512066|459354928|FG000|Extension Period|Adverse Event|0|||
127653903|NCT04512066|459354929|FG001|Extension Period|Adverse Event|1|||
127653904|NCT04512066|459354930|FG002|Extension Period|Adverse Event|4|||
127653905|NCT04512066|459354931|FG003|Extension Period|Adverse Event|3|||
127653906|NCT04512066|459354932|FG004|Extension Period|Adverse Event|1|||
127653907|NCT04512066|459354933|FG005|Extension Period|Adverse Event|3|||
127653908|NCT04512066|459354928|FG000|Extension Period|Death|0|||
127653909|NCT04512066|459354929|FG001|Extension Period|Death|0|||
127653910|NCT04512066|459354930|FG002|Extension Period|Death|0|||
127653911|NCT04512066|459354931|FG003|Extension Period|Death|0|||
127653912|NCT04512066|459354932|FG004|Extension Period|Death|0|||
127653913|NCT04512066|459354933|FG005|Extension Period|Death|1|||
127653914|NCT04512066|459354928|FG000|Extension Period|Lack of Efficacy|0|||
127653915|NCT04512066|459354929|FG001|Extension Period|Lack of Efficacy|4|||
127653916|NCT04512066|459354930|FG002|Extension Period|Lack of Efficacy|4|||
127653917|NCT04512066|459354931|FG003|Extension Period|Lack of Efficacy|1|||
127653918|NCT04512066|459354932|FG004|Extension Period|Lack of Efficacy|3|||
127653919|NCT04512066|459354933|FG005|Extension Period|Lack of Efficacy|3|||
127653920|NCT04512066|459354928|FG000|Extension Period|Lost to Follow-up|0|||
127653921|NCT04512066|459354929|FG001|Extension Period|Lost to Follow-up|1|||
127653922|NCT04512066|459354930|FG002|Extension Period|Lost to Follow-up|5|||
127653923|NCT04512066|459354931|FG003|Extension Period|Lost to Follow-up|2|||
127653924|NCT04512066|459354932|FG004|Extension Period|Lost to Follow-up|3|||
127653925|NCT04512066|459354933|FG005|Extension Period|Lost to Follow-up|2|||
127653926|NCT04512066|459354928|FG000|Extension Period|Non-compliance with study drug|0|||
127653927|NCT04512066|459354929|FG001|Extension Period|Non-compliance with study drug|1|||
127653928|NCT04512066|459354930|FG002|Extension Period|Non-compliance with study drug|0|||
127653929|NCT04512066|459354931|FG003|Extension Period|Non-compliance with study drug|0|||
127653930|NCT04512066|459354932|FG004|Extension Period|Non-compliance with study drug|0|||
127653931|NCT04512066|459354933|FG005|Extension Period|Non-compliance with study drug|1|||
127653932|NCT04512066|459354928|FG000|Extension Period|Other|0|||
127653933|NCT04512066|459354929|FG001|Extension Period|Other|2|||
127653934|NCT04512066|459354930|FG002|Extension Period|Other|0|||
127653935|NCT04512066|459354931|FG003|Extension Period|Other|0|||
127653936|NCT04512066|459354932|FG004|Extension Period|Other|0|||
127653937|NCT04512066|459354933|FG005|Extension Period|Other|0|||
127653938|NCT04512066|459354928|FG000|Extension Period|Physician Decision|0|||
127653939|NCT04512066|459354929|FG001|Extension Period|Physician Decision|2|||
127653940|NCT04512066|459354930|FG002|Extension Period|Physician Decision|0|||
127653941|NCT04512066|459354931|FG003|Extension Period|Physician Decision|1|||
127653942|NCT04512066|459354932|FG004|Extension Period|Physician Decision|1|||
127653943|NCT04512066|459354933|FG005|Extension Period|Physician Decision|0|||
127653944|NCT04512066|459354928|FG000|Extension Period|Withdrawal by Subject|0|||
127880572|NCT01915498|460183519|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
127653945|NCT04512066|459354929|FG001|Extension Period|Withdrawal by Subject|3|||
127653946|NCT04512066|459354930|FG002|Extension Period|Withdrawal by Subject|7|||
127653947|NCT04512066|459354931|FG003|Extension Period|Withdrawal by Subject|11|||
127653948|NCT04512066|459354932|FG004|Extension Period|Withdrawal by Subject|8|||
127653949|NCT04512066|459354933|FG005|Extension Period|Withdrawal by Subject|4|||
127653950|NCT03520400|459354934|FG000|Overall Study|Physician Decision|15|||
127653951|NCT03520400|459354935|FG001|Overall Study|Physician Decision|7|||
127653952|NCT00445679|459354938|FG000|Overall Study|Adverse Event|22|||
127653953|NCT00445679|459354939|FG001|Overall Study|Adverse Event|12|||
127653954|NCT00445679|459354940|FG002|Overall Study|Adverse Event|30|||
127653955|NCT00445679|459354941|FG003|Overall Study|Adverse Event|19|||
127653956|NCT00445679|459354938|FG000|Overall Study|Failed to return|1|||
127653957|NCT00445679|459354939|FG001|Overall Study|Failed to return|3|||
127653958|NCT00445679|459354940|FG002|Overall Study|Failed to return|2|||
127653959|NCT00445679|459354941|FG003|Overall Study|Failed to return|2|||
127653960|NCT00445679|459354938|FG000|Overall Study|Physician Decision|0|||
127653961|NCT00445679|459354939|FG001|Overall Study|Physician Decision|0|||
127653962|NCT00445679|459354940|FG002|Overall Study|Physician Decision|1|||
127653963|NCT00445679|459354941|FG003|Overall Study|Physician Decision|0|||
127653964|NCT00445679|459354938|FG000|Overall Study|Lost to Follow-up|10|||
127653965|NCT00445679|459354939|FG001|Overall Study|Lost to Follow-up|6|||
127653966|NCT00445679|459354940|FG002|Overall Study|Lost to Follow-up|6|||
127653967|NCT00445679|459354941|FG003|Overall Study|Lost to Follow-up|5|||
127653968|NCT00445679|459354938|FG000|Overall Study|Compliance|3|||
127653969|NCT00445679|459354939|FG001|Overall Study|Compliance|2|||
127653970|NCT00445679|459354940|FG002|Overall Study|Compliance|1|||
127653971|NCT00445679|459354941|FG003|Overall Study|Compliance|2|||
127653972|NCT00445679|459354938|FG000|Overall Study|Withdrawal of Informed Consent|0|||
127653973|NCT00445679|459354939|FG001|Overall Study|Withdrawal of Informed Consent|0|||
127653974|NCT00445679|459354940|FG002|Overall Study|Withdrawal of Informed Consent|1|||
127653975|NCT00445679|459354941|FG003|Overall Study|Withdrawal of Informed Consent|0|||
127653976|NCT00445679|459354938|FG000|Overall Study|Protocol Violation|2|||
127653977|NCT00445679|459354939|FG001|Overall Study|Protocol Violation|3|||
127653978|NCT00445679|459354940|FG002|Overall Study|Protocol Violation|3|||
127653979|NCT00445679|459354941|FG003|Overall Study|Protocol Violation|1|||
127653980|NCT00445679|459354938|FG000|Overall Study|Withdrawal by Subject|8|||
127653981|NCT00445679|459354939|FG001|Overall Study|Withdrawal by Subject|14|||
127653982|NCT00445679|459354940|FG002|Overall Study|Withdrawal by Subject|20|||
127653983|NCT00445679|459354941|FG003|Overall Study|Withdrawal by Subject|18|||
127653984|NCT00445679|459354938|FG000|Overall Study|Lack of Efficacy|2|||
127653985|NCT00445679|459354939|FG001|Overall Study|Lack of Efficacy|6|||
127653986|NCT00445679|459354940|FG002|Overall Study|Lack of Efficacy|2|||
127653987|NCT00445679|459354941|FG003|Overall Study|Lack of Efficacy|0|||
127653988|NCT01654601|459354945|FG000|1st Administration|Withdrawal by Subject|2|||
127653989|NCT01654601|459354946|FG001|1st Administration|Withdrawal by Subject|0|||
127653990|NCT01654601|459354945|FG000|1st Administration|Protocol Violation|0|||
127653991|NCT01654601|459354946|FG001|1st Administration|Protocol Violation|2|||
127653992|NCT01654601|459354945|FG000|2nd Administration|Adverse Event|1|||
127653993|NCT01654601|459354946|FG001|2nd Administration|Adverse Event|0|||
127653994|NCT01654601|459354945|FG000|2nd Administration|Protocol Violation|0|||
127653995|NCT01654601|459354946|FG001|2nd Administration|Protocol Violation|1|||
127653996|NCT03535337|459354949|FG000|Stage 2 Randomization|Lost to Follow-up|0|||
127653997|NCT03535337|459354950|FG001|Stage 2 Randomization|Lost to Follow-up|0|||
127986395|NCT01313221|460574101|FG000|Overall Study|Lost to Follow-up|6|||
127986396|NCT01313221|460574102|FG001|Overall Study|Lost to Follow-up|3|||
127986397|NCT01313221|460574103|FG002|Overall Study|Lost to Follow-up|1|||
127986398|NCT01313221|460574101|FG000|Overall Study|Other|1|||
127986399|NCT01313221|460574102|FG001|Overall Study|Other|0|||
127986400|NCT01313221|460574103|FG002|Overall Study|Other|0|||
127986401|NCT01313221|460574101|FG000|Overall Study|Adverse Event|0|||
127986402|NCT01313221|460574102|FG001|Overall Study|Adverse Event|0|||
127986403|NCT01313221|460574103|FG002|Overall Study|Adverse Event|7|||
127986404|NCT01313221|460574101|FG000|Overall Study|Disease progression|0|||
127653998|NCT03535337|459354951|FG002|Stage 2 Randomization|Lost to Follow-up|2|||
127653999|NCT03535337|459354952|FG003|Stage 2 Randomization|Lost to Follow-up|1|||
127654000|NCT03535337|459354953|FG004|Stage 2 Randomization|Lost to Follow-up|5|||
127986405|NCT01313221|460574102|FG001|Overall Study|Disease progression|0|||
127654001|NCT03535337|459354954|FG005|Stage 2 Randomization|Lost to Follow-up|4|||
127654002|NCT03535337|459354955|FG006|Stage 2 Randomization|Lost to Follow-up|3|||
127654003|NCT03535337|459354956|FG007|Stage 2 Randomization|Lost to Follow-up|6|||
127654004|NCT03535337|459354957|FG008|Stage 2 Randomization|Lost to Follow-up|0|||
127654005|NCT03535337|459354958|FG009|Stage 2 Randomization|Lost to Follow-up|2|||
127654006|NCT02272725|459354959|FG000|Overall Study|equipment malfunction|2|||
127654007|NCT02272725|459354960|FG001|Overall Study|equipment malfunction|0|||
127654008|NCT00369681|459356847|FG000|Overall Study|Death|1|||
127654009|NCT03505476|459356848|FG000|Overall Study|Physician Decision|18|||
127654010|NCT03505476|459356848|FG000|Overall Study|Device Malfunctioned|101|||
127654011|NCT03505476|459356848|FG000|Overall Study|Data Corrupt|6|||
127654012|NCT03505476|459356848|FG000|Overall Study|Device application insufficiant|3|||
127986406|NCT01313221|460574103|FG002|Overall Study|Disease progression|2|||
127986407|NCT01313221|460574101|FG000|Overall Study|Physician Decision|0|||
127986408|NCT01313221|460574102|FG001|Overall Study|Physician Decision|0|||
127986409|NCT01313221|460574103|FG002|Overall Study|Physician Decision|2|||
127986410|NCT01313221|460574101|FG000|Overall Study|Pregnancy|0|||
127986411|NCT01313221|460574102|FG001|Overall Study|Pregnancy|0|||
127986412|NCT01313221|460574103|FG002|Overall Study|Pregnancy|2|||
127986413|NCT00994214|460574104|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
127986414|NCT00994214|460574105|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
127986415|NCT00994214|460574106|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
127986416|NCT00994214|460574107|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
127986417|NCT00994214|460574104|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
127986418|NCT00994214|460574105|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
127986419|NCT00994214|460574106|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
127986420|NCT00994214|460574107|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
127986421|NCT00994214|460574104|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
127986422|NCT00994214|460574105|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
127986423|NCT00994214|460574106|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
127986424|NCT00994214|460574107|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
127986425|NCT00994214|460574104|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
127986426|NCT00994214|460574105|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
127986427|NCT00994214|460574106|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
127986428|NCT00994214|460574107|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
127986429|NCT00994214|460574104|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
127986430|NCT00994214|460574105|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
127986431|NCT00994214|460574106|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
127986432|NCT00994214|460574107|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
127986433|NCT00994214|460574104|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
127986434|NCT00994214|460574105|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
127986435|NCT00994214|460574106|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
127986436|NCT00994214|460574107|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
127986437|NCT04591015|460574109|FG000|Overall Study|Death|6|||
127986438|NCT04591015|460574110|FG001|Overall Study|Death|4|||
127986439|NCT04591015|460574109|FG000|Overall Study|Withdrawal by Subject|6|||
127986440|NCT04591015|460574110|FG001|Overall Study|Withdrawal by Subject|3|||
127986441|NCT04591015|460574109|FG000|Overall Study|Lost to Follow-up|16|||
127986442|NCT04591015|460574110|FG001|Overall Study|Lost to Follow-up|11|||
127986443|NCT02686814|460574111|FG000|Overall Study|Physician Decision|14|||
127986444|NCT02686814|460574111|FG000|Overall Study|Withdrawal by Subject|4|||
127986445|NCT02686814|460574111|FG000|Overall Study|Death|1|||
127986446|NCT00290693|460574112|FG000|Overall Study|Withdrawal by Subject|2|||
127986447|NCT02907619|460574113|FG000|Overall Study|Study terminated by sponsor|18|||
127986448|NCT02907619|460574114|FG001|Overall Study|Study terminated by sponsor|18|||
127986449|NCT02907619|460574115|FG002|Overall Study|Study terminated by sponsor|19|||
127986450|NCT02907619|460574113|FG000|Overall Study|Death|0|||
127986451|NCT02907619|460574114|FG001|Overall Study|Death|0|||
127986452|NCT02907619|460574115|FG002|Overall Study|Death|1|||
127986453|NCT02907619|460574113|FG000|Overall Study|Withdrawal by Subject|1|||
127986454|NCT02907619|460574114|FG001|Overall Study|Withdrawal by Subject|1|||
127986455|NCT02907619|460574115|FG002|Overall Study|Withdrawal by Subject|0|||
127986456|NCT02907619|460574113|FG000|Overall Study|Other|0|||
127986457|NCT02907619|460574114|FG001|Overall Study|Other|1|||
127986458|NCT02907619|460574115|FG002|Overall Study|Other|0|||
127986459|NCT01908582|460574116|FG000|Period 2|Physician Decision|1|||
127986460|NCT01908582|460574116|FG000|Period 2|Withdrawal by Subject|1|||
127986461|NCT03484403|460574120|FG000|Overall Study|Withdrawal by Subject|6|||
127986462|NCT03484403|460574121|FG001|Overall Study|Withdrawal by Subject|4|||
127986463|NCT04767529|460574128|FG000|Overall Study|Adverse Event|0|||
127986464|NCT04767529|460574129|FG001|Overall Study|Adverse Event|4|||
127986465|NCT04767529|460574130|FG002|Overall Study|Adverse Event|3|||
127986466|NCT04767529|460574128|FG000|Overall Study|clinical outcomes endpoint (excluding death)|1|||
127986467|NCT04767529|460574129|FG001|Overall Study|clinical outcomes endpoint (excluding death)|3|||
127986468|NCT04767529|460574130|FG002|Overall Study|clinical outcomes endpoint (excluding death)|3|||
127986469|NCT04767529|460574128|FG000|Overall Study|Required use of a prohibited medication|0|||
127986470|NCT04767529|460574129|FG001|Overall Study|Required use of a prohibited medication|1|||
127986471|NCT04767529|460574130|FG002|Overall Study|Required use of a prohibited medication|0|||
127986472|NCT04767529|460574128|FG000|Overall Study|Withdrawal by Subject|7|||
127986473|NCT04767529|460574129|FG001|Overall Study|Withdrawal by Subject|5|||
127986474|NCT04767529|460574130|FG002|Overall Study|Withdrawal by Subject|4|||
127986475|NCT04767529|460574128|FG000|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|1|||
127986476|NCT04767529|460574129|FG001|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|0|||
127654013|NCT03075904|459356849|FG000|Overall Study|Physician Decision|3|||
127654014|NCT03075904|459356849|FG000|Overall Study|Need for Medication not Permitted|1|||
127654015|NCT00539643|459356850|FG000|Overall Study|Adverse Event|1|||
127654016|NCT00539643|459356851|FG001|Overall Study|Adverse Event|0|||
127654017|NCT00539643|459356850|FG000|Overall Study|Death|2|||
127654018|NCT00539643|459356851|FG001|Overall Study|Death|1|||
127654019|NCT00539643|459356850|FG000|Overall Study|Physician Decision|3|||
127654020|NCT00539643|459356851|FG001|Overall Study|Physician Decision|1|||
127654021|NCT00539643|459356850|FG000|Overall Study|Withdrawal by Subject|0|||
127654022|NCT00539643|459356851|FG001|Overall Study|Withdrawal by Subject|1|||
127654023|NCT01480596|459356856|FG000|Overall Study|Adverse Event|3|||
127654024|NCT01480596|459356857|FG001|Overall Study|Adverse Event|0|||
127654025|NCT01480596|459356856|FG000|Overall Study|MG exacerbation or change in medication|2|||
127654026|NCT01480596|459356857|FG001|Overall Study|MG exacerbation or change in medication|2|||
127654027|NCT04503096|459356858|FG000|Overall Study|Withdrawal by Subject|3|||
127654028|NCT02343003|459356859|FG000|Overall Study|Withdrawal by Subject|9|||
127654029|NCT02343003|459356860|FG001|Overall Study|Withdrawal by Subject|4|||
127654030|NCT02343003|459356859|FG000|Overall Study|Lost to Follow-up|5|||
127654031|NCT02343003|459356860|FG001|Overall Study|Lost to Follow-up|1|||
127654032|NCT02343003|459356859|FG000|Overall Study|Protocol Violation|1|||
127654033|NCT02343003|459356860|FG001|Overall Study|Protocol Violation|0|||
127654034|NCT02343003|459356859|FG000|Overall Study|Death|0|||
127654035|NCT02343003|459356860|FG001|Overall Study|Death|1|||
127654036|NCT02343003|459356859|FG000|Overall Study|exclusion criteria met|1|||
127654037|NCT02343003|459356860|FG001|Overall Study|exclusion criteria met|1|||
127654038|NCT02343003|459356859|FG000|Overall Study|terminated by sponsor|2|||
127654039|NCT02343003|459356860|FG001|Overall Study|terminated by sponsor|0|||
127654040|NCT02281760|459356862|FG000|Overall Study|Withdrawal by Subject|1|||
127654041|NCT01576367|459356867|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
127654042|NCT01576367|459356867|FG000|Overall Study|Moved to commercial use after 6 months|1|||
127654043|NCT01453348|459356868|FG000|Overall Study|Death|0|||
127654044|NCT01453348|459356869|FG001|Overall Study|Death|0|||
127654045|NCT01453348|459356870|FG002|Overall Study|Death|1|||
127654046|NCT01453348|459356868|FG000|Overall Study|Withdrawal by Subject|0|||
127654047|NCT01453348|459356869|FG001|Overall Study|Withdrawal by Subject|1|||
127654048|NCT01453348|459356870|FG002|Overall Study|Withdrawal by Subject|0|||
127654049|NCT01453348|459356868|FG000|Overall Study|Protocol Violation|1|||
127654050|NCT01453348|459356869|FG001|Overall Study|Protocol Violation|0|||
127654051|NCT01453348|459356870|FG002|Overall Study|Protocol Violation|0|||
127654052|NCT04359771|459356875|FG000|Overall Study|Lack of Efficacy|2|||
127654053|NCT04359771|459356876|FG001|Overall Study|Lack of Efficacy|2|||
127654054|NCT00954733|459356877|FG000|Overall Study|blood gas machine did not work|1|||
127654055|NCT03592277|459356878|FG000|Overall Study|Withdrawal by Subject|6|||
127654056|NCT03592277|459356879|FG001|Overall Study|Withdrawal by Subject|8|||
127654057|NCT00622713|459356880|FG000|Overall Study|Adverse Event|35|||
127654058|NCT00622713|459356880|FG000|Overall Study|Administrative problems|4|||
127654059|NCT00622713|459356880|FG000|Overall Study|Withdrawal by Subject|11|||
127654060|NCT00622713|459356880|FG000|Overall Study|Lost to Follow-up|5|||
127654061|NCT00622713|459356880|FG000|Overall Study|Death|2|||
127654062|NCT00622713|459356880|FG000|Overall Study|Subject no longer required study drug|1|||
127654063|NCT00622713|459356880|FG000|Overall Study|Did not meet eligibility criteria|1|||
127654064|NCT01462162|459356885|FG000|Overall Study|Adverse Event|5|||
127654065|NCT01462162|459356885|FG000|Overall Study|Lack of Efficacy|4|||
127654066|NCT01462162|459356885|FG000|Overall Study|Abnormal laboratory parameters|1|||
127986477|NCT04767529|460574130|FG002|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|3|||
127986478|NCT04767529|460574128|FG000|Overall Study|Lost to Follow-up|0|||
127986479|NCT04767529|460574129|FG001|Overall Study|Lost to Follow-up|2|||
127986480|NCT04767529|460574130|FG002|Overall Study|Lost to Follow-up|3|||
127986481|NCT02722746|460574136|FG000|Overall Study|Withdrawal by Subject|0|||
127986482|NCT02722746|460574137|FG001|Overall Study|Withdrawal by Subject|1|||
127986483|NCT02722746|460574138|FG002|Overall Study|Withdrawal by Subject|0|||
127986484|NCT02722746|460574136|FG000|Overall Study|Protocol Violation|8|||
127986485|NCT02722746|460574137|FG001|Overall Study|Protocol Violation|4|||
127654067|NCT01462162|459356885|FG000|Overall Study|Other|2|||
127654068|NCT03485911|459356886|FG000|Part 1|Perceived lack of efficacy|1|||
127654069|NCT03485911|459356887|FG001|Part 1|Perceived lack of efficacy|1|||
127654070|NCT03485911|459356888|FG002|Part 1|Perceived lack of efficacy|2|||
127654071|NCT03485911|459356889|FG003|Part 1|Perceived lack of efficacy|0|||
127654072|NCT03485911|459356886|FG000|Part 1|Subject withdrew consent|0|||
127654073|NCT03485911|459356887|FG001|Part 1|Subject withdrew consent|1|||
127654074|NCT03485911|459356888|FG002|Part 1|Subject withdrew consent|0|||
127654075|NCT03485911|459356889|FG003|Part 1|Subject withdrew consent|1|||
127654076|NCT03485911|459356886|FG000|Part 1|Lab abnormalities/AEs|3|||
127986486|NCT02722746|460574138|FG002|Overall Study|Protocol Violation|6|||
127986487|NCT02636699|460574145|FG000|Screening Period|Inclusion/Exclusion Failure|0|||
127986488|NCT02636699|460574146|FG001|Screening Period|Inclusion/Exclusion Failure|0|||
127986489|NCT02636699|460574147|FG002|Screening Period|Inclusion/Exclusion Failure|117|||
127654077|NCT03485911|459356887|FG001|Part 1|Lab abnormalities/AEs|1|||
127654078|NCT03485911|459356888|FG002|Part 1|Lab abnormalities/AEs|1|||
127654079|NCT03485911|459356889|FG003|Part 1|Lab abnormalities/AEs|0|||
127654080|NCT03485911|459356886|FG000|Part 1|Withdrew Consent prior to dosing|0|||
127654081|NCT03485911|459356887|FG001|Part 1|Withdrew Consent prior to dosing|0|||
127654082|NCT03485911|459356888|FG002|Part 1|Withdrew Consent prior to dosing|0|||
127654083|NCT03485911|459356889|FG003|Part 1|Withdrew Consent prior to dosing|1|||
127654084|NCT03485911|459356886|FG000|Part 1|Other NOS|0|||
127654085|NCT03485911|459356887|FG001|Part 1|Other NOS|0|||
127654086|NCT03485911|459356888|FG002|Part 1|Other NOS|0|||
127654087|NCT03485911|459356889|FG003|Part 1|Other NOS|1|||
127654088|NCT03485911|459356886|FG000|Part 2|Perceived lack of efficacy|5|||
127654089|NCT03485911|459356887|FG001|Part 2|Perceived lack of efficacy|3|||
127654090|NCT03485911|459356888|FG002|Part 2|Perceived lack of efficacy|0|||
127654091|NCT03485911|459356889|FG003|Part 2|Perceived lack of efficacy|2|||
127654092|NCT03485911|459356886|FG000|Part 2|Subject withdrew consent|1|||
127654093|NCT03485911|459356887|FG001|Part 2|Subject withdrew consent|0|||
127654094|NCT03485911|459356888|FG002|Part 2|Subject withdrew consent|2|||
127654095|NCT03485911|459356889|FG003|Part 2|Subject withdrew consent|1|||
127654096|NCT03485911|459356886|FG000|Part 2|Lab abnormalities/AEs|1|||
127654097|NCT03485911|459356887|FG001|Part 2|Lab abnormalities/AEs|2|||
127654098|NCT03485911|459356888|FG002|Part 2|Lab abnormalities/AEs|0|||
127654099|NCT03485911|459356889|FG003|Part 2|Lab abnormalities/AEs|0|||
127654100|NCT03485911|459356886|FG000|Part 2|Other NOS|0|||
127654101|NCT03485911|459356887|FG001|Part 2|Other NOS|1|||
127654102|NCT03485911|459356888|FG002|Part 2|Other NOS|0|||
127654103|NCT03485911|459356889|FG003|Part 2|Other NOS|0|||
127654104|NCT03485911|459356886|FG000|Part 2|Intercurrent illness/new medical condition|1|||
127654105|NCT03485911|459356887|FG001|Part 2|Intercurrent illness/new medical condition|0|||
127654106|NCT03485911|459356888|FG002|Part 2|Intercurrent illness/new medical condition|0|||
127654107|NCT03485911|459356889|FG003|Part 2|Intercurrent illness/new medical condition|0|||
127654108|NCT03485911|459356886|FG000|Part 2|Investigator judgement|1|||
127654109|NCT03485911|459356887|FG001|Part 2|Investigator judgement|0|||
127654110|NCT03485911|459356888|FG002|Part 2|Investigator judgement|0|||
127654111|NCT03485911|459356889|FG003|Part 2|Investigator judgement|0|||
127654112|NCT03485911|459356886|FG000|Part 3|Perceived lack of efficacy|2|||
127654113|NCT03485911|459356887|FG001|Part 3|Perceived lack of efficacy|2|||
127654114|NCT03485911|459356888|FG002|Part 3|Perceived lack of efficacy|2|||
127654115|NCT03485911|459356889|FG003|Part 3|Perceived lack of efficacy|0|||
127654116|NCT03485911|459356886|FG000|Part 3|Subject withdrew consent|1|||
127654117|NCT03485911|459356887|FG001|Part 3|Subject withdrew consent|4|||
127654118|NCT03485911|459356888|FG002|Part 3|Subject withdrew consent|0|||
127654119|NCT03485911|459356889|FG003|Part 3|Subject withdrew consent|1|||
127654120|NCT03485911|459356886|FG000|Part 3|Lab abnormalities/AEs|1|||
127654121|NCT03485911|459356887|FG001|Part 3|Lab abnormalities/AEs|1|||
127654122|NCT03485911|459356888|FG002|Part 3|Lab abnormalities/AEs|0|||
127654123|NCT03485911|459356889|FG003|Part 3|Lab abnormalities/AEs|2|||
127654124|NCT03485911|459356886|FG000|Part 3|Other NOS|1|||
127654125|NCT03485911|459356887|FG001|Part 3|Other NOS|1|||
127654126|NCT03485911|459356888|FG002|Part 3|Other NOS|0|||
127654127|NCT03485911|459356889|FG003|Part 3|Other NOS|0|||
127654128|NCT03485911|459356886|FG000|Part 3|Intercurrent illness/new medical condition|0|||
127654129|NCT03485911|459356887|FG001|Part 3|Intercurrent illness/new medical condition|1|||
127654130|NCT03485911|459356888|FG002|Part 3|Intercurrent illness/new medical condition|1|||
127654131|NCT03485911|459356889|FG003|Part 3|Intercurrent illness/new medical condition|0|||
127654132|NCT03485911|459356886|FG000|Part 3|Sponsor discontinuation|1|||
127654133|NCT03485911|459356887|FG001|Part 3|Sponsor discontinuation|0|||
127654134|NCT03485911|459356888|FG002|Part 3|Sponsor discontinuation|0|||
127654135|NCT03485911|459356889|FG003|Part 3|Sponsor discontinuation|0|||
127654136|NCT03485911|459356886|FG000|Part 3|Berotralstat provided by alternative means|13|||
127654137|NCT03485911|459356887|FG001|Part 3|Berotralstat provided by alternative means|13|||
127654138|NCT03485911|459356888|FG002|Part 3|Berotralstat provided by alternative means|7|||
127654139|NCT03485911|459356889|FG003|Part 3|Berotralstat provided by alternative means|7|||
127654140|NCT01346514|459356890|FG000|Overall Study|Lost to Follow-up|19|||
127654141|NCT01346514|459356891|FG001|Overall Study|Lost to Follow-up|30|||
127654142|NCT01346514|459356890|FG000|Overall Study|Withdrawal by Subject|7|||
127880573|NCT01915498|460183520|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
127880574|NCT01915498|460183521|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
127880575|NCT01915498|460183522|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
127880576|NCT01915498|460183523|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
127880577|NCT01915498|460183524|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
127880578|NCT01915498|460183525|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
127880579|NCT01915498|460183526|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
127880580|NCT01915498|460183527|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
127880581|NCT01915498|460183528|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
127880582|NCT01915498|460183529|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
127880583|NCT01915498|460183530|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
127654143|NCT01346514|459356891|FG001|Overall Study|Withdrawal by Subject|3|||
127654144|NCT01346514|459356890|FG000|Overall Study|Death|3|||
127986490|NCT02636699|460574145|FG000|Screening Period|Withdrawal by Subject|0|||
127986491|NCT02636699|460574146|FG001|Screening Period|Withdrawal by Subject|0|||
127986492|NCT02636699|460574147|FG002|Screening Period|Withdrawal by Subject|23|||
127986493|NCT02636699|460574145|FG000|Screening Period|Adverse Event|0|||
127986494|NCT02636699|460574146|FG001|Screening Period|Adverse Event|0|||
127986495|NCT02636699|460574147|FG002|Screening Period|Adverse Event|1|||
127986496|NCT02636699|460574145|FG000|Screening Period|Other not specified|0|||
127986497|NCT02636699|460574146|FG001|Screening Period|Other not specified|0|||
127986498|NCT02636699|460574147|FG002|Screening Period|Other not specified|3|||
127986499|NCT02636699|460574145|FG000|Treatment and Follow-up Periods|Adverse Event|4|||
127986500|NCT02636699|460574146|FG001|Treatment and Follow-up Periods|Adverse Event|0|||
127986501|NCT02636699|460574147|FG002|Treatment and Follow-up Periods|Adverse Event|0|||
127986502|NCT02636699|460574145|FG000|Treatment and Follow-up Periods|Lost to Follow-up|3|||
127986503|NCT02636699|460574146|FG001|Treatment and Follow-up Periods|Lost to Follow-up|3|||
127986504|NCT02636699|460574147|FG002|Treatment and Follow-up Periods|Lost to Follow-up|0|||
127986505|NCT02636699|460574145|FG000|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|2|||
127986506|NCT02636699|460574146|FG001|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
127986507|NCT02636699|460574147|FG002|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
127986508|NCT02636699|460574145|FG000|Treatment and Follow-up Periods|Physician Decision|0|||
127986509|NCT02636699|460574146|FG001|Treatment and Follow-up Periods|Physician Decision|1|||
127986510|NCT02636699|460574147|FG002|Treatment and Follow-up Periods|Physician Decision|0|||
127986511|NCT02636699|460574145|FG000|Treatment and Follow-up Periods|Withdrawal by Subject|13|||
127986512|NCT02636699|460574146|FG001|Treatment and Follow-up Periods|Withdrawal by Subject|6|||
127986513|NCT02636699|460574147|FG002|Treatment and Follow-up Periods|Withdrawal by Subject|0|||
127986514|NCT02636699|460574145|FG000|Treatment and Follow-up Periods|Other|3|||
127986515|NCT02636699|460574146|FG001|Treatment and Follow-up Periods|Other|1|||
127986516|NCT02636699|460574147|FG002|Treatment and Follow-up Periods|Other|0|||
127986517|NCT02305446|460574156|FG000|Overall Study|Adverse Event|1|||
127986518|NCT01636947|460574157|FG000|Overall Study|Not Treated|2|||
127654145|NCT01346514|459356891|FG001|Overall Study|Death|4|||
127654146|NCT00909480|459356892|FG000|Overall Study|Adverse Event|5|||
127654147|NCT00909480|459356893|FG001|Overall Study|Adverse Event|3|||
127986519|NCT01636947|460574158|FG001|Overall Study|Not Treated|2|||
127986520|NCT01636947|460574157|FG000|Overall Study|Lost to Follow-up|4|||
127986521|NCT01636947|460574158|FG001|Overall Study|Lost to Follow-up|0|||
127986522|NCT01636947|460574157|FG000|Overall Study|Protocol Violation|1|||
127986523|NCT01636947|460574158|FG001|Overall Study|Protocol Violation|1|||
127654148|NCT00909480|459356892|FG000|Overall Study|Protocol Violation|6|||
127654149|NCT00909480|459356893|FG001|Overall Study|Protocol Violation|8|||
127654150|NCT00909480|459356892|FG000|Overall Study|Withdrawal criteria|9|||
127654151|NCT00909480|459356893|FG001|Overall Study|Withdrawal criteria|11|||
127654152|NCT00909480|459356892|FG000|Overall Study|Unclassified|18|||
127654153|NCT00909480|459356893|FG001|Overall Study|Unclassified|19|||
127654154|NCT01215357|459356897|FG000|Overall Study|Withdrawal by Subject|3|||
127654155|NCT01215357|459356897|FG000|Overall Study|Protocol Violation|9|||
127654156|NCT03002038|459356904|FG000|Overall Study|Adverse Event|3|||
127654157|NCT03002038|459356905|FG001|Overall Study|Adverse Event|1|||
127654158|NCT03002038|459356904|FG000|Overall Study|Withdrawal by Subject|8|||
127654159|NCT03002038|459356905|FG001|Overall Study|Withdrawal by Subject|4|||
127654160|NCT03002038|459356904|FG000|Overall Study|Immigration to another region|0|||
127654161|NCT03002038|459356905|FG001|Overall Study|Immigration to another region|2|||
127654162|NCT02904902|459356914|FG000|Overall Study|Withdrawal by Subject|1|||
127654163|NCT01216163|459356923|FG000|Overall Study|Withdrawal by Subject|1|||
127654164|NCT01216163|459356924|FG001|Overall Study|Withdrawal by Subject|1|||
127654165|NCT01216163|459356925|FG002|Overall Study|Withdrawal by Subject|0|||
127654166|NCT02914314|459356926|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
127654167|NCT02914314|459356927|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
127654168|NCT02914314|459356928|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
127654169|NCT02914314|459356929|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
127654170|NCT02914314|459356926|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
127654171|NCT02914314|459356927|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
127654172|NCT02914314|459356928|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
127654173|NCT02914314|459356929|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
127654174|NCT02914314|459356926|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
127654175|NCT02914314|459356927|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
127654176|NCT02914314|459356928|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
127654177|NCT02914314|459356929|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
127654178|NCT02914314|459356926|FG000|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
127986524|NCT01636947|460574157|FG000|Overall Study|Withdrawal by Subject|3|||
127986525|NCT01636947|460574158|FG001|Overall Study|Withdrawal by Subject|3|||
127986526|NCT01636947|460574157|FG000|Overall Study|Adverse Event|1|||
127986527|NCT01636947|460574158|FG001|Overall Study|Adverse Event|1|||
127986528|NCT01636947|460574157|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
127654179|NCT02914314|459356927|FG001|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
127654180|NCT02914314|459356928|FG002|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|1|||
127654181|NCT02914314|459356929|FG003|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
127654182|NCT02914314|459356926|FG000|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
127654183|NCT02914314|459356927|FG001|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
127654184|NCT02914314|459356928|FG002|Extension Phase (Up to 36 Weeks)|Participant choice|1|||
127654185|NCT02914314|459356929|FG003|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
127654186|NCT04146896|459356940|FG000|Overall Study|Adverse Event|5|||
127654187|NCT04146896|459356941|FG001|Overall Study|Adverse Event|8|||
127654188|NCT04146896|459356940|FG000|Overall Study|Lack of Efficacy|3|||
127654189|NCT04146896|459356941|FG001|Overall Study|Lack of Efficacy|2|||
127654190|NCT04146896|459356940|FG000|Overall Study|Lost to Follow-up|0|||
127654191|NCT04146896|459356941|FG001|Overall Study|Lost to Follow-up|1|||
127654192|NCT04146896|459356940|FG000|Overall Study|Non-compliance|5|||
127654193|NCT04146896|459356941|FG001|Overall Study|Non-compliance|4|||
127654194|NCT04146896|459356940|FG000|Overall Study|Withdrawal by Subject|3|||
127654195|NCT04146896|459356941|FG001|Overall Study|Withdrawal by Subject|5|||
127654196|NCT04146896|459356940|FG000|Overall Study|Randomized in error|1|||
127654197|NCT04146896|459356941|FG001|Overall Study|Randomized in error|2|||
127654198|NCT02118337|459356942|FG000|Overall Study|Other|1|||
127654199|NCT02118337|459356943|FG001|Overall Study|Other|0|||
127654200|NCT02118337|459356944|FG002|Overall Study|Other|0|||
127654201|NCT02118337|459356945|FG003|Overall Study|Other|0|||
127654202|NCT02118337|459356946|FG004|Overall Study|Other|2|||
127654203|NCT02118337|459356947|FG005|Overall Study|Other|3|||
127654204|NCT02118337|459356948|FG006|Overall Study|Other|1|||
127654205|NCT02118337|459356949|FG007|Overall Study|Other|28|||
127654206|NCT02118337|459356950|FG008|Overall Study|Other|15|||
127654207|NCT02118337|459356942|FG000|Overall Study|Lost to Follow-up|0|||
127654208|NCT02118337|459356943|FG001|Overall Study|Lost to Follow-up|0|||
127654209|NCT02118337|459356944|FG002|Overall Study|Lost to Follow-up|0|||
127654210|NCT02118337|459356945|FG003|Overall Study|Lost to Follow-up|0|||
127654211|NCT02118337|459356946|FG004|Overall Study|Lost to Follow-up|0|||
127654212|NCT02118337|459356947|FG005|Overall Study|Lost to Follow-up|0|||
127654213|NCT02118337|459356948|FG006|Overall Study|Lost to Follow-up|0|||
127654214|NCT02118337|459356949|FG007|Overall Study|Lost to Follow-up|1|||
127654215|NCT02118337|459356950|FG008|Overall Study|Lost to Follow-up|0|||
127654216|NCT02118337|459356942|FG000|Overall Study|Withdrawal by Subject|1|||
127654217|NCT02118337|459356943|FG001|Overall Study|Withdrawal by Subject|3|||
127654218|NCT02118337|459356944|FG002|Overall Study|Withdrawal by Subject|2|||
127654219|NCT02118337|459356945|FG003|Overall Study|Withdrawal by Subject|1|||
127654220|NCT02118337|459356946|FG004|Overall Study|Withdrawal by Subject|2|||
127654221|NCT02118337|459356947|FG005|Overall Study|Withdrawal by Subject|2|||
127654222|NCT02118337|459356948|FG006|Overall Study|Withdrawal by Subject|1|||
127654223|NCT02118337|459356949|FG007|Overall Study|Withdrawal by Subject|4|||
127654224|NCT02118337|459356950|FG008|Overall Study|Withdrawal by Subject|2|||
127654225|NCT02118337|459356942|FG000|Overall Study|Death|2|||
127654226|NCT02118337|459356943|FG001|Overall Study|Death|2|||
127654227|NCT02118337|459356944|FG002|Overall Study|Death|1|||
127654228|NCT02118337|459356945|FG003|Overall Study|Death|2|||
127654229|NCT02118337|459356946|FG004|Overall Study|Death|5|||
127654230|NCT02118337|459356947|FG005|Overall Study|Death|1|||
127654231|NCT02118337|459356948|FG006|Overall Study|Death|2|||
127654232|NCT02118337|459356949|FG007|Overall Study|Death|9|||
127654233|NCT02118337|459356950|FG008|Overall Study|Death|4|||
127654234|NCT04296890|459356951|FG000|Overall Study|Withdrawal by Subject|1|||
127654235|NCT04296890|459356951|FG000|Overall Study|Death|62|||
127654236|NCT04296890|459356951|FG000|Overall Study|Lost to Follow-up|3|||
127654237|NCT04296890|459356951|FG000|Overall Study|Other than specified|2|||
127654238|NCT05400746|459356952|FG000|Overall Study|Trial terminated early due to IMP availability|0|||
127654239|NCT05400746|459356953|FG001|Overall Study|Trial terminated early due to IMP availability|4|||
127654240|NCT05400746|459356954|FG002|Overall Study|Trial terminated early due to IMP availability|1|||
127654241|NCT03300570|459356960|FG000|Overall Study|Adverse Event|0|||
127654242|NCT03300570|459356961|FG001|Overall Study|Adverse Event|1|||
127654243|NCT03300570|459356960|FG000|Overall Study|Withdrawal by Subject|1|||
127654244|NCT03300570|459356961|FG001|Overall Study|Withdrawal by Subject|0|||
127654245|NCT03300570|459356960|FG000|Overall Study|Inadequate bowel prep|1|||
127654246|NCT03300570|459356961|FG001|Overall Study|Inadequate bowel prep|0|||
127654247|NCT03188120|459356962|FG000|Overall Study|Adverse Event|4|||
127654248|NCT03188120|459356962|FG000|Overall Study|Insufficient Effectiveness|8|||
127654249|NCT03188120|459356962|FG000|Overall Study|Improved|12|||
127654250|NCT03188120|459356962|FG000|Overall Study|Lost to Follow-up|7|||
127880584|NCT01915498|460183531|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
127880585|NCT01915498|460183532|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
127880586|NCT01915498|460183533|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
127880587|NCT01915498|460183534|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
127880588|NCT01915498|460183535|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
127654251|NCT03188120|459356962|FG000|Overall Study|Other than specified|3|||
127654252|NCT03188120|459356962|FG000|Overall Study|No visit after the first visit|13|||
127654253|NCT01235403|459356964|FG000|Overall Study|Adverse Event|14|||
127654254|NCT01235403|459356964|FG000|Overall Study|Lost to Follow-up|2|||
127654255|NCT01235403|459356964|FG000|Overall Study|Withdrawal by Subject|4|||
127654256|NCT01235403|459356964|FG000|Overall Study|Lack of Efficacy|2|||
127654257|NCT01235403|459356964|FG000|Overall Study|Other reasons for premature termination|4|||
127654258|NCT02296190|459356965|FG000|Overall Study|Lost to Follow-up|0|||
127654259|NCT02296190|459356966|FG001|Overall Study|Lost to Follow-up|0|||
127654260|NCT02296190|459356967|FG002|Overall Study|Lost to Follow-up|0|||
127654261|NCT02296190|459356968|FG003|Overall Study|Lost to Follow-up|0|||
127654262|NCT02296190|459356969|FG004|Overall Study|Lost to Follow-up|1|||
127654263|NCT02296190|459356970|FG005|Overall Study|Lost to Follow-up|0|||
127654264|NCT02296190|459356965|FG000|Overall Study|Failure to induce PSVT|6|||
127654265|NCT02296190|459356966|FG001|Overall Study|Failure to induce PSVT|10|||
127654266|NCT02296190|459356967|FG002|Overall Study|Failure to induce PSVT|5|||
127654267|NCT02296190|459356968|FG003|Overall Study|Failure to induce PSVT|13|||
127654268|NCT02296190|459356969|FG004|Overall Study|Failure to induce PSVT|8|||
127654269|NCT02296190|459356970|FG005|Overall Study|Failure to induce PSVT|0|||
127654270|NCT02296190|459356965|FG000|Overall Study|Physician Decision|1|||
127654271|NCT02296190|459356966|FG001|Overall Study|Physician Decision|1|||
127654272|NCT02296190|459356967|FG002|Overall Study|Physician Decision|0|||
127654273|NCT02296190|459356968|FG003|Overall Study|Physician Decision|1|||
127654274|NCT02296190|459356969|FG004|Overall Study|Physician Decision|2|||
127654275|NCT02296190|459356970|FG005|Overall Study|Physician Decision|0|||
127654276|NCT02296190|459356965|FG000|Overall Study|Withdrawal by Subject|0|||
127654277|NCT02296190|459356966|FG001|Overall Study|Withdrawal by Subject|1|||
127654278|NCT02296190|459356967|FG002|Overall Study|Withdrawal by Subject|0|||
127654279|NCT02296190|459356968|FG003|Overall Study|Withdrawal by Subject|0|||
127654280|NCT02296190|459356969|FG004|Overall Study|Withdrawal by Subject|0|||
127654281|NCT02296190|459356970|FG005|Overall Study|Withdrawal by Subject|0|||
127654282|NCT02296190|459356965|FG000|Overall Study|PSVT < 5 minutes|5|||
127654283|NCT02296190|459356966|FG001|Overall Study|PSVT < 5 minutes|6|||
127654284|NCT02296190|459356967|FG002|Overall Study|PSVT < 5 minutes|6|||
127654285|NCT02296190|459356968|FG003|Overall Study|PSVT < 5 minutes|6|||
127654286|NCT02296190|459356969|FG004|Overall Study|PSVT < 5 minutes|5|||
127654287|NCT02296190|459356970|FG005|Overall Study|PSVT < 5 minutes|0|||
127654288|NCT02296190|459356965|FG000|Overall Study|Patient was given Propofol|0|||
127654289|NCT02296190|459356966|FG001|Overall Study|Patient was given Propofol|1|||
127654290|NCT02296190|459356967|FG002|Overall Study|Patient was given Propofol|0|||
127654291|NCT02296190|459356968|FG003|Overall Study|Patient was given Propofol|1|||
127654292|NCT02296190|459356969|FG004|Overall Study|Patient was given Propofol|0|||
127654293|NCT02296190|459356970|FG005|Overall Study|Patient was given Propofol|0|||
127654294|NCT02296190|459356965|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
127654295|NCT02296190|459356966|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
127654296|NCT02296190|459356967|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
127654297|NCT02296190|459356968|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
127654298|NCT02296190|459356969|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
127654299|NCT02296190|459356970|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
127654300|NCT02296190|459356965|FG000|Overall Study|Blood pressure <100 after sedation|0|||
127654301|NCT02296190|459356966|FG001|Overall Study|Blood pressure <100 after sedation|0|||
127654302|NCT02296190|459356967|FG002|Overall Study|Blood pressure <100 after sedation|0|||
127654303|NCT02296190|459356968|FG003|Overall Study|Blood pressure <100 after sedation|1|||
127654304|NCT02296190|459356969|FG004|Overall Study|Blood pressure <100 after sedation|0|||
127654305|NCT02296190|459356970|FG005|Overall Study|Blood pressure <100 after sedation|0|||
127654306|NCT02296190|459356965|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
127654307|NCT02296190|459356966|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
127654308|NCT02296190|459356967|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
127654309|NCT02296190|459356968|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
127654310|NCT02296190|459356969|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
127654311|NCT02296190|459356970|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
127654312|NCT02296190|459356965|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
127654313|NCT02296190|459356966|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
127654314|NCT02296190|459356967|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
127880589|NCT01915498|460183517|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
127880590|NCT01915498|460183518|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
127880591|NCT01915498|460183519|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
127880592|NCT01915498|460183520|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
127880593|NCT01915498|460183521|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
127880594|NCT01915498|460183522|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
127880595|NCT01915498|460183523|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
127654315|NCT02296190|459356968|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
127654316|NCT02296190|459356969|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
127654317|NCT02296190|459356970|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
127654318|NCT02296190|459356965|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
127654319|NCT02296190|459356966|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
127654320|NCT02296190|459356967|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
127654321|NCT02296190|459356968|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
127654322|NCT02296190|459356969|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
127654323|NCT02296190|459356970|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
127654324|NCT02296190|459356965|FG000|Overall Study|Lab result not available in time|1|||
127654325|NCT02296190|459356966|FG001|Overall Study|Lab result not available in time|0|||
127654326|NCT02296190|459356967|FG002|Overall Study|Lab result not available in time|0|||
127654327|NCT02296190|459356968|FG003|Overall Study|Lab result not available in time|0|||
127654328|NCT02296190|459356969|FG004|Overall Study|Lab result not available in time|0|||
127654329|NCT02296190|459356970|FG005|Overall Study|Lab result not available in time|0|||
127654330|NCT02978443|459356971|FG000|Overall Study|Withdrawal by Subject|1|||
127654331|NCT02978443|459356971|FG000|Overall Study|Adverse Event|3|||
127654332|NCT02978443|459356971|FG000|Overall Study|Disease Progression on study|6|||
127654333|NCT02978443|459356971|FG000|Overall Study|Death|1|||
127654334|NCT02978443|459356971|FG000|Overall Study|Physician Decision|1|||
127654335|NCT02978443|459356971|FG000|Overall Study|Switch to alternative therapy|1|||
127654336|NCT02978443|459356971|FG000|Overall Study|Refused further treatment|1|||
127654337|NCT00717314|459356972|FG000|Overall Study|Adverse Event|3|||
127880596|NCT01915498|460183524|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
127880597|NCT01915498|460183525|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
127880598|NCT01915498|460183526|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
127880599|NCT01915498|460183527|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
127880600|NCT01915498|460183528|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
127880601|NCT01915498|460183529|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
127880602|NCT01915498|460183530|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
127880603|NCT01915498|460183531|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
127880604|NCT01915498|460183532|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
127880605|NCT01915498|460183533|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
127880606|NCT01915498|460183534|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
127880607|NCT01915498|460183535|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
127880608|NCT01915498|460183517|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
127880609|NCT01915498|460183518|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
127880610|NCT01915498|460183519|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
127880611|NCT01915498|460183520|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
127880612|NCT01915498|460183521|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
127880613|NCT01915498|460183522|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
127880614|NCT01915498|460183523|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
127880615|NCT01915498|460183524|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
127880616|NCT01915498|460183525|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
127880617|NCT01915498|460183526|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
127880618|NCT01915498|460183527|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
127880619|NCT01915498|460183528|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
127880620|NCT01915498|460183529|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
127880621|NCT01915498|460183530|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
127880622|NCT01915498|460183531|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
127880623|NCT01915498|460183532|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
127880624|NCT01915498|460183533|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
127880625|NCT01915498|460183534|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
127880626|NCT01915498|460183535|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
127880627|NCT01915498|460183517|FG000|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
127880628|NCT01915498|460183518|FG001|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
127880629|NCT01915498|460183519|FG002|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
127880630|NCT01915498|460183520|FG003|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
127880631|NCT01915498|460183521|FG004|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
127880632|NCT01915498|460183522|FG005|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
127880633|NCT01915498|460183523|FG006|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
127880634|NCT01915498|460183524|FG007|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
127880635|NCT01915498|460183525|FG008|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
127880636|NCT01915498|460183526|FG009|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
127880637|NCT01915498|460183527|FG010|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
127880638|NCT01915498|460183528|FG011|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
127880639|NCT01915498|460183529|FG012|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
127880640|NCT01915498|460183530|FG013|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
127654338|NCT00717314|459356973|FG001|Overall Study|Adverse Event|2|||
127654339|NCT00717314|459356972|FG000|Overall Study|Protocol Violation|1|||
127654340|NCT00717314|459356973|FG001|Overall Study|Protocol Violation|0|||
127654341|NCT00717314|459356972|FG000|Overall Study|Lost to Follow-up|1|||
127654342|NCT00717314|459356973|FG001|Overall Study|Lost to Follow-up|5|||
127654343|NCT00717314|459356972|FG000|Overall Study|Withdrawal by Subject|1|||
127654344|NCT00717314|459356973|FG001|Overall Study|Withdrawal by Subject|3|||
127654345|NCT00117156|459356974|FG000|Overall Study|Adverse Event|9|||
127654346|NCT00117156|459356974|FG000|Overall Study|Physician Decision|1|||
127654347|NCT00117156|459356974|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
127654348|NCT01521884|459356977|FG000|Overall Study|Non Responders|10|||
127654349|NCT01521884|459356977|FG000|Overall Study|Adverse Event|5|||
127654350|NCT01521884|459356977|FG000|Overall Study|Pregnancy|1|||
127654351|NCT01521884|459356977|FG000|Overall Study|Withdrawal by Subject|1|||
127654352|NCT01521884|459356977|FG000|Overall Study|Physician Decision|2|||
127654353|NCT01521884|459356977|FG000|Overall Study|Protocol Violation|3|||
127654354|NCT01521884|459356977|FG000|Overall Study|Participant non-eligible|1|||
127654355|NCT01521884|459356977|FG000|Overall Study|Lost to Follow-up|4|||
127654356|NCT03238300|459356978|FG000|Baseline (Before Intervention)|Physician Decision|0|||
127654357|NCT03238300|459356979|FG001|Baseline (Before Intervention)|Physician Decision|1|||
127654358|NCT03238300|459356978|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
127654359|NCT03238300|459356979|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
127654360|NCT03238300|459356978|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
127654361|NCT03238300|459356979|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
127654362|NCT03238300|459356978|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
127654363|NCT03238300|459356979|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
127654364|NCT01435655|459356984|FG000|Overall Study|Death|2|||
127654365|NCT01435655|459356984|FG000|Overall Study|Other|1|||
127654366|NCT01975220|459356985|FG000|Test Period 1|Not treated|0|||
127654367|NCT01975220|459356986|FG001|Test Period 1|Not treated|1|||
127654368|NCT01975220|459356987|FG002|Test Period 1|Not treated|0|||
127654369|NCT01975220|459356988|FG003|Test Period 1|Not treated|0|||
127654370|NCT01975220|459356989|FG004|Test Period 1|Not treated|0|||
127654371|NCT01975220|459356990|FG005|Test Period 1|Not treated|0|||
127654372|NCT02839343|459356991|FG000|Overall Study|Withdrawal by Subject|3|||
127654373|NCT02839343|459356992|FG001|Overall Study|Withdrawal by Subject|1|||
127654374|NCT02839343|459356991|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
127654375|NCT02839343|459356992|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
127654376|NCT02839343|459356991|FG000|Overall Study|Adverse Event|1|||
127654377|NCT02839343|459356992|FG001|Overall Study|Adverse Event|0|||
127654378|NCT00661661|459356993|FG000|Overall Study|Adverse Event|99|||
127654379|NCT00661661|459356994|FG001|Overall Study|Adverse Event|24|||
127654380|NCT00661661|459356993|FG000|Overall Study|Lack of Efficacy|3|||
127654381|NCT00661661|459356994|FG001|Overall Study|Lack of Efficacy|2|||
127654382|NCT00661661|459356993|FG000|Overall Study|Lost to Follow-up|0|||
127654383|NCT00661661|459356994|FG001|Overall Study|Lost to Follow-up|1|||
127654384|NCT00661661|459356993|FG000|Overall Study|Withdrawal by Subject|15|||
127654385|NCT00661661|459356994|FG001|Overall Study|Withdrawal by Subject|5|||
127654386|NCT00661661|459356993|FG000|Overall Study|Other|22|||
127654387|NCT00661661|459356994|FG001|Overall Study|Other|7|||
127654388|NCT00661661|459356993|FG000|Overall Study|Not assigned treatment|1|||
127654389|NCT00661661|459356994|FG001|Overall Study|Not assigned treatment|0|||
127654390|NCT01893827|459356995|FG000|Overall Study|Lost to Follow-up|19|||
127654391|NCT01893827|459356996|FG001|Overall Study|Lost to Follow-up|26|||
127654392|NCT04182880|459356999|FG000|Overall Study|Pregnancy|1|||
127654393|NCT04182880|459357000|FG001|Overall Study|Pregnancy|0|||
127654394|NCT03389477|459357001|FG000|Step 1|Withdrawal by Subject|1|||
127654395|NCT03389477|459357002|FG001|Step 1|Withdrawal by Subject|0|||
127654396|NCT03389477|459357001|FG000|Step 2|Withdrawal by Subject|1|||
127654397|NCT03389477|459357002|FG001|Step 2|Withdrawal by Subject|2|||
127654398|NCT03389477|459357001|FG000|Step 2|Disease progression|1|||
127654399|NCT03389477|459357002|FG001|Step 2|Disease progression|0|||
127654400|NCT03389477|459357001|FG000|Step 2|Death|0|||
127654401|NCT03389477|459357002|FG001|Step 2|Death|1|||
127986529|NCT01636947|460574158|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
127654402|NCT03389477|459357001|FG000|Step 2|Poor performance status and nutrition|0|||
127654403|NCT03389477|459357002|FG001|Step 2|Poor performance status and nutrition|1|||
127654404|NCT03389477|459357001|FG000|Step 3|Withdrawal after 3 cycles|0|||
127654405|NCT03389477|459357002|FG001|Step 3|Withdrawal after 3 cycles|1|||
127654406|NCT03389477|459357001|FG000|Step 3|Still receiving active treatment|4|||
127654407|NCT03389477|459357002|FG001|Step 3|Still receiving active treatment|0|||
127654408|NCT03389477|459357001|FG000|Step 3|Progressive disease after 2 cycles|1|||
127654409|NCT03389477|459357002|FG001|Step 3|Progressive disease after 2 cycles|0|||
127654410|NCT03403426|459357005|FG000|Overall Study|Death|1|||
127654411|NCT03403426|459357005|FG000|Overall Study|Lost to Follow-up|2|||
127654412|NCT00909428|459357006|FG000|Overall Study|Lost to Follow-up|13|||
127654413|NCT00909428|459357007|FG001|Overall Study|Lost to Follow-up|10|||
127654414|NCT00909428|459357008|FG002|Overall Study|Lost to Follow-up|9|||
127654415|NCT03021668|459357009|FG000|Overall Study|Physician Decision|0|||
127880641|NCT01915498|460183531|FG014|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
127542721|NCT01231984|458954593|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
127542722|NCT01680341|458954595|FG000|Overall Study|Adverse Event|3|||
127542723|NCT01680341|458954596|FG001|Overall Study|Adverse Event|2|||
127542724|NCT01680341|458954595|FG000|Overall Study|Unclassified|18|||
127542725|NCT01680341|458954596|FG001|Overall Study|Unclassified|15|||
127542726|NCT00481832|458954597|FG000|Enrollment|Physician Decision|8|||
127542727|NCT00481832|458954597|FG000|Enrollment|Unable to collect enough stem cells|2|||
127542728|NCT00481832|458954597|FG000|Inter-transplant Period|Adverse Event|4|||
127542729|NCT00481832|458954597|FG000|Inter-transplant Period|Death|3|||
127542730|NCT00481832|458954597|FG000|Inter-transplant Period|Physician Decision|4|||
127542731|NCT00481832|458954597|FG000|Inter-transplant Period|Disease relapse|11|||
127542732|NCT00481832|458954597|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
127542733|NCT02558894|458954600|FG000|Overall Study|Death; any cause, entire study duration|28|||
127542734|NCT02558894|458954601|FG001|Overall Study|Death; any cause, entire study duration|31|||
127542735|NCT02558894|458954600|FG000|Overall Study|Withdrawal by Subject|2|||
127542736|NCT02558894|458954601|FG001|Overall Study|Withdrawal by Subject|1|||
127542737|NCT02558894|458954600|FG000|Overall Study|Closure of Part A|2|||
127542738|NCT02558894|458954601|FG001|Overall Study|Closure of Part A|1|||
127542739|NCT02992288|458954602|FG000|Overall Study|Adverse Event|8|||
127542740|NCT02992288|458954603|FG001|Overall Study|Adverse Event|2|||
127542741|NCT02992288|458954604|FG002|Overall Study|Adverse Event|2|||
127542742|NCT02992288|458954605|FG003|Overall Study|Adverse Event|2|||
127542743|NCT02992288|458954606|FG004|Overall Study|Adverse Event|2|||
127542744|NCT02992288|458954607|FG005|Overall Study|Adverse Event|7|||
127542745|NCT02992288|458954602|FG000|Overall Study|Non-compliance with study drug|0|||
127542746|NCT02992288|458954603|FG001|Overall Study|Non-compliance with study drug|1|||
127542747|NCT02992288|458954604|FG002|Overall Study|Non-compliance with study drug|1|||
127542748|NCT02992288|458954605|FG003|Overall Study|Non-compliance with study drug|0|||
127542749|NCT02992288|458954606|FG004|Overall Study|Non-compliance with study drug|1|||
127542750|NCT02992288|458954607|FG005|Overall Study|Non-compliance with study drug|0|||
127542751|NCT02992288|458954602|FG000|Overall Study|Physician Decision|3|||
127542752|NCT02992288|458954603|FG001|Overall Study|Physician Decision|0|||
127542753|NCT02992288|458954604|FG002|Overall Study|Physician Decision|1|||
127542754|NCT02992288|458954605|FG003|Overall Study|Physician Decision|0|||
127542755|NCT02992288|458954606|FG004|Overall Study|Physician Decision|0|||
127542756|NCT02992288|458954607|FG005|Overall Study|Physician Decision|1|||
127542757|NCT02992288|458954602|FG000|Overall Study|Death|2|||
127542758|NCT02992288|458954603|FG001|Overall Study|Death|0|||
127542759|NCT02992288|458954604|FG002|Overall Study|Death|2|||
127542760|NCT02992288|458954605|FG003|Overall Study|Death|1|||
127542761|NCT02992288|458954606|FG004|Overall Study|Death|2|||
127542762|NCT02992288|458954607|FG005|Overall Study|Death|0|||
127542763|NCT02992288|458954602|FG000|Overall Study|Lost to Follow-up|0|||
127542764|NCT02992288|458954603|FG001|Overall Study|Lost to Follow-up|0|||
127542765|NCT02992288|458954604|FG002|Overall Study|Lost to Follow-up|0|||
127542766|NCT02992288|458954605|FG003|Overall Study|Lost to Follow-up|1|||
127542767|NCT02992288|458954606|FG004|Overall Study|Lost to Follow-up|0|||
127542768|NCT02992288|458954607|FG005|Overall Study|Lost to Follow-up|0|||
127542769|NCT02992288|458954602|FG000|Overall Study|Protocol Violation|0|||
127542770|NCT02992288|458954603|FG001|Overall Study|Protocol Violation|0|||
127542771|NCT02992288|458954604|FG002|Overall Study|Protocol Violation|0|||
127542772|NCT02992288|458954605|FG003|Overall Study|Protocol Violation|0|||
127542773|NCT02992288|458954606|FG004|Overall Study|Protocol Violation|0|||
127542774|NCT02992288|458954607|FG005|Overall Study|Protocol Violation|1|||
127542775|NCT02992288|458954602|FG000|Overall Study|Withdrawal by Subject|4|||
127542776|NCT02992288|458954603|FG001|Overall Study|Withdrawal by Subject|2|||
127542777|NCT02992288|458954604|FG002|Overall Study|Withdrawal by Subject|1|||
127542778|NCT02992288|458954605|FG003|Overall Study|Withdrawal by Subject|5|||
127542779|NCT02992288|458954606|FG004|Overall Study|Withdrawal by Subject|3|||
127542780|NCT02992288|458954607|FG005|Overall Study|Withdrawal by Subject|4|||
127542781|NCT02006472|458954611|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
127542782|NCT02006472|458954612|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
127542783|NCT02006472|458954613|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
127542784|NCT02006472|458954614|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
127542785|NCT02006472|458954615|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
127542786|NCT02006472|458954611|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
127542787|NCT02006472|458954612|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
127542788|NCT02006472|458954613|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
127542789|NCT02006472|458954614|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
127542790|NCT02006472|458954615|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
127542791|NCT02006472|458954611|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
127542792|NCT02006472|458954612|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
127542793|NCT02006472|458954613|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
127542794|NCT02006472|458954614|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
127542795|NCT02006472|458954615|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
127654416|NCT03021668|459357010|FG001|Overall Study|Physician Decision|1|||
127654417|NCT01122381|459357011|FG000|Overall Study|study terminated early|0|||
127654418|NCT01122381|459357012|FG001|Overall Study|study terminated early|1|||
127654419|NCT02217280|459357013|FG000|Overall Study|Withdrawal by Subject|2|||
127654420|NCT02217280|459357013|FG000|Overall Study|Post-consent sceen fail|2|||
127654421|NCT03474549|459357014|FG000|Overall Study|Death|31|||
127654422|NCT03474549|459357014|FG000|Overall Study|Lost to Follow-up|4|||
127654423|NCT03474549|459357014|FG000|Overall Study|Withdrawal by Subject|2|||
127654424|NCT03445065|459357017|FG000|Overall Study|Withdrawal by Subject|3|||
127654425|NCT03445065|459357018|FG001|Overall Study|Withdrawal by Subject|6|||
127880642|NCT01915498|460183532|FG015|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
127880643|NCT01915498|460183533|FG016|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
127880644|NCT01915498|460183534|FG017|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
127880645|NCT01915498|460183535|FG018|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|2|||
127880646|NCT01915498|460183517|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
127880647|NCT01915498|460183518|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
127880648|NCT01915498|460183519|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
127880649|NCT01915498|460183520|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
127986530|NCT00957424|460574159|FG000|Overall Study|Lost to Follow-up|19|||
127986531|NCT00957424|460574159|FG000|Overall Study|Protocol Violation|3|||
127986532|NCT00957424|460574159|FG000|Overall Study|Withdrawal by Subject|1|||
127986533|NCT05182606|460574165|FG000|Post-implementation (12 Months After)|Did not participate in the post-implementation survey|30|||
127986534|NCT01955109|460574168|FG000|Overall Study|Adverse Event|2|||
127542796|NCT02006472|458954611|FG000|Period 1 (Through Week 26)|Other|1|||
127542797|NCT02006472|458954612|FG001|Period 1 (Through Week 26)|Other|5|||
127542798|NCT02006472|458954613|FG002|Period 1 (Through Week 26)|Other|0|||
127542799|NCT02006472|458954614|FG003|Period 1 (Through Week 26)|Other|2|||
127542800|NCT02006472|458954615|FG004|Period 1 (Through Week 26)|Other|3|||
127542801|NCT02006472|458954611|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
127542802|NCT02006472|458954612|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
127542803|NCT02006472|458954613|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
127542804|NCT02006472|458954614|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
127542805|NCT02006472|458954615|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
127542806|NCT02006472|458954611|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
127542807|NCT02006472|458954612|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
127542808|NCT02006472|458954613|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
127542809|NCT02006472|458954614|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
127542810|NCT02006472|458954615|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
127542811|NCT02006472|458954611|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
127542812|NCT02006472|458954612|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
127542813|NCT02006472|458954613|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
127542814|NCT02006472|458954614|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
127542815|NCT02006472|458954615|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
127542816|NCT02006472|458954611|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
127542817|NCT02006472|458954612|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
127542818|NCT02006472|458954613|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
127542819|NCT02006472|458954614|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
127542820|NCT02006472|458954615|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
127542821|NCT02006472|458954611|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
127542822|NCT02006472|458954612|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
127542823|NCT02006472|458954613|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
127542824|NCT02006472|458954614|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
127542825|NCT02006472|458954615|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
127542826|NCT02006472|458954611|FG000|Period 2 (Through Week 52)|Other|0|||
127542827|NCT02006472|458954612|FG001|Period 2 (Through Week 52)|Other|1|||
127542828|NCT02006472|458954613|FG002|Period 2 (Through Week 52)|Other|0|||
127542829|NCT02006472|458954614|FG003|Period 2 (Through Week 52)|Other|1|||
127542830|NCT02006472|458954615|FG004|Period 2 (Through Week 52)|Other|0|||
127542831|NCT02006472|458954611|FG000|Period 2 (Through Week 52)|Not treated|0|||
127542832|NCT02006472|458954612|FG001|Period 2 (Through Week 52)|Not treated|0|||
127542833|NCT02006472|458954613|FG002|Period 2 (Through Week 52)|Not treated|2|||
127542834|NCT02006472|458954614|FG003|Period 2 (Through Week 52)|Not treated|0|||
127542835|NCT02006472|458954615|FG004|Period 2 (Through Week 52)|Not treated|0|||
127542836|NCT02006472|458954611|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
127542837|NCT02006472|458954612|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
127542838|NCT02006472|458954613|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
127542839|NCT02006472|458954614|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
127542840|NCT02006472|458954615|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
127542841|NCT02006472|458954611|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
127542842|NCT02006472|458954612|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
127542843|NCT02006472|458954613|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
127654426|NCT03445065|459357019|FG002|Overall Study|Withdrawal by Subject|2|||
127654427|NCT03445065|459357020|FG003|Overall Study|Withdrawal by Subject|2|||
127654428|NCT03445065|459357017|FG000|Overall Study|Other|4|||
127654429|NCT03445065|459357018|FG001|Overall Study|Other|3|||
127654430|NCT03445065|459357019|FG002|Overall Study|Other|3|||
127654431|NCT03445065|459357020|FG003|Overall Study|Other|1|||
127654432|NCT03315130|459357021|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
127654433|NCT03315130|459357022|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
127654434|NCT03315130|459357023|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
127654435|NCT03315130|459357024|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
127654436|NCT03315130|459357021|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
127654437|NCT03315130|459357022|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
127654438|NCT03315130|459357023|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
127654439|NCT03315130|459357024|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
127654440|NCT03315130|459357021|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
127654441|NCT03315130|459357022|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
127654442|NCT03315130|459357023|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
127654443|NCT03315130|459357024|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
127654444|NCT03315130|459357021|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
127654445|NCT03315130|459357022|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
127654446|NCT03315130|459357023|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
127654447|NCT03315130|459357024|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
127654448|NCT03315130|459357021|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
127654449|NCT03315130|459357022|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
127654450|NCT03315130|459357023|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
127654451|NCT03315130|459357024|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
127654452|NCT03315130|459357021|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
127654453|NCT03315130|459357022|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
127654454|NCT03315130|459357023|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
127654455|NCT03315130|459357024|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
127654456|NCT02089230|459357025|FG000|Overall Study|Death|0|||
127654457|NCT02089230|459357026|FG001|Overall Study|Death|0|||
127654458|NCT02089230|459357027|FG002|Overall Study|Death|2|||
127654459|NCT02089230|459357025|FG000|Overall Study|Seeking Alternative Therapy|0|||
127654460|NCT02089230|459357026|FG001|Overall Study|Seeking Alternative Therapy|0|||
127654461|NCT02089230|459357027|FG002|Overall Study|Seeking Alternative Therapy|4|||
127654462|NCT02202434|459358657|FG000|Overall Study|Death|70|||
127654463|NCT02202434|459358658|FG001|Overall Study|Death|39|||
127654464|NCT02202434|459358659|FG002|Overall Study|Death|13|||
127654465|NCT02202434|459358660|FG003|Overall Study|Death|27|||
127654466|NCT02202434|459358657|FG000|Overall Study|Lost to Follow-up|1|||
127654467|NCT02202434|459358658|FG001|Overall Study|Lost to Follow-up|1|||
127654468|NCT02202434|459358659|FG002|Overall Study|Lost to Follow-up|1|||
127654469|NCT02202434|459358660|FG003|Overall Study|Lost to Follow-up|0|||
127654470|NCT02202434|459358657|FG000|Overall Study|Physician Decision|2|||
127654471|NCT02202434|459358658|FG001|Overall Study|Physician Decision|3|||
127654472|NCT02202434|459358659|FG002|Overall Study|Physician Decision|0|||
127654473|NCT02202434|459358660|FG003|Overall Study|Physician Decision|0|||
127654474|NCT02202434|459358657|FG000|Overall Study|Withdrawal by Subject|13|||
127654475|NCT02202434|459358658|FG001|Overall Study|Withdrawal by Subject|14|||
127654476|NCT02202434|459358659|FG002|Overall Study|Withdrawal by Subject|1|||
127654477|NCT02202434|459358660|FG003|Overall Study|Withdrawal by Subject|4|||
127654478|NCT02202434|459358657|FG000|Overall Study|Completed Study|1|||
127654479|NCT02202434|459358658|FG001|Overall Study|Completed Study|0|||
127880650|NCT01915498|460183521|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
127880651|NCT01915498|460183522|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
127880652|NCT01915498|460183523|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
127880653|NCT01915498|460183524|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
127654480|NCT02202434|459358659|FG002|Overall Study|Completed Study|0|||
127654481|NCT02202434|459358660|FG003|Overall Study|Completed Study|0|||
127880654|NCT01915498|460183525|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
127654482|NCT02202434|459358657|FG000|Overall Study|Visit Missed|21|||
127654483|NCT02202434|459358658|FG001|Overall Study|Visit Missed|12|||
127654484|NCT02202434|459358659|FG002|Overall Study|Visit Missed|0|||
127880655|NCT01915498|460183526|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
127654485|NCT02202434|459358660|FG003|Overall Study|Visit Missed|5|||
127654486|NCT02202434|459358657|FG000|Overall Study|Other|1|||
127654487|NCT02202434|459358658|FG001|Overall Study|Other|0|||
127654488|NCT02202434|459358659|FG002|Overall Study|Other|0|||
127654489|NCT02202434|459358660|FG003|Overall Study|Other|1|||
127986535|NCT01955109|460574169|FG001|Overall Study|Adverse Event|0|||
127654490|NCT03528174|459358667|FG000|Overall Study|Adverse Event|1|||
127654491|NCT03528174|459358667|FG000|Overall Study|sensors dislodged|1|||
127654492|NCT00979602|459358668|FG000|Overall Study|Serious Adverse Event|5|||
127654493|NCT00979602|459358669|FG001|Overall Study|Serious Adverse Event|3|||
127542844|NCT02006472|458954614|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
127542845|NCT02006472|458954615|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
127542846|NCT00499486|458954616|FG000|Overall Study|Withdrawal by Subject|16|||
127542847|NCT00656513|458954617|FG000|Overall Study|Protocol Violation|1|||
127542848|NCT00656513|458954618|FG001|Overall Study|Protocol Violation|0|||
127542849|NCT00656513|458954619|FG002|Overall Study|Protocol Violation|2|||
127542850|NCT00656513|458954617|FG000|Overall Study|Withdrawal by Subject|0|||
127542851|NCT00656513|458954618|FG001|Overall Study|Withdrawal by Subject|11|||
127542852|NCT00656513|458954619|FG002|Overall Study|Withdrawal by Subject|4|||
127542853|NCT00656513|458954617|FG000|Overall Study|Death|0|||
127542854|NCT00656513|458954618|FG001|Overall Study|Death|0|||
127542855|NCT00656513|458954619|FG002|Overall Study|Death|1|||
127542856|NCT00656513|458954617|FG000|Overall Study|Missing data|0|||
127542857|NCT00656513|458954618|FG001|Overall Study|Missing data|11|||
127542858|NCT00656513|458954619|FG002|Overall Study|Missing data|9|||
127542859|NCT00656513|458954617|FG000|Overall Study|Incomplete treatment|3|||
127542860|NCT00656513|458954618|FG001|Overall Study|Incomplete treatment|0|||
127542861|NCT00656513|458954619|FG002|Overall Study|Incomplete treatment|0|||
127542862|NCT00656513|458954617|FG000|Overall Study|Treatment completed outside of timeframe|0|||
127542863|NCT00656513|458954618|FG001|Overall Study|Treatment completed outside of timeframe|3|||
127542864|NCT00656513|458954619|FG002|Overall Study|Treatment completed outside of timeframe|1|||
127542865|NCT00656513|458954617|FG000|Overall Study|Missing baseline form|0|||
127542866|NCT00656513|458954618|FG001|Overall Study|Missing baseline form|5|||
127542867|NCT00656513|458954619|FG002|Overall Study|Missing baseline form|5|||
127542868|NCT00087152|458954620|FG000|Overall Study|Ineligible|6|||
127542869|NCT01436149|458954626|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
127542870|NCT01436149|458954627|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
127542871|NCT01436149|458954628|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
127542872|NCT01436149|458954626|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
127542873|NCT01436149|458954627|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
127542874|NCT01436149|458954628|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
127542875|NCT01436149|458954626|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
127542876|NCT01436149|458954627|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
127542877|NCT01436149|458954628|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
127542878|NCT01436149|458954626|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
127542879|NCT01436149|458954627|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
127542880|NCT01436149|458954628|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
127542881|NCT01436149|458954626|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
127542882|NCT01436149|458954627|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
127542883|NCT01436149|458954628|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
127542884|NCT01436149|458954626|FG000|Antidepressant Lead-in Phase|Other|119|||
127542885|NCT01436149|458954627|FG001|Antidepressant Lead-in Phase|Other|0|||
127542886|NCT01436149|458954628|FG002|Antidepressant Lead-in Phase|Other|0|||
127542887|NCT01436149|458954626|FG000|Randomized Phase|Adverse Event|9|||
127542888|NCT01436149|458954627|FG001|Randomized Phase|Adverse Event|10|||
127542889|NCT01436149|458954628|FG002|Randomized Phase|Adverse Event|11|||
127542890|NCT01436149|458954626|FG000|Randomized Phase|Protocol Violation|4|||
127542891|NCT01436149|458954627|FG001|Randomized Phase|Protocol Violation|5|||
127542892|NCT01436149|458954628|FG002|Randomized Phase|Protocol Violation|0|||
127542893|NCT01436149|458954626|FG000|Randomized Phase|Withdrawal by Subject|16|||
127542894|NCT01436149|458954627|FG001|Randomized Phase|Withdrawal by Subject|10|||
127542895|NCT01436149|458954628|FG002|Randomized Phase|Withdrawal by Subject|10|||
127542896|NCT01436149|458954626|FG000|Randomized Phase|Lost to Follow-up|34|||
127542897|NCT01436149|458954627|FG001|Randomized Phase|Lost to Follow-up|5|||
127542898|NCT01436149|458954628|FG002|Randomized Phase|Lost to Follow-up|6|||
127542899|NCT01436149|458954626|FG000|Randomized Phase|Lack of Efficacy|0|||
127542900|NCT01436149|458954627|FG001|Randomized Phase|Lack of Efficacy|0|||
127542901|NCT01436149|458954628|FG002|Randomized Phase|Lack of Efficacy|1|||
127542902|NCT01436149|458954626|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
127542903|NCT01436149|458954627|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
127542904|NCT01436149|458954628|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
127542905|NCT01436149|458954626|FG000|Randomized Phase|Other|12|||
127542906|NCT01436149|458954627|FG001|Randomized Phase|Other|5|||
127542907|NCT01436149|458954628|FG002|Randomized Phase|Other|11|||
127542908|NCT00322881|458954632|FG000|Overall Study|Death|2|||
127542909|NCT00322881|458954632|FG000|Overall Study|Adverse Event|1|||
127542910|NCT00322881|458954632|FG000|Overall Study|Disease Progression|2|||
127542911|NCT00561652|458954633|FG000|Overall Study|Withdrawal by Subject|0|||
127542912|NCT00561652|458954634|FG001|Overall Study|Withdrawal by Subject|1|||
127542913|NCT04484961|458954637|FG000|Overall Study|Lost to Follow-up|9|||
127542914|NCT04484961|458954638|FG001|Overall Study|Lost to Follow-up|9|||
127542915|NCT01667900|458954639|FG000|Part B|Death|0|||
127542916|NCT01667900|458954640|FG001|Part B|Death|0|||
127542917|NCT01667900|458954641|FG002|Part B|Death|0|||
127542918|NCT01667900|458954642|FG003|Part B|Death|0|||
127542919|NCT01667900|458954643|FG004|Part B|Death|0|||
127654494|NCT00979602|459358668|FG000|Overall Study|Protocol Violation|3|||
127654495|NCT00979602|459358669|FG001|Overall Study|Protocol Violation|0|||
127654496|NCT00979602|459358668|FG000|Overall Study|Withdrawal by Subject|31|||
127654497|NCT00979602|459358669|FG001|Overall Study|Withdrawal by Subject|25|||
127654498|NCT00979602|459358668|FG000|Overall Study|Lost to Follow-up|100|||
127654499|NCT00979602|459358669|FG001|Overall Study|Lost to Follow-up|96|||
127654500|NCT00979602|459358668|FG000|Overall Study|Migrated/moved from study area|3|||
127654501|NCT00979602|459358669|FG001|Overall Study|Migrated/moved from study area|6|||
127654502|NCT00979602|459358668|FG000|Overall Study|Others|3|||
127654503|NCT00979602|459358669|FG001|Overall Study|Others|3|||
127654504|NCT01719237|459358670|FG000|Overall Study|Physician Decision|0|||
127654505|NCT01719237|459358671|FG001|Overall Study|Physician Decision|1|||
127654506|NCT02712398|459358672|FG000|Overall Study|Withdrawal by Subject|6|||
127654507|NCT02712398|459358672|FG000|Overall Study|Lost to Follow-up|6|||
127654508|NCT02712398|459358672|FG000|Overall Study|Sponsor Decision|1|||
127654509|NCT02712398|459358672|FG000|Overall Study|Physician Decision|1|||
127654510|NCT02712398|459358672|FG000|Overall Study|Death|2|||
127654511|NCT02712398|459358672|FG000|Overall Study|Re-operation|21|||
127654512|NCT04091360|459358675|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
127654513|NCT04091360|459358676|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
127654514|NCT04091360|459358677|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
127654515|NCT04091360|459358678|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
127654516|NCT04091360|459358679|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
127654517|NCT04091360|459358680|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
127654518|NCT04091360|459358681|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
127654519|NCT04091360|459358682|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
127654520|NCT04091360|459358683|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
127654521|NCT04091360|459358684|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
127654522|NCT04091360|459358675|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
127654523|NCT04091360|459358676|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
127654524|NCT04091360|459358677|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
127654525|NCT04091360|459358678|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
127654526|NCT04091360|459358679|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
127654527|NCT04091360|459358680|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
127654528|NCT04091360|459358681|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
127654529|NCT04091360|459358682|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
127654530|NCT04091360|459358683|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
127654531|NCT04091360|459358684|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
127654532|NCT04091360|459358675|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
127654533|NCT04091360|459358676|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
127654534|NCT04091360|459358677|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
127654535|NCT04091360|459358678|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
127654536|NCT04091360|459358679|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
127654537|NCT04091360|459358680|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
127654538|NCT04091360|459358681|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
127654539|NCT04091360|459358682|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
127654540|NCT04091360|459358683|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
127654541|NCT04091360|459358684|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
127654542|NCT04772053|459358689|FG000|Overall Study|Physician Decision|2|||
127654543|NCT04772053|459358689|FG000|Overall Study|Withdrawal by Subject|3|||
127654544|NCT04772053|459358689|FG000|Overall Study|Study Terminated by Sponsor|1|||
127654545|NCT04599101|459358690|FG000|Overall Study|Lost to Follow-up|5|||
127654546|NCT04599101|459358691|FG001|Overall Study|Lost to Follow-up|5|||
127654547|NCT00098254|459358694|FG000|Overall Study|Adverse Event|2|||
127654548|NCT00098254|459358694|FG000|Overall Study|Death|1|||
127654549|NCT04631705|459358701|FG000|Overall Study|Withdrawal by Subject|0|||
127654550|NCT04631705|459358702|FG001|Overall Study|Withdrawal by Subject|0|||
127654551|NCT04631705|459358703|FG002|Overall Study|Withdrawal by Subject|0|||
127654552|NCT04631705|459358704|FG003|Overall Study|Withdrawal by Subject|0|||
127654553|NCT04631705|459358705|FG004|Overall Study|Withdrawal by Subject|0|||
127654554|NCT04631705|459358706|FG005|Overall Study|Withdrawal by Subject|0|||
127654555|NCT04631705|459358707|FG006|Overall Study|Withdrawal by Subject|1|||
127880656|NCT01915498|460183527|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
127654556|NCT04631705|459358708|FG007|Overall Study|Withdrawal by Subject|0|||
127654557|NCT04631705|459358709|FG008|Overall Study|Withdrawal by Subject|0|||
127654558|NCT02130284|459358710|FG000|Overall Study|Withdrawal by Subject|3|||
127654559|NCT02130284|459358710|FG000|Overall Study|Subject Withdrew Consent|1|||
127654560|NCT02130284|459358710|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
127654561|NCT02130284|459358710|FG000|Overall Study|Subject was screened as backup for study|3|||
127654562|NCT02130284|459358710|FG000|Overall Study|Screen Failure|1|||
127654563|NCT01875185|459358711|FG000|Overall Study|study was terminated|52|||
127654564|NCT01875185|459358712|FG001|Overall Study|study was terminated|48|||
127654565|NCT04838613|459358713|FG000|Overall Study|Withdrawal by Subject|3|||
127654566|NCT04838613|459358714|FG001|Overall Study|Withdrawal by Subject|6|||
127654567|NCT04838613|459358713|FG000|Overall Study|Protocol Deviation|3|||
127654568|NCT04838613|459358714|FG001|Overall Study|Protocol Deviation|2|||
127654569|NCT04838613|459358713|FG000|Overall Study|Technical Problems|0|||
127654570|NCT04838613|459358714|FG001|Overall Study|Technical Problems|5|||
127654571|NCT04838613|459358713|FG000|Overall Study|Physician Decision|2|||
127654572|NCT04838613|459358714|FG001|Overall Study|Physician Decision|0|||
127654573|NCT01686581|459358715|FG000|Overall Study|Side-effects or Health Problems|15|||
127654574|NCT01686581|459358715|FG000|Overall Study|Lack of Efficacy|90|||
127654575|NCT01686581|459358715|FG000|Overall Study|Participant Concerned about Risks|6|||
127654576|NCT01686581|459358715|FG000|Overall Study|Thinks Injections Too Painful|8|||
127654577|NCT01686581|459358715|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
127654578|NCT01686581|459358715|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
127654579|NCT01686581|459358715|FG000|Overall Study|Thinks it is Inconvenient|17|||
127654580|NCT01686581|459358715|FG000|Overall Study|Other Miscellaneous Reasons|36|||
127654581|NCT01686581|459358715|FG000|Overall Study|Reason Missing|1|||
127654582|NCT01807650|459358716|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
127654583|NCT01807650|459358716|FG000|Overall Study|Adverse Event|5|||
127654584|NCT01807650|459358716|FG000|Overall Study|Other|2|||
127654585|NCT00736489|459358719|FG000|Period 1|Lost to Follow-up|1|||
127654586|NCT00736489|459358720|FG001|Period 1|Lost to Follow-up|0|||
127654587|NCT00736489|459358721|FG002|Period 1|Lost to Follow-up|0|||
127654588|NCT00736489|459358722|FG003|Period 1|Lost to Follow-up|0|||
127654589|NCT00736489|459358723|FG004|Period 1|Lost to Follow-up|0|||
127654590|NCT00736489|459358724|FG005|Period 1|Lost to Follow-up|0|||
127654591|NCT00736489|459358719|FG000|Period 1|Withdrawal by Subject|0|||
127654592|NCT00736489|459358720|FG001|Period 1|Withdrawal by Subject|0|||
127654593|NCT00736489|459358721|FG002|Period 1|Withdrawal by Subject|0|||
127654594|NCT00736489|459358722|FG003|Period 1|Withdrawal by Subject|0|||
127654595|NCT00736489|459358723|FG004|Period 1|Withdrawal by Subject|0|||
127654596|NCT00736489|459358724|FG005|Period 1|Withdrawal by Subject|1|||
127654597|NCT00116844|459358725|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
127654598|NCT00116844|459358726|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
127654599|NCT00116844|459358725|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
127654600|NCT00116844|459358726|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
127654601|NCT00116844|459358725|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
127654602|NCT00116844|459358726|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
127654603|NCT00116844|459358725|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
127654604|NCT00116844|459358726|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
127654605|NCT00116844|459358725|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
127654606|NCT00116844|459358726|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
127654607|NCT00116844|459358725|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
127654608|NCT00116844|459358726|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
127654609|NCT00116844|459358725|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
127654610|NCT00116844|459358726|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
127654611|NCT00116844|459358725|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
127654612|NCT00116844|459358726|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
127654613|NCT00116844|459358725|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
127654614|NCT00116844|459358726|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
127654615|NCT01933880|459358727|FG000|Overall Study|Withdrawal by Subject|5|||
127654616|NCT01933880|459358728|FG001|Overall Study|Withdrawal by Subject|0|||
127654617|NCT01933880|459358727|FG000|Overall Study|Lack of Efficacy|1|||
127654618|NCT01933880|459358728|FG001|Overall Study|Lack of Efficacy|0|||
127654619|NCT01933880|459358727|FG000|Overall Study|Concomitant medication Interference|0|||
127654620|NCT01933880|459358728|FG001|Overall Study|Concomitant medication Interference|1|||
127654621|NCT01933880|459358727|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
127654622|NCT01933880|459358728|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
127542920|NCT01667900|458954644|FG005|Part B|Death|0|||
127542921|NCT01667900|458954645|FG006|Part B|Death|0|||
127542922|NCT01667900|458954646|FG007|Part B|Death|0|||
127542923|NCT01667900|458954647|FG008|Part B|Death|0|||
127542924|NCT01667900|458954648|FG009|Part B|Death|0|||
127542925|NCT01667900|458954649|FG010|Part B|Death|0|||
127542926|NCT01667900|458954650|FG011|Part B|Death|0|||
127542927|NCT01667900|458954651|FG012|Part B|Death|0|||
127542928|NCT01667900|458954652|FG013|Part B|Death|0|||
127542929|NCT01667900|458954653|FG014|Part B|Death|0|||
127542930|NCT01667900|458954654|FG015|Part B|Death|0|||
127542931|NCT01667900|458954655|FG016|Part B|Death|1|||
127542932|NCT01667900|458954656|FG017|Part B|Death|0|||
127542933|NCT01667900|458954657|FG018|Part B|Death|0|||
127542934|NCT01667900|458954658|FG019|Part B|Death|0|||
127542935|NCT00976274|458954660|FG000|Overall Study|Lost to Follow-up|5|||
127654623|NCT01933880|459358727|FG000|Overall Study|Other|4|||
127654624|NCT01933880|459358728|FG001|Overall Study|Other|0|||
127654625|NCT01933880|459358727|FG000|Overall Study|Protocol Violation|1|||
127654626|NCT01933880|459358728|FG001|Overall Study|Protocol Violation|0|||
127654627|NCT02395133|459358729|FG000|Overall Study|Adverse Event|4|||
127654628|NCT02395133|459358730|FG001|Overall Study|Adverse Event|1|||
127654629|NCT02395133|459358731|FG002|Overall Study|Adverse Event|3|||
127654630|NCT02395133|459358732|FG003|Overall Study|Adverse Event|0|||
127654631|NCT02395133|459358729|FG000|Overall Study|Lack of Efficacy|1|||
127654632|NCT02395133|459358730|FG001|Overall Study|Lack of Efficacy|0|||
127654633|NCT02395133|459358731|FG002|Overall Study|Lack of Efficacy|1|||
127654634|NCT02395133|459358732|FG003|Overall Study|Lack of Efficacy|1|||
127654635|NCT02395133|459358729|FG000|Overall Study|Protocol Violation|1|||
127654636|NCT02395133|459358730|FG001|Overall Study|Protocol Violation|1|||
127654637|NCT02395133|459358731|FG002|Overall Study|Protocol Violation|0|||
127654638|NCT02395133|459358732|FG003|Overall Study|Protocol Violation|3|||
127654639|NCT02395133|459358729|FG000|Overall Study|Lost to Follow-up|0|||
127654640|NCT02395133|459358730|FG001|Overall Study|Lost to Follow-up|1|||
127654641|NCT02395133|459358731|FG002|Overall Study|Lost to Follow-up|1|||
127654642|NCT02395133|459358732|FG003|Overall Study|Lost to Follow-up|0|||
127654643|NCT02395133|459358729|FG000|Overall Study|Pregnancy|0|||
127654644|NCT02395133|459358730|FG001|Overall Study|Pregnancy|0|||
127654645|NCT02395133|459358731|FG002|Overall Study|Pregnancy|3|||
127654646|NCT02395133|459358732|FG003|Overall Study|Pregnancy|0|||
127654647|NCT02395133|459358729|FG000|Overall Study|Consent withdrawn with no reason given|1|||
127654648|NCT02395133|459358730|FG001|Overall Study|Consent withdrawn with no reason given|3|||
127654649|NCT02395133|459358731|FG002|Overall Study|Consent withdrawn with no reason given|0|||
127654650|NCT02395133|459358732|FG003|Overall Study|Consent withdrawn with no reason given|2|||
127654651|NCT02395133|459358729|FG000|Overall Study|Consent withdrawn with personal reason|0|||
127654652|NCT02395133|459358730|FG001|Overall Study|Consent withdrawn with personal reason|1|||
127654653|NCT02395133|459358731|FG002|Overall Study|Consent withdrawn with personal reason|0|||
127654654|NCT02395133|459358732|FG003|Overall Study|Consent withdrawn with personal reason|3|||
127654655|NCT02395133|459358729|FG000|Overall Study|Sponsor decision|2|||
127654656|NCT02395133|459358730|FG001|Overall Study|Sponsor decision|0|||
127654657|NCT02395133|459358731|FG002|Overall Study|Sponsor decision|0|||
127654658|NCT02395133|459358732|FG003|Overall Study|Sponsor decision|1|||
127654659|NCT02395133|459358729|FG000|Overall Study|Other than specified above|5|||
127654660|NCT02395133|459358730|FG001|Overall Study|Other than specified above|2|||
127654661|NCT02395133|459358731|FG002|Overall Study|Other than specified above|2|||
127654662|NCT02395133|459358732|FG003|Overall Study|Other than specified above|4|||
127654663|NCT00962247|459358733|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
127654664|NCT00962247|459358733|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
127654665|NCT00738101|459358739|FG000|Overall Study|Physician Decision|5|||
127654666|NCT00738101|459358739|FG000|Overall Study|Death|1|||
127654667|NCT00738101|459358739|FG000|Overall Study|Repeat enrollment|1|||
127654668|NCT00709059|459358745|FG000|Overall Study|Lost to Follow-up|34|||
127654669|NCT00709059|459358745|FG000|Overall Study|Withdrawal by Subject|19|||
127654670|NCT00709059|459358745|FG000|Overall Study|Physician Decision|7|||
127654671|NCT00709059|459358745|FG000|Overall Study|Disease complication|3|||
127654672|NCT00709059|459358745|FG000|Overall Study|Side effects|20|||
127542936|NCT00976274|458954661|FG001|Overall Study|Lost to Follow-up|5|||
127542937|NCT00976274|458954660|FG000|Overall Study|Withdrawal by Subject|1|||
127542938|NCT00976274|458954661|FG001|Overall Study|Withdrawal by Subject|1|||
127542939|NCT00976274|458954660|FG000|Overall Study|Physician Decision|1|||
127542940|NCT00976274|458954661|FG001|Overall Study|Physician Decision|2|||
127542941|NCT01075243|458954662|FG000|Overall Study|Lost to Follow-up|5|||
127542942|NCT01075243|458954663|FG001|Overall Study|Lost to Follow-up|2|||
127542943|NCT01075243|458954664|FG002|Overall Study|Lost to Follow-up|0|||
127542944|NCT01075243|458954662|FG000|Overall Study|Withdrawal by Subject|1|||
127542945|NCT01075243|458954663|FG001|Overall Study|Withdrawal by Subject|1|||
127542946|NCT01075243|458954664|FG002|Overall Study|Withdrawal by Subject|0|||
127542947|NCT00627393|458954667|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
127542948|NCT00627393|458954668|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
127542949|NCT00627393|458954667|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
127542950|NCT00627393|458954668|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
127542951|NCT00627393|458954667|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
127542952|NCT00627393|458954668|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
127542953|NCT00627393|458954667|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
127542954|NCT00627393|458954668|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
127542955|NCT00004563|458954671|FG000|Overall Study|Withdrawal by Subject|20|||
127542956|NCT00004563|458954672|FG001|Overall Study|Withdrawal by Subject|16|||
127542957|NCT00004563|458954671|FG000|Overall Study|Lack of Efficacy|3|||
127542958|NCT00004563|458954672|FG001|Overall Study|Lack of Efficacy|5|||
127542959|NCT00004563|458954671|FG000|Overall Study|Death|2|||
127542960|NCT00004563|458954672|FG001|Overall Study|Death|3|||
127654673|NCT00709059|459358745|FG000|Overall Study|Serious side effects|11|||
127654674|NCT01786330|459358746|FG000|Overall Study|Withdrawal by Subject|0|||
127654675|NCT01786330|459358747|FG001|Overall Study|Withdrawal by Subject|1|||
127654676|NCT01786330|459358746|FG000|Overall Study|Lost to Follow-up|0|||
127654677|NCT01786330|459358747|FG001|Overall Study|Lost to Follow-up|1|||
127654678|NCT01786330|459358746|FG000|Overall Study|Excluded intraoperatively|0|||
127654679|NCT01786330|459358747|FG001|Overall Study|Excluded intraoperatively|1|||
127654680|NCT01786330|459358746|FG000|Overall Study|Protocol Violation|1|||
127654681|NCT01786330|459358747|FG001|Overall Study|Protocol Violation|0|||
127654682|NCT02969525|459358750|FG000|Double-Blind Period|Adverse Event|0|||
127654683|NCT02969525|459358751|FG001|Double-Blind Period|Adverse Event|0|||
127654684|NCT02969525|459358752|FG002|Double-Blind Period|Adverse Event|1|||
127654685|NCT02969525|459358753|FG003|Double-Blind Period|Adverse Event|1|||
127654686|NCT02969525|459358754|FG004|Double-Blind Period|Adverse Event|0|||
127654687|NCT02969525|459358755|FG005|Double-Blind Period|Adverse Event|0|||
127654688|NCT02969525|459358756|FG006|Double-Blind Period|Adverse Event|0|||
127654689|NCT02969525|459358757|FG007|Double-Blind Period|Adverse Event|0|||
127654690|NCT02969525|459358758|FG008|Double-Blind Period|Adverse Event|0|||
127654691|NCT02969525|459358759|FG009|Double-Blind Period|Adverse Event|0|||
127654692|NCT02969525|459358760|FG010|Double-Blind Period|Adverse Event|0|||
127654693|NCT02969525|459358761|FG011|Double-Blind Period|Adverse Event|0|||
127654694|NCT02969525|459358750|FG000|Double-Blind Period|LOW EGFR|0|||
127654695|NCT02969525|459358751|FG001|Double-Blind Period|LOW EGFR|0|||
127654696|NCT02969525|459358752|FG002|Double-Blind Period|LOW EGFR|0|||
127654697|NCT02969525|459358753|FG003|Double-Blind Period|LOW EGFR|1|||
127654698|NCT02969525|459358754|FG004|Double-Blind Period|LOW EGFR|0|||
127654699|NCT02969525|459358755|FG005|Double-Blind Period|LOW EGFR|0|||
127654700|NCT02969525|459358756|FG006|Double-Blind Period|LOW EGFR|0|||
127654701|NCT02969525|459358757|FG007|Double-Blind Period|LOW EGFR|0|||
127654702|NCT02969525|459358758|FG008|Double-Blind Period|LOW EGFR|0|||
127654703|NCT02969525|459358759|FG009|Double-Blind Period|LOW EGFR|0|||
127654704|NCT02969525|459358760|FG010|Double-Blind Period|LOW EGFR|0|||
127654705|NCT02969525|459358761|FG011|Double-Blind Period|LOW EGFR|0|||
127654706|NCT02969525|459358750|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
127654707|NCT02969525|459358751|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
127654708|NCT02969525|459358752|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
127654709|NCT02969525|459358753|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
127654710|NCT02969525|459358754|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
127654711|NCT02969525|459358755|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
127654712|NCT02969525|459358756|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
127654713|NCT02969525|459358757|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
127654714|NCT02969525|459358758|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
127654715|NCT02969525|459358759|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
127986536|NCT01955109|460574168|FG000|Overall Study|Participant unwilling to continue|35|||
127542961|NCT01056822|458954673|FG000|Overall Study|Adverse Event|0|||
127542962|NCT01056822|458954674|FG001|Overall Study|Adverse Event|1|||
127542963|NCT01056822|458954673|FG000|Overall Study|Protocol Violation|6|||
127542964|NCT01056822|458954674|FG001|Overall Study|Protocol Violation|5|||
127542965|NCT01056822|458954673|FG000|Overall Study|Withdrawal by Subject|1|||
127542966|NCT01056822|458954674|FG001|Overall Study|Withdrawal by Subject|1|||
127542967|NCT01056822|458954673|FG000|Overall Study|Lost to Follow-up|1|||
127542968|NCT01056822|458954674|FG001|Overall Study|Lost to Follow-up|0|||
127542969|NCT00762164|458954679|FG000|Overall Study|Lost to Follow-up|1|||
127542970|NCT00762164|458954680|FG001|Overall Study|Lost to Follow-up|1|||
127542971|NCT00762164|458954679|FG000|Overall Study|Discontinued medication|2|||
127542972|NCT00762164|458954680|FG001|Overall Study|Discontinued medication|0|||
127542973|NCT00762164|458954679|FG000|Overall Study|Withdrawal by Subject|0|||
127542974|NCT00762164|458954680|FG001|Overall Study|Withdrawal by Subject|1|||
127542975|NCT03094416|458954683|FG000|Run-in|Screening failure|8|||
127542976|NCT03094416|458954683|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
127542977|NCT03094416|458954683|FG000|Run-in|Withdrawal by Subject|3|||
127542978|NCT03094416|458954683|FG000|Treatment Period|Withdrawal by Subject|2|||
127542979|NCT04528641|458954685|FG000|Overall Study|Withdrawal by Subject|0|||
127542980|NCT04528641|458954686|FG001|Overall Study|Withdrawal by Subject|0|||
127542981|NCT04528641|458954687|FG002|Overall Study|Withdrawal by Subject|0|||
127542982|NCT04528641|458954688|FG003|Overall Study|Withdrawal by Subject|1|||
127542983|NCT04528641|458954689|FG004|Overall Study|Withdrawal by Subject|0|||
127542984|NCT04528641|458954690|FG005|Overall Study|Withdrawal by Subject|1|||
127542985|NCT04366349|458954691|FG000|Overall Study|Withdrawal by Subject|1|||
127542986|NCT04366349|458954692|FG001|Overall Study|Withdrawal by Subject|0|||
127542987|NCT04366349|458954693|FG002|Overall Study|Withdrawal by Subject|0|||
127542988|NCT04366349|458954694|FG003|Overall Study|Withdrawal by Subject|0|||
127542989|NCT04366349|458954695|FG004|Overall Study|Withdrawal by Subject|0|||
127542990|NCT04366349|458954696|FG005|Overall Study|Withdrawal by Subject|0|||
127654716|NCT02969525|459358760|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
127654717|NCT02969525|459358761|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
127654718|NCT02969525|459358750|FG000|Dose-Blind Period|Adverse Event|0|||
127654719|NCT02969525|459358751|FG001|Dose-Blind Period|Adverse Event|0|||
127654720|NCT02969525|459358752|FG002|Dose-Blind Period|Adverse Event|0|||
127986537|NCT01955109|460574169|FG001|Overall Study|Participant unwilling to continue|7|||
127986538|NCT01955109|460574168|FG000|Overall Study|Physician Decision|2|||
127986539|NCT01955109|460574169|FG001|Overall Study|Physician Decision|0|||
127986540|NCT01955109|460574168|FG000|Overall Study|Lost to Follow-up|3|||
127986541|NCT01955109|460574169|FG001|Overall Study|Lost to Follow-up|1|||
127986542|NCT01955109|460574168|FG000|Overall Study|Non-compliance|3|||
127986543|NCT01955109|460574169|FG001|Overall Study|Non-compliance|1|||
127986544|NCT00369161|460574175|FG000|Overall Study|Adverse Event|15|||
127986545|NCT00369161|460574176|FG001|Overall Study|Adverse Event|13|||
127986546|NCT00369161|460574175|FG000|Overall Study|Abnormal laboratory value|0|||
127986547|NCT00369161|460574176|FG001|Overall Study|Abnormal laboratory value|1|||
127986548|NCT00369161|460574175|FG000|Overall Study|Lack of Efficacy|3|||
127986549|NCT00369161|460574176|FG001|Overall Study|Lack of Efficacy|1|||
127986550|NCT00369161|460574175|FG000|Overall Study|Protocol Violation|0|||
127986551|NCT00369161|460574176|FG001|Overall Study|Protocol Violation|2|||
127986552|NCT00369161|460574175|FG000|Overall Study|Withdrawal by Subject|2|||
127986553|NCT00369161|460574176|FG001|Overall Study|Withdrawal by Subject|3|||
127986554|NCT00369161|460574175|FG000|Overall Study|Death|1|||
127986555|NCT00369161|460574176|FG001|Overall Study|Death|2|||
127986556|NCT00369161|460574175|FG000|Overall Study|Graft loss|4|||
127654721|NCT02969525|459358753|FG003|Dose-Blind Period|Adverse Event|0|||
127654722|NCT02969525|459358754|FG004|Dose-Blind Period|Adverse Event|0|||
127654723|NCT02969525|459358755|FG005|Dose-Blind Period|Adverse Event|0|||
127654724|NCT02969525|459358756|FG006|Dose-Blind Period|Adverse Event|0|||
127654725|NCT02969525|459358757|FG007|Dose-Blind Period|Adverse Event|0|||
127654726|NCT02969525|459358758|FG008|Dose-Blind Period|Adverse Event|0|||
127654727|NCT02969525|459358759|FG009|Dose-Blind Period|Adverse Event|1|||
127654728|NCT02969525|459358760|FG010|Dose-Blind Period|Adverse Event|1|||
127654729|NCT02969525|459358761|FG011|Dose-Blind Period|Adverse Event|1|||
127654730|NCT02969525|459358750|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
127654731|NCT02969525|459358751|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
127654732|NCT02969525|459358752|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
127654733|NCT02969525|459358753|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
127654734|NCT02969525|459358754|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
127654735|NCT02969525|459358755|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
127654736|NCT02969525|459358756|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
127654737|NCT02969525|459358757|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
127654738|NCT02969525|459358758|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
127654739|NCT02969525|459358759|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
127654740|NCT02969525|459358760|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
127654741|NCT02969525|459358761|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
127654742|NCT02969525|459358750|FG000|Dose-Blind Period|Non-cooperating patient|0|||
127654743|NCT02969525|459358751|FG001|Dose-Blind Period|Non-cooperating patient|0|||
127654744|NCT02969525|459358752|FG002|Dose-Blind Period|Non-cooperating patient|0|||
127654745|NCT02969525|459358753|FG003|Dose-Blind Period|Non-cooperating patient|0|||
127654746|NCT02969525|459358754|FG004|Dose-Blind Period|Non-cooperating patient|0|||
127654747|NCT02969525|459358755|FG005|Dose-Blind Period|Non-cooperating patient|0|||
127654748|NCT02969525|459358756|FG006|Dose-Blind Period|Non-cooperating patient|0|||
127654749|NCT02969525|459358757|FG007|Dose-Blind Period|Non-cooperating patient|0|||
127654750|NCT02969525|459358758|FG008|Dose-Blind Period|Non-cooperating patient|0|||
127654751|NCT02969525|459358759|FG009|Dose-Blind Period|Non-cooperating patient|0|||
127654752|NCT02969525|459358760|FG010|Dose-Blind Period|Non-cooperating patient|0|||
127654753|NCT02969525|459358761|FG011|Dose-Blind Period|Non-cooperating patient|1|||
127654754|NCT02969525|459358750|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
127654755|NCT02969525|459358751|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
127654756|NCT02969525|459358752|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
127654757|NCT02969525|459358753|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
127654758|NCT02969525|459358754|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
127654759|NCT02969525|459358755|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
127654760|NCT02969525|459358756|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
127654761|NCT02969525|459358757|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
127654762|NCT02969525|459358758|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
127654763|NCT02969525|459358759|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
127654764|NCT02969525|459358760|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
127654765|NCT02969525|459358761|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
127654766|NCT02172625|459358762|FG000|Overall Study|Adverse Event|0|||
127986557|NCT00369161|460574176|FG001|Overall Study|Graft loss|0|||
127986558|NCT00369161|460574175|FG000|Overall Study|Administrative Problem|2|||
127986559|NCT00369161|460574176|FG001|Overall Study|Administrative Problem|2|||
127986560|NCT00750919|460574177|FG000|Overall Study|Adverse Event|9|||
127654767|NCT02172625|459358763|FG001|Overall Study|Adverse Event|1|||
127654768|NCT02172625|459358762|FG000|Overall Study|Pregnancy|0|||
127654769|NCT02172625|459358763|FG001|Overall Study|Pregnancy|1|||
127654770|NCT02172625|459358762|FG000|Overall Study|car accident|0|||
127654771|NCT02172625|459358763|FG001|Overall Study|car accident|1|||
127654772|NCT00524030|459358764|FG000|Overall Study|Lack of Efficacy|10|||
127654773|NCT00524030|459358765|FG001|Overall Study|Lack of Efficacy|24|||
127654774|NCT00524030|459358764|FG000|Overall Study|Lost to Follow-up|0|||
127654775|NCT00524030|459358765|FG001|Overall Study|Lost to Follow-up|2|||
127654776|NCT00524030|459358764|FG000|Overall Study|Withdrawal by Subject|3|||
127654777|NCT00524030|459358765|FG001|Overall Study|Withdrawal by Subject|8|||
127654778|NCT00524030|459358764|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
127654779|NCT00524030|459358765|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
127654780|NCT00524030|459358764|FG000|Overall Study|Protocol Violation|0|||
127654781|NCT00524030|459358765|FG001|Overall Study|Protocol Violation|1|||
127654782|NCT00524030|459358764|FG000|Overall Study|Pregnancy|1|||
127654783|NCT00524030|459358765|FG001|Overall Study|Pregnancy|0|||
127654784|NCT00524030|459358764|FG000|Overall Study|Adverse Event|3|||
127654785|NCT00524030|459358765|FG001|Overall Study|Adverse Event|21|||
127654786|NCT00524030|459358764|FG000|Overall Study|Death|0|||
127654787|NCT00524030|459358765|FG001|Overall Study|Death|1|||
127654788|NCT02392611|459360178|FG000|Overall Study|Adverse Event|0|||
127654789|NCT02392611|459360179|FG001|Overall Study|Adverse Event|0|||
127654790|NCT02392611|459360180|FG002|Overall Study|Adverse Event|0|||
127654791|NCT02392611|459360181|FG003|Overall Study|Adverse Event|1|||
127654792|NCT02392611|459360182|FG004|Overall Study|Adverse Event|0|||
127654793|NCT02392611|459360183|FG005|Overall Study|Adverse Event|0|||
127654794|NCT02392611|459360184|FG006|Overall Study|Adverse Event|0|||
127654795|NCT02392611|459360185|FG007|Overall Study|Adverse Event|0|||
127654796|NCT02392611|459360186|FG008|Overall Study|Adverse Event|0|||
127654797|NCT02392611|459360178|FG000|Overall Study|Progressive disease|0|||
127654798|NCT02392611|459360179|FG001|Overall Study|Progressive disease|0|||
127654799|NCT02392611|459360180|FG002|Overall Study|Progressive disease|0|||
127654800|NCT02392611|459360181|FG003|Overall Study|Progressive disease|2|||
127654801|NCT02392611|459360182|FG004|Overall Study|Progressive disease|1|||
127654802|NCT02392611|459360183|FG005|Overall Study|Progressive disease|0|||
127654803|NCT02392611|459360184|FG006|Overall Study|Progressive disease|0|||
127654804|NCT02392611|459360185|FG007|Overall Study|Progressive disease|0|||
127654805|NCT02392611|459360186|FG008|Overall Study|Progressive disease|0|||
127654806|NCT02392611|459360178|FG000|Overall Study|Death|1|||
127654807|NCT02392611|459360179|FG001|Overall Study|Death|0|||
127654808|NCT02392611|459360180|FG002|Overall Study|Death|0|||
127654809|NCT02392611|459360181|FG003|Overall Study|Death|0|||
127654810|NCT02392611|459360182|FG004|Overall Study|Death|0|||
127654811|NCT02392611|459360183|FG005|Overall Study|Death|1|||
127654812|NCT02392611|459360184|FG006|Overall Study|Death|0|||
127654813|NCT02392611|459360185|FG007|Overall Study|Death|0|||
127654814|NCT02392611|459360186|FG008|Overall Study|Death|0|||
127654815|NCT02392611|459360178|FG000|Overall Study|Withdrawal by Subject|0|||
127654816|NCT02392611|459360179|FG001|Overall Study|Withdrawal by Subject|0|||
127654817|NCT02392611|459360180|FG002|Overall Study|Withdrawal by Subject|0|||
127654818|NCT02392611|459360181|FG003|Overall Study|Withdrawal by Subject|1|||
127654819|NCT02392611|459360182|FG004|Overall Study|Withdrawal by Subject|0|||
127654820|NCT02392611|459360183|FG005|Overall Study|Withdrawal by Subject|0|||
127654821|NCT02392611|459360184|FG006|Overall Study|Withdrawal by Subject|0|||
127654822|NCT02392611|459360185|FG007|Overall Study|Withdrawal by Subject|0|||
127654823|NCT02392611|459360186|FG008|Overall Study|Withdrawal by Subject|0|||
127654824|NCT02392611|459360178|FG000|Overall Study|Lost to Follow-up|0|||
127654825|NCT02392611|459360179|FG001|Overall Study|Lost to Follow-up|0|||
127654826|NCT02392611|459360180|FG002|Overall Study|Lost to Follow-up|0|||
127654827|NCT02392611|459360181|FG003|Overall Study|Lost to Follow-up|0|||
127654828|NCT02392611|459360182|FG004|Overall Study|Lost to Follow-up|0|||
127654829|NCT02392611|459360183|FG005|Overall Study|Lost to Follow-up|0|||
127654830|NCT02392611|459360184|FG006|Overall Study|Lost to Follow-up|1|||
127654831|NCT02392611|459360185|FG007|Overall Study|Lost to Follow-up|0|||
127654832|NCT02392611|459360186|FG008|Overall Study|Lost to Follow-up|0|||
127654833|NCT02392611|459360178|FG000|Overall Study|Enrolled, not treated|0|||
127654834|NCT02392611|459360179|FG001|Overall Study|Enrolled, not treated|0|||
127654835|NCT02392611|459360180|FG002|Overall Study|Enrolled, not treated|0|||
127654836|NCT02392611|459360181|FG003|Overall Study|Enrolled, not treated|2|||
127654837|NCT02392611|459360182|FG004|Overall Study|Enrolled, not treated|0|||
127654838|NCT02392611|459360183|FG005|Overall Study|Enrolled, not treated|0|||
127654839|NCT02392611|459360184|FG006|Overall Study|Enrolled, not treated|0|||
127654840|NCT02392611|459360185|FG007|Overall Study|Enrolled, not treated|0|||
127654841|NCT02392611|459360186|FG008|Overall Study|Enrolled, not treated|0|||
127654842|NCT03585296|459360200|FG000|Overall Study|Adverse Event|1|||
127654843|NCT03585296|459360200|FG000|Overall Study|Lost to Follow-up|2|||
127654844|NCT03585296|459360200|FG000|Overall Study|Withdrawal by Subject|2|||
127654845|NCT00462670|459360201|FG000|Overall Study|Adverse Event|3|||
127654846|NCT00462670|459360202|FG001|Overall Study|Adverse Event|5|||
127654847|NCT00462670|459360201|FG000|Overall Study|Lack of Efficacy|1|||
127986561|NCT00750919|460574177|FG000|Overall Study|Withdrawal by Subject|1|||
127986562|NCT00750919|460574177|FG000|Overall Study|Lack of Efficacy|8|||
127986563|NCT00750919|460574177|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
127986564|NCT00750919|460574177|FG000|Overall Study|Other|36|||
127986565|NCT02147067|460574180|FG000|Overall Study|Withdrawal by Subject|2|||
127654848|NCT00462670|459360202|FG001|Overall Study|Lack of Efficacy|0|||
127654849|NCT00462670|459360201|FG000|Overall Study|Protocol Violation|1|||
127654850|NCT00462670|459360202|FG001|Overall Study|Protocol Violation|0|||
127654851|NCT00462670|459360201|FG000|Overall Study|Resolution of signs and symptoms|0|||
127654852|NCT00462670|459360202|FG001|Overall Study|Resolution of signs and symptoms|2|||
127654853|NCT02110732|459360203|FG000|Overall Study|Physician Decision|5|||
127654854|NCT02110732|459360204|FG001|Overall Study|Physician Decision|2|||
127542991|NCT03341299|458954697|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
127542992|NCT03341299|458954698|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
127542993|NCT03341299|458954699|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
127542994|NCT03341299|458954700|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
127542995|NCT02018562|458954704|FG000|Overall Study|Withdrawal by Subject|2|||
127542996|NCT02018562|458954705|FG001|Overall Study|Withdrawal by Subject|0|||
127542997|NCT02018562|458954704|FG000|Overall Study|Discharged prior to study completion|1|||
127542998|NCT02018562|458954705|FG001|Overall Study|Discharged prior to study completion|0|||
127542999|NCT05194124|458954707|FG000|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
127543000|NCT05194124|458954708|FG001|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
127543001|NCT05194124|458954709|FG002|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
127543002|NCT05194124|458954710|FG003|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|1|||
127543003|NCT05194124|458954711|FG004|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
127543004|NCT05194124|458954712|FG005|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|2|||
127543005|NCT05194124|458954713|FG006|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
127543006|NCT05194124|458954714|FG007|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
127543007|NCT05194124|458954715|FG008|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
127543008|NCT05194124|458954716|FG009|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
127543009|NCT05194124|458954707|FG000|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
127543010|NCT05194124|458954708|FG001|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
127543011|NCT05194124|458954709|FG002|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
127543012|NCT05194124|458954710|FG003|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
127543013|NCT05194124|458954711|FG004|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
127543014|NCT05194124|458954712|FG005|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
127543015|NCT05194124|458954713|FG006|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
127543016|NCT05194124|458954714|FG007|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
127543017|NCT05194124|458954715|FG008|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
127543018|NCT05194124|458954716|FG009|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|1|||
127543019|NCT04609319|458954717|FG000|Overall Study|Death|64|||
127543020|NCT04609319|458954718|FG001|Overall Study|Death|49|||
127543021|NCT04609319|458954719|FG002|Overall Study|Death|1|||
127543022|NCT04609319|458954717|FG000|Overall Study|Withdrawal of consent|15|||
127543023|NCT04609319|458954718|FG001|Overall Study|Withdrawal of consent|3|||
127543024|NCT04609319|458954719|FG002|Overall Study|Withdrawal of consent|0|||
127543025|NCT04609319|458954717|FG000|Overall Study|Lost to Follow-up|20|||
127543026|NCT04609319|458954718|FG001|Overall Study|Lost to Follow-up|33|||
127543027|NCT04609319|458954719|FG002|Overall Study|Lost to Follow-up|0|||
127543028|NCT04609319|458954717|FG000|Overall Study|Alive until end of follow-up|60|||
127543029|NCT04609319|458954718|FG001|Overall Study|Alive until end of follow-up|53|||
127543030|NCT04609319|458954719|FG002|Overall Study|Alive until end of follow-up|1|||
127543031|NCT03474588|458954720|FG000|Overall Study|Withdrawal by Subject|4|||
127543032|NCT03474588|458954721|FG001|Overall Study|Withdrawal by Subject|3|||
127543033|NCT03474588|458954720|FG000|Overall Study|Death|0|||
127543034|NCT03474588|458954721|FG001|Overall Study|Death|1|||
127543035|NCT03804528|458954723|FG000|Overall Study|Time Commitment|18|||
127543036|NCT03804528|458954723|FG000|Overall Study|Health Reasons|5|||
127543037|NCT01607957|458954724|FG000|Overall Study|Not treated|1|||
127543038|NCT01607957|458954725|FG001|Overall Study|Not treated|1|||
127543039|NCT01607957|458954724|FG000|Overall Study|Death|367|||
127543040|NCT01607957|458954725|FG001|Overall Study|Death|211|||
127543041|NCT01607957|458954724|FG000|Overall Study|Lost to Follow-up|3|||
127543042|NCT01607957|458954725|FG001|Overall Study|Lost to Follow-up|3|||
127543043|NCT01607957|458954724|FG000|Overall Study|Participant refusal|1|||
127543044|NCT01607957|458954725|FG001|Overall Study|Participant refusal|0|||
127543045|NCT00945009|458954732|FG000|Overall Study|Lack of Efficacy|10|||
127543046|NCT00945009|458954733|FG001|Overall Study|Lack of Efficacy|0|||
127543047|NCT00945009|458954734|FG002|Overall Study|Lack of Efficacy|0|||
127543048|NCT00945009|458954732|FG000|Overall Study|Physician Decision|21|||
127543049|NCT00945009|458954733|FG001|Overall Study|Physician Decision|4|||
127986566|NCT02147067|460574181|FG001|Overall Study|Withdrawal by Subject|2|||
127986567|NCT01404949|460574182|FG000|Overall Study|Not Treated|1|||
127654855|NCT02110732|459360203|FG000|Overall Study|Lost to Follow-up|1|||
127654856|NCT02110732|459360204|FG001|Overall Study|Lost to Follow-up|1|||
127654857|NCT00633932|459360205|FG000|Overall Study|Adverse Event|1|||
127654858|NCT00633932|459360206|FG001|Overall Study|Adverse Event|3|||
127654859|NCT00633932|459360207|FG002|Overall Study|Adverse Event|4|||
127654860|NCT00633932|459360205|FG000|Overall Study|Withdrawal by Subject|3|||
127654861|NCT00633932|459360206|FG001|Overall Study|Withdrawal by Subject|9|||
127654862|NCT00633932|459360207|FG002|Overall Study|Withdrawal by Subject|1|||
127654863|NCT00633932|459360205|FG000|Overall Study|Lost to Follow-up|1|||
127654864|NCT00633932|459360206|FG001|Overall Study|Lost to Follow-up|0|||
127654865|NCT00633932|459360207|FG002|Overall Study|Lost to Follow-up|2|||
127654866|NCT00633932|459360205|FG000|Overall Study|Protocol Violation|5|||
127654867|NCT00633932|459360206|FG001|Overall Study|Protocol Violation|2|||
127654868|NCT00633932|459360207|FG002|Overall Study|Protocol Violation|3|||
127654869|NCT00633932|459360205|FG000|Overall Study|Physician Decision|0|||
127654870|NCT00633932|459360206|FG001|Overall Study|Physician Decision|0|||
127654871|NCT00633932|459360207|FG002|Overall Study|Physician Decision|1|||
127654872|NCT00633932|459360205|FG000|Overall Study|Doctor's judgement|1|||
127654873|NCT00633932|459360206|FG001|Overall Study|Doctor's judgement|0|||
127654874|NCT00633932|459360207|FG002|Overall Study|Doctor's judgement|0|||
127654875|NCT00633932|459360205|FG000|Overall Study|Moved Away|1|||
127654876|NCT00633932|459360206|FG001|Overall Study|Moved Away|0|||
127654877|NCT00633932|459360207|FG002|Overall Study|Moved Away|0|||
127654878|NCT00482274|459360208|FG000|Overall Study|Adverse Event|1|||
127654879|NCT04836858|459360209|FG000|Overall Study|Adverse Event|0|||
127654880|NCT04836858|459360210|FG001|Overall Study|Adverse Event|0|||
127654881|NCT04836858|459360211|FG002|Overall Study|Adverse Event|0|||
127654882|NCT04836858|459360212|FG003|Overall Study|Adverse Event|1|||
127654883|NCT04836858|459360209|FG000|Overall Study|Lost to Follow-up|1|||
127654884|NCT04836858|459360210|FG001|Overall Study|Lost to Follow-up|0|||
127654885|NCT04836858|459360211|FG002|Overall Study|Lost to Follow-up|0|||
127654886|NCT04836858|459360212|FG003|Overall Study|Lost to Follow-up|0|||
127654887|NCT04836858|459360209|FG000|Overall Study|Subject/Guardian decision|3|||
127654888|NCT04836858|459360210|FG001|Overall Study|Subject/Guardian decision|0|||
127654889|NCT04836858|459360211|FG002|Overall Study|Subject/Guardian decision|0|||
127654890|NCT04836858|459360212|FG003|Overall Study|Subject/Guardian decision|1|||
127654891|NCT04836858|459360209|FG000|Overall Study|Randomized but not treated|4|||
127654892|NCT04836858|459360210|FG001|Overall Study|Randomized but not treated|0|||
127654893|NCT04836858|459360211|FG002|Overall Study|Randomized but not treated|0|||
127654894|NCT04836858|459360212|FG003|Overall Study|Randomized but not treated|0|||
127654895|NCT02948959|459360213|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
127654896|NCT02948959|459360214|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
127654897|NCT02948959|459360213|FG000|52 Weeks Treatment Period|Adverse Event|2|||
127654898|NCT02948959|459360214|FG001|52 Weeks Treatment Period|Adverse Event|5|||
127654899|NCT02948959|459360213|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
127654900|NCT02948959|459360214|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
127654901|NCT02948959|459360213|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
127654902|NCT02948959|459360214|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
127654903|NCT02948959|459360213|FG000|52 Weeks Treatment Period|Randomized by error|0|||
127654904|NCT02948959|459360214|FG001|52 Weeks Treatment Period|Randomized by error|5|||
127654905|NCT02948959|459360213|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
127654906|NCT02948959|459360214|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
127654907|NCT02948959|459360213|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
127654908|NCT02948959|459360214|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
127654909|NCT02948959|459360213|FG000|52 Weeks Treatment Period|Change of residence location|0|||
127654910|NCT02948959|459360214|FG001|52 Weeks Treatment Period|Change of residence location|1|||
127654911|NCT02948959|459360213|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
127654912|NCT02948959|459360214|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
127654913|NCT02948959|459360213|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
127654914|NCT02948959|459360214|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
127654915|NCT02948959|459360213|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
127654916|NCT02948959|459360214|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
127654917|NCT02948959|459360213|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
127654918|NCT02948959|459360214|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
127654919|NCT02948959|459360213|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
127654920|NCT02948959|459360214|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
127654921|NCT02948959|459360213|FG000|12 Weeks Follow-up Period|Study site closure|1|||
127654922|NCT02948959|459360214|FG001|12 Weeks Follow-up Period|Study site closure|0|||
127654923|NCT00597714|459360217|FG000|Overall Study|Death|56|||
127654924|NCT00597714|459360218|FG001|Overall Study|Death|46|||
127654925|NCT00597714|459360219|FG002|Overall Study|Death|0|||
127654926|NCT00597714|459360217|FG000|Overall Study|Recipient death|0|||
127654927|NCT00597714|459360218|FG001|Overall Study|Recipient death|0|||
127654928|NCT00597714|459360219|FG002|Overall Study|Recipient death|10|||
127654929|NCT01350141|459360220|FG000|Overall Study|Lost to Follow-up|1|||
127986568|NCT01017601|460574185|FG000|Overall Study|Disease Progression|12|||
127986569|NCT01017601|460574186|FG001|Overall Study|Disease Progression|12|||
127986570|NCT01017601|460574185|FG000|Overall Study|Withdrawal by Subject|0|||
127986571|NCT01017601|460574186|FG001|Overall Study|Withdrawal by Subject|1|||
127986572|NCT00574795|460574192|FG000|Infant Series|Withdrawal by Subject|2|||
127986573|NCT00574795|460574192|FG000|Infant Series|Protocol Violation|2|||
127986574|NCT00574795|460574192|FG000|Infant Series|Adverse Event|1|||
127986575|NCT00574795|460574192|FG000|After Infant Series|Withdrawal by Subject|1|||
127986576|NCT00574795|460574192|FG000|After Infant Series|Adverse Event|2|||
127986577|NCT00574795|460574192|FG000|Toddler Dose|Withdrawal by Subject|1|||
127986578|NCT02638259|460574193|FG000|Treatment Period 1|Adverse Event|1|||
127986579|NCT02638259|460574194|FG001|Treatment Period 1|Adverse Event|5|||
127986580|NCT02638259|460574193|FG000|Treatment Period 1|Death|0|||
127986581|NCT02638259|460574194|FG001|Treatment Period 1|Death|1|||
127986582|NCT02638259|460574193|FG000|Treatment Period 1|Lack of Efficacy|0|||
127986583|NCT02638259|460574194|FG001|Treatment Period 1|Lack of Efficacy|1|||
127986584|NCT02638259|460574193|FG000|Treatment Period 1|Protocol Violation|0|||
127986585|NCT02638259|460574194|FG001|Treatment Period 1|Protocol Violation|3|||
127986586|NCT02638259|460574193|FG000|Treatment Period 1|Withdrawal by Subject|4|||
127986587|NCT02638259|460574194|FG001|Treatment Period 1|Withdrawal by Subject|6|||
127986588|NCT02638259|460574193|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
127986589|NCT02638259|460574194|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
127986590|NCT02638259|460574193|FG000|Treatment Period 2|Adverse Event|5|||
127986591|NCT02638259|460574194|FG001|Treatment Period 2|Adverse Event|4|||
127986592|NCT02638259|460574193|FG000|Treatment Period 2|Withdrawal by Subject|1|||
127986593|NCT02638259|460574194|FG001|Treatment Period 2|Withdrawal by Subject|7|||
127986594|NCT01706575|460574195|FG000|Overall Study|Participant Withdrew Consent|4|||
127986595|NCT01706575|460574195|FG000|Overall Study|Lost to Follow-up|2|||
127986596|NCT01706575|460574195|FG000|Overall Study|Started but not Treated|6|||
127986597|NCT01094782|460574196|FG000|Overall Study|Withdrawal by Subject|5|||
127986598|NCT01094782|460574197|FG001|Overall Study|Withdrawal by Subject|5|||
127986599|NCT01094782|460574198|FG002|Overall Study|Withdrawal by Subject|1|||
127986600|NCT01094782|460574199|FG003|Overall Study|Withdrawal by Subject|5|||
127986601|NCT01094782|460574200|FG004|Overall Study|Withdrawal by Subject|5|||
127986602|NCT01094782|460574201|FG005|Overall Study|Withdrawal by Subject|0|||
127986603|NCT01094782|460574196|FG000|Overall Study|Lost to Follow-up|1|||
127986604|NCT01094782|460574197|FG001|Overall Study|Lost to Follow-up|0|||
127986605|NCT01094782|460574198|FG002|Overall Study|Lost to Follow-up|0|||
127986606|NCT01094782|460574199|FG003|Overall Study|Lost to Follow-up|2|||
127986607|NCT01094782|460574200|FG004|Overall Study|Lost to Follow-up|1|||
127986608|NCT01094782|460574201|FG005|Overall Study|Lost to Follow-up|4|||
127986609|NCT01094782|460574196|FG000|Overall Study|Positive Drug Screen|2|||
127986610|NCT01094782|460574197|FG001|Overall Study|Positive Drug Screen|2|||
127986611|NCT01094782|460574198|FG002|Overall Study|Positive Drug Screen|1|||
127986612|NCT01094782|460574199|FG003|Overall Study|Positive Drug Screen|1|||
127986613|NCT01094782|460574200|FG004|Overall Study|Positive Drug Screen|3|||
127986614|NCT01094782|460574201|FG005|Overall Study|Positive Drug Screen|2|||
127986615|NCT01094782|460574196|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
127986616|NCT01094782|460574197|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
127986617|NCT01094782|460574198|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
127986618|NCT01094782|460574199|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
127986619|NCT01094782|460574200|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
127986620|NCT01094782|460574201|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
127986621|NCT01094782|460574196|FG000|Overall Study|Unable to Complete Questionnaires|0|||
127986622|NCT01094782|460574197|FG001|Overall Study|Unable to Complete Questionnaires|1|||
127986623|NCT01094782|460574198|FG002|Overall Study|Unable to Complete Questionnaires|0|||
127986624|NCT01094782|460574199|FG003|Overall Study|Unable to Complete Questionnaires|0|||
127986625|NCT01094782|460574200|FG004|Overall Study|Unable to Complete Questionnaires|0|||
127986626|NCT01094782|460574201|FG005|Overall Study|Unable to Complete Questionnaires|0|||
127986627|NCT01094782|460574196|FG000|Overall Study|Healthy Subject Had Pain|0|||
127654930|NCT01350141|459360221|FG001|Overall Study|Lost to Follow-up|0|||
127986628|NCT01094782|460574197|FG001|Overall Study|Healthy Subject Had Pain|1|||
127986629|NCT01094782|460574198|FG002|Overall Study|Healthy Subject Had Pain|0|||
127986630|NCT01094782|460574199|FG003|Overall Study|Healthy Subject Had Pain|0|||
127986631|NCT01094782|460574200|FG004|Overall Study|Healthy Subject Had Pain|0|||
127654931|NCT01350141|459360222|FG002|Overall Study|Lost to Follow-up|1|||
127986632|NCT01094782|460574201|FG005|Overall Study|Healthy Subject Had Pain|0|||
127986633|NCT01094782|460574196|FG000|Overall Study|Hypertension|0|||
127986634|NCT01094782|460574197|FG001|Overall Study|Hypertension|0|||
127986635|NCT01094782|460574198|FG002|Overall Study|Hypertension|1|||
127986636|NCT01094782|460574199|FG003|Overall Study|Hypertension|0|||
127986637|NCT01094782|460574200|FG004|Overall Study|Hypertension|0|||
127986638|NCT01094782|460574201|FG005|Overall Study|Hypertension|0|||
127986639|NCT01094782|460574196|FG000|Overall Study|Wrong Pain Condition|0|||
127986640|NCT01094782|460574197|FG001|Overall Study|Wrong Pain Condition|0|||
127986641|NCT01094782|460574198|FG002|Overall Study|Wrong Pain Condition|0|||
127654932|NCT01350141|459360220|FG000|Overall Study|Withdrawal by Subject|1|||
127654933|NCT01350141|459360221|FG001|Overall Study|Withdrawal by Subject|0|||
127654934|NCT01350141|459360222|FG002|Overall Study|Withdrawal by Subject|0|||
127654935|NCT01350141|459360220|FG000|Overall Study|Randomized but not treated|1|||
127654936|NCT01350141|459360221|FG001|Overall Study|Randomized but not treated|0|||
127654937|NCT01350141|459360222|FG002|Overall Study|Randomized but not treated|0|||
127654938|NCT00519896|459360223|FG000|Overall Study|Protocol Violation|1|||
127654939|NCT00519896|459360223|FG000|Overall Study|Adverse Event|1|||
127654940|NCT00810082|459360224|FG000|Overall Study|Lost to Follow-up|0|||
127654941|NCT00810082|459360225|FG001|Overall Study|Lost to Follow-up|4|||
127654942|NCT01588990|459360226|FG000|Phase A|Withdrawal by Subject|5|||
127654943|NCT01588990|459360226|FG000|Phase A|Physician Decision|11|||
127654944|NCT01588990|459360226|FG000|Phase A|Other|14|||
127654945|NCT01588990|459360226|FG000|Phase A|Lost to Follow-up|1|||
127654946|NCT01588990|459360226|FG000|Phase A|Death|5|||
127654947|NCT01588990|459360226|FG000|Phase A|Adverse Event|28|||
127654948|NCT01588990|459360226|FG000|Phase A|Still on therapy at end of study|6|||
127654949|NCT01588990|459360226|FG000|Phase B|Adverse Event|2|||
127654950|NCT01588990|459360226|FG000|Phase B|Still on therapy at end of study|5|||
127654951|NCT01588990|459360226|FG000|Phase B|Withdrawal by Subject|3|||
127654952|NCT01588990|459360226|FG000|Phase B|Physician Decision|4|||
127654953|NCT01588990|459360226|FG000|Phase B|Other|2|||
127654954|NCT02367716|459360231|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
127654955|NCT02508532|459360232|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
127654956|NCT02508532|459360233|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
127654957|NCT02508532|459360234|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
127654958|NCT02508532|459360235|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
127654959|NCT02508532|459360236|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
127654960|NCT02508532|459360237|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
127986642|NCT01094782|460574199|FG003|Overall Study|Wrong Pain Condition|2|||
127986643|NCT01094782|460574200|FG004|Overall Study|Wrong Pain Condition|1|||
127986644|NCT01094782|460574201|FG005|Overall Study|Wrong Pain Condition|1|||
127654961|NCT02508532|459360238|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
127654962|NCT02508532|459360239|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
127654963|NCT02508532|459360240|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
127654964|NCT02508532|459360232|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
127654965|NCT02508532|459360233|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
127654966|NCT02508532|459360234|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
127654967|NCT02508532|459360235|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
127654968|NCT02508532|459360236|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
127654969|NCT02508532|459360237|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
127654970|NCT02508532|459360238|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
127654971|NCT02508532|459360239|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
127654972|NCT02508532|459360240|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
127654973|NCT02508532|459360232|FG000|Part 2 - Treatment|Disease Progression|0|||
127654974|NCT02508532|459360233|FG001|Part 2 - Treatment|Disease Progression|0|||
127654975|NCT02508532|459360234|FG002|Part 2 - Treatment|Disease Progression|0|||
127654976|NCT02508532|459360235|FG003|Part 2 - Treatment|Disease Progression|0|||
127654977|NCT02508532|459360236|FG004|Part 2 - Treatment|Disease Progression|0|||
127654978|NCT02508532|459360237|FG005|Part 2 - Treatment|Disease Progression|0|||
127654979|NCT02508532|459360238|FG006|Part 2 - Treatment|Disease Progression|0|||
127654980|NCT02508532|459360239|FG007|Part 2 - Treatment|Disease Progression|0|||
127654981|NCT02508532|459360240|FG008|Part 2 - Treatment|Disease Progression|118|||
127654982|NCT02508532|459360232|FG000|Part 2 - Treatment|Adverse Event|0|||
127654983|NCT02508532|459360233|FG001|Part 2 - Treatment|Adverse Event|0|||
127654984|NCT02508532|459360234|FG002|Part 2 - Treatment|Adverse Event|0|||
127654985|NCT02508532|459360235|FG003|Part 2 - Treatment|Adverse Event|0|||
127654986|NCT02508532|459360236|FG004|Part 2 - Treatment|Adverse Event|0|||
127654987|NCT02508532|459360237|FG005|Part 2 - Treatment|Adverse Event|0|||
127654988|NCT02508532|459360238|FG006|Part 2 - Treatment|Adverse Event|0|||
127654989|NCT02508532|459360239|FG007|Part 2 - Treatment|Adverse Event|0|||
127986645|NCT01094782|460574196|FG000|Overall Study|Recent Interventional Injection|0|||
127654990|NCT02508532|459360240|FG008|Part 2 - Treatment|Adverse Event|49|||
127654991|NCT02508532|459360232|FG000|Part 2 - Treatment|Physician Decision|0|||
127654992|NCT02508532|459360233|FG001|Part 2 - Treatment|Physician Decision|0|||
127654993|NCT02508532|459360234|FG002|Part 2 - Treatment|Physician Decision|0|||
127654994|NCT02508532|459360235|FG003|Part 2 - Treatment|Physician Decision|0|||
127654995|NCT02508532|459360236|FG004|Part 2 - Treatment|Physician Decision|0|||
127654996|NCT02508532|459360237|FG005|Part 2 - Treatment|Physician Decision|0|||
127654997|NCT02508532|459360238|FG006|Part 2 - Treatment|Physician Decision|0|||
127986646|NCT01094782|460574197|FG001|Overall Study|Recent Interventional Injection|0|||
127986647|NCT01094782|460574198|FG002|Overall Study|Recent Interventional Injection|0|||
127654998|NCT02508532|459360239|FG007|Part 2 - Treatment|Physician Decision|0|||
127986648|NCT01094782|460574199|FG003|Overall Study|Recent Interventional Injection|0|||
127654999|NCT02508532|459360240|FG008|Part 2 - Treatment|Physician Decision|12|||
127655000|NCT02508532|459360232|FG000|Part 2 - Treatment|Administrative|0|||
127655001|NCT02508532|459360233|FG001|Part 2 - Treatment|Administrative|0|||
127655002|NCT02508532|459360234|FG002|Part 2 - Treatment|Administrative|0|||
127655003|NCT02508532|459360235|FG003|Part 2 - Treatment|Administrative|0|||
127655004|NCT02508532|459360236|FG004|Part 2 - Treatment|Administrative|0|||
127655005|NCT02508532|459360237|FG005|Part 2 - Treatment|Administrative|0|||
127655006|NCT02508532|459360238|FG006|Part 2 - Treatment|Administrative|0|||
127655007|NCT02508532|459360239|FG007|Part 2 - Treatment|Administrative|0|||
127655008|NCT02508532|459360240|FG008|Part 2 - Treatment|Administrative|3|||
127655009|NCT02508532|459360232|FG000|Part 2 - Treatment|Sponsor Decision|0|||
127655010|NCT02508532|459360233|FG001|Part 2 - Treatment|Sponsor Decision|0|||
127655011|NCT02508532|459360234|FG002|Part 2 - Treatment|Sponsor Decision|0|||
127655012|NCT02508532|459360235|FG003|Part 2 - Treatment|Sponsor Decision|0|||
127655013|NCT02508532|459360236|FG004|Part 2 - Treatment|Sponsor Decision|0|||
127655014|NCT02508532|459360237|FG005|Part 2 - Treatment|Sponsor Decision|0|||
127655015|NCT02508532|459360238|FG006|Part 2 - Treatment|Sponsor Decision|0|||
127655016|NCT02508532|459360239|FG007|Part 2 - Treatment|Sponsor Decision|0|||
127655017|NCT02508532|459360240|FG008|Part 2 - Treatment|Sponsor Decision|28|||
127655018|NCT02508532|459360232|FG000|Part 2 - Treatment|Death|0|||
127655019|NCT02508532|459360233|FG001|Part 2 - Treatment|Death|0|||
127655020|NCT02508532|459360234|FG002|Part 2 - Treatment|Death|0|||
127655021|NCT02508532|459360235|FG003|Part 2 - Treatment|Death|0|||
127655022|NCT02508532|459360236|FG004|Part 2 - Treatment|Death|0|||
127655023|NCT02508532|459360237|FG005|Part 2 - Treatment|Death|0|||
127655024|NCT02508532|459360238|FG006|Part 2 - Treatment|Death|0|||
127655025|NCT02508532|459360239|FG007|Part 2 - Treatment|Death|0|||
127655026|NCT02508532|459360240|FG008|Part 2 - Treatment|Death|1|||
127655027|NCT02508532|459360232|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
127655028|NCT02508532|459360233|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
127655029|NCT02508532|459360234|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
127655030|NCT02508532|459360235|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
127655031|NCT02508532|459360236|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
127655032|NCT02508532|459360237|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
127655033|NCT02508532|459360238|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
127655034|NCT02508532|459360239|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
127655035|NCT02508532|459360240|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
127655036|NCT02508532|459360232|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
127655037|NCT02508532|459360233|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
127655038|NCT02508532|459360234|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
127655039|NCT02508532|459360235|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
127655040|NCT02508532|459360236|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
127655041|NCT02508532|459360237|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
127655042|NCT02508532|459360238|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
127655043|NCT02508532|459360239|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
127655044|NCT02508532|459360240|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
127655045|NCT02508532|459360232|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
127655046|NCT02508532|459360233|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
127655047|NCT02508532|459360234|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
127655048|NCT02508532|459360235|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
127655049|NCT02508532|459360236|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
127655050|NCT02508532|459360237|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
127655051|NCT02508532|459360238|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
127655052|NCT02508532|459360239|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
127655053|NCT02508532|459360240|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
127655054|NCT02508532|459360232|FG000|Part 1 and Part 2 End of Study|Death|0|||
127655055|NCT02508532|459360233|FG001|Part 1 and Part 2 End of Study|Death|4|||
127655056|NCT02508532|459360234|FG002|Part 1 and Part 2 End of Study|Death|2|||
127655057|NCT02508532|459360235|FG003|Part 1 and Part 2 End of Study|Death|4|||
127655058|NCT02508532|459360236|FG004|Part 1 and Part 2 End of Study|Death|3|||
127655059|NCT02508532|459360237|FG005|Part 1 and Part 2 End of Study|Death|0|||
127655060|NCT02508532|459360238|FG006|Part 1 and Part 2 End of Study|Death|0|||
127655061|NCT02508532|459360239|FG007|Part 1 and Part 2 End of Study|Death|1|||
127655062|NCT02508532|459360240|FG008|Part 1 and Part 2 End of Study|Death|111|||
127655063|NCT02508532|459360232|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
127655064|NCT02508532|459360233|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
127655065|NCT02508532|459360234|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
127655066|NCT02508532|459360235|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
127655067|NCT02508532|459360236|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
127655068|NCT02508532|459360237|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
127880657|NCT01915498|460183528|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
127880658|NCT01915498|460183529|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
127655069|NCT02508532|459360238|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
127655070|NCT02508532|459360239|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
127655071|NCT02508532|459360240|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
127655072|NCT02508532|459360232|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
127655073|NCT02508532|459360233|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
127655074|NCT02508532|459360234|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
127655075|NCT02508532|459360235|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
127655076|NCT02508532|459360236|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
127655077|NCT02508532|459360237|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
127655078|NCT02508532|459360238|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
127655079|NCT02508532|459360239|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
127655080|NCT02508532|459360240|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
127655081|NCT02508532|459360232|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
127655082|NCT02508532|459360233|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
127655083|NCT02508532|459360234|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
127655084|NCT02508532|459360235|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
127655085|NCT02508532|459360236|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
127655086|NCT02508532|459360237|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
127655087|NCT02508532|459360238|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
127655088|NCT02508532|459360239|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
127655089|NCT02508532|459360240|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
127655090|NCT02508532|459360232|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
127655091|NCT02508532|459360233|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
127655092|NCT02508532|459360234|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
127655093|NCT02508532|459360235|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
127655094|NCT02508532|459360236|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
127655095|NCT02508532|459360237|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
127655096|NCT02508532|459360238|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
127655097|NCT02508532|459360239|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
127655098|NCT02508532|459360240|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
127655099|NCT02508532|459360232|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
127655100|NCT02508532|459360233|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
127655101|NCT02508532|459360234|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
127655102|NCT02508532|459360235|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
127655103|NCT02508532|459360236|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
127655104|NCT02508532|459360237|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
127655105|NCT02508532|459360238|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
127655106|NCT02508532|459360239|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
127655107|NCT02508532|459360240|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
127655108|NCT03097861|459360243|FG000|Overall Study|Adverse Event|3|||
127655109|NCT03097861|459360244|FG001|Overall Study|Adverse Event|8|||
127655110|NCT03097861|459360245|FG002|Overall Study|Adverse Event|4|||
127655111|NCT03097861|459360243|FG000|Overall Study|Investigator Decision|0|||
127655112|NCT03097861|459360244|FG001|Overall Study|Investigator Decision|1|||
127655113|NCT03097861|459360245|FG002|Overall Study|Investigator Decision|0|||
127655114|NCT03097861|459360243|FG000|Overall Study|Lost to Follow-up|0|||
127655115|NCT03097861|459360244|FG001|Overall Study|Lost to Follow-up|7|||
127655116|NCT03097861|459360245|FG002|Overall Study|Lost to Follow-up|1|||
127655117|NCT03097861|459360243|FG000|Overall Study|Withdrawal by Subject|1|||
127655118|NCT03097861|459360244|FG001|Overall Study|Withdrawal by Subject|5|||
127655119|NCT03097861|459360245|FG002|Overall Study|Withdrawal by Subject|3|||
127655120|NCT03097861|459360243|FG000|Overall Study|Reason not provided|3|||
127655121|NCT03097861|459360244|FG001|Overall Study|Reason not provided|1|||
127655122|NCT03097861|459360245|FG002|Overall Study|Reason not provided|1|||
127655123|NCT00154310|459360246|FG000|Overall Study|Adverse Event|19|||
127655124|NCT00154310|459360247|FG001|Overall Study|Adverse Event|9|||
127655125|NCT00154310|459360246|FG000|Overall Study|Lack of Efficacy|5|||
127655126|NCT00154310|459360247|FG001|Overall Study|Lack of Efficacy|4|||
127655127|NCT00154310|459360246|FG000|Overall Study|Protocol Violation|4|||
127655128|NCT00154310|459360247|FG001|Overall Study|Protocol Violation|2|||
127655129|NCT00154310|459360246|FG000|Overall Study|Withdrawal by Subject|9|||
127655130|NCT00154310|459360247|FG001|Overall Study|Withdrawal by Subject|3|||
127655131|NCT00154310|459360246|FG000|Overall Study|Lost to Follow-up|0|||
127655132|NCT00154310|459360247|FG001|Overall Study|Lost to Follow-up|8|||
127655133|NCT00154310|459360246|FG000|Overall Study|Administrative problems|0|||
127655134|NCT00154310|459360247|FG001|Overall Study|Administrative problems|1|||
127655135|NCT00154310|459360246|FG000|Overall Study|Death|0|||
127655136|NCT00154310|459360247|FG001|Overall Study|Death|1|||
127655137|NCT04399356|459360248|FG000|Overall Study|Lost to Follow-up|1|||
127655138|NCT04399356|459360249|FG001|Overall Study|Lost to Follow-up|1|||
127655139|NCT04399356|459360248|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
127655140|NCT04399356|459360249|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
127655141|NCT04399356|459360248|FG000|Overall Study|Withdrawal by Subject|1|||
127986649|NCT01094782|460574200|FG004|Overall Study|Recent Interventional Injection|0|||
127655142|NCT04399356|459360249|FG001|Overall Study|Withdrawal by Subject|0|||
127655143|NCT01834222|459360257|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
127655144|NCT04251065|459360258|FG000|Overall Study|Death|2|||
127655145|NCT04251065|459360258|FG000|Overall Study|Lack of Efficacy|3|||
127655146|NCT04251065|459360258|FG000|Overall Study|Death|1|||
127655147|NCT01054573|459360259|FG000|Overall Study|Adverse Event|1|||
127655148|NCT01054573|459360260|FG001|Overall Study|Adverse Event|0|||
127655149|NCT01054573|459360261|FG002|Overall Study|Adverse Event|1|||
127655150|NCT01054573|459360262|FG003|Overall Study|Adverse Event|1|||
127655151|NCT01054573|459360259|FG000|Overall Study|Lost to Follow-up|0|||
127655152|NCT01054573|459360260|FG001|Overall Study|Lost to Follow-up|2|||
127655153|NCT01054573|459360261|FG002|Overall Study|Lost to Follow-up|0|||
127655154|NCT01054573|459360262|FG003|Overall Study|Lost to Follow-up|0|||
127655155|NCT01054573|459360259|FG000|Overall Study|Withdrawal by Subject|0|||
127655156|NCT01054573|459360260|FG001|Overall Study|Withdrawal by Subject|2|||
127655157|NCT01054573|459360261|FG002|Overall Study|Withdrawal by Subject|2|||
127655158|NCT01054573|459360262|FG003|Overall Study|Withdrawal by Subject|1|||
127655159|NCT05266963|459360266|FG000|Drug Period A|Withdrawal by Subject|0|||
127655160|NCT05266963|459360267|FG001|Drug Period A|Withdrawal by Subject|1|||
127655161|NCT01725386|459360268|FG000|Overall Study|Death|84|||
127655162|NCT01725386|459360269|FG001|Overall Study|Death|40|||
127655163|NCT01725386|459360268|FG000|Overall Study|Lost to Follow-up|81|||
127655164|NCT01725386|459360269|FG001|Overall Study|Lost to Follow-up|6|||
127655165|NCT01725386|459360268|FG000|Overall Study|Withdrawal by Subject|10|||
127655166|NCT01725386|459360269|FG001|Overall Study|Withdrawal by Subject|0|||
127655167|NCT03812536|459360270|FG000|Overall Study|Protocol Violation|2|||
127655168|NCT03812536|459360271|FG001|Overall Study|Protocol Violation|0|||
127655169|NCT03812536|459360270|FG000|Overall Study|Withdrawal by Subject|1|||
127655170|NCT03812536|459360271|FG001|Overall Study|Withdrawal by Subject|1|||
127655171|NCT00152009|459360272|FG000|Overall Study|Adverse Event|9|||
127655172|NCT00152009|459360273|FG001|Overall Study|Adverse Event|13|||
127655173|NCT00152009|459360274|FG002|Overall Study|Adverse Event|20|||
127655174|NCT00152009|459360275|FG003|Overall Study|Adverse Event|1|||
127655175|NCT00152009|459360272|FG000|Overall Study|Protocol Violation|3|||
127655176|NCT00152009|459360273|FG001|Overall Study|Protocol Violation|0|||
127655177|NCT00152009|459360274|FG002|Overall Study|Protocol Violation|0|||
127655178|NCT00152009|459360275|FG003|Overall Study|Protocol Violation|1|||
127655179|NCT00152009|459360272|FG000|Overall Study|Withdrawal by Subject|2|||
127655180|NCT00152009|459360273|FG001|Overall Study|Withdrawal by Subject|3|||
127655181|NCT00152009|459360274|FG002|Overall Study|Withdrawal by Subject|4|||
127655182|NCT00152009|459360275|FG003|Overall Study|Withdrawal by Subject|9|||
127655183|NCT00152009|459360272|FG000|Overall Study|Lost to Follow-up|2|||
127655184|NCT00152009|459360273|FG001|Overall Study|Lost to Follow-up|4|||
127655185|NCT00152009|459360274|FG002|Overall Study|Lost to Follow-up|3|||
127655186|NCT00152009|459360275|FG003|Overall Study|Lost to Follow-up|3|||
127655187|NCT00152009|459360272|FG000|Overall Study|Lack of Efficacy|8|||
127655188|NCT00152009|459360273|FG001|Overall Study|Lack of Efficacy|6|||
127655189|NCT00152009|459360274|FG002|Overall Study|Lack of Efficacy|7|||
127655190|NCT00152009|459360275|FG003|Overall Study|Lack of Efficacy|15|||
127655191|NCT00152009|459360272|FG000|Overall Study|ECG abnormalities|2|||
127655192|NCT00152009|459360273|FG001|Overall Study|ECG abnormalities|2|||
127655193|NCT00152009|459360274|FG002|Overall Study|ECG abnormalities|2|||
127655194|NCT00152009|459360275|FG003|Overall Study|ECG abnormalities|1|||
127655195|NCT00152009|459360272|FG000|Overall Study|Sponsor's decision|3|||
127655196|NCT00152009|459360273|FG001|Overall Study|Sponsor's decision|3|||
127655197|NCT00152009|459360274|FG002|Overall Study|Sponsor's decision|1|||
127655198|NCT00152009|459360275|FG003|Overall Study|Sponsor's decision|3|||
127655199|NCT01306201|459360277|FG000|Overall Study|Arrhythmia|4|||
127655200|NCT01306201|459360277|FG000|Overall Study|Files could not be processed|3|||
127655201|NCT01306201|459360277|FG000|Overall Study|Files unreadable|3|||
127655202|NCT04702568|459360278|FG000|Overall Study|Transitioned to the BCX9930-205 roll-over study|10|||
127655203|NCT04702568|459360279|FG001|Overall Study|Transitioned to the BCX9930-205 roll-over study|4|||
127655204|NCT04702568|459360278|FG000|Overall Study|Pregnancy|1|||
127655205|NCT04702568|459360279|FG001|Overall Study|Pregnancy|0|||
127655206|NCT04702568|459360278|FG000|Overall Study|Bone marrow transplant|1|||
127655207|NCT04702568|459360279|FG001|Overall Study|Bone marrow transplant|0|||
127655208|NCT04702568|459360278|FG000|Overall Study|Withdrawn due to Investigator decision|0|||
127655209|NCT04702568|459360279|FG001|Overall Study|Withdrawn due to Investigator decision|1|||
127655210|NCT04702568|459360278|FG000|Overall Study|Withdrawal by Subject|0|||
127655211|NCT04702568|459360279|FG001|Overall Study|Withdrawal by Subject|2|||
127655212|NCT00393523|459360280|FG000|Overall Study|Lost to Follow-up|0|||
127655213|NCT00393523|459360281|FG001|Overall Study|Lost to Follow-up|0|||
127655214|NCT00393523|459360282|FG002|Overall Study|Lost to Follow-up|0|||
127655215|NCT00393523|459360283|FG003|Overall Study|Lost to Follow-up|2|||
127655216|NCT00393523|459360284|FG004|Overall Study|Lost to Follow-up|1|||
127655217|NCT00393523|459360280|FG000|Overall Study|Protocol Violation|6|||
127655218|NCT00393523|459360281|FG001|Overall Study|Protocol Violation|2|||
127655219|NCT00393523|459360282|FG002|Overall Study|Protocol Violation|0|||
127986650|NCT01094782|460574201|FG005|Overall Study|Recent Interventional Injection|1|||
127543050|NCT00945009|458954734|FG002|Overall Study|Physician Decision|3|||
127655220|NCT00393523|459360283|FG003|Overall Study|Protocol Violation|1|||
127655221|NCT00393523|459360284|FG004|Overall Study|Protocol Violation|0|||
127655222|NCT00393523|459360280|FG000|Overall Study|Withdrawal by Subject|6|||
127655223|NCT00393523|459360281|FG001|Overall Study|Withdrawal by Subject|7|||
127655224|NCT00393523|459360282|FG002|Overall Study|Withdrawal by Subject|2|||
127655225|NCT00393523|459360283|FG003|Overall Study|Withdrawal by Subject|3|||
127655226|NCT00393523|459360284|FG004|Overall Study|Withdrawal by Subject|0|||
127655227|NCT00393523|459360280|FG000|Overall Study|Difficulties in specimen collection|0|||
127655228|NCT00393523|459360281|FG001|Overall Study|Difficulties in specimen collection|0|||
127655229|NCT00393523|459360282|FG002|Overall Study|Difficulties in specimen collection|1|||
127655230|NCT00393523|459360283|FG003|Overall Study|Difficulties in specimen collection|0|||
127655231|NCT00393523|459360284|FG004|Overall Study|Difficulties in specimen collection|0|||
127655232|NCT00393523|459360280|FG000|Overall Study|Vaccine supply issue|0|||
127655233|NCT00393523|459360281|FG001|Overall Study|Vaccine supply issue|0|||
127655234|NCT00393523|459360282|FG002|Overall Study|Vaccine supply issue|1|||
127655235|NCT00393523|459360283|FG003|Overall Study|Vaccine supply issue|0|||
127655236|NCT00393523|459360284|FG004|Overall Study|Vaccine supply issue|0|||
127655237|NCT00423852|459360285|FG000|Overall Study|Removed pior to the high-dose portion|3|||
127655238|NCT01515189|459360287|FG000|Induction|Disease Progression|109|||
127655239|NCT01515189|459360288|FG001|Induction|Disease Progression|155|||
127655240|NCT01515189|459360287|FG000|Induction|Study drug toxicity|86|||
127655241|NCT01515189|459360288|FG001|Induction|Study drug toxicity|36|||
127655242|NCT01515189|459360287|FG000|Induction|Death|24|||
127655243|NCT01515189|459360288|FG001|Induction|Death|17|||
127655244|NCT01515189|459360287|FG000|Induction|Adverse Event|14|||
127655245|NCT01515189|459360288|FG001|Induction|Adverse Event|9|||
127655246|NCT01515189|459360287|FG000|Induction|Withdrawal by Subject|3|||
127655247|NCT01515189|459360288|FG001|Induction|Withdrawal by Subject|9|||
127655248|NCT01515189|459360287|FG000|Induction|No longer meets study criteria|0|||
127655249|NCT01515189|459360288|FG001|Induction|No longer meets study criteria|2|||
127655250|NCT01515189|459360287|FG000|Induction|Lost to Follow-up|1|||
127655251|NCT01515189|459360288|FG001|Induction|Lost to Follow-up|0|||
127655252|NCT01515189|459360287|FG000|Induction|Other|0|||
127655253|NCT01515189|459360288|FG001|Induction|Other|4|||
127655254|NCT01515189|459360287|FG000|First Re-Induction Phase|Disease progression|6|||
127655255|NCT01515189|459360288|FG001|First Re-Induction Phase|Disease progression|14|||
127655256|NCT01515189|459360287|FG000|First Re-Induction Phase|Study drug toxicity|5|||
127655257|NCT01515189|459360288|FG001|First Re-Induction Phase|Study drug toxicity|0|||
127655258|NCT01515189|459360287|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
127655259|NCT01515189|459360288|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
127655260|NCT01515189|459360287|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
127655261|NCT01515189|459360288|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
127655262|NCT01515189|459360287|FG000|First Re-Induction Phase|Other|1|||
127655263|NCT01515189|459360288|FG001|First Re-Induction Phase|Other|0|||
127655264|NCT03787680|459360289|FG000|Overall Study|Physician Decision|2|||
127655265|NCT03787680|459360290|FG001|Overall Study|Physician Decision|3|||
127655266|NCT03787680|459360289|FG000|Overall Study|Adverse Event|7|||
127655267|NCT03787680|459360290|FG001|Overall Study|Adverse Event|3|||
127655268|NCT03787680|459360289|FG000|Overall Study|Withdrawal by Subject|2|||
127655269|NCT03787680|459360290|FG001|Overall Study|Withdrawal by Subject|1|||
127655270|NCT05229653|459360291|FG000|Overall Study|Lost to Follow-up|1|||
127655271|NCT05229653|459360292|FG001|Overall Study|Lost to Follow-up|0|||
127655272|NCT00594217|459360293|FG000|Overall Study|Withdrawal by Subject|1|||
127655273|NCT00594217|459360294|FG001|Overall Study|Withdrawal by Subject|3|||
127655274|NCT05672680|459360295|FG000|Overall Study|Patient Did Not Complete the Form|5|||
127655275|NCT05672680|459360296|FG001|Overall Study|Patient Did Not Complete the Form|4|||
127655276|NCT05672680|459360295|FG000|Overall Study|Procedure Aborted|1|||
127655277|NCT05672680|459360296|FG001|Overall Study|Procedure Aborted|0|||
127655278|NCT03635489|459360297|FG000|Overall Study|Death|19|||
127655279|NCT03635489|459360298|FG001|Overall Study|Death|13|||
127655280|NCT03635489|459360297|FG000|Overall Study|Lost to Follow-up|1|||
127655281|NCT03635489|459360298|FG001|Overall Study|Lost to Follow-up|2|||
127655282|NCT03635489|459360297|FG000|Overall Study|Withdrawal by Subject|1|||
127655283|NCT03635489|459360298|FG001|Overall Study|Withdrawal by Subject|2|||
127655284|NCT03635489|459360297|FG000|Overall Study|Study Ended by Sponsor|28|||
127655285|NCT03635489|459360298|FG001|Overall Study|Study Ended by Sponsor|34|||
127655286|NCT00943306|459360299|FG000|Overall Study|Physician Decision|1|||
127655287|NCT00943306|459360299|FG000|Overall Study|Death|1|||
127655288|NCT00943306|459360299|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
127655289|NCT01036022|459360300|FG000|Overall Study|Adverse Event|1|||
127655290|NCT01036022|459360301|FG001|Overall Study|Adverse Event|3|||
127655291|NCT01036022|459360302|FG002|Overall Study|Adverse Event|2|||
127655292|NCT01036022|459360303|FG003|Overall Study|Adverse Event|1|||
127655293|NCT01036022|459360304|FG004|Overall Study|Adverse Event|0|||
127655294|NCT01036022|459360305|FG005|Overall Study|Adverse Event|2|||
127655295|NCT01036022|459360300|FG000|Overall Study|Lack of Efficacy|1|||
127655296|NCT01036022|459360301|FG001|Overall Study|Lack of Efficacy|1|||
127655297|NCT01036022|459360302|FG002|Overall Study|Lack of Efficacy|1|||
127655298|NCT01036022|459360303|FG003|Overall Study|Lack of Efficacy|0|||
127655299|NCT01036022|459360304|FG004|Overall Study|Lack of Efficacy|1|||
127655300|NCT01036022|459360305|FG005|Overall Study|Lack of Efficacy|1|||
127655301|NCT01036022|459360300|FG000|Overall Study|Physician Decision|0|||
127655302|NCT01036022|459360301|FG001|Overall Study|Physician Decision|0|||
127655303|NCT01036022|459360302|FG002|Overall Study|Physician Decision|1|||
127655304|NCT01036022|459360303|FG003|Overall Study|Physician Decision|0|||
127655305|NCT01036022|459360304|FG004|Overall Study|Physician Decision|0|||
127655306|NCT01036022|459360305|FG005|Overall Study|Physician Decision|0|||
127655307|NCT01036022|459360300|FG000|Overall Study|Withdrawal by Subject|0|||
127655308|NCT01036022|459360301|FG001|Overall Study|Withdrawal by Subject|0|||
127655309|NCT01036022|459360302|FG002|Overall Study|Withdrawal by Subject|0|||
127655310|NCT01036022|459360303|FG003|Overall Study|Withdrawal by Subject|1|||
127655311|NCT01036022|459360304|FG004|Overall Study|Withdrawal by Subject|2|||
127655312|NCT01036022|459360305|FG005|Overall Study|Withdrawal by Subject|0|||
127655313|NCT00576732|459360306|FG000|DOUBLE BLIND|Adverse Event|0|||
127655314|NCT00576732|459360307|FG001|DOUBLE BLIND|Adverse Event|0|||
127655315|NCT00576732|459360308|FG002|DOUBLE BLIND|Adverse Event|1|||
127655316|NCT00576732|459360309|FG003|DOUBLE BLIND|Adverse Event|0|||
127655317|NCT00576732|459360310|FG004|DOUBLE BLIND|Adverse Event|0|||
127655318|NCT00576732|459360311|FG005|DOUBLE BLIND|Adverse Event|0|||
127655319|NCT00576732|459360306|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
127655320|NCT00576732|459360307|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
127655321|NCT00576732|459360308|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
127655322|NCT00576732|459360309|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
127655323|NCT00576732|459360310|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
127655324|NCT00576732|459360311|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
127655325|NCT00576732|459360306|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
127655326|NCT00576732|459360307|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
127655327|NCT00576732|459360308|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
127655328|NCT00576732|459360309|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
127655329|NCT00576732|459360310|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
127655330|NCT00576732|459360311|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
127655331|NCT00576732|459360306|FG000|DOUBLE BLIND|OTHER|0|||
127655332|NCT00576732|459360307|FG001|DOUBLE BLIND|OTHER|2|||
127655333|NCT00576732|459360308|FG002|DOUBLE BLIND|OTHER|1|||
127655334|NCT00576732|459360309|FG003|DOUBLE BLIND|OTHER|0|||
127655335|NCT00576732|459360310|FG004|DOUBLE BLIND|OTHER|0|||
127655336|NCT00576732|459360311|FG005|DOUBLE BLIND|OTHER|0|||
127655337|NCT00576732|459360306|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
127655338|NCT00576732|459360307|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
127655339|NCT00576732|459360308|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
127655340|NCT00576732|459360309|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
127655341|NCT00576732|459360310|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
127655342|NCT00576732|459360311|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
127655343|NCT00576732|459360306|FG000|DOUBLE BLIND|Protocol Violation|1|||
127655344|NCT00576732|459360307|FG001|DOUBLE BLIND|Protocol Violation|0|||
127655345|NCT00576732|459360308|FG002|DOUBLE BLIND|Protocol Violation|0|||
127655346|NCT00576732|459360309|FG003|DOUBLE BLIND|Protocol Violation|0|||
127655347|NCT00576732|459360310|FG004|DOUBLE BLIND|Protocol Violation|0|||
127655348|NCT00576732|459360311|FG005|DOUBLE BLIND|Protocol Violation|0|||
127986651|NCT01094782|460574196|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
127986652|NCT01094782|460574197|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
127655349|NCT00576732|459360306|FG000|OPEN LABEL|Adverse Event|0|||
127655350|NCT00576732|459360307|FG001|OPEN LABEL|Adverse Event|0|||
127655351|NCT00576732|459360308|FG002|OPEN LABEL|Adverse Event|0|||
127655352|NCT00576732|459360309|FG003|OPEN LABEL|Adverse Event|4|||
127655353|NCT00576732|459360310|FG004|OPEN LABEL|Adverse Event|0|||
127655354|NCT00576732|459360311|FG005|OPEN LABEL|Adverse Event|1|||
127655355|NCT00576732|459360306|FG000|OPEN LABEL|Lost to Follow-up|0|||
127655356|NCT00576732|459360307|FG001|OPEN LABEL|Lost to Follow-up|0|||
127655357|NCT00576732|459360308|FG002|OPEN LABEL|Lost to Follow-up|0|||
127655358|NCT00576732|459360309|FG003|OPEN LABEL|Lost to Follow-up|2|||
127655359|NCT00576732|459360310|FG004|OPEN LABEL|Lost to Follow-up|1|||
127655360|NCT00576732|459360311|FG005|OPEN LABEL|Lost to Follow-up|1|||
127655361|NCT00576732|459360306|FG000|OPEN LABEL|Withdrawal by Subject|0|||
127986653|NCT01094782|460574198|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
127655362|NCT00576732|459360307|FG001|OPEN LABEL|Withdrawal by Subject|0|||
127655363|NCT00576732|459360308|FG002|OPEN LABEL|Withdrawal by Subject|0|||
127655364|NCT00576732|459360309|FG003|OPEN LABEL|Withdrawal by Subject|1|||
127655365|NCT00576732|459360310|FG004|OPEN LABEL|Withdrawal by Subject|0|||
127655366|NCT00576732|459360311|FG005|OPEN LABEL|Withdrawal by Subject|1|||
127655367|NCT00576732|459360306|FG000|OPEN LABEL|OTHER|0|||
127655368|NCT00576732|459360307|FG001|OPEN LABEL|OTHER|0|||
127655369|NCT00576732|459360308|FG002|OPEN LABEL|OTHER|0|||
127655370|NCT00576732|459360309|FG003|OPEN LABEL|OTHER|0|||
127655371|NCT00576732|459360310|FG004|OPEN LABEL|OTHER|0|||
127655372|NCT00576732|459360311|FG005|OPEN LABEL|OTHER|2|||
127655373|NCT00576732|459360306|FG000|OPEN LABEL|Lack of Efficacy|0|||
127655374|NCT00576732|459360307|FG001|OPEN LABEL|Lack of Efficacy|0|||
127655375|NCT00576732|459360308|FG002|OPEN LABEL|Lack of Efficacy|0|||
127655376|NCT00576732|459360309|FG003|OPEN LABEL|Lack of Efficacy|2|||
127655377|NCT00576732|459360310|FG004|OPEN LABEL|Lack of Efficacy|2|||
127655378|NCT00576732|459360311|FG005|OPEN LABEL|Lack of Efficacy|3|||
127655379|NCT00576732|459360306|FG000|OPEN LABEL|Protocol Violation|0|||
127655380|NCT00576732|459360307|FG001|OPEN LABEL|Protocol Violation|0|||
127655381|NCT00576732|459360308|FG002|OPEN LABEL|Protocol Violation|0|||
127655382|NCT00576732|459360309|FG003|OPEN LABEL|Protocol Violation|2|||
127655383|NCT00576732|459360310|FG004|OPEN LABEL|Protocol Violation|1|||
127655384|NCT00576732|459360311|FG005|OPEN LABEL|Protocol Violation|0|||
127655385|NCT05076149|459360314|FG000|Overall Study|Adverse Event|3|||
127655386|NCT05076149|459360315|FG001|Overall Study|Adverse Event|9|||
127655387|NCT05076149|459360314|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
127655388|NCT05076149|459360315|FG001|Overall Study|Withdrawal of consent (not due to AE)|3|||
127655389|NCT05076149|459360314|FG000|Overall Study|Lost to Follow-up|0|||
127655390|NCT05076149|459360315|FG001|Overall Study|Lost to Follow-up|1|||
127655391|NCT05076149|459360314|FG000|Overall Study|Commercial drug is available for participant|0|||
127655392|NCT05076149|459360315|FG001|Overall Study|Commercial drug is available for participant|1|||
127655393|NCT05076149|459360314|FG000|Overall Study|Other non compliance|1|||
127655394|NCT05076149|459360315|FG001|Overall Study|Other non compliance|1|||
127655395|NCT05076149|459360314|FG000|Overall Study|Physician Decision|0|||
127655396|NCT05076149|459360315|FG001|Overall Study|Physician Decision|1|||
127655397|NCT05076149|459360314|FG000|Overall Study|Other|5|||
127655398|NCT05076149|459360315|FG001|Overall Study|Other|4|||
127655399|NCT05096208|459360316|FG000|Overall Study|Lost to Follow-up|3|||
127655400|NCT05096208|459360317|FG001|Overall Study|Lost to Follow-up|5|||
127655401|NCT05096208|459360318|FG002|Overall Study|Lost to Follow-up|5|||
127655402|NCT05096208|459360319|FG003|Overall Study|Lost to Follow-up|2|||
127655403|NCT05096208|459360316|FG000|Overall Study|Withdrawal by Subject|0|||
127655404|NCT05096208|459360317|FG001|Overall Study|Withdrawal by Subject|1|||
127655405|NCT05096208|459360318|FG002|Overall Study|Withdrawal by Subject|2|||
127655406|NCT05096208|459360319|FG003|Overall Study|Withdrawal by Subject|3|||
127655407|NCT05096208|459360316|FG000|Overall Study|No longer met eligibility criteria|1|||
127655408|NCT05096208|459360317|FG001|Overall Study|No longer met eligibility criteria|0|||
127655409|NCT05096208|459360318|FG002|Overall Study|No longer met eligibility criteria|0|||
127655410|NCT05096208|459360319|FG003|Overall Study|No longer met eligibility criteria|0|||
127655411|NCT05096208|459360316|FG000|Overall Study|Other|0|||
127655412|NCT05096208|459360317|FG001|Overall Study|Other|0|||
127655413|NCT05096208|459360318|FG002|Overall Study|Other|1|||
127655414|NCT05096208|459360319|FG003|Overall Study|Other|0|||
127655415|NCT02087501|459360320|FG000|Overall Study|Death|7|||
127655416|NCT02087501|459360320|FG000|Overall Study|Open repair of aneurysm|1|||
127655417|NCT02087501|459360320|FG000|Overall Study|Lost to Follow-up|2|||
127655418|NCT00094328|459360321|FG000|Overall Study|Lost to Follow-up|1|||
127655419|NCT02213328|459360323|FG000|Overall Study|Withdrawal by Subject|10|||
127655420|NCT02213328|459360323|FG000|Overall Study|Physician Decision|2|||
127655421|NCT02213328|459360323|FG000|Overall Study|Lost to Follow-up|16|||
127655422|NCT02487095|459360327|FG000|Dose Expansion|Unable to scan/restage participant|0|||
127655423|NCT02487095|459360328|FG001|Dose Expansion|Unable to scan/restage participant|0|||
127655424|NCT02487095|459360329|FG002|Dose Expansion|Unable to scan/restage participant|0|||
127655425|NCT02487095|459360330|FG003|Dose Expansion|Unable to scan/restage participant|0|||
127655426|NCT02487095|459360331|FG004|Dose Expansion|Unable to scan/restage participant|1|||
127655427|NCT01279343|459360332|FG000|Overall Study|Did not receive treatment|2|||
127655428|NCT01279343|459360333|FG001|Overall Study|Did not receive treatment|6|||
127986654|NCT01094782|460574199|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
127986655|NCT01094782|460574200|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
127986656|NCT01094782|460574201|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
127986657|NCT01094782|460574196|FG000|Overall Study|Noncompliance With Study Schedule|0|||
127986658|NCT01094782|460574197|FG001|Overall Study|Noncompliance With Study Schedule|0|||
127986659|NCT01094782|460574198|FG002|Overall Study|Noncompliance With Study Schedule|0|||
127986660|NCT01094782|460574199|FG003|Overall Study|Noncompliance With Study Schedule|1|||
127986661|NCT01094782|460574200|FG004|Overall Study|Noncompliance With Study Schedule|0|||
127655429|NCT02613221|459360339|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
127655430|NCT02613221|459360339|FG000|Overall Study|Adverse Event|2|||
127655431|NCT02613221|459360339|FG000|Overall Study|Voluntary Discontinuation|1|||
127655432|NCT02613221|459360339|FG000|Overall Study|Delayed Treatment|1|||
127655433|NCT02613221|459360339|FG000|Overall Study|Enrolled but Not Treated|1|||
127655434|NCT00399763|459360342|FG000|Overall Study|Lost to Follow-up|2|||
127655435|NCT00399763|459360343|FG001|Overall Study|Lost to Follow-up|3|||
127655436|NCT01657266|459360347|FG000|Overall Study|Lost to Follow-up|2|||
127655437|NCT01657266|459360348|FG001|Overall Study|Lost to Follow-up|2|||
127655438|NCT01657266|459360347|FG000|Overall Study|Adverse Event|2|||
127655439|NCT01657266|459360348|FG001|Overall Study|Adverse Event|3|||
127655440|NCT01816763|459361560|FG000|Overall Study|The main reason for an incomplete survey|4|||
127655441|NCT01816763|459361561|FG001|Overall Study|The main reason for an incomplete survey|15|||
127655442|NCT01816763|459361562|FG002|Overall Study|The main reason for an incomplete survey|11|||
127655443|NCT00429494|459361566|FG000|Overall Study|Withdrawal by Subject|9|||
127655444|NCT00429494|459361566|FG000|Overall Study|Death|6|||
127655445|NCT00976703|459361569|FG000|Overall Study|Physician Decision|1|||
127655446|NCT00976703|459361570|FG001|Overall Study|Physician Decision|1|||
127655447|NCT00976703|459361569|FG000|Overall Study|ineligible for study|2|||
127655448|NCT00976703|459361570|FG001|Overall Study|ineligible for study|2|||
127655449|NCT03075501|459361573|FG000|Overall Study|Scheduling difficulties|15|||
127655450|NCT03075501|459361574|FG001|Overall Study|Scheduling difficulties|9|||
127655451|NCT01062763|459361575|FG000|Overall Study|Adverse Event|3|||
127655452|NCT01062763|459361576|FG001|Overall Study|Adverse Event|4|||
127655453|NCT02494921|459361577|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
127655454|NCT02494921|459361578|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
127655455|NCT02494921|459361579|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
127655456|NCT02494921|459361580|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
127655457|NCT02494921|459361581|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
127655458|NCT02494921|459361577|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
127655459|NCT02494921|459361578|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
127655460|NCT02494921|459361579|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
127655461|NCT02494921|459361580|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
127655462|NCT02494921|459361581|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
127655463|NCT02494921|459361577|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
127655464|NCT02494921|459361578|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
127655465|NCT02494921|459361579|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
127655466|NCT02494921|459361580|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
127655467|NCT02494921|459361581|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
127655468|NCT02714868|459361584|FG000|Overall Study|Withdrawal by Subject|3|||
127655469|NCT02714868|459361585|FG001|Overall Study|Withdrawal by Subject|0|||
127655470|NCT02714868|459361584|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
127655471|NCT02714868|459361585|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
127655472|NCT02714868|459361584|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
127655473|NCT02714868|459361585|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
127655474|NCT03447730|459361592|FG000|Overall Study|Adverse Event|0|||
127655475|NCT03447730|459361593|FG001|Overall Study|Adverse Event|2|||
127655476|NCT03447730|459361594|FG002|Overall Study|Adverse Event|0|||
127655477|NCT00572624|459361596|FG000|Overall Study|Lost to Follow-up|10|||
127655478|NCT00572624|459361597|FG001|Overall Study|Lost to Follow-up|4|||
127655479|NCT00572624|459361596|FG000|Overall Study|Wanted to do a different diet program|1|||
127655480|NCT00572624|459361597|FG001|Overall Study|Wanted to do a different diet program|0|||
127655481|NCT00572624|459361596|FG000|Overall Study|Medication change|1|||
127655482|NCT00572624|459361597|FG001|Overall Study|Medication change|0|||
127655483|NCT00572624|459361596|FG000|Overall Study|Started a new job-- no time for study|1|||
127655484|NCT00572624|459361597|FG001|Overall Study|Started a new job-- no time for study|0|||
127655485|NCT00572624|459361596|FG000|Overall Study|Admitted to being a smoker|1|||
127655486|NCT00572624|459361597|FG001|Overall Study|Admitted to being a smoker|0|||
127655487|NCT00572624|459361596|FG000|Overall Study|Refused to do the stress test|1|||
127655488|NCT00572624|459361597|FG001|Overall Study|Refused to do the stress test|0|||
127655489|NCT00572624|459361596|FG000|Overall Study|Problem with vascular access|1|||
127655490|NCT00572624|459361597|FG001|Overall Study|Problem with vascular access|0|||
127655491|NCT00572624|459361596|FG000|Overall Study|Health issues unrelated to the study|1|||
127655492|NCT00572624|459361597|FG001|Overall Study|Health issues unrelated to the study|0|||
127655493|NCT05458024|459361600|FG000|Overall Study|Withdrawal by Subject|1|||
127655494|NCT05458024|459361601|FG001|Overall Study|Withdrawal by Subject|1|||
127655495|NCT02667886|459361605|FG000|Dose Escalation (Part A)|Adverse Event|1|||
127655496|NCT02667886|459361606|FG001|Dose Escalation (Part A)|Adverse Event|3|||
127655497|NCT02667886|459361607|FG002|Dose Escalation (Part A)|Adverse Event|1|||
127655498|NCT02667886|459361608|FG003|Dose Escalation (Part A)|Adverse Event|0|||
127655499|NCT02667886|459361609|FG004|Dose Escalation (Part A)|Adverse Event|0|||
127655500|NCT02667886|459361605|FG000|Dose Escalation (Part A)|Disease Progression|1|||
127655501|NCT02667886|459361606|FG001|Dose Escalation (Part A)|Disease Progression|4|||
127655502|NCT02667886|459361607|FG002|Dose Escalation (Part A)|Disease Progression|3|||
127655503|NCT02667886|459361608|FG003|Dose Escalation (Part A)|Disease Progression|0|||
127655504|NCT02667886|459361609|FG004|Dose Escalation (Part A)|Disease Progression|0|||
127655505|NCT02667886|459361605|FG000|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
127655506|NCT02667886|459361606|FG001|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
127655507|NCT02667886|459361607|FG002|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|2|||
127655508|NCT02667886|459361608|FG003|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
127655509|NCT02667886|459361609|FG004|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
127655510|NCT02667886|459361605|FG000|Dose Expansion (Part B)|Adverse Event|0|||
127655511|NCT02667886|459361606|FG001|Dose Expansion (Part B)|Adverse Event|0|||
127655512|NCT02667886|459361607|FG002|Dose Expansion (Part B)|Adverse Event|0|||
127655513|NCT02667886|459361608|FG003|Dose Expansion (Part B)|Adverse Event|9|||
127655514|NCT02667886|459361609|FG004|Dose Expansion (Part B)|Adverse Event|0|||
127655515|NCT02667886|459361605|FG000|Dose Expansion (Part B)|Clinical Deterioration|0|||
127655516|NCT02667886|459361606|FG001|Dose Expansion (Part B)|Clinical Deterioration|0|||
127655517|NCT02667886|459361607|FG002|Dose Expansion (Part B)|Clinical Deterioration|0|||
127655518|NCT02667886|459361608|FG003|Dose Expansion (Part B)|Clinical Deterioration|3|||
127655519|NCT02667886|459361609|FG004|Dose Expansion (Part B)|Clinical Deterioration|0|||
127655520|NCT02667886|459361605|FG000|Dose Expansion (Part B)|Disease Progression|0|||
127655521|NCT02667886|459361606|FG001|Dose Expansion (Part B)|Disease Progression|0|||
127655522|NCT02667886|459361607|FG002|Dose Expansion (Part B)|Disease Progression|0|||
127655523|NCT02667886|459361608|FG003|Dose Expansion (Part B)|Disease Progression|38|||
127655524|NCT02667886|459361609|FG004|Dose Expansion (Part B)|Disease Progression|0|||
127655525|NCT02667886|459361605|FG000|Dose Expansion (Part B)|Withdrawal by Subject|0|||
127655526|NCT02667886|459361606|FG001|Dose Expansion (Part B)|Withdrawal by Subject|0|||
127655527|NCT02667886|459361607|FG002|Dose Expansion (Part B)|Withdrawal by Subject|0|||
127655528|NCT02667886|459361608|FG003|Dose Expansion (Part B)|Withdrawal by Subject|4|||
127655529|NCT02667886|459361609|FG004|Dose Expansion (Part B)|Withdrawal by Subject|0|||
127655530|NCT02667886|459361605|FG000|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
127655531|NCT02667886|459361606|FG001|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
127655532|NCT02667886|459361607|FG002|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
127655533|NCT02667886|459361608|FG003|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
127655534|NCT02667886|459361609|FG004|Dose Escalation and Expansion (Part C)|Adverse Event|1|||
127655535|NCT02667886|459361605|FG000|Dose Escalation and Expansion (Part C)|DLT|0|||
127655536|NCT02667886|459361606|FG001|Dose Escalation and Expansion (Part C)|DLT|0|||
127655537|NCT02667886|459361607|FG002|Dose Escalation and Expansion (Part C)|DLT|0|||
127655538|NCT02667886|459361608|FG003|Dose Escalation and Expansion (Part C)|DLT|0|||
127655539|NCT02667886|459361609|FG004|Dose Escalation and Expansion (Part C)|DLT|2|||
127655540|NCT00747123|459361610|FG000|Overall Study|Investigator's request|0|||
127655541|NCT00747123|459361611|FG001|Overall Study|Investigator's request|0|||
127655542|NCT00747123|459361612|FG002|Overall Study|Investigator's request|1|||
127655543|NCT00747123|459361613|FG003|Overall Study|Investigator's request|0|||
127655544|NCT00747123|459361610|FG000|Overall Study|Withdrew consent|0|||
127655545|NCT00747123|459361611|FG001|Overall Study|Withdrew consent|1|||
127655546|NCT00747123|459361612|FG002|Overall Study|Withdrew consent|0|||
127655547|NCT00747123|459361613|FG003|Overall Study|Withdrew consent|0|||
127655548|NCT00747123|459361610|FG000|Overall Study|Adverse Event|0|||
127655549|NCT00747123|459361611|FG001|Overall Study|Adverse Event|1|||
127655550|NCT00747123|459361612|FG002|Overall Study|Adverse Event|0|||
127655551|NCT00747123|459361613|FG003|Overall Study|Adverse Event|1|||
127655552|NCT01395823|459361625|FG000|Overall Study|Death|4|||
127655553|NCT01395823|459361626|FG001|Overall Study|Death|4|||
127655554|NCT01395823|459361625|FG000|Overall Study|Physician Decision|3|||
127655555|NCT01395823|459361626|FG001|Overall Study|Physician Decision|1|||
127655556|NCT01395823|459361625|FG000|Overall Study|Lost to Follow-up|1|||
127655557|NCT01395823|459361626|FG001|Overall Study|Lost to Follow-up|0|||
127655558|NCT01395823|459361625|FG000|Overall Study|Transplant|1|||
127655559|NCT01395823|459361626|FG001|Overall Study|Transplant|0|||
127655560|NCT01395823|459361625|FG000|Overall Study|GI symptoms|1|||
127655561|NCT01395823|459361626|FG001|Overall Study|GI symptoms|0|||
127655562|NCT01395823|459361625|FG000|Overall Study|Withdrawal by Subject|5|||
127655563|NCT01395823|459361626|FG001|Overall Study|Withdrawal by Subject|4|||
127655564|NCT01483937|459361628|FG000|Overall Study|Withdrawal by Subject|4|||
127655565|NCT01483937|459361629|FG001|Overall Study|Withdrawal by Subject|3|||
127655566|NCT05778526|459361634|FG000|Overall Study|Lost to Follow-up|0|||
127655567|NCT05778526|459361635|FG001|Overall Study|Lost to Follow-up|1|||
127655568|NCT05778526|459361636|FG002|Overall Study|Lost to Follow-up|3|||
127655569|NCT05778526|459361634|FG000|Overall Study|Protocol Violation|0|||
127655570|NCT05778526|459361635|FG001|Overall Study|Protocol Violation|0|||
127655571|NCT05778526|459361636|FG002|Overall Study|Protocol Violation|8|||
127655572|NCT04534114|459361639|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
127655573|NCT04534114|459361640|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
127655574|NCT04534114|459361641|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
127655575|NCT04534114|459361642|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
127655576|NCT04534114|459361639|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
127655577|NCT04534114|459361640|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
127655578|NCT04534114|459361641|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
127655579|NCT04534114|459361642|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
127655580|NCT04534114|459361639|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
127655581|NCT04534114|459361640|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
127655582|NCT04534114|459361641|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
127655583|NCT04534114|459361642|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
127880659|NCT01915498|460183530|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
127655584|NCT04534114|459361639|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
127655585|NCT04534114|459361640|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
127655586|NCT04534114|459361641|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
127655587|NCT04534114|459361642|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
127655588|NCT04534114|459361639|FG000|Main Treatment Period|Physician Decision|0|||
127655589|NCT04534114|459361640|FG001|Main Treatment Period|Physician Decision|0|||
127655590|NCT04534114|459361641|FG002|Main Treatment Period|Physician Decision|0|||
127655591|NCT04534114|459361642|FG003|Main Treatment Period|Physician Decision|1|||
127655592|NCT04534114|459361639|FG000|Main Treatment Period|Death|1|||
127655593|NCT04534114|459361640|FG001|Main Treatment Period|Death|0|||
127655594|NCT04534114|459361641|FG002|Main Treatment Period|Death|0|||
127655595|NCT04534114|459361642|FG003|Main Treatment Period|Death|1|||
127655596|NCT04534114|459361639|FG000|Main Treatment Period|Other reason|1|||
127655597|NCT04534114|459361640|FG001|Main Treatment Period|Other reason|1|||
127655598|NCT04534114|459361641|FG002|Main Treatment Period|Other reason|0|||
127655599|NCT04534114|459361642|FG003|Main Treatment Period|Other reason|0|||
127655600|NCT04534114|459361639|FG000|Main Treatment Period|Participant decision|1|||
127655601|NCT04534114|459361640|FG001|Main Treatment Period|Participant decision|3|||
127655602|NCT04534114|459361641|FG002|Main Treatment Period|Participant decision|3|||
127655603|NCT04534114|459361642|FG003|Main Treatment Period|Participant decision|1|||
127655604|NCT04534114|459361639|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
127655605|NCT04534114|459361640|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
127655606|NCT04534114|459361641|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
127655607|NCT04534114|459361642|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
127655608|NCT04534114|459361639|FG000|Main Treatment Period|Adverse Event|4|||
127655609|NCT04534114|459361640|FG001|Main Treatment Period|Adverse Event|2|||
127655610|NCT04534114|459361641|FG002|Main Treatment Period|Adverse Event|1|||
127655611|NCT04534114|459361642|FG003|Main Treatment Period|Adverse Event|2|||
127986662|NCT01094782|460574201|FG005|Overall Study|Noncompliance With Study Schedule|0|||
127655612|NCT04534114|459361639|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
127655613|NCT04534114|459361640|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
127655614|NCT04534114|459361641|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
127655615|NCT04534114|459361642|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
127655616|NCT04534114|459361639|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
127655617|NCT04534114|459361640|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
127655618|NCT04534114|459361641|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
127655619|NCT04534114|459361642|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
127655620|NCT04534114|459361639|FG000|Extension Treatment Period|Other reason|0|||
127655621|NCT04534114|459361640|FG001|Extension Treatment Period|Other reason|1|||
127655622|NCT04534114|459361641|FG002|Extension Treatment Period|Other reason|0|||
127655623|NCT04534114|459361642|FG003|Extension Treatment Period|Other reason|0|||
127655624|NCT04534114|459361639|FG000|Extension Treatment Period|Death|0|||
127655625|NCT04534114|459361640|FG001|Extension Treatment Period|Death|0|||
127655626|NCT04534114|459361641|FG002|Extension Treatment Period|Death|1|||
127655627|NCT04534114|459361642|FG003|Extension Treatment Period|Death|2|||
127655628|NCT04534114|459361639|FG000|Extension Treatment Period|Adverse Event|0|||
127655629|NCT04534114|459361640|FG001|Extension Treatment Period|Adverse Event|1|||
127655630|NCT04534114|459361641|FG002|Extension Treatment Period|Adverse Event|0|||
127655631|NCT04534114|459361642|FG003|Extension Treatment Period|Adverse Event|1|||
127655632|NCT04534114|459361639|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
127655633|NCT04534114|459361640|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
127655634|NCT04534114|459361641|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
127655635|NCT04534114|459361642|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
127655636|NCT03287414|459361643|FG000|Treatment Epoch|Adverse Event|0|||
127655637|NCT03287414|459361644|FG001|Treatment Epoch|Adverse Event|1|||
127655638|NCT03287414|459361643|FG000|Treatment Epoch|Study terminated by sponsor|2|||
127655639|NCT03287414|459361644|FG001|Treatment Epoch|Study terminated by sponsor|2|||
127655640|NCT03287414|459361643|FG000|Treatment Epoch|Subject/Guardian decision|4|||
127986663|NCT02536781|460574218|FG000|Overall Study|Lost to Follow-up|2|||
127655641|NCT03287414|459361644|FG001|Treatment Epoch|Subject/Guardian decision|0|||
127655642|NCT03287414|459361643|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
127655643|NCT03287414|459361644|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
127655644|NCT03287414|459361643|FG000|Treatment Epoch|Withdrawal by Subject|1|||
127655645|NCT03287414|459361644|FG001|Treatment Epoch|Withdrawal by Subject|0|||
127986664|NCT02536781|460574219|FG001|Overall Study|Lost to Follow-up|0|||
127655646|NCT03287414|459361643|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
127655647|NCT03287414|459361644|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
127655648|NCT03287414|459361643|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
127655649|NCT03287414|459361644|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
127655650|NCT02759185|459361645|FG000|Stage 1|Adverse Event|0|||
127655651|NCT02759185|459361646|FG001|Stage 1|Adverse Event|1|||
127655652|NCT02759185|459361647|FG002|Stage 1|Adverse Event|3|||
127655653|NCT02759185|459361648|FG003|Stage 1|Adverse Event|0|||
127655654|NCT02759185|459361649|FG004|Stage 1|Adverse Event|0|||
127655655|NCT02759185|459361650|FG005|Stage 1|Adverse Event|0|||
127655656|NCT02759185|459361651|FG006|Stage 1|Adverse Event|0|||
127655657|NCT02759185|459361645|FG000|Stage 1|Withdrawal by Subject|1|||
127655658|NCT02759185|459361646|FG001|Stage 1|Withdrawal by Subject|0|||
127655659|NCT02759185|459361647|FG002|Stage 1|Withdrawal by Subject|0|||
127655660|NCT02759185|459361648|FG003|Stage 1|Withdrawal by Subject|0|||
127655661|NCT02759185|459361649|FG004|Stage 1|Withdrawal by Subject|0|||
127655662|NCT02759185|459361650|FG005|Stage 1|Withdrawal by Subject|0|||
127655663|NCT02759185|459361651|FG006|Stage 1|Withdrawal by Subject|0|||
127655664|NCT02759185|459361645|FG000|Stage 2|Adverse Event|0|||
127655665|NCT02759185|459361646|FG001|Stage 2|Adverse Event|0|||
127655666|NCT02759185|459361647|FG002|Stage 2|Adverse Event|0|||
127655667|NCT02759185|459361648|FG003|Stage 2|Adverse Event|0|||
127655668|NCT02759185|459361649|FG004|Stage 2|Adverse Event|1|||
127655669|NCT02759185|459361650|FG005|Stage 2|Adverse Event|2|||
127655670|NCT02759185|459361651|FG006|Stage 2|Adverse Event|0|||
127655671|NCT02759185|459361645|FG000|Stage 2|Withdrawal by Subject|0|||
127655672|NCT02759185|459361646|FG001|Stage 2|Withdrawal by Subject|0|||
127655673|NCT02759185|459361647|FG002|Stage 2|Withdrawal by Subject|0|||
127655674|NCT02759185|459361648|FG003|Stage 2|Withdrawal by Subject|0|||
127655675|NCT02759185|459361649|FG004|Stage 2|Withdrawal by Subject|1|||
127655676|NCT02759185|459361650|FG005|Stage 2|Withdrawal by Subject|1|||
127655677|NCT02759185|459361651|FG006|Stage 2|Withdrawal by Subject|1|||
127655678|NCT02668016|459361652|FG000|Month 2|Withdrew due to other health condition preventing continuation with the protocol|1|||
127655679|NCT02668016|459361652|FG000|Month 2|Withdrew due to repeated failure to provide treatment scores|1|||
127655680|NCT02668016|459361652|FG000|Month 2|Not applicable - stopped trial medication for rest of month but continued in the trial|4|||
127655681|NCT02668016|459361652|FG000|Month 4|Withdrawal due to severe symptoms|1|||
127655682|NCT02668016|459361652|FG000|Month 4|Withdrawal due to non-compliance with trial protocol|1|||
127655683|NCT02668016|459361652|FG000|Month 4|Not applicable - stopped trial medication for rest of month but continued in the trial|3|||
127655684|NCT02668016|459361652|FG000|Month 6|Withdrawal as decided side effects non longer statin mediated|1|||
127655685|NCT02668016|459361652|FG000|Month 6|Withdrawal due to severe symptoms|2|||
127655686|NCT02668016|459361652|FG000|Month 6|Withdrawal due to other health issues preventing continuation with the protocol|1|||
127655687|NCT02668016|459361652|FG000|Month 6|Not applicable - stopped trial medication for rest of month but continued in the trial|2|||
127655688|NCT02668016|459361652|FG000|Month 8|Withdrawal due to severe symptoms|1|||
127655689|NCT02668016|459361652|FG000|Month 8|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
127655690|NCT02668016|459361652|FG000|Month 10|Withdrawal due to intercurrent social stresses|1|||
127655691|NCT02668016|459361652|FG000|Month 10|Withdrawal due to severe symptoms|1|||
127655692|NCT02668016|459361652|FG000|Month 10|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
127655693|NCT02234063|459361662|FG000|Overall Study|Lost to Follow-up|235|||
127655694|NCT02234063|459361663|FG001|Overall Study|Lost to Follow-up|42|||
127655695|NCT02234063|459361662|FG000|Overall Study|Withdrawal by Subject|20|||
127655696|NCT02234063|459361663|FG001|Overall Study|Withdrawal by Subject|1|||
127655697|NCT02946918|459361666|FG000|Overall Study|Patient unblinded himself|1|||
127655698|NCT02946918|459361667|FG001|Overall Study|Patient unblinded himself|0|||
127655699|NCT02946918|459361666|FG000|Overall Study|Physician Decision|0|||
127655700|NCT02946918|459361667|FG001|Overall Study|Physician Decision|2|||
127655701|NCT02946918|459361666|FG000|Overall Study|Ran out of study medication|0|||
127655702|NCT02946918|459361667|FG001|Overall Study|Ran out of study medication|1|||
127655703|NCT01125722|459361668|FG000|Overall Study|Withdrawal by Subject|2|||
127655704|NCT01125722|459361669|FG001|Overall Study|Withdrawal by Subject|1|||
127655705|NCT01125722|459361668|FG000|Overall Study|Lost to Follow-up|1|||
127655706|NCT01125722|459361669|FG001|Overall Study|Lost to Follow-up|0|||
127655707|NCT00069784|459361670|FG000|Overall Study|Adverse Event|105|||
127655708|NCT00069784|459361671|FG001|Overall Study|Adverse Event|0|||
127655709|NCT00069784|459361670|FG000|Overall Study|Withdrawal by Subject|1090|||
127655710|NCT00069784|459361671|FG001|Overall Study|Withdrawal by Subject|0|||
127655711|NCT00069784|459361670|FG000|Overall Study|Other|17|||
127655712|NCT00069784|459361671|FG001|Overall Study|Other|0|||
127655713|NCT02294474|459361675|FG000|Overall Study|Adverse Event|7|||
127655714|NCT02294474|459361676|FG001|Overall Study|Adverse Event|7|||
127655715|NCT02294474|459361675|FG000|Overall Study|Lack of Efficacy|2|||
127655716|NCT02294474|459361676|FG001|Overall Study|Lack of Efficacy|1|||
127986665|NCT01048099|460574220|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
127986666|NCT01048099|460574220|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
127986667|NCT01969084|460574221|FG000|Overall Study|Adverse Event|0|||
127986668|NCT01969084|460574222|FG001|Overall Study|Adverse Event|1|||
127655717|NCT02294474|459361675|FG000|Overall Study|Protocol Violation|4|||
127655718|NCT02294474|459361676|FG001|Overall Study|Protocol Violation|2|||
127655719|NCT02294474|459361675|FG000|Overall Study|Other than specified above|12|||
127986669|NCT03089853|460575507|FG000|Overall Study|Lost to Follow-up|2|||
127986670|NCT03089853|460575508|FG001|Overall Study|Lost to Follow-up|1|||
127986671|NCT00441363|460575509|FG000|Overall Study|Adverse Event|4|||
127655720|NCT02294474|459361676|FG001|Overall Study|Other than specified above|12|||
127655721|NCT05200936|459361677|FG000|Overall Study|Withdrawal by Subject|2|||
127655722|NCT05200936|459361678|FG001|Overall Study|Withdrawal by Subject|2|||
127655723|NCT05200936|459361677|FG000|Overall Study|Lost to Follow-up|2|||
127655724|NCT05200936|459361678|FG001|Overall Study|Lost to Follow-up|0|||
127655725|NCT05200936|459361677|FG000|Overall Study|Pregnancy|0|||
127655726|NCT05200936|459361678|FG001|Overall Study|Pregnancy|1|||
127655727|NCT01672853|459361680|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
127655728|NCT01672853|459361681|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
127655729|NCT01672853|459361682|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
127655730|NCT01672853|459361680|FG000|Overall Study|Pregnancy|0|||
127655731|NCT01672853|459361681|FG001|Overall Study|Pregnancy|1|||
127655732|NCT01672853|459361682|FG002|Overall Study|Pregnancy|0|||
127655733|NCT01672853|459361680|FG000|Overall Study|Investigator's Discretion|1|||
127655734|NCT01672853|459361681|FG001|Overall Study|Investigator's Discretion|0|||
127655735|NCT01672853|459361682|FG002|Overall Study|Investigator's Discretion|0|||
127655736|NCT01672853|459361680|FG000|Overall Study|Withdrew Consent|5|||
127655737|NCT01672853|459361681|FG001|Overall Study|Withdrew Consent|5|||
127655738|NCT01672853|459361682|FG002|Overall Study|Withdrew Consent|5|||
127655739|NCT01672853|459361680|FG000|Overall Study|Adverse Event|4|||
127655740|NCT01672853|459361681|FG001|Overall Study|Adverse Event|6|||
127655741|NCT01672853|459361682|FG002|Overall Study|Adverse Event|8|||
127655742|NCT01672853|459361680|FG000|Overall Study|Lost to Follow-up|0|||
127655743|NCT01672853|459361681|FG001|Overall Study|Lost to Follow-up|1|||
127655744|NCT01672853|459361682|FG002|Overall Study|Lost to Follow-up|0|||
127655745|NCT01672853|459361680|FG000|Overall Study|Randomized but Never Treated|0|||
127655746|NCT01672853|459361681|FG001|Overall Study|Randomized but Never Treated|0|||
127655747|NCT01672853|459361682|FG002|Overall Study|Randomized but Never Treated|1|||
127655748|NCT02944656|459361684|FG000|Overall Study|No longer eligible|3|||
127655749|NCT02944656|459361685|FG001|Overall Study|No longer eligible|0|||
127655750|NCT02944656|459361684|FG000|Overall Study|Lost to Follow-up|7|||
127655751|NCT02944656|459361685|FG001|Overall Study|Lost to Follow-up|10|||
127655752|NCT00118898|459361686|FG000|Overall Study|Death|6|||
127655753|NCT00118898|459361687|FG001|Overall Study|Death|11|||
127655754|NCT00118898|459361688|FG002|Overall Study|Death|6|||
127655755|NCT00118898|459361689|FG003|Overall Study|Death|8|||
127655756|NCT00118898|459361686|FG000|Overall Study|Lost to Follow-up|26|||
127655757|NCT00118898|459361687|FG001|Overall Study|Lost to Follow-up|34|||
127655758|NCT00118898|459361688|FG002|Overall Study|Lost to Follow-up|33|||
127655759|NCT00118898|459361689|FG003|Overall Study|Lost to Follow-up|33|||
127655760|NCT00118898|459361686|FG000|Overall Study|Withdrawal by Subject|10|||
127655761|NCT00118898|459361687|FG001|Overall Study|Withdrawal by Subject|5|||
127655762|NCT00118898|459361688|FG002|Overall Study|Withdrawal by Subject|8|||
127655763|NCT00118898|459361689|FG003|Overall Study|Withdrawal by Subject|8|||
127655764|NCT00118898|459361686|FG000|Overall Study|Site Closure|33|||
127655765|NCT00118898|459361687|FG001|Overall Study|Site Closure|31|||
127655766|NCT00118898|459361688|FG002|Overall Study|Site Closure|28|||
127655767|NCT00118898|459361689|FG003|Overall Study|Site Closure|37|||
127655768|NCT00118898|459361686|FG000|Overall Study|Severe debilitation|1|||
127655769|NCT00118898|459361687|FG001|Overall Study|Severe debilitation|4|||
127655770|NCT00118898|459361688|FG002|Overall Study|Severe debilitation|6|||
127655771|NCT00118898|459361689|FG003|Overall Study|Severe debilitation|4|||
127655772|NCT00118898|459361686|FG000|Overall Study|Not compliant with requirements|11|||
127655773|NCT00118898|459361687|FG001|Overall Study|Not compliant with requirements|13|||
127655774|NCT00118898|459361688|FG002|Overall Study|Not compliant with requirements|11|||
127655775|NCT00118898|459361689|FG003|Overall Study|Not compliant with requirements|11|||
127655776|NCT00118898|459361686|FG000|Overall Study|Not able to get to clinic|34|||
127655777|NCT00118898|459361687|FG001|Overall Study|Not able to get to clinic|43|||
127986672|NCT00441363|460575510|FG001|Overall Study|Adverse Event|2|||
127655778|NCT00118898|459361688|FG002|Overall Study|Not able to get to clinic|31|||
127655779|NCT00118898|459361689|FG003|Overall Study|Not able to get to clinic|40|||
127655780|NCT00311155|459363025|FG000|Overall Study|Adverse Event|21|||
127655781|NCT00311155|459363025|FG000|Overall Study|Withdrawal by Subject|17|||
127655782|NCT00311155|459363025|FG000|Overall Study|Did not meet entry criteria|55|||
127655783|NCT02243631|459363026|FG000|Overall Study|no synovial fluid on second aspirate|0|||
127655784|NCT02243631|459363027|FG001|Overall Study|no synovial fluid on second aspirate|1|||
127655785|NCT01785628|459363030|FG000|Overall Study|Lost to Follow-up|2|||
127986673|NCT00441363|460575509|FG000|Overall Study|Withdrawal by Subject|3|||
127655786|NCT01785628|459363031|FG001|Overall Study|Lost to Follow-up|3|||
127655787|NCT00840996|459363032|FG000|Overall Study|Withdrawal by Subject|1|||
127655788|NCT00840996|459363033|FG001|Overall Study|Withdrawal by Subject|0|||
127986674|NCT00441363|460575510|FG001|Overall Study|Withdrawal by Subject|4|||
127655789|NCT02746575|459363034|FG000|Overall Study|Surgery cancelled or time chaned|13|||
127655790|NCT02746575|459363034|FG000|Overall Study|Received epidural|10|||
127655791|NCT02746575|459363034|FG000|Overall Study|Withdrawal by Subject|3|||
127655792|NCT02746575|459363034|FG000|Overall Study|Bradycardia/hypotension|9|||
127655793|NCT02746575|459363034|FG000|Overall Study|Study paused|8|||
127655794|NCT02746575|459363034|FG000|Overall Study|put on beta-blocker|3|||
127655795|NCT02746575|459363034|FG000|Overall Study|type of surgery|1|||
127655796|NCT02746575|459363034|FG000|Overall Study|typ of surgery|1|||
127655797|NCT02746575|459363034|FG000|Overall Study|PI unavailable|1|||
127655798|NCT02746575|459363034|FG000|Overall Study|Unknown history of CVA|1|||
127655799|NCT00957931|459363037|FG000|Overall Study|Death|4|||
127655800|NCT00857805|459363038|FG000|Overall Study|Withdrawal by Subject|1|||
127655801|NCT00857805|459363039|FG001|Overall Study|Withdrawal by Subject|1|||
127655802|NCT04867785|459363040|FG000|Overall Study|Adverse Event|1|||
127655803|NCT04867785|459363041|FG001|Overall Study|Adverse Event|0|||
127655804|NCT04867785|459363042|FG002|Overall Study|Adverse Event|1|||
127655805|NCT04867785|459363043|FG003|Overall Study|Adverse Event|0|||
127655806|NCT04867785|459363044|FG004|Overall Study|Adverse Event|0|||
127655807|NCT04867785|459363045|FG005|Overall Study|Adverse Event|0|||
127655808|NCT04867785|459363046|FG006|Overall Study|Adverse Event|0|||
127655809|NCT04867785|459363047|FG007|Overall Study|Adverse Event|2|||
127655810|NCT04867785|459363040|FG000|Overall Study|Lost to Follow-up|4|||
127655811|NCT04867785|459363041|FG001|Overall Study|Lost to Follow-up|4|||
127655812|NCT04867785|459363042|FG002|Overall Study|Lost to Follow-up|3|||
127655813|NCT04867785|459363043|FG003|Overall Study|Lost to Follow-up|2|||
127655814|NCT04867785|459363044|FG004|Overall Study|Lost to Follow-up|0|||
127655815|NCT04867785|459363045|FG005|Overall Study|Lost to Follow-up|1|||
127655816|NCT04867785|459363046|FG006|Overall Study|Lost to Follow-up|0|||
127655817|NCT04867785|459363047|FG007|Overall Study|Lost to Follow-up|1|||
127655818|NCT04867785|459363040|FG000|Overall Study|Withdrawal by Subject|6|||
127655819|NCT04867785|459363041|FG001|Overall Study|Withdrawal by Subject|2|||
127655820|NCT04867785|459363042|FG002|Overall Study|Withdrawal by Subject|2|||
127655821|NCT04867785|459363043|FG003|Overall Study|Withdrawal by Subject|1|||
127655822|NCT04867785|459363044|FG004|Overall Study|Withdrawal by Subject|2|||
127655823|NCT04867785|459363045|FG005|Overall Study|Withdrawal by Subject|0|||
127655824|NCT04867785|459363046|FG006|Overall Study|Withdrawal by Subject|2|||
127655825|NCT04867785|459363047|FG007|Overall Study|Withdrawal by Subject|5|||
127655826|NCT04867785|459363040|FG000|Overall Study|Physician Decision|0|||
127655827|NCT04867785|459363041|FG001|Overall Study|Physician Decision|0|||
127655828|NCT04867785|459363042|FG002|Overall Study|Physician Decision|0|||
127655829|NCT04867785|459363043|FG003|Overall Study|Physician Decision|0|||
127655830|NCT04867785|459363044|FG004|Overall Study|Physician Decision|0|||
127655831|NCT04867785|459363045|FG005|Overall Study|Physician Decision|0|||
127655832|NCT04867785|459363046|FG006|Overall Study|Physician Decision|0|||
127655833|NCT04867785|459363047|FG007|Overall Study|Physician Decision|1|||
127655834|NCT04867785|459363040|FG000|Overall Study|Inadvertent Enrollment|0|||
127655835|NCT04867785|459363041|FG001|Overall Study|Inadvertent Enrollment|0|||
127655836|NCT04867785|459363042|FG002|Overall Study|Inadvertent Enrollment|0|||
127655837|NCT04867785|459363043|FG003|Overall Study|Inadvertent Enrollment|1|||
127655838|NCT04867785|459363044|FG004|Overall Study|Inadvertent Enrollment|1|||
127655839|NCT04867785|459363045|FG005|Overall Study|Inadvertent Enrollment|0|||
127655840|NCT04867785|459363046|FG006|Overall Study|Inadvertent Enrollment|0|||
127655841|NCT04867785|459363047|FG007|Overall Study|Inadvertent Enrollment|1|||
127655842|NCT04867785|459363040|FG000|Overall Study|Eligibility Criteria Not Met|0|||
127655843|NCT04867785|459363041|FG001|Overall Study|Eligibility Criteria Not Met|0|||
127655844|NCT04867785|459363042|FG002|Overall Study|Eligibility Criteria Not Met|0|||
127655845|NCT04867785|459363043|FG003|Overall Study|Eligibility Criteria Not Met|0|||
127655846|NCT04867785|459363044|FG004|Overall Study|Eligibility Criteria Not Met|0|||
127655847|NCT04867785|459363045|FG005|Overall Study|Eligibility Criteria Not Met|0|||
127655848|NCT04867785|459363046|FG006|Overall Study|Eligibility Criteria Not Met|0|||
127655849|NCT04867785|459363047|FG007|Overall Study|Eligibility Criteria Not Met|1|||
127655850|NCT01289041|459363048|FG000|Overall Study|Adverse Event|24|||
127655851|NCT01289041|459363048|FG000|Overall Study|Physician Decision|1|||
127655852|NCT01289041|459363048|FG000|Overall Study|Progressive Disease|41|||
127655853|NCT01289041|459363048|FG000|Overall Study|Withdrawal by Subject|3|||
127655854|NCT01289041|459363048|FG000|Overall Study|Death|1|||
127655855|NCT03239873|459363055|FG000|Overall Study|Lost to Follow-up|15|||
127655856|NCT03239873|459363056|FG001|Overall Study|Lost to Follow-up|16|||
127655857|NCT03239873|459363055|FG000|Overall Study|Physician Decision|1|||
127655858|NCT03239873|459363056|FG001|Overall Study|Physician Decision|0|||
127655859|NCT03239873|459363055|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
127543051|NCT00945009|458954732|FG000|Overall Study|Protocol Violation|6|||
127655860|NCT03239873|459363056|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
127655861|NCT03239873|459363055|FG000|Overall Study|Withdrawal by Subject|2|||
127655862|NCT03239873|459363056|FG001|Overall Study|Withdrawal by Subject|0|||
127655863|NCT03239873|459363055|FG000|Overall Study|Contraindication to study medication|1|||
127655864|NCT03239873|459363056|FG001|Overall Study|Contraindication to study medication|0|||
127655865|NCT03239873|459363055|FG000|Overall Study|Protocol Violation|1|||
127655866|NCT03239873|459363056|FG001|Overall Study|Protocol Violation|0|||
127655867|NCT00605319|459363061|FG000|Overall Study|Adverse Event|6|||
127655868|NCT02670538|459363062|FG000|Overall Study|Withdrawal of Consent|8|||
127655869|NCT02670538|459363063|FG001|Overall Study|Withdrawal of Consent|6|||
127655870|NCT02670538|459363064|FG002|Overall Study|Withdrawal of Consent|5|||
127655871|NCT02670538|459363062|FG000|Overall Study|Lost to Follow-up|8|||
127655872|NCT02670538|459363063|FG001|Overall Study|Lost to Follow-up|12|||
127655873|NCT02670538|459363064|FG002|Overall Study|Lost to Follow-up|7|||
127655874|NCT02670538|459363062|FG000|Overall Study|Adverse Event|5|||
127655875|NCT02670538|459363063|FG001|Overall Study|Adverse Event|5|||
127655876|NCT02670538|459363064|FG002|Overall Study|Adverse Event|11|||
127655877|NCT02670538|459363062|FG000|Overall Study|Lack of Efficacy|7|||
127655878|NCT02670538|459363063|FG001|Overall Study|Lack of Efficacy|1|||
127655879|NCT02670538|459363064|FG002|Overall Study|Lack of Efficacy|2|||
127655880|NCT02670538|459363062|FG000|Overall Study|Protocol Violation|3|||
127655881|NCT02670538|459363063|FG001|Overall Study|Protocol Violation|4|||
127655882|NCT02670538|459363064|FG002|Overall Study|Protocol Violation|1|||
127655883|NCT02670538|459363062|FG000|Overall Study|Noncompliance with Study Drug|1|||
127655884|NCT02670538|459363063|FG001|Overall Study|Noncompliance with Study Drug|3|||
127655885|NCT02670538|459363064|FG002|Overall Study|Noncompliance with Study Drug|2|||
127655886|NCT02670538|459363062|FG000|Overall Study|Other Miscellaneous Reasons|0|||
127655887|NCT02670538|459363063|FG001|Overall Study|Other Miscellaneous Reasons|1|||
127655888|NCT02670538|459363064|FG002|Overall Study|Other Miscellaneous Reasons|2|||
127655889|NCT01250119|459363065|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
127655890|NCT01250119|459363066|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
127655891|NCT01250119|459363065|FG000|Diagnostic Phase|Participants Not Tested|44|||
127655892|NCT01250119|459363066|FG001|Diagnostic Phase|Participants Not Tested|0|||
127655893|NCT01250119|459363065|FG000|Treatment Phase|Progressive Disease|0|||
127655894|NCT01250119|459363066|FG001|Treatment Phase|Progressive Disease|32|||
127655895|NCT01250119|459363065|FG000|Treatment Phase|Death|0|||
127655896|NCT01250119|459363066|FG001|Treatment Phase|Death|2|||
127655897|NCT01250119|459363065|FG000|Treatment Phase|Withdrawal by Subject|0|||
127655898|NCT01250119|459363066|FG001|Treatment Phase|Withdrawal by Subject|1|||
127655899|NCT01250119|459363065|FG000|Treatment Phase|Adverse Event|0|||
127655900|NCT01250119|459363066|FG001|Treatment Phase|Adverse Event|2|||
127655901|NCT01250119|459363065|FG000|Treatment Phase|Unknown reason|0|||
127655902|NCT01250119|459363066|FG001|Treatment Phase|Unknown reason|4|||
127655903|NCT02887989|459363070|FG000|Overall Study|Withdrawal by Subject|8|||
127655904|NCT02887989|459363071|FG001|Overall Study|Withdrawal by Subject|11|||
127655905|NCT02887989|459363070|FG000|Overall Study|Death|1|||
127655906|NCT02887989|459363071|FG001|Overall Study|Death|0|||
127655907|NCT05648357|459363072|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|3|||
127655908|NCT00255346|459363073|FG000|Overall Study|Adverse Event|1|||
127655909|NCT00255346|459363074|FG001|Overall Study|Adverse Event|0|||
127655910|NCT00255346|459363075|FG002|Overall Study|Adverse Event|0|||
127655911|NCT00255346|459363076|FG003|Overall Study|Adverse Event|0|||
127655912|NCT00255346|459363077|FG004|Overall Study|Adverse Event|0|||
127655913|NCT00674323|459363078|FG000|Overall Study|Adverse Event|0|||
127655914|NCT00674323|459363079|FG001|Overall Study|Adverse Event|1|||
127655915|NCT00674323|459363080|FG002|Overall Study|Adverse Event|0|||
127655916|NCT00674323|459363078|FG000|Overall Study|Protocol Violation|1|||
127655917|NCT00674323|459363079|FG001|Overall Study|Protocol Violation|0|||
127655918|NCT00674323|459363080|FG002|Overall Study|Protocol Violation|0|||
127655919|NCT00409786|459363087|FG000|Overall Study|Withdrawal by Subject|3|||
127655920|NCT01077362|459363093|FG000|Overall Study|Lack of Efficacy|13|||
127655921|NCT01077362|459363094|FG001|Overall Study|Lack of Efficacy|8|||
127655922|NCT01077362|459363095|FG002|Overall Study|Lack of Efficacy|10|||
127655923|NCT01077362|459363093|FG000|Overall Study|Lost to Follow-up|1|||
127655924|NCT01077362|459363094|FG001|Overall Study|Lost to Follow-up|0|||
127655925|NCT01077362|459363095|FG002|Overall Study|Lost to Follow-up|3|||
127655926|NCT01077362|459363093|FG000|Overall Study|Adverse Event|12|||
127655927|NCT01077362|459363094|FG001|Overall Study|Adverse Event|7|||
127655928|NCT01077362|459363095|FG002|Overall Study|Adverse Event|4|||
127655929|NCT01077362|459363093|FG000|Overall Study|Withdrawal by Subject|5|||
127655930|NCT01077362|459363094|FG001|Overall Study|Withdrawal by Subject|3|||
127655931|NCT01077362|459363095|FG002|Overall Study|Withdrawal by Subject|5|||
127655932|NCT01077362|459363093|FG000|Overall Study|Other|0|||
127655933|NCT01077362|459363094|FG001|Overall Study|Other|1|||
127655934|NCT01077362|459363095|FG002|Overall Study|Other|2|||
127655935|NCT00301080|459363096|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
127655936|NCT00301080|459363097|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
127655937|NCT00301080|459363098|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
127655938|NCT00301080|459363099|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
127655939|NCT00301080|459363100|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
127655940|NCT01641926|459363101|FG000|Overall Study|Adverse Event|5|||
127655941|NCT01641926|459363102|FG001|Overall Study|Adverse Event|2|||
127655942|NCT01641926|459363103|FG002|Overall Study|Adverse Event|3|||
127655943|NCT01641926|459363104|FG003|Overall Study|Adverse Event|1|||
127655944|NCT01641926|459363101|FG000|Overall Study|Lost to Follow-up|2|||
127655945|NCT01641926|459363102|FG001|Overall Study|Lost to Follow-up|2|||
127655946|NCT01641926|459363103|FG002|Overall Study|Lost to Follow-up|1|||
127655947|NCT01641926|459363104|FG003|Overall Study|Lost to Follow-up|0|||
127655948|NCT01641926|459363101|FG000|Overall Study|Physician Decision|6|||
127655949|NCT01641926|459363102|FG001|Overall Study|Physician Decision|5|||
127655950|NCT01641926|459363103|FG002|Overall Study|Physician Decision|0|||
127655951|NCT01641926|459363104|FG003|Overall Study|Physician Decision|1|||
127655952|NCT01641926|459363101|FG000|Overall Study|Protocol Violation|1|||
127655953|NCT01641926|459363102|FG001|Overall Study|Protocol Violation|0|||
127655954|NCT01641926|459363103|FG002|Overall Study|Protocol Violation|0|||
127655955|NCT01641926|459363104|FG003|Overall Study|Protocol Violation|1|||
127655956|NCT01641926|459363101|FG000|Overall Study|Withdrawal by Subject|13|||
127655957|NCT01641926|459363102|FG001|Overall Study|Withdrawal by Subject|5|||
127655958|NCT01641926|459363103|FG002|Overall Study|Withdrawal by Subject|6|||
127655959|NCT01641926|459363104|FG003|Overall Study|Withdrawal by Subject|1|||
127655960|NCT01641926|459363101|FG000|Overall Study|Not Treated|1|||
127655961|NCT01641926|459363102|FG001|Overall Study|Not Treated|1|||
127655962|NCT01641926|459363103|FG002|Overall Study|Not Treated|1|||
127655963|NCT01641926|459363104|FG003|Overall Study|Not Treated|0|||
127655964|NCT02567825|459363111|FG000|Overall Study|No follow-up post-randomization|5|||
127655965|NCT02567825|459363112|FG001|Overall Study|No follow-up post-randomization|1|||
127655966|NCT02567825|459363111|FG000|Overall Study|Follow-up less than 23 months|16|||
127655967|NCT02567825|459363112|FG001|Overall Study|Follow-up less than 23 months|20|||
127655968|NCT01540565|459363114|FG000|Overall Study|Ineligible|2|||
127655969|NCT01678820|459363115|FG000|Overall Study|Study Terminated by Sponsor|45|||
127655970|NCT01678820|459363116|FG001|Overall Study|Study Terminated by Sponsor|43|||
127655971|NCT01678820|459363117|FG002|Overall Study|Study Terminated by Sponsor|43|||
127655972|NCT01678820|459363115|FG000|Overall Study|Withdrawal by Subject|2|||
127655973|NCT01678820|459363116|FG001|Overall Study|Withdrawal by Subject|5|||
127655974|NCT01678820|459363117|FG002|Overall Study|Withdrawal by Subject|2|||
127655975|NCT01678820|459363115|FG000|Overall Study|Protocol Specified Criteria|2|||
127655976|NCT01678820|459363116|FG001|Overall Study|Protocol Specified Criteria|3|||
127655977|NCT01678820|459363117|FG002|Overall Study|Protocol Specified Criteria|1|||
127655978|NCT01678820|459363115|FG000|Overall Study|Adverse Event|2|||
127655979|NCT01678820|459363116|FG001|Overall Study|Adverse Event|2|||
127655980|NCT01678820|459363117|FG002|Overall Study|Adverse Event|2|||
127655981|NCT01678820|459363115|FG000|Overall Study|Lost to Follow-up|7|||
127655982|NCT01678820|459363116|FG001|Overall Study|Lost to Follow-up|2|||
127655983|NCT01678820|459363117|FG002|Overall Study|Lost to Follow-up|2|||
127655984|NCT01678820|459363115|FG000|Overall Study|Non-compliance with study drug|0|||
127655985|NCT01678820|459363116|FG001|Overall Study|Non-compliance with study drug|1|||
127655986|NCT01678820|459363117|FG002|Overall Study|Non-compliance with study drug|0|||
127655987|NCT01678820|459363115|FG000|Overall Study|Physician Decision|0|||
127655988|NCT01678820|459363116|FG001|Overall Study|Physician Decision|0|||
127655989|NCT01678820|459363117|FG002|Overall Study|Physician Decision|1|||
127655990|NCT01678820|459363115|FG000|Overall Study|Protocol Violation|4|||
127655991|NCT01678820|459363116|FG001|Overall Study|Protocol Violation|5|||
127655992|NCT01678820|459363117|FG002|Overall Study|Protocol Violation|4|||
127655993|NCT01678820|459363115|FG000|Overall Study|Not treated with double-blind study drug|0|||
127655994|NCT01678820|459363116|FG001|Overall Study|Not treated with double-blind study drug|2|||
127655995|NCT01678820|459363117|FG002|Overall Study|Not treated with double-blind study drug|2|||
127655996|NCT02306265|459363118|FG000|Overall Study|Withdrawal by Subject|1|||
127655997|NCT04488003|459363119|FG000|Assessed for Eligibility|Screen Failure|24|||
127655998|NCT04488003|459363120|FG001|Assessed for Eligibility|Screen Failure|0|||
127655999|NCT04488003|459363121|FG002|Assessed for Eligibility|Screen Failure|0|||
127656000|NCT04488003|459363119|FG000|Assessed for Eligibility|Adverse Event|1|||
127656001|NCT04488003|459363120|FG001|Assessed for Eligibility|Adverse Event|0|||
127656002|NCT04488003|459363121|FG002|Assessed for Eligibility|Adverse Event|0|||
127656003|NCT04488003|459363119|FG000|Assessed for Eligibility|Death|1|||
127656004|NCT04488003|459363120|FG001|Assessed for Eligibility|Death|0|||
127656005|NCT04488003|459363121|FG002|Assessed for Eligibility|Death|0|||
127656006|NCT04488003|459363119|FG000|Assessed for Eligibility|Physician Decision|1|||
127656007|NCT04488003|459363120|FG001|Assessed for Eligibility|Physician Decision|0|||
127656008|NCT04488003|459363121|FG002|Assessed for Eligibility|Physician Decision|0|||
127656009|NCT04488003|459363119|FG000|Allocated to Treatment|Progressive Disease|51|||
127656010|NCT04488003|459363120|FG001|Allocated to Treatment|Progressive Disease|0|||
127656011|NCT04488003|459363121|FG002|Allocated to Treatment|Progressive Disease|0|||
127656012|NCT04488003|459363119|FG000|Allocated to Treatment|Withdrawal by Subject|7|||
127656013|NCT04488003|459363120|FG001|Allocated to Treatment|Withdrawal by Subject|0|||
127656014|NCT04488003|459363121|FG002|Allocated to Treatment|Withdrawal by Subject|0|||
127656015|NCT04488003|459363119|FG000|Allocated to Treatment|Adverse Event|6|||
127656016|NCT04488003|459363120|FG001|Allocated to Treatment|Adverse Event|0|||
127656017|NCT04488003|459363121|FG002|Allocated to Treatment|Adverse Event|0|||
127656018|NCT04488003|459363119|FG000|Allocated to Treatment|Other|5|||
127656019|NCT04488003|459363120|FG001|Allocated to Treatment|Other|0|||
127656020|NCT04488003|459363121|FG002|Allocated to Treatment|Other|0|||
127880660|NCT01915498|460183531|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
127543052|NCT00945009|458954733|FG001|Overall Study|Protocol Violation|1|||
127656021|NCT04488003|459363119|FG000|Allocated to Treatment|Physician Decision|4|||
127656022|NCT04488003|459363120|FG001|Allocated to Treatment|Physician Decision|0|||
127656023|NCT04488003|459363121|FG002|Allocated to Treatment|Physician Decision|0|||
127656024|NCT04488003|459363119|FG000|Allocated to Treatment|Death|4|||
127656025|NCT04488003|459363120|FG001|Allocated to Treatment|Death|0|||
127656026|NCT04488003|459363121|FG002|Allocated to Treatment|Death|0|||
127656027|NCT01350505|459363125|FG000|Overall Study|Lost to Follow-up|4|||
127656028|NCT04145037|459363128|FG000|Overall Study|Study terminated|2|||
127656029|NCT04145037|459363129|FG001|Overall Study|Study terminated|0|||
127656030|NCT04145037|459363128|FG000|Overall Study|Withdrawal by Subject|1|||
127656031|NCT04145037|459363129|FG001|Overall Study|Withdrawal by Subject|0|||
127656032|NCT04145037|459363128|FG000|Overall Study|Lost to Follow-up|1|||
127656033|NCT04145037|459363129|FG001|Overall Study|Lost to Follow-up|0|||
127656034|NCT02307513|459363132|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
127656035|NCT02307513|459363133|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
127656036|NCT02307513|459363132|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
127656037|NCT02307513|459363133|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
127656038|NCT02307513|459363132|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
127656039|NCT02307513|459363133|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
127656040|NCT02307513|459363132|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
127656041|NCT02307513|459363133|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
127656042|NCT02307513|459363132|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
127656043|NCT02307513|459363133|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
127656044|NCT02307513|459363132|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
127656045|NCT02307513|459363133|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
127656046|NCT02307513|459363132|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
127656047|NCT02307513|459363133|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
127656048|NCT02307513|459363132|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
127656049|NCT02307513|459363133|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
127656050|NCT02307513|459363132|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
127656051|NCT02307513|459363133|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
127656052|NCT02307513|459363132|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
127656053|NCT02307513|459363133|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
127656054|NCT02307513|459363132|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
127656055|NCT02307513|459363133|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
127656056|NCT02307513|459363132|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
127656057|NCT02307513|459363133|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
127656058|NCT02307513|459363132|FG000|Long-term Extension|Physician Decision|1|||
127656059|NCT02307513|459363133|FG001|Long-term Extension|Physician Decision|0|||
127656060|NCT00744263|459363134|FG000|Overall Study|Death|3006|||
127656061|NCT00744263|459363135|FG001|Overall Study|Death|3005|||
127656062|NCT00744263|459363134|FG000|Overall Study|Lost to Follow-up|2038|||
127656063|NCT00744263|459363135|FG001|Overall Study|Lost to Follow-up|2135|||
127656064|NCT00744263|459363134|FG000|Overall Study|Withdrawal by Subject|166|||
127656065|NCT00744263|459363135|FG001|Overall Study|Withdrawal by Subject|150|||
127656066|NCT00744263|459363134|FG000|Overall Study|Physician Decision|20|||
127656067|NCT00744263|459363135|FG001|Overall Study|Physician Decision|23|||
127656068|NCT00744263|459363134|FG000|Overall Study|Protocol Violation|3|||
127656069|NCT00744263|459363135|FG001|Overall Study|Protocol Violation|5|||
127656070|NCT00744263|459363134|FG000|Overall Study|Adverse Event|1|||
127656071|NCT00744263|459363135|FG001|Overall Study|Adverse Event|0|||
127656072|NCT00744263|459363134|FG000|Overall Study|Other|2|||
127656073|NCT00744263|459363135|FG001|Overall Study|Other|2|||
127656074|NCT00130793|459363138|FG000|Overall Study|Lost to Follow-up|1|||
127656075|NCT00130793|459363139|FG001|Overall Study|Lost to Follow-up|4|||
127656076|NCT00130793|459363138|FG000|Overall Study|Withdrew consent|2|||
127656077|NCT00130793|459363139|FG001|Overall Study|Withdrew consent|0|||
127656078|NCT00453102|459363142|FG000|Overall Study|Withdrawal by Subject|2|||
127656079|NCT02541383|459363150|FG000|Overall Study|Death|50|||
127656080|NCT02541383|459363151|FG001|Overall Study|Death|37|||
127656081|NCT02541383|459363152|FG002|Overall Study|Death|48|||
127656082|NCT02541383|459363153|FG003|Overall Study|Death|41|||
127656083|NCT02541383|459363154|FG004|Overall Study|Death|21|||
127656084|NCT02541383|459363155|FG005|Overall Study|Death|25|||
127656085|NCT02541383|459363150|FG000|Overall Study|Lost to Follow-up|5|||
127656086|NCT02541383|459363151|FG001|Overall Study|Lost to Follow-up|3|||
127986675|NCT00441363|460575509|FG000|Overall Study|Physician Decision|6|||
127986676|NCT00441363|460575510|FG001|Overall Study|Physician Decision|7|||
127656087|NCT02541383|459363152|FG002|Overall Study|Lost to Follow-up|1|||
127656088|NCT02541383|459363153|FG003|Overall Study|Lost to Follow-up|1|||
127656089|NCT02541383|459363154|FG004|Overall Study|Lost to Follow-up|3|||
127656090|NCT02541383|459363155|FG005|Overall Study|Lost to Follow-up|0|||
127656091|NCT02541383|459363150|FG000|Overall Study|Consent withdrawn|5|||
127656092|NCT02541383|459363151|FG001|Overall Study|Consent withdrawn|6|||
127656093|NCT02541383|459363152|FG002|Overall Study|Consent withdrawn|1|||
127656094|NCT02541383|459363153|FG003|Overall Study|Consent withdrawn|1|||
127656095|NCT02541383|459363154|FG004|Overall Study|Consent withdrawn|0|||
127656096|NCT02541383|459363155|FG005|Overall Study|Consent withdrawn|0|||
127656097|NCT02541383|459363150|FG000|Overall Study|Sponsor's decision|1|||
127656098|NCT02541383|459363151|FG001|Overall Study|Sponsor's decision|1|||
127656099|NCT02541383|459363152|FG002|Overall Study|Sponsor's decision|0|||
127656100|NCT02541383|459363153|FG003|Overall Study|Sponsor's decision|0|||
127656101|NCT02541383|459363154|FG004|Overall Study|Sponsor's decision|0|||
127656102|NCT02541383|459363155|FG005|Overall Study|Sponsor's decision|0|||
127656103|NCT02690077|459363156|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
127656104|NCT02690077|459363157|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
127656105|NCT02690077|459363156|FG000|Overall Study|Withdrawal by Subject|0|||
127656106|NCT02690077|459363157|FG001|Overall Study|Withdrawal by Subject|5|||
127656107|NCT02690077|459363156|FG000|Overall Study|Excluded by IRB|0|||
127656108|NCT02690077|459363157|FG001|Overall Study|Excluded by IRB|2|||
127656109|NCT01845974|459363158|FG000|Overall Study|screen failure|1|||
127656110|NCT01845974|459363159|FG001|Overall Study|screen failure|0|||
127656111|NCT00405639|459363161|FG000|Overall Study|Withdrawal by Subject|1|||
127656112|NCT00405639|459363162|FG001|Overall Study|Withdrawal by Subject|0|||
127656113|NCT00405639|459363161|FG000|Overall Study|Adverse Event|1|||
127656114|NCT00405639|459363162|FG001|Overall Study|Adverse Event|0|||
127656115|NCT00405639|459363161|FG000|Overall Study|Seizure prior to receiving BNP|1|||
127656116|NCT00405639|459363162|FG001|Overall Study|Seizure prior to receiving BNP|0|||
127656117|NCT00265330|459363163|FG000|Overall Study|Adverse Event|41|||
127656118|NCT00265330|459363163|FG000|Overall Study|Lost to Follow-up|8|||
127656119|NCT00265330|459363163|FG000|Overall Study|Withdrawal by Subject|34|||
127656120|NCT00265330|459363163|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
127656121|NCT00265330|459363163|FG000|Overall Study|Lack of Efficacy|4|||
127656122|NCT00265330|459363163|FG000|Overall Study|Family Scheduling Conflicts|1|||
127656123|NCT00265330|459363163|FG000|Overall Study|Began Taking Formulary Geodon|1|||
127656124|NCT00265330|459363163|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
127656125|NCT00265330|459363163|FG000|Overall Study|Site Closed by Sponsor|1|||
127656126|NCT00265330|459363163|FG000|Overall Study|Principal Investigators Request|1|||
127656127|NCT00265330|459363163|FG000|Overall Study|Withdrew Consent|1|||
127656128|NCT00265330|459363163|FG000|Overall Study|Protocol Violation|1|||
127656129|NCT03108157|459363164|FG000|Overall Study|Protocol Violation|15|||
127656130|NCT03108157|459363165|FG001|Overall Study|Protocol Violation|4|||
127656131|NCT05067933|459363179|FG000|Overall Study|Withdrawal by Subject|2|||
127656132|NCT05067933|459363180|FG001|Overall Study|Withdrawal by Subject|0|||
127656133|NCT05067933|459363181|FG002|Overall Study|Withdrawal by Subject|0|||
127656134|NCT05067933|459363182|FG003|Overall Study|Withdrawal by Subject|0|||
127656135|NCT05067933|459363183|FG004|Overall Study|Withdrawal by Subject|0|||
127656136|NCT05067933|459363184|FG005|Overall Study|Withdrawal by Subject|0|||
127656137|NCT05067933|459363179|FG000|Overall Study|Lost to Follow-up|1|||
127656138|NCT05067933|459363180|FG001|Overall Study|Lost to Follow-up|1|||
127656139|NCT05067933|459363181|FG002|Overall Study|Lost to Follow-up|1|||
127656140|NCT05067933|459363182|FG003|Overall Study|Lost to Follow-up|2|||
127656141|NCT05067933|459363183|FG004|Overall Study|Lost to Follow-up|1|||
127656142|NCT05067933|459363184|FG005|Overall Study|Lost to Follow-up|0|||
127656143|NCT05067933|459363179|FG000|Overall Study|Miscellaneous|1|||
127656144|NCT05067933|459363180|FG001|Overall Study|Miscellaneous|0|||
127656145|NCT05067933|459363181|FG002|Overall Study|Miscellaneous|0|||
127656146|NCT05067933|459363182|FG003|Overall Study|Miscellaneous|0|||
127656147|NCT05067933|459363183|FG004|Overall Study|Miscellaneous|0|||
127656148|NCT05067933|459363184|FG005|Overall Study|Miscellaneous|0|||
127656149|NCT05067933|459363179|FG000|Overall Study|Death|0|||
127656150|NCT05067933|459363180|FG001|Overall Study|Death|0|||
127656151|NCT05067933|459363181|FG002|Overall Study|Death|0|||
127656152|NCT05067933|459363182|FG003|Overall Study|Death|1|||
127656153|NCT05067933|459363183|FG004|Overall Study|Death|0|||
127656154|NCT05067933|459363184|FG005|Overall Study|Death|0|||
127656155|NCT01065350|459363190|FG000|Overall Study|Received incorrect drug allocation|0|||
127986677|NCT00441363|460575509|FG000|Overall Study|Lost to Follow-up|2|||
127986678|NCT00441363|460575510|FG001|Overall Study|Lost to Follow-up|2|||
127986679|NCT00441363|460575509|FG000|Overall Study|Other|2|||
127986680|NCT00441363|460575510|FG001|Overall Study|Other|0|||
127656156|NCT01065350|459363191|FG001|Overall Study|Received incorrect drug allocation|1|||
127656157|NCT03443713|459363192|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
127656158|NCT03443713|459363193|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
127656159|NCT03443713|459363194|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
127986681|NCT04114656|460575513|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
127656160|NCT05879198|459363196|FG000|Overall Study|Lost to Follow-up|1|||
127656161|NCT00663117|459364662|FG000|Overall Study|Lack of Efficacy|1|||
127656162|NCT00663117|459364663|FG001|Overall Study|Lack of Efficacy|0|||
127656163|NCT01992549|459364668|FG000|Overall Study|Lost to Follow-up|2|||
127656164|NCT01992549|459364668|FG000|Overall Study|Serious Adverse Event|1|||
127656165|NCT01992549|459364668|FG000|Overall Study|Product Switch to Extend Half Life|1|||
127656166|NCT00767104|459364674|FG000|Overall Study|Lost to Follow-up|1|||
127656167|NCT00767104|459364675|FG001|Overall Study|Lost to Follow-up|2|||
127656168|NCT03285295|459364678|FG000|Alinity s HBsAg|Protocol Violation|11|||
127656169|NCT03285295|459364679|FG001|Alinity s HBsAg|Protocol Violation|0|||
127656170|NCT03285295|459364680|FG002|Alinity s HBsAg|Protocol Violation|0|||
127656171|NCT03285295|459364681|FG003|Alinity s HBsAg|Protocol Violation|0|||
127656172|NCT03285295|459364682|FG004|Alinity s HBsAg|Protocol Violation|0|||
127656173|NCT03285295|459364678|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
127656174|NCT03285295|459364679|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
127656175|NCT03285295|459364680|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
127656176|NCT03285295|459364681|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
127656177|NCT03285295|459364682|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
127656178|NCT03285295|459364678|FG000|Alinity s HBsAg|No Results Generated|74|||
127656179|NCT03285295|459364679|FG001|Alinity s HBsAg|No Results Generated|6|||
127656180|NCT03285295|459364680|FG002|Alinity s HBsAg|No Results Generated|0|||
127656181|NCT03285295|459364681|FG003|Alinity s HBsAg|No Results Generated|0|||
127656182|NCT03285295|459364682|FG004|Alinity s HBsAg|No Results Generated|0|||
127656183|NCT03285295|459364678|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
127656184|NCT03285295|459364679|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
127656185|NCT03285295|459364680|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
127656186|NCT03285295|459364681|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
127656187|NCT03285295|459364682|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
127656188|NCT03285295|459364678|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
127656189|NCT03285295|459364679|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
127656190|NCT03285295|459364680|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
127656191|NCT03285295|459364681|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
127656192|NCT03285295|459364682|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
127656193|NCT03285295|459364678|FG000|Alinity s HTLV I/II|No Results Generated|70|||
127656194|NCT03285295|459364679|FG001|Alinity s HTLV I/II|No Results Generated|0|||
127656195|NCT03285295|459364680|FG002|Alinity s HTLV I/II|No Results Generated|0|||
127656196|NCT03285295|459364681|FG003|Alinity s HTLV I/II|No Results Generated|0|||
127656197|NCT03285295|459364682|FG004|Alinity s HTLV I/II|No Results Generated|0|||
127656198|NCT03285295|459364678|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
127656199|NCT03285295|459364679|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
127656200|NCT03285295|459364680|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
127656201|NCT03285295|459364681|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
127656202|NCT03285295|459364682|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
127656203|NCT03285295|459364678|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
127656204|NCT03285295|459364679|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
127656205|NCT03285295|459364680|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
127656206|NCT03285295|459364681|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
127656207|NCT03285295|459364682|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
127656208|NCT03285295|459364678|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
127656209|NCT03285295|459364679|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
127656210|NCT03285295|459364680|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
127656211|NCT03285295|459364681|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
127656212|NCT03285295|459364682|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
127656213|NCT03285295|459364678|FG000|Alinity s Anti-HCV|No Results Generated|71|||
127656214|NCT03285295|459364679|FG001|Alinity s Anti-HCV|No Results Generated|0|||
127656215|NCT03285295|459364680|FG002|Alinity s Anti-HCV|No Results Generated|0|||
127656216|NCT03285295|459364681|FG003|Alinity s Anti-HCV|No Results Generated|0|||
127656217|NCT03285295|459364682|FG004|Alinity s Anti-HCV|No Results Generated|0|||
127656218|NCT03285295|459364678|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
127656219|NCT03285295|459364679|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
127656220|NCT03285295|459364680|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
127656221|NCT03285295|459364681|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
127656222|NCT03285295|459364682|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
127656223|NCT03285295|459364678|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
127656224|NCT03285295|459364679|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
127656225|NCT03285295|459364680|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
127656226|NCT03285295|459364681|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
127656227|NCT03285295|459364682|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
127656228|NCT03285295|459364678|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
127656229|NCT03285295|459364679|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
127656230|NCT03285295|459364680|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
127656231|NCT03285295|459364681|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
127656232|NCT03285295|459364682|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
127656233|NCT03285295|459364678|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
127656234|NCT03285295|459364679|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
127656235|NCT03285295|459364680|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
127656236|NCT03285295|459364681|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
127656237|NCT03285295|459364682|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
127656238|NCT03285295|459364678|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
127656239|NCT03285295|459364679|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
127986682|NCT04114656|460575514|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
127986683|NCT04114656|460575513|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
127986684|NCT04114656|460575514|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
127986685|NCT04114656|460575513|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
127986686|NCT04114656|460575514|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
127543053|NCT00945009|458954734|FG002|Overall Study|Protocol Violation|0|||
127543054|NCT00945009|458954732|FG000|Overall Study|Withdrawal by Subject|1|||
127543055|NCT00945009|458954733|FG001|Overall Study|Withdrawal by Subject|0|||
127543056|NCT00945009|458954734|FG002|Overall Study|Withdrawal by Subject|0|||
127543057|NCT00945009|458954732|FG000|Overall Study|Ineligible|6|||
127543058|NCT00945009|458954733|FG001|Overall Study|Ineligible|1|||
127543059|NCT00945009|458954734|FG002|Overall Study|Ineligible|0|||
127543060|NCT00945009|458954732|FG000|Overall Study|Inevaluable|0|||
127543061|NCT00945009|458954733|FG001|Overall Study|Inevaluable|1|||
127543062|NCT00945009|458954734|FG002|Overall Study|Inevaluable|0|||
127543063|NCT00945009|458954732|FG000|Overall Study|Refusal of further protocol|1|||
127543064|NCT00945009|458954733|FG001|Overall Study|Refusal of further protocol|0|||
127543065|NCT00945009|458954734|FG002|Overall Study|Refusal of further protocol|0|||
127543066|NCT04607005|458954735|FG000|Overall Study|Adverse Event|0|||
127543067|NCT04607005|458954736|FG001|Overall Study|Adverse Event|1|||
127543068|NCT04607005|458954735|FG000|Overall Study|Lack of Efficacy|1|||
127543069|NCT04607005|458954736|FG001|Overall Study|Lack of Efficacy|6|||
127543070|NCT04607005|458954735|FG000|Overall Study|Withdrawal by Subject|4|||
127543071|NCT04607005|458954736|FG001|Overall Study|Withdrawal by Subject|9|||
127543072|NCT04607005|458954735|FG000|Overall Study|Participant reached protocol-defined stopping criteria|1|||
127543073|NCT04607005|458954736|FG001|Overall Study|Participant reached protocol-defined stopping criteria|0|||
127543074|NCT03919773|458954737|FG000|First Intervention- (12 Weeks)|Adverse Event|1|||
127543075|NCT03919773|458954738|FG001|First Intervention- (12 Weeks)|Adverse Event|1|||
127543076|NCT03919773|458954737|FG000|First Intervention- (12 Weeks)|Protocol Violation|0|||
127543077|NCT03919773|458954738|FG001|First Intervention- (12 Weeks)|Protocol Violation|1|||
127543078|NCT04659044|458954739|FG000|Induction|Physician Decision|1|||
127543079|NCT04659044|458954739|FG000|Induction|Adverse Event|2|||
127543080|NCT03589859|458954740|FG000|Overall Study|Withdrawal by Subject|0|||
127543081|NCT03589859|458954741|FG001|Overall Study|Withdrawal by Subject|6|||
127543082|NCT02331134|458954742|FG000|Overall Study|Withdrawal by Subject|1|||
127543083|NCT04966013|458954743|FG000|Overall Study|Withdrawal by Subject|0|||
127543084|NCT04966013|458954744|FG001|Overall Study|Withdrawal by Subject|2|||
127543085|NCT04966013|458954745|FG002|Overall Study|Withdrawal by Subject|1|||
127543086|NCT04966013|458954743|FG000|Overall Study|Adverse Event|2|||
127543087|NCT04966013|458954744|FG001|Overall Study|Adverse Event|1|||
127543088|NCT04966013|458954745|FG002|Overall Study|Adverse Event|1|||
127543089|NCT03518086|458954749|FG000|Overall Study|Adverse Event|23|||
127543090|NCT03518086|458954750|FG001|Overall Study|Adverse Event|15|||
127543091|NCT03518086|458954751|FG002|Overall Study|Adverse Event|3|||
127543092|NCT03518086|458954752|FG003|Overall Study|Adverse Event|2|||
127543093|NCT03518086|458954749|FG000|Overall Study|Withdrawal by Subject|8|||
127543094|NCT03518086|458954750|FG001|Overall Study|Withdrawal by Subject|5|||
127543095|NCT03518086|458954751|FG002|Overall Study|Withdrawal by Subject|1|||
127543096|NCT03518086|458954752|FG003|Overall Study|Withdrawal by Subject|0|||
127543097|NCT03518086|458954749|FG000|Overall Study|Lack of Efficacy|5|||
127543098|NCT03518086|458954750|FG001|Overall Study|Lack of Efficacy|5|||
127543099|NCT03518086|458954751|FG002|Overall Study|Lack of Efficacy|0|||
127543100|NCT03518086|458954752|FG003|Overall Study|Lack of Efficacy|2|||
127543101|NCT03518086|458954749|FG000|Overall Study|Protocol Violation|1|||
127543102|NCT03518086|458954750|FG001|Overall Study|Protocol Violation|5|||
127543103|NCT03518086|458954751|FG002|Overall Study|Protocol Violation|1|||
127543104|NCT03518086|458954752|FG003|Overall Study|Protocol Violation|3|||
127543105|NCT03518086|458954749|FG000|Overall Study|Lost to Follow-up|0|||
127543106|NCT03518086|458954750|FG001|Overall Study|Lost to Follow-up|3|||
127543107|NCT03518086|458954751|FG002|Overall Study|Lost to Follow-up|0|||
127543108|NCT03518086|458954752|FG003|Overall Study|Lost to Follow-up|0|||
127543109|NCT03518086|458954749|FG000|Overall Study|Insufficient Diary Data|0|||
127543110|NCT03518086|458954750|FG001|Overall Study|Insufficient Diary Data|2|||
127543111|NCT03518086|458954751|FG002|Overall Study|Insufficient Diary Data|0|||
127543112|NCT03518086|458954752|FG003|Overall Study|Insufficient Diary Data|0|||
127543113|NCT03518086|458954749|FG000|Overall Study|Non- compliance to Protocol|0|||
127543114|NCT03518086|458954750|FG001|Overall Study|Non- compliance to Protocol|1|||
127656240|NCT03285295|459364680|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
127543115|NCT03518086|458954751|FG002|Overall Study|Non- compliance to Protocol|0|||
127543116|NCT03518086|458954752|FG003|Overall Study|Non- compliance to Protocol|0|||
127543117|NCT03518086|458954749|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
127656241|NCT03285295|459364681|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
127656242|NCT03285295|459364682|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
127543118|NCT03518086|458954750|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
127543119|NCT03518086|458954751|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
127656243|NCT03285295|459364678|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
127656244|NCT03285295|459364679|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
127656245|NCT03285295|459364680|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
127656246|NCT03285295|459364681|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
127656247|NCT03285295|459364682|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
127656248|NCT03285295|459364678|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
127656249|NCT03285295|459364679|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
127656250|NCT03285295|459364680|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
127656251|NCT03285295|459364681|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
127656252|NCT03285295|459364682|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
127656253|NCT03285295|459364678|FG000|Alinity s Anti-HBc|No Results Generated|70|||
127656254|NCT03285295|459364679|FG001|Alinity s Anti-HBc|No Results Generated|0|||
127656255|NCT03285295|459364680|FG002|Alinity s Anti-HBc|No Results Generated|0|||
127656256|NCT03285295|459364681|FG003|Alinity s Anti-HBc|No Results Generated|0|||
127656257|NCT03285295|459364682|FG004|Alinity s Anti-HBc|No Results Generated|0|||
127656258|NCT03285295|459364678|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
127656259|NCT03285295|459364679|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
127656260|NCT03285295|459364680|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
127656261|NCT03285295|459364681|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
127656262|NCT03285295|459364682|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
127656263|NCT03285295|459364678|FG000|Alinity s Chagas|Protocol Violation|76|||
127656264|NCT03285295|459364679|FG001|Alinity s Chagas|Protocol Violation|0|||
127656265|NCT03285295|459364680|FG002|Alinity s Chagas|Protocol Violation|0|||
127656266|NCT03285295|459364681|FG003|Alinity s Chagas|Protocol Violation|0|||
127656267|NCT03285295|459364682|FG004|Alinity s Chagas|Protocol Violation|0|||
127656268|NCT03285295|459364678|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
127656269|NCT03285295|459364679|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
127656270|NCT03285295|459364680|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
127656271|NCT03285295|459364681|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
127656272|NCT03285295|459364682|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
127656273|NCT03285295|459364678|FG000|Alinity s Chagas|No Results Generated|105|||
127656274|NCT03285295|459364679|FG001|Alinity s Chagas|No Results Generated|0|||
127656275|NCT03285295|459364680|FG002|Alinity s Chagas|No Results Generated|0|||
127656276|NCT03285295|459364681|FG003|Alinity s Chagas|No Results Generated|0|||
127656277|NCT03285295|459364682|FG004|Alinity s Chagas|No Results Generated|0|||
127656278|NCT03285295|459364678|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
127656279|NCT03285295|459364679|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
127656280|NCT03285295|459364680|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
127656281|NCT03285295|459364681|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
127656282|NCT03285295|459364682|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
127656283|NCT02045433|459364686|FG000|Overall Study|Withdrawal by Subject|1|||
127656284|NCT02176421|459364687|FG000|Overall Study|Lost to Follow-up|4|||
127656285|NCT02176421|459364687|FG000|Overall Study|Adverse Event|1|||
127656286|NCT02145078|459364690|FG000|Overall Study|Death|1|||
127656287|NCT02145078|459364690|FG000|Overall Study|Reason not given|3|||
127656288|NCT02440594|459364691|FG000|Overall Study|Lost to Follow-up|34|||
127656289|NCT02440594|459364692|FG001|Overall Study|Lost to Follow-up|33|||
127656290|NCT02440594|459364693|FG002|Overall Study|Lost to Follow-up|54|||
127656291|NCT02440594|459364694|FG003|Overall Study|Lost to Follow-up|47|||
127656292|NCT02440594|459364695|FG004|Overall Study|Lost to Follow-up|5|||
127656293|NCT02440594|459364696|FG005|Overall Study|Lost to Follow-up|4|||
127656294|NCT02440594|459364697|FG006|Overall Study|Lost to Follow-up|28|||
127656295|NCT02440594|459364698|FG007|Overall Study|Lost to Follow-up|48|||
127986687|NCT04114656|460575513|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
127986688|NCT04114656|460575514|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
127986689|NCT04114656|460575513|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
127986690|NCT04114656|460575514|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
127986691|NCT02578940|460575515|FG000|Overall Study|Screening failure|5|||
127986692|NCT02578940|460575515|FG000|Overall Study|Lost to Follow-up|1|||
127986693|NCT03326518|460575523|FG000|Overall Study|Protocol Violation|1|||
127986694|NCT03326518|460575524|FG001|Overall Study|Protocol Violation|0|||
127986695|NCT03326518|460575525|FG002|Overall Study|Protocol Violation|0|||
127986696|NCT03326518|460575523|FG000|Overall Study|Withdrawal by Subject|1|||
127986697|NCT03326518|460575524|FG001|Overall Study|Withdrawal by Subject|0|||
127986698|NCT03326518|460575525|FG002|Overall Study|Withdrawal by Subject|0|||
127986699|NCT03326518|460575523|FG000|Overall Study|Lost to Follow-up|1|||
127986700|NCT03326518|460575524|FG001|Overall Study|Lost to Follow-up|0|||
127986701|NCT03326518|460575525|FG002|Overall Study|Lost to Follow-up|1|||
127986702|NCT01375374|460575528|FG000|Overall Study|Adverse Event|1|||
127986703|NCT02065518|460575529|FG000|Overall Study|Lost to Follow-up|3|||
127656296|NCT02440594|459364691|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
127656297|NCT02440594|459364692|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
127656298|NCT02440594|459364693|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
127656299|NCT02440594|459364694|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
127656300|NCT02440594|459364695|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
127656301|NCT02440594|459364696|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
127656302|NCT02440594|459364697|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
127656303|NCT02440594|459364698|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
127656304|NCT02440594|459364691|FG000|Overall Study|Withdrawal by Subject|81|||
127656305|NCT02440594|459364692|FG001|Overall Study|Withdrawal by Subject|67|||
127656306|NCT02440594|459364693|FG002|Overall Study|Withdrawal by Subject|59|||
127656307|NCT02440594|459364694|FG003|Overall Study|Withdrawal by Subject|38|||
127656308|NCT02440594|459364695|FG004|Overall Study|Withdrawal by Subject|2|||
127656309|NCT02440594|459364696|FG005|Overall Study|Withdrawal by Subject|2|||
127656310|NCT02440594|459364697|FG006|Overall Study|Withdrawal by Subject|7|||
127656311|NCT02440594|459364698|FG007|Overall Study|Withdrawal by Subject|7|||
127656312|NCT02440594|459364691|FG000|Overall Study|Administratively w/drawn|3|||
127656313|NCT02440594|459364692|FG001|Overall Study|Administratively w/drawn|2|||
127656314|NCT02440594|459364693|FG002|Overall Study|Administratively w/drawn|0|||
127656315|NCT02440594|459364694|FG003|Overall Study|Administratively w/drawn|0|||
127656316|NCT02440594|459364695|FG004|Overall Study|Administratively w/drawn|0|||
127656317|NCT02440594|459364696|FG005|Overall Study|Administratively w/drawn|0|||
127656318|NCT02440594|459364697|FG006|Overall Study|Administratively w/drawn|2|||
127656319|NCT02440594|459364698|FG007|Overall Study|Administratively w/drawn|1|||
127656320|NCT02341456|459364699|FG000|Overall Study|Disease progression|2|||
127656321|NCT02341456|459364700|FG001|Overall Study|Disease progression|3|||
127656322|NCT02341456|459364701|FG002|Overall Study|Disease progression|1|||
127656323|NCT02341456|459364699|FG000|Overall Study|Death|1|||
127656324|NCT02341456|459364700|FG001|Overall Study|Death|1|||
127656325|NCT02341456|459364701|FG002|Overall Study|Death|1|||
127656326|NCT02341456|459364699|FG000|Overall Study|Withdrawal by Subject|0|||
127656327|NCT02341456|459364700|FG001|Overall Study|Withdrawal by Subject|1|||
127656328|NCT02341456|459364701|FG002|Overall Study|Withdrawal by Subject|1|||
127656329|NCT02341456|459364699|FG000|Overall Study|Moved to local access programme.|0|||
127656330|NCT02341456|459364700|FG001|Overall Study|Moved to local access programme.|1|||
127656331|NCT02341456|459364701|FG002|Overall Study|Moved to local access programme.|1|||
127656332|NCT02341456|459364699|FG000|Overall Study|Physician Decision|1|||
127656333|NCT02341456|459364700|FG001|Overall Study|Physician Decision|0|||
127656334|NCT02341456|459364701|FG002|Overall Study|Physician Decision|0|||
127656335|NCT01111838|459364704|FG000|Overall Study|Patient Ineligible|2|||
127656336|NCT01111838|459364704|FG000|Overall Study|Not Treated|3|||
127656337|NCT01111838|459364704|FG000|Overall Study|Clinical deterioration|1|||
127656338|NCT01111838|459364704|FG000|Overall Study|Other Complicating Disease|1|||
127656339|NCT00641719|459364705|FG000|Overall Study|Lack of Efficacy|1|||
127656340|NCT00641719|459364706|FG001|Overall Study|Lack of Efficacy|2|||
127656341|NCT00641719|459364705|FG000|Overall Study|Adverse Event|24|||
127656342|NCT00641719|459364706|FG001|Overall Study|Adverse Event|29|||
127656343|NCT00641719|459364705|FG000|Overall Study|Withdrawal by Subject|4|||
127656344|NCT00641719|459364706|FG001|Overall Study|Withdrawal by Subject|4|||
127656345|NCT00641719|459364705|FG000|Overall Study|Reason Not Specified|1|||
127656346|NCT00641719|459364706|FG001|Overall Study|Reason Not Specified|2|||
127656347|NCT03303469|459364707|FG000|Overall Study|Lost to Follow-up|2|||
127656348|NCT04741802|459364709|FG000|Overall Study|Death|1|||
127656349|NCT04741802|459364709|FG000|Overall Study|Lost to Follow-up|11|||
127656350|NCT01785563|459364711|FG000|Overall Study|Physician Decision|10|||
127656351|NCT01785563|459364711|FG000|Overall Study|Withdrawal by Subject|1|||
127656352|NCT01785563|459364711|FG000|Overall Study|Protocol Violation|2|||
127656353|NCT01872910|459364712|FG000|Overall Study|Lost to Follow-up|2|||
127656354|NCT01872910|459364713|FG001|Overall Study|Lost to Follow-up|0|||
127656355|NCT01872910|459364714|FG002|Overall Study|Lost to Follow-up|2|||
127986704|NCT02065518|460575530|FG001|Overall Study|Lost to Follow-up|4|||
127986705|NCT02065518|460575531|FG002|Overall Study|Lost to Follow-up|0|||
127986706|NCT02065518|460575532|FG003|Overall Study|Lost to Follow-up|3|||
127986707|NCT02065518|460575529|FG000|Overall Study|Withdrawal by Subject|3|||
127986708|NCT02065518|460575530|FG001|Overall Study|Withdrawal by Subject|4|||
127986709|NCT02065518|460575531|FG002|Overall Study|Withdrawal by Subject|9|||
127986710|NCT02065518|460575532|FG003|Overall Study|Withdrawal by Subject|2|||
127986711|NCT04849416|460575533|FG000|Overall Study|Ongoing Treatment|12|||
127656356|NCT01872910|459364715|FG003|Overall Study|Lost to Follow-up|0|||
127656357|NCT01872910|459364716|FG004|Overall Study|Lost to Follow-up|0|||
127656358|NCT01872910|459364717|FG005|Overall Study|Lost to Follow-up|0|||
127656359|NCT03101241|459364719|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
127656360|NCT03101241|459364720|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
127656361|NCT03101241|459364719|FG000|Overall Study|Participant withdrew consent|3|||
127656362|NCT03101241|459364720|FG001|Overall Study|Participant withdrew consent|1|||
127656363|NCT03101241|459364719|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
127656364|NCT03101241|459364720|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
127656365|NCT03101241|459364719|FG000|Overall Study|Lost to Follow-up|2|||
127656366|NCT03101241|459364720|FG001|Overall Study|Lost to Follow-up|0|||
127656367|NCT03101241|459364719|FG000|Overall Study|Lack of Efficacy|0|||
127656368|NCT03101241|459364720|FG001|Overall Study|Lack of Efficacy|1|||
127656369|NCT03101241|459364719|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
127656370|NCT03101241|459364720|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
127656371|NCT03469349|459364721|FG000|Overall Study|Withdrawal by Subject|1|||
127656372|NCT03469349|459364722|FG001|Overall Study|Withdrawal by Subject|3|||
127656373|NCT03469349|459364721|FG000|Overall Study|Progressive Disease|0|||
127656374|NCT03469349|459364722|FG001|Overall Study|Progressive Disease|1|||
127656375|NCT03469349|459364721|FG000|Overall Study|Lost to Follow-up|2|||
127656376|NCT03469349|459364722|FG001|Overall Study|Lost to Follow-up|2|||
127656377|NCT03469349|459364721|FG000|Overall Study|Adverse Event|2|||
127656378|NCT03469349|459364722|FG001|Overall Study|Adverse Event|4|||
127656379|NCT02357810|459364729|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
127656380|NCT02357810|459364729|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
127656381|NCT02357810|459364729|FG000|Reached 12 Weeks Response|Adverse Event|5|||
127656382|NCT02357810|459364729|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
127656383|NCT02357810|459364729|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
127656384|NCT02357810|459364729|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
127656385|NCT02357810|459364729|FG000|Reached 12 Weeks Response|Death|1|||
127656386|NCT02357810|459364729|FG000|Reached 12 Weeks Response|Physician Decision|1|||
127656387|NCT02357810|459364729|FG000|Reached 12 Weeks Response|Other|1|||
127656388|NCT02357810|459364729|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
127656389|NCT02357810|459364729|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
127656390|NCT02357810|459364729|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
127656391|NCT02357810|459364729|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
127986712|NCT04849416|460575534|FG001|Overall Study|Ongoing Treatment|5|||
127986713|NCT04849416|460575535|FG002|Overall Study|Ongoing Treatment|3|||
127986714|NCT04849416|460575533|FG000|Overall Study|On Post-Treatment Follow-up|8|||
127986715|NCT04849416|460575534|FG001|Overall Study|On Post-Treatment Follow-up|9|||
127986716|NCT04849416|460575535|FG002|Overall Study|On Post-Treatment Follow-up|10|||
127986717|NCT04849416|460575533|FG000|Overall Study|Withdrawal by Subject|0|||
127986718|NCT04849416|460575534|FG001|Overall Study|Withdrawal by Subject|0|||
127986719|NCT04849416|460575535|FG002|Overall Study|Withdrawal by Subject|1|||
127986720|NCT04849416|460575533|FG000|Overall Study|Lost to Follow-up|1|||
127986721|NCT04849416|460575534|FG001|Overall Study|Lost to Follow-up|0|||
127986722|NCT04849416|460575535|FG002|Overall Study|Lost to Follow-up|0|||
127986723|NCT01716520|460575544|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
127986724|NCT01716520|460575545|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
127986725|NCT01716520|460575546|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
127986726|NCT01716520|460575547|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
127986727|NCT01716520|460575548|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
127986728|NCT01716520|460575549|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
127986729|NCT01716520|460575544|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
127986730|NCT01716520|460575545|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
127986731|NCT01716520|460575546|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
127986732|NCT01716520|460575547|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
127986733|NCT01716520|460575548|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
127986734|NCT01716520|460575549|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
127986735|NCT01716520|460575544|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
127986736|NCT01716520|460575545|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
127986737|NCT01716520|460575546|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
127986738|NCT01716520|460575547|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
127986739|NCT01716520|460575548|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
127986740|NCT01716520|460575549|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
127986741|NCT01716520|460575544|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
127986742|NCT01716520|460575545|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
127986743|NCT01716520|460575546|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
127986744|NCT01716520|460575547|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
127986745|NCT01716520|460575548|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
127986746|NCT01716520|460575549|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
127986747|NCT01716520|460575544|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
127986748|NCT01716520|460575545|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
127986749|NCT01716520|460575546|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
127986750|NCT01716520|460575547|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
127656392|NCT02357810|459364729|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
127656393|NCT02357810|459364729|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
127656394|NCT00980005|459364730|FG000|Overall Study|Withdrawal by Subject|6|||
127656395|NCT00980005|459364731|FG001|Overall Study|Withdrawal by Subject|17|||
127656396|NCT00980005|459364730|FG000|Overall Study|Lost to Follow-up|37|||
127986751|NCT01716520|460575548|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
127656397|NCT00980005|459364731|FG001|Overall Study|Lost to Follow-up|43|||
127656398|NCT00980005|459364730|FG000|Overall Study|Other|4|||
127656399|NCT00980005|459364731|FG001|Overall Study|Other|3|||
127656400|NCT00692406|459364732|FG000|Overall Study|PI dropped, bad data|57|||
127656401|NCT05952297|459364734|FG000|Overall Study|Withdrawal by Subject|1|||
127656402|NCT05952297|459364735|FG001|Overall Study|Withdrawal by Subject|0|||
127656403|NCT00525265|459364738|FG000|Overall Study|Protocol Violation|1|||
127656404|NCT00525265|459364739|FG001|Overall Study|Protocol Violation|0|||
127656405|NCT03107377|459364740|FG000|Overall Study|Adverse Event|3|||
127656406|NCT03107377|459364741|FG001|Overall Study|Adverse Event|3|||
127656407|NCT03107377|459364740|FG000|Overall Study|Protocol Violation|9|||
127656408|NCT03107377|459364741|FG001|Overall Study|Protocol Violation|12|||
127656409|NCT03107377|459364740|FG000|Overall Study|Physician Decision|3|||
127656410|NCT03107377|459364741|FG001|Overall Study|Physician Decision|6|||
127656411|NCT03107377|459364740|FG000|Overall Study|Pregnancy|7|||
127656412|NCT03107377|459364741|FG001|Overall Study|Pregnancy|7|||
127656413|NCT03107377|459364740|FG000|Overall Study|Withdrawal by Subject|16|||
127656414|NCT03107377|459364741|FG001|Overall Study|Withdrawal by Subject|22|||
127656415|NCT03107377|459364740|FG000|Overall Study|Lost to Follow-up|37|||
127656416|NCT03107377|459364741|FG001|Overall Study|Lost to Follow-up|34|||
127656417|NCT03107377|459364740|FG000|Overall Study|Other reason not specified|16|||
127656418|NCT03107377|459364741|FG001|Overall Study|Other reason not specified|15|||
127656419|NCT00211237|459364742|FG000|Baseline|Withdrew|1|||
127656420|NCT00211237|459364743|FG001|Baseline|Withdrew|3|||
127656421|NCT00211237|459364744|FG002|Baseline|Withdrew|0|||
127656422|NCT00211237|459364742|FG000|Baseline|Refused random assignment|1|||
127656423|NCT00211237|459364743|FG001|Baseline|Refused random assignment|0|||
127986752|NCT01716520|460575549|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
127986753|NCT01716520|460575544|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
127986754|NCT01716520|460575545|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
127986755|NCT01716520|460575546|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
127986756|NCT01716520|460575547|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
127656424|NCT00211237|459364744|FG002|Baseline|Refused random assignment|0|||
127656425|NCT00211237|459364742|FG000|1 Month|Death|2|||
127656426|NCT00211237|459364743|FG001|1 Month|Death|1|||
127656427|NCT00211237|459364744|FG002|1 Month|Death|0|||
127656428|NCT00211237|459364742|FG000|1 Month|Lost to Follow-up|0|||
127656429|NCT00211237|459364743|FG001|1 Month|Lost to Follow-up|2|||
127656430|NCT00211237|459364744|FG002|1 Month|Lost to Follow-up|0|||
127656431|NCT00211237|459364742|FG000|1 Month|Withdrew|0|||
127656432|NCT00211237|459364743|FG001|1 Month|Withdrew|4|||
127656433|NCT00211237|459364744|FG002|1 Month|Withdrew|0|||
127656434|NCT00211237|459364742|FG000|1 Month|Additional surgery needed|1|||
127656435|NCT00211237|459364743|FG001|1 Month|Additional surgery needed|0|||
127656436|NCT00211237|459364744|FG002|1 Month|Additional surgery needed|0|||
127656437|NCT00211237|459364742|FG000|1 Month|Non-medical problem|0|||
127656438|NCT00211237|459364743|FG001|1 Month|Non-medical problem|2|||
127656439|NCT00211237|459364744|FG002|1 Month|Non-medical problem|0|||
127986757|NCT01716520|460575548|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
127986758|NCT01716520|460575549|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
127986759|NCT01716520|460575544|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
127986760|NCT01716520|460575545|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
127986761|NCT01716520|460575546|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
127986762|NCT01716520|460575547|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
127986763|NCT01716520|460575548|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
127986764|NCT01716520|460575549|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
127986765|NCT01716520|460575544|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
127986766|NCT01716520|460575545|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
127986767|NCT01716520|460575546|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
127986768|NCT01716520|460575547|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
127986769|NCT01716520|460575548|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
127986770|NCT01716520|460575549|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
127986771|NCT01716520|460575544|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
127986772|NCT01716520|460575545|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
127986773|NCT01716520|460575546|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
127986774|NCT01716520|460575547|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
127656440|NCT00211237|459364742|FG000|3 Months|Death|7|||
127656441|NCT00211237|459364743|FG001|3 Months|Death|3|||
127656442|NCT00211237|459364744|FG002|3 Months|Death|0|||
127656443|NCT00211237|459364742|FG000|3 Months|Could not comply with protocol|1|||
127656444|NCT00211237|459364743|FG001|3 Months|Could not comply with protocol|0|||
127656445|NCT00211237|459364744|FG002|3 Months|Could not comply with protocol|0|||
127656446|NCT00211237|459364742|FG000|3 Months|Withdrew|0|||
127656447|NCT00211237|459364743|FG001|3 Months|Withdrew|1|||
127656448|NCT00211237|459364744|FG002|3 Months|Withdrew|0|||
127656449|NCT00211237|459364742|FG000|3 Months|Non-medical problem|0|||
127656450|NCT00211237|459364743|FG001|3 Months|Non-medical problem|0|||
127656451|NCT00211237|459364744|FG002|3 Months|Non-medical problem|1|||
127986775|NCT01716520|460575548|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
127986776|NCT01716520|460575549|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
127986777|NCT01716520|460575544|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
127986778|NCT01716520|460575545|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
127986779|NCT01716520|460575546|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
127986780|NCT01716520|460575547|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
127986781|NCT01716520|460575548|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
127986782|NCT01716520|460575549|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
127986783|NCT01716520|460575544|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
127986784|NCT01716520|460575545|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
127986785|NCT01716520|460575546|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
127986786|NCT01716520|460575547|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
127986787|NCT01716520|460575548|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
127986788|NCT01716520|460575549|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
127986789|NCT01716520|460575544|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
127986790|NCT01716520|460575545|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
127986791|NCT01716520|460575546|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
127986792|NCT01716520|460575547|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
127986793|NCT01716520|460575548|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
127986794|NCT01716520|460575549|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
127986795|NCT01716520|460575544|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
127986796|NCT01716520|460575545|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
127986797|NCT01716520|460575546|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
127986798|NCT01716520|460575547|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
127986799|NCT01716520|460575548|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
127986800|NCT01716520|460575549|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
127986801|NCT01716520|460575544|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
127986802|NCT01716520|460575545|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
127986803|NCT01716520|460575546|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
127986804|NCT01716520|460575547|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
127986805|NCT01716520|460575548|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
127986806|NCT01716520|460575549|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
127986807|NCT01716520|460575544|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
127986808|NCT01716520|460575545|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
127986809|NCT01716520|460575546|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
127986810|NCT01716520|460575547|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
127986811|NCT01716520|460575548|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
127986812|NCT01716520|460575549|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
127986813|NCT01937884|460575555|FG000|Overall Study|Withdrawal by Subject|1|||
127986814|NCT01937884|460575556|FG001|Overall Study|Withdrawal by Subject|0|||
127986815|NCT00004088|460575557|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
127986816|NCT00004088|460575557|FG000|Overall Study|Withdrawal by Subject|1|||
127986817|NCT00004088|460575557|FG000|Overall Study|Protocol Violation|3|||
127986818|NCT00004088|460575557|FG000|Overall Study|Physician Decision|1|||
127986819|NCT00981058|460575558|FG000|Overall Study|Progressive Disease|38|||
127986820|NCT00981058|460575559|FG001|Overall Study|Progressive Disease|31|||
127986821|NCT00981058|460575558|FG000|Overall Study|Lost to Follow-up|3|||
127986822|NCT00981058|460575559|FG001|Overall Study|Lost to Follow-up|2|||
127986823|NCT00981058|460575558|FG000|Overall Study|Physician Decision|4|||
127986824|NCT00981058|460575559|FG001|Overall Study|Physician Decision|5|||
127986825|NCT00981058|460575558|FG000|Overall Study|Randomization Error|0|||
127986826|NCT00981058|460575559|FG001|Overall Study|Randomization Error|1|||
127986827|NCT00981058|460575558|FG000|Overall Study|Withdrawal by Subject|24|||
127986828|NCT00981058|460575559|FG001|Overall Study|Withdrawal by Subject|22|||
127986829|NCT02667587|460575560|FG000|Pre-Treatment|Not reported|1|||
127986830|NCT02667587|460575561|FG001|Pre-Treatment|Not reported|0|||
127986831|NCT02667587|460575560|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
127986832|NCT02667587|460575561|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
127986833|NCT02667587|460575560|FG000|Pre-Treatment|Participant withdrew consent|0|||
127656452|NCT00211237|459364742|FG000|6 Months|Death|6|||
127656453|NCT00211237|459364743|FG001|6 Months|Death|0|||
127656454|NCT00211237|459364744|FG002|6 Months|Death|3|||
127656455|NCT00211237|459364742|FG000|6 Months|Lost to Follow-up|2|||
127986834|NCT02667587|460575561|FG001|Pre-Treatment|Participant withdrew consent|1|||
127986835|NCT02667587|460575560|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
127986836|NCT02667587|460575561|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
127656456|NCT00211237|459364743|FG001|6 Months|Lost to Follow-up|0|||
127986837|NCT02667587|460575560|FG000|End of Treatment|Disease Progression|193|||
127986838|NCT02667587|460575561|FG001|End of Treatment|Disease Progression|226|||
127656457|NCT00211237|459364744|FG002|6 Months|Lost to Follow-up|0|||
127656458|NCT00211237|459364742|FG000|6 Months|Could not comply with protocol|0|||
127656459|NCT00211237|459364743|FG001|6 Months|Could not comply with protocol|2|||
127656460|NCT00211237|459364744|FG002|6 Months|Could not comply with protocol|0|||
127656461|NCT00211237|459364742|FG000|12 Months|Death|8|||
127656462|NCT00211237|459364743|FG001|12 Months|Death|2|||
127656463|NCT00211237|459364744|FG002|12 Months|Death|3|||
127656464|NCT00211237|459364742|FG000|12 Months|Lost to Follow-up|1|||
127656465|NCT00211237|459364743|FG001|12 Months|Lost to Follow-up|0|||
127656466|NCT00211237|459364744|FG002|12 Months|Lost to Follow-up|1|||
127656467|NCT00211237|459364742|FG000|12 Months|Withdrew|0|||
127656468|NCT00211237|459364743|FG001|12 Months|Withdrew|0|||
127656469|NCT00211237|459364744|FG002|12 Months|Withdrew|1|||
127656470|NCT00211237|459364742|FG000|12 Months|unrelated medical problem|0|||
127656471|NCT00211237|459364743|FG001|12 Months|unrelated medical problem|0|||
127656472|NCT00211237|459364744|FG002|12 Months|unrelated medical problem|1|||
127656473|NCT01013792|459364745|FG000|Overall Study|Study suspended|2|||
127656474|NCT01013792|459364746|FG001|Overall Study|Study suspended|1|||
127656475|NCT01013792|459364745|FG000|Overall Study|Adverse Event|0|||
127656476|NCT01013792|459364746|FG001|Overall Study|Adverse Event|3|||
127656477|NCT01013792|459364745|FG000|Overall Study|Lost to Follow-up|0|||
127656478|NCT01013792|459364746|FG001|Overall Study|Lost to Follow-up|1|||
127656479|NCT02100722|459364747|FG000|Overall Study|Withdrawal pre-procedure|4|||
127656480|NCT02100722|459364748|FG001|Overall Study|Withdrawal pre-procedure|9|||
127656481|NCT02100722|459364747|FG000|Overall Study|Withdrawal post-procedure|0|||
127656482|NCT02100722|459364748|FG001|Overall Study|Withdrawal post-procedure|3|||
127656483|NCT02100722|459364747|FG000|Overall Study|Lost to Follow-up|2|||
127656484|NCT02100722|459364748|FG001|Overall Study|Lost to Follow-up|2|||
127656485|NCT02100722|459364747|FG000|Overall Study|Continuing on study|751|||
127656486|NCT02100722|459364748|FG001|Overall Study|Continuing on study|729|||
127656487|NCT05796518|459364754|FG000|Overall Study|Were enrolled but did not complete the intervention|2|||
127656488|NCT03500640|459364755|FG000|DPP Core Program (0-6 Months)|Lost to Follow-up|26|||
127656489|NCT03500640|459364756|FG001|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
127656490|NCT03500640|459364757|FG002|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
127656491|NCT03500640|459364755|FG000|DPP Core Program (0-6 Months)|Withdrawal by Subject|21|||
127656492|NCT03500640|459364756|FG001|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
127656493|NCT03500640|459364757|FG002|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
127656494|NCT03500640|459364755|FG000|DPP Core Program (0-6 Months)|No Exercise Clearance|3|||
127656495|NCT03500640|459364756|FG001|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
127656496|NCT03500640|459364757|FG002|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
127656497|NCT03500640|459364755|FG000|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|6|||
127656498|NCT03500640|459364756|FG001|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
127656499|NCT03500640|459364757|FG002|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
127656500|NCT03500640|459364755|FG000|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|0|||
127656501|NCT03500640|459364756|FG001|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|33|||
127656502|NCT03500640|459364757|FG002|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|41|||
127656503|NCT03500640|459364755|FG000|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|0|||
127656504|NCT03500640|459364756|FG001|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|1|||
127656505|NCT03500640|459364757|FG002|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|4|||
127656506|NCT03500640|459364755|FG000|Follow-up Contacts (13-18 Months)|Lost to Follow-up|0|||
127656507|NCT03500640|459364756|FG001|Follow-up Contacts (13-18 Months)|Lost to Follow-up|1|||
127656508|NCT03500640|459364757|FG002|Follow-up Contacts (13-18 Months)|Lost to Follow-up|9|||
127656509|NCT03500640|459364755|FG000|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|0|||
127656510|NCT03500640|459364756|FG001|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
127656511|NCT03500640|459364757|FG002|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
127656512|NCT03500640|459364755|FG000|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|0|||
127656513|NCT03500640|459364756|FG001|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|2|||
127656514|NCT03500640|459364757|FG002|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|1|||
127656515|NCT03500640|459364755|FG000|Follow-Up Contacts (19-24 Months)|Death|0|||
127656516|NCT03500640|459364756|FG001|Follow-Up Contacts (19-24 Months)|Death|1|||
127656517|NCT03500640|459364757|FG002|Follow-Up Contacts (19-24 Months)|Death|0|||
127656518|NCT01650519|459364758|FG000|Overall Study|Withdrawal by Subject|1|||
127656519|NCT01650519|459364759|FG001|Overall Study|Withdrawal by Subject|0|||
127656520|NCT05408468|459364762|FG000|Overall Study|Lost to Follow-up|3|||
127986839|NCT02667587|460575560|FG000|End of Treatment|Study Drug Toxicity|75|||
127986840|NCT02667587|460575561|FG001|End of Treatment|Study Drug Toxicity|19|||
127656521|NCT05408468|459364763|FG001|Overall Study|Lost to Follow-up|1|||
127656522|NCT05408468|459364762|FG000|Overall Study|Physician Decision|1|||
127656523|NCT05408468|459364763|FG001|Overall Study|Physician Decision|0|||
127543120|NCT03518086|458954752|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
127656524|NCT05408468|459364762|FG000|Overall Study|Overwhelmed by clinical situation|3|||
127656525|NCT05408468|459364763|FG001|Overall Study|Overwhelmed by clinical situation|0|||
127656526|NCT05408468|459364762|FG000|Overall Study|Personal illness precluding participation|1|||
127656527|NCT05408468|459364763|FG001|Overall Study|Personal illness precluding participation|0|||
127986841|NCT02667587|460575560|FG000|End of Treatment|Death|2|||
127986842|NCT02667587|460575561|FG001|End of Treatment|Death|1|||
127986843|NCT02667587|460575560|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
127986844|NCT02667587|460575561|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
127986845|NCT02667587|460575560|FG000|End of Treatment|participant request to discontinue treatment|33|||
127986846|NCT02667587|460575561|FG001|End of Treatment|participant request to discontinue treatment|35|||
127986847|NCT02667587|460575560|FG000|End of Treatment|participant withdrew consent|5|||
127986848|NCT02667587|460575561|FG001|End of Treatment|participant withdrew consent|6|||
127986849|NCT02667587|460575560|FG000|End of Treatment|Lost to Follow-up|1|||
127986850|NCT02667587|460575561|FG001|End of Treatment|Lost to Follow-up|2|||
127986851|NCT02667587|460575560|FG000|End of Treatment|maximum clinical benefit|4|||
127986852|NCT02667587|460575561|FG001|End of Treatment|maximum clinical benefit|4|||
127986853|NCT02667587|460575560|FG000|End of Treatment|poor or non compliant|0|||
127986854|NCT02667587|460575561|FG001|End of Treatment|poor or non compliant|1|||
127986855|NCT02667587|460575560|FG000|End of Treatment|participant no longer meets study criteria|1|||
127986856|NCT02667587|460575561|FG001|End of Treatment|participant no longer meets study criteria|1|||
127986857|NCT02667587|460575560|FG000|End of Treatment|administrative reason by sponsor|1|||
127986858|NCT02667587|460575561|FG001|End of Treatment|administrative reason by sponsor|29|||
127986859|NCT02667587|460575560|FG000|End of Treatment|other reasonse|21|||
127986860|NCT02667587|460575561|FG001|End of Treatment|other reasonse|10|||
127656528|NCT05408468|459364762|FG000|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
127656529|NCT05408468|459364763|FG001|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
127656530|NCT04186403|459364764|FG000|Overall Study|Adverse Event|1|||
127656531|NCT04186403|459364765|FG001|Overall Study|Adverse Event|8|||
127656532|NCT04186403|459364764|FG000|Overall Study|Lost to Follow-up|7|||
127656533|NCT04186403|459364765|FG001|Overall Study|Lost to Follow-up|3|||
127656534|NCT04186403|459364764|FG000|Overall Study|Physician Decision|1|||
127986861|NCT01134263|460575562|FG000|Overall Study|Serious adverse event|2|||
127986862|NCT01134263|460575563|FG001|Overall Study|Serious adverse event|1|||
127656535|NCT04186403|459364765|FG001|Overall Study|Physician Decision|0|||
127986863|NCT01134263|460575564|FG002|Overall Study|Serious adverse event|1|||
127986864|NCT01134263|460575565|FG003|Overall Study|Serious adverse event|1|||
127986865|NCT01134263|460575566|FG004|Overall Study|Serious adverse event|1|||
127986866|NCT01134263|460575562|FG000|Overall Study|Other adverse event|1|||
127986867|NCT01134263|460575563|FG001|Overall Study|Other adverse event|2|||
127986868|NCT01134263|460575564|FG002|Overall Study|Other adverse event|5|||
127986869|NCT01134263|460575565|FG003|Overall Study|Other adverse event|3|||
127986870|NCT01134263|460575566|FG004|Overall Study|Other adverse event|0|||
127986871|NCT01134263|460575562|FG000|Overall Study|Protocol Violation|8|||
127986872|NCT01134263|460575563|FG001|Overall Study|Protocol Violation|7|||
127986873|NCT01134263|460575564|FG002|Overall Study|Protocol Violation|2|||
127986874|NCT01134263|460575565|FG003|Overall Study|Protocol Violation|4|||
127986875|NCT01134263|460575566|FG004|Overall Study|Protocol Violation|2|||
127986876|NCT01134263|460575562|FG000|Overall Study|Lost to Follow-up|4|||
127656536|NCT04186403|459364764|FG000|Overall Study|Withdrawal by Subject|7|||
127656537|NCT04186403|459364765|FG001|Overall Study|Withdrawal by Subject|8|||
127656538|NCT04186403|459364764|FG000|Overall Study|Other: Not Related to Covid-19|3|||
127656539|NCT04186403|459364765|FG001|Overall Study|Other: Not Related to Covid-19|0|||
127656540|NCT01008475|459364767|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
127656541|NCT01008475|459364768|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
127656542|NCT01008475|459364769|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
127656543|NCT01008475|459364770|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
127656544|NCT01008475|459364771|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
127656545|NCT01008475|459364772|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
127656546|NCT01008475|459364773|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
127656547|NCT02917941|459364775|FG000|Treatment Period|Adverse Event|11|||
127656548|NCT02917941|459364775|FG000|Treatment Period|Progressive Disease|11|||
127656549|NCT02917941|459364775|FG000|Treatment Period|Reason not Specified|2|||
127656550|NCT02917941|459364775|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
127656551|NCT02917941|459364775|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
127656552|NCT02716038|459364788|FG000|Overall Study|Not evaluable|1|||
127986877|NCT01134263|460575563|FG001|Overall Study|Lost to Follow-up|3|||
127986878|NCT01134263|460575564|FG002|Overall Study|Lost to Follow-up|5|||
127986879|NCT01134263|460575565|FG003|Overall Study|Lost to Follow-up|3|||
127986880|NCT01134263|460575566|FG004|Overall Study|Lost to Follow-up|1|||
127986881|NCT01134263|460575562|FG000|Overall Study|Withdrawal by Subject|8|||
127986882|NCT01134263|460575563|FG001|Overall Study|Withdrawal by Subject|6|||
127986883|NCT01134263|460575564|FG002|Overall Study|Withdrawal by Subject|16|||
127656553|NCT02716038|459364788|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
127656554|NCT02716038|459364788|FG000|Overall Study|Unresectable|3|||
127986884|NCT01134263|460575565|FG003|Overall Study|Withdrawal by Subject|7|||
127986885|NCT01134263|460575566|FG004|Overall Study|Withdrawal by Subject|5|||
127986886|NCT01134263|460575562|FG000|Overall Study|Enrolled, but not treated|1|||
127656555|NCT03573908|459364789|FG000|Treatment Period|Adverse Event|4|||
127656556|NCT03573908|459364790|FG001|Treatment Period|Adverse Event|9|||
127656557|NCT03573908|459364791|FG002|Treatment Period|Adverse Event|0|||
127656558|NCT03573908|459364792|FG003|Treatment Period|Adverse Event|0|||
127656559|NCT03573908|459364793|FG004|Treatment Period|Adverse Event|0|||
127656560|NCT03573908|459364789|FG000|Treatment Period|Protocol Violation|1|||
127656561|NCT03573908|459364790|FG001|Treatment Period|Protocol Violation|0|||
127656562|NCT03573908|459364791|FG002|Treatment Period|Protocol Violation|0|||
127656563|NCT03573908|459364792|FG003|Treatment Period|Protocol Violation|0|||
127656564|NCT03573908|459364793|FG004|Treatment Period|Protocol Violation|0|||
127656565|NCT03573908|459364789|FG000|Treatment Period|Withdrawal by Subject|7|||
127656566|NCT03573908|459364790|FG001|Treatment Period|Withdrawal by Subject|5|||
127656567|NCT03573908|459364791|FG002|Treatment Period|Withdrawal by Subject|0|||
127656568|NCT03573908|459364792|FG003|Treatment Period|Withdrawal by Subject|0|||
127656569|NCT03573908|459364793|FG004|Treatment Period|Withdrawal by Subject|0|||
127656570|NCT03573908|459364789|FG000|Treatment Period|Lost to Follow-up|7|||
127656571|NCT03573908|459364790|FG001|Treatment Period|Lost to Follow-up|6|||
127656572|NCT03573908|459364791|FG002|Treatment Period|Lost to Follow-up|0|||
127656573|NCT03573908|459364792|FG003|Treatment Period|Lost to Follow-up|0|||
127656574|NCT03573908|459364793|FG004|Treatment Period|Lost to Follow-up|0|||
127656575|NCT03573908|459364789|FG000|Treatment Period|Pregnancy|1|||
127656576|NCT03573908|459364790|FG001|Treatment Period|Pregnancy|0|||
127656577|NCT03573908|459364791|FG002|Treatment Period|Pregnancy|0|||
127656578|NCT03573908|459364792|FG003|Treatment Period|Pregnancy|0|||
127656579|NCT03573908|459364793|FG004|Treatment Period|Pregnancy|0|||
127656580|NCT03573908|459364789|FG000|Treatment Period|Other, Not Specified|4|||
127656581|NCT03573908|459364790|FG001|Treatment Period|Other, Not Specified|6|||
127656582|NCT03573908|459364791|FG002|Treatment Period|Other, Not Specified|0|||
127656583|NCT03573908|459364792|FG003|Treatment Period|Other, Not Specified|0|||
127656584|NCT03573908|459364793|FG004|Treatment Period|Other, Not Specified|0|||
127656585|NCT03573908|459364789|FG000|Randomized Withdrawal Period|Adverse Event|0|||
127656586|NCT03573908|459364790|FG001|Randomized Withdrawal Period|Adverse Event|0|||
127656587|NCT03573908|459364791|FG002|Randomized Withdrawal Period|Adverse Event|3|||
127656588|NCT03573908|459364792|FG003|Randomized Withdrawal Period|Adverse Event|0|||
127656589|NCT03573908|459364793|FG004|Randomized Withdrawal Period|Adverse Event|0|||
127656590|NCT03573908|459364789|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
127656591|NCT03573908|459364790|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
127656592|NCT03573908|459364791|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
127656593|NCT03573908|459364792|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
127656594|NCT03573908|459364793|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
127656595|NCT03573908|459364789|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
127656596|NCT03573908|459364790|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
127656597|NCT03573908|459364791|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
127656598|NCT03573908|459364792|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
127656599|NCT03573908|459364793|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
127656600|NCT03573908|459364789|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
127656601|NCT03573908|459364790|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
127656602|NCT03573908|459364791|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
127656603|NCT03573908|459364792|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
127656604|NCT03573908|459364793|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
127656605|NCT04006925|459364794|FG000|Overall Study|Side effects|2|||
127656606|NCT04006925|459364795|FG001|Overall Study|Side effects|0|||
127656607|NCT02669095|459364800|FG000|Overall Study|Adverse Event|1|||
127656608|NCT02669095|459364801|FG001|Overall Study|Adverse Event|0|||
127656609|NCT02669095|459364800|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
127656610|NCT02669095|459364801|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
127656611|NCT02669095|459364800|FG000|Overall Study|Torn Lens|0|||
127656612|NCT02669095|459364801|FG001|Overall Study|Torn Lens|1|||
127880661|NCT01915498|460183532|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
127880662|NCT01915498|460183533|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
127880663|NCT01915498|460183534|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
127880664|NCT01915498|460183535|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|1|||
127880665|NCT01915498|460183517|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
127880666|NCT01915498|460183518|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
127880667|NCT01915498|460183519|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
127880668|NCT01915498|460183520|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
127880669|NCT01915498|460183521|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
127986887|NCT01134263|460575563|FG001|Overall Study|Enrolled, but not treated|1|||
127656613|NCT02669095|459364800|FG000|Overall Study|Visit 5 assessments not completed|0|||
127656614|NCT02669095|459364801|FG001|Overall Study|Visit 5 assessments not completed|1|||
127656615|NCT01555164|459364803|FG000|Overall Study|Adverse Event|5|||
127656616|NCT01555164|459364804|FG001|Overall Study|Adverse Event|7|||
127656617|NCT01555164|459364803|FG000|Overall Study|Hyperglycemia|0|||
127656618|NCT01555164|459364804|FG001|Overall Study|Hyperglycemia|1|||
127656619|NCT01555164|459364803|FG000|Overall Study|Investigator's Discretion|2|||
127656620|NCT01555164|459364804|FG001|Overall Study|Investigator's Discretion|2|||
127656621|NCT01555164|459364803|FG000|Overall Study|Lost to Follow-up|4|||
127656622|NCT01555164|459364804|FG001|Overall Study|Lost to Follow-up|3|||
127656623|NCT01555164|459364803|FG000|Overall Study|Protocol Violation|9|||
127656624|NCT01555164|459364804|FG001|Overall Study|Protocol Violation|5|||
127656625|NCT01555164|459364803|FG000|Overall Study|Subject Non-compliance|14|||
127656626|NCT01555164|459364804|FG001|Overall Study|Subject Non-compliance|6|||
127656627|NCT01555164|459364803|FG000|Overall Study|Subject Withdrew Consent|6|||
127656628|NCT01555164|459364804|FG001|Overall Study|Subject Withdrew Consent|11|||
127656629|NCT00926003|459364805|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
127656630|NCT00926003|459364806|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
127656631|NCT00926003|459364807|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
127656632|NCT00926003|459364805|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
127656633|NCT00926003|459364806|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
127656634|NCT00926003|459364807|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
127656635|NCT01709305|459364810|FG000|Phase 1|Clinical Adverse Event|80|||
127656636|NCT01709305|459364811|FG001|Phase 1|Clinical Adverse Event|0|||
127656637|NCT01709305|459364812|FG002|Phase 1|Clinical Adverse Event|0|||
127656638|NCT01709305|459364813|FG003|Phase 1|Clinical Adverse Event|0|||
127656639|NCT01709305|459364814|FG004|Phase 1|Clinical Adverse Event|0|||
127656640|NCT01709305|459364810|FG000|Phase 1|Death|2|||
127656641|NCT01709305|459364811|FG001|Phase 1|Death|0|||
127656642|NCT01709305|459364812|FG002|Phase 1|Death|0|||
127656643|NCT01709305|459364813|FG003|Phase 1|Death|0|||
127986888|NCT01134263|460575564|FG002|Overall Study|Enrolled, but not treated|0|||
127986889|NCT01134263|460575565|FG003|Overall Study|Enrolled, but not treated|1|||
127986890|NCT01134263|460575566|FG004|Overall Study|Enrolled, but not treated|0|||
127986891|NCT04165135|460575567|FG000|Overall Study|Protocol Violation|10|||
127986892|NCT04165135|460575567|FG000|Overall Study|Participants withdrawal of consent|5|||
127656644|NCT01709305|459364814|FG004|Phase 1|Death|0|||
127656645|NCT01709305|459364810|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
127656646|NCT01709305|459364811|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
127656647|NCT01709305|459364812|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
127656648|NCT01709305|459364813|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
127656649|NCT01709305|459364814|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
127656650|NCT01709305|459364810|FG000|Phase 1|Laboratory Adverse Event|16|||
127656651|NCT01709305|459364811|FG001|Phase 1|Laboratory Adverse Event|0|||
127656652|NCT01709305|459364812|FG002|Phase 1|Laboratory Adverse Event|0|||
127656653|NCT01709305|459364813|FG003|Phase 1|Laboratory Adverse Event|0|||
127656654|NCT01709305|459364814|FG004|Phase 1|Laboratory Adverse Event|0|||
127656655|NCT01709305|459364810|FG000|Phase 1|Lost to Follow-up|147|||
127656656|NCT01709305|459364811|FG001|Phase 1|Lost to Follow-up|0|||
127986893|NCT01618916|460575570|FG000|Overall Study|Adverse Event|1|||
127986894|NCT01618916|460575571|FG001|Overall Study|Adverse Event|0|||
127986895|NCT01618916|460575572|FG002|Overall Study|Adverse Event|0|||
127986896|NCT01618916|460575573|FG003|Overall Study|Adverse Event|0|||
127986897|NCT01618916|460575574|FG004|Overall Study|Adverse Event|0|||
127986898|NCT01618916|460575575|FG005|Overall Study|Adverse Event|0|||
127986899|NCT01618916|460575570|FG000|Overall Study|Withdrawal by Subject|0|||
127986900|NCT01618916|460575571|FG001|Overall Study|Withdrawal by Subject|1|||
127986901|NCT01618916|460575572|FG002|Overall Study|Withdrawal by Subject|1|||
127986902|NCT01618916|460575573|FG003|Overall Study|Withdrawal by Subject|0|||
127986903|NCT01618916|460575574|FG004|Overall Study|Withdrawal by Subject|1|||
127986904|NCT01618916|460575575|FG005|Overall Study|Withdrawal by Subject|0|||
127986905|NCT01618916|460575570|FG000|Overall Study|Lost to Follow-up|1|||
127986906|NCT01618916|460575571|FG001|Overall Study|Lost to Follow-up|0|||
127986907|NCT01618916|460575572|FG002|Overall Study|Lost to Follow-up|0|||
127986908|NCT01618916|460575573|FG003|Overall Study|Lost to Follow-up|2|||
127656657|NCT01709305|459364812|FG002|Phase 1|Lost to Follow-up|0|||
127656658|NCT01709305|459364813|FG003|Phase 1|Lost to Follow-up|0|||
127656659|NCT01709305|459364814|FG004|Phase 1|Lost to Follow-up|0|||
127656660|NCT01709305|459364810|FG000|Phase 1|Travel, moving, etc.|30|||
127656661|NCT01709305|459364811|FG001|Phase 1|Travel, moving, etc.|0|||
127656662|NCT01709305|459364812|FG002|Phase 1|Travel, moving, etc.|0|||
127986909|NCT01618916|460575574|FG004|Overall Study|Lost to Follow-up|0|||
127986910|NCT01618916|460575575|FG005|Overall Study|Lost to Follow-up|0|||
127986911|NCT04521114|460575576|FG000|Overall Study|Lost to Follow-up|1|||
127986912|NCT04521114|460575577|FG001|Overall Study|Lost to Follow-up|2|||
127986913|NCT04521114|460575578|FG002|Overall Study|Lost to Follow-up|0|||
127986914|NCT04521114|460575576|FG000|Overall Study|Withdrawal by Subject|1|||
127656663|NCT01709305|459364813|FG003|Phase 1|Travel, moving, etc.|0|||
127656664|NCT01709305|459364814|FG004|Phase 1|Travel, moving, etc.|0|||
127656665|NCT01709305|459364810|FG000|Phase 1|Physician Decision|13|||
127656666|NCT01709305|459364811|FG001|Phase 1|Physician Decision|0|||
127656667|NCT01709305|459364812|FG002|Phase 1|Physician Decision|0|||
127656668|NCT01709305|459364813|FG003|Phase 1|Physician Decision|0|||
127656669|NCT01709305|459364814|FG004|Phase 1|Physician Decision|0|||
127656670|NCT01709305|459364810|FG000|Phase 1|Protocol Violation|118|||
127656671|NCT01709305|459364811|FG001|Phase 1|Protocol Violation|0|||
127656672|NCT01709305|459364812|FG002|Phase 1|Protocol Violation|0|||
127656673|NCT01709305|459364813|FG003|Phase 1|Protocol Violation|0|||
127656674|NCT01709305|459364814|FG004|Phase 1|Protocol Violation|0|||
127656675|NCT01709305|459364810|FG000|Phase 1|Withdrawal by Subject|218|||
127656676|NCT01709305|459364811|FG001|Phase 1|Withdrawal by Subject|0|||
127986915|NCT04521114|460575577|FG001|Overall Study|Withdrawal by Subject|2|||
127986916|NCT04521114|460575578|FG002|Overall Study|Withdrawal by Subject|2|||
127986917|NCT04521114|460575576|FG000|Overall Study|Adverse Event|1|||
127986918|NCT04521114|460575577|FG001|Overall Study|Adverse Event|0|||
127986919|NCT04521114|460575578|FG002|Overall Study|Adverse Event|0|||
127986920|NCT04521114|460575576|FG000|Overall Study|Sponsor Wish|1|||
127986921|NCT04521114|460575577|FG001|Overall Study|Sponsor Wish|0|||
127986922|NCT04521114|460575578|FG002|Overall Study|Sponsor Wish|0|||
127986923|NCT04521114|460575576|FG000|Overall Study|Withdrawal of Consent|2|||
127986924|NCT04521114|460575577|FG001|Overall Study|Withdrawal of Consent|2|||
127986925|NCT04521114|460575578|FG002|Overall Study|Withdrawal of Consent|0|||
127986926|NCT01133288|460575581|FG000|Eligibility Assessment|met exclusion criteria|5|||
127986927|NCT01133288|460575581|FG000|Intervention Allocation|study terminated|2|||
127986928|NCT00438256|460575582|FG000|Overall Study|Ineligible for Resection|2|||
127986929|NCT00438256|460575583|FG001|Overall Study|Ineligible for Resection|1|||
127986930|NCT00438256|460575584|FG002|Overall Study|Ineligible for Resection|1|||
127986931|NCT00438256|460575585|FG003|Overall Study|Ineligible for Resection|7|||
127986932|NCT00438256|460575582|FG000|Overall Study|Excluded final Diagnosis|0|||
127986933|NCT00438256|460575583|FG001|Overall Study|Excluded final Diagnosis|0|||
127986934|NCT00438256|460575584|FG002|Overall Study|Excluded final Diagnosis|0|||
127986935|NCT00438256|460575585|FG003|Overall Study|Excluded final Diagnosis|2|||
127986936|NCT02912455|460575595|FG000|Overall Study|Withdrawal by Subject|0|||
127986937|NCT02912455|460575596|FG001|Overall Study|Withdrawal by Subject|1|||
127986938|NCT02912455|460575595|FG000|Overall Study|Lack of Efficacy|0|||
127986939|NCT02912455|460575596|FG001|Overall Study|Lack of Efficacy|1|||
127986940|NCT02912455|460575595|FG000|Overall Study|Lost to Follow-up|2|||
127986941|NCT02912455|460575596|FG001|Overall Study|Lost to Follow-up|1|||
127986942|NCT00957905|460575597|FG000|Part B|Not Treated|0|||
127986943|NCT00957905|460575598|FG001|Part B|Not Treated|1|||
127986944|NCT00957905|460575597|FG000|Part B|Physician Decision|0|||
127986945|NCT00957905|460575598|FG001|Part B|Physician Decision|1|||
127986946|NCT00957905|460575597|FG000|Part B|Death|0|||
127986947|NCT00957905|460575598|FG001|Part B|Death|1|||
127986948|NCT00957905|460575597|FG000|Part B|Protocol Violation|0|||
127986949|NCT00957905|460575598|FG001|Part B|Protocol Violation|1|||
127986950|NCT02073656|460575599|FG000|Primary Study|Lost to Follow-up|6|||
127986951|NCT02073656|460575599|FG000|Primary Study|Death|1|||
127986952|NCT02073656|460575599|FG000|Primary Study|Withdrew Consent|1|||
127986953|NCT01625689|460575604|FG000|Overall Study|Migration|2|||
127986954|NCT01625689|460575605|FG001|Overall Study|Migration|1|||
127986955|NCT01810783|460575608|FG000|Overall Study|Adverse Event|32|||
127986956|NCT01810783|460575608|FG000|Overall Study|Withdrawal by Subject|22|||
127986957|NCT01810783|460575608|FG000|Overall Study|Lack of Efficacy|12|||
127986958|NCT01810783|460575608|FG000|Overall Study|Lost to Follow-up|10|||
127986959|NCT01810783|460575608|FG000|Overall Study|Protocol Violation|5|||
127986960|NCT01810783|460575608|FG000|Overall Study|Non-compliance with IMP|4|||
127986961|NCT01810783|460575608|FG000|Overall Study|Adminstrative or other reason(s)|23|||
127986962|NCT01810783|460575608|FG000|Overall Study|Enrolled, not treated|1|||
127986963|NCT02134353|460575609|FG000|Overall Study|Adverse Event|10|||
127986964|NCT02134353|460575610|FG001|Overall Study|Adverse Event|6|||
127986965|NCT02134353|460575609|FG000|Overall Study|Lost to Follow-up|1|||
127986966|NCT02134353|460575610|FG001|Overall Study|Lost to Follow-up|1|||
127986967|NCT02134353|460575609|FG000|Overall Study|Lack of Efficacy|2|||
127986968|NCT02134353|460575610|FG001|Overall Study|Lack of Efficacy|1|||
127656677|NCT01709305|459364812|FG002|Phase 1|Withdrawal by Subject|0|||
127656678|NCT01709305|459364813|FG003|Phase 1|Withdrawal by Subject|0|||
127986969|NCT02134353|460575609|FG000|Overall Study|Withdrawal by Subject|12|||
127656679|NCT01709305|459364814|FG004|Phase 1|Withdrawal by Subject|0|||
127986970|NCT02134353|460575610|FG001|Overall Study|Withdrawal by Subject|13|||
127656680|NCT01709305|459364810|FG000|Phase 2|Clinical Adverse Event|0|||
127656681|NCT01709305|459364811|FG001|Phase 2|Clinical Adverse Event|10|||
127656682|NCT01709305|459364812|FG002|Phase 2|Clinical Adverse Event|10|||
127986971|NCT02134353|460575609|FG000|Overall Study|Death|0|||
127986972|NCT02134353|460575610|FG001|Overall Study|Death|1|||
127986973|NCT02134353|460575609|FG000|Overall Study|Pregnancy|0|||
127986974|NCT02134353|460575610|FG001|Overall Study|Pregnancy|1|||
127986975|NCT02134353|460575609|FG000|Overall Study|Relocation|1|||
127986976|NCT02134353|460575610|FG001|Overall Study|Relocation|0|||
127986977|NCT02134353|460575609|FG000|Overall Study|Other - Patient's Choice|0|||
127986978|NCT02134353|460575610|FG001|Overall Study|Other - Patient's Choice|1|||
127656683|NCT01709305|459364813|FG003|Phase 2|Clinical Adverse Event|6|||
127656684|NCT01709305|459364814|FG004|Phase 2|Clinical Adverse Event|11|||
127656685|NCT01709305|459364810|FG000|Phase 2|Death|0|||
127656686|NCT01709305|459364811|FG001|Phase 2|Death|0|||
127986979|NCT00477607|460575611|FG000|Overall Study|Lost to Follow-up|7|||
127986980|NCT00477607|460575612|FG001|Overall Study|Lost to Follow-up|7|||
127986981|NCT00358956|460575613|FG000|Overall Study|Adverse Event|3|||
127986982|NCT00358956|460575613|FG000|Overall Study|condition under investigation worsened|4|||
127986983|NCT00358956|460575613|FG000|Overall Study|Withdrawal by Subject|1|||
127986984|NCT04776018|460575614|FG000|Overall Study|Death|0|||
127986985|NCT04776018|460575615|FG001|Overall Study|Death|1|||
127986986|NCT04776018|460575616|FG002|Overall Study|Death|4|||
127986987|NCT04776018|460575617|FG003|Overall Study|Death|1|||
127986988|NCT04776018|460575618|FG004|Overall Study|Death|4|||
127986989|NCT04776018|460575619|FG005|Overall Study|Death|0|||
127986990|NCT04776018|460575620|FG006|Overall Study|Death|0|||
127986991|NCT04776018|460575614|FG000|Overall Study|Study terminated by sponsor|2|||
127986992|NCT04776018|460575615|FG001|Overall Study|Study terminated by sponsor|1|||
127986993|NCT04776018|460575616|FG002|Overall Study|Study terminated by sponsor|4|||
127986994|NCT04776018|460575617|FG003|Overall Study|Study terminated by sponsor|0|||
127986995|NCT04776018|460575618|FG004|Overall Study|Study terminated by sponsor|3|||
127986996|NCT04776018|460575619|FG005|Overall Study|Study terminated by sponsor|0|||
127986997|NCT04776018|460575620|FG006|Overall Study|Study terminated by sponsor|0|||
127986998|NCT04776018|460575614|FG000|Overall Study|Withdrawal by Subject|1|||
127986999|NCT04776018|460575615|FG001|Overall Study|Withdrawal by Subject|0|||
127987000|NCT04776018|460575616|FG002|Overall Study|Withdrawal by Subject|0|||
127987001|NCT04776018|460575617|FG003|Overall Study|Withdrawal by Subject|2|||
127987002|NCT04776018|460575618|FG004|Overall Study|Withdrawal by Subject|1|||
127987003|NCT04776018|460575619|FG005|Overall Study|Withdrawal by Subject|0|||
127987004|NCT04776018|460575620|FG006|Overall Study|Withdrawal by Subject|0|||
127987005|NCT04776018|460575614|FG000|Overall Study|Other|0|||
127987006|NCT04776018|460575615|FG001|Overall Study|Other|1|||
127987007|NCT04776018|460575616|FG002|Overall Study|Other|1|||
127987008|NCT04776018|460575617|FG003|Overall Study|Other|0|||
127987009|NCT04776018|460575618|FG004|Overall Study|Other|0|||
127987010|NCT04776018|460575619|FG005|Overall Study|Other|0|||
127987011|NCT04776018|460575620|FG006|Overall Study|Other|0|||
127987012|NCT04776018|460575614|FG000|Overall Study|Lost to Follow-up|0|||
127987013|NCT04776018|460575615|FG001|Overall Study|Lost to Follow-up|0|||
127987014|NCT04776018|460575616|FG002|Overall Study|Lost to Follow-up|1|||
127987015|NCT04776018|460575617|FG003|Overall Study|Lost to Follow-up|0|||
127987016|NCT04776018|460575618|FG004|Overall Study|Lost to Follow-up|0|||
127987017|NCT04776018|460575619|FG005|Overall Study|Lost to Follow-up|0|||
127987018|NCT04776018|460575620|FG006|Overall Study|Lost to Follow-up|0|||
127987019|NCT02908074|460575621|FG000|Overall Study|sponsor/ICON decision|0|||
127987020|NCT02908074|460575622|FG001|Overall Study|sponsor/ICON decision|0|||
127987021|NCT02908074|460575623|FG002|Overall Study|sponsor/ICON decision|1|||
127987022|NCT02908074|460575624|FG003|Overall Study|sponsor/ICON decision|0|||
127987023|NCT02908074|460575625|FG004|Overall Study|sponsor/ICON decision|0|||
127987024|NCT02908074|460575626|FG005|Overall Study|sponsor/ICON decision|0|||
127987025|NCT02908074|460575621|FG000|Overall Study|Protocol Violation|0|||
127987026|NCT02908074|460575622|FG001|Overall Study|Protocol Violation|1|||
127987027|NCT02908074|460575623|FG002|Overall Study|Protocol Violation|0|||
127987028|NCT02908074|460575624|FG003|Overall Study|Protocol Violation|0|||
127987029|NCT02908074|460575625|FG004|Overall Study|Protocol Violation|0|||
127987030|NCT02908074|460575626|FG005|Overall Study|Protocol Violation|0|||
127987031|NCT02908074|460575621|FG000|Overall Study|Adverse Event|5|||
127987032|NCT02908074|460575622|FG001|Overall Study|Adverse Event|2|||
127987033|NCT02908074|460575623|FG002|Overall Study|Adverse Event|0|||
127987034|NCT02908074|460575624|FG003|Overall Study|Adverse Event|0|||
127987035|NCT02908074|460575625|FG004|Overall Study|Adverse Event|1|||
127987036|NCT02908074|460575626|FG005|Overall Study|Adverse Event|0|||
127987037|NCT02908074|460575621|FG000|Overall Study|AESI|1|||
127987038|NCT02908074|460575622|FG001|Overall Study|AESI|0|||
127987039|NCT02908074|460575623|FG002|Overall Study|AESI|1|||
127987040|NCT02908074|460575624|FG003|Overall Study|AESI|0|||
127987041|NCT02908074|460575625|FG004|Overall Study|AESI|1|||
127987042|NCT02908074|460575626|FG005|Overall Study|AESI|0|||
127987043|NCT02908074|460575621|FG000|Overall Study|Discontinuation criteria per protocol|0|||
127987044|NCT02908074|460575622|FG001|Overall Study|Discontinuation criteria per protocol|0|||
127987045|NCT02908074|460575623|FG002|Overall Study|Discontinuation criteria per protocol|1|||
127987046|NCT02908074|460575624|FG003|Overall Study|Discontinuation criteria per protocol|0|||
127987047|NCT02908074|460575625|FG004|Overall Study|Discontinuation criteria per protocol|0|||
127987048|NCT02908074|460575626|FG005|Overall Study|Discontinuation criteria per protocol|1|||
127987049|NCT02908074|460575621|FG000|Overall Study|Withdrawal by Subject|3|||
127987050|NCT02908074|460575622|FG001|Overall Study|Withdrawal by Subject|2|||
127987051|NCT02908074|460575623|FG002|Overall Study|Withdrawal by Subject|2|||
127987052|NCT02908074|460575624|FG003|Overall Study|Withdrawal by Subject|2|||
127987053|NCT02908074|460575625|FG004|Overall Study|Withdrawal by Subject|2|||
127543121|NCT03518086|458954749|FG000|Overall Study|Site Terminated by Sponsor|0|||
127987054|NCT02908074|460575626|FG005|Overall Study|Withdrawal by Subject|2|||
127987055|NCT02908074|460575621|FG000|Overall Study|Lost to Follow-up|0|||
127987056|NCT02908074|460575622|FG001|Overall Study|Lost to Follow-up|1|||
127987057|NCT02908074|460575623|FG002|Overall Study|Lost to Follow-up|1|||
127656687|NCT01709305|459364812|FG002|Phase 2|Death|1|||
127656688|NCT01709305|459364813|FG003|Phase 2|Death|0|||
127656689|NCT01709305|459364814|FG004|Phase 2|Death|0|||
127656690|NCT01709305|459364810|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
127656691|NCT01709305|459364811|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
127656692|NCT01709305|459364812|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
127656693|NCT01709305|459364813|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
127656694|NCT01709305|459364814|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
127656695|NCT01709305|459364810|FG000|Phase 2|Laboratory Adverse Event|0|||
127656696|NCT01709305|459364811|FG001|Phase 2|Laboratory Adverse Event|1|||
127656697|NCT01709305|459364812|FG002|Phase 2|Laboratory Adverse Event|0|||
127656698|NCT01709305|459364813|FG003|Phase 2|Laboratory Adverse Event|1|||
127656699|NCT01709305|459364814|FG004|Phase 2|Laboratory Adverse Event|1|||
127656700|NCT01709305|459364810|FG000|Phase 2|Lost to Follow-up|0|||
127656701|NCT01709305|459364811|FG001|Phase 2|Lost to Follow-up|10|||
127656702|NCT01709305|459364812|FG002|Phase 2|Lost to Follow-up|6|||
127656703|NCT01709305|459364813|FG003|Phase 2|Lost to Follow-up|9|||
127656704|NCT01709305|459364814|FG004|Phase 2|Lost to Follow-up|5|||
127656705|NCT01709305|459364810|FG000|Phase 2|Travel, moving, etc.|0|||
127656706|NCT01709305|459364811|FG001|Phase 2|Travel, moving, etc.|2|||
127656707|NCT01709305|459364812|FG002|Phase 2|Travel, moving, etc.|3|||
127656708|NCT01709305|459364813|FG003|Phase 2|Travel, moving, etc.|3|||
127656709|NCT01709305|459364814|FG004|Phase 2|Travel, moving, etc.|5|||
127656710|NCT01709305|459364810|FG000|Phase 2|Physician Decision|0|||
127656711|NCT01709305|459364811|FG001|Phase 2|Physician Decision|2|||
127656712|NCT01709305|459364812|FG002|Phase 2|Physician Decision|0|||
127656713|NCT01709305|459364813|FG003|Phase 2|Physician Decision|1|||
127656714|NCT01709305|459364814|FG004|Phase 2|Physician Decision|2|||
127656715|NCT01709305|459364810|FG000|Phase 2|Protocol Violation|0|||
127656716|NCT01709305|459364811|FG001|Phase 2|Protocol Violation|19|||
127656717|NCT01709305|459364812|FG002|Phase 2|Protocol Violation|19|||
127656718|NCT01709305|459364813|FG003|Phase 2|Protocol Violation|13|||
127656719|NCT01709305|459364814|FG004|Phase 2|Protocol Violation|9|||
127656720|NCT01709305|459364810|FG000|Phase 2|Withdrawal by Subject|0|||
127656721|NCT01709305|459364811|FG001|Phase 2|Withdrawal by Subject|8|||
127656722|NCT01709305|459364812|FG002|Phase 2|Withdrawal by Subject|6|||
127656723|NCT01709305|459364813|FG003|Phase 2|Withdrawal by Subject|15|||
127656724|NCT01709305|459364814|FG004|Phase 2|Withdrawal by Subject|12|||
127656725|NCT01396317|459364817|FG000|Overall Study|Adverse Event|1|||
127656726|NCT01396317|459364818|FG001|Overall Study|Adverse Event|0|||
127656727|NCT00171873|459364822|FG000|Overall Study|Withdrawal by Subject|4|||
127656728|NCT00171873|459364823|FG001|Overall Study|Withdrawal by Subject|2|||
127656729|NCT00171873|459364822|FG000|Overall Study|Adverse Event|5|||
127656730|NCT00171873|459364823|FG001|Overall Study|Adverse Event|0|||
127656731|NCT00171873|459364822|FG000|Overall Study|Switched to Octreotide|0|||
127656732|NCT00171873|459364823|FG001|Overall Study|Switched to Octreotide|1|||
127656733|NCT02073097|459364827|FG000|Overall Study|Adverse Event|0|||
127656734|NCT02073097|459364828|FG001|Overall Study|Adverse Event|0|||
127656735|NCT02073097|459364829|FG002|Overall Study|Adverse Event|0|||
127656736|NCT02073097|459364830|FG003|Overall Study|Adverse Event|0|||
127656737|NCT02073097|459364831|FG004|Overall Study|Adverse Event|0|||
127656738|NCT02073097|459364832|FG005|Overall Study|Adverse Event|0|||
127656739|NCT02073097|459364833|FG006|Overall Study|Adverse Event|0|||
127880670|NCT01915498|460183522|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
127880671|NCT01915498|460183523|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
127880672|NCT01915498|460183524|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
127880673|NCT01915498|460183525|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
127880674|NCT01915498|460183526|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
127880675|NCT01915498|460183527|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
127880676|NCT01915498|460183528|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
127880677|NCT01915498|460183529|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
127880678|NCT01915498|460183530|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
127880679|NCT01915498|460183531|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
127880680|NCT01915498|460183532|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
127880681|NCT01915498|460183533|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
127880682|NCT01915498|460183534|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
127880683|NCT01915498|460183535|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|1|||
127880684|NCT01907516|460183536|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
127656740|NCT02073097|459364834|FG007|Overall Study|Adverse Event|2|||
127656741|NCT02073097|459364827|FG000|Overall Study|Withdrawal by Subject|0|||
127656742|NCT02073097|459364828|FG001|Overall Study|Withdrawal by Subject|0|||
127656743|NCT02073097|459364829|FG002|Overall Study|Withdrawal by Subject|0|||
127656744|NCT02073097|459364830|FG003|Overall Study|Withdrawal by Subject|0|||
127656745|NCT02073097|459364831|FG004|Overall Study|Withdrawal by Subject|0|||
127656746|NCT02073097|459364832|FG005|Overall Study|Withdrawal by Subject|0|||
127656747|NCT02073097|459364833|FG006|Overall Study|Withdrawal by Subject|0|||
127987058|NCT02908074|460575624|FG003|Overall Study|Lost to Follow-up|1|||
127987059|NCT02908074|460575625|FG004|Overall Study|Lost to Follow-up|0|||
127987060|NCT02908074|460575626|FG005|Overall Study|Lost to Follow-up|1|||
127987061|NCT03403621|460575629|FG000|Overall Study|Withdrawal by Subject|2|||
127987062|NCT03403621|460575630|FG001|Overall Study|Withdrawal by Subject|2|||
127987063|NCT00583102|460575631|FG000|Overall Study|Adverse Event|3|||
127987064|NCT03611582|460575634|FG000|Overall Study|Adverse Event|26|||
127987065|NCT03611582|460575635|FG001|Overall Study|Adverse Event|6|||
127987066|NCT03611582|460575634|FG000|Overall Study|Protocol Violation|0|||
127987067|NCT03611582|460575635|FG001|Overall Study|Protocol Violation|1|||
127987068|NCT03611582|460575634|FG000|Overall Study|Pregnancy|1|||
127987069|NCT03611582|460575635|FG001|Overall Study|Pregnancy|2|||
127987070|NCT03611582|460575634|FG000|Overall Study|Lack of Efficacy|0|||
127987071|NCT03611582|460575635|FG001|Overall Study|Lack of Efficacy|1|||
127987072|NCT03611582|460575634|FG000|Overall Study|At the discretion of the investigator|1|||
127987073|NCT03611582|460575635|FG001|Overall Study|At the discretion of the investigator|0|||
127987074|NCT03611582|460575634|FG000|Overall Study|Safety concern as judged by the investigator|1|||
127987075|NCT03611582|460575635|FG001|Overall Study|Safety concern as judged by the investigator|2|||
127987076|NCT03611582|460575634|FG000|Overall Study|Withdrawal by Subject|4|||
127987077|NCT03611582|460575635|FG001|Overall Study|Withdrawal by Subject|3|||
127987078|NCT03611582|460575634|FG000|Overall Study|Lost to Follow-up|18|||
127987079|NCT03611582|460575635|FG001|Overall Study|Lost to Follow-up|7|||
127987080|NCT03611582|460575634|FG000|Overall Study|other|17|||
127987081|NCT03611582|460575635|FG001|Overall Study|other|16|||
127987082|NCT04459598|460575636|FG000|Overall Study|Adverse Event|1|||
127987083|NCT04459598|460575637|FG001|Overall Study|Adverse Event|1|||
127987084|NCT01078298|460575638|FG000|Overall Study|Lost to Follow-up|12|||
127987085|NCT01078298|460575639|FG001|Overall Study|Lost to Follow-up|13|||
127987086|NCT01078298|460575638|FG000|Overall Study|Withdrawal by Subject|31|||
127987087|NCT01078298|460575639|FG001|Overall Study|Withdrawal by Subject|33|||
127987088|NCT01078298|460575638|FG000|Overall Study|Protocol Violation|6|||
127987089|NCT01078298|460575639|FG001|Overall Study|Protocol Violation|6|||
127987090|NCT01078298|460575638|FG000|Overall Study|Adverse Event|6|||
127987091|NCT01078298|460575639|FG001|Overall Study|Adverse Event|5|||
127987092|NCT01078298|460575638|FG000|Overall Study|Death|2|||
127987093|NCT01078298|460575639|FG001|Overall Study|Death|0|||
127987094|NCT01078298|460575638|FG000|Overall Study|Did not meet entrance criteria|0|||
127987095|NCT01078298|460575639|FG001|Overall Study|Did not meet entrance criteria|1|||
127987096|NCT01078298|460575638|FG000|Overall Study|Other|24|||
127987097|NCT01078298|460575639|FG001|Overall Study|Other|32|||
127987098|NCT00866333|460575640|FG000|Overall Study|Withdrawal of consent|0|||
127987099|NCT00866333|460575641|FG001|Overall Study|Withdrawal of consent|1|||
127987100|NCT00866333|460575642|FG002|Overall Study|Withdrawal of consent|2|||
127987101|NCT00866333|460575640|FG000|Overall Study|Reason not Specified|3|||
127987102|NCT00866333|460575641|FG001|Overall Study|Reason not Specified|1|||
127987103|NCT00866333|460575642|FG002|Overall Study|Reason not Specified|1|||
127987104|NCT00866333|460575640|FG000|Overall Study|Study Terminated by Sponsor|2|||
127987105|NCT00866333|460575641|FG001|Overall Study|Study Terminated by Sponsor|5|||
127987106|NCT00866333|460575642|FG002|Overall Study|Study Terminated by Sponsor|9|||
127987107|NCT01108237|460577211|FG000|Overall Study|No alignment data|2|||
127987108|NCT01108237|460577212|FG001|Overall Study|No alignment data|15|||
127987109|NCT01108237|460577211|FG000|Overall Study|Did not meet criteria for analysis|7|||
127987110|NCT01108237|460577212|FG001|Overall Study|Did not meet criteria for analysis|0|||
127987111|NCT00564278|460577214|FG000|Overall Study|Lost to Follow-up|35|||
127987112|NCT00564278|460577215|FG001|Overall Study|Lost to Follow-up|33|||
127987113|NCT00564278|460577214|FG000|Overall Study|Physician Decision|1|||
127987114|NCT00564278|460577215|FG001|Overall Study|Physician Decision|2|||
127987115|NCT00564278|460577214|FG000|Overall Study|Withdrawal by Subject|11|||
127987116|NCT00564278|460577215|FG001|Overall Study|Withdrawal by Subject|7|||
127987117|NCT06439095|460577216|FG000|Overall Study|Lost to Follow-up|2|||
127987118|NCT03341936|460577217|FG000|Overall Study|Ineligible|1|||
127987119|NCT03341936|460577217|FG000|Overall Study|Disease Progression|2|||
127987120|NCT03341936|460577217|FG000|Overall Study|Withdrew Consent|4|||
127987121|NCT03341936|460577217|FG000|Overall Study|Non-Compliance|1|||
127987122|NCT03341936|460577217|FG000|Overall Study|Physician Decision|1|||
127987123|NCT03341936|460577217|FG000|Overall Study|Withdrawal by Subject|1|||
127987124|NCT03341936|460577217|FG000|Overall Study|Other|1|||
127987125|NCT02368886|460577218|FG000|Overall Study|Cancel|1|||
127987126|NCT02368886|460577219|FG001|Overall Study|Cancel|1|||
127987127|NCT02368886|460577220|FG002|Overall Study|Cancel|1|||
127987128|NCT02368886|460577221|FG003|Overall Study|Cancel|3|||
127987129|NCT02368886|460577218|FG000|Overall Study|Ineligible|0|||
127987130|NCT02368886|460577219|FG001|Overall Study|Ineligible|0|||
127987131|NCT02368886|460577220|FG002|Overall Study|Ineligible|0|||
127987132|NCT02368886|460577221|FG003|Overall Study|Ineligible|1|||
127987133|NCT02173379|460577223|FG000|Overall Study|Lost to Follow-up|89|||
127987134|NCT02173379|460577224|FG001|Overall Study|Lost to Follow-up|81|||
127987135|NCT02173379|460577223|FG000|Overall Study|Withdrawal by Subject|24|||
127987136|NCT02173379|460577224|FG001|Overall Study|Withdrawal by Subject|29|||
127656748|NCT02073097|459364834|FG007|Overall Study|Withdrawal by Subject|2|||
127656749|NCT02073097|459364827|FG000|Overall Study|Death|0|||
127656750|NCT02073097|459364828|FG001|Overall Study|Death|0|||
127656751|NCT02073097|459364829|FG002|Overall Study|Death|0|||
127656752|NCT02073097|459364830|FG003|Overall Study|Death|0|||
127656753|NCT02073097|459364831|FG004|Overall Study|Death|0|||
127656754|NCT02073097|459364832|FG005|Overall Study|Death|0|||
127656755|NCT02073097|459364833|FG006|Overall Study|Death|0|||
127656756|NCT02073097|459364834|FG007|Overall Study|Death|1|||
127656757|NCT02073097|459364827|FG000|Overall Study|Physician Decision|0|||
127656758|NCT02073097|459364828|FG001|Overall Study|Physician Decision|0|||
127656759|NCT02073097|459364829|FG002|Overall Study|Physician Decision|0|||
127656760|NCT02073097|459364830|FG003|Overall Study|Physician Decision|0|||
127656761|NCT02073097|459364831|FG004|Overall Study|Physician Decision|0|||
127656762|NCT02073097|459364832|FG005|Overall Study|Physician Decision|0|||
127656763|NCT02073097|459364833|FG006|Overall Study|Physician Decision|0|||
127656764|NCT02073097|459364834|FG007|Overall Study|Physician Decision|1|||
127656765|NCT02769065|459366675|FG000|Overall Study|Voluntary Withdrawal|1|||
127656766|NCT02769065|459366676|FG001|Overall Study|Voluntary Withdrawal|0|||
127656767|NCT02769065|459366677|FG002|Overall Study|Voluntary Withdrawal|0|||
127656768|NCT02769065|459366678|FG003|Overall Study|Voluntary Withdrawal|0|||
127656769|NCT02769065|459366679|FG004|Overall Study|Voluntary Withdrawal|0|||
127656770|NCT02769065|459366680|FG005|Overall Study|Voluntary Withdrawal|0|||
127656771|NCT02769065|459366681|FG006|Overall Study|Voluntary Withdrawal|0|||
127656772|NCT02769065|459366682|FG007|Overall Study|Voluntary Withdrawal|0|||
127656773|NCT02769065|459366683|FG008|Overall Study|Voluntary Withdrawal|0|||
127656774|NCT02769065|459366684|FG009|Overall Study|Voluntary Withdrawal|0|||
127656775|NCT02769065|459366685|FG010|Overall Study|Voluntary Withdrawal|0|||
127656776|NCT02769065|459366686|FG011|Overall Study|Voluntary Withdrawal|0|||
127656777|NCT02769065|459366687|FG012|Overall Study|Voluntary Withdrawal|0|||
127656778|NCT02769065|459366688|FG013|Overall Study|Voluntary Withdrawal|0|||
127656779|NCT02769065|459366689|FG014|Overall Study|Voluntary Withdrawal|0|||
127656780|NCT02769065|459366690|FG015|Overall Study|Voluntary Withdrawal|0|||
127656781|NCT02769065|459366691|FG016|Overall Study|Voluntary Withdrawal|0|||
127656782|NCT02769065|459366692|FG017|Overall Study|Voluntary Withdrawal|0|||
127656783|NCT02769065|459366693|FG018|Overall Study|Voluntary Withdrawal|0|||
127656784|NCT02769065|459366694|FG019|Overall Study|Voluntary Withdrawal|0|||
127656785|NCT02769065|459366695|FG020|Overall Study|Voluntary Withdrawal|0|||
127656786|NCT02769065|459366696|FG021|Overall Study|Voluntary Withdrawal|0|||
127656787|NCT02769065|459366697|FG022|Overall Study|Voluntary Withdrawal|0|||
127656788|NCT02769065|459366698|FG023|Overall Study|Voluntary Withdrawal|0|||
127656789|NCT02769065|459366699|FG024|Overall Study|Voluntary Withdrawal|0|||
127656790|NCT02769065|459366700|FG025|Overall Study|Voluntary Withdrawal|0|||
127656791|NCT02769065|459366701|FG026|Overall Study|Voluntary Withdrawal|0|||
127656792|NCT02769065|459366702|FG027|Overall Study|Voluntary Withdrawal|0|||
127656793|NCT02769065|459366703|FG028|Overall Study|Voluntary Withdrawal|0|||
127656794|NCT02769065|459366704|FG029|Overall Study|Voluntary Withdrawal|0|||
127656795|NCT02769065|459366675|FG000|Overall Study|Reason Not Specified|0|||
127656796|NCT02769065|459366676|FG001|Overall Study|Reason Not Specified|0|||
127656797|NCT02769065|459366677|FG002|Overall Study|Reason Not Specified|0|||
127656798|NCT02769065|459366678|FG003|Overall Study|Reason Not Specified|0|||
127656799|NCT02769065|459366679|FG004|Overall Study|Reason Not Specified|0|||
127656800|NCT02769065|459366680|FG005|Overall Study|Reason Not Specified|0|||
127656801|NCT02769065|459366681|FG006|Overall Study|Reason Not Specified|1|||
127656802|NCT02769065|459366682|FG007|Overall Study|Reason Not Specified|0|||
127656803|NCT02769065|459366683|FG008|Overall Study|Reason Not Specified|0|||
127656804|NCT02769065|459366684|FG009|Overall Study|Reason Not Specified|0|||
127987137|NCT02173379|460577223|FG000|Overall Study|Physician Decision|8|||
127987138|NCT02173379|460577224|FG001|Overall Study|Physician Decision|8|||
127987139|NCT02173379|460577223|FG000|Overall Study|Death|75|||
127987140|NCT02173379|460577224|FG001|Overall Study|Death|72|||
127987141|NCT02173379|460577223|FG000|Overall Study|Other Reason|1|||
127987142|NCT02173379|460577224|FG001|Overall Study|Other Reason|0|||
127656805|NCT02769065|459366685|FG010|Overall Study|Reason Not Specified|0|||
127656806|NCT02769065|459366686|FG011|Overall Study|Reason Not Specified|0|||
127656807|NCT02769065|459366687|FG012|Overall Study|Reason Not Specified|0|||
127656808|NCT02769065|459366688|FG013|Overall Study|Reason Not Specified|0|||
127656809|NCT02769065|459366689|FG014|Overall Study|Reason Not Specified|0|||
127656810|NCT02769065|459366690|FG015|Overall Study|Reason Not Specified|0|||
127656811|NCT02769065|459366691|FG016|Overall Study|Reason Not Specified|0|||
127656812|NCT02769065|459366692|FG017|Overall Study|Reason Not Specified|0|||
127656813|NCT02769065|459366693|FG018|Overall Study|Reason Not Specified|0|||
127656814|NCT02769065|459366694|FG019|Overall Study|Reason Not Specified|0|||
127656815|NCT02769065|459366695|FG020|Overall Study|Reason Not Specified|0|||
127656816|NCT02769065|459366696|FG021|Overall Study|Reason Not Specified|0|||
127656817|NCT02769065|459366697|FG022|Overall Study|Reason Not Specified|0|||
127987143|NCT04942210|460577229|FG000|Overall Study|Adverse Event|0|||
127987144|NCT04942210|460577230|FG001|Overall Study|Adverse Event|1|||
127656818|NCT02769065|459366698|FG023|Overall Study|Reason Not Specified|0|||
127656819|NCT02769065|459366699|FG024|Overall Study|Reason Not Specified|0|||
127656820|NCT02769065|459366700|FG025|Overall Study|Reason Not Specified|0|||
127656821|NCT02769065|459366701|FG026|Overall Study|Reason Not Specified|0|||
127656822|NCT02769065|459366702|FG027|Overall Study|Reason Not Specified|0|||
127656823|NCT02769065|459366703|FG028|Overall Study|Reason Not Specified|0|||
127656824|NCT02769065|459366704|FG029|Overall Study|Reason Not Specified|0|||
127656825|NCT02769065|459366675|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
127656826|NCT02769065|459366676|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
127656827|NCT02769065|459366677|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
127656828|NCT02769065|459366678|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
127656829|NCT02769065|459366679|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
127656830|NCT02769065|459366680|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
127656831|NCT02769065|459366681|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
127656832|NCT02769065|459366682|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
127656833|NCT02769065|459366683|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
127656834|NCT02769065|459366684|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
127656835|NCT02769065|459366685|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
127656836|NCT02769065|459366686|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
127656837|NCT02769065|459366687|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
127656838|NCT02769065|459366688|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
127656839|NCT02769065|459366689|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
127656840|NCT02769065|459366690|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
127656841|NCT02769065|459366691|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
127656842|NCT02769065|459366692|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
127656843|NCT02769065|459366693|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
127656844|NCT02769065|459366694|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
127656845|NCT02769065|459366695|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
127656846|NCT02769065|459366696|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
127656847|NCT02769065|459366697|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
127656848|NCT02769065|459366698|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
127656849|NCT02769065|459366699|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
127656850|NCT02769065|459366700|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
127656851|NCT02769065|459366701|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
127656852|NCT02769065|459366702|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
127656853|NCT02769065|459366703|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
127656854|NCT02769065|459366704|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
127656855|NCT02764775|459366707|FG000|Overall Study|Death|1|||
127656856|NCT02764775|459366707|FG000|Overall Study|Lost to Follow-up|2|||
127656857|NCT02764775|459366707|FG000|Overall Study|Withdrawal by Subject|3|||
127656858|NCT01590771|459366711|FG000|Overall Study|Other Protocol Specified Criteria|5|||
127656859|NCT01590771|459366712|FG001|Overall Study|Other Protocol Specified Criteria|14|||
127656860|NCT01590771|459366711|FG000|Overall Study|Withdrawal by Subject|8|||
127656861|NCT01590771|459366712|FG001|Overall Study|Withdrawal by Subject|15|||
127656862|NCT01590771|459366711|FG000|Overall Study|Protocol Violation|1|||
127656863|NCT01590771|459366712|FG001|Overall Study|Protocol Violation|2|||
127656864|NCT01590771|459366711|FG000|Overall Study|Lost to Follow-up|1|||
127656865|NCT01590771|459366712|FG001|Overall Study|Lost to Follow-up|1|||
127656866|NCT01590771|459366711|FG000|Overall Study|Lack of Efficacy|1|||
127656867|NCT01590771|459366712|FG001|Overall Study|Lack of Efficacy|0|||
127656868|NCT01590771|459366711|FG000|Overall Study|Adverse Event|3|||
127656869|NCT01590771|459366712|FG001|Overall Study|Adverse Event|7|||
127656870|NCT04022889|459366713|FG000|Stage 1: Period 1|Adverse Event|1|||
127656871|NCT04022889|459366714|FG001|Stage 1: Period 1|Adverse Event|0|||
127656872|NCT04022889|459366715|FG002|Stage 1: Period 1|Adverse Event|0|||
127656873|NCT04022889|459366713|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
127656874|NCT04022889|459366714|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
127656875|NCT04022889|459366715|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
127656876|NCT04022889|459366713|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
127656877|NCT04022889|459366714|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
127656878|NCT04022889|459366715|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
127656879|NCT04022889|459366713|FG000|Stage 2|Screen Failure|0|||
127656880|NCT04022889|459366714|FG001|Stage 2|Screen Failure|0|||
127987145|NCT04942210|460577229|FG000|Overall Study|Protocol Deviation|4|||
127987146|NCT04942210|460577230|FG001|Overall Study|Protocol Deviation|1|||
127656881|NCT04022889|459366715|FG002|Stage 2|Screen Failure|3|||
127656882|NCT04022889|459366713|FG000|Stage 2|Ineligible for apheresis donation|0|||
127656883|NCT04022889|459366714|FG001|Stage 2|Ineligible for apheresis donation|0|||
127656884|NCT04022889|459366715|FG002|Stage 2|Ineligible for apheresis donation|2|||
127656885|NCT04022889|459366713|FG000|Stage 2|Adverse Event|0|||
127656886|NCT04022889|459366714|FG001|Stage 2|Adverse Event|0|||
127656887|NCT04022889|459366715|FG002|Stage 2|Adverse Event|2|||
127656888|NCT04022889|459366713|FG000|Stage 2|Protocol Violation|0|||
127987147|NCT04942210|460577229|FG000|Overall Study|Withdrawal by Subject|5|||
127656889|NCT04022889|459366714|FG001|Stage 2|Protocol Violation|0|||
127656890|NCT04022889|459366715|FG002|Stage 2|Protocol Violation|1|||
127656891|NCT04022889|459366713|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
127656892|NCT04022889|459366714|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
127656893|NCT04022889|459366715|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
127656894|NCT01900054|459366723|FG000|Overall Study|Physician Decision|1|||
127656895|NCT01900054|459366723|FG000|Overall Study|Withdrawal by Subject|1|||
127656896|NCT01186328|459366724|FG000|Overall Study|Death|1|||
127656897|NCT01186328|459366725|FG001|Overall Study|Death|0|||
127656898|NCT01186328|459366726|FG002|Overall Study|Death|0|||
127656899|NCT03015116|459366729|FG000|Overall Study|Lost to Follow-up|3|||
127656900|NCT03015116|459366730|FG001|Overall Study|Lost to Follow-up|0|||
127987148|NCT04942210|460577230|FG001|Overall Study|Withdrawal by Subject|2|||
127987149|NCT04942210|460577229|FG000|Overall Study|Lost to Follow-up|16|||
127987150|NCT04942210|460577230|FG001|Overall Study|Lost to Follow-up|7|||
127987151|NCT04942210|460577229|FG000|Overall Study|Ongoing at the time of DBL date|60|||
127987152|NCT04942210|460577230|FG001|Overall Study|Ongoing at the time of DBL date|25|||
127987153|NCT04942210|460577229|FG000|Overall Study|Randomized but did not receive vaccination|3|||
127987154|NCT04942210|460577230|FG001|Overall Study|Randomized but did not receive vaccination|0|||
127987155|NCT02570750|460577231|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
127987156|NCT02570750|460577232|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
127987157|NCT02570750|460577231|FG000|Overall Study|Protocol deviation|4|||
127987158|NCT02570750|460577232|FG001|Overall Study|Protocol deviation|2|||
127987159|NCT02570750|460577231|FG000|Overall Study|Withdrawal by Subject|5|||
127987160|NCT02570750|460577232|FG001|Overall Study|Withdrawal by Subject|0|||
127987161|NCT02570750|460577231|FG000|Overall Study|Lost to Follow-up|2|||
127987162|NCT02570750|460577232|FG001|Overall Study|Lost to Follow-up|2|||
127987163|NCT02570750|460577231|FG000|Overall Study|Adverse Event|2|||
127987164|NCT02570750|460577232|FG001|Overall Study|Adverse Event|1|||
127987165|NCT04122625|460577233|FG000|Part A (up to 2.92 Years)|Death|2|||
127987166|NCT04122625|460577234|FG001|Part A (up to 2.92 Years)|Death|4|||
127987167|NCT04122625|460577235|FG002|Part A (up to 2.92 Years)|Death|0|||
127987168|NCT04122625|460577236|FG003|Part A (up to 2.92 Years)|Death|0|||
127987169|NCT04122625|460577237|FG004|Part A (up to 2.92 Years)|Death|0|||
127987170|NCT04122625|460577238|FG005|Part A (up to 2.92 Years)|Death|0|||
127987171|NCT04122625|460577233|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
127987172|NCT04122625|460577234|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
127987173|NCT04122625|460577235|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
127987174|NCT04122625|460577236|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
127987175|NCT04122625|460577237|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
127987176|NCT04122625|460577238|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
127987177|NCT04122625|460577233|FG000|Part B (up to 2.33 Years)|Death|0|||
127987178|NCT04122625|460577234|FG001|Part B (up to 2.33 Years)|Death|0|||
127987179|NCT04122625|460577235|FG002|Part B (up to 2.33 Years)|Death|5|||
127987180|NCT04122625|460577236|FG003|Part B (up to 2.33 Years)|Death|7|||
127987181|NCT04122625|460577237|FG004|Part B (up to 2.33 Years)|Death|6|||
127987182|NCT04122625|460577238|FG005|Part B (up to 2.33 Years)|Death|7|||
127987183|NCT02776670|460577239|FG000|Overall Study|Adverse Event|0|||
127987184|NCT02776670|460577240|FG001|Overall Study|Adverse Event|2|||
127987185|NCT02776670|460577239|FG000|Overall Study|Protocol Violation|0|||
127987186|NCT02776670|460577240|FG001|Overall Study|Protocol Violation|2|||
127987187|NCT02776670|460577239|FG000|Overall Study|Withdrawal by Subject|0|||
127987188|NCT02776670|460577240|FG001|Overall Study|Withdrawal by Subject|1|||
127987189|NCT02776670|460577239|FG000|Overall Study|Other - Reason not given|0|||
127987190|NCT02776670|460577240|FG001|Overall Study|Other - Reason not given|1|||
127987191|NCT01038752|460577242|FG000|Overall Study|Tumor Progression|2|||
127987192|NCT01038752|460577243|FG001|Overall Study|Tumor Progression|2|||
127987193|NCT01038752|460577242|FG000|Overall Study|Lost to Follow-up|3|||
127987194|NCT01038752|460577243|FG001|Overall Study|Lost to Follow-up|3|||
127987195|NCT00530790|460577244|FG000|Overall Study|Adverse Event|2|||
127987196|NCT00530790|460577244|FG000|Overall Study|Withdrawal by Subject|2|||
127987197|NCT00530790|460577244|FG000|Overall Study|Physician Decision|1|||
127656901|NCT03015116|459366731|FG002|Overall Study|Lost to Follow-up|2|||
127656902|NCT03015116|459366729|FG000|Overall Study|Withdrawal by Subject|3|||
127656903|NCT03015116|459366730|FG001|Overall Study|Withdrawal by Subject|1|||
127656904|NCT03015116|459366731|FG002|Overall Study|Withdrawal by Subject|0|||
127987198|NCT00575510|460577251|FG000|Overall Study|Lost to Follow-up|4|||
127987199|NCT00575510|460577252|FG001|Overall Study|Lost to Follow-up|6|||
127987200|NCT00575510|460577253|FG002|Overall Study|Lost to Follow-up|9|||
127987201|NCT00575510|460577251|FG000|Overall Study|Withdrawal by Subject|1|||
127987202|NCT00575510|460577252|FG001|Overall Study|Withdrawal by Subject|0|||
127656905|NCT03015116|459366729|FG000|Overall Study|Subject has New Medical Status|1|||
127656906|NCT03015116|459366730|FG001|Overall Study|Subject has New Medical Status|0|||
127987203|NCT00575510|460577253|FG002|Overall Study|Withdrawal by Subject|0|||
127656907|NCT03015116|459366731|FG002|Overall Study|Subject has New Medical Status|0|||
127656908|NCT03015116|459366729|FG000|Overall Study|Physician Decision|0|||
127656909|NCT03015116|459366730|FG001|Overall Study|Physician Decision|1|||
127987204|NCT00575510|460577251|FG000|Overall Study|Clinic Called Patient|7|||
127987205|NCT00575510|460577252|FG001|Overall Study|Clinic Called Patient|7|||
127987206|NCT00575510|460577253|FG002|Overall Study|Clinic Called Patient|7|||
127987207|NCT00575510|460577251|FG000|Overall Study|Pregnancy|0|||
127987208|NCT00575510|460577252|FG001|Overall Study|Pregnancy|0|||
127987209|NCT00575510|460577253|FG002|Overall Study|Pregnancy|1|||
127987210|NCT01084538|460577256|FG000|Overall Study|Drug not available|30|||
127987211|NCT01084538|460577256|FG000|Overall Study|Adverse Event|9|||
127987212|NCT01084538|460577256|FG000|Overall Study|Kidney transplant|6|||
127987213|NCT01084538|460577256|FG000|Overall Study|Serious Adverse Event|3|||
127987214|NCT01084538|460577256|FG000|Overall Study|Lack of effectiveness|2|||
127987215|NCT01084538|460577256|FG000|Overall Study|Patient noncompliance|2|||
127987216|NCT01084538|460577256|FG000|Overall Study|Hyperphosphatemia|2|||
127656910|NCT03015116|459366731|FG002|Overall Study|Physician Decision|0|||
127656911|NCT02200939|459366733|FG000|Overall Study|Participant withdrew consent|0|||
127656912|NCT02200939|459366734|FG001|Overall Study|Participant withdrew consent|1|||
127656913|NCT02200939|459366733|FG000|Overall Study|Lost to Follow-up|2|||
127656914|NCT02200939|459366734|FG001|Overall Study|Lost to Follow-up|9|||
127656915|NCT02200939|459366733|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
127656916|NCT02200939|459366734|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
127656917|NCT02762981|459366735|FG000|Overall Study|Adverse Event|2|||
127656918|NCT02762981|459366736|FG001|Overall Study|Adverse Event|3|||
127656919|NCT02762981|459366737|FG002|Overall Study|Adverse Event|1|||
127656920|NCT02762981|459366738|FG003|Overall Study|Adverse Event|1|||
127656921|NCT02762981|459366739|FG004|Overall Study|Adverse Event|3|||
127656922|NCT02762981|459366735|FG000|Overall Study|Physician Decision|0|||
127656923|NCT02762981|459366736|FG001|Overall Study|Physician Decision|1|||
127656924|NCT02762981|459366737|FG002|Overall Study|Physician Decision|0|||
127656925|NCT02762981|459366738|FG003|Overall Study|Physician Decision|0|||
127656926|NCT02762981|459366739|FG004|Overall Study|Physician Decision|1|||
127656927|NCT02762981|459366735|FG000|Overall Study|Disease progression|11|||
127656928|NCT02762981|459366736|FG001|Overall Study|Disease progression|23|||
127656929|NCT02762981|459366737|FG002|Overall Study|Disease progression|4|||
127656930|NCT02762981|459366738|FG003|Overall Study|Disease progression|10|||
127656931|NCT02762981|459366739|FG004|Overall Study|Disease progression|1|||
127656932|NCT02762981|459366735|FG000|Overall Study|Enrolled not treated|1|||
127656933|NCT02762981|459366736|FG001|Overall Study|Enrolled not treated|5|||
127656934|NCT02762981|459366737|FG002|Overall Study|Enrolled not treated|0|||
127656935|NCT02762981|459366738|FG003|Overall Study|Enrolled not treated|2|||
127656936|NCT02762981|459366739|FG004|Overall Study|Enrolled not treated|0|||
127656937|NCT02762981|459366735|FG000|Overall Study|Other|2|||
127656938|NCT02762981|459366736|FG001|Overall Study|Other|3|||
127656939|NCT02762981|459366737|FG002|Overall Study|Other|1|||
127656940|NCT02762981|459366738|FG003|Overall Study|Other|0|||
127656941|NCT02762981|459366739|FG004|Overall Study|Other|0|||
127656942|NCT02762981|459366735|FG000|Overall Study|Missing|1|||
127656943|NCT02762981|459366736|FG001|Overall Study|Missing|0|||
127656944|NCT02762981|459366737|FG002|Overall Study|Missing|0|||
127656945|NCT02762981|459366738|FG003|Overall Study|Missing|0|||
127656946|NCT02762981|459366739|FG004|Overall Study|Missing|0|||
127656947|NCT02762981|459366735|FG000|Overall Study|Withdrawal by Subject|0|||
127656948|NCT02762981|459366736|FG001|Overall Study|Withdrawal by Subject|5|||
127656949|NCT02762981|459366737|FG002|Overall Study|Withdrawal by Subject|1|||
127656950|NCT02762981|459366738|FG003|Overall Study|Withdrawal by Subject|3|||
127656951|NCT02762981|459366739|FG004|Overall Study|Withdrawal by Subject|0|||
127656952|NCT00976482|459366742|FG000|Overall Study|Death|208|||
127656953|NCT00976482|459366742|FG000|Overall Study|Withdrawal by Subject|45|||
127656954|NCT00976482|459366742|FG000|Overall Study|Center terminated|1|||
127656955|NCT00976482|459366742|FG000|Overall Study|Protocol Violation|5|||
127656956|NCT00720902|459366743|FG000|Overall Study|Withdrawal by Subject|1|||
127656957|NCT00720902|459366744|FG001|Overall Study|Withdrawal by Subject|0|||
127656958|NCT00720902|459366743|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
127656959|NCT00720902|459366744|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
127656960|NCT02254408|459366748|FG000|Overall Study|Randomized But Not Treated|1|||
127656961|NCT02254408|459366749|FG001|Overall Study|Randomized But Not Treated|3|||
127656962|NCT02254408|459366748|FG000|Overall Study|Adverse Event|1|||
127656963|NCT02254408|459366749|FG001|Overall Study|Adverse Event|0|||
127656964|NCT02254408|459366748|FG000|Overall Study|Death|2|||
127656965|NCT02254408|459366749|FG001|Overall Study|Death|3|||
127656966|NCT02254408|459366748|FG000|Overall Study|Investigator's Discretion|0|||
127656967|NCT02254408|459366749|FG001|Overall Study|Investigator's Discretion|1|||
127656968|NCT02254408|459366748|FG000|Overall Study|Withdrawal by Subject|3|||
127656969|NCT02254408|459366749|FG001|Overall Study|Withdrawal by Subject|3|||
127656970|NCT02254408|459366748|FG000|Overall Study|Lost to Follow-up|1|||
127987217|NCT01084538|460577256|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
127656971|NCT02254408|459366749|FG001|Overall Study|Lost to Follow-up|0|||
127656972|NCT02914184|459366750|FG000|Overall Study|Lost to Follow-up|7|||
127656973|NCT02914184|459366751|FG001|Overall Study|Lost to Follow-up|10|||
127656974|NCT02914184|459366752|FG002|Overall Study|Lost to Follow-up|8|||
127656975|NCT02914184|459366753|FG003|Overall Study|Lost to Follow-up|7|||
127656976|NCT02914184|459366750|FG000|Overall Study|Withdrawal by Subject|4|||
127656977|NCT02914184|459366751|FG001|Overall Study|Withdrawal by Subject|2|||
127656978|NCT02914184|459366752|FG002|Overall Study|Withdrawal by Subject|7|||
127656979|NCT02914184|459366753|FG003|Overall Study|Withdrawal by Subject|3|||
127656980|NCT02914184|459366750|FG000|Overall Study|Other|1|||
127656981|NCT02914184|459366751|FG001|Overall Study|Other|0|||
127656982|NCT02914184|459366752|FG002|Overall Study|Other|0|||
127656983|NCT02914184|459366753|FG003|Overall Study|Other|0|||
127656984|NCT02914184|459366750|FG000|Overall Study|Migrated/moved from the study area|2|||
127656985|NCT02914184|459366751|FG001|Overall Study|Migrated/moved from the study area|1|||
127656986|NCT02914184|459366752|FG002|Overall Study|Migrated/moved from the study area|2|||
127656987|NCT02914184|459366753|FG003|Overall Study|Migrated/moved from the study area|1|||
127656988|NCT00798174|459366754|FG000|Overall Study|inability to implant azygos coil|3|||
127656989|NCT00798174|459366755|FG001|Overall Study|inability to implant azygos coil|3|||
127656990|NCT00798174|459366754|FG000|Overall Study|Inability to sedate for DFT testing|1|||
127656991|NCT00798174|459366755|FG001|Overall Study|Inability to sedate for DFT testing|0|||
127656992|NCT01478113|459366756|FG000|Overall Study|Withdrawal by Subject|0|||
127656993|NCT01478113|459366757|FG001|Overall Study|Withdrawal by Subject|1|||
127656994|NCT01478113|459366756|FG000|Overall Study|Physician Decision|1|||
127656995|NCT01478113|459366757|FG001|Overall Study|Physician Decision|0|||
127656996|NCT01112514|459366763|FG000|Overall Study|Lost to Follow-up|1|||
127656997|NCT01118455|459366764|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
127656998|NCT01118455|459366765|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
127656999|NCT03327402|459366766|FG000|Overall Study|Withdrawal by Subject|1|||
127657000|NCT03327402|459366766|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
127657001|NCT03810313|459366770|FG000|Overall Study|Study terminated by sponsor|164|||
127657002|NCT03810313|459366771|FG001|Overall Study|Study terminated by sponsor|159|||
127657003|NCT03810313|459366770|FG000|Overall Study|Subject decision|10|||
127657004|NCT03810313|459366771|FG001|Overall Study|Subject decision|11|||
127657005|NCT03810313|459366770|FG000|Overall Study|Lost to Follow-up|3|||
127657006|NCT03810313|459366771|FG001|Overall Study|Lost to Follow-up|3|||
127657007|NCT03810313|459366770|FG000|Overall Study|Adverse Event|2|||
127657008|NCT03810313|459366771|FG001|Overall Study|Adverse Event|1|||
127657009|NCT03810313|459366770|FG000|Overall Study|Death|2|||
127657010|NCT03810313|459366771|FG001|Overall Study|Death|1|||
127657011|NCT03810313|459366770|FG000|Overall Study|Physician Decision|0|||
127657012|NCT03810313|459366771|FG001|Overall Study|Physician Decision|1|||
127657013|NCT00584805|459366772|FG000|Overall Study|No longer at risk of exposure|39|||
127657014|NCT00584805|459366772|FG000|Overall Study|Relocation|36|||
127657015|NCT00584805|459366772|FG000|Overall Study|Withdrawal by Subject|18|||
127657016|NCT00584805|459366772|FG000|Overall Study|Non-compliance|1|||
127657017|NCT00584805|459366772|FG000|Overall Study|Lost to follow up|3|||
127657018|NCT00584805|459366772|FG000|Overall Study|Screen failures|2|||
127657019|NCT01993823|459366773|FG000|Overall Study|Requested by the patient|6|||
127657020|NCT01993823|459366774|FG001|Overall Study|Requested by the patient|11|||
127657021|NCT01993823|459366773|FG000|Overall Study|Protocol Violation|0|||
127657022|NCT01993823|459366774|FG001|Overall Study|Protocol Violation|1|||
127657023|NCT01993823|459366773|FG000|Overall Study|Lost to Follow-up|1|||
127657024|NCT01993823|459366774|FG001|Overall Study|Lost to Follow-up|4|||
127657025|NCT03029780|459366775|FG000|Overall Study|Disease Progression|20|||
127657026|NCT03029780|459366776|FG001|Overall Study|Disease Progression|22|||
127657027|NCT03029780|459366775|FG000|Overall Study|Study Drug Toxicity|15|||
127657028|NCT03029780|459366776|FG001|Overall Study|Study Drug Toxicity|11|||
127657029|NCT03029780|459366775|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
127657030|NCT03029780|459366776|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
127657031|NCT03029780|459366775|FG000|Overall Study|Participant request to discontinue study treatment|4|||
127657032|NCT03029780|459366776|FG001|Overall Study|Participant request to discontinue study treatment|1|||
127657033|NCT03029780|459366775|FG000|Overall Study|Maximum clinical benefit|1|||
127987218|NCT01084538|460577256|FG000|Overall Study|Change of residence|2|||
127657034|NCT03029780|459366776|FG001|Overall Study|Maximum clinical benefit|0|||
127987219|NCT01084538|460577256|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
127987220|NCT01084538|460577256|FG000|Overall Study|Reason unknown|8|||
127657035|NCT03029780|459366775|FG000|Overall Study|Participant no longer meets study criteria|0|||
127987221|NCT02279745|460577257|FG000|Overall Study|Adverse Event|7|||
127987222|NCT02279745|460577257|FG000|Overall Study|Death|6|||
127657036|NCT03029780|459366776|FG001|Overall Study|Participant no longer meets study criteria|1|||
127657037|NCT03029780|459366775|FG000|Overall Study|Other reasons|6|||
127657038|NCT03029780|459366776|FG001|Overall Study|Other reasons|6|||
127657039|NCT03029780|459366775|FG000|Overall Study|Not reported|1|||
127657040|NCT03029780|459366776|FG001|Overall Study|Not reported|1|||
127987223|NCT02279745|460577257|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
127987224|NCT02279745|460577257|FG000|Overall Study|Withdrawal by Subject|2|||
127657041|NCT03029780|459366775|FG000|Overall Study|Death|2|||
127657042|NCT03029780|459366776|FG001|Overall Study|Death|6|||
127657043|NCT03066622|459366777|FG000|Overall Study|Lost to Follow-up|24|||
127657044|NCT03066622|459366778|FG001|Overall Study|Lost to Follow-up|25|||
127657045|NCT03066622|459366777|FG000|Overall Study|Withdrawal by Subject|2|||
127657046|NCT03066622|459366778|FG001|Overall Study|Withdrawal by Subject|1|||
127657047|NCT01460160|459366779|FG000|Treatment Phase|Lack of Efficacy|3|||
127657048|NCT01460160|459366779|FG000|Treatment Phase|Study Drug Toxicity|2|||
127657049|NCT01460160|459366779|FG000|Treatment Phase|Adverse Event|8|||
127657050|NCT01460160|459366779|FG000|Treatment Phase|Withdrawal by Subject|4|||
127657051|NCT01460160|459366779|FG000|Treatment Phase|Death|2|||
127657052|NCT01460160|459366779|FG000|Treatment Phase|Other reasons|9|||
127657053|NCT01460160|459366779|FG000|Follow-up Phase|Withdrawal by Subject|4|||
127657054|NCT01460160|459366779|FG000|Follow-up Phase|Death|14|||
127657055|NCT01460160|459366779|FG000|Follow-up Phase|Lost to Follow-up|7|||
127657056|NCT01460160|459366779|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
127657057|NCT01460160|459366779|FG000|Follow-up Phase|Other and not reported reasons|5|||
127657058|NCT01616771|459366780|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
127657059|NCT00100932|459366781|FG000|Overall Study|Adverse Event|11|||
127657060|NCT00100932|459366782|FG001|Overall Study|Adverse Event|2|||
127657061|NCT00100932|459366781|FG000|Overall Study|Withdrawal by Subject|6|||
127657062|NCT00100932|459366782|FG001|Overall Study|Withdrawal by Subject|0|||
127657063|NCT00100932|459366781|FG000|Overall Study|Progressive Disease|44|||
127657064|NCT00100932|459366782|FG001|Overall Study|Progressive Disease|18|||
127657065|NCT00100932|459366781|FG000|Overall Study|Physician Decision|7|||
127657066|NCT00100932|459366782|FG001|Overall Study|Physician Decision|5|||
127657067|NCT00100932|459366781|FG000|Overall Study|Other|5|||
127657068|NCT00100932|459366782|FG001|Overall Study|Other|2|||
127657069|NCT00744328|459366783|FG000|Overall Study|Lost to Follow-up|2|||
127657070|NCT00744328|459366784|FG001|Overall Study|Lost to Follow-up|5|||
127657071|NCT00744328|459366785|FG002|Overall Study|Lost to Follow-up|3|||
127657072|NCT00744328|459366783|FG000|Overall Study|Withdrawal by Subject|5|||
127657073|NCT00744328|459366784|FG001|Overall Study|Withdrawal by Subject|3|||
127657074|NCT00744328|459366785|FG002|Overall Study|Withdrawal by Subject|4|||
127657075|NCT00744328|459366783|FG000|Overall Study|Found ineligible after randomization|0|||
127657076|NCT00744328|459366784|FG001|Overall Study|Found ineligible after randomization|0|||
127657077|NCT00744328|459366785|FG002|Overall Study|Found ineligible after randomization|1|||
127657078|NCT02387216|459366791|FG000|Overall Study|Progressive disease|2|||
127657079|NCT02387216|459366792|FG001|Overall Study|Progressive disease|0|||
127657080|NCT02387216|459366791|FG000|Overall Study|Withdrawal by Subject|3|||
127657081|NCT02387216|459366792|FG001|Overall Study|Withdrawal by Subject|5|||
127657082|NCT02387216|459366791|FG000|Overall Study|Physician Decision|2|||
127657083|NCT02387216|459366792|FG001|Overall Study|Physician Decision|0|||
127657084|NCT02387216|459366791|FG000|Overall Study|Sponsor Decision|28|||
127657085|NCT02387216|459366792|FG001|Overall Study|Sponsor Decision|12|||
127657086|NCT02387216|459366791|FG000|Overall Study|Death|60|||
127657087|NCT02387216|459366792|FG001|Overall Study|Death|23|||
127657088|NCT02387216|459366791|FG000|Overall Study|Other|5|||
127657089|NCT02387216|459366792|FG001|Overall Study|Other|4|||
127657090|NCT02387216|459366791|FG000|Overall Study|Lost to Follow-up|0|||
127657091|NCT02387216|459366792|FG001|Overall Study|Lost to Follow-up|3|||
127657092|NCT04498247|459366793|FG000|Overall Study|Lost to Follow-up|0|||
127657093|NCT04498247|459366794|FG001|Overall Study|Lost to Follow-up|0|||
127657094|NCT04498247|459366795|FG002|Overall Study|Lost to Follow-up|0|||
127657095|NCT04498247|459366796|FG003|Overall Study|Lost to Follow-up|1|||
127657096|NCT04498247|459366797|FG004|Overall Study|Lost to Follow-up|0|||
127657097|NCT04498247|459366798|FG005|Overall Study|Lost to Follow-up|0|||
127657098|NCT04498247|459366799|FG006|Overall Study|Lost to Follow-up|0|||
127657099|NCT04498247|459366800|FG007|Overall Study|Lost to Follow-up|0|||
127657100|NCT04498247|459366793|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
127657101|NCT04498247|459366794|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
127657102|NCT04498247|459366795|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
127657103|NCT04498247|459366796|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
127657104|NCT04498247|459366797|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
127657105|NCT04498247|459366798|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
127657106|NCT04498247|459366799|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
127657107|NCT04498247|459366800|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
127657108|NCT04498247|459366793|FG000|Overall Study|Withdrawal by Subject|0|||
127657109|NCT04498247|459366794|FG001|Overall Study|Withdrawal by Subject|8|||
127657110|NCT04498247|459366795|FG002|Overall Study|Withdrawal by Subject|0|||
127657111|NCT04498247|459366796|FG003|Overall Study|Withdrawal by Subject|7|||
127657112|NCT04498247|459366797|FG004|Overall Study|Withdrawal by Subject|0|||
127657113|NCT04498247|459366798|FG005|Overall Study|Withdrawal by Subject|0|||
127657114|NCT04498247|459366799|FG006|Overall Study|Withdrawal by Subject|1|||
127657115|NCT04498247|459366800|FG007|Overall Study|Withdrawal by Subject|0|||
127657116|NCT04498247|459366793|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
127657117|NCT04498247|459366794|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
127657118|NCT04498247|459366795|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
127657119|NCT04498247|459366796|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
127657120|NCT04498247|459366797|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
127657121|NCT04498247|459366798|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
127657122|NCT04498247|459366799|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
127657123|NCT04498247|459366800|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
127657124|NCT04041440|459366801|FG000|Overall Study|Withdrawal by Subject|0|||
127657125|NCT04041440|459366802|FG001|Overall Study|Withdrawal by Subject|1|||
127657126|NCT04041440|459366801|FG000|Overall Study|Lost to Follow-up|0|||
127657127|NCT04041440|459366802|FG001|Overall Study|Lost to Follow-up|1|||
127657128|NCT01381874|459366803|FG000|Overall Study|Lost to Follow-up|1|||
127657129|NCT01381874|459366804|FG001|Overall Study|Lost to Follow-up|1|||
127657130|NCT01381874|459366805|FG002|Overall Study|Lost to Follow-up|0|||
127657131|NCT01381874|459366803|FG000|Overall Study|Withdrawal by Subject|9|||
127657132|NCT01381874|459366804|FG001|Overall Study|Withdrawal by Subject|10|||
127657133|NCT01381874|459366805|FG002|Overall Study|Withdrawal by Subject|9|||
127987225|NCT02279745|460577257|FG000|Overall Study|Pregnancy|1|||
127987226|NCT02279745|460577257|FG000|Overall Study|Study Non-compliance|1|||
127987227|NCT02279745|460577257|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
127987228|NCT00380718|460577258|FG000|Overall Study|Adverse Event|1|||
127987229|NCT00380718|460577258|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
127987230|NCT00106639|460577265|FG000|Overall Study|Adverse Event|3|||
127987231|NCT00106639|460577266|FG001|Overall Study|Adverse Event|4|||
127987232|NCT00106639|460577267|FG002|Overall Study|Adverse Event|1|||
127987233|NCT00106639|460577265|FG000|Overall Study|Protocol Violation|0|||
127987234|NCT00106639|460577266|FG001|Overall Study|Protocol Violation|1|||
127987235|NCT00106639|460577267|FG002|Overall Study|Protocol Violation|0|||
127987236|NCT00106639|460577265|FG000|Overall Study|Withdrawal by Subject|0|||
127987237|NCT00106639|460577266|FG001|Overall Study|Withdrawal by Subject|1|||
127987238|NCT00106639|460577267|FG002|Overall Study|Withdrawal by Subject|0|||
127987239|NCT00106639|460577265|FG000|Overall Study|Participant defaulted|0|||
127987240|NCT00106639|460577266|FG001|Overall Study|Participant defaulted|1|||
127987241|NCT00106639|460577267|FG002|Overall Study|Participant defaulted|1|||
127987242|NCT01210144|460577269|FG000|Overall Study|Lack of ovarian response|1|||
127987243|NCT01210144|460577270|FG001|Overall Study|Lack of ovarian response|0|||
127987244|NCT01210144|460577269|FG000|Overall Study|No fertilization|1|||
127987245|NCT01210144|460577270|FG001|Overall Study|No fertilization|0|||
127987246|NCT01210144|460577269|FG000|Overall Study|No transfer|1|||
127987247|NCT01210144|460577270|FG001|Overall Study|No transfer|0|||
127987248|NCT00494221|460577275|FG000|Overall Study|Death|15|||
127987249|NCT00494221|460577276|FG001|Overall Study|Death|9|||
127987250|NCT00494221|460577277|FG002|Overall Study|Death|14|||
127987251|NCT00494221|460577275|FG000|Overall Study|Withdrawal by Subject|1|||
127987252|NCT00494221|460577276|FG001|Overall Study|Withdrawal by Subject|2|||
127987253|NCT00494221|460577277|FG002|Overall Study|Withdrawal by Subject|0|||
127987254|NCT01900431|460577279|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
127987255|NCT01900431|460577280|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
127987256|NCT01900431|460577281|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
127987257|NCT01900431|460577279|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
127987258|NCT01900431|460577280|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
127987259|NCT01900431|460577281|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
127987260|NCT01900431|460577279|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
127987261|NCT01900431|460577280|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
127987262|NCT01900431|460577281|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
127987263|NCT01900431|460577279|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
127987264|NCT01900431|460577280|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
127987265|NCT01900431|460577281|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
127987266|NCT01900431|460577279|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
127987267|NCT01900431|460577280|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
127987268|NCT01900431|460577281|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
127987269|NCT01900431|460577279|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
127987270|NCT01900431|460577280|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
127987271|NCT01900431|460577281|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
127987272|NCT01900431|460577279|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
127987273|NCT01900431|460577280|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
127987274|NCT01900431|460577281|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
127987275|NCT01900431|460577279|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
127987276|NCT01900431|460577280|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
127657134|NCT01381874|459366803|FG000|Overall Study|Other|67|||
127987277|NCT01900431|460577281|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
127987278|NCT01900431|460577279|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
127987279|NCT01900431|460577280|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
127657135|NCT01381874|459366804|FG001|Overall Study|Other|52|||
127657136|NCT01381874|459366805|FG002|Overall Study|Other|67|||
127657137|NCT02247804|459366806|FG000|Treatment Period 1|Adverse Event|9|||
127657138|NCT02247804|459366807|FG001|Treatment Period 1|Adverse Event|2|||
127657139|NCT02247804|459366808|FG002|Treatment Period 1|Adverse Event|0|||
127657140|NCT02247804|459366806|FG000|Treatment Period 1|Lack of Efficacy|0|||
127657141|NCT02247804|459366807|FG001|Treatment Period 1|Lack of Efficacy|0|||
127657142|NCT02247804|459366808|FG002|Treatment Period 1|Lack of Efficacy|2|||
127657143|NCT02247804|459366806|FG000|Treatment Period 1|Lost to Follow-up|1|||
127657144|NCT02247804|459366807|FG001|Treatment Period 1|Lost to Follow-up|0|||
127657145|NCT02247804|459366808|FG002|Treatment Period 1|Lost to Follow-up|2|||
127657146|NCT02247804|459366806|FG000|Treatment Period 1|Personal Reasons|7|||
127657147|NCT02247804|459366807|FG001|Treatment Period 1|Personal Reasons|1|||
127657148|NCT02247804|459366808|FG002|Treatment Period 1|Personal Reasons|2|||
127657149|NCT02247804|459366806|FG000|Treatment Period 1|Protocol Deviation|0|||
127657150|NCT02247804|459366807|FG001|Treatment Period 1|Protocol Deviation|0|||
127657151|NCT02247804|459366808|FG002|Treatment Period 1|Protocol Deviation|1|||
127657152|NCT02247804|459366806|FG000|Treatment Period 1|Randomized but not Treated|5|||
127657153|NCT02247804|459366807|FG001|Treatment Period 1|Randomized but not Treated|1|||
127657154|NCT02247804|459366808|FG002|Treatment Period 1|Randomized but not Treated|1|||
127657155|NCT02247804|459366806|FG000|Treatment Period 2|Adverse Event|6|||
127657156|NCT02247804|459366807|FG001|Treatment Period 2|Adverse Event|3|||
127657157|NCT02247804|459366808|FG002|Treatment Period 2|Adverse Event|3|||
127657158|NCT02247804|459366806|FG000|Treatment Period 2|Lack of Efficacy|0|||
127657159|NCT02247804|459366807|FG001|Treatment Period 2|Lack of Efficacy|0|||
127657160|NCT02247804|459366808|FG002|Treatment Period 2|Lack of Efficacy|1|||
127657161|NCT02247804|459366806|FG000|Treatment Period 2|Lost to Follow-up|0|||
127657162|NCT02247804|459366807|FG001|Treatment Period 2|Lost to Follow-up|1|||
127657163|NCT02247804|459366808|FG002|Treatment Period 2|Lost to Follow-up|1|||
127657164|NCT02247804|459366806|FG000|Treatment Period 2|Personal Reasons|2|||
127657165|NCT02247804|459366807|FG001|Treatment Period 2|Personal Reasons|1|||
127657166|NCT02247804|459366808|FG002|Treatment Period 2|Personal Reasons|1|||
127657167|NCT02247804|459366806|FG000|Treatment Period 2|Reason not Specified|0|||
127657168|NCT02247804|459366807|FG001|Treatment Period 2|Reason not Specified|0|||
127657169|NCT02247804|459366808|FG002|Treatment Period 2|Reason not Specified|2|||
127657170|NCT02247804|459366806|FG000|Treatment Period 3|Adverse Event|4|||
127657171|NCT02247804|459366807|FG001|Treatment Period 3|Adverse Event|3|||
127657172|NCT02247804|459366808|FG002|Treatment Period 3|Adverse Event|3|||
127657173|NCT02247804|459366806|FG000|Treatment Period 3|Lack of Efficacy|0|||
127657174|NCT02247804|459366807|FG001|Treatment Period 3|Lack of Efficacy|1|||
127657175|NCT02247804|459366808|FG002|Treatment Period 3|Lack of Efficacy|0|||
127657176|NCT02247804|459366806|FG000|Treatment Period 3|Lost to Follow-up|1|||
127657177|NCT02247804|459366807|FG001|Treatment Period 3|Lost to Follow-up|2|||
127657178|NCT02247804|459366808|FG002|Treatment Period 3|Lost to Follow-up|2|||
127657179|NCT02247804|459366806|FG000|Treatment Period 3|Personal Reasons|4|||
127657180|NCT02247804|459366807|FG001|Treatment Period 3|Personal Reasons|3|||
127657181|NCT02247804|459366808|FG002|Treatment Period 3|Personal Reasons|2|||
127657182|NCT02247804|459366806|FG000|Treatment Period 3|Reason not Specified|2|||
127657183|NCT02247804|459366807|FG001|Treatment Period 3|Reason not Specified|1|||
127657184|NCT02247804|459366808|FG002|Treatment Period 3|Reason not Specified|3|||
127657185|NCT02917265|459366809|FG000|Overall Study|Physician Decision|1|||
127657186|NCT02917265|459366810|FG001|Overall Study|Physician Decision|0|||
127657187|NCT02917265|459366809|FG000|Overall Study|Withdrawal by Subject|1|||
127657188|NCT02917265|459366810|FG001|Overall Study|Withdrawal by Subject|0|||
127657189|NCT00452413|459366811|FG000|Overall Study|Progressive Disease|4|||
127657190|NCT00452413|459366812|FG001|Overall Study|Progressive Disease|11|||
127657191|NCT00452413|459366813|FG002|Overall Study|Progressive Disease|30|||
127657192|NCT00452413|459366811|FG000|Overall Study|Withdrawal by Subject|0|||
127657193|NCT00452413|459366812|FG001|Overall Study|Withdrawal by Subject|1|||
127657194|NCT00452413|459366813|FG002|Overall Study|Withdrawal by Subject|4|||
127657195|NCT00452413|459366811|FG000|Overall Study|Adverse Event|0|||
127657196|NCT00452413|459366812|FG001|Overall Study|Adverse Event|0|||
127657197|NCT00452413|459366813|FG002|Overall Study|Adverse Event|5|||
127657198|NCT00452413|459366811|FG000|Overall Study|Physician Decision|0|||
127657199|NCT00452413|459366812|FG001|Overall Study|Physician Decision|0|||
127657200|NCT00452413|459366813|FG002|Overall Study|Physician Decision|4|||
127657201|NCT00452413|459366811|FG000|Overall Study|Death due to study disease|0|||
127657202|NCT00452413|459366812|FG001|Overall Study|Death due to study disease|0|||
127657203|NCT00452413|459366813|FG002|Overall Study|Death due to study disease|2|||
127657204|NCT00452413|459366811|FG000|Overall Study|Death due to adverse event (AE)|0|||
127657205|NCT00452413|459366812|FG001|Overall Study|Death due to adverse event (AE)|0|||
127657206|NCT00452413|459366813|FG002|Overall Study|Death due to adverse event (AE)|1|||
127657207|NCT00452413|459366811|FG000|Overall Study|On treatment|0|||
127657208|NCT00452413|459366812|FG001|Overall Study|On treatment|0|||
127657209|NCT00452413|459366813|FG002|Overall Study|On treatment|3|||
127657210|NCT01248962|459366814|FG000|Overall Study|Withdrawal by Subject|1|||
127657211|NCT01248962|459366815|FG001|Overall Study|Withdrawal by Subject|1|||
127657212|NCT01248962|459366814|FG000|Overall Study|Adverse Event|2|||
127657213|NCT01248962|459366815|FG001|Overall Study|Adverse Event|1|||
127657214|NCT01248962|459366814|FG000|Overall Study|Complete Response after 4 Cycles|1|||
127657215|NCT01248962|459366815|FG001|Overall Study|Complete Response after 4 Cycles|0|||
127657216|NCT01248962|459366814|FG000|Overall Study|Complete Response after 3 Cycles|0|||
127657217|NCT01248962|459366815|FG001|Overall Study|Complete Response after 3 Cycles|1|||
127657218|NCT01248962|459366814|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
127657219|NCT01248962|459366815|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
127657220|NCT03283696|459366816|FG000|Overall Study|Physician Decision|5|||
127657221|NCT03283696|459366817|FG001|Overall Study|Physician Decision|6|||
127657222|NCT03283696|459366816|FG000|Overall Study|Withdrawal by Subject|2|||
127657223|NCT03283696|459366817|FG001|Overall Study|Withdrawal by Subject|0|||
127657224|NCT01539863|459366821|FG000|Overall Study|Lost to Follow-up|5|||
127657225|NCT01539863|459366822|FG001|Overall Study|Lost to Follow-up|4|||
127657226|NCT02765490|459366825|FG000|Overall Study|Lost to Follow-up|1|||
127657227|NCT02765490|459366826|FG001|Overall Study|Lost to Follow-up|1|||
127657228|NCT02765490|459366825|FG000|Overall Study|Other|0|||
127657229|NCT02765490|459366826|FG001|Overall Study|Other|1|||
127657230|NCT02765490|459366825|FG000|Overall Study|Death|0|||
127657231|NCT02765490|459366826|FG001|Overall Study|Death|1|||
127657232|NCT00007475|459366829|FG000|Overall Study|Withdrawal by Subject|1|||
127657233|NCT00007475|459366830|FG001|Overall Study|Withdrawal by Subject|0|||
127657234|NCT00007475|459366831|FG002|Overall Study|Withdrawal by Subject|0|||
127657235|NCT00007475|459366832|FG003|Overall Study|Withdrawal by Subject|0|||
127657236|NCT00007475|459366829|FG000|Overall Study|Adverse Event|3|||
127657237|NCT00007475|459366830|FG001|Overall Study|Adverse Event|0|||
127657238|NCT00007475|459366831|FG002|Overall Study|Adverse Event|0|||
127657239|NCT00007475|459366832|FG003|Overall Study|Adverse Event|0|||
127657240|NCT01512745|459366834|FG000|Overall Study|Adverse Event|22|||
127657241|NCT01512745|459366835|FG001|Overall Study|Adverse Event|3|||
127657242|NCT01512745|459366834|FG000|Overall Study|Death|9|||
127657243|NCT01512745|459366835|FG001|Overall Study|Death|13|||
127657244|NCT01512745|459366834|FG000|Overall Study|Withdrawal by Subject|2|||
127657245|NCT01512745|459366835|FG001|Overall Study|Withdrawal by Subject|2|||
127657246|NCT01512745|459366834|FG000|Overall Study|Lost to Follow-up|4|||
127657247|NCT01512745|459366835|FG001|Overall Study|Lost to Follow-up|0|||
127657248|NCT01512745|459366834|FG000|Overall Study|Lack of Efficacy|2|||
127657249|NCT01512745|459366835|FG001|Overall Study|Lack of Efficacy|2|||
127657250|NCT01512745|459366834|FG000|Overall Study|Protocol Violation|1|||
127657251|NCT01512745|459366835|FG001|Overall Study|Protocol Violation|0|||
127657252|NCT00936221|459366836|FG000|Overall Study|Withdrawal by Subject|1|||
127657253|NCT00936221|459366837|FG001|Overall Study|Withdrawal by Subject|1|||
127657254|NCT03151395|459366838|FG000|Overall Study|Adverse Event|2|||
127657255|NCT03151395|459366838|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
127657256|NCT03151395|459366838|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
127657257|NCT03151395|459366838|FG000|Overall Study|Unspecified reason|4|||
127657258|NCT00879996|459366839|FG000|Overall Study|Lost to Follow-up|7|||
127657259|NCT00879996|459366840|FG001|Overall Study|Lost to Follow-up|6|||
127657260|NCT00879996|459366839|FG000|Overall Study|non-compliance|6|||
127657261|NCT00879996|459366840|FG001|Overall Study|non-compliance|4|||
127657262|NCT00879996|459366839|FG000|Overall Study|Physician Decision|1|||
127657263|NCT00879996|459366840|FG001|Overall Study|Physician Decision|2|||
127657264|NCT00879996|459366839|FG000|Overall Study|psychiatric problem|0|||
127657265|NCT00879996|459366840|FG001|Overall Study|psychiatric problem|1|||
127657266|NCT00879996|459366839|FG000|Overall Study|put on parole|1|||
127657267|NCT00879996|459366840|FG001|Overall Study|put on parole|0|||
127657268|NCT02597933|459366842|FG000|Overall Study|Withdrawal by Subject|7|||
127657269|NCT02597933|459366843|FG001|Overall Study|Withdrawal by Subject|5|||
127657270|NCT02597933|459366842|FG000|Overall Study|Protocol Violation|2|||
127657271|NCT02597933|459366843|FG001|Overall Study|Protocol Violation|2|||
127657272|NCT02597933|459366842|FG000|Overall Study|Adverse Event|20|||
127657273|NCT02597933|459366843|FG001|Overall Study|Adverse Event|28|||
127657274|NCT02597933|459366842|FG000|Overall Study|Not treated|2|||
127657275|NCT02597933|459366843|FG001|Overall Study|Not treated|2|||
127657276|NCT02597933|459366842|FG000|Overall Study|Other than stated above|7|||
127657277|NCT02597933|459366843|FG001|Overall Study|Other than stated above|14|||
127657278|NCT01617005|459366846|FG000|Overall Study|Pregnancy|1|||
127657279|NCT01617005|459366846|FG000|Overall Study|Lack of motivation for treatment|1|||
127657280|NCT04078035|459366850|FG000|Session 2|Lost to Follow-up|3|||
127657281|NCT04078035|459366851|FG001|Session 2|Lost to Follow-up|1|||
127657282|NCT04078035|459366850|FG000|Session 2|Unable to insert IV - participant elected to withdraw|8|||
127657283|NCT04078035|459366851|FG001|Session 2|Unable to insert IV - participant elected to withdraw|8|||
127987280|NCT01900431|460577281|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
127987281|NCT03755518|460577285|FG000|Overall Study|Lack of Efficacy|10|||
127657284|NCT00612534|459366852|FG000|Overall Study|Adverse Event|0|||
127657285|NCT00612534|459366853|FG001|Overall Study|Adverse Event|4|||
127657286|NCT00612534|459366854|FG002|Overall Study|Adverse Event|2|||
127657287|NCT00612534|459366855|FG003|Overall Study|Adverse Event|1|||
127657288|NCT00612534|459366852|FG000|Overall Study|Lack of Efficacy|13|||
127657289|NCT00612534|459366853|FG001|Overall Study|Lack of Efficacy|12|||
127987282|NCT03755518|460577285|FG000|Overall Study|Adverse Event|7|||
127987283|NCT03755518|460577285|FG000|Overall Study|Study Terminated by Sponsor|5|||
127987284|NCT03755518|460577285|FG000|Overall Study|Death|1|||
127987285|NCT03755518|460577285|FG000|Overall Study|Withdrawal by Subject|3|||
127987286|NCT03755518|460577285|FG000|Overall Study|Progressive Disease|4|||
127987287|NCT03755518|460577285|FG000|Overall Study|Bone Marrow Transplant|4|||
127987288|NCT03755518|460577285|FG000|Overall Study|Physicians Decision|1|||
127987289|NCT03755518|460577285|FG000|Overall Study|Relapse|1|||
127987290|NCT03755518|460577285|FG000|Overall Study|Withdrawal by Investigator for Non Compliance|1|||
127987291|NCT03755518|460577285|FG000|Overall Study|Withdrawal by PI|1|||
127987292|NCT03172364|460577286|FG000|Overall Study|Adverse Event|1|||
127987293|NCT03172364|460577287|FG001|Overall Study|Adverse Event|1|||
127987294|NCT03172364|460577286|FG000|Overall Study|Protocol Violation|1|||
127987295|NCT03172364|460577287|FG001|Overall Study|Protocol Violation|0|||
127987296|NCT01714609|460577288|FG000|Overall Study|Protocol Violation|1|||
127987297|NCT01714609|460577289|FG001|Overall Study|Protocol Violation|0|||
127987298|NCT00630747|460577290|FG000|Overall Study|Death|1|||
127987299|NCT00630747|460577290|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
127987300|NCT00630747|460577290|FG000|Overall Study|Returned to country of origin|1|||
127987301|NCT02732327|460577293|FG000|Overall Study|Protocol Violation|0|||
127987302|NCT02732327|460577294|FG001|Overall Study|Protocol Violation|1|||
127987303|NCT04503668|460577295|FG000|Overall Study|Incomplete data|4|||
127987304|NCT04503668|460577296|FG001|Overall Study|Incomplete data|3|||
127987305|NCT04503668|460577295|FG000|Overall Study|Withdrawal by Subject|1|||
127987306|NCT04503668|460577296|FG001|Overall Study|Withdrawal by Subject|1|||
127987307|NCT04503668|460577295|FG000|Overall Study|Adverse Event|2|||
127987308|NCT04503668|460577296|FG001|Overall Study|Adverse Event|0|||
127987309|NCT02306694|460577297|FG000|Overall Study|Withdrawal by Subject|3|||
127987310|NCT02306694|460577297|FG000|Overall Study|Lost to Follow-up|1|||
127987311|NCT00603382|460577298|FG000|Overall Study|Adverse Event|0|||
127987312|NCT00603382|460577299|FG001|Overall Study|Adverse Event|1|||
127987313|NCT00603382|460577300|FG002|Overall Study|Adverse Event|1|||
127987314|NCT00603382|460577301|FG003|Overall Study|Adverse Event|2|||
127987315|NCT00603382|460577302|FG004|Overall Study|Adverse Event|1|||
127987316|NCT00603382|460577303|FG005|Overall Study|Adverse Event|2|||
127987317|NCT00603382|460577298|FG000|Overall Study|Lack of Efficacy|14|||
127987318|NCT00603382|460577299|FG001|Overall Study|Lack of Efficacy|9|||
127987319|NCT00603382|460577300|FG002|Overall Study|Lack of Efficacy|3|||
127987320|NCT00603382|460577301|FG003|Overall Study|Lack of Efficacy|6|||
127987321|NCT00603382|460577302|FG004|Overall Study|Lack of Efficacy|6|||
127987322|NCT00603382|460577303|FG005|Overall Study|Lack of Efficacy|11|||
127987323|NCT00603382|460577298|FG000|Overall Study|Protocol Violation|1|||
127987324|NCT00603382|460577299|FG001|Overall Study|Protocol Violation|0|||
127987325|NCT00603382|460577300|FG002|Overall Study|Protocol Violation|1|||
127987326|NCT00603382|460577301|FG003|Overall Study|Protocol Violation|2|||
127987327|NCT00603382|460577302|FG004|Overall Study|Protocol Violation|1|||
127987328|NCT00603382|460577303|FG005|Overall Study|Protocol Violation|0|||
127987329|NCT00603382|460577298|FG000|Overall Study|Lost to Follow-up|0|||
127987330|NCT00603382|460577299|FG001|Overall Study|Lost to Follow-up|1|||
127987331|NCT00603382|460577300|FG002|Overall Study|Lost to Follow-up|1|||
127987332|NCT00603382|460577301|FG003|Overall Study|Lost to Follow-up|1|||
127987333|NCT00603382|460577302|FG004|Overall Study|Lost to Follow-up|0|||
127987334|NCT00603382|460577303|FG005|Overall Study|Lost to Follow-up|1|||
127987335|NCT00603382|460577298|FG000|Overall Study|Physician Decision|0|||
127987336|NCT00603382|460577299|FG001|Overall Study|Physician Decision|0|||
127987337|NCT00603382|460577300|FG002|Overall Study|Physician Decision|2|||
127987338|NCT00603382|460577301|FG003|Overall Study|Physician Decision|0|||
127987339|NCT00603382|460577302|FG004|Overall Study|Physician Decision|1|||
127987340|NCT00603382|460577303|FG005|Overall Study|Physician Decision|3|||
127987341|NCT00603382|460577298|FG000|Overall Study|Withdrawal by Subject|3|||
127987342|NCT00603382|460577299|FG001|Overall Study|Withdrawal by Subject|3|||
127987343|NCT00603382|460577300|FG002|Overall Study|Withdrawal by Subject|1|||
127657290|NCT00612534|459366854|FG002|Overall Study|Lack of Efficacy|5|||
127657291|NCT00612534|459366855|FG003|Overall Study|Lack of Efficacy|16|||
127987344|NCT00603382|460577301|FG003|Overall Study|Withdrawal by Subject|1|||
127987345|NCT00603382|460577302|FG004|Overall Study|Withdrawal by Subject|0|||
127987346|NCT00603382|460577303|FG005|Overall Study|Withdrawal by Subject|1|||
127987347|NCT03782974|460577304|FG000|Overall Study|Withdrawal by Subject|7|||
127987348|NCT03782974|460577305|FG001|Overall Study|Withdrawal by Subject|7|||
127987349|NCT03782974|460577304|FG000|Overall Study|Pregnancy|1|||
127987350|NCT03782974|460577305|FG001|Overall Study|Pregnancy|0|||
127987351|NCT00395642|460577306|FG000|Overall Study|Death|4|||
127987352|NCT00395642|460577306|FG000|Overall Study|Lost to Follow-up|1|||
127987353|NCT00395642|460577306|FG000|Overall Study|Physician Decision|7|||
127987354|NCT00395642|460577306|FG000|Overall Study|Withdrawal by Subject|1|||
127987355|NCT01783821|460577309|FG000|Overall Study|Screen Failure|1|||
127987356|NCT01783821|460577310|FG001|Overall Study|Screen Failure|1|||
127987357|NCT02333383|460577313|FG000|Overall Study|Adalimumab discontinuation|21|||
127987358|NCT02333383|460577313|FG000|Overall Study|Lost to Follow-up|15|||
127657292|NCT00612534|459366852|FG000|Overall Study|Other Reason|0|||
127657293|NCT00612534|459366853|FG001|Overall Study|Other Reason|1|||
127657294|NCT00612534|459366854|FG002|Overall Study|Other Reason|0|||
127657295|NCT00612534|459366855|FG003|Overall Study|Other Reason|0|||
127657296|NCT02223754|459366856|FG000|Period 1|Adverse Event|1|||
127657297|NCT02223754|459366857|FG001|Period 1|Adverse Event|0|||
127657298|NCT02223754|459366856|FG000|Period 1|Lost to Follow-up|0|||
127657299|NCT02223754|459366857|FG001|Period 1|Lost to Follow-up|1|||
127657300|NCT02223754|459366856|FG000|Period 1|Protocol Violation|2|||
127657301|NCT02223754|459366857|FG001|Period 1|Protocol Violation|4|||
127657302|NCT02223754|459366856|FG000|Period 1|Withdrawal by Subject|0|||
127657303|NCT02223754|459366857|FG001|Period 1|Withdrawal by Subject|4|||
127657304|NCT02223754|459366856|FG000|Period 1|Test Article No Longer Available|1|||
127657305|NCT02223754|459366857|FG001|Period 1|Test Article No Longer Available|5|||
127657306|NCT02223754|459366856|FG000|Period 1|Unsatisfactory Visual Response|0|||
127657307|NCT02223754|459366857|FG001|Period 1|Unsatisfactory Visual Response|1|||
127657308|NCT02223754|459366856|FG000|Period 2|Adverse Event|0|||
127657309|NCT02223754|459366857|FG001|Period 2|Adverse Event|1|||
127657310|NCT02223754|459366856|FG000|Period 2|Protocol Violation|1|||
127657311|NCT02223754|459366857|FG001|Period 2|Protocol Violation|0|||
127657312|NCT02223754|459366856|FG000|Period 2|Lens Discomfort|1|||
127657313|NCT02223754|459366857|FG001|Period 2|Lens Discomfort|1|||
127657314|NCT02223754|459366856|FG000|Period 2|Lost to Follow-up|1|||
127987359|NCT02333383|460577313|FG000|Overall Study|Withdrawal by Subject|3|||
127657315|NCT02223754|459366857|FG001|Period 2|Lost to Follow-up|0|||
127657316|NCT02223754|459366856|FG000|Period 2|Test Article No Longer Available|0|||
127657317|NCT02223754|459366857|FG001|Period 2|Test Article No Longer Available|1|||
127657318|NCT00510458|459366858|FG000|Overall Study|5 year not evaluable/missed|21|||
127657319|NCT00510458|459366858|FG000|Overall Study|Death|1|||
127657320|NCT00510458|459366858|FG000|Overall Study|Terminated|14|||
127657321|NCT00510458|459366858|FG000|Overall Study|Lost to Follow-up|6|||
127657322|NCT00510458|459366858|FG000|Overall Study|Withdrawal by Subject|3|||
127657323|NCT00510458|459366858|FG000|Overall Study|Revision|2|||
127657324|NCT00539279|459366859|FG000|Treatment|Withdrawal by Subject|10|||
127657325|NCT00539279|459366860|FG001|Treatment|Withdrawal by Subject|8|||
127657326|NCT00539279|459366859|FG000|Treatment|Death|1|||
127657327|NCT00539279|459366860|FG001|Treatment|Death|0|||
127657328|NCT00539279|459366859|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
127657329|NCT00539279|459366860|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
127657330|NCT00539279|459366859|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
127657331|NCT00539279|459366860|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
127987360|NCT02333383|460577313|FG000|Overall Study|Transfer to another hospital|2|||
127987361|NCT01907217|460577314|FG000|Overall Study|Withdrawal by Subject|0|||
127987362|NCT01907217|460577315|FG001|Overall Study|Withdrawal by Subject|2|||
127987363|NCT00659776|460577324|FG000|Overall Study|Withdrawal by Subject|12|||
127987364|NCT00659776|460577325|FG001|Overall Study|Withdrawal by Subject|2|||
127987365|NCT00659776|460577326|FG002|Overall Study|Withdrawal by Subject|0|||
127987366|NCT01180049|460577327|FG000|Overall Study|Other|9|||
127987367|NCT01180049|460577328|FG001|Overall Study|Other|7|||
127987368|NCT01180049|460577327|FG000|Overall Study|Lost to Follow-up|8|||
127987369|NCT01180049|460577328|FG001|Overall Study|Lost to Follow-up|6|||
127987370|NCT01180049|460577327|FG000|Overall Study|Death|36|||
127987371|NCT01180049|460577328|FG001|Overall Study|Death|35|||
127987372|NCT00350779|460577332|FG000|Overall Study|Adverse Event|4|||
127987373|NCT00350779|460577333|FG001|Overall Study|Adverse Event|2|||
127987374|NCT00350779|460577332|FG000|Overall Study|Lack of Efficacy|0|||
127987375|NCT00350779|460577333|FG001|Overall Study|Lack of Efficacy|4|||
127987376|NCT00350779|460577332|FG000|Overall Study|Lost to Follow-up|2|||
127987377|NCT00350779|460577333|FG001|Overall Study|Lost to Follow-up|0|||
127987378|NCT00350779|460577332|FG000|Overall Study|Physician Decision|2|||
127987379|NCT00350779|460577333|FG001|Overall Study|Physician Decision|4|||
127987380|NCT00350779|460577332|FG000|Overall Study|Protocol Violation|3|||
127987381|NCT00350779|460577333|FG001|Overall Study|Protocol Violation|1|||
127657332|NCT01693692|459366861|FG000|Overall Study|Withdrawal by Subject|12|||
127657333|NCT01693692|459366862|FG001|Overall Study|Withdrawal by Subject|10|||
127657334|NCT01693692|459366863|FG002|Overall Study|Withdrawal by Subject|11|||
127657335|NCT01693692|459366861|FG000|Overall Study|Adverse Event|7|||
127657336|NCT01693692|459366862|FG001|Overall Study|Adverse Event|14|||
127657337|NCT01693692|459366863|FG002|Overall Study|Adverse Event|9|||
127657338|NCT01693692|459366861|FG000|Overall Study|Physician Decision|0|||
127657339|NCT01693692|459366862|FG001|Overall Study|Physician Decision|0|||
127657340|NCT01693692|459366863|FG002|Overall Study|Physician Decision|1|||
127987382|NCT00350779|460577332|FG000|Overall Study|Withdrawal by Subject|9|||
127657341|NCT01693692|459366861|FG000|Overall Study|Protocol Violation|5|||
127657342|NCT01693692|459366862|FG001|Overall Study|Protocol Violation|4|||
127987383|NCT00350779|460577333|FG001|Overall Study|Withdrawal by Subject|8|||
127657343|NCT01693692|459366863|FG002|Overall Study|Protocol Violation|6|||
127657344|NCT01693692|459366861|FG000|Overall Study|Lost to Follow-up|2|||
127987384|NCT00350779|460577332|FG000|Overall Study|Patient Moved|2|||
127987385|NCT00350779|460577333|FG001|Overall Study|Patient Moved|1|||
127657345|NCT01693692|459366862|FG001|Overall Study|Lost to Follow-up|2|||
127657346|NCT01693692|459366863|FG002|Overall Study|Lost to Follow-up|3|||
127657347|NCT01693692|459366861|FG000|Overall Study|Other|4|||
127657348|NCT01693692|459366862|FG001|Overall Study|Other|4|||
127657349|NCT01693692|459366863|FG002|Overall Study|Other|6|||
127657350|NCT01382940|459368696|FG000|Overall Study|Adverse Event|19|||
127657351|NCT01382940|459368696|FG000|Overall Study|Lost to Follow-up|4|||
127657352|NCT01382940|459368696|FG000|Overall Study|Physician Decision|7|||
127657353|NCT01382940|459368696|FG000|Overall Study|Withdrawal by Subject|23|||
127657354|NCT01382940|459368696|FG000|Overall Study|Protocol Violation|20|||
127657355|NCT01486758|459368699|FG000|Overall Study|Lost to Follow-up|0|||
127657356|NCT01486758|459368700|FG001|Overall Study|Lost to Follow-up|1|||
127657357|NCT03093428|459368712|FG000|Overall Study|Not eligible for treatment|2|||
127657358|NCT03093428|459368713|FG001|Overall Study|Not eligible for treatment|1|||
127657359|NCT03093428|459368712|FG000|Overall Study|Progression|14|||
127657360|NCT03093428|459368713|FG001|Overall Study|Progression|4|||
127657361|NCT03093428|459368712|FG000|Overall Study|Death|1|||
127657362|NCT03093428|459368713|FG001|Overall Study|Death|0|||
127657363|NCT03093428|459368712|FG000|Overall Study|Adverse Event|1|||
127657364|NCT03093428|459368713|FG001|Overall Study|Adverse Event|0|||
127657365|NCT03093428|459368712|FG000|Overall Study|Withdrawal by Subject|1|||
127657366|NCT03093428|459368713|FG001|Overall Study|Withdrawal by Subject|1|||
127657367|NCT03980184|459368714|FG000|Overall Study|Dropped out before treatment|2|||
127657368|NCT03980184|459368715|FG001|Overall Study|Dropped out before treatment|2|||
127657369|NCT03980184|459368714|FG000|Overall Study|Lost to Follow-up|11|||
127657370|NCT03980184|459368715|FG001|Overall Study|Lost to Follow-up|13|||
127657371|NCT01642602|459368717|FG000|Overall Study|Adverse Event|2|||
127657372|NCT02291432|459368718|FG000|Overall Study|Withdrawal by Subject|2|||
127657373|NCT00422799|459368724|FG000|Overall Study|Withdrawal by Subject|6|||
127657374|NCT00422799|459368724|FG000|Overall Study|Adverse Event|7|||
127657375|NCT02091739|459368726|FG000|MP: 16 Weeks|Adverse Event|1|||
127657376|NCT02091739|459368727|FG001|MP: 16 Weeks|Adverse Event|1|||
127657377|NCT02091739|459368728|FG002|MP: 16 Weeks|Adverse Event|1|||
127657378|NCT02091739|459368729|FG003|MP: 16 Weeks|Adverse Event|0|||
127657379|NCT02091739|459368730|FG004|MP: 16 Weeks|Adverse Event|0|||
127657380|NCT02091739|459368726|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
127657381|NCT02091739|459368727|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
127657382|NCT02091739|459368728|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
127657383|NCT02091739|459368729|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
127657384|NCT02091739|459368730|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
127657385|NCT02091739|459368726|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
127657386|NCT02091739|459368727|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
127657387|NCT02091739|459368728|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
127657388|NCT02091739|459368729|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
127657389|NCT02091739|459368730|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
127657390|NCT02091739|459368726|FG000|EP: 48 Weeks|Other|0|||
127657391|NCT02091739|459368727|FG001|EP: 48 Weeks|Other|0|||
127657392|NCT02091739|459368728|FG002|EP: 48 Weeks|Other|0|||
127657393|NCT02091739|459368729|FG003|EP: 48 Weeks|Other|1|||
127657394|NCT02091739|459368730|FG004|EP: 48 Weeks|Other|0|||
127657395|NCT02091739|459368726|FG000|EP: 48 Weeks|Death|0|||
127657396|NCT02091739|459368727|FG001|EP: 48 Weeks|Death|0|||
127657397|NCT02091739|459368728|FG002|EP: 48 Weeks|Death|0|||
127657398|NCT02091739|459368729|FG003|EP: 48 Weeks|Death|3|||
127657399|NCT02091739|459368730|FG004|EP: 48 Weeks|Death|2|||
127657400|NCT02091739|459368726|FG000|EP: 48 Weeks|Adverse Event|0|||
127657401|NCT02091739|459368727|FG001|EP: 48 Weeks|Adverse Event|0|||
127657402|NCT02091739|459368728|FG002|EP: 48 Weeks|Adverse Event|0|||
127657403|NCT02091739|459368729|FG003|EP: 48 Weeks|Adverse Event|2|||
127657404|NCT02091739|459368730|FG004|EP: 48 Weeks|Adverse Event|6|||
127657405|NCT02091739|459368726|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
127657406|NCT02091739|459368727|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
127657407|NCT02091739|459368728|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
127657408|NCT02091739|459368729|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
127657409|NCT02091739|459368730|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
127657410|NCT01737996|459368737|FG000|Overall Study|Adverse Event|0|||
127657411|NCT01737996|459368738|FG001|Overall Study|Adverse Event|1|||
127657412|NCT01737996|459368739|FG002|Overall Study|Adverse Event|1|||
127657413|NCT01737996|459368737|FG000|Overall Study|Withdrawal by Subject|0|||
127657414|NCT01737996|459368738|FG001|Overall Study|Withdrawal by Subject|0|||
127657415|NCT01737996|459368739|FG002|Overall Study|Withdrawal by Subject|1|||
127657416|NCT03119610|459368740|FG000|Overall Study|Adverse Event|1|||
127657417|NCT03119610|459368741|FG001|Overall Study|Adverse Event|0|||
127657418|NCT03119610|459368740|FG000|Overall Study|Lost to Follow-up|0|||
127657419|NCT03119610|459368741|FG001|Overall Study|Lost to Follow-up|1|||
127657420|NCT00114634|459368742|FG000|Overall Study|failure to return forms|3|||
127657421|NCT01003184|459368743|FG000|Overall Study|Adverse Event|12|||
127657422|NCT01003184|459368744|FG001|Overall Study|Adverse Event|5|||
127657423|NCT01003184|459368743|FG000|Overall Study|Lost to Follow-up|1|||
127657424|NCT01003184|459368744|FG001|Overall Study|Lost to Follow-up|0|||
127657425|NCT01003184|459368743|FG000|Overall Study|Loss of glucose control|1|||
127657426|NCT01003184|459368744|FG001|Overall Study|Loss of glucose control|1|||
127657427|NCT01003184|459368743|FG000|Overall Study|Protocol Violation|3|||
127657428|NCT01003184|459368744|FG001|Overall Study|Protocol Violation|0|||
127657429|NCT01003184|459368743|FG000|Overall Study|Withdrawal by Subject|1|||
127657430|NCT01003184|459368744|FG001|Overall Study|Withdrawal by Subject|6|||
127657431|NCT01003184|459368743|FG000|Overall Study|Physician Decision|1|||
127657432|NCT01003184|459368744|FG001|Overall Study|Physician Decision|0|||
127657433|NCT00557622|459368745|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
127657434|NCT00557622|459368746|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
127657435|NCT00557622|459368745|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
127657436|NCT00557622|459368746|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
127657437|NCT00557622|459368745|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
127657438|NCT00557622|459368746|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
127657439|NCT01468922|459368747|FG000|Overall Study|Screening failure|0|||
127657440|NCT01468922|459368748|FG001|Overall Study|Screening failure|0|||
127657441|NCT01468922|459368749|FG002|Overall Study|Screening failure|0|||
127657442|NCT01468922|459368750|FG003|Overall Study|Screening failure|0|||
127657443|NCT01468922|459368751|FG004|Overall Study|Screening failure|0|||
127657444|NCT01468922|459368752|FG005|Overall Study|Screening failure|0|||
127657445|NCT01468922|459368753|FG006|Overall Study|Screening failure|0|||
127657446|NCT01468922|459368754|FG007|Overall Study|Screening failure|0|||
127657447|NCT01468922|459368755|FG008|Overall Study|Screening failure|1|||
127657448|NCT01468922|459368747|FG000|Overall Study|Per patient choice|1|||
127657449|NCT01468922|459368748|FG001|Overall Study|Per patient choice|0|||
127987386|NCT00350779|460577332|FG000|Overall Study|Non-compliance with study procedures|0|||
127657450|NCT01468922|459368749|FG002|Overall Study|Per patient choice|0|||
127657451|NCT01468922|459368750|FG003|Overall Study|Per patient choice|0|||
127657452|NCT01468922|459368751|FG004|Overall Study|Per patient choice|0|||
127657453|NCT01468922|459368752|FG005|Overall Study|Per patient choice|0|||
127657454|NCT01468922|459368753|FG006|Overall Study|Per patient choice|0|||
127657455|NCT01468922|459368754|FG007|Overall Study|Per patient choice|0|||
127657456|NCT01468922|459368755|FG008|Overall Study|Per patient choice|0|||
127657457|NCT01468922|459368747|FG000|Overall Study|Switched to alternative treatment|1|||
127657458|NCT01468922|459368748|FG001|Overall Study|Switched to alternative treatment|0|||
127657459|NCT01468922|459368749|FG002|Overall Study|Switched to alternative treatment|0|||
127657460|NCT01468922|459368750|FG003|Overall Study|Switched to alternative treatment|0|||
127657461|NCT01468922|459368751|FG004|Overall Study|Switched to alternative treatment|1|||
127657462|NCT01468922|459368752|FG005|Overall Study|Switched to alternative treatment|0|||
127657463|NCT01468922|459368753|FG006|Overall Study|Switched to alternative treatment|0|||
127657464|NCT01468922|459368754|FG007|Overall Study|Switched to alternative treatment|0|||
127657465|NCT01468922|459368755|FG008|Overall Study|Switched to alternative treatment|0|||
127657466|NCT01468922|459368747|FG000|Overall Study|Enrolled on new protocol|0|||
127657467|NCT01468922|459368748|FG001|Overall Study|Enrolled on new protocol|0|||
127657468|NCT01468922|459368749|FG002|Overall Study|Enrolled on new protocol|0|||
127657469|NCT01468922|459368750|FG003|Overall Study|Enrolled on new protocol|0|||
127657470|NCT01468922|459368751|FG004|Overall Study|Enrolled on new protocol|1|||
127657471|NCT01468922|459368752|FG005|Overall Study|Enrolled on new protocol|0|||
127657472|NCT01468922|459368753|FG006|Overall Study|Enrolled on new protocol|0|||
127657473|NCT01468922|459368754|FG007|Overall Study|Enrolled on new protocol|0|||
127987387|NCT00350779|460577333|FG001|Overall Study|Non-compliance with study procedures|1|||
127987388|NCT02012959|460577334|FG000|Treatment Phase A|Adverse Event|2|||
127987389|NCT02012959|460577335|FG001|Treatment Phase A|Adverse Event|0|||
127987390|NCT02012959|460577336|FG002|Treatment Phase A|Adverse Event|0|||
127987391|NCT02012959|460577337|FG003|Treatment Phase A|Adverse Event|0|||
127987392|NCT02012959|460577338|FG004|Treatment Phase A|Adverse Event|0|||
127987393|NCT01687283|460578806|FG000|Overall Study|Adverse Event|11|||
127987394|NCT01687283|460578807|FG001|Overall Study|Adverse Event|4|||
127987395|NCT01687283|460578806|FG000|Overall Study|Lack of Efficacy|3|||
127987396|NCT01687283|460578807|FG001|Overall Study|Lack of Efficacy|1|||
127987397|NCT01687283|460578806|FG000|Overall Study|Protocol Violation|1|||
127987398|NCT01687283|460578807|FG001|Overall Study|Protocol Violation|3|||
127987399|NCT01687283|460578806|FG000|Overall Study|protocol defined stopping criteria|8|||
127987400|NCT01687283|460578807|FG001|Overall Study|protocol defined stopping criteria|10|||
127987401|NCT01687283|460578806|FG000|Overall Study|Lost to Follow-up|1|||
127987402|NCT01687283|460578807|FG001|Overall Study|Lost to Follow-up|1|||
127987403|NCT01687283|460578806|FG000|Overall Study|Investigator discretion|2|||
127987404|NCT01687283|460578807|FG001|Overall Study|Investigator discretion|0|||
127987405|NCT01687283|460578806|FG000|Overall Study|Withdrawal by Subject|9|||
127987406|NCT01687283|460578807|FG001|Overall Study|Withdrawal by Subject|8|||
127657474|NCT01468922|459368755|FG008|Overall Study|Enrolled on new protocol|0|||
127657475|NCT01468922|459368747|FG000|Overall Study|Adverse Event|0|||
127657476|NCT01468922|459368748|FG001|Overall Study|Adverse Event|0|||
127657477|NCT01468922|459368749|FG002|Overall Study|Adverse Event|0|||
127657478|NCT01468922|459368750|FG003|Overall Study|Adverse Event|0|||
127657479|NCT01468922|459368751|FG004|Overall Study|Adverse Event|0|||
127657480|NCT01468922|459368752|FG005|Overall Study|Adverse Event|0|||
127657481|NCT01468922|459368753|FG006|Overall Study|Adverse Event|0|||
127657482|NCT01468922|459368754|FG007|Overall Study|Adverse Event|1|||
127657483|NCT01468922|459368755|FG008|Overall Study|Adverse Event|0|||
127657484|NCT01468922|459368747|FG000|Overall Study|Infection of blood|0|||
127657485|NCT01468922|459368748|FG001|Overall Study|Infection of blood|0|||
127657486|NCT01468922|459368749|FG002|Overall Study|Infection of blood|0|||
127657487|NCT01468922|459368750|FG003|Overall Study|Infection of blood|0|||
127657488|NCT01468922|459368751|FG004|Overall Study|Infection of blood|0|||
127657489|NCT01468922|459368752|FG005|Overall Study|Infection of blood|0|||
127657490|NCT01468922|459368753|FG006|Overall Study|Infection of blood|0|||
127657491|NCT01468922|459368754|FG007|Overall Study|Infection of blood|1|||
127657492|NCT01468922|459368755|FG008|Overall Study|Infection of blood|0|||
127657493|NCT01468922|459368747|FG000|Overall Study|Patient choice - surgery|0|||
127657494|NCT01468922|459368748|FG001|Overall Study|Patient choice - surgery|0|||
127657495|NCT01468922|459368749|FG002|Overall Study|Patient choice - surgery|0|||
127657496|NCT01468922|459368750|FG003|Overall Study|Patient choice - surgery|0|||
127657497|NCT01468922|459368751|FG004|Overall Study|Patient choice - surgery|0|||
127657498|NCT01468922|459368752|FG005|Overall Study|Patient choice - surgery|0|||
127657499|NCT01468922|459368753|FG006|Overall Study|Patient choice - surgery|0|||
127657500|NCT01468922|459368754|FG007|Overall Study|Patient choice - surgery|1|||
127657501|NCT01468922|459368755|FG008|Overall Study|Patient choice - surgery|0|||
127657502|NCT01468922|459368747|FG000|Overall Study|Refused further treatment|0|||
127657503|NCT01468922|459368748|FG001|Overall Study|Refused further treatment|0|||
127657504|NCT01468922|459368749|FG002|Overall Study|Refused further treatment|0|||
127657505|NCT01468922|459368750|FG003|Overall Study|Refused further treatment|0|||
127657506|NCT01468922|459368751|FG004|Overall Study|Refused further treatment|0|||
127657507|NCT01468922|459368752|FG005|Overall Study|Refused further treatment|0|||
127657508|NCT01468922|459368753|FG006|Overall Study|Refused further treatment|0|||
127657509|NCT01468922|459368754|FG007|Overall Study|Refused further treatment|1|||
127657510|NCT01468922|459368755|FG008|Overall Study|Refused further treatment|0|||
127657511|NCT01719224|459368760|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
127657512|NCT01719224|459368761|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
127657513|NCT02563522|459368762|FG000|Overall Study|Adverse Event|2|||
127657514|NCT02563522|459368763|FG001|Overall Study|Adverse Event|3|||
127657515|NCT02563522|459368762|FG000|Overall Study|Lost to Follow-up|1|||
127657516|NCT02563522|459368763|FG001|Overall Study|Lost to Follow-up|0|||
127657517|NCT02563522|459368762|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
127657518|NCT02563522|459368763|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
127657519|NCT00675506|459368767|FG000|Overall Study|Lost to Follow-up|1|||
127657520|NCT00675506|459368768|FG001|Overall Study|Lost to Follow-up|5|||
127657521|NCT00675506|459368767|FG000|Overall Study|Lost interest|3|||
127657522|NCT00675506|459368768|FG001|Overall Study|Lost interest|5|||
127657523|NCT00675506|459368767|FG000|Overall Study|Elevated fasting glucose|2|||
127657524|NCT00675506|459368768|FG001|Overall Study|Elevated fasting glucose|1|||
127657525|NCT00675506|459368767|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
127657526|NCT00675506|459368768|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
127657527|NCT00675506|459368767|FG000|Overall Study|Elevated IGF-1|2|||
127657528|NCT00675506|459368768|FG001|Overall Study|Elevated IGF-1|0|||
127657529|NCT00675506|459368767|FG000|Overall Study|Hypersensitivity Reaction|1|||
127657530|NCT00675506|459368768|FG001|Overall Study|Hypersensitivity Reaction|0|||
127657531|NCT00675506|459368767|FG000|Overall Study|Disclosed history of cancer|1|||
127657532|NCT00675506|459368768|FG001|Overall Study|Disclosed history of cancer|0|||
127657533|NCT00675506|459368767|FG000|Overall Study|Declined participation|1|||
127657534|NCT00675506|459368768|FG001|Overall Study|Declined participation|0|||
127657535|NCT00675506|459368767|FG000|Overall Study|Schedule conflict|0|||
127657536|NCT00675506|459368768|FG001|Overall Study|Schedule conflict|1|||
127657537|NCT03820323|459368769|FG000|Overall Study|Lost to Follow-up|2|||
127657538|NCT03820323|459368770|FG001|Overall Study|Lost to Follow-up|1|||
127657539|NCT03820323|459368769|FG000|Overall Study|Missed 12-month visit|22|||
127657540|NCT03820323|459368770|FG001|Overall Study|Missed 12-month visit|14|||
127987407|NCT00642954|460578808|FG000|Overall Study|Progressive Disease|3|||
127987408|NCT00642954|460578809|FG001|Overall Study|Progressive Disease|3|||
127657541|NCT03820323|459368769|FG000|Overall Study|Death|2|||
127987409|NCT00642954|460578810|FG002|Overall Study|Progressive Disease|3|||
127657542|NCT03820323|459368770|FG001|Overall Study|Death|1|||
127987410|NCT00642954|460578811|FG003|Overall Study|Progressive Disease|3|||
127657543|NCT03820323|459368769|FG000|Overall Study|Transferred out|13|||
127657544|NCT03820323|459368770|FG001|Overall Study|Transferred out|11|||
127657545|NCT03820323|459368769|FG000|Overall Study|Terminated|0|||
127657546|NCT03820323|459368770|FG001|Overall Study|Terminated|3|||
127657547|NCT03820323|459368769|FG000|Overall Study|Withdrawal by Subject|1|||
127987411|NCT00642954|460578812|FG004|Overall Study|Progressive Disease|9|||
127987412|NCT00642954|460578808|FG000|Overall Study|Withdrawal by Subject|0|||
127987413|NCT00642954|460578809|FG001|Overall Study|Withdrawal by Subject|0|||
127657548|NCT03820323|459368770|FG001|Overall Study|Withdrawal by Subject|6|||
127657549|NCT01107743|459368771|FG000|Overall Study|Protocol Violation|46|||
127657550|NCT00308737|459368772|FG000|Overall Study|Adverse Event|104|||
127657551|NCT00308737|459368773|FG001|Overall Study|Adverse Event|9|||
127657552|NCT00308737|459368774|FG002|Overall Study|Adverse Event|0|||
127657553|NCT00308737|459368772|FG000|Overall Study|Death|4|||
127657554|NCT00308737|459368773|FG001|Overall Study|Death|3|||
127657555|NCT00308737|459368774|FG002|Overall Study|Death|0|||
127657556|NCT00308737|459368772|FG000|Overall Study|Lost to Follow-up|56|||
127657557|NCT00308737|459368773|FG001|Overall Study|Lost to Follow-up|80|||
127657558|NCT00308737|459368774|FG002|Overall Study|Lost to Follow-up|5|||
127657559|NCT00308737|459368772|FG000|Overall Study|Physician Decision|15|||
127657560|NCT00308737|459368773|FG001|Overall Study|Physician Decision|2|||
127657561|NCT00308737|459368774|FG002|Overall Study|Physician Decision|1|||
127657562|NCT00308737|459368772|FG000|Overall Study|Protocol Violation|34|||
127657563|NCT00308737|459368773|FG001|Overall Study|Protocol Violation|9|||
127657564|NCT00308737|459368774|FG002|Overall Study|Protocol Violation|5|||
127657565|NCT00308737|459368772|FG000|Overall Study|Withdrawal by Subject|218|||
127657566|NCT00308737|459368773|FG001|Overall Study|Withdrawal by Subject|166|||
127657567|NCT00308737|459368774|FG002|Overall Study|Withdrawal by Subject|18|||
127657568|NCT00308737|459368772|FG000|Overall Study|Various|32|||
127657569|NCT00308737|459368773|FG001|Overall Study|Various|20|||
127657570|NCT00308737|459368774|FG002|Overall Study|Various|8|||
127657571|NCT01225822|459368786|FG000|Overall Study|Adverse Event|13|||
127657572|NCT01225822|459368787|FG001|Overall Study|Adverse Event|31|||
127657573|NCT01225822|459368788|FG002|Overall Study|Adverse Event|18|||
127657574|NCT01225822|459368789|FG003|Overall Study|Adverse Event|23|||
127657575|NCT01225822|459368790|FG004|Overall Study|Adverse Event|14|||
127657576|NCT01225822|459368786|FG000|Overall Study|Protocol Violation|6|||
127657577|NCT01225822|459368787|FG001|Overall Study|Protocol Violation|8|||
127657578|NCT01225822|459368788|FG002|Overall Study|Protocol Violation|6|||
127657579|NCT01225822|459368789|FG003|Overall Study|Protocol Violation|7|||
127657580|NCT01225822|459368790|FG004|Overall Study|Protocol Violation|4|||
127657581|NCT01225822|459368786|FG000|Overall Study|Lost to Follow-up|0|||
127657582|NCT01225822|459368787|FG001|Overall Study|Lost to Follow-up|0|||
127657583|NCT01225822|459368788|FG002|Overall Study|Lost to Follow-up|0|||
127657584|NCT01225822|459368789|FG003|Overall Study|Lost to Follow-up|1|||
127657585|NCT01225822|459368790|FG004|Overall Study|Lost to Follow-up|0|||
127657586|NCT01225822|459368786|FG000|Overall Study|Withdrawal by Subject|6|||
127657587|NCT01225822|459368787|FG001|Overall Study|Withdrawal by Subject|7|||
127657588|NCT01225822|459368788|FG002|Overall Study|Withdrawal by Subject|7|||
127657589|NCT01225822|459368789|FG003|Overall Study|Withdrawal by Subject|11|||
127657590|NCT01225822|459368790|FG004|Overall Study|Withdrawal by Subject|6|||
127657591|NCT01225822|459368786|FG000|Overall Study|Other|13|||
127657592|NCT01225822|459368787|FG001|Overall Study|Other|10|||
127657593|NCT01225822|459368788|FG002|Overall Study|Other|7|||
127657594|NCT01225822|459368789|FG003|Overall Study|Other|10|||
127657595|NCT01225822|459368790|FG004|Overall Study|Other|7|||
127657596|NCT03679767|459368791|FG000|Overall Study|Death|16|||
127657597|NCT03679767|459368792|FG001|Overall Study|Death|11|||
127657598|NCT03679767|459368793|FG002|Overall Study|Death|17|||
127657599|NCT03679767|459368794|FG003|Overall Study|Death|10|||
127657600|NCT03679767|459368791|FG000|Overall Study|Lost to Follow-up|1|||
127657601|NCT03679767|459368792|FG001|Overall Study|Lost to Follow-up|1|||
127657602|NCT03679767|459368793|FG002|Overall Study|Lost to Follow-up|1|||
127657603|NCT03679767|459368794|FG003|Overall Study|Lost to Follow-up|1|||
127657604|NCT03679767|459368791|FG000|Overall Study|Withdrawal by Subject|0|||
127657605|NCT03679767|459368792|FG001|Overall Study|Withdrawal by Subject|0|||
127657606|NCT03679767|459368793|FG002|Overall Study|Withdrawal by Subject|0|||
127657607|NCT03679767|459368794|FG003|Overall Study|Withdrawal by Subject|1|||
127987414|NCT00642954|460578810|FG002|Overall Study|Withdrawal by Subject|0|||
127987415|NCT00642954|460578811|FG003|Overall Study|Withdrawal by Subject|0|||
127987416|NCT00642954|460578812|FG004|Overall Study|Withdrawal by Subject|1|||
127987417|NCT00642954|460578808|FG000|Overall Study|Adverse Event|1|||
127657608|NCT03679767|459368791|FG000|Overall Study|Follow-up Completed|18|||
127657609|NCT03679767|459368792|FG001|Overall Study|Follow-up Completed|11|||
127657610|NCT03679767|459368793|FG002|Overall Study|Follow-up Completed|11|||
127657611|NCT03679767|459368794|FG003|Overall Study|Follow-up Completed|20|||
127657612|NCT03679767|459368791|FG000|Overall Study|Entered Hospice Care|0|||
127657613|NCT03679767|459368792|FG001|Overall Study|Entered Hospice Care|0|||
127657614|NCT03679767|459368793|FG002|Overall Study|Entered Hospice Care|0|||
127657615|NCT03679767|459368794|FG003|Overall Study|Entered Hospice Care|1|||
127657616|NCT03679767|459368791|FG000|Overall Study|Progressive Disease|0|||
127657617|NCT03679767|459368792|FG001|Overall Study|Progressive Disease|0|||
127657618|NCT03679767|459368793|FG002|Overall Study|Progressive Disease|0|||
127657619|NCT03679767|459368794|FG003|Overall Study|Progressive Disease|1|||
127657620|NCT02954458|459368795|FG000|Overall Study|Adverse Event|0|||
127987418|NCT00642954|460578809|FG001|Overall Study|Adverse Event|1|||
127657621|NCT02954458|459368796|FG001|Overall Study|Adverse Event|0|||
127657622|NCT02954458|459368797|FG002|Overall Study|Adverse Event|0|||
127657623|NCT02954458|459368798|FG003|Overall Study|Adverse Event|1|||
127657624|NCT02954458|459368795|FG000|Overall Study|Withdrawal by Subject|0|||
127657625|NCT02954458|459368796|FG001|Overall Study|Withdrawal by Subject|0|||
127987419|NCT00642954|460578810|FG002|Overall Study|Adverse Event|0|||
127657626|NCT02954458|459368797|FG002|Overall Study|Withdrawal by Subject|0|||
127657627|NCT02954458|459368798|FG003|Overall Study|Withdrawal by Subject|1|||
127657628|NCT02954458|459368795|FG000|Overall Study|Physician Decision|0|||
127657629|NCT02954458|459368796|FG001|Overall Study|Physician Decision|0|||
127657630|NCT02954458|459368797|FG002|Overall Study|Physician Decision|1|||
127657631|NCT02954458|459368798|FG003|Overall Study|Physician Decision|1|||
127657632|NCT02954458|459368795|FG000|Overall Study|Lost to Follow-up|1|||
127657633|NCT02954458|459368796|FG001|Overall Study|Lost to Follow-up|0|||
127657634|NCT02954458|459368797|FG002|Overall Study|Lost to Follow-up|0|||
127657635|NCT02954458|459368798|FG003|Overall Study|Lost to Follow-up|1|||
127657636|NCT02954458|459368795|FG000|Overall Study|Death|0|||
127657637|NCT02954458|459368796|FG001|Overall Study|Death|0|||
127657638|NCT02954458|459368797|FG002|Overall Study|Death|0|||
127657639|NCT02954458|459368798|FG003|Overall Study|Death|1|||
127657640|NCT02954458|459368795|FG000|Overall Study|Other|0|||
127657641|NCT02954458|459368796|FG001|Overall Study|Other|0|||
127657642|NCT02954458|459368797|FG002|Overall Study|Other|0|||
127657643|NCT02954458|459368798|FG003|Overall Study|Other|7|||
127657644|NCT01407354|459368799|FG000|First Intervention|Withdrawal by Subject|0|||
127657645|NCT01407354|459368800|FG001|First Intervention|Withdrawal by Subject|2|||
127657646|NCT01407354|459368799|FG000|First Intervention|Adverse Event|1|||
127657647|NCT01407354|459368800|FG001|First Intervention|Adverse Event|0|||
127657648|NCT01407354|459368799|FG000|First Intervention|Physician Decision|1|||
127657649|NCT01407354|459368800|FG001|First Intervention|Physician Decision|0|||
127657650|NCT02204579|459368801|FG000|Overall Study|Screen failures|2|||
127657651|NCT02120664|459368804|FG000|Overall Study|Withdrawal by Subject|0|||
127657652|NCT02120664|459368805|FG001|Overall Study|Withdrawal by Subject|0|||
127657653|NCT02120664|459368806|FG002|Overall Study|Withdrawal by Subject|0|||
127657654|NCT02120664|459368807|FG003|Overall Study|Withdrawal by Subject|1|||
127657655|NCT02120664|459368808|FG004|Overall Study|Withdrawal by Subject|0|||
127657656|NCT03916744|459368809|FG000|Overall Study|Withdrawal by Subject|0|||
127657657|NCT03916744|459368810|FG001|Overall Study|Withdrawal by Subject|1|||
127657658|NCT03916744|459368811|FG002|Overall Study|Withdrawal by Subject|2|||
127657659|NCT04524598|459368814|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
127657660|NCT04524598|459368815|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
127657661|NCT04524598|459368816|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
127657662|NCT04524598|459368817|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
127657663|NCT04524598|459368818|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
127657664|NCT04524598|459368814|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
127657665|NCT04524598|459368815|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
127657666|NCT04524598|459368816|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
127657667|NCT04524598|459368817|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
127657668|NCT04524598|459368818|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
127657669|NCT04524598|459368814|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
127657670|NCT04524598|459368815|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
127657671|NCT04524598|459368816|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
127657672|NCT04524598|459368817|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
127657673|NCT04524598|459368818|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
127657674|NCT04524598|459368814|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
127657675|NCT04524598|459368815|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
127657676|NCT04524598|459368816|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
127657677|NCT04524598|459368817|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
127657678|NCT04524598|459368818|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
127657679|NCT04524598|459368814|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
127657680|NCT04524598|459368815|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
127657681|NCT04524598|459368816|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
127657682|NCT04524598|459368817|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
127657683|NCT04524598|459368818|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
127657684|NCT04524598|459368814|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
127657685|NCT04524598|459368815|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
127657686|NCT04524598|459368816|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
127657687|NCT04524598|459368817|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
127657688|NCT04524598|459368818|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
127657689|NCT04524598|459368814|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
127657690|NCT04524598|459368815|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
127657691|NCT04524598|459368816|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
127657692|NCT04524598|459368817|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
127657693|NCT04524598|459368818|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
127657694|NCT04395183|459368819|FG000|Overall Study|Withdrawal by Subject|1|||
127880685|NCT01907516|460183537|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
127657695|NCT04395183|459368820|FG001|Overall Study|Withdrawal by Subject|0|||
127657696|NCT04395183|459368821|FG002|Overall Study|Withdrawal by Subject|2|||
127657697|NCT04395183|459368822|FG003|Overall Study|Withdrawal by Subject|2|||
127657698|NCT03556358|459368823|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
127657699|NCT03556358|459368824|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
127657700|NCT03556358|459368823|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
127657701|NCT03556358|459368824|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
127657702|NCT03556358|459368823|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
127657703|NCT03556358|459368824|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
127657704|NCT03556358|459368823|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
127657705|NCT03556358|459368824|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
127657706|NCT03556358|459368823|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
127657707|NCT03556358|459368824|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
127657708|NCT03556358|459368823|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
127657709|NCT03556358|459368824|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
127657710|NCT03556358|459368823|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
127657711|NCT03556358|459368824|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
127657712|NCT01351025|459368828|FG000|Week 0 - 20|Lost to Follow-up|2|||
127657713|NCT01351025|459368829|FG001|Week 0 - 20|Lost to Follow-up|1|||
127657714|NCT01351025|459368828|FG000|Week 0 - 20|Withdrawal by Subject|1|||
127657715|NCT01351025|459368829|FG001|Week 0 - 20|Withdrawal by Subject|0|||
127657716|NCT01351025|459368828|FG000|Week 24 - 44|Lost to Follow-up|0|||
127657717|NCT01351025|459368829|FG001|Week 24 - 44|Lost to Follow-up|2|||
127657718|NCT01351025|459368828|FG000|Week 24 - 44|Site closed|0|||
127657719|NCT01351025|459368829|FG001|Week 24 - 44|Site closed|1|||
127657720|NCT01351025|459368828|FG000|Week 24 - 44|unable to get to clinic|1|||
127657721|NCT01351025|459368829|FG001|Week 24 - 44|unable to get to clinic|1|||
127657722|NCT02569710|459368834|FG000|Overall Study|Adverse Event|1|||
127657723|NCT02569710|459368835|FG001|Overall Study|Adverse Event|0|||
127657724|NCT02569710|459368836|FG002|Overall Study|Adverse Event|0|||
127657725|NCT02569710|459368837|FG003|Overall Study|Adverse Event|0|||
127657726|NCT02569710|459368838|FG004|Overall Study|Adverse Event|0|||
127657727|NCT02569710|459368839|FG005|Overall Study|Adverse Event|0|||
127657728|NCT02569710|459368840|FG006|Overall Study|Adverse Event|0|||
127657729|NCT02569710|459368841|FG007|Overall Study|Adverse Event|0|||
127657730|NCT02569710|459368842|FG008|Overall Study|Adverse Event|0|||
127657731|NCT02569710|459368843|FG009|Overall Study|Adverse Event|0|||
127657732|NCT02569710|459368834|FG000|Overall Study|Lost to Follow-up|0|||
127657733|NCT02569710|459368835|FG001|Overall Study|Lost to Follow-up|0|||
127657734|NCT02569710|459368836|FG002|Overall Study|Lost to Follow-up|0|||
127657735|NCT02569710|459368837|FG003|Overall Study|Lost to Follow-up|0|||
127657736|NCT02569710|459368838|FG004|Overall Study|Lost to Follow-up|0|||
127657737|NCT02569710|459368839|FG005|Overall Study|Lost to Follow-up|0|||
127657738|NCT02569710|459368840|FG006|Overall Study|Lost to Follow-up|1|||
127657739|NCT02569710|459368841|FG007|Overall Study|Lost to Follow-up|0|||
127657740|NCT02569710|459368842|FG008|Overall Study|Lost to Follow-up|1|||
127657741|NCT02569710|459368843|FG009|Overall Study|Lost to Follow-up|0|||
127657742|NCT02569710|459368834|FG000|Overall Study|Virologic failure|0|||
127657743|NCT02569710|459368835|FG001|Overall Study|Virologic failure|0|||
127657744|NCT02569710|459368836|FG002|Overall Study|Virologic failure|0|||
127657745|NCT02569710|459368837|FG003|Overall Study|Virologic failure|0|||
127657746|NCT02569710|459368838|FG004|Overall Study|Virologic failure|1|||
127657747|NCT02569710|459368839|FG005|Overall Study|Virologic failure|0|||
127657748|NCT02569710|459368840|FG006|Overall Study|Virologic failure|1|||
127657749|NCT02569710|459368841|FG007|Overall Study|Virologic failure|0|||
127657750|NCT02569710|459368842|FG008|Overall Study|Virologic failure|0|||
127657751|NCT02569710|459368843|FG009|Overall Study|Virologic failure|0|||
127657752|NCT02569710|459368834|FG000|Overall Study|Withdrawal by Subject|0|||
127657753|NCT02569710|459368835|FG001|Overall Study|Withdrawal by Subject|0|||
127657754|NCT02569710|459368836|FG002|Overall Study|Withdrawal by Subject|0|||
127657755|NCT02569710|459368837|FG003|Overall Study|Withdrawal by Subject|0|||
127657756|NCT02569710|459368838|FG004|Overall Study|Withdrawal by Subject|0|||
127657757|NCT02569710|459368839|FG005|Overall Study|Withdrawal by Subject|1|||
127657758|NCT02569710|459368840|FG006|Overall Study|Withdrawal by Subject|0|||
127657759|NCT02569710|459368841|FG007|Overall Study|Withdrawal by Subject|0|||
127657760|NCT02569710|459368842|FG008|Overall Study|Withdrawal by Subject|0|||
127657761|NCT02569710|459368843|FG009|Overall Study|Withdrawal by Subject|0|||
127657762|NCT01861522|459368844|FG000|Overall Study|Adverse Event|1|||
127657763|NCT01861522|459368845|FG001|Overall Study|Adverse Event|0|||
127657764|NCT01861522|459368844|FG000|Overall Study|Withdrawal by Subject|2|||
127657765|NCT01861522|459368845|FG001|Overall Study|Withdrawal by Subject|0|||
127657766|NCT00550550|459368846|FG000|Overall Study|Adverse Event|13|||
127657767|NCT00550550|459368847|FG001|Overall Study|Adverse Event|5|||
127543122|NCT03518086|458954750|FG001|Overall Study|Site Terminated by Sponsor|1|||
127987420|NCT00642954|460578811|FG003|Overall Study|Adverse Event|0|||
127657768|NCT00550550|459368846|FG000|Overall Study|Treatment Failure|0|||
127657769|NCT00550550|459368847|FG001|Overall Study|Treatment Failure|1|||
127657770|NCT00550550|459368846|FG000|Overall Study|Lost to Follow-up|4|||
127657771|NCT00550550|459368847|FG001|Overall Study|Lost to Follow-up|0|||
127657772|NCT00550550|459368846|FG000|Overall Study|Withdrawal by Subject|10|||
127657773|NCT00550550|459368847|FG001|Overall Study|Withdrawal by Subject|8|||
127657774|NCT00550550|459368846|FG000|Overall Study|Protocol Violation|5|||
127657775|NCT00550550|459368847|FG001|Overall Study|Protocol Violation|14|||
127657776|NCT00550550|459368846|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
127657777|NCT00550550|459368847|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
127657778|NCT00550550|459368846|FG000|Overall Study|Randomized But Not Treated|1|||
127657779|NCT00550550|459368847|FG001|Overall Study|Randomized But Not Treated|0|||
127657780|NCT03757234|459368848|FG000|Overall Study|Adverse Event|0|||
127657781|NCT03757234|459368849|FG001|Overall Study|Adverse Event|0|||
127657782|NCT03757234|459368850|FG002|Overall Study|Adverse Event|0|||
127657783|NCT03757234|459368851|FG003|Overall Study|Adverse Event|0|||
127657784|NCT03757234|459368852|FG004|Overall Study|Adverse Event|1|||
127657785|NCT03757234|459368848|FG000|Overall Study|Lost to Follow-up|1|||
127657786|NCT03757234|459368849|FG001|Overall Study|Lost to Follow-up|0|||
127657787|NCT03757234|459368850|FG002|Overall Study|Lost to Follow-up|0|||
127657788|NCT03757234|459368851|FG003|Overall Study|Lost to Follow-up|0|||
127657789|NCT03757234|459368852|FG004|Overall Study|Lost to Follow-up|1|||
127657790|NCT03757234|459368848|FG000|Overall Study|Withdrawal by Subject|1|||
127657791|NCT03757234|459368849|FG001|Overall Study|Withdrawal by Subject|1|||
127657792|NCT03757234|459368850|FG002|Overall Study|Withdrawal by Subject|0|||
127657793|NCT03757234|459368851|FG003|Overall Study|Withdrawal by Subject|1|||
127657794|NCT03757234|459368852|FG004|Overall Study|Withdrawal by Subject|2|||
127657795|NCT03757234|459368848|FG000|Overall Study|Other|1|||
127657796|NCT03757234|459368849|FG001|Overall Study|Other|1|||
127657797|NCT03757234|459368850|FG002|Overall Study|Other|0|||
127657798|NCT03757234|459368851|FG003|Overall Study|Other|0|||
127657799|NCT03757234|459368852|FG004|Overall Study|Other|0|||
127657800|NCT01338012|459368859|FG000|Overall Study|Death|4|||
127657801|NCT01338012|459368859|FG000|Overall Study|Study terminated|4|||
127657802|NCT02714205|459368860|FG000|Overall Study|Cannot tolerate medication|1|||
127657803|NCT02714205|459368861|FG001|Overall Study|Cannot tolerate medication|0|||
127657804|NCT02714205|459368860|FG000|Overall Study|Adverse Event|2|||
127657805|NCT02714205|459368861|FG001|Overall Study|Adverse Event|0|||
127657806|NCT02714205|459368860|FG000|Overall Study|Too busy|1|||
127657807|NCT02714205|459368861|FG001|Overall Study|Too busy|0|||
127657808|NCT02714205|459368860|FG000|Overall Study|Incomplete outcome data|0|||
127657809|NCT02714205|459368861|FG001|Overall Study|Incomplete outcome data|1|||
127657810|NCT00381641|459368862|FG000|Overall Study|Withdrawal by Subject|0|||
127657811|NCT00381641|459368863|FG001|Overall Study|Withdrawal by Subject|2|||
127657812|NCT01598298|459368864|FG000|Overall Study|Not eligible|5|||
127657813|NCT01598298|459368865|FG001|Overall Study|Not eligible|5|||
127657814|NCT01598298|459368864|FG000|Overall Study|Adverse Event|21|||
127657815|NCT01598298|459368865|FG001|Overall Study|Adverse Event|19|||
127657816|NCT01598298|459368864|FG000|Overall Study|Progression/relapse|0|||
127657817|NCT01598298|459368865|FG001|Overall Study|Progression/relapse|2|||
127657818|NCT01598298|459368864|FG000|Overall Study|Withdrawal by Subject|10|||
127657819|NCT01598298|459368865|FG001|Overall Study|Withdrawal by Subject|15|||
127657820|NCT01598298|459368864|FG000|Overall Study|Other reason (not protocol specified)|4|||
127657821|NCT01598298|459368865|FG001|Overall Study|Other reason (not protocol specified)|0|||
127657822|NCT03813147|459368866|FG000|Overall Study|Lack of Efficacy|4|||
127657823|NCT03813147|459368867|FG001|Overall Study|Lack of Efficacy|4|||
127657824|NCT03813147|459368866|FG000|Overall Study|Physician Decision|2|||
127657825|NCT03813147|459368867|FG001|Overall Study|Physician Decision|1|||
127657826|NCT02936037|459370737|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
127987421|NCT00642954|460578812|FG004|Overall Study|Adverse Event|6|||
127987422|NCT01663857|460578813|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
127987423|NCT01663857|460578814|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
127657827|NCT02936037|459370738|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
127657828|NCT02936037|459370737|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
127657829|NCT02936037|459370738|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
127657830|NCT02936037|459370737|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
127657831|NCT02936037|459370738|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
127657832|NCT02936037|459370737|FG000|Double-Blind Treatment Period|Death|0|||
127657833|NCT02936037|459370738|FG001|Double-Blind Treatment Period|Death|1|||
127657834|NCT02936037|459370737|FG000|Double-Blind Treatment Period|Adverse Event|11|||
127657835|NCT02936037|459370738|FG001|Double-Blind Treatment Period|Adverse Event|11|||
127657836|NCT02936037|459370737|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
127657837|NCT02936037|459370738|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
127657838|NCT02936037|459370737|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
127987424|NCT01663857|460578815|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
127657839|NCT02936037|459370738|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
127657840|NCT02936037|459370737|FG000|Open Label Extension|Adverse Event|0|||
127657841|NCT02936037|459370738|FG001|Open Label Extension|Adverse Event|3|||
127657842|NCT02936037|459370737|FG000|Open Label Extension|Other|0|||
127657843|NCT02936037|459370738|FG001|Open Label Extension|Other|3|||
127657844|NCT02936037|459370737|FG000|Open Label Extension|Withdrawal by Subject|0|||
127657845|NCT02936037|459370738|FG001|Open Label Extension|Withdrawal by Subject|4|||
127987425|NCT01663857|460578816|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
127987426|NCT01663857|460578813|FG000|Overall Study|Lost to Follow-up|0|||
127987427|NCT01663857|460578814|FG001|Overall Study|Lost to Follow-up|0|||
127987428|NCT01663857|460578815|FG002|Overall Study|Lost to Follow-up|3|||
127987429|NCT01663857|460578816|FG003|Overall Study|Lost to Follow-up|1|||
127987430|NCT03041467|460578817|FG000|Overall Study|Death|46|||
127657846|NCT04567693|459370739|FG000|Overall Study|Death|0|||
127657847|NCT04567693|459370740|FG001|Overall Study|Death|0|||
127657848|NCT04567693|459370741|FG002|Overall Study|Death|2|||
127657849|NCT04567693|459370739|FG000|Overall Study|Lost to Follow-up|1|||
127657850|NCT04567693|459370740|FG001|Overall Study|Lost to Follow-up|0|||
127657851|NCT04567693|459370741|FG002|Overall Study|Lost to Follow-up|2|||
127657852|NCT04567693|459370739|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
127657853|NCT04567693|459370740|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
127657854|NCT04567693|459370741|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
127657855|NCT03462706|459370742|FG000|Overall Study|Polyp was pedunculated|1|||
127657856|NCT03462706|459370743|FG001|Overall Study|Polyp was pedunculated|0|||
127657857|NCT03462706|459370744|FG002|Overall Study|Polyp was pedunculated|1|||
127657858|NCT03462706|459370745|FG003|Overall Study|Polyp was pedunculated|0|||
127657859|NCT03462706|459370742|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
127657860|NCT03462706|459370743|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
127657861|NCT03462706|459370744|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
127657862|NCT03462706|459370745|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
127657863|NCT04105972|459370750|FG000|Overall Study|Adverse Event|2|||
127657864|NCT04105972|459370751|FG001|Overall Study|Adverse Event|1|||
127657865|NCT00553202|459370752|FG000|Overall Study|Death|16|||
127657866|NCT00553202|459370752|FG000|Overall Study|Lost to Follow-up|1|||
127657867|NCT00553202|459370752|FG000|Overall Study|Physician Decision|28|||
127657868|NCT00553202|459370752|FG000|Overall Study|Withdrawal by Subject|1|||
127657869|NCT00553202|459370752|FG000|Overall Study|No donor identified|16|||
127657870|NCT00553202|459370752|FG000|Overall Study|Fails to meet organ function|6|||
127657871|NCT02593305|459370753|FG000|Post 1|Comparison only group. No intervention.|0|||
127987431|NCT03041467|460578818|FG001|Overall Study|Death|39|||
127987432|NCT03041467|460578817|FG000|Overall Study|Withdrawal by Subject|36|||
127987433|NCT03041467|460578818|FG001|Overall Study|Withdrawal by Subject|37|||
127987434|NCT03041467|460578817|FG000|Overall Study|Lost to Follow-up|6|||
127987435|NCT03041467|460578818|FG001|Overall Study|Lost to Follow-up|8|||
127987436|NCT03041467|460578817|FG000|Overall Study|Declined consent for study extension|21|||
127987437|NCT03041467|460578818|FG001|Overall Study|Declined consent for study extension|33|||
127987438|NCT03041467|460578817|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
127987439|NCT03041467|460578818|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
127987440|NCT02732015|460578819|FG000|Overall Study|Lost to Follow-up|0|||
127987441|NCT02732015|460578820|FG001|Overall Study|Lost to Follow-up|1|||
127987442|NCT03052920|460578821|FG000|Overall Study|Withdrawal by Subject|1|||
127987443|NCT01980628|460578822|FG000|Overall Study|Adverse Event|12|||
127987444|NCT01980628|460578822|FG000|Overall Study|Physician Decision|5|||
127987445|NCT01980628|460578822|FG000|Overall Study|Withdrawal by Subject|4|||
127987446|NCT01980628|460578822|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
127987447|NCT03015194|460578823|FG000|Overall Study|Death|10|||
127987448|NCT03015194|460578823|FG000|Overall Study|Withdrawal by Subject|2|||
127543123|NCT03518086|458954751|FG002|Overall Study|Site Terminated by Sponsor|0|||
127543124|NCT03518086|458954752|FG003|Overall Study|Site Terminated by Sponsor|0|||
127543125|NCT03518086|458954749|FG000|Overall Study|Pregnancy|0|||
127657872|NCT02593305|459370754|FG001|Post 1|Comparison only group. No intervention.|0|||
127657873|NCT02593305|459370755|FG002|Post 1|Comparison only group. No intervention.|10|||
127657874|NCT01161472|459370756|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
127657875|NCT01161472|459370757|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
127657876|NCT01161472|459370758|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
127657877|NCT01161472|459370759|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
127657878|NCT00768430|459370782|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
127657879|NCT00768430|459370783|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
127657880|NCT00041756|459370785|FG000|Overall Study|Adverse Event|4|||
127657881|NCT00041756|459370786|FG001|Overall Study|Adverse Event|10|||
127987449|NCT02469168|460578826|FG000|Overall Study|Trial closed|1|||
127987450|NCT02469168|460578827|FG001|Overall Study|Trial closed|0|||
127987451|NCT00255840|460578830|FG000|Overall Study|Lost to Follow-up|10|||
127987452|NCT00255840|460578831|FG001|Overall Study|Lost to Follow-up|14|||
127987453|NCT00255840|460578830|FG000|Overall Study|Discontinued intervention|53|||
127987454|NCT00255840|460578831|FG001|Overall Study|Discontinued intervention|56|||
127987455|NCT02131636|460578836|FG000|Overall Study|Personal Reasons|4|||
127987456|NCT02131636|460578837|FG001|Overall Study|Personal Reasons|4|||
127657882|NCT00041756|459370787|FG002|Overall Study|Adverse Event|6|||
127657883|NCT00041756|459370788|FG003|Overall Study|Adverse Event|11|||
127657884|NCT00041756|459370789|FG004|Overall Study|Adverse Event|34|||
127657885|NCT00041756|459370785|FG000|Overall Study|Protocol Violation|1|||
127657886|NCT00041756|459370786|FG001|Overall Study|Protocol Violation|1|||
127657887|NCT00041756|459370787|FG002|Overall Study|Protocol Violation|2|||
127657888|NCT00041756|459370788|FG003|Overall Study|Protocol Violation|2|||
127657889|NCT00041756|459370789|FG004|Overall Study|Protocol Violation|1|||
127657890|NCT00041756|459370785|FG000|Overall Study|Withdrawal by Subject|3|||
127657891|NCT00041756|459370786|FG001|Overall Study|Withdrawal by Subject|3|||
127657892|NCT00041756|459370787|FG002|Overall Study|Withdrawal by Subject|4|||
127657893|NCT00041756|459370788|FG003|Overall Study|Withdrawal by Subject|2|||
127657894|NCT00041756|459370789|FG004|Overall Study|Withdrawal by Subject|3|||
127657895|NCT00041756|459370785|FG000|Overall Study|Lost to Follow-up|0|||
127657896|NCT00041756|459370786|FG001|Overall Study|Lost to Follow-up|1|||
127657897|NCT00041756|459370787|FG002|Overall Study|Lost to Follow-up|0|||
127657898|NCT00041756|459370788|FG003|Overall Study|Lost to Follow-up|1|||
127657899|NCT00041756|459370789|FG004|Overall Study|Lost to Follow-up|0|||
127657900|NCT00041756|459370785|FG000|Overall Study|Unable to meet protocol criteria|0|||
127657901|NCT00041756|459370786|FG001|Overall Study|Unable to meet protocol criteria|0|||
127657902|NCT00041756|459370787|FG002|Overall Study|Unable to meet protocol criteria|1|||
127657903|NCT00041756|459370788|FG003|Overall Study|Unable to meet protocol criteria|0|||
127657904|NCT00041756|459370789|FG004|Overall Study|Unable to meet protocol criteria|1|||
127657905|NCT00041756|459370785|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
127657906|NCT00041756|459370786|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
127657907|NCT00041756|459370787|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
127657908|NCT00041756|459370788|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
127657909|NCT00041756|459370789|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
127657910|NCT00603265|459370790|FG000|Overall Study|Adverse Event|2|||
127657911|NCT00603265|459370791|FG001|Overall Study|Adverse Event|11|||
127657912|NCT00603265|459370792|FG002|Overall Study|Adverse Event|1|||
127657913|NCT00603265|459370790|FG000|Overall Study|Withdrawal by Subject|1|||
127657914|NCT00603265|459370791|FG001|Overall Study|Withdrawal by Subject|2|||
127657915|NCT00603265|459370792|FG002|Overall Study|Withdrawal by Subject|1|||
127657916|NCT00603265|459370790|FG000|Overall Study|Lack of Efficacy|3|||
127657917|NCT00603265|459370791|FG001|Overall Study|Lack of Efficacy|0|||
127657918|NCT00603265|459370792|FG002|Overall Study|Lack of Efficacy|3|||
127657919|NCT00603265|459370790|FG000|Overall Study|Lost to Follow-up|0|||
127657920|NCT00603265|459370791|FG001|Overall Study|Lost to Follow-up|1|||
127657921|NCT00603265|459370792|FG002|Overall Study|Lost to Follow-up|0|||
127657922|NCT00603265|459370790|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
127987457|NCT02131636|460578836|FG000|Overall Study|Lost to Follow-up|4|||
127987458|NCT02131636|460578837|FG001|Overall Study|Lost to Follow-up|0|||
127987459|NCT02131636|460578836|FG000|Overall Study|Adverse Event|4|||
127987460|NCT02131636|460578837|FG001|Overall Study|Adverse Event|1|||
127987461|NCT06226649|460578839|FG000|Overall Study|Withdrawal by Subject|4|||
127987462|NCT06226649|460578840|FG001|Overall Study|Withdrawal by Subject|1|||
127987463|NCT04847232|460578841|FG000|Overall Study|Death|123|||
127987464|NCT04847232|460578842|FG001|Overall Study|Death|115|||
127987465|NCT04847232|460578841|FG000|Overall Study|Lost to Follow-up|3|||
127987466|NCT04847232|460578842|FG001|Overall Study|Lost to Follow-up|10|||
127987467|NCT04847232|460578841|FG000|Overall Study|Withdrawal by Subject|73|||
127987468|NCT04847232|460578842|FG001|Overall Study|Withdrawal by Subject|101|||
127987469|NCT04847232|460578841|FG000|Overall Study|"Subcategories under Other not reported."|1150|||
127987470|NCT04847232|460578842|FG001|Overall Study|"Subcategories under Other not reported."|1115|||
127987471|NCT00715520|460578843|FG000|Overall Study|Screen failure|8|||
127987472|NCT00715520|460578844|FG001|Overall Study|Screen failure|1|||
127657923|NCT00603265|459370791|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
127657924|NCT00603265|459370792|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
127657925|NCT00603265|459370790|FG000|Overall Study|Participant Left Country, No Responses|0|||
127657926|NCT00603265|459370791|FG001|Overall Study|Participant Left Country, No Responses|1|||
127657927|NCT00603265|459370792|FG002|Overall Study|Participant Left Country, No Responses|0|||
127657928|NCT00603265|459370790|FG000|Overall Study|Protocol Violation|1|||
127987473|NCT00715520|460578845|FG002|Overall Study|Screen failure|1|||
127987474|NCT00715520|460578843|FG000|Overall Study|Withdrawal by Subject|2|||
127657929|NCT00603265|459370791|FG001|Overall Study|Protocol Violation|0|||
127657930|NCT00603265|459370792|FG002|Overall Study|Protocol Violation|0|||
127657931|NCT02002884|459370793|FG000|Main Period (MP)|Other|0|||
127657932|NCT02002884|459370794|FG001|Main Period (MP)|Other|3|||
127657933|NCT02002884|459370795|FG002|Main Period (MP)|Other|3|||
127657934|NCT02002884|459370796|FG003|Main Period (MP)|Other|0|||
127987475|NCT00715520|460578844|FG001|Overall Study|Withdrawal by Subject|0|||
127987476|NCT00715520|460578845|FG002|Overall Study|Withdrawal by Subject|1|||
127987477|NCT02290925|460578846|FG000|First Period of Three Months|Lost to Follow-up|2|||
127987478|NCT02290925|460578847|FG001|First Period of Three Months|Lost to Follow-up|1|||
127987479|NCT02290925|460578846|FG000|First Period of Three Months|Death|1|||
127987480|NCT02290925|460578847|FG001|First Period of Three Months|Death|0|||
127987481|NCT02290925|460578846|FG000|First Period of Three Months|Insulin Started|1|||
127987482|NCT02290925|460578847|FG001|First Period of Three Months|Insulin Started|1|||
127987483|NCT02290925|460578846|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
127987484|NCT02290925|460578847|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
127987485|NCT02290925|460578846|FG000|Second Period of 3 Months|insulin started|0|||
127987486|NCT02290925|460578847|FG001|Second Period of 3 Months|insulin started|1|||
127987487|NCT05697627|460578850|FG000|Overall Study|Adverse Event|1|||
127987488|NCT04348500|460578851|FG000|Overall Study|Death|2|||
127987489|NCT04348500|460578852|FG001|Overall Study|Death|2|||
127987490|NCT04348500|460578851|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
127987491|NCT04348500|460578852|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
127987492|NCT01410240|460578853|FG000|Overall Study|Physician Decision|0|||
127987493|NCT01410240|460578854|FG001|Overall Study|Physician Decision|0|||
127987494|NCT01410240|460578855|FG002|Overall Study|Physician Decision|1|||
127987495|NCT01410240|460578853|FG000|Overall Study|Missed week 6 assessments|1|||
127987496|NCT01410240|460578854|FG001|Overall Study|Missed week 6 assessments|1|||
127987497|NCT01410240|460578855|FG002|Overall Study|Missed week 6 assessments|1|||
127987498|NCT03699540|460578856|FG000|Overall Study|Lost to Follow-up|1|||
127987499|NCT02697591|460578861|FG000|Overall Study|Lost to Follow-up|0|||
127987500|NCT02697591|460578862|FG001|Overall Study|Lost to Follow-up|0|||
127657935|NCT02002884|459370793|FG000|Main Period (MP)|Adverse Event|0|||
127657936|NCT02002884|459370794|FG001|Main Period (MP)|Adverse Event|1|||
127657937|NCT02002884|459370795|FG002|Main Period (MP)|Adverse Event|1|||
127657938|NCT02002884|459370796|FG003|Main Period (MP)|Adverse Event|0|||
127657939|NCT02002884|459370793|FG000|Main Period (MP)|Withdrawal by Subject|6|||
127657940|NCT02002884|459370794|FG001|Main Period (MP)|Withdrawal by Subject|2|||
127657941|NCT02002884|459370795|FG002|Main Period (MP)|Withdrawal by Subject|2|||
127657942|NCT02002884|459370796|FG003|Main Period (MP)|Withdrawal by Subject|0|||
127657943|NCT02002884|459370793|FG000|Main Period (MP)|Lost to Follow-up|0|||
127657944|NCT02002884|459370794|FG001|Main Period (MP)|Lost to Follow-up|0|||
127657945|NCT02002884|459370795|FG002|Main Period (MP)|Lost to Follow-up|2|||
127657946|NCT02002884|459370796|FG003|Main Period (MP)|Lost to Follow-up|0|||
127657947|NCT02002884|459370793|FG000|Open-Label Extension Period (OLEX)|Other|0|||
127657948|NCT02002884|459370794|FG001|Open-Label Extension Period (OLEX)|Other|0|||
127657949|NCT02002884|459370795|FG002|Open-Label Extension Period (OLEX)|Other|0|||
127657950|NCT02002884|459370796|FG003|Open-Label Extension Period (OLEX)|Other|24|||
127657951|NCT02002884|459370793|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
127657952|NCT02002884|459370794|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
127657953|NCT02002884|459370795|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
127657954|NCT02002884|459370796|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
127657955|NCT02002884|459370793|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
127657956|NCT02002884|459370794|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
127657957|NCT02002884|459370795|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
127657958|NCT02002884|459370796|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
127657959|NCT02002884|459370793|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
127657960|NCT02002884|459370794|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
127657961|NCT02002884|459370795|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
127657962|NCT02002884|459370796|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
127657963|NCT02002884|459370793|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
127657964|NCT02002884|459370794|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
127657965|NCT02002884|459370795|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
127657966|NCT02002884|459370796|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
127657967|NCT02966002|459370797|FG000|Overall Study|Withdrawal by Subject|2|||
127657968|NCT02966002|459370797|FG000|Overall Study|Adverse Event|1|||
127657969|NCT02966002|459370797|FG000|Overall Study|Lost to Follow-up|1|||
127657970|NCT03377790|459370798|FG000|Overall Study|Withdrawal by Subject|1|||
127657971|NCT03377790|459370799|FG001|Overall Study|Withdrawal by Subject|0|||
127657972|NCT03377790|459370798|FG000|Overall Study|Adverse Event|1|||
127657973|NCT03377790|459370799|FG001|Overall Study|Adverse Event|0|||
127657974|NCT03377790|459370798|FG000|Overall Study|Lost to Follow-up|0|||
127987501|NCT02697591|460578863|FG002|Overall Study|Lost to Follow-up|0|||
127987502|NCT02697591|460578864|FG003|Overall Study|Lost to Follow-up|0|||
127987503|NCT02697591|460578865|FG004|Overall Study|Lost to Follow-up|0|||
127987504|NCT02697591|460578866|FG005|Overall Study|Lost to Follow-up|1|||
127987505|NCT02697591|460578867|FG006|Overall Study|Lost to Follow-up|1|||
127987506|NCT02697591|460578868|FG007|Overall Study|Lost to Follow-up|0|||
127657975|NCT03377790|459370799|FG001|Overall Study|Lost to Follow-up|2|||
127657976|NCT03377790|459370798|FG000|Overall Study|Randomized but not treated|1|||
127657977|NCT03377790|459370799|FG001|Overall Study|Randomized but not treated|0|||
127657978|NCT03377790|459370798|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
127657979|NCT03377790|459370799|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
127657980|NCT02632786|459370800|FG000|Overall Study|Adverse Event|2|||
127657981|NCT02632786|459370801|FG001|Overall Study|Adverse Event|1|||
127657982|NCT02632786|459370800|FG000|Overall Study|Death|3|||
127657983|NCT02632786|459370801|FG001|Overall Study|Death|2|||
127657984|NCT02632786|459370800|FG000|Overall Study|Physician Decision|5|||
127657985|NCT02632786|459370801|FG001|Overall Study|Physician Decision|4|||
127657986|NCT02632786|459370800|FG000|Overall Study|Withdrawal by Subject|1|||
127657987|NCT02632786|459370801|FG001|Overall Study|Withdrawal by Subject|0|||
127657988|NCT00152763|459370802|FG000|Overall Study|Death|4|||
127657989|NCT00152763|459370803|FG001|Overall Study|Death|1|||
127657990|NCT00152763|459370804|FG002|Overall Study|Death|2|||
127657991|NCT00152763|459370805|FG003|Overall Study|Death|1|||
127657992|NCT00152763|459370802|FG000|Overall Study|Lost to Follow-up|6|||
127657993|NCT00152763|459370803|FG001|Overall Study|Lost to Follow-up|4|||
127657994|NCT00152763|459370804|FG002|Overall Study|Lost to Follow-up|2|||
127657995|NCT00152763|459370805|FG003|Overall Study|Lost to Follow-up|13|||
127657996|NCT00569803|459370806|FG000|Overall Study|Lost to Follow-up|1|||
127657997|NCT00569803|459370807|FG001|Overall Study|Lost to Follow-up|0|||
127657998|NCT00569803|459370808|FG002|Overall Study|Lost to Follow-up|0|||
127657999|NCT00569803|459370809|FG003|Overall Study|Lost to Follow-up|0|||
127658000|NCT00569803|459370810|FG004|Overall Study|Lost to Follow-up|0|||
127658001|NCT00569803|459370811|FG005|Overall Study|Lost to Follow-up|0|||
127658002|NCT00569803|459370812|FG006|Overall Study|Lost to Follow-up|0|||
127658003|NCT00569803|459370813|FG007|Overall Study|Lost to Follow-up|0|||
127658004|NCT00569803|459370806|FG000|Overall Study|injection syringe leaked during dosing|0|||
127658005|NCT00569803|459370807|FG001|Overall Study|injection syringe leaked during dosing|0|||
127658006|NCT00569803|459370808|FG002|Overall Study|injection syringe leaked during dosing|0|||
127658007|NCT00569803|459370809|FG003|Overall Study|injection syringe leaked during dosing|1|||
127658008|NCT00569803|459370810|FG004|Overall Study|injection syringe leaked during dosing|0|||
127658009|NCT00569803|459370811|FG005|Overall Study|injection syringe leaked during dosing|0|||
127658010|NCT00569803|459370812|FG006|Overall Study|injection syringe leaked during dosing|0|||
127658011|NCT00569803|459370813|FG007|Overall Study|injection syringe leaked during dosing|0|||
127658012|NCT00569803|459370806|FG000|Overall Study|Withdrawal by Subject|0|||
127658013|NCT00569803|459370807|FG001|Overall Study|Withdrawal by Subject|0|||
127658014|NCT00569803|459370808|FG002|Overall Study|Withdrawal by Subject|0|||
127658015|NCT00569803|459370809|FG003|Overall Study|Withdrawal by Subject|0|||
127658016|NCT00569803|459370810|FG004|Overall Study|Withdrawal by Subject|0|||
127658017|NCT00569803|459370811|FG005|Overall Study|Withdrawal by Subject|0|||
127658018|NCT00569803|459370812|FG006|Overall Study|Withdrawal by Subject|0|||
127658019|NCT00569803|459370813|FG007|Overall Study|Withdrawal by Subject|1|||
127658020|NCT01235975|459370814|FG000|Overall Study|Serious Adverse Event|0|||
127658021|NCT01235975|459370815|FG001|Overall Study|Serious Adverse Event|1|||
127658022|NCT01235975|459370814|FG000|Overall Study|Withdrawal by Subject|8|||
127658023|NCT01235975|459370815|FG001|Overall Study|Withdrawal by Subject|2|||
127658024|NCT01235975|459370814|FG000|Overall Study|Migrated/moved from study area|2|||
127658025|NCT01235975|459370815|FG001|Overall Study|Migrated/moved from study area|1|||
127658026|NCT01235975|459370814|FG000|Overall Study|Lost to Follow-up|7|||
127658027|NCT01235975|459370815|FG001|Overall Study|Lost to Follow-up|3|||
127658028|NCT00791921|459370816|FG000|Overall Study|Protocol planed|24|||
127658029|NCT00791921|459370817|FG001|Overall Study|Protocol planed|88|||
127658030|NCT00791921|459370816|FG000|Overall Study|Withdrawal by Subject|1|||
127658031|NCT00791921|459370817|FG001|Overall Study|Withdrawal by Subject|2|||
127658032|NCT00791921|459370816|FG000|Overall Study|Adverse Event|8|||
127658033|NCT00791921|459370817|FG001|Overall Study|Adverse Event|2|||
127658034|NCT00791921|459370816|FG000|Overall Study|Lack of Efficacy|0|||
127658035|NCT00791921|459370817|FG001|Overall Study|Lack of Efficacy|2|||
127658036|NCT00791921|459370816|FG000|Overall Study|Lack of study drug administration|1|||
127658037|NCT00791921|459370817|FG001|Overall Study|Lack of study drug administration|1|||
127658038|NCT00791921|459370816|FG000|Overall Study|Reason other than those above|0|||
127658039|NCT00791921|459370817|FG001|Overall Study|Reason other than those above|1|||
127658040|NCT00474175|459370818|FG000|Overall Study|Lack of Efficacy|0|||
127658041|NCT00474175|459370819|FG001|Overall Study|Lack of Efficacy|0|||
127658042|NCT00474175|459370820|FG002|Overall Study|Lack of Efficacy|1|||
127658043|NCT00474175|459370818|FG000|Overall Study|Withdrawal by Subject|0|||
127658044|NCT00474175|459370819|FG001|Overall Study|Withdrawal by Subject|1|||
127658045|NCT00474175|459370820|FG002|Overall Study|Withdrawal by Subject|1|||
127658046|NCT00474175|459370818|FG000|Overall Study|Ineligible|1|||
127658047|NCT00474175|459370819|FG001|Overall Study|Ineligible|3|||
127658048|NCT00474175|459370820|FG002|Overall Study|Ineligible|1|||
127658049|NCT00474175|459370818|FG000|Overall Study|Protocol Violation|0|||
127658050|NCT00474175|459370819|FG001|Overall Study|Protocol Violation|2|||
127658051|NCT00474175|459370820|FG002|Overall Study|Protocol Violation|1|||
127658052|NCT00474175|459370818|FG000|Overall Study|Administrative|0|||
127658053|NCT00474175|459370819|FG001|Overall Study|Administrative|1|||
127658054|NCT00474175|459370820|FG002|Overall Study|Administrative|0|||
127658055|NCT01619787|459370823|FG000|Overall Study|Lost to Follow-up|5|||
127658056|NCT03560258|459370824|FG000|Overall Study|Lost to Follow-up|3|||
127658057|NCT03560258|459370825|FG001|Overall Study|Lost to Follow-up|0|||
127658058|NCT03560258|459370826|FG002|Overall Study|Lost to Follow-up|0|||
127658059|NCT03560258|459370824|FG000|Overall Study|Protocol Violation|0|||
127658060|NCT03560258|459370825|FG001|Overall Study|Protocol Violation|1|||
127658061|NCT03560258|459370826|FG002|Overall Study|Protocol Violation|0|||
127658062|NCT03560258|459370824|FG000|Overall Study|Withdrawal by Subject|0|||
127658063|NCT03560258|459370825|FG001|Overall Study|Withdrawal by Subject|0|||
127658064|NCT03560258|459370826|FG002|Overall Study|Withdrawal by Subject|1|||
127658065|NCT00192023|459370836|FG000|Period III - Double-Blind|Adverse Event|3|||
127658066|NCT00192023|459370837|FG001|Period III - Double-Blind|Adverse Event|0|||
127658067|NCT00192023|459370836|FG000|Period III - Double-Blind|Physician Decision|2|||
127658068|NCT00192023|459370837|FG001|Period III - Double-Blind|Physician Decision|0|||
127658069|NCT00192023|459370836|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
127658070|NCT00192023|459370837|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
127658071|NCT00192023|459370836|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
127658072|NCT00192023|459370837|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
127658073|NCT00192023|459370836|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
127658074|NCT00192023|459370837|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
127658075|NCT00192023|459370836|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
127658076|NCT00192023|459370837|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
127658077|NCT00192023|459370836|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
127658078|NCT00192023|459370837|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
127658079|NCT00192023|459370836|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
127658080|NCT00192023|459370837|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
127658081|NCT00192023|459370836|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
127658082|NCT00192023|459370837|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
127658083|NCT00192023|459370836|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
127658084|NCT00192023|459370837|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
127658085|NCT02086162|459370838|FG000|Overall Study|Withdrawal by Subject|4|||
127658086|NCT02086162|459370839|FG001|Overall Study|Withdrawal by Subject|4|||
127658087|NCT02086162|459370838|FG000|Overall Study|moved|1|||
127658088|NCT02086162|459370839|FG001|Overall Study|moved|1|||
127658089|NCT02086162|459370838|FG000|Overall Study|Lost to Follow-up|4|||
127658090|NCT02086162|459370839|FG001|Overall Study|Lost to Follow-up|2|||
127658091|NCT02086162|459370838|FG000|Overall Study|Death|1|||
127658092|NCT02086162|459370839|FG001|Overall Study|Death|0|||
127658093|NCT01027364|459370840|FG000|Overall Study|Adverse Event|1|||
127658094|NCT01027364|459370841|FG001|Overall Study|Adverse Event|0|||
127658095|NCT01027364|459370842|FG002|Overall Study|Adverse Event|1|||
127658096|NCT01027364|459370843|FG003|Overall Study|Adverse Event|0|||
127658097|NCT01027364|459370840|FG000|Overall Study|Lost to Follow-up|1|||
127658098|NCT01027364|459370841|FG001|Overall Study|Lost to Follow-up|0|||
127658099|NCT01027364|459370842|FG002|Overall Study|Lost to Follow-up|0|||
127658100|NCT01027364|459370843|FG003|Overall Study|Lost to Follow-up|0|||
127658101|NCT01027364|459370840|FG000|Overall Study|Protocol Violation|1|||
127658102|NCT01027364|459370841|FG001|Overall Study|Protocol Violation|0|||
127658103|NCT01027364|459370842|FG002|Overall Study|Protocol Violation|0|||
127658104|NCT01027364|459370843|FG003|Overall Study|Protocol Violation|1|||
127658105|NCT01027364|459370840|FG000|Overall Study|Withdrawal by Subject|1|||
127658106|NCT01027364|459370841|FG001|Overall Study|Withdrawal by Subject|2|||
127658107|NCT01027364|459370842|FG002|Overall Study|Withdrawal by Subject|0|||
127658108|NCT01027364|459370843|FG003|Overall Study|Withdrawal by Subject|0|||
127658109|NCT00245856|459370847|FG000|Period Two|Withdrawal by Subject|0|||
127658110|NCT00245856|459370848|FG001|Period Two|Withdrawal by Subject|1|||
127658111|NCT03662997|459370850|FG000|Overall Study|Adverse Event|0|||
127658112|NCT03662997|459370851|FG001|Overall Study|Adverse Event|2|||
127658113|NCT03662997|459370852|FG002|Overall Study|Adverse Event|0|||
127658114|NCT03662997|459370853|FG003|Overall Study|Adverse Event|0|||
127658115|NCT03000673|459370854|FG000|Overall Study|Withdrawal by Subject|1|||
127658116|NCT03000673|459370855|FG001|Overall Study|Withdrawal by Subject|0|||
127658117|NCT03000673|459370856|FG002|Overall Study|Withdrawal by Subject|0|||
127658118|NCT03000673|459370857|FG003|Overall Study|Withdrawal by Subject|0|||
127658119|NCT01121484|459370858|FG000|Overall Study|Adverse Event|12|||
127543126|NCT03518086|458954750|FG001|Overall Study|Pregnancy|0|||
127543127|NCT03518086|458954751|FG002|Overall Study|Pregnancy|0|||
127543128|NCT03518086|458954752|FG003|Overall Study|Pregnancy|2|||
127543129|NCT05967260|458954753|FG000|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|0|||
127543130|NCT05967260|458954754|FG001|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|1|||
127543131|NCT00626106|458954755|FG000|Overall Study|Withdrawal by Subject|2|||
127658120|NCT01121484|459370859|FG001|Overall Study|Adverse Event|5|||
127658121|NCT01121484|459370858|FG000|Overall Study|Lack of Efficacy|3|||
127658122|NCT01121484|459370859|FG001|Overall Study|Lack of Efficacy|11|||
127658123|NCT01121484|459370858|FG000|Overall Study|Lost to Follow-up|5|||
127658124|NCT01121484|459370859|FG001|Overall Study|Lost to Follow-up|9|||
127658125|NCT01121484|459370858|FG000|Overall Study|Physician Decision|0|||
127658126|NCT01121484|459370859|FG001|Overall Study|Physician Decision|3|||
127658127|NCT01121484|459370858|FG000|Overall Study|Protocol Violation|1|||
127658128|NCT01121484|459370859|FG001|Overall Study|Protocol Violation|0|||
127658129|NCT01121484|459370858|FG000|Overall Study|Withdrawal by Subject|8|||
127658130|NCT01121484|459370859|FG001|Overall Study|Withdrawal by Subject|7|||
127658131|NCT01121484|459370858|FG000|Overall Study|Discontinuation of study by sponsor|0|||
127658132|NCT01121484|459370859|FG001|Overall Study|Discontinuation of study by sponsor|1|||
127658133|NCT01121484|459370858|FG000|Overall Study|Other|3|||
127658134|NCT01121484|459370859|FG001|Overall Study|Other|3|||
127658135|NCT01121484|459370858|FG000|Overall Study|Randomized, not treated|1|||
127658136|NCT01121484|459370859|FG001|Overall Study|Randomized, not treated|4|||
127658137|NCT00562978|459370860|FG000|Overall Study|Patient had imaging dose only|1|||
127658138|NCT00562978|459370861|FG001|Overall Study|Patient had imaging dose only|11|||
127658139|NCT02912468|459370867|FG000|Overall Study|Adverse Event|3|||
127658140|NCT02912468|459370868|FG001|Overall Study|Adverse Event|2|||
127658141|NCT02912468|459370867|FG000|Overall Study|Withdrawal by Subject|6|||
127658142|NCT02912468|459370868|FG001|Overall Study|Withdrawal by Subject|2|||
127658143|NCT02912468|459370867|FG000|Overall Study|Randomized and not treated|0|||
127658144|NCT02912468|459370868|FG001|Overall Study|Randomized and not treated|1|||
127658145|NCT03853317|459370871|FG000|Overall Study|Progressive Disease|5|||
127658146|NCT03853317|459370871|FG000|Overall Study|Adverse Event|1|||
127658147|NCT03853317|459370871|FG000|Overall Study|Death|1|||
127658148|NCT03853317|459370871|FG000|Overall Study|other event|2|||
127658149|NCT01320735|459370874|FG000|Overall Study|Adverse Event|3|||
127658150|NCT01320735|459370874|FG000|Overall Study|Withdrawal by Subject|3|||
127658151|NCT01320735|459370874|FG000|Overall Study|Lost to Follow-up|13|||
127987507|NCT02697591|460578869|FG008|Overall Study|Lost to Follow-up|0|||
127987508|NCT02697591|460578870|FG009|Overall Study|Lost to Follow-up|1|||
127987509|NCT02697591|460578861|FG000|Overall Study|Withdrawal by Subject|1|||
127987510|NCT02697591|460578862|FG001|Overall Study|Withdrawal by Subject|1|||
127987511|NCT02697591|460578863|FG002|Overall Study|Withdrawal by Subject|2|||
127987512|NCT02697591|460578864|FG003|Overall Study|Withdrawal by Subject|1|||
127987513|NCT02697591|460578865|FG004|Overall Study|Withdrawal by Subject|7|||
127987514|NCT02697591|460578866|FG005|Overall Study|Withdrawal by Subject|6|||
127987515|NCT02697591|460578867|FG006|Overall Study|Withdrawal by Subject|9|||
127987516|NCT02697591|460578868|FG007|Overall Study|Withdrawal by Subject|1|||
127987517|NCT02697591|460578869|FG008|Overall Study|Withdrawal by Subject|6|||
127987518|NCT02697591|460578870|FG009|Overall Study|Withdrawal by Subject|10|||
127987519|NCT02697591|460578861|FG000|Overall Study|Physician Decision|1|||
127987520|NCT02697591|460578862|FG001|Overall Study|Physician Decision|0|||
127987521|NCT02697591|460578863|FG002|Overall Study|Physician Decision|0|||
127987522|NCT02697591|460578864|FG003|Overall Study|Physician Decision|0|||
127987523|NCT02697591|460578865|FG004|Overall Study|Physician Decision|1|||
127987524|NCT02697591|460578866|FG005|Overall Study|Physician Decision|2|||
127987525|NCT02697591|460578867|FG006|Overall Study|Physician Decision|0|||
127987526|NCT02697591|460578868|FG007|Overall Study|Physician Decision|0|||
127987527|NCT02697591|460578869|FG008|Overall Study|Physician Decision|1|||
127987528|NCT02697591|460578870|FG009|Overall Study|Physician Decision|1|||
127987529|NCT02697591|460578861|FG000|Overall Study|Death|2|||
127987530|NCT02697591|460578862|FG001|Overall Study|Death|3|||
127987531|NCT02697591|460578863|FG002|Overall Study|Death|1|||
127987532|NCT02697591|460578864|FG003|Overall Study|Death|1|||
127987533|NCT02697591|460578865|FG004|Overall Study|Death|4|||
127987534|NCT02697591|460578866|FG005|Overall Study|Death|5|||
127987535|NCT02697591|460578867|FG006|Overall Study|Death|3|||
127987536|NCT02697591|460578868|FG007|Overall Study|Death|1|||
127987537|NCT02697591|460578869|FG008|Overall Study|Death|1|||
127987538|NCT02697591|460578870|FG009|Overall Study|Death|5|||
127987539|NCT02697591|460578861|FG000|Overall Study|Reason not Specified|0|||
127987540|NCT02697591|460578862|FG001|Overall Study|Reason not Specified|0|||
127987541|NCT02697591|460578863|FG002|Overall Study|Reason not Specified|0|||
127987542|NCT02697591|460578864|FG003|Overall Study|Reason not Specified|1|||
127987543|NCT02697591|460578865|FG004|Overall Study|Reason not Specified|1|||
127987544|NCT02697591|460578866|FG005|Overall Study|Reason not Specified|2|||
127987545|NCT02697591|460578867|FG006|Overall Study|Reason not Specified|3|||
127987546|NCT02697591|460578868|FG007|Overall Study|Reason not Specified|1|||
127987547|NCT02697591|460578869|FG008|Overall Study|Reason not Specified|1|||
127987548|NCT02697591|460578870|FG009|Overall Study|Reason not Specified|3|||
127987549|NCT00624832|460578875|FG000|Overall Study|Adverse Event|0|||
127987550|NCT00624832|460578876|FG001|Overall Study|Adverse Event|1|||
127658152|NCT01320735|459370874|FG000|Overall Study|Administrative Reason|6|||
127658153|NCT01320735|459370874|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
127658154|NCT01320735|459370874|FG000|Overall Study|Protocol Violation|1|||
127658155|NCT01320735|459370874|FG000|Overall Study|Other|1|||
127658156|NCT01320735|459370874|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
127987551|NCT00624832|460578877|FG002|Overall Study|Adverse Event|0|||
127987552|NCT00624832|460578878|FG003|Overall Study|Adverse Event|1|||
127987553|NCT00624832|460578875|FG000|Overall Study|Abnormal Laboratory Value|2|||
127987554|NCT00624832|460578876|FG001|Overall Study|Abnormal Laboratory Value|0|||
127658157|NCT01320735|459370874|FG000|Overall Study|Investigator Unable to be Contacted|17|||
127658158|NCT00406419|459370879|FG000|Overall Study|Death|3|||
127658159|NCT00406419|459370880|FG001|Overall Study|Death|1|||
127658160|NCT00406419|459370881|FG002|Overall Study|Death|4|||
127658161|NCT00406419|459370879|FG000|Overall Study|Protocol Violation|6|||
127658162|NCT00406419|459370880|FG001|Overall Study|Protocol Violation|2|||
127658163|NCT00406419|459370881|FG002|Overall Study|Protocol Violation|5|||
127658164|NCT00406419|459370879|FG000|Overall Study|Study Terminated by Sponsor|260|||
127658165|NCT00406419|459370880|FG001|Overall Study|Study Terminated by Sponsor|288|||
127658166|NCT00406419|459370881|FG002|Overall Study|Study Terminated by Sponsor|282|||
127658167|NCT00406419|459370879|FG000|Overall Study|Withdrawal by Subject|17|||
127658168|NCT00406419|459370880|FG001|Overall Study|Withdrawal by Subject|24|||
127658169|NCT00406419|459370881|FG002|Overall Study|Withdrawal by Subject|26|||
127658170|NCT00406419|459370879|FG000|Overall Study|Lack of Efficacy|12|||
127658171|NCT00406419|459370880|FG001|Overall Study|Lack of Efficacy|1|||
127658172|NCT00406419|459370881|FG002|Overall Study|Lack of Efficacy|6|||
127658173|NCT00406419|459370879|FG000|Overall Study|Non-Compliance with Study Drug|5|||
127658174|NCT00406419|459370880|FG001|Overall Study|Non-Compliance with Study Drug|6|||
127658175|NCT00406419|459370881|FG002|Overall Study|Non-Compliance with Study Drug|3|||
127658176|NCT00406419|459370879|FG000|Overall Study|Adverse Event|10|||
127658177|NCT00406419|459370880|FG001|Overall Study|Adverse Event|12|||
127658178|NCT00406419|459370881|FG002|Overall Study|Adverse Event|16|||
127658179|NCT00406419|459370879|FG000|Overall Study|Lost to Follow-up|11|||
127658180|NCT00406419|459370880|FG001|Overall Study|Lost to Follow-up|10|||
127658181|NCT00406419|459370881|FG002|Overall Study|Lost to Follow-up|5|||
127658182|NCT01913639|459370882|FG000|Overall Study|Not Eligible|3|||
127658183|NCT01290822|459370883|FG000|Overall Study|Withdrawal by Subject|1|||
127658184|NCT01290822|459370883|FG000|Overall Study|Physician Decision|10|||
127658185|NCT00089895|459370886|FG000|Overall Study|Consent Withdrawn|11|||
127658186|NCT00089895|459370887|FG001|Overall Study|Consent Withdrawn|14|||
127658187|NCT00089895|459370886|FG000|Overall Study|Technical reason|7|||
127658188|NCT00089895|459370887|FG001|Overall Study|Technical reason|2|||
127658189|NCT00089895|459370886|FG000|Overall Study|Surgery|0|||
127658190|NCT00089895|459370887|FG001|Overall Study|Surgery|1|||
127658191|NCT00089895|459370886|FG000|Overall Study|Bleeding|0|||
127658192|NCT00089895|459370887|FG001|Overall Study|Bleeding|2|||
127658193|NCT00089895|459370886|FG000|Overall Study|Physician Decision|3|||
127658194|NCT00089895|459370887|FG001|Overall Study|Physician Decision|7|||
127658195|NCT00089895|459370886|FG000|Overall Study|Exclusion criteria met|6|||
127658196|NCT00089895|459370887|FG001|Overall Study|Exclusion criteria met|6|||
127658197|NCT00089895|459370886|FG000|Overall Study|Not otherwise specified|4|||
127658198|NCT00089895|459370887|FG001|Overall Study|Not otherwise specified|8|||
127658199|NCT00089895|459370886|FG000|Overall Study|Missing|4|||
127658200|NCT00089895|459370887|FG001|Overall Study|Missing|2|||
127658201|NCT05644353|459370890|FG000|Overall Study|Physician Decision|1|||
127658202|NCT05644353|459370891|FG001|Overall Study|Physician Decision|0|||
127658203|NCT05644353|459370892|FG002|Overall Study|Physician Decision|0|||
127658204|NCT05644353|459370893|FG003|Overall Study|Physician Decision|0|||
127658205|NCT05644353|459370894|FG004|Overall Study|Physician Decision|0|||
127987555|NCT00624832|460578877|FG002|Overall Study|Abnormal Laboratory Value|0|||
127987556|NCT00624832|460578878|FG003|Overall Study|Abnormal Laboratory Value|0|||
127987557|NCT04379700|460578879|FG000|Overall Study|Withdrawal by Subject|10|||
127987558|NCT04379700|460578879|FG000|Overall Study|Screen Fail|4|||
127987559|NCT04379700|460578879|FG000|Overall Study|Lost to Follow-up|3|||
127987560|NCT00592592|460578880|FG000|Overall Study|Patient found ineligible upon chart review|1|||
127987561|NCT02005627|460578883|FG000|Overall Study|Lost to Follow-up|1|||
127987562|NCT02005627|460578884|FG001|Overall Study|Lost to Follow-up|2|||
127987563|NCT02005627|460578883|FG000|Overall Study|Withdrawal by Subject|1|||
127987564|NCT02005627|460578884|FG001|Overall Study|Withdrawal by Subject|2|||
127987565|NCT00938587|460578885|FG000|Overall Study|Adverse Event|2|||
127987566|NCT00938587|460578886|FG001|Overall Study|Adverse Event|0|||
127987567|NCT00938587|460578887|FG002|Overall Study|Adverse Event|0|||
127987568|NCT00938587|460578888|FG003|Overall Study|Adverse Event|2|||
127987569|NCT00938587|460578885|FG000|Overall Study|Did not meet entrance criteria|0|||
127987570|NCT00938587|460578886|FG001|Overall Study|Did not meet entrance criteria|0|||
127987571|NCT00938587|460578887|FG002|Overall Study|Did not meet entrance criteria|1|||
127658206|NCT05644353|459370895|FG005|Overall Study|Physician Decision|0|||
127658207|NCT05644353|459370890|FG000|Overall Study|Protocol Violation|1|||
127658208|NCT05644353|459370891|FG001|Overall Study|Protocol Violation|0|||
127658209|NCT05644353|459370892|FG002|Overall Study|Protocol Violation|0|||
127658210|NCT05644353|459370893|FG003|Overall Study|Protocol Violation|0|||
127658211|NCT05644353|459370894|FG004|Overall Study|Protocol Violation|0|||
127658212|NCT05644353|459370895|FG005|Overall Study|Protocol Violation|0|||
127658213|NCT05644353|459370890|FG000|Overall Study|Withdrawal by Subject|0|||
127658214|NCT05644353|459370891|FG001|Overall Study|Withdrawal by Subject|2|||
127658215|NCT05644353|459370892|FG002|Overall Study|Withdrawal by Subject|0|||
127658216|NCT05644353|459370893|FG003|Overall Study|Withdrawal by Subject|0|||
127987572|NCT00938587|460578888|FG003|Overall Study|Did not meet entrance criteria|0|||
127658217|NCT05644353|459370894|FG004|Overall Study|Withdrawal by Subject|1|||
127658218|NCT05644353|459370895|FG005|Overall Study|Withdrawal by Subject|0|||
127658219|NCT05644353|459370890|FG000|Overall Study|Lost to Follow-up|0|||
127658220|NCT05644353|459370891|FG001|Overall Study|Lost to Follow-up|0|||
127658221|NCT05644353|459370892|FG002|Overall Study|Lost to Follow-up|1|||
127658222|NCT05644353|459370893|FG003|Overall Study|Lost to Follow-up|0|||
127658223|NCT05644353|459370894|FG004|Overall Study|Lost to Follow-up|0|||
127658224|NCT05644353|459370895|FG005|Overall Study|Lost to Follow-up|0|||
127658225|NCT01535274|459370896|FG000|Overall Study|Determined to be ineligible|0|||
127658226|NCT01535274|459370897|FG001|Overall Study|Determined to be ineligible|1|||
127658227|NCT01535274|459370896|FG000|Overall Study|Misallocated to propofol intervention|0|||
127658228|NCT01535274|459370897|FG001|Overall Study|Misallocated to propofol intervention|1|||
127658229|NCT02778399|459370899|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
127658230|NCT02778399|459370900|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
127658231|NCT02778399|459370901|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
127658232|NCT02778399|459370902|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
127658233|NCT02778399|459370903|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
127658234|NCT02778399|459370904|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
127658235|NCT02778399|459370899|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
127658236|NCT02778399|459370900|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
127658237|NCT02778399|459370901|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
127658238|NCT02778399|459370902|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
127658239|NCT02778399|459370903|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
127658240|NCT02778399|459370904|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
127658241|NCT02778399|459370899|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
127658242|NCT02778399|459370900|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
127658243|NCT02778399|459370901|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
127658244|NCT02778399|459370902|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
127658245|NCT02778399|459370903|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
127658246|NCT02778399|459370904|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
127658247|NCT02778399|459370899|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
127658248|NCT02778399|459370900|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
127658249|NCT02778399|459370901|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
127658250|NCT02778399|459370902|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
127658251|NCT02778399|459370903|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
127658252|NCT02778399|459370904|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
127658253|NCT02778399|459370899|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
127658254|NCT02778399|459370900|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
127658255|NCT02778399|459370901|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
127658256|NCT02778399|459370902|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
127658257|NCT02778399|459370903|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
127658258|NCT02778399|459370904|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
127658259|NCT02778399|459370899|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
127658260|NCT02778399|459370900|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
127658261|NCT02778399|459370901|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
127658262|NCT02778399|459370902|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
127658263|NCT02778399|459370903|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
127658264|NCT02778399|459370904|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
127658265|NCT02778399|459370899|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
127658266|NCT02778399|459370900|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
127987573|NCT00938587|460578885|FG000|Overall Study|Withdrawal by Subject|1|||
127987574|NCT00938587|460578886|FG001|Overall Study|Withdrawal by Subject|1|||
127987575|NCT00938587|460578887|FG002|Overall Study|Withdrawal by Subject|0|||
127987576|NCT00938587|460578888|FG003|Overall Study|Withdrawal by Subject|0|||
127987577|NCT00048997|460578891|FG000|Overall Study|Protocol Violation|7|||
127987578|NCT00048997|460578892|FG001|Overall Study|Protocol Violation|2|||
127987579|NCT00048997|460578891|FG000|Overall Study|Withdrawal by Subject|6|||
127987580|NCT00048997|460578892|FG001|Overall Study|Withdrawal by Subject|1|||
127987581|NCT02819440|460578893|FG000|Overall Study|Adverse Event|3|||
127987582|NCT02819440|460578894|FG001|Overall Study|Adverse Event|1|||
127987583|NCT02819440|460578893|FG000|Overall Study|Lost to Follow-up|1|||
127987584|NCT02819440|460578894|FG001|Overall Study|Lost to Follow-up|3|||
127987585|NCT02819440|460578893|FG000|Overall Study|Withdrawal by Subject|9|||
127987586|NCT02819440|460578894|FG001|Overall Study|Withdrawal by Subject|8|||
127987587|NCT02007278|460578895|FG000|Overall Study|Failure to comply with an eligibility|0|||
127987588|NCT02007278|460578896|FG001|Overall Study|Failure to comply with an eligibility|1|||
127658267|NCT02778399|459370901|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
127987589|NCT02007278|460578895|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
127987590|NCT02007278|460578896|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
127987591|NCT02007278|460578895|FG000|Overall Study|Incorrect medication administration|1|||
127987592|NCT02007278|460578896|FG001|Overall Study|Incorrect medication administration|0|||
127658268|NCT02778399|459370902|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
127658269|NCT02778399|459370903|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
127658270|NCT02778399|459370904|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
127658271|NCT02778399|459370899|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
127658272|NCT02778399|459370900|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
127658273|NCT02778399|459370901|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
127658274|NCT02778399|459370902|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
127658275|NCT02778399|459370903|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
127658276|NCT02778399|459370904|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
127658277|NCT02778399|459370899|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
127658278|NCT02778399|459370900|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
127658279|NCT02778399|459370901|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
127658280|NCT02778399|459370902|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
127658281|NCT02778399|459370903|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
127658282|NCT02778399|459370904|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
127658283|NCT02778399|459370899|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
127658284|NCT02778399|459370900|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
127658285|NCT02778399|459370901|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
127658286|NCT02778399|459370902|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
127658287|NCT02778399|459370903|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
127658288|NCT02778399|459370904|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
127658289|NCT02778399|459370899|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
127658290|NCT02778399|459370900|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
127658291|NCT02778399|459370901|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
127658292|NCT02778399|459370902|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
127658293|NCT02778399|459370903|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
127658294|NCT02778399|459370904|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
127658295|NCT02009696|459370908|FG000|Overall Study|Withdrawal by Subject|2|||
127987593|NCT02007278|460578895|FG000|Overall Study|Mis-randomization|1|||
127987594|NCT02007278|460578896|FG001|Overall Study|Mis-randomization|1|||
127987595|NCT02886884|460578897|FG000|Follow-up|Withdrawal by Subject|0|||
127987596|NCT02886884|460578898|FG001|Follow-up|Withdrawal by Subject|0|||
127987597|NCT02886884|460578899|FG002|Follow-up|Withdrawal by Subject|0|||
127987598|NCT02886884|460578900|FG003|Follow-up|Withdrawal by Subject|1|||
127987599|NCT00435188|460578901|FG000|Overall Study|Death|1|||
127987600|NCT00435188|460578902|FG001|Overall Study|Death|6|||
127987601|NCT00435188|460578901|FG000|Overall Study|Withdrawal by Subject|16|||
127987602|NCT00435188|460578902|FG001|Overall Study|Withdrawal by Subject|11|||
127987603|NCT00435188|460578901|FG000|Overall Study|Lost to Follow-up|5|||
127987604|NCT00435188|460578902|FG001|Overall Study|Lost to Follow-up|6|||
127987605|NCT00055497|460578907|FG000|Overall Study|Adverse Event|1|||
127987606|NCT00055497|460578908|FG001|Overall Study|Adverse Event|1|||
127987607|NCT00055497|460578909|FG002|Overall Study|Adverse Event|1|||
127987608|NCT00055497|460578910|FG003|Overall Study|Adverse Event|28|||
127987609|NCT00055497|460578907|FG000|Overall Study|Withdrawal by Subject|3|||
127987610|NCT00055497|460578908|FG001|Overall Study|Withdrawal by Subject|1|||
127987611|NCT00055497|460578909|FG002|Overall Study|Withdrawal by Subject|1|||
127987612|NCT00055497|460578910|FG003|Overall Study|Withdrawal by Subject|15|||
127987613|NCT00055497|460578907|FG000|Overall Study|Lost to Follow-up|0|||
127987614|NCT00055497|460578908|FG001|Overall Study|Lost to Follow-up|1|||
127987615|NCT00055497|460578909|FG002|Overall Study|Lost to Follow-up|0|||
127987616|NCT00055497|460578910|FG003|Overall Study|Lost to Follow-up|5|||
127987617|NCT00055497|460578907|FG000|Overall Study|Protocol Violation|0|||
127987618|NCT00055497|460578908|FG001|Overall Study|Protocol Violation|0|||
127987619|NCT00055497|460578909|FG002|Overall Study|Protocol Violation|0|||
127987620|NCT00055497|460578910|FG003|Overall Study|Protocol Violation|3|||
127987621|NCT00055497|460578907|FG000|Overall Study|Lack of Efficacy|1|||
127987622|NCT00055497|460578908|FG001|Overall Study|Lack of Efficacy|0|||
127658296|NCT00447954|459370910|FG000|Overall Study|Adverse Event|0|||
127658297|NCT00447954|459370911|FG001|Overall Study|Adverse Event|2|||
127658298|NCT00447954|459370912|FG002|Overall Study|Adverse Event|0|||
127658299|NCT00447954|459370910|FG000|Overall Study|Withdrawal by Subject|0|||
127987623|NCT00055497|460578909|FG002|Overall Study|Lack of Efficacy|0|||
127658300|NCT00447954|459370911|FG001|Overall Study|Withdrawal by Subject|1|||
127987624|NCT00055497|460578910|FG003|Overall Study|Lack of Efficacy|27|||
127987625|NCT00055497|460578907|FG000|Overall Study|Administrative Reasons|0|||
127987626|NCT00055497|460578908|FG001|Overall Study|Administrative Reasons|0|||
127987627|NCT00055497|460578909|FG002|Overall Study|Administrative Reasons|0|||
127987628|NCT00055497|460578910|FG003|Overall Study|Administrative Reasons|1|||
127987629|NCT00055497|460578907|FG000|Overall Study|Other|0|||
127987630|NCT00055497|460578908|FG001|Overall Study|Other|0|||
127987631|NCT00055497|460578909|FG002|Overall Study|Other|0|||
127987632|NCT00055497|460578910|FG003|Overall Study|Other|11|||
127987633|NCT00731731|460578911|FG000|Overall Study|Protocol Violation|0|||
127658301|NCT00447954|459370912|FG002|Overall Study|Withdrawal by Subject|1|||
127658302|NCT00447954|459370910|FG000|Overall Study|Lost to Follow-up|0|||
127658303|NCT00447954|459370911|FG001|Overall Study|Lost to Follow-up|1|||
127658304|NCT00447954|459370912|FG002|Overall Study|Lost to Follow-up|0|||
127658305|NCT00447954|459370910|FG000|Overall Study|Exclusionary event prior to implant procedure|1|||
127658306|NCT00447954|459370911|FG001|Overall Study|Exclusionary event prior to implant procedure|0|||
127658307|NCT00447954|459370912|FG002|Overall Study|Exclusionary event prior to implant procedure|0|||
127658308|NCT00856661|459370913|FG000|Overall Study|Death|15|||
127658309|NCT00856661|459370914|FG001|Overall Study|Death|18|||
127658310|NCT00856661|459370913|FG000|Overall Study|Protocol Violation|2|||
127658311|NCT00856661|459370914|FG001|Overall Study|Protocol Violation|1|||
127658312|NCT00856661|459370913|FG000|Overall Study|Withdrawal by Subject|1|||
127658313|NCT00856661|459370914|FG001|Overall Study|Withdrawal by Subject|2|||
127658314|NCT00856661|459370913|FG000|Overall Study|Lost to Follow-up|1|||
127658315|NCT00856661|459370914|FG001|Overall Study|Lost to Follow-up|3|||
127658316|NCT00856661|459370913|FG000|Overall Study|Physician Judgement|8|||
127658317|NCT00856661|459370914|FG001|Overall Study|Physician Judgement|5|||
127658318|NCT04152343|459370915|FG000|Overall Study|Transplanted|5|||
127658319|NCT04152343|459370915|FG000|Overall Study|Death|20|||
127658320|NCT04152343|459370915|FG000|Overall Study|Lost to Follow-up|3|||
127658321|NCT01164228|459370920|FG000|Overall Study|Progression|24|||
127658322|NCT01164228|459370921|FG001|Overall Study|Progression|25|||
127658323|NCT01164228|459370920|FG000|Overall Study|Adverse Event|13|||
127658324|NCT01164228|459370921|FG001|Overall Study|Adverse Event|7|||
127658325|NCT01164228|459370920|FG000|Overall Study|Death|1|||
127658326|NCT01164228|459370921|FG001|Overall Study|Death|1|||
127658327|NCT01164228|459370920|FG000|Overall Study|Withdrawal by Subject|2|||
127658328|NCT01164228|459370921|FG001|Overall Study|Withdrawal by Subject|0|||
127658329|NCT01164228|459370920|FG000|Overall Study|Physician Decision|1|||
127658330|NCT01164228|459370921|FG001|Overall Study|Physician Decision|2|||
127658331|NCT01164228|459370920|FG000|Overall Study|Symptomatic deterioration|1|||
127658332|NCT01164228|459370921|FG001|Overall Study|Symptomatic deterioration|0|||
127658333|NCT01164228|459370920|FG000|Overall Study|Never started treatment|1|||
127658334|NCT01164228|459370921|FG001|Overall Study|Never started treatment|3|||
127658335|NCT01164228|459370920|FG000|Overall Study|Ineligible|1|||
127658336|NCT01164228|459370921|FG001|Overall Study|Ineligible|0|||
127658337|NCT01965938|459370922|FG000|Overall Study|Withdrawal by Subject|1|||
127658338|NCT01965938|459370923|FG001|Overall Study|Withdrawal by Subject|0|||
127658339|NCT04287868|459370924|FG000|Overall Study|Screening fail|1|||
127658340|NCT04287868|459370925|FG001|Overall Study|Screening fail|0|||
127658341|NCT04666922|459372503|FG000|Overall Study|Withdrawal by Subject|1|||
127658342|NCT04666922|459372504|FG001|Overall Study|Withdrawal by Subject|0|||
127658343|NCT04666922|459372505|FG002|Overall Study|Withdrawal by Subject|0|||
127658344|NCT04666922|459372506|FG003|Overall Study|Withdrawal by Subject|0|||
127658345|NCT04666922|459372507|FG004|Overall Study|Withdrawal by Subject|0|||
127658346|NCT04666922|459372508|FG005|Overall Study|Withdrawal by Subject|0|||
127658347|NCT04666922|459372509|FG006|Overall Study|Withdrawal by Subject|0|||
127658348|NCT00244374|459372510|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
127658349|NCT00244374|459372511|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
127658350|NCT00244374|459372512|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
127658351|NCT00244374|459372513|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
127658352|NCT00244374|459372514|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
127658353|NCT00244374|459372510|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
127658354|NCT00244374|459372511|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
127658355|NCT00244374|459372512|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
127658356|NCT00244374|459372513|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
127658357|NCT00244374|459372514|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
127658358|NCT00244374|459372510|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
127658359|NCT00244374|459372511|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
127658360|NCT00244374|459372512|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
127658361|NCT00244374|459372513|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
127658362|NCT00244374|459372514|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
127658363|NCT00244374|459372510|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
127658364|NCT00244374|459372511|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
127658365|NCT00244374|459372512|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
127658366|NCT00244374|459372513|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
127658367|NCT00244374|459372514|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
127658368|NCT00244374|459372510|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
127658369|NCT00244374|459372511|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
127658370|NCT00244374|459372512|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
127658371|NCT00244374|459372513|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
127658372|NCT00244374|459372514|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
127658373|NCT00244374|459372510|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
127658374|NCT00244374|459372511|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
127658375|NCT00244374|459372512|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
127658376|NCT00244374|459372513|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
127658377|NCT00244374|459372514|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
127658378|NCT00244374|459372510|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
127658379|NCT00244374|459372511|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
127658380|NCT00244374|459372512|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
127658381|NCT00244374|459372513|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
127658382|NCT00244374|459372514|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
127658383|NCT00244374|459372510|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
127658384|NCT00244374|459372511|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
127658385|NCT00244374|459372512|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
127658386|NCT00244374|459372513|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
127658387|NCT00244374|459372514|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
127658388|NCT00244374|459372510|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
127658389|NCT00244374|459372511|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
127658390|NCT00244374|459372512|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
127658391|NCT00244374|459372513|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
127658392|NCT00244374|459372514|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
127658393|NCT03722264|459372515|FG000|Overall Study|Physician Decision|3|||
127658394|NCT02959671|459372516|FG000|Overall Study|Adverse Event|2|||
127658395|NCT02959671|459372516|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
127658396|NCT04651114|459372523|FG000|Overall Study|Withdrawal by Subject|8|||
127658397|NCT01923896|459372528|FG000|Overall Study|Adverse Event|1|||
127658398|NCT01923896|459372529|FG001|Overall Study|Adverse Event|0|||
127658399|NCT00474929|459372534|FG000|Overall Study|Withdrawal by Subject|0|||
127658400|NCT00474929|459372535|FG001|Overall Study|Withdrawal by Subject|1|||
127658401|NCT00474929|459372536|FG002|Overall Study|Withdrawal by Subject|0|||
127658402|NCT00474929|459372537|FG003|Overall Study|Withdrawal by Subject|0|||
127658403|NCT00474929|459372538|FG004|Overall Study|Withdrawal by Subject|0|||
127658404|NCT00474929|459372534|FG000|Overall Study|Unrelated medical condition|0|||
127658405|NCT00474929|459372535|FG001|Overall Study|Unrelated medical condition|0|||
127658406|NCT00474929|459372536|FG002|Overall Study|Unrelated medical condition|1|||
127658407|NCT00474929|459372537|FG003|Overall Study|Unrelated medical condition|0|||
127658408|NCT00474929|459372538|FG004|Overall Study|Unrelated medical condition|0|||
127658409|NCT00474929|459372534|FG000|Overall Study|Physician Decision|0|||
127658410|NCT00474929|459372535|FG001|Overall Study|Physician Decision|0|||
127658411|NCT00474929|459372536|FG002|Overall Study|Physician Decision|1|||
127658412|NCT00474929|459372537|FG003|Overall Study|Physician Decision|2|||
127658413|NCT00474929|459372538|FG004|Overall Study|Physician Decision|0|||
127658414|NCT03661996|459372541|FG000|Overall Study|Adverse Event|0|||
127658415|NCT03661996|459372542|FG001|Overall Study|Adverse Event|0|||
127658416|NCT03661996|459372543|FG002|Overall Study|Adverse Event|1|||
127658417|NCT03661996|459372544|FG003|Overall Study|Adverse Event|1|||
127658418|NCT03661996|459372545|FG004|Overall Study|Adverse Event|0|||
127658419|NCT03661996|459372541|FG000|Overall Study|Lost to Follow-up|5|||
127658420|NCT03661996|459372542|FG001|Overall Study|Lost to Follow-up|1|||
127987634|NCT00731731|460578912|FG001|Overall Study|Protocol Violation|0|||
127987635|NCT00731731|460578913|FG002|Overall Study|Protocol Violation|1|||
127987636|NCT00731731|460578911|FG000|Overall Study|Cancel prior to treatment|0|||
127658421|NCT03661996|459372543|FG002|Overall Study|Lost to Follow-up|2|||
127658422|NCT03661996|459372544|FG003|Overall Study|Lost to Follow-up|2|||
127658423|NCT03661996|459372545|FG004|Overall Study|Lost to Follow-up|6|||
127658424|NCT03661996|459372541|FG000|Overall Study|Physician Decision|1|||
127658425|NCT03661996|459372542|FG001|Overall Study|Physician Decision|1|||
127658426|NCT03661996|459372543|FG002|Overall Study|Physician Decision|1|||
127658427|NCT03661996|459372544|FG003|Overall Study|Physician Decision|2|||
127658428|NCT03661996|459372545|FG004|Overall Study|Physician Decision|0|||
127658429|NCT03661996|459372541|FG000|Overall Study|Protocol Violation|0|||
127658430|NCT03661996|459372542|FG001|Overall Study|Protocol Violation|0|||
127658431|NCT03661996|459372543|FG002|Overall Study|Protocol Violation|0|||
127658432|NCT03661996|459372544|FG003|Overall Study|Protocol Violation|0|||
127658433|NCT03661996|459372545|FG004|Overall Study|Protocol Violation|1|||
127987637|NCT00731731|460578912|FG001|Overall Study|Cancel prior to treatment|0|||
127987638|NCT00731731|460578913|FG002|Overall Study|Cancel prior to treatment|2|||
127658434|NCT03661996|459372541|FG000|Overall Study|Withdrawal by Subject|3|||
127987639|NCT03970200|460578914|FG000|Overall Study|Death|2|||
127987640|NCT03970200|460578915|FG001|Overall Study|Death|2|||
127987641|NCT03970200|460578916|FG002|Overall Study|Death|1|||
127987642|NCT03970200|460578914|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
127987643|NCT03970200|460578915|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
127987644|NCT03970200|460578916|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
127987645|NCT02112877|460578917|FG000|Overall Study|Withdrawal by Subject|1|||
127987646|NCT02112877|460578918|FG001|Overall Study|Withdrawal by Subject|7|||
127987647|NCT02112877|460578917|FG000|Overall Study|Visit Missed|1|||
127987648|NCT02112877|460578918|FG001|Overall Study|Visit Missed|6|||
127987649|NCT01693185|460578919|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
127987650|NCT01693185|460578920|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
127987651|NCT01606748|460578925|FG000|Overall Study|Adverse Event|1|||
127987652|NCT01606748|460578926|FG001|Overall Study|Adverse Event|0|||
127987653|NCT01606748|460578925|FG000|Overall Study|Progressive Disease|1|||
127987654|NCT01606748|460578926|FG001|Overall Study|Progressive Disease|0|||
127987655|NCT01606748|460578925|FG000|Overall Study|Withdrawal by Subject|1|||
127987656|NCT01606748|460578926|FG001|Overall Study|Withdrawal by Subject|0|||
127987657|NCT03742258|460578930|FG000|Continued Treatment After 1st Response|Adverse Event|0|||
127987658|NCT03742258|460578931|FG001|Continued Treatment After 1st Response|Adverse Event|1|||
127987659|NCT03742258|460578932|FG002|Continued Treatment After 1st Response|Adverse Event|1|||
127987660|NCT03742258|460578930|FG000|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
127987661|NCT03742258|460578931|FG001|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
127987662|NCT03742258|460578932|FG002|Continued Treatment After 1st Response|Withdrawal by Subject|1|||
127987663|NCT03742258|460578930|FG000|Survival Follow-Up|Still in Follow-up|0|||
127987664|NCT03742258|460578931|FG001|Survival Follow-Up|Still in Follow-up|0|||
127987665|NCT03742258|460578932|FG002|Survival Follow-Up|Still in Follow-up|2|||
127987666|NCT02083653|460578935|FG000|Overall Study|Randomized but not Treated|0|||
127987667|NCT02083653|460578936|FG001|Overall Study|Randomized but not Treated|2|||
127987668|NCT02083653|460578937|FG002|Overall Study|Randomized but not Treated|7|||
127987669|NCT02083653|460578935|FG000|Overall Study|Adverse Event|12|||
127987670|NCT02083653|460578936|FG001|Overall Study|Adverse Event|5|||
127987671|NCT02083653|460578937|FG002|Overall Study|Adverse Event|4|||
127987672|NCT02083653|460578935|FG000|Overall Study|Lost to Follow-up|1|||
127987673|NCT02083653|460578936|FG001|Overall Study|Lost to Follow-up|0|||
127987674|NCT02083653|460578937|FG002|Overall Study|Lost to Follow-up|0|||
127987675|NCT02083653|460578935|FG000|Overall Study|Death|2|||
127987676|NCT02083653|460578936|FG001|Overall Study|Death|2|||
127987677|NCT02083653|460578937|FG002|Overall Study|Death|2|||
127987678|NCT02083653|460578935|FG000|Overall Study|Progressive Disease|65|||
127987679|NCT02083653|460578936|FG001|Overall Study|Progressive Disease|73|||
127987680|NCT02083653|460578937|FG002|Overall Study|Progressive Disease|63|||
127987681|NCT02083653|460578935|FG000|Overall Study|Withdrawal by Subject|2|||
127987682|NCT02083653|460578936|FG001|Overall Study|Withdrawal by Subject|1|||
127987683|NCT02083653|460578937|FG002|Overall Study|Withdrawal by Subject|2|||
127987684|NCT02083653|460578935|FG000|Overall Study|Other Events|0|||
127658435|NCT03661996|459372542|FG001|Overall Study|Withdrawal by Subject|5|||
127658436|NCT03661996|459372543|FG002|Overall Study|Withdrawal by Subject|1|||
127658437|NCT03661996|459372544|FG003|Overall Study|Withdrawal by Subject|7|||
127658438|NCT03661996|459372545|FG004|Overall Study|Withdrawal by Subject|7|||
127658439|NCT03661996|459372541|FG000|Overall Study|Sponsors Decision|2|||
127658440|NCT03661996|459372542|FG001|Overall Study|Sponsors Decision|0|||
127658441|NCT03661996|459372543|FG002|Overall Study|Sponsors Decision|0|||
127658442|NCT03661996|459372544|FG003|Overall Study|Sponsors Decision|0|||
127658443|NCT03661996|459372545|FG004|Overall Study|Sponsors Decision|0|||
127658444|NCT03661996|459372541|FG000|Overall Study|Other|1|||
127658445|NCT03661996|459372542|FG001|Overall Study|Other|1|||
127658446|NCT03661996|459372543|FG002|Overall Study|Other|1|||
127658447|NCT03661996|459372544|FG003|Overall Study|Other|1|||
127658448|NCT03661996|459372545|FG004|Overall Study|Other|0|||
127658449|NCT00068380|459372546|FG000|Overall Study|Withdrawal by Subject|3|||
127658450|NCT00068380|459372546|FG000|Overall Study|Adverse Event|2|||
127658451|NCT01190215|459372547|FG000|Up to Month 6|Lost to Follow-up|2|||
127658452|NCT01190215|459372548|FG001|Up to Month 6|Lost to Follow-up|0|||
127987685|NCT02083653|460578936|FG001|Overall Study|Other Events|2|||
127987686|NCT02083653|460578937|FG002|Overall Study|Other Events|2|||
127987687|NCT02083653|460578935|FG000|Overall Study|Reason Missing|0|||
127658453|NCT00067990|459372565|FG000|Overall Study|Death|5|||
127658454|NCT00067990|459372566|FG001|Overall Study|Death|7|||
127658455|NCT00067990|459372565|FG000|Overall Study|ESRD, Non IF/TA|1|||
127987688|NCT02083653|460578936|FG001|Overall Study|Reason Missing|0|||
127987689|NCT02083653|460578937|FG002|Overall Study|Reason Missing|4|||
127987690|NCT03084315|460578938|FG000|Overall Study|Lost to Follow-up|8|||
127987691|NCT03084315|460578939|FG001|Overall Study|Lost to Follow-up|7|||
127987692|NCT03084315|460578938|FG000|Overall Study|Withdrawal by Subject|2|||
127987693|NCT03084315|460578939|FG001|Overall Study|Withdrawal by Subject|2|||
127987694|NCT01952080|460578940|FG000|Overall Study|Withdrawal by Subject|0|||
127987695|NCT01952080|460578941|FG001|Overall Study|Withdrawal by Subject|0|||
127987696|NCT01952080|460578942|FG002|Overall Study|Withdrawal by Subject|0|||
127987697|NCT01952080|460578943|FG003|Overall Study|Withdrawal by Subject|1|||
127987698|NCT01952080|460578940|FG000|Overall Study|Protocol Non-compliance|0|||
127987699|NCT01952080|460578941|FG001|Overall Study|Protocol Non-compliance|1|||
127987700|NCT01952080|460578942|FG002|Overall Study|Protocol Non-compliance|0|||
127987701|NCT01952080|460578943|FG003|Overall Study|Protocol Non-compliance|0|||
127987702|NCT00564395|460578944|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
127987703|NCT00564395|460578945|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
127987704|NCT00564395|460578944|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
127987705|NCT00564395|460578945|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
127987706|NCT00594386|460578946|FG000|Overall Study|Major protocol violation|2|||
127987707|NCT00594386|460578946|FG000|Overall Study|Lack of Efficacy|12|||
127987708|NCT00594386|460578946|FG000|Overall Study|Adverse Event|68|||
127987709|NCT00594386|460578946|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
127987710|NCT00594386|460578946|FG000|Overall Study|Subject withdrew consent|35|||
127987711|NCT00594386|460578946|FG000|Overall Study|Study ended per sponsor|115|||
127987712|NCT00594386|460578946|FG000|Overall Study|Lost to Follow-up|6|||
127987713|NCT00594386|460578946|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
127987714|NCT00594386|460578946|FG000|Overall Study|Other: Subject moved to Seattle|1|||
127987715|NCT00594386|460578946|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
127987716|NCT00594386|460578946|FG000|Overall Study|Other: Study terminated per investigator|2|||
127987717|NCT00594386|460578946|FG000|Overall Study|Other: Sponsor closure of study|1|||
127987718|NCT00594386|460578946|FG000|Overall Study|Other: Site terminated participation|1|||
127987719|NCT00594386|460578946|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
127987720|NCT00594386|460578946|FG000|Overall Study|Other: Loss of drivers license|1|||
127987721|NCT00094536|460578949|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
127987722|NCT00094536|460578949|FG000|Treatment and Follow-up|Adverse Event|4|||
127987723|NCT00094536|460578949|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
127987724|NCT00094536|460578949|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
127987725|NCT00094536|460578949|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
127987726|NCT00094536|460578949|FG000|Treatment and Follow-up|Subject non-compliance|9|||
127987727|NCT00094536|460578949|FG000|Treatment and Follow-up|Unable to attend visits|1|||
127987728|NCT01905592|460578950|FG000|Overall Study|Disease Progression|51|||
127987729|NCT01905592|460578951|FG001|Overall Study|Disease Progression|110|||
127987730|NCT01905592|460578950|FG000|Overall Study|Toxicity|1|||
127987731|NCT01905592|460578951|FG001|Overall Study|Toxicity|16|||
127987732|NCT01905592|460578950|FG000|Overall Study|Physician Decision|0|||
127987733|NCT01905592|460578951|FG001|Overall Study|Physician Decision|2|||
127987734|NCT01905592|460578950|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
127987735|NCT01905592|460578951|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
127987736|NCT01905592|460578950|FG000|Overall Study|Protocol Violation|0|||
127987737|NCT01905592|460578951|FG001|Overall Study|Protocol Violation|1|||
127987738|NCT01905592|460578950|FG000|Overall Study|Sponsor's decision|1|||
127987739|NCT01905592|460578951|FG001|Overall Study|Sponsor's decision|1|||
127987740|NCT01905592|460578950|FG000|Overall Study|Not treated|7|||
127987741|NCT01905592|460578951|FG001|Overall Study|Not treated|3|||
127987742|NCT01905592|460578950|FG000|Overall Study|Withdrawal by Subject|10|||
127987743|NCT01905592|460578951|FG001|Overall Study|Withdrawal by Subject|2|||
127987744|NCT04494425|460580779|FG000|Overall Study|Death|160|||
127987745|NCT04494425|460580780|FG001|Overall Study|Death|166|||
127987746|NCT04494425|460580779|FG000|Overall Study|Withdrawal by Subject|10|||
127987747|NCT04494425|460580780|FG001|Overall Study|Withdrawal by Subject|40|||
127987748|NCT04494425|460580779|FG000|Overall Study|Other|1|||
127987749|NCT04494425|460580780|FG001|Overall Study|Other|1|||
127987750|NCT04494425|460580779|FG000|Overall Study|Ongoing at the time of PCD|265|||
127987751|NCT04494425|460580780|FG001|Overall Study|Ongoing at the time of PCD|223|||
127987752|NCT01190189|460580784|FG000|Overall Study|Lost to Follow-up|4|||
127987753|NCT01190189|460580784|FG000|Overall Study|Withdrawal by Subject|1|||
127987754|NCT01190189|460580784|FG000|Overall Study|Migrated/moved from study area|1|||
127987755|NCT00433017|460580785|FG000|Overall Study|Adverse Event|5|||
127987756|NCT00433017|460580786|FG001|Overall Study|Adverse Event|3|||
127987757|NCT00433017|460580785|FG000|Overall Study|Withdrawal by Subject|4|||
127658456|NCT00067990|459372566|FG001|Overall Study|ESRD, Non IF/TA|3|||
127987758|NCT00433017|460580786|FG001|Overall Study|Withdrawal by Subject|5|||
127987759|NCT00433017|460580785|FG000|Overall Study|Lost to Follow-up|3|||
127987760|NCT00433017|460580786|FG001|Overall Study|Lost to Follow-up|4|||
127987761|NCT00433017|460580785|FG000|Overall Study|Administrative problems|80|||
127987762|NCT00433017|460580786|FG001|Overall Study|Administrative problems|86|||
127987763|NCT00433017|460580785|FG000|Overall Study|Protocol Violation|1|||
127987764|NCT00433017|460580786|FG001|Overall Study|Protocol Violation|0|||
127987765|NCT00433017|460580785|FG000|Overall Study|Death|2|||
127987766|NCT00433017|460580786|FG001|Overall Study|Death|2|||
127987767|NCT00433017|460580785|FG000|Overall Study|Subject no longer requires study drug|1|||
127987768|NCT00433017|460580786|FG001|Overall Study|Subject no longer requires study drug|1|||
127987769|NCT03959488|460580789|FG000|Season 1|Other|6|||
127658457|NCT00067990|459372565|FG000|Overall Study|Withdrawal by Subject|4|||
127658458|NCT00067990|459372566|FG001|Overall Study|Withdrawal by Subject|12|||
127658459|NCT01973491|459372567|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
127658460|NCT01973491|459372567|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
127658461|NCT01973491|459372567|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
127658462|NCT01928225|459372575|FG000|Overall Study|Pregnancy|1|||
127658463|NCT01928225|459372576|FG001|Overall Study|Pregnancy|0|||
127658464|NCT01928225|459372575|FG000|Overall Study|basaloid cervical cancer|1|||
127658465|NCT01928225|459372576|FG001|Overall Study|basaloid cervical cancer|0|||
127658466|NCT01928225|459372575|FG000|Overall Study|Lost to Follow-up|1|||
127658467|NCT01928225|459372576|FG001|Overall Study|Lost to Follow-up|3|||
127658468|NCT01454830|459372580|FG000|Overall Study|Withdrawal by Subject|4|||
127987770|NCT03959488|460580790|FG001|Season 1|Other|7|||
127987771|NCT03959488|460580791|FG002|Season 1|Other|0|||
127987772|NCT03959488|460580792|FG003|Season 1|Other|0|||
127987773|NCT03959488|460580793|FG004|Season 1|Other|0|||
127987774|NCT03959488|460580789|FG000|Season 1|Withdrawal by parent/guardian|43|||
127987775|NCT03959488|460580790|FG001|Season 1|Withdrawal by parent/guardian|28|||
127658469|NCT01454830|459372581|FG001|Overall Study|Withdrawal by Subject|4|||
127658470|NCT01454830|459372580|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
127658471|NCT01454830|459372581|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
127658472|NCT01454830|459372580|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
127658473|NCT01454830|459372581|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
127658474|NCT01454830|459372580|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
127658475|NCT01454830|459372581|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
127658476|NCT01454830|459372580|FG000|Overall Study|Withdrawal - no polysomnography|3|||
127658477|NCT01454830|459372581|FG001|Overall Study|Withdrawal - no polysomnography|2|||
127658478|NCT01965158|459372585|FG000|Overall Study|Adverse Event|14|||
127987776|NCT03959488|460580791|FG002|Season 1|Withdrawal by parent/guardian|0|||
127987777|NCT03959488|460580792|FG003|Season 1|Withdrawal by parent/guardian|0|||
127987778|NCT03959488|460580793|FG004|Season 1|Withdrawal by parent/guardian|0|||
127987779|NCT03959488|460580789|FG000|Season 1|Due to COVID-19 pandemic|2|||
127987780|NCT03959488|460580790|FG001|Season 1|Due to COVID-19 pandemic|3|||
127987781|NCT03959488|460580791|FG002|Season 1|Due to COVID-19 pandemic|0|||
127987782|NCT03959488|460580792|FG003|Season 1|Due to COVID-19 pandemic|0|||
127987783|NCT03959488|460580793|FG004|Season 1|Due to COVID-19 pandemic|0|||
127987784|NCT03959488|460580789|FG000|Season 1|Lost to Follow-up|17|||
127987785|NCT03959488|460580790|FG001|Season 1|Lost to Follow-up|7|||
127987786|NCT03959488|460580791|FG002|Season 1|Lost to Follow-up|0|||
127987787|NCT03959488|460580792|FG003|Season 1|Lost to Follow-up|0|||
127987788|NCT03959488|460580793|FG004|Season 1|Lost to Follow-up|0|||
127987789|NCT03959488|460580789|FG000|Season 1|Death|5|||
127987790|NCT03959488|460580790|FG001|Season 1|Death|1|||
127987791|NCT03959488|460580791|FG002|Season 1|Death|0|||
127987792|NCT03959488|460580792|FG003|Season 1|Death|0|||
127987793|NCT03959488|460580793|FG004|Season 1|Death|0|||
127987794|NCT03959488|460580789|FG000|Season 2|Other|0|||
127987795|NCT03959488|460580790|FG001|Season 2|Other|0|||
127987796|NCT03959488|460580791|FG002|Season 2|Other|2|||
127987797|NCT03959488|460580792|FG003|Season 2|Other|0|||
127987798|NCT03959488|460580793|FG004|Season 2|Other|0|||
127987799|NCT03959488|460580789|FG000|Season 2|Withdrawal by parent/guardian|0|||
127987800|NCT03959488|460580790|FG001|Season 2|Withdrawal by parent/guardian|0|||
127987801|NCT03959488|460580791|FG002|Season 2|Withdrawal by parent/guardian|3|||
127987802|NCT03959488|460580792|FG003|Season 2|Withdrawal by parent/guardian|1|||
127987803|NCT03959488|460580793|FG004|Season 2|Withdrawal by parent/guardian|1|||
127658479|NCT01965158|459372586|FG001|Overall Study|Adverse Event|5|||
127658480|NCT01965158|459372585|FG000|Overall Study|Withdrawal by Subject|16|||
127658481|NCT01965158|459372586|FG001|Overall Study|Withdrawal by Subject|24|||
127658482|NCT01965158|459372585|FG000|Overall Study|Lost to Follow-up|7|||
127658483|NCT01965158|459372586|FG001|Overall Study|Lost to Follow-up|5|||
127658484|NCT01965158|459372585|FG000|Overall Study|Protocol Violation|1|||
127658485|NCT01965158|459372586|FG001|Overall Study|Protocol Violation|1|||
127658486|NCT01965158|459372585|FG000|Overall Study|Other - Miscellaneous|3|||
127658487|NCT01965158|459372586|FG001|Overall Study|Other - Miscellaneous|0|||
127987804|NCT03959488|460580789|FG000|Season 2|Lost to Follow-up|0|||
127987805|NCT03959488|460580790|FG001|Season 2|Lost to Follow-up|0|||
127987806|NCT03959488|460580791|FG002|Season 2|Lost to Follow-up|1|||
127987807|NCT03959488|460580792|FG003|Season 2|Lost to Follow-up|0|||
127987808|NCT03959488|460580793|FG004|Season 2|Lost to Follow-up|1|||
127658488|NCT02006121|459372589|FG000|Double Blind Phase|Adverse Event|6|||
127658489|NCT02006121|459372590|FG001|Double Blind Phase|Adverse Event|0|||
127658490|NCT02006121|459372589|FG000|Double Blind Phase|Lack of Efficacy|1|||
127658491|NCT02006121|459372590|FG001|Double Blind Phase|Lack of Efficacy|16|||
127987809|NCT01026818|460580794|FG000|Screening Period|Entry Criteria Not Met|105|||
127987810|NCT01026818|460580795|FG001|Screening Period|Entry Criteria Not Met|0|||
127987811|NCT01026818|460580796|FG002|Screening Period|Entry Criteria Not Met|0|||
127987812|NCT01026818|460580797|FG003|Screening Period|Entry Criteria Not Met|0|||
127987813|NCT01026818|460580794|FG000|Screening Period|Withdrawal by Subject|49|||
127987814|NCT01026818|460580795|FG001|Screening Period|Withdrawal by Subject|0|||
127987815|NCT01026818|460580796|FG002|Screening Period|Withdrawal by Subject|0|||
127987816|NCT01026818|460580797|FG003|Screening Period|Withdrawal by Subject|0|||
127987817|NCT01026818|460580794|FG000|Screening Period|Protocol Deviation|3|||
127987818|NCT01026818|460580795|FG001|Screening Period|Protocol Deviation|0|||
127987819|NCT01026818|460580796|FG002|Screening Period|Protocol Deviation|0|||
127987820|NCT01026818|460580797|FG003|Screening Period|Protocol Deviation|0|||
127987821|NCT01026818|460580794|FG000|Screening Period|Adverse Event|2|||
127987822|NCT01026818|460580795|FG001|Screening Period|Adverse Event|0|||
127987823|NCT01026818|460580796|FG002|Screening Period|Adverse Event|0|||
127987824|NCT01026818|460580797|FG003|Screening Period|Adverse Event|0|||
127987825|NCT01026818|460580794|FG000|Screening Period|Physician Decision|1|||
127987826|NCT01026818|460580795|FG001|Screening Period|Physician Decision|0|||
127987827|NCT01026818|460580796|FG002|Screening Period|Physician Decision|0|||
127987828|NCT01026818|460580797|FG003|Screening Period|Physician Decision|0|||
127987829|NCT01026818|460580794|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
127987830|NCT01026818|460580795|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
127987831|NCT01026818|460580796|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
127987832|NCT01026818|460580797|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
127987833|NCT01026818|460580794|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
127987834|NCT01026818|460580795|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
127987835|NCT01026818|460580796|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
127987836|NCT01026818|460580797|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
127987837|NCT01026818|460580794|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
127987838|NCT01026818|460580795|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
127987839|NCT01026818|460580796|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
127987840|NCT01026818|460580797|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
127987841|NCT01026818|460580794|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
127987842|NCT01026818|460580795|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
127987843|NCT01026818|460580796|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
127987844|NCT01026818|460580797|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
127987845|NCT01026818|460580794|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
127987846|NCT01026818|460580795|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
127987847|NCT01026818|460580796|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
127987848|NCT01026818|460580797|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
127987849|NCT01026818|460580794|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
127987850|NCT01026818|460580795|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
127987851|NCT01026818|460580796|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
127987852|NCT01026818|460580797|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
127987853|NCT01026818|460580794|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
127987854|NCT01026818|460580795|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
127987855|NCT01026818|460580796|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
127987856|NCT01026818|460580797|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
127987857|NCT01026818|460580794|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
127987858|NCT01026818|460580795|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
127987859|NCT01026818|460580796|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
127987860|NCT01026818|460580797|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
127987861|NCT01026818|460580794|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
127987862|NCT01026818|460580795|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
127987863|NCT01026818|460580796|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
127987864|NCT01026818|460580797|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
127987865|NCT01026818|460580794|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
127987866|NCT01026818|460580795|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
127987867|NCT01026818|460580796|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
127987868|NCT01026818|460580797|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
127987869|NCT01026818|460580794|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
127987870|NCT01026818|460580795|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
127987871|NCT01026818|460580796|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
127987872|NCT01026818|460580797|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
127987873|NCT01026818|460580794|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
127987874|NCT01026818|460580795|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
127987875|NCT01026818|460580796|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
127987876|NCT01026818|460580797|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
127987877|NCT01026818|460580794|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
127987878|NCT01026818|460580795|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
127987879|NCT01026818|460580796|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
127987880|NCT01026818|460580797|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
127987881|NCT01026818|460580794|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
127987882|NCT01026818|460580795|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
127987883|NCT01026818|460580796|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
127987884|NCT01026818|460580797|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
127987885|NCT01026818|460580794|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
127987886|NCT01026818|460580795|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
127987887|NCT01026818|460580796|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
127987888|NCT01026818|460580797|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
127658492|NCT02006121|459372589|FG000|Double Blind Phase|Withdrawal by Subject|3|||
127658493|NCT02006121|459372590|FG001|Double Blind Phase|Withdrawal by Subject|4|||
127658494|NCT02006121|459372589|FG000|Double Blind Phase|Non-compliance with study drug|1|||
127658495|NCT02006121|459372590|FG001|Double Blind Phase|Non-compliance with study drug|3|||
127658496|NCT02006121|459372589|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
127987889|NCT01026818|460580794|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
127987890|NCT01026818|460580795|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
127987891|NCT01026818|460580796|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
127987892|NCT01026818|460580797|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
127987893|NCT01026818|460580794|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
127987894|NCT01026818|460580795|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
127987895|NCT01026818|460580796|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
127987896|NCT01026818|460580797|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
127987897|NCT01026818|460580794|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
127987898|NCT01026818|460580795|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
127987899|NCT01026818|460580796|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
127987900|NCT01026818|460580797|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
127987901|NCT01026818|460580794|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
127987902|NCT01026818|460580795|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
127987903|NCT01026818|460580796|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
127987904|NCT01026818|460580797|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
127987905|NCT01760447|460580798|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
127987906|NCT01760447|460580799|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
127987907|NCT01760447|460580800|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
127987908|NCT01760447|460580801|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
127987909|NCT01760447|460580798|FG000|Weeks 0-20|Withdrawal by Subject|2|||
127987910|NCT01760447|460580799|FG001|Weeks 0-20|Withdrawal by Subject|0|||
127987911|NCT01760447|460580800|FG002|Weeks 0-20|Withdrawal by Subject|1|||
127987912|NCT01760447|460580801|FG003|Weeks 0-20|Withdrawal by Subject|0|||
127987913|NCT01760447|460580798|FG000|Weeks 0-20|Lost to Follow-up|1|||
127987914|NCT01760447|460580799|FG001|Weeks 0-20|Lost to Follow-up|0|||
127987915|NCT01760447|460580800|FG002|Weeks 0-20|Lost to Follow-up|1|||
127987916|NCT01760447|460580801|FG003|Weeks 0-20|Lost to Follow-up|1|||
127987917|NCT01760447|460580798|FG000|Weeks 0-20|Randomized but not treated|0|||
127658497|NCT02006121|459372590|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
127987918|NCT01760447|460580799|FG001|Weeks 0-20|Randomized but not treated|0|||
127987919|NCT01760447|460580800|FG002|Weeks 0-20|Randomized but not treated|2|||
127987920|NCT01760447|460580801|FG003|Weeks 0-20|Randomized but not treated|0|||
127987921|NCT01760447|460580798|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
127987922|NCT01760447|460580799|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
127987923|NCT01760447|460580800|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
127987924|NCT01760447|460580801|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
127987925|NCT01760447|460580798|FG000|Weeks 20-54|Withdrawal by Subject|2|||
127658498|NCT02006121|459372589|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
127658499|NCT02006121|459372590|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
127658500|NCT02006121|459372589|FG000|Open Label Phase|Adverse Event|15|||
127658501|NCT02006121|459372590|FG001|Open Label Phase|Adverse Event|0|||
127658502|NCT02006121|459372589|FG000|Open Label Phase|Lack of Efficacy|2|||
127658503|NCT02006121|459372590|FG001|Open Label Phase|Lack of Efficacy|0|||
127658504|NCT02006121|459372589|FG000|Open Label Phase|Protocol Violation|2|||
127658505|NCT02006121|459372590|FG001|Open Label Phase|Protocol Violation|0|||
127658506|NCT02006121|459372589|FG000|Open Label Phase|Withdrawal by Subject|3|||
127658507|NCT02006121|459372590|FG001|Open Label Phase|Withdrawal by Subject|0|||
127658508|NCT02006121|459372589|FG000|Open Label Phase|Non-compliance with study drug|3|||
127658509|NCT02006121|459372590|FG001|Open Label Phase|Non-compliance with study drug|0|||
127658510|NCT02693834|459372591|FG000|Baseline Measurement|Withdrawal by Subject|1|||
127658511|NCT02693834|459372592|FG001|Baseline Measurement|Withdrawal by Subject|0|||
127658512|NCT02693834|459372591|FG000|Baseline Measurement|Adverse Event|1|||
127987926|NCT01760447|460580799|FG001|Weeks 20-54|Withdrawal by Subject|1|||
127658513|NCT02693834|459372592|FG001|Baseline Measurement|Adverse Event|0|||
127658514|NCT02693834|459372591|FG000|Week 2 Practice|Adverse Event|0|||
127658515|NCT02693834|459372592|FG001|Week 2 Practice|Adverse Event|1|||
127658516|NCT04848662|459372593|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
127987927|NCT01760447|460580800|FG002|Weeks 20-54|Withdrawal by Subject|1|||
127987928|NCT01760447|460580801|FG003|Weeks 20-54|Withdrawal by Subject|2|||
127987929|NCT01760447|460580798|FG000|Weeks 20-54|Lost to Follow-up|0|||
127987930|NCT01760447|460580799|FG001|Weeks 20-54|Lost to Follow-up|0|||
127987931|NCT01760447|460580800|FG002|Weeks 20-54|Lost to Follow-up|1|||
127987932|NCT01760447|460580801|FG003|Weeks 20-54|Lost to Follow-up|2|||
127987933|NCT03488563|460580802|FG000|Overall Study|Lost to Follow-up|7|||
127987934|NCT03488563|460580803|FG001|Overall Study|Lost to Follow-up|6|||
127987935|NCT03488563|460580804|FG002|Overall Study|Lost to Follow-up|7|||
127987936|NCT03488563|460580802|FG000|Overall Study|Withdrawal by Subject|8|||
127987937|NCT03488563|460580803|FG001|Overall Study|Withdrawal by Subject|7|||
127987938|NCT03488563|460580804|FG002|Overall Study|Withdrawal by Subject|7|||
127987939|NCT03488563|460580802|FG000|Overall Study|Physician Decision|0|||
127987940|NCT03488563|460580803|FG001|Overall Study|Physician Decision|0|||
127987941|NCT03488563|460580804|FG002|Overall Study|Physician Decision|1|||
127987942|NCT03488563|460580802|FG000|Overall Study|Protocol Violation|3|||
127987943|NCT03488563|460580803|FG001|Overall Study|Protocol Violation|2|||
127987944|NCT03488563|460580804|FG002|Overall Study|Protocol Violation|6|||
127987945|NCT03488563|460580802|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
127987946|NCT03488563|460580803|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
127987947|NCT03488563|460580804|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
127987948|NCT03488563|460580802|FG000|Overall Study|Use of prohibited medication|2|||
127987949|NCT03488563|460580803|FG001|Overall Study|Use of prohibited medication|0|||
127987950|NCT03488563|460580804|FG002|Overall Study|Use of prohibited medication|0|||
127987951|NCT03488563|460580802|FG000|Overall Study|Adverse Event|1|||
127987952|NCT03488563|460580803|FG001|Overall Study|Adverse Event|0|||
127987953|NCT03488563|460580804|FG002|Overall Study|Adverse Event|1|||
127987954|NCT03488563|460580802|FG000|Overall Study|Subject returned for ET visit|0|||
127987955|NCT03488563|460580803|FG001|Overall Study|Subject returned for ET visit|1|||
127987956|NCT03488563|460580804|FG002|Overall Study|Subject returned for ET visit|0|||
127987957|NCT03488563|460580802|FG000|Overall Study|Sponsor's decision|0|||
127987958|NCT03488563|460580803|FG001|Overall Study|Sponsor's decision|0|||
127987959|NCT03488563|460580804|FG002|Overall Study|Sponsor's decision|1|||
127987960|NCT02815267|460580805|FG000|Double-Blind Phase|Adverse Event|0|||
127987961|NCT02815267|460580806|FG001|Double-Blind Phase|Adverse Event|3|||
127987962|NCT02815267|460580805|FG000|Double-Blind Phase|Lost to Follow-up|17|||
127987963|NCT02815267|460580806|FG001|Double-Blind Phase|Lost to Follow-up|9|||
127987964|NCT02815267|460580805|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
127987965|NCT02815267|460580806|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
127987966|NCT02815267|460580805|FG000|Double-Blind Phase|Protocol Violation|3|||
127987967|NCT02815267|460580806|FG001|Double-Blind Phase|Protocol Violation|2|||
127987968|NCT02815267|460580805|FG000|Double-Blind Phase|Site withdrawal|1|||
127987969|NCT02815267|460580806|FG001|Double-Blind Phase|Site withdrawal|6|||
127987970|NCT02815267|460580805|FG000|Double-Blind Phase|Received a disallowed medication|1|||
127987971|NCT02815267|460580806|FG001|Double-Blind Phase|Received a disallowed medication|1|||
127987972|NCT02815267|460580805|FG000|Open-Label Phase|Adverse Event|1|||
127987973|NCT02815267|460580806|FG001|Open-Label Phase|Adverse Event|1|||
127987974|NCT02815267|460580805|FG000|Open-Label Phase|Lost to Follow-up|23|||
127987975|NCT02815267|460580806|FG001|Open-Label Phase|Lost to Follow-up|9|||
127987976|NCT02815267|460580805|FG000|Open-Label Phase|Withdrawal by Subject|24|||
127987977|NCT02815267|460580806|FG001|Open-Label Phase|Withdrawal by Subject|13|||
127987978|NCT02815267|460580805|FG000|Open-Label Phase|Protocol Violation|0|||
127987979|NCT02815267|460580806|FG001|Open-Label Phase|Protocol Violation|1|||
127987980|NCT02815267|460580805|FG000|Open-Label Phase|Administrative|21|||
127987981|NCT02815267|460580806|FG001|Open-Label Phase|Administrative|12|||
127987982|NCT02815267|460580805|FG000|Open-Label Phase|Other|2|||
127987983|NCT02815267|460580806|FG001|Open-Label Phase|Other|5|||
127987984|NCT03594955|460580809|FG000|Overall Study|Adverse Event|1|||
127987985|NCT03594955|460580809|FG000|Overall Study|Progressive disease|5|||
127987986|NCT03594955|460580809|FG000|Overall Study|Sponsor's decision|1|||
127987987|NCT04278924|460580812|FG000|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
127987988|NCT04278924|460580813|FG001|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
127987989|NCT04278924|460580814|FG002|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
127987990|NCT04278924|460580815|FG003|Double Blind Period (Main Study)|Withdrawal by Subject|2|||
127987991|NCT04278924|460580816|FG004|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
127987992|NCT04278924|460580817|FG005|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
127987993|NCT04278924|460580818|FG006|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
127987994|NCT04278924|460580812|FG000|Double Blind Period (Main Study)|Reason Not Specified|0|||
127987995|NCT04278924|460580813|FG001|Double Blind Period (Main Study)|Reason Not Specified|1|||
127987996|NCT04278924|460580814|FG002|Double Blind Period (Main Study)|Reason Not Specified|0|||
127987997|NCT04278924|460580815|FG003|Double Blind Period (Main Study)|Reason Not Specified|0|||
127987998|NCT04278924|460580816|FG004|Double Blind Period (Main Study)|Reason Not Specified|0|||
127987999|NCT04278924|460580817|FG005|Double Blind Period (Main Study)|Reason Not Specified|0|||
127988000|NCT04278924|460580818|FG006|Double Blind Period (Main Study)|Reason Not Specified|0|||
127988001|NCT05600036|460580819|FG000|Overall Study|Adverse Event|0|||
127988002|NCT05600036|460580820|FG001|Overall Study|Adverse Event|2|||
127988003|NCT05600036|460580821|FG002|Overall Study|Adverse Event|1|||
127988004|NCT05600036|460580822|FG003|Overall Study|Adverse Event|0|||
127988005|NCT05600036|460580823|FG004|Overall Study|Adverse Event|1|||
127988006|NCT05600036|460580824|FG005|Overall Study|Adverse Event|0|||
127988007|NCT05600036|460580819|FG000|Overall Study|Lost to Follow-up|0|||
127988008|NCT05600036|460580820|FG001|Overall Study|Lost to Follow-up|2|||
127988009|NCT05600036|460580821|FG002|Overall Study|Lost to Follow-up|1|||
127988010|NCT05600036|460580822|FG003|Overall Study|Lost to Follow-up|1|||
127988011|NCT05600036|460580823|FG004|Overall Study|Lost to Follow-up|0|||
127988012|NCT05600036|460580824|FG005|Overall Study|Lost to Follow-up|0|||
127988013|NCT05600036|460580819|FG000|Overall Study|Protocol Violation|0|||
127988014|NCT05600036|460580820|FG001|Overall Study|Protocol Violation|0|||
127988015|NCT05600036|460580821|FG002|Overall Study|Protocol Violation|2|||
127988016|NCT05600036|460580822|FG003|Overall Study|Protocol Violation|0|||
127988017|NCT05600036|460580823|FG004|Overall Study|Protocol Violation|0|||
127988018|NCT05600036|460580824|FG005|Overall Study|Protocol Violation|0|||
127988019|NCT05600036|460580819|FG000|Overall Study|Withdrawal by Subject|0|||
127988020|NCT05600036|460580820|FG001|Overall Study|Withdrawal by Subject|1|||
127988021|NCT05600036|460580821|FG002|Overall Study|Withdrawal by Subject|2|||
127988022|NCT05600036|460580822|FG003|Overall Study|Withdrawal by Subject|0|||
127988023|NCT05600036|460580823|FG004|Overall Study|Withdrawal by Subject|3|||
127988024|NCT05600036|460580824|FG005|Overall Study|Withdrawal by Subject|5|||
127988025|NCT05600036|460580819|FG000|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
127988026|NCT05600036|460580820|FG001|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
127988027|NCT05600036|460580821|FG002|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
127988028|NCT05600036|460580822|FG003|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|1|||
127988029|NCT05600036|460580823|FG004|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
127988030|NCT05600036|460580824|FG005|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
127988031|NCT05600036|460580819|FG000|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
127988032|NCT05600036|460580820|FG001|Overall Study|Subject Can't Continue With Week 16 Visit|1|||
127988033|NCT05600036|460580821|FG002|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
127988034|NCT05600036|460580822|FG003|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
127988035|NCT05600036|460580823|FG004|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
127988036|NCT05600036|460580824|FG005|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
127988037|NCT05600036|460580819|FG000|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
127988038|NCT05600036|460580820|FG001|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
127988039|NCT05600036|460580821|FG002|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
127988040|NCT05600036|460580822|FG003|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|1|||
127988041|NCT05600036|460580823|FG004|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
127988042|NCT05600036|460580824|FG005|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
127988043|NCT01006590|460580825|FG000|Overall Study|Adverse Event|2|||
127988044|NCT01006590|460580826|FG001|Overall Study|Adverse Event|3|||
127988045|NCT01006590|460580825|FG000|Overall Study|Death|1|||
127988046|NCT01006590|460580826|FG001|Overall Study|Death|1|||
127988047|NCT01006590|460580825|FG000|Overall Study|Lost to Follow-up|1|||
127988048|NCT01006590|460580826|FG001|Overall Study|Lost to Follow-up|1|||
127988049|NCT01006590|460580825|FG000|Overall Study|Protocol Violation|1|||
127988050|NCT01006590|460580826|FG001|Overall Study|Protocol Violation|0|||
127988051|NCT01006590|460580825|FG000|Overall Study|Withdrawal by Subject|4|||
127988052|NCT01006590|460580826|FG001|Overall Study|Withdrawal by Subject|2|||
127988053|NCT01006590|460580825|FG000|Overall Study|Study specific discontinuation criteria|16|||
127988054|NCT01006590|460580826|FG001|Overall Study|Study specific discontinuation criteria|23|||
127988055|NCT01006590|460580825|FG000|Overall Study|Other|3|||
127988056|NCT01006590|460580826|FG001|Overall Study|Other|2|||
127988057|NCT03332095|460580827|FG000|Overall Study|Lost to Follow-up|1|||
127988058|NCT03332095|460580828|FG001|Overall Study|Lost to Follow-up|0|||
127988059|NCT03332095|460580827|FG000|Overall Study|Pregnancy|0|||
127988060|NCT03332095|460580828|FG001|Overall Study|Pregnancy|1|||
127988061|NCT02700698|460580829|FG000|Overall Study|Withdrawal by Subject|1|||
127988062|NCT02700698|460580830|FG001|Overall Study|Withdrawal by Subject|0|||
127988063|NCT00703118|460580831|FG000|Overall Study|Adverse Event|1|||
127988064|NCT00703118|460580832|FG001|Overall Study|Adverse Event|2|||
127988065|NCT00703118|460580833|FG002|Overall Study|Adverse Event|2|||
127988066|NCT00703118|460580831|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
127988067|NCT00703118|460580832|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
127988068|NCT00703118|460580833|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
127988069|NCT00703118|460580831|FG000|Overall Study|Lost to Follow-up|6|||
127988070|NCT00703118|460580832|FG001|Overall Study|Lost to Follow-up|4|||
127988071|NCT00703118|460580833|FG002|Overall Study|Lost to Follow-up|4|||
127988072|NCT00703118|460580831|FG000|Overall Study|Withdrawal by Subject|8|||
127988073|NCT00703118|460580832|FG001|Overall Study|Withdrawal by Subject|7|||
127988074|NCT00703118|460580833|FG002|Overall Study|Withdrawal by Subject|13|||
127988075|NCT00703118|460580831|FG000|Overall Study|Other|0|||
127988076|NCT00703118|460580832|FG001|Overall Study|Other|0|||
127988077|NCT00703118|460580833|FG002|Overall Study|Other|1|||
127988078|NCT05053035|460580840|FG000|Overall Study|Withdrawal by Subject|1|||
127988079|NCT05053035|460580841|FG001|Overall Study|Withdrawal by Subject|0|||
127988080|NCT00548249|460580846|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
127988081|NCT00548249|460580847|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
127988082|NCT00548249|460580848|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
127988083|NCT00548249|460580849|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
127988084|NCT00548249|460580850|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
127988085|NCT00548249|460580846|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
127988086|NCT00548249|460580847|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
127988087|NCT00548249|460580848|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
127988088|NCT00548249|460580849|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
127988089|NCT00548249|460580850|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
127988090|NCT00548249|460580846|FG000|Overall Study|Protocol Violation|1|||
127988091|NCT00548249|460580847|FG001|Overall Study|Protocol Violation|1|||
127988092|NCT00548249|460580848|FG002|Overall Study|Protocol Violation|4|||
127988093|NCT00548249|460580849|FG003|Overall Study|Protocol Violation|0|||
127988094|NCT00548249|460580850|FG004|Overall Study|Protocol Violation|3|||
127988095|NCT00548249|460580846|FG000|Overall Study|Miscellaneous|2|||
127658517|NCT04848662|459372594|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
127658518|NCT00152971|459372595|FG000|Overall Study|Adverse Event|12|||
127658519|NCT00152971|459372596|FG001|Overall Study|Adverse Event|10|||
127658520|NCT00152971|459372597|FG002|Overall Study|Adverse Event|9|||
127658521|NCT00152971|459372595|FG000|Overall Study|Protocol Violation|10|||
127658522|NCT00152971|459372596|FG001|Overall Study|Protocol Violation|11|||
127658523|NCT00152971|459372597|FG002|Overall Study|Protocol Violation|8|||
127658524|NCT00152971|459372595|FG000|Overall Study|Lost to Follow-up|17|||
127658525|NCT00152971|459372596|FG001|Overall Study|Lost to Follow-up|14|||
127658526|NCT00152971|459372597|FG002|Overall Study|Lost to Follow-up|13|||
127658527|NCT00152971|459372595|FG000|Overall Study|Withdrawal by Subject|9|||
127658528|NCT00152971|459372596|FG001|Overall Study|Withdrawal by Subject|8|||
127658529|NCT00152971|459372597|FG002|Overall Study|Withdrawal by Subject|14|||
127658530|NCT00152971|459372595|FG000|Overall Study|Other|3|||
127658531|NCT00152971|459372596|FG001|Overall Study|Other|5|||
127658532|NCT00152971|459372597|FG002|Overall Study|Other|5|||
127658533|NCT00152971|459372595|FG000|Treatment|Adverse Event|49|||
127658534|NCT00152971|459372596|FG001|Treatment|Adverse Event|40|||
127658535|NCT00152971|459372597|FG002|Treatment|Adverse Event|54|||
127658536|NCT00152971|459372595|FG000|Treatment|Protocol Violation|8|||
127658537|NCT00152971|459372596|FG001|Treatment|Protocol Violation|6|||
127658538|NCT00152971|459372597|FG002|Treatment|Protocol Violation|10|||
127658539|NCT00152971|459372595|FG000|Treatment|Lost to Follow-up|1|||
127658540|NCT00152971|459372596|FG001|Treatment|Lost to Follow-up|2|||
127658541|NCT00152971|459372597|FG002|Treatment|Lost to Follow-up|1|||
127658542|NCT00152971|459372595|FG000|Treatment|Withdrawal by Subject|4|||
127658543|NCT00152971|459372596|FG001|Treatment|Withdrawal by Subject|4|||
127658544|NCT00152971|459372597|FG002|Treatment|Withdrawal by Subject|5|||
127658545|NCT00152971|459372595|FG000|Treatment|Other|9|||
127658546|NCT00152971|459372596|FG001|Treatment|Other|11|||
127658547|NCT00152971|459372597|FG002|Treatment|Other|10|||
127658548|NCT01396395|459372617|FG000|Overall Study|Withdrawal by Subject|10|||
127658549|NCT01396395|459372618|FG001|Overall Study|Withdrawal by Subject|12|||
127658550|NCT01396395|459372617|FG000|Overall Study|Protocol Violation|3|||
127658551|NCT01396395|459372618|FG001|Overall Study|Protocol Violation|1|||
127658552|NCT01396395|459372617|FG000|Overall Study|Adverse Event|10|||
127658553|NCT01396395|459372618|FG001|Overall Study|Adverse Event|2|||
127658554|NCT01396395|459372617|FG000|Overall Study|Lost to Follow-up|17|||
127658555|NCT01396395|459372618|FG001|Overall Study|Lost to Follow-up|11|||
127658556|NCT01396395|459372617|FG000|Overall Study|Other|0|||
127658557|NCT01396395|459372618|FG001|Overall Study|Other|1|||
127988096|NCT00548249|460580847|FG001|Overall Study|Miscellaneous|3|||
127988097|NCT00548249|460580848|FG002|Overall Study|Miscellaneous|2|||
127988098|NCT00548249|460580849|FG003|Overall Study|Miscellaneous|0|||
127658558|NCT00882921|459372620|FG000|Overall Study|Death|2|||
127658559|NCT00882921|459372620|FG000|Overall Study|Other|3|||
127658560|NCT00882921|459372620|FG000|Overall Study|Lost to Follow-up|2|||
127658561|NCT00882921|459372620|FG000|Overall Study|Termination By Investigator|3|||
127658562|NCT00882921|459372620|FG000|Overall Study|Withdrawal Of Consent|1|||
127658563|NCT05490329|459372621|FG000|2-Arm Randomized Control Trial|Lost to Follow-up|8|||
127658564|NCT05490329|459372622|FG001|2-Arm Randomized Control Trial|Lost to Follow-up|25|||
127658565|NCT05490329|459372621|FG000|2-Arm Randomized Control Trial|Withdrawal by Subject|0|||
127988099|NCT00548249|460580850|FG004|Overall Study|Miscellaneous|2|||
127988100|NCT00548249|460580846|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
127658566|NCT05490329|459372622|FG001|2-Arm Randomized Control Trial|Withdrawal by Subject|1|||
127658567|NCT05490329|459372621|FG000|Standard of Care - App Access Crossover|Lost to Follow-up|9|||
127658568|NCT05490329|459372622|FG001|Standard of Care - App Access Crossover|Lost to Follow-up|0|||
127658569|NCT02460263|459372623|FG000|Transition Period|Withdrawal by Subject|1|||
127658570|NCT02460263|459372623|FG000|Transition Period|Death|1|||
127658571|NCT03176238|459372624|FG000|Overall Study|Unacceptable AEs|15|||
127658572|NCT03176238|459372625|FG001|Overall Study|Unacceptable AEs|8|||
127988101|NCT00548249|460580847|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
127658573|NCT03176238|459372624|FG000|Overall Study|Abnormal lab value(s)|2|||
127658574|NCT03176238|459372625|FG001|Overall Study|Abnormal lab value(s)|0|||
127658575|NCT03176238|459372624|FG000|Overall Study|Inter-current illness|0|||
127658576|NCT03176238|459372625|FG001|Overall Study|Inter-current illness|1|||
127658577|NCT03176238|459372624|FG000|Overall Study|Consent withdrawal|14|||
127658578|NCT03176238|459372625|FG001|Overall Study|Consent withdrawal|2|||
127658579|NCT03176238|459372624|FG000|Overall Study|Lost to Follow-up|3|||
127658580|NCT03176238|459372625|FG001|Overall Study|Lost to Follow-up|0|||
127658581|NCT03176238|459372624|FG000|Overall Study|Administrative problems|1|||
127658582|NCT03176238|459372625|FG001|Overall Study|Administrative problems|0|||
127658583|NCT03176238|459372624|FG000|Overall Study|Death|3|||
127658584|NCT03176238|459372625|FG001|Overall Study|Death|0|||
127658585|NCT03176238|459372624|FG000|Overall Study|Disease Progression|133|||
127658586|NCT03176238|459372625|FG001|Overall Study|Disease Progression|22|||
127658587|NCT03176238|459372624|FG000|Overall Study|Tx duration completed per EAP|0|||
127658588|NCT03176238|459372625|FG001|Overall Study|Tx duration completed per EAP|1|||
127658589|NCT03176238|459372624|FG000|Overall Study|Patient is switched to commercial drug|16|||
127658590|NCT03176238|459372625|FG001|Overall Study|Patient is switched to commercial drug|1|||
127658591|NCT03176238|459372624|FG000|Overall Study|Protocol Violation|1|||
127658592|NCT03176238|459372625|FG001|Overall Study|Protocol Violation|0|||
127658593|NCT03176238|459372624|FG000|Overall Study|Changes in the patient's condition|2|||
127658594|NCT03176238|459372625|FG001|Overall Study|Changes in the patient's condition|1|||
127658595|NCT03176238|459372624|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
127658596|NCT03176238|459372625|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
127658597|NCT02301156|459372626|FG000|Overall Study|Adverse Event|13|||
127658598|NCT02301156|459372627|FG001|Overall Study|Adverse Event|14|||
127658599|NCT02301156|459372626|FG000|Overall Study|Death|1|||
127658600|NCT02301156|459372627|FG001|Overall Study|Death|5|||
127658601|NCT02301156|459372626|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
127658602|NCT02301156|459372627|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
127658603|NCT02301156|459372626|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
127658604|NCT02301156|459372627|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
127658605|NCT02301156|459372626|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
127658606|NCT02301156|459372627|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
127658607|NCT02301156|459372626|FG000|Overall Study|Reason not Specified|6|||
127658608|NCT02301156|459372627|FG001|Overall Study|Reason not Specified|3|||
127658609|NCT02090634|459372628|FG000|Overall Study|Lost to Follow-up|0|||
127988102|NCT00548249|460580848|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
127988103|NCT00548249|460580849|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
127988104|NCT00548249|460580850|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
127988105|NCT00548249|460580846|FG000|Overall Study|Adverse Event|2|||
127988106|NCT00548249|460580847|FG001|Overall Study|Adverse Event|2|||
127988107|NCT00548249|460580848|FG002|Overall Study|Adverse Event|0|||
127988108|NCT00548249|460580849|FG003|Overall Study|Adverse Event|1|||
127988109|NCT00548249|460580850|FG004|Overall Study|Adverse Event|1|||
127988110|NCT00548249|460580846|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
127988111|NCT00548249|460580847|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
127988112|NCT00548249|460580848|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
127988113|NCT00548249|460580849|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
127988114|NCT00548249|460580850|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
127988115|NCT00548249|460580846|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
127988116|NCT00548249|460580847|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
127988117|NCT00548249|460580848|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
127658610|NCT02090634|459372629|FG001|Overall Study|Lost to Follow-up|1|||
127658611|NCT02090634|459372628|FG000|Overall Study|Death|0|||
127658612|NCT02090634|459372629|FG001|Overall Study|Death|1|||
127658613|NCT02090634|459372628|FG000|Overall Study|Protocol Violation|3|||
127658614|NCT02090634|459372629|FG001|Overall Study|Protocol Violation|1|||
127658615|NCT02090634|459372628|FG000|Overall Study|Adverse Event|2|||
127658616|NCT02090634|459372629|FG001|Overall Study|Adverse Event|0|||
127658617|NCT00886639|459372630|FG000|Overall Study|acute exacerbation|14|||
127658618|NCT00886639|459372630|FG000|Overall Study|non-compliance|2|||
127658619|NCT03203694|459372631|FG000|Overall Study|Withdrawal by Subject|2|||
127658620|NCT03203694|459372632|FG001|Overall Study|Withdrawal by Subject|0|||
127988118|NCT00548249|460580849|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
127988119|NCT00548249|460580850|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
127988120|NCT00548249|460580846|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
127988121|NCT00548249|460580847|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
127988122|NCT00548249|460580848|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
127988123|NCT00548249|460580849|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
127988124|NCT00548249|460580850|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
127988125|NCT00548249|460580846|FG000|Overall Study|Prolonged hospitalization|0|||
127988126|NCT00548249|460580847|FG001|Overall Study|Prolonged hospitalization|0|||
127988127|NCT00548249|460580848|FG002|Overall Study|Prolonged hospitalization|2|||
127988128|NCT00548249|460580849|FG003|Overall Study|Prolonged hospitalization|1|||
127988129|NCT00548249|460580850|FG004|Overall Study|Prolonged hospitalization|0|||
127988130|NCT00548249|460580846|FG000|Overall Study|Withdrawal by Subject|2|||
127988131|NCT00548249|460580847|FG001|Overall Study|Withdrawal by Subject|0|||
127988132|NCT00548249|460580848|FG002|Overall Study|Withdrawal by Subject|0|||
127988133|NCT00548249|460580849|FG003|Overall Study|Withdrawal by Subject|0|||
127988134|NCT00548249|460580850|FG004|Overall Study|Withdrawal by Subject|0|||
127988135|NCT00548249|460580846|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
127988136|NCT00548249|460580847|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
127988137|NCT00548249|460580848|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
127988138|NCT00548249|460580849|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
127988139|NCT00548249|460580850|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
127988140|NCT00548249|460580846|FG000|Overall Study|Sponsor's request|0|||
127988141|NCT00548249|460580847|FG001|Overall Study|Sponsor's request|0|||
127988142|NCT00548249|460580848|FG002|Overall Study|Sponsor's request|0|||
127988143|NCT00548249|460580849|FG003|Overall Study|Sponsor's request|1|||
127988144|NCT00548249|460580850|FG004|Overall Study|Sponsor's request|0|||
127988145|NCT03003000|460580851|FG000|Overall Study|Adverse Event|1|||
127988146|NCT03003000|460580852|FG001|Overall Study|Adverse Event|2|||
127988147|NCT03003000|460580853|FG002|Overall Study|Adverse Event|3|||
127988148|NCT03003000|460580851|FG000|Overall Study|Lack of Efficacy|1|||
127988149|NCT03003000|460580852|FG001|Overall Study|Lack of Efficacy|0|||
127988150|NCT03003000|460580853|FG002|Overall Study|Lack of Efficacy|0|||
127988151|NCT03003000|460580851|FG000|Overall Study|Non-compliant with protocol|0|||
127988152|NCT03003000|460580852|FG001|Overall Study|Non-compliant with protocol|1|||
127988153|NCT03003000|460580853|FG002|Overall Study|Non-compliant with protocol|1|||
127988154|NCT03003000|460580851|FG000|Overall Study|Refused to continue medication|2|||
127988155|NCT03003000|460580852|FG001|Overall Study|Refused to continue medication|0|||
127988156|NCT03003000|460580853|FG002|Overall Study|Refused to continue medication|0|||
127988157|NCT03003000|460580851|FG000|Overall Study|Other than listed|1|||
127988158|NCT03003000|460580852|FG001|Overall Study|Other than listed|1|||
127988159|NCT03003000|460580853|FG002|Overall Study|Other than listed|1|||
127988160|NCT04933617|460580855|FG000|Dose Escalation|Early closure of study|0|||
127988161|NCT04933617|460580856|FG001|Dose Escalation|Early closure of study|3|||
127988162|NCT04933617|460580857|FG002|Dose Escalation|Early closure of study|0|||
127988163|NCT04933617|460580858|FG003|Dose Escalation|Early closure of study|0|||
127988164|NCT04933617|460580859|FG004|Dose Escalation|Early closure of study|0|||
127988165|NCT02191046|460580861|FG000|Overall Study|low compliance|5|||
127988166|NCT02191046|460580862|FG001|Overall Study|low compliance|1|||
127988167|NCT03760458|460580863|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
127988168|NCT03760458|460580864|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
127988169|NCT03760458|460580865|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
127988170|NCT03760458|460580866|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
127988171|NCT03760458|460580867|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
127988172|NCT00002525|460580881|FG000|Overall Study|Adverse Event|36|||
127988173|NCT00002525|460580882|FG001|Overall Study|Adverse Event|0|||
127988174|NCT00002525|460580881|FG000|Overall Study|Death|5|||
127988175|NCT00002525|460580882|FG001|Overall Study|Death|0|||
127988176|NCT00002525|460580881|FG000|Overall Study|Withdrawal by Subject|11|||
127988177|NCT00002525|460580882|FG001|Overall Study|Withdrawal by Subject|0|||
127988178|NCT00002525|460580881|FG000|Overall Study|Start non-protocol therapy|1|||
127988179|NCT00002525|460580882|FG001|Overall Study|Start non-protocol therapy|0|||
127988180|NCT00002525|460580881|FG000|Overall Study|Other complicating disease|1|||
127988181|NCT00002525|460580882|FG001|Overall Study|Other complicating disease|0|||
127988182|NCT00002525|460580881|FG000|Overall Study|Duke's A, B1, D disease|92|||
127988183|NCT00002525|460580882|FG001|Overall Study|Duke's A, B1, D disease|0|||
127988184|NCT00002525|460580881|FG000|Overall Study|Error|6|||
127988185|NCT00002525|460580882|FG001|Overall Study|Error|0|||
127988186|NCT00002525|460580881|FG000|Overall Study|Other|26|||
127988187|NCT00002525|460580882|FG001|Overall Study|Other|0|||
127988188|NCT00002525|460580881|FG000|Overall Study|Never start protocol therapy|8|||
127988189|NCT00002525|460580882|FG001|Overall Study|Never start protocol therapy|0|||
127988190|NCT03230838|460580884|FG000|Overall Study|Withdrawal by Subject|3|||
127988191|NCT03230838|460580885|FG001|Overall Study|Withdrawal by Subject|0|||
127988192|NCT03230838|460580884|FG000|Overall Study|Temperature excursion|1|||
127988193|NCT03230838|460580885|FG001|Overall Study|Temperature excursion|0|||
127988194|NCT01915771|460580890|FG000|Day 1|Withdrawal by Subject|1|||
127988195|NCT01915771|460580890|FG000|Day 15|Withdrawal by Subject|1|||
127988196|NCT03420222|460580891|FG000|Overall Study|Withdrawal by Subject|5|||
127988197|NCT03420222|460580892|FG001|Overall Study|Withdrawal by Subject|0|||
127988198|NCT03420222|460580891|FG000|Overall Study|Physician Decision|0|||
127988199|NCT03420222|460580892|FG001|Overall Study|Physician Decision|1|||
127988200|NCT02697734|460580893|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
127988201|NCT02697734|460580894|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
127988202|NCT02697734|460580893|FG000|Core Phase - up to Week 48|Adverse Event|1|||
127988203|NCT02697734|460580894|FG001|Core Phase - up to Week 48|Adverse Event|2|||
127988204|NCT02697734|460580893|FG000|Core Phase - up to Week 48|Physician Decision|1|||
127988205|NCT02697734|460580894|FG001|Core Phase - up to Week 48|Physician Decision|0|||
127988206|NCT02697734|460580893|FG000|Optional Extension Phase|Adverse Event|5|||
127988207|NCT02697734|460580894|FG001|Optional Extension Phase|Adverse Event|1|||
127988208|NCT02697734|460580893|FG000|Optional Extension Phase|Physician Decision|0|||
127988209|NCT02697734|460580894|FG001|Optional Extension Phase|Physician Decision|1|||
127988210|NCT02334384|460580895|FG000|Overall Study|Lost to Follow-up|1|||
127988211|NCT02334384|460580896|FG001|Overall Study|Lost to Follow-up|1|||
127988212|NCT02651688|460580897|FG000|Overall Study|Non-compliance|0|||
127988213|NCT02651688|460580898|FG001|Overall Study|Non-compliance|0|||
127988214|NCT02651688|460580899|FG002|Overall Study|Non-compliance|1|||
127988215|NCT02651688|460580897|FG000|Overall Study|Principal Investigator (PI) decision|0|||
127988216|NCT02651688|460580898|FG001|Overall Study|Principal Investigator (PI) decision|2|||
127988217|NCT02651688|460580899|FG002|Overall Study|Principal Investigator (PI) decision|0|||
127988218|NCT02651688|460580897|FG000|Overall Study|Lost to Follow-up|1|||
127988219|NCT02651688|460580898|FG001|Overall Study|Lost to Follow-up|3|||
127988220|NCT02651688|460580899|FG002|Overall Study|Lost to Follow-up|0|||
127988221|NCT02651688|460580897|FG000|Overall Study|Withdrawal by Subject|1|||
127988222|NCT02651688|460580898|FG001|Overall Study|Withdrawal by Subject|0|||
127988223|NCT02651688|460580899|FG002|Overall Study|Withdrawal by Subject|2|||
127988224|NCT00048165|460580900|FG000|Completed 6 Months Study|Administration/Other|8|||
127988225|NCT00048165|460580901|FG001|Completed 6 Months Study|Administration/Other|8|||
127988226|NCT00048165|460580900|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
127988227|NCT00048165|460580901|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
127988228|NCT00048165|460580900|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
127988229|NCT00048165|460580901|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
127988230|NCT00048165|460580900|FG000|Completed 6 Months Study|Death|12|||
127988231|NCT00048165|460580901|FG001|Completed 6 Months Study|Death|6|||
127988232|NCT00048165|460580900|FG000|Completed 6 Months Study|Insufficient therapy|1|||
127658621|NCT03203694|459372633|FG002|Overall Study|Withdrawal by Subject|0|||
127658622|NCT03203694|459372634|FG003|Overall Study|Withdrawal by Subject|0|||
127988233|NCT00048165|460580901|FG001|Completed 6 Months Study|Insufficient therapy|4|||
127988234|NCT00048165|460580900|FG000|Completed 6 Months Study|Other violation|4|||
127988235|NCT00048165|460580901|FG001|Completed 6 Months Study|Other violation|6|||
127988236|NCT00048165|460580900|FG000|Completed 6 Months Study|Refused treatment|5|||
127988237|NCT00048165|460580901|FG001|Completed 6 Months Study|Refused treatment|5|||
127988238|NCT00048165|460580900|FG000|Completed 6 Months Study|Violation criteria|0|||
127988239|NCT00048165|460580901|FG001|Completed 6 Months Study|Violation criteria|2|||
127988240|NCT00048165|460580900|FG000|Completed 6 Months Study|Did not receive study drug|6|||
127988241|NCT00048165|460580901|FG001|Completed 6 Months Study|Did not receive study drug|6|||
127988242|NCT00048165|460580900|FG000|Completed 12 Months Study|Administration/Other|0|||
127988243|NCT00048165|460580901|FG001|Completed 12 Months Study|Administration/Other|2|||
127988244|NCT00048165|460580900|FG000|Completed 12 Months Study|Death|2|||
127988245|NCT00048165|460580901|FG001|Completed 12 Months Study|Death|1|||
127988246|NCT00048165|460580900|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
127988247|NCT00048165|460580901|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
127988248|NCT01429441|460580902|FG000|Overall Study|Adverse Event|5|||
127988249|NCT01429441|460580903|FG001|Overall Study|Adverse Event|1|||
127988250|NCT01429441|460580902|FG000|Overall Study|Death|0|||
127988251|NCT01429441|460580903|FG001|Overall Study|Death|2|||
127988252|NCT01429441|460580902|FG000|Overall Study|Lost to Follow-up|5|||
127988253|NCT01429441|460580903|FG001|Overall Study|Lost to Follow-up|2|||
127988254|NCT01429441|460580902|FG000|Overall Study|Physician Decision|1|||
127988255|NCT01429441|460580903|FG001|Overall Study|Physician Decision|0|||
127988256|NCT01429441|460580902|FG000|Overall Study|Withdrawal by Subject|27|||
127988257|NCT01429441|460580903|FG001|Overall Study|Withdrawal by Subject|18|||
127988258|NCT00621517|460580909|FG000|Overall Study|Lost to Follow-up|3|||
127988259|NCT00621517|460580910|FG001|Overall Study|Lost to Follow-up|3|||
127988260|NCT00621517|460580909|FG000|Overall Study|Withdrawal by Subject|3|||
127658623|NCT03203694|459372635|FG004|Overall Study|Withdrawal by Subject|0|||
127658624|NCT03203694|459372636|FG005|Overall Study|Withdrawal by Subject|0|||
127988261|NCT00621517|460580910|FG001|Overall Study|Withdrawal by Subject|4|||
127988262|NCT00621517|460580909|FG000|Overall Study|Adverse Event|1|||
127988263|NCT00621517|460580910|FG001|Overall Study|Adverse Event|0|||
127988264|NCT02155322|460580912|FG000|Overall Study|Adverse Event|1|||
127988265|NCT02155322|460580912|FG000|Overall Study|Physician Decision|1|||
127988266|NCT02155322|460580912|FG000|Overall Study|Relapse/Recurrence|8|||
127988267|NCT02155322|460580912|FG000|Overall Study|Withdrawal by Subject|4|||
127988268|NCT00073008|460580913|FG000|Overall Study|Missing|6|||
127988269|NCT00073008|460580914|FG001|Overall Study|Missing|6|||
127988270|NCT00073008|460580913|FG000|Overall Study|Withdrawal by Subject|2|||
127988271|NCT00073008|460580914|FG001|Overall Study|Withdrawal by Subject|2|||
127988272|NCT00073008|460580913|FG000|Overall Study|Lost to Follow-up|1|||
127988273|NCT00073008|460580914|FG001|Overall Study|Lost to Follow-up|3|||
127988274|NCT00073008|460580913|FG000|Overall Study|Death|46|||
127988275|NCT00073008|460580914|FG001|Overall Study|Death|47|||
127988276|NCT00073008|460580913|FG000|Overall Study|"Other selected on Case Report Form"|7|||
127988277|NCT00073008|460580914|FG001|Overall Study|"Other selected on Case Report Form"|5|||
127988278|NCT02669667|460580915|FG000|Overall Study|Lost to Follow-up|0|||
127988279|NCT02669667|460580916|FG001|Overall Study|Lost to Follow-up|0|||
127988280|NCT02669667|460580917|FG002|Overall Study|Lost to Follow-up|0|||
127988281|NCT02669667|460580918|FG003|Overall Study|Lost to Follow-up|0|||
127988282|NCT02669667|460580919|FG004|Overall Study|Lost to Follow-up|0|||
127988283|NCT02669667|460580920|FG005|Overall Study|Lost to Follow-up|1|||
127988284|NCT02669667|460580921|FG006|Overall Study|Lost to Follow-up|0|||
127988285|NCT02839876|460580922|FG000|Overall Study|Protocol Violation|10|||
127988286|NCT02839876|460580923|FG001|Overall Study|Protocol Violation|11|||
127988287|NCT02071082|460580930|FG000|Overall Study|Enrolled and Never Treated|1|||
127988288|NCT02071082|460580931|FG001|Overall Study|Enrolled and Never Treated|1|||
127988289|NCT02071082|460580930|FG000|Overall Study|Adverse Event|0|||
127988290|NCT02071082|460580931|FG001|Overall Study|Adverse Event|1|||
127988291|NCT02071082|460580930|FG000|Overall Study|Withdrew Consent|0|||
127988292|NCT02071082|460580931|FG001|Overall Study|Withdrew Consent|4|||
127988293|NCT02071082|460580930|FG000|Overall Study|Lost to Follow-up|1|||
127988294|NCT02071082|460580931|FG001|Overall Study|Lost to Follow-up|1|||
127988295|NCT00958412|460580935|FG000|Overall Study|Study prematurely terminated|18|||
127988296|NCT02227368|460582374|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
127988297|NCT02227368|460582375|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
127988298|NCT02227368|460582374|FG000|Overall Study|Lost to Follow-up|1|||
127988299|NCT02227368|460582375|FG001|Overall Study|Lost to Follow-up|0|||
127988300|NCT02227368|460582374|FG000|Overall Study|Adverse Event|1|||
127988301|NCT02227368|460582375|FG001|Overall Study|Adverse Event|0|||
127988302|NCT02510820|460582379|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
127988303|NCT02510820|460582380|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
127988304|NCT02510820|460582379|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
127988305|NCT02510820|460582380|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
127988306|NCT03046056|460582381|FG000|Overall Study|Non-responder at Week 10|6|||
127988307|NCT03046056|460582382|FG001|Overall Study|Non-responder at Week 10|6|||
127988308|NCT03046056|460582383|FG002|Overall Study|Non-responder at Week 10|4|||
127988309|NCT03046056|460582381|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
127988310|NCT03046056|460582382|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
127988311|NCT03046056|460582383|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
127988312|NCT03046056|460582381|FG000|Overall Study|Adverse Event|1|||
127988313|NCT03046056|460582382|FG001|Overall Study|Adverse Event|5|||
127988314|NCT03046056|460582383|FG002|Overall Study|Adverse Event|0|||
127988315|NCT03046056|460582381|FG000|Overall Study|Non-compliance With Study Drug|0|||
127988316|NCT03046056|460582382|FG001|Overall Study|Non-compliance With Study Drug|0|||
127988317|NCT03046056|460582383|FG002|Overall Study|Non-compliance With Study Drug|2|||
127988318|NCT03046056|460582381|FG000|Overall Study|Protocol Violation|1|||
127988319|NCT03046056|460582382|FG001|Overall Study|Protocol Violation|1|||
127988320|NCT03046056|460582383|FG002|Overall Study|Protocol Violation|0|||
127988321|NCT03046056|460582381|FG000|Overall Study|Investigator's Discretion|0|||
127988322|NCT03046056|460582382|FG001|Overall Study|Investigator's Discretion|1|||
127988323|NCT03046056|460582383|FG002|Overall Study|Investigator's Discretion|0|||
127988324|NCT03046056|460582381|FG000|Overall Study|Withdrew Consent|1|||
127988325|NCT03046056|460582382|FG001|Overall Study|Withdrew Consent|0|||
127988326|NCT03046056|460582383|FG002|Overall Study|Withdrew Consent|0|||
127988327|NCT02913105|460582384|FG000|Overall Study|Adverse Event|11|||
127988328|NCT02913105|460582385|FG001|Overall Study|Adverse Event|0|||
127988329|NCT02913105|460582386|FG002|Overall Study|Adverse Event|4|||
127988330|NCT02913105|460582384|FG000|Overall Study|Non-Compliance With Study Drug|0|||
127988331|NCT02913105|460582385|FG001|Overall Study|Non-Compliance With Study Drug|0|||
127988332|NCT02913105|460582386|FG002|Overall Study|Non-Compliance With Study Drug|1|||
127988333|NCT02913105|460582384|FG000|Overall Study|Reason Not Specified|3|||
127988334|NCT02913105|460582385|FG001|Overall Study|Reason Not Specified|1|||
127988335|NCT02913105|460582386|FG002|Overall Study|Reason Not Specified|1|||
127988336|NCT02913105|460582384|FG000|Overall Study|Physician Decision|1|||
127988337|NCT02913105|460582385|FG001|Overall Study|Physician Decision|1|||
127988338|NCT02913105|460582386|FG002|Overall Study|Physician Decision|0|||
127988339|NCT02913105|460582384|FG000|Overall Study|Withdrawal by Subject|0|||
127988340|NCT02913105|460582385|FG001|Overall Study|Withdrawal by Subject|3|||
127988341|NCT02913105|460582386|FG002|Overall Study|Withdrawal by Subject|1|||
127988342|NCT01317004|460582387|FG000|Overall Study|Withdrawal by Subject|1|||
127988343|NCT01317004|460582388|FG001|Overall Study|Withdrawal by Subject|4|||
127988344|NCT01317004|460582387|FG000|Overall Study|Protocol Violation|0|||
127988345|NCT01317004|460582388|FG001|Overall Study|Protocol Violation|2|||
127988346|NCT01317004|460582387|FG000|Overall Study|Adverse Event|3|||
127988347|NCT01317004|460582388|FG001|Overall Study|Adverse Event|3|||
127988348|NCT01344759|460582392|FG000|Overall Study|Patients failed to reach sedation level|0|||
127988349|NCT01344759|460582393|FG001|Overall Study|Patients failed to reach sedation level|2|||
127988350|NCT01153009|460582394|FG000|Overall Study|Adverse Event|4|||
127988351|NCT01153009|460582395|FG001|Overall Study|Adverse Event|14|||
127988352|NCT01153009|460582396|FG002|Overall Study|Adverse Event|14|||
127988353|NCT01153009|460582397|FG003|Overall Study|Adverse Event|10|||
127988354|NCT01153009|460582394|FG000|Overall Study|Lack of Efficacy|9|||
127988355|NCT01153009|460582395|FG001|Overall Study|Lack of Efficacy|0|||
127988356|NCT01153009|460582396|FG002|Overall Study|Lack of Efficacy|2|||
127988357|NCT01153009|460582397|FG003|Overall Study|Lack of Efficacy|1|||
127988358|NCT01153009|460582394|FG000|Overall Study|Noncompliance with Study Medication|1|||
127988359|NCT01153009|460582395|FG001|Overall Study|Noncompliance with Study Medication|3|||
127988360|NCT01153009|460582396|FG002|Overall Study|Noncompliance with Study Medication|4|||
127988361|NCT01153009|460582397|FG003|Overall Study|Noncompliance with Study Medication|1|||
127658625|NCT01103960|459372642|FG000|Overall Study|Adverse Event|2|||
127658626|NCT01103960|459372643|FG001|Overall Study|Adverse Event|1|||
127658627|NCT01103960|459372642|FG000|Overall Study|Withdrawal by Subject|2|||
127658628|NCT01103960|459372643|FG001|Overall Study|Withdrawal by Subject|1|||
127658629|NCT01103960|459372642|FG000|Overall Study|Other|1|||
127658630|NCT01103960|459372643|FG001|Overall Study|Other|0|||
127658631|NCT02875834|459372644|FG000|Open-label Phase|Withdrawal by Subject|3|||
127658632|NCT02875834|459372645|FG001|Open-label Phase|Withdrawal by Subject|0|||
127658633|NCT02875834|459372646|FG002|Open-label Phase|Withdrawal by Subject|0|||
127658634|NCT02875834|459372647|FG003|Open-label Phase|Withdrawal by Subject|0|||
127658635|NCT02875834|459372644|FG000|Open-label Phase|(Not collected)|4|||
127658636|NCT02875834|459372645|FG001|Open-label Phase|(Not collected)|0|||
127658637|NCT02875834|459372646|FG002|Open-label Phase|(Not collected)|0|||
127658638|NCT02875834|459372647|FG003|Open-label Phase|(Not collected)|0|||
127658639|NCT02875834|459372644|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
127658640|NCT02875834|459372645|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
127658641|NCT02875834|459372646|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
127658642|NCT02875834|459372647|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
127658643|NCT02875834|459372644|FG000|Randomized Treatment Phase|Protocol Violation|0|||
127658644|NCT02875834|459372645|FG001|Randomized Treatment Phase|Protocol Violation|2|||
127988362|NCT01153009|460582394|FG000|Overall Study|Protocol Deviations|4|||
127988363|NCT01153009|460582395|FG001|Overall Study|Protocol Deviations|3|||
127988364|NCT01153009|460582396|FG002|Overall Study|Protocol Deviations|3|||
127988365|NCT01153009|460582397|FG003|Overall Study|Protocol Deviations|2|||
127988366|NCT01153009|460582394|FG000|Overall Study|Withdrawal of Consent|5|||
127988367|NCT01153009|460582395|FG001|Overall Study|Withdrawal of Consent|5|||
127988368|NCT01153009|460582396|FG002|Overall Study|Withdrawal of Consent|4|||
127988369|NCT01153009|460582397|FG003|Overall Study|Withdrawal of Consent|6|||
127988370|NCT01153009|460582394|FG000|Overall Study|Lost to Follow-up|8|||
127988371|NCT01153009|460582395|FG001|Overall Study|Lost to Follow-up|8|||
127988372|NCT01153009|460582396|FG002|Overall Study|Lost to Follow-up|11|||
127988373|NCT01153009|460582397|FG003|Overall Study|Lost to Follow-up|15|||
127988374|NCT01153009|460582394|FG000|Overall Study|Other|1|||
127988375|NCT01153009|460582395|FG001|Overall Study|Other|1|||
127988376|NCT01153009|460582396|FG002|Overall Study|Other|3|||
127988377|NCT01153009|460582397|FG003|Overall Study|Other|2|||
127988378|NCT04003623|460582399|FG000|Overall Study|Withdrawal by Subject|1|||
127988379|NCT04003623|460582400|FG001|Overall Study|Withdrawal by Subject|0|||
127988380|NCT00703326|460582402|FG000|Overall Study|Lost to Follow-up|47|||
127988381|NCT00703326|460582403|FG001|Overall Study|Lost to Follow-up|18|||
127988382|NCT00703326|460582402|FG000|Overall Study|Withdrawal by Subject|54|||
127988383|NCT00703326|460582403|FG001|Overall Study|Withdrawal by Subject|20|||
127658645|NCT02875834|459372646|FG002|Randomized Treatment Phase|Protocol Violation|0|||
127988384|NCT00703326|460582402|FG000|Overall Study|Adverse Event|1|||
127988385|NCT00703326|460582403|FG001|Overall Study|Adverse Event|0|||
127988386|NCT01744483|460582407|FG000|Overall Study|Death|9|||
127988387|NCT01744483|460582408|FG001|Overall Study|Death|4|||
127658646|NCT02875834|459372647|FG003|Randomized Treatment Phase|Protocol Violation|0|||
127658647|NCT02875834|459372644|FG000|Randomized Treatment Phase|(Not collected)|0|||
127658648|NCT02875834|459372645|FG001|Randomized Treatment Phase|(Not collected)|9|||
127658649|NCT02875834|459372646|FG002|Randomized Treatment Phase|(Not collected)|10|||
127988388|NCT01744483|460582409|FG002|Overall Study|Death|11|||
127988389|NCT01744483|460582407|FG000|Overall Study|Lost to Follow-up|8|||
127988390|NCT01744483|460582408|FG001|Overall Study|Lost to Follow-up|9|||
127988391|NCT01744483|460582409|FG002|Overall Study|Lost to Follow-up|11|||
127988392|NCT01744483|460582407|FG000|Overall Study|Protocol Violation|1|||
127988393|NCT01744483|460582408|FG001|Overall Study|Protocol Violation|2|||
127988394|NCT01744483|460582409|FG002|Overall Study|Protocol Violation|1|||
127988395|NCT01744483|460582407|FG000|Overall Study|Withdrawal by Subject|4|||
127658650|NCT02875834|459372647|FG003|Randomized Treatment Phase|(Not collected)|9|||
127658651|NCT01032044|459372650|FG000|Overall Study|Protocol Violation|14|||
127658652|NCT01032044|459372651|FG001|Overall Study|Protocol Violation|8|||
127658653|NCT01032044|459372650|FG000|Overall Study|Adverse Event|0|||
127658654|NCT01032044|459372651|FG001|Overall Study|Adverse Event|1|||
127658655|NCT01032044|459372650|FG000|Overall Study|Lost to Follow-up|11|||
127658656|NCT01032044|459372651|FG001|Overall Study|Lost to Follow-up|11|||
127658657|NCT03311230|459372652|FG000|Overall Study|Withdrawal by Subject|1|||
127658658|NCT03311230|459372653|FG001|Overall Study|Withdrawal by Subject|4|||
127658659|NCT03311230|459372654|FG002|Overall Study|Withdrawal by Subject|2|||
127658660|NCT03311230|459372655|FG003|Overall Study|Withdrawal by Subject|7|||
127658661|NCT03311230|459372652|FG000|Overall Study|Unrelated injury|0|||
127658662|NCT03311230|459372653|FG001|Overall Study|Unrelated injury|1|||
127658663|NCT03311230|459372654|FG002|Overall Study|Unrelated injury|0|||
127658664|NCT03311230|459372655|FG003|Overall Study|Unrelated injury|0|||
127658665|NCT03342053|459372656|FG000|Overall Study|Adverse Event|2|||
127658666|NCT03342053|459372657|FG001|Overall Study|Adverse Event|0|||
127658667|NCT03342053|459372656|FG000|Overall Study|Withdrawal by Subject|0|||
127658668|NCT03342053|459372657|FG001|Overall Study|Withdrawal by Subject|1|||
127658669|NCT01302938|459372658|FG000|Overall Study|Withdrawal by Subject|1|||
127658670|NCT01302938|459372659|FG001|Overall Study|Withdrawal by Subject|0|||
127658671|NCT01302938|459372658|FG000|Overall Study|Adverse Event|1|||
127658672|NCT01302938|459372659|FG001|Overall Study|Adverse Event|0|||
127658673|NCT01233609|459372660|FG000|Overall Study|Death|1|||
127658674|NCT01233609|459372661|FG001|Overall Study|Death|0|||
127658675|NCT01233609|459372660|FG000|Overall Study|Lost to Follow-up|3|||
127658676|NCT01233609|459372661|FG001|Overall Study|Lost to Follow-up|1|||
127658677|NCT01233609|459372660|FG000|Overall Study|Adverse Event|2|||
127658678|NCT01233609|459372661|FG001|Overall Study|Adverse Event|1|||
127658679|NCT01233609|459372660|FG000|Overall Study|Withdrawal by Subject|3|||
127658680|NCT01233609|459372661|FG001|Overall Study|Withdrawal by Subject|0|||
127658681|NCT02961374|459372662|FG000|Overall Study|Adverse Event|4|||
127658682|NCT00735644|459372663|FG000|Overall Study|Did not receive study vaccine|0|||
127658683|NCT00735644|459372664|FG001|Overall Study|Did not receive study vaccine|1|||
127658684|NCT00735644|459372665|FG002|Overall Study|Did not receive study vaccine|0|||
127658685|NCT00735644|459372666|FG003|Overall Study|Did not receive study vaccine|0|||
127658686|NCT00735644|459372667|FG004|Overall Study|Did not receive study vaccine|0|||
127658687|NCT00735644|459372663|FG000|Overall Study|Withdrawal by Subject|0|||
127658688|NCT00735644|459372664|FG001|Overall Study|Withdrawal by Subject|1|||
127658689|NCT00735644|459372665|FG002|Overall Study|Withdrawal by Subject|1|||
127658690|NCT00735644|459372666|FG003|Overall Study|Withdrawal by Subject|1|||
127658691|NCT00735644|459372667|FG004|Overall Study|Withdrawal by Subject|0|||
127658692|NCT01518946|459372676|FG000|Open-label Phase|Other|4|||
127658693|NCT01518946|459372677|FG001|Open-label Phase|Other|0|||
127658694|NCT01518946|459372678|FG002|Open-label Phase|Other|0|||
127658695|NCT01518946|459372676|FG000|Randomized Phase (First Intervention)|Other|0|||
127658696|NCT01518946|459372677|FG001|Randomized Phase (First Intervention)|Other|1|||
127658697|NCT01518946|459372678|FG002|Randomized Phase (First Intervention)|Other|0|||
127658698|NCT00384059|459372679|FG000|Infant Series|Not consented|2|||
127658699|NCT00384059|459372680|FG001|Infant Series|Not consented|6|||
127658700|NCT00384059|459372679|FG000|Infant Series|Withdrawal by Subject|2|||
127658701|NCT00384059|459372680|FG001|Infant Series|Withdrawal by Subject|2|||
127658702|NCT00384059|459372679|FG000|Infant Series|Adverse Event|1|||
127658703|NCT00384059|459372680|FG001|Infant Series|Adverse Event|2|||
127658704|NCT00384059|459372679|FG000|Infant Series|Protocol Violation|1|||
127658705|NCT00384059|459372680|FG001|Infant Series|Protocol Violation|2|||
127658706|NCT00384059|459372679|FG000|Infant Series|Lost to Follow-up|0|||
127658707|NCT00384059|459372680|FG001|Infant Series|Lost to Follow-up|1|||
127658708|NCT00384059|459372679|FG000|After Infant Series|Protocol Violation|2|||
127988396|NCT01744483|460582408|FG001|Overall Study|Withdrawal by Subject|6|||
127988397|NCT01744483|460582409|FG002|Overall Study|Withdrawal by Subject|2|||
127988398|NCT01744483|460582407|FG000|Overall Study|No ICU Admit|5|||
127988399|NCT01744483|460582408|FG001|Overall Study|No ICU Admit|1|||
127988400|NCT01744483|460582409|FG002|Overall Study|No ICU Admit|2|||
127658709|NCT00384059|459372680|FG001|After Infant Series|Protocol Violation|3|||
127658710|NCT00384059|459372679|FG000|After Infant Series|Withdrawal by Subject|2|||
127658711|NCT00384059|459372680|FG001|After Infant Series|Withdrawal by Subject|2|||
127658712|NCT00384059|459372679|FG000|After Infant Series|Failed to Return|0|||
127658713|NCT00384059|459372680|FG001|After Infant Series|Failed to Return|2|||
127988401|NCT01744483|460582407|FG000|Overall Study|Routed to OSH|2|||
127988402|NCT01744483|460582408|FG001|Overall Study|Routed to OSH|0|||
127988403|NCT01744483|460582409|FG002|Overall Study|Routed to OSH|1|||
127658714|NCT00384059|459372679|FG000|After Infant Series|Adverse Event|0|||
127988404|NCT03214679|460582411|FG000|Overall Study|Lost to Follow-up|12|||
127658715|NCT00384059|459372680|FG001|After Infant Series|Adverse Event|1|||
127658716|NCT00384059|459372679|FG000|After Infant Series|Physician Decision|0|||
127658717|NCT00384059|459372680|FG001|After Infant Series|Physician Decision|1|||
127988405|NCT03214679|460582412|FG001|Overall Study|Lost to Follow-up|14|||
127988406|NCT03214679|460582411|FG000|Overall Study|not eligible|2|||
127988407|NCT03214679|460582412|FG001|Overall Study|not eligible|0|||
127988408|NCT01754766|460582425|FG000|Overall Study|Personal reasons|1|||
127988409|NCT01754766|460582426|FG001|Overall Study|Personal reasons|1|||
127658718|NCT00384059|459372679|FG000|After Infant Series|Lost to Follow-up|0|||
127658719|NCT00384059|459372680|FG001|After Infant Series|Lost to Follow-up|1|||
127658720|NCT00384059|459372679|FG000|Toddler Dose|Lost to Follow-up|1|||
127658721|NCT00384059|459372680|FG001|Toddler Dose|Lost to Follow-up|1|||
127658722|NCT00384059|459372679|FG000|Toddler Dose|Failed to return|0|||
127658723|NCT00384059|459372680|FG001|Toddler Dose|Failed to return|1|||
127658724|NCT00235443|459374603|FG000|Overall Study|Adverse Event|4|||
127658725|NCT00235443|459374604|FG001|Overall Study|Adverse Event|12|||
127658726|NCT00235443|459374605|FG002|Overall Study|Adverse Event|17|||
127658727|NCT00235443|459374606|FG003|Overall Study|Adverse Event|44|||
127658728|NCT00235443|459374607|FG004|Overall Study|Adverse Event|10|||
127658729|NCT00235443|459374608|FG005|Overall Study|Adverse Event|15|||
127658730|NCT00235443|459374603|FG000|Overall Study|Lack of Efficacy|0|||
127658731|NCT00235443|459374604|FG001|Overall Study|Lack of Efficacy|1|||
127658732|NCT00235443|459374605|FG002|Overall Study|Lack of Efficacy|5|||
127658733|NCT00235443|459374606|FG003|Overall Study|Lack of Efficacy|12|||
127658734|NCT00235443|459374607|FG004|Overall Study|Lack of Efficacy|2|||
127658735|NCT00235443|459374608|FG005|Overall Study|Lack of Efficacy|9|||
127658736|NCT00235443|459374603|FG000|Overall Study|Withdrawal by Subject|3|||
127658737|NCT00235443|459374604|FG001|Overall Study|Withdrawal by Subject|9|||
127658738|NCT00235443|459374605|FG002|Overall Study|Withdrawal by Subject|25|||
127658739|NCT00235443|459374606|FG003|Overall Study|Withdrawal by Subject|24|||
127658740|NCT00235443|459374607|FG004|Overall Study|Withdrawal by Subject|10|||
127658741|NCT00235443|459374608|FG005|Overall Study|Withdrawal by Subject|12|||
127658742|NCT00235443|459374603|FG000|Overall Study|Lost to Follow-up|0|||
127658743|NCT00235443|459374604|FG001|Overall Study|Lost to Follow-up|8|||
127658744|NCT00235443|459374605|FG002|Overall Study|Lost to Follow-up|6|||
127658745|NCT00235443|459374606|FG003|Overall Study|Lost to Follow-up|6|||
127658746|NCT00235443|459374607|FG004|Overall Study|Lost to Follow-up|4|||
127658747|NCT00235443|459374608|FG005|Overall Study|Lost to Follow-up|3|||
127658748|NCT00235443|459374603|FG000|Overall Study|Unsatisfactory compliance|0|||
127658749|NCT00235443|459374604|FG001|Overall Study|Unsatisfactory compliance|2|||
127658750|NCT00235443|459374605|FG002|Overall Study|Unsatisfactory compliance|3|||
127658751|NCT00235443|459374606|FG003|Overall Study|Unsatisfactory compliance|4|||
127658752|NCT00235443|459374607|FG004|Overall Study|Unsatisfactory compliance|1|||
127658753|NCT00235443|459374608|FG005|Overall Study|Unsatisfactory compliance|0|||
127658754|NCT00235443|459374603|FG000|Overall Study|Other reasons for premature termination|1|||
127658755|NCT00235443|459374604|FG001|Overall Study|Other reasons for premature termination|6|||
127658756|NCT00235443|459374605|FG002|Overall Study|Other reasons for premature termination|6|||
127658757|NCT00235443|459374606|FG003|Overall Study|Other reasons for premature termination|7|||
127988410|NCT01754766|460582427|FG002|Overall Study|Personal reasons|0|||
127988411|NCT01709409|460582430|FG000|Overall Study|Protocol Violation|1|||
127658758|NCT00235443|459374607|FG004|Overall Study|Other reasons for premature termination|3|||
127658759|NCT00235443|459374608|FG005|Overall Study|Other reasons for premature termination|6|||
127658760|NCT03029247|459374609|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
127658761|NCT03029247|459374610|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
127658762|NCT03029247|459374609|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
127658763|NCT03029247|459374610|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
127658764|NCT03029247|459374609|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
127658765|NCT03029247|459374610|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
127988412|NCT01709409|460582431|FG001|Overall Study|Protocol Violation|0|||
127988413|NCT02412878|460582432|FG000|Overall Study|Withdrawal by Subject|19|||
127988414|NCT02412878|460582433|FG001|Overall Study|Withdrawal by Subject|10|||
127988415|NCT02412878|460582432|FG000|Overall Study|Lost to Follow-up|2|||
127988416|NCT02412878|460582433|FG001|Overall Study|Lost to Follow-up|3|||
127988417|NCT02190721|460582434|FG000|Overall Study|Patient was out of the city|0|||
127658766|NCT03029247|459374609|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
127988418|NCT02190721|460582435|FG001|Overall Study|Patient was out of the city|1|||
127988419|NCT02190721|460582436|FG002|Overall Study|Patient was out of the city|0|||
127988420|NCT04571385|460582437|FG000|Overall Study|Participant non-compliance|1|||
127988421|NCT04571385|460582438|FG001|Overall Study|Participant non-compliance|0|||
127543132|NCT00626106|458954756|FG001|Overall Study|Withdrawal by Subject|1|||
127658767|NCT03029247|459374610|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
127658768|NCT01976364|459374613|FG000|Main Study (36 Months)|Adverse Event|63|||
127658769|NCT01976364|459374614|FG001|Main Study (36 Months)|Adverse Event|0|||
127658770|NCT01976364|459374615|FG002|Main Study (36 Months)|Adverse Event|0|||
127658771|NCT01976364|459374613|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
127658772|NCT01976364|459374614|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
127543133|NCT00626106|458954755|FG000|Overall Study|Lost to Follow-up|1|||
127988422|NCT04571385|460582439|FG002|Overall Study|Participant non-compliance|0|||
127988423|NCT04571385|460582437|FG000|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
127988424|NCT04571385|460582438|FG001|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|1|||
127988425|NCT04571385|460582439|FG002|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
127988426|NCT04571385|460582437|FG000|Overall Study|Screen failure|0|||
127988427|NCT04571385|460582438|FG001|Overall Study|Screen failure|0|||
127988428|NCT04571385|460582439|FG002|Overall Study|Screen failure|1|||
127988429|NCT02263729|460582441|FG000|Overall Study|Lost to Follow-up|1|||
127988430|NCT02263729|460582442|FG001|Overall Study|Lost to Follow-up|1|||
127988431|NCT01212159|460582443|FG000|Overall Study|Withdrawal by Subject|12|||
127988432|NCT01212159|460582444|FG001|Overall Study|Withdrawal by Subject|12|||
127988433|NCT05025332|460582445|FG000|Screening|Screen failure|12|||
127988434|NCT05025332|460582445|FG000|Treatment & Follow Up|Protocol Violation|1|||
127988435|NCT05025332|460582445|FG000|Treatment & Follow Up|Adverse Event|4|||
127988436|NCT01306214|460582446|FG000|Overall Study|Death|0|||
127988437|NCT01306214|460582447|FG001|Overall Study|Death|0|||
127988438|NCT01306214|460582448|FG002|Overall Study|Death|1|||
127988439|NCT01306214|460582446|FG000|Overall Study|Lost to Follow-up|3|||
127988440|NCT01306214|460582447|FG001|Overall Study|Lost to Follow-up|5|||
127988441|NCT01306214|460582448|FG002|Overall Study|Lost to Follow-up|4|||
127988442|NCT01306214|460582446|FG000|Overall Study|Withdrawal by Subject|24|||
127988443|NCT01306214|460582447|FG001|Overall Study|Withdrawal by Subject|22|||
127988444|NCT01306214|460582448|FG002|Overall Study|Withdrawal by Subject|16|||
127988445|NCT01306214|460582446|FG000|Overall Study|Not treated|1|||
127988446|NCT01306214|460582447|FG001|Overall Study|Not treated|1|||
127658773|NCT01976364|459374615|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
127658774|NCT01976364|459374613|FG000|Main Study (36 Months)|Other|13|||
127658775|NCT01976364|459374614|FG001|Main Study (36 Months)|Other|0|||
127658776|NCT01976364|459374615|FG002|Main Study (36 Months)|Other|0|||
127658777|NCT01976364|459374613|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
127658778|NCT01976364|459374614|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
127658779|NCT01976364|459374615|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
127658780|NCT01976364|459374613|FG000|Main Study (36 Months)|Medication error|1|||
127658781|NCT01976364|459374614|FG001|Main Study (36 Months)|Medication error|0|||
127658782|NCT01976364|459374615|FG002|Main Study (36 Months)|Medication error|0|||
127658783|NCT01976364|459374613|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
127658784|NCT01976364|459374614|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
127658785|NCT01976364|459374615|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
127658786|NCT01976364|459374613|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
127658787|NCT01976364|459374614|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
127658788|NCT01976364|459374615|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
127658789|NCT01976364|459374613|FG000|Main Study (36 Months)|Protocol Violation|13|||
127658790|NCT01976364|459374614|FG001|Main Study (36 Months)|Protocol Violation|0|||
127658791|NCT01976364|459374615|FG002|Main Study (36 Months)|Protocol Violation|0|||
127658792|NCT01976364|459374613|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
127658793|NCT01976364|459374614|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
127658794|NCT01976364|459374615|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
127658795|NCT01976364|459374613|FG000|Main Study (36 Months)|Death|5|||
127658796|NCT01976364|459374614|FG001|Main Study (36 Months)|Death|0|||
127658797|NCT01976364|459374615|FG002|Main Study (36 Months)|Death|0|||
127658798|NCT01976364|459374613|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
127658799|NCT01976364|459374614|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
127658800|NCT01976364|459374615|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
127658801|NCT01976364|459374613|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
127658802|NCT01976364|459374614|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
127658803|NCT01976364|459374615|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
127658804|NCT01976364|459374613|FG000|Sub-study (12 Months)|Protocol Violation|0|||
127658805|NCT01976364|459374614|FG001|Sub-study (12 Months)|Protocol Violation|1|||
127658806|NCT01976364|459374615|FG002|Sub-study (12 Months)|Protocol Violation|1|||
127658807|NCT01976364|459374613|FG000|Sub-study (12 Months)|Adverse Event|0|||
127658808|NCT01976364|459374614|FG001|Sub-study (12 Months)|Adverse Event|4|||
127658809|NCT01976364|459374615|FG002|Sub-study (12 Months)|Adverse Event|3|||
127658810|NCT02757521|459374616|FG000|Overall Study|Adverse Event|1|||
127658811|NCT02757521|459374617|FG001|Overall Study|Adverse Event|0|||
127658812|NCT00003511|459374618|FG000|Overall Study|Not evaluable|4|||
127658813|NCT02318719|459374626|FG000|Double-blind Phase|Adverse Event|7|||
127988447|NCT01306214|460582448|FG002|Overall Study|Not treated|1|||
127988448|NCT01928199|460582449|FG000|Overall Study|Lost to Follow-up|2|||
127658814|NCT02318719|459374627|FG001|Double-blind Phase|Adverse Event|6|||
127988449|NCT01928199|460582450|FG001|Overall Study|Lost to Follow-up|1|||
127543134|NCT00626106|458954756|FG001|Overall Study|Lost to Follow-up|4|||
127543135|NCT00626106|458954755|FG000|Overall Study|Death|64|||
127658815|NCT02318719|459374628|FG002|Double-blind Phase|Adverse Event|12|||
127658816|NCT02318719|459374629|FG003|Double-blind Phase|Adverse Event|4|||
127658817|NCT02318719|459374630|FG004|Double-blind Phase|Adverse Event|0|||
127658818|NCT02318719|459374626|FG000|Double-blind Phase|Lack of Efficacy|5|||
127658819|NCT02318719|459374627|FG001|Double-blind Phase|Lack of Efficacy|0|||
127658820|NCT02318719|459374628|FG002|Double-blind Phase|Lack of Efficacy|1|||
127658821|NCT02318719|459374629|FG003|Double-blind Phase|Lack of Efficacy|1|||
127988450|NCT01928199|460582449|FG000|Overall Study|Withdrawal by Subject|3|||
127988451|NCT01928199|460582450|FG001|Overall Study|Withdrawal by Subject|5|||
127988452|NCT04575584|460582451|FG000|Overall Study|Death|6|||
127988453|NCT04575584|460582452|FG001|Overall Study|Death|4|||
127988454|NCT04575584|460582453|FG002|Overall Study|Death|6|||
127988455|NCT04575584|460582454|FG003|Overall Study|Death|2|||
127988456|NCT04575584|460582455|FG004|Overall Study|Death|0|||
127988457|NCT04575584|460582456|FG005|Overall Study|Death|0|||
127988458|NCT04575584|460582451|FG000|Overall Study|Lost to Follow-up|1|||
127988459|NCT04575584|460582452|FG001|Overall Study|Lost to Follow-up|1|||
127988460|NCT04575584|460582453|FG002|Overall Study|Lost to Follow-up|1|||
127988461|NCT04575584|460582454|FG003|Overall Study|Lost to Follow-up|1|||
127988462|NCT04575584|460582455|FG004|Overall Study|Lost to Follow-up|0|||
127988463|NCT04575584|460582456|FG005|Overall Study|Lost to Follow-up|0|||
127988464|NCT04575584|460582451|FG000|Overall Study|Physician Decision|0|||
127988465|NCT04575584|460582452|FG001|Overall Study|Physician Decision|1|||
127988466|NCT04575584|460582453|FG002|Overall Study|Physician Decision|1|||
127988467|NCT04575584|460582454|FG003|Overall Study|Physician Decision|1|||
127988468|NCT04575584|460582455|FG004|Overall Study|Physician Decision|0|||
127988469|NCT04575584|460582456|FG005|Overall Study|Physician Decision|0|||
127988470|NCT04575584|460582451|FG000|Overall Study|Withdrawal by Subject|7|||
127988471|NCT04575584|460582452|FG001|Overall Study|Withdrawal by Subject|9|||
127658822|NCT02318719|459374630|FG004|Double-blind Phase|Lack of Efficacy|0|||
127658823|NCT02318719|459374626|FG000|Double-blind Phase|Protocol Violation|0|||
127658824|NCT02318719|459374627|FG001|Double-blind Phase|Protocol Violation|1|||
127658825|NCT02318719|459374628|FG002|Double-blind Phase|Protocol Violation|3|||
127658826|NCT02318719|459374629|FG003|Double-blind Phase|Protocol Violation|0|||
127658827|NCT02318719|459374630|FG004|Double-blind Phase|Protocol Violation|0|||
127658828|NCT02318719|459374626|FG000|Double-blind Phase|Withdrawal by Subject|25|||
127658829|NCT02318719|459374627|FG001|Double-blind Phase|Withdrawal by Subject|7|||
127658830|NCT02318719|459374628|FG002|Double-blind Phase|Withdrawal by Subject|9|||
127658831|NCT02318719|459374629|FG003|Double-blind Phase|Withdrawal by Subject|10|||
127658832|NCT02318719|459374630|FG004|Double-blind Phase|Withdrawal by Subject|0|||
127658833|NCT02318719|459374626|FG000|Double-blind Phase|Other|1|||
127658834|NCT02318719|459374627|FG001|Double-blind Phase|Other|2|||
127658835|NCT02318719|459374628|FG002|Double-blind Phase|Other|0|||
127658836|NCT02318719|459374629|FG003|Double-blind Phase|Other|0|||
127658837|NCT02318719|459374630|FG004|Double-blind Phase|Other|0|||
127658838|NCT02318719|459374626|FG000|Open-label Extension Phase|Adverse Event|0|||
127658839|NCT02318719|459374627|FG001|Open-label Extension Phase|Adverse Event|0|||
127658840|NCT02318719|459374628|FG002|Open-label Extension Phase|Adverse Event|0|||
127658841|NCT02318719|459374629|FG003|Open-label Extension Phase|Adverse Event|0|||
127658842|NCT02318719|459374630|FG004|Open-label Extension Phase|Adverse Event|15|||
127658843|NCT02318719|459374626|FG000|Open-label Extension Phase|Death|0|||
127658844|NCT02318719|459374627|FG001|Open-label Extension Phase|Death|0|||
127658845|NCT02318719|459374628|FG002|Open-label Extension Phase|Death|0|||
127658846|NCT02318719|459374629|FG003|Open-label Extension Phase|Death|0|||
127658847|NCT02318719|459374630|FG004|Open-label Extension Phase|Death|1|||
127658848|NCT02318719|459374626|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
127658849|NCT02318719|459374627|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
127658850|NCT02318719|459374628|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
127658851|NCT02318719|459374629|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
127658852|NCT02318719|459374630|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
127658853|NCT02318719|459374626|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
127658854|NCT02318719|459374627|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
127658855|NCT02318719|459374628|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
127658856|NCT02318719|459374629|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
127658857|NCT02318719|459374630|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
127658858|NCT02318719|459374626|FG000|Open-label Extension Phase|Other|0|||
127658859|NCT02318719|459374627|FG001|Open-label Extension Phase|Other|0|||
127658860|NCT02318719|459374628|FG002|Open-label Extension Phase|Other|0|||
127658861|NCT02318719|459374629|FG003|Open-label Extension Phase|Other|0|||
127658862|NCT02318719|459374630|FG004|Open-label Extension Phase|Other|7|||
127988472|NCT04575584|460582453|FG002|Overall Study|Withdrawal by Subject|5|||
127988473|NCT04575584|460582454|FG003|Overall Study|Withdrawal by Subject|3|||
127658863|NCT01868035|459374631|FG000|Overall Study|Lost to Follow-up|3|||
127658864|NCT01868035|459374631|FG000|Overall Study|Withdrawal by Subject|1|||
127658865|NCT01868035|459374631|FG000|Overall Study|Progressive Disease|2|||
127658866|NCT01868035|459374631|FG000|Overall Study|Non-compliance|1|||
127658867|NCT00432835|459374632|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
127658868|NCT00432835|459374633|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
127658869|NCT00802659|459374634|FG000|Overall Study|Physician Decision|0|||
127988474|NCT04575584|460582455|FG004|Overall Study|Withdrawal by Subject|0|||
127988475|NCT04575584|460582456|FG005|Overall Study|Withdrawal by Subject|0|||
127988476|NCT04575584|460582451|FG000|Overall Study|Not recorded|0|||
127988477|NCT04575584|460582452|FG001|Overall Study|Not recorded|0|||
127988478|NCT04575584|460582453|FG002|Overall Study|Not recorded|0|||
127988479|NCT04575584|460582454|FG003|Overall Study|Not recorded|1|||
127658870|NCT00802659|459374635|FG001|Overall Study|Physician Decision|1|||
127658871|NCT00802659|459374636|FG002|Overall Study|Physician Decision|0|||
127658872|NCT00802659|459374637|FG003|Overall Study|Physician Decision|0|||
127658873|NCT00423293|459374638|FG000|Overall Study|Ineligible / No protocol treatment|11|||
127658874|NCT01912222|459374641|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
127658875|NCT01912222|459374642|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
127658876|NCT01912222|459374643|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
127658877|NCT01912222|459374641|FG000|Part B: Treatment Period|Progressive disease|10|||
127658878|NCT01912222|459374642|FG001|Part B: Treatment Period|Progressive disease|12|||
127658879|NCT01912222|459374643|FG002|Part B: Treatment Period|Progressive disease|15|||
127658880|NCT01912222|459374641|FG000|Part B: Treatment Period|Adverse Event|1|||
127658881|NCT01912222|459374642|FG001|Part B: Treatment Period|Adverse Event|2|||
127658882|NCT01912222|459374643|FG002|Part B: Treatment Period|Adverse Event|3|||
127658883|NCT01912222|459374641|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
127658884|NCT01912222|459374642|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
127658885|NCT01912222|459374643|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
127658886|NCT05340751|459374644|FG000|Overall Study|Physician Decision|3|||
127658887|NCT04399551|459374645|FG000|Overall Study|Adverse Event|15|||
127658888|NCT04399551|459374645|FG000|Overall Study|Withdrawal by Subject|6|||
127658889|NCT04399551|459374645|FG000|Overall Study|Physician Decision|3|||
127658890|NCT04399551|459374645|FG000|Overall Study|Lost to Follow-up|2|||
127658891|NCT04399551|459374645|FG000|Overall Study|Protocol Deviation|2|||
127658892|NCT01014975|459374646|FG000|Overall Study|Withdrawal by Subject|1|||
127658893|NCT01014975|459374647|FG001|Overall Study|Withdrawal by Subject|0|||
127658894|NCT01014975|459374648|FG002|Overall Study|Withdrawal by Subject|1|||
127658895|NCT01014975|459374646|FG000|Overall Study|Death|3|||
127658896|NCT01014975|459374647|FG001|Overall Study|Death|3|||
127658897|NCT01014975|459374648|FG002|Overall Study|Death|4|||
127658898|NCT01014975|459374646|FG000|Overall Study|Lost to Follow-up|0|||
127658899|NCT01014975|459374647|FG001|Overall Study|Lost to Follow-up|0|||
127658900|NCT01014975|459374648|FG002|Overall Study|Lost to Follow-up|1|||
127658901|NCT02961881|459374651|FG000|Overall Study|Adverse Event|1|||
127658902|NCT02961881|459374652|FG001|Overall Study|Adverse Event|2|||
127658903|NCT02961881|459374653|FG002|Overall Study|Adverse Event|2|||
127658904|NCT02961881|459374654|FG003|Overall Study|Adverse Event|0|||
127658905|NCT02961881|459374655|FG004|Overall Study|Adverse Event|1|||
127658906|NCT02961881|459374651|FG000|Overall Study|Participant request|0|||
127658907|NCT02961881|459374652|FG001|Overall Study|Participant request|2|||
127658908|NCT02961881|459374653|FG002|Overall Study|Participant request|0|||
127658909|NCT02961881|459374654|FG003|Overall Study|Participant request|0|||
127658910|NCT02961881|459374655|FG004|Overall Study|Participant request|0|||
127658911|NCT02961881|459374651|FG000|Overall Study|Disease progression|1|||
127658912|NCT02961881|459374652|FG001|Overall Study|Disease progression|0|||
127658913|NCT02961881|459374653|FG002|Overall Study|Disease progression|1|||
127658914|NCT02961881|459374654|FG003|Overall Study|Disease progression|0|||
127658915|NCT02961881|459374655|FG004|Overall Study|Disease progression|0|||
127658916|NCT01912781|459374656|FG000|Overall Study|Withdrawal by Subject|2|||
127658917|NCT01912781|459374657|FG001|Overall Study|Withdrawal by Subject|0|||
127658918|NCT00854295|459374660|FG000|Overall Study|Death|7|||
127658919|NCT00854295|459374661|FG001|Overall Study|Death|0|||
127658920|NCT00854295|459374662|FG002|Overall Study|Death|1|||
127658921|NCT00854295|459374663|FG003|Overall Study|Death|1|||
127658922|NCT00854295|459374660|FG000|Overall Study|Adverse Event|6|||
127658923|NCT00854295|459374661|FG001|Overall Study|Adverse Event|1|||
127658924|NCT00854295|459374662|FG002|Overall Study|Adverse Event|1|||
127658925|NCT00854295|459374663|FG003|Overall Study|Adverse Event|3|||
127658926|NCT00854295|459374660|FG000|Overall Study|Lost to Follow-up|18|||
127988480|NCT04575584|460582455|FG004|Overall Study|Not recorded|0|||
127988481|NCT04575584|460582456|FG005|Overall Study|Not recorded|0|||
127988482|NCT02769312|460582469|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
127988483|NCT02769312|460582470|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
127988484|NCT02769312|460582469|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
127988485|NCT02769312|460582470|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
127988486|NCT02769312|460582469|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
127658927|NCT00854295|459374661|FG001|Overall Study|Lost to Follow-up|5|||
127658928|NCT00854295|459374662|FG002|Overall Study|Lost to Follow-up|21|||
127658929|NCT00854295|459374663|FG003|Overall Study|Lost to Follow-up|21|||
127658930|NCT00854295|459374660|FG000|Overall Study|Physician Decision|10|||
127658931|NCT00854295|459374661|FG001|Overall Study|Physician Decision|0|||
127658932|NCT00854295|459374662|FG002|Overall Study|Physician Decision|0|||
127658933|NCT00854295|459374663|FG003|Overall Study|Physician Decision|0|||
127658934|NCT03154359|459374664|FG000|Overall Study|Adverse Event|1|||
127658935|NCT03154359|459374664|FG000|Overall Study|Lack of Efficacy|2|||
127658936|NCT03154359|459374664|FG000|Overall Study|Lost to Follow-up|3|||
127658937|NCT03154359|459374664|FG000|Overall Study|Physician Decision|3|||
127658938|NCT03154359|459374664|FG000|Overall Study|Protocol Violation|4|||
127988487|NCT02769312|460582470|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
127988488|NCT02769312|460582469|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
127658939|NCT03154359|459374664|FG000|Overall Study|Withdrawal by Subject|5|||
127658940|NCT03154359|459374664|FG000|Overall Study|Disruption of study due to COVID-19|4|||
127658941|NCT04250337|459374665|FG000|Overall Study|Adverse Event|0|||
127658942|NCT04250337|459374666|FG001|Overall Study|Adverse Event|3|||
127658943|NCT04250337|459374665|FG000|Overall Study|Lack of Efficacy|1|||
127658944|NCT04250337|459374666|FG001|Overall Study|Lack of Efficacy|3|||
127658945|NCT04250337|459374665|FG000|Overall Study|Physician Decision|1|||
127658946|NCT04250337|459374666|FG001|Overall Study|Physician Decision|0|||
127658947|NCT04250337|459374665|FG000|Overall Study|Protocol Deviation|2|||
127658948|NCT04250337|459374666|FG001|Overall Study|Protocol Deviation|2|||
127658949|NCT04250337|459374665|FG000|Overall Study|Withdrawal by Subject|4|||
127658950|NCT04250337|459374666|FG001|Overall Study|Withdrawal by Subject|3|||
127658951|NCT05033743|459374672|FG000|Overall Study|Lost to Follow-up|1|||
127658952|NCT05033743|459374672|FG000|Overall Study|Protocol Violation|2|||
127658953|NCT05033743|459374672|FG000|Overall Study|Withdrawal by Subject|1|||
127658954|NCT03321006|459374675|FG000|Overall Study|Death|1|||
127658955|NCT03321006|459374676|FG001|Overall Study|Death|0|||
127658956|NCT03321006|459374675|FG000|Overall Study|Lack of Efficacy|1|||
127658957|NCT03321006|459374676|FG001|Overall Study|Lack of Efficacy|0|||
127658958|NCT00885352|459374679|FG000|Overall Study|Adverse Event|2|||
127658959|NCT00885352|459374680|FG001|Overall Study|Adverse Event|3|||
127658960|NCT00885352|459374679|FG000|Overall Study|Lost to Follow-up|2|||
127658961|NCT00885352|459374680|FG001|Overall Study|Lost to Follow-up|2|||
127658962|NCT00885352|459374679|FG000|Overall Study|Physician Decision|0|||
127658963|NCT00885352|459374680|FG001|Overall Study|Physician Decision|3|||
127658964|NCT00885352|459374679|FG000|Overall Study|Protocol Violation|0|||
127658965|NCT00885352|459374680|FG001|Overall Study|Protocol Violation|2|||
127658966|NCT00885352|459374679|FG000|Overall Study|Withdrawal by Subject|1|||
127658967|NCT00885352|459374680|FG001|Overall Study|Withdrawal by Subject|5|||
127658968|NCT00885352|459374679|FG000|Overall Study|Contradiction to study medication|0|||
127658969|NCT00885352|459374680|FG001|Overall Study|Contradiction to study medication|2|||
127658970|NCT00885352|459374679|FG000|Overall Study|Excluded medication|2|||
127658971|NCT00885352|459374680|FG001|Overall Study|Excluded medication|2|||
127658972|NCT00885352|459374679|FG000|Overall Study|Lab abnormalities|1|||
127658973|NCT00885352|459374680|FG001|Overall Study|Lab abnormalities|1|||
127658974|NCT00365378|459374681|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
127658975|NCT00365378|459374682|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
127658976|NCT00365378|459374683|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
127658977|NCT00365378|459374681|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
127658978|NCT00365378|459374682|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
127658979|NCT00365378|459374683|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
127658980|NCT00365378|459374681|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
127658981|NCT00365378|459374682|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
127988489|NCT02769312|460582470|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
127988490|NCT02769312|460582469|FG000|Follow-up|Lost to Follow-up|1|||
127988491|NCT02769312|460582470|FG001|Follow-up|Lost to Follow-up|1|||
127988492|NCT00631163|460582471|FG000|Number of Participants in Year 1|Adverse Event|12|||
127988493|NCT00631163|460582471|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
127988494|NCT00631163|460582471|FG000|Number of Participants in Year 1|Death|6|||
127988495|NCT00631163|460582471|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
127988496|NCT00631163|460582471|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
127988497|NCT00631163|460582471|FG000|Number of Participants in Year 1|Administrative problems|6|||
127988498|NCT00631163|460582471|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
127988499|NCT00631163|460582471|FG000|Number of Participants in Year 2|Adverse Event|1|||
127988500|NCT00631163|460582471|FG000|Number of Participants in Year 2|Protocol Violation|1|||
127988501|NCT00631163|460582471|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
127988502|NCT02714036|460582472|FG000|Overall Study|Adverse Event|9|||
127988503|NCT02714036|460582473|FG001|Overall Study|Adverse Event|2|||
127988504|NCT02714036|460582472|FG000|Overall Study|Withdrawal by Subject|3|||
127988505|NCT02714036|460582473|FG001|Overall Study|Withdrawal by Subject|2|||
127988506|NCT00329745|460582475|FG000|Overall Study|Protocol Violation|1|||
127988507|NCT00329745|460582476|FG001|Overall Study|Protocol Violation|0|||
127988508|NCT00329745|460582475|FG000|Overall Study|Withdrawal by Subject|0|||
127988509|NCT00329745|460582476|FG001|Overall Study|Withdrawal by Subject|1|||
127658982|NCT00365378|459374683|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
127658983|NCT00365378|459374681|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
127543136|NCT00626106|458954756|FG001|Overall Study|Death|19|||
127658984|NCT00365378|459374682|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
127658985|NCT00365378|459374683|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
127988510|NCT00329745|460582475|FG000|Overall Study|Lost to Follow-up|86|||
127543137|NCT05417438|458954757|FG000|Overall Study|Withdrawal by Subject|3|||
127658986|NCT00365378|459374681|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
127658987|NCT00365378|459374682|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
127988511|NCT00329745|460582476|FG001|Overall Study|Lost to Follow-up|101|||
127988512|NCT01597492|460582477|FG000|Overall Study|Withdrawal by Subject|1|||
127988513|NCT01597492|460582478|FG001|Overall Study|Withdrawal by Subject|2|||
127988514|NCT01597492|460582477|FG000|Overall Study|Adverse Event|3|||
127988515|NCT01597492|460582478|FG001|Overall Study|Adverse Event|0|||
127988516|NCT01597492|460582477|FG000|Overall Study|Lost to Follow-up|0|||
127988517|NCT01597492|460582478|FG001|Overall Study|Lost to Follow-up|2|||
127988518|NCT01597492|460582477|FG000|Overall Study|Other Reason|2|||
127988519|NCT01597492|460582478|FG001|Overall Study|Other Reason|0|||
127988520|NCT01204918|460582479|FG000|Overall Study|Withdrawal by Subject|4|||
127988521|NCT01204918|460582480|FG001|Overall Study|Withdrawal by Subject|10|||
127988522|NCT01204918|460582481|FG002|Overall Study|Withdrawal by Subject|5|||
127988523|NCT03517449|460582484|FG000|Overall Study|Death|184|||
127988524|NCT03517449|460582485|FG001|Overall Study|Death|236|||
127988525|NCT03517449|460582484|FG000|Overall Study|Lost to Follow-up|0|||
127988526|NCT03517449|460582485|FG001|Overall Study|Lost to Follow-up|2|||
127988527|NCT03517449|460582484|FG000|Overall Study|Withdrawal by Subject|7|||
127988528|NCT03517449|460582485|FG001|Overall Study|Withdrawal by Subject|26|||
127988529|NCT03517449|460582484|FG000|Overall Study|Participants Ongoing|220|||
127988530|NCT03517449|460582485|FG001|Overall Study|Participants Ongoing|152|||
127988531|NCT00431067|460582488|FG000|Overall Study|Other Adverse Event|9|||
127988532|NCT00431067|460582488|FG000|Overall Study|Progressive disease|30|||
127988533|NCT00431067|460582488|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
127988534|NCT00849290|460582489|FG000|Overall Study|Adverse Event|3|||
127988535|NCT00849290|460582489|FG000|Overall Study|Death|14|||
127988536|NCT00849290|460582489|FG000|Overall Study|Withdrawal by Subject|11|||
127988537|NCT00849290|460582489|FG000|Overall Study|Lost to Follow-up|2|||
127988538|NCT00849290|460582489|FG000|Overall Study|Protocol Violation|5|||
127988539|NCT00849290|460582489|FG000|Overall Study|Disease Progression|20|||
127988540|NCT00830518|460582502|FG000|Overall Study|Progressive Disease|18|||
127988541|NCT00830518|460582503|FG001|Overall Study|Progressive Disease|8|||
127988542|NCT00830518|460582502|FG000|Overall Study|Symptomatic Deterioration|4|||
127988543|NCT00830518|460582503|FG001|Overall Study|Symptomatic Deterioration|1|||
127988544|NCT00830518|460582502|FG000|Overall Study|Adverse Event|14|||
127988545|NCT00830518|460582503|FG001|Overall Study|Adverse Event|1|||
127988546|NCT00830518|460582502|FG000|Overall Study|Withdrawal by Patient|2|||
127988547|NCT00830518|460582503|FG001|Overall Study|Withdrawal by Patient|0|||
127988548|NCT00830518|460582502|FG000|Overall Study|Reason not Specified|8|||
127988549|NCT00830518|460582503|FG001|Overall Study|Reason not Specified|1|||
127988550|NCT00913770|460582510|FG000|Overall Study|Unable to contact|24|||
127988551|NCT00913770|460582511|FG001|Overall Study|Unable to contact|19|||
127988552|NCT00913770|460582512|FG002|Overall Study|Unable to contact|13|||
127988553|NCT00913770|460582510|FG000|Overall Study|Refused|11|||
127988554|NCT00913770|460582511|FG001|Overall Study|Refused|10|||
127988555|NCT00913770|460582512|FG002|Overall Study|Refused|8|||
127988556|NCT03337048|460582513|FG000|Overall Study|Withdrawal by Subject|2|||
127988557|NCT03337048|460582514|FG001|Overall Study|Withdrawal by Subject|0|||
127988558|NCT03337048|460582515|FG002|Overall Study|Withdrawal by Subject|0|||
127988559|NCT02791438|460582518|FG000|Treatment Period|Adverse Event|1|||
127988560|NCT02791438|460582519|FG001|Treatment Period|Adverse Event|0|||
127988561|NCT02791438|460582518|FG000|Treatment Period|Withdrawal by Subject|0|||
127988562|NCT02791438|460582519|FG001|Treatment Period|Withdrawal by Subject|1|||
127988563|NCT02791438|460582518|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
127988564|NCT02791438|460582519|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
127988565|NCT01156051|460582523|FG000|Overall Study|Lost to Follow-up|1|||
127988566|NCT01156051|460582524|FG001|Overall Study|Lost to Follow-up|0|||
127988567|NCT01156051|460582523|FG000|Overall Study|patient not compliant with protocol|0|||
127988568|NCT01156051|460582524|FG001|Overall Study|patient not compliant with protocol|1|||
127988569|NCT01428115|460582526|FG000|Overall Study|Lack of Efficacy|3|||
127988570|NCT01428115|460582526|FG000|Overall Study|Lost to Follow-up|10|||
127988571|NCT01428115|460582526|FG000|Overall Study|Pregnancy|1|||
127988572|NCT01428115|460582526|FG000|Overall Study|Protocol Violation|3|||
127988573|NCT01428115|460582526|FG000|Overall Study|Withdrawal by Subject|4|||
127988574|NCT02620384|460582527|FG000|Overall Study|Adverse Event|2|||
127988575|NCT02620384|460582528|FG001|Overall Study|Adverse Event|1|||
127988576|NCT02620384|460582527|FG000|Overall Study|Discharged prior to 2nd dose|2|||
127988577|NCT02620384|460582528|FG001|Overall Study|Discharged prior to 2nd dose|5|||
127988578|NCT02620384|460582527|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
127988579|NCT02620384|460582528|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
127988580|NCT02494401|460582529|FG000|Overall Study|Lost to Follow-up|22|||
127988581|NCT02494401|460582530|FG001|Overall Study|Lost to Follow-up|25|||
127988582|NCT02494401|460582529|FG000|Overall Study|Withdrawal by Subject|3|||
127988583|NCT02494401|460582530|FG001|Overall Study|Withdrawal by Subject|2|||
127988584|NCT00966355|460582531|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
127988585|NCT00966355|460582532|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
127988586|NCT00966355|460582533|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
127988587|NCT00966355|460582531|FG000|Overall Study|newly diagnosed advanced HCC|11|||
127988588|NCT00966355|460582532|FG001|Overall Study|newly diagnosed advanced HCC|12|||
127988589|NCT00966355|460582533|FG002|Overall Study|newly diagnosed advanced HCC|10|||
127988590|NCT00966355|460582531|FG000|Overall Study|Lost to Follow-up|5|||
127988591|NCT00966355|460582532|FG001|Overall Study|Lost to Follow-up|4|||
127988592|NCT00966355|460582533|FG002|Overall Study|Lost to Follow-up|3|||
127988593|NCT01270321|460584497|FG000|Overall Study|Death|3|||
127988594|NCT01270321|460584498|FG001|Overall Study|Death|1|||
127988595|NCT01270321|460584499|FG002|Overall Study|Death|4|||
127988596|NCT01270321|460584497|FG000|Overall Study|Adverse Event|7|||
127988597|NCT01270321|460584498|FG001|Overall Study|Adverse Event|9|||
127988598|NCT01270321|460584499|FG002|Overall Study|Adverse Event|5|||
127988599|NCT01393106|460584501|FG000|Overall Study|Adverse Event|3|||
127988600|NCT01393106|460584501|FG000|Overall Study|Withdrawal by Subject|1|||
127988601|NCT01393106|460584501|FG000|Overall Study|Lack of Efficacy|1|||
127988602|NCT05437640|460584504|FG000|Washout (1 Week)|Adverse Event|1|||
127988603|NCT05437640|460584505|FG001|Washout (1 Week)|Adverse Event|0|||
127988604|NCT00904917|460584506|FG000|Overall Study|Lost to Follow-up|2|||
127988605|NCT00904917|460584507|FG001|Overall Study|Lost to Follow-up|2|||
127988606|NCT00904917|460584508|FG002|Overall Study|Lost to Follow-up|2|||
127988607|NCT00904917|460584509|FG003|Overall Study|Lost to Follow-up|2|||
127988608|NCT04228965|460584512|FG000|Overall Study|Lost to Follow-up|26|||
127988609|NCT04228965|460584513|FG001|Overall Study|Lost to Follow-up|11|||
127988610|NCT04228965|460584512|FG000|Overall Study|Withdrawal by Subject|18|||
127988611|NCT04228965|460584513|FG001|Overall Study|Withdrawal by Subject|5|||
127988612|NCT00734656|460584516|FG000|Lab Session 1|Withdrawal by Subject|2|||
127988613|NCT00734656|460584517|FG001|Lab Session 1|Withdrawal by Subject|0|||
127988614|NCT00734656|460584518|FG002|Lab Session 1|Withdrawal by Subject|0|||
127988615|NCT00734656|460584519|FG003|Lab Session 1|Withdrawal by Subject|0|||
127988616|NCT00734656|460584516|FG000|Washout 1|Withdrawal by Subject|1|||
127988617|NCT00734656|460584517|FG001|Washout 1|Withdrawal by Subject|5|||
127988618|NCT00734656|460584518|FG002|Washout 1|Withdrawal by Subject|2|||
127988619|NCT00734656|460584519|FG003|Washout 1|Withdrawal by Subject|3|||
127988620|NCT00734656|460584516|FG000|Lab Session 2|Withdrawal by Subject|1|||
127988621|NCT00734656|460584517|FG001|Lab Session 2|Withdrawal by Subject|0|||
127988622|NCT00734656|460584518|FG002|Lab Session 2|Withdrawal by Subject|0|||
127658988|NCT00365378|459374683|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
127658989|NCT00365378|459374681|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
127658990|NCT00365378|459374682|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
127658991|NCT00365378|459374683|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
127658992|NCT00365378|459374681|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
127988623|NCT00734656|460584519|FG003|Lab Session 2|Withdrawal by Subject|1|||
127988624|NCT00734656|460584516|FG000|Washout 2|Withdrawal by Subject|1|||
127988625|NCT00734656|460584517|FG001|Washout 2|Withdrawal by Subject|1|||
127988626|NCT00734656|460584518|FG002|Washout 2|Withdrawal by Subject|1|||
127988627|NCT00734656|460584519|FG003|Washout 2|Withdrawal by Subject|0|||
127988628|NCT00734656|460584516|FG000|Washout 3|Withdrawal by Subject|1|||
127988629|NCT00734656|460584517|FG001|Washout 3|Withdrawal by Subject|0|||
127988630|NCT00734656|460584518|FG002|Washout 3|Withdrawal by Subject|0|||
127988631|NCT00734656|460584519|FG003|Washout 3|Withdrawal by Subject|1|||
127988632|NCT00734656|460584516|FG000|Lab Session 4|Withdrawal by Subject|0|||
127988633|NCT00734656|460584517|FG001|Lab Session 4|Withdrawal by Subject|0|||
127988634|NCT00734656|460584518|FG002|Lab Session 4|Withdrawal by Subject|0|||
127988635|NCT00734656|460584519|FG003|Lab Session 4|Withdrawal by Subject|1|||
127988636|NCT03915626|460584520|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
127988637|NCT04676152|460584521|FG000|Overall Study|screen fail|9|||
127988638|NCT01502956|460584529|FG000|Overall Study|Death|0|||
127988639|NCT01502956|460584530|FG001|Overall Study|Death|2|||
127988640|NCT01502956|460584529|FG000|Overall Study|Lost to Follow-up|14|||
127988641|NCT01502956|460584530|FG001|Overall Study|Lost to Follow-up|11|||
127988642|NCT01502956|460584529|FG000|Overall Study|Physician Decision|2|||
127988643|NCT01502956|460584530|FG001|Overall Study|Physician Decision|3|||
127988644|NCT01502956|460584529|FG000|Overall Study|Withdrawal by Subject|8|||
127988645|NCT01502956|460584530|FG001|Overall Study|Withdrawal by Subject|10|||
127988646|NCT01031004|460584533|FG000|Overall Study|Protocol Violation|0|||
127988647|NCT01031004|460584534|FG001|Overall Study|Protocol Violation|1|||
127988648|NCT01031004|460584533|FG000|Overall Study|Lost to Follow-up|1|||
127988649|NCT01031004|460584534|FG001|Overall Study|Lost to Follow-up|0|||
127988650|NCT01641471|460584535|FG000|Overall Study|Withdrawal by Subject|19|||
127988651|NCT01641471|460584536|FG001|Overall Study|Withdrawal by Subject|19|||
127988652|NCT01641471|460584535|FG000|Overall Study|Lost to Follow-up|2|||
127988653|NCT01641471|460584536|FG001|Overall Study|Lost to Follow-up|4|||
127988654|NCT01641471|460584535|FG000|Overall Study|Protocol Violation|2|||
127543138|NCT03253393|458954760|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
127988655|NCT01641471|460584536|FG001|Overall Study|Protocol Violation|4|||
127658993|NCT00365378|459374682|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
127988656|NCT02634801|460584540|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
127988657|NCT02634801|460584541|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
127988658|NCT02634801|460584542|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
127988659|NCT02634801|460584540|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
127988660|NCT02634801|460584541|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
127988661|NCT02634801|460584542|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
127988662|NCT02634801|460584540|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
127988663|NCT02634801|460584541|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
127642281|NCT03252587|459310078|FG000|Overall Study|Withdrawal by Subject|8|||
127642282|NCT03252587|459310079|FG001|Overall Study|Withdrawal by Subject|4|||
127642283|NCT03252587|459310080|FG002|Overall Study|Withdrawal by Subject|4|||
127642284|NCT03252587|459310081|FG003|Overall Study|Withdrawal by Subject|4|||
127642285|NCT03252587|459310078|FG000|Overall Study|Other Reasons|2|||
127642286|NCT03252587|459310079|FG001|Overall Study|Other Reasons|5|||
127642287|NCT03252587|459310080|FG002|Overall Study|Other Reasons|5|||
127642288|NCT03252587|459310081|FG003|Overall Study|Other Reasons|4|||
127642289|NCT04052204|459310082|FG000|Overall Study|Death|1|||
127642290|NCT04052204|459310083|FG001|Overall Study|Death|0|||
127642291|NCT04052204|459310084|FG002|Overall Study|Death|0|||
127642292|NCT04052204|459310082|FG000|Overall Study|Progressive disease|1|||
127642293|NCT04052204|459310083|FG001|Overall Study|Progressive disease|0|||
127642294|NCT04052204|459310084|FG002|Overall Study|Progressive disease|0|||
127642295|NCT04052204|459310082|FG000|Overall Study|Other|1|||
127642296|NCT04052204|459310083|FG001|Overall Study|Other|0|||
127642297|NCT04052204|459310084|FG002|Overall Study|Other|0|||
127642298|NCT02395042|459310092|FG000|Treatment 1 Period|Adverse Event|1|||
127642299|NCT02395042|459310093|FG001|Treatment 1 Period|Adverse Event|3|||
127642300|NCT02395042|459310094|FG002|Treatment 1 Period|Adverse Event|1|||
127642301|NCT02395042|459310092|FG000|Treatment 1 Period|Lack of Efficacy|1|||
127642302|NCT02395042|459310093|FG001|Treatment 1 Period|Lack of Efficacy|1|||
127642303|NCT02395042|459310094|FG002|Treatment 1 Period|Lack of Efficacy|0|||
127642304|NCT02395042|459310092|FG000|Treatment 1 Period|Lost to Follow-up|1|||
127642305|NCT02395042|459310093|FG001|Treatment 1 Period|Lost to Follow-up|0|||
127642306|NCT02395042|459310094|FG002|Treatment 1 Period|Lost to Follow-up|0|||
127642307|NCT02395042|459310092|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
127642308|NCT02395042|459310093|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
127642309|NCT02395042|459310094|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
127642310|NCT02395042|459310092|FG000|Treatment 2 Period|Lack of Efficacy|1|||
127642311|NCT02395042|459310093|FG001|Treatment 2 Period|Lack of Efficacy|1|||
127642312|NCT02395042|459310094|FG002|Treatment 2 Period|Lack of Efficacy|0|||
127642313|NCT02192502|459310096|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
127642314|NCT02192502|459310097|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
127642315|NCT02192502|459310096|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
127642316|NCT02192502|459310097|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
127642317|NCT02192502|459310096|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
127642318|NCT02192502|459310097|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
127642319|NCT00003298|459310098|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
127642320|NCT00003298|459310098|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
127642321|NCT00003298|459310098|FG000|Surgery|Unresectable at surgery|3|||
127642322|NCT00003298|459310098|FG000|Surgery|Progression before surgery|2|||
127642323|NCT00003298|459310098|FG000|Surgery|Unevaluable and off study|2|||
127642324|NCT00003298|459310098|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
127642325|NCT00003298|459310098|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
127642326|NCT00003298|459310098|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
127642327|NCT00003298|459310098|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
127642328|NCT00003298|459310098|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
127642329|NCT00003298|459310098|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
127642330|NCT00003298|459310098|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
127642331|NCT00003298|459310098|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
127642332|NCT00003298|459310098|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
127642333|NCT00003298|459310098|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
127642334|NCT00584727|459310105|FG000|First Intervention|Discontinuation|0|||
127642335|NCT00584727|459310106|FG001|First Intervention|Discontinuation|0|||
127642336|NCT00584727|459310107|FG002|First Intervention|Discontinuation|1|||
127642337|NCT00584727|459310108|FG003|First Intervention|Discontinuation|0|||
127642338|NCT00584727|459310109|FG004|First Intervention|Discontinuation|0|||
127642339|NCT00584727|459310110|FG005|First Intervention|Discontinuation|0|||
127642340|NCT00584727|459310105|FG000|Third Intervention|Protocol Violation|0|||
127642341|NCT00584727|459310106|FG001|Third Intervention|Protocol Violation|0|||
127642342|NCT00584727|459310107|FG002|Third Intervention|Protocol Violation|1|||
127642343|NCT00584727|459310108|FG003|Third Intervention|Protocol Violation|0|||
127642344|NCT00584727|459310109|FG004|Third Intervention|Protocol Violation|4|||
127642345|NCT00584727|459310110|FG005|Third Intervention|Protocol Violation|2|||
127642346|NCT01922076|459310111|FG000|Overall Study|Adverse Event|0|||
127642347|NCT01922076|459310112|FG001|Overall Study|Adverse Event|0|||
127642348|NCT01922076|459310113|FG002|Overall Study|Adverse Event|0|||
127988664|NCT02634801|460584542|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
127988665|NCT02634801|460584540|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
127988666|NCT02634801|460584541|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
127988667|NCT02634801|460584542|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
127988668|NCT02634801|460584540|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
127658994|NCT00365378|459374683|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
127658995|NCT00365378|459374681|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
127658996|NCT00365378|459374682|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
127658997|NCT00365378|459374683|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
127658998|NCT00365378|459374681|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
127658999|NCT00365378|459374682|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
127659000|NCT00365378|459374683|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
127659001|NCT00365378|459374681|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
127659002|NCT00365378|459374682|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
127659003|NCT00365378|459374683|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
127659004|NCT00365378|459374681|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
127659005|NCT00365378|459374682|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
127659006|NCT00365378|459374683|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
127659007|NCT00365378|459374681|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
127659008|NCT00365378|459374682|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
127659009|NCT00365378|459374683|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
127659010|NCT00365378|459374681|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
127659011|NCT00365378|459374682|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
127659012|NCT00365378|459374683|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
127659013|NCT00365378|459374681|FG000|Extension|Adverse Event|0|||
127659014|NCT00365378|459374682|FG001|Extension|Adverse Event|0|||
127659015|NCT00365378|459374683|FG002|Extension|Adverse Event|1|||
127659016|NCT00365378|459374681|FG000|Extension|Moved|0|||
127659017|NCT00365378|459374682|FG001|Extension|Moved|0|||
127659018|NCT00365378|459374683|FG002|Extension|Moved|8|||
127659019|NCT00365378|459374681|FG000|Extension|Lost to Follow-up|0|||
127659020|NCT00365378|459374682|FG001|Extension|Lost to Follow-up|0|||
127659021|NCT00365378|459374683|FG002|Extension|Lost to Follow-up|57|||
127659022|NCT00365378|459374681|FG000|Extension|Protocol Violation|0|||
127659023|NCT00365378|459374682|FG001|Extension|Protocol Violation|0|||
127659024|NCT00365378|459374683|FG002|Extension|Protocol Violation|2|||
127659025|NCT00365378|459374681|FG000|Extension|Withdrawal by Subject|0|||
127659026|NCT00365378|459374682|FG001|Extension|Withdrawal by Subject|0|||
127659027|NCT00365378|459374683|FG002|Extension|Withdrawal by Subject|98|||
127659028|NCT00365378|459374681|FG000|Extension|Other|0|||
127659029|NCT00365378|459374682|FG001|Extension|Other|0|||
127659030|NCT00365378|459374683|FG002|Extension|Other|31|||
127659031|NCT04161807|459374689|FG000|Overall Study|Withdrawal by Subject|2|||
127659032|NCT04161807|459374689|FG000|Overall Study|Performed only 1 treatment|2|||
127659033|NCT00669903|459374692|FG000|Overall Study|Adverse Event|0|||
127659034|NCT00669903|459374693|FG001|Overall Study|Adverse Event|1|||
127659035|NCT00669903|459374694|FG002|Overall Study|Adverse Event|3|||
127659036|NCT00669903|459374695|FG003|Overall Study|Adverse Event|1|||
127659037|NCT00669903|459374692|FG000|Overall Study|Withdrawal by Subject|0|||
127659038|NCT00669903|459374693|FG001|Overall Study|Withdrawal by Subject|2|||
127659039|NCT00669903|459374694|FG002|Overall Study|Withdrawal by Subject|2|||
127659040|NCT00669903|459374695|FG003|Overall Study|Withdrawal by Subject|2|||
127659041|NCT00669903|459374692|FG000|Overall Study|Lost to Follow-up|1|||
127659042|NCT00669903|459374693|FG001|Overall Study|Lost to Follow-up|1|||
127659043|NCT00669903|459374694|FG002|Overall Study|Lost to Follow-up|0|||
127659044|NCT00669903|459374695|FG003|Overall Study|Lost to Follow-up|1|||
127659045|NCT00669903|459374692|FG000|Overall Study|Protocol Violation|0|||
127659046|NCT00669903|459374693|FG001|Overall Study|Protocol Violation|1|||
127659047|NCT00669903|459374694|FG002|Overall Study|Protocol Violation|0|||
127659048|NCT00669903|459374695|FG003|Overall Study|Protocol Violation|0|||
127659049|NCT04789577|459374699|FG000|Overall Study|Withdrawal by Subject|1|||
127988669|NCT02634801|460584541|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
127659050|NCT04789577|459374700|FG001|Overall Study|Withdrawal by Subject|1|||
127659051|NCT04789577|459374701|FG002|Overall Study|Withdrawal by Subject|1|||
127659052|NCT04789577|459374702|FG003|Overall Study|Withdrawal by Subject|3|||
127659053|NCT04789577|459374703|FG004|Overall Study|Withdrawal by Subject|1|||
127659054|NCT04789577|459374704|FG005|Overall Study|Withdrawal by Subject|7|||
127659055|NCT04789577|459374705|FG006|Overall Study|Withdrawal by Subject|1|||
127659056|NCT04789577|459374699|FG000|Overall Study|Lost to Follow-up|7|||
127659057|NCT04789577|459374700|FG001|Overall Study|Lost to Follow-up|12|||
127659058|NCT04789577|459374701|FG002|Overall Study|Lost to Follow-up|7|||
127659059|NCT04789577|459374702|FG003|Overall Study|Lost to Follow-up|10|||
127659060|NCT04789577|459374703|FG004|Overall Study|Lost to Follow-up|8|||
127659061|NCT04789577|459374704|FG005|Overall Study|Lost to Follow-up|6|||
127659062|NCT04789577|459374705|FG006|Overall Study|Lost to Follow-up|10|||
127659063|NCT04789577|459374699|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
127659064|NCT04789577|459374700|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
127659065|NCT04789577|459374701|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
127659066|NCT04789577|459374702|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
127659067|NCT04789577|459374703|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
127659068|NCT04789577|459374704|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
127659069|NCT04789577|459374705|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
127659070|NCT04789577|459374699|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
127659071|NCT04789577|459374700|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
127659072|NCT04789577|459374701|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
127659073|NCT04789577|459374702|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
127659074|NCT04789577|459374703|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
127659075|NCT04789577|459374704|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
127659076|NCT04789577|459374705|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
127659077|NCT01827254|459374706|FG000|Overall Study|Death|10|||
127659078|NCT01827254|459374706|FG000|Overall Study|Case report form not completed|4|||
127659079|NCT01827254|459374706|FG000|Overall Study|Invalidated centre|3|||
127659080|NCT01827254|459374706|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
127988670|NCT02634801|460584542|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
127988671|NCT02634801|460584540|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
127988672|NCT02634801|460584541|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
127988673|NCT02634801|460584542|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
127988674|NCT02634801|460584540|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
127988675|NCT02634801|460584541|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
127988676|NCT02634801|460584542|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
127988677|NCT02634801|460584540|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
127988678|NCT02634801|460584541|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
127988679|NCT02634801|460584542|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
127988680|NCT02634801|460584540|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
127988681|NCT02634801|460584541|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
127988682|NCT02634801|460584542|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
127988683|NCT02634801|460584540|FG000|Follow-up Period|Lost to Follow-up|3|||
127988684|NCT02634801|460584541|FG001|Follow-up Period|Lost to Follow-up|1|||
127988685|NCT02634801|460584542|FG002|Follow-up Period|Lost to Follow-up|2|||
127988686|NCT02634801|460584540|FG000|Follow-up Period|Physician Decision|0|||
127988687|NCT02634801|460584541|FG001|Follow-up Period|Physician Decision|0|||
127988688|NCT02634801|460584542|FG002|Follow-up Period|Physician Decision|1|||
127988689|NCT02634801|460584540|FG000|Follow-up Period|Withdrawal by Subject|1|||
127988690|NCT02634801|460584541|FG001|Follow-up Period|Withdrawal by Subject|2|||
127988691|NCT02634801|460584542|FG002|Follow-up Period|Withdrawal by Subject|5|||
127988692|NCT02634801|460584540|FG000|Follow-up Period|Adverse Event|1|||
127988693|NCT02634801|460584541|FG001|Follow-up Period|Adverse Event|5|||
127988694|NCT02634801|460584542|FG002|Follow-up Period|Adverse Event|0|||
127988695|NCT02626000|460584545|FG000|Overall Study|Decision by Sponsor|1|||
127988696|NCT02626000|460584545|FG000|Overall Study|Death|29|||
127988697|NCT02335346|460584564|FG000|Overall Study|Adverse Event|11|||
127988698|NCT02335346|460584564|FG000|Overall Study|Withdrawal by Subject|1|||
127988699|NCT03300050|460584565|FG000|Overall Study|Lost to Follow-up|2|||
127988700|NCT03300050|460584566|FG001|Overall Study|Lost to Follow-up|1|||
127988701|NCT03300050|460584567|FG002|Overall Study|Lost to Follow-up|0|||
127988702|NCT03300050|460584568|FG003|Overall Study|Lost to Follow-up|0|||
127988703|NCT03300050|460584569|FG004|Overall Study|Lost to Follow-up|1|||
127988704|NCT03300050|460584565|FG000|Overall Study|Withdrawal by Subject|1|||
127988705|NCT03300050|460584566|FG001|Overall Study|Withdrawal by Subject|1|||
127988706|NCT03300050|460584567|FG002|Overall Study|Withdrawal by Subject|1|||
127988707|NCT03300050|460584568|FG003|Overall Study|Withdrawal by Subject|0|||
127988708|NCT03300050|460584569|FG004|Overall Study|Withdrawal by Subject|0|||
127988709|NCT03300050|460584565|FG000|Overall Study|Death|0|||
127988710|NCT03300050|460584566|FG001|Overall Study|Death|0|||
127659081|NCT01827254|459374706|FG000|Overall Study|Did not complete re-challenge|1|||
127659082|NCT01827254|459374706|FG000|Overall Study|Disease progression|36|||
127659083|NCT01827254|459374706|FG000|Overall Study|Intolerance to treatment|4|||
127659084|NCT01923389|459374718|FG000|Overall Study|Protocol Violation|1|||
127659085|NCT01923389|459374719|FG001|Overall Study|Protocol Violation|0|||
127988711|NCT03300050|460584567|FG002|Overall Study|Death|1|||
127988712|NCT03300050|460584568|FG003|Overall Study|Death|0|||
127659086|NCT03292146|459374723|FG000|Baseline to 12 Months|Relocation|1|||
127659087|NCT03292146|459374724|FG001|Baseline to 12 Months|Relocation|0|||
127659088|NCT03292146|459374723|FG000|Baseline to 12 Months|Seeking higher level of care for eating disorder|1|||
127988713|NCT03300050|460584569|FG004|Overall Study|Death|0|||
127988714|NCT03300050|460584565|FG000|Overall Study|Not Eligible at Randomization|0|||
127988715|NCT03300050|460584566|FG001|Overall Study|Not Eligible at Randomization|0|||
127988716|NCT03300050|460584567|FG002|Overall Study|Not Eligible at Randomization|1|||
127659089|NCT03292146|459374724|FG001|Baseline to 12 Months|Seeking higher level of care for eating disorder|0|||
127705130|NCT01928394|459551579|FG012|Treatment Period|Poor/non-compliance|1|||
127659090|NCT03292146|459374723|FG000|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|0|||
127659091|NCT03292146|459374724|FG001|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|1|||
127659092|NCT03292146|459374723|FG000|12 Months to 24 Months|Planning pregnancy|2|||
127659093|NCT03292146|459374724|FG001|12 Months to 24 Months|Planning pregnancy|2|||
127659094|NCT03292146|459374723|FG000|12 Months to 24 Months|Personal reasons|1|||
127659095|NCT03292146|459374724|FG001|12 Months to 24 Months|Personal reasons|0|||
127659096|NCT03292146|459374723|FG000|12 Months to 24 Months|Lost to Follow-up|0|||
127659097|NCT03292146|459374724|FG001|12 Months to 24 Months|Lost to Follow-up|1|||
127659098|NCT00545363|459374727|FG000|Overall Study|Adverse Event|6|||
127659099|NCT00545363|459374728|FG001|Overall Study|Adverse Event|7|||
127659100|NCT00545363|459374727|FG000|Overall Study|Withdrawal by Subject|6|||
127659101|NCT00545363|459374728|FG001|Overall Study|Withdrawal by Subject|5|||
127659102|NCT00545363|459374727|FG000|Overall Study|Non-compliance|3|||
127659103|NCT00545363|459374728|FG001|Overall Study|Non-compliance|1|||
127659104|NCT00545363|459374727|FG000|Overall Study|Did not meet entry criteria|1|||
127659105|NCT00545363|459374728|FG001|Overall Study|Did not meet entry criteria|1|||
127988717|NCT03300050|460584568|FG003|Overall Study|Not Eligible at Randomization|1|||
127988718|NCT03300050|460584569|FG004|Overall Study|Not Eligible at Randomization|0|||
127988719|NCT02178358|460584570|FG000|Overall Study|Withdrawal by Subject|0|||
127988720|NCT02178358|460584571|FG001|Overall Study|Withdrawal by Subject|2|||
127988721|NCT02178358|460584572|FG002|Overall Study|Withdrawal by Subject|2|||
127988722|NCT02178358|460584570|FG000|Overall Study|Lost to Follow-up|1|||
127988723|NCT02178358|460584571|FG001|Overall Study|Lost to Follow-up|0|||
127988724|NCT02178358|460584572|FG002|Overall Study|Lost to Follow-up|0|||
127988725|NCT01066663|460584573|FG000|Overall Study|Adverse Event|0|||
127988726|NCT01066663|460584574|FG001|Overall Study|Adverse Event|0|||
127988727|NCT01066663|460584575|FG002|Overall Study|Adverse Event|1|||
127988728|NCT01090050|460584576|FG000|Overall Study|Lost to Follow-up|0|||
127988729|NCT01090050|460584577|FG001|Overall Study|Lost to Follow-up|1|||
127988730|NCT01090050|460584576|FG000|Overall Study|Lack of Efficacy|1|||
127988731|NCT01090050|460584577|FG001|Overall Study|Lack of Efficacy|5|||
127988732|NCT01090050|460584576|FG000|Overall Study|Physician Decision|0|||
127988733|NCT01090050|460584577|FG001|Overall Study|Physician Decision|1|||
127988734|NCT03539484|460584578|FG000|Overall Study|Death|1|||
127988735|NCT03539484|460584579|FG001|Overall Study|Death|0|||
127988736|NCT03539484|460584580|FG002|Overall Study|Death|0|||
127988737|NCT03539484|460584581|FG003|Overall Study|Death|2|||
127988738|NCT03539484|460584582|FG004|Overall Study|Death|8|||
127988739|NCT03539484|460584583|FG005|Overall Study|Death|3|||
127988740|NCT03539484|460584584|FG006|Overall Study|Death|0|||
127988741|NCT03539484|460584578|FG000|Overall Study|Lost to Follow-up|0|||
127988742|NCT03539484|460584579|FG001|Overall Study|Lost to Follow-up|1|||
127988743|NCT03539484|460584580|FG002|Overall Study|Lost to Follow-up|0|||
127988744|NCT03539484|460584581|FG003|Overall Study|Lost to Follow-up|0|||
127988745|NCT03539484|460584582|FG004|Overall Study|Lost to Follow-up|1|||
127988746|NCT03539484|460584583|FG005|Overall Study|Lost to Follow-up|0|||
127988747|NCT03539484|460584584|FG006|Overall Study|Lost to Follow-up|0|||
127988748|NCT03539484|460584578|FG000|Overall Study|Withdrawal by Subject|0|||
127988749|NCT03539484|460584579|FG001|Overall Study|Withdrawal by Subject|0|||
127988750|NCT03539484|460584580|FG002|Overall Study|Withdrawal by Subject|0|||
127988751|NCT03539484|460584581|FG003|Overall Study|Withdrawal by Subject|0|||
127988752|NCT03539484|460584582|FG004|Overall Study|Withdrawal by Subject|2|||
127988753|NCT03539484|460584583|FG005|Overall Study|Withdrawal by Subject|0|||
127988754|NCT03539484|460584584|FG006|Overall Study|Withdrawal by Subject|1|||
127988755|NCT03539484|460584578|FG000|Overall Study|Study Terminated by Sponsor|0|||
127988756|NCT03539484|460584579|FG001|Overall Study|Study Terminated by Sponsor|0|||
127988757|NCT03539484|460584580|FG002|Overall Study|Study Terminated by Sponsor|1|||
127988758|NCT03539484|460584581|FG003|Overall Study|Study Terminated by Sponsor|1|||
127988759|NCT03539484|460584582|FG004|Overall Study|Study Terminated by Sponsor|2|||
127988760|NCT03539484|460584583|FG005|Overall Study|Study Terminated by Sponsor|2|||
127988761|NCT03539484|460584584|FG006|Overall Study|Study Terminated by Sponsor|1|||
127988762|NCT02232061|460584585|FG000|Overall Study|Administrative problems|1|||
127659106|NCT00545363|459374727|FG000|Overall Study|Lost to Follow-up|2|||
127659107|NCT00545363|459374728|FG001|Overall Study|Lost to Follow-up|0|||
127659108|NCT00545363|459374727|FG000|Overall Study|Other|1|||
127659109|NCT00545363|459374728|FG001|Overall Study|Other|1|||
127988763|NCT02232061|460584585|FG000|Overall Study|Withdrawal by Subject|1|||
127988764|NCT00560703|460584587|FG000|Overall Study|Adverse Event|0|||
127988765|NCT00560703|460584588|FG001|Overall Study|Adverse Event|2|||
127988766|NCT00560703|460584587|FG000|Overall Study|Protocol Violation|0|||
127988767|NCT00560703|460584588|FG001|Overall Study|Protocol Violation|2|||
127988768|NCT00560703|460584587|FG000|Overall Study|Withdrawal by Subject|0|||
127988769|NCT00560703|460584588|FG001|Overall Study|Withdrawal by Subject|1|||
127988770|NCT00560703|460584587|FG000|Overall Study|non-compliance|0|||
127988771|NCT00560703|460584588|FG001|Overall Study|non-compliance|1|||
127988772|NCT00339833|460584590|FG000|Overall Study|Withdrawal by Subject|1|||
127988773|NCT00339833|460584591|FG001|Overall Study|Withdrawal by Subject|2|||
127988774|NCT00339833|460584590|FG000|Overall Study|toothache|0|||
127988775|NCT00339833|460584591|FG001|Overall Study|toothache|1|||
127988776|NCT00339833|460584590|FG000|Overall Study|indigestion|0|||
127988777|NCT00339833|460584591|FG001|Overall Study|indigestion|1|||
127988778|NCT00339833|460584590|FG000|Overall Study|Chest pain|0|||
127988779|NCT00339833|460584591|FG001|Overall Study|Chest pain|1|||
127988780|NCT00339833|460584590|FG000|Overall Study|minor infection|0|||
127988781|NCT00339833|460584591|FG001|Overall Study|minor infection|1|||
127659110|NCT00366301|459374729|FG000|Overall Study|Lost to Follow-up|4|||
127659111|NCT00366301|459374730|FG001|Overall Study|Lost to Follow-up|4|||
127659112|NCT00366301|459374731|FG002|Overall Study|Lost to Follow-up|3|||
127659113|NCT00366301|459374732|FG003|Overall Study|Lost to Follow-up|7|||
127659114|NCT00366301|459374729|FG000|Overall Study|Withdrawal by Subject|4|||
127659115|NCT00366301|459374730|FG001|Overall Study|Withdrawal by Subject|2|||
127659116|NCT00366301|459374731|FG002|Overall Study|Withdrawal by Subject|1|||
127659117|NCT00366301|459374732|FG003|Overall Study|Withdrawal by Subject|1|||
127659118|NCT01348776|459374737|FG000|Overall Study|Lost to Follow-up|3|||
127659119|NCT01463293|459374738|FG000|Overall Study|Lost to Follow-up|1|||
127659120|NCT01463293|459374739|FG001|Overall Study|Lost to Follow-up|4|||
127659121|NCT01463293|459374740|FG002|Overall Study|Lost to Follow-up|5|||
127659122|NCT01463293|459374738|FG000|Overall Study|Adverse Event|1|||
127659123|NCT01463293|459374739|FG001|Overall Study|Adverse Event|2|||
127659124|NCT01463293|459374740|FG002|Overall Study|Adverse Event|0|||
127659125|NCT01463293|459374738|FG000|Overall Study|Withdrawal by Subject|4|||
127659126|NCT01463293|459374739|FG001|Overall Study|Withdrawal by Subject|10|||
127659127|NCT01463293|459374740|FG002|Overall Study|Withdrawal by Subject|5|||
127659128|NCT01463293|459374738|FG000|Overall Study|Other|0|||
127659129|NCT01463293|459374739|FG001|Overall Study|Other|0|||
127659130|NCT01463293|459374740|FG002|Overall Study|Other|2|||
127659131|NCT03125941|459374744|FG000|Overall Study|did not receive intervention|1|||
127659132|NCT03125941|459374745|FG001|Overall Study|did not receive intervention|2|||
127659133|NCT00779584|459374746|FG000|Overall Study|Protocol Violation|0|||
127659134|NCT00779584|459374747|FG001|Overall Study|Protocol Violation|0|||
127659135|NCT00779584|459374748|FG002|Overall Study|Protocol Violation|0|||
127659136|NCT00779584|459374749|FG003|Overall Study|Protocol Violation|0|||
127659137|NCT00779584|459374750|FG004|Overall Study|Protocol Violation|0|||
127659138|NCT00779584|459374751|FG005|Overall Study|Protocol Violation|1|||
127659139|NCT00779584|459374752|FG006|Overall Study|Protocol Violation|0|||
127659140|NCT00779584|459374753|FG007|Overall Study|Protocol Violation|0|||
127659141|NCT00779584|459374754|FG008|Overall Study|Protocol Violation|0|||
127659142|NCT00779584|459374746|FG000|Overall Study|Withdrawal by Subject|1|||
127659143|NCT00779584|459374747|FG001|Overall Study|Withdrawal by Subject|1|||
127659144|NCT00779584|459374748|FG002|Overall Study|Withdrawal by Subject|2|||
127659145|NCT00779584|459374749|FG003|Overall Study|Withdrawal by Subject|0|||
127659146|NCT00779584|459374750|FG004|Overall Study|Withdrawal by Subject|0|||
127659147|NCT00779584|459374751|FG005|Overall Study|Withdrawal by Subject|2|||
127659148|NCT00779584|459374752|FG006|Overall Study|Withdrawal by Subject|1|||
127659149|NCT00779584|459374753|FG007|Overall Study|Withdrawal by Subject|0|||
127659150|NCT00779584|459374754|FG008|Overall Study|Withdrawal by Subject|0|||
127659151|NCT00779584|459374746|FG000|Overall Study|Lost to Follow-up|0|||
127659152|NCT00779584|459374747|FG001|Overall Study|Lost to Follow-up|0|||
127659153|NCT00779584|459374748|FG002|Overall Study|Lost to Follow-up|0|||
127659154|NCT00779584|459374749|FG003|Overall Study|Lost to Follow-up|0|||
127659155|NCT00779584|459374750|FG004|Overall Study|Lost to Follow-up|1|||
127659156|NCT00779584|459374751|FG005|Overall Study|Lost to Follow-up|0|||
127659157|NCT00779584|459374752|FG006|Overall Study|Lost to Follow-up|0|||
127659158|NCT00779584|459374753|FG007|Overall Study|Lost to Follow-up|0|||
127659159|NCT00779584|459374754|FG008|Overall Study|Lost to Follow-up|0|||
127659160|NCT00779584|459374746|FG000|Overall Study|Progression of Disease|0|||
127659161|NCT00779584|459374747|FG001|Overall Study|Progression of Disease|1|||
127659162|NCT00779584|459374748|FG002|Overall Study|Progression of Disease|2|||
127659163|NCT00779584|459374749|FG003|Overall Study|Progression of Disease|6|||
127988782|NCT00339833|460584590|FG000|Overall Study|Poor venous access|2|||
127988783|NCT00339833|460584591|FG001|Overall Study|Poor venous access|2|||
127988784|NCT00339833|460584590|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
127988785|NCT00339833|460584591|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
127988786|NCT00339833|460584590|FG000|Overall Study|Error in data records|1|||
127988787|NCT00339833|460584591|FG001|Overall Study|Error in data records|0|||
127659164|NCT00779584|459374750|FG004|Overall Study|Progression of Disease|5|||
127659165|NCT00779584|459374751|FG005|Overall Study|Progression of Disease|1|||
127659166|NCT00779584|459374752|FG006|Overall Study|Progression of Disease|4|||
127659167|NCT00779584|459374753|FG007|Overall Study|Progression of Disease|2|||
127988788|NCT02476916|460584592|FG000|Core Period|Adverse Event|2|||
127659168|NCT00779584|459374754|FG008|Overall Study|Progression of Disease|1|||
127659169|NCT00779584|459374746|FG000|Overall Study|Adverse Event|1|||
127659170|NCT00779584|459374747|FG001|Overall Study|Adverse Event|0|||
127988789|NCT02476916|460584593|FG001|Core Period|Adverse Event|2|||
127659171|NCT00779584|459374748|FG002|Overall Study|Adverse Event|2|||
127659172|NCT00779584|459374749|FG003|Overall Study|Adverse Event|0|||
127988790|NCT02476916|460584592|FG000|Core Period|Investigator decision|1|||
127988791|NCT02476916|460584593|FG001|Core Period|Investigator decision|1|||
127988792|NCT02476916|460584592|FG000|Core Period|Withdrawal by Subject|3|||
127988793|NCT02476916|460584593|FG001|Core Period|Withdrawal by Subject|0|||
127988794|NCT02476916|460584592|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
127988795|NCT02476916|460584593|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
127988796|NCT02476916|460584592|FG000|Extension Period|On Treatment|12|||
127988797|NCT02476916|460584593|FG001|Extension Period|On Treatment|17|||
127988798|NCT06010732|460584594|FG000|Crossover Period 1|Protocol Violation|0|||
127988799|NCT06010732|460584595|FG001|Crossover Period 1|Protocol Violation|0|||
127988800|NCT06010732|460584596|FG002|Crossover Period 1|Protocol Violation|1|||
127988801|NCT06010732|460584597|FG003|Crossover Period 1|Protocol Violation|0|||
127988802|NCT06010732|460584598|FG004|Crossover Period 1|Protocol Violation|1|||
127988803|NCT06010732|460584599|FG005|Crossover Period 1|Protocol Violation|0|||
127988804|NCT06010732|460584594|FG000|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
127988805|NCT06010732|460584595|FG001|Washout Between Periods 1 and 2|Withdrawal by Subject|1|||
127988806|NCT06010732|460584596|FG002|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
127988807|NCT06010732|460584597|FG003|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
127988808|NCT06010732|460584598|FG004|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
127988809|NCT06010732|460584599|FG005|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
127988810|NCT06010732|460584594|FG000|Crossover Period 2|Adverse Event|0|||
127988811|NCT06010732|460584595|FG001|Crossover Period 2|Adverse Event|1|||
127988812|NCT06010732|460584596|FG002|Crossover Period 2|Adverse Event|0|||
127988813|NCT06010732|460584597|FG003|Crossover Period 2|Adverse Event|0|||
127988814|NCT06010732|460584598|FG004|Crossover Period 2|Adverse Event|0|||
127988815|NCT06010732|460584599|FG005|Crossover Period 2|Adverse Event|0|||
127988816|NCT06010732|460584594|FG000|Crossover Period 2|broken denture|0|||
127988817|NCT06010732|460584595|FG001|Crossover Period 2|broken denture|0|||
127988818|NCT06010732|460584596|FG002|Crossover Period 2|broken denture|1|||
127988819|NCT06010732|460584597|FG003|Crossover Period 2|broken denture|0|||
127988820|NCT06010732|460584598|FG004|Crossover Period 2|broken denture|0|||
127988821|NCT06010732|460584599|FG005|Crossover Period 2|broken denture|0|||
127988822|NCT04401202|460584600|FG000|Overall Study|Lost to Follow-up|2|||
127988823|NCT04401202|460584601|FG001|Overall Study|Lost to Follow-up|2|||
127988824|NCT04401202|460584600|FG000|Overall Study|Adverse Event|0|||
127988825|NCT04401202|460584601|FG001|Overall Study|Adverse Event|1|||
127988826|NCT04401202|460584600|FG000|Overall Study|Hospitalized|4|||
127988827|NCT04401202|460584601|FG001|Overall Study|Hospitalized|1|||
127988828|NCT01853696|460584616|FG000|Overall Study|Withdrawal by Subject|1|||
127988829|NCT01853696|460584617|FG001|Overall Study|Withdrawal by Subject|1|||
127988830|NCT01853696|460584616|FG000|Overall Study|Lost to Follow-up|5|||
127988831|NCT01853696|460584617|FG001|Overall Study|Lost to Follow-up|4|||
127988832|NCT01119846|460584618|FG000|Overall Study|Adverse Event|1|||
127988833|NCT01119846|460584619|FG001|Overall Study|Adverse Event|0|||
127988834|NCT01119846|460584620|FG002|Overall Study|Adverse Event|6|||
127988835|NCT01119846|460584618|FG000|Overall Study|Physician Decision|1|||
127988836|NCT01119846|460584619|FG001|Overall Study|Physician Decision|0|||
127988837|NCT01119846|460584620|FG002|Overall Study|Physician Decision|0|||
127988838|NCT01119846|460584618|FG000|Overall Study|Protocol Violation|0|||
127988839|NCT01119846|460584619|FG001|Overall Study|Protocol Violation|0|||
127988840|NCT01119846|460584620|FG002|Overall Study|Protocol Violation|1|||
127988841|NCT01119846|460584618|FG000|Overall Study|Withdrawal by Subject|0|||
127988842|NCT01119846|460584619|FG001|Overall Study|Withdrawal by Subject|0|||
127988843|NCT01119846|460584620|FG002|Overall Study|Withdrawal by Subject|4|||
127988844|NCT03304184|460584625|FG000|Overall Study|Withdrawal by Subject|1|||
127988845|NCT03304184|460584626|FG001|Overall Study|Withdrawal by Subject|2|||
127988846|NCT04527978|460584627|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
127988847|NCT04527978|460584628|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
127988848|NCT01370616|460584629|FG000|Overall Study|Adverse Event|11|||
127988849|NCT01370616|460584630|FG001|Overall Study|Adverse Event|16|||
127988850|NCT01370616|460584629|FG000|Overall Study|Death|1|||
127988851|NCT01370616|460584630|FG001|Overall Study|Death|0|||
127988852|NCT01370616|460584629|FG000|Overall Study|Lack of Efficacy|6|||
127988853|NCT01370616|460584630|FG001|Overall Study|Lack of Efficacy|2|||
127988854|NCT01370616|460584629|FG000|Overall Study|Lost to Follow-up|0|||
127988855|NCT01370616|460584630|FG001|Overall Study|Lost to Follow-up|3|||
127988856|NCT01370616|460584629|FG000|Overall Study|Physician Decision|6|||
127988857|NCT01370616|460584630|FG001|Overall Study|Physician Decision|6|||
127988858|NCT01370616|460584629|FG000|Overall Study|Progressive Disease|0|||
127988859|NCT01370616|460584630|FG001|Overall Study|Progressive Disease|1|||
127988860|NCT01370616|460584629|FG000|Overall Study|Recovery|1|||
127642349|NCT01922076|459310114|FG003|Overall Study|Adverse Event|0|||
127642350|NCT01922076|459310115|FG004|Overall Study|Adverse Event|1|||
127642351|NCT01922076|459310116|FG005|Overall Study|Adverse Event|0|||
127642352|NCT01922076|459310117|FG006|Overall Study|Adverse Event|0|||
127642353|NCT01922076|459310111|FG000|Overall Study|Physician Decision|0|||
127642354|NCT01922076|459310112|FG001|Overall Study|Physician Decision|0|||
127642355|NCT01922076|459310113|FG002|Overall Study|Physician Decision|1|||
127642356|NCT01922076|459310114|FG003|Overall Study|Physician Decision|0|||
127659173|NCT00779584|459374750|FG004|Overall Study|Adverse Event|0|||
127659174|NCT00779584|459374751|FG005|Overall Study|Adverse Event|0|||
127659175|NCT00779584|459374752|FG006|Overall Study|Adverse Event|2|||
127659176|NCT00779584|459374753|FG007|Overall Study|Adverse Event|1|||
127659177|NCT00779584|459374754|FG008|Overall Study|Adverse Event|1|||
127659178|NCT00779584|459374746|FG000|Overall Study|Symptomatic Deterioration|1|||
127659179|NCT00779584|459374747|FG001|Overall Study|Symptomatic Deterioration|1|||
127659180|NCT00779584|459374748|FG002|Overall Study|Symptomatic Deterioration|1|||
127659181|NCT00779584|459374749|FG003|Overall Study|Symptomatic Deterioration|0|||
127659182|NCT00779584|459374750|FG004|Overall Study|Symptomatic Deterioration|0|||
127659183|NCT00779584|459374751|FG005|Overall Study|Symptomatic Deterioration|1|||
127659184|NCT00779584|459374752|FG006|Overall Study|Symptomatic Deterioration|1|||
127659185|NCT00779584|459374753|FG007|Overall Study|Symptomatic Deterioration|0|||
127659186|NCT00779584|459374754|FG008|Overall Study|Symptomatic Deterioration|0|||
127659187|NCT00779584|459374746|FG000|Overall Study|Ongoing in Study|0|||
127659188|NCT00779584|459374747|FG001|Overall Study|Ongoing in Study|0|||
127659189|NCT00779584|459374748|FG002|Overall Study|Ongoing in Study|0|||
127659190|NCT00779584|459374749|FG003|Overall Study|Ongoing in Study|0|||
127659191|NCT00779584|459374750|FG004|Overall Study|Ongoing in Study|1|||
127659192|NCT00779584|459374751|FG005|Overall Study|Ongoing in Study|1|||
127659193|NCT00779584|459374752|FG006|Overall Study|Ongoing in Study|0|||
127659194|NCT00779584|459374753|FG007|Overall Study|Ongoing in Study|0|||
127659195|NCT00779584|459374754|FG008|Overall Study|Ongoing in Study|0|||
127659196|NCT02878213|459374757|FG000|Overall Study|Withdrawal by Subject|2|||
127659197|NCT02878213|459374757|FG000|Overall Study|Adverse Event|1|||
127659198|NCT02494206|459374760|FG000|Overall Study|Adverse Event|1|||
127659199|NCT02494206|459374760|FG000|Overall Study|Disease Progression|1|||
127659200|NCT04986982|459374761|FG000|Overall Study|Withdrawal by Subject|3|||
127659201|NCT04986982|459374762|FG001|Overall Study|Withdrawal by Subject|1|||
127659202|NCT04986982|459374761|FG000|Overall Study|Lack of Efficacy|0|||
127659203|NCT04986982|459374762|FG001|Overall Study|Lack of Efficacy|2|||
127659204|NCT04986982|459374761|FG000|Overall Study|Ineligibility|3|||
127659205|NCT04986982|459374762|FG001|Overall Study|Ineligibility|0|||
127659206|NCT04986982|459374761|FG000|Overall Study|Adverse Event|4|||
127659207|NCT04986982|459374762|FG001|Overall Study|Adverse Event|4|||
127659208|NCT04986982|459374761|FG000|Overall Study|Lost to Follow-up|0|||
127659209|NCT04986982|459374762|FG001|Overall Study|Lost to Follow-up|1|||
127659210|NCT04986982|459374761|FG000|Overall Study|Sponsor's discretion|1|||
127659211|NCT04986982|459374762|FG001|Overall Study|Sponsor's discretion|0|||
127659212|NCT01155661|459374763|FG000|Overall Study|Adverse Event|101|||
127659213|NCT01155661|459374763|FG000|Overall Study|Death|1|||
127659214|NCT01155661|459374763|FG000|Overall Study|Lack of Efficacy|32|||
127659215|NCT01155661|459374763|FG000|Overall Study|Lost to Follow-up|22|||
127659216|NCT01155661|459374763|FG000|Overall Study|Physician Decision|3|||
127659217|NCT01155661|459374763|FG000|Overall Study|Protocol Violation|35|||
127659218|NCT01155661|459374763|FG000|Overall Study|Withdrawal by Subject|73|||
127659219|NCT01155661|459374763|FG000|Overall Study|Sponsor Decision|13|||
127659220|NCT01370005|459374765|FG000|Overall Study|Not treated|1|||
127659221|NCT01370005|459374766|FG001|Overall Study|Not treated|0|||
127659222|NCT01370005|459374767|FG002|Overall Study|Not treated|0|||
127659223|NCT01370005|459374765|FG000|Overall Study|Adverse Event|5|||
127659224|NCT01370005|459374766|FG001|Overall Study|Adverse Event|5|||
127659225|NCT01370005|459374767|FG002|Overall Study|Adverse Event|6|||
127659226|NCT01370005|459374765|FG000|Overall Study|Lack of Efficacy|1|||
127659227|NCT01370005|459374766|FG001|Overall Study|Lack of Efficacy|0|||
127659228|NCT01370005|459374767|FG002|Overall Study|Lack of Efficacy|0|||
127659229|NCT01370005|459374765|FG000|Overall Study|Non compliant with protocol|0|||
127659230|NCT01370005|459374766|FG001|Overall Study|Non compliant with protocol|1|||
127659231|NCT01370005|459374767|FG002|Overall Study|Non compliant with protocol|2|||
127659232|NCT01370005|459374765|FG000|Overall Study|Lost to Follow-up|1|||
127659233|NCT01370005|459374766|FG001|Overall Study|Lost to Follow-up|1|||
127659234|NCT01370005|459374767|FG002|Overall Study|Lost to Follow-up|1|||
127659235|NCT01370005|459374765|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
127659236|NCT01370005|459374766|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
127659237|NCT01370005|459374767|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
127659238|NCT01370005|459374765|FG000|Overall Study|Other reason not defined above|3|||
127659239|NCT01370005|459374766|FG001|Overall Study|Other reason not defined above|0|||
127659240|NCT01370005|459374767|FG002|Overall Study|Other reason not defined above|2|||
127659241|NCT02302066|459374768|FG000|Overall Study|Adverse Event|1|||
127659242|NCT02302066|459374769|FG001|Overall Study|Adverse Event|1|||
127659243|NCT02302066|459374770|FG002|Overall Study|Adverse Event|3|||
127659244|NCT02302066|459374771|FG003|Overall Study|Adverse Event|0|||
127659245|NCT02302066|459374768|FG000|Overall Study|Lost to Follow-up|4|||
127659246|NCT02302066|459374769|FG001|Overall Study|Lost to Follow-up|5|||
127659247|NCT02302066|459374770|FG002|Overall Study|Lost to Follow-up|24|||
127659248|NCT02302066|459374771|FG003|Overall Study|Lost to Follow-up|7|||
127659249|NCT02302066|459374768|FG000|Overall Study|Withdrawal by Subject|25|||
127659250|NCT02302066|459374769|FG001|Overall Study|Withdrawal by Subject|58|||
127659251|NCT02302066|459374770|FG002|Overall Study|Withdrawal by Subject|124|||
127988861|NCT01370616|460584630|FG001|Overall Study|Recovery|0|||
127988862|NCT01370616|460584629|FG000|Overall Study|Technical Problems|3|||
127988863|NCT01370616|460584630|FG001|Overall Study|Technical Problems|5|||
127659252|NCT02302066|459374771|FG003|Overall Study|Withdrawal by Subject|33|||
127659253|NCT02302066|459374768|FG000|Overall Study|Pregnancy|2|||
127659254|NCT02302066|459374769|FG001|Overall Study|Pregnancy|10|||
127659255|NCT02302066|459374770|FG002|Overall Study|Pregnancy|12|||
127659256|NCT02302066|459374771|FG003|Overall Study|Pregnancy|0|||
127659257|NCT02302066|459374768|FG000|Overall Study|Reason Not Specified|1|||
127659258|NCT02302066|459374769|FG001|Overall Study|Reason Not Specified|1|||
127659259|NCT02302066|459374770|FG002|Overall Study|Reason Not Specified|9|||
127659260|NCT02302066|459374771|FG003|Overall Study|Reason Not Specified|1|||
127659261|NCT02638623|459374773|FG000|Overall Study|Surgery timing|5|||
127659262|NCT02638623|459374774|FG001|Overall Study|Surgery timing|6|||
127659263|NCT02638623|459374773|FG000|Overall Study|Not given intervention|2|||
127659264|NCT02638623|459374774|FG001|Overall Study|Not given intervention|0|||
127659265|NCT01871558|459374777|FG000|Overall Study|Other reason|0|||
127659266|NCT01871558|459374778|FG001|Overall Study|Other reason|1|||
127659267|NCT01871558|459374777|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
127659268|NCT01871558|459374778|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
127659269|NCT01871558|459374777|FG000|Overall Study|Withdrawal by Subject|2|||
127659270|NCT01871558|459374778|FG001|Overall Study|Withdrawal by Subject|0|||
127659271|NCT02041923|459374779|FG000|Overall Study|Lost to Follow-up|26|||
127659272|NCT02041923|459374780|FG001|Overall Study|Lost to Follow-up|30|||
127659273|NCT00874432|459374782|FG000|Overall Study|Withdrawal by Subject|1|||
127659274|NCT00874432|459374783|FG001|Overall Study|Withdrawal by Subject|0|||
127659275|NCT00874432|459374784|FG002|Overall Study|Withdrawal by Subject|0|||
127659276|NCT00874432|459374785|FG003|Overall Study|Withdrawal by Subject|0|||
127659277|NCT00874432|459374782|FG000|Overall Study|Physician Decision|1|||
127659278|NCT00874432|459374783|FG001|Overall Study|Physician Decision|0|||
127659279|NCT00874432|459374784|FG002|Overall Study|Physician Decision|0|||
127659280|NCT00874432|459374785|FG003|Overall Study|Physician Decision|0|||
127659281|NCT00874432|459374782|FG000|Overall Study|Other|1|||
127659282|NCT00874432|459374783|FG001|Overall Study|Other|2|||
127659283|NCT00874432|459374784|FG002|Overall Study|Other|8|||
127659284|NCT00874432|459374785|FG003|Overall Study|Other|3|||
127659285|NCT01167179|459376493|FG000|Overall Study|disease recurrence|4|||
127659286|NCT01167179|459376494|FG001|Overall Study|disease recurrence|4|||
127659287|NCT01167179|459376493|FG000|Overall Study|Death|4|||
127659288|NCT01167179|459376494|FG001|Overall Study|Death|10|||
127659289|NCT01167179|459376493|FG000|Overall Study|Withdrawal by Subject|1|||
127659290|NCT01167179|459376494|FG001|Overall Study|Withdrawal by Subject|2|||
127659291|NCT01167179|459376493|FG000|Overall Study|diverse|6|||
127659292|NCT01167179|459376494|FG001|Overall Study|diverse|5|||
127659293|NCT02781506|459376495|FG000|Overall Study|Adverse Event|5|||
127659294|NCT01158378|459376496|FG000|Overall Study|Death|4|||
127659295|NCT01158378|459376497|FG001|Overall Study|Death|5|||
127659296|NCT01158378|459376496|FG000|Overall Study|Lost to Follow-up|2|||
127659297|NCT01158378|459376497|FG001|Overall Study|Lost to Follow-up|4|||
127659298|NCT01158378|459376496|FG000|Overall Study|Withdrawal by Subject|4|||
127659299|NCT01158378|459376497|FG001|Overall Study|Withdrawal by Subject|0|||
127659300|NCT03017235|459376498|FG000|Overall Study|Withdrawal by Subject|4|||
127659301|NCT03017235|459376499|FG001|Overall Study|Withdrawal by Subject|3|||
127659302|NCT03017235|459376498|FG000|Overall Study|Lost to Follow-up|2|||
127659303|NCT03017235|459376499|FG001|Overall Study|Lost to Follow-up|7|||
127659304|NCT03017235|459376498|FG000|Overall Study|Adverse Event|0|||
127659305|NCT03017235|459376499|FG001|Overall Study|Adverse Event|1|||
127659306|NCT03017235|459376498|FG000|Overall Study|Protocol Violation|2|||
127659307|NCT03017235|459376499|FG001|Overall Study|Protocol Violation|1|||
127659308|NCT03017235|459376498|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
127659309|NCT03017235|459376499|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
127659310|NCT02593539|459376503|FG000|Overall Study|Adverse Event|1|||
127988864|NCT01370616|460584629|FG000|Overall Study|Withdrawal by Subject|34|||
127988865|NCT01370616|460584630|FG001|Overall Study|Withdrawal by Subject|34|||
127659311|NCT00649389|459376504|FG000|Overall Study|Adverse Event|22|||
127659312|NCT00649389|459376505|FG001|Overall Study|Adverse Event|46|||
127659313|NCT00649389|459376506|FG002|Overall Study|Adverse Event|38|||
127659314|NCT00649389|459376507|FG003|Overall Study|Adverse Event|48|||
127659315|NCT00649389|459376504|FG000|Overall Study|Lost to Follow-up|15|||
127659316|NCT00649389|459376505|FG001|Overall Study|Lost to Follow-up|17|||
127659317|NCT00649389|459376506|FG002|Overall Study|Lost to Follow-up|21|||
127659318|NCT00649389|459376507|FG003|Overall Study|Lost to Follow-up|26|||
127659319|NCT00649389|459376504|FG000|Overall Study|Protocol Violation|11|||
127659320|NCT00649389|459376505|FG001|Overall Study|Protocol Violation|13|||
127659321|NCT00649389|459376506|FG002|Overall Study|Protocol Violation|9|||
127659322|NCT00649389|459376507|FG003|Overall Study|Protocol Violation|8|||
127659323|NCT00649389|459376504|FG000|Overall Study|Withdrawal by Subject|20|||
127659324|NCT00649389|459376505|FG001|Overall Study|Withdrawal by Subject|21|||
127659325|NCT00649389|459376506|FG002|Overall Study|Withdrawal by Subject|19|||
127659326|NCT00649389|459376507|FG003|Overall Study|Withdrawal by Subject|23|||
127659327|NCT00649389|459376504|FG000|Overall Study|Other|3|||
127659328|NCT00649389|459376505|FG001|Overall Study|Other|9|||
127659329|NCT00649389|459376506|FG002|Overall Study|Other|1|||
127659330|NCT00649389|459376507|FG003|Overall Study|Other|6|||
127659331|NCT01806740|459376508|FG000|Overall Study|Withdrawal by Subject|4|||
127659332|NCT01806740|459376508|FG000|Overall Study|Physician Decision|1|||
127659333|NCT01806740|459376508|FG000|Overall Study|Patient's refusal of treatment|1|||
127659334|NCT02105636|459376517|FG000|Pre-Treatment|Disease Progression|1|||
127659335|NCT02105636|459376518|FG001|Pre-Treatment|Disease Progression|0|||
127659336|NCT02105636|459376517|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
127659337|NCT02105636|459376518|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
127659338|NCT02105636|459376517|FG000|Pre-Treatment|Participant withdrew consent|0|||
127659339|NCT02105636|459376518|FG001|Pre-Treatment|Participant withdrew consent|6|||
127659340|NCT02105636|459376517|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
127659341|NCT02105636|459376518|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
127659342|NCT02105636|459376517|FG000|Treatment|Study Drug Toxicity|14|||
127988866|NCT02324699|460584631|FG000|Overall Study|study terminated|1|||
127988867|NCT01605825|460584636|FG000|Overall Study|Adverse Event|4|||
127988868|NCT01605825|460584637|FG001|Overall Study|Adverse Event|2|||
127988869|NCT01605825|460584636|FG000|Overall Study|Withdrawal by Subject|0|||
127988870|NCT01605825|460584637|FG001|Overall Study|Withdrawal by Subject|1|||
127988871|NCT01605825|460584636|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
127988872|NCT01605825|460584637|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
127988873|NCT01605825|460584636|FG000|Overall Study|Non-Compliance with Protocol|3|||
127659343|NCT02105636|459376518|FG001|Treatment|Study Drug Toxicity|10|||
127659344|NCT02105636|459376517|FG000|Treatment|Adverse event unrelated to study drug|19|||
127659345|NCT02105636|459376518|FG001|Treatment|Adverse event unrelated to study drug|3|||
127659346|NCT02105636|459376517|FG000|Treatment|Participant request to discontinue study treatment|8|||
127988874|NCT01605825|460584637|FG001|Overall Study|Non-Compliance with Protocol|0|||
127988875|NCT01578499|460584642|FG000|Overall Study|Reason not Specified|0|||
127988876|NCT01578499|460584643|FG001|Overall Study|Reason not Specified|1|||
127988877|NCT01578499|460584642|FG000|Overall Study|Lost to Follow-up|2|||
127988878|NCT01578499|460584643|FG001|Overall Study|Lost to Follow-up|1|||
127988879|NCT01578499|460584642|FG000|Overall Study|Withdrawal by Subject|10|||
127988880|NCT01578499|460584643|FG001|Overall Study|Withdrawal by Subject|16|||
127988881|NCT01578499|460584642|FG000|Overall Study|Death|20|||
127988882|NCT01578499|460584643|FG001|Overall Study|Death|25|||
127988883|NCT01578499|460584642|FG000|Overall Study|Died and End of Study Page not Completed|2|||
127988884|NCT01578499|460584643|FG001|Overall Study|Died and End of Study Page not Completed|0|||
127988885|NCT02670382|460584644|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
127988886|NCT02670382|460584645|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
127988887|NCT03244618|460584646|FG000|Overall Study|Lost to Follow-up|3|||
127988888|NCT03244618|460584647|FG001|Overall Study|Lost to Follow-up|4|||
127988889|NCT03244618|460584646|FG000|Overall Study|Protocol Violation|4|||
127988890|NCT03244618|460584647|FG001|Overall Study|Protocol Violation|3|||
127988891|NCT03244618|460584646|FG000|Overall Study|Withdrawal by Subject|0|||
127988892|NCT03244618|460584647|FG001|Overall Study|Withdrawal by Subject|2|||
127988893|NCT03469999|460584650|FG000|Overall Study|Lost to Follow-up|2|||
127988894|NCT00394771|460584651|FG000|Overall Study|Did not meet protocol requirements|1|||
127988895|NCT00394771|460584652|FG001|Overall Study|Did not meet protocol requirements|0|||
127988896|NCT00394771|460584653|FG002|Overall Study|Did not meet protocol requirements|2|||
127988897|NCT00394771|460584654|FG003|Overall Study|Did not meet protocol requirements|0|||
127988898|NCT00394771|460584651|FG000|Overall Study|Protocol Violation|2|||
127988899|NCT00394771|460584652|FG001|Overall Study|Protocol Violation|4|||
127988900|NCT00394771|460584653|FG002|Overall Study|Protocol Violation|9|||
127988901|NCT00394771|460584654|FG003|Overall Study|Protocol Violation|7|||
127988902|NCT00394771|460584651|FG000|Overall Study|Withdrawal by Subject|10|||
127988903|NCT00394771|460584652|FG001|Overall Study|Withdrawal by Subject|6|||
127988904|NCT00394771|460584653|FG002|Overall Study|Withdrawal by Subject|8|||
127988905|NCT00394771|460584654|FG003|Overall Study|Withdrawal by Subject|12|||
127988906|NCT00394771|460584651|FG000|Overall Study|Adverse Event|10|||
127659347|NCT02105636|459376518|FG001|Treatment|Participant request to discontinue study treatment|6|||
127659348|NCT02105636|459376517|FG000|Treatment|Participant withdrew consent|5|||
127659349|NCT02105636|459376518|FG001|Treatment|Participant withdrew consent|1|||
127988907|NCT00394771|460584652|FG001|Overall Study|Adverse Event|5|||
127988908|NCT00394771|460584653|FG002|Overall Study|Adverse Event|12|||
127988909|NCT00394771|460584654|FG003|Overall Study|Adverse Event|8|||
127988910|NCT00394771|460584651|FG000|Overall Study|Participant pregnant|0|||
127988911|NCT00394771|460584652|FG001|Overall Study|Participant pregnant|1|||
127659350|NCT02105636|459376517|FG000|Treatment|Lost to Follow-up|1|||
127659351|NCT02105636|459376518|FG001|Treatment|Lost to Follow-up|0|||
127659352|NCT02105636|459376517|FG000|Treatment|Maximum Clinical Benefit|1|||
127659353|NCT02105636|459376518|FG001|Treatment|Maximum Clinical Benefit|3|||
127659354|NCT02105636|459376517|FG000|Treatment|Poor/Non-compliance|0|||
127659355|NCT02105636|459376518|FG001|Treatment|Poor/Non-compliance|1|||
127659356|NCT02105636|459376517|FG000|Treatment|Participant no longer meets study criteria|1|||
127659357|NCT02105636|459376518|FG001|Treatment|Participant no longer meets study criteria|0|||
127659358|NCT02105636|459376517|FG000|Treatment|Other reasons|1|||
127659359|NCT02105636|459376518|FG001|Treatment|Other reasons|0|||
127659360|NCT02105636|459376517|FG000|Treatment|Disease Progression|185|||
127659361|NCT02105636|459376518|FG001|Treatment|Disease Progression|87|||
127659362|NCT00592319|459376520|FG000|Overall Study|Lost to Follow-up|0|||
127659363|NCT00592319|459376521|FG001|Overall Study|Lost to Follow-up|3|||
127659364|NCT03321513|459376525|FG000|Overall Study|Death|11|||
127659365|NCT03321513|459376526|FG001|Overall Study|Death|5|||
127659366|NCT03321513|459376525|FG000|Overall Study|Withdrawal by Subject|5|||
127659367|NCT03321513|459376526|FG001|Overall Study|Withdrawal by Subject|10|||
127659368|NCT03321513|459376525|FG000|Overall Study|Lost to Follow-up|10|||
127659369|NCT03321513|459376526|FG001|Overall Study|Lost to Follow-up|11|||
127659370|NCT00312858|459376528|FG000|Overall Study|Adverse Event|0|||
127659371|NCT00312858|459376529|FG001|Overall Study|Adverse Event|1|||
127659372|NCT00312858|459376528|FG000|Overall Study|Lost to Follow-up|25|||
127659373|NCT00312858|459376529|FG001|Overall Study|Lost to Follow-up|42|||
127659374|NCT00312858|459376528|FG000|Overall Study|Protocol Violation|3|||
127659375|NCT00312858|459376529|FG001|Overall Study|Protocol Violation|8|||
127659376|NCT00312858|459376528|FG000|Overall Study|Withdraw by Participant|20|||
127659377|NCT00312858|459376529|FG001|Overall Study|Withdraw by Participant|20|||
127659378|NCT00312858|459376528|FG000|Overall Study|Participant Moved|11|||
127659379|NCT00312858|459376529|FG001|Overall Study|Participant Moved|10|||
127659380|NCT00312858|459376528|FG000|Overall Study|Other|9|||
127659381|NCT00312858|459376529|FG001|Overall Study|Other|12|||
127659382|NCT01336634|459376530|FG000|Overall Study|Study closed/terminated|5|||
127659383|NCT01336634|459376531|FG001|Overall Study|Study closed/terminated|6|||
127659384|NCT01336634|459376532|FG002|Overall Study|Study closed/terminated|6|||
127659385|NCT01336634|459376530|FG000|Overall Study|Lost to Follow-up|2|||
127659386|NCT01336634|459376531|FG001|Overall Study|Lost to Follow-up|1|||
127659387|NCT01336634|459376532|FG002|Overall Study|Lost to Follow-up|1|||
127659388|NCT01336634|459376530|FG000|Overall Study|Physician Decision|1|||
127659389|NCT01336634|459376531|FG001|Overall Study|Physician Decision|1|||
127659390|NCT01336634|459376532|FG002|Overall Study|Physician Decision|0|||
127659391|NCT01336634|459376530|FG000|Overall Study|Withdrawal by Subject|6|||
127659392|NCT01336634|459376531|FG001|Overall Study|Withdrawal by Subject|0|||
127659393|NCT01336634|459376532|FG002|Overall Study|Withdrawal by Subject|2|||
127659394|NCT01863043|459376533|FG000|Overall Study|Death|6|||
127659395|NCT01863043|459376534|FG001|Overall Study|Death|1|||
127659396|NCT01863043|459376533|FG000|Overall Study|Withdrawal by Subject|0|||
127659397|NCT01863043|459376534|FG001|Overall Study|Withdrawal by Subject|2|||
127659398|NCT01863043|459376533|FG000|Overall Study|Adverse Event|7|||
127659399|NCT01863043|459376534|FG001|Overall Study|Adverse Event|8|||
127659400|NCT01863043|459376533|FG000|Overall Study|exclusion criteria found after enrollment|0|||
127659401|NCT01863043|459376534|FG001|Overall Study|exclusion criteria found after enrollment|1|||
127659402|NCT04537897|459376535|FG000|Overall Study|Other than listed|0|||
127659403|NCT04537897|459376536|FG001|Overall Study|Other than listed|0|||
127659404|NCT04537897|459376537|FG002|Overall Study|Other than listed|0|||
127659405|NCT04537897|459376538|FG003|Overall Study|Other than listed|0|||
127659406|NCT04537897|459376539|FG004|Overall Study|Other than listed|0|||
127659407|NCT04537897|459376540|FG005|Overall Study|Other than listed|0|||
127659408|NCT04537897|459376541|FG006|Overall Study|Other than listed|1|||
127659409|NCT04537897|459376542|FG007|Overall Study|Other than listed|0|||
127659410|NCT04537897|459376543|FG008|Overall Study|Other than listed|0|||
127659411|NCT04537897|459376535|FG000|Overall Study|Adverse Event|0|||
127659412|NCT04537897|459376536|FG001|Overall Study|Adverse Event|0|||
127659413|NCT04537897|459376537|FG002|Overall Study|Adverse Event|0|||
127659414|NCT04537897|459376538|FG003|Overall Study|Adverse Event|1|||
127659415|NCT04537897|459376539|FG004|Overall Study|Adverse Event|0|||
127659416|NCT04537897|459376540|FG005|Overall Study|Adverse Event|0|||
127659417|NCT04537897|459376541|FG006|Overall Study|Adverse Event|0|||
127659418|NCT04537897|459376542|FG007|Overall Study|Adverse Event|0|||
127659419|NCT04537897|459376543|FG008|Overall Study|Adverse Event|0|||
127659420|NCT04537897|459376535|FG000|Overall Study|Withdrawal by Subject|0|||
127988912|NCT00394771|460584653|FG002|Overall Study|Participant pregnant|2|||
127988913|NCT00394771|460584654|FG003|Overall Study|Participant pregnant|2|||
127659421|NCT04537897|459376536|FG001|Overall Study|Withdrawal by Subject|1|||
127659422|NCT04537897|459376537|FG002|Overall Study|Withdrawal by Subject|0|||
127659423|NCT04537897|459376538|FG003|Overall Study|Withdrawal by Subject|0|||
127659424|NCT04537897|459376539|FG004|Overall Study|Withdrawal by Subject|0|||
127659425|NCT04537897|459376540|FG005|Overall Study|Withdrawal by Subject|0|||
127659426|NCT04537897|459376541|FG006|Overall Study|Withdrawal by Subject|0|||
127659427|NCT04537897|459376542|FG007|Overall Study|Withdrawal by Subject|0|||
127659428|NCT04537897|459376543|FG008|Overall Study|Withdrawal by Subject|0|||
127659429|NCT00197028|459376547|FG000|Overall Study|Adverse Event|2|||
127659430|NCT00197028|459376548|FG001|Overall Study|Adverse Event|2|||
127659431|NCT00197028|459376547|FG000|Overall Study|Protocol Violation|2|||
127988914|NCT00394771|460584651|FG000|Overall Study|Lost to Follow-up|15|||
127988915|NCT00394771|460584652|FG001|Overall Study|Lost to Follow-up|15|||
127988916|NCT00394771|460584653|FG002|Overall Study|Lost to Follow-up|13|||
127988917|NCT00394771|460584654|FG003|Overall Study|Lost to Follow-up|10|||
127988918|NCT00394771|460584651|FG000|Overall Study|Other|3|||
127988919|NCT00394771|460584652|FG001|Overall Study|Other|3|||
127988920|NCT00394771|460584653|FG002|Overall Study|Other|1|||
127988921|NCT00394771|460584654|FG003|Overall Study|Other|0|||
127988922|NCT00586898|460584659|FG000|Overall Study|Adverse Event|1|||
127988923|NCT00586898|460584659|FG000|Overall Study|Patiemt Non-compliance|1|||
127988924|NCT00586898|460584659|FG000|Overall Study|Evaluable for Toxicity Only|5|||
127988925|NCT03816007|460584660|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
127988926|NCT03816007|460584661|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
127988927|NCT03816007|460584660|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
127988928|NCT03816007|460584661|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
127988929|NCT03816007|460584660|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
127988930|NCT03816007|460584661|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
127988931|NCT01926197|460584662|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
127988932|NCT01926197|460584663|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
127988933|NCT01926197|460584662|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
127988934|NCT01926197|460584663|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
127988935|NCT02101359|460584665|FG000|Overall Study|Not included|23|||
127988936|NCT02101359|460584666|FG001|Overall Study|Not included|13|||
127988937|NCT02101359|460584665|FG000|Overall Study|Withdrawal by Subject|5|||
127988938|NCT02101359|460584666|FG001|Overall Study|Withdrawal by Subject|4|||
127988939|NCT02101359|460584665|FG000|Overall Study|Lost to Follow-up|1|||
127988940|NCT02101359|460584666|FG001|Overall Study|Lost to Follow-up|0|||
127988941|NCT02101359|460584665|FG000|Overall Study|Protocol Violation|0|||
127988942|NCT02101359|460584666|FG001|Overall Study|Protocol Violation|2|||
127988943|NCT01483599|460584668|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
127988944|NCT01483599|460584669|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
127988945|NCT01483599|460584670|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
127988946|NCT01483599|460584671|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
127988947|NCT01483599|460584672|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
127988948|NCT01483599|460584673|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
127988949|NCT01483599|460584674|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
127988950|NCT01483599|460584675|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
127988951|NCT01483599|460584676|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
127988952|NCT01483599|460584677|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
127988953|NCT01483599|460584678|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
127988954|NCT01483599|460584679|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
127988955|NCT01483599|460584680|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
127988956|NCT01483599|460584681|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
127988957|NCT01483599|460584668|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
127988958|NCT01483599|460584669|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
127988959|NCT01483599|460584670|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
127988960|NCT01483599|460584671|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
127988961|NCT01483599|460584672|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
127988962|NCT01483599|460584673|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
127988963|NCT01483599|460584674|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
127988964|NCT01483599|460584675|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
127988965|NCT01483599|460584676|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
127988966|NCT01483599|460584677|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
127988967|NCT01483599|460584678|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
127659432|NCT00197028|459376548|FG001|Overall Study|Protocol Violation|1|||
127659433|NCT00197028|459376547|FG000|Overall Study|Withdrawal by Subject|8|||
127659434|NCT00197028|459376548|FG001|Overall Study|Withdrawal by Subject|12|||
127659435|NCT00197028|459376547|FG000|Overall Study|Lost to Follow-up|1|||
127659436|NCT00197028|459376548|FG001|Overall Study|Lost to Follow-up|0|||
127659437|NCT00197028|459376547|FG000|Overall Study|Other|3|||
127659438|NCT00197028|459376548|FG001|Overall Study|Other|6|||
127659439|NCT01372605|459376553|FG000|Overall Study|Death|1|||
127659440|NCT01372605|459376554|FG001|Overall Study|Death|2|||
127659441|NCT01372605|459376553|FG000|Overall Study|Lost to Follow-up|2|||
127659442|NCT01372605|459376554|FG001|Overall Study|Lost to Follow-up|1|||
127659443|NCT01372605|459376553|FG000|Overall Study|Withdrawal by Subject|4|||
127659444|NCT01372605|459376554|FG001|Overall Study|Withdrawal by Subject|7|||
127659445|NCT01372605|459376553|FG000|Overall Study|Moved|3|||
127988968|NCT01483599|460584679|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
127659446|NCT01372605|459376554|FG001|Overall Study|Moved|0|||
127659447|NCT01372605|459376553|FG000|Overall Study|Changed medical home|2|||
127659448|NCT01372605|459376554|FG001|Overall Study|Changed medical home|0|||
127659449|NCT01108510|459376555|FG000|Overall Study|Randomized but Not Treated|5|||
127642357|NCT01922076|459310115|FG004|Overall Study|Physician Decision|0|||
127642358|NCT01922076|459310116|FG005|Overall Study|Physician Decision|0|||
127642359|NCT01922076|459310117|FG006|Overall Study|Physician Decision|0|||
127642360|NCT01922076|459310111|FG000|Overall Study|Withdrawal by Subject|0|||
127642361|NCT01922076|459310112|FG001|Overall Study|Withdrawal by Subject|0|||
127642362|NCT01922076|459310113|FG002|Overall Study|Withdrawal by Subject|0|||
127642363|NCT01922076|459310114|FG003|Overall Study|Withdrawal by Subject|1|||
127642364|NCT01922076|459310115|FG004|Overall Study|Withdrawal by Subject|0|||
127642365|NCT01922076|459310116|FG005|Overall Study|Withdrawal by Subject|1|||
127642366|NCT01922076|459310117|FG006|Overall Study|Withdrawal by Subject|1|||
127642367|NCT01018394|459310120|FG000|Overall Study|Withdrawal by Subject|5|||
127642368|NCT01018394|459310121|FG001|Overall Study|Withdrawal by Subject|5|||
127642369|NCT01018394|459310120|FG000|Overall Study|Lost to Follow-up|4|||
127642370|NCT01018394|459310121|FG001|Overall Study|Lost to Follow-up|3|||
127642371|NCT00683644|459310122|FG000|Overall Study|Withdrawal by Subject|4|||
127642372|NCT00683644|459310123|FG001|Overall Study|Withdrawal by Subject|2|||
127642373|NCT00683644|459310122|FG000|Overall Study|Lost to Follow-up|1|||
127642374|NCT00683644|459310123|FG001|Overall Study|Lost to Follow-up|4|||
127642375|NCT00683644|459310122|FG000|Overall Study|Adverse Event|1|||
127642376|NCT00683644|459310123|FG001|Overall Study|Adverse Event|2|||
127642377|NCT00683644|459310122|FG000|Overall Study|Low copper, other health problems,|7|||
127642378|NCT00683644|459310123|FG001|Overall Study|Low copper, other health problems,|6|||
127642379|NCT01669122|459310124|FG000|Period I|Lost to Follow-up|1|||
127642380|NCT01669122|459310124|FG000|Washout Period II|Protocol Violation|2|||
127642381|NCT03762473|459310125|FG000|Overall Study|Death|1|||
127642382|NCT03762473|459310126|FG001|Overall Study|Death|0|||
127642383|NCT05132699|459310127|FG000|Overall Study|Withdrawal by Subject|3|||
127642384|NCT05132699|459310128|FG001|Overall Study|Withdrawal by Subject|0|||
127642385|NCT02858895|459310131|FG000|Overall Study|Disease progression|31|||
127642386|NCT02858895|459310131|FG000|Overall Study|Death|2|||
127642387|NCT02858895|459310131|FG000|Overall Study|Adverse Event|1|||
127642388|NCT02858895|459310131|FG000|Overall Study|Withdrawal by Subject|3|||
127642389|NCT02858895|459310131|FG000|Overall Study|hospice,|1|||
127642390|NCT02858895|459310131|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
127642391|NCT02277444|459310143|FG000|Overall Study|Adverse Event|10|||
127642392|NCT02277444|459310143|FG000|Overall Study|Withdrawal by Subject|3|||
127642393|NCT02277444|459310143|FG000|Overall Study|Other|1|||
127642394|NCT02277444|459310143|FG000|Overall Study|Enrolled and not Treated|3|||
127642395|NCT02277444|459310143|FG000|Overall Study|Ongoing|113|||
127642396|NCT00844857|459313016|FG000|Overall Study|Adverse Event|24|||
127642397|NCT00844857|459313017|FG001|Overall Study|Adverse Event|5|||
127642398|NCT00844857|459313016|FG000|Overall Study|Sponsor Decision|1|||
127642399|NCT00844857|459313017|FG001|Overall Study|Sponsor Decision|1|||
127642400|NCT00844857|459313016|FG000|Overall Study|Physician Decision|2|||
127642401|NCT00844857|459313017|FG001|Overall Study|Physician Decision|0|||
127642402|NCT00844857|459313016|FG000|Overall Study|Parent/Caregiver Decision|6|||
127642403|NCT00844857|459313017|FG001|Overall Study|Parent/Caregiver Decision|2|||
127642404|NCT00844857|459313016|FG000|Overall Study|Withdrawal by Subject|8|||
127642405|NCT00844857|459313017|FG001|Overall Study|Withdrawal by Subject|7|||
127642406|NCT00844857|459313016|FG000|Overall Study|Protocol Violation|6|||
127642407|NCT00844857|459313017|FG001|Overall Study|Protocol Violation|0|||
127642408|NCT00844857|459313016|FG000|Overall Study|Lack of Efficacy|5|||
127642409|NCT00844857|459313017|FG001|Overall Study|Lack of Efficacy|5|||
127642410|NCT00844857|459313016|FG000|Overall Study|Clinical Relapse|0|||
127642411|NCT00844857|459313017|FG001|Overall Study|Clinical Relapse|1|||
127642412|NCT00844857|459313016|FG000|Overall Study|Entry Criteria Not Met|0|||
127642413|NCT00844857|459313017|FG001|Overall Study|Entry Criteria Not Met|1|||
127642414|NCT00844857|459313016|FG000|Overall Study|Lost to Follow-up|2|||
127642415|NCT00844857|459313017|FG001|Overall Study|Lost to Follow-up|3|||
127642416|NCT00844857|459313016|FG000|Overall Study|Did Not Take Study Drug|3|||
127642417|NCT00844857|459313017|FG001|Overall Study|Did Not Take Study Drug|1|||
127642418|NCT00844857|459313016|FG000|Overall Study|Good Clinical Practice Violations|21|||
127642419|NCT00844857|459313017|FG001|Overall Study|Good Clinical Practice Violations|11|||
127642420|NCT03393000|459313024|FG000|Overall Study|Death|11|||
127642421|NCT03393000|459313024|FG000|Overall Study|Withdrawal by Subject|2|||
127642422|NCT03393000|459313024|FG000|Overall Study|Physician Decision|1|||
127642423|NCT01773070|459313025|FG000|Overall Study|Withdrawal by Subject|24|||
127642424|NCT01773070|459313025|FG000|Overall Study|Lost to Follow-up|39|||
127642425|NCT01773070|459313025|FG000|Overall Study|Other|15|||
127642426|NCT01773070|459313025|FG000|Overall Study|Death (unrelated to study procedures)|3|||
127642427|NCT03643952|459313026|FG000|Overall Study|Lack of Efficacy|1|||
127642428|NCT04528069|459313027|FG000|Overall Study|Adverse Event|1|||
127642429|NCT04528069|459313027|FG000|Overall Study|Lost to Follow-up|1|||
127642430|NCT04528069|459313027|FG000|Overall Study|Patient Unable to Come|1|||
127642431|NCT04528069|459313027|FG000|Overall Study|Patient Unable to Attend|1|||
127642432|NCT02525874|459313030|FG000|Overall Study|Other|1|||
127642433|NCT02525874|459313030|FG000|Overall Study|Investigator Decision|1|||
127642434|NCT02525874|459313030|FG000|Overall Study|Consent withdrawn|22|||
127642435|NCT02525874|459313030|FG000|Overall Study|Non-compliance with study drug|3|||
127642436|NCT02525874|459313030|FG000|Overall Study|Adverse Event|17|||
127642437|NCT02525874|459313030|FG000|Overall Study|Lost to Follow-up|7|||
127642438|NCT02525874|459313030|FG000|Overall Study|Disease progression, defined by protocol|2|||
127642439|NCT02525874|459313030|FG000|Overall Study|Disease relapse|4|||
127642440|NCT02525874|459313030|FG000|Overall Study|Alternative Treatment for MS|2|||
127642441|NCT02525874|459313030|FG000|Overall Study|New lesions in Brain|1|||
127642442|NCT01692782|459313033|FG000|Overall Study|Adverse Event|12|||
127642443|NCT01692782|459313034|FG001|Overall Study|Adverse Event|32|||
127642444|NCT01692782|459313035|FG002|Overall Study|Adverse Event|2|||
127642445|NCT01692782|459313033|FG000|Overall Study|Lack of Efficacy|1|||
127642446|NCT01692782|459313034|FG001|Overall Study|Lack of Efficacy|2|||
127642447|NCT01692782|459313035|FG002|Overall Study|Lack of Efficacy|0|||
127642448|NCT01692782|459313033|FG000|Overall Study|Lost to Follow-up|2|||
127642449|NCT01692782|459313034|FG001|Overall Study|Lost to Follow-up|7|||
127642450|NCT01692782|459313035|FG002|Overall Study|Lost to Follow-up|1|||
127642451|NCT01692782|459313033|FG000|Overall Study|Pregnancy|1|||
127642452|NCT01692782|459313034|FG001|Overall Study|Pregnancy|0|||
127642453|NCT01692782|459313035|FG002|Overall Study|Pregnancy|0|||
127642454|NCT01692782|459313033|FG000|Overall Study|Protocol Violation|1|||
127642455|NCT01692782|459313034|FG001|Overall Study|Protocol Violation|0|||
127642456|NCT01692782|459313035|FG002|Overall Study|Protocol Violation|2|||
127642457|NCT01692782|459313033|FG000|Overall Study|Non-complance with study drug|0|||
127642458|NCT01692782|459313034|FG001|Overall Study|Non-complance with study drug|4|||
127642459|NCT01692782|459313035|FG002|Overall Study|Non-complance with study drug|1|||
127642460|NCT01692782|459313033|FG000|Overall Study|Non-compliant with study visits|0|||
127642461|NCT01692782|459313034|FG001|Overall Study|Non-compliant with study visits|0|||
127642462|NCT01692782|459313035|FG002|Overall Study|Non-compliant with study visits|1|||
127642463|NCT01692782|459313033|FG000|Overall Study|SAE not related to study drug|0|||
127642464|NCT01692782|459313034|FG001|Overall Study|SAE not related to study drug|1|||
127642465|NCT01692782|459313035|FG002|Overall Study|SAE not related to study drug|0|||
127642466|NCT01692782|459313033|FG000|Overall Study|Withdrawal by Subject|3|||
127642467|NCT01692782|459313034|FG001|Overall Study|Withdrawal by Subject|10|||
127642468|NCT01692782|459313035|FG002|Overall Study|Withdrawal by Subject|3|||
127642469|NCT03945188|459313041|FG000|Overall Study|Protocol Violation|1|||
127642470|NCT03945188|459313042|FG001|Overall Study|Protocol Violation|0|||
127642471|NCT03945188|459313041|FG000|Overall Study|Disease worsening|79|||
127642472|NCT03945188|459313042|FG001|Overall Study|Disease worsening|73|||
127642473|NCT03945188|459313041|FG000|Overall Study|Physician Decision|2|||
127642474|NCT03945188|459313042|FG001|Overall Study|Physician Decision|2|||
127642475|NCT03945188|459313041|FG000|Overall Study|Lack of Efficacy|7|||
127642476|NCT03945188|459313042|FG001|Overall Study|Lack of Efficacy|4|||
127642477|NCT03945188|459313041|FG000|Overall Study|Pregnancy|2|||
127642478|NCT03945188|459313042|FG001|Overall Study|Pregnancy|0|||
127642479|NCT03945188|459313041|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
127642480|NCT03945188|459313042|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
127642481|NCT03945188|459313041|FG000|Overall Study|Adverse Event|10|||
127642482|NCT03945188|459313042|FG001|Overall Study|Adverse Event|5|||
127642483|NCT03945188|459313041|FG000|Overall Study|Other|2|||
127642484|NCT03945188|459313042|FG001|Overall Study|Other|2|||
127642485|NCT03945188|459313041|FG000|Overall Study|Lost to Follow-up|1|||
127642486|NCT03945188|459313042|FG001|Overall Study|Lost to Follow-up|2|||
127642487|NCT02219048|459313052|FG000|Overall Study|Adverse Event|2|||
127642488|NCT02219048|459313053|FG001|Overall Study|Adverse Event|5|||
127642489|NCT02219048|459313052|FG000|Overall Study|No longer meets eligibility criteria|1|||
127642490|NCT02219048|459313053|FG001|Overall Study|No longer meets eligibility criteria|0|||
127642491|NCT02219048|459313052|FG000|Overall Study|Study terminated by sponsor|16|||
127642492|NCT02219048|459313053|FG001|Overall Study|Study terminated by sponsor|15|||
127642493|NCT02219048|459313052|FG000|Overall Study|Withdrawal by Subject|2|||
127642494|NCT02219048|459313053|FG001|Overall Study|Withdrawal by Subject|0|||
127642495|NCT02219048|459313052|FG000|Overall Study|Other|0|||
127642496|NCT02219048|459313053|FG001|Overall Study|Other|1|||
127642497|NCT01618162|459313070|FG000|Overall Study|Protocol Violation|13|||
127642498|NCT01618162|459313071|FG001|Overall Study|Protocol Violation|10|||
127642499|NCT01618162|459313070|FG000|Overall Study|Adverse Event|9|||
127642500|NCT01618162|459313071|FG001|Overall Study|Adverse Event|2|||
127642501|NCT01618162|459313070|FG000|Overall Study|Withdrawal Criteria|2|||
127642502|NCT01618162|459313071|FG001|Overall Study|Withdrawal Criteria|10|||
127642503|NCT01618162|459313070|FG000|Overall Study|Unclassified|14|||
127642504|NCT01618162|459313071|FG001|Overall Study|Unclassified|13|||
127642505|NCT04124926|459313072|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
127988969|NCT01483599|460584680|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
127988970|NCT01483599|460584681|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
127988971|NCT01483599|460584668|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
127988972|NCT01483599|460584669|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
127988973|NCT01483599|460584670|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
127988974|NCT01483599|460584671|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
127988975|NCT01483599|460584672|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
127988976|NCT01483599|460584673|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
127988977|NCT01483599|460584674|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
127659450|NCT01108510|459376556|FG001|Overall Study|Randomized but Not Treated|1|||
127659451|NCT01108510|459376555|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
127659452|NCT01108510|459376556|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
127659453|NCT01108510|459376555|FG000|Overall Study|Adverse Event|26|||
127659454|NCT01108510|459376556|FG001|Overall Study|Adverse Event|19|||
127659455|NCT01108510|459376555|FG000|Overall Study|Lost to Follow-up|20|||
127659456|NCT01108510|459376556|FG001|Overall Study|Lost to Follow-up|17|||
127659457|NCT01108510|459376555|FG000|Overall Study|Withdrew Consent|21|||
127659458|NCT01108510|459376556|FG001|Overall Study|Withdrew Consent|15|||
127659459|NCT01108510|459376555|FG000|Overall Study|Investigator's Discretion|12|||
127659460|NCT01108510|459376556|FG001|Overall Study|Investigator's Discretion|10|||
127659461|NCT01108510|459376555|FG000|Overall Study|Participant Noncompliance|5|||
127659462|NCT01108510|459376556|FG001|Overall Study|Participant Noncompliance|7|||
127659463|NCT01108510|459376555|FG000|Overall Study|Lack of Efficacy|3|||
127659464|NCT01108510|459376556|FG001|Overall Study|Lack of Efficacy|0|||
127659465|NCT01108510|459376555|FG000|Overall Study|Pregnancy|0|||
127659466|NCT01108510|459376556|FG001|Overall Study|Pregnancy|3|||
127659467|NCT01108510|459376555|FG000|Overall Study|Death|1|||
127659468|NCT01108510|459376556|FG001|Overall Study|Death|1|||
127659469|NCT02796963|459376557|FG000|Overall Study|Lost to Follow-up|89|||
127659470|NCT02796963|459376558|FG001|Overall Study|Lost to Follow-up|76|||
127659471|NCT02796963|459376559|FG002|Overall Study|Lost to Follow-up|69|||
127659472|NCT02796963|459376560|FG003|Overall Study|Lost to Follow-up|72|||
127659473|NCT00951509|459376561|FG000|Overall Study|Withdrawal by Subject|2|||
127659474|NCT00582491|459376562|FG000|Overall Study|Withdrawal by Subject|1|||
127659475|NCT00582491|459376563|FG001|Overall Study|Withdrawal by Subject|0|||
127659476|NCT04192630|459376564|FG000|Overall Study|Discontinued before surgery|2|||
127659477|NCT04192630|459376565|FG001|Overall Study|Discontinued before surgery|0|||
127659478|NCT04192630|459376564|FG000|Overall Study|Discontinued after surgery|5|||
127659479|NCT04192630|459376565|FG001|Overall Study|Discontinued after surgery|3|||
127659480|NCT01425632|459376566|FG000|Overall Study|Adverse Event|0|||
127659481|NCT01425632|459376567|FG001|Overall Study|Adverse Event|1|||
127659482|NCT01425632|459376568|FG002|Overall Study|Adverse Event|1|||
127659483|NCT01425632|459376566|FG000|Overall Study|Physician Decision|1|||
127659484|NCT01425632|459376567|FG001|Overall Study|Physician Decision|0|||
127659485|NCT01425632|459376568|FG002|Overall Study|Physician Decision|0|||
127659486|NCT01425632|459376566|FG000|Overall Study|Protocol Violation|0|||
127659487|NCT01425632|459376567|FG001|Overall Study|Protocol Violation|0|||
127659488|NCT01425632|459376568|FG002|Overall Study|Protocol Violation|2|||
127659489|NCT01425632|459376566|FG000|Overall Study|Withdrawal by Subject|0|||
127659490|NCT01425632|459376567|FG001|Overall Study|Withdrawal by Subject|0|||
127659491|NCT01425632|459376568|FG002|Overall Study|Withdrawal by Subject|1|||
127659492|NCT01208415|459376571|FG000|Overall Study|Death|1|||
127659493|NCT01208415|459376571|FG000|Overall Study|Lost to Follow-up|2|||
127659494|NCT01208415|459376571|FG000|Overall Study|Withdrawal by Subject|3|||
127659495|NCT01208415|459376571|FG000|Overall Study|Device not placed|1|||
127659496|NCT01208415|459376571|FG000|Overall Study|Still be eligible for follow-up|33|||
127659497|NCT01115491|459376572|FG000|Overall Study|Death|22|||
127659498|NCT01115491|459376572|FG000|Overall Study|Adverse Event|3|||
127659499|NCT01115491|459376572|FG000|Overall Study|Lost to Follow-up|3|||
127659500|NCT01115491|459376572|FG000|Overall Study|Withdrawal by Subject|1|||
127659501|NCT01115491|459376572|FG000|Overall Study|Physician Decision|1|||
127659502|NCT04297241|459376573|FG000|Overall Study|Withdrawal by Subject|1|||
127659503|NCT04297241|459376573|FG000|Overall Study|Adverse Event|1|||
127659504|NCT04297241|459376573|FG000|Overall Study|Physician Decision|3|||
127659505|NCT01003639|459376576|FG000|Overall Study|Lost to Follow-up|6|||
127659506|NCT01003639|459376577|FG001|Overall Study|Lost to Follow-up|9|||
127659507|NCT01003639|459376576|FG000|Overall Study|Withdrawal by Subject|9|||
127659508|NCT01003639|459376577|FG001|Overall Study|Withdrawal by Subject|5|||
127659509|NCT01003639|459376576|FG000|Overall Study|Lack of Efficacy|1|||
127659510|NCT01003639|459376577|FG001|Overall Study|Lack of Efficacy|6|||
127659511|NCT01003639|459376576|FG000|Overall Study|Adverse Event|0|||
127659512|NCT01003639|459376577|FG001|Overall Study|Adverse Event|1|||
127659513|NCT01003639|459376576|FG000|Overall Study|Protocol Violation|0|||
127659514|NCT01003639|459376577|FG001|Overall Study|Protocol Violation|1|||
127659515|NCT01003639|459376576|FG000|Overall Study|Physician Decision|1|||
127659516|NCT01003639|459376577|FG001|Overall Study|Physician Decision|0|||
127659517|NCT04362137|459376581|FG000|Overall Study|Death|9|||
127659518|NCT04362137|459376582|FG001|Overall Study|Death|3|||
127988978|NCT01483599|460584675|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
127988979|NCT01483599|460584676|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
127659519|NCT04362137|459376581|FG000|Overall Study|Patient decision|6|||
127659520|NCT04362137|459376582|FG001|Overall Study|Patient decision|3|||
127659521|NCT04362137|459376581|FG000|Overall Study|Adverse Event|1|||
127659522|NCT04362137|459376582|FG001|Overall Study|Adverse Event|0|||
127659523|NCT04362137|459376581|FG000|Overall Study|Lost to Follow-up|1|||
127659524|NCT04362137|459376582|FG001|Overall Study|Lost to Follow-up|0|||
127659525|NCT04362137|459376581|FG000|Overall Study|Protocol deviation|1|||
127659526|NCT04362137|459376582|FG001|Overall Study|Protocol deviation|0|||
127659527|NCT03306043|459376586|FG000|Overall Study|Adverse Event|1|||
127659528|NCT03306043|459376586|FG000|Overall Study|Lost to Follow-up|1|||
127659529|NCT03306043|459376586|FG000|Overall Study|Withdrawal by Subject|2|||
127659530|NCT00785538|459376587|FG000|Treatment Period|Adverse Event|1|||
127659531|NCT00785538|459376588|FG001|Treatment Period|Adverse Event|2|||
127659532|NCT00785538|459376589|FG002|Treatment Period|Adverse Event|2|||
127659533|NCT00785538|459376590|FG003|Treatment Period|Adverse Event|0|||
127659534|NCT00785538|459376587|FG000|Treatment Period|Withdrawal by Subject|0|||
127659535|NCT00785538|459376588|FG001|Treatment Period|Withdrawal by Subject|0|||
127659536|NCT00785538|459376589|FG002|Treatment Period|Withdrawal by Subject|0|||
127659537|NCT00785538|459376590|FG003|Treatment Period|Withdrawal by Subject|1|||
127659538|NCT04276090|459376591|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
127659539|NCT04276090|459376592|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
127659540|NCT01799720|459376593|FG000|Overall Study|Withdrawal by Subject|3|||
127659541|NCT01799720|459376594|FG001|Overall Study|Withdrawal by Subject|0|||
127659542|NCT01799720|459376595|FG002|Overall Study|Withdrawal by Subject|0|||
127659543|NCT01799720|459376593|FG000|Overall Study|Protocol Violation|0|||
127659544|NCT01799720|459376594|FG001|Overall Study|Protocol Violation|1|||
127659545|NCT01799720|459376595|FG002|Overall Study|Protocol Violation|0|||
127659546|NCT01799720|459376593|FG000|Overall Study|Pregnancy|0|||
127659547|NCT01799720|459376594|FG001|Overall Study|Pregnancy|0|||
127659548|NCT01799720|459376595|FG002|Overall Study|Pregnancy|1|||
127659549|NCT01234649|459376596|FG000|Overall Study|Withdrawal by Subject|32|||
127659550|NCT01234649|459376597|FG001|Overall Study|Withdrawal by Subject|26|||
127659551|NCT01234649|459376596|FG000|Overall Study|Pregnancy|6|||
127659552|NCT01234649|459376597|FG001|Overall Study|Pregnancy|6|||
127659553|NCT01234649|459376596|FG000|Overall Study|intolerant to side effects|4|||
127988980|NCT01483599|460584677|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
127988981|NCT01483599|460584678|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
127988982|NCT01483599|460584679|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
127988983|NCT01483599|460584680|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
127988984|NCT01483599|460584681|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
127988985|NCT01483599|460584668|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
127988986|NCT01483599|460584669|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
127988987|NCT01483599|460584670|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
127988988|NCT01483599|460584671|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
127988989|NCT01483599|460584672|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
127988990|NCT01483599|460584673|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
127988991|NCT01483599|460584674|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
127988992|NCT01483599|460584675|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
127988993|NCT01483599|460584676|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
127988994|NCT01483599|460584677|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
127988995|NCT01483599|460584678|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
127988996|NCT01483599|460584679|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
127988997|NCT01483599|460584680|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
127988998|NCT01483599|460584681|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
127988999|NCT01483599|460584668|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
127989000|NCT01483599|460584669|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
127989001|NCT01483599|460584670|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
127989002|NCT01483599|460584671|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
127989003|NCT01483599|460584672|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
127989004|NCT01483599|460584673|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
127989005|NCT01483599|460584674|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
127659554|NCT01234649|459376597|FG001|Overall Study|intolerant to side effects|3|||
127659555|NCT01234649|459376596|FG000|Overall Study|Allergic reaction|1|||
127659556|NCT01234649|459376597|FG001|Overall Study|Allergic reaction|0|||
127659557|NCT01234649|459376596|FG000|Overall Study|Lack of Efficacy|0|||
127659558|NCT01234649|459376597|FG001|Overall Study|Lack of Efficacy|3|||
127659559|NCT00318149|459376600|FG000|Overall Study|Adverse Event|0|||
127659560|NCT00318149|459376601|FG001|Overall Study|Adverse Event|0|||
127989006|NCT01483599|460584675|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
127989007|NCT01483599|460584676|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
127659561|NCT00318149|459376602|FG002|Overall Study|Adverse Event|0|||
127989008|NCT01483599|460584677|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
127989009|NCT01483599|460584678|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
127989010|NCT01483599|460584679|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
127989011|NCT01483599|460584680|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
127989012|NCT01483599|460584681|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
127989013|NCT01483599|460584668|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
127989014|NCT01483599|460584669|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
127989015|NCT01483599|460584670|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
127989016|NCT01483599|460584671|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
127989017|NCT01483599|460584672|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
127989018|NCT01483599|460584673|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
127989019|NCT01483599|460584674|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
127989020|NCT01483599|460584675|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
127989021|NCT01483599|460584676|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
127989022|NCT01483599|460584677|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
127989023|NCT01483599|460584678|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
127989024|NCT01483599|460584679|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
127989025|NCT01483599|460584680|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
127989026|NCT01483599|460584681|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
127989027|NCT01483599|460584668|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
127989028|NCT01483599|460584669|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
127989029|NCT01483599|460584670|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
127989030|NCT01483599|460584671|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
127989031|NCT01483599|460584672|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
127989032|NCT01483599|460584673|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
127989033|NCT01483599|460584674|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
127989034|NCT01483599|460584675|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
127989035|NCT01483599|460584676|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
127989036|NCT01483599|460584677|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
127989037|NCT01483599|460584678|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
127989038|NCT01483599|460584679|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
127989039|NCT01483599|460584680|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
127989040|NCT01483599|460584681|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
127989041|NCT01483599|460584668|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
127989042|NCT01483599|460584669|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
127989043|NCT01483599|460584670|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
127989044|NCT01483599|460584671|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
127989045|NCT01483599|460584672|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
127989046|NCT01483599|460584673|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
127989047|NCT01483599|460584674|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
127989048|NCT01483599|460584675|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
127989049|NCT01483599|460584676|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
127989050|NCT01483599|460584677|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
127989051|NCT01483599|460584678|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
127989052|NCT01483599|460584679|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
127989053|NCT01483599|460584680|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
127659562|NCT00318149|459376603|FG003|Overall Study|Adverse Event|0|||
127659563|NCT00318149|459376604|FG004|Overall Study|Adverse Event|0|||
127659564|NCT00318149|459376605|FG005|Overall Study|Adverse Event|2|||
127659565|NCT00785707|459376611|FG000|Overall Study|Lost to Follow-up|7|||
127659566|NCT00105586|459376612|FG000|Overall Study|Adverse Event|4|||
127659567|NCT00105586|459376613|FG001|Overall Study|Adverse Event|3|||
127659568|NCT00105586|459376612|FG000|Overall Study|Physician Decision|13|||
127659569|NCT00105586|459376613|FG001|Overall Study|Physician Decision|13|||
127659570|NCT02306122|459376614|FG000|Initial Physician Randomization|Physician Decision|0|||
127659571|NCT02306122|459376615|FG001|Initial Physician Randomization|Physician Decision|0|||
127659572|NCT02306122|459376616|FG002|Initial Physician Randomization|Physician Decision|0|||
127659573|NCT02306122|459376617|FG003|Initial Physician Randomization|Physician Decision|0|||
127659574|NCT02306122|459376618|FG004|Initial Physician Randomization|Physician Decision|0|||
127659575|NCT02306122|459376619|FG005|Initial Physician Randomization|Physician Decision|0|||
127659576|NCT02306122|459376620|FG006|Initial Physician Randomization|Physician Decision|0|||
127659577|NCT02306122|459376621|FG007|Initial Physician Randomization|Physician Decision|0|||
127989054|NCT01483599|460584681|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
127659578|NCT02306122|459376622|FG008|Initial Physician Randomization|Physician Decision|1|||
127659579|NCT02306122|459376623|FG009|Initial Physician Randomization|Physician Decision|0|||
127989055|NCT01483599|460584668|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
127989056|NCT01483599|460584669|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
127989057|NCT01483599|460584670|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
127989058|NCT01483599|460584671|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
127989059|NCT01483599|460584672|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
127989060|NCT01483599|460584673|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
127989061|NCT01483599|460584674|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
127989062|NCT01483599|460584675|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
127989063|NCT01483599|460584676|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
127989064|NCT01483599|460584677|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
127989065|NCT01483599|460584678|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
127989066|NCT01483599|460584679|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
127989067|NCT01483599|460584680|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
127989068|NCT01483599|460584681|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
127989069|NCT01483599|460584668|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
127989070|NCT01483599|460584669|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
127989071|NCT01483599|460584670|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
127989072|NCT01483599|460584671|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
127989073|NCT01483599|460584672|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
127989074|NCT01483599|460584673|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
127989075|NCT01483599|460584674|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
127989076|NCT01483599|460584675|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
127989077|NCT01483599|460584676|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
127989078|NCT01483599|460584677|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
127989079|NCT01483599|460584678|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
127989080|NCT01483599|460584679|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
127989081|NCT01483599|460584680|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
127989082|NCT01483599|460584681|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
127659580|NCT02306122|459376624|FG010|Initial Physician Randomization|Physician Decision|0|||
127659581|NCT02262260|459376625|FG000|Overall Study|Adverse Event|4|||
127659582|NCT02262260|459376626|FG001|Overall Study|Adverse Event|1|||
127659583|NCT02262260|459376625|FG000|Overall Study|Withdrawal of consent|4|||
127659584|NCT02262260|459376626|FG001|Overall Study|Withdrawal of consent|2|||
127659585|NCT02262260|459376625|FG000|Overall Study|Lost to Follow-up|1|||
127659586|NCT02262260|459376626|FG001|Overall Study|Lost to Follow-up|2|||
127659587|NCT02262260|459376625|FG000|Overall Study|Protocol deviation|2|||
127659588|NCT02262260|459376626|FG001|Overall Study|Protocol deviation|5|||
127659589|NCT01794117|459376630|FG000|Overall Study|Adverse Event|1|||
127659590|NCT01794117|459376631|FG001|Overall Study|Adverse Event|0|||
127659591|NCT01794117|459376632|FG002|Overall Study|Adverse Event|0|||
127659592|NCT01794117|459376633|FG003|Overall Study|Adverse Event|0|||
127659593|NCT01794117|459376630|FG000|Overall Study|Participant noncompliance|0|||
127659594|NCT01794117|459376631|FG001|Overall Study|Participant noncompliance|1|||
127659595|NCT01794117|459376632|FG002|Overall Study|Participant noncompliance|0|||
127659596|NCT01794117|459376633|FG003|Overall Study|Participant noncompliance|0|||
127659597|NCT01794117|459376630|FG000|Overall Study|Refused further treatment|0|||
127659598|NCT01794117|459376631|FG001|Overall Study|Refused further treatment|2|||
127659599|NCT01794117|459376632|FG002|Overall Study|Refused further treatment|0|||
127659600|NCT01794117|459376633|FG003|Overall Study|Refused further treatment|0|||
127659601|NCT03734991|459376634|FG000|Overall Study|Adverse Event|4|||
127659602|NCT03734991|459376635|FG001|Overall Study|Adverse Event|0|||
127659603|NCT03734991|459376634|FG000|Overall Study|Lost to Follow-up|4|||
127659604|NCT03734991|459376635|FG001|Overall Study|Lost to Follow-up|0|||
127659605|NCT03734991|459376634|FG000|Overall Study|Physician Decision|0|||
127659606|NCT03734991|459376635|FG001|Overall Study|Physician Decision|1|||
127659607|NCT03734991|459376634|FG000|Overall Study|Pregnancy|1|||
127659608|NCT03734991|459376635|FG001|Overall Study|Pregnancy|0|||
127659609|NCT03734991|459376634|FG000|Overall Study|Withdrawal by Subject|6|||
127659610|NCT03734991|459376635|FG001|Overall Study|Withdrawal by Subject|3|||
127659611|NCT03734991|459376634|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
127659612|NCT03734991|459376635|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
127659613|NCT03734991|459376634|FG000|Overall Study|Other|2|||
127659614|NCT03734991|459376635|FG001|Overall Study|Other|2|||
127659615|NCT02322814|459376638|FG000|Overall Study|Death|7|||
127659616|NCT02322814|459376639|FG001|Overall Study|Death|29|||
127659617|NCT02322814|459376640|FG002|Overall Study|Death|32|||
127989083|NCT01859949|460586326|FG000|Overall Study|Family Matters|0|||
127989084|NCT01859949|460586327|FG001|Overall Study|Family Matters|1|||
127659618|NCT02322814|459376641|FG003|Overall Study|Death|23|||
127659619|NCT02322814|459376642|FG004|Overall Study|Death|14|||
127659620|NCT02322814|459376638|FG000|Overall Study|Lost to Follow-up|1|||
127659621|NCT02322814|459376639|FG001|Overall Study|Lost to Follow-up|3|||
127659622|NCT02322814|459376640|FG002|Overall Study|Lost to Follow-up|3|||
127659623|NCT02322814|459376641|FG003|Overall Study|Lost to Follow-up|1|||
127989085|NCT01859949|460586326|FG000|Overall Study|Physician Decision|2|||
127989086|NCT01859949|460586327|FG001|Overall Study|Physician Decision|4|||
127989087|NCT01859949|460586326|FG000|Overall Study|Withdrawal by Subject|11|||
127989088|NCT01859949|460586327|FG001|Overall Study|Withdrawal by Subject|10|||
127989089|NCT01859949|460586326|FG000|Overall Study|Protocol Violation|1|||
127989090|NCT01859949|460586327|FG001|Overall Study|Protocol Violation|1|||
127659624|NCT02322814|459376642|FG004|Overall Study|Lost to Follow-up|0|||
127659625|NCT02322814|459376638|FG000|Overall Study|Various Reasons|2|||
127659626|NCT02322814|459376639|FG001|Overall Study|Various Reasons|0|||
127659627|NCT02322814|459376640|FG002|Overall Study|Various Reasons|1|||
127659628|NCT02322814|459376641|FG003|Overall Study|Various Reasons|1|||
127659629|NCT02322814|459376642|FG004|Overall Study|Various Reasons|0|||
127659630|NCT02322814|459376638|FG000|Overall Study|Progressive Disease|0|||
127659631|NCT02322814|459376639|FG001|Overall Study|Progressive Disease|0|||
127659632|NCT02322814|459376640|FG002|Overall Study|Progressive Disease|0|||
127659633|NCT02322814|459376641|FG003|Overall Study|Progressive Disease|1|||
127659634|NCT02322814|459376642|FG004|Overall Study|Progressive Disease|1|||
127659635|NCT02322814|459376638|FG000|Overall Study|Protocol Violation|1|||
127659636|NCT02322814|459376639|FG001|Overall Study|Protocol Violation|0|||
127659637|NCT02322814|459376640|FG002|Overall Study|Protocol Violation|0|||
127659638|NCT02322814|459376641|FG003|Overall Study|Protocol Violation|0|||
127659639|NCT02322814|459376642|FG004|Overall Study|Protocol Violation|0|||
127659640|NCT02322814|459376638|FG000|Overall Study|Study Terminated by Sponsor|0|||
127659641|NCT02322814|459376639|FG001|Overall Study|Study Terminated by Sponsor|7|||
127659642|NCT02322814|459376640|FG002|Overall Study|Study Terminated by Sponsor|9|||
127659643|NCT02322814|459376641|FG003|Overall Study|Study Terminated by Sponsor|5|||
127659644|NCT02322814|459376642|FG004|Overall Study|Study Terminated by Sponsor|13|||
127659645|NCT02322814|459376638|FG000|Overall Study|Withdrawal by Subject|5|||
127659646|NCT02322814|459376639|FG001|Overall Study|Withdrawal by Subject|4|||
127659647|NCT02322814|459376640|FG002|Overall Study|Withdrawal by Subject|2|||
127659648|NCT02322814|459376641|FG003|Overall Study|Withdrawal by Subject|1|||
127989091|NCT01859949|460586326|FG000|Overall Study|Adverse Event|0|||
127989092|NCT01859949|460586327|FG001|Overall Study|Adverse Event|1|||
127989093|NCT01890759|460586328|FG000|Overall Study|Protocol Violation|0|||
127989094|NCT01890759|460586329|FG001|Overall Study|Protocol Violation|2|||
127989095|NCT01890759|460586328|FG000|Overall Study|Lost to Follow-up|0|||
127989096|NCT01890759|460586329|FG001|Overall Study|Lost to Follow-up|2|||
127989097|NCT01890759|460586328|FG000|Overall Study|Withdrawal by Subject|2|||
127989098|NCT01890759|460586329|FG001|Overall Study|Withdrawal by Subject|8|||
127989099|NCT00385827|460586330|FG000|Part 1|Adverse Event|1|||
127989100|NCT00385827|460586331|FG001|Part 1|Adverse Event|0|||
127989101|NCT00385827|460586332|FG002|Part 1|Adverse Event|0|||
127989102|NCT00385827|460586330|FG000|Part 1|Death|2|||
127989103|NCT00385827|460586331|FG001|Part 1|Death|0|||
127989104|NCT00385827|460586332|FG002|Part 1|Death|0|||
127989105|NCT00385827|460586330|FG000|Part 1|Lack of Efficacy|5|||
127989106|NCT00385827|460586331|FG001|Part 1|Lack of Efficacy|0|||
127989107|NCT00385827|460586332|FG002|Part 1|Lack of Efficacy|0|||
127989108|NCT00385827|460586330|FG000|Part 1|Other|1|||
127989109|NCT00385827|460586331|FG001|Part 1|Other|0|||
127989110|NCT00385827|460586332|FG002|Part 1|Other|0|||
127989111|NCT00385827|460586330|FG000|Part 2|Adverse Event|0|||
127989112|NCT00385827|460586331|FG001|Part 2|Adverse Event|6|||
127989113|NCT00385827|460586332|FG002|Part 2|Adverse Event|10|||
127989114|NCT00385827|460586330|FG000|Part 2|Death|0|||
127989115|NCT00385827|460586331|FG001|Part 2|Death|0|||
127989116|NCT00385827|460586332|FG002|Part 2|Death|2|||
127989117|NCT00385827|460586330|FG000|Part 2|Lack of Efficacy|0|||
127989118|NCT00385827|460586331|FG001|Part 2|Lack of Efficacy|14|||
127989119|NCT00385827|460586332|FG002|Part 2|Lack of Efficacy|13|||
127989120|NCT00385827|460586330|FG000|Part 2|Randomized but not treated|0|||
127989121|NCT00385827|460586331|FG001|Part 2|Randomized but not treated|2|||
127659649|NCT02322814|459376642|FG004|Overall Study|Withdrawal by Subject|3|||
127989122|NCT00385827|460586332|FG002|Part 2|Randomized but not treated|2|||
127989123|NCT00385827|460586330|FG000|Part 2|Other|0|||
127989124|NCT00385827|460586331|FG001|Part 2|Other|11|||
127989125|NCT00385827|460586332|FG002|Part 2|Other|21|||
127989126|NCT00410072|460586333|FG000|Day 1 to Week 48|Adverse Event|1|||
127989127|NCT00410072|460586334|FG001|Day 1 to Week 48|Adverse Event|2|||
127989128|NCT00410072|460586333|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
127659650|NCT00591864|459376643|FG000|Overall Study|Incomplete Imaging|5|||
127659651|NCT00118092|459376644|FG000|Overall Study|Withdrawal by Subject|1|||
127659652|NCT00118092|459376644|FG000|Overall Study|Protocol Violation|1|||
127989129|NCT00410072|460586334|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
127989130|NCT00410072|460586333|FG000|Day 1 to Week 48|Other|0|||
127989131|NCT00410072|460586334|FG001|Day 1 to Week 48|Other|1|||
127659653|NCT02459093|459376645|FG000|Overall Study|Protocol Violation|6|||
127659654|NCT02459093|459376646|FG001|Overall Study|Protocol Violation|11|||
127659655|NCT02459093|459376645|FG000|Overall Study|Lost to Follow-up|6|||
127659656|NCT02459093|459376646|FG001|Overall Study|Lost to Follow-up|7|||
127989132|NCT00410072|460586333|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
127989133|NCT00410072|460586334|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
127989134|NCT00410072|460586333|FG000|Day 1 to Week 48|Pregnancy|0|||
127989135|NCT00410072|460586334|FG001|Day 1 to Week 48|Pregnancy|2|||
127989136|NCT00410072|460586333|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
127989137|NCT00410072|460586334|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
127989138|NCT00410072|460586333|FG000|After Week 48 to Week 96|Adverse Event|1|||
127989139|NCT00410072|460586334|FG001|After Week 48 to Week 96|Adverse Event|2|||
127989140|NCT00410072|460586333|FG000|After Week 48 to Week 96|Death|0|||
127989141|NCT00410072|460586334|FG001|After Week 48 to Week 96|Death|1|||
127989142|NCT00410072|460586333|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
127989143|NCT00410072|460586334|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
127989144|NCT00410072|460586333|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
127989145|NCT00410072|460586334|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
127989146|NCT00410072|460586333|FG000|After Week 48 to Week 96|Other|2|||
127989147|NCT00410072|460586334|FG001|After Week 48 to Week 96|Other|0|||
127989148|NCT00410072|460586333|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
127989149|NCT00410072|460586334|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
127989150|NCT00410072|460586333|FG000|After Week 48 to Week 96|Pregnancy|0|||
127989151|NCT00410072|460586334|FG001|After Week 48 to Week 96|Pregnancy|2|||
127989152|NCT00410072|460586333|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
127989153|NCT00410072|460586334|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
127989154|NCT01421147|460586339|FG000|Treatment Period|Adverse Event|2|||
127989155|NCT01421147|460586340|FG001|Treatment Period|Adverse Event|3|||
127989156|NCT01421147|460586339|FG000|Treatment Period|Lost to Follow-up|2|||
127989157|NCT01421147|460586340|FG001|Treatment Period|Lost to Follow-up|1|||
127989158|NCT01421147|460586339|FG000|Treatment Period|Physician Decision|2|||
127989159|NCT01421147|460586340|FG001|Treatment Period|Physician Decision|2|||
127989160|NCT01421147|460586339|FG000|Treatment Period|Withdrawal by Subject|10|||
127989161|NCT01421147|460586340|FG001|Treatment Period|Withdrawal by Subject|5|||
127989162|NCT01421147|460586339|FG000|Extension Period|Adverse Event|0|||
127989163|NCT01421147|460586340|FG001|Extension Period|Adverse Event|2|||
127989164|NCT01421147|460586339|FG000|Extension Period|Death|0|||
127989165|NCT01421147|460586340|FG001|Extension Period|Death|1|||
127989166|NCT01421147|460586339|FG000|Extension Period|Lost to Follow-up|2|||
127989167|NCT01421147|460586340|FG001|Extension Period|Lost to Follow-up|5|||
127989168|NCT01421147|460586339|FG000|Extension Period|Physician Decision|1|||
127989169|NCT01421147|460586340|FG001|Extension Period|Physician Decision|0|||
127989170|NCT01421147|460586339|FG000|Extension Period|Withdrawal by Subject|5|||
127989171|NCT01421147|460586340|FG001|Extension Period|Withdrawal by Subject|3|||
127989172|NCT03307837|460586342|FG000|Overall Study|Withdrawal by Subject|0|||
127989173|NCT03307837|460586343|FG001|Overall Study|Withdrawal by Subject|0|||
127989174|NCT03307837|460586344|FG002|Overall Study|Withdrawal by Subject|1|||
127989175|NCT03307837|460586345|FG003|Overall Study|Withdrawal by Subject|0|||
127989176|NCT03307837|460586346|FG004|Overall Study|Withdrawal by Subject|0|||
127989177|NCT03307837|460586347|FG005|Overall Study|Withdrawal by Subject|1|||
127989178|NCT03307837|460586342|FG000|Overall Study|Lost to Follow-up|1|||
127989179|NCT03307837|460586343|FG001|Overall Study|Lost to Follow-up|1|||
127989180|NCT03307837|460586344|FG002|Overall Study|Lost to Follow-up|0|||
127989181|NCT03307837|460586345|FG003|Overall Study|Lost to Follow-up|0|||
127989182|NCT03307837|460586346|FG004|Overall Study|Lost to Follow-up|0|||
127989183|NCT03307837|460586347|FG005|Overall Study|Lost to Follow-up|1|||
127989184|NCT02155309|460586350|FG000|Overall Study|Protocol Violation|0|||
127989185|NCT02155309|460586351|FG001|Overall Study|Protocol Violation|0|||
127989186|NCT02155309|460586352|FG002|Overall Study|Protocol Violation|1|||
127989187|NCT00662311|460586355|FG000|Overall Study|Respiratory Infection|1|||
127989188|NCT00662311|460586356|FG001|Overall Study|Respiratory Infection|0|||
127989189|NCT00662311|460586357|FG002|Overall Study|Respiratory Infection|0|||
127989190|NCT01467271|460586358|FG000|Overall Study|Death|84|||
127989191|NCT01467271|460586358|FG000|Overall Study|Lost to Follow-up|83|||
127989192|NCT01467271|460586358|FG000|Overall Study|Retraction of patient's consent|21|||
127989193|NCT01467271|460586358|FG000|Overall Study|Other reason|14|||
127989194|NCT01939223|460586376|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
127989195|NCT01939223|460586377|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
127642722|NCT01506193|459313117|FG002|Overall Study|Migrated/moved from study area|1|||
127642723|NCT01506193|459313115|FG000|Overall Study|Adverse event, non-fatal|0|||
127642724|NCT01506193|459313116|FG001|Overall Study|Adverse event, non-fatal|0|||
127642725|NCT01506193|459313117|FG002|Overall Study|Adverse event, non-fatal|1|||
127642726|NCT01506193|459313115|FG000|Overall Study|Withdrawal by Subject|5|||
127642727|NCT01506193|459313116|FG001|Overall Study|Withdrawal by Subject|1|||
127642728|NCT01506193|459313117|FG002|Overall Study|Withdrawal by Subject|8|||
127642729|NCT01506193|459313115|FG000|Overall Study|Lost to Follow-up|8|||
127642730|NCT01506193|459313116|FG001|Overall Study|Lost to Follow-up|3|||
127642731|NCT01506193|459313117|FG002|Overall Study|Lost to Follow-up|3|||
127642732|NCT04575467|459313121|FG000|Overall Study|Adverse Event|0|||
127642733|NCT04575467|459313122|FG001|Overall Study|Adverse Event|1|||
127642734|NCT04575467|459313123|FG002|Overall Study|Adverse Event|0|||
127642735|NCT04575467|459313124|FG003|Overall Study|Adverse Event|0|||
127642736|NCT01328574|459313125|FG000|Overall Study|Refused further treatment|1|||
127989196|NCT01939223|460586376|FG000|Overall Study|Disease recurrence (radiological)|1|||
127989197|NCT01939223|460586377|FG001|Overall Study|Disease recurrence (radiological)|3|||
127989198|NCT01939223|460586376|FG000|Overall Study|Study stopped by Sponsor|5|||
127989199|NCT01939223|460586377|FG001|Overall Study|Study stopped by Sponsor|7|||
127659657|NCT02736968|459376654|FG000|Overall Study|Lost to Follow-up|0|||
127659658|NCT02736968|459376655|FG001|Overall Study|Lost to Follow-up|0|||
127659659|NCT02736968|459376656|FG002|Overall Study|Lost to Follow-up|0|||
127659660|NCT02736968|459376657|FG003|Overall Study|Lost to Follow-up|0|||
127659661|NCT02736968|459376658|FG004|Overall Study|Lost to Follow-up|0|||
127659662|NCT02736968|459376659|FG005|Overall Study|Lost to Follow-up|0|||
127659663|NCT02736968|459376660|FG006|Overall Study|Lost to Follow-up|5|||
127659664|NCT02736968|459376661|FG007|Overall Study|Lost to Follow-up|2|||
127659665|NCT02736968|459376654|FG000|Overall Study|COVID-19 Pandemic|0|||
127659666|NCT02736968|459376655|FG001|Overall Study|COVID-19 Pandemic|0|||
127659667|NCT02736968|459376656|FG002|Overall Study|COVID-19 Pandemic|0|||
127989200|NCT01939223|460586376|FG000|Overall Study|Withdrawal by Subject|6|||
127989201|NCT01939223|460586377|FG001|Overall Study|Withdrawal by Subject|0|||
127989202|NCT03624569|460586378|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
127989203|NCT03624569|460586379|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
127989204|NCT03624569|460586378|FG000|Second Intervention (2 Weeks)|Protocol Violation|1|||
127989205|NCT03624569|460586379|FG001|Second Intervention (2 Weeks)|Protocol Violation|1|||
127989206|NCT01557517|460586380|FG000|Overall Study|Death|1|||
127989207|NCT01557517|460586381|FG001|Overall Study|Death|0|||
127989208|NCT01557517|460586380|FG000|Overall Study|Refused further treatment|0|||
127989209|NCT01557517|460586381|FG001|Overall Study|Refused further treatment|2|||
127989210|NCT01557517|460586380|FG000|Overall Study|Adverse Event|0|||
127989211|NCT01557517|460586381|FG001|Overall Study|Adverse Event|2|||
127989212|NCT01557517|460586380|FG000|Overall Study|Pt declined before treatment started|1|||
127989213|NCT01557517|460586381|FG001|Overall Study|Pt declined before treatment started|0|||
127989214|NCT03585712|460586386|FG000|Treatment Period 1|Protocol Violation|1|||
127989215|NCT03585712|460586387|FG001|Treatment Period 1|Protocol Violation|0|||
127989216|NCT03585712|460586388|FG002|Treatment Period 1|Protocol Violation|0|||
127989217|NCT03585712|460586386|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
127989218|NCT03585712|460586387|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
127659668|NCT02736968|459376657|FG003|Overall Study|COVID-19 Pandemic|0|||
127659669|NCT02736968|459376658|FG004|Overall Study|COVID-19 Pandemic|0|||
127659670|NCT02736968|459376659|FG005|Overall Study|COVID-19 Pandemic|0|||
127659671|NCT02736968|459376660|FG006|Overall Study|COVID-19 Pandemic|2|||
127659672|NCT02736968|459376661|FG007|Overall Study|COVID-19 Pandemic|0|||
127659673|NCT02736968|459376654|FG000|Overall Study|Withdrawal by Subject|0|||
127659674|NCT02736968|459376655|FG001|Overall Study|Withdrawal by Subject|0|||
127659675|NCT02736968|459376656|FG002|Overall Study|Withdrawal by Subject|0|||
127659676|NCT02736968|459376657|FG003|Overall Study|Withdrawal by Subject|0|||
127659677|NCT02736968|459376658|FG004|Overall Study|Withdrawal by Subject|0|||
127659678|NCT02736968|459376659|FG005|Overall Study|Withdrawal by Subject|0|||
127659679|NCT02736968|459376660|FG006|Overall Study|Withdrawal by Subject|1|||
127659680|NCT02736968|459376661|FG007|Overall Study|Withdrawal by Subject|0|||
127659681|NCT00147225|459376662|FG000|Overall Study|Withdrawal by Subject|1|||
127659682|NCT00147225|459376663|FG001|Overall Study|Withdrawal by Subject|0|||
127659683|NCT00147225|459376664|FG002|Overall Study|Withdrawal by Subject|1|||
127659684|NCT00147225|459376665|FG003|Overall Study|Withdrawal by Subject|0|||
127659685|NCT00147225|459376666|FG004|Overall Study|Withdrawal by Subject|0|||
127659686|NCT00147225|459376667|FG005|Overall Study|Withdrawal by Subject|1|||
127659687|NCT00147225|459376662|FG000|Overall Study|Adverse Event|0|||
127659688|NCT00147225|459376663|FG001|Overall Study|Adverse Event|0|||
127659689|NCT00147225|459376664|FG002|Overall Study|Adverse Event|1|||
127659690|NCT00147225|459376665|FG003|Overall Study|Adverse Event|1|||
127659691|NCT00147225|459376666|FG004|Overall Study|Adverse Event|0|||
127659692|NCT00147225|459376667|FG005|Overall Study|Adverse Event|0|||
127659693|NCT00147225|459376662|FG000|Overall Study|Screen Failure|0|||
127659694|NCT00147225|459376663|FG001|Overall Study|Screen Failure|0|||
127659695|NCT00147225|459376664|FG002|Overall Study|Screen Failure|0|||
127659696|NCT00147225|459376665|FG003|Overall Study|Screen Failure|0|||
127659697|NCT00147225|459376666|FG004|Overall Study|Screen Failure|1|||
127659698|NCT00147225|459376667|FG005|Overall Study|Screen Failure|0|||
127659699|NCT00147225|459376662|FG000|Overall Study|Chemotherapy Changed|0|||
127659700|NCT00147225|459376663|FG001|Overall Study|Chemotherapy Changed|0|||
127659701|NCT00147225|459376664|FG002|Overall Study|Chemotherapy Changed|0|||
127659702|NCT00147225|459376665|FG003|Overall Study|Chemotherapy Changed|0|||
127659703|NCT00147225|459376666|FG004|Overall Study|Chemotherapy Changed|0|||
127659704|NCT00147225|459376667|FG005|Overall Study|Chemotherapy Changed|1|||
127659705|NCT02049710|459376670|FG000|Overall Study|Lost to Follow-up|319|||
127659706|NCT02049710|459376671|FG001|Overall Study|Lost to Follow-up|324|||
127989219|NCT03585712|460586388|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
127989220|NCT03585712|460586386|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
127989221|NCT03585712|460586387|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
127989222|NCT03585712|460586388|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
127989223|NCT03585712|460586386|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
127989224|NCT03585712|460586387|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
127989225|NCT03585712|460586388|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
127989226|NCT03004924|460586393|FG000|Overall Study|Adverse Event|6|||
127989227|NCT03004924|460586394|FG001|Overall Study|Adverse Event|5|||
127989228|NCT03004924|460586395|FG002|Overall Study|Adverse Event|10|||
127989229|NCT03004924|460586393|FG000|Overall Study|Protocol Violation|4|||
127989230|NCT03004924|460586394|FG001|Overall Study|Protocol Violation|0|||
127989231|NCT03004924|460586395|FG002|Overall Study|Protocol Violation|1|||
127989232|NCT03004924|460586393|FG000|Overall Study|Withdrawal by Subject|5|||
127989233|NCT03004924|460586394|FG001|Overall Study|Withdrawal by Subject|3|||
127989234|NCT03004924|460586395|FG002|Overall Study|Withdrawal by Subject|5|||
127989235|NCT03004924|460586393|FG000|Overall Study|Lost to Follow-up|6|||
127989236|NCT03004924|460586394|FG001|Overall Study|Lost to Follow-up|1|||
127989237|NCT03004924|460586395|FG002|Overall Study|Lost to Follow-up|4|||
127989238|NCT03004924|460586393|FG000|Overall Study|Lack of Efficacy|2|||
127989239|NCT03004924|460586394|FG001|Overall Study|Lack of Efficacy|4|||
127989240|NCT03004924|460586395|FG002|Overall Study|Lack of Efficacy|2|||
127989241|NCT03004924|460586393|FG000|Overall Study|Physician Decision|1|||
127989242|NCT03004924|460586394|FG001|Overall Study|Physician Decision|0|||
127989243|NCT03004924|460586395|FG002|Overall Study|Physician Decision|1|||
127989244|NCT03004924|460586393|FG000|Overall Study|Withdrawal by parent/guardian|1|||
127989245|NCT03004924|460586394|FG001|Overall Study|Withdrawal by parent/guardian|0|||
127989246|NCT03004924|460586395|FG002|Overall Study|Withdrawal by parent/guardian|2|||
127989247|NCT03004924|460586393|FG000|Overall Study|Screen Failure|1|||
127989248|NCT03004924|460586394|FG001|Overall Study|Screen Failure|0|||
127989249|NCT03004924|460586395|FG002|Overall Study|Screen Failure|0|||
127989250|NCT03004924|460586393|FG000|Overall Study|Pregnancy|0|||
127989251|NCT03004924|460586394|FG001|Overall Study|Pregnancy|1|||
127989252|NCT03004924|460586395|FG002|Overall Study|Pregnancy|0|||
127989253|NCT03004924|460586393|FG000|Overall Study|Terminated by Sponsor|0|||
127989254|NCT03004924|460586394|FG001|Overall Study|Terminated by Sponsor|0|||
127989255|NCT03004924|460586395|FG002|Overall Study|Terminated by Sponsor|1|||
127989256|NCT03004924|460586393|FG000|Overall Study|Missed Study Visit|0|||
127989257|NCT03004924|460586394|FG001|Overall Study|Missed Study Visit|0|||
127989258|NCT03004924|460586395|FG002|Overall Study|Missed Study Visit|2|||
127659707|NCT03713021|459376674|FG000|Overall Study|Did not have CT sim scan available|6|||
127659708|NCT03713021|459376674|FG000|Overall Study|Not eligible|4|||
127659709|NCT03713021|459376674|FG000|Overall Study|Issues with TraceIT markers|5|||
127659710|NCT00386308|459378088|FG000|Overall Study|Adverse Event|3|||
127659711|NCT00386308|459378089|FG001|Overall Study|Adverse Event|3|||
127659712|NCT00386308|459378088|FG000|Overall Study|Protocol Violation|2|||
127659713|NCT00386308|459378089|FG001|Overall Study|Protocol Violation|5|||
127659714|NCT00386308|459378088|FG000|Overall Study|Lack of Efficacy|0|||
127659715|NCT00386308|459378089|FG001|Overall Study|Lack of Efficacy|2|||
127659716|NCT00386308|459378088|FG000|Overall Study|Lost to Follow-up|10|||
127659717|NCT00386308|459378089|FG001|Overall Study|Lost to Follow-up|6|||
127659718|NCT00386308|459378088|FG000|Overall Study|Withdrawal by Subject|6|||
127659719|NCT00386308|459378089|FG001|Overall Study|Withdrawal by Subject|2|||
127659720|NCT00386308|459378088|FG000|Overall Study|Other Event|8|||
127659721|NCT00386308|459378089|FG001|Overall Study|Other Event|1|||
127659722|NCT02906683|459378090|FG000|Overall Study|Adverse Event|0|||
127659723|NCT02906683|459378091|FG001|Overall Study|Adverse Event|1|||
127659724|NCT02906683|459378092|FG002|Overall Study|Adverse Event|0|||
127659725|NCT02906683|459378090|FG000|Overall Study|Physician Decision|0|||
127659726|NCT02906683|459378091|FG001|Overall Study|Physician Decision|1|||
127659727|NCT02906683|459378092|FG002|Overall Study|Physician Decision|1|||
127659728|NCT02906683|459378090|FG000|Overall Study|Withdrawal by Subject|0|||
127659729|NCT02906683|459378091|FG001|Overall Study|Withdrawal by Subject|2|||
127989259|NCT03004924|460586393|FG000|Overall Study|HSV1 Positive|1|||
127659730|NCT02906683|459378092|FG002|Overall Study|Withdrawal by Subject|1|||
127659731|NCT02906683|459378090|FG000|Overall Study|Patient did not meet the eligibility criteria for the study|1|||
127989260|NCT03004924|460586394|FG001|Overall Study|HSV1 Positive|0|||
127989261|NCT03004924|460586395|FG002|Overall Study|HSV1 Positive|0|||
127989262|NCT01280682|460586396|FG000|Overall Study|Lost to Follow-up|0|||
127989263|NCT01280682|460586397|FG001|Overall Study|Lost to Follow-up|6|||
127989264|NCT01280682|460586396|FG000|Overall Study|Withdrawal by Subject|0|||
127659732|NCT02906683|459378091|FG001|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
127659733|NCT02906683|459378092|FG002|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
127989265|NCT01280682|460586397|FG001|Overall Study|Withdrawal by Subject|7|||
127989266|NCT00269477|460586400|FG000|Overall Study|Protocol Violation|5|||
127989267|NCT00269477|460586401|FG001|Overall Study|Protocol Violation|5|||
127659734|NCT02906683|459378090|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
127989268|NCT00269477|460586402|FG002|Overall Study|Protocol Violation|1|||
127989269|NCT00269477|460586403|FG003|Overall Study|Protocol Violation|0|||
127989270|NCT00269477|460586400|FG000|Overall Study|Missed post-vaccination blood draw|0|||
127659735|NCT02906683|459378091|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
127659736|NCT02906683|459378092|FG002|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
127659737|NCT01340482|459378093|FG000|Overall Study|Adverse Event|2|||
127659738|NCT01340482|459378094|FG001|Overall Study|Adverse Event|0|||
127659739|NCT01340482|459378095|FG002|Overall Study|Adverse Event|0|||
127659740|NCT01282476|459378096|FG000|Overall Study|Death|11|||
127659741|NCT00437125|459378097|FG000|Overall Study|Adverse Event|12|||
127989271|NCT00269477|460586401|FG001|Overall Study|Missed post-vaccination blood draw|1|||
127989272|NCT00269477|460586402|FG002|Overall Study|Missed post-vaccination blood draw|0|||
127989273|NCT00269477|460586403|FG003|Overall Study|Missed post-vaccination blood draw|0|||
127989274|NCT01964716|460586404|FG000|Overall Study|Withdrawal by Subject|2|||
127989275|NCT01964716|460586405|FG001|Overall Study|Withdrawal by Subject|3|||
127989276|NCT01964716|460586404|FG000|Overall Study|Lost to Follow-up|1|||
127989277|NCT01964716|460586405|FG001|Overall Study|Lost to Follow-up|2|||
127989278|NCT01964716|460586404|FG000|Overall Study|No longer met eligibility criteria|1|||
127989279|NCT01964716|460586405|FG001|Overall Study|No longer met eligibility criteria|1|||
127989280|NCT01964716|460586404|FG000|Overall Study|Death|1|||
127989281|NCT01964716|460586405|FG001|Overall Study|Death|0|||
127989282|NCT01464619|460586406|FG000|Overall Study|Lost to Follow-up|3|||
127989283|NCT01464619|460586407|FG001|Overall Study|Lost to Follow-up|4|||
127989284|NCT01863732|460586413|FG000|Overall Study|Adverse Event|2|||
127989285|NCT01863732|460586414|FG001|Overall Study|Adverse Event|0|||
127989286|NCT01863732|460586415|FG002|Overall Study|Adverse Event|3|||
127989287|NCT01863732|460586416|FG003|Overall Study|Adverse Event|3|||
127989288|NCT01863732|460586413|FG000|Overall Study|Lack of Efficacy|1|||
127989289|NCT01863732|460586414|FG001|Overall Study|Lack of Efficacy|0|||
127989290|NCT01863732|460586415|FG002|Overall Study|Lack of Efficacy|2|||
127989291|NCT01863732|460586416|FG003|Overall Study|Lack of Efficacy|1|||
127989292|NCT01863732|460586413|FG000|Overall Study|Lost to Follow-up|2|||
127989293|NCT01863732|460586414|FG001|Overall Study|Lost to Follow-up|2|||
127989294|NCT01863732|460586415|FG002|Overall Study|Lost to Follow-up|1|||
127989295|NCT01863732|460586416|FG003|Overall Study|Lost to Follow-up|1|||
127989296|NCT01863732|460586413|FG000|Overall Study|Physician Decision|1|||
127989297|NCT01863732|460586414|FG001|Overall Study|Physician Decision|0|||
127989298|NCT01863732|460586415|FG002|Overall Study|Physician Decision|1|||
127989299|NCT01863732|460586416|FG003|Overall Study|Physician Decision|0|||
127989300|NCT01863732|460586413|FG000|Overall Study|Pregnancy|0|||
127989301|NCT01863732|460586414|FG001|Overall Study|Pregnancy|0|||
127989302|NCT01863732|460586415|FG002|Overall Study|Pregnancy|0|||
127989303|NCT01863732|460586416|FG003|Overall Study|Pregnancy|1|||
127989304|NCT01863732|460586413|FG000|Overall Study|Technical problems|0|||
127989305|NCT01863732|460586414|FG001|Overall Study|Technical problems|1|||
127989306|NCT01863732|460586415|FG002|Overall Study|Technical problems|1|||
127989307|NCT01863732|460586416|FG003|Overall Study|Technical problems|0|||
127989308|NCT01863732|460586413|FG000|Overall Study|Subject/guardian decision|6|||
127989309|NCT01863732|460586414|FG001|Overall Study|Subject/guardian decision|9|||
127989310|NCT01863732|460586415|FG002|Overall Study|Subject/guardian decision|3|||
127989311|NCT01863732|460586416|FG003|Overall Study|Subject/guardian decision|1|||
127989312|NCT01863732|460586413|FG000|Overall Study|Death|1|||
127989313|NCT01863732|460586414|FG001|Overall Study|Death|0|||
127989314|NCT01863732|460586415|FG002|Overall Study|Death|0|||
127989315|NCT01863732|460586416|FG003|Overall Study|Death|1|||
127989316|NCT00460746|460586419|FG000|Overall Study|Adverse Event|1|||
127989317|NCT00460746|460586419|FG000|Overall Study|Lost to Follow-up|1|||
127989318|NCT01603394|460586426|FG000|Overall Study|Adverse Event|1|||
127989319|NCT01215435|460586428|FG000|Overall Study|Adverse Event|1|||
127989320|NCT01215435|460586429|FG001|Overall Study|Adverse Event|0|||
127989321|NCT01215435|460586428|FG000|Overall Study|Protocol Violation|2|||
127989322|NCT01215435|460586429|FG001|Overall Study|Protocol Violation|0|||
127989323|NCT01215435|460586428|FG000|Overall Study|Withdrawal Criteria|8|||
127989324|NCT01215435|460586429|FG001|Overall Study|Withdrawal Criteria|11|||
127659742|NCT00437125|459378097|FG000|Overall Study|Death|1|||
127659743|NCT00437125|459378097|FG000|Overall Study|Clinical Relapse|1|||
127659744|NCT00437125|459378097|FG000|Overall Study|Lack of Efficacy|1|||
127989325|NCT01215435|460586428|FG000|Overall Study|Lost to Follow-up|3|||
127989326|NCT01215435|460586429|FG001|Overall Study|Lost to Follow-up|0|||
127659745|NCT00437125|459378097|FG000|Overall Study|Lost to Follow-up|1|||
127989327|NCT01215435|460586428|FG000|Overall Study|Unclassified|5|||
127989328|NCT01215435|460586429|FG001|Overall Study|Unclassified|5|||
127989329|NCT00840034|460586430|FG000|Acute Treatment Phase|Adverse Event|6|||
127659746|NCT00437125|459378097|FG000|Overall Study|Withdrawal by Subject|13|||
127659747|NCT00437125|459378097|FG000|Overall Study|Withdrawal by Caregiver|2|||
127989330|NCT00840034|460586431|FG001|Acute Treatment Phase|Adverse Event|8|||
127989331|NCT00840034|460586430|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
127989332|NCT00840034|460586431|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
127659748|NCT00437125|459378097|FG000|Overall Study|Physician Decision|1|||
127989333|NCT00840034|460586430|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
127989334|NCT00840034|460586431|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
127989335|NCT00840034|460586430|FG000|Acute Treatment Phase|Physician Decision|0|||
127659749|NCT02248961|459378100|FG000|Overall Study|Adverse Event|1|||
127659750|NCT02248961|459378101|FG001|Overall Study|Adverse Event|0|||
127659751|NCT02248961|459378100|FG000|Overall Study|Withdrawal by Subject|1|||
127659752|NCT02248961|459378101|FG001|Overall Study|Withdrawal by Subject|2|||
127659753|NCT02248961|459378100|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
127659754|NCT02248961|459378101|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
127659755|NCT00453310|459378106|FG000|Overall Study|Progression of Disease|10|||
127659756|NCT01267825|459378107|FG000|Overall Study|study terminated. no data collected.|1|||
127659757|NCT01267825|459378108|FG001|Overall Study|study terminated. no data collected.|0|||
127659758|NCT00871351|459378109|FG000|Overall Study|Withdrawal by Subject|1|||
127659759|NCT00871351|459378110|FG001|Overall Study|Withdrawal by Subject|0|||
127659760|NCT00871351|459378111|FG002|Overall Study|Withdrawal by Subject|0|||
127659761|NCT00871351|459378109|FG000|Overall Study|Adverse Event|3|||
127659762|NCT00871351|459378110|FG001|Overall Study|Adverse Event|1|||
127659763|NCT00871351|459378111|FG002|Overall Study|Adverse Event|0|||
127659764|NCT00744237|459378112|FG000|Overall Study|Lack of Efficacy|1|||
127659765|NCT00744237|459378113|FG001|Overall Study|Lack of Efficacy|1|||
127659766|NCT00744237|459378114|FG002|Overall Study|Lack of Efficacy|0|||
127659767|NCT00744237|459378112|FG000|Overall Study|Withdrawal by Subject|9|||
127659768|NCT00744237|459378113|FG001|Overall Study|Withdrawal by Subject|5|||
127659769|NCT00744237|459378114|FG002|Overall Study|Withdrawal by Subject|3|||
127659770|NCT00744237|459378112|FG000|Overall Study|Lost to Follow-up|1|||
127659771|NCT00744237|459378113|FG001|Overall Study|Lost to Follow-up|1|||
127659772|NCT00744237|459378114|FG002|Overall Study|Lost to Follow-up|1|||
127659773|NCT00744237|459378112|FG000|Overall Study|Protocol Violation|3|||
127659774|NCT00744237|459378113|FG001|Overall Study|Protocol Violation|4|||
127659775|NCT00744237|459378114|FG002|Overall Study|Protocol Violation|3|||
127659776|NCT00744237|459378112|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
127989336|NCT00840034|460586431|FG001|Acute Treatment Phase|Physician Decision|1|||
127989337|NCT00840034|460586430|FG000|Acute Treatment Phase|Protocol Violation|2|||
127989338|NCT00840034|460586431|FG001|Acute Treatment Phase|Protocol Violation|4|||
127989339|NCT00840034|460586430|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
127989340|NCT00840034|460586431|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
127989341|NCT00840034|460586430|FG000|Taper Phase|Adverse Event|1|||
127989342|NCT00840034|460586431|FG001|Taper Phase|Adverse Event|0|||
127989343|NCT00840034|460586430|FG000|Taper Phase|Lost to Follow-up|1|||
127989344|NCT00840034|460586431|FG001|Taper Phase|Lost to Follow-up|1|||
127989345|NCT00840034|460586430|FG000|Taper Phase|Withdrawal by Subject|1|||
127989346|NCT00840034|460586431|FG001|Taper Phase|Withdrawal by Subject|1|||
127989347|NCT02179749|460586440|FG000|Overall Study|Adverse Event|0|||
127989348|NCT02179749|460586441|FG001|Overall Study|Adverse Event|0|||
127989349|NCT02179749|460586442|FG002|Overall Study|Adverse Event|1|||
127989350|NCT02179749|460586440|FG000|Overall Study|Withdrawal by Subject|0|||
127989351|NCT02179749|460586441|FG001|Overall Study|Withdrawal by Subject|0|||
127989352|NCT02179749|460586442|FG002|Overall Study|Withdrawal by Subject|1|||
127989353|NCT02756364|460586444|FG000|Overall Study|Site Terminated by Sponsor|24|||
127989354|NCT02756364|460586445|FG001|Overall Study|Site Terminated by Sponsor|30|||
127989355|NCT02756364|460586446|FG002|Overall Study|Site Terminated by Sponsor|21|||
127989356|NCT02756364|460586444|FG000|Overall Study|Death|20|||
127989357|NCT02756364|460586445|FG001|Overall Study|Death|15|||
127989358|NCT02756364|460586446|FG002|Overall Study|Death|18|||
127989359|NCT02756364|460586444|FG000|Overall Study|Withdrawal by Patient|2|||
127989360|NCT02756364|460586445|FG001|Overall Study|Withdrawal by Patient|1|||
127989361|NCT02756364|460586446|FG002|Overall Study|Withdrawal by Patient|8|||
127989362|NCT02756364|460586444|FG000|Overall Study|Lost to Follow-up|0|||
127989363|NCT02756364|460586445|FG001|Overall Study|Lost to Follow-up|1|||
127989364|NCT02756364|460586446|FG002|Overall Study|Lost to Follow-up|1|||
127659777|NCT00744237|459378113|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
127659778|NCT00744237|459378114|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
127659779|NCT00744237|459378112|FG000|Overall Study|Dosing Error|1|||
127989375|NCT02223364|460586449|FG000|Overall Study|Protocol Violation|3|||
127659780|NCT00744237|459378113|FG001|Overall Study|Dosing Error|0|||
127659781|NCT00744237|459378114|FG002|Overall Study|Dosing Error|1|||
127659782|NCT00744237|459378112|FG000|Overall Study|Study Drug Error|1|||
127659783|NCT00744237|459378113|FG001|Overall Study|Study Drug Error|0|||
127989376|NCT02223364|460586450|FG001|Overall Study|Protocol Violation|0|||
127989377|NCT02223364|460586451|FG002|Overall Study|Protocol Violation|3|||
127659784|NCT00744237|459378114|FG002|Overall Study|Study Drug Error|0|||
127659785|NCT00744237|459378112|FG000|Overall Study|Prohibited Concomitant Medication|0|||
127659786|NCT00744237|459378113|FG001|Overall Study|Prohibited Concomitant Medication|0|||
127659787|NCT00744237|459378114|FG002|Overall Study|Prohibited Concomitant Medication|1|||
127659788|NCT00744237|459378112|FG000|Overall Study|Poor Compliance|0|||
127659789|NCT00744237|459378113|FG001|Overall Study|Poor Compliance|2|||
127659790|NCT00744237|459378114|FG002|Overall Study|Poor Compliance|0|||
127659791|NCT00744237|459378112|FG000|Overall Study|Administrative. Site Closed|1|||
127659792|NCT00744237|459378113|FG001|Overall Study|Administrative. Site Closed|1|||
127659793|NCT00744237|459378114|FG002|Overall Study|Administrative. Site Closed|1|||
127659794|NCT00744237|459378112|FG000|Overall Study|Adverse Event|9|||
127659795|NCT00744237|459378113|FG001|Overall Study|Adverse Event|13|||
127659796|NCT00744237|459378114|FG002|Overall Study|Adverse Event|5|||
127659797|NCT02791490|459378116|FG000|Overall Study|Lost to Follow-up|1|||
127659798|NCT02791490|459378117|FG001|Overall Study|Lost to Follow-up|2|||
127659799|NCT02791490|459378116|FG000|Overall Study|Withdrawal by Subject|2|||
127659800|NCT02791490|459378117|FG001|Overall Study|Withdrawal by Subject|6|||
127659801|NCT01984424|459378118|FG000|Overall Study|Withdrawal by Subject|3|||
127659802|NCT01984424|459378119|FG001|Overall Study|Withdrawal by Subject|5|||
127659803|NCT01984424|459378118|FG000|Overall Study|Sponsor Decision|0|||
127659804|NCT01984424|459378119|FG001|Overall Study|Sponsor Decision|1|||
127659805|NCT01984424|459378118|FG000|Overall Study|Lost to Follow-up|0|||
127659806|NCT01984424|459378119|FG001|Overall Study|Lost to Follow-up|1|||
127659807|NCT02802319|459378120|FG000|Overall Study|Physician Decision|2|||
127659808|NCT02802319|459378121|FG001|Overall Study|Physician Decision|1|||
127659809|NCT02802319|459378120|FG000|Overall Study|Lost to Follow-up|0|||
127659810|NCT02802319|459378121|FG001|Overall Study|Lost to Follow-up|4|||
127659811|NCT00077636|459378122|FG000|Overall Study|Refused Treatment|9|||
127659812|NCT00077636|459378123|FG001|Overall Study|Refused Treatment|31|||
127659813|NCT00077636|459378122|FG000|Overall Study|Admin|3|||
127659814|NCT00077636|459378123|FG001|Overall Study|Admin|3|||
127659815|NCT00077636|459378122|FG000|Overall Study|Withdrawal by Subject|2|||
127659816|NCT00077636|459378123|FG001|Overall Study|Withdrawal by Subject|2|||
127659817|NCT00077636|459378122|FG000|Overall Study|Adverse Event|17|||
127659818|NCT00077636|459378123|FG001|Overall Study|Adverse Event|34|||
127659819|NCT00077636|459378122|FG000|Overall Study|Protocol Violation|0|||
127659820|NCT00077636|459378123|FG001|Overall Study|Protocol Violation|2|||
127659821|NCT00077636|459378122|FG000|Overall Study|Lost to Follow-up|10|||
127659822|NCT00077636|459378123|FG001|Overall Study|Lost to Follow-up|18|||
127659823|NCT00077636|459378122|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
127659824|NCT00077636|459378123|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
127659825|NCT03545113|459378124|FG000|Overall Study|Surgery Cancelled|1|||
127659826|NCT03545113|459378125|FG001|Overall Study|Surgery Cancelled|0|||
127659827|NCT03545113|459378124|FG000|Overall Study|Death|1|||
127659828|NCT03545113|459378125|FG001|Overall Study|Death|0|||
127659829|NCT03545113|459378124|FG000|Overall Study|Adverse Event|2|||
127659830|NCT03545113|459378125|FG001|Overall Study|Adverse Event|0|||
127659831|NCT03545113|459378124|FG000|Overall Study|Received different surgery|1|||
127659832|NCT03545113|459378125|FG001|Overall Study|Received different surgery|0|||
127659833|NCT02032173|459378126|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
127659834|NCT01993017|459378129|FG000|Overall Study|Death|23|||
127659835|NCT01993017|459378130|FG001|Overall Study|Death|26|||
127659836|NCT01993017|459378131|FG002|Overall Study|Death|18|||
127659837|NCT01993017|459378129|FG000|Overall Study|Could not be contacted|43|||
127659838|NCT01993017|459378130|FG001|Overall Study|Could not be contacted|42|||
127659839|NCT01993017|459378131|FG002|Overall Study|Could not be contacted|38|||
127659840|NCT01993017|459378129|FG000|Overall Study|Dropped out|19|||
127659841|NCT01993017|459378130|FG001|Overall Study|Dropped out|6|||
127659842|NCT01993017|459378131|FG002|Overall Study|Dropped out|11|||
127659843|NCT01993017|459378129|FG000|Overall Study|Other reasons|17|||
127659844|NCT01993017|459378130|FG001|Overall Study|Other reasons|11|||
127659845|NCT01993017|459378131|FG002|Overall Study|Other reasons|7|||
127659846|NCT01993017|459378129|FG000|Overall Study|Ineligible after randomization|4|||
127659847|NCT01993017|459378130|FG001|Overall Study|Ineligible after randomization|5|||
127659848|NCT01993017|459378131|FG002|Overall Study|Ineligible after randomization|5|||
127659849|NCT01683994|459378132|FG000|Overall Study|Withdrawal by Subject|1|||
127659850|NCT01683994|459378133|FG001|Overall Study|Withdrawal by Subject|0|||
127659851|NCT01683994|459378134|FG002|Overall Study|Withdrawal by Subject|0|||
127659852|NCT01683994|459378135|FG003|Overall Study|Withdrawal by Subject|1|||
127659853|NCT01683994|459378136|FG004|Overall Study|Withdrawal by Subject|0|||
127659854|NCT01683994|459378132|FG000|Overall Study|Intercurrent illness|0|||
127659855|NCT01683994|459378133|FG001|Overall Study|Intercurrent illness|0|||
127659856|NCT01683994|459378134|FG002|Overall Study|Intercurrent illness|0|||
127659857|NCT01683994|459378135|FG003|Overall Study|Intercurrent illness|2|||
127659858|NCT01683994|459378136|FG004|Overall Study|Intercurrent illness|1|||
127659859|NCT02960763|459378138|FG000|Step 1|Withdrawal by Subject|10|||
127659860|NCT02960763|459378139|FG001|Step 1|Withdrawal by Subject|8|||
127659861|NCT02960763|459378140|FG002|Step 1|Withdrawal by Subject|13|||
127659862|NCT02960763|459378141|FG003|Step 1|Withdrawal by Subject|0|||
127659863|NCT02960763|459378142|FG004|Step 1|Withdrawal by Subject|0|||
127989378|NCT02223364|460586449|FG000|Overall Study|subject expired before surgery|1|||
127989379|NCT02223364|460586450|FG001|Overall Study|subject expired before surgery|0|||
127989380|NCT02223364|460586451|FG002|Overall Study|subject expired before surgery|0|||
127989381|NCT02223364|460586449|FG000|Overall Study|Physician Decision|1|||
127989382|NCT02223364|460586450|FG001|Overall Study|Physician Decision|0|||
127989383|NCT02223364|460586451|FG002|Overall Study|Physician Decision|0|||
127989384|NCT00793546|460586452|FG000|Overall Study|Death|3|||
127989385|NCT00793546|460586453|FG001|Overall Study|Death|0|||
127989386|NCT00793546|460586452|FG000|Overall Study|Lost to Follow-up|1|||
127989387|NCT00793546|460586453|FG001|Overall Study|Lost to Follow-up|0|||
127989388|NCT00793546|460586452|FG000|Overall Study|Withdrawal by Subject|1|||
127989389|NCT00793546|460586453|FG001|Overall Study|Withdrawal by Subject|1|||
127989390|NCT00793546|460586452|FG000|Overall Study|Study Terminated by Sponsor|8|||
127989391|NCT00793546|460586453|FG001|Overall Study|Study Terminated by Sponsor|27|||
127989392|NCT00793546|460586452|FG000|Overall Study|Other|1|||
127989393|NCT00793546|460586453|FG001|Overall Study|Other|0|||
127989394|NCT01841567|460586454|FG000|Overall Study|Adverse Event|3|||
127989395|NCT01416155|460586455|FG000|Overall Study|Adverse Event|8|||
127989396|NCT01416155|460586455|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
127989397|NCT01416155|460586455|FG000|Overall Study|Withdrawal by Subject|33|||
127989398|NCT01416155|460586455|FG000|Overall Study|Investigator decision|8|||
127989399|NCT01416155|460586455|FG000|Overall Study|Other|7|||
127989400|NCT02984267|460586460|FG000|Overall Study|Protocol Violation|1|||
127989401|NCT02984267|460586461|FG001|Overall Study|Protocol Violation|0|||
127989402|NCT02984267|460586460|FG000|Overall Study|Withdrawal by Subject|0|||
127989403|NCT02984267|460586461|FG001|Overall Study|Withdrawal by Subject|1|||
127989404|NCT00742027|460586462|FG000|Overall Study|Disease Progression|76|||
127989405|NCT00742027|460586462|FG000|Overall Study|New Cancer Therapy|19|||
127989406|NCT00742027|460586462|FG000|Overall Study|Withdrawal by Subject|18|||
127989407|NCT00742027|460586462|FG000|Overall Study|Death|7|||
127989408|NCT00742027|460586462|FG000|Overall Study|Lost to Follow-up|4|||
127989409|NCT00742027|460586462|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
127989410|NCT00742027|460586462|FG000|Overall Study|Missing|2|||
127989411|NCT00742027|460586462|FG000|Overall Study|Administrative Problems|1|||
127989412|NCT03597139|460586463|FG000|Overall Study|Adverse Event|3|||
127989413|NCT03597139|460586464|FG001|Overall Study|Adverse Event|0|||
127989414|NCT03597139|460586463|FG000|Overall Study|Protocol Non-compliance|1|||
127989415|NCT03597139|460586464|FG001|Overall Study|Protocol Non-compliance|0|||
127989416|NCT00520767|460586466|FG000|Overall Study|Death|2|||
127989417|NCT00382109|460586469|FG000|Overall Study|Adverse Event|3|||
127989418|NCT00382109|460586470|FG001|Overall Study|Adverse Event|0|||
127989419|NCT00382109|460586469|FG000|Overall Study|Physician Decision|6|||
127989420|NCT00382109|460586470|FG001|Overall Study|Physician Decision|1|||
127989421|NCT00382109|460586469|FG000|Overall Study|Withdrawal by Subject|1|||
127989422|NCT00382109|460586470|FG001|Overall Study|Withdrawal by Subject|0|||
127989423|NCT00382109|460586469|FG000|Overall Study|ineligible|2|||
127989424|NCT00382109|460586470|FG001|Overall Study|ineligible|0|||
127989425|NCT00382109|460586469|FG000|Overall Study|Other|0|||
127989426|NCT00382109|460586470|FG001|Overall Study|Other|2|||
127989427|NCT00382109|460586469|FG000|Overall Study|consent withdrawal|0|||
127989428|NCT00382109|460586470|FG001|Overall Study|consent withdrawal|1|||
127989429|NCT01249833|460586471|FG000|Overall Study|Lost to Follow-up|0|||
127989430|NCT01249833|460586472|FG001|Overall Study|Lost to Follow-up|1|||
127989431|NCT03796676|460586473|FG000|Overall Study|Adverse Event|2|||
127989432|NCT03796676|460586474|FG001|Overall Study|Adverse Event|1|||
127989433|NCT03796676|460586475|FG002|Overall Study|Adverse Event|2|||
127989434|NCT03796676|460586473|FG000|Overall Study|Lost to Follow-up|2|||
127989435|NCT03796676|460586474|FG001|Overall Study|Lost to Follow-up|1|||
127989436|NCT03796676|460586475|FG002|Overall Study|Lost to Follow-up|0|||
127989437|NCT03796676|460586473|FG000|Overall Study|Protocol Violation|0|||
127989438|NCT03796676|460586474|FG001|Overall Study|Protocol Violation|0|||
127989439|NCT03796676|460586475|FG002|Overall Study|Protocol Violation|1|||
127989440|NCT03796676|460586473|FG000|Overall Study|Withdrawal by Subject|1|||
127989441|NCT03796676|460586474|FG001|Overall Study|Withdrawal by Subject|1|||
127989442|NCT03796676|460586475|FG002|Overall Study|Withdrawal by Subject|0|||
127989443|NCT03796676|460586473|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
127989444|NCT03796676|460586474|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
127989445|NCT03796676|460586475|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
127989446|NCT00248833|460586479|FG000|Overall Study|Adverse Event|2|||
127989447|NCT00248833|460586480|FG001|Overall Study|Adverse Event|0|||
127989448|NCT00248833|460586481|FG002|Overall Study|Adverse Event|0|||
127989449|NCT00248833|460586479|FG000|Overall Study|Withdrawal by Subject|0|||
127989450|NCT00248833|460586480|FG001|Overall Study|Withdrawal by Subject|1|||
127989451|NCT00248833|460586481|FG002|Overall Study|Withdrawal by Subject|1|||
127989452|NCT00248833|460586479|FG000|Overall Study|Lost to Follow-up|1|||
127989453|NCT00248833|460586480|FG001|Overall Study|Lost to Follow-up|1|||
127989454|NCT00248833|460586481|FG002|Overall Study|Lost to Follow-up|1|||
127989455|NCT00248833|460586479|FG000|Overall Study|Other|0|||
127989456|NCT00248833|460586480|FG001|Overall Study|Other|1|||
127989457|NCT00248833|460586481|FG002|Overall Study|Other|0|||
127989458|NCT01900899|460586482|FG000|Overall Study|Withdrawal by Subject|7|||
127659864|NCT02960763|459378138|FG000|Step 1|Lost to Follow-up|7|||
127659865|NCT02960763|459378139|FG001|Step 1|Lost to Follow-up|9|||
127659866|NCT02960763|459378140|FG002|Step 1|Lost to Follow-up|12|||
127989459|NCT01900899|460586483|FG001|Overall Study|Withdrawal by Subject|1|||
127989460|NCT01900899|460586482|FG000|Overall Study|Migrated from study area|2|||
127659867|NCT02960763|459378141|FG003|Step 1|Lost to Follow-up|0|||
127659868|NCT02960763|459378142|FG004|Step 1|Lost to Follow-up|0|||
127659869|NCT02960763|459378138|FG000|Step 1|Death|1|||
127659870|NCT02960763|459378139|FG001|Step 1|Death|1|||
127659871|NCT02960763|459378140|FG002|Step 1|Death|1|||
127659872|NCT02960763|459378141|FG003|Step 1|Death|0|||
127659873|NCT02960763|459378142|FG004|Step 1|Death|0|||
127659874|NCT02960763|459378138|FG000|Step 1|Investigator discretion|1|||
127659875|NCT02960763|459378139|FG001|Step 1|Investigator discretion|0|||
127659876|NCT02960763|459378140|FG002|Step 1|Investigator discretion|1|||
127659877|NCT02960763|459378141|FG003|Step 1|Investigator discretion|0|||
127659878|NCT02960763|459378142|FG004|Step 1|Investigator discretion|0|||
127659879|NCT02960763|459378138|FG000|Step 1|Other|0|||
127659880|NCT02960763|459378139|FG001|Step 1|Other|0|||
127659881|NCT02960763|459378140|FG002|Step 1|Other|1|||
127659882|NCT02960763|459378141|FG003|Step 1|Other|0|||
127659883|NCT02960763|459378142|FG004|Step 1|Other|0|||
127659884|NCT02960763|459378138|FG000|Step 2|Withdrawal by Subject|0|||
127659885|NCT02960763|459378139|FG001|Step 2|Withdrawal by Subject|0|||
127659886|NCT02960763|459378140|FG002|Step 2|Withdrawal by Subject|0|||
127659887|NCT02960763|459378141|FG003|Step 2|Withdrawal by Subject|7|||
127659888|NCT02960763|459378142|FG004|Step 2|Withdrawal by Subject|3|||
127659889|NCT02960763|459378138|FG000|Step 2|Lost to Follow-up|0|||
127659890|NCT02960763|459378139|FG001|Step 2|Lost to Follow-up|0|||
127659891|NCT02960763|459378140|FG002|Step 2|Lost to Follow-up|0|||
127659892|NCT02960763|459378141|FG003|Step 2|Lost to Follow-up|4|||
127659893|NCT02960763|459378142|FG004|Step 2|Lost to Follow-up|1|||
127659894|NCT02960763|459378138|FG000|Step 2|Investigator discretion|0|||
127659895|NCT02960763|459378139|FG001|Step 2|Investigator discretion|0|||
127659896|NCT02960763|459378140|FG002|Step 2|Investigator discretion|0|||
127659897|NCT02960763|459378141|FG003|Step 2|Investigator discretion|0|||
127659898|NCT02960763|459378142|FG004|Step 2|Investigator discretion|1|||
127659899|NCT03638635|459378146|FG000|Initial Hospitalization|Study terminated prematurely|0|||
127659900|NCT03638635|459378147|FG001|Initial Hospitalization|Study terminated prematurely|1|||
127659901|NCT03638635|459378146|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
127659902|NCT03638635|459378147|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
127659903|NCT03638635|459378146|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
127659904|NCT03638635|459378147|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
127659905|NCT00313911|459378154|FG000|Overall Study|Serious adverse event|6|||
127659906|NCT00313911|459378155|FG001|Overall Study|Serious adverse event|1|||
127659907|NCT00313911|459378154|FG000|Overall Study|Adverse Event|2|||
127659908|NCT00313911|459378155|FG001|Overall Study|Adverse Event|3|||
127659909|NCT00313911|459378154|FG000|Overall Study|Protocol Violation|19|||
127659910|NCT00313911|459378155|FG001|Overall Study|Protocol Violation|10|||
127659911|NCT00313911|459378154|FG000|Overall Study|Lost to Follow-up|27|||
127659912|NCT00313911|459378155|FG001|Overall Study|Lost to Follow-up|14|||
127659913|NCT00313911|459378154|FG000|Overall Study|Withdrawal by Subject|39|||
127659914|NCT00313911|459378155|FG001|Overall Study|Withdrawal by Subject|12|||
127659915|NCT00313911|459378154|FG000|Overall Study|Did not meet age criteria|1|||
127659916|NCT00313911|459378155|FG001|Overall Study|Did not meet age criteria|1|||
127659917|NCT01533714|459378156|FG000|Overall Study|Adverse Event|0|||
127659918|NCT01533714|459378157|FG001|Overall Study|Adverse Event|1|||
127659919|NCT01533714|459378158|FG002|Overall Study|Adverse Event|2|||
127659920|NCT01533714|459378159|FG003|Overall Study|Adverse Event|2|||
127989461|NCT01900899|460586483|FG001|Overall Study|Migrated from study area|0|||
127659921|NCT01533714|459378160|FG004|Overall Study|Adverse Event|2|||
127659922|NCT01533714|459378161|FG005|Overall Study|Adverse Event|1|||
127989462|NCT00723697|460586486|FG000|Overall Study|Physician questionnaires not received|2|||
127659923|NCT01533714|459378156|FG000|Overall Study|Lack of Efficacy|0|||
127659924|NCT01533714|459378157|FG001|Overall Study|Lack of Efficacy|0|||
127659925|NCT01533714|459378158|FG002|Overall Study|Lack of Efficacy|0|||
127659926|NCT01533714|459378159|FG003|Overall Study|Lack of Efficacy|0|||
127659927|NCT01533714|459378160|FG004|Overall Study|Lack of Efficacy|0|||
127659928|NCT01533714|459378161|FG005|Overall Study|Lack of Efficacy|1|||
127659929|NCT01533714|459378156|FG000|Overall Study|Withdrawal by Subject|0|||
127989463|NCT00723697|460586486|FG000|Overall Study|Missing Informed Consent Form|10|||
127659930|NCT01533714|459378157|FG001|Overall Study|Withdrawal by Subject|1|||
127659931|NCT01533714|459378158|FG002|Overall Study|Withdrawal by Subject|0|||
127659932|NCT01533714|459378159|FG003|Overall Study|Withdrawal by Subject|1|||
127659933|NCT01533714|459378160|FG004|Overall Study|Withdrawal by Subject|1|||
127659934|NCT01533714|459378161|FG005|Overall Study|Withdrawal by Subject|0|||
127659935|NCT01533714|459378156|FG000|Overall Study|Exclusion criteria|0|||
127659936|NCT01533714|459378157|FG001|Overall Study|Exclusion criteria|1|||
127659937|NCT01533714|459378158|FG002|Overall Study|Exclusion criteria|0|||
127989464|NCT00723697|460586486|FG000|Overall Study|Other exclusion criteria applied|6|||
127989465|NCT00171158|460587876|FG000|Core Study|Death|27|||
127989466|NCT00171158|460587876|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
127989467|NCT00171158|460587876|FG000|Core Study|Protocol Violation|4|||
127989468|NCT00171158|460587876|FG000|Core Study|Administrative problems|1|||
127989469|NCT00171158|460587876|FG000|Core Study|Adverse event, non-fatal|21|||
127989470|NCT00171158|460587876|FG000|Core Study|Consent withdrawn by subject|6|||
127989471|NCT00171158|460587876|FG000|Core Study|No longer required drug (BMT)|14|||
127989472|NCT00171158|460587876|FG000|Core Study|Abnormal Laboratory Values|2|||
127659938|NCT01533714|459378159|FG003|Overall Study|Exclusion criteria|0|||
127659939|NCT01533714|459378160|FG004|Overall Study|Exclusion criteria|0|||
127659940|NCT01533714|459378161|FG005|Overall Study|Exclusion criteria|0|||
127659941|NCT01533714|459378156|FG000|Overall Study|Positive for purified protein derivative|0|||
127659942|NCT01533714|459378157|FG001|Overall Study|Positive for purified protein derivative|0|||
127659943|NCT01533714|459378158|FG002|Overall Study|Positive for purified protein derivative|1|||
127659944|NCT01533714|459378159|FG003|Overall Study|Positive for purified protein derivative|0|||
127659945|NCT01533714|459378160|FG004|Overall Study|Positive for purified protein derivative|1|||
127659946|NCT01533714|459378161|FG005|Overall Study|Positive for purified protein derivative|0|||
127659947|NCT01533714|459378156|FG000|Overall Study|Withdrawal criteria|0|||
127659948|NCT01533714|459378157|FG001|Overall Study|Withdrawal criteria|0|||
127659949|NCT01533714|459378158|FG002|Overall Study|Withdrawal criteria|1|||
127659950|NCT01533714|459378159|FG003|Overall Study|Withdrawal criteria|0|||
127659951|NCT01533714|459378160|FG004|Overall Study|Withdrawal criteria|3|||
127659952|NCT01533714|459378161|FG005|Overall Study|Withdrawal criteria|1|||
127659953|NCT01533714|459378156|FG000|Overall Study|Ineligibility reason|0|||
127659954|NCT01533714|459378157|FG001|Overall Study|Ineligibility reason|0|||
127659955|NCT01533714|459378158|FG002|Overall Study|Ineligibility reason|0|||
127659956|NCT01533714|459378159|FG003|Overall Study|Ineligibility reason|1|||
127659957|NCT01533714|459378160|FG004|Overall Study|Ineligibility reason|0|||
127659958|NCT01533714|459378161|FG005|Overall Study|Ineligibility reason|0|||
127659959|NCT00251927|459378166|FG000|Overall Study|Adverse Event|3|||
127659960|NCT00251927|459378167|FG001|Overall Study|Adverse Event|15|||
127659961|NCT00251927|459378166|FG000|Overall Study|Lack of Efficacy|22|||
127659962|NCT00251927|459378167|FG001|Overall Study|Lack of Efficacy|16|||
127659963|NCT00251927|459378166|FG000|Overall Study|Lost to Follow-up|22|||
127659964|NCT00251927|459378167|FG001|Overall Study|Lost to Follow-up|8|||
127659965|NCT00251927|459378166|FG000|Overall Study|Protocol Violation|1|||
127659966|NCT00251927|459378167|FG001|Overall Study|Protocol Violation|2|||
127659967|NCT00251927|459378166|FG000|Overall Study|Pregnancy|2|||
127659968|NCT00251927|459378167|FG001|Overall Study|Pregnancy|0|||
127659969|NCT00251927|459378166|FG000|Overall Study|Withdrawal by Subject|40|||
127659970|NCT00251927|459378167|FG001|Overall Study|Withdrawal by Subject|25|||
127659971|NCT00251927|459378166|FG000|Overall Study|Study-specific discont. achieved|13|||
127659972|NCT00251927|459378167|FG001|Overall Study|Study-specific discont. achieved|2|||
127659973|NCT00251927|459378166|FG000|Overall Study|Study procedure non-compliance|5|||
127659974|NCT00251927|459378167|FG001|Overall Study|Study procedure non-compliance|6|||
127659975|NCT02222896|459378177|FG000|Abdomen|Did not qualify|34|||
127659976|NCT02222896|459378178|FG001|Abdomen|Did not qualify|10|||
127659977|NCT02222896|459378179|FG002|Abdomen|Did not qualify|32|||
127659978|NCT02222896|459378177|FG000|Groin|Did not qualify|43|||
127659979|NCT02222896|459378178|FG001|Groin|Did not qualify|9|||
127659980|NCT02222896|459378179|FG002|Groin|Did not qualify|40|||
127659981|NCT02226172|459378184|FG000|Overall Study|Participant refused further follow-up|4|||
127659982|NCT02226172|459378184|FG000|Overall Study|Other|5|||
127659983|NCT02226172|459378184|FG000|Overall Study|Death|1|||
127659984|NCT02226172|459378184|FG000|Overall Study|Study terminated by sponsor|1|||
127659985|NCT02226172|459378184|FG000|Overall Study|Adverse Event|6|||
127659986|NCT01865617|459378185|FG000|Overall Study|Death|27|||
127659987|NCT01865617|459378186|FG001|Overall Study|Death|3|||
127659988|NCT01865617|459378187|FG002|Overall Study|Death|1|||
127989473|NCT00171158|460587876|FG000|Core Study|Lost to Follow-up|1|||
127989474|NCT00171158|460587876|FG000|E2 Extension|Other|7|||
127659989|NCT01865617|459378188|FG003|Overall Study|Death|1|||
127659990|NCT01865617|459378189|FG004|Overall Study|Death|5|||
127659991|NCT01865617|459378190|FG005|Overall Study|Death|1|||
127989475|NCT03536663|460587879|FG000|Endexo|Protocol Violation|1|||
127659992|NCT01865617|459378191|FG006|Overall Study|Death|11|||
127659993|NCT01865617|459378192|FG007|Overall Study|Death|1|||
127659994|NCT01865617|459378193|FG008|Overall Study|Death|11|||
127989476|NCT00762034|460587880|FG000|Induction Period|Protocol Violation|1|||
127659995|NCT01865617|459378194|FG009|Overall Study|Death|3|||
127659996|NCT01865617|459378195|FG010|Overall Study|Death|32|||
127659997|NCT01865617|459378196|FG011|Overall Study|Death|6|||
127659998|NCT01865617|459378197|FG012|Overall Study|Death|13|||
127659999|NCT01865617|459378185|FG000|Overall Study|Lost to Follow-up|2|||
127660000|NCT01865617|459378186|FG001|Overall Study|Lost to Follow-up|0|||
127660001|NCT01865617|459378187|FG002|Overall Study|Lost to Follow-up|0|||
127660002|NCT01865617|459378188|FG003|Overall Study|Lost to Follow-up|0|||
127989477|NCT00762034|460587881|FG001|Induction Period|Protocol Violation|2|||
127989478|NCT00762034|460587880|FG000|Induction Period|Entry Criterion Not Met|12|||
127989479|NCT00762034|460587881|FG001|Induction Period|Entry Criterion Not Met|11|||
127989480|NCT00762034|460587880|FG000|Induction Period|Adverse Event|27|||
127989481|NCT00762034|460587881|FG001|Induction Period|Adverse Event|38|||
127989482|NCT00762034|460587880|FG000|Induction Period|Lost to Follow-up|1|||
127989483|NCT00762034|460587881|FG001|Induction Period|Lost to Follow-up|1|||
127989484|NCT00762034|460587880|FG000|Induction Period|Progressive Disease|73|||
127989485|NCT00762034|460587881|FG001|Induction Period|Progressive Disease|55|||
127989486|NCT00762034|460587880|FG000|Induction Period|Physician Decision|21|||
127989487|NCT00762034|460587881|FG001|Induction Period|Physician Decision|20|||
127989488|NCT00762034|460587880|FG000|Induction Period|Withdrawal by Subject|15|||
127989489|NCT00762034|460587881|FG001|Induction Period|Withdrawal by Subject|19|||
127989490|NCT00762034|460587880|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
127989491|NCT00762034|460587881|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
127989492|NCT00762034|460587880|FG000|Induction Period|Deaths Due to Study Disease|9|||
127660003|NCT01865617|459378189|FG004|Overall Study|Lost to Follow-up|0|||
127660004|NCT01865617|459378190|FG005|Overall Study|Lost to Follow-up|0|||
127660005|NCT01865617|459378191|FG006|Overall Study|Lost to Follow-up|0|||
127660006|NCT01865617|459378192|FG007|Overall Study|Lost to Follow-up|0|||
127660007|NCT01865617|459378193|FG008|Overall Study|Lost to Follow-up|0|||
127660008|NCT01865617|459378194|FG009|Overall Study|Lost to Follow-up|0|||
127660009|NCT01865617|459378195|FG010|Overall Study|Lost to Follow-up|0|||
127660010|NCT01865617|459378196|FG011|Overall Study|Lost to Follow-up|0|||
127660011|NCT01865617|459378197|FG012|Overall Study|Lost to Follow-up|0|||
127660012|NCT01865617|459378185|FG000|Overall Study|Withdrawal by Subject|1|||
127660013|NCT01865617|459378186|FG001|Overall Study|Withdrawal by Subject|0|||
127660014|NCT01865617|459378187|FG002|Overall Study|Withdrawal by Subject|0|||
127660015|NCT01865617|459378188|FG003|Overall Study|Withdrawal by Subject|0|||
127660016|NCT01865617|459378189|FG004|Overall Study|Withdrawal by Subject|0|||
127660017|NCT01865617|459378190|FG005|Overall Study|Withdrawal by Subject|0|||
127660018|NCT01865617|459378191|FG006|Overall Study|Withdrawal by Subject|0|||
127660019|NCT01865617|459378192|FG007|Overall Study|Withdrawal by Subject|0|||
127660020|NCT01865617|459378193|FG008|Overall Study|Withdrawal by Subject|0|||
127660021|NCT01865617|459378194|FG009|Overall Study|Withdrawal by Subject|0|||
127660022|NCT01865617|459378195|FG010|Overall Study|Withdrawal by Subject|0|||
127660023|NCT01865617|459378196|FG011|Overall Study|Withdrawal by Subject|0|||
127660024|NCT01865617|459378197|FG012|Overall Study|Withdrawal by Subject|0|||
127660025|NCT01865617|459378185|FG000|Overall Study|Patient proceeded to new therapy|0|||
127660026|NCT01865617|459378186|FG001|Overall Study|Patient proceeded to new therapy|0|||
127660027|NCT01865617|459378187|FG002|Overall Study|Patient proceeded to new therapy|0|||
127660028|NCT01865617|459378188|FG003|Overall Study|Patient proceeded to new therapy|0|||
127660029|NCT01865617|459378189|FG004|Overall Study|Patient proceeded to new therapy|2|||
127660030|NCT01865617|459378190|FG005|Overall Study|Patient proceeded to new therapy|0|||
127660031|NCT01865617|459378191|FG006|Overall Study|Patient proceeded to new therapy|0|||
127660032|NCT01865617|459378192|FG007|Overall Study|Patient proceeded to new therapy|0|||
127660033|NCT01865617|459378193|FG008|Overall Study|Patient proceeded to new therapy|0|||
127660034|NCT01865617|459378194|FG009|Overall Study|Patient proceeded to new therapy|0|||
127660035|NCT01865617|459378195|FG010|Overall Study|Patient proceeded to new therapy|0|||
127660036|NCT01865617|459378196|FG011|Overall Study|Patient proceeded to new therapy|0|||
127660037|NCT01865617|459378197|FG012|Overall Study|Patient proceeded to new therapy|0|||
127660038|NCT01865617|459378185|FG000|Overall Study|Other|0|||
127660039|NCT01865617|459378186|FG001|Overall Study|Other|0|||
127660040|NCT01865617|459378187|FG002|Overall Study|Other|0|||
127660041|NCT01865617|459378188|FG003|Overall Study|Other|0|||
127660042|NCT01865617|459378189|FG004|Overall Study|Other|0|||
127660043|NCT01865617|459378190|FG005|Overall Study|Other|0|||
127660044|NCT01865617|459378191|FG006|Overall Study|Other|1|||
127660045|NCT01865617|459378192|FG007|Overall Study|Other|0|||
127660046|NCT01865617|459378193|FG008|Overall Study|Other|0|||
127660047|NCT01865617|459378194|FG009|Overall Study|Other|0|||
127660048|NCT01865617|459378195|FG010|Overall Study|Other|0|||
127989493|NCT00762034|460587881|FG001|Induction Period|Deaths Due to Study Disease|9|||
127989494|NCT00762034|460587880|FG000|Maintenance Period|Protocol Violation|1|||
127989495|NCT00762034|460587881|FG001|Maintenance Period|Protocol Violation|3|||
127989496|NCT00762034|460587880|FG000|Maintenance Period|Entry Criterion Not Met|0|||
127989497|NCT00762034|460587881|FG001|Maintenance Period|Entry Criterion Not Met|2|||
127989498|NCT00762034|460587880|FG000|Maintenance Period|Adverse Event|42|||
127989499|NCT00762034|460587881|FG001|Maintenance Period|Adverse Event|26|||
127989500|NCT00762034|460587880|FG000|Maintenance Period|Progressive Disease|186|||
127660049|NCT01865617|459378196|FG011|Overall Study|Other|0|||
127660050|NCT01865617|459378197|FG012|Overall Study|Other|0|||
127660051|NCT00258440|459378201|FG000|Overall Study|Withdrawal by Subject|0|||
127660052|NCT00258440|459378202|FG001|Overall Study|Withdrawal by Subject|0|||
127660053|NCT00258440|459378203|FG002|Overall Study|Withdrawal by Subject|1|||
127660054|NCT00737061|459378204|FG000|Waiting Period|Lost to Follow-up|6|||
127660055|NCT00737061|459378204|FG000|Waiting Period|Withdrawal by Subject|1|||
127989501|NCT00762034|460587881|FG001|Maintenance Period|Progressive Disease|224|||
127989502|NCT00762034|460587880|FG000|Maintenance Period|Physician Decision|25|||
127989503|NCT00762034|460587881|FG001|Maintenance Period|Physician Decision|20|||
127989504|NCT00762034|460587880|FG000|Maintenance Period|Withdrawal by Subject|34|||
127989505|NCT00762034|460587881|FG001|Maintenance Period|Withdrawal by Subject|14|||
127989506|NCT00762034|460587880|FG000|Maintenance Period|Death not due to study disease|2|||
127660056|NCT00737061|459378204|FG000|Waiting Period|Bilateral placement failure|34|||
127660057|NCT00737061|459378204|FG000|Waiting Period|Deemed patent following HSG|26|||
127660058|NCT00737061|459378204|FG000|Waiting Period|Alternative contraception failure|3|||
127660059|NCT00737061|459378204|FG000|Waiting Period|Elected surgical tubal ligation|5|||
127660060|NCT00737061|459378204|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
127660061|NCT00737061|459378204|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
127660062|NCT00737061|459378204|FG000|1 Year Wearing Period|Discontinued reilance|3|||
127989507|NCT00762034|460587881|FG001|Maintenance Period|Death not due to study disease|5|||
127660063|NCT00737061|459378204|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
127660064|NCT01844115|459378207|FG000|Overall Study|Adverse Event|4|||
127660065|NCT01844115|459378208|FG001|Overall Study|Adverse Event|22|||
127660066|NCT01844115|459378207|FG000|Overall Study|Lack of Efficacy|1|||
127660067|NCT01844115|459378208|FG001|Overall Study|Lack of Efficacy|4|||
127660068|NCT01844115|459378207|FG000|Overall Study|Protocol Violation|12|||
127660069|NCT01844115|459378208|FG001|Overall Study|Protocol Violation|10|||
127660070|NCT01844115|459378207|FG000|Overall Study|Withdrawal by Subject|11|||
127660071|NCT01844115|459378208|FG001|Overall Study|Withdrawal by Subject|11|||
127660072|NCT01844115|459378207|FG000|Overall Study|Lost to Follow-up|11|||
127660073|NCT01844115|459378208|FG001|Overall Study|Lost to Follow-up|10|||
127660074|NCT01844115|459378207|FG000|Overall Study|Pregnancy|0|||
127989508|NCT00762034|460587880|FG000|Maintenance Period|Death due to study disease|3|||
127660075|NCT01844115|459378208|FG001|Overall Study|Pregnancy|1|||
127660076|NCT00758160|459378209|FG000|Overall Study|No Longer Requires Study Medication|4|||
127660077|NCT00758160|459378209|FG000|Overall Study|Administration Problems|3|||
127660078|NCT00758160|459378209|FG000|Overall Study|Adverse Event|15|||
127660079|NCT00758160|459378209|FG000|Overall Study|Lack of Efficacy|10|||
127660080|NCT00758160|459378209|FG000|Overall Study|Lost to Follow-up|14|||
127660081|NCT00758160|459378209|FG000|Overall Study|Protocol Violation|12|||
127660082|NCT00758160|459378209|FG000|Overall Study|Withdrawal by Subject|8|||
127660083|NCT02153359|459378210|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
127660084|NCT02153359|459378211|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
127660085|NCT04422639|459378212|FG000|Overall Study|Death|1|||
127660086|NCT04422639|459378213|FG001|Overall Study|Death|0|||
127660087|NCT04422639|459378212|FG000|Overall Study|study closed prior to completion of FU visits|0|||
127660088|NCT04422639|459378213|FG001|Overall Study|study closed prior to completion of FU visits|2|||
127660089|NCT01964521|459378214|FG000|Overall Study|Lost to Follow-up|4|||
127660090|NCT01258660|459378216|FG000|Overall Study|Adverse Event|2|||
127660091|NCT01258660|459378217|FG001|Overall Study|Adverse Event|4|||
127660092|NCT01258660|459378216|FG000|Overall Study|Withdrawal by Subject|3|||
127660093|NCT01258660|459378217|FG001|Overall Study|Withdrawal by Subject|0|||
127660094|NCT01258660|459378216|FG000|Overall Study|due to relocation|2|||
127660095|NCT01258660|459378217|FG001|Overall Study|due to relocation|0|||
127660096|NCT01258660|459378216|FG000|Overall Study|Protocol Violation|0|||
127660097|NCT01258660|459378217|FG001|Overall Study|Protocol Violation|1|||
127660098|NCT01258660|459378216|FG000|Overall Study|Invalid for primary analysis data set|4|||
127660099|NCT01258660|459378217|FG001|Overall Study|Invalid for primary analysis data set|6|||
127660100|NCT01193582|459378218|FG000|Vaccination Series|Withdrawal by Subject|11|||
127660101|NCT01193582|459378219|FG001|Vaccination Series|Withdrawal by Subject|13|||
127989509|NCT00762034|460587881|FG001|Maintenance Period|Death due to study disease|3|||
127989510|NCT00762034|460587880|FG000|Maintenance Period|Other|1|||
127989511|NCT00762034|460587881|FG001|Maintenance Period|Other|1|||
127989512|NCT02442206|460587882|FG000|Period 1|Adverse Event|1|||
127989513|NCT02442206|460587883|FG001|Period 1|Adverse Event|1|||
127989514|NCT02442206|460587882|FG000|Period 1|withdrew consent|0|||
127989515|NCT02442206|460587883|FG001|Period 1|withdrew consent|1|||
127989516|NCT02442206|460587882|FG000|Period 1|COPD exacerbation|0|||
127989517|NCT02442206|460587883|FG001|Period 1|COPD exacerbation|1|||
127989518|NCT02442206|460587882|FG000|Period 2|Adverse Event|1|||
127989519|NCT02442206|460587883|FG001|Period 2|Adverse Event|0|||
127660102|NCT01193582|459378220|FG002|Vaccination Series|Withdrawal by Subject|8|||
127660103|NCT01193582|459378221|FG003|Vaccination Series|Withdrawal by Subject|3|||
127660104|NCT01193582|459378218|FG000|12 Month Follow-up|Death|0|||
127660105|NCT01193582|459378219|FG001|12 Month Follow-up|Death|0|||
127989520|NCT00497146|460587884|FG000|Treatment Period|Adverse Event|6|||
127989521|NCT00497146|460587885|FG001|Treatment Period|Adverse Event|2|||
127660106|NCT01193582|459378220|FG002|12 Month Follow-up|Death|1|||
127660107|NCT01193582|459378221|FG003|12 Month Follow-up|Death|0|||
127660108|NCT01193582|459378218|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
127660109|NCT01193582|459378219|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
127660110|NCT01193582|459378220|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
127660111|NCT01193582|459378221|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
127989522|NCT00497146|460587884|FG000|Treatment Period|Withdrawal by Subject|5|||
127660112|NCT02401308|459378222|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
127660113|NCT02401308|459378223|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
127660114|NCT02998021|459378224|FG000|Overall Study|Withdrawal by Subject|3|||
127660115|NCT02998021|459378225|FG001|Overall Study|Withdrawal by Subject|1|||
127660116|NCT02998021|459378224|FG000|Overall Study|unsafe home|0|||
127660117|NCT02998021|459378225|FG001|Overall Study|unsafe home|1|||
127660118|NCT01734434|459378226|FG000|Overall Study|Death Infant|3|||
127660119|NCT01734434|459378227|FG001|Overall Study|Death Infant|1|||
127660120|NCT01734434|459378228|FG002|Overall Study|Death Infant|17|||
127660121|NCT01734434|459378229|FG003|Overall Study|Death Infant|5|||
127660122|NCT01734434|459378226|FG000|Overall Study|Lost to Follow-up|2|||
127660123|NCT01734434|459378227|FG001|Overall Study|Lost to Follow-up|9|||
127660124|NCT01734434|459378228|FG002|Overall Study|Lost to Follow-up|67|||
127660125|NCT01734434|459378229|FG003|Overall Study|Lost to Follow-up|11|||
127660126|NCT01734434|459378226|FG000|Overall Study|No Live Birth|1|||
127660127|NCT01734434|459378227|FG001|Overall Study|No Live Birth|2|||
127660128|NCT01734434|459378228|FG002|Overall Study|No Live Birth|32|||
127660129|NCT01734434|459378229|FG003|Overall Study|No Live Birth|6|||
127660130|NCT01734434|459378226|FG000|Overall Study|Withdrawal by Subject|4|||
127660131|NCT01734434|459378227|FG001|Overall Study|Withdrawal by Subject|0|||
127660132|NCT01734434|459378228|FG002|Overall Study|Withdrawal by Subject|8|||
127660133|NCT01734434|459378229|FG003|Overall Study|Withdrawal by Subject|1|||
127660134|NCT01734434|459378226|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
127660135|NCT01734434|459378227|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
127660136|NCT01734434|459378228|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
127660137|NCT01734434|459378229|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
127660138|NCT01734434|459378226|FG000|Overall Study|Subject Not Reachable|0|||
127660139|NCT01734434|459378227|FG001|Overall Study|Subject Not Reachable|0|||
127660140|NCT01734434|459378228|FG002|Overall Study|Subject Not Reachable|1|||
127660141|NCT01734434|459378229|FG003|Overall Study|Subject Not Reachable|0|||
127660142|NCT01734434|459378226|FG000|Overall Study|Treatment Defaulter|0|||
127660143|NCT01734434|459378227|FG001|Overall Study|Treatment Defaulter|0|||
127660144|NCT01734434|459378228|FG002|Overall Study|Treatment Defaulter|1|||
127660145|NCT01734434|459378229|FG003|Overall Study|Treatment Defaulter|0|||
127660146|NCT01734434|459378226|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
127660147|NCT01734434|459378227|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
127660148|NCT01734434|459378228|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
127660149|NCT01734434|459378229|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
127660150|NCT01734434|459378226|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
127989523|NCT00497146|460587885|FG001|Treatment Period|Withdrawal by Subject|9|||
127989524|NCT00497146|460587884|FG000|Treatment Period|Lost to Follow-up|1|||
127989525|NCT00497146|460587885|FG001|Treatment Period|Lost to Follow-up|3|||
127989526|NCT00497146|460587884|FG000|Treatment Period|Required dialysis|4|||
127660151|NCT01734434|459378227|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
127660152|NCT01734434|459378228|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
127660153|NCT01734434|459378229|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
127660154|NCT01567865|459378232|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
127660155|NCT01567865|459378233|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
127660156|NCT01567865|459378234|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
127660157|NCT01567865|459378235|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
127660158|NCT01567865|459378232|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
127660159|NCT01567865|459378233|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
127989527|NCT00497146|460587885|FG001|Treatment Period|Required dialysis|1|||
127989528|NCT00497146|460587884|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
127989529|NCT00497146|460587885|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
127989530|NCT00497146|460587884|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
127989531|NCT00497146|460587885|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
127989532|NCT00497146|460587884|FG000|Treatment Period|Other Reason|2|||
127989533|NCT00497146|460587885|FG001|Treatment Period|Other Reason|3|||
127989534|NCT00497146|460587884|FG000|Long-term Follow-up Period|Adverse Event|2|||
127989535|NCT00497146|460587885|FG001|Long-term Follow-up Period|Adverse Event|2|||
127660160|NCT01567865|459378234|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
127660161|NCT01567865|459378235|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
127660162|NCT00309608|459378238|FG000|Overall Study|Adverse Event|1|||
127660163|NCT00309608|459378239|FG001|Overall Study|Adverse Event|5|||
127660164|NCT00309608|459378240|FG002|Overall Study|Adverse Event|3|||
127660165|NCT00309608|459378241|FG003|Overall Study|Adverse Event|2|||
127989536|NCT00497146|460587884|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
127660166|NCT00309608|459378242|FG004|Overall Study|Adverse Event|3|||
127660167|NCT00309608|459378238|FG000|Overall Study|Protocol Violation|2|||
127660168|NCT00309608|459378239|FG001|Overall Study|Protocol Violation|0|||
127660169|NCT00309608|459378240|FG002|Overall Study|Protocol Violation|0|||
127660170|NCT00309608|459378241|FG003|Overall Study|Protocol Violation|0|||
127660171|NCT00309608|459378242|FG004|Overall Study|Protocol Violation|0|||
127660172|NCT00309608|459378238|FG000|Overall Study|Lost to Follow-up|0|||
127660173|NCT00309608|459378239|FG001|Overall Study|Lost to Follow-up|0|||
127660174|NCT00309608|459378240|FG002|Overall Study|Lost to Follow-up|2|||
127660175|NCT00309608|459378241|FG003|Overall Study|Lost to Follow-up|0|||
127660176|NCT00309608|459378242|FG004|Overall Study|Lost to Follow-up|1|||
127660177|NCT00309608|459378238|FG000|Overall Study|Withdrawal by Subject|1|||
127660178|NCT00309608|459378239|FG001|Overall Study|Withdrawal by Subject|4|||
127660179|NCT00309608|459378240|FG002|Overall Study|Withdrawal by Subject|2|||
127660180|NCT00309608|459378241|FG003|Overall Study|Withdrawal by Subject|0|||
127660181|NCT00309608|459378242|FG004|Overall Study|Withdrawal by Subject|0|||
127660182|NCT00309608|459378238|FG000|Overall Study|Other incl. Lack of efficacy|10|||
127660183|NCT00309608|459378239|FG001|Overall Study|Other incl. Lack of efficacy|4|||
127660184|NCT00309608|459378240|FG002|Overall Study|Other incl. Lack of efficacy|3|||
127660185|NCT00309608|459378241|FG003|Overall Study|Other incl. Lack of efficacy|4|||
127660186|NCT00309608|459378242|FG004|Overall Study|Other incl. Lack of efficacy|0|||
127660187|NCT00621296|459378249|FG000|Overall Study|Adverse Event|2|||
127660188|NCT00621296|459378249|FG000|Overall Study|Lack of Efficacy|1|||
127660189|NCT00621296|459378249|FG000|Overall Study|Physician Decision|7|||
127660190|NCT00621296|459378249|FG000|Overall Study|Unmatch Criteria|1|||
127660191|NCT00621296|459378249|FG000|Overall Study|Stopping Criteria|3|||
127660192|NCT03391960|459378250|FG000|Overall Study|Protocol Violation|0|||
127989537|NCT00497146|460587885|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
127989538|NCT00497146|460587884|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
127989539|NCT00497146|460587885|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
127989540|NCT00497146|460587884|FG000|Long-term Follow-up Period|Other|0|||
127989541|NCT00497146|460587885|FG001|Long-term Follow-up Period|Other|1|||
127989542|NCT01471444|460587886|FG000|Overall Study|Physician Decision|3|||
127660193|NCT03391960|459378251|FG001|Overall Study|Protocol Violation|0|||
127660194|NCT03518658|459380182|FG000|Overall Study|Other|51|||
127989543|NCT01471444|460587887|FG001|Overall Study|Physician Decision|2|||
127989544|NCT01471444|460587886|FG000|Overall Study|Withdrawal by Subject|0|||
127989545|NCT01471444|460587887|FG001|Overall Study|Withdrawal by Subject|1|||
127989546|NCT01299896|460587890|FG000|Overall Study|Withdrawal by Subject|1|||
127989547|NCT01299896|460587891|FG001|Overall Study|Withdrawal by Subject|7|||
127989548|NCT01299896|460587890|FG000|Overall Study|Lost to Follow-up|0|||
127989549|NCT01299896|460587891|FG001|Overall Study|Lost to Follow-up|11|||
127989550|NCT02107313|460587892|FG000|Overall Study|One participant did not do the FED cohor|0|||
127989551|NCT02107313|460587893|FG001|Overall Study|One participant did not do the FED cohor|1|||
127989552|NCT00582426|460587904|FG000|Overall Study|Lost to Follow-up|0|||
127989553|NCT00582426|460587905|FG001|Overall Study|Lost to Follow-up|2|||
127989554|NCT00582426|460587904|FG000|Overall Study|Adverse Event|4|||
127989555|NCT00582426|460587905|FG001|Overall Study|Adverse Event|2|||
127989556|NCT00582426|460587904|FG000|Overall Study|Protocol Violation|6|||
127989557|NCT00582426|460587905|FG001|Overall Study|Protocol Violation|2|||
127989558|NCT00582426|460587904|FG000|Overall Study|Death|4|||
127989559|NCT00582426|460587905|FG001|Overall Study|Death|3|||
127989560|NCT00582426|460587904|FG000|Overall Study|Withdrawal by Subject|3|||
127989561|NCT00582426|460587905|FG001|Overall Study|Withdrawal by Subject|2|||
127989562|NCT00582426|460587904|FG000|Overall Study|Disease Progression|2|||
127989563|NCT00582426|460587905|FG001|Overall Study|Disease Progression|2|||
127989564|NCT00582426|460587904|FG000|Overall Study|Use of illicit drugs|1|||
127989565|NCT00582426|460587905|FG001|Overall Study|Use of illicit drugs|0|||
127989566|NCT02164318|460587906|FG000|Overall Study|Withdrawal by Subject|0|||
127989567|NCT02164318|460587907|FG001|Overall Study|Withdrawal by Subject|1|||
127989568|NCT02164318|460587908|FG002|Overall Study|Withdrawal by Subject|0|||
127989569|NCT02164318|460587909|FG003|Overall Study|Withdrawal by Subject|1|||
127989570|NCT01548768|460587914|FG000|Overall Study|Withdrawal by Subject|0|||
127989571|NCT01548768|460587915|FG001|Overall Study|Withdrawal by Subject|2|||
127989572|NCT01548768|460587916|FG002|Overall Study|Withdrawal by Subject|1|||
127989573|NCT01548768|460587917|FG003|Overall Study|Withdrawal by Subject|0|||
127660195|NCT03518658|459380183|FG001|Overall Study|Other|0|||
127660196|NCT00999661|459380186|FG000|Overall Study|Lost to Follow-up|59|||
127660197|NCT00999661|459380186|FG000|Overall Study|Adverse Event|1|||
127660198|NCT00999661|459380186|FG000|Overall Study|Withdrawal by Subject|1|||
127989574|NCT01548768|460587914|FG000|Overall Study|Physician Decision|1|||
127989575|NCT01548768|460587915|FG001|Overall Study|Physician Decision|0|||
127989576|NCT01548768|460587916|FG002|Overall Study|Physician Decision|0|||
127989577|NCT01548768|460587917|FG003|Overall Study|Physician Decision|0|||
127989578|NCT01548768|460587914|FG000|Overall Study|Adverse Event|0|||
127989579|NCT01548768|460587915|FG001|Overall Study|Adverse Event|0|||
127989580|NCT01548768|460587916|FG002|Overall Study|Adverse Event|0|||
127989581|NCT01548768|460587917|FG003|Overall Study|Adverse Event|1|||
127989582|NCT01548768|460587914|FG000|Overall Study|Non-Compliance|0|||
127660199|NCT00999661|459380186|FG000|Overall Study|Not meeting eligibility criteria|9|||
127660200|NCT00917267|459380187|FG000|Overall Study|Adverse Event|15|||
127989583|NCT01548768|460587915|FG001|Overall Study|Non-Compliance|0|||
127989584|NCT01548768|460587916|FG002|Overall Study|Non-Compliance|0|||
127989585|NCT01548768|460587917|FG003|Overall Study|Non-Compliance|3|||
127989586|NCT03084302|460587918|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
127989587|NCT03084302|460587918|FG000|Overall Study|No valid objective monitor data|6|||
127989588|NCT00929994|460587919|FG000|Overall Study|Withdrawal by Subject|1|||
127989589|NCT00929994|460587919|FG000|Overall Study|medical issue unrelated to intervention|4|||
127989590|NCT00929994|460587919|FG000|Overall Study|employment|1|||
127989591|NCT01214668|460587920|FG000|Overall Study|Adverse Event|0|||
127989592|NCT01214668|460587921|FG001|Overall Study|Adverse Event|1|||
127989593|NCT01214668|460587922|FG002|Overall Study|Adverse Event|0|||
127989594|NCT01214668|460587923|FG003|Overall Study|Adverse Event|2|||
127989595|NCT01214668|460587924|FG004|Overall Study|Adverse Event|1|||
127989596|NCT01214668|460587925|FG005|Overall Study|Adverse Event|1|||
127989597|NCT01214668|460587920|FG000|Overall Study|Death|0|||
127660201|NCT00917267|459380188|FG001|Overall Study|Adverse Event|36|||
127660202|NCT00917267|459380187|FG000|Overall Study|Physician Decision|2|||
127660203|NCT00917267|459380188|FG001|Overall Study|Physician Decision|4|||
127660204|NCT00917267|459380187|FG000|Overall Study|Protocol Violation|9|||
127660205|NCT00917267|459380188|FG001|Overall Study|Protocol Violation|18|||
127989598|NCT01214668|460587921|FG001|Overall Study|Death|0|||
127989599|NCT01214668|460587922|FG002|Overall Study|Death|1|||
127989600|NCT01214668|460587923|FG003|Overall Study|Death|0|||
127989601|NCT01214668|460587924|FG004|Overall Study|Death|0|||
127989602|NCT01214668|460587925|FG005|Overall Study|Death|0|||
127660206|NCT00917267|459380187|FG000|Overall Study|Withdrawal by Subject|5|||
127660207|NCT00917267|459380188|FG001|Overall Study|Withdrawal by Subject|12|||
127660208|NCT00917267|459380187|FG000|Overall Study|Lost to follow up|0|||
127660209|NCT00917267|459380188|FG001|Overall Study|Lost to follow up|2|||
127660210|NCT00917267|459380187|FG000|Overall Study|Entry Criteria Not Met|1|||
127660211|NCT00917267|459380188|FG001|Overall Study|Entry Criteria Not Met|0|||
127660212|NCT00917267|459380187|FG000|Overall Study|Sponsor Decision|5|||
127660213|NCT00917267|459380188|FG001|Overall Study|Sponsor Decision|5|||
127660214|NCT00917267|459380187|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
127660215|NCT00917267|459380188|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
127660216|NCT01017120|459380194|FG000|Overall Study|Adverse Event|9|||
127660217|NCT01017120|459380195|FG001|Overall Study|Adverse Event|0|||
127660218|NCT01017120|459380194|FG000|Overall Study|Lost to Follow-up|13|||
127660219|NCT01017120|459380195|FG001|Overall Study|Lost to Follow-up|11|||
127660220|NCT01017120|459380194|FG000|Overall Study|Lack of Efficacy|1|||
127660221|NCT01017120|459380195|FG001|Overall Study|Lack of Efficacy|0|||
127660222|NCT01017120|459380194|FG000|Overall Study|Withdrawal by Subject|39|||
127660223|NCT01017120|459380195|FG001|Overall Study|Withdrawal by Subject|21|||
127660224|NCT01017120|459380194|FG000|Overall Study|Pregnancy|1|||
127660225|NCT01017120|459380195|FG001|Overall Study|Pregnancy|1|||
127660226|NCT01017120|459380194|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
127660227|NCT01017120|459380195|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
127660228|NCT01017120|459380194|FG000|Overall Study|Relocated Out of Town|0|||
127660229|NCT01017120|459380195|FG001|Overall Study|Relocated Out of Town|2|||
127660230|NCT01017120|459380194|FG000|Overall Study|Protocol Violation|1|||
127660231|NCT01017120|459380195|FG001|Overall Study|Protocol Violation|0|||
127660232|NCT01017120|459380194|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
127660233|NCT01017120|459380195|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
127660234|NCT00289770|459380200|FG000|Year 15|Withdrawal by Subject|1|||
127660235|NCT01702428|459380201|FG000|Overall Study|Adverse Event|2|||
127660236|NCT01702428|459380202|FG001|Overall Study|Adverse Event|0|||
127660237|NCT01702428|459380203|FG002|Overall Study|Adverse Event|0|||
127660238|NCT01702428|459380204|FG003|Overall Study|Adverse Event|0|||
127660239|NCT01702428|459380201|FG000|Overall Study|Lost to Follow-up|33|||
127660240|NCT01702428|459380202|FG001|Overall Study|Lost to Follow-up|41|||
127660241|NCT01702428|459380203|FG002|Overall Study|Lost to Follow-up|37|||
127660242|NCT01702428|459380204|FG003|Overall Study|Lost to Follow-up|44|||
127660243|NCT01702428|459380201|FG000|Overall Study|Parents cannot assist to site|1|||
127660244|NCT01702428|459380202|FG001|Overall Study|Parents cannot assist to site|0|||
127660245|NCT01702428|459380203|FG002|Overall Study|Parents cannot assist to site|1|||
127660246|NCT01702428|459380204|FG003|Overall Study|Parents cannot assist to site|0|||
127660247|NCT01702428|459380201|FG000|Overall Study|Lost Coverage|0|||
127660248|NCT01702428|459380202|FG001|Overall Study|Lost Coverage|0|||
127660249|NCT01702428|459380203|FG002|Overall Study|Lost Coverage|0|||
127660250|NCT01702428|459380204|FG003|Overall Study|Lost Coverage|1|||
127660251|NCT01702428|459380201|FG000|Overall Study|Lost Health Plan|3|||
127989603|NCT01214668|460587920|FG000|Overall Study|Progressive Disease|4|||
127989604|NCT01214668|460587921|FG001|Overall Study|Progressive Disease|2|||
127660252|NCT01702428|459380202|FG001|Overall Study|Lost Health Plan|5|||
127989605|NCT01214668|460587922|FG002|Overall Study|Progressive Disease|5|||
127989606|NCT01214668|460587923|FG003|Overall Study|Progressive Disease|4|||
127989607|NCT01214668|460587924|FG004|Overall Study|Progressive Disease|4|||
127989608|NCT01214668|460587925|FG005|Overall Study|Progressive Disease|5|||
127660253|NCT01702428|459380203|FG002|Overall Study|Lost Health Plan|0|||
127989609|NCT01214668|460587920|FG000|Overall Study|Withdrawal by Subject|0|||
127989610|NCT01214668|460587921|FG001|Overall Study|Withdrawal by Subject|0|||
127989611|NCT01214668|460587922|FG002|Overall Study|Withdrawal by Subject|0|||
127989612|NCT01214668|460587923|FG003|Overall Study|Withdrawal by Subject|0|||
127989613|NCT01214668|460587924|FG004|Overall Study|Withdrawal by Subject|1|||
127989614|NCT01214668|460587925|FG005|Overall Study|Withdrawal by Subject|0|||
127989615|NCT01964989|460587926|FG000|Overall Study|Protocol Violation|3|||
127660254|NCT01702428|459380204|FG003|Overall Study|Lost Health Plan|2|||
127660255|NCT01702428|459380201|FG000|Overall Study|Mother transferred care|0|||
127660256|NCT01702428|459380202|FG001|Overall Study|Mother transferred care|1|||
127660257|NCT01702428|459380203|FG002|Overall Study|Mother transferred care|0|||
127660258|NCT01702428|459380204|FG003|Overall Study|Mother transferred care|0|||
127660259|NCT01702428|459380201|FG000|Overall Study|Parents too busy|1|||
127660260|NCT01702428|459380202|FG001|Overall Study|Parents too busy|0|||
127660261|NCT01702428|459380203|FG002|Overall Study|Parents too busy|0|||
127660262|NCT01702428|459380204|FG003|Overall Study|Parents too busy|0|||
127660263|NCT01702428|459380201|FG000|Overall Study|Protocol Violation|3|||
127660264|NCT01702428|459380202|FG001|Overall Study|Protocol Violation|0|||
127660265|NCT01702428|459380203|FG002|Overall Study|Protocol Violation|1|||
127660266|NCT01702428|459380204|FG003|Overall Study|Protocol Violation|0|||
127660267|NCT01702428|459380201|FG000|Overall Study|Withdrawal by Subject|21|||
127660268|NCT01702428|459380202|FG001|Overall Study|Withdrawal by Subject|23|||
127660269|NCT01702428|459380203|FG002|Overall Study|Withdrawal by Subject|14|||
127660270|NCT01702428|459380204|FG003|Overall Study|Withdrawal by Subject|10|||
127660271|NCT00154063|459380207|FG000|Overall Study|Adverse Event|4|||
127660272|NCT00154063|459380208|FG001|Overall Study|Adverse Event|8|||
127660273|NCT00154063|459380207|FG000|Overall Study|Protocol Violation|1|||
127660274|NCT00154063|459380208|FG001|Overall Study|Protocol Violation|1|||
127660275|NCT00154063|459380207|FG000|Overall Study|Investigator or Sponsor Request|0|||
127660276|NCT00154063|459380208|FG001|Overall Study|Investigator or Sponsor Request|1|||
127660277|NCT00154063|459380207|FG000|Overall Study|Withdrawal by Subject|4|||
127660278|NCT00154063|459380208|FG001|Overall Study|Withdrawal by Subject|9|||
127660279|NCT00154063|459380207|FG000|Overall Study|Other|3|||
127660280|NCT00154063|459380208|FG001|Overall Study|Other|3|||
127660281|NCT02091869|459380209|FG000|Overall Study|Withdrawal by Subject|0|||
127660282|NCT02091869|459380210|FG001|Overall Study|Withdrawal by Subject|3|||
127660283|NCT01804673|459380211|FG000|Overall Study|Adverse Event|4|||
127660284|NCT01804673|459380211|FG000|Overall Study|Withdrawal by Subject|1|||
127660285|NCT01804673|459380211|FG000|Overall Study|Lack of Efficacy|9|||
127660286|NCT01804673|459380211|FG000|Overall Study|Change to Oral Therapy|37|||
127660287|NCT01804673|459380211|FG000|Overall Study|No Further Therapy Required|84|||
127989616|NCT01964989|460587927|FG001|Overall Study|Protocol Violation|4|||
127989617|NCT01964989|460587926|FG000|Overall Study|Administrative Reason|103|||
127989618|NCT01964989|460587927|FG001|Overall Study|Administrative Reason|95|||
127989619|NCT01964989|460587926|FG000|Overall Study|Adverse Event|0|||
127660288|NCT01804673|459380211|FG000|Overall Study|Use of Prohibited Medication|1|||
127660289|NCT01804673|459380211|FG000|Overall Study|Other|4|||
127660290|NCT00451217|459380215|FG000|Overall Study|Lost to Follow-up|0|||
127660291|NCT00451217|459380216|FG001|Overall Study|Lost to Follow-up|1|||
127660292|NCT00451217|459380217|FG002|Overall Study|Lost to Follow-up|1|||
127660293|NCT00451217|459380218|FG003|Overall Study|Lost to Follow-up|1|||
127660294|NCT00451217|459380215|FG000|Overall Study|Withdrawal by Subject|1|||
127660295|NCT00451217|459380216|FG001|Overall Study|Withdrawal by Subject|0|||
127660296|NCT00451217|459380217|FG002|Overall Study|Withdrawal by Subject|0|||
127660297|NCT00451217|459380218|FG003|Overall Study|Withdrawal by Subject|0|||
127660298|NCT00451217|459380215|FG000|Overall Study|Not Treated|1|||
127660299|NCT00451217|459380216|FG001|Overall Study|Not Treated|1|||
127660300|NCT00451217|459380217|FG002|Overall Study|Not Treated|3|||
127660301|NCT00451217|459380218|FG003|Overall Study|Not Treated|4|||
127660302|NCT02406261|459380219|FG000|Period 1|Lost to Follow-up|2|||
127660303|NCT02406261|459380220|FG001|Period 1|Lost to Follow-up|0|||
127660304|NCT02406261|459380219|FG000|Period 1|Adverse Event|1|||
127989620|NCT01964989|460587927|FG001|Overall Study|Adverse Event|1|||
127989621|NCT01964989|460587926|FG000|Overall Study|Death|1|||
127989622|NCT01964989|460587927|FG001|Overall Study|Death|3|||
127660305|NCT02406261|459380220|FG001|Period 1|Adverse Event|0|||
127660306|NCT02406261|459380219|FG000|Period 2|Physician Decision|0|||
127660307|NCT02406261|459380220|FG001|Period 2|Physician Decision|1|||
127660308|NCT02406261|459380219|FG000|Period 2|Protocol Violation|0|||
127660309|NCT02406261|459380220|FG001|Period 2|Protocol Violation|1|||
127660310|NCT02406261|459380219|FG000|Period 2|Withdrawal by Subject|0|||
127989623|NCT01964989|460587926|FG000|Overall Study|Withdrawal by Subject|156|||
127989624|NCT01964989|460587927|FG001|Overall Study|Withdrawal by Subject|160|||
127660311|NCT02406261|459380220|FG001|Period 2|Withdrawal by Subject|1|||
127660312|NCT00439179|459380228|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
127660313|NCT00439179|459380229|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
127660314|NCT00439179|459380230|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
127660315|NCT00439179|459380231|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
127989625|NCT01964989|460587926|FG000|Overall Study|Lost to Follow-up|254|||
127660316|NCT01613027|459380234|FG000|Overall Study|Lost to Follow-up|5|||
127660317|NCT01613027|459380234|FG000|Overall Study|Switched Physician|1|||
127660318|NCT01613027|459380234|FG000|Overall Study|Lack of Efficacy|1|||
127660319|NCT01613027|459380234|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
127660320|NCT00993317|459380235|FG000|Overall Study|Adverse Event|2|||
127660321|NCT00993317|459380236|FG001|Overall Study|Adverse Event|4|||
127660322|NCT00993317|459380235|FG000|Overall Study|Lack of Efficacy|18|||
127660323|NCT00993317|459380236|FG001|Overall Study|Lack of Efficacy|18|||
127660324|NCT00993317|459380235|FG000|Overall Study|Withdrawal by Subject|0|||
127660325|NCT00993317|459380236|FG001|Overall Study|Withdrawal by Subject|2|||
127660326|NCT00993317|459380235|FG000|Overall Study|Investigator's opinion|0|||
127660327|NCT00993317|459380236|FG001|Overall Study|Investigator's opinion|1|||
127660328|NCT00993317|459380235|FG000|Overall Study|Early study termination at the site|1|||
127660329|NCT00993317|459380236|FG001|Overall Study|Early study termination at the site|0|||
127660330|NCT03856996|459380243|FG000|Overall Study|Withdrawal by Subject|1|||
127660331|NCT03856996|459380244|FG001|Overall Study|Withdrawal by Subject|0|||
127660332|NCT03856996|459380243|FG000|Overall Study|Lost to Follow-up|0|||
127660333|NCT03856996|459380244|FG001|Overall Study|Lost to Follow-up|1|||
127660334|NCT03856996|459380243|FG000|Overall Study|Adverse Event|1|||
127660335|NCT03856996|459380244|FG001|Overall Study|Adverse Event|1|||
127660336|NCT03856996|459380243|FG000|Overall Study|Other|1|||
127660337|NCT03856996|459380244|FG001|Overall Study|Other|0|||
127660338|NCT02340520|459380245|FG000|Overall Study|Lost to Follow-up|1|||
127660339|NCT02340520|459380245|FG000|Overall Study|Patient did not take drug as specified|1|||
127660340|NCT02340520|459380245|FG000|Overall Study|Withdrawal by Subject|1|||
127660341|NCT01464255|459380246|FG000|Overall Study|unresolve corneal staining|0|||
127660342|NCT01464255|459380247|FG001|Overall Study|unresolve corneal staining|1|||
127660343|NCT01231503|459380248|FG000|Overall Study|Adverse Event|0|||
127660344|NCT01231503|459380249|FG001|Overall Study|Adverse Event|0|||
127660345|NCT01231503|459380250|FG002|Overall Study|Adverse Event|0|||
127660346|NCT01231503|459380251|FG003|Overall Study|Adverse Event|0|||
127660347|NCT01231503|459380252|FG004|Overall Study|Adverse Event|0|||
127660348|NCT01231503|459380253|FG005|Overall Study|Adverse Event|1|||
127660349|NCT01231503|459380254|FG006|Overall Study|Adverse Event|0|||
127660350|NCT01231503|459380255|FG007|Overall Study|Adverse Event|0|||
127660351|NCT01231503|459380248|FG000|Overall Study|Adverse event, serious fatal|0|||
127660352|NCT01231503|459380249|FG001|Overall Study|Adverse event, serious fatal|0|||
127660353|NCT01231503|459380250|FG002|Overall Study|Adverse event, serious fatal|1|||
127660354|NCT01231503|459380251|FG003|Overall Study|Adverse event, serious fatal|1|||
127660355|NCT01231503|459380252|FG004|Overall Study|Adverse event, serious fatal|0|||
127660356|NCT01231503|459380253|FG005|Overall Study|Adverse event, serious fatal|1|||
127660357|NCT01231503|459380254|FG006|Overall Study|Adverse event, serious fatal|0|||
127660358|NCT01231503|459380255|FG007|Overall Study|Adverse event, serious fatal|0|||
127660359|NCT01231503|459380248|FG000|Overall Study|Withdrawal by Subject|6|||
127660360|NCT01231503|459380249|FG001|Overall Study|Withdrawal by Subject|3|||
127660361|NCT01231503|459380250|FG002|Overall Study|Withdrawal by Subject|3|||
127660362|NCT01231503|459380251|FG003|Overall Study|Withdrawal by Subject|1|||
127660363|NCT01231503|459380252|FG004|Overall Study|Withdrawal by Subject|3|||
127660364|NCT01231503|459380253|FG005|Overall Study|Withdrawal by Subject|5|||
127660365|NCT01231503|459380254|FG006|Overall Study|Withdrawal by Subject|1|||
127660366|NCT01231503|459380255|FG007|Overall Study|Withdrawal by Subject|2|||
127660367|NCT01231503|459380248|FG000|Overall Study|Lost to Follow-up|8|||
127660368|NCT01231503|459380249|FG001|Overall Study|Lost to Follow-up|10|||
127660369|NCT01231503|459380250|FG002|Overall Study|Lost to Follow-up|8|||
127660370|NCT01231503|459380251|FG003|Overall Study|Lost to Follow-up|5|||
127660371|NCT01231503|459380252|FG004|Overall Study|Lost to Follow-up|7|||
127660372|NCT01231503|459380253|FG005|Overall Study|Lost to Follow-up|9|||
127660373|NCT01231503|459380254|FG006|Overall Study|Lost to Follow-up|6|||
127660374|NCT01231503|459380255|FG007|Overall Study|Lost to Follow-up|6|||
127660375|NCT01231503|459380248|FG000|Overall Study|Protocol Violation|0|||
127660376|NCT01231503|459380249|FG001|Overall Study|Protocol Violation|0|||
127660377|NCT01231503|459380250|FG002|Overall Study|Protocol Violation|0|||
127660378|NCT01231503|459380251|FG003|Overall Study|Protocol Violation|1|||
127660379|NCT01231503|459380252|FG004|Overall Study|Protocol Violation|0|||
127660380|NCT01231503|459380253|FG005|Overall Study|Protocol Violation|0|||
127989626|NCT01964989|460587927|FG001|Overall Study|Lost to Follow-up|232|||
127989627|NCT01964989|460587926|FG000|Overall Study|Other|267|||
127660381|NCT01231503|459380254|FG006|Overall Study|Protocol Violation|0|||
127660382|NCT01231503|459380255|FG007|Overall Study|Protocol Violation|0|||
127660383|NCT01586338|459380256|FG000|Overall Study|Adverse Event|3|||
127660384|NCT01586338|459380256|FG000|Overall Study|Lost to Follow-up|1|||
127660385|NCT01586338|459380256|FG000|Overall Study|Withdrawal by participant|3|||
127660386|NCT01586338|459380256|FG000|Overall Study|Other|1|||
127660387|NCT00284089|459380257|FG000|Multiple Dose Phase|Adverse Event|1|||
127660388|NCT00284089|459380258|FG001|Multiple Dose Phase|Adverse Event|0|||
127660389|NCT00284089|459380259|FG002|Multiple Dose Phase|Adverse Event|1|||
127660390|NCT00284089|459380260|FG003|Multiple Dose Phase|Adverse Event|1|||
127989628|NCT01964989|460587927|FG001|Overall Study|Other|252|||
127989629|NCT04126317|460587931|FG000|Overall Study|Adverse Event|0|||
127989630|NCT04126317|460587932|FG001|Overall Study|Adverse Event|1|||
127989631|NCT04126317|460587931|FG000|Overall Study|Withdrawal by Subject|4|||
127989632|NCT04126317|460587932|FG001|Overall Study|Withdrawal by Subject|1|||
127989633|NCT00424593|460587933|FG000|Acute Double-Blind Period|Adverse Event|16|||
127989634|NCT00424593|460587934|FG001|Acute Double-Blind Period|Adverse Event|7|||
127989635|NCT00424593|460587933|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
127989636|NCT00424593|460587934|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
127660391|NCT00284089|459380257|FG000|Multiple Dose Phase|Protocol Violation|0|||
127660392|NCT00284089|459380258|FG001|Multiple Dose Phase|Protocol Violation|0|||
127660393|NCT00284089|459380259|FG002|Multiple Dose Phase|Protocol Violation|1|||
127660394|NCT00284089|459380260|FG003|Multiple Dose Phase|Protocol Violation|0|||
127660395|NCT00284089|459380257|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
127660396|NCT00284089|459380258|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
127660397|NCT00284089|459380259|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
127660398|NCT00284089|459380260|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
127660399|NCT00284089|459380257|FG000|Multiple Dose Phase|Death|0|||
127989637|NCT00424593|460587933|FG000|Acute Double-Blind Period|Protocol Violation|2|||
127989638|NCT00424593|460587934|FG001|Acute Double-Blind Period|Protocol Violation|2|||
127989639|NCT00424593|460587933|FG000|Acute Double-Blind Period|Physician Decision|1|||
127989640|NCT00424593|460587934|FG001|Acute Double-Blind Period|Physician Decision|2|||
127989641|NCT00424593|460587933|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
127989642|NCT00424593|460587934|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
127989643|NCT00424593|460587933|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
127989644|NCT00424593|460587934|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
127989645|NCT00424593|460587933|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
127989646|NCT00424593|460587934|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
127989647|NCT00424593|460587933|FG000|Dose-Blind Extension Period|Adverse Event|18|||
127660400|NCT00284089|459380258|FG001|Multiple Dose Phase|Death|0|||
127660401|NCT00284089|459380259|FG002|Multiple Dose Phase|Death|1|||
127660402|NCT00284089|459380260|FG003|Multiple Dose Phase|Death|1|||
127660403|NCT00284089|459380257|FG000|Extension Phase|Adverse Event|0|||
127660404|NCT00284089|459380258|FG001|Extension Phase|Adverse Event|0|||
127660405|NCT00284089|459380259|FG002|Extension Phase|Adverse Event|2|||
127660406|NCT00284089|459380260|FG003|Extension Phase|Adverse Event|2|||
127660407|NCT00284089|459380257|FG000|Extension Phase|condition no longer requires study drug|2|||
127660408|NCT00284089|459380258|FG001|Extension Phase|condition no longer requires study drug|0|||
127660409|NCT00284089|459380259|FG002|Extension Phase|condition no longer requires study drug|2|||
127660410|NCT00284089|459380260|FG003|Extension Phase|condition no longer requires study drug|7|||
127660411|NCT00284089|459380257|FG000|Extension Phase|Protocol Violation|0|||
127660412|NCT00284089|459380258|FG001|Extension Phase|Protocol Violation|0|||
127660413|NCT00284089|459380259|FG002|Extension Phase|Protocol Violation|1|||
127660414|NCT00284089|459380260|FG003|Extension Phase|Protocol Violation|0|||
127660415|NCT00284089|459380257|FG000|Extension Phase|Withdrawal by Subject|0|||
127660416|NCT00284089|459380258|FG001|Extension Phase|Withdrawal by Subject|0|||
127660417|NCT00284089|459380259|FG002|Extension Phase|Withdrawal by Subject|1|||
127660418|NCT00284089|459380260|FG003|Extension Phase|Withdrawal by Subject|3|||
127660419|NCT01146574|459380263|FG000|Overall Study|Death|0|||
127660420|NCT01146574|459380264|FG001|Overall Study|Death|1|||
127660421|NCT01146574|459380265|FG002|Overall Study|Death|1|||
127660422|NCT01146574|459380266|FG003|Overall Study|Death|0|||
127660423|NCT01146574|459380267|FG004|Overall Study|Death|0|||
127660424|NCT01146574|459380268|FG005|Overall Study|Death|0|||
127660425|NCT01146574|459380269|FG006|Overall Study|Death|0|||
127660426|NCT01146574|459380263|FG000|Overall Study|Other reasons|0|||
127660427|NCT01146574|459380264|FG001|Overall Study|Other reasons|0|||
127660428|NCT01146574|459380265|FG002|Overall Study|Other reasons|3|||
127660429|NCT01146574|459380266|FG003|Overall Study|Other reasons|0|||
127660430|NCT01146574|459380267|FG004|Overall Study|Other reasons|0|||
127660431|NCT01146574|459380268|FG005|Overall Study|Other reasons|0|||
127660432|NCT01146574|459380269|FG006|Overall Study|Other reasons|0|||
127660433|NCT01146574|459380263|FG000|Overall Study|Kidney transplant|0|||
127989648|NCT00424593|460587934|FG001|Dose-Blind Extension Period|Adverse Event|0|||
127989649|NCT00424593|460587933|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
127989650|NCT00424593|460587934|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
127660434|NCT01146574|459380264|FG001|Overall Study|Kidney transplant|0|||
127660435|NCT01146574|459380265|FG002|Overall Study|Kidney transplant|1|||
127660436|NCT01146574|459380266|FG003|Overall Study|Kidney transplant|1|||
127660437|NCT01146574|459380267|FG004|Overall Study|Kidney transplant|0|||
127660438|NCT01146574|459380268|FG005|Overall Study|Kidney transplant|0|||
127660439|NCT01146574|459380269|FG006|Overall Study|Kidney transplant|0|||
127660440|NCT01146574|459380263|FG000|Overall Study|Withdrew consent|0|||
127660441|NCT01146574|459380264|FG001|Overall Study|Withdrew consent|0|||
127660442|NCT01146574|459380265|FG002|Overall Study|Withdrew consent|1|||
127660443|NCT01146574|459380266|FG003|Overall Study|Withdrew consent|1|||
127660444|NCT01146574|459380267|FG004|Overall Study|Withdrew consent|2|||
127989651|NCT00424593|460587933|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
127660445|NCT01146574|459380268|FG005|Overall Study|Withdrew consent|1|||
127660446|NCT01146574|459380269|FG006|Overall Study|Withdrew consent|1|||
127660447|NCT03051659|459380270|FG000|Treatment Period|Withdrawal by Subject|0|||
127660448|NCT03051659|459380271|FG001|Treatment Period|Withdrawal by Subject|2|||
127660449|NCT03051659|459380270|FG000|Survival Follow-up|Lost to Follow-up|23|||
127660450|NCT03051659|459380271|FG001|Survival Follow-up|Lost to Follow-up|22|||
127660451|NCT01076088|459380272|FG000|Overall Study|Adverse Event|1|||
127660452|NCT01076088|459380273|FG001|Overall Study|Adverse Event|6|||
127660453|NCT01076088|459380274|FG002|Overall Study|Adverse Event|3|||
127660454|NCT01076088|459380275|FG003|Overall Study|Adverse Event|2|||
127660455|NCT01076088|459380276|FG004|Overall Study|Adverse Event|3|||
127660456|NCT01076088|459380277|FG005|Overall Study|Adverse Event|3|||
127660457|NCT01076088|459380272|FG000|Overall Study|Lost to Follow-up|1|||
127660458|NCT01076088|459380273|FG001|Overall Study|Lost to Follow-up|1|||
127660459|NCT01076088|459380274|FG002|Overall Study|Lost to Follow-up|0|||
127660460|NCT01076088|459380275|FG003|Overall Study|Lost to Follow-up|1|||
127660461|NCT01076088|459380276|FG004|Overall Study|Lost to Follow-up|1|||
127660462|NCT01076088|459380277|FG005|Overall Study|Lost to Follow-up|2|||
127660463|NCT01076088|459380272|FG000|Overall Study|Non-compliance with study drug|0|||
127660464|NCT01076088|459380273|FG001|Overall Study|Non-compliance with study drug|0|||
127660465|NCT01076088|459380274|FG002|Overall Study|Non-compliance with study drug|0|||
127660466|NCT01076088|459380275|FG003|Overall Study|Non-compliance with study drug|1|||
127660467|NCT01076088|459380276|FG004|Overall Study|Non-compliance with study drug|0|||
127660468|NCT01076088|459380277|FG005|Overall Study|Non-compliance with study drug|0|||
127660469|NCT01076088|459380272|FG000|Overall Study|Physician Decision|1|||
127660470|NCT01076088|459380273|FG001|Overall Study|Physician Decision|3|||
127660471|NCT01076088|459380274|FG002|Overall Study|Physician Decision|0|||
127660472|NCT01076088|459380275|FG003|Overall Study|Physician Decision|1|||
127660473|NCT01076088|459380276|FG004|Overall Study|Physician Decision|1|||
127660474|NCT01076088|459380277|FG005|Overall Study|Physician Decision|0|||
127660475|NCT01076088|459380272|FG000|Overall Study|Withdrawal by Subject|8|||
127660476|NCT01076088|459380273|FG001|Overall Study|Withdrawal by Subject|8|||
127660477|NCT01076088|459380274|FG002|Overall Study|Withdrawal by Subject|14|||
127660478|NCT01076088|459380275|FG003|Overall Study|Withdrawal by Subject|10|||
127660479|NCT01076088|459380276|FG004|Overall Study|Withdrawal by Subject|11|||
127660480|NCT01076088|459380277|FG005|Overall Study|Withdrawal by Subject|17|||
127660481|NCT01076088|459380272|FG000|Overall Study|Other protocol specified criteria|0|||
127660482|NCT01076088|459380273|FG001|Overall Study|Other protocol specified criteria|0|||
127660483|NCT01076088|459380274|FG002|Overall Study|Other protocol specified criteria|0|||
127660484|NCT01076088|459380275|FG003|Overall Study|Other protocol specified criteria|0|||
127660485|NCT01076088|459380276|FG004|Overall Study|Other protocol specified criteria|0|||
127660486|NCT01076088|459380277|FG005|Overall Study|Other protocol specified criteria|1|||
127660487|NCT03053492|459380278|FG000|Overall Study|Adverse Event|1|||
127660488|NCT03053492|459380279|FG001|Overall Study|Adverse Event|1|||
127660489|NCT03053492|459380278|FG000|Overall Study|Withdrawal by Subject|7|||
127660490|NCT03053492|459380279|FG001|Overall Study|Withdrawal by Subject|5|||
127660491|NCT00786474|459380280|FG000|Overall Study|Death|5|||
127989652|NCT00424593|460587934|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
127989653|NCT00424593|460587933|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
127989654|NCT00424593|460587934|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
127989655|NCT00424593|460587933|FG000|Dose-Blind Extension Period|Physician Decision|3|||
127989656|NCT00424593|460587934|FG001|Dose-Blind Extension Period|Physician Decision|0|||
127989657|NCT01796301|460587935|FG000|Overall Study|Withdrawal by Subject|15|||
127989658|NCT01796301|460587936|FG001|Overall Study|Withdrawal by Subject|15|||
127989659|NCT01796301|460587935|FG000|Overall Study|Lost to Follow-up|3|||
127989660|NCT01796301|460587936|FG001|Overall Study|Lost to Follow-up|3|||
127989661|NCT01796301|460587935|FG000|Overall Study|Death|0|||
127989662|NCT01796301|460587936|FG001|Overall Study|Death|1|||
127989663|NCT01796301|460587935|FG000|Overall Study|Decision by Sponsor|0|||
127989664|NCT01796301|460587936|FG001|Overall Study|Decision by Sponsor|1|||
127660492|NCT00786474|459380281|FG001|Overall Study|Death|4|||
127660493|NCT00786474|459380280|FG000|Overall Study|Withdrawal by Subject|23|||
127660494|NCT00786474|459380281|FG001|Overall Study|Withdrawal by Subject|31|||
127660495|NCT00786474|459380280|FG000|Overall Study|Lost to Follow-up|3|||
127989665|NCT00667563|460587937|FG000|Overall Study|Protocol Violation|24|||
127989666|NCT02985021|460587939|FG000|Overall Study|Inability to comply with study procedures|1|||
127989667|NCT02756819|460587940|FG000|Overall Study|Lost for observation|23|||
127989668|NCT02756819|460587940|FG000|Overall Study|Patient's unwillingness|16|||
127660496|NCT00786474|459380281|FG001|Overall Study|Lost to Follow-up|3|||
127660497|NCT00786474|459380280|FG000|Overall Study|Physician Decision|2|||
127660498|NCT00786474|459380281|FG001|Overall Study|Physician Decision|1|||
127660499|NCT00786474|459380280|FG000|Overall Study|Other|4|||
127660500|NCT00786474|459380281|FG001|Overall Study|Other|4|||
127660501|NCT01868074|459380282|FG000|Overall Study|Lost to Follow-up|3|||
127660502|NCT01868074|459380283|FG001|Overall Study|Lost to Follow-up|2|||
127989669|NCT02756819|460587940|FG000|Overall Study|Insufficient efficacy|2|||
127989670|NCT02756819|460587940|FG000|Overall Study|Adverse Event|2|||
127660503|NCT01868074|459380282|FG000|Overall Study|Withdrawal by Subject|4|||
127660504|NCT01868074|459380283|FG001|Overall Study|Withdrawal by Subject|2|||
127660505|NCT01544491|459380284|FG000|Overall Study|Withdrawal by Subject|3|||
127660506|NCT01544491|459380285|FG001|Overall Study|Withdrawal by Subject|2|||
127660507|NCT01544491|459380284|FG000|Overall Study|Lost to Follow-up|0|||
127660508|NCT01544491|459380285|FG001|Overall Study|Lost to Follow-up|1|||
127660509|NCT01544491|459380284|FG000|Overall Study|administrative problems|2|||
127660510|NCT01544491|459380285|FG001|Overall Study|administrative problems|0|||
127660511|NCT00967018|459380286|FG000|Overall Study|Adverse Event|2|||
127660512|NCT00967018|459380286|FG000|Overall Study|Physician Decision|7|||
127660513|NCT00967018|459380286|FG000|Overall Study|Lost to Follow-up|2|||
127660514|NCT00967018|459380286|FG000|Overall Study|Withdrawal by Subject|1|||
127660515|NCT00967018|459380286|FG000|Overall Study|Miscellaneous Reasons|9|||
127660516|NCT04642469|459380291|FG000|Overall Study|Failure to meet inclusion/exclusion criteria|1|||
127660517|NCT04642469|459380292|FG001|Overall Study|Failure to meet inclusion/exclusion criteria|0|||
127660518|NCT04642469|459380291|FG000|Overall Study|Death|1|||
127660519|NCT04642469|459380292|FG001|Overall Study|Death|2|||
127660520|NCT04642469|459380291|FG000|Overall Study|Study/site closed following amendment 1|11|||
127660521|NCT04642469|459380292|FG001|Overall Study|Study/site closed following amendment 1|11|||
127660522|NCT04642469|459380291|FG000|Overall Study|Other|1|||
127660523|NCT04642469|459380292|FG001|Overall Study|Other|1|||
127660524|NCT04642469|459380291|FG000|Overall Study|Withdrawal by Subject|1|||
127660525|NCT04642469|459380292|FG001|Overall Study|Withdrawal by Subject|0|||
127660526|NCT00680056|459380295|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
127660527|NCT00680056|459380296|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
127660528|NCT00680056|459380295|FG000|Second Intervention|Protocol Violation|3|||
127660529|NCT00680056|459380296|FG001|Second Intervention|Protocol Violation|1|||
127660530|NCT02733042|459380297|FG000|Overall Study|Adverse Event|1|||
127660531|NCT02733042|459380298|FG001|Overall Study|Adverse Event|0|||
127660532|NCT02733042|459380299|FG002|Overall Study|Adverse Event|1|||
127660533|NCT02733042|459380300|FG003|Overall Study|Adverse Event|1|||
127660534|NCT02733042|459380301|FG004|Overall Study|Adverse Event|0|||
127660535|NCT02733042|459380302|FG005|Overall Study|Adverse Event|0|||
127660536|NCT02733042|459380303|FG006|Overall Study|Adverse Event|0|||
127660537|NCT02733042|459380304|FG007|Overall Study|Adverse Event|0|||
127989671|NCT02756819|460587940|FG000|Overall Study|Reason not Specified|9|||
127989672|NCT00264290|460587941|FG000|Intervention (8 Weeks)|Adverse Event|1|||
127660538|NCT02733042|459380305|FG008|Overall Study|Adverse Event|0|||
127660539|NCT02733042|459380306|FG009|Overall Study|Adverse Event|0|||
127660540|NCT02733042|459380307|FG010|Overall Study|Adverse Event|2|||
127989673|NCT00264290|460587942|FG001|Intervention (8 Weeks)|Adverse Event|0|||
127989674|NCT00790556|460587943|FG000|Treatment Period 1|Physician Decision|1|||
127989675|NCT00790556|460587944|FG001|Treatment Period 1|Physician Decision|0|||
127989676|NCT00790556|460587943|FG000|Treatment Period 1|Withdrawal by Subject|1|||
127989677|NCT00790556|460587944|FG001|Treatment Period 1|Withdrawal by Subject|0|||
127989678|NCT04399889|460587953|FG000|Overall Study|Death|5|||
127989679|NCT04399889|460587954|FG001|Overall Study|Death|1|||
127989680|NCT04399889|460587955|FG002|Overall Study|Death|1|||
127989681|NCT00217581|460587956|FG000|Overall Study|Withdrawal by Subject|1|||
127989682|NCT03077607|460587961|FG000|Period 1 (15 Days)|Adverse Event|1|||
127989683|NCT03077607|460587962|FG001|Period 1 (15 Days)|Adverse Event|0|||
127989684|NCT03077607|460587961|FG000|Period 1 (15 Days)|Death|1|||
127989685|NCT03077607|460587962|FG001|Period 1 (15 Days)|Death|0|||
127989686|NCT03077607|460587961|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
127989687|NCT03077607|460587962|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
127989688|NCT03077607|460587961|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
127989689|NCT03077607|460587962|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
127989690|NCT01005901|460587963|FG000|Overall Study|Withdrawal by Subject|38|||
127989691|NCT01005901|460587964|FG001|Overall Study|Withdrawal by Subject|14|||
127989692|NCT01005901|460587963|FG000|Overall Study|Adverse Event|30|||
127989693|NCT01005901|460587964|FG001|Overall Study|Adverse Event|16|||
127989694|NCT01005901|460587963|FG000|Overall Study|Administrative problems|21|||
127989695|NCT01005901|460587964|FG001|Overall Study|Administrative problems|13|||
127989696|NCT01005901|460587963|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
127989697|NCT01005901|460587964|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
127989698|NCT01005901|460587963|FG000|Overall Study|Protocol Violation|4|||
127660541|NCT02733042|459380308|FG011|Overall Study|Adverse Event|2|||
127660542|NCT02733042|459380309|FG012|Overall Study|Adverse Event|0|||
127660543|NCT02733042|459380310|FG013|Overall Study|Adverse Event|2|||
127660544|NCT02733042|459380311|FG014|Overall Study|Adverse Event|0|||
127660545|NCT02733042|459380312|FG015|Overall Study|Adverse Event|0|||
127660546|NCT02733042|459380313|FG016|Overall Study|Adverse Event|0|||
127989699|NCT01005901|460587964|FG001|Overall Study|Protocol Violation|3|||
127989700|NCT01005901|460587963|FG000|Overall Study|Death|2|||
127989701|NCT01005901|460587964|FG001|Overall Study|Death|3|||
127660547|NCT02733042|459380314|FG017|Overall Study|Adverse Event|1|||
127989702|NCT01005901|460587963|FG000|Overall Study|Lost to Follow-up|1|||
127989703|NCT01005901|460587964|FG001|Overall Study|Lost to Follow-up|2|||
127989704|NCT01005901|460587963|FG000|Overall Study|Patient's inability to use the device|1|||
127989705|NCT01005901|460587964|FG001|Overall Study|Patient's inability to use the device|1|||
127989706|NCT01005901|460587963|FG000|Overall Study|No longer requires study drug|0|||
127989707|NCT01005901|460587964|FG001|Overall Study|No longer requires study drug|1|||
127989708|NCT00760487|460587965|FG000|Overall Study|Unilateral implantation|3|||
127989709|NCT06360588|460587966|FG000|Overall Study|Adverse Event|3|||
127989710|NCT06360588|460587966|FG000|Overall Study|Death|2|||
127989711|NCT06360588|460587966|FG000|Overall Study|Disease Progression|14|||
127989712|NCT06360588|460587966|FG000|Overall Study|Withdrawal by Subject|1|||
127989713|NCT06360588|460587966|FG000|Overall Study|Lack of Efficacy|1|||
127989714|NCT06360588|460587966|FG000|Overall Study|Ineligible|1|||
127989715|NCT02087943|460587967|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
127660548|NCT02733042|459380315|FG018|Overall Study|Adverse Event|0|||
127660549|NCT02733042|459380297|FG000|Overall Study|Progressive Disease|2|||
127660550|NCT02733042|459380298|FG001|Overall Study|Progressive Disease|1|||
127989716|NCT02087943|460587968|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
127989717|NCT02087943|460587969|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
127989718|NCT02087943|460587970|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
127989719|NCT02087943|460587971|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
127989720|NCT02087943|460587967|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
127989721|NCT02087943|460587968|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
127989722|NCT02087943|460587969|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
127989723|NCT02087943|460587970|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
127989724|NCT02087943|460587971|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
127989725|NCT02087943|460587967|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
127989726|NCT02087943|460587968|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
127989727|NCT02087943|460587969|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
127989728|NCT02087943|460587970|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
127989729|NCT02087943|460587971|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
127989730|NCT02087943|460587967|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
127989731|NCT02087943|460587968|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
127989732|NCT02087943|460587969|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
127989733|NCT02087943|460587970|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
127989734|NCT02087943|460587971|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
127989735|NCT02087943|460587967|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
127989736|NCT02087943|460587968|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
127989737|NCT02087943|460587969|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
127989738|NCT02087943|460587970|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
127989739|NCT02087943|460587971|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
127989740|NCT02087943|460587967|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
127989741|NCT02087943|460587968|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
127989742|NCT02087943|460587969|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
127989743|NCT02087943|460587970|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
127989744|NCT02087943|460587971|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
127989745|NCT02087943|460587967|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
127989746|NCT02087943|460587968|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
127989747|NCT02087943|460587969|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
127989748|NCT02087943|460587970|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
127989749|NCT02087943|460587971|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
127989750|NCT02087943|460587967|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
127989751|NCT02087943|460587968|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
127989752|NCT02087943|460587969|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
127989753|NCT02087943|460587970|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
127989754|NCT02087943|460587971|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
127989755|NCT02087943|460587967|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
127989756|NCT02087943|460587968|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
127660551|NCT02733042|459380299|FG002|Overall Study|Progressive Disease|3|||
127660552|NCT02733042|459380300|FG003|Overall Study|Progressive Disease|1|||
127989757|NCT02087943|460587969|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
127989758|NCT02087943|460587970|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
127989759|NCT02087943|460587971|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
127989760|NCT02087943|460587967|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
127989761|NCT02087943|460587968|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
127660553|NCT02733042|459380301|FG004|Overall Study|Progressive Disease|2|||
127660554|NCT02733042|459380302|FG005|Overall Study|Progressive Disease|3|||
127660555|NCT02733042|459380303|FG006|Overall Study|Progressive Disease|0|||
127989762|NCT02087943|460587969|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
127660556|NCT02733042|459380304|FG007|Overall Study|Progressive Disease|3|||
127660557|NCT02733042|459380305|FG008|Overall Study|Progressive Disease|3|||
127989763|NCT02087943|460587970|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
127989764|NCT02087943|460587971|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
127989765|NCT03836209|460587973|FG000|Overall Study|Adverse Event|5|||
127989766|NCT03836209|460587974|FG001|Overall Study|Adverse Event|2|||
127989767|NCT03836209|460587973|FG000|Overall Study|Death|4|||
127989768|NCT03836209|460587974|FG001|Overall Study|Death|1|||
127989769|NCT03836209|460587973|FG000|Overall Study|Lack of Efficacy|7|||
127989770|NCT03836209|460587974|FG001|Overall Study|Lack of Efficacy|10|||
127989771|NCT03836209|460587973|FG000|Overall Study|Physician Decision|7|||
127989772|NCT03836209|460587974|FG001|Overall Study|Physician Decision|11|||
127989773|NCT03836209|460587973|FG000|Overall Study|Protocol Violation|0|||
127989774|NCT03836209|460587974|FG001|Overall Study|Protocol Violation|3|||
127989775|NCT03836209|460587973|FG000|Overall Study|Withdrawal by Subject|2|||
127989776|NCT03836209|460587974|FG001|Overall Study|Withdrawal by Subject|10|||
127989777|NCT03836209|460587973|FG000|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|55|||
127989778|NCT03836209|460587974|FG001|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|44|||
127989779|NCT03739710|460587975|FG000|Overall Study|Screen Failed|81|||
127989780|NCT01424241|460587976|FG000|Overall Study|Withdrawal by Subject|1|||
127989781|NCT01424241|460587976|FG000|Overall Study|Time constraints|2|||
127989782|NCT05259917|460587977|FG000|Overall Study|Protocol Violation|0|||
127989783|NCT05259917|460587978|FG001|Overall Study|Protocol Violation|0|||
127989784|NCT05259917|460587979|FG002|Overall Study|Protocol Violation|1|||
127989785|NCT05259917|460587980|FG003|Overall Study|Protocol Violation|0|||
127989786|NCT05259917|460587981|FG004|Overall Study|Protocol Violation|0|||
127989787|NCT05259917|460587982|FG005|Overall Study|Protocol Violation|0|||
127660558|NCT02733042|459380306|FG009|Overall Study|Progressive Disease|2|||
127660559|NCT02733042|459380307|FG010|Overall Study|Progressive Disease|2|||
127660560|NCT02733042|459380308|FG011|Overall Study|Progressive Disease|2|||
127660561|NCT02733042|459380309|FG012|Overall Study|Progressive Disease|8|||
127660562|NCT02733042|459380310|FG013|Overall Study|Progressive Disease|1|||
127660563|NCT02733042|459380311|FG014|Overall Study|Progressive Disease|4|||
127660564|NCT02733042|459380312|FG015|Overall Study|Progressive Disease|7|||
127660565|NCT02733042|459380313|FG016|Overall Study|Progressive Disease|2|||
127660566|NCT02733042|459380314|FG017|Overall Study|Progressive Disease|3|||
127660567|NCT02733042|459380315|FG018|Overall Study|Progressive Disease|4|||
127660568|NCT02733042|459380297|FG000|Overall Study|Withdrawal by Subject|0|||
127660569|NCT02733042|459380298|FG001|Overall Study|Withdrawal by Subject|1|||
127660570|NCT02733042|459380299|FG002|Overall Study|Withdrawal by Subject|2|||
127660571|NCT02733042|459380300|FG003|Overall Study|Withdrawal by Subject|1|||
127660572|NCT02733042|459380301|FG004|Overall Study|Withdrawal by Subject|1|||
127660573|NCT02733042|459380302|FG005|Overall Study|Withdrawal by Subject|0|||
127660574|NCT02733042|459380303|FG006|Overall Study|Withdrawal by Subject|0|||
127660575|NCT02733042|459380304|FG007|Overall Study|Withdrawal by Subject|0|||
127660576|NCT02733042|459380305|FG008|Overall Study|Withdrawal by Subject|1|||
127660577|NCT02733042|459380306|FG009|Overall Study|Withdrawal by Subject|1|||
127660578|NCT02733042|459380307|FG010|Overall Study|Withdrawal by Subject|0|||
127660579|NCT02733042|459380308|FG011|Overall Study|Withdrawal by Subject|2|||
127660580|NCT02733042|459380309|FG012|Overall Study|Withdrawal by Subject|1|||
127660581|NCT02733042|459380310|FG013|Overall Study|Withdrawal by Subject|1|||
127660582|NCT02733042|459380311|FG014|Overall Study|Withdrawal by Subject|0|||
127660583|NCT02733042|459380312|FG015|Overall Study|Withdrawal by Subject|0|||
127660584|NCT02733042|459380313|FG016|Overall Study|Withdrawal by Subject|0|||
127660585|NCT02733042|459380314|FG017|Overall Study|Withdrawal by Subject|0|||
127660586|NCT02733042|459380315|FG018|Overall Study|Withdrawal by Subject|0|||
127660587|NCT02733042|459380297|FG000|Overall Study|Other Reasons|0|||
127660588|NCT02733042|459380298|FG001|Overall Study|Other Reasons|0|||
127660589|NCT02733042|459380299|FG002|Overall Study|Other Reasons|1|||
127660590|NCT02733042|459380300|FG003|Overall Study|Other Reasons|0|||
127660591|NCT02733042|459380301|FG004|Overall Study|Other Reasons|0|||
127660592|NCT02733042|459380302|FG005|Overall Study|Other Reasons|0|||
127660593|NCT02733042|459380303|FG006|Overall Study|Other Reasons|0|||
127660594|NCT02733042|459380304|FG007|Overall Study|Other Reasons|0|||
127660595|NCT02733042|459380305|FG008|Overall Study|Other Reasons|0|||
127660596|NCT02733042|459380306|FG009|Overall Study|Other Reasons|1|||
127660597|NCT02733042|459380307|FG010|Overall Study|Other Reasons|1|||
127660598|NCT02733042|459380308|FG011|Overall Study|Other Reasons|0|||
127660599|NCT02733042|459380309|FG012|Overall Study|Other Reasons|0|||
127660600|NCT02733042|459380310|FG013|Overall Study|Other Reasons|0|||
127660601|NCT02733042|459380311|FG014|Overall Study|Other Reasons|0|||
127660602|NCT02733042|459380312|FG015|Overall Study|Other Reasons|1|||
127989788|NCT05259917|460587977|FG000|Overall Study|Lost to Follow-up|0|||
127989789|NCT05259917|460587978|FG001|Overall Study|Lost to Follow-up|0|||
127989790|NCT05259917|460587979|FG002|Overall Study|Lost to Follow-up|1|||
127989791|NCT05259917|460587980|FG003|Overall Study|Lost to Follow-up|0|||
127989792|NCT05259917|460587981|FG004|Overall Study|Lost to Follow-up|0|||
127660603|NCT02733042|459380313|FG016|Overall Study|Other Reasons|0|||
127660604|NCT02733042|459380314|FG017|Overall Study|Other Reasons|1|||
127660605|NCT02733042|459380315|FG018|Overall Study|Other Reasons|0|||
127660606|NCT02733042|459380297|FG000|Overall Study|Death|0|||
127660607|NCT02733042|459380298|FG001|Overall Study|Death|0|||
127660608|NCT02733042|459380299|FG002|Overall Study|Death|0|||
127660609|NCT02733042|459380300|FG003|Overall Study|Death|0|||
127660610|NCT02733042|459380301|FG004|Overall Study|Death|0|||
127660611|NCT02733042|459380302|FG005|Overall Study|Death|0|||
127660612|NCT02733042|459380303|FG006|Overall Study|Death|1|||
127660613|NCT02733042|459380304|FG007|Overall Study|Death|0|||
127660614|NCT02733042|459380305|FG008|Overall Study|Death|1|||
127660615|NCT02733042|459380306|FG009|Overall Study|Death|0|||
127660616|NCT02733042|459380307|FG010|Overall Study|Death|1|||
127660617|NCT02733042|459380308|FG011|Overall Study|Death|0|||
127660618|NCT02733042|459380309|FG012|Overall Study|Death|0|||
127660619|NCT02733042|459380310|FG013|Overall Study|Death|0|||
127660620|NCT02733042|459380311|FG014|Overall Study|Death|1|||
127660621|NCT02733042|459380312|FG015|Overall Study|Death|2|||
127660622|NCT02733042|459380313|FG016|Overall Study|Death|0|||
127660623|NCT02733042|459380314|FG017|Overall Study|Death|0|||
127660624|NCT02733042|459380315|FG018|Overall Study|Death|0|||
127660625|NCT01821898|459380316|FG000|Overall Study|Withdrawal by Subject|2|||
127660626|NCT01821898|459380317|FG001|Overall Study|Withdrawal by Subject|1|||
127660627|NCT00337662|459380320|FG000|Study Period II|Lost to Follow-up|0|||
127660628|NCT00337662|459380321|FG001|Study Period II|Lost to Follow-up|0|||
127660629|NCT00337662|459380322|FG002|Study Period II|Lost to Follow-up|0|||
127660630|NCT00337662|459380323|FG003|Study Period II|Lost to Follow-up|35|||
127660631|NCT00337662|459380320|FG000|Study Period II|Withdrawal by Subject|0|||
127660632|NCT00337662|459380321|FG001|Study Period II|Withdrawal by Subject|0|||
127660633|NCT00337662|459380322|FG002|Study Period II|Withdrawal by Subject|0|||
127660634|NCT00337662|459380323|FG003|Study Period II|Withdrawal by Subject|20|||
127660635|NCT00337662|459380320|FG000|Study Period II|Adverse Event|0|||
127660636|NCT00337662|459380321|FG001|Study Period II|Adverse Event|0|||
127660637|NCT00337662|459380322|FG002|Study Period II|Adverse Event|0|||
127660638|NCT00337662|459380323|FG003|Study Period II|Adverse Event|16|||
127660639|NCT00337662|459380320|FG000|Study Period II|Physician Decision|0|||
127660640|NCT00337662|459380321|FG001|Study Period II|Physician Decision|0|||
127660641|NCT00337662|459380322|FG002|Study Period II|Physician Decision|0|||
127660642|NCT00337662|459380323|FG003|Study Period II|Physician Decision|13|||
127660643|NCT00337662|459380320|FG000|Study Period II|Entry Criteria Not Met|0|||
127660644|NCT00337662|459380321|FG001|Study Period II|Entry Criteria Not Met|0|||
127660645|NCT00337662|459380322|FG002|Study Period II|Entry Criteria Not Met|0|||
127660646|NCT00337662|459380323|FG003|Study Period II|Entry Criteria Not Met|6|||
127660647|NCT00337662|459380320|FG000|Study Period II|Protocol Violation|0|||
127660648|NCT00337662|459380321|FG001|Study Period II|Protocol Violation|0|||
127660649|NCT00337662|459380322|FG002|Study Period II|Protocol Violation|0|||
127660650|NCT00337662|459380323|FG003|Study Period II|Protocol Violation|6|||
127660651|NCT00337662|459380320|FG000|Study Period II|Lack of Efficacy|0|||
127660652|NCT00337662|459380321|FG001|Study Period II|Lack of Efficacy|0|||
127989793|NCT05259917|460587982|FG005|Overall Study|Lost to Follow-up|1|||
127989794|NCT05259917|460587977|FG000|Overall Study|Physician Decision|0|||
127989795|NCT05259917|460587978|FG001|Overall Study|Physician Decision|1|||
127989796|NCT05259917|460587979|FG002|Overall Study|Physician Decision|0|||
127989797|NCT05259917|460587980|FG003|Overall Study|Physician Decision|0|||
127989798|NCT05259917|460587981|FG004|Overall Study|Physician Decision|0|||
127989799|NCT05259917|460587982|FG005|Overall Study|Physician Decision|0|||
127989800|NCT05259917|460587977|FG000|Overall Study|Withdrawal by Subject|0|||
127989801|NCT05259917|460587978|FG001|Overall Study|Withdrawal by Subject|1|||
127989802|NCT05259917|460587979|FG002|Overall Study|Withdrawal by Subject|0|||
127989803|NCT05259917|460587980|FG003|Overall Study|Withdrawal by Subject|0|||
127989804|NCT05259917|460587981|FG004|Overall Study|Withdrawal by Subject|1|||
127989805|NCT05259917|460587982|FG005|Overall Study|Withdrawal by Subject|1|||
127660653|NCT00337662|459380322|FG002|Study Period II|Lack of Efficacy|0|||
127660654|NCT00337662|459380323|FG003|Study Period II|Lack of Efficacy|7|||
127660655|NCT00337662|459380320|FG000|Study Period II|Sponsor Decision|0|||
127660656|NCT00337662|459380321|FG001|Study Period II|Sponsor Decision|0|||
127660657|NCT00337662|459380322|FG002|Study Period II|Sponsor Decision|0|||
127660658|NCT00337662|459380323|FG003|Study Period II|Sponsor Decision|2|||
127660659|NCT00337662|459380320|FG000|Study Period II|Parent/Caregiver Decision|0|||
127989806|NCT05259917|460587977|FG000|Overall Study|Trial Termination by Sponsor|7|||
127989807|NCT05259917|460587978|FG001|Overall Study|Trial Termination by Sponsor|2|||
127989808|NCT05259917|460587979|FG002|Overall Study|Trial Termination by Sponsor|3|||
127989809|NCT05259917|460587980|FG003|Overall Study|Trial Termination by Sponsor|5|||
127989810|NCT05259917|460587981|FG004|Overall Study|Trial Termination by Sponsor|11|||
127660660|NCT00337662|459380321|FG001|Study Period II|Parent/Caregiver Decision|0|||
127660661|NCT00337662|459380322|FG002|Study Period II|Parent/Caregiver Decision|0|||
127660662|NCT00337662|459380323|FG003|Study Period II|Parent/Caregiver Decision|1|||
127660663|NCT00337662|459380320|FG000|Study Period III|Lost to Follow-up|14|||
127660664|NCT00337662|459380321|FG001|Study Period III|Lost to Follow-up|16|||
127660665|NCT00337662|459380322|FG002|Study Period III|Lost to Follow-up|14|||
127660666|NCT00337662|459380323|FG003|Study Period III|Lost to Follow-up|0|||
127660667|NCT00337662|459380320|FG000|Study Period III|Withdrawal by Subject|18|||
127660668|NCT00337662|459380321|FG001|Study Period III|Withdrawal by Subject|14|||
127660669|NCT00337662|459380322|FG002|Study Period III|Withdrawal by Subject|12|||
127660670|NCT00337662|459380323|FG003|Study Period III|Withdrawal by Subject|0|||
127660671|NCT00337662|459380320|FG000|Study Period III|Adverse Event|9|||
127660672|NCT00337662|459380321|FG001|Study Period III|Adverse Event|10|||
127660673|NCT00337662|459380322|FG002|Study Period III|Adverse Event|8|||
127660674|NCT00337662|459380323|FG003|Study Period III|Adverse Event|0|||
127660675|NCT00337662|459380320|FG000|Study Period III|Protocol Violation|3|||
127660676|NCT00337662|459380321|FG001|Study Period III|Protocol Violation|8|||
127660677|NCT00337662|459380322|FG002|Study Period III|Protocol Violation|2|||
127660678|NCT00337662|459380323|FG003|Study Period III|Protocol Violation|0|||
127660679|NCT00337662|459380320|FG000|Study Period III|Physician Decision|6|||
127660680|NCT00337662|459380321|FG001|Study Period III|Physician Decision|5|||
127660681|NCT00337662|459380322|FG002|Study Period III|Physician Decision|0|||
127660682|NCT00337662|459380323|FG003|Study Period III|Physician Decision|0|||
127660683|NCT00337662|459380320|FG000|Study Period III|Entry Criteria Not Met|4|||
127660684|NCT00337662|459380321|FG001|Study Period III|Entry Criteria Not Met|1|||
127660685|NCT00337662|459380322|FG002|Study Period III|Entry Criteria Not Met|3|||
127660686|NCT00337662|459380323|FG003|Study Period III|Entry Criteria Not Met|0|||
127660687|NCT00337662|459380320|FG000|Study Period III|Lack of Efficacy|4|||
127660688|NCT00337662|459380321|FG001|Study Period III|Lack of Efficacy|4|||
127660689|NCT00337662|459380322|FG002|Study Period III|Lack of Efficacy|2|||
127660690|NCT00337662|459380323|FG003|Study Period III|Lack of Efficacy|0|||
127660691|NCT00337662|459380320|FG000|Study Period III|Parent/Caregiver Decision|0|||
127660692|NCT00337662|459380321|FG001|Study Period III|Parent/Caregiver Decision|0|||
127660693|NCT00337662|459380322|FG002|Study Period III|Parent/Caregiver Decision|2|||
127660694|NCT00337662|459380323|FG003|Study Period III|Parent/Caregiver Decision|0|||
127660695|NCT00337662|459380320|FG000|Study Period III|Sponsor Decision|1|||
127660696|NCT00337662|459380321|FG001|Study Period III|Sponsor Decision|0|||
127660697|NCT00337662|459380322|FG002|Study Period III|Sponsor Decision|1|||
127660698|NCT00337662|459380323|FG003|Study Period III|Sponsor Decision|0|||
127660699|NCT00337662|459380320|FG000|Study Period III|Clinical Relapse|1|||
127660700|NCT00337662|459380321|FG001|Study Period III|Clinical Relapse|0|||
127660701|NCT00337662|459380322|FG002|Study Period III|Clinical Relapse|0|||
127660702|NCT00337662|459380323|FG003|Study Period III|Clinical Relapse|0|||
127660703|NCT03691948|459380324|FG000|Overall Study|Lost to Follow-up|1|||
127660704|NCT03691948|459380325|FG001|Overall Study|Lost to Follow-up|3|||
127989811|NCT05259917|460587982|FG005|Overall Study|Trial Termination by Sponsor|4|||
127989812|NCT05259917|460587977|FG000|Overall Study|Other|1|||
127989813|NCT05259917|460587978|FG001|Overall Study|Other|0|||
127989814|NCT05259917|460587979|FG002|Overall Study|Other|2|||
127989815|NCT05259917|460587980|FG003|Overall Study|Other|0|||
127989816|NCT05259917|460587981|FG004|Overall Study|Other|0|||
127660705|NCT02344537|459380327|FG000|Overall Study|Protocol Violation|1|||
127660706|NCT02344537|459380328|FG001|Overall Study|Protocol Violation|1|||
127660707|NCT02344537|459380327|FG000|Overall Study|Subject started another treatment after wk 6|1|||
127660708|NCT02344537|459380328|FG001|Overall Study|Subject started another treatment after wk 6|0|||
127660709|NCT02344537|459380327|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
127660710|NCT02344537|459380328|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
127660711|NCT00960752|459380330|FG000|Overall Study|Adverse Event|0|||
127660712|NCT00960752|459380331|FG001|Overall Study|Adverse Event|0|||
127660713|NCT00960752|459380332|FG002|Overall Study|Adverse Event|1|||
127660714|NCT00960752|459380330|FG000|Overall Study|Progression|0|||
127660715|NCT00960752|459380331|FG001|Overall Study|Progression|0|||
127660716|NCT00960752|459380332|FG002|Overall Study|Progression|1|||
127660717|NCT02180438|459380338|FG000|Overall Study|Lost to Follow-up|1|||
127660718|NCT00180713|459380342|FG000|Overall Study|Withdrawal by Subject|2|||
127660719|NCT00180713|459380343|FG001|Overall Study|Withdrawal by Subject|0|||
127660720|NCT00180713|459380342|FG000|Overall Study|Adverse Event|3|||
127660721|NCT00180713|459380343|FG001|Overall Study|Adverse Event|3|||
127660722|NCT00655551|459380348|FG000|All Periods Combined|Adverse Event|0|||
127660723|NCT00655551|459380349|FG001|All Periods Combined|Adverse Event|3|||
127660724|NCT00655551|459380350|FG002|All Periods Combined|Adverse Event|4|||
127660725|NCT00655551|459380348|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
127660726|NCT00655551|459380349|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
127660727|NCT00655551|459380350|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
127660728|NCT00655551|459380348|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
127660729|NCT00655551|459380349|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
127989817|NCT05259917|460587982|FG005|Overall Study|Other|0|||
127989818|NCT00482170|460587983|FG000|Overall Study|Adverse Event|5|||
127660730|NCT00655551|459380350|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
127660731|NCT00655551|459380348|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
127660732|NCT00655551|459380349|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
127660733|NCT00655551|459380350|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
127989819|NCT00482170|460587984|FG001|Overall Study|Adverse Event|14|||
127660734|NCT01051063|459380351|FG000|Overall Study|Death|2|||
127660735|NCT01051063|459380352|FG001|Overall Study|Death|2|||
127660736|NCT01051063|459380351|FG000|Overall Study|Withdrawal by Subject|1|||
127989820|NCT00482170|460587983|FG000|Overall Study|Withdrawal by Subject|6|||
127989821|NCT00482170|460587984|FG001|Overall Study|Withdrawal by Subject|1|||
127989822|NCT00482170|460587983|FG000|Overall Study|Protocol Violation|2|||
127989823|NCT00482170|460587984|FG001|Overall Study|Protocol Violation|3|||
127989824|NCT00482170|460587983|FG000|Overall Study|Lost to Follow-up|2|||
127989825|NCT00482170|460587984|FG001|Overall Study|Lost to Follow-up|0|||
127989826|NCT00482170|460587983|FG000|Overall Study|Unspecified reason|0|||
127989827|NCT00482170|460587984|FG001|Overall Study|Unspecified reason|2|||
127989828|NCT00162097|460587985|FG000|Overall Study|Participant no longer met study criteria|0|||
127989829|NCT00162097|460587986|FG001|Overall Study|Participant no longer met study criteria|0|||
127989830|NCT00162097|460587987|FG002|Overall Study|Participant no longer met study criteria|0|||
127989831|NCT00162097|460587988|FG003|Overall Study|Participant no longer met study criteria|1|||
127989832|NCT01658904|460587995|FG000|Overall Study|Principal Investigator discretion|2|||
127989833|NCT01658904|460587996|FG001|Overall Study|Principal Investigator discretion|0|||
127989834|NCT01658904|460587997|FG002|Overall Study|Principal Investigator discretion|0|||
127989835|NCT00080483|460587998|FG000|Overall Study|Lost to Follow-up|1|||
127989836|NCT00080483|460587999|FG001|Overall Study|Lost to Follow-up|1|||
127989837|NCT00080483|460587998|FG000|Overall Study|Physician Decision|1|||
127989838|NCT00080483|460587999|FG001|Overall Study|Physician Decision|1|||
127989839|NCT04399538|460588006|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
127989840|NCT04399538|460588007|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
127989841|NCT04399538|460588008|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
127989842|NCT04399538|460588009|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
127989843|NCT04399538|460588010|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
127989844|NCT04399538|460588006|FG000|Double-Blind Treatment|Adverse Event|0|||
127989845|NCT04399538|460588007|FG001|Double-Blind Treatment|Adverse Event|0|||
127989846|NCT04399538|460588008|FG002|Double-Blind Treatment|Adverse Event|0|||
127989847|NCT04399538|460588009|FG003|Double-Blind Treatment|Adverse Event|0|||
127989848|NCT04399538|460588010|FG004|Double-Blind Treatment|Adverse Event|1|||
127989849|NCT04399538|460588006|FG000|Follow-Up|Adverse Event|0|||
127989850|NCT04399538|460588007|FG001|Follow-Up|Adverse Event|0|||
127989851|NCT04399538|460588008|FG002|Follow-Up|Adverse Event|0|||
127989852|NCT04399538|460588009|FG003|Follow-Up|Adverse Event|0|||
127989853|NCT04399538|460588010|FG004|Follow-Up|Adverse Event|1|||
127989854|NCT04399538|460588006|FG000|Follow-Up|Withdrawal by Subject|0|||
127989855|NCT04399538|460588007|FG001|Follow-Up|Withdrawal by Subject|0|||
127989856|NCT04399538|460588008|FG002|Follow-Up|Withdrawal by Subject|0|||
127989857|NCT04399538|460588009|FG003|Follow-Up|Withdrawal by Subject|2|||
127989858|NCT04399538|460588010|FG004|Follow-Up|Withdrawal by Subject|0|||
127989859|NCT00636961|460588015|FG000|Period 1|Administrative problems|1|||
127989860|NCT00636961|460588016|FG001|Period 1|Administrative problems|1|||
127989861|NCT00636961|460588015|FG000|Period 2|Adverse Event|1|||
127989862|NCT00636961|460588016|FG001|Period 2|Adverse Event|0|||
127989863|NCT02187029|460590070|FG000|Overall Study|Adverse Event|0|||
127989864|NCT02187029|460590071|FG001|Overall Study|Adverse Event|1|||
127989865|NCT02187029|460590072|FG002|Overall Study|Adverse Event|1|||
127989866|NCT02187029|460590073|FG003|Overall Study|Adverse Event|0|||
127989867|NCT02187029|460590070|FG000|Overall Study|Study Terminated by Sponsor|0|||
127989868|NCT02187029|460590071|FG001|Overall Study|Study Terminated by Sponsor|0|||
127989869|NCT02187029|460590072|FG002|Overall Study|Study Terminated by Sponsor|10|||
127989870|NCT02187029|460590073|FG003|Overall Study|Study Terminated by Sponsor|3|||
127989871|NCT02187029|460590070|FG000|Overall Study|Withdrawal by Subject|1|||
127989872|NCT02187029|460590071|FG001|Overall Study|Withdrawal by Subject|0|||
127660737|NCT01051063|459380352|FG001|Overall Study|Withdrawal by Subject|1|||
127660738|NCT01051063|459380351|FG000|Overall Study|Termination of the study|5|||
127660739|NCT01051063|459380352|FG001|Overall Study|Termination of the study|0|||
127660740|NCT01051063|459380351|FG000|Overall Study|Moved from the study site area|1|||
127660741|NCT01051063|459380352|FG001|Overall Study|Moved from the study site area|0|||
127660742|NCT01051063|459380351|FG000|Overall Study|Other|1|||
127660743|NCT01051063|459380352|FG001|Overall Study|Other|0|||
127660744|NCT01051063|459380351|FG000|Overall Study|Lost to Follow-up|0|||
127989873|NCT02187029|460590072|FG002|Overall Study|Withdrawal by Subject|0|||
127989874|NCT02187029|460590073|FG003|Overall Study|Withdrawal by Subject|0|||
127989875|NCT03042910|460590075|FG000|Overall Study|Adverse Event|1|||
127989876|NCT03042910|460590075|FG000|Overall Study|Disease Progression|2|||
127989877|NCT03042910|460590075|FG000|Overall Study|Withdrawal by Subject|3|||
127989878|NCT03042910|460590075|FG000|Overall Study|Enrolled but not treated|1|||
127989879|NCT01491841|460590080|FG000|Overall Study|Screen Failure|10|||
127660745|NCT01051063|459380352|FG001|Overall Study|Lost to Follow-up|1|||
127660746|NCT03857841|459380356|FG000|Overall Study|Death|1|||
127989880|NCT01491841|460590080|FG000|Overall Study|Withdrawal by Subject|1|||
127989881|NCT02933528|460590081|FG000|Overall Study|Lost to Follow-up|2|||
127989882|NCT01301079|460590082|FG000|Overall Study|Lost to Follow-up|2|||
127989883|NCT01301079|460590083|FG001|Overall Study|Lost to Follow-up|2|||
127989884|NCT02496039|460590085|FG000|Overall Study|Adverse Event|3|||
127660747|NCT03857841|459380357|FG001|Overall Study|Death|0|||
127660748|NCT03857841|459380358|FG002|Overall Study|Death|0|||
127660749|NCT03857841|459380359|FG003|Overall Study|Death|0|||
127660750|NCT03857841|459380356|FG000|Overall Study|Study Terminated by Sponsor|1|||
127660751|NCT03857841|459380357|FG001|Overall Study|Study Terminated by Sponsor|0|||
127660752|NCT03857841|459380358|FG002|Overall Study|Study Terminated by Sponsor|0|||
127660753|NCT03857841|459380359|FG003|Overall Study|Study Terminated by Sponsor|0|||
127660754|NCT04921969|459380360|FG000|VC Period (Day 1 to Week 8)|Adverse Event|0|||
127660755|NCT04921969|459380361|FG001|VC Period (Day 1 to Week 8)|Adverse Event|1|||
127660756|NCT04921969|459380362|FG002|VC Period (Day 1 to Week 8)|Adverse Event|1|||
127660757|NCT04921969|459380363|FG003|VC Period (Day 1 to Week 8)|Adverse Event|0|||
127660758|NCT04921969|459380364|FG004|VC Period (Day 1 to Week 8)|Adverse Event|0|||
127660759|NCT04921969|459380365|FG005|VC Period (Day 1 to Week 8)|Adverse Event|0|||
127660760|NCT04921969|459380366|FG006|VC Period (Day 1 to Week 8)|Adverse Event|0|||
127660761|NCT04921969|459380360|FG000|VC Period (Day 1 to Week 8)|Lack of Efficacy|2|||
127660762|NCT04921969|459380361|FG001|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
127660763|NCT04921969|459380362|FG002|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
127660764|NCT04921969|459380363|FG003|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
127660765|NCT04921969|459380364|FG004|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
127660766|NCT04921969|459380365|FG005|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
127660767|NCT04921969|459380366|FG006|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
127660768|NCT04921969|459380360|FG000|VC Period (Day 1 to Week 8)|Lost to Follow-up|2|||
127660769|NCT04921969|459380361|FG001|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
127660770|NCT04921969|459380362|FG002|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
127660771|NCT04921969|459380363|FG003|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
127660772|NCT04921969|459380364|FG004|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
127660773|NCT04921969|459380365|FG005|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
127660774|NCT04921969|459380366|FG006|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
127660775|NCT04921969|459380360|FG000|VC Period (Day 1 to Week 8)|Physician Decision|0|||
127660776|NCT04921969|459380361|FG001|VC Period (Day 1 to Week 8)|Physician Decision|1|||
127660777|NCT04921969|459380362|FG002|VC Period (Day 1 to Week 8)|Physician Decision|1|||
127660778|NCT04921969|459380363|FG003|VC Period (Day 1 to Week 8)|Physician Decision|0|||
127660779|NCT04921969|459380364|FG004|VC Period (Day 1 to Week 8)|Physician Decision|0|||
127660780|NCT04921969|459380365|FG005|VC Period (Day 1 to Week 8)|Physician Decision|0|||
127989885|NCT02496039|460590085|FG000|Overall Study|Protocol Violation|1|||
127989886|NCT04472494|460590086|FG000|Pre-treatment|Other reasons|2|||
127660781|NCT04921969|459380366|FG006|VC Period (Day 1 to Week 8)|Physician Decision|0|||
127660782|NCT04921969|459380360|FG000|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
127660783|NCT04921969|459380361|FG001|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
127660784|NCT04921969|459380362|FG002|VC Period (Day 1 to Week 8)|Protocol Violation|1|||
127660785|NCT04921969|459380363|FG003|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
127660786|NCT04921969|459380364|FG004|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
127660787|NCT04921969|459380365|FG005|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
127660788|NCT04921969|459380366|FG006|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
127660789|NCT04921969|459380360|FG000|VC Period (Day 1 to Week 8)|Withdrawal by Subject|9|||
127660790|NCT04921969|459380361|FG001|VC Period (Day 1 to Week 8)|Withdrawal by Subject|5|||
127660791|NCT04921969|459380362|FG002|VC Period (Day 1 to Week 8)|Withdrawal by Subject|8|||
127660792|NCT04921969|459380363|FG003|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
127660793|NCT04921969|459380364|FG004|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
127660794|NCT04921969|459380365|FG005|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
127660795|NCT04921969|459380366|FG006|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
127660796|NCT04921969|459380360|FG000|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|3|||
127660797|NCT04921969|459380361|FG001|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|2|||
127660798|NCT04921969|459380362|FG002|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
127660799|NCT04921969|459380363|FG003|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
127660800|NCT04921969|459380364|FG004|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
127660801|NCT04921969|459380365|FG005|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
127660802|NCT04921969|459380366|FG006|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
127660803|NCT04921969|459380360|FG000|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
127660804|NCT04921969|459380361|FG001|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
127660805|NCT04921969|459380362|FG002|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
127660806|NCT04921969|459380363|FG003|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
127660807|NCT04921969|459380364|FG004|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
127660808|NCT04921969|459380365|FG005|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
127660809|NCT04921969|459380366|FG006|LTS Period (Weeks 8 to 52)|Adverse Event|1|||
127660810|NCT04921969|459380360|FG000|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
127660811|NCT04921969|459380361|FG001|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
127660812|NCT04921969|459380362|FG002|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
127989887|NCT04472494|460590087|FG001|Pre-treatment|Other reasons|0|||
127989888|NCT04472494|460590086|FG000|Treatment|Death|5|||
127989889|NCT04472494|460590087|FG001|Treatment|Death|2|||
127660813|NCT04921969|459380363|FG003|LTS Period (Weeks 8 to 52)|Lack of Efficacy|1|||
127660814|NCT04921969|459380364|FG004|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
127660815|NCT04921969|459380365|FG005|LTS Period (Weeks 8 to 52)|Lack of Efficacy|3|||
127660816|NCT04921969|459380366|FG006|LTS Period (Weeks 8 to 52)|Lack of Efficacy|2|||
127660817|NCT04921969|459380360|FG000|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
127660818|NCT04921969|459380361|FG001|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
127660819|NCT04921969|459380362|FG002|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
127660820|NCT04921969|459380363|FG003|LTS Period (Weeks 8 to 52)|Lost to Follow-up|1|||
127660821|NCT04921969|459380364|FG004|LTS Period (Weeks 8 to 52)|Lost to Follow-up|6|||
127660822|NCT04921969|459380365|FG005|LTS Period (Weeks 8 to 52)|Lost to Follow-up|18|||
127660823|NCT04921969|459380366|FG006|LTS Period (Weeks 8 to 52)|Lost to Follow-up|9|||
127660824|NCT04921969|459380360|FG000|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
127660825|NCT04921969|459380361|FG001|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
127660826|NCT04921969|459380362|FG002|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
127660827|NCT04921969|459380363|FG003|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
127660828|NCT04921969|459380364|FG004|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
127660829|NCT04921969|459380365|FG005|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
127660830|NCT04921969|459380366|FG006|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
127660831|NCT04921969|459380360|FG000|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
127660832|NCT04921969|459380361|FG001|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
127660833|NCT04921969|459380362|FG002|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
127660834|NCT04921969|459380363|FG003|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|2|||
127660835|NCT04921969|459380364|FG004|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
127660836|NCT04921969|459380365|FG005|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|22|||
127660837|NCT04921969|459380366|FG006|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|18|||
127660838|NCT04921969|459380360|FG000|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
127660839|NCT04921969|459380361|FG001|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
127660840|NCT04921969|459380362|FG002|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
127660841|NCT04921969|459380363|FG003|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
127660842|NCT04921969|459380364|FG004|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
127660843|NCT04921969|459380365|FG005|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
127660844|NCT04921969|459380366|FG006|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|2|||
127660845|NCT04921969|459380360|FG000|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
127660846|NCT04921969|459380361|FG001|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
127660847|NCT04921969|459380362|FG002|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
127660848|NCT04921969|459380363|FG003|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
127660849|NCT04921969|459380364|FG004|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
127660850|NCT04921969|459380365|FG005|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
127660851|NCT04921969|459380366|FG006|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
127989890|NCT04472494|460590086|FG000|Treatment|Hospital discharge|1|||
127989891|NCT04472494|460590087|FG001|Treatment|Hospital discharge|1|||
127989892|NCT00571103|460590088|FG000|Overall Study|Withdrawal by Subject|1|||
127989893|NCT00571103|460590088|FG000|Overall Study|Lost to Follow-up|1|||
127989894|NCT01308463|460590089|FG000|Overall Study|Study Discontinued|23|||
127989895|NCT01308463|460590089|FG000|Overall Study|Death|4|||
127989896|NCT01308463|460590089|FG000|Overall Study|Revision|2|||
127989897|NCT03297021|460590090|FG000|Overall Study|Incomplete/illegible data sheet|4|||
127989898|NCT03297021|460590091|FG001|Overall Study|Incomplete/illegible data sheet|2|||
127989899|NCT03297021|460590092|FG002|Overall Study|Incomplete/illegible data sheet|3|||
127989900|NCT03297021|460590090|FG000|Overall Study|Missing Post-Op Data|1|||
127660852|NCT04921969|459380360|FG000|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
127660853|NCT04921969|459380361|FG001|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
127660854|NCT04921969|459380362|FG002|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
127660855|NCT04921969|459380363|FG003|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
127660856|NCT04921969|459380364|FG004|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
127660857|NCT04921969|459380365|FG005|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
127660858|NCT04921969|459380366|FG006|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
127660859|NCT01091428|459382083|FG000|Phase 1|Progressive Disease|24|||
127660860|NCT01091428|459382084|FG001|Phase 1|Progressive Disease|8|||
127660861|NCT01091428|459382085|FG002|Phase 1|Progressive Disease|0|||
127660862|NCT01091428|459382086|FG003|Phase 1|Progressive Disease|0|||
127660863|NCT01091428|459382083|FG000|Phase 1|Symptomatic Deterioration|3|||
127660864|NCT01091428|459382084|FG001|Phase 1|Symptomatic Deterioration|2|||
127989901|NCT03297021|460590091|FG001|Overall Study|Missing Post-Op Data|2|||
127989902|NCT03297021|460590092|FG002|Overall Study|Missing Post-Op Data|1|||
127989903|NCT00948922|460590094|FG000|Overall Study|Did not start study treatment|2|||
127989904|NCT00948922|460590095|FG001|Overall Study|Did not start study treatment|5|||
127989905|NCT00948922|460590096|FG002|Overall Study|Did not start study treatment|0|||
127989906|NCT00948922|460590094|FG000|Overall Study|Withdrawal by Subject|0|||
127660865|NCT01091428|459382085|FG002|Phase 1|Symptomatic Deterioration|0|||
127660866|NCT01091428|459382086|FG003|Phase 1|Symptomatic Deterioration|0|||
127660867|NCT01091428|459382083|FG000|Phase 1|Adverse Event|2|||
127660868|NCT01091428|459382084|FG001|Phase 1|Adverse Event|0|||
127660869|NCT01091428|459382085|FG002|Phase 1|Adverse Event|0|||
127660870|NCT01091428|459382086|FG003|Phase 1|Adverse Event|0|||
127660871|NCT01091428|459382083|FG000|Phase 1|Withdrawal by Subject|7|||
127660872|NCT01091428|459382084|FG001|Phase 1|Withdrawal by Subject|0|||
127660873|NCT01091428|459382085|FG002|Phase 1|Withdrawal by Subject|0|||
127660874|NCT01091428|459382086|FG003|Phase 1|Withdrawal by Subject|0|||
127660875|NCT01091428|459382083|FG000|Phase 1|Reason not specified|0|||
127660876|NCT01091428|459382084|FG001|Phase 1|Reason not specified|1|||
127660877|NCT01091428|459382085|FG002|Phase 1|Reason not specified|0|||
127660878|NCT01091428|459382086|FG003|Phase 1|Reason not specified|0|||
127660879|NCT01091428|459382083|FG000|Phase 1|Single-Patient IND|2|||
127660880|NCT01091428|459382084|FG001|Phase 1|Single-Patient IND|0|||
127660881|NCT01091428|459382085|FG002|Phase 1|Single-Patient IND|0|||
127660882|NCT01091428|459382086|FG003|Phase 1|Single-Patient IND|0|||
127660883|NCT01091428|459382083|FG000|Phase 2|Progressive Disease|0|||
127660884|NCT01091428|459382084|FG001|Phase 2|Progressive Disease|0|||
127660885|NCT01091428|459382085|FG002|Phase 2|Progressive Disease|44|||
127660886|NCT01091428|459382086|FG003|Phase 2|Progressive Disease|46|||
127660887|NCT01091428|459382083|FG000|Phase 2|Symptomatic Deterioration|0|||
127660888|NCT01091428|459382084|FG001|Phase 2|Symptomatic Deterioration|0|||
127660889|NCT01091428|459382085|FG002|Phase 2|Symptomatic Deterioration|1|||
127660890|NCT01091428|459382086|FG003|Phase 2|Symptomatic Deterioration|6|||
127660891|NCT01091428|459382083|FG000|Phase 2|Adverse Event|0|||
127660892|NCT01091428|459382084|FG001|Phase 2|Adverse Event|0|||
127660893|NCT01091428|459382085|FG002|Phase 2|Adverse Event|12|||
127660894|NCT01091428|459382086|FG003|Phase 2|Adverse Event|5|||
127660895|NCT01091428|459382083|FG000|Phase 2|Withdrawal by Subject|0|||
127660896|NCT01091428|459382084|FG001|Phase 2|Withdrawal by Subject|0|||
127660897|NCT01091428|459382085|FG002|Phase 2|Withdrawal by Subject|9|||
127660898|NCT01091428|459382086|FG003|Phase 2|Withdrawal by Subject|8|||
127660899|NCT01091428|459382083|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
127660900|NCT01091428|459382084|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
127660901|NCT01091428|459382085|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
127660902|NCT01091428|459382086|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
127660903|NCT01091428|459382083|FG000|Phase 2|Reason not specified|0|||
127660904|NCT01091428|459382084|FG001|Phase 2|Reason not specified|0|||
127660905|NCT01091428|459382085|FG002|Phase 2|Reason not specified|4|||
127660906|NCT01091428|459382086|FG003|Phase 2|Reason not specified|3|||
127660907|NCT01091428|459382083|FG000|Phase 2|Physician Decision|0|||
127660908|NCT01091428|459382084|FG001|Phase 2|Physician Decision|0|||
127660909|NCT01091428|459382085|FG002|Phase 2|Physician Decision|2|||
127660910|NCT01091428|459382086|FG003|Phase 2|Physician Decision|0|||
127660911|NCT02531295|459382087|FG000|Overall Study|The study was terminated (Halted Prematurely).|0|||
127660912|NCT02531295|459382088|FG001|Overall Study|The study was terminated (Halted Prematurely).|0|||
127660913|NCT02531295|459382089|FG002|Overall Study|The study was terminated (Halted Prematurely).|0|||
127660914|NCT02531295|459382090|FG003|Overall Study|The study was terminated (Halted Prematurely).|0|||
127660915|NCT02531295|459382091|FG004|Overall Study|The study was terminated (Halted Prematurely).|0|||
127660916|NCT02531295|459382092|FG005|Overall Study|The study was terminated (Halted Prematurely).|1|||
127660917|NCT04424290|459382094|FG000|Overall Study|Not treated|0|||
127660918|NCT04424290|459382095|FG001|Overall Study|Not treated|0|||
127660919|NCT04424290|459382096|FG002|Overall Study|Not treated|1|||
127660920|NCT04424290|459382097|FG003|Overall Study|Not treated|0|||
127660921|NCT04424290|459382098|FG004|Overall Study|Not treated|1|||
127660922|NCT04424290|459382094|FG000|Overall Study|Adverse Event|0|||
127660923|NCT04424290|459382095|FG001|Overall Study|Adverse Event|0|||
127660924|NCT04424290|459382096|FG002|Overall Study|Adverse Event|0|||
127660925|NCT04424290|459382097|FG003|Overall Study|Adverse Event|2|||
127660926|NCT04424290|459382098|FG004|Overall Study|Adverse Event|0|||
127660927|NCT04424290|459382094|FG000|Overall Study|Withdrawal by Subject|0|||
127660928|NCT04424290|459382095|FG001|Overall Study|Withdrawal by Subject|0|||
127660929|NCT04424290|459382096|FG002|Overall Study|Withdrawal by Subject|0|||
127660930|NCT04424290|459382097|FG003|Overall Study|Withdrawal by Subject|0|||
127660931|NCT04424290|459382098|FG004|Overall Study|Withdrawal by Subject|1|||
127660932|NCT04424290|459382094|FG000|Overall Study|Other than listed|0|||
127660933|NCT04424290|459382095|FG001|Overall Study|Other than listed|0|||
127660934|NCT04424290|459382096|FG002|Overall Study|Other than listed|0|||
127660935|NCT04424290|459382097|FG003|Overall Study|Other than listed|1|||
127660936|NCT04424290|459382098|FG004|Overall Study|Other than listed|0|||
127660937|NCT04249336|459382101|FG000|Overall Study|Lost to Follow-up|3|||
127660938|NCT04249336|459382102|FG001|Overall Study|Lost to Follow-up|3|||
127660939|NCT04249336|459382103|FG002|Overall Study|Lost to Follow-up|3|||
127660940|NCT04249336|459382104|FG003|Overall Study|Lost to Follow-up|3|||
127660941|NCT01242176|459382105|FG000|Washout Period of 7 Days|Adverse Event|0|||
127660942|NCT01242176|459382106|FG001|Washout Period of 7 Days|Adverse Event|2|||
127660943|NCT01242176|459382105|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
127989907|NCT00948922|460590095|FG001|Overall Study|Withdrawal by Subject|2|||
127989908|NCT00948922|460590096|FG002|Overall Study|Withdrawal by Subject|1|||
127989909|NCT00948922|460590094|FG000|Overall Study|Death|3|||
127989910|NCT00948922|460590095|FG001|Overall Study|Death|0|||
127989911|NCT00948922|460590096|FG002|Overall Study|Death|0|||
127989912|NCT00948922|460590094|FG000|Overall Study|Disease progression|0|||
127989913|NCT00948922|460590095|FG001|Overall Study|Disease progression|1|||
127989914|NCT00948922|460590096|FG002|Overall Study|Disease progression|0|||
127989915|NCT00948922|460590094|FG000|Overall Study|Insurance issues|1|||
127989916|NCT00948922|460590095|FG001|Overall Study|Insurance issues|0|||
127989917|NCT00948922|460590096|FG002|Overall Study|Insurance issues|0|||
127989918|NCT00948922|460590094|FG000|Overall Study|Transplant eligibility issues|2|||
127989919|NCT00948922|460590095|FG001|Overall Study|Transplant eligibility issues|3|||
127989920|NCT00948922|460590096|FG002|Overall Study|Transplant eligibility issues|0|||
127989921|NCT00948922|460590094|FG000|Overall Study|Not evaluable at time of analysis|0|||
127989922|NCT00948922|460590095|FG001|Overall Study|Not evaluable at time of analysis|3|||
127989923|NCT00948922|460590096|FG002|Overall Study|Not evaluable at time of analysis|0|||
127989924|NCT02784288|460590097|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
127989925|NCT02734862|460590098|FG000|Part A|Death|3|||
127989926|NCT02734862|460590099|FG001|Part A|Death|4|||
127989927|NCT02734862|460590100|FG002|Part A|Death|6|||
127989928|NCT02734862|460590098|FG000|Part A|Lost to Follow-up|2|||
127660944|NCT01242176|459382106|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
127660945|NCT03390036|459382107|FG000|Overall Study|Lost to Follow-up|1|||
127660946|NCT03390036|459382108|FG001|Overall Study|Lost to Follow-up|0|||
127660947|NCT03390036|459382109|FG002|Overall Study|Lost to Follow-up|0|||
127660948|NCT03390036|459382107|FG000|Overall Study|Lack of Efficacy|1|||
127660949|NCT03390036|459382108|FG001|Overall Study|Lack of Efficacy|0|||
127660950|NCT03390036|459382109|FG002|Overall Study|Lack of Efficacy|0|||
127660951|NCT00358215|459382110|FG000|Overall Study|Ineligibility determined|4|||
127660952|NCT00358215|459382111|FG001|Overall Study|Ineligibility determined|3|||
127660953|NCT00358215|459382110|FG000|Overall Study|Adverse Event|83|||
127660954|NCT00358215|459382111|FG001|Overall Study|Adverse Event|65|||
127660955|NCT00358215|459382110|FG000|Overall Study|Withdrawal by Subject|111|||
127660956|NCT00358215|459382111|FG001|Overall Study|Withdrawal by Subject|102|||
127660957|NCT00358215|459382110|FG000|Overall Study|Participant request|65|||
127660958|NCT00358215|459382111|FG001|Overall Study|Participant request|64|||
127660959|NCT00358215|459382110|FG000|Overall Study|Physician Decision|47|||
127660960|NCT00358215|459382111|FG001|Overall Study|Physician Decision|39|||
127660961|NCT00358215|459382110|FG000|Overall Study|Lost to Follow-up|16|||
127660962|NCT00358215|459382111|FG001|Overall Study|Lost to Follow-up|22|||
127660963|NCT00358215|459382110|FG000|Overall Study|Death|265|||
127660964|NCT00358215|459382111|FG001|Overall Study|Death|281|||
127660965|NCT00358215|459382110|FG000|Overall Study|Protocol Violation|64|||
127660966|NCT00358215|459382111|FG001|Overall Study|Protocol Violation|59|||
127660967|NCT00358215|459382110|FG000|Overall Study|Pregnancy|1|||
127660968|NCT00358215|459382111|FG001|Overall Study|Pregnancy|0|||
127660969|NCT00358215|459382110|FG000|Overall Study|Other|21|||
127660970|NCT00358215|459382111|FG001|Overall Study|Other|14|||
127660971|NCT00358215|459382110|FG000|Overall Study|Did not receive investigational product|2|||
127543139|NCT03253393|458954761|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
127543140|NCT03253393|458954762|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
127543141|NCT00385671|458956475|FG000|Overall Study|Adverse Event|14|||
127543142|NCT00385671|458956476|FG001|Overall Study|Adverse Event|27|||
127543143|NCT00385671|458956477|FG002|Overall Study|Adverse Event|18|||
127543144|NCT00385671|458956475|FG000|Overall Study|Lack of Efficacy|5|||
127543145|NCT00385671|458956476|FG001|Overall Study|Lack of Efficacy|9|||
127660972|NCT00358215|459382111|FG001|Overall Study|Did not receive investigational product|3|||
127660973|NCT04329104|459382118|FG000|Efficacy Study|Withdrawal by Subject|0|||
127660974|NCT04329104|459382119|FG001|Efficacy Study|Withdrawal by Subject|0|||
127660975|NCT04329104|459382120|FG002|Efficacy Study|Withdrawal by Subject|0|||
127660976|NCT04329104|459382121|FG003|Efficacy Study|Withdrawal by Subject|5|||
127660977|NCT04329104|459382122|FG004|Efficacy Study|Withdrawal by Subject|6|||
127660978|NCT04329104|459382123|FG005|Efficacy Study|Withdrawal by Subject|8|||
127660979|NCT03884231|459382124|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
127989929|NCT02734862|460590099|FG001|Part A|Lost to Follow-up|1|||
127543146|NCT00385671|458956477|FG002|Overall Study|Lack of Efficacy|5|||
127660980|NCT03884231|459382124|FG000|Overall Study|Subject Withdrew Consent|1|||
127660981|NCT03884231|459382124|FG000|Overall Study|MRI Scan Not Performed|1|||
127989930|NCT02734862|460590100|FG002|Part A|Lost to Follow-up|1|||
127989931|NCT02734862|460590098|FG000|Part A|Withdrawal by Subject|1|||
127989932|NCT02734862|460590099|FG001|Part A|Withdrawal by Subject|1|||
127989933|NCT02734862|460590100|FG002|Part A|Withdrawal by Subject|2|||
127660982|NCT01853254|459382125|FG000|Overall Study|Abnormal Laboratory Test|1|||
127660983|NCT01853254|459382125|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
127989934|NCT02734862|460590098|FG000|Part A|Physician Decision|2|||
127989935|NCT02734862|460590099|FG001|Part A|Physician Decision|0|||
127989936|NCT02734862|460590100|FG002|Part A|Physician Decision|1|||
127989937|NCT02734862|460590098|FG000|Part A|Adverse Event|2|||
127989938|NCT02734862|460590099|FG001|Part A|Adverse Event|0|||
127660984|NCT01853254|459382125|FG000|Overall Study|Death|1|||
127660985|NCT01853254|459382125|FG000|Overall Study|Failure to Return|43|||
127989939|NCT02734862|460590100|FG002|Part A|Adverse Event|1|||
127989940|NCT02734862|460590098|FG000|Part A|Noncompliance|1|||
127989941|NCT02734862|460590099|FG001|Part A|Noncompliance|1|||
127660986|NCT01853254|459382125|FG000|Overall Study|Insufficient Therapeutic Response|22|||
127660987|NCT01853254|459382125|FG000|Overall Study|Refusal of Treatment|1|||
127660988|NCT01853254|459382125|FG000|Overall Study|Other Protocol Violation|1|||
127660989|NCT01853254|459382125|FG000|Overall Study|Withdrawal of Consent|16|||
127989942|NCT02734862|460590100|FG002|Part A|Noncompliance|0|||
127989943|NCT02734862|460590098|FG000|Part A|Other|1|||
127989944|NCT02734862|460590099|FG001|Part A|Other|1|||
127989945|NCT02734862|460590100|FG002|Part A|Other|3|||
127989946|NCT02734862|460590098|FG000|Part B|Death|8|||
127989947|NCT02734862|460590099|FG001|Part B|Death|3|||
127989948|NCT02734862|460590100|FG002|Part B|Death|5|||
127660990|NCT01853254|459382125|FG000|Overall Study|Administrative/Other|16|||
127660991|NCT01087723|459382131|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
127660992|NCT01087723|459382132|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
127660993|NCT01087723|459382131|FG000|Overall Study|Withdrawal by Subject|10|||
127660994|NCT01087723|459382132|FG001|Overall Study|Withdrawal by Subject|13|||
127660995|NCT01087723|459382131|FG000|Overall Study|Physician Decision|2|||
127660996|NCT01087723|459382132|FG001|Overall Study|Physician Decision|0|||
127660997|NCT01087723|459382131|FG000|Overall Study|Lost to Follow-up|1|||
127989949|NCT02734862|460590098|FG000|Part B|Lost to Follow-up|2|||
127989950|NCT02734862|460590099|FG001|Part B|Lost to Follow-up|2|||
127989951|NCT02734862|460590100|FG002|Part B|Lost to Follow-up|0|||
127989952|NCT02734862|460590098|FG000|Part B|Withdrawal by Subject|3|||
127989953|NCT02734862|460590099|FG001|Part B|Withdrawal by Subject|1|||
127989954|NCT02734862|460590100|FG002|Part B|Withdrawal by Subject|0|||
127660998|NCT01087723|459382132|FG001|Overall Study|Lost to Follow-up|4|||
127660999|NCT01087723|459382131|FG000|Overall Study|Reason Not Specified|1|||
127661000|NCT01087723|459382132|FG001|Overall Study|Reason Not Specified|2|||
127661001|NCT00806624|459382134|FG000|Overall Study|Adverse Event|2|||
127661002|NCT00806624|459382135|FG001|Overall Study|Adverse Event|8|||
127661003|NCT00806624|459382136|FG002|Overall Study|Adverse Event|0|||
127661004|NCT00806624|459382134|FG000|Overall Study|Death|0|||
127661005|NCT00806624|459382135|FG001|Overall Study|Death|1|||
127661006|NCT00806624|459382136|FG002|Overall Study|Death|1|||
127661007|NCT00806624|459382134|FG000|Overall Study|Lost to Follow-up|1|||
127661008|NCT00806624|459382135|FG001|Overall Study|Lost to Follow-up|0|||
127661009|NCT00806624|459382136|FG002|Overall Study|Lost to Follow-up|1|||
127661010|NCT00806624|459382134|FG000|Overall Study|Withdrawal by Subject|6|||
127661011|NCT00806624|459382135|FG001|Overall Study|Withdrawal by Subject|3|||
127661012|NCT00806624|459382136|FG002|Overall Study|Withdrawal by Subject|3|||
127661013|NCT00806624|459382134|FG000|Overall Study|discontinued before start of treatment|0|||
127661014|NCT00806624|459382135|FG001|Overall Study|discontinued before start of treatment|0|||
127661015|NCT00806624|459382136|FG002|Overall Study|discontinued before start of treatment|1|||
127661016|NCT00467142|459382161|FG000|Overall Study|Withdrawal by Subject|1|||
127661017|NCT00467142|459382161|FG000|Overall Study|Adverse Event|1|||
127661018|NCT00467142|459382161|FG000|Overall Study|Protocol Violation|1|||
127661019|NCT03893825|459382164|FG000|Overall Study|Death|2|||
127661020|NCT03893825|459382165|FG001|Overall Study|Death|1|||
127661021|NCT03893825|459382164|FG000|Overall Study|Adverse Event|0|||
127661022|NCT03893825|459382165|FG001|Overall Study|Adverse Event|2|||
127661023|NCT03893825|459382164|FG000|Overall Study|Withdrawal by Subject|19|||
127661024|NCT03893825|459382165|FG001|Overall Study|Withdrawal by Subject|21|||
127661025|NCT03893825|459382164|FG000|Overall Study|Protocol deviation|1|||
127661026|NCT03893825|459382165|FG001|Overall Study|Protocol deviation|0|||
127661027|NCT03893825|459382164|FG000|Overall Study|Lost to Follow-up|10|||
127989955|NCT02734862|460590098|FG000|Part B|Other|0|||
127989956|NCT02734862|460590099|FG001|Part B|Other|1|||
127661028|NCT03893825|459382165|FG001|Overall Study|Lost to Follow-up|10|||
127989957|NCT02734862|460590100|FG002|Part B|Other|0|||
127989958|NCT02757625|460590101|FG000|Overall Study|Investigator's discretion|0|||
127989959|NCT02757625|460590102|FG001|Overall Study|Investigator's discretion|0|||
127989960|NCT02757625|460590103|FG002|Overall Study|Investigator's discretion|1|||
127661029|NCT03893825|459382164|FG000|Overall Study|Other than specified|7|||
127661030|NCT03893825|459382165|FG001|Overall Study|Other than specified|6|||
127661031|NCT00734214|459382190|FG000|Overall Study|Withdrawal by Subject|3|||
127661032|NCT00734214|459382191|FG001|Overall Study|Withdrawal by Subject|4|||
127661033|NCT00734214|459382190|FG000|Overall Study|MD withdrawal|1|||
127989961|NCT02757625|460590104|FG003|Overall Study|Investigator's discretion|0|||
127989962|NCT02757625|460590101|FG000|Overall Study|Adverse Event|0|||
127989963|NCT02757625|460590102|FG001|Overall Study|Adverse Event|0|||
127989964|NCT02757625|460590103|FG002|Overall Study|Adverse Event|1|||
127989965|NCT02757625|460590104|FG003|Overall Study|Adverse Event|0|||
127989966|NCT04854057|460590105|FG000|Overall Study|Adverse Event|0|||
127989967|NCT04854057|460590106|FG001|Overall Study|Adverse Event|1|||
127661034|NCT00734214|459382191|FG001|Overall Study|MD withdrawal|0|||
127661035|NCT03632434|459382203|FG000|Overall Study|Withdrawal by Subject|2|||
127661036|NCT01751113|459382204|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
127661037|NCT01751113|459382205|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
127661038|NCT01751113|459382206|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
127661039|NCT01751113|459382207|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
127661040|NCT01751113|459382208|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
127661041|NCT01751113|459382209|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
127661042|NCT01751113|459382204|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
127661043|NCT01751113|459382205|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
127661044|NCT01751113|459382206|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
127661045|NCT01751113|459382207|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
127661046|NCT01751113|459382208|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
127661047|NCT01751113|459382209|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
127661048|NCT01775930|459382210|FG000|Overall Study|Futility stopping boundary met|1|||
127661049|NCT01551303|459382212|FG000|Overall Study|failed awareness check on vision test|4|||
127661050|NCT01551303|459382213|FG001|Overall Study|failed awareness check on vision test|7|||
127661051|NCT00363896|459382214|FG000|Overall Study|Withdrawal by Subject|29|||
127661052|NCT00363896|459382215|FG001|Overall Study|Withdrawal by Subject|16|||
127661053|NCT00363896|459382214|FG000|Overall Study|Adverse Event|24|||
127661054|NCT00363896|459382215|FG001|Overall Study|Adverse Event|13|||
127661055|NCT00363896|459382214|FG000|Overall Study|COPD exacerbation|13|||
127661056|NCT00363896|459382215|FG001|Overall Study|COPD exacerbation|7|||
127661057|NCT00363896|459382214|FG000|Overall Study|Lack of Efficacy|12|||
127661058|NCT00363896|459382215|FG001|Overall Study|Lack of Efficacy|8|||
127661059|NCT00363896|459382214|FG000|Overall Study|Protocol Violation|6|||
127661060|NCT00363896|459382215|FG001|Overall Study|Protocol Violation|1|||
127661061|NCT00363896|459382214|FG000|Overall Study|Lost to Follow-up|3|||
127661062|NCT00363896|459382215|FG001|Overall Study|Lost to Follow-up|0|||
127661063|NCT00363896|459382214|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
127661064|NCT00363896|459382215|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
127661065|NCT00363896|459382214|FG000|Overall Study|Other|1|||
127661066|NCT00363896|459382215|FG001|Overall Study|Other|2|||
127661067|NCT00924469|459382220|FG000|Overall Study|Adverse Event|2|||
127661068|NCT00924469|459382221|FG001|Overall Study|Adverse Event|0|||
127661069|NCT00924469|459382220|FG000|Overall Study|Withdrawal by Subject|0|||
127661070|NCT00924469|459382221|FG001|Overall Study|Withdrawal by Subject|1|||
127661071|NCT00924469|459382220|FG000|Overall Study|Lost to Follow-up|0|||
127661072|NCT00924469|459382221|FG001|Overall Study|Lost to Follow-up|1|||
127661073|NCT00630058|459382222|FG000|Overall Study|Adverse Event|1|||
127661074|NCT00630058|459382223|FG001|Overall Study|Adverse Event|1|||
127661075|NCT00630058|459382222|FG000|Overall Study|Withdrawal by Subject|0|||
127661076|NCT00630058|459382223|FG001|Overall Study|Withdrawal by Subject|1|||
127661077|NCT00630058|459382222|FG000|Overall Study|stopping criteria|3|||
127661078|NCT00630058|459382223|FG001|Overall Study|stopping criteria|2|||
127661079|NCT01651936|459382224|FG000|Base Study|Adverse Event|3|||
127661080|NCT01651936|459382225|FG001|Base Study|Adverse Event|0|||
127661081|NCT01651936|459382226|FG002|Base Study|Adverse Event|0|||
127661082|NCT01651936|459382224|FG000|Base Study|Withdrawal by Subject|1|||
127661083|NCT01651936|459382225|FG001|Base Study|Withdrawal by Subject|1|||
127661084|NCT01651936|459382226|FG002|Base Study|Withdrawal by Subject|0|||
127661085|NCT01651936|459382224|FG000|Base Study|Early Escape|2|||
127661086|NCT01651936|459382225|FG001|Base Study|Early Escape|8|||
127661087|NCT01651936|459382226|FG002|Base Study|Early Escape|0|||
127661088|NCT01651936|459382224|FG000|Base Study|Study terminated by sponsor|21|||
127661089|NCT01651936|459382225|FG001|Base Study|Study terminated by sponsor|16|||
127661090|NCT01651936|459382226|FG002|Base Study|Study terminated by sponsor|0|||
127661091|NCT01651936|459382224|FG000|Extension Study|Lack of Efficacy|0|||
127661092|NCT01651936|459382225|FG001|Extension Study|Lack of Efficacy|0|||
127661093|NCT01651936|459382226|FG002|Extension Study|Lack of Efficacy|1|||
127661094|NCT01651936|459382224|FG000|Extension Study|Study terminated by sponsor|0|||
127661095|NCT01651936|459382225|FG001|Extension Study|Study terminated by sponsor|0|||
127661096|NCT01651936|459382226|FG002|Extension Study|Study terminated by sponsor|13|||
127661097|NCT03044353|459382227|FG000|Overall Study|Adverse Event|0|||
127661098|NCT03044353|459382228|FG001|Overall Study|Adverse Event|1|||
127661099|NCT03044353|459382229|FG002|Overall Study|Adverse Event|0|||
127661100|NCT02141659|459382239|FG000|Overall Study|Major Protocol Deviation|0|||
127661101|NCT02141659|459382240|FG001|Overall Study|Major Protocol Deviation|1|||
127661102|NCT02141659|459382241|FG002|Overall Study|Major Protocol Deviation|0|||
127661103|NCT02141659|459382242|FG003|Overall Study|Major Protocol Deviation|0|||
127661104|NCT02141659|459382243|FG004|Overall Study|Major Protocol Deviation|0|||
127661105|NCT02141659|459382244|FG005|Overall Study|Major Protocol Deviation|0|||
127661106|NCT02141659|459382239|FG000|Overall Study|Lack of Efficacy|0|||
127661107|NCT02141659|459382240|FG001|Overall Study|Lack of Efficacy|0|||
127661108|NCT02141659|459382241|FG002|Overall Study|Lack of Efficacy|0|||
127661109|NCT02141659|459382242|FG003|Overall Study|Lack of Efficacy|0|||
127661110|NCT02141659|459382243|FG004|Overall Study|Lack of Efficacy|0|||
127661111|NCT02141659|459382244|FG005|Overall Study|Lack of Efficacy|1|||
127661112|NCT02141659|459382239|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
127661113|NCT02141659|459382240|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
127661114|NCT02141659|459382241|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
127661115|NCT02141659|459382242|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
127661116|NCT02141659|459382243|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
127661117|NCT02141659|459382244|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
127661118|NCT02743793|459382251|FG000|Overall Study|Death|1|||
127661119|NCT02743793|459382252|FG001|Overall Study|Death|1|||
127661120|NCT02743793|459382251|FG000|Overall Study|Withdrawal by Subject|0|||
127661121|NCT02743793|459382252|FG001|Overall Study|Withdrawal by Subject|1|||
127661122|NCT02743793|459382251|FG000|Overall Study|Screen Failure|4|||
127661123|NCT02743793|459382252|FG001|Overall Study|Screen Failure|0|||
127661124|NCT02743793|459382251|FG000|Overall Study|No Primary Care Physician|0|||
127661125|NCT02743793|459382252|FG001|Overall Study|No Primary Care Physician|1|||
127661126|NCT02743793|459382251|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
127661127|NCT02743793|459382252|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
127661128|NCT02743793|459382251|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
127661129|NCT02743793|459382252|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
127661130|NCT01461993|459382258|FG000|Overall Study|Withdrawal by Subject|60|||
127661131|NCT01461993|459382259|FG001|Overall Study|Withdrawal by Subject|53|||
127661132|NCT01461993|459382260|FG002|Overall Study|Withdrawal by Subject|16|||
127661133|NCT01461993|459382258|FG000|Overall Study|Lost to Follow-up|44|||
127661134|NCT01461993|459382259|FG001|Overall Study|Lost to Follow-up|48|||
127661135|NCT01461993|459382260|FG002|Overall Study|Lost to Follow-up|22|||
127661136|NCT01461993|459382258|FG000|Overall Study|Protocol Violation|10|||
127661137|NCT01461993|459382259|FG001|Overall Study|Protocol Violation|9|||
127661138|NCT01461993|459382260|FG002|Overall Study|Protocol Violation|7|||
127661139|NCT01461993|459382258|FG000|Overall Study|Adverse Event|9|||
127661140|NCT01461993|459382259|FG001|Overall Study|Adverse Event|11|||
127661141|NCT01461993|459382260|FG002|Overall Study|Adverse Event|3|||
127661142|NCT01461993|459382258|FG000|Overall Study|No longer met eligibility criteria|13|||
127661143|NCT01461993|459382259|FG001|Overall Study|No longer met eligibility criteria|18|||
127661144|NCT01461993|459382260|FG002|Overall Study|No longer met eligibility criteria|10|||
127661145|NCT01461993|459382258|FG000|Overall Study|Did not meet entrance criteria|2|||
127661146|NCT01461993|459382259|FG001|Overall Study|Did not meet entrance criteria|3|||
127661147|NCT01461993|459382260|FG002|Overall Study|Did not meet entrance criteria|0|||
127661148|NCT01461993|459382258|FG000|Overall Study|Other|13|||
127661149|NCT01461993|459382259|FG001|Overall Study|Other|15|||
127661150|NCT01461993|459382260|FG002|Overall Study|Other|6|||
127661151|NCT00219141|459382262|FG000|Overall Study|Adverse Event|4|||
127661152|NCT00219141|459382263|FG001|Overall Study|Adverse Event|10|||
127661153|NCT00219141|459382264|FG002|Overall Study|Adverse Event|5|||
127661154|NCT00219141|459382262|FG000|Overall Study|Lack of Efficacy|3|||
127661155|NCT00219141|459382263|FG001|Overall Study|Lack of Efficacy|2|||
127661156|NCT00219141|459382264|FG002|Overall Study|Lack of Efficacy|0|||
127661157|NCT00219141|459382262|FG000|Overall Study|Administrative problems|0|||
127989968|NCT02131233|460590107|FG000|Overall Study|Not Treated|2|||
127989969|NCT02131233|460590108|FG001|Overall Study|Not Treated|3|||
127989970|NCT02131233|460590107|FG000|Overall Study|Adverse Event|7|||
127989971|NCT02131233|460590108|FG001|Overall Study|Adverse Event|6|||
127989972|NCT02131233|460590107|FG000|Overall Study|Death|0|||
127989973|NCT02131233|460590108|FG001|Overall Study|Death|1|||
127989974|NCT02131233|460590107|FG000|Overall Study|Lack of Efficacy|6|||
127989975|NCT02131233|460590108|FG001|Overall Study|Lack of Efficacy|3|||
127989976|NCT02131233|460590107|FG000|Overall Study|Lost to Follow-up|14|||
127989977|NCT02131233|460590108|FG001|Overall Study|Lost to Follow-up|13|||
127989978|NCT02131233|460590107|FG000|Overall Study|Non-Compliance With Study Drug|8|||
127989979|NCT02131233|460590108|FG001|Overall Study|Non-Compliance With Study Drug|5|||
127989980|NCT02131233|460590107|FG000|Overall Study|Physician Decision|7|||
127989981|NCT02131233|460590108|FG001|Overall Study|Physician Decision|0|||
127661158|NCT00219141|459382263|FG001|Overall Study|Administrative problems|1|||
127661159|NCT00219141|459382264|FG002|Overall Study|Administrative problems|0|||
127661160|NCT00219141|459382262|FG000|Overall Study|Lost to Follow-up|2|||
127661161|NCT00219141|459382263|FG001|Overall Study|Lost to Follow-up|4|||
127661162|NCT00219141|459382264|FG002|Overall Study|Lost to Follow-up|1|||
127543147|NCT00385671|458956475|FG000|Overall Study|Lost to Follow-up|6|||
127661163|NCT00219141|459382262|FG000|Overall Study|Protocol Violation|3|||
127661164|NCT00219141|459382263|FG001|Overall Study|Protocol Violation|1|||
127661165|NCT00219141|459382264|FG002|Overall Study|Protocol Violation|1|||
127661166|NCT00219141|459382262|FG000|Overall Study|Withdrawal by Subject|1|||
127661167|NCT00219141|459382263|FG001|Overall Study|Withdrawal by Subject|3|||
127661168|NCT00219141|459382264|FG002|Overall Study|Withdrawal by Subject|5|||
127989982|NCT02131233|460590107|FG000|Overall Study|Pregnancy|4|||
127989983|NCT02131233|460590108|FG001|Overall Study|Pregnancy|0|||
127989984|NCT02131233|460590107|FG000|Overall Study|Withdrawal by Subject|18|||
127989985|NCT02131233|460590108|FG001|Overall Study|Withdrawal by Subject|11|||
127989986|NCT03519919|460590109|FG000|Overall Study|Withdrawal by Subject|1|||
127989987|NCT03519919|460590109|FG000|Overall Study|Lack of Efficacy|1|||
127989988|NCT03519919|460590109|FG000|Overall Study|Screen Failure|1|||
127989989|NCT02095197|460590110|FG000|Overall Study|Lost to Follow-up|0|||
127989990|NCT02095197|460590111|FG001|Overall Study|Lost to Follow-up|3|||
127989991|NCT05114564|460590112|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
127989992|NCT05114564|460590113|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
127989993|NCT05114564|460590112|FG000|First Intervention|Adverse Event|0|||
127989994|NCT05114564|460590113|FG001|First Intervention|Adverse Event|1|||
127989995|NCT00493311|460590114|FG000|Overall Study|Need for rescue medication|2|||
127989996|NCT00493311|460590115|FG001|Overall Study|Need for rescue medication|2|||
127989997|NCT02829047|460590116|FG000|Overall Study|Withdrawal by Subject|1|||
127989998|NCT04217317|460590122|FG000|Overall Study|Lack of Efficacy|4|||
127989999|NCT04217317|460590122|FG000|Overall Study|Physician Decision|1|||
127990000|NCT04313400|460590123|FG000|Overall Study|Withdrawal by Subject|0|||
127990001|NCT04313400|460590124|FG001|Overall Study|Withdrawal by Subject|0|||
127990002|NCT04313400|460590125|FG002|Overall Study|Withdrawal by Subject|0|||
127990003|NCT04313400|460590126|FG003|Overall Study|Withdrawal by Subject|0|||
127990004|NCT04313400|460590127|FG004|Overall Study|Withdrawal by Subject|0|||
127990005|NCT04313400|460590128|FG005|Overall Study|Withdrawal by Subject|4|||
127990006|NCT04313400|460590129|FG006|Overall Study|Withdrawal by Subject|1|||
127990007|NCT04313400|460590123|FG000|Overall Study|Adverse Event|0|||
127990008|NCT04313400|460590124|FG001|Overall Study|Adverse Event|0|||
127990009|NCT04313400|460590125|FG002|Overall Study|Adverse Event|0|||
127990010|NCT04313400|460590126|FG003|Overall Study|Adverse Event|0|||
127990011|NCT04313400|460590127|FG004|Overall Study|Adverse Event|0|||
127990012|NCT04313400|460590128|FG005|Overall Study|Adverse Event|1|||
127990013|NCT04313400|460590129|FG006|Overall Study|Adverse Event|0|||
127990014|NCT04313400|460590123|FG000|Overall Study|Lost to Follow-up|0|||
127990015|NCT04313400|460590124|FG001|Overall Study|Lost to Follow-up|0|||
127990016|NCT04313400|460590125|FG002|Overall Study|Lost to Follow-up|0|||
127990017|NCT04313400|460590126|FG003|Overall Study|Lost to Follow-up|0|||
127990018|NCT04313400|460590127|FG004|Overall Study|Lost to Follow-up|0|||
127990019|NCT04313400|460590128|FG005|Overall Study|Lost to Follow-up|1|||
127990020|NCT04313400|460590129|FG006|Overall Study|Lost to Follow-up|0|||
127990021|NCT01808222|460590135|FG000|Overall Study|mpMR scan was not performed|1|||
127990022|NCT02383355|460590136|FG000|Overall Study|Adverse Event|2|||
127990023|NCT02383355|460590137|FG001|Overall Study|Adverse Event|0|||
127990024|NCT01146561|460590139|FG000|Overall Study|Withdrawal by Subject|1|||
127990025|NCT01146561|460590139|FG000|Overall Study|Lost to Follow-up|1|||
127990026|NCT01778751|460590141|FG000|Overall Study|Lost to Follow-up|1|||
127990027|NCT01778751|460590142|FG001|Overall Study|Lost to Follow-up|0|||
127990028|NCT01778751|460590141|FG000|Overall Study|Withdrawal by Subject|0|||
127990029|NCT01778751|460590142|FG001|Overall Study|Withdrawal by Subject|2|||
127990030|NCT01778751|460590141|FG000|Overall Study|Transfered care|1|||
127990031|NCT01778751|460590142|FG001|Overall Study|Transfered care|0|||
127990032|NCT03628716|460590145|FG000|Overall Study|Adverse Event|1|||
127990033|NCT03628716|460590146|FG001|Overall Study|Adverse Event|1|||
127990034|NCT03628716|460590145|FG000|Overall Study|Death|1|||
127990035|NCT03628716|460590146|FG001|Overall Study|Death|0|||
127990036|NCT03628716|460590145|FG000|Overall Study|Lack of Efficacy|15|||
127990037|NCT03628716|460590146|FG001|Overall Study|Lack of Efficacy|20|||
127990038|NCT03628716|460590145|FG000|Overall Study|Withdrawal by Subject|1|||
127990039|NCT03628716|460590146|FG001|Overall Study|Withdrawal by Subject|2|||
127990040|NCT03628716|460590145|FG000|Overall Study|Study Terminated by Sponsor|1|||
127990041|NCT03628716|460590146|FG001|Overall Study|Study Terminated by Sponsor|0|||
127990042|NCT01573754|460590148|FG000|Overall Study|Noncompliance or remission not achieved|3|||
127990043|NCT01573754|460590149|FG001|Overall Study|Noncompliance or remission not achieved|15|||
127990044|NCT00829829|460590150|FG000|Overall Study|Protocol Violation|0|||
127990045|NCT00829829|460590151|FG001|Overall Study|Protocol Violation|3|||
127661169|NCT00219141|459382262|FG000|Overall Study|Condition no longer requires study drug|1|||
127661170|NCT00219141|459382263|FG001|Overall Study|Condition no longer requires study drug|0|||
127661171|NCT00219141|459382264|FG002|Overall Study|Condition no longer requires study drug|0|||
127661172|NCT01088529|459382265|FG000|Overall Study|Did not receive study treatment|0|||
127990046|NCT00829829|460590152|FG002|Overall Study|Protocol Violation|0|||
127990047|NCT00829829|460590150|FG000|Overall Study|Adverse Event|4|||
127990048|NCT00829829|460590151|FG001|Overall Study|Adverse Event|4|||
127990049|NCT00829829|460590152|FG002|Overall Study|Adverse Event|3|||
127990050|NCT00829829|460590150|FG000|Overall Study|Withdrawal by Subject|8|||
127990051|NCT00829829|460590151|FG001|Overall Study|Withdrawal by Subject|4|||
127990052|NCT00829829|460590152|FG002|Overall Study|Withdrawal by Subject|2|||
127990053|NCT00829829|460590150|FG000|Overall Study|Decision by the Sponsor|1|||
127990054|NCT00829829|460590151|FG001|Overall Study|Decision by the Sponsor|0|||
127990055|NCT00829829|460590152|FG002|Overall Study|Decision by the Sponsor|2|||
127990056|NCT00829829|460590150|FG000|Overall Study|Lost to Follow-up|7|||
127990057|NCT00829829|460590151|FG001|Overall Study|Lost to Follow-up|3|||
127990058|NCT00829829|460590152|FG002|Overall Study|Lost to Follow-up|3|||
127990059|NCT00829829|460590150|FG000|Overall Study|Other than specified above|2|||
127990060|NCT00829829|460590151|FG001|Overall Study|Other than specified above|2|||
127990061|NCT00829829|460590152|FG002|Overall Study|Other than specified above|1|||
127990062|NCT02685072|460590153|FG000|Treatment Period|Lost to Follow-up|12|||
127990063|NCT02685072|460590154|FG001|Treatment Period|Lost to Follow-up|6|||
127990064|NCT02685072|460590153|FG000|Treatment Period|Withdrawal by Subject|1|||
127990065|NCT02685072|460590154|FG001|Treatment Period|Withdrawal by Subject|3|||
127990066|NCT02685072|460590153|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
127990067|NCT02685072|460590154|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
127990068|NCT01994902|460590155|FG000|Test Period 1|Withdrawal by Subject|3|||
127990069|NCT01994902|460590156|FG001|Test Period 1|Withdrawal by Subject|0|||
127990070|NCT01994902|460590155|FG000|Test Period 1|device deficiency with adverse event|0|||
127661173|NCT01088529|459382266|FG001|Overall Study|Did not receive study treatment|1|||
127661174|NCT02838628|459382268|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
127661175|NCT02838628|459382269|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
127661176|NCT02838628|459382268|FG000|Recurrence Follow-up Period|Adverse Event|1|||
127661177|NCT02838628|459382269|FG001|Recurrence Follow-up Period|Adverse Event|0|||
127661178|NCT02838628|459382268|FG000|Recurrence Follow-up Period|Non-compliance|0|||
127990071|NCT01994902|460590156|FG001|Test Period 1|device deficiency with adverse event|1|||
127990072|NCT01994902|460590155|FG000|Test Period 1|Adverse Event|2|||
127990073|NCT01994902|460590156|FG001|Test Period 1|Adverse Event|1|||
127990074|NCT01994902|460590155|FG000|Test Period 1|Lack of Efficacy|0|||
127990075|NCT01994902|460590156|FG001|Test Period 1|Lack of Efficacy|1|||
127990076|NCT01994902|460590155|FG000|Test Period 1|bag too small|1|||
127990077|NCT01994902|460590156|FG001|Test Period 1|bag too small|0|||
127990078|NCT01994902|460590155|FG000|Test Period 2|Withdrawal by Subject|0|||
127661179|NCT02838628|459382269|FG001|Recurrence Follow-up Period|Non-compliance|1|||
127661180|NCT02838628|459382268|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
127661181|NCT02838628|459382269|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
127661182|NCT02838628|459382268|FG000|Recurrence Follow-up Period|Other un-specified|1|||
127661183|NCT02838628|459382269|FG001|Recurrence Follow-up Period|Other un-specified|1|||
127661184|NCT02066532|459382272|FG000|Phase II|Withdrawal by Subject|1|||
127661185|NCT02066532|459382273|FG001|Phase II|Withdrawal by Subject|0|||
127661186|NCT02066532|459382274|FG002|Phase II|Withdrawal by Subject|0|||
127661187|NCT02066532|459382275|FG003|Phase II|Withdrawal by Subject|0|||
127661188|NCT01265823|459382276|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
127661189|NCT01265823|459382276|FG000|Overall Study|Failure to Return|4|||
127661190|NCT01265823|459382276|FG000|Overall Study|Protocol Violation|1|||
127661191|NCT01265823|459382276|FG000|Overall Study|Participant Request|1|||
127661192|NCT01018563|459382277|FG000|Overall Study|Termination of the study by Sponsor|2|||
127661193|NCT01018563|459382278|FG001|Overall Study|Termination of the study by Sponsor|1|||
127661194|NCT00514046|459382282|FG000|Overall Study|transferred to another protocol|2|||
127661195|NCT00514046|459382283|FG001|Overall Study|transferred to another protocol|1|||
127661196|NCT00514046|459382284|FG002|Overall Study|transferred to another protocol|3|||
127661197|NCT00514046|459382285|FG003|Overall Study|transferred to another protocol|0|||
127661198|NCT00514046|459382286|FG004|Overall Study|transferred to another protocol|1|||
127661199|NCT00514046|459382287|FG005|Overall Study|transferred to another protocol|0|||
127661200|NCT00514046|459382288|FG006|Overall Study|transferred to another protocol|0|||
127661201|NCT00514046|459382289|FG007|Overall Study|transferred to another protocol|0|||
127661202|NCT00514046|459382290|FG008|Overall Study|transferred to another protocol|0|||
127661203|NCT00514046|459382282|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
127661204|NCT00514046|459382283|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
127661205|NCT00514046|459382284|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
127661206|NCT00514046|459382285|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
127661207|NCT00514046|459382286|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
127661208|NCT00514046|459382287|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
127661209|NCT00514046|459382288|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
127661210|NCT00514046|459382289|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
127661211|NCT00514046|459382290|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
127661212|NCT00514046|459382282|FG000|Overall Study|Disease progression on study|0|||
127661213|NCT00514046|459382283|FG001|Overall Study|Disease progression on study|0|||
127661214|NCT00514046|459382284|FG002|Overall Study|Disease progression on study|2|||
127661215|NCT00514046|459382285|FG003|Overall Study|Disease progression on study|0|||
127661216|NCT00514046|459382286|FG004|Overall Study|Disease progression on study|0|||
127661217|NCT00514046|459382287|FG005|Overall Study|Disease progression on study|1|||
127990079|NCT01994902|460590156|FG001|Test Period 2|Withdrawal by Subject|2|||
127990080|NCT01994902|460590155|FG000|Test Period 2|Lack of Efficacy|0|||
127990081|NCT01994902|460590156|FG001|Test Period 2|Lack of Efficacy|1|||
127990082|NCT01994902|460590155|FG000|Test Period 2|Other|0|||
127661218|NCT00514046|459382288|FG006|Overall Study|Disease progression on study|0|||
127661219|NCT00514046|459382289|FG007|Overall Study|Disease progression on study|0|||
127661220|NCT00514046|459382290|FG008|Overall Study|Disease progression on study|0|||
127990083|NCT01994902|460590156|FG001|Test Period 2|Other|3|||
127990084|NCT02634710|460590157|FG000|Overall Study|Death|4|||
127990085|NCT02717442|460590159|FG000|Overall Study|Study Terminated by Sponsor|31|||
127990086|NCT02717442|460590160|FG001|Overall Study|Study Terminated by Sponsor|29|||
127990087|NCT02717442|460590159|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
127990088|NCT02717442|460590160|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
127990089|NCT02717442|460590159|FG000|Overall Study|Other - Not Specified|2|||
127990090|NCT02717442|460590160|FG001|Overall Study|Other - Not Specified|0|||
127990091|NCT00528372|460590164|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
127990092|NCT00528372|460590165|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
127990093|NCT00528372|460590166|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
127990094|NCT00528372|460590167|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
127990095|NCT00528372|460590168|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
127990096|NCT00528372|460590169|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
127990097|NCT00528372|460590170|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
127990098|NCT00528372|460590171|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
127990099|NCT00528372|460590172|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
127990100|NCT00528372|460590164|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
127661221|NCT00383240|459382292|FG000|Overall Study|Adverse Event|4|||
127661222|NCT00383240|459382293|FG001|Overall Study|Adverse Event|6|||
127661223|NCT00383240|459382294|FG002|Overall Study|Adverse Event|9|||
127661224|NCT00383240|459382295|FG003|Overall Study|Adverse Event|7|||
127661225|NCT00383240|459382292|FG000|Overall Study|Treatment Failure|8|||
127990101|NCT00528372|460590165|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
127990102|NCT00528372|460590166|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
127990103|NCT00528372|460590167|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
127990104|NCT00528372|460590168|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
127990105|NCT00528372|460590169|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
127990106|NCT00528372|460590170|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
127990107|NCT00528372|460590171|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
127990108|NCT00528372|460590172|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
127990109|NCT00528372|460590164|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
127990110|NCT00528372|460590165|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
127990111|NCT00528372|460590166|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
127990112|NCT00528372|460590167|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
127990113|NCT00528372|460590168|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
127990114|NCT00528372|460590169|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
127990115|NCT00528372|460590170|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
127990116|NCT00528372|460590171|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
127990117|NCT00528372|460590172|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
127990118|NCT00528372|460590164|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
127990119|NCT00528372|460590165|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
127990120|NCT00528372|460590166|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
127990121|NCT00528372|460590167|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
127990122|NCT00528372|460590168|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
127990123|NCT00528372|460590169|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
127990124|NCT00528372|460590170|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
127990125|NCT00528372|460590171|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
127990126|NCT00528372|460590172|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
127990127|NCT00528372|460590164|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
127990128|NCT00528372|460590165|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
127990129|NCT00528372|460590166|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
127990130|NCT00528372|460590167|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
127990131|NCT00528372|460590168|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
127990132|NCT00528372|460590169|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
127990133|NCT00528372|460590170|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
127990134|NCT00528372|460590171|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
127990135|NCT00528372|460590172|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
127990136|NCT00528372|460590164|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
127990137|NCT00528372|460590165|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
127990138|NCT00528372|460590166|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
127990139|NCT00528372|460590167|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
127990140|NCT00528372|460590168|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
127661226|NCT00383240|459382293|FG001|Overall Study|Treatment Failure|13|||
127661227|NCT00383240|459382294|FG002|Overall Study|Treatment Failure|47|||
127661228|NCT00383240|459382295|FG003|Overall Study|Treatment Failure|46|||
127990141|NCT00528372|460590169|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
127990142|NCT00528372|460590170|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
127990143|NCT00528372|460590171|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
127990144|NCT00528372|460590172|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
127990145|NCT00528372|460590164|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
127990146|NCT00528372|460590165|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
127990147|NCT00528372|460590166|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
127990148|NCT00528372|460590167|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
127990149|NCT00528372|460590168|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
127990150|NCT00528372|460590169|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
127990151|NCT00528372|460590170|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
127990152|NCT00528372|460590171|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
127990153|NCT00528372|460590172|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
127990154|NCT00528372|460590164|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
127990155|NCT00528372|460590165|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
127990156|NCT00528372|460590166|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
127990157|NCT00528372|460590167|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
127990158|NCT00528372|460590168|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
127990159|NCT00528372|460590169|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
127990160|NCT00528372|460590170|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
127990161|NCT00528372|460590171|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
127990162|NCT00528372|460590172|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
127990163|NCT00528372|460590164|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
127990164|NCT00528372|460590165|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
127990165|NCT00528372|460590166|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
127990166|NCT00528372|460590167|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
127990167|NCT00528372|460590168|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
127990168|NCT00528372|460590169|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
127990169|NCT00528372|460590170|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
127990170|NCT00528372|460590171|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
127990171|NCT00528372|460590172|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
127990172|NCT00528372|460590164|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
127990173|NCT00528372|460590165|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
127990174|NCT00528372|460590166|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
127990175|NCT00528372|460590167|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
127990176|NCT00528372|460590168|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
127990177|NCT00528372|460590169|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
127990178|NCT00528372|460590170|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
127990179|NCT00528372|460590171|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
127990180|NCT00528372|460590172|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
127990181|NCT00528372|460590164|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
127990182|NCT00528372|460590165|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
127990183|NCT00528372|460590166|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
127990184|NCT00528372|460590167|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
127543148|NCT00385671|458956476|FG001|Overall Study|Lost to Follow-up|6|||
127543149|NCT00385671|458956477|FG002|Overall Study|Lost to Follow-up|5|||
127543150|NCT00385671|458956475|FG000|Overall Study|Physician Decision|2|||
127543151|NCT00385671|458956476|FG001|Overall Study|Physician Decision|1|||
127543152|NCT00385671|458956477|FG002|Overall Study|Physician Decision|2|||
127543153|NCT00385671|458956475|FG000|Overall Study|Protocol Violation|5|||
127990185|NCT00528372|460590168|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
127990186|NCT00528372|460590169|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
127990187|NCT00528372|460590170|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
127990188|NCT00528372|460590171|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
127990189|NCT00528372|460590172|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
127990190|NCT00528372|460590164|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
127990191|NCT00528372|460590165|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
127990192|NCT00528372|460590166|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
127990193|NCT00528372|460590167|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
127990194|NCT00528372|460590168|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
127990195|NCT00528372|460590169|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
127990196|NCT00528372|460590170|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
127543154|NCT00385671|458956476|FG001|Overall Study|Protocol Violation|2|||
127543155|NCT00385671|458956477|FG002|Overall Study|Protocol Violation|1|||
127543156|NCT00385671|458956475|FG000|Overall Study|Sponsor Decision|2|||
127543157|NCT00385671|458956476|FG001|Overall Study|Sponsor Decision|2|||
127990197|NCT00528372|460590171|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
127990198|NCT00528372|460590172|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
127990199|NCT00528372|460590164|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
127990200|NCT00528372|460590165|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
127990201|NCT00528372|460590166|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
127990202|NCT00528372|460590167|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
127990203|NCT00528372|460590168|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
127990204|NCT00528372|460590169|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
127990205|NCT00528372|460590170|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
127990206|NCT00528372|460590171|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
127990207|NCT00528372|460590172|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
127990208|NCT00528372|460590164|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
127990209|NCT00528372|460590165|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
127990210|NCT00528372|460590166|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
127990211|NCT00528372|460590167|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
127990212|NCT00528372|460590168|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
127990213|NCT00528372|460590169|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
127990214|NCT00528372|460590170|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
127990215|NCT00528372|460590171|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
127990216|NCT00528372|460590172|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
127990217|NCT00528372|460590164|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
127990218|NCT00528372|460590165|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
127990219|NCT00528372|460590166|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
127990220|NCT00528372|460590167|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
127990221|NCT00528372|460590168|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
127990222|NCT00528372|460590169|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
127990223|NCT00528372|460590170|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
127990224|NCT00528372|460590171|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
127990225|NCT00528372|460590172|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
127990226|NCT02772809|460590178|FG000|Overall Study|not completed some tasks|6|||
127990227|NCT00534105|460590179|FG000|Overall Study|Lost to Follow-up|23|||
127990228|NCT00534105|460590180|FG001|Overall Study|Lost to Follow-up|39|||
127990229|NCT02774005|460590181|FG000|Overall Study|Adverse Event|8|||
127990230|NCT02774005|460590181|FG000|Overall Study|Withdrawal by Subject|23|||
127990231|NCT02774005|460590181|FG000|Overall Study|Lost to Follow-up|7|||
127990232|NCT02774005|460590181|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
127990233|NCT02774005|460590181|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
127990234|NCT02774005|460590181|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
127990235|NCT02774005|460590181|FG000|Overall Study|Death|1|||
127990236|NCT02774005|460590181|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
127990237|NCT02774005|460590181|FG000|Overall Study|Lack of compliance with study medication|4|||
127990238|NCT02774005|460590181|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
127990239|NCT02774005|460590181|FG000|Overall Study|another study|1|||
127990240|NCT02774005|460590181|FG000|Overall Study|cardiologist imposed travel restriction|1|||
127990241|NCT03275389|460590185|FG000|Overall Study|Lost to Follow-up|10|||
127990242|NCT03275389|460590186|FG001|Overall Study|Lost to Follow-up|10|||
127990243|NCT03275389|460590187|FG002|Overall Study|Lost to Follow-up|19|||
127990244|NCT03275389|460590188|FG003|Overall Study|Lost to Follow-up|12|||
127990245|NCT03275389|460590189|FG004|Overall Study|Lost to Follow-up|11|||
127990246|NCT03275389|460590190|FG005|Overall Study|Lost to Follow-up|12|||
127990247|NCT03275389|460590191|FG006|Overall Study|Lost to Follow-up|21|||
127990248|NCT03275389|460590192|FG007|Overall Study|Lost to Follow-up|15|||
127990249|NCT03275389|460590193|FG008|Overall Study|Lost to Follow-up|12|||
127990250|NCT03275389|460590194|FG009|Overall Study|Lost to Follow-up|14|||
127990251|NCT03275389|460590185|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
127990252|NCT03275389|460590186|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
127990253|NCT03275389|460590187|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
127990254|NCT03275389|460590188|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
127990255|NCT03275389|460590189|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
127990256|NCT03275389|460590190|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
127990257|NCT03275389|460590191|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
127990258|NCT03275389|460590192|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
127990259|NCT03275389|460590193|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
127990260|NCT03275389|460590194|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
127990261|NCT03275389|460590185|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
127990262|NCT03275389|460590186|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
127990263|NCT03275389|460590187|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
127990264|NCT03275389|460590188|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
127990265|NCT03275389|460590189|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
127990266|NCT03275389|460590190|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
127990267|NCT03275389|460590191|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
127990268|NCT03275389|460590192|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
127990269|NCT03275389|460590193|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
127990270|NCT03275389|460590194|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
127990271|NCT03275389|460590185|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127990272|NCT03275389|460590186|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
127990273|NCT03275389|460590187|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127990274|NCT03275389|460590188|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
127990275|NCT03275389|460590189|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127990276|NCT03275389|460590190|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127990277|NCT03275389|460590191|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
127990278|NCT03275389|460590192|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127990279|NCT03275389|460590193|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127990280|NCT03275389|460590194|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127990281|NCT03275389|460590185|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
127990282|NCT03275389|460590186|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
127990283|NCT03275389|460590187|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
127990284|NCT03275389|460590188|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
127990285|NCT03275389|460590189|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
127990286|NCT03275389|460590190|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
127990287|NCT03275389|460590191|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
127990288|NCT03275389|460590192|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
127990289|NCT03275389|460590193|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
127990290|NCT03275389|460590194|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
127990291|NCT03275389|460590185|FG000|Overall Study|Other|0|||
127990292|NCT03275389|460590186|FG001|Overall Study|Other|4|||
127990293|NCT03275389|460590187|FG002|Overall Study|Other|3|||
127990294|NCT03275389|460590188|FG003|Overall Study|Other|2|||
127990295|NCT03275389|460590189|FG004|Overall Study|Other|2|||
127990296|NCT03275389|460590190|FG005|Overall Study|Other|2|||
127990297|NCT03275389|460590191|FG006|Overall Study|Other|0|||
127990298|NCT03275389|460590192|FG007|Overall Study|Other|0|||
127990299|NCT03275389|460590193|FG008|Overall Study|Other|1|||
127990300|NCT03275389|460590194|FG009|Overall Study|Other|0|||
127990301|NCT02432144|460590195|FG000|Overall Study|Participant Non-Compliance|1|||
127990302|NCT00978341|460590196|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
127990303|NCT00978341|460590197|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
127990304|NCT03035916|460590198|FG000|Overall Study|Puncture failed|0|||
127990305|NCT03035916|460590199|FG001|Overall Study|Puncture failed|2|||
127990306|NCT03035916|460590200|FG002|Overall Study|Puncture failed|0|||
127990307|NCT00448812|460590201|FG000|Year 2|Missed visit but remained in study|4|||
127990308|NCT00448812|460590202|FG001|Year 2|Missed visit but remained in study|1|||
127990309|NCT00448812|460590201|FG000|Year 3|Withdrawal by Subject|1|||
127990310|NCT00448812|460590202|FG001|Year 3|Withdrawal by Subject|3|||
127990311|NCT00448812|460590201|FG000|Year 3|Lost to Follow-up|1|||
127990312|NCT00448812|460590202|FG001|Year 3|Lost to Follow-up|0|||
127990313|NCT00448812|460590201|FG000|Year 3|Missed visit but remained in study|2|||
127990314|NCT00448812|460590202|FG001|Year 3|Missed visit but remained in study|0|||
127990315|NCT00448812|460590201|FG000|Year 5|Missed visit but remained in study|1|||
127990316|NCT00448812|460590202|FG001|Year 5|Missed visit but remained in study|0|||
127990317|NCT03885999|460590203|FG000|Overall Study|Adverse Event|1|||
127990318|NCT02452554|460590204|FG000|Overall Study|Death|2|||
127990319|NCT02452554|460590205|FG001|Overall Study|Death|1|||
127990320|NCT02452554|460590206|FG002|Overall Study|Death|0|||
127990321|NCT02452554|460590207|FG003|Overall Study|Death|0|||
127990322|NCT02452554|460590208|FG004|Overall Study|Death|0|||
127990323|NCT02452554|460590209|FG005|Overall Study|Death|0|||
127990324|NCT02452554|460590204|FG000|Overall Study|Lack of Efficacy|13|||
127990325|NCT02452554|460590205|FG001|Overall Study|Lack of Efficacy|14|||
127990326|NCT02452554|460590206|FG002|Overall Study|Lack of Efficacy|9|||
127990327|NCT02452554|460590207|FG003|Overall Study|Lack of Efficacy|1|||
127990328|NCT02452554|460590208|FG004|Overall Study|Lack of Efficacy|5|||
127990329|NCT02452554|460590209|FG005|Overall Study|Lack of Efficacy|8|||
127990330|NCT02452554|460590204|FG000|Overall Study|Physician Decision|0|||
127990331|NCT02452554|460590205|FG001|Overall Study|Physician Decision|1|||
127990332|NCT02452554|460590206|FG002|Overall Study|Physician Decision|0|||
127661229|NCT00383240|459382292|FG000|Overall Study|Lost to Follow-up|3|||
127990333|NCT02452554|460590207|FG003|Overall Study|Physician Decision|0|||
127990334|NCT02452554|460590208|FG004|Overall Study|Physician Decision|0|||
127990335|NCT02452554|460590209|FG005|Overall Study|Physician Decision|0|||
127661230|NCT00383240|459382293|FG001|Overall Study|Lost to Follow-up|0|||
127990336|NCT02452554|460590204|FG000|Overall Study|Withdrawal by Subject|1|||
127990337|NCT02452554|460590205|FG001|Overall Study|Withdrawal by Subject|0|||
127990338|NCT02452554|460590206|FG002|Overall Study|Withdrawal by Subject|2|||
127990339|NCT02452554|460590207|FG003|Overall Study|Withdrawal by Subject|0|||
127990340|NCT02452554|460590208|FG004|Overall Study|Withdrawal by Subject|0|||
127990341|NCT02452554|460590209|FG005|Overall Study|Withdrawal by Subject|1|||
127990342|NCT02452554|460590204|FG000|Overall Study|Ineligible|0|||
127990343|NCT02452554|460590205|FG001|Overall Study|Ineligible|1|||
127990344|NCT02452554|460590206|FG002|Overall Study|Ineligible|0|||
127990345|NCT02452554|460590207|FG003|Overall Study|Ineligible|0|||
127990346|NCT02452554|460590208|FG004|Overall Study|Ineligible|0|||
127990347|NCT02452554|460590209|FG005|Overall Study|Ineligible|0|||
127990348|NCT02452554|460590204|FG000|Overall Study|Never Received Treatment|1|||
127990349|NCT02452554|460590205|FG001|Overall Study|Never Received Treatment|0|||
127990350|NCT02452554|460590206|FG002|Overall Study|Never Received Treatment|0|||
127990351|NCT02452554|460590207|FG003|Overall Study|Never Received Treatment|0|||
127990352|NCT02452554|460590208|FG004|Overall Study|Never Received Treatment|0|||
127990353|NCT02452554|460590209|FG005|Overall Study|Never Received Treatment|0|||
127990354|NCT00467558|460590212|FG000|Overall Study|Lost to Follow-up|2|||
127990355|NCT00467558|460590213|FG001|Overall Study|Lost to Follow-up|0|||
127990356|NCT02636439|460590214|FG000|Overall Study|Adverse Event|2|||
127990357|NCT02636439|460590215|FG001|Overall Study|Adverse Event|2|||
127990358|NCT02636439|460590214|FG000|Overall Study|Lost to Follow-up|1|||
127990359|NCT02636439|460590215|FG001|Overall Study|Lost to Follow-up|0|||
127990360|NCT02636439|460590214|FG000|Overall Study|Non-compliance|1|||
127990361|NCT02636439|460590215|FG001|Overall Study|Non-compliance|1|||
127990362|NCT02636439|460590214|FG000|Overall Study|Personal reasons|2|||
127990363|NCT02636439|460590215|FG001|Overall Study|Personal reasons|0|||
127990364|NCT05188729|460590217|FG000|Overall Study|Withdrawal by Subject|0|||
127990365|NCT05188729|460590218|FG001|Overall Study|Withdrawal by Subject|0|||
127990366|NCT05188729|460590219|FG002|Overall Study|Withdrawal by Subject|0|||
127990367|NCT05188729|460590220|FG003|Overall Study|Withdrawal by Subject|0|||
127990368|NCT05188729|460590221|FG004|Overall Study|Withdrawal by Subject|0|||
127990369|NCT05188729|460590222|FG005|Overall Study|Withdrawal by Subject|0|||
127990370|NCT05188729|460590223|FG006|Overall Study|Withdrawal by Subject|0|||
127990371|NCT05188729|460590224|FG007|Overall Study|Withdrawal by Subject|0|||
127990372|NCT05188729|460590225|FG008|Overall Study|Withdrawal by Subject|0|||
127990373|NCT05188729|460590226|FG009|Overall Study|Withdrawal by Subject|1|||
127990374|NCT05188729|460590227|FG010|Overall Study|Withdrawal by Subject|0|||
127990375|NCT05188729|460590228|FG011|Overall Study|Withdrawal by Subject|0|||
127990376|NCT05188729|460590229|FG012|Overall Study|Withdrawal by Subject|0|||
127990377|NCT05188729|460590217|FG000|Overall Study|Lost to Follow-up|0|||
127990378|NCT05188729|460590218|FG001|Overall Study|Lost to Follow-up|0|||
127990379|NCT05188729|460590219|FG002|Overall Study|Lost to Follow-up|0|||
127990380|NCT05188729|460590220|FG003|Overall Study|Lost to Follow-up|0|||
127990381|NCT05188729|460590221|FG004|Overall Study|Lost to Follow-up|0|||
127990382|NCT05188729|460590222|FG005|Overall Study|Lost to Follow-up|0|||
127990383|NCT05188729|460590223|FG006|Overall Study|Lost to Follow-up|0|||
127990384|NCT05188729|460590224|FG007|Overall Study|Lost to Follow-up|0|||
127990385|NCT05188729|460590225|FG008|Overall Study|Lost to Follow-up|0|||
127990386|NCT05188729|460590226|FG009|Overall Study|Lost to Follow-up|0|||
127990387|NCT05188729|460590227|FG010|Overall Study|Lost to Follow-up|1|||
127990388|NCT05188729|460590228|FG011|Overall Study|Lost to Follow-up|1|||
127990389|NCT05188729|460590229|FG012|Overall Study|Lost to Follow-up|0|||
127990390|NCT00376532|460592222|FG000|Overall Study|Lack sufficient blood sample|6|||
127990391|NCT00376532|460592223|FG001|Overall Study|Lack sufficient blood sample|6|||
127990392|NCT04227405|460592224|FG000|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|26|||
127990393|NCT04227405|460592225|FG001|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|78|||
127990394|NCT04227405|460592224|FG000|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|82|||
127990395|NCT04227405|460592225|FG001|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|68|||
127990396|NCT04227405|460592224|FG000|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|68|||
127990397|NCT04227405|460592225|FG001|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|48|||
127661231|NCT00383240|459382294|FG002|Overall Study|Lost to Follow-up|0|||
127661232|NCT00383240|459382295|FG003|Overall Study|Lost to Follow-up|2|||
127990398|NCT02757352|460592228|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
127990399|NCT02757352|460592229|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
127990400|NCT02757352|460592230|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
127990401|NCT02757352|460592231|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
127990402|NCT02757352|460592232|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
127661233|NCT00383240|459382292|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
127661234|NCT00383240|459382293|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
127990403|NCT02757352|460592233|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
127990404|NCT02757352|460592234|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
127990405|NCT02757352|460592235|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
127990406|NCT02757352|460592236|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
127990407|NCT02757352|460592237|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
127990408|NCT02757352|460592228|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
127990409|NCT02757352|460592229|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
127990410|NCT02757352|460592230|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
127990411|NCT02757352|460592231|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
127990412|NCT02757352|460592232|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
127990413|NCT02757352|460592233|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
127990414|NCT02757352|460592234|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
127990415|NCT02757352|460592235|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
127990416|NCT02757352|460592236|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
127990417|NCT02757352|460592237|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
127990418|NCT02757352|460592228|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
127990419|NCT02757352|460592229|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
127990420|NCT02757352|460592230|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
127990421|NCT02757352|460592231|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
127990422|NCT02757352|460592232|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
127990423|NCT02757352|460592233|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
127990424|NCT02757352|460592234|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
127990425|NCT02757352|460592235|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
127990426|NCT02757352|460592236|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
127990427|NCT02757352|460592237|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
127990428|NCT02757352|460592228|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
127990429|NCT02757352|460592229|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
127990430|NCT02757352|460592230|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
127990431|NCT02757352|460592231|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
127990432|NCT02757352|460592232|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
127990433|NCT02757352|460592233|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
127990434|NCT02757352|460592234|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
127990435|NCT02757352|460592235|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
127990436|NCT02757352|460592236|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
127990437|NCT02757352|460592237|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
127990438|NCT02757352|460592228|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
127990439|NCT02757352|460592229|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
127990440|NCT02757352|460592230|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
127990441|NCT02757352|460592231|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
127990442|NCT02757352|460592232|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
127990443|NCT02757352|460592233|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
127990444|NCT02757352|460592234|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
127990445|NCT02757352|460592235|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
127990446|NCT02757352|460592236|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
127990447|NCT02757352|460592237|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
127990448|NCT02757352|460592228|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
127990449|NCT02757352|460592229|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
127990450|NCT02757352|460592230|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
127990451|NCT02757352|460592231|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
127990452|NCT02757352|460592232|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
127990453|NCT02757352|460592233|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
127990454|NCT02757352|460592234|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
127990455|NCT02757352|460592235|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
127990456|NCT02757352|460592236|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
127990457|NCT02757352|460592237|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
127990458|NCT02757352|460592228|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
127990459|NCT02757352|460592229|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
127990460|NCT02757352|460592230|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
127990461|NCT02757352|460592231|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
127990462|NCT02757352|460592232|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
127990463|NCT02757352|460592233|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
127990464|NCT02757352|460592234|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
127990465|NCT02757352|460592235|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
127990466|NCT02757352|460592236|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
127661235|NCT00383240|459382294|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
127661236|NCT00383240|459382295|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
127990467|NCT02757352|460592237|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
127990468|NCT02757352|460592228|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
127990469|NCT02757352|460592229|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
127990470|NCT02757352|460592230|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
127990471|NCT02757352|460592231|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
127990472|NCT02757352|460592232|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
127990473|NCT02757352|460592233|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
127990474|NCT02757352|460592234|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
127990475|NCT02757352|460592235|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
127990476|NCT02757352|460592236|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
127990477|NCT02757352|460592237|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
127990478|NCT02757352|460592228|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
127990479|NCT02757352|460592229|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
127990480|NCT02757352|460592230|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
127990481|NCT02757352|460592231|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
127990482|NCT02757352|460592232|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
127990483|NCT02757352|460592233|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
127990484|NCT02757352|460592234|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
127990485|NCT02757352|460592235|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
127990486|NCT02757352|460592236|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
127990487|NCT02757352|460592237|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
127990488|NCT02757352|460592228|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
127990489|NCT02757352|460592229|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
127990490|NCT02757352|460592230|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
127990491|NCT02757352|460592231|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
127990492|NCT02757352|460592232|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
127990493|NCT02757352|460592233|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
127990494|NCT02757352|460592234|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
127990495|NCT02757352|460592235|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
127990496|NCT02757352|460592236|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
127990497|NCT02757352|460592237|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
127990498|NCT02757352|460592228|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
127990499|NCT02757352|460592229|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
127990500|NCT02757352|460592230|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
127990501|NCT02757352|460592231|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
127990502|NCT02757352|460592232|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
127990503|NCT02757352|460592233|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
127990504|NCT02757352|460592234|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
127990505|NCT02757352|460592235|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
127990506|NCT02757352|460592236|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
127990507|NCT02757352|460592237|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
127990508|NCT02757352|460592228|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
127990509|NCT02757352|460592229|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
127990510|NCT02757352|460592230|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
127990511|NCT02757352|460592231|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
127990512|NCT02757352|460592232|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
127990513|NCT02757352|460592233|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
127990514|NCT02757352|460592234|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
127990515|NCT02757352|460592235|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
127990516|NCT02757352|460592236|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
127990517|NCT02757352|460592237|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
127990518|NCT02757352|460592228|FG000|Follow-Up Period|Adverse Event|0|||
127990519|NCT02757352|460592229|FG001|Follow-Up Period|Adverse Event|0|||
127990520|NCT02757352|460592230|FG002|Follow-Up Period|Adverse Event|0|||
127990521|NCT02757352|460592231|FG003|Follow-Up Period|Adverse Event|0|||
127990522|NCT02757352|460592232|FG004|Follow-Up Period|Adverse Event|0|||
127990523|NCT02757352|460592233|FG005|Follow-Up Period|Adverse Event|0|||
127990524|NCT02757352|460592234|FG006|Follow-Up Period|Adverse Event|1|||
127990525|NCT02757352|460592235|FG007|Follow-Up Period|Adverse Event|0|||
127990526|NCT02757352|460592236|FG008|Follow-Up Period|Adverse Event|2|||
127990527|NCT02757352|460592237|FG009|Follow-Up Period|Adverse Event|0|||
127990528|NCT02757352|460592228|FG000|Follow-Up Period|Lost to Follow-up|0|||
127990529|NCT02757352|460592229|FG001|Follow-Up Period|Lost to Follow-up|0|||
127990530|NCT02757352|460592230|FG002|Follow-Up Period|Lost to Follow-up|0|||
127990531|NCT02757352|460592231|FG003|Follow-Up Period|Lost to Follow-up|0|||
127990532|NCT02757352|460592232|FG004|Follow-Up Period|Lost to Follow-up|0|||
127990533|NCT02757352|460592233|FG005|Follow-Up Period|Lost to Follow-up|0|||
127661237|NCT00383240|459382292|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
127661238|NCT00383240|459382293|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
127661239|NCT00383240|459382294|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
127661240|NCT00383240|459382295|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
127661241|NCT00383240|459382292|FG000|Overall Study|Protocol Violation|4|||
127661242|NCT00383240|459382293|FG001|Overall Study|Protocol Violation|5|||
127990534|NCT02757352|460592234|FG006|Follow-Up Period|Lost to Follow-up|0|||
127990535|NCT02757352|460592235|FG007|Follow-Up Period|Lost to Follow-up|0|||
127990536|NCT02757352|460592236|FG008|Follow-Up Period|Lost to Follow-up|1|||
127990537|NCT02757352|460592237|FG009|Follow-Up Period|Lost to Follow-up|0|||
127990538|NCT02757352|460592228|FG000|Follow-Up Period|Lack of Efficacy|0|||
127990539|NCT02757352|460592229|FG001|Follow-Up Period|Lack of Efficacy|0|||
127990540|NCT02757352|460592230|FG002|Follow-Up Period|Lack of Efficacy|0|||
127990541|NCT02757352|460592231|FG003|Follow-Up Period|Lack of Efficacy|0|||
127990542|NCT02757352|460592232|FG004|Follow-Up Period|Lack of Efficacy|0|||
127990543|NCT02757352|460592233|FG005|Follow-Up Period|Lack of Efficacy|0|||
127990544|NCT02757352|460592234|FG006|Follow-Up Period|Lack of Efficacy|0|||
127990545|NCT02757352|460592235|FG007|Follow-Up Period|Lack of Efficacy|0|||
127990546|NCT02757352|460592236|FG008|Follow-Up Period|Lack of Efficacy|1|||
127990547|NCT02757352|460592237|FG009|Follow-Up Period|Lack of Efficacy|1|||
127990548|NCT02757352|460592228|FG000|Follow-Up Period|Withdrawal by Subject|0|||
127990549|NCT02757352|460592229|FG001|Follow-Up Period|Withdrawal by Subject|0|||
127990550|NCT02757352|460592230|FG002|Follow-Up Period|Withdrawal by Subject|0|||
127990551|NCT02757352|460592231|FG003|Follow-Up Period|Withdrawal by Subject|0|||
127990552|NCT02757352|460592232|FG004|Follow-Up Period|Withdrawal by Subject|0|||
127990553|NCT02757352|460592233|FG005|Follow-Up Period|Withdrawal by Subject|0|||
127990554|NCT02757352|460592234|FG006|Follow-Up Period|Withdrawal by Subject|0|||
127990555|NCT02757352|460592235|FG007|Follow-Up Period|Withdrawal by Subject|1|||
127990556|NCT02757352|460592236|FG008|Follow-Up Period|Withdrawal by Subject|6|||
127990557|NCT02757352|460592237|FG009|Follow-Up Period|Withdrawal by Subject|2|||
127990558|NCT00802672|460592238|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
127990559|NCT00802672|460592239|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
127990560|NCT00802672|460592240|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
127990561|NCT00802672|460592238|FG000|Overall Study|Adverse Event|1|||
127990562|NCT00802672|460592239|FG001|Overall Study|Adverse Event|1|||
127990563|NCT00802672|460592240|FG002|Overall Study|Adverse Event|1|||
127990564|NCT00802672|460592238|FG000|Overall Study|Protocol Violation|2|||
127990565|NCT00802672|460592239|FG001|Overall Study|Protocol Violation|1|||
127990566|NCT00802672|460592240|FG002|Overall Study|Protocol Violation|1|||
127990567|NCT00802672|460592238|FG000|Overall Study|Lost to Follow-up|5|||
127990568|NCT00802672|460592239|FG001|Overall Study|Lost to Follow-up|5|||
127990569|NCT00802672|460592240|FG002|Overall Study|Lost to Follow-up|3|||
127990570|NCT00802672|460592238|FG000|Overall Study|Withdrawal by Subject|1|||
127990571|NCT00802672|460592239|FG001|Overall Study|Withdrawal by Subject|1|||
127990572|NCT00802672|460592240|FG002|Overall Study|Withdrawal by Subject|2|||
127990573|NCT00802672|460592238|FG000|Overall Study|other|3|||
127990574|NCT00802672|460592239|FG001|Overall Study|other|1|||
127990575|NCT00802672|460592240|FG002|Overall Study|other|2|||
127990576|NCT02090283|460592245|FG000|Overall Study|Withdrawal by Subject|6|||
127990577|NCT02090283|460592246|FG001|Overall Study|Withdrawal by Subject|6|||
127990578|NCT02090283|460592247|FG002|Overall Study|Withdrawal by Subject|6|||
127990579|NCT02090283|460592245|FG000|Overall Study|Sponsor Terminated Study|6|||
127990580|NCT02090283|460592246|FG001|Overall Study|Sponsor Terminated Study|6|||
127990581|NCT02090283|460592247|FG002|Overall Study|Sponsor Terminated Study|1|||
127990582|NCT02090283|460592245|FG000|Overall Study|Lost to Follow-up|2|||
127990583|NCT02090283|460592246|FG001|Overall Study|Lost to Follow-up|2|||
127990584|NCT02090283|460592247|FG002|Overall Study|Lost to Follow-up|3|||
127990585|NCT02090283|460592245|FG000|Overall Study|Adverse Event|1|||
127990586|NCT02090283|460592246|FG001|Overall Study|Adverse Event|1|||
127990587|NCT02090283|460592247|FG002|Overall Study|Adverse Event|0|||
127990588|NCT02090283|460592245|FG000|Overall Study|Protocol Violation|2|||
127990589|NCT02090283|460592246|FG001|Overall Study|Protocol Violation|0|||
127990590|NCT02090283|460592247|FG002|Overall Study|Protocol Violation|0|||
127990591|NCT01411319|460592253|FG000|Overall Study|Lost to Follow-up|1|||
127990592|NCT02499263|460592254|FG000|Overall Study|Lost to Follow-up|9|||
127990593|NCT02499263|460592254|FG000|Overall Study|Participant's withdrawal of consent|4|||
127990594|NCT02499263|460592254|FG000|Overall Study|Lack of Efficacy|22|||
127990595|NCT02499263|460592254|FG000|Overall Study|investigator's judgment|12|||
127990596|NCT02499263|460592254|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
127990597|NCT02499263|460592254|FG000|Overall Study|Participant's decision|3|||
127990598|NCT02499263|460592254|FG000|Overall Study|Pregnancy|1|||
127661243|NCT00383240|459382294|FG002|Overall Study|Protocol Violation|9|||
127990599|NCT02075008|460592261|FG000|Overall Study|Technical problems|1|||
127990600|NCT02075008|460592261|FG000|Overall Study|Pregnancy|1|||
127990601|NCT02075008|460592261|FG000|Overall Study|Physician Decision|1|||
127990602|NCT02075008|460592261|FG000|Overall Study|Lost to Follow-up|1|||
127990603|NCT02075008|460592261|FG000|Overall Study|Lack of Efficacy|1|||
127990604|NCT02075008|460592261|FG000|Overall Study|Death|1|||
127990605|NCT02075008|460592261|FG000|Overall Study|Adverse Event|5|||
127990606|NCT02075008|460592261|FG000|Overall Study|Withdrawal by Subject|6|||
127990607|NCT02075008|460592261|FG000|Overall Study|Study terminated by Sponsor|159|||
127990608|NCT00660595|460592262|FG000|Overall Study|Lost to Follow-up|0|||
127990609|NCT00660595|460592263|FG001|Overall Study|Lost to Follow-up|1|||
127990610|NCT00660595|460592262|FG000|Overall Study|Did not consent to participate in study|12|||
127990611|NCT00660595|460592263|FG001|Overall Study|Did not consent to participate in study|8|||
127990612|NCT00660595|460592262|FG000|Overall Study|Participant left hospital|1|||
127990613|NCT00660595|460592263|FG001|Overall Study|Participant left hospital|0|||
127990614|NCT00660595|460592262|FG000|Overall Study|Non Specified reasons|5|||
127990615|NCT00660595|460592263|FG001|Overall Study|Non Specified reasons|0|||
127990616|NCT05205005|460592278|FG000|Overall Study|Withdrawal by Subject|1|||
127990617|NCT05205005|460592279|FG001|Overall Study|Withdrawal by Subject|0|||
127990618|NCT05205005|460592278|FG000|Overall Study|Adverse Event|1|||
127990619|NCT05205005|460592279|FG001|Overall Study|Adverse Event|0|||
127990620|NCT01148459|460592282|FG000|Overall Study|Serious Adverse Event|5|||
127990621|NCT01148459|460592283|FG001|Overall Study|Serious Adverse Event|4|||
127990622|NCT01148459|460592282|FG000|Overall Study|Withdrawal by Subject|1|||
127990623|NCT01148459|460592283|FG001|Overall Study|Withdrawal by Subject|0|||
127990624|NCT01148459|460592282|FG000|Overall Study|Migrated/moved from study area|3|||
127990625|NCT01148459|460592283|FG001|Overall Study|Migrated/moved from study area|6|||
127990626|NCT01148459|460592282|FG000|Overall Study|Lost to Follow-up|2|||
127990627|NCT01148459|460592283|FG001|Overall Study|Lost to Follow-up|0|||
127990628|NCT01148459|460592282|FG000|Overall Study|Refusal|1|||
127990629|NCT01148459|460592283|FG001|Overall Study|Refusal|0|||
127990630|NCT01148459|460592282|FG000|Overall Study|Failure to comply with study procedures|0|||
127990631|NCT01148459|460592283|FG001|Overall Study|Failure to comply with study procedures|1|||
127990632|NCT00694356|460592284|FG000|Overall Study|Adverse Event|1|||
127990633|NCT00694356|460592285|FG001|Overall Study|Adverse Event|0|||
127990634|NCT00694356|460592286|FG002|Overall Study|Adverse Event|0|||
127990635|NCT00694356|460592284|FG000|Overall Study|Progressive Disease|2|||
127990636|NCT00694356|460592285|FG001|Overall Study|Progressive Disease|6|||
127990637|NCT00694356|460592286|FG002|Overall Study|Progressive Disease|6|||
127990638|NCT00645671|460592296|FG000|Overall Study|Protocol Violation|1|||
127990639|NCT00645671|460592297|FG001|Overall Study|Protocol Violation|0|||
127990640|NCT00645671|460592296|FG000|Overall Study|Withdrawal by Subject|0|||
127990641|NCT00645671|460592297|FG001|Overall Study|Withdrawal by Subject|4|||
127990642|NCT00645671|460592296|FG000|Overall Study|Adverse Event|0|||
127990643|NCT00645671|460592297|FG001|Overall Study|Adverse Event|1|||
127990644|NCT00645671|460592296|FG000|Overall Study|Physician Decision|0|||
127990645|NCT00645671|460592297|FG001|Overall Study|Physician Decision|1|||
127990646|NCT02779075|460592298|FG000|Overall Study|Withdrawal by Subject|1|||
127990647|NCT02779075|460592299|FG001|Overall Study|Withdrawal by Subject|3|||
127990648|NCT02779075|460592298|FG000|Overall Study|IV lost during 2nd study|1|||
127990649|NCT02779075|460592299|FG001|Overall Study|IV lost during 2nd study|0|||
127990650|NCT01951573|460592300|FG000|Washout Period|Adverse Event|0|||
127990651|NCT01951573|460592301|FG001|Washout Period|Adverse Event|1|||
127990660|NCT00707980|460592304|FG000|Overall Study|Adverse Event|49|||
127990661|NCT00707980|460592304|FG000|Overall Study|Lack of Efficacy|35|||
127990662|NCT00707980|460592304|FG000|Overall Study|Non-Compliance with Study Drug|28|||
127990663|NCT00707980|460592304|FG000|Overall Study|Protocol Deviations|19|||
127990664|NCT00707980|460592304|FG000|Overall Study|Withdrawal of Consent|81|||
127990665|NCT00707980|460592304|FG000|Overall Study|Lost to Follow-up|59|||
127990666|NCT00707980|460592304|FG000|Overall Study|Other|39|||
127990667|NCT01909973|460592305|FG000|Overall Study|Lost to Follow-up|1|||
127990668|NCT01909973|460592306|FG001|Overall Study|Lost to Follow-up|0|||
127990669|NCT00460239|460592307|FG000|Overall Study|Physician Decision|0|||
127990670|NCT00460239|460592308|FG001|Overall Study|Physician Decision|1|||
127990671|NCT00460239|460592309|FG002|Overall Study|Physician Decision|0|||
127990672|NCT00460239|460592310|FG003|Overall Study|Physician Decision|0|||
127990673|NCT00460239|460592311|FG004|Overall Study|Physician Decision|0|||
127990674|NCT00460239|460592312|FG005|Overall Study|Physician Decision|2|||
127990675|NCT00460239|460592313|FG006|Overall Study|Physician Decision|0|||
127661244|NCT00383240|459382295|FG003|Overall Study|Protocol Violation|6|||
127990676|NCT00460239|460592314|FG007|Overall Study|Physician Decision|0|||
127990677|NCT00460239|460592315|FG008|Overall Study|Physician Decision|0|||
127990678|NCT00460239|460592307|FG000|Overall Study|Withdrawal by Subject|0|||
127990679|NCT00460239|460592308|FG001|Overall Study|Withdrawal by Subject|0|||
127990680|NCT00460239|460592309|FG002|Overall Study|Withdrawal by Subject|0|||
127990681|NCT00460239|460592310|FG003|Overall Study|Withdrawal by Subject|0|||
127990682|NCT00460239|460592311|FG004|Overall Study|Withdrawal by Subject|0|||
127990683|NCT00460239|460592312|FG005|Overall Study|Withdrawal by Subject|1|||
127990684|NCT00460239|460592313|FG006|Overall Study|Withdrawal by Subject|0|||
127990685|NCT00460239|460592314|FG007|Overall Study|Withdrawal by Subject|0|||
127990686|NCT00460239|460592315|FG008|Overall Study|Withdrawal by Subject|0|||
127990687|NCT01690299|460592339|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
127990688|NCT01690299|460592340|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
127990689|NCT01690299|460592341|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
127990690|NCT01690299|460592342|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
127990691|NCT01690299|460592343|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
127990692|NCT01690299|460592344|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
127990693|NCT01690299|460592339|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
127990694|NCT01690299|460592340|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
127990695|NCT01690299|460592341|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
127990696|NCT01690299|460592342|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
127990697|NCT01690299|460592343|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
127990698|NCT01690299|460592344|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
127990699|NCT01690299|460592339|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
127990700|NCT01690299|460592340|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
127990701|NCT01690299|460592341|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
127990702|NCT01690299|460592342|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
127990703|NCT01690299|460592343|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
127990704|NCT01690299|460592344|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
127990705|NCT01690299|460592339|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
127990706|NCT01690299|460592340|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
127990707|NCT01690299|460592341|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
127990708|NCT01690299|460592342|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
127990709|NCT01690299|460592343|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
127990710|NCT01690299|460592344|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
127990711|NCT01690299|460592339|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
127990712|NCT01690299|460592340|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
127990713|NCT01690299|460592341|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
127990714|NCT01690299|460592342|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
127990715|NCT01690299|460592343|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
127990716|NCT01690299|460592344|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
127990717|NCT01690299|460592339|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
127990718|NCT01690299|460592340|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
127990719|NCT01690299|460592341|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
127990720|NCT01690299|460592342|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
127990721|NCT01690299|460592343|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
127990722|NCT01690299|460592344|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
127990723|NCT01690299|460592339|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
127990724|NCT01690299|460592340|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
127543158|NCT00385671|458956477|FG002|Overall Study|Sponsor Decision|1|||
127543159|NCT00385671|458956475|FG000|Overall Study|Withdrawal by Subject|4|||
127661245|NCT00383240|459382292|FG000|Overall Study|Did not meet protocol eligibility|9|||
127661246|NCT00383240|459382293|FG001|Overall Study|Did not meet protocol eligibility|4|||
127661247|NCT00383240|459382294|FG002|Overall Study|Did not meet protocol eligibility|9|||
127661248|NCT00383240|459382295|FG003|Overall Study|Did not meet protocol eligibility|3|||
127661249|NCT00383240|459382292|FG000|Overall Study|Administrative|1|||
127661250|NCT00383240|459382293|FG001|Overall Study|Administrative|1|||
127661251|NCT00383240|459382294|FG002|Overall Study|Administrative|0|||
127661252|NCT00383240|459382295|FG003|Overall Study|Administrative|0|||
127661253|NCT02023879|459382299|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
127661254|NCT02023879|459382300|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
127661255|NCT02023879|459382301|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
127661256|NCT02023879|459382299|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
127661257|NCT02023879|459382300|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
127661258|NCT02023879|459382301|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
127661259|NCT02023879|459382299|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
127661260|NCT02023879|459382300|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
127661261|NCT02023879|459382301|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
127661262|NCT02023879|459382299|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
127661263|NCT02023879|459382300|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
127661264|NCT02023879|459382301|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
127990725|NCT01690299|460592341|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
127661265|NCT02023879|459382299|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
127661266|NCT02023879|459382300|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
127661267|NCT02023879|459382301|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
127661268|NCT02023879|459382299|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
127661269|NCT02023879|459382300|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
127661270|NCT02023879|459382301|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
127661271|NCT02023879|459382299|FG000|Extension Open Label Treatment|Adverse Event|1|||
127661272|NCT02023879|459382300|FG001|Extension Open Label Treatment|Adverse Event|7|||
127661273|NCT02023879|459382301|FG002|Extension Open Label Treatment|Adverse Event|3|||
127661274|NCT02023879|459382299|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
127661275|NCT02023879|459382300|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
127661276|NCT02023879|459382301|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
127661277|NCT02023879|459382299|FG000|Extension Open Label Treatment|Participant moved|1|||
127661278|NCT02023879|459382300|FG001|Extension Open Label Treatment|Participant moved|2|||
127661279|NCT02023879|459382301|FG002|Extension Open Label Treatment|Participant moved|0|||
127661280|NCT02023879|459382299|FG000|Extension Open Label Treatment|Other than specified above|2|||
127661281|NCT02023879|459382300|FG001|Extension Open Label Treatment|Other than specified above|7|||
127661282|NCT02023879|459382301|FG002|Extension Open Label Treatment|Other than specified above|2|||
127661283|NCT02924389|459382302|FG000|Overall Study|Lost to Follow-up|1|||
127661284|NCT02924389|459382303|FG001|Overall Study|Lost to Follow-up|0|||
127661285|NCT02924389|459382302|FG000|Overall Study|Physician Decision|2|||
127661286|NCT02924389|459382303|FG001|Overall Study|Physician Decision|0|||
127661287|NCT02924389|459382302|FG000|Overall Study|Withdrawal by Subject|3|||
127661288|NCT02924389|459382303|FG001|Overall Study|Withdrawal by Subject|0|||
127661289|NCT02924389|459382302|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
127661290|NCT02924389|459382303|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
127661291|NCT03918239|459384459|FG000|Overall Study|Lost to Follow-up|3|||
127661292|NCT03918239|459384460|FG001|Overall Study|Lost to Follow-up|1|||
127661293|NCT03918239|459384459|FG000|Overall Study|Pregnancy|0|||
127661294|NCT03918239|459384460|FG001|Overall Study|Pregnancy|2|||
127661295|NCT03918239|459384459|FG000|Overall Study|Withdrawal by Subject|3|||
127661296|NCT03918239|459384460|FG001|Overall Study|Withdrawal by Subject|3|||
127661297|NCT03918239|459384459|FG000|Overall Study|positive urine drug screening results|4|||
127661298|NCT03918239|459384460|FG001|Overall Study|positive urine drug screening results|1|||
127661299|NCT00593554|459384464|FG000|Overall Study|Death|1|||
127661300|NCT00593554|459384465|FG001|Overall Study|Death|2|||
127661301|NCT00593554|459384464|FG000|Overall Study|Physician Decision|0|||
127661302|NCT00593554|459384465|FG001|Overall Study|Physician Decision|1|||
127661303|NCT00593554|459384464|FG000|Overall Study|Withdrawal by Subject|1|||
127661304|NCT00593554|459384465|FG001|Overall Study|Withdrawal by Subject|0|||
127661305|NCT00593554|459384464|FG000|Overall Study|Disease Progression|1|||
127661306|NCT00593554|459384465|FG001|Overall Study|Disease Progression|2|||
127661307|NCT01024959|459384466|FG000|Overall Study|ineligible|12|||
127661308|NCT01024959|459384466|FG000|Overall Study|results not evaluable|12|||
127661309|NCT01024959|459384466|FG000|Overall Study|missing results required for analysis|17|||
127661310|NCT00636792|459384467|FG000|Overall Study|Adverse Event|16|||
127661311|NCT00636792|459384467|FG000|Overall Study|Physician Decision|7|||
127661312|NCT00636792|459384467|FG000|Overall Study|Progressive Disease|4|||
127661313|NCT00636792|459384467|FG000|Overall Study|Withdrawal by Subject|3|||
127661314|NCT00636792|459384467|FG000|Overall Study|Other|3|||
127661315|NCT01987596|459384470|FG000|Overall Study|Physician Decision|1|||
127661316|NCT01987596|459384471|FG001|Overall Study|Physician Decision|0|||
127661317|NCT01987596|459384470|FG000|Overall Study|Progressive Disease; missing all period|0|||
127661318|NCT01987596|459384471|FG001|Overall Study|Progressive Disease; missing all period|1|||
127661319|NCT00709592|459384472|FG000|Overall Study|Unable to proceed to transplant|0|||
127661320|NCT00709592|459384473|FG001|Overall Study|Unable to proceed to transplant|1|||
127661321|NCT01129336|459384474|FG000|Overall Study|Protocol Violation|1|||
127661322|NCT01129336|459384475|FG001|Overall Study|Protocol Violation|0|||
127661323|NCT01129336|459384474|FG000|Overall Study|Disease Progression|1|||
127661324|NCT01129336|459384475|FG001|Overall Study|Disease Progression|4|||
127661325|NCT01129336|459384474|FG000|Overall Study|Lost to Follow-up|1|||
127661326|NCT01129336|459384475|FG001|Overall Study|Lost to Follow-up|0|||
127661327|NCT01129336|459384474|FG000|Overall Study|Withdrawal by Subject|7|||
127661328|NCT01129336|459384475|FG001|Overall Study|Withdrawal by Subject|4|||
127661329|NCT01129336|459384474|FG000|Overall Study|Adverse Event|0|||
127661330|NCT01129336|459384475|FG001|Overall Study|Adverse Event|1|||
127661331|NCT01129336|459384474|FG000|Overall Study|Missing Study Completion Status|2|||
127661332|NCT01129336|459384475|FG001|Overall Study|Missing Study Completion Status|3|||
127661333|NCT01129336|459384474|FG000|Overall Study|Death|0|||
127661334|NCT01129336|459384475|FG001|Overall Study|Death|4|||
127661335|NCT00358150|459384476|FG000|Overall Study|Adverse Event|3|||
127661336|NCT00358150|459384476|FG000|Overall Study|Withdrawal by Subject|1|||
127661337|NCT00358150|459384476|FG000|Overall Study|Undefined|3|||
127661338|NCT04668989|459384477|FG000|First Intervention|Covid-19 related self-isolation|0|||
127661339|NCT04668989|459384478|FG001|First Intervention|Covid-19 related self-isolation|1|||
127661340|NCT04668989|459384477|FG000|Second Intervention|Adverse Event|0|||
127661341|NCT04668989|459384478|FG001|Second Intervention|Adverse Event|1|||
127661342|NCT00179010|459384479|FG000|Overall Study|Muscle probe defective|1|||
127661343|NCT00179010|459384480|FG001|Overall Study|Muscle probe defective|1|||
127661344|NCT00179010|459384479|FG000|Overall Study|Failure to place arterial line|0|||
127661345|NCT00179010|459384480|FG001|Overall Study|Failure to place arterial line|1|||
127661346|NCT01622348|459384481|FG000|Overall Study|Withdrawal by Subject|1|||
127661347|NCT01622348|459384482|FG001|Overall Study|Withdrawal by Subject|0|||
127661348|NCT01622348|459384483|FG002|Overall Study|Withdrawal by Subject|1|||
127661349|NCT01592695|459384488|FG000|Overall Study|Lost to Follow-up|8|||
127661350|NCT01592695|459384489|FG001|Overall Study|Lost to Follow-up|4|||
127661351|NCT00919893|459384490|FG000|Overall Study|Protocol Violation|19|||
127661352|NCT00919893|459384491|FG001|Overall Study|Protocol Violation|9|||
127661353|NCT01375959|459384495|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
127661354|NCT01375959|459384496|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
127661355|NCT01375959|459384495|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
127661356|NCT01375959|459384496|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
127661357|NCT01375959|459384495|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
127661358|NCT01375959|459384496|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
127661359|NCT00178256|459384497|FG000|Overall Study|Adverse Event|2|||
127661360|NCT00178256|459384498|FG001|Overall Study|Adverse Event|0|||
127661361|NCT00178256|459384499|FG002|Overall Study|Adverse Event|0|||
127661362|NCT00178256|459384500|FG003|Overall Study|Adverse Event|0|||
127661363|NCT00178256|459384497|FG000|Overall Study|Death|0|||
127661364|NCT00178256|459384498|FG001|Overall Study|Death|1|||
127661365|NCT00178256|459384499|FG002|Overall Study|Death|0|||
127661366|NCT00178256|459384500|FG003|Overall Study|Death|1|||
127661367|NCT00178256|459384497|FG000|Overall Study|Cancer progression|2|||
127661368|NCT00178256|459384498|FG001|Overall Study|Cancer progression|0|||
127661369|NCT00178256|459384499|FG002|Overall Study|Cancer progression|0|||
127661370|NCT00178256|459384500|FG003|Overall Study|Cancer progression|1|||
127661371|NCT01763788|459384501|FG000|Overall Study|Lost to Follow-up|0|||
127661372|NCT01763788|459384502|FG001|Overall Study|Lost to Follow-up|0|||
127661373|NCT01763788|459384503|FG002|Overall Study|Lost to Follow-up|1|||
127661374|NCT01763788|459384504|FG003|Overall Study|Lost to Follow-up|0|||
127661375|NCT02086552|459384507|FG000|Overall Study|Withdrawal by Subject|1|||
127661376|NCT00708305|459384508|FG000|Period 1|Protocol Violation|1|||
127661377|NCT00708305|459384509|FG001|Period 1|Protocol Violation|0|||
127661378|NCT00708305|459384510|FG002|Period 1|Protocol Violation|1|||
127661379|NCT00708305|459384511|FG003|Period 1|Protocol Violation|0|||
127661380|NCT00708305|459384508|FG000|Period 1|Other Reason|0|||
127661381|NCT00708305|459384509|FG001|Period 1|Other Reason|0|||
127661382|NCT00708305|459384510|FG002|Period 1|Other Reason|0|||
127661383|NCT00708305|459384511|FG003|Period 1|Other Reason|2|||
127661384|NCT00708305|459384508|FG000|Period 2|Lost to Follow-up|0|||
127661385|NCT00708305|459384509|FG001|Period 2|Lost to Follow-up|1|||
127661386|NCT00708305|459384510|FG002|Period 2|Lost to Follow-up|0|||
127661387|NCT00708305|459384511|FG003|Period 2|Lost to Follow-up|0|||
127661388|NCT00708305|459384508|FG000|Period 2|Protocol Violation|0|||
127661389|NCT00708305|459384509|FG001|Period 2|Protocol Violation|1|||
127661390|NCT00708305|459384510|FG002|Period 2|Protocol Violation|0|||
127661391|NCT00708305|459384511|FG003|Period 2|Protocol Violation|0|||
127661392|NCT00708305|459384508|FG000|Period 2|Other Reason|1|||
127661393|NCT00708305|459384509|FG001|Period 2|Other Reason|0|||
127661394|NCT00708305|459384510|FG002|Period 2|Other Reason|0|||
127661395|NCT00708305|459384511|FG003|Period 2|Other Reason|1|||
127661396|NCT00708305|459384508|FG000|Period 3|Protocol Violation|0|||
127661397|NCT00708305|459384509|FG001|Period 3|Protocol Violation|2|||
127661398|NCT00708305|459384510|FG002|Period 3|Protocol Violation|0|||
127543160|NCT00385671|458956476|FG001|Overall Study|Withdrawal by Subject|4|||
127661399|NCT00708305|459384511|FG003|Period 3|Protocol Violation|0|||
127661400|NCT00708305|459384508|FG000|Period 3|Other Reason|1|||
127661401|NCT00708305|459384509|FG001|Period 3|Other Reason|0|||
127661402|NCT00708305|459384510|FG002|Period 3|Other Reason|0|||
127661403|NCT00708305|459384511|FG003|Period 3|Other Reason|0|||
127661404|NCT02771210|459384516|FG000|Period 1|Adverse Event|5|||
127661405|NCT02771210|459384517|FG001|Period 1|Adverse Event|3|||
127661406|NCT02771210|459384516|FG000|Period 1|Lack of Efficacy|3|||
127661407|NCT02771210|459384517|FG001|Period 1|Lack of Efficacy|6|||
127661408|NCT02771210|459384516|FG000|Period 1|Lost to Follow-up|2|||
127661409|NCT02771210|459384517|FG001|Period 1|Lost to Follow-up|0|||
127661410|NCT02771210|459384516|FG000|Period 1|Physician Decision|0|||
127661411|NCT02771210|459384517|FG001|Period 1|Physician Decision|1|||
127661412|NCT02771210|459384516|FG000|Period 1|Withdrawal by Subject|0|||
127661413|NCT02771210|459384517|FG001|Period 1|Withdrawal by Subject|3|||
127661414|NCT02771210|459384516|FG000|Period 1|Withdrawal of informed consent|1|||
127661415|NCT02771210|459384517|FG001|Period 1|Withdrawal of informed consent|5|||
127661416|NCT02771210|459384516|FG000|Period 2|Adverse Event|1|||
127661417|NCT02771210|459384517|FG001|Period 2|Adverse Event|0|||
127661418|NCT02771210|459384516|FG000|Period 2|Lack of Efficacy|0|||
127661419|NCT02771210|459384517|FG001|Period 2|Lack of Efficacy|1|||
127661420|NCT02771210|459384516|FG000|Period 2|Withdrawal by Subject|1|||
127661421|NCT02771210|459384517|FG001|Period 2|Withdrawal by Subject|0|||
127661422|NCT02771210|459384516|FG000|Period 2|Withdrawal of informed consent|0|||
127661423|NCT02771210|459384517|FG001|Period 2|Withdrawal of informed consent|2|||
127661424|NCT04012814|459384520|FG000|Overall Study|Lost to Follow-up|4|||
127661425|NCT04012814|459384520|FG000|Overall Study|Withdrawal by Subject|2|||
127661426|NCT04012814|459384520|FG000|Overall Study|Protocol Violation|1|||
127661427|NCT04012814|459384520|FG000|Overall Study|Adverse Event|1|||
127661428|NCT04397523|459384521|FG000|Overall Study|Lost to Follow-up|3|||
127661429|NCT04397523|459384521|FG000|Overall Study|Transfer from/to other hospital|8|||
127661430|NCT01275196|459384522|FG000|Overall Study|Adverse Event|3|||
127661431|NCT01275196|459384523|FG001|Overall Study|Adverse Event|5|||
127661432|NCT01275196|459384522|FG000|Overall Study|Withdrawal by Subject|4|||
127661433|NCT01275196|459384523|FG001|Overall Study|Withdrawal by Subject|5|||
127661434|NCT01275196|459384522|FG000|Overall Study|Lost to Follow-up|1|||
127661435|NCT01275196|459384523|FG001|Overall Study|Lost to Follow-up|0|||
127661436|NCT01275196|459384522|FG000|Overall Study|Disease Progression|6|||
127661437|NCT01275196|459384523|FG001|Overall Study|Disease Progression|5|||
127661438|NCT01275196|459384522|FG000|Overall Study|Protocol Violation|1|||
127661439|NCT01275196|459384523|FG001|Overall Study|Protocol Violation|0|||
127661440|NCT01275196|459384522|FG000|Overall Study|Suboptimal response/treatment failure|5|||
127661441|NCT01275196|459384523|FG001|Overall Study|Suboptimal response/treatment failure|6|||
127661442|NCT00684762|459384525|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
127661443|NCT00684762|459384526|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
127661444|NCT02572817|459384527|FG000|Overall Study|Death|6|||
127661445|NCT02572817|459384528|FG001|Overall Study|Death|3|||
127661446|NCT02572817|459384527|FG000|Overall Study|Lost to Follow-up|3|||
127661447|NCT02572817|459384528|FG001|Overall Study|Lost to Follow-up|3|||
127661448|NCT02441946|459384531|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
127661449|NCT02441946|459384532|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
127661450|NCT02441946|459384533|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
127661451|NCT02441946|459384531|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
127661452|NCT02441946|459384532|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
127661453|NCT02441946|459384533|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
127661454|NCT02441946|459384531|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
127661455|NCT02441946|459384532|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
127661456|NCT02441946|459384533|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
127661457|NCT02441946|459384531|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
127661458|NCT02441946|459384532|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
127661459|NCT02441946|459384533|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
127661460|NCT02441946|459384531|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
127661461|NCT02441946|459384532|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
127661462|NCT02441946|459384533|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
127661463|NCT02441946|459384531|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
127661464|NCT02441946|459384532|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
127661465|NCT02441946|459384533|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
127661466|NCT02441946|459384531|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
127661467|NCT02441946|459384532|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
127661468|NCT02441946|459384533|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
127661469|NCT02441946|459384531|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
127661470|NCT02441946|459384532|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
127661471|NCT02441946|459384533|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
127661472|NCT02441946|459384531|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
127661473|NCT02441946|459384532|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
127661474|NCT02441946|459384533|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
127661475|NCT02441946|459384531|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
127661476|NCT02441946|459384532|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
127661477|NCT02441946|459384533|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
127661478|NCT02441946|459384531|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
127661479|NCT02441946|459384532|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
127661480|NCT02441946|459384533|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
127661481|NCT02111213|459384534|FG000|Overall Study|Withdrawal by Subject|3|||
127661482|NCT02111213|459384535|FG001|Overall Study|Withdrawal by Subject|2|||
127661483|NCT02111213|459384534|FG000|Overall Study|Lost to Follow-up|3|||
127661484|NCT02111213|459384535|FG001|Overall Study|Lost to Follow-up|4|||
127661485|NCT02761629|459384536|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
127661486|NCT02761629|459384537|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
127661487|NCT02761629|459384536|FG000|Overall Study|Insufficient Therapeutic Response|2|||
127661488|NCT02761629|459384537|FG001|Overall Study|Insufficient Therapeutic Response|7|||
127661489|NCT02761629|459384536|FG000|Overall Study|Failure to Return|2|||
127661490|NCT02761629|459384537|FG001|Overall Study|Failure to Return|4|||
127661491|NCT02761629|459384536|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
127661492|NCT02761629|459384537|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
127661493|NCT02761629|459384536|FG000|Overall Study|Protocol Violation|2|||
127661494|NCT02761629|459384537|FG001|Overall Study|Protocol Violation|2|||
127661495|NCT02761629|459384536|FG000|Overall Study|Withdrawal by Subject|0|||
127661496|NCT02761629|459384537|FG001|Overall Study|Withdrawal by Subject|3|||
127661497|NCT02761629|459384536|FG000|Overall Study|Other|0|||
127661498|NCT02761629|459384537|FG001|Overall Study|Other|2|||
127661499|NCT02761629|459384536|FG000|Overall Study|Lost to Follow-up|4|||
127661500|NCT02761629|459384537|FG001|Overall Study|Lost to Follow-up|1|||
127661501|NCT02761629|459384536|FG000|Overall Study|Randomized But Not Treated|8|||
127661502|NCT02761629|459384537|FG001|Overall Study|Randomized But Not Treated|4|||
127661503|NCT02001974|459384538|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
127661504|NCT02001974|459384539|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
127661505|NCT02001974|459384540|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
127661506|NCT02001974|459384538|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
127661507|NCT02001974|459384539|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
127661508|NCT02001974|459384540|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
127661509|NCT02001974|459384538|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
127661510|NCT02001974|459384539|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
127661511|NCT02001974|459384540|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
127661512|NCT02001974|459384538|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
127661513|NCT02001974|459384539|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
127661514|NCT02001974|459384540|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
127661515|NCT00210119|459384541|FG000|Overall Study|Protocol Violation|1|||
127661516|NCT00210119|459384541|FG000|Overall Study|Withdrawal by Subject|1|||
127661517|NCT01830881|459384542|FG000|Overall Study|Changed decision to have an abortion|0|||
127661518|NCT01830881|459384543|FG001|Overall Study|Changed decision to have an abortion|1|||
127661519|NCT00119262|459384544|FG000|Overall Study|Lack of Efficacy|0|||
127661520|NCT00119262|459384545|FG001|Overall Study|Lack of Efficacy|3|||
127661521|NCT00119262|459384544|FG000|Overall Study|Withdrawal by Subject|12|||
127661522|NCT00119262|459384545|FG001|Overall Study|Withdrawal by Subject|11|||
127661523|NCT00119262|459384544|FG000|Overall Study|Adverse Event|33|||
127661524|NCT00119262|459384545|FG001|Overall Study|Adverse Event|35|||
127661525|NCT00119262|459384544|FG000|Overall Study|other disease|0|||
127661526|NCT00119262|459384545|FG001|Overall Study|other disease|2|||
127661527|NCT00119262|459384544|FG000|Overall Study|ineligble|1|||
127661528|NCT00119262|459384545|FG001|Overall Study|ineligble|2|||
127661529|NCT00119262|459384544|FG000|Overall Study|others|0|||
127661530|NCT00119262|459384545|FG001|Overall Study|others|5|||
127661531|NCT02038764|459384546|FG000|Overall Study|Adverse Event|0|||
127661532|NCT02038764|459384547|FG001|Overall Study|Adverse Event|0|||
127661533|NCT02038764|459384548|FG002|Overall Study|Adverse Event|1|||
127661534|NCT02038764|459384549|FG003|Overall Study|Adverse Event|0|||
127661535|NCT02038764|459384550|FG004|Overall Study|Adverse Event|0|||
127661536|NCT02038764|459384546|FG000|Overall Study|Lost to Follow-up|0|||
127661537|NCT02038764|459384547|FG001|Overall Study|Lost to Follow-up|1|||
127661538|NCT02038764|459384548|FG002|Overall Study|Lost to Follow-up|0|||
127661539|NCT02038764|459384549|FG003|Overall Study|Lost to Follow-up|0|||
127661540|NCT02038764|459384550|FG004|Overall Study|Lost to Follow-up|0|||
127661541|NCT02038764|459384546|FG000|Overall Study|Withdrawal by Subject|0|||
127661542|NCT02038764|459384547|FG001|Overall Study|Withdrawal by Subject|0|||
127661543|NCT02038764|459384548|FG002|Overall Study|Withdrawal by Subject|0|||
127661544|NCT02038764|459384549|FG003|Overall Study|Withdrawal by Subject|0|||
127661545|NCT02038764|459384550|FG004|Overall Study|Withdrawal by Subject|1|||
127661546|NCT02038764|459384546|FG000|Overall Study|Other|1|||
127661547|NCT02038764|459384547|FG001|Overall Study|Other|0|||
127661548|NCT02038764|459384548|FG002|Overall Study|Other|1|||
127661549|NCT02038764|459384549|FG003|Overall Study|Other|0|||
127661550|NCT02038764|459384550|FG004|Overall Study|Other|0|||
127661551|NCT04844918|459384553|FG000|Overall Study|Adverse Event|7|||
127661552|NCT04844918|459384554|FG001|Overall Study|Adverse Event|8|||
127661553|NCT04844918|459384555|FG002|Overall Study|Adverse Event|5|||
127661554|NCT04844918|459384553|FG000|Overall Study|Physician Decision|0|||
127661555|NCT04844918|459384554|FG001|Overall Study|Physician Decision|1|||
127661556|NCT04844918|459384555|FG002|Overall Study|Physician Decision|0|||
127661557|NCT04844918|459384553|FG000|Overall Study|Withdrawal by Subject|6|||
127661558|NCT04844918|459384554|FG001|Overall Study|Withdrawal by Subject|3|||
127661559|NCT04844918|459384555|FG002|Overall Study|Withdrawal by Subject|3|||
127661560|NCT04844918|459384553|FG000|Overall Study|Participants Excluded Due to GCP Compliance Issue|15|||
127661561|NCT04844918|459384554|FG001|Overall Study|Participants Excluded Due to GCP Compliance Issue|13|||
127661562|NCT04844918|459384555|FG002|Overall Study|Participants Excluded Due to GCP Compliance Issue|14|||
127661563|NCT05033080|459384561|FG000|Overall Study|Adverse Event|4|||
127661564|NCT05033080|459384562|FG001|Overall Study|Adverse Event|4|||
127661565|NCT05033080|459384561|FG000|Overall Study|Withdrawal of consent (not due to AE)|5|||
127661566|NCT05033080|459384562|FG001|Overall Study|Withdrawal of consent (not due to AE)|5|||
127661567|NCT05033080|459384561|FG000|Overall Study|Lost to Follow-up|1|||
127661568|NCT05033080|459384562|FG001|Overall Study|Lost to Follow-up|0|||
127661569|NCT05033080|459384561|FG000|Overall Study|Other non-compliance|0|||
127661570|NCT05033080|459384562|FG001|Overall Study|Other non-compliance|1|||
127661571|NCT05033080|459384561|FG000|Overall Study|Physician Decision|0|||
127661572|NCT05033080|459384562|FG001|Overall Study|Physician Decision|1|||
127661573|NCT05033080|459384561|FG000|Overall Study|Other|1|||
127661574|NCT05033080|459384562|FG001|Overall Study|Other|1|||
127661575|NCT01263106|459384563|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
127661576|NCT01263106|459384564|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
127661577|NCT01680458|459384565|FG000|Overall Study|Protocol Violation|3|||
127661578|NCT03012061|459384576|FG000|Overall Study|Withdrawal by Subject|1|||
127661579|NCT03012061|459384577|FG001|Overall Study|Withdrawal by Subject|5|||
127661580|NCT03012061|459384578|FG002|Overall Study|Withdrawal by Subject|4|||
127661581|NCT03012061|459384576|FG000|Overall Study|Investigator Site Closed|1|||
127661582|NCT03012061|459384577|FG001|Overall Study|Investigator Site Closed|2|||
127661583|NCT03012061|459384578|FG002|Overall Study|Investigator Site Closed|0|||
127661584|NCT03012061|459384576|FG000|Overall Study|Lost to Follow-up|2|||
127661585|NCT03012061|459384577|FG001|Overall Study|Lost to Follow-up|1|||
127661586|NCT03012061|459384578|FG002|Overall Study|Lost to Follow-up|0|||
127661587|NCT03012061|459384576|FG000|Overall Study|Study closed/ Terminated|0|||
127661588|NCT03012061|459384577|FG001|Overall Study|Study closed/ Terminated|0|||
127661589|NCT03012061|459384578|FG002|Overall Study|Study closed/ Terminated|1|||
127661590|NCT03012061|459384576|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
127661591|NCT03012061|459384577|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
127661592|NCT03012061|459384578|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
127661593|NCT03012061|459384576|FG000|Overall Study|Protocol Violation|0|||
127661594|NCT03012061|459384577|FG001|Overall Study|Protocol Violation|0|||
127661595|NCT03012061|459384578|FG002|Overall Study|Protocol Violation|2|||
127661596|NCT03012061|459384576|FG000|Overall Study|Lack of Efficacy|0|||
127661597|NCT03012061|459384577|FG001|Overall Study|Lack of Efficacy|1|||
127661598|NCT03012061|459384578|FG002|Overall Study|Lack of Efficacy|0|||
127661599|NCT03012061|459384576|FG000|Overall Study|Adverse Event|2|||
127661600|NCT03012061|459384577|FG001|Overall Study|Adverse Event|0|||
127661601|NCT03012061|459384578|FG002|Overall Study|Adverse Event|0|||
127661602|NCT02696902|459384579|FG000|Overall Study|Lost to Follow-up|0|||
127661603|NCT02696902|459384580|FG001|Overall Study|Lost to Follow-up|1|||
127661604|NCT02696902|459384581|FG002|Overall Study|Lost to Follow-up|1|||
127661605|NCT02696902|459384579|FG000|Overall Study|Withdrawal by Subject|0|||
127661606|NCT02696902|459384580|FG001|Overall Study|Withdrawal by Subject|0|||
127661607|NCT02696902|459384581|FG002|Overall Study|Withdrawal by Subject|1|||
127661608|NCT02696902|459384579|FG000|Overall Study|Death|19|||
127661609|NCT02696902|459384580|FG001|Overall Study|Death|3|||
127661610|NCT02696902|459384581|FG002|Overall Study|Death|24|||
127661611|NCT02696902|459384579|FG000|Overall Study|Participant not fit post-randomization|0|||
127661612|NCT02696902|459384580|FG001|Overall Study|Participant not fit post-randomization|0|||
127661613|NCT02696902|459384581|FG002|Overall Study|Participant not fit post-randomization|1|||
127661614|NCT02696902|459384579|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
127661615|NCT02696902|459384580|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
127661616|NCT02696902|459384581|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
127661617|NCT02696902|459384579|FG000|Overall Study|Principal investigator's decision|1|||
127661618|NCT02696902|459384580|FG001|Overall Study|Principal investigator's decision|0|||
127661619|NCT02696902|459384581|FG002|Overall Study|Principal investigator's decision|0|||
127661620|NCT02696902|459384579|FG000|Overall Study|Sponsor's decision|1|||
127661621|NCT02696902|459384580|FG001|Overall Study|Sponsor's decision|0|||
127661622|NCT02696902|459384581|FG002|Overall Study|Sponsor's decision|0|||
127661623|NCT02696902|459384579|FG000|Overall Study|Transferred to other hospital|1|||
127661624|NCT02696902|459384580|FG001|Overall Study|Transferred to other hospital|0|||
127661625|NCT02696902|459384581|FG002|Overall Study|Transferred to other hospital|0|||
127661626|NCT05822921|459384584|FG000|Overall Study|Lost to Follow-up|1|||
127661627|NCT05822921|459384585|FG001|Overall Study|Lost to Follow-up|1|||
127661628|NCT00544544|459384586|FG000|Overall Study|Withdrawal by Subject|1|||
127661629|NCT00544544|459384586|FG000|Overall Study|Adverse Event|1|||
127661630|NCT00544544|459384586|FG000|Overall Study|Lost to Follow-up|1|||
127661631|NCT03406702|459384587|FG000|Overall Study|Missed Day 27 Dosing|1|||
127661632|NCT01857622|459384593|FG000|Overall Study|Adverse Event|5|||
127661633|NCT01857622|459384594|FG001|Overall Study|Adverse Event|0|||
127661634|NCT01857622|459384595|FG002|Overall Study|Adverse Event|2|||
127661635|NCT01857622|459384593|FG000|Overall Study|Physician Decision|1|||
127661636|NCT01857622|459384594|FG001|Overall Study|Physician Decision|0|||
127661637|NCT01857622|459384595|FG002|Overall Study|Physician Decision|0|||
127661638|NCT01857622|459384593|FG000|Overall Study|Protocol Violation|4|||
127661639|NCT01857622|459384594|FG001|Overall Study|Protocol Violation|1|||
127661640|NCT01857622|459384595|FG002|Overall Study|Protocol Violation|0|||
127661641|NCT01857622|459384593|FG000|Overall Study|Withdrawal by Subject|1|||
127661642|NCT01857622|459384594|FG001|Overall Study|Withdrawal by Subject|0|||
127661643|NCT01857622|459384595|FG002|Overall Study|Withdrawal by Subject|0|||
127661644|NCT01291225|459384596|FG000|Overall Study|Lost to Follow-up|85|||
127661645|NCT01291225|459384597|FG001|Overall Study|Lost to Follow-up|39|||
127661646|NCT01267253|459384598|FG000|Overall Study|Ineligible - required test not done|1|||
127661647|NCT01267253|459384598|FG000|Overall Study|Inevaluable-never received study treatme|2|||
127661648|NCT04318093|459384599|FG000|Overall Study|Adverse Event|2|||
127661649|NCT04318093|459384600|FG001|Overall Study|Adverse Event|2|||
127661650|NCT04318093|459384599|FG000|Overall Study|Participant withdrew consent|1|||
127661651|NCT04318093|459384600|FG001|Overall Study|Participant withdrew consent|0|||
127661652|NCT04318093|459384599|FG000|Overall Study|Other reasons|0|||
127661653|NCT04318093|459384600|FG001|Overall Study|Other reasons|1|||
127661654|NCT02855164|459384603|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
127661655|NCT02855164|459384604|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
127661656|NCT02855164|459384605|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
127661657|NCT02855164|459384606|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
127661658|NCT02855164|459384607|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
127661659|NCT02855164|459384608|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
127661660|NCT02855164|459384609|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
127661661|NCT02855164|459384610|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
127661662|NCT02855164|459384603|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
127661663|NCT02855164|459384604|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
127661664|NCT02855164|459384605|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
127661665|NCT02855164|459384606|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
127661666|NCT02855164|459384607|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
127661667|NCT02855164|459384608|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
127661668|NCT02855164|459384609|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
127661669|NCT02855164|459384610|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
127661670|NCT02855164|459384603|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
127661671|NCT02855164|459384604|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
127661672|NCT02855164|459384605|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
127661673|NCT02855164|459384606|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
127661674|NCT02855164|459384607|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
127661675|NCT02855164|459384608|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
127661676|NCT02855164|459384609|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
127661677|NCT02855164|459384610|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
127661678|NCT02855164|459384603|FG000|Part C (Randomized Set)|Adverse Event|0|||
127661679|NCT02855164|459384604|FG001|Part C (Randomized Set)|Adverse Event|0|||
127661680|NCT02855164|459384605|FG002|Part C (Randomized Set)|Adverse Event|0|||
127661681|NCT02855164|459384606|FG003|Part C (Randomized Set)|Adverse Event|0|||
127661682|NCT02855164|459384607|FG004|Part C (Randomized Set)|Adverse Event|0|||
127661683|NCT02855164|459384608|FG005|Part C (Randomized Set)|Adverse Event|5|||
127661684|NCT02855164|459384609|FG006|Part C (Randomized Set)|Adverse Event|9|||
127661685|NCT02855164|459384610|FG007|Part C (Randomized Set)|Adverse Event|2|||
127661686|NCT02855164|459384603|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
127661687|NCT02855164|459384604|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
127661688|NCT02855164|459384605|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
127661689|NCT02855164|459384606|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
127661690|NCT02855164|459384607|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
127661691|NCT02855164|459384608|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
127661692|NCT02855164|459384609|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
127661693|NCT02855164|459384610|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
127661694|NCT02855164|459384603|FG000|Part C (Randomized Set)|Physician Decision|0|||
127661695|NCT02855164|459384604|FG001|Part C (Randomized Set)|Physician Decision|0|||
127661696|NCT02855164|459384605|FG002|Part C (Randomized Set)|Physician Decision|0|||
127661697|NCT02855164|459384606|FG003|Part C (Randomized Set)|Physician Decision|0|||
127661698|NCT02855164|459384607|FG004|Part C (Randomized Set)|Physician Decision|0|||
127661699|NCT02855164|459384608|FG005|Part C (Randomized Set)|Physician Decision|1|||
127661700|NCT02855164|459384609|FG006|Part C (Randomized Set)|Physician Decision|0|||
127661701|NCT02855164|459384610|FG007|Part C (Randomized Set)|Physician Decision|1|||
127661702|NCT02855164|459384603|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
127661703|NCT02855164|459384604|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
127661704|NCT02855164|459384605|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
127661705|NCT02855164|459384606|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
127661706|NCT02855164|459384607|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
127661707|NCT02855164|459384608|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
127661708|NCT02855164|459384609|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
127661709|NCT02855164|459384610|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
127661710|NCT00876460|459384611|FG000|Combination Therapy Phase|Progressive disease|2|||
127661711|NCT00876460|459384612|FG001|Combination Therapy Phase|Progressive disease|3|||
127661712|NCT00876460|459384613|FG002|Combination Therapy Phase|Progressive disease|3|||
127661713|NCT00876460|459384614|FG003|Combination Therapy Phase|Progressive disease|3|||
127661714|NCT00876460|459384615|FG004|Combination Therapy Phase|Progressive disease|3|||
127661715|NCT00876460|459384616|FG005|Combination Therapy Phase|Progressive disease|1|||
127661716|NCT00876460|459384617|FG006|Combination Therapy Phase|Progressive disease|1|||
127661717|NCT00876460|459384618|FG007|Combination Therapy Phase|Progressive disease|1|||
127661718|NCT00876460|459384611|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
127661719|NCT00876460|459384612|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
127661720|NCT00876460|459384613|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
127661721|NCT00876460|459384614|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
127661722|NCT00876460|459384615|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
127661723|NCT00876460|459384616|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
127661724|NCT00876460|459384617|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
127661725|NCT00876460|459384618|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
127661726|NCT00876460|459384611|FG000|Combination Therapy Phase|Adverse Event|0|||
127661727|NCT00876460|459384612|FG001|Combination Therapy Phase|Adverse Event|2|||
127661728|NCT00876460|459384613|FG002|Combination Therapy Phase|Adverse Event|0|||
127661729|NCT00876460|459384614|FG003|Combination Therapy Phase|Adverse Event|2|||
127661730|NCT00876460|459384615|FG004|Combination Therapy Phase|Adverse Event|2|||
127661731|NCT00876460|459384616|FG005|Combination Therapy Phase|Adverse Event|0|||
127661732|NCT00876460|459384617|FG006|Combination Therapy Phase|Adverse Event|3|||
127661733|NCT00876460|459384618|FG007|Combination Therapy Phase|Adverse Event|2|||
127661734|NCT00876460|459384611|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
127661735|NCT00876460|459384612|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
127661736|NCT00876460|459384613|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
127661737|NCT00876460|459384614|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
127661738|NCT00876460|459384615|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
127661739|NCT00876460|459384616|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
127661740|NCT00876460|459384617|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
127661741|NCT00876460|459384618|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
127661742|NCT00876460|459384611|FG000|Combination Therapy Phase|Other reason not defined above|0|||
127661743|NCT00876460|459384612|FG001|Combination Therapy Phase|Other reason not defined above|0|||
127661744|NCT00876460|459384613|FG002|Combination Therapy Phase|Other reason not defined above|0|||
127661745|NCT00876460|459384614|FG003|Combination Therapy Phase|Other reason not defined above|0|||
127661746|NCT00876460|459384615|FG004|Combination Therapy Phase|Other reason not defined above|0|||
127661747|NCT00876460|459384616|FG005|Combination Therapy Phase|Other reason not defined above|0|||
127661748|NCT00876460|459384617|FG006|Combination Therapy Phase|Other reason not defined above|1|||
127661749|NCT00876460|459384618|FG007|Combination Therapy Phase|Other reason not defined above|2|||
127661750|NCT00876460|459384611|FG000|Combination Therapy Phase|Not treated|0|||
127661751|NCT00876460|459384612|FG001|Combination Therapy Phase|Not treated|0|||
127661752|NCT00876460|459384613|FG002|Combination Therapy Phase|Not treated|0|||
127661753|NCT00876460|459384614|FG003|Combination Therapy Phase|Not treated|0|||
127661754|NCT00876460|459384615|FG004|Combination Therapy Phase|Not treated|0|||
127661755|NCT00876460|459384616|FG005|Combination Therapy Phase|Not treated|0|||
127661756|NCT00876460|459384617|FG006|Combination Therapy Phase|Not treated|1|||
127661757|NCT00876460|459384618|FG007|Combination Therapy Phase|Not treated|0|||
127661758|NCT00876460|459384611|FG000|Mono Therapy Phase|Progressive disease|0|||
127661759|NCT00876460|459384612|FG001|Mono Therapy Phase|Progressive disease|0|||
127661760|NCT00876460|459384613|FG002|Mono Therapy Phase|Progressive disease|0|||
127661761|NCT00876460|459384614|FG003|Mono Therapy Phase|Progressive disease|0|||
127661762|NCT00876460|459384615|FG004|Mono Therapy Phase|Progressive disease|2|||
127661763|NCT00876460|459384616|FG005|Mono Therapy Phase|Progressive disease|0|||
127661764|NCT00876460|459384617|FG006|Mono Therapy Phase|Progressive disease|1|||
127661765|NCT00876460|459384618|FG007|Mono Therapy Phase|Progressive disease|3|||
127661766|NCT00876460|459384611|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
127661767|NCT00876460|459384612|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
127661768|NCT00876460|459384613|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
127661769|NCT00876460|459384614|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
127661770|NCT00876460|459384615|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
127661771|NCT00876460|459384616|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
127661772|NCT00876460|459384617|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
127661773|NCT00876460|459384618|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
127661774|NCT00876460|459384611|FG000|Mono Therapy Phase|Adverse Event|0|||
127661775|NCT00876460|459384612|FG001|Mono Therapy Phase|Adverse Event|0|||
127661776|NCT00876460|459384613|FG002|Mono Therapy Phase|Adverse Event|0|||
127661777|NCT00876460|459384614|FG003|Mono Therapy Phase|Adverse Event|1|||
127661778|NCT00876460|459384615|FG004|Mono Therapy Phase|Adverse Event|0|||
127661779|NCT00876460|459384616|FG005|Mono Therapy Phase|Adverse Event|0|||
127661780|NCT00876460|459384617|FG006|Mono Therapy Phase|Adverse Event|0|||
127661781|NCT00876460|459384618|FG007|Mono Therapy Phase|Adverse Event|0|||
127661782|NCT00127413|459384620|FG000|Overall Study|Lost to Follow-up|6|||
127661783|NCT00127413|459384621|FG001|Overall Study|Lost to Follow-up|4|||
127661784|NCT00127413|459384622|FG002|Overall Study|Lost to Follow-up|8|||
127661785|NCT00127413|459384623|FG003|Overall Study|Lost to Follow-up|2|||
127661786|NCT00547911|459384626|FG000|Overall Study|Adverse Event|0|||
127661787|NCT00547911|459384627|FG001|Overall Study|Adverse Event|0|||
127661788|NCT00547911|459384628|FG002|Overall Study|Adverse Event|0|||
127661789|NCT00547911|459384629|FG003|Overall Study|Adverse Event|1|||
127661790|NCT00547911|459384630|FG004|Overall Study|Adverse Event|0|||
127661791|NCT00547911|459384631|FG005|Overall Study|Adverse Event|0|||
127661792|NCT01644474|459384633|FG000|Overall Study|Poor compliance to protocol|1|||
127661793|NCT01644474|459384634|FG001|Overall Study|Poor compliance to protocol|0|||
127661794|NCT01644474|459384633|FG000|Overall Study|Consent withdrawn by participant|0|||
127661795|NCT01644474|459384634|FG001|Overall Study|Consent withdrawn by participant|1|||
127661796|NCT01644474|459384633|FG000|Overall Study|Participant moved|0|||
127661797|NCT01644474|459384634|FG001|Overall Study|Participant moved|1|||
127661798|NCT01644474|459384633|FG000|Overall Study|Adverse Event|4|||
127661799|NCT01644474|459384634|FG001|Overall Study|Adverse Event|5|||
127661800|NCT01644474|459384633|FG000|Overall Study|Site scheduling error|1|||
127661801|NCT01644474|459384634|FG001|Overall Study|Site scheduling error|1|||
127661802|NCT01644474|459384633|FG000|Overall Study|Protocol Violation|1|||
127661803|NCT01644474|459384634|FG001|Overall Study|Protocol Violation|0|||
127661804|NCT02044458|459384638|FG000|Overall Study|Protocol Violation|3|||
127990726|NCT01690299|460592342|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
127990727|NCT01690299|460592343|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
127661805|NCT02044458|459384639|FG001|Overall Study|Protocol Violation|8|||
127661806|NCT02601937|459384640|FG000|Period 1: Dose Escalation Phase|Adverse Event|0|||
127661807|NCT02601937|459384641|FG001|Period 1: Dose Escalation Phase|Adverse Event|0|||
127661808|NCT02601937|459384642|FG002|Period 1: Dose Escalation Phase|Adverse Event|0|||
127661809|NCT02601937|459384643|FG003|Period 1: Dose Escalation Phase|Adverse Event|0|||
127661810|NCT02601937|459384644|FG004|Period 1: Dose Escalation Phase|Adverse Event|0|||
127661811|NCT02601937|459384645|FG005|Period 1: Dose Escalation Phase|Adverse Event|1|||
127661812|NCT02601937|459384646|FG006|Period 1: Dose Escalation Phase|Adverse Event|0|||
127661813|NCT02601937|459384647|FG007|Period 1: Dose Escalation Phase|Adverse Event|0|||
127990728|NCT01690299|460592344|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
127990729|NCT01690299|460592339|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
127990730|NCT01690299|460592340|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
127990731|NCT01690299|460592341|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
127990732|NCT01690299|460592342|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
127990733|NCT01690299|460592343|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
127990734|NCT01690299|460592344|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
127990735|NCT01690299|460592339|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
127990736|NCT01690299|460592340|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
127990737|NCT01690299|460592341|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
127990738|NCT01690299|460592342|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
127990739|NCT01690299|460592343|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
127990740|NCT01690299|460592344|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
127990741|NCT01690299|460592339|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
127990742|NCT01690299|460592340|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
127990743|NCT01690299|460592341|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
127990744|NCT01690299|460592342|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
127990745|NCT01690299|460592343|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
127990746|NCT01690299|460592344|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
127990747|NCT01753115|460592345|FG000|Overall Study|Lost to Follow-up|3|||
127990748|NCT01753115|460592346|FG001|Overall Study|Lost to Follow-up|6|||
127990749|NCT01753115|460592347|FG002|Overall Study|Lost to Follow-up|8|||
127990750|NCT01753115|460592345|FG000|Overall Study|Withdrawal by Subject|6|||
127990751|NCT01753115|460592346|FG001|Overall Study|Withdrawal by Subject|5|||
127990752|NCT01753115|460592347|FG002|Overall Study|Withdrawal by Subject|6|||
127990753|NCT01753115|460592345|FG000|Overall Study|Subject non-compliant|3|||
127990754|NCT01753115|460592346|FG001|Overall Study|Subject non-compliant|3|||
127990755|NCT01753115|460592347|FG002|Overall Study|Subject non-compliant|0|||
127990756|NCT01753115|460592345|FG000|Overall Study|Used excluded drug|0|||
127990757|NCT01753115|460592346|FG001|Overall Study|Used excluded drug|1|||
127990758|NCT01753115|460592347|FG002|Overall Study|Used excluded drug|0|||
127990759|NCT00496587|460592351|FG000|Overall Study|Adverse Event|2|||
127990760|NCT00496587|460592351|FG000|Overall Study|Progressive Disease|24|||
127990761|NCT00496587|460592351|FG000|Overall Study|Withdrawal by Subject|2|||
127990762|NCT00496587|460592351|FG000|Overall Study|Death|1|||
127990763|NCT00496587|460592351|FG000|Overall Study|Complications unrelated|2|||
127990764|NCT00524680|460592358|FG000|Overall Study|progression|0|||
127661814|NCT02601937|459384648|FG008|Period 1: Dose Escalation Phase|Adverse Event|0|||
127661815|NCT02601937|459384649|FG009|Period 1: Dose Escalation Phase|Adverse Event|0|||
127661816|NCT02601937|459384650|FG010|Period 1: Dose Escalation Phase|Adverse Event|0|||
127661817|NCT02601937|459384640|FG000|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
127661818|NCT02601937|459384641|FG001|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
127661819|NCT02601937|459384642|FG002|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
127990765|NCT00524680|460592359|FG001|Overall Study|progression|0|||
127990766|NCT00524680|460592360|FG002|Overall Study|progression|0|||
127990767|NCT00524680|460592361|FG003|Overall Study|progression|1|||
127990768|NCT00524680|460592358|FG000|Overall Study|Adverse Event|2|||
127990769|NCT00524680|460592359|FG001|Overall Study|Adverse Event|0|||
127990770|NCT00524680|460592360|FG002|Overall Study|Adverse Event|0|||
127990771|NCT00524680|460592361|FG003|Overall Study|Adverse Event|1|||
127661820|NCT02601937|459384643|FG003|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
127661821|NCT02601937|459384644|FG004|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
127661822|NCT02601937|459384645|FG005|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
127661823|NCT02601937|459384646|FG006|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
127661824|NCT02601937|459384647|FG007|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
127990772|NCT00524680|460592358|FG000|Overall Study|Other|0|||
127990773|NCT00524680|460592359|FG001|Overall Study|Other|1|||
127990774|NCT00524680|460592360|FG002|Overall Study|Other|2|||
127990775|NCT00524680|460592361|FG003|Overall Study|Other|3|||
127990776|NCT00524680|460592358|FG000|Overall Study|Withdrawal by Subject|1|||
127990777|NCT00524680|460592359|FG001|Overall Study|Withdrawal by Subject|0|||
127990778|NCT00524680|460592360|FG002|Overall Study|Withdrawal by Subject|1|||
127990779|NCT00524680|460592361|FG003|Overall Study|Withdrawal by Subject|1|||
127661825|NCT02601937|459384648|FG008|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
127661826|NCT02601937|459384649|FG009|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
127661827|NCT02601937|459384650|FG010|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
127661828|NCT02601937|459384640|FG000|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
127990780|NCT03124537|460592362|FG000|Overall Study|Lost to Follow-up|3|||
127990781|NCT03124537|460592363|FG001|Overall Study|Lost to Follow-up|5|||
127990782|NCT03124537|460592362|FG000|Overall Study|App Crash, Incomplete Data|7|||
127990783|NCT03124537|460592363|FG001|Overall Study|App Crash, Incomplete Data|8|||
127661829|NCT02601937|459384641|FG001|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
127661830|NCT02601937|459384642|FG002|Period 1: Dose Escalation Phase|Unacceptable toxicity|1|||
127661831|NCT02601937|459384643|FG003|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
127661832|NCT02601937|459384644|FG004|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
127661833|NCT02601937|459384645|FG005|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
127990784|NCT01607346|460592366|FG000|Overall Study|Adverse Event|3|||
127990785|NCT00856843|460592368|FG000|Overall Study|Withdrawal by Subject|1|||
127990786|NCT00856843|460592369|FG001|Overall Study|Withdrawal by Subject|5|||
127661834|NCT02601937|459384646|FG006|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
127661835|NCT02601937|459384647|FG007|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
127661836|NCT02601937|459384648|FG008|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
127661837|NCT02601937|459384649|FG009|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
127661838|NCT02601937|459384650|FG010|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
127661839|NCT02601937|459384640|FG000|Period 1: Dose Escalation Phase|Progressive disease|7|||
127661840|NCT02601937|459384641|FG001|Period 1: Dose Escalation Phase|Progressive disease|6|||
127661841|NCT02601937|459384642|FG002|Period 1: Dose Escalation Phase|Progressive disease|5|||
127661842|NCT02601937|459384643|FG003|Period 1: Dose Escalation Phase|Progressive disease|6|||
127661843|NCT02601937|459384644|FG004|Period 1: Dose Escalation Phase|Progressive disease|6|||
127661844|NCT02601937|459384645|FG005|Period 1: Dose Escalation Phase|Progressive disease|4|||
127661845|NCT02601937|459384646|FG006|Period 1: Dose Escalation Phase|Progressive disease|6|||
127661846|NCT02601937|459384647|FG007|Period 1: Dose Escalation Phase|Progressive disease|0|||
127661847|NCT02601937|459384648|FG008|Period 1: Dose Escalation Phase|Progressive disease|0|||
127661848|NCT02601937|459384649|FG009|Period 1: Dose Escalation Phase|Progressive disease|0|||
127661849|NCT02601937|459384650|FG010|Period 1: Dose Escalation Phase|Progressive disease|0|||
127661850|NCT02601937|459384640|FG000|Period 2: Dose Expansion Cohort|Adverse Event|0|||
127661851|NCT02601937|459384641|FG001|Period 2: Dose Expansion Cohort|Adverse Event|0|||
127661852|NCT02601937|459384642|FG002|Period 2: Dose Expansion Cohort|Adverse Event|0|||
127661853|NCT02601937|459384643|FG003|Period 2: Dose Expansion Cohort|Adverse Event|0|||
127661854|NCT02601937|459384644|FG004|Period 2: Dose Expansion Cohort|Adverse Event|0|||
127661855|NCT02601937|459384645|FG005|Period 2: Dose Expansion Cohort|Adverse Event|0|||
127661856|NCT02601937|459384646|FG006|Period 2: Dose Expansion Cohort|Adverse Event|0|||
127661857|NCT02601937|459384647|FG007|Period 2: Dose Expansion Cohort|Adverse Event|0|||
127661858|NCT02601937|459384648|FG008|Period 2: Dose Expansion Cohort|Adverse Event|0|||
127661859|NCT02601937|459384649|FG009|Period 2: Dose Expansion Cohort|Adverse Event|1|||
127661860|NCT02601937|459384650|FG010|Period 2: Dose Expansion Cohort|Adverse Event|0|||
127990787|NCT00856843|460592368|FG000|Overall Study|Lack of Efficacy|1|||
127990788|NCT00856843|460592369|FG001|Overall Study|Lack of Efficacy|0|||
127990789|NCT01451554|460592373|FG000|Overall Study|Withdrawal by Subject|14|||
127990790|NCT01451554|460592374|FG001|Overall Study|Withdrawal by Subject|9|||
127661861|NCT02601937|459384640|FG000|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
127661862|NCT02601937|459384641|FG001|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
127661863|NCT02601937|459384642|FG002|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
127661864|NCT02601937|459384643|FG003|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
127661865|NCT02601937|459384644|FG004|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
127661866|NCT02601937|459384645|FG005|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
127661867|NCT02601937|459384646|FG006|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
127661868|NCT02601937|459384647|FG007|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|2|||
127661869|NCT02601937|459384648|FG008|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
127661870|NCT02601937|459384649|FG009|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
127661871|NCT02601937|459384650|FG010|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
127661872|NCT02601937|459384640|FG000|Period 2: Dose Expansion Cohort|Physician Decision|0|||
127661873|NCT02601937|459384641|FG001|Period 2: Dose Expansion Cohort|Physician Decision|0|||
127661874|NCT02601937|459384642|FG002|Period 2: Dose Expansion Cohort|Physician Decision|0|||
127661875|NCT02601937|459384643|FG003|Period 2: Dose Expansion Cohort|Physician Decision|0|||
127661876|NCT02601937|459384644|FG004|Period 2: Dose Expansion Cohort|Physician Decision|0|||
127661877|NCT02601937|459384645|FG005|Period 2: Dose Expansion Cohort|Physician Decision|0|||
127661878|NCT02601937|459384646|FG006|Period 2: Dose Expansion Cohort|Physician Decision|0|||
127661879|NCT02601937|459384647|FG007|Period 2: Dose Expansion Cohort|Physician Decision|0|||
127661880|NCT02601937|459384648|FG008|Period 2: Dose Expansion Cohort|Physician Decision|0|||
127661881|NCT02601937|459384649|FG009|Period 2: Dose Expansion Cohort|Physician Decision|1|||
127661882|NCT02601937|459384650|FG010|Period 2: Dose Expansion Cohort|Physician Decision|1|||
127661883|NCT02601937|459384640|FG000|Period 2: Dose Expansion Cohort|Progressive disease|0|||
127661884|NCT02601937|459384641|FG001|Period 2: Dose Expansion Cohort|Progressive disease|0|||
127661885|NCT02601937|459384642|FG002|Period 2: Dose Expansion Cohort|Progressive disease|0|||
127661886|NCT02601937|459384643|FG003|Period 2: Dose Expansion Cohort|Progressive disease|0|||
127661887|NCT02601937|459384644|FG004|Period 2: Dose Expansion Cohort|Progressive disease|0|||
127661888|NCT02601937|459384645|FG005|Period 2: Dose Expansion Cohort|Progressive disease|0|||
127661889|NCT02601937|459384646|FG006|Period 2: Dose Expansion Cohort|Progressive disease|0|||
127661890|NCT02601937|459384647|FG007|Period 2: Dose Expansion Cohort|Progressive disease|16|||
127661891|NCT02601937|459384648|FG008|Period 2: Dose Expansion Cohort|Progressive disease|17|||
127661892|NCT02601937|459384649|FG009|Period 2: Dose Expansion Cohort|Progressive disease|14|||
127661893|NCT02601937|459384650|FG010|Period 2: Dose Expansion Cohort|Progressive disease|4|||
127661894|NCT02601937|459384640|FG000|Period 2: Dose Expansion Cohort|Other|0|||
127661895|NCT02601937|459384641|FG001|Period 2: Dose Expansion Cohort|Other|0|||
127661896|NCT02601937|459384642|FG002|Period 2: Dose Expansion Cohort|Other|0|||
127661897|NCT02601937|459384643|FG003|Period 2: Dose Expansion Cohort|Other|0|||
127661898|NCT02601937|459384644|FG004|Period 2: Dose Expansion Cohort|Other|0|||
127661899|NCT02601937|459384645|FG005|Period 2: Dose Expansion Cohort|Other|0|||
127661900|NCT02601937|459384646|FG006|Period 2: Dose Expansion Cohort|Other|0|||
127661901|NCT02601937|459384647|FG007|Period 2: Dose Expansion Cohort|Other|0|||
127661902|NCT02601937|459384648|FG008|Period 2: Dose Expansion Cohort|Other|2|||
127661903|NCT02601937|459384649|FG009|Period 2: Dose Expansion Cohort|Other|2|||
127661904|NCT02601937|459384650|FG010|Period 2: Dose Expansion Cohort|Other|0|||
127661905|NCT02601937|459384640|FG000|Period 2: Dose Expansion Cohort|Death|0|||
127661906|NCT02601937|459384641|FG001|Period 2: Dose Expansion Cohort|Death|0|||
127661907|NCT02601937|459384642|FG002|Period 2: Dose Expansion Cohort|Death|0|||
127661908|NCT02601937|459384643|FG003|Period 2: Dose Expansion Cohort|Death|0|||
127661909|NCT02601937|459384644|FG004|Period 2: Dose Expansion Cohort|Death|0|||
127661910|NCT02601937|459384645|FG005|Period 2: Dose Expansion Cohort|Death|0|||
127661911|NCT02601937|459384646|FG006|Period 2: Dose Expansion Cohort|Death|0|||
127661912|NCT02601937|459384647|FG007|Period 2: Dose Expansion Cohort|Death|0|||
127661913|NCT02601937|459384648|FG008|Period 2: Dose Expansion Cohort|Death|1|||
127661914|NCT02601937|459384649|FG009|Period 2: Dose Expansion Cohort|Death|0|||
127661915|NCT02601937|459384650|FG010|Period 2: Dose Expansion Cohort|Death|0|||
127661916|NCT01040780|459386631|FG000|Overall Study|Protocol Violation|1|||
127661917|NCT01040780|459386632|FG001|Overall Study|Protocol Violation|3|||
127661918|NCT00802737|459386633|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
127661919|NCT00802737|459386634|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
127661920|NCT00802737|459386635|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
127661921|NCT00802737|459386633|FG000|Overall Study|Death|6|||
127661922|NCT00802737|459386634|FG001|Overall Study|Death|5|||
127661923|NCT00802737|459386635|FG002|Overall Study|Death|1|||
127661924|NCT00802737|459386633|FG000|Overall Study|Adverse Event|1|||
127661925|NCT00802737|459386634|FG001|Overall Study|Adverse Event|0|||
127661926|NCT00802737|459386635|FG002|Overall Study|Adverse Event|0|||
127661927|NCT00802737|459386633|FG000|Overall Study|Received Prohibited Therapy|1|||
127661928|NCT00802737|459386634|FG001|Overall Study|Received Prohibited Therapy|0|||
127661929|NCT00802737|459386635|FG002|Overall Study|Received Prohibited Therapy|0|||
127661930|NCT00802737|459386633|FG000|Overall Study|Ongoing CLL-Treatment|0|||
127661931|NCT00802737|459386634|FG001|Overall Study|Ongoing CLL-Treatment|1|||
127661932|NCT00802737|459386635|FG002|Overall Study|Ongoing CLL-Treatment|0|||
127661933|NCT00802737|459386633|FG000|Overall Study|Participant too Unwell|0|||
127661934|NCT00802737|459386634|FG001|Overall Study|Participant too Unwell|2|||
127661935|NCT00802737|459386635|FG002|Overall Study|Participant too Unwell|0|||
127661936|NCT03864926|459386643|FG000|Overall Study|Death|0|||
127661937|NCT03864926|459386644|FG001|Overall Study|Death|2|||
127661938|NCT00445601|459386645|FG000|Overall Study|Withdrawal by Subject|11|||
127661939|NCT00445601|459386646|FG001|Overall Study|Withdrawal by Subject|11|||
127661940|NCT00445601|459386645|FG000|Overall Study|TURBT Complication|12|||
127661941|NCT00445601|459386646|FG001|Overall Study|TURBT Complication|8|||
127661942|NCT00445601|459386645|FG000|Overall Study|Incorrect Disease Status|6|||
127661943|NCT00445601|459386646|FG001|Overall Study|Incorrect Disease Status|6|||
127661944|NCT00445601|459386645|FG000|Overall Study|Drug Delivery Issue|2|||
127661945|NCT00445601|459386646|FG001|Overall Study|Drug Delivery Issue|2|||
127661946|NCT00445601|459386645|FG000|Overall Study|Adverse Event|2|||
127661947|NCT00445601|459386646|FG001|Overall Study|Adverse Event|0|||
127661948|NCT00445601|459386645|FG000|Overall Study|Death prior to TURBT|0|||
127661949|NCT00445601|459386646|FG001|Overall Study|Death prior to TURBT|1|||
127661950|NCT02930122|459386654|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
127543161|NCT00385671|458956477|FG002|Overall Study|Withdrawal by Subject|4|||
127543162|NCT01775501|458956478|FG000|Overall Study|Discontinued prior to treatment|1|||
127543163|NCT03007966|458956483|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
127543164|NCT03007966|458956484|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
127543165|NCT00248625|458956485|FG000|Overall Study|Withdrawal by Subject|0|||
127543166|NCT00248625|458956486|FG001|Overall Study|Withdrawal by Subject|2|||
127543167|NCT03182374|458956487|FG000|Overall Study|Lost to Follow-up|3|||
127543168|NCT03182374|458956488|FG001|Overall Study|Lost to Follow-up|2|||
127543169|NCT03182374|458956487|FG000|Overall Study|Lack of Efficacy|8|||
127543170|NCT03182374|458956488|FG001|Overall Study|Lack of Efficacy|14|||
127543171|NCT03182374|458956487|FG000|Overall Study|Withdrawal by Subject|1|||
127543172|NCT03182374|458956488|FG001|Overall Study|Withdrawal by Subject|1|||
127543173|NCT03182374|458956487|FG000|Overall Study|exit for non-compliance|1|||
127543174|NCT03182374|458956488|FG001|Overall Study|exit for non-compliance|1|||
127543175|NCT03182374|458956487|FG000|Overall Study|one subject was randomized but not treated|1|||
127543176|NCT03182374|458956488|FG001|Overall Study|one subject was randomized but not treated|0|||
127543177|NCT03182374|458956487|FG000|Overall Study|Other reasons|0|||
127543178|NCT03182374|458956488|FG001|Overall Study|Other reasons|3|||
127543179|NCT03085095|458956489|FG000|Overall Study|Adverse Event|23|||
127543180|NCT03085095|458956490|FG001|Overall Study|Adverse Event|8|||
127543181|NCT03085095|458956489|FG000|Overall Study|Protocol Violation|0|||
127543182|NCT03085095|458956490|FG001|Overall Study|Protocol Violation|1|||
127543183|NCT03085095|458956489|FG000|Overall Study|Lost to Follow-up|2|||
127543184|NCT03085095|458956490|FG001|Overall Study|Lost to Follow-up|1|||
127543185|NCT03085095|458956489|FG000|Overall Study|Withdrawal by Subject|17|||
127543186|NCT03085095|458956490|FG001|Overall Study|Withdrawal by Subject|6|||
127543187|NCT03085095|458956489|FG000|Overall Study|Physician Decision|9|||
127543188|NCT03085095|458956490|FG001|Overall Study|Physician Decision|3|||
127543189|NCT03085095|458956489|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
127543190|NCT03085095|458956490|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
127543191|NCT03085095|458956489|FG000|Overall Study|Did not Receive Study Drug|2|||
127543192|NCT03085095|458956490|FG001|Overall Study|Did not Receive Study Drug|2|||
127543193|NCT03085095|458956489|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
127543194|NCT03085095|458956490|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
127543195|NCT00408317|458956491|FG000|First Intervention Period|Adverse Event|0|||
127543196|NCT00408317|458956492|FG001|First Intervention Period|Adverse Event|1|||
127543197|NCT00408317|458956491|FG000|Second Intervention Period|Adverse Event|2|||
127543198|NCT00408317|458956492|FG001|Second Intervention Period|Adverse Event|0|||
127543199|NCT00408317|458956491|FG000|Second Intervention Period|Protocol Violation|0|||
127543200|NCT00408317|458956492|FG001|Second Intervention Period|Protocol Violation|1|||
127543201|NCT00408317|458956491|FG000|Second Intervention Period|Withdrawal of consent|0|||
127543202|NCT00408317|458956492|FG001|Second Intervention Period|Withdrawal of consent|1|||
127543203|NCT03822117|458956493|FG000|Overall Study|Death|18|||
127661951|NCT02930122|459386655|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
127661952|NCT01681368|459386656|FG000|Overall Study|Refused further treatment|1|||
127661953|NCT01681368|459386656|FG000|Overall Study|Refused further follow up|1|||
127543204|NCT03822117|458956494|FG001|Overall Study|Death|17|||
127543205|NCT03822117|458956495|FG002|Overall Study|Death|12|||
127543206|NCT03822117|458956496|FG003|Overall Study|Death|4|||
127543207|NCT03822117|458956493|FG000|Overall Study|Lost to Follow-up|1|||
127543208|NCT03822117|458956494|FG001|Overall Study|Lost to Follow-up|2|||
127543209|NCT03822117|458956495|FG002|Overall Study|Lost to Follow-up|3|||
127543210|NCT03822117|458956496|FG003|Overall Study|Lost to Follow-up|0|||
127661954|NCT01807221|459386657|FG000|Overall Study|Progressive disease|1|||
127661955|NCT01807221|459386658|FG001|Overall Study|Progressive disease|0|||
127661956|NCT01807221|459386659|FG002|Overall Study|Progressive disease|1|||
127661957|NCT01807221|459386660|FG003|Overall Study|Progressive disease|0|||
127661958|NCT01807221|459386661|FG004|Overall Study|Progressive disease|0|||
127661959|NCT01807221|459386662|FG005|Overall Study|Progressive disease|0|||
127661960|NCT01807221|459386657|FG000|Overall Study|Death|7|||
127661961|NCT01807221|459386658|FG001|Overall Study|Death|9|||
127661962|NCT01807221|459386659|FG002|Overall Study|Death|4|||
127661963|NCT01807221|459386660|FG003|Overall Study|Death|2|||
127661964|NCT01807221|459386661|FG004|Overall Study|Death|1|||
127661965|NCT01807221|459386662|FG005|Overall Study|Death|6|||
127661966|NCT01807221|459386657|FG000|Overall Study|Physician Decision|2|||
127661967|NCT01807221|459386658|FG001|Overall Study|Physician Decision|1|||
127661968|NCT01807221|459386659|FG002|Overall Study|Physician Decision|0|||
127661969|NCT01807221|459386660|FG003|Overall Study|Physician Decision|0|||
127661970|NCT01807221|459386661|FG004|Overall Study|Physician Decision|0|||
127661971|NCT01807221|459386662|FG005|Overall Study|Physician Decision|0|||
127661972|NCT01807221|459386657|FG000|Overall Study|Adverse Event|33|||
127543211|NCT03822117|458956493|FG000|Overall Study|Study Terminated by Sponsor|25|||
127543212|NCT03822117|458956494|FG001|Overall Study|Study Terminated by Sponsor|11|||
127543213|NCT03822117|458956495|FG002|Overall Study|Study Terminated by Sponsor|6|||
127543214|NCT03822117|458956496|FG003|Overall Study|Study Terminated by Sponsor|0|||
127543215|NCT03822117|458956493|FG000|Overall Study|Withdrawal by Subject|4|||
127543216|NCT03822117|458956494|FG001|Overall Study|Withdrawal by Subject|0|||
127543217|NCT03822117|458956495|FG002|Overall Study|Withdrawal by Subject|3|||
127543218|NCT03822117|458956496|FG003|Overall Study|Withdrawal by Subject|0|||
127543219|NCT03822117|458956493|FG000|Overall Study|Disease Progression|1|||
127543220|NCT03822117|458956494|FG001|Overall Study|Disease Progression|2|||
127543221|NCT03822117|458956495|FG002|Overall Study|Disease Progression|1|||
127543222|NCT03822117|458956496|FG003|Overall Study|Disease Progression|0|||
127543223|NCT03822117|458956493|FG000|Overall Study|Never Returned to Hospital|0|||
127543224|NCT03822117|458956494|FG001|Overall Study|Never Returned to Hospital|0|||
127543225|NCT03822117|458956495|FG002|Overall Study|Never Returned to Hospital|1|||
127543226|NCT03822117|458956496|FG003|Overall Study|Never Returned to Hospital|0|||
127543227|NCT01074502|458956497|FG000|Overall Study|Withdrawal by Subject|1|||
127543228|NCT03198715|458956498|FG000|Overall Study|Death|0|||
127543229|NCT03198715|458956499|FG001|Overall Study|Death|0|||
127543230|NCT03198715|458956500|FG002|Overall Study|Death|1|||
127543231|NCT03198715|458956501|FG003|Overall Study|Death|0|||
127543232|NCT03198715|458956502|FG004|Overall Study|Death|2|||
127543233|NCT03198715|458956498|FG000|Overall Study|Other|0|||
127543234|NCT03198715|458956499|FG001|Overall Study|Other|1|||
127543235|NCT03198715|458956500|FG002|Overall Study|Other|1|||
127543236|NCT03198715|458956501|FG003|Overall Study|Other|0|||
127543237|NCT03198715|458956502|FG004|Overall Study|Other|0|||
127543238|NCT00726063|458956506|FG000|Overall Study|Adverse Event|9|||
127543239|NCT00726063|458956507|FG001|Overall Study|Adverse Event|7|||
127543240|NCT02007096|458956508|FG000|Overall Study|medication not available|2|||
127543241|NCT02007096|458956509|FG001|Overall Study|medication not available|0|||
127543242|NCT02007096|458956508|FG000|Overall Study|did not inject saline|0|||
127543243|NCT02007096|458956509|FG001|Overall Study|did not inject saline|3|||
127543244|NCT02007096|458956508|FG000|Overall Study|did not follow postoperative protocol|8|||
127543245|NCT02007096|458956509|FG001|Overall Study|did not follow postoperative protocol|11|||
127543246|NCT02007096|458956508|FG000|Overall Study|converted to open surgery|1|||
127543247|NCT02007096|458956509|FG001|Overall Study|converted to open surgery|1|||
127543248|NCT02007096|458956508|FG000|Overall Study|no mesh placed|0|||
127543249|NCT02007096|458956509|FG001|Overall Study|no mesh placed|1|||
127543250|NCT05176314|458956512|FG000|Overall Study|Lost to Follow-up|2|||
127543251|NCT05176314|458956512|FG000|Overall Study|Physician Decision|1|||
127543252|NCT05176314|458956512|FG000|Overall Study|Adverse Event|1|||
127543253|NCT00286468|458956513|FG000|Overall Study|Hyperglycemic Rescue|28|||
127543254|NCT00286468|458956514|FG001|Overall Study|Hyperglycemic Rescue|30|||
127543255|NCT00286468|458956515|FG002|Overall Study|Hyperglycemic Rescue|31|||
127543256|NCT00286468|458956513|FG000|Overall Study|Adverse Event|2|||
127543257|NCT00286468|458956514|FG001|Overall Study|Adverse Event|6|||
127543258|NCT00286468|458956515|FG002|Overall Study|Adverse Event|4|||
127543259|NCT00286468|458956513|FG000|Overall Study|Protocol Violation|0|||
127543260|NCT00286468|458956514|FG001|Overall Study|Protocol Violation|3|||
127543261|NCT00286468|458956515|FG002|Overall Study|Protocol Violation|1|||
127543262|NCT00286468|458956513|FG000|Overall Study|Lost to Follow-up|1|||
127543263|NCT00286468|458956514|FG001|Overall Study|Lost to Follow-up|1|||
127543264|NCT00286468|458956515|FG002|Overall Study|Lost to Follow-up|2|||
127543265|NCT00286468|458956513|FG000|Overall Study|Withdrawal by Subject|3|||
127543266|NCT00286468|458956514|FG001|Overall Study|Withdrawal by Subject|8|||
127543267|NCT00286468|458956515|FG002|Overall Study|Withdrawal by Subject|11|||
127661973|NCT01807221|459386658|FG001|Overall Study|Adverse Event|22|||
127661974|NCT01807221|459386659|FG002|Overall Study|Adverse Event|26|||
127661975|NCT01807221|459386660|FG003|Overall Study|Adverse Event|25|||
127661976|NCT01807221|459386661|FG004|Overall Study|Adverse Event|18|||
127661977|NCT01807221|459386662|FG005|Overall Study|Adverse Event|21|||
127661978|NCT01807221|459386657|FG000|Overall Study|Protocol Violation|0|||
127661979|NCT01807221|459386658|FG001|Overall Study|Protocol Violation|2|||
127661980|NCT01807221|459386659|FG002|Overall Study|Protocol Violation|1|||
127661981|NCT01807221|459386660|FG003|Overall Study|Protocol Violation|2|||
127661982|NCT01807221|459386661|FG004|Overall Study|Protocol Violation|0|||
127661983|NCT01807221|459386662|FG005|Overall Study|Protocol Violation|1|||
127661984|NCT01807221|459386657|FG000|Overall Study|Non-compliance|1|||
127661985|NCT01807221|459386658|FG001|Overall Study|Non-compliance|2|||
127661986|NCT01807221|459386659|FG002|Overall Study|Non-compliance|0|||
127661987|NCT01807221|459386660|FG003|Overall Study|Non-compliance|1|||
127661988|NCT01807221|459386661|FG004|Overall Study|Non-compliance|0|||
127661989|NCT01807221|459386662|FG005|Overall Study|Non-compliance|0|||
127661990|NCT01807221|459386657|FG000|Overall Study|Logistical difficulties|0|||
127661991|NCT01807221|459386658|FG001|Overall Study|Logistical difficulties|1|||
127661992|NCT01807221|459386659|FG002|Overall Study|Logistical difficulties|0|||
127661993|NCT01807221|459386660|FG003|Overall Study|Logistical difficulties|0|||
127661994|NCT01807221|459386661|FG004|Overall Study|Logistical difficulties|1|||
127661995|NCT01807221|459386662|FG005|Overall Study|Logistical difficulties|0|||
127661996|NCT01807221|459386657|FG000|Overall Study|Withdrawal by Subject|33|||
127661997|NCT01807221|459386658|FG001|Overall Study|Withdrawal by Subject|15|||
127661998|NCT01807221|459386659|FG002|Overall Study|Withdrawal by Subject|8|||
127661999|NCT01807221|459386660|FG003|Overall Study|Withdrawal by Subject|14|||
127662000|NCT01807221|459386661|FG004|Overall Study|Withdrawal by Subject|16|||
127662001|NCT01807221|459386662|FG005|Overall Study|Withdrawal by Subject|13|||
127662002|NCT01807221|459386657|FG000|Overall Study|Sponsor decision|2|||
127662003|NCT01807221|459386658|FG001|Overall Study|Sponsor decision|0|||
127662004|NCT01807221|459386659|FG002|Overall Study|Sponsor decision|1|||
127662005|NCT01807221|459386660|FG003|Overall Study|Sponsor decision|1|||
127662006|NCT01807221|459386661|FG004|Overall Study|Sponsor decision|0|||
127662007|NCT01807221|459386662|FG005|Overall Study|Sponsor decision|0|||
127662008|NCT01807221|459386657|FG000|Overall Study|Lost to Follow-up|1|||
127662009|NCT01807221|459386658|FG001|Overall Study|Lost to Follow-up|0|||
127662010|NCT01807221|459386659|FG002|Overall Study|Lost to Follow-up|2|||
127662011|NCT01807221|459386660|FG003|Overall Study|Lost to Follow-up|1|||
127662012|NCT01807221|459386661|FG004|Overall Study|Lost to Follow-up|0|||
127662013|NCT01807221|459386662|FG005|Overall Study|Lost to Follow-up|0|||
127662014|NCT02609659|459386663|FG000|Overall Study|Adverse Event|1|||
127662015|NCT02609659|459386663|FG000|Overall Study|Lost to Follow-up|6|||
127662016|NCT02609659|459386663|FG000|Overall Study|Other|1|||
127662017|NCT01004250|459386664|FG000|Induction Therapy Period|Adverse Event|10|||
127662018|NCT01004250|459386664|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
127662019|NCT01004250|459386664|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
127662020|NCT01004250|459386664|FG000|Induction Therapy Period|Physician Decision|2|||
127662021|NCT01004250|459386664|FG000|Maintenance Therapy Period|Adverse Event|15|||
127662022|NCT01004250|459386664|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
127662023|NCT01004250|459386664|FG000|Maintenance Therapy Period|Protocol Violation|1|||
127662024|NCT01004250|459386664|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
127662025|NCT01004250|459386664|FG000|Maintenance Therapy Period|Physician Decision|4|||
127662026|NCT01004250|459386664|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
127662027|NCT00594906|459386665|FG000|Overall Study|Physician Decision|1|||
127662028|NCT00594906|459386666|FG001|Overall Study|Physician Decision|0|||
127662029|NCT00594906|459386665|FG000|Overall Study|Physician Decision|0|||
127662030|NCT00594906|459386666|FG001|Overall Study|Physician Decision|1|||
127662031|NCT00594906|459386665|FG000|Overall Study|Death|0|||
127662032|NCT00594906|459386666|FG001|Overall Study|Death|1|||
127662033|NCT00867490|459386667|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
127662034|NCT00867490|459386667|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
127662035|NCT00867490|459386667|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
127662036|NCT00867490|459386667|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
127662037|NCT00867490|459386667|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
127662038|NCT02823964|459386668|FG000|Overall Study|Adverse Event|2|||
127662039|NCT02823964|459386668|FG000|Overall Study|Physician Decision|1|||
127662040|NCT02823964|459386668|FG000|Overall Study|Lack of Efficacy|1|||
127662041|NCT02823964|459386668|FG000|Overall Study|Withdrawal by Subject|1|||
127662042|NCT00390455|459386669|FG000|Overall Study|Adverse Event|17|||
127662043|NCT00390455|459386670|FG001|Overall Study|Adverse Event|3|||
127662044|NCT00390455|459386669|FG000|Overall Study|Withdrawal by Subject|8|||
127543268|NCT00286468|458956513|FG000|Overall Study|Physician Decision|3|||
127662045|NCT00390455|459386670|FG001|Overall Study|Withdrawal by Subject|8|||
127662046|NCT00390455|459386669|FG000|Overall Study|Alternate Treatment|0|||
127662047|NCT00390455|459386670|FG001|Overall Study|Alternate Treatment|1|||
127662048|NCT00390455|459386669|FG000|Overall Study|Other Medical Reasons|7|||
127662049|NCT00390455|459386670|FG001|Overall Study|Other Medical Reasons|11|||
127662050|NCT00794820|459386674|FG000|Overall Study|Adverse Event|11|||
127662051|NCT00794820|459386674|FG000|Overall Study|Secondary Malignancies|2|||
127662052|NCT00794820|459386674|FG000|Overall Study|Resistant Disease|2|||
127662053|NCT00794820|459386674|FG000|Overall Study|Ineligible/Screen Failure|1|||
127662054|NCT04076020|459386675|FG000|Overall Study|Death|4|||
127662055|NCT04076020|459386676|FG001|Overall Study|Death|6|||
127662056|NCT04076020|459386675|FG000|Overall Study|Withdrawal by Subject|12|||
127662057|NCT04076020|459386676|FG001|Overall Study|Withdrawal by Subject|8|||
127662058|NCT02310126|459386678|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
127662059|NCT02310126|459386679|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
127662060|NCT02310126|459386678|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
127662061|NCT02310126|459386679|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
127662062|NCT03537261|459386689|FG000|Overall Study|Lost to Follow-up|4|||
127662063|NCT03537261|459386690|FG001|Overall Study|Lost to Follow-up|5|||
127662064|NCT03537261|459386689|FG000|Overall Study|Withdrawal by Subject|4|||
127662065|NCT03537261|459386690|FG001|Overall Study|Withdrawal by Subject|6|||
127662066|NCT03537261|459386689|FG000|Overall Study|Did not return study questionnaires|0|||
127662067|NCT03537261|459386690|FG001|Overall Study|Did not return study questionnaires|1|||
127662068|NCT03237013|459386691|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
127662069|NCT03237013|459386692|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
127662070|NCT03237013|459386693|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
127662071|NCT00502996|459386696|FG000|Overall Study|Lost to Follow-up|9|||
127662072|NCT00502996|459386696|FG000|Overall Study|Protocol Violation|2|||
127662073|NCT00502996|459386696|FG000|Overall Study|Treatment failure|25|||
127662074|NCT00502996|459386696|FG000|Overall Study|Withdrawal Informed Consent|6|||
127662075|NCT00502996|459386696|FG000|Overall Study|Adverse Event|2|||
127662076|NCT01729728|459386697|FG000|Overall Study|Adverse Event|0|||
127662077|NCT01729728|459386698|FG001|Overall Study|Adverse Event|6|||
127662078|NCT01729728|459386699|FG002|Overall Study|Adverse Event|0|||
127662079|NCT01729728|459386697|FG000|Overall Study|Protocol Violation|1|||
127662080|NCT01729728|459386698|FG001|Overall Study|Protocol Violation|0|||
127662081|NCT01729728|459386699|FG002|Overall Study|Protocol Violation|1|||
127662082|NCT02500979|459386700|FG000|Period 1|Hyperglycemia|1|||
127662083|NCT02500979|459386701|FG001|Period 1|Hyperglycemia|0|||
127662084|NCT02500979|459386700|FG000|Period 1|Severe non-compliance to protocol|0|||
127662085|NCT02500979|459386701|FG001|Period 1|Severe non-compliance to protocol|1|||
127662086|NCT02500979|459386700|FG000|Period 1|Adverse Event|1|||
127662087|NCT02500979|459386701|FG001|Period 1|Adverse Event|0|||
127662088|NCT02500979|459386700|FG000|Period 1|Subject decision|2|||
127662089|NCT02500979|459386701|FG001|Period 1|Subject decision|0|||
127662090|NCT02500979|459386700|FG000|Period 2|Change in risk|1|||
127662091|NCT02500979|459386701|FG001|Period 2|Change in risk|0|||
127662092|NCT00672958|459386704|FG000|Overall Study|Adverse Event|11|||
127662093|NCT00672958|459386705|FG001|Overall Study|Adverse Event|9|||
127662094|NCT00672958|459386704|FG000|Overall Study|Lack of Efficacy|6|||
127662095|NCT00672958|459386705|FG001|Overall Study|Lack of Efficacy|11|||
127662096|NCT00672958|459386704|FG000|Overall Study|Non-compliance with study drug|2|||
127662097|NCT00672958|459386705|FG001|Overall Study|Non-compliance with study drug|3|||
127662098|NCT00672958|459386704|FG000|Overall Study|Protocol deviations|11|||
127662099|NCT00672958|459386705|FG001|Overall Study|Protocol deviations|5|||
127662100|NCT00672958|459386704|FG000|Overall Study|Voluntary withdrawal|12|||
127662101|NCT00672958|459386705|FG001|Overall Study|Voluntary withdrawal|8|||
127662102|NCT00672958|459386704|FG000|Overall Study|Lost to Follow-up|22|||
127662103|NCT00672958|459386705|FG001|Overall Study|Lost to Follow-up|17|||
127662104|NCT00672958|459386704|FG000|Overall Study|Reason not specified|0|||
127662105|NCT00672958|459386705|FG001|Overall Study|Reason not specified|3|||
127662106|NCT01380990|459386706|FG000|Overall Study|Treatment Failure|1|||
127662107|NCT01380990|459386707|FG001|Overall Study|Treatment Failure|0|||
127662108|NCT01380990|459386706|FG000|Overall Study|Death|0|||
127662109|NCT01380990|459386707|FG001|Overall Study|Death|1|||
127662110|NCT02374593|459386709|FG000|Overall Study|non-compliant|2|||
127662111|NCT02374593|459386710|FG001|Overall Study|non-compliant|0|||
127662112|NCT04267614|459386711|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
127662113|NCT04267614|459386711|FG000|Overall Study|Lost to Follow-up|115|||
127662114|NCT04827134|459386712|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
127662115|NCT04827134|459386713|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
127662116|NCT04827134|459386714|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
127662117|NCT04827134|459386715|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
127662118|NCT00988351|459386716|FG000|Overall Study|Withdrawal by Subject|8|||
127662119|NCT00988351|459386717|FG001|Overall Study|Withdrawal by Subject|0|||
127662120|NCT00988351|459386716|FG000|Overall Study|Lost to Follow-up|6|||
127662121|NCT00988351|459386717|FG001|Overall Study|Lost to Follow-up|9|||
127662122|NCT00988351|459386716|FG000|Overall Study|not using CPAP|5|||
127662123|NCT00988351|459386717|FG001|Overall Study|not using CPAP|3|||
127662124|NCT01927731|459386732|FG000|Overall Study|Graft Failure|1|||
127662125|NCT01927731|459386733|FG001|Overall Study|Graft Failure|2|||
127662126|NCT01927731|459386732|FG000|Overall Study|Physician Decision|2|||
127662127|NCT01927731|459386733|FG001|Overall Study|Physician Decision|3|||
127662128|NCT01927731|459386732|FG000|Overall Study|Withdrawal by Subject|0|||
127662129|NCT01927731|459386733|FG001|Overall Study|Withdrawal by Subject|2|||
127662130|NCT01927731|459386732|FG000|Overall Study|Death|0|||
127662131|NCT01927731|459386733|FG001|Overall Study|Death|3|||
127662132|NCT01388530|459386734|FG000|Overall Study|Lost to Follow-up|5|||
127662133|NCT02836613|459386739|FG000|Overall Study|Accidental drowning|1|||
127662134|NCT02836613|459386740|FG001|Overall Study|Accidental drowning|0|||
127662135|NCT02836613|459386739|FG000|Overall Study|Lost to Follow-up|0|||
127662136|NCT02836613|459386740|FG001|Overall Study|Lost to Follow-up|1|||
127662137|NCT02836613|459386739|FG000|Overall Study|Withdrawal by Subject|0|||
127662138|NCT02836613|459386740|FG001|Overall Study|Withdrawal by Subject|2|||
127662139|NCT03881059|459386741|FG000|Treatment Period - Part A|Adverse Event|1|||
127662140|NCT03881059|459386742|FG001|Treatment Period - Part A|Adverse Event|3|||
127662141|NCT03881059|459386743|FG002|Treatment Period - Part A|Adverse Event|4|||
127662142|NCT03881059|459386741|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
127662143|NCT03881059|459386742|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
127662144|NCT03881059|459386743|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
127662145|NCT03881059|459386741|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
127662146|NCT03881059|459386742|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
127662147|NCT03881059|459386743|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
127662148|NCT03881059|459386741|FG000|Treatment Period - Part A|Other reasons|2|||
127662149|NCT03881059|459386742|FG001|Treatment Period - Part A|Other reasons|1|||
127662150|NCT03881059|459386743|FG002|Treatment Period - Part A|Other reasons|0|||
127662151|NCT03881059|459386741|FG000|Treatment Period - Part B|Adverse Event|0|||
127662152|NCT03881059|459386742|FG001|Treatment Period - Part B|Adverse Event|0|||
127662153|NCT03881059|459386743|FG002|Treatment Period - Part B|Adverse Event|3|||
127662154|NCT03881059|459386741|FG000|Treatment Period - Part B|Death|0|||
127662155|NCT03881059|459386742|FG001|Treatment Period - Part B|Death|1|||
127662156|NCT03881059|459386743|FG002|Treatment Period - Part B|Death|1|||
127662157|NCT03881059|459386741|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
127662158|NCT03881059|459386742|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
127662159|NCT03881059|459386743|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
127662160|NCT03881059|459386741|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
127662161|NCT03881059|459386742|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
127662162|NCT03881059|459386743|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
127662163|NCT03881059|459386741|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
127662164|NCT03881059|459386742|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
127662165|NCT03881059|459386743|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
127662166|NCT03881059|459386741|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
127662167|NCT03881059|459386742|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
127662168|NCT03881059|459386743|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
127662169|NCT03881059|459386741|FG000|Treatment Period - Part B|Other reasons|4|||
127662170|NCT03881059|459386742|FG001|Treatment Period - Part B|Other reasons|3|||
127662171|NCT03881059|459386743|FG002|Treatment Period - Part B|Other reasons|3|||
127662172|NCT05284019|459386744|FG000|Overall Study|Study terminated|2|||
127662173|NCT05284019|459386745|FG001|Overall Study|Study terminated|2|||
127662174|NCT05284019|459386746|FG002|Overall Study|Study terminated|2|||
127662175|NCT05284019|459386747|FG003|Overall Study|Study terminated|5|||
127662176|NCT05284019|459386748|FG004|Overall Study|Study terminated|15|||
127662177|NCT05284019|459386744|FG000|Overall Study|Withdrawal by Subject|0|||
127662178|NCT05284019|459386745|FG001|Overall Study|Withdrawal by Subject|0|||
127662179|NCT05284019|459386746|FG002|Overall Study|Withdrawal by Subject|0|||
127662180|NCT05284019|459386747|FG003|Overall Study|Withdrawal by Subject|1|||
127662181|NCT05284019|459386748|FG004|Overall Study|Withdrawal by Subject|1|||
127662182|NCT05284019|459386744|FG000|Overall Study|Lost to Follow-up|1|||
127662183|NCT05284019|459386745|FG001|Overall Study|Lost to Follow-up|0|||
127662184|NCT05284019|459386746|FG002|Overall Study|Lost to Follow-up|0|||
127662185|NCT05284019|459386747|FG003|Overall Study|Lost to Follow-up|2|||
127662186|NCT05284019|459386748|FG004|Overall Study|Lost to Follow-up|1|||
127662187|NCT02065570|459386749|FG000|Induction Study|Adverse Event|5|||
127662188|NCT02065570|459386750|FG001|Induction Study|Adverse Event|12|||
127662189|NCT02065570|459386751|FG002|Induction Study|Adverse Event|0|||
127662190|NCT02065570|459386752|FG003|Induction Study|Adverse Event|0|||
127662191|NCT02065570|459386749|FG000|Induction Study|Withdrawal by Subject|2|||
127662192|NCT02065570|459386750|FG001|Induction Study|Withdrawal by Subject|3|||
127662193|NCT02065570|459386751|FG002|Induction Study|Withdrawal by Subject|0|||
127662194|NCT02065570|459386752|FG003|Induction Study|Withdrawal by Subject|0|||
127662195|NCT02065570|459386749|FG000|Induction Study|Lost to Follow-up|1|||
127662196|NCT02065570|459386750|FG001|Induction Study|Lost to Follow-up|1|||
127662197|NCT02065570|459386751|FG002|Induction Study|Lost to Follow-up|0|||
127662198|NCT02065570|459386752|FG003|Induction Study|Lost to Follow-up|0|||
127662199|NCT02065570|459386749|FG000|Induction Study|Other, Not Specified|6|||
127662200|NCT02065570|459386750|FG001|Induction Study|Other, Not Specified|5|||
127662201|NCT02065570|459386751|FG002|Induction Study|Other, Not Specified|0|||
127662202|NCT02065570|459386752|FG003|Induction Study|Other, Not Specified|0|||
127662203|NCT02065570|459386749|FG000|Maintenance Study|Adverse Event|0|||
127662204|NCT02065570|459386750|FG001|Maintenance Study|Adverse Event|0|||
127662205|NCT02065570|459386751|FG002|Maintenance Study|Adverse Event|8|||
127662206|NCT02065570|459386752|FG003|Maintenance Study|Adverse Event|8|||
127662207|NCT02065570|459386749|FG000|Maintenance Study|Withdrawal by Subject|0|||
127662208|NCT02065570|459386750|FG001|Maintenance Study|Withdrawal by Subject|0|||
127662209|NCT02065570|459386751|FG002|Maintenance Study|Withdrawal by Subject|1|||
127662210|NCT02065570|459386752|FG003|Maintenance Study|Withdrawal by Subject|4|||
127662211|NCT02065570|459386749|FG000|Maintenance Study|Lost to Follow-up|0|||
127662212|NCT02065570|459386750|FG001|Maintenance Study|Lost to Follow-up|0|||
127662213|NCT02065570|459386751|FG002|Maintenance Study|Lost to Follow-up|2|||
127662214|NCT02065570|459386752|FG003|Maintenance Study|Lost to Follow-up|2|||
127662215|NCT02065570|459386749|FG000|Maintenance Study|Other, Not Specified|0|||
127662216|NCT02065570|459386750|FG001|Maintenance Study|Other, Not Specified|0|||
127662217|NCT02065570|459386751|FG002|Maintenance Study|Other, Not Specified|11|||
127662218|NCT02065570|459386752|FG003|Maintenance Study|Other, Not Specified|5|||
127662219|NCT00287469|459386753|FG000|Overall Study|serious adverse event|1|||
127662220|NCT00287469|459386754|FG001|Overall Study|serious adverse event|6|||
127662221|NCT00287469|459386753|FG000|Overall Study|Adverse Event|1|||
127662222|NCT00287469|459386754|FG001|Overall Study|Adverse Event|1|||
127662223|NCT00287469|459386753|FG000|Overall Study|moved from area|144|||
127662224|NCT00287469|459386754|FG001|Overall Study|moved from area|138|||
127662225|NCT00287469|459386753|FG000|Overall Study|Lost to Follow-up|74|||
127662226|NCT00287469|459386754|FG001|Overall Study|Lost to Follow-up|69|||
127662227|NCT01266993|459386757|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
127662228|NCT01266993|459386758|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
127662229|NCT01266993|459386757|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
127662230|NCT01266993|459386758|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
127662231|NCT02293837|459386759|FG000|Overall Study|Lost to Follow-up|0|||
127662232|NCT02293837|459386760|FG001|Overall Study|Lost to Follow-up|2|||
127662233|NCT02293837|459386761|FG002|Overall Study|Lost to Follow-up|1|||
127662234|NCT02293837|459386762|FG003|Overall Study|Lost to Follow-up|0|||
127662235|NCT02293837|459386759|FG000|Overall Study|Withdrawal by Subject|2|||
127662236|NCT02293837|459386760|FG001|Overall Study|Withdrawal by Subject|1|||
127662237|NCT02293837|459386761|FG002|Overall Study|Withdrawal by Subject|2|||
127662238|NCT02293837|459386762|FG003|Overall Study|Withdrawal by Subject|1|||
127662239|NCT02293837|459386759|FG000|Overall Study|COVID-19 Related|1|||
127662240|NCT02293837|459386760|FG001|Overall Study|COVID-19 Related|1|||
127662241|NCT02293837|459386761|FG002|Overall Study|COVID-19 Related|0|||
127662242|NCT02293837|459386762|FG003|Overall Study|COVID-19 Related|0|||
127662243|NCT02293837|459386759|FG000|Overall Study|Participant ill and could not be infused|0|||
127662244|NCT02293837|459386760|FG001|Overall Study|Participant ill and could not be infused|0|||
127662245|NCT02293837|459386761|FG002|Overall Study|Participant ill and could not be infused|1|||
127662246|NCT02293837|459386762|FG003|Overall Study|Participant ill and could not be infused|0|||
127662247|NCT04779242|459386763|FG000|Overall Study|Adverse Event|1|||
127662248|NCT04779242|459386764|FG001|Overall Study|Adverse Event|1|||
127662249|NCT04779242|459386763|FG000|Overall Study|Lost to Follow-up|2|||
127662250|NCT04779242|459386764|FG001|Overall Study|Lost to Follow-up|4|||
127662251|NCT04779242|459386763|FG000|Overall Study|Withdrawal by Subject|7|||
127662252|NCT04779242|459386764|FG001|Overall Study|Withdrawal by Subject|9|||
127662253|NCT04779242|459386763|FG000|Overall Study|Death|6|||
127662254|NCT04779242|459386764|FG001|Overall Study|Death|6|||
127662255|NCT04779242|459386763|FG000|Overall Study|COVID-19 related reasons|2|||
127662256|NCT04779242|459386764|FG001|Overall Study|COVID-19 related reasons|1|||
127662257|NCT04779242|459386763|FG000|Overall Study|Unavailability for post therapy evaluation Visit|8|||
127662258|NCT04779242|459386764|FG001|Overall Study|Unavailability for post therapy evaluation Visit|4|||
127662259|NCT04779242|459386763|FG000|Overall Study|Martial Law in Ukraine|2|||
127662260|NCT04779242|459386764|FG001|Overall Study|Martial Law in Ukraine|3|||
127662261|NCT03285113|459386767|FG000|Overall Study|Unable to implant leads|2|||
127662262|NCT00849680|459386768|FG000|Overall Study|Adverse Event|0|||
127662263|NCT00849680|459386769|FG001|Overall Study|Adverse Event|0|||
127662264|NCT00849680|459386770|FG002|Overall Study|Adverse Event|0|||
127662265|NCT00849680|459386771|FG003|Overall Study|Adverse Event|0|||
127662266|NCT00849680|459386772|FG004|Overall Study|Adverse Event|0|||
127662267|NCT00849680|459386773|FG005|Overall Study|Adverse Event|0|||
127662268|NCT00849680|459386774|FG006|Overall Study|Adverse Event|2|||
127662269|NCT00849680|459386775|FG007|Overall Study|Adverse Event|0|||
127662270|NCT00849680|459386768|FG000|Overall Study|Lost to Follow-up|7|||
127662271|NCT00849680|459386769|FG001|Overall Study|Lost to Follow-up|3|||
127662272|NCT00849680|459386770|FG002|Overall Study|Lost to Follow-up|12|||
127662273|NCT00849680|459386771|FG003|Overall Study|Lost to Follow-up|11|||
127543269|NCT00286468|458956514|FG001|Overall Study|Physician Decision|2|||
127662274|NCT00849680|459386772|FG004|Overall Study|Lost to Follow-up|8|||
127662275|NCT00849680|459386773|FG005|Overall Study|Lost to Follow-up|11|||
127662276|NCT00849680|459386774|FG006|Overall Study|Lost to Follow-up|12|||
127662277|NCT00849680|459386775|FG007|Overall Study|Lost to Follow-up|5|||
127662278|NCT00849680|459386768|FG000|Overall Study|Subject moved|1|||
127662279|NCT00849680|459386769|FG001|Overall Study|Subject moved|0|||
127662280|NCT00849680|459386770|FG002|Overall Study|Subject moved|3|||
127662281|NCT00849680|459386771|FG003|Overall Study|Subject moved|1|||
127662282|NCT00849680|459386772|FG004|Overall Study|Subject moved|0|||
127662283|NCT00849680|459386773|FG005|Overall Study|Subject moved|2|||
127662284|NCT00849680|459386774|FG006|Overall Study|Subject moved|2|||
127662285|NCT00849680|459386775|FG007|Overall Study|Subject moved|2|||
127662286|NCT00849680|459386768|FG000|Overall Study|Withdrawal by Subject|2|||
127662287|NCT00849680|459386769|FG001|Overall Study|Withdrawal by Subject|0|||
127662288|NCT00849680|459386770|FG002|Overall Study|Withdrawal by Subject|0|||
127662289|NCT00849680|459386771|FG003|Overall Study|Withdrawal by Subject|2|||
127662290|NCT00849680|459386772|FG004|Overall Study|Withdrawal by Subject|2|||
127662291|NCT00849680|459386773|FG005|Overall Study|Withdrawal by Subject|2|||
127662292|NCT00849680|459386774|FG006|Overall Study|Withdrawal by Subject|1|||
127662293|NCT00849680|459386775|FG007|Overall Study|Withdrawal by Subject|1|||
127662294|NCT00849680|459386768|FG000|Overall Study|Subject unable to comply with protocol|1|||
127662295|NCT00849680|459386769|FG001|Overall Study|Subject unable to comply with protocol|0|||
127662296|NCT00849680|459386770|FG002|Overall Study|Subject unable to comply with protocol|0|||
127662297|NCT00849680|459386771|FG003|Overall Study|Subject unable to comply with protocol|0|||
127662298|NCT00849680|459386772|FG004|Overall Study|Subject unable to comply with protocol|0|||
127662299|NCT00849680|459386773|FG005|Overall Study|Subject unable to comply with protocol|0|||
127662300|NCT00849680|459386774|FG006|Overall Study|Subject unable to comply with protocol|0|||
127662301|NCT00849680|459386775|FG007|Overall Study|Subject unable to comply with protocol|0|||
127662302|NCT02942004|459386778|FG000|Overall Study|Withdrawal by Subject|0|||
127662303|NCT02942004|459386779|FG001|Overall Study|Withdrawal by Subject|2|||
127662304|NCT02942004|459386780|FG002|Overall Study|Withdrawal by Subject|3|||
127662305|NCT02942004|459386778|FG000|Overall Study|Lost to Follow-up|1|||
127662306|NCT02942004|459386779|FG001|Overall Study|Lost to Follow-up|1|||
127662307|NCT02942004|459386780|FG002|Overall Study|Lost to Follow-up|2|||
127662308|NCT02942004|459386778|FG000|Overall Study|Randomized but not dosed|3|||
127662309|NCT02942004|459386779|FG001|Overall Study|Randomized but not dosed|9|||
127662310|NCT02942004|459386780|FG002|Overall Study|Randomized but not dosed|4|||
127662311|NCT03382600|459386781|FG000|Overall Study|Adverse Event|3|||
127662312|NCT03382600|459386782|FG001|Overall Study|Adverse Event|3|||
127662313|NCT03382600|459386781|FG000|Overall Study|Clinical Disease Progression|2|||
127662314|NCT03382600|459386782|FG001|Overall Study|Clinical Disease Progression|4|||
127662315|NCT03382600|459386781|FG000|Overall Study|Radiological Progression|40|||
127662316|NCT03382600|459386782|FG001|Overall Study|Radiological Progression|31|||
127662317|NCT03382600|459386781|FG000|Overall Study|Withdrawal by Subject|0|||
127662318|NCT03382600|459386782|FG001|Overall Study|Withdrawal by Subject|1|||
127662319|NCT03382600|459386781|FG000|Overall Study|Other|9|||
127662320|NCT03382600|459386782|FG001|Overall Study|Other|7|||
127662321|NCT01448044|459386783|FG000|Treatment Period|Adverse Event|4|||
127662322|NCT01448044|459386784|FG001|Treatment Period|Adverse Event|3|||
127662323|NCT01448044|459386783|FG000|Treatment Period|Lack of Efficacy|5|||
127662324|NCT01448044|459386784|FG001|Treatment Period|Lack of Efficacy|12|||
127662325|NCT01448044|459386783|FG000|Treatment Period|Subject requested discontinue study drug|1|||
127662326|NCT01448044|459386784|FG001|Treatment Period|Subject requested discontinue study drug|0|||
127662327|NCT01448044|459386783|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
127662328|NCT01448044|459386784|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
127662329|NCT01448044|459386783|FG000|Treatment Period|Participant does not meet study criteria|1|||
127662330|NCT01448044|459386784|FG001|Treatment Period|Participant does not meet study criteria|0|||
127662331|NCT01448044|459386783|FG000|Treatment Period|Lost to Follow-up|2|||
127662332|NCT01448044|459386784|FG001|Treatment Period|Lost to Follow-up|1|||
127662333|NCT01448044|459386783|FG000|Treatment Period|Other reason|2|||
127662334|NCT01448044|459386784|FG001|Treatment Period|Other reason|0|||
127662335|NCT01448044|459386783|FG000|Follow Up Period|Withdrawal by Subject|1|||
127662336|NCT01448044|459386784|FG001|Follow Up Period|Withdrawal by Subject|1|||
127662337|NCT01448044|459386783|FG000|Follow Up Period|Lost to Follow-up|6|||
127662338|NCT01448044|459386784|FG001|Follow Up Period|Lost to Follow-up|2|||
127662339|NCT01448044|459386783|FG000|Follow Up Period|Other|5|||
127662340|NCT01448044|459386784|FG001|Follow Up Period|Other|11|||
127662341|NCT01000376|459386785|FG000|Cycle 1 Day 1|Adverse Event|1|||
127662342|NCT01000376|459386786|FG001|Cycle 1 Day 1|Adverse Event|0|||
127662343|NCT01000376|459386785|FG000|Cycle 1 Day 1|Progressive Disease|1|||
127662344|NCT01000376|459386786|FG001|Cycle 1 Day 1|Progressive Disease|0|||
127662345|NCT00896454|459386787|FG000|Overall Study|Death|10|||
127662346|NCT00896454|459386787|FG000|Overall Study|Adverse Event|8|||
127662347|NCT00896454|459386787|FG000|Overall Study|Disease Progression|5|||
127662348|NCT00896454|459386787|FG000|Overall Study|Other|4|||
127662349|NCT00896454|459386787|FG000|Overall Study|Requirement for alternative therapy|3|||
127662350|NCT00896454|459386787|FG000|Overall Study|Ongoing in study|2|||
127662351|NCT00896454|459386787|FG000|Overall Study|Withdrawal by Subject|1|||
127662352|NCT03688711|459386788|FG000|Overall Study|Withdrawal by Subject|0|||
127662353|NCT03688711|459386789|FG001|Overall Study|Withdrawal by Subject|1|||
127662354|NCT03560245|459386794|FG000|Overall Study|Withdrawal by Subject|3|||
127662355|NCT03560245|459386795|FG001|Overall Study|Withdrawal by Subject|2|||
127662356|NCT03560245|459386794|FG000|Overall Study|Adverse Event|1|||
127662357|NCT03560245|459386795|FG001|Overall Study|Adverse Event|1|||
127662358|NCT03560245|459386794|FG000|Overall Study|Protocol Violation|1|||
127662359|NCT03560245|459386795|FG001|Overall Study|Protocol Violation|0|||
127662360|NCT03560245|459386794|FG000|Overall Study|Death|0|||
127662361|NCT03560245|459386795|FG001|Overall Study|Death|1|||
127662362|NCT03560245|459386794|FG000|Overall Study|Lost to Follow-up|0|||
127662363|NCT03560245|459386795|FG001|Overall Study|Lost to Follow-up|1|||
127662364|NCT03560245|459386794|FG000|Overall Study|Physician Decision|0|||
127662365|NCT03560245|459386795|FG001|Overall Study|Physician Decision|1|||
127662366|NCT03560245|459386794|FG000|Overall Study|Other|0|||
127662367|NCT03560245|459386795|FG001|Overall Study|Other|1|||
127662368|NCT02058290|459386813|FG000|Overall Study|Protocol Violation|2|||
127662369|NCT02058290|459386814|FG001|Overall Study|Protocol Violation|1|||
127662370|NCT02058290|459386813|FG000|Overall Study|Physician Decision|1|||
127662371|NCT02058290|459386814|FG001|Overall Study|Physician Decision|0|||
127662372|NCT02058290|459386813|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
127662373|NCT02058290|459386814|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
127662374|NCT02058290|459386813|FG000|Overall Study|Withdrawal by Subject|0|||
127662375|NCT02058290|459386814|FG001|Overall Study|Withdrawal by Subject|1|||
127662376|NCT01625910|459388717|FG000|Overall Study|Lost to Follow-up|3|||
127662377|NCT01625910|459388718|FG001|Overall Study|Lost to Follow-up|4|||
127662378|NCT02391038|459388719|FG000|Overall Study|Progressive disease|3|||
127662379|NCT02391038|459388720|FG001|Overall Study|Progressive disease|3|||
127662380|NCT02391038|459388721|FG002|Overall Study|Progressive disease|6|||
127662381|NCT02959138|459388722|FG000|Overall Study|Enrolled but Never Treated|0|||
127662382|NCT02959138|459388723|FG001|Overall Study|Enrolled but Never Treated|1|||
127662383|NCT02959138|459388724|FG002|Overall Study|Enrolled but Never Treated|0|||
127662384|NCT04213989|459388725|FG000|Overall Study|Withdrawal by Subject|3|||
127662385|NCT04213989|459388726|FG001|Overall Study|Withdrawal by Subject|2|||
127662386|NCT04213989|459388725|FG000|Overall Study|Physician Decision|1|||
127662387|NCT04213989|459388726|FG001|Overall Study|Physician Decision|0|||
127662388|NCT04213989|459388725|FG000|Overall Study|Lost to Follow-up|0|||
127662389|NCT04213989|459388726|FG001|Overall Study|Lost to Follow-up|4|||
127662390|NCT01189890|459388729|FG000|Overall Study|Adverse Event|3|||
127662391|NCT01189890|459388730|FG001|Overall Study|Adverse Event|4|||
127662392|NCT01189890|459388729|FG000|Overall Study|Lack of Efficacy|7|||
127662393|NCT01189890|459388730|FG001|Overall Study|Lack of Efficacy|2|||
127662394|NCT01189890|459388729|FG000|Overall Study|Lost to Follow-up|1|||
127662395|NCT01189890|459388730|FG001|Overall Study|Lost to Follow-up|7|||
127662396|NCT01189890|459388729|FG000|Overall Study|Protocol Violation|1|||
127662397|NCT01189890|459388730|FG001|Overall Study|Protocol Violation|5|||
127662398|NCT01189890|459388729|FG000|Overall Study|Withdrawal by Subject|15|||
127662399|NCT01189890|459388730|FG001|Overall Study|Withdrawal by Subject|11|||
127662400|NCT01189890|459388729|FG000|Overall Study|Non Compliance|0|||
127662401|NCT01189890|459388730|FG001|Overall Study|Non Compliance|1|||
127662402|NCT01189890|459388729|FG000|Overall Study|Physician Decision|5|||
127662403|NCT01189890|459388730|FG001|Overall Study|Physician Decision|4|||
127662404|NCT01189890|459388729|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
127662405|NCT01189890|459388730|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
127662406|NCT01155388|459388733|FG000|Overall Study|Adverse Event|1|||
127662407|NCT01155388|459388734|FG001|Overall Study|Adverse Event|0|||
127662408|NCT03943589|459388735|FG000|Overall Study|Death|1|||
127662409|NCT03943589|459388735|FG000|Overall Study|Diagnosed with encephalomyelitis|1|||
127662410|NCT00900627|459388736|FG000|Overall Study|Condition under investigation worsened|4|||
127662411|NCT00900627|459388737|FG001|Overall Study|Condition under investigation worsened|0|||
127662412|NCT00900627|459388738|FG002|Overall Study|Condition under investigation worsened|5|||
127662413|NCT00900627|459388739|FG003|Overall Study|Condition under investigation worsened|3|||
127662414|NCT00900627|459388740|FG004|Overall Study|Condition under investigation worsened|0|||
127662415|NCT00900627|459388741|FG005|Overall Study|Condition under investigation worsened|0|||
127662416|NCT00900627|459388736|FG000|Overall Study|Withdrawal by Subject|1|||
127662417|NCT00900627|459388737|FG001|Overall Study|Withdrawal by Subject|0|||
127662418|NCT00900627|459388738|FG002|Overall Study|Withdrawal by Subject|1|||
127662419|NCT00900627|459388739|FG003|Overall Study|Withdrawal by Subject|0|||
127662420|NCT00900627|459388740|FG004|Overall Study|Withdrawal by Subject|1|||
127662421|NCT00900627|459388741|FG005|Overall Study|Withdrawal by Subject|2|||
127662422|NCT00900627|459388736|FG000|Overall Study|Adverse Event|1|||
127662423|NCT00900627|459388737|FG001|Overall Study|Adverse Event|2|||
127662424|NCT00900627|459388738|FG002|Overall Study|Adverse Event|0|||
127662425|NCT00900627|459388739|FG003|Overall Study|Adverse Event|3|||
127662426|NCT00900627|459388740|FG004|Overall Study|Adverse Event|0|||
127662427|NCT00900627|459388741|FG005|Overall Study|Adverse Event|0|||
127990791|NCT01402986|460592375|FG000|Overall Study|Withdrawal by Subject|7|||
127662428|NCT00900627|459388736|FG000|Overall Study|Death|0|||
127662429|NCT00900627|459388737|FG001|Overall Study|Death|0|||
127662430|NCT00900627|459388738|FG002|Overall Study|Death|0|||
127662431|NCT00900627|459388739|FG003|Overall Study|Death|0|||
127662432|NCT00900627|459388740|FG004|Overall Study|Death|28|||
127662433|NCT00900627|459388741|FG005|Overall Study|Death|24|||
127662434|NCT00373295|459388742|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
127662435|NCT00373295|459388743|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
127662436|NCT00373295|459388744|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
127662437|NCT00373295|459388745|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
127662438|NCT00373295|459388746|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
127662439|NCT00373295|459388747|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
127662440|NCT00830947|459388748|FG000|Overall Study|Lost to Follow-up|4|||
127662441|NCT00830947|459388749|FG001|Overall Study|Lost to Follow-up|4|||
127662442|NCT00962585|459388756|FG000|Overall Study|Adverse Event|0|||
127662443|NCT00962585|459388757|FG001|Overall Study|Adverse Event|2|||
127662444|NCT00962585|459388758|FG002|Overall Study|Adverse Event|1|||
127662445|NCT00962585|459388759|FG003|Overall Study|Adverse Event|0|||
127662446|NCT00962585|459388756|FG000|Overall Study|Lost to Follow-up|3|||
127662447|NCT00962585|459388757|FG001|Overall Study|Lost to Follow-up|0|||
127662448|NCT00962585|459388758|FG002|Overall Study|Lost to Follow-up|1|||
127662449|NCT00962585|459388759|FG003|Overall Study|Lost to Follow-up|0|||
127662450|NCT00962585|459388756|FG000|Overall Study|Protocol Violation|0|||
127662451|NCT00962585|459388757|FG001|Overall Study|Protocol Violation|0|||
127662452|NCT00962585|459388758|FG002|Overall Study|Protocol Violation|1|||
127662453|NCT00962585|459388759|FG003|Overall Study|Protocol Violation|0|||
127662454|NCT00962585|459388756|FG000|Overall Study|Withdrawal by Subject|1|||
127662455|NCT00962585|459388757|FG001|Overall Study|Withdrawal by Subject|0|||
127662456|NCT00962585|459388758|FG002|Overall Study|Withdrawal by Subject|0|||
127662457|NCT00962585|459388759|FG003|Overall Study|Withdrawal by Subject|0|||
127662458|NCT00962585|459388756|FG000|Overall Study|Withdrew Consent|2|||
127662459|NCT00962585|459388757|FG001|Overall Study|Withdrew Consent|0|||
127662460|NCT00962585|459388758|FG002|Overall Study|Withdrew Consent|0|||
127662461|NCT00962585|459388759|FG003|Overall Study|Withdrew Consent|0|||
127662462|NCT02254421|459388762|FG000|Overall Study|Randomized but Not Treated|1|||
127662463|NCT02254421|459388763|FG001|Overall Study|Randomized but Not Treated|0|||
127662464|NCT02254421|459388762|FG000|Overall Study|Death|0|||
127662465|NCT02254421|459388763|FG001|Overall Study|Death|2|||
127662466|NCT02254421|459388762|FG000|Overall Study|Withdrew Consent|1|||
127662467|NCT02254421|459388763|FG001|Overall Study|Withdrew Consent|1|||
127662468|NCT00839917|459388767|FG000|Overall Study|Lost to Follow-up|1|||
127662469|NCT00839917|459388768|FG001|Overall Study|Lost to Follow-up|0|||
127662470|NCT00839917|459388767|FG000|Overall Study|Did not receive vaccine|0|||
127662471|NCT00839917|459388768|FG001|Overall Study|Did not receive vaccine|1|||
127662472|NCT01254565|459388769|FG000|Overall Study|Non-compliance to Study Procedures|0|||
127662473|NCT01254565|459388770|FG001|Overall Study|Non-compliance to Study Procedures|0|||
127662474|NCT01254565|459388771|FG002|Overall Study|Non-compliance to Study Procedures|0|||
127662475|NCT01254565|459388772|FG003|Overall Study|Non-compliance to Study Procedures|0|||
127662476|NCT01254565|459388773|FG004|Overall Study|Non-compliance to Study Procedures|1|||
127662477|NCT01254565|459388774|FG005|Overall Study|Non-compliance to Study Procedures|0|||
127662478|NCT01254565|459388769|FG000|Overall Study|Did not Receive Treatment|1|||
127662479|NCT01254565|459388770|FG001|Overall Study|Did not Receive Treatment|1|||
127662480|NCT01254565|459388771|FG002|Overall Study|Did not Receive Treatment|0|||
127543270|NCT00286468|458956515|FG002|Overall Study|Physician Decision|1|||
127543271|NCT02923726|458956516|FG000|Overall Study|Death|196|||
127543272|NCT02923726|458956517|FG001|Overall Study|Death|175|||
127543273|NCT02923726|458956516|FG000|Overall Study|Withdrawal by Subject|337|||
127543274|NCT02923726|458956517|FG001|Overall Study|Withdrawal by Subject|307|||
127543275|NCT00074711|458956519|FG000|Overall Study|Withdrawal by Subject|1|||
127543276|NCT00074711|458956520|FG001|Overall Study|Withdrawal by Subject|1|||
127543277|NCT00074711|458956519|FG000|Overall Study|Lost to Follow-up|10|||
127543278|NCT00074711|458956520|FG001|Overall Study|Lost to Follow-up|8|||
127543279|NCT00074711|458956519|FG000|Overall Study|Participant stopped study drug|4|||
127543280|NCT00074711|458956520|FG001|Overall Study|Participant stopped study drug|6|||
127543281|NCT03466658|458956521|FG000|Overall Study|Withdrawal by Subject|3|||
127543282|NCT05365217|458956522|FG000|Treatment Period 1|Withdrawal by Subject|1|||
127543283|NCT05365217|458956523|FG001|Treatment Period 1|Withdrawal by Subject|0|||
127543284|NCT00129402|458956526|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
127543285|NCT00129402|458956527|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
127543286|NCT00129402|458956528|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
127543287|NCT00129402|458956529|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
127543288|NCT00129402|458956530|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
127543289|NCT00129402|458956531|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
127543290|NCT00129402|458956532|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
127543291|NCT00129402|458956526|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
127543292|NCT00129402|458956527|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
127543293|NCT00129402|458956528|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
127543294|NCT00129402|458956529|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
127543295|NCT00129402|458956530|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
127662481|NCT01254565|459388772|FG003|Overall Study|Did not Receive Treatment|0|||
127662482|NCT01254565|459388773|FG004|Overall Study|Did not Receive Treatment|3|||
127662483|NCT01254565|459388774|FG005|Overall Study|Did not Receive Treatment|4|||
127662484|NCT01254565|459388769|FG000|Overall Study|Other|0|||
127662485|NCT01254565|459388770|FG001|Overall Study|Other|0|||
127662486|NCT01254565|459388771|FG002|Overall Study|Other|0|||
127662487|NCT01254565|459388772|FG003|Overall Study|Other|1|||
127662488|NCT01254565|459388773|FG004|Overall Study|Other|0|||
127662489|NCT01254565|459388774|FG005|Overall Study|Other|0|||
127662490|NCT00472186|459388775|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
127662491|NCT00472186|459388776|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
127662492|NCT03354637|459388777|FG000|Double-blind Period|Protocol Violation|2|||
127662493|NCT03354637|459388778|FG001|Double-blind Period|Protocol Violation|0|||
127662494|NCT03354637|459388779|FG002|Double-blind Period|Protocol Violation|0|||
127662495|NCT03354637|459388777|FG000|Double-blind Period|Adverse Event|1|||
127662496|NCT03354637|459388778|FG001|Double-blind Period|Adverse Event|2|||
127662497|NCT03354637|459388779|FG002|Double-blind Period|Adverse Event|0|||
127662498|NCT03354637|459388777|FG000|Double-blind Period|Lost to Follow-up|3|||
127662499|NCT03354637|459388778|FG001|Double-blind Period|Lost to Follow-up|4|||
127662500|NCT03354637|459388779|FG002|Double-blind Period|Lost to Follow-up|3|||
127662501|NCT03354637|459388777|FG000|Double-blind Period|Withdrawal by Subject|10|||
127662502|NCT03354637|459388778|FG001|Double-blind Period|Withdrawal by Subject|6|||
127662503|NCT03354637|459388779|FG002|Double-blind Period|Withdrawal by Subject|4|||
127662504|NCT03354637|459388777|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
127662505|NCT03354637|459388778|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
127662506|NCT03354637|459388779|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
127662507|NCT03354637|459388777|FG000|Open Label Extension|Adverse Event|0|||
127662508|NCT03354637|459388778|FG001|Open Label Extension|Adverse Event|0|||
127662509|NCT03354637|459388779|FG002|Open Label Extension|Adverse Event|1|||
127662510|NCT03354637|459388777|FG000|Open Label Extension|Lost to Follow-up|0|||
127662511|NCT03354637|459388778|FG001|Open Label Extension|Lost to Follow-up|0|||
127662512|NCT03354637|459388779|FG002|Open Label Extension|Lost to Follow-up|2|||
127662513|NCT03354637|459388777|FG000|Open Label Extension|Withdrawal by Subject|0|||
127662514|NCT03354637|459388778|FG001|Open Label Extension|Withdrawal by Subject|0|||
127662515|NCT03354637|459388779|FG002|Open Label Extension|Withdrawal by Subject|5|||
127662516|NCT03354637|459388777|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
127662517|NCT03354637|459388778|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
127662518|NCT03354637|459388779|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
127662519|NCT03354637|459388777|FG000|Open Label Extension|Subject Noncompliance|0|||
127662520|NCT03354637|459388778|FG001|Open Label Extension|Subject Noncompliance|0|||
127662521|NCT03354637|459388779|FG002|Open Label Extension|Subject Noncompliance|1|||
127662522|NCT03354637|459388777|FG000|Open Label Extension|Lack of Efficacy|0|||
127662523|NCT03354637|459388778|FG001|Open Label Extension|Lack of Efficacy|0|||
127662524|NCT03354637|459388779|FG002|Open Label Extension|Lack of Efficacy|1|||
127662525|NCT03354637|459388777|FG000|Open Label Extension|Physician Decision|0|||
127662526|NCT03354637|459388778|FG001|Open Label Extension|Physician Decision|0|||
127662527|NCT03354637|459388779|FG002|Open Label Extension|Physician Decision|1|||
127662528|NCT02726399|459388780|FG000|Overall Study|Participant Non-Compliance|1|||
127662529|NCT02726399|459388780|FG000|Overall Study|Adverse Event|2|||
127662530|NCT02726399|459388780|FG000|Overall Study|Progression of disease|4|||
127662531|NCT02564055|459388781|FG000|Overall Study|Adverse Event|1|||
127662532|NCT02564055|459388782|FG001|Overall Study|Adverse Event|0|||
127662533|NCT02564055|459388783|FG002|Overall Study|Adverse Event|4|||
127662534|NCT02564055|459388784|FG003|Overall Study|Adverse Event|1|||
127662535|NCT02564055|459388785|FG004|Overall Study|Adverse Event|4|||
127662536|NCT02564055|459388786|FG005|Overall Study|Adverse Event|1|||
127662537|NCT02564055|459388781|FG000|Overall Study|Protocol Violation|1|||
127662538|NCT02564055|459388782|FG001|Overall Study|Protocol Violation|0|||
127662539|NCT02564055|459388783|FG002|Overall Study|Protocol Violation|0|||
127662540|NCT02564055|459388784|FG003|Overall Study|Protocol Violation|0|||
127662541|NCT02564055|459388785|FG004|Overall Study|Protocol Violation|0|||
127662542|NCT02564055|459388786|FG005|Overall Study|Protocol Violation|0|||
127662543|NCT02564055|459388781|FG000|Overall Study|Reached stopping criteria|0|||
127662544|NCT02564055|459388782|FG001|Overall Study|Reached stopping criteria|0|||
127662545|NCT02564055|459388783|FG002|Overall Study|Reached stopping criteria|0|||
127662546|NCT02564055|459388784|FG003|Overall Study|Reached stopping criteria|0|||
127662547|NCT02564055|459388785|FG004|Overall Study|Reached stopping criteria|0|||
127662548|NCT02564055|459388786|FG005|Overall Study|Reached stopping criteria|1|||
127662549|NCT02564055|459388781|FG000|Overall Study|Lost to Follow-up|0|||
127662550|NCT02564055|459388782|FG001|Overall Study|Lost to Follow-up|1|||
127662551|NCT02564055|459388783|FG002|Overall Study|Lost to Follow-up|4|||
127662552|NCT02564055|459388784|FG003|Overall Study|Lost to Follow-up|2|||
127662553|NCT02564055|459388785|FG004|Overall Study|Lost to Follow-up|1|||
127662554|NCT02564055|459388786|FG005|Overall Study|Lost to Follow-up|0|||
127662555|NCT02564055|459388781|FG000|Overall Study|Physician Decision|0|||
127662556|NCT02564055|459388782|FG001|Overall Study|Physician Decision|0|||
127662557|NCT02564055|459388783|FG002|Overall Study|Physician Decision|1|||
127662558|NCT02564055|459388784|FG003|Overall Study|Physician Decision|0|||
127662559|NCT02564055|459388785|FG004|Overall Study|Physician Decision|0|||
127662560|NCT02564055|459388786|FG005|Overall Study|Physician Decision|0|||
127662561|NCT02564055|459388781|FG000|Overall Study|Withdrawal by Subject|4|||
127662562|NCT02564055|459388782|FG001|Overall Study|Withdrawal by Subject|4|||
127662563|NCT02564055|459388783|FG002|Overall Study|Withdrawal by Subject|3|||
127662564|NCT02564055|459388784|FG003|Overall Study|Withdrawal by Subject|3|||
127662565|NCT02564055|459388785|FG004|Overall Study|Withdrawal by Subject|10|||
127662566|NCT02564055|459388786|FG005|Overall Study|Withdrawal by Subject|10|||
127662567|NCT04747275|459388787|FG000|Overall Study|Study terminated|0|||
127662568|NCT04747275|459388788|FG001|Overall Study|Study terminated|1|||
127662569|NCT03268590|459388792|FG000|Overall Study|Previously unknown exclusion criteria|1|||
127662570|NCT00531011|459388793|FG000|Overall Study|Withdrawal by Subject|2|||
127662571|NCT00531011|459388794|FG001|Overall Study|Withdrawal by Subject|4|||
127662572|NCT00531011|459388793|FG000|Overall Study|Death|1|||
127662573|NCT00531011|459388794|FG001|Overall Study|Death|0|||
127662574|NCT00531011|459388793|FG000|Overall Study|Lost to Follow-up|1|||
127662575|NCT00531011|459388794|FG001|Overall Study|Lost to Follow-up|0|||
127662576|NCT00531011|459388793|FG000|Overall Study|Physician Decision|0|||
127662577|NCT00531011|459388794|FG001|Overall Study|Physician Decision|3|||
127662578|NCT02139982|459388797|FG000|Overall Study|Lack of Efficacy|0|||
127662579|NCT02139982|459388798|FG001|Overall Study|Lack of Efficacy|1|||
127662580|NCT02139982|459388799|FG002|Overall Study|Lack of Efficacy|0|||
127662581|NCT02139982|459388800|FG003|Overall Study|Lack of Efficacy|1|||
127662582|NCT02139982|459388801|FG004|Overall Study|Lack of Efficacy|0|||
127662583|NCT02139982|459388802|FG005|Overall Study|Lack of Efficacy|0|||
127662584|NCT02139982|459388803|FG006|Overall Study|Lack of Efficacy|0|||
127662585|NCT02139982|459388804|FG007|Overall Study|Lack of Efficacy|0|||
127662586|NCT02139982|459388805|FG008|Overall Study|Lack of Efficacy|0|||
127662587|NCT02139982|459388806|FG009|Overall Study|Lack of Efficacy|0|||
127662588|NCT04254679|459388839|FG000|Overall Study|Protocol Violation|1|||
127662589|NCT04254679|459388840|FG001|Overall Study|Protocol Violation|1|||
127662590|NCT04254679|459388839|FG000|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|2|||
127662591|NCT04254679|459388840|FG001|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|1|||
127662592|NCT02206152|459388845|FG000|Pre-Randomization|Withdrawal by Subject|2|||
127662593|NCT00478608|459388846|FG000|Overall Study|Adverse Event|1|||
127662594|NCT00478608|459388846|FG000|Overall Study|Serious Adverse Event|14|||
127662595|NCT00478608|459388846|FG000|Overall Study|Withdrawal by Subject|2|||
127662596|NCT00478608|459388846|FG000|Overall Study|Protocol Violation|3|||
127662597|NCT02080520|459388847|FG000|Overall Study|Self-reported symptoms|5|||
127662598|NCT02080520|459388848|FG001|Overall Study|Self-reported symptoms|6|||
127662599|NCT02080520|459388847|FG000|Overall Study|Unable to contact|2|||
127662600|NCT02080520|459388848|FG001|Overall Study|Unable to contact|1|||
127662601|NCT02080520|459388847|FG000|Overall Study|Initiated aspirin|2|||
127662602|NCT02080520|459388848|FG001|Overall Study|Initiated aspirin|0|||
127662603|NCT02080520|459388847|FG000|Overall Study|Atrial fibrillation|1|||
127662604|NCT02080520|459388848|FG001|Overall Study|Atrial fibrillation|1|||
127662605|NCT02080520|459388847|FG000|Overall Study|Cancer|1|||
127662606|NCT02080520|459388848|FG001|Overall Study|Cancer|2|||
127662607|NCT02080520|459388847|FG000|Overall Study|Not interested in study|1|||
127662608|NCT02080520|459388848|FG001|Overall Study|Not interested in study|3|||
127662609|NCT02080520|459388847|FG000|Overall Study|Too busy|1|||
127662610|NCT02080520|459388848|FG001|Overall Study|Too busy|1|||
127662611|NCT02080520|459388847|FG000|Overall Study|Work-related injury|1|||
127662612|NCT02080520|459388848|FG001|Overall Study|Work-related injury|0|||
127662613|NCT02080520|459388847|FG000|Overall Study|Personal reasons|0|||
127662614|NCT02080520|459388848|FG001|Overall Study|Personal reasons|3|||
127662615|NCT01394250|459388856|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
127662616|NCT01394250|459388857|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
127662617|NCT01394250|459388856|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
127662618|NCT01394250|459388857|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
127662619|NCT00579982|459388859|FG000|Overall Study|Adverse Event|4|||
127662620|NCT00579982|459388859|FG000|Overall Study|Protocol Violation|4|||
127662621|NCT01313923|459388861|FG000|Overall Study|Physician Decision|3|||
127662622|NCT02471404|459388862|FG000|Overall Study|Adverse Event|7|||
127662623|NCT02471404|459388863|FG001|Overall Study|Adverse Event|1|||
127662624|NCT02471404|459388864|FG002|Overall Study|Adverse Event|2|||
127662625|NCT02471404|459388862|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
127662626|NCT02471404|459388863|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
127662627|NCT02471404|459388864|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
127662628|NCT02471404|459388862|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
127662629|NCT02471404|459388863|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
127662630|NCT02471404|459388864|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
127662631|NCT02471404|459388862|FG000|Overall Study|Lost to Follow-up|1|||
127662632|NCT02471404|459388863|FG001|Overall Study|Lost to Follow-up|1|||
127662633|NCT02471404|459388864|FG002|Overall Study|Lost to Follow-up|3|||
127662634|NCT02471404|459388862|FG000|Overall Study|Protocol Violation|1|||
127662635|NCT02471404|459388863|FG001|Overall Study|Protocol Violation|0|||
127662636|NCT02471404|459388864|FG002|Overall Study|Protocol Violation|0|||
127662637|NCT02471404|459388862|FG000|Overall Study|Withdrawal by Subject|8|||
127662638|NCT02471404|459388863|FG001|Overall Study|Withdrawal by Subject|4|||
127662639|NCT02471404|459388864|FG002|Overall Study|Withdrawal by Subject|5|||
127662640|NCT02471404|459388862|FG000|Overall Study|Other reasons not specified|10|||
127662641|NCT02471404|459388863|FG001|Overall Study|Other reasons not specified|7|||
127662642|NCT02471404|459388864|FG002|Overall Study|Other reasons not specified|12|||
127662643|NCT00305864|459388865|FG000|Overall Study|Ineligible / No protocol treatment|0|||
127662644|NCT00305864|459388866|FG001|Overall Study|Ineligible / No protocol treatment|1|||
127662645|NCT00305864|459388867|FG002|Overall Study|Ineligible / No protocol treatment|1|||
127662646|NCT00305864|459388868|FG003|Overall Study|Ineligible / No protocol treatment|13|||
127662647|NCT00507026|459388873|FG000|Overall Study|Lack of Efficacy|6|||
127662648|NCT00507026|459388874|FG001|Overall Study|Lack of Efficacy|4|||
127662649|NCT00507026|459388875|FG002|Overall Study|Lack of Efficacy|21|||
127662650|NCT00507026|459388873|FG000|Overall Study|Withdrawal by Subject|2|||
127662651|NCT00507026|459388874|FG001|Overall Study|Withdrawal by Subject|0|||
127662652|NCT00507026|459388875|FG002|Overall Study|Withdrawal by Subject|0|||
127662653|NCT00507026|459388873|FG000|Overall Study|Investigator Decision|1|||
127662654|NCT00507026|459388874|FG001|Overall Study|Investigator Decision|0|||
127662655|NCT00507026|459388875|FG002|Overall Study|Investigator Decision|0|||
127662656|NCT00507026|459388873|FG000|Overall Study|Adverse Event|2|||
127662657|NCT00507026|459388874|FG001|Overall Study|Adverse Event|0|||
127662658|NCT00507026|459388875|FG002|Overall Study|Adverse Event|0|||
127662659|NCT00507026|459388873|FG000|Overall Study|Protocol Violation|1|||
127662660|NCT00507026|459388874|FG001|Overall Study|Protocol Violation|0|||
127662661|NCT00507026|459388875|FG002|Overall Study|Protocol Violation|0|||
127662662|NCT00507026|459388873|FG000|Overall Study|Other|1|||
127662663|NCT00507026|459388874|FG001|Overall Study|Other|0|||
127662664|NCT00507026|459388875|FG002|Overall Study|Other|0|||
127662665|NCT02372058|459388876|FG000|Overall Study|Withdrawal by Subject|3|||
127662666|NCT02061761|459388879|FG000|Overall Study|Disease progression|2|||
127662667|NCT02061761|459388880|FG001|Overall Study|Disease progression|8|||
127662668|NCT02061761|459388881|FG002|Overall Study|Disease progression|4|||
127662669|NCT02061761|459388882|FG003|Overall Study|Disease progression|5|||
127662670|NCT02061761|459388883|FG004|Overall Study|Disease progression|9|||
127662671|NCT02061761|459388884|FG005|Overall Study|Disease progression|3|||
127662672|NCT02061761|459388885|FG006|Overall Study|Disease progression|1|||
127662673|NCT02061761|459388886|FG007|Overall Study|Disease progression|2|||
127662674|NCT02061761|459388887|FG008|Overall Study|Disease progression|28|||
127662675|NCT02061761|459388879|FG000|Overall Study|Study Drug toxicity|0|||
127662676|NCT02061761|459388880|FG001|Overall Study|Study Drug toxicity|0|||
127662677|NCT02061761|459388881|FG002|Overall Study|Study Drug toxicity|0|||
127662678|NCT02061761|459388882|FG003|Overall Study|Study Drug toxicity|0|||
127662679|NCT02061761|459388883|FG004|Overall Study|Study Drug toxicity|0|||
127662680|NCT02061761|459388884|FG005|Overall Study|Study Drug toxicity|1|||
127662681|NCT02061761|459388885|FG006|Overall Study|Study Drug toxicity|0|||
127662682|NCT02061761|459388886|FG007|Overall Study|Study Drug toxicity|2|||
127662683|NCT02061761|459388887|FG008|Overall Study|Study Drug toxicity|6|||
127662684|NCT02061761|459388879|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
127662685|NCT02061761|459388880|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
127662686|NCT02061761|459388881|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
127662687|NCT02061761|459388882|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
127662688|NCT02061761|459388883|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
127662689|NCT02061761|459388884|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
127662690|NCT02061761|459388885|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
127662691|NCT02061761|459388886|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
127662692|NCT02061761|459388887|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
127662693|NCT02061761|459388879|FG000|Overall Study|Participant request to discontinue study treatment|0|||
127662694|NCT02061761|459388880|FG001|Overall Study|Participant request to discontinue study treatment|0|||
127662695|NCT02061761|459388881|FG002|Overall Study|Participant request to discontinue study treatment|2|||
127662696|NCT02061761|459388882|FG003|Overall Study|Participant request to discontinue study treatment|2|||
127662697|NCT02061761|459388883|FG004|Overall Study|Participant request to discontinue study treatment|0|||
127662698|NCT02061761|459388884|FG005|Overall Study|Participant request to discontinue study treatment|1|||
127662699|NCT02061761|459388885|FG006|Overall Study|Participant request to discontinue study treatment|0|||
127662700|NCT02061761|459388886|FG007|Overall Study|Participant request to discontinue study treatment|0|||
127662701|NCT02061761|459388887|FG008|Overall Study|Participant request to discontinue study treatment|2|||
127662702|NCT02061761|459388879|FG000|Overall Study|Withdrawal by Subject|0|||
127662703|NCT02061761|459388880|FG001|Overall Study|Withdrawal by Subject|0|||
127662704|NCT02061761|459388881|FG002|Overall Study|Withdrawal by Subject|0|||
127662705|NCT02061761|459388882|FG003|Overall Study|Withdrawal by Subject|0|||
127662706|NCT02061761|459388883|FG004|Overall Study|Withdrawal by Subject|0|||
127662707|NCT02061761|459388884|FG005|Overall Study|Withdrawal by Subject|0|||
127662708|NCT02061761|459388885|FG006|Overall Study|Withdrawal by Subject|0|||
127662709|NCT02061761|459388886|FG007|Overall Study|Withdrawal by Subject|0|||
127662710|NCT02061761|459388887|FG008|Overall Study|Withdrawal by Subject|2|||
127662711|NCT02061761|459388879|FG000|Overall Study|Maximum clinical benefit|0|||
127662712|NCT02061761|459388880|FG001|Overall Study|Maximum clinical benefit|0|||
127662713|NCT02061761|459388881|FG002|Overall Study|Maximum clinical benefit|0|||
127662714|NCT02061761|459388882|FG003|Overall Study|Maximum clinical benefit|1|||
127662715|NCT02061761|459388883|FG004|Overall Study|Maximum clinical benefit|0|||
127662716|NCT02061761|459388884|FG005|Overall Study|Maximum clinical benefit|0|||
127662717|NCT02061761|459388885|FG006|Overall Study|Maximum clinical benefit|0|||
127662718|NCT02061761|459388886|FG007|Overall Study|Maximum clinical benefit|0|||
127662719|NCT02061761|459388887|FG008|Overall Study|Maximum clinical benefit|6|||
127662720|NCT02061761|459388879|FG000|Overall Study|Participant no longer meets study criteria|0|||
127662721|NCT02061761|459388880|FG001|Overall Study|Participant no longer meets study criteria|0|||
127662722|NCT02061761|459388881|FG002|Overall Study|Participant no longer meets study criteria|0|||
127662723|NCT02061761|459388882|FG003|Overall Study|Participant no longer meets study criteria|0|||
127662724|NCT02061761|459388883|FG004|Overall Study|Participant no longer meets study criteria|0|||
127662725|NCT02061761|459388884|FG005|Overall Study|Participant no longer meets study criteria|0|||
127662726|NCT02061761|459388885|FG006|Overall Study|Participant no longer meets study criteria|0|||
127662727|NCT02061761|459388886|FG007|Overall Study|Participant no longer meets study criteria|0|||
127662728|NCT02061761|459388887|FG008|Overall Study|Participant no longer meets study criteria|1|||
127662729|NCT02061761|459388879|FG000|Overall Study|Other reasons|0|||
127662730|NCT02061761|459388880|FG001|Overall Study|Other reasons|0|||
127662731|NCT02061761|459388881|FG002|Overall Study|Other reasons|0|||
127662732|NCT02061761|459388882|FG003|Overall Study|Other reasons|0|||
127662733|NCT02061761|459388883|FG004|Overall Study|Other reasons|2|||
127662734|NCT02061761|459388884|FG005|Overall Study|Other reasons|0|||
127662735|NCT02061761|459388885|FG006|Overall Study|Other reasons|0|||
127662736|NCT02061761|459388886|FG007|Overall Study|Other reasons|0|||
127662737|NCT02061761|459388887|FG008|Overall Study|Other reasons|6|||
127662738|NCT02500316|459388894|FG000|Overall Study|Adverse Event|3|||
127662739|NCT02500316|459388894|FG000|Overall Study|Lost to Follow-up|2|||
127662740|NCT02500316|459388894|FG000|Overall Study|Protocol Violation|1|||
127662741|NCT02500316|459388894|FG000|Overall Study|Withdrawal by Subject|15|||
127662742|NCT02500316|459388894|FG000|Overall Study|Final height achieved|5|||
127662743|NCT02500316|459388894|FG000|Overall Study|Due to war activity|1|||
127662744|NCT02611830|459388896|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
127662745|NCT02611830|459388897|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
127662746|NCT02611830|459388898|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
127662747|NCT02611830|459388899|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
127662748|NCT02611830|459388896|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
127662749|NCT02611830|459388897|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
127662750|NCT02611830|459388898|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
127662751|NCT02611830|459388899|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
127662752|NCT02611830|459388896|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
127662753|NCT02611830|459388897|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
127662754|NCT02611830|459388898|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
127662755|NCT02611830|459388899|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
127662756|NCT02611830|459388896|FG000|OL Induction Phase|Lack of Efficacy|9|||
127662757|NCT02611830|459388897|FG001|OL Induction Phase|Lack of Efficacy|0|||
127662758|NCT02611830|459388898|FG002|OL Induction Phase|Lack of Efficacy|0|||
127662759|NCT02611830|459388899|FG003|OL Induction Phase|Lack of Efficacy|0|||
127662760|NCT02611830|459388896|FG000|OL Induction Phase|Reason not specified|3|||
127662761|NCT02611830|459388897|FG001|OL Induction Phase|Reason not specified|0|||
127662762|NCT02611830|459388898|FG002|OL Induction Phase|Reason not specified|0|||
127662763|NCT02611830|459388899|FG003|OL Induction Phase|Reason not specified|0|||
127662764|NCT02611830|459388896|FG000|Maintenance Phase|Lack of Efficacy|0|||
127662765|NCT02611830|459388897|FG001|Maintenance Phase|Lack of Efficacy|29|||
127662766|NCT02611830|459388898|FG002|Maintenance Phase|Lack of Efficacy|18|||
127662767|NCT02611830|459388899|FG003|Maintenance Phase|Lack of Efficacy|6|||
127662768|NCT02611830|459388896|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
127662769|NCT02611830|459388897|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
127662770|NCT02611830|459388898|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
127662771|NCT02611830|459388899|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
127662772|NCT02611830|459388896|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
127662773|NCT02611830|459388897|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
127662774|NCT02611830|459388898|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
127662775|NCT02611830|459388899|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
127662776|NCT02611830|459388896|FG000|Maintenance Phase|Lost to Follow-up|0|||
127662777|NCT02611830|459388897|FG001|Maintenance Phase|Lost to Follow-up|0|||
127662778|NCT02611830|459388898|FG002|Maintenance Phase|Lost to Follow-up|0|||
127662779|NCT02611830|459388899|FG003|Maintenance Phase|Lost to Follow-up|1|||
127662780|NCT02611830|459388896|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
127662781|NCT02611830|459388897|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
127662782|NCT02611830|459388898|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
127662783|NCT02611830|459388899|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
127662784|NCT02611830|459388896|FG000|Maintenance Phase|Pregnancy|0|||
127662785|NCT02611830|459388897|FG001|Maintenance Phase|Pregnancy|0|||
127662786|NCT02611830|459388898|FG002|Maintenance Phase|Pregnancy|1|||
127662787|NCT02611830|459388899|FG003|Maintenance Phase|Pregnancy|0|||
127662788|NCT02611830|459388896|FG000|Maintenance Phase|Reason not specified|0|||
127662789|NCT02611830|459388897|FG001|Maintenance Phase|Reason not specified|1|||
127662790|NCT02611830|459388898|FG002|Maintenance Phase|Reason not specified|4|||
127662791|NCT02611830|459388899|FG003|Maintenance Phase|Reason not specified|0|||
127662792|NCT00903786|459388905|FG000|Overall Study|Physician Decision|6|||
127662793|NCT00903786|459388905|FG000|Overall Study|Lack of Efficacy|5|||
127662794|NCT00903786|459388905|FG000|Overall Study|Reason other than lack of efficacy|4|||
127662795|NCT01163747|459388909|FG000|Overall Study|Adverse Event|0|||
127662796|NCT01163747|459388910|FG001|Overall Study|Adverse Event|5|||
127662797|NCT01163747|459388909|FG000|Overall Study|Insufficient Therapeutic Response|0|||
127662798|NCT01163747|459388910|FG001|Overall Study|Insufficient Therapeutic Response|1|||
127662799|NCT01163747|459388909|FG000|Overall Study|Protocol Violation|0|||
127662800|NCT01163747|459388910|FG001|Overall Study|Protocol Violation|1|||
127662801|NCT01163747|459388909|FG000|Overall Study|Refused Treatment|6|||
127662802|NCT01163747|459388910|FG001|Overall Study|Refused Treatment|4|||
127662803|NCT03363659|459388911|FG000|Overall Study|Adverse Event|1|||
127662804|NCT03363659|459388911|FG000|Overall Study|Screen fail|1|||
127662805|NCT03363659|459388911|FG000|Overall Study|Withdrawal by Subject|1|||
127662806|NCT03872388|459388912|FG000|Overall Study|Disease Progression|0|||
127662807|NCT03872388|459388913|FG001|Overall Study|Disease Progression|0|||
127662808|NCT03872388|459388914|FG002|Overall Study|Disease Progression|0|||
127662809|NCT03872388|459388915|FG003|Overall Study|Disease Progression|0|||
127662810|NCT03872388|459388916|FG004|Overall Study|Disease Progression|0|||
127662811|NCT03872388|459388917|FG005|Overall Study|Disease Progression|0|||
127662812|NCT03872388|459388918|FG006|Overall Study|Disease Progression|1|||
127662813|NCT03872388|459388919|FG007|Overall Study|Disease Progression|1|||
127662814|NCT00581113|459390663|FG000|Overall Study|Withdrawal by Subject|0|||
127662815|NCT00581113|459390664|FG001|Overall Study|Withdrawal by Subject|1|||
127662816|NCT00619476|459390665|FG000|Overall Study|Adverse Event|12|||
127662817|NCT00619476|459390666|FG001|Overall Study|Adverse Event|6|||
127662818|NCT00619476|459390667|FG002|Overall Study|Adverse Event|12|||
127662819|NCT00619476|459390668|FG003|Overall Study|Adverse Event|16|||
127662820|NCT00619476|459390665|FG000|Overall Study|Lack of Efficacy|6|||
127662821|NCT00619476|459390666|FG001|Overall Study|Lack of Efficacy|1|||
127662822|NCT00619476|459390667|FG002|Overall Study|Lack of Efficacy|1|||
127662823|NCT00619476|459390668|FG003|Overall Study|Lack of Efficacy|4|||
127662824|NCT00619476|459390665|FG000|Overall Study|Protocol Violation|5|||
127662825|NCT00619476|459390666|FG001|Overall Study|Protocol Violation|4|||
127662826|NCT00619476|459390667|FG002|Overall Study|Protocol Violation|4|||
127662827|NCT00619476|459390668|FG003|Overall Study|Protocol Violation|9|||
127662828|NCT00619476|459390665|FG000|Overall Study|Lost to Follow-up|1|||
127662829|NCT00619476|459390666|FG001|Overall Study|Lost to Follow-up|2|||
127662830|NCT00619476|459390667|FG002|Overall Study|Lost to Follow-up|0|||
127662831|NCT00619476|459390668|FG003|Overall Study|Lost to Follow-up|1|||
127662832|NCT00619476|459390665|FG000|Overall Study|Investigator Discretion|2|||
127662833|NCT00619476|459390666|FG001|Overall Study|Investigator Discretion|2|||
127662834|NCT00619476|459390667|FG002|Overall Study|Investigator Discretion|2|||
127662835|NCT00619476|459390668|FG003|Overall Study|Investigator Discretion|0|||
127662836|NCT00619476|459390665|FG000|Overall Study|Withdrawal by Subject|5|||
127662837|NCT00619476|459390666|FG001|Overall Study|Withdrawal by Subject|7|||
127662838|NCT00619476|459390667|FG002|Overall Study|Withdrawal by Subject|5|||
127662839|NCT00619476|459390668|FG003|Overall Study|Withdrawal by Subject|4|||
127662840|NCT01811563|459390669|FG000|Overall Study|Lost to Follow-up|5|||
127662841|NCT01811563|459390670|FG001|Overall Study|Lost to Follow-up|2|||
127662842|NCT01811563|459390669|FG000|Overall Study|Incorrect Randomization procedure|0|||
127662843|NCT01811563|459390670|FG001|Overall Study|Incorrect Randomization procedure|1|||
127662844|NCT01327547|459390671|FG000|Overall Study|Adverse Event|4|||
127662845|NCT01327547|459390672|FG001|Overall Study|Adverse Event|1|||
127662846|NCT01327547|459390671|FG000|Overall Study|Death|1|||
127662847|NCT01327547|459390672|FG001|Overall Study|Death|2|||
127662848|NCT01327547|459390671|FG000|Overall Study|Lost to Follow-up|6|||
127662849|NCT01327547|459390672|FG001|Overall Study|Lost to Follow-up|6|||
127662850|NCT01327547|459390671|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
127662851|NCT01327547|459390672|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
127662852|NCT01327547|459390671|FG000|Overall Study|Withdrawal by Subject|3|||
127662853|NCT01327547|459390672|FG001|Overall Study|Withdrawal by Subject|7|||
127662854|NCT01327547|459390671|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
127662855|NCT01327547|459390672|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
127662856|NCT01327547|459390671|FG000|Overall Study|Protocol Violation|1|||
127662857|NCT01327547|459390672|FG001|Overall Study|Protocol Violation|0|||
127662858|NCT01327547|459390671|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
127662859|NCT01327547|459390672|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
127662860|NCT01327547|459390671|FG000|Overall Study|Required prohibited medication|2|||
127662861|NCT01327547|459390672|FG001|Overall Study|Required prohibited medication|0|||
127662862|NCT01327547|459390671|FG000|Overall Study|Non-compliance with study procedures|1|||
127662863|NCT01327547|459390672|FG001|Overall Study|Non-compliance with study procedures|0|||
127662864|NCT01327547|459390671|FG000|Overall Study|By investigator in subject's interest|0|||
127662865|NCT01327547|459390672|FG001|Overall Study|By investigator in subject's interest|1|||
127662866|NCT00329719|459390673|FG000|Overall Study|Lost to Follow-up|0|||
127662867|NCT00329719|459390674|FG001|Overall Study|Lost to Follow-up|0|||
127662868|NCT00329719|459390675|FG002|Overall Study|Lost to Follow-up|0|||
127662869|NCT00329719|459390676|FG003|Overall Study|Lost to Follow-up|1|||
127662870|NCT02462083|459390679|FG000|Overall Study|Sponsor request|39|||
127543296|NCT00129402|458956531|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
127543297|NCT00129402|458956532|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
127543298|NCT00129402|458956526|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
127543299|NCT00129402|458956527|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
127543300|NCT00129402|458956528|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
127543301|NCT00129402|458956529|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
127543302|NCT00129402|458956530|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
127543303|NCT00129402|458956531|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
127543304|NCT00129402|458956532|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
127543305|NCT00129402|458956526|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
127543306|NCT00129402|458956527|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
127543307|NCT00129402|458956528|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
127543308|NCT00129402|458956529|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
127543309|NCT00129402|458956530|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
127543310|NCT00129402|458956531|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
127543311|NCT00129402|458956532|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
127543312|NCT00129402|458956526|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
127543313|NCT00129402|458956527|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
127543314|NCT00129402|458956528|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
127543315|NCT00129402|458956529|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
127543316|NCT00129402|458956530|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
127543317|NCT00129402|458956531|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
127543318|NCT00129402|458956532|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
127543319|NCT00129402|458956526|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
127543320|NCT00129402|458956527|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
127543321|NCT00129402|458956528|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
127543322|NCT00129402|458956529|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
127543323|NCT00129402|458956530|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
127543324|NCT00129402|458956531|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
127543325|NCT00129402|458956532|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
127543326|NCT00129402|458956526|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
127543327|NCT00129402|458956527|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
127543328|NCT00129402|458956528|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
127543329|NCT00129402|458956529|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
127543330|NCT00129402|458956530|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
127543331|NCT00129402|458956531|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
127543332|NCT00129402|458956532|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
127543333|NCT00129402|458956526|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
127543334|NCT00129402|458956527|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
127543335|NCT00129402|458956528|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
127543336|NCT00129402|458956529|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
127543337|NCT00129402|458956530|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
127543338|NCT00129402|458956531|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
127543339|NCT00129402|458956532|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
127543340|NCT00129402|458956526|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
127543341|NCT00129402|458956527|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
127543342|NCT00129402|458956528|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
127543343|NCT00129402|458956529|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
127543344|NCT00129402|458956530|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
127543345|NCT00129402|458956531|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
127543346|NCT00129402|458956532|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
127543347|NCT00129402|458956526|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
127662871|NCT02462083|459390679|FG000|Overall Study|Withdrawal by Subject|87|||
127662872|NCT02462083|459390679|FG000|Overall Study|Lost to Follow-up|41|||
127662873|NCT02462083|459390679|FG000|Overall Study|Lack of Efficacy|151|||
127662874|NCT02462083|459390679|FG000|Overall Study|Pregnancy|1|||
127662875|NCT02462083|459390679|FG000|Overall Study|Protocol Violation|6|||
127662876|NCT02462083|459390679|FG000|Overall Study|Adverse Event|33|||
127662877|NCT02462083|459390679|FG000|Overall Study|Worsening condition|16|||
127662878|NCT02462083|459390679|FG000|Overall Study|Other than specified|45|||
127662879|NCT02291289|459390680|FG000|Induction Treatment|Withdrawal by Subject|0|||
127662880|NCT02291289|459390681|FG001|Induction Treatment|Withdrawal by Subject|0|||
127662881|NCT02291289|459390682|FG002|Induction Treatment|Withdrawal by Subject|0|||
127662882|NCT02291289|459390683|FG003|Induction Treatment|Withdrawal by Subject|24|||
127662883|NCT02291289|459390684|FG004|Induction Treatment|Withdrawal by Subject|0|||
127662884|NCT02291289|459390685|FG005|Induction Treatment|Withdrawal by Subject|0|||
127662885|NCT02291289|459390686|FG006|Induction Treatment|Withdrawal by Subject|0|||
127662886|NCT02291289|459390687|FG007|Induction Treatment|Withdrawal by Subject|0|||
127662887|NCT02291289|459390688|FG008|Induction Treatment|Withdrawal by Subject|0|||
127662888|NCT02291289|459390689|FG009|Induction Treatment|Withdrawal by Subject|18|||
127662889|NCT02291289|459390690|FG010|Induction Treatment|Withdrawal by Subject|0|||
127662890|NCT02291289|459390691|FG011|Induction Treatment|Withdrawal by Subject|0|||
127662891|NCT02291289|459390692|FG012|Induction Treatment|Withdrawal by Subject|0|||
127662892|NCT02291289|459390680|FG000|Induction Treatment|Adverse Event|0|||
127662893|NCT02291289|459390681|FG001|Induction Treatment|Adverse Event|0|||
127662894|NCT02291289|459390682|FG002|Induction Treatment|Adverse Event|0|||
127662895|NCT02291289|459390683|FG003|Induction Treatment|Adverse Event|3|||
127662896|NCT02291289|459390684|FG004|Induction Treatment|Adverse Event|0|||
127662897|NCT02291289|459390685|FG005|Induction Treatment|Adverse Event|0|||
127662898|NCT02291289|459390686|FG006|Induction Treatment|Adverse Event|0|||
127662899|NCT02291289|459390687|FG007|Induction Treatment|Adverse Event|0|||
127662900|NCT02291289|459390688|FG008|Induction Treatment|Adverse Event|0|||
127662901|NCT02291289|459390689|FG009|Induction Treatment|Adverse Event|1|||
127662902|NCT02291289|459390690|FG010|Induction Treatment|Adverse Event|0|||
127662903|NCT02291289|459390691|FG011|Induction Treatment|Adverse Event|0|||
127662904|NCT02291289|459390692|FG012|Induction Treatment|Adverse Event|0|||
127662905|NCT02291289|459390680|FG000|Induction Treatment|Death|25|||
127662906|NCT02291289|459390681|FG001|Induction Treatment|Death|0|||
127662907|NCT02291289|459390682|FG002|Induction Treatment|Death|0|||
127662908|NCT02291289|459390683|FG003|Induction Treatment|Death|111|||
127662909|NCT02291289|459390684|FG004|Induction Treatment|Death|0|||
127662910|NCT02291289|459390685|FG005|Induction Treatment|Death|0|||
127662911|NCT02291289|459390686|FG006|Induction Treatment|Death|1|||
127662912|NCT02291289|459390687|FG007|Induction Treatment|Death|0|||
127662913|NCT02291289|459390688|FG008|Induction Treatment|Death|0|||
127662914|NCT02291289|459390689|FG009|Induction Treatment|Death|82|||
127662915|NCT02291289|459390690|FG010|Induction Treatment|Death|0|||
127662916|NCT02291289|459390691|FG011|Induction Treatment|Death|0|||
127662917|NCT02291289|459390692|FG012|Induction Treatment|Death|0|||
127662918|NCT02291289|459390680|FG000|Induction Treatment|Lost to Follow-up|1|||
127662919|NCT02291289|459390681|FG001|Induction Treatment|Lost to Follow-up|0|||
127662920|NCT02291289|459390682|FG002|Induction Treatment|Lost to Follow-up|0|||
127662921|NCT02291289|459390683|FG003|Induction Treatment|Lost to Follow-up|12|||
127662922|NCT02291289|459390684|FG004|Induction Treatment|Lost to Follow-up|0|||
127662923|NCT02291289|459390685|FG005|Induction Treatment|Lost to Follow-up|0|||
127662924|NCT02291289|459390686|FG006|Induction Treatment|Lost to Follow-up|0|||
127662925|NCT02291289|459390687|FG007|Induction Treatment|Lost to Follow-up|0|||
127662926|NCT02291289|459390688|FG008|Induction Treatment|Lost to Follow-up|0|||
127662927|NCT02291289|459390689|FG009|Induction Treatment|Lost to Follow-up|9|||
127662928|NCT02291289|459390690|FG010|Induction Treatment|Lost to Follow-up|0|||
127662929|NCT02291289|459390691|FG011|Induction Treatment|Lost to Follow-up|0|||
127662930|NCT02291289|459390692|FG012|Induction Treatment|Lost to Follow-up|0|||
127662931|NCT02291289|459390680|FG000|Induction Treatment|Non-Compliance|0|||
127662932|NCT02291289|459390681|FG001|Induction Treatment|Non-Compliance|0|||
127662933|NCT02291289|459390682|FG002|Induction Treatment|Non-Compliance|0|||
127662934|NCT02291289|459390683|FG003|Induction Treatment|Non-Compliance|1|||
127662935|NCT02291289|459390684|FG004|Induction Treatment|Non-Compliance|0|||
127662936|NCT02291289|459390685|FG005|Induction Treatment|Non-Compliance|0|||
127662937|NCT02291289|459390686|FG006|Induction Treatment|Non-Compliance|0|||
127662938|NCT02291289|459390687|FG007|Induction Treatment|Non-Compliance|0|||
127662939|NCT02291289|459390688|FG008|Induction Treatment|Non-Compliance|0|||
127662940|NCT02291289|459390689|FG009|Induction Treatment|Non-Compliance|1|||
127662941|NCT02291289|459390690|FG010|Induction Treatment|Non-Compliance|0|||
127662942|NCT02291289|459390691|FG011|Induction Treatment|Non-Compliance|0|||
127662943|NCT02291289|459390692|FG012|Induction Treatment|Non-Compliance|0|||
127662944|NCT02291289|459390680|FG000|Induction Treatment|Reason Not Specified|0|||
127662945|NCT02291289|459390681|FG001|Induction Treatment|Reason Not Specified|0|||
127662946|NCT02291289|459390682|FG002|Induction Treatment|Reason Not Specified|0|||
127662947|NCT02291289|459390683|FG003|Induction Treatment|Reason Not Specified|4|||
127662948|NCT02291289|459390684|FG004|Induction Treatment|Reason Not Specified|0|||
127662949|NCT02291289|459390685|FG005|Induction Treatment|Reason Not Specified|0|||
127662950|NCT02291289|459390686|FG006|Induction Treatment|Reason Not Specified|0|||
127662951|NCT02291289|459390687|FG007|Induction Treatment|Reason Not Specified|0|||
127662952|NCT02291289|459390688|FG008|Induction Treatment|Reason Not Specified|0|||
127662953|NCT02291289|459390689|FG009|Induction Treatment|Reason Not Specified|7|||
127662954|NCT02291289|459390690|FG010|Induction Treatment|Reason Not Specified|0|||
127662955|NCT02291289|459390691|FG011|Induction Treatment|Reason Not Specified|0|||
127662956|NCT02291289|459390692|FG012|Induction Treatment|Reason Not Specified|0|||
127662957|NCT02291289|459390680|FG000|Induction Treatment|Physician Decision|0|||
127662958|NCT02291289|459390681|FG001|Induction Treatment|Physician Decision|0|||
127662959|NCT02291289|459390682|FG002|Induction Treatment|Physician Decision|0|||
127662960|NCT02291289|459390683|FG003|Induction Treatment|Physician Decision|3|||
127662961|NCT02291289|459390684|FG004|Induction Treatment|Physician Decision|0|||
127662962|NCT02291289|459390685|FG005|Induction Treatment|Physician Decision|0|||
127662963|NCT02291289|459390686|FG006|Induction Treatment|Physician Decision|0|||
127662964|NCT02291289|459390687|FG007|Induction Treatment|Physician Decision|0|||
127662965|NCT02291289|459390688|FG008|Induction Treatment|Physician Decision|0|||
127662966|NCT02291289|459390689|FG009|Induction Treatment|Physician Decision|1|||
127662967|NCT02291289|459390690|FG010|Induction Treatment|Physician Decision|0|||
127662968|NCT02291289|459390691|FG011|Induction Treatment|Physician Decision|0|||
127662969|NCT02291289|459390692|FG012|Induction Treatment|Physician Decision|0|||
127662970|NCT02291289|459390680|FG000|Induction Treatment|Protocol Violation|0|||
127662971|NCT02291289|459390681|FG001|Induction Treatment|Protocol Violation|0|||
127662972|NCT02291289|459390682|FG002|Induction Treatment|Protocol Violation|0|||
127662973|NCT02291289|459390683|FG003|Induction Treatment|Protocol Violation|3|||
127662974|NCT02291289|459390684|FG004|Induction Treatment|Protocol Violation|0|||
127662975|NCT02291289|459390685|FG005|Induction Treatment|Protocol Violation|0|||
127662976|NCT02291289|459390686|FG006|Induction Treatment|Protocol Violation|0|||
127662977|NCT02291289|459390687|FG007|Induction Treatment|Protocol Violation|0|||
127662978|NCT02291289|459390688|FG008|Induction Treatment|Protocol Violation|0|||
127662979|NCT02291289|459390689|FG009|Induction Treatment|Protocol Violation|2|||
127662980|NCT02291289|459390690|FG010|Induction Treatment|Protocol Violation|0|||
127662981|NCT02291289|459390691|FG011|Induction Treatment|Protocol Violation|0|||
127662982|NCT02291289|459390692|FG012|Induction Treatment|Protocol Violation|0|||
127662983|NCT02291289|459390680|FG000|Induction Treatment|Missing|4|||
127662984|NCT02291289|459390681|FG001|Induction Treatment|Missing|0|||
127662985|NCT02291289|459390682|FG002|Induction Treatment|Missing|0|||
127662986|NCT02291289|459390683|FG003|Induction Treatment|Missing|14|||
127662987|NCT02291289|459390684|FG004|Induction Treatment|Missing|0|||
127662988|NCT02291289|459390685|FG005|Induction Treatment|Missing|0|||
127662989|NCT02291289|459390686|FG006|Induction Treatment|Missing|0|||
127662990|NCT02291289|459390687|FG007|Induction Treatment|Missing|0|||
127662991|NCT02291289|459390688|FG008|Induction Treatment|Missing|0|||
127662992|NCT02291289|459390689|FG009|Induction Treatment|Missing|54|||
127662993|NCT02291289|459390690|FG010|Induction Treatment|Missing|0|||
127662994|NCT02291289|459390691|FG011|Induction Treatment|Missing|0|||
127662995|NCT02291289|459390692|FG012|Induction Treatment|Missing|0|||
127662996|NCT02291289|459390680|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
127662997|NCT02291289|459390681|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
127662998|NCT02291289|459390682|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
127662999|NCT02291289|459390683|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
127663000|NCT02291289|459390684|FG004|Maintenance Treatment Phase|Withdrawal by Subject|15|||
127663001|NCT02291289|459390685|FG005|Maintenance Treatment Phase|Withdrawal by Subject|12|||
127663002|NCT02291289|459390686|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
127663003|NCT02291289|459390687|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
127663004|NCT02291289|459390688|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
127663005|NCT02291289|459390689|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
127663006|NCT02291289|459390690|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
127663007|NCT02291289|459390691|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
127663008|NCT02291289|459390692|FG012|Maintenance Treatment Phase|Withdrawal by Subject|0|||
127663009|NCT02291289|459390680|FG000|Maintenance Treatment Phase|Death|0|||
127663010|NCT02291289|459390681|FG001|Maintenance Treatment Phase|Death|29|||
127663011|NCT02291289|459390682|FG002|Maintenance Treatment Phase|Death|16|||
127663012|NCT02291289|459390683|FG003|Maintenance Treatment Phase|Death|0|||
127663013|NCT02291289|459390684|FG004|Maintenance Treatment Phase|Death|188|||
127663014|NCT02291289|459390685|FG005|Maintenance Treatment Phase|Death|107|||
127663015|NCT02291289|459390686|FG006|Maintenance Treatment Phase|Death|0|||
127663016|NCT02291289|459390687|FG007|Maintenance Treatment Phase|Death|1|||
127663017|NCT02291289|459390688|FG008|Maintenance Treatment Phase|Death|1|||
127663018|NCT02291289|459390689|FG009|Maintenance Treatment Phase|Death|0|||
127663019|NCT02291289|459390690|FG010|Maintenance Treatment Phase|Death|46|||
127663020|NCT02291289|459390691|FG011|Maintenance Treatment Phase|Death|19|||
127663021|NCT02291289|459390692|FG012|Maintenance Treatment Phase|Death|0|||
127663022|NCT02291289|459390680|FG000|Maintenance Treatment Phase|Adverse Event|0|||
127663023|NCT02291289|459390681|FG001|Maintenance Treatment Phase|Adverse Event|0|||
127663024|NCT02291289|459390682|FG002|Maintenance Treatment Phase|Adverse Event|0|||
127663025|NCT02291289|459390683|FG003|Maintenance Treatment Phase|Adverse Event|0|||
127663026|NCT02291289|459390684|FG004|Maintenance Treatment Phase|Adverse Event|1|||
127663027|NCT02291289|459390685|FG005|Maintenance Treatment Phase|Adverse Event|1|||
127663028|NCT02291289|459390686|FG006|Maintenance Treatment Phase|Adverse Event|0|||
127663029|NCT02291289|459390687|FG007|Maintenance Treatment Phase|Adverse Event|0|||
127663030|NCT02291289|459390688|FG008|Maintenance Treatment Phase|Adverse Event|0|||
127663031|NCT02291289|459390689|FG009|Maintenance Treatment Phase|Adverse Event|0|||
127663032|NCT02291289|459390690|FG010|Maintenance Treatment Phase|Adverse Event|0|||
127663033|NCT02291289|459390691|FG011|Maintenance Treatment Phase|Adverse Event|0|||
127663034|NCT02291289|459390692|FG012|Maintenance Treatment Phase|Adverse Event|0|||
127663035|NCT02291289|459390680|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
127663036|NCT02291289|459390681|FG001|Maintenance Treatment Phase|Lost to Follow-up|1|||
127663037|NCT02291289|459390682|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
127663038|NCT02291289|459390683|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
127663039|NCT02291289|459390684|FG004|Maintenance Treatment Phase|Lost to Follow-up|15|||
127663040|NCT02291289|459390685|FG005|Maintenance Treatment Phase|Lost to Follow-up|4|||
127663041|NCT02291289|459390686|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
127663042|NCT02291289|459390687|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
127663043|NCT02291289|459390688|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
127663044|NCT02291289|459390689|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
127663045|NCT02291289|459390690|FG010|Maintenance Treatment Phase|Lost to Follow-up|3|||
127663046|NCT02291289|459390691|FG011|Maintenance Treatment Phase|Lost to Follow-up|3|||
127663047|NCT02291289|459390692|FG012|Maintenance Treatment Phase|Lost to Follow-up|0|||
127663048|NCT02291289|459390680|FG000|Maintenance Treatment Phase|Reason Not Specified|0|||
127663049|NCT02291289|459390681|FG001|Maintenance Treatment Phase|Reason Not Specified|0|||
127663050|NCT02291289|459390682|FG002|Maintenance Treatment Phase|Reason Not Specified|0|||
127663051|NCT02291289|459390683|FG003|Maintenance Treatment Phase|Reason Not Specified|0|||
127663052|NCT02291289|459390684|FG004|Maintenance Treatment Phase|Reason Not Specified|7|||
127663053|NCT02291289|459390685|FG005|Maintenance Treatment Phase|Reason Not Specified|2|||
127663054|NCT02291289|459390686|FG006|Maintenance Treatment Phase|Reason Not Specified|0|||
127663055|NCT02291289|459390687|FG007|Maintenance Treatment Phase|Reason Not Specified|1|||
127663056|NCT02291289|459390688|FG008|Maintenance Treatment Phase|Reason Not Specified|0|||
127663057|NCT02291289|459390689|FG009|Maintenance Treatment Phase|Reason Not Specified|0|||
127663058|NCT02291289|459390690|FG010|Maintenance Treatment Phase|Reason Not Specified|1|||
127663059|NCT02291289|459390691|FG011|Maintenance Treatment Phase|Reason Not Specified|0|||
127663060|NCT02291289|459390692|FG012|Maintenance Treatment Phase|Reason Not Specified|0|||
127663061|NCT02291289|459390680|FG000|Maintenance Treatment Phase|Physician Decision|0|||
127663062|NCT02291289|459390681|FG001|Maintenance Treatment Phase|Physician Decision|2|||
127663063|NCT02291289|459390682|FG002|Maintenance Treatment Phase|Physician Decision|0|||
127663064|NCT02291289|459390683|FG003|Maintenance Treatment Phase|Physician Decision|0|||
127663065|NCT02291289|459390684|FG004|Maintenance Treatment Phase|Physician Decision|3|||
127663066|NCT02291289|459390685|FG005|Maintenance Treatment Phase|Physician Decision|0|||
127663067|NCT02291289|459390686|FG006|Maintenance Treatment Phase|Physician Decision|0|||
127663068|NCT02291289|459390687|FG007|Maintenance Treatment Phase|Physician Decision|0|||
127663069|NCT02291289|459390688|FG008|Maintenance Treatment Phase|Physician Decision|0|||
127663070|NCT02291289|459390689|FG009|Maintenance Treatment Phase|Physician Decision|0|||
127663071|NCT02291289|459390690|FG010|Maintenance Treatment Phase|Physician Decision|1|||
127663072|NCT02291289|459390691|FG011|Maintenance Treatment Phase|Physician Decision|3|||
127663073|NCT02291289|459390692|FG012|Maintenance Treatment Phase|Physician Decision|0|||
127663074|NCT02291289|459390680|FG000|Maintenance Treatment Phase|Not Treated|0|||
127663075|NCT02291289|459390681|FG001|Maintenance Treatment Phase|Not Treated|0|||
127663076|NCT02291289|459390682|FG002|Maintenance Treatment Phase|Not Treated|2|||
127663077|NCT02291289|459390683|FG003|Maintenance Treatment Phase|Not Treated|0|||
127663078|NCT02291289|459390684|FG004|Maintenance Treatment Phase|Not Treated|0|||
127663079|NCT02291289|459390685|FG005|Maintenance Treatment Phase|Not Treated|0|||
127663080|NCT02291289|459390686|FG006|Maintenance Treatment Phase|Not Treated|0|||
127663081|NCT02291289|459390687|FG007|Maintenance Treatment Phase|Not Treated|0|||
127663082|NCT02291289|459390688|FG008|Maintenance Treatment Phase|Not Treated|0|||
127663083|NCT02291289|459390689|FG009|Maintenance Treatment Phase|Not Treated|0|||
127663084|NCT02291289|459390690|FG010|Maintenance Treatment Phase|Not Treated|0|||
127663085|NCT02291289|459390691|FG011|Maintenance Treatment Phase|Not Treated|0|||
127663086|NCT02291289|459390692|FG012|Maintenance Treatment Phase|Not Treated|0|||
127663087|NCT02291289|459390680|FG000|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
127663088|NCT02291289|459390681|FG001|Maintenance Treatment Phase|Study Ended by Sponsor|1|||
127663089|NCT02291289|459390682|FG002|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
127663090|NCT02291289|459390683|FG003|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
127663091|NCT02291289|459390684|FG004|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
127663092|NCT02291289|459390685|FG005|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
127663093|NCT02291289|459390686|FG006|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
127663094|NCT02291289|459390687|FG007|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
127663095|NCT02291289|459390688|FG008|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
127663096|NCT02291289|459390689|FG009|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
127663097|NCT02291289|459390690|FG010|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
127663098|NCT02291289|459390691|FG011|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
127663099|NCT02291289|459390692|FG012|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
127663100|NCT02291289|459390680|FG000|Maintenance Treatment Phase|Non-Compliance|0|||
127663101|NCT02291289|459390681|FG001|Maintenance Treatment Phase|Non-Compliance|1|||
127663102|NCT02291289|459390682|FG002|Maintenance Treatment Phase|Non-Compliance|0|||
127663103|NCT02291289|459390683|FG003|Maintenance Treatment Phase|Non-Compliance|0|||
127663104|NCT02291289|459390684|FG004|Maintenance Treatment Phase|Non-Compliance|2|||
127663105|NCT02291289|459390685|FG005|Maintenance Treatment Phase|Non-Compliance|1|||
127663106|NCT02291289|459390686|FG006|Maintenance Treatment Phase|Non-Compliance|0|||
127663107|NCT02291289|459390687|FG007|Maintenance Treatment Phase|Non-Compliance|0|||
127663108|NCT02291289|459390688|FG008|Maintenance Treatment Phase|Non-Compliance|0|||
127663109|NCT02291289|459390689|FG009|Maintenance Treatment Phase|Non-Compliance|0|||
127663110|NCT02291289|459390690|FG010|Maintenance Treatment Phase|Non-Compliance|0|||
127663111|NCT02291289|459390691|FG011|Maintenance Treatment Phase|Non-Compliance|0|||
127663112|NCT02291289|459390692|FG012|Maintenance Treatment Phase|Non-Compliance|0|||
127663113|NCT02291289|459390680|FG000|Early Disease Progression|Death|0|||
127663114|NCT02291289|459390681|FG001|Early Disease Progression|Death|0|||
127663115|NCT02291289|459390682|FG002|Early Disease Progression|Death|0|||
127663116|NCT02291289|459390683|FG003|Early Disease Progression|Death|0|||
127663117|NCT02291289|459390684|FG004|Early Disease Progression|Death|0|||
127663118|NCT02291289|459390685|FG005|Early Disease Progression|Death|0|||
127663119|NCT02291289|459390686|FG006|Early Disease Progression|Death|0|||
127663120|NCT02291289|459390687|FG007|Early Disease Progression|Death|0|||
127663121|NCT02291289|459390688|FG008|Early Disease Progression|Death|0|||
127663122|NCT02291289|459390689|FG009|Early Disease Progression|Death|0|||
127663123|NCT02291289|459390690|FG010|Early Disease Progression|Death|0|||
127663124|NCT02291289|459390691|FG011|Early Disease Progression|Death|0|||
127663125|NCT02291289|459390692|FG012|Early Disease Progression|Death|10|||
127663126|NCT02291289|459390680|FG000|Early Disease Progression|Lost to Follow-up|0|||
127663127|NCT02291289|459390681|FG001|Early Disease Progression|Lost to Follow-up|0|||
127663128|NCT02291289|459390682|FG002|Early Disease Progression|Lost to Follow-up|0|||
127663129|NCT02291289|459390683|FG003|Early Disease Progression|Lost to Follow-up|0|||
127663130|NCT02291289|459390684|FG004|Early Disease Progression|Lost to Follow-up|0|||
127663131|NCT02291289|459390685|FG005|Early Disease Progression|Lost to Follow-up|0|||
127663132|NCT02291289|459390686|FG006|Early Disease Progression|Lost to Follow-up|0|||
127663133|NCT02291289|459390687|FG007|Early Disease Progression|Lost to Follow-up|0|||
127663134|NCT02291289|459390688|FG008|Early Disease Progression|Lost to Follow-up|0|||
127663135|NCT02291289|459390689|FG009|Early Disease Progression|Lost to Follow-up|0|||
127663136|NCT02291289|459390690|FG010|Early Disease Progression|Lost to Follow-up|0|||
127663137|NCT02291289|459390691|FG011|Early Disease Progression|Lost to Follow-up|0|||
127663138|NCT02291289|459390692|FG012|Early Disease Progression|Lost to Follow-up|1|||
127663139|NCT01642186|459390695|FG000|Overall Study|Death|0|||
127663140|NCT01642186|459390696|FG001|Overall Study|Death|2|||
127663141|NCT01642186|459390697|FG002|Overall Study|Death|2|||
127663142|NCT01642186|459390695|FG000|Overall Study|Lost to Follow-up|0|||
127663143|NCT01642186|459390696|FG001|Overall Study|Lost to Follow-up|0|||
127663144|NCT01642186|459390697|FG002|Overall Study|Lost to Follow-up|1|||
127663145|NCT00506285|459390704|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
127663146|NCT00506285|459390705|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
127663147|NCT00506285|459390704|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
127663148|NCT00506285|459390705|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
127663149|NCT00506285|459390704|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
127663150|NCT00506285|459390705|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
127663151|NCT00506285|459390704|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
127663152|NCT00506285|459390705|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
127663153|NCT00506285|459390704|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
127663154|NCT00506285|459390705|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
127663155|NCT01089556|459390706|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
127663156|NCT01089556|459390707|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
127663157|NCT01089556|459390708|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
127663158|NCT01089556|459390709|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
127663159|NCT01089556|459390710|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
127663160|NCT01089556|459390711|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
127663161|NCT01089556|459390706|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
127663162|NCT01089556|459390707|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
127663163|NCT01089556|459390708|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
127663164|NCT01089556|459390709|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
127663165|NCT01089556|459390710|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
127663166|NCT01089556|459390711|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
127663167|NCT01089556|459390706|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
127663168|NCT01089556|459390707|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
127663169|NCT01089556|459390708|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
127663170|NCT01089556|459390709|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
127663171|NCT01089556|459390710|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
127663172|NCT01089556|459390711|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
127663173|NCT01089556|459390706|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
127663174|NCT01089556|459390707|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
127663175|NCT01089556|459390708|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
127663176|NCT01089556|459390709|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
127663177|NCT01089556|459390710|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
127663178|NCT01089556|459390711|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
127663179|NCT01089556|459390706|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
127663180|NCT01089556|459390707|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
127663181|NCT01089556|459390708|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
127663182|NCT01089556|459390709|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
127663183|NCT01089556|459390710|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
127663184|NCT01089556|459390711|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
127663185|NCT01089556|459390706|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
127663186|NCT01089556|459390707|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
127663187|NCT01089556|459390708|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
127663188|NCT01089556|459390709|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
127663189|NCT01089556|459390710|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
127663190|NCT01089556|459390711|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
127663191|NCT01089556|459390706|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
127663192|NCT01089556|459390707|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
127663193|NCT01089556|459390708|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
127663194|NCT01089556|459390709|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
127663195|NCT01089556|459390710|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
127663196|NCT01089556|459390711|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
127663197|NCT01089556|459390706|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
127663198|NCT01089556|459390707|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
127663199|NCT01089556|459390708|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
127663200|NCT01089556|459390709|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
127663201|NCT01089556|459390710|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
127663202|NCT01089556|459390711|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
127663203|NCT01089556|459390706|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
127663204|NCT01089556|459390707|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
127663205|NCT01089556|459390708|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
127663206|NCT01089556|459390709|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
127663207|NCT01089556|459390710|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
127663208|NCT01089556|459390711|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
127663209|NCT01089556|459390706|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
127663210|NCT01089556|459390707|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
127663211|NCT01089556|459390708|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
127663212|NCT01089556|459390709|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
127663213|NCT01089556|459390710|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
127663214|NCT01089556|459390711|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
127663215|NCT01089556|459390706|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
127663216|NCT01089556|459390707|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
127663217|NCT01089556|459390708|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
127663218|NCT01089556|459390709|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
127663219|NCT01089556|459390710|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
127663220|NCT01089556|459390711|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
127663221|NCT01089556|459390706|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
127663222|NCT01089556|459390707|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
127663223|NCT01089556|459390708|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
127663224|NCT01089556|459390709|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
127663225|NCT01089556|459390710|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
127663226|NCT01089556|459390711|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
127663227|NCT01089556|459390706|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
127663228|NCT01089556|459390707|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
127663229|NCT01089556|459390708|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
127663230|NCT01089556|459390709|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
127663231|NCT01089556|459390710|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
127663232|NCT01089556|459390711|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
127663233|NCT01089556|459390706|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
127663234|NCT01089556|459390707|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
127663235|NCT01089556|459390708|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
127663236|NCT01089556|459390709|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
127663237|NCT01089556|459390710|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
127663238|NCT01089556|459390711|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
127663239|NCT01089556|459390706|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
127663240|NCT01089556|459390707|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
127663241|NCT01089556|459390708|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
127663242|NCT01089556|459390709|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
127663243|NCT01089556|459390710|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
127663244|NCT01089556|459390711|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
127663245|NCT01238575|459390712|FG000|Overall Study|Lack of Efficacy|2|||
127663246|NCT01238575|459390713|FG001|Overall Study|Lack of Efficacy|4|||
127663247|NCT01238575|459390712|FG000|Overall Study|Adverse Event|2|||
127663248|NCT01238575|459390713|FG001|Overall Study|Adverse Event|0|||
127663249|NCT01950273|459390716|FG000|Overall Study|Protocol Violation|1|||
127663250|NCT01950273|459390717|FG001|Overall Study|Protocol Violation|0|||
127663251|NCT01950273|459390716|FG000|Overall Study|Withdrawal by Subject|2|||
127663252|NCT01950273|459390717|FG001|Overall Study|Withdrawal by Subject|0|||
127663253|NCT01950273|459390716|FG000|Overall Study|Other not defined above|1|||
127663254|NCT01950273|459390717|FG001|Overall Study|Other not defined above|0|||
127663255|NCT00432679|459390722|FG000|Overall Study|Adverse Event|2|||
127663256|NCT00432679|459390723|FG001|Overall Study|Adverse Event|1|||
127663257|NCT00432679|459390722|FG000|Overall Study|Withdrawal by Subject|3|||
127663258|NCT00432679|459390723|FG001|Overall Study|Withdrawal by Subject|2|||
127663259|NCT01177813|459390728|FG000|Overall Study|Adverse Event|8|||
127663260|NCT01177813|459390729|FG001|Overall Study|Adverse Event|2|||
127663261|NCT01177813|459390730|FG002|Overall Study|Adverse Event|4|||
127663262|NCT01177813|459390731|FG003|Overall Study|Adverse Event|6|||
127663263|NCT01177813|459390732|FG004|Overall Study|Adverse Event|3|||
127663264|NCT01177813|459390728|FG000|Overall Study|Lack of Efficacy|1|||
127663265|NCT01177813|459390729|FG001|Overall Study|Lack of Efficacy|0|||
127663266|NCT01177813|459390730|FG002|Overall Study|Lack of Efficacy|0|||
127663267|NCT01177813|459390731|FG003|Overall Study|Lack of Efficacy|0|||
127663268|NCT01177813|459390732|FG004|Overall Study|Lack of Efficacy|0|||
127663269|NCT01177813|459390728|FG000|Overall Study|Protocol Violation|3|||
127663270|NCT01177813|459390729|FG001|Overall Study|Protocol Violation|2|||
127663271|NCT01177813|459390730|FG002|Overall Study|Protocol Violation|2|||
127663272|NCT01177813|459390731|FG003|Overall Study|Protocol Violation|0|||
127663273|NCT01177813|459390732|FG004|Overall Study|Protocol Violation|1|||
127663274|NCT01177813|459390728|FG000|Overall Study|Lost to Follow-up|12|||
127663275|NCT01177813|459390729|FG001|Overall Study|Lost to Follow-up|5|||
127663276|NCT01177813|459390730|FG002|Overall Study|Lost to Follow-up|6|||
127663277|NCT01177813|459390731|FG003|Overall Study|Lost to Follow-up|3|||
127663278|NCT01177813|459390732|FG004|Overall Study|Lost to Follow-up|0|||
127663279|NCT01177813|459390728|FG000|Overall Study|Withdrawal by Subject|12|||
127663280|NCT01177813|459390729|FG001|Overall Study|Withdrawal by Subject|7|||
127663281|NCT01177813|459390730|FG002|Overall Study|Withdrawal by Subject|6|||
127663282|NCT01177813|459390731|FG003|Overall Study|Withdrawal by Subject|5|||
127663283|NCT01177813|459390732|FG004|Overall Study|Withdrawal by Subject|3|||
127663284|NCT01177813|459390728|FG000|Overall Study|Other reason not defined above|5|||
127663285|NCT01177813|459390729|FG001|Overall Study|Other reason not defined above|2|||
127663286|NCT01177813|459390730|FG002|Overall Study|Other reason not defined above|2|||
127663287|NCT01177813|459390731|FG003|Overall Study|Other reason not defined above|3|||
127663288|NCT01177813|459390732|FG004|Overall Study|Other reason not defined above|2|||
127663289|NCT00109928|459390735|FG000|Overall Study|Adverse Event|2|||
127663290|NCT00109928|459390735|FG000|Overall Study|Progression|6|||
127663291|NCT00109928|459390735|FG000|Overall Study|Death|2|||
127663292|NCT00109928|459390735|FG000|Overall Study|not protocol specified|2|||
127663293|NCT00109928|459390735|FG000|Overall Study|not eligible|1|||
127663294|NCT01196104|459390736|FG000|Overall Study|Lost to Follow-up|1|||
127663295|NCT01196104|459390737|FG001|Overall Study|Lost to Follow-up|0|||
127663296|NCT01196104|459390736|FG000|Overall Study|Physician Decision|0|||
127663297|NCT01196104|459390737|FG001|Overall Study|Physician Decision|1|||
127663298|NCT01196104|459390736|FG000|Overall Study|Withdrawal by Subject|3|||
127663299|NCT01196104|459390737|FG001|Overall Study|Withdrawal by Subject|3|||
127663300|NCT01196104|459390736|FG000|Overall Study|Various|0|||
127663301|NCT01196104|459390737|FG001|Overall Study|Various|1|||
127663302|NCT00610675|459390738|FG000|Overall Study|Untreated|4|||
127663303|NCT00610675|459390738|FG000|Overall Study|Adverse Event|67|||
127663304|NCT00610675|459390738|FG000|Overall Study|Insufficient Effect|31|||
127663305|NCT00610675|459390738|FG000|Overall Study|Withdrawal by Subject|28|||
127663306|NCT00610675|459390738|FG000|Overall Study|Reasons unrelated to trial|27|||
127663307|NCT00610675|459390738|FG000|Overall Study|Lack of Compliance|7|||
127663308|NCT00610675|459390738|FG000|Overall Study|Lost to Follow-up|31|||
127663309|NCT00610675|459390738|FG000|Overall Study|Other reason (not specified)|25|||
127663310|NCT01316692|459390741|FG000|Overall Study|Adverse Event|5|||
127663311|NCT01316692|459390741|FG000|Overall Study|Disease Progression|7|||
127663312|NCT03772314|459390748|FG000|Overall Study|Adverse Event|7|||
127663313|NCT03772314|459390749|FG001|Overall Study|Adverse Event|2|||
127663314|NCT01536145|459390750|FG000|Overall Study|Progressive disease|3|||
127663315|NCT01536145|459390751|FG001|Overall Study|Progressive disease|4|||
127663316|NCT01536145|459390752|FG002|Overall Study|Progressive disease|1|||
127663317|NCT01536145|459390753|FG003|Overall Study|Progressive disease|2|||
127663318|NCT01536145|459390754|FG004|Overall Study|Progressive disease|1|||
127663319|NCT01536145|459390755|FG005|Overall Study|Progressive disease|2|||
127663320|NCT01536145|459390756|FG006|Overall Study|Progressive disease|1|||
127663321|NCT01536145|459390757|FG007|Overall Study|Progressive disease|2|||
127663322|NCT01536145|459390758|FG008|Overall Study|Progressive disease|1|||
127663323|NCT01536145|459390759|FG009|Overall Study|Progressive disease|3|||
127663324|NCT01536145|459390760|FG010|Overall Study|Progressive disease|3|||
127663325|NCT01536145|459390750|FG000|Overall Study|Withdrawal by Subject|0|||
127663326|NCT01536145|459390751|FG001|Overall Study|Withdrawal by Subject|0|||
127663327|NCT01536145|459390752|FG002|Overall Study|Withdrawal by Subject|1|||
127663328|NCT01536145|459390753|FG003|Overall Study|Withdrawal by Subject|0|||
127663329|NCT01536145|459390754|FG004|Overall Study|Withdrawal by Subject|0|||
127663330|NCT01536145|459390755|FG005|Overall Study|Withdrawal by Subject|1|||
127663331|NCT01536145|459390756|FG006|Overall Study|Withdrawal by Subject|0|||
127663332|NCT01536145|459390757|FG007|Overall Study|Withdrawal by Subject|0|||
127663333|NCT01536145|459390758|FG008|Overall Study|Withdrawal by Subject|2|||
127663334|NCT01536145|459390759|FG009|Overall Study|Withdrawal by Subject|0|||
127663335|NCT01536145|459390760|FG010|Overall Study|Withdrawal by Subject|2|||
127663336|NCT01536145|459390750|FG000|Overall Study|Other|0|||
127663337|NCT01536145|459390751|FG001|Overall Study|Other|0|||
127663338|NCT01536145|459390752|FG002|Overall Study|Other|0|||
127663339|NCT01536145|459390753|FG003|Overall Study|Other|0|||
127663340|NCT01536145|459390754|FG004|Overall Study|Other|1|||
127663341|NCT01536145|459390755|FG005|Overall Study|Other|0|||
127663342|NCT01536145|459390756|FG006|Overall Study|Other|0|||
127663343|NCT01536145|459390757|FG007|Overall Study|Other|0|||
127663344|NCT01536145|459390758|FG008|Overall Study|Other|0|||
127663345|NCT01536145|459390759|FG009|Overall Study|Other|3|||
127663346|NCT01536145|459390760|FG010|Overall Study|Other|2|||
127663347|NCT01536145|459390750|FG000|Overall Study|Death|0|||
127663348|NCT01536145|459390751|FG001|Overall Study|Death|0|||
127663349|NCT01536145|459390752|FG002|Overall Study|Death|0|||
127663350|NCT01536145|459390753|FG003|Overall Study|Death|0|||
127663351|NCT01536145|459390754|FG004|Overall Study|Death|0|||
127663352|NCT01536145|459390755|FG005|Overall Study|Death|0|||
127663353|NCT01536145|459390756|FG006|Overall Study|Death|1|||
127663354|NCT01536145|459390757|FG007|Overall Study|Death|0|||
127663355|NCT01536145|459390758|FG008|Overall Study|Death|0|||
127663356|NCT01536145|459390759|FG009|Overall Study|Death|0|||
127663357|NCT01536145|459390760|FG010|Overall Study|Death|0|||
127663358|NCT01536145|459390750|FG000|Overall Study|Adverse Event|0|||
127663359|NCT01536145|459390751|FG001|Overall Study|Adverse Event|0|||
127663360|NCT01536145|459390752|FG002|Overall Study|Adverse Event|0|||
127663361|NCT01536145|459390753|FG003|Overall Study|Adverse Event|0|||
127663362|NCT01536145|459390754|FG004|Overall Study|Adverse Event|0|||
127663363|NCT01536145|459390755|FG005|Overall Study|Adverse Event|0|||
127663364|NCT01536145|459390756|FG006|Overall Study|Adverse Event|0|||
127663365|NCT01536145|459390757|FG007|Overall Study|Adverse Event|2|||
127663366|NCT01536145|459390758|FG008|Overall Study|Adverse Event|0|||
127663367|NCT01536145|459390759|FG009|Overall Study|Adverse Event|0|||
127663368|NCT01536145|459390760|FG010|Overall Study|Adverse Event|3|||
127663369|NCT01284140|459390763|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
127663370|NCT01284140|459390764|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
127663371|NCT01284140|459390763|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
127663372|NCT01284140|459390764|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
127663373|NCT00088205|459390765|FG000|Overall Study|Adverse Event|4|||
127663374|NCT00088205|459390765|FG000|Overall Study|Progressive Disease|51|||
127663375|NCT00088205|459390765|FG000|Overall Study|Physician Decision|1|||
127663376|NCT00088205|459390765|FG000|Overall Study|Death Due to Study Disease|4|||
127663377|NCT03192215|459390766|FG000|Overall Study|Death|28|||
127663378|NCT03192215|459390767|FG001|Overall Study|Death|23|||
127663379|NCT03192215|459390766|FG000|Overall Study|Lost to Follow-up|10|||
127663380|NCT03192215|459390767|FG001|Overall Study|Lost to Follow-up|15|||
127663381|NCT03192215|459390766|FG000|Overall Study|Withdrawal by Subject|49|||
127663382|NCT03192215|459390767|FG001|Overall Study|Withdrawal by Subject|48|||
127663383|NCT03192215|459390766|FG000|Overall Study|Other as reported in analysis|4|||
127663384|NCT03192215|459390767|FG001|Overall Study|Other as reported in analysis|1|||
127663385|NCT05199233|459390770|FG000|Overall Study|Lack of Efficacy|1|||
127663386|NCT02443103|459390777|FG000|Overall Study|Adverse Event|2|||
127663387|NCT02443103|459390777|FG000|Overall Study|Noncompliance|1|||
127663388|NCT01630590|459390778|FG000|Overall Study|Adverse Event|9|||
127663389|NCT01630590|459390778|FG000|Overall Study|Lack of Efficacy|37|||
127663390|NCT01630590|459390778|FG000|Overall Study|Withdrawal by Subject|4|||
127663391|NCT01630590|459390778|FG000|Overall Study|2nd primary tumor|2|||
127663392|NCT01630590|459390778|FG000|Overall Study|Automobile accident|1|||
127663393|NCT01630590|459390778|FG000|Overall Study|Maximum benefit|4|||
127663394|NCT02366936|459390779|FG000|Overall Study|Withdrawal by Subject|2|||
127663395|NCT02366936|459390779|FG000|Overall Study|Lost to Follow-up|4|||
127663396|NCT02366936|459390779|FG000|Overall Study|Physician Decision|2|||
127663397|NCT03358329|459390782|FG000|Overall Study|Lost to Follow-up|2|||
127663398|NCT03358329|459390782|FG000|Overall Study|Withdrawal by Subject|2|||
127663399|NCT02982720|459390783|FG000|Overall Study|Adverse Event|3|||
127663400|NCT02982720|459390783|FG000|Overall Study|Death|1|||
127663401|NCT00065468|459390788|FG000|Overall Study|Death|172|||
127663402|NCT00065468|459390789|FG001|Overall Study|Death|169|||
127663403|NCT00065468|459390790|FG002|Overall Study|Death|171|||
127663404|NCT00065468|459390788|FG000|Overall Study|Withdrawal by Subject|3|||
127663405|NCT00065468|459390789|FG001|Overall Study|Withdrawal by Subject|4|||
127663406|NCT00065468|459390790|FG002|Overall Study|Withdrawal by Subject|5|||
127663407|NCT00065468|459390788|FG000|Overall Study|Lost to Follow-up|5|||
127663408|NCT00065468|459390789|FG001|Overall Study|Lost to Follow-up|3|||
127663409|NCT00065468|459390790|FG002|Overall Study|Lost to Follow-up|2|||
127663410|NCT00065468|459390788|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
127663411|NCT00065468|459390789|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
127663412|NCT00065468|459390790|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
127663413|NCT00065468|459390788|FG000|Overall Study|Disease progression|0|||
127663414|NCT00065468|459390789|FG001|Overall Study|Disease progression|0|||
127663415|NCT00065468|459390790|FG002|Overall Study|Disease progression|1|||
127663416|NCT00065468|459390788|FG000|Overall Study|Other|14|||
127663417|NCT00065468|459390789|FG001|Overall Study|Other|24|||
127663418|NCT00065468|459390790|FG002|Overall Study|Other|18|||
127663419|NCT01225835|459390791|FG000|Overall Study|Completed protocol|2|||
127663420|NCT01225835|459390792|FG001|Overall Study|Completed protocol|1|||
127663421|NCT01225835|459390791|FG000|Overall Study|Did not meet hCG criterion|2|||
127663422|NCT01225835|459390792|FG001|Overall Study|Did not meet hCG criterion|0|||
127663423|NCT01225835|459390791|FG000|Overall Study|Adverse Event|2|||
127663424|NCT01225835|459390792|FG001|Overall Study|Adverse Event|1|||
127663425|NCT01225835|459390791|FG000|Overall Study|Other|1|||
127663426|NCT01225835|459390792|FG001|Overall Study|Other|1|||
127663427|NCT02589392|459390793|FG000|Overall Study|Adverse Event|1|||
127663428|NCT02589392|459390794|FG001|Overall Study|Adverse Event|1|||
127663429|NCT02589392|459390793|FG000|Overall Study|Withdrawal by Subject|1|||
127663430|NCT02589392|459390794|FG001|Overall Study|Withdrawal by Subject|2|||
127663431|NCT02589392|459390793|FG000|Overall Study|Protocol Violation|1|||
127663432|NCT02589392|459390794|FG001|Overall Study|Protocol Violation|1|||
127663433|NCT02589392|459390793|FG000|Overall Study|Lost to Follow-up|2|||
127663434|NCT02589392|459390794|FG001|Overall Study|Lost to Follow-up|2|||
127663435|NCT02589392|459390793|FG000|Overall Study|Sponsor decision to withdraw subject|1|||
127663436|NCT02589392|459390794|FG001|Overall Study|Sponsor decision to withdraw subject|0|||
127663437|NCT02207374|459390799|FG000|Overall Study|Withdrawal by Subject|5|||
127663438|NCT02207374|459390800|FG001|Overall Study|Withdrawal by Subject|9|||
127663439|NCT02207374|459390801|FG002|Overall Study|Withdrawal by Subject|4|||
127663440|NCT02207374|459390799|FG000|Overall Study|Death|1|||
127663441|NCT02207374|459390800|FG001|Overall Study|Death|0|||
127663442|NCT02207374|459390801|FG002|Overall Study|Death|1|||
127663443|NCT02207374|459390799|FG000|Overall Study|Missing follow-up information|0|||
127663444|NCT02207374|459390800|FG001|Overall Study|Missing follow-up information|1|||
127663445|NCT02207374|459390801|FG002|Overall Study|Missing follow-up information|1|||
127663446|NCT02087150|459390802|FG000|Overall Study|Death|0|||
127663447|NCT02087150|459390803|FG001|Overall Study|Death|1|||
127663448|NCT02087150|459390804|FG002|Overall Study|Death|0|||
127663449|NCT02087150|459390802|FG000|Overall Study|Lost to Follow-up|6|||
127663450|NCT02087150|459390803|FG001|Overall Study|Lost to Follow-up|13|||
127663451|NCT02087150|459390804|FG002|Overall Study|Lost to Follow-up|7|||
127663452|NCT02087150|459390802|FG000|Overall Study|Withdrawal by Subject|2|||
127663453|NCT02087150|459390803|FG001|Overall Study|Withdrawal by Subject|5|||
127663454|NCT02087150|459390804|FG002|Overall Study|Withdrawal by Subject|3|||
127663455|NCT02087150|459390802|FG000|Overall Study|Physician Decision|0|||
127663456|NCT02087150|459390803|FG001|Overall Study|Physician Decision|1|||
127663457|NCT02087150|459390804|FG002|Overall Study|Physician Decision|0|||
127663458|NCT02087150|459390802|FG000|Overall Study|Procedure not done|1|||
127663459|NCT02087150|459390803|FG001|Overall Study|Procedure not done|13|||
127663460|NCT02087150|459390804|FG002|Overall Study|Procedure not done|0|||
127663461|NCT02087150|459390802|FG000|Overall Study|F/U not completed w/in study window|0|||
127663462|NCT02087150|459390803|FG001|Overall Study|F/U not completed w/in study window|0|||
127663463|NCT02087150|459390804|FG002|Overall Study|F/U not completed w/in study window|1|||
127663464|NCT02087150|459390802|FG000|Overall Study|Other|1|||
127663465|NCT02087150|459390803|FG001|Overall Study|Other|0|||
127663466|NCT02087150|459390804|FG002|Overall Study|Other|0|||
127663467|NCT02087150|459390802|FG000|Overall Study|Pt moved out of town|0|||
127663468|NCT02087150|459390803|FG001|Overall Study|Pt moved out of town|1|||
127663469|NCT02087150|459390804|FG002|Overall Study|Pt moved out of town|0|||
127990792|NCT01402986|460592376|FG001|Overall Study|Withdrawal by Subject|10|||
127663470|NCT00972179|459390807|FG000|Overall Study|Noncompliance|1|||
127663471|NCT00972179|459390808|FG001|Overall Study|Noncompliance|0|||
127663472|NCT00972179|459390809|FG002|Overall Study|Noncompliance|0|||
127663473|NCT00972179|459390810|FG003|Overall Study|Noncompliance|0|||
127663474|NCT00972179|459390811|FG004|Overall Study|Noncompliance|1|||
127663475|NCT00972179|459390812|FG005|Overall Study|Noncompliance|0|||
127663476|NCT00972179|459390813|FG006|Overall Study|Noncompliance|1|||
127663477|NCT00972179|459390807|FG000|Overall Study|Withdrawal by Subject|0|||
127663478|NCT00972179|459390808|FG001|Overall Study|Withdrawal by Subject|3|||
127663479|NCT00972179|459390809|FG002|Overall Study|Withdrawal by Subject|0|||
127663480|NCT00972179|459390810|FG003|Overall Study|Withdrawal by Subject|1|||
127663481|NCT00972179|459390811|FG004|Overall Study|Withdrawal by Subject|0|||
127663482|NCT00972179|459390812|FG005|Overall Study|Withdrawal by Subject|0|||
127663483|NCT00972179|459390813|FG006|Overall Study|Withdrawal by Subject|2|||
127663484|NCT00972179|459390807|FG000|Overall Study|Administrative Decision|0|||
127663485|NCT00972179|459390808|FG001|Overall Study|Administrative Decision|0|||
127663486|NCT00972179|459390809|FG002|Overall Study|Administrative Decision|0|||
127663487|NCT00972179|459390810|FG003|Overall Study|Administrative Decision|0|||
127663488|NCT00972179|459390811|FG004|Overall Study|Administrative Decision|1|||
127663489|NCT00972179|459390812|FG005|Overall Study|Administrative Decision|0|||
127663490|NCT00972179|459390813|FG006|Overall Study|Administrative Decision|0|||
127663491|NCT00972179|459390807|FG000|Overall Study|Lost to Follow-up|0|||
127663492|NCT00972179|459390808|FG001|Overall Study|Lost to Follow-up|0|||
127663493|NCT00972179|459390809|FG002|Overall Study|Lost to Follow-up|1|||
127663494|NCT00972179|459390810|FG003|Overall Study|Lost to Follow-up|0|||
127663495|NCT00972179|459390811|FG004|Overall Study|Lost to Follow-up|0|||
127663496|NCT00972179|459390812|FG005|Overall Study|Lost to Follow-up|3|||
127663497|NCT00972179|459390813|FG006|Overall Study|Lost to Follow-up|1|||
127663498|NCT02285595|459390815|FG000|Overall Study|Lost to Follow-up|14|||
127663499|NCT02285595|459390815|FG000|Overall Study|Withdrawal by Subject|1|||
127990793|NCT01402986|460592377|FG002|Overall Study|Withdrawal by Subject|7|||
127990794|NCT01402986|460592378|FG003|Overall Study|Withdrawal by Subject|13|||
127990795|NCT01402986|460592375|FG000|Overall Study|Death|0|||
127990796|NCT01402986|460592376|FG001|Overall Study|Death|0|||
127663500|NCT00195715|459390816|FG000|Overall Study|Adverse Event|122|||
127663501|NCT00195715|459390816|FG000|Overall Study|Withdrawal by Subject|58|||
127663502|NCT00195715|459390816|FG000|Overall Study|Lost to Follow-up|27|||
127663503|NCT00195715|459390816|FG000|Overall Study|Protocol Violation|13|||
127663504|NCT00195715|459390816|FG000|Overall Study|Lack of Efficacy|93|||
127663505|NCT00195715|459390816|FG000|Overall Study|Pregnancy|14|||
127663506|NCT00195715|459390816|FG000|Overall Study|Investigative site closure|8|||
127663507|NCT00195715|459390816|FG000|Overall Study|Subject moved/relocated|7|||
127663508|NCT00195715|459390816|FG000|Overall Study|Subject non-compliance|6|||
127663509|NCT00195715|459390816|FG000|Overall Study|Subject started commercial Humira|5|||
127663510|NCT00195715|459390816|FG000|Overall Study|Subject choice|3|||
127663511|NCT00195715|459390816|FG000|Overall Study|Loss of response/no improvement|3|||
127663512|NCT00195715|459390816|FG000|Overall Study|Sponsor stopped study|1|||
127663513|NCT00195715|459390816|FG000|Overall Study|Administrative reasons|2|||
127663514|NCT00195715|459390816|FG000|Overall Study|Investigator's decision|2|||
127663515|NCT00195715|459390816|FG000|Overall Study|Subject wants to get pregnant|4|||
127663516|NCT00195715|459390816|FG000|Overall Study|Use of prohibited medication|2|||
127663517|NCT00195715|459390816|FG000|Overall Study|Planned surgery|2|||
127663518|NCT00195715|459390816|FG000|Overall Study|Increased infection rate|1|||
127663519|NCT00195715|459390816|FG000|Overall Study|Ineligible|1|||
127663520|NCT00195715|459390816|FG000|Overall Study|Colonic stricture|1|||
127663521|NCT00195715|459390816|FG000|Overall Study|Sponsor discontinued trial|1|||
127663522|NCT00195715|459390816|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
127663523|NCT00845871|459390820|FG000|Assessment Period|Adverse Event|2|||
127663524|NCT00845871|459390820|FG000|Assessment Period|Abnormal laboratory values|1|||
127663525|NCT00845871|459390820|FG000|Assessment Period|Abnormal test procedure results|1|||
127663526|NCT00845871|459390820|FG000|Assessment Period|Patient withdrew consent|3|||
127663527|NCT00064025|459390829|FG000|Overall Study|Ineligible|4|||
127663528|NCT00064025|459390829|FG000|Overall Study|Inevaluable|3|||
127663529|NCT02468934|459390832|FG000|Overall Study|Withdrawal by Subject|4|||
127663530|NCT02468934|459390832|FG000|Overall Study|Screen Failure|3|||
127663531|NCT01370603|459390833|FG000|Period 1|Adverse Event|5|||
127663532|NCT01370603|459390834|FG001|Period 1|Adverse Event|3|||
127663533|NCT01370603|459390833|FG000|Period 1|Lost to Follow-up|2|||
127990797|NCT01402986|460592377|FG002|Overall Study|Death|0|||
127990798|NCT01402986|460592378|FG003|Overall Study|Death|2|||
127663534|NCT01370603|459390834|FG001|Period 1|Lost to Follow-up|0|||
127663535|NCT01370603|459390833|FG000|Period 1|Protocol Violation|2|||
127663536|NCT01370603|459390834|FG001|Period 1|Protocol Violation|2|||
127663537|NCT01370603|459390833|FG000|Period 1|Withdrawal by Subject|5|||
127663538|NCT01370603|459390834|FG001|Period 1|Withdrawal by Subject|5|||
127663539|NCT01370603|459390833|FG000|Crossover Washout|Adverse Event|2|||
127663540|NCT01370603|459390834|FG001|Crossover Washout|Adverse Event|1|||
127663541|NCT01370603|459390833|FG000|Crossover Washout|Lost to Follow-up|2|||
127663542|NCT01370603|459390834|FG001|Crossover Washout|Lost to Follow-up|0|||
127663543|NCT01370603|459390833|FG000|Crossover Washout|Protocol Violation|1|||
127663544|NCT01370603|459390834|FG001|Crossover Washout|Protocol Violation|0|||
127663545|NCT01370603|459390833|FG000|Crossover Washout|Withdrawal by Subject|4|||
127990799|NCT01402986|460592375|FG000|Overall Study|Lost to Follow-up|0|||
127663546|NCT01370603|459390834|FG001|Crossover Washout|Withdrawal by Subject|1|||
127663547|NCT01370603|459390833|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
127663548|NCT01370603|459390834|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
127663549|NCT01370603|459390833|FG000|Period 2|Adverse Event|1|||
127663550|NCT01370603|459390834|FG001|Period 2|Adverse Event|4|||
127663551|NCT01370603|459390833|FG000|Period 2|Lost to Follow-up|1|||
127663552|NCT01370603|459390834|FG001|Period 2|Lost to Follow-up|0|||
127663553|NCT01370603|459390833|FG000|Period 2|Withdrawal by Subject|1|||
127663554|NCT01370603|459390834|FG001|Period 2|Withdrawal by Subject|0|||
127663555|NCT03681639|459393304|FG000|Overall Study|Death|4|||
127663556|NCT03681639|459393304|FG000|Overall Study|Lost to Follow-up|2|||
127663557|NCT03681639|459393304|FG000|Overall Study|Withdrawal by Subject|1|||
127663558|NCT03681639|459393304|FG000|Overall Study|Adverse Event|2|||
127663559|NCT00654940|459393305|FG000|Period 1|Adverse Event|0|||
127663560|NCT00654940|459393306|FG001|Period 1|Adverse Event|1|||
127663561|NCT00654940|459393305|FG000|Period 1|Intolerable Pain Level|1|||
127663562|NCT00654940|459393306|FG001|Period 1|Intolerable Pain Level|0|||
127663563|NCT04714216|459393307|FG000|Overall Study|Did not initiate AID due to CGM inaccuracies|2|||
127663564|NCT04714216|459393307|FG000|Overall Study|Discharged prior to 48 hours of AID|2|||
127663565|NCT01818141|459393308|FG000|Overall Study|Withdrawal by Subject|2|||
127663566|NCT01818141|459393309|FG001|Overall Study|Withdrawal by Subject|0|||
127663567|NCT01818141|459393308|FG000|Overall Study|No baseline C.diff colonies|1|||
127663568|NCT01818141|459393309|FG001|Overall Study|No baseline C.diff colonies|1|||
127663569|NCT01818141|459393308|FG000|Overall Study|Lost to Follow-up|0|||
127663570|NCT01818141|459393309|FG001|Overall Study|Lost to Follow-up|2|||
127663571|NCT04834362|459393313|FG000|Overall Study|Death|1|||
127663572|NCT04834362|459393314|FG001|Overall Study|Death|2|||
127663573|NCT00513019|459393318|FG000|Overall Study|Adverse Event|1|||
127663574|NCT00513019|459393319|FG001|Overall Study|Adverse Event|0|||
127663575|NCT00513019|459393318|FG000|Overall Study|Withdrawal by Subject|4|||
127663576|NCT00513019|459393319|FG001|Overall Study|Withdrawal by Subject|5|||
127663577|NCT01755689|459393320|FG000|Overall Study|Withdrawal by Subject|1|||
127663578|NCT01755689|459393321|FG001|Overall Study|Withdrawal by Subject|3|||
127663579|NCT01755689|459393322|FG002|Overall Study|Withdrawal by Subject|2|||
127663580|NCT01755689|459393323|FG003|Overall Study|Withdrawal by Subject|1|||
127663581|NCT01755689|459393324|FG004|Overall Study|Withdrawal by Subject|1|||
127663582|NCT01755689|459393320|FG000|Overall Study|Migrated/moved from study area|0|||
127663583|NCT01755689|459393321|FG001|Overall Study|Migrated/moved from study area|1|||
127663584|NCT01755689|459393322|FG002|Overall Study|Migrated/moved from study area|1|||
127990800|NCT01402986|460592376|FG001|Overall Study|Lost to Follow-up|0|||
127990801|NCT01402986|460592377|FG002|Overall Study|Lost to Follow-up|0|||
127990802|NCT01402986|460592378|FG003|Overall Study|Lost to Follow-up|1|||
127990803|NCT01402986|460592375|FG000|Overall Study|Other|2|||
127990804|NCT01402986|460592376|FG001|Overall Study|Other|5|||
127990805|NCT01402986|460592377|FG002|Overall Study|Other|1|||
127990806|NCT01402986|460592378|FG003|Overall Study|Other|6|||
127990807|NCT02427802|460592379|FG000|Overall Study|Adverse Event|11|||
127990808|NCT02427802|460592380|FG001|Overall Study|Adverse Event|3|||
127990809|NCT02427802|460592381|FG002|Overall Study|Adverse Event|7|||
127990810|NCT02427802|460592379|FG000|Overall Study|Death|0|||
127663585|NCT01755689|459393323|FG003|Overall Study|Migrated/moved from study area|1|||
127663586|NCT01755689|459393324|FG004|Overall Study|Migrated/moved from study area|1|||
127663587|NCT01755689|459393320|FG000|Overall Study|Lost to Follow-up|1|||
127663588|NCT01755689|459393321|FG001|Overall Study|Lost to Follow-up|0|||
127663589|NCT01755689|459393322|FG002|Overall Study|Lost to Follow-up|1|||
127663590|NCT01755689|459393323|FG003|Overall Study|Lost to Follow-up|0|||
127663591|NCT01755689|459393324|FG004|Overall Study|Lost to Follow-up|2|||
127663592|NCT01755689|459393320|FG000|Overall Study|Pregnancy|1|||
127663593|NCT01755689|459393321|FG001|Overall Study|Pregnancy|1|||
127663594|NCT01755689|459393322|FG002|Overall Study|Pregnancy|2|||
127663595|NCT01755689|459393323|FG003|Overall Study|Pregnancy|4|||
127663596|NCT01755689|459393324|FG004|Overall Study|Pregnancy|2|||
127663597|NCT01995357|459393325|FG000|Period 5|Lack of Efficacy|1|||
127663598|NCT01995357|459393326|FG001|Period 5|Lack of Efficacy|0|||
127663599|NCT01995357|459393327|FG002|Period 5|Lack of Efficacy|0|||
127663600|NCT01995357|459393328|FG003|Period 5|Lack of Efficacy|0|||
127663601|NCT01995357|459393329|FG004|Period 5|Lack of Efficacy|0|||
127990811|NCT02427802|460592380|FG001|Overall Study|Death|4|||
127663602|NCT01995357|459393330|FG005|Period 5|Lack of Efficacy|0|||
127663603|NCT01995357|459393325|FG000|Period 5|Adverse Event|1|||
127663604|NCT01995357|459393326|FG001|Period 5|Adverse Event|0|||
127663605|NCT01995357|459393327|FG002|Period 5|Adverse Event|1|||
127663606|NCT01995357|459393328|FG003|Period 5|Adverse Event|0|||
127663607|NCT01995357|459393329|FG004|Period 5|Adverse Event|0|||
127663608|NCT01995357|459393330|FG005|Period 5|Adverse Event|0|||
127663609|NCT02955277|459393331|FG000|Pre-Post Intervention|Withdrawal by Subject|5|||
127663610|NCT02955277|459393332|FG001|Pre-Post Intervention|Withdrawal by Subject|6|||
127663611|NCT02955277|459393331|FG000|Post to Follow-up|Lost to Follow-up|8|||
127663612|NCT02955277|459393332|FG001|Post to Follow-up|Lost to Follow-up|11|||
127990812|NCT02427802|460592381|FG002|Overall Study|Death|1|||
127990813|NCT02427802|460592379|FG000|Overall Study|Lost to Follow-up|13|||
127663613|NCT01668147|459393339|FG000|Overall Study|Withdrawal by Subject|6|||
127663614|NCT01809210|459393340|FG000|Overall Study|Withdrawal by Subject|0|||
127663615|NCT01809210|459393341|FG001|Overall Study|Withdrawal by Subject|0|||
127663616|NCT01809210|459393342|FG002|Overall Study|Withdrawal by Subject|1|||
127663617|NCT01809210|459393343|FG003|Overall Study|Withdrawal by Subject|1|||
127663618|NCT01809210|459393344|FG004|Overall Study|Withdrawal by Subject|1|||
127663619|NCT01809210|459393345|FG005|Overall Study|Withdrawal by Subject|0|||
127663620|NCT01809210|459393346|FG006|Overall Study|Withdrawal by Subject|4|||
127663621|NCT01809210|459393340|FG000|Overall Study|Death|1|||
127663622|NCT01809210|459393341|FG001|Overall Study|Death|1|||
127663623|NCT01809210|459393342|FG002|Overall Study|Death|2|||
127663624|NCT01809210|459393343|FG003|Overall Study|Death|0|||
127663625|NCT01809210|459393344|FG004|Overall Study|Death|1|||
127663626|NCT01809210|459393345|FG005|Overall Study|Death|3|||
127663627|NCT01809210|459393346|FG006|Overall Study|Death|1|||
127663628|NCT00590980|459393347|FG000|Overall Study|Did not meet all inclusion criteria|10|||
127663629|NCT03699124|459393348|FG000|Overall Study|Adverse Event|6|||
127663630|NCT03699124|459393349|FG001|Overall Study|Adverse Event|5|||
127663631|NCT03699124|459393350|FG002|Overall Study|Adverse Event|2|||
127663632|NCT03699124|459393348|FG000|Overall Study|Death|0|||
127663633|NCT03699124|459393349|FG001|Overall Study|Death|2|||
127663634|NCT03699124|459393350|FG002|Overall Study|Death|0|||
127663635|NCT03699124|459393348|FG000|Overall Study|Lost to Follow-up|20|||
127663636|NCT03699124|459393349|FG001|Overall Study|Lost to Follow-up|16|||
127663637|NCT03699124|459393350|FG002|Overall Study|Lost to Follow-up|15|||
127663638|NCT03699124|459393348|FG000|Overall Study|Protocol Violation|1|||
127663639|NCT03699124|459393349|FG001|Overall Study|Protocol Violation|0|||
127990814|NCT02427802|460592380|FG001|Overall Study|Lost to Follow-up|8|||
127990815|NCT02427802|460592381|FG002|Overall Study|Lost to Follow-up|8|||
127663640|NCT03699124|459393350|FG002|Overall Study|Protocol Violation|0|||
127663641|NCT03699124|459393348|FG000|Overall Study|Withdrawal by Subject|13|||
127663642|NCT03699124|459393349|FG001|Overall Study|Withdrawal by Subject|14|||
127663643|NCT03699124|459393350|FG002|Overall Study|Withdrawal by Subject|13|||
127663644|NCT03699124|459393348|FG000|Overall Study|Other reasons|5|||
127663645|NCT03699124|459393349|FG001|Overall Study|Other reasons|3|||
127663646|NCT03699124|459393350|FG002|Overall Study|Other reasons|10|||
127663647|NCT01118962|459393351|FG000|Overall Study|Adverse Event|2|||
127663648|NCT01118962|459393351|FG000|Overall Study|Lack of Efficacy|1|||
127663649|NCT01118962|459393351|FG000|Overall Study|Protocol Violation|1|||
127663650|NCT01118962|459393351|FG000|Overall Study|Withdrawal by Subject|4|||
127663651|NCT01118962|459393351|FG000|Overall Study|Pregnancy|1|||
127663652|NCT01118962|459393351|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
127663653|NCT00262743|459393352|FG000|Overall Study|Adverse Event|0|||
127663654|NCT00262743|459393353|FG001|Overall Study|Adverse Event|9|||
127663655|NCT00262743|459393352|FG000|Overall Study|Disease progression|0|||
127663656|NCT00262743|459393353|FG001|Overall Study|Disease progression|3|||
127663657|NCT04430335|459393358|FG000|Overall Study|Withdrawal by Subject|1|||
127663658|NCT01591460|459393375|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
127663659|NCT01591460|459393375|FG000|Overall Study|Futility Rule (Week 12)|7|||
127663660|NCT01591460|459393375|FG000|Overall Study|Futility Rule (Week 24)|3|||
127663661|NCT01591460|459393375|FG000|Overall Study|Rebound or Breakthrough|3|||
127663662|NCT01591460|459393375|FG000|Overall Study|Treatment Discontinued by Error|1|||
127663663|NCT01591460|459393375|FG000|Overall Study|Lost to Follow-up|1|||
127663664|NCT01591460|459393375|FG000|Overall Study|Noncompliance|1|||
127663665|NCT01591460|459393375|FG000|Overall Study|Participant Refusal|3|||
127663666|NCT01591460|459393375|FG000|Overall Study|Withdrawal by Subject|1|||
127663667|NCT01591460|459393375|FG000|Overall Study|Protocol Violation|1|||
127663668|NCT03230864|459393376|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
127663669|NCT03230864|459393377|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
127663670|NCT03230864|459393378|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
127663671|NCT03230864|459393379|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
127663672|NCT03230864|459393376|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
127663673|NCT03230864|459393377|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
127663674|NCT03230864|459393378|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
127663675|NCT03230864|459393379|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
127663676|NCT03230864|459393376|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
127663677|NCT03230864|459393377|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
127663678|NCT03230864|459393378|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
127663679|NCT03230864|459393379|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
127663680|NCT03230864|459393376|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
127663681|NCT03230864|459393377|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
127663682|NCT03230864|459393378|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
127663683|NCT03230864|459393379|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
127663684|NCT03230864|459393376|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
127705131|NCT01928394|459551580|FG013|Treatment Period|Poor/non-compliance|0|||
127663685|NCT03230864|459393377|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
127663686|NCT03230864|459393378|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
127663687|NCT03230864|459393379|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
127663688|NCT03230864|459393376|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
127663689|NCT03230864|459393377|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
127663690|NCT03230864|459393378|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
127663691|NCT03230864|459393379|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
127663692|NCT03230864|459393376|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
127663693|NCT03230864|459393377|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
127663694|NCT03230864|459393378|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
127663695|NCT03230864|459393379|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
127663696|NCT03230864|459393376|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
127663697|NCT03230864|459393377|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
127663698|NCT03230864|459393378|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
127663699|NCT03230864|459393379|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
127663700|NCT03230864|459393376|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
127663701|NCT03230864|459393377|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
127663702|NCT03230864|459393378|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
127663703|NCT03230864|459393379|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
127663704|NCT03230864|459393376|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
127663705|NCT03230864|459393377|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
127663706|NCT03230864|459393378|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
127663707|NCT03230864|459393379|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
127663708|NCT01744496|459393386|FG000|Titration Period|Adverse Event|2|||
127663709|NCT01744496|459393387|FG001|Titration Period|Adverse Event|1|||
127663710|NCT01744496|459393386|FG000|Titration Period|Personal reasons|0|||
127663711|NCT01744496|459393387|FG001|Titration Period|Personal reasons|1|||
127663712|NCT01744496|459393386|FG000|Maintenance Period|Adverse Event|1|||
127663713|NCT01744496|459393387|FG001|Maintenance Period|Adverse Event|3|||
127663714|NCT01744496|459393386|FG000|Maintenance Period|Protocol Violation|1|||
127663715|NCT01744496|459393387|FG001|Maintenance Period|Protocol Violation|0|||
127663716|NCT01744496|459393386|FG000|Maintenance Period|Withdrawal by Subject|1|||
127663717|NCT01744496|459393387|FG001|Maintenance Period|Withdrawal by Subject|1|||
127663718|NCT01744496|459393386|FG000|Maintenance Period|Subject left town|1|||
127663719|NCT01744496|459393387|FG001|Maintenance Period|Subject left town|0|||
127663720|NCT01567163|459393388|FG000|Overall Study|Progressive Disease|2|||
127663721|NCT01567163|459393388|FG000|Overall Study|Lost to Follow-up|2|||
127663722|NCT03405662|459393389|FG000|Overall Study|COVID-19 restriction|1|||
127663723|NCT03405662|459393390|FG001|Overall Study|COVID-19 restriction|0|||
127663724|NCT03405662|459393389|FG000|Overall Study|unblinding|0|||
127663725|NCT03405662|459393390|FG001|Overall Study|unblinding|1|||
127663726|NCT03405662|459393389|FG000|Overall Study|placement in memory care facility|0|||
127663727|NCT03405662|459393390|FG001|Overall Study|placement in memory care facility|2|||
127663728|NCT00983619|459393391|FG000|Overall Study|Lost to Follow-up|0|||
127663729|NCT00983619|459393392|FG001|Overall Study|Lost to Follow-up|1|||
127663730|NCT00983619|459393393|FG002|Overall Study|Lost to Follow-up|0|||
127663731|NCT00983619|459393394|FG003|Overall Study|Lost to Follow-up|0|||
127663732|NCT00983619|459393395|FG004|Overall Study|Lost to Follow-up|0|||
127663733|NCT00983619|459393396|FG005|Overall Study|Lost to Follow-up|2|||
127663734|NCT00983619|459393397|FG006|Overall Study|Lost to Follow-up|0|||
127663735|NCT00983619|459393398|FG007|Overall Study|Lost to Follow-up|0|||
127663736|NCT00983619|459393399|FG008|Overall Study|Lost to Follow-up|0|||
127663737|NCT00983619|459393400|FG009|Overall Study|Lost to Follow-up|0|||
127663738|NCT00983619|459393401|FG010|Overall Study|Lost to Follow-up|0|||
127663739|NCT00983619|459393402|FG011|Overall Study|Lost to Follow-up|2|||
127663740|NCT00983619|459393391|FG000|Overall Study|Withdrawal by Subject|2|||
127663741|NCT00983619|459393392|FG001|Overall Study|Withdrawal by Subject|1|||
127663742|NCT00983619|459393393|FG002|Overall Study|Withdrawal by Subject|1|||
127663743|NCT00983619|459393394|FG003|Overall Study|Withdrawal by Subject|3|||
127663744|NCT00983619|459393395|FG004|Overall Study|Withdrawal by Subject|1|||
127663745|NCT00983619|459393396|FG005|Overall Study|Withdrawal by Subject|23|||
127663746|NCT00983619|459393397|FG006|Overall Study|Withdrawal by Subject|0|||
127663747|NCT00983619|459393398|FG007|Overall Study|Withdrawal by Subject|0|||
127663748|NCT00983619|459393399|FG008|Overall Study|Withdrawal by Subject|0|||
127663749|NCT00983619|459393400|FG009|Overall Study|Withdrawal by Subject|0|||
127663750|NCT00983619|459393401|FG010|Overall Study|Withdrawal by Subject|1|||
127663751|NCT00983619|459393402|FG011|Overall Study|Withdrawal by Subject|1|||
127663752|NCT00983619|459393391|FG000|Overall Study|Death|0|||
127663753|NCT00983619|459393392|FG001|Overall Study|Death|2|||
127663754|NCT00983619|459393393|FG002|Overall Study|Death|2|||
127663755|NCT00983619|459393394|FG003|Overall Study|Death|1|||
127663756|NCT00983619|459393395|FG004|Overall Study|Death|2|||
127663757|NCT00983619|459393396|FG005|Overall Study|Death|30|||
127663758|NCT00983619|459393397|FG006|Overall Study|Death|1|||
127663759|NCT00983619|459393398|FG007|Overall Study|Death|0|||
127663760|NCT00983619|459393399|FG008|Overall Study|Death|1|||
127663761|NCT00983619|459393400|FG009|Overall Study|Death|2|||
127663762|NCT00983619|459393401|FG010|Overall Study|Death|9|||
127663763|NCT00983619|459393402|FG011|Overall Study|Death|8|||
127663764|NCT00983619|459393391|FG000|Overall Study|Other|1|||
127663765|NCT00983619|459393392|FG001|Overall Study|Other|0|||
127663766|NCT00983619|459393393|FG002|Overall Study|Other|0|||
127663767|NCT00983619|459393394|FG003|Overall Study|Other|1|||
127663768|NCT00983619|459393395|FG004|Overall Study|Other|0|||
127663769|NCT00983619|459393396|FG005|Overall Study|Other|12|||
127663770|NCT00983619|459393397|FG006|Overall Study|Other|2|||
127663771|NCT00983619|459393398|FG007|Overall Study|Other|2|||
127663772|NCT00983619|459393399|FG008|Overall Study|Other|0|||
127663773|NCT00983619|459393400|FG009|Overall Study|Other|1|||
127663774|NCT00983619|459393401|FG010|Overall Study|Other|1|||
127663775|NCT00983619|459393402|FG011|Overall Study|Other|0|||
127663776|NCT04716881|459393405|FG000|Overall Study|Adverse Event|1|||
127663777|NCT04716881|459393405|FG000|Overall Study|Lost to Follow-up|1|||
127663778|NCT01558674|459393408|FG000|Part 1|Study Terminated by Sponsor|10|||
127663779|NCT01558674|459393409|FG001|Part 1|Study Terminated by Sponsor|0|||
127663780|NCT01558674|459393408|FG000|Part 1|Withdrawal by Subject|1|||
127663781|NCT01558674|459393409|FG001|Part 1|Withdrawal by Subject|0|||
127663782|NCT04147260|459393410|FG000|Overall Study|Adverse Event|1|||
127663783|NCT04147260|459393411|FG001|Overall Study|Adverse Event|0|||
127663784|NCT04147260|459393412|FG002|Overall Study|Adverse Event|1|||
127663785|NCT04147260|459393413|FG003|Overall Study|Adverse Event|2|||
127990816|NCT02427802|460592379|FG000|Overall Study|Physician Decision|4|||
127990817|NCT02427802|460592380|FG001|Overall Study|Physician Decision|2|||
127990818|NCT02427802|460592381|FG002|Overall Study|Physician Decision|4|||
127990819|NCT02427802|460592379|FG000|Overall Study|Withdrawal by Subject|10|||
127990820|NCT02427802|460592380|FG001|Overall Study|Withdrawal by Subject|5|||
127990821|NCT02427802|460592381|FG002|Overall Study|Withdrawal by Subject|11|||
127990822|NCT02427802|460592379|FG000|Overall Study|Protocol Violation|3|||
127990823|NCT02427802|460592380|FG001|Overall Study|Protocol Violation|1|||
127990824|NCT02427802|460592381|FG002|Overall Study|Protocol Violation|1|||
127990825|NCT02427802|460592379|FG000|Overall Study|protocol specific treatment unrelated|18|||
127990826|NCT02427802|460592380|FG001|Overall Study|protocol specific treatment unrelated|11|||
127663786|NCT04147260|459393414|FG004|Overall Study|Adverse Event|0|||
127663787|NCT04147260|459393410|FG000|Overall Study|Withdrawal by Subject|0|||
127663788|NCT04147260|459393411|FG001|Overall Study|Withdrawal by Subject|0|||
127663789|NCT04147260|459393412|FG002|Overall Study|Withdrawal by Subject|1|||
127663790|NCT04147260|459393413|FG003|Overall Study|Withdrawal by Subject|1|||
127663791|NCT04147260|459393414|FG004|Overall Study|Withdrawal by Subject|0|||
127663792|NCT01734850|459393415|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
127663793|NCT01734850|459393416|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
127663794|NCT01734850|459393417|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
127663795|NCT01734850|459393415|FG000|Overall Study|Not infused due to manufacturing failure|0|||
127663796|NCT01734850|459393416|FG001|Overall Study|Not infused due to manufacturing failure|0|||
127663797|NCT01734850|459393417|FG002|Overall Study|Not infused due to manufacturing failure|1|||
127663798|NCT00750893|459393418|FG000|Overall Study|Adverse Event|5|||
127663799|NCT00750893|459393418|FG000|Overall Study|Withdrawal by Subject|10|||
127663800|NCT00750893|459393418|FG000|Overall Study|Lost to Follow-up|510|||
127663801|NCT00750893|459393418|FG000|Overall Study|Other|17|||
127663802|NCT02420327|459393419|FG000|Overall Study|Adverse Event|7|||
127663803|NCT02420327|459393419|FG000|Overall Study|Pregnancy|1|||
127990827|NCT02427802|460592381|FG002|Overall Study|protocol specific treatment unrelated|11|||
127990828|NCT01085084|460592382|FG000|Overall Study|Withdrawal by Subject|1|||
127990829|NCT01085084|460592383|FG001|Overall Study|Withdrawal by Subject|0|||
127663804|NCT02420327|459393419|FG000|Overall Study|Withdrawal by Subject|6|||
127990830|NCT01085084|460592384|FG002|Overall Study|Withdrawal by Subject|0|||
127990831|NCT01085084|460592382|FG000|Overall Study|Lost to Follow-up|2|||
127990832|NCT01085084|460592383|FG001|Overall Study|Lost to Follow-up|1|||
127990833|NCT01085084|460592384|FG002|Overall Study|Lost to Follow-up|1|||
127663805|NCT02420327|459393419|FG000|Overall Study|Lost to Follow-up|1|||
127663806|NCT02420327|459393419|FG000|Overall Study|Protocol Violation|1|||
127663807|NCT02204293|459393420|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
127663808|NCT02204293|459393421|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
127663809|NCT02204293|459393422|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
127663810|NCT02204293|459393423|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
127663811|NCT02204293|459393424|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
127663812|NCT02204293|459393425|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
127663813|NCT02204293|459393420|FG000|Core Study Part I|Adverse Event|1|||
127663814|NCT02204293|459393421|FG001|Core Study Part I|Adverse Event|0|||
127663815|NCT02204293|459393422|FG002|Core Study Part I|Adverse Event|0|||
127663816|NCT02204293|459393423|FG003|Core Study Part I|Adverse Event|0|||
127663817|NCT02204293|459393424|FG004|Core Study Part I|Adverse Event|0|||
127663818|NCT02204293|459393425|FG005|Core Study Part I|Adverse Event|0|||
127663819|NCT02204293|459393420|FG000|Core Study Part I|Physician Decision|0|||
127990834|NCT01085084|460592382|FG000|Overall Study|Adverse Event|4|||
127990835|NCT01085084|460592383|FG001|Overall Study|Adverse Event|3|||
127990836|NCT01085084|460592384|FG002|Overall Study|Adverse Event|6|||
127990837|NCT01085084|460592382|FG000|Overall Study|Treatment Failure|0|||
127990838|NCT01085084|460592383|FG001|Overall Study|Treatment Failure|1|||
127990839|NCT01085084|460592384|FG002|Overall Study|Treatment Failure|2|||
127990840|NCT02749799|460592385|FG000|Overall Study|Adverse Event|2|||
127990841|NCT02749799|460592385|FG000|Overall Study|Lost to Follow-up|4|||
127990842|NCT02749799|460592385|FG000|Overall Study|Protocol Violation|1|||
127663820|NCT02204293|459393421|FG001|Core Study Part I|Physician Decision|3|||
127663821|NCT02204293|459393422|FG002|Core Study Part I|Physician Decision|0|||
127663822|NCT02204293|459393423|FG003|Core Study Part I|Physician Decision|0|||
127663823|NCT02204293|459393424|FG004|Core Study Part I|Physician Decision|0|||
127663824|NCT02204293|459393425|FG005|Core Study Part I|Physician Decision|0|||
127663825|NCT02204293|459393420|FG000|LTE Phase|Study Suspended|0|||
127663826|NCT02204293|459393421|FG001|LTE Phase|Study Suspended|0|||
127663827|NCT02204293|459393422|FG002|LTE Phase|Study Suspended|0|||
127663828|NCT02204293|459393423|FG003|LTE Phase|Study Suspended|0|||
127663829|NCT02204293|459393424|FG004|LTE Phase|Study Suspended|0|||
127663830|NCT02204293|459393425|FG005|LTE Phase|Study Suspended|7|||
127663831|NCT00393094|459393427|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
127663832|NCT00393094|459393427|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
127663833|NCT02019602|459393428|FG000|Screening Period|Ineligibility|4|||
127663834|NCT02019602|459393429|FG001|Screening Period|Ineligibility|0|||
127663835|NCT02019602|459393428|FG000|Screening Period|Adverse Event|1|||
127663836|NCT02019602|459393429|FG001|Screening Period|Adverse Event|0|||
127663837|NCT03523871|459393432|FG000|Overall Study|Death|1|||
127663838|NCT04285229|459393433|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
127663839|NCT04285229|459393434|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
127663840|NCT04285229|459393435|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
127663841|NCT04285229|459393436|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
127663842|NCT04285229|459393437|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
127663843|NCT04285229|459393438|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
127663844|NCT04285229|459393433|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
127663845|NCT04285229|459393434|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
127663846|NCT04285229|459393435|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
127663847|NCT04285229|459393436|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
127663848|NCT04285229|459393437|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
127663849|NCT04285229|459393438|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
127663850|NCT04285229|459393433|FG000|Extended Treatment Period|Adverse Event|0|||
127663851|NCT04285229|459393434|FG001|Extended Treatment Period|Adverse Event|0|||
127663852|NCT04285229|459393435|FG002|Extended Treatment Period|Adverse Event|0|||
127663853|NCT04285229|459393436|FG003|Extended Treatment Period|Adverse Event|1|||
127663854|NCT04285229|459393437|FG004|Extended Treatment Period|Adverse Event|0|||
127663855|NCT04285229|459393438|FG005|Extended Treatment Period|Adverse Event|0|||
127663856|NCT04285229|459393433|FG000|Extended Treatment Period|Physician Decision|0|||
127663857|NCT04285229|459393434|FG001|Extended Treatment Period|Physician Decision|0|||
127663858|NCT04285229|459393435|FG002|Extended Treatment Period|Physician Decision|1|||
127663859|NCT04285229|459393436|FG003|Extended Treatment Period|Physician Decision|0|||
127663860|NCT04285229|459393437|FG004|Extended Treatment Period|Physician Decision|0|||
127663861|NCT04285229|459393438|FG005|Extended Treatment Period|Physician Decision|0|||
127663862|NCT04285229|459393433|FG000|Follow-up Period|Adverse Event|0|||
127663863|NCT04285229|459393434|FG001|Follow-up Period|Adverse Event|0|||
127663864|NCT04285229|459393435|FG002|Follow-up Period|Adverse Event|0|||
127663865|NCT04285229|459393436|FG003|Follow-up Period|Adverse Event|0|||
127663866|NCT04285229|459393437|FG004|Follow-up Period|Adverse Event|1|||
127663867|NCT04285229|459393438|FG005|Follow-up Period|Adverse Event|4|||
127663868|NCT04285229|459393433|FG000|Follow-up Period|Withdrawal by Subject|0|||
127663869|NCT04285229|459393434|FG001|Follow-up Period|Withdrawal by Subject|0|||
127663870|NCT04285229|459393435|FG002|Follow-up Period|Withdrawal by Subject|0|||
127990843|NCT02749799|460592385|FG000|Overall Study|Withdrawal by Subject|1|||
127990844|NCT02634983|460592386|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
127663871|NCT04285229|459393436|FG003|Follow-up Period|Withdrawal by Subject|0|||
127663872|NCT04285229|459393437|FG004|Follow-up Period|Withdrawal by Subject|0|||
127663873|NCT04285229|459393438|FG005|Follow-up Period|Withdrawal by Subject|5|||
127663874|NCT04285229|459393433|FG000|Follow-up Period|Covid-19|0|||
127663875|NCT04285229|459393434|FG001|Follow-up Period|Covid-19|0|||
127663876|NCT04285229|459393435|FG002|Follow-up Period|Covid-19|0|||
127663877|NCT04285229|459393436|FG003|Follow-up Period|Covid-19|0|||
127663878|NCT04285229|459393437|FG004|Follow-up Period|Covid-19|0|||
127663879|NCT04285229|459393438|FG005|Follow-up Period|Covid-19|2|||
127663880|NCT04285229|459393433|FG000|Follow-up Period|Physician Decision|0|||
127663881|NCT04285229|459393434|FG001|Follow-up Period|Physician Decision|0|||
127663882|NCT04285229|459393435|FG002|Follow-up Period|Physician Decision|0|||
127990845|NCT02634983|460592387|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
127663883|NCT04285229|459393436|FG003|Follow-up Period|Physician Decision|0|||
127663884|NCT04285229|459393437|FG004|Follow-up Period|Physician Decision|0|||
127663885|NCT04285229|459393438|FG005|Follow-up Period|Physician Decision|1|||
127663886|NCT01406717|459393439|FG000|Overall Study|Subject non-compliance|4|||
127663887|NCT01406717|459393440|FG001|Overall Study|Subject non-compliance|3|||
127663888|NCT01406717|459393439|FG000|Overall Study|Protocol Violation|5|||
127663889|NCT01406717|459393440|FG001|Overall Study|Protocol Violation|1|||
127663890|NCT01406717|459393439|FG000|Overall Study|Lost to Follow-up|14|||
127663891|NCT01406717|459393440|FG001|Overall Study|Lost to Follow-up|8|||
127663892|NCT01406717|459393439|FG000|Overall Study|Withdrawal by Subject|19|||
127663893|NCT01406717|459393440|FG001|Overall Study|Withdrawal by Subject|15|||
127663894|NCT01406717|459393439|FG000|Overall Study|Adverse Event|1|||
127663895|NCT01406717|459393440|FG001|Overall Study|Adverse Event|2|||
127663896|NCT01406717|459393439|FG000|Overall Study|Lack of Efficacy|0|||
127663897|NCT01406717|459393440|FG001|Overall Study|Lack of Efficacy|1|||
127663898|NCT01406717|459393439|FG000|Overall Study|Non-completion of visit activity|0|||
127663899|NCT01406717|459393440|FG001|Overall Study|Non-completion of visit activity|1|||
127663900|NCT03257995|459393441|FG000|Overall Study|Adverse Event|0|||
127663901|NCT03257995|459393442|FG001|Overall Study|Adverse Event|1|||
127663902|NCT03257995|459393443|FG002|Overall Study|Adverse Event|0|||
127663903|NCT03257995|459393444|FG003|Overall Study|Adverse Event|0|||
127663904|NCT03257995|459393445|FG004|Overall Study|Adverse Event|0|||
127663905|NCT03257995|459393446|FG005|Overall Study|Adverse Event|0|||
127663906|NCT03257995|459393441|FG000|Overall Study|Protocol deviation|0|||
127663907|NCT03257995|459393442|FG001|Overall Study|Protocol deviation|0|||
127663908|NCT03257995|459393443|FG002|Overall Study|Protocol deviation|0|||
127663909|NCT03257995|459393444|FG003|Overall Study|Protocol deviation|0|||
127663910|NCT03257995|459393445|FG004|Overall Study|Protocol deviation|0|||
127663911|NCT03257995|459393446|FG005|Overall Study|Protocol deviation|2|||
127663912|NCT01556763|459393451|FG000|Overall Study|Withdrawal by Subject|0|||
127663913|NCT01556763|459393452|FG001|Overall Study|Withdrawal by Subject|1|||
127663914|NCT01556763|459393453|FG002|Overall Study|Withdrawal by Subject|0|||
127663915|NCT02584855|459393454|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
127663916|NCT02584855|459393455|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
127663917|NCT02584855|459393456|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
127663918|NCT02584855|459393457|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
127663919|NCT02584855|459393458|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
127663920|NCT02584855|459393459|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
127663921|NCT02584855|459393454|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
127663922|NCT02584855|459393455|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
127663923|NCT02584855|459393456|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
127663924|NCT02584855|459393457|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
127663925|NCT02584855|459393458|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
127663926|NCT02584855|459393459|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
127663927|NCT02584855|459393454|FG000|Open-Label Treatment Period|Adverse Event|14|||
127663928|NCT02584855|459393455|FG001|Open-Label Treatment Period|Adverse Event|0|||
127663929|NCT02584855|459393456|FG002|Open-Label Treatment Period|Adverse Event|0|||
127663930|NCT02584855|459393457|FG003|Open-Label Treatment Period|Adverse Event|0|||
127663931|NCT02584855|459393458|FG004|Open-Label Treatment Period|Adverse Event|0|||
127663932|NCT02584855|459393459|FG005|Open-Label Treatment Period|Adverse Event|0|||
127663933|NCT02584855|459393454|FG000|Open-Label Treatment Period|Death|2|||
127663934|NCT02584855|459393455|FG001|Open-Label Treatment Period|Death|0|||
127663935|NCT02584855|459393456|FG002|Open-Label Treatment Period|Death|0|||
127663936|NCT02584855|459393457|FG003|Open-Label Treatment Period|Death|0|||
127663937|NCT02584855|459393458|FG004|Open-Label Treatment Period|Death|0|||
127663938|NCT02584855|459393459|FG005|Open-Label Treatment Period|Death|0|||
127663939|NCT02584855|459393454|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
127663940|NCT02584855|459393455|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
127663941|NCT02584855|459393456|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
127663942|NCT02584855|459393457|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
127663943|NCT02584855|459393458|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
127663944|NCT02584855|459393459|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
127663945|NCT02584855|459393454|FG000|Open-Label Treatment Period|Protocol Violation|1|||
127663946|NCT02584855|459393455|FG001|Open-Label Treatment Period|Protocol Violation|0|||
127663947|NCT02584855|459393456|FG002|Open-Label Treatment Period|Protocol Violation|0|||
127663948|NCT02584855|459393457|FG003|Open-Label Treatment Period|Protocol Violation|0|||
127663949|NCT02584855|459393458|FG004|Open-Label Treatment Period|Protocol Violation|0|||
127663950|NCT02584855|459393459|FG005|Open-Label Treatment Period|Protocol Violation|0|||
127663951|NCT02584855|459393454|FG000|Open-Label Treatment Period|No PI Available|2|||
127663952|NCT02584855|459393455|FG001|Open-Label Treatment Period|No PI Available|0|||
127663953|NCT02584855|459393456|FG002|Open-Label Treatment Period|No PI Available|0|||
127663954|NCT02584855|459393457|FG003|Open-Label Treatment Period|No PI Available|0|||
127663955|NCT02584855|459393458|FG004|Open-Label Treatment Period|No PI Available|0|||
127663956|NCT02584855|459393459|FG005|Open-Label Treatment Period|No PI Available|0|||
127663957|NCT02584855|459393454|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
127663958|NCT02584855|459393455|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
127663959|NCT02584855|459393456|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
127663960|NCT02584855|459393457|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
127663961|NCT02584855|459393458|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
127663962|NCT02584855|459393459|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
127663963|NCT02584855|459393454|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
127663964|NCT02584855|459393455|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
127663965|NCT02584855|459393456|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
127663966|NCT02584855|459393457|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
127663967|NCT02584855|459393458|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
127663968|NCT02584855|459393459|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
127663969|NCT02584855|459393454|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
127663970|NCT02584855|459393455|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
127663971|NCT02584855|459393456|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
127663972|NCT02584855|459393457|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
127663973|NCT02584855|459393458|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
127663974|NCT02584855|459393459|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
127663975|NCT02584855|459393454|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
127663976|NCT02584855|459393455|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
127663977|NCT02584855|459393456|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
127663978|NCT02584855|459393457|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
127663979|NCT02584855|459393458|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
127663980|NCT02584855|459393459|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
127663981|NCT02584855|459393454|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
127663982|NCT02584855|459393455|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
127663983|NCT02584855|459393456|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
127663984|NCT02584855|459393457|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
127663985|NCT02584855|459393458|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
127663986|NCT02584855|459393459|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
127663987|NCT02584855|459393454|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
127663988|NCT02584855|459393455|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
127663989|NCT02584855|459393456|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
127663990|NCT02584855|459393457|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
127663991|NCT02584855|459393458|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
127663992|NCT02584855|459393459|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
127663993|NCT02584855|459393454|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
127663994|NCT02584855|459393455|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
127663995|NCT02584855|459393456|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
127663996|NCT02584855|459393457|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
127663997|NCT02584855|459393458|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
127663998|NCT02584855|459393459|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
127663999|NCT02337478|459393460|FG000|Overall Study|Lack of Efficacy|5|||
127664000|NCT02258464|459393461|FG000|Overall Study|Progressive disease (PD)|9|||
127664001|NCT02258464|459393462|FG001|Overall Study|Progressive disease (PD)|17|||
127664002|NCT02258464|459393461|FG000|Overall Study|Study drug never administered|1|||
127664003|NCT02258464|459393462|FG001|Overall Study|Study drug never administered|1|||
127664004|NCT02258464|459393461|FG000|Overall Study|AE not related to clinical PD|1|||
127664005|NCT02258464|459393462|FG001|Overall Study|AE not related to clinical PD|3|||
127664006|NCT02258464|459393461|FG000|Overall Study|Withdrawal by Subject|5|||
127664007|NCT02258464|459393462|FG001|Overall Study|Withdrawal by Subject|4|||
127664008|NCT02258464|459393461|FG000|Overall Study|AE related to clinical PD|1|||
127664009|NCT02258464|459393462|FG001|Overall Study|AE related to clinical PD|0|||
127664010|NCT02138747|459393463|FG000|Treatment Period 1|Adverse Event|10|||
127664011|NCT02138747|459393464|FG001|Treatment Period 1|Adverse Event|14|||
127990846|NCT02070978|460592388|FG000|Overall Study|Adverse Event|6|||
127990847|NCT02070978|460592389|FG001|Overall Study|Adverse Event|2|||
127990848|NCT02070978|460592390|FG002|Overall Study|Adverse Event|0|||
127664012|NCT02138747|459393465|FG002|Treatment Period 1|Adverse Event|2|||
127664013|NCT02138747|459393466|FG003|Treatment Period 1|Adverse Event|1|||
127664014|NCT02138747|459393463|FG000|Treatment Period 1|Lost to Follow-up|0|||
127664015|NCT02138747|459393464|FG001|Treatment Period 1|Lost to Follow-up|1|||
127664016|NCT02138747|459393465|FG002|Treatment Period 1|Lost to Follow-up|1|||
127664017|NCT02138747|459393466|FG003|Treatment Period 1|Lost to Follow-up|0|||
127664018|NCT02138747|459393463|FG000|Treatment Period 1|Protocol Violation|0|||
127664019|NCT02138747|459393464|FG001|Treatment Period 1|Protocol Violation|2|||
127664020|NCT02138747|459393465|FG002|Treatment Period 1|Protocol Violation|0|||
127664021|NCT02138747|459393466|FG003|Treatment Period 1|Protocol Violation|0|||
127664022|NCT02138747|459393463|FG000|Treatment Period 1|Withdrawal by Subject|8|||
127990849|NCT02070978|460592388|FG000|Overall Study|Lost to Follow-up|1|||
127990850|NCT02070978|460592389|FG001|Overall Study|Lost to Follow-up|3|||
127664023|NCT02138747|459393464|FG001|Treatment Period 1|Withdrawal by Subject|4|||
127664024|NCT02138747|459393465|FG002|Treatment Period 1|Withdrawal by Subject|1|||
127664025|NCT02138747|459393466|FG003|Treatment Period 1|Withdrawal by Subject|3|||
127664026|NCT02138747|459393463|FG000|Treatment Period 1|Other - Miscellaneous|2|||
127664027|NCT02138747|459393464|FG001|Treatment Period 1|Other - Miscellaneous|4|||
127664028|NCT02138747|459393465|FG002|Treatment Period 1|Other - Miscellaneous|0|||
127664029|NCT02138747|459393466|FG003|Treatment Period 1|Other - Miscellaneous|0|||
127664030|NCT02138747|459393463|FG000|Treatment Period 2|Adverse Event|6|||
127664031|NCT02138747|459393464|FG001|Treatment Period 2|Adverse Event|3|||
127664032|NCT02138747|459393465|FG002|Treatment Period 2|Adverse Event|1|||
127664033|NCT02138747|459393466|FG003|Treatment Period 2|Adverse Event|1|||
127664034|NCT02138747|459393463|FG000|Treatment Period 2|Lost to Follow-up|2|||
127664035|NCT02138747|459393464|FG001|Treatment Period 2|Lost to Follow-up|0|||
127664036|NCT02138747|459393465|FG002|Treatment Period 2|Lost to Follow-up|0|||
127664037|NCT02138747|459393466|FG003|Treatment Period 2|Lost to Follow-up|0|||
127664038|NCT02138747|459393463|FG000|Treatment Period 2|Protocol Violation|1|||
127664039|NCT02138747|459393464|FG001|Treatment Period 2|Protocol Violation|0|||
127664040|NCT02138747|459393465|FG002|Treatment Period 2|Protocol Violation|0|||
127664041|NCT02138747|459393466|FG003|Treatment Period 2|Protocol Violation|0|||
127664042|NCT02138747|459393463|FG000|Treatment Period 2|Withdrawal by Subject|5|||
127664043|NCT02138747|459393464|FG001|Treatment Period 2|Withdrawal by Subject|4|||
127664044|NCT02138747|459393465|FG002|Treatment Period 2|Withdrawal by Subject|1|||
127664045|NCT02138747|459393466|FG003|Treatment Period 2|Withdrawal by Subject|2|||
127664046|NCT02138747|459393463|FG000|Treatment Period 2|Other - Miscellaneous|3|||
127664047|NCT02138747|459393464|FG001|Treatment Period 2|Other - Miscellaneous|0|||
127664048|NCT02138747|459393465|FG002|Treatment Period 2|Other - Miscellaneous|0|||
127664049|NCT02138747|459393466|FG003|Treatment Period 2|Other - Miscellaneous|0|||
127664050|NCT04170296|459393467|FG000|Overall Study|Adverse Event|1|||
127664051|NCT04170296|459393468|FG001|Overall Study|Adverse Event|0|||
127664052|NCT04170296|459393467|FG000|Overall Study|Withdrawal by Subject|3|||
127664053|NCT04170296|459393468|FG001|Overall Study|Withdrawal by Subject|2|||
127664054|NCT04170296|459393467|FG000|Overall Study|Lost to Follow-up|4|||
127664055|NCT04170296|459393468|FG001|Overall Study|Lost to Follow-up|2|||
127664056|NCT00932646|459393469|FG000|Overall Study|Adverse Event|2|||
127664057|NCT00932646|459393470|FG001|Overall Study|Adverse Event|1|||
127664058|NCT00932646|459393471|FG002|Overall Study|Adverse Event|1|||
127664059|NCT00932646|459393472|FG003|Overall Study|Adverse Event|1|||
127664060|NCT00932646|459393469|FG000|Overall Study|Lost to Follow-up|2|||
127664061|NCT00932646|459393470|FG001|Overall Study|Lost to Follow-up|1|||
127664062|NCT00932646|459393471|FG002|Overall Study|Lost to Follow-up|0|||
127664063|NCT00932646|459393472|FG003|Overall Study|Lost to Follow-up|0|||
127664064|NCT00932646|459393469|FG000|Overall Study|Withdrawal by Subject|1|||
127664065|NCT00932646|459393470|FG001|Overall Study|Withdrawal by Subject|1|||
127664066|NCT00932646|459393471|FG002|Overall Study|Withdrawal by Subject|3|||
127664067|NCT00932646|459393472|FG003|Overall Study|Withdrawal by Subject|0|||
127664068|NCT00653263|459393473|FG000|Overall Study|Withdrawal by Subject|1|||
127664069|NCT00653263|459393473|FG000|Overall Study|Physician Decision|1|||
127664070|NCT03567993|459393482|FG000|Overall Study|Lost to Follow-up|4|||
127664071|NCT03567993|459393483|FG001|Overall Study|Lost to Follow-up|2|||
127664072|NCT03567993|459393482|FG000|Overall Study|Death|1|||
127664073|NCT03567993|459393483|FG001|Overall Study|Death|1|||
127664074|NCT03567993|459393482|FG000|Overall Study|Withdrawal by Subject|1|||
127664075|NCT03567993|459393483|FG001|Overall Study|Withdrawal by Subject|0|||
127664076|NCT02218489|459393488|FG000|Overall Study|Withdrawal by Subject|4|||
127664077|NCT02218489|459393489|FG001|Overall Study|Withdrawal by Subject|3|||
127664078|NCT02218489|459393488|FG000|Overall Study|Lost to Follow-up|1|||
127664079|NCT02218489|459393489|FG001|Overall Study|Lost to Follow-up|0|||
127664080|NCT05221749|459393490|FG000|Overall Study|Lost to Follow-up|2|||
127664081|NCT05221749|459393491|FG001|Overall Study|Lost to Follow-up|3|||
127664082|NCT02404493|459393492|FG000|Overall Study|Adverse Event|1|||
127664083|NCT02404493|459393493|FG001|Overall Study|Adverse Event|1|||
127664084|NCT02388074|459393494|FG000|Overall Study|Lost in Transit|2|||
127664085|NCT02388074|459393494|FG000|Overall Study|Sample Not Returned|1|||
127664086|NCT02133924|459393497|FG000|Overall Study|Death|38|||
127664087|NCT02133924|459393497|FG000|Overall Study|Physician Decision|1|||
127664088|NCT02133924|459393497|FG000|Overall Study|Withdrawal by Subject|3|||
127664089|NCT00003458|459393498|FG000|Overall Study|Not evaluable|4|||
127664090|NCT01254890|459393499|FG000|Overall Study|Ineligible|0|||
127664091|NCT01254890|459393500|FG001|Overall Study|Ineligible|3|||
127664092|NCT01254890|459393499|FG000|Overall Study|Withdrawal by Subject|1|||
127664093|NCT01254890|459393500|FG001|Overall Study|Withdrawal by Subject|2|||
127664094|NCT01254890|459393499|FG000|Overall Study|Disease Progression|0|||
127664095|NCT01254890|459393500|FG001|Overall Study|Disease Progression|5|||
127664096|NCT04039503|459393505|FG000|Overall Study|Adverse Event|3|||
127664097|NCT04039503|459393506|FG001|Overall Study|Adverse Event|0|||
127664098|NCT04039503|459393507|FG002|Overall Study|Adverse Event|2|||
127664099|NCT04039503|459393508|FG003|Overall Study|Adverse Event|0|||
127664100|NCT04039503|459393505|FG000|Overall Study|Lost to Follow-up|0|||
127664101|NCT04039503|459393506|FG001|Overall Study|Lost to Follow-up|0|||
127664102|NCT04039503|459393507|FG002|Overall Study|Lost to Follow-up|1|||
127664103|NCT04039503|459393508|FG003|Overall Study|Lost to Follow-up|0|||
127664104|NCT04039503|459393505|FG000|Overall Study|Protocol Violation|0|||
127664105|NCT04039503|459393506|FG001|Overall Study|Protocol Violation|1|||
127664106|NCT04039503|459393507|FG002|Overall Study|Protocol Violation|2|||
127664107|NCT04039503|459393508|FG003|Overall Study|Protocol Violation|1|||
127664108|NCT04039503|459393505|FG000|Overall Study|Withdrawal by Subject|4|||
127664109|NCT04039503|459393506|FG001|Overall Study|Withdrawal by Subject|3|||
127664110|NCT04039503|459393507|FG002|Overall Study|Withdrawal by Subject|5|||
127664111|NCT04039503|459393508|FG003|Overall Study|Withdrawal by Subject|2|||
127664112|NCT04157686|459393510|FG000|Overall Study|Adverse Event|1|||
127990851|NCT02070978|460592390|FG002|Overall Study|Lost to Follow-up|4|||
127990852|NCT02070978|460592388|FG000|Overall Study|Withdrawal by Subject|3|||
127990853|NCT02070978|460592389|FG001|Overall Study|Withdrawal by Subject|5|||
127990854|NCT02070978|460592390|FG002|Overall Study|Withdrawal by Subject|3|||
127990855|NCT02070978|460592388|FG000|Overall Study|Protocol Violation|1|||
127990856|NCT02070978|460592389|FG001|Overall Study|Protocol Violation|0|||
127990857|NCT02070978|460592390|FG002|Overall Study|Protocol Violation|3|||
127990858|NCT02070978|460592388|FG000|Overall Study|Lack of Efficacy|0|||
127990859|NCT02070978|460592389|FG001|Overall Study|Lack of Efficacy|1|||
127990860|NCT02070978|460592390|FG002|Overall Study|Lack of Efficacy|0|||
127990861|NCT02070978|460592388|FG000|Overall Study|Death|0|||
127990862|NCT02070978|460592389|FG001|Overall Study|Death|0|||
127990863|NCT02070978|460592390|FG002|Overall Study|Death|2|||
127990864|NCT02070978|460592388|FG000|Overall Study|Un-specified|3|||
127990865|NCT02070978|460592389|FG001|Overall Study|Un-specified|2|||
127990866|NCT02070978|460592390|FG002|Overall Study|Un-specified|2|||
127664113|NCT04157686|459393511|FG001|Overall Study|Adverse Event|0|||
127664114|NCT04157686|459393512|FG002|Overall Study|Adverse Event|1|||
127664115|NCT04157686|459393513|FG003|Overall Study|Adverse Event|0|||
127664116|NCT04157686|459393514|FG004|Overall Study|Adverse Event|1|||
127664117|NCT04157686|459393515|FG005|Overall Study|Adverse Event|0|||
127664118|NCT04157686|459393516|FG006|Overall Study|Adverse Event|0|||
127664119|NCT04157686|459393517|FG007|Overall Study|Adverse Event|0|||
127664120|NCT04157686|459393510|FG000|Overall Study|Pregnancy|0|||
127664121|NCT04157686|459393511|FG001|Overall Study|Pregnancy|1|||
127664122|NCT04157686|459393512|FG002|Overall Study|Pregnancy|3|||
127664123|NCT04157686|459393513|FG003|Overall Study|Pregnancy|0|||
127664124|NCT04157686|459393514|FG004|Overall Study|Pregnancy|0|||
127664125|NCT04157686|459393515|FG005|Overall Study|Pregnancy|0|||
127664126|NCT04157686|459393516|FG006|Overall Study|Pregnancy|3|||
127664127|NCT04157686|459393517|FG007|Overall Study|Pregnancy|0|||
127664128|NCT04157686|459393510|FG000|Overall Study|Lost to Follow-up|1|||
127664129|NCT04157686|459393511|FG001|Overall Study|Lost to Follow-up|2|||
127664130|NCT04157686|459393512|FG002|Overall Study|Lost to Follow-up|8|||
127664131|NCT04157686|459393513|FG003|Overall Study|Lost to Follow-up|6|||
127664132|NCT04157686|459393514|FG004|Overall Study|Lost to Follow-up|6|||
127664133|NCT04157686|459393515|FG005|Overall Study|Lost to Follow-up|3|||
127664134|NCT04157686|459393516|FG006|Overall Study|Lost to Follow-up|7|||
127664135|NCT04157686|459393517|FG007|Overall Study|Lost to Follow-up|9|||
127664136|NCT04157686|459393510|FG000|Overall Study|Lack of Efficacy|0|||
127664137|NCT04157686|459393511|FG001|Overall Study|Lack of Efficacy|0|||
127664138|NCT04157686|459393512|FG002|Overall Study|Lack of Efficacy|0|||
127664139|NCT04157686|459393513|FG003|Overall Study|Lack of Efficacy|0|||
127664140|NCT04157686|459393514|FG004|Overall Study|Lack of Efficacy|0|||
127664141|NCT04157686|459393515|FG005|Overall Study|Lack of Efficacy|2|||
127664142|NCT04157686|459393516|FG006|Overall Study|Lack of Efficacy|0|||
127664143|NCT04157686|459393517|FG007|Overall Study|Lack of Efficacy|1|||
127664144|NCT04157686|459393510|FG000|Overall Study|Withdrawal by Subject|10|||
127664145|NCT04157686|459393511|FG001|Overall Study|Withdrawal by Subject|10|||
127664146|NCT04157686|459393512|FG002|Overall Study|Withdrawal by Subject|12|||
127664147|NCT04157686|459393513|FG003|Overall Study|Withdrawal by Subject|20|||
127664148|NCT04157686|459393514|FG004|Overall Study|Withdrawal by Subject|12|||
127664149|NCT04157686|459393515|FG005|Overall Study|Withdrawal by Subject|11|||
127664150|NCT04157686|459393516|FG006|Overall Study|Withdrawal by Subject|18|||
127664151|NCT04157686|459393517|FG007|Overall Study|Withdrawal by Subject|24|||
127664152|NCT04157686|459393510|FG000|Overall Study|Physician Decision|0|||
127664153|NCT04157686|459393511|FG001|Overall Study|Physician Decision|0|||
127664154|NCT04157686|459393512|FG002|Overall Study|Physician Decision|1|||
127664155|NCT04157686|459393513|FG003|Overall Study|Physician Decision|0|||
127664156|NCT04157686|459393514|FG004|Overall Study|Physician Decision|1|||
127664157|NCT04157686|459393515|FG005|Overall Study|Physician Decision|0|||
127664158|NCT04157686|459393516|FG006|Overall Study|Physician Decision|3|||
127664159|NCT04157686|459393517|FG007|Overall Study|Physician Decision|0|||
127664160|NCT04157686|459393510|FG000|Overall Study|Death|0|||
127664161|NCT04157686|459393511|FG001|Overall Study|Death|0|||
127990867|NCT02070978|460592388|FG000|Overall Study|Terminated by Sponsor|33|||
127664162|NCT04157686|459393512|FG002|Overall Study|Death|0|||
127664163|NCT04157686|459393513|FG003|Overall Study|Death|2|||
127664164|NCT04157686|459393514|FG004|Overall Study|Death|0|||
127990868|NCT02070978|460592389|FG001|Overall Study|Terminated by Sponsor|40|||
127664165|NCT04157686|459393515|FG005|Overall Study|Death|0|||
127664166|NCT04157686|459393516|FG006|Overall Study|Death|0|||
127664167|NCT04157686|459393517|FG007|Overall Study|Death|0|||
127664168|NCT04157686|459393510|FG000|Overall Study|Protocol Violation|0|||
127664169|NCT04157686|459393511|FG001|Overall Study|Protocol Violation|0|||
127664170|NCT04157686|459393512|FG002|Overall Study|Protocol Violation|0|||
127664171|NCT04157686|459393513|FG003|Overall Study|Protocol Violation|0|||
127664172|NCT04157686|459393514|FG004|Overall Study|Protocol Violation|1|||
127664173|NCT04157686|459393515|FG005|Overall Study|Protocol Violation|0|||
127664174|NCT04157686|459393516|FG006|Overall Study|Protocol Violation|0|||
127664175|NCT04157686|459393517|FG007|Overall Study|Protocol Violation|0|||
127664176|NCT04157686|459393510|FG000|Overall Study|COVID-19, Family Reasons etc.|0|||
127664177|NCT04157686|459393511|FG001|Overall Study|COVID-19, Family Reasons etc.|2|||
127664178|NCT04157686|459393512|FG002|Overall Study|COVID-19, Family Reasons etc.|4|||
127664179|NCT04157686|459393513|FG003|Overall Study|COVID-19, Family Reasons etc.|1|||
127664180|NCT04157686|459393514|FG004|Overall Study|COVID-19, Family Reasons etc.|4|||
127664181|NCT04157686|459393515|FG005|Overall Study|COVID-19, Family Reasons etc.|6|||
127664182|NCT04157686|459393516|FG006|Overall Study|COVID-19, Family Reasons etc.|0|||
127664183|NCT04157686|459393517|FG007|Overall Study|COVID-19, Family Reasons etc.|1|||
127664184|NCT01216293|459393518|FG000|Main Study|Adverse Event|1|||
127664185|NCT01216293|459393519|FG001|Main Study|Adverse Event|4|||
127664186|NCT01216293|459393520|FG002|Main Study|Adverse Event|2|||
127664187|NCT01216293|459393518|FG000|Main Study|Major Protocol Deviation|1|||
127664188|NCT01216293|459393519|FG001|Main Study|Major Protocol Deviation|0|||
127664189|NCT01216293|459393520|FG002|Main Study|Major Protocol Deviation|1|||
127664190|NCT01216293|459393518|FG000|Main Study|Lost to Follow-up|3|||
127664191|NCT01216293|459393519|FG001|Main Study|Lost to Follow-up|1|||
127664192|NCT01216293|459393520|FG002|Main Study|Lost to Follow-up|0|||
127664193|NCT01216293|459393518|FG000|Main Study|Voluntary Withdrawal|2|||
127664194|NCT01216293|459393519|FG001|Main Study|Voluntary Withdrawal|2|||
127664195|NCT01216293|459393520|FG002|Main Study|Voluntary Withdrawal|2|||
127664196|NCT01216293|459393518|FG000|Main Study|Other Reason Not Specified|0|||
127664197|NCT01216293|459393519|FG001|Main Study|Other Reason Not Specified|1|||
127664198|NCT01216293|459393520|FG002|Main Study|Other Reason Not Specified|1|||
127664199|NCT01216293|459393518|FG000|Main Study|Randomized, Not Treated|1|||
127664200|NCT01216293|459393519|FG001|Main Study|Randomized, Not Treated|0|||
127664201|NCT01216293|459393520|FG002|Main Study|Randomized, Not Treated|0|||
127664202|NCT01216293|459393518|FG000|Calcium Absorption Substudy|Adverse Event|0|||
127664203|NCT01216293|459393519|FG001|Calcium Absorption Substudy|Adverse Event|2|||
127664204|NCT01216293|459393520|FG002|Calcium Absorption Substudy|Adverse Event|0|||
127664205|NCT01216293|459393518|FG000|Calcium Absorption Substudy|Major Protocol Deviation|1|||
127664206|NCT01216293|459393519|FG001|Calcium Absorption Substudy|Major Protocol Deviation|0|||
127664207|NCT01216293|459393520|FG002|Calcium Absorption Substudy|Major Protocol Deviation|0|||
127664208|NCT01216293|459393518|FG000|Calcium Absorption Substudy|Voluntary Withdrawal|1|||
127664209|NCT01216293|459393519|FG001|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
127664210|NCT01216293|459393520|FG002|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
127664211|NCT01671748|459393521|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
127664212|NCT01671748|459393522|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
127664213|NCT01671748|459393521|FG000|4 Week run-in Phase|Adverse Event|1|||
127664214|NCT01671748|459393522|FG001|4 Week run-in Phase|Adverse Event|0|||
127664215|NCT01671748|459393521|FG000|4 Week run-in Phase|Not eligible|9|||
127664216|NCT01671748|459393522|FG001|4 Week run-in Phase|Not eligible|0|||
127664217|NCT03204695|459395003|FG000|Overall Study|Death|1|||
127664218|NCT03204695|459395003|FG000|Overall Study|Participant was treated with another device|1|||
127664219|NCT03204695|459395003|FG000|Overall Study|Physician Decision|2|||
127664220|NCT01349829|459395004|FG000|Overall Study|Lost to Follow-up|4|||
127664221|NCT01349829|459395005|FG001|Overall Study|Lost to Follow-up|8|||
127664222|NCT01349829|459395004|FG000|Overall Study|Consent withdrawal|3|||
127664223|NCT01349829|459395005|FG001|Overall Study|Consent withdrawal|8|||
127664224|NCT01349829|459395004|FG000|Overall Study|Migrated/moved|2|||
127664225|NCT01349829|459395005|FG001|Overall Study|Migrated/moved|7|||
127664226|NCT02555371|459395006|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
127664227|NCT02555371|459395007|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
127990869|NCT02070978|460592390|FG002|Overall Study|Terminated by Sponsor|39|||
127664228|NCT02555371|459395008|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
127664229|NCT02555371|459395009|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
127664230|NCT02555371|459395010|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
127664231|NCT02555371|459395006|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
127664232|NCT02555371|459395007|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
127664233|NCT02555371|459395008|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
127664234|NCT02555371|459395009|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
127664235|NCT02555371|459395010|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
127664236|NCT02555371|459395006|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
127664237|NCT02555371|459395007|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
127990870|NCT03749109|460592391|FG000|Overall Study|Adverse Event|2|||
127990871|NCT03749109|460592392|FG001|Overall Study|Adverse Event|0|||
127990872|NCT03178851|460592393|FG000|Overall Study|Death|48|||
127990873|NCT03178851|460592394|FG001|Overall Study|Death|2|||
127990874|NCT03178851|460592395|FG002|Overall Study|Death|25|||
127990875|NCT03178851|460592393|FG000|Overall Study|Withdrawal by Subject|8|||
127990876|NCT03178851|460592394|FG001|Overall Study|Withdrawal by Subject|0|||
127664238|NCT02555371|459395008|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
127664239|NCT02555371|459395009|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
127664240|NCT02555371|459395010|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
127664241|NCT02555371|459395006|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
127664242|NCT02555371|459395007|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
127664243|NCT02555371|459395008|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
127664244|NCT02555371|459395009|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
127664245|NCT02555371|459395010|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
127664246|NCT02555371|459395006|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
127990877|NCT03178851|460592395|FG002|Overall Study|Withdrawal by Subject|0|||
127990878|NCT03178851|460592393|FG000|Overall Study|Lost to Follow-up|5|||
127990879|NCT03178851|460592394|FG001|Overall Study|Lost to Follow-up|2|||
127990880|NCT03178851|460592395|FG002|Overall Study|Lost to Follow-up|0|||
127664247|NCT02555371|459395007|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
127664248|NCT02555371|459395008|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
127664249|NCT02555371|459395009|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
127664250|NCT02555371|459395010|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
127664251|NCT02555371|459395006|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
127664252|NCT02555371|459395007|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
127664253|NCT02555371|459395008|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
127664254|NCT02555371|459395009|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
127664255|NCT02555371|459395010|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
127664256|NCT02555371|459395006|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
127664257|NCT02555371|459395007|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
127664258|NCT02555371|459395008|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
127664259|NCT02555371|459395009|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
127664260|NCT02555371|459395010|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
127664261|NCT02555371|459395006|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
127664262|NCT02555371|459395007|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
127664263|NCT02555371|459395008|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
127664264|NCT02555371|459395009|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
127664265|NCT02555371|459395010|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
127664266|NCT02555371|459395006|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
127664267|NCT02555371|459395007|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
127664268|NCT02555371|459395008|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
127664269|NCT02555371|459395009|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
127664270|NCT02555371|459395010|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
127990881|NCT03178851|460592393|FG000|Overall Study|Adverse Event|0|||
127990882|NCT03178851|460592394|FG001|Overall Study|Adverse Event|0|||
127990883|NCT03178851|460592395|FG002|Overall Study|Adverse Event|1|||
127664271|NCT02555371|459395006|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
127664272|NCT02555371|459395007|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
127664273|NCT02555371|459395008|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
127664274|NCT02555371|459395009|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
127664275|NCT02555371|459395010|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
127664276|NCT02555371|459395006|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
127664277|NCT02555371|459395007|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
127664278|NCT02555371|459395008|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
127664279|NCT02555371|459395009|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
127990884|NCT03178851|460592393|FG000|Overall Study|Study Termination by Sponsor|31|||
127990885|NCT03178851|460592394|FG001|Overall Study|Study Termination by Sponsor|7|||
127990886|NCT03178851|460592395|FG002|Overall Study|Study Termination by Sponsor|26|||
127990887|NCT03951753|460592396|FG000|Overall Study|Adverse Event|1|||
127990888|NCT03951753|460592397|FG001|Overall Study|Adverse Event|0|||
127990889|NCT03951753|460592398|FG002|Overall Study|Adverse Event|3|||
127990890|NCT03951753|460592396|FG000|Overall Study|Withdrawal by Subject|3|||
127990891|NCT03951753|460592397|FG001|Overall Study|Withdrawal by Subject|1|||
127990892|NCT03951753|460592398|FG002|Overall Study|Withdrawal by Subject|0|||
127990893|NCT03951753|460592396|FG000|Overall Study|Lost to Follow-up|0|||
127664280|NCT02555371|459395010|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
127664281|NCT02555371|459395006|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
127664282|NCT02555371|459395007|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
127990894|NCT03951753|460592397|FG001|Overall Study|Lost to Follow-up|0|||
127990895|NCT03951753|460592398|FG002|Overall Study|Lost to Follow-up|1|||
127990896|NCT02669043|460592403|FG000|Overall Study|Didn't meet I/E criteria|4|||
127990897|NCT02552888|460592406|FG000|Overall Study|Lost to Follow-up|1|||
127990898|NCT02552888|460592407|FG001|Overall Study|Lost to Follow-up|1|||
127990899|NCT00401193|460594982|FG000|Overall Study|Adverse Event|1|||
127664283|NCT02555371|459395008|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
127664284|NCT02555371|459395009|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
127664285|NCT02555371|459395010|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
127664286|NCT02555371|459395006|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
127664287|NCT02555371|459395007|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
127664288|NCT02555371|459395008|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
127664289|NCT02555371|459395009|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
127664290|NCT02555371|459395010|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
127664291|NCT02555371|459395006|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
127664292|NCT02555371|459395007|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
127664293|NCT02555371|459395008|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
127664294|NCT02555371|459395009|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
127664295|NCT02555371|459395010|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
127664296|NCT03095599|459395011|FG000|Overall Study|Withdrawal by Subject|1|||
127664297|NCT03095599|459395012|FG001|Overall Study|Withdrawal by Subject|0|||
127664298|NCT03095599|459395011|FG000|Overall Study|Lost to Follow-up|1|||
127664299|NCT03095599|459395012|FG001|Overall Study|Lost to Follow-up|0|||
127664300|NCT03095599|459395011|FG000|Overall Study|Withdrawal prior to vaccination|1|||
127664301|NCT03095599|459395012|FG001|Overall Study|Withdrawal prior to vaccination|0|||
127664302|NCT00742885|459395015|FG000|Overall Study|Lost to Follow-up|1|||
127664303|NCT00742885|459395016|FG001|Overall Study|Lost to Follow-up|0|||
127664304|NCT04781647|459395017|FG000|Overall Study|Study terminated by Sponsor|11|||
127664305|NCT04781647|459395018|FG001|Overall Study|Study terminated by Sponsor|9|||
127664306|NCT04781647|459395019|FG002|Overall Study|Study terminated by Sponsor|9|||
127664307|NCT04781647|459395017|FG000|Overall Study|Withdrawal by Subject|1|||
127664308|NCT04781647|459395018|FG001|Overall Study|Withdrawal by Subject|2|||
127664309|NCT04781647|459395019|FG002|Overall Study|Withdrawal by Subject|0|||
127664310|NCT04781647|459395017|FG000|Overall Study|Adverse Event|0|||
127664311|NCT04781647|459395018|FG001|Overall Study|Adverse Event|1|||
127664312|NCT04781647|459395019|FG002|Overall Study|Adverse Event|1|||
127664313|NCT04781647|459395017|FG000|Overall Study|Protocol Violation|1|||
127664314|NCT04781647|459395018|FG001|Overall Study|Protocol Violation|0|||
127664315|NCT04781647|459395019|FG002|Overall Study|Protocol Violation|0|||
127664316|NCT04781647|459395017|FG000|Overall Study|Pregnancy|0|||
127664317|NCT04781647|459395018|FG001|Overall Study|Pregnancy|0|||
127664318|NCT04781647|459395019|FG002|Overall Study|Pregnancy|1|||
127664319|NCT04781647|459395017|FG000|Overall Study|Virology rebounded|1|||
127664320|NCT04781647|459395018|FG001|Overall Study|Virology rebounded|0|||
127664321|NCT04781647|459395019|FG002|Overall Study|Virology rebounded|0|||
127664322|NCT02018861|459395026|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
127664323|NCT02018861|459395027|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
127664324|NCT02018861|459395028|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
127664325|NCT02018861|459395029|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
127664326|NCT02018861|459395030|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
127664327|NCT02018861|459395031|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
127664328|NCT02018861|459395032|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
127664329|NCT02018861|459395033|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
127664330|NCT02018861|459395034|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
127664331|NCT02018861|459395035|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
127664332|NCT02018861|459395026|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
127664333|NCT02018861|459395027|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
127990900|NCT00401193|460594983|FG001|Overall Study|Adverse Event|3|||
127990901|NCT00401193|460594984|FG002|Overall Study|Adverse Event|1|||
127990902|NCT00401193|460594982|FG000|Overall Study|Protocol Violation|3|||
127990903|NCT00401193|460594983|FG001|Overall Study|Protocol Violation|1|||
127990904|NCT00401193|460594984|FG002|Overall Study|Protocol Violation|1|||
127990905|NCT00401193|460594982|FG000|Overall Study|Lost to Follow-up|6|||
127990906|NCT00401193|460594983|FG001|Overall Study|Lost to Follow-up|5|||
127990907|NCT00401193|460594984|FG002|Overall Study|Lost to Follow-up|1|||
127664334|NCT02018861|459395028|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
127664335|NCT02018861|459395029|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
127664336|NCT02018861|459395030|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
127990908|NCT00401193|460594982|FG000|Overall Study|Withdrawal by Subject|2|||
127990909|NCT00401193|460594983|FG001|Overall Study|Withdrawal by Subject|0|||
127990910|NCT00401193|460594984|FG002|Overall Study|Withdrawal by Subject|1|||
127990911|NCT00401193|460594982|FG000|Overall Study|Other Event|3|||
127664337|NCT02018861|459395031|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
127664338|NCT02018861|459395032|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
127990912|NCT00401193|460594983|FG001|Overall Study|Other Event|2|||
127664339|NCT02018861|459395033|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
127664340|NCT02018861|459395034|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
127664341|NCT02018861|459395035|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
127664342|NCT02018861|459395026|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
127664343|NCT02018861|459395027|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
127664344|NCT02018861|459395028|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
127664345|NCT02018861|459395029|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
127664346|NCT02018861|459395030|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
127664347|NCT02018861|459395031|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
127664348|NCT02018861|459395032|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
127664349|NCT02018861|459395033|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
127664350|NCT02018861|459395034|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
127664351|NCT02018861|459395035|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
127664352|NCT02018861|459395026|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
127664353|NCT02018861|459395027|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
127664354|NCT02018861|459395028|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
127664355|NCT02018861|459395029|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
127664356|NCT02018861|459395030|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
127664357|NCT02018861|459395031|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
127664358|NCT02018861|459395032|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
127664359|NCT02018861|459395033|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
127664360|NCT02018861|459395034|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
127664361|NCT02018861|459395035|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
127664362|NCT02018861|459395026|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
127664363|NCT02018861|459395027|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
127664364|NCT02018861|459395028|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
127664365|NCT02018861|459395029|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
127664366|NCT02018861|459395030|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
127664367|NCT02018861|459395031|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
127664368|NCT02018861|459395032|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
127664369|NCT02018861|459395033|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
127664370|NCT02018861|459395034|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
127664371|NCT02018861|459395035|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
127664372|NCT02018861|459395026|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
127664373|NCT02018861|459395027|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
127664374|NCT02018861|459395028|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
127664375|NCT02018861|459395029|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
127664376|NCT02018861|459395030|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
127664377|NCT02018861|459395031|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
127664378|NCT02018861|459395032|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
127664379|NCT02018861|459395033|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
127664380|NCT02018861|459395034|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
127664381|NCT02018861|459395035|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
127664382|NCT02018861|459395026|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
127664383|NCT02018861|459395027|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
127664384|NCT02018861|459395028|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
127664385|NCT02018861|459395029|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
127664386|NCT02018861|459395030|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
127664387|NCT02018861|459395031|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
127664388|NCT02018861|459395032|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
127664389|NCT02018861|459395033|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
127664390|NCT02018861|459395034|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
127664391|NCT02018861|459395035|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
127664392|NCT02018861|459395026|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
127664393|NCT02018861|459395027|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
127664394|NCT02018861|459395028|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
127664395|NCT02018861|459395029|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
127664396|NCT02018861|459395030|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
127664397|NCT02018861|459395031|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
127664398|NCT02018861|459395032|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
127664399|NCT02018861|459395033|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
127664400|NCT02018861|459395034|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
127664401|NCT02018861|459395035|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
127664402|NCT02018861|459395026|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
127664403|NCT02018861|459395027|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
127664404|NCT02018861|459395028|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
127664405|NCT02018861|459395029|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
127664406|NCT02018861|459395030|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
127664407|NCT02018861|459395031|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
127664408|NCT02018861|459395032|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
127664409|NCT02018861|459395033|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
127664410|NCT02018861|459395034|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
127664411|NCT02018861|459395035|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
127664412|NCT02018861|459395026|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
127664413|NCT02018861|459395027|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
127664414|NCT02018861|459395028|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
127664415|NCT02018861|459395029|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
127664416|NCT02018861|459395030|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
127664417|NCT02018861|459395031|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
127664418|NCT02018861|459395032|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
127664419|NCT02018861|459395033|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
127664420|NCT02018861|459395034|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
127990913|NCT00401193|460594984|FG002|Overall Study|Other Event|2|||
127990914|NCT00398216|460594985|FG000|Overall Study|Adverse Event|4|||
127990915|NCT00398216|460594986|FG001|Overall Study|Adverse Event|2|||
127990916|NCT00398216|460594987|FG002|Overall Study|Adverse Event|5|||
127990917|NCT00398216|460594988|FG003|Overall Study|Adverse Event|7|||
127990918|NCT00398216|460594989|FG004|Overall Study|Adverse Event|2|||
127664421|NCT02018861|459395035|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
127664422|NCT02018861|459395026|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
127664423|NCT02018861|459395027|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
127664424|NCT02018861|459395028|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
127990919|NCT00398216|460594985|FG000|Overall Study|Protocol Violation|2|||
127990920|NCT00398216|460594986|FG001|Overall Study|Protocol Violation|4|||
127990921|NCT00398216|460594987|FG002|Overall Study|Protocol Violation|5|||
127664425|NCT02018861|459395029|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
127664426|NCT02018861|459395030|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
127664427|NCT02018861|459395031|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
127990922|NCT00398216|460594988|FG003|Overall Study|Protocol Violation|7|||
127990923|NCT00398216|460594989|FG004|Overall Study|Protocol Violation|5|||
127990924|NCT00398216|460594985|FG000|Overall Study|Lost to Follow-up|1|||
127990925|NCT00398216|460594986|FG001|Overall Study|Lost to Follow-up|6|||
127990926|NCT00398216|460594987|FG002|Overall Study|Lost to Follow-up|4|||
127990927|NCT00398216|460594988|FG003|Overall Study|Lost to Follow-up|4|||
127990928|NCT00398216|460594989|FG004|Overall Study|Lost to Follow-up|1|||
127990929|NCT00398216|460594985|FG000|Overall Study|Death|0|||
127664428|NCT02018861|459395032|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
127664429|NCT02018861|459395033|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
127664430|NCT02018861|459395034|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
127664431|NCT02018861|459395035|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
127664432|NCT02018861|459395026|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
127664433|NCT02018861|459395027|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
127664434|NCT02018861|459395028|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
127664435|NCT02018861|459395029|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
127664436|NCT02018861|459395030|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
127664437|NCT02018861|459395031|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
127664438|NCT02018861|459395032|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
127664439|NCT02018861|459395033|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
127664440|NCT02018861|459395034|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
127664441|NCT02018861|459395035|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
127664442|NCT02018861|459395026|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
127664443|NCT02018861|459395027|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
127664444|NCT02018861|459395028|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
127664445|NCT02018861|459395029|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
127664446|NCT02018861|459395030|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
127664447|NCT02018861|459395031|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
127664448|NCT02018861|459395032|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
127664449|NCT02018861|459395033|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
127990930|NCT00398216|460594986|FG001|Overall Study|Death|3|||
127990931|NCT00398216|460594987|FG002|Overall Study|Death|0|||
127990932|NCT00398216|460594988|FG003|Overall Study|Death|0|||
127990933|NCT00398216|460594989|FG004|Overall Study|Death|0|||
127990934|NCT00398216|460594985|FG000|Overall Study|Withdrawal by Subject|1|||
127990935|NCT00398216|460594986|FG001|Overall Study|Withdrawal by Subject|0|||
127990936|NCT00398216|460594987|FG002|Overall Study|Withdrawal by Subject|3|||
127990937|NCT00398216|460594988|FG003|Overall Study|Withdrawal by Subject|1|||
127990938|NCT00398216|460594989|FG004|Overall Study|Withdrawal by Subject|2|||
127990939|NCT00398216|460594985|FG000|Overall Study|administrative reasons|3|||
127664450|NCT02018861|459395034|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
127664451|NCT02018861|459395035|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
127990940|NCT00398216|460594986|FG001|Overall Study|administrative reasons|4|||
127990941|NCT00398216|460594987|FG002|Overall Study|administrative reasons|4|||
127664452|NCT00504348|459395036|FG000|Overall Study|Adverse Event|3|||
127664453|NCT00504348|459395036|FG000|Overall Study|Lack of Efficacy|4|||
127664454|NCT00504348|459395036|FG000|Overall Study|Physician Decision|1|||
127664455|NCT01474512|459395040|FG000|Induction Period|Adverse Event|6|||
127664456|NCT01474512|459395041|FG001|Induction Period|Adverse Event|10|||
127664457|NCT01474512|459395042|FG002|Induction Period|Adverse Event|10|||
127664458|NCT01474512|459395043|FG003|Induction Period|Adverse Event|0|||
127664459|NCT01474512|459395044|FG004|Induction Period|Adverse Event|0|||
127664460|NCT01474512|459395045|FG005|Induction Period|Adverse Event|0|||
127664461|NCT01474512|459395046|FG006|Induction Period|Adverse Event|0|||
127664462|NCT01474512|459395047|FG007|Induction Period|Adverse Event|0|||
127664463|NCT01474512|459395048|FG008|Induction Period|Adverse Event|0|||
127664464|NCT01474512|459395049|FG009|Induction Period|Adverse Event|0|||
127664465|NCT01474512|459395050|FG010|Induction Period|Adverse Event|0|||
127664466|NCT01474512|459395051|FG011|Induction Period|Adverse Event|0|||
127664467|NCT01474512|459395052|FG012|Induction Period|Adverse Event|0|||
127664468|NCT01474512|459395053|FG013|Induction Period|Adverse Event|0|||
127664469|NCT01474512|459395054|FG014|Induction Period|Adverse Event|0|||
127664470|NCT01474512|459395055|FG015|Induction Period|Adverse Event|0|||
127664471|NCT01474512|459395056|FG016|Induction Period|Adverse Event|0|||
127664472|NCT01474512|459395057|FG017|Induction Period|Adverse Event|0|||
127664473|NCT01474512|459395040|FG000|Induction Period|Lack of Efficacy|7|||
127664474|NCT01474512|459395041|FG001|Induction Period|Lack of Efficacy|1|||
127664475|NCT01474512|459395042|FG002|Induction Period|Lack of Efficacy|0|||
127664476|NCT01474512|459395043|FG003|Induction Period|Lack of Efficacy|0|||
127664477|NCT01474512|459395044|FG004|Induction Period|Lack of Efficacy|0|||
127664478|NCT01474512|459395045|FG005|Induction Period|Lack of Efficacy|0|||
127664479|NCT01474512|459395046|FG006|Induction Period|Lack of Efficacy|0|||
127664480|NCT01474512|459395047|FG007|Induction Period|Lack of Efficacy|0|||
127664481|NCT01474512|459395048|FG008|Induction Period|Lack of Efficacy|0|||
127664482|NCT01474512|459395049|FG009|Induction Period|Lack of Efficacy|0|||
127664483|NCT01474512|459395050|FG010|Induction Period|Lack of Efficacy|0|||
127664484|NCT01474512|459395051|FG011|Induction Period|Lack of Efficacy|0|||
127664485|NCT01474512|459395052|FG012|Induction Period|Lack of Efficacy|0|||
127664486|NCT01474512|459395053|FG013|Induction Period|Lack of Efficacy|0|||
127664487|NCT01474512|459395054|FG014|Induction Period|Lack of Efficacy|0|||
127664488|NCT01474512|459395055|FG015|Induction Period|Lack of Efficacy|0|||
127664489|NCT01474512|459395056|FG016|Induction Period|Lack of Efficacy|0|||
127664490|NCT01474512|459395057|FG017|Induction Period|Lack of Efficacy|0|||
127664491|NCT01474512|459395040|FG000|Induction Period|Withdrawal by Subject|6|||
127664492|NCT01474512|459395041|FG001|Induction Period|Withdrawal by Subject|6|||
127664493|NCT01474512|459395042|FG002|Induction Period|Withdrawal by Subject|5|||
127664494|NCT01474512|459395043|FG003|Induction Period|Withdrawal by Subject|0|||
127664495|NCT01474512|459395044|FG004|Induction Period|Withdrawal by Subject|0|||
127664496|NCT01474512|459395045|FG005|Induction Period|Withdrawal by Subject|0|||
127664497|NCT01474512|459395046|FG006|Induction Period|Withdrawal by Subject|0|||
127664498|NCT01474512|459395047|FG007|Induction Period|Withdrawal by Subject|0|||
127664499|NCT01474512|459395048|FG008|Induction Period|Withdrawal by Subject|0|||
127664500|NCT01474512|459395049|FG009|Induction Period|Withdrawal by Subject|0|||
127664501|NCT01474512|459395050|FG010|Induction Period|Withdrawal by Subject|0|||
127664502|NCT01474512|459395051|FG011|Induction Period|Withdrawal by Subject|0|||
127664503|NCT01474512|459395052|FG012|Induction Period|Withdrawal by Subject|0|||
127664504|NCT01474512|459395053|FG013|Induction Period|Withdrawal by Subject|0|||
127664505|NCT01474512|459395054|FG014|Induction Period|Withdrawal by Subject|0|||
127664506|NCT01474512|459395055|FG015|Induction Period|Withdrawal by Subject|0|||
127664507|NCT01474512|459395056|FG016|Induction Period|Withdrawal by Subject|0|||
127664508|NCT01474512|459395057|FG017|Induction Period|Withdrawal by Subject|0|||
127664509|NCT01474512|459395040|FG000|Induction Period|Protocol Violation|3|||
127664510|NCT01474512|459395041|FG001|Induction Period|Protocol Violation|6|||
127990942|NCT00398216|460594988|FG003|Overall Study|administrative reasons|3|||
127664511|NCT01474512|459395042|FG002|Induction Period|Protocol Violation|0|||
127664512|NCT01474512|459395043|FG003|Induction Period|Protocol Violation|0|||
127664513|NCT01474512|459395044|FG004|Induction Period|Protocol Violation|0|||
127664514|NCT01474512|459395045|FG005|Induction Period|Protocol Violation|0|||
127664515|NCT01474512|459395046|FG006|Induction Period|Protocol Violation|0|||
127664516|NCT01474512|459395047|FG007|Induction Period|Protocol Violation|0|||
127664517|NCT01474512|459395048|FG008|Induction Period|Protocol Violation|0|||
127664518|NCT01474512|459395049|FG009|Induction Period|Protocol Violation|0|||
127664519|NCT01474512|459395050|FG010|Induction Period|Protocol Violation|0|||
127664520|NCT01474512|459395051|FG011|Induction Period|Protocol Violation|0|||
127664521|NCT01474512|459395052|FG012|Induction Period|Protocol Violation|0|||
127664522|NCT01474512|459395053|FG013|Induction Period|Protocol Violation|0|||
127664523|NCT01474512|459395054|FG014|Induction Period|Protocol Violation|0|||
127664524|NCT01474512|459395055|FG015|Induction Period|Protocol Violation|0|||
127664525|NCT01474512|459395056|FG016|Induction Period|Protocol Violation|0|||
127664526|NCT01474512|459395057|FG017|Induction Period|Protocol Violation|0|||
127664527|NCT01474512|459395040|FG000|Induction Period|Sponsor Decision|1|||
127664528|NCT01474512|459395041|FG001|Induction Period|Sponsor Decision|1|||
127664529|NCT01474512|459395042|FG002|Induction Period|Sponsor Decision|1|||
127664530|NCT01474512|459395043|FG003|Induction Period|Sponsor Decision|0|||
127664531|NCT01474512|459395044|FG004|Induction Period|Sponsor Decision|0|||
127990943|NCT00398216|460594989|FG004|Overall Study|administrative reasons|3|||
127664532|NCT01474512|459395045|FG005|Induction Period|Sponsor Decision|0|||
127664533|NCT01474512|459395046|FG006|Induction Period|Sponsor Decision|0|||
127990944|NCT00398216|460594985|FG000|Overall Study|entrance criteria|0|||
127664534|NCT01474512|459395047|FG007|Induction Period|Sponsor Decision|0|||
127664535|NCT01474512|459395048|FG008|Induction Period|Sponsor Decision|0|||
127664536|NCT01474512|459395049|FG009|Induction Period|Sponsor Decision|0|||
127664537|NCT01474512|459395050|FG010|Induction Period|Sponsor Decision|0|||
127664538|NCT01474512|459395051|FG011|Induction Period|Sponsor Decision|0|||
127664539|NCT01474512|459395052|FG012|Induction Period|Sponsor Decision|0|||
127664540|NCT01474512|459395053|FG013|Induction Period|Sponsor Decision|0|||
127664541|NCT01474512|459395054|FG014|Induction Period|Sponsor Decision|0|||
127664542|NCT01474512|459395055|FG015|Induction Period|Sponsor Decision|0|||
127664543|NCT01474512|459395056|FG016|Induction Period|Sponsor Decision|0|||
127664544|NCT01474512|459395057|FG017|Induction Period|Sponsor Decision|0|||
127664545|NCT01474512|459395040|FG000|Induction Period|Lost to Follow-up|1|||
127990945|NCT00398216|460594986|FG001|Overall Study|entrance criteria|0|||
127990946|NCT00398216|460594987|FG002|Overall Study|entrance criteria|0|||
127664546|NCT01474512|459395041|FG001|Induction Period|Lost to Follow-up|0|||
127664547|NCT01474512|459395042|FG002|Induction Period|Lost to Follow-up|2|||
127664548|NCT01474512|459395043|FG003|Induction Period|Lost to Follow-up|0|||
127664549|NCT01474512|459395044|FG004|Induction Period|Lost to Follow-up|0|||
127664550|NCT01474512|459395045|FG005|Induction Period|Lost to Follow-up|0|||
127664551|NCT01474512|459395046|FG006|Induction Period|Lost to Follow-up|0|||
127664552|NCT01474512|459395047|FG007|Induction Period|Lost to Follow-up|0|||
127664553|NCT01474512|459395048|FG008|Induction Period|Lost to Follow-up|0|||
127664554|NCT01474512|459395049|FG009|Induction Period|Lost to Follow-up|0|||
127990947|NCT00398216|460594988|FG003|Overall Study|entrance criteria|0|||
127990948|NCT00398216|460594989|FG004|Overall Study|entrance criteria|2|||
127990949|NCT01048944|460594990|FG000|Overall Study|Protocol Violation|8|||
127990950|NCT01048944|460594991|FG001|Overall Study|Protocol Violation|10|||
127990951|NCT01048944|460594992|FG002|Overall Study|Protocol Violation|10|||
127990952|NCT01048944|460594993|FG003|Overall Study|Protocol Violation|2|||
127990953|NCT01844817|460594994|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
127990954|NCT01844817|460594995|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
127990955|NCT01844817|460594994|FG000|Treatment|Progressive Disease|27|||
127990956|NCT01844817|460594995|FG001|Treatment|Progressive Disease|36|||
127990957|NCT01844817|460594994|FG000|Treatment|Adverse Event|17|||
127990958|NCT01844817|460594995|FG001|Treatment|Adverse Event|9|||
127664555|NCT01474512|459395050|FG010|Induction Period|Lost to Follow-up|0|||
127664556|NCT01474512|459395051|FG011|Induction Period|Lost to Follow-up|0|||
127664557|NCT01474512|459395052|FG012|Induction Period|Lost to Follow-up|0|||
127664558|NCT01474512|459395053|FG013|Induction Period|Lost to Follow-up|0|||
127664559|NCT01474512|459395054|FG014|Induction Period|Lost to Follow-up|0|||
127664560|NCT01474512|459395055|FG015|Induction Period|Lost to Follow-up|0|||
127664561|NCT01474512|459395056|FG016|Induction Period|Lost to Follow-up|0|||
127664562|NCT01474512|459395057|FG017|Induction Period|Lost to Follow-up|0|||
127990959|NCT01844817|460594994|FG000|Treatment|Withdrawal by Subject|10|||
127664563|NCT01474512|459395040|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
127990960|NCT01844817|460594995|FG001|Treatment|Withdrawal by Subject|6|||
127664564|NCT01474512|459395041|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
127664565|NCT01474512|459395042|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
127664566|NCT01474512|459395043|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
127664567|NCT01474512|459395044|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
127664568|NCT01474512|459395045|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
127664569|NCT01474512|459395046|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
127664570|NCT01474512|459395047|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
127664571|NCT01474512|459395048|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
127664572|NCT01474512|459395049|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
127990961|NCT01844817|460594994|FG000|Treatment|Death|10|||
127990962|NCT01844817|460594995|FG001|Treatment|Death|8|||
127990963|NCT01844817|460594994|FG000|Treatment|Lost to Follow-up|0|||
127664573|NCT01474512|459395050|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
127664574|NCT01474512|459395051|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
127990964|NCT01844817|460594995|FG001|Treatment|Lost to Follow-up|1|||
127664575|NCT01474512|459395052|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
127990965|NCT01844817|460594994|FG000|Treatment|Other|0|||
127990966|NCT01844817|460594995|FG001|Treatment|Other|3|||
127990967|NCT02207400|460594996|FG000|Overall Study|Adverse Event|1|||
127990968|NCT02207400|460594997|FG001|Overall Study|Adverse Event|1|||
127990969|NCT02207400|460594996|FG000|Overall Study|Lost to Follow-up|6|||
127990970|NCT02207400|460594997|FG001|Overall Study|Lost to Follow-up|7|||
127990971|NCT02207400|460594996|FG000|Overall Study|Protocol Violation|1|||
127990972|NCT02207400|460594997|FG001|Overall Study|Protocol Violation|1|||
127990973|NCT02207400|460594996|FG000|Overall Study|Withdrawal by Subject|8|||
127990974|NCT02207400|460594997|FG001|Overall Study|Withdrawal by Subject|4|||
127990975|NCT02207400|460594996|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
127990976|NCT02207400|460594997|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
127990977|NCT03396822|460594998|FG000|Overall Study|No meningeal enhancement on baseline scan|8|||
127990978|NCT03396822|460594998|FG000|Overall Study|Physician Decision|1|||
127990979|NCT03638466|460594999|FG000|Overall Study|Early Termination|0|||
127990980|NCT03638466|460595000|FG001|Overall Study|Early Termination|1|||
127990981|NCT03251482|460595001|FG000|Overall Study|Withdrawal by Subject|0|||
127990982|NCT03251482|460595002|FG001|Overall Study|Withdrawal by Subject|1|||
127990983|NCT03251482|460595003|FG002|Overall Study|Withdrawal by Subject|0|||
127664576|NCT01474512|459395053|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
127664577|NCT01474512|459395054|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
127990984|NCT03251482|460595004|FG003|Overall Study|Withdrawal by Subject|0|||
127990985|NCT03251482|460595005|FG004|Overall Study|Withdrawal by Subject|0|||
127990986|NCT02362425|460595006|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
127990987|NCT02362425|460595007|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
127990988|NCT02362425|460595008|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
127990989|NCT02362425|460595009|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
127990990|NCT02362425|460595006|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
127990991|NCT02362425|460595007|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
127990992|NCT02362425|460595008|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
127990993|NCT02362425|460595009|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
127990994|NCT02362425|460595006|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
127990995|NCT02362425|460595007|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
127990996|NCT02362425|460595008|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
127990997|NCT02362425|460595009|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
127990998|NCT02362425|460595006|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
127990999|NCT02362425|460595007|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
127991000|NCT02362425|460595008|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
127991001|NCT02362425|460595009|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
127991002|NCT02362425|460595006|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
127991003|NCT02362425|460595007|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
127991004|NCT02362425|460595008|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
127991005|NCT02362425|460595009|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
127991006|NCT02362425|460595006|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
127991007|NCT02362425|460595007|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
127991008|NCT02362425|460595008|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
127991009|NCT02362425|460595009|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
127991010|NCT02362425|460595006|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
127991011|NCT02362425|460595007|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
127991012|NCT02362425|460595008|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
127991013|NCT02362425|460595009|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
127991014|NCT02362425|460595006|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
127664578|NCT01474512|459395055|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
127664579|NCT01474512|459395056|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
127664580|NCT01474512|459395057|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
127664581|NCT01474512|459395040|FG000|Maintenance Period|Adverse Event|0|||
127664582|NCT01474512|459395041|FG001|Maintenance Period|Adverse Event|0|||
127991015|NCT02362425|460595007|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
127991016|NCT02362425|460595008|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
127991017|NCT02362425|460595009|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
127991018|NCT02688764|460595015|FG000|Overall Study|Adverse Event|3|||
127991019|NCT02688764|460595016|FG001|Overall Study|Adverse Event|3|||
127991020|NCT02688764|460595015|FG000|Overall Study|AE/Kidney transplant|1|||
127991021|NCT02688764|460595016|FG001|Overall Study|AE/Kidney transplant|0|||
127991022|NCT02688764|460595015|FG000|Overall Study|AE/Lack of efficacy|1|||
127991023|NCT02688764|460595016|FG001|Overall Study|AE/Lack of efficacy|0|||
127991024|NCT02688764|460595015|FG000|Overall Study|AE/Non-compl.|1|||
127991025|NCT02688764|460595016|FG001|Overall Study|AE/Non-compl.|0|||
127664583|NCT01474512|459395042|FG002|Maintenance Period|Adverse Event|0|||
127664584|NCT01474512|459395043|FG003|Maintenance Period|Adverse Event|4|||
127664585|NCT01474512|459395044|FG004|Maintenance Period|Adverse Event|2|||
127664586|NCT01474512|459395045|FG005|Maintenance Period|Adverse Event|7|||
127664587|NCT01474512|459395046|FG006|Maintenance Period|Adverse Event|0|||
127664588|NCT01474512|459395047|FG007|Maintenance Period|Adverse Event|19|||
127664589|NCT01474512|459395048|FG008|Maintenance Period|Adverse Event|1|||
127664590|NCT01474512|459395049|FG009|Maintenance Period|Adverse Event|3|||
127664591|NCT01474512|459395050|FG010|Maintenance Period|Adverse Event|0|||
127664592|NCT01474512|459395051|FG011|Maintenance Period|Adverse Event|0|||
127664593|NCT01474512|459395052|FG012|Maintenance Period|Adverse Event|0|||
127664594|NCT01474512|459395053|FG013|Maintenance Period|Adverse Event|0|||
127664595|NCT01474512|459395054|FG014|Maintenance Period|Adverse Event|0|||
127664596|NCT01474512|459395055|FG015|Maintenance Period|Adverse Event|0|||
127991026|NCT02688764|460595015|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
127991027|NCT02688764|460595016|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
127991028|NCT02688764|460595015|FG000|Overall Study|AE/Other|0|||
127991029|NCT02688764|460595016|FG001|Overall Study|AE/Other|1|||
127991030|NCT02688764|460595015|FG000|Overall Study|AE/Physician decision|1|||
127991031|NCT02688764|460595016|FG001|Overall Study|AE/Physician decision|0|||
127991032|NCT02688764|460595015|FG000|Overall Study|AE/Withd. parent|3|||
127991033|NCT02688764|460595016|FG001|Overall Study|AE/Withd. parent|0|||
127991034|NCT02688764|460595015|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
127991035|NCT02688764|460595016|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
127991036|NCT02688764|460595015|FG000|Overall Study|AE/Withd. subject|1|||
127991037|NCT02688764|460595016|FG001|Overall Study|AE/Withd. subject|0|||
127991038|NCT02688764|460595015|FG000|Overall Study|Kidney transplant|10|||
127991039|NCT02688764|460595016|FG001|Overall Study|Kidney transplant|4|||
127991040|NCT02688764|460595015|FG000|Overall Study|Lack of Efficacy|3|||
127991041|NCT02688764|460595016|FG001|Overall Study|Lack of Efficacy|2|||
127991042|NCT02688764|460595015|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
127991043|NCT02688764|460595016|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
127991044|NCT02688764|460595015|FG000|Overall Study|Non-compliance with study drug|4|||
127991045|NCT02688764|460595016|FG001|Overall Study|Non-compliance with study drug|0|||
127991046|NCT02688764|460595015|FG000|Overall Study|Non-compl./Physician decision|2|||
127991047|NCT02688764|460595016|FG001|Overall Study|Non-compl./Physician decision|0|||
127991048|NCT02688764|460595015|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
127991049|NCT02688764|460595016|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
127991050|NCT02688764|460595015|FG000|Overall Study|Non-compl./Withd. subject|0|||
127991051|NCT02688764|460595016|FG001|Overall Study|Non-compl./Withd. subject|2|||
127991052|NCT02688764|460595015|FG000|Overall Study|Phosphorus level outside safe range|0|||
127991053|NCT02688764|460595016|FG001|Overall Study|Phosphorus level outside safe range|1|||
127991054|NCT02688764|460595015|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
127991055|NCT02688764|460595016|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
127991056|NCT02688764|460595015|FG000|Overall Study|Study drug taste/Withd. parent|1|||
127991057|NCT02688764|460595016|FG001|Overall Study|Study drug taste/Withd. parent|0|||
127991058|NCT02688764|460595015|FG000|Overall Study|Subject moving out|2|||
127991059|NCT02688764|460595016|FG001|Overall Study|Subject moving out|0|||
127991060|NCT02688764|460595015|FG000|Overall Study|Subject taken off dialysis|1|||
127991061|NCT02688764|460595016|FG001|Overall Study|Subject taken off dialysis|0|||
127991062|NCT02688764|460595015|FG000|Overall Study|Withdrawal by parent|3|||
127991063|NCT02688764|460595016|FG001|Overall Study|Withdrawal by parent|0|||
127991064|NCT02579382|460595020|FG000|Main Study Phase|Lost to Follow-up|0|||
127991065|NCT02579382|460595021|FG001|Main Study Phase|Lost to Follow-up|0|||
127991066|NCT02579382|460595022|FG002|Main Study Phase|Lost to Follow-up|2|||
127991067|NCT02579382|460595023|FG003|Main Study Phase|Lost to Follow-up|0|||
127991068|NCT02579382|460595020|FG000|Main Study Phase|Withdrew Consent|0|||
127991069|NCT02579382|460595021|FG001|Main Study Phase|Withdrew Consent|0|||
127991070|NCT02579382|460595022|FG002|Main Study Phase|Withdrew Consent|0|||
127991071|NCT02579382|460595023|FG003|Main Study Phase|Withdrew Consent|2|||
127991072|NCT02579382|460595020|FG000|Main Study Phase|Lack of Efficacy|0|||
127991073|NCT02579382|460595021|FG001|Main Study Phase|Lack of Efficacy|0|||
127991074|NCT02579382|460595022|FG002|Main Study Phase|Lack of Efficacy|0|||
127991075|NCT02579382|460595023|FG003|Main Study Phase|Lack of Efficacy|1|||
127991076|NCT02579382|460595020|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
127991077|NCT02579382|460595021|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
127991078|NCT02579382|460595022|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
127991079|NCT02579382|460595023|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
127991080|NCT02579382|460595020|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
127664597|NCT01474512|459395056|FG016|Maintenance Period|Adverse Event|0|||
127991081|NCT02579382|460595021|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
127664598|NCT01474512|459395057|FG017|Maintenance Period|Adverse Event|0|||
127991082|NCT02579382|460595022|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
127991083|NCT02579382|460595023|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
127991084|NCT02579382|460595020|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
127664599|NCT01474512|459395040|FG000|Maintenance Period|Withdrawal by Subject|0|||
127991085|NCT02579382|460595021|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
127991086|NCT02579382|460595022|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
127991087|NCT02579382|460595023|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
127991088|NCT02579382|460595020|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
127991089|NCT02579382|460595021|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
127991090|NCT02579382|460595022|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
127991091|NCT02579382|460595023|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
127991092|NCT02579382|460595020|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
127991093|NCT02579382|460595021|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
127991094|NCT02579382|460595022|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
127991095|NCT02579382|460595023|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
127991096|NCT02579382|460595020|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
127991097|NCT02579382|460595021|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
127991098|NCT02579382|460595022|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
127991099|NCT02579382|460595023|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
127991100|NCT03026283|460595025|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
127991101|NCT03026283|460595026|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
127991102|NCT03026283|460595027|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
127991103|NCT03026283|460595028|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
127991104|NCT03026283|460595029|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
127991105|NCT03026283|460595030|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
127991106|NCT03026283|460595031|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
127991107|NCT03026283|460595032|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
127991108|NCT03026283|460595025|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
127991109|NCT03026283|460595026|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
127991110|NCT03026283|460595027|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
127991111|NCT03026283|460595028|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
127991112|NCT03026283|460595029|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
127991113|NCT03026283|460595030|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
127991114|NCT03026283|460595031|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
127664600|NCT01474512|459395041|FG001|Maintenance Period|Withdrawal by Subject|0|||
127664601|NCT01474512|459395042|FG002|Maintenance Period|Withdrawal by Subject|0|||
127664602|NCT01474512|459395043|FG003|Maintenance Period|Withdrawal by Subject|6|||
127664603|NCT01474512|459395044|FG004|Maintenance Period|Withdrawal by Subject|2|||
127664604|NCT01474512|459395045|FG005|Maintenance Period|Withdrawal by Subject|3|||
127664605|NCT01474512|459395046|FG006|Maintenance Period|Withdrawal by Subject|1|||
127664606|NCT01474512|459395047|FG007|Maintenance Period|Withdrawal by Subject|6|||
127664607|NCT01474512|459395048|FG008|Maintenance Period|Withdrawal by Subject|3|||
127664608|NCT01474512|459395049|FG009|Maintenance Period|Withdrawal by Subject|1|||
127664609|NCT01474512|459395050|FG010|Maintenance Period|Withdrawal by Subject|0|||
127664610|NCT01474512|459395051|FG011|Maintenance Period|Withdrawal by Subject|0|||
127664611|NCT01474512|459395052|FG012|Maintenance Period|Withdrawal by Subject|0|||
127664612|NCT01474512|459395053|FG013|Maintenance Period|Withdrawal by Subject|0|||
127664613|NCT01474512|459395054|FG014|Maintenance Period|Withdrawal by Subject|0|||
127664614|NCT01474512|459395055|FG015|Maintenance Period|Withdrawal by Subject|0|||
127664615|NCT01474512|459395056|FG016|Maintenance Period|Withdrawal by Subject|0|||
127664616|NCT01474512|459395057|FG017|Maintenance Period|Withdrawal by Subject|0|||
127664617|NCT01474512|459395040|FG000|Maintenance Period|Lost to Follow-up|0|||
127664618|NCT01474512|459395041|FG001|Maintenance Period|Lost to Follow-up|0|||
127664619|NCT01474512|459395042|FG002|Maintenance Period|Lost to Follow-up|0|||
127664620|NCT01474512|459395043|FG003|Maintenance Period|Lost to Follow-up|3|||
127664621|NCT01474512|459395044|FG004|Maintenance Period|Lost to Follow-up|3|||
127664622|NCT01474512|459395045|FG005|Maintenance Period|Lost to Follow-up|0|||
127664623|NCT01474512|459395046|FG006|Maintenance Period|Lost to Follow-up|0|||
127664624|NCT01474512|459395047|FG007|Maintenance Period|Lost to Follow-up|2|||
127664625|NCT01474512|459395048|FG008|Maintenance Period|Lost to Follow-up|1|||
127664626|NCT01474512|459395049|FG009|Maintenance Period|Lost to Follow-up|1|||
127664627|NCT01474512|459395050|FG010|Maintenance Period|Lost to Follow-up|0|||
127664628|NCT01474512|459395051|FG011|Maintenance Period|Lost to Follow-up|0|||
127664629|NCT01474512|459395052|FG012|Maintenance Period|Lost to Follow-up|0|||
127664630|NCT01474512|459395053|FG013|Maintenance Period|Lost to Follow-up|0|||
127664631|NCT01474512|459395054|FG014|Maintenance Period|Lost to Follow-up|0|||
127664632|NCT01474512|459395055|FG015|Maintenance Period|Lost to Follow-up|0|||
127664633|NCT01474512|459395056|FG016|Maintenance Period|Lost to Follow-up|0|||
127664634|NCT01474512|459395057|FG017|Maintenance Period|Lost to Follow-up|0|||
127664635|NCT01474512|459395040|FG000|Maintenance Period|Death|0|||
127664636|NCT01474512|459395041|FG001|Maintenance Period|Death|0|||
127664637|NCT01474512|459395042|FG002|Maintenance Period|Death|0|||
127664638|NCT01474512|459395043|FG003|Maintenance Period|Death|0|||
127664639|NCT01474512|459395044|FG004|Maintenance Period|Death|0|||
127664640|NCT01474512|459395045|FG005|Maintenance Period|Death|2|||
127664641|NCT01474512|459395046|FG006|Maintenance Period|Death|0|||
127991115|NCT03026283|460595032|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
127991116|NCT03026283|460595025|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
127991117|NCT03026283|460595026|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
127991118|NCT03026283|460595027|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
127991119|NCT03026283|460595028|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
127991120|NCT03026283|460595029|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
127991121|NCT03026283|460595030|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
127991122|NCT03026283|460595031|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
127991123|NCT03026283|460595032|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
127991124|NCT03026283|460595025|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
127991125|NCT03026283|460595026|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
127991126|NCT03026283|460595027|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
127991127|NCT03026283|460595028|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
127991128|NCT03026283|460595029|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
127991129|NCT03026283|460595030|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
127991130|NCT03026283|460595031|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
127991131|NCT03026283|460595032|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
127991132|NCT03026283|460595025|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
127991133|NCT03026283|460595026|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
127991134|NCT03026283|460595027|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
127991135|NCT03026283|460595028|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
127991136|NCT03026283|460595029|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
127991137|NCT03026283|460595030|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
127991138|NCT03026283|460595031|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
127991139|NCT03026283|460595032|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
127991140|NCT03026283|460595025|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
127991141|NCT03026283|460595026|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
127991142|NCT03026283|460595027|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
127991143|NCT03026283|460595028|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
127991144|NCT03026283|460595029|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
127991145|NCT03026283|460595030|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
127991146|NCT03026283|460595031|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
127991147|NCT03026283|460595032|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
127991148|NCT03026283|460595025|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
127991149|NCT03026283|460595026|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
127991150|NCT03026283|460595027|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
127991151|NCT03026283|460595028|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
127991152|NCT03026283|460595029|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
127991153|NCT03026283|460595030|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
127991154|NCT03026283|460595031|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
127991155|NCT03026283|460595032|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
127991156|NCT03026283|460595025|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
127991157|NCT03026283|460595026|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
127991158|NCT03026283|460595027|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
127991159|NCT03026283|460595028|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
127991160|NCT03026283|460595029|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
127991161|NCT03026283|460595030|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
127991162|NCT03026283|460595031|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
127991163|NCT03026283|460595032|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
127991164|NCT03026283|460595025|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
127991165|NCT03026283|460595026|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
127991166|NCT03026283|460595027|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
127991167|NCT03026283|460595028|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
127991168|NCT03026283|460595029|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
127991169|NCT03026283|460595030|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
127991170|NCT03026283|460595031|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
127991171|NCT03026283|460595032|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
127991172|NCT03782571|460595033|FG000|Period 1|Withdrawal by Subject|1|||
127991173|NCT03782571|460595034|FG001|Period 1|Withdrawal by Subject|0|||
127991174|NCT03782571|460595035|FG002|Period 1|Withdrawal by Subject|0|||
127991175|NCT03782571|460595036|FG003|Period 1|Withdrawal by Subject|0|||
127991176|NCT03782571|460595033|FG000|Period 3|Subject Unable to Attend V5|1|||
127991177|NCT03782571|460595034|FG001|Period 3|Subject Unable to Attend V5|0|||
127991178|NCT03782571|460595035|FG002|Period 3|Subject Unable to Attend V5|0|||
127664642|NCT01474512|459395047|FG007|Maintenance Period|Death|0|||
127664643|NCT01474512|459395048|FG008|Maintenance Period|Death|0|||
127664644|NCT01474512|459395049|FG009|Maintenance Period|Death|0|||
127664645|NCT01474512|459395050|FG010|Maintenance Period|Death|0|||
127664646|NCT01474512|459395051|FG011|Maintenance Period|Death|0|||
127664647|NCT01474512|459395052|FG012|Maintenance Period|Death|0|||
127664648|NCT01474512|459395053|FG013|Maintenance Period|Death|0|||
127664649|NCT01474512|459395054|FG014|Maintenance Period|Death|0|||
127664650|NCT01474512|459395055|FG015|Maintenance Period|Death|0|||
127664651|NCT01474512|459395056|FG016|Maintenance Period|Death|0|||
127664652|NCT01474512|459395057|FG017|Maintenance Period|Death|0|||
127664653|NCT01474512|459395040|FG000|Maintenance Period|Physician Decision|0|||
127664654|NCT01474512|459395041|FG001|Maintenance Period|Physician Decision|0|||
127664655|NCT01474512|459395042|FG002|Maintenance Period|Physician Decision|0|||
127664656|NCT01474512|459395043|FG003|Maintenance Period|Physician Decision|0|||
127664657|NCT01474512|459395044|FG004|Maintenance Period|Physician Decision|0|||
127664658|NCT01474512|459395045|FG005|Maintenance Period|Physician Decision|1|||
127664659|NCT01474512|459395046|FG006|Maintenance Period|Physician Decision|0|||
127664660|NCT01474512|459395047|FG007|Maintenance Period|Physician Decision|2|||
127664661|NCT01474512|459395048|FG008|Maintenance Period|Physician Decision|0|||
127664662|NCT01474512|459395049|FG009|Maintenance Period|Physician Decision|0|||
127664663|NCT01474512|459395050|FG010|Maintenance Period|Physician Decision|0|||
127664664|NCT01474512|459395051|FG011|Maintenance Period|Physician Decision|0|||
127664665|NCT01474512|459395052|FG012|Maintenance Period|Physician Decision|0|||
127664666|NCT01474512|459395053|FG013|Maintenance Period|Physician Decision|0|||
127664667|NCT01474512|459395054|FG014|Maintenance Period|Physician Decision|0|||
127664668|NCT01474512|459395055|FG015|Maintenance Period|Physician Decision|0|||
127664669|NCT01474512|459395056|FG016|Maintenance Period|Physician Decision|0|||
127664670|NCT01474512|459395057|FG017|Maintenance Period|Physician Decision|0|||
127664671|NCT01474512|459395040|FG000|Maintenance Period|Clinical Relapse|0|||
127664672|NCT01474512|459395041|FG001|Maintenance Period|Clinical Relapse|0|||
127664673|NCT01474512|459395042|FG002|Maintenance Period|Clinical Relapse|0|||
127664674|NCT01474512|459395043|FG003|Maintenance Period|Clinical Relapse|1|||
127991179|NCT03782571|460595036|FG003|Period 3|Subject Unable to Attend V5|0|||
127991180|NCT03782571|460595033|FG000|Period 3|Adverse Event|1|||
127664675|NCT01474512|459395044|FG004|Maintenance Period|Clinical Relapse|0|||
127664676|NCT01474512|459395045|FG005|Maintenance Period|Clinical Relapse|0|||
127664677|NCT01474512|459395046|FG006|Maintenance Period|Clinical Relapse|0|||
127664678|NCT01474512|459395047|FG007|Maintenance Period|Clinical Relapse|0|||
127664679|NCT01474512|459395048|FG008|Maintenance Period|Clinical Relapse|0|||
127664680|NCT01474512|459395049|FG009|Maintenance Period|Clinical Relapse|0|||
127664681|NCT01474512|459395050|FG010|Maintenance Period|Clinical Relapse|0|||
127664682|NCT01474512|459395051|FG011|Maintenance Period|Clinical Relapse|0|||
127664683|NCT01474512|459395052|FG012|Maintenance Period|Clinical Relapse|0|||
127664684|NCT01474512|459395053|FG013|Maintenance Period|Clinical Relapse|0|||
127664685|NCT01474512|459395054|FG014|Maintenance Period|Clinical Relapse|0|||
127664686|NCT01474512|459395055|FG015|Maintenance Period|Clinical Relapse|0|||
127664687|NCT01474512|459395056|FG016|Maintenance Period|Clinical Relapse|0|||
127664688|NCT01474512|459395057|FG017|Maintenance Period|Clinical Relapse|0|||
127664689|NCT01474512|459395040|FG000|Maintenance Period|Lack of Efficacy|0|||
127664690|NCT01474512|459395041|FG001|Maintenance Period|Lack of Efficacy|0|||
127664691|NCT01474512|459395042|FG002|Maintenance Period|Lack of Efficacy|0|||
127664692|NCT01474512|459395043|FG003|Maintenance Period|Lack of Efficacy|1|||
127664693|NCT01474512|459395044|FG004|Maintenance Period|Lack of Efficacy|0|||
127664694|NCT01474512|459395045|FG005|Maintenance Period|Lack of Efficacy|0|||
127664695|NCT01474512|459395046|FG006|Maintenance Period|Lack of Efficacy|0|||
127543348|NCT00129402|458956527|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
127543349|NCT00129402|458956528|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
127543350|NCT00129402|458956529|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
127543351|NCT00129402|458956530|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
127543352|NCT00129402|458956531|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
127664696|NCT01474512|459395047|FG007|Maintenance Period|Lack of Efficacy|11|||
127664697|NCT01474512|459395048|FG008|Maintenance Period|Lack of Efficacy|11|||
127664698|NCT01474512|459395049|FG009|Maintenance Period|Lack of Efficacy|12|||
127664699|NCT01474512|459395050|FG010|Maintenance Period|Lack of Efficacy|0|||
127664700|NCT01474512|459395051|FG011|Maintenance Period|Lack of Efficacy|0|||
127664701|NCT01474512|459395052|FG012|Maintenance Period|Lack of Efficacy|0|||
127664702|NCT01474512|459395053|FG013|Maintenance Period|Lack of Efficacy|0|||
127664703|NCT01474512|459395054|FG014|Maintenance Period|Lack of Efficacy|0|||
127664704|NCT01474512|459395055|FG015|Maintenance Period|Lack of Efficacy|0|||
127664705|NCT01474512|459395056|FG016|Maintenance Period|Lack of Efficacy|0|||
127664706|NCT01474512|459395057|FG017|Maintenance Period|Lack of Efficacy|0|||
127664707|NCT01474512|459395040|FG000|Maintenance Period|Protocol Violation|0|||
127664708|NCT01474512|459395041|FG001|Maintenance Period|Protocol Violation|0|||
127664709|NCT01474512|459395042|FG002|Maintenance Period|Protocol Violation|0|||
127991181|NCT03782571|460595034|FG001|Period 3|Adverse Event|0|||
127543353|NCT00129402|458956532|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
127543354|NCT00129402|458956526|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
127543355|NCT00129402|458956527|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
127543356|NCT00129402|458956528|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
127543357|NCT00129402|458956529|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
127543358|NCT00129402|458956530|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
127543359|NCT00129402|458956531|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
127543360|NCT00129402|458956532|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
127543361|NCT00129402|458956526|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
127543362|NCT00129402|458956527|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
127543363|NCT00129402|458956528|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
127543364|NCT00129402|458956529|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
127543365|NCT00129402|458956530|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
127543366|NCT00129402|458956531|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
127991182|NCT03782571|460595035|FG002|Period 3|Adverse Event|0|||
127991183|NCT03782571|460595036|FG003|Period 3|Adverse Event|0|||
127991184|NCT02213380|460595048|FG000|Underwent Randomization|Withdrawal by Subject|2|||
127991185|NCT02213380|460595049|FG001|Underwent Randomization|Withdrawal by Subject|0|||
127991186|NCT02213380|460595048|FG000|Underwent Randomization|Not treated|3|||
127991187|NCT02213380|460595049|FG001|Underwent Randomization|Not treated|3|||
127991188|NCT02213380|460595048|FG000|Per-protocol Analysis|Protocol Violation|32|||
127991189|NCT02213380|460595049|FG001|Per-protocol Analysis|Protocol Violation|36|||
127991190|NCT00184002|460595050|FG000|Overall Study|Adverse Event|9|||
127991191|NCT00184002|460595050|FG000|Overall Study|Death|3|||
127991192|NCT00184002|460595050|FG000|Overall Study|Physician Decision|1|||
127991193|NCT00184002|460595050|FG000|Overall Study|Withdrawal by Subject|4|||
127991194|NCT01763203|460595051|FG000|Overall Study|Death|4|||
127991195|NCT01763203|460595052|FG001|Overall Study|Death|7|||
127991196|NCT01763203|460595051|FG000|Overall Study|Lost to Follow-up|12|||
127991197|NCT01763203|460595052|FG001|Overall Study|Lost to Follow-up|12|||
127991198|NCT01763203|460595051|FG000|Overall Study|Withdrawal by Subject|8|||
127991199|NCT01763203|460595052|FG001|Overall Study|Withdrawal by Subject|12|||
127991200|NCT01763203|460595051|FG000|Overall Study|Moved out of study region|7|||
127991201|NCT01763203|460595052|FG001|Overall Study|Moved out of study region|10|||
127991202|NCT01763203|460595051|FG000|Overall Study|Physician Decision|2|||
127991203|NCT01763203|460595052|FG001|Overall Study|Physician Decision|1|||
127991204|NCT02187861|460595053|FG000|Overall Study|Adverse Event|2|||
127991205|NCT02187861|460595054|FG001|Overall Study|Adverse Event|1|||
127991206|NCT02187861|460595055|FG002|Overall Study|Adverse Event|2|||
127991207|NCT02187861|460595056|FG003|Overall Study|Adverse Event|1|||
127991208|NCT02187861|460595053|FG000|Overall Study|Death|0|||
127991209|NCT02187861|460595054|FG001|Overall Study|Death|3|||
127991210|NCT02187861|460595055|FG002|Overall Study|Death|1|||
127991211|NCT02187861|460595056|FG003|Overall Study|Death|2|||
127991212|NCT02187861|460595053|FG000|Overall Study|Physician Decision|0|||
127991213|NCT02187861|460595054|FG001|Overall Study|Physician Decision|1|||
127991214|NCT02187861|460595055|FG002|Overall Study|Physician Decision|0|||
127991215|NCT02187861|460595056|FG003|Overall Study|Physician Decision|3|||
127991216|NCT02187861|460595053|FG000|Overall Study|Progressive Disease|4|||
127991217|NCT02187861|460595054|FG001|Overall Study|Progressive Disease|42|||
127991218|NCT02187861|460595055|FG002|Overall Study|Progressive Disease|19|||
127991219|NCT02187861|460595056|FG003|Overall Study|Progressive Disease|22|||
127991220|NCT02187861|460595053|FG000|Overall Study|Withdrawal by Subject|0|||
127991221|NCT02187861|460595054|FG001|Overall Study|Withdrawal by Subject|0|||
127991222|NCT02187861|460595055|FG002|Overall Study|Withdrawal by Subject|3|||
127991223|NCT02187861|460595056|FG003|Overall Study|Withdrawal by Subject|3|||
127991224|NCT02187861|460595053|FG000|Overall Study|Other|0|||
127991225|NCT02187861|460595054|FG001|Overall Study|Other|1|||
127991226|NCT02187861|460595055|FG002|Overall Study|Other|7|||
127991227|NCT02187861|460595056|FG003|Overall Study|Other|1|||
127991228|NCT01152996|460595057|FG000|Overall Study|Withdrawal by Subject|142|||
127991229|NCT01152996|460595057|FG000|Overall Study|Adverse Event|115|||
127991230|NCT01152996|460595057|FG000|Overall Study|Lost to Follow-up|112|||
127991231|NCT01152996|460595057|FG000|Overall Study|Lack of Efficacy|68|||
127991232|NCT01152996|460595057|FG000|Overall Study|Noncompliance|41|||
127991233|NCT01152996|460595057|FG000|Overall Study|Other|36|||
127991234|NCT01152996|460595057|FG000|Overall Study|Protocol Violation|22|||
127991235|NCT01152996|460595057|FG000|Overall Study|Elevated liver enzymes|1|||
127991236|NCT02072941|460595058|FG000|Overall Study|Withdrawal by Subject|29|||
127991237|NCT02072941|460595059|FG001|Overall Study|Withdrawal by Subject|21|||
127991238|NCT02072941|460595058|FG000|Overall Study|Lost to Follow-up|4|||
127991239|NCT02072941|460595059|FG001|Overall Study|Lost to Follow-up|4|||
127991240|NCT02072941|460595058|FG000|Overall Study|Death|3|||
127991241|NCT02072941|460595059|FG001|Overall Study|Death|2|||
127991242|NCT02072941|460595058|FG000|Overall Study|Removed by Study Staff|2|||
127991243|NCT02072941|460595059|FG001|Overall Study|Removed by Study Staff|2|||
127991244|NCT02020889|460595060|FG000|Overall Study|Adverse Event|0|||
127991245|NCT02020889|460595061|FG001|Overall Study|Adverse Event|1|||
127991246|NCT02020889|460595060|FG000|Overall Study|Lack of Efficacy|1|||
127991247|NCT02020889|460595061|FG001|Overall Study|Lack of Efficacy|0|||
127991248|NCT02020889|460595060|FG000|Overall Study|Lost to Follow-up|1|||
127991249|NCT02020889|460595061|FG001|Overall Study|Lost to Follow-up|0|||
127991250|NCT02020889|460595060|FG000|Overall Study|Physician Decision|2|||
127991251|NCT02020889|460595061|FG001|Overall Study|Physician Decision|0|||
127991252|NCT02020889|460595060|FG000|Overall Study|Withdrawal by Subject|3|||
127991253|NCT02020889|460595061|FG001|Overall Study|Withdrawal by Subject|2|||
127991254|NCT03224624|460595065|FG000|Overall Study|Lost to Follow-up|9|||
127991255|NCT03224624|460595066|FG001|Overall Study|Lost to Follow-up|4|||
127991256|NCT03224624|460595065|FG000|Overall Study|Death|1|||
127991257|NCT03224624|460595066|FG001|Overall Study|Death|0|||
127991258|NCT01884545|460595067|FG000|Overall Study|Lost to Follow-up|6|||
127991259|NCT01884545|460595068|FG001|Overall Study|Lost to Follow-up|4|||
127991260|NCT01884545|460595069|FG002|Overall Study|Lost to Follow-up|9|||
127991261|NCT01884545|460595070|FG003|Overall Study|Lost to Follow-up|4|||
127991262|NCT01884545|460595067|FG000|Overall Study|Patient withdrawn|7|||
127991263|NCT01884545|460595068|FG001|Overall Study|Patient withdrawn|12|||
127991264|NCT01884545|460595069|FG002|Overall Study|Patient withdrawn|5|||
127991265|NCT01884545|460595070|FG003|Overall Study|Patient withdrawn|5|||
127991266|NCT01884545|460595067|FG000|Overall Study|Non-adherence|0|||
127991267|NCT01884545|460595068|FG001|Overall Study|Non-adherence|2|||
127991268|NCT01884545|460595069|FG002|Overall Study|Non-adherence|0|||
127991269|NCT01884545|460595070|FG003|Overall Study|Non-adherence|0|||
127991270|NCT02782377|460595071|FG000|Overall Study|Physician Decision|5|||
127991271|NCT02521792|460595072|FG000|Overall Study|Study Terminated|6|||
127991272|NCT00303472|460595073|FG000|Treatment Period|Adverse Event|0|||
127991273|NCT00303472|460595074|FG001|Treatment Period|Adverse Event|0|||
127991274|NCT00303472|460595075|FG002|Treatment Period|Adverse Event|0|||
127991275|NCT00303472|460595076|FG003|Treatment Period|Adverse Event|0|||
127991276|NCT00303472|460595077|FG004|Treatment Period|Adverse Event|1|||
127991277|NCT00303472|460595078|FG005|Treatment Period|Adverse Event|0|||
127991278|NCT00303472|460595079|FG006|Treatment Period|Adverse Event|0|||
127991279|NCT00303472|460595073|FG000|Treatment Period|Death|0|||
127991280|NCT00303472|460595074|FG001|Treatment Period|Death|0|||
127991281|NCT00303472|460595075|FG002|Treatment Period|Death|0|||
127991282|NCT00303472|460595076|FG003|Treatment Period|Death|1|||
127991283|NCT00303472|460595077|FG004|Treatment Period|Death|0|||
127991284|NCT00303472|460595078|FG005|Treatment Period|Death|0|||
127991285|NCT00303472|460595079|FG006|Treatment Period|Death|1|||
127991286|NCT00303472|460595073|FG000|Treatment Period|Withdrawal by Subject|0|||
127991287|NCT00303472|460595074|FG001|Treatment Period|Withdrawal by Subject|0|||
127991288|NCT00303472|460595075|FG002|Treatment Period|Withdrawal by Subject|0|||
127991289|NCT00303472|460595076|FG003|Treatment Period|Withdrawal by Subject|1|||
127991290|NCT00303472|460595077|FG004|Treatment Period|Withdrawal by Subject|0|||
127991291|NCT00303472|460595078|FG005|Treatment Period|Withdrawal by Subject|1|||
127991292|NCT00303472|460595079|FG006|Treatment Period|Withdrawal by Subject|0|||
127991293|NCT00303472|460595073|FG000|Treatment Period|Other|0|||
127664710|NCT01474512|459395043|FG003|Maintenance Period|Protocol Violation|1|||
127664711|NCT01474512|459395044|FG004|Maintenance Period|Protocol Violation|0|||
127991294|NCT00303472|460595074|FG001|Treatment Period|Other|0|||
127991295|NCT00303472|460595075|FG002|Treatment Period|Other|0|||
127991296|NCT00303472|460595076|FG003|Treatment Period|Other|0|||
127991297|NCT00303472|460595077|FG004|Treatment Period|Other|1|||
127991298|NCT00303472|460595078|FG005|Treatment Period|Other|0|||
127991299|NCT00303472|460595079|FG006|Treatment Period|Other|1|||
127991300|NCT00303472|460595073|FG000|Treatment Period|Disease Progression (to AML)|0|||
127991301|NCT00303472|460595074|FG001|Treatment Period|Disease Progression (to AML)|0|||
127991302|NCT00303472|460595075|FG002|Treatment Period|Disease Progression (to AML)|0|||
127991303|NCT00303472|460595076|FG003|Treatment Period|Disease Progression (to AML)|0|||
127991304|NCT00303472|460595077|FG004|Treatment Period|Disease Progression (to AML)|1|||
127991305|NCT00303472|460595078|FG005|Treatment Period|Disease Progression (to AML)|0|||
127664712|NCT01474512|459395045|FG005|Maintenance Period|Protocol Violation|0|||
127664713|NCT01474512|459395046|FG006|Maintenance Period|Protocol Violation|0|||
127664714|NCT01474512|459395047|FG007|Maintenance Period|Protocol Violation|1|||
127991306|NCT00303472|460595079|FG006|Treatment Period|Disease Progression (to AML)|0|||
127991307|NCT00303472|460595073|FG000|Treatment Extension (Optional)|Adverse Event|1|||
127991308|NCT00303472|460595074|FG001|Treatment Extension (Optional)|Adverse Event|0|||
127991309|NCT00303472|460595075|FG002|Treatment Extension (Optional)|Adverse Event|1|||
127991310|NCT00303472|460595076|FG003|Treatment Extension (Optional)|Adverse Event|0|||
127991311|NCT00303472|460595077|FG004|Treatment Extension (Optional)|Adverse Event|0|||
127991312|NCT00303472|460595078|FG005|Treatment Extension (Optional)|Adverse Event|0|||
127991313|NCT00303472|460595079|FG006|Treatment Extension (Optional)|Adverse Event|0|||
127991314|NCT00303472|460595073|FG000|Treatment Extension (Optional)|Death|2|||
127991315|NCT00303472|460595074|FG001|Treatment Extension (Optional)|Death|0|||
127991316|NCT00303472|460595075|FG002|Treatment Extension (Optional)|Death|1|||
127991317|NCT00303472|460595076|FG003|Treatment Extension (Optional)|Death|0|||
127991318|NCT00303472|460595077|FG004|Treatment Extension (Optional)|Death|0|||
127991319|NCT00303472|460595078|FG005|Treatment Extension (Optional)|Death|0|||
127991320|NCT00303472|460595079|FG006|Treatment Extension (Optional)|Death|0|||
127991321|NCT00303472|460595073|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
127991322|NCT00303472|460595074|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
127991323|NCT00303472|460595075|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
127991324|NCT00303472|460595076|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
127991325|NCT00303472|460595077|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
127991326|NCT00303472|460595078|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
127991327|NCT00303472|460595079|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
127991328|NCT00303472|460595073|FG000|Treatment Extension (Optional)|Physician Decision|0|||
127991329|NCT00303472|460595074|FG001|Treatment Extension (Optional)|Physician Decision|4|||
127991330|NCT00303472|460595075|FG002|Treatment Extension (Optional)|Physician Decision|2|||
127991331|NCT00303472|460595076|FG003|Treatment Extension (Optional)|Physician Decision|3|||
127991332|NCT00303472|460595077|FG004|Treatment Extension (Optional)|Physician Decision|2|||
127991333|NCT00303472|460595078|FG005|Treatment Extension (Optional)|Physician Decision|0|||
127991334|NCT00303472|460595079|FG006|Treatment Extension (Optional)|Physician Decision|0|||
127991335|NCT00303472|460595073|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
127991336|NCT00303472|460595074|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
127991337|NCT00303472|460595075|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
127991338|NCT00303472|460595076|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
127991339|NCT00303472|460595077|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
127991340|NCT00303472|460595078|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
127991341|NCT00303472|460595079|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
127991342|NCT00303472|460595073|FG000|Treatment Extension (Optional)|Other|0|||
127991343|NCT00303472|460595074|FG001|Treatment Extension (Optional)|Other|2|||
127991344|NCT00303472|460595075|FG002|Treatment Extension (Optional)|Other|4|||
127991345|NCT00303472|460595076|FG003|Treatment Extension (Optional)|Other|2|||
127991346|NCT00303472|460595077|FG004|Treatment Extension (Optional)|Other|1|||
127991347|NCT00303472|460595078|FG005|Treatment Extension (Optional)|Other|0|||
127991348|NCT00303472|460595079|FG006|Treatment Extension (Optional)|Other|0|||
127991349|NCT00303472|460595073|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
127991350|NCT00303472|460595074|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
127991351|NCT00303472|460595075|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
127991352|NCT00303472|460595076|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
127991353|NCT00303472|460595077|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
127991354|NCT00303472|460595078|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
127991355|NCT00303472|460595079|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
127991356|NCT02937636|460595081|FG000|Overall Study|Other (Not specified)|3|||
127991357|NCT02937636|460595082|FG001|Overall Study|Other (Not specified)|2|||
127991358|NCT00770913|460595083|FG000|Overall Study|Adverse Event|1|||
127991359|NCT00770913|460595084|FG001|Overall Study|Adverse Event|3|||
127991360|NCT00770913|460595085|FG002|Overall Study|Adverse Event|6|||
127991361|NCT00770913|460595083|FG000|Overall Study|Refusal to continue participation|6|||
127991362|NCT00770913|460595084|FG001|Overall Study|Refusal to continue participation|4|||
127991363|NCT00770913|460595085|FG002|Overall Study|Refusal to continue participation|5|||
127991364|NCT00770913|460595083|FG000|Overall Study|Physician Decision|0|||
127991365|NCT00770913|460595084|FG001|Overall Study|Physician Decision|1|||
127991366|NCT00770913|460595085|FG002|Overall Study|Physician Decision|1|||
127991367|NCT00770913|460595083|FG000|Overall Study|Protocol Violation|3|||
127991368|NCT00770913|460595084|FG001|Overall Study|Protocol Violation|0|||
127991369|NCT00770913|460595085|FG002|Overall Study|Protocol Violation|1|||
127991370|NCT00770913|460595083|FG000|Overall Study|Incorrect drug was allocated|1|||
127991371|NCT00770913|460595084|FG001|Overall Study|Incorrect drug was allocated|0|||
127991372|NCT00770913|460595085|FG002|Overall Study|Incorrect drug was allocated|0|||
127991373|NCT00359294|460595089|FG000|Overall Study|Progressive disease|1|||
127991374|NCT00359294|460595090|FG001|Overall Study|Progressive disease|1|||
127991375|NCT00359294|460595091|FG002|Overall Study|Progressive disease|2|||
127991376|NCT00359294|460595092|FG003|Overall Study|Progressive disease|3|||
127991377|NCT00359294|460595093|FG004|Overall Study|Progressive disease|2|||
127991378|NCT00359294|460595089|FG000|Overall Study|Withdrawal by Subject|0|||
127991379|NCT00359294|460595090|FG001|Overall Study|Withdrawal by Subject|0|||
127991380|NCT00359294|460595091|FG002|Overall Study|Withdrawal by Subject|0|||
127991381|NCT00359294|460595092|FG003|Overall Study|Withdrawal by Subject|0|||
127991382|NCT00359294|460595093|FG004|Overall Study|Withdrawal by Subject|1|||
127991383|NCT00359294|460595089|FG000|Overall Study|Not treated|0|||
127664715|NCT01474512|459395048|FG008|Maintenance Period|Protocol Violation|0|||
127664716|NCT01474512|459395049|FG009|Maintenance Period|Protocol Violation|1|||
127664717|NCT01474512|459395050|FG010|Maintenance Period|Protocol Violation|0|||
127664718|NCT01474512|459395051|FG011|Maintenance Period|Protocol Violation|0|||
127991384|NCT00359294|460595090|FG001|Overall Study|Not treated|0|||
127991385|NCT00359294|460595091|FG002|Overall Study|Not treated|0|||
127664719|NCT01474512|459395052|FG012|Maintenance Period|Protocol Violation|0|||
127664720|NCT01474512|459395053|FG013|Maintenance Period|Protocol Violation|0|||
127664721|NCT01474512|459395054|FG014|Maintenance Period|Protocol Violation|0|||
127664722|NCT01474512|459395055|FG015|Maintenance Period|Protocol Violation|0|||
127664723|NCT01474512|459395056|FG016|Maintenance Period|Protocol Violation|0|||
127664724|NCT01474512|459395057|FG017|Maintenance Period|Protocol Violation|0|||
127664725|NCT01474512|459395040|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
127664726|NCT01474512|459395041|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
127664727|NCT01474512|459395042|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
127664728|NCT01474512|459395043|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
127664729|NCT01474512|459395044|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
127664730|NCT01474512|459395045|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
127664731|NCT01474512|459395046|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
127664732|NCT01474512|459395047|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
127664733|NCT01474512|459395048|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
127664734|NCT01474512|459395049|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
127664735|NCT01474512|459395050|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
127664736|NCT01474512|459395051|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
127664737|NCT01474512|459395052|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
127664738|NCT01474512|459395053|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
127664739|NCT01474512|459395054|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
127991386|NCT00359294|460595092|FG003|Overall Study|Not treated|1|||
127664740|NCT01474512|459395055|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
127664741|NCT01474512|459395056|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
127664742|NCT01474512|459395057|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
127664743|NCT01474512|459395040|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
127664744|NCT01474512|459395041|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
127991387|NCT00359294|460595093|FG004|Overall Study|Not treated|0|||
127991388|NCT00359294|460595089|FG000|Overall Study|Physician Decision|0|||
127991389|NCT00359294|460595090|FG001|Overall Study|Physician Decision|0|||
127991390|NCT00359294|460595091|FG002|Overall Study|Physician Decision|1|||
127991391|NCT00359294|460595092|FG003|Overall Study|Physician Decision|0|||
127991392|NCT00359294|460595093|FG004|Overall Study|Physician Decision|0|||
127991393|NCT02347072|460595096|FG000|Overall Study|Adverse Event|2|||
127991394|NCT02347072|460595096|FG000|Overall Study|Withdrawal by Subject|6|||
127991395|NCT02347072|460595096|FG000|Overall Study|Physician Decision|1|||
127991396|NCT02347072|460595096|FG000|Overall Study|Lost to Follow-up|2|||
127991397|NCT02347072|460595096|FG000|Overall Study|Protocol Violation|1|||
127991398|NCT02347072|460595096|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
127991399|NCT03681184|460595104|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
127991400|NCT03681184|460595105|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
127991401|NCT01098162|460595106|FG000|Overall Study|Adverse Event|37|||
127991402|NCT01098162|460595106|FG000|Overall Study|Lack of Efficacy|4|||
127991403|NCT01098162|460595106|FG000|Overall Study|Wish of Patient|7|||
127991404|NCT01098162|460595106|FG000|Overall Study|Lost to Follow-up|9|||
127991405|NCT01098162|460595106|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
127991406|NCT01098162|460595106|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
127991407|NCT01098162|460595106|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
127991408|NCT01098162|460595106|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
127991409|NCT01098162|460595106|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
127991410|NCT01098162|460595106|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
127991411|NCT01098162|460595106|FG000|Overall Study|Other Reason|1|||
127991412|NCT01098162|460595106|FG000|Overall Study|Reason Unknown|26|||
127991413|NCT00625183|460595107|FG000|Overall Study|Disease Progression|1|||
127664745|NCT01474512|459395042|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
127664746|NCT01474512|459395043|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
127664747|NCT01474512|459395044|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
127664748|NCT01474512|459395045|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
127991414|NCT04318132|460595108|FG000|Overall Study|Protocol Violation|0|||
127991415|NCT04318132|460595109|FG001|Overall Study|Protocol Violation|0|||
127991416|NCT04318132|460595110|FG002|Overall Study|Protocol Violation|3|||
127991417|NCT04318132|460595111|FG003|Overall Study|Protocol Violation|0|||
127991418|NCT04424914|460595112|FG000|Overall Study|Other|0|||
127991419|NCT04424914|460595113|FG001|Overall Study|Other|0|||
127991420|NCT04424914|460595114|FG002|Overall Study|Other|28|||
127991421|NCT04424914|460595112|FG000|Overall Study|Withdrawal by Subject|3|||
127991422|NCT04424914|460595113|FG001|Overall Study|Withdrawal by Subject|0|||
127991423|NCT04424914|460595114|FG002|Overall Study|Withdrawal by Subject|0|||
127991424|NCT04424914|460595112|FG000|Overall Study|Study terminated by sponsor|23|||
127991425|NCT04424914|460595113|FG001|Overall Study|Study terminated by sponsor|7|||
127991426|NCT04424914|460595114|FG002|Overall Study|Study terminated by sponsor|0|||
127991427|NCT04424914|460595112|FG000|Overall Study|Lost to Follow-up|0|||
127991428|NCT04424914|460595113|FG001|Overall Study|Lost to Follow-up|0|||
127991429|NCT04424914|460595114|FG002|Overall Study|Lost to Follow-up|1|||
127991430|NCT04424914|460595112|FG000|Overall Study|Death|3|||
127991431|NCT04424914|460595113|FG001|Overall Study|Death|1|||
127991432|NCT04424914|460595114|FG002|Overall Study|Death|0|||
127991433|NCT03383692|460595119|FG000|Overall Study|Progressive disease as per RECIST|3|||
127991434|NCT03383692|460595120|FG001|Overall Study|Progressive disease as per RECIST|3|||
127991435|NCT03383692|460595119|FG000|Overall Study|Clinical progression|0|||
127991436|NCT03383692|460595120|FG001|Overall Study|Clinical progression|1|||
127991437|NCT03383692|460595119|FG000|Overall Study|Adverse Event|3|||
127991438|NCT03383692|460595120|FG001|Overall Study|Adverse Event|0|||
127991439|NCT00893971|460595125|FG000|Overall Study|Physician Decision|3|||
127991440|NCT02453256|460595126|FG000|Double Blind Period|Death|1|||
127991441|NCT02453256|460595127|FG001|Double Blind Period|Death|1|||
127991442|NCT02453256|460595126|FG000|Double Blind Period|Adverse Event|3|||
127991443|NCT02453256|460595127|FG001|Double Blind Period|Adverse Event|2|||
127991444|NCT02453256|460595126|FG000|Double Blind Period|Withdrawal by Subject|9|||
127991445|NCT02453256|460595127|FG001|Double Blind Period|Withdrawal by Subject|5|||
127991446|NCT02453256|460595126|FG000|Double Blind Period|Other|0|||
127991447|NCT02453256|460595127|FG001|Double Blind Period|Other|1|||
127991448|NCT02453256|460595126|FG000|Open Label Period|Adverse Event|1|||
127991449|NCT02453256|460595127|FG001|Open Label Period|Adverse Event|3|||
127991450|NCT02453256|460595126|FG000|Open Label Period|Death|0|||
127991451|NCT02453256|460595127|FG001|Open Label Period|Death|1|||
127991452|NCT02453256|460595126|FG000|Open Label Period|Lost to Follow-up|1|||
127991453|NCT02453256|460595127|FG001|Open Label Period|Lost to Follow-up|0|||
127991454|NCT02453256|460595126|FG000|Open Label Period|Other|0|||
127991455|NCT02453256|460595127|FG001|Open Label Period|Other|2|||
127991456|NCT02453256|460595126|FG000|Open Label Period|Withdrawal by Subject|5|||
127991457|NCT02453256|460595127|FG001|Open Label Period|Withdrawal by Subject|1|||
127991458|NCT01366638|460595128|FG000|Overall Study|Withdrawal by Subject|0|||
127991459|NCT01366638|460595129|FG001|Overall Study|Withdrawal by Subject|0|||
127991460|NCT01366638|460595130|FG002|Overall Study|Withdrawal by Subject|6|||
127991461|NCT01366638|460595128|FG000|Overall Study|Other|1|||
127991462|NCT01366638|460595129|FG001|Overall Study|Other|0|||
127991463|NCT01366638|460595130|FG002|Overall Study|Other|0|||
127991464|NCT01237327|460595131|FG000|Overall Study|Protocol Violation: Core Study|1|||
127991465|NCT01237327|460595132|FG001|Overall Study|Protocol Violation: Core Study|0|||
127991466|NCT01237327|460595131|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
127991467|NCT01237327|460595132|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
127991468|NCT01237327|460595131|FG000|Overall Study|Progression of Disease: Core Study|18|||
127991469|NCT01237327|460595132|FG001|Overall Study|Progression of Disease: Core Study|22|||
127991470|NCT01237327|460595131|FG000|Overall Study|Progression of Disease: Extension Study|15|||
127991471|NCT01237327|460595132|FG001|Overall Study|Progression of Disease: Extension Study|13|||
127991472|NCT01237327|460595131|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
127991473|NCT01237327|460595132|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
127991474|NCT01237327|460595131|FG000|Overall Study|Withdrawal by Subject|1|||
127991475|NCT01237327|460595132|FG001|Overall Study|Withdrawal by Subject|3|||
127991476|NCT01237327|460595131|FG000|Overall Study|Lost to Follow-up|3|||
127991477|NCT01237327|460595132|FG001|Overall Study|Lost to Follow-up|0|||
127991478|NCT02483572|460595135|FG000|Overall Study|Withdrawal by Subject|1|||
127991479|NCT02483572|460595136|FG001|Overall Study|Withdrawal by Subject|0|||
127991480|NCT02483572|460595135|FG000|Overall Study|Lost to Follow-up|1|||
127991481|NCT02483572|460595136|FG001|Overall Study|Lost to Follow-up|0|||
127991482|NCT02483572|460595135|FG000|Overall Study|Physician Decision|0|||
127991483|NCT02483572|460595136|FG001|Overall Study|Physician Decision|1|||
127991484|NCT05052697|460595137|FG000|Substudy A|Lost to Follow-up|0|||
127991485|NCT05052697|460595138|FG001|Substudy A|Lost to Follow-up|0|||
127991486|NCT05052697|460595139|FG002|Substudy A|Lost to Follow-up|0|||
127991487|NCT05052697|460595140|FG003|Substudy A|Lost to Follow-up|0|||
127991488|NCT05052697|460595141|FG004|Substudy A|Lost to Follow-up|0|||
127991489|NCT05052697|460595142|FG005|Substudy A|Lost to Follow-up|1|||
127991490|NCT05052697|460595143|FG006|Substudy A|Lost to Follow-up|0|||
127991491|NCT05052697|460595144|FG007|Substudy A|Lost to Follow-up|0|||
127991492|NCT05052697|460595145|FG008|Substudy A|Lost to Follow-up|0|||
127991493|NCT05052697|460595146|FG009|Substudy A|Lost to Follow-up|0|||
127991494|NCT05052697|460595147|FG010|Substudy A|Lost to Follow-up|0|||
127991495|NCT05052697|460595148|FG011|Substudy A|Lost to Follow-up|0|||
127991496|NCT05052697|460595149|FG012|Substudy A|Lost to Follow-up|0|||
127991497|NCT05052697|460595150|FG013|Substudy A|Lost to Follow-up|0|||
127991498|NCT05052697|460595151|FG014|Substudy A|Lost to Follow-up|0|||
127991499|NCT05052697|460595152|FG015|Substudy A|Lost to Follow-up|2|||
127991500|NCT05052697|460595153|FG016|Substudy A|Lost to Follow-up|0|||
127991501|NCT05052697|460595154|FG017|Substudy A|Lost to Follow-up|0|||
127991502|NCT05052697|460595155|FG018|Substudy A|Lost to Follow-up|0|||
127991503|NCT05052697|460595156|FG019|Substudy A|Lost to Follow-up|0|||
127991504|NCT05052697|460595157|FG020|Substudy A|Lost to Follow-up|0|||
127991505|NCT05052697|460595158|FG021|Substudy A|Lost to Follow-up|0|||
127991506|NCT05052697|460595159|FG022|Substudy A|Lost to Follow-up|0|||
127991507|NCT05052697|460595160|FG023|Substudy A|Lost to Follow-up|0|||
127991508|NCT05052697|460595161|FG024|Substudy A|Lost to Follow-up|0|||
127991509|NCT05052697|460595162|FG025|Substudy A|Lost to Follow-up|0|||
127991510|NCT05052697|460595163|FG026|Substudy A|Lost to Follow-up|0|||
127991511|NCT05052697|460595164|FG027|Substudy A|Lost to Follow-up|0|||
127991512|NCT05052697|460595165|FG028|Substudy A|Lost to Follow-up|0|||
127991513|NCT05052697|460595166|FG029|Substudy A|Lost to Follow-up|0|||
127991514|NCT05052697|460595167|FG030|Substudy A|Lost to Follow-up|0|||
127991515|NCT05052697|460595168|FG031|Substudy A|Lost to Follow-up|0|||
127991516|NCT05052697|460595169|FG032|Substudy A|Lost to Follow-up|0|||
127991517|NCT05052697|460595170|FG033|Substudy A|Lost to Follow-up|0|||
127991518|NCT05052697|460595137|FG000|Substudy A|No longer met eligibility criteria|0|||
127991519|NCT05052697|460595138|FG001|Substudy A|No longer met eligibility criteria|0|||
127991520|NCT05052697|460595139|FG002|Substudy A|No longer met eligibility criteria|0|||
127991521|NCT05052697|460595140|FG003|Substudy A|No longer met eligibility criteria|0|||
127991522|NCT05052697|460595141|FG004|Substudy A|No longer met eligibility criteria|0|||
127991523|NCT05052697|460595142|FG005|Substudy A|No longer met eligibility criteria|0|||
127991524|NCT05052697|460595143|FG006|Substudy A|No longer met eligibility criteria|0|||
127991525|NCT05052697|460595144|FG007|Substudy A|No longer met eligibility criteria|0|||
127991526|NCT05052697|460595145|FG008|Substudy A|No longer met eligibility criteria|0|||
127991527|NCT05052697|460595146|FG009|Substudy A|No longer met eligibility criteria|0|||
127991528|NCT05052697|460595147|FG010|Substudy A|No longer met eligibility criteria|0|||
127991529|NCT05052697|460595148|FG011|Substudy A|No longer met eligibility criteria|0|||
127991530|NCT05052697|460595149|FG012|Substudy A|No longer met eligibility criteria|0|||
127991531|NCT05052697|460595150|FG013|Substudy A|No longer met eligibility criteria|1|||
127991532|NCT05052697|460595151|FG014|Substudy A|No longer met eligibility criteria|0|||
127991533|NCT05052697|460595152|FG015|Substudy A|No longer met eligibility criteria|0|||
127991534|NCT05052697|460595153|FG016|Substudy A|No longer met eligibility criteria|0|||
127991535|NCT05052697|460595154|FG017|Substudy A|No longer met eligibility criteria|0|||
127991536|NCT05052697|460595155|FG018|Substudy A|No longer met eligibility criteria|0|||
127991537|NCT05052697|460595156|FG019|Substudy A|No longer met eligibility criteria|0|||
127991538|NCT05052697|460595157|FG020|Substudy A|No longer met eligibility criteria|0|||
127991539|NCT05052697|460595158|FG021|Substudy A|No longer met eligibility criteria|0|||
127991540|NCT05052697|460595159|FG022|Substudy A|No longer met eligibility criteria|0|||
127991541|NCT05052697|460595160|FG023|Substudy A|No longer met eligibility criteria|0|||
127991542|NCT05052697|460595161|FG024|Substudy A|No longer met eligibility criteria|0|||
127991543|NCT05052697|460595162|FG025|Substudy A|No longer met eligibility criteria|0|||
127991544|NCT05052697|460595163|FG026|Substudy A|No longer met eligibility criteria|0|||
127991545|NCT05052697|460595164|FG027|Substudy A|No longer met eligibility criteria|0|||
127991546|NCT05052697|460595165|FG028|Substudy A|No longer met eligibility criteria|0|||
127991547|NCT05052697|460595166|FG029|Substudy A|No longer met eligibility criteria|0|||
127991548|NCT05052697|460595167|FG030|Substudy A|No longer met eligibility criteria|0|||
127991549|NCT05052697|460595168|FG031|Substudy A|No longer met eligibility criteria|0|||
127991550|NCT05052697|460595169|FG032|Substudy A|No longer met eligibility criteria|0|||
127991551|NCT05052697|460595170|FG033|Substudy A|No longer met eligibility criteria|0|||
127991552|NCT05052697|460595137|FG000|Substudy A|Not vaccinated|0|||
127991553|NCT05052697|460595138|FG001|Substudy A|Not vaccinated|0|||
127991554|NCT05052697|460595139|FG002|Substudy A|Not vaccinated|0|||
127991555|NCT05052697|460595140|FG003|Substudy A|Not vaccinated|1|||
127991556|NCT05052697|460595141|FG004|Substudy A|Not vaccinated|0|||
127991557|NCT05052697|460595142|FG005|Substudy A|Not vaccinated|0|||
127991558|NCT05052697|460595143|FG006|Substudy A|Not vaccinated|0|||
127991559|NCT05052697|460595144|FG007|Substudy A|Not vaccinated|0|||
127991560|NCT05052697|460595145|FG008|Substudy A|Not vaccinated|1|||
127991561|NCT05052697|460595146|FG009|Substudy A|Not vaccinated|0|||
127991562|NCT05052697|460595147|FG010|Substudy A|Not vaccinated|0|||
127991563|NCT05052697|460595148|FG011|Substudy A|Not vaccinated|0|||
127991564|NCT05052697|460595149|FG012|Substudy A|Not vaccinated|0|||
127991565|NCT05052697|460595150|FG013|Substudy A|Not vaccinated|0|||
127991566|NCT05052697|460595151|FG014|Substudy A|Not vaccinated|0|||
127991567|NCT05052697|460595152|FG015|Substudy A|Not vaccinated|0|||
127991568|NCT05052697|460595153|FG016|Substudy A|Not vaccinated|0|||
127991569|NCT05052697|460595154|FG017|Substudy A|Not vaccinated|0|||
127991570|NCT05052697|460595155|FG018|Substudy A|Not vaccinated|0|||
127543367|NCT00129402|458956532|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
127991571|NCT05052697|460595156|FG019|Substudy A|Not vaccinated|0|||
127991572|NCT05052697|460595157|FG020|Substudy A|Not vaccinated|0|||
127991573|NCT05052697|460595158|FG021|Substudy A|Not vaccinated|0|||
127991574|NCT05052697|460595159|FG022|Substudy A|Not vaccinated|0|||
127991575|NCT05052697|460595160|FG023|Substudy A|Not vaccinated|0|||
127991576|NCT05052697|460595161|FG024|Substudy A|Not vaccinated|0|||
127991577|NCT05052697|460595162|FG025|Substudy A|Not vaccinated|0|||
127991578|NCT05052697|460595163|FG026|Substudy A|Not vaccinated|0|||
127991579|NCT05052697|460595164|FG027|Substudy A|Not vaccinated|0|||
127991580|NCT05052697|460595165|FG028|Substudy A|Not vaccinated|0|||
127991581|NCT05052697|460595166|FG029|Substudy A|Not vaccinated|0|||
127991582|NCT05052697|460595167|FG030|Substudy A|Not vaccinated|0|||
127991583|NCT05052697|460595168|FG031|Substudy A|Not vaccinated|0|||
127991584|NCT05052697|460595169|FG032|Substudy A|Not vaccinated|0|||
127991585|NCT05052697|460595170|FG033|Substudy A|Not vaccinated|0|||
127991586|NCT05052697|460595137|FG000|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
127991587|NCT05052697|460595138|FG001|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
127991588|NCT05052697|460595139|FG002|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
127991589|NCT05052697|460595140|FG003|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
127991590|NCT05052697|460595141|FG004|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
127991591|NCT05052697|460595142|FG005|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
127991592|NCT05052697|460595143|FG006|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
127991593|NCT05052697|460595144|FG007|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
127991594|NCT05052697|460595145|FG008|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
127991595|NCT05052697|460595146|FG009|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
127991596|NCT05052697|460595147|FG010|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
127991597|NCT05052697|460595148|FG011|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
127991598|NCT05052697|460595149|FG012|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
127991599|NCT05052697|460595150|FG013|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
127991600|NCT05052697|460595151|FG014|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
127991601|NCT05052697|460595152|FG015|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
127991602|NCT05052697|460595153|FG016|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
127991603|NCT05052697|460595154|FG017|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
127991604|NCT05052697|460595155|FG018|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
127991605|NCT05052697|460595156|FG019|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
127991606|NCT05052697|460595157|FG020|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
127991607|NCT05052697|460595158|FG021|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
127991608|NCT05052697|460595159|FG022|SubStudy B: Initial Enrollment|Withdrawal by Subject|2|||
127991609|NCT05052697|460595160|FG023|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
127991610|NCT05052697|460595161|FG024|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
127991611|NCT05052697|460595162|FG025|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
127991612|NCT05052697|460595163|FG026|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
127991613|NCT05052697|460595164|FG027|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
127991614|NCT05052697|460595165|FG028|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
127991615|NCT05052697|460595166|FG029|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
127991616|NCT05052697|460595167|FG030|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
127991617|NCT05052697|460595168|FG031|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
127991618|NCT05052697|460595169|FG032|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
127991619|NCT05052697|460595170|FG033|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
127991620|NCT05052697|460595137|FG000|SubStudy B: Initial Enrollment|Physician Decision|0|||
127991621|NCT05052697|460595138|FG001|SubStudy B: Initial Enrollment|Physician Decision|0|||
127991622|NCT05052697|460595139|FG002|SubStudy B: Initial Enrollment|Physician Decision|0|||
127991623|NCT05052697|460595140|FG003|SubStudy B: Initial Enrollment|Physician Decision|0|||
127991624|NCT05052697|460595141|FG004|SubStudy B: Initial Enrollment|Physician Decision|0|||
127991625|NCT05052697|460595142|FG005|SubStudy B: Initial Enrollment|Physician Decision|0|||
127991626|NCT05052697|460595143|FG006|SubStudy B: Initial Enrollment|Physician Decision|0|||
127991627|NCT05052697|460595144|FG007|SubStudy B: Initial Enrollment|Physician Decision|0|||
127991628|NCT05052697|460595145|FG008|SubStudy B: Initial Enrollment|Physician Decision|0|||
127991629|NCT05052697|460595146|FG009|SubStudy B: Initial Enrollment|Physician Decision|0|||
127991630|NCT05052697|460595147|FG010|SubStudy B: Initial Enrollment|Physician Decision|0|||
127991631|NCT05052697|460595148|FG011|SubStudy B: Initial Enrollment|Physician Decision|0|||
127991632|NCT05052697|460595149|FG012|SubStudy B: Initial Enrollment|Physician Decision|0|||
127991633|NCT05052697|460595150|FG013|SubStudy B: Initial Enrollment|Physician Decision|0|||
127991634|NCT05052697|460595151|FG014|SubStudy B: Initial Enrollment|Physician Decision|0|||
127991635|NCT05052697|460595152|FG015|SubStudy B: Initial Enrollment|Physician Decision|0|||
127991636|NCT05052697|460595153|FG016|SubStudy B: Initial Enrollment|Physician Decision|0|||
127991637|NCT05052697|460595154|FG017|SubStudy B: Initial Enrollment|Physician Decision|1|||
127991638|NCT05052697|460595155|FG018|SubStudy B: Initial Enrollment|Physician Decision|0|||
127991639|NCT05052697|460595156|FG019|SubStudy B: Initial Enrollment|Physician Decision|0|||
127991640|NCT05052697|460595157|FG020|SubStudy B: Initial Enrollment|Physician Decision|0|||
127991641|NCT05052697|460595158|FG021|SubStudy B: Initial Enrollment|Physician Decision|0|||
127991642|NCT05052697|460595159|FG022|SubStudy B: Initial Enrollment|Physician Decision|0|||
127991643|NCT05052697|460595160|FG023|SubStudy B: Initial Enrollment|Physician Decision|0|||
127991644|NCT05052697|460595161|FG024|SubStudy B: Initial Enrollment|Physician Decision|0|||
127991645|NCT05052697|460595162|FG025|SubStudy B: Initial Enrollment|Physician Decision|0|||
127991646|NCT05052697|460595163|FG026|SubStudy B: Initial Enrollment|Physician Decision|0|||
127991647|NCT05052697|460595164|FG027|SubStudy B: Initial Enrollment|Physician Decision|0|||
127991648|NCT05052697|460595165|FG028|SubStudy B: Initial Enrollment|Physician Decision|0|||
127991649|NCT05052697|460595166|FG029|SubStudy B: Initial Enrollment|Physician Decision|0|||
127991650|NCT05052697|460595167|FG030|SubStudy B: Initial Enrollment|Physician Decision|0|||
127991651|NCT05052697|460595168|FG031|SubStudy B: Initial Enrollment|Physician Decision|0|||
127991652|NCT05052697|460595169|FG032|SubStudy B: Initial Enrollment|Physician Decision|0|||
127991653|NCT05052697|460595170|FG033|SubStudy B: Initial Enrollment|Physician Decision|0|||
127991654|NCT05052697|460595137|FG000|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
127991655|NCT05052697|460595138|FG001|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
127991656|NCT05052697|460595139|FG002|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
127991657|NCT05052697|460595140|FG003|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
127991658|NCT05052697|460595141|FG004|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
127991659|NCT05052697|460595142|FG005|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
127991660|NCT05052697|460595143|FG006|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
127991661|NCT05052697|460595144|FG007|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
127991662|NCT05052697|460595145|FG008|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
127991663|NCT05052697|460595146|FG009|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
127991664|NCT05052697|460595147|FG010|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
127991665|NCT05052697|460595148|FG011|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
127991666|NCT05052697|460595149|FG012|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
127991667|NCT05052697|460595150|FG013|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
127991668|NCT05052697|460595151|FG014|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
127991669|NCT05052697|460595152|FG015|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
127991670|NCT05052697|460595153|FG016|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
127991671|NCT05052697|460595154|FG017|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
127991672|NCT05052697|460595155|FG018|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
127991673|NCT05052697|460595156|FG019|SubStudy B: Initial Enrollment|Lost to Follow-up|1|||
127991674|NCT05052697|460595157|FG020|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
127991675|NCT05052697|460595158|FG021|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
127991676|NCT05052697|460595159|FG022|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
127991677|NCT05052697|460595160|FG023|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
127991678|NCT05052697|460595161|FG024|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
127991679|NCT05052697|460595162|FG025|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
127991680|NCT05052697|460595163|FG026|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
127991681|NCT05052697|460595164|FG027|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
127991682|NCT05052697|460595165|FG028|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
127991683|NCT05052697|460595166|FG029|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
127991684|NCT05052697|460595167|FG030|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
127991685|NCT05052697|460595168|FG031|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
127991686|NCT05052697|460595169|FG032|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
127991687|NCT05052697|460595170|FG033|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
127991688|NCT05052697|460595137|FG000|SubStudy B: Initial Enrollment|Not vaccinated|0|||
127991689|NCT05052697|460595138|FG001|SubStudy B: Initial Enrollment|Not vaccinated|0|||
127991690|NCT05052697|460595139|FG002|SubStudy B: Initial Enrollment|Not vaccinated|0|||
127991691|NCT05052697|460595140|FG003|SubStudy B: Initial Enrollment|Not vaccinated|0|||
127991692|NCT05052697|460595141|FG004|SubStudy B: Initial Enrollment|Not vaccinated|0|||
127991693|NCT05052697|460595142|FG005|SubStudy B: Initial Enrollment|Not vaccinated|0|||
127991694|NCT05052697|460595143|FG006|SubStudy B: Initial Enrollment|Not vaccinated|0|||
127991695|NCT05052697|460595144|FG007|SubStudy B: Initial Enrollment|Not vaccinated|0|||
127991696|NCT05052697|460595145|FG008|SubStudy B: Initial Enrollment|Not vaccinated|0|||
127991697|NCT05052697|460595146|FG009|SubStudy B: Initial Enrollment|Not vaccinated|0|||
127991698|NCT05052697|460595147|FG010|SubStudy B: Initial Enrollment|Not vaccinated|0|||
127991699|NCT05052697|460595148|FG011|SubStudy B: Initial Enrollment|Not vaccinated|0|||
127991700|NCT05052697|460595149|FG012|SubStudy B: Initial Enrollment|Not vaccinated|0|||
127991701|NCT05052697|460595150|FG013|SubStudy B: Initial Enrollment|Not vaccinated|0|||
127991702|NCT05052697|460595151|FG014|SubStudy B: Initial Enrollment|Not vaccinated|0|||
127991703|NCT05052697|460595152|FG015|SubStudy B: Initial Enrollment|Not vaccinated|0|||
127991704|NCT05052697|460595153|FG016|SubStudy B: Initial Enrollment|Not vaccinated|0|||
127991705|NCT05052697|460595154|FG017|SubStudy B: Initial Enrollment|Not vaccinated|1|||
127991706|NCT05052697|460595155|FG018|SubStudy B: Initial Enrollment|Not vaccinated|0|||
127991707|NCT05052697|460595156|FG019|SubStudy B: Initial Enrollment|Not vaccinated|0|||
127991708|NCT05052697|460595157|FG020|SubStudy B: Initial Enrollment|Not vaccinated|0|||
127991709|NCT05052697|460595158|FG021|SubStudy B: Initial Enrollment|Not vaccinated|0|||
127991710|NCT05052697|460595159|FG022|SubStudy B: Initial Enrollment|Not vaccinated|0|||
127991711|NCT05052697|460595160|FG023|SubStudy B: Initial Enrollment|Not vaccinated|0|||
127991712|NCT05052697|460595161|FG024|SubStudy B: Initial Enrollment|Not vaccinated|0|||
127991713|NCT05052697|460595162|FG025|SubStudy B: Initial Enrollment|Not vaccinated|1|||
127991714|NCT05052697|460595163|FG026|SubStudy B: Initial Enrollment|Not vaccinated|0|||
127991715|NCT05052697|460595164|FG027|SubStudy B: Initial Enrollment|Not vaccinated|1|||
127991716|NCT05052697|460595165|FG028|SubStudy B: Initial Enrollment|Not vaccinated|0|||
127664749|NCT01474512|459395046|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
127664750|NCT01474512|459395047|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
127664751|NCT01474512|459395048|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
127664752|NCT01474512|459395049|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
127664753|NCT01474512|459395050|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
127664754|NCT01474512|459395051|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
127664755|NCT01474512|459395052|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
127664756|NCT01474512|459395053|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
127664757|NCT01474512|459395054|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
127664758|NCT01474512|459395055|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
127664759|NCT01474512|459395056|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
127664760|NCT01474512|459395057|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
127664761|NCT01474512|459395040|FG000|Long-Term Extension Period|Adverse Event|0|||
127664762|NCT01474512|459395041|FG001|Long-Term Extension Period|Adverse Event|0|||
127664763|NCT01474512|459395042|FG002|Long-Term Extension Period|Adverse Event|0|||
127664764|NCT01474512|459395043|FG003|Long-Term Extension Period|Adverse Event|0|||
127664765|NCT01474512|459395044|FG004|Long-Term Extension Period|Adverse Event|0|||
127664766|NCT01474512|459395045|FG005|Long-Term Extension Period|Adverse Event|0|||
127664767|NCT01474512|459395046|FG006|Long-Term Extension Period|Adverse Event|0|||
127664768|NCT01474512|459395047|FG007|Long-Term Extension Period|Adverse Event|0|||
127664769|NCT01474512|459395048|FG008|Long-Term Extension Period|Adverse Event|0|||
127664770|NCT01474512|459395049|FG009|Long-Term Extension Period|Adverse Event|0|||
127991717|NCT05052697|460595166|FG029|SubStudy B: Initial Enrollment|Not vaccinated|0|||
127991718|NCT05052697|460595167|FG030|SubStudy B: Initial Enrollment|Not vaccinated|0|||
127991719|NCT05052697|460595168|FG031|SubStudy B: Initial Enrollment|Not vaccinated|0|||
127991720|NCT05052697|460595169|FG032|SubStudy B: Initial Enrollment|Not vaccinated|0|||
127991721|NCT05052697|460595170|FG033|SubStudy B: Initial Enrollment|Not vaccinated|0|||
127991722|NCT05052697|460595137|FG000|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
127991723|NCT05052697|460595138|FG001|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
127991724|NCT05052697|460595139|FG002|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
127991725|NCT05052697|460595140|FG003|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
127991726|NCT05052697|460595141|FG004|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
127991727|NCT05052697|460595142|FG005|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
127991728|NCT05052697|460595143|FG006|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
127991729|NCT05052697|460595144|FG007|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
127991730|NCT05052697|460595145|FG008|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
127991731|NCT05052697|460595146|FG009|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
127991732|NCT05052697|460595147|FG010|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
127991733|NCT05052697|460595148|FG011|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
127991734|NCT05052697|460595149|FG012|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
127991735|NCT05052697|460595150|FG013|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
127991736|NCT05052697|460595151|FG014|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
127991737|NCT05052697|460595152|FG015|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
127991738|NCT05052697|460595153|FG016|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
127991739|NCT05052697|460595154|FG017|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
127991740|NCT05052697|460595155|FG018|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
127991741|NCT05052697|460595156|FG019|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
127991742|NCT05052697|460595157|FG020|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
127991743|NCT05052697|460595158|FG021|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
127991744|NCT05052697|460595159|FG022|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
127991745|NCT05052697|460595160|FG023|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
127991746|NCT05052697|460595161|FG024|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
127991747|NCT05052697|460595162|FG025|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
127991748|NCT05052697|460595163|FG026|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
127991749|NCT05052697|460595164|FG027|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
127991750|NCT05052697|460595165|FG028|Substudy B: Expanded Enrollment|Withdrawal by Subject|2|||
127991751|NCT05052697|460595166|FG029|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
127991752|NCT05052697|460595167|FG030|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
127991753|NCT05052697|460595168|FG031|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
127991754|NCT05052697|460595169|FG032|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
127991755|NCT05052697|460595170|FG033|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
127991756|NCT05052697|460595137|FG000|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
127991757|NCT05052697|460595138|FG001|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
127991758|NCT05052697|460595139|FG002|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
127991759|NCT05052697|460595140|FG003|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
127664771|NCT01474512|459395050|FG010|Long-Term Extension Period|Adverse Event|0|||
127664772|NCT01474512|459395051|FG011|Long-Term Extension Period|Adverse Event|1|||
127664773|NCT01474512|459395052|FG012|Long-Term Extension Period|Adverse Event|57|||
127991760|NCT05052697|460595141|FG004|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
127991761|NCT05052697|460595142|FG005|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
127991762|NCT05052697|460595143|FG006|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
127991763|NCT05052697|460595144|FG007|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
127991764|NCT05052697|460595145|FG008|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
127991765|NCT05052697|460595146|FG009|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
127991766|NCT05052697|460595147|FG010|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
127991767|NCT05052697|460595148|FG011|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
127991768|NCT05052697|460595149|FG012|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
127991769|NCT05052697|460595150|FG013|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
127991770|NCT05052697|460595151|FG014|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
127991771|NCT05052697|460595152|FG015|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
127991772|NCT05052697|460595153|FG016|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
127991773|NCT05052697|460595154|FG017|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
127991774|NCT05052697|460595155|FG018|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
127991775|NCT05052697|460595156|FG019|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
127991776|NCT05052697|460595157|FG020|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
127991777|NCT05052697|460595158|FG021|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
127991778|NCT05052697|460595159|FG022|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
127991779|NCT05052697|460595160|FG023|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
127991780|NCT05052697|460595161|FG024|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
127991781|NCT05052697|460595162|FG025|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
127991782|NCT05052697|460595163|FG026|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
127991783|NCT05052697|460595164|FG027|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
127991784|NCT05052697|460595165|FG028|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
127991785|NCT05052697|460595166|FG029|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
127991786|NCT05052697|460595167|FG030|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
127991787|NCT05052697|460595168|FG031|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
127991788|NCT05052697|460595169|FG032|Substudy B: Expanded Enrollment|Lost to Follow-up|2|||
127991789|NCT05052697|460595170|FG033|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
127991790|NCT05052697|460595137|FG000|Substudy B: Expanded Enrollment|Refused study procedure|0|||
127991791|NCT05052697|460595138|FG001|Substudy B: Expanded Enrollment|Refused study procedure|0|||
127991792|NCT05052697|460595139|FG002|Substudy B: Expanded Enrollment|Refused study procedure|0|||
127991793|NCT05052697|460595140|FG003|Substudy B: Expanded Enrollment|Refused study procedure|0|||
127991794|NCT05052697|460595141|FG004|Substudy B: Expanded Enrollment|Refused study procedure|0|||
127991795|NCT05052697|460595142|FG005|Substudy B: Expanded Enrollment|Refused study procedure|0|||
127991796|NCT05052697|460595143|FG006|Substudy B: Expanded Enrollment|Refused study procedure|0|||
127991797|NCT05052697|460595144|FG007|Substudy B: Expanded Enrollment|Refused study procedure|0|||
127991798|NCT05052697|460595145|FG008|Substudy B: Expanded Enrollment|Refused study procedure|0|||
127991799|NCT05052697|460595146|FG009|Substudy B: Expanded Enrollment|Refused study procedure|0|||
127991800|NCT05052697|460595147|FG010|Substudy B: Expanded Enrollment|Refused study procedure|0|||
127991801|NCT05052697|460595148|FG011|Substudy B: Expanded Enrollment|Refused study procedure|0|||
127991802|NCT05052697|460595149|FG012|Substudy B: Expanded Enrollment|Refused study procedure|0|||
127991803|NCT05052697|460595150|FG013|Substudy B: Expanded Enrollment|Refused study procedure|0|||
127991804|NCT05052697|460595151|FG014|Substudy B: Expanded Enrollment|Refused study procedure|0|||
127991805|NCT05052697|460595152|FG015|Substudy B: Expanded Enrollment|Refused study procedure|0|||
127991806|NCT05052697|460595153|FG016|Substudy B: Expanded Enrollment|Refused study procedure|0|||
127991807|NCT05052697|460595154|FG017|Substudy B: Expanded Enrollment|Refused study procedure|0|||
127991808|NCT05052697|460595155|FG018|Substudy B: Expanded Enrollment|Refused study procedure|0|||
127991809|NCT05052697|460595156|FG019|Substudy B: Expanded Enrollment|Refused study procedure|0|||
127991810|NCT05052697|460595157|FG020|Substudy B: Expanded Enrollment|Refused study procedure|0|||
127991811|NCT05052697|460595158|FG021|Substudy B: Expanded Enrollment|Refused study procedure|0|||
127991812|NCT05052697|460595159|FG022|Substudy B: Expanded Enrollment|Refused study procedure|0|||
127991813|NCT05052697|460595160|FG023|Substudy B: Expanded Enrollment|Refused study procedure|0|||
127991814|NCT05052697|460595161|FG024|Substudy B: Expanded Enrollment|Refused study procedure|0|||
127991815|NCT05052697|460595162|FG025|Substudy B: Expanded Enrollment|Refused study procedure|0|||
127991816|NCT05052697|460595163|FG026|Substudy B: Expanded Enrollment|Refused study procedure|0|||
127991817|NCT05052697|460595164|FG027|Substudy B: Expanded Enrollment|Refused study procedure|0|||
127991818|NCT05052697|460595165|FG028|Substudy B: Expanded Enrollment|Refused study procedure|0|||
127991819|NCT05052697|460595166|FG029|Substudy B: Expanded Enrollment|Refused study procedure|0|||
127991820|NCT05052697|460595167|FG030|Substudy B: Expanded Enrollment|Refused study procedure|0|||
127664774|NCT01474512|459395053|FG013|Long-Term Extension Period|Adverse Event|58|||
127664775|NCT01474512|459395054|FG014|Long-Term Extension Period|Adverse Event|0|||
127664776|NCT01474512|459395055|FG015|Long-Term Extension Period|Adverse Event|0|||
127991821|NCT05052697|460595168|FG031|Substudy B: Expanded Enrollment|Refused study procedure|0|||
127991822|NCT05052697|460595169|FG032|Substudy B: Expanded Enrollment|Refused study procedure|1|||
127991823|NCT05052697|460595170|FG033|Substudy B: Expanded Enrollment|Refused study procedure|0|||
127991824|NCT05052697|460595137|FG000|Substudy B: Expanded Enrollment|Not vaccinated|0|||
127991825|NCT05052697|460595138|FG001|Substudy B: Expanded Enrollment|Not vaccinated|0|||
127991826|NCT05052697|460595139|FG002|Substudy B: Expanded Enrollment|Not vaccinated|0|||
127991827|NCT05052697|460595140|FG003|Substudy B: Expanded Enrollment|Not vaccinated|0|||
127991828|NCT05052697|460595141|FG004|Substudy B: Expanded Enrollment|Not vaccinated|0|||
127991829|NCT05052697|460595142|FG005|Substudy B: Expanded Enrollment|Not vaccinated|0|||
127991830|NCT05052697|460595143|FG006|Substudy B: Expanded Enrollment|Not vaccinated|0|||
127991831|NCT05052697|460595144|FG007|Substudy B: Expanded Enrollment|Not vaccinated|0|||
127991832|NCT05052697|460595145|FG008|Substudy B: Expanded Enrollment|Not vaccinated|0|||
127991833|NCT05052697|460595146|FG009|Substudy B: Expanded Enrollment|Not vaccinated|0|||
127991834|NCT05052697|460595147|FG010|Substudy B: Expanded Enrollment|Not vaccinated|0|||
127991835|NCT05052697|460595148|FG011|Substudy B: Expanded Enrollment|Not vaccinated|0|||
127991836|NCT05052697|460595149|FG012|Substudy B: Expanded Enrollment|Not vaccinated|0|||
127991837|NCT05052697|460595150|FG013|Substudy B: Expanded Enrollment|Not vaccinated|0|||
127991838|NCT05052697|460595151|FG014|Substudy B: Expanded Enrollment|Not vaccinated|0|||
127991839|NCT05052697|460595152|FG015|Substudy B: Expanded Enrollment|Not vaccinated|0|||
127991840|NCT05052697|460595153|FG016|Substudy B: Expanded Enrollment|Not vaccinated|0|||
127991841|NCT05052697|460595154|FG017|Substudy B: Expanded Enrollment|Not vaccinated|0|||
127991842|NCT05052697|460595155|FG018|Substudy B: Expanded Enrollment|Not vaccinated|0|||
127991843|NCT05052697|460595156|FG019|Substudy B: Expanded Enrollment|Not vaccinated|0|||
127991844|NCT05052697|460595157|FG020|Substudy B: Expanded Enrollment|Not vaccinated|0|||
127991845|NCT05052697|460595158|FG021|Substudy B: Expanded Enrollment|Not vaccinated|0|||
127991846|NCT05052697|460595159|FG022|Substudy B: Expanded Enrollment|Not vaccinated|0|||
127991847|NCT05052697|460595160|FG023|Substudy B: Expanded Enrollment|Not vaccinated|0|||
127991848|NCT05052697|460595161|FG024|Substudy B: Expanded Enrollment|Not vaccinated|0|||
127991849|NCT05052697|460595162|FG025|Substudy B: Expanded Enrollment|Not vaccinated|0|||
127991850|NCT05052697|460595163|FG026|Substudy B: Expanded Enrollment|Not vaccinated|0|||
127991851|NCT05052697|460595164|FG027|Substudy B: Expanded Enrollment|Not vaccinated|0|||
127991852|NCT05052697|460595165|FG028|Substudy B: Expanded Enrollment|Not vaccinated|1|||
127991853|NCT05052697|460595166|FG029|Substudy B: Expanded Enrollment|Not vaccinated|2|||
127991854|NCT05052697|460595167|FG030|Substudy B: Expanded Enrollment|Not vaccinated|1|||
127991855|NCT05052697|460595168|FG031|Substudy B: Expanded Enrollment|Not vaccinated|0|||
127991856|NCT05052697|460595169|FG032|Substudy B: Expanded Enrollment|Not vaccinated|0|||
127991857|NCT05052697|460595170|FG033|Substudy B: Expanded Enrollment|Not vaccinated|0|||
127991858|NCT01289574|460595171|FG000|Overall Study|Lack of Efficacy|4|||
127991859|NCT01289574|460595172|FG001|Overall Study|Lack of Efficacy|0|||
127991860|NCT01289574|460595173|FG002|Overall Study|Lack of Efficacy|1|||
127991861|NCT01289574|460595171|FG000|Overall Study|Lost to Follow-up|2|||
127991862|NCT01289574|460595172|FG001|Overall Study|Lost to Follow-up|0|||
127991863|NCT01289574|460595173|FG002|Overall Study|Lost to Follow-up|1|||
127991864|NCT01289574|460595171|FG000|Overall Study|Withdrawal by Subject|1|||
127991865|NCT01289574|460595172|FG001|Overall Study|Withdrawal by Subject|1|||
127991866|NCT01289574|460595173|FG002|Overall Study|Withdrawal by Subject|1|||
127991867|NCT01289574|460595171|FG000|Overall Study|Adverse Event|0|||
127991868|NCT01289574|460595172|FG001|Overall Study|Adverse Event|1|||
127991869|NCT01289574|460595173|FG002|Overall Study|Adverse Event|0|||
127991870|NCT01289574|460595171|FG000|Overall Study|Subject wanted alternate treatment|0|||
127991871|NCT01289574|460595172|FG001|Overall Study|Subject wanted alternate treatment|1|||
127991872|NCT01289574|460595173|FG002|Overall Study|Subject wanted alternate treatment|0|||
127991873|NCT00262002|460595174|FG000|Overall Study|Adverse Event|2|||
127991874|NCT00262002|460595175|FG001|Overall Study|Adverse Event|1|||
127991875|NCT00262002|460595176|FG002|Overall Study|Adverse Event|0|||
127991876|NCT00262002|460595177|FG003|Overall Study|Adverse Event|0|||
127991877|NCT00262002|460595178|FG004|Overall Study|Adverse Event|0|||
127991878|NCT00262002|460595179|FG005|Overall Study|Adverse Event|1|||
127991879|NCT00262002|460595180|FG006|Overall Study|Adverse Event|0|||
127991880|NCT00262002|460595174|FG000|Overall Study|Withdrawal by Subject|4|||
127991881|NCT00262002|460595175|FG001|Overall Study|Withdrawal by Subject|2|||
127991882|NCT00262002|460595176|FG002|Overall Study|Withdrawal by Subject|0|||
127664777|NCT01474512|459395056|FG016|Long-Term Extension Period|Adverse Event|0|||
127664778|NCT01474512|459395057|FG017|Long-Term Extension Period|Adverse Event|0|||
127664779|NCT01474512|459395040|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
127664780|NCT01474512|459395041|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
127664781|NCT01474512|459395042|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
127664782|NCT01474512|459395043|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
127664783|NCT01474512|459395044|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
127664784|NCT01474512|459395045|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
127664785|NCT01474512|459395046|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
127991883|NCT00262002|460595177|FG003|Overall Study|Withdrawal by Subject|1|||
127991884|NCT00262002|460595178|FG004|Overall Study|Withdrawal by Subject|2|||
127991885|NCT00262002|460595179|FG005|Overall Study|Withdrawal by Subject|2|||
127991886|NCT00262002|460595180|FG006|Overall Study|Withdrawal by Subject|2|||
127991887|NCT00262002|460595174|FG000|Overall Study|Lost to Follow-up|2|||
127664786|NCT01474512|459395047|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
127664787|NCT01474512|459395048|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
127664788|NCT01474512|459395049|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
127664789|NCT01474512|459395050|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
127664790|NCT01474512|459395051|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
127664791|NCT01474512|459395052|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
127664792|NCT01474512|459395053|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
127664793|NCT01474512|459395054|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
127664794|NCT01474512|459395055|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
127880686|NCT01907516|460183536|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
127880687|NCT01907516|460183537|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
127880688|NCT01907516|460183536|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
127880689|NCT01907516|460183537|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
127880690|NCT01907516|460183536|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
127880691|NCT01907516|460183537|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
127880692|NCT00633217|460183540|FG000|Overall Study|Adverse Event|5|||
127880693|NCT00633217|460183541|FG001|Overall Study|Adverse Event|9|||
127880694|NCT00633217|460183540|FG000|Overall Study|Lack of Efficacy|0|||
127880695|NCT00633217|460183541|FG001|Overall Study|Lack of Efficacy|2|||
127880696|NCT00633217|460183540|FG000|Overall Study|Protocol Violation|3|||
127880697|NCT00633217|460183541|FG001|Overall Study|Protocol Violation|7|||
127880698|NCT00633217|460183540|FG000|Overall Study|Lost to Follow-up|2|||
127880699|NCT00633217|460183541|FG001|Overall Study|Lost to Follow-up|2|||
127880700|NCT00633217|460183540|FG000|Overall Study|Investigator Discretion|2|||
127880701|NCT00633217|460183541|FG001|Overall Study|Investigator Discretion|0|||
127880702|NCT00633217|460183540|FG000|Overall Study|Withdrew Consent|3|||
127880703|NCT00633217|460183541|FG001|Overall Study|Withdrew Consent|3|||
127880704|NCT04881448|460183542|FG000|Overall Study|Study cancelled by sponsor|220|||
127880705|NCT04881448|460183542|FG000|Overall Study|Withdrawal by Subject|2|||
127880706|NCT04881448|460183542|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
127880707|NCT00005879|460183547|FG000|Overall Study|Withdrawal by Subject|8|||
127880708|NCT00005879|460183548|FG001|Overall Study|Withdrawal by Subject|10|||
127880709|NCT05022121|460183550|FG000|Overall Study|Lack of Efficacy|1|||
127880710|NCT05022121|460183551|FG001|Overall Study|Lack of Efficacy|0|||
127880711|NCT05022121|460183550|FG000|Overall Study|Lost to Follow-up|0|||
127880712|NCT05022121|460183551|FG001|Overall Study|Lost to Follow-up|2|||
127880713|NCT02395536|460183558|FG000|Overall Study|Lost to Follow-up|4|||
127880714|NCT02395536|460183559|FG001|Overall Study|Lost to Follow-up|4|||
127880715|NCT02395536|460183558|FG000|Overall Study|Death|2|||
127880716|NCT02395536|460183559|FG001|Overall Study|Death|0|||
127880717|NCT02395536|460183558|FG000|Overall Study|Physician Decision|4|||
127880718|NCT02395536|460183559|FG001|Overall Study|Physician Decision|6|||
127880719|NCT02395536|460183558|FG000|Overall Study|Withdrawal by Subject|9|||
127880720|NCT02395536|460183559|FG001|Overall Study|Withdrawal by Subject|17|||
127880721|NCT02395536|460183558|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
127880722|NCT02395536|460183559|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
127880723|NCT02395536|460183558|FG000|Overall Study|Insurance issue|0|||
127880724|NCT02395536|460183559|FG001|Overall Study|Insurance issue|1|||
127880725|NCT01788163|460186011|FG000|Overall Study|Other|53|||
127880726|NCT01788163|460186012|FG001|Overall Study|Other|0|||
127880727|NCT01788163|460186013|FG002|Overall Study|Other|0|||
127880728|NCT01788163|460186014|FG003|Overall Study|Other|0|||
127880729|NCT01788163|460186015|FG004|Overall Study|Other|0|||
127880730|NCT01788163|460186016|FG005|Overall Study|Other|7|||
127880731|NCT01788163|460186017|FG006|Overall Study|Other|1|||
127880732|NCT01788163|460186018|FG007|Overall Study|Other|48|||
127880733|NCT01788163|460186019|FG008|Overall Study|Other|15|||
127880734|NCT01788163|460186011|FG000|Overall Study|Withdrawal by Subject|2|||
127880735|NCT01788163|460186012|FG001|Overall Study|Withdrawal by Subject|0|||
127880736|NCT01788163|460186013|FG002|Overall Study|Withdrawal by Subject|0|||
127880737|NCT01788163|460186014|FG003|Overall Study|Withdrawal by Subject|0|||
127880738|NCT01788163|460186015|FG004|Overall Study|Withdrawal by Subject|0|||
127880739|NCT01788163|460186016|FG005|Overall Study|Withdrawal by Subject|0|||
127880740|NCT01788163|460186017|FG006|Overall Study|Withdrawal by Subject|0|||
127880741|NCT01788163|460186018|FG007|Overall Study|Withdrawal by Subject|0|||
127880742|NCT01788163|460186019|FG008|Overall Study|Withdrawal by Subject|1|||
127880743|NCT00545441|460186020|FG000|Overall Study|Fistula draining at 6 months|2|||
127880744|NCT00545441|460186021|FG001|Overall Study|Fistula draining at 6 months|4|||
127880745|NCT00545441|460186020|FG000|Overall Study|Lost to Follow-up|9|||
127880746|NCT00545441|460186021|FG001|Overall Study|Lost to Follow-up|5|||
127880747|NCT00545441|460186020|FG000|Overall Study|Technical failure|0|||
127880748|NCT00545441|460186021|FG001|Overall Study|Technical failure|1|||
127880749|NCT00545441|460186020|FG000|Overall Study|Withdrawal by Subject|1|||
127880750|NCT00545441|460186021|FG001|Overall Study|Withdrawal by Subject|1|||
127880751|NCT00545441|460186020|FG000|Overall Study|Persistence or recurrence of fistula|5|||
127880752|NCT00545441|460186021|FG001|Overall Study|Persistence or recurrence of fistula|2|||
127880753|NCT00545441|460186020|FG000|Overall Study|Patients were not treated|1|||
127991888|NCT00262002|460595175|FG001|Overall Study|Lost to Follow-up|0|||
127991889|NCT00262002|460595176|FG002|Overall Study|Lost to Follow-up|0|||
127991890|NCT00262002|460595177|FG003|Overall Study|Lost to Follow-up|2|||
127991891|NCT00262002|460595178|FG004|Overall Study|Lost to Follow-up|0|||
127991892|NCT00262002|460595179|FG005|Overall Study|Lost to Follow-up|1|||
127991893|NCT00262002|460595180|FG006|Overall Study|Lost to Follow-up|0|||
127991894|NCT00262002|460595174|FG000|Overall Study|Inapropriate enrollment|0|||
127991895|NCT00262002|460595175|FG001|Overall Study|Inapropriate enrollment|1|||
127991896|NCT00262002|460595176|FG002|Overall Study|Inapropriate enrollment|0|||
127991897|NCT00262002|460595177|FG003|Overall Study|Inapropriate enrollment|0|||
127991898|NCT00262002|460595178|FG004|Overall Study|Inapropriate enrollment|0|||
127991899|NCT00262002|460595179|FG005|Overall Study|Inapropriate enrollment|0|||
127991900|NCT00262002|460595180|FG006|Overall Study|Inapropriate enrollment|0|||
127991901|NCT00262002|460595174|FG000|Overall Study|Protocol Violation|3|||
127991902|NCT00262002|460595175|FG001|Overall Study|Protocol Violation|2|||
127991903|NCT00262002|460595176|FG002|Overall Study|Protocol Violation|0|||
127991904|NCT00262002|460595177|FG003|Overall Study|Protocol Violation|2|||
127991905|NCT00262002|460595178|FG004|Overall Study|Protocol Violation|5|||
127991906|NCT00262002|460595179|FG005|Overall Study|Protocol Violation|3|||
127991907|NCT00262002|460595180|FG006|Overall Study|Protocol Violation|2|||
127991908|NCT00262002|460595174|FG000|Overall Study|Unable to classify|0|||
127991909|NCT00262002|460595175|FG001|Overall Study|Unable to classify|0|||
127991910|NCT00262002|460595176|FG002|Overall Study|Unable to classify|0|||
127991911|NCT00262002|460595177|FG003|Overall Study|Unable to classify|0|||
127991912|NCT00262002|460595178|FG004|Overall Study|Unable to classify|0|||
127991913|NCT00262002|460595179|FG005|Overall Study|Unable to classify|0|||
127991914|NCT00262002|460595180|FG006|Overall Study|Unable to classify|2|||
127991915|NCT01790516|460595181|FG000|Overall Study|Physician Decision|1|||
127991916|NCT01790516|460595182|FG001|Overall Study|Physician Decision|0|||
127991917|NCT01554163|460595183|FG000|Overall Study|Adverse Event|3|||
127991918|NCT01554163|460595184|FG001|Overall Study|Adverse Event|0|||
127991919|NCT01554163|460595183|FG000|Overall Study|Lack of Efficacy|1|||
127991920|NCT01554163|460595184|FG001|Overall Study|Lack of Efficacy|0|||
127991921|NCT01554163|460595183|FG000|Overall Study|Lost to Follow-up|1|||
127991922|NCT01554163|460595184|FG001|Overall Study|Lost to Follow-up|0|||
127991923|NCT01554163|460595183|FG000|Overall Study|Non-Compliance With Study Drug|1|||
127991924|NCT01554163|460595184|FG001|Overall Study|Non-Compliance With Study Drug|1|||
127991925|NCT01554163|460595183|FG000|Overall Study|Protocol Violation|0|||
127991926|NCT01554163|460595184|FG001|Overall Study|Protocol Violation|4|||
127991927|NCT01554163|460595183|FG000|Overall Study|Withdrawal by Subject|1|||
127991928|NCT01554163|460595184|FG001|Overall Study|Withdrawal by Subject|5|||
127991929|NCT01554163|460595183|FG000|Overall Study|Not Treated|1|||
127991930|NCT01554163|460595184|FG001|Overall Study|Not Treated|0|||
127991931|NCT02226120|460595185|FG000|Overall Study|Adverse Event|60|||
127991932|NCT02226120|460595185|FG000|Overall Study|Death|172|||
127991933|NCT02226120|460595185|FG000|Overall Study|Study terminated by sponsor|1|||
127991934|NCT02226120|460595185|FG000|Overall Study|Technical problems|4|||
127991935|NCT02226120|460595185|FG000|Overall Study|Lost to Follow-up|13|||
127991936|NCT02226120|460595185|FG000|Overall Study|Physician Decision|21|||
127991937|NCT02226120|460595185|FG000|Overall Study|Withdrawal by parent/guardian|36|||
127991938|NCT02226120|460595185|FG000|Overall Study|Non-compliance with study drug|10|||
127991939|NCT02226120|460595185|FG000|Overall Study|Protocol deviation|1|||
127991940|NCT02226120|460595185|FG000|Overall Study|missing treatment disposition pages|2|||
127991941|NCT03034135|460595186|FG000|Overall Study|Withdrawal by Subject|2|||
127991942|NCT01972464|460595190|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
127991943|NCT01972464|460595191|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
127991944|NCT01972464|460595190|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
127991945|NCT01972464|460595191|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
127991946|NCT01972464|460595190|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
127991947|NCT01972464|460595191|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
127991948|NCT01972464|460595190|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
127991949|NCT01972464|460595191|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
127991950|NCT01133704|460596633|FG000|Overall Study|Death|44|||
127991951|NCT01133704|460596634|FG001|Overall Study|Death|26|||
127991952|NCT01133704|460596633|FG000|Overall Study|Patient refused to continue|4|||
127991953|NCT01133704|460596634|FG001|Overall Study|Patient refused to continue|0|||
127991954|NCT01133704|460596633|FG000|Overall Study|Study Closure|1|||
127991955|NCT01133704|460596634|FG001|Overall Study|Study Closure|0|||
127991956|NCT02447328|460596636|FG000|Overall Study|Withdrawal by Subject|1|||
127991957|NCT00314808|460596637|FG000|Overall Study|Disease Progression without AE|4|||
127991958|NCT00314808|460596637|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
127991959|NCT04304508|460596638|FG000|Overall Study|Subject Decision|29|||
127991960|NCT04304508|460596639|FG001|Overall Study|Subject Decision|39|||
127991961|NCT04304508|460596640|FG002|Overall Study|Subject Decision|37|||
127991962|NCT04304508|460596641|FG003|Overall Study|Subject Decision|48|||
127991963|NCT04304508|460596638|FG000|Overall Study|Death|6|||
127991964|NCT04304508|460596639|FG001|Overall Study|Death|1|||
127991965|NCT04304508|460596640|FG002|Overall Study|Death|8|||
127991966|NCT04304508|460596641|FG003|Overall Study|Death|5|||
127991967|NCT04304508|460596638|FG000|Overall Study|Non-compliance With Study Drug|3|||
127991968|NCT04304508|460596639|FG001|Overall Study|Non-compliance With Study Drug|1|||
127991969|NCT04304508|460596640|FG002|Overall Study|Non-compliance With Study Drug|2|||
127991970|NCT04304508|460596641|FG003|Overall Study|Non-compliance With Study Drug|0|||
127991971|NCT04304508|460596638|FG000|Overall Study|Switching To Other Therapy|1|||
127991972|NCT04304508|460596639|FG001|Overall Study|Switching To Other Therapy|1|||
127991973|NCT04304508|460596640|FG002|Overall Study|Switching To Other Therapy|1|||
127991974|NCT04304508|460596641|FG003|Overall Study|Switching To Other Therapy|2|||
127991975|NCT04304508|460596638|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
127991976|NCT04304508|460596639|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
127991977|NCT04304508|460596640|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
127991978|NCT04304508|460596641|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
127991979|NCT04304508|460596638|FG000|Overall Study|Withdrawal by Subject|7|||
127991980|NCT04304508|460596639|FG001|Overall Study|Withdrawal by Subject|5|||
127991981|NCT04304508|460596640|FG002|Overall Study|Withdrawal by Subject|11|||
127991982|NCT04304508|460596641|FG003|Overall Study|Withdrawal by Subject|6|||
127991983|NCT04304508|460596638|FG000|Overall Study|Logistical Difficulties|2|||
127991984|NCT04304508|460596639|FG001|Overall Study|Logistical Difficulties|2|||
127991985|NCT04304508|460596640|FG002|Overall Study|Logistical Difficulties|3|||
127991986|NCT04304508|460596641|FG003|Overall Study|Logistical Difficulties|2|||
127991987|NCT04304508|460596638|FG000|Overall Study|Missing Information|1|||
127991988|NCT04304508|460596639|FG001|Overall Study|Missing Information|2|||
127991989|NCT04304508|460596640|FG002|Overall Study|Missing Information|1|||
127991990|NCT04304508|460596641|FG003|Overall Study|Missing Information|3|||
127991991|NCT04304508|460596638|FG000|Overall Study|Other|7|||
127991992|NCT04304508|460596639|FG001|Overall Study|Other|6|||
127991993|NCT04304508|460596640|FG002|Overall Study|Other|5|||
127991994|NCT04304508|460596641|FG003|Overall Study|Other|4|||
127991995|NCT04304508|460596638|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
127991996|NCT04304508|460596639|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
127991997|NCT04304508|460596640|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
127991998|NCT04304508|460596641|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
127991999|NCT04304508|460596638|FG000|Overall Study|Physician Decision|3|||
127992000|NCT04304508|460596639|FG001|Overall Study|Physician Decision|4|||
127992001|NCT04304508|460596640|FG002|Overall Study|Physician Decision|9|||
127992002|NCT04304508|460596641|FG003|Overall Study|Physician Decision|7|||
127992003|NCT04304508|460596638|FG000|Overall Study|Study drug never administered|10|||
127992004|NCT04304508|460596639|FG001|Overall Study|Study drug never administered|4|||
127992005|NCT04304508|460596640|FG002|Overall Study|Study drug never administered|4|||
127992006|NCT04304508|460596641|FG003|Overall Study|Study drug never administered|4|||
127992007|NCT04304508|460596638|FG000|Overall Study|Adverse Event|49|||
127992008|NCT04304508|460596639|FG001|Overall Study|Adverse Event|50|||
127992009|NCT04304508|460596640|FG002|Overall Study|Adverse Event|51|||
127992010|NCT04304508|460596641|FG003|Overall Study|Adverse Event|56|||
127992011|NCT04304508|460596638|FG000|Overall Study|Lost to Follow-up|1|||
127992012|NCT04304508|460596639|FG001|Overall Study|Lost to Follow-up|5|||
127992013|NCT04304508|460596640|FG002|Overall Study|Lost to Follow-up|2|||
127992014|NCT04304508|460596641|FG003|Overall Study|Lost to Follow-up|3|||
127992015|NCT02113007|460596648|FG000|Overall Study|Progressive disease|2|||
127992016|NCT00885378|460596649|FG000|Overall Study|Lack of Efficacy|2|||
127992017|NCT00885378|460596650|FG001|Overall Study|Lack of Efficacy|2|||
127992018|NCT00885378|460596649|FG000|Overall Study|Withdrawal by Subject|1|||
127992019|NCT00885378|460596650|FG001|Overall Study|Withdrawal by Subject|2|||
127992020|NCT00885378|460596649|FG000|Overall Study|Lost to Follow-up|1|||
127992021|NCT00885378|460596650|FG001|Overall Study|Lost to Follow-up|2|||
127992022|NCT00885378|460596649|FG000|Overall Study|Poor/Noncompliance|2|||
127992023|NCT00885378|460596650|FG001|Overall Study|Poor/Noncompliance|2|||
127992024|NCT00885378|460596649|FG000|Overall Study|Protocol Violation|2|||
127992025|NCT00885378|460596650|FG001|Overall Study|Protocol Violation|0|||
127992026|NCT04750278|460596651|FG000|Overall Study|Death|9|||
127992027|NCT04750278|460596652|FG001|Overall Study|Death|10|||
127992028|NCT04750278|460596653|FG002|Overall Study|Death|10|||
127992029|NCT04750278|460596651|FG000|Overall Study|Withdrawal by Subject|4|||
127992030|NCT04750278|460596652|FG001|Overall Study|Withdrawal by Subject|1|||
127992031|NCT04750278|460596653|FG002|Overall Study|Withdrawal by Subject|2|||
127992032|NCT04750278|460596651|FG000|Overall Study|Lost to Follow-up|1|||
127992033|NCT04750278|460596652|FG001|Overall Study|Lost to Follow-up|1|||
127992034|NCT04750278|460596653|FG002|Overall Study|Lost to Follow-up|1|||
127992035|NCT04750278|460596651|FG000|Overall Study|Pregnancy|1|||
127992036|NCT04750278|460596652|FG001|Overall Study|Pregnancy|0|||
127992037|NCT04750278|460596653|FG002|Overall Study|Pregnancy|0|||
127992038|NCT04750278|460596651|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
127992039|NCT04750278|460596652|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
127992040|NCT04750278|460596653|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
127880754|NCT00545441|460186021|FG001|Overall Study|Patients were not treated|3|||
127880755|NCT00265239|460186022|FG000|Overall Study|Adverse Event|2|||
127880756|NCT00265239|460186023|FG001|Overall Study|Adverse Event|1|||
127880757|NCT02803138|460186028|FG000|Overall Study|Failure to return|38|||
127880758|NCT02803138|460186028|FG000|Overall Study|Insufficient virological response|2|||
127880759|NCT02803138|460186028|FG000|Overall Study|Withdrawn consent|1|||
127880760|NCT02803138|460186028|FG000|Overall Study|Death|1|||
127880761|NCT02803138|460186028|FG000|Overall Study|Other, not specified|28|||
127880762|NCT04071366|460186029|FG000|Part 1: Open-label (29 Days)|Death|4|||
127992041|NCT04750278|460596651|FG000|Overall Study|Non-compliance|0|||
127992042|NCT04750278|460596652|FG001|Overall Study|Non-compliance|0|||
127992043|NCT04750278|460596653|FG002|Overall Study|Non-compliance|1|||
127664795|NCT01474512|459395056|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
127664796|NCT01474512|459395057|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
127664797|NCT01474512|459395040|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
127664798|NCT01474512|459395041|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
127664799|NCT01474512|459395042|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
127664800|NCT01474512|459395043|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
127664801|NCT01474512|459395044|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
127664802|NCT01474512|459395045|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
127664803|NCT01474512|459395046|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
127664804|NCT01474512|459395047|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
127664805|NCT01474512|459395048|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
127664806|NCT01474512|459395049|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
127664807|NCT01474512|459395050|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
127664808|NCT01474512|459395051|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
127664809|NCT01474512|459395052|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
127664810|NCT01474512|459395053|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
127664811|NCT01474512|459395054|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
127664812|NCT01474512|459395055|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
127664813|NCT01474512|459395056|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
127664814|NCT01474512|459395057|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
127664815|NCT01474512|459395040|FG000|Long-Term Extension Period|Physician Decision|0|||
127992044|NCT04750278|460596651|FG000|Overall Study|Transfer to Outside Facility|0|||
127992045|NCT04750278|460596652|FG001|Overall Study|Transfer to Outside Facility|2|||
127992046|NCT04750278|460596653|FG002|Overall Study|Transfer to Outside Facility|1|||
127992047|NCT04750278|460596651|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
127992048|NCT04750278|460596652|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
127992049|NCT04750278|460596653|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
127992050|NCT04750278|460596651|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
127992051|NCT04750278|460596652|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
127992052|NCT04750278|460596653|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
127992053|NCT01775787|460596654|FG000|First 7-10 Days|Adverse Event|0|||
127992054|NCT01775787|460596655|FG001|First 7-10 Days|Adverse Event|1|||
127992055|NCT01775787|460596654|FG000|First 7-10 Days|family emergency|0|||
127992056|NCT01775787|460596655|FG001|First 7-10 Days|family emergency|1|||
127992057|NCT01775787|460596654|FG000|First 7-10 Days|time commitment|0|||
127992058|NCT01775787|460596655|FG001|First 7-10 Days|time commitment|2|||
127992059|NCT01775787|460596654|FG000|First 7-10 Days|concerns with using IV|1|||
127992060|NCT01775787|460596655|FG001|First 7-10 Days|concerns with using IV|2|||
127992061|NCT01775787|460596654|FG000|Second 7-10 Days|time commitment|0|||
127992062|NCT01775787|460596655|FG001|Second 7-10 Days|time commitment|1|||
127992063|NCT01775787|460596654|FG000|Second 7-10 Days|concerns with using IV|0|||
127992064|NCT01775787|460596655|FG001|Second 7-10 Days|concerns with using IV|1|||
127992065|NCT01616758|460596660|FG000|Overall Study|Adverse Event|1|||
127992066|NCT01616758|460596660|FG000|Overall Study|Withdrawal by Subject|2|||
127992067|NCT01616758|460596660|FG000|Overall Study|Disease progression|18|||
127992068|NCT01616758|460596660|FG000|Overall Study|Study termination by Sponsor|1|||
127992069|NCT04076319|460596665|FG000|Overall Study|Withdrawal by Subject|2|||
127992070|NCT04076319|460596666|FG001|Overall Study|Withdrawal by Subject|0|||
127992071|NCT04076319|460596665|FG000|Overall Study|Death|1|||
127992072|NCT04076319|460596666|FG001|Overall Study|Death|0|||
127664816|NCT01474512|459395041|FG001|Long-Term Extension Period|Physician Decision|0|||
127664817|NCT01474512|459395042|FG002|Long-Term Extension Period|Physician Decision|0|||
127664818|NCT01474512|459395043|FG003|Long-Term Extension Period|Physician Decision|0|||
127664819|NCT01474512|459395044|FG004|Long-Term Extension Period|Physician Decision|0|||
127664820|NCT01474512|459395045|FG005|Long-Term Extension Period|Physician Decision|0|||
127880763|NCT04071366|460186030|FG001|Part 1: Open-label (29 Days)|Death|2|||
127880764|NCT04071366|460186031|FG002|Part 1: Open-label (29 Days)|Death|8|||
127992073|NCT01054222|460596667|FG000|Overall Study|Lack of Efficacy|1|||
127992074|NCT01054222|460596667|FG000|Overall Study|Lost to Follow-up|4|||
127992075|NCT01054222|460596667|FG000|Overall Study|Withdrawal by Subject|6|||
127992076|NCT00824655|460596668|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
127992077|NCT00824655|460596669|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
127992078|NCT00824655|460596668|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
127992079|NCT00824655|460596669|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
127992080|NCT03252145|460596670|FG000|Overall Study|Withdrawal by Subject|1|||
127992081|NCT03252145|460596671|FG001|Overall Study|Withdrawal by Subject|0|||
127992082|NCT03252145|460596670|FG000|Overall Study|Complicating Disease|1|||
127992083|NCT03252145|460596671|FG001|Overall Study|Complicating Disease|2|||
127992084|NCT03504189|460596672|FG000|Overall Study|Withdrawal by Subject|1|||
127992085|NCT03504189|460596672|FG000|Overall Study|Screening Failure|1|||
127992086|NCT03504189|460596672|FG000|Overall Study|Device Failure|2|||
127992087|NCT03091738|460596673|FG000|Overall Study|Adverse Event|1|||
127992088|NCT03091738|460596673|FG000|Overall Study|Lost to Follow-up|1|||
127992089|NCT04336475|460596674|FG000|Overall Study|pain|1|||
127992090|NCT04336475|460596675|FG001|Overall Study|pain|0|||
127992091|NCT04336475|460596674|FG000|Overall Study|upper respiratory infection|1|||
127992092|NCT04336475|460596675|FG001|Overall Study|upper respiratory infection|0|||
127992093|NCT04336475|460596674|FG000|Overall Study|Lost to Follow-up|0|||
127992094|NCT04336475|460596675|FG001|Overall Study|Lost to Follow-up|2|||
127992095|NCT03498313|460596687|FG000|Experimental Period 1|Adverse Event|1|||
127992096|NCT03498313|460596688|FG001|Experimental Period 1|Adverse Event|0|||
127992097|NCT03498313|460596689|FG002|Experimental Period 1|Adverse Event|0|||
127992098|NCT03498313|460596690|FG003|Experimental Period 1|Adverse Event|1|||
127992099|NCT03498313|460596691|FG004|Experimental Period 1|Adverse Event|0|||
127992100|NCT03498313|460596692|FG005|Experimental Period 1|Adverse Event|0|||
127992101|NCT03498313|460596687|FG000|Experimental Period 1|Withdrawal by Subject|0|||
127992102|NCT03498313|460596688|FG001|Experimental Period 1|Withdrawal by Subject|1|||
127992103|NCT03498313|460596689|FG002|Experimental Period 1|Withdrawal by Subject|0|||
127992104|NCT03498313|460596690|FG003|Experimental Period 1|Withdrawal by Subject|0|||
127992105|NCT03498313|460596691|FG004|Experimental Period 1|Withdrawal by Subject|0|||
127992106|NCT03498313|460596692|FG005|Experimental Period 1|Withdrawal by Subject|0|||
127992107|NCT03498313|460596687|FG000|Washout Period 1|Anovulation|1|||
127992108|NCT03498313|460596688|FG001|Washout Period 1|Anovulation|0|||
127992109|NCT03498313|460596689|FG002|Washout Period 1|Anovulation|0|||
127992110|NCT03498313|460596690|FG003|Washout Period 1|Anovulation|0|||
127992111|NCT03498313|460596691|FG004|Washout Period 1|Anovulation|0|||
127992112|NCT03498313|460596692|FG005|Washout Period 1|Anovulation|0|||
127992113|NCT03498313|460596687|FG000|Washout Period 1|Withdrawal by Subject|0|||
127992114|NCT03498313|460596688|FG001|Washout Period 1|Withdrawal by Subject|3|||
127992115|NCT03498313|460596689|FG002|Washout Period 1|Withdrawal by Subject|0|||
127992116|NCT03498313|460596690|FG003|Washout Period 1|Withdrawal by Subject|1|||
127992117|NCT03498313|460596691|FG004|Washout Period 1|Withdrawal by Subject|0|||
127992118|NCT03498313|460596692|FG005|Washout Period 1|Withdrawal by Subject|1|||
127992119|NCT03498313|460596687|FG000|Experimental Period 2|Adverse Event|0|||
127992120|NCT03498313|460596688|FG001|Experimental Period 2|Adverse Event|0|||
127992121|NCT03498313|460596689|FG002|Experimental Period 2|Adverse Event|0|||
127992122|NCT03498313|460596690|FG003|Experimental Period 2|Adverse Event|0|||
127992123|NCT03498313|460596691|FG004|Experimental Period 2|Adverse Event|1|||
127992124|NCT03498313|460596692|FG005|Experimental Period 2|Adverse Event|2|||
127992125|NCT03498313|460596687|FG000|Washout Period 2|Physician Decision|1|||
127992126|NCT03498313|460596688|FG001|Washout Period 2|Physician Decision|0|||
127992127|NCT03498313|460596689|FG002|Washout Period 2|Physician Decision|0|||
127992128|NCT03498313|460596690|FG003|Washout Period 2|Physician Decision|1|||
127992129|NCT03498313|460596691|FG004|Washout Period 2|Physician Decision|0|||
127992130|NCT03498313|460596692|FG005|Washout Period 2|Physician Decision|1|||
127992131|NCT03498313|460596687|FG000|Washout Period 2|Withdrawal by Subject|3|||
127992132|NCT03498313|460596688|FG001|Washout Period 2|Withdrawal by Subject|2|||
127992133|NCT03498313|460596689|FG002|Washout Period 2|Withdrawal by Subject|0|||
127992134|NCT03498313|460596690|FG003|Washout Period 2|Withdrawal by Subject|0|||
127992135|NCT03498313|460596691|FG004|Washout Period 2|Withdrawal by Subject|2|||
127992136|NCT03498313|460596692|FG005|Washout Period 2|Withdrawal by Subject|0|||
127992137|NCT03498313|460596687|FG000|Washout Period 2|Anovulation|0|||
127992138|NCT03498313|460596688|FG001|Washout Period 2|Anovulation|0|||
127992139|NCT03498313|460596689|FG002|Washout Period 2|Anovulation|0|||
127992140|NCT03498313|460596690|FG003|Washout Period 2|Anovulation|0|||
127992141|NCT03498313|460596691|FG004|Washout Period 2|Anovulation|0|||
127992142|NCT03498313|460596692|FG005|Washout Period 2|Anovulation|1|||
127992143|NCT02171429|460596693|FG000|Overall Study|Other|0|||
127992144|NCT02171429|460596694|FG001|Overall Study|Other|1|||
127992145|NCT02171429|460596695|FG002|Overall Study|Other|1|||
127992146|NCT02171429|460596693|FG000|Overall Study|Non-Compliance|0|||
127992147|NCT02171429|460596694|FG001|Overall Study|Non-Compliance|0|||
127992148|NCT02171429|460596695|FG002|Overall Study|Non-Compliance|1|||
127992149|NCT02171429|460596693|FG000|Overall Study|Physician Decision|0|||
127992150|NCT02171429|460596694|FG001|Overall Study|Physician Decision|0|||
127992151|NCT02171429|460596695|FG002|Overall Study|Physician Decision|1|||
127992152|NCT02171429|460596693|FG000|Overall Study|Withdrawal by Subject|1|||
127992153|NCT02171429|460596694|FG001|Overall Study|Withdrawal by Subject|1|||
127992154|NCT02171429|460596695|FG002|Overall Study|Withdrawal by Subject|1|||
127992155|NCT02171429|460596693|FG000|Overall Study|Lost to Follow-up|0|||
127992156|NCT02171429|460596694|FG001|Overall Study|Lost to Follow-up|1|||
127992157|NCT02171429|460596695|FG002|Overall Study|Lost to Follow-up|0|||
127992158|NCT02171429|460596693|FG000|Overall Study|Death|0|||
127992159|NCT02171429|460596694|FG001|Overall Study|Death|0|||
127992160|NCT02171429|460596695|FG002|Overall Study|Death|1|||
127992161|NCT02768792|460596699|FG000|Overall Study|Adverse Event|1|||
127992162|NCT05980013|460596700|FG000|Overall Study|Withdrawal by Subject|0|||
127992163|NCT05980013|460596701|FG001|Overall Study|Withdrawal by Subject|1|||
127992164|NCT05980013|460596700|FG000|Overall Study|Device Error|0|||
127992165|NCT05980013|460596701|FG001|Overall Study|Device Error|1|||
127992166|NCT01768559|460596706|FG000|Overall Study|Randomized but not treated|0|||
127992167|NCT01768559|460596707|FG001|Overall Study|Randomized but not treated|0|||
127992168|NCT01768559|460596708|FG002|Overall Study|Randomized but not treated|1|||
127992169|NCT01768559|460596706|FG000|Overall Study|Adverse Event|15|||
127992170|NCT01768559|460596707|FG001|Overall Study|Adverse Event|2|||
127992171|NCT01768559|460596708|FG002|Overall Study|Adverse Event|5|||
127992172|NCT01768559|460596706|FG000|Overall Study|Lack of Efficacy|6|||
127992173|NCT01768559|460596707|FG001|Overall Study|Lack of Efficacy|4|||
127992174|NCT01768559|460596708|FG002|Overall Study|Lack of Efficacy|0|||
127992175|NCT01768559|460596706|FG000|Overall Study|Poor compliance to protocol|0|||
127992176|NCT01768559|460596707|FG001|Overall Study|Poor compliance to protocol|3|||
127992177|NCT01768559|460596708|FG002|Overall Study|Poor compliance to protocol|2|||
127992178|NCT01768559|460596706|FG000|Overall Study|Other than specified|9|||
127992179|NCT01768559|460596707|FG001|Overall Study|Other than specified|8|||
127992180|NCT01768559|460596708|FG002|Overall Study|Other than specified|5|||
127992181|NCT03146741|460596709|FG000|Overall Study|Txp with non-HCV+ heart|4|||
127992182|NCT03146741|460596709|FG000|Overall Study|Listeted for MOT|2|||
127992183|NCT03146741|460596709|FG000|Overall Study|Physician Decision|2|||
127992184|NCT03146741|460596709|FG000|Overall Study|Awaiting txp|2|||
127992185|NCT00398047|460596714|FG000|Overall Study|all patient progressed before completion|3|||
127992186|NCT01188668|460596715|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
127992187|NCT01188668|460596715|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
127992188|NCT01188668|460596715|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
127992189|NCT00902746|460596716|FG000|Overall Study|Protocol Violation|7|||
127992190|NCT00902746|460596716|FG000|Overall Study|Withdrawal by Subject|16|||
127992191|NCT00902746|460596716|FG000|Overall Study|Adverse Event|8|||
127992192|NCT00902746|460596716|FG000|Overall Study|Lost to Follow-up|3|||
127992193|NCT00902746|460596716|FG000|Overall Study|Physician Decision|2|||
127992194|NCT02081001|460596717|FG000|Overall Study|Adverse Event|0|||
127992195|NCT02081001|460596718|FG001|Overall Study|Adverse Event|0|||
127992196|NCT02081001|460596719|FG002|Overall Study|Adverse Event|0|||
127992197|NCT02081001|460596720|FG003|Overall Study|Adverse Event|0|||
127992198|NCT02081001|460596721|FG004|Overall Study|Adverse Event|1|||
127992199|NCT02081001|460596722|FG005|Overall Study|Adverse Event|0|||
127992200|NCT02081001|460596723|FG006|Overall Study|Adverse Event|0|||
127992201|NCT02081001|460596724|FG007|Overall Study|Adverse Event|0|||
127992202|NCT02081001|460596725|FG008|Overall Study|Adverse Event|0|||
127992203|NCT02081001|460596726|FG009|Overall Study|Adverse Event|0|||
127992204|NCT02081001|460596727|FG010|Overall Study|Adverse Event|0|||
127992205|NCT02081001|460596728|FG011|Overall Study|Adverse Event|0|||
127992206|NCT02588092|460596739|FG000|Overall Study|Death|4|||
127992207|NCT02588092|460596740|FG001|Overall Study|Death|3|||
127992208|NCT02588092|460596741|FG002|Overall Study|Death|3|||
127992209|NCT02588092|460596742|FG003|Overall Study|Death|3|||
127992210|NCT02588092|460596743|FG004|Overall Study|Death|2|||
127992211|NCT02588092|460596744|FG005|Overall Study|Death|2|||
127992212|NCT02588092|460596745|FG006|Overall Study|Death|2|||
127992213|NCT02588092|460596746|FG007|Overall Study|Death|1|||
127992214|NCT02588092|460596747|FG008|Overall Study|Death|5|||
127992215|NCT02588092|460596748|FG009|Overall Study|Death|2|||
127992216|NCT02588092|460596739|FG000|Overall Study|Withdrawal by Subject|0|||
127992217|NCT02588092|460596740|FG001|Overall Study|Withdrawal by Subject|0|||
127992218|NCT02588092|460596741|FG002|Overall Study|Withdrawal by Subject|0|||
127992219|NCT02588092|460596742|FG003|Overall Study|Withdrawal by Subject|0|||
127664821|NCT01474512|459395046|FG006|Long-Term Extension Period|Physician Decision|0|||
127992220|NCT02588092|460596743|FG004|Overall Study|Withdrawal by Subject|0|||
127992221|NCT02588092|460596744|FG005|Overall Study|Withdrawal by Subject|1|||
127992222|NCT02588092|460596745|FG006|Overall Study|Withdrawal by Subject|1|||
127664822|NCT01474512|459395047|FG007|Long-Term Extension Period|Physician Decision|0|||
127992223|NCT02588092|460596746|FG007|Overall Study|Withdrawal by Subject|2|||
127992224|NCT02588092|460596747|FG008|Overall Study|Withdrawal by Subject|0|||
127992225|NCT02588092|460596748|FG009|Overall Study|Withdrawal by Subject|0|||
127992226|NCT02588092|460596739|FG000|Overall Study|Started Another Treatment|0|||
127992227|NCT02588092|460596740|FG001|Overall Study|Started Another Treatment|0|||
127992228|NCT02588092|460596741|FG002|Overall Study|Started Another Treatment|0|||
127992229|NCT02588092|460596742|FG003|Overall Study|Started Another Treatment|0|||
127992230|NCT02588092|460596743|FG004|Overall Study|Started Another Treatment|1|||
127992231|NCT02588092|460596744|FG005|Overall Study|Started Another Treatment|0|||
127992232|NCT02588092|460596745|FG006|Overall Study|Started Another Treatment|0|||
127992233|NCT02588092|460596746|FG007|Overall Study|Started Another Treatment|1|||
127992234|NCT02588092|460596747|FG008|Overall Study|Started Another Treatment|0|||
127992235|NCT02588092|460596748|FG009|Overall Study|Started Another Treatment|0|||
127992236|NCT02588092|460596739|FG000|Overall Study|Sponsor Decision|0|||
127992237|NCT02588092|460596740|FG001|Overall Study|Sponsor Decision|0|||
127992238|NCT02588092|460596741|FG002|Overall Study|Sponsor Decision|0|||
127992239|NCT02588092|460596742|FG003|Overall Study|Sponsor Decision|0|||
127992240|NCT02588092|460596743|FG004|Overall Study|Sponsor Decision|0|||
127992241|NCT02588092|460596744|FG005|Overall Study|Sponsor Decision|0|||
127992242|NCT02588092|460596745|FG006|Overall Study|Sponsor Decision|0|||
127992243|NCT02588092|460596746|FG007|Overall Study|Sponsor Decision|0|||
127992244|NCT02588092|460596747|FG008|Overall Study|Sponsor Decision|1|||
127992245|NCT02588092|460596748|FG009|Overall Study|Sponsor Decision|1|||
127992246|NCT01030718|460596751|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
127992247|NCT01030718|460596752|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
127992248|NCT01030718|460596753|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
127992249|NCT01030718|460596751|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
127992250|NCT01030718|460596752|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
127992251|NCT01030718|460596753|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
127992252|NCT01030718|460596751|FG000|Studies CA180-031 and -036 Combined|Death|0|||
127992253|NCT01030718|460596752|FG001|Studies CA180-031 and -036 Combined|Death|1|||
127992254|NCT01030718|460596753|FG002|Studies CA180-031 and -036 Combined|Death|0|||
127992255|NCT01030718|460596751|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
127992256|NCT01030718|460596752|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
127992257|NCT01030718|460596753|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
127992258|NCT01030718|460596751|FG000|Study CA180-036 Only|insufficient effect|1|||
127992259|NCT01030718|460596752|FG001|Study CA180-036 Only|insufficient effect|1|||
127992260|NCT01030718|460596753|FG002|Study CA180-036 Only|insufficient effect|5|||
127992261|NCT01030718|460596751|FG000|Study CA180-036 Only|Adverse Event|2|||
127992262|NCT01030718|460596752|FG001|Study CA180-036 Only|Adverse Event|3|||
127992263|NCT01030718|460596753|FG002|Study CA180-036 Only|Adverse Event|0|||
127992264|NCT01030718|460596751|FG000|Study CA180-036 Only|Death|0|||
127992265|NCT01030718|460596752|FG001|Study CA180-036 Only|Death|1|||
127992266|NCT01030718|460596753|FG002|Study CA180-036 Only|Death|0|||
127992267|NCT01030718|460596751|FG000|Study CA180-036 Only|Other Reasons|0|||
127992268|NCT01030718|460596752|FG001|Study CA180-036 Only|Other Reasons|2|||
127992269|NCT01030718|460596753|FG002|Study CA180-036 Only|Other Reasons|0|||
127992270|NCT00423813|460596754|FG000|Overall Study|Adverse Event|11|||
127992271|NCT00423813|460596755|FG001|Overall Study|Adverse Event|30|||
127992272|NCT00423813|460596756|FG002|Overall Study|Adverse Event|40|||
127992273|NCT00423813|460596754|FG000|Overall Study|Withdrawal by Subject|6|||
127992274|NCT00423813|460596755|FG001|Overall Study|Withdrawal by Subject|8|||
127992275|NCT00423813|460596756|FG002|Overall Study|Withdrawal by Subject|5|||
127992276|NCT00423813|460596754|FG000|Overall Study|Lost to Follow-up|5|||
127992277|NCT00423813|460596755|FG001|Overall Study|Lost to Follow-up|4|||
127992278|NCT00423813|460596756|FG002|Overall Study|Lost to Follow-up|4|||
127992279|NCT00423813|460596754|FG000|Overall Study|Lack of Efficacy|23|||
127992280|NCT00423813|460596755|FG001|Overall Study|Lack of Efficacy|18|||
127992281|NCT00423813|460596756|FG002|Overall Study|Lack of Efficacy|19|||
127992282|NCT00423813|460596754|FG000|Overall Study|Physician Decision|2|||
127992283|NCT00423813|460596755|FG001|Overall Study|Physician Decision|0|||
127992284|NCT00423813|460596756|FG002|Overall Study|Physician Decision|0|||
127992285|NCT00423813|460596754|FG000|Overall Study|Sponsor Decision|0|||
127992286|NCT00423813|460596755|FG001|Overall Study|Sponsor Decision|1|||
127992287|NCT00423813|460596756|FG002|Overall Study|Sponsor Decision|0|||
127992288|NCT00423813|460596754|FG000|Overall Study|Protocol Violation|9|||
127992289|NCT00423813|460596755|FG001|Overall Study|Protocol Violation|4|||
127992290|NCT00423813|460596756|FG002|Overall Study|Protocol Violation|4|||
127992291|NCT00423813|460596754|FG000|Overall Study|Pregnancy|0|||
127992292|NCT00423813|460596755|FG001|Overall Study|Pregnancy|0|||
127992293|NCT00423813|460596756|FG002|Overall Study|Pregnancy|1|||
127992294|NCT00423813|460596754|FG000|Overall Study|Subject started night shift work|1|||
127992295|NCT00423813|460596755|FG001|Overall Study|Subject started night shift work|0|||
127992296|NCT00423813|460596756|FG002|Overall Study|Subject started night shift work|0|||
127992297|NCT00423813|460596754|FG000|Overall Study|Will start exclusionary medications|0|||
127992298|NCT00423813|460596755|FG001|Overall Study|Will start exclusionary medications|1|||
127992299|NCT00423813|460596756|FG002|Overall Study|Will start exclusionary medications|0|||
127992300|NCT00423813|460596754|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
127992301|NCT00423813|460596755|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
127992302|NCT00423813|460596756|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
127992303|NCT01386944|460596758|FG000|Overall Study|Adverse Event|26|||
127992304|NCT01386944|460596758|FG000|Overall Study|Lack of Efficacy|14|||
127992305|NCT01386944|460596758|FG000|Overall Study|Lost to Follow-up|8|||
127992306|NCT01386944|460596758|FG000|Overall Study|Unspecified reason|8|||
127992307|NCT03883477|460596759|FG000|Overall Study|Death|1|||
127992308|NCT03883477|460596760|FG001|Overall Study|Death|0|||
127992309|NCT03883477|460596759|FG000|Overall Study|Protocol Violation|0|||
127992310|NCT03883477|460596760|FG001|Overall Study|Protocol Violation|1|||
127992311|NCT03853291|460596761|FG000|Overall Study|Lost to Follow-up|1|||
127992312|NCT03853291|460596762|FG001|Overall Study|Lost to Follow-up|2|||
127992313|NCT03853291|460596763|FG002|Overall Study|Lost to Follow-up|0|||
127992314|NCT03853291|460596764|FG003|Overall Study|Lost to Follow-up|0|||
127992315|NCT03853291|460596765|FG004|Overall Study|Lost to Follow-up|0|||
127992316|NCT03853291|460596766|FG005|Overall Study|Lost to Follow-up|0|||
127992317|NCT03853291|460596761|FG000|Overall Study|Determined to be ineligible|1|||
127992318|NCT03853291|460596762|FG001|Overall Study|Determined to be ineligible|1|||
127992319|NCT03853291|460596763|FG002|Overall Study|Determined to be ineligible|0|||
127992320|NCT03853291|460596764|FG003|Overall Study|Determined to be ineligible|0|||
127992321|NCT03853291|460596765|FG004|Overall Study|Determined to be ineligible|0|||
127992322|NCT03853291|460596766|FG005|Overall Study|Determined to be ineligible|0|||
127992323|NCT03148067|460596769|FG000|Overall Study|Lost to Follow-up|3|||
127992324|NCT03148067|460596769|FG000|Overall Study|Death|1|||
127992325|NCT00492232|460596772|FG000|Placebo Run-in|Adverse Event|0|||
127992326|NCT00492232|460596773|FG001|Placebo Run-in|Adverse Event|2|||
127992327|NCT00492232|460596772|FG000|Placebo Run-in|Protocol Violation|0|||
127992328|NCT00492232|460596773|FG001|Placebo Run-in|Protocol Violation|3|||
127992329|NCT00492232|460596772|FG000|Placebo Run-in|Lost to Follow-up|0|||
127992330|NCT00492232|460596773|FG001|Placebo Run-in|Lost to Follow-up|3|||
127992331|NCT00492232|460596772|FG000|Placebo Run-in|Withdrawal by Subject|0|||
127992332|NCT00492232|460596773|FG001|Placebo Run-in|Withdrawal by Subject|8|||
127992333|NCT00492232|460596772|FG000|Placebo Run-in|Pregnancy|0|||
127992334|NCT00492232|460596773|FG001|Placebo Run-in|Pregnancy|1|||
127992335|NCT00492232|460596772|FG000|Placebo Run-in|Entrance criteria not met|0|||
127992336|NCT00492232|460596773|FG001|Placebo Run-in|Entrance criteria not met|45|||
127992337|NCT00492232|460596772|FG000|Placebo Run-in|Other|0|||
127992338|NCT00492232|460596773|FG001|Placebo Run-in|Other|6|||
127992339|NCT00492232|460596772|FG000|Placebo Run-in|Missing|0|||
127992340|NCT00492232|460596773|FG001|Placebo Run-in|Missing|2|||
127992341|NCT00492232|460596772|FG000|Double-Blind Treatment|Adverse Event|1|||
127992342|NCT00492232|460596773|FG001|Double-Blind Treatment|Adverse Event|2|||
127992343|NCT00492232|460596772|FG000|Double-Blind Treatment|Protocol Violation|3|||
127992344|NCT00492232|460596773|FG001|Double-Blind Treatment|Protocol Violation|7|||
127992345|NCT00492232|460596772|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
127992346|NCT00492232|460596773|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
127992347|NCT00492232|460596772|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
127992348|NCT00492232|460596773|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
127992349|NCT00492232|460596772|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
127992350|NCT00492232|460596773|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
127992351|NCT00492232|460596772|FG000|Double-Blind Treatment|Other|6|||
127992352|NCT00492232|460596773|FG001|Double-Blind Treatment|Other|5|||
127992353|NCT00492232|460596772|FG000|Double-Blind Treatment|Randomized not treated|1|||
127992354|NCT00492232|460596773|FG001|Double-Blind Treatment|Randomized not treated|0|||
127992355|NCT00492232|460596772|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
127992356|NCT00492232|460596773|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
127992357|NCT01216332|460596774|FG000|Overall Study|Withdrawal by Subject|4|||
127992358|NCT01216332|460596775|FG001|Overall Study|Withdrawal by Subject|0|||
127992359|NCT00636636|460596776|FG000|Overall Study|Other reason|4|||
127992360|NCT00636636|460596777|FG001|Overall Study|Other reason|6|||
127992361|NCT00636636|460596776|FG000|Overall Study|Adverse Event|19|||
127992362|NCT00636636|460596777|FG001|Overall Study|Adverse Event|8|||
127992363|NCT00636636|460596776|FG000|Overall Study|Lack of Efficacy|7|||
127992364|NCT00636636|460596777|FG001|Overall Study|Lack of Efficacy|12|||
127992365|NCT00636636|460596776|FG000|Overall Study|Protocol Violation|2|||
127992366|NCT00636636|460596777|FG001|Overall Study|Protocol Violation|2|||
127992367|NCT00636636|460596776|FG000|Overall Study|Lost to Follow-up|0|||
127992368|NCT00636636|460596777|FG001|Overall Study|Lost to Follow-up|1|||
127992369|NCT00636636|460596776|FG000|Overall Study|Death|0|||
127992370|NCT00636636|460596777|FG001|Overall Study|Death|1|||
127992371|NCT00636636|460596776|FG000|Overall Study|Withdrawal by Subject|4|||
127992372|NCT00636636|460596777|FG001|Overall Study|Withdrawal by Subject|9|||
127992373|NCT00524173|460596778|FG000|Overall Study|Lost to Follow-up|0|||
127992374|NCT00524173|460596779|FG001|Overall Study|Lost to Follow-up|1|||
127992375|NCT00524173|460596778|FG000|Overall Study|Death|1|||
127992376|NCT00524173|460596779|FG001|Overall Study|Death|0|||
127664823|NCT01474512|459395048|FG008|Long-Term Extension Period|Physician Decision|0|||
127992377|NCT00524173|460596778|FG000|Overall Study|Had not reached endpoint at study close|4|||
127992378|NCT00524173|460596779|FG001|Overall Study|Had not reached endpoint at study close|1|||
127992379|NCT04811664|460596780|FG000|Overall Study|Lost to Follow-up|78|||
127992380|NCT04811664|460596781|FG001|Overall Study|Lost to Follow-up|125|||
127992381|NCT04811664|460596782|FG002|Overall Study|Lost to Follow-up|46|||
127992382|NCT04811664|460596780|FG000|Overall Study|Withdrawal by Subject|39|||
127992383|NCT04811664|460596781|FG001|Overall Study|Withdrawal by Subject|76|||
127992384|NCT04811664|460596782|FG002|Overall Study|Withdrawal by Subject|12|||
127992385|NCT04811664|460596780|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
127992386|NCT04811664|460596781|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
127992387|NCT04811664|460596782|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
127992388|NCT04811664|460596780|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
127992389|NCT04811664|460596781|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
127992390|NCT04811664|460596782|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
127992391|NCT04811664|460596780|FG000|Overall Study|Protocol Violation|0|||
127992392|NCT04811664|460596781|FG001|Overall Study|Protocol Violation|5|||
127992393|NCT04811664|460596782|FG002|Overall Study|Protocol Violation|11|||
127992394|NCT04811664|460596780|FG000|Overall Study|Study Terminated by Sponsor|4|||
127992395|NCT04811664|460596781|FG001|Overall Study|Study Terminated by Sponsor|3|||
127992396|NCT04811664|460596782|FG002|Overall Study|Study Terminated by Sponsor|34|||
127992397|NCT04811664|460596780|FG000|Overall Study|Early Study Closure|3|||
127992398|NCT04811664|460596781|FG001|Overall Study|Early Study Closure|7|||
127992399|NCT04811664|460596782|FG002|Overall Study|Early Study Closure|79|||
127992400|NCT04811664|460596780|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
127992401|NCT04811664|460596781|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
127992402|NCT04811664|460596782|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
127992403|NCT02526160|460599075|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
127992404|NCT02526160|460599076|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
127992405|NCT02526160|460599075|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
127992406|NCT02526160|460599076|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
127992407|NCT02526160|460599075|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
127992408|NCT02526160|460599076|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
127992409|NCT02526160|460599075|FG000|Open-Label Treatment Extension Period I|Death|0|||
127992410|NCT02526160|460599076|FG001|Open-Label Treatment Extension Period I|Death|1|||
127992411|NCT02526160|460599075|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
127992412|NCT02526160|460599076|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
127992413|NCT02526160|460599075|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
127992414|NCT02526160|460599076|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
127992415|NCT02526160|460599075|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
127992416|NCT02526160|460599076|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
127992417|NCT02526160|460599075|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
127992418|NCT02526160|460599076|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
127992419|NCT04985942|460599081|FG000|Overall Study|Adverse Event|14|||
127992420|NCT04985942|460599082|FG001|Overall Study|Adverse Event|2|||
127992421|NCT04985942|460599081|FG000|Overall Study|Lack of Efficacy|0|||
127992422|NCT04985942|460599082|FG001|Overall Study|Lack of Efficacy|3|||
127992423|NCT04985942|460599081|FG000|Overall Study|Lost to Follow-up|1|||
127992424|NCT04985942|460599082|FG001|Overall Study|Lost to Follow-up|1|||
127992425|NCT04985942|460599081|FG000|Overall Study|Protocol Violation|1|||
127992426|NCT04985942|460599082|FG001|Overall Study|Protocol Violation|1|||
127992427|NCT04985942|460599081|FG000|Overall Study|Withdrawal by Subject|5|||
127992428|NCT04985942|460599082|FG001|Overall Study|Withdrawal by Subject|4|||
127992429|NCT03630705|460599083|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
127992430|NCT03630705|460599084|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
127992431|NCT03630705|460599085|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
127992432|NCT03630705|460599086|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
127992433|NCT03630705|460599083|FG000|Overall Study|Lost to Follow-up|1|||
127992434|NCT03630705|460599084|FG001|Overall Study|Lost to Follow-up|2|||
127992435|NCT03630705|460599085|FG002|Overall Study|Lost to Follow-up|0|||
127992436|NCT03630705|460599086|FG003|Overall Study|Lost to Follow-up|0|||
127992437|NCT02849704|460599087|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
127992438|NCT02849704|460599088|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
127992439|NCT02849704|460599087|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
127992440|NCT02849704|460599088|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
127992441|NCT02849704|460599087|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
127992442|NCT02849704|460599088|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
127992443|NCT02576977|460599091|FG000|Overall Study|Adverse Event|13|||
127992444|NCT02576977|460599092|FG001|Overall Study|Adverse Event|2|||
127992445|NCT02576977|460599091|FG000|Overall Study|Death|73|||
127992446|NCT02576977|460599092|FG001|Overall Study|Death|60|||
127992447|NCT02576977|460599091|FG000|Overall Study|Screen failure|1|||
127992448|NCT02576977|460599092|FG001|Overall Study|Screen failure|0|||
127992449|NCT02576977|460599091|FG000|Overall Study|Study Terminated at Selected Sites|27|||
127992450|NCT02576977|460599092|FG001|Overall Study|Study Terminated at Selected Sites|50|||
127992451|NCT02576977|460599091|FG000|Overall Study|Withdrawal by Subject|11|||
127992452|NCT02576977|460599092|FG001|Overall Study|Withdrawal by Subject|11|||
127992453|NCT02576977|460599091|FG000|Overall Study|Final Disposition Unknown|0|||
127992454|NCT02576977|460599092|FG001|Overall Study|Final Disposition Unknown|1|||
127992455|NCT02576977|460599091|FG000|Overall Study|Lost to Follow-up|1|||
127992456|NCT02576977|460599092|FG001|Overall Study|Lost to Follow-up|0|||
127992457|NCT02576977|460599091|FG000|Overall Study|Progressive Disease|0|||
127992458|NCT02576977|460599092|FG001|Overall Study|Progressive Disease|1|||
127992459|NCT01128400|460599095|FG000|Overall Study|Lost to Follow-up|1|||
127992460|NCT01128400|460599096|FG001|Overall Study|Lost to Follow-up|0|||
127992461|NCT01128400|460599097|FG002|Overall Study|Lost to Follow-up|1|||
127992462|NCT01128400|460599095|FG000|Overall Study|Screening failure|1|||
127992463|NCT01128400|460599096|FG001|Overall Study|Screening failure|0|||
127992464|NCT01128400|460599097|FG002|Overall Study|Screening failure|0|||
127992465|NCT01128400|460599095|FG000|Overall Study|were not invited to participate on taste|0|||
127992466|NCT01128400|460599096|FG001|Overall Study|were not invited to participate on taste|0|||
127992467|NCT01128400|460599097|FG002|Overall Study|were not invited to participate on taste|15|||
127992468|NCT01128400|460599095|FG000|Overall Study|Excluded due to sinus problems|0|||
127992469|NCT01128400|460599096|FG001|Overall Study|Excluded due to sinus problems|1|||
127992470|NCT01128400|460599097|FG002|Overall Study|Excluded due to sinus problems|0|||
127992471|NCT00199849|460599099|FG000|Overall Study|Unrelated illness or complication|0|||
127992472|NCT00199849|460599100|FG001|Overall Study|Unrelated illness or complication|1|||
127992473|NCT00199849|460599101|FG002|Overall Study|Unrelated illness or complication|0|||
127992474|NCT00199849|460599099|FG000|Overall Study|Progressive disease requiring intervention|0|||
127992475|NCT00199849|460599100|FG001|Overall Study|Progressive disease requiring intervention|0|||
127992476|NCT00199849|460599101|FG002|Overall Study|Progressive disease requiring intervention|1|||
127992477|NCT00199849|460599099|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
127992478|NCT00199849|460599100|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
127992479|NCT00199849|460599101|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
127992480|NCT04727528|460599102|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
127992481|NCT04727528|460599103|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
127992482|NCT04727528|460599102|FG000|Open-label Period|Randomized who did not receive treatment|1|||
127992483|NCT04727528|460599103|FG001|Open-label Period|Randomized who did not receive treatment|0|||
127992484|NCT04727528|460599102|FG000|Double-blind Treatment Phase|Adverse Event|0|||
127992485|NCT04727528|460599103|FG001|Double-blind Treatment Phase|Adverse Event|1|||
127992486|NCT04727528|460599102|FG000|Double-blind Treatment Phase|Death|0|||
127992487|NCT04727528|460599103|FG001|Double-blind Treatment Phase|Death|1|||
127992488|NCT04727528|460599102|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
127992489|NCT04727528|460599103|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
127992490|NCT04727528|460599102|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
127992491|NCT04727528|460599103|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
127992492|NCT04727528|460599102|FG000|Double-blind Treatment Phase|Physician Decision|0|||
127992493|NCT04727528|460599103|FG001|Double-blind Treatment Phase|Physician Decision|1|||
127992494|NCT04727528|460599102|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
127992495|NCT04727528|460599103|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
127992496|NCT01763827|460599106|FG000|Overall Study|Withdrawal by Subject|1|||
127992497|NCT01763827|460599107|FG001|Overall Study|Withdrawal by Subject|0|||
127992498|NCT01763827|460599108|FG002|Overall Study|Withdrawal by Subject|0|||
127992499|NCT01763827|460599109|FG003|Overall Study|Withdrawal by Subject|0|||
127992500|NCT01763827|460599110|FG004|Overall Study|Withdrawal by Subject|2|||
127992501|NCT01763827|460599111|FG005|Overall Study|Withdrawal by Subject|0|||
127992502|NCT01763827|460599106|FG000|Overall Study|Decision by sponsor|2|||
127992503|NCT01763827|460599107|FG001|Overall Study|Decision by sponsor|0|||
127992504|NCT01763827|460599108|FG002|Overall Study|Decision by sponsor|3|||
127992505|NCT01763827|460599109|FG003|Overall Study|Decision by sponsor|0|||
127992506|NCT01763827|460599110|FG004|Overall Study|Decision by sponsor|2|||
127992507|NCT01763827|460599111|FG005|Overall Study|Decision by sponsor|1|||
127992508|NCT01763827|460599106|FG000|Overall Study|Lost to Follow-up|0|||
127992509|NCT01763827|460599107|FG001|Overall Study|Lost to Follow-up|1|||
127992510|NCT01763827|460599108|FG002|Overall Study|Lost to Follow-up|1|||
127992511|NCT01763827|460599109|FG003|Overall Study|Lost to Follow-up|1|||
127992512|NCT01763827|460599110|FG004|Overall Study|Lost to Follow-up|2|||
127992513|NCT01763827|460599111|FG005|Overall Study|Lost to Follow-up|1|||
127992514|NCT01826981|460599116|FG000|Overall Study|Lack of Efficacy|0|||
127992515|NCT01826981|460599117|FG001|Overall Study|Lack of Efficacy|1|||
127992516|NCT01826981|460599118|FG002|Overall Study|Lack of Efficacy|0|||
127992517|NCT01826981|460599119|FG003|Overall Study|Lack of Efficacy|0|||
127992518|NCT01826981|460599120|FG004|Overall Study|Lack of Efficacy|5|||
127992519|NCT01826981|460599121|FG005|Overall Study|Lack of Efficacy|0|||
127992520|NCT01826981|460599122|FG006|Overall Study|Lack of Efficacy|0|||
127992521|NCT01826981|460599123|FG007|Overall Study|Lack of Efficacy|8|||
127992522|NCT01826981|460599124|FG008|Overall Study|Lack of Efficacy|7|||
127992523|NCT01826981|460599125|FG009|Overall Study|Lack of Efficacy|0|||
127992524|NCT01826981|460599126|FG010|Overall Study|Lack of Efficacy|1|||
127992525|NCT01826981|460599127|FG011|Overall Study|Lack of Efficacy|0|||
127992526|NCT01826981|460599128|FG012|Overall Study|Lack of Efficacy|0|||
127992527|NCT01826981|460599129|FG013|Overall Study|Lack of Efficacy|3|||
127992528|NCT01826981|460599130|FG014|Overall Study|Lack of Efficacy|0|||
127992529|NCT01826981|460599116|FG000|Overall Study|Lost to Follow-up|0|||
127992530|NCT01826981|460599117|FG001|Overall Study|Lost to Follow-up|0|||
127992531|NCT01826981|460599118|FG002|Overall Study|Lost to Follow-up|0|||
127992532|NCT01826981|460599119|FG003|Overall Study|Lost to Follow-up|0|||
127992533|NCT01826981|460599120|FG004|Overall Study|Lost to Follow-up|1|||
127992534|NCT01826981|460599121|FG005|Overall Study|Lost to Follow-up|1|||
127992535|NCT01826981|460599122|FG006|Overall Study|Lost to Follow-up|0|||
127992536|NCT01826981|460599123|FG007|Overall Study|Lost to Follow-up|1|||
127992537|NCT01826981|460599124|FG008|Overall Study|Lost to Follow-up|0|||
127992538|NCT01826981|460599125|FG009|Overall Study|Lost to Follow-up|1|||
127992539|NCT01826981|460599126|FG010|Overall Study|Lost to Follow-up|1|||
127992540|NCT01826981|460599127|FG011|Overall Study|Lost to Follow-up|1|||
127992541|NCT01826981|460599128|FG012|Overall Study|Lost to Follow-up|1|||
127992542|NCT01826981|460599129|FG013|Overall Study|Lost to Follow-up|0|||
127992543|NCT01826981|460599130|FG014|Overall Study|Lost to Follow-up|0|||
127992544|NCT01826981|460599116|FG000|Overall Study|Withdrew Consent|0|||
127992545|NCT01826981|460599117|FG001|Overall Study|Withdrew Consent|0|||
127992546|NCT01826981|460599118|FG002|Overall Study|Withdrew Consent|0|||
127992547|NCT01826981|460599119|FG003|Overall Study|Withdrew Consent|0|||
127992548|NCT01826981|460599120|FG004|Overall Study|Withdrew Consent|0|||
127992549|NCT01826981|460599121|FG005|Overall Study|Withdrew Consent|0|||
127992550|NCT01826981|460599122|FG006|Overall Study|Withdrew Consent|1|||
127992551|NCT01826981|460599123|FG007|Overall Study|Withdrew Consent|1|||
127992552|NCT01826981|460599124|FG008|Overall Study|Withdrew Consent|0|||
127992553|NCT01826981|460599125|FG009|Overall Study|Withdrew Consent|0|||
127992554|NCT01826981|460599126|FG010|Overall Study|Withdrew Consent|0|||
127992555|NCT01826981|460599127|FG011|Overall Study|Withdrew Consent|1|||
127992556|NCT01826981|460599128|FG012|Overall Study|Withdrew Consent|0|||
127992557|NCT01826981|460599129|FG013|Overall Study|Withdrew Consent|1|||
127992558|NCT01826981|460599130|FG014|Overall Study|Withdrew Consent|0|||
127992559|NCT01826981|460599116|FG000|Overall Study|Adverse Event|0|||
127992560|NCT01826981|460599117|FG001|Overall Study|Adverse Event|0|||
127992561|NCT01826981|460599118|FG002|Overall Study|Adverse Event|0|||
127992562|NCT01826981|460599119|FG003|Overall Study|Adverse Event|0|||
127992563|NCT01826981|460599120|FG004|Overall Study|Adverse Event|1|||
127992564|NCT01826981|460599121|FG005|Overall Study|Adverse Event|0|||
127992565|NCT01826981|460599122|FG006|Overall Study|Adverse Event|0|||
127992566|NCT01826981|460599123|FG007|Overall Study|Adverse Event|0|||
127992567|NCT01826981|460599124|FG008|Overall Study|Adverse Event|0|||
127992568|NCT01826981|460599125|FG009|Overall Study|Adverse Event|0|||
127992569|NCT01826981|460599126|FG010|Overall Study|Adverse Event|0|||
127992570|NCT01826981|460599127|FG011|Overall Study|Adverse Event|0|||
127992571|NCT01826981|460599128|FG012|Overall Study|Adverse Event|0|||
127992572|NCT01826981|460599129|FG013|Overall Study|Adverse Event|0|||
127992573|NCT01826981|460599130|FG014|Overall Study|Adverse Event|0|||
127992574|NCT01826981|460599116|FG000|Overall Study|Upper G-I Haemorrhage|0|||
127992575|NCT01826981|460599117|FG001|Overall Study|Upper G-I Haemorrhage|0|||
127992576|NCT01826981|460599118|FG002|Overall Study|Upper G-I Haemorrhage|0|||
127992577|NCT01826981|460599119|FG003|Overall Study|Upper G-I Haemorrhage|0|||
127992578|NCT01826981|460599120|FG004|Overall Study|Upper G-I Haemorrhage|0|||
127992579|NCT01826981|460599121|FG005|Overall Study|Upper G-I Haemorrhage|0|||
127992580|NCT01826981|460599122|FG006|Overall Study|Upper G-I Haemorrhage|0|||
127992581|NCT01826981|460599123|FG007|Overall Study|Upper G-I Haemorrhage|0|||
127992582|NCT01826981|460599124|FG008|Overall Study|Upper G-I Haemorrhage|0|||
127992583|NCT01826981|460599125|FG009|Overall Study|Upper G-I Haemorrhage|0|||
127992584|NCT01826981|460599126|FG010|Overall Study|Upper G-I Haemorrhage|0|||
127992585|NCT01826981|460599127|FG011|Overall Study|Upper G-I Haemorrhage|0|||
127992586|NCT01826981|460599128|FG012|Overall Study|Upper G-I Haemorrhage|0|||
127992587|NCT01826981|460599129|FG013|Overall Study|Upper G-I Haemorrhage|1|||
127992588|NCT01826981|460599130|FG014|Overall Study|Upper G-I Haemorrhage|0|||
127992589|NCT01826981|460599116|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
127992590|NCT01826981|460599117|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
127992591|NCT01826981|460599118|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
127992592|NCT01826981|460599119|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
127992593|NCT01826981|460599120|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
127992594|NCT01826981|460599121|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
127992595|NCT01826981|460599122|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
127992596|NCT01826981|460599123|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
127992597|NCT01826981|460599124|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
127992598|NCT01826981|460599125|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
127992599|NCT01826981|460599126|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
127992600|NCT01826981|460599127|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
127992601|NCT01826981|460599128|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
127992602|NCT01826981|460599129|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
127992603|NCT01826981|460599130|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
127992604|NCT02906579|460599131|FG000|Overall Study|Adverse Event|1|||
127992605|NCT02906579|460599131|FG000|Overall Study|Physician Decision|1|||
127992606|NCT02030119|460599132|FG000|Overall Study|Withdrawal by Subject|3|||
127992607|NCT02030119|460599133|FG001|Overall Study|Withdrawal by Subject|1|||
127992608|NCT02030119|460599134|FG002|Overall Study|Withdrawal by Subject|5|||
127992609|NCT02030119|460599135|FG003|Overall Study|Withdrawal by Subject|3|||
127992610|NCT02030119|460599132|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
127992611|NCT02030119|460599133|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
127992612|NCT02030119|460599134|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
127992613|NCT02030119|460599135|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
127992614|NCT00759655|460599136|FG000|Overall Study|Termination of the study by sponsor|1|||
127992615|NCT02793947|460599137|FG000|Overall Study|Death|1|||
127992616|NCT02793947|460599138|FG001|Overall Study|Death|0|||
127992617|NCT02793947|460599137|FG000|Overall Study|Physician Decision|1|||
127992618|NCT02793947|460599138|FG001|Overall Study|Physician Decision|5|||
127992619|NCT03746405|460599148|FG000|Overall Study|Withdrawal by Subject|3|||
127992620|NCT03746405|460599149|FG001|Overall Study|Withdrawal by Subject|0|||
127992621|NCT03746405|460599148|FG000|Overall Study|technical difficulties|0|||
127992622|NCT03746405|460599149|FG001|Overall Study|technical difficulties|2|||
127992623|NCT03479008|460599150|FG000|Overall Study|Withdrawal by Subject|3|||
127992624|NCT00412932|460599151|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
127992625|NCT00412932|460599151|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
127992626|NCT00412932|460599151|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
127992627|NCT00412932|460599151|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
127992628|NCT00412932|460599151|FG000|Olmesartan (Olm) 20 mg|Other|1|||
127992629|NCT00412932|460599151|FG000|Olmesartan 40 mg|Adverse Event|4|||
127992630|NCT00412932|460599151|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
127992631|NCT00412932|460599151|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
127992632|NCT00412932|460599151|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
127992633|NCT00412932|460599151|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
127992634|NCT00412932|460599151|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
127992635|NCT00412932|460599151|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
127992636|NCT01490840|460599152|FG000|Phase 1|Lost to Follow-up|1|||
127992637|NCT01490840|460599153|FG001|Phase 1|Lost to Follow-up|0|||
127992638|NCT01490840|460599152|FG000|Phase 1|Adverse Event|2|||
127992639|NCT01490840|460599153|FG001|Phase 1|Adverse Event|1|||
127992640|NCT01490840|460599152|FG000|Phase 1|Withdrawal by Subject|6|||
127992641|NCT01490840|460599153|FG001|Phase 1|Withdrawal by Subject|5|||
127992642|NCT01490840|460599152|FG000|Phase 1|Visit 6a omitted|1|||
127992643|NCT01490840|460599153|FG001|Phase 1|Visit 6a omitted|0|||
127992644|NCT01490840|460599152|FG000|Phase 2|Withdrawal by Subject|4|||
127992645|NCT01490840|460599153|FG001|Phase 2|Withdrawal by Subject|3|||
127992646|NCT01490840|460599152|FG000|Phase 2|Permanent interruption of fingolimod|0|||
127992647|NCT01490840|460599153|FG001|Phase 2|Permanent interruption of fingolimod|1|||
127992648|NCT01490840|460599152|FG000|Phase 2|Lost to Follow-up|1|||
127992649|NCT01490840|460599153|FG001|Phase 2|Lost to Follow-up|1|||
127992650|NCT01490840|460599152|FG000|Phase 2|Adverse Event|1|||
127992651|NCT01490840|460599153|FG001|Phase 2|Adverse Event|1|||
127992652|NCT02753816|460599155|FG000|Overall Study|Protocol Violation|0|||
127992653|NCT02753816|460599156|FG001|Overall Study|Protocol Violation|1|||
127992654|NCT02753816|460599157|FG002|Overall Study|Protocol Violation|0|||
127992655|NCT01465230|460599158|FG000|Overall Study|Withdrawal by Subject|2|||
127992656|NCT01738919|460599161|FG000|Overall Study|Lost to Follow-up|1|||
127992657|NCT01738919|460599162|FG001|Overall Study|Lost to Follow-up|0|||
127992658|NCT01738919|460599161|FG000|Overall Study|Immigrated|0|||
127992659|NCT01738919|460599162|FG001|Overall Study|Immigrated|1|||
127992660|NCT01738919|460599161|FG000|Overall Study|Withdrawal by Subject|0|||
127992661|NCT01738919|460599162|FG001|Overall Study|Withdrawal by Subject|1|||
127992662|NCT01738919|460599161|FG000|Overall Study|Not treated in accordance to guidelines|0|||
127992663|NCT01738919|460599162|FG001|Overall Study|Not treated in accordance to guidelines|1|||
127992664|NCT01473940|460599166|FG000|Induction Therapy|Death|0|||
127992665|NCT01473940|460599167|FG001|Induction Therapy|Death|0|||
127992666|NCT01473940|460599168|FG002|Induction Therapy|Death|1|||
127992667|NCT01473940|460599169|FG003|Induction Therapy|Death|1|||
127992668|NCT01473940|460599166|FG000|Induction Therapy|Progressive Disease|0|||
127992669|NCT01473940|460599167|FG001|Induction Therapy|Progressive Disease|1|||
127992670|NCT01473940|460599168|FG002|Induction Therapy|Progressive Disease|1|||
127992671|NCT01473940|460599169|FG003|Induction Therapy|Progressive Disease|0|||
127992672|NCT01473940|460599166|FG000|Maintenance Therapy|Progressive Disease|1|||
127992673|NCT01473940|460599167|FG001|Maintenance Therapy|Progressive Disease|2|||
127992674|NCT01473940|460599168|FG002|Maintenance Therapy|Progressive Disease|1|||
127992675|NCT01473940|460599169|FG003|Maintenance Therapy|Progressive Disease|4|||
127992676|NCT00547248|460599170|FG000|Overall Study|Protocol Violation|0|||
127992677|NCT00547248|460599171|FG001|Overall Study|Protocol Violation|0|||
127992678|NCT00547248|460599172|FG002|Overall Study|Protocol Violation|1|||
127992679|NCT00547248|460599173|FG003|Overall Study|Protocol Violation|1|||
127992680|NCT00547248|460599170|FG000|Overall Study|Migrated/moved from study area|0|||
127992681|NCT00547248|460599171|FG001|Overall Study|Migrated/moved from study area|0|||
127992682|NCT00547248|460599172|FG002|Overall Study|Migrated/moved from study area|2|||
127992683|NCT00547248|460599173|FG003|Overall Study|Migrated/moved from study area|0|||
127992684|NCT00547248|460599170|FG000|Overall Study|Withdrawal by Subject|0|||
127992685|NCT00547248|460599171|FG001|Overall Study|Withdrawal by Subject|0|||
127992686|NCT00547248|460599172|FG002|Overall Study|Withdrawal by Subject|7|||
127992687|NCT00547248|460599173|FG003|Overall Study|Withdrawal by Subject|1|||
127992688|NCT00534248|460599174|FG000|Overall Study|Adverse Event|19|||
127992689|NCT00534248|460599175|FG001|Overall Study|Adverse Event|29|||
127992690|NCT00534248|460599174|FG000|Overall Study|Lost to Follow-up|353|||
127992691|NCT00534248|460599175|FG001|Overall Study|Lost to Follow-up|375|||
127992692|NCT00534248|460599174|FG000|Overall Study|Other protocol specified criteria|13|||
127992693|NCT00534248|460599175|FG001|Overall Study|Other protocol specified criteria|3|||
127992694|NCT00534248|460599174|FG000|Overall Study|Physician Decision|10|||
127992695|NCT00534248|460599175|FG001|Overall Study|Physician Decision|7|||
127992696|NCT00534248|460599174|FG000|Overall Study|Protocol Violation|3|||
127992697|NCT00534248|460599175|FG001|Overall Study|Protocol Violation|4|||
127992698|NCT00534248|460599174|FG000|Overall Study|Withdrawal by Subject|263|||
127992699|NCT00534248|460599175|FG001|Overall Study|Withdrawal by Subject|255|||
127992700|NCT02849171|460599178|FG000|Overall Study|Withdrawal by Subject|1|||
127992701|NCT02849171|460599178|FG000|Overall Study|Not treated|1|||
127992702|NCT02532257|460599179|FG000|Overall Study|Adverse Event|2|||
127992703|NCT02532257|460599179|FG000|Overall Study|Physician Decision|4|||
127992704|NCT02532257|460599179|FG000|Overall Study|Withdrawal by Subject|3|||
127992705|NCT02532257|460599179|FG000|Overall Study|Progressive Disease|10|||
127992706|NCT02259400|460599182|FG000|Overall Study|Death|0|||
127992707|NCT02259400|460599183|FG001|Overall Study|Death|2|||
127992708|NCT00697593|460599185|FG000|Overall Study|Adverse Event|3|||
127992709|NCT00697593|460599185|FG000|Overall Study|Protocol Violation|1|||
127992710|NCT00697593|460599185|FG000|Overall Study|Lack of Efficacy|3|||
127992711|NCT00697593|460599185|FG000|Overall Study|Suspension of the study by sponsor|12|||
127992712|NCT02964338|460599186|FG000|Overall Study|Sponsor terminated study for futility|12|||
127992713|NCT02964338|460599187|FG001|Overall Study|Sponsor terminated study for futility|15|||
127992714|NCT02964338|460599188|FG002|Overall Study|Sponsor terminated study for futility|14|||
127992715|NCT02964338|460599186|FG000|Overall Study|Lack of Efficacy|0|||
127992716|NCT02964338|460599187|FG001|Overall Study|Lack of Efficacy|3|||
127992717|NCT02964338|460599188|FG002|Overall Study|Lack of Efficacy|0|||
127992718|NCT02964338|460599186|FG000|Overall Study|Lost to Follow-up|1|||
127992719|NCT02964338|460599187|FG001|Overall Study|Lost to Follow-up|0|||
127992720|NCT02964338|460599188|FG002|Overall Study|Lost to Follow-up|3|||
127992721|NCT02964338|460599186|FG000|Overall Study|Protocol Violation|0|||
127992722|NCT02964338|460599187|FG001|Overall Study|Protocol Violation|1|||
127992723|NCT02964338|460599188|FG002|Overall Study|Protocol Violation|0|||
127992724|NCT02964338|460599186|FG000|Overall Study|Withdrawal by Subject|1|||
127992725|NCT02964338|460599187|FG001|Overall Study|Withdrawal by Subject|3|||
127992726|NCT02964338|460599188|FG002|Overall Study|Withdrawal by Subject|1|||
127992727|NCT02964338|460599186|FG000|Overall Study|Adverse Event|2|||
127992728|NCT02964338|460599187|FG001|Overall Study|Adverse Event|1|||
127992729|NCT02964338|460599188|FG002|Overall Study|Adverse Event|1|||
127992730|NCT02964338|460599186|FG000|Overall Study|Non-compliant with e-diary|0|||
127992731|NCT02964338|460599187|FG001|Overall Study|Non-compliant with e-diary|1|||
127992732|NCT02964338|460599188|FG002|Overall Study|Non-compliant with e-diary|0|||
127992733|NCT02964338|460599186|FG000|Overall Study|Did not meet criteria|1|||
127992734|NCT02964338|460599187|FG001|Overall Study|Did not meet criteria|0|||
127992735|NCT02964338|460599188|FG002|Overall Study|Did not meet criteria|0|||
127992736|NCT02372383|460599192|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
127992737|NCT02372383|460599193|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
127992738|NCT02372383|460599194|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
127992739|NCT01704755|460599198|FG000|Overall Study|Adverse Event|4|||
127992740|NCT01704755|460599199|FG001|Overall Study|Adverse Event|1|||
127992741|NCT01704755|460599198|FG000|Overall Study|Lost to Follow-up|3|||
127992742|NCT01704755|460599199|FG001|Overall Study|Lost to Follow-up|4|||
127992743|NCT01704755|460599198|FG000|Overall Study|Withdrew consent|1|||
127992744|NCT01704755|460599199|FG001|Overall Study|Withdrew consent|1|||
127992745|NCT01704755|460599198|FG000|Overall Study|Other (not specified)|3|||
127992746|NCT01704755|460599199|FG001|Overall Study|Other (not specified)|1|||
127992747|NCT01704755|460599198|FG000|Overall Study|Withdrew consent and personal issues|1|||
127992748|NCT01704755|460599199|FG001|Overall Study|Withdrew consent and personal issues|0|||
127992749|NCT04105842|460599200|FG000|Overall Study|Withdrawal by Subject|2|||
127992750|NCT02087670|460599201|FG000|Overall Study|Withdrawal by Subject|3|||
127992751|NCT02087670|460599202|FG001|Overall Study|Withdrawal by Subject|2|||
127992752|NCT01639703|460599203|FG000|Overall Study|Withdrawal by Subject|5|||
127992753|NCT01639703|460599203|FG000|Overall Study|Other reason|7|||
127992754|NCT01042392|460599204|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
127992755|NCT01042392|460599205|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
127992756|NCT01042392|460599206|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
127992757|NCT01042392|460599207|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
127992758|NCT01042392|460599204|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
127992759|NCT01042392|460599205|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
127992760|NCT01042392|460599206|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
127992761|NCT01042392|460599207|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
127992762|NCT01042392|460599204|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
127992763|NCT01042392|460599205|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
127992764|NCT01042392|460599206|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
127992765|NCT01042392|460599207|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
127992766|NCT01042392|460599204|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
127992767|NCT01042392|460599205|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
127992768|NCT01042392|460599206|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
127992769|NCT01042392|460599207|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
127992770|NCT01042392|460599204|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
127992771|NCT01042392|460599205|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
127992772|NCT01042392|460599206|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
127992773|NCT01042392|460599207|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
127992774|NCT01042392|460599204|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
127992775|NCT01042392|460599205|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
127992776|NCT01042392|460599206|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
127992777|NCT01042392|460599207|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
127992778|NCT01042392|460599204|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
127992779|NCT01042392|460599205|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
127992780|NCT01042392|460599206|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
127992781|NCT01042392|460599207|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
127992782|NCT01042392|460599204|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
127992783|NCT01042392|460599205|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
127992784|NCT01042392|460599206|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
127992785|NCT01042392|460599207|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
127992786|NCT01042392|460599204|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
127992787|NCT01042392|460599205|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
127992788|NCT01042392|460599206|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
127992789|NCT01042392|460599207|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
127992790|NCT00587795|460599208|FG000|Overall Study|Withdrawal by Subject|1|||
127992791|NCT00587795|460599209|FG001|Overall Study|Withdrawal by Subject|0|||
127992792|NCT02869893|460599214|FG000|Overall Study|participant aversion to IV|5|||
127992793|NCT02869893|460599214|FG000|Overall Study|participant fear of MRI scanner|2|||
127992794|NCT00837967|460599215|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
127992795|NCT00837967|460599216|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
127992796|NCT00551525|460599217|FG000|Overall Study|Protocol Violation|5|||
127992797|NCT04676724|460599218|FG000|Overall Study|Adverse Event|2|||
127992798|NCT04676724|460599219|FG001|Overall Study|Adverse Event|0|||
127992799|NCT04676724|460599218|FG000|Overall Study|Lost to Follow-up|1|||
127992800|NCT04676724|460599219|FG001|Overall Study|Lost to Follow-up|0|||
127992801|NCT04676724|460599218|FG000|Overall Study|Physician Decision|0|||
127992802|NCT04676724|460599219|FG001|Overall Study|Physician Decision|1|||
127992803|NCT04676724|460599218|FG000|Overall Study|Withdrawal by Subject|3|||
127992804|NCT04676724|460599219|FG001|Overall Study|Withdrawal by Subject|2|||
127992805|NCT00099632|460599235|FG000|Overall Study|Lost to Follow-up|1|||
127992806|NCT00099632|460599236|FG001|Overall Study|Lost to Follow-up|0|||
127992807|NCT00099632|460599237|FG002|Overall Study|Lost to Follow-up|3|||
127992808|NCT00099632|460599238|FG003|Overall Study|Lost to Follow-up|1|||
127992809|NCT00099632|460599239|FG004|Overall Study|Lost to Follow-up|1|||
127992810|NCT00099632|460599240|FG005|Overall Study|Lost to Follow-up|0|||
127992811|NCT00099632|460599235|FG000|Overall Study|Withdrawal by Subject|0|||
127992812|NCT00099632|460599236|FG001|Overall Study|Withdrawal by Subject|1|||
127992813|NCT00099632|460599237|FG002|Overall Study|Withdrawal by Subject|0|||
127992814|NCT00099632|460599238|FG003|Overall Study|Withdrawal by Subject|0|||
127992815|NCT00099632|460599239|FG004|Overall Study|Withdrawal by Subject|0|||
127992816|NCT00099632|460599240|FG005|Overall Study|Withdrawal by Subject|1|||
127992817|NCT00099632|460599235|FG000|Overall Study|Protocol Violation|0|||
127992818|NCT00099632|460599236|FG001|Overall Study|Protocol Violation|0|||
127992819|NCT00099632|460599237|FG002|Overall Study|Protocol Violation|0|||
127992820|NCT00099632|460599238|FG003|Overall Study|Protocol Violation|0|||
127992821|NCT00099632|460599239|FG004|Overall Study|Protocol Violation|0|||
127664824|NCT01474512|459395049|FG009|Long-Term Extension Period|Physician Decision|0|||
127992822|NCT00099632|460599240|FG005|Overall Study|Protocol Violation|1|||
127992823|NCT03762681|460599246|FG000|Part 1|Withdrawal by Subject|0|||
127992824|NCT03762681|460599247|FG001|Part 1|Withdrawal by Subject|0|||
127664825|NCT01474512|459395050|FG010|Long-Term Extension Period|Physician Decision|0|||
127992825|NCT03762681|460599248|FG002|Part 1|Withdrawal by Subject|0|||
127992826|NCT03762681|460599249|FG003|Part 1|Withdrawal by Subject|1|||
127992827|NCT03762681|460599250|FG004|Part 1|Withdrawal by Subject|0|||
127992828|NCT03762681|460599251|FG005|Part 1|Withdrawal by Subject|0|||
127992829|NCT03762681|460599252|FG006|Part 1|Withdrawal by Subject|0|||
127992830|NCT03762681|460599253|FG007|Part 1|Withdrawal by Subject|0|||
127992831|NCT03762681|460599246|FG000|Part 2a|Pandemic Travel Restrictions|0|||
127992832|NCT03762681|460599247|FG001|Part 2a|Pandemic Travel Restrictions|0|||
127992833|NCT03762681|460599248|FG002|Part 2a|Pandemic Travel Restrictions|0|||
127992834|NCT03762681|460599249|FG003|Part 2a|Pandemic Travel Restrictions|0|||
127992835|NCT03762681|460599250|FG004|Part 2a|Pandemic Travel Restrictions|0|||
127992836|NCT03762681|460599251|FG005|Part 2a|Pandemic Travel Restrictions|0|||
127992837|NCT03762681|460599252|FG006|Part 2a|Pandemic Travel Restrictions|0|||
127992838|NCT03762681|460599253|FG007|Part 2a|Pandemic Travel Restrictions|1|||
127992839|NCT02137226|460599254|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
127992840|NCT02137226|460599255|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
127992841|NCT02137226|460599256|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
127992842|NCT02137226|460599257|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
127992843|NCT02137226|460599258|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
127992844|NCT02137226|460599254|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
127992845|NCT02137226|460599255|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
127992846|NCT02137226|460599256|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
127992847|NCT02137226|460599257|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
127992848|NCT02137226|460599258|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
127992849|NCT02137226|460599254|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
127992850|NCT02137226|460599255|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
127992851|NCT02137226|460599256|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
127992852|NCT02137226|460599257|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
127992853|NCT02137226|460599258|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
127992854|NCT02137226|460599254|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
127992855|NCT02137226|460599255|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
127992856|NCT02137226|460599256|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
127992857|NCT02137226|460599257|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
127992858|NCT02137226|460599258|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
127992859|NCT02137226|460599254|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
127992860|NCT02137226|460599255|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
127992861|NCT02137226|460599256|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
127992862|NCT02137226|460599257|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
127992863|NCT02137226|460599258|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
127992864|NCT02137226|460599254|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
127992865|NCT02137226|460599255|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
127992866|NCT02137226|460599256|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
127992867|NCT02137226|460599257|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
127992868|NCT02137226|460599258|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
127992869|NCT02137226|460599254|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
127992870|NCT02137226|460599255|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
127992871|NCT02137226|460599256|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
127992872|NCT02137226|460599257|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
127992873|NCT02137226|460599258|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
127992874|NCT02137226|460599254|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
127992875|NCT02137226|460599255|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
127992876|NCT02137226|460599256|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
127992877|NCT02137226|460599257|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
127992878|NCT02137226|460599258|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
127992879|NCT02137226|460599254|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
127992880|NCT02137226|460599255|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
127992881|NCT02137226|460599256|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
127992882|NCT02137226|460599257|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
127992883|NCT02137226|460599258|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
127992884|NCT02137226|460599254|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
127992885|NCT02137226|460599255|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
127992886|NCT02137226|460599256|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
127992887|NCT02137226|460599257|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
127992888|NCT02137226|460599258|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
127992889|NCT02137226|460599254|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
127992890|NCT02137226|460599255|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
127992891|NCT02137226|460599256|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
127992892|NCT02137226|460599257|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
127992893|NCT02137226|460599258|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
127992894|NCT02137226|460599254|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
127992895|NCT02137226|460599255|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
127992896|NCT02137226|460599256|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
127992897|NCT02137226|460599257|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
127992898|NCT02137226|460599258|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
127992899|NCT00003896|460599265|FG000|Overall Study|Adverse Event|16|||
127992900|NCT00003896|460599265|FG000|Overall Study|Withdrawal by Subject|1|||
127992901|NCT00003896|460599265|FG000|Overall Study|Lack of Efficacy|1|||
127992902|NCT00003896|460599265|FG000|Overall Study|Death|3|||
127992903|NCT00003896|460599265|FG000|Overall Study|not protocol specified|3|||
127992904|NCT00003896|460599265|FG000|Overall Study|ineligible|5|||
127992905|NCT01398358|460599266|FG000|Overall Study|Lost to Follow-up|11|||
127992906|NCT01398358|460599267|FG001|Overall Study|Lost to Follow-up|21|||
127992907|NCT01398358|460599268|FG002|Overall Study|Lost to Follow-up|18|||
127992908|NCT01398358|460599266|FG000|Overall Study|Withdrawal by Subject|3|||
127992909|NCT01398358|460599267|FG001|Overall Study|Withdrawal by Subject|2|||
127992910|NCT01398358|460599268|FG002|Overall Study|Withdrawal by Subject|2|||
127992911|NCT01398358|460599266|FG000|Overall Study|no longer eligible|1|||
127992912|NCT01398358|460599267|FG001|Overall Study|no longer eligible|0|||
127992913|NCT01398358|460599268|FG002|Overall Study|no longer eligible|1|||
127992914|NCT00985686|460599270|FG000|Overall Study|Lost to Follow-up|1|||
127992915|NCT00985686|460599271|FG001|Overall Study|Lost to Follow-up|1|||
127992916|NCT00985686|460599272|FG002|Overall Study|Lost to Follow-up|0|||
127992917|NCT00985686|460599273|FG003|Overall Study|Lost to Follow-up|2|||
127992918|NCT01670045|460599274|FG000|Overall Study|Withdrawal by Subject|3|||
127992919|NCT01670045|460599274|FG000|Overall Study|Adverse Event|1|||
127992920|NCT01670045|460599274|FG000|Overall Study|Death|1|||
127992921|NCT01670045|460599274|FG000|Overall Study|Lost to Follow-up|11|||
127992922|NCT02559570|460599276|FG000|Overall Study|Adverse Event|0|||
127992923|NCT02559570|460599277|FG001|Overall Study|Adverse Event|2|||
127992924|NCT02559570|460599278|FG002|Overall Study|Adverse Event|0|||
127992925|NCT02559570|460599279|FG003|Overall Study|Adverse Event|1|||
127992926|NCT02559570|460599280|FG004|Overall Study|Adverse Event|0|||
127992927|NCT02559570|460599276|FG000|Overall Study|Withdrawal of Consent|0|||
127992928|NCT02559570|460599277|FG001|Overall Study|Withdrawal of Consent|0|||
127992929|NCT02559570|460599278|FG002|Overall Study|Withdrawal of Consent|1|||
127992930|NCT02559570|460599279|FG003|Overall Study|Withdrawal of Consent|2|||
127992931|NCT02559570|460599280|FG004|Overall Study|Withdrawal of Consent|1|||
127992932|NCT02559570|460599276|FG000|Overall Study|Lost to Follow-up|1|||
127992933|NCT02559570|460599277|FG001|Overall Study|Lost to Follow-up|0|||
127992934|NCT02559570|460599278|FG002|Overall Study|Lost to Follow-up|0|||
127992935|NCT02559570|460599279|FG003|Overall Study|Lost to Follow-up|0|||
127992936|NCT02559570|460599280|FG004|Overall Study|Lost to Follow-up|0|||
127992937|NCT02559570|460599276|FG000|Overall Study|Protocol Violation|1|||
127992938|NCT02559570|460599277|FG001|Overall Study|Protocol Violation|0|||
127992939|NCT02559570|460599278|FG002|Overall Study|Protocol Violation|0|||
127992940|NCT02559570|460599279|FG003|Overall Study|Protocol Violation|0|||
127992941|NCT02559570|460599280|FG004|Overall Study|Protocol Violation|1|||
127992942|NCT02559570|460599276|FG000|Overall Study|Other Miscellaneous Reasons|0|||
127992943|NCT02559570|460599277|FG001|Overall Study|Other Miscellaneous Reasons|0|||
127664826|NCT01474512|459395051|FG011|Long-Term Extension Period|Physician Decision|0|||
127664827|NCT01474512|459395052|FG012|Long-Term Extension Period|Physician Decision|21|||
127664828|NCT01474512|459395053|FG013|Long-Term Extension Period|Physician Decision|21|||
127664829|NCT01474512|459395054|FG014|Long-Term Extension Period|Physician Decision|0|||
127992944|NCT02559570|460599278|FG002|Overall Study|Other Miscellaneous Reasons|1|||
127992945|NCT02559570|460599279|FG003|Overall Study|Other Miscellaneous Reasons|0|||
127992946|NCT02559570|460599280|FG004|Overall Study|Other Miscellaneous Reasons|0|||
127992947|NCT01310127|460600814|FG000|Overall Study|Protocol Violation|1|||
127992948|NCT01310127|460600815|FG001|Overall Study|Protocol Violation|1|||
127992949|NCT01310127|460600814|FG000|Overall Study|advanced psc cataract outlier|1|||
127992950|NCT01310127|460600815|FG001|Overall Study|advanced psc cataract outlier|0|||
127992951|NCT00741598|460600816|FG000|Overall Study|Lost to Follow-up|3|||
127992952|NCT00741598|460600817|FG001|Overall Study|Lost to Follow-up|4|||
127992953|NCT00741598|460600816|FG000|Overall Study|Lack of Efficacy|1|||
127992954|NCT00741598|460600817|FG001|Overall Study|Lack of Efficacy|2|||
127992955|NCT00741598|460600816|FG000|Overall Study|Physician Decision|1|||
127992956|NCT00741598|460600817|FG001|Overall Study|Physician Decision|1|||
127992957|NCT00741598|460600816|FG000|Overall Study|Pregnancy|1|||
127992958|NCT00741598|460600817|FG001|Overall Study|Pregnancy|0|||
127992959|NCT00741598|460600816|FG000|Overall Study|Withdrawal by Subject|3|||
127992960|NCT00741598|460600817|FG001|Overall Study|Withdrawal by Subject|2|||
127992961|NCT05446142|460600825|FG000|Period 2|Adverse Event|1|||
127992962|NCT05446142|460600826|FG001|Period 2|Adverse Event|0|||
127992963|NCT05446142|460600827|FG002|Period 2|Adverse Event|0|||
127992964|NCT05446142|460600828|FG003|Period 2|Adverse Event|0|||
127992965|NCT05446142|460600829|FG004|Period 2|Adverse Event|0|||
127992966|NCT05446142|460600830|FG005|Period 2|Adverse Event|0|||
127992967|NCT02098395|460600831|FG000|Overall Study|Protocol Violation|2|||
127664830|NCT01474512|459395055|FG015|Long-Term Extension Period|Physician Decision|0|||
127992968|NCT02098395|460600832|FG001|Overall Study|Protocol Violation|2|||
127992969|NCT02098395|460600833|FG002|Overall Study|Protocol Violation|0|||
127992970|NCT02098395|460600834|FG003|Overall Study|Protocol Violation|7|||
127992971|NCT02098395|460600831|FG000|Overall Study|Withdrawal by Subject|10|||
127992972|NCT02098395|460600832|FG001|Overall Study|Withdrawal by Subject|10|||
127992973|NCT02098395|460600833|FG002|Overall Study|Withdrawal by Subject|5|||
127992974|NCT02098395|460600834|FG003|Overall Study|Withdrawal by Subject|13|||
127992975|NCT02098395|460600831|FG000|Overall Study|Adverse Event|12|||
127992976|NCT02098395|460600832|FG001|Overall Study|Adverse Event|19|||
127992977|NCT02098395|460600833|FG002|Overall Study|Adverse Event|34|||
127992978|NCT02098395|460600834|FG003|Overall Study|Adverse Event|2|||
127992979|NCT02098395|460600831|FG000|Overall Study|Lost to Follow-up|2|||
127992980|NCT02098395|460600832|FG001|Overall Study|Lost to Follow-up|1|||
127992981|NCT02098395|460600833|FG002|Overall Study|Lost to Follow-up|0|||
127992982|NCT02098395|460600834|FG003|Overall Study|Lost to Follow-up|3|||
127992983|NCT02098395|460600831|FG000|Overall Study|Unclassified|0|||
127992984|NCT02098395|460600832|FG001|Overall Study|Unclassified|0|||
127992985|NCT02098395|460600833|FG002|Overall Study|Unclassified|3|||
127992986|NCT02098395|460600834|FG003|Overall Study|Unclassified|2|||
127992987|NCT00110357|460600837|FG000|Overall Study|Deterioration without progression|2|||
127992988|NCT00110357|460600838|FG001|Overall Study|Deterioration without progression|0|||
127992989|NCT00110357|460600837|FG000|Overall Study|Disease progression/relapse|20|||
127992990|NCT00110357|460600838|FG001|Overall Study|Disease progression/relapse|15|||
127992991|NCT00110357|460600837|FG000|Overall Study|Study Closure|1|||
127992992|NCT00110357|460600838|FG001|Overall Study|Study Closure|0|||
127992993|NCT00110357|460600837|FG000|Overall Study|Study Drug Toxicity|1|||
127992994|NCT00110357|460600838|FG001|Overall Study|Study Drug Toxicity|3|||
127992995|NCT00110357|460600837|FG000|Overall Study|Withdrawal by Subject|3|||
127992996|NCT00110357|460600838|FG001|Overall Study|Withdrawal by Subject|1|||
127992997|NCT03382418|460600839|FG000|Overall Study|Withdrawal by Subject|1|||
127992998|NCT03382418|460600840|FG001|Overall Study|Withdrawal by Subject|0|||
127992999|NCT03382418|460600841|FG002|Overall Study|Withdrawal by Subject|0|||
127993000|NCT03382418|460600839|FG000|Overall Study|Lost to Follow-up|2|||
127993001|NCT03382418|460600840|FG001|Overall Study|Lost to Follow-up|3|||
127993002|NCT03382418|460600841|FG002|Overall Study|Lost to Follow-up|0|||
127993003|NCT04633226|460600842|FG000|Overall Study|Withdrawal by parent/guardian|4|||
127993004|NCT04633226|460600842|FG000|Overall Study|Randomized by mistake without study treatment|1|||
127993005|NCT01151345|460600843|FG000|First Intervention Period|Protocol Violation|0|||
127993006|NCT01151345|460600844|FG001|First Intervention Period|Protocol Violation|1|||
127993007|NCT01348100|460600847|FG000|Overall Study|Subject Withdrew Consent|0|||
127993008|NCT01348100|460600848|FG001|Overall Study|Subject Withdrew Consent|0|||
127993009|NCT01348100|460600849|FG002|Overall Study|Subject Withdrew Consent|2|||
127993010|NCT01348100|460600850|FG003|Overall Study|Subject Withdrew Consent|0|||
127993011|NCT01348100|460600851|FG004|Overall Study|Subject Withdrew Consent|1|||
127993012|NCT01348100|460600852|FG005|Overall Study|Subject Withdrew Consent|0|||
127993013|NCT01348100|460600853|FG006|Overall Study|Subject Withdrew Consent|1|||
127993014|NCT01348100|460600847|FG000|Overall Study|Protocol Deviation|0|||
127993015|NCT01348100|460600848|FG001|Overall Study|Protocol Deviation|0|||
127993016|NCT01348100|460600849|FG002|Overall Study|Protocol Deviation|0|||
127993017|NCT01348100|460600850|FG003|Overall Study|Protocol Deviation|1|||
127993018|NCT01348100|460600851|FG004|Overall Study|Protocol Deviation|0|||
127993019|NCT01348100|460600852|FG005|Overall Study|Protocol Deviation|0|||
127993020|NCT01348100|460600853|FG006|Overall Study|Protocol Deviation|0|||
127993021|NCT01348100|460600847|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
127993022|NCT01348100|460600848|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
127993023|NCT01348100|460600849|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
127993024|NCT01348100|460600850|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
127993025|NCT01348100|460600851|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
127993026|NCT01348100|460600852|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
127993027|NCT01348100|460600853|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
127993028|NCT01348100|460600847|FG000|Overall Study|Lost to Follow-up|0|||
127993029|NCT01348100|460600848|FG001|Overall Study|Lost to Follow-up|0|||
127993030|NCT01348100|460600849|FG002|Overall Study|Lost to Follow-up|0|||
127993031|NCT01348100|460600850|FG003|Overall Study|Lost to Follow-up|0|||
127993032|NCT01348100|460600851|FG004|Overall Study|Lost to Follow-up|0|||
127993033|NCT01348100|460600852|FG005|Overall Study|Lost to Follow-up|0|||
127993034|NCT01348100|460600853|FG006|Overall Study|Lost to Follow-up|1|||
127993035|NCT01348100|460600847|FG000|Overall Study|Administrative Problems|0|||
127993036|NCT01348100|460600848|FG001|Overall Study|Administrative Problems|0|||
127993037|NCT01348100|460600849|FG002|Overall Study|Administrative Problems|0|||
127993038|NCT01348100|460600850|FG003|Overall Study|Administrative Problems|0|||
127664831|NCT01474512|459395056|FG016|Long-Term Extension Period|Physician Decision|0|||
127993039|NCT01348100|460600851|FG004|Overall Study|Administrative Problems|0|||
127993040|NCT01348100|460600852|FG005|Overall Study|Administrative Problems|1|||
127993041|NCT01348100|460600853|FG006|Overall Study|Administrative Problems|1|||
127993042|NCT03882957|460600856|FG000|Overall Study|Did not complete all three arms|1|||
127993043|NCT03134911|460600859|FG000|Overall Study|Screen failure|31|||
127993044|NCT03134911|460600859|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
127993045|NCT00420628|460600864|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
127993046|NCT00420628|460600865|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
127993047|NCT00420628|460600864|FG000|Overall Study|Lost to Follow-up|3|||
127993048|NCT00420628|460600865|FG001|Overall Study|Lost to Follow-up|2|||
127993049|NCT00420628|460600864|FG000|Overall Study|Adverse Event|1|||
127993050|NCT00420628|460600865|FG001|Overall Study|Adverse Event|0|||
127993051|NCT00396383|460600870|FG000|Overall Study|Death|2|||
127993052|NCT00396383|460600870|FG000|Overall Study|Lost to Follow-up|1|||
127993053|NCT02787083|460600873|FG000|Overall Study|Adverse Event|1|||
127993054|NCT02787083|460600874|FG001|Overall Study|Adverse Event|0|||
127993055|NCT02787083|460600873|FG000|Overall Study|Withdrawal by Subject|2|||
127993056|NCT02787083|460600874|FG001|Overall Study|Withdrawal by Subject|2|||
127993057|NCT02710084|460600875|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
127993058|NCT02710084|460600876|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
127993059|NCT05305989|460600877|FG000|Overall Study|Other|3|||
127993060|NCT05305989|460600878|FG001|Overall Study|Other|2|||
127993061|NCT05305989|460600879|FG002|Overall Study|Other|0|||
127993062|NCT05305989|460600877|FG000|Overall Study|Sponsor decision|2|||
127993063|NCT05305989|460600878|FG001|Overall Study|Sponsor decision|1|||
127993064|NCT05305989|460600879|FG002|Overall Study|Sponsor decision|0|||
127993065|NCT05305989|460600877|FG000|Overall Study|Protocol Violation|0|||
127993066|NCT05305989|460600878|FG001|Overall Study|Protocol Violation|1|||
127993067|NCT05305989|460600879|FG002|Overall Study|Protocol Violation|0|||
127993068|NCT05305989|460600877|FG000|Overall Study|Investigator decision|1|||
127993069|NCT05305989|460600878|FG001|Overall Study|Investigator decision|2|||
127993070|NCT05305989|460600879|FG002|Overall Study|Investigator decision|0|||
127993071|NCT05305989|460600877|FG000|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|3|||
127993072|NCT05305989|460600878|FG001|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
127993073|NCT05305989|460600879|FG002|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
127993074|NCT05305989|460600877|FG000|Overall Study|Adverse Event|1|||
127993075|NCT05305989|460600878|FG001|Overall Study|Adverse Event|1|||
127993076|NCT05305989|460600879|FG002|Overall Study|Adverse Event|0|||
127993077|NCT05305989|460600877|FG000|Overall Study|Enrolled but never dosed|3|||
127993078|NCT05305989|460600878|FG001|Overall Study|Enrolled but never dosed|2|||
127993079|NCT05305989|460600879|FG002|Overall Study|Enrolled but never dosed|1|||
127993080|NCT03162328|460600880|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
127993081|NCT03162328|460600881|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
127993082|NCT03162328|460600882|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
127993083|NCT03162328|460600880|FG000|Screening Period|Withdrawal by Subject|1|||
127993084|NCT03162328|460600881|FG001|Screening Period|Withdrawal by Subject|0|||
127993085|NCT03162328|460600882|FG002|Screening Period|Withdrawal by Subject|0|||
127993086|NCT03162328|460600880|FG000|Study Period|Withdrawal by Subject|0|||
127993087|NCT03162328|460600881|FG001|Study Period|Withdrawal by Subject|0|||
127993088|NCT03162328|460600882|FG002|Study Period|Withdrawal by Subject|1|||
127993089|NCT00282152|460600883|FG000|Overall Study|Withdrawal by Subject|1|||
127993090|NCT00282152|460600884|FG001|Overall Study|Withdrawal by Subject|0|||
127993091|NCT00585325|460600885|FG000|Overall Study|Withdrawal by Subject|1|||
127993092|NCT00585325|460600886|FG001|Overall Study|Withdrawal by Subject|1|||
127993093|NCT03301831|460600887|FG000|Overall Study|Lost to Follow-up|5|||
127993094|NCT03301831|460600888|FG001|Overall Study|Lost to Follow-up|3|||
127993095|NCT03301831|460600887|FG000|Overall Study|Protocol Violation|4|||
127993096|NCT03301831|460600888|FG001|Overall Study|Protocol Violation|0|||
127993097|NCT03301831|460600887|FG000|Overall Study|Withdrawal by Subject|11|||
127993098|NCT03301831|460600888|FG001|Overall Study|Withdrawal by Subject|0|||
127993099|NCT03092791|460600889|FG000|Overall Study|Lost to Follow-up|0|||
127993100|NCT03092791|460600890|FG001|Overall Study|Lost to Follow-up|0|||
127993101|NCT03092791|460600891|FG002|Overall Study|Lost to Follow-up|0|||
127993102|NCT03092791|460600892|FG003|Overall Study|Lost to Follow-up|0|||
127993103|NCT03092791|460600893|FG004|Overall Study|Lost to Follow-up|0|||
127993104|NCT03092791|460600894|FG005|Overall Study|Lost to Follow-up|0|||
127993105|NCT03092791|460600895|FG006|Overall Study|Lost to Follow-up|1|||
127993106|NCT03092791|460600896|FG007|Overall Study|Lost to Follow-up|0|||
127993107|NCT03092791|460600889|FG000|Overall Study|Withdrawal of Consent|0|||
127993108|NCT03092791|460600890|FG001|Overall Study|Withdrawal of Consent|0|||
127993109|NCT03092791|460600891|FG002|Overall Study|Withdrawal of Consent|0|||
127993110|NCT03092791|460600892|FG003|Overall Study|Withdrawal of Consent|0|||
127664832|NCT01474512|459395057|FG017|Long-Term Extension Period|Physician Decision|0|||
127993111|NCT03092791|460600893|FG004|Overall Study|Withdrawal of Consent|4|||
127993112|NCT03092791|460600894|FG005|Overall Study|Withdrawal of Consent|12|||
127993113|NCT03092791|460600895|FG006|Overall Study|Withdrawal of Consent|6|||
127993114|NCT03092791|460600896|FG007|Overall Study|Withdrawal of Consent|4|||
127993115|NCT03092791|460600889|FG000|Overall Study|Study Termination|0|||
127993116|NCT03092791|460600890|FG001|Overall Study|Study Termination|0|||
127993117|NCT03092791|460600891|FG002|Overall Study|Study Termination|0|||
127993118|NCT03092791|460600892|FG003|Overall Study|Study Termination|0|||
127993119|NCT03092791|460600893|FG004|Overall Study|Study Termination|55|||
127993120|NCT03092791|460600894|FG005|Overall Study|Study Termination|46|||
127993121|NCT03092791|460600895|FG006|Overall Study|Study Termination|53|||
127993122|NCT03092791|460600896|FG007|Overall Study|Study Termination|55|||
127993123|NCT03092791|460600889|FG000|Overall Study|Death|0|||
127993124|NCT03092791|460600890|FG001|Overall Study|Death|0|||
127993125|NCT03092791|460600891|FG002|Overall Study|Death|0|||
127993126|NCT03092791|460600892|FG003|Overall Study|Death|0|||
127993127|NCT03092791|460600893|FG004|Overall Study|Death|0|||
127993128|NCT03092791|460600894|FG005|Overall Study|Death|1|||
127993129|NCT03092791|460600895|FG006|Overall Study|Death|0|||
127993130|NCT03092791|460600896|FG007|Overall Study|Death|1|||
127993131|NCT03092791|460600889|FG000|Overall Study|Reason Not Specified|0|||
127993132|NCT03092791|460600890|FG001|Overall Study|Reason Not Specified|0|||
127993133|NCT03092791|460600891|FG002|Overall Study|Reason Not Specified|0|||
127993134|NCT03092791|460600892|FG003|Overall Study|Reason Not Specified|0|||
127993135|NCT03092791|460600893|FG004|Overall Study|Reason Not Specified|1|||
127993136|NCT03092791|460600894|FG005|Overall Study|Reason Not Specified|1|||
127993137|NCT03092791|460600895|FG006|Overall Study|Reason Not Specified|0|||
127993138|NCT03092791|460600896|FG007|Overall Study|Reason Not Specified|0|||
127993139|NCT02182830|460600898|FG000|Overall Study|Not Treated|1|||
127993140|NCT02182830|460600899|FG001|Overall Study|Not Treated|1|||
127993141|NCT02182830|460600898|FG000|Overall Study|Trial stopped, reason missing|3|||
127993142|NCT02182830|460600899|FG001|Overall Study|Trial stopped, reason missing|3|||
127993143|NCT02182830|460600898|FG000|Overall Study|Consent withdrawn|8|||
127993144|NCT02182830|460600899|FG001|Overall Study|Consent withdrawn|8|||
127993145|NCT02182830|460600898|FG000|Overall Study|Lost to Follow-up|3|||
127993146|NCT02182830|460600899|FG001|Overall Study|Lost to Follow-up|3|||
127993147|NCT00154375|460600900|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
127993148|NCT00154375|460600901|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
127993149|NCT00154375|460600900|FG000|Overall Study|Adverse Event|18|||
127993150|NCT00154375|460600901|FG001|Overall Study|Adverse Event|20|||
127993151|NCT00154375|460600900|FG000|Overall Study|Withdrawal by Subject|14|||
127993152|NCT00154375|460600901|FG001|Overall Study|Withdrawal by Subject|10|||
127993153|NCT00154375|460600900|FG000|Overall Study|Death|5|||
127993154|NCT00154375|460600901|FG001|Overall Study|Death|13|||
127993155|NCT00154375|460600900|FG000|Overall Study|Study drug no longer required|5|||
127993156|NCT00154375|460600901|FG001|Overall Study|Study drug no longer required|3|||
127993157|NCT00154375|460600900|FG000|Overall Study|Lost to Follow-up|2|||
127993158|NCT00154375|460600901|FG001|Overall Study|Lost to Follow-up|1|||
127993159|NCT00154375|460600900|FG000|Overall Study|Abnormal laboratory value(s)|0|||
127993160|NCT00154375|460600901|FG001|Overall Study|Abnormal laboratory value(s)|2|||
127993161|NCT00154375|460600900|FG000|Overall Study|Protocol Violation|0|||
127993162|NCT00154375|460600901|FG001|Overall Study|Protocol Violation|1|||
127993163|NCT00154375|460600900|FG000|Overall Study|Suspected progression of disease|44|||
127993164|NCT00154375|460600901|FG001|Overall Study|Suspected progression of disease|30|||
127993165|NCT02348008|460600902|FG000|Overall Study|Adverse Event|2|||
127993166|NCT02348008|460600903|FG001|Overall Study|Adverse Event|3|||
127993167|NCT02348008|460600904|FG002|Overall Study|Adverse Event|3|||
127993168|NCT02348008|460600902|FG000|Overall Study|Disease Progression|1|||
127993169|NCT02348008|460600903|FG001|Overall Study|Disease Progression|5|||
127993170|NCT02348008|460600904|FG002|Overall Study|Disease Progression|16|||
127993171|NCT02348008|460600902|FG000|Overall Study|Withdrawal by Subject|0|||
127993172|NCT02348008|460600903|FG001|Overall Study|Withdrawal by Subject|1|||
127993173|NCT02348008|460600904|FG002|Overall Study|Withdrawal by Subject|0|||
127993174|NCT02348008|460600902|FG000|Overall Study|Symptomatic Deterioration|0|||
127993175|NCT02348008|460600903|FG001|Overall Study|Symptomatic Deterioration|1|||
127993176|NCT02348008|460600904|FG002|Overall Study|Symptomatic Deterioration|0|||
127993177|NCT00334295|460600909|FG000|Overall Study|Patients received fewer than 3 injection|5|||
127993178|NCT03268005|460600910|FG000|Overall Study|Death|2|||
127993179|NCT03268005|460600911|FG001|Overall Study|Death|1|||
127993180|NCT03268005|460600910|FG000|Overall Study|Lost to Follow-up|2|||
127993181|NCT03268005|460600911|FG001|Overall Study|Lost to Follow-up|2|||
127993182|NCT03268005|460600910|FG000|Overall Study|Withdrawal by Subject|11|||
127993183|NCT03268005|460600911|FG001|Overall Study|Withdrawal by Subject|11|||
127993184|NCT00792116|460600913|FG000|Overall Study|Lost to Follow-up|0|||
127664833|NCT01474512|459395040|FG000|Long-Term Extension Period|Clinical Relapse|0|||
127664834|NCT01474512|459395041|FG001|Long-Term Extension Period|Clinical Relapse|0|||
127993185|NCT00792116|460600914|FG001|Overall Study|Lost to Follow-up|1|||
127993186|NCT00792116|460600913|FG000|Overall Study|Discontnued intervention|1|||
127993187|NCT00792116|460600914|FG001|Overall Study|Discontnued intervention|0|||
127993188|NCT00980655|460600915|FG000|Overall Study|Adverse Event|13|||
127993189|NCT00980655|460600916|FG001|Overall Study|Adverse Event|31|||
127993190|NCT00980655|460600915|FG000|Overall Study|Death|0|||
127993191|NCT00980655|460600916|FG001|Overall Study|Death|7|||
127993192|NCT00980655|460600915|FG000|Overall Study|Protocol Violation|2|||
127993193|NCT00980655|460600916|FG001|Overall Study|Protocol Violation|7|||
127993194|NCT00980655|460600915|FG000|Overall Study|Withdrawal by Subject|0|||
127993195|NCT00980655|460600916|FG001|Overall Study|Withdrawal by Subject|4|||
127993196|NCT00980655|460600915|FG000|Overall Study|Lost to Follow-up|0|||
127993197|NCT00980655|460600916|FG001|Overall Study|Lost to Follow-up|1|||
127993198|NCT00980655|460600915|FG000|Overall Study|Parent/legal guardian request|1|||
127993199|NCT00980655|460600916|FG001|Overall Study|Parent/legal guardian request|0|||
127993200|NCT00980655|460600915|FG000|Overall Study|Other|0|||
127993201|NCT00980655|460600916|FG001|Overall Study|Other|1|||
127993202|NCT00845676|460600922|FG000|Overall Study|Virologic breakthrough at week 20|1|||
127993203|NCT00845676|460600922|FG000|Overall Study|Adverse Event|1|||
127993204|NCT00481767|460600924|FG000|Overall Study|Withdrawal by Subject|16|||
127993205|NCT00481767|460600925|FG001|Overall Study|Withdrawal by Subject|11|||
127993206|NCT00481767|460600924|FG000|Overall Study|Lost to Follow-up|16|||
127993207|NCT00481767|460600925|FG001|Overall Study|Lost to Follow-up|10|||
127993208|NCT01941537|460600926|FG000|Overall Study|Lack of Efficacy|1|||
127993209|NCT01941537|460600927|FG001|Overall Study|Lack of Efficacy|2|||
127993210|NCT01941537|460600926|FG000|Overall Study|Lost to Follow-up|1|||
127993211|NCT01941537|460600927|FG001|Overall Study|Lost to Follow-up|0|||
127993212|NCT01941537|460600926|FG000|Overall Study|Pregnancy|1|||
127993213|NCT01941537|460600927|FG001|Overall Study|Pregnancy|0|||
127993214|NCT01941537|460600926|FG000|Overall Study|Adverse Event|1|||
127993215|NCT01941537|460600927|FG001|Overall Study|Adverse Event|0|||
127993216|NCT01941537|460600926|FG000|Overall Study|Withdrawal by Subject|0|||
127993217|NCT01941537|460600927|FG001|Overall Study|Withdrawal by Subject|1|||
127993218|NCT02557516|460600929|FG000|Overall Study|Adverse Event|1|||
127993219|NCT02557516|460600930|FG001|Overall Study|Adverse Event|0|||
127993220|NCT02557516|460600931|FG002|Overall Study|Adverse Event|2|||
127993221|NCT02557516|460600932|FG003|Overall Study|Adverse Event|1|||
127993222|NCT02557516|460600929|FG000|Overall Study|Disease progression|0|||
127993223|NCT02557516|460600930|FG001|Overall Study|Disease progression|2|||
127993224|NCT02557516|460600931|FG002|Overall Study|Disease progression|0|||
127993225|NCT02557516|460600932|FG003|Overall Study|Disease progression|0|||
127993226|NCT02557516|460600929|FG000|Overall Study|Physician Decision|0|||
127993227|NCT02557516|460600930|FG001|Overall Study|Physician Decision|2|||
127993228|NCT02557516|460600931|FG002|Overall Study|Physician Decision|0|||
127993229|NCT02557516|460600932|FG003|Overall Study|Physician Decision|0|||
127993230|NCT02557516|460600929|FG000|Overall Study|Sponsor decision|0|||
127993231|NCT02557516|460600930|FG001|Overall Study|Sponsor decision|1|||
127993232|NCT02557516|460600931|FG002|Overall Study|Sponsor decision|2|||
127993233|NCT02557516|460600932|FG003|Overall Study|Sponsor decision|8|||
127993234|NCT01025284|460602637|FG000|Overall Study|Investigator Decision|0|||
127993235|NCT01025284|460602638|FG001|Overall Study|Investigator Decision|1|||
127993236|NCT01025284|460602639|FG002|Overall Study|Investigator Decision|0|||
127993237|NCT01025284|460602637|FG000|Overall Study|Withdrawal by Subject|0|||
127993238|NCT01025284|460602638|FG001|Overall Study|Withdrawal by Subject|1|||
127993239|NCT01025284|460602639|FG002|Overall Study|Withdrawal by Subject|0|||
127993240|NCT00905567|460602640|FG000|Washout|Withdrawal by Subject|0|||
127993241|NCT00905567|460602641|FG001|Washout|Withdrawal by Subject|1|||
127993242|NCT02542397|460602642|FG000|Overall Study|Death|2|||
127993243|NCT02542397|460602642|FG000|Overall Study|Physician Decision|6|||
127993244|NCT02542397|460602642|FG000|Overall Study|Withdrawal by Subject|6|||
127993245|NCT02542397|460602642|FG000|Overall Study|Lost to Follow-up|2|||
127993246|NCT02630563|460602649|FG000|Overall Study|Administrative|1|||
127993247|NCT02239640|460602652|FG000|Overall Study|Withdrawal by Subject|3|||
127993248|NCT02239640|460602652|FG000|Overall Study|Lost to Follow-up|72|||
127993249|NCT02239640|460602652|FG000|Overall Study|Death|142|||
127993250|NCT00621257|460602653|FG000|Overall Study|Lost to Follow-up|4|||
127993251|NCT00621257|460602654|FG001|Overall Study|Lost to Follow-up|0|||
127993252|NCT00621257|460602655|FG002|Overall Study|Lost to Follow-up|2|||
127993253|NCT00621257|460602656|FG003|Overall Study|Lost to Follow-up|4|||
127993254|NCT00621257|460602657|FG004|Overall Study|Lost to Follow-up|7|||
127993255|NCT00621257|460602653|FG000|Overall Study|Adverse Event|0|||
127993256|NCT00621257|460602654|FG001|Overall Study|Adverse Event|1|||
127993257|NCT00621257|460602655|FG002|Overall Study|Adverse Event|1|||
127993258|NCT00621257|460602656|FG003|Overall Study|Adverse Event|0|||
127993259|NCT00621257|460602657|FG004|Overall Study|Adverse Event|0|||
127993260|NCT00621257|460602653|FG000|Overall Study|Physician Decision|0|||
127993261|NCT00621257|460602654|FG001|Overall Study|Physician Decision|2|||
127664835|NCT01474512|459395042|FG002|Long-Term Extension Period|Clinical Relapse|0|||
127993262|NCT00621257|460602655|FG002|Overall Study|Physician Decision|0|||
127993263|NCT00621257|460602656|FG003|Overall Study|Physician Decision|1|||
127993264|NCT00621257|460602657|FG004|Overall Study|Physician Decision|1|||
127993265|NCT00621257|460602653|FG000|Overall Study|Withdrawal by Subject|0|||
127993266|NCT00621257|460602654|FG001|Overall Study|Withdrawal by Subject|0|||
127993267|NCT00621257|460602655|FG002|Overall Study|Withdrawal by Subject|0|||
127993268|NCT00621257|460602656|FG003|Overall Study|Withdrawal by Subject|1|||
127993269|NCT00621257|460602657|FG004|Overall Study|Withdrawal by Subject|1|||
127993270|NCT01255904|460602658|FG000|Overall Study|Physician Decision|1|||
127993271|NCT01255904|460602659|FG001|Overall Study|Physician Decision|4|||
127993272|NCT02061813|460602660|FG000|Overall Study|Withdrawal by Subject|1|||
127993273|NCT02061813|460602660|FG000|Overall Study|Protocol Violation|2|||
127993274|NCT01705080|460602663|FG000|Overall Study|Missed visit|10|||
127993275|NCT01705080|460602664|FG001|Overall Study|Missed visit|4|||
127993276|NCT01705080|460602665|FG002|Overall Study|Missed visit|1|||
127993277|NCT01705080|460602663|FG000|Overall Study|Death|4|||
127993278|NCT01705080|460602664|FG001|Overall Study|Death|4|||
127993279|NCT01705080|460602665|FG002|Overall Study|Death|6|||
127993280|NCT01705080|460602663|FG000|Overall Study|Withdrawal by Subject|61|||
127993281|NCT01705080|460602664|FG001|Overall Study|Withdrawal by Subject|44|||
127993282|NCT01705080|460602665|FG002|Overall Study|Withdrawal by Subject|9|||
127993283|NCT00206427|460602667|FG000|Overall Study|Adverse Event|2|||
127993284|NCT03130959|460602683|FG000|Overall Study|Disease progression|19|||
127993285|NCT03130959|460602684|FG001|Overall Study|Disease progression|7|||
127993286|NCT03130959|460602685|FG002|Overall Study|Disease progression|12|||
127993287|NCT03130959|460602686|FG003|Overall Study|Disease progression|7|||
127993288|NCT03130959|460602687|FG004|Overall Study|Disease progression|12|||
127993289|NCT03130959|460602688|FG005|Overall Study|Disease progression|3|||
127993290|NCT03130959|460602689|FG006|Overall Study|Disease progression|6|||
127993291|NCT03130959|460602690|FG007|Overall Study|Disease progression|3|||
127993292|NCT03130959|460602691|FG008|Overall Study|Disease progression|15|||
127993293|NCT03130959|460602692|FG009|Overall Study|Disease progression|8|||
127993294|NCT03130959|460602683|FG000|Overall Study|Study drug toxicity|2|||
127993295|NCT03130959|460602684|FG001|Overall Study|Study drug toxicity|2|||
127993296|NCT03130959|460602685|FG002|Overall Study|Study drug toxicity|1|||
127993297|NCT03130959|460602686|FG003|Overall Study|Study drug toxicity|2|||
127993298|NCT03130959|460602687|FG004|Overall Study|Study drug toxicity|1|||
127993299|NCT03130959|460602688|FG005|Overall Study|Study drug toxicity|1|||
127993300|NCT03130959|460602689|FG006|Overall Study|Study drug toxicity|3|||
127993301|NCT03130959|460602690|FG007|Overall Study|Study drug toxicity|0|||
127993302|NCT03130959|460602691|FG008|Overall Study|Study drug toxicity|3|||
127993303|NCT03130959|460602692|FG009|Overall Study|Study drug toxicity|3|||
127993304|NCT03130959|460602683|FG000|Overall Study|Other reasons|0|||
127993305|NCT03130959|460602684|FG001|Overall Study|Other reasons|0|||
127993306|NCT03130959|460602685|FG002|Overall Study|Other reasons|0|||
127993307|NCT03130959|460602686|FG003|Overall Study|Other reasons|0|||
127993308|NCT03130959|460602687|FG004|Overall Study|Other reasons|0|||
127993309|NCT03130959|460602688|FG005|Overall Study|Other reasons|1|||
127993310|NCT03130959|460602689|FG006|Overall Study|Other reasons|1|||
127993311|NCT03130959|460602690|FG007|Overall Study|Other reasons|0|||
127993312|NCT03130959|460602691|FG008|Overall Study|Other reasons|0|||
127993313|NCT03130959|460602692|FG009|Overall Study|Other reasons|0|||
127993314|NCT03130959|460602683|FG000|Overall Study|Subject request to discontinue therapy|0|||
127993315|NCT03130959|460602684|FG001|Overall Study|Subject request to discontinue therapy|0|||
127993316|NCT03130959|460602685|FG002|Overall Study|Subject request to discontinue therapy|1|||
127993317|NCT03130959|460602686|FG003|Overall Study|Subject request to discontinue therapy|1|||
127993318|NCT03130959|460602687|FG004|Overall Study|Subject request to discontinue therapy|0|||
127993319|NCT03130959|460602688|FG005|Overall Study|Subject request to discontinue therapy|0|||
127993320|NCT03130959|460602689|FG006|Overall Study|Subject request to discontinue therapy|1|||
127993321|NCT03130959|460602690|FG007|Overall Study|Subject request to discontinue therapy|1|||
127993322|NCT03130959|460602691|FG008|Overall Study|Subject request to discontinue therapy|0|||
127993323|NCT03130959|460602692|FG009|Overall Study|Subject request to discontinue therapy|0|||
127993324|NCT03130959|460602683|FG000|Overall Study|Not reported|0|||
127993325|NCT03130959|460602684|FG001|Overall Study|Not reported|0|||
127993326|NCT03130959|460602685|FG002|Overall Study|Not reported|0|||
127993327|NCT03130959|460602686|FG003|Overall Study|Not reported|1|||
127993328|NCT03130959|460602687|FG004|Overall Study|Not reported|0|||
127993329|NCT03130959|460602688|FG005|Overall Study|Not reported|1|||
127993330|NCT03130959|460602689|FG006|Overall Study|Not reported|0|||
127993331|NCT03130959|460602690|FG007|Overall Study|Not reported|0|||
127664836|NCT01474512|459395043|FG003|Long-Term Extension Period|Clinical Relapse|0|||
127664837|NCT01474512|459395044|FG004|Long-Term Extension Period|Clinical Relapse|0|||
127664838|NCT01474512|459395045|FG005|Long-Term Extension Period|Clinical Relapse|0|||
127664839|NCT01474512|459395046|FG006|Long-Term Extension Period|Clinical Relapse|0|||
127664840|NCT01474512|459395047|FG007|Long-Term Extension Period|Clinical Relapse|0|||
127664841|NCT01474512|459395048|FG008|Long-Term Extension Period|Clinical Relapse|0|||
127664842|NCT01474512|459395049|FG009|Long-Term Extension Period|Clinical Relapse|0|||
127664843|NCT01474512|459395050|FG010|Long-Term Extension Period|Clinical Relapse|0|||
127664844|NCT01474512|459395051|FG011|Long-Term Extension Period|Clinical Relapse|0|||
127993332|NCT03130959|460602691|FG008|Overall Study|Not reported|0|||
127993333|NCT03130959|460602692|FG009|Overall Study|Not reported|1|||
127993334|NCT03130959|460602683|FG000|Overall Study|Adverse Event unrelated to drug|0|||
127993335|NCT03130959|460602684|FG001|Overall Study|Adverse Event unrelated to drug|0|||
127993336|NCT03130959|460602685|FG002|Overall Study|Adverse Event unrelated to drug|1|||
127993337|NCT03130959|460602686|FG003|Overall Study|Adverse Event unrelated to drug|1|||
127993338|NCT03130959|460602687|FG004|Overall Study|Adverse Event unrelated to drug|1|||
127993339|NCT03130959|460602688|FG005|Overall Study|Adverse Event unrelated to drug|0|||
127993340|NCT03130959|460602689|FG006|Overall Study|Adverse Event unrelated to drug|1|||
127664845|NCT01474512|459395052|FG012|Long-Term Extension Period|Clinical Relapse|9|||
127993341|NCT03130959|460602690|FG007|Overall Study|Adverse Event unrelated to drug|0|||
127993342|NCT03130959|460602691|FG008|Overall Study|Adverse Event unrelated to drug|1|||
127993343|NCT03130959|460602692|FG009|Overall Study|Adverse Event unrelated to drug|1|||
127993344|NCT03130959|460602683|FG000|Overall Study|Participant withdrew consent|0|||
127993345|NCT03130959|460602684|FG001|Overall Study|Participant withdrew consent|1|||
127993346|NCT03130959|460602685|FG002|Overall Study|Participant withdrew consent|0|||
127993347|NCT03130959|460602686|FG003|Overall Study|Participant withdrew consent|2|||
127993348|NCT03130959|460602687|FG004|Overall Study|Participant withdrew consent|1|||
127993349|NCT03130959|460602688|FG005|Overall Study|Participant withdrew consent|0|||
127993350|NCT03130959|460602689|FG006|Overall Study|Participant withdrew consent|0|||
127993351|NCT03130959|460602690|FG007|Overall Study|Participant withdrew consent|0|||
127993352|NCT03130959|460602691|FG008|Overall Study|Participant withdrew consent|0|||
127993353|NCT03130959|460602692|FG009|Overall Study|Participant withdrew consent|2|||
127993354|NCT03130959|460602683|FG000|Overall Study|Administrative reason by sponsor|1|||
127993355|NCT03130959|460602684|FG001|Overall Study|Administrative reason by sponsor|0|||
127993356|NCT03130959|460602685|FG002|Overall Study|Administrative reason by sponsor|1|||
127993357|NCT03130959|460602686|FG003|Overall Study|Administrative reason by sponsor|0|||
127993358|NCT03130959|460602687|FG004|Overall Study|Administrative reason by sponsor|0|||
127993359|NCT03130959|460602688|FG005|Overall Study|Administrative reason by sponsor|0|||
127993360|NCT03130959|460602689|FG006|Overall Study|Administrative reason by sponsor|0|||
127993361|NCT03130959|460602690|FG007|Overall Study|Administrative reason by sponsor|0|||
127993362|NCT03130959|460602691|FG008|Overall Study|Administrative reason by sponsor|0|||
127993363|NCT03130959|460602692|FG009|Overall Study|Administrative reason by sponsor|0|||
127993364|NCT03130959|460602683|FG000|Overall Study|Lost to Follow-up|1|||
127993365|NCT03130959|460602684|FG001|Overall Study|Lost to Follow-up|0|||
127993366|NCT03130959|460602685|FG002|Overall Study|Lost to Follow-up|0|||
127993367|NCT03130959|460602686|FG003|Overall Study|Lost to Follow-up|0|||
127993368|NCT03130959|460602687|FG004|Overall Study|Lost to Follow-up|0|||
127993369|NCT03130959|460602688|FG005|Overall Study|Lost to Follow-up|0|||
127993370|NCT03130959|460602689|FG006|Overall Study|Lost to Follow-up|0|||
127993371|NCT03130959|460602690|FG007|Overall Study|Lost to Follow-up|0|||
127993372|NCT03130959|460602691|FG008|Overall Study|Lost to Follow-up|0|||
127993373|NCT03130959|460602692|FG009|Overall Study|Lost to Follow-up|0|||
127993374|NCT02384538|460602693|FG000|Overall Study|Adverse Event|1|||
127993375|NCT02384538|460602694|FG001|Overall Study|Adverse Event|4|||
127993376|NCT02384538|460602693|FG000|Overall Study|Lack of Efficacy|4|||
127993377|NCT02384538|460602694|FG001|Overall Study|Lack of Efficacy|4|||
127993378|NCT02384538|460602693|FG000|Overall Study|Withdrew Consent|0|||
127993379|NCT02384538|460602694|FG001|Overall Study|Withdrew Consent|4|||
127993380|NCT02384538|460602693|FG000|Overall Study|Other|1|||
127993381|NCT02384538|460602694|FG001|Overall Study|Other|3|||
127993382|NCT00313586|460602697|FG000|Overall Study|Disease progression|14|||
127993383|NCT00313586|460602698|FG001|Overall Study|Disease progression|19|||
127993384|NCT00313586|460602699|FG002|Overall Study|Disease progression|10|||
127993385|NCT00313586|460602700|FG003|Overall Study|Disease progression|3|||
127993386|NCT00313586|460602697|FG000|Overall Study|Adverse Event|12|||
127993387|NCT00313586|460602698|FG001|Overall Study|Adverse Event|18|||
127993388|NCT00313586|460602699|FG002|Overall Study|Adverse Event|3|||
127993389|NCT00313586|460602700|FG003|Overall Study|Adverse Event|10|||
127993390|NCT00313586|460602697|FG000|Overall Study|Death|11|||
127993391|NCT00313586|460602698|FG001|Overall Study|Death|8|||
127993392|NCT00313586|460602699|FG002|Overall Study|Death|1|||
127993393|NCT00313586|460602700|FG003|Overall Study|Death|7|||
127993394|NCT00313586|460602697|FG000|Overall Study|Withdrawal by Subject|13|||
127993395|NCT00313586|460602698|FG001|Overall Study|Withdrawal by Subject|6|||
127993396|NCT00313586|460602699|FG002|Overall Study|Withdrawal by Subject|6|||
127993397|NCT00313586|460602700|FG003|Overall Study|Withdrawal by Subject|2|||
127993398|NCT00313586|460602697|FG000|Overall Study|Alternative therapy|3|||
127993399|NCT00313586|460602698|FG001|Overall Study|Alternative therapy|6|||
127993400|NCT00313586|460602699|FG002|Overall Study|Alternative therapy|2|||
127993401|NCT00313586|460602700|FG003|Overall Study|Alternative therapy|0|||
127993402|NCT00313586|460602697|FG000|Overall Study|Other complicating disease|2|||
127993403|NCT00313586|460602698|FG001|Overall Study|Other complicating disease|2|||
127993404|NCT00313586|460602699|FG002|Overall Study|Other complicating disease|0|||
127993405|NCT00313586|460602700|FG003|Overall Study|Other complicating disease|0|||
127993406|NCT00313586|460602697|FG000|Overall Study|Did not achieve HI-major/better response|10|||
127993407|NCT00313586|460602698|FG001|Overall Study|Did not achieve HI-major/better response|7|||
127993408|NCT00313586|460602699|FG002|Overall Study|Did not achieve HI-major/better response|2|||
127993409|NCT00313586|460602700|FG003|Overall Study|Did not achieve HI-major/better response|1|||
127993410|NCT00313586|460602697|FG000|Overall Study|Physician Decision|2|||
127993411|NCT00313586|460602698|FG001|Overall Study|Physician Decision|1|||
127993412|NCT00313586|460602699|FG002|Overall Study|Physician Decision|0|||
127993413|NCT00313586|460602700|FG003|Overall Study|Physician Decision|0|||
127993414|NCT00313586|460602697|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
127993415|NCT00313586|460602698|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
127993416|NCT00313586|460602699|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
127664846|NCT01474512|459395053|FG013|Long-Term Extension Period|Clinical Relapse|9|||
127664847|NCT01474512|459395054|FG014|Long-Term Extension Period|Clinical Relapse|0|||
127664848|NCT01474512|459395055|FG015|Long-Term Extension Period|Clinical Relapse|0|||
127664849|NCT01474512|459395056|FG016|Long-Term Extension Period|Clinical Relapse|0|||
127664850|NCT01474512|459395057|FG017|Long-Term Extension Period|Clinical Relapse|0|||
127664851|NCT01474512|459395040|FG000|Long-Term Extension Period|Death|0|||
127664852|NCT01474512|459395041|FG001|Long-Term Extension Period|Death|0|||
127664853|NCT01474512|459395042|FG002|Long-Term Extension Period|Death|0|||
127664854|NCT01474512|459395043|FG003|Long-Term Extension Period|Death|0|||
127664855|NCT01474512|459395044|FG004|Long-Term Extension Period|Death|0|||
127664856|NCT01474512|459395045|FG005|Long-Term Extension Period|Death|0|||
127664857|NCT01474512|459395046|FG006|Long-Term Extension Period|Death|0|||
127664858|NCT01474512|459395047|FG007|Long-Term Extension Period|Death|0|||
127664859|NCT01474512|459395048|FG008|Long-Term Extension Period|Death|0|||
127880765|NCT04071366|460186032|FG003|Part 1: Open-label (29 Days)|Death|0|||
127880766|NCT04071366|460186033|FG004|Part 1: Open-label (29 Days)|Death|0|||
127880767|NCT04071366|460186029|FG000|Part 1: Open-label (29 Days)|Progressive Disease|0|||
127880768|NCT04071366|460186030|FG001|Part 1: Open-label (29 Days)|Progressive Disease|0|||
127880769|NCT04071366|460186031|FG002|Part 1: Open-label (29 Days)|Progressive Disease|4|||
127880770|NCT04071366|460186032|FG003|Part 1: Open-label (29 Days)|Progressive Disease|0|||
127880771|NCT04071366|460186033|FG004|Part 1: Open-label (29 Days)|Progressive Disease|0|||
127880772|NCT04071366|460186029|FG000|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
127880773|NCT04071366|460186030|FG001|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
127880774|NCT04071366|460186031|FG002|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
127880775|NCT04071366|460186032|FG003|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
127880776|NCT04071366|460186033|FG004|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
127880777|NCT04071366|460186029|FG000|Part 2: Randomized (29 Days)|Death|0|||
127880778|NCT04071366|460186030|FG001|Part 2: Randomized (29 Days)|Death|0|||
127880779|NCT04071366|460186031|FG002|Part 2: Randomized (29 Days)|Death|0|||
127880780|NCT04071366|460186032|FG003|Part 2: Randomized (29 Days)|Death|2|||
127880781|NCT04071366|460186033|FG004|Part 2: Randomized (29 Days)|Death|2|||
127880782|NCT04071366|460186029|FG000|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
127880783|NCT04071366|460186030|FG001|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
127880784|NCT04071366|460186031|FG002|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
127880785|NCT04071366|460186032|FG003|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
127880786|NCT04071366|460186033|FG004|Part 2: Randomized (29 Days)|Lost to Follow-up|1|||
127880787|NCT04071366|460186029|FG000|Part 2: Randomized (29 Days)|Physician Decision|0|||
127880788|NCT04071366|460186030|FG001|Part 2: Randomized (29 Days)|Physician Decision|0|||
127880789|NCT04071366|460186031|FG002|Part 2: Randomized (29 Days)|Physician Decision|0|||
127880790|NCT04071366|460186032|FG003|Part 2: Randomized (29 Days)|Physician Decision|0|||
127880791|NCT04071366|460186033|FG004|Part 2: Randomized (29 Days)|Physician Decision|1|||
127880792|NCT04071366|460186029|FG000|Part 2: Randomized (29 Days)|Progressive Disease|0|||
127880793|NCT04071366|460186030|FG001|Part 2: Randomized (29 Days)|Progressive Disease|0|||
127880794|NCT04071366|460186031|FG002|Part 2: Randomized (29 Days)|Progressive Disease|0|||
127880795|NCT04071366|460186032|FG003|Part 2: Randomized (29 Days)|Progressive Disease|2|||
127880796|NCT04071366|460186033|FG004|Part 2: Randomized (29 Days)|Progressive Disease|4|||
127880797|NCT04071366|460186029|FG000|Part 2: Randomized (29 Days)|Protocol Violation|0|||
127880798|NCT04071366|460186030|FG001|Part 2: Randomized (29 Days)|Protocol Violation|0|||
127880799|NCT04071366|460186031|FG002|Part 2: Randomized (29 Days)|Protocol Violation|0|||
127880800|NCT04071366|460186032|FG003|Part 2: Randomized (29 Days)|Protocol Violation|0|||
127880801|NCT04071366|460186033|FG004|Part 2: Randomized (29 Days)|Protocol Violation|1|||
127880802|NCT04071366|460186029|FG000|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
127880803|NCT04071366|460186030|FG001|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
127880804|NCT04071366|460186031|FG002|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
127880805|NCT04071366|460186032|FG003|Part 2: Randomized (29 Days)|Withdrawal by Subject|1|||
127880806|NCT04071366|460186033|FG004|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
127880807|NCT04071366|460186029|FG000|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
127880808|NCT04071366|460186030|FG001|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
127880809|NCT04071366|460186031|FG002|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
127880810|NCT04071366|460186032|FG003|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|1|||
127880811|NCT04071366|460186033|FG004|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
127880812|NCT00021229|460186034|FG000|Overall Study|Adverse Event|10|||
127880813|NCT00021229|460186035|FG001|Overall Study|Adverse Event|5|||
127880814|NCT00021229|460186036|FG002|Overall Study|Adverse Event|2|||
127880815|NCT00021229|460186034|FG000|Overall Study|Death|0|||
127880816|NCT00021229|460186035|FG001|Overall Study|Death|1|||
127880817|NCT00021229|460186036|FG002|Overall Study|Death|0|||
127880818|NCT00021229|460186034|FG000|Overall Study|Withdrawal by Subject|7|||
127880819|NCT00021229|460186035|FG001|Overall Study|Withdrawal by Subject|7|||
127880820|NCT00021229|460186036|FG002|Overall Study|Withdrawal by Subject|1|||
127880821|NCT00021229|460186034|FG000|Overall Study|Progressive Disease|15|||
127993417|NCT00313586|460602700|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
127993418|NCT00313586|460602697|FG000|Overall Study|Lost insurance|0|||
127993419|NCT00313586|460602698|FG001|Overall Study|Lost insurance|1|||
127993420|NCT00313586|460602699|FG002|Overall Study|Lost insurance|0|||
127993421|NCT00313586|460602700|FG003|Overall Study|Lost insurance|0|||
127993422|NCT00313586|460602697|FG000|Overall Study|Moved|0|||
127993423|NCT00313586|460602698|FG001|Overall Study|Moved|1|||
127993424|NCT00313586|460602699|FG002|Overall Study|Moved|0|||
127993425|NCT00313586|460602700|FG003|Overall Study|Moved|0|||
127993426|NCT00313586|460602697|FG000|Overall Study|Death before starting treatment|1|||
127993427|NCT00313586|460602698|FG001|Overall Study|Death before starting treatment|0|||
127993428|NCT00313586|460602699|FG002|Overall Study|Death before starting treatment|0|||
127993429|NCT00313586|460602700|FG003|Overall Study|Death before starting treatment|0|||
127993430|NCT03076996|460602701|FG000|Overall Study|Withdrawal by Subject|2|||
127993431|NCT03076996|460602701|FG000|Overall Study|Lost to Follow-up|3|||
127993432|NCT03076996|460602701|FG000|Overall Study|Literacy precluded participation|1|||
127993433|NCT03117361|460602702|FG000|Overall Study|Progressive disease|5|||
127993434|NCT03117361|460602702|FG000|Overall Study|Death|1|||
127993435|NCT03117361|460602702|FG000|Overall Study|Physician Decision|2|||
127993436|NCT03117361|460602702|FG000|Overall Study|On study treatment at the end of study|1|||
127993437|NCT03117361|460602702|FG000|Overall Study|Treatment-related adverse event|1|||
127993438|NCT03280056|460602707|FG000|Overall Study|Withdrawal by Subject|12|||
127993439|NCT03280056|460602708|FG001|Overall Study|Withdrawal by Subject|14|||
127993440|NCT03280056|460602707|FG000|Overall Study|Death|9|||
127993441|NCT03280056|460602708|FG001|Overall Study|Death|2|||
127993442|NCT03280056|460602707|FG000|Overall Study|Adverse Event|1|||
127993443|NCT03280056|460602708|FG001|Overall Study|Adverse Event|3|||
127993444|NCT03280056|460602707|FG000|Overall Study|Lost to Follow-up|1|||
127993445|NCT03280056|460602708|FG001|Overall Study|Lost to Follow-up|1|||
127993446|NCT03280056|460602707|FG000|Overall Study|Physician Decision|0|||
127993447|NCT03280056|460602708|FG001|Overall Study|Physician Decision|1|||
127993448|NCT03280056|460602707|FG000|Overall Study|Early Discontinuation|1|||
127993449|NCT03280056|460602708|FG001|Overall Study|Early Discontinuation|0|||
127993450|NCT02144077|460602709|FG000|Overall Study|Withdrawal by Subject|3|||
127993451|NCT02144077|460602710|FG001|Overall Study|Withdrawal by Subject|3|||
127993452|NCT02144077|460602709|FG000|Overall Study|Adverse Event|2|||
127993453|NCT02144077|460602710|FG001|Overall Study|Adverse Event|3|||
127993454|NCT02144077|460602709|FG000|Overall Study|Lost to Follow-up|2|||
127993455|NCT02144077|460602710|FG001|Overall Study|Lost to Follow-up|2|||
127993456|NCT02144077|460602709|FG000|Overall Study|Protocol Violation|1|||
127993457|NCT02144077|460602710|FG001|Overall Study|Protocol Violation|2|||
127993458|NCT02144077|460602709|FG000|Overall Study|Death|0|||
127993459|NCT02144077|460602710|FG001|Overall Study|Death|1|||
127993460|NCT02144077|460602709|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
127993461|NCT02144077|460602710|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
127993462|NCT00610168|460602711|FG000|Overall Study|Withdrawal by Subject|2|||
127993463|NCT00610168|460602712|FG001|Overall Study|Withdrawal by Subject|0|||
127993464|NCT00943592|460602713|FG000|Overall Study|Death|3|||
127993465|NCT01247350|460602714|FG000|Overall Study|Adverse Event|0|||
127993466|NCT01247350|460602715|FG001|Overall Study|Adverse Event|0|||
127993467|NCT01247350|460602716|FG002|Overall Study|Adverse Event|1|||
127993468|NCT01247350|460602717|FG003|Overall Study|Adverse Event|0|||
127993469|NCT01247350|460602718|FG004|Overall Study|Adverse Event|0|||
127993470|NCT01247350|460602714|FG000|Overall Study|Withdrawal by Subject|0|||
127993471|NCT01247350|460602715|FG001|Overall Study|Withdrawal by Subject|0|||
127993472|NCT01247350|460602716|FG002|Overall Study|Withdrawal by Subject|0|||
127993473|NCT01247350|460602717|FG003|Overall Study|Withdrawal by Subject|1|||
127993474|NCT01247350|460602718|FG004|Overall Study|Withdrawal by Subject|0|||
127993475|NCT01247350|460602714|FG000|Overall Study|Entry criteria not met|0|||
127993476|NCT01247350|460602715|FG001|Overall Study|Entry criteria not met|0|||
127993477|NCT01247350|460602716|FG002|Overall Study|Entry criteria not met|0|||
127993478|NCT01247350|460602717|FG003|Overall Study|Entry criteria not met|0|||
127993479|NCT01247350|460602718|FG004|Overall Study|Entry criteria not met|1|||
127993480|NCT00169104|460602719|FG000|Overall Study|Withdrawal by Subject|2|||
127993481|NCT00169104|460602720|FG001|Overall Study|Withdrawal by Subject|0|||
127993482|NCT00169104|460602719|FG000|Overall Study|Protocol Violation|0|||
127993483|NCT00169104|460602720|FG001|Overall Study|Protocol Violation|1|||
127993484|NCT00169104|460602719|FG000|Overall Study|Physician Decision|0|||
127993485|NCT00169104|460602720|FG001|Overall Study|Physician Decision|1|||
127993486|NCT01540981|460602726|FG000|Overall Study|Withdrawal by Subject|1|||
127664860|NCT01474512|459395049|FG009|Long-Term Extension Period|Death|0|||
127993487|NCT01540981|460602727|FG001|Overall Study|Withdrawal by Subject|0|||
127993488|NCT00141518|460602730|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
127993489|NCT00141518|460602731|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
127993490|NCT00141518|460602732|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
127993491|NCT00141518|460602730|FG000|Overall Study|Adverse Event|7|||
127993492|NCT00141518|460602731|FG001|Overall Study|Adverse Event|5|||
127993493|NCT00141518|460602732|FG002|Overall Study|Adverse Event|2|||
127993494|NCT00141518|460602730|FG000|Overall Study|Withdrawal by Subject|2|||
127993495|NCT00141518|460602731|FG001|Overall Study|Withdrawal by Subject|0|||
127993496|NCT00141518|460602732|FG002|Overall Study|Withdrawal by Subject|2|||
127993497|NCT00141518|460602730|FG000|Overall Study|Protocol Violation|1|||
127993498|NCT00141518|460602731|FG001|Overall Study|Protocol Violation|1|||
127993499|NCT00141518|460602732|FG002|Overall Study|Protocol Violation|2|||
127993500|NCT00141518|460602730|FG000|Overall Study|Lack of Efficacy|5|||
127993501|NCT00141518|460602731|FG001|Overall Study|Lack of Efficacy|0|||
127993502|NCT00141518|460602732|FG002|Overall Study|Lack of Efficacy|0|||
127993503|NCT01806168|460602733|FG000|Overall Study|Adverse Event|1|||
127993504|NCT01806168|460602734|FG001|Overall Study|Adverse Event|0|||
127993505|NCT01806168|460602735|FG002|Overall Study|Adverse Event|0|||
127993506|NCT01806168|460602733|FG000|Overall Study|Withdrawal by Subject|0|||
127993507|NCT01806168|460602734|FG001|Overall Study|Withdrawal by Subject|1|||
127993508|NCT01806168|460602735|FG002|Overall Study|Withdrawal by Subject|2|||
127993509|NCT01806168|460602733|FG000|Overall Study|Protocol Violation|0|||
127993510|NCT01806168|460602734|FG001|Overall Study|Protocol Violation|0|||
127993511|NCT01806168|460602735|FG002|Overall Study|Protocol Violation|1|||
127993512|NCT01029262|460602738|FG000|Overall Study|Adverse Event|9|||
127993513|NCT01029262|460602739|FG001|Overall Study|Adverse Event|52|||
127993514|NCT01029262|460602738|FG000|Overall Study|Lack of therapeutic effect|57|||
127993515|NCT01029262|460602739|FG001|Overall Study|Lack of therapeutic effect|76|||
127664861|NCT01474512|459395050|FG010|Long-Term Extension Period|Death|0|||
127993516|NCT01029262|460602738|FG000|Overall Study|Withdrawal by Subject|10|||
127993517|NCT01029262|460602739|FG001|Overall Study|Withdrawal by Subject|17|||
127993518|NCT01029262|460602738|FG000|Overall Study|Protocol Violation|2|||
127993519|NCT01029262|460602739|FG001|Overall Study|Protocol Violation|3|||
127993520|NCT01029262|460602738|FG000|Overall Study|Miscellaneous|1|||
127993521|NCT01029262|460602739|FG001|Overall Study|Miscellaneous|9|||
127993522|NCT01029262|460602738|FG000|Overall Study|Death|0|||
127993523|NCT01029262|460602739|FG001|Overall Study|Death|3|||
127993524|NCT03410992|460602742|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
127993525|NCT03410992|460602743|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
127993526|NCT03410992|460602744|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
127993527|NCT03410992|460602745|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
127993528|NCT03410992|460602746|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
127993529|NCT03410992|460602747|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
127993530|NCT03410992|460602748|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
127993531|NCT03410992|460602749|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
127993532|NCT03410992|460602750|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
127993533|NCT03410992|460602751|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
127993534|NCT03410992|460602752|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
127993535|NCT03410992|460602742|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
127993536|NCT03410992|460602743|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
127993537|NCT03410992|460602744|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
127993538|NCT03410992|460602745|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
127993539|NCT03410992|460602746|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
127993540|NCT03410992|460602747|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
127993541|NCT03410992|460602748|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
127993542|NCT03410992|460602749|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
127993543|NCT03410992|460602750|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
127993544|NCT03410992|460602751|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
127993545|NCT03410992|460602752|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
127993546|NCT03410992|460602742|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
127993547|NCT03410992|460602743|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
127993548|NCT03410992|460602744|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
127993549|NCT03410992|460602745|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
127993550|NCT03410992|460602746|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
127993551|NCT03410992|460602747|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
127993552|NCT03410992|460602748|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
127993553|NCT03410992|460602749|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
127993554|NCT03410992|460602750|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
127993555|NCT03410992|460602751|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
127993556|NCT03410992|460602752|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
127993557|NCT03410992|460602742|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
127993558|NCT03410992|460602743|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
127993559|NCT03410992|460602744|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
127993560|NCT03410992|460602745|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
127993561|NCT03410992|460602746|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
127993562|NCT03410992|460602747|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
127993563|NCT03410992|460602748|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
127993564|NCT03410992|460602749|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
127993565|NCT03410992|460602750|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
127993566|NCT03410992|460602751|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
127993567|NCT03410992|460602752|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
127993568|NCT03410992|460602742|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
127993569|NCT03410992|460602743|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
127993570|NCT03410992|460602744|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
127993571|NCT03410992|460602745|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
127993572|NCT03410992|460602746|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
127993573|NCT03410992|460602747|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
127993574|NCT03410992|460602748|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
127993575|NCT03410992|460602749|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
127993576|NCT03410992|460602750|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
127993577|NCT03410992|460602751|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
127993578|NCT03410992|460602752|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
127993579|NCT03410992|460602742|FG000|Week 16 Assessment|Incorrect escapers|0|||
127993580|NCT03410992|460602743|FG001|Week 16 Assessment|Incorrect escapers|6|||
127993581|NCT03410992|460602744|FG002|Week 16 Assessment|Incorrect escapers|0|||
127993582|NCT03410992|460602745|FG003|Week 16 Assessment|Incorrect escapers|0|||
127993583|NCT03410992|460602746|FG004|Week 16 Assessment|Incorrect escapers|0|||
127993584|NCT03410992|460602747|FG005|Week 16 Assessment|Incorrect escapers|0|||
127993585|NCT03410992|460602748|FG006|Week 16 Assessment|Incorrect escapers|0|||
127993586|NCT03410992|460602749|FG007|Week 16 Assessment|Incorrect escapers|0|||
127993587|NCT03410992|460602750|FG008|Week 16 Assessment|Incorrect escapers|0|||
127993588|NCT03410992|460602751|FG009|Week 16 Assessment|Incorrect escapers|0|||
127993589|NCT03410992|460602752|FG010|Week 16 Assessment|Incorrect escapers|0|||
127993590|NCT03410992|460602742|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
127993591|NCT03410992|460602743|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
127993592|NCT03410992|460602744|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
127993593|NCT03410992|460602745|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
127993594|NCT03410992|460602746|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
127993595|NCT03410992|460602747|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
127993596|NCT03410992|460602748|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
127993597|NCT03410992|460602749|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
127993598|NCT03410992|460602750|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
127993599|NCT03410992|460602751|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
127993600|NCT03410992|460602752|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
127993601|NCT03410992|460602742|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
127993602|NCT03410992|460602743|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
127993603|NCT03410992|460602744|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
127993604|NCT03410992|460602745|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
127993605|NCT03410992|460602746|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
127993606|NCT03410992|460602747|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
127993607|NCT03410992|460602748|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
127993608|NCT03410992|460602749|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
127993609|NCT03410992|460602750|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
127993610|NCT03410992|460602751|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
127993611|NCT03410992|460602752|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
127993612|NCT03410992|460602742|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
127993613|NCT03410992|460602743|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
127993614|NCT03410992|460602744|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
127993615|NCT03410992|460602745|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
127993616|NCT03410992|460602746|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
127993617|NCT03410992|460602747|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
127993618|NCT03410992|460602748|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
127993619|NCT03410992|460602749|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
127993620|NCT03410992|460602750|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
127664862|NCT01474512|459395051|FG011|Long-Term Extension Period|Death|0|||
127664863|NCT01474512|459395052|FG012|Long-Term Extension Period|Death|9|||
127664864|NCT01474512|459395053|FG013|Long-Term Extension Period|Death|9|||
127664865|NCT01474512|459395054|FG014|Long-Term Extension Period|Death|0|||
127993621|NCT03410992|460602751|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
127993622|NCT03410992|460602752|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
127993623|NCT03410992|460602742|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
127993624|NCT03410992|460602743|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
127664866|NCT01474512|459395055|FG015|Long-Term Extension Period|Death|0|||
127664867|NCT01474512|459395056|FG016|Long-Term Extension Period|Death|0|||
127664868|NCT01474512|459395057|FG017|Long-Term Extension Period|Death|0|||
127664869|NCT01474512|459395040|FG000|Long-Term Extension Period|Sponsor Decision|0|||
127664870|NCT01474512|459395041|FG001|Long-Term Extension Period|Sponsor Decision|0|||
127664871|NCT01474512|459395042|FG002|Long-Term Extension Period|Sponsor Decision|0|||
127664872|NCT01474512|459395043|FG003|Long-Term Extension Period|Sponsor Decision|0|||
127664873|NCT01474512|459395044|FG004|Long-Term Extension Period|Sponsor Decision|0|||
127664874|NCT01474512|459395045|FG005|Long-Term Extension Period|Sponsor Decision|0|||
127880822|NCT00021229|460186035|FG001|Overall Study|Progressive Disease|19|||
127880823|NCT00021229|460186036|FG002|Overall Study|Progressive Disease|12|||
127880824|NCT00021229|460186034|FG000|Overall Study|Protocol Violation|1|||
127880825|NCT00021229|460186035|FG001|Overall Study|Protocol Violation|1|||
127880826|NCT00021229|460186036|FG002|Overall Study|Protocol Violation|0|||
127880827|NCT00021229|460186034|FG000|Overall Study|Physician Decision|0|||
127880828|NCT00021229|460186035|FG001|Overall Study|Physician Decision|0|||
127880829|NCT00021229|460186036|FG002|Overall Study|Physician Decision|1|||
127880830|NCT00021229|460186034|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
127880831|NCT00021229|460186035|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
127880832|NCT00021229|460186036|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
127880833|NCT02156466|460186037|FG000|Overall Study|Adverse Event|0|||
127880834|NCT02156466|460186038|FG001|Overall Study|Adverse Event|0|||
127880835|NCT02156466|460186039|FG002|Overall Study|Adverse Event|1|||
127880836|NCT02156466|460186040|FG003|Overall Study|Adverse Event|1|||
127880837|NCT02156466|460186041|FG004|Overall Study|Adverse Event|0|||
127880838|NCT02156466|460186037|FG000|Overall Study|Quantiferon Positivity|0|||
127880839|NCT02156466|460186038|FG001|Overall Study|Quantiferon Positivity|0|||
127880840|NCT02156466|460186039|FG002|Overall Study|Quantiferon Positivity|0|||
127880841|NCT02156466|460186040|FG003|Overall Study|Quantiferon Positivity|1|||
127880842|NCT02156466|460186041|FG004|Overall Study|Quantiferon Positivity|0|||
127880843|NCT02237118|460186042|FG000|Overall Study|Protocol Violation|0|||
127880844|NCT02237118|460186043|FG001|Overall Study|Protocol Violation|1|||
127880845|NCT02237118|460186042|FG000|Overall Study|consent withdrawn|1|||
127880846|NCT02237118|460186043|FG001|Overall Study|consent withdrawn|0|||
127880847|NCT01268683|460186046|FG000|Overall Study|Lost to Follow-up|1|||
127880848|NCT01268683|460186046|FG000|Overall Study|Death|1|||
127880849|NCT02216214|460186047|FG000|Overall Study|Randomized Never Received Study Drug|1|||
127880850|NCT02216214|460186048|FG001|Overall Study|Randomized Never Received Study Drug|0|||
127880851|NCT02216214|460186047|FG000|Overall Study|Adverse Event|10|||
127880852|NCT02216214|460186048|FG001|Overall Study|Adverse Event|8|||
127880853|NCT02216214|460186047|FG000|Overall Study|Lack of Efficacy|2|||
127880854|NCT02216214|460186048|FG001|Overall Study|Lack of Efficacy|2|||
127880855|NCT02216214|460186047|FG000|Overall Study|Lost to Follow-up|3|||
127880856|NCT02216214|460186048|FG001|Overall Study|Lost to Follow-up|2|||
127880857|NCT02216214|460186047|FG000|Overall Study|Protocol Violation|4|||
127880858|NCT02216214|460186048|FG001|Overall Study|Protocol Violation|2|||
127880859|NCT02216214|460186047|FG000|Overall Study|Withdrawal by Subject|22|||
127880860|NCT02216214|460186048|FG001|Overall Study|Withdrawal by Subject|20|||
127880861|NCT02216214|460186047|FG000|Overall Study|Study Terminated By Sponsor|0|||
127880862|NCT02216214|460186048|FG001|Overall Study|Study Terminated By Sponsor|1|||
127880863|NCT02216214|460186047|FG000|Overall Study|Miscellaneous|1|||
127880864|NCT02216214|460186048|FG001|Overall Study|Miscellaneous|1|||
127880865|NCT00713830|460186049|FG000|Overall Study|Adverse Event|23|||
127880866|NCT00713830|460186050|FG001|Overall Study|Adverse Event|71|||
127880867|NCT00713830|460186049|FG000|Overall Study|Lack of Efficacy|24|||
127880868|NCT00713830|460186050|FG001|Overall Study|Lack of Efficacy|16|||
127880869|NCT00713830|460186049|FG000|Overall Study|Lost to Follow-up|2|||
127880870|NCT00713830|460186050|FG001|Overall Study|Lost to Follow-up|9|||
127880871|NCT00713830|460186049|FG000|Overall Study|Withdrawal by Subject|13|||
127880872|NCT00713830|460186050|FG001|Overall Study|Withdrawal by Subject|23|||
127880873|NCT00713830|460186049|FG000|Overall Study|Poor Compliance to Protocol|7|||
127880874|NCT00713830|460186050|FG001|Overall Study|Poor Compliance to Protocol|14|||
127880875|NCT00713830|460186049|FG000|Overall Study|Familial and Personal Reasons|9|||
127880876|NCT00713830|460186050|FG001|Overall Study|Familial and Personal Reasons|34|||
127880877|NCT00713830|460186049|FG000|Overall Study|Sponsor Decision|4|||
127880878|NCT00713830|460186050|FG001|Overall Study|Sponsor Decision|10|||
127880879|NCT03981614|460186053|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
127880880|NCT03981614|460186054|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
127880881|NCT03981614|460186055|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
127880882|NCT00499252|460186056|FG000|Overall Study|Adverse Event|3|||
127880883|NCT00499252|460186056|FG000|Overall Study|Refused further treatment|2|||
127880884|NCT00499252|460186056|FG000|Overall Study|Ineligible|4|||
127880885|NCT00499252|460186056|FG000|Overall Study|<no further label>|3|||
127880886|NCT00566631|460186057|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
127880887|NCT00566631|460186057|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
127664875|NCT01474512|459395046|FG006|Long-Term Extension Period|Sponsor Decision|0|||
127664876|NCT01474512|459395047|FG007|Long-Term Extension Period|Sponsor Decision|0|||
127664877|NCT01474512|459395048|FG008|Long-Term Extension Period|Sponsor Decision|0|||
127664878|NCT01474512|459395049|FG009|Long-Term Extension Period|Sponsor Decision|0|||
127664879|NCT01474512|459395050|FG010|Long-Term Extension Period|Sponsor Decision|0|||
127664880|NCT01474512|459395051|FG011|Long-Term Extension Period|Sponsor Decision|0|||
127664881|NCT01474512|459395052|FG012|Long-Term Extension Period|Sponsor Decision|6|||
127664882|NCT01474512|459395053|FG013|Long-Term Extension Period|Sponsor Decision|6|||
127664883|NCT01474512|459395054|FG014|Long-Term Extension Period|Sponsor Decision|0|||
127664884|NCT01474512|459395055|FG015|Long-Term Extension Period|Sponsor Decision|0|||
127664885|NCT01474512|459395056|FG016|Long-Term Extension Period|Sponsor Decision|0|||
127664886|NCT01474512|459395057|FG017|Long-Term Extension Period|Sponsor Decision|0|||
127664887|NCT01474512|459395040|FG000|Long-Term Extension Period|Protocol Violation|0|||
127664888|NCT01474512|459395041|FG001|Long-Term Extension Period|Protocol Violation|0|||
127664889|NCT01474512|459395042|FG002|Long-Term Extension Period|Protocol Violation|0|||
127664890|NCT01474512|459395043|FG003|Long-Term Extension Period|Protocol Violation|0|||
127664891|NCT01474512|459395044|FG004|Long-Term Extension Period|Protocol Violation|0|||
127664892|NCT01474512|459395045|FG005|Long-Term Extension Period|Protocol Violation|0|||
127664893|NCT01474512|459395046|FG006|Long-Term Extension Period|Protocol Violation|0|||
127664894|NCT01474512|459395047|FG007|Long-Term Extension Period|Protocol Violation|0|||
127664895|NCT01474512|459395048|FG008|Long-Term Extension Period|Protocol Violation|0|||
127664896|NCT01474512|459395049|FG009|Long-Term Extension Period|Protocol Violation|0|||
127664897|NCT01474512|459395050|FG010|Long-Term Extension Period|Protocol Violation|0|||
127664898|NCT01474512|459395051|FG011|Long-Term Extension Period|Protocol Violation|0|||
127664899|NCT01474512|459395052|FG012|Long-Term Extension Period|Protocol Violation|5|||
127664900|NCT01474512|459395053|FG013|Long-Term Extension Period|Protocol Violation|5|||
127664901|NCT01474512|459395054|FG014|Long-Term Extension Period|Protocol Violation|0|||
127664902|NCT01474512|459395055|FG015|Long-Term Extension Period|Protocol Violation|0|||
127664903|NCT01474512|459395056|FG016|Long-Term Extension Period|Protocol Violation|0|||
127664904|NCT01474512|459395057|FG017|Long-Term Extension Period|Protocol Violation|0|||
127664905|NCT01474512|459395040|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
127664906|NCT01474512|459395041|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
127664907|NCT01474512|459395042|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
127664908|NCT01474512|459395043|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
127664909|NCT01474512|459395044|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
127664910|NCT01474512|459395045|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
127664911|NCT01474512|459395046|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
127664912|NCT01474512|459395047|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
127664913|NCT01474512|459395048|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
127664914|NCT01474512|459395049|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
127664915|NCT01474512|459395050|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
127664916|NCT01474512|459395051|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
127664917|NCT01474512|459395052|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
127664918|NCT01474512|459395053|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
127664919|NCT01474512|459395054|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
127664920|NCT01474512|459395055|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
127664921|NCT01474512|459395056|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
127664922|NCT01474512|459395057|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
127664923|NCT01474512|459395040|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
127664924|NCT01474512|459395041|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
127664925|NCT01474512|459395042|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
127664926|NCT01474512|459395043|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
127664927|NCT01474512|459395044|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
127664928|NCT01474512|459395045|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
127664929|NCT01474512|459395046|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
127664930|NCT01474512|459395047|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
127664931|NCT01474512|459395048|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
127664932|NCT01474512|459395049|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
127664933|NCT01474512|459395050|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
127664934|NCT01474512|459395051|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
127664935|NCT01474512|459395052|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
127664936|NCT01474512|459395053|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
127664937|NCT01474512|459395054|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
127664938|NCT01474512|459395055|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
127664939|NCT01474512|459395056|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
127664940|NCT01474512|459395057|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
127664941|NCT01474512|459395040|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
127664942|NCT01474512|459395041|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
127993625|NCT03410992|460602744|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
127993626|NCT03410992|460602745|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
127993627|NCT03410992|460602746|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
127993628|NCT03410992|460602747|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
127993629|NCT03410992|460602748|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
127993630|NCT03410992|460602749|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
127993631|NCT03410992|460602750|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
127993632|NCT03410992|460602751|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
127993633|NCT03410992|460602752|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
127993634|NCT03410992|460602742|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
127993635|NCT03410992|460602743|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
127993636|NCT03410992|460602744|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
127993637|NCT03410992|460602745|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
127993638|NCT03410992|460602746|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
127993639|NCT03410992|460602747|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
127993640|NCT03410992|460602748|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
127993641|NCT03410992|460602749|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
127993642|NCT03410992|460602750|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
127993643|NCT03410992|460602751|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
127993644|NCT03410992|460602752|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
127993645|NCT03410992|460602742|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
127993646|NCT03410992|460602743|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
127993647|NCT03410992|460602744|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
127993648|NCT03410992|460602745|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
127993649|NCT03410992|460602746|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
127993650|NCT03410992|460602747|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
127993651|NCT03410992|460602748|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
127993652|NCT03410992|460602749|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
127993653|NCT03410992|460602750|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
127993654|NCT03410992|460602751|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
127993655|NCT03410992|460602752|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
127993656|NCT02438280|460602753|FG000|Overall Study|Physician Decision|1|||
127993657|NCT02438280|460602754|FG001|Overall Study|Physician Decision|0|||
127993658|NCT02260817|460602755|FG000|Overall Study|Lost to Follow-up|0|||
127993659|NCT02260817|460602756|FG001|Overall Study|Lost to Follow-up|14|||
127993660|NCT02260817|460602755|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
127993661|NCT02260817|460602756|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
127993662|NCT02260817|460602755|FG000|Overall Study|Observation, no biopsy|0|||
127993663|NCT02260817|460602756|FG001|Overall Study|Observation, no biopsy|1|||
127993664|NCT02260817|460602755|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
127993665|NCT02260817|460602756|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
127993666|NCT02260817|460602755|FG000|Overall Study|Protocol Violation|0|||
127993667|NCT02260817|460602756|FG001|Overall Study|Protocol Violation|14|||
127993668|NCT03299101|460602757|FG000|Overall Study|Lost to Follow-up|1|||
127993669|NCT03299101|460602757|FG000|Overall Study|Withdrawal by Subject|5|||
127993670|NCT03299101|460602757|FG000|Overall Study|Surgery was changed|3|||
127993671|NCT03299101|460602757|FG000|Overall Study|Not enough time to complete prehab|1|||
127993672|NCT02091414|460602759|FG000|Overall Study|Withdrawal by Subject|2|||
127993673|NCT02091414|460602759|FG000|Overall Study|Death|2|||
127993674|NCT00435461|460602760|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
127993675|NCT00435461|460602761|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
127993676|NCT00435461|460602762|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
127993677|NCT00435461|460602760|FG000|Overall Study|Protocol Violation|6|||
127993678|NCT00435461|460602761|FG001|Overall Study|Protocol Violation|9|||
127993679|NCT00435461|460602762|FG002|Overall Study|Protocol Violation|10|||
127993680|NCT00435461|460602760|FG000|Overall Study|Participant randomized(inadequate score)|1|||
127993681|NCT00435461|460602761|FG001|Overall Study|Participant randomized(inadequate score)|0|||
127993682|NCT00435461|460602762|FG002|Overall Study|Participant randomized(inadequate score)|0|||
127993683|NCT00435461|460602760|FG000|Overall Study|Compliance less than 80 percent|1|||
127993684|NCT00435461|460602761|FG001|Overall Study|Compliance less than 80 percent|0|||
127993685|NCT00435461|460602762|FG002|Overall Study|Compliance less than 80 percent|0|||
127993686|NCT00435461|460602760|FG000|Overall Study|In error, two study medications switched|1|||
127993687|NCT00435461|460602761|FG001|Overall Study|In error, two study medications switched|0|||
127993688|NCT00435461|460602762|FG002|Overall Study|In error, two study medications switched|0|||
127993689|NCT00435461|460602760|FG000|Overall Study|Lack of Efficacy|2|||
127664943|NCT01474512|459395042|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
127664944|NCT01474512|459395043|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
127993690|NCT00435461|460602761|FG001|Overall Study|Lack of Efficacy|1|||
127993691|NCT00435461|460602762|FG002|Overall Study|Lack of Efficacy|0|||
127993692|NCT00435461|460602760|FG000|Overall Study|Withdrawal by Subject|1|||
127993693|NCT00435461|460602761|FG001|Overall Study|Withdrawal by Subject|0|||
127664945|NCT01474512|459395044|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
127664946|NCT01474512|459395045|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
127664947|NCT01474512|459395046|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
127664948|NCT01474512|459395047|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
127664949|NCT01474512|459395048|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
127664950|NCT01474512|459395049|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
127664951|NCT01474512|459395050|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
127664952|NCT01474512|459395051|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
127664953|NCT01474512|459395052|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
127664954|NCT01474512|459395053|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
127664955|NCT01474512|459395054|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
127664956|NCT01474512|459395055|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
127993694|NCT00435461|460602762|FG002|Overall Study|Withdrawal by Subject|2|||
127993695|NCT00435461|460602760|FG000|Overall Study|Randomized in error|1|||
127993696|NCT00435461|460602761|FG001|Overall Study|Randomized in error|0|||
127993697|NCT00435461|460602762|FG002|Overall Study|Randomized in error|0|||
127993698|NCT00435461|460602760|FG000|Overall Study|Participant could not tolerate symptoms|0|||
127993699|NCT00435461|460602761|FG001|Overall Study|Participant could not tolerate symptoms|0|||
127993700|NCT00435461|460602762|FG002|Overall Study|Participant could not tolerate symptoms|1|||
127993701|NCT00435461|460602760|FG000|Overall Study|Participant could not swallow capsule|0|||
127993702|NCT00435461|460602761|FG001|Overall Study|Participant could not swallow capsule|0|||
127993703|NCT00435461|460602762|FG002|Overall Study|Participant could not swallow capsule|1|||
127993704|NCT00435461|460602760|FG000|Overall Study|Pregnancy|2|||
127993705|NCT00435461|460602761|FG001|Overall Study|Pregnancy|0|||
127993706|NCT00435461|460602762|FG002|Overall Study|Pregnancy|0|||
127993707|NCT00435461|460602760|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
127993708|NCT00435461|460602761|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
127993709|NCT00435461|460602762|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
127993710|NCT00435461|460602760|FG000|Overall Study|Participant ended study one day early|1|||
127993711|NCT00435461|460602761|FG001|Overall Study|Participant ended study one day early|0|||
127993712|NCT00435461|460602762|FG002|Overall Study|Participant ended study one day early|0|||
127993713|NCT00435461|460602760|FG000|Overall Study|Noncompliance with study requirements|1|||
127993714|NCT00435461|460602761|FG001|Overall Study|Noncompliance with study requirements|1|||
127993715|NCT00435461|460602762|FG002|Overall Study|Noncompliance with study requirements|1|||
127993716|NCT00435461|460602760|FG000|Overall Study|Adverse Event|1|||
127993717|NCT00435461|460602761|FG001|Overall Study|Adverse Event|2|||
127993718|NCT00435461|460602762|FG002|Overall Study|Adverse Event|6|||
127993719|NCT00435461|460602760|FG000|Overall Study|Non-Compliance of diary|2|||
127993720|NCT00435461|460602761|FG001|Overall Study|Non-Compliance of diary|0|||
127993721|NCT00435461|460602762|FG002|Overall Study|Non-Compliance of diary|1|||
127993722|NCT00435461|460602760|FG000|Overall Study|Lost to Follow-up|1|||
127993723|NCT00435461|460602761|FG001|Overall Study|Lost to Follow-up|1|||
127993724|NCT00435461|460602762|FG002|Overall Study|Lost to Follow-up|2|||
127993725|NCT00547157|460602771|FG000|Overall Study|Other|1|||
127993726|NCT00547157|460602772|FG001|Overall Study|Other|0|||
127993727|NCT00547157|460602771|FG000|Overall Study|Death|38|||
127993728|NCT00547157|460602772|FG001|Overall Study|Death|18|||
127993729|NCT00547157|460602771|FG000|Overall Study|Withdrawal by Subject|3|||
127993730|NCT00547157|460602772|FG001|Overall Study|Withdrawal by Subject|1|||
127993731|NCT00547157|460602771|FG000|Overall Study|Administrative decision|3|||
127993732|NCT00547157|460602772|FG001|Overall Study|Administrative decision|2|||
127993733|NCT00547157|460602771|FG000|Overall Study|Lost to Follow-up|4|||
127993734|NCT00547157|460602772|FG001|Overall Study|Lost to Follow-up|2|||
127993735|NCT05415462|460602773|FG000|Overall Study|Death|18|||
127993736|NCT05415462|460602774|FG001|Overall Study|Death|10|||
127993737|NCT05415462|460602773|FG000|Overall Study|Lost to Follow-up|72|||
127993738|NCT05415462|460602774|FG001|Overall Study|Lost to Follow-up|64|||
127993739|NCT05415462|460602773|FG000|Overall Study|Physician Decision|5|||
127993740|NCT05415462|460602774|FG001|Overall Study|Physician Decision|5|||
127664957|NCT01474512|459395056|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
127664958|NCT01474512|459395057|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
127664959|NCT01474512|459395040|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
127664960|NCT01474512|459395041|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
127664961|NCT01474512|459395042|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
127664962|NCT01474512|459395043|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
127664963|NCT01474512|459395044|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
127993741|NCT05415462|460602773|FG000|Overall Study|Protocol Deviation|1|||
127993742|NCT05415462|460602774|FG001|Overall Study|Protocol Deviation|0|||
127993743|NCT05415462|460602773|FG000|Overall Study|Withdrawal by Subject|129|||
127993744|NCT05415462|460602774|FG001|Overall Study|Withdrawal by Subject|101|||
127993745|NCT05415462|460602773|FG000|Overall Study|Other Than Specified|8|||
127993746|NCT05415462|460602774|FG001|Overall Study|Other Than Specified|8|||
127993747|NCT04186221|460602775|FG000|Overall Study|Death|1|||
127993748|NCT01134393|460602778|FG000|Overall Study|Adverse Event|18|||
127993749|NCT01134393|460602778|FG000|Overall Study|Lack of Efficacy|2|||
127993750|NCT01134393|460602778|FG000|Overall Study|Protocol Violation|12|||
127993751|NCT01134393|460602778|FG000|Overall Study|Lost to Follow-up|3|||
127993752|NCT01134393|460602778|FG000|Overall Study|Withdrawal by Subject|11|||
127664964|NCT01474512|459395045|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
127664965|NCT01474512|459395046|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
127664966|NCT01474512|459395047|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
127664967|NCT01474512|459395048|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
127664968|NCT01474512|459395049|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
127664969|NCT01474512|459395050|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
127664970|NCT01474512|459395051|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
127664971|NCT01474512|459395052|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
127664972|NCT01474512|459395053|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
127664973|NCT01474512|459395054|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
127664974|NCT01474512|459395055|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
127664975|NCT01474512|459395056|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
127664976|NCT01474512|459395057|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
127664977|NCT01474512|459395040|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
127664978|NCT01474512|459395041|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
127993753|NCT01134393|460602778|FG000|Overall Study|Other|6|||
127993754|NCT00531947|460602779|FG000|Overall Study|Adverse Event|5|||
127993755|NCT00531947|460602780|FG001|Overall Study|Adverse Event|10|||
127993756|NCT00531947|460602779|FG000|Overall Study|Lost to Follow-up|12|||
127993757|NCT00531947|460602780|FG001|Overall Study|Lost to Follow-up|9|||
127993758|NCT00531947|460602779|FG000|Overall Study|Withdrawal by Subject|14|||
127993759|NCT00531947|460602780|FG001|Overall Study|Withdrawal by Subject|19|||
127993760|NCT00531947|460602779|FG000|Overall Study|Protocol Violation|2|||
127993761|NCT00531947|460602780|FG001|Overall Study|Protocol Violation|1|||
127993762|NCT00531947|460602779|FG000|Overall Study|Non-Compliance|4|||
127993763|NCT00531947|460602780|FG001|Overall Study|Non-Compliance|7|||
127993764|NCT00531947|460602779|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
127993765|NCT00531947|460602780|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
127993766|NCT01087203|460602785|FG000|Overall Study|Lost to Follow-up|2|||
127993767|NCT01087203|460602786|FG001|Overall Study|Lost to Follow-up|0|||
127993768|NCT01087203|460602785|FG000|Overall Study|Withdrawal by Subject|2|||
127993769|NCT01087203|460602786|FG001|Overall Study|Withdrawal by Subject|6|||
127993770|NCT01087203|460602785|FG000|Overall Study|Lack of Efficacy|1|||
127993771|NCT01087203|460602786|FG001|Overall Study|Lack of Efficacy|2|||
127993772|NCT01087203|460602785|FG000|Overall Study|Study terminated by sponsor|27|||
127993773|NCT01087203|460602786|FG001|Overall Study|Study terminated by sponsor|27|||
127993774|NCT02588664|460602795|FG000|Overall Study|Death|56|||
127993775|NCT02588664|460602796|FG001|Overall Study|Death|55|||
127993776|NCT02588664|460602795|FG000|Overall Study|Lost to Follow-up|1305|||
127993777|NCT02588664|460602796|FG001|Overall Study|Lost to Follow-up|990|||
127993778|NCT01429298|460602797|FG000|Overall Study|Protocol Violation|4|||
127993779|NCT01429298|460602798|FG001|Overall Study|Protocol Violation|6|||
127993780|NCT02903420|460602799|FG000|Overall Study|Death|3|||
127993781|NCT03300180|460602802|FG000|Baseline|Withdrawal by Subject|4|||
127993782|NCT03300180|460602803|FG001|Baseline|Withdrawal by Subject|6|||
127993783|NCT03300180|460602804|FG002|Baseline|Withdrawal by Subject|4|||
127993784|NCT03300180|460602802|FG000|6 Month Outcome|Withdrawal by Subject|12|||
127993785|NCT03300180|460602803|FG001|6 Month Outcome|Withdrawal by Subject|12|||
127993786|NCT03300180|460602804|FG002|6 Month Outcome|Withdrawal by Subject|19|||
127993787|NCT03300180|460602802|FG000|6 Month Outcome|Death|2|||
127993788|NCT03300180|460602803|FG001|6 Month Outcome|Death|4|||
127993789|NCT03300180|460602804|FG002|6 Month Outcome|Death|3|||
127993790|NCT03300180|460602802|FG000|6 Month Outcome|Missed Assessment|43|||
127993791|NCT03300180|460602803|FG001|6 Month Outcome|Missed Assessment|52|||
127993792|NCT03300180|460602804|FG002|6 Month Outcome|Missed Assessment|46|||
127993793|NCT03300180|460602802|FG000|12 Month Outcome|Withdrawal by Subject|3|||
127993794|NCT03300180|460602803|FG001|12 Month Outcome|Withdrawal by Subject|6|||
127993795|NCT03300180|460602804|FG002|12 Month Outcome|Withdrawal by Subject|6|||
127993796|NCT03300180|460602802|FG000|12 Month Outcome|Death|9|||
127993797|NCT03300180|460602803|FG001|12 Month Outcome|Death|6|||
127993798|NCT03300180|460602804|FG002|12 Month Outcome|Death|6|||
127993799|NCT03300180|460602802|FG000|12 Month Outcome|Missed Assessment|62|||
127993800|NCT03300180|460602803|FG001|12 Month Outcome|Missed Assessment|59|||
127993801|NCT03300180|460602804|FG002|12 Month Outcome|Missed Assessment|58|||
127993802|NCT03300180|460602802|FG000|18 Month Outcome Assessment|Withdrawal by Subject|14|||
127993803|NCT03300180|460602803|FG001|18 Month Outcome Assessment|Withdrawal by Subject|4|||
127993804|NCT03300180|460602804|FG002|18 Month Outcome Assessment|Withdrawal by Subject|13|||
127993805|NCT03300180|460602802|FG000|18 Month Outcome Assessment|Death|8|||
127993806|NCT03300180|460602803|FG001|18 Month Outcome Assessment|Death|5|||
127993807|NCT03300180|460602804|FG002|18 Month Outcome Assessment|Death|5|||
127993808|NCT03300180|460602802|FG000|18 Month Outcome Assessment|Missed Assessment|49|||
127993809|NCT03300180|460602803|FG001|18 Month Outcome Assessment|Missed Assessment|61|||
127993810|NCT03300180|460602804|FG002|18 Month Outcome Assessment|Missed Assessment|44|||
127993811|NCT03300180|460602802|FG000|24 Month Outcome Assessment|Withdrawal by Subject|6|||
127993812|NCT03300180|460602803|FG001|24 Month Outcome Assessment|Withdrawal by Subject|10|||
127993813|NCT03300180|460602804|FG002|24 Month Outcome Assessment|Withdrawal by Subject|4|||
127993814|NCT03300180|460602802|FG000|24 Month Outcome Assessment|Death|13|||
127993815|NCT03300180|460602803|FG001|24 Month Outcome Assessment|Death|13|||
127993816|NCT03300180|460602804|FG002|24 Month Outcome Assessment|Death|3|||
127993817|NCT03300180|460602802|FG000|24 Month Outcome Assessment|Missed Assessment|17|||
127993818|NCT03300180|460602803|FG001|24 Month Outcome Assessment|Missed Assessment|21|||
127993819|NCT03300180|460602804|FG002|24 Month Outcome Assessment|Missed Assessment|38|||
127993820|NCT04378569|460604636|FG000|Overall Study|Adverse Event|0|||
127993821|NCT04378569|460604637|FG001|Overall Study|Adverse Event|0|||
127993822|NCT04378569|460604638|FG002|Overall Study|Adverse Event|2|||
127993823|NCT04378569|460604639|FG003|Overall Study|Adverse Event|0|||
127993824|NCT04378569|460604640|FG004|Overall Study|Adverse Event|3|||
127993825|NCT04378569|460604641|FG005|Overall Study|Adverse Event|3|||
127993826|NCT04378569|460604636|FG000|Overall Study|Lost to Follow-up|0|||
127993827|NCT04378569|460604637|FG001|Overall Study|Lost to Follow-up|3|||
127993828|NCT04378569|460604638|FG002|Overall Study|Lost to Follow-up|1|||
127993829|NCT04378569|460604639|FG003|Overall Study|Lost to Follow-up|0|||
127993830|NCT04378569|460604640|FG004|Overall Study|Lost to Follow-up|1|||
127993831|NCT04378569|460604641|FG005|Overall Study|Lost to Follow-up|1|||
127993832|NCT04378569|460604636|FG000|Overall Study|Protocol Violation|0|||
127993833|NCT04378569|460604637|FG001|Overall Study|Protocol Violation|0|||
127993834|NCT04378569|460604638|FG002|Overall Study|Protocol Violation|0|||
127993835|NCT04378569|460604639|FG003|Overall Study|Protocol Violation|0|||
127993836|NCT04378569|460604640|FG004|Overall Study|Protocol Violation|0|||
127993837|NCT04378569|460604641|FG005|Overall Study|Protocol Violation|1|||
127993838|NCT04378569|460604636|FG000|Overall Study|Withdrawal by Subject|0|||
127993839|NCT04378569|460604637|FG001|Overall Study|Withdrawal by Subject|6|||
127993840|NCT04378569|460604638|FG002|Overall Study|Withdrawal by Subject|7|||
127993841|NCT04378569|460604639|FG003|Overall Study|Withdrawal by Subject|4|||
127993842|NCT04378569|460604640|FG004|Overall Study|Withdrawal by Subject|5|||
127993843|NCT04378569|460604641|FG005|Overall Study|Withdrawal by Subject|4|||
127993844|NCT04378569|460604636|FG000|Overall Study|Lack of response|0|||
127993845|NCT04378569|460604637|FG001|Overall Study|Lack of response|0|||
127993846|NCT04378569|460604638|FG002|Overall Study|Lack of response|1|||
127993847|NCT04378569|460604639|FG003|Overall Study|Lack of response|0|||
127993848|NCT04378569|460604640|FG004|Overall Study|Lack of response|1|||
127993849|NCT04378569|460604641|FG005|Overall Study|Lack of response|1|||
127993850|NCT01962948|460604642|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
127993851|NCT01962948|460604643|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
127993852|NCT01962948|460604644|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
127993853|NCT01962948|460604645|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
127993854|NCT02501161|460604651|FG000|Overall Study|Adverse Event|2|||
127993855|NCT02501161|460604652|FG001|Overall Study|Adverse Event|6|||
127993856|NCT02501161|460604651|FG000|Overall Study|Lost to Follow-up|7|||
127993857|NCT02501161|460604652|FG001|Overall Study|Lost to Follow-up|4|||
127993858|NCT02501161|460604651|FG000|Overall Study|Withdrawal by Subject|10|||
127993859|NCT02501161|460604652|FG001|Overall Study|Withdrawal by Subject|15|||
127993860|NCT02501161|460604651|FG000|Overall Study|Other|3|||
127993861|NCT02501161|460604652|FG001|Overall Study|Other|0|||
127993862|NCT00667992|460604653|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
127993863|NCT00667992|460604654|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
127993864|NCT00667992|460604653|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
127993865|NCT00667992|460604654|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
127993866|NCT00667992|460604653|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
127993867|NCT00667992|460604654|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
127664979|NCT01474512|459395042|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
127664980|NCT01474512|459395043|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
127664981|NCT01474512|459395044|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
127664982|NCT01474512|459395045|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
127664983|NCT01474512|459395046|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
127664984|NCT01474512|459395047|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
127664985|NCT01474512|459395048|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
127664986|NCT01474512|459395049|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
127993868|NCT00667992|460604653|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
127993869|NCT00667992|460604654|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
127993870|NCT00667992|460604653|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
127993871|NCT00667992|460604654|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
127993872|NCT00667992|460604653|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
127993873|NCT00667992|460604654|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
127993874|NCT00667992|460604653|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
127664987|NCT01474512|459395050|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
127664988|NCT01474512|459395051|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
127993875|NCT00667992|460604654|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
127993876|NCT00667992|460604653|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
127993877|NCT00667992|460604654|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
127993878|NCT00667992|460604653|FG000|Wash-out|Not within one doubling dilution|4|||
127993879|NCT00667992|460604654|FG001|Wash-out|Not within one doubling dilution|3|||
127993880|NCT00667992|460604653|FG000|Wash-out|Failure to wash-out|2|||
127993881|NCT00667992|460604654|FG001|Wash-out|Failure to wash-out|2|||
127993882|NCT00667992|460604653|FG000|Wash-out|Withdrawal by Subject|1|||
127993883|NCT00667992|460604654|FG001|Wash-out|Withdrawal by Subject|0|||
127993884|NCT00667992|460604653|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
127993885|NCT00667992|460604654|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
127993886|NCT00667992|460604653|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
127993887|NCT00667992|460604654|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
127993888|NCT01957579|460604656|FG000|Overall Study|Withdrawal of concent|0|||
127993889|NCT01957579|460604657|FG001|Overall Study|Withdrawal of concent|1|||
127993890|NCT01957579|460604658|FG002|Overall Study|Withdrawal of concent|0|||
127993891|NCT01957579|460604659|FG003|Overall Study|Withdrawal of concent|0|||
127993892|NCT01957579|460604656|FG000|Overall Study|Death|0|||
127993893|NCT01957579|460604657|FG001|Overall Study|Death|0|||
127993894|NCT01957579|460604658|FG002|Overall Study|Death|2|||
127993895|NCT01957579|460604659|FG003|Overall Study|Death|0|||
127993896|NCT01639144|460604660|FG000|Overall Study|Withdrawal by Subject|4|||
127993897|NCT01639144|460604661|FG001|Overall Study|Withdrawal by Subject|2|||
127993898|NCT01639144|460604660|FG000|Overall Study|Physician Decision|2|||
127993899|NCT01639144|460604661|FG001|Overall Study|Physician Decision|0|||
127993900|NCT01639144|460604660|FG000|Overall Study|Met postoperative exclusion criteria|4|||
127993901|NCT01639144|460604661|FG001|Overall Study|Met postoperative exclusion criteria|3|||
127993902|NCT01000974|460604664|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
127993903|NCT01000974|460604665|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
127993904|NCT01000974|460604666|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
127993905|NCT01000974|460604664|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
127993906|NCT01000974|460604665|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
127993907|NCT01000974|460604666|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
127993908|NCT01000974|460604664|FG000|Primary Vaccination Phase|Protocol Violation|40|||
127993909|NCT01000974|460604665|FG001|Primary Vaccination Phase|Protocol Violation|3|||
127993910|NCT01000974|460604666|FG002|Primary Vaccination Phase|Protocol Violation|2|||
127993911|NCT01000974|460604664|FG000|Primary Vaccination Phase|Adverse Event|14|||
127993912|NCT01000974|460604665|FG001|Primary Vaccination Phase|Adverse Event|2|||
127993913|NCT01000974|460604666|FG002|Primary Vaccination Phase|Adverse Event|2|||
127993914|NCT01000974|460604664|FG000|Primary Vaccination Phase|Other|4|||
127993915|NCT01000974|460604665|FG001|Primary Vaccination Phase|Other|9|||
127993916|NCT01000974|460604666|FG002|Primary Vaccination Phase|Other|12|||
127993917|NCT01000974|460604664|FG000|Booster Vaccination Phase|Protocol Violation|0|||
127993918|NCT01000974|460604665|FG001|Booster Vaccination Phase|Protocol Violation|0|||
127993919|NCT01000974|460604666|FG002|Booster Vaccination Phase|Protocol Violation|2|||
127993920|NCT01000974|460604664|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
127993921|NCT01000974|460604665|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
127993922|NCT01000974|460604666|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
127993923|NCT01000974|460604664|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
127664989|NCT01474512|459395052|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
127993924|NCT01000974|460604665|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
127993925|NCT01000974|460604666|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
127993926|NCT01000974|460604664|FG000|Booster Vaccination Phase|Other|24|||
127993927|NCT01000974|460604665|FG001|Booster Vaccination Phase|Other|6|||
127993928|NCT01000974|460604666|FG002|Booster Vaccination Phase|Other|4|||
127993929|NCT02750332|460604667|FG000|Treatment Period 1|Withdrawal by Subject|0|||
127993930|NCT02750332|460604668|FG001|Treatment Period 1|Withdrawal by Subject|1|||
127993931|NCT02485483|460604673|FG000|Overall Study|Depression at baseline|15|||
127993932|NCT02485483|460604674|FG001|Overall Study|Depression at baseline|0|||
127993933|NCT02485483|460604673|FG000|Overall Study|Discontinued after baseline|39|||
127993934|NCT02485483|460604674|FG001|Overall Study|Discontinued after baseline|0|||
127993935|NCT01724177|460604676|FG000|Overall Study|Adverse Event|8|||
127993936|NCT01724177|460604676|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
127993937|NCT01724177|460604676|FG000|Overall Study|Nervous participant|1|||
127993938|NCT01724177|460604676|FG000|Overall Study|Serious Adverse Event Related|1|||
127993939|NCT00281697|460604681|FG000|Overall Study|> 60 days since last dose of study drug|4|||
127993940|NCT00281697|460604682|FG001|Overall Study|> 60 days since last dose of study drug|4|||
127664990|NCT01474512|459395053|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
127993941|NCT00281697|460604681|FG000|Overall Study|Adverse Event|54|||
127993942|NCT00281697|460604682|FG001|Overall Study|Adverse Event|15|||
127993943|NCT00281697|460604681|FG000|Overall Study|Death|8|||
127664991|NCT01474512|459395054|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
127664992|NCT01474512|459395055|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
127664993|NCT01474512|459395056|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
127664994|NCT01474512|459395057|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
127993944|NCT00281697|460604682|FG001|Overall Study|Death|3|||
127993945|NCT00281697|460604681|FG000|Overall Study|Disease progression|279|||
127993946|NCT00281697|460604682|FG001|Overall Study|Disease progression|149|||
127993947|NCT00281697|460604681|FG000|Overall Study|Other|5|||
127993948|NCT00281697|460604682|FG001|Overall Study|Other|6|||
127993949|NCT00281697|460604681|FG000|Overall Study|Physician's decision to withdraw|15|||
127993950|NCT00281697|460604682|FG001|Overall Study|Physician's decision to withdraw|12|||
127993951|NCT00281697|460604681|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
127993952|NCT00281697|460604682|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
127993953|NCT00281697|460604681|FG000|Overall Study|Did not receive study drug|3|||
127993954|NCT00281697|460604682|FG001|Overall Study|Did not receive study drug|2|||
127993955|NCT00632125|460604683|FG000|Overall Study|Death|82|||
127993956|NCT00632125|460604683|FG000|Overall Study|Withdrawal by Subject|44|||
127993957|NCT00632125|460604683|FG000|Overall Study|Adverse Event|36|||
127993958|NCT00632125|460604683|FG000|Overall Study|Renal transplantation|17|||
127993959|NCT00632125|460604683|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
127993960|NCT00632125|460604683|FG000|Overall Study|Non-compliance|8|||
127993961|NCT00632125|460604683|FG000|Overall Study|Development of uncontrolled hypertension|5|||
127993962|NCT00632125|460604683|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
127993963|NCT04446429|460604684|FG000|Overall Study|Lost to Follow-up|6|||
127993964|NCT04446429|460604685|FG001|Overall Study|Lost to Follow-up|0|||
127993965|NCT00540644|460604686|FG000|Overall Study|Adverse Event|3|||
127993966|NCT00540644|460604687|FG001|Overall Study|Adverse Event|1|||
127993967|NCT00540644|460604686|FG000|Overall Study|Disease Progression|3|||
127993968|NCT00540644|460604687|FG001|Overall Study|Disease Progression|1|||
127993969|NCT00540644|460604686|FG000|Overall Study|Physician Decision|0|||
127993970|NCT00540644|460604687|FG001|Overall Study|Physician Decision|5|||
127993971|NCT00540644|460604686|FG000|Overall Study|Withdrawal by Subject|2|||
127993972|NCT00540644|460604687|FG001|Overall Study|Withdrawal by Subject|2|||
127993973|NCT00540644|460604686|FG000|Overall Study|Noncomplilance|1|||
127993974|NCT00540644|460604687|FG001|Overall Study|Noncomplilance|0|||
127993975|NCT00809094|460604689|FG000|Overall Study|Lost to Follow-up|0|||
127993976|NCT00809094|460604690|FG001|Overall Study|Lost to Follow-up|1|||
127993977|NCT00397189|460604691|FG000|3 Weeks Period|Lost to Follow-up|5|||
127993978|NCT00397189|460604692|FG001|3 Weeks Period|Lost to Follow-up|4|||
127993979|NCT00397189|460604691|FG000|3 Weeks Period|Adverse Event|3|||
127993980|NCT00397189|460604692|FG001|3 Weeks Period|Adverse Event|2|||
127664995|NCT01474512|459395040|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
127664996|NCT01474512|459395041|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
127664997|NCT01474512|459395042|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
127664998|NCT01474512|459395043|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
127664999|NCT01474512|459395044|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
127665000|NCT01474512|459395045|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
127665001|NCT01474512|459395046|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
127665002|NCT01474512|459395047|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
127665003|NCT01474512|459395048|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
127665004|NCT01474512|459395049|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
127665005|NCT01474512|459395050|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
127665006|NCT01474512|459395051|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
127665007|NCT01474512|459395052|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
127665008|NCT01474512|459395053|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
127665009|NCT01474512|459395054|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
127665010|NCT01474512|459395055|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
127665011|NCT01474512|459395056|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
127665012|NCT01474512|459395057|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
127665013|NCT01474512|459395040|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
127665014|NCT01474512|459395041|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
127665015|NCT01474512|459395042|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
127665016|NCT01474512|459395043|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
127665017|NCT01474512|459395044|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
127665018|NCT01474512|459395045|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
127665019|NCT01474512|459395046|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
127993981|NCT00397189|460604691|FG000|3 Weeks Period|Withdrawal by Subject|13|||
127993982|NCT00397189|460604692|FG001|3 Weeks Period|Withdrawal by Subject|9|||
127993983|NCT00397189|460604691|FG000|3 Weeks Period|Physician Decision|0|||
127993984|NCT00397189|460604692|FG001|3 Weeks Period|Physician Decision|2|||
127665020|NCT01474512|459395047|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
127665021|NCT01474512|459395048|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
127665022|NCT01474512|459395049|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
127665023|NCT01474512|459395050|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
127993985|NCT00397189|460604691|FG000|3 Weeks Period|Protocol Violation|0|||
127993986|NCT00397189|460604692|FG001|3 Weeks Period|Protocol Violation|3|||
127993987|NCT00397189|460604691|FG000|3 Weeks Period|Other|0|||
127993988|NCT00397189|460604692|FG001|3 Weeks Period|Other|2|||
127993989|NCT01535443|460604693|FG000|Overall Study|Physician Decision|3|||
127993990|NCT00232557|460604696|FG000|Overall Study|Lost to Follow-up|3|||
127993991|NCT00232557|460604697|FG001|Overall Study|Lost to Follow-up|5|||
127993992|NCT01059773|460604698|FG000|Overall Study|Adverse Event|2|||
127993993|NCT01059773|460604699|FG001|Overall Study|Adverse Event|2|||
127993994|NCT01059773|460604698|FG000|Overall Study|Withdrawal by Subject|1|||
127993995|NCT01059773|460604699|FG001|Overall Study|Withdrawal by Subject|5|||
127993996|NCT01059773|460604698|FG000|Overall Study|Lost to Follow-up|1|||
127993997|NCT01059773|460604699|FG001|Overall Study|Lost to Follow-up|1|||
127665024|NCT01474512|459395051|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
127665025|NCT01474512|459395052|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
127665026|NCT01474512|459395053|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
127665027|NCT01474512|459395054|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
127665028|NCT01474512|459395055|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
127665029|NCT01474512|459395056|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
127665030|NCT01474512|459395057|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
127665031|NCT01474512|459395040|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
127665032|NCT01474512|459395041|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
127665033|NCT01474512|459395042|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
127665034|NCT01474512|459395043|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
127665035|NCT01474512|459395044|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
127665036|NCT01474512|459395045|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
127665037|NCT01474512|459395046|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
127665038|NCT01474512|459395047|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
127665039|NCT01474512|459395048|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
127665040|NCT01474512|459395049|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
127665041|NCT01474512|459395050|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
127665042|NCT01474512|459395051|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
127665043|NCT01474512|459395052|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
127665044|NCT01474512|459395053|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
127665045|NCT01474512|459395054|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
127665046|NCT01474512|459395055|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
127665047|NCT01474512|459395056|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
127665048|NCT01474512|459395057|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
127665049|NCT01474512|459395040|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
127665050|NCT01474512|459395041|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
127665051|NCT01474512|459395042|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
127665052|NCT01474512|459395043|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
127665053|NCT01474512|459395044|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
127665054|NCT01474512|459395045|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
127665055|NCT01474512|459395046|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
127665056|NCT01474512|459395047|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
127665057|NCT01474512|459395048|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
127665058|NCT01474512|459395049|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
127665059|NCT01474512|459395050|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
127665060|NCT01474512|459395051|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
127665061|NCT01474512|459395052|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
127665062|NCT01474512|459395053|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
127665063|NCT01474512|459395054|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
127665064|NCT01474512|459395055|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
127665065|NCT01474512|459395056|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
127665066|NCT01474512|459395057|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
127665067|NCT01474512|459395040|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
127665068|NCT01474512|459395041|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
127665069|NCT01474512|459395042|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
127665070|NCT01474512|459395043|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
127665071|NCT01474512|459395044|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
127665072|NCT01474512|459395045|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
127665073|NCT01474512|459395046|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
127665074|NCT01474512|459395047|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
127665075|NCT01474512|459395048|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
127665076|NCT01474512|459395049|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
127665077|NCT01474512|459395050|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
127665078|NCT01474512|459395051|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
127665079|NCT01474512|459395052|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
127665080|NCT01474512|459395053|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
127665081|NCT01474512|459395054|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
127665082|NCT01474512|459395055|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
127665083|NCT01474512|459395056|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
127993998|NCT01059773|460604698|FG000|Overall Study|Pregnancy|1|||
127665084|NCT01474512|459395057|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
127665085|NCT01474512|459395040|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
127993999|NCT01059773|460604699|FG001|Overall Study|Pregnancy|1|||
127665086|NCT01474512|459395041|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
127665087|NCT01474512|459395042|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
127665088|NCT01474512|459395043|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
127665089|NCT01474512|459395044|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
127665090|NCT01474512|459395045|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
127665091|NCT01474512|459395046|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
127665092|NCT01474512|459395047|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
127665093|NCT01474512|459395048|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
127994000|NCT01059773|460604698|FG000|Overall Study|Protocol Violation|6|||
127994001|NCT01059773|460604699|FG001|Overall Study|Protocol Violation|2|||
127994002|NCT01059773|460604698|FG000|Overall Study|Physician Decision|5|||
127994003|NCT01059773|460604699|FG001|Overall Study|Physician Decision|4|||
127994004|NCT01059773|460604698|FG000|Overall Study|Lack of Efficacy|3|||
127665094|NCT01474512|459395049|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
127665095|NCT01474512|459395050|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
127665096|NCT01474512|459395051|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
127665097|NCT01474512|459395052|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
127665098|NCT01474512|459395053|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
127665099|NCT01474512|459395054|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
127665100|NCT01474512|459395055|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
127665101|NCT01474512|459395056|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
127665102|NCT01474512|459395057|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
127665103|NCT01474512|459395040|FG000|Post-Treatment Follow-Up|Death|0|||
127994005|NCT01059773|460604699|FG001|Overall Study|Lack of Efficacy|3|||
127994006|NCT01059773|460604698|FG000|Overall Study|Death|0|||
127994007|NCT01059773|460604699|FG001|Overall Study|Death|1|||
127665104|NCT01474512|459395041|FG001|Post-Treatment Follow-Up|Death|0|||
127665105|NCT01474512|459395042|FG002|Post-Treatment Follow-Up|Death|0|||
127665106|NCT01474512|459395043|FG003|Post-Treatment Follow-Up|Death|0|||
127994008|NCT01059773|460604698|FG000|Overall Study|Malignancy including squamous cell skin|0|||
127994009|NCT01059773|460604699|FG001|Overall Study|Malignancy including squamous cell skin|1|||
127994010|NCT01059773|460604698|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
127994011|NCT01059773|460604699|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
127994012|NCT01059773|460604698|FG000|Overall Study|Other|1|||
127994013|NCT01059773|460604699|FG001|Overall Study|Other|3|||
127994014|NCT01300247|460604704|FG000|Overall Study|Death|1|||
127994015|NCT01300247|460604705|FG001|Overall Study|Death|1|||
127994016|NCT01300247|460604704|FG000|Overall Study|Lost to Follow-up|2|||
127994017|NCT01300247|460604705|FG001|Overall Study|Lost to Follow-up|0|||
127994018|NCT01300247|460604704|FG000|Overall Study|Withdrawal by Subject|1|||
127994019|NCT01300247|460604705|FG001|Overall Study|Withdrawal by Subject|0|||
127994020|NCT01300247|460604704|FG000|Overall Study|Non-Compliance|0|||
127994021|NCT01300247|460604705|FG001|Overall Study|Non-Compliance|1|||
127994022|NCT01556932|460604706|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
127994023|NCT01556932|460604707|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
127994024|NCT01882803|460604708|FG000|Overall Study|Disease Progression|1|||
127994025|NCT01882803|460604708|FG000|Overall Study|Withdrawal by Subject|9|||
127994026|NCT01882803|460604708|FG000|Overall Study|Death|68|||
127994027|NCT01882803|460604708|FG000|Overall Study|Physician Decision|3|||
127994028|NCT01882803|460604708|FG000|Overall Study|Lost to Follow-up|3|||
127994029|NCT01882803|460604708|FG000|Overall Study|Follow-up Completed|39|||
127994030|NCT01882803|460604708|FG000|Overall Study|Study Terminated by the Sponsor|6|||
127994031|NCT01563913|460604709|FG000|Overall Study|Physician Decision|1|||
127994032|NCT01563913|460604710|FG001|Overall Study|Physician Decision|0|||
127994033|NCT01563913|460604709|FG000|Overall Study|Spouse Passed Away|1|||
127994034|NCT01563913|460604710|FG001|Overall Study|Spouse Passed Away|0|||
127994035|NCT03066778|460604711|FG000|Overall Study|Death|195|||
127994036|NCT03066778|460604712|FG001|Overall Study|Death|205|||
127994037|NCT03066778|460604711|FG000|Overall Study|Withdrawal by Subject|5|||
127994038|NCT03066778|460604712|FG001|Overall Study|Withdrawal by Subject|7|||
127994039|NCT02328937|460604713|FG000|Period 1|Lost to Follow-up|0|||
127994040|NCT02328937|460604714|FG001|Period 1|Lost to Follow-up|0|||
127994041|NCT02328937|460604715|FG002|Period 1|Lost to Follow-up|0|||
127994042|NCT02328937|460604716|FG003|Period 1|Lost to Follow-up|1|||
127994043|NCT02328937|460604717|FG004|Period 1|Lost to Follow-up|0|||
127665107|NCT01474512|459395044|FG004|Post-Treatment Follow-Up|Death|0|||
127665108|NCT01474512|459395045|FG005|Post-Treatment Follow-Up|Death|0|||
127665109|NCT01474512|459395046|FG006|Post-Treatment Follow-Up|Death|0|||
127665110|NCT01474512|459395047|FG007|Post-Treatment Follow-Up|Death|0|||
127665111|NCT01474512|459395048|FG008|Post-Treatment Follow-Up|Death|0|||
127994044|NCT02328937|460604718|FG005|Period 1|Lost to Follow-up|0|||
127994045|NCT02328937|460604713|FG000|Period 2|Adverse Event|0|||
127994046|NCT02328937|460604714|FG001|Period 2|Adverse Event|0|||
127994047|NCT02328937|460604715|FG002|Period 2|Adverse Event|1|||
127994048|NCT02328937|460604716|FG003|Period 2|Adverse Event|0|||
127994049|NCT02328937|460604717|FG004|Period 2|Adverse Event|0|||
127994050|NCT02328937|460604718|FG005|Period 2|Adverse Event|0|||
127994051|NCT03665077|460604719|FG000|Overall Study|Lost to Follow-up|2|||
127994052|NCT03665077|460604719|FG000|Overall Study|Physician Decision|2|||
127994053|NCT03231306|460604724|FG000|Overall Study|<15% reduction in target tumor volume from baseline after Course 8 of therapy|3|||
127994054|NCT03231306|460604724|FG000|Overall Study|<20% reduction in target tumor volume from baseline after Course 12 of therapy|4|||
127994055|NCT03231306|460604724|FG000|Overall Study|Treatment delay > 21 days|2|||
127994056|NCT03231306|460604724|FG000|Overall Study|Refusal of further protocol therapy by subject/parent/guardian|6|||
127994057|NCT03231306|460604724|FG000|Overall Study|Non-compliance that in the opinion of the investigator does not allow for ongoing participation|5|||
127994058|NCT03231306|460604724|FG000|Overall Study|Binimetinib-related toxicity requiring removal from protocol therapy|3|||
127994059|NCT03231306|460604724|FG000|Overall Study|Subject Relocation Due to Covid Restrictions|1|||
127994060|NCT03231306|460604724|FG000|Overall Study|More than 1 Reason|2|||
127994061|NCT02306850|460604725|FG000|Overall Study|Lack of Efficacy|2|||
127994062|NCT00237692|460604726|FG000|Overall Study|Lost to Follow-up|9|||
127994063|NCT00237692|460604727|FG001|Overall Study|Lost to Follow-up|3|||
127994064|NCT00237692|460604728|FG002|Overall Study|Lost to Follow-up|5|||
127994065|NCT00237692|460604729|FG003|Overall Study|Lost to Follow-up|3|||
127994066|NCT00237692|460604726|FG000|Overall Study|Death|1|||
127994067|NCT00237692|460604727|FG001|Overall Study|Death|2|||
127994068|NCT00237692|460604728|FG002|Overall Study|Death|2|||
127994069|NCT00237692|460604729|FG003|Overall Study|Death|3|||
127994070|NCT00237692|460604726|FG000|Overall Study|Excluded - did not meet criteria|4|||
127994071|NCT00237692|460604727|FG001|Overall Study|Excluded - did not meet criteria|3|||
127994072|NCT00237692|460604728|FG002|Overall Study|Excluded - did not meet criteria|5|||
127994073|NCT00237692|460604729|FG003|Overall Study|Excluded - did not meet criteria|9|||
127994074|NCT00237692|460604726|FG000|Overall Study|Withdrawal by Subject|4|||
127994075|NCT00237692|460604727|FG001|Overall Study|Withdrawal by Subject|6|||
127994076|NCT00237692|460604728|FG002|Overall Study|Withdrawal by Subject|10|||
127994077|NCT00237692|460604729|FG003|Overall Study|Withdrawal by Subject|4|||
127994078|NCT02420262|460604730|FG000|Overall Study|Adverse Event|1|||
127994079|NCT02420262|460604731|FG001|Overall Study|Adverse Event|0|||
127994080|NCT02420262|460604730|FG000|Overall Study|Withdrawal by Subject|1|||
127994081|NCT02420262|460604731|FG001|Overall Study|Withdrawal by Subject|4|||
127994082|NCT02420262|460604730|FG000|Overall Study|Unclassified|0|||
127994083|NCT02420262|460604731|FG001|Overall Study|Unclassified|1|||
127994084|NCT00685360|460604735|FG000|Overall Study|Lost to Follow-up|0|||
127994085|NCT00685360|460604736|FG001|Overall Study|Lost to Follow-up|1|||
127994086|NCT00685360|460604737|FG002|Overall Study|Lost to Follow-up|2|||
127994087|NCT00685360|460604735|FG000|Overall Study|Adverse Event|4|||
127994088|NCT00685360|460604736|FG001|Overall Study|Adverse Event|6|||
127994089|NCT00685360|460604737|FG002|Overall Study|Adverse Event|4|||
127994090|NCT00685360|460604735|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
127994091|NCT00685360|460604736|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
127994092|NCT00685360|460604737|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
127994093|NCT00685360|460604735|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
127994094|NCT00685360|460604736|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
127994095|NCT00685360|460604737|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
127994096|NCT00685360|460604735|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
127994097|NCT00685360|460604736|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
127994098|NCT00685360|460604737|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
127994099|NCT00685360|460604735|FG000|Overall Study|Protocol Deviation|0|||
127994100|NCT00685360|460604736|FG001|Overall Study|Protocol Deviation|1|||
127994101|NCT00685360|460604737|FG002|Overall Study|Protocol Deviation|1|||
127994102|NCT04865419|460604738|FG000|Overall Study|Other|1|||
127994103|NCT04865419|460604739|FG001|Overall Study|Other|2|||
127994104|NCT04865419|460604740|FG002|Overall Study|Other|2|||
127994105|NCT04865419|460604741|FG003|Overall Study|Other|1|||
127994106|NCT04865419|460604742|FG004|Overall Study|Other|3|||
127994107|NCT04865419|460604743|FG005|Overall Study|Other|0|||
127994108|NCT04865419|460604744|FG006|Overall Study|Other|0|||
127994109|NCT04865419|460604745|FG007|Overall Study|Other|1|||
127994110|NCT04865419|460604746|FG008|Overall Study|Other|0|||
127994111|NCT04865419|460604747|FG009|Overall Study|Other|0|||
127994112|NCT04865419|460604748|FG010|Overall Study|Other|0|||
127994113|NCT04865419|460604738|FG000|Overall Study|Withdrawal by Subject|0|||
127994114|NCT04865419|460604739|FG001|Overall Study|Withdrawal by Subject|1|||
127994115|NCT04865419|460604740|FG002|Overall Study|Withdrawal by Subject|1|||
127994116|NCT04865419|460604741|FG003|Overall Study|Withdrawal by Subject|0|||
127994117|NCT04865419|460604742|FG004|Overall Study|Withdrawal by Subject|0|||
127994118|NCT04865419|460604743|FG005|Overall Study|Withdrawal by Subject|0|||
127994119|NCT04865419|460604744|FG006|Overall Study|Withdrawal by Subject|0|||
127994120|NCT04865419|460604745|FG007|Overall Study|Withdrawal by Subject|1|||
127994121|NCT04865419|460604746|FG008|Overall Study|Withdrawal by Subject|2|||
127994122|NCT04865419|460604747|FG009|Overall Study|Withdrawal by Subject|1|||
127994123|NCT04865419|460604748|FG010|Overall Study|Withdrawal by Subject|0|||
127994124|NCT04865419|460604738|FG000|Overall Study|Study terminated by Sponsor|0|||
127994125|NCT04865419|460604739|FG001|Overall Study|Study terminated by Sponsor|0|||
127994126|NCT04865419|460604740|FG002|Overall Study|Study terminated by Sponsor|0|||
127994127|NCT04865419|460604741|FG003|Overall Study|Study terminated by Sponsor|2|||
127994128|NCT04865419|460604742|FG004|Overall Study|Study terminated by Sponsor|2|||
127994129|NCT04865419|460604743|FG005|Overall Study|Study terminated by Sponsor|0|||
127994130|NCT04865419|460604744|FG006|Overall Study|Study terminated by Sponsor|0|||
127994131|NCT04865419|460604745|FG007|Overall Study|Study terminated by Sponsor|0|||
127994132|NCT04865419|460604746|FG008|Overall Study|Study terminated by Sponsor|0|||
127994133|NCT04865419|460604747|FG009|Overall Study|Study terminated by Sponsor|0|||
127994134|NCT04865419|460604748|FG010|Overall Study|Study terminated by Sponsor|1|||
127994135|NCT04865419|460604738|FG000|Overall Study|Death|3|||
127994136|NCT04865419|460604739|FG001|Overall Study|Death|1|||
127994137|NCT04865419|460604740|FG002|Overall Study|Death|4|||
127994138|NCT04865419|460604741|FG003|Overall Study|Death|2|||
127994139|NCT04865419|460604742|FG004|Overall Study|Death|5|||
127994140|NCT04865419|460604743|FG005|Overall Study|Death|2|||
127665112|NCT01474512|459395049|FG009|Post-Treatment Follow-Up|Death|0|||
127665113|NCT01474512|459395050|FG010|Post-Treatment Follow-Up|Death|0|||
127665114|NCT01474512|459395051|FG011|Post-Treatment Follow-Up|Death|0|||
127665115|NCT01474512|459395052|FG012|Post-Treatment Follow-Up|Death|0|||
127665116|NCT01474512|459395053|FG013|Post-Treatment Follow-Up|Death|0|||
127665117|NCT01474512|459395054|FG014|Post-Treatment Follow-Up|Death|0|||
127665118|NCT01474512|459395055|FG015|Post-Treatment Follow-Up|Death|0|||
127665119|NCT01474512|459395056|FG016|Post-Treatment Follow-Up|Death|1|||
127994141|NCT04865419|460604744|FG006|Overall Study|Death|1|||
127994142|NCT04865419|460604745|FG007|Overall Study|Death|1|||
127994143|NCT04865419|460604746|FG008|Overall Study|Death|2|||
127994144|NCT04865419|460604747|FG009|Overall Study|Death|2|||
127994145|NCT04865419|460604748|FG010|Overall Study|Death|1|||
127994146|NCT04865419|460604738|FG000|Overall Study|Lost to Follow-up|0|||
127994147|NCT04865419|460604739|FG001|Overall Study|Lost to Follow-up|0|||
127994148|NCT04865419|460604740|FG002|Overall Study|Lost to Follow-up|0|||
127994149|NCT04865419|460604741|FG003|Overall Study|Lost to Follow-up|0|||
127994150|NCT04865419|460604742|FG004|Overall Study|Lost to Follow-up|0|||
127994151|NCT04865419|460604743|FG005|Overall Study|Lost to Follow-up|0|||
127994152|NCT04865419|460604744|FG006|Overall Study|Lost to Follow-up|0|||
127994153|NCT04865419|460604745|FG007|Overall Study|Lost to Follow-up|0|||
127994154|NCT04865419|460604746|FG008|Overall Study|Lost to Follow-up|0|||
127994155|NCT04865419|460604747|FG009|Overall Study|Lost to Follow-up|1|||
127994156|NCT04865419|460604748|FG010|Overall Study|Lost to Follow-up|0|||
127994157|NCT04208412|460604749|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
127994158|NCT04208412|460604750|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
127994159|NCT04208412|460604749|FG000|Overall Study|Withdrawal by Subject|1|||
127994160|NCT04208412|460604750|FG001|Overall Study|Withdrawal by Subject|0|||
127994161|NCT04208412|460604749|FG000|Overall Study|Lost to Follow-up|0|||
127994162|NCT04208412|460604750|FG001|Overall Study|Lost to Follow-up|1|||
127994163|NCT01904032|460604759|FG000|Overall Study|Adverse Event|3|||
127994164|NCT01904032|460604760|FG001|Overall Study|Adverse Event|1|||
127994165|NCT01904032|460604759|FG000|Overall Study|Lost to Follow-up|4|||
127994166|NCT01904032|460604760|FG001|Overall Study|Lost to Follow-up|2|||
127994167|NCT04074330|460604769|FG000|Dose Escalation (up to 19.36 Months)|Death|0|||
127994168|NCT04074330|460604770|FG001|Dose Escalation (up to 19.36 Months)|Death|2|||
127994169|NCT04074330|460604771|FG002|Dose Escalation (up to 19.36 Months)|Death|0|||
127994170|NCT04074330|460604772|FG003|Dose Escalation (up to 19.36 Months)|Death|1|||
127994171|NCT04074330|460604773|FG004|Dose Escalation (up to 19.36 Months)|Death|4|||
127994172|NCT04074330|460604774|FG005|Dose Escalation (up to 19.36 Months)|Death|1|||
127994173|NCT04074330|460604775|FG006|Dose Escalation (up to 19.36 Months)|Death|0|||
127994174|NCT04074330|460604776|FG007|Dose Escalation (up to 19.36 Months)|Death|0|||
127994175|NCT04074330|460604777|FG008|Dose Escalation (up to 19.36 Months)|Death|0|||
127994176|NCT04074330|460604778|FG009|Dose Escalation (up to 19.36 Months)|Death|0|||
127994177|NCT04074330|460604769|FG000|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
127665120|NCT01474512|459395057|FG017|Post-Treatment Follow-Up|Death|0|||
127665121|NCT01023308|459395062|FG000|Overall Study|Abnormal test proceedure results|3|||
127994178|NCT04074330|460604770|FG001|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
127994179|NCT04074330|460604771|FG002|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
127994180|NCT04074330|460604772|FG003|Dose Escalation (up to 19.36 Months)|Progressive Disease|5|||
127994181|NCT04074330|460604773|FG004|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
127994182|NCT04074330|460604774|FG005|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
127994183|NCT04074330|460604775|FG006|Dose Escalation (up to 19.36 Months)|Progressive Disease|1|||
127994184|NCT04074330|460604776|FG007|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
127994185|NCT04074330|460604777|FG008|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
127994186|NCT04074330|460604778|FG009|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
127994187|NCT04074330|460604769|FG000|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
127994188|NCT04074330|460604770|FG001|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
127994189|NCT04074330|460604771|FG002|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|1|||
127994190|NCT04074330|460604772|FG003|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
127994191|NCT04074330|460604773|FG004|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
127994192|NCT04074330|460604774|FG005|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
127994193|NCT04074330|460604775|FG006|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
127994194|NCT04074330|460604776|FG007|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
127994195|NCT04074330|460604777|FG008|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
127994196|NCT04074330|460604778|FG009|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
127994197|NCT04074330|460604769|FG000|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
127994198|NCT04074330|460604770|FG001|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
127994199|NCT04074330|460604771|FG002|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
127994200|NCT04074330|460604772|FG003|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
127994201|NCT04074330|460604773|FG004|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
127994202|NCT04074330|460604774|FG005|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
127994203|NCT04074330|460604775|FG006|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
127994204|NCT04074330|460604776|FG007|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
127994205|NCT04074330|460604777|FG008|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
127665122|NCT01023308|459395063|FG001|Overall Study|Abnormal test proceedure results|8|||
127665123|NCT01023308|459395062|FG000|Overall Study|Administrative problems|2|||
127665124|NCT01023308|459395063|FG001|Overall Study|Administrative problems|1|||
127665125|NCT01023308|459395062|FG000|Overall Study|Adverse Event|130|||
127665126|NCT01023308|459395063|FG001|Overall Study|Adverse Event|66|||
127665127|NCT01023308|459395062|FG000|Overall Study|Death|21|||
127665128|NCT01023308|459395063|FG001|Overall Study|Death|17|||
127665129|NCT01023308|459395062|FG000|Overall Study|Disease progression|82|||
127665130|NCT01023308|459395063|FG001|Overall Study|Disease progression|153|||
127665131|NCT01023308|459395062|FG000|Overall Study|New Cancer therapy|4|||
127665132|NCT01023308|459395063|FG001|Overall Study|New Cancer therapy|7|||
127665133|NCT01023308|459395062|FG000|Overall Study|Protocol Violation|3|||
127665134|NCT01023308|459395063|FG001|Overall Study|Protocol Violation|4|||
127665135|NCT01023308|459395062|FG000|Overall Study|Untreated|5|||
127665136|NCT01023308|459395063|FG001|Overall Study|Untreated|5|||
127665137|NCT01023308|459395062|FG000|Overall Study|Lost to Follow-up|1|||
127665138|NCT01023308|459395063|FG001|Overall Study|Lost to Follow-up|0|||
127665139|NCT01023308|459395062|FG000|Overall Study|Withdrawal by Subject|34|||
127665140|NCT01023308|459395063|FG001|Overall Study|Withdrawal by Subject|18|||
127665141|NCT00551213|459395064|FG000|Overall Study|Adverse Event|6|||
127665142|NCT00551213|459395065|FG001|Overall Study|Adverse Event|3|||
127665143|NCT00551213|459395064|FG000|Overall Study|Progressive Disease|41|||
127665144|NCT00551213|459395065|FG001|Overall Study|Progressive Disease|12|||
127665145|NCT00551213|459395064|FG000|Overall Study|Withdrawal by Subject|2|||
127665146|NCT00551213|459395065|FG001|Overall Study|Withdrawal by Subject|0|||
127665147|NCT00551213|459395064|FG000|Overall Study|Not Treated|1|||
127665148|NCT00551213|459395065|FG001|Overall Study|Not Treated|2|||
127665149|NCT01890967|459395066|FG000|Overall Study|Adverse Event|3|||
127665150|NCT01890967|459395067|FG001|Overall Study|Adverse Event|3|||
127665151|NCT01890967|459395068|FG002|Overall Study|Adverse Event|3|||
127665152|NCT01890967|459395069|FG003|Overall Study|Adverse Event|2|||
127665153|NCT01890967|459395070|FG004|Overall Study|Adverse Event|1|||
127665154|NCT01890967|459395071|FG005|Overall Study|Adverse Event|7|||
127665155|NCT01890967|459395066|FG000|Overall Study|Death|1|||
127665156|NCT01890967|459395067|FG001|Overall Study|Death|0|||
127665157|NCT01890967|459395068|FG002|Overall Study|Death|0|||
127665158|NCT01890967|459395069|FG003|Overall Study|Death|0|||
127665159|NCT01890967|459395070|FG004|Overall Study|Death|0|||
127665160|NCT01890967|459395071|FG005|Overall Study|Death|0|||
127665161|NCT01890967|459395066|FG000|Overall Study|Lost to Follow-up|1|||
127665162|NCT01890967|459395067|FG001|Overall Study|Lost to Follow-up|1|||
127665163|NCT01890967|459395068|FG002|Overall Study|Lost to Follow-up|1|||
127665164|NCT01890967|459395069|FG003|Overall Study|Lost to Follow-up|1|||
127665165|NCT01890967|459395070|FG004|Overall Study|Lost to Follow-up|0|||
127665166|NCT01890967|459395071|FG005|Overall Study|Lost to Follow-up|1|||
127665167|NCT01890967|459395066|FG000|Overall Study|Protocol Violation|0|||
127665168|NCT01890967|459395067|FG001|Overall Study|Protocol Violation|3|||
127665169|NCT01890967|459395068|FG002|Overall Study|Protocol Violation|3|||
127665170|NCT01890967|459395069|FG003|Overall Study|Protocol Violation|2|||
127665171|NCT01890967|459395070|FG004|Overall Study|Protocol Violation|4|||
127665172|NCT01890967|459395071|FG005|Overall Study|Protocol Violation|1|||
127665173|NCT01890967|459395066|FG000|Overall Study|Sponsor Decision|2|||
127665174|NCT01890967|459395067|FG001|Overall Study|Sponsor Decision|0|||
127665175|NCT01890967|459395068|FG002|Overall Study|Sponsor Decision|1|||
127665176|NCT01890967|459395069|FG003|Overall Study|Sponsor Decision|3|||
127665177|NCT01890967|459395070|FG004|Overall Study|Sponsor Decision|2|||
127665178|NCT01890967|459395071|FG005|Overall Study|Sponsor Decision|3|||
127665179|NCT01890967|459395066|FG000|Overall Study|Withdrawal by Subject|3|||
127994206|NCT04074330|460604778|FG009|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
127994207|NCT04074330|460604769|FG000|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
127994208|NCT04074330|460604770|FG001|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
127994209|NCT04074330|460604771|FG002|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
127994210|NCT04074330|460604772|FG003|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
127994211|NCT04074330|460604773|FG004|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|2|||
127994212|NCT04074330|460604774|FG005|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
127994213|NCT04074330|460604775|FG006|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
127994214|NCT04074330|460604776|FG007|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
127994215|NCT04074330|460604777|FG008|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
127994216|NCT04074330|460604778|FG009|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
127994217|NCT04074330|460604769|FG000|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
127994218|NCT04074330|460604770|FG001|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
127994219|NCT04074330|460604771|FG002|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
127994220|NCT04074330|460604772|FG003|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
127994221|NCT04074330|460604773|FG004|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
127994222|NCT04074330|460604774|FG005|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
127994223|NCT04074330|460604775|FG006|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
127994224|NCT04074330|460604776|FG007|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
127994225|NCT04074330|460604777|FG008|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
127994226|NCT04074330|460604778|FG009|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
127994227|NCT04074330|460604769|FG000|Dose Expansion (up to 42 Months)|Death|0|||
127994228|NCT04074330|460604770|FG001|Dose Expansion (up to 42 Months)|Death|0|||
127994229|NCT04074330|460604771|FG002|Dose Expansion (up to 42 Months)|Death|0|||
127994230|NCT04074330|460604772|FG003|Dose Expansion (up to 42 Months)|Death|0|||
127994231|NCT04074330|460604773|FG004|Dose Expansion (up to 42 Months)|Death|0|||
127994232|NCT04074330|460604774|FG005|Dose Expansion (up to 42 Months)|Death|0|||
127994233|NCT04074330|460604775|FG006|Dose Expansion (up to 42 Months)|Death|0|||
127994234|NCT04074330|460604776|FG007|Dose Expansion (up to 42 Months)|Death|0|||
127994235|NCT04074330|460604777|FG008|Dose Expansion (up to 42 Months)|Death|1|||
127994236|NCT04074330|460604778|FG009|Dose Expansion (up to 42 Months)|Death|0|||
127994237|NCT04074330|460604769|FG000|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
127994238|NCT04074330|460604770|FG001|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
127994239|NCT04074330|460604771|FG002|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
127994240|NCT04074330|460604772|FG003|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
127994241|NCT04074330|460604773|FG004|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
127994242|NCT04074330|460604774|FG005|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
127994243|NCT04074330|460604775|FG006|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
127994244|NCT04074330|460604776|FG007|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
127994245|NCT04074330|460604777|FG008|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
127994246|NCT04074330|460604778|FG009|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
127994247|NCT00184093|460604779|FG000|Overall Study|Adverse Event|3|||
127994248|NCT00184093|460604779|FG000|Overall Study|Lost to Follow-up|3|||
127994249|NCT00184093|460604779|FG000|Overall Study|Physician Decision|1|||
127994250|NCT00184093|460604779|FG000|Overall Study|Withdrawal by Subject|2|||
127994251|NCT01903993|460604780|FG000|Overall Study|Death|118|||
127994252|NCT01903993|460604781|FG001|Overall Study|Death|121|||
127994253|NCT01903993|460604780|FG000|Overall Study|Withdrawal by Subject|15|||
127994254|NCT01903993|460604781|FG001|Overall Study|Withdrawal by Subject|4|||
127994255|NCT01903993|460604780|FG000|Overall Study|Lost to Follow-up|2|||
127994256|NCT01903993|460604781|FG001|Overall Study|Lost to Follow-up|3|||
127994257|NCT01903993|460604780|FG000|Overall Study|Study Terminated by Sponsor|8|||
127994258|NCT01903993|460604781|FG001|Overall Study|Study Terminated by Sponsor|14|||
127994259|NCT01903993|460604780|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
127994260|NCT01903993|460604781|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
127994261|NCT05095311|460604782|FG000|Overall Study|Lost to Follow-up|7|||
127994262|NCT05095311|460604783|FG001|Overall Study|Lost to Follow-up|0|||
127994263|NCT05095311|460604784|FG002|Overall Study|Lost to Follow-up|0|||
127994264|NCT00972283|460604785|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
127994265|NCT00972283|460604786|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
127994266|NCT00972283|460604785|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
127994267|NCT00972283|460604786|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
127994268|NCT00972283|460604785|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
127994269|NCT00972283|460604786|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
127665180|NCT01890967|459395067|FG001|Overall Study|Withdrawal by Subject|4|||
127665181|NCT01890967|459395068|FG002|Overall Study|Withdrawal by Subject|2|||
127665182|NCT01890967|459395069|FG003|Overall Study|Withdrawal by Subject|3|||
127994270|NCT00972283|460604785|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
127994271|NCT00972283|460604786|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
127994272|NCT00972283|460604785|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
127994273|NCT00972283|460604786|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
127994274|NCT00972283|460604785|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
127994275|NCT00972283|460604786|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
127994276|NCT00972283|460604785|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
127994277|NCT00972283|460604786|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
127994278|NCT00972283|460604785|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
127994279|NCT00972283|460604786|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
127994280|NCT00972283|460604785|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
127994281|NCT00972283|460604786|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
127994282|NCT00972283|460604785|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
127994283|NCT00972283|460604786|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
127994284|NCT01868165|460604789|FG000|Overall Study|Withdrawal by Subject|36|||
127994285|NCT01868165|460604789|FG000|Overall Study|Physician Decision|2|||
127994286|NCT01868165|460604789|FG000|Overall Study|Lost to Follow-up|3|||
127994287|NCT01868165|460604789|FG000|Overall Study|Death|4|||
127994288|NCT01124292|460604793|FG000|Overall Study|Lost to Follow-up|2|||
127994289|NCT01124292|460604794|FG001|Overall Study|Lost to Follow-up|4|||
127994290|NCT01124292|460604795|FG002|Overall Study|Lost to Follow-up|3|||
127994291|NCT01124292|460604793|FG000|Overall Study|Physician Decision|0|||
127994292|NCT01124292|460604794|FG001|Overall Study|Physician Decision|3|||
127994293|NCT01124292|460604795|FG002|Overall Study|Physician Decision|2|||
127994294|NCT01124292|460604793|FG000|Overall Study|Withdrawal by Subject|0|||
127994295|NCT01124292|460604794|FG001|Overall Study|Withdrawal by Subject|6|||
127994296|NCT01124292|460604795|FG002|Overall Study|Withdrawal by Subject|2|||
127994297|NCT01124292|460604793|FG000|Overall Study|medical issue unrelated to the study|0|||
127994298|NCT01124292|460604794|FG001|Overall Study|medical issue unrelated to the study|0|||
127994299|NCT01124292|460604795|FG002|Overall Study|medical issue unrelated to the study|2|||
127994300|NCT01124292|460604793|FG000|Overall Study|piercing track closed|0|||
127994301|NCT01124292|460604794|FG001|Overall Study|piercing track closed|2|||
127994302|NCT01124292|460604795|FG002|Overall Study|piercing track closed|1|||
127994303|NCT03373461|460604796|FG000|Part 2|Adverse Event|0|||
127994304|NCT03373461|460604797|FG001|Part 2|Adverse Event|1|||
127994305|NCT03373461|460604798|FG002|Part 2|Adverse Event|0|||
127994306|NCT03373461|460604799|FG003|Part 2|Adverse Event|0|||
127994307|NCT03373461|460604800|FG004|Part 2|Adverse Event|1|||
127994308|NCT01919164|460606497|FG000|Overall Study|Adverse Event|6|||
127994309|NCT01919164|460606498|FG001|Overall Study|Adverse Event|4|||
127994310|NCT01919164|460606499|FG002|Overall Study|Adverse Event|9|||
127994311|NCT01919164|460606500|FG003|Overall Study|Adverse Event|3|||
127994312|NCT01919164|460606501|FG004|Overall Study|Adverse Event|2|||
127994313|NCT01919164|460606497|FG000|Overall Study|Lost to Follow-up|2|||
127994314|NCT01919164|460606498|FG001|Overall Study|Lost to Follow-up|2|||
127994315|NCT01919164|460606499|FG002|Overall Study|Lost to Follow-up|2|||
127994316|NCT01919164|460606500|FG003|Overall Study|Lost to Follow-up|0|||
127994317|NCT01919164|460606501|FG004|Overall Study|Lost to Follow-up|4|||
127994318|NCT01919164|460606497|FG000|Overall Study|Death|1|||
127994319|NCT01919164|460606498|FG001|Overall Study|Death|0|||
127994320|NCT01919164|460606499|FG002|Overall Study|Death|0|||
127994321|NCT01919164|460606500|FG003|Overall Study|Death|0|||
127994322|NCT01919164|460606501|FG004|Overall Study|Death|0|||
127994323|NCT01919164|460606497|FG000|Overall Study|Protocol Violation|6|||
127994324|NCT01919164|460606498|FG001|Overall Study|Protocol Violation|0|||
127994325|NCT01919164|460606499|FG002|Overall Study|Protocol Violation|3|||
127994326|NCT01919164|460606500|FG003|Overall Study|Protocol Violation|2|||
127994327|NCT01919164|460606501|FG004|Overall Study|Protocol Violation|2|||
127994328|NCT01919164|460606497|FG000|Overall Study|Disease progression|2|||
127994329|NCT01919164|460606498|FG001|Overall Study|Disease progression|2|||
127994330|NCT01919164|460606499|FG002|Overall Study|Disease progression|1|||
127994331|NCT01919164|460606500|FG003|Overall Study|Disease progression|2|||
127994332|NCT01919164|460606501|FG004|Overall Study|Disease progression|1|||
127994333|NCT01919164|460606497|FG000|Overall Study|Withdrew consent|13|||
127994334|NCT01919164|460606498|FG001|Overall Study|Withdrew consent|13|||
127994335|NCT01919164|460606499|FG002|Overall Study|Withdrew consent|14|||
127994336|NCT01919164|460606500|FG003|Overall Study|Withdrew consent|14|||
127994337|NCT01919164|460606501|FG004|Overall Study|Withdrew consent|9|||
127994338|NCT01919164|460606497|FG000|Overall Study|Other Un-specified|13|||
127994339|NCT01919164|460606498|FG001|Overall Study|Other Un-specified|9|||
127994340|NCT01919164|460606499|FG002|Overall Study|Other Un-specified|8|||
127994341|NCT01919164|460606500|FG003|Overall Study|Other Un-specified|7|||
127994342|NCT01919164|460606501|FG004|Overall Study|Other Un-specified|15|||
127994343|NCT00588146|460606502|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
127994344|NCT00588146|460606503|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
127994345|NCT02823470|460606504|FG000|Overall Study|Adverse Event|1|||
127994346|NCT02823470|460606505|FG001|Overall Study|Adverse Event|0|||
127994347|NCT02823470|460606504|FG000|Overall Study|Study terminated by sponsor|8|||
127994348|NCT02823470|460606505|FG001|Overall Study|Study terminated by sponsor|15|||
127994349|NCT00463801|460606508|FG000|Overall Study|Protocol Violation|1|||
127994350|NCT00463801|460606508|FG000|Overall Study|Lack of Efficacy|2|||
127994351|NCT00463801|460606508|FG000|Overall Study|Adverse Event|4|||
127994352|NCT00463801|460606508|FG000|Overall Study|Lost to Follow-up|5|||
127994353|NCT00463801|460606508|FG000|Overall Study|No longer require therapy|1|||
127994354|NCT02315664|460606509|FG000|Overall Study|Lost to Follow-up|1|||
127994355|NCT02315664|460606510|FG001|Overall Study|Lost to Follow-up|1|||
127994356|NCT02315664|460606509|FG000|Overall Study|Withdrawal by Subject|0|||
127994357|NCT02315664|460606510|FG001|Overall Study|Withdrawal by Subject|3|||
127994358|NCT02748057|460606514|FG000|Overall Study|Adverse Event|1|||
127994359|NCT02748057|460606515|FG001|Overall Study|Adverse Event|0|||
127994360|NCT02748057|460606514|FG000|Overall Study|Physician Decision|0|||
127994361|NCT02748057|460606515|FG001|Overall Study|Physician Decision|1|||
127994362|NCT02748057|460606514|FG000|Overall Study|Protocol Violation|2|||
127994363|NCT02748057|460606515|FG001|Overall Study|Protocol Violation|1|||
127994364|NCT02748057|460606514|FG000|Overall Study|Participant Moved|1|||
127994365|NCT02748057|460606515|FG001|Overall Study|Participant Moved|0|||
127994366|NCT02748057|460606514|FG000|Overall Study|Withdrawal by Subject|1|||
127994367|NCT02748057|460606515|FG001|Overall Study|Withdrawal by Subject|0|||
127994368|NCT01990573|460606516|FG000|Overall Study|Physician Decision|0|||
127994369|NCT01990573|460606517|FG001|Overall Study|Physician Decision|0|||
127994370|NCT01990573|460606518|FG002|Overall Study|Physician Decision|1|||
127994371|NCT03335813|460606523|FG000|Overall Study|Withdrawal by Subject|1|||
127994372|NCT02492165|460606526|FG000|Overall Study|Withdrawal by Subject|0|||
127994373|NCT02492165|460606527|FG001|Overall Study|Withdrawal by Subject|1|||
127994374|NCT02492165|460606528|FG002|Overall Study|Withdrawal by Subject|0|||
127994375|NCT02492165|460606529|FG003|Overall Study|Withdrawal by Subject|0|||
127994376|NCT02256917|460606530|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
127994377|NCT02256917|460606530|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
127994378|NCT02256917|460606530|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
127994379|NCT02256917|460606530|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
127994380|NCT02256917|460606530|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
127994381|NCT00715299|460606532|FG000|Overall Study|Withdrawal by Subject|1|||
127994382|NCT00715299|460606532|FG000|Overall Study|Adverse Event|3|||
127994383|NCT00715299|460606532|FG000|Overall Study|failed the pre-screen exercise test|2|||
127994384|NCT00872521|460606533|FG000|Completed PAD Induction|Patient choice|0|||
127994385|NCT00872521|460606534|FG001|Completed PAD Induction|Patient choice|1|||
127994386|NCT00872521|460606535|FG002|Completed PAD Induction|Patient choice|0|||
127994387|NCT00872521|460606533|FG000|Completed PAD Induction|Disease progression|0|||
127994388|NCT00872521|460606534|FG001|Completed PAD Induction|Disease progression|2|||
127994389|NCT00872521|460606535|FG002|Completed PAD Induction|Disease progression|0|||
127994390|NCT00872521|460606533|FG000|Completed PAD Induction|Adverse Event|4|||
127994391|NCT00872521|460606534|FG001|Completed PAD Induction|Adverse Event|0|||
127665183|NCT01890967|459395070|FG004|Overall Study|Withdrawal by Subject|3|||
127665184|NCT01890967|459395071|FG005|Overall Study|Withdrawal by Subject|1|||
127665185|NCT01383993|459395073|FG000|Overall Study|Adverse Event|1|||
127665186|NCT01383993|459395074|FG001|Overall Study|Adverse Event|1|||
127665187|NCT01383993|459395075|FG002|Overall Study|Adverse Event|0|||
127665188|NCT01383993|459395073|FG000|Overall Study|Withdrawal by Subject|0|||
127665189|NCT01383993|459395074|FG001|Overall Study|Withdrawal by Subject|0|||
127665190|NCT01383993|459395075|FG002|Overall Study|Withdrawal by Subject|1|||
127665191|NCT01383993|459395073|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
127665192|NCT01383993|459395074|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
127665193|NCT01383993|459395075|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
127665194|NCT02561455|459395078|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
127665195|NCT02561455|459395079|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
127665196|NCT02561455|459395080|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
127665197|NCT02561455|459395081|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
127665198|NCT02561455|459395078|FG000|Overall Study|Withdrawal by Subject|1|||
127665199|NCT02561455|459395079|FG001|Overall Study|Withdrawal by Subject|0|||
127665200|NCT02561455|459395080|FG002|Overall Study|Withdrawal by Subject|1|||
127665201|NCT02561455|459395081|FG003|Overall Study|Withdrawal by Subject|0|||
127665202|NCT02561455|459395078|FG000|Overall Study|Disease Progression|0|||
127665203|NCT02561455|459395079|FG001|Overall Study|Disease Progression|1|||
127665204|NCT02561455|459395080|FG002|Overall Study|Disease Progression|0|||
127665205|NCT02561455|459395081|FG003|Overall Study|Disease Progression|0|||
127665206|NCT03249376|459395084|FG000|Overall Study|Adverse Event|11|||
127665207|NCT03249376|459395085|FG001|Overall Study|Adverse Event|5|||
127994392|NCT00872521|460606535|FG002|Completed PAD Induction|Adverse Event|0|||
127994393|NCT00872521|460606533|FG000|Completed PAD Induction|Death|1|||
127994394|NCT00872521|460606534|FG001|Completed PAD Induction|Death|1|||
127994395|NCT00872521|460606535|FG002|Completed PAD Induction|Death|0|||
127994396|NCT00872521|460606533|FG000|Primary Endpoint Analysis|Other|1|||
127994397|NCT00872521|460606534|FG001|Primary Endpoint Analysis|Other|2|||
127994398|NCT00872521|460606535|FG002|Primary Endpoint Analysis|Other|0|||
127994399|NCT00872521|460606533|FG000|Primary Endpoint Analysis|Patient choice|0|||
127994400|NCT00872521|460606534|FG001|Primary Endpoint Analysis|Patient choice|1|||
127994401|NCT00872521|460606535|FG002|Primary Endpoint Analysis|Patient choice|0|||
127994402|NCT00872521|460606533|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
127994403|NCT00872521|460606534|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
127994404|NCT00872521|460606535|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
127994405|NCT00872521|460606533|FG000|Primary Endpoint Analysis|Patient response missing|0|||
127994406|NCT00872521|460606534|FG001|Primary Endpoint Analysis|Patient response missing|0|||
127994407|NCT00872521|460606535|FG002|Primary Endpoint Analysis|Patient response missing|1|||
127994408|NCT00872521|460606533|FG000|Completed 3-month Follow up|Other|0|||
127994409|NCT00872521|460606534|FG001|Completed 3-month Follow up|Other|2|||
127994410|NCT00872521|460606535|FG002|Completed 3-month Follow up|Other|0|||
127994411|NCT00872521|460606533|FG000|Completed 3-month Follow up|Physician Decision|0|||
127994412|NCT00872521|460606534|FG001|Completed 3-month Follow up|Physician Decision|1|||
127994413|NCT00872521|460606535|FG002|Completed 3-month Follow up|Physician Decision|0|||
127994414|NCT00872521|460606533|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
127994415|NCT00872521|460606534|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
127994416|NCT00872521|460606535|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
127994417|NCT02982863|460606536|FG000|Overall Study|Not eligible patients|809|||
127994418|NCT02982863|460606537|FG001|Overall Study|Not eligible patients|4261|||
127994419|NCT02982863|460606538|FG002|Overall Study|Not eligible patients|1852|||
127994420|NCT02982863|460606539|FG003|Overall Study|Not eligible patients|1400|||
127994421|NCT02982863|460606540|FG004|Overall Study|Not eligible patients|492|||
127994422|NCT02457195|460606541|FG000|Overall Study|Adverse Event|3|||
127994423|NCT02457195|460606541|FG000|Overall Study|Protocol Violation|2|||
127994424|NCT02457195|460606541|FG000|Overall Study|Withdrawal by Subject|4|||
127994425|NCT01896193|460606542|FG000|Overall Study|Lack of Efficacy|20|||
127994426|NCT01896193|460606543|FG001|Overall Study|Lack of Efficacy|11|||
127994427|NCT01896193|460606542|FG000|Overall Study|Protocol Violation|0|||
127994428|NCT01896193|460606543|FG001|Overall Study|Protocol Violation|1|||
127994429|NCT01896193|460606542|FG000|Overall Study|Withdrew Consent|1|||
127994430|NCT01896193|460606543|FG001|Overall Study|Withdrew Consent|0|||
127994431|NCT04819438|460606544|FG000|Overall Study|Withdrawal by Subject|1|||
127994432|NCT04819438|460606545|FG001|Overall Study|Withdrawal by Subject|0|||
127994433|NCT04819438|460606544|FG000|Overall Study|Adverse Event|0|||
127994434|NCT04819438|460606545|FG001|Overall Study|Adverse Event|1|||
127994435|NCT04819438|460606544|FG000|Overall Study|Protocol Violation|0|||
127994436|NCT04819438|460606545|FG001|Overall Study|Protocol Violation|1|||
127994437|NCT03465709|460606546|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
127994438|NCT03465709|460606546|FG000|Overall Study|Withdrawal by Subject|3|||
127994439|NCT05359952|460606547|FG000|Overall Study|Lost to Follow-up|1|||
127994440|NCT05359952|460606548|FG001|Overall Study|Lost to Follow-up|0|||
127994441|NCT03060291|460606549|FG000|3-month Follow-up|Declined to respond|8|||
127994442|NCT03060291|460606550|FG001|3-month Follow-up|Declined to respond|10|||
127994443|NCT03060291|460606551|FG002|3-month Follow-up|Declined to respond|2|||
127994444|NCT03060291|460606549|FG000|6-month Follow-up|Declined to respond|7|||
127994445|NCT03060291|460606550|FG001|6-month Follow-up|Declined to respond|13|||
127994446|NCT03060291|460606551|FG002|6-month Follow-up|Declined to respond|4|||
127994447|NCT03060291|460606549|FG000|12-month Follow-up|Declined to respond|7|||
127994448|NCT03060291|460606550|FG001|12-month Follow-up|Declined to respond|16|||
127994449|NCT03060291|460606551|FG002|12-month Follow-up|Declined to respond|6|||
127994450|NCT00996034|460606556|FG000|Overall Study|Lost to Follow-up|2|||
127994451|NCT00996034|460606556|FG000|Overall Study|withdrawn by PI|1|||
127994452|NCT00158262|460606557|FG000|Overall Study|Lost to Follow-up|1|||
127994453|NCT00158262|460606558|FG001|Overall Study|Lost to Follow-up|1|||
127994454|NCT02959918|460606559|FG000|Overall Study|Adverse Event|1|||
127994455|NCT02959918|460606560|FG001|Overall Study|Adverse Event|1|||
127994456|NCT02959918|460606561|FG002|Overall Study|Adverse Event|2|||
127994457|NCT02959918|460606562|FG003|Overall Study|Adverse Event|0|||
127994458|NCT02959918|460606563|FG004|Overall Study|Adverse Event|0|||
127994459|NCT02959918|460606564|FG005|Overall Study|Adverse Event|2|||
127543368|NCT00129402|458956526|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
127543369|NCT00129402|458956527|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
127665208|NCT03249376|459395084|FG000|Overall Study|Lack of Efficacy|2|||
127994460|NCT02959918|460606565|FG006|Overall Study|Adverse Event|2|||
127994461|NCT02959918|460606566|FG007|Overall Study|Adverse Event|1|||
127994462|NCT02959918|460606567|FG008|Overall Study|Adverse Event|2|||
127994463|NCT02959918|460606568|FG009|Overall Study|Adverse Event|1|||
127994464|NCT02959918|460606569|FG010|Overall Study|Adverse Event|1|||
127994465|NCT02959918|460606570|FG011|Overall Study|Adverse Event|3|||
127994466|NCT02959918|460606571|FG012|Overall Study|Adverse Event|2|||
127994467|NCT02959918|460606572|FG013|Overall Study|Adverse Event|4|||
127994468|NCT02959918|460606559|FG000|Overall Study|Lost to Follow-up|0|||
127994469|NCT02959918|460606560|FG001|Overall Study|Lost to Follow-up|0|||
127994470|NCT02959918|460606561|FG002|Overall Study|Lost to Follow-up|0|||
127994471|NCT02959918|460606562|FG003|Overall Study|Lost to Follow-up|0|||
127994472|NCT02959918|460606563|FG004|Overall Study|Lost to Follow-up|0|||
127994473|NCT02959918|460606564|FG005|Overall Study|Lost to Follow-up|0|||
127994474|NCT02959918|460606565|FG006|Overall Study|Lost to Follow-up|0|||
127994475|NCT02959918|460606566|FG007|Overall Study|Lost to Follow-up|0|||
127994476|NCT02959918|460606567|FG008|Overall Study|Lost to Follow-up|0|||
127994477|NCT02959918|460606568|FG009|Overall Study|Lost to Follow-up|1|||
127994478|NCT02959918|460606569|FG010|Overall Study|Lost to Follow-up|0|||
127994479|NCT02959918|460606570|FG011|Overall Study|Lost to Follow-up|0|||
127994480|NCT02959918|460606571|FG012|Overall Study|Lost to Follow-up|1|||
127994481|NCT02959918|460606572|FG013|Overall Study|Lost to Follow-up|0|||
127994482|NCT02959918|460606559|FG000|Overall Study|Withdrawal by Subject|0|||
127994483|NCT02959918|460606560|FG001|Overall Study|Withdrawal by Subject|0|||
127994484|NCT02959918|460606561|FG002|Overall Study|Withdrawal by Subject|1|||
127994485|NCT02959918|460606562|FG003|Overall Study|Withdrawal by Subject|2|||
127994486|NCT02959918|460606563|FG004|Overall Study|Withdrawal by Subject|0|||
127994487|NCT02959918|460606564|FG005|Overall Study|Withdrawal by Subject|0|||
127994488|NCT02959918|460606565|FG006|Overall Study|Withdrawal by Subject|1|||
127994489|NCT02959918|460606566|FG007|Overall Study|Withdrawal by Subject|0|||
127994490|NCT02959918|460606567|FG008|Overall Study|Withdrawal by Subject|1|||
127994491|NCT02959918|460606568|FG009|Overall Study|Withdrawal by Subject|1|||
127994492|NCT02959918|460606569|FG010|Overall Study|Withdrawal by Subject|2|||
127994493|NCT02959918|460606570|FG011|Overall Study|Withdrawal by Subject|3|||
127994494|NCT02959918|460606571|FG012|Overall Study|Withdrawal by Subject|1|||
127994495|NCT02959918|460606572|FG013|Overall Study|Withdrawal by Subject|1|||
127994496|NCT02959918|460606559|FG000|Overall Study|Protocol Violation|0|||
127994497|NCT02959918|460606560|FG001|Overall Study|Protocol Violation|0|||
127994498|NCT02959918|460606561|FG002|Overall Study|Protocol Violation|1|||
127994499|NCT02959918|460606562|FG003|Overall Study|Protocol Violation|0|||
127994500|NCT02959918|460606563|FG004|Overall Study|Protocol Violation|0|||
127994501|NCT02959918|460606564|FG005|Overall Study|Protocol Violation|1|||
127994502|NCT02959918|460606565|FG006|Overall Study|Protocol Violation|0|||
127994503|NCT02959918|460606566|FG007|Overall Study|Protocol Violation|0|||
127994504|NCT02959918|460606567|FG008|Overall Study|Protocol Violation|2|||
127994505|NCT02959918|460606568|FG009|Overall Study|Protocol Violation|1|||
127994506|NCT02959918|460606569|FG010|Overall Study|Protocol Violation|0|||
127994507|NCT02959918|460606570|FG011|Overall Study|Protocol Violation|1|||
127994508|NCT02959918|460606571|FG012|Overall Study|Protocol Violation|1|||
127994509|NCT02959918|460606572|FG013|Overall Study|Protocol Violation|0|||
127994510|NCT02959918|460606559|FG000|Overall Study|Stopping Rule Met|1|||
127994511|NCT02959918|460606560|FG001|Overall Study|Stopping Rule Met|0|||
127994512|NCT02959918|460606561|FG002|Overall Study|Stopping Rule Met|3|||
127994513|NCT02959918|460606562|FG003|Overall Study|Stopping Rule Met|4|||
127994514|NCT02959918|460606563|FG004|Overall Study|Stopping Rule Met|5|||
127994515|NCT02959918|460606564|FG005|Overall Study|Stopping Rule Met|3|||
127994516|NCT02959918|460606565|FG006|Overall Study|Stopping Rule Met|2|||
127994517|NCT02959918|460606566|FG007|Overall Study|Stopping Rule Met|4|||
127994518|NCT02959918|460606567|FG008|Overall Study|Stopping Rule Met|1|||
127994519|NCT02959918|460606568|FG009|Overall Study|Stopping Rule Met|1|||
127994520|NCT02959918|460606569|FG010|Overall Study|Stopping Rule Met|3|||
127994521|NCT02959918|460606570|FG011|Overall Study|Stopping Rule Met|5|||
127994522|NCT02959918|460606571|FG012|Overall Study|Stopping Rule Met|2|||
127994523|NCT02959918|460606572|FG013|Overall Study|Stopping Rule Met|1|||
127994524|NCT02959918|460606559|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
127994525|NCT02959918|460606560|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
127994526|NCT02959918|460606561|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
127994527|NCT02959918|460606562|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
127994528|NCT02959918|460606563|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
127994529|NCT02959918|460606564|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
127994530|NCT02959918|460606565|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
127994531|NCT02959918|460606566|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
127994532|NCT02959918|460606567|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
127994533|NCT02959918|460606568|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
127994534|NCT02959918|460606569|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
127994535|NCT02959918|460606570|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
127994536|NCT02959918|460606571|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
127994537|NCT02959918|460606572|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
127994538|NCT02959918|460606559|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
127994539|NCT02959918|460606560|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
127994540|NCT02959918|460606561|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
127994541|NCT02959918|460606562|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
127994542|NCT02959918|460606563|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
127994543|NCT02959918|460606564|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
127994544|NCT02959918|460606565|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
127665209|NCT03249376|459395085|FG001|Overall Study|Lack of Efficacy|4|||
127994545|NCT02959918|460606566|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
127994546|NCT02959918|460606567|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
127994547|NCT02959918|460606568|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
127994548|NCT02959918|460606569|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
127994549|NCT02959918|460606570|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
127994550|NCT02959918|460606571|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
127994551|NCT02959918|460606572|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
127994552|NCT02959918|460606559|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
127994553|NCT02959918|460606560|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
127994554|NCT02959918|460606561|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
127994555|NCT02959918|460606562|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
127994556|NCT02959918|460606563|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
127994557|NCT02959918|460606564|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
127994558|NCT02959918|460606565|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
127994559|NCT02959918|460606566|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
127994560|NCT02959918|460606567|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
127994561|NCT02959918|460606568|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
127994562|NCT02959918|460606569|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
127994563|NCT02959918|460606570|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
127994564|NCT02959918|460606571|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
127994565|NCT02959918|460606572|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
127994566|NCT02959918|460606559|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
127994567|NCT02959918|460606560|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
127994568|NCT02959918|460606561|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
127994569|NCT02959918|460606562|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
127994570|NCT02959918|460606563|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
127994571|NCT02959918|460606564|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
127994572|NCT02959918|460606565|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
127994573|NCT02959918|460606566|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
127994574|NCT02959918|460606567|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
127994575|NCT02959918|460606568|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
127994576|NCT02959918|460606569|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
127994577|NCT02959918|460606570|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
127994578|NCT02959918|460606571|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
127994579|NCT02959918|460606572|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
127994580|NCT02585713|460606576|FG000|Overall Study|Withdrew prior to treatment|2|||
127994581|NCT02585713|460606577|FG001|Overall Study|Withdrew prior to treatment|7|||
127994582|NCT02585713|460606576|FG000|Overall Study|Other|3|||
127994583|NCT02585713|460606577|FG001|Overall Study|Other|1|||
127994584|NCT03173456|460606580|FG000|Baseline|Medication dispensing system malfunction'|0|||
127994585|NCT03173456|460606581|FG001|Baseline|Medication dispensing system malfunction'|1|||
127994586|NCT03173456|460606582|FG002|Baseline|Medication dispensing system malfunction'|0|||
127994587|NCT03173456|460606583|FG003|Baseline|Medication dispensing system malfunction'|0|||
127994588|NCT03173456|460606584|FG004|Baseline|Medication dispensing system malfunction'|2|||
127994589|NCT03173456|460606580|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
127994590|NCT03173456|460606581|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
127994591|NCT03173456|460606582|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
127994592|NCT03173456|460606583|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
127994593|NCT03173456|460606584|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
127994594|NCT01733121|460606585|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
127994595|NCT01733121|460606586|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
127994596|NCT01733121|460606585|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
127994597|NCT01733121|460606586|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
127994598|NCT01733121|460606585|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
127994599|NCT01733121|460606586|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
127994600|NCT01733121|460606585|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
127994601|NCT01733121|460606586|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
127994602|NCT04501952|460606595|FG000|Overall Study|Adverse Event|0|||
127994603|NCT04501952|460606596|FG001|Overall Study|Adverse Event|3|||
127994604|NCT04501952|460606595|FG000|Overall Study|Investigator's Discretion|0|||
127994605|NCT04501952|460606596|FG001|Overall Study|Investigator's Discretion|1|||
127994606|NCT04501952|460606595|FG000|Overall Study|Protocol Violation|1|||
127994607|NCT04501952|460606596|FG001|Overall Study|Protocol Violation|1|||
127994608|NCT04501952|460606595|FG000|Overall Study|Withdrew Consent|5|||
127994609|NCT04501952|460606596|FG001|Overall Study|Withdrew Consent|4|||
127994610|NCT04501952|460606595|FG000|Overall Study|Lost to Follow-up|7|||
127994611|NCT04501952|460606596|FG001|Overall Study|Lost to Follow-up|2|||
127994612|NCT04501952|460606595|FG000|Overall Study|Randomized and Never Treated|13|||
127994613|NCT04501952|460606596|FG001|Overall Study|Randomized and Never Treated|9|||
127994614|NCT03061188|460606597|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
127994615|NCT03061188|460606598|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
127994616|NCT03061188|460606599|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
127994617|NCT03061188|460606600|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
127994618|NCT03061188|460606597|FG000|On Follow-up for 3 Years|Death|0|||
127994619|NCT03061188|460606598|FG001|On Follow-up for 3 Years|Death|3|||
127994620|NCT03061188|460606599|FG002|On Follow-up for 3 Years|Death|5|||
127994621|NCT03061188|460606600|FG003|On Follow-up for 3 Years|Death|4|||
127994622|NCT03061188|460606597|FG000|On Follow-up for 3 Years|Withdrawal by Subject|0|||
127994623|NCT03061188|460606598|FG001|On Follow-up for 3 Years|Withdrawal by Subject|0|||
127994624|NCT03061188|460606599|FG002|On Follow-up for 3 Years|Withdrawal by Subject|0|||
127994625|NCT03061188|460606600|FG003|On Follow-up for 3 Years|Withdrawal by Subject|1|||
127994626|NCT00436826|460606601|FG000|Double Blind Period (DBP)|Adverse Event|2|||
127994627|NCT00436826|460606602|FG001|Double Blind Period (DBP)|Adverse Event|0|||
127994628|NCT00436826|460606603|FG002|Double Blind Period (DBP)|Adverse Event|0|||
127994629|NCT00436826|460606604|FG003|Double Blind Period (DBP)|Adverse Event|0|||
127994630|NCT00436826|460606605|FG004|Double Blind Period (DBP)|Adverse Event|0|||
127994631|NCT00436826|460606606|FG005|Double Blind Period (DBP)|Adverse Event|0|||
127994632|NCT00436826|460606601|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
127994633|NCT00436826|460606602|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
127994634|NCT00436826|460606603|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
127994635|NCT00436826|460606604|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
127994636|NCT00436826|460606605|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
127994637|NCT00436826|460606606|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
127994638|NCT00436826|460606601|FG000|Double Blind Period (DBP)|Other|10|||
127994639|NCT00436826|460606602|FG001|Double Blind Period (DBP)|Other|11|||
127994640|NCT00436826|460606603|FG002|Double Blind Period (DBP)|Other|0|||
127994641|NCT00436826|460606604|FG003|Double Blind Period (DBP)|Other|0|||
127994642|NCT00436826|460606605|FG004|Double Blind Period (DBP)|Other|0|||
127994643|NCT00436826|460606606|FG005|Double Blind Period (DBP)|Other|0|||
127994644|NCT00436826|460606601|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
127994645|NCT00436826|460606602|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
127994646|NCT00436826|460606603|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
127994647|NCT00436826|460606604|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
127994648|NCT00436826|460606605|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
127994649|NCT00436826|460606606|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
127994650|NCT00436826|460606601|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
127994651|NCT00436826|460606602|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
127994652|NCT00436826|460606603|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
127994653|NCT00436826|460606604|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
127994654|NCT00436826|460606605|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
127994655|NCT00436826|460606606|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
127994656|NCT00436826|460606601|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
127994657|NCT00436826|460606602|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
127994658|NCT00436826|460606603|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
127994659|NCT00436826|460606604|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
127994660|NCT00436826|460606605|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
127994661|NCT00436826|460606606|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
127994662|NCT00784719|460606607|FG000|Overall Study|Adverse Event|0|||
127994663|NCT00784719|460606608|FG001|Overall Study|Adverse Event|2|||
127994664|NCT00784719|460606609|FG002|Overall Study|Adverse Event|0|||
127994665|NCT00784719|460606610|FG003|Overall Study|Adverse Event|0|||
127994666|NCT00784719|460606611|FG004|Overall Study|Adverse Event|1|||
127994667|NCT00784719|460606612|FG005|Overall Study|Adverse Event|1|||
127994668|NCT00784719|460606613|FG006|Overall Study|Adverse Event|1|||
127994669|NCT00784719|460606607|FG000|Overall Study|Lost to Follow-up|0|||
127994670|NCT00784719|460606608|FG001|Overall Study|Lost to Follow-up|0|||
127994671|NCT00784719|460606609|FG002|Overall Study|Lost to Follow-up|0|||
127994672|NCT00784719|460606610|FG003|Overall Study|Lost to Follow-up|0|||
127994673|NCT00784719|460606611|FG004|Overall Study|Lost to Follow-up|1|||
127994674|NCT00784719|460606612|FG005|Overall Study|Lost to Follow-up|1|||
127994675|NCT00784719|460606613|FG006|Overall Study|Lost to Follow-up|0|||
127994676|NCT00784719|460606607|FG000|Overall Study|Other|2|||
127994677|NCT00784719|460606608|FG001|Overall Study|Other|1|||
127994678|NCT00784719|460606609|FG002|Overall Study|Other|1|||
127994679|NCT00784719|460606610|FG003|Overall Study|Other|0|||
127994680|NCT00784719|460606611|FG004|Overall Study|Other|2|||
127994681|NCT00784719|460606612|FG005|Overall Study|Other|1|||
127543370|NCT00129402|458956528|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
127994682|NCT00784719|460606613|FG006|Overall Study|Other|3|||
127994683|NCT00784719|460606607|FG000|Overall Study|Withdrawal by Subject|1|||
127994684|NCT00784719|460606608|FG001|Overall Study|Withdrawal by Subject|0|||
127994685|NCT00784719|460606609|FG002|Overall Study|Withdrawal by Subject|0|||
127994686|NCT00784719|460606610|FG003|Overall Study|Withdrawal by Subject|0|||
127994687|NCT00784719|460606611|FG004|Overall Study|Withdrawal by Subject|2|||
127994688|NCT00784719|460606612|FG005|Overall Study|Withdrawal by Subject|0|||
127994689|NCT00784719|460606613|FG006|Overall Study|Withdrawal by Subject|1|||
127994690|NCT05464420|460606616|FG000|Overall Study|Death|0|||
127994691|NCT05464420|460606617|FG001|Overall Study|Death|0|||
127994692|NCT05464420|460606618|FG002|Overall Study|Death|0|||
127994693|NCT05464420|460606619|FG003|Overall Study|Death|1|||
127994694|NCT05464420|460606616|FG000|Overall Study|Lost to Follow-up|16|||
127994695|NCT05464420|460606617|FG001|Overall Study|Lost to Follow-up|11|||
127994696|NCT05464420|460606618|FG002|Overall Study|Lost to Follow-up|11|||
127994697|NCT05464420|460606619|FG003|Overall Study|Lost to Follow-up|11|||
127994698|NCT05464420|460606616|FG000|Overall Study|Randomized in Error Without Study Treatment|0|||
127994699|NCT05464420|460606617|FG001|Overall Study|Randomized in Error Without Study Treatment|1|||
127994700|NCT05464420|460606618|FG002|Overall Study|Randomized in Error Without Study Treatment|0|||
127994701|NCT05464420|460606619|FG003|Overall Study|Randomized in Error Without Study Treatment|0|||
127994702|NCT05464420|460606616|FG000|Overall Study|Withdrawal by Subject|4|||
127994703|NCT05464420|460606617|FG001|Overall Study|Withdrawal by Subject|8|||
127994704|NCT05464420|460606618|FG002|Overall Study|Withdrawal by Subject|3|||
127994705|NCT05464420|460606619|FG003|Overall Study|Withdrawal by Subject|1|||
127994706|NCT05464420|460606616|FG000|Overall Study|Protocol Violation|0|||
127994707|NCT05464420|460606617|FG001|Overall Study|Protocol Violation|0|||
127994708|NCT05464420|460606618|FG002|Overall Study|Protocol Violation|1|||
127994709|NCT05464420|460606619|FG003|Overall Study|Protocol Violation|1|||
127994710|NCT05464420|460606616|FG000|Overall Study|Unable to Adhere to Study Schedule|0|||
127994711|NCT05464420|460606617|FG001|Overall Study|Unable to Adhere to Study Schedule|0|||
127994712|NCT05464420|460606618|FG002|Overall Study|Unable to Adhere to Study Schedule|1|||
127994713|NCT05464420|460606619|FG003|Overall Study|Unable to Adhere to Study Schedule|0|||
127994714|NCT01383018|460606620|FG000|Overall Study|Adverse Event|14|||
127994715|NCT01383018|460606620|FG000|Overall Study|Death|10|||
127994716|NCT01383018|460606620|FG000|Overall Study|Lost to Follow-up|5|||
127994717|NCT01383018|460606620|FG000|Overall Study|Physician Decision|5|||
127994718|NCT01383018|460606620|FG000|Overall Study|Withdrawal by Subject|9|||
127994719|NCT01383018|460606620|FG000|Overall Study|Subject not implanted|76|||
127994720|NCT01383018|460606620|FG000|Overall Study|Missed Visit|247|||
127994721|NCT01383018|460606620|FG000|Overall Study|Site closed early-not compliance related|7|||
127994722|NCT01383018|460606620|FG000|Overall Study|Patient moved away from site|1|||
127994723|NCT01383018|460606620|FG000|Overall Study|Subject Incarcerated|1|||
127994724|NCT02282163|460606631|FG000|Overall Study|Protocol Violation|1|||
127994725|NCT01603407|460606632|FG000|Overall Study|Adverse Event|1|||
127994726|NCT01603407|460606633|FG001|Overall Study|Adverse Event|1|||
127994727|NCT01603407|460606634|FG002|Overall Study|Adverse Event|1|||
127994728|NCT01603407|460606632|FG000|Overall Study|Protocol Violation|2|||
127994729|NCT01603407|460606633|FG001|Overall Study|Protocol Violation|2|||
127994730|NCT01603407|460606634|FG002|Overall Study|Protocol Violation|0|||
127994731|NCT01603407|460606632|FG000|Overall Study|Withdrawal by Subject|8|||
127994732|NCT01603407|460606633|FG001|Overall Study|Withdrawal by Subject|5|||
127994733|NCT01603407|460606634|FG002|Overall Study|Withdrawal by Subject|7|||
127994734|NCT01603407|460606632|FG000|Overall Study|Lost to Follow-up|0|||
127994735|NCT01603407|460606633|FG001|Overall Study|Lost to Follow-up|3|||
127994736|NCT01603407|460606634|FG002|Overall Study|Lost to Follow-up|2|||
127994737|NCT02500719|460606635|FG000|Overall Study|Lost to Follow-up|2|||
127994738|NCT02500719|460606636|FG001|Overall Study|Lost to Follow-up|3|||
127994739|NCT02500719|460606635|FG000|Overall Study|Trauma history|1|||
127994740|NCT02500719|460606636|FG001|Overall Study|Trauma history|0|||
127994741|NCT02500719|460606635|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
127994742|NCT02500719|460606636|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
127994743|NCT02500719|460606635|FG000|Overall Study|Did not meet criteria for PTSD|0|||
127994744|NCT02500719|460606636|FG001|Overall Study|Did not meet criteria for PTSD|1|||
127994745|NCT02500719|460606635|FG000|Overall Study|Claustrophobia|0|||
127994746|NCT02500719|460606636|FG001|Overall Study|Claustrophobia|1|||
127994747|NCT02500719|460606635|FG000|Overall Study|History of head trauma|0|||
127994748|NCT02500719|460606636|FG001|Overall Study|History of head trauma|1|||
127994749|NCT01990768|460606637|FG000|Intervention Started|Found to be ineligible|14|||
127994750|NCT01990768|460606638|FG001|Intervention Started|Found to be ineligible|13|||
127994751|NCT01990768|460606639|FG002|Intervention Started|Found to be ineligible|11|||
127994752|NCT01990768|460606637|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
127994753|NCT01990768|460606638|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
127994754|NCT01990768|460606639|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
127994755|NCT01990768|460606637|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
127994756|NCT01990768|460606638|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
127994757|NCT01990768|460606639|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
127994758|NCT01990768|460606637|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
127994759|NCT01990768|460606638|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
127994760|NCT01990768|460606639|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
127994761|NCT01990768|460606637|FG000|Intervention Started|Patient care priority|1|||
127994762|NCT01990768|460606638|FG001|Intervention Started|Patient care priority|2|||
127994763|NCT01990768|460606639|FG002|Intervention Started|Patient care priority|3|||
127994764|NCT01990768|460606637|FG000|Intervention Started|IV lost|2|||
127994765|NCT01990768|460606638|FG001|Intervention Started|IV lost|2|||
127994766|NCT01990768|460606639|FG002|Intervention Started|IV lost|2|||
127994767|NCT01990768|460606637|FG000|Intervention Started|Required CPR|1|||
127994768|NCT01990768|460606638|FG001|Intervention Started|Required CPR|1|||
127994769|NCT01990768|460606639|FG002|Intervention Started|Required CPR|0|||
127994770|NCT01990768|460606637|FG000|Intervention Started|Seizure or hx of seizure|0|||
127994771|NCT01990768|460606638|FG001|Intervention Started|Seizure or hx of seizure|0|||
127994772|NCT01990768|460606639|FG002|Intervention Started|Seizure or hx of seizure|2|||
127994773|NCT01990768|460606637|FG000|Intervention Started|Discovered to be pregnant|0|||
127994774|NCT01990768|460606638|FG001|Intervention Started|Discovered to be pregnant|1|||
127994775|NCT01990768|460606639|FG002|Intervention Started|Discovered to be pregnant|0|||
127994776|NCT01990768|460606637|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
127994777|NCT01990768|460606638|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
127994778|NCT01990768|460606639|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
127994779|NCT01990768|460606637|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
127994780|NCT01990768|460606638|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
127994781|NCT01990768|460606639|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
127994782|NCT01990768|460606637|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
127994783|NCT01990768|460606638|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
127994784|NCT01990768|460606639|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
127994785|NCT01990768|460606637|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
127994786|NCT01990768|460606638|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
127994787|NCT01990768|460606639|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
127994788|NCT01990768|460606637|FG000|Prehospital Study Drug Infusion|Death|3|||
127994789|NCT01990768|460606638|FG001|Prehospital Study Drug Infusion|Death|1|||
127994790|NCT01990768|460606639|FG002|Prehospital Study Drug Infusion|Death|1|||
127994791|NCT01990768|460606637|FG000|Prehospital Study Drug Infusion|Discharged|2|||
127994792|NCT01990768|460606638|FG001|Prehospital Study Drug Infusion|Discharged|1|||
127994793|NCT01990768|460606639|FG002|Prehospital Study Drug Infusion|Discharged|0|||
127994794|NCT01990768|460606637|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
127994795|NCT01990768|460606638|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
127994796|NCT01990768|460606639|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
127994797|NCT01990768|460606637|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
127994798|NCT01990768|460606638|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
127994799|NCT01990768|460606639|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
127994800|NCT01990768|460606637|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
127994801|NCT01990768|460606638|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
127994802|NCT01990768|460606639|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
127994803|NCT01990768|460606637|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
127994804|NCT01990768|460606638|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
127994805|NCT01990768|460606639|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
127994806|NCT01990768|460606637|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
127994807|NCT01990768|460606638|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
127994808|NCT01990768|460606639|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
127994809|NCT01990768|460606637|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
127994810|NCT01990768|460606638|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
127994811|NCT01990768|460606639|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
127994812|NCT01990768|460606637|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
127994813|NCT01990768|460606638|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
127994814|NCT01990768|460606639|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
127994815|NCT01990768|460606637|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
127994816|NCT01990768|460606638|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
127994817|NCT01990768|460606639|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
127994818|NCT01990768|460606637|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
127994819|NCT01990768|460606638|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
127994820|NCT01990768|460606639|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
127994821|NCT01990768|460606637|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
127543371|NCT00129402|458956529|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
127994822|NCT01990768|460606638|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
127994823|NCT01990768|460606639|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
127994824|NCT01990768|460606637|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
127994825|NCT01990768|460606638|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
127994826|NCT01990768|460606639|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
127994827|NCT01990768|460606637|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
127994828|NCT01990768|460606638|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
127994829|NCT01990768|460606639|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
127994830|NCT01990768|460606637|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
127994831|NCT01990768|460606638|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
127994832|NCT01990768|460606639|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
127994833|NCT01990768|460606637|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
127994834|NCT01990768|460606638|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
127994835|NCT01990768|460606639|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
127994836|NCT01990768|460606637|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
127994837|NCT01990768|460606638|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
127994838|NCT01990768|460606639|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
127994839|NCT01990768|460606637|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
127994840|NCT01990768|460606638|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
127994841|NCT01990768|460606639|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
127994842|NCT01990768|460606637|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
127994843|NCT01990768|460606638|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
127994844|NCT01990768|460606639|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
127994845|NCT01990768|460606637|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
127994846|NCT01990768|460606638|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
127994847|NCT01990768|460606639|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
127994848|NCT01990768|460606637|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
127994849|NCT01990768|460606638|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
127994850|NCT01990768|460606639|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
127994851|NCT01990768|460606637|FG000|6-Month Follow-up|No contact information|5|||
127994852|NCT01990768|460606638|FG001|6-Month Follow-up|No contact information|6|||
127994853|NCT01990768|460606639|FG002|6-Month Follow-up|No contact information|5|||
127994854|NCT01990768|460606637|FG000|6-Month Follow-up|Homeless|4|||
127994855|NCT01990768|460606638|FG001|6-Month Follow-up|Homeless|3|||
127994856|NCT01990768|460606639|FG002|6-Month Follow-up|Homeless|6|||
127994857|NCT01990768|460606637|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
127994858|NCT01990768|460606638|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
127994859|NCT01990768|460606639|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
127994860|NCT01990768|460606637|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
127994861|NCT01990768|460606638|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
127994862|NCT01990768|460606639|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
127994863|NCT01990768|460606637|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
127994864|NCT01990768|460606638|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
127994865|NCT01990768|460606639|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
127994866|NCT03538691|460606640|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
127994867|NCT03538691|460606641|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
127994868|NCT03538691|460606642|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
127994869|NCT03538691|460606643|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
127994870|NCT03538691|460606640|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
127994871|NCT03538691|460606641|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
127994872|NCT03538691|460606642|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
127994873|NCT03538691|460606643|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
127994874|NCT03538691|460606640|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
127994875|NCT03538691|460606641|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
127994876|NCT03538691|460606642|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
127994877|NCT03538691|460606643|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
127994878|NCT03538691|460606640|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
127994879|NCT03538691|460606641|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
127994880|NCT03538691|460606642|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
127994881|NCT03538691|460606643|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
127994882|NCT03538691|460606640|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
127994883|NCT03538691|460606641|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
127994884|NCT03538691|460606642|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
127994885|NCT03538691|460606643|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
127665210|NCT03249376|459395084|FG000|Overall Study|Protocol Violation|3|||
127665211|NCT03249376|459395085|FG001|Overall Study|Protocol Violation|2|||
127665212|NCT03249376|459395084|FG000|Overall Study|Physician Decision|0|||
127994886|NCT03538691|460606640|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
127994887|NCT03538691|460606641|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
127994888|NCT03538691|460606642|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
127994889|NCT03538691|460606643|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
127994890|NCT03538691|460606640|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
127994891|NCT03538691|460606641|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
127994892|NCT03538691|460606642|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
127994893|NCT03538691|460606643|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
127994894|NCT03538691|460606640|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
127994895|NCT03538691|460606641|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
127994896|NCT03538691|460606642|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
127994897|NCT03538691|460606643|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
127994898|NCT03538691|460606640|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
127994899|NCT03538691|460606641|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
127994900|NCT03538691|460606642|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
127994901|NCT03538691|460606643|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
127994902|NCT03538691|460606640|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
127994903|NCT03538691|460606641|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
127994904|NCT03538691|460606642|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
127994905|NCT03538691|460606643|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
127994906|NCT03538691|460606640|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
127994907|NCT03538691|460606641|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
127994908|NCT03538691|460606642|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
127994909|NCT03538691|460606643|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
127994910|NCT03538691|460606640|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
127994911|NCT03538691|460606641|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
127994912|NCT03538691|460606642|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
127994913|NCT03538691|460606643|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
127994914|NCT03538691|460606640|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
127994915|NCT03538691|460606641|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
127994916|NCT03538691|460606642|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
127994917|NCT03538691|460606643|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
127994918|NCT03538691|460606640|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
127994919|NCT03538691|460606641|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
127994920|NCT03538691|460606642|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
127994921|NCT03538691|460606643|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
127994922|NCT03538691|460606640|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
127994923|NCT03538691|460606641|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
127994924|NCT03538691|460606642|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
127994925|NCT03538691|460606643|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
127994926|NCT03538691|460606640|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
127994927|NCT03538691|460606641|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
127994928|NCT03538691|460606642|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
127994929|NCT03538691|460606643|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
127994930|NCT03538691|460606640|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
127994931|NCT03538691|460606641|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
127994932|NCT03538691|460606642|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
127994933|NCT03538691|460606643|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
127994934|NCT03538691|460606640|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
127994935|NCT03538691|460606641|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
127994936|NCT03538691|460606642|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
127994937|NCT03538691|460606643|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
127994938|NCT03538691|460606640|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
127994939|NCT03538691|460606641|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
127994940|NCT03538691|460606642|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
127994941|NCT03538691|460606643|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
127994942|NCT03538691|460606640|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
127994943|NCT03538691|460606641|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
127994944|NCT03538691|460606642|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
127994945|NCT03538691|460606643|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
127994946|NCT03538691|460606640|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
127994947|NCT03538691|460606641|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
127994948|NCT03538691|460606642|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
127994949|NCT03538691|460606643|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
127994950|NCT03538691|460606640|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
127994951|NCT03538691|460606641|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
127994952|NCT03538691|460606642|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
127994953|NCT03538691|460606643|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
127994954|NCT03538691|460606640|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
127994955|NCT03538691|460606641|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
127994956|NCT03538691|460606642|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
127994957|NCT03538691|460606643|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
127994958|NCT03538691|460606640|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
127994959|NCT03538691|460606641|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
127994960|NCT03538691|460606642|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
127994961|NCT03538691|460606643|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
127994962|NCT03538691|460606640|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
127994963|NCT03538691|460606641|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
127994964|NCT03538691|460606642|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
127994965|NCT03538691|460606643|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
127994966|NCT03538691|460606640|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
127994967|NCT03538691|460606641|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
127994968|NCT03538691|460606642|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
127994969|NCT03538691|460606643|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
127994970|NCT03538691|460606640|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
127994971|NCT03538691|460606641|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
127994972|NCT03538691|460606642|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
127994973|NCT03538691|460606643|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
127994974|NCT03538691|460606640|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
127994975|NCT03538691|460606641|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
127994976|NCT03538691|460606642|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
127994977|NCT03538691|460606643|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
127994978|NCT06597084|460606644|FG000|Overall Study|Withdrawal by Subject|4|||
127994979|NCT06597084|460606645|FG001|Overall Study|Withdrawal by Subject|9|||
127994980|NCT06597084|460606644|FG000|Overall Study|Consent was not given by the patient until V2|0|||
127994981|NCT06597084|460606645|FG001|Overall Study|Consent was not given by the patient until V2|3|||
127994982|NCT06597084|460606644|FG000|Overall Study|Physician Decision|1|||
127994983|NCT06597084|460606645|FG001|Overall Study|Physician Decision|0|||
127994984|NCT06597084|460606644|FG000|Overall Study|Adverse Event|3|||
127994985|NCT06597084|460606645|FG001|Overall Study|Adverse Event|2|||
127994986|NCT06597084|460606644|FG000|Overall Study|Death|4|||
127994987|NCT06597084|460606645|FG001|Overall Study|Death|0|||
127994988|NCT06597084|460606644|FG000|Overall Study|Stroke more than 7 days after primary stroke|2|||
127994989|NCT06597084|460606645|FG001|Overall Study|Stroke more than 7 days after primary stroke|6|||
127994990|NCT06597084|460606644|FG000|Overall Study|Lost to Follow-up|4|||
127994991|NCT06597084|460606645|FG001|Overall Study|Lost to Follow-up|2|||
127994992|NCT06597084|460606644|FG000|Overall Study|Other. Not specified|1|||
127994993|NCT06597084|460606645|FG001|Overall Study|Other. Not specified|0|||
127994994|NCT01588405|460606646|FG000|Overall Study|Adverse Event|1|||
127994995|NCT01588405|460606646|FG000|Overall Study|Clinical Worsening|1|||
127994996|NCT02029274|460606652|FG000|Overall Study|Adverse Event|1|||
127994997|NCT02029274|460606653|FG001|Overall Study|Adverse Event|0|||
127994998|NCT02029274|460606654|FG002|Overall Study|Adverse Event|2|||
127994999|NCT02029274|460606655|FG003|Overall Study|Adverse Event|2|||
127995000|NCT01243177|460606658|FG000|Overall Study|Lack of Efficacy|47|||
127995001|NCT01243177|460606659|FG001|Overall Study|Lack of Efficacy|31|||
127995002|NCT01243177|460606658|FG000|Overall Study|Protocol Violation|11|||
127995003|NCT01243177|460606659|FG001|Overall Study|Protocol Violation|10|||
127995004|NCT01243177|460606658|FG000|Overall Study|Lost to Follow-up|15|||
127995005|NCT01243177|460606659|FG001|Overall Study|Lost to Follow-up|18|||
127995006|NCT01243177|460606658|FG000|Overall Study|Withdrawal by Subject|46|||
127995007|NCT01243177|460606659|FG001|Overall Study|Withdrawal by Subject|38|||
127995008|NCT01243177|460606658|FG000|Overall Study|AE, serious fatal|0|||
127995009|NCT01243177|460606659|FG001|Overall Study|AE, serious fatal|1|||
127995010|NCT01243177|460606658|FG000|Overall Study|SAE, non-fatal|7|||
127995011|NCT01243177|460606659|FG001|Overall Study|SAE, non-fatal|9|||
127665213|NCT03249376|459395085|FG001|Overall Study|Physician Decision|2|||
127995012|NCT01243177|460606658|FG000|Overall Study|AE, non-serious non-fatal|40|||
127995013|NCT01243177|460606659|FG001|Overall Study|AE, non-serious non-fatal|58|||
127995014|NCT01243177|460606658|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
127995015|NCT01243177|460606659|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
127995016|NCT01243177|460606658|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
127995017|NCT01243177|460606659|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
127995018|NCT01243177|460606658|FG000|Overall Study|Other Reason|11|||
127995019|NCT01243177|460606659|FG001|Overall Study|Other Reason|12|||
127995020|NCT03654729|460608512|FG000|Overall Study|Death|9|||
127995021|NCT03654729|460608513|FG001|Overall Study|Death|9|||
127995022|NCT03654729|460608514|FG002|Overall Study|Death|16|||
127995023|NCT03654729|460608512|FG000|Overall Study|Withdrawal by Subject|8|||
127995024|NCT03654729|460608513|FG001|Overall Study|Withdrawal by Subject|6|||
127995025|NCT03654729|460608514|FG002|Overall Study|Withdrawal by Subject|4|||
127995026|NCT03654729|460608512|FG000|Overall Study|Study terminated by Sponsor|3|||
127995027|NCT03654729|460608513|FG001|Overall Study|Study terminated by Sponsor|5|||
127995028|NCT03654729|460608514|FG002|Overall Study|Study terminated by Sponsor|4|||
127995029|NCT03654729|460608512|FG000|Overall Study|Not reported|2|||
127995030|NCT03654729|460608513|FG001|Overall Study|Not reported|4|||
127995031|NCT03654729|460608514|FG002|Overall Study|Not reported|5|||
127995032|NCT03654729|460608512|FG000|Overall Study|Progressive disease|3|||
127995033|NCT03654729|460608513|FG001|Overall Study|Progressive disease|0|||
127995034|NCT03654729|460608514|FG002|Overall Study|Progressive disease|0|||
127995035|NCT03654729|460608512|FG000|Overall Study|Lost to Follow-up|2|||
127995036|NCT03654729|460608513|FG001|Overall Study|Lost to Follow-up|0|||
127995037|NCT03654729|460608514|FG002|Overall Study|Lost to Follow-up|0|||
127995038|NCT03654729|460608512|FG000|Overall Study|Physician Decision|2|||
127995039|NCT03654729|460608513|FG001|Overall Study|Physician Decision|0|||
127995040|NCT03654729|460608514|FG002|Overall Study|Physician Decision|0|||
127995041|NCT03654729|460608512|FG000|Overall Study|Protocol Violation|1|||
127995042|NCT03654729|460608513|FG001|Overall Study|Protocol Violation|1|||
127995043|NCT03654729|460608514|FG002|Overall Study|Protocol Violation|0|||
127995044|NCT03654729|460608512|FG000|Overall Study|Non-compliance with study drug|0|||
127995045|NCT03654729|460608513|FG001|Overall Study|Non-compliance with study drug|1|||
127995046|NCT03654729|460608514|FG002|Overall Study|Non-compliance with study drug|0|||
127995047|NCT03654729|460608512|FG000|Overall Study|Site terminated by Sponsor|1|||
127995048|NCT03654729|460608513|FG001|Overall Study|Site terminated by Sponsor|0|||
127995049|NCT03654729|460608514|FG002|Overall Study|Site terminated by Sponsor|0|||
127995050|NCT04530838|460608515|FG000|Overall Study|Other|2|||
127995051|NCT04530838|460608516|FG001|Overall Study|Other|1|||
127995052|NCT04530838|460608517|FG002|Overall Study|Other|0|||
127995053|NCT04530838|460608515|FG000|Overall Study|Physician Decision|0|||
127995054|NCT04530838|460608516|FG001|Overall Study|Physician Decision|0|||
127995055|NCT04530838|460608517|FG002|Overall Study|Physician Decision|1|||
127995056|NCT04530838|460608515|FG000|Overall Study|Death|0|||
127995057|NCT04530838|460608516|FG001|Overall Study|Death|0|||
127995058|NCT04530838|460608517|FG002|Overall Study|Death|1|||
127995059|NCT04530838|460608515|FG000|Overall Study|Adverse Event|0|||
127995060|NCT04530838|460608516|FG001|Overall Study|Adverse Event|1|||
127995061|NCT04530838|460608517|FG002|Overall Study|Adverse Event|0|||
127995062|NCT04530838|460608515|FG000|Overall Study|No longer meets eligibility criteria|1|||
127995063|NCT04530838|460608516|FG001|Overall Study|No longer meets eligibility criteria|0|||
127995064|NCT04530838|460608517|FG002|Overall Study|No longer meets eligibility criteria|2|||
127995065|NCT04530838|460608515|FG000|Overall Study|Withdrawal by parent/guardian|5|||
127995066|NCT04530838|460608516|FG001|Overall Study|Withdrawal by parent/guardian|2|||
127995067|NCT04530838|460608517|FG002|Overall Study|Withdrawal by parent/guardian|2|||
127995068|NCT00803712|460608518|FG000|Overall Study|Noncompliance|3|||
127995069|NCT00803712|460608519|FG001|Overall Study|Noncompliance|0|||
127995070|NCT00803712|460608518|FG000|Overall Study|Adverse Event|5|||
127995071|NCT00803712|460608519|FG001|Overall Study|Adverse Event|0|||
127995072|NCT00803712|460608518|FG000|Overall Study|Death|8|||
127995073|NCT00803712|460608519|FG001|Overall Study|Death|7|||
127995074|NCT00803712|460608518|FG000|Overall Study|Lost to Follow-up|3|||
127995075|NCT00803712|460608519|FG001|Overall Study|Lost to Follow-up|1|||
127995076|NCT00803712|460608518|FG000|Overall Study|Withdrawal by Subject|2|||
127995077|NCT00803712|460608519|FG001|Overall Study|Withdrawal by Subject|4|||
127995078|NCT00803712|460608518|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
127995079|NCT00803712|460608519|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
127995080|NCT00803712|460608518|FG000|Overall Study|Protocol criteria (other)|0|||
127995081|NCT00803712|460608519|FG001|Overall Study|Protocol criteria (other)|2|||
127995082|NCT00803712|460608518|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
127995083|NCT00803712|460608519|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
127995084|NCT00803712|460608518|FG000|Overall Study|Administrative decision|2|||
127995085|NCT00803712|460608519|FG001|Overall Study|Administrative decision|3|||
127995086|NCT00803712|460608518|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
127995087|NCT00803712|460608519|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
127995088|NCT02100839|460608526|FG000|Multiple Ascending Dose|Adverse Event|2|||
127995089|NCT02100839|460608527|FG001|Multiple Ascending Dose|Adverse Event|0|||
127995090|NCT02100839|460608526|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
127995091|NCT02100839|460608527|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
127995092|NCT00669318|460608530|FG000|Overall Study|Withdrawal by Subject|2|||
127995093|NCT01073163|460608531|FG000|Overall Study|Adverse Event|1|||
127995094|NCT01073163|460608531|FG000|Overall Study|Disease Progression|1|||
127995095|NCT01073163|460608531|FG000|Overall Study|Early termination|1|||
127995096|NCT01677182|460608532|FG000|Overall Study|Adverse Event|2|||
127995097|NCT01677182|460608533|FG001|Overall Study|Adverse Event|1|||
127995098|NCT01677182|460608534|FG002|Overall Study|Adverse Event|8|||
127995099|NCT01677182|460608532|FG000|Overall Study|Protocol Violation|5|||
127995100|NCT01677182|460608533|FG001|Overall Study|Protocol Violation|1|||
127995101|NCT01677182|460608534|FG002|Overall Study|Protocol Violation|4|||
127995102|NCT01677182|460608532|FG000|Overall Study|Lost to Follow-up|4|||
127995103|NCT01677182|460608533|FG001|Overall Study|Lost to Follow-up|0|||
127995104|NCT01677182|460608534|FG002|Overall Study|Lost to Follow-up|3|||
127995105|NCT01677182|460608532|FG000|Overall Study|Withdrawal by Subject|7|||
127995106|NCT01677182|460608533|FG001|Overall Study|Withdrawal by Subject|12|||
127995107|NCT01677182|460608534|FG002|Overall Study|Withdrawal by Subject|10|||
127995108|NCT01677182|460608532|FG000|Overall Study|Study termination|12|||
127995109|NCT01677182|460608533|FG001|Overall Study|Study termination|9|||
127995110|NCT01677182|460608534|FG002|Overall Study|Study termination|11|||
127995111|NCT01677182|460608532|FG000|Overall Study|Lack of Efficacy|3|||
127995112|NCT01677182|460608533|FG001|Overall Study|Lack of Efficacy|0|||
127995113|NCT01677182|460608534|FG002|Overall Study|Lack of Efficacy|1|||
127995114|NCT01677182|460608532|FG000|Overall Study|Other reasons|1|||
127995115|NCT01677182|460608533|FG001|Overall Study|Other reasons|5|||
127995116|NCT01677182|460608534|FG002|Overall Study|Other reasons|2|||
127995117|NCT00762762|460608539|FG000|Overall Study|Did not return for appointments|6|||
127995118|NCT00762762|460608540|FG001|Overall Study|Did not return for appointments|8|||
127995119|NCT02489448|460608541|FG000|Overall Study|Death|3|||
127995120|NCT02489448|460608541|FG000|Overall Study|Withdrawal by Subject|2|||
127995121|NCT02781818|460608550|FG000|Overall Study|Lost to Follow-up|4|||
127995122|NCT02781818|460608551|FG001|Overall Study|Lost to Follow-up|2|||
127995123|NCT02781818|460608552|FG002|Overall Study|Lost to Follow-up|1|||
127995124|NCT00524771|460608553|FG000|Overall Study|Protocol Violation|220|||
127995125|NCT00524771|460608554|FG001|Overall Study|Protocol Violation|585|||
127995126|NCT01223404|460608555|FG000|First Intervention (1 Day)|Adverse Event|0|||
127995127|NCT01223404|460608556|FG001|First Intervention (1 Day)|Adverse Event|0|||
127995128|NCT01223404|460608557|FG002|First Intervention (1 Day)|Adverse Event|0|||
127995129|NCT01223404|460608558|FG003|First Intervention (1 Day)|Adverse Event|1|||
127995130|NCT01223404|460608559|FG004|First Intervention (1 Day)|Adverse Event|0|||
127665214|NCT03249376|459395084|FG000|Overall Study|Withdrawal by Subject|3|||
127665215|NCT03249376|459395085|FG001|Overall Study|Withdrawal by Subject|9|||
127665216|NCT03249376|459395084|FG000|Overall Study|LTFU|2|||
127665217|NCT03249376|459395085|FG001|Overall Study|LTFU|1|||
127665218|NCT01686932|459395093|FG000|Period 1|Adverse Event|1|||
127665219|NCT01686932|459395094|FG001|Period 1|Adverse Event|1|||
127665220|NCT01364727|459395097|FG000|Overall Study|Not Eligible|2|||
127665221|NCT01009047|459395099|FG000|Overall Study|Adverse Event|5|||
127665222|NCT01009047|459395100|FG001|Overall Study|Adverse Event|0|||
127665223|NCT01009047|459395099|FG000|Overall Study|Lost to Follow-up|0|||
127665224|NCT01009047|459395100|FG001|Overall Study|Lost to Follow-up|2|||
127665225|NCT01009047|459395099|FG000|Overall Study|Lack of Efficacy|4|||
127665226|NCT01009047|459395100|FG001|Overall Study|Lack of Efficacy|11|||
127665227|NCT01009047|459395099|FG000|Overall Study|Withdrawal by consent|16|||
127665228|NCT01009047|459395100|FG001|Overall Study|Withdrawal by consent|11|||
127665229|NCT01009047|459395099|FG000|Overall Study|Other|3|||
127665230|NCT01009047|459395100|FG001|Overall Study|Other|2|||
127665231|NCT01555021|459395101|FG000|Overall Study|Lost to Follow-up|1|||
127665232|NCT01555021|459395102|FG001|Overall Study|Lost to Follow-up|2|||
127665233|NCT03875911|459395107|FG000|Overall Study|Lost to Follow-up|3|||
127665234|NCT03875911|459395108|FG001|Overall Study|Lost to Follow-up|6|||
127665235|NCT03875911|459395109|FG002|Overall Study|Lost to Follow-up|2|||
127665236|NCT03875911|459395107|FG000|Overall Study|Surgery cancelled|1|||
127665237|NCT03875911|459395108|FG001|Overall Study|Surgery cancelled|0|||
127665238|NCT03875911|459395109|FG002|Overall Study|Surgery cancelled|1|||
127665239|NCT03875911|459395107|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
127995131|NCT01223404|460608560|FG005|First Intervention (1 Day)|Adverse Event|0|||
127665240|NCT03875911|459395108|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
127665241|NCT03875911|459395109|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
127995132|NCT01223404|460608555|FG000|Second Intervention (1 Day)|Adverse Event|1|||
127995133|NCT01223404|460608556|FG001|Second Intervention (1 Day)|Adverse Event|0|||
127995134|NCT01223404|460608557|FG002|Second Intervention (1 Day)|Adverse Event|0|||
127995135|NCT01223404|460608558|FG003|Second Intervention (1 Day)|Adverse Event|0|||
127665242|NCT03824938|459395112|FG000|Overall Study|Withdrawal by Subject|2|||
127665243|NCT03824938|459395113|FG001|Overall Study|Withdrawal by Subject|1|||
127995136|NCT01223404|460608559|FG004|Second Intervention (1 Day)|Adverse Event|0|||
127995137|NCT01223404|460608560|FG005|Second Intervention (1 Day)|Adverse Event|0|||
127995138|NCT01223404|460608555|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
127995139|NCT01223404|460608556|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
127995140|NCT01223404|460608557|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
127995141|NCT01223404|460608558|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
127995142|NCT01223404|460608559|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
127995143|NCT01223404|460608560|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
127995144|NCT00707057|460608561|FG000|Overall Study|Withdrawal by Subject|8|||
127995145|NCT00707057|460608562|FG001|Overall Study|Withdrawal by Subject|3|||
127995146|NCT00707057|460608561|FG000|Overall Study|Dosed incorrectly|0|||
127995147|NCT00707057|460608562|FG001|Overall Study|Dosed incorrectly|1|||
127995148|NCT02915159|460608568|FG000|Overall Study|Participant no longer meets criteria|2|||
127995149|NCT02915159|460608569|FG001|Overall Study|Participant no longer meets criteria|0|||
127995150|NCT02915159|460608568|FG000|Overall Study|poor/non-compliance|1|||
127995151|NCT02915159|460608569|FG001|Overall Study|poor/non-compliance|0|||
127995152|NCT02915159|460608568|FG000|Overall Study|Participant withdrew consent|5|||
127995153|NCT02915159|460608569|FG001|Overall Study|Participant withdrew consent|1|||
127995154|NCT02915159|460608568|FG000|Overall Study|Request to discontinue treatment|1|||
127995155|NCT02915159|460608569|FG001|Overall Study|Request to discontinue treatment|2|||
127995156|NCT02915159|460608568|FG000|Overall Study|Adverse Event|2|||
127995157|NCT02915159|460608569|FG001|Overall Study|Adverse Event|2|||
127995158|NCT02915159|460608568|FG000|Overall Study|Lack of Efficacy|0|||
127995159|NCT02915159|460608569|FG001|Overall Study|Lack of Efficacy|3|||
127995160|NCT02821416|460608572|FG000|Overall Study|Adverse Event|0|||
127995161|NCT02821416|460608573|FG001|Overall Study|Adverse Event|1|||
127995162|NCT02821416|460608572|FG000|Overall Study|Withdrawal by Subject|2|||
127995163|NCT02821416|460608573|FG001|Overall Study|Withdrawal by Subject|0|||
127995164|NCT02821416|460608572|FG000|Overall Study|Lost to Follow-up|1|||
127995165|NCT02821416|460608573|FG001|Overall Study|Lost to Follow-up|0|||
127995166|NCT01001520|460608580|FG000|Medication Period 1|Withdrawal by Subject|2|||
127995167|NCT01001520|460608581|FG001|Medication Period 1|Withdrawal by Subject|2|||
127995168|NCT01001520|460608580|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
127995169|NCT01001520|460608581|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
127995170|NCT01001520|460608580|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
127995171|NCT01001520|460608581|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
127995172|NCT01001520|460608580|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
127995173|NCT01001520|460608581|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
127995174|NCT01001520|460608580|FG000|Washout Period|Withdrawal by Subject|2|||
127995175|NCT01001520|460608581|FG001|Washout Period|Withdrawal by Subject|1|||
127995176|NCT01001520|460608580|FG000|Medication Period 2|Withdrawal by Subject|0|||
127995177|NCT01001520|460608581|FG001|Medication Period 2|Withdrawal by Subject|3|||
127995178|NCT00878800|460608589|FG000|Overall Study|Adverse Event|0|||
127995179|NCT00878800|460608590|FG001|Overall Study|Adverse Event|0|||
127995180|NCT00878800|460608591|FG002|Overall Study|Adverse Event|2|||
127995181|NCT00878800|460608592|FG003|Overall Study|Adverse Event|0|||
127995182|NCT00878800|460608593|FG004|Overall Study|Adverse Event|1|||
127995183|NCT00878800|460608589|FG000|Overall Study|Progressive disease|1|||
127995184|NCT00878800|460608590|FG001|Overall Study|Progressive disease|5|||
127995185|NCT00878800|460608591|FG002|Overall Study|Progressive disease|6|||
127995186|NCT00878800|460608592|FG003|Overall Study|Progressive disease|5|||
127995187|NCT00878800|460608593|FG004|Overall Study|Progressive disease|13|||
127995188|NCT00878800|460608589|FG000|Overall Study|Withdrew consent|1|||
127995189|NCT00878800|460608590|FG001|Overall Study|Withdrew consent|1|||
127995190|NCT00878800|460608591|FG002|Overall Study|Withdrew consent|0|||
127995191|NCT00878800|460608592|FG003|Overall Study|Withdrew consent|1|||
127995192|NCT00878800|460608593|FG004|Overall Study|Withdrew consent|1|||
127995193|NCT00878800|460608589|FG000|Overall Study|Death|0|||
127995194|NCT00878800|460608590|FG001|Overall Study|Death|0|||
127995195|NCT00878800|460608591|FG002|Overall Study|Death|1|||
127995196|NCT00878800|460608592|FG003|Overall Study|Death|0|||
127995197|NCT00878800|460608593|FG004|Overall Study|Death|0|||
127995198|NCT00878800|460608589|FG000|Overall Study|Other|1|||
127995199|NCT00878800|460608590|FG001|Overall Study|Other|1|||
127995200|NCT00878800|460608591|FG002|Overall Study|Other|0|||
127995201|NCT00878800|460608592|FG003|Overall Study|Other|0|||
127995202|NCT00878800|460608593|FG004|Overall Study|Other|1|||
127995203|NCT00613821|460608594|FG000|Overall Study|Withdrawal by Subject|1|||
127995204|NCT00613821|460608595|FG001|Overall Study|Withdrawal by Subject|0|||
127995205|NCT00613821|460608594|FG000|Overall Study|Physician Decision|1|||
127995206|NCT00613821|460608595|FG001|Overall Study|Physician Decision|1|||
127995207|NCT02302846|460608596|FG000|Overall Study|Withdrawal by Subject|1|||
127995208|NCT01468454|460608597|FG000|Overall Study|Did not have surgery after PET|9|||
127995209|NCT04435808|460608598|FG000|Overall Study|Study stopped by DSMB|0|||
127995210|NCT04435808|460608599|FG001|Overall Study|Study stopped by DSMB|1|||
127995211|NCT02620787|460608600|FG000|Overall Study|Adverse Event|1|||
127995212|NCT02620787|460608601|FG001|Overall Study|Adverse Event|0|||
127995213|NCT02620787|460608600|FG000|Overall Study|Eligibility Criteria Not Met|1|||
127995214|NCT02620787|460608601|FG001|Overall Study|Eligibility Criteria Not Met|0|||
127995215|NCT00807612|460608604|FG000|Overall Study|Death|8|||
127995216|NCT00807612|460608604|FG000|Overall Study|Study early termination|5|||
127995217|NCT00807612|460608604|FG000|Overall Study|Withdrawal by Subject|1|||
127995218|NCT02258659|460608606|FG000|Overall Study|Withdrawal by Subject|1|||
127995219|NCT04892446|460608607|FG000|Overall Study|Death|4|||
127995220|NCT04892446|460608608|FG001|Overall Study|Death|4|||
127995221|NCT04892446|460608609|FG002|Overall Study|Death|0|||
127995222|NCT04892446|460608607|FG000|Overall Study|Withdrew consent|3|||
127995223|NCT04892446|460608608|FG001|Overall Study|Withdrew consent|0|||
127995224|NCT04892446|460608609|FG002|Overall Study|Withdrew consent|1|||
127995225|NCT04892446|460608607|FG000|Overall Study|Investigator's discretion|1|||
127995226|NCT04892446|460608608|FG001|Overall Study|Investigator's discretion|1|||
127995227|NCT04892446|460608609|FG002|Overall Study|Investigator's discretion|0|||
127995228|NCT04892446|460608607|FG000|Overall Study|Study terminated by sponsor|0|||
127995229|NCT04892446|460608608|FG001|Overall Study|Study terminated by sponsor|0|||
127995230|NCT04892446|460608609|FG002|Overall Study|Study terminated by sponsor|2|||
127995231|NCT00272844|460608610|FG000|Overall Study|Withdrawal by Subject|5|||
127995232|NCT00705341|460608613|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
127995233|NCT00705341|460608614|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
127995234|NCT00705341|460608615|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
127995235|NCT00705341|460608616|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
127995236|NCT00705341|460608613|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
127995237|NCT00705341|460608614|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
127995238|NCT00705341|460608615|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
127995239|NCT00705341|460608616|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
127995240|NCT00791700|460608617|FG000|Overall Study|Insufficient clinical response|1|||
127995241|NCT00791700|460608618|FG001|Overall Study|Insufficient clinical response|4|||
127995242|NCT00791700|460608619|FG002|Overall Study|Insufficient clinical response|1|||
127995243|NCT00791700|460608620|FG003|Overall Study|Insufficient clinical response|8|||
127995244|NCT00791700|460608617|FG000|Overall Study|No longer willing to participate|1|||
127995245|NCT00791700|460608618|FG001|Overall Study|No longer willing to participate|1|||
127995246|NCT00791700|460608619|FG002|Overall Study|No longer willing to participate|0|||
127995247|NCT00791700|460608620|FG003|Overall Study|No longer willing to participate|8|||
127995248|NCT00791700|460608617|FG000|Overall Study|Non-compliance with study treatment|0|||
127995249|NCT00791700|460608618|FG001|Overall Study|Non-compliance with study treatment|2|||
127995250|NCT00791700|460608619|FG002|Overall Study|Non-compliance with study treatment|0|||
127995251|NCT00791700|460608620|FG003|Overall Study|Non-compliance with study treatment|4|||
127995252|NCT00791700|460608617|FG000|Overall Study|Withdrawn due to pregnancy|0|||
127995253|NCT00791700|460608618|FG001|Overall Study|Withdrawn due to pregnancy|0|||
127995254|NCT00791700|460608619|FG002|Overall Study|Withdrawn due to pregnancy|0|||
127995255|NCT00791700|460608620|FG003|Overall Study|Withdrawn due to pregnancy|1|||
127995256|NCT00791700|460608617|FG000|Overall Study|Other|0|||
127995257|NCT00791700|460608618|FG001|Overall Study|Other|1|||
127995258|NCT00791700|460608619|FG002|Overall Study|Other|0|||
127995259|NCT00791700|460608620|FG003|Overall Study|Other|1|||
127995260|NCT00791700|460608617|FG000|Overall Study|Death|0|||
127995261|NCT00791700|460608618|FG001|Overall Study|Death|0|||
127995262|NCT00791700|460608619|FG002|Overall Study|Death|0|||
127995263|NCT00791700|460608620|FG003|Overall Study|Death|1|||
127995264|NCT00791700|460608617|FG000|Overall Study|Lost to Follow-up|4|||
127995265|NCT00791700|460608618|FG001|Overall Study|Lost to Follow-up|3|||
127995266|NCT00791700|460608619|FG002|Overall Study|Lost to Follow-up|4|||
127995267|NCT00791700|460608620|FG003|Overall Study|Lost to Follow-up|6|||
127995268|NCT00791700|460608617|FG000|Overall Study|Adverse Event|0|||
127995269|NCT00791700|460608618|FG001|Overall Study|Adverse Event|0|||
127995270|NCT00791700|460608619|FG002|Overall Study|Adverse Event|1|||
127995271|NCT00791700|460608620|FG003|Overall Study|Adverse Event|1|||
127995272|NCT01720524|460608623|FG000|Part A|Insufficient Clinical Response|2|||
127995273|NCT01720524|460608624|FG001|Part A|Insufficient Clinical Response|4|||
127995274|NCT01720524|460608623|FG000|Part A|Adverse Event|2|||
127995275|NCT01720524|460608624|FG001|Part A|Adverse Event|2|||
127995276|NCT01720524|460608623|FG000|Part A|Death|2|||
127995277|NCT01720524|460608624|FG001|Part A|Death|1|||
127995278|NCT01720524|460608623|FG000|Part A|Lost to Follow-up|0|||
127995279|NCT01720524|460608624|FG001|Part A|Lost to Follow-up|1|||
127995280|NCT01720524|460608623|FG000|Part A|Missed 28 day follow-up visit|1|||
127995281|NCT01720524|460608624|FG001|Part A|Missed 28 day follow-up visit|1|||
127995282|NCT01720524|460608623|FG000|Part A|Withdrawal by Subject|0|||
127995283|NCT01720524|460608624|FG001|Part A|Withdrawal by Subject|1|||
127995284|NCT01720524|460608623|FG000|Part A|Other|0|||
127995285|NCT01720524|460608624|FG001|Part A|Other|1|||
127995286|NCT01720524|460608623|FG000|Part A|Lost to Follow-up|0|||
127995287|NCT01720524|460608624|FG001|Part A|Lost to Follow-up|1|||
127995288|NCT01720524|460608623|FG000|Part B|No longer willing to participate in study|1|||
127995289|NCT01720524|460608624|FG001|Part B|No longer willing to participate in study|4|||
127995290|NCT01720524|460608623|FG000|Part B|Other|2|||
127995291|NCT01720524|460608624|FG001|Part B|Other|0|||
127995292|NCT01720524|460608623|FG000|Part B|Lost to Follow-up|2|||
127995293|NCT01720524|460608624|FG001|Part B|Lost to Follow-up|3|||
127995294|NCT01720524|460608623|FG000|Part B|Death|0|||
127995295|NCT01720524|460608624|FG001|Part B|Death|2|||
127995296|NCT00527826|460608628|FG000|Overall Study|Adverse Event|10|||
127995297|NCT00527826|460608629|FG001|Overall Study|Adverse Event|10|||
127995298|NCT00527826|460608628|FG000|Overall Study|Lost to Follow-up|3|||
127995299|NCT00527826|460608629|FG001|Overall Study|Lost to Follow-up|2|||
127995300|NCT00527826|460608628|FG000|Overall Study|Withdrawal by Subject|5|||
127995301|NCT00527826|460608629|FG001|Overall Study|Withdrawal by Subject|8|||
127995302|NCT00527826|460608628|FG000|Overall Study|Inclusion Criteria Not Met|3|||
127995303|NCT00527826|460608629|FG001|Overall Study|Inclusion Criteria Not Met|3|||
127995304|NCT00527826|460608628|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
127995305|NCT00527826|460608629|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
127995306|NCT00527826|460608628|FG000|Overall Study|Additional Intake of Viani forte|0|||
127995307|NCT00527826|460608629|FG001|Overall Study|Additional Intake of Viani forte|1|||
127995308|NCT00527826|460608628|FG000|Overall Study|Participant moved away|0|||
127995309|NCT00527826|460608629|FG001|Overall Study|Participant moved away|1|||
127995310|NCT02105285|460608632|FG000|Overall Study|Adverse Event|1|||
127995311|NCT02105285|460608633|FG001|Overall Study|Adverse Event|1|||
127995312|NCT02105285|460608634|FG002|Overall Study|Adverse Event|0|||
127995313|NCT02105285|460608632|FG000|Overall Study|Protocol Violation|0|||
127995314|NCT02105285|460608633|FG001|Overall Study|Protocol Violation|1|||
127995315|NCT02105285|460608634|FG002|Overall Study|Protocol Violation|0|||
127995316|NCT02105285|460608632|FG000|Overall Study|Withdrawal by Subject|1|||
127995317|NCT02105285|460608633|FG001|Overall Study|Withdrawal by Subject|0|||
127995318|NCT02105285|460608634|FG002|Overall Study|Withdrawal by Subject|0|||
127995319|NCT01421641|460608635|FG000|Overall Study|Protocol Violation|2|||
127995320|NCT01421641|460608636|FG001|Overall Study|Protocol Violation|2|||
127995321|NCT02609984|460608638|FG000|Overall Study|Death|29|||
127995322|NCT02609984|460608639|FG001|Overall Study|Death|26|||
127995323|NCT02609984|460608638|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
127995324|NCT02609984|460608639|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
127995325|NCT02609984|460608638|FG000|Overall Study|Lost to Follow-up|1|||
127995326|NCT02609984|460608639|FG001|Overall Study|Lost to Follow-up|2|||
127995327|NCT02609984|460608638|FG000|Overall Study|Withdrawal by Subject|0|||
127995328|NCT02609984|460608639|FG001|Overall Study|Withdrawal by Subject|1|||
127995329|NCT02609984|460608638|FG000|Overall Study|Disease Progression|2|||
127995330|NCT02609984|460608639|FG001|Overall Study|Disease Progression|0|||
127995331|NCT02504320|460608640|FG000|Treatment Period 1|Positive Drug Screen|0|||
127995332|NCT02504320|460608641|FG001|Treatment Period 1|Positive Drug Screen|0|||
127995333|NCT02504320|460608642|FG002|Treatment Period 1|Positive Drug Screen|1|||
127995334|NCT02504320|460608643|FG003|Treatment Period 1|Positive Drug Screen|0|||
127995335|NCT02504320|460608640|FG000|Treatment Period 2|Positive Drug Screen|0|||
127995336|NCT02504320|460608641|FG001|Treatment Period 2|Positive Drug Screen|1|||
127995337|NCT02504320|460608642|FG002|Treatment Period 2|Positive Drug Screen|0|||
127995338|NCT02504320|460608643|FG003|Treatment Period 2|Positive Drug Screen|0|||
127995339|NCT02504320|460608640|FG000|Treatment Period 3|Positive Drug Screen|0|||
127995340|NCT02504320|460608641|FG001|Treatment Period 3|Positive Drug Screen|0|||
127995341|NCT02504320|460608642|FG002|Treatment Period 3|Positive Drug Screen|0|||
127995342|NCT02504320|460608643|FG003|Treatment Period 3|Positive Drug Screen|1|||
127995343|NCT02504320|460608640|FG000|Treatment Period 3|Adverse Event|0|||
127995344|NCT02504320|460608641|FG001|Treatment Period 3|Adverse Event|0|||
127995345|NCT02504320|460608642|FG002|Treatment Period 3|Adverse Event|1|||
127995346|NCT02504320|460608643|FG003|Treatment Period 3|Adverse Event|0|||
127995347|NCT01210222|460608644|FG000|Overall Study|Ineligible|2|||
127995348|NCT01210222|460608644|FG000|Overall Study|Never treated|1|||
127995349|NCT00941304|460608645|FG000|Overall Study|Lost to Follow-up|1|||
127995350|NCT00941304|460608646|FG001|Overall Study|Lost to Follow-up|0|||
127995351|NCT00941304|460608647|FG002|Overall Study|Lost to Follow-up|0|||
127995352|NCT00941304|460608648|FG003|Overall Study|Lost to Follow-up|0|||
127995353|NCT00941304|460608649|FG004|Overall Study|Lost to Follow-up|0|||
127995354|NCT03293394|460608650|FG000|Follow-up (6 Months)|Adverse Event|4|||
127995355|NCT03293394|460608651|FG001|Follow-up (6 Months)|Adverse Event|2|||
127995356|NCT04978337|460608654|FG000|Overall Study|Withdrawal by Subject|0|||
127995357|NCT04978337|460608655|FG001|Overall Study|Withdrawal by Subject|1|||
127995358|NCT01408901|460608658|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
127665244|NCT03824938|459395114|FG002|Overall Study|Withdrawal by Subject|0|||
127995359|NCT01408901|460608659|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
127995360|NCT01408901|460608660|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
127995361|NCT01408901|460608661|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
127995362|NCT01408901|460608658|FG000|6-Week Follow-Up|Death|1|||
127995363|NCT01408901|460608659|FG001|6-Week Follow-Up|Death|0|||
127995364|NCT01408901|460608660|FG002|6-Week Follow-Up|Death|0|||
127995365|NCT01408901|460608661|FG003|6-Week Follow-Up|Death|0|||
127995366|NCT01408901|460608658|FG000|6-Week Follow-Up|Cancelled visit|0|||
127995367|NCT01408901|460608659|FG001|6-Week Follow-Up|Cancelled visit|1|||
127995368|NCT01408901|460608660|FG002|6-Week Follow-Up|Cancelled visit|0|||
127995369|NCT01408901|460608661|FG003|6-Week Follow-Up|Cancelled visit|2|||
127995370|NCT01408901|460608658|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
127995371|NCT01408901|460608659|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
127995372|NCT01408901|460608660|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
127995373|NCT01408901|460608661|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
127995374|NCT01408901|460608658|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
127995375|NCT01408901|460608659|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
127995376|NCT01408901|460608660|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
127995377|NCT01408901|460608661|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
127995378|NCT01408901|460608658|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
127995379|NCT01408901|460608659|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
127995380|NCT01408901|460608660|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
127995381|NCT01408901|460608661|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
127995382|NCT01408901|460608658|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
127995383|NCT01408901|460608659|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
127995384|NCT01408901|460608660|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
127995385|NCT01408901|460608661|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
127995386|NCT01408901|460608658|FG000|26-Week Follow-Up|Death|0|||
127995387|NCT01408901|460608659|FG001|26-Week Follow-Up|Death|1|||
127995388|NCT01408901|460608660|FG002|26-Week Follow-Up|Death|0|||
127995389|NCT01408901|460608661|FG003|26-Week Follow-Up|Death|0|||
127995390|NCT01436227|460608665|FG000|Overall Study|Adverse Event|7|||
127995391|NCT01436227|460608665|FG000|Overall Study|Death|1|||
127995392|NCT01436227|460608665|FG000|Overall Study|Lack of Efficacy|1|||
127995393|NCT01436227|460608665|FG000|Overall Study|Lost to Follow-up|3|||
127995394|NCT01436227|460608665|FG000|Overall Study|Physician Decision|1|||
127995395|NCT01436227|460608665|FG000|Overall Study|Withdrawal by Subject|7|||
127995396|NCT01436227|460608665|FG000|Overall Study|Disease progression, relapse|6|||
127995397|NCT04004260|460608666|FG000|Overall Study|Withdrawal by Subject|7|||
127995398|NCT04004260|460608667|FG001|Overall Study|Withdrawal by Subject|3|||
127995399|NCT04004260|460608666|FG000|Overall Study|Lost to Follow-up|22|||
127995400|NCT04004260|460608667|FG001|Overall Study|Lost to Follow-up|12|||
127995401|NCT04004260|460608666|FG000|Overall Study|Did not engage in intervention|13|||
127995402|NCT04004260|460608667|FG001|Overall Study|Did not engage in intervention|17|||
127995403|NCT01765569|460608672|FG000|Period B|Withdrawal by Subject|1|||
127995404|NCT01765569|460608672|FG000|Period C|Death|1|||
127995405|NCT03414229|460608673|FG000|Overall Study|Adverse Event|1|||
127995406|NCT03414229|460608674|FG001|Overall Study|Adverse Event|0|||
127995407|NCT03414229|460608675|FG002|Overall Study|Adverse Event|2|||
127995408|NCT03414229|460608676|FG003|Overall Study|Adverse Event|1|||
127995409|NCT03414229|460608673|FG000|Overall Study|Lack of Efficacy|7|||
127995410|NCT03414229|460608674|FG001|Overall Study|Lack of Efficacy|4|||
127995411|NCT03414229|460608675|FG002|Overall Study|Lack of Efficacy|1|||
127995412|NCT03414229|460608676|FG003|Overall Study|Lack of Efficacy|9|||
127995413|NCT03414229|460608673|FG000|Overall Study|Change in therapy|1|||
127995414|NCT03414229|460608674|FG001|Overall Study|Change in therapy|0|||
127995415|NCT03414229|460608675|FG002|Overall Study|Change in therapy|0|||
127995416|NCT03414229|460608676|FG003|Overall Study|Change in therapy|0|||
127995417|NCT03414229|460608673|FG000|Overall Study|Pregnancy|0|||
127995418|NCT03414229|460608674|FG001|Overall Study|Pregnancy|0|||
127995419|NCT03414229|460608675|FG002|Overall Study|Pregnancy|1|||
127995420|NCT03414229|460608676|FG003|Overall Study|Pregnancy|0|||
127995421|NCT03414229|460608673|FG000|Overall Study|Withdrawal by Subject|0|||
127995422|NCT03414229|460608674|FG001|Overall Study|Withdrawal by Subject|1|||
127995423|NCT03414229|460608675|FG002|Overall Study|Withdrawal by Subject|1|||
127995424|NCT03414229|460608676|FG003|Overall Study|Withdrawal by Subject|0|||
127995425|NCT04533438|460608680|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
127995426|NCT04533438|460608681|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
127995427|NCT05568797|460608685|FG000|Overall Study|Adverse Event|0|||
127995428|NCT05568797|460608686|FG001|Overall Study|Adverse Event|8|||
127995429|NCT05568797|460608685|FG000|Overall Study|Lost to Follow-up|2|||
127995430|NCT05568797|460608686|FG001|Overall Study|Lost to Follow-up|3|||
127995431|NCT05568797|460608685|FG000|Overall Study|Withdrawal by Subject|1|||
127995432|NCT05568797|460608686|FG001|Overall Study|Withdrawal by Subject|10|||
127995433|NCT05568797|460608685|FG000|Overall Study|Other|2|||
127995434|NCT05568797|460608686|FG001|Overall Study|Other|2|||
127995435|NCT03131687|460608688|FG000|Overall Study|Adverse Event|0|||
127995436|NCT03131687|460608689|FG001|Overall Study|Adverse Event|1|||
127995437|NCT03131687|460608690|FG002|Overall Study|Adverse Event|0|||
127995438|NCT03131687|460608691|FG003|Overall Study|Adverse Event|1|||
127995439|NCT03131687|460608692|FG004|Overall Study|Adverse Event|2|||
127665245|NCT03824938|459395115|FG003|Overall Study|Withdrawal by Subject|2|||
127995440|NCT03131687|460608693|FG005|Overall Study|Adverse Event|2|||
127995441|NCT03131687|460608688|FG000|Overall Study|Death|1|||
127995442|NCT03131687|460608689|FG001|Overall Study|Death|0|||
127995443|NCT03131687|460608690|FG002|Overall Study|Death|0|||
127995444|NCT03131687|460608691|FG003|Overall Study|Death|0|||
127995445|NCT03131687|460608692|FG004|Overall Study|Death|0|||
127995446|NCT03131687|460608693|FG005|Overall Study|Death|0|||
127995447|NCT03131687|460608688|FG000|Overall Study|Withdrawal by Subject|3|||
127995448|NCT03131687|460608689|FG001|Overall Study|Withdrawal by Subject|3|||
127995449|NCT03131687|460608690|FG002|Overall Study|Withdrawal by Subject|3|||
127995450|NCT03131687|460608691|FG003|Overall Study|Withdrawal by Subject|1|||
127995451|NCT03131687|460608692|FG004|Overall Study|Withdrawal by Subject|2|||
127995452|NCT03131687|460608693|FG005|Overall Study|Withdrawal by Subject|1|||
127995453|NCT03131687|460608688|FG000|Overall Study|Lost to Follow-up|1|||
127995454|NCT03131687|460608689|FG001|Overall Study|Lost to Follow-up|4|||
127995455|NCT03131687|460608690|FG002|Overall Study|Lost to Follow-up|0|||
127995456|NCT03131687|460608691|FG003|Overall Study|Lost to Follow-up|1|||
127995457|NCT03131687|460608692|FG004|Overall Study|Lost to Follow-up|4|||
127995458|NCT03131687|460608693|FG005|Overall Study|Lost to Follow-up|2|||
127995459|NCT03131687|460608688|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
127995460|NCT03131687|460608689|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
127995461|NCT03131687|460608690|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
127995462|NCT03131687|460608691|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
127995463|NCT03131687|460608692|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
127995464|NCT03131687|460608693|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
127995465|NCT03131687|460608688|FG000|Overall Study|Principle Investigator Decision|0|||
127995466|NCT03131687|460608689|FG001|Overall Study|Principle Investigator Decision|1|||
127995467|NCT03131687|460608690|FG002|Overall Study|Principle Investigator Decision|0|||
127995468|NCT03131687|460608691|FG003|Overall Study|Principle Investigator Decision|0|||
127995469|NCT03131687|460608692|FG004|Overall Study|Principle Investigator Decision|0|||
127995470|NCT03131687|460608693|FG005|Overall Study|Principle Investigator Decision|0|||
127995471|NCT03131687|460608688|FG000|Overall Study|Inadvertent Enrollment|0|||
127995472|NCT03131687|460608689|FG001|Overall Study|Inadvertent Enrollment|0|||
127995473|NCT03131687|460608690|FG002|Overall Study|Inadvertent Enrollment|0|||
127995474|NCT03131687|460608691|FG003|Overall Study|Inadvertent Enrollment|1|||
127995475|NCT03131687|460608692|FG004|Overall Study|Inadvertent Enrollment|0|||
127995476|NCT03131687|460608693|FG005|Overall Study|Inadvertent Enrollment|0|||
127995477|NCT00869128|460608695|FG000|Overall Study|lack of Compliance|6|||
127995478|NCT00869128|460608696|FG001|Overall Study|lack of Compliance|6|||
127995479|NCT02998996|460608702|FG000|Overall Study|Lost to Follow-up|0|||
127995480|NCT02998996|460608703|FG001|Overall Study|Lost to Follow-up|0|||
127995481|NCT02998996|460608704|FG002|Overall Study|Lost to Follow-up|1|||
127995482|NCT02998996|460608705|FG003|Overall Study|Lost to Follow-up|0|||
127995483|NCT02998996|460608706|FG004|Overall Study|Lost to Follow-up|0|||
127995484|NCT02998996|460608707|FG005|Overall Study|Lost to Follow-up|0|||
127995485|NCT02998996|460608702|FG000|Overall Study|Pregnancy|0|||
127995486|NCT02998996|460608703|FG001|Overall Study|Pregnancy|1|||
127995487|NCT02998996|460608704|FG002|Overall Study|Pregnancy|0|||
127995488|NCT02998996|460608705|FG003|Overall Study|Pregnancy|0|||
127995489|NCT02998996|460608706|FG004|Overall Study|Pregnancy|0|||
127995490|NCT02998996|460608707|FG005|Overall Study|Pregnancy|0|||
127995491|NCT02998996|460608702|FG000|Overall Study|Family reasons|0|||
127995492|NCT02998996|460608703|FG001|Overall Study|Family reasons|0|||
127995493|NCT02998996|460608704|FG002|Overall Study|Family reasons|0|||
127995494|NCT02998996|460608705|FG003|Overall Study|Family reasons|0|||
127995495|NCT02998996|460608706|FG004|Overall Study|Family reasons|1|||
127995496|NCT02998996|460608707|FG005|Overall Study|Family reasons|0|||
127995497|NCT01118663|460608708|FG000|Overall Study|Adverse Event|2|||
127995498|NCT01118663|460608709|FG001|Overall Study|Adverse Event|1|||
127995499|NCT01118663|460608708|FG000|Overall Study|Withdrawal by Subject|0|||
127995500|NCT01118663|460608709|FG001|Overall Study|Withdrawal by Subject|1|||
127995501|NCT02716584|460608710|FG000|Overall Study|Lost to Follow-up|8|||
127995502|NCT02716584|460608711|FG001|Overall Study|Lost to Follow-up|5|||
127995503|NCT05279131|460608712|FG000|Overall Study|Lost to Follow-up|1|||
127995504|NCT05279131|460608712|FG000|Overall Study|Death|1|||
127995505|NCT05279131|460608712|FG000|Overall Study|Physician Decision|1|||
127995506|NCT05251233|460610008|FG000|Overall Study|Disease progression - did not start treatment|0|||
127995507|NCT05251233|460610009|FG001|Overall Study|Disease progression - did not start treatment|0|||
127995508|NCT05251233|460610010|FG002|Overall Study|Disease progression - did not start treatment|5|||
127995509|NCT05251233|460610008|FG000|Overall Study|Determined to be ineligible - did not start treatment|0|||
127995510|NCT05251233|460610009|FG001|Overall Study|Determined to be ineligible - did not start treatment|0|||
127995511|NCT05251233|460610010|FG002|Overall Study|Determined to be ineligible - did not start treatment|7|||
127995512|NCT05251233|460610008|FG000|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
127995513|NCT05251233|460610009|FG001|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
127995514|NCT05251233|460610010|FG002|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|1|||
127995515|NCT05251233|460610008|FG000|Overall Study|Had a total gastrectomy - did not start treatment|0|||
127995516|NCT05251233|460610009|FG001|Overall Study|Had a total gastrectomy - did not start treatment|0|||
127995517|NCT05251233|460610010|FG002|Overall Study|Had a total gastrectomy - did not start treatment|1|||
127995518|NCT05251233|460610008|FG000|Overall Study|Death - did not start treatment|3|||
127995519|NCT05251233|460610009|FG001|Overall Study|Death - did not start treatment|0|||
127995520|NCT05251233|460610010|FG002|Overall Study|Death - did not start treatment|0|||
127995521|NCT05251233|460610008|FG000|Overall Study|Withdrawal by Subject|2|||
127995522|NCT05251233|460610009|FG001|Overall Study|Withdrawal by Subject|2|||
127995523|NCT05251233|460610010|FG002|Overall Study|Withdrawal by Subject|0|||
127995524|NCT05251233|460610008|FG000|Overall Study|Other complicating disease|2|||
127995525|NCT05251233|460610009|FG001|Overall Study|Other complicating disease|1|||
127995526|NCT05251233|460610010|FG002|Overall Study|Other complicating disease|0|||
127995527|NCT05251233|460610008|FG000|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
127995528|NCT05251233|460610009|FG001|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
127995529|NCT05251233|460610010|FG002|Overall Study|Attending physician did not order medication for patient - did not start treatment|1|||
127995530|NCT05251233|460610008|FG000|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
127995531|NCT05251233|460610009|FG001|Overall Study|Patient was ordered NPO and had NGT placed.|1|||
127995532|NCT05251233|460610010|FG002|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
127995533|NCT03272347|460610015|FG000|Overall Study|Death|0|||
127995534|NCT03272347|460610016|FG001|Overall Study|Death|0|||
127995535|NCT03272347|460610017|FG002|Overall Study|Death|0|||
127995536|NCT03272347|460610018|FG003|Overall Study|Death|1|||
127995537|NCT03272347|460610015|FG000|Overall Study|Lost to Follow-up|1|||
127995538|NCT03272347|460610016|FG001|Overall Study|Lost to Follow-up|3|||
127995539|NCT03272347|460610017|FG002|Overall Study|Lost to Follow-up|5|||
127995540|NCT03272347|460610018|FG003|Overall Study|Lost to Follow-up|1|||
127995541|NCT03272347|460610015|FG000|Overall Study|Physician Decision|4|||
127995542|NCT03272347|460610016|FG001|Overall Study|Physician Decision|2|||
127995543|NCT03272347|460610017|FG002|Overall Study|Physician Decision|5|||
127995544|NCT03272347|460610018|FG003|Overall Study|Physician Decision|4|||
127995545|NCT03272347|460610015|FG000|Overall Study|Screen Failure|1|||
127995546|NCT03272347|460610016|FG001|Overall Study|Screen Failure|0|||
127995547|NCT03272347|460610017|FG002|Overall Study|Screen Failure|0|||
127995548|NCT03272347|460610018|FG003|Overall Study|Screen Failure|0|||
127995549|NCT03272347|460610015|FG000|Overall Study|Withdrawal by Subject|5|||
127995550|NCT03272347|460610016|FG001|Overall Study|Withdrawal by Subject|1|||
127995551|NCT03272347|460610017|FG002|Overall Study|Withdrawal by Subject|2|||
127995552|NCT03272347|460610018|FG003|Overall Study|Withdrawal by Subject|1|||
127995553|NCT00703677|460610019|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
127995554|NCT00940888|460610020|FG000|Overall Study|Unsuccessful Implant|4|||
127995555|NCT00940888|460610020|FG000|Overall Study|Death|461|||
127995556|NCT00940888|460610020|FG000|Overall Study|Withdrawn - Non-Death|364|||
127995557|NCT00940888|460610020|FG000|Overall Study|Lost to Follow-up|6|||
127995558|NCT04441788|460610023|FG000|Overall Study|Voluntary Withdrawl|0|||
127995559|NCT04441788|460610024|FG001|Overall Study|Voluntary Withdrawl|1|||
127995560|NCT04441788|460610025|FG002|Overall Study|Voluntary Withdrawl|0|||
127995561|NCT04441788|460610023|FG000|Overall Study|Ineligibility|1|||
127995562|NCT04441788|460610024|FG001|Overall Study|Ineligibility|0|||
127995563|NCT04441788|460610025|FG002|Overall Study|Ineligibility|0|||
127995564|NCT04441788|460610023|FG000|Overall Study|Adverse Event|0|||
127995565|NCT04441788|460610024|FG001|Overall Study|Adverse Event|0|||
127995566|NCT04441788|460610025|FG002|Overall Study|Adverse Event|4|||
127995567|NCT04441788|460610023|FG000|Overall Study|Study Terminated by Sponsor|16|||
127995568|NCT04441788|460610024|FG001|Overall Study|Study Terminated by Sponsor|16|||
127995569|NCT04441788|460610025|FG002|Overall Study|Study Terminated by Sponsor|12|||
127995570|NCT03859648|460610032|FG000|Overall Study|Lost to Follow-up|1|||
127995571|NCT03859648|460610032|FG000|Overall Study|Adverse Event|1|||
127995572|NCT00391872|460610033|FG000|Overall Study|Protocol Violation|7|||
127995573|NCT00391872|460610034|FG001|Overall Study|Protocol Violation|2|||
127995574|NCT00391872|460610033|FG000|Overall Study|Withdrawal by Subject|296|||
127995575|NCT00391872|460610034|FG001|Overall Study|Withdrawal by Subject|249|||
127995576|NCT00391872|460610033|FG000|Overall Study|Reason unknown|2|||
127995577|NCT00391872|460610034|FG001|Overall Study|Reason unknown|4|||
127995578|NCT00391872|460610033|FG000|Overall Study|Lost to Follow-up|2|||
127995579|NCT00391872|460610034|FG001|Overall Study|Lost to Follow-up|0|||
127995580|NCT02861664|460610036|FG000|Overall Study|Withdrawal of Consent|0|||
127995581|NCT02861664|460610037|FG001|Overall Study|Withdrawal of Consent|1|||
127995582|NCT01239394|460610038|FG000|Overall Study|Adverse Event|1|||
127995583|NCT00905632|460610040|FG000|Overall Study|Adverse Event|0|||
127995584|NCT00905632|460610041|FG001|Overall Study|Adverse Event|0|||
127995585|NCT00905632|460610042|FG002|Overall Study|Adverse Event|0|||
127995586|NCT00905632|460610043|FG003|Overall Study|Adverse Event|0|||
127995587|NCT00905632|460610044|FG004|Overall Study|Adverse Event|0|||
127995588|NCT00905632|460610045|FG005|Overall Study|Adverse Event|1|||
127995589|NCT00905632|460610046|FG006|Overall Study|Adverse Event|4|||
127995590|NCT01307891|460610048|FG000|Overall Study|Progressive Disease|3|||
127995591|NCT01307891|460610049|FG001|Overall Study|Progressive Disease|1|||
127995592|NCT02937740|460610050|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
127995593|NCT02937740|460610051|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
127995594|NCT02937740|460610050|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
127995595|NCT02937740|460610051|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
127995596|NCT02937740|460610050|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
127995597|NCT02937740|460610051|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
127995598|NCT02937740|460610050|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
127995599|NCT02937740|460610051|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
127995600|NCT02937740|460610050|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
127995601|NCT02937740|460610051|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
127995602|NCT02937740|460610050|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
127995603|NCT02937740|460610051|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
127995604|NCT00305227|460610054|FG000|Overall Study|Lost to Follow-up|7|||
127995605|NCT00305227|460610055|FG001|Overall Study|Lost to Follow-up|6|||
127995606|NCT04085601|460610056|FG000|Overall Study|Lost to Follow-up|1|||
127995607|NCT04085601|460610057|FG001|Overall Study|Lost to Follow-up|0|||
127995608|NCT04085601|460610056|FG000|Overall Study|Death|1|||
127995609|NCT04085601|460610057|FG001|Overall Study|Death|1|||
127995610|NCT03492437|460610058|FG000|Treatment Period 2|Withdrawal by Subject|0|||
127995611|NCT03492437|460610059|FG001|Treatment Period 2|Withdrawal by Subject|1|||
127995612|NCT04534517|460610061|FG000|Overall Study|Adverse Event|1|||
127995613|NCT04534517|460610061|FG000|Overall Study|Withdrawal by Subject|1|||
127995614|NCT04534517|460610061|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
127995615|NCT04534517|460610061|FG000|Overall Study|COVID-19 Related|1|||
127995616|NCT03872843|460610062|FG000|Overall Study|Lost to Follow-up|5|||
127995617|NCT03872843|460610063|FG001|Overall Study|Lost to Follow-up|7|||
127995618|NCT00823264|460610064|FG000|Overall Study|Protocol Violation|2|||
127995619|NCT00823264|460610065|FG001|Overall Study|Protocol Violation|0|||
127995620|NCT05133323|460610066|FG000|Overall Study|Lack of Efficacy|0|||
127995621|NCT05133323|460610067|FG001|Overall Study|Lack of Efficacy|0|||
127995622|NCT05133323|460610068|FG002|Overall Study|Lack of Efficacy|1|||
127995623|NCT05133323|460610066|FG000|Overall Study|Withdrawal by Subject|2|||
127995624|NCT05133323|460610067|FG001|Overall Study|Withdrawal by Subject|1|||
127995625|NCT05133323|460610068|FG002|Overall Study|Withdrawal by Subject|0|||
127995626|NCT00113295|460610069|FG000|Overall Study|Adverse Event|4|||
127995627|NCT00113295|460610070|FG001|Overall Study|Adverse Event|1|||
127995628|NCT00113295|460610069|FG000|Overall Study|Unrelated Medical Illness|1|||
127995629|NCT00113295|460610070|FG001|Overall Study|Unrelated Medical Illness|0|||
127995630|NCT01714544|460610071|FG000|Overall Study|Lost to Follow-up|1|||
127995631|NCT01714544|460610071|FG000|Overall Study|Physician Decision|1|||
127995632|NCT01714544|460610071|FG000|Overall Study|Withdrawal by Subject|1|||
127995633|NCT00577772|460610080|FG000|Overall Study|Lost to Follow-up|0|||
127995634|NCT00577772|460610081|FG001|Overall Study|Lost to Follow-up|1|||
127995635|NCT00572455|460610082|FG000|Stage I (14 Days)|Adverse Event|0|||
127995636|NCT00572455|460610083|FG001|Stage I (14 Days)|Adverse Event|0|||
127995637|NCT00572455|460610084|FG002|Stage I (14 Days)|Adverse Event|0|||
127995638|NCT00572455|460610085|FG003|Stage I (14 Days)|Adverse Event|0|||
127995639|NCT00572455|460610086|FG004|Stage I (14 Days)|Adverse Event|0|||
127995640|NCT00572455|460610087|FG005|Stage I (14 Days)|Adverse Event|3|||
127995641|NCT00572455|460610088|FG006|Stage I (14 Days)|Adverse Event|0|||
127995642|NCT00572455|460610089|FG007|Stage I (14 Days)|Adverse Event|0|||
127995643|NCT00572455|460610090|FG008|Stage I (14 Days)|Adverse Event|0|||
127995644|NCT00572455|460610091|FG009|Stage I (14 Days)|Adverse Event|0|||
127995645|NCT00572455|460610092|FG010|Stage I (14 Days)|Adverse Event|0|||
127995646|NCT00572455|460610093|FG011|Stage I (14 Days)|Adverse Event|0|||
127995647|NCT00572455|460610094|FG012|Stage I (14 Days)|Adverse Event|0|||
127995648|NCT00572455|460610095|FG013|Stage I (14 Days)|Adverse Event|0|||
127995649|NCT00572455|460610082|FG000|Stage I (14 Days)|Other|0|||
127995650|NCT00572455|460610083|FG001|Stage I (14 Days)|Other|0|||
127665246|NCT03824938|459395116|FG004|Overall Study|Withdrawal by Subject|0|||
127665247|NCT03824938|459395117|FG005|Overall Study|Withdrawal by Subject|1|||
127665248|NCT03824938|459395112|FG000|Overall Study|Lost to Follow-up|0|||
127665249|NCT03824938|459395113|FG001|Overall Study|Lost to Follow-up|1|||
127665250|NCT03824938|459395114|FG002|Overall Study|Lost to Follow-up|0|||
127665251|NCT03824938|459395115|FG003|Overall Study|Lost to Follow-up|0|||
127665252|NCT03824938|459395116|FG004|Overall Study|Lost to Follow-up|1|||
127665253|NCT03824938|459395117|FG005|Overall Study|Lost to Follow-up|0|||
127665254|NCT01990300|459395121|FG000|Overall Study|Case Report Forms Uncollected|89|||
127665255|NCT01990300|459395121|FG000|Overall Study|Protocol Deviation|53|||
127665256|NCT00322374|459395124|FG000|Starting Dose|Physician Decision|2|||
127665257|NCT00322374|459395125|FG001|Starting Dose|Physician Decision|0|||
127995651|NCT00572455|460610084|FG002|Stage I (14 Days)|Other|0|||
127995652|NCT00572455|460610085|FG003|Stage I (14 Days)|Other|0|||
127995653|NCT00572455|460610086|FG004|Stage I (14 Days)|Other|1|||
127995654|NCT00572455|460610087|FG005|Stage I (14 Days)|Other|0|||
127665258|NCT00322374|459395126|FG002|Starting Dose|Physician Decision|0|||
127665259|NCT00322374|459395127|FG003|Starting Dose|Physician Decision|0|||
127995655|NCT00572455|460610088|FG006|Stage I (14 Days)|Other|0|||
127995656|NCT00572455|460610089|FG007|Stage I (14 Days)|Other|0|||
127995657|NCT00572455|460610090|FG008|Stage I (14 Days)|Other|0|||
127995658|NCT00572455|460610091|FG009|Stage I (14 Days)|Other|0|||
127995659|NCT00572455|460610092|FG010|Stage I (14 Days)|Other|0|||
127995660|NCT00572455|460610093|FG011|Stage I (14 Days)|Other|0|||
127665260|NCT00322374|459395124|FG000|Starting Dose|Study Drug Toxicity|4|||
127995661|NCT00572455|460610094|FG012|Stage I (14 Days)|Other|0|||
127995662|NCT00572455|460610095|FG013|Stage I (14 Days)|Other|0|||
127995663|NCT00572455|460610082|FG000|Stage II (28 Days)|Adverse Event|0|||
127995664|NCT00572455|460610083|FG001|Stage II (28 Days)|Adverse Event|0|||
127995665|NCT00572455|460610084|FG002|Stage II (28 Days)|Adverse Event|0|||
127995666|NCT00572455|460610085|FG003|Stage II (28 Days)|Adverse Event|0|||
127995667|NCT00572455|460610086|FG004|Stage II (28 Days)|Adverse Event|0|||
127995668|NCT00572455|460610087|FG005|Stage II (28 Days)|Adverse Event|0|||
127995669|NCT00572455|460610088|FG006|Stage II (28 Days)|Adverse Event|0|||
127995670|NCT00572455|460610089|FG007|Stage II (28 Days)|Adverse Event|0|||
127995671|NCT00572455|460610090|FG008|Stage II (28 Days)|Adverse Event|1|||
127995672|NCT00572455|460610091|FG009|Stage II (28 Days)|Adverse Event|3|||
127995673|NCT00572455|460610092|FG010|Stage II (28 Days)|Adverse Event|3|||
127995674|NCT00572455|460610093|FG011|Stage II (28 Days)|Adverse Event|4|||
127995675|NCT00572455|460610094|FG012|Stage II (28 Days)|Adverse Event|5|||
127995676|NCT00572455|460610095|FG013|Stage II (28 Days)|Adverse Event|1|||
127995677|NCT00572455|460610082|FG000|Stage II (28 Days)|Death|0|||
127995678|NCT00572455|460610083|FG001|Stage II (28 Days)|Death|0|||
127995679|NCT00572455|460610084|FG002|Stage II (28 Days)|Death|0|||
127995680|NCT00572455|460610085|FG003|Stage II (28 Days)|Death|0|||
127995681|NCT00572455|460610086|FG004|Stage II (28 Days)|Death|0|||
127995682|NCT00572455|460610087|FG005|Stage II (28 Days)|Death|0|||
127995683|NCT00572455|460610088|FG006|Stage II (28 Days)|Death|0|||
127995684|NCT00572455|460610089|FG007|Stage II (28 Days)|Death|0|||
127995685|NCT00572455|460610090|FG008|Stage II (28 Days)|Death|1|||
127995686|NCT00572455|460610091|FG009|Stage II (28 Days)|Death|0|||
127995687|NCT00572455|460610092|FG010|Stage II (28 Days)|Death|0|||
127995688|NCT00572455|460610093|FG011|Stage II (28 Days)|Death|0|||
127995689|NCT00572455|460610094|FG012|Stage II (28 Days)|Death|0|||
127995690|NCT00572455|460610095|FG013|Stage II (28 Days)|Death|0|||
127995691|NCT00572455|460610082|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
127995692|NCT00572455|460610083|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
127995693|NCT00572455|460610084|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
127995694|NCT00572455|460610085|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
127995695|NCT00572455|460610086|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
127995696|NCT00572455|460610087|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
127995697|NCT00572455|460610088|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
127995698|NCT00572455|460610089|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
127995699|NCT00572455|460610090|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
127995700|NCT00572455|460610091|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
127995701|NCT00572455|460610092|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
127995702|NCT00572455|460610093|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
127995703|NCT00572455|460610094|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
127995704|NCT00572455|460610095|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
127995705|NCT00572455|460610082|FG000|Stage II (28 Days)|Other|0|||
127995706|NCT00572455|460610083|FG001|Stage II (28 Days)|Other|0|||
127995707|NCT00572455|460610084|FG002|Stage II (28 Days)|Other|0|||
127995708|NCT00572455|460610085|FG003|Stage II (28 Days)|Other|0|||
127995709|NCT00572455|460610086|FG004|Stage II (28 Days)|Other|0|||
127995710|NCT00572455|460610087|FG005|Stage II (28 Days)|Other|0|||
127995711|NCT00572455|460610088|FG006|Stage II (28 Days)|Other|0|||
127995712|NCT00572455|460610089|FG007|Stage II (28 Days)|Other|0|||
127995713|NCT00572455|460610090|FG008|Stage II (28 Days)|Other|1|||
127995714|NCT00572455|460610091|FG009|Stage II (28 Days)|Other|0|||
127995715|NCT00572455|460610092|FG010|Stage II (28 Days)|Other|0|||
127995716|NCT00572455|460610093|FG011|Stage II (28 Days)|Other|0|||
127995717|NCT00572455|460610094|FG012|Stage II (28 Days)|Other|0|||
127995718|NCT00572455|460610095|FG013|Stage II (28 Days)|Other|0|||
127995719|NCT00572455|460610082|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
127995720|NCT00572455|460610083|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
127995721|NCT00572455|460610084|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
127995722|NCT00572455|460610085|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
127995723|NCT00572455|460610086|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
127995724|NCT00572455|460610087|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
127995725|NCT00572455|460610088|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
127995726|NCT00572455|460610089|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
127995727|NCT00572455|460610090|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
127995728|NCT00572455|460610091|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
127995729|NCT00572455|460610092|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
127995730|NCT00572455|460610093|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
127995731|NCT00572455|460610094|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
127995732|NCT00572455|460610095|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
127995733|NCT02824224|460610096|FG000|Overall Study|Discontinued, IUS expulsion|0|||
127995734|NCT02824224|460610097|FG001|Overall Study|Discontinued, IUS expulsion|1|||
127995735|NCT02824224|460610096|FG000|Overall Study|Did not show up for allocation visit|2|||
127995736|NCT02824224|460610097|FG001|Overall Study|Did not show up for allocation visit|0|||
127995737|NCT04152083|460610100|FG000|Overall Study|Lost to Follow-up|2|||
127995738|NCT04152083|460610101|FG001|Overall Study|Lost to Follow-up|1|||
127995739|NCT04152083|460610100|FG000|Overall Study|Adverse Event|1|||
127995740|NCT04152083|460610101|FG001|Overall Study|Adverse Event|0|||
127995741|NCT04152083|460610100|FG000|Overall Study|Randomized but not treated|3|||
127995742|NCT04152083|460610101|FG001|Overall Study|Randomized but not treated|2|||
127995743|NCT00856999|460610102|FG000|Overall Study|Withdrawal by Subject|5|||
127995744|NCT02465437|460610107|FG000|Overall Study|Physician Decision|0|||
127995745|NCT02465437|460610108|FG001|Overall Study|Physician Decision|0|||
127995746|NCT02465437|460610109|FG002|Overall Study|Physician Decision|1|||
127995747|NCT02465437|460610110|FG003|Overall Study|Physician Decision|0|||
127995748|NCT02465437|460610107|FG000|Overall Study|Withdrawal by Subject|1|||
127995749|NCT02465437|460610108|FG001|Overall Study|Withdrawal by Subject|0|||
127995750|NCT02465437|460610109|FG002|Overall Study|Withdrawal by Subject|0|||
127995751|NCT02465437|460610110|FG003|Overall Study|Withdrawal by Subject|1|||
127995752|NCT02465437|460610107|FG000|Overall Study|Adverse Event|0|||
127995753|NCT02465437|460610108|FG001|Overall Study|Adverse Event|1|||
127995754|NCT02465437|460610109|FG002|Overall Study|Adverse Event|0|||
127995755|NCT02465437|460610110|FG003|Overall Study|Adverse Event|0|||
127995756|NCT00003483|460610111|FG000|Overall Study|Not evaluable|1|||
127995757|NCT02907463|460610117|FG000|Overall Study|Lost to Follow-up|17|||
127995758|NCT02907463|460610117|FG000|Overall Study|Death|10|||
127995759|NCT02907463|460610117|FG000|Overall Study|Withdrawal by Subject|4|||
127995760|NCT02907463|460610117|FG000|Overall Study|MIS Approach was not used|2|||
127995761|NCT02907463|460610117|FG000|Overall Study|Not Implanted with Study Device|2|||
127995762|NCT02907463|460610117|FG000|Overall Study|Device Explanted|1|||
127995763|NCT02907463|460610117|FG000|Overall Study|Missing Exit Form|1|||
127995764|NCT01266824|460610118|FG000|Overall Study|Study terminated prior to completion|2|||
127995765|NCT01266824|460610119|FG001|Overall Study|Study terminated prior to completion|3|||
127665261|NCT00322374|459395125|FG001|Starting Dose|Study Drug Toxicity|0|||
127665262|NCT00322374|459395126|FG002|Starting Dose|Study Drug Toxicity|0|||
127665263|NCT00322374|459395127|FG003|Starting Dose|Study Drug Toxicity|0|||
127665264|NCT00322374|459395124|FG000|First Escalation|Documented Disease Progression|0|||
127665265|NCT00322374|459395125|FG001|First Escalation|Documented Disease Progression|6|||
127665266|NCT00322374|459395126|FG002|First Escalation|Documented Disease Progression|0|||
127665267|NCT00322374|459395127|FG003|First Escalation|Documented Disease Progression|0|||
127665268|NCT00322374|459395124|FG000|First Escalation|Physician Decision|0|||
127665269|NCT00322374|459395125|FG001|First Escalation|Physician Decision|12|||
127665270|NCT00322374|459395126|FG002|First Escalation|Physician Decision|0|||
127665271|NCT00322374|459395127|FG003|First Escalation|Physician Decision|0|||
127665272|NCT00322374|459395124|FG000|First Escalation|Study Drug Toxicity|0|||
127995766|NCT00411450|460610120|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
127995767|NCT01716663|460610121|FG000|Overall Study|Withdrawn prior to procedure|4|||
127995768|NCT01716663|460610121|FG000|Overall Study|Treated with non-study catheter|2|||
127995769|NCT00614874|460610122|FG000|Overall Study|Protocol Violation|1|||
127995770|NCT00614874|460610122|FG000|Overall Study|Withdrawal by Subject|1|||
127995771|NCT02028507|460610123|FG000|Overall Study|Progressive Disease|122|||
127665273|NCT00322374|459395125|FG001|First Escalation|Study Drug Toxicity|11|||
127995772|NCT02028507|460610124|FG001|Overall Study|Progressive Disease|90|||
127995773|NCT02028507|460610125|FG002|Overall Study|Progressive Disease|102|||
127995774|NCT02028507|460610126|FG003|Overall Study|Progressive Disease|89|||
127995775|NCT02028507|460610123|FG000|Overall Study|Adverse Event|8|||
127995776|NCT02028507|460610124|FG001|Overall Study|Adverse Event|25|||
127995777|NCT02028507|460610125|FG002|Overall Study|Adverse Event|3|||
127995778|NCT02028507|460610126|FG003|Overall Study|Adverse Event|16|||
127995779|NCT02028507|460610123|FG000|Overall Study|Withdrawal by Subject|6|||
127995780|NCT02028507|460610124|FG001|Overall Study|Withdrawal by Subject|8|||
127995781|NCT02028507|460610125|FG002|Overall Study|Withdrawal by Subject|5|||
127995782|NCT02028507|460610126|FG003|Overall Study|Withdrawal by Subject|9|||
127995783|NCT02028507|460610123|FG000|Overall Study|Protocol Violation|2|||
127995784|NCT02028507|460610124|FG001|Overall Study|Protocol Violation|4|||
127995785|NCT02028507|460610125|FG002|Overall Study|Protocol Violation|1|||
127995786|NCT02028507|460610126|FG003|Overall Study|Protocol Violation|3|||
127665274|NCT00322374|459395126|FG002|First Escalation|Study Drug Toxicity|0|||
127665275|NCT00322374|459395127|FG003|First Escalation|Study Drug Toxicity|0|||
127995787|NCT02028507|460610123|FG000|Overall Study|Physician Decision|0|||
127995788|NCT02028507|460610124|FG001|Overall Study|Physician Decision|4|||
127995789|NCT02028507|460610125|FG002|Overall Study|Physician Decision|0|||
127995790|NCT02028507|460610126|FG003|Overall Study|Physician Decision|0|||
127995791|NCT02028507|460610123|FG000|Overall Study|Death|1|||
127995792|NCT02028507|460610124|FG001|Overall Study|Death|0|||
127665276|NCT00322374|459395124|FG000|First Escalation|Participant Request|0|||
127880888|NCT00566631|460186057|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
127880889|NCT00566631|460186057|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
127880890|NCT00566631|460186057|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
127880891|NCT00566631|460186057|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
127995793|NCT02028507|460610125|FG002|Overall Study|Death|1|||
127995794|NCT02028507|460610126|FG003|Overall Study|Death|3|||
127995795|NCT02028507|460610123|FG000|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
127995796|NCT02028507|460610124|FG001|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
127995797|NCT02028507|460610125|FG002|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
127995798|NCT02028507|460610126|FG003|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
127995799|NCT02028507|460610123|FG000|Overall Study|Second Invasive Primary Malignancy|1|||
127995800|NCT02028507|460610124|FG001|Overall Study|Second Invasive Primary Malignancy|0|||
127995801|NCT02028507|460610125|FG002|Overall Study|Second Invasive Primary Malignancy|0|||
127995802|NCT02028507|460610126|FG003|Overall Study|Second Invasive Primary Malignancy|1|||
127995803|NCT02028507|460610123|FG000|Overall Study|Randomized But Not Treated|3|||
127995804|NCT02028507|460610124|FG001|Overall Study|Randomized But Not Treated|6|||
127665277|NCT00322374|459395125|FG001|First Escalation|Participant Request|1|||
127995805|NCT02028507|460610125|FG002|Overall Study|Randomized But Not Treated|0|||
127995806|NCT02028507|460610126|FG003|Overall Study|Randomized But Not Treated|4|||
127995807|NCT02028507|460610123|FG000|Overall Study|Enzyme defect|0|||
127995808|NCT02028507|460610124|FG001|Overall Study|Enzyme defect|0|||
127995809|NCT02028507|460610125|FG002|Overall Study|Enzyme defect|0|||
127995810|NCT02028507|460610126|FG003|Overall Study|Enzyme defect|1|||
127995811|NCT02028507|460610123|FG000|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
127995812|NCT02028507|460610124|FG001|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
127995813|NCT02028507|460610125|FG002|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
127995814|NCT02028507|460610126|FG003|Overall Study|Patient was not able to take whole dose of capecitabine|1|||
127995815|NCT02028507|460610123|FG000|Overall Study|Ongoing at date of cut-off 30-May-2019|10|||
127995816|NCT02028507|460610124|FG001|Overall Study|Ongoing at date of cut-off 30-May-2019|5|||
127995817|NCT02028507|460610125|FG002|Overall Study|Ongoing at date of cut-off 30-May-2019|37|||
127995818|NCT02028507|460610126|FG003|Overall Study|Ongoing at date of cut-off 30-May-2019|28|||
127995819|NCT01808261|460610128|FG000|Overall Study|Physician Decision|0|||
127995820|NCT01808261|460610129|FG001|Overall Study|Physician Decision|2|||
127995821|NCT01808261|460610128|FG000|Overall Study|Study Closed/Terminated|25|||
127995822|NCT01808261|460610129|FG001|Overall Study|Study Closed/Terminated|23|||
127995823|NCT01808261|460610128|FG000|Overall Study|Adverse event, non-fatal|2|||
127995824|NCT01808261|460610129|FG001|Overall Study|Adverse event, non-fatal|0|||
127995825|NCT01808261|460610128|FG000|Overall Study|Consent withdrawn by subject|6|||
127995826|NCT01808261|460610129|FG001|Overall Study|Consent withdrawn by subject|7|||
127995827|NCT01808261|460610128|FG000|Overall Study|Lost to Follow-up|3|||
127995828|NCT01808261|460610129|FG001|Overall Study|Lost to Follow-up|1|||
127995829|NCT03046953|460610133|FG000|Overall Study|Relapse/progressive disease|21|||
127995830|NCT03046953|460610133|FG000|Overall Study|Death|2|||
127995831|NCT03046953|460610133|FG000|Overall Study|Withdrawal by Subject|3|||
127995832|NCT04039204|460610134|FG000|Overall Study|Withdrawal by Subject|0|||
127995833|NCT04039204|460610135|FG001|Overall Study|Withdrawal by Subject|2|||
127995834|NCT01189461|460610136|FG000|Overall Study|Lack of Efficacy|13|||
127995835|NCT01189461|460610136|FG000|Overall Study|Lost to Follow-up|1|||
127995836|NCT01189461|460610136|FG000|Overall Study|Withdrawal by Subject|6|||
127995837|NCT01189461|460610136|FG000|Overall Study|Protocol Violation|1|||
127995838|NCT01189461|460610136|FG000|Overall Study|Adverse Event|2|||
127995839|NCT01189461|460610136|FG000|Overall Study|Did not meet entrance criteria|3|||
127995840|NCT01189461|460610136|FG000|Overall Study|Other|8|||
127995841|NCT00656175|460610138|FG000|Overall Study|Adverse Event|1|||
127995842|NCT00656175|460610139|FG001|Overall Study|Adverse Event|0|||
127995843|NCT00656175|460610138|FG000|Overall Study|Transportation issues|0|||
127995844|NCT00656175|460610139|FG001|Overall Study|Transportation issues|1|||
127995845|NCT04162795|460610145|FG000|Overall Study|Other|16|||
127995846|NCT04162795|460610145|FG000|Overall Study|Screen failures|10|||
127665278|NCT00322374|459395126|FG002|First Escalation|Participant Request|0|||
127665279|NCT00322374|459395127|FG003|First Escalation|Participant Request|0|||
127665280|NCT00322374|459395124|FG000|Second Escalation|Physician Decision|0|||
127665281|NCT00322374|459395125|FG001|Second Escalation|Physician Decision|0|||
127665282|NCT00322374|459395126|FG002|Second Escalation|Physician Decision|5|||
127665283|NCT00322374|459395127|FG003|Second Escalation|Physician Decision|0|||
127665284|NCT00322374|459395124|FG000|Second Escalation|Study Drug Toxicity|0|||
127665285|NCT00322374|459395125|FG001|Second Escalation|Study Drug Toxicity|0|||
127665286|NCT00322374|459395126|FG002|Second Escalation|Study Drug Toxicity|1|||
127665287|NCT00322374|459395127|FG003|Second Escalation|Study Drug Toxicity|0|||
127665288|NCT01058863|459395128|FG000|Overall Study|Lost to Follow-up|1|||
127995847|NCT05259163|460611747|FG000|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|1|||
127995848|NCT05259163|460611748|FG001|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|0|||
127995849|NCT01381926|460611751|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
127995850|NCT01381926|460611752|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
127665289|NCT01058863|459395128|FG000|Overall Study|Withdrawal by Subject|1|||
127665290|NCT01058863|459395128|FG000|Overall Study|Sponsor requested withdrawal|1|||
127995851|NCT01381926|460611751|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
127995852|NCT01381926|460611752|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
127665291|NCT01058863|459395128|FG000|Overall Study|Randomized in error|1|||
127665292|NCT00681187|459395129|FG000|Overall Study|Withdrawal by Subject|1|||
127665293|NCT00681187|459395130|FG001|Overall Study|Withdrawal by Subject|0|||
127995853|NCT02624947|460611753|FG000|Maternal Participants|Adverse Event|5|||
127995854|NCT02624947|460611754|FG001|Maternal Participants|Adverse Event|0|||
127995855|NCT02624947|460611753|FG000|Maternal Participants|Investigator Decision|5|||
127995856|NCT02624947|460611754|FG001|Maternal Participants|Investigator Decision|3|||
127995857|NCT02624947|460611753|FG000|Maternal Participants|Lost to Follow-up|54|||
127995858|NCT02624947|460611754|FG001|Maternal Participants|Lost to Follow-up|24|||
127995859|NCT02624947|460611753|FG000|Maternal Participants|Non Compliance|8|||
127995860|NCT02624947|460611754|FG001|Maternal Participants|Non Compliance|5|||
127995861|NCT02624947|460611753|FG000|Maternal Participants|Sponsor Request|1|||
127995862|NCT02624947|460611754|FG001|Maternal Participants|Sponsor Request|1|||
127995863|NCT02624947|460611753|FG000|Maternal Participants|Voluntary withdrawal unrelated to AE|48|||
127995864|NCT02624947|460611754|FG001|Maternal Participants|Voluntary withdrawal unrelated to AE|27|||
127995865|NCT02624947|460611753|FG000|Maternal Participants|Miscellaneous|23|||
127995866|NCT02624947|460611754|FG001|Maternal Participants|Miscellaneous|15|||
127995867|NCT02624947|460611753|FG000|Infant Participants|Adverse Event|18|||
127995868|NCT02624947|460611754|FG001|Infant Participants|Adverse Event|11|||
127995869|NCT02624947|460611753|FG000|Infant Participants|Investigator Decision|5|||
127995870|NCT02624947|460611754|FG001|Infant Participants|Investigator Decision|4|||
127995871|NCT02624947|460611753|FG000|Infant Participants|Lost to Follow-up|93|||
127995872|NCT02624947|460611754|FG001|Infant Participants|Lost to Follow-up|58|||
127995873|NCT02624947|460611753|FG000|Infant Participants|Non Compliance|17|||
127995874|NCT02624947|460611754|FG001|Infant Participants|Non Compliance|7|||
127995875|NCT02624947|460611753|FG000|Infant Participants|Sponsor Request|0|||
127995876|NCT02624947|460611754|FG001|Infant Participants|Sponsor Request|1|||
127995877|NCT02624947|460611753|FG000|Infant Participants|Voluntary Withdrawal unrelated to AE|48|||
127995878|NCT02624947|460611754|FG001|Infant Participants|Voluntary Withdrawal unrelated to AE|25|||
127995879|NCT02624947|460611753|FG000|Infant Participants|Miscellaneous|50|||
127995880|NCT02624947|460611754|FG001|Infant Participants|Miscellaneous|26|||
127995881|NCT01971567|460611764|FG000|Overall Study|Withdrawal by Subject|3|||
127995882|NCT01971567|460611765|FG001|Overall Study|Withdrawal by Subject|2|||
127995883|NCT01971567|460611764|FG000|Overall Study|Lost to Follow-up|1|||
127995884|NCT01971567|460611765|FG001|Overall Study|Lost to Follow-up|0|||
127995885|NCT00215644|460611768|FG000|Overall Study|Disease Progression|28|||
127995886|NCT00215644|460611769|FG001|Overall Study|Disease Progression|10|||
127995887|NCT00215644|460611768|FG000|Overall Study|Adverse Event|2|||
127995888|NCT00215644|460611769|FG001|Overall Study|Adverse Event|9|||
127995889|NCT00215644|460611768|FG000|Overall Study|Death|1|||
127995890|NCT00215644|460611769|FG001|Overall Study|Death|2|||
127995891|NCT00215644|460611768|FG000|Overall Study|Withdrawal by Subject|1|||
127995892|NCT00215644|460611769|FG001|Overall Study|Withdrawal by Subject|0|||
127995893|NCT00215644|460611768|FG000|Overall Study|Other|3|||
127995894|NCT00215644|460611769|FG001|Overall Study|Other|15|||
127995895|NCT00215644|460611768|FG000|Overall Study|Randomized but Not Treated|1|||
127995896|NCT00215644|460611769|FG001|Overall Study|Randomized but Not Treated|0|||
127995897|NCT00954122|460611770|FG000|Overall Study|Withdrawal by Subject|5|||
127995898|NCT00954122|460611770|FG000|Overall Study|Adverse Event|1|||
127995899|NCT00954122|460611770|FG000|Overall Study|Safety Reason|1|||
127995900|NCT03365934|460611771|FG000|Overall Study|Adverse Event|1|||
127995901|NCT03365934|460611771|FG000|Overall Study|Withdrawal by Subject|1|||
127995902|NCT04194489|460611772|FG000|Overall Study|Withdrawal by Subject|5|||
127995903|NCT04194489|460611772|FG000|Overall Study|Lost to Follow-up|48|||
127995904|NCT00522548|460611778|FG000|Overall Study|Adverse Event|2|||
127995905|NCT00522548|460611779|FG001|Overall Study|Adverse Event|2|||
127995906|NCT00522548|460611778|FG000|Overall Study|Withdrawal by Subject|0|||
127995907|NCT00522548|460611779|FG001|Overall Study|Withdrawal by Subject|2|||
127995908|NCT02121795|460611780|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
127995909|NCT02121795|460611781|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
127995910|NCT02121795|460611780|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
127995911|NCT02121795|460611781|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
127995912|NCT02121795|460611780|FG000|Double-Blind Phase|Lost to Follow-up|7|||
127995913|NCT02121795|460611781|FG001|Double-Blind Phase|Lost to Follow-up|4|||
127995914|NCT02121795|460611780|FG000|Double-Blind Phase|Physician Decision|2|||
127995915|NCT02121795|460611781|FG001|Double-Blind Phase|Physician Decision|5|||
127995916|NCT02121795|460611780|FG000|Double-Blind Phase|Adverse Event|5|||
127995917|NCT02121795|460611781|FG001|Double-Blind Phase|Adverse Event|0|||
127995918|NCT02121795|460611780|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
127995919|NCT02121795|460611781|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
127995920|NCT02121795|460611780|FG000|Double-Blind Phase|Protocol Violation|0|||
127995921|NCT02121795|460611781|FG001|Double-Blind Phase|Protocol Violation|3|||
127995922|NCT02121795|460611780|FG000|Double-Blind Phase|Death|1|||
127995923|NCT02121795|460611781|FG001|Double-Blind Phase|Death|1|||
127995924|NCT02121795|460611780|FG000|Open-Label Phase|Physician Decision|8|||
127995925|NCT02121795|460611781|FG001|Open-Label Phase|Physician Decision|8|||
127995926|NCT02121795|460611780|FG000|Open-Label Phase|Withdrawal by Subject|3|||
127995927|NCT02121795|460611781|FG001|Open-Label Phase|Withdrawal by Subject|2|||
127995928|NCT02121795|460611780|FG000|Open-Label Phase|Lost to Follow-up|1|||
127995929|NCT02121795|460611781|FG001|Open-Label Phase|Lost to Follow-up|0|||
127995930|NCT00666211|460611782|FG000|Overall Study|Withdrawal by Subject|10|||
127995931|NCT00666211|460611783|FG001|Overall Study|Withdrawal by Subject|13|||
127995932|NCT00666211|460611782|FG000|Overall Study|went off medication, no more pain|1|||
127995933|NCT00666211|460611783|FG001|Overall Study|went off medication, no more pain|0|||
127995934|NCT00666211|460611782|FG000|Overall Study|patient non-compliant|6|||
127995935|NCT00666211|460611783|FG001|Overall Study|patient non-compliant|6|||
127995936|NCT00666211|460611782|FG000|Overall Study|disease progression|1|||
127995937|NCT00666211|460611783|FG001|Overall Study|disease progression|8|||
127995938|NCT00666211|460611782|FG000|Overall Study|Lost to Follow-up|2|||
127995939|NCT00666211|460611783|FG001|Overall Study|Lost to Follow-up|0|||
127995940|NCT00666211|460611782|FG000|Overall Study|toxicity|0|||
127995941|NCT00666211|460611783|FG001|Overall Study|toxicity|2|||
127995942|NCT00666211|460611782|FG000|Overall Study|hospital admission|0|||
127995943|NCT00666211|460611783|FG001|Overall Study|hospital admission|5|||
127995944|NCT00666211|460611782|FG000|Overall Study|Death|0|||
127995945|NCT00666211|460611783|FG001|Overall Study|Death|2|||
127995946|NCT00666211|460611782|FG000|Overall Study|off tx for other complicating disease|0|||
127995947|NCT00666211|460611783|FG001|Overall Study|off tx for other complicating disease|1|||
127995948|NCT00666211|460611782|FG000|Overall Study|Physician Decision|0|||
127995949|NCT00666211|460611783|FG001|Overall Study|Physician Decision|1|||
127995950|NCT02609386|460611786|FG000|Overall Study|Withdrawal by Subject|6|||
127995951|NCT02609386|460611787|FG001|Overall Study|Withdrawal by Subject|1|||
127995952|NCT02609386|460611786|FG000|Overall Study|Lost to Follow-up|3|||
127995953|NCT02609386|460611787|FG001|Overall Study|Lost to Follow-up|5|||
127995954|NCT02609386|460611786|FG000|Overall Study|Death|19|||
127995955|NCT02609386|460611787|FG001|Overall Study|Death|9|||
127995956|NCT02609386|460611786|FG000|Overall Study|Physician Decision|0|||
127995957|NCT02609386|460611787|FG001|Overall Study|Physician Decision|2|||
127995958|NCT02299388|460611790|FG000|Overall Study|Withdrawal by Subject|0|||
127995959|NCT02299388|460611791|FG001|Overall Study|Withdrawal by Subject|1|||
127995960|NCT03334188|460611795|FG000|Overall Study|Withdrawal by Subject|0|||
127995961|NCT03334188|460611796|FG001|Overall Study|Withdrawal by Subject|1|||
127995962|NCT03334188|460611795|FG000|Overall Study|Death|1|||
127995963|NCT03334188|460611796|FG001|Overall Study|Death|0|||
127995964|NCT03334188|460611795|FG000|Overall Study|Never had qualifying clinic visit|7|||
127995965|NCT03334188|460611796|FG001|Overall Study|Never had qualifying clinic visit|7|||
127995966|NCT03373760|460611799|FG000|Overall Study|Adverse Event|8|||
127995967|NCT03373760|460611799|FG000|Overall Study|Disease Progression|46|||
127995968|NCT03373760|460611799|FG000|Overall Study|Death|4|||
127995969|NCT01093586|460611800|FG000|Overall Study|Failed to engraft|3|||
127995970|NCT03442088|460611801|FG000|Overall Study|Adverse Event|1|||
127995971|NCT03442088|460611801|FG000|Overall Study|Lack of Efficacy|2|||
127995972|NCT03442088|460611801|FG000|Overall Study|Lost to Follow-up|2|||
127995973|NCT00105989|460611802|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
127995974|NCT00105989|460611803|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
127995975|NCT00105989|460611802|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
127995976|NCT00105989|460611803|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
127995977|NCT00105989|460611802|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
127995978|NCT00105989|460611803|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
127995979|NCT00105989|460611802|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
127995980|NCT00105989|460611803|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
127995981|NCT00105989|460611802|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
127995982|NCT00105989|460611803|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
127995983|NCT00105989|460611802|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
127995984|NCT00105989|460611803|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
127995985|NCT00105989|460611802|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
127995986|NCT00105989|460611803|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
127995987|NCT00105989|460611802|FG000|Acute - Open Label: Week 0-10|Death|1|||
127995988|NCT00105989|460611803|FG001|Acute - Open Label: Week 0-10|Death|0|||
127995989|NCT00105989|460611802|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
127995990|NCT00105989|460611803|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
127995991|NCT00105989|460611802|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
127995992|NCT00105989|460611803|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
127995993|NCT00105989|460611802|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
127995994|NCT00105989|460611803|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
127995995|NCT00105989|460611802|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
127995996|NCT00105989|460611803|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
127995997|NCT00105989|460611802|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
127995998|NCT00105989|460611803|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
127995999|NCT00105989|460611802|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
127996000|NCT00105989|460611803|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
127996001|NCT00105989|460611802|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
127996002|NCT00105989|460611803|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
127996003|NCT00105989|460611802|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
127996004|NCT00105989|460611803|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
127996005|NCT00105989|460611802|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
127996006|NCT00105989|460611803|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
127996007|NCT00105989|460611802|FG000|Continuation - Open Label:Week 10-34|Death|0|||
127996008|NCT00105989|460611803|FG001|Continuation - Open Label:Week 10-34|Death|0|||
127996009|NCT00105989|460611802|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
127996010|NCT00105989|460611803|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
127996011|NCT00105989|460611802|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
127996012|NCT00105989|460611803|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
127996013|NCT00105989|460611802|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
127996014|NCT00105989|460611803|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
127996015|NCT00105989|460611802|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
127996016|NCT00105989|460611803|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
127996017|NCT00105989|460611802|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
127996018|NCT00105989|460611803|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
127996019|NCT00105989|460611802|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
127996020|NCT00105989|460611803|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
127996021|NCT00105989|460611802|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
127996022|NCT00105989|460611803|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
127996023|NCT00105989|460611802|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
127996024|NCT00105989|460611803|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
127996025|NCT00105989|460611802|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
127996026|NCT00105989|460611803|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
127996027|NCT00105989|460611802|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
127996028|NCT00105989|460611803|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
127996029|NCT00105989|460611802|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
127996030|NCT00105989|460611803|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
127996031|NCT00105989|460611802|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
127996032|NCT00105989|460611803|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
127996033|NCT00357877|460611804|FG000|Overall Study|Death|2|||
127996034|NCT00357877|460611805|FG001|Overall Study|Death|1|||
127996035|NCT00357877|460611804|FG000|Overall Study|Lost to Follow-up|20|||
127996036|NCT00357877|460611805|FG001|Overall Study|Lost to Follow-up|23|||
127996037|NCT00357877|460611804|FG000|Overall Study|Withdrawal by Subject|3|||
127996038|NCT00357877|460611805|FG001|Overall Study|Withdrawal by Subject|3|||
127996039|NCT00357877|460611804|FG000|Overall Study|Administrative withdrawal|1|||
127996040|NCT00357877|460611805|FG001|Overall Study|Administrative withdrawal|1|||
127996041|NCT00357877|460611804|FG000|Overall Study|Other|0|||
127996042|NCT00357877|460611805|FG001|Overall Study|Other|2|||
127996043|NCT04668209|460611806|FG000|Overall Study|Withdrawal by Subject|2|||
127996044|NCT04668209|460611807|FG001|Overall Study|Withdrawal by Subject|2|||
127996045|NCT04668209|460611806|FG000|Overall Study|Lost to Follow-up|3|||
127996046|NCT04668209|460611807|FG001|Overall Study|Lost to Follow-up|4|||
127996047|NCT04668209|460611806|FG000|Overall Study|Subject Expired|2|||
127996048|NCT04668209|460611807|FG001|Overall Study|Subject Expired|0|||
127996049|NCT04668209|460611806|FG000|Overall Study|Withdrawn from study|0|||
127996050|NCT04668209|460611807|FG001|Overall Study|Withdrawn from study|1|||
127996051|NCT04668209|460611806|FG000|Overall Study|Adverse Event|0|||
127996052|NCT04668209|460611807|FG001|Overall Study|Adverse Event|1|||
127996053|NCT01869777|460611814|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
127996054|NCT00613366|460611817|FG000|Overall Study|Withdrawal by Subject|3|||
127996055|NCT00613366|460611818|FG001|Overall Study|Withdrawal by Subject|2|||
127996056|NCT00766597|460611819|FG000|Overall Study|Unexpected closure of study|4|||
127996057|NCT00766597|460611819|FG000|Overall Study|Without CCR5-tropic virus|5|||
127996058|NCT01135524|460611823|FG000|Overall Study|Withdrawal by Subject|14|||
127996059|NCT01135524|460611823|FG000|Overall Study|Adverse Event|20|||
127996060|NCT01135524|460611823|FG000|Overall Study|Lost to Follow-up|3|||
127996061|NCT01135524|460611823|FG000|Overall Study|Administrative|151|||
127996062|NCT01135524|460611823|FG000|Overall Study|Lack of Efficacy|8|||
127996063|NCT03318003|460611824|FG000|Overall Study|Withdrawal by Subject|1|||
127996064|NCT03318003|460611825|FG001|Overall Study|Withdrawal by Subject|1|||
127996065|NCT03318003|460611824|FG000|Overall Study|fetal loss|0|||
127996066|NCT03318003|460611825|FG001|Overall Study|fetal loss|1|||
127996067|NCT00511810|460611833|FG000|Overall Study|Lost to Follow-up|1|||
127996068|NCT00511810|460611834|FG001|Overall Study|Lost to Follow-up|2|||
127996069|NCT00511810|460611833|FG000|Overall Study|Lack of Efficacy|0|||
127996070|NCT00511810|460611834|FG001|Overall Study|Lack of Efficacy|2|||
127665294|NCT00681187|459395129|FG000|Overall Study|Death|0|||
127996071|NCT00511810|460611833|FG000|Overall Study|Refused second scn|0|||
127996072|NCT00511810|460611834|FG001|Overall Study|Refused second scn|1|||
127996073|NCT00627497|460611837|FG000|Overall Study|Lost to Follow-up|1|||
127996074|NCT00627497|460611838|FG001|Overall Study|Lost to Follow-up|1|||
127996075|NCT00627497|460611839|FG002|Overall Study|Lost to Follow-up|0|||
127996076|NCT00627497|460611840|FG003|Overall Study|Lost to Follow-up|0|||
127996077|NCT01502033|460611841|FG000|Overall Study|1 participant had scalp discomfort|1|||
127996078|NCT01502033|460611841|FG000|Overall Study|1 participant had worsening depression|1|||
127996079|NCT01502033|460611841|FG000|Overall Study|1 participant went back to school|1|||
127996080|NCT02080364|460611845|FG000|Baseline Period|Protocol Violation|2|||
127996081|NCT02080364|460611846|FG001|Baseline Period|Protocol Violation|1|||
127996082|NCT02080364|460611847|FG002|Baseline Period|Protocol Violation|0|||
127996083|NCT02080364|460611848|FG003|Baseline Period|Protocol Violation|0|||
127996084|NCT02080364|460611845|FG000|Baseline Period|Other|0|||
127996085|NCT02080364|460611846|FG001|Baseline Period|Other|1|||
127996086|NCT02080364|460611847|FG002|Baseline Period|Other|1|||
127996087|NCT02080364|460611848|FG003|Baseline Period|Other|0|||
127996088|NCT02080364|460611845|FG000|Treatment Period|Adverse Event|10|||
127996089|NCT02080364|460611846|FG001|Treatment Period|Adverse Event|15|||
127996090|NCT02080364|460611847|FG002|Treatment Period|Adverse Event|11|||
127996091|NCT02080364|460611848|FG003|Treatment Period|Adverse Event|14|||
127996092|NCT02080364|460611845|FG000|Treatment Period|Lost to Follow-up|2|||
127996093|NCT02080364|460611846|FG001|Treatment Period|Lost to Follow-up|3|||
127996094|NCT02080364|460611847|FG002|Treatment Period|Lost to Follow-up|5|||
127996095|NCT02080364|460611848|FG003|Treatment Period|Lost to Follow-up|0|||
127996096|NCT02080364|460611845|FG000|Treatment Period|Protocol Violation|5|||
127996097|NCT02080364|460611846|FG001|Treatment Period|Protocol Violation|3|||
127996098|NCT02080364|460611847|FG002|Treatment Period|Protocol Violation|5|||
127996099|NCT02080364|460611848|FG003|Treatment Period|Protocol Violation|1|||
127996100|NCT02080364|460611845|FG000|Treatment Period|Withdrawal by Subject|16|||
127996101|NCT02080364|460611846|FG001|Treatment Period|Withdrawal by Subject|16|||
127996102|NCT02080364|460611847|FG002|Treatment Period|Withdrawal by Subject|15|||
127996103|NCT02080364|460611848|FG003|Treatment Period|Withdrawal by Subject|10|||
127996104|NCT02080364|460611845|FG000|Treatment Period|Study Terminated by Sponsor|0|||
127996105|NCT02080364|460611846|FG001|Treatment Period|Study Terminated by Sponsor|0|||
127996106|NCT02080364|460611847|FG002|Treatment Period|Study Terminated by Sponsor|180|||
127996107|NCT02080364|460611848|FG003|Treatment Period|Study Terminated by Sponsor|183|||
127996108|NCT02080364|460611845|FG000|Treatment Period|Other|14|||
127996109|NCT02080364|460611846|FG001|Treatment Period|Other|12|||
127996110|NCT02080364|460611847|FG002|Treatment Period|Other|21|||
127996111|NCT02080364|460611848|FG003|Treatment Period|Other|16|||
127996112|NCT02497404|460611849|FG000|Overall Study|Adverse Event|1|||
127996113|NCT02797678|460611871|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
127996114|NCT02797678|460611872|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
127996115|NCT02797678|460611873|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
127996116|NCT02797678|460611874|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
127996117|NCT02797678|460611871|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
127996118|NCT02797678|460611872|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
127996119|NCT02797678|460611873|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
127996120|NCT02797678|460611874|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
127996121|NCT02797678|460611871|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
127996122|NCT02797678|460611872|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
127996123|NCT02797678|460611873|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
127996124|NCT02797678|460611874|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
127996125|NCT02401035|460611875|FG000|Overall Study|Withdrawal by Subject|1|||
127996126|NCT02401035|460611876|FG001|Overall Study|Withdrawal by Subject|0|||
127996127|NCT01066871|460611884|FG000|Overall Study|Lost to Follow-up|0|||
127996128|NCT01066871|460611885|FG001|Overall Study|Lost to Follow-up|2|||
127996129|NCT01066871|460611886|FG002|Overall Study|Lost to Follow-up|2|||
127996130|NCT01066871|460611887|FG003|Overall Study|Lost to Follow-up|0|||
127996131|NCT01066871|460611884|FG000|Overall Study|Protocol Violation|1|||
127996132|NCT01066871|460611885|FG001|Overall Study|Protocol Violation|0|||
127996133|NCT01066871|460611886|FG002|Overall Study|Protocol Violation|3|||
127996134|NCT01066871|460611887|FG003|Overall Study|Protocol Violation|2|||
127996135|NCT01066871|460611884|FG000|Overall Study|Lack of Efficacy|0|||
127996136|NCT01066871|460611885|FG001|Overall Study|Lack of Efficacy|0|||
127996137|NCT01066871|460611886|FG002|Overall Study|Lack of Efficacy|0|||
127996138|NCT01066871|460611887|FG003|Overall Study|Lack of Efficacy|1|||
127996139|NCT01066871|460611884|FG000|Overall Study|Withdrawal by Subject|3|||
127996140|NCT01066871|460611885|FG001|Overall Study|Withdrawal by Subject|1|||
127996141|NCT01066871|460611886|FG002|Overall Study|Withdrawal by Subject|0|||
127996142|NCT01066871|460611887|FG003|Overall Study|Withdrawal by Subject|0|||
127996143|NCT01066871|460611884|FG000|Overall Study|Other|0|||
127996144|NCT01066871|460611885|FG001|Overall Study|Other|2|||
127996145|NCT01066871|460611886|FG002|Overall Study|Other|1|||
127996146|NCT01066871|460611887|FG003|Overall Study|Other|2|||
127996147|NCT01409915|460613559|FG000|Overall Study|Adverse Event|0|||
127996148|NCT01409915|460613560|FG001|Overall Study|Adverse Event|2|||
127996149|NCT01409915|460613559|FG000|Overall Study|Withdrawal by Subject|0|||
127996150|NCT01409915|460613560|FG001|Overall Study|Withdrawal by Subject|1|||
127996151|NCT01409915|460613559|FG000|Overall Study|Protocol Violation|1|||
127996152|NCT01409915|460613560|FG001|Overall Study|Protocol Violation|0|||
127996153|NCT04826484|460613561|FG000|Overall Study|Lost to Follow-up|2|||
127996154|NCT04826484|460613562|FG001|Overall Study|Lost to Follow-up|0|||
127996155|NCT02250300|460613564|FG000|Expansion Phase|Death|6|||
127996156|NCT02250300|460613565|FG001|Expansion Phase|Death|7|||
127996157|NCT02250300|460613566|FG002|Expansion Phase|Death|0|||
127996158|NCT02250300|460613567|FG003|Expansion Phase|Death|0|||
127996159|NCT03569098|460613568|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
127996160|NCT03569098|460613569|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
127996161|NCT03569098|460613570|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
127996162|NCT03569098|460613568|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
127996163|NCT03569098|460613569|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
127996164|NCT03569098|460613570|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
127996165|NCT03569098|460613568|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
127996166|NCT03569098|460613569|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
127996167|NCT03569098|460613570|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
127996168|NCT03569098|460613568|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
127996169|NCT03569098|460613569|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
127996170|NCT03569098|460613570|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
127996171|NCT03569098|460613568|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
127996172|NCT03569098|460613569|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
127996173|NCT03569098|460613570|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
127996174|NCT03569098|460613568|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
127996175|NCT03569098|460613569|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
127996176|NCT03569098|460613570|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
127996177|NCT03569098|460613568|FG000|Double-Blind Treatment Cycle 1|Other|1|||
127996178|NCT03569098|460613569|FG001|Double-Blind Treatment Cycle 1|Other|0|||
127996179|NCT03569098|460613570|FG002|Double-Blind Treatment Cycle 1|Other|1|||
127996180|NCT03569098|460613568|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
127996181|NCT03569098|460613569|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
127996182|NCT03569098|460613570|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
127996183|NCT03569098|460613568|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
127996184|NCT03569098|460613569|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
127996185|NCT03569098|460613570|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
127996186|NCT03569098|460613568|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
127996187|NCT03569098|460613569|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
127996188|NCT03569098|460613570|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
127996189|NCT03569098|460613568|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
127996190|NCT03569098|460613569|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
127996191|NCT03569098|460613570|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
127996192|NCT03569098|460613568|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
127996193|NCT03569098|460613569|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
127996194|NCT03569098|460613570|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
127996195|NCT03569098|460613568|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
127996196|NCT03569098|460613569|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
127996197|NCT03569098|460613570|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
127996198|NCT00758498|460613571|FG000|Overall Study|Adverse Event|2|||
127996199|NCT00758498|460613572|FG001|Overall Study|Adverse Event|2|||
127996200|NCT00758498|460613573|FG002|Overall Study|Adverse Event|3|||
127996201|NCT00758498|460613571|FG000|Overall Study|Subject legally detained out of state|1|||
127996202|NCT00758498|460613572|FG001|Overall Study|Subject legally detained out of state|0|||
127996203|NCT00758498|460613573|FG002|Overall Study|Subject legally detained out of state|0|||
127996204|NCT00758498|460613571|FG000|Overall Study|Withdrawal by Subject|0|||
127996205|NCT00758498|460613572|FG001|Overall Study|Withdrawal by Subject|0|||
127996206|NCT00758498|460613573|FG002|Overall Study|Withdrawal by Subject|1|||
127996207|NCT00758498|460613571|FG000|Overall Study|Noncompliance to study procedures|0|||
127996208|NCT00758498|460613572|FG001|Overall Study|Noncompliance to study procedures|0|||
127996209|NCT00758498|460613573|FG002|Overall Study|Noncompliance to study procedures|1|||
127996210|NCT01516736|460613578|FG000|Overall Study|Withdrawal by Subject|10|||
127996211|NCT01516736|460613579|FG001|Overall Study|Withdrawal by Subject|4|||
127996212|NCT01516736|460613578|FG000|Overall Study|Adverse Event|4|||
127996213|NCT01516736|460613579|FG001|Overall Study|Adverse Event|5|||
127996214|NCT01516736|460613578|FG000|Overall Study|Death|3|||
127996215|NCT01516736|460613579|FG001|Overall Study|Death|1|||
127996216|NCT01516736|460613578|FG000|Overall Study|Physician Decision|2|||
127996217|NCT01516736|460613579|FG001|Overall Study|Physician Decision|1|||
127996218|NCT01516736|460613578|FG000|Overall Study|Lack of Efficacy|1|||
127665295|NCT00681187|459395130|FG001|Overall Study|Death|1|||
127665296|NCT00681187|459395129|FG000|Overall Study|Adverse Event|0|||
127996219|NCT01516736|460613579|FG001|Overall Study|Lack of Efficacy|0|||
127996220|NCT01516736|460613578|FG000|Overall Study|Protocol Violation|0|||
127996221|NCT01516736|460613579|FG001|Overall Study|Protocol Violation|1|||
127996222|NCT01516736|460613578|FG000|Overall Study|Other (not specified)|0|||
127996223|NCT01516736|460613579|FG001|Overall Study|Other (not specified)|1|||
127996224|NCT01697800|460613580|FG000|Overall Study|Death|0|||
127996225|NCT01697800|460613581|FG001|Overall Study|Death|1|||
127996226|NCT02683239|460613591|FG000|Overall Study|Protocol Violation|35|||
127996227|NCT02683239|460613592|FG001|Overall Study|Protocol Violation|23|||
127996228|NCT02683239|460613593|FG002|Overall Study|Protocol Violation|26|||
127996229|NCT02683239|460613594|FG003|Overall Study|Protocol Violation|4|||
127996230|NCT02683239|460613595|FG004|Overall Study|Protocol Violation|35|||
127996231|NCT02683239|460613596|FG005|Overall Study|Protocol Violation|4|||
127996232|NCT02683239|460613597|FG006|Overall Study|Protocol Violation|5|||
127996233|NCT02683239|460613591|FG000|Overall Study|Adverse Event|64|||
127996234|NCT02683239|460613592|FG001|Overall Study|Adverse Event|39|||
127996235|NCT02683239|460613593|FG002|Overall Study|Adverse Event|42|||
127996236|NCT02683239|460613594|FG003|Overall Study|Adverse Event|16|||
127996237|NCT02683239|460613595|FG004|Overall Study|Adverse Event|189|||
127996238|NCT02683239|460613596|FG005|Overall Study|Adverse Event|9|||
127996239|NCT02683239|460613597|FG006|Overall Study|Adverse Event|9|||
127996240|NCT02683239|460613591|FG000|Overall Study|Physician Decision|38|||
127996241|NCT02683239|460613592|FG001|Overall Study|Physician Decision|19|||
127996242|NCT02683239|460613593|FG002|Overall Study|Physician Decision|14|||
127996243|NCT02683239|460613594|FG003|Overall Study|Physician Decision|73|||
127996244|NCT02683239|460613595|FG004|Overall Study|Physician Decision|143|||
127996245|NCT02683239|460613596|FG005|Overall Study|Physician Decision|14|||
127996246|NCT02683239|460613597|FG006|Overall Study|Physician Decision|15|||
127996247|NCT02683239|460613591|FG000|Overall Study|Withdrawal by Subject|187|||
127996248|NCT02683239|460613592|FG001|Overall Study|Withdrawal by Subject|99|||
127996249|NCT02683239|460613593|FG002|Overall Study|Withdrawal by Subject|91|||
127996250|NCT02683239|460613594|FG003|Overall Study|Withdrawal by Subject|18|||
127996251|NCT02683239|460613595|FG004|Overall Study|Withdrawal by Subject|248|||
127996252|NCT02683239|460613596|FG005|Overall Study|Withdrawal by Subject|22|||
127996253|NCT02683239|460613597|FG006|Overall Study|Withdrawal by Subject|28|||
127996254|NCT02683239|460613591|FG000|Overall Study|Lost to Follow-up|77|||
127996255|NCT02683239|460613592|FG001|Overall Study|Lost to Follow-up|24|||
127996256|NCT02683239|460613593|FG002|Overall Study|Lost to Follow-up|25|||
127996257|NCT02683239|460613594|FG003|Overall Study|Lost to Follow-up|7|||
127996258|NCT02683239|460613595|FG004|Overall Study|Lost to Follow-up|88|||
127996259|NCT02683239|460613596|FG005|Overall Study|Lost to Follow-up|8|||
127996260|NCT02683239|460613597|FG006|Overall Study|Lost to Follow-up|11|||
127996261|NCT02683239|460613591|FG000|Overall Study|Death|9|||
127996262|NCT02683239|460613592|FG001|Overall Study|Death|5|||
127996263|NCT02683239|460613593|FG002|Overall Study|Death|8|||
127996264|NCT02683239|460613594|FG003|Overall Study|Death|0|||
127996265|NCT02683239|460613595|FG004|Overall Study|Death|12|||
127996266|NCT02683239|460613596|FG005|Overall Study|Death|1|||
127996267|NCT02683239|460613597|FG006|Overall Study|Death|0|||
127996268|NCT02683239|460613591|FG000|Overall Study|Lack of Efficacy|50|||
127996269|NCT02683239|460613592|FG001|Overall Study|Lack of Efficacy|23|||
127996270|NCT02683239|460613593|FG002|Overall Study|Lack of Efficacy|12|||
127996271|NCT02683239|460613594|FG003|Overall Study|Lack of Efficacy|2|||
127996272|NCT02683239|460613595|FG004|Overall Study|Lack of Efficacy|29|||
127996273|NCT02683239|460613596|FG005|Overall Study|Lack of Efficacy|2|||
127996274|NCT02683239|460613597|FG006|Overall Study|Lack of Efficacy|3|||
127996275|NCT02683239|460613591|FG000|Overall Study|Missing data|0|||
127665297|NCT00681187|459395130|FG001|Overall Study|Adverse Event|1|||
127665298|NCT03653416|459395131|FG000|Overall Study|Protocol Violation|6|||
127665299|NCT03653416|459395132|FG001|Overall Study|Protocol Violation|1|||
127665300|NCT04230980|459395133|FG000|Overall Study|Lost to Follow-up|1|||
127665301|NCT04230980|459395134|FG001|Overall Study|Lost to Follow-up|2|||
127665302|NCT04230980|459395133|FG000|Overall Study|Adverse Event|0|||
127665303|NCT04230980|459395134|FG001|Overall Study|Adverse Event|1|||
127665304|NCT02788006|459395136|FG000|Overall Study|Patient not treated|1|||
127665305|NCT03050398|459395139|FG000|Overall Study|Study terminated by sponsor|8|||
127665306|NCT00598481|459395140|FG000|Treatment|Physician Decision|1|||
127665307|NCT01994720|459395141|FG000|Overall Study|Withdrawal by Subject|46|||
127996276|NCT02683239|460613592|FG001|Overall Study|Missing data|1|||
127665308|NCT01994720|459395142|FG001|Overall Study|Withdrawal by Subject|56|||
127996277|NCT02683239|460613593|FG002|Overall Study|Missing data|1|||
127996278|NCT02683239|460613594|FG003|Overall Study|Missing data|0|||
127996279|NCT02683239|460613595|FG004|Overall Study|Missing data|1|||
127996280|NCT02683239|460613596|FG005|Overall Study|Missing data|0|||
127996281|NCT02683239|460613597|FG006|Overall Study|Missing data|0|||
127665309|NCT01991197|459395143|FG000|Overall Study|Lost to Follow-up|1|||
127996282|NCT00873730|460613600|FG000|Overall Study|Protocol Deviation|5|||
127996283|NCT00873730|460613601|FG001|Overall Study|Protocol Deviation|2|||
127996284|NCT00873730|460613600|FG000|Overall Study|Adverse Event|0|||
127996285|NCT00873730|460613601|FG001|Overall Study|Adverse Event|2|||
127996286|NCT00873730|460613600|FG000|Overall Study|Withdrawal by Subject|0|||
127996287|NCT00873730|460613601|FG001|Overall Study|Withdrawal by Subject|1|||
127996288|NCT00873730|460613600|FG000|Overall Study|Sponsor decision|1|||
127996289|NCT00873730|460613601|FG001|Overall Study|Sponsor decision|0|||
127996290|NCT00103662|460613602|FG000|Overall Study|Entered Rescue Procedure|0|||
127996291|NCT00103662|460613603|FG001|Overall Study|Entered Rescue Procedure|7|||
127996292|NCT00103662|460613602|FG000|Overall Study|Death|7|||
127996293|NCT00103662|460613603|FG001|Overall Study|Death|7|||
127996294|NCT00103662|460613602|FG000|Overall Study|Elective Withdrawal|5|||
127996295|NCT00103662|460613603|FG001|Overall Study|Elective Withdrawal|5|||
127996296|NCT00103662|460613602|FG000|Overall Study|Lost to Follow-up|0|||
127996297|NCT00103662|460613603|FG001|Overall Study|Lost to Follow-up|1|||
127996298|NCT00103662|460613602|FG000|Overall Study|Other|6|||
127996299|NCT00103662|460613603|FG001|Overall Study|Other|9|||
127996300|NCT00103662|460613602|FG000|Overall Study|Failed mobilization|0|||
127996301|NCT00103662|460613603|FG001|Overall Study|Failed mobilization|4|||
127996302|NCT00103662|460613602|FG000|Overall Study|Intercurrent illness|1|||
127996303|NCT00103662|460613603|FG001|Overall Study|Intercurrent illness|0|||
127996304|NCT00943397|460613604|FG000|Overall Study|Adverse Event|0|||
127996305|NCT00943397|460613605|FG001|Overall Study|Adverse Event|6|||
127996306|NCT00943397|460613604|FG000|Overall Study|Lost to Follow-up|0|||
127996307|NCT00943397|460613605|FG001|Overall Study|Lost to Follow-up|4|||
127996308|NCT00943397|460613604|FG000|Overall Study|Protocol Violation|2|||
127996309|NCT00943397|460613605|FG001|Overall Study|Protocol Violation|5|||
127996310|NCT00943397|460613604|FG000|Overall Study|Withdrawal by Subject|1|||
127996311|NCT00943397|460613605|FG001|Overall Study|Withdrawal by Subject|1|||
127996312|NCT00943397|460613604|FG000|Overall Study|Site terminated and other|12|||
127996313|NCT00943397|460613605|FG001|Overall Study|Site terminated and other|56|||
127996314|NCT04878055|460613606|FG000|Overall Study|Patient transferred in another department|0|||
127996315|NCT04878055|460613607|FG001|Overall Study|Patient transferred in another department|2|||
127996316|NCT04878055|460613606|FG000|Overall Study|Physician Decision|1|||
127996317|NCT04878055|460613607|FG001|Overall Study|Physician Decision|1|||
127996318|NCT04878055|460613606|FG000|Overall Study|Day 60 visit not performed by mistake|0|||
127996319|NCT04878055|460613607|FG001|Overall Study|Day 60 visit not performed by mistake|4|||
127996320|NCT04878055|460613606|FG000|Overall Study|Adverse Event|12|||
127996321|NCT04878055|460613607|FG001|Overall Study|Adverse Event|7|||
127996322|NCT04878055|460613606|FG000|Overall Study|Other|5|||
127996323|NCT04878055|460613607|FG001|Overall Study|Other|0|||
127996324|NCT04878055|460613606|FG000|Overall Study|Withdrawal by Subject|7|||
127996325|NCT04878055|460613607|FG001|Overall Study|Withdrawal by Subject|3|||
127996326|NCT04878055|460613606|FG000|Overall Study|Lost to Follow-up|10|||
127996327|NCT04878055|460613607|FG001|Overall Study|Lost to Follow-up|1|||
127996328|NCT01968811|460613608|FG000|Overall Study|Protocol Violation|4|||
127996329|NCT01968811|460613608|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
127996330|NCT05225558|460613612|FG000|Overall Study|Withdrawal by Subject|4|||
127996331|NCT05225558|460613613|FG001|Overall Study|Withdrawal by Subject|3|||
127996332|NCT05225558|460613612|FG000|Overall Study|Adverse Event|1|||
127996333|NCT05225558|460613613|FG001|Overall Study|Adverse Event|0|||
127996334|NCT05225558|460613612|FG000|Overall Study|If the following treatment failure criteria are met during treatment period|1|||
127996335|NCT05225558|460613613|FG001|Overall Study|If the following treatment failure criteria are met during treatment period|2|||
127996336|NCT05225558|460613612|FG000|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|4|||
127996337|NCT05225558|460613613|FG001|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|2|||
127996338|NCT03006562|460613614|FG000|Overall Study|Lost to Follow-up|0|||
127996339|NCT03006562|460613615|FG001|Overall Study|Lost to Follow-up|1|||
127996340|NCT02427841|460613617|FG000|Overall Study|Lack of Efficacy|5|||
127996341|NCT02427841|460613617|FG000|Overall Study|Physician Decision|2|||
127996342|NCT02427841|460613617|FG000|Overall Study|Withdrawal by Subject|1|||
127996343|NCT02592447|460613620|FG000|Overall Study|Lost to Follow-up|1|||
127996344|NCT02592447|460613621|FG001|Overall Study|Lost to Follow-up|0|||
127996345|NCT02592447|460613620|FG000|Overall Study|Ineligible after randomization|1|||
127996346|NCT02592447|460613621|FG001|Overall Study|Ineligible after randomization|0|||
127996347|NCT02592447|460613620|FG000|Overall Study|Withdrawal by Subject|0|||
127996348|NCT02592447|460613621|FG001|Overall Study|Withdrawal by Subject|1|||
127665310|NCT01991197|459395144|FG001|Overall Study|Lost to Follow-up|1|||
127665311|NCT01991197|459395143|FG000|Overall Study|Physician Decision|0|||
127665312|NCT01991197|459395144|FG001|Overall Study|Physician Decision|2|||
127665313|NCT01991197|459395143|FG000|Overall Study|Withdrawal by Subject|2|||
127665314|NCT01991197|459395144|FG001|Overall Study|Withdrawal by Subject|0|||
127996349|NCT01841970|460613622|FG000|Overall Study|Withdrawal by Subject|1|||
127996350|NCT01841970|460613622|FG000|Overall Study|Physician Decision|2|||
127996351|NCT01841970|460613622|FG000|Overall Study|Lost to Follow-up|8|||
127996352|NCT01048541|460613627|FG000|Overall Study|Withdrawal by Subject|1|||
127996353|NCT01048541|460613628|FG001|Overall Study|Withdrawal by Subject|0|||
127996354|NCT00327717|460613629|FG000|Overall Study|Adverse Event|6|||
127996355|NCT00327717|460613630|FG001|Overall Study|Adverse Event|6|||
127996356|NCT00327717|460613629|FG000|Overall Study|Lack of Efficacy|0|||
127665315|NCT02397460|459395148|FG000|Treatment Period 2|Adverse Event|0|||
127996357|NCT00327717|460613630|FG001|Overall Study|Lack of Efficacy|1|||
127996358|NCT00327717|460613629|FG000|Overall Study|Withdrawal by Subject|3|||
127996359|NCT00327717|460613630|FG001|Overall Study|Withdrawal by Subject|7|||
127996360|NCT01737879|460613631|FG000|Overall Study|Death|1|||
127996361|NCT01737879|460613631|FG000|Overall Study|Sponsor decision|40|||
127996362|NCT05285787|460613632|FG000|Overall Study|Withdrawal by Subject|1|||
127996363|NCT02360280|460613636|FG000|Overall Study|Withdrawal by Subject|2|||
127996364|NCT02360280|460613637|FG001|Overall Study|Withdrawal by Subject|0|||
127996365|NCT02360280|460613636|FG000|Overall Study|Adverse Event|0|||
127996366|NCT02360280|460613637|FG001|Overall Study|Adverse Event|1|||
127996367|NCT02360280|460613636|FG000|Overall Study|Lost to Follow-up|1|||
127996368|NCT02360280|460613637|FG001|Overall Study|Lost to Follow-up|0|||
127996369|NCT02472886|460613638|FG000|Overall Study|Lack of Efficacy|0|||
127996370|NCT02472886|460613639|FG001|Overall Study|Lack of Efficacy|2|||
127996371|NCT02472886|460613640|FG002|Overall Study|Lack of Efficacy|1|||
127996372|NCT00320788|460613641|FG000|Overall Study|Adverse Event|0|||
127996373|NCT00320788|460613642|FG001|Overall Study|Adverse Event|0|||
127996374|NCT00320788|460613643|FG002|Overall Study|Adverse Event|0|||
127996375|NCT00320788|460613644|FG003|Overall Study|Adverse Event|1|||
127996376|NCT00320788|460613645|FG004|Overall Study|Adverse Event|0|||
127996377|NCT00320788|460613641|FG000|Overall Study|Death|0|||
127996378|NCT00320788|460613642|FG001|Overall Study|Death|0|||
127996379|NCT00320788|460613643|FG002|Overall Study|Death|1|||
127996380|NCT00320788|460613644|FG003|Overall Study|Death|0|||
127996381|NCT00320788|460613645|FG004|Overall Study|Death|1|||
127996382|NCT00320788|460613641|FG000|Overall Study|Lost to Follow-up|0|||
127996383|NCT00320788|460613642|FG001|Overall Study|Lost to Follow-up|2|||
127996384|NCT00320788|460613643|FG002|Overall Study|Lost to Follow-up|1|||
127996385|NCT00320788|460613644|FG003|Overall Study|Lost to Follow-up|0|||
127996386|NCT00320788|460613645|FG004|Overall Study|Lost to Follow-up|0|||
127996387|NCT00320788|460613641|FG000|Overall Study|Decision by the Sponsor|1|||
127996388|NCT00320788|460613642|FG001|Overall Study|Decision by the Sponsor|1|||
127996389|NCT00320788|460613643|FG002|Overall Study|Decision by the Sponsor|0|||
127996390|NCT00320788|460613644|FG003|Overall Study|Decision by the Sponsor|0|||
127996391|NCT00320788|460613645|FG004|Overall Study|Decision by the Sponsor|1|||
127996392|NCT00320788|460613641|FG000|Overall Study|Other|1|||
127996393|NCT00320788|460613642|FG001|Overall Study|Other|2|||
127996394|NCT00320788|460613643|FG002|Overall Study|Other|1|||
127996395|NCT00320788|460613644|FG003|Overall Study|Other|1|||
127996396|NCT00320788|460613645|FG004|Overall Study|Other|1|||
127996397|NCT00320788|460613641|FG000|Overall Study|Physician Decision|1|||
127996398|NCT00320788|460613642|FG001|Overall Study|Physician Decision|1|||
127996399|NCT00320788|460613643|FG002|Overall Study|Physician Decision|0|||
127996400|NCT00320788|460613644|FG003|Overall Study|Physician Decision|0|||
127996401|NCT00320788|460613645|FG004|Overall Study|Physician Decision|0|||
127996402|NCT00320788|460613641|FG000|Overall Study|Protocol Violation|0|||
127996403|NCT00320788|460613642|FG001|Overall Study|Protocol Violation|0|||
127996404|NCT00320788|460613643|FG002|Overall Study|Protocol Violation|0|||
127996405|NCT00320788|460613644|FG003|Overall Study|Protocol Violation|0|||
127996406|NCT00320788|460613645|FG004|Overall Study|Protocol Violation|1|||
127996407|NCT00320788|460613641|FG000|Overall Study|Withdrawal by Subject|3|||
127996408|NCT00320788|460613642|FG001|Overall Study|Withdrawal by Subject|0|||
127996409|NCT00320788|460613643|FG002|Overall Study|Withdrawal by Subject|0|||
127996410|NCT00320788|460613644|FG003|Overall Study|Withdrawal by Subject|3|||
127996411|NCT00320788|460613645|FG004|Overall Study|Withdrawal by Subject|1|||
127996412|NCT00627926|460613646|FG000|Overall Study|Adverse Event|26|||
127996413|NCT00627926|460613647|FG001|Overall Study|Adverse Event|37|||
127996414|NCT00627926|460613648|FG002|Overall Study|Adverse Event|36|||
127996415|NCT00627926|460613646|FG000|Overall Study|Death|1|||
127996416|NCT00627926|460613647|FG001|Overall Study|Death|0|||
127996417|NCT00627926|460613648|FG002|Overall Study|Death|0|||
127996418|NCT00627926|460613646|FG000|Overall Study|Lost to Follow-up|4|||
127996419|NCT00627926|460613647|FG001|Overall Study|Lost to Follow-up|3|||
127996420|NCT00627926|460613648|FG002|Overall Study|Lost to Follow-up|4|||
127996421|NCT00627926|460613646|FG000|Overall Study|Withdrawal by Subject|2|||
127996422|NCT00627926|460613647|FG001|Overall Study|Withdrawal by Subject|1|||
127996423|NCT00627926|460613648|FG002|Overall Study|Withdrawal by Subject|0|||
127996424|NCT00627926|460613646|FG000|Overall Study|Lack of Efficacy|118|||
127996425|NCT00627926|460613647|FG001|Overall Study|Lack of Efficacy|40|||
127996426|NCT00627926|460613648|FG002|Overall Study|Lack of Efficacy|38|||
127996427|NCT00627926|460613646|FG000|Overall Study|Noncompliance/unspecified|8|||
127996428|NCT00627926|460613647|FG001|Overall Study|Noncompliance/unspecified|23|||
127996429|NCT00627926|460613648|FG002|Overall Study|Noncompliance/unspecified|17|||
127996430|NCT03360019|460613652|FG000|Overall Study|Withdrawal by Subject|2|||
127996431|NCT03360019|460613653|FG001|Overall Study|Withdrawal by Subject|0|||
127996432|NCT03360019|460613654|FG002|Overall Study|Withdrawal by Subject|0|||
127996433|NCT03360019|460613652|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
127996434|NCT03360019|460613653|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
127996435|NCT03360019|460613654|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
127665316|NCT02397460|459395149|FG001|Treatment Period 2|Adverse Event|0|||
127996436|NCT01462110|460613655|FG000|Overall Study|Adverse Event|1|||
127996437|NCT01462110|460613656|FG001|Overall Study|Adverse Event|0|||
127996438|NCT02149264|460613662|FG000|Overall Study|Withdrawal by Subject|9|||
127996439|NCT02149264|460613662|FG000|Overall Study|Adverse Event|7|||
127996440|NCT02149264|460613662|FG000|Overall Study|Physician Decision|3|||
127996441|NCT02149264|460613662|FG000|Overall Study|Protocol Violation|1|||
127996442|NCT03283930|460613663|FG000|Overall Study|Scheduling conflict|8|||
127996443|NCT03283930|460613664|FG001|Overall Study|Scheduling conflict|10|||
127996444|NCT03283930|460613663|FG000|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
127996445|NCT03283930|460613664|FG001|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
127996446|NCT03283930|460613663|FG000|Overall Study|Technical software issue|2|||
127996447|NCT03283930|460613664|FG001|Overall Study|Technical software issue|2|||
127996448|NCT00805129|460613665|FG000|Overall Study|Not treated|1|||
127996449|NCT02499120|460613666|FG000|Overall Study|Death|52|||
127665317|NCT02397460|459395150|FG002|Treatment Period 2|Adverse Event|0|||
127996450|NCT02499120|460613667|FG001|Overall Study|Death|43|||
127996451|NCT02499120|460613666|FG000|Overall Study|Lost to Follow-up|1|||
127996452|NCT02499120|460613667|FG001|Overall Study|Lost to Follow-up|2|||
127996453|NCT02499120|460613666|FG000|Overall Study|Participant refused further follow-up|1|||
127996454|NCT02499120|460613667|FG001|Overall Study|Participant refused further follow-up|0|||
127996455|NCT02499120|460613666|FG000|Overall Study|Withdrawal by Subject|2|||
127665318|NCT02397460|459395151|FG003|Treatment Period 2|Adverse Event|0|||
127665319|NCT02397460|459395152|FG004|Treatment Period 2|Adverse Event|0|||
127665320|NCT02397460|459395153|FG005|Treatment Period 2|Adverse Event|0|||
127665321|NCT02397460|459395154|FG006|Treatment Period 2|Adverse Event|0|||
127665322|NCT02397460|459395155|FG007|Treatment Period 2|Adverse Event|1|||
127665323|NCT02397460|459395148|FG000|Treatment Period 4|Adverse Event|0|||
127665324|NCT02397460|459395149|FG001|Treatment Period 4|Adverse Event|1|||
127665325|NCT02397460|459395150|FG002|Treatment Period 4|Adverse Event|0|||
127665326|NCT02397460|459395151|FG003|Treatment Period 4|Adverse Event|0|||
127665327|NCT02397460|459395152|FG004|Treatment Period 4|Adverse Event|0|||
127665328|NCT02397460|459395153|FG005|Treatment Period 4|Adverse Event|0|||
127665329|NCT02397460|459395154|FG006|Treatment Period 4|Adverse Event|0|||
127665330|NCT02397460|459395155|FG007|Treatment Period 4|Adverse Event|0|||
127665331|NCT02397460|459395148|FG000|Treatment Period 4|Physician Decision|0|||
127665332|NCT02397460|459395149|FG001|Treatment Period 4|Physician Decision|0|||
127665333|NCT02397460|459395150|FG002|Treatment Period 4|Physician Decision|0|||
127665334|NCT02397460|459395151|FG003|Treatment Period 4|Physician Decision|0|||
127665335|NCT02397460|459395152|FG004|Treatment Period 4|Physician Decision|1|||
127665336|NCT02397460|459395153|FG005|Treatment Period 4|Physician Decision|0|||
127665337|NCT02397460|459395154|FG006|Treatment Period 4|Physician Decision|0|||
127665338|NCT02397460|459395155|FG007|Treatment Period 4|Physician Decision|0|||
127665339|NCT00776100|459395158|FG000|Overall Study|Disease Progression|1|||
127665340|NCT00776100|459395159|FG001|Overall Study|Disease Progression|0|||
127665341|NCT04793464|459395162|FG000|Overall Study|Lost to Follow-up|458|||
127665342|NCT04793464|459395163|FG001|Overall Study|Lost to Follow-up|168|||
127665343|NCT04793464|459395164|FG002|Overall Study|Lost to Follow-up|5|||
127665344|NCT04793464|459395162|FG000|Overall Study|Withdrawal by Subject|43|||
127665345|NCT04793464|459395163|FG001|Overall Study|Withdrawal by Subject|15|||
127665346|NCT04793464|459395164|FG002|Overall Study|Withdrawal by Subject|0|||
127665347|NCT00641186|459395165|FG000|Overall Study|Adverse Event|3|||
127665348|NCT02169830|459396814|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
127665349|NCT02169830|459396815|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
127665350|NCT02169830|459396816|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
127665351|NCT02169830|459396814|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
127665352|NCT02169830|459396815|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
127665353|NCT02169830|459396816|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
127665354|NCT02169830|459396814|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
127665355|NCT02169830|459396815|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
127665356|NCT02169830|459396816|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
127665357|NCT02169830|459396814|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
127665358|NCT02169830|459396815|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
127665359|NCT02169830|459396816|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
127665360|NCT02169830|459396814|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
127665361|NCT02169830|459396815|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
127665362|NCT02169830|459396816|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
127665363|NCT03615482|459396817|FG000|Overall Study|Death|1|||
127665364|NCT03615482|459396818|FG001|Overall Study|Death|0|||
127665365|NCT03615482|459396817|FG000|Overall Study|Lost to Follow-up|7|||
127665366|NCT03615482|459396818|FG001|Overall Study|Lost to Follow-up|7|||
127665367|NCT03615482|459396817|FG000|Overall Study|Physician Decision|2|||
127665368|NCT03615482|459396818|FG001|Overall Study|Physician Decision|3|||
127665369|NCT03615482|459396817|FG000|Overall Study|Withdrawal by Subject|7|||
127996456|NCT02499120|460613667|FG001|Overall Study|Withdrawal by Subject|5|||
127996457|NCT02499120|460613666|FG000|Overall Study|Other|9|||
127665370|NCT03615482|459396818|FG001|Overall Study|Withdrawal by Subject|7|||
127665371|NCT01500226|459396821|FG000|Overall Study|Adverse Event|31|||
127665372|NCT01500226|459396822|FG001|Overall Study|Adverse Event|38|||
127665373|NCT01500226|459396821|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
127665374|NCT01500226|459396822|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
127665375|NCT01500226|459396821|FG000|Overall Study|Withdrawal by Subject|93|||
127665376|NCT01500226|459396822|FG001|Overall Study|Withdrawal by Subject|96|||
127665377|NCT01500226|459396821|FG000|Overall Study|Death|12|||
127665378|NCT01500226|459396822|FG001|Overall Study|Death|4|||
127665379|NCT01500226|459396821|FG000|Overall Study|Disease Progression|16|||
127665380|NCT01500226|459396822|FG001|Overall Study|Disease Progression|14|||
127665381|NCT01500226|459396821|FG000|Overall Study|Protocol Violation|53|||
127665382|NCT01500226|459396822|FG001|Overall Study|Protocol Violation|39|||
127996458|NCT02499120|460613667|FG001|Overall Study|Other|10|||
127996459|NCT00964028|460613672|FG000|Overall Study|Withdrawal by Subject|0|||
127996460|NCT00964028|460613673|FG001|Overall Study|Withdrawal by Subject|1|||
127996461|NCT02385110|460613674|FG000|Overall Study|Early Death|1|||
127996462|NCT02385110|460613675|FG001|Overall Study|Early Death|0|||
127996463|NCT03472521|460613676|FG000|Overall Study|Lost to Follow-up|3|||
127996464|NCT03472521|460613677|FG001|Overall Study|Lost to Follow-up|2|||
127996465|NCT03472521|460613676|FG000|Overall Study|Discontinued intervention|3|||
127996466|NCT03472521|460613677|FG001|Overall Study|Discontinued intervention|1|||
127996467|NCT00534638|460613682|FG000|Overall Study|Withdrawal by Subject|3|||
127996468|NCT00534638|460613683|FG001|Overall Study|Withdrawal by Subject|4|||
127996469|NCT00534638|460613682|FG000|Overall Study|Migrated/moved from study area|13|||
127996470|NCT00534638|460613683|FG001|Overall Study|Migrated/moved from study area|11|||
127996471|NCT00534638|460613682|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
127996472|NCT00534638|460613683|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
127996473|NCT00534638|460613682|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
127996474|NCT00534638|460613683|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
127996475|NCT00534638|460613682|FG000|Overall Study|Other|1685|||
127996476|NCT00534638|460613683|FG001|Overall Study|Other|902|||
127996477|NCT02106351|460613684|FG000|Treatment Cycle 1|Adverse Event|2|||
127996478|NCT02106351|460613685|FG001|Treatment Cycle 1|Adverse Event|0|||
127996479|NCT02106351|460613686|FG002|Treatment Cycle 1|Adverse Event|0|||
127996480|NCT02106351|460613684|FG000|Treatment Cycle 1|Consent withdrawn|1|||
127996481|NCT02106351|460613685|FG001|Treatment Cycle 1|Consent withdrawn|0|||
127996482|NCT02106351|460613686|FG002|Treatment Cycle 1|Consent withdrawn|2|||
127996483|NCT02106351|460613684|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
127996484|NCT02106351|460613685|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
127996485|NCT02106351|460613686|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
127996486|NCT02106351|460613684|FG000|Treatment Cycle 1|Other|0|||
127996487|NCT02106351|460613685|FG001|Treatment Cycle 1|Other|3|||
127996488|NCT02106351|460613686|FG002|Treatment Cycle 1|Other|1|||
127996489|NCT02106351|460613684|FG000|Treatment Cycle 1|Randomised but not treated|1|||
127996490|NCT02106351|460613685|FG001|Treatment Cycle 1|Randomised but not treated|0|||
127996491|NCT02106351|460613686|FG002|Treatment Cycle 1|Randomised but not treated|1|||
127996492|NCT02106351|460613684|FG000|Treatment Cycle 2|Adverse Event|0|||
127996493|NCT02106351|460613685|FG001|Treatment Cycle 2|Adverse Event|2|||
127996494|NCT02106351|460613686|FG002|Treatment Cycle 2|Adverse Event|0|||
127996495|NCT02106351|460613684|FG000|Treatment Cycle 2|Consent withdrawn|0|||
127996496|NCT02106351|460613685|FG001|Treatment Cycle 2|Consent withdrawn|1|||
127996497|NCT02106351|460613686|FG002|Treatment Cycle 2|Consent withdrawn|1|||
127996498|NCT02106351|460613684|FG000|Treatment Cycle 2|Other|0|||
127996499|NCT02106351|460613685|FG001|Treatment Cycle 2|Other|2|||
127996500|NCT02106351|460613686|FG002|Treatment Cycle 2|Other|2|||
127996501|NCT02106351|460613684|FG000|Treatment Cycle 3|Adverse Event|0|||
127996502|NCT02106351|460613685|FG001|Treatment Cycle 3|Adverse Event|1|||
127996503|NCT02106351|460613686|FG002|Treatment Cycle 3|Adverse Event|0|||
127996504|NCT02106351|460613684|FG000|Treatment Cycle 3|Consent withdrawn|0|||
127665383|NCT01500226|459396821|FG000|Overall Study|Physician Decision|17|||
127665384|NCT01500226|459396822|FG001|Overall Study|Physician Decision|15|||
127665385|NCT01500226|459396821|FG000|Overall Study|Lack of Efficacy|14|||
127665386|NCT01500226|459396822|FG001|Overall Study|Lack of Efficacy|30|||
127665387|NCT01500226|459396821|FG000|Overall Study|Lost to Follow-up|9|||
127665388|NCT01500226|459396822|FG001|Overall Study|Lost to Follow-up|5|||
127665389|NCT01500226|459396821|FG000|Overall Study|Other Reasons|19|||
127665390|NCT01500226|459396822|FG001|Overall Study|Other Reasons|16|||
127665391|NCT04212169|459396823|FG000|Overall Study|Adverse Event|0|||
127665392|NCT04212169|459396824|FG001|Overall Study|Adverse Event|0|||
127996505|NCT02106351|460613685|FG001|Treatment Cycle 3|Consent withdrawn|0|||
127996506|NCT02106351|460613686|FG002|Treatment Cycle 3|Consent withdrawn|2|||
127996507|NCT02106351|460613684|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
127996508|NCT02106351|460613685|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
127996509|NCT02106351|460613686|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
127665393|NCT04212169|459396825|FG002|Overall Study|Adverse Event|0|||
127996510|NCT02106351|460613684|FG000|Treatment Cycle 3|Other|0|||
127996511|NCT02106351|460613685|FG001|Treatment Cycle 3|Other|2|||
127996512|NCT02106351|460613686|FG002|Treatment Cycle 3|Other|3|||
127996513|NCT02106351|460613684|FG000|Treatment Cycle 4|Consent withdrawn|0|||
127996514|NCT02106351|460613685|FG001|Treatment Cycle 4|Consent withdrawn|0|||
127996515|NCT02106351|460613686|FG002|Treatment Cycle 4|Consent withdrawn|2|||
127996516|NCT02106351|460613684|FG000|Treatment Cycle 4|Other|0|||
127996517|NCT02106351|460613685|FG001|Treatment Cycle 4|Other|1|||
127996518|NCT02106351|460613686|FG002|Treatment Cycle 4|Other|0|||
127996519|NCT00520039|460613687|FG000|Overall Study|Exclusion criteria met at first visit|7|||
127996520|NCT00520039|460613688|FG001|Overall Study|Exclusion criteria met at first visit|5|||
127996521|NCT02329327|460613689|FG000|Overall Study|Death|78|||
127996522|NCT02329327|460613690|FG001|Overall Study|Death|0|||
127996523|NCT02329327|460613689|FG000|Overall Study|Withdrawal by Subject|3|||
127996524|NCT02329327|460613690|FG001|Overall Study|Withdrawal by Subject|0|||
127996525|NCT02329327|460613689|FG000|Overall Study|Lost to Follow-up|4|||
127996526|NCT02329327|460613690|FG001|Overall Study|Lost to Follow-up|0|||
127996527|NCT01801111|460613691|FG000|Overall Study|Adverse Event|12|||
127996528|NCT01801111|460613691|FG000|Overall Study|Death|8|||
127996529|NCT01801111|460613691|FG000|Overall Study|Physician Decision|5|||
127996530|NCT01801111|460613691|FG000|Overall Study|Other|1|||
127996531|NCT01801111|460613691|FG000|Overall Study|Withdrawal by Subject|4|||
127996532|NCT01801111|460613691|FG000|Overall Study|Study Terminated by Sponsor|27|||
127996533|NCT01801111|460613691|FG000|Overall Study|Progressive Disease|81|||
127996534|NCT01223937|460613692|FG000|Overall Study|Withdrawal by Subject|3|||
127996535|NCT01223937|460613693|FG001|Overall Study|Withdrawal by Subject|2|||
127996536|NCT01223937|460613692|FG000|Overall Study|Lost to Follow-up|1|||
127996537|NCT01223937|460613693|FG001|Overall Study|Lost to Follow-up|4|||
127996538|NCT01223937|460613692|FG000|Overall Study|Adverse Event|1|||
127996539|NCT01223937|460613693|FG001|Overall Study|Adverse Event|4|||
127996540|NCT01223937|460613692|FG000|Overall Study|Protocol Violation|8|||
127996541|NCT01223937|460613693|FG001|Overall Study|Protocol Violation|7|||
127996542|NCT01223937|460613692|FG000|Overall Study|Other|4|||
127996543|NCT01223937|460613693|FG001|Overall Study|Other|1|||
127996544|NCT05176717|460613695|FG000|Overall Study|Sponsor Decision|1|||
127996545|NCT05176717|460613696|FG001|Overall Study|Sponsor Decision|2|||
127996546|NCT05176717|460613697|FG002|Overall Study|Sponsor Decision|2|||
127996547|NCT00765817|460613699|FG000|Overall Study|Adverse Event|13|||
127996548|NCT00765817|460613700|FG001|Overall Study|Adverse Event|1|||
127996549|NCT00765817|460613699|FG000|Overall Study|Death|0|||
127996550|NCT00765817|460613700|FG001|Overall Study|Death|1|||
127996551|NCT00765817|460613699|FG000|Overall Study|Entry criteria not met|2|||
127996552|NCT00765817|460613700|FG001|Overall Study|Entry criteria not met|2|||
127996553|NCT00765817|460613699|FG000|Overall Study|Loss of glucose control|0|||
127996554|NCT00765817|460613700|FG001|Overall Study|Loss of glucose control|2|||
127996555|NCT00765817|460613699|FG000|Overall Study|Lost to Follow-up|1|||
127996556|NCT00765817|460613700|FG001|Overall Study|Lost to Follow-up|3|||
127996557|NCT00765817|460613699|FG000|Overall Study|Physician Decision|2|||
127996558|NCT00765817|460613700|FG001|Overall Study|Physician Decision|1|||
127996559|NCT00765817|460613699|FG000|Overall Study|Protocol Violation|1|||
127996560|NCT00765817|460613700|FG001|Overall Study|Protocol Violation|1|||
127996561|NCT00765817|460613699|FG000|Overall Study|Subject decision|7|||
127996562|NCT00765817|460613700|FG001|Overall Study|Subject decision|11|||
127996563|NCT02308228|460613701|FG000|Overall Study|Adverse Event|3|||
127996564|NCT02308228|460613702|FG001|Overall Study|Adverse Event|4|||
127996565|NCT02308228|460613701|FG000|Overall Study|Withdrawal by Subject|5|||
127996566|NCT02308228|460613702|FG001|Overall Study|Withdrawal by Subject|3|||
127996567|NCT03999749|460613705|FG000|Overall Study|Toxicity|16|||
127996568|NCT03999749|460613705|FG000|Overall Study|Withdrawal by Subject|3|||
127996569|NCT03999749|460613705|FG000|Overall Study|Disease progression|26|||
127996570|NCT03999749|460613705|FG000|Overall Study|Physician Decision|4|||
127996571|NCT03999749|460613705|FG000|Overall Study|Death|5|||
127996572|NCT03999749|460613705|FG000|Overall Study|Patient deemed ineligible after treatment|1|||
127996573|NCT00255164|460613706|FG000|Overall Study|Adverse Event|10|||
127996574|NCT00255164|460613707|FG001|Overall Study|Adverse Event|6|||
127996575|NCT00255164|460613708|FG002|Overall Study|Adverse Event|9|||
127996576|NCT00255164|460613706|FG000|Overall Study|Lost to Follow-up|4|||
127996577|NCT00255164|460613707|FG001|Overall Study|Lost to Follow-up|3|||
127996578|NCT00255164|460613708|FG002|Overall Study|Lost to Follow-up|4|||
127996579|NCT00255164|460613706|FG000|Overall Study|Withdrawal by Subject|18|||
127996580|NCT00255164|460613707|FG001|Overall Study|Withdrawal by Subject|17|||
127996581|NCT00255164|460613708|FG002|Overall Study|Withdrawal by Subject|8|||
127996582|NCT00255164|460613706|FG000|Overall Study|Noncompliance|0|||
127996583|NCT00255164|460613707|FG001|Overall Study|Noncompliance|1|||
127996584|NCT00255164|460613708|FG002|Overall Study|Noncompliance|2|||
127996585|NCT00255164|460613706|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
127996586|NCT00255164|460613707|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
127996587|NCT00255164|460613708|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
127996588|NCT00255164|460613706|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
127996589|NCT00255164|460613707|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
127996590|NCT00255164|460613708|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
127665394|NCT04212169|459396826|FG003|Overall Study|Adverse Event|2|||
127665395|NCT04212169|459396823|FG000|Overall Study|Lost to Follow-up|1|||
127665396|NCT04212169|459396824|FG001|Overall Study|Lost to Follow-up|0|||
127665397|NCT04212169|459396825|FG002|Overall Study|Lost to Follow-up|0|||
127665398|NCT04212169|459396826|FG003|Overall Study|Lost to Follow-up|2|||
127665399|NCT04212169|459396823|FG000|Overall Study|Withdrawal by Subject|10|||
127996591|NCT00255164|460613706|FG000|Overall Study|Possible Barrett's Esophagus|1|||
127996592|NCT00255164|460613707|FG001|Overall Study|Possible Barrett's Esophagus|3|||
127996593|NCT00255164|460613708|FG002|Overall Study|Possible Barrett's Esophagus|8|||
127996594|NCT00255164|460613706|FG000|Overall Study|Esophageal Stricture|0|||
127996595|NCT00255164|460613707|FG001|Overall Study|Esophageal Stricture|0|||
127996596|NCT00255164|460613708|FG002|Overall Study|Esophageal Stricture|1|||
127996597|NCT00255164|460613706|FG000|Overall Study|Therapeutic Failure|11|||
127996598|NCT00255164|460613707|FG001|Overall Study|Therapeutic Failure|2|||
127996599|NCT00255164|460613708|FG002|Overall Study|Therapeutic Failure|3|||
127996600|NCT05219968|460613709|FG000|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|6|||
127996601|NCT05219968|460613710|FG001|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
127996602|NCT05219968|460613711|FG002|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
127996603|NCT05219968|460613712|FG003|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
127665400|NCT04212169|459396824|FG001|Overall Study|Withdrawal by Subject|2|||
127665401|NCT04212169|459396825|FG002|Overall Study|Withdrawal by Subject|5|||
127665402|NCT04212169|459396826|FG003|Overall Study|Withdrawal by Subject|7|||
127665403|NCT04212169|459396823|FG000|Overall Study|Other reason, unspecified|3|||
127665404|NCT04212169|459396824|FG001|Overall Study|Other reason, unspecified|1|||
127996604|NCT05219968|460613713|FG004|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
127996605|NCT05219968|460613709|FG000|Week 24 Treatment Period|Bilateral dislodgement|13|||
127996606|NCT05219968|460613710|FG001|Week 24 Treatment Period|Bilateral dislodgement|0|||
127996607|NCT05219968|460613711|FG002|Week 24 Treatment Period|Bilateral dislodgement|0|||
127996608|NCT05219968|460613712|FG003|Week 24 Treatment Period|Bilateral dislodgement|0|||
127996609|NCT05219968|460613713|FG004|Week 24 Treatment Period|Bilateral dislodgement|0|||
127996610|NCT05219968|460613709|FG000|Week 24 Treatment Period|Withdrawal by Subject|2|||
127996611|NCT05219968|460613710|FG001|Week 24 Treatment Period|Withdrawal by Subject|2|||
127996612|NCT05219968|460613711|FG002|Week 24 Treatment Period|Withdrawal by Subject|0|||
127996613|NCT05219968|460613712|FG003|Week 24 Treatment Period|Withdrawal by Subject|0|||
127996614|NCT05219968|460613713|FG004|Week 24 Treatment Period|Withdrawal by Subject|0|||
127996615|NCT05219968|460613709|FG000|Week 24 Treatment Period|Adverse Event|3|||
127996616|NCT05219968|460613710|FG001|Week 24 Treatment Period|Adverse Event|0|||
127996617|NCT05219968|460613711|FG002|Week 24 Treatment Period|Adverse Event|0|||
127996618|NCT05219968|460613712|FG003|Week 24 Treatment Period|Adverse Event|0|||
127996619|NCT05219968|460613713|FG004|Week 24 Treatment Period|Adverse Event|0|||
127996620|NCT05219968|460613709|FG000|Week 24 Treatment Period|Physician Decision|0|||
127996621|NCT05219968|460613710|FG001|Week 24 Treatment Period|Physician Decision|1|||
127996622|NCT05219968|460613711|FG002|Week 24 Treatment Period|Physician Decision|0|||
127996623|NCT05219968|460613712|FG003|Week 24 Treatment Period|Physician Decision|0|||
127996624|NCT05219968|460613713|FG004|Week 24 Treatment Period|Physician Decision|0|||
127996625|NCT05219968|460613709|FG000|Week 24 Treatment Period|Other, not specified|3|||
127996626|NCT05219968|460613710|FG001|Week 24 Treatment Period|Other, not specified|0|||
127996627|NCT05219968|460613711|FG002|Week 24 Treatment Period|Other, not specified|0|||
127996628|NCT05219968|460613712|FG003|Week 24 Treatment Period|Other, not specified|0|||
127996629|NCT05219968|460613713|FG004|Week 24 Treatment Period|Other, not specified|0|||
127996630|NCT05219968|460613709|FG000|Safety Extension Period|Treatment administration failure|0|||
127996631|NCT05219968|460613710|FG001|Safety Extension Period|Treatment administration failure|0|||
127996632|NCT05219968|460613711|FG002|Safety Extension Period|Treatment administration failure|0|||
127996633|NCT05219968|460613712|FG003|Safety Extension Period|Treatment administration failure|1|||
127996634|NCT05219968|460613713|FG004|Safety Extension Period|Treatment administration failure|4|||
127996635|NCT05219968|460613709|FG000|Safety Extension Period|Bilateral dislodgement|0|||
127996636|NCT05219968|460613710|FG001|Safety Extension Period|Bilateral dislodgement|0|||
127996637|NCT05219968|460613711|FG002|Safety Extension Period|Bilateral dislodgement|4|||
127996638|NCT05219968|460613712|FG003|Safety Extension Period|Bilateral dislodgement|0|||
127996639|NCT05219968|460613713|FG004|Safety Extension Period|Bilateral dislodgement|1|||
127996640|NCT05219968|460613709|FG000|Safety Extension Period|Withdrawal by Subject|0|||
127996641|NCT05219968|460613710|FG001|Safety Extension Period|Withdrawal by Subject|0|||
127996642|NCT05219968|460613711|FG002|Safety Extension Period|Withdrawal by Subject|2|||
127996643|NCT05219968|460613712|FG003|Safety Extension Period|Withdrawal by Subject|0|||
127665405|NCT04212169|459396825|FG002|Overall Study|Other reason, unspecified|0|||
127665406|NCT04212169|459396826|FG003|Overall Study|Other reason, unspecified|2|||
127996644|NCT05219968|460613713|FG004|Safety Extension Period|Withdrawal by Subject|4|||
127996645|NCT05219968|460613709|FG000|Safety Extension Period|Adverse Event|0|||
127996646|NCT05219968|460613710|FG001|Safety Extension Period|Adverse Event|0|||
127996647|NCT05219968|460613711|FG002|Safety Extension Period|Adverse Event|2|||
127996648|NCT05219968|460613712|FG003|Safety Extension Period|Adverse Event|1|||
127996649|NCT05219968|460613713|FG004|Safety Extension Period|Adverse Event|1|||
127996650|NCT05219968|460613709|FG000|Safety Extension Period|Lost to Follow-up|0|||
127996651|NCT05219968|460613710|FG001|Safety Extension Period|Lost to Follow-up|0|||
127996652|NCT05219968|460613711|FG002|Safety Extension Period|Lost to Follow-up|0|||
127996653|NCT05219968|460613712|FG003|Safety Extension Period|Lost to Follow-up|1|||
127996654|NCT05219968|460613713|FG004|Safety Extension Period|Lost to Follow-up|0|||
127996655|NCT04587336|460613714|FG000|Overall Study|Lost to Follow-up|1|||
127996656|NCT04587336|460613715|FG001|Overall Study|Lost to Follow-up|0|||
127996657|NCT00103285|460615566|FG000|Induction|Adverse Event|14|||
127996658|NCT00103285|460615567|FG001|Induction|Adverse Event|0|||
127996659|NCT00103285|460615568|FG002|Induction|Adverse Event|0|||
127996660|NCT00103285|460615569|FG003|Induction|Adverse Event|0|||
127996661|NCT00103285|460615570|FG004|Induction|Adverse Event|0|||
127996662|NCT00103285|460615571|FG005|Induction|Adverse Event|0|||
127996663|NCT00103285|460615572|FG006|Induction|Adverse Event|0|||
127996664|NCT00103285|460615573|FG007|Induction|Adverse Event|0|||
127996665|NCT00103285|460615566|FG000|Induction|Death|24|||
127996666|NCT00103285|460615567|FG001|Induction|Death|0|||
127996667|NCT00103285|460615568|FG002|Induction|Death|0|||
127996668|NCT00103285|460615569|FG003|Induction|Death|0|||
127996669|NCT00103285|460615570|FG004|Induction|Death|0|||
127996670|NCT00103285|460615571|FG005|Induction|Death|0|||
127996671|NCT00103285|460615572|FG006|Induction|Death|0|||
127996672|NCT00103285|460615573|FG007|Induction|Death|0|||
127996673|NCT00103285|460615566|FG000|Induction|Physician Decision|103|||
127665407|NCT03685708|459396833|FG000|Overall Study|Withdrawal by Subject|0|||
127665408|NCT03685708|459396834|FG001|Overall Study|Withdrawal by Subject|0|||
127665409|NCT03685708|459396835|FG002|Overall Study|Withdrawal by Subject|1|||
127996674|NCT00103285|460615567|FG001|Induction|Physician Decision|0|||
127996675|NCT00103285|460615568|FG002|Induction|Physician Decision|0|||
127996676|NCT00103285|460615569|FG003|Induction|Physician Decision|0|||
127996677|NCT00103285|460615570|FG004|Induction|Physician Decision|0|||
127996678|NCT00103285|460615571|FG005|Induction|Physician Decision|0|||
127996679|NCT00103285|460615572|FG006|Induction|Physician Decision|0|||
127996680|NCT00103285|460615573|FG007|Induction|Physician Decision|0|||
127996681|NCT00103285|460615566|FG000|Induction|Withdrawal by Subject|1|||
127996682|NCT00103285|460615567|FG001|Induction|Withdrawal by Subject|0|||
127996683|NCT00103285|460615568|FG002|Induction|Withdrawal by Subject|0|||
127996684|NCT00103285|460615569|FG003|Induction|Withdrawal by Subject|0|||
127996685|NCT00103285|460615570|FG004|Induction|Withdrawal by Subject|0|||
127996686|NCT00103285|460615571|FG005|Induction|Withdrawal by Subject|0|||
127996687|NCT00103285|460615572|FG006|Induction|Withdrawal by Subject|0|||
127996688|NCT00103285|460615573|FG007|Induction|Withdrawal by Subject|0|||
127996689|NCT00103285|460615566|FG000|Induction|Ineligible|43|||
127996690|NCT00103285|460615567|FG001|Induction|Ineligible|0|||
127996691|NCT00103285|460615568|FG002|Induction|Ineligible|0|||
127996692|NCT00103285|460615569|FG003|Induction|Ineligible|0|||
127996693|NCT00103285|460615570|FG004|Induction|Ineligible|0|||
127996694|NCT00103285|460615571|FG005|Induction|Ineligible|0|||
127996695|NCT00103285|460615572|FG006|Induction|Ineligible|0|||
127996696|NCT00103285|460615573|FG007|Induction|Ineligible|0|||
127996697|NCT00103285|460615566|FG000|Induction|Refusal|906|||
127996698|NCT00103285|460615567|FG001|Induction|Refusal|0|||
127996699|NCT00103285|460615568|FG002|Induction|Refusal|0|||
127996700|NCT00103285|460615569|FG003|Induction|Refusal|0|||
127996701|NCT00103285|460615570|FG004|Induction|Refusal|0|||
127996702|NCT00103285|460615571|FG005|Induction|Refusal|0|||
127996703|NCT00103285|460615572|FG006|Induction|Refusal|0|||
127996704|NCT00103285|460615573|FG007|Induction|Refusal|0|||
127996705|NCT00103285|460615566|FG000|Induction|Other|258|||
127996706|NCT00103285|460615567|FG001|Induction|Other|0|||
127996707|NCT00103285|460615568|FG002|Induction|Other|0|||
127665410|NCT03685708|459396833|FG000|Overall Study|Screen Fail|0|||
127665411|NCT03685708|459396834|FG001|Overall Study|Screen Fail|1|||
127665412|NCT03685708|459396835|FG002|Overall Study|Screen Fail|1|||
127665413|NCT03685708|459396833|FG000|Overall Study|COVID 19 Pandemic|1|||
127665414|NCT03685708|459396834|FG001|Overall Study|COVID 19 Pandemic|1|||
127996708|NCT00103285|460615569|FG003|Induction|Other|0|||
127996709|NCT00103285|460615570|FG004|Induction|Other|0|||
127996710|NCT00103285|460615571|FG005|Induction|Other|0|||
127996711|NCT00103285|460615572|FG006|Induction|Other|0|||
127996712|NCT00103285|460615573|FG007|Induction|Other|0|||
127996713|NCT00103285|460615566|FG000|Response Assignment|Adverse Event|0|||
127996714|NCT00103285|460615567|FG001|Response Assignment|Adverse Event|8|||
127996715|NCT00103285|460615568|FG002|Response Assignment|Adverse Event|3|||
127665415|NCT03685708|459396835|FG002|Overall Study|COVID 19 Pandemic|6|||
127665416|NCT03685708|459396833|FG000|Overall Study|Disease Progression|0|||
127996716|NCT00103285|460615569|FG003|Response Assignment|Adverse Event|2|||
127996717|NCT00103285|460615570|FG004|Response Assignment|Adverse Event|3|||
127996718|NCT00103285|460615571|FG005|Response Assignment|Adverse Event|1|||
127996719|NCT00103285|460615572|FG006|Response Assignment|Adverse Event|1|||
127996720|NCT00103285|460615573|FG007|Response Assignment|Adverse Event|2|||
127996721|NCT00103285|460615566|FG000|Response Assignment|Death|0|||
127996722|NCT00103285|460615567|FG001|Response Assignment|Death|5|||
127996723|NCT00103285|460615568|FG002|Response Assignment|Death|2|||
127996724|NCT00103285|460615569|FG003|Response Assignment|Death|2|||
127996725|NCT00103285|460615570|FG004|Response Assignment|Death|3|||
127996726|NCT00103285|460615571|FG005|Response Assignment|Death|1|||
127996727|NCT00103285|460615572|FG006|Response Assignment|Death|0|||
127996728|NCT00103285|460615573|FG007|Response Assignment|Death|8|||
127996729|NCT00103285|460615566|FG000|Response Assignment|Lost to Follow-up|0|||
127996730|NCT00103285|460615567|FG001|Response Assignment|Lost to Follow-up|9|||
127996731|NCT00103285|460615568|FG002|Response Assignment|Lost to Follow-up|5|||
127996732|NCT00103285|460615569|FG003|Response Assignment|Lost to Follow-up|5|||
127996733|NCT00103285|460615570|FG004|Response Assignment|Lost to Follow-up|1|||
127996734|NCT00103285|460615571|FG005|Response Assignment|Lost to Follow-up|2|||
127996735|NCT00103285|460615572|FG006|Response Assignment|Lost to Follow-up|2|||
127996736|NCT00103285|460615573|FG007|Response Assignment|Lost to Follow-up|5|||
127996737|NCT00103285|460615566|FG000|Response Assignment|Physician Decision|0|||
127996738|NCT00103285|460615567|FG001|Response Assignment|Physician Decision|13|||
127996739|NCT00103285|460615568|FG002|Response Assignment|Physician Decision|14|||
127996740|NCT00103285|460615569|FG003|Response Assignment|Physician Decision|9|||
127996741|NCT00103285|460615570|FG004|Response Assignment|Physician Decision|13|||
127996742|NCT00103285|460615571|FG005|Response Assignment|Physician Decision|7|||
127996743|NCT00103285|460615572|FG006|Response Assignment|Physician Decision|4|||
127996744|NCT00103285|460615573|FG007|Response Assignment|Physician Decision|35|||
127996745|NCT00103285|460615566|FG000|Response Assignment|Protocol Violation|0|||
127996746|NCT00103285|460615567|FG001|Response Assignment|Protocol Violation|2|||
127996747|NCT00103285|460615568|FG002|Response Assignment|Protocol Violation|0|||
127996748|NCT00103285|460615569|FG003|Response Assignment|Protocol Violation|0|||
127996749|NCT00103285|460615570|FG004|Response Assignment|Protocol Violation|0|||
127996750|NCT00103285|460615571|FG005|Response Assignment|Protocol Violation|0|||
127996751|NCT00103285|460615572|FG006|Response Assignment|Protocol Violation|0|||
127996752|NCT00103285|460615573|FG007|Response Assignment|Protocol Violation|0|||
127996753|NCT00103285|460615566|FG000|Response Assignment|Withdrawal by Subject|0|||
127996754|NCT00103285|460615567|FG001|Response Assignment|Withdrawal by Subject|4|||
127996755|NCT00103285|460615568|FG002|Response Assignment|Withdrawal by Subject|1|||
127996756|NCT00103285|460615569|FG003|Response Assignment|Withdrawal by Subject|1|||
127996757|NCT00103285|460615570|FG004|Response Assignment|Withdrawal by Subject|2|||
127996758|NCT00103285|460615571|FG005|Response Assignment|Withdrawal by Subject|2|||
127996759|NCT00103285|460615572|FG006|Response Assignment|Withdrawal by Subject|0|||
127996760|NCT00103285|460615573|FG007|Response Assignment|Withdrawal by Subject|2|||
127996761|NCT00103285|460615566|FG000|Response Assignment|Ineligible|0|||
127996762|NCT00103285|460615567|FG001|Response Assignment|Ineligible|8|||
127996763|NCT00103285|460615568|FG002|Response Assignment|Ineligible|6|||
127996764|NCT00103285|460615569|FG003|Response Assignment|Ineligible|2|||
127996765|NCT00103285|460615570|FG004|Response Assignment|Ineligible|0|||
127996766|NCT00103285|460615571|FG005|Response Assignment|Ineligible|3|||
127996767|NCT00103285|460615572|FG006|Response Assignment|Ineligible|1|||
127996768|NCT00103285|460615573|FG007|Response Assignment|Ineligible|5|||
127996769|NCT00103285|460615566|FG000|Response Assignment|Refusal|0|||
127996770|NCT00103285|460615567|FG001|Response Assignment|Refusal|53|||
127996771|NCT00103285|460615568|FG002|Response Assignment|Refusal|5|||
127996772|NCT00103285|460615569|FG003|Response Assignment|Refusal|3|||
127996773|NCT00103285|460615570|FG004|Response Assignment|Refusal|25|||
127996774|NCT00103285|460615571|FG005|Response Assignment|Refusal|15|||
127996775|NCT00103285|460615572|FG006|Response Assignment|Refusal|30|||
127996776|NCT00103285|460615573|FG007|Response Assignment|Refusal|10|||
127996777|NCT00103285|460615566|FG000|Response Assignment|Other|0|||
127996778|NCT00103285|460615567|FG001|Response Assignment|Other|30|||
127996779|NCT00103285|460615568|FG002|Response Assignment|Other|48|||
127996780|NCT00103285|460615569|FG003|Response Assignment|Other|38|||
127996781|NCT00103285|460615570|FG004|Response Assignment|Other|37|||
127996782|NCT00103285|460615571|FG005|Response Assignment|Other|17|||
127996783|NCT00103285|460615572|FG006|Response Assignment|Other|11|||
127996784|NCT00103285|460615573|FG007|Response Assignment|Other|53|||
127996785|NCT00452439|460615575|FG000|Overall Study|Lost to Follow-up|1|||
127996786|NCT00452439|460615576|FG001|Overall Study|Lost to Follow-up|1|||
127996787|NCT00452439|460615575|FG000|Overall Study|Refused Treatment|4|||
127996788|NCT00452439|460615576|FG001|Overall Study|Refused Treatment|3|||
127996789|NCT00452439|460615575|FG000|Overall Study|Death|3|||
127996790|NCT00452439|460615576|FG001|Overall Study|Death|1|||
127996791|NCT00452439|460615575|FG000|Overall Study|Bone Marrow Transplant|0|||
127996792|NCT00452439|460615576|FG001|Overall Study|Bone Marrow Transplant|1|||
127996793|NCT00452439|460615575|FG000|Overall Study|Too Ill to Continue|0|||
127996794|NCT00452439|460615576|FG001|Overall Study|Too Ill to Continue|1|||
127996795|NCT00452439|460615575|FG000|Overall Study|Failed to achieve complete response|2|||
127996796|NCT00452439|460615576|FG001|Overall Study|Failed to achieve complete response|0|||
127996797|NCT00452439|460615575|FG000|Overall Study|Relapse|3|||
127996798|NCT00452439|460615576|FG001|Overall Study|Relapse|0|||
127996799|NCT00452439|460615575|FG000|Overall Study|Fracture|1|||
127996800|NCT00452439|460615576|FG001|Overall Study|Fracture|0|||
127996801|NCT03512353|460615578|FG000|Overall Study|Sponsor Decision|3|||
127996802|NCT03512353|460615578|FG000|Overall Study|Death|1|||
127996803|NCT01877668|460615580|FG000|Overall Study|Death|0|||
127996804|NCT01877668|460615581|FG001|Overall Study|Death|0|||
127665417|NCT03685708|459396834|FG001|Overall Study|Disease Progression|0|||
127665418|NCT03685708|459396835|FG002|Overall Study|Disease Progression|1|||
127665419|NCT04006366|459396838|FG000|Overall Study|Withdrawal by Subject|1|||
127665420|NCT00627042|459396845|FG000|Overall Study|Withdrawal by Subject|2|||
127665421|NCT02268552|459396846|FG000|Part 1|Death|1|||
127665422|NCT02268552|459396847|FG001|Part 1|Death|1|||
127665423|NCT02268552|459396848|FG002|Part 1|Death|1|||
127665424|NCT02268552|459396849|FG003|Part 1|Death|2|||
127665425|NCT02268552|459396850|FG004|Part 1|Death|0|||
127665426|NCT02268552|459396851|FG005|Part 1|Death|0|||
127665427|NCT02268552|459396852|FG006|Part 1|Death|0|||
127996805|NCT01877668|460615582|FG002|Overall Study|Death|0|||
127996806|NCT01877668|460615583|FG003|Overall Study|Death|1|||
127996807|NCT01877668|460615584|FG004|Overall Study|Death|0|||
127996808|NCT01877668|460615580|FG000|Overall Study|No longer met study criteria|1|||
127996809|NCT01877668|460615581|FG001|Overall Study|No longer met study criteria|0|||
127996810|NCT01877668|460615582|FG002|Overall Study|No longer met study criteria|1|||
127996811|NCT01877668|460615583|FG003|Overall Study|No longer met study criteria|0|||
127996812|NCT01877668|460615584|FG004|Overall Study|No longer met study criteria|0|||
127996813|NCT01877668|460615580|FG000|Overall Study|Insufficient clinical response|0|||
127996814|NCT01877668|460615581|FG001|Overall Study|Insufficient clinical response|1|||
127996815|NCT01877668|460615582|FG002|Overall Study|Insufficient clinical response|2|||
127996816|NCT01877668|460615583|FG003|Overall Study|Insufficient clinical response|2|||
127996817|NCT01877668|460615584|FG004|Overall Study|Insufficient clinical response|0|||
127996818|NCT01877668|460615580|FG000|Overall Study|Lost to Follow-up|0|||
127996819|NCT01877668|460615581|FG001|Overall Study|Lost to Follow-up|2|||
127996820|NCT01877668|460615582|FG002|Overall Study|Lost to Follow-up|1|||
127996821|NCT01877668|460615583|FG003|Overall Study|Lost to Follow-up|0|||
127996822|NCT01877668|460615584|FG004|Overall Study|Lost to Follow-up|0|||
127996823|NCT01877668|460615580|FG000|Overall Study|Withdrawal by Subject|2|||
127996824|NCT01877668|460615581|FG001|Overall Study|Withdrawal by Subject|0|||
127996825|NCT01877668|460615582|FG002|Overall Study|Withdrawal by Subject|3|||
127996826|NCT01877668|460615583|FG003|Overall Study|Withdrawal by Subject|2|||
127996827|NCT01877668|460615584|FG004|Overall Study|Withdrawal by Subject|2|||
127996828|NCT01877668|460615580|FG000|Overall Study|Other|1|||
127996829|NCT01877668|460615581|FG001|Overall Study|Other|1|||
127996830|NCT01877668|460615582|FG002|Overall Study|Other|1|||
127996831|NCT01877668|460615583|FG003|Overall Study|Other|1|||
127665428|NCT02268552|459396846|FG000|Part 1|Subject/guardian decision|0|||
127665429|NCT02268552|459396847|FG001|Part 1|Subject/guardian decision|0|||
127665430|NCT02268552|459396848|FG002|Part 1|Subject/guardian decision|0|||
127665431|NCT02268552|459396849|FG003|Part 1|Subject/guardian decision|1|||
127665432|NCT02268552|459396850|FG004|Part 1|Subject/guardian decision|0|||
127665433|NCT02268552|459396851|FG005|Part 1|Subject/guardian decision|0|||
127665434|NCT02268552|459396852|FG006|Part 1|Subject/guardian decision|0|||
127665435|NCT02268552|459396846|FG000|Part 2|Death|0|||
127665436|NCT02268552|459396847|FG001|Part 2|Death|0|||
127665437|NCT02268552|459396848|FG002|Part 2|Death|0|||
127665438|NCT02268552|459396849|FG003|Part 2|Death|0|||
127665439|NCT02268552|459396850|FG004|Part 2|Death|0|||
127665440|NCT02268552|459396851|FG005|Part 2|Death|0|||
127665441|NCT02268552|459396852|FG006|Part 2|Death|2|||
127665442|NCT02268552|459396846|FG000|Part 2|Subject/guardian decision|0|||
127665443|NCT02268552|459396847|FG001|Part 2|Subject/guardian decision|0|||
127665444|NCT02268552|459396848|FG002|Part 2|Subject/guardian decision|0|||
127665445|NCT02268552|459396849|FG003|Part 2|Subject/guardian decision|0|||
127665446|NCT02268552|459396850|FG004|Part 2|Subject/guardian decision|0|||
127665447|NCT02268552|459396851|FG005|Part 2|Subject/guardian decision|0|||
127665448|NCT02268552|459396852|FG006|Part 2|Subject/guardian decision|1|||
127665449|NCT02268552|459396846|FG000|Part 3 Extension|Death|0|||
127665450|NCT02268552|459396847|FG001|Part 3 Extension|Death|1|||
127665451|NCT02268552|459396848|FG002|Part 3 Extension|Death|1|||
127996832|NCT01877668|460615584|FG004|Overall Study|Other|3|||
127996833|NCT01877668|460615580|FG000|Overall Study|Protocol Violation|1|||
127996834|NCT01877668|460615581|FG001|Overall Study|Protocol Violation|1|||
127665452|NCT02268552|459396849|FG003|Part 3 Extension|Death|1|||
127665453|NCT02268552|459396850|FG004|Part 3 Extension|Death|1|||
127665454|NCT02268552|459396851|FG005|Part 3 Extension|Death|1|||
127665455|NCT02268552|459396852|FG006|Part 3 Extension|Death|0|||
127665456|NCT02268552|459396846|FG000|Part 3 Extension|Early termination of trial|1|||
127665457|NCT02268552|459396847|FG001|Part 3 Extension|Early termination of trial|0|||
127665458|NCT02268552|459396848|FG002|Part 3 Extension|Early termination of trial|0|||
127665459|NCT02268552|459396849|FG003|Part 3 Extension|Early termination of trial|0|||
127665460|NCT02268552|459396850|FG004|Part 3 Extension|Early termination of trial|2|||
127665461|NCT02268552|459396851|FG005|Part 3 Extension|Early termination of trial|9|||
127665462|NCT02268552|459396852|FG006|Part 3 Extension|Early termination of trial|11|||
127665463|NCT02268552|459396846|FG000|Part 3 Extension|Subject/guardian decision|0|||
127665464|NCT02268552|459396847|FG001|Part 3 Extension|Subject/guardian decision|0|||
127665465|NCT02268552|459396848|FG002|Part 3 Extension|Subject/guardian decision|0|||
127996835|NCT01877668|460615582|FG002|Overall Study|Protocol Violation|0|||
127996836|NCT01877668|460615583|FG003|Overall Study|Protocol Violation|0|||
127996837|NCT01877668|460615584|FG004|Overall Study|Protocol Violation|3|||
127996838|NCT01877668|460615580|FG000|Overall Study|Adverse event related to study drug|2|||
127996839|NCT01877668|460615581|FG001|Overall Study|Adverse event related to study drug|2|||
127996840|NCT01877668|460615582|FG002|Overall Study|Adverse event related to study drug|2|||
127996841|NCT01877668|460615583|FG003|Overall Study|Adverse event related to study drug|2|||
127996842|NCT01877668|460615584|FG004|Overall Study|Adverse event related to study drug|1|||
127996843|NCT01877668|460615580|FG000|Overall Study|Adverse event unrelated to study drug|4|||
127996844|NCT01877668|460615581|FG001|Overall Study|Adverse event unrelated to study drug|1|||
127996845|NCT01877668|460615582|FG002|Overall Study|Adverse event unrelated to study drug|2|||
127996846|NCT01877668|460615583|FG003|Overall Study|Adverse event unrelated to study drug|0|||
127996847|NCT01877668|460615584|FG004|Overall Study|Adverse event unrelated to study drug|1|||
127996848|NCT04147247|460615586|FG000|Overall Study|Progressive disease|3|||
127996849|NCT04147247|460615587|FG001|Overall Study|Progressive disease|3|||
127996850|NCT04147247|460615588|FG002|Overall Study|Progressive disease|4|||
127996851|NCT04147247|460615589|FG003|Overall Study|Progressive disease|4|||
127996852|NCT04147247|460615590|FG004|Overall Study|Progressive disease|3|||
127996853|NCT04147247|460615586|FG000|Overall Study|Physician Decision|0|||
127996854|NCT04147247|460615587|FG001|Overall Study|Physician Decision|1|||
127996855|NCT04147247|460615588|FG002|Overall Study|Physician Decision|0|||
127996856|NCT04147247|460615589|FG003|Overall Study|Physician Decision|0|||
127996857|NCT04147247|460615590|FG004|Overall Study|Physician Decision|0|||
127996858|NCT04147247|460615586|FG000|Overall Study|Clinical Disease Progression|0|||
127996859|NCT04147247|460615587|FG001|Overall Study|Clinical Disease Progression|0|||
127996860|NCT04147247|460615588|FG002|Overall Study|Clinical Disease Progression|0|||
127996861|NCT04147247|460615589|FG003|Overall Study|Clinical Disease Progression|0|||
127996862|NCT04147247|460615590|FG004|Overall Study|Clinical Disease Progression|1|||
127996863|NCT04147247|460615586|FG000|Overall Study|Adverse Event|0|||
127996864|NCT04147247|460615587|FG001|Overall Study|Adverse Event|0|||
127996865|NCT04147247|460615588|FG002|Overall Study|Adverse Event|1|||
127996866|NCT04147247|460615589|FG003|Overall Study|Adverse Event|0|||
127996867|NCT04147247|460615590|FG004|Overall Study|Adverse Event|1|||
127996868|NCT00994110|460615591|FG000|Overall Study|Withdrawal by Subject|9|||
127996869|NCT00994110|460615592|FG001|Overall Study|Withdrawal by Subject|9|||
127996870|NCT00994110|460615591|FG000|Overall Study|Not Treated|4|||
127996871|NCT00994110|460615592|FG001|Overall Study|Not Treated|8|||
127996872|NCT00994110|460615591|FG000|Overall Study|Adverse Event|1|||
127996873|NCT00994110|460615592|FG001|Overall Study|Adverse Event|0|||
127996874|NCT00994110|460615591|FG000|Overall Study|Patient not resected|41|||
127996875|NCT00994110|460615592|FG001|Overall Study|Patient not resected|52|||
127996876|NCT00994110|460615591|FG000|Overall Study|Pt not eligible|10|||
127996877|NCT00994110|460615592|FG001|Overall Study|Pt not eligible|5|||
127996878|NCT01111565|460615593|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
127996879|NCT01111565|460615594|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
127996880|NCT01111565|460615595|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
127996881|NCT01111565|460615596|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
127996882|NCT01111565|460615597|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
127996883|NCT01111565|460615593|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
127996884|NCT01111565|460615594|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
127996885|NCT01111565|460615595|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
127996886|NCT01111565|460615596|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
127996887|NCT01111565|460615597|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
127996888|NCT01111565|460615593|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
127996889|NCT01111565|460615594|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
127996890|NCT01111565|460615595|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
127996891|NCT01111565|460615596|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
127996892|NCT01111565|460615597|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
127996893|NCT01111565|460615593|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
127996894|NCT01111565|460615594|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
127996895|NCT01111565|460615595|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
127996896|NCT01111565|460615596|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
127996897|NCT01111565|460615597|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
127996898|NCT01111565|460615593|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
127996899|NCT01111565|460615594|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
127996900|NCT01111565|460615595|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
127996901|NCT01111565|460615596|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
127996902|NCT01111565|460615597|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
127996903|NCT01111565|460615593|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
127996904|NCT01111565|460615594|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
127996905|NCT01111565|460615595|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
127996906|NCT01111565|460615596|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
127996907|NCT01111565|460615597|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
127996908|NCT01111565|460615593|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
127996909|NCT01111565|460615594|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
127996910|NCT01111565|460615595|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
127996911|NCT01111565|460615596|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
127996912|NCT01111565|460615597|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
127996913|NCT01111565|460615593|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
127996914|NCT01111565|460615594|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
127996915|NCT01111565|460615595|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
127996916|NCT01111565|460615596|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
127996917|NCT01111565|460615597|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
127996918|NCT01111565|460615593|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
127996919|NCT01111565|460615594|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
127996920|NCT01111565|460615595|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
127996921|NCT01111565|460615596|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
127996922|NCT01111565|460615597|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
127996923|NCT01111565|460615593|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
127996924|NCT01111565|460615594|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
127996925|NCT01111565|460615595|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
127996926|NCT01111565|460615596|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
127996927|NCT01111565|460615597|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
127996928|NCT01111565|460615593|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
127996929|NCT01111565|460615594|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
127996930|NCT01111565|460615595|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
127996931|NCT01111565|460615596|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
127996932|NCT01111565|460615597|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
127996933|NCT01111565|460615593|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
127996934|NCT01111565|460615594|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
127996935|NCT01111565|460615595|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
127996936|NCT01111565|460615596|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
127996937|NCT01111565|460615597|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
127996938|NCT00368108|460615598|FG000|Overall Study|Adverse Event|38|||
127996939|NCT00368108|460615599|FG001|Overall Study|Adverse Event|26|||
127996940|NCT00368108|460615600|FG002|Overall Study|Adverse Event|44|||
127996941|NCT00368108|460615598|FG000|Overall Study|Abnormal Laboratory Value|0|||
127996942|NCT00368108|460615599|FG001|Overall Study|Abnormal Laboratory Value|0|||
127996943|NCT00368108|460615600|FG002|Overall Study|Abnormal Laboratory Value|3|||
127996944|NCT00368108|460615598|FG000|Overall Study|Protocol Violation|5|||
127996945|NCT00368108|460615599|FG001|Overall Study|Protocol Violation|9|||
127996946|NCT00368108|460615600|FG002|Overall Study|Protocol Violation|9|||
127996947|NCT00368108|460615598|FG000|Overall Study|Withdrawal by Subject|9|||
127996948|NCT00368108|460615599|FG001|Overall Study|Withdrawal by Subject|3|||
127996949|NCT00368108|460615600|FG002|Overall Study|Withdrawal by Subject|5|||
127996950|NCT00368108|460615598|FG000|Overall Study|Lack of Efficacy|7|||
127996951|NCT00368108|460615599|FG001|Overall Study|Lack of Efficacy|8|||
127996952|NCT00368108|460615600|FG002|Overall Study|Lack of Efficacy|5|||
127996953|NCT00368108|460615598|FG000|Overall Study|Physician Decision|2|||
127996954|NCT00368108|460615599|FG001|Overall Study|Physician Decision|0|||
127996955|NCT00368108|460615600|FG002|Overall Study|Physician Decision|1|||
127996956|NCT00368108|460615598|FG000|Overall Study|Other|3|||
127996957|NCT00368108|460615599|FG001|Overall Study|Other|7|||
127996958|NCT00368108|460615600|FG002|Overall Study|Other|1|||
127996959|NCT04131712|460615601|FG000|Overall Study|COVID related|0|||
127996960|NCT04131712|460615602|FG001|Overall Study|COVID related|0|||
127996961|NCT04131712|460615603|FG002|Overall Study|COVID related|2|||
127996962|NCT04131712|460615604|FG003|Overall Study|COVID related|0|||
127996963|NCT04131712|460615601|FG000|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
127996964|NCT04131712|460615602|FG001|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
127996965|NCT04131712|460615603|FG002|Overall Study|PI withdrawal, subject could not follow study schedule|1|||
127996966|NCT04131712|460615604|FG003|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
127996967|NCT00130689|460615605|FG000|Overall Study|Progressive Disease|29|||
127996968|NCT00130689|460615605|FG000|Overall Study|Death|1|||
127996969|NCT00130689|460615605|FG000|Overall Study|Clinical Deterioration|4|||
127996970|NCT00130689|460615605|FG000|Overall Study|Withdrawal by Subject|3|||
127996971|NCT00130689|460615605|FG000|Overall Study|Ineligible|6|||
127996972|NCT02254772|460615607|FG000|Overall Study|Ineligible|1|||
127996973|NCT02254772|460615607|FG000|Overall Study|Withdrawal by Subject|1|||
127996974|NCT03904420|460615608|FG000|Overall Study|Study terminated|2|||
127996975|NCT03904420|460615609|FG001|Overall Study|Study terminated|2|||
127996976|NCT01001910|460615610|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
127996977|NCT01089127|460615611|FG000|Overall Study|Adverse Event|5|||
127996978|NCT01089127|460615612|FG001|Overall Study|Adverse Event|1|||
127665466|NCT02268552|459396849|FG003|Part 3 Extension|Subject/guardian decision|0|||
127996979|NCT01089127|460615613|FG002|Overall Study|Adverse Event|1|||
127996980|NCT01089127|460615614|FG003|Overall Study|Adverse Event|0|||
127996981|NCT01089127|460615615|FG004|Overall Study|Adverse Event|0|||
127996982|NCT01089127|460615616|FG005|Overall Study|Adverse Event|1|||
127996983|NCT01089127|460615611|FG000|Overall Study|Subject withdrew consent|0|||
127996984|NCT01089127|460615612|FG001|Overall Study|Subject withdrew consent|1|||
127996985|NCT01089127|460615613|FG002|Overall Study|Subject withdrew consent|1|||
127996986|NCT01089127|460615614|FG003|Overall Study|Subject withdrew consent|1|||
127996987|NCT01089127|460615615|FG004|Overall Study|Subject withdrew consent|0|||
127996988|NCT01089127|460615616|FG005|Overall Study|Subject withdrew consent|2|||
127996989|NCT01089127|460615611|FG000|Overall Study|Abnormal test procedure result(s)|2|||
127996990|NCT01089127|460615612|FG001|Overall Study|Abnormal test procedure result(s)|1|||
127996991|NCT01089127|460615613|FG002|Overall Study|Abnormal test procedure result(s)|0|||
127996992|NCT01089127|460615614|FG003|Overall Study|Abnormal test procedure result(s)|0|||
127996993|NCT01089127|460615615|FG004|Overall Study|Abnormal test procedure result(s)|0|||
127996994|NCT01089127|460615616|FG005|Overall Study|Abnormal test procedure result(s)|0|||
127996995|NCT01089127|460615611|FG000|Overall Study|Lost to Follow-up|1|||
127996996|NCT01089127|460615612|FG001|Overall Study|Lost to Follow-up|1|||
127996997|NCT01089127|460615613|FG002|Overall Study|Lost to Follow-up|0|||
127996998|NCT01089127|460615614|FG003|Overall Study|Lost to Follow-up|0|||
127996999|NCT01089127|460615615|FG004|Overall Study|Lost to Follow-up|1|||
127997000|NCT01089127|460615616|FG005|Overall Study|Lost to Follow-up|0|||
127997001|NCT01089127|460615611|FG000|Overall Study|Protocol deviation|0|||
127997002|NCT01089127|460615612|FG001|Overall Study|Protocol deviation|1|||
127997003|NCT01089127|460615613|FG002|Overall Study|Protocol deviation|0|||
127997004|NCT01089127|460615614|FG003|Overall Study|Protocol deviation|0|||
127997005|NCT01089127|460615615|FG004|Overall Study|Protocol deviation|1|||
127997006|NCT01089127|460615616|FG005|Overall Study|Protocol deviation|0|||
127997007|NCT03200548|460615617|FG000|Overall Study|Withdrawal by Subject|5|||
127997008|NCT03200548|460615618|FG001|Overall Study|Withdrawal by Subject|11|||
127997009|NCT03200548|460615619|FG002|Overall Study|Withdrawal by Subject|7|||
127997010|NCT03200548|460615620|FG003|Overall Study|Withdrawal by Subject|6|||
127997011|NCT00447772|460615621|FG000|Overall Study|Lack of Efficacy|3|||
127997012|NCT00447772|460615621|FG000|Overall Study|Insufficient compliance|6|||
127997013|NCT00447772|460615621|FG000|Overall Study|Discontinuation of drug therapy|1|||
127997014|NCT00447772|460615621|FG000|Overall Study|Lost to Follow-up|9|||
127997015|NCT00447772|460615621|FG000|Overall Study|Withdrawal by Subject|1|||
127997016|NCT00447772|460615621|FG000|Overall Study|Unable to attend all study visits|2|||
127997017|NCT00447772|460615621|FG000|Overall Study|Adverse Event|1|||
127997018|NCT00447772|460615621|FG000|Overall Study|Patient relocated|1|||
127997019|NCT00447772|460615621|FG000|Overall Study|Incomplete documentation at visit 1|1|||
127997020|NCT00447772|460615621|FG000|Overall Study|Chemotherapy for lung cancer|1|||
127997021|NCT00447772|460615621|FG000|Overall Study|Premature re-injection required|1|||
127997022|NCT00716456|460615622|FG000|Overall Study|Adverse Event|0|||
127997023|NCT00716456|460615623|FG001|Overall Study|Adverse Event|2|||
127997024|NCT00716456|460615624|FG002|Overall Study|Adverse Event|0|||
127997025|NCT00875563|460615629|FG000|Overall Study|Death|4|||
127997026|NCT00875563|460615629|FG000|Overall Study|Withdrawal by Subject|7|||
127997027|NCT00875563|460615629|FG000|Overall Study|No long-term (3-5 year) consent|6|||
127997028|NCT00875563|460615629|FG000|Overall Study|Still be eligible for follow-up|7|||
127997029|NCT02896569|460615632|FG000|Overall Study|Lost to Follow-up|2|||
127997030|NCT02896569|460615633|FG001|Overall Study|Lost to Follow-up|1|||
127997031|NCT02896569|460615632|FG000|Overall Study|Physician Decision|1|||
127997032|NCT02896569|460615633|FG001|Overall Study|Physician Decision|3|||
127997033|NCT02896569|460615632|FG000|Overall Study|Adverse Event|0|||
127997034|NCT02896569|460615633|FG001|Overall Study|Adverse Event|1|||
127997035|NCT02896569|460615632|FG000|Overall Study|Withdrawal by Subject|1|||
127997036|NCT02896569|460615633|FG001|Overall Study|Withdrawal by Subject|0|||
127997037|NCT00970489|460615636|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
127997038|NCT00970489|460615637|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
127997039|NCT05417412|460615638|FG000|Overall Study|Lost to Follow-up|2|||
127665467|NCT02268552|459396850|FG004|Part 3 Extension|Subject/guardian decision|0|||
127665468|NCT02268552|459396851|FG005|Part 3 Extension|Subject/guardian decision|0|||
127665469|NCT02268552|459396852|FG006|Part 3 Extension|Subject/guardian decision|1|||
127665470|NCT01154036|459396853|FG000|Phase I|Physician Decision|0|||
127997040|NCT03478371|460615641|FG000|Overall Study|non-compliance|1|||
127997041|NCT03478371|460615641|FG000|Overall Study|Lost to Follow-up|4|||
127997042|NCT02849743|460615642|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
127997043|NCT02849743|460615643|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
127997044|NCT02849743|460615642|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
127997045|NCT02849743|460615643|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
127997046|NCT03874013|460615650|FG000|Overall Study|Adverse Event|0|||
127997047|NCT03874013|460615651|FG001|Overall Study|Adverse Event|1|||
127997048|NCT00922116|460615652|FG000|Overall Study|Adverse Event|4|||
127997049|NCT00922116|460615652|FG000|Overall Study|Death|1|||
127997050|NCT00922116|460615652|FG000|Overall Study|Lost to Follow-up|1|||
127997051|NCT00922116|460615652|FG000|Overall Study|Withdrawal by Subject|4|||
127997052|NCT00922116|460615652|FG000|Overall Study|Other|5|||
127997053|NCT04607135|460615653|FG000|Overall Study|Physician Decision|1|||
127997054|NCT04607135|460615653|FG000|Overall Study|Withdrawal by Subject|1|||
127997055|NCT04607135|460615653|FG000|Overall Study|Equipment not working|3|||
127997056|NCT06060496|460615654|FG000|Overall Study|Withdrawal by Subject|2|||
127997057|NCT06060496|460615654|FG000|Overall Study|Lost to Follow-up|2|||
127997058|NCT03990051|460615655|FG000|Masked Period|Lost to Follow-up|1|||
127997059|NCT03990051|460615656|FG001|Masked Period|Lost to Follow-up|0|||
127997060|NCT03990051|460615655|FG000|Long Term Period|Death|1|||
127997061|NCT03990051|460615656|FG001|Long Term Period|Death|1|||
127997062|NCT03990051|460615655|FG000|Long Term Period|Lost to Follow-up|7|||
127997063|NCT03990051|460615656|FG001|Long Term Period|Lost to Follow-up|2|||
127997064|NCT00618826|460615657|FG000|Overall Study|Adverse Event|1|||
127997065|NCT01509664|460615659|FG000|Overall Study|Lost to Follow-up|15|||
127665471|NCT01154036|459396854|FG001|Phase I|Physician Decision|1|||
127665472|NCT01154036|459396855|FG002|Phase I|Physician Decision|0|||
127665473|NCT01154036|459396856|FG003|Phase I|Physician Decision|0|||
127665474|NCT01154036|459396857|FG004|Phase I|Physician Decision|0|||
127665475|NCT01154036|459396858|FG005|Phase I|Physician Decision|0|||
127665476|NCT01154036|459396859|FG006|Phase I|Physician Decision|0|||
127665477|NCT01154036|459396860|FG007|Phase I|Physician Decision|0|||
127665478|NCT01154036|459396853|FG000|Phase I|Lost to Follow-up|0|||
127665479|NCT01154036|459396854|FG001|Phase I|Lost to Follow-up|3|||
127665480|NCT01154036|459396855|FG002|Phase I|Lost to Follow-up|6|||
127665481|NCT01154036|459396856|FG003|Phase I|Lost to Follow-up|0|||
127665482|NCT01154036|459396857|FG004|Phase I|Lost to Follow-up|0|||
127665483|NCT01154036|459396858|FG005|Phase I|Lost to Follow-up|0|||
127665484|NCT01154036|459396859|FG006|Phase I|Lost to Follow-up|0|||
127665485|NCT01154036|459396860|FG007|Phase I|Lost to Follow-up|0|||
127665486|NCT01154036|459396853|FG000|Phase I|Protocol Violation|0|||
127665487|NCT01154036|459396854|FG001|Phase I|Protocol Violation|3|||
127665488|NCT01154036|459396855|FG002|Phase I|Protocol Violation|9|||
127665489|NCT01154036|459396856|FG003|Phase I|Protocol Violation|0|||
127665490|NCT01154036|459396857|FG004|Phase I|Protocol Violation|0|||
127665491|NCT01154036|459396858|FG005|Phase I|Protocol Violation|0|||
127665492|NCT01154036|459396859|FG006|Phase I|Protocol Violation|0|||
127665493|NCT01154036|459396860|FG007|Phase I|Protocol Violation|0|||
127665494|NCT01154036|459396853|FG000|Phase I|Withdrawal by Subject|2|||
127665495|NCT01154036|459396854|FG001|Phase I|Withdrawal by Subject|10|||
127665496|NCT01154036|459396855|FG002|Phase I|Withdrawal by Subject|29|||
127665497|NCT01154036|459396856|FG003|Phase I|Withdrawal by Subject|0|||
127665498|NCT01154036|459396857|FG004|Phase I|Withdrawal by Subject|0|||
127665499|NCT01154036|459396858|FG005|Phase I|Withdrawal by Subject|0|||
127665500|NCT01154036|459396859|FG006|Phase I|Withdrawal by Subject|0|||
127665501|NCT01154036|459396860|FG007|Phase I|Withdrawal by Subject|0|||
127665502|NCT01154036|459396853|FG000|Phase I|Adverse Event|1|||
127665503|NCT01154036|459396854|FG001|Phase I|Adverse Event|11|||
127665504|NCT01154036|459396855|FG002|Phase I|Adverse Event|12|||
127665505|NCT01154036|459396856|FG003|Phase I|Adverse Event|0|||
127665506|NCT01154036|459396857|FG004|Phase I|Adverse Event|0|||
127665507|NCT01154036|459396858|FG005|Phase I|Adverse Event|0|||
127665508|NCT01154036|459396859|FG006|Phase I|Adverse Event|0|||
127665509|NCT01154036|459396860|FG007|Phase I|Adverse Event|0|||
127665510|NCT01154036|459396853|FG000|Phase II|Adverse Event|0|||
127665511|NCT01154036|459396854|FG001|Phase II|Adverse Event|0|||
127665512|NCT01154036|459396855|FG002|Phase II|Adverse Event|0|||
127665513|NCT01154036|459396856|FG003|Phase II|Adverse Event|0|||
127665514|NCT01154036|459396857|FG004|Phase II|Adverse Event|1|||
127665515|NCT01154036|459396858|FG005|Phase II|Adverse Event|1|||
127665516|NCT01154036|459396859|FG006|Phase II|Adverse Event|1|||
127665517|NCT01154036|459396860|FG007|Phase II|Adverse Event|1|||
127665518|NCT01154036|459396853|FG000|Phase II|Physician Decision|0|||
127665519|NCT01154036|459396854|FG001|Phase II|Physician Decision|0|||
127665520|NCT01154036|459396855|FG002|Phase II|Physician Decision|0|||
127665521|NCT01154036|459396856|FG003|Phase II|Physician Decision|0|||
127997066|NCT01509664|460615660|FG001|Overall Study|Lost to Follow-up|21|||
127665522|NCT01154036|459396857|FG004|Phase II|Physician Decision|0|||
127665523|NCT01154036|459396858|FG005|Phase II|Physician Decision|0|||
127997067|NCT00807885|460615667|FG000|Overall Study|Lost to Follow-up|0|||
127997068|NCT00807885|460615668|FG001|Overall Study|Lost to Follow-up|0|||
127665524|NCT01154036|459396859|FG006|Phase II|Physician Decision|1|||
127665525|NCT01154036|459396860|FG007|Phase II|Physician Decision|0|||
127997069|NCT00807885|460615669|FG002|Overall Study|Lost to Follow-up|0|||
127997070|NCT00807885|460615670|FG003|Overall Study|Lost to Follow-up|0|||
127665526|NCT01154036|459396853|FG000|Phase II|Lost to Follow-up|0|||
127665527|NCT01154036|459396854|FG001|Phase II|Lost to Follow-up|0|||
127665528|NCT01154036|459396855|FG002|Phase II|Lost to Follow-up|0|||
127665529|NCT01154036|459396856|FG003|Phase II|Lost to Follow-up|1|||
127665530|NCT01154036|459396857|FG004|Phase II|Lost to Follow-up|2|||
127665531|NCT01154036|459396858|FG005|Phase II|Lost to Follow-up|0|||
127665532|NCT01154036|459396859|FG006|Phase II|Lost to Follow-up|2|||
127665533|NCT01154036|459396860|FG007|Phase II|Lost to Follow-up|1|||
127997071|NCT00807885|460615671|FG004|Overall Study|Lost to Follow-up|0|||
127997072|NCT00807885|460615672|FG005|Overall Study|Lost to Follow-up|1|||
127997073|NCT00807885|460615673|FG006|Overall Study|Lost to Follow-up|0|||
127997074|NCT00807885|460615674|FG007|Overall Study|Lost to Follow-up|0|||
127997075|NCT00807885|460615675|FG008|Overall Study|Lost to Follow-up|0|||
127997076|NCT02364388|460615676|FG000|Overall Study|Protocol Violation|1|||
127997077|NCT02364388|460615676|FG000|Overall Study|Technical Failure|3|||
127997078|NCT02364388|460615676|FG000|Overall Study|No OA/US data|2|||
127997079|NCT02364388|460615676|FG000|Overall Study|No Biopsy|2|||
127997080|NCT03126786|460615677|FG000|Overall Study|Adverse Event|3|||
127997081|NCT03126786|460615678|FG001|Overall Study|Adverse Event|0|||
127997082|NCT03126786|460615677|FG000|Overall Study|Lost to Follow-up|0|||
127997083|NCT03126786|460615678|FG001|Overall Study|Lost to Follow-up|1|||
127997084|NCT03126786|460615677|FG000|Overall Study|Withdrawal by Subject|3|||
127997085|NCT03126786|460615678|FG001|Overall Study|Withdrawal by Subject|1|||
127997086|NCT00905424|460615679|FG000|Overall Study|Lost to Follow-up|3|||
127997087|NCT00905424|460615680|FG001|Overall Study|Lost to Follow-up|3|||
127997088|NCT00905424|460615679|FG000|Overall Study|Withdrawal by Subject|1|||
127997089|NCT00905424|460615680|FG001|Overall Study|Withdrawal by Subject|2|||
127997090|NCT00905424|460615679|FG000|Overall Study|Adverse Event|4|||
127997091|NCT00905424|460615680|FG001|Overall Study|Adverse Event|2|||
127997092|NCT00905424|460615679|FG000|Overall Study|Non-compliance with study medication|2|||
127997093|NCT00905424|460615680|FG001|Overall Study|Non-compliance with study medication|0|||
127997094|NCT00905424|460615679|FG000|Overall Study|Sponsor decision|1|||
127997095|NCT00905424|460615680|FG001|Overall Study|Sponsor decision|0|||
127997096|NCT00905424|460615679|FG000|Overall Study|Positive urine drug screen|0|||
127997097|NCT00905424|460615680|FG001|Overall Study|Positive urine drug screen|1|||
127997098|NCT00905424|460615679|FG000|Overall Study|Non-adherence to visit schedule|0|||
127997099|NCT00905424|460615680|FG001|Overall Study|Non-adherence to visit schedule|1|||
127997100|NCT00991289|460615681|FG000|Overall Study|Adverse Event|1|||
127997101|NCT00991289|460615681|FG000|Overall Study|Physician Decision|2|||
127997102|NCT00991289|460615681|FG000|Overall Study|Withdrawal by Subject|3|||
127997103|NCT00991289|460615681|FG000|Overall Study|Lost to Follow-up|4|||
127997104|NCT00991289|460615681|FG000|Overall Study|Protocol Violation|2|||
127997105|NCT00426764|460615682|FG000|Overall Study|Protocol Violation|1|||
127997106|NCT00426764|460615682|FG000|Overall Study|Withdrawal by Subject|4|||
127997107|NCT00426764|460615682|FG000|Overall Study|Physician Decision|6|||
127997108|NCT00426764|460615682|FG000|Overall Study|Compassionate Use|1|||
127997109|NCT00426764|460615682|FG000|Overall Study|Progressive Disease|83|||
127997110|NCT00426764|460615682|FG000|Overall Study|Adverse Event|24|||
127997111|NCT00426764|460615682|FG000|Overall Study|Other|1|||
127997112|NCT00426764|460615682|FG000|Overall Study|Death|1|||
127997113|NCT00426764|460615682|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
127997114|NCT00379899|460615683|FG000|Overall Study|Adverse Event|7|||
127997115|NCT00379899|460615684|FG001|Overall Study|Adverse Event|3|||
127997116|NCT00379899|460615683|FG000|Overall Study|Death|10|||
127997117|NCT00379899|460615684|FG001|Overall Study|Death|10|||
127997118|NCT00379899|460615683|FG000|Overall Study|Lost to Follow-up|2|||
127997119|NCT00379899|460615684|FG001|Overall Study|Lost to Follow-up|4|||
127997120|NCT00379899|460615683|FG000|Overall Study|Physician Decision|3|||
127997121|NCT00379899|460615684|FG001|Overall Study|Physician Decision|4|||
127997122|NCT00379899|460615683|FG000|Overall Study|Withdrawal by Subject|5|||
127997123|NCT00379899|460615684|FG001|Overall Study|Withdrawal by Subject|5|||
127997124|NCT00379899|460615683|FG000|Overall Study|Ineligibility determined|0|||
127997125|NCT00379899|460615684|FG001|Overall Study|Ineligibility determined|1|||
127997126|NCT00379899|460615683|FG000|Overall Study|Noncompliance|1|||
127997127|NCT00379899|460615684|FG001|Overall Study|Noncompliance|1|||
127997128|NCT00379899|460615683|FG000|Overall Study|Parathyroidectomy|0|||
127997129|NCT00379899|460615684|FG001|Overall Study|Parathyroidectomy|2|||
127997130|NCT00379899|460615683|FG000|Overall Study|Renal transplantation|5|||
127997131|NCT00379899|460615684|FG001|Overall Study|Renal transplantation|4|||
127997132|NCT00379899|460615683|FG000|Overall Study|Coronary artery bypass graft|1|||
127997133|NCT00379899|460615684|FG001|Overall Study|Coronary artery bypass graft|1|||
127997134|NCT00379899|460615683|FG000|Overall Study|Other protocol-specified criteria|3|||
127997135|NCT00379899|460615684|FG001|Overall Study|Other protocol-specified criteria|4|||
127997136|NCT00379899|460615683|FG000|Overall Study|Other|3|||
127997137|NCT00379899|460615684|FG001|Overall Study|Other|1|||
127997138|NCT05225389|460615687|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
127997139|NCT03804268|460615688|FG000|Overall Study|Adverse Event|2|||
127997140|NCT03804268|460615689|FG001|Overall Study|Adverse Event|2|||
127997141|NCT03804268|460615688|FG000|Overall Study|Withdrawal by Subject|2|||
127997142|NCT03804268|460615689|FG001|Overall Study|Withdrawal by Subject|0|||
127997143|NCT03804268|460615688|FG000|Overall Study|Lost to Follow-up|1|||
127997144|NCT03804268|460615689|FG001|Overall Study|Lost to Follow-up|0|||
127997145|NCT03804268|460615688|FG000|Overall Study|Physician Decision|2|||
127997146|NCT03804268|460615689|FG001|Overall Study|Physician Decision|0|||
127997147|NCT02716779|460615690|FG000|Monotherapy|Adverse Event|0|||
127997148|NCT02716779|460615691|FG001|Monotherapy|Adverse Event|1|||
127997149|NCT02716779|460615692|FG002|Monotherapy|Adverse Event|1|||
127997150|NCT02716779|460615690|FG000|Combination Therapy|Adverse Event|0|||
127997151|NCT02716779|460615691|FG001|Combination Therapy|Adverse Event|2|||
127997152|NCT02716779|460615692|FG002|Combination Therapy|Adverse Event|1|||
127997153|NCT01843803|460615695|FG000|Overall Study|not a Veteran, did not see provider|1|||
127997154|NCT01843803|460615696|FG001|Overall Study|not a Veteran, did not see provider|3|||
127997155|NCT03311841|460615697|FG000|14-day Wash-out|Adverse Event|0|||
127997156|NCT03311841|460615698|FG001|14-day Wash-out|Adverse Event|1|||
127665534|NCT01154036|459396853|FG000|Phase II|Protocol Violation|0|||
127665535|NCT01154036|459396854|FG001|Phase II|Protocol Violation|0|||
127997157|NCT03311841|460615699|FG002|14-day Wash-out|Adverse Event|0|||
127997158|NCT03311841|460615700|FG003|14-day Wash-out|Adverse Event|0|||
127997159|NCT03311841|460615701|FG004|14-day Wash-out|Adverse Event|0|||
127997160|NCT03311841|460615697|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
127997161|NCT03311841|460615698|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
127997162|NCT03311841|460615699|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
127997163|NCT03311841|460615700|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
127997164|NCT03311841|460615701|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
127997165|NCT01051817|460615709|FG000|Overall Study|Adverse Event|0|||
127997166|NCT01051817|460615710|FG001|Overall Study|Adverse Event|2|||
127997167|NCT01051817|460615709|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
127997168|NCT01051817|460615710|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
127997169|NCT01051817|460615709|FG000|Overall Study|Withdrawal by Subject|3|||
127997170|NCT01051817|460615710|FG001|Overall Study|Withdrawal by Subject|5|||
127997171|NCT01051817|460615709|FG000|Overall Study|Protocol Violation|0|||
127997172|NCT01051817|460615710|FG001|Overall Study|Protocol Violation|1|||
127997173|NCT01026948|460615711|FG000|Overall Study|Physician Decision|8|||
127997174|NCT00753675|460615716|FG000|Overall Study|other reason|11|||
127997175|NCT00753675|460615717|FG001|Overall Study|other reason|12|||
127997176|NCT00753675|460615718|FG002|Overall Study|other reason|13|||
127997177|NCT00753675|460615716|FG000|Overall Study|Death|1|||
127997178|NCT00753675|460615717|FG001|Overall Study|Death|2|||
127997179|NCT00753675|460615718|FG002|Overall Study|Death|4|||
127997180|NCT00753675|460615716|FG000|Overall Study|Adverse Event|11|||
127997181|NCT00753675|460615717|FG001|Overall Study|Adverse Event|9|||
127997182|NCT00753675|460615718|FG002|Overall Study|Adverse Event|4|||
127997183|NCT00753675|460615716|FG000|Overall Study|Objective progression of disease|35|||
127997184|NCT00753675|460615717|FG001|Overall Study|Objective progression of disease|35|||
127997185|NCT00753675|460615718|FG002|Overall Study|Objective progression of disease|35|||
127997186|NCT00753675|460615716|FG000|Overall Study|Withdrawal by Subject|0|||
127997187|NCT00753675|460615717|FG001|Overall Study|Withdrawal by Subject|1|||
127997188|NCT00753675|460615718|FG002|Overall Study|Withdrawal by Subject|0|||
127997189|NCT00753675|460615716|FG000|Overall Study|Lost to Follow-up|1|||
127997190|NCT00753675|460615717|FG001|Overall Study|Lost to Follow-up|0|||
127997191|NCT00753675|460615718|FG002|Overall Study|Lost to Follow-up|0|||
127997192|NCT02686164|460615719|FG000|Overall Study|Adverse Event|1|||
127997193|NCT02686164|460615719|FG000|Overall Study|Withdrawal of consent|1|||
127997194|NCT02686164|460615719|FG000|Overall Study|Clinical progression|1|||
127997195|NCT02824627|460615722|FG000|Overall Study|Adverse Event|1|||
127997196|NCT02824627|460615723|FG001|Overall Study|Adverse Event|2|||
127997197|NCT02824627|460615722|FG000|Overall Study|Lost to Follow-up|2|||
127997198|NCT02824627|460615723|FG001|Overall Study|Lost to Follow-up|1|||
127997199|NCT00672633|460615724|FG000|Overall Study|Withdrawal by Subject|0|||
127997200|NCT00672633|460615725|FG001|Overall Study|Withdrawal by Subject|1|||
127665536|NCT01154036|459396855|FG002|Phase II|Protocol Violation|0|||
127665537|NCT01154036|459396856|FG003|Phase II|Protocol Violation|0|||
127665538|NCT01154036|459396857|FG004|Phase II|Protocol Violation|1|||
127665539|NCT01154036|459396858|FG005|Phase II|Protocol Violation|2|||
127665540|NCT01154036|459396859|FG006|Phase II|Protocol Violation|0|||
127665541|NCT01154036|459396860|FG007|Phase II|Protocol Violation|0|||
127665542|NCT01154036|459396853|FG000|Phase II|Withdrawal by Subject|0|||
127665543|NCT01154036|459396854|FG001|Phase II|Withdrawal by Subject|0|||
127665544|NCT01154036|459396855|FG002|Phase II|Withdrawal by Subject|0|||
127665545|NCT01154036|459396856|FG003|Phase II|Withdrawal by Subject|0|||
127665546|NCT01154036|459396857|FG004|Phase II|Withdrawal by Subject|4|||
127665547|NCT01154036|459396858|FG005|Phase II|Withdrawal by Subject|2|||
127665548|NCT01154036|459396859|FG006|Phase II|Withdrawal by Subject|5|||
127997201|NCT00571662|460615733|FG000|Overall Study|Withdrawal by Subject|2|||
127997202|NCT00571662|460615733|FG000|Overall Study|psychiatric instability|1|||
127997203|NCT00571662|460615733|FG000|Overall Study|Adverse Event|5|||
127997204|NCT01839916|460615734|FG000|Overall Study|Death|9|||
127997205|NCT01839916|460615734|FG000|Overall Study|Physician Decision|17|||
127997206|NCT01839916|460615734|FG000|Overall Study|Relapse|12|||
127997207|NCT01839916|460615734|FG000|Overall Study|GVHD|2|||
127997208|NCT01839916|460615734|FG000|Overall Study|Graft Failure|1|||
127997209|NCT04235504|460615739|FG000|Study Phase|Withdrawal by Subject|5|||
127665549|NCT01154036|459396860|FG007|Phase II|Withdrawal by Subject|4|||
127665550|NCT00997243|459396861|FG000|Overall Study|Early termination of study by sponsor|7|||
127665551|NCT01349907|459396862|FG000|Overall Study|Adverse Event|37|||
127997210|NCT04235504|460615740|FG001|Study Phase|Withdrawal by Subject|2|||
127997211|NCT04235504|460615741|FG002|Study Phase|Withdrawal by Subject|0|||
127997212|NCT04235504|460615742|FG003|Study Phase|Withdrawal by Subject|0|||
127997213|NCT04235504|460615739|FG000|Continuation Phase|Withdrawal by Subject|0|||
127997214|NCT04235504|460615740|FG001|Continuation Phase|Withdrawal by Subject|4|||
127997215|NCT04235504|460615741|FG002|Continuation Phase|Withdrawal by Subject|0|||
127997216|NCT04235504|460615742|FG003|Continuation Phase|Withdrawal by Subject|0|||
127997217|NCT04235504|460615739|FG000|Continuation Phase|Adverse Event|0|||
127997218|NCT04235504|460615740|FG001|Continuation Phase|Adverse Event|1|||
127997219|NCT04235504|460615741|FG002|Continuation Phase|Adverse Event|0|||
127997220|NCT04235504|460615742|FG003|Continuation Phase|Adverse Event|0|||
127997221|NCT04235504|460615739|FG000|Continuation Phase|Physician Decision|1|||
127997222|NCT04235504|460615740|FG001|Continuation Phase|Physician Decision|2|||
127997223|NCT04235504|460615741|FG002|Continuation Phase|Physician Decision|1|||
127997224|NCT04235504|460615742|FG003|Continuation Phase|Physician Decision|0|||
127997225|NCT00181883|460615749|FG000|Overall Study|Lack of Efficacy|2|||
127997226|NCT00181883|460615749|FG000|Overall Study|Treatment Limiting AEs|3|||
127997227|NCT00181883|460615749|FG000|Overall Study|Withdrawal by Subject|4|||
127997228|NCT00181883|460615749|FG000|Overall Study|Lost to Follow-up|1|||
127997229|NCT00101868|460615750|FG000|Overall Study|Death|10|||
127997230|NCT00101868|460615751|FG001|Overall Study|Death|10|||
127997231|NCT00101868|460615750|FG000|Overall Study|Withdrawal by Subject|8|||
127997232|NCT00101868|460615751|FG001|Overall Study|Withdrawal by Subject|9|||
127997233|NCT00101868|460615750|FG000|Overall Study|Protocol Violation|3|||
127997234|NCT00101868|460615751|FG001|Overall Study|Protocol Violation|0|||
127997235|NCT00101868|460615750|FG000|Overall Study|Lost to Follow-up|8|||
127997236|NCT00101868|460615751|FG001|Overall Study|Lost to Follow-up|13|||
127997237|NCT00069823|460615752|FG000|Overall Study|Did not have follow-up diary cards|6|||
127997238|NCT00069823|460615753|FG001|Overall Study|Did not have follow-up diary cards|3|||
127997239|NCT03560869|460615754|FG000|Overall Study|Withdrawal by Subject|3|||
127997240|NCT03560869|460615755|FG001|Overall Study|Withdrawal by Subject|4|||
127997241|NCT03560869|460615754|FG000|Overall Study|Screening failure|4|||
127997242|NCT03560869|460615755|FG001|Overall Study|Screening failure|4|||
127997243|NCT03560869|460615754|FG000|Overall Study|Withdrawal by PI|0|||
127997244|NCT03560869|460615755|FG001|Overall Study|Withdrawal by PI|1|||
127665552|NCT01349907|459396863|FG001|Overall Study|Adverse Event|11|||
127665553|NCT01349907|459396862|FG000|Overall Study|Treatment failure|13|||
127665554|NCT01349907|459396863|FG001|Overall Study|Treatment failure|4|||
127665555|NCT01349907|459396862|FG000|Overall Study|Lost to Follow-up|25|||
127665556|NCT01349907|459396863|FG001|Overall Study|Lost to Follow-up|6|||
127665557|NCT01349907|459396862|FG000|Overall Study|Withdrawal by Subject|30|||
127665558|NCT01349907|459396863|FG001|Overall Study|Withdrawal by Subject|8|||
127665559|NCT01349907|459396862|FG000|Overall Study|Protocol Violation|33|||
127665560|NCT01349907|459396863|FG001|Overall Study|Protocol Violation|13|||
127665561|NCT01349907|459396862|FG000|Overall Study|Administrative|1|||
127665562|NCT01349907|459396863|FG001|Overall Study|Administrative|1|||
127665563|NCT03583541|459396868|FG000|Overall Study|Lost to Follow-up|31|||
127665564|NCT03583541|459396869|FG001|Overall Study|Lost to Follow-up|65|||
127665565|NCT04102540|459396870|FG000|Overall Study|Withdrawn by PI|2|||
127665566|NCT04102540|459396870|FG000|Overall Study|Lost to Follow-up|6|||
127665567|NCT00280293|459396873|FG000|Overall Study|Protocol Violation|3|||
127665568|NCT00280293|459396874|FG001|Overall Study|Protocol Violation|0|||
127665569|NCT00280293|459396873|FG000|Overall Study|Physician Decision|5|||
127665570|NCT00280293|459396874|FG001|Overall Study|Physician Decision|4|||
127665571|NCT00280293|459396873|FG000|Overall Study|Lost to Follow-up|14|||
127665572|NCT00280293|459396874|FG001|Overall Study|Lost to Follow-up|12|||
127665573|NCT00280293|459396873|FG000|Overall Study|Withdrawal by Subject|3|||
127665574|NCT00280293|459396874|FG001|Overall Study|Withdrawal by Subject|5|||
127665575|NCT00280293|459396873|FG000|Overall Study|Incarceration/Legal Reasons|1|||
127665576|NCT00280293|459396874|FG001|Overall Study|Incarceration/Legal Reasons|1|||
127665577|NCT00280293|459396873|FG000|Overall Study|Adverse Event|0|||
127665578|NCT00280293|459396874|FG001|Overall Study|Adverse Event|1|||
127665579|NCT01458249|459396875|FG000|Overall Study|Not treated|1|||
127665580|NCT01458249|459396875|FG000|Overall Study|Adverse Event|4|||
127665581|NCT01458249|459396875|FG000|Overall Study|Other|2|||
127997245|NCT01210482|460615756|FG000|Overall Study|Protocol Violation|1|||
127665582|NCT01458249|459396875|FG000|Overall Study|Ongoing|1|||
127997246|NCT01210482|460615756|FG000|Overall Study|Case Report Forms were not collected|18|||
127997247|NCT01210482|460615756|FG000|Overall Study|Duplicated|2|||
127997248|NCT01210482|460615756|FG000|Overall Study|No Drug Administration|28|||
127997249|NCT03284853|460615757|FG000|Overall Study|Adverse Event|40|||
127997250|NCT03284853|460615758|FG001|Overall Study|Adverse Event|4|||
127997251|NCT03284853|460615757|FG000|Overall Study|Withdrawal by Subject|5|||
127665583|NCT01348854|459396878|FG000|Overall Study|Lost to Follow-up|2|||
127665584|NCT01348854|459396879|FG001|Overall Study|Lost to Follow-up|1|||
127665585|NCT01348854|459396878|FG000|Overall Study|Withdrawal by Subject|1|||
127665586|NCT01348854|459396879|FG001|Overall Study|Withdrawal by Subject|0|||
127665587|NCT04011384|459396882|FG000|Overall Study|Withdrawal by Subject|2|||
127997252|NCT03284853|460615758|FG001|Overall Study|Withdrawal by Subject|1|||
127665588|NCT04011384|459396883|FG001|Overall Study|Withdrawal by Subject|0|||
127665589|NCT01094171|459396884|FG000|Overall Study|Lost to Follow-up|2|||
127665590|NCT01094171|459396884|FG000|Overall Study|Informed consent withdrawal|4|||
127665591|NCT01094171|459396884|FG000|Overall Study|Migration from the study area|3|||
127997253|NCT03284853|460615757|FG000|Overall Study|Lost to Follow-up|1|||
127997254|NCT03284853|460615758|FG001|Overall Study|Lost to Follow-up|0|||
127997255|NCT03284853|460615757|FG000|Overall Study|Lack of Efficacy|1|||
127997256|NCT03284853|460615758|FG001|Overall Study|Lack of Efficacy|0|||
127997257|NCT03284853|460615757|FG000|Overall Study|Disallowed Concurrent Medication|1|||
127997258|NCT03284853|460615758|FG001|Overall Study|Disallowed Concurrent Medication|1|||
127997259|NCT03284853|460615757|FG000|Overall Study|Protocol Violation|3|||
127997260|NCT03284853|460615758|FG001|Overall Study|Protocol Violation|3|||
127997261|NCT03284853|460615757|FG000|Overall Study|Death|0|||
127997262|NCT03284853|460615758|FG001|Overall Study|Death|1|||
127997263|NCT03284853|460615757|FG000|Overall Study|Other - Reason not reported in CSR|4|||
127997264|NCT03284853|460615758|FG001|Overall Study|Other - Reason not reported in CSR|3|||
127997265|NCT01845597|460617617|FG000|Overall Study|Death|8|||
127997266|NCT01845597|460617617|FG000|Overall Study|Lost to Follow-up|22|||
127997267|NCT02581488|460617620|FG000|Overall Study|Adverse Event|6|||
127997268|NCT02581488|460617621|FG001|Overall Study|Adverse Event|7|||
127997269|NCT02581488|460617620|FG000|Overall Study|Lost to Follow-up|1|||
127997270|NCT02581488|460617621|FG001|Overall Study|Lost to Follow-up|0|||
127997271|NCT02581488|460617620|FG000|Overall Study|Withdrawal by Subject|1|||
127997272|NCT02581488|460617621|FG001|Overall Study|Withdrawal by Subject|0|||
127997273|NCT02581488|460617620|FG000|Overall Study|Non-Compliance|1|||
127997274|NCT02581488|460617621|FG001|Overall Study|Non-Compliance|0|||
127997275|NCT02581488|460617620|FG000|Overall Study|Protocol Violation|0|||
127997276|NCT02581488|460617621|FG001|Overall Study|Protocol Violation|4|||
127997277|NCT01302418|460617622|FG000|Overall Study|Protocol Violation|9|||
127997278|NCT01302418|460617622|FG000|Overall Study|Non-evaluable|9|||
127997279|NCT00377637|460617624|FG000|Induction Phase|Adverse Event|12|||
127997280|NCT00377637|460617625|FG001|Induction Phase|Adverse Event|21|||
127997281|NCT00377637|460617626|FG002|Induction Phase|Adverse Event|0|||
127997282|NCT00377637|460617627|FG003|Induction Phase|Adverse Event|0|||
127997283|NCT00377637|460617624|FG000|Induction Phase|Deterioration/serum creatinine|2|||
127997284|NCT00377637|460617625|FG001|Induction Phase|Deterioration/serum creatinine|0|||
127997285|NCT00377637|460617626|FG002|Induction Phase|Deterioration/serum creatinine|0|||
127997286|NCT00377637|460617627|FG003|Induction Phase|Deterioration/serum creatinine|0|||
127997287|NCT00377637|460617624|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
127997288|NCT00377637|460617625|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
127997289|NCT00377637|460617626|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
127997290|NCT00377637|460617627|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
127997291|NCT00377637|460617624|FG000|Induction Phase|Lost to Follow-up|2|||
127997292|NCT00377637|460617625|FG001|Induction Phase|Lost to Follow-up|1|||
127997293|NCT00377637|460617626|FG002|Induction Phase|Lost to Follow-up|0|||
127997294|NCT00377637|460617627|FG003|Induction Phase|Lost to Follow-up|0|||
127997295|NCT00377637|460617624|FG000|Induction Phase|Death|1|||
127997296|NCT00377637|460617625|FG001|Induction Phase|Death|3|||
127997297|NCT00377637|460617626|FG002|Induction Phase|Death|0|||
127997298|NCT00377637|460617627|FG003|Induction Phase|Death|0|||
127997299|NCT00377637|460617624|FG000|Induction Phase|Withdrawal by Subject|5|||
127997300|NCT00377637|460617625|FG001|Induction Phase|Withdrawal by Subject|6|||
127997301|NCT00377637|460617626|FG002|Induction Phase|Withdrawal by Subject|0|||
127997302|NCT00377637|460617627|FG003|Induction Phase|Withdrawal by Subject|0|||
127997303|NCT00377637|460617624|FG000|Induction Phase|Physician Decision|3|||
127997304|NCT00377637|460617625|FG001|Induction Phase|Physician Decision|1|||
127997305|NCT00377637|460617626|FG002|Induction Phase|Physician Decision|0|||
127997306|NCT00377637|460617627|FG003|Induction Phase|Physician Decision|0|||
127665592|NCT01094171|459396884|FG000|Overall Study|Other|1|||
127665593|NCT01676220|459396885|FG000|Overall Study|Randomized But Not Treated|4|||
127665594|NCT01676220|459396886|FG001|Overall Study|Randomized But Not Treated|1|||
127665595|NCT01676220|459396885|FG000|Overall Study|Adverse Event|10|||
127665596|NCT01676220|459396886|FG001|Overall Study|Adverse Event|8|||
127665597|NCT01676220|459396885|FG000|Overall Study|Lack of Efficacy|2|||
127665598|NCT01676220|459396886|FG001|Overall Study|Lack of Efficacy|5|||
127665599|NCT01676220|459396885|FG000|Overall Study|Protocol Violation|11|||
127997307|NCT00377637|460617624|FG000|Induction Phase|Sponsor decision|1|||
127997308|NCT00377637|460617625|FG001|Induction Phase|Sponsor decision|2|||
127997309|NCT00377637|460617626|FG002|Induction Phase|Sponsor decision|0|||
127997310|NCT00377637|460617627|FG003|Induction Phase|Sponsor decision|0|||
127997311|NCT00377637|460617624|FG000|Induction Phase|Non-Compliance|1|||
127997312|NCT00377637|460617625|FG001|Induction Phase|Non-Compliance|0|||
127997313|NCT00377637|460617626|FG002|Induction Phase|Non-Compliance|0|||
127997314|NCT00377637|460617627|FG003|Induction Phase|Non-Compliance|0|||
127997315|NCT00377637|460617624|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
127665600|NCT01676220|459396886|FG001|Overall Study|Protocol Violation|12|||
127665601|NCT01676220|459396885|FG000|Overall Study|Received Rescue Therapy|14|||
127665602|NCT01676220|459396886|FG001|Overall Study|Received Rescue Therapy|22|||
127997316|NCT00377637|460617625|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
127997317|NCT00377637|460617626|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
127997318|NCT00377637|460617627|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
127997319|NCT00377637|460617624|FG000|Maintenance Phase|Adverse Event|0|||
127997320|NCT00377637|460617625|FG001|Maintenance Phase|Adverse Event|0|||
127997321|NCT00377637|460617626|FG002|Maintenance Phase|Adverse Event|29|||
127997322|NCT00377637|460617627|FG003|Maintenance Phase|Adverse Event|43|||
127997323|NCT00377637|460617624|FG000|Maintenance Phase|Physician Decision|0|||
127997324|NCT00377637|460617625|FG001|Maintenance Phase|Physician Decision|0|||
127997325|NCT00377637|460617626|FG002|Maintenance Phase|Physician Decision|5|||
127997326|NCT00377637|460617627|FG003|Maintenance Phase|Physician Decision|4|||
127997327|NCT00377637|460617624|FG000|Maintenance Phase|Lost to Follow-up|0|||
127997328|NCT00377637|460617625|FG001|Maintenance Phase|Lost to Follow-up|0|||
127997329|NCT00377637|460617626|FG002|Maintenance Phase|Lost to Follow-up|3|||
127997330|NCT00377637|460617627|FG003|Maintenance Phase|Lost to Follow-up|1|||
127997331|NCT00377637|460617624|FG000|Maintenance Phase|Withdrawal by Subject|0|||
127997332|NCT00377637|460617625|FG001|Maintenance Phase|Withdrawal by Subject|0|||
127997333|NCT00377637|460617626|FG002|Maintenance Phase|Withdrawal by Subject|3|||
127997334|NCT00377637|460617627|FG003|Maintenance Phase|Withdrawal by Subject|3|||
127997335|NCT00377637|460617624|FG000|Maintenance Phase|Sponsor decision|0|||
127997336|NCT00377637|460617625|FG001|Maintenance Phase|Sponsor decision|0|||
127997337|NCT00377637|460617626|FG002|Maintenance Phase|Sponsor decision|2|||
127997338|NCT00377637|460617627|FG003|Maintenance Phase|Sponsor decision|3|||
127997339|NCT00377637|460617624|FG000|Maintenance Phase|Non-compliance|0|||
127997340|NCT00377637|460617625|FG001|Maintenance Phase|Non-compliance|0|||
127997341|NCT00377637|460617626|FG002|Maintenance Phase|Non-compliance|1|||
127997342|NCT00377637|460617627|FG003|Maintenance Phase|Non-compliance|1|||
127997343|NCT00377637|460617624|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
127997344|NCT00377637|460617625|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
127997345|NCT00377637|460617626|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
127997346|NCT00377637|460617627|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
127997347|NCT00377637|460617624|FG000|Maintenance Phase|Death|0|||
127997348|NCT00377637|460617625|FG001|Maintenance Phase|Death|0|||
127997349|NCT00377637|460617626|FG002|Maintenance Phase|Death|0|||
127997350|NCT00377637|460617627|FG003|Maintenance Phase|Death|1|||
127997351|NCT01254656|460617628|FG000|Overall Study|Discontinued due to termination of study|40|||
127997352|NCT01254656|460617629|FG001|Overall Study|Discontinued due to termination of study|39|||
127997353|NCT01254656|460617630|FG002|Overall Study|Discontinued due to termination of study|13|||
127997354|NCT01254656|460617628|FG000|Overall Study|Lack of Efficacy|3|||
127997355|NCT01254656|460617629|FG001|Overall Study|Lack of Efficacy|0|||
127997356|NCT01254656|460617630|FG002|Overall Study|Lack of Efficacy|0|||
127997357|NCT01254656|460617628|FG000|Overall Study|Lost to Follow-up|1|||
127997358|NCT01254656|460617629|FG001|Overall Study|Lost to Follow-up|0|||
127665603|NCT01676220|459396885|FG000|Overall Study|Personal Reason|34|||
127665604|NCT01676220|459396886|FG001|Overall Study|Personal Reason|45|||
127665605|NCT01676220|459396885|FG000|Overall Study|Lost to Follow-up|11|||
127665606|NCT01676220|459396886|FG001|Overall Study|Lost to Follow-up|18|||
127665607|NCT01676220|459396885|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
127665608|NCT01676220|459396886|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
127665609|NCT01676220|459396885|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
127665610|NCT01676220|459396886|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
127665611|NCT01676220|459396885|FG000|Overall Study|Perceived Lack of Efficacy|3|||
127665612|NCT01676220|459396886|FG001|Overall Study|Perceived Lack of Efficacy|1|||
127665613|NCT01676220|459396885|FG000|Overall Study|Non Serious Hypoglycemia|2|||
127665614|NCT01676220|459396886|FG001|Overall Study|Non Serious Hypoglycemia|0|||
127665615|NCT01676220|459396885|FG000|Overall Study|No More Need of Insulin|1|||
127665616|NCT01676220|459396886|FG001|Overall Study|No More Need of Insulin|0|||
127665617|NCT02269943|459396887|FG000|Treatment Period|Death|0|||
127665618|NCT02269943|459396888|FG001|Treatment Period|Death|1|||
127665619|NCT02269943|459396887|FG000|Treatment Period|Adverse Event|1|||
127665620|NCT02269943|459396888|FG001|Treatment Period|Adverse Event|10|||
127665621|NCT02269943|459396887|FG000|Treatment Period|Progressive Disease|5|||
127665622|NCT02269943|459396888|FG001|Treatment Period|Progressive Disease|17|||
127665623|NCT02269943|459396887|FG000|Treatment Period|Symptomatic Deterioration|0|||
127665624|NCT02269943|459396888|FG001|Treatment Period|Symptomatic Deterioration|2|||
127997359|NCT01254656|460617630|FG002|Overall Study|Lost to Follow-up|2|||
127997360|NCT01254656|460617628|FG000|Overall Study|Withdrawal by Subject|2|||
127997361|NCT01254656|460617629|FG001|Overall Study|Withdrawal by Subject|2|||
127997362|NCT01254656|460617630|FG002|Overall Study|Withdrawal by Subject|1|||
127997363|NCT01254656|460617628|FG000|Overall Study|Pregnancy|0|||
127997364|NCT01254656|460617629|FG001|Overall Study|Pregnancy|0|||
127997365|NCT01254656|460617630|FG002|Overall Study|Pregnancy|2|||
127665625|NCT02269943|459396887|FG000|Follow-Up Survival Period|Death|3|||
127665626|NCT02269943|459396888|FG001|Follow-Up Survival Period|Death|16|||
127665627|NCT02269943|459396887|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
127665628|NCT02269943|459396888|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
127997366|NCT01254656|460617628|FG000|Overall Study|Adverse Event|1|||
127997367|NCT01254656|460617629|FG001|Overall Study|Adverse Event|1|||
127997368|NCT01254656|460617630|FG002|Overall Study|Adverse Event|0|||
127997369|NCT01254656|460617628|FG000|Overall Study|Death|0|||
127997370|NCT01254656|460617629|FG001|Overall Study|Death|1|||
127997371|NCT01254656|460617630|FG002|Overall Study|Death|0|||
127997372|NCT02532374|460617659|FG000|Overall Study|Withdrawal by Subject|1|||
127997373|NCT02532374|460617659|FG000|Overall Study|Physician Decision|1|||
127997374|NCT03286218|460617660|FG000|Qualification Phase Period 1|Adverse Event|1|||
127997375|NCT03286218|460617661|FG001|Qualification Phase Period 1|Adverse Event|0|||
127997376|NCT03286218|460617662|FG002|Qualification Phase Period 1|Adverse Event|0|||
127997377|NCT03286218|460617663|FG003|Qualification Phase Period 1|Adverse Event|0|||
127997378|NCT03286218|460617664|FG004|Qualification Phase Period 1|Adverse Event|0|||
127997379|NCT03286218|460617665|FG005|Qualification Phase Period 1|Adverse Event|0|||
127997380|NCT03286218|460617666|FG006|Qualification Phase Period 1|Adverse Event|0|||
127997381|NCT03286218|460617667|FG007|Qualification Phase Period 1|Adverse Event|0|||
127997382|NCT03286218|460617668|FG008|Qualification Phase Period 1|Adverse Event|0|||
127665629|NCT02269943|459396887|FG000|Follow-Up Survival Period|Alive|2|||
127665630|NCT02269943|459396888|FG001|Follow-Up Survival Period|Alive|8|||
127665631|NCT02213055|459396889|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
127665632|NCT02213055|459396890|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
127665633|NCT02213055|459396889|FG000|Overall Study|Protocol was not Followed during Study|1|||
127665634|NCT02213055|459396890|FG001|Overall Study|Protocol was not Followed during Study|0|||
127665635|NCT02213055|459396889|FG000|Overall Study|Documentation Issue at Enrollment|1|||
127665636|NCT02213055|459396890|FG001|Overall Study|Documentation Issue at Enrollment|0|||
127665637|NCT02213055|459396889|FG000|Overall Study|Documentation Issue during Study|10|||
127665638|NCT02213055|459396890|FG001|Overall Study|Documentation Issue during Study|0|||
127665639|NCT02213055|459396889|FG000|Overall Study|Did not have Live Lice|8|||
127997383|NCT03286218|460617669|FG009|Qualification Phase Period 1|Adverse Event|0|||
127997384|NCT03286218|460617670|FG010|Qualification Phase Period 1|Adverse Event|0|||
127997385|NCT03286218|460617671|FG011|Qualification Phase Period 1|Adverse Event|0|||
127997386|NCT03286218|460617660|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
127997387|NCT03286218|460617661|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
127997388|NCT03286218|460617662|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
127997389|NCT03286218|460617663|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
127997390|NCT03286218|460617664|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
127997391|NCT03286218|460617665|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
127997392|NCT03286218|460617666|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
127997393|NCT03286218|460617667|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
127997394|NCT03286218|460617668|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
127997395|NCT03286218|460617669|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
127997396|NCT03286218|460617670|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
127997397|NCT03286218|460617671|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
127997398|NCT03286218|460617660|FG000|Qualification Phase Period 2|Adverse Event|0|||
127997399|NCT03286218|460617661|FG001|Qualification Phase Period 2|Adverse Event|1|||
127997400|NCT03286218|460617662|FG002|Qualification Phase Period 2|Adverse Event|0|||
127997401|NCT03286218|460617663|FG003|Qualification Phase Period 2|Adverse Event|0|||
127997402|NCT03286218|460617664|FG004|Qualification Phase Period 2|Adverse Event|0|||
127997403|NCT03286218|460617665|FG005|Qualification Phase Period 2|Adverse Event|0|||
127997404|NCT03286218|460617666|FG006|Qualification Phase Period 2|Adverse Event|0|||
127997405|NCT03286218|460617667|FG007|Qualification Phase Period 2|Adverse Event|0|||
127997406|NCT03286218|460617668|FG008|Qualification Phase Period 2|Adverse Event|0|||
127997407|NCT03286218|460617669|FG009|Qualification Phase Period 2|Adverse Event|0|||
127997408|NCT03286218|460617670|FG010|Qualification Phase Period 2|Adverse Event|0|||
127997409|NCT03286218|460617671|FG011|Qualification Phase Period 2|Adverse Event|0|||
127997410|NCT03286218|460617660|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
127997411|NCT03286218|460617661|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
127997412|NCT03286218|460617662|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
127997413|NCT03286218|460617663|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
127997414|NCT03286218|460617664|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
127997415|NCT03286218|460617665|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
127665640|NCT02213055|459396890|FG001|Overall Study|Did not have Live Lice|0|||
127665641|NCT02213055|459396889|FG000|Overall Study|Had another Treatment during the Study|3|||
127997416|NCT03286218|460617666|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
127997417|NCT03286218|460617667|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
127997418|NCT03286218|460617668|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
127997419|NCT03286218|460617669|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
127665642|NCT02213055|459396890|FG001|Overall Study|Had another Treatment during the Study|0|||
127997420|NCT03286218|460617670|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
127997421|NCT03286218|460617671|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
127997422|NCT03286218|460617660|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
127997423|NCT03286218|460617661|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
127997424|NCT03286218|460617662|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
127997425|NCT03286218|460617663|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
127997426|NCT03286218|460617664|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
127997427|NCT03286218|460617665|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
127997428|NCT03286218|460617666|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
127997429|NCT03286218|460617667|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
127997430|NCT03286218|460617668|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
127997431|NCT03286218|460617669|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
127997432|NCT03286218|460617670|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
127997433|NCT03286218|460617671|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
127997434|NCT03286218|460617660|FG000|Qualification Phase Period 2|Protocol Violation|2|||
127997435|NCT03286218|460617661|FG001|Qualification Phase Period 2|Protocol Violation|0|||
127997436|NCT03286218|460617662|FG002|Qualification Phase Period 2|Protocol Violation|0|||
127997437|NCT03286218|460617663|FG003|Qualification Phase Period 2|Protocol Violation|0|||
127997438|NCT03286218|460617664|FG004|Qualification Phase Period 2|Protocol Violation|0|||
127997439|NCT03286218|460617665|FG005|Qualification Phase Period 2|Protocol Violation|0|||
127997440|NCT03286218|460617666|FG006|Qualification Phase Period 2|Protocol Violation|0|||
127997441|NCT03286218|460617667|FG007|Qualification Phase Period 2|Protocol Violation|0|||
127997442|NCT03286218|460617668|FG008|Qualification Phase Period 2|Protocol Violation|0|||
127997443|NCT03286218|460617669|FG009|Qualification Phase Period 2|Protocol Violation|0|||
127997444|NCT03286218|460617670|FG010|Qualification Phase Period 2|Protocol Violation|0|||
127997445|NCT03286218|460617671|FG011|Qualification Phase Period 2|Protocol Violation|0|||
127997446|NCT03286218|460617660|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
127997447|NCT03286218|460617661|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
127997448|NCT03286218|460617662|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
127997449|NCT03286218|460617663|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
127997450|NCT03286218|460617664|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
127997451|NCT03286218|460617665|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
127997452|NCT03286218|460617666|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
127997453|NCT03286218|460617667|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
127997454|NCT03286218|460617668|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
127997455|NCT03286218|460617669|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
127997456|NCT03286218|460617670|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
127997457|NCT03286218|460617671|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
127997458|NCT03286218|460617660|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
127997459|NCT03286218|460617661|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
127997460|NCT03286218|460617662|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
127997461|NCT03286218|460617663|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
127997462|NCT03286218|460617664|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
127997463|NCT03286218|460617665|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
127997464|NCT03286218|460617666|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
127997465|NCT03286218|460617667|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
127997466|NCT03286218|460617668|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
127997467|NCT03286218|460617669|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
127997468|NCT03286218|460617670|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
127997469|NCT03286218|460617671|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
127997470|NCT03286218|460617660|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
127997471|NCT03286218|460617661|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
127997472|NCT03286218|460617662|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
127997473|NCT03286218|460617663|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
127997474|NCT03286218|460617664|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
127997475|NCT03286218|460617665|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
127997476|NCT03286218|460617666|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
127997477|NCT03286218|460617667|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
127997478|NCT03286218|460617668|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
127997479|NCT03286218|460617669|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
127997480|NCT03286218|460617670|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
127997481|NCT03286218|460617671|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
127997482|NCT02762084|460617674|FG000|Overall Study|Withdrawal by Subject|1|||
127997483|NCT02762084|460617675|FG001|Overall Study|Withdrawal by Subject|0|||
127997484|NCT02762084|460617676|FG002|Overall Study|Withdrawal by Subject|0|||
127997485|NCT02762084|460617674|FG000|Overall Study|Adverse Event|0|||
127997486|NCT02762084|460617675|FG001|Overall Study|Adverse Event|0|||
127997487|NCT02762084|460617676|FG002|Overall Study|Adverse Event|1|||
127997488|NCT01348139|460617679|FG000|Period 1|Adverse Event|1|||
127997489|NCT01348139|460617680|FG001|Period 1|Adverse Event|0|||
127997490|NCT01348139|460617681|FG002|Period 1|Adverse Event|0|||
127997491|NCT01348139|460617682|FG003|Period 1|Adverse Event|0|||
127997492|NCT01348139|460617683|FG004|Period 1|Adverse Event|0|||
127997493|NCT01348139|460617684|FG005|Period 1|Adverse Event|0|||
127997494|NCT01781962|460617689|FG000|Overall Study|Other Miscellaneous Reasons|5|||
127997495|NCT03257436|460617690|FG000|Overall Study|Withdrawal by Subject|76|||
127997496|NCT03257436|460617690|FG000|Overall Study|Death|19|||
127997497|NCT01619852|460617691|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
127997498|NCT01619852|460617692|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
127997499|NCT01619852|460617691|FG000|3 Month Follow up|Lost to Follow-up|31|||
127997500|NCT01619852|460617692|FG001|3 Month Follow up|Lost to Follow-up|34|||
127997501|NCT03428100|460617693|FG000|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
127997502|NCT03428100|460617694|FG001|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
127997503|NCT03428100|460617695|FG002|Double-Blind Treatment Week 0 to Week 52|Adverse Event|3|||
127997504|NCT03428100|460617696|FG003|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
127997505|NCT03428100|460617697|FG004|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
127997506|NCT03428100|460617698|FG005|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
127997507|NCT03428100|460617699|FG006|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
127997508|NCT03428100|460617700|FG007|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
127997509|NCT03428100|460617701|FG008|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
127997510|NCT03428100|460617702|FG009|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
127997511|NCT03428100|460617703|FG010|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
127997512|NCT03428100|460617704|FG011|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
127997513|NCT03428100|460617705|FG012|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
127997514|NCT03428100|460617706|FG013|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
127997515|NCT03428100|460617707|FG014|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
127997516|NCT03428100|460617708|FG015|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
127997517|NCT03428100|460617709|FG016|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
127997518|NCT03428100|460617710|FG017|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
127997519|NCT03428100|460617711|FG018|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
127997520|NCT03428100|460617693|FG000|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|16|||
127997521|NCT03428100|460617694|FG001|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|10|||
127997522|NCT03428100|460617695|FG002|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|7|||
127997523|NCT03428100|460617696|FG003|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|6|||
127997524|NCT03428100|460617697|FG004|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
127997525|NCT03428100|460617698|FG005|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
127997526|NCT03428100|460617699|FG006|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
127997527|NCT03428100|460617700|FG007|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
127997528|NCT03428100|460617701|FG008|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
127997529|NCT03428100|460617702|FG009|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
127997530|NCT03428100|460617703|FG010|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
127997531|NCT03428100|460617704|FG011|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
127997532|NCT03428100|460617705|FG012|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
127997533|NCT03428100|460617706|FG013|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
127997534|NCT03428100|460617707|FG014|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
127997535|NCT03428100|460617708|FG015|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
127997536|NCT03428100|460617709|FG016|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
127997537|NCT03428100|460617710|FG017|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
127997538|NCT03428100|460617711|FG018|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
127997539|NCT03428100|460617693|FG000|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
127997540|NCT03428100|460617694|FG001|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
127997541|NCT03428100|460617695|FG002|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
127997542|NCT03428100|460617696|FG003|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
127997543|NCT03428100|460617697|FG004|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
127997544|NCT03428100|460617698|FG005|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
127997545|NCT03428100|460617699|FG006|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
127997546|NCT03428100|460617700|FG007|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
127997547|NCT03428100|460617701|FG008|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
127997548|NCT03428100|460617702|FG009|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
127997549|NCT03428100|460617703|FG010|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
127997550|NCT03428100|460617704|FG011|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
127997551|NCT03428100|460617705|FG012|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
127997552|NCT03428100|460617706|FG013|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
127997553|NCT03428100|460617707|FG014|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
127997554|NCT03428100|460617708|FG015|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
127997555|NCT03428100|460617709|FG016|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
127665643|NCT02213055|459396889|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
127665644|NCT02213055|459396890|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
127665645|NCT02213055|459396889|FG000|Overall Study|Did not Return to School|5|||
127665646|NCT02213055|459396890|FG001|Overall Study|Did not Return to School|0|||
127665647|NCT00231894|459396891|FG000|Overall Study|Withdrawal by Subject|1|||
127665648|NCT00231894|459396892|FG001|Overall Study|Withdrawal by Subject|1|||
127665649|NCT02025205|459396893|FG000|Overall Study|Withdrawal by Subject|1|||
127997556|NCT03428100|460617710|FG017|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
127997557|NCT03428100|460617711|FG018|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
127997558|NCT03428100|460617693|FG000|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|4|||
127997559|NCT03428100|460617694|FG001|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
127665650|NCT02025205|459396894|FG001|Overall Study|Withdrawal by Subject|1|||
127665651|NCT02025205|459396893|FG000|Overall Study|Protocol Violation|2|||
127665652|NCT02025205|459396894|FG001|Overall Study|Protocol Violation|1|||
127665653|NCT02025205|459396893|FG000|Overall Study|Death|0|||
127665654|NCT02025205|459396894|FG001|Overall Study|Death|1|||
127665655|NCT01767129|459396895|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
127665656|NCT01767129|459396896|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
127665657|NCT03389893|459396897|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
127665658|NCT03389893|459396898|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
127665659|NCT03389893|459396899|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
127665660|NCT03389893|459396900|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
127665661|NCT03389893|459396897|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
127665662|NCT03389893|459396898|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
127665663|NCT03389893|459396899|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
127665664|NCT03389893|459396900|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
127665665|NCT03389893|459396897|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
127665666|NCT03389893|459396898|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
127665667|NCT03389893|459396899|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
127665668|NCT03389893|459396900|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
127665669|NCT03389893|459396897|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
127665670|NCT03389893|459396898|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
127665671|NCT03389893|459396899|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
127665672|NCT03389893|459396900|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
127665673|NCT01232556|459396904|FG000|Overall Study|Withdrawal by Subject|21|||
127665674|NCT01232556|459396905|FG001|Overall Study|Withdrawal by Subject|17|||
127665675|NCT01232556|459396904|FG000|Overall Study|Death|97|||
127665676|NCT01232556|459396905|FG001|Overall Study|Death|97|||
127665677|NCT01232556|459396904|FG000|Overall Study|Lost to Follow-up|0|||
127665678|NCT01232556|459396905|FG001|Overall Study|Lost to Follow-up|2|||
127665679|NCT01232556|459396904|FG000|Overall Study|Terminated by Sponsor|35|||
127665680|NCT01232556|459396905|FG001|Overall Study|Terminated by Sponsor|51|||
127997560|NCT03428100|460617695|FG002|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
127997561|NCT03428100|460617696|FG003|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
127997562|NCT03428100|460617697|FG004|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
127997563|NCT03428100|460617698|FG005|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
127997564|NCT03428100|460617699|FG006|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
127997565|NCT03428100|460617700|FG007|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
127997566|NCT03428100|460617701|FG008|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
127997567|NCT03428100|460617702|FG009|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
127997568|NCT03428100|460617703|FG010|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
127997569|NCT03428100|460617704|FG011|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
127997570|NCT03428100|460617705|FG012|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
127997571|NCT03428100|460617706|FG013|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
127997572|NCT03428100|460617707|FG014|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
127997573|NCT03428100|460617708|FG015|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
127997574|NCT03428100|460617709|FG016|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
127997575|NCT03428100|460617710|FG017|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
127997576|NCT03428100|460617711|FG018|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
127997577|NCT03428100|460617693|FG000|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
127665681|NCT01232556|459396904|FG000|Overall Study|Other|6|||
127665682|NCT01232556|459396905|FG001|Overall Study|Other|4|||
127665683|NCT02448719|459396906|FG000|Overall Study|Withdrawal by Subject|0|||
127665684|NCT02448719|459396907|FG001|Overall Study|Withdrawal by Subject|0|||
127665685|NCT02448719|459396908|FG002|Overall Study|Withdrawal by Subject|0|||
127665686|NCT02448719|459396909|FG003|Overall Study|Withdrawal by Subject|0|||
127665687|NCT02448719|459396910|FG004|Overall Study|Withdrawal by Subject|1|||
127665688|NCT02448719|459396911|FG005|Overall Study|Withdrawal by Subject|0|||
127997578|NCT03428100|460617694|FG001|Double-Blind Treatment Week 0 to Week 52|Physician Decision|1|||
127997579|NCT03428100|460617695|FG002|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
127997580|NCT03428100|460617696|FG003|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
127997581|NCT03428100|460617697|FG004|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
127997582|NCT03428100|460617698|FG005|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
127997583|NCT03428100|460617699|FG006|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
127997584|NCT03428100|460617700|FG007|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
127997585|NCT03428100|460617701|FG008|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
127997586|NCT03428100|460617702|FG009|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
127997587|NCT03428100|460617703|FG010|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
127997588|NCT03428100|460617704|FG011|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
127997589|NCT03428100|460617705|FG012|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
127997590|NCT03428100|460617706|FG013|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
127997591|NCT03428100|460617707|FG014|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
127997592|NCT03428100|460617708|FG015|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
127997593|NCT03428100|460617709|FG016|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
127997594|NCT03428100|460617710|FG017|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
127997595|NCT03428100|460617711|FG018|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
127997596|NCT03428100|460617693|FG000|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
127997597|NCT03428100|460617694|FG001|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
127997598|NCT03428100|460617695|FG002|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
127997599|NCT03428100|460617696|FG003|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
127997600|NCT03428100|460617697|FG004|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
127997601|NCT03428100|460617698|FG005|Long-Term Extension Week 52 to Week 200|Adverse Event|4|||
127997602|NCT03428100|460617699|FG006|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
127997603|NCT03428100|460617700|FG007|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
127997604|NCT03428100|460617701|FG008|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
127997605|NCT03428100|460617702|FG009|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
127997606|NCT03428100|460617703|FG010|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
127997607|NCT03428100|460617704|FG011|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
127997608|NCT03428100|460617705|FG012|Long-Term Extension Week 52 to Week 200|Adverse Event|3|||
127997609|NCT03428100|460617706|FG013|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
127997610|NCT03428100|460617707|FG014|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
127997611|NCT03428100|460617708|FG015|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
127997612|NCT03428100|460617709|FG016|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
127997613|NCT03428100|460617710|FG017|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
127997614|NCT03428100|460617711|FG018|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
127997615|NCT03428100|460617693|FG000|Long-Term Extension Week 52 to Week 200|Death|0|||
127997616|NCT03428100|460617694|FG001|Long-Term Extension Week 52 to Week 200|Death|0|||
127997617|NCT03428100|460617695|FG002|Long-Term Extension Week 52 to Week 200|Death|0|||
127997618|NCT03428100|460617696|FG003|Long-Term Extension Week 52 to Week 200|Death|0|||
127997619|NCT03428100|460617697|FG004|Long-Term Extension Week 52 to Week 200|Death|0|||
127997620|NCT03428100|460617698|FG005|Long-Term Extension Week 52 to Week 200|Death|0|||
127997621|NCT03428100|460617699|FG006|Long-Term Extension Week 52 to Week 200|Death|0|||
127997622|NCT03428100|460617700|FG007|Long-Term Extension Week 52 to Week 200|Death|1|||
127997623|NCT03428100|460617701|FG008|Long-Term Extension Week 52 to Week 200|Death|0|||
127997624|NCT03428100|460617702|FG009|Long-Term Extension Week 52 to Week 200|Death|0|||
127997625|NCT03428100|460617703|FG010|Long-Term Extension Week 52 to Week 200|Death|0|||
127997626|NCT03428100|460617704|FG011|Long-Term Extension Week 52 to Week 200|Death|0|||
127997627|NCT03428100|460617705|FG012|Long-Term Extension Week 52 to Week 200|Death|0|||
127997628|NCT03428100|460617706|FG013|Long-Term Extension Week 52 to Week 200|Death|0|||
127997629|NCT03428100|460617707|FG014|Long-Term Extension Week 52 to Week 200|Death|0|||
127997630|NCT03428100|460617708|FG015|Long-Term Extension Week 52 to Week 200|Death|0|||
127997631|NCT03428100|460617709|FG016|Long-Term Extension Week 52 to Week 200|Death|0|||
127997632|NCT03428100|460617710|FG017|Long-Term Extension Week 52 to Week 200|Death|0|||
127997633|NCT03428100|460617711|FG018|Long-Term Extension Week 52 to Week 200|Death|0|||
127997634|NCT03428100|460617693|FG000|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
127997635|NCT03428100|460617694|FG001|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
127997636|NCT03428100|460617695|FG002|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
127997637|NCT03428100|460617696|FG003|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
127997638|NCT03428100|460617697|FG004|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
127997639|NCT03428100|460617698|FG005|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
127997640|NCT03428100|460617699|FG006|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
127665689|NCT02448719|459396912|FG006|Overall Study|Withdrawal by Subject|0|||
127997641|NCT03428100|460617700|FG007|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
127665690|NCT02448719|459396913|FG007|Overall Study|Withdrawal by Subject|0|||
127997642|NCT03428100|460617701|FG008|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
127997643|NCT03428100|460617702|FG009|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
127997644|NCT03428100|460617703|FG010|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
127997645|NCT03428100|460617704|FG011|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
127997646|NCT03428100|460617705|FG012|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
127997647|NCT03428100|460617706|FG013|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
127997648|NCT03428100|460617707|FG014|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|6|||
127997649|NCT03428100|460617708|FG015|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
127997650|NCT03428100|460617709|FG016|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
127997651|NCT03428100|460617710|FG017|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
127997652|NCT03428100|460617711|FG018|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|1|||
127997653|NCT03428100|460617693|FG000|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
127997654|NCT03428100|460617694|FG001|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
127997655|NCT03428100|460617695|FG002|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
127997656|NCT03428100|460617696|FG003|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
127997657|NCT03428100|460617697|FG004|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
127997658|NCT03428100|460617698|FG005|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
127997659|NCT03428100|460617699|FG006|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
127997660|NCT03428100|460617700|FG007|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
127997661|NCT03428100|460617701|FG008|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
127997662|NCT03428100|460617702|FG009|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
127997663|NCT03428100|460617703|FG010|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
127997664|NCT03428100|460617704|FG011|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
127997665|NCT03428100|460617705|FG012|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
127997666|NCT03428100|460617706|FG013|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
127997667|NCT03428100|460617707|FG014|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
127997668|NCT03428100|460617708|FG015|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
127997669|NCT03428100|460617709|FG016|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
127997670|NCT03428100|460617710|FG017|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
127997671|NCT03428100|460617711|FG018|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
127997672|NCT03428100|460617693|FG000|Long-Term Extension Week 52 to Week 200|Other|0|||
127997673|NCT03428100|460617694|FG001|Long-Term Extension Week 52 to Week 200|Other|0|||
127997674|NCT03428100|460617695|FG002|Long-Term Extension Week 52 to Week 200|Other|0|||
127997675|NCT03428100|460617696|FG003|Long-Term Extension Week 52 to Week 200|Other|0|||
127997676|NCT03428100|460617697|FG004|Long-Term Extension Week 52 to Week 200|Other|0|||
127997677|NCT03428100|460617698|FG005|Long-Term Extension Week 52 to Week 200|Other|0|||
127997678|NCT03428100|460617699|FG006|Long-Term Extension Week 52 to Week 200|Other|2|||
127997679|NCT03428100|460617700|FG007|Long-Term Extension Week 52 to Week 200|Other|0|||
127997680|NCT03428100|460617701|FG008|Long-Term Extension Week 52 to Week 200|Other|0|||
127997681|NCT03428100|460617702|FG009|Long-Term Extension Week 52 to Week 200|Other|0|||
127997682|NCT03428100|460617703|FG010|Long-Term Extension Week 52 to Week 200|Other|0|||
127997683|NCT03428100|460617704|FG011|Long-Term Extension Week 52 to Week 200|Other|1|||
127997684|NCT03428100|460617705|FG012|Long-Term Extension Week 52 to Week 200|Other|0|||
127997685|NCT03428100|460617706|FG013|Long-Term Extension Week 52 to Week 200|Other|0|||
127997686|NCT03428100|460617707|FG014|Long-Term Extension Week 52 to Week 200|Other|0|||
127997687|NCT03428100|460617708|FG015|Long-Term Extension Week 52 to Week 200|Other|0|||
127997688|NCT03428100|460617709|FG016|Long-Term Extension Week 52 to Week 200|Other|0|||
127997689|NCT03428100|460617710|FG017|Long-Term Extension Week 52 to Week 200|Other|2|||
127997690|NCT03428100|460617711|FG018|Long-Term Extension Week 52 to Week 200|Other|1|||
127997691|NCT03428100|460617693|FG000|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
127997692|NCT03428100|460617694|FG001|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
127997693|NCT03428100|460617695|FG002|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
127997694|NCT03428100|460617696|FG003|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
127997695|NCT03428100|460617697|FG004|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
127997696|NCT03428100|460617698|FG005|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
127997697|NCT03428100|460617699|FG006|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
127997698|NCT03428100|460617700|FG007|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
127997699|NCT03428100|460617701|FG008|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
127997700|NCT03428100|460617702|FG009|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
127997701|NCT03428100|460617703|FG010|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
127997702|NCT03428100|460617704|FG011|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
127997703|NCT03428100|460617705|FG012|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
127997704|NCT03428100|460617706|FG013|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
127997705|NCT03428100|460617707|FG014|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
127997706|NCT03428100|460617708|FG015|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
127997707|NCT03428100|460617709|FG016|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
127997708|NCT03428100|460617710|FG017|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
127997709|NCT03428100|460617711|FG018|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
127997710|NCT03428100|460617693|FG000|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
127997711|NCT03428100|460617694|FG001|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
127997712|NCT03428100|460617695|FG002|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
127997713|NCT03428100|460617696|FG003|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
127997714|NCT03428100|460617697|FG004|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|10|||
127997715|NCT03428100|460617698|FG005|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|4|||
127997716|NCT03428100|460617699|FG006|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
127665691|NCT02448719|459396914|FG008|Overall Study|Withdrawal by Subject|0|||
127665692|NCT02448719|459396915|FG009|Overall Study|Withdrawal by Subject|0|||
127665693|NCT02448719|459396916|FG010|Overall Study|Withdrawal by Subject|0|||
127665694|NCT01024751|459396917|FG000|Enrolled Participants|Ineligible at baseline|3|||
127665695|NCT01024751|459396918|FG001|Enrolled Participants|Ineligible at baseline|4|||
127665696|NCT01024751|459396917|FG000|Eligible Participants|Withdrawal by Subject|0|||
127665697|NCT01024751|459396918|FG001|Eligible Participants|Withdrawal by Subject|1|||
127665698|NCT01024751|459396917|FG000|Eligible Participants|Lost to Follow-up|0|||
127665699|NCT01024751|459396918|FG001|Eligible Participants|Lost to Follow-up|1|||
127665700|NCT01024751|459396917|FG000|Eligible Participants|Ineligible|0|||
127665701|NCT01024751|459396918|FG001|Eligible Participants|Ineligible|1|||
127665702|NCT02040090|459396920|FG000|Overall Study|Adverse Event|2|||
127665703|NCT02040090|459396921|FG001|Overall Study|Adverse Event|0|||
127665704|NCT02040090|459396920|FG000|Overall Study|Physician Decision|1|||
127665705|NCT02040090|459396921|FG001|Overall Study|Physician Decision|0|||
127665706|NCT02040090|459396920|FG000|Overall Study|Withdrawal by Subject|0|||
127665707|NCT02040090|459396921|FG001|Overall Study|Withdrawal by Subject|1|||
127665708|NCT02040090|459396920|FG000|Overall Study|Lost to Follow-up|0|||
127665709|NCT02040090|459396921|FG001|Overall Study|Lost to Follow-up|1|||
127665710|NCT00895843|459396922|FG000|Overall Study|Protocol Violation|12|||
127665711|NCT00895843|459396923|FG001|Overall Study|Protocol Violation|12|||
127665712|NCT04963062|459396931|FG000|Overall Study|withdrew by the study team|4|||
127665713|NCT04963062|459396932|FG001|Overall Study|withdrew by the study team|2|||
127665714|NCT03873246|459396933|FG000|Overall Study|Adverse Event|1|||
127665715|NCT03873246|459396934|FG001|Overall Study|Adverse Event|3|||
127665716|NCT03873246|459396935|FG002|Overall Study|Adverse Event|3|||
127665717|NCT03873246|459396933|FG000|Overall Study|Lost to Follow-up|4|||
127665718|NCT03873246|459396934|FG001|Overall Study|Lost to Follow-up|4|||
127665719|NCT03873246|459396935|FG002|Overall Study|Lost to Follow-up|5|||
127665720|NCT03873246|459396933|FG000|Overall Study|Protocol Violation|0|||
127665721|NCT03873246|459396934|FG001|Overall Study|Protocol Violation|1|||
127665722|NCT03873246|459396935|FG002|Overall Study|Protocol Violation|0|||
127665723|NCT03873246|459396933|FG000|Overall Study|Withdrawal by Subject|0|||
127665724|NCT03873246|459396934|FG001|Overall Study|Withdrawal by Subject|4|||
127665725|NCT03873246|459396935|FG002|Overall Study|Withdrawal by Subject|1|||
127665726|NCT01857323|459396936|FG000|Overall Study|Adverse Event|1|||
127665727|NCT01857323|459396936|FG000|Overall Study|Withdrawal by Subject|3|||
127665728|NCT01857323|459396936|FG000|Overall Study|Non-compliance|1|||
127665729|NCT01857323|459396936|FG000|Overall Study|Protocol Violation|6|||
127665730|NCT01857323|459396936|FG000|Overall Study|Lost to Follow-up|1|||
127665731|NCT01857323|459396936|FG000|Overall Study|Other|4|||
127665732|NCT01857323|459396936|FG000|Overall Study|Did not complete 180 doses|48|||
127665733|NCT03658811|459396937|FG000|Overall Study|Lost to Follow-up|3|||
127665734|NCT00946647|459396941|FG000|Phase 1 Part|Adverse Event|2|||
127665735|NCT00946647|459396942|FG001|Phase 1 Part|Adverse Event|5|||
127665736|NCT00946647|459396943|FG002|Phase 1 Part|Adverse Event|3|||
127665737|NCT00946647|459396944|FG003|Phase 1 Part|Adverse Event|0|||
127665738|NCT00946647|459396945|FG004|Phase 1 Part|Adverse Event|0|||
127665739|NCT00946647|459396941|FG000|Phase 1 Part|Disease progression|3|||
127665740|NCT00946647|459396942|FG001|Phase 1 Part|Disease progression|6|||
127665741|NCT00946647|459396943|FG002|Phase 1 Part|Disease progression|1|||
127665742|NCT00946647|459396944|FG003|Phase 1 Part|Disease progression|0|||
127665743|NCT00946647|459396945|FG004|Phase 1 Part|Disease progression|0|||
127665744|NCT00946647|459396941|FG000|Phase 1 Part|Withdrawal by Subject|1|||
127665745|NCT00946647|459396942|FG001|Phase 1 Part|Withdrawal by Subject|4|||
127665746|NCT00946647|459396943|FG002|Phase 1 Part|Withdrawal by Subject|3|||
127665747|NCT00946647|459396944|FG003|Phase 1 Part|Withdrawal by Subject|0|||
127665748|NCT00946647|459396945|FG004|Phase 1 Part|Withdrawal by Subject|0|||
127665749|NCT00946647|459396941|FG000|Phase 1 Part|Abnormal values|0|||
127665750|NCT00946647|459396942|FG001|Phase 1 Part|Abnormal values|2|||
127665751|NCT00946647|459396943|FG002|Phase 1 Part|Abnormal values|0|||
127665752|NCT00946647|459396944|FG003|Phase 1 Part|Abnormal values|0|||
127665753|NCT00946647|459396945|FG004|Phase 1 Part|Abnormal values|0|||
127665754|NCT00946647|459396941|FG000|Phase 1 Part|Reason missing|0|||
127665755|NCT00946647|459396942|FG001|Phase 1 Part|Reason missing|1|||
127665756|NCT00946647|459396943|FG002|Phase 1 Part|Reason missing|0|||
127997717|NCT03428100|460617700|FG007|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
127997718|NCT03428100|460617701|FG008|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
127997719|NCT03428100|460617702|FG009|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
127997720|NCT03428100|460617703|FG010|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
127997721|NCT03428100|460617704|FG011|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
127997722|NCT03428100|460617705|FG012|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
127997723|NCT03428100|460617706|FG013|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|6|||
127997724|NCT03428100|460617707|FG014|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|12|||
127997725|NCT03428100|460617708|FG015|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|5|||
127997726|NCT03428100|460617709|FG016|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
127997727|NCT03428100|460617710|FG017|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|1|||
127997728|NCT03428100|460617711|FG018|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
127997729|NCT03428100|460617693|FG000|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
127997730|NCT03428100|460617694|FG001|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
127997731|NCT03428100|460617695|FG002|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
127997732|NCT03428100|460617696|FG003|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
127997733|NCT03428100|460617697|FG004|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
127997734|NCT03428100|460617698|FG005|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
127997735|NCT03428100|460617699|FG006|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
127997736|NCT03428100|460617700|FG007|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
127997737|NCT03428100|460617701|FG008|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
127997738|NCT03428100|460617702|FG009|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|6|||
127997739|NCT03428100|460617703|FG010|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|13|||
127997740|NCT03428100|460617704|FG011|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
127997741|NCT03428100|460617705|FG012|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
127997742|NCT03428100|460617706|FG013|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
127997743|NCT03428100|460617707|FG014|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|1|||
127997744|NCT03428100|460617708|FG015|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
127997745|NCT03428100|460617709|FG016|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|4|||
127997746|NCT03428100|460617710|FG017|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
127997747|NCT03428100|460617711|FG018|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
127997748|NCT04556760|460617712|FG000|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
127997749|NCT04556760|460617713|FG001|Treatment Period 1 (72 Hours)|Withdrawal by Subject|1|||
127997750|NCT04556760|460617714|FG002|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
127997751|NCT04556760|460617715|FG003|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
127997752|NCT04556760|460617716|FG004|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
127997753|NCT04556760|460617717|FG005|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
127997754|NCT04556760|460617712|FG000|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
127997755|NCT04556760|460617713|FG001|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
127997756|NCT04556760|460617714|FG002|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
127997757|NCT04556760|460617715|FG003|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|1|||
127997758|NCT04556760|460617716|FG004|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
127997759|NCT04556760|460617717|FG005|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
127997760|NCT02168491|460617718|FG000|Overall Study|Withdrawal by Subject|1|||
127997761|NCT01096160|460617723|FG000|Overall Study|Adverse Event|0|||
127997762|NCT01096160|460617724|FG001|Overall Study|Adverse Event|0|||
127997763|NCT01096160|460617725|FG002|Overall Study|Adverse Event|1|||
127997764|NCT01096160|460617726|FG003|Overall Study|Adverse Event|0|||
127997765|NCT01096160|460617727|FG004|Overall Study|Adverse Event|0|||
127997766|NCT01096160|460617728|FG005|Overall Study|Adverse Event|0|||
127997767|NCT01096160|460617729|FG006|Overall Study|Adverse Event|0|||
127997768|NCT01096160|460617730|FG007|Overall Study|Adverse Event|0|||
127997769|NCT01096160|460617731|FG008|Overall Study|Adverse Event|0|||
127997770|NCT01096160|460617732|FG009|Overall Study|Adverse Event|1|||
127997771|NCT01096160|460617723|FG000|Overall Study|Met stopping criteria per protocol|0|||
127997772|NCT01096160|460617724|FG001|Overall Study|Met stopping criteria per protocol|0|||
127997773|NCT01096160|460617725|FG002|Overall Study|Met stopping criteria per protocol|0|||
127997774|NCT01096160|460617726|FG003|Overall Study|Met stopping criteria per protocol|0|||
127997775|NCT01096160|460617727|FG004|Overall Study|Met stopping criteria per protocol|1|||
127997776|NCT01096160|460617728|FG005|Overall Study|Met stopping criteria per protocol|0|||
127997777|NCT01096160|460617729|FG006|Overall Study|Met stopping criteria per protocol|2|||
127997778|NCT01096160|460617730|FG007|Overall Study|Met stopping criteria per protocol|0|||
127997779|NCT01096160|460617731|FG008|Overall Study|Met stopping criteria per protocol|2|||
127665757|NCT00946647|459396944|FG003|Phase 1 Part|Reason missing|0|||
127997780|NCT01096160|460617732|FG009|Overall Study|Met stopping criteria per protocol|0|||
127997781|NCT01610037|460617733|FG000|All Patients|Adverse Event|27|||
127997782|NCT01610037|460617734|FG001|All Patients|Adverse Event|22|||
127997783|NCT01610037|460617735|FG002|All Patients|Adverse Event|26|||
127997784|NCT01610037|460617733|FG000|All Patients|Withdrawal by Subject|12|||
127997785|NCT01610037|460617734|FG001|All Patients|Withdrawal by Subject|10|||
127997786|NCT01610037|460617735|FG002|All Patients|Withdrawal by Subject|20|||
127997787|NCT01610037|460617733|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
127997788|NCT01610037|460617734|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
127997789|NCT01610037|460617735|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
127997790|NCT01610037|460617733|FG000|All Patients|Death|4|||
127997791|NCT01610037|460617734|FG001|All Patients|Death|2|||
127997792|NCT01610037|460617735|FG002|All Patients|Death|1|||
127997793|NCT01610037|460617733|FG000|All Patients|Protocol deviation|4|||
127997794|NCT01610037|460617734|FG001|All Patients|Protocol deviation|3|||
127997795|NCT01610037|460617735|FG002|All Patients|Protocol deviation|3|||
127997796|NCT01610037|460617733|FG000|All Patients|Abnormal laboratory value|1|||
127997797|NCT01610037|460617734|FG001|All Patients|Abnormal laboratory value|1|||
127997798|NCT01610037|460617735|FG002|All Patients|Abnormal laboratory value|0|||
127997799|NCT01610037|460617733|FG000|All Patients|Administrative problems|1|||
127997800|NCT01610037|460617734|FG001|All Patients|Administrative problems|4|||
127997801|NCT01610037|460617735|FG002|All Patients|Administrative problems|4|||
127997802|NCT01610037|460617733|FG000|All Patients|Lost to Follow-up|1|||
127997803|NCT01610037|460617734|FG001|All Patients|Lost to Follow-up|0|||
127997804|NCT01610037|460617735|FG002|All Patients|Lost to Follow-up|0|||
127997805|NCT01610037|460617733|FG000|All Patients|Abnormal test procedure result(s)|0|||
127997806|NCT01610037|460617734|FG001|All Patients|Abnormal test procedure result(s)|1|||
127997807|NCT01610037|460617735|FG002|All Patients|Abnormal test procedure result(s)|3|||
127997808|NCT01610037|460617733|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
127997809|NCT01610037|460617734|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
127997810|NCT01610037|460617735|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
127997811|NCT01610037|460617733|FG000|Treatment and Follow up Period|Death|10|||
127997812|NCT01610037|460617734|FG001|Treatment and Follow up Period|Death|5|||
127997813|NCT01610037|460617735|FG002|Treatment and Follow up Period|Death|4|||
127997814|NCT01610037|460617733|FG000|Treatment and Follow up Period|Administrative problems|1|||
127997815|NCT01610037|460617734|FG001|Treatment and Follow up Period|Administrative problems|3|||
127997816|NCT01610037|460617735|FG002|Treatment and Follow up Period|Administrative problems|2|||
127997817|NCT01610037|460617733|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
127997818|NCT01610037|460617734|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
127997819|NCT01610037|460617735|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
127997820|NCT00705757|460617737|FG000|Overall Study|Lack of Efficacy|5|||
127997821|NCT00705757|460617738|FG001|Overall Study|Lack of Efficacy|1|||
127997822|NCT00705757|460617739|FG002|Overall Study|Lack of Efficacy|3|||
127997823|NCT00705757|460617737|FG000|Overall Study|Lost to Follow-up|7|||
127997824|NCT00705757|460617738|FG001|Overall Study|Lost to Follow-up|6|||
127997825|NCT00705757|460617739|FG002|Overall Study|Lost to Follow-up|6|||
127997826|NCT00705757|460617737|FG000|Overall Study|Withdrawal by Subject|1|||
127997827|NCT00705757|460617738|FG001|Overall Study|Withdrawal by Subject|1|||
127997828|NCT00705757|460617739|FG002|Overall Study|Withdrawal by Subject|2|||
127997829|NCT01411852|460617740|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
127997830|NCT01411852|460617741|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
127997831|NCT01411852|460617740|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
127997832|NCT01411852|460617741|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
127997833|NCT01411852|460617740|FG000|Prehospital Intervention Phase|Found to be under age|0|||
127997834|NCT01411852|460617741|FG001|Prehospital Intervention Phase|Found to be under age|1|||
127997835|NCT01411852|460617740|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
127997836|NCT01411852|460617741|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
127997837|NCT01411852|460617740|FG000|Hospital Intervention Phase|Severe head injury|5|||
127997838|NCT01411852|460617741|FG001|Hospital Intervention Phase|Severe head injury|4|||
127997839|NCT01411852|460617740|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
127997840|NCT01411852|460617741|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
127997841|NCT01411852|460617740|FG000|Hospital Intervention Phase|Miscommunication error|1|||
127997842|NCT01411852|460617741|FG001|Hospital Intervention Phase|Miscommunication error|2|||
127997843|NCT01411852|460617740|FG000|Hospital Intervention Phase|CPR administered|3|||
127997844|NCT01411852|460617741|FG001|Hospital Intervention Phase|CPR administered|1|||
127997845|NCT01411852|460617740|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
127997846|NCT01411852|460617741|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
127997847|NCT01411852|460617740|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
127997848|NCT01411852|460617741|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
127997849|NCT01411852|460617740|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
127997850|NCT01411852|460617741|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
127997851|NCT01411852|460617740|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
127997852|NCT01411852|460617741|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
127997853|NCT01411852|460617740|FG000|Hospital Intervention Phase|Other ineligible|2|||
127997854|NCT01411852|460617741|FG001|Hospital Intervention Phase|Other ineligible|2|||
127997855|NCT01411852|460617740|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
127997856|NCT01411852|460617741|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
127997857|NCT01411852|460617740|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
127997858|NCT01411852|460617741|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
127997859|NCT01411852|460617740|FG000|Hospital Intervention Phase|Vascular access failed|1|||
127997860|NCT01411852|460617741|FG001|Hospital Intervention Phase|Vascular access failed|0|||
127997861|NCT03193047|460617742|FG000|Overall Study|Physician Decision|1|||
127997862|NCT03193047|460617743|FG001|Overall Study|Physician Decision|0|||
127997863|NCT03193047|460617742|FG000|Overall Study|Participant Left State|1|||
127997864|NCT03193047|460617743|FG001|Overall Study|Participant Left State|0|||
127997865|NCT03743025|460617746|FG000|Overall Study|Surgery was cancelled|2|||
127997866|NCT03743025|460617747|FG001|Overall Study|Surgery was cancelled|1|||
127997867|NCT02420119|460617748|FG000|Overall Study|insufficient laboratory data|5|||
127997868|NCT00149396|460617749|FG000|Overall Study|Death|15|||
127997869|NCT00149396|460617749|FG000|Overall Study|Withdrawal by Subject|1|||
127997870|NCT00149396|460617749|FG000|Overall Study|Subject noncompliance|2|||
127997871|NCT00149396|460617749|FG000|Overall Study|other treatment|5|||
127997872|NCT00186485|460617752|FG000|Overall Study|Lost to Follow-up|3|||
127997873|NCT00227539|460617753|FG000|Overall Study|Protocol Violation|1|||
127997874|NCT00673257|460617754|FG000|Overall Study|Withdrawal by Subject|4|||
127997875|NCT00673257|460617754|FG000|Overall Study|Unable to obtain specimen|1|||
127997876|NCT02256839|460617755|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
127997877|NCT02256839|460617756|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
127997878|NCT01938846|460617773|FG000|Overall Study|Progressive disease|26|||
127997879|NCT01938846|460617774|FG001|Overall Study|Progressive disease|18|||
127997880|NCT01938846|460617775|FG002|Overall Study|Progressive disease|16|||
127997881|NCT01938846|460617773|FG000|Overall Study|Adverse Event|8|||
127997882|NCT01938846|460617774|FG001|Overall Study|Adverse Event|4|||
127997883|NCT01938846|460617775|FG002|Overall Study|Adverse Event|3|||
127997884|NCT01938846|460617773|FG000|Overall Study|Withdrawal by Subject|2|||
127997885|NCT01938846|460617774|FG001|Overall Study|Withdrawal by Subject|2|||
127997886|NCT01938846|460617775|FG002|Overall Study|Withdrawal by Subject|1|||
127997887|NCT01938846|460617773|FG000|Overall Study|Other than listed|5|||
127997888|NCT01938846|460617774|FG001|Overall Study|Other than listed|1|||
127997889|NCT01938846|460617775|FG002|Overall Study|Other than listed|4|||
127997890|NCT02324361|460617778|FG000|Overall Study|Lost to Follow-up|5|||
127997891|NCT02324361|460617779|FG001|Overall Study|Lost to Follow-up|2|||
127997892|NCT01931397|460617789|FG000|Overall Study|Physician Decision|2|||
127997893|NCT01931397|460617789|FG000|Overall Study|Withdrawal by Subject|8|||
127997894|NCT01931397|460617789|FG000|Overall Study|moved out of state|1|||
127997895|NCT02058589|460617793|FG000|Overall Study|Serious Adverse Event|1|||
127997896|NCT02058589|460617794|FG001|Overall Study|Serious Adverse Event|1|||
127997897|NCT02058589|460617793|FG000|Overall Study|Non-Serious Adverse Event|1|||
127997898|NCT02058589|460617794|FG001|Overall Study|Non-Serious Adverse Event|0|||
127997899|NCT02058589|460617793|FG000|Overall Study|Withdrawal by Subject|0|||
127997900|NCT02058589|460617794|FG001|Overall Study|Withdrawal by Subject|1|||
127997901|NCT02143024|460617795|FG000|Overall Study|Lost to Follow-up|1|||
127997902|NCT02143024|460617796|FG001|Overall Study|Lost to Follow-up|1|||
127997903|NCT02143024|460617795|FG000|Overall Study|Withdrawal by Subject|1|||
127997904|NCT02143024|460617796|FG001|Overall Study|Withdrawal by Subject|0|||
127997905|NCT01945944|460617797|FG000|Overall Study|Adverse Event|0|||
127997906|NCT01945944|460617798|FG001|Overall Study|Adverse Event|2|||
127997907|NCT01945944|460617797|FG000|Overall Study|Physician Decision|1|||
127997908|NCT01945944|460617798|FG001|Overall Study|Physician Decision|0|||
127997909|NCT01945944|460617797|FG000|Overall Study|Withdrawal by Subject|0|||
127997910|NCT01945944|460617798|FG001|Overall Study|Withdrawal by Subject|1|||
127997911|NCT04771013|460619655|FG000|Overall Study|Withdrawal by Subject|2|||
127997912|NCT04771013|460619656|FG001|Overall Study|Withdrawal by Subject|0|||
127997913|NCT04771013|460619655|FG000|Overall Study|Death|0|||
127997914|NCT04771013|460619656|FG001|Overall Study|Death|5|||
127997915|NCT04771013|460619655|FG000|Overall Study|Referred to another hospital before day 20|0|||
127997916|NCT04771013|460619656|FG001|Overall Study|Referred to another hospital before day 20|1|||
127997917|NCT00823134|460619657|FG000|Overall Study|Invalid measurement|1|||
127997918|NCT00493012|460619659|FG000|Overall Study|Lost to Follow-up|18|||
127997919|NCT00493012|460619660|FG001|Overall Study|Lost to Follow-up|17|||
127997920|NCT01519817|460619661|FG000|Overall Study|Withdrawal by Subject|1|||
127997921|NCT01519817|460619662|FG001|Overall Study|Withdrawal by Subject|0|||
127997922|NCT01519817|460619663|FG002|Overall Study|Withdrawal by Subject|0|||
127997923|NCT01519817|460619664|FG003|Overall Study|Withdrawal by Subject|0|||
127997924|NCT01519817|460619661|FG000|Overall Study|Off study due to infection|0|||
127997925|NCT01519817|460619662|FG001|Overall Study|Off study due to infection|0|||
127997926|NCT01519817|460619663|FG002|Overall Study|Off study due to infection|0|||
127997927|NCT01519817|460619664|FG003|Overall Study|Off study due to infection|1|||
127997928|NCT03234036|460619670|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
127997929|NCT03234036|460619671|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
127997930|NCT03234036|460619672|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
127997931|NCT03234036|460619673|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
127997932|NCT02999789|460619674|FG000|Overall Study|Withdrawal by Subject|0|||
127997933|NCT02999789|460619675|FG001|Overall Study|Withdrawal by Subject|1|||
127997934|NCT02999789|460619674|FG000|Overall Study|Became ineligible|1|||
127997935|NCT02999789|460619675|FG001|Overall Study|Became ineligible|2|||
127997936|NCT04547140|460619678|FG000|Overall Study|Adverse Event|0|||
127997937|NCT04547140|460619679|FG001|Overall Study|Adverse Event|1|||
127997938|NCT04547140|460619678|FG000|Overall Study|Withdrawal by Subject|0|||
127997939|NCT04547140|460619679|FG001|Overall Study|Withdrawal by Subject|1|||
127997940|NCT04547140|460619678|FG000|Overall Study|Lost to Follow-up|3|||
127997941|NCT04547140|460619679|FG001|Overall Study|Lost to Follow-up|1|||
127997942|NCT04547140|460619678|FG000|Overall Study|Death|2|||
127997943|NCT04547140|460619679|FG001|Overall Study|Death|1|||
127997944|NCT04547140|460619678|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
127997945|NCT04547140|460619679|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
127997946|NCT04547140|460619678|FG000|Overall Study|Pregnancy|1|||
127997947|NCT04547140|460619679|FG001|Overall Study|Pregnancy|0|||
127997948|NCT04547140|460619678|FG000|Overall Study|Reason Not Specified|4|||
127997949|NCT04547140|460619679|FG001|Overall Study|Reason Not Specified|1|||
127997950|NCT04613739|460619680|FG000|Overall Study|Lost to Follow-up|6|||
127997951|NCT04613739|460619681|FG001|Overall Study|Lost to Follow-up|9|||
127997952|NCT04613739|460619680|FG000|Overall Study|potentially duplicative/fraudulent|1|||
127997953|NCT04613739|460619681|FG001|Overall Study|potentially duplicative/fraudulent|3|||
127997954|NCT00003537|460619682|FG000|Overall Study|Not evalauable|1|||
127997955|NCT00737100|460619688|FG000|Overall Study|Adverse Event|6|||
127997956|NCT00737100|460619689|FG001|Overall Study|Adverse Event|5|||
127997957|NCT00737100|460619690|FG002|Overall Study|Adverse Event|3|||
127997958|NCT00737100|460619688|FG000|Overall Study|Lost to Follow-up|0|||
127997959|NCT00737100|460619689|FG001|Overall Study|Lost to Follow-up|1|||
127997960|NCT00737100|460619690|FG002|Overall Study|Lost to Follow-up|0|||
127997961|NCT00737100|460619688|FG000|Overall Study|Withdrawal by Subject|0|||
127997962|NCT00737100|460619689|FG001|Overall Study|Withdrawal by Subject|0|||
127997963|NCT00737100|460619690|FG002|Overall Study|Withdrawal by Subject|3|||
127997964|NCT00737100|460619688|FG000|Overall Study|Reason discontinued not explained above|1|||
127997965|NCT00737100|460619689|FG001|Overall Study|Reason discontinued not explained above|1|||
127997966|NCT00737100|460619690|FG002|Overall Study|Reason discontinued not explained above|1|||
127997967|NCT00735943|460619693|FG000|Overall Study|Lost to Follow-up|1|||
127997968|NCT00735943|460619693|FG000|Overall Study|Adverse Event|1|||
127997969|NCT01265394|460619694|FG000|Overall Study|Subjects withdrawn|37|||
127997970|NCT01719380|460619699|FG000|Overall Study|Adverse Event|0|||
127997971|NCT01719380|460619700|FG001|Overall Study|Adverse Event|0|||
127665758|NCT00946647|459396945|FG004|Phase 1 Part|Reason missing|0|||
127665759|NCT00946647|459396941|FG000|Phase ll Part|Untreated|0|||
127665760|NCT00946647|459396942|FG001|Phase ll Part|Untreated|0|||
127665761|NCT00946647|459396943|FG002|Phase ll Part|Untreated|0|||
127665762|NCT00946647|459396944|FG003|Phase ll Part|Untreated|0|||
127665763|NCT00946647|459396945|FG004|Phase ll Part|Untreated|2|||
127665764|NCT00946647|459396941|FG000|Phase ll Part|Adverse Event|0|||
127665765|NCT00946647|459396942|FG001|Phase ll Part|Adverse Event|0|||
127665766|NCT00946647|459396943|FG002|Phase ll Part|Adverse Event|0|||
127665767|NCT00946647|459396944|FG003|Phase ll Part|Adverse Event|10|||
127665768|NCT00946647|459396945|FG004|Phase ll Part|Adverse Event|6|||
127665769|NCT00946647|459396941|FG000|Phase ll Part|Withdrawal by Subject|0|||
127665770|NCT00946647|459396942|FG001|Phase ll Part|Withdrawal by Subject|0|||
127665771|NCT00946647|459396943|FG002|Phase ll Part|Withdrawal by Subject|0|||
127665772|NCT00946647|459396944|FG003|Phase ll Part|Withdrawal by Subject|8|||
127665773|NCT00946647|459396945|FG004|Phase ll Part|Withdrawal by Subject|6|||
127665774|NCT00946647|459396941|FG000|Phase ll Part|Administrative problems|0|||
127665775|NCT00946647|459396942|FG001|Phase ll Part|Administrative problems|0|||
127665776|NCT00946647|459396943|FG002|Phase ll Part|Administrative problems|0|||
127997972|NCT01719380|460619701|FG002|Overall Study|Adverse Event|1|||
127997973|NCT01719380|460619702|FG003|Overall Study|Adverse Event|2|||
127997974|NCT01719380|460619703|FG004|Overall Study|Adverse Event|0|||
127997975|NCT01719380|460619704|FG005|Overall Study|Adverse Event|1|||
127997976|NCT01719380|460619705|FG006|Overall Study|Adverse Event|0|||
127997977|NCT01719380|460619706|FG007|Overall Study|Adverse Event|1|||
127997978|NCT01719380|460619707|FG008|Overall Study|Adverse Event|4|||
127997979|NCT01719380|460619708|FG009|Overall Study|Adverse Event|3|||
127997980|NCT01719380|460619699|FG000|Overall Study|Death|0|||
127997981|NCT01719380|460619700|FG001|Overall Study|Death|1|||
127665777|NCT00946647|459396944|FG003|Phase ll Part|Administrative problems|3|||
127665778|NCT00946647|459396945|FG004|Phase ll Part|Administrative problems|8|||
127997982|NCT01719380|460619701|FG002|Overall Study|Death|0|||
127997983|NCT01719380|460619702|FG003|Overall Study|Death|0|||
127997984|NCT01719380|460619703|FG004|Overall Study|Death|0|||
127997985|NCT01719380|460619704|FG005|Overall Study|Death|0|||
127997986|NCT01719380|460619705|FG006|Overall Study|Death|0|||
127997987|NCT01719380|460619706|FG007|Overall Study|Death|0|||
127997988|NCT01719380|460619707|FG008|Overall Study|Death|3|||
127997989|NCT01719380|460619708|FG009|Overall Study|Death|3|||
127997990|NCT01719380|460619699|FG000|Overall Study|Participant/Guardian Decision|0|||
127997991|NCT01719380|460619700|FG001|Overall Study|Participant/Guardian Decision|0|||
127997992|NCT01719380|460619701|FG002|Overall Study|Participant/Guardian Decision|1|||
127997993|NCT01719380|460619702|FG003|Overall Study|Participant/Guardian Decision|0|||
127997994|NCT01719380|460619703|FG004|Overall Study|Participant/Guardian Decision|0|||
127997995|NCT01719380|460619704|FG005|Overall Study|Participant/Guardian Decision|0|||
127997996|NCT01719380|460619705|FG006|Overall Study|Participant/Guardian Decision|0|||
127997997|NCT01719380|460619706|FG007|Overall Study|Participant/Guardian Decision|0|||
127997998|NCT01719380|460619707|FG008|Overall Study|Participant/Guardian Decision|2|||
127997999|NCT01719380|460619708|FG009|Overall Study|Participant/Guardian Decision|2|||
127998000|NCT01719380|460619699|FG000|Overall Study|Physician Decision|0|||
127998001|NCT01719380|460619700|FG001|Overall Study|Physician Decision|0|||
127998002|NCT01719380|460619701|FG002|Overall Study|Physician Decision|2|||
127998003|NCT01719380|460619702|FG003|Overall Study|Physician Decision|0|||
127998004|NCT01719380|460619703|FG004|Overall Study|Physician Decision|0|||
127998005|NCT01719380|460619704|FG005|Overall Study|Physician Decision|0|||
127998006|NCT01719380|460619705|FG006|Overall Study|Physician Decision|0|||
127998007|NCT01719380|460619706|FG007|Overall Study|Physician Decision|0|||
127998008|NCT01719380|460619707|FG008|Overall Study|Physician Decision|1|||
127998009|NCT01719380|460619708|FG009|Overall Study|Physician Decision|1|||
127998010|NCT01719380|460619699|FG000|Overall Study|Lack of Efficacy|2|||
127998011|NCT01719380|460619700|FG001|Overall Study|Lack of Efficacy|6|||
127998012|NCT01719380|460619701|FG002|Overall Study|Lack of Efficacy|5|||
127998013|NCT01719380|460619702|FG003|Overall Study|Lack of Efficacy|6|||
127998014|NCT01719380|460619703|FG004|Overall Study|Lack of Efficacy|3|||
127998015|NCT01719380|460619704|FG005|Overall Study|Lack of Efficacy|7|||
127998016|NCT01719380|460619705|FG006|Overall Study|Lack of Efficacy|10|||
127998017|NCT01719380|460619706|FG007|Overall Study|Lack of Efficacy|6|||
127665779|NCT00946647|459396941|FG000|Phase ll Part|Death|0|||
127665780|NCT00946647|459396942|FG001|Phase ll Part|Death|0|||
127665781|NCT00946647|459396943|FG002|Phase ll Part|Death|0|||
127665782|NCT00946647|459396944|FG003|Phase ll Part|Death|7|||
127665783|NCT00946647|459396945|FG004|Phase ll Part|Death|4|||
127665784|NCT00946647|459396941|FG000|Phase ll Part|Disease progression|0|||
127665785|NCT00946647|459396942|FG001|Phase ll Part|Disease progression|0|||
127665786|NCT00946647|459396943|FG002|Phase ll Part|Disease progression|0|||
127665787|NCT00946647|459396944|FG003|Phase ll Part|Disease progression|6|||
127665788|NCT00946647|459396945|FG004|Phase ll Part|Disease progression|14|||
127665789|NCT00946647|459396941|FG000|Phase ll Part|Protocol Violation|0|||
127665790|NCT00946647|459396942|FG001|Phase ll Part|Protocol Violation|0|||
127665791|NCT00946647|459396943|FG002|Phase ll Part|Protocol Violation|0|||
127665792|NCT00946647|459396944|FG003|Phase ll Part|Protocol Violation|4|||
127665793|NCT00946647|459396945|FG004|Phase ll Part|Protocol Violation|2|||
127665794|NCT00946647|459396941|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
127665795|NCT00946647|459396942|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
127665796|NCT00946647|459396943|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
127665797|NCT00946647|459396944|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
127665798|NCT00946647|459396945|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
127665799|NCT01349660|459396946|FG000|Overall Study|Still Receiving Study Treatment|0|||
127665800|NCT01349660|459396947|FG001|Overall Study|Still Receiving Study Treatment|0|||
127665801|NCT01349660|459396948|FG002|Overall Study|Still Receiving Study Treatment|1|||
127665802|NCT01349660|459396946|FG000|Overall Study|Disease Progression|2|||
127665803|NCT01349660|459396947|FG001|Overall Study|Disease Progression|4|||
127665804|NCT01349660|459396948|FG002|Overall Study|Disease Progression|50|||
127665805|NCT01349660|459396946|FG000|Overall Study|Adverse Event|1|||
127998018|NCT01719380|460619707|FG008|Overall Study|Lack of Efficacy|39|||
127998019|NCT01719380|460619708|FG009|Overall Study|Lack of Efficacy|42|||
127665806|NCT01349660|459396947|FG001|Overall Study|Adverse Event|1|||
127665807|NCT01349660|459396948|FG002|Overall Study|Adverse Event|12|||
127665808|NCT01349660|459396946|FG000|Overall Study|Withdrawal by Subject|2|||
127665809|NCT01349660|459396947|FG001|Overall Study|Withdrawal by Subject|0|||
127665810|NCT01349660|459396948|FG002|Overall Study|Withdrawal by Subject|9|||
127665811|NCT01349660|459396946|FG000|Overall Study|Death|1|||
127998020|NCT01719380|460619699|FG000|Overall Study|Progressive Disease|0|||
127998021|NCT01719380|460619700|FG001|Overall Study|Progressive Disease|0|||
127998022|NCT01719380|460619701|FG002|Overall Study|Progressive Disease|0|||
127998023|NCT01719380|460619702|FG003|Overall Study|Progressive Disease|0|||
127998024|NCT01719380|460619703|FG004|Overall Study|Progressive Disease|0|||
127998025|NCT01719380|460619704|FG005|Overall Study|Progressive Disease|0|||
127998026|NCT01719380|460619705|FG006|Overall Study|Progressive Disease|0|||
127665812|NCT01349660|459396947|FG001|Overall Study|Death|1|||
127665813|NCT01349660|459396948|FG002|Overall Study|Death|0|||
127665814|NCT01349660|459396946|FG000|Overall Study|Non-Permitted Interventions|0|||
127998027|NCT01719380|460619706|FG007|Overall Study|Progressive Disease|0|||
127998028|NCT01719380|460619707|FG008|Overall Study|Progressive Disease|1|||
127998029|NCT01719380|460619708|FG009|Overall Study|Progressive Disease|0|||
127998030|NCT01064414|460619709|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
127998031|NCT01064414|460619710|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
127998032|NCT01064414|460619711|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
127998033|NCT01064414|460619709|FG000|Core Period: Baseline to Week 26|Death|0|||
127998034|NCT01064414|460619710|FG001|Core Period: Baseline to Week 26|Death|1|||
127998035|NCT01064414|460619711|FG002|Core Period: Baseline to Week 26|Death|0|||
127998036|NCT01064414|460619709|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
127998037|NCT01064414|460619710|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
127998038|NCT01064414|460619711|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
127998039|NCT01064414|460619709|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
127998040|NCT01064414|460619710|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
127998041|NCT01064414|460619711|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
127998042|NCT01064414|460619709|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
127998043|NCT01064414|460619710|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
127998044|NCT01064414|460619711|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
127998045|NCT01064414|460619709|FG000|Core Period: Baseline to Week 26|Other|4|||
127998046|NCT01064414|460619710|FG001|Core Period: Baseline to Week 26|Other|7|||
127998047|NCT01064414|460619711|FG002|Core Period: Baseline to Week 26|Other|2|||
127998048|NCT01064414|460619709|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
127998049|NCT01064414|460619710|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
127998050|NCT01064414|460619711|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
127665815|NCT01349660|459396947|FG001|Overall Study|Non-Permitted Interventions|0|||
127665816|NCT01349660|459396948|FG002|Overall Study|Non-Permitted Interventions|2|||
127665817|NCT01349660|459396946|FG000|Overall Study|Study Compliance|0|||
127665818|NCT01349660|459396947|FG001|Overall Study|Study Compliance|0|||
127665819|NCT01349660|459396948|FG002|Overall Study|Study Compliance|1|||
127665820|NCT01349660|459396946|FG000|Overall Study|Declining Performance Status|0|||
127665821|NCT01349660|459396947|FG001|Overall Study|Declining Performance Status|0|||
127665822|NCT01349660|459396948|FG002|Overall Study|Declining Performance Status|1|||
127665823|NCT00519636|459396949|FG000|Treatment Period 1|Adverse Event|1|||
127665824|NCT00519636|459396950|FG001|Treatment Period 1|Adverse Event|0|||
127665825|NCT00519636|459396951|FG002|Treatment Period 1|Adverse Event|1|||
127665826|NCT00519636|459396952|FG003|Treatment Period 1|Adverse Event|0|||
127665827|NCT00519636|459396949|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
127665828|NCT00519636|459396950|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
127665829|NCT00519636|459396951|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
127665830|NCT00519636|459396952|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
127665831|NCT00519636|459396949|FG000|Washout Period|Adverse Event|2|||
127665832|NCT00519636|459396950|FG001|Washout Period|Adverse Event|1|||
127665833|NCT00519636|459396951|FG002|Washout Period|Adverse Event|1|||
127665834|NCT00519636|459396952|FG003|Washout Period|Adverse Event|0|||
127665835|NCT00519636|459396949|FG000|Washout Period|Lost to Follow-up|1|||
127665836|NCT00519636|459396950|FG001|Washout Period|Lost to Follow-up|0|||
127665837|NCT00519636|459396951|FG002|Washout Period|Lost to Follow-up|0|||
127665838|NCT00519636|459396952|FG003|Washout Period|Lost to Follow-up|0|||
127665839|NCT00519636|459396949|FG000|Washout Period|Protocol Violation|0|||
127665840|NCT00519636|459396950|FG001|Washout Period|Protocol Violation|0|||
127665841|NCT00519636|459396951|FG002|Washout Period|Protocol Violation|1|||
127665842|NCT00519636|459396952|FG003|Washout Period|Protocol Violation|2|||
127665843|NCT00519636|459396949|FG000|Washout Period|Withdrawal by Subject|1|||
127665844|NCT00519636|459396950|FG001|Washout Period|Withdrawal by Subject|0|||
127665845|NCT00519636|459396951|FG002|Washout Period|Withdrawal by Subject|1|||
127665846|NCT00519636|459396952|FG003|Washout Period|Withdrawal by Subject|0|||
127665847|NCT00519636|459396949|FG000|Washout Period|Failed to meet continuation criteria|14|||
127665848|NCT00519636|459396950|FG001|Washout Period|Failed to meet continuation criteria|11|||
127665849|NCT00519636|459396951|FG002|Washout Period|Failed to meet continuation criteria|9|||
127665850|NCT00519636|459396952|FG003|Washout Period|Failed to meet continuation criteria|3|||
127665851|NCT00519636|459396949|FG000|Washout Period|Out of pollen area > 48 hours|1|||
127665852|NCT00519636|459396950|FG001|Washout Period|Out of pollen area > 48 hours|0|||
127665853|NCT00519636|459396951|FG002|Washout Period|Out of pollen area > 48 hours|0|||
127665854|NCT00519636|459396952|FG003|Washout Period|Out of pollen area > 48 hours|0|||
127665855|NCT00519636|459396949|FG000|Washout Period|Participating in study at another site|1|||
127665856|NCT00519636|459396950|FG001|Washout Period|Participating in study at another site|0|||
127665857|NCT00519636|459396951|FG002|Washout Period|Participating in study at another site|0|||
127665858|NCT00519636|459396952|FG003|Washout Period|Participating in study at another site|0|||
127665859|NCT00519636|459396949|FG000|Washout Period|Non-compliant|0|||
127665860|NCT00519636|459396950|FG001|Washout Period|Non-compliant|1|||
127665861|NCT00519636|459396951|FG002|Washout Period|Non-compliant|0|||
127665862|NCT00519636|459396952|FG003|Washout Period|Non-compliant|0|||
127665863|NCT00519636|459396949|FG000|Washout Period|Per doctors request|0|||
127665864|NCT00519636|459396950|FG001|Washout Period|Per doctors request|1|||
127665865|NCT00519636|459396951|FG002|Washout Period|Per doctors request|0|||
127665866|NCT00519636|459396952|FG003|Washout Period|Per doctors request|0|||
127998051|NCT01064414|460619709|FG000|Extension Period: Week 26 to Week 52|Death|0|||
127998052|NCT01064414|460619710|FG001|Extension Period: Week 26 to Week 52|Death|1|||
127998053|NCT01064414|460619711|FG002|Extension Period: Week 26 to Week 52|Death|0|||
127998054|NCT01064414|460619709|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
127998055|NCT01064414|460619710|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
127998056|NCT01064414|460619711|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
127998057|NCT01064414|460619709|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
127998058|NCT01064414|460619710|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
127998059|NCT01064414|460619711|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
127998060|NCT01064414|460619709|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
127998061|NCT01064414|460619710|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
127998062|NCT01064414|460619711|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
127665867|NCT00519636|459396949|FG000|Washout Period|Subject randomized in error|0|||
127665868|NCT00519636|459396950|FG001|Washout Period|Subject randomized in error|0|||
127665869|NCT00519636|459396951|FG002|Washout Period|Subject randomized in error|1|||
127665870|NCT00519636|459396952|FG003|Washout Period|Subject randomized in error|0|||
127665871|NCT00519636|459396949|FG000|Washout Period|Prohibited medications|0|||
127665872|NCT00519636|459396950|FG001|Washout Period|Prohibited medications|0|||
127665873|NCT00519636|459396951|FG002|Washout Period|Prohibited medications|1|||
127665874|NCT00519636|459396952|FG003|Washout Period|Prohibited medications|0|||
127665875|NCT00519636|459396949|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
127665876|NCT00519636|459396950|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
127665877|NCT00519636|459396951|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
127665878|NCT00519636|459396952|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
127665879|NCT00519636|459396949|FG000|Treatment Period 2|Subject randomized in error|0|||
127665880|NCT00519636|459396950|FG001|Treatment Period 2|Subject randomized in error|1|||
127665881|NCT00519636|459396951|FG002|Treatment Period 2|Subject randomized in error|0|||
127665882|NCT00519636|459396952|FG003|Treatment Period 2|Subject randomized in error|0|||
127665883|NCT00519636|459396949|FG000|Treatment Period 2|Per doctors request|0|||
127665884|NCT00519636|459396950|FG001|Treatment Period 2|Per doctors request|0|||
127665885|NCT00519636|459396951|FG002|Treatment Period 2|Per doctors request|1|||
127665886|NCT00519636|459396952|FG003|Treatment Period 2|Per doctors request|0|||
127665887|NCT00519636|459396949|FG000|Treatment Period 2|Subject misrandomized|0|||
127665888|NCT00519636|459396950|FG001|Treatment Period 2|Subject misrandomized|0|||
127665889|NCT00519636|459396951|FG002|Treatment Period 2|Subject misrandomized|0|||
127665890|NCT00519636|459396952|FG003|Treatment Period 2|Subject misrandomized|1|||
127665891|NCT00519636|459396949|FG000|Post Study Period|Subject randomized in error|0|||
127665892|NCT00519636|459396950|FG001|Post Study Period|Subject randomized in error|0|||
127665893|NCT00519636|459396951|FG002|Post Study Period|Subject randomized in error|0|||
127665894|NCT00519636|459396952|FG003|Post Study Period|Subject randomized in error|1|||
127665895|NCT02846558|459396957|FG000|Overall Study|Adverse Event|1|||
127665896|NCT02846558|459396958|FG001|Overall Study|Adverse Event|0|||
127665897|NCT02846558|459396959|FG002|Overall Study|Adverse Event|0|||
127665898|NCT02846558|459396960|FG003|Overall Study|Adverse Event|0|||
127665899|NCT02846558|459396957|FG000|Overall Study|Withdrawal by Subject|5|||
127665900|NCT02846558|459396958|FG001|Overall Study|Withdrawal by Subject|4|||
127665901|NCT02846558|459396959|FG002|Overall Study|Withdrawal by Subject|2|||
127665902|NCT02846558|459396960|FG003|Overall Study|Withdrawal by Subject|2|||
127665903|NCT02846558|459396957|FG000|Overall Study|Lost to Follow-up|2|||
127665904|NCT02846558|459396958|FG001|Overall Study|Lost to Follow-up|0|||
127665905|NCT02846558|459396959|FG002|Overall Study|Lost to Follow-up|0|||
127665906|NCT02846558|459396960|FG003|Overall Study|Lost to Follow-up|0|||
127665907|NCT00904150|459396970|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
127665908|NCT00904150|459396971|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
127665909|NCT00904150|459396970|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
127665910|NCT00904150|459396971|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
127665911|NCT04129580|459398413|FG000|Overall Study|Lost to Follow-up|14|||
127665912|NCT04129580|459398414|FG001|Overall Study|Lost to Follow-up|25|||
127665913|NCT00224133|459398417|FG000|Overall Study|Adverse Event|93|||
127665914|NCT00224133|459398417|FG000|Overall Study|Protocol Violation|6|||
127665915|NCT00224133|459398417|FG000|Overall Study|Withdrawal by Subject|33|||
127665916|NCT00224133|459398417|FG000|Overall Study|Lack of Efficacy|58|||
127665917|NCT00224133|459398417|FG000|Overall Study|Lost to Follow-up|21|||
127665918|NCT00224133|459398417|FG000|Overall Study|Physician Decision|1|||
127665919|NCT00224133|459398417|FG000|Overall Study|Other|14|||
127665920|NCT02718417|459398419|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
127665921|NCT02718417|459398420|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
127665922|NCT02718417|459398421|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
127665923|NCT02718417|459398419|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
127998063|NCT01064414|460619709|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
127998064|NCT01064414|460619710|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
127998065|NCT01064414|460619711|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
127998066|NCT01064414|460619709|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
127998067|NCT01064414|460619710|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
127998068|NCT01064414|460619711|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
127998069|NCT01064414|460619709|FG000|Extension Period: Week 26 to Week 52|Other|5|||
127998070|NCT01064414|460619710|FG001|Extension Period: Week 26 to Week 52|Other|2|||
127998071|NCT01064414|460619711|FG002|Extension Period: Week 26 to Week 52|Other|1|||
127998072|NCT00249873|460619712|FG000|Overall Study|Not treated|7|||
127998073|NCT00249873|460619713|FG001|Overall Study|Not treated|8|||
127998074|NCT00249873|460619712|FG000|Overall Study|Significant thrombocytopenia|9|||
127998075|NCT00249873|460619713|FG001|Overall Study|Significant thrombocytopenia|8|||
127998076|NCT00249873|460619712|FG000|Overall Study|Severe allergic reaction|8|||
127998077|NCT00249873|460619713|FG001|Overall Study|Severe allergic reaction|1|||
127998078|NCT00249873|460619712|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
127998079|NCT00249873|460619713|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
127998080|NCT00249873|460619712|FG000|Overall Study|Other Serious Adverse Event|86|||
127998081|NCT00249873|460619713|FG001|Overall Study|Other Serious Adverse Event|97|||
127998082|NCT00249873|460619712|FG000|Overall Study|Qualifying condition not present|20|||
127998083|NCT00249873|460619713|FG001|Overall Study|Qualifying condition not present|23|||
127998084|NCT00249873|460619712|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
127998085|NCT00249873|460619713|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
127998086|NCT00249873|460619712|FG000|Overall Study|Withdrawal by Subject|504|||
127998087|NCT00249873|460619713|FG001|Overall Study|Withdrawal by Subject|466|||
127998088|NCT00249873|460619712|FG000|Overall Study|Lost to Follow-up|4|||
127998089|NCT00249873|460619713|FG001|Overall Study|Lost to Follow-up|7|||
127998090|NCT00249873|460619712|FG000|Overall Study|Minor bleeding|99|||
127998091|NCT00249873|460619713|FG001|Overall Study|Minor bleeding|37|||
127998092|NCT00249873|460619712|FG000|Overall Study|Non-compliance|41|||
127998093|NCT00249873|460619713|FG001|Overall Study|Non-compliance|46|||
127998094|NCT00249873|460619712|FG000|Overall Study|Other non serious Adverse Event|112|||
127998095|NCT00249873|460619713|FG001|Overall Study|Other non serious Adverse Event|108|||
127998096|NCT00249873|460619712|FG000|Overall Study|Other contraindicated medication|1|||
127998097|NCT00249873|460619713|FG001|Overall Study|Other contraindicated medication|0|||
127998098|NCT00249873|460619712|FG000|Overall Study|Patient not wish to continue after May08|3|||
127998099|NCT00249873|460619713|FG001|Overall Study|Patient not wish to continue after May08|4|||
127998100|NCT00249873|460619712|FG000|Overall Study|Physician withdrew consent|59|||
127998101|NCT00249873|460619713|FG001|Overall Study|Physician withdrew consent|60|||
127998102|NCT00249873|460619712|FG000|Overall Study|Open label clopidogrel required|31|||
127998103|NCT00249873|460619713|FG001|Overall Study|Open label clopidogrel required|42|||
127998104|NCT00249873|460619712|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
127998105|NCT00249873|460619713|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
127998106|NCT00249873|460619712|FG000|Overall Study|Oral anticoagulant required|159|||
127998107|NCT00249873|460619713|FG001|Overall Study|Oral anticoagulant required|157|||
127998108|NCT00249873|460619712|FG000|Overall Study|Study drug intolerance|5|||
127998109|NCT00249873|460619713|FG001|Overall Study|Study drug intolerance|0|||
127998110|NCT00249873|460619712|FG000|Overall Study|Surgery/ procedure|9|||
127998111|NCT00249873|460619713|FG001|Overall Study|Surgery/ procedure|9|||
127998112|NCT00249873|460619712|FG000|Overall Study|Event related to cardiac condition|12|||
127998113|NCT00249873|460619713|FG001|Overall Study|Event related to cardiac condition|21|||
127998114|NCT00249873|460619712|FG000|Overall Study|Thromboembolic/outcome event|82|||
127998115|NCT00249873|460619713|FG001|Overall Study|Thromboembolic/outcome event|122|||
127998116|NCT03131167|460619714|FG000|Overall Study|Other (Unspecified)|0|||
127998117|NCT03131167|460619715|FG001|Overall Study|Other (Unspecified)|0|||
127998118|NCT03131167|460619716|FG002|Overall Study|Other (Unspecified)|0|||
127998119|NCT03131167|460619717|FG003|Overall Study|Other (Unspecified)|0|||
127998120|NCT03131167|460619718|FG004|Overall Study|Other (Unspecified)|0|||
127998121|NCT03131167|460619719|FG005|Overall Study|Other (Unspecified)|1|||
127998122|NCT03131167|460619720|FG006|Overall Study|Other (Unspecified)|0|||
127998123|NCT03131167|460619721|FG007|Overall Study|Other (Unspecified)|0|||
127998124|NCT03131167|460619722|FG008|Overall Study|Other (Unspecified)|0|||
127998125|NCT03131167|460619723|FG009|Overall Study|Other (Unspecified)|0|||
127998126|NCT03131167|460619724|FG010|Overall Study|Other (Unspecified)|0|||
127880892|NCT00566631|460186057|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
127887240|NCT01890785|460210523|FG000|Third Intervention|Withdrawal by Subject|0|||
127887241|NCT01890785|460210524|FG001|Third Intervention|Withdrawal by Subject|1|||
127887242|NCT01890785|460210525|FG002|Third Intervention|Withdrawal by Subject|0|||
127887243|NCT01890785|460210526|FG003|Third Intervention|Withdrawal by Subject|0|||
127887244|NCT01890785|460210527|FG004|Third Intervention|Withdrawal by Subject|0|||
127887245|NCT01890785|460210528|FG005|Third Intervention|Withdrawal by Subject|0|||
127887246|NCT02746705|460210531|FG000|Overall Study|Physician Decision|1|||
127887247|NCT02746705|460210532|FG001|Overall Study|Physician Decision|1|||
127998127|NCT03131167|460619725|FG011|Overall Study|Other (Unspecified)|0|||
127998128|NCT03131167|460619726|FG012|Overall Study|Other (Unspecified)|0|||
127998129|NCT00165503|460619727|FG000|Overall Study|Death|1|||
127998130|NCT00165503|460619727|FG000|Overall Study|Lost to Follow-up|12|||
127998131|NCT00165503|460619727|FG000|Overall Study|Unresectable|3|||
127998132|NCT00643201|460619728|FG000|Randomized, Completed 6 Months of Study|Death|20|||
127998133|NCT00643201|460619729|FG001|Randomized, Completed 6 Months of Study|Death|26|||
127998134|NCT00643201|460619728|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
127998135|NCT00643201|460619729|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
127998136|NCT00643201|460619728|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
127998137|NCT00643201|460619729|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
127998138|NCT00643201|460619728|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
127998139|NCT00643201|460619729|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
127998140|NCT00643201|460619728|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
127998141|NCT00643201|460619729|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
127998142|NCT00643201|460619728|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
127998143|NCT00643201|460619729|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
127998144|NCT00643201|460619728|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
127998145|NCT00643201|460619729|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
127998146|NCT00643201|460619728|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
127998147|NCT00643201|460619729|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
127998148|NCT00643201|460619728|FG000|Randomized, Completed 6 Months of Study|Other|107|||
127998149|NCT00643201|460619729|FG001|Randomized, Completed 6 Months of Study|Other|107|||
127998150|NCT00643201|460619728|FG000|Completed Study Follow Up|Death|28|||
127998151|NCT00643201|460619729|FG001|Completed Study Follow Up|Death|34|||
127998152|NCT00643201|460619728|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
127998153|NCT00643201|460619729|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
127998154|NCT00643201|460619728|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
127998155|NCT00643201|460619729|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
127998156|NCT00643201|460619728|FG000|Completed Study Follow Up|non-specified|1|||
127998157|NCT00643201|460619729|FG001|Completed Study Follow Up|non-specified|0|||
127998158|NCT02976519|460619730|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
127998159|NCT02976519|460619731|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
127998160|NCT02976519|460619732|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
127998161|NCT02976519|460619733|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
127998162|NCT02976519|460619734|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
127998163|NCT02976519|460619735|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
127998164|NCT02976519|460619736|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
127998165|NCT02976519|460619730|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
127998166|NCT02976519|460619731|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
127998167|NCT02976519|460619732|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
127998168|NCT02976519|460619733|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
127998169|NCT02976519|460619734|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
127998170|NCT02976519|460619735|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
127998171|NCT02976519|460619736|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
127998172|NCT02976519|460619730|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
127998173|NCT02976519|460619731|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
127998174|NCT02976519|460619732|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
127998175|NCT02976519|460619733|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
127998176|NCT02976519|460619734|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
127998177|NCT02976519|460619735|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
127998178|NCT02976519|460619736|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
127998179|NCT02976519|460619730|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
127998180|NCT02976519|460619731|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
127998181|NCT02976519|460619732|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
127998182|NCT02976519|460619733|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
127998183|NCT02976519|460619734|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
127998184|NCT02976519|460619735|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
127998185|NCT02976519|460619736|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
127998186|NCT02976519|460619730|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
127998187|NCT02976519|460619731|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
127998188|NCT02976519|460619732|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
127998189|NCT02976519|460619733|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
127998190|NCT02976519|460619734|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
127998191|NCT02976519|460619735|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
127998192|NCT02976519|460619736|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
127998193|NCT02346708|460619737|FG000|Overall Study|Adverse Event|2|||
127998194|NCT02346708|460619738|FG001|Overall Study|Adverse Event|0|||
127998195|NCT02346708|460619737|FG000|Overall Study|Protocol Violation|0|||
127998196|NCT02346708|460619738|FG001|Overall Study|Protocol Violation|1|||
127998197|NCT00928434|460619739|FG000|Overall Study|Adverse Event|14|||
127998198|NCT00928434|460619740|FG001|Overall Study|Adverse Event|5|||
127998199|NCT00928434|460619741|FG002|Overall Study|Adverse Event|18|||
127998200|NCT00928434|460619739|FG000|Overall Study|Protocol Violation|5|||
127998201|NCT00928434|460619740|FG001|Overall Study|Protocol Violation|0|||
127998202|NCT00928434|460619741|FG002|Overall Study|Protocol Violation|8|||
127998203|NCT00928434|460619739|FG000|Overall Study|Physician Decision|2|||
127998204|NCT00928434|460619740|FG001|Overall Study|Physician Decision|0|||
127998205|NCT00928434|460619741|FG002|Overall Study|Physician Decision|3|||
127998206|NCT00928434|460619739|FG000|Overall Study|Lost to Follow-up|1|||
127998207|NCT00928434|460619740|FG001|Overall Study|Lost to Follow-up|0|||
127998208|NCT00928434|460619741|FG002|Overall Study|Lost to Follow-up|3|||
127998209|NCT00928434|460619739|FG000|Overall Study|Withdrawal by Subject|5|||
127998210|NCT00928434|460619740|FG001|Overall Study|Withdrawal by Subject|3|||
127998211|NCT00928434|460619741|FG002|Overall Study|Withdrawal by Subject|2|||
127998212|NCT00928434|460619739|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
127998213|NCT00928434|460619740|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
127998214|NCT00928434|460619741|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
127998215|NCT00928434|460619739|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
127998216|NCT00928434|460619740|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
127998217|NCT00928434|460619741|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
127998218|NCT00928434|460619739|FG000|Overall Study|Other (not meeting above criteria)|5|||
127998219|NCT00928434|460619740|FG001|Overall Study|Other (not meeting above criteria)|1|||
127998220|NCT00928434|460619741|FG002|Overall Study|Other (not meeting above criteria)|2|||
127998221|NCT01278342|460619744|FG000|Overall Study|Physician Decision|0|||
127998222|NCT01278342|460619745|FG001|Overall Study|Physician Decision|1|||
127998223|NCT01278342|460619746|FG002|Overall Study|Physician Decision|0|||
127998224|NCT01278342|460619744|FG000|Overall Study|Lost to Follow-up|1|||
127998225|NCT01278342|460619745|FG001|Overall Study|Lost to Follow-up|0|||
127998226|NCT01278342|460619746|FG002|Overall Study|Lost to Follow-up|0|||
127998227|NCT01278342|460619744|FG000|Overall Study|Administrative problems|2|||
127998228|NCT01278342|460619745|FG001|Overall Study|Administrative problems|0|||
127998229|NCT01278342|460619746|FG002|Overall Study|Administrative problems|0|||
127998230|NCT01278342|460619744|FG000|Overall Study|Other|1|||
127998231|NCT01278342|460619745|FG001|Overall Study|Other|0|||
127998232|NCT01278342|460619746|FG002|Overall Study|Other|0|||
127998233|NCT00313846|460619752|FG000|Overall Study|Withdrawal by Subject|2|||
127998234|NCT00313846|460619753|FG001|Overall Study|Withdrawal by Subject|0|||
127998235|NCT00313846|460619752|FG000|Overall Study|Adverse Event|1|||
127998236|NCT00313846|460619753|FG001|Overall Study|Adverse Event|8|||
127998237|NCT00313846|460619752|FG000|Overall Study|Administrative|2|||
127998238|NCT00313846|460619753|FG001|Overall Study|Administrative|3|||
127998239|NCT01462630|460619755|FG000|Overall Study|Did not initiate therapy|3|||
127998240|NCT01462630|460619755|FG000|Overall Study|Death|1|||
127998241|NCT01462630|460619755|FG000|Overall Study|Protocol Violation|2|||
127998242|NCT01462630|460619755|FG000|Overall Study|Adverse Event|1|||
127998243|NCT01765296|460619756|FG000|Overall Study|Protocol Violation|0|||
127998244|NCT01765296|460619757|FG001|Overall Study|Protocol Violation|5|||
127998245|NCT01765296|460619758|FG002|Overall Study|Protocol Violation|4|||
127998246|NCT01765296|460619756|FG000|Overall Study|Withdrawal by Subject|4|||
127998247|NCT01765296|460619757|FG001|Overall Study|Withdrawal by Subject|2|||
127665924|NCT02718417|459398420|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
127665925|NCT02718417|459398421|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
127665926|NCT02718417|459398419|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
127665927|NCT02718417|459398420|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
127665928|NCT02718417|459398421|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
127665929|NCT02718417|459398419|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
127665930|NCT02718417|459398420|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
127665931|NCT02718417|459398421|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
127665932|NCT02718417|459398419|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
127998248|NCT01765296|460619758|FG002|Overall Study|Withdrawal by Subject|2|||
127998249|NCT01765296|460619756|FG000|Overall Study|Adverse Event|1|||
127998250|NCT01765296|460619757|FG001|Overall Study|Adverse Event|13|||
127998251|NCT01765296|460619758|FG002|Overall Study|Adverse Event|5|||
127998252|NCT01765296|460619756|FG000|Overall Study|Lack of Efficacy|0|||
127998253|NCT01765296|460619757|FG001|Overall Study|Lack of Efficacy|0|||
127998254|NCT01765296|460619758|FG002|Overall Study|Lack of Efficacy|2|||
127998255|NCT03933449|460619759|FG000|Overall Study|Adverse Event|6|||
127998256|NCT03933449|460619760|FG001|Overall Study|Adverse Event|4|||
127998257|NCT03933449|460619759|FG000|Overall Study|Death|55|||
127665933|NCT02718417|459398420|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
127998258|NCT03933449|460619760|FG001|Overall Study|Death|57|||
127998259|NCT03933449|460619759|FG000|Overall Study|Sponsor Decision|1|||
127998260|NCT03933449|460619760|FG001|Overall Study|Sponsor Decision|0|||
127998261|NCT02659943|460619761|FG000|Overall Study|Switched to alternative treatment|1|||
127998262|NCT02659943|460619762|FG001|Overall Study|Switched to alternative treatment|1|||
127998263|NCT02659943|460619763|FG002|Overall Study|Switched to alternative treatment|0|||
127998264|NCT02659943|460619764|FG003|Overall Study|Switched to alternative treatment|2|||
127665934|NCT02718417|459398421|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
127665935|NCT02718417|459398419|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
127665936|NCT02718417|459398420|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
127665937|NCT02718417|459398421|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
127665938|NCT02718417|459398419|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
127998265|NCT02659943|460619765|FG004|Overall Study|Switched to alternative treatment|1|||
127998266|NCT02659943|460619766|FG005|Overall Study|Switched to alternative treatment|0|||
127998267|NCT02659943|460619767|FG006|Overall Study|Switched to alternative treatment|1|||
127998268|NCT02659943|460619761|FG000|Overall Study|Disease progression on study|0|||
127665939|NCT02718417|459398420|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
127665940|NCT02718417|459398421|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
127665941|NCT02718417|459398419|FG000|Chemotherapy Phase (CP)|Other|2|||
127998269|NCT02659943|460619762|FG001|Overall Study|Disease progression on study|1|||
127998270|NCT02659943|460619763|FG002|Overall Study|Disease progression on study|1|||
127998271|NCT02659943|460619764|FG003|Overall Study|Disease progression on study|1|||
127998272|NCT02659943|460619765|FG004|Overall Study|Disease progression on study|1|||
127998273|NCT02659943|460619766|FG005|Overall Study|Disease progression on study|4|||
127998274|NCT02659943|460619767|FG006|Overall Study|Disease progression on study|0|||
127998275|NCT02659943|460619761|FG000|Overall Study|Patient's condition per principal investigator|0|||
127998276|NCT02659943|460619762|FG001|Overall Study|Patient's condition per principal investigator|0|||
127998277|NCT02659943|460619763|FG002|Overall Study|Patient's condition per principal investigator|0|||
127998278|NCT02659943|460619764|FG003|Overall Study|Patient's condition per principal investigator|0|||
127998279|NCT02659943|460619765|FG004|Overall Study|Patient's condition per principal investigator|0|||
127998280|NCT02659943|460619766|FG005|Overall Study|Patient's condition per principal investigator|1|||
127998281|NCT02659943|460619767|FG006|Overall Study|Patient's condition per principal investigator|0|||
127998282|NCT02659943|460619761|FG000|Overall Study|Ineligible|0|||
127998283|NCT02659943|460619762|FG001|Overall Study|Ineligible|0|||
127998284|NCT02659943|460619763|FG002|Overall Study|Ineligible|0|||
127998285|NCT02659943|460619764|FG003|Overall Study|Ineligible|0|||
127998286|NCT02659943|460619765|FG004|Overall Study|Ineligible|0|||
127998287|NCT02659943|460619766|FG005|Overall Study|Ineligible|0|||
127998288|NCT02659943|460619767|FG006|Overall Study|Ineligible|1|||
127998289|NCT02659943|460619761|FG000|Overall Study|No longer meets eligibility|0|||
127998290|NCT02659943|460619762|FG001|Overall Study|No longer meets eligibility|0|||
127998291|NCT02659943|460619763|FG002|Overall Study|No longer meets eligibility|0|||
127998292|NCT02659943|460619764|FG003|Overall Study|No longer meets eligibility|0|||
127998293|NCT02659943|460619765|FG004|Overall Study|No longer meets eligibility|0|||
127998294|NCT02659943|460619766|FG005|Overall Study|No longer meets eligibility|0|||
127998295|NCT02659943|460619767|FG006|Overall Study|No longer meets eligibility|1|||
127998296|NCT02659943|460619761|FG000|Overall Study|No treatment, per protocol|0|||
127998297|NCT02659943|460619762|FG001|Overall Study|No treatment, per protocol|0|||
127998298|NCT02659943|460619763|FG002|Overall Study|No treatment, per protocol|0|||
127998299|NCT02659943|460619764|FG003|Overall Study|No treatment, per protocol|0|||
127998300|NCT02659943|460619765|FG004|Overall Study|No treatment, per protocol|0|||
127998301|NCT02659943|460619766|FG005|Overall Study|No treatment, per protocol|0|||
127998302|NCT02659943|460619767|FG006|Overall Study|No treatment, per protocol|3|||
127998303|NCT01576575|460619768|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
127998304|NCT01576575|460619768|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
127998305|NCT01576575|460619768|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
127998306|NCT01723072|460619769|FG000|Overall Study|Withdrawal by Subject|7|||
127998307|NCT01723072|460619770|FG001|Overall Study|Withdrawal by Subject|13|||
127998308|NCT01723072|460619769|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
127998309|NCT01723072|460619770|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
127998310|NCT01723072|460619769|FG000|Overall Study|Other|4|||
127998311|NCT01723072|460619770|FG001|Overall Study|Other|3|||
127998312|NCT02221648|460619774|FG000|Overall Study|Withdrawal by Subject|3|||
127998313|NCT02221648|460619775|FG001|Overall Study|Withdrawal by Subject|3|||
127998314|NCT01922258|460619781|FG000|Overall Study|Lost to Follow-up|1|||
127998315|NCT01922258|460619782|FG001|Overall Study|Lost to Follow-up|1|||
127998316|NCT01922258|460619781|FG000|Overall Study|Adverse Event|9|||
127998317|NCT01922258|460619782|FG001|Overall Study|Adverse Event|2|||
127665942|NCT02718417|459398420|FG001|Chemotherapy Phase (CP)|Other|0|||
127998318|NCT01922258|460619781|FG000|Overall Study|Met Withdrawal Criteria|0|||
127998319|NCT01922258|460619782|FG001|Overall Study|Met Withdrawal Criteria|4|||
127998320|NCT01922258|460619781|FG000|Overall Study|Withdrawn by the Investigator|1|||
127998321|NCT01922258|460619782|FG001|Overall Study|Withdrawn by the Investigator|4|||
127998322|NCT01922258|460619781|FG000|Overall Study|Withdrawal by participant|5|||
127998323|NCT01922258|460619782|FG001|Overall Study|Withdrawal by participant|5|||
127998324|NCT04552132|460619783|FG000|Overall Study|Lost to Follow-up|4|||
127998325|NCT04552132|460619784|FG001|Overall Study|Lost to Follow-up|3|||
127998326|NCT04552132|460619783|FG000|Overall Study|Protocol Violation|1|||
127998327|NCT04552132|460619784|FG001|Overall Study|Protocol Violation|0|||
127998328|NCT01951417|460619785|FG000|Overall Study|Withdrawal by Subject|1|||
127998329|NCT01951417|460619785|FG000|Overall Study|Protocol Violation|2|||
127998330|NCT01951417|460619785|FG000|Overall Study|Lost to Follow-up|6|||
127998331|NCT01598610|460619790|FG000|Overall Study|Adverse Event|1|||
127998332|NCT01705977|460619791|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
127998333|NCT01705977|460619792|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
127998334|NCT01705977|460619791|FG000|Treatment Period (Year 1)|Adverse Event|57|||
127998335|NCT01705977|460619792|FG001|Treatment Period (Year 1)|Adverse Event|49|||
127998336|NCT01705977|460619791|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
127998337|NCT01705977|460619792|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
127998338|NCT01705977|460619791|FG000|Treatment Period (Year 1)|Site closure|3|||
127998339|NCT01705977|460619792|FG001|Treatment Period (Year 1)|Site closure|2|||
127998340|NCT01705977|460619791|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
127998341|NCT01705977|460619792|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
127998342|NCT01705977|460619791|FG000|Treatment Period (Year 1)|Physician Decision|48|||
127998343|NCT01705977|460619792|FG001|Treatment Period (Year 1)|Physician Decision|38|||
127998344|NCT01705977|460619791|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
127998345|NCT01705977|460619792|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
127998346|NCT01705977|460619791|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
127998347|NCT01705977|460619792|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
127998348|NCT01705977|460619791|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
127998349|NCT01705977|460619792|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
127998350|NCT01705977|460619791|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
127998351|NCT01705977|460619792|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
127998352|NCT01705977|460619791|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
127998353|NCT01705977|460619792|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
127998354|NCT01705977|460619791|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
127998355|NCT01705977|460619792|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
127998356|NCT03066830|460619793|FG000|Overall Study|At the Participant's own Request|16|||
127998357|NCT03066830|460619794|FG001|Overall Study|At the Participant's own Request|17|||
127998358|NCT03066830|460619793|FG000|Overall Study|Other|3|||
127998359|NCT03066830|460619794|FG001|Overall Study|Other|0|||
127998360|NCT03066830|460619793|FG000|Overall Study|Poor Compliance to Protocol|1|||
127998361|NCT03066830|460619794|FG001|Overall Study|Poor Compliance to Protocol|0|||
127998362|NCT03066830|460619793|FG000|Overall Study|Adverse Event|2|||
127998363|NCT03066830|460619794|FG001|Overall Study|Adverse Event|2|||
127998364|NCT03066830|460619793|FG000|Overall Study|Lost to Follow-up|11|||
127998365|NCT03066830|460619794|FG001|Overall Study|Lost to Follow-up|3|||
127998366|NCT02039778|460619796|FG000|Overall Study|Death|2|||
127998367|NCT02039778|460619796|FG000|Overall Study|Withdrawal by Subject|1|||
127998368|NCT02039778|460619796|FG000|Overall Study|Never started the protocol treatment|1|||
127998369|NCT00096538|460619797|FG000|Overall Study|Withdrawal by Subject|1|||
127998370|NCT00808067|460619799|FG000|Overall Study|Major/minor bleed|30|||
127998371|NCT00808067|460619800|FG001|Overall Study|Major/minor bleed|44|||
127998372|NCT00808067|460619799|FG000|Overall Study|Outcome event - other|33|||
127998373|NCT00808067|460619800|FG001|Overall Study|Outcome event - other|25|||
127998374|NCT00808067|460619799|FG000|Overall Study|Adverse Event|111|||
127998375|NCT00808067|460619800|FG001|Overall Study|Adverse Event|121|||
127998376|NCT00808067|460619799|FG000|Overall Study|Hospitalization (not including surgery)|18|||
127998377|NCT00808067|460619800|FG001|Overall Study|Hospitalization (not including surgery)|17|||
127998378|NCT00808067|460619799|FG000|Overall Study|Hospitalization due to surgery|37|||
127998379|NCT00808067|460619800|FG001|Overall Study|Hospitalization due to surgery|40|||
127998380|NCT00808067|460619799|FG000|Overall Study|Reduced creatinine clearance|53|||
127665943|NCT02718417|459398421|FG002|Chemotherapy Phase (CP)|Other|1|||
127665944|NCT02718417|459398419|FG000|Maintenance Phase (MP)|Adverse Event|21|||
127665945|NCT02718417|459398420|FG001|Maintenance Phase (MP)|Adverse Event|26|||
127665946|NCT02718417|459398421|FG002|Maintenance Phase (MP)|Adverse Event|0|||
127665947|NCT02718417|459398419|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
127665948|NCT02718417|459398420|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
127887248|NCT02746705|460210531|FG000|Overall Study|Lost to Follow-up|1|||
127887249|NCT02746705|460210532|FG001|Overall Study|Lost to Follow-up|0|||
127887250|NCT02746705|460210531|FG000|Overall Study|outlier scores deemed not valid|0|||
127887251|NCT02746705|460210532|FG001|Overall Study|outlier scores deemed not valid|1|||
127887252|NCT00575328|460210533|FG000|Overall Study|Adverse Event|1|||
127887253|NCT00575328|460210534|FG001|Overall Study|Adverse Event|1|||
127887254|NCT00575328|460210533|FG000|Overall Study|Lost to Follow-up|2|||
127887255|NCT00575328|460210534|FG001|Overall Study|Lost to Follow-up|1|||
127887256|NCT02124746|460210535|FG000|Overall Study|Adverse Event|2|||
127887257|NCT02124746|460210536|FG001|Overall Study|Adverse Event|1|||
127887258|NCT02124746|460210537|FG002|Overall Study|Adverse Event|2|||
127887259|NCT02124746|460210535|FG000|Overall Study|Death|2|||
127998381|NCT00808067|460619800|FG001|Overall Study|Reduced creatinine clearance|55|||
127998382|NCT00808067|460619799|FG000|Overall Study|Elevated LFT results|7|||
127998383|NCT00808067|460619800|FG001|Overall Study|Elevated LFT results|3|||
127998384|NCT00808067|460619799|FG000|Overall Study|Patient refused to take study medication|65|||
127998385|NCT00808067|460619800|FG001|Overall Study|Patient refused to take study medication|76|||
127998386|NCT00808067|460619799|FG000|Overall Study|Missing|1|||
127998387|NCT00808067|460619800|FG001|Overall Study|Missing|0|||
127998388|NCT00808067|460619799|FG000|Overall Study|Death|1|||
127998389|NCT00808067|460619800|FG001|Overall Study|Death|1|||
127998390|NCT00808067|460619799|FG000|Overall Study|Procedure|6|||
127998391|NCT00808067|460619800|FG001|Overall Study|Procedure|7|||
127998392|NCT00808067|460619799|FG000|Overall Study|Withdrawal by Subject|21|||
127998393|NCT00808067|460619800|FG001|Overall Study|Withdrawal by Subject|25|||
127998394|NCT00808067|460619799|FG000|Overall Study|Site closed|4|||
127998395|NCT00808067|460619800|FG001|Overall Study|Site closed|3|||
127998396|NCT00808067|460619799|FG000|Overall Study|Physician Decision|47|||
127998397|NCT00808067|460619800|FG001|Overall Study|Physician Decision|38|||
127998398|NCT00808067|460619799|FG000|Overall Study|Protocol Violation|3|||
127998399|NCT00808067|460619800|FG001|Overall Study|Protocol Violation|11|||
127998400|NCT00808067|460619799|FG000|Overall Study|Patient elected|7|||
127998401|NCT00808067|460619800|FG001|Overall Study|Patient elected|9|||
127998402|NCT00808067|460619799|FG000|Overall Study|Site closed for cause|19|||
127998403|NCT00808067|460619800|FG001|Overall Study|Site closed for cause|19|||
127998404|NCT00808067|460619799|FG000|Overall Study|Other reason not defined above|5|||
127998405|NCT00808067|460619800|FG001|Overall Study|Other reason not defined above|5|||
127998406|NCT00808067|460619799|FG000|Overall Study|Excluded from analysis|13|||
127998407|NCT00808067|460619800|FG001|Overall Study|Excluded from analysis|19|||
127998408|NCT02532283|460619801|FG000|Overall Study|Adverse Event|0|||
127998409|NCT02532283|460619802|FG001|Overall Study|Adverse Event|1|||
127998410|NCT02532283|460619801|FG000|Overall Study|Death|1|||
127998411|NCT02532283|460619802|FG001|Overall Study|Death|0|||
127998412|NCT02532283|460619801|FG000|Overall Study|Lost to Follow-up|0|||
127998413|NCT02532283|460619802|FG001|Overall Study|Lost to Follow-up|1|||
127998414|NCT02532283|460619801|FG000|Overall Study|Withdrawal by Subject|8|||
127998415|NCT02532283|460619802|FG001|Overall Study|Withdrawal by Subject|3|||
127998416|NCT00490971|460619809|FG000|Acute/Continuation|Adverse Event|62|||
127998417|NCT00490971|460619810|FG001|Acute/Continuation|Adverse Event|13|||
127998418|NCT00490971|460619811|FG002|Acute/Continuation|Adverse Event|0|||
127998419|NCT00490971|460619812|FG003|Acute/Continuation|Adverse Event|0|||
127998420|NCT00490971|460619813|FG004|Acute/Continuation|Adverse Event|0|||
127998421|NCT00490971|460619809|FG000|Acute/Continuation|Death|2|||
127998422|NCT00490971|460619810|FG001|Acute/Continuation|Death|0|||
127998423|NCT00490971|460619811|FG002|Acute/Continuation|Death|0|||
127998424|NCT00490971|460619812|FG003|Acute/Continuation|Death|0|||
127998425|NCT00490971|460619813|FG004|Acute/Continuation|Death|0|||
127998426|NCT00490971|460619809|FG000|Acute/Continuation|Lack of Efficacy|106|||
127998427|NCT00490971|460619810|FG001|Acute/Continuation|Lack of Efficacy|12|||
127998428|NCT00490971|460619811|FG002|Acute/Continuation|Lack of Efficacy|0|||
127998429|NCT00490971|460619812|FG003|Acute/Continuation|Lack of Efficacy|0|||
127998430|NCT00490971|460619813|FG004|Acute/Continuation|Lack of Efficacy|0|||
127998431|NCT00490971|460619809|FG000|Acute/Continuation|Lost to Follow-up|23|||
127998432|NCT00490971|460619810|FG001|Acute/Continuation|Lost to Follow-up|7|||
127998433|NCT00490971|460619811|FG002|Acute/Continuation|Lost to Follow-up|0|||
127998434|NCT00490971|460619812|FG003|Acute/Continuation|Lost to Follow-up|0|||
127998435|NCT00490971|460619813|FG004|Acute/Continuation|Lost to Follow-up|0|||
127998436|NCT00490971|460619809|FG000|Acute/Continuation|Protocol Violation|10|||
127998437|NCT00490971|460619810|FG001|Acute/Continuation|Protocol Violation|2|||
127998438|NCT00490971|460619811|FG002|Acute/Continuation|Protocol Violation|0|||
127998439|NCT00490971|460619812|FG003|Acute/Continuation|Protocol Violation|0|||
127998440|NCT00490971|460619813|FG004|Acute/Continuation|Protocol Violation|0|||
127998441|NCT00490971|460619809|FG000|Acute/Continuation|Withdrawal by Subject|92|||
127998442|NCT00490971|460619810|FG001|Acute/Continuation|Withdrawal by Subject|24|||
127998443|NCT00490971|460619811|FG002|Acute/Continuation|Withdrawal by Subject|0|||
127998444|NCT00490971|460619812|FG003|Acute/Continuation|Withdrawal by Subject|0|||
127998445|NCT00490971|460619813|FG004|Acute/Continuation|Withdrawal by Subject|0|||
127998446|NCT00490971|460619809|FG000|Acute/Continuation|Other|11|||
127998447|NCT00490971|460619810|FG001|Acute/Continuation|Other|4|||
127998448|NCT00490971|460619811|FG002|Acute/Continuation|Other|0|||
127998449|NCT00490971|460619812|FG003|Acute/Continuation|Other|0|||
127998450|NCT00490971|460619813|FG004|Acute/Continuation|Other|0|||
127998451|NCT00490971|460619809|FG000|Maintenance|Adverse Event|0|||
127998452|NCT00490971|460619810|FG001|Maintenance|Adverse Event|0|||
127998453|NCT00490971|460619811|FG002|Maintenance|Adverse Event|4|||
127998454|NCT00490971|460619812|FG003|Maintenance|Adverse Event|5|||
127998455|NCT00490971|460619813|FG004|Maintenance|Adverse Event|7|||
127998456|NCT00490971|460619809|FG000|Maintenance|Death|0|||
127998457|NCT00490971|460619810|FG001|Maintenance|Death|0|||
127998458|NCT00490971|460619811|FG002|Maintenance|Death|0|||
127998459|NCT00490971|460619812|FG003|Maintenance|Death|2|||
127998460|NCT00490971|460619813|FG004|Maintenance|Death|0|||
127998461|NCT00490971|460619809|FG000|Maintenance|Lost to Follow-up|0|||
127665949|NCT02718417|459398421|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
127665950|NCT02718417|459398419|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
127665951|NCT02718417|459398420|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
127665952|NCT02718417|459398421|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
127998462|NCT00490971|460619810|FG001|Maintenance|Lost to Follow-up|0|||
127998463|NCT00490971|460619811|FG002|Maintenance|Lost to Follow-up|5|||
127998464|NCT00490971|460619812|FG003|Maintenance|Lost to Follow-up|8|||
127998465|NCT00490971|460619813|FG004|Maintenance|Lost to Follow-up|10|||
127998466|NCT00490971|460619809|FG000|Maintenance|Pregnancy|0|||
127998467|NCT00490971|460619810|FG001|Maintenance|Pregnancy|0|||
127998468|NCT00490971|460619811|FG002|Maintenance|Pregnancy|1|||
127998469|NCT00490971|460619812|FG003|Maintenance|Pregnancy|0|||
127998470|NCT00490971|460619813|FG004|Maintenance|Pregnancy|0|||
127998471|NCT00490971|460619809|FG000|Maintenance|Protocol Violation|0|||
127998472|NCT00490971|460619810|FG001|Maintenance|Protocol Violation|0|||
127998473|NCT00490971|460619811|FG002|Maintenance|Protocol Violation|4|||
127998474|NCT00490971|460619812|FG003|Maintenance|Protocol Violation|1|||
127998475|NCT00490971|460619813|FG004|Maintenance|Protocol Violation|1|||
127998476|NCT00490971|460619809|FG000|Maintenance|Withdrawal by Subject|0|||
127998477|NCT00490971|460619810|FG001|Maintenance|Withdrawal by Subject|0|||
127998478|NCT00490971|460619811|FG002|Maintenance|Withdrawal by Subject|26|||
127998479|NCT00490971|460619812|FG003|Maintenance|Withdrawal by Subject|28|||
127998480|NCT00490971|460619813|FG004|Maintenance|Withdrawal by Subject|18|||
127998481|NCT00490971|460619809|FG000|Maintenance|Other|0|||
127998482|NCT00490971|460619810|FG001|Maintenance|Other|0|||
127998483|NCT00490971|460619811|FG002|Maintenance|Other|11|||
127998484|NCT00490971|460619812|FG003|Maintenance|Other|9|||
127998485|NCT00490971|460619813|FG004|Maintenance|Other|3|||
127998486|NCT01212094|460621479|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
127998487|NCT01212094|460621480|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
127998488|NCT01212094|460621481|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
127998489|NCT01212094|460621479|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
127998490|NCT01212094|460621480|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
127998491|NCT01212094|460621481|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
127998492|NCT01212094|460621479|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
127998493|NCT01212094|460621480|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
127998494|NCT01212094|460621481|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
127998495|NCT01212094|460621479|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
127998496|NCT01212094|460621480|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
127998497|NCT01212094|460621481|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
127998498|NCT01212094|460621479|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
127998499|NCT01212094|460621480|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
127998500|NCT01212094|460621481|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
127998501|NCT01212094|460621479|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
127998502|NCT01212094|460621480|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
127998503|NCT01212094|460621481|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
127998504|NCT02019550|460621483|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
127998505|NCT02019550|460621484|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
127998506|NCT02291029|460621489|FG000|Overall Study|Withdrawal by Subject|0|||
127998507|NCT02291029|460621490|FG001|Overall Study|Withdrawal by Subject|0|||
127998508|NCT02291029|460621491|FG002|Overall Study|Withdrawal by Subject|1|||
127998509|NCT02291029|460621492|FG003|Overall Study|Withdrawal by Subject|0|||
127998510|NCT02291029|460621493|FG004|Overall Study|Withdrawal by Subject|0|||
127998511|NCT02291029|460621494|FG005|Overall Study|Withdrawal by Subject|0|||
127998512|NCT02291029|460621489|FG000|Overall Study|Adverse Event|0|||
127998513|NCT02291029|460621490|FG001|Overall Study|Adverse Event|1|||
127998514|NCT02291029|460621491|FG002|Overall Study|Adverse Event|0|||
127998515|NCT02291029|460621492|FG003|Overall Study|Adverse Event|0|||
127998516|NCT02291029|460621493|FG004|Overall Study|Adverse Event|0|||
127665953|NCT02718417|459398419|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
127998517|NCT02291029|460621494|FG005|Overall Study|Adverse Event|0|||
127998518|NCT02922153|460621495|FG000|Overall Study|Death|8|||
127998519|NCT02922153|460621496|FG001|Overall Study|Death|1|||
127665954|NCT02718417|459398420|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
127998520|NCT02922153|460621495|FG000|Overall Study|Lost to Follow-up|1|||
127998521|NCT02922153|460621496|FG001|Overall Study|Lost to Follow-up|0|||
127998522|NCT02922153|460621495|FG000|Overall Study|Physician Decision|1|||
127998523|NCT02922153|460621496|FG001|Overall Study|Physician Decision|1|||
127998524|NCT02692586|460621499|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
127665955|NCT02718417|459398421|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
127998525|NCT02692586|460621499|FG000|Overall Study|Received adjunctive thrombolytics|2|||
127998526|NCT01051557|460621501|FG000|Overall Study|Physician Decision|1|||
127998527|NCT01051557|460621502|FG001|Overall Study|Physician Decision|0|||
127998528|NCT01051557|460621503|FG002|Overall Study|Physician Decision|0|||
127998529|NCT01051557|460621504|FG003|Overall Study|Physician Decision|0|||
127998530|NCT01051557|460621505|FG004|Overall Study|Physician Decision|0|||
127998531|NCT01051557|460621506|FG005|Overall Study|Physician Decision|0|||
127998532|NCT01051557|460621507|FG006|Overall Study|Physician Decision|0|||
127998533|NCT01051557|460621501|FG000|Overall Study|disease progression|3|||
127998534|NCT01051557|460621502|FG001|Overall Study|disease progression|3|||
127998535|NCT01051557|460621503|FG002|Overall Study|disease progression|5|||
127998536|NCT01051557|460621504|FG003|Overall Study|disease progression|2|||
127998537|NCT01051557|460621505|FG004|Overall Study|disease progression|4|||
127998538|NCT01051557|460621506|FG005|Overall Study|disease progression|3|||
127998539|NCT01051557|460621507|FG006|Overall Study|disease progression|1|||
127998540|NCT01051557|460621501|FG000|Overall Study|Withdrawal by Subject|0|||
127998541|NCT01051557|460621502|FG001|Overall Study|Withdrawal by Subject|0|||
127998542|NCT01051557|460621503|FG002|Overall Study|Withdrawal by Subject|1|||
127998543|NCT01051557|460621504|FG003|Overall Study|Withdrawal by Subject|0|||
127998544|NCT01051557|460621505|FG004|Overall Study|Withdrawal by Subject|2|||
127998545|NCT01051557|460621506|FG005|Overall Study|Withdrawal by Subject|0|||
127998546|NCT01051557|460621507|FG006|Overall Study|Withdrawal by Subject|1|||
127998547|NCT01051557|460621501|FG000|Overall Study|Adverse Event|0|||
127998548|NCT01051557|460621502|FG001|Overall Study|Adverse Event|0|||
127998549|NCT01051557|460621503|FG002|Overall Study|Adverse Event|0|||
127998550|NCT01051557|460621504|FG003|Overall Study|Adverse Event|1|||
127998551|NCT01051557|460621505|FG004|Overall Study|Adverse Event|1|||
127998552|NCT01051557|460621506|FG005|Overall Study|Adverse Event|3|||
127998553|NCT01051557|460621507|FG006|Overall Study|Adverse Event|4|||
127998554|NCT04110314|460621508|FG000|Overall Study|Did not meet inclusion criteria|35255|||
127998555|NCT04110314|460621509|FG001|Overall Study|Did not meet inclusion criteria|35104|||
127998556|NCT04110314|460621510|FG002|Overall Study|Did not meet inclusion criteria|35636|||
127998557|NCT04110314|460621511|FG003|Overall Study|Did not meet inclusion criteria|35135|||
127998558|NCT04110314|460621512|FG004|Overall Study|Did not meet inclusion criteria|35247|||
127998559|NCT04110314|460621513|FG005|Overall Study|Did not meet inclusion criteria|35727|||
127998560|NCT01178125|460621522|FG000|Overall Study|Lost to Follow-up|397|||
127998561|NCT01178125|460621522|FG000|Overall Study|Adverse Event|244|||
127998562|NCT01178125|460621522|FG000|Overall Study|Withdrawal by Subject|209|||
127998563|NCT01178125|460621522|FG000|Overall Study|Noncompliance|184|||
127998564|NCT01178125|460621522|FG000|Overall Study|Pregnancy|55|||
127998565|NCT01178125|460621522|FG000|Overall Study|Other Reason|39|||
127998566|NCT01178125|460621522|FG000|Overall Study|Sponsor Decision|28|||
127998567|NCT01178125|460621522|FG000|Overall Study|Protocol Violation|17|||
127998568|NCT01178125|460621522|FG000|Overall Study|Investigator Decision|5|||
127998569|NCT02948829|460621523|FG000|Overall Study|Lost to Follow-up|2|||
127998570|NCT02948829|460621523|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
127998571|NCT02948829|460621523|FG000|Overall Study|Pregnancy|1|||
127998572|NCT02948829|460621523|FG000|Overall Study|Other: Reason not Specified|8|||
127998573|NCT01004978|460621524|FG000|Overall Study|Disease progression|31|||
127998574|NCT01004978|460621525|FG001|Overall Study|Disease progression|48|||
127998575|NCT01004978|460621524|FG000|Overall Study|Adverse Event|42|||
127998576|NCT01004978|460621525|FG001|Overall Study|Adverse Event|22|||
127998577|NCT01004978|460621524|FG000|Overall Study|Death|3|||
127998578|NCT01004978|460621525|FG001|Overall Study|Death|2|||
127998579|NCT01004978|460621524|FG000|Overall Study|Withdrawal by Subject|16|||
127998580|NCT01004978|460621525|FG001|Overall Study|Withdrawal by Subject|16|||
127998581|NCT01004978|460621524|FG000|Overall Study|Alternative therapy|4|||
127998582|NCT01004978|460621525|FG001|Overall Study|Alternative therapy|8|||
127998583|NCT01004978|460621524|FG000|Overall Study|Physician Decision|6|||
127998584|NCT01004978|460621525|FG001|Overall Study|Physician Decision|3|||
127998585|NCT01004978|460621524|FG000|Overall Study|Other complicating disease|2|||
127998586|NCT01004978|460621525|FG001|Overall Study|Other complicating disease|2|||
127998587|NCT01004978|460621524|FG000|Overall Study|Protocol Violation|2|||
127998588|NCT01004978|460621525|FG001|Overall Study|Protocol Violation|3|||
127998589|NCT01004978|460621524|FG000|Overall Study|Non-compliance|3|||
127998590|NCT01004978|460621525|FG001|Overall Study|Non-compliance|2|||
127998591|NCT01004978|460621524|FG000|Overall Study|Ineligible|1|||
127998592|NCT01004978|460621525|FG001|Overall Study|Ineligible|0|||
127998593|NCT01004978|460621524|FG000|Overall Study|Unblinded|0|||
127998594|NCT01004978|460621525|FG001|Overall Study|Unblinded|1|||
127998595|NCT01004978|460621524|FG000|Overall Study|Performance status worsening|0|||
127998596|NCT01004978|460621525|FG001|Overall Study|Performance status worsening|1|||
127998597|NCT01004978|460621524|FG000|Overall Study|Never started treatment|8|||
127998598|NCT01004978|460621525|FG001|Overall Study|Never started treatment|9|||
127998599|NCT00369915|460621526|FG000|Overall Study|expected side effects|2|||
127998600|NCT00369915|460621527|FG001|Overall Study|expected side effects|1|||
127998601|NCT00369915|460621526|FG000|Overall Study|Withdrawal by Subject|4|||
127998602|NCT00369915|460621527|FG001|Overall Study|Withdrawal by Subject|1|||
127998603|NCT00369915|460621526|FG000|Overall Study|W/drawl by investigators|0|||
127998604|NCT00369915|460621527|FG001|Overall Study|W/drawl by investigators|1|||
127998605|NCT01711983|460621528|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
127998606|NCT01711983|460621528|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
127998607|NCT01711983|460621528|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
127998608|NCT01711983|460621528|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
127998609|NCT01447407|460621529|FG000|Overall Study|Withdrawal by Subject|2|||
127998610|NCT01447407|460621530|FG001|Overall Study|Withdrawal by Subject|0|||
127998611|NCT01447407|460621531|FG002|Overall Study|Withdrawal by Subject|0|||
127998612|NCT01447407|460621532|FG003|Overall Study|Withdrawal by Subject|1|||
127998613|NCT01447407|460621529|FG000|Overall Study|Physician Decision|0|||
127998614|NCT01447407|460621530|FG001|Overall Study|Physician Decision|0|||
127998615|NCT01447407|460621531|FG002|Overall Study|Physician Decision|1|||
127998616|NCT01447407|460621532|FG003|Overall Study|Physician Decision|1|||
127998617|NCT00268983|460621533|FG000|Overall Study|Death|3|||
127998618|NCT00268983|460621534|FG001|Overall Study|Death|0|||
127998619|NCT00321906|460621541|FG000|Overall Study|Adverse Event|36|||
127998620|NCT00321906|460621542|FG001|Overall Study|Adverse Event|44|||
127998621|NCT00321906|460621541|FG000|Overall Study|Death|9|||
127998622|NCT00321906|460621542|FG001|Overall Study|Death|6|||
127998623|NCT00321906|460621541|FG000|Overall Study|Lost to Follow-up|1|||
127998624|NCT00321906|460621542|FG001|Overall Study|Lost to Follow-up|2|||
127998625|NCT00321906|460621541|FG000|Overall Study|Withdrawal by Subject|0|||
127998626|NCT00321906|460621542|FG001|Overall Study|Withdrawal by Subject|4|||
127998627|NCT00838097|460621545|FG000|Overall Study|Ineligibility determined|6|||
127998628|NCT00838097|460621545|FG000|Overall Study|Adverse Event|2|||
127998629|NCT00838097|460621545|FG000|Overall Study|Withdrawal by Subject|3|||
127998630|NCT00838097|460621545|FG000|Overall Study|Requirement for alternative therapy|2|||
127998631|NCT00838097|460621545|FG000|Overall Study|Physician Decision|4|||
127998632|NCT00838097|460621545|FG000|Overall Study|Lost to Follow-up|11|||
127998633|NCT00838097|460621545|FG000|Overall Study|Death|6|||
127998634|NCT00838097|460621545|FG000|Overall Study|Protocol-specified criteria|142|||
127998635|NCT00871234|460621546|FG000|Overall Study|Adverse Event|2|||
127998636|NCT00871234|460621546|FG000|Overall Study|Lost to Follow-up|3|||
127998637|NCT03380377|460621549|FG000|Overall Study|Physician Decision|1|||
127998638|NCT03380377|460621549|FG000|Overall Study|Withdrawal by Subject|1|||
127998639|NCT02600923|460621552|FG000|Overall Study|Death|10|||
127998640|NCT02600923|460621552|FG000|Overall Study|Adverse Event|3|||
127998641|NCT02600923|460621552|FG000|Overall Study|Global deterioration of health status|2|||
127998642|NCT02600923|460621552|FG000|Overall Study|Insufficient clinical response|6|||
127998643|NCT02600923|460621552|FG000|Overall Study|Lost to Follow-up|1|||
127998644|NCT02600923|460621552|FG000|Overall Study|Withdrawal by Subject|5|||
127998645|NCT02600923|460621552|FG000|Overall Study|Objective progression or relapse|50|||
127998646|NCT02600923|460621552|FG000|Overall Study|Study terminated by Sponsor|53|||
127998647|NCT02600923|460621552|FG000|Overall Study|Not treated|1|||
127998648|NCT00792909|460621553|FG000|Overall Study|Withdrawal by Subject|0|||
127998649|NCT00792909|460621554|FG001|Overall Study|Withdrawal by Subject|1|||
127998650|NCT00792909|460621555|FG002|Overall Study|Withdrawal by Subject|0|||
127998651|NCT00128661|460621558|FG000|Overall Study|Adverse Event|14|||
127998652|NCT00128661|460621559|FG001|Overall Study|Adverse Event|11|||
127998653|NCT00128661|460621558|FG000|Overall Study|Lost to Follow-up|10|||
127998654|NCT00128661|460621559|FG001|Overall Study|Lost to Follow-up|7|||
127998655|NCT00128661|460621558|FG000|Overall Study|Withdrawal by Subject|243|||
127998656|NCT00128661|460621559|FG001|Overall Study|Withdrawal by Subject|232|||
127998657|NCT00128661|460621558|FG000|Overall Study|Other|7|||
127998658|NCT00128661|460621559|FG001|Overall Study|Other|8|||
127998659|NCT01261390|460621561|FG000|Overall Study|Significant Concurrent Illness|1|||
127998660|NCT01261390|460621562|FG001|Overall Study|Significant Concurrent Illness|0|||
127998661|NCT01261390|460621563|FG002|Overall Study|Significant Concurrent Illness|1|||
127998662|NCT01261390|460621564|FG003|Overall Study|Significant Concurrent Illness|0|||
127665956|NCT02718417|459398419|FG000|Maintenance Phase (MP)|Physician's decision|6|||
127665957|NCT02718417|459398420|FG001|Maintenance Phase (MP)|Physician's decision|7|||
127665958|NCT02718417|459398421|FG002|Maintenance Phase (MP)|Physician's decision|0|||
127665959|NCT02718417|459398419|FG000|Maintenance Phase (MP)|Progressive disease|100|||
127665960|NCT02718417|459398420|FG001|Maintenance Phase (MP)|Progressive disease|88|||
127998663|NCT01261390|460621561|FG000|Overall Study|Dissatisfaction with Treatment|2|||
127998664|NCT01261390|460621562|FG001|Overall Study|Dissatisfaction with Treatment|1|||
127998665|NCT01261390|460621563|FG002|Overall Study|Dissatisfaction with Treatment|1|||
127998666|NCT01261390|460621564|FG003|Overall Study|Dissatisfaction with Treatment|2|||
127998667|NCT01261390|460621561|FG000|Overall Study|Relocation|0|||
127998668|NCT01261390|460621562|FG001|Overall Study|Relocation|1|||
127998669|NCT01261390|460621563|FG002|Overall Study|Relocation|0|||
127998670|NCT01261390|460621564|FG003|Overall Study|Relocation|0|||
127998671|NCT01261390|460621561|FG000|Overall Study|Loss of Interest in the Study|3|||
127998672|NCT01261390|460621562|FG001|Overall Study|Loss of Interest in the Study|1|||
127998673|NCT01261390|460621563|FG002|Overall Study|Loss of Interest in the Study|0|||
127998674|NCT01261390|460621564|FG003|Overall Study|Loss of Interest in the Study|0|||
127998675|NCT01261390|460621561|FG000|Overall Study|Lost to Follow-up|1|||
127998676|NCT01261390|460621562|FG001|Overall Study|Lost to Follow-up|6|||
127998677|NCT01261390|460621563|FG002|Overall Study|Lost to Follow-up|5|||
127998678|NCT01261390|460621564|FG003|Overall Study|Lost to Follow-up|6|||
127998679|NCT00977613|460621569|FG000|Overall Study|Lost to Follow-up|16|||
127998680|NCT01497067|460621570|FG000|Overall Study|Lost to Follow-up|56|||
127998681|NCT01497067|460621570|FG000|Overall Study|Adverse Event|3|||
127998682|NCT01497067|460621570|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
127998683|NCT01497067|460621570|FG000|Overall Study|Other|13|||
127998684|NCT04346199|460621573|FG000|Overall Study|Death|8|||
127998685|NCT04346199|460621574|FG001|Overall Study|Death|9|||
127998686|NCT04346199|460621573|FG000|Overall Study|Lost to Follow-up|0|||
127998687|NCT04346199|460621574|FG001|Overall Study|Lost to Follow-up|1|||
127998688|NCT04346199|460621573|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
127998689|NCT04346199|460621574|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
127998690|NCT04346199|460621573|FG000|Overall Study|Withdrawal by Subject|5|||
127998691|NCT04346199|460621574|FG001|Overall Study|Withdrawal by Subject|1|||
127998692|NCT02989402|460621575|FG000|Overall Study|Adverse event, or serious adverse event|4|||
127998693|NCT02989402|460621575|FG000|Overall Study|Death|2|||
127998694|NCT02989402|460621575|FG000|Overall Study|Discontinuation of study treatment and premature patient withdrawal|3|||
127998695|NCT02989402|460621575|FG000|Overall Study|Lost to Follow-up|8|||
127998696|NCT02989402|460621575|FG000|Overall Study|Patient no longer on monotherapy|1|||
127998697|NCT02989402|460621575|FG000|Overall Study|Patient stopped Exelon® patch treatment|1|||
127998698|NCT02989402|460621575|FG000|Overall Study|Withdrawal by Subject|7|||
127998699|NCT02989402|460621575|FG000|Overall Study|Other|2|||
127998700|NCT05404711|460621589|FG000|Completed Study Visit|Withdrawal by Subject|1|||
127998701|NCT05404711|460621589|FG000|Completed 75-gram, 2-hour CGM-OGTT|Incomplete due to illness|1|||
127998702|NCT05404711|460621589|FG000|Completed 75-gram, 2-hour CGM-OGTT|CGM fell off early|3|||
127998703|NCT05404711|460621589|FG000|Valid 75-gram, 2-hour CGM-OGTT|No date/time recorded|4|||
127998704|NCT05404711|460621589|FG000|Valid 75-gram, 2-hour CGM-OGTT|Vomited after drinking glucose beverage at home|1|||
127998705|NCT05404711|460621589|FG000|Completed, Valid Lab-OGTT and CGM-OGTT|Incomplete glucose beverage for lab-OGTT|1|||
127998706|NCT04376515|460621592|FG000|Overall Study|Found to have been vaccinated before study start|6|||
127998707|NCT04376515|460621593|FG001|Overall Study|Found to have been vaccinated before study start|6|||
127998708|NCT01683604|460621595|FG000|Overall Study|Adverse Event|2|||
127998709|NCT01683604|460621595|FG000|Overall Study|Lack of Efficacy|1|||
127998710|NCT01683604|460621595|FG000|Overall Study|Other|2|||
127998711|NCT03430856|460621599|FG000|Overall Study|Adverse Event|0|||
127998712|NCT03430856|460621600|FG001|Overall Study|Adverse Event|1|||
127998713|NCT03430856|460621601|FG002|Overall Study|Adverse Event|0|||
127998714|NCT03430856|460621599|FG000|Overall Study|Rescue criteria|1|||
127998715|NCT03430856|460621600|FG001|Overall Study|Rescue criteria|1|||
127998716|NCT03430856|460621601|FG002|Overall Study|Rescue criteria|0|||
127998717|NCT03430856|460621599|FG000|Overall Study|Voluntary withdrawal of consent|1|||
127998718|NCT03430856|460621600|FG001|Overall Study|Voluntary withdrawal of consent|1|||
127998719|NCT03430856|460621601|FG002|Overall Study|Voluntary withdrawal of consent|1|||
127998720|NCT01949142|460621604|FG000|Overall Study|Withdrawal of consent|1|||
127998721|NCT01949142|460621605|FG001|Overall Study|Withdrawal of consent|0|||
127998722|NCT01949142|460621604|FG000|Overall Study|Lost to Follow-up|1|||
127998723|NCT01949142|460621605|FG001|Overall Study|Lost to Follow-up|1|||
127998724|NCT01949142|460621604|FG000|Overall Study|Parent changed their mind|1|||
127998725|NCT01949142|460621605|FG001|Overall Study|Parent changed their mind|0|||
127998726|NCT00565604|460621609|FG000|Overall Study|Failure to treat|2|||
127998727|NCT00565604|460621609|FG000|Overall Study|Lost to Follow-up|2|||
127998728|NCT05027815|460621610|FG000|Overall Study|Death|2|||
127998729|NCT05027815|460621611|FG001|Overall Study|Death|1|||
127998730|NCT01395810|460621612|FG000|Overall Study|Adverse Event|0|||
127998731|NCT01395810|460621613|FG001|Overall Study|Adverse Event|1|||
127998732|NCT01395810|460621614|FG002|Overall Study|Adverse Event|0|||
127998733|NCT01395810|460621615|FG003|Overall Study|Adverse Event|0|||
127998734|NCT01395810|460621612|FG000|Overall Study|Lack of Efficacy|0|||
127998735|NCT01395810|460621613|FG001|Overall Study|Lack of Efficacy|1|||
127998736|NCT01395810|460621614|FG002|Overall Study|Lack of Efficacy|0|||
127998737|NCT01395810|460621615|FG003|Overall Study|Lack of Efficacy|0|||
127998738|NCT01395810|460621612|FG000|Overall Study|Withdrawal criteria|0|||
127998739|NCT01395810|460621613|FG001|Overall Study|Withdrawal criteria|2|||
127998740|NCT01395810|460621614|FG002|Overall Study|Withdrawal criteria|0|||
127998741|NCT01395810|460621615|FG003|Overall Study|Withdrawal criteria|0|||
127998742|NCT01395810|460621612|FG000|Overall Study|Unclassified|2|||
127998743|NCT01395810|460621613|FG001|Overall Study|Unclassified|0|||
127998744|NCT01395810|460621614|FG002|Overall Study|Unclassified|0|||
127998745|NCT01395810|460621615|FG003|Overall Study|Unclassified|0|||
127998746|NCT03677869|460621616|FG000|Overall Study|Withdrawal by Subject|1|||
127998747|NCT04265261|460621618|FG000|Overall Study|Adverse Event|2|||
127998748|NCT04265261|460621619|FG001|Overall Study|Adverse Event|0|||
127998749|NCT04265261|460621620|FG002|Overall Study|Adverse Event|0|||
127998750|NCT04265261|460621618|FG000|Overall Study|Death|1|||
127998751|NCT04265261|460621619|FG001|Overall Study|Death|0|||
127998752|NCT04265261|460621620|FG002|Overall Study|Death|0|||
127998753|NCT04265261|460621618|FG000|Overall Study|Lost to Follow-up|4|||
127665961|NCT02718417|459398421|FG002|Maintenance Phase (MP)|Progressive disease|0|||
127665962|NCT02718417|459398419|FG000|Maintenance Phase (MP)|Other|2|||
127665963|NCT02718417|459398420|FG001|Maintenance Phase (MP)|Other|1|||
127665964|NCT02718417|459398421|FG002|Maintenance Phase (MP)|Other|0|||
127665965|NCT02718417|459398419|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
127665966|NCT02718417|459398420|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
127665967|NCT02718417|459398421|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
127665968|NCT02718417|459398419|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
127665969|NCT02718417|459398420|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
127665970|NCT02718417|459398421|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
127665971|NCT02718417|459398419|FG000|Observation Phase (OP)|Adverse Event|0|||
127665972|NCT02718417|459398420|FG001|Observation Phase (OP)|Adverse Event|0|||
127665973|NCT02718417|459398421|FG002|Observation Phase (OP)|Adverse Event|1|||
127665974|NCT02718417|459398419|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
127665975|NCT02718417|459398420|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
127665976|NCT02718417|459398421|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
127665977|NCT02718417|459398419|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
127665978|NCT02718417|459398420|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
127665979|NCT02718417|459398421|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
127665980|NCT02718417|459398419|FG000|Observation Phase (OP)|Physician Decision|0|||
127665981|NCT02718417|459398420|FG001|Observation Phase (OP)|Physician Decision|0|||
127665982|NCT02718417|459398421|FG002|Observation Phase (OP)|Physician Decision|9|||
127665983|NCT02718417|459398419|FG000|Observation Phase (OP)|Progressive disease|0|||
127665984|NCT02718417|459398420|FG001|Observation Phase (OP)|Progressive disease|0|||
127665985|NCT02718417|459398421|FG002|Observation Phase (OP)|Progressive disease|92|||
127665986|NCT02718417|459398419|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
127665987|NCT02718417|459398420|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
127665988|NCT02718417|459398421|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
127665989|NCT02718417|459398419|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
127665990|NCT02718417|459398420|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
127665991|NCT02718417|459398421|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
127665992|NCT02718417|459398419|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
127665993|NCT02718417|459398420|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
127665994|NCT02718417|459398421|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
127665995|NCT02718417|459398419|FG000|Observation Phase (OP)|Other|0|||
127665996|NCT02718417|459398420|FG001|Observation Phase (OP)|Other|0|||
127665997|NCT02718417|459398421|FG002|Observation Phase (OP)|Other|7|||
127665998|NCT02718417|459398419|FG000|Follow-up Phase|Adverse Event|3|||
127665999|NCT02718417|459398420|FG001|Follow-up Phase|Adverse Event|1|||
127666000|NCT02718417|459398421|FG002|Follow-up Phase|Adverse Event|1|||
127666001|NCT02718417|459398419|FG000|Follow-up Phase|Other|4|||
127666002|NCT02718417|459398420|FG001|Follow-up Phase|Other|6|||
127666003|NCT02718417|459398421|FG002|Follow-up Phase|Other|4|||
127666004|NCT02718417|459398419|FG000|Follow-up Phase|Withdrawal by Subject|19|||
127666005|NCT02718417|459398420|FG001|Follow-up Phase|Withdrawal by Subject|17|||
127666006|NCT02718417|459398421|FG002|Follow-up Phase|Withdrawal by Subject|5|||
127666007|NCT02718417|459398419|FG000|Follow-up Phase|Study terminated by sponsor|100|||
127666008|NCT02718417|459398420|FG001|Follow-up Phase|Study terminated by sponsor|138|||
127666009|NCT02718417|459398421|FG002|Follow-up Phase|Study terminated by sponsor|6|||
127666010|NCT02718417|459398419|FG000|Follow-up Phase|Lost to Follow-up|2|||
127666011|NCT02718417|459398420|FG001|Follow-up Phase|Lost to Follow-up|3|||
127666012|NCT02718417|459398421|FG002|Follow-up Phase|Lost to Follow-up|0|||
127666013|NCT02718417|459398419|FG000|Follow-up Phase|Death leading to discontinuation|7|||
127666014|NCT02718417|459398420|FG001|Follow-up Phase|Death leading to discontinuation|7|||
127666015|NCT02718417|459398421|FG002|Follow-up Phase|Death leading to discontinuation|3|||
127666016|NCT02718417|459398419|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
127666017|NCT02718417|459398420|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
127666018|NCT02718417|459398421|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
127666019|NCT02718417|459398419|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
127666020|NCT02718417|459398420|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
127666021|NCT02718417|459398421|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
127666022|NCT02718417|459398419|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
127666023|NCT02718417|459398420|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
127666024|NCT02718417|459398421|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
127666025|NCT02718417|459398419|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
127666026|NCT02718417|459398420|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
127666027|NCT02718417|459398421|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
127666028|NCT02718417|459398419|FG000|Long-term Follow-up Phase|Other|0|||
127666029|NCT02718417|459398420|FG001|Long-term Follow-up Phase|Other|2|||
127998754|NCT04265261|460621619|FG001|Overall Study|Lost to Follow-up|1|||
127998755|NCT04265261|460621620|FG002|Overall Study|Lost to Follow-up|3|||
127998756|NCT04265261|460621618|FG000|Overall Study|Non-Compliance with Study Drug|1|||
127998757|NCT04265261|460621619|FG001|Overall Study|Non-Compliance with Study Drug|1|||
127998758|NCT04265261|460621620|FG002|Overall Study|Non-Compliance with Study Drug|0|||
127998759|NCT04265261|460621618|FG000|Overall Study|Physician Decision|0|||
127998760|NCT04265261|460621619|FG001|Overall Study|Physician Decision|0|||
127998761|NCT04265261|460621620|FG002|Overall Study|Physician Decision|1|||
127998762|NCT04265261|460621618|FG000|Overall Study|Protocol Deviation|0|||
127998763|NCT04265261|460621619|FG001|Overall Study|Protocol Deviation|2|||
127998764|NCT04265261|460621620|FG002|Overall Study|Protocol Deviation|0|||
127998765|NCT04265261|460621618|FG000|Overall Study|Withdrawal by Subject|2|||
127998766|NCT04265261|460621619|FG001|Overall Study|Withdrawal by Subject|1|||
127998767|NCT04265261|460621620|FG002|Overall Study|Withdrawal by Subject|4|||
127998768|NCT03877224|460621621|FG000|Overall Study|Death|3|||
127998769|NCT03877224|460621622|FG001|Overall Study|Death|2|||
127666030|NCT02718417|459398421|FG002|Long-term Follow-up Phase|Other|0|||
127666031|NCT00795132|459398427|FG000|Overall Study|Death|1|||
127998770|NCT03877224|460621621|FG000|Overall Study|Withdrawal by Subject|1|||
127998771|NCT03877224|460621622|FG001|Overall Study|Withdrawal by Subject|6|||
127998772|NCT03877224|460621621|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
127998773|NCT03877224|460621622|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
127998774|NCT04754542|460621623|FG000|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
127998775|NCT04754542|460621624|FG001|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
127998776|NCT00419757|460623121|FG000|Overall Study|Adverse Event|1|||
127666032|NCT00795132|459398427|FG000|Overall Study|Relapse|2|||
127666033|NCT02451930|459398428|FG000|Overall Study|Death|0|||
127998777|NCT00419757|460623122|FG001|Overall Study|Adverse Event|4|||
127998778|NCT00419757|460623121|FG000|Overall Study|Lost to Follow-up|1|||
127998779|NCT00419757|460623122|FG001|Overall Study|Lost to Follow-up|4|||
127666034|NCT02451930|459398429|FG001|Overall Study|Death|15|||
127666035|NCT02451930|459398428|FG000|Overall Study|Lost to Follow-up|0|||
127666036|NCT02451930|459398429|FG001|Overall Study|Lost to Follow-up|3|||
127666037|NCT02451930|459398428|FG000|Overall Study|Sponsor Decision|2|||
127666038|NCT02451930|459398429|FG001|Overall Study|Sponsor Decision|10|||
127666039|NCT02451930|459398428|FG000|Overall Study|Withdrawal by Subject|0|||
127666040|NCT02451930|459398429|FG001|Overall Study|Withdrawal by Subject|1|||
127666041|NCT02451930|459398428|FG000|Overall Study|Other|0|||
127666042|NCT02451930|459398429|FG001|Overall Study|Other|1|||
127666043|NCT01440049|459398430|FG000|Overall Study|Adverse Event|5|||
127666044|NCT03415022|459398435|FG000|Overall Study|Withdrawal by Subject|1|||
127666045|NCT03415022|459398436|FG001|Overall Study|Withdrawal by Subject|2|||
127666046|NCT03415022|459398435|FG000|Overall Study|COVID-19 Suspension|2|||
127666047|NCT03415022|459398436|FG001|Overall Study|COVID-19 Suspension|3|||
127666048|NCT03415022|459398435|FG000|Overall Study|Lost to Follow-up|2|||
127666049|NCT03415022|459398436|FG001|Overall Study|Lost to Follow-up|0|||
127666050|NCT04466618|459398437|FG000|Overall Study|Withdrawal by Subject|0|||
127666051|NCT04466618|459398438|FG001|Overall Study|Withdrawal by Subject|1|||
127666052|NCT02056119|459398446|FG000|Overall Study|Death|1|||
127666053|NCT02056119|459398447|FG001|Overall Study|Death|2|||
127666054|NCT02056119|459398446|FG000|Overall Study|Intubated for less than 24 hrs|2|||
127666055|NCT02056119|459398447|FG001|Overall Study|Intubated for less than 24 hrs|7|||
127666056|NCT02056119|459398446|FG000|Overall Study|No aerosol treatments were given.|3|||
127666057|NCT02056119|459398447|FG001|Overall Study|No aerosol treatments were given.|2|||
127666058|NCT02056119|459398446|FG000|Overall Study|Received Metaneb treatment|0|||
127666059|NCT02056119|459398447|FG001|Overall Study|Received Metaneb treatment|2|||
127666060|NCT02056119|459398446|FG000|Overall Study|Protocol Violation|4|||
127666061|NCT02056119|459398447|FG001|Overall Study|Protocol Violation|7|||
127666062|NCT03220737|459398448|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
127666063|NCT03220737|459398449|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
127666064|NCT03220737|459398450|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
127666065|NCT03220737|459398451|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
127666066|NCT03220737|459398452|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
127666067|NCT03220737|459398453|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
127666068|NCT03220737|459398454|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
127998780|NCT00419757|460623121|FG000|Overall Study|Withdrawal by Subject|7|||
127998781|NCT00419757|460623122|FG001|Overall Study|Withdrawal by Subject|1|||
127998782|NCT00419757|460623121|FG000|Overall Study|Protocol Violation|2|||
127998783|NCT00419757|460623122|FG001|Overall Study|Protocol Violation|3|||
127998784|NCT00419757|460623121|FG000|Overall Study|Study specific discontinuation criteria|4|||
127998785|NCT00419757|460623122|FG001|Overall Study|Study specific discontinuation criteria|8|||
127998786|NCT00419757|460623121|FG000|Overall Study|Multiple reasons|3|||
127666069|NCT03220737|459398448|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
127666070|NCT03220737|459398449|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
127666071|NCT03220737|459398450|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
127666072|NCT03220737|459398451|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
127998787|NCT00419757|460623122|FG001|Overall Study|Multiple reasons|1|||
127998788|NCT00327340|460623123|FG000|Overall Study|Withdrawal by Subject|1|||
127998789|NCT00327340|460623124|FG001|Overall Study|Withdrawal by Subject|5|||
127998790|NCT00327340|460623123|FG000|Overall Study|Physician Decision|1|||
127998791|NCT00327340|460623124|FG001|Overall Study|Physician Decision|1|||
127998792|NCT00327340|460623123|FG000|Overall Study|Disease Progression|10|||
127998793|NCT00327340|460623124|FG001|Overall Study|Disease Progression|19|||
127998794|NCT00327340|460623123|FG000|Overall Study|Symptomatic Disease|0|||
127998795|NCT00327340|460623124|FG001|Overall Study|Symptomatic Disease|2|||
127998796|NCT00327340|460623123|FG000|Overall Study|Adverse Event|3|||
127998797|NCT00327340|460623124|FG001|Overall Study|Adverse Event|3|||
127998798|NCT03316586|460623129|FG000|Overall Study|Adverse Event|2|||
127998799|NCT03316586|460623129|FG000|Overall Study|Physician Decision|3|||
127998800|NCT03316586|460623129|FG000|Overall Study|Lack of Efficacy|10|||
127998801|NCT03316586|460623129|FG000|Overall Study|still on treatment|1|||
127998802|NCT03316586|460623129|FG000|Overall Study|Patient needed radiation therapy|1|||
127998803|NCT03316586|460623129|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
127998804|NCT01396083|460623132|FG000|Overall Study|Adverse Event|2|||
127998805|NCT01396083|460623133|FG001|Overall Study|Adverse Event|28|||
127998806|NCT01396083|460623132|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
127998807|NCT01396083|460623133|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
127998808|NCT01396083|460623132|FG000|Overall Study|Consent withdrawn|4|||
127998809|NCT01396083|460623133|FG001|Overall Study|Consent withdrawn|5|||
127998810|NCT01396083|460623132|FG000|Overall Study|Protocol deviation(s)|0|||
127998811|NCT01396083|460623133|FG001|Overall Study|Protocol deviation(s)|1|||
127998812|NCT01396083|460623132|FG000|Overall Study|Abnormal laboratory value(s)|1|||
127998813|NCT01396083|460623133|FG001|Overall Study|Abnormal laboratory value(s)|0|||
127998814|NCT01396083|460623132|FG000|Overall Study|Administrative problems|1|||
127998815|NCT01396083|460623133|FG001|Overall Study|Administrative problems|0|||
127998816|NCT01396083|460623132|FG000|Overall Study|Lost to Follow-up|1|||
127998817|NCT01396083|460623133|FG001|Overall Study|Lost to Follow-up|0|||
127998818|NCT02806713|460623134|FG000|Overall Study|Urethral injury during procedure|1|||
127998819|NCT02806713|460623135|FG001|Overall Study|Urethral injury during procedure|0|||
127998820|NCT02806713|460623134|FG000|Overall Study|cancelled surgery|1|||
127998821|NCT02806713|460623135|FG001|Overall Study|cancelled surgery|2|||
127998822|NCT00735709|460623136|FG000|Overall Study|Adverse Event|2|||
127998823|NCT00735709|460623137|FG001|Overall Study|Adverse Event|3|||
127998824|NCT00735709|460623138|FG002|Overall Study|Adverse Event|1|||
127998825|NCT00735709|460623139|FG003|Overall Study|Adverse Event|5|||
127998826|NCT00735709|460623136|FG000|Overall Study|Lack of Efficacy|8|||
127998827|NCT00735709|460623137|FG001|Overall Study|Lack of Efficacy|4|||
127998828|NCT00735709|460623138|FG002|Overall Study|Lack of Efficacy|2|||
127998829|NCT00735709|460623139|FG003|Overall Study|Lack of Efficacy|3|||
127998830|NCT00735709|460623136|FG000|Overall Study|Noncompliance|0|||
127998831|NCT00735709|460623137|FG001|Overall Study|Noncompliance|0|||
127998832|NCT00735709|460623138|FG002|Overall Study|Noncompliance|1|||
127998833|NCT00735709|460623139|FG003|Overall Study|Noncompliance|0|||
127998834|NCT00735709|460623136|FG000|Overall Study|Protocol deviations|1|||
127998835|NCT00735709|460623137|FG001|Overall Study|Protocol deviations|2|||
127998836|NCT00735709|460623138|FG002|Overall Study|Protocol deviations|1|||
127998837|NCT00735709|460623139|FG003|Overall Study|Protocol deviations|1|||
127998838|NCT00735709|460623136|FG000|Overall Study|Voluntary Withdrawal|1|||
127998839|NCT00735709|460623137|FG001|Overall Study|Voluntary Withdrawal|3|||
127998840|NCT00735709|460623138|FG002|Overall Study|Voluntary Withdrawal|5|||
127998841|NCT00735709|460623139|FG003|Overall Study|Voluntary Withdrawal|7|||
127998842|NCT00735709|460623136|FG000|Overall Study|Lost to Follow-up|0|||
127998843|NCT00735709|460623137|FG001|Overall Study|Lost to Follow-up|1|||
127998844|NCT00735709|460623138|FG002|Overall Study|Lost to Follow-up|1|||
127998845|NCT00735709|460623139|FG003|Overall Study|Lost to Follow-up|1|||
127998846|NCT00735709|460623136|FG000|Overall Study|Excluded medication|1|||
127998847|NCT00735709|460623137|FG001|Overall Study|Excluded medication|0|||
127998848|NCT00735709|460623138|FG002|Overall Study|Excluded medication|0|||
127998849|NCT00735709|460623139|FG003|Overall Study|Excluded medication|1|||
127998850|NCT01165307|460623141|FG000|Overall Study|Lost to Follow-up|11|||
127998851|NCT01165307|460623142|FG001|Overall Study|Lost to Follow-up|3|||
127998852|NCT01165307|460623141|FG000|Overall Study|Withdrawal by Subject|2|||
127998853|NCT01165307|460623142|FG001|Overall Study|Withdrawal by Subject|0|||
127998854|NCT01165307|460623141|FG000|Overall Study|Subject not available for contact|1|||
127998855|NCT01165307|460623142|FG001|Overall Study|Subject not available for contact|0|||
127998856|NCT00521365|460623146|FG000|Overall Study|Adverse Event|3|||
127998857|NCT00521365|460623146|FG000|Overall Study|Lost to Follow-up|6|||
127998858|NCT00521365|460623146|FG000|Overall Study|Protocol deviation|2|||
127998859|NCT00521365|460623146|FG000|Overall Study|Drug compliance|3|||
127998860|NCT00521365|460623146|FG000|Overall Study|Usage of not allowed drugs|6|||
127998861|NCT03627832|460623147|FG000|Overall Study|Withdrawal by Subject|10|||
127998862|NCT03627832|460623148|FG001|Overall Study|Withdrawal by Subject|1|||
127998863|NCT03150082|460623149|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
127998864|NCT03150082|460623150|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
127998865|NCT00458003|460623155|FG000|Overall Study|Non protocol spinal anesthesia|1|||
127998866|NCT00458003|460623156|FG001|Overall Study|Non protocol spinal anesthesia|1|||
127998867|NCT00809445|460623157|FG000|1 Month Follow-up|Lost contact|1|||
127998868|NCT00809445|460623158|FG001|1 Month Follow-up|Lost contact|2|||
127998869|NCT00809445|460623159|FG002|1 Month Follow-up|Lost contact|1|||
127998870|NCT00809445|460623157|FG000|1 Month Follow-up|Withdrew consent|1|||
127998871|NCT00809445|460623158|FG001|1 Month Follow-up|Withdrew consent|1|||
127998872|NCT00809445|460623159|FG002|1 Month Follow-up|Withdrew consent|1|||
127998873|NCT00809445|460623157|FG000|1 Month Follow-up|Death|0|||
127998874|NCT00809445|460623158|FG001|1 Month Follow-up|Death|1|||
127998875|NCT00809445|460623159|FG002|1 Month Follow-up|Death|1|||
127998876|NCT00809445|460623157|FG000|1 Month Follow-up|Incarcerated|0|||
127998877|NCT00809445|460623158|FG001|1 Month Follow-up|Incarcerated|0|||
127998878|NCT00809445|460623159|FG002|1 Month Follow-up|Incarcerated|1|||
127998879|NCT00809445|460623157|FG000|6 Month Follow-up|Lost contact|16|||
127998880|NCT00809445|460623158|FG001|6 Month Follow-up|Lost contact|14|||
127998881|NCT00809445|460623159|FG002|6 Month Follow-up|Lost contact|14|||
127998882|NCT00809445|460623157|FG000|6 Month Follow-up|Death|2|||
127998883|NCT00809445|460623158|FG001|6 Month Follow-up|Death|1|||
127998884|NCT00809445|460623159|FG002|6 Month Follow-up|Death|1|||
127998885|NCT00809445|460623157|FG000|6 Month Follow-up|Incarcerated|6|||
127998886|NCT00809445|460623158|FG001|6 Month Follow-up|Incarcerated|8|||
127998887|NCT00809445|460623159|FG002|6 Month Follow-up|Incarcerated|8|||
127998888|NCT00809445|460623157|FG000|6 Month Follow-up|Withdrew consent|0|||
127998889|NCT00809445|460623158|FG001|6 Month Follow-up|Withdrew consent|0|||
127998890|NCT00809445|460623159|FG002|6 Month Follow-up|Withdrew consent|1|||
127998891|NCT02048722|460623160|FG000|2 Cycles of Treatment|Adverse Event|2|||
127998892|NCT02048722|460623160|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
127998893|NCT02048722|460623160|FG000|2 Cycles of Treatment|Progressive Disease|2|||
127998894|NCT02048722|460623160|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
127998895|NCT02048722|460623160|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
127998896|NCT02048722|460623160|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
127998897|NCT01272908|460623163|FG000|Initial Treatment Period|Adverse Event|1|||
127998898|NCT01272908|460623163|FG000|Initial Treatment Period|Lack of Efficacy|5|||
127998899|NCT01272908|460623163|FG000|Initial Treatment Period|Protocol Violation|1|||
127998900|NCT01272908|460623163|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
127998901|NCT01272908|460623163|FG000|Re-Treatment Period|Adverse Event|2|||
127998902|NCT01272908|460623163|FG000|Re-Treatment Period|Lack of Efficacy|3|||
127998903|NCT01272908|460623163|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
127998904|NCT03489343|460623164|FG000|Overall Study|Documented progressive disease|1|||
127998905|NCT03489343|460623165|FG001|Overall Study|Documented progressive disease|0|||
127666073|NCT03220737|459398452|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
127666074|NCT03220737|459398453|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
127666075|NCT03220737|459398454|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
127666076|NCT03220737|459398448|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
127666077|NCT03220737|459398449|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
127666078|NCT03220737|459398450|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
127666079|NCT03220737|459398451|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
127666080|NCT03220737|459398452|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
127666081|NCT03220737|459398453|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
127666082|NCT03220737|459398454|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
127666083|NCT03220737|459398448|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
127666084|NCT03220737|459398449|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
127666085|NCT03220737|459398450|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
127666086|NCT03220737|459398451|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
127666087|NCT03220737|459398452|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
127666088|NCT03220737|459398453|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
127666089|NCT03220737|459398454|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
127666090|NCT03220737|459398448|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
127666091|NCT03220737|459398449|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
127666092|NCT03220737|459398450|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
127666093|NCT03220737|459398451|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
127666094|NCT03220737|459398452|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
127666095|NCT03220737|459398453|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
127666096|NCT03220737|459398454|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
127666097|NCT03220737|459398448|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
127666098|NCT03220737|459398449|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
127666099|NCT03220737|459398450|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
127666100|NCT03220737|459398451|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
127998906|NCT03489343|460623166|FG002|Overall Study|Documented progressive disease|3|||
127998907|NCT03489343|460623167|FG003|Overall Study|Documented progressive disease|1|||
127998908|NCT03489343|460623168|FG004|Overall Study|Documented progressive disease|3|||
127998909|NCT03489343|460623169|FG005|Overall Study|Documented progressive disease|5|||
127998910|NCT03489343|460623170|FG006|Overall Study|Documented progressive disease|4|||
127666101|NCT03220737|459398452|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
127666102|NCT03220737|459398453|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
127666103|NCT03220737|459398454|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
127666104|NCT03220737|459398448|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
127666105|NCT03220737|459398449|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
127666106|NCT03220737|459398450|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
127666107|NCT03220737|459398451|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
127666108|NCT03220737|459398452|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
127666109|NCT03220737|459398453|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
127666110|NCT03220737|459398454|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
127666111|NCT03220737|459398448|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
127666112|NCT03220737|459398449|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
127666113|NCT03220737|459398450|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
127666114|NCT03220737|459398451|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
127887260|NCT02124746|460210536|FG001|Overall Study|Death|1|||
127887261|NCT02124746|460210537|FG002|Overall Study|Death|3|||
127887262|NCT02124746|460210535|FG000|Overall Study|Lack of Efficacy|3|||
127887263|NCT02124746|460210536|FG001|Overall Study|Lack of Efficacy|2|||
127887264|NCT02124746|460210537|FG002|Overall Study|Lack of Efficacy|2|||
127887265|NCT02124746|460210535|FG000|Overall Study|Physician Decision|6|||
127887266|NCT02124746|460210536|FG001|Overall Study|Physician Decision|4|||
127887267|NCT02124746|460210537|FG002|Overall Study|Physician Decision|5|||
127887268|NCT02124746|460210535|FG000|Overall Study|Non-Compliance with Study Drug|0|||
127887269|NCT02124746|460210536|FG001|Overall Study|Non-Compliance with Study Drug|1|||
127887270|NCT02124746|460210537|FG002|Overall Study|Non-Compliance with Study Drug|0|||
127887271|NCT02124746|460210535|FG000|Overall Study|Withdrawal by Subject|3|||
127887272|NCT02124746|460210536|FG001|Overall Study|Withdrawal by Subject|3|||
127887273|NCT02124746|460210537|FG002|Overall Study|Withdrawal by Subject|0|||
127887274|NCT02124746|460210535|FG000|Overall Study|Study Terminated by Sponsor|0|||
127887275|NCT02124746|460210536|FG001|Overall Study|Study Terminated by Sponsor|0|||
127887276|NCT02124746|460210537|FG002|Overall Study|Study Terminated by Sponsor|6|||
127887277|NCT02124746|460210535|FG000|Overall Study|Disease Progression|3|||
127887278|NCT02124746|460210536|FG001|Overall Study|Disease Progression|6|||
127887279|NCT02124746|460210537|FG002|Overall Study|Disease Progression|4|||
127887280|NCT00571922|460210538|FG000|Overall Study|Completion unknown|36|||
127887281|NCT00571922|460210539|FG001|Overall Study|Completion unknown|36|||
127887282|NCT02191579|460210550|FG000|Treatment 1|Multiple Reasons Specified|27|||
127887283|NCT02191579|460210551|FG001|Treatment 1|Multiple Reasons Specified|58|||
127887284|NCT02191579|460210550|FG000|Treatment 2|Multiple Reasons Specified|0|||
127887285|NCT02191579|460210551|FG001|Treatment 2|Multiple Reasons Specified|25|||
127887286|NCT03940586|460210560|FG000|Overall Study|Death|3|||
127887287|NCT03940586|460210561|FG001|Overall Study|Death|2|||
127887288|NCT03940586|460210562|FG002|Overall Study|Death|0|||
127887289|NCT03940586|460210560|FG000|Overall Study|Physician Decision|1|||
127887290|NCT03940586|460210561|FG001|Overall Study|Physician Decision|0|||
127887291|NCT03940586|460210562|FG002|Overall Study|Physician Decision|1|||
127887292|NCT03940586|460210560|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
127887293|NCT03940586|460210561|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
127887294|NCT03940586|460210562|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
127887295|NCT03940586|460210560|FG000|Overall Study|Not Treated|0|||
127887296|NCT03940586|460210561|FG001|Overall Study|Not Treated|2|||
127887297|NCT03940586|460210562|FG002|Overall Study|Not Treated|0|||
127887298|NCT00964223|460210563|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
127887299|NCT03077828|460210564|FG000|Treatment Cycles|Death|1|||
127887300|NCT03077828|460210564|FG000|Treatment Cycles|Withdrawal by Subject|1|||
127887301|NCT03077828|460210564|FG000|Treatment Cycles|Screen Fail|2|||
127887302|NCT03077828|460210564|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
127887303|NCT03077828|460210564|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
127887304|NCT03077828|460210564|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
127887305|NCT03077828|460210564|FG000|Follow-up|Patients still in follow-up|15|||
127887306|NCT00345683|460210568|FG000|Overall Study|Lost to Follow-up|19|||
127887307|NCT00345683|460210569|FG001|Overall Study|Lost to Follow-up|7|||
127887308|NCT00345683|460210568|FG000|Overall Study|Other|6|||
127887309|NCT00345683|460210569|FG001|Overall Study|Other|2|||
127887310|NCT04288115|460210570|FG000|Overall Study|Withdrawal by Subject|0|||
127887311|NCT04288115|460210571|FG001|Overall Study|Withdrawal by Subject|1|||
127887312|NCT04288115|460210570|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
127887313|NCT04288115|460210571|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
127887314|NCT00729365|460210573|FG000|Overall Study|Physician Decision|33|||
127887315|NCT00729365|460210574|FG001|Overall Study|Physician Decision|6|||
127887316|NCT00729365|460210575|FG002|Overall Study|Physician Decision|7|||
127887317|NCT01298596|460210578|FG000|Overall Study|Withdrawal by Subject|1|||
127998911|NCT03489343|460623164|FG000|Overall Study|Adverse Event|0|||
127998912|NCT03489343|460623165|FG001|Overall Study|Adverse Event|1|||
127998913|NCT03489343|460623166|FG002|Overall Study|Adverse Event|0|||
127998914|NCT03489343|460623167|FG003|Overall Study|Adverse Event|0|||
127998915|NCT03489343|460623168|FG004|Overall Study|Adverse Event|0|||
127998916|NCT03489343|460623169|FG005|Overall Study|Adverse Event|1|||
127998917|NCT03489343|460623170|FG006|Overall Study|Adverse Event|0|||
127998918|NCT03489343|460623164|FG000|Overall Study|Withdrawal by Subject|0|||
127998919|NCT03489343|460623165|FG001|Overall Study|Withdrawal by Subject|0|||
127998920|NCT03489343|460623166|FG002|Overall Study|Withdrawal by Subject|0|||
127998921|NCT03489343|460623167|FG003|Overall Study|Withdrawal by Subject|1|||
127998922|NCT03489343|460623168|FG004|Overall Study|Withdrawal by Subject|0|||
127998923|NCT03489343|460623169|FG005|Overall Study|Withdrawal by Subject|1|||
127998924|NCT03489343|460623170|FG006|Overall Study|Withdrawal by Subject|1|||
127998925|NCT03489343|460623164|FG000|Overall Study|Clinical progression|0|||
127998926|NCT03489343|460623165|FG001|Overall Study|Clinical progression|0|||
127998927|NCT03489343|460623166|FG002|Overall Study|Clinical progression|0|||
127998928|NCT03489343|460623167|FG003|Overall Study|Clinical progression|1|||
127998929|NCT03489343|460623168|FG004|Overall Study|Clinical progression|0|||
127998930|NCT03489343|460623169|FG005|Overall Study|Clinical progression|0|||
127998931|NCT03489343|460623170|FG006|Overall Study|Clinical progression|1|||
127998932|NCT01158261|460623171|FG000|Overall Study|Lost to Follow-up|9|||
127998933|NCT01158261|460623171|FG000|Overall Study|Death|7|||
127998934|NCT01158261|460623171|FG000|Overall Study|Withdrawal by Subject|1|||
127998935|NCT03143101|460623172|FG000|Overall Study|Withdrawal by Subject|0|||
127998936|NCT03143101|460623173|FG001|Overall Study|Withdrawal by Subject|1|||
127998937|NCT03143101|460623174|FG002|Overall Study|Withdrawal by Subject|0|||
127998938|NCT03143101|460623172|FG000|Overall Study|Lost to Follow-up|2|||
127998939|NCT03143101|460623173|FG001|Overall Study|Lost to Follow-up|2|||
127666115|NCT03220737|459398452|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
127666116|NCT03220737|459398453|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
127666117|NCT03220737|459398454|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
127666118|NCT00594932|459398457|FG000|First 3 Months|Withdrawal by Subject|1|||
127666119|NCT00594932|459398458|FG001|First 3 Months|Withdrawal by Subject|3|||
127998940|NCT03143101|460623174|FG002|Overall Study|Lost to Follow-up|0|||
127998941|NCT01630135|460623176|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
127666120|NCT00594932|459398457|FG000|Final 3 Months|Withdrawal by Subject|4|||
127666121|NCT00594932|459398458|FG001|Final 3 Months|Withdrawal by Subject|3|||
127666122|NCT04496167|459398459|FG000|Overall Study|Adverse Event|6|||
127666123|NCT04496167|459398460|FG001|Overall Study|Adverse Event|2|||
127666124|NCT04496167|459398459|FG000|Overall Study|Withdrawal by Subject|7|||
127666125|NCT04496167|459398460|FG001|Overall Study|Withdrawal by Subject|6|||
127666126|NCT04496167|459398459|FG000|Overall Study|Lost to Follow-up|3|||
127666127|NCT04496167|459398460|FG001|Overall Study|Lost to Follow-up|5|||
127666128|NCT04496167|459398459|FG000|Overall Study|Not Treated|1|||
127666129|NCT04496167|459398460|FG001|Overall Study|Not Treated|2|||
127666130|NCT04496167|459398459|FG000|Overall Study|Other Than Specified|1|||
127666131|NCT04496167|459398460|FG001|Overall Study|Other Than Specified|1|||
127666132|NCT03018106|459398463|FG000|Overall Study|Lost to Follow-up|0|||
127666133|NCT03018106|459398464|FG001|Overall Study|Lost to Follow-up|1|||
127666134|NCT00136916|459398465|FG000|Overall Study|Never received study treatment|3|||
127666135|NCT00136916|459398466|FG001|Overall Study|Never received study treatment|5|||
127666136|NCT00136916|459398465|FG000|Overall Study|Death|1|||
127666137|NCT00136916|459398466|FG001|Overall Study|Death|3|||
127666138|NCT00136916|459398465|FG000|Overall Study|Adverse Event|27|||
127666139|NCT00136916|459398466|FG001|Overall Study|Adverse Event|8|||
127666140|NCT00136916|459398465|FG000|Overall Study|Laboratory abnormality|0|||
127666141|NCT00136916|459398466|FG001|Overall Study|Laboratory abnormality|1|||
127666142|NCT00136916|459398465|FG000|Overall Study|Lack of Efficacy|13|||
127666143|NCT00136916|459398466|FG001|Overall Study|Lack of Efficacy|3|||
127666144|NCT00136916|459398465|FG000|Overall Study|Lost to Follow-up|12|||
127666145|NCT00136916|459398466|FG001|Overall Study|Lost to Follow-up|14|||
127666146|NCT00136916|459398465|FG000|Overall Study|Withdrawal by Subject|44|||
127666147|NCT00136916|459398466|FG001|Overall Study|Withdrawal by Subject|46|||
127666148|NCT00136916|459398465|FG000|Overall Study|Other|22|||
127666149|NCT00136916|459398466|FG001|Overall Study|Other|24|||
127666150|NCT00136916|459398465|FG000|Overall Study|Discontinued in follow up period|3|||
127666151|NCT00136916|459398466|FG001|Overall Study|Discontinued in follow up period|0|||
127998942|NCT01630135|460623177|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
127998943|NCT05227118|460623180|FG000|Overall Study|Adverse Event|0|||
127998944|NCT05227118|460623181|FG001|Overall Study|Adverse Event|0|||
127998945|NCT05227118|460623182|FG002|Overall Study|Adverse Event|1|||
127998946|NCT05227118|460623183|FG003|Overall Study|Adverse Event|0|||
127998947|NCT05227118|460623180|FG000|Overall Study|Withdrawal by Subject|0|||
127998948|NCT05227118|460623181|FG001|Overall Study|Withdrawal by Subject|0|||
127666152|NCT03619174|459398467|FG000|Overall Study|Lost to Follow-up|3|||
127666153|NCT03619174|459398468|FG001|Overall Study|Lost to Follow-up|0|||
127998949|NCT05227118|460623182|FG002|Overall Study|Withdrawal by Subject|2|||
127998950|NCT05227118|460623183|FG003|Overall Study|Withdrawal by Subject|0|||
127998951|NCT03727841|460623189|FG000|Overall Study|Physician Decision|3|||
127998952|NCT03727841|460623190|FG001|Overall Study|Physician Decision|1|||
127998953|NCT01601496|460623191|FG000|Overall Study|Physician Decision|1|||
127998954|NCT01601496|460623191|FG000|Overall Study|Withdrawal by Subject|1|||
127998955|NCT01601496|460623191|FG000|Overall Study|Lost to Follow-up|6|||
127998956|NCT01601496|460623191|FG000|Overall Study|Death|4|||
127998957|NCT01601496|460623191|FG000|Overall Study|Other: patient refusal to continue|3|||
127998958|NCT03243305|460623192|FG000|Overall Study|Lost to Follow-up|250|||
127998959|NCT03243305|460623192|FG000|Overall Study|Withdrawal by Subject|170|||
127998960|NCT03243305|460623192|FG000|Overall Study|Pregnancy|104|||
127998961|NCT03243305|460623192|FG000|Overall Study|Non-Compliance with Study Drug|38|||
127998962|NCT03243305|460623192|FG000|Overall Study|Adverse Event|23|||
127998963|NCT03243305|460623192|FG000|Overall Study|No sexually active|26|||
127998964|NCT03243305|460623192|FG000|Overall Study|Physician Decision|22|||
127998965|NCT03243305|460623192|FG000|Overall Study|Protocol Violation|22|||
127998966|NCT03243305|460623192|FG000|Overall Study|Study method no longer primary method|12|||
127998967|NCT03243305|460623192|FG000|Overall Study|Study Terminated by Sponsor|1|||
127998968|NCT03243305|460623192|FG000|Overall Study|Early terminations|267|||
127998969|NCT02689804|460623193|FG000|Overall Study|Withdrawal by Subject|2|||
127998970|NCT02689804|460623194|FG001|Overall Study|Withdrawal by Subject|0|||
127998971|NCT01166750|460623202|FG000|Overall Study|Lost to Follow-up|1|||
127998972|NCT01166750|460623203|FG001|Overall Study|Lost to Follow-up|0|||
127998973|NCT01585246|460623204|FG000|Overall Study|Lost to Follow-up|0|||
127998974|NCT01585246|460623205|FG001|Overall Study|Lost to Follow-up|0|||
127998975|NCT01585246|460623206|FG002|Overall Study|Lost to Follow-up|2|||
127998976|NCT01585246|460623207|FG003|Overall Study|Lost to Follow-up|1|||
127998977|NCT01585246|460623208|FG004|Overall Study|Lost to Follow-up|0|||
127998978|NCT01585246|460623204|FG000|Overall Study|Protocol Violation|0|||
127998979|NCT01585246|460623205|FG001|Overall Study|Protocol Violation|0|||
127998980|NCT01585246|460623206|FG002|Overall Study|Protocol Violation|0|||
127998981|NCT01585246|460623207|FG003|Overall Study|Protocol Violation|0|||
127998982|NCT01585246|460623208|FG004|Overall Study|Protocol Violation|1|||
127998983|NCT01585246|460623204|FG000|Overall Study|Withdrawal by Subject|0|||
127998984|NCT01585246|460623205|FG001|Overall Study|Withdrawal by Subject|0|||
127998985|NCT01585246|460623206|FG002|Overall Study|Withdrawal by Subject|1|||
127998986|NCT01585246|460623207|FG003|Overall Study|Withdrawal by Subject|2|||
127998987|NCT01585246|460623208|FG004|Overall Study|Withdrawal by Subject|1|||
127998988|NCT01585246|460623204|FG000|Overall Study|Other|0|||
127998989|NCT01585246|460623205|FG001|Overall Study|Other|1|||
127998990|NCT01585246|460623206|FG002|Overall Study|Other|1|||
127998991|NCT01585246|460623207|FG003|Overall Study|Other|1|||
127998992|NCT01585246|460623208|FG004|Overall Study|Other|0|||
127998993|NCT04396626|460623209|FG000|Overall Study|Premature termination of study|975|||
127998994|NCT02417753|460623210|FG000|Overall Study|Death|1|||
127998995|NCT03113968|460623213|FG000|Overall Study|Withdrawal by Subject|31|||
127998996|NCT03113968|460623214|FG001|Overall Study|Withdrawal by Subject|4|||
127998997|NCT04805671|460623217|FG000|Overall Study|Death|2|||
127998998|NCT04805671|460623218|FG001|Overall Study|Death|7|||
127998999|NCT04805671|460623217|FG000|Overall Study|Lost to Follow-up|1|||
127999000|NCT04805671|460623218|FG001|Overall Study|Lost to Follow-up|0|||
127999001|NCT04805671|460623217|FG000|Overall Study|Withdrawal by Subject|9|||
127999002|NCT04805671|460623218|FG001|Overall Study|Withdrawal by Subject|7|||
127999003|NCT04805671|460623217|FG000|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|178|||
127999004|NCT04805671|460623218|FG001|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|177|||
127999005|NCT02111174|460623223|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
127999006|NCT02111174|460623224|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
127999007|NCT02111174|460623223|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
127999008|NCT02111174|460623224|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
127999009|NCT02111174|460623223|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
127999010|NCT02111174|460623224|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
127999011|NCT02111174|460623223|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
127999012|NCT02111174|460623224|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
127999013|NCT01657162|460623225|FG000|Overall Study|Adverse Event|26|||
127999014|NCT01657162|460623226|FG001|Overall Study|Adverse Event|36|||
127999015|NCT01657162|460623225|FG000|Overall Study|Withdrawal by Subject|13|||
127999016|NCT01657162|460623226|FG001|Overall Study|Withdrawal by Subject|13|||
127999017|NCT01657162|460623225|FG000|Overall Study|Continuing Significant Deterioration|9|||
127999018|NCT01657162|460623226|FG001|Overall Study|Continuing Significant Deterioration|3|||
127999019|NCT01657162|460623225|FG000|Overall Study|Refusal of Treatment|4|||
127999020|NCT01657162|460623226|FG001|Overall Study|Refusal of Treatment|6|||
127999021|NCT01657162|460623225|FG000|Overall Study|Lost to Follow-up|3|||
127999022|NCT01657162|460623226|FG001|Overall Study|Lost to Follow-up|4|||
127999023|NCT01657162|460623225|FG000|Overall Study|Death|2|||
127999024|NCT01657162|460623226|FG001|Overall Study|Death|3|||
127999025|NCT01657162|460623225|FG000|Overall Study|Inability to Complete Study Procedures|1|||
127999026|NCT01657162|460623226|FG001|Overall Study|Inability to Complete Study Procedures|7|||
127999027|NCT01657162|460623225|FG000|Overall Study|Protocol Violation|1|||
127999028|NCT01657162|460623226|FG001|Overall Study|Protocol Violation|0|||
127999029|NCT01657162|460623225|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
127999030|NCT01657162|460623226|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
127999031|NCT01657162|460623225|FG000|Overall Study|Other than Specified|0|||
127999032|NCT01657162|460623226|FG001|Overall Study|Other than Specified|2|||
127999033|NCT00901342|460623227|FG000|Overall Study|Adverse Event|1|||
127999034|NCT00901342|460623227|FG000|Overall Study|Death|4|||
127999035|NCT00901342|460623227|FG000|Overall Study|Disease progression|1|||
127999036|NCT00901342|460623227|FG000|Overall Study|Withdrawal by Subject|9|||
127999037|NCT01691378|460623238|FG000|Overall Study|Withdrawal by Subject|2|||
127999038|NCT01691378|460623239|FG001|Overall Study|Withdrawal by Subject|0|||
127999039|NCT01691378|460623238|FG000|Overall Study|Lost to Follow-up|5|||
127999040|NCT01691378|460623239|FG001|Overall Study|Lost to Follow-up|2|||
127999041|NCT01827592|460623240|FG000|Overall Study|Adverse Event|11|||
127999042|NCT01827592|460623241|FG001|Overall Study|Adverse Event|9|||
127999043|NCT01827592|460623242|FG002|Overall Study|Adverse Event|2|||
127999044|NCT01827592|460623240|FG000|Overall Study|Physician Decision|0|||
127999045|NCT01827592|460623241|FG001|Overall Study|Physician Decision|2|||
127999046|NCT01827592|460623242|FG002|Overall Study|Physician Decision|1|||
127999047|NCT01827592|460623240|FG000|Overall Study|Protocol Violation|2|||
127999048|NCT01827592|460623241|FG001|Overall Study|Protocol Violation|1|||
127999049|NCT01827592|460623242|FG002|Overall Study|Protocol Violation|0|||
127999050|NCT01827592|460623240|FG000|Overall Study|Lost to Follow-up|1|||
127999051|NCT01827592|460623241|FG001|Overall Study|Lost to Follow-up|2|||
127999052|NCT01827592|460623242|FG002|Overall Study|Lost to Follow-up|2|||
127999053|NCT01827592|460623240|FG000|Overall Study|Withdrawal by Subject|12|||
127999054|NCT01827592|460623241|FG001|Overall Study|Withdrawal by Subject|11|||
127999055|NCT01827592|460623242|FG002|Overall Study|Withdrawal by Subject|11|||
127999056|NCT01827592|460623240|FG000|Overall Study|Patient's substantial non-compliance|1|||
127999057|NCT01827592|460623241|FG001|Overall Study|Patient's substantial non-compliance|1|||
127999058|NCT01827592|460623242|FG002|Overall Study|Patient's substantial non-compliance|6|||
127999059|NCT01827592|460623240|FG000|Overall Study|Trial terminated by Sponsor|47|||
127999060|NCT01827592|460623241|FG001|Overall Study|Trial terminated by Sponsor|53|||
127999061|NCT01827592|460623242|FG002|Overall Study|Trial terminated by Sponsor|51|||
127999062|NCT01827592|460623240|FG000|Overall Study|Others|0|||
127999063|NCT01827592|460623241|FG001|Overall Study|Others|1|||
127999064|NCT01827592|460623242|FG002|Overall Study|Others|3|||
127999065|NCT00751140|460623243|FG000|Overall Study|benign angioma excluded from analysis|1|||
127999066|NCT04001803|460623244|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
127999067|NCT04001803|460623244|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
127999068|NCT04001803|460623244|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
127999069|NCT04001803|460623244|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
127999070|NCT04001803|460623244|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
127999071|NCT04001803|460623244|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
127999072|NCT04001803|460623244|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
127999073|NCT04001803|460623244|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
127999074|NCT04001803|460623244|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
127999075|NCT04001803|460623244|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
127999076|NCT02493517|460623245|FG000|Overall Study|Protocol Violation|1|||
127999077|NCT02493517|460623246|FG001|Overall Study|Protocol Violation|2|||
127999078|NCT02493517|460623245|FG000|Overall Study|Withdrawal by Subject|1|||
127999079|NCT02493517|460623246|FG001|Overall Study|Withdrawal by Subject|2|||
127999080|NCT02493517|460623245|FG000|Overall Study|Adverse Event|0|||
127999081|NCT02493517|460623246|FG001|Overall Study|Adverse Event|2|||
127999082|NCT02493517|460623245|FG000|Overall Study|Missed study visit|0|||
127999083|NCT02493517|460623246|FG001|Overall Study|Missed study visit|1|||
127999084|NCT03718429|460623248|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
127999085|NCT03718429|460623249|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
127999086|NCT03718429|460623250|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
127999087|NCT03718429|460623251|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
127999088|NCT00325819|460623253|FG000|Overall Study|Study product lost in mail|2|||
127999089|NCT00325819|460623254|FG001|Overall Study|Study product lost in mail|1|||
127999090|NCT00325819|460623253|FG000|Overall Study|Did not take a dose of study product|4|||
127999091|NCT00325819|460623254|FG001|Overall Study|Did not take a dose of study product|9|||
127999092|NCT00325819|460623253|FG000|Overall Study|Lost to Follow-up|3|||
127999093|NCT00325819|460623254|FG001|Overall Study|Lost to Follow-up|3|||
127999094|NCT02346877|460623255|FG000|Overall Study|Adverse Event|1|||
127999095|NCT02346877|460623256|FG001|Overall Study|Adverse Event|0|||
127999096|NCT02346877|460623255|FG000|Overall Study|Administrative Decision|1|||
127999097|NCT02346877|460623256|FG001|Overall Study|Administrative Decision|0|||
127999098|NCT02346877|460623255|FG000|Overall Study|Sponsor Decision|12|||
127999099|NCT02346877|460623256|FG001|Overall Study|Sponsor Decision|0|||
127999100|NCT02346877|460623255|FG000|Overall Study|Missing|5|||
127999101|NCT02346877|460623256|FG001|Overall Study|Missing|0|||
127999102|NCT03811821|460623257|FG000|Overall Study|Adverse Event|1|||
127999103|NCT03811821|460623258|FG001|Overall Study|Adverse Event|1|||
127999104|NCT03811821|460623257|FG000|Overall Study|Withdrawal by Subject|5|||
127999105|NCT03811821|460623258|FG001|Overall Study|Withdrawal by Subject|4|||
127999106|NCT03811821|460623257|FG000|Overall Study|Lost to Follow-up|2|||
127999107|NCT03811821|460623258|FG001|Overall Study|Lost to Follow-up|2|||
127999108|NCT03811821|460623257|FG000|Overall Study|Contraindication for treatment|0|||
127999109|NCT03811821|460623258|FG001|Overall Study|Contraindication for treatment|1|||
127999110|NCT03811821|460623257|FG000|Overall Study|Tolerability|0|||
127999111|NCT03811821|460623258|FG001|Overall Study|Tolerability|3|||
127999112|NCT03811821|460623257|FG000|Overall Study|Comorbidities|0|||
127999113|NCT03811821|460623258|FG001|Overall Study|Comorbidities|2|||
127999114|NCT04888494|460623259|FG000|Overall Study|Lost to Follow-up|2|||
127999115|NCT04888494|460623260|FG001|Overall Study|Lost to Follow-up|3|||
127999116|NCT04888494|460623259|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
127999117|NCT04888494|460623260|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
127999118|NCT00447902|460623266|FG000|Overall Study|Adverse Event|0|||
127999119|NCT00447902|460623267|FG001|Overall Study|Adverse Event|3|||
127999120|NCT00447902|460623266|FG000|Overall Study|Protocol Violation|1|||
127999121|NCT00447902|460623267|FG001|Overall Study|Protocol Violation|0|||
127999122|NCT00447902|460623266|FG000|Overall Study|Withdrawal by Subject|0|||
127999123|NCT00447902|460623267|FG001|Overall Study|Withdrawal by Subject|1|||
127999124|NCT00447902|460623266|FG000|Overall Study|included patients who discontinued|1|||
127999125|NCT00447902|460623267|FG001|Overall Study|included patients who discontinued|1|||
127999126|NCT00447902|460623266|FG000|Overall Study|Lack of Efficacy|2|||
127999127|NCT00447902|460623267|FG001|Overall Study|Lack of Efficacy|1|||
127999128|NCT02317991|460625060|FG000|Overall Study|Adverse Event|12|||
127999129|NCT02317991|460625060|FG000|Overall Study|Death|4|||
127999130|NCT02317991|460625060|FG000|Overall Study|Withdrawal by Subject|8|||
127999131|NCT02317991|460625060|FG000|Overall Study|Progressive Disease|41|||
127999132|NCT01325350|460625061|FG000|Overall Study|Adverse Event|3|||
127999133|NCT01325350|460625062|FG001|Overall Study|Adverse Event|3|||
127999134|NCT01325350|460625063|FG002|Overall Study|Adverse Event|3|||
127999135|NCT01325350|460625064|FG003|Overall Study|Adverse Event|1|||
127999136|NCT01325350|460625065|FG004|Overall Study|Adverse Event|2|||
127999137|NCT01325350|460625061|FG000|Overall Study|Pregnancy|0|||
127999138|NCT01325350|460625062|FG001|Overall Study|Pregnancy|0|||
127999139|NCT01325350|460625063|FG002|Overall Study|Pregnancy|1|||
127999140|NCT01325350|460625064|FG003|Overall Study|Pregnancy|0|||
127999141|NCT01325350|460625065|FG004|Overall Study|Pregnancy|1|||
127999142|NCT01325350|460625061|FG000|Overall Study|Lost to Follow-up|1|||
127999143|NCT01325350|460625062|FG001|Overall Study|Lost to Follow-up|0|||
127999144|NCT01325350|460625063|FG002|Overall Study|Lost to Follow-up|5|||
127999145|NCT01325350|460625064|FG003|Overall Study|Lost to Follow-up|1|||
127999146|NCT01325350|460625065|FG004|Overall Study|Lost to Follow-up|5|||
127999147|NCT01325350|460625061|FG000|Overall Study|Personal Reasons|2|||
127999148|NCT01325350|460625062|FG001|Overall Study|Personal Reasons|1|||
127999149|NCT01325350|460625063|FG002|Overall Study|Personal Reasons|6|||
127666154|NCT03619174|459398467|FG000|Overall Study|Withdrawal by Subject|4|||
127666155|NCT03619174|459398468|FG001|Overall Study|Withdrawal by Subject|3|||
127666156|NCT03619174|459398467|FG000|Overall Study|Pregnancy|1|||
127666157|NCT03619174|459398468|FG001|Overall Study|Pregnancy|1|||
127666158|NCT03619174|459398467|FG000|Overall Study|Discomfort during treatment|1|||
127666159|NCT03619174|459398468|FG001|Overall Study|Discomfort during treatment|0|||
127666160|NCT03486899|459398469|FG000|Overall Study|Lost to Follow-up|4|||
127666161|NCT03486899|459398470|FG001|Overall Study|Lost to Follow-up|1|||
127999150|NCT01325350|460625064|FG003|Overall Study|Personal Reasons|5|||
127999151|NCT01325350|460625065|FG004|Overall Study|Personal Reasons|3|||
127999152|NCT01325350|460625061|FG000|Overall Study|Protocol Violation|0|||
127999153|NCT01325350|460625062|FG001|Overall Study|Protocol Violation|0|||
127999154|NCT01325350|460625063|FG002|Overall Study|Protocol Violation|0|||
127999155|NCT01325350|460625064|FG003|Overall Study|Protocol Violation|1|||
127999156|NCT01325350|460625065|FG004|Overall Study|Protocol Violation|0|||
127999157|NCT01325350|460625061|FG000|Overall Study|Withdrawal by Subject|0|||
127999158|NCT01325350|460625062|FG001|Overall Study|Withdrawal by Subject|0|||
127999159|NCT01325350|460625063|FG002|Overall Study|Withdrawal by Subject|1|||
127999160|NCT01325350|460625064|FG003|Overall Study|Withdrawal by Subject|1|||
127999161|NCT01325350|460625065|FG004|Overall Study|Withdrawal by Subject|0|||
127999162|NCT01325350|460625061|FG000|Overall Study|Did Not Receive Treatment|0|||
127999163|NCT01325350|460625062|FG001|Overall Study|Did Not Receive Treatment|1|||
127999164|NCT01325350|460625063|FG002|Overall Study|Did Not Receive Treatment|1|||
127999165|NCT01325350|460625064|FG003|Overall Study|Did Not Receive Treatment|0|||
127999166|NCT01325350|460625065|FG004|Overall Study|Did Not Receive Treatment|1|||
127999167|NCT01716806|460625066|FG000|Overall Study|Patient withdrawal of consent|4|||
127999168|NCT01716806|460625067|FG001|Overall Study|Patient withdrawal of consent|2|||
127666162|NCT03486899|459398471|FG002|Overall Study|Lost to Follow-up|4|||
127999169|NCT01716806|460625068|FG002|Overall Study|Patient withdrawal of consent|4|||
127999170|NCT01716806|460625069|FG003|Overall Study|Patient withdrawal of consent|3|||
127999171|NCT01716806|460625070|FG004|Overall Study|Patient withdrawal of consent|2|||
127999172|NCT01716806|460625071|FG005|Overall Study|Patient withdrawal of consent|0|||
127999173|NCT01716806|460625066|FG000|Overall Study|Lost to Follow-up|3|||
127999174|NCT01716806|460625067|FG001|Overall Study|Lost to Follow-up|3|||
127999175|NCT01716806|460625068|FG002|Overall Study|Lost to Follow-up|0|||
127999176|NCT01716806|460625069|FG003|Overall Study|Lost to Follow-up|2|||
127999177|NCT01716806|460625070|FG004|Overall Study|Lost to Follow-up|1|||
127999178|NCT01716806|460625071|FG005|Overall Study|Lost to Follow-up|0|||
127999179|NCT01716806|460625066|FG000|Overall Study|Death|13|||
127999180|NCT01716806|460625067|FG001|Overall Study|Death|9|||
127999181|NCT01716806|460625068|FG002|Overall Study|Death|12|||
127999182|NCT01716806|460625069|FG003|Overall Study|Death|4|||
127999183|NCT01716806|460625070|FG004|Overall Study|Death|10|||
127999184|NCT01716806|460625071|FG005|Overall Study|Death|5|||
127999185|NCT01716806|460625066|FG000|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
127999186|NCT01716806|460625067|FG001|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
127999187|NCT01716806|460625068|FG002|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
127999188|NCT01716806|460625069|FG003|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
127999189|NCT01716806|460625070|FG004|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
127999190|NCT01716806|460625071|FG005|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
127999191|NCT01716806|460625066|FG000|Overall Study|PI decision|0|||
127999192|NCT01716806|460625067|FG001|Overall Study|PI decision|0|||
127999193|NCT01716806|460625068|FG002|Overall Study|PI decision|0|||
127999194|NCT01716806|460625069|FG003|Overall Study|PI decision|0|||
127999195|NCT01716806|460625070|FG004|Overall Study|PI decision|1|||
127999196|NCT01716806|460625071|FG005|Overall Study|PI decision|0|||
127999197|NCT01716806|460625066|FG000|Overall Study|Change in performance status|1|||
127999198|NCT01716806|460625067|FG001|Overall Study|Change in performance status|0|||
127999199|NCT01716806|460625068|FG002|Overall Study|Change in performance status|0|||
127999200|NCT01716806|460625069|FG003|Overall Study|Change in performance status|0|||
127999201|NCT01716806|460625070|FG004|Overall Study|Change in performance status|0|||
127999202|NCT01716806|460625071|FG005|Overall Study|Change in performance status|0|||
127999203|NCT01716806|460625066|FG000|Overall Study|Sponsor terminated enrollment into Part C|0|||
127999204|NCT01716806|460625067|FG001|Overall Study|Sponsor terminated enrollment into Part C|0|||
127999205|NCT01716806|460625068|FG002|Overall Study|Sponsor terminated enrollment into Part C|1|||
127999206|NCT01716806|460625069|FG003|Overall Study|Sponsor terminated enrollment into Part C|0|||
127999207|NCT01716806|460625070|FG004|Overall Study|Sponsor terminated enrollment into Part C|0|||
127999208|NCT01716806|460625071|FG005|Overall Study|Sponsor terminated enrollment into Part C|0|||
127999209|NCT01716806|460625066|FG000|Overall Study|Sponsor direction|7|||
127999210|NCT01716806|460625067|FG001|Overall Study|Sponsor direction|8|||
127999211|NCT01716806|460625068|FG002|Overall Study|Sponsor direction|5|||
127999212|NCT01716806|460625069|FG003|Overall Study|Sponsor direction|12|||
127999213|NCT01716806|460625070|FG004|Overall Study|Sponsor direction|16|||
127999214|NCT01716806|460625071|FG005|Overall Study|Sponsor direction|1|||
127999215|NCT00956839|460625072|FG000|Overall Study|Lost to Follow-up|3|||
127999216|NCT00956839|460625073|FG001|Overall Study|Lost to Follow-up|0|||
127999217|NCT00956839|460625074|FG002|Overall Study|Lost to Follow-up|3|||
127999218|NCT03506438|460625075|FG000|Overall Study|Lost to Follow-up|8|||
127999219|NCT03506438|460625076|FG001|Overall Study|Lost to Follow-up|7|||
127999220|NCT03506438|460625077|FG002|Overall Study|Lost to Follow-up|8|||
127999221|NCT03506438|460625078|FG003|Overall Study|Lost to Follow-up|7|||
127999222|NCT03506438|460625079|FG004|Overall Study|Lost to Follow-up|0|||
127999223|NCT03506438|460625080|FG005|Overall Study|Lost to Follow-up|0|||
127999224|NCT03527277|460625081|FG000|Overall Study|Withdrawal by Subject|5|||
127999225|NCT03527277|460625082|FG001|Overall Study|Withdrawal by Subject|0|||
127999226|NCT03527277|460625081|FG000|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|0|||
127999227|NCT03527277|460625082|FG001|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|1|||
127999228|NCT03527277|460625081|FG000|Overall Study|Withdrawn by PI due to dietary miscompliance|1|||
127999229|NCT03527277|460625082|FG001|Overall Study|Withdrawn by PI due to dietary miscompliance|0|||
127999230|NCT01128296|460625083|FG000|Overall Study|Physician Decision|0|||
127999231|NCT01128296|460625084|FG001|Overall Study|Physician Decision|0|||
127999232|NCT01128296|460625085|FG002|Overall Study|Physician Decision|0|||
127999233|NCT01128296|460625086|FG003|Overall Study|Physician Decision|0|||
127999234|NCT01128296|460625087|FG004|Overall Study|Physician Decision|0|||
127999235|NCT01128296|460625088|FG005|Overall Study|Physician Decision|3|||
127999236|NCT01128296|460625083|FG000|Overall Study|Withdrawal by Subject|0|||
127999237|NCT01128296|460625084|FG001|Overall Study|Withdrawal by Subject|0|||
127999238|NCT01128296|460625085|FG002|Overall Study|Withdrawal by Subject|0|||
127999239|NCT01128296|460625086|FG003|Overall Study|Withdrawal by Subject|0|||
127999240|NCT01128296|460625087|FG004|Overall Study|Withdrawal by Subject|0|||
127999241|NCT01128296|460625088|FG005|Overall Study|Withdrawal by Subject|2|||
127999242|NCT04155463|460625089|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
127999243|NCT04155463|460625090|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
127999244|NCT01914393|460625093|FG000|Overall Study|Protocol Violation|11|||
127999245|NCT01914393|460625094|FG001|Overall Study|Protocol Violation|3|||
127999246|NCT01914393|460625095|FG002|Overall Study|Protocol Violation|19|||
127999247|NCT01914393|460625093|FG000|Overall Study|Lack of Efficacy|11|||
127999248|NCT01914393|460625094|FG001|Overall Study|Lack of Efficacy|16|||
127999249|NCT01914393|460625095|FG002|Overall Study|Lack of Efficacy|5|||
127999250|NCT01914393|460625093|FG000|Overall Study|no reason given|14|||
127999251|NCT01914393|460625094|FG001|Overall Study|no reason given|8|||
127999252|NCT01914393|460625095|FG002|Overall Study|no reason given|16|||
127999253|NCT01914393|460625093|FG000|Overall Study|Adverse Event|29|||
127999254|NCT01914393|460625094|FG001|Overall Study|Adverse Event|18|||
127999255|NCT01914393|460625095|FG002|Overall Study|Adverse Event|31|||
127999256|NCT01914393|460625093|FG000|Overall Study|Withdrawal by Subject|38|||
127999257|NCT01914393|460625094|FG001|Overall Study|Withdrawal by Subject|20|||
127999258|NCT01914393|460625095|FG002|Overall Study|Withdrawal by Subject|47|||
127999259|NCT01914393|460625093|FG000|Overall Study|Lost to Follow-up|12|||
127999260|NCT01914393|460625094|FG001|Overall Study|Lost to Follow-up|6|||
127999261|NCT01914393|460625095|FG002|Overall Study|Lost to Follow-up|19|||
127999262|NCT01914393|460625093|FG000|Overall Study|subject never dosed|0|||
127999263|NCT01914393|460625094|FG001|Overall Study|subject never dosed|0|||
127999264|NCT01914393|460625095|FG002|Overall Study|subject never dosed|1|||
127999265|NCT01718483|460625096|FG000|Overall Study|Withdrawal by Subject|14|||
127999266|NCT01718483|460625097|FG001|Overall Study|Withdrawal by Subject|12|||
127999267|NCT01718483|460625096|FG000|Overall Study|Adverse Event|5|||
127999268|NCT01718483|460625097|FG001|Overall Study|Adverse Event|12|||
127999269|NCT01718483|460625096|FG000|Overall Study|Lost to Follow-up|8|||
127999270|NCT01718483|460625097|FG001|Overall Study|Lost to Follow-up|3|||
127999271|NCT01718483|460625096|FG000|Overall Study|Protocol Violation|4|||
127999272|NCT01718483|460625097|FG001|Overall Study|Protocol Violation|2|||
127999273|NCT01718483|460625096|FG000|Overall Study|Other|1|||
127999274|NCT01718483|460625097|FG001|Overall Study|Other|4|||
127999275|NCT01718483|460625096|FG000|Overall Study|Pregnancy|1|||
127999276|NCT01718483|460625097|FG001|Overall Study|Pregnancy|1|||
127999277|NCT01718483|460625096|FG000|Overall Study|Lack of Efficacy|1|||
127999278|NCT01718483|460625097|FG001|Overall Study|Lack of Efficacy|0|||
127999279|NCT01831427|460625100|FG000|Overall Study|Adverse Event|0|||
127999280|NCT01831427|460625101|FG001|Overall Study|Adverse Event|1|||
127999281|NCT01831427|460625102|FG002|Overall Study|Adverse Event|0|||
127999282|NCT01831427|460625103|FG003|Overall Study|Adverse Event|0|||
127999283|NCT01831427|460625104|FG004|Overall Study|Adverse Event|0|||
127999284|NCT01831427|460625105|FG005|Overall Study|Adverse Event|1|||
127999285|NCT01831427|460625106|FG006|Overall Study|Adverse Event|0|||
127999286|NCT01831427|460625107|FG007|Overall Study|Adverse Event|1|||
127999287|NCT01831427|460625108|FG008|Overall Study|Adverse Event|0|||
127999288|NCT01831427|460625109|FG009|Overall Study|Adverse Event|0|||
127999289|NCT01831427|460625110|FG010|Overall Study|Adverse Event|2|||
127999290|NCT01831427|460625100|FG000|Overall Study|Investigator's Discretion|0|||
127999291|NCT01831427|460625101|FG001|Overall Study|Investigator's Discretion|0|||
127999292|NCT01831427|460625102|FG002|Overall Study|Investigator's Discretion|0|||
127999293|NCT01831427|460625103|FG003|Overall Study|Investigator's Discretion|1|||
127999294|NCT01831427|460625104|FG004|Overall Study|Investigator's Discretion|0|||
127999295|NCT01831427|460625105|FG005|Overall Study|Investigator's Discretion|0|||
127999296|NCT01831427|460625106|FG006|Overall Study|Investigator's Discretion|0|||
127999297|NCT01831427|460625107|FG007|Overall Study|Investigator's Discretion|0|||
127999298|NCT01831427|460625108|FG008|Overall Study|Investigator's Discretion|0|||
127999299|NCT01831427|460625109|FG009|Overall Study|Investigator's Discretion|0|||
127999300|NCT01831427|460625110|FG010|Overall Study|Investigator's Discretion|0|||
127999301|NCT01831427|460625100|FG000|Overall Study|Withdrew Consent|0|||
127999302|NCT01831427|460625101|FG001|Overall Study|Withdrew Consent|0|||
127999303|NCT01831427|460625102|FG002|Overall Study|Withdrew Consent|0|||
127999304|NCT01831427|460625103|FG003|Overall Study|Withdrew Consent|0|||
127999305|NCT01831427|460625104|FG004|Overall Study|Withdrew Consent|0|||
127999306|NCT01831427|460625105|FG005|Overall Study|Withdrew Consent|0|||
127999307|NCT01831427|460625106|FG006|Overall Study|Withdrew Consent|2|||
127999308|NCT01831427|460625107|FG007|Overall Study|Withdrew Consent|0|||
127999309|NCT01831427|460625108|FG008|Overall Study|Withdrew Consent|0|||
127999310|NCT01831427|460625109|FG009|Overall Study|Withdrew Consent|1|||
127999311|NCT01831427|460625110|FG010|Overall Study|Withdrew Consent|1|||
127999312|NCT00536510|460625111|FG000|Overall Study|Adverse Event|27|||
127999313|NCT00536510|460625112|FG001|Overall Study|Adverse Event|4|||
127999314|NCT00536510|460625111|FG000|Overall Study|Lost to Follow-up|11|||
127999315|NCT00536510|460625112|FG001|Overall Study|Lost to Follow-up|8|||
127999316|NCT00536510|460625111|FG000|Overall Study|Protocol Violation|4|||
127999317|NCT00536510|460625112|FG001|Overall Study|Protocol Violation|5|||
127999318|NCT00536510|460625111|FG000|Overall Study|Withdrawal by Subject|16|||
127999319|NCT00536510|460625112|FG001|Overall Study|Withdrawal by Subject|9|||
127999320|NCT00536510|460625111|FG000|Overall Study|Flushing with Product|20|||
127999321|NCT00536510|460625112|FG001|Overall Study|Flushing with Product|0|||
127999322|NCT00536510|460625111|FG000|Overall Study|Laboratory Adverse Event|2|||
127999323|NCT00536510|460625112|FG001|Overall Study|Laboratory Adverse Event|1|||
127999324|NCT00536510|460625111|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
127999325|NCT00536510|460625112|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
127999326|NCT02169505|460625113|FG000|Overall Study|Withdrawal by Subject|1|||
127999327|NCT00048035|460625114|FG000|Core Period|Early Withdrawals|4|||
127999328|NCT00048035|460625115|FG001|Core Period|Early Withdrawals|2|||
127999329|NCT00048035|460625116|FG002|Core Period|Early Withdrawals|1|||
127999330|NCT00048035|460625117|FG003|Core Period|Early Withdrawals|1|||
127999331|NCT00048035|460625118|FG004|Core Period|Early Withdrawals|1|||
127999332|NCT00048035|460625119|FG005|Core Period|Early Withdrawals|1|||
127999333|NCT00048035|460625120|FG006|Core Period|Early Withdrawals|0|||
127999334|NCT00048035|460625121|FG007|Core Period|Early Withdrawals|0|||
127999335|NCT00048035|460625114|FG000|Extension Year 1|Early Withdrawals|0|||
127999336|NCT00048035|460625115|FG001|Extension Year 1|Early Withdrawals|0|||
127999337|NCT00048035|460625116|FG002|Extension Year 1|Early Withdrawals|0|||
127999338|NCT00048035|460625117|FG003|Extension Year 1|Early Withdrawals|0|||
127999339|NCT00048035|460625118|FG004|Extension Year 1|Early Withdrawals|0|||
127999340|NCT00048035|460625119|FG005|Extension Year 1|Early Withdrawals|0|||
127999341|NCT00048035|460625120|FG006|Extension Year 1|Early Withdrawals|11|||
127999342|NCT00048035|460625121|FG007|Extension Year 1|Early Withdrawals|11|||
127999343|NCT00048035|460625114|FG000|Extension Year 2|Early Withdrawals|0|||
127999344|NCT00048035|460625115|FG001|Extension Year 2|Early Withdrawals|0|||
127999345|NCT00048035|460625116|FG002|Extension Year 2|Early Withdrawals|0|||
127999346|NCT00048035|460625117|FG003|Extension Year 2|Early Withdrawals|0|||
127999347|NCT00048035|460625118|FG004|Extension Year 2|Early Withdrawals|0|||
127999348|NCT00048035|460625119|FG005|Extension Year 2|Early Withdrawals|0|||
127999349|NCT00048035|460625120|FG006|Extension Year 2|Early Withdrawals|3|||
127999350|NCT00048035|460625121|FG007|Extension Year 2|Early Withdrawals|3|||
127999351|NCT02035553|460625122|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
127999352|NCT02035553|460625123|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
127999353|NCT02035553|460625122|FG000|Overall Study|Adverse Event|10|||
127999354|NCT02035553|460625123|FG001|Overall Study|Adverse Event|6|||
127999355|NCT02035553|460625122|FG000|Overall Study|Physician Decision|3|||
127999356|NCT02035553|460625123|FG001|Overall Study|Physician Decision|2|||
127999357|NCT02035553|460625122|FG000|Overall Study|Lack of Efficacy|1|||
127999358|NCT02035553|460625123|FG001|Overall Study|Lack of Efficacy|1|||
127999359|NCT02035553|460625122|FG000|Overall Study|Withdrawal by Subject|4|||
127999360|NCT02035553|460625123|FG001|Overall Study|Withdrawal by Subject|7|||
127999361|NCT02035553|460625122|FG000|Overall Study|Non-compliance with Study Drug|0|||
127999362|NCT02035553|460625123|FG001|Overall Study|Non-compliance with Study Drug|1|||
127999363|NCT02035553|460625122|FG000|Overall Study|Lost to Follow-up|0|||
127999364|NCT02035553|460625123|FG001|Overall Study|Lost to Follow-up|1|||
127999365|NCT02035553|460625122|FG000|Overall Study|Other Reason|0|||
127999366|NCT02035553|460625123|FG001|Overall Study|Other Reason|4|||
127999367|NCT05137717|460625124|FG000|Overall Study|Death|2|||
127999368|NCT05137717|460625124|FG000|Overall Study|Withdrawal by Subject|6|||
127999369|NCT02735980|460625125|FG000|Overall Study|Adverse Event|0|||
127999370|NCT02735980|460625126|FG001|Overall Study|Adverse Event|4|||
127999371|NCT02735980|460625127|FG002|Overall Study|Adverse Event|1|||
127999372|NCT02735980|460625125|FG000|Overall Study|Death|5|||
127999373|NCT02735980|460625126|FG001|Overall Study|Death|4|||
127999374|NCT02735980|460625127|FG002|Overall Study|Death|0|||
127999375|NCT02735980|460625125|FG000|Overall Study|Physician Decision|3|||
127999376|NCT02735980|460625126|FG001|Overall Study|Physician Decision|1|||
127999377|NCT02735980|460625127|FG002|Overall Study|Physician Decision|0|||
127999378|NCT02735980|460625125|FG000|Overall Study|Screen failure|1|||
127999379|NCT02735980|460625126|FG001|Overall Study|Screen failure|0|||
127999380|NCT02735980|460625127|FG002|Overall Study|Screen failure|0|||
127999381|NCT02735980|460625125|FG000|Overall Study|Withdrawal by Subject|1|||
127999382|NCT02735980|460625126|FG001|Overall Study|Withdrawal by Subject|2|||
127999383|NCT02735980|460625127|FG002|Overall Study|Withdrawal by Subject|0|||
127999384|NCT00509899|460625128|FG000|Overall Study|Progressive disease|1|||
127999385|NCT00509899|460625129|FG001|Overall Study|Progressive disease|3|||
127999386|NCT00509899|460625130|FG002|Overall Study|Progressive disease|5|||
127999387|NCT00509899|460625131|FG003|Overall Study|Progressive disease|1|||
127999388|NCT00509899|460625132|FG004|Overall Study|Progressive disease|0|||
127999389|NCT00509899|460625133|FG005|Overall Study|Progressive disease|1|||
127999390|NCT00509899|460625134|FG006|Overall Study|Progressive disease|0|||
127999391|NCT00509899|460625135|FG007|Overall Study|Progressive disease|0|||
127999392|NCT00509899|460625128|FG000|Overall Study|Unacceptable Toxicity|1|||
127999393|NCT00509899|460625129|FG001|Overall Study|Unacceptable Toxicity|0|||
127999394|NCT00509899|460625130|FG002|Overall Study|Unacceptable Toxicity|0|||
127999395|NCT00509899|460625131|FG003|Overall Study|Unacceptable Toxicity|2|||
127999396|NCT00509899|460625132|FG004|Overall Study|Unacceptable Toxicity|0|||
127999397|NCT00509899|460625133|FG005|Overall Study|Unacceptable Toxicity|0|||
127999398|NCT00509899|460625134|FG006|Overall Study|Unacceptable Toxicity|0|||
127999399|NCT00509899|460625135|FG007|Overall Study|Unacceptable Toxicity|0|||
127999400|NCT00509899|460625128|FG000|Overall Study|Withdrawal by Subject|6|||
127999401|NCT00509899|460625129|FG001|Overall Study|Withdrawal by Subject|2|||
127999402|NCT00509899|460625130|FG002|Overall Study|Withdrawal by Subject|3|||
127999403|NCT00509899|460625131|FG003|Overall Study|Withdrawal by Subject|0|||
127999404|NCT00509899|460625132|FG004|Overall Study|Withdrawal by Subject|3|||
127999405|NCT00509899|460625133|FG005|Overall Study|Withdrawal by Subject|2|||
127999406|NCT00509899|460625134|FG006|Overall Study|Withdrawal by Subject|0|||
127999407|NCT00509899|460625135|FG007|Overall Study|Withdrawal by Subject|0|||
127999408|NCT00509899|460625128|FG000|Overall Study|Physician Decision|4|||
127999409|NCT00509899|460625129|FG001|Overall Study|Physician Decision|2|||
127999410|NCT00509899|460625130|FG002|Overall Study|Physician Decision|7|||
127999411|NCT00509899|460625131|FG003|Overall Study|Physician Decision|0|||
127999412|NCT00509899|460625132|FG004|Overall Study|Physician Decision|1|||
127999413|NCT00509899|460625133|FG005|Overall Study|Physician Decision|4|||
127999414|NCT00509899|460625134|FG006|Overall Study|Physician Decision|0|||
127999415|NCT00509899|460625135|FG007|Overall Study|Physician Decision|0|||
127999416|NCT00509899|460625128|FG000|Overall Study|Intercurrent Illness|1|||
127999417|NCT00509899|460625129|FG001|Overall Study|Intercurrent Illness|0|||
127999418|NCT00509899|460625130|FG002|Overall Study|Intercurrent Illness|0|||
127999419|NCT00509899|460625131|FG003|Overall Study|Intercurrent Illness|1|||
127999420|NCT00509899|460625132|FG004|Overall Study|Intercurrent Illness|0|||
127999421|NCT00509899|460625133|FG005|Overall Study|Intercurrent Illness|1|||
127999422|NCT00509899|460625134|FG006|Overall Study|Intercurrent Illness|0|||
127999423|NCT00509899|460625135|FG007|Overall Study|Intercurrent Illness|0|||
127999424|NCT00509899|460625128|FG000|Overall Study|Death|2|||
127999425|NCT00509899|460625129|FG001|Overall Study|Death|2|||
127999426|NCT00509899|460625130|FG002|Overall Study|Death|3|||
127999427|NCT00509899|460625131|FG003|Overall Study|Death|0|||
127999428|NCT00509899|460625132|FG004|Overall Study|Death|1|||
127999429|NCT00509899|460625133|FG005|Overall Study|Death|1|||
127999430|NCT00509899|460625134|FG006|Overall Study|Death|1|||
127999431|NCT00509899|460625135|FG007|Overall Study|Death|1|||
127999432|NCT00509899|460625128|FG000|Overall Study|Lack of Efficacy|1|||
127999433|NCT00509899|460625129|FG001|Overall Study|Lack of Efficacy|0|||
127999434|NCT00509899|460625130|FG002|Overall Study|Lack of Efficacy|2|||
127999435|NCT00509899|460625131|FG003|Overall Study|Lack of Efficacy|0|||
127999436|NCT00509899|460625132|FG004|Overall Study|Lack of Efficacy|0|||
127999437|NCT00509899|460625133|FG005|Overall Study|Lack of Efficacy|1|||
127999438|NCT00509899|460625134|FG006|Overall Study|Lack of Efficacy|0|||
127999439|NCT00509899|460625135|FG007|Overall Study|Lack of Efficacy|0|||
127999440|NCT02326272|460625136|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
127999441|NCT02326272|460625137|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
127999442|NCT02326272|460625138|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
127999443|NCT02326272|460625139|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
127999444|NCT02326272|460625140|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
127999445|NCT02326272|460625141|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
127999446|NCT02326272|460625142|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
127999447|NCT02326272|460625143|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
127999448|NCT02326272|460625144|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
127999449|NCT02326272|460625145|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
127999450|NCT02326272|460625146|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
127999451|NCT02326272|460625147|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
127999452|NCT02326272|460625148|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
127999453|NCT02326272|460625149|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
127999454|NCT02326272|460625150|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
127999455|NCT02326272|460625136|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
127999456|NCT02326272|460625137|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
127999457|NCT02326272|460625138|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
127999458|NCT02326272|460625139|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
127999459|NCT02326272|460625140|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
127999460|NCT02326272|460625141|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
127999461|NCT02326272|460625142|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
127999462|NCT02326272|460625143|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
127999463|NCT02326272|460625144|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
127999464|NCT02326272|460625145|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
127999465|NCT02326272|460625146|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
127999466|NCT02326272|460625147|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
127999467|NCT02326272|460625148|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
127999468|NCT02326272|460625149|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
127999469|NCT02326272|460625150|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
127999470|NCT02326272|460625136|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
127999471|NCT02326272|460625137|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
127999472|NCT02326272|460625138|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
127999473|NCT02326272|460625139|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
127999474|NCT02326272|460625140|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
127999475|NCT02326272|460625141|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
127999476|NCT02326272|460625142|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
127999477|NCT02326272|460625143|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
127999478|NCT02326272|460625144|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
127999479|NCT02326272|460625145|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
127999480|NCT02326272|460625146|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
127999481|NCT02326272|460625147|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
127999482|NCT02326272|460625148|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
127999483|NCT02326272|460625149|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
127999484|NCT02326272|460625150|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
127999485|NCT02326272|460625136|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
127999486|NCT02326272|460625137|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
127999487|NCT02326272|460625138|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
127999488|NCT02326272|460625139|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
127999489|NCT02326272|460625140|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
127999490|NCT02326272|460625141|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
127999491|NCT02326272|460625142|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
127999492|NCT02326272|460625143|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
127999493|NCT02326272|460625144|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
127999494|NCT02326272|460625145|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
127999495|NCT02326272|460625146|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
127999496|NCT02326272|460625147|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
127999497|NCT02326272|460625148|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
127999498|NCT02326272|460625149|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
127999499|NCT02326272|460625150|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
127999500|NCT02326272|460625136|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
127999501|NCT02326272|460625137|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
127999502|NCT02326272|460625138|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
127999503|NCT02326272|460625139|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
127999504|NCT02326272|460625140|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
127999505|NCT02326272|460625141|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
127999506|NCT02326272|460625142|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
127999507|NCT02326272|460625143|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
127999508|NCT02326272|460625144|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
127999509|NCT02326272|460625145|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
127999510|NCT02326272|460625146|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
127999511|NCT02326272|460625147|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
127666163|NCT03486899|459398472|FG003|Overall Study|Lost to Follow-up|3|||
127666164|NCT03486899|459398469|FG000|Overall Study|Death|1|||
127666165|NCT03486899|459398470|FG001|Overall Study|Death|0|||
127666166|NCT03486899|459398471|FG002|Overall Study|Death|0|||
127666167|NCT03486899|459398472|FG003|Overall Study|Death|1|||
127666168|NCT03486899|459398469|FG000|Overall Study|Adverse Event|0|||
127666169|NCT03486899|459398470|FG001|Overall Study|Adverse Event|2|||
127666170|NCT03486899|459398471|FG002|Overall Study|Adverse Event|0|||
127999512|NCT02326272|460625148|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
127999513|NCT02326272|460625149|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
127999514|NCT02326272|460625150|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
127999515|NCT02326272|460625136|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
127999516|NCT02326272|460625137|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
127999517|NCT02326272|460625138|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
127999518|NCT02326272|460625139|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
127999519|NCT02326272|460625140|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
127999520|NCT02326272|460625141|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
127999521|NCT02326272|460625142|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
127999522|NCT02326272|460625143|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
127999523|NCT02326272|460625144|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
127999524|NCT02326272|460625145|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
127999525|NCT02326272|460625146|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
127666171|NCT03486899|459398472|FG003|Overall Study|Adverse Event|2|||
127666172|NCT03486899|459398469|FG000|Overall Study|Withdrawal by Subject|3|||
127999526|NCT02326272|460625147|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
127999527|NCT02326272|460625148|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
127999528|NCT02326272|460625149|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
127999529|NCT02326272|460625150|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
127999530|NCT02326272|460625136|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
127999531|NCT02326272|460625137|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
127999532|NCT02326272|460625138|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
127999533|NCT02326272|460625139|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
127999534|NCT02326272|460625140|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
127999535|NCT02326272|460625141|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
127999536|NCT02326272|460625142|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
127999537|NCT02326272|460625143|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
127999538|NCT02326272|460625144|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
127999539|NCT02326272|460625145|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
127999540|NCT02326272|460625146|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
127999541|NCT02326272|460625147|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
127999542|NCT02326272|460625148|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
127999543|NCT02326272|460625149|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
127999544|NCT02326272|460625150|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
127999545|NCT02326272|460625136|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
127999546|NCT02326272|460625137|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
127999547|NCT02326272|460625138|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
127999548|NCT02326272|460625139|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
127999549|NCT02326272|460625140|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
127999550|NCT02326272|460625141|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
127999551|NCT02326272|460625142|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
127999552|NCT02326272|460625143|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
127999553|NCT02326272|460625144|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
127999554|NCT02326272|460625145|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
127999555|NCT02326272|460625146|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
127999556|NCT02326272|460625147|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
127999557|NCT02326272|460625148|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
127999558|NCT02326272|460625149|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
127999559|NCT02326272|460625150|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
127999560|NCT02326272|460625136|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
127999561|NCT02326272|460625137|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
127999562|NCT02326272|460625138|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
127999563|NCT02326272|460625139|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
127999564|NCT02326272|460625140|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
127999565|NCT02326272|460625141|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
127999566|NCT02326272|460625142|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
127999567|NCT02326272|460625143|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
127999568|NCT02326272|460625144|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
127999569|NCT02326272|460625145|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
127999570|NCT02326272|460625146|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
127999571|NCT02326272|460625147|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
127999572|NCT02326272|460625148|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
127999573|NCT02326272|460625149|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
127999574|NCT02326272|460625150|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
127999575|NCT02326272|460625136|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127999576|NCT02326272|460625137|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127999577|NCT02326272|460625138|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127999578|NCT02326272|460625139|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127999579|NCT02326272|460625140|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127999580|NCT02326272|460625141|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
127999581|NCT02326272|460625142|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127999582|NCT02326272|460625143|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
127999583|NCT02326272|460625144|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127999584|NCT02326272|460625145|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127999585|NCT02326272|460625146|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127999586|NCT02326272|460625147|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127999587|NCT02326272|460625148|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127999588|NCT02326272|460625149|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127999589|NCT02326272|460625150|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127999590|NCT02326272|460625136|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
127999591|NCT02326272|460625137|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
127999592|NCT02326272|460625138|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
127999593|NCT02326272|460625139|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
127999594|NCT02326272|460625140|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
127999595|NCT02326272|460625141|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
127999596|NCT02326272|460625142|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
127999597|NCT02326272|460625143|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
127999598|NCT02326272|460625144|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
127999599|NCT02326272|460625145|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
127999600|NCT02326272|460625146|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
127999601|NCT02326272|460625147|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
127999602|NCT02326272|460625148|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
127999603|NCT02326272|460625149|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
127999604|NCT02326272|460625150|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
127999605|NCT02326272|460625136|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
127999606|NCT02326272|460625137|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
127999607|NCT02326272|460625138|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
127999608|NCT02326272|460625139|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
127999609|NCT02326272|460625140|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
127999610|NCT02326272|460625141|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
127999611|NCT02326272|460625142|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
127999612|NCT02326272|460625143|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
127999613|NCT02326272|460625144|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
127999614|NCT02326272|460625145|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
127999615|NCT02326272|460625146|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
127999616|NCT02326272|460625147|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
127999617|NCT02326272|460625148|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
127999618|NCT02326272|460625149|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
127999619|NCT02326272|460625150|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
127999620|NCT02326272|460625136|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
127999621|NCT02326272|460625137|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
127999622|NCT02326272|460625138|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
127999623|NCT02326272|460625139|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
127999624|NCT02326272|460625140|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
127999625|NCT02326272|460625141|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
127999626|NCT02326272|460625142|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
127999627|NCT02326272|460625143|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
127999628|NCT02326272|460625144|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
127999629|NCT02326272|460625145|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
127999630|NCT02326272|460625146|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
127999631|NCT02326272|460625147|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
127999632|NCT02326272|460625148|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
127999633|NCT02326272|460625149|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
127999634|NCT02326272|460625150|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
127999635|NCT02326272|460625136|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
127999636|NCT02326272|460625137|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
127999637|NCT02326272|460625138|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
127999638|NCT02326272|460625139|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
127999639|NCT02326272|460625140|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
127999640|NCT02326272|460625141|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
127999641|NCT02326272|460625142|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
127999642|NCT02326272|460625143|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
127999643|NCT02326272|460625144|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
127999644|NCT02326272|460625145|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
127999645|NCT02326272|460625146|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
127999646|NCT02326272|460625147|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
127666173|NCT03486899|459398470|FG001|Overall Study|Withdrawal by Subject|7|||
127666174|NCT03486899|459398471|FG002|Overall Study|Withdrawal by Subject|4|||
127666175|NCT03486899|459398472|FG003|Overall Study|Withdrawal by Subject|3|||
127666176|NCT03486899|459398469|FG000|Overall Study|Other Reasons|0|||
127999647|NCT02326272|460625148|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
127999648|NCT02326272|460625149|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
127666177|NCT03486899|459398470|FG001|Overall Study|Other Reasons|1|||
127666178|NCT03486899|459398471|FG002|Overall Study|Other Reasons|0|||
127666179|NCT03486899|459398472|FG003|Overall Study|Other Reasons|1|||
127666180|NCT01010217|459398475|FG000|Overall Study|Lost to Follow-up|4|||
127666181|NCT01010217|459398476|FG001|Overall Study|Lost to Follow-up|5|||
127666182|NCT01010217|459398477|FG002|Overall Study|Lost to Follow-up|1|||
127666183|NCT01010217|459398478|FG003|Overall Study|Lost to Follow-up|0|||
127666184|NCT01010217|459398479|FG004|Overall Study|Lost to Follow-up|0|||
127666185|NCT01010217|459398475|FG000|Overall Study|Withdrawal by Subject|1|||
127666186|NCT01010217|459398476|FG001|Overall Study|Withdrawal by Subject|0|||
127666187|NCT01010217|459398477|FG002|Overall Study|Withdrawal by Subject|0|||
127666188|NCT01010217|459398478|FG003|Overall Study|Withdrawal by Subject|0|||
127666189|NCT01010217|459398479|FG004|Overall Study|Withdrawal by Subject|0|||
127666190|NCT01010217|459398475|FG000|Overall Study|Physician Decision|0|||
127666191|NCT01010217|459398476|FG001|Overall Study|Physician Decision|0|||
127666192|NCT01010217|459398477|FG002|Overall Study|Physician Decision|0|||
127666193|NCT01010217|459398478|FG003|Overall Study|Physician Decision|6|||
127999649|NCT02326272|460625150|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
127999650|NCT02326272|460625136|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
127999651|NCT02326272|460625137|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
127999652|NCT02326272|460625138|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
127999653|NCT02326272|460625139|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
127999654|NCT02326272|460625140|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
127999655|NCT02326272|460625141|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
127999656|NCT02326272|460625142|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
127999657|NCT02326272|460625143|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
127999658|NCT02326272|460625144|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
127999659|NCT02326272|460625145|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
127999660|NCT02326272|460625146|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
127999661|NCT02326272|460625147|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
127999662|NCT02326272|460625148|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
127999663|NCT02326272|460625149|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
127999664|NCT02326272|460625150|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
127999665|NCT02326272|460625136|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
127999666|NCT02326272|460625137|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
127999667|NCT02326272|460625138|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
127999668|NCT02326272|460625139|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
127999669|NCT02326272|460625140|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
127999670|NCT02326272|460625141|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
127999671|NCT02326272|460625142|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
127999672|NCT02326272|460625143|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
127999673|NCT02326272|460625144|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
127999674|NCT02326272|460625145|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
127999675|NCT02326272|460625146|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
127999676|NCT02326272|460625147|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
127999677|NCT02326272|460625148|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
127999678|NCT02326272|460625149|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
127999679|NCT02326272|460625150|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
127999680|NCT02326272|460625136|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
127999681|NCT02326272|460625137|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
127999682|NCT02326272|460625138|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
127999683|NCT02326272|460625139|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
127999684|NCT02326272|460625140|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
127999685|NCT02326272|460625141|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
127999686|NCT02326272|460625142|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
127999687|NCT02326272|460625143|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
127999688|NCT02326272|460625144|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
127999689|NCT02326272|460625145|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
127999690|NCT02326272|460625146|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
127666194|NCT01010217|459398479|FG004|Overall Study|Physician Decision|3|||
127666195|NCT01439711|459398480|FG000|Overall Study|Ineligible|13|||
127666196|NCT01439711|459398480|FG000|Overall Study|Cancel|3|||
127999691|NCT02326272|460625147|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
127999692|NCT02326272|460625148|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
127999693|NCT02326272|460625149|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
127999694|NCT02326272|460625150|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
127999695|NCT02326272|460625136|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
127999696|NCT02326272|460625137|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
127999697|NCT02326272|460625138|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
127999698|NCT02326272|460625139|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
127999699|NCT02326272|460625140|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
127999700|NCT02326272|460625141|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
127999701|NCT02326272|460625142|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
127999702|NCT02326272|460625143|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
127999703|NCT02326272|460625144|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
127999704|NCT02326272|460625145|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
127999705|NCT02326272|460625146|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
127999706|NCT02326272|460625147|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
127999707|NCT02326272|460625148|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
127999708|NCT02326272|460625149|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
127999709|NCT02326272|460625150|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
127999710|NCT02326272|460625136|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
127999711|NCT02326272|460625137|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
127999712|NCT02326272|460625138|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
127999713|NCT02326272|460625139|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
127999714|NCT02326272|460625140|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
127999715|NCT02326272|460625141|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
127999716|NCT02326272|460625142|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
127999717|NCT02326272|460625143|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
127999718|NCT02326272|460625144|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
127999719|NCT02326272|460625145|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
127999720|NCT02326272|460625146|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
127999721|NCT02326272|460625147|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
127999722|NCT02326272|460625148|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
127999723|NCT02326272|460625149|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
127999724|NCT02326272|460625150|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
127999725|NCT02326272|460625136|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127999726|NCT02326272|460625137|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127999727|NCT02326272|460625138|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127999728|NCT02326272|460625139|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127999729|NCT02326272|460625140|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127999730|NCT02326272|460625141|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127999731|NCT02326272|460625142|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127999732|NCT02326272|460625143|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127999733|NCT02326272|460625144|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127999734|NCT02326272|460625145|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127999735|NCT02326272|460625146|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
127999736|NCT02326272|460625147|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127999737|NCT02326272|460625148|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
127999738|NCT02326272|460625149|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127999739|NCT02326272|460625150|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127999740|NCT02326272|460625136|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
127999741|NCT02326272|460625137|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
127999742|NCT02326272|460625138|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
127999743|NCT02326272|460625139|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
127999744|NCT02326272|460625140|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
127999745|NCT02326272|460625141|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
127999746|NCT02326272|460625142|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
127999747|NCT02326272|460625143|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
127999748|NCT02326272|460625144|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
127999749|NCT02326272|460625145|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
127999750|NCT02326272|460625146|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
127666197|NCT01439711|459398480|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
127999751|NCT02326272|460625147|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
127999752|NCT02326272|460625148|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
127999753|NCT02326272|460625149|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
127999754|NCT02326272|460625150|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
127999755|NCT02326272|460625136|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
127999756|NCT02326272|460625137|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
127999757|NCT02326272|460625138|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
127999758|NCT02326272|460625139|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
127999759|NCT02326272|460625140|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
127999760|NCT02326272|460625141|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
127999761|NCT02326272|460625142|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
127999762|NCT02326272|460625143|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
127999763|NCT02326272|460625144|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
127999764|NCT02326272|460625145|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
127999765|NCT02326272|460625146|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
127999766|NCT02326272|460625147|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
127999767|NCT02326272|460625148|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
127999768|NCT02326272|460625149|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
127999769|NCT02326272|460625150|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
127999770|NCT02326272|460625136|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
127999771|NCT02326272|460625137|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
127999772|NCT02326272|460625138|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
127999773|NCT02326272|460625139|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
127999774|NCT02326272|460625140|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
127999775|NCT02326272|460625141|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
127999776|NCT02326272|460625142|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
127666198|NCT01439711|459398480|FG000|Overall Study|Adverse Event|5|||
127666199|NCT01439711|459398480|FG000|Overall Study|Withdrawal by Subject|3|||
127666200|NCT01439711|459398480|FG000|Overall Study|Progression During Active Tx|3|||
127666201|NCT01439711|459398480|FG000|Overall Study|Noncompliance|3|||
127666202|NCT01439711|459398480|FG000|Overall Study|No MRI|9|||
127666203|NCT04242875|459398481|FG000|Overall Study|Adverse Event|2|||
127666204|NCT01012973|459398482|FG000|Overall Study|Adverse Event|5|||
127666205|NCT01012973|459398483|FG001|Overall Study|Adverse Event|5|||
127666206|NCT01012973|459398482|FG000|Overall Study|Lack of Efficacy|0|||
127666207|NCT01012973|459398483|FG001|Overall Study|Lack of Efficacy|5|||
127666208|NCT01012973|459398482|FG000|Overall Study|Lost to Follow-up|1|||
127666209|NCT01012973|459398483|FG001|Overall Study|Lost to Follow-up|0|||
127666210|NCT01012973|459398482|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
127666211|NCT01012973|459398483|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
127666212|NCT01012973|459398482|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
127666213|NCT01012973|459398483|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
127666214|NCT01012973|459398482|FG000|Overall Study|Protocol Violation|5|||
127666215|NCT01012973|459398483|FG001|Overall Study|Protocol Violation|2|||
127666216|NCT01012973|459398482|FG000|Overall Study|Withdrawal by Subject|4|||
127666217|NCT01012973|459398483|FG001|Overall Study|Withdrawal by Subject|6|||
127666218|NCT01782326|459398486|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
127666219|NCT01782326|459398487|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
127666220|NCT01782326|459398486|FG000|Planned Treatment Epoch|Death|29|||
127666221|NCT01782326|459398487|FG001|Planned Treatment Epoch|Death|30|||
127666222|NCT01782326|459398486|FG000|Planned Treatment Epoch|Physician Decision|18|||
127666223|NCT01782326|459398487|FG001|Planned Treatment Epoch|Physician Decision|16|||
127666224|NCT01782326|459398486|FG000|Planned Treatment Epoch|Protocol deviation|2|||
127666225|NCT01782326|459398487|FG001|Planned Treatment Epoch|Protocol deviation|3|||
127666226|NCT01782326|459398486|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
127666227|NCT01782326|459398487|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
127666228|NCT01782326|459398486|FG000|Planned Treatment Epoch|Technical problems|0|||
127666229|NCT01782326|459398487|FG001|Planned Treatment Epoch|Technical problems|4|||
127666230|NCT01782326|459398486|FG000|Double-blind Treatment|Adverse Event|129|||
127666231|NCT01782326|459398487|FG001|Double-blind Treatment|Adverse Event|145|||
127666232|NCT01782326|459398486|FG000|Double-blind Treatment|Subject/guardian decision|111|||
127666233|NCT01782326|459398487|FG001|Double-blind Treatment|Subject/guardian decision|125|||
127666234|NCT01782326|459398486|FG000|Double-blind Treatment|Lack of Efficacy|17|||
127666235|NCT01782326|459398487|FG001|Double-blind Treatment|Lack of Efficacy|22|||
127666236|NCT01782326|459398486|FG000|Double-blind Treatment|Physician Decision|13|||
127666237|NCT01782326|459398487|FG001|Double-blind Treatment|Physician Decision|16|||
127666238|NCT01782326|459398486|FG000|Double-blind Treatment|Protocol deviation|8|||
127666239|NCT01782326|459398487|FG001|Double-blind Treatment|Protocol deviation|7|||
127666240|NCT01782326|459398486|FG000|Double-blind Treatment|Technical problems|0|||
127666241|NCT01782326|459398487|FG001|Double-blind Treatment|Technical problems|5|||
127666242|NCT01473420|459398488|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
127999777|NCT02326272|460625143|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
127999778|NCT02326272|460625144|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
127666243|NCT01473420|459398489|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
127666244|NCT01473420|459398488|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
127666245|NCT01473420|459398489|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
127666246|NCT01473420|459398488|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
127666247|NCT01473420|459398489|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
127666248|NCT01473420|459398488|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
127666249|NCT01473420|459398489|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
127666250|NCT01473420|459398488|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
127666251|NCT01473420|459398489|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
127999779|NCT02326272|460625145|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
127999780|NCT02326272|460625146|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
127666252|NCT01473420|459398488|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
127666253|NCT01473420|459398489|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
127666254|NCT01473420|459398488|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
127666255|NCT01473420|459398489|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
127666256|NCT01473420|459398488|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
127666257|NCT01473420|459398489|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
127666258|NCT01473420|459398488|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
127999781|NCT02326272|460625147|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
127999782|NCT02326272|460625148|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
127999783|NCT02326272|460625149|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
127999784|NCT02326272|460625150|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
127999785|NCT02326272|460625136|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
127999786|NCT02326272|460625137|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
127999787|NCT02326272|460625138|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
127999788|NCT02326272|460625139|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
127999789|NCT02326272|460625140|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
127999790|NCT02326272|460625141|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
127999791|NCT02326272|460625142|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
127999792|NCT02326272|460625143|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
127999793|NCT02326272|460625144|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
127999794|NCT02326272|460625145|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
127999795|NCT02326272|460625146|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
127999796|NCT02326272|460625147|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
127999797|NCT02326272|460625148|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
127999798|NCT02326272|460625149|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
127999799|NCT02326272|460625150|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
127999800|NCT02326272|460625136|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
127999801|NCT02326272|460625137|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
127999802|NCT02326272|460625138|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
127999803|NCT02326272|460625139|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
127999804|NCT02326272|460625140|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
127999805|NCT02326272|460625141|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
127999806|NCT02326272|460625142|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
127999807|NCT02326272|460625143|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
127999808|NCT02326272|460625144|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
127999809|NCT02326272|460625145|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
127999810|NCT02326272|460625146|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
127999811|NCT02326272|460625147|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
127999812|NCT02326272|460625148|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
127999813|NCT02326272|460625149|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
127999814|NCT02326272|460625150|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
127999815|NCT02326272|460625136|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
127999816|NCT02326272|460625137|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
127999817|NCT02326272|460625138|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
127999818|NCT02326272|460625139|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
127999819|NCT02326272|460625140|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
127999820|NCT02326272|460625141|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
127999821|NCT02326272|460625142|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
127999822|NCT02326272|460625143|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
127999823|NCT02326272|460625144|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
127999824|NCT02326272|460625145|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
127999825|NCT02326272|460625146|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
127999826|NCT02326272|460625147|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
127999827|NCT02326272|460625148|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
127666259|NCT01473420|459398489|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
127666260|NCT01473420|459398488|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
127999828|NCT02326272|460625149|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
127999829|NCT02326272|460625150|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
127999830|NCT03713684|460625151|FG000|Overall Study|Adverse Event|1|||
127999831|NCT03713684|460625152|FG001|Overall Study|Adverse Event|3|||
127999832|NCT03713684|460625153|FG002|Overall Study|Adverse Event|1|||
127999833|NCT03713684|460625154|FG003|Overall Study|Adverse Event|0|||
127999834|NCT03713684|460625151|FG000|Overall Study|Poor compliance to protocol|2|||
127999835|NCT03713684|460625152|FG001|Overall Study|Poor compliance to protocol|1|||
127999836|NCT03713684|460625153|FG002|Overall Study|Poor compliance to protocol|0|||
127999837|NCT03713684|460625154|FG003|Overall Study|Poor compliance to protocol|1|||
127999838|NCT03713684|460625151|FG000|Overall Study|Withdrawal by Subject|14|||
127999839|NCT03713684|460625152|FG001|Overall Study|Withdrawal by Subject|6|||
127999840|NCT03713684|460625153|FG002|Overall Study|Withdrawal by Subject|14|||
127999841|NCT03713684|460625154|FG003|Overall Study|Withdrawal by Subject|16|||
127999842|NCT03713684|460625151|FG000|Overall Study|Other than specified|69|||
127999843|NCT03713684|460625152|FG001|Overall Study|Other than specified|77|||
127999844|NCT03713684|460625153|FG002|Overall Study|Other than specified|73|||
127999845|NCT03713684|460625154|FG003|Overall Study|Other than specified|70|||
127999846|NCT02185417|460625155|FG000|Overall Study|Death|448|||
127999847|NCT02185417|460625156|FG001|Overall Study|Death|446|||
127999848|NCT02185417|460625157|FG002|Overall Study|Death|0|||
127999849|NCT02185417|460625155|FG000|Overall Study|Withdrawal by Subject|7|||
127999850|NCT02185417|460625156|FG001|Overall Study|Withdrawal by Subject|12|||
127999851|NCT02185417|460625157|FG002|Overall Study|Withdrawal by Subject|0|||
127999852|NCT00974311|460625158|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
127999853|NCT00974311|460625159|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
127999854|NCT00974311|460625158|FG000|DB Phase (up to 24 Months)|Death|561|||
127999855|NCT00974311|460625159|FG001|DB Phase (up to 24 Months)|Death|298|||
127999856|NCT00974311|460625158|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
127999857|NCT00974311|460625159|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
127999858|NCT00974311|460625158|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
127999859|NCT00974311|460625159|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
127999860|NCT00974311|460625158|FG000|DB Phase (up to 24 Months)|Other|1|||
127999861|NCT00974311|460625159|FG001|DB Phase (up to 24 Months)|Other|0|||
127999862|NCT00974311|460625158|FG000|OLE Phase (up to 77 Months)|Death|14|||
127999863|NCT00974311|460625159|FG001|OLE Phase (up to 77 Months)|Death|21|||
127999864|NCT00974311|460625158|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
127999865|NCT00974311|460625159|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
127999866|NCT00974311|460625158|FG000|OLE Phase (up to 77 Months)|Other|15|||
127999867|NCT00974311|460625159|FG001|OLE Phase (up to 77 Months)|Other|2|||
127999868|NCT00974311|460625158|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
127999869|NCT00974311|460625159|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
127999870|NCT02595502|460625160|FG000|Period 1|Adverse Event|0|||
127999871|NCT02595502|460625161|FG001|Period 1|Adverse Event|1|||
127999872|NCT02595502|460625160|FG000|Period 1|Withdrawal by Subject|1|||
127999873|NCT02595502|460625161|FG001|Period 1|Withdrawal by Subject|0|||
127999874|NCT02595502|460625160|FG000|Period 1|Lost to Follow-up|0|||
127999875|NCT02595502|460625161|FG001|Period 1|Lost to Follow-up|1|||
127999876|NCT02595502|460625160|FG000|Period 2|Adverse Event|1|||
127999877|NCT02595502|460625161|FG001|Period 2|Adverse Event|1|||
127999878|NCT02595502|460625160|FG000|Period 2|Received incorrect lens at Period 1|0|||
127999879|NCT02595502|460625161|FG001|Period 2|Received incorrect lens at Period 1|1|||
127999880|NCT02595502|460625160|FG000|Period 3|Protocol Violation|0|||
127999881|NCT02595502|460625161|FG001|Period 3|Protocol Violation|1|||
127999882|NCT02595502|460625160|FG000|Period 3|Lost to Follow-up|1|||
127999883|NCT02595502|460625161|FG001|Period 3|Lost to Follow-up|0|||
127999884|NCT02595502|460625160|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
127999885|NCT02595502|460625161|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
127999886|NCT05556148|460625162|FG000|Overall Study|Early Termination|29|||
127999887|NCT05556148|460625162|FG000|Overall Study|Baseline Tasks Expired|4|||
127999888|NCT05556148|460625162|FG000|Overall Study|Family Emergency: Could no longer take part|1|||
127999889|NCT05556148|460625162|FG000|Overall Study|No Longer Wished to Participate|1|||
127999890|NCT05556148|460625162|FG000|Overall Study|Bacterial Conjunctivitis|1|||
127999891|NCT00676403|460625170|FG000|Overall Study|Adverse Event|1|||
127999892|NCT00676403|460625171|FG001|Overall Study|Adverse Event|2|||
127999893|NCT00676403|460625172|FG002|Overall Study|Adverse Event|0|||
127999894|NCT00676403|460625173|FG003|Overall Study|Adverse Event|5|||
127999895|NCT00676403|460625174|FG004|Overall Study|Adverse Event|1|||
127999896|NCT00676403|460625175|FG005|Overall Study|Adverse Event|2|||
127999897|NCT00676403|460625170|FG000|Overall Study|Lost to Follow-up|0|||
127999898|NCT00676403|460625171|FG001|Overall Study|Lost to Follow-up|0|||
127999899|NCT00676403|460625172|FG002|Overall Study|Lost to Follow-up|0|||
127999900|NCT00676403|460625173|FG003|Overall Study|Lost to Follow-up|0|||
127999901|NCT00676403|460625174|FG004|Overall Study|Lost to Follow-up|0|||
127999902|NCT00676403|460625175|FG005|Overall Study|Lost to Follow-up|1|||
127999903|NCT00676403|460625170|FG000|Overall Study|Reason Unspecified|1|||
127999904|NCT00676403|460625171|FG001|Overall Study|Reason Unspecified|0|||
127999905|NCT00676403|460625172|FG002|Overall Study|Reason Unspecified|1|||
127999906|NCT00676403|460625173|FG003|Overall Study|Reason Unspecified|0|||
127999907|NCT00676403|460625174|FG004|Overall Study|Reason Unspecified|0|||
127999908|NCT00676403|460625175|FG005|Overall Study|Reason Unspecified|1|||
127999909|NCT00676403|460625170|FG000|Overall Study|Withdrawal by Subject|0|||
127999910|NCT00676403|460625171|FG001|Overall Study|Withdrawal by Subject|0|||
127999911|NCT00676403|460625172|FG002|Overall Study|Withdrawal by Subject|0|||
127999912|NCT00676403|460625173|FG003|Overall Study|Withdrawal by Subject|0|||
127999913|NCT00676403|460625174|FG004|Overall Study|Withdrawal by Subject|0|||
127999914|NCT00676403|460625175|FG005|Overall Study|Withdrawal by Subject|1|||
127999915|NCT01746862|460625176|FG000|Overall Study|Withdrawal by Subject|1|||
127999916|NCT01746862|460625177|FG001|Overall Study|Withdrawal by Subject|1|||
127999917|NCT01746862|460625176|FG000|Overall Study|Protocol Violation|1|||
127999918|NCT01746862|460625177|FG001|Overall Study|Protocol Violation|0|||
127999919|NCT01746862|460625176|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
127999920|NCT01746862|460625177|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
127999921|NCT01746862|460625176|FG000|Overall Study|Entered puberty during the study|1|||
127999922|NCT01746862|460625177|FG001|Overall Study|Entered puberty during the study|0|||
127999923|NCT04742673|460625178|FG000|Overall Study|Did not receive any study drug and not included in assessments or results|4|||
127999924|NCT04742673|460625179|FG001|Overall Study|Did not receive any study drug and not included in assessments or results|3|||
127999925|NCT06058390|460625181|FG000|Overall Study|Lost to Follow-up|0|||
127999926|NCT06058390|460625182|FG001|Overall Study|Lost to Follow-up|0|||
127999927|NCT06058390|460625183|FG002|Overall Study|Lost to Follow-up|2|||
127999928|NCT06058390|460625184|FG003|Overall Study|Lost to Follow-up|1|||
127999929|NCT06058390|460625181|FG000|Overall Study|Physician Decision|0|||
127999930|NCT06058390|460625182|FG001|Overall Study|Physician Decision|0|||
127999931|NCT06058390|460625183|FG002|Overall Study|Physician Decision|0|||
127999932|NCT06058390|460625184|FG003|Overall Study|Physician Decision|1|||
127999933|NCT06058390|460625181|FG000|Overall Study|Participants did not receive any study intervention|0|||
127999934|NCT06058390|460625182|FG001|Overall Study|Participants did not receive any study intervention|0|||
127999935|NCT06058390|460625183|FG002|Overall Study|Participants did not receive any study intervention|0|||
127999936|NCT06058390|460625184|FG003|Overall Study|Participants did not receive any study intervention|1|||
127999937|NCT03361306|460625185|FG000|Overall Study|Death|6|||
127999938|NCT04073303|460625186|FG000|Overall Study|Adverse Event|0|||
127999939|NCT04073303|460625187|FG001|Overall Study|Adverse Event|2|||
127999940|NCT04073303|460625186|FG000|Overall Study|Withdrawal by Subject|16|||
127999941|NCT04073303|460625187|FG001|Overall Study|Withdrawal by Subject|36|||
127999942|NCT04073303|460625186|FG000|Overall Study|Lost to Follow-up|6|||
127999943|NCT04073303|460625187|FG001|Overall Study|Lost to Follow-up|1|||
127999944|NCT04073303|460625186|FG000|Overall Study|Protocol Deviation|0|||
127999945|NCT04073303|460625187|FG001|Overall Study|Protocol Deviation|4|||
127999946|NCT04073303|460625186|FG000|Overall Study|Other|1|||
127999947|NCT04073303|460625187|FG001|Overall Study|Other|1|||
127999948|NCT02131064|460625189|FG000|Overall Study|Death|5|||
127999949|NCT02131064|460625190|FG001|Overall Study|Death|6|||
127999950|NCT02131064|460625189|FG000|Overall Study|Lost to Follow-up|4|||
127999951|NCT02131064|460625190|FG001|Overall Study|Lost to Follow-up|8|||
127999952|NCT02131064|460625189|FG000|Overall Study|Withdrawal by Subject|14|||
127999953|NCT02131064|460625190|FG001|Overall Study|Withdrawal by Subject|18|||
127999954|NCT02131064|460625189|FG000|Overall Study|Other|2|||
127999955|NCT02131064|460625190|FG001|Overall Study|Other|2|||
127999956|NCT00810069|460625193|FG000|Lead-in Period I|Adverse Event|43|||
127999957|NCT00810069|460625194|FG001|Lead-in Period I|Adverse Event|0|||
127999958|NCT00810069|460625195|FG002|Lead-in Period I|Adverse Event|0|||
127999959|NCT00810069|460625193|FG000|Lead-in Period I|Lack of Efficacy|1|||
127999960|NCT00810069|460625194|FG001|Lead-in Period I|Lack of Efficacy|0|||
127999961|NCT00810069|460625195|FG002|Lead-in Period I|Lack of Efficacy|0|||
127999962|NCT00810069|460625193|FG000|Lead-in Period I|Lost to Follow-up|19|||
127999963|NCT00810069|460625194|FG001|Lead-in Period I|Lost to Follow-up|0|||
127999964|NCT00810069|460625195|FG002|Lead-in Period I|Lost to Follow-up|0|||
127999965|NCT00810069|460625193|FG000|Lead-in Period I|Physician Decision|1|||
127999966|NCT00810069|460625194|FG001|Lead-in Period I|Physician Decision|0|||
127999967|NCT00810069|460625195|FG002|Lead-in Period I|Physician Decision|0|||
127999968|NCT00810069|460625193|FG000|Lead-in Period I|Protocol Violation|1|||
127999969|NCT00810069|460625194|FG001|Lead-in Period I|Protocol Violation|0|||
127999970|NCT00810069|460625195|FG002|Lead-in Period I|Protocol Violation|0|||
127999971|NCT00810069|460625193|FG000|Lead-in Period I|Withdrawal by Subject|46|||
127999972|NCT00810069|460625194|FG001|Lead-in Period I|Withdrawal by Subject|0|||
127999973|NCT00810069|460625195|FG002|Lead-in Period I|Withdrawal by Subject|0|||
127999974|NCT00810069|460625193|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
127999975|NCT00810069|460625194|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
127999976|NCT00810069|460625195|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
127999977|NCT00810069|460625193|FG000|Lead-in Period I|Randomization criteria not met|158|||
127999978|NCT00810069|460625194|FG001|Lead-in Period I|Randomization criteria not met|0|||
127999979|NCT00810069|460625195|FG002|Lead-in Period I|Randomization criteria not met|0|||
127999980|NCT00810069|460625193|FG000|Double-Blind Period II|Adverse Event|0|||
127666261|NCT01473420|459398489|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
127666262|NCT01473420|459398488|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
127666263|NCT01473420|459398489|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
127666264|NCT01473420|459398488|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
127666265|NCT01473420|459398489|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
127666266|NCT01473420|459398488|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
127666267|NCT01473420|459398489|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
127666268|NCT04172987|459398495|FG000|Lead In Period|Adverse Event|1|||
127666269|NCT04172987|459398495|FG000|Lead In Period|Protocol Violation|1|||
127666270|NCT04172987|459398495|FG000|Period 1|Physician Decision|1|||
127666271|NCT04172987|459398495|FG000|Period 2|Adverse Event|5|||
127666272|NCT04172987|459398495|FG000|Period 2|Dosing Termination by Sponsor|4|||
127666273|NCT00738530|459398503|FG000|Overall Study|Death|220|||
127666274|NCT00738530|459398504|FG001|Overall Study|Death|224|||
127999981|NCT00810069|460625194|FG001|Double-Blind Period II|Adverse Event|9|||
127999982|NCT00810069|460625195|FG002|Double-Blind Period II|Adverse Event|8|||
127999983|NCT00810069|460625193|FG000|Double-Blind Period II|Lack of Efficacy|0|||
127999984|NCT00810069|460625194|FG001|Double-Blind Period II|Lack of Efficacy|7|||
127999985|NCT00810069|460625195|FG002|Double-Blind Period II|Lack of Efficacy|12|||
127999986|NCT00810069|460625193|FG000|Double-Blind Period II|Lost to Follow-up|0|||
127999987|NCT00810069|460625194|FG001|Double-Blind Period II|Lost to Follow-up|9|||
127999988|NCT00810069|460625195|FG002|Double-Blind Period II|Lost to Follow-up|9|||
127666275|NCT00738530|459398503|FG000|Overall Study|Lost to Follow-up|8|||
127666276|NCT00738530|459398504|FG001|Overall Study|Lost to Follow-up|6|||
127666277|NCT00738530|459398503|FG000|Overall Study|Withdrawal by Subject|6|||
127666278|NCT00738530|459398504|FG001|Overall Study|Withdrawal by Subject|8|||
127666279|NCT01628510|459398505|FG000|Overall Study|Withdrawal by Subject|0|||
127666280|NCT01628510|459398506|FG001|Overall Study|Withdrawal by Subject|4|||
127666281|NCT01628510|459398505|FG000|Overall Study|Death|3|||
127666282|NCT01628510|459398506|FG001|Overall Study|Death|1|||
127999989|NCT00810069|460625193|FG000|Double-Blind Period II|Physician Decision|0|||
127999990|NCT00810069|460625194|FG001|Double-Blind Period II|Physician Decision|0|||
127999991|NCT00810069|460625195|FG002|Double-Blind Period II|Physician Decision|1|||
127999992|NCT00810069|460625193|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
127999993|NCT00810069|460625194|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
127999994|NCT00810069|460625195|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
127999995|NCT00810069|460625193|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
127999996|NCT00810069|460625194|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
127999997|NCT00810069|460625195|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
127999998|NCT00810069|460625193|FG000|Double-Blind Period II|Clinical relapse|0|||
127999999|NCT00810069|460625194|FG001|Double-Blind Period II|Clinical relapse|3|||
128000000|NCT00810069|460625195|FG002|Double-Blind Period II|Clinical relapse|0|||
128000001|NCT00810069|460625193|FG000|Double-Blind Period II|Protocol Violation|0|||
128000002|NCT00810069|460625194|FG001|Double-Blind Period II|Protocol Violation|7|||
128000003|NCT00810069|460625195|FG002|Double-Blind Period II|Protocol Violation|6|||
128000004|NCT02899065|460625199|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
128000005|NCT02899065|460625200|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
128000006|NCT02899065|460625199|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
128000007|NCT02899065|460625200|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
128000008|NCT02899065|460625199|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
128000009|NCT02899065|460625200|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
128000010|NCT00971867|460625201|FG000|Overall Study|Adverse Event|4|||
128000011|NCT00971867|460625201|FG000|Overall Study|Participant Withdrew Consent|1|||
128000012|NCT00971867|460625201|FG000|Overall Study|Disease Progression|6|||
128000013|NCT04767373|460625202|FG000|Overall Study|Death|6|||
128000014|NCT04767373|460625203|FG001|Overall Study|Death|3|||
128000015|NCT04767373|460625202|FG000|Overall Study|Lost to Follow-up|67|||
128000016|NCT04767373|460625203|FG001|Overall Study|Lost to Follow-up|35|||
128000017|NCT04767373|460625202|FG000|Overall Study|Physician Decision|15|||
128000018|NCT04767373|460625203|FG001|Overall Study|Physician Decision|4|||
128000019|NCT04767373|460625202|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
128000020|NCT04767373|460625203|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
128000021|NCT04767373|460625202|FG000|Overall Study|Withdrawal By Parent/Guardian|75|||
127666283|NCT04179461|459398507|FG000|Overall Study|Lost to Follow-up|4|||
127666284|NCT01653847|459398508|FG000|Overall Study|Withdrawal by Subject|1|||
127666285|NCT01653847|459398509|FG001|Overall Study|Withdrawal by Subject|0|||
127666286|NCT04707391|459398510|FG000|Overall Study|Adverse Event|5|||
127666287|NCT04707391|459398511|FG001|Overall Study|Adverse Event|8|||
127880893|NCT00566631|460186057|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
128000022|NCT04767373|460625203|FG001|Overall Study|Withdrawal By Parent/Guardian|40|||
128000023|NCT04767373|460625202|FG000|Overall Study|Other|1|||
128000024|NCT04767373|460625203|FG001|Overall Study|Other|2|||
128000025|NCT02983045|460625205|FG000|Overall Study|Withdrawal by Subject|0|||
128000026|NCT02983045|460625206|FG001|Overall Study|Withdrawal by Subject|1|||
128000027|NCT02983045|460625207|FG002|Overall Study|Withdrawal by Subject|0|||
128000028|NCT02983045|460625208|FG003|Overall Study|Withdrawal by Subject|5|||
128000029|NCT02983045|460625209|FG004|Overall Study|Withdrawal by Subject|0|||
128000030|NCT02983045|460625210|FG005|Overall Study|Withdrawal by Subject|72|||
128000031|NCT02983045|460625211|FG006|Overall Study|Withdrawal by Subject|0|||
128000032|NCT02983045|460625212|FG007|Overall Study|Withdrawal by Subject|0|||
128000033|NCT02983045|460625213|FG008|Overall Study|Withdrawal by Subject|0|||
128000034|NCT02983045|460625214|FG009|Overall Study|Withdrawal by Subject|2|||
128000035|NCT02983045|460625205|FG000|Overall Study|Lost to Follow-up|0|||
128000036|NCT02983045|460625206|FG001|Overall Study|Lost to Follow-up|0|||
128000037|NCT02983045|460625207|FG002|Overall Study|Lost to Follow-up|0|||
128000038|NCT02983045|460625208|FG003|Overall Study|Lost to Follow-up|0|||
128000039|NCT02983045|460625209|FG004|Overall Study|Lost to Follow-up|0|||
128000040|NCT02983045|460625210|FG005|Overall Study|Lost to Follow-up|10|||
128000041|NCT02983045|460625211|FG006|Overall Study|Lost to Follow-up|0|||
128000042|NCT02983045|460625212|FG007|Overall Study|Lost to Follow-up|0|||
128000043|NCT02983045|460625213|FG008|Overall Study|Lost to Follow-up|0|||
128000044|NCT02983045|460625214|FG009|Overall Study|Lost to Follow-up|0|||
128000045|NCT00593918|460625215|FG000|Overall Study|Withdrawal by Subject|5|||
128000046|NCT00593918|460625216|FG001|Overall Study|Withdrawal by Subject|24|||
128000047|NCT02658669|460625217|FG000|Overall Study|Lost to Follow-up|7|||
128000048|NCT02658669|460625218|FG001|Overall Study|Lost to Follow-up|5|||
128000049|NCT03421379|460625220|FG000|Period 1|Withdrawal by Subject|0|||
128000050|NCT03421379|460625221|FG001|Period 1|Withdrawal by Subject|1|||
128000051|NCT03421379|460625220|FG000|Period 1|Physician Decision|1|||
128000052|NCT03421379|460625221|FG001|Period 1|Physician Decision|1|||
128000053|NCT03421379|460625220|FG000|Period 1|Did not receive treatment|1|||
128000054|NCT03421379|460625221|FG001|Period 1|Did not receive treatment|2|||
128000055|NCT02782741|460625222|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
128000056|NCT02782741|460625223|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
128000057|NCT02782741|460625224|FG002|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
128000058|NCT02782741|460625222|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
128000059|NCT02782741|460625223|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
128000060|NCT02782741|460625224|FG002|Blinded Treatment Period: up to Week 49|Other|0|||
128000061|NCT02782741|460625222|FG000|Open-label Long-term: Week 50 to 289|Adverse Event|2|||
128000062|NCT02782741|460625223|FG001|Open-label Long-term: Week 50 to 289|Adverse Event|3|||
128000063|NCT02782741|460625224|FG002|Open-label Long-term: Week 50 to 289|Adverse Event|0|||
128000064|NCT02782741|460625222|FG000|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
128000065|NCT02782741|460625223|FG001|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|1|||
128000066|NCT02782741|460625224|FG002|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
128000067|NCT02782741|460625222|FG000|Open-label Long-term: Week 50 to 289|Other|5|||
128000068|NCT02782741|460625223|FG001|Open-label Long-term: Week 50 to 289|Other|4|||
128000069|NCT02782741|460625224|FG002|Open-label Long-term: Week 50 to 289|Other|0|||
128000070|NCT04157088|460625225|FG000|Overall Study|Study terminated by sponsor|23|||
128000071|NCT04157088|460625225|FG000|Overall Study|Withdrawal by Subject|4|||
128000072|NCT04157088|460625225|FG000|Overall Study|Lost to Follow-up|2|||
128000073|NCT04157088|460625225|FG000|Overall Study|Death|1|||
128000074|NCT00992017|460625226|FG000|Overall Study|Lost to Follow-up|2|||
128000075|NCT00992017|460625226|FG000|Overall Study|Withdrawal by Subject|2|||
128000076|NCT00992017|460625226|FG000|Overall Study|Unable to get to clinic|5|||
128000077|NCT00992017|460625226|FG000|Overall Study|Not adhere to study requirements|1|||
128000078|NCT02155985|460625236|FG000|Overall Study|Withdrawal by Subject|0|||
128000079|NCT02155985|460625237|FG001|Overall Study|Withdrawal by Subject|0|||
128000080|NCT02155985|460625238|FG002|Overall Study|Withdrawal by Subject|1|||
128000081|NCT02155985|460625236|FG000|Overall Study|Lost to Follow-up|1|||
128000082|NCT02155985|460625237|FG001|Overall Study|Lost to Follow-up|0|||
128000083|NCT02155985|460625238|FG002|Overall Study|Lost to Follow-up|0|||
128000084|NCT02998151|460625241|FG000|Overall Study|Withdrawal by Subject|3|||
128000085|NCT02998151|460625241|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
128000086|NCT02998151|460625241|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
128000087|NCT02573259|460625242|FG000|Overall Study|Death|1|||
128000088|NCT02573259|460625243|FG001|Overall Study|Death|6|||
128000089|NCT02573259|460625244|FG002|Overall Study|Death|5|||
128000090|NCT02573259|460625245|FG003|Overall Study|Death|6|||
128000091|NCT02573259|460625246|FG004|Overall Study|Death|9|||
128000092|NCT02573259|460625247|FG005|Overall Study|Death|32|||
128000093|NCT02573259|460625248|FG006|Overall Study|Death|21|||
128000094|NCT02573259|460625242|FG000|Overall Study|Lost to Follow-up|0|||
128000095|NCT02573259|460625243|FG001|Overall Study|Lost to Follow-up|0|||
128000096|NCT02573259|460625244|FG002|Overall Study|Lost to Follow-up|0|||
128000097|NCT02573259|460625245|FG003|Overall Study|Lost to Follow-up|0|||
128000098|NCT02573259|460625246|FG004|Overall Study|Lost to Follow-up|0|||
128000099|NCT02573259|460625247|FG005|Overall Study|Lost to Follow-up|2|||
128000100|NCT02573259|460625248|FG006|Overall Study|Lost to Follow-up|1|||
128000101|NCT02573259|460625242|FG000|Overall Study|Participant refused further follow-up|0|||
128000102|NCT02573259|460625243|FG001|Overall Study|Participant refused further follow-up|2|||
128000103|NCT02573259|460625244|FG002|Overall Study|Participant refused further follow-up|1|||
128000104|NCT02573259|460625245|FG003|Overall Study|Participant refused further follow-up|0|||
128000105|NCT02573259|460625246|FG004|Overall Study|Participant refused further follow-up|3|||
128000106|NCT02573259|460625247|FG005|Overall Study|Participant refused further follow-up|20|||
128000107|NCT02573259|460625248|FG006|Overall Study|Participant refused further follow-up|7|||
128000108|NCT02573259|460625242|FG000|Overall Study|Other|0|||
128000109|NCT02573259|460625243|FG001|Overall Study|Other|0|||
128000110|NCT02573259|460625244|FG002|Overall Study|Other|0|||
128000111|NCT02573259|460625245|FG003|Overall Study|Other|0|||
128000112|NCT02573259|460625246|FG004|Overall Study|Other|1|||
128000113|NCT02573259|460625247|FG005|Overall Study|Other|4|||
128000114|NCT02573259|460625248|FG006|Overall Study|Other|5|||
128000115|NCT01817075|460625254|FG000|Overall Study|Adverse Event|7|||
128000116|NCT01817075|460625255|FG001|Overall Study|Adverse Event|5|||
128000117|NCT01817075|460625254|FG000|Overall Study|Physician Decision|9|||
128000118|NCT01817075|460625255|FG001|Overall Study|Physician Decision|12|||
128000119|NCT01817075|460625254|FG000|Overall Study|Withdrawal by Subject|31|||
128000120|NCT01817075|460625255|FG001|Overall Study|Withdrawal by Subject|15|||
128000121|NCT01817075|460625254|FG000|Overall Study|Received Sorafenib after enrollment|0|||
128000122|NCT01817075|460625255|FG001|Overall Study|Received Sorafenib after enrollment|1|||
128000123|NCT01817075|460625254|FG000|Overall Study|Ineligible|0|||
128000124|NCT01817075|460625255|FG001|Overall Study|Ineligible|2|||
128000125|NCT05212168|460625256|FG000|Overall Study|Lost to Follow-up|0|||
128000126|NCT05212168|460625257|FG001|Overall Study|Lost to Follow-up|3|||
128000127|NCT05212168|460625256|FG000|Overall Study|Study terminated by sponsor|30|||
128000128|NCT05212168|460625257|FG001|Overall Study|Study terminated by sponsor|27|||
128000129|NCT05212168|460625256|FG000|Overall Study|Other|4|||
128000130|NCT05212168|460625257|FG001|Overall Study|Other|7|||
128000131|NCT03934216|460626976|FG000|Overall Study|Other Reasons|5|||
128000132|NCT03934216|460626977|FG001|Overall Study|Other Reasons|5|||
128000133|NCT03934216|460626976|FG000|Overall Study|Adverse Event|22|||
128000134|NCT03934216|460626977|FG001|Overall Study|Adverse Event|11|||
128000135|NCT03934216|460626976|FG000|Overall Study|Lack of Efficacy|8|||
128000136|NCT03934216|460626977|FG001|Overall Study|Lack of Efficacy|7|||
128000137|NCT03934216|460626976|FG000|Overall Study|Lost to Follow-up|2|||
128000138|NCT03934216|460626977|FG001|Overall Study|Lost to Follow-up|0|||
128000139|NCT03934216|460626976|FG000|Overall Study|Non-Compliance with Study Drug|1|||
128000140|NCT03934216|460626977|FG001|Overall Study|Non-Compliance with Study Drug|1|||
128000141|NCT03934216|460626976|FG000|Overall Study|Pregnancy|1|||
128000142|NCT03934216|460626977|FG001|Overall Study|Pregnancy|0|||
128000143|NCT03934216|460626976|FG000|Overall Study|Withdrawal by Subject|18|||
128000144|NCT03934216|460626977|FG001|Overall Study|Withdrawal by Subject|6|||
128000145|NCT03934216|460626976|FG000|Overall Study|Randomized but not treated|1|||
128000146|NCT03934216|460626977|FG001|Overall Study|Randomized but not treated|1|||
128000147|NCT00619827|460626978|FG000|Overall Study|Adverse Event|1|||
128000148|NCT00619827|460626979|FG001|Overall Study|Adverse Event|2|||
128000149|NCT00619827|460626978|FG000|Overall Study|Withdrawal by Subject|2|||
128000150|NCT00619827|460626979|FG001|Overall Study|Withdrawal by Subject|2|||
128000151|NCT01063855|460626980|FG000|Overall Study|Adverse Event|4|||
128000152|NCT01063855|460626981|FG001|Overall Study|Adverse Event|4|||
128000153|NCT01063855|460626980|FG000|Overall Study|Death|0|||
128000154|NCT01063855|460626981|FG001|Overall Study|Death|1|||
128000155|NCT01063855|460626980|FG000|Overall Study|Lost to Follow-up|8|||
128000156|NCT01063855|460626981|FG001|Overall Study|Lost to Follow-up|4|||
128000157|NCT01063855|460626980|FG000|Overall Study|Pregnancy|1|||
128000158|NCT01063855|460626981|FG001|Overall Study|Pregnancy|0|||
128000159|NCT01063855|460626980|FG000|Overall Study|Lack of Efficacy|0|||
128000160|NCT01063855|460626981|FG001|Overall Study|Lack of Efficacy|1|||
128000161|NCT01063855|460626980|FG000|Overall Study|Withdrawal by Subject|11|||
128000162|NCT01063855|460626981|FG001|Overall Study|Withdrawal by Subject|8|||
128000163|NCT01063855|460626980|FG000|Overall Study|Reason not specified|13|||
128000164|NCT01063855|460626981|FG001|Overall Study|Reason not specified|11|||
128000165|NCT02163395|460626984|FG000|Overall Study|Withdrawal by Subject|1|||
128000166|NCT02163395|460626984|FG000|Overall Study|Lost to Follow-up|3|||
128000167|NCT02163395|460626984|FG000|Overall Study|Adverse Event|1|||
128000168|NCT01854697|460626994|FG000|Overall Study|Adverse Event|1|||
128000169|NCT01854697|460626995|FG001|Overall Study|Adverse Event|0|||
128000170|NCT01854697|460626996|FG002|Overall Study|Adverse Event|0|||
128000171|NCT01854697|460626997|FG003|Overall Study|Adverse Event|0|||
128000172|NCT01854697|460626998|FG004|Overall Study|Adverse Event|1|||
128000173|NCT01854697|460626994|FG000|Overall Study|Lost to Follow-up|4|||
128000174|NCT01854697|460626995|FG001|Overall Study|Lost to Follow-up|1|||
128000175|NCT01854697|460626996|FG002|Overall Study|Lost to Follow-up|1|||
128000176|NCT01854697|460626997|FG003|Overall Study|Lost to Follow-up|2|||
128000177|NCT01854697|460626998|FG004|Overall Study|Lost to Follow-up|0|||
128000178|NCT01854697|460626994|FG000|Overall Study|To enter another AbbVie study|1|||
128000179|NCT01854697|460626995|FG001|Overall Study|To enter another AbbVie study|0|||
128000180|NCT01854697|460626996|FG002|Overall Study|To enter another AbbVie study|0|||
127666288|NCT04707391|459398510|FG000|Overall Study|Lost to Follow-up|44|||
127666289|NCT04707391|459398511|FG001|Overall Study|Lost to Follow-up|31|||
127666290|NCT04707391|459398510|FG000|Overall Study|Protocol Violation|1|||
127666291|NCT04707391|459398511|FG001|Overall Study|Protocol Violation|5|||
127666292|NCT04707391|459398510|FG000|Overall Study|Withdrawal by Subject|27|||
127666293|NCT04707391|459398511|FG001|Overall Study|Withdrawal by Subject|25|||
127666294|NCT04707391|459398510|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
127666295|NCT04707391|459398511|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
127666296|NCT04707391|459398510|FG000|Overall Study|Other|0|||
127666297|NCT04707391|459398511|FG001|Overall Study|Other|2|||
127666298|NCT03246672|459398512|FG000|Overall Study|Lost to Follow-up|2|||
127666299|NCT01347645|459398513|FG000|Overall Study|Death|1|||
127666300|NCT01347645|459398514|FG001|Overall Study|Death|5|||
127666301|NCT01347645|459398515|FG002|Overall Study|Death|2|||
127666302|NCT01347645|459398516|FG003|Overall Study|Death|7|||
127666303|NCT01347645|459398517|FG004|Overall Study|Death|7|||
127666304|NCT01347645|459398513|FG000|Overall Study|Lost to Follow-up|1|||
127666305|NCT01347645|459398514|FG001|Overall Study|Lost to Follow-up|1|||
128000181|NCT01854697|460626997|FG003|Overall Study|To enter another AbbVie study|0|||
127666306|NCT01347645|459398515|FG002|Overall Study|Lost to Follow-up|0|||
127666307|NCT01347645|459398516|FG003|Overall Study|Lost to Follow-up|1|||
127666308|NCT01347645|459398517|FG004|Overall Study|Lost to Follow-up|1|||
127666309|NCT01347645|459398513|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
127666310|NCT01347645|459398514|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
127666311|NCT01347645|459398515|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
127666312|NCT01347645|459398516|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
127666313|NCT01347645|459398517|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
127666314|NCT01347645|459398513|FG000|Overall Study|Other|1|||
127666315|NCT01347645|459398514|FG001|Overall Study|Other|0|||
127666316|NCT01347645|459398515|FG002|Overall Study|Other|0|||
127666317|NCT01347645|459398516|FG003|Overall Study|Other|0|||
127666318|NCT01347645|459398517|FG004|Overall Study|Other|1|||
127666319|NCT01347645|459398513|FG000|Overall Study|Withdrawal by Subject|0|||
127666320|NCT01347645|459398514|FG001|Overall Study|Withdrawal by Subject|0|||
127666321|NCT01347645|459398515|FG002|Overall Study|Withdrawal by Subject|0|||
127666322|NCT01347645|459398516|FG003|Overall Study|Withdrawal by Subject|3|||
127666323|NCT01347645|459398517|FG004|Overall Study|Withdrawal by Subject|3|||
127666324|NCT01347645|459398513|FG000|Overall Study|Physician Decision|0|||
127666325|NCT01347645|459398514|FG001|Overall Study|Physician Decision|0|||
127666326|NCT01347645|459398515|FG002|Overall Study|Physician Decision|0|||
127666327|NCT01347645|459398516|FG003|Overall Study|Physician Decision|0|||
127666328|NCT01347645|459398517|FG004|Overall Study|Physician Decision|1|||
127666329|NCT01347645|459398513|FG000|Overall Study|Adverse Event|0|||
127666330|NCT01347645|459398514|FG001|Overall Study|Adverse Event|0|||
127666331|NCT01347645|459398515|FG002|Overall Study|Adverse Event|0|||
127666332|NCT01347645|459398516|FG003|Overall Study|Adverse Event|1|||
128000182|NCT01854697|460626998|FG004|Overall Study|To enter another AbbVie study|1|||
128000183|NCT01854697|460626994|FG000|Overall Study|Withdrew Consent|0|||
128000184|NCT01854697|460626995|FG001|Overall Study|Withdrew Consent|1|||
128000185|NCT01854697|460626996|FG002|Overall Study|Withdrew Consent|0|||
128000186|NCT01854697|460626997|FG003|Overall Study|Withdrew Consent|1|||
128000187|NCT01854697|460626998|FG004|Overall Study|Withdrew Consent|0|||
128000188|NCT01854697|460626994|FG000|Overall Study|Other|0|||
128000189|NCT01854697|460626995|FG001|Overall Study|Other|1|||
128000190|NCT01854697|460626996|FG002|Overall Study|Other|1|||
128000191|NCT01854697|460626997|FG003|Overall Study|Other|0|||
128000192|NCT01854697|460626998|FG004|Overall Study|Other|0|||
128000193|NCT00115778|460627002|FG000|Overall Study|Withdrawal by Subject|0|||
128000194|NCT00115778|460627003|FG001|Overall Study|Withdrawal by Subject|1|||
128000195|NCT00528424|460627006|FG000|Overall Study|Lost to Follow-up|13|||
128000196|NCT00528424|460627006|FG000|Overall Study|Withdrew consent|2|||
128000197|NCT00528424|460627006|FG000|Overall Study|Administrative reason|2|||
128000198|NCT00528424|460627006|FG000|Overall Study|Other|12|||
128000199|NCT00483652|460627007|FG000|Double-blind Treatment Period|Protocol Violation|2|||
128000200|NCT00483652|460627008|FG001|Double-blind Treatment Period|Protocol Violation|1|||
128000201|NCT00483652|460627007|FG000|Double-blind Treatment Period|Adverse Event|3|||
127666333|NCT01347645|459398517|FG004|Overall Study|Adverse Event|1|||
127666334|NCT00388362|459398518|FG000|Enrolled|Ineligible|1|||
127666335|NCT00388362|459398518|FG000|Enrolled|Adverse Event|9|||
127666336|NCT00388362|459398518|FG000|Enrolled|Death|1|||
128000202|NCT00483652|460627008|FG001|Double-blind Treatment Period|Adverse Event|4|||
128000203|NCT00483652|460627007|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
127666337|NCT00388362|459398518|FG000|Enrolled|Loss insurance|1|||
127666338|NCT00388362|459398518|FG000|Enrolled|Withdrawal by Subject|1|||
127666339|NCT00388362|459398518|FG000|Remained on Study Median of 514 Days|Death|2|||
127666340|NCT01141660|459398519|FG000|Overall Study|Physician Decision|0|||
128000204|NCT00483652|460627008|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
128000205|NCT00483652|460627007|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
128000206|NCT00483652|460627008|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
128000207|NCT00468585|460627009|FG000|Overall Study|Patient not treated|1|||
128000208|NCT00468585|460627010|FG001|Overall Study|Patient not treated|0|||
128000209|NCT00468585|460627011|FG002|Overall Study|Patient not treated|1|||
128000210|NCT00468585|460627012|FG003|Overall Study|Patient not treated|0|||
127666341|NCT01141660|459398520|FG001|Overall Study|Physician Decision|12|||
128000211|NCT00468585|460627009|FG000|Overall Study|Patient found to be ineligible|0|||
128000212|NCT00468585|460627010|FG001|Overall Study|Patient found to be ineligible|0|||
128000213|NCT00468585|460627011|FG002|Overall Study|Patient found to be ineligible|1|||
128000214|NCT00468585|460627012|FG003|Overall Study|Patient found to be ineligible|0|||
128000215|NCT00468585|460627009|FG000|Overall Study|Adverse Event|0|||
128000216|NCT00468585|460627010|FG001|Overall Study|Adverse Event|0|||
128000217|NCT00468585|460627011|FG002|Overall Study|Adverse Event|1|||
128000218|NCT00468585|460627012|FG003|Overall Study|Adverse Event|0|||
128000219|NCT00468585|460627009|FG000|Overall Study|Withdrawal by Subject|0|||
128000220|NCT00468585|460627010|FG001|Overall Study|Withdrawal by Subject|0|||
128000221|NCT00468585|460627011|FG002|Overall Study|Withdrawal by Subject|2|||
128000222|NCT00468585|460627012|FG003|Overall Study|Withdrawal by Subject|1|||
128000223|NCT02154139|460627013|FG000|Overall Study|Injection not administered|2|||
128000224|NCT02154139|460627013|FG000|Overall Study|Other|2|||
128000225|NCT02154139|460627013|FG000|Overall Study|Investigator transferred|3|||
128000226|NCT02087774|460627014|FG000|Overall Study|Were absent day of data collection|8|||
128000227|NCT02087774|460627015|FG001|Overall Study|Were absent day of data collection|20|||
128000228|NCT02157519|460627023|FG000|Overall Study|Death|3|||
128000229|NCT02157519|460627024|FG001|Overall Study|Death|1|||
128000230|NCT02157519|460627023|FG000|Overall Study|Withdrawal by Subject|7|||
128000231|NCT02157519|460627024|FG001|Overall Study|Withdrawal by Subject|0|||
128000232|NCT02157519|460627023|FG000|Overall Study|Lost to Follow-up|1|||
128000233|NCT02157519|460627024|FG001|Overall Study|Lost to Follow-up|0|||
128000234|NCT01656395|460627025|FG000|Overall Study|Adverse Event|1|||
128000235|NCT01656395|460627026|FG001|Overall Study|Adverse Event|14|||
128000236|NCT01656395|460627027|FG002|Overall Study|Adverse Event|5|||
128000237|NCT01656395|460627028|FG003|Overall Study|Adverse Event|4|||
128000238|NCT01656395|460627029|FG004|Overall Study|Adverse Event|5|||
128000239|NCT01656395|460627030|FG005|Overall Study|Adverse Event|7|||
127666342|NCT00209027|459398522|FG000|Overall Study|study terminated|10|||
127666343|NCT00209027|459398523|FG001|Overall Study|study terminated|0|||
127666344|NCT01932996|459398524|FG000|Overall Study|Protocol Violation|2|||
127666345|NCT01932996|459398525|FG001|Overall Study|Protocol Violation|0|||
127666346|NCT01848834|459398526|FG000|Overall Study|Adverse Event|3|||
127666347|NCT01848834|459398527|FG001|Overall Study|Adverse Event|11|||
127666348|NCT01848834|459398528|FG002|Overall Study|Adverse Event|3|||
127666349|NCT01848834|459398529|FG003|Overall Study|Adverse Event|5|||
127666350|NCT01848834|459398530|FG004|Overall Study|Adverse Event|9|||
127666351|NCT01848834|459398526|FG000|Overall Study|Death|2|||
127666352|NCT01848834|459398527|FG001|Overall Study|Death|11|||
127666353|NCT01848834|459398528|FG002|Overall Study|Death|1|||
127666354|NCT01848834|459398529|FG003|Overall Study|Death|8|||
127666355|NCT01848834|459398530|FG004|Overall Study|Death|27|||
127666356|NCT01848834|459398526|FG000|Overall Study|Excluded Medication|5|||
127666357|NCT01848834|459398527|FG001|Overall Study|Excluded Medication|4|||
127666358|NCT01848834|459398528|FG002|Overall Study|Excluded Medication|3|||
127666359|NCT01848834|459398529|FG003|Overall Study|Excluded Medication|6|||
127666360|NCT01848834|459398530|FG004|Overall Study|Excluded Medication|6|||
127666361|NCT01848834|459398526|FG000|Overall Study|Lost to Follow-up|5|||
127666362|NCT01848834|459398527|FG001|Overall Study|Lost to Follow-up|5|||
127666363|NCT01848834|459398528|FG002|Overall Study|Lost to Follow-up|3|||
127666364|NCT01848834|459398529|FG003|Overall Study|Lost to Follow-up|0|||
127666365|NCT01848834|459398530|FG004|Overall Study|Lost to Follow-up|3|||
127666366|NCT01848834|459398526|FG000|Overall Study|Physician Decision|1|||
127666367|NCT01848834|459398527|FG001|Overall Study|Physician Decision|3|||
127666368|NCT01848834|459398528|FG002|Overall Study|Physician Decision|4|||
127666369|NCT01848834|459398529|FG003|Overall Study|Physician Decision|0|||
127666370|NCT01848834|459398530|FG004|Overall Study|Physician Decision|11|||
127666371|NCT01848834|459398526|FG000|Overall Study|Protocol Violation|0|||
127666372|NCT01848834|459398527|FG001|Overall Study|Protocol Violation|0|||
127666373|NCT01848834|459398528|FG002|Overall Study|Protocol Violation|0|||
127666374|NCT01848834|459398529|FG003|Overall Study|Protocol Violation|0|||
127666375|NCT01848834|459398530|FG004|Overall Study|Protocol Violation|1|||
128000240|NCT01656395|460627031|FG006|Overall Study|Adverse Event|0|||
127666376|NCT01848834|459398526|FG000|Overall Study|Sponsor Decision|1|||
128000241|NCT01656395|460627032|FG007|Overall Study|Adverse Event|0|||
128000242|NCT01656395|460627025|FG000|Overall Study|Lack of Efficacy|1|||
128000243|NCT01656395|460627026|FG001|Overall Study|Lack of Efficacy|8|||
128000244|NCT01656395|460627027|FG002|Overall Study|Lack of Efficacy|6|||
127666377|NCT01848834|459398527|FG001|Overall Study|Sponsor Decision|1|||
128000245|NCT01656395|460627028|FG003|Overall Study|Lack of Efficacy|1|||
128000246|NCT01656395|460627029|FG004|Overall Study|Lack of Efficacy|1|||
128000247|NCT01656395|460627030|FG005|Overall Study|Lack of Efficacy|6|||
128000248|NCT01656395|460627031|FG006|Overall Study|Lack of Efficacy|0|||
128000249|NCT01656395|460627032|FG007|Overall Study|Lack of Efficacy|0|||
128000250|NCT01656395|460627025|FG000|Overall Study|Lost to Follow-up|1|||
128000251|NCT01656395|460627026|FG001|Overall Study|Lost to Follow-up|0|||
128000252|NCT01656395|460627027|FG002|Overall Study|Lost to Follow-up|0|||
128000253|NCT01656395|460627028|FG003|Overall Study|Lost to Follow-up|0|||
128000254|NCT01656395|460627029|FG004|Overall Study|Lost to Follow-up|0|||
128000255|NCT01656395|460627030|FG005|Overall Study|Lost to Follow-up|0|||
128000256|NCT01656395|460627031|FG006|Overall Study|Lost to Follow-up|0|||
128000257|NCT01656395|460627032|FG007|Overall Study|Lost to Follow-up|0|||
128000258|NCT01656395|460627025|FG000|Overall Study|Non-Compliance with Study Drug|1|||
128000259|NCT01656395|460627026|FG001|Overall Study|Non-Compliance with Study Drug|1|||
128000260|NCT01656395|460627027|FG002|Overall Study|Non-Compliance with Study Drug|0|||
128000261|NCT01656395|460627028|FG003|Overall Study|Non-Compliance with Study Drug|0|||
128000262|NCT01656395|460627029|FG004|Overall Study|Non-Compliance with Study Drug|1|||
128000263|NCT01656395|460627030|FG005|Overall Study|Non-Compliance with Study Drug|1|||
128000264|NCT01656395|460627031|FG006|Overall Study|Non-Compliance with Study Drug|0|||
128000265|NCT01656395|460627032|FG007|Overall Study|Non-Compliance with Study Drug|0|||
128000266|NCT01656395|460627025|FG000|Overall Study|Other|0|||
128000267|NCT01656395|460627026|FG001|Overall Study|Other|0|||
128000268|NCT01656395|460627027|FG002|Overall Study|Other|1|||
128000269|NCT01656395|460627028|FG003|Overall Study|Other|0|||
128000270|NCT01656395|460627029|FG004|Overall Study|Other|0|||
128000271|NCT01656395|460627030|FG005|Overall Study|Other|1|||
128000272|NCT01656395|460627031|FG006|Overall Study|Other|0|||
128000273|NCT01656395|460627032|FG007|Overall Study|Other|0|||
128000274|NCT01656395|460627025|FG000|Overall Study|Physician Decision|2|||
128000275|NCT01656395|460627026|FG001|Overall Study|Physician Decision|3|||
128000276|NCT01656395|460627027|FG002|Overall Study|Physician Decision|3|||
128000277|NCT01656395|460627028|FG003|Overall Study|Physician Decision|2|||
128000278|NCT01656395|460627029|FG004|Overall Study|Physician Decision|3|||
128000279|NCT01656395|460627030|FG005|Overall Study|Physician Decision|3|||
128000280|NCT01656395|460627031|FG006|Overall Study|Physician Decision|0|||
128000281|NCT01656395|460627032|FG007|Overall Study|Physician Decision|0|||
128000282|NCT01656395|460627025|FG000|Overall Study|Pregnancy|0|||
128000283|NCT01656395|460627026|FG001|Overall Study|Pregnancy|0|||
128000284|NCT01656395|460627027|FG002|Overall Study|Pregnancy|1|||
128000285|NCT01656395|460627028|FG003|Overall Study|Pregnancy|0|||
128000286|NCT01656395|460627029|FG004|Overall Study|Pregnancy|0|||
128000287|NCT01656395|460627030|FG005|Overall Study|Pregnancy|0|||
128000288|NCT01656395|460627031|FG006|Overall Study|Pregnancy|0|||
128000289|NCT01656395|460627032|FG007|Overall Study|Pregnancy|0|||
128000290|NCT01656395|460627025|FG000|Overall Study|Progressive Disease|0|||
128000291|NCT01656395|460627026|FG001|Overall Study|Progressive Disease|0|||
128000292|NCT01656395|460627027|FG002|Overall Study|Progressive Disease|0|||
128000293|NCT01656395|460627028|FG003|Overall Study|Progressive Disease|0|||
128000294|NCT01656395|460627029|FG004|Overall Study|Progressive Disease|0|||
128000295|NCT01656395|460627030|FG005|Overall Study|Progressive Disease|1|||
128000296|NCT01656395|460627031|FG006|Overall Study|Progressive Disease|0|||
128000297|NCT01656395|460627032|FG007|Overall Study|Progressive Disease|0|||
128000298|NCT01656395|460627025|FG000|Overall Study|Protocol Violation|6|||
128000299|NCT01656395|460627026|FG001|Overall Study|Protocol Violation|6|||
128000300|NCT01656395|460627027|FG002|Overall Study|Protocol Violation|9|||
128000301|NCT01656395|460627028|FG003|Overall Study|Protocol Violation|2|||
128000302|NCT01656395|460627029|FG004|Overall Study|Protocol Violation|4|||
128000303|NCT01656395|460627030|FG005|Overall Study|Protocol Violation|10|||
128000304|NCT01656395|460627031|FG006|Overall Study|Protocol Violation|0|||
128000305|NCT01656395|460627032|FG007|Overall Study|Protocol Violation|0|||
128000306|NCT01656395|460627025|FG000|Overall Study|Screen Failure|2|||
128000307|NCT01656395|460627026|FG001|Overall Study|Screen Failure|1|||
128000308|NCT01656395|460627027|FG002|Overall Study|Screen Failure|7|||
128000309|NCT01656395|460627028|FG003|Overall Study|Screen Failure|1|||
128000310|NCT01656395|460627029|FG004|Overall Study|Screen Failure|0|||
128000311|NCT01656395|460627030|FG005|Overall Study|Screen Failure|8|||
128000312|NCT01656395|460627031|FG006|Overall Study|Screen Failure|0|||
128000313|NCT01656395|460627032|FG007|Overall Study|Screen Failure|0|||
128000314|NCT01656395|460627025|FG000|Overall Study|Withdrawal by Subject|3|||
128000315|NCT01656395|460627026|FG001|Overall Study|Withdrawal by Subject|1|||
128000316|NCT01656395|460627027|FG002|Overall Study|Withdrawal by Subject|4|||
128000317|NCT01656395|460627028|FG003|Overall Study|Withdrawal by Subject|2|||
128000318|NCT01656395|460627029|FG004|Overall Study|Withdrawal by Subject|0|||
128000319|NCT01656395|460627030|FG005|Overall Study|Withdrawal by Subject|3|||
128000320|NCT01656395|460627031|FG006|Overall Study|Withdrawal by Subject|0|||
128000321|NCT01656395|460627032|FG007|Overall Study|Withdrawal by Subject|0|||
128000322|NCT03075267|460627033|FG000|Overall Study|Protocol Violation|1|||
128000323|NCT03075267|460627034|FG001|Overall Study|Protocol Violation|0|||
128000324|NCT03075267|460627035|FG002|Overall Study|Protocol Violation|0|||
128000325|NCT00661089|460627041|FG000|Overall Study|1 subject withdrawal|0|||
128000326|NCT00661089|460627042|FG001|Overall Study|1 subject withdrawal|1|||
128000327|NCT00661089|460627041|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
128000328|NCT00661089|460627042|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
128000329|NCT00274742|460627043|FG000|Overall Study|Adverse Event|0|||
128000330|NCT00274742|460627044|FG001|Overall Study|Adverse Event|4|||
128000331|NCT00274742|460627045|FG002|Overall Study|Adverse Event|1|||
128000332|NCT00274742|460627046|FG003|Overall Study|Adverse Event|4|||
128000333|NCT00274742|460627047|FG004|Overall Study|Adverse Event|12|||
128000334|NCT00274742|460627048|FG005|Overall Study|Adverse Event|3|||
128000335|NCT00274742|460627043|FG000|Overall Study|Lost to Follow-up|0|||
128000336|NCT00274742|460627044|FG001|Overall Study|Lost to Follow-up|0|||
128000337|NCT00274742|460627045|FG002|Overall Study|Lost to Follow-up|0|||
128000338|NCT00274742|460627046|FG003|Overall Study|Lost to Follow-up|0|||
128000339|NCT00274742|460627047|FG004|Overall Study|Lost to Follow-up|1|||
128000340|NCT00274742|460627048|FG005|Overall Study|Lost to Follow-up|0|||
128000341|NCT00274742|460627043|FG000|Overall Study|End of Study|0|||
128000342|NCT00274742|460627044|FG001|Overall Study|End of Study|0|||
128000343|NCT00274742|460627045|FG002|Overall Study|End of Study|0|||
128000344|NCT00274742|460627046|FG003|Overall Study|End of Study|1|||
128000345|NCT00274742|460627047|FG004|Overall Study|End of Study|0|||
128000346|NCT00274742|460627048|FG005|Overall Study|End of Study|0|||
128000347|NCT00274742|460627043|FG000|Overall Study|Disease Progression|0|||
128000348|NCT00274742|460627044|FG001|Overall Study|Disease Progression|1|||
128000349|NCT00274742|460627045|FG002|Overall Study|Disease Progression|1|||
128000350|NCT00274742|460627046|FG003|Overall Study|Disease Progression|0|||
128000351|NCT00274742|460627047|FG004|Overall Study|Disease Progression|1|||
128000352|NCT00274742|460627048|FG005|Overall Study|Disease Progression|0|||
128000353|NCT00274742|460627043|FG000|Overall Study|Other|0|||
128000354|NCT00274742|460627044|FG001|Overall Study|Other|3|||
128000355|NCT00274742|460627045|FG002|Overall Study|Other|0|||
128000356|NCT00274742|460627046|FG003|Overall Study|Other|0|||
128000357|NCT00274742|460627047|FG004|Overall Study|Other|2|||
128000358|NCT00274742|460627048|FG005|Overall Study|Other|0|||
128000359|NCT01529606|460627052|FG000|Overall Study|Lost to Follow-up|21|||
128000360|NCT01529606|460627053|FG001|Overall Study|Lost to Follow-up|18|||
128000361|NCT01900444|460627059|FG000|Overall Study|Protocol Violation|2|||
128000362|NCT01900444|460627059|FG000|Overall Study|Lost to Follow-up|1|||
128000363|NCT00072384|460627062|FG000|Overall Study|Physician Decision|1|||
128000364|NCT00072384|460627062|FG000|Overall Study|Ineligible|8|||
128000365|NCT01825200|460627063|FG000|Overall Study|Lost to Follow-up|5|||
128000366|NCT01825200|460627064|FG001|Overall Study|Lost to Follow-up|6|||
128000367|NCT01825200|460627063|FG000|Overall Study|Withdrawal by Subject|0|||
128000368|NCT01825200|460627064|FG001|Overall Study|Withdrawal by Subject|1|||
128000369|NCT00490035|460627065|FG000|Overall Study|AE, non-serious non-fatal|3|||
128000370|NCT00490035|460627066|FG001|Overall Study|AE, non-serious non-fatal|4|||
128000371|NCT00490035|460627067|FG002|Overall Study|AE, non-serious non-fatal|4|||
128000372|NCT00490035|460627068|FG003|Overall Study|AE, non-serious non-fatal|5|||
128000373|NCT00490035|460627065|FG000|Overall Study|Lost to Follow-up|2|||
128000374|NCT00490035|460627066|FG001|Overall Study|Lost to Follow-up|0|||
128000375|NCT00490035|460627067|FG002|Overall Study|Lost to Follow-up|1|||
128000376|NCT00490035|460627068|FG003|Overall Study|Lost to Follow-up|0|||
128000377|NCT00490035|460627065|FG000|Overall Study|Withdrawal by Subject|2|||
128000378|NCT00490035|460627066|FG001|Overall Study|Withdrawal by Subject|1|||
128000379|NCT00490035|460627067|FG002|Overall Study|Withdrawal by Subject|1|||
128000380|NCT00490035|460627068|FG003|Overall Study|Withdrawal by Subject|0|||
128000381|NCT00490035|460627065|FG000|Overall Study|Other reason|0|||
128000382|NCT00490035|460627066|FG001|Overall Study|Other reason|1|||
128000383|NCT00490035|460627067|FG002|Overall Study|Other reason|3|||
127666378|NCT01848834|459398528|FG002|Overall Study|Sponsor Decision|0|||
127666379|NCT01848834|459398529|FG003|Overall Study|Sponsor Decision|1|||
127666380|NCT01848834|459398530|FG004|Overall Study|Sponsor Decision|1|||
127666381|NCT01848834|459398526|FG000|Overall Study|Withdrawal by Subject|2|||
127666382|NCT01848834|459398527|FG001|Overall Study|Withdrawal by Subject|13|||
127666383|NCT01848834|459398528|FG002|Overall Study|Withdrawal by Subject|10|||
128000384|NCT00490035|460627068|FG003|Overall Study|Other reason|1|||
128000385|NCT00490035|460627065|FG000|Overall Study|AE, serious fatal|1|||
127666384|NCT01848834|459398529|FG003|Overall Study|Withdrawal by Subject|6|||
127666385|NCT01848834|459398530|FG004|Overall Study|Withdrawal by Subject|36|||
127666386|NCT03259373|459398539|FG000|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|636|||
127666387|NCT03259373|459398540|FG001|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|118|||
128000386|NCT00490035|460627066|FG001|Overall Study|AE, serious fatal|0|||
128000387|NCT00490035|460627067|FG002|Overall Study|AE, serious fatal|0|||
128000388|NCT00490035|460627068|FG003|Overall Study|AE, serious fatal|0|||
127880894|NCT00566631|460186057|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
128000389|NCT00490035|460627065|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
128000390|NCT00490035|460627066|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
128000391|NCT00490035|460627067|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
128000392|NCT00490035|460627068|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
127666388|NCT03259373|459398539|FG000|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|320|||
127666389|NCT03259373|459398540|FG001|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|344|||
128000393|NCT00490035|460627065|FG000|Overall Study|AE of unknown type|0|||
128000394|NCT00490035|460627066|FG001|Overall Study|AE of unknown type|0|||
128000395|NCT00490035|460627067|FG002|Overall Study|AE of unknown type|2|||
128000396|NCT00490035|460627068|FG003|Overall Study|AE of unknown type|0|||
128000397|NCT05209880|460627074|FG000|1-Month Follow-up|Spoke with Doctor|5|||
128000398|NCT05209880|460627075|FG001|1-Month Follow-up|Spoke with Doctor|5|||
128000399|NCT05209880|460627074|FG000|1-Month Follow-up|Lost to Follow-up|7|||
128000400|NCT05209880|460627075|FG001|1-Month Follow-up|Lost to Follow-up|9|||
128000401|NCT05209880|460627074|FG000|1-Month Follow-up|Discontinued|0|||
128000402|NCT05209880|460627075|FG001|1-Month Follow-up|Discontinued|1|||
128000403|NCT05209880|460627074|FG000|3-Month Follow-up|Spoke with Doctor|17|||
128000404|NCT05209880|460627075|FG001|3-Month Follow-up|Spoke with Doctor|7|||
128000405|NCT05209880|460627074|FG000|3-Month Follow-up|Lost to Follow-up|8|||
128000406|NCT05209880|460627075|FG001|3-Month Follow-up|Lost to Follow-up|10|||
128000407|NCT05209880|460627074|FG000|3-Month Follow-up|Discontinued|1|||
128000408|NCT05209880|460627075|FG001|3-Month Follow-up|Discontinued|3|||
128000409|NCT05209880|460627074|FG000|6-Month Follow-up|Spoke with Doctor|25|||
128000410|NCT05209880|460627075|FG001|6-Month Follow-up|Spoke with Doctor|14|||
128000411|NCT05209880|460627074|FG000|6-Month Follow-up|Lost to Follow-up|9|||
128000412|NCT05209880|460627075|FG001|6-Month Follow-up|Lost to Follow-up|14|||
128000413|NCT05209880|460627074|FG000|6-Month Follow-up|Discontinued|1|||
128000414|NCT05209880|460627075|FG001|6-Month Follow-up|Discontinued|3|||
128000415|NCT04144322|460627078|FG000|Overall Study|Lack of Efficacy|2|||
128000416|NCT04144322|460627079|FG001|Overall Study|Lack of Efficacy|2|||
127666390|NCT03259373|459398539|FG000|Overall Study|Unable to be identified in dataset used for analysis|43|||
127666391|NCT03259373|459398540|FG001|Overall Study|Unable to be identified in dataset used for analysis|49|||
127666392|NCT03259373|459398539|FG000|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3446|||
127666393|NCT03259373|459398540|FG001|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3599|||
127666394|NCT03259373|459398539|FG000|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|32|||
127666395|NCT03259373|459398540|FG001|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|63|||
127666396|NCT03259373|459398539|FG000|Overall Study|On OAC treatment at follow up start (due to data lags)|4272|||
127666397|NCT03259373|459398540|FG001|Overall Study|On OAC treatment at follow up start (due to data lags)|4411|||
127666398|NCT04894903|459398541|FG000|Overall Study|Death|1|||
127666399|NCT04894903|459398542|FG001|Overall Study|Death|0|||
127666400|NCT04894903|459398541|FG000|Overall Study|Pregnancy|1|||
127666401|NCT04894903|459398542|FG001|Overall Study|Pregnancy|0|||
127666402|NCT04894903|459398541|FG000|Overall Study|Withdrawal by Subject|1|||
127666403|NCT04894903|459398542|FG001|Overall Study|Withdrawal by Subject|1|||
127666404|NCT04894903|459398541|FG000|Overall Study|moved or exited health system|1|||
127666405|NCT04894903|459398542|FG001|Overall Study|moved or exited health system|3|||
127666406|NCT00322868|459400178|FG000|Overall Study|disease progression|1|||
127666407|NCT02176928|459400181|FG000|Overall Study|Lost to Follow-up|2|||
127666408|NCT02176928|459400182|FG001|Overall Study|Lost to Follow-up|4|||
127666409|NCT01155726|459400190|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
127666410|NCT01155726|459400191|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
127666411|NCT01155726|459400192|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
127666412|NCT01155726|459400193|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
127666413|NCT02459587|459400194|FG000|3-Month Follow-up Assessment|Death|0|||
127666414|NCT02459587|459400195|FG001|3-Month Follow-up Assessment|Death|2|||
127666415|NCT02459587|459400194|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
127666416|NCT02459587|459400195|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
127666417|NCT02459587|459400194|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
127666418|NCT02459587|459400195|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
127666419|NCT02459587|459400194|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
127666420|NCT02459587|459400195|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
127666421|NCT02459587|459400194|FG000|6-month Follow-up Assessment|Death|2|||
127666422|NCT02459587|459400195|FG001|6-month Follow-up Assessment|Death|1|||
127666423|NCT02459587|459400194|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
128000417|NCT04817332|460627080|FG000|Overall Study|Lost to Follow-up|3|||
128000418|NCT04817332|460627081|FG001|Overall Study|Lost to Follow-up|3|||
128000419|NCT04817332|460627080|FG000|Overall Study|Protocol Violation|2|||
128000420|NCT04817332|460627081|FG001|Overall Study|Protocol Violation|0|||
128000421|NCT04795466|460627087|FG000|Overall Study|Adverse Event|3|||
127666424|NCT02459587|459400195|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
127666425|NCT02459587|459400194|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
127666426|NCT02459587|459400195|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
127880895|NCT00566631|460186057|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
128000422|NCT04795466|460627088|FG001|Overall Study|Adverse Event|1|||
128000423|NCT04795466|460627087|FG000|Overall Study|Physician Decision|1|||
127666427|NCT02459587|459400194|FG000|12-month Follow-up Assessment|Death|2|||
127666428|NCT02459587|459400195|FG001|12-month Follow-up Assessment|Death|0|||
127666429|NCT02459587|459400194|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
127666430|NCT02459587|459400195|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
127666431|NCT02459587|459400194|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
127666432|NCT02459587|459400195|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
128000424|NCT04795466|460627088|FG001|Overall Study|Physician Decision|0|||
128000425|NCT04795466|460627087|FG000|Overall Study|Withdrawal by Subject|2|||
128000426|NCT04795466|460627088|FG001|Overall Study|Withdrawal by Subject|1|||
128000427|NCT05635045|460627089|FG000|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
128000428|NCT05635045|460627090|FG001|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
128000429|NCT05635045|460627091|FG002|Overall Study|measurements were not usable due material error in imaging agent supplied|1|||
128000430|NCT05635045|460627092|FG003|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
128000431|NCT02421419|460627098|FG000|Overall Study|Physician Decision|0|||
128000432|NCT02421419|460627099|FG001|Overall Study|Physician Decision|0|||
128000433|NCT02421419|460627100|FG002|Overall Study|Physician Decision|1|||
128000434|NCT00196105|460627106|FG000|Overall Study|Lost to Follow-up|4|||
128000435|NCT00196105|460627107|FG001|Overall Study|Lost to Follow-up|5|||
128000436|NCT00196105|460627108|FG002|Overall Study|Lost to Follow-up|7|||
128000437|NCT04863872|460627109|FG000|Overall Study|Withdrawal by Subject|4|||
128000438|NCT04863872|460627110|FG001|Overall Study|Withdrawal by Subject|15|||
128000439|NCT04863872|460627109|FG000|Overall Study|Death|5|||
128000440|NCT04863872|460627110|FG001|Overall Study|Death|2|||
128000441|NCT04863872|460627109|FG000|Overall Study|Lost to Follow-up|2|||
128000442|NCT04863872|460627110|FG001|Overall Study|Lost to Follow-up|1|||
128000443|NCT04058028|460627111|FG000|Overall Study|Withdrawal of Consent from Study|12|||
128000444|NCT04058028|460627112|FG001|Overall Study|Withdrawal of Consent from Study|8|||
128000445|NCT04058028|460627113|FG002|Overall Study|Withdrawal of Consent from Study|6|||
128000446|NCT04058028|460627114|FG003|Overall Study|Withdrawal of Consent from Study|7|||
128000447|NCT04058028|460627111|FG000|Overall Study|Decision by Sponsor|13|||
128000448|NCT04058028|460627112|FG001|Overall Study|Decision by Sponsor|4|||
128000449|NCT04058028|460627113|FG002|Overall Study|Decision by Sponsor|1|||
128000450|NCT04058028|460627114|FG003|Overall Study|Decision by Sponsor|35|||
128000451|NCT04058028|460627111|FG000|Overall Study|Lost to Follow-up|1|||
128000452|NCT04058028|460627112|FG001|Overall Study|Lost to Follow-up|1|||
128000453|NCT04058028|460627113|FG002|Overall Study|Lost to Follow-up|1|||
128000454|NCT04058028|460627114|FG003|Overall Study|Lost to Follow-up|0|||
128000455|NCT04058028|460627111|FG000|Overall Study|Death|0|||
128000456|NCT04058028|460627112|FG001|Overall Study|Death|1|||
128000457|NCT04058028|460627113|FG002|Overall Study|Death|0|||
128000458|NCT04058028|460627114|FG003|Overall Study|Death|0|||
128000459|NCT03771963|460627115|FG000|Overall Study|Lost to Follow-up|22|||
128000460|NCT03771963|460627115|FG000|Overall Study|Withdrawal of Consent|10|||
128000461|NCT00485069|460627116|FG000|Overall Study|Adverse Event|10|||
128000462|NCT00485069|460627117|FG001|Overall Study|Adverse Event|4|||
128000463|NCT00485069|460627116|FG000|Overall Study|Lack of Efficacy|2|||
128000464|NCT00485069|460627117|FG001|Overall Study|Lack of Efficacy|1|||
128000465|NCT00485069|460627116|FG000|Overall Study|Protocol Violation|0|||
128000466|NCT00485069|460627117|FG001|Overall Study|Protocol Violation|1|||
128000467|NCT00485069|460627116|FG000|Overall Study|Withdrawal by Subject|6|||
128000468|NCT00485069|460627117|FG001|Overall Study|Withdrawal by Subject|6|||
128000469|NCT03014206|460627118|FG000|Overall Study|Registration Violation|12|||
128000470|NCT02864407|460627120|FG000|Overall Study|Protocol Violation|3|||
128000471|NCT02864407|460627120|FG000|Overall Study|Lost to Follow-up|115|||
128000472|NCT02864407|460627120|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
128000473|NCT02864407|460627120|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
128000474|NCT02864407|460627120|FG000|Overall Study|Consent prior to the contract date|1|||
128000475|NCT04577794|460627121|FG000|Overall Study|Adverse Event|1|||
128000476|NCT04577794|460627122|FG001|Overall Study|Adverse Event|1|||
128000477|NCT02849080|460627123|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
128000478|NCT02849080|460627124|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
128000479|NCT02849080|460627125|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
128000480|NCT02849080|460627126|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
128000481|NCT02849080|460627123|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
128000482|NCT02849080|460627124|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
128000483|NCT02849080|460627125|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
128000484|NCT02849080|460627126|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
128000485|NCT02849080|460627123|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
128000486|NCT02849080|460627124|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
128000487|NCT02849080|460627125|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
128000488|NCT02849080|460627126|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
128000489|NCT02849080|460627123|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
128000490|NCT02849080|460627124|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
128000491|NCT02849080|460627125|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
127666433|NCT02459587|459400194|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
127666434|NCT02459587|459400195|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
127666435|NCT00884286|459400199|FG000|Overall Study|Progressive disease|21|||
127666436|NCT00884286|459400200|FG001|Overall Study|Progressive disease|28|||
127666437|NCT00884286|459400199|FG000|Overall Study|Toxicity|4|||
127666438|NCT00884286|459400200|FG001|Overall Study|Toxicity|1|||
127666439|NCT00884286|459400199|FG000|Overall Study|Death|2|||
127666440|NCT00884286|459400200|FG001|Overall Study|Death|2|||
127666441|NCT00884286|459400199|FG000|Overall Study|Physician Decision|1|||
127666442|NCT00884286|459400200|FG001|Overall Study|Physician Decision|0|||
127666443|NCT00884286|459400199|FG000|Overall Study|Septic shock|1|||
127666444|NCT00884286|459400200|FG001|Overall Study|Septic shock|0|||
127666445|NCT00884286|459400199|FG000|Overall Study|Thrombus in right auricle|1|||
127666446|NCT00884286|459400200|FG001|Overall Study|Thrombus in right auricle|0|||
127666447|NCT00884286|459400199|FG000|Overall Study|Not treated|2|||
127666448|NCT00884286|459400200|FG001|Overall Study|Not treated|1|||
127666449|NCT00884286|459400199|FG000|Overall Study|Comprised lung carcinoma|0|||
127666450|NCT00884286|459400200|FG001|Overall Study|Comprised lung carcinoma|1|||
127666451|NCT01720797|459400201|FG000|Overall Study|Withdrawal by Subject|3|||
127666452|NCT01720797|459400202|FG001|Overall Study|Withdrawal by Subject|0|||
127666453|NCT03541642|459400208|FG000|Overall Study|Withdrawal by Subject|1|||
127666454|NCT03541642|459400209|FG001|Overall Study|Withdrawal by Subject|2|||
128000492|NCT02849080|460627126|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
128000493|NCT02849080|460627123|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
128000494|NCT02849080|460627124|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
128000495|NCT02849080|460627125|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
127666455|NCT03541642|459400208|FG000|Overall Study|Lost to Follow-up|16|||
127666456|NCT03541642|459400209|FG001|Overall Study|Lost to Follow-up|12|||
127666457|NCT03541642|459400208|FG000|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
127666458|NCT03541642|459400209|FG001|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
127666459|NCT01083160|459400214|FG000|Overall Study|Adverse Event|1|||
127666460|NCT00918749|459400215|FG000|Overall Study|Adverse Event|1|||
127666461|NCT00918749|459400216|FG001|Overall Study|Adverse Event|0|||
127666462|NCT00918749|459400217|FG002|Overall Study|Adverse Event|1|||
127666463|NCT00918749|459400215|FG000|Overall Study|Lost to Follow-up|0|||
127666464|NCT00918749|459400216|FG001|Overall Study|Lost to Follow-up|0|||
127666465|NCT00918749|459400217|FG002|Overall Study|Lost to Follow-up|1|||
127666466|NCT00918749|459400215|FG000|Overall Study|Withdrawal by Subject|5|||
127666467|NCT00918749|459400216|FG001|Overall Study|Withdrawal by Subject|3|||
127666468|NCT00918749|459400217|FG002|Overall Study|Withdrawal by Subject|5|||
127666469|NCT00918749|459400215|FG000|Overall Study|No Study Medication Taken|1|||
127666470|NCT00918749|459400216|FG001|Overall Study|No Study Medication Taken|0|||
127666471|NCT00918749|459400217|FG002|Overall Study|No Study Medication Taken|0|||
127666472|NCT01951092|459400218|FG000|Overall Study|Lost to Follow-up|10|||
127666473|NCT01951092|459400218|FG000|Overall Study|Incarceration|1|||
127666474|NCT01951092|459400218|FG000|Overall Study|Transfer of Care|1|||
127666475|NCT01712789|459400219|FG000|Overall Study|Lack of Efficacy|2|||
127666476|NCT01712789|459400219|FG000|Overall Study|Lost to Follow-up|1|||
127666477|NCT01712789|459400219|FG000|Overall Study|Progressive Disease|504|||
127666478|NCT01712789|459400219|FG000|Overall Study|Death|57|||
127666479|NCT01712789|459400219|FG000|Overall Study|Adverse Event|52|||
127666480|NCT01712789|459400219|FG000|Overall Study|Miscellaneous|31|||
127666481|NCT01712789|459400219|FG000|Overall Study|Withdrawal by Subject|21|||
127666482|NCT01712789|459400219|FG000|Overall Study|Transition to Commercial Treatment|8|||
127666483|NCT01712789|459400219|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
127666484|NCT01708187|459400220|FG000|Overall Study|Lost to Follow-up|0|||
127666485|NCT01708187|459400221|FG001|Overall Study|Lost to Follow-up|1|||
127666486|NCT00873093|459400222|FG000|Overall Study|Adverse Event|0|||
127666487|NCT00873093|459400223|FG001|Overall Study|Adverse Event|2|||
127666488|NCT00873093|459400224|FG002|Overall Study|Adverse Event|0|||
127666489|NCT00873093|459400225|FG003|Overall Study|Adverse Event|0|||
127666490|NCT00873093|459400226|FG004|Overall Study|Adverse Event|0|||
127666491|NCT00873093|459400222|FG000|Overall Study|Death|0|||
127666492|NCT00873093|459400223|FG001|Overall Study|Death|3|||
127666493|NCT00873093|459400224|FG002|Overall Study|Death|2|||
127666494|NCT00873093|459400225|FG003|Overall Study|Death|0|||
127666495|NCT00873093|459400226|FG004|Overall Study|Death|0|||
127666496|NCT00873093|459400222|FG000|Overall Study|Physician Decision|0|||
128000496|NCT02849080|460627126|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
127666497|NCT00873093|459400223|FG001|Overall Study|Physician Decision|17|||
127666498|NCT00873093|459400224|FG002|Overall Study|Physician Decision|10|||
127666499|NCT00873093|459400225|FG003|Overall Study|Physician Decision|10|||
127666500|NCT00873093|459400226|FG004|Overall Study|Physician Decision|2|||
127666501|NCT00873093|459400222|FG000|Overall Study|Withdrawal by Subject|1|||
127666502|NCT00873093|459400223|FG001|Overall Study|Withdrawal by Subject|4|||
127666503|NCT00873093|459400224|FG002|Overall Study|Withdrawal by Subject|4|||
127666504|NCT00873093|459400225|FG003|Overall Study|Withdrawal by Subject|0|||
127666505|NCT00873093|459400226|FG004|Overall Study|Withdrawal by Subject|0|||
128000497|NCT02849080|460627123|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
128000498|NCT02849080|460627124|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
128000499|NCT02849080|460627125|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
128000500|NCT02849080|460627126|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
128000501|NCT01819727|460627127|FG000|Overall Study|Adverse Event|8|||
128000502|NCT01819727|460627128|FG001|Overall Study|Adverse Event|9|||
128000503|NCT01819727|460627127|FG000|Overall Study|Death|1|||
128000504|NCT01819727|460627128|FG001|Overall Study|Death|0|||
127666506|NCT00873093|459400222|FG000|Overall Study|Ineligible|0|||
127666507|NCT00873093|459400223|FG001|Overall Study|Ineligible|1|||
127666508|NCT00873093|459400224|FG002|Overall Study|Ineligible|0|||
128000505|NCT01819727|460627127|FG000|Overall Study|Lost to Follow-up|1|||
128000506|NCT01819727|460627128|FG001|Overall Study|Lost to Follow-up|1|||
128000507|NCT01819727|460627127|FG000|Overall Study|Physician Decision|3|||
128000508|NCT01819727|460627128|FG001|Overall Study|Physician Decision|2|||
128000509|NCT01819727|460627127|FG000|Overall Study|Pregnancy|1|||
128000510|NCT01819727|460627128|FG001|Overall Study|Pregnancy|0|||
128000511|NCT01819727|460627127|FG000|Overall Study|Protocol Violation|0|||
128000512|NCT01819727|460627128|FG001|Overall Study|Protocol Violation|2|||
128000513|NCT01819727|460627127|FG000|Overall Study|Study Terminated by Sponsor|0|||
128000514|NCT01819727|460627128|FG001|Overall Study|Study Terminated by Sponsor|1|||
128000515|NCT01819727|460627127|FG000|Overall Study|Withdrawal by Subject|6|||
128000516|NCT01819727|460627128|FG001|Overall Study|Withdrawal by Subject|11|||
128000517|NCT01819727|460627127|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
128000518|NCT01819727|460627128|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
128000519|NCT01819727|460627127|FG000|Overall Study|Quit due to lack of health benifits|0|||
128000520|NCT01819727|460627128|FG001|Overall Study|Quit due to lack of health benifits|1|||
128000521|NCT03839394|460627132|FG000|Overall Study|Lost to Follow-up|6|||
127666509|NCT00873093|459400225|FG003|Overall Study|Ineligible|1|||
127666510|NCT00873093|459400226|FG004|Overall Study|Ineligible|0|||
127666511|NCT03055832|459400228|FG000|Week 2|Withdrawal by Subject|1|||
127666512|NCT03055832|459400229|FG001|Week 2|Withdrawal by Subject|0|||
127666513|NCT01163149|459400239|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
127666514|NCT01163149|459400240|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
127666515|NCT01163149|459400241|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
127666516|NCT01163149|459400239|FG000|Extension Treatment Period|Adverse Event|0|||
127666517|NCT01163149|459400240|FG001|Extension Treatment Period|Adverse Event|1|||
127666518|NCT01163149|459400241|FG002|Extension Treatment Period|Adverse Event|0|||
127666519|NCT01163149|459400239|FG000|Extension Treatment Period|Noncompliance|0|||
127666520|NCT01163149|459400240|FG001|Extension Treatment Period|Noncompliance|0|||
127666521|NCT01163149|459400241|FG002|Extension Treatment Period|Noncompliance|1|||
127666522|NCT02806336|459400242|FG000|Overall Study|Physician Decision|1|||
127666523|NCT02806336|459400243|FG001|Overall Study|Physician Decision|0|||
127666524|NCT02806336|459400242|FG000|Overall Study|Withdrawal by Subject|2|||
127666525|NCT02806336|459400243|FG001|Overall Study|Withdrawal by Subject|4|||
127666526|NCT02806336|459400242|FG000|Overall Study|COVID-19 research shut down|3|||
127666527|NCT02806336|459400243|FG001|Overall Study|COVID-19 research shut down|4|||
127666528|NCT02806336|459400242|FG000|Overall Study|Lack of Efficacy|0|||
127666529|NCT02806336|459400243|FG001|Overall Study|Lack of Efficacy|1|||
127666530|NCT01923428|459400252|FG000|Overall Study|Adverse Event|8|||
127666531|NCT01923428|459400253|FG001|Overall Study|Adverse Event|6|||
127666532|NCT01923428|459400254|FG002|Overall Study|Adverse Event|3|||
127666533|NCT01923428|459400255|FG003|Overall Study|Adverse Event|3|||
127666534|NCT01923428|459400252|FG000|Overall Study|Withdrawal by Subject|5|||
127666535|NCT01923428|459400253|FG001|Overall Study|Withdrawal by Subject|3|||
127666536|NCT01923428|459400254|FG002|Overall Study|Withdrawal by Subject|0|||
127666537|NCT01923428|459400255|FG003|Overall Study|Withdrawal by Subject|4|||
127666538|NCT01923428|459400252|FG000|Overall Study|Lost to Follow-up|2|||
127666539|NCT01923428|459400253|FG001|Overall Study|Lost to Follow-up|1|||
127666540|NCT01923428|459400254|FG002|Overall Study|Lost to Follow-up|5|||
127666541|NCT01923428|459400255|FG003|Overall Study|Lost to Follow-up|0|||
127666542|NCT01923428|459400252|FG000|Overall Study|Protocol Violation|3|||
127666543|NCT01923428|459400253|FG001|Overall Study|Protocol Violation|0|||
127666544|NCT01923428|459400254|FG002|Overall Study|Protocol Violation|2|||
128000522|NCT03839394|460627133|FG001|Overall Study|Lost to Follow-up|8|||
127666545|NCT01923428|459400255|FG003|Overall Study|Protocol Violation|1|||
127666546|NCT01923428|459400252|FG000|Overall Study|Non Compliance to treatment|1|||
127666547|NCT01923428|459400253|FG001|Overall Study|Non Compliance to treatment|2|||
127666548|NCT01923428|459400254|FG002|Overall Study|Non Compliance to treatment|0|||
128000523|NCT03839394|460627132|FG000|Overall Study|Withdrawal by Subject|0|||
128000524|NCT03839394|460627133|FG001|Overall Study|Withdrawal by Subject|2|||
128000525|NCT01367249|460627134|FG000|Overall Study|Withdrawal by Subject|6|||
128000526|NCT01367249|460627135|FG001|Overall Study|Withdrawal by Subject|6|||
128000527|NCT01367249|460627134|FG000|Overall Study|Other|3|||
127666549|NCT01923428|459400255|FG003|Overall Study|Non Compliance to treatment|1|||
127666550|NCT01923428|459400252|FG000|Overall Study|Lack of Efficacy|0|||
127666551|NCT01923428|459400253|FG001|Overall Study|Lack of Efficacy|0|||
127666552|NCT01923428|459400254|FG002|Overall Study|Lack of Efficacy|1|||
127666553|NCT01923428|459400255|FG003|Overall Study|Lack of Efficacy|1|||
127666554|NCT01822353|459400256|FG000|Overall Study|Adverse Event|1|||
127666555|NCT01822353|459400257|FG001|Overall Study|Adverse Event|3|||
127666556|NCT01822353|459400258|FG002|Overall Study|Adverse Event|1|||
127666557|NCT01822353|459400256|FG000|Overall Study|Pregnancy|0|||
127666558|NCT01822353|459400257|FG001|Overall Study|Pregnancy|1|||
127666559|NCT01822353|459400258|FG002|Overall Study|Pregnancy|0|||
127666560|NCT01822353|459400256|FG000|Overall Study|Withdrawal by Subject|3|||
127666561|NCT01822353|459400257|FG001|Overall Study|Withdrawal by Subject|1|||
127666562|NCT01822353|459400258|FG002|Overall Study|Withdrawal by Subject|0|||
127666563|NCT02550873|459400259|FG000|Randomized Double Blind|Adverse Event|3|||
127666564|NCT02550873|459400260|FG001|Randomized Double Blind|Adverse Event|1|||
127666565|NCT02550873|459400261|FG002|Randomized Double Blind|Adverse Event|0|||
127666566|NCT02550873|459400259|FG000|Randomized Double Blind|Disease progression|1|||
127666567|NCT02550873|459400260|FG001|Randomized Double Blind|Disease progression|1|||
127666568|NCT02550873|459400261|FG002|Randomized Double Blind|Disease progression|0|||
127666569|NCT02550873|459400259|FG000|Open Label Extension|Study ongoing|0|||
127666570|NCT02550873|459400260|FG001|Open Label Extension|Study ongoing|0|||
127666571|NCT02550873|459400261|FG002|Open Label Extension|Study ongoing|111|||
127666572|NCT01368211|459400266|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
127666573|NCT01368211|459400267|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
127666574|NCT01987830|459400269|FG000|Overall Study|Never received baseline scan|1|||
127666575|NCT03990363|459400270|FG000|Overall Study|Withdrawal by Subject|10|||
127666576|NCT03990363|459400271|FG001|Overall Study|Withdrawal by Subject|9|||
127666577|NCT03990363|459400272|FG002|Overall Study|Withdrawal by Subject|18|||
127666578|NCT03990363|459400273|FG003|Overall Study|Withdrawal by Subject|11|||
127666579|NCT03990363|459400274|FG004|Overall Study|Withdrawal by Subject|9|||
127666580|NCT03990363|459400270|FG000|Overall Study|Physician Decision|1|||
127666581|NCT03990363|459400271|FG001|Overall Study|Physician Decision|0|||
127666582|NCT03990363|459400272|FG002|Overall Study|Physician Decision|0|||
127666583|NCT03990363|459400273|FG003|Overall Study|Physician Decision|0|||
127666584|NCT03990363|459400274|FG004|Overall Study|Physician Decision|0|||
127666585|NCT03990363|459400270|FG000|Overall Study|Adverse Event|1|||
127666586|NCT03990363|459400271|FG001|Overall Study|Adverse Event|3|||
127666587|NCT03990363|459400272|FG002|Overall Study|Adverse Event|2|||
127666588|NCT03990363|459400273|FG003|Overall Study|Adverse Event|2|||
127666589|NCT03990363|459400274|FG004|Overall Study|Adverse Event|0|||
127666590|NCT03990363|459400270|FG000|Overall Study|Death|14|||
127666591|NCT03990363|459400271|FG001|Overall Study|Death|8|||
127666592|NCT03990363|459400272|FG002|Overall Study|Death|14|||
127666593|NCT03990363|459400273|FG003|Overall Study|Death|10|||
127666594|NCT03990363|459400274|FG004|Overall Study|Death|11|||
127666595|NCT03990363|459400270|FG000|Overall Study|Failure to meet randomization criteria|0|||
127666596|NCT03990363|459400271|FG001|Overall Study|Failure to meet randomization criteria|1|||
127666597|NCT03990363|459400272|FG002|Overall Study|Failure to meet randomization criteria|1|||
127666598|NCT03990363|459400273|FG003|Overall Study|Failure to meet randomization criteria|0|||
127666599|NCT03990363|459400274|FG004|Overall Study|Failure to meet randomization criteria|0|||
127666600|NCT03990363|459400270|FG000|Overall Study|Lost to Follow-up|0|||
127666601|NCT03990363|459400271|FG001|Overall Study|Lost to Follow-up|0|||
127666602|NCT03990363|459400272|FG002|Overall Study|Lost to Follow-up|0|||
127666603|NCT03990363|459400273|FG003|Overall Study|Lost to Follow-up|1|||
127666604|NCT03990363|459400274|FG004|Overall Study|Lost to Follow-up|2|||
127666605|NCT03990363|459400270|FG000|Overall Study|Non-compliance with study drug|2|||
127666606|NCT03990363|459400271|FG001|Overall Study|Non-compliance with study drug|1|||
127666607|NCT03990363|459400272|FG002|Overall Study|Non-compliance with study drug|2|||
127666608|NCT03990363|459400273|FG003|Overall Study|Non-compliance with study drug|0|||
128000528|NCT01367249|460627135|FG001|Overall Study|Other|10|||
128000529|NCT02358031|460629137|FG000|Overall Study|Death|253|||
128000530|NCT02358031|460629138|FG001|Overall Study|Death|237|||
128000531|NCT02358031|460629139|FG002|Overall Study|Death|266|||
128000532|NCT02358031|460629137|FG000|Overall Study|Lost to Follow-up|1|||
128000533|NCT02358031|460629138|FG001|Overall Study|Lost to Follow-up|1|||
127666609|NCT03990363|459400274|FG004|Overall Study|Non-compliance with study drug|0|||
127666610|NCT03990363|459400270|FG000|Overall Study|Study terminated by sponsor|0|||
127666611|NCT03990363|459400271|FG001|Overall Study|Study terminated by sponsor|1|||
128000534|NCT02358031|460629139|FG002|Overall Study|Lost to Follow-up|0|||
128000535|NCT02358031|460629137|FG000|Overall Study|Withdrawal by Subject|19|||
127666612|NCT03990363|459400272|FG002|Overall Study|Study terminated by sponsor|0|||
127666613|NCT03990363|459400273|FG003|Overall Study|Study terminated by sponsor|0|||
127666614|NCT03990363|459400274|FG004|Overall Study|Study terminated by sponsor|0|||
127666615|NCT03990363|459400270|FG000|Overall Study|Site terminated by sponsor|2|||
127666616|NCT03990363|459400271|FG001|Overall Study|Site terminated by sponsor|1|||
127666617|NCT03990363|459400272|FG002|Overall Study|Site terminated by sponsor|2|||
127666618|NCT03990363|459400273|FG003|Overall Study|Site terminated by sponsor|0|||
127666619|NCT03990363|459400274|FG004|Overall Study|Site terminated by sponsor|2|||
127666620|NCT03990363|459400270|FG000|Overall Study|Not categorized|5|||
128000536|NCT02358031|460629138|FG001|Overall Study|Withdrawal by Subject|14|||
128000537|NCT02358031|460629139|FG002|Overall Study|Withdrawal by Subject|18|||
128000538|NCT02358031|460629137|FG000|Overall Study|Sponsor Decision|26|||
128000539|NCT02358031|460629138|FG001|Overall Study|Sponsor Decision|28|||
128000540|NCT02358031|460629139|FG002|Overall Study|Sponsor Decision|16|||
128000541|NCT05664581|460629140|FG000|Overall Study|Withdrawal by Subject|2|||
128000542|NCT03101150|460629143|FG000|Overall Study|Lost to Follow-up|2|||
128000543|NCT03101150|460629144|FG001|Overall Study|Lost to Follow-up|4|||
128000544|NCT03101150|460629143|FG000|Overall Study|Miscarriage|3|||
128000545|NCT03101150|460629144|FG001|Overall Study|Miscarriage|6|||
128000546|NCT03163446|460629145|FG000|Overall Study|Unable to return for Day 180 visit|2|||
128000547|NCT03163446|460629146|FG001|Overall Study|Unable to return for Day 180 visit|0|||
128000548|NCT03163446|460629145|FG000|Overall Study|Withdrawal by Subject|2|||
128000549|NCT03163446|460629146|FG001|Overall Study|Withdrawal by Subject|6|||
128000550|NCT03163446|460629145|FG000|Overall Study|Death|16|||
128000551|NCT03163446|460629146|FG001|Overall Study|Death|5|||
128000552|NCT03163446|460629145|FG000|Overall Study|Lost to Follow-up|6|||
128000553|NCT03163446|460629146|FG001|Overall Study|Lost to Follow-up|5|||
128000554|NCT03163446|460629145|FG000|Overall Study|Physician Decision|1|||
128000555|NCT03163446|460629146|FG001|Overall Study|Physician Decision|1|||
128000556|NCT03163446|460629145|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
128000557|NCT03163446|460629146|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
128000558|NCT01317641|460629147|FG000|Overall Study|Not treated|0|||
128000559|NCT01317641|460629148|FG001|Overall Study|Not treated|0|||
128000560|NCT01317641|460629149|FG002|Overall Study|Not treated|0|||
128000561|NCT01317641|460629150|FG003|Overall Study|Not treated|0|||
128000562|NCT01317641|460629151|FG004|Overall Study|Not treated|0|||
128000563|NCT01317641|460629152|FG005|Overall Study|Not treated|0|||
128000564|NCT01317641|460629153|FG006|Overall Study|Not treated|0|||
128000565|NCT01317641|460629154|FG007|Overall Study|Not treated|1|||
128000566|NCT01317641|460629155|FG008|Overall Study|Not treated|1|||
128000567|NCT01317641|460629147|FG000|Overall Study|Adverse Event|0|||
128000568|NCT01317641|460629148|FG001|Overall Study|Adverse Event|1|||
128000569|NCT01317641|460629149|FG002|Overall Study|Adverse Event|0|||
128000570|NCT01317641|460629150|FG003|Overall Study|Adverse Event|1|||
128000571|NCT01317641|460629151|FG004|Overall Study|Adverse Event|0|||
128000572|NCT01317641|460629152|FG005|Overall Study|Adverse Event|0|||
128000573|NCT01317641|460629153|FG006|Overall Study|Adverse Event|2|||
128000574|NCT01317641|460629154|FG007|Overall Study|Adverse Event|1|||
128000575|NCT01317641|460629155|FG008|Overall Study|Adverse Event|0|||
128000576|NCT01317641|460629147|FG000|Overall Study|Protocol Violation|1|||
128000577|NCT01317641|460629148|FG001|Overall Study|Protocol Violation|0|||
128000578|NCT01317641|460629149|FG002|Overall Study|Protocol Violation|0|||
128000579|NCT01317641|460629150|FG003|Overall Study|Protocol Violation|0|||
128000580|NCT01317641|460629151|FG004|Overall Study|Protocol Violation|0|||
128000581|NCT01317641|460629152|FG005|Overall Study|Protocol Violation|0|||
128000582|NCT01317641|460629153|FG006|Overall Study|Protocol Violation|0|||
128000583|NCT01317641|460629154|FG007|Overall Study|Protocol Violation|0|||
128000584|NCT01317641|460629155|FG008|Overall Study|Protocol Violation|0|||
128000585|NCT01317641|460629147|FG000|Overall Study|Disease progression|0|||
128000586|NCT01317641|460629148|FG001|Overall Study|Disease progression|0|||
128000587|NCT01317641|460629149|FG002|Overall Study|Disease progression|0|||
128000588|NCT01317641|460629150|FG003|Overall Study|Disease progression|0|||
128000589|NCT01317641|460629151|FG004|Overall Study|Disease progression|0|||
128000590|NCT01317641|460629152|FG005|Overall Study|Disease progression|0|||
128000591|NCT01317641|460629153|FG006|Overall Study|Disease progression|0|||
128000592|NCT01317641|460629154|FG007|Overall Study|Disease progression|3|||
128000593|NCT01317641|460629155|FG008|Overall Study|Disease progression|4|||
128000594|NCT01317641|460629147|FG000|Overall Study|Withdrawal by Subject|0|||
128000595|NCT01317641|460629148|FG001|Overall Study|Withdrawal by Subject|0|||
128000596|NCT01317641|460629149|FG002|Overall Study|Withdrawal by Subject|0|||
128000597|NCT01317641|460629150|FG003|Overall Study|Withdrawal by Subject|0|||
128000598|NCT01317641|460629151|FG004|Overall Study|Withdrawal by Subject|0|||
128000599|NCT01317641|460629152|FG005|Overall Study|Withdrawal by Subject|0|||
128000600|NCT01317641|460629153|FG006|Overall Study|Withdrawal by Subject|1|||
128000601|NCT01317641|460629154|FG007|Overall Study|Withdrawal by Subject|0|||
128000602|NCT01317641|460629155|FG008|Overall Study|Withdrawal by Subject|0|||
128000603|NCT00611806|460629156|FG000|Overall Study|Withdrawal by Subject|8|||
128000604|NCT00611806|460629157|FG001|Overall Study|Withdrawal by Subject|2|||
128000605|NCT00611806|460629156|FG000|Overall Study|Adverse Event|2|||
128000606|NCT00611806|460629157|FG001|Overall Study|Adverse Event|1|||
128000607|NCT00611806|460629156|FG000|Overall Study|Lost to Follow-up|6|||
128000608|NCT00611806|460629157|FG001|Overall Study|Lost to Follow-up|0|||
128000609|NCT01228591|460629158|FG000|Baseline|Lack of Efficacy|1|||
128000610|NCT01228591|460629159|FG001|Baseline|Lack of Efficacy|2|||
128000611|NCT01921517|460629160|FG000|Overall Study|Lost to Follow-up|5|||
128000612|NCT01921517|460629161|FG001|Overall Study|Lost to Follow-up|0|||
128000613|NCT01921517|460629160|FG000|Overall Study|Newly diagnosed health concern|2|||
128000614|NCT01921517|460629161|FG001|Overall Study|Newly diagnosed health concern|0|||
128000615|NCT01921517|460629160|FG000|Overall Study|Physician Decision|0|||
128000616|NCT01921517|460629161|FG001|Overall Study|Physician Decision|2|||
127666621|NCT03990363|459400271|FG001|Overall Study|Not categorized|5|||
127666622|NCT03990363|459400272|FG002|Overall Study|Not categorized|3|||
127666623|NCT03990363|459400273|FG003|Overall Study|Not categorized|2|||
127666624|NCT03990363|459400274|FG004|Overall Study|Not categorized|2|||
128000617|NCT01921517|460629160|FG000|Overall Study|Withdrawal by Subject|7|||
128000618|NCT01921517|460629161|FG001|Overall Study|Withdrawal by Subject|3|||
128000619|NCT01921517|460629160|FG000|Overall Study|Subject missed final imaging|1|||
128000620|NCT01921517|460629161|FG001|Overall Study|Subject missed final imaging|4|||
128000621|NCT02787304|460629162|FG000|Overall Study|Adverse Event|9|||
128000622|NCT02787304|460629163|FG001|Overall Study|Adverse Event|3|||
128000623|NCT02787304|460629164|FG002|Overall Study|Adverse Event|8|||
128000624|NCT02787304|460629165|FG003|Overall Study|Adverse Event|1|||
128000625|NCT02787304|460629162|FG000|Overall Study|Withdrawal by Subject|1|||
128000626|NCT02787304|460629163|FG001|Overall Study|Withdrawal by Subject|4|||
128000627|NCT02787304|460629164|FG002|Overall Study|Withdrawal by Subject|0|||
128000628|NCT02787304|460629165|FG003|Overall Study|Withdrawal by Subject|0|||
128000629|NCT02787304|460629162|FG000|Overall Study|Lost to Follow-up|1|||
128000630|NCT02787304|460629163|FG001|Overall Study|Lost to Follow-up|0|||
128000631|NCT02787304|460629164|FG002|Overall Study|Lost to Follow-up|0|||
128000632|NCT02787304|460629165|FG003|Overall Study|Lost to Follow-up|1|||
128000633|NCT02787304|460629162|FG000|Overall Study|Noncompliance with study drug|0|||
128000634|NCT02787304|460629163|FG001|Overall Study|Noncompliance with study drug|0|||
128000635|NCT02787304|460629164|FG002|Overall Study|Noncompliance with study drug|1|||
128000636|NCT02787304|460629165|FG003|Overall Study|Noncompliance with study drug|0|||
128000637|NCT02787304|460629162|FG000|Overall Study|Physician Decision|0|||
128000638|NCT02787304|460629163|FG001|Overall Study|Physician Decision|0|||
128000639|NCT02787304|460629164|FG002|Overall Study|Physician Decision|1|||
128000640|NCT02787304|460629165|FG003|Overall Study|Physician Decision|0|||
128000641|NCT02787304|460629162|FG000|Overall Study|Study terminated by sponsor|25|||
128000642|NCT02787304|460629163|FG001|Overall Study|Study terminated by sponsor|31|||
128000643|NCT02787304|460629164|FG002|Overall Study|Study terminated by sponsor|31|||
128000644|NCT02787304|460629165|FG003|Overall Study|Study terminated by sponsor|32|||
128000645|NCT03110354|460629171|FG000|Overall Study|Death|1|||
128000646|NCT03110354|460629172|FG001|Overall Study|Death|0|||
128000647|NCT03110354|460629173|FG002|Overall Study|Death|0|||
128000648|NCT03110354|460629174|FG003|Overall Study|Death|1|||
128000649|NCT03110354|460629175|FG004|Overall Study|Death|0|||
128000650|NCT03110354|460629171|FG000|Overall Study|Start of new therapy|0|||
128000651|NCT03110354|460629172|FG001|Overall Study|Start of new therapy|0|||
128000652|NCT03110354|460629173|FG002|Overall Study|Start of new therapy|0|||
128000653|NCT03110354|460629174|FG003|Overall Study|Start of new therapy|0|||
128000654|NCT03110354|460629175|FG004|Overall Study|Start of new therapy|1|||
128000655|NCT03110354|460629171|FG000|Overall Study|Failure to achieve response|2|||
128000656|NCT03110354|460629172|FG001|Overall Study|Failure to achieve response|3|||
128000657|NCT03110354|460629173|FG002|Overall Study|Failure to achieve response|0|||
128000658|NCT03110354|460629174|FG003|Overall Study|Failure to achieve response|2|||
128000659|NCT03110354|460629175|FG004|Overall Study|Failure to achieve response|1|||
128000660|NCT03110354|460629171|FG000|Overall Study|Progressive disease|1|||
128000661|NCT03110354|460629172|FG001|Overall Study|Progressive disease|1|||
128000662|NCT03110354|460629173|FG002|Overall Study|Progressive disease|3|||
128000663|NCT03110354|460629174|FG003|Overall Study|Progressive disease|4|||
128000664|NCT03110354|460629175|FG004|Overall Study|Progressive disease|2|||
128000665|NCT03110354|460629171|FG000|Overall Study|Adverse Event|0|||
128000666|NCT03110354|460629172|FG001|Overall Study|Adverse Event|0|||
128000667|NCT03110354|460629173|FG002|Overall Study|Adverse Event|0|||
128000668|NCT03110354|460629174|FG003|Overall Study|Adverse Event|2|||
128000669|NCT03110354|460629175|FG004|Overall Study|Adverse Event|2|||
128000670|NCT03110354|460629171|FG000|Overall Study|Other|0|||
128000671|NCT03110354|460629172|FG001|Overall Study|Other|0|||
128000672|NCT03110354|460629173|FG002|Overall Study|Other|0|||
128000673|NCT03110354|460629174|FG003|Overall Study|Other|1|||
128000674|NCT03110354|460629175|FG004|Overall Study|Other|1|||
128000675|NCT00379834|460629176|FG000|Overall Study|Time constraints|2|||
128000676|NCT01298700|460629178|FG000|Overall Study|Adverse Event|50|||
128000677|NCT01298700|460629179|FG001|Overall Study|Adverse Event|51|||
128000678|NCT01298700|460629178|FG000|Overall Study|Lack of Efficacy|9|||
128000679|NCT01298700|460629179|FG001|Overall Study|Lack of Efficacy|14|||
128000680|NCT01298700|460629178|FG000|Overall Study|Lost to Follow-up|5|||
128000681|NCT01298700|460629179|FG001|Overall Study|Lost to Follow-up|2|||
128000682|NCT01298700|460629178|FG000|Overall Study|Withdrawal by Subject|12|||
127666625|NCT05764239|459400279|FG000|DEP (Part 1)|Study terminated by Sponsor|28|||
127666626|NCT05764239|459400279|FG000|DEP (Part 1)|Withdrawal by Subject|3|||
128000683|NCT01298700|460629179|FG001|Overall Study|Withdrawal by Subject|9|||
128000684|NCT01298700|460629178|FG000|Overall Study|Protocol Violation|6|||
128000685|NCT01298700|460629179|FG001|Overall Study|Protocol Violation|4|||
128000686|NCT01298700|460629178|FG000|Overall Study|Other Miscellaneous Reasons|16|||
128000687|NCT01298700|460629179|FG001|Overall Study|Other Miscellaneous Reasons|15|||
128000688|NCT01298700|460629178|FG000|Overall Study|Did not Receive Study Drug|3|||
128000689|NCT01298700|460629179|FG001|Overall Study|Did not Receive Study Drug|5|||
128000690|NCT01001429|460629182|FG000|Overall Study|surgery cancelled|0|||
128000691|NCT01001429|460629183|FG001|Overall Study|surgery cancelled|1|||
128000692|NCT00643760|460629188|FG000|Overall Study|Adverse Event|11|||
128000693|NCT00643760|460629189|FG001|Overall Study|Adverse Event|5|||
128000694|NCT00643760|460629190|FG002|Overall Study|Adverse Event|12|||
128000695|NCT00643760|460629191|FG003|Overall Study|Adverse Event|21|||
128000696|NCT00643760|460629192|FG004|Overall Study|Adverse Event|6|||
128000697|NCT00643760|460629188|FG000|Overall Study|Lack of Efficacy|3|||
128000698|NCT00643760|460629189|FG001|Overall Study|Lack of Efficacy|1|||
128000699|NCT00643760|460629190|FG002|Overall Study|Lack of Efficacy|0|||
128000700|NCT00643760|460629191|FG003|Overall Study|Lack of Efficacy|4|||
128000701|NCT00643760|460629192|FG004|Overall Study|Lack of Efficacy|3|||
128000702|NCT00643760|460629188|FG000|Overall Study|Protocol Violation|7|||
128000703|NCT00643760|460629189|FG001|Overall Study|Protocol Violation|6|||
128000704|NCT00643760|460629190|FG002|Overall Study|Protocol Violation|4|||
128000705|NCT00643760|460629191|FG003|Overall Study|Protocol Violation|4|||
128000706|NCT00643760|460629192|FG004|Overall Study|Protocol Violation|6|||
128000707|NCT00643760|460629188|FG000|Overall Study|Lost to Follow-up|6|||
128000708|NCT00643760|460629189|FG001|Overall Study|Lost to Follow-up|2|||
128000709|NCT00643760|460629190|FG002|Overall Study|Lost to Follow-up|1|||
128000710|NCT00643760|460629191|FG003|Overall Study|Lost to Follow-up|3|||
128000711|NCT00643760|460629192|FG004|Overall Study|Lost to Follow-up|3|||
128000712|NCT00643760|460629188|FG000|Overall Study|Investigator Discretion|0|||
128000713|NCT00643760|460629189|FG001|Overall Study|Investigator Discretion|0|||
128000714|NCT00643760|460629190|FG002|Overall Study|Investigator Discretion|0|||
128000715|NCT00643760|460629191|FG003|Overall Study|Investigator Discretion|2|||
128000716|NCT00643760|460629192|FG004|Overall Study|Investigator Discretion|0|||
128000717|NCT00643760|460629188|FG000|Overall Study|Withdrawal by Subject|3|||
128000718|NCT00643760|460629189|FG001|Overall Study|Withdrawal by Subject|1|||
128000719|NCT00643760|460629190|FG002|Overall Study|Withdrawal by Subject|2|||
128000720|NCT00643760|460629191|FG003|Overall Study|Withdrawal by Subject|4|||
128000721|NCT00643760|460629192|FG004|Overall Study|Withdrawal by Subject|1|||
128000722|NCT02063672|460629193|FG000|Overall Study|Ongoing Follow-up|27|||
128000723|NCT02063672|460629194|FG001|Overall Study|Ongoing Follow-up|14|||
128000724|NCT02063672|460629193|FG000|Overall Study|Death|5|||
128000725|NCT02063672|460629194|FG001|Overall Study|Death|3|||
128000726|NCT02063672|460629193|FG000|Overall Study|Lost to Follow-up|1|||
128000727|NCT02063672|460629194|FG001|Overall Study|Lost to Follow-up|3|||
128000728|NCT02063672|460629193|FG000|Overall Study|Withdrawal by Subject|2|||
128000729|NCT02063672|460629194|FG001|Overall Study|Withdrawal by Subject|2|||
128000730|NCT01053741|460629195|FG000|2nd Study Intervention|Physician Decision|0|||
128000731|NCT01053741|460629196|FG001|2nd Study Intervention|Physician Decision|1|||
128000732|NCT00104052|460629198|FG000|Overall Study|Adverse Event|1|||
128000733|NCT00104052|460629198|FG000|Overall Study|Lack of Efficacy|26|||
128000734|NCT00104052|460629198|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
128000735|NCT02619617|460629213|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
128000736|NCT02619617|460629214|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
128000737|NCT02619617|460629213|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
128000738|NCT02619617|460629214|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
128000739|NCT02515630|460629215|FG000|Overall Study|Withdrawal by Subject|5|||
128000740|NCT02515630|460629215|FG000|Overall Study|Adverse Event|4|||
128000741|NCT02515630|460629215|FG000|Overall Study|Physician Decision|4|||
128000742|NCT02515630|460629215|FG000|Overall Study|Death|2|||
128000743|NCT02515630|460629215|FG000|Overall Study|Disease Progression|1|||
128000744|NCT00230048|460629222|FG000|Overall Study|Lost to Follow-up|13|||
128000745|NCT00230048|460629223|FG001|Overall Study|Lost to Follow-up|18|||
128000746|NCT01566604|460629224|FG000|Overall Study|Patient's inability to use the device|1|||
128000747|NCT01566604|460629225|FG001|Overall Study|Patient's inability to use the device|0|||
128000748|NCT01566604|460629224|FG000|Overall Study|Administrative problems|1|||
128000749|NCT01566604|460629225|FG001|Overall Study|Administrative problems|0|||
127666627|NCT05764239|459400279|FG000|DEP (Part 1)|Non-compliance with study drug|2|||
127666628|NCT05764239|459400279|FG000|DEP (Part 1)|Adverse Event|1|||
127666629|NCT05764239|459400279|FG000|DEP (Part 1)|Lost to Follow-up|1|||
127666630|NCT05764239|459400279|FG000|RWP (Part 2, SYNB1934v1)|Study terminated by Sponsor|7|||
128000750|NCT01566604|460629224|FG000|Overall Study|Lack of Efficacy|1|||
128000751|NCT01566604|460629225|FG001|Overall Study|Lack of Efficacy|2|||
128000752|NCT01566604|460629224|FG000|Overall Study|Protocol deviation|2|||
128000753|NCT01566604|460629225|FG001|Overall Study|Protocol deviation|0|||
128000754|NCT01566604|460629224|FG000|Overall Study|Abnormal laboratory value|2|||
128000755|NCT01566604|460629225|FG001|Overall Study|Abnormal laboratory value|0|||
127666631|NCT05764239|459400279|FG000|RWP (Part 2, SYNB1934v1)|Non-compliance with study drug|2|||
128000756|NCT01566604|460629224|FG000|Overall Study|Death|4|||
128000757|NCT01566604|460629225|FG001|Overall Study|Death|1|||
128000758|NCT01566604|460629224|FG000|Overall Study|Adverse Event|4|||
128000759|NCT01566604|460629225|FG001|Overall Study|Adverse Event|2|||
128000760|NCT01566604|460629224|FG000|Overall Study|Withdrawal by Subject|9|||
128000761|NCT01566604|460629225|FG001|Overall Study|Withdrawal by Subject|6|||
128000762|NCT03225170|460629226|FG000|Overall Study|Lost to Follow-up|4|||
127666632|NCT05764239|459400279|FG000|RWP (Part 2, Placebo)|Study terminated by Sponsor|8|||
127666633|NCT05764239|459400279|FG000|OLE (Part 3)|Study terminated by Sponsor|10|||
127666634|NCT00057811|459400280|FG000|Overall Study|Lack of Efficacy|1|||
127666635|NCT00057811|459400281|FG001|Overall Study|Lack of Efficacy|4|||
127666636|NCT00057811|459400280|FG000|Overall Study|Physician Decision|1|||
127666637|NCT00057811|459400281|FG001|Overall Study|Physician Decision|0|||
127666638|NCT00057811|459400280|FG000|Overall Study|Withdrawal by Subject|3|||
127666639|NCT00057811|459400281|FG001|Overall Study|Withdrawal by Subject|4|||
127666640|NCT00057811|459400280|FG000|Overall Study|Ineligible|4|||
127666641|NCT00057811|459400281|FG001|Overall Study|Ineligible|2|||
127666642|NCT00057811|459400280|FG000|Overall Study|Inevaluable|1|||
127666643|NCT00057811|459400281|FG001|Overall Study|Inevaluable|2|||
127666644|NCT00556374|459400282|FG000|Overall Study|Withdrawal by Subject|235|||
127666645|NCT00556374|459400283|FG001|Overall Study|Withdrawal by Subject|205|||
127666646|NCT00556374|459400282|FG000|Overall Study|Death|158|||
127666647|NCT00556374|459400283|FG001|Overall Study|Death|127|||
127666648|NCT00556374|459400282|FG000|Overall Study|Lost to Follow-up|24|||
127666649|NCT00556374|459400283|FG001|Overall Study|Lost to Follow-up|17|||
127666650|NCT00556374|459400282|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
127666651|NCT00556374|459400283|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
127666652|NCT04562779|459400284|FG000|Overall Study|Lost to Follow-up|7|||
127666653|NCT04562779|459400285|FG001|Overall Study|Lost to Follow-up|5|||
127666654|NCT04562779|459400286|FG002|Overall Study|Lost to Follow-up|10|||
127666655|NCT04562779|459400284|FG000|Overall Study|Protocol Violation|2|||
127666656|NCT04562779|459400285|FG001|Overall Study|Protocol Violation|2|||
127666657|NCT04562779|459400286|FG002|Overall Study|Protocol Violation|0|||
127666658|NCT00333138|459400287|FG000|Core Study (6 Months)|Adverse Event|4|||
127666659|NCT00333138|459400288|FG001|Core Study (6 Months)|Adverse Event|5|||
127666660|NCT00333138|459400289|FG002|Core Study (6 Months)|Adverse Event|8|||
127666661|NCT00333138|459400287|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
127666662|NCT00333138|459400288|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
127666663|NCT00333138|459400289|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
127666664|NCT00333138|459400287|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
127666665|NCT00333138|459400288|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
127666666|NCT00333138|459400289|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
127666667|NCT00333138|459400287|FG000|Core Study (6 Months)|Protocol Violation|1|||
127666668|NCT00333138|459400288|FG001|Core Study (6 Months)|Protocol Violation|0|||
127666669|NCT00333138|459400289|FG002|Core Study (6 Months)|Protocol Violation|1|||
127666670|NCT00333138|459400287|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
127666671|NCT00333138|459400288|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
127666672|NCT00333138|459400289|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
127666673|NCT00333138|459400287|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
127666674|NCT00333138|459400288|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
127666675|NCT00333138|459400289|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
127666676|NCT00333138|459400287|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
127666677|NCT00333138|459400288|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
128000763|NCT03225170|460629227|FG001|Overall Study|Lost to Follow-up|4|||
128000764|NCT03225170|460629228|FG002|Overall Study|Lost to Follow-up|0|||
128000765|NCT03225170|460629226|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
128000766|NCT03225170|460629227|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
128000767|NCT03225170|460629228|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
128000768|NCT00731822|460629233|FG000|Overall Study|Adverse Event|2|||
128000769|NCT00731822|460629234|FG001|Overall Study|Adverse Event|1|||
128000770|NCT00731822|460629233|FG000|Overall Study|Protocol Violation|1|||
128000771|NCT00731822|460629234|FG001|Overall Study|Protocol Violation|0|||
128000772|NCT00731822|460629233|FG000|Overall Study|Lost to Follow-up|1|||
128000773|NCT00731822|460629234|FG001|Overall Study|Lost to Follow-up|0|||
128000774|NCT03589807|460629239|FG000|Overall Study|Lost to Follow-up|0|||
128000775|NCT03589807|460629240|FG001|Overall Study|Lost to Follow-up|2|||
128000776|NCT03589807|460629241|FG002|Overall Study|Lost to Follow-up|2|||
128000777|NCT03589807|460629242|FG003|Overall Study|Lost to Follow-up|3|||
128000778|NCT03589807|460629243|FG004|Overall Study|Lost to Follow-up|1|||
127666678|NCT00333138|459400289|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
127666679|NCT00333138|459400287|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
127666680|NCT00333138|459400288|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
127666681|NCT00333138|459400289|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
127666682|NCT00333138|459400287|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
127666683|NCT00333138|459400288|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
127666684|NCT00333138|459400289|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
127666685|NCT00333138|459400287|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
128000779|NCT03589807|460629244|FG005|Overall Study|Lost to Follow-up|1|||
128000780|NCT03589807|460629239|FG000|Overall Study|Withdrawal by Subject|0|||
128000781|NCT03589807|460629240|FG001|Overall Study|Withdrawal by Subject|5|||
128000782|NCT03589807|460629241|FG002|Overall Study|Withdrawal by Subject|0|||
128000783|NCT03589807|460629242|FG003|Overall Study|Withdrawal by Subject|0|||
128000784|NCT03589807|460629243|FG004|Overall Study|Withdrawal by Subject|0|||
128000785|NCT03589807|460629244|FG005|Overall Study|Withdrawal by Subject|0|||
128000786|NCT03589807|460629239|FG000|Overall Study|Protocol Violation|0|||
128000787|NCT03589807|460629240|FG001|Overall Study|Protocol Violation|0|||
128000788|NCT03589807|460629241|FG002|Overall Study|Protocol Violation|0|||
128000789|NCT03589807|460629242|FG003|Overall Study|Protocol Violation|1|||
128000790|NCT03589807|460629243|FG004|Overall Study|Protocol Violation|0|||
128000791|NCT03589807|460629244|FG005|Overall Study|Protocol Violation|0|||
128000792|NCT03589807|460629239|FG000|Overall Study|Enrolled but treatment not administered|0|||
128000793|NCT03589807|460629240|FG001|Overall Study|Enrolled but treatment not administered|0|||
128000794|NCT03589807|460629241|FG002|Overall Study|Enrolled but treatment not administered|0|||
128000795|NCT03589807|460629242|FG003|Overall Study|Enrolled but treatment not administered|0|||
128000796|NCT03589807|460629243|FG004|Overall Study|Enrolled but treatment not administered|1|||
128000797|NCT03589807|460629244|FG005|Overall Study|Enrolled but treatment not administered|0|||
128000798|NCT00385918|460629254|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
128000799|NCT00385918|460629255|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
128000800|NCT00385918|460629256|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
128000801|NCT00385918|460629254|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
128000802|NCT00385918|460629255|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
128000803|NCT00385918|460629256|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
128000804|NCT00385918|460629254|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
128000805|NCT00385918|460629255|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
128000806|NCT00385918|460629256|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
128000807|NCT00385918|460629254|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
128000808|NCT00385918|460629255|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
128000809|NCT00385918|460629256|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
128000810|NCT00385918|460629254|FG000|Intervention Phase After Randomization|Physician Decision|1|||
128000811|NCT00385918|460629255|FG001|Intervention Phase After Randomization|Physician Decision|0|||
128000812|NCT00385918|460629256|FG002|Intervention Phase After Randomization|Physician Decision|0|||
128000813|NCT00385918|460629254|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
128000814|NCT00385918|460629255|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
128000815|NCT00385918|460629256|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
128000816|NCT01676701|460629257|FG000|Overall Study|Protocol Violation|1|||
127666686|NCT00333138|459400288|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
127666687|NCT00333138|459400289|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
127666688|NCT00333138|459400287|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
127666689|NCT00333138|459400288|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
127666690|NCT00333138|459400289|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
127666691|NCT00333138|459400287|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
127666692|NCT00333138|459400288|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
127666693|NCT00333138|459400289|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
127666694|NCT00333138|459400287|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
127666695|NCT00333138|459400288|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
127666696|NCT00333138|459400289|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
127666697|NCT00333138|459400287|FG000|Extension Study (Month6 to End of Study)|Death|0|||
127666698|NCT00333138|459400288|FG001|Extension Study (Month6 to End of Study)|Death|1|||
127666699|NCT00333138|459400289|FG002|Extension Study (Month6 to End of Study)|Death|0|||
127666700|NCT04630756|459400290|FG000|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|1|||
127666701|NCT04630756|459400291|FG001|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
127666702|NCT04630756|459400292|FG002|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
127666703|NCT05593211|459400293|FG000|Overall Study|Withdrawal by Subject|1|||
127666704|NCT03077620|459400294|FG000|Overall Study|Unable to place lumbar catheter|1|||
127666705|NCT03077620|459400295|FG001|Overall Study|Unable to place lumbar catheter|0|||
127666706|NCT03077620|459400296|FG002|Overall Study|Unable to place lumbar catheter|1|||
127666707|NCT03077620|459400297|FG003|Overall Study|Unable to place lumbar catheter|0|||
127666708|NCT03077620|459400294|FG000|Overall Study|Withdrawal by Subject|0|||
127666709|NCT03077620|459400295|FG001|Overall Study|Withdrawal by Subject|1|||
127666710|NCT03077620|459400296|FG002|Overall Study|Withdrawal by Subject|0|||
127666711|NCT03077620|459400297|FG003|Overall Study|Withdrawal by Subject|0|||
127666712|NCT03077620|459400294|FG000|Overall Study|Physician Decision|0|||
127666713|NCT03077620|459400295|FG001|Overall Study|Physician Decision|0|||
127666714|NCT03077620|459400296|FG002|Overall Study|Physician Decision|1|||
127666715|NCT03077620|459400297|FG003|Overall Study|Physician Decision|0|||
128000817|NCT01676701|460629258|FG001|Overall Study|Protocol Violation|0|||
128000818|NCT01676701|460629257|FG000|Overall Study|Sponsor Decision|3|||
127666716|NCT03225846|459400298|FG000|Overall Study|Adverse Event|0|||
128000819|NCT01676701|460629258|FG001|Overall Study|Sponsor Decision|4|||
128000820|NCT05502302|460629263|FG000|Overall Study|Lost to Follow-up|6|||
128000821|NCT05502302|460629263|FG000|Overall Study|Death|2|||
128000822|NCT01628848|460629267|FG000|Overall Study|Adverse Event|9|||
127666717|NCT03225846|459400299|FG001|Overall Study|Adverse Event|0|||
127666718|NCT03225846|459400300|FG002|Overall Study|Adverse Event|0|||
127666719|NCT03225846|459400301|FG003|Overall Study|Adverse Event|0|||
127666720|NCT03225846|459400302|FG004|Overall Study|Adverse Event|0|||
127666721|NCT03225846|459400303|FG005|Overall Study|Adverse Event|0|||
127666722|NCT03225846|459400304|FG006|Overall Study|Adverse Event|6|||
127666723|NCT03225846|459400298|FG000|Overall Study|Withdrawal by Subject|0|||
127666724|NCT03225846|459400299|FG001|Overall Study|Withdrawal by Subject|1|||
127666725|NCT03225846|459400300|FG002|Overall Study|Withdrawal by Subject|0|||
127666726|NCT03225846|459400301|FG003|Overall Study|Withdrawal by Subject|0|||
127666727|NCT03225846|459400302|FG004|Overall Study|Withdrawal by Subject|0|||
127666728|NCT03225846|459400303|FG005|Overall Study|Withdrawal by Subject|0|||
127666729|NCT03225846|459400304|FG006|Overall Study|Withdrawal by Subject|0|||
127666730|NCT03225846|459400298|FG000|Overall Study|Death|0|||
127666731|NCT03225846|459400299|FG001|Overall Study|Death|1|||
127666732|NCT03225846|459400300|FG002|Overall Study|Death|0|||
127666733|NCT03225846|459400301|FG003|Overall Study|Death|0|||
127666734|NCT03225846|459400302|FG004|Overall Study|Death|0|||
127666735|NCT03225846|459400303|FG005|Overall Study|Death|0|||
127666736|NCT03225846|459400304|FG006|Overall Study|Death|0|||
127666737|NCT03225846|459400298|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
127666738|NCT03225846|459400299|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
127666739|NCT03225846|459400300|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
127666740|NCT03225846|459400301|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
127666741|NCT03225846|459400302|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
127666742|NCT03225846|459400303|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
128000823|NCT01628848|460629268|FG001|Overall Study|Adverse Event|7|||
128000824|NCT01628848|460629267|FG000|Overall Study|Lack of Efficacy|0|||
128000825|NCT01628848|460629268|FG001|Overall Study|Lack of Efficacy|4|||
128000826|NCT01628848|460629267|FG000|Overall Study|Withdrawal by Subject|0|||
128000827|NCT01628848|460629268|FG001|Overall Study|Withdrawal by Subject|2|||
128000828|NCT01628848|460629267|FG000|Overall Study|Physician Decision|3|||
128000829|NCT01628848|460629268|FG001|Overall Study|Physician Decision|1|||
128000830|NCT00003471|460629269|FG000|Overall Study|Not evaluable|4|||
128000831|NCT02104895|460629270|FG000|Overall Study|Withdrawal by Subject|0|||
128000832|NCT02104895|460629271|FG001|Overall Study|Withdrawal by Subject|14|||
128000833|NCT03311945|460629273|FG000|Overall Study|Adverse Event|2|||
128000834|NCT03311945|460629273|FG000|Overall Study|Lack of Efficacy|1|||
128000835|NCT01107925|460629274|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
128000836|NCT01107925|460629275|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
128000837|NCT01107925|460629276|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
128000838|NCT01107925|460629277|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
128000839|NCT01107925|460629278|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
128000840|NCT01107925|460629279|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
128000841|NCT01107925|460629274|FG000|Period 2|Withdrawal by Subject|0|||
128000842|NCT01107925|460629275|FG001|Period 2|Withdrawal by Subject|1|||
128000843|NCT01107925|460629276|FG002|Period 2|Withdrawal by Subject|0|||
128000844|NCT01107925|460629277|FG003|Period 2|Withdrawal by Subject|0|||
128000845|NCT01107925|460629278|FG004|Period 2|Withdrawal by Subject|0|||
128000846|NCT01107925|460629279|FG005|Period 2|Withdrawal by Subject|1|||
128000847|NCT04877990|460629280|FG000|Treatment|Other reasons|3|||
128000848|NCT04877990|460629281|FG001|Treatment|Other reasons|1|||
128000849|NCT04877990|460629280|FG000|Treatment|Administrative reasons by sponsor|17|||
128000850|NCT04877990|460629281|FG001|Treatment|Administrative reasons by sponsor|33|||
128000851|NCT04877990|460629280|FG000|Treatment|Withdrawal by Subject|2|||
128000852|NCT04877990|460629281|FG001|Treatment|Withdrawal by Subject|6|||
128000853|NCT04877990|460629280|FG000|Treatment|Adverse Event|2|||
128000854|NCT04877990|460629281|FG001|Treatment|Adverse Event|1|||
127666743|NCT03225846|459400304|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
127666744|NCT03225846|459400298|FG000|Overall Study|Patient decision|0|||
127666745|NCT03225846|459400299|FG001|Overall Study|Patient decision|0|||
127666746|NCT03225846|459400300|FG002|Overall Study|Patient decision|0|||
127666747|NCT03225846|459400301|FG003|Overall Study|Patient decision|0|||
127666748|NCT03225846|459400302|FG004|Overall Study|Patient decision|0|||
127666749|NCT03225846|459400303|FG005|Overall Study|Patient decision|0|||
127666750|NCT03225846|459400304|FG006|Overall Study|Patient decision|1|||
127666751|NCT00996580|459400305|FG000|Overall Study|Adverse Event|466|||
128000855|NCT01619878|460629282|FG000|6 Week Follow-up Phase|Adverse Event|1|||
128000856|NCT01619878|460629282|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
128000857|NCT01619878|460629282|FG000|Follow-up at 12 Months of Age|Death|2|||
128000858|NCT02895295|460629285|FG000|Overall Study|Survey Non-response|71|||
128000859|NCT02895295|460629286|FG001|Overall Study|Survey Non-response|94|||
128000860|NCT02895295|460629287|FG002|Overall Study|Survey Non-response|92|||
128000861|NCT04821830|460629288|FG000|Overall Study|Withdrawal by Subject|1|||
128000862|NCT04821830|460629289|FG001|Overall Study|Withdrawal by Subject|0|||
128000863|NCT00960804|460629290|FG000|Overall Study|Adverse Event|1|||
128000864|NCT00960804|460629291|FG001|Overall Study|Adverse Event|0|||
128000865|NCT00960804|460629292|FG002|Overall Study|Adverse Event|0|||
128000866|NCT00960804|460629290|FG000|Overall Study|Withdrawal by Subject|1|||
128000867|NCT00960804|460629291|FG001|Overall Study|Withdrawal by Subject|0|||
128000868|NCT00960804|460629292|FG002|Overall Study|Withdrawal by Subject|0|||
128000869|NCT00960804|460629290|FG000|Overall Study|Study terminated by the sponsor|5|||
128000870|NCT00960804|460629291|FG001|Overall Study|Study terminated by the sponsor|4|||
127666752|NCT00996580|459400305|FG000|Overall Study|Lost to Follow-up|480|||
127666753|NCT00996580|459400305|FG000|Overall Study|Noncompliance with the protocol|137|||
127666754|NCT00996580|459400305|FG000|Overall Study|Physician Decision|5|||
127666755|NCT00996580|459400305|FG000|Overall Study|Pregnancy|68|||
127666756|NCT00996580|459400305|FG000|Overall Study|Protocol Violation|16|||
127666757|NCT00996580|459400305|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
127666758|NCT00996580|459400305|FG000|Overall Study|Withdrawal by Subject|217|||
127666759|NCT00996580|459400305|FG000|Overall Study|Other|29|||
127666760|NCT05708846|459400306|FG000|Overall Study|Death|5|||
127666761|NCT05708846|459400306|FG000|Overall Study|Withdrawal by Subject|20|||
127666762|NCT02036515|459400307|FG000|Overall Study|Adverse Event|1|||
127666763|NCT02036515|459400308|FG001|Overall Study|Adverse Event|1|||
127666764|NCT02036515|459400309|FG002|Overall Study|Adverse Event|2|||
127666765|NCT02036515|459400307|FG000|Overall Study|Lost to Follow-up|0|||
127666766|NCT02036515|459400308|FG001|Overall Study|Lost to Follow-up|2|||
127666767|NCT02036515|459400309|FG002|Overall Study|Lost to Follow-up|0|||
127666768|NCT02036515|459400307|FG000|Overall Study|Non-compliance with study drug|0|||
127666769|NCT02036515|459400308|FG001|Overall Study|Non-compliance with study drug|0|||
127666770|NCT02036515|459400309|FG002|Overall Study|Non-compliance with study drug|2|||
128000871|NCT00960804|460629292|FG002|Overall Study|Study terminated by the sponsor|10|||
128000872|NCT00490919|460629293|FG000|Open-label Run-in Period|Adverse Event|239|||
128000873|NCT00490919|460629294|FG001|Open-label Run-in Period|Adverse Event|0|||
128000874|NCT00490919|460629295|FG002|Open-label Run-in Period|Adverse Event|0|||
128000875|NCT00490919|460629293|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
128000876|NCT00490919|460629294|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
128000877|NCT00490919|460629295|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
128000878|NCT00490919|460629293|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
128000879|NCT00490919|460629294|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
128000880|NCT00490919|460629295|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
128000881|NCT00490919|460629293|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
128000882|NCT00490919|460629294|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
128000883|NCT00490919|460629295|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
128000884|NCT00490919|460629293|FG000|Open-label Run-in Period|Administrative|40|||
128000885|NCT00490919|460629294|FG001|Open-label Run-in Period|Administrative|0|||
128000886|NCT00490919|460629295|FG002|Open-label Run-in Period|Administrative|0|||
128000887|NCT00490919|460629293|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
128000888|NCT00490919|460629294|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
128000889|NCT00490919|460629295|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
128000890|NCT00490919|460629293|FG000|Double-blind Phase|Adverse Event|0|||
128000891|NCT00490919|460629294|FG001|Double-blind Phase|Adverse Event|40|||
128000892|NCT00490919|460629295|FG002|Double-blind Phase|Adverse Event|20|||
128000893|NCT00490919|460629293|FG000|Double-blind Phase|Withdrawal by Subject|0|||
128000894|NCT00490919|460629294|FG001|Double-blind Phase|Withdrawal by Subject|10|||
128000895|NCT00490919|460629295|FG002|Double-blind Phase|Withdrawal by Subject|11|||
128000896|NCT00490919|460629293|FG000|Double-blind Phase|Lost to Follow-up|0|||
128000897|NCT00490919|460629294|FG001|Double-blind Phase|Lost to Follow-up|8|||
128000898|NCT00490919|460629295|FG002|Double-blind Phase|Lost to Follow-up|11|||
128000899|NCT00490919|460629293|FG000|Double-blind Phase|Lack of Efficacy|0|||
127666771|NCT02036515|459400307|FG000|Overall Study|Screen failure|0|||
127666772|NCT02036515|459400308|FG001|Overall Study|Screen failure|2|||
127666773|NCT02036515|459400309|FG002|Overall Study|Screen failure|0|||
127666774|NCT02036515|459400307|FG000|Overall Study|Withdrawal by Subject|4|||
127666775|NCT02036515|459400308|FG001|Overall Study|Withdrawal by Subject|7|||
128000900|NCT00490919|460629294|FG001|Double-blind Phase|Lack of Efficacy|22|||
128000901|NCT00490919|460629295|FG002|Double-blind Phase|Lack of Efficacy|36|||
127666776|NCT02036515|459400309|FG002|Overall Study|Withdrawal by Subject|9|||
127666777|NCT02036515|459400307|FG000|Overall Study|Hyperglycemia|0|||
127666778|NCT02036515|459400308|FG001|Overall Study|Hyperglycemia|0|||
127666779|NCT02036515|459400309|FG002|Overall Study|Hyperglycemia|1|||
128000902|NCT00490919|460629293|FG000|Double-blind Phase|Administrative|0|||
128000903|NCT00490919|460629294|FG001|Double-blind Phase|Administrative|6|||
128000904|NCT00490919|460629295|FG002|Double-blind Phase|Administrative|6|||
128000905|NCT00715559|460631166|FG000|Overall Study|medication not tolerated - nausea|1|||
128000906|NCT01051921|460631169|FG000|Overall Study|Physician Decision|9|||
128000907|NCT01051921|460631169|FG000|Overall Study|Adverse Event|8|||
127666780|NCT00238420|459400310|FG000|Overall Study|Protocol Violation|1|||
127666781|NCT00238420|459400311|FG001|Overall Study|Protocol Violation|1|||
127666782|NCT00663962|459400312|FG000|Overall Study|somnolence|1|||
127666783|NCT00663962|459400313|FG001|Overall Study|somnolence|0|||
127666784|NCT02102464|459400314|FG000|Randomized Study|Withdrawal by Subject|0|||
127666785|NCT02102464|459400315|FG001|Randomized Study|Withdrawal by Subject|1|||
128000908|NCT01051921|460631169|FG000|Overall Study|Withdrawal by Subject|7|||
128000909|NCT01051921|460631169|FG000|Overall Study|Lost to Follow-up|4|||
127666786|NCT02102464|459400316|FG002|Randomized Study|Withdrawal by Subject|0|||
127666787|NCT04140890|459400317|FG000|Overall Study|Withdrawal by Subject|0|||
127666788|NCT04140890|459400318|FG001|Overall Study|Withdrawal by Subject|1|||
127666789|NCT01700348|459400319|FG000|Overall Study|Withdrawal by Subject|22|||
127666790|NCT01700348|459400319|FG000|Overall Study|Lost to Follow-up|1|||
128000910|NCT01051921|460631169|FG000|Overall Study|virological failure|1|||
128000911|NCT01051921|460631169|FG000|Overall Study|patient moved|1|||
128000912|NCT00116688|460631174|FG000|Overall Study|Protocol deviation|1|||
128000913|NCT00116688|460631175|FG001|Overall Study|Protocol deviation|0|||
128000914|NCT00116688|460631174|FG000|Overall Study|Noncompliance|3|||
128000915|NCT00116688|460631175|FG001|Overall Study|Noncompliance|1|||
128000916|NCT00116688|460631174|FG000|Overall Study|Adverse Event|11|||
128000917|NCT00116688|460631175|FG001|Overall Study|Adverse Event|0|||
128000918|NCT00116688|460631174|FG000|Overall Study|Withdrawal by Subject|26|||
128000919|NCT00116688|460631175|FG001|Overall Study|Withdrawal by Subject|2|||
128000920|NCT00116688|460631174|FG000|Overall Study|Requirement for alternative therapy|11|||
128000921|NCT00116688|460631175|FG001|Overall Study|Requirement for alternative therapy|1|||
128000922|NCT00116688|460631174|FG000|Overall Study|Physician Decision|7|||
128000923|NCT00116688|460631175|FG001|Overall Study|Physician Decision|0|||
128000924|NCT00116688|460631174|FG000|Overall Study|Lost to Follow-up|3|||
128000925|NCT00116688|460631175|FG001|Overall Study|Lost to Follow-up|0|||
128000926|NCT00116688|460631174|FG000|Overall Study|Death|15|||
128000927|NCT00116688|460631175|FG001|Overall Study|Death|0|||
128000928|NCT00116688|460631174|FG000|Overall Study|Protocol-specified criteria|3|||
128000929|NCT00116688|460631175|FG001|Overall Study|Protocol-specified criteria|0|||
128000930|NCT00116688|460631174|FG000|Overall Study|Pregnancy|1|||
128000931|NCT00116688|460631175|FG001|Overall Study|Pregnancy|0|||
128000932|NCT00116688|460631174|FG000|Overall Study|Other|11|||
128000933|NCT00116688|460631175|FG001|Overall Study|Other|0|||
128000934|NCT01775670|460631179|FG000|Overall Study|Lost to Follow-up|1|||
128000935|NCT01775670|460631180|FG001|Overall Study|Lost to Follow-up|1|||
128000936|NCT04006145|460631182|FG000|Overall Study|Lost to Follow-up|0|||
128000937|NCT04006145|460631183|FG001|Overall Study|Lost to Follow-up|1|||
128000938|NCT04006145|460631182|FG000|Overall Study|Other|1|||
128000939|NCT04006145|460631183|FG001|Overall Study|Other|2|||
128000940|NCT00010257|460631186|FG000|Overall Study|Withdrawal by Subject|1|||
128000941|NCT00010257|460631187|FG001|Overall Study|Withdrawal by Subject|0|||
128000942|NCT02498678|460631193|FG000|Overall Study|interference from the surgical team|0|||
128000943|NCT02498678|460631194|FG001|Overall Study|interference from the surgical team|2|||
128000944|NCT00239720|460631199|FG000|Overall Study|Adverse Event|1|||
128000945|NCT00239720|460631200|FG001|Overall Study|Adverse Event|0|||
128000946|NCT00239720|460631199|FG000|Overall Study|Lost to Follow-up|0|||
127666791|NCT03958630|459400320|FG000|Overall Study|Withdrawal by Subject|0|||
127666792|NCT03958630|459400321|FG001|Overall Study|Withdrawal by Subject|0|||
127666793|NCT03958630|459400322|FG002|Overall Study|Withdrawal by Subject|1|||
127666794|NCT03958630|459400320|FG000|Overall Study|Withdrawn due to the 2019 pandemic|0|||
127666795|NCT03958630|459400321|FG001|Overall Study|Withdrawn due to the 2019 pandemic|0|||
127666796|NCT03958630|459400322|FG002|Overall Study|Withdrawn due to the 2019 pandemic|1|||
127666797|NCT01824472|459400325|FG000|Overall Study|Lost to Follow-up|0|||
127666798|NCT01824472|459400326|FG001|Overall Study|Lost to Follow-up|0|||
127666799|NCT01824472|459400327|FG002|Overall Study|Lost to Follow-up|1|||
127666800|NCT01824472|459400325|FG000|Overall Study|Withdrawal by Subject|1|||
127666801|NCT01824472|459400326|FG001|Overall Study|Withdrawal by Subject|5|||
127666802|NCT01824472|459400327|FG002|Overall Study|Withdrawal by Subject|3|||
127666803|NCT01824472|459400325|FG000|Overall Study|Ineligible post randomization&screening|0|||
128000947|NCT00239720|460631200|FG001|Overall Study|Lost to Follow-up|1|||
128000948|NCT01484951|460631201|FG000|Overall Study|Adverse Event|3|||
128000949|NCT01484951|460631201|FG000|Overall Study|Personal Reasons|1|||
127666804|NCT01824472|459400326|FG001|Overall Study|Ineligible post randomization&screening|2|||
127666805|NCT01824472|459400327|FG002|Overall Study|Ineligible post randomization&screening|0|||
127666806|NCT01815736|459400330|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
128000950|NCT01484951|460631201|FG000|Overall Study|Non-Compliance|1|||
128000951|NCT01249417|460631202|FG000|Randomised Population|Study treatment not received|0|||
128000952|NCT01249417|460631203|FG001|Randomised Population|Study treatment not received|0|||
128000953|NCT01249417|460631204|FG002|Randomised Population|Study treatment not received|2|||
128000954|NCT01249417|460631202|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
128000955|NCT01249417|460631203|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
128000956|NCT01249417|460631204|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
128000957|NCT01249417|460631202|FG000|Treatment Phase - ITT Population|Other|0|||
128000958|NCT01249417|460631203|FG001|Treatment Phase - ITT Population|Other|0|||
128000959|NCT01249417|460631204|FG002|Treatment Phase - ITT Population|Other|1|||
128000960|NCT01249417|460631202|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
128000961|NCT01249417|460631203|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
128000962|NCT01249417|460631204|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
128000963|NCT01249417|460631202|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
128000964|NCT01249417|460631203|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
128000965|NCT01249417|460631204|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
128000966|NCT01249417|460631202|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
128000967|NCT01249417|460631203|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
128000968|NCT01249417|460631204|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
128000969|NCT00917124|460631205|FG000|Overall Study|Protocol Violation|4|||
128000970|NCT00917124|460631206|FG001|Overall Study|Protocol Violation|6|||
128000971|NCT00126594|460631208|FG000|Overall Study|Ineligible|2|||
128000972|NCT00126594|460631209|FG001|Overall Study|Ineligible|0|||
128000973|NCT00126594|460631208|FG000|Overall Study|Withdrawal by Subject|0|||
128000974|NCT00126594|460631209|FG001|Overall Study|Withdrawal by Subject|4|||
128000975|NCT00126594|460631208|FG000|Overall Study|Physician Decision|1|||
128000976|NCT00126594|460631209|FG001|Overall Study|Physician Decision|3|||
128000977|NCT00126594|460631208|FG000|Overall Study|Adverse Event|7|||
128000978|NCT00126594|460631209|FG001|Overall Study|Adverse Event|5|||
128000979|NCT00126594|460631208|FG000|Overall Study|Non-compliance|0|||
128000980|NCT00126594|460631209|FG001|Overall Study|Non-compliance|1|||
128000981|NCT00126594|460631208|FG000|Overall Study|Disease Progression|29|||
128000982|NCT00126594|460631209|FG001|Overall Study|Disease Progression|24|||
128000983|NCT03769649|460631210|FG000|Overall Study|Lost to Follow-up|4|||
128000984|NCT01290718|460631213|FG000|Overall Study|Early termination of the study|4|||
128000985|NCT00473655|460631214|FG000|Overall Study|Lost to Follow-up|9|||
128000986|NCT00473655|460631215|FG001|Overall Study|Lost to Follow-up|5|||
128000987|NCT00473655|460631216|FG002|Overall Study|Lost to Follow-up|8|||
128000988|NCT00243919|460631217|FG000|Overall Study|Death|3|||
128000989|NCT00243919|460631218|FG001|Overall Study|Death|4|||
128000990|NCT00243919|460631219|FG002|Overall Study|Death|6|||
128000991|NCT00243919|460631217|FG000|Overall Study|Withdrawal by Subject|6|||
128000992|NCT00243919|460631218|FG001|Overall Study|Withdrawal by Subject|6|||
128000993|NCT00243919|460631219|FG002|Overall Study|Withdrawal by Subject|2|||
128000994|NCT00243919|460631217|FG000|Overall Study|Lost to Follow-up|6|||
128000995|NCT00243919|460631218|FG001|Overall Study|Lost to Follow-up|7|||
128000996|NCT00243919|460631219|FG002|Overall Study|Lost to Follow-up|3|||
128000997|NCT00243919|460631217|FG000|Overall Study|Administrative Error|1|||
128000998|NCT00243919|460631218|FG001|Overall Study|Administrative Error|0|||
128000999|NCT00243919|460631219|FG002|Overall Study|Administrative Error|0|||
128001000|NCT00243919|460631217|FG000|Overall Study|Physician Decision|1|||
128001001|NCT00243919|460631218|FG001|Overall Study|Physician Decision|1|||
128001002|NCT00243919|460631219|FG002|Overall Study|Physician Decision|0|||
128001003|NCT01268267|460631222|FG000|Overall Study|Protocol Violation|1|||
128001004|NCT04176939|460631223|FG000|Overall Study|Withdrawal by Subject|5|||
128001005|NCT04176939|460631223|FG000|Overall Study|Migrated / Moved From The Study Area|1|||
128001006|NCT04176939|460631223|FG000|Overall Study|Lost to Follow-up|2|||
128001007|NCT04176939|460631223|FG000|Overall Study|Unspecified reason|4|||
128001008|NCT04176939|460631223|FG000|Overall Study|Adverse Event Requiring Expedited Reporting|7|||
128001009|NCT04919317|460631230|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
128001010|NCT04919317|460631231|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
128001011|NCT04919317|460631230|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
128001012|NCT04919317|460631231|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
128001013|NCT02869789|460631232|FG000|Overall Study|Disease progression|184|||
128001014|NCT02869789|460631233|FG001|Overall Study|Disease progression|109|||
128001015|NCT02869789|460631234|FG002|Overall Study|Disease progression|260|||
128001016|NCT02869789|460631235|FG003|Overall Study|Disease progression|19|||
128001017|NCT02869789|460631232|FG000|Overall Study|Study drug toxicity|90|||
128001018|NCT02869789|460631233|FG001|Overall Study|Study drug toxicity|32|||
128001019|NCT02869789|460631234|FG002|Overall Study|Study drug toxicity|55|||
128001020|NCT02869789|460631235|FG003|Overall Study|Study drug toxicity|14|||
128001021|NCT02869789|460631232|FG000|Overall Study|Death|7|||
128001022|NCT02869789|460631233|FG001|Overall Study|Death|3|||
128001023|NCT02869789|460631234|FG002|Overall Study|Death|5|||
128001024|NCT02869789|460631235|FG003|Overall Study|Death|1|||
128001025|NCT02869789|460631232|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
128001026|NCT02869789|460631233|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
128001027|NCT02869789|460631234|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
128001028|NCT02869789|460631235|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
128001029|NCT02869789|460631232|FG000|Overall Study|Participant request to discontinue study treatment|10|||
128001030|NCT02869789|460631233|FG001|Overall Study|Participant request to discontinue study treatment|5|||
128001031|NCT02869789|460631234|FG002|Overall Study|Participant request to discontinue study treatment|5|||
128001032|NCT02869789|460631235|FG003|Overall Study|Participant request to discontinue study treatment|3|||
127666807|NCT01815736|459400331|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
127666808|NCT01815736|459400330|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
127666809|NCT01815736|459400331|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
127666810|NCT01815736|459400330|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
128001033|NCT02869789|460631232|FG000|Overall Study|Withdrawal by Subject|5|||
128001034|NCT02869789|460631233|FG001|Overall Study|Withdrawal by Subject|2|||
128001035|NCT02869789|460631234|FG002|Overall Study|Withdrawal by Subject|7|||
128001036|NCT02869789|460631235|FG003|Overall Study|Withdrawal by Subject|2|||
128001037|NCT02869789|460631232|FG000|Overall Study|Lost to Follow-up|0|||
128001038|NCT02869789|460631233|FG001|Overall Study|Lost to Follow-up|0|||
128001039|NCT02869789|460631234|FG002|Overall Study|Lost to Follow-up|2|||
128001040|NCT02869789|460631235|FG003|Overall Study|Lost to Follow-up|0|||
128001041|NCT02869789|460631232|FG000|Overall Study|Maximum clinical benefit|5|||
128001042|NCT02869789|460631233|FG001|Overall Study|Maximum clinical benefit|2|||
128001043|NCT02869789|460631234|FG002|Overall Study|Maximum clinical benefit|1|||
128001044|NCT02869789|460631235|FG003|Overall Study|Maximum clinical benefit|0|||
128001045|NCT02869789|460631232|FG000|Overall Study|Poor/Non-compliance|0|||
128001046|NCT02869789|460631233|FG001|Overall Study|Poor/Non-compliance|2|||
128001047|NCT02869789|460631234|FG002|Overall Study|Poor/Non-compliance|1|||
128001048|NCT02869789|460631235|FG003|Overall Study|Poor/Non-compliance|0|||
128001049|NCT02869789|460631232|FG000|Overall Study|Participant no longer meets study criteria|0|||
128001050|NCT02869789|460631233|FG001|Overall Study|Participant no longer meets study criteria|1|||
128001051|NCT02869789|460631234|FG002|Overall Study|Participant no longer meets study criteria|1|||
128001052|NCT02869789|460631235|FG003|Overall Study|Participant no longer meets study criteria|0|||
128001053|NCT02869789|460631232|FG000|Overall Study|Administrative reason by sponsor|0|||
128001054|NCT02869789|460631233|FG001|Overall Study|Administrative reason by sponsor|0|||
128001055|NCT02869789|460631234|FG002|Overall Study|Administrative reason by sponsor|1|||
128001056|NCT02869789|460631235|FG003|Overall Study|Administrative reason by sponsor|0|||
128001057|NCT02869789|460631232|FG000|Overall Study|Other reasons|4|||
128001058|NCT02869789|460631233|FG001|Overall Study|Other reasons|8|||
128001059|NCT02869789|460631234|FG002|Overall Study|Other reasons|6|||
128001060|NCT02869789|460631235|FG003|Overall Study|Other reasons|0|||
128001061|NCT01443858|460631250|FG000|Overall Study|Withdrawal by Subject|9|||
128001062|NCT01443858|460631251|FG001|Overall Study|Withdrawal by Subject|8|||
128001063|NCT01443858|460631252|FG002|Overall Study|Withdrawal by Subject|5|||
128001064|NCT01443858|460631250|FG000|Overall Study|Lack of Efficacy|1|||
128001065|NCT01443858|460631251|FG001|Overall Study|Lack of Efficacy|0|||
128001066|NCT01443858|460631252|FG002|Overall Study|Lack of Efficacy|0|||
128001067|NCT01443858|460631250|FG000|Overall Study|Lost to Follow-up|5|||
128001068|NCT01443858|460631251|FG001|Overall Study|Lost to Follow-up|5|||
128001069|NCT01443858|460631252|FG002|Overall Study|Lost to Follow-up|2|||
128001070|NCT02849587|460631254|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
128001071|NCT02849587|460631255|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
128001072|NCT02849587|460631256|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
128001073|NCT02849587|460631254|FG000|Overall Study|Withdrawal by Subject|0|||
128001074|NCT02849587|460631255|FG001|Overall Study|Withdrawal by Subject|1|||
128001075|NCT02849587|460631256|FG002|Overall Study|Withdrawal by Subject|0|||
128001076|NCT00549549|460631264|FG000|Overall Study|Adverse Event|5|||
128001077|NCT00549549|460631265|FG001|Overall Study|Adverse Event|3|||
128001078|NCT00549549|460631266|FG002|Overall Study|Adverse Event|1|||
128001079|NCT00549549|460631267|FG003|Overall Study|Adverse Event|9|||
128001080|NCT00549549|460631264|FG000|Overall Study|Lack of Efficacy|9|||
128001081|NCT00549549|460631265|FG001|Overall Study|Lack of Efficacy|6|||
128001082|NCT00549549|460631266|FG002|Overall Study|Lack of Efficacy|4|||
128001083|NCT00549549|460631267|FG003|Overall Study|Lack of Efficacy|2|||
128001084|NCT00549549|460631264|FG000|Overall Study|Lost to Follow-up|1|||
128001085|NCT00549549|460631265|FG001|Overall Study|Lost to Follow-up|0|||
128001086|NCT00549549|460631266|FG002|Overall Study|Lost to Follow-up|1|||
128001087|NCT00549549|460631267|FG003|Overall Study|Lost to Follow-up|2|||
128001088|NCT00549549|460631264|FG000|Overall Study|Withdrawal by Subject|0|||
128001089|NCT00549549|460631265|FG001|Overall Study|Withdrawal by Subject|4|||
128001090|NCT00549549|460631266|FG002|Overall Study|Withdrawal by Subject|1|||
128001091|NCT00549549|460631267|FG003|Overall Study|Withdrawal by Subject|0|||
128001092|NCT00549549|460631264|FG000|Overall Study|Other|9|||
128001093|NCT00549549|460631265|FG001|Overall Study|Other|9|||
128001094|NCT00549549|460631266|FG002|Overall Study|Other|9|||
128001095|NCT00549549|460631267|FG003|Overall Study|Other|11|||
128001096|NCT00549549|460631264|FG000|Overall Study|Randomized but not treated|0|||
128001097|NCT00549549|460631265|FG001|Overall Study|Randomized but not treated|0|||
128001098|NCT00549549|460631266|FG002|Overall Study|Randomized but not treated|1|||
128001099|NCT00549549|460631267|FG003|Overall Study|Randomized but not treated|1|||
128001100|NCT02155699|460631268|FG000|Overall Study|Withdrawal by Subject|0|||
128001101|NCT02155699|460631269|FG001|Overall Study|Withdrawal by Subject|3|||
128001102|NCT02155699|460631270|FG002|Overall Study|Withdrawal by Subject|6|||
128001103|NCT02155699|460631271|FG003|Overall Study|Withdrawal by Subject|1|||
128001104|NCT02155699|460631268|FG000|Overall Study|Lost to Follow-up|0|||
128001105|NCT02155699|460631269|FG001|Overall Study|Lost to Follow-up|0|||
128001106|NCT02155699|460631270|FG002|Overall Study|Lost to Follow-up|0|||
128001107|NCT02155699|460631271|FG003|Overall Study|Lost to Follow-up|3|||
128001108|NCT02155699|460631268|FG000|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
128001109|NCT02155699|460631269|FG001|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
128001110|NCT02155699|460631270|FG002|Overall Study|Emergence of Psychosis or Substance disorder during protocol|2|||
128001111|NCT02155699|460631271|FG003|Overall Study|Emergence of Psychosis or Substance disorder during protocol|1|||
128001112|NCT02227784|460631272|FG000|Double-Blind Phase|Adverse Event|3|||
128001113|NCT02227784|460631273|FG001|Double-Blind Phase|Adverse Event|2|||
128001114|NCT02227784|460631274|FG002|Double-Blind Phase|Adverse Event|1|||
128001115|NCT02227784|460631275|FG003|Double-Blind Phase|Adverse Event|3|||
128001116|NCT02227784|460631276|FG004|Double-Blind Phase|Adverse Event|0|||
128001117|NCT02227784|460631272|FG000|Double-Blind Phase|Physician Decision|1|||
128001118|NCT02227784|460631273|FG001|Double-Blind Phase|Physician Decision|0|||
128001119|NCT02227784|460631274|FG002|Double-Blind Phase|Physician Decision|0|||
128001120|NCT02227784|460631275|FG003|Double-Blind Phase|Physician Decision|1|||
128001121|NCT02227784|460631276|FG004|Double-Blind Phase|Physician Decision|0|||
128001122|NCT02227784|460631272|FG000|Double-Blind Phase|Protocol Violation|0|||
128001123|NCT02227784|460631273|FG001|Double-Blind Phase|Protocol Violation|0|||
128001124|NCT02227784|460631274|FG002|Double-Blind Phase|Protocol Violation|1|||
128001125|NCT02227784|460631275|FG003|Double-Blind Phase|Protocol Violation|1|||
128001126|NCT02227784|460631276|FG004|Double-Blind Phase|Protocol Violation|0|||
128001127|NCT02227784|460631272|FG000|Double-Blind Phase|Sponsor Decision|34|||
128001128|NCT02227784|460631273|FG001|Double-Blind Phase|Sponsor Decision|15|||
128001129|NCT02227784|460631274|FG002|Double-Blind Phase|Sponsor Decision|14|||
128001130|NCT02227784|460631275|FG003|Double-Blind Phase|Sponsor Decision|32|||
128001131|NCT02227784|460631276|FG004|Double-Blind Phase|Sponsor Decision|0|||
128001132|NCT02227784|460631272|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
128001133|NCT02227784|460631273|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
128001134|NCT02227784|460631274|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
128001135|NCT02227784|460631275|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
128001136|NCT02227784|460631276|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
128001137|NCT02227784|460631272|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
128001138|NCT02227784|460631273|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
128001139|NCT02227784|460631274|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
128001140|NCT02227784|460631275|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
128001141|NCT02227784|460631276|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
128001142|NCT02227784|460631272|FG000|Open-Label Extension Phase (OLE)|Death|0|||
128001143|NCT02227784|460631273|FG001|Open-Label Extension Phase (OLE)|Death|0|||
128001144|NCT02227784|460631274|FG002|Open-Label Extension Phase (OLE)|Death|0|||
128001145|NCT02227784|460631275|FG003|Open-Label Extension Phase (OLE)|Death|0|||
128001146|NCT02227784|460631276|FG004|Open-Label Extension Phase (OLE)|Death|1|||
128001147|NCT02227784|460631272|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
128001148|NCT02227784|460631273|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
128001149|NCT02227784|460631274|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
128001150|NCT02227784|460631275|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
128001151|NCT02227784|460631276|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
128001152|NCT02227784|460631272|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
128001153|NCT02227784|460631273|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
128001154|NCT02227784|460631274|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
128001155|NCT02227784|460631275|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
128001156|NCT02227784|460631276|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
128001157|NCT00248651|460631279|FG000|Overall Study|Withdrawal by Subject|28|||
128001158|NCT00248651|460631280|FG001|Overall Study|Withdrawal by Subject|40|||
128001159|NCT00248651|460631281|FG002|Overall Study|Withdrawal by Subject|32|||
128001160|NCT02688933|460631284|FG000|Overall Study|Adverse Event|3|||
128001161|NCT02688933|460631285|FG001|Overall Study|Adverse Event|1|||
128001162|NCT02688933|460631284|FG000|Overall Study|Lack of Efficacy|2|||
128001163|NCT02688933|460631285|FG001|Overall Study|Lack of Efficacy|2|||
128001164|NCT02688933|460631284|FG000|Overall Study|Poor compliance to protocol|7|||
128001165|NCT02688933|460631285|FG001|Overall Study|Poor compliance to protocol|4|||
128001166|NCT02688933|460631284|FG000|Overall Study|Hypoglycemia|2|||
128001167|NCT02688933|460631285|FG001|Overall Study|Hypoglycemia|0|||
128001168|NCT02688933|460631284|FG000|Overall Study|Other than Specified|14|||
128001169|NCT02688933|460631285|FG001|Overall Study|Other than Specified|25|||
128001170|NCT02688933|460631284|FG000|Overall Study|Lost to Follow-up|1|||
128001171|NCT02688933|460631285|FG001|Overall Study|Lost to Follow-up|5|||
128001172|NCT01275144|460631286|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
128001173|NCT01275144|460631287|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
128001174|NCT00828113|460631288|FG000|Overall Study|Withdrawal by Subject|27|||
128001175|NCT00828113|460631289|FG001|Overall Study|Withdrawal by Subject|26|||
128001176|NCT00828113|460631288|FG000|Overall Study|Lost to Follow-up|3|||
127666811|NCT01815736|459400331|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
127666812|NCT01815736|459400330|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
127666813|NCT01815736|459400331|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
127666814|NCT01815736|459400330|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
127666815|NCT01815736|459400331|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
127666816|NCT01815736|459400330|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
127666817|NCT01815736|459400331|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
127666818|NCT01815736|459400330|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
127666819|NCT01815736|459400331|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
127666820|NCT01815736|459400330|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
128001177|NCT00828113|460631289|FG001|Overall Study|Lost to Follow-up|5|||
128001178|NCT01365130|460631290|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
128001179|NCT05607576|460631292|FG000|Overall Study|immediate sensor error|2|||
128001180|NCT05607576|460631292|FG000|Overall Study|Physician Decision|2|||
128001181|NCT00810199|460631293|FG000|Overall Study|Adverse Event|24|||
128001182|NCT00810199|460631294|FG001|Overall Study|Adverse Event|26|||
128001183|NCT00810199|460631293|FG000|Overall Study|Death|4|||
128001184|NCT00810199|460631294|FG001|Overall Study|Death|6|||
128001185|NCT00810199|460631293|FG000|Overall Study|Withdrew consent|9|||
128001186|NCT00810199|460631294|FG001|Overall Study|Withdrew consent|12|||
128001187|NCT00810199|460631293|FG000|Overall Study|Insufficient therapeutic response|5|||
128001188|NCT00810199|460631294|FG001|Overall Study|Insufficient therapeutic response|14|||
128001189|NCT00810199|460631293|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
128001190|NCT00810199|460631294|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
128001191|NCT00810199|460631293|FG000|Overall Study|Administrative/Other|5|||
128001192|NCT00810199|460631294|FG001|Overall Study|Administrative/Other|6|||
128001193|NCT00810199|460631293|FG000|Overall Study|Protocol Violation|2|||
128001194|NCT00810199|460631294|FG001|Overall Study|Protocol Violation|6|||
128001195|NCT00810199|460631293|FG000|Overall Study|Failure to return|1|||
128001196|NCT00810199|460631294|FG001|Overall Study|Failure to return|4|||
128001197|NCT00810199|460631293|FG000|Overall Study|Did not receive study drug|2|||
128001198|NCT00810199|460631294|FG001|Overall Study|Did not receive study drug|1|||
128001199|NCT01091246|460631295|FG000|Overall Study|Lost to Follow-up|23|||
128001200|NCT01091246|460631296|FG001|Overall Study|Lost to Follow-up|11|||
128001201|NCT01091246|460631297|FG002|Overall Study|Lost to Follow-up|7|||
128001202|NCT01091246|460631295|FG000|Overall Study|Adverse Event|1|||
128001203|NCT01091246|460631296|FG001|Overall Study|Adverse Event|0|||
128001204|NCT01091246|460631297|FG002|Overall Study|Adverse Event|1|||
128001205|NCT01091246|460631295|FG000|Overall Study|Withdrawal by Subject|9|||
128001206|NCT01091246|460631296|FG001|Overall Study|Withdrawal by Subject|5|||
128001207|NCT01091246|460631297|FG002|Overall Study|Withdrawal by Subject|4|||
128001208|NCT01091246|460631295|FG000|Overall Study|Subject not dosed|2|||
128001209|NCT01091246|460631296|FG001|Overall Study|Subject not dosed|0|||
128001210|NCT01091246|460631297|FG002|Overall Study|Subject not dosed|1|||
128001211|NCT02287038|460631298|FG000|Overall Study|Stopped attending appointments|3|||
128001212|NCT02287038|460631299|FG001|Overall Study|Stopped attending appointments|2|||
128001213|NCT02287038|460631298|FG000|Overall Study|Anxiety after starting medication|0|||
128001214|NCT02287038|460631299|FG001|Overall Study|Anxiety after starting medication|1|||
128001215|NCT02287038|460631298|FG000|Overall Study|Nausea after starting medication|1|||
128001216|NCT02287038|460631299|FG001|Overall Study|Nausea after starting medication|0|||
128001217|NCT02287038|460631298|FG000|Overall Study|Abnormal ECG after starting medication|1|||
128001218|NCT02287038|460631299|FG001|Overall Study|Abnormal ECG after starting medication|0|||
128001219|NCT01676012|460631305|FG000|Overall Study|Adverse Event|2|||
128001220|NCT01676012|460631305|FG000|Overall Study|incomplete set of videos|1|||
128001221|NCT02667301|460631310|FG000|Overall Study|Adverse Event|1|||
128001222|NCT02667301|460631310|FG000|Overall Study|Lack of Efficacy|1|||
128001223|NCT03528551|460631312|FG000|Overall Study|Lost to Follow-up|0|||
128001224|NCT03528551|460631313|FG001|Overall Study|Lost to Follow-up|1|||
128001225|NCT03528551|460631314|FG002|Overall Study|Lost to Follow-up|0|||
128001226|NCT03528551|460631312|FG000|Overall Study|Transferred to other arm/group|2|||
128001227|NCT03528551|460631313|FG001|Overall Study|Transferred to other arm/group|3|||
128001228|NCT03528551|460631314|FG002|Overall Study|Transferred to other arm/group|0|||
128001229|NCT03528551|460631312|FG000|Overall Study|Withdrawal by parent/guardian|0|||
128001230|NCT03528551|460631313|FG001|Overall Study|Withdrawal by parent/guardian|5|||
128001231|NCT03528551|460631314|FG002|Overall Study|Withdrawal by parent/guardian|0|||
128001232|NCT03528551|460631312|FG000|Overall Study|Protocol Violation|0|||
128001233|NCT03528551|460631313|FG001|Overall Study|Protocol Violation|3|||
128001234|NCT03528551|460631314|FG002|Overall Study|Protocol Violation|0|||
128001235|NCT03528551|460631312|FG000|Overall Study|Withdrawal by Subject|0|||
128001236|NCT03528551|460631313|FG001|Overall Study|Withdrawal by Subject|7|||
128001237|NCT03528551|460631314|FG002|Overall Study|Withdrawal by Subject|0|||
128001238|NCT00846586|460631315|FG000|Overall Study|Adverse Event|20|||
128001239|NCT00846586|460631316|FG001|Overall Study|Adverse Event|10|||
128001240|NCT00846586|460631315|FG000|Overall Study|Subject withdrew consent|8|||
127666821|NCT01815736|459400331|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
127666822|NCT01815736|459400330|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
127666823|NCT01815736|459400331|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
127666824|NCT01815736|459400330|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
127666825|NCT01815736|459400331|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
127666826|NCT01815736|459400330|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
127666827|NCT01815736|459400331|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
127666828|NCT01815736|459400330|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
127666829|NCT01815736|459400331|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
127666830|NCT01815736|459400330|FG000|Extension Treatment Phase- After Week 96|Death|1|||
127666831|NCT01815736|459400331|FG001|Extension Treatment Phase- After Week 96|Death|0|||
127666832|NCT03040687|459400333|FG000|Overall Study|Withdrawal by Subject|1|||
127666833|NCT03040687|459400334|FG001|Overall Study|Withdrawal by Subject|0|||
127666834|NCT03040687|459400335|FG002|Overall Study|Withdrawal by Subject|0|||
127666835|NCT00550173|459400336|FG000|Overall Study|Death|45|||
127666836|NCT00550173|459400337|FG001|Overall Study|Death|38|||
127666837|NCT00550173|459400338|FG002|Overall Study|Death|50|||
127666838|NCT00550173|459400336|FG000|Overall Study|Physician Decision|1|||
127666839|NCT00550173|459400337|FG001|Overall Study|Physician Decision|2|||
127666840|NCT00550173|459400338|FG002|Overall Study|Physician Decision|2|||
127666841|NCT00550173|459400336|FG000|Overall Study|Withdrawal by Subject|9|||
127666842|NCT00550173|459400337|FG001|Overall Study|Withdrawal by Subject|12|||
127666843|NCT00550173|459400338|FG002|Overall Study|Withdrawal by Subject|17|||
127666844|NCT00550173|459400336|FG000|Overall Study|Sponsor Decision|13|||
127666845|NCT00550173|459400337|FG001|Overall Study|Sponsor Decision|7|||
127666846|NCT00550173|459400338|FG002|Overall Study|Sponsor Decision|1|||
127666847|NCT00550173|459400336|FG000|Overall Study|Lost to Follow-up|4|||
127666848|NCT00550173|459400337|FG001|Overall Study|Lost to Follow-up|4|||
127666849|NCT00550173|459400338|FG002|Overall Study|Lost to Follow-up|3|||
127666850|NCT00810641|459400339|FG000|Overall Study|Withdrawal by Subject|0|||
127666851|NCT00810641|459400340|FG001|Overall Study|Withdrawal by Subject|1|||
127666852|NCT00810641|459400341|FG002|Overall Study|Withdrawal by Subject|2|||
127666853|NCT01388543|459400342|FG000|Day 14|Adverse Event|1|||
127666854|NCT01388543|459400343|FG001|Day 14|Adverse Event|4|||
127666855|NCT01556243|459400344|FG000|Overall Study|Ineligible|34|||
127666856|NCT01556243|459400344|FG000|Overall Study|Converted to mastectomy|14|||
127666857|NCT01556243|459400344|FG000|Overall Study|Unable to achieve negative margins|2|||
127666858|NCT01556243|459400344|FG000|Overall Study|Withdrawal by Subject|16|||
127666859|NCT02325713|459400347|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
127666860|NCT02325713|459400348|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
127666861|NCT02325713|459400349|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
127666862|NCT02325713|459400350|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
127666863|NCT02325713|459400351|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
127666864|NCT02325713|459400352|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
127666865|NCT02325713|459400353|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
127666866|NCT02325713|459400354|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
128001241|NCT00846586|460631316|FG001|Overall Study|Subject withdrew consent|10|||
128001242|NCT00846586|460631315|FG000|Overall Study|Administrative problems|5|||
127666867|NCT02325713|459400355|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
127666868|NCT02325713|459400356|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
127666869|NCT02325713|459400357|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
127666870|NCT02325713|459400358|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
127666871|NCT02325713|459400359|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
128001243|NCT00846586|460631316|FG001|Overall Study|Administrative problems|4|||
128001244|NCT00846586|460631315|FG000|Overall Study|Death|2|||
128001245|NCT00846586|460631316|FG001|Overall Study|Death|0|||
128001246|NCT00846586|460631315|FG000|Overall Study|Protocol deviation|2|||
128001247|NCT00846586|460631316|FG001|Overall Study|Protocol deviation|6|||
128001248|NCT00846586|460631315|FG000|Overall Study|Abnormal test procedure result(s)|1|||
128001249|NCT00846586|460631316|FG001|Overall Study|Abnormal test procedure result(s)|0|||
128001250|NCT00846586|460631315|FG000|Overall Study|Lost to Follow-up|1|||
128001251|NCT00846586|460631316|FG001|Overall Study|Lost to Follow-up|4|||
128001252|NCT00846586|460631315|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
128001253|NCT00846586|460631316|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
128001254|NCT01061606|460631317|FG000|Overall Study|Adverse Event|1|||
128001255|NCT01061606|460631317|FG000|Overall Study|Death|1|||
128001256|NCT01061606|460631317|FG000|Overall Study|Disease Progression|4|||
127666872|NCT02325713|459400360|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
127666873|NCT02325713|459400361|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
127666874|NCT02325713|459400362|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
128001257|NCT01061606|460631317|FG000|Overall Study|alternative therapy|2|||
128001258|NCT00735007|460631318|FG000|Overall Study|Adverse Event|4|||
128001259|NCT00735007|460631318|FG000|Overall Study|Protocol Violation|1|||
128001260|NCT00715403|460631319|FG000|Overall Study|Progressive disease|0|||
128001261|NCT00715403|460631320|FG001|Overall Study|Progressive disease|1|||
128001262|NCT00715403|460631321|FG002|Overall Study|Progressive disease|3|||
128001263|NCT00715403|460631322|FG003|Overall Study|Progressive disease|9|||
128001264|NCT00715403|460631323|FG004|Overall Study|Progressive disease|5|||
128001265|NCT00715403|460631324|FG005|Overall Study|Progressive disease|14|||
128001266|NCT00715403|460631325|FG006|Overall Study|Progressive disease|1|||
128001267|NCT00715403|460631319|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
128001268|NCT00715403|460631320|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
128001269|NCT00715403|460631321|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
128001270|NCT00715403|460631322|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
128001271|NCT00715403|460631323|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
128001272|NCT00715403|460631324|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
128001273|NCT00715403|460631325|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
128001274|NCT00715403|460631319|FG000|Overall Study|Other Adverse Event than DLT|1|||
128001275|NCT00715403|460631320|FG001|Overall Study|Other Adverse Event than DLT|0|||
128001276|NCT00715403|460631321|FG002|Overall Study|Other Adverse Event than DLT|0|||
128001277|NCT00715403|460631322|FG003|Overall Study|Other Adverse Event than DLT|0|||
128001278|NCT00715403|460631323|FG004|Overall Study|Other Adverse Event than DLT|0|||
128001279|NCT00715403|460631324|FG005|Overall Study|Other Adverse Event than DLT|2|||
128001280|NCT00715403|460631325|FG006|Overall Study|Other Adverse Event than DLT|0|||
128001281|NCT00715403|460631319|FG000|Overall Study|Protocol Violation|0|||
128001282|NCT00715403|460631320|FG001|Overall Study|Protocol Violation|0|||
128001283|NCT00715403|460631321|FG002|Overall Study|Protocol Violation|0|||
128001284|NCT00715403|460631322|FG003|Overall Study|Protocol Violation|0|||
128001285|NCT00715403|460631323|FG004|Overall Study|Protocol Violation|0|||
128001286|NCT00715403|460631324|FG005|Overall Study|Protocol Violation|1|||
128001287|NCT00715403|460631325|FG006|Overall Study|Protocol Violation|0|||
128001288|NCT00715403|460631319|FG000|Overall Study|Other reason not defined above|0|||
128001289|NCT00715403|460631320|FG001|Overall Study|Other reason not defined above|0|||
128001290|NCT00715403|460631321|FG002|Overall Study|Other reason not defined above|1|||
128001291|NCT00715403|460631322|FG003|Overall Study|Other reason not defined above|0|||
128001292|NCT00715403|460631323|FG004|Overall Study|Other reason not defined above|1|||
128001293|NCT00715403|460631324|FG005|Overall Study|Other reason not defined above|1|||
128001294|NCT00715403|460631325|FG006|Overall Study|Other reason not defined above|0|||
128001295|NCT03644017|460631326|FG000|Overall Study|Access Abandonment|5|||
128001296|NCT03644017|460631326|FG000|Overall Study|Kidney Transplant|2|||
128001297|NCT02700048|460631327|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
128001298|NCT02700048|460631328|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
128001299|NCT02175225|460631329|FG000|Overall Study|Withdrawal by Subject|1|||
128001300|NCT02175225|460631330|FG001|Overall Study|Withdrawal by Subject|2|||
128001301|NCT02175225|460631329|FG000|Overall Study|Lost to Follow-up|6|||
128001302|NCT02175225|460631330|FG001|Overall Study|Lost to Follow-up|7|||
128001303|NCT02175225|460631329|FG000|Overall Study|Study drug not administered|1|||
128001304|NCT02175225|460631330|FG001|Overall Study|Study drug not administered|2|||
128001305|NCT02340000|460631333|FG000|Time Period 1|Withdrawal by Subject|6|||
128001306|NCT02340000|460631334|FG001|Time Period 1|Withdrawal by Subject|8|||
128001307|NCT02340000|460631333|FG000|Time Period 1|Lost to Follow-up|6|||
128001308|NCT02340000|460631334|FG001|Time Period 1|Lost to Follow-up|7|||
128001309|NCT02340000|460631333|FG000|Time Period 2|Withdrawal by Subject|9|||
128001310|NCT02340000|460631334|FG001|Time Period 2|Withdrawal by Subject|7|||
128001311|NCT02340000|460631333|FG000|Time Period 2|Lost to Follow-up|10|||
128001312|NCT02340000|460631334|FG001|Time Period 2|Lost to Follow-up|8|||
128001313|NCT01883895|460631335|FG000|Overall Study|Lost to Follow-up|2|||
128001314|NCT00073918|460631336|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
128001315|NCT00073918|460631336|FG000|Overall Study|Rapid disease progression|2|||
128001316|NCT00073918|460631336|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
128001317|NCT00919633|460631339|FG000|Overall Study|Adverse Event|1|||
128001318|NCT00919633|460631340|FG001|Overall Study|Adverse Event|9|||
128001319|NCT00919633|460631341|FG002|Overall Study|Adverse Event|12|||
128001320|NCT00919633|460631342|FG003|Overall Study|Adverse Event|10|||
128001321|NCT00919633|460631339|FG000|Overall Study|Death|0|||
128001322|NCT00919633|460631340|FG001|Overall Study|Death|0|||
128001323|NCT00919633|460631341|FG002|Overall Study|Death|2|||
128001324|NCT00919633|460631342|FG003|Overall Study|Death|0|||
128001325|NCT00919633|460631339|FG000|Overall Study|Lack of Efficacy|17|||
128001326|NCT00919633|460631340|FG001|Overall Study|Lack of Efficacy|3|||
128001327|NCT00919633|460631341|FG002|Overall Study|Lack of Efficacy|2|||
128001328|NCT00919633|460631342|FG003|Overall Study|Lack of Efficacy|3|||
128001329|NCT00919633|460631339|FG000|Overall Study|Withdrawal by Subject|1|||
128001330|NCT00919633|460631340|FG001|Overall Study|Withdrawal by Subject|2|||
128001331|NCT00919633|460631341|FG002|Overall Study|Withdrawal by Subject|4|||
128001332|NCT00919633|460631342|FG003|Overall Study|Withdrawal by Subject|3|||
128001333|NCT00919633|460631339|FG000|Overall Study|Lost to Follow-up|3|||
128001334|NCT00919633|460631340|FG001|Overall Study|Lost to Follow-up|1|||
127666875|NCT02325713|459400347|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
127666876|NCT02325713|459400348|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
127666877|NCT02325713|459400349|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
127666878|NCT02325713|459400350|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
127666879|NCT02325713|459400351|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
127666880|NCT02325713|459400352|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
127666881|NCT02325713|459400353|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
127666882|NCT02325713|459400354|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
127666883|NCT02325713|459400355|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
127666884|NCT02325713|459400356|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
127666885|NCT02325713|459400357|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
127666886|NCT02325713|459400358|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
127666887|NCT02325713|459400359|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
127666888|NCT02325713|459400360|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
127666889|NCT02325713|459400361|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
127666890|NCT02325713|459400362|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
127666891|NCT02325713|459400347|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
127666892|NCT02325713|459400348|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
127666893|NCT02325713|459400349|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
127666894|NCT02325713|459400350|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
127666895|NCT02325713|459400351|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
127666896|NCT02325713|459400352|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
127666897|NCT02325713|459400353|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
127666898|NCT02325713|459400354|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
127666899|NCT02325713|459400355|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
127666900|NCT02325713|459400356|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
127666901|NCT02325713|459400357|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
127666902|NCT02325713|459400358|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
127666903|NCT02325713|459400359|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
127666904|NCT02325713|459400360|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
127666905|NCT02325713|459400361|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
127666906|NCT02325713|459400362|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
127666907|NCT02684903|459400364|FG000|Overall Study|COVID-19 shutdown of lab|4|||
127666908|NCT02684903|459400365|FG001|Overall Study|COVID-19 shutdown of lab|6|||
127666909|NCT02684903|459400364|FG000|Overall Study|Lost to Follow-up|31|||
127666910|NCT02684903|459400365|FG001|Overall Study|Lost to Follow-up|41|||
127666911|NCT00107380|459401759|FG000|Overall Study|Adverse Event|7|||
127666912|NCT00107380|459401759|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
127666913|NCT00107380|459401759|FG000|Overall Study|Progression/relapse|4|||
127666914|NCT00107380|459401759|FG000|Overall Study|Death|3|||
127666915|NCT00107380|459401759|FG000|Overall Study|Other - not protocol specified|7|||
127666916|NCT00107380|459401759|FG000|Overall Study|Ineligible|2|||
127666917|NCT03673098|459401760|FG000|Overall Study|Lost to Follow-up|2|||
127666918|NCT03673098|459401761|FG001|Overall Study|Lost to Follow-up|3|||
127666919|NCT03673098|459401760|FG000|Overall Study|Withdrawal by Subject|6|||
127666920|NCT03673098|459401761|FG001|Overall Study|Withdrawal by Subject|1|||
127666921|NCT03673098|459401760|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
127666922|NCT03673098|459401761|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
127666923|NCT01781611|459401762|FG000|Overall Study|Adverse Event|4|||
127666924|NCT01781611|459401763|FG001|Overall Study|Adverse Event|0|||
127666925|NCT03639675|459401764|FG000|Overall Study|Withdrawal by Subject|1|||
127666926|NCT01477749|459401765|FG000|Overall Study|Physician Decision|4|||
127666927|NCT02118714|459401767|FG000|Overall Study|Lost to Follow-up|2|||
127666928|NCT02118714|459401767|FG000|Overall Study|Protocol Violation|1|||
127666929|NCT01628874|459401769|FG000|Overall Study|Physician Decision|1|||
127666930|NCT01628874|459401770|FG001|Overall Study|Physician Decision|1|||
127666931|NCT01628874|459401769|FG000|Overall Study|Age >4 months|4|||
127666932|NCT01628874|459401770|FG001|Overall Study|Age >4 months|2|||
127666933|NCT01152554|459401771|FG000|Overall Study|Withdrawal by Subject|73|||
127666934|NCT01152554|459401772|FG001|Overall Study|Withdrawal by Subject|28|||
127666935|NCT01152554|459401771|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
127666936|NCT01152554|459401772|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
127666937|NCT01152554|459401771|FG000|Overall Study|Adverse Event|67|||
127666938|NCT01152554|459401772|FG001|Overall Study|Adverse Event|14|||
127666939|NCT01152554|459401771|FG000|Overall Study|Severe non-compliance to protocol|36|||
127666940|NCT01152554|459401772|FG001|Overall Study|Severe non-compliance to protocol|14|||
127666941|NCT01152554|459401771|FG000|Overall Study|Condition under investigation worsened|5|||
127666942|NCT01152554|459401772|FG001|Overall Study|Condition under investigation worsened|2|||
127666943|NCT01152554|459401771|FG000|Overall Study|Lack of Efficacy|20|||
127666944|NCT01152554|459401772|FG001|Overall Study|Lack of Efficacy|3|||
127666945|NCT01152554|459401771|FG000|Overall Study|Study-specific withdrawal criteria|17|||
128001335|NCT00919633|460631341|FG002|Overall Study|Lost to Follow-up|0|||
128001336|NCT00919633|460631342|FG003|Overall Study|Lost to Follow-up|2|||
128001337|NCT00919633|460631339|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
128001338|NCT00919633|460631340|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
128001339|NCT00919633|460631341|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
128001340|NCT00919633|460631342|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
128001341|NCT00919633|460631339|FG000|Overall Study|Protocol Violation|0|||
128001342|NCT00919633|460631340|FG001|Overall Study|Protocol Violation|0|||
128001343|NCT00919633|460631341|FG002|Overall Study|Protocol Violation|0|||
128001344|NCT00919633|460631342|FG003|Overall Study|Protocol Violation|1|||
128001345|NCT00919633|460631339|FG000|Overall Study|Physician Decision|0|||
127666946|NCT01152554|459401772|FG001|Overall Study|Study-specific withdrawal criteria|8|||
127666947|NCT01152554|459401771|FG000|Overall Study|Lost to Follow-up|87|||
127666948|NCT01152554|459401772|FG001|Overall Study|Lost to Follow-up|32|||
127666949|NCT01152554|459401771|FG000|Overall Study|Other|28|||
127666950|NCT01152554|459401772|FG001|Overall Study|Other|8|||
127666951|NCT01152554|459401771|FG000|Overall Study|Death|1|||
127666952|NCT01152554|459401772|FG001|Overall Study|Death|1|||
127666953|NCT02117544|459401773|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
127666954|NCT02117544|459401774|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
127666955|NCT00184028|459401775|FG000|Overall Study|Death|1|||
127666956|NCT00184028|459401775|FG000|Overall Study|Lack of Efficacy|4|||
127666957|NCT00184028|459401775|FG000|Overall Study|Adverse Event|2|||
127666958|NCT00184028|459401775|FG000|Overall Study|Withdrawal by Subject|1|||
127666959|NCT00184028|459401775|FG000|Overall Study|Non-compliance|2|||
127666960|NCT01354938|459401778|FG000|Overall Study|Lost to Follow-up|1|||
127666961|NCT02335268|459401779|FG000|Overall Study|Physician Decision|5|||
127666962|NCT02335268|459401780|FG001|Overall Study|Physician Decision|1|||
127666963|NCT02335268|459401779|FG000|Overall Study|Lack of Efficacy|2|||
127666964|NCT02335268|459401780|FG001|Overall Study|Lack of Efficacy|1|||
127666965|NCT02335268|459401779|FG000|Overall Study|Adverse Event|5|||
127666966|NCT02335268|459401780|FG001|Overall Study|Adverse Event|2|||
127666967|NCT02335268|459401779|FG000|Overall Study|increase blasts|2|||
127666968|NCT02335268|459401780|FG001|Overall Study|increase blasts|0|||
127666969|NCT02335268|459401779|FG000|Overall Study|Withdrawal by Subject|3|||
127666970|NCT02335268|459401780|FG001|Overall Study|Withdrawal by Subject|2|||
127666971|NCT01192295|459401784|FG000|Overall Study|Adverse Event|3|||
127666972|NCT01192295|459401785|FG001|Overall Study|Adverse Event|7|||
127666973|NCT01192295|459401784|FG000|Overall Study|Withdrawal by Subject|3|||
127666974|NCT01192295|459401785|FG001|Overall Study|Withdrawal by Subject|4|||
127666975|NCT01192295|459401784|FG000|Overall Study|Lost to Follow-up|0|||
127666976|NCT01192295|459401785|FG001|Overall Study|Lost to Follow-up|1|||
127666977|NCT01192295|459401784|FG000|Overall Study|Lack of Efficacy|0|||
127666978|NCT01192295|459401785|FG001|Overall Study|Lack of Efficacy|5|||
127666979|NCT01192295|459401784|FG000|Overall Study|Administrative|4|||
127666980|NCT01192295|459401785|FG001|Overall Study|Administrative|6|||
127666981|NCT03785340|459401788|FG000|Overall Study|Lost to Follow-up|2|||
127666982|NCT03785340|459401789|FG001|Overall Study|Lost to Follow-up|0|||
127666983|NCT03785340|459401788|FG000|Overall Study|Adverse Event|1|||
127666984|NCT03785340|459401789|FG001|Overall Study|Adverse Event|0|||
127666985|NCT04320615|459401795|FG000|Overall Study|Withdrawal by Subject|4|||
127666986|NCT04320615|459401796|FG001|Overall Study|Withdrawal by Subject|10|||
127666987|NCT04320615|459401795|FG000|Overall Study|Physician Decision|2|||
127666988|NCT04320615|459401796|FG001|Overall Study|Physician Decision|0|||
127666989|NCT04320615|459401795|FG000|Overall Study|Other|2|||
127666990|NCT04320615|459401796|FG001|Overall Study|Other|0|||
127666991|NCT04320615|459401795|FG000|Overall Study|Lost to Follow-up|5|||
127666992|NCT04320615|459401796|FG001|Overall Study|Lost to Follow-up|23|||
127666993|NCT04320615|459401795|FG000|Overall Study|Death|35|||
127666994|NCT04320615|459401796|FG001|Overall Study|Death|71|||
127666995|NCT01449721|459401797|FG000|Overall Study|Physician Decision|0|||
127666996|NCT01449721|459401798|FG001|Overall Study|Physician Decision|1|||
127666997|NCT01449721|459401797|FG000|Overall Study|Physician Decision|0|||
128001346|NCT00919633|460631340|FG001|Overall Study|Physician Decision|0|||
128001347|NCT00919633|460631341|FG002|Overall Study|Physician Decision|0|||
127666998|NCT01449721|459401798|FG001|Overall Study|Physician Decision|1|||
127666999|NCT00003509|459401799|FG000|Overall Study|Not evaluable|5|||
127667000|NCT03285711|459401800|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
127667001|NCT03285711|459401801|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
127667002|NCT03285711|459401802|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
127667003|NCT03285711|459401803|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
127667004|NCT03285711|459401800|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
127667005|NCT03285711|459401801|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
127667006|NCT03285711|459401802|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
127667007|NCT03285711|459401803|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
127667008|NCT03285711|459401800|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
127667009|NCT03285711|459401801|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
127667010|NCT03285711|459401802|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
127667011|NCT03285711|459401803|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
127667012|NCT03285711|459401800|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
127667013|NCT03285711|459401801|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
127667014|NCT03285711|459401802|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
127667015|NCT03285711|459401803|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
127667016|NCT02431533|459401804|FG000|Overall Study|Withdrawal by Subject|1|||
127667017|NCT02431533|459401805|FG001|Overall Study|Withdrawal by Subject|3|||
127667018|NCT02431533|459401804|FG000|Overall Study|Developed Exclusionary criteria|1|||
127667019|NCT02431533|459401805|FG001|Overall Study|Developed Exclusionary criteria|0|||
127667020|NCT00885495|459401806|FG000|Overall Study|Adverse Event|1|||
127667021|NCT00885495|459401807|FG001|Overall Study|Adverse Event|2|||
127667022|NCT00885495|459401806|FG000|Overall Study|Protocol Violation|0|||
127667023|NCT00885495|459401807|FG001|Overall Study|Protocol Violation|1|||
127667024|NCT00885495|459401806|FG000|Overall Study|Withdrawal by Subject|1|||
127667025|NCT00885495|459401807|FG001|Overall Study|Withdrawal by Subject|0|||
127667026|NCT02107443|459401808|FG000|Overall Study|Death|42|||
127667027|NCT02107443|459401809|FG001|Overall Study|Death|30|||
127667028|NCT02107443|459401808|FG000|Overall Study|Study Protocol Violation|3|||
127667029|NCT02107443|459401809|FG001|Overall Study|Study Protocol Violation|1|||
127667030|NCT02107443|459401808|FG000|Overall Study|Registered but Not Eligible|0|||
127667031|NCT02107443|459401809|FG001|Overall Study|Registered but Not Eligible|1|||
127667032|NCT02107443|459401808|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
127667033|NCT02107443|459401809|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
127667034|NCT02107443|459401808|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
127667035|NCT02107443|459401809|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
127667036|NCT02107443|459401808|FG000|Overall Study|Withdrawal: Changed Mind|2|||
127667037|NCT02107443|459401809|FG001|Overall Study|Withdrawal: Changed Mind|0|||
127667038|NCT02107443|459401808|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
127667039|NCT02107443|459401809|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
127667040|NCT02107443|459401808|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
127667041|NCT02107443|459401809|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
127667042|NCT02107443|459401808|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
127667043|NCT02107443|459401809|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
127667044|NCT02107443|459401808|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
127667045|NCT02107443|459401809|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
127667046|NCT02107443|459401808|FG000|Overall Study|Withdrawal: Other Medical|9|||
127667047|NCT02107443|459401809|FG001|Overall Study|Withdrawal: Other Medical|5|||
127667048|NCT02107443|459401808|FG000|Overall Study|Withdrawal: Disease Progression|4|||
127667049|NCT02107443|459401809|FG001|Overall Study|Withdrawal: Disease Progression|2|||
127667050|NCT02107443|459401808|FG000|Overall Study|Withdrawal: Personal Issues|0|||
127667051|NCT02107443|459401809|FG001|Overall Study|Withdrawal: Personal Issues|3|||
127667052|NCT01400893|459401810|FG000|Overall Study|Death|27|||
127667053|NCT01400893|459401811|FG001|Overall Study|Death|21|||
127667054|NCT01400893|459401810|FG000|Overall Study|Lost to Follow-up|0|||
127667055|NCT01400893|459401811|FG001|Overall Study|Lost to Follow-up|6|||
127667056|NCT01513967|459401821|FG000|Overall Study|Pregnancy|0|||
127667057|NCT01513967|459401822|FG001|Overall Study|Pregnancy|0|||
127667058|NCT01513967|459401823|FG002|Overall Study|Pregnancy|0|||
127667059|NCT01513967|459401824|FG003|Overall Study|Pregnancy|0|||
127667060|NCT01513967|459401825|FG004|Overall Study|Pregnancy|0|||
127667061|NCT01513967|459401826|FG005|Overall Study|Pregnancy|0|||
127667062|NCT01513967|459401827|FG006|Overall Study|Pregnancy|1|||
127667063|NCT01513967|459401828|FG007|Overall Study|Pregnancy|0|||
127667064|NCT01513967|459401821|FG000|Overall Study|missed a study visit|0|||
127667065|NCT01513967|459401822|FG001|Overall Study|missed a study visit|0|||
127667066|NCT01513967|459401823|FG002|Overall Study|missed a study visit|0|||
127667067|NCT01513967|459401824|FG003|Overall Study|missed a study visit|0|||
127667068|NCT01513967|459401825|FG004|Overall Study|missed a study visit|0|||
127667069|NCT01513967|459401826|FG005|Overall Study|missed a study visit|0|||
127667070|NCT01513967|459401827|FG006|Overall Study|missed a study visit|1|||
127667071|NCT01513967|459401828|FG007|Overall Study|missed a study visit|0|||
127667072|NCT01513967|459401821|FG000|Overall Study|excluded due to positive drug screen|0|||
127667073|NCT01513967|459401822|FG001|Overall Study|excluded due to positive drug screen|0|||
127667074|NCT01513967|459401823|FG002|Overall Study|excluded due to positive drug screen|0|||
127667075|NCT01513967|459401824|FG003|Overall Study|excluded due to positive drug screen|0|||
127667076|NCT01513967|459401825|FG004|Overall Study|excluded due to positive drug screen|0|||
127667077|NCT01513967|459401826|FG005|Overall Study|excluded due to positive drug screen|0|||
127667078|NCT01513967|459401827|FG006|Overall Study|excluded due to positive drug screen|0|||
127667079|NCT01513967|459401828|FG007|Overall Study|excluded due to positive drug screen|2|||
127667080|NCT01513967|459401821|FG000|Overall Study|Physician Decision|0|||
127667081|NCT01513967|459401822|FG001|Overall Study|Physician Decision|0|||
127667082|NCT01513967|459401823|FG002|Overall Study|Physician Decision|0|||
127667083|NCT01513967|459401824|FG003|Overall Study|Physician Decision|0|||
127667084|NCT01513967|459401825|FG004|Overall Study|Physician Decision|0|||
127667085|NCT01513967|459401826|FG005|Overall Study|Physician Decision|1|||
127667086|NCT01513967|459401827|FG006|Overall Study|Physician Decision|0|||
127667087|NCT01513967|459401828|FG007|Overall Study|Physician Decision|0|||
127667088|NCT02711826|459401829|FG000|Overall Study|Physician Decision|0|||
127667089|NCT02711826|459401830|FG001|Overall Study|Physician Decision|0|||
127667090|NCT02711826|459401831|FG002|Overall Study|Physician Decision|0|||
127667091|NCT02711826|459401832|FG003|Overall Study|Physician Decision|1|||
127667092|NCT02711826|459401833|FG004|Overall Study|Physician Decision|0|||
127667093|NCT02711826|459401829|FG000|Overall Study|Withdrawal by Subject|0|||
127667094|NCT02711826|459401830|FG001|Overall Study|Withdrawal by Subject|1|||
127667095|NCT02711826|459401831|FG002|Overall Study|Withdrawal by Subject|0|||
127667096|NCT02711826|459401832|FG003|Overall Study|Withdrawal by Subject|4|||
127667097|NCT02711826|459401833|FG004|Overall Study|Withdrawal by Subject|0|||
127667098|NCT02711826|459401829|FG000|Overall Study|Failure to manufacture cellular product|0|||
127667099|NCT02711826|459401830|FG001|Overall Study|Failure to manufacture cellular product|0|||
127667100|NCT02711826|459401831|FG002|Overall Study|Failure to manufacture cellular product|5|||
127667101|NCT02711826|459401832|FG003|Overall Study|Failure to manufacture cellular product|0|||
127667102|NCT02711826|459401833|FG004|Overall Study|Failure to manufacture cellular product|0|||
127667103|NCT02711826|459401829|FG000|Overall Study|Infusion canceled for active infection|0|||
127667104|NCT02711826|459401830|FG001|Overall Study|Infusion canceled for active infection|1|||
127667105|NCT02711826|459401831|FG002|Overall Study|Infusion canceled for active infection|0|||
127667106|NCT02711826|459401832|FG003|Overall Study|Infusion canceled for active infection|0|||
127667107|NCT02711826|459401833|FG004|Overall Study|Infusion canceled for active infection|0|||
127667108|NCT02711826|459401829|FG000|Overall Study|Screen failures|0|||
127667109|NCT02711826|459401830|FG001|Overall Study|Screen failures|0|||
127667110|NCT02711826|459401831|FG002|Overall Study|Screen failures|0|||
127667111|NCT02711826|459401832|FG003|Overall Study|Screen failures|4|||
127667112|NCT02711826|459401833|FG004|Overall Study|Screen failures|0|||
127667113|NCT02906202|459401834|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
127667114|NCT01960790|459401835|FG000|Overall Study|Survey forms could not be recovered|3|||
127667115|NCT01960790|459401835|FG000|Overall Study|Treat with Humira outside survey period|3|||
127667116|NCT01960790|459401835|FG000|Overall Study|Transferred to another hospital|4|||
127667117|NCT01960790|459401835|FG000|Overall Study|Unevaluable for safety|1|||
127667118|NCT01563978|459401841|FG000|Overall Study|Physician Decision|1|||
127667119|NCT01563978|459401842|FG001|Overall Study|Physician Decision|0|||
127667120|NCT01563978|459401841|FG000|Overall Study|Lost to Follow-up|1|||
127667121|NCT01563978|459401842|FG001|Overall Study|Lost to Follow-up|0|||
127667122|NCT01563978|459401841|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
127667123|NCT01563978|459401842|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
127667124|NCT01563978|459401841|FG000|Overall Study|Adverse Event|1|||
127667125|NCT01563978|459401842|FG001|Overall Study|Adverse Event|2|||
127667126|NCT00729690|459401843|FG000|Overall Study|IT Catheter Malfunction|0|||
127667127|NCT00729690|459401844|FG001|Overall Study|IT Catheter Malfunction|2|||
127667128|NCT00729690|459401845|FG002|Overall Study|IT Catheter Malfunction|2|||
127667129|NCT02169219|459401848|FG000|Overall Study|Lack of Efficacy|6|||
127667130|NCT02886936|459401855|FG000|Overall Study|Lost to Follow-up|4|||
127667131|NCT02886936|459401856|FG001|Overall Study|Lost to Follow-up|3|||
127667132|NCT02886936|459401857|FG002|Overall Study|Lost to Follow-up|0|||
127667133|NCT02320721|459401858|FG000|Overall Study|Adverse Event|6|||
127667134|NCT02320721|459401859|FG001|Overall Study|Adverse Event|6|||
127667135|NCT02320721|459401858|FG000|Overall Study|Lack of Efficacy|2|||
127667136|NCT02320721|459401859|FG001|Overall Study|Lack of Efficacy|0|||
127667137|NCT02320721|459401858|FG000|Overall Study|Poor compliance to protocol|3|||
127667138|NCT02320721|459401859|FG001|Overall Study|Poor compliance to protocol|7|||
127667139|NCT02320721|459401858|FG000|Overall Study|Randomized but not treated|0|||
127667140|NCT02320721|459401859|FG001|Overall Study|Randomized but not treated|1|||
127667141|NCT02320721|459401858|FG000|Overall Study|Hypoglycemia|1|||
127667142|NCT02320721|459401859|FG001|Overall Study|Hypoglycemia|0|||
127667143|NCT02320721|459401858|FG000|Overall Study|Other than specified above|15|||
127667144|NCT02320721|459401859|FG001|Overall Study|Other than specified above|20|||
127667145|NCT00847301|459401860|FG000|Overall Study|Adverse Event|35|||
127667146|NCT00847301|459401860|FG000|Overall Study|Switch to other anticoagulants|16|||
127667147|NCT00847301|459401860|FG000|Overall Study|Lost to Follow-up|1|||
127667148|NCT00847301|459401860|FG000|Overall Study|No prescription after hospital discharge|1|||
127667149|NCT00847301|459401860|FG000|Overall Study|Other reason not defined above|1|||
127667150|NCT04248465|459401864|FG000|Randomized-Controlled Period|Death|12|||
127667151|NCT04248465|459401865|FG001|Randomized-Controlled Period|Death|5|||
127667152|NCT04248465|459401864|FG000|Randomized-Controlled Period|Adverse Event|2|||
127667153|NCT04248465|459401865|FG001|Randomized-Controlled Period|Adverse Event|0|||
127667154|NCT04248465|459401864|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
127667155|NCT04248465|459401865|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
127667156|NCT04248465|459401864|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
127667157|NCT04248465|459401865|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
127667158|NCT04248465|459401864|FG000|Randomized-Controlled Period|Physician Decision|1|||
127667159|NCT04248465|459401865|FG001|Randomized-Controlled Period|Physician Decision|1|||
127667160|NCT04248465|459401864|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
127667161|NCT04248465|459401865|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
127667162|NCT04248465|459401864|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
127667163|NCT04248465|459401865|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
127667164|NCT04248465|459401864|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
127667165|NCT04248465|459401865|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
127667166|NCT03621982|459401866|FG000|Overall Study|Withdrawal by Subject|1|||
127667167|NCT03621982|459401867|FG001|Overall Study|Withdrawal by Subject|0|||
127667168|NCT03621982|459401868|FG002|Overall Study|Withdrawal by Subject|0|||
127667169|NCT03621982|459401869|FG003|Overall Study|Withdrawal by Subject|1|||
127667170|NCT03621982|459401870|FG004|Overall Study|Withdrawal by Subject|0|||
127667171|NCT03621982|459401871|FG005|Overall Study|Withdrawal by Subject|1|||
127667172|NCT03621982|459401872|FG006|Overall Study|Withdrawal by Subject|1|||
127667173|NCT03621982|459401873|FG007|Overall Study|Withdrawal by Subject|0|||
127667174|NCT03621982|459401874|FG008|Overall Study|Withdrawal by Subject|1|||
127667175|NCT03621982|459401875|FG009|Overall Study|Withdrawal by Subject|0|||
127667176|NCT03621982|459401876|FG010|Overall Study|Withdrawal by Subject|2|||
127667177|NCT03621982|459401877|FG011|Overall Study|Withdrawal by Subject|1|||
127667178|NCT03621982|459401878|FG012|Overall Study|Withdrawal by Subject|2|||
127667179|NCT03621982|459401879|FG013|Overall Study|Withdrawal by Subject|2|||
127667180|NCT03621982|459401866|FG000|Overall Study|Investigator/Sponsor decision|0|||
127667181|NCT03621982|459401867|FG001|Overall Study|Investigator/Sponsor decision|0|||
127667182|NCT03621982|459401868|FG002|Overall Study|Investigator/Sponsor decision|0|||
127667183|NCT03621982|459401869|FG003|Overall Study|Investigator/Sponsor decision|0|||
127667184|NCT03621982|459401870|FG004|Overall Study|Investigator/Sponsor decision|0|||
127667185|NCT03621982|459401871|FG005|Overall Study|Investigator/Sponsor decision|0|||
127667186|NCT03621982|459401872|FG006|Overall Study|Investigator/Sponsor decision|0|||
127667187|NCT03621982|459401873|FG007|Overall Study|Investigator/Sponsor decision|0|||
127667188|NCT03621982|459401874|FG008|Overall Study|Investigator/Sponsor decision|0|||
127667189|NCT03621982|459401875|FG009|Overall Study|Investigator/Sponsor decision|0|||
127667190|NCT03621982|459401876|FG010|Overall Study|Investigator/Sponsor decision|0|||
127667191|NCT03621982|459401877|FG011|Overall Study|Investigator/Sponsor decision|4|||
127667192|NCT03621982|459401878|FG012|Overall Study|Investigator/Sponsor decision|0|||
127667193|NCT03621982|459401879|FG013|Overall Study|Investigator/Sponsor decision|2|||
127667194|NCT03621982|459401866|FG000|Overall Study|Death|2|||
127667195|NCT03621982|459401867|FG001|Overall Study|Death|4|||
127667196|NCT03621982|459401868|FG002|Overall Study|Death|4|||
127667197|NCT03621982|459401869|FG003|Overall Study|Death|3|||
127667198|NCT03621982|459401870|FG004|Overall Study|Death|8|||
127667199|NCT03621982|459401871|FG005|Overall Study|Death|4|||
127667200|NCT03621982|459401872|FG006|Overall Study|Death|6|||
127667201|NCT03621982|459401873|FG007|Overall Study|Death|3|||
127667202|NCT03621982|459401874|FG008|Overall Study|Death|0|||
127667203|NCT03621982|459401875|FG009|Overall Study|Death|3|||
127667204|NCT03621982|459401876|FG010|Overall Study|Death|8|||
127667205|NCT03621982|459401877|FG011|Overall Study|Death|4|||
127667206|NCT03621982|459401878|FG012|Overall Study|Death|2|||
127667207|NCT03621982|459401879|FG013|Overall Study|Death|2|||
127667208|NCT03621982|459401866|FG000|Overall Study|Lost to Follow-up|0|||
127667209|NCT03621982|459401867|FG001|Overall Study|Lost to Follow-up|0|||
127667210|NCT03621982|459401868|FG002|Overall Study|Lost to Follow-up|1|||
127667211|NCT03621982|459401869|FG003|Overall Study|Lost to Follow-up|0|||
127667212|NCT03621982|459401870|FG004|Overall Study|Lost to Follow-up|0|||
127667213|NCT03621982|459401871|FG005|Overall Study|Lost to Follow-up|0|||
127667214|NCT03621982|459401872|FG006|Overall Study|Lost to Follow-up|1|||
127667215|NCT03621982|459401873|FG007|Overall Study|Lost to Follow-up|0|||
127667216|NCT03621982|459401874|FG008|Overall Study|Lost to Follow-up|0|||
127667217|NCT03621982|459401875|FG009|Overall Study|Lost to Follow-up|1|||
127667218|NCT03621982|459401876|FG010|Overall Study|Lost to Follow-up|0|||
127667219|NCT03621982|459401877|FG011|Overall Study|Lost to Follow-up|0|||
127667220|NCT03621982|459401878|FG012|Overall Study|Lost to Follow-up|0|||
127667221|NCT03621982|459401879|FG013|Overall Study|Lost to Follow-up|0|||
127667222|NCT00442286|459401880|FG000|Overall Study|Death|2|||
127667223|NCT00442286|459401881|FG001|Overall Study|Death|2|||
127667224|NCT00442286|459401880|FG000|Overall Study|Lost to Follow-up|1|||
127667225|NCT00442286|459401881|FG001|Overall Study|Lost to Follow-up|0|||
127667226|NCT00442286|459401880|FG000|Overall Study|Withdrawal by Subject|2|||
127667227|NCT00442286|459401881|FG001|Overall Study|Withdrawal by Subject|0|||
127667228|NCT00442286|459401880|FG000|Overall Study|System explanted|1|||
127667229|NCT00442286|459401881|FG001|Overall Study|System explanted|0|||
127667230|NCT00442286|459401880|FG000|Overall Study|Patient Injury|1|||
127667231|NCT00442286|459401881|FG001|Overall Study|Patient Injury|0|||
127667232|NCT01544582|459401884|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
127667233|NCT01544582|459401885|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
127667234|NCT01544582|459401886|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
127667235|NCT01544582|459401887|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
127667236|NCT01544582|459401884|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
128001348|NCT00919633|460631342|FG003|Overall Study|Physician Decision|1|||
128001349|NCT00919633|460631339|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
128001350|NCT00919633|460631340|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
127667237|NCT01544582|459401885|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
127667238|NCT01544582|459401886|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
127667239|NCT01544582|459401887|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
127667240|NCT01544582|459401884|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
127667241|NCT01544582|459401885|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
127667242|NCT01544582|459401886|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
127667243|NCT01544582|459401887|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
127667244|NCT01544582|459401884|FG000|Analysis Population|Physician Decision|0|||
127667245|NCT01544582|459401885|FG001|Analysis Population|Physician Decision|13|||
127667246|NCT01544582|459401886|FG002|Analysis Population|Physician Decision|10|||
127667247|NCT01544582|459401887|FG003|Analysis Population|Physician Decision|9|||
127667248|NCT01544582|459401884|FG000|Analysis Population|Safety Reason|0|||
127667249|NCT01544582|459401885|FG001|Analysis Population|Safety Reason|33|||
127667250|NCT01544582|459401886|FG002|Analysis Population|Safety Reason|31|||
127667251|NCT01544582|459401887|FG003|Analysis Population|Safety Reason|8|||
127667252|NCT01544582|459401884|FG000|Analysis Population|Effectiveness Reason|0|||
127667253|NCT01544582|459401885|FG001|Analysis Population|Effectiveness Reason|48|||
127667254|NCT01544582|459401886|FG002|Analysis Population|Effectiveness Reason|29|||
127667255|NCT01544582|459401887|FG003|Analysis Population|Effectiveness Reason|12|||
127667256|NCT01544582|459401884|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
127667257|NCT01544582|459401885|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
127667258|NCT01544582|459401886|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
127667259|NCT01544582|459401887|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
127667260|NCT01544582|459401884|FG000|Analysis Population|Lost to Follow-up|0|||
127667261|NCT01544582|459401885|FG001|Analysis Population|Lost to Follow-up|6|||
127667262|NCT01544582|459401886|FG002|Analysis Population|Lost to Follow-up|6|||
127667263|NCT01544582|459401887|FG003|Analysis Population|Lost to Follow-up|5|||
127667264|NCT01544582|459401884|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
127667265|NCT01544582|459401885|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
127667266|NCT01544582|459401886|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
127667267|NCT01544582|459401887|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
127667268|NCT01544582|459401884|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
127667269|NCT01544582|459401885|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
127667270|NCT01544582|459401886|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
127667271|NCT01544582|459401887|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
127667272|NCT01544582|459401884|FG000|Analysis Population|Intolerance|0|||
127667273|NCT01544582|459401885|FG001|Analysis Population|Intolerance|1|||
127667274|NCT01544582|459401886|FG002|Analysis Population|Intolerance|0|||
127667275|NCT01544582|459401887|FG003|Analysis Population|Intolerance|0|||
127667276|NCT01544582|459401884|FG000|Analysis Population|Liver Transplantation|0|||
127667277|NCT01544582|459401885|FG001|Analysis Population|Liver Transplantation|0|||
127667278|NCT01544582|459401886|FG002|Analysis Population|Liver Transplantation|1|||
127667279|NCT01544582|459401887|FG003|Analysis Population|Liver Transplantation|0|||
127667280|NCT01544582|459401884|FG000|Analysis Population|No Social Insurance|0|||
127667281|NCT01544582|459401885|FG001|Analysis Population|No Social Insurance|0|||
127667282|NCT01544582|459401886|FG002|Analysis Population|No Social Insurance|1|||
127667283|NCT01544582|459401887|FG003|Analysis Population|No Social Insurance|0|||
127667284|NCT01544582|459401884|FG000|Analysis Population|Poor Adherence|0|||
127667285|NCT01544582|459401885|FG001|Analysis Population|Poor Adherence|0|||
127667286|NCT01544582|459401886|FG002|Analysis Population|Poor Adherence|1|||
127667287|NCT01544582|459401887|FG003|Analysis Population|Poor Adherence|0|||
127667288|NCT01544582|459401884|FG000|Analysis Population|Poor Participant Compliance|0|||
127667289|NCT01544582|459401885|FG001|Analysis Population|Poor Participant Compliance|1|||
127667290|NCT01544582|459401886|FG002|Analysis Population|Poor Participant Compliance|0|||
127667291|NCT01544582|459401887|FG003|Analysis Population|Poor Participant Compliance|0|||
127667292|NCT01544582|459401884|FG000|Analysis Population|Programmed Surgery|0|||
127667293|NCT01544582|459401885|FG001|Analysis Population|Programmed Surgery|1|||
127667294|NCT01544582|459401886|FG002|Analysis Population|Programmed Surgery|0|||
127667295|NCT01544582|459401887|FG003|Analysis Population|Programmed Surgery|0|||
127667296|NCT01544582|459401884|FG000|Analysis Population|Participant in Jail|0|||
127667297|NCT01544582|459401885|FG001|Analysis Population|Participant in Jail|0|||
127667298|NCT01544582|459401886|FG002|Analysis Population|Participant in Jail|1|||
127667299|NCT01544582|459401887|FG003|Analysis Population|Participant in Jail|0|||
127667300|NCT03428815|459401888|FG000|Overall Study|Lost to Follow-up|2|||
127667301|NCT03428815|459401889|FG001|Overall Study|Lost to Follow-up|2|||
127667302|NCT03428815|459401888|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
127667303|NCT03428815|459401889|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
127667304|NCT03428815|459401888|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
128001351|NCT00919633|460631341|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
127667305|NCT03428815|459401889|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
127667306|NCT00245011|459401896|FG000|Overall Study|Lack of Efficacy|1|||
127667307|NCT03317379|459401899|FG000|Overall Study|Lost to Follow-up|0|||
127667308|NCT03317379|459401900|FG001|Overall Study|Lost to Follow-up|3|||
127667309|NCT03317379|459401901|FG002|Overall Study|Lost to Follow-up|2|||
127667310|NCT01354106|459401906|FG000|Overall Study|Withdrawal by Subject|2|||
127667311|NCT00731042|459403554|FG000|Second Intervention|Did not meet inclusion criteria|0|||
127667312|NCT00731042|459403555|FG001|Second Intervention|Did not meet inclusion criteria|2|||
127667313|NCT02692235|459403556|FG000|Overall Study|Withdrawal by Subject|2|||
127667314|NCT02692235|459403557|FG001|Overall Study|Withdrawal by Subject|1|||
127667315|NCT02692235|459403556|FG000|Overall Study|Adverse Event|1|||
127667316|NCT02692235|459403557|FG001|Overall Study|Adverse Event|2|||
127667317|NCT00802841|459403558|FG000|Overall Study|Administrative problems|1|||
127667318|NCT00802841|459403559|FG001|Overall Study|Administrative problems|0|||
127667319|NCT00802841|459403558|FG000|Overall Study|Lost to Follow-up|2|||
127667320|NCT00802841|459403559|FG001|Overall Study|Lost to Follow-up|1|||
127667321|NCT00802841|459403558|FG000|Overall Study|Death|1|||
127667322|NCT00802841|459403559|FG001|Overall Study|Death|2|||
127667323|NCT00802841|459403558|FG000|Overall Study|Adverse Event|8|||
127667324|NCT00802841|459403559|FG001|Overall Study|Adverse Event|2|||
127667325|NCT00802841|459403558|FG000|Overall Study|Disease progression|7|||
127667326|NCT00802841|459403559|FG001|Overall Study|Disease progression|3|||
127667327|NCT00802841|459403558|FG000|Overall Study|Withdrawal by Subject|9|||
127667328|NCT00802841|459403559|FG001|Overall Study|Withdrawal by Subject|5|||
127667329|NCT00802841|459403558|FG000|Overall Study|Protocol deviation|2|||
127667330|NCT00802841|459403559|FG001|Overall Study|Protocol deviation|6|||
127667331|NCT00802841|459403558|FG000|Overall Study|Treatment duration completed|66|||
127667332|NCT00802841|459403559|FG001|Overall Study|Treatment duration completed|76|||
127667333|NCT02711995|459403562|FG000|Washout (90 Days)|Conflicting medication|1|||
128001352|NCT00919633|460631342|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
127667334|NCT03531905|459403567|FG000|Overall Study|Withdrawal by Subject|3|||
128001353|NCT00919633|460631339|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
128001354|NCT00919633|460631340|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
128001355|NCT00919633|460631341|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
128001356|NCT00919633|460631342|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
128001357|NCT01121263|460631343|FG000|Overall Study|Death|3|||
128001358|NCT01121263|460631344|FG001|Overall Study|Death|2|||
128001359|NCT01121263|460631343|FG000|Overall Study|Lost to Follow-up|22|||
128001360|NCT01121263|460631344|FG001|Overall Study|Lost to Follow-up|12|||
127667335|NCT03531905|459403568|FG001|Overall Study|Withdrawal by Subject|3|||
127667336|NCT03531905|459403569|FG002|Overall Study|Withdrawal by Subject|2|||
127667337|NCT03531905|459403567|FG000|Overall Study|Lost to Follow-up|2|||
127667338|NCT03531905|459403568|FG001|Overall Study|Lost to Follow-up|2|||
127667339|NCT03531905|459403569|FG002|Overall Study|Lost to Follow-up|1|||
127667340|NCT03531905|459403567|FG000|Overall Study|Participant was out of town|1|||
127667341|NCT03531905|459403568|FG001|Overall Study|Participant was out of town|0|||
127667342|NCT03531905|459403569|FG002|Overall Study|Participant was out of town|0|||
127667343|NCT03531905|459403567|FG000|Overall Study|Could not speak with the participant|1|||
127667344|NCT03531905|459403568|FG001|Overall Study|Could not speak with the participant|0|||
127667345|NCT03531905|459403569|FG002|Overall Study|Could not speak with the participant|0|||
127667346|NCT01536262|459403577|FG000|Overall Study|Adverse Event|6|||
127667347|NCT01536262|459403578|FG001|Overall Study|Adverse Event|1|||
127667348|NCT01536262|459403579|FG002|Overall Study|Adverse Event|2|||
127667349|NCT01536262|459403577|FG000|Overall Study|Withdrawal by Subject|1|||
127667350|NCT01536262|459403578|FG001|Overall Study|Withdrawal by Subject|1|||
127667351|NCT01536262|459403579|FG002|Overall Study|Withdrawal by Subject|0|||
127667352|NCT01536262|459403577|FG000|Overall Study|Other than stated above|1|||
127667353|NCT01536262|459403578|FG001|Overall Study|Other than stated above|0|||
127667354|NCT01536262|459403579|FG002|Overall Study|Other than stated above|0|||
127667355|NCT02485353|459403583|FG000|Overall Study|Death|1|||
127667356|NCT02485353|459403583|FG000|Overall Study|Disease Progression|1|||
127667357|NCT01021332|459403584|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
127667358|NCT01021332|459403584|FG000|Overall Study|Adverse Event|43|||
127667359|NCT01021332|459403584|FG000|Overall Study|Lack of Efficacy|19|||
127667360|NCT01021332|459403584|FG000|Overall Study|Withdrawal of Consent|23|||
127667361|NCT01021332|459403584|FG000|Overall Study|Lost to Follow-up|4|||
127667362|NCT01021332|459403584|FG000|Overall Study|Protocol Violation|9|||
127667363|NCT01021332|459403584|FG000|Overall Study|Miscellaneous|3|||
128001361|NCT01121263|460631343|FG000|Overall Study|Withdrawal by Subject|0|||
128001362|NCT01121263|460631344|FG001|Overall Study|Withdrawal by Subject|1|||
128001363|NCT03810456|460631345|FG000|Treatment|Urgent Family Matters|3|||
127667364|NCT03487666|459403585|FG000|Overall Study|Disease progression|4|||
127667365|NCT03487666|459403586|FG001|Overall Study|Disease progression|2|||
127667366|NCT03487666|459403587|FG002|Overall Study|Disease progression|0|||
127667367|NCT03487666|459403585|FG000|Overall Study|Adverse Event|0|||
128001364|NCT03810456|460631346|FG001|Treatment|Urgent Family Matters|0|||
127667368|NCT03487666|459403586|FG001|Overall Study|Adverse Event|0|||
127667369|NCT03487666|459403587|FG002|Overall Study|Adverse Event|1|||
127667370|NCT02748512|459403592|FG000|Overall Study|Lost to Follow-up|1|||
127667371|NCT02748512|459403593|FG001|Overall Study|Lost to Follow-up|1|||
127667372|NCT02264574|459403595|FG000|Overall Study|Death|21|||
127667373|NCT02264574|459403596|FG001|Overall Study|Death|21|||
127667374|NCT02264574|459403595|FG000|Overall Study|Withdrawal by Subject|8|||
127667375|NCT02264574|459403596|FG001|Overall Study|Withdrawal by Subject|6|||
127667376|NCT02264574|459403595|FG000|Overall Study|Other, Not Specified|0|||
127667377|NCT02264574|459403596|FG001|Overall Study|Other, Not Specified|3|||
127667378|NCT02886728|459403597|FG000|Overall Study|Withdrew Consent|31|||
127667379|NCT02886728|459403598|FG001|Overall Study|Withdrew Consent|13|||
127667380|NCT02886728|459403599|FG002|Overall Study|Withdrew Consent|11|||
127667381|NCT02886728|459403600|FG003|Overall Study|Withdrew Consent|47|||
127667382|NCT02886728|459403597|FG000|Overall Study|Lost to Follow-up|12|||
127667383|NCT02886728|459403598|FG001|Overall Study|Lost to Follow-up|6|||
127667384|NCT02886728|459403599|FG002|Overall Study|Lost to Follow-up|13|||
127667385|NCT02886728|459403600|FG003|Overall Study|Lost to Follow-up|12|||
127667386|NCT02886728|459403597|FG000|Overall Study|Adverse Event|13|||
127667387|NCT02886728|459403598|FG001|Overall Study|Adverse Event|5|||
127667388|NCT02886728|459403599|FG002|Overall Study|Adverse Event|5|||
127667389|NCT02886728|459403600|FG003|Overall Study|Adverse Event|11|||
127667390|NCT02886728|459403597|FG000|Overall Study|Investigator's Discretion|11|||
127667391|NCT02886728|459403598|FG001|Overall Study|Investigator's Discretion|7|||
127667392|NCT02886728|459403599|FG002|Overall Study|Investigator's Discretion|5|||
127667393|NCT02886728|459403600|FG003|Overall Study|Investigator's Discretion|11|||
127667394|NCT02886728|459403597|FG000|Overall Study|Death|3|||
127667395|NCT02886728|459403598|FG001|Overall Study|Death|1|||
127667396|NCT02886728|459403599|FG002|Overall Study|Death|0|||
127667397|NCT02886728|459403600|FG003|Overall Study|Death|0|||
127667398|NCT02886728|459403597|FG000|Overall Study|Protocol Violation|0|||
127667399|NCT02886728|459403598|FG001|Overall Study|Protocol Violation|0|||
127667400|NCT02886728|459403599|FG002|Overall Study|Protocol Violation|0|||
127667401|NCT02886728|459403600|FG003|Overall Study|Protocol Violation|4|||
127667402|NCT02886728|459403597|FG000|Overall Study|Non-Compliance with Study Drug|1|||
127667403|NCT02886728|459403598|FG001|Overall Study|Non-Compliance with Study Drug|0|||
127667404|NCT02886728|459403599|FG002|Overall Study|Non-Compliance with Study Drug|1|||
127667405|NCT02886728|459403600|FG003|Overall Study|Non-Compliance with Study Drug|0|||
127667406|NCT02886728|459403597|FG000|Overall Study|Pregnancy|0|||
127667407|NCT02886728|459403598|FG001|Overall Study|Pregnancy|0|||
127667408|NCT02886728|459403599|FG002|Overall Study|Pregnancy|1|||
127667409|NCT02886728|459403600|FG003|Overall Study|Pregnancy|0|||
127667410|NCT02886728|459403597|FG000|Overall Study|Randomized but Not Dosed|1|||
127667411|NCT02886728|459403598|FG001|Overall Study|Randomized but Not Dosed|0|||
127667412|NCT02886728|459403599|FG002|Overall Study|Randomized but Not Dosed|0|||
127667413|NCT02886728|459403600|FG003|Overall Study|Randomized but Not Dosed|2|||
127667414|NCT04990440|459403603|FG000|Overall Study|Sponsor's Decision|0|||
127667415|NCT04990440|459403604|FG001|Overall Study|Sponsor's Decision|0|||
128001365|NCT03810456|460631347|FG002|Treatment|Urgent Family Matters|0|||
128001366|NCT03810456|460631345|FG000|Treatment|Scheduling Conflicts|0|||
128001367|NCT03810456|460631346|FG001|Treatment|Scheduling Conflicts|11|||
128001368|NCT03810456|460631347|FG002|Treatment|Scheduling Conflicts|0|||
128001369|NCT03810456|460631345|FG000|Treatment|No Longer Interested|0|||
128001370|NCT03810456|460631346|FG001|Treatment|No Longer Interested|12|||
128001371|NCT03810456|460631347|FG002|Treatment|No Longer Interested|0|||
128001372|NCT03810456|460631345|FG000|Treatment|Transportation Issues|0|||
128001373|NCT03810456|460631346|FG001|Treatment|Transportation Issues|1|||
128001374|NCT03810456|460631347|FG002|Treatment|Transportation Issues|0|||
128001375|NCT03810456|460631345|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
128001376|NCT03810456|460631346|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
128001377|NCT03810456|460631347|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
128001378|NCT03810456|460631345|FG000|1 Month Follow-Up|Relocated to Different State|1|||
128001379|NCT03810456|460631346|FG001|1 Month Follow-Up|Relocated to Different State|0|||
128001380|NCT03810456|460631347|FG002|1 Month Follow-Up|Relocated to Different State|1|||
128001381|NCT03810456|460631345|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
128001382|NCT03810456|460631346|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
127667416|NCT04990440|459403605|FG002|Overall Study|Sponsor's Decision|1|||
128001383|NCT03810456|460631347|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
127667417|NCT00724061|459403608|FG000|Dose Escalation Phase|Adverse Event|2|||
127667418|NCT00724061|459403608|FG000|Dose Escalation Phase|Disease Progression|3|||
127667419|NCT00688259|459403612|FG000|Overall Study|Lost to Follow-up|2|||
127667420|NCT00688259|459403613|FG001|Overall Study|Lost to Follow-up|4|||
128001384|NCT03810456|460631345|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
128001385|NCT03810456|460631346|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
127667421|NCT00688259|459403612|FG000|Overall Study|Physician Decision|1|||
127667422|NCT00688259|459403613|FG001|Overall Study|Physician Decision|0|||
127667423|NCT00688259|459403612|FG000|Overall Study|Withdrawal by Subject|2|||
127667424|NCT00688259|459403613|FG001|Overall Study|Withdrawal by Subject|0|||
128001386|NCT03810456|460631347|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
128001387|NCT03810456|460631345|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
128001388|NCT03810456|460631346|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
128001389|NCT03810456|460631347|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
128001390|NCT03810456|460631345|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
128001391|NCT03810456|460631346|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
128001392|NCT03810456|460631347|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
128001393|NCT03810456|460631345|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
128001394|NCT03810456|460631346|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
128001395|NCT03810456|460631347|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
128001396|NCT02007720|460631348|FG000|Overall Study|Withdrawal by Subject|9|||
128001397|NCT02007720|460631349|FG001|Overall Study|Withdrawal by Subject|11|||
128001398|NCT02007720|460631348|FG000|Overall Study|study terminated by sponsor|58|||
128001399|NCT02007720|460631349|FG001|Overall Study|study terminated by sponsor|54|||
128001400|NCT02007720|460631348|FG000|Overall Study|technical problem|4|||
128001401|NCT02007720|460631349|FG001|Overall Study|technical problem|2|||
127667425|NCT00688259|459403612|FG000|Overall Study|Declined Interview|2|||
127667426|NCT00688259|459403613|FG001|Overall Study|Declined Interview|3|||
127667427|NCT00688259|459403612|FG000|Overall Study|Hospitalized at Follow-up|0|||
127667428|NCT00688259|459403613|FG001|Overall Study|Hospitalized at Follow-up|1|||
127667429|NCT01310868|459403614|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
127667430|NCT02411591|459403615|FG000|Overall Study|Adverse Event|0|||
127667431|NCT02411591|459403616|FG001|Overall Study|Adverse Event|4|||
127667432|NCT02411591|459403617|FG002|Overall Study|Adverse Event|2|||
127667433|NCT02411591|459403615|FG000|Overall Study|Withdrawal by Subject|0|||
127667434|NCT02411591|459403616|FG001|Overall Study|Withdrawal by Subject|3|||
127667435|NCT02411591|459403617|FG002|Overall Study|Withdrawal by Subject|0|||
127667436|NCT02411591|459403615|FG000|Overall Study|Physician Decision|0|||
127667437|NCT02411591|459403616|FG001|Overall Study|Physician Decision|3|||
127667438|NCT02411591|459403617|FG002|Overall Study|Physician Decision|1|||
127667439|NCT02954575|459403618|FG000|Overall Study|Withdrawal by Subject|2|||
127667440|NCT02954575|459403618|FG000|Overall Study|Adverse Event|1|||
127667441|NCT02491892|459403620|FG000|Overall Study|Adverse Event|1|||
127667442|NCT02491892|459403621|FG001|Overall Study|Adverse Event|1|||
127667443|NCT02491892|459403620|FG000|Overall Study|Death|1|||
127667444|NCT02491892|459403621|FG001|Overall Study|Death|1|||
127667445|NCT02491892|459403620|FG000|Overall Study|Lack of Efficacy|37|||
127667446|NCT02491892|459403621|FG001|Overall Study|Lack of Efficacy|36|||
127667447|NCT02491892|459403620|FG000|Overall Study|Refused Treatment|1|||
127667448|NCT02491892|459403621|FG001|Overall Study|Refused Treatment|0|||
127667449|NCT02491892|459403620|FG000|Overall Study|Lost to Follow-up|1|||
127667450|NCT02491892|459403621|FG001|Overall Study|Lost to Follow-up|0|||
127667451|NCT04227340|459403622|FG000|Overall Study|Withdrawal by Subject|3|||
127667452|NCT01066156|459403623|FG000|Overall Study|ineligible|2|||
127667453|NCT01066156|459403623|FG000|Overall Study|Lost to Follow-up|7|||
127667454|NCT01066156|459403623|FG000|Overall Study|Withdrawal by Subject|1|||
127667455|NCT00661258|459403633|FG000|Overall Study|Death|1|||
127667456|NCT00661258|459403634|FG001|Overall Study|Death|0|||
127667457|NCT00661258|459403633|FG000|Overall Study|caught by police and in detox center|2|||
127667458|NCT00661258|459403634|FG001|Overall Study|caught by police and in detox center|1|||
127667459|NCT03890120|459403635|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
127667460|NCT03890120|459403636|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
127667461|NCT03890120|459403637|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
127667462|NCT03890120|459403638|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
127667463|NCT03890120|459403635|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
128001402|NCT02007720|460631348|FG000|Overall Study|patient followd less than 165 days|11|||
128001403|NCT02007720|460631349|FG001|Overall Study|patient followd less than 165 days|5|||
128001404|NCT01386606|460633353|FG000|Overall Study|Adverse Event|0|||
128001405|NCT01386606|460633354|FG001|Overall Study|Adverse Event|1|||
128001406|NCT01386606|460633355|FG002|Overall Study|Adverse Event|0|||
128001407|NCT01386606|460633356|FG003|Overall Study|Adverse Event|0|||
128001408|NCT01386606|460633353|FG000|Overall Study|Withdrawal by Subject|0|||
128001409|NCT01386606|460633354|FG001|Overall Study|Withdrawal by Subject|1|||
128001410|NCT01386606|460633355|FG002|Overall Study|Withdrawal by Subject|1|||
128001411|NCT01386606|460633356|FG003|Overall Study|Withdrawal by Subject|0|||
127667464|NCT03890120|459403636|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
127667465|NCT03890120|459403637|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
127667466|NCT03890120|459403638|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
127667467|NCT03890120|459403635|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
127667468|NCT03890120|459403636|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
128001412|NCT01386606|460633353|FG000|Overall Study|Protocol Violation|1|||
127667469|NCT03890120|459403637|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
127667470|NCT03890120|459403638|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
127667471|NCT03890120|459403635|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
127667472|NCT03890120|459403636|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
128001413|NCT01386606|460633354|FG001|Overall Study|Protocol Violation|0|||
127667473|NCT03890120|459403637|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
127667474|NCT03890120|459403638|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
127667475|NCT03890120|459403635|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
127667476|NCT03890120|459403636|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
127667477|NCT03890120|459403637|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
127667478|NCT03890120|459403638|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
127667479|NCT03890120|459403635|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
127667480|NCT03890120|459403636|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
127667481|NCT03890120|459403637|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
127667482|NCT03890120|459403638|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
127667483|NCT03890120|459403635|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
127667484|NCT03890120|459403636|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
127667485|NCT03890120|459403637|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
127667486|NCT03890120|459403638|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
127667487|NCT03890120|459403635|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
127667488|NCT03890120|459403636|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
127667489|NCT03890120|459403637|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
127667490|NCT03890120|459403638|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
127667491|NCT03890120|459403635|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
127667492|NCT03890120|459403636|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
127667493|NCT03890120|459403637|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
127667494|NCT03890120|459403638|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
127667495|NCT03890120|459403635|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
127667496|NCT03890120|459403636|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
127667497|NCT03890120|459403637|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
127667498|NCT03890120|459403638|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
127667499|NCT03890120|459403635|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
127667500|NCT03890120|459403636|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
127667501|NCT03890120|459403637|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
127667502|NCT03890120|459403638|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
127667503|NCT03890120|459403635|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
127667504|NCT03890120|459403636|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
127667505|NCT03890120|459403637|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
127667506|NCT03890120|459403638|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
127667507|NCT03890120|459403635|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
127667508|NCT03890120|459403636|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
127667509|NCT03890120|459403637|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
127667510|NCT03890120|459403638|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
127667511|NCT00683449|459403639|FG000|Overall Study|Lost to Follow-up|0|||
127667512|NCT00683449|459403640|FG001|Overall Study|Lost to Follow-up|1|||
127667513|NCT00683449|459403641|FG002|Overall Study|Lost to Follow-up|0|||
127667514|NCT00683449|459403642|FG003|Overall Study|Lost to Follow-up|0|||
127667515|NCT00683449|459403643|FG004|Overall Study|Lost to Follow-up|0|||
127667516|NCT02559817|459403646|FG000|Treatment Period|Adverse Event|1|||
127667517|NCT02559817|459403647|FG001|Treatment Period|Adverse Event|0|||
127667518|NCT02559817|459403648|FG002|Treatment Period|Adverse Event|1|||
127667519|NCT02559817|459403649|FG003|Treatment Period|Adverse Event|0|||
127667520|NCT02559817|459403650|FG004|Treatment Period|Adverse Event|0|||
127667521|NCT02559817|459403646|FG000|Treatment Period|Lack of Efficacy|0|||
127667522|NCT02559817|459403647|FG001|Treatment Period|Lack of Efficacy|1|||
127667523|NCT02559817|459403648|FG002|Treatment Period|Lack of Efficacy|0|||
127667524|NCT02559817|459403649|FG003|Treatment Period|Lack of Efficacy|0|||
127667525|NCT02559817|459403650|FG004|Treatment Period|Lack of Efficacy|0|||
127667526|NCT02559817|459403646|FG000|Treatment Period|Lost to Follow-up|0|||
127667527|NCT02559817|459403647|FG001|Treatment Period|Lost to Follow-up|1|||
127667528|NCT02559817|459403648|FG002|Treatment Period|Lost to Follow-up|0|||
127667529|NCT02559817|459403649|FG003|Treatment Period|Lost to Follow-up|1|||
127667530|NCT02559817|459403650|FG004|Treatment Period|Lost to Follow-up|0|||
127667531|NCT02559817|459403646|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
127667532|NCT02559817|459403647|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
127667533|NCT02559817|459403648|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
128001414|NCT01386606|460633355|FG002|Overall Study|Protocol Violation|1|||
128001415|NCT01386606|460633356|FG003|Overall Study|Protocol Violation|1|||
128001416|NCT01386606|460633353|FG000|Overall Study|Lost to Follow-up|2|||
127667534|NCT02559817|459403649|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
128001417|NCT01386606|460633354|FG001|Overall Study|Lost to Follow-up|0|||
127667535|NCT02559817|459403650|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
127667536|NCT02559817|459403646|FG000|Treatment Period|Protocol Violation|0|||
127667537|NCT02559817|459403647|FG001|Treatment Period|Protocol Violation|0|||
128001418|NCT01386606|460633355|FG002|Overall Study|Lost to Follow-up|0|||
128001419|NCT01386606|460633356|FG003|Overall Study|Lost to Follow-up|0|||
128001420|NCT01386606|460633353|FG000|Overall Study|Subject incarcerated|0|||
128001421|NCT01386606|460633354|FG001|Overall Study|Subject incarcerated|1|||
128001422|NCT01386606|460633355|FG002|Overall Study|Subject incarcerated|0|||
128001423|NCT01386606|460633356|FG003|Overall Study|Subject incarcerated|0|||
128001424|NCT01386606|460633353|FG000|Overall Study|Unable to draw PK|1|||
128001425|NCT01386606|460633354|FG001|Overall Study|Unable to draw PK|0|||
128001426|NCT01386606|460633355|FG002|Overall Study|Unable to draw PK|0|||
128001427|NCT01386606|460633356|FG003|Overall Study|Unable to draw PK|0|||
128001428|NCT01386606|460633353|FG000|Overall Study|T levels too high|0|||
128001429|NCT01386606|460633354|FG001|Overall Study|T levels too high|1|||
128001430|NCT01386606|460633355|FG002|Overall Study|T levels too high|1|||
128001431|NCT01386606|460633356|FG003|Overall Study|T levels too high|0|||
128001432|NCT01022203|460633359|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
128001433|NCT01022203|460633360|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
128001434|NCT01022203|460633359|FG000|Post Treatment Assessment|Physician Decision|2|||
128001435|NCT01022203|460633360|FG001|Post Treatment Assessment|Physician Decision|0|||
128001436|NCT01022203|460633359|FG000|Post Treatment Assessment|Adverse Event|0|||
128001437|NCT01022203|460633360|FG001|Post Treatment Assessment|Adverse Event|2|||
128001438|NCT01022203|460633359|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
128001439|NCT01022203|460633360|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
128001440|NCT01094288|460633363|FG000|Overall Study|Adverse Event|0|||
128001441|NCT01094288|460633364|FG001|Overall Study|Adverse Event|3|||
128001442|NCT01094288|460633365|FG002|Overall Study|Adverse Event|1|||
128001443|NCT01094288|460633366|FG003|Overall Study|Adverse Event|1|||
128001444|NCT01094288|460633367|FG004|Overall Study|Adverse Event|0|||
128001445|NCT01094288|460633368|FG005|Overall Study|Adverse Event|0|||
128001446|NCT01094288|460633369|FG006|Overall Study|Adverse Event|0|||
128001447|NCT01094288|460633370|FG007|Overall Study|Adverse Event|0|||
128001448|NCT01094288|460633363|FG000|Overall Study|Withdrawal by Subject|0|||
128001449|NCT01094288|460633364|FG001|Overall Study|Withdrawal by Subject|1|||
128001450|NCT01094288|460633365|FG002|Overall Study|Withdrawal by Subject|2|||
128001451|NCT01094288|460633366|FG003|Overall Study|Withdrawal by Subject|0|||
128001452|NCT01094288|460633367|FG004|Overall Study|Withdrawal by Subject|0|||
128001453|NCT01094288|460633368|FG005|Overall Study|Withdrawal by Subject|0|||
128001454|NCT01094288|460633369|FG006|Overall Study|Withdrawal by Subject|0|||
128001455|NCT01094288|460633370|FG007|Overall Study|Withdrawal by Subject|2|||
128001456|NCT01094288|460633363|FG000|Overall Study|Initiation of Alternative Therapy|0|||
128001457|NCT01094288|460633364|FG001|Overall Study|Initiation of Alternative Therapy|0|||
128001458|NCT01094288|460633365|FG002|Overall Study|Initiation of Alternative Therapy|1|||
128001459|NCT01094288|460633366|FG003|Overall Study|Initiation of Alternative Therapy|0|||
128001460|NCT01094288|460633367|FG004|Overall Study|Initiation of Alternative Therapy|0|||
128001461|NCT01094288|460633368|FG005|Overall Study|Initiation of Alternative Therapy|0|||
128001462|NCT01094288|460633369|FG006|Overall Study|Initiation of Alternative Therapy|0|||
128001463|NCT01094288|460633370|FG007|Overall Study|Initiation of Alternative Therapy|0|||
128001464|NCT01094288|460633363|FG000|Overall Study|Reason not Specified|2|||
128001465|NCT01094288|460633364|FG001|Overall Study|Reason not Specified|3|||
128001466|NCT01094288|460633365|FG002|Overall Study|Reason not Specified|0|||
128001467|NCT01094288|460633366|FG003|Overall Study|Reason not Specified|1|||
128001468|NCT01094288|460633367|FG004|Overall Study|Reason not Specified|0|||
127667538|NCT02559817|459403648|FG002|Treatment Period|Protocol Violation|0|||
127667539|NCT02559817|459403649|FG003|Treatment Period|Protocol Violation|1|||
127667540|NCT02559817|459403650|FG004|Treatment Period|Protocol Violation|0|||
127667541|NCT01925170|459403652|FG000|Overall Study|Unverified cancer status|53|||
127667542|NCT00577720|459403653|FG000|Overall Study|Adverse Event|2|||
127667543|NCT00577720|459403654|FG001|Overall Study|Adverse Event|1|||
127667544|NCT00577720|459403655|FG002|Overall Study|Adverse Event|0|||
127667545|NCT00577720|459403656|FG003|Overall Study|Adverse Event|4|||
127667546|NCT00577720|459403653|FG000|Overall Study|Lost to Follow-up|0|||
127667547|NCT00577720|459403654|FG001|Overall Study|Lost to Follow-up|0|||
128001469|NCT01094288|460633368|FG005|Overall Study|Reason not Specified|0|||
128001470|NCT01094288|460633369|FG006|Overall Study|Reason not Specified|0|||
128001471|NCT01094288|460633370|FG007|Overall Study|Reason not Specified|0|||
128001472|NCT01094288|460633363|FG000|Overall Study|Ongoing Participants|0|||
128001473|NCT01094288|460633364|FG001|Overall Study|Ongoing Participants|3|||
128001474|NCT01094288|460633365|FG002|Overall Study|Ongoing Participants|0|||
128001475|NCT01094288|460633366|FG003|Overall Study|Ongoing Participants|0|||
128001476|NCT01094288|460633367|FG004|Overall Study|Ongoing Participants|0|||
128001477|NCT01094288|460633368|FG005|Overall Study|Ongoing Participants|0|||
128001478|NCT01094288|460633369|FG006|Overall Study|Ongoing Participants|0|||
128001479|NCT01094288|460633370|FG007|Overall Study|Ongoing Participants|0|||
128001480|NCT01317940|460633371|FG000|Overall Study|Death|1|||
128001481|NCT01317940|460633372|FG001|Overall Study|Death|0|||
127667548|NCT00577720|459403655|FG002|Overall Study|Lost to Follow-up|1|||
127667549|NCT00577720|459403656|FG003|Overall Study|Lost to Follow-up|0|||
127667550|NCT00577720|459403653|FG000|Overall Study|Protocol Violation|0|||
127667551|NCT00577720|459403654|FG001|Overall Study|Protocol Violation|0|||
127667552|NCT00577720|459403655|FG002|Overall Study|Protocol Violation|0|||
127667553|NCT00577720|459403656|FG003|Overall Study|Protocol Violation|1|||
127667554|NCT00577720|459403653|FG000|Overall Study|Withdrawal by Subject|2|||
127667555|NCT00577720|459403654|FG001|Overall Study|Withdrawal by Subject|0|||
127667556|NCT00577720|459403655|FG002|Overall Study|Withdrawal by Subject|0|||
127667557|NCT00577720|459403656|FG003|Overall Study|Withdrawal by Subject|2|||
127667558|NCT02839681|459403657|FG000|Overall Study|Death|2|||
127667559|NCT00772928|459403658|FG000|Overall Study|Lost to Follow-up|9|||
127667560|NCT00772928|459403659|FG001|Overall Study|Lost to Follow-up|6|||
127667561|NCT00772928|459403658|FG000|Overall Study|Protocol Violation|10|||
127667562|NCT00772928|459403659|FG001|Overall Study|Protocol Violation|12|||
127667563|NCT00772928|459403658|FG000|Overall Study|Withdrawal by Subject|25|||
127667564|NCT00772928|459403659|FG001|Overall Study|Withdrawal by Subject|22|||
127667565|NCT00772928|459403658|FG000|Overall Study|Did not receive vaccine|0|||
127667566|NCT00772928|459403659|FG001|Overall Study|Did not receive vaccine|1|||
127667567|NCT03100838|459403660|FG000|Overall Study|Adverse Event|1|||
127667568|NCT03100838|459403661|FG001|Overall Study|Adverse Event|0|||
127667569|NCT03100838|459403662|FG002|Overall Study|Adverse Event|0|||
127667570|NCT03100838|459403663|FG003|Overall Study|Adverse Event|0|||
127667571|NCT03100838|459403660|FG000|Overall Study|Physician Decision|1|||
127667572|NCT03100838|459403661|FG001|Overall Study|Physician Decision|1|||
127667573|NCT03100838|459403662|FG002|Overall Study|Physician Decision|1|||
127667574|NCT03100838|459403663|FG003|Overall Study|Physician Decision|1|||
127667575|NCT03100838|459403660|FG000|Overall Study|Pregnancy|0|||
127667576|NCT03100838|459403661|FG001|Overall Study|Pregnancy|1|||
127667577|NCT03100838|459403662|FG002|Overall Study|Pregnancy|0|||
127667578|NCT03100838|459403663|FG003|Overall Study|Pregnancy|0|||
127667579|NCT03100838|459403660|FG000|Overall Study|Lost to Follow-up|0|||
127667580|NCT03100838|459403661|FG001|Overall Study|Lost to Follow-up|0|||
127667581|NCT03100838|459403662|FG002|Overall Study|Lost to Follow-up|1|||
127667582|NCT03100838|459403663|FG003|Overall Study|Lost to Follow-up|0|||
127667583|NCT02554513|459403665|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
127667584|NCT02554513|459403666|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
127667585|NCT01670500|459403671|FG000|Overall Study|Withdrawal by Subject|1|||
127667586|NCT01670500|459403672|FG001|Overall Study|Withdrawal by Subject|0|||
127667587|NCT03473756|459403673|FG000|Overall Study|Withdrawal by Subject|1|||
127667588|NCT03473756|459403674|FG001|Overall Study|Withdrawal by Subject|4|||
127667589|NCT03473756|459403673|FG000|Overall Study|Adverse Event|6|||
127667590|NCT03473756|459403674|FG001|Overall Study|Adverse Event|7|||
127667591|NCT03473756|459403673|FG000|Overall Study|Lack of Efficacy|3|||
127667592|NCT03473756|459403674|FG001|Overall Study|Lack of Efficacy|10|||
127667593|NCT03473756|459403673|FG000|Overall Study|Physician Decision|0|||
127667594|NCT03473756|459403674|FG001|Overall Study|Physician Decision|2|||
127667595|NCT03473756|459403673|FG000|Overall Study|End of study treatment|0|||
127667596|NCT03473756|459403674|FG001|Overall Study|End of study treatment|2|||
127667597|NCT03473756|459403673|FG000|Overall Study|Lost to Follow-up|0|||
127667598|NCT03473756|459403674|FG001|Overall Study|Lost to Follow-up|1|||
127667599|NCT02148718|459403675|FG000|Overall Study|Protocol Violation|26|||
127667600|NCT02148718|459403675|FG000|Overall Study|Discontinued Study Prematurely|5|||
127667601|NCT00333788|459403676|FG000|Overall Study|Adverse Event|44|||
127667602|NCT00333788|459403676|FG000|Overall Study|Lack of Efficacy|80|||
127667603|NCT00333788|459403676|FG000|Overall Study|Lost to Follow-up|2|||
127667604|NCT00333788|459403676|FG000|Overall Study|Withdrawal by Subject|24|||
127667605|NCT00333788|459403676|FG000|Overall Study|Other: Non-compliance|2|||
127667606|NCT00333788|459403676|FG000|Overall Study|Other: Moved|2|||
127667607|NCT00333788|459403676|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
127667608|NCT00333788|459403676|FG000|Overall Study|Other: Investigator decision|1|||
127667609|NCT00333788|459403676|FG000|Overall Study|Other: Quality of life concern|1|||
127667610|NCT00333788|459403676|FG000|Overall Study|Other: Sponsor decision|1|||
127667611|NCT00333788|459403676|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
127667612|NCT00333788|459403676|FG000|Overall Study|Other: Medical monitor decision|1|||
127667613|NCT00333788|459403676|FG000|Overall Study|Other: Physician decision|1|||
127667614|NCT00333788|459403676|FG000|Overall Study|Other: Signed consent for another study|1|||
127667615|NCT04951479|459403677|FG000|Overall Study|Pre-existing Acute Knee Injury|1|||
127667616|NCT04131907|459403679|FG000|Overall Study|Adverse Event|2|||
127667617|NCT04131907|459403680|FG001|Overall Study|Adverse Event|0|||
127667618|NCT04131907|459403681|FG002|Overall Study|Adverse Event|0|||
127667619|NCT04131907|459403679|FG000|Overall Study|Physician Decision|4|||
127667620|NCT04131907|459403680|FG001|Overall Study|Physician Decision|22|||
127667621|NCT04131907|459403681|FG002|Overall Study|Physician Decision|0|||
127667622|NCT04131907|459403679|FG000|Overall Study|Withdrawal by Subject|2|||
127667623|NCT04131907|459403680|FG001|Overall Study|Withdrawal by Subject|0|||
127667624|NCT04131907|459403681|FG002|Overall Study|Withdrawal by Subject|1|||
127667625|NCT04131907|459403679|FG000|Overall Study|Treatment failure|2|||
127667626|NCT04131907|459403680|FG001|Overall Study|Treatment failure|0|||
127667627|NCT04131907|459403681|FG002|Overall Study|Treatment failure|1|||
127667628|NCT01778062|459403682|FG000|Overall Study|Adverse Event|1|||
127667629|NCT01778062|459403683|FG001|Overall Study|Adverse Event|3|||
127667630|NCT01778062|459403682|FG000|Overall Study|Consent Withdrawal|1|||
127667631|NCT01778062|459403683|FG001|Overall Study|Consent Withdrawal|5|||
127667632|NCT01778062|459403682|FG000|Overall Study|major protocol deviation|4|||
127667633|NCT01778062|459403683|FG001|Overall Study|major protocol deviation|3|||
127667634|NCT04445155|459403684|FG000|Overall Study|Lost to Follow-up|11|||
127667635|NCT04445155|459403685|FG001|Overall Study|Lost to Follow-up|2|||
127667636|NCT04445155|459403686|FG002|Overall Study|Lost to Follow-up|3|||
127667637|NCT04445155|459403687|FG003|Overall Study|Lost to Follow-up|0|||
127667638|NCT04445155|459403684|FG000|Overall Study|Withdrawal by Subject|8|||
127667639|NCT04445155|459403685|FG001|Overall Study|Withdrawal by Subject|0|||
127667640|NCT04445155|459403686|FG002|Overall Study|Withdrawal by Subject|0|||
127667641|NCT04445155|459403687|FG003|Overall Study|Withdrawal by Subject|0|||
127667642|NCT04445155|459403684|FG000|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|12|||
127667643|NCT04445155|459403685|FG001|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
127667644|NCT04445155|459403686|FG002|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
127667645|NCT04445155|459403687|FG003|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
127667646|NCT04445155|459403684|FG000|Overall Study|Only completed a portion of the final outcome measures (T2)|4|||
127667647|NCT04445155|459403685|FG001|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
127667648|NCT04445155|459403686|FG002|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
127667649|NCT04445155|459403687|FG003|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
127667650|NCT01213173|459403690|FG000|Overall Study|Protocol Violation|2|||
127667651|NCT01213173|459403691|FG001|Overall Study|Protocol Violation|0|||
127667652|NCT01213173|459403690|FG000|Overall Study|Adverse Event|4|||
127667653|NCT01213173|459403691|FG001|Overall Study|Adverse Event|8|||
127667654|NCT01213173|459403690|FG000|Overall Study|Withdrawal by Subject|5|||
127667655|NCT01213173|459403691|FG001|Overall Study|Withdrawal by Subject|5|||
127667656|NCT01213173|459403690|FG000|Overall Study|Incorrect Enrollment|1|||
127667657|NCT01213173|459403691|FG001|Overall Study|Incorrect Enrollment|3|||
127667658|NCT02353832|459403694|FG000|Overall Study|Ineligible after enrollment|1|||
127667659|NCT02353832|459403694|FG000|Overall Study|Lost to Follow-up|1|||
127667660|NCT04880161|459403695|FG000|Overall Study|Withdrawal by Subject|1|||
127667661|NCT04880161|459403696|FG001|Overall Study|Withdrawal by Subject|0|||
127667662|NCT04880161|459403695|FG000|Overall Study|Lack of Compliance|1|||
127667663|NCT04880161|459403696|FG001|Overall Study|Lack of Compliance|1|||
127667664|NCT04880161|459403695|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
127667665|NCT04880161|459403696|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
127667666|NCT04880161|459403695|FG000|Overall Study|Screen Failure|0|||
127667667|NCT04880161|459403696|FG001|Overall Study|Screen Failure|1|||
127667668|NCT01115998|459405067|FG000|Overall Study|Lost to Follow-up|6|||
127667669|NCT01115998|459405068|FG001|Overall Study|Lost to Follow-up|6|||
127667670|NCT01268059|459405069|FG000|Overall Study|Lost to Follow-up|0|||
127667671|NCT01268059|459405070|FG001|Overall Study|Lost to Follow-up|1|||
127667672|NCT01268059|459405071|FG002|Overall Study|Lost to Follow-up|0|||
127667673|NCT01268059|459405072|FG003|Overall Study|Lost to Follow-up|0|||
127667674|NCT01268059|459405069|FG000|Overall Study|Withdrawal by Subject|7|||
128001482|NCT01317940|460633373|FG002|Overall Study|Death|1|||
128001483|NCT01317940|460633374|FG003|Overall Study|Death|0|||
128001484|NCT01317940|460633375|FG004|Overall Study|Death|0|||
128001485|NCT01317940|460633376|FG005|Overall Study|Death|0|||
128001486|NCT01317940|460633371|FG000|Overall Study|Lost to Follow-up|0|||
128001487|NCT01317940|460633372|FG001|Overall Study|Lost to Follow-up|0|||
128001488|NCT01317940|460633373|FG002|Overall Study|Lost to Follow-up|1|||
128001489|NCT01317940|460633374|FG003|Overall Study|Lost to Follow-up|1|||
128001490|NCT01317940|460633375|FG004|Overall Study|Lost to Follow-up|1|||
128001491|NCT01317940|460633376|FG005|Overall Study|Lost to Follow-up|0|||
128001492|NCT01317940|460633371|FG000|Overall Study|Change in therapy plan|0|||
128001493|NCT01317940|460633372|FG001|Overall Study|Change in therapy plan|0|||
128001494|NCT01317940|460633373|FG002|Overall Study|Change in therapy plan|3|||
128001495|NCT01317940|460633374|FG003|Overall Study|Change in therapy plan|0|||
128001496|NCT01317940|460633375|FG004|Overall Study|Change in therapy plan|0|||
128001497|NCT01317940|460633376|FG005|Overall Study|Change in therapy plan|0|||
128001498|NCT04152200|460633377|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
128001499|NCT04152200|460633378|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
127667675|NCT01268059|459405070|FG001|Overall Study|Withdrawal by Subject|4|||
127667676|NCT01268059|459405071|FG002|Overall Study|Withdrawal by Subject|0|||
127667677|NCT01268059|459405072|FG003|Overall Study|Withdrawal by Subject|0|||
127667678|NCT01268059|459405069|FG000|Overall Study|Death|20|||
127667679|NCT01268059|459405070|FG001|Overall Study|Death|30|||
127667680|NCT01268059|459405071|FG002|Overall Study|Death|3|||
127667681|NCT01268059|459405072|FG003|Overall Study|Death|5|||
128001500|NCT04980014|460633379|FG000|Overall Study|Participants who are Duplicated|1|||
128001501|NCT04980014|460633379|FG000|Overall Study|Follow-up Failure|13|||
127667682|NCT01268059|459405069|FG000|Overall Study|Progression of disease|1|||
127667683|NCT01268059|459405070|FG001|Overall Study|Progression of disease|0|||
127667684|NCT01268059|459405071|FG002|Overall Study|Progression of disease|0|||
127667685|NCT01268059|459405072|FG003|Overall Study|Progression of disease|0|||
127667686|NCT02819479|459405073|FG000|Overall Study|Adverse Event|2|||
127667687|NCT01646320|459405074|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
127667688|NCT01646320|459405075|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
127667689|NCT01646320|459405074|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
127667690|NCT01646320|459405075|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
127667691|NCT01646320|459405074|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
127667692|NCT01646320|459405075|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
127667693|NCT01646320|459405074|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
127667694|NCT01646320|459405075|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
127667695|NCT01646320|459405074|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
127667696|NCT01646320|459405075|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
127667697|NCT01646320|459405074|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
127667698|NCT01646320|459405075|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
127667699|NCT01646320|459405074|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
127667700|NCT01646320|459405075|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
127667701|NCT01646320|459405074|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
127667702|NCT01646320|459405075|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
127667703|NCT01646320|459405074|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
127667704|NCT01646320|459405075|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
127667705|NCT01646320|459405074|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
127667706|NCT01646320|459405075|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
127667707|NCT01646320|459405074|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
127667708|NCT01646320|459405075|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
127667709|NCT01489020|459405076|FG000|Overall Study|Withdrawal by Subject|1|||
127667710|NCT01489020|459405077|FG001|Overall Study|Withdrawal by Subject|0|||
127667711|NCT01489020|459405078|FG002|Overall Study|Withdrawal by Subject|0|||
127667712|NCT01489020|459405079|FG003|Overall Study|Withdrawal by Subject|0|||
127667713|NCT01489020|459405080|FG004|Overall Study|Withdrawal by Subject|0|||
127667714|NCT01489020|459405081|FG005|Overall Study|Withdrawal by Subject|0|||
127667715|NCT01489020|459405076|FG000|Overall Study|Adverse Event|0|||
127667716|NCT01489020|459405077|FG001|Overall Study|Adverse Event|0|||
127667717|NCT01489020|459405078|FG002|Overall Study|Adverse Event|3|||
128001502|NCT04980014|460633379|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
128001503|NCT04980014|460633379|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
128001504|NCT04980014|460633379|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
128001505|NCT00593814|460633380|FG000|Overall Study|Death|7|||
128001506|NCT00593814|460633381|FG001|Overall Study|Death|0|||
128001507|NCT00593814|460633380|FG000|Overall Study|Withdrawal by Subject|7|||
128001508|NCT00593814|460633381|FG001|Overall Study|Withdrawal by Subject|0|||
128001509|NCT00593814|460633380|FG000|Overall Study|Lost to Follow-up|7|||
128001510|NCT00593814|460633381|FG001|Overall Study|Lost to Follow-up|0|||
128001511|NCT00593814|460633380|FG000|Overall Study|Physician Decision|3|||
128001512|NCT00593814|460633381|FG001|Overall Study|Physician Decision|0|||
128001513|NCT02699996|460633382|FG000|Overall Study|Withdrawal by Subject|5|||
128001514|NCT02699996|460633383|FG001|Overall Study|Withdrawal by Subject|2|||
128001515|NCT04069715|460633384|FG000|Overall Study|Lost to Follow-up|1|||
128001516|NCT04069715|460633385|FG001|Overall Study|Lost to Follow-up|1|||
128001517|NCT04069715|460633384|FG000|Overall Study|Physician Decision|1|||
128001518|NCT04069715|460633385|FG001|Overall Study|Physician Decision|1|||
128001519|NCT04069715|460633384|FG000|Overall Study|Withdrawal by Subject|3|||
128001520|NCT04069715|460633385|FG001|Overall Study|Withdrawal by Subject|3|||
128001521|NCT02723188|460633386|FG000|Overall Study|Withdrawal by Subject|1|||
128001522|NCT02723188|460633387|FG001|Overall Study|Withdrawal by Subject|0|||
128001523|NCT02723188|460633388|FG002|Overall Study|Withdrawal by Subject|0|||
128001524|NCT01095835|460633389|FG000|Overall Study|Adverse Event|8|||
128001525|NCT01095835|460633390|FG001|Overall Study|Adverse Event|6|||
128001526|NCT01095835|460633391|FG002|Overall Study|Adverse Event|6|||
128001527|NCT01095835|460633389|FG000|Overall Study|Lack of Efficacy|0|||
128001528|NCT01095835|460633390|FG001|Overall Study|Lack of Efficacy|1|||
127667718|NCT01489020|459405079|FG003|Overall Study|Adverse Event|0|||
127667719|NCT01489020|459405080|FG004|Overall Study|Adverse Event|3|||
127667720|NCT01489020|459405081|FG005|Overall Study|Adverse Event|0|||
127667721|NCT01489020|459405076|FG000|Overall Study|Concomitant disease|0|||
127667722|NCT01489020|459405077|FG001|Overall Study|Concomitant disease|0|||
128001529|NCT01095835|460633391|FG002|Overall Study|Lack of Efficacy|0|||
127667723|NCT01489020|459405078|FG002|Overall Study|Concomitant disease|0|||
127667724|NCT01489020|459405079|FG003|Overall Study|Concomitant disease|0|||
128001530|NCT01095835|460633389|FG000|Overall Study|Physician Decision|0|||
128001531|NCT01095835|460633390|FG001|Overall Study|Physician Decision|0|||
127667725|NCT01489020|459405080|FG004|Overall Study|Concomitant disease|3|||
127667726|NCT01489020|459405081|FG005|Overall Study|Concomitant disease|0|||
127667727|NCT01174550|459405082|FG000|Overall Study|Death|75|||
127667728|NCT01174550|459405083|FG001|Overall Study|Death|74|||
127667729|NCT01174550|459405082|FG000|Overall Study|Lost to Follow-up|652|||
127667730|NCT01174550|459405083|FG001|Overall Study|Lost to Follow-up|510|||
127667731|NCT01174550|459405082|FG000|Overall Study|Withdrawal by Subject|543|||
127667732|NCT01174550|459405083|FG001|Overall Study|Withdrawal by Subject|289|||
127667733|NCT05257837|459405084|FG000|Overall Study|Excluded (did not find the guns)|4|||
127667734|NCT05257837|459405085|FG001|Overall Study|Excluded (did not find the guns)|2|||
127667735|NCT05257837|459405086|FG002|Overall Study|Excluded (did not find the guns)|4|||
127667736|NCT05257837|459405087|FG003|Overall Study|Excluded (did not find the guns)|0|||
127667737|NCT01625338|459405088|FG000|Overall Study|Enrolled but not Treated|0|||
127667738|NCT01625338|459405089|FG001|Overall Study|Enrolled but not Treated|0|||
127667739|NCT01625338|459405090|FG002|Overall Study|Enrolled but not Treated|1|||
127667740|NCT01625338|459405088|FG000|Overall Study|Efficacy Failure|27|||
127667741|NCT01625338|459405089|FG001|Overall Study|Efficacy Failure|39|||
127667742|NCT01625338|459405090|FG002|Overall Study|Efficacy Failure|31|||
127667743|NCT01625338|459405088|FG000|Overall Study|Lost to Follow-up|3|||
127667744|NCT01625338|459405089|FG001|Overall Study|Lost to Follow-up|3|||
127667745|NCT01625338|459405090|FG002|Overall Study|Lost to Follow-up|2|||
127667746|NCT01625338|459405088|FG000|Overall Study|Investigator Decision|0|||
127667747|NCT01625338|459405089|FG001|Overall Study|Investigator Decision|2|||
127667748|NCT01625338|459405090|FG002|Overall Study|Investigator Decision|1|||
127667749|NCT01625338|459405088|FG000|Overall Study|Subject Withdrew Consent|1|||
127667750|NCT01625338|459405089|FG001|Overall Study|Subject Withdrew Consent|0|||
128001532|NCT01095835|460633391|FG002|Overall Study|Physician Decision|1|||
128001533|NCT01095835|460633389|FG000|Overall Study|Withdrawal by Subject|1|||
128001534|NCT01095835|460633390|FG001|Overall Study|Withdrawal by Subject|3|||
128001535|NCT01095835|460633391|FG002|Overall Study|Withdrawal by Subject|0|||
128001536|NCT01095835|460633389|FG000|Overall Study|Non study compliance|0|||
128001537|NCT01095835|460633390|FG001|Overall Study|Non study compliance|0|||
128001538|NCT01095835|460633391|FG002|Overall Study|Non study compliance|1|||
128001539|NCT01095835|460633389|FG000|Overall Study|Protocol Violation|1|||
128001540|NCT01095835|460633390|FG001|Overall Study|Protocol Violation|2|||
128001541|NCT01095835|460633391|FG002|Overall Study|Protocol Violation|0|||
128001542|NCT01198002|460633392|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
127667751|NCT01625338|459405090|FG002|Overall Study|Subject Withdrew Consent|2|||
127667752|NCT01625338|459405088|FG000|Overall Study|Adverse Event|1|||
127667753|NCT01625338|459405089|FG001|Overall Study|Adverse Event|0|||
128001543|NCT01198002|460633393|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
127667754|NCT01625338|459405090|FG002|Overall Study|Adverse Event|1|||
128001544|NCT01198002|460633394|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
128001545|NCT01198002|460633392|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
128001546|NCT01198002|460633393|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
128001547|NCT01198002|460633394|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
128001548|NCT01198002|460633392|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
128001549|NCT01198002|460633393|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
128001550|NCT01198002|460633394|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
128001551|NCT01198002|460633392|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
128001552|NCT01198002|460633393|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
128001553|NCT01198002|460633394|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
128001554|NCT01198002|460633392|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
128001555|NCT01198002|460633393|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
128001556|NCT01198002|460633394|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
128001557|NCT01198002|460633392|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
128001558|NCT01198002|460633393|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
128001559|NCT01198002|460633394|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
128001560|NCT01198002|460633392|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
128001561|NCT01198002|460633393|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
127667755|NCT01625338|459405088|FG000|Overall Study|Study Discontinued by Sponsor|0|||
127667756|NCT01625338|459405089|FG001|Overall Study|Study Discontinued by Sponsor|0|||
127667757|NCT01625338|459405090|FG002|Overall Study|Study Discontinued by Sponsor|1|||
128001562|NCT01198002|460633394|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
128001563|NCT01198002|460633392|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
128001564|NCT01198002|460633393|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
128001565|NCT01198002|460633394|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
128001566|NCT01198002|460633392|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
127667758|NCT05343455|459405095|FG000|Overall Study|Withdrawal by Subject|4|||
127667759|NCT05343455|459405096|FG001|Overall Study|Withdrawal by Subject|9|||
127667760|NCT05343455|459405097|FG002|Overall Study|Withdrawal by Subject|7|||
127667761|NCT05343455|459405095|FG000|Overall Study|Adverse Event|2|||
127667762|NCT05343455|459405096|FG001|Overall Study|Adverse Event|1|||
127667763|NCT05343455|459405097|FG002|Overall Study|Adverse Event|2|||
128001567|NCT01198002|460633393|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
127667764|NCT05343455|459405095|FG000|Overall Study|Lost to Follow-up|1|||
127667765|NCT05343455|459405096|FG001|Overall Study|Lost to Follow-up|1|||
127667766|NCT05343455|459405097|FG002|Overall Study|Lost to Follow-up|3|||
127667767|NCT05343455|459405095|FG000|Overall Study|Pregnancy|1|||
127667768|NCT05343455|459405096|FG001|Overall Study|Pregnancy|0|||
127667769|NCT05343455|459405097|FG002|Overall Study|Pregnancy|0|||
127667770|NCT05343455|459405095|FG000|Overall Study|Physician Decision|0|||
127667771|NCT05343455|459405096|FG001|Overall Study|Physician Decision|0|||
127667772|NCT05343455|459405097|FG002|Overall Study|Physician Decision|1|||
127667773|NCT05343455|459405095|FG000|Overall Study|Protocol Violation|0|||
127667774|NCT05343455|459405096|FG001|Overall Study|Protocol Violation|1|||
127667775|NCT05343455|459405097|FG002|Overall Study|Protocol Violation|1|||
127667776|NCT00765362|459405098|FG000|Overall Study|Death|9|||
127667777|NCT00765362|459405098|FG000|Overall Study|Adverse Event|2|||
127667778|NCT00765362|459405098|FG000|Overall Study|Protocol Violation|18|||
127667779|NCT00765362|459405098|FG000|Overall Study|Withdrawal by Subject|13|||
127667780|NCT00765362|459405098|FG000|Overall Study|Lost to Follow-up|95|||
127667781|NCT03930186|459405099|FG000|Weeks 0 to 16|Adverse Event|6|||
127667782|NCT03930186|459405099|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
127667783|NCT03930186|459405099|FG000|Weeks 16 to 32|Adverse Event|1|||
127667784|NCT03930186|459405099|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
127667785|NCT01636362|459405102|FG000|Overall Study|Physician Decision|6|||
127667786|NCT01636362|459405102|FG000|Overall Study|Subject healed, not returning|1|||
127667787|NCT01636362|459405102|FG000|Overall Study|Withdrawal by Subject|1|||
127667788|NCT03712098|459405113|FG000|Overall Study|Lost to Follow-up|3|||
127667789|NCT03712098|459405114|FG001|Overall Study|Lost to Follow-up|7|||
127667790|NCT03712098|459405113|FG000|Overall Study|Withdrawal by Subject|9|||
127667791|NCT03712098|459405114|FG001|Overall Study|Withdrawal by Subject|4|||
127667792|NCT03712098|459405113|FG000|Overall Study|Protocol Violation|2|||
127667793|NCT03712098|459405114|FG001|Overall Study|Protocol Violation|1|||
127667794|NCT00953160|459405117|FG000|Overall Study|Lost to Follow-up|23|||
127667795|NCT00953160|459405117|FG000|Overall Study|Withdrawal by Subject|4|||
127667796|NCT02724020|459405120|FG000|Overall Study|Death|16|||
127667797|NCT02724020|459405121|FG001|Overall Study|Death|18|||
127667798|NCT02724020|459405122|FG002|Overall Study|Death|19|||
127667799|NCT02724020|459405120|FG000|Overall Study|Lost to Follow-up|0|||
127667800|NCT02724020|459405121|FG001|Overall Study|Lost to Follow-up|3|||
127667801|NCT02724020|459405122|FG002|Overall Study|Lost to Follow-up|0|||
127667802|NCT02724020|459405120|FG000|Overall Study|Site Terminated by Sponsor|15|||
127667803|NCT02724020|459405121|FG001|Overall Study|Site Terminated by Sponsor|8|||
127667804|NCT02724020|459405122|FG002|Overall Study|Site Terminated by Sponsor|8|||
127667805|NCT02724020|459405120|FG000|Overall Study|Withdrawal by Subject|1|||
127667806|NCT02724020|459405121|FG001|Overall Study|Withdrawal by Subject|3|||
127667807|NCT02724020|459405122|FG002|Overall Study|Withdrawal by Subject|5|||
127667808|NCT00425503|459405123|FG000|Overall Study|Adverse Event|2|||
127667809|NCT00425503|459405123|FG000|Overall Study|Protocol Violation|1|||
128001568|NCT01198002|460633394|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
128001569|NCT01198002|460633392|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
128001570|NCT01198002|460633393|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
128001571|NCT01198002|460633394|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
128001572|NCT01198002|460633392|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
128001573|NCT01198002|460633393|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
128001574|NCT01198002|460633394|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
128001575|NCT01198002|460633392|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
128001576|NCT01198002|460633393|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
128001577|NCT01198002|460633394|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
128001578|NCT01198002|460633392|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
128001579|NCT01198002|460633393|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
127667810|NCT00479674|459405126|FG000|Overall Study|Adverse Event|18|||
127667811|NCT00479674|459405126|FG000|Overall Study|Withdrawal by Subject|6|||
127667812|NCT00479674|459405126|FG000|Overall Study|Physician Decision|14|||
127667813|NCT00479674|459405126|FG000|Overall Study|none provided|3|||
127667814|NCT02059161|459405129|FG000|Overall Study|Pregnancy|0|||
127667815|NCT02059161|459405130|FG001|Overall Study|Pregnancy|2|||
127667816|NCT02059161|459405129|FG000|Overall Study|Adverse Event|2|||
127667817|NCT02059161|459405130|FG001|Overall Study|Adverse Event|6|||
127667818|NCT02059161|459405129|FG000|Overall Study|Lost to Follow-up|20|||
127667819|NCT02059161|459405130|FG001|Overall Study|Lost to Follow-up|12|||
127667820|NCT02059161|459405129|FG000|Overall Study|Physician Decision|4|||
127667821|NCT02059161|459405130|FG001|Overall Study|Physician Decision|4|||
127667822|NCT02059161|459405129|FG000|Overall Study|Protocol Violation|1|||
127667823|NCT02059161|459405130|FG001|Overall Study|Protocol Violation|1|||
127667824|NCT02059161|459405129|FG000|Overall Study|Withdrawal by Subject|16|||
127667825|NCT02059161|459405130|FG001|Overall Study|Withdrawal by Subject|13|||
127667826|NCT02059161|459405129|FG000|Overall Study|Randomized in error, no study drug|0|||
128001580|NCT01198002|460633394|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
127667827|NCT02059161|459405130|FG001|Overall Study|Randomized in error, no study drug|1|||
127667828|NCT02059161|459405129|FG000|Overall Study|Non-compliance with study drug|6|||
127667829|NCT02059161|459405130|FG001|Overall Study|Non-compliance with study drug|2|||
127667830|NCT01723826|459405135|FG000|Overall Study|Adverse Event|4|||
127667831|NCT01723826|459405136|FG001|Overall Study|Adverse Event|1|||
127667832|NCT01723826|459405137|FG002|Overall Study|Adverse Event|4|||
127667833|NCT01723826|459405138|FG003|Overall Study|Adverse Event|5|||
127667834|NCT01723826|459405135|FG000|Overall Study|Death according to AE eCRF|2|||
127667835|NCT01723826|459405136|FG001|Overall Study|Death according to AE eCRF|3|||
127667836|NCT01723826|459405137|FG002|Overall Study|Death according to AE eCRF|3|||
127667837|NCT01723826|459405138|FG003|Overall Study|Death according to AE eCRF|7|||
127667838|NCT01723826|459405135|FG000|Overall Study|Lost to Follow-up|1|||
127667839|NCT01723826|459405136|FG001|Overall Study|Lost to Follow-up|3|||
127667840|NCT01723826|459405137|FG002|Overall Study|Lost to Follow-up|1|||
127667841|NCT01723826|459405138|FG003|Overall Study|Lost to Follow-up|1|||
127667842|NCT01723826|459405135|FG000|Overall Study|Non-compliance|0|||
127667843|NCT01723826|459405136|FG001|Overall Study|Non-compliance|1|||
127667844|NCT01723826|459405137|FG002|Overall Study|Non-compliance|3|||
127667845|NCT01723826|459405138|FG003|Overall Study|Non-compliance|3|||
127667846|NCT01723826|459405135|FG000|Overall Study|Non-compliance With Study Drug|0|||
127667847|NCT01723826|459405136|FG001|Overall Study|Non-compliance With Study Drug|1|||
127667848|NCT01723826|459405137|FG002|Overall Study|Non-compliance With Study Drug|0|||
127667849|NCT01723826|459405138|FG003|Overall Study|Non-compliance With Study Drug|0|||
127667850|NCT01723826|459405135|FG000|Overall Study|Other Reason|8|||
127667851|NCT01723826|459405136|FG001|Overall Study|Other Reason|6|||
127667852|NCT01723826|459405137|FG002|Overall Study|Other Reason|12|||
127667853|NCT01723826|459405138|FG003|Overall Study|Other Reason|14|||
127667854|NCT01723826|459405135|FG000|Overall Study|Physician Decision|1|||
127667855|NCT01723826|459405136|FG001|Overall Study|Physician Decision|3|||
127667856|NCT01723826|459405137|FG002|Overall Study|Physician Decision|4|||
127667857|NCT01723826|459405138|FG003|Overall Study|Physician Decision|11|||
127667858|NCT01723826|459405135|FG000|Overall Study|Protocol Violation|1|||
127667859|NCT01723826|459405136|FG001|Overall Study|Protocol Violation|1|||
127667860|NCT01723826|459405137|FG002|Overall Study|Protocol Violation|3|||
127667861|NCT01723826|459405138|FG003|Overall Study|Protocol Violation|1|||
127667862|NCT01723826|459405135|FG000|Overall Study|Withdrawal by Subject|10|||
127667863|NCT01723826|459405136|FG001|Overall Study|Withdrawal by Subject|17|||
127667864|NCT01723826|459405137|FG002|Overall Study|Withdrawal by Subject|27|||
127667865|NCT01723826|459405138|FG003|Overall Study|Withdrawal by Subject|48|||
127667866|NCT02013687|459405139|FG000|Overall Study|Lost to Follow-up|0|||
127667867|NCT02013687|459405140|FG001|Overall Study|Lost to Follow-up|0|||
127667868|NCT02013687|459405141|FG002|Overall Study|Lost to Follow-up|1|||
127667869|NCT02013687|459405142|FG003|Overall Study|Lost to Follow-up|0|||
127667870|NCT02013687|459405139|FG000|Overall Study|Protocol Violation|0|||
127667871|NCT02013687|459405140|FG001|Overall Study|Protocol Violation|0|||
127667872|NCT02013687|459405141|FG002|Overall Study|Protocol Violation|0|||
127667873|NCT02013687|459405142|FG003|Overall Study|Protocol Violation|1|||
127667874|NCT02013687|459405139|FG000|Overall Study|Withdrawal by Subject|0|||
127667875|NCT02013687|459405140|FG001|Overall Study|Withdrawal by Subject|0|||
127667876|NCT02013687|459405141|FG002|Overall Study|Withdrawal by Subject|0|||
127667877|NCT02013687|459405142|FG003|Overall Study|Withdrawal by Subject|1|||
127667878|NCT02013687|459405139|FG000|Overall Study|Missed visits due to patient travel|0|||
127667879|NCT02013687|459405140|FG001|Overall Study|Missed visits due to patient travel|0|||
127667880|NCT02013687|459405141|FG002|Overall Study|Missed visits due to patient travel|1|||
127667881|NCT02013687|459405142|FG003|Overall Study|Missed visits due to patient travel|0|||
127667882|NCT01627340|459405143|FG000|Overall Study|Adverse Event|1|||
127667883|NCT01627340|459405144|FG001|Overall Study|Adverse Event|0|||
127667884|NCT01627340|459405143|FG000|Overall Study|Lost to Follow-up|8|||
127667885|NCT01627340|459405144|FG001|Overall Study|Lost to Follow-up|4|||
127667886|NCT01627340|459405143|FG000|Overall Study|Pregnancy|1|||
127667887|NCT01627340|459405144|FG001|Overall Study|Pregnancy|0|||
127667888|NCT01627340|459405143|FG000|Overall Study|Withdrawal by Subject|2|||
127667889|NCT01627340|459405144|FG001|Overall Study|Withdrawal by Subject|0|||
127667890|NCT01272011|459405145|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
127667891|NCT01272011|459405146|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
127667892|NCT01272011|459405147|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
127667893|NCT01657032|459405148|FG000|Overall Study|Lost to Follow-up|0|||
127667894|NCT01657032|459405149|FG001|Overall Study|Lost to Follow-up|7|||
127667895|NCT03633903|459405150|FG000|Overall Study|Withdrawal by Subject|1|||
127667896|NCT03633903|459405151|FG001|Overall Study|Withdrawal by Subject|2|||
127667897|NCT03633903|459405150|FG000|Overall Study|Lost to Follow-up|5|||
127667898|NCT03633903|459405151|FG001|Overall Study|Lost to Follow-up|5|||
127667899|NCT05968482|459405152|FG000|First Crossover Period|Withdrawal by Subject|0|||
127667900|NCT05968482|459405153|FG001|First Crossover Period|Withdrawal by Subject|0|||
127667901|NCT05968482|459405154|FG002|First Crossover Period|Withdrawal by Subject|1|||
127667902|NCT05968482|459405155|FG003|First Crossover Period|Withdrawal by Subject|0|||
127667903|NCT05968482|459405156|FG004|First Crossover Period|Withdrawal by Subject|0|||
127667904|NCT05968482|459405157|FG005|First Crossover Period|Withdrawal by Subject|0|||
128001581|NCT01198002|460633392|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
127667905|NCT05968482|459405152|FG000|First Crossover Period|Adverse Event|0|||
127667906|NCT05968482|459405153|FG001|First Crossover Period|Adverse Event|0|||
127667907|NCT05968482|459405154|FG002|First Crossover Period|Adverse Event|0|||
127667908|NCT05968482|459405155|FG003|First Crossover Period|Adverse Event|0|||
127667909|NCT05968482|459405156|FG004|First Crossover Period|Adverse Event|0|||
127667910|NCT05968482|459405157|FG005|First Crossover Period|Adverse Event|1|||
127667911|NCT05968482|459405152|FG000|Second Crossover Period|Withdrawal by Subject|0|||
127667912|NCT05968482|459405153|FG001|Second Crossover Period|Withdrawal by Subject|0|||
127667913|NCT05968482|459405154|FG002|Second Crossover Period|Withdrawal by Subject|0|||
127667914|NCT05968482|459405155|FG003|Second Crossover Period|Withdrawal by Subject|0|||
127667915|NCT05968482|459405156|FG004|Second Crossover Period|Withdrawal by Subject|1|||
127667916|NCT05968482|459405157|FG005|Second Crossover Period|Withdrawal by Subject|0|||
127667917|NCT05968482|459405152|FG000|Third Crossover Period|Adverse Event|0|||
127667918|NCT05968482|459405153|FG001|Third Crossover Period|Adverse Event|0|||
127667919|NCT05968482|459405154|FG002|Third Crossover Period|Adverse Event|0|||
127667920|NCT05968482|459405155|FG003|Third Crossover Period|Adverse Event|0|||
127667921|NCT05968482|459405156|FG004|Third Crossover Period|Adverse Event|1|||
127667922|NCT05968482|459405157|FG005|Third Crossover Period|Adverse Event|0|||
128001582|NCT01198002|460633393|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
128001583|NCT01198002|460633394|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
128001584|NCT01198002|460633392|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
127667923|NCT05968482|459405152|FG000|Third Crossover Period|failure to meet continuation criteria|0|||
127667924|NCT05968482|459405153|FG001|Third Crossover Period|failure to meet continuation criteria|1|||
127667925|NCT05968482|459405154|FG002|Third Crossover Period|failure to meet continuation criteria|0|||
127667926|NCT05968482|459405155|FG003|Third Crossover Period|failure to meet continuation criteria|0|||
127667927|NCT05968482|459405156|FG004|Third Crossover Period|failure to meet continuation criteria|0|||
127667928|NCT05968482|459405157|FG005|Third Crossover Period|failure to meet continuation criteria|0|||
127667929|NCT00761774|459405161|FG000|Overall Study|Adverse Event|17|||
127667930|NCT00761774|459405161|FG000|Overall Study|Lack of Efficacy|37|||
127667931|NCT00761774|459405161|FG000|Overall Study|Lost to Follow-up|2|||
127667932|NCT00761774|459405161|FG000|Overall Study|Withdrawal by Subject|9|||
127667933|NCT00761774|459405161|FG000|Overall Study|Non-compliance|4|||
127667934|NCT00761774|459405161|FG000|Overall Study|End of study|2|||
127667935|NCT00761774|459405161|FG000|Overall Study|Reclassification of seizures|1|||
127667936|NCT00761774|459405161|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
127667937|NCT00761774|459405161|FG000|Overall Study|Sponsor decision|1|||
127667938|NCT00761774|459405161|FG000|Overall Study|Investigator clinical judgement|1|||
127667939|NCT00761774|459405161|FG000|Overall Study|Patient moved out of study area|1|||
127667940|NCT00761774|459405161|FG000|Overall Study|Coordinator leaving site|1|||
127667941|NCT00761774|459405161|FG000|Overall Study|Subject IP non-compliance|1|||
127667942|NCT00761774|459405161|FG000|Overall Study|IP stopped by hospital physician|1|||
127667943|NCT01077024|459405162|FG000|Overall Study|Lost to Follow-up|20|||
127667944|NCT01077024|459405163|FG001|Overall Study|Lost to Follow-up|14|||
127667945|NCT01077024|459405162|FG000|Overall Study|Withdrawal by Subject|0|||
127667946|NCT01077024|459405163|FG001|Overall Study|Withdrawal by Subject|2|||
127667947|NCT01077024|459405162|FG000|Overall Study|Incarcerated|7|||
127667948|NCT01077024|459405163|FG001|Overall Study|Incarcerated|8|||
127667949|NCT01077024|459405162|FG000|Overall Study|Other|4|||
127667950|NCT01077024|459405163|FG001|Overall Study|Other|4|||
127667951|NCT03379233|459405164|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
127667952|NCT03379233|459405165|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
127667953|NCT01603121|459405166|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
127667954|NCT01603121|459405167|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
127667955|NCT02300311|459405170|FG000|Overall Study|Other than the reason specified|1|||
127667956|NCT02300311|459405171|FG001|Overall Study|Other than the reason specified|0|||
127667957|NCT02300311|459405170|FG000|Overall Study|Refused to continue taking medication|18|||
127667958|NCT02300311|459405171|FG001|Overall Study|Refused to continue taking medication|0|||
127667959|NCT02687919|459405172|FG000|Overall Study|Withdrawal by Subject|6|||
127667960|NCT02687919|459405173|FG001|Overall Study|Withdrawal by Subject|6|||
127667961|NCT02687919|459405172|FG000|Overall Study|Protocol Violation|2|||
127667962|NCT02687919|459405173|FG001|Overall Study|Protocol Violation|0|||
127667963|NCT01656759|459405174|FG000|Overall Study|Protocol Violation|2|||
127667964|NCT01656759|459405175|FG001|Overall Study|Protocol Violation|3|||
128001585|NCT01198002|460633393|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
127667965|NCT00419003|459405176|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
127667966|NCT00419003|459405177|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
127667967|NCT00419003|459405176|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
127667968|NCT00419003|459405177|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
127667969|NCT02531438|459405178|FG000|Overall Study|Adverse Event|7|||
128001586|NCT01198002|460633394|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
128001587|NCT03652818|460633402|FG000|Overall Study|Adverse Event|1|||
128001588|NCT03652818|460633403|FG001|Overall Study|Adverse Event|0|||
128001589|NCT03652818|460633404|FG002|Overall Study|Adverse Event|0|||
128001590|NCT03652818|460633405|FG003|Overall Study|Adverse Event|0|||
128001591|NCT03652818|460633406|FG004|Overall Study|Adverse Event|0|||
128001592|NCT03652818|460633402|FG000|Overall Study|Physician Decision|1|||
128001593|NCT03652818|460633403|FG001|Overall Study|Physician Decision|0|||
128001594|NCT03652818|460633404|FG002|Overall Study|Physician Decision|0|||
128001595|NCT03652818|460633405|FG003|Overall Study|Physician Decision|0|||
128001596|NCT03652818|460633406|FG004|Overall Study|Physician Decision|0|||
128001597|NCT03652818|460633402|FG000|Overall Study|Lost to Follow-up|0|||
128001598|NCT03652818|460633403|FG001|Overall Study|Lost to Follow-up|1|||
128001599|NCT03652818|460633404|FG002|Overall Study|Lost to Follow-up|2|||
128001600|NCT03652818|460633405|FG003|Overall Study|Lost to Follow-up|1|||
128001601|NCT03652818|460633406|FG004|Overall Study|Lost to Follow-up|1|||
128001602|NCT03964207|460633407|FG000|First Treatment|Withdrawal by Subject|1|||
128001603|NCT03964207|460633408|FG001|First Treatment|Withdrawal by Subject|2|||
128001604|NCT03964207|460633407|FG000|First Treatment|Protocol Violation|1|||
128001605|NCT03964207|460633408|FG001|First Treatment|Protocol Violation|0|||
128001606|NCT03964207|460633407|FG000|First Treatment|Lost to Follow-up|1|||
128001607|NCT03964207|460633408|FG001|First Treatment|Lost to Follow-up|0|||
128001608|NCT03964207|460633407|FG000|Second Treatment|Lost to Follow-up|0|||
128001609|NCT03964207|460633408|FG001|Second Treatment|Lost to Follow-up|1|||
128001610|NCT03964207|460633407|FG000|Second Treatment|Adverse Event|1|||
128001611|NCT03964207|460633408|FG001|Second Treatment|Adverse Event|2|||
128001612|NCT01930539|460633409|FG000|Overall Study|Withdrawal by Subject|2|||
128001613|NCT01930539|460633410|FG001|Overall Study|Withdrawal by Subject|2|||
128001614|NCT01241279|460633411|FG000|Overall Study|Lost to Follow-up|0|||
128001615|NCT01241279|460633412|FG001|Overall Study|Lost to Follow-up|1|||
128001616|NCT00301834|460633415|FG000|Overall Study|Death|1|||
127667970|NCT02531438|459405179|FG001|Overall Study|Adverse Event|9|||
127667971|NCT02531438|459405178|FG000|Overall Study|Lost to Follow-up|0|||
127667972|NCT02531438|459405179|FG001|Overall Study|Lost to Follow-up|3|||
127667973|NCT02531438|459405178|FG000|Overall Study|Withdrawal by Subject|7|||
127667974|NCT02531438|459405179|FG001|Overall Study|Withdrawal by Subject|8|||
127667975|NCT02531438|459405178|FG000|Overall Study|Physician Decision|0|||
127667976|NCT02531438|459405179|FG001|Overall Study|Physician Decision|1|||
127667977|NCT02531438|459405178|FG000|Overall Study|Death|6|||
127667978|NCT02531438|459405179|FG001|Overall Study|Death|3|||
127667979|NCT02531438|459405178|FG000|Overall Study|Randomized, but Not Treated|4|||
127667980|NCT02531438|459405179|FG001|Overall Study|Randomized, but Not Treated|0|||
127667981|NCT02531438|459405178|FG000|Overall Study|Missed EOT/PTE Visit|5|||
127667982|NCT02531438|459405179|FG001|Overall Study|Missed EOT/PTE Visit|2|||
127667983|NCT02531438|459405178|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
127667984|NCT02531438|459405179|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
127667985|NCT00801242|459405186|FG000|Overall Study|Adverse Event|10|||
127667986|NCT00801242|459405186|FG000|Overall Study|Withdrawal by Subject|13|||
127667987|NCT00801242|459405186|FG000|Overall Study|Protocol Violation|5|||
127667988|NCT00801242|459405186|FG000|Overall Study|Physician Decision|3|||
127667989|NCT00801242|459405186|FG000|Overall Study|Lost to Follow-up|1|||
127667990|NCT00801242|459405186|FG000|Overall Study|Miscellaneous reasons|20|||
127667991|NCT02015195|459405187|FG000|Overall Study|Adverse Event|0|||
127667992|NCT02015195|459405188|FG001|Overall Study|Adverse Event|0|||
127667993|NCT02015195|459405189|FG002|Overall Study|Adverse Event|0|||
127667994|NCT02015195|459405190|FG003|Overall Study|Adverse Event|1|||
127667995|NCT02015195|459405191|FG004|Overall Study|Adverse Event|0|||
127667996|NCT02015195|459405192|FG005|Overall Study|Adverse Event|0|||
127667997|NCT02015195|459405193|FG006|Overall Study|Adverse Event|0|||
127667998|NCT01318811|459405194|FG000|Overall Study|Physician Decision|1|||
127667999|NCT01318811|459405195|FG001|Overall Study|Physician Decision|1|||
127668000|NCT01318811|459405194|FG000|Overall Study|CRRT stopped for head CT|0|||
127668001|NCT01318811|459405195|FG001|Overall Study|CRRT stopped for head CT|1|||
127668002|NCT01318811|459405194|FG000|Overall Study|Death|0|||
128001617|NCT01811732|460633416|FG000|Overall Study|Lost to Follow-up|24|||
127668003|NCT01318811|459405195|FG001|Overall Study|Death|1|||
127668004|NCT01318811|459405194|FG000|Overall Study|CRRT stopped for head MRI|0|||
127668005|NCT01318811|459405195|FG001|Overall Study|CRRT stopped for head MRI|1|||
127668006|NCT00811187|459405196|FG000|Overall Study|Unable to place device / procedure abort|3|||
127668007|NCT00811187|459405197|FG001|Overall Study|Unable to place device / procedure abort|3|||
127668008|NCT00131911|459405198|FG000|Overall Study|Withdrawal by Subject|1|||
127668009|NCT00131911|459405199|FG001|Overall Study|Withdrawal by Subject|0|||
127668010|NCT00329303|459405200|FG000|Overall Study|Lack of Efficacy|1|||
128001618|NCT01811732|460633417|FG001|Overall Study|Lost to Follow-up|30|||
128001619|NCT01811732|460633416|FG000|Overall Study|Withdrawal by Subject|16|||
128001620|NCT01811732|460633417|FG001|Overall Study|Withdrawal by Subject|10|||
128001621|NCT01811732|460633416|FG000|Overall Study|Adverse Event|3|||
128001622|NCT01811732|460633417|FG001|Overall Study|Adverse Event|9|||
128001623|NCT01811732|460633416|FG000|Overall Study|Lack of Efficacy|3|||
128001624|NCT01811732|460633417|FG001|Overall Study|Lack of Efficacy|1|||
128001625|NCT01811732|460633416|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
128001626|NCT01811732|460633417|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
128001627|NCT01811732|460633416|FG000|Overall Study|Physician Decision|2|||
128001628|NCT01811732|460633417|FG001|Overall Study|Physician Decision|0|||
128001629|NCT01811732|460633416|FG000|Overall Study|Death|1|||
128001630|NCT01811732|460633417|FG001|Overall Study|Death|1|||
128001631|NCT01811732|460633416|FG000|Overall Study|Insufficient venous access|0|||
128001632|NCT01811732|460633417|FG001|Overall Study|Insufficient venous access|1|||
128001633|NCT01811732|460633416|FG000|Overall Study|Protocol Violation|0|||
128001634|NCT01811732|460633417|FG001|Overall Study|Protocol Violation|1|||
127668011|NCT00329303|459405201|FG001|Overall Study|Lack of Efficacy|0|||
127668012|NCT00329303|459405200|FG000|Overall Study|Decision of the sponsor|0|||
127668013|NCT00329303|459405201|FG001|Overall Study|Decision of the sponsor|1|||
127668014|NCT00329303|459405200|FG000|Overall Study|Patient no longer available|1|||
127668015|NCT00329303|459405201|FG001|Overall Study|Patient no longer available|0|||
127668016|NCT00329303|459405200|FG000|Overall Study|Patient relocated|0|||
128001635|NCT01811732|460633416|FG000|Overall Study|Subject incarcerated|1|||
128001636|NCT01811732|460633417|FG001|Overall Study|Subject incarcerated|2|||
128001637|NCT01811732|460633416|FG000|Overall Study|Admitted to another facility|1|||
128001638|NCT01811732|460633417|FG001|Overall Study|Admitted to another facility|0|||
128001639|NCT01811732|460633416|FG000|Overall Study|Correct study drug not available on site|1|||
128001640|NCT01811732|460633417|FG001|Overall Study|Correct study drug not available on site|0|||
128001641|NCT01405560|460633420|FG000|Overall Study|Physician Decision|1|||
128001642|NCT02452047|460633421|FG000|Overall Study|Adverse Event|0|||
128001643|NCT02452047|460633422|FG001|Overall Study|Adverse Event|1|||
128001644|NCT02452047|460633423|FG002|Overall Study|Adverse Event|1|||
128001645|NCT02452047|460633421|FG000|Overall Study|Death|1|||
128001646|NCT02452047|460633422|FG001|Overall Study|Death|3|||
128001647|NCT02452047|460633423|FG002|Overall Study|Death|1|||
128001648|NCT02452047|460633421|FG000|Overall Study|Physician Decision|1|||
128001649|NCT02452047|460633422|FG001|Overall Study|Physician Decision|0|||
128001650|NCT02452047|460633423|FG002|Overall Study|Physician Decision|0|||
128001651|NCT02452047|460633421|FG000|Overall Study|Lost to Follow-up|1|||
128001652|NCT02452047|460633422|FG001|Overall Study|Lost to Follow-up|1|||
128001653|NCT02452047|460633423|FG002|Overall Study|Lost to Follow-up|0|||
128001654|NCT02452047|460633421|FG000|Overall Study|Withdrawal by Subject|1|||
128001655|NCT02452047|460633422|FG001|Overall Study|Withdrawal by Subject|0|||
128001656|NCT02452047|460633423|FG002|Overall Study|Withdrawal by Subject|0|||
128001657|NCT00288912|460633424|FG000|Overall Study|Developed exclusion criterion|4|||
128001658|NCT00288912|460633425|FG001|Overall Study|Developed exclusion criterion|6|||
128001659|NCT00288912|460633426|FG002|Overall Study|Developed exclusion criterion|7|||
128001660|NCT00288912|460633424|FG000|Overall Study|Lost to Follow-up|9|||
128001661|NCT00288912|460633425|FG001|Overall Study|Lost to Follow-up|6|||
128001662|NCT00288912|460633426|FG002|Overall Study|Lost to Follow-up|9|||
128001663|NCT00288912|460633424|FG000|Overall Study|Withdrawal by Subject|4|||
128001664|NCT00288912|460633425|FG001|Overall Study|Withdrawal by Subject|5|||
128001665|NCT00288912|460633426|FG002|Overall Study|Withdrawal by Subject|12|||
128001666|NCT01607593|460633428|FG000|Overall Study|Adverse Event|15|||
128001667|NCT01607593|460633428|FG000|Overall Study|Lack of Efficacy|16|||
128001668|NCT01607593|460633428|FG000|Overall Study|Lost to Follow-up|25|||
128001669|NCT01607593|460633428|FG000|Overall Study|Continuation|33|||
128001670|NCT01607593|460633428|FG000|Overall Study|Other|4|||
128001671|NCT05081388|460633429|FG000|Overall Study|Adverse Event|1|||
128001672|NCT05081388|460633430|FG001|Overall Study|Adverse Event|0|||
128001673|NCT05081388|460633431|FG002|Overall Study|Adverse Event|0|||
128001674|NCT05081388|460633432|FG003|Overall Study|Adverse Event|0|||
128001675|NCT05081388|460633433|FG004|Overall Study|Adverse Event|0|||
128001676|NCT05081388|460633429|FG000|Overall Study|Lost to Follow-up|0|||
128001677|NCT05081388|460633430|FG001|Overall Study|Lost to Follow-up|1|||
128001678|NCT05081388|460633431|FG002|Overall Study|Lost to Follow-up|0|||
128001679|NCT05081388|460633432|FG003|Overall Study|Lost to Follow-up|0|||
128001680|NCT05081388|460633433|FG004|Overall Study|Lost to Follow-up|0|||
128001681|NCT05081388|460633429|FG000|Overall Study|Subject decision|0|||
128001682|NCT05081388|460633430|FG001|Overall Study|Subject decision|0|||
128001683|NCT05081388|460633431|FG002|Overall Study|Subject decision|0|||
128001684|NCT05081388|460633432|FG003|Overall Study|Subject decision|1|||
128001685|NCT05081388|460633433|FG004|Overall Study|Subject decision|0|||
127668017|NCT00329303|459405201|FG001|Overall Study|Patient relocated|1|||
127668018|NCT00994279|459405206|FG000|Overall Study|Withdrawal by Subject|2|||
127668019|NCT00994279|459405207|FG001|Overall Study|Withdrawal by Subject|2|||
128001686|NCT02059239|460633434|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
128001687|NCT02059239|460633435|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
128001688|NCT02059239|460633434|FG000|Overall Study|Physician Decision|1|||
128001689|NCT02059239|460633435|FG001|Overall Study|Physician Decision|0|||
128001690|NCT02219685|460633436|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
128001691|NCT02219685|460633437|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
128001692|NCT02219685|460633436|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
128001693|NCT02219685|460633437|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
127668020|NCT00994279|459405206|FG000|Overall Study|Toxicity|1|||
127668021|NCT00994279|459405207|FG001|Overall Study|Toxicity|0|||
127668022|NCT00994279|459405206|FG000|Overall Study|Multiple reasons|1|||
127668023|NCT00994279|459405207|FG001|Overall Study|Multiple reasons|3|||
127668024|NCT01606189|459405208|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
127668025|NCT01606189|459405209|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
127668026|NCT01606189|459405210|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
127668027|NCT01606189|459405211|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
127668028|NCT01606189|459405212|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
127668029|NCT01606189|459405213|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
127668030|NCT01606189|459405208|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
127668031|NCT01606189|459405209|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
127668032|NCT01606189|459405210|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
127668033|NCT01606189|459405211|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
127668034|NCT01606189|459405212|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
127668035|NCT01606189|459405213|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
127668036|NCT00162942|459405214|FG000|Overall Study|Adverse Event|10|||
127668037|NCT00162942|459405215|FG001|Overall Study|Adverse Event|6|||
128001694|NCT02127658|460633438|FG000|Overall Study|Screen Fail (Not MRSA on culture check)|2|||
128001695|NCT02127658|460633439|FG001|Overall Study|Screen Fail (Not MRSA on culture check)|0|||
128001696|NCT02127658|460633438|FG000|Overall Study|Withdrawal by Subject|0|||
127668038|NCT00162942|459405214|FG000|Overall Study|Death|1|||
127668039|NCT00162942|459405215|FG001|Overall Study|Death|0|||
127668040|NCT00162942|459405214|FG000|Overall Study|Withdrawal by Subject|3|||
127668041|NCT00162942|459405215|FG001|Overall Study|Withdrawal by Subject|6|||
127668042|NCT00162942|459405214|FG000|Overall Study|Physician Decision|1|||
127668043|NCT00162942|459405215|FG001|Overall Study|Physician Decision|0|||
127668044|NCT00162942|459405214|FG000|Overall Study|Enter Open-Label Study|76|||
127668045|NCT00162942|459405215|FG001|Overall Study|Enter Open-Label Study|35|||
127668046|NCT00162942|459405214|FG000|Overall Study|Alternate Therapy|6|||
127668047|NCT00162942|459405215|FG001|Overall Study|Alternate Therapy|2|||
127668048|NCT00162942|459405214|FG000|Overall Study|Lack of Efficacy|1|||
127668049|NCT00162942|459405215|FG001|Overall Study|Lack of Efficacy|0|||
127668050|NCT00162942|459405214|FG000|Overall Study|Flare During Active Treatment|7|||
127668051|NCT00162942|459405215|FG001|Overall Study|Flare During Active Treatment|3|||
127668052|NCT00162942|459405214|FG000|Overall Study|2 or more consecutive treatments missed|1|||
127668053|NCT00162942|459405215|FG001|Overall Study|2 or more consecutive treatments missed|0|||
127668054|NCT02162732|459405216|FG000|Overall Study|Biopsy not performed.|18|||
127668055|NCT01167023|459405217|FG000|Overall Study|Lost to Follow-up|0|||
127668056|NCT01167023|459405218|FG001|Overall Study|Lost to Follow-up|1|||
127668057|NCT01167023|459405219|FG002|Overall Study|Lost to Follow-up|1|||
127668058|NCT01167023|459405217|FG000|Overall Study|Screen Failure|0|||
127668059|NCT01167023|459405218|FG001|Overall Study|Screen Failure|1|||
127668060|NCT01167023|459405219|FG002|Overall Study|Screen Failure|0|||
127668061|NCT01167023|459405217|FG000|Overall Study|Sponsor Decision|0|||
127668062|NCT01167023|459405218|FG001|Overall Study|Sponsor Decision|1|||
127668063|NCT01167023|459405219|FG002|Overall Study|Sponsor Decision|0|||
127668064|NCT01167023|459405217|FG000|Overall Study|Withdrawal by Subject|0|||
127668065|NCT01167023|459405218|FG001|Overall Study|Withdrawal by Subject|0|||
127668066|NCT01167023|459405219|FG002|Overall Study|Withdrawal by Subject|1|||
127668067|NCT02049437|459405220|FG000|Period 1|Adverse Event|1|||
127668068|NCT02049437|459405221|FG001|Period 1|Adverse Event|1|||
127668069|NCT02049437|459405220|FG000|Period 1|Adverse Event|1|||
127668070|NCT02049437|459405221|FG001|Period 1|Adverse Event|0|||
127668071|NCT03387514|459405222|FG000|Overall Study|Withdrawal by Subject|2|||
127668072|NCT03387514|459405222|FG000|Overall Study|Physician Decision|1|||
127668073|NCT03387514|459405222|FG000|Overall Study|Lost to Follow-up|2|||
127668074|NCT00394095|459407077|FG000|Screening|Withdrawal by Subject|1|||
127668075|NCT00394095|459407078|FG001|Screening|Withdrawal by Subject|0|||
127668076|NCT00394095|459407077|FG000|Randomized|Withdrawal by Subject|5|||
127668077|NCT00394095|459407078|FG001|Randomized|Withdrawal by Subject|1|||
127668078|NCT00394095|459407077|FG000|Randomized|Adverse Event|1|||
127668079|NCT00394095|459407078|FG001|Randomized|Adverse Event|1|||
127668080|NCT00394095|459407077|FG000|Randomized|Overdose|1|||
127668081|NCT00394095|459407078|FG001|Randomized|Overdose|0|||
128001697|NCT02127658|460633439|FG001|Overall Study|Withdrawal by Subject|2|||
127668082|NCT00394095|459407077|FG000|Randomized|Lost to Follow-up|1|||
127668083|NCT00394095|459407078|FG001|Randomized|Lost to Follow-up|2|||
127668084|NCT04213846|459407079|FG000|Overall Study|Withdrawal by Subject|7|||
127668085|NCT04213846|459407080|FG001|Overall Study|Withdrawal by Subject|6|||
127668086|NCT04213846|459407079|FG000|Overall Study|Lost to Follow-up|15|||
127668087|NCT04213846|459407080|FG001|Overall Study|Lost to Follow-up|21|||
127668088|NCT04423393|459407081|FG000|Overall Study|Withdrawal by Subject|0|||
127668089|NCT04423393|459407082|FG001|Overall Study|Withdrawal by Subject|0|||
127668090|NCT04423393|459407083|FG002|Overall Study|Withdrawal by Subject|0|||
127668091|NCT04423393|459407084|FG003|Overall Study|Withdrawal by Subject|0|||
127668092|NCT04423393|459407085|FG004|Overall Study|Withdrawal by Subject|0|||
128001698|NCT02127658|460633438|FG000|Overall Study|Physician Decision|0|||
128001699|NCT02127658|460633439|FG001|Overall Study|Physician Decision|1|||
128001700|NCT01867008|460633440|FG000|Overall Study|Withdrawal by Subject|1|||
128001701|NCT01534273|460633441|FG000|Period 1|Physician Decision|0|||
128001702|NCT01534273|460633442|FG001|Period 1|Physician Decision|0|||
128001703|NCT01534273|460633443|FG002|Period 1|Physician Decision|0|||
128001704|NCT01534273|460633444|FG003|Period 1|Physician Decision|1|||
128001705|NCT01534273|460633445|FG004|Period 1|Physician Decision|0|||
127543372|NCT00129402|458956530|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
127543373|NCT00129402|458956531|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
127543374|NCT00129402|458956532|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
127543375|NCT01527149|458956533|FG000|Overall Study|Death|2|||
127543376|NCT03125395|458956535|FG000|Overall Study|Adverse Event|2|||
127543377|NCT03125395|458956535|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
127543378|NCT03125395|458956535|FG000|Overall Study|Physician Decision|2|||
127543379|NCT03125395|458956535|FG000|Overall Study|Commercial drug is available|5|||
127543380|NCT04218240|458956537|FG000|Overall Study|Withdrawal by Subject|6|||
127543381|NCT04218240|458956538|FG001|Overall Study|Withdrawal by Subject|0|||
127543382|NCT04218240|458956537|FG000|Overall Study|Lack of Efficacy|24|||
127543383|NCT04218240|458956538|FG001|Overall Study|Lack of Efficacy|19|||
127543384|NCT04218240|458956537|FG000|Overall Study|Physician Decision|0|||
127543385|NCT04218240|458956538|FG001|Overall Study|Physician Decision|1|||
127543386|NCT04218240|458956537|FG000|Overall Study|Not Dosed Never met WD criteria|4|||
127543387|NCT04218240|458956538|FG001|Overall Study|Not Dosed Never met WD criteria|1|||
127543388|NCT01643668|458956541|FG000|Overall Study|Death|1|||
127543389|NCT03253796|458956542|FG000|Period 1: Run-In|Adverse Event|4|||
127543390|NCT03253796|458956543|FG001|Period 1: Run-In|Adverse Event|0|||
127543391|NCT03253796|458956544|FG002|Period 1: Run-In|Adverse Event|0|||
127543392|NCT03253796|458956545|FG003|Period 1: Run-In|Adverse Event|0|||
127543393|NCT03253796|458956546|FG004|Period 1: Run-In|Adverse Event|0|||
127543394|NCT03253796|458956542|FG000|Period 1: Run-In|Lack of Efficacy|1|||
127543395|NCT03253796|458956543|FG001|Period 1: Run-In|Lack of Efficacy|0|||
127543396|NCT03253796|458956544|FG002|Period 1: Run-In|Lack of Efficacy|0|||
127543397|NCT03253796|458956545|FG003|Period 1: Run-In|Lack of Efficacy|0|||
127543398|NCT03253796|458956546|FG004|Period 1: Run-In|Lack of Efficacy|0|||
127543399|NCT03253796|458956542|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
127543400|NCT03253796|458956543|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
127543401|NCT03253796|458956544|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
127543402|NCT03253796|458956545|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
127543403|NCT03253796|458956546|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
127543404|NCT03253796|458956542|FG000|Period 1: Run-In|Protocol Violation|5|||
127543405|NCT03253796|458956543|FG001|Period 1: Run-In|Protocol Violation|0|||
127543406|NCT03253796|458956544|FG002|Period 1: Run-In|Protocol Violation|0|||
127543407|NCT03253796|458956545|FG003|Period 1: Run-In|Protocol Violation|0|||
127543408|NCT03253796|458956546|FG004|Period 1: Run-In|Protocol Violation|0|||
127543409|NCT03253796|458956542|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
127543410|NCT03253796|458956543|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
127543411|NCT03253796|458956544|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
127543412|NCT03253796|458956545|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
127543413|NCT03253796|458956546|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
127543414|NCT03253796|458956542|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
127543415|NCT03253796|458956543|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
127543416|NCT03253796|458956544|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
127543417|NCT03253796|458956545|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
127543418|NCT03253796|458956546|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
127543419|NCT03253796|458956542|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
127543420|NCT03253796|458956543|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
127543421|NCT03253796|458956544|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
127543422|NCT03253796|458956545|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
127543423|NCT03253796|458956546|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
127543424|NCT03253796|458956542|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
127543425|NCT03253796|458956543|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
127543426|NCT03253796|458956544|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
127543427|NCT03253796|458956545|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
127543428|NCT03253796|458956546|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
127543429|NCT03253796|458956542|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
127543430|NCT03253796|458956543|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
127543431|NCT03253796|458956544|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
127543432|NCT03253796|458956545|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
127668093|NCT04423393|459407086|FG005|Overall Study|Withdrawal by Subject|1|||
128001706|NCT01534273|460633446|FG005|Period 1|Physician Decision|0|||
128001707|NCT01534273|460633447|FG006|Period 1|Physician Decision|0|||
128001708|NCT03586050|460633448|FG000|Overall Study|Death|3|||
128001709|NCT03586050|460633448|FG000|Overall Study|Withdrawal by Subject|2|||
128001710|NCT01435759|460633449|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
128001711|NCT01435759|460633450|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
128001712|NCT01435759|460633451|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
128001713|NCT01435759|460633452|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
128001714|NCT01435759|460633453|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
128001715|NCT01435759|460633454|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
128001716|NCT01435759|460633449|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
128001717|NCT01435759|460633450|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
128001718|NCT01435759|460633451|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
128001719|NCT01435759|460633452|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
128001720|NCT01435759|460633453|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
128001721|NCT01435759|460633454|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
128001722|NCT01435759|460633449|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
128001723|NCT01435759|460633450|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
128001724|NCT01435759|460633451|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
128001725|NCT01435759|460633452|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
128001726|NCT01435759|460633453|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
128001727|NCT01435759|460633454|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
128001728|NCT01435759|460633449|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
128001729|NCT01435759|460633450|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
128001730|NCT01435759|460633451|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
128001731|NCT01435759|460633452|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
128001732|NCT01435759|460633453|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
128001733|NCT01435759|460633454|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
127668094|NCT04423393|459407087|FG006|Overall Study|Withdrawal by Subject|0|||
127668095|NCT04423393|459407088|FG007|Overall Study|Withdrawal by Subject|0|||
127668096|NCT04423393|459407089|FG008|Overall Study|Withdrawal by Subject|0|||
127668097|NCT04423393|459407090|FG009|Overall Study|Withdrawal by Subject|0|||
127668098|NCT04423393|459407091|FG010|Overall Study|Withdrawal by Subject|0|||
127668099|NCT04423393|459407092|FG011|Overall Study|Withdrawal by Subject|0|||
127668100|NCT04423393|459407093|FG012|Overall Study|Withdrawal by Subject|0|||
127668101|NCT04423393|459407094|FG013|Overall Study|Withdrawal by Subject|1|||
127668102|NCT04423393|459407095|FG014|Overall Study|Withdrawal by Subject|0|||
127668103|NCT04423393|459407096|FG015|Overall Study|Withdrawal by Subject|0|||
127668104|NCT04423393|459407097|FG016|Overall Study|Withdrawal by Subject|0|||
127668105|NCT04423393|459407098|FG017|Overall Study|Withdrawal by Subject|0|||
127668106|NCT04423393|459407081|FG000|Overall Study|Sponsor Decision|0|||
127668107|NCT04423393|459407082|FG001|Overall Study|Sponsor Decision|0|||
127668108|NCT04423393|459407083|FG002|Overall Study|Sponsor Decision|0|||
127668109|NCT04423393|459407084|FG003|Overall Study|Sponsor Decision|0|||
127668110|NCT04423393|459407085|FG004|Overall Study|Sponsor Decision|0|||
127668111|NCT04423393|459407086|FG005|Overall Study|Sponsor Decision|0|||
127668112|NCT04423393|459407087|FG006|Overall Study|Sponsor Decision|0|||
127668113|NCT04423393|459407088|FG007|Overall Study|Sponsor Decision|0|||
127668114|NCT04423393|459407089|FG008|Overall Study|Sponsor Decision|0|||
127668115|NCT04423393|459407090|FG009|Overall Study|Sponsor Decision|0|||
127668116|NCT04423393|459407091|FG010|Overall Study|Sponsor Decision|0|||
127668117|NCT04423393|459407092|FG011|Overall Study|Sponsor Decision|0|||
127668118|NCT04423393|459407093|FG012|Overall Study|Sponsor Decision|0|||
127668119|NCT04423393|459407094|FG013|Overall Study|Sponsor Decision|1|||
127668120|NCT04423393|459407095|FG014|Overall Study|Sponsor Decision|0|||
127668121|NCT04423393|459407096|FG015|Overall Study|Sponsor Decision|0|||
127668122|NCT04423393|459407097|FG016|Overall Study|Sponsor Decision|0|||
127668123|NCT04423393|459407098|FG017|Overall Study|Sponsor Decision|0|||
127668124|NCT03850444|459407101|FG000|Overall Study|Adverse Event|16|||
127668125|NCT03850444|459407102|FG001|Overall Study|Adverse Event|10|||
127668126|NCT03850444|459407101|FG000|Overall Study|Death|87|||
127668127|NCT03850444|459407102|FG001|Overall Study|Death|107|||
127668128|NCT03850444|459407101|FG000|Overall Study|Lost to Follow-up|1|||
127668129|NCT03850444|459407102|FG001|Overall Study|Lost to Follow-up|1|||
127668130|NCT03850444|459407101|FG000|Overall Study|Withdrawal by Subject|1|||
127668131|NCT03850444|459407102|FG001|Overall Study|Withdrawal by Subject|5|||
127668132|NCT03850444|459407101|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
127668133|NCT03850444|459407102|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
127668134|NCT04096365|459407103|FG000|Overall Study|Adverse Event|1|||
128001734|NCT01435759|460633449|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
128001735|NCT01435759|460633450|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
128001736|NCT01435759|460633451|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
127668135|NCT05310084|459407104|FG000|Overall Study|Withdrawal by Subject|2|||
127668136|NCT05310084|459407105|FG001|Overall Study|Withdrawal by Subject|3|||
127668137|NCT05310084|459407104|FG000|Overall Study|Participant availability|0|||
127668138|NCT05310084|459407105|FG001|Overall Study|Participant availability|4|||
127668139|NCT05310084|459407104|FG000|Overall Study|Lost to Follow-up|1|||
127668140|NCT05310084|459407105|FG001|Overall Study|Lost to Follow-up|1|||
127668141|NCT05310084|459407104|FG000|Overall Study|Adverse Event|1|||
127668142|NCT05310084|459407105|FG001|Overall Study|Adverse Event|1|||
127668143|NCT05310084|459407104|FG000|Overall Study|Randomized but not vaccinated|4|||
127668144|NCT05310084|459407105|FG001|Overall Study|Randomized but not vaccinated|2|||
127668145|NCT01598987|459407107|FG000|Baseline to Month 12|Administrative problems|2|||
127668146|NCT01598987|459407107|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
127668147|NCT01598987|459407107|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
127668148|NCT01598987|459407107|FG000|Baseline to 24 Month|Administrative problems|2|||
127668149|NCT01598987|459407107|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
127668150|NCT02107274|459407108|FG000|Treatment vs. Placebo|Adverse Event|3|||
127668151|NCT02107274|459407109|FG001|Treatment vs. Placebo|Adverse Event|0|||
127668152|NCT02107274|459407108|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
127668153|NCT02107274|459407109|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
127668154|NCT02107274|459407108|FG000|Control Phase|Lost to Follow-up|1|||
127668155|NCT02107274|459407109|FG001|Control Phase|Lost to Follow-up|1|||
127668156|NCT02107274|459407108|FG000|Control Phase|Death|2|||
127668157|NCT02107274|459407109|FG001|Control Phase|Death|0|||
127668158|NCT02107274|459407108|FG000|Control Phase|Adverse Event|0|||
127668159|NCT02107274|459407109|FG001|Control Phase|Adverse Event|1|||
127668160|NCT01036087|459407111|FG000|Overall Study|Adverse Event|2|||
127668161|NCT01036087|459407111|FG000|Overall Study|Lack of Efficacy|1|||
127668162|NCT02424344|459407115|FG000|Overall Study|Lack of Efficacy|0|||
127668163|NCT02424344|459407116|FG001|Overall Study|Lack of Efficacy|1|||
127668164|NCT02424344|459407115|FG000|Overall Study|Withdrawal by Subject|2|||
127668165|NCT02424344|459407116|FG001|Overall Study|Withdrawal by Subject|1|||
127668166|NCT02424344|459407115|FG000|Overall Study|Lost to Follow-up|1|||
127668167|NCT02424344|459407116|FG001|Overall Study|Lost to Follow-up|0|||
127668168|NCT02424344|459407115|FG000|Overall Study|Adverse Event|4|||
127668169|NCT02424344|459407116|FG001|Overall Study|Adverse Event|8|||
127668170|NCT01511536|459407123|FG000|Phase 1|Other|0|||
127668171|NCT01511536|459407124|FG001|Phase 1|Other|1|||
127668172|NCT01511536|459407125|FG002|Phase 1|Other|0|||
127668173|NCT01511536|459407123|FG000|Phase 2|Other|0|||
127668174|NCT01511536|459407124|FG001|Phase 2|Other|0|||
127668175|NCT01511536|459407125|FG002|Phase 2|Other|9|||
127668176|NCT03019458|459407132|FG000|Overall Study|Death|0|||
127668177|NCT03019458|459407133|FG001|Overall Study|Death|1|||
127668178|NCT00557505|459407134|FG000|Overall Study|Death|0|||
127668179|NCT00557505|459407135|FG001|Overall Study|Death|0|||
127668180|NCT00557505|459407136|FG002|Overall Study|Death|0|||
127668181|NCT00557505|459407137|FG003|Overall Study|Death|0|||
127668182|NCT00557505|459407138|FG004|Overall Study|Death|0|||
127668183|NCT00557505|459407139|FG005|Overall Study|Death|0|||
127668184|NCT00557505|459407140|FG006|Overall Study|Death|0|||
127668185|NCT00557505|459407141|FG007|Overall Study|Death|0|||
127668186|NCT00557505|459407142|FG008|Overall Study|Death|1|||
127668187|NCT00557505|459407134|FG000|Overall Study|Adverse Event|0|||
128001737|NCT01435759|460633452|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
128001738|NCT01435759|460633453|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
128001739|NCT01435759|460633454|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
128001740|NCT01435759|460633449|FG000|Antidepressant Lead-in Phase|Other|119|||
128001741|NCT01435759|460633450|FG001|Antidepressant Lead-in Phase|Other|0|||
127668188|NCT00557505|459407135|FG001|Overall Study|Adverse Event|0|||
127668189|NCT00557505|459407136|FG002|Overall Study|Adverse Event|1|||
127668190|NCT00557505|459407137|FG003|Overall Study|Adverse Event|0|||
127668191|NCT00557505|459407138|FG004|Overall Study|Adverse Event|0|||
127668192|NCT00557505|459407139|FG005|Overall Study|Adverse Event|0|||
127668193|NCT00557505|459407140|FG006|Overall Study|Adverse Event|1|||
127668194|NCT00557505|459407141|FG007|Overall Study|Adverse Event|0|||
127668195|NCT00557505|459407142|FG008|Overall Study|Adverse Event|0|||
127668196|NCT00557505|459407134|FG000|Overall Study|Global deterioration of health|1|||
127668197|NCT00557505|459407135|FG001|Overall Study|Global deterioration of health|0|||
127668198|NCT00557505|459407136|FG002|Overall Study|Global deterioration of health|0|||
127668199|NCT00557505|459407137|FG003|Overall Study|Global deterioration of health|0|||
127668200|NCT00557505|459407138|FG004|Overall Study|Global deterioration of health|0|||
127668201|NCT00557505|459407139|FG005|Overall Study|Global deterioration of health|0|||
127668202|NCT00557505|459407140|FG006|Overall Study|Global deterioration of health|0|||
128001742|NCT01435759|460633451|FG002|Antidepressant Lead-in Phase|Other|0|||
127668203|NCT00557505|459407141|FG007|Overall Study|Global deterioration of health|0|||
127668204|NCT00557505|459407142|FG008|Overall Study|Global deterioration of health|0|||
127668205|NCT00557505|459407134|FG000|Overall Study|Objective progression or relapse|2|||
127668206|NCT00557505|459407135|FG001|Overall Study|Objective progression or relapse|3|||
127543433|NCT03253796|458956546|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
127668207|NCT00557505|459407136|FG002|Overall Study|Objective progression or relapse|3|||
127668208|NCT00557505|459407137|FG003|Overall Study|Objective progression or relapse|2|||
127668209|NCT00557505|459407138|FG004|Overall Study|Objective progression or relapse|2|||
127668210|NCT00557505|459407139|FG005|Overall Study|Objective progression or relapse|3|||
127668211|NCT00557505|459407140|FG006|Overall Study|Objective progression or relapse|2|||
127668212|NCT00557505|459407141|FG007|Overall Study|Objective progression or relapse|5|||
127668213|NCT00557505|459407142|FG008|Overall Study|Objective progression or relapse|15|||
127668214|NCT00557505|459407134|FG000|Overall Study|Withdrawal by Subject|0|||
127668215|NCT00557505|459407135|FG001|Overall Study|Withdrawal by Subject|0|||
127668216|NCT00557505|459407136|FG002|Overall Study|Withdrawal by Subject|0|||
127668217|NCT00557505|459407137|FG003|Overall Study|Withdrawal by Subject|1|||
127668218|NCT00557505|459407138|FG004|Overall Study|Withdrawal by Subject|0|||
127668219|NCT00557505|459407139|FG005|Overall Study|Withdrawal by Subject|0|||
127668220|NCT00557505|459407140|FG006|Overall Study|Withdrawal by Subject|0|||
127668221|NCT00557505|459407141|FG007|Overall Study|Withdrawal by Subject|0|||
127668222|NCT00557505|459407142|FG008|Overall Study|Withdrawal by Subject|1|||
127668223|NCT00031447|459407143|FG000|Overall Study|Lost to Follow-up|0|||
127668224|NCT00031447|459407144|FG001|Overall Study|Lost to Follow-up|1|||
127668225|NCT00031447|459407143|FG000|Overall Study|Non-compliant|1|||
127668226|NCT00031447|459407144|FG001|Overall Study|Non-compliant|1|||
127668227|NCT00031447|459407143|FG000|Overall Study|Re-activation of Disease|2|||
127668228|NCT00031447|459407144|FG001|Overall Study|Re-activation of Disease|1|||
127668229|NCT00031447|459407143|FG000|Overall Study|Disruption of blinded study drug supply|7|||
127668230|NCT00031447|459407144|FG001|Overall Study|Disruption of blinded study drug supply|4|||
127668231|NCT01244763|459407145|FG000|Overall Study|Adverse Event|1|||
127668232|NCT01244763|459407146|FG001|Overall Study|Adverse Event|0|||
127668233|NCT01244763|459407147|FG002|Overall Study|Adverse Event|0|||
127668234|NCT01244763|459407148|FG003|Overall Study|Adverse Event|0|||
127668235|NCT01244763|459407149|FG004|Overall Study|Adverse Event|0|||
127668236|NCT01244763|459407150|FG005|Overall Study|Adverse Event|1|||
127668237|NCT01244763|459407145|FG000|Overall Study|Death|1|||
127668238|NCT01244763|459407146|FG001|Overall Study|Death|0|||
127668239|NCT01244763|459407147|FG002|Overall Study|Death|1|||
127668240|NCT01244763|459407148|FG003|Overall Study|Death|0|||
127668241|NCT01244763|459407149|FG004|Overall Study|Death|2|||
127668242|NCT01244763|459407150|FG005|Overall Study|Death|0|||
127668243|NCT01244763|459407145|FG000|Overall Study|Physician Decision|0|||
127668244|NCT01244763|459407146|FG001|Overall Study|Physician Decision|0|||
127668245|NCT01244763|459407147|FG002|Overall Study|Physician Decision|1|||
127668246|NCT01244763|459407148|FG003|Overall Study|Physician Decision|0|||
127668247|NCT01244763|459407149|FG004|Overall Study|Physician Decision|0|||
127668248|NCT01244763|459407150|FG005|Overall Study|Physician Decision|0|||
127668249|NCT01244763|459407145|FG000|Overall Study|Withdrawal by Subject|1|||
127668250|NCT01244763|459407146|FG001|Overall Study|Withdrawal by Subject|2|||
127668251|NCT01244763|459407147|FG002|Overall Study|Withdrawal by Subject|0|||
127668252|NCT01244763|459407148|FG003|Overall Study|Withdrawal by Subject|1|||
127668253|NCT01244763|459407149|FG004|Overall Study|Withdrawal by Subject|1|||
127668254|NCT01244763|459407150|FG005|Overall Study|Withdrawal by Subject|2|||
127668255|NCT01244763|459407145|FG000|Overall Study|Lost to Follow-up|0|||
127668256|NCT01244763|459407146|FG001|Overall Study|Lost to Follow-up|1|||
127668257|NCT01244763|459407147|FG002|Overall Study|Lost to Follow-up|0|||
127668258|NCT01244763|459407148|FG003|Overall Study|Lost to Follow-up|0|||
127668259|NCT01244763|459407149|FG004|Overall Study|Lost to Follow-up|0|||
127668260|NCT01244763|459407150|FG005|Overall Study|Lost to Follow-up|0|||
127668261|NCT01244763|459407145|FG000|Overall Study|Enrolled into the Extension Study|0|||
127668262|NCT01244763|459407146|FG001|Overall Study|Enrolled into the Extension Study|0|||
127668263|NCT01244763|459407147|FG002|Overall Study|Enrolled into the Extension Study|0|||
127668264|NCT01244763|459407148|FG003|Overall Study|Enrolled into the Extension Study|0|||
127668265|NCT01244763|459407149|FG004|Overall Study|Enrolled into the Extension Study|0|||
128001743|NCT01435759|460633452|FG003|Antidepressant Lead-in Phase|Other|0|||
128001744|NCT01435759|460633453|FG004|Antidepressant Lead-in Phase|Other|0|||
128001745|NCT01435759|460633454|FG005|Antidepressant Lead-in Phase|Other|0|||
128001746|NCT01435759|460633449|FG000|Double-blind Phase|Adverse Event|7|||
128001747|NCT01435759|460633450|FG001|Double-blind Phase|Adverse Event|0|||
128001748|NCT01435759|460633451|FG002|Double-blind Phase|Adverse Event|1|||
128001749|NCT01435759|460633452|FG003|Double-blind Phase|Adverse Event|1|||
128001750|NCT01435759|460633453|FG004|Double-blind Phase|Adverse Event|1|||
127668266|NCT01244763|459407150|FG005|Overall Study|Enrolled into the Extension Study|1|||
127668267|NCT00519779|459407152|FG000|Overall Study|Withdrawal by Subject|0|||
127668268|NCT00519779|459407153|FG001|Overall Study|Withdrawal by Subject|1|||
127668269|NCT01561079|459407154|FG000|Overall Study|Physician Decision|17|||
128001751|NCT01435759|460633454|FG005|Double-blind Phase|Adverse Event|3|||
128001752|NCT01435759|460633449|FG000|Double-blind Phase|Protocol Violation|2|||
127668270|NCT01561079|459407154|FG000|Overall Study|Withdrawal by Subject|59|||
127668271|NCT01561079|459407154|FG000|Overall Study|Protocol Violation|2|||
127668272|NCT03330119|459407155|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
127668273|NCT03330119|459407156|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
128001753|NCT01435759|460633450|FG001|Double-blind Phase|Protocol Violation|0|||
128001754|NCT01435759|460633451|FG002|Double-blind Phase|Protocol Violation|1|||
127668274|NCT00664521|459407168|FG000|Overall Study|Adverse Event|4|||
127668275|NCT00664521|459407169|FG001|Overall Study|Adverse Event|1|||
127668276|NCT00664521|459407168|FG000|Overall Study|Lost to Follow-up|1|||
127668277|NCT00664521|459407169|FG001|Overall Study|Lost to Follow-up|0|||
127668278|NCT00664521|459407168|FG000|Overall Study|Other|1|||
127668279|NCT00664521|459407169|FG001|Overall Study|Other|0|||
127668280|NCT02459964|459407170|FG000|Overall Study|Withdrawal by Subject|0|||
127668281|NCT02459964|459407171|FG001|Overall Study|Withdrawal by Subject|0|||
127668282|NCT02459964|459407172|FG002|Overall Study|Withdrawal by Subject|1|||
127668283|NCT02459964|459407170|FG000|Overall Study|Abnormal EKG changes|0|||
127668284|NCT02459964|459407171|FG001|Overall Study|Abnormal EKG changes|0|||
127668285|NCT02459964|459407172|FG002|Overall Study|Abnormal EKG changes|1|||
127668286|NCT00367237|459407173|FG000|Overall Study|Adverse Event|7|||
127668287|NCT00367237|459407174|FG001|Overall Study|Adverse Event|2|||
128001755|NCT01435759|460633452|FG003|Double-blind Phase|Protocol Violation|2|||
128001756|NCT01435759|460633453|FG004|Double-blind Phase|Protocol Violation|0|||
128001757|NCT01435759|460633454|FG005|Double-blind Phase|Protocol Violation|1|||
127668288|NCT00367237|459407173|FG000|Overall Study|Lost to Follow-up|1|||
127668289|NCT00367237|459407174|FG001|Overall Study|Lost to Follow-up|0|||
127668290|NCT00367237|459407173|FG000|Overall Study|Withdrawal by Subject|0|||
127668291|NCT00367237|459407174|FG001|Overall Study|Withdrawal by Subject|4|||
127668292|NCT00367237|459407173|FG000|Overall Study|Protocol Violation|2|||
127668293|NCT00367237|459407174|FG001|Overall Study|Protocol Violation|5|||
127668294|NCT00550732|459407175|FG000|Overall Study|Death|4|||
127668295|NCT00550732|459407175|FG000|Overall Study|Withdrawal by Subject|2|||
127668296|NCT00550732|459407175|FG000|Overall Study|Physician Decision|2|||
127668297|NCT00550732|459407175|FG000|Overall Study|Lost to Follow-up|1|||
127668298|NCT00550732|459407175|FG000|Overall Study|Palliative care|1|||
127668299|NCT00550732|459407175|FG000|Overall Study|Adverse Event|1|||
128001758|NCT01435759|460633449|FG000|Double-blind Phase|Withdrawal by Subject|17|||
128001759|NCT01435759|460633450|FG001|Double-blind Phase|Withdrawal by Subject|4|||
128001760|NCT01435759|460633451|FG002|Double-blind Phase|Withdrawal by Subject|3|||
128001761|NCT01435759|460633452|FG003|Double-blind Phase|Withdrawal by Subject|4|||
128001762|NCT01435759|460633453|FG004|Double-blind Phase|Withdrawal by Subject|2|||
128001763|NCT01435759|460633454|FG005|Double-blind Phase|Withdrawal by Subject|2|||
128001764|NCT01435759|460633449|FG000|Double-blind Phase|Lost to Follow-up|31|||
128001765|NCT01435759|460633450|FG001|Double-blind Phase|Lost to Follow-up|1|||
128001766|NCT01435759|460633451|FG002|Double-blind Phase|Lost to Follow-up|2|||
128001767|NCT01435759|460633452|FG003|Double-blind Phase|Lost to Follow-up|0|||
128001768|NCT01435759|460633453|FG004|Double-blind Phase|Lost to Follow-up|3|||
128001769|NCT01435759|460633454|FG005|Double-blind Phase|Lost to Follow-up|3|||
128001770|NCT01435759|460633449|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
128001771|NCT01435759|460633450|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
128001772|NCT01435759|460633451|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
128001773|NCT01435759|460633452|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
128001774|NCT01435759|460633453|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
128001775|NCT01435759|460633454|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
128001776|NCT01435759|460633449|FG000|Double-blind Phase|Other|8|||
128001777|NCT01435759|460633450|FG001|Double-blind Phase|Other|2|||
128001778|NCT01435759|460633451|FG002|Double-blind Phase|Other|0|||
128001779|NCT01435759|460633452|FG003|Double-blind Phase|Other|2|||
128001780|NCT01435759|460633453|FG004|Double-blind Phase|Other|0|||
128001781|NCT01435759|460633454|FG005|Double-blind Phase|Other|0|||
128001782|NCT01211145|460633455|FG000|Overall Study|Reason not specified|3|||
128001783|NCT01211145|460633456|FG001|Overall Study|Reason not specified|2|||
127668300|NCT03302910|459407179|FG000|Overall Study|Protocol Violation|1|||
127668301|NCT03302910|459407180|FG001|Overall Study|Protocol Violation|0|||
127668302|NCT02800928|459407183|FG000|Overall Study|Withdrawal by Subject|1|||
127668303|NCT02800928|459407184|FG001|Overall Study|Withdrawal by Subject|1|||
127668304|NCT02800928|459407183|FG000|Overall Study|Protocol Violation|1|||
127668305|NCT02800928|459407184|FG001|Overall Study|Protocol Violation|1|||
127668306|NCT04004208|459407191|FG000|Overall Study|Withdrawal by parent/guardian|1|||
127668307|NCT04004208|459407192|FG001|Overall Study|Withdrawal by parent/guardian|1|||
127668308|NCT04004208|459407191|FG000|Overall Study|Death|3|||
128001784|NCT01211145|460633457|FG002|Overall Study|Reason not specified|2|||
127668309|NCT04004208|459407192|FG001|Overall Study|Death|0|||
127668310|NCT04004208|459407191|FG000|Overall Study|COVID-19 pandemic|1|||
127668311|NCT04004208|459407192|FG001|Overall Study|COVID-19 pandemic|0|||
128001785|NCT01211145|460633458|FG003|Overall Study|Reason not specified|1|||
128001786|NCT01211145|460633455|FG000|Overall Study|Lost to Follow-up|3|||
128001787|NCT01211145|460633456|FG001|Overall Study|Lost to Follow-up|2|||
128001788|NCT01211145|460633457|FG002|Overall Study|Lost to Follow-up|1|||
127668312|NCT04004208|459407191|FG000|Overall Study|Physician Decision|1|||
127668313|NCT04004208|459407192|FG001|Overall Study|Physician Decision|0|||
127668314|NCT04004208|459407191|FG000|Overall Study|Adverse Event|1|||
128001789|NCT01211145|460633458|FG003|Overall Study|Lost to Follow-up|2|||
128001790|NCT01211145|460633455|FG000|Overall Study|Study-specific withdrawal criteria|1|||
128001791|NCT01211145|460633456|FG001|Overall Study|Study-specific withdrawal criteria|0|||
128001792|NCT01211145|460633457|FG002|Overall Study|Study-specific withdrawal criteria|0|||
128001793|NCT01211145|460633458|FG003|Overall Study|Study-specific withdrawal criteria|0|||
128001794|NCT01211145|460633455|FG000|Overall Study|Severe noncompliance to protocol|1|||
128001795|NCT01211145|460633456|FG001|Overall Study|Severe noncompliance to protocol|0|||
128001796|NCT01211145|460633457|FG002|Overall Study|Severe noncompliance to protocol|0|||
128001797|NCT01211145|460633458|FG003|Overall Study|Severe noncompliance to protocol|0|||
128001798|NCT01211145|460633455|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
128001799|NCT01211145|460633456|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
128001800|NCT01211145|460633457|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
128001801|NCT01211145|460633458|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
128001802|NCT01211145|460633455|FG000|Overall Study|Patient decision|2|||
128001803|NCT01211145|460633456|FG001|Overall Study|Patient decision|1|||
128001804|NCT01211145|460633457|FG002|Overall Study|Patient decision|0|||
128001805|NCT01211145|460633458|FG003|Overall Study|Patient decision|2|||
128001806|NCT00570401|460633459|FG000|Overall Study|Adverse Event|2|||
128001807|NCT04202497|460633460|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
128001808|NCT04202497|460633461|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
128001809|NCT04202497|460633462|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
128001810|NCT04202497|460633463|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
128001811|NCT02115607|460633470|FG000|Overall Study|Withdrawal by Subject|1|||
127668315|NCT04004208|459407192|FG001|Overall Study|Adverse Event|1|||
127668316|NCT00570661|459407204|FG000|Overall Study|Disease worsening|5|||
127668317|NCT00570661|459407204|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
127668318|NCT00570661|459407204|FG000|Overall Study|Adverse Event|1|||
127668319|NCT01734382|459407205|FG000|Part 1|Adverse Event|2|||
127668320|NCT01734382|459407206|FG001|Part 1|Adverse Event|0|||
127668321|NCT01734382|459407207|FG002|Part 1|Adverse Event|0|||
127668322|NCT01734382|459407205|FG000|Part 2|Adverse Event|0|||
127668323|NCT01734382|459407206|FG001|Part 2|Adverse Event|0|||
127668324|NCT01734382|459407207|FG002|Part 2|Adverse Event|1|||
127668325|NCT01734382|459407205|FG000|Part 2|Lack of Efficacy|0|||
127668326|NCT01734382|459407206|FG001|Part 2|Lack of Efficacy|1|||
127668327|NCT01734382|459407207|FG002|Part 2|Lack of Efficacy|1|||
127668328|NCT01734382|459407205|FG000|Part 2|Other|0|||
127668329|NCT01734382|459407206|FG001|Part 2|Other|0|||
127668330|NCT01734382|459407207|FG002|Part 2|Other|1|||
127668331|NCT01734382|459407205|FG000|Part 2|Physician Decision|0|||
127668332|NCT01734382|459407206|FG001|Part 2|Physician Decision|0|||
127668333|NCT01734382|459407207|FG002|Part 2|Physician Decision|3|||
127668334|NCT01734382|459407205|FG000|Part 2|Protocol Violation|0|||
127668335|NCT01734382|459407206|FG001|Part 2|Protocol Violation|1|||
127668336|NCT01734382|459407207|FG002|Part 2|Protocol Violation|0|||
127668337|NCT01734382|459407205|FG000|Part 2|Withdrawal by Subject|0|||
127668338|NCT01734382|459407206|FG001|Part 2|Withdrawal by Subject|0|||
127668339|NCT01734382|459407207|FG002|Part 2|Withdrawal by Subject|1|||
127668340|NCT02400307|459407208|FG000|Overall Study|Enrolled and Never Dosed|1|||
127668341|NCT02400307|459407209|FG001|Overall Study|Enrolled and Never Dosed|0|||
127668342|NCT01052662|459407212|FG000|Overall Study|Lost to Follow-up|15|||
127668343|NCT01052662|459407213|FG001|Overall Study|Lost to Follow-up|13|||
127668344|NCT01052662|459407214|FG002|Overall Study|Lost to Follow-up|18|||
127668345|NCT01052662|459407212|FG000|Overall Study|Withdrawal by Subject|3|||
127668346|NCT01052662|459407213|FG001|Overall Study|Withdrawal by Subject|2|||
127668347|NCT01052662|459407214|FG002|Overall Study|Withdrawal by Subject|1|||
127668348|NCT01052662|459407212|FG000|Overall Study|Pharmacy issue|1|||
127668349|NCT01052662|459407213|FG001|Overall Study|Pharmacy issue|3|||
127668350|NCT01052662|459407214|FG002|Overall Study|Pharmacy issue|3|||
127668351|NCT01052662|459407212|FG000|Overall Study|Adverse Event|1|||
127668352|NCT01052662|459407213|FG001|Overall Study|Adverse Event|1|||
127668353|NCT01052662|459407214|FG002|Overall Study|Adverse Event|0|||
127668354|NCT01052662|459407212|FG000|Overall Study|Legal Problem|2|||
127668355|NCT01052662|459407213|FG001|Overall Study|Legal Problem|0|||
127668356|NCT01052662|459407214|FG002|Overall Study|Legal Problem|0|||
127668357|NCT01052662|459407212|FG000|Overall Study|Administrative|0|||
127668358|NCT01052662|459407213|FG001|Overall Study|Administrative|3|||
127668359|NCT01052662|459407214|FG002|Overall Study|Administrative|0|||
127668360|NCT02015663|459407216|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
127668361|NCT02015663|459407217|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
127668362|NCT02015663|459407216|FG000|Overall Study|Withdrawal by Subject|1|||
127668363|NCT02015663|459407217|FG001|Overall Study|Withdrawal by Subject|0|||
127668364|NCT02015663|459407216|FG000|Overall Study|Protocol Violation|0|||
127668365|NCT02015663|459407217|FG001|Overall Study|Protocol Violation|1|||
128001812|NCT00102596|460633474|FG000|Part A|Screen failures|6|||
127668366|NCT02015663|459407216|FG000|Overall Study|Adverse Event|3|||
127668367|NCT02015663|459407217|FG001|Overall Study|Adverse Event|0|||
127668368|NCT02015663|459407216|FG000|Overall Study|Administrative problems|10|||
127668369|NCT02015663|459407217|FG001|Overall Study|Administrative problems|11|||
127668370|NCT01113463|459407218|FG000|Overall Study|Physician Decision|5|||
127668371|NCT00146640|459407222|FG000|Overall Study|Adverse Event|12|||
128001813|NCT00102596|460633475|FG001|Part A|Screen failures|0|||
128001814|NCT00102596|460633474|FG000|Part A|Adverse Event|1|||
128001815|NCT00102596|460633475|FG001|Part A|Adverse Event|0|||
128001816|NCT00069264|460633477|FG000|Overall Study|Adverse Event|3|||
127642737|NCT01483924|459313126|FG000|Overall Study|Withdrawal by Subject|2|||
127642738|NCT01483924|459313127|FG001|Overall Study|Withdrawal by Subject|0|||
127642739|NCT01483924|459313128|FG002|Overall Study|Withdrawal by Subject|0|||
127642740|NCT01483924|459313129|FG003|Overall Study|Withdrawal by Subject|1|||
127642741|NCT01483924|459313130|FG004|Overall Study|Withdrawal by Subject|1|||
127642742|NCT01483924|459313126|FG000|Overall Study|Adverse Event|0|||
127642743|NCT01483924|459313127|FG001|Overall Study|Adverse Event|0|||
127642744|NCT01483924|459313128|FG002|Overall Study|Adverse Event|1|||
127642745|NCT01483924|459313129|FG003|Overall Study|Adverse Event|1|||
127642746|NCT01483924|459313130|FG004|Overall Study|Adverse Event|0|||
127642747|NCT01483924|459313126|FG000|Overall Study|Non-compliance|0|||
127642748|NCT01483924|459313127|FG001|Overall Study|Non-compliance|0|||
127642749|NCT01483924|459313128|FG002|Overall Study|Non-compliance|0|||
127642750|NCT01483924|459313129|FG003|Overall Study|Non-compliance|1|||
127642751|NCT01483924|459313130|FG004|Overall Study|Non-compliance|1|||
127642752|NCT01483924|459313126|FG000|Overall Study|Sponsor concern over ECG result|0|||
127642753|NCT01483924|459313127|FG001|Overall Study|Sponsor concern over ECG result|0|||
127642754|NCT01483924|459313128|FG002|Overall Study|Sponsor concern over ECG result|0|||
127642755|NCT01483924|459313129|FG003|Overall Study|Sponsor concern over ECG result|1|||
127642756|NCT01483924|459313130|FG004|Overall Study|Sponsor concern over ECG result|0|||
127642757|NCT03565887|459313138|FG000|Overall Study|Adverse Event|1|||
127642758|NCT03565887|459313139|FG001|Overall Study|Adverse Event|0|||
127642759|NCT03565887|459313138|FG000|Overall Study|Withdrawal by Subject|0|||
127642760|NCT03565887|459313139|FG001|Overall Study|Withdrawal by Subject|2|||
127642761|NCT01994954|459313140|FG000|Overall Study|Death|1|||
127642762|NCT01994954|459313141|FG001|Overall Study|Death|0|||
127642763|NCT01994954|459313140|FG000|Overall Study|Withdrawal by Subject|9|||
127642764|NCT01994954|459313141|FG001|Overall Study|Withdrawal by Subject|14|||
127642765|NCT01994954|459313140|FG000|Overall Study|Physician Decision|2|||
127642766|NCT01994954|459313141|FG001|Overall Study|Physician Decision|2|||
127642767|NCT01994954|459313140|FG000|Overall Study|Lost to Follow-up|8|||
127642768|NCT01994954|459313141|FG001|Overall Study|Lost to Follow-up|10|||
127642769|NCT01994954|459313140|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
127642770|NCT01994954|459313141|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
127642771|NCT00449176|459313142|FG000|Overall Study|Withdrawal by Subject|39|||
127642772|NCT00449176|459313143|FG001|Overall Study|Withdrawal by Subject|43|||
127642773|NCT00449176|459313144|FG002|Overall Study|Withdrawal by Subject|59|||
127642774|NCT00449176|459313142|FG000|Overall Study|Lost to Follow-up|13|||
127642775|NCT00449176|459313143|FG001|Overall Study|Lost to Follow-up|8|||
127642776|NCT00449176|459313144|FG002|Overall Study|Lost to Follow-up|12|||
127642777|NCT00449176|459313142|FG000|Overall Study|Adverse Event|51|||
127642778|NCT00449176|459313143|FG001|Overall Study|Adverse Event|107|||
127642779|NCT00449176|459313144|FG002|Overall Study|Adverse Event|15|||
127642780|NCT00449176|459313142|FG000|Overall Study|Lack of Efficacy|13|||
127642781|NCT00449176|459313143|FG001|Overall Study|Lack of Efficacy|7|||
127642782|NCT00449176|459313144|FG002|Overall Study|Lack of Efficacy|50|||
127642783|NCT00449176|459313142|FG000|Overall Study|Study drug non-compliant|14|||
127642784|NCT00449176|459313143|FG001|Overall Study|Study drug non-compliant|11|||
127642785|NCT00449176|459313144|FG002|Overall Study|Study drug non-compliant|11|||
127642786|NCT00449176|459313142|FG000|Overall Study|all other|22|||
127642787|NCT00449176|459313143|FG001|Overall Study|all other|19|||
127642788|NCT00449176|459313144|FG002|Overall Study|all other|20|||
127642789|NCT01454583|459313151|FG000|1st Year|Lost to Follow-up|1057|||
127642790|NCT01454583|459313152|FG001|1st Year|Lost to Follow-up|318|||
127642791|NCT01454583|459313153|FG002|1st Year|Lost to Follow-up|180|||
127642792|NCT01454583|459313151|FG000|2nd Year|Lost to Follow-up|3965|||
127642793|NCT01454583|459313152|FG001|2nd Year|Lost to Follow-up|1049|||
127642794|NCT01454583|459313153|FG002|2nd Year|Lost to Follow-up|737|||
127642795|NCT01454583|459313151|FG000|3rd Year|Lost to Follow-up|1959|||
127642796|NCT01454583|459313152|FG001|3rd Year|Lost to Follow-up|512|||
127642797|NCT01454583|459313153|FG002|3rd Year|Lost to Follow-up|297|||
127642798|NCT02677116|459313154|FG000|Overall Study|Adverse Event|0|||
127642799|NCT02677116|459313155|FG001|Overall Study|Adverse Event|1|||
127642800|NCT02677116|459313156|FG002|Overall Study|Adverse Event|0|||
127642801|NCT02677116|459313157|FG003|Overall Study|Adverse Event|0|||
127642802|NCT02677116|459313158|FG004|Overall Study|Adverse Event|0|||
127642803|NCT02677116|459313159|FG005|Overall Study|Adverse Event|1|||
127642804|NCT02677116|459313160|FG006|Overall Study|Adverse Event|1|||
127642805|NCT02677116|459313161|FG007|Overall Study|Adverse Event|0|||
127642806|NCT02677116|459313162|FG008|Overall Study|Adverse Event|0|||
127642807|NCT02677116|459313154|FG000|Overall Study|Physician Decision|0|||
127642808|NCT02677116|459313155|FG001|Overall Study|Physician Decision|2|||
127642809|NCT02677116|459313156|FG002|Overall Study|Physician Decision|3|||
127668372|NCT00146640|459407223|FG001|Overall Study|Adverse Event|10|||
127668373|NCT00146640|459407222|FG000|Overall Study|Medical Reasons|3|||
128001817|NCT00069264|460633477|FG000|Overall Study|Progressive Disease|23|||
127668374|NCT00146640|459407223|FG001|Overall Study|Medical Reasons|0|||
127668375|NCT00146640|459407222|FG000|Overall Study|Non-Medical Reasons|8|||
127668376|NCT00146640|459407223|FG001|Overall Study|Non-Medical Reasons|4|||
127668377|NCT03293485|459407224|FG000|Overall Study|Death|1|||
127668378|NCT03293485|459407224|FG000|Overall Study|Screen Failure|2|||
127668379|NCT03293485|459407224|FG000|Overall Study|Withdrawal by Subject|2|||
127668380|NCT03023332|459407225|FG000|Overall Study|Withdrawal by Subject|10|||
127668381|NCT03023332|459407226|FG001|Overall Study|Withdrawal by Subject|5|||
127668382|NCT03023332|459407227|FG002|Overall Study|Withdrawal by Subject|4|||
127668383|NCT03023332|459407228|FG003|Overall Study|Withdrawal by Subject|7|||
127668384|NCT03023332|459407225|FG000|Overall Study|Lost to Follow-up|13|||
127668385|NCT03023332|459407226|FG001|Overall Study|Lost to Follow-up|16|||
127668386|NCT03023332|459407227|FG002|Overall Study|Lost to Follow-up|8|||
127668387|NCT03023332|459407228|FG003|Overall Study|Lost to Follow-up|13|||
127668388|NCT03023332|459407225|FG000|Overall Study|Death|1|||
127668389|NCT03023332|459407226|FG001|Overall Study|Death|0|||
127668390|NCT03023332|459407227|FG002|Overall Study|Death|0|||
127668391|NCT03023332|459407228|FG003|Overall Study|Death|0|||
127668392|NCT02408549|459407231|FG000|Overall Study|Adverse Event|15|||
127668393|NCT02408549|459407231|FG000|Overall Study|Death|4|||
127668394|NCT02408549|459407231|FG000|Overall Study|Lack of Efficacy|17|||
127668395|NCT02408549|459407231|FG000|Overall Study|Protocol Violation|4|||
127668396|NCT02408549|459407231|FG000|Overall Study|Lost to Follow-up|6|||
127668397|NCT02408549|459407231|FG000|Overall Study|Consent withdrawn|30|||
127668398|NCT02408549|459407231|FG000|Overall Study|Neurology research program closing at site|1|||
127668399|NCT02408549|459407231|FG000|Overall Study|Site closure|1|||
127668400|NCT02408549|459407231|FG000|Overall Study|Pregnancy|1|||
127668401|NCT02408549|459407231|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
127668402|NCT02408549|459407231|FG000|Overall Study|Subject moved to another place, far from site|1|||
127668403|NCT02408549|459407231|FG000|Overall Study|Study terminated at site|1|||
127668404|NCT00410384|459407232|FG000|Overall Study|Withdrawal by Subject|28|||
127668405|NCT00410384|459407233|FG001|Overall Study|Withdrawal by Subject|17|||
127668406|NCT00410384|459407234|FG002|Overall Study|Withdrawal by Subject|20|||
127668407|NCT00410384|459407232|FG000|Overall Study|Adverse Event|23|||
127668408|NCT00410384|459407233|FG001|Overall Study|Adverse Event|18|||
127668409|NCT00410384|459407234|FG002|Overall Study|Adverse Event|23|||
127668410|NCT00410384|459407232|FG000|Overall Study|Lack of Efficacy|20|||
127668411|NCT00410384|459407233|FG001|Overall Study|Lack of Efficacy|12|||
127668412|NCT00410384|459407234|FG002|Overall Study|Lack of Efficacy|17|||
127668413|NCT00410384|459407232|FG000|Overall Study|Lack of Compliance|2|||
127668414|NCT00410384|459407233|FG001|Overall Study|Lack of Compliance|2|||
127668415|NCT00410384|459407234|FG002|Overall Study|Lack of Compliance|2|||
127668416|NCT00410384|459407232|FG000|Overall Study|Lost to Follow-up|4|||
127668417|NCT00410384|459407233|FG001|Overall Study|Lost to Follow-up|6|||
127668418|NCT00410384|459407234|FG002|Overall Study|Lost to Follow-up|6|||
127668419|NCT00410384|459407232|FG000|Overall Study|Protocol Violation|6|||
127668420|NCT00410384|459407233|FG001|Overall Study|Protocol Violation|6|||
127668421|NCT00410384|459407234|FG002|Overall Study|Protocol Violation|6|||
127668422|NCT00410384|459407232|FG000|Overall Study|Physician Decision|3|||
127668423|NCT00410384|459407233|FG001|Overall Study|Physician Decision|3|||
127668424|NCT00410384|459407234|FG002|Overall Study|Physician Decision|4|||
127668425|NCT00410384|459407232|FG000|Overall Study|Other|3|||
127668426|NCT00410384|459407233|FG001|Overall Study|Other|8|||
127668427|NCT00410384|459407234|FG002|Overall Study|Other|4|||
127668428|NCT01253200|459407237|FG000|Overall Study|Death|1|||
127668429|NCT01253200|459407238|FG001|Overall Study|Death|0|||
127668430|NCT01253200|459407239|FG002|Overall Study|Death|0|||
127668431|NCT01253200|459407240|FG003|Overall Study|Death|0|||
127668432|NCT01253200|459407241|FG004|Overall Study|Death|0|||
127668433|NCT01253200|459407237|FG000|Overall Study|Lost to Follow-up|1|||
127668434|NCT01253200|459407238|FG001|Overall Study|Lost to Follow-up|1|||
127543434|NCT03253796|458956542|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
127668435|NCT01253200|459407239|FG002|Overall Study|Lost to Follow-up|0|||
127668436|NCT01253200|459407240|FG003|Overall Study|Lost to Follow-up|0|||
127668437|NCT01253200|459407241|FG004|Overall Study|Lost to Follow-up|0|||
127668438|NCT01253200|459407237|FG000|Overall Study|Withdrawal by Subject|2|||
127668439|NCT01253200|459407238|FG001|Overall Study|Withdrawal by Subject|0|||
127668440|NCT01253200|459407239|FG002|Overall Study|Withdrawal by Subject|0|||
127668441|NCT01253200|459407240|FG003|Overall Study|Withdrawal by Subject|0|||
127668442|NCT01253200|459407241|FG004|Overall Study|Withdrawal by Subject|0|||
127668443|NCT01253200|459407237|FG000|Overall Study|Protocol Violation|1|||
127668444|NCT01253200|459407238|FG001|Overall Study|Protocol Violation|4|||
127668445|NCT01253200|459407239|FG002|Overall Study|Protocol Violation|0|||
127668446|NCT01253200|459407240|FG003|Overall Study|Protocol Violation|0|||
127668447|NCT01253200|459407241|FG004|Overall Study|Protocol Violation|5|||
127668448|NCT01253200|459407237|FG000|Overall Study|intents|10|||
127668449|NCT01253200|459407238|FG001|Overall Study|intents|10|||
127668450|NCT01253200|459407239|FG002|Overall Study|intents|1|||
127668451|NCT01253200|459407240|FG003|Overall Study|intents|3|||
127668452|NCT01253200|459407241|FG004|Overall Study|intents|0|||
127668453|NCT01253200|459407237|FG000|Overall Study|Attempts|6|||
127668454|NCT01253200|459407238|FG001|Overall Study|Attempts|4|||
127668455|NCT01253200|459407239|FG002|Overall Study|Attempts|1|||
127668456|NCT01253200|459407240|FG003|Overall Study|Attempts|2|||
127668457|NCT01253200|459407241|FG004|Overall Study|Attempts|0|||
127668458|NCT04529538|459407243|FG000|Overall Study|Lost to Follow-up|3|||
127668459|NCT04529538|459407244|FG001|Overall Study|Lost to Follow-up|2|||
127668460|NCT04529538|459407245|FG002|Overall Study|Lost to Follow-up|1|||
127668461|NCT04529538|459407246|FG003|Overall Study|Lost to Follow-up|0|||
127668462|NCT04529538|459407247|FG004|Overall Study|Lost to Follow-up|1|||
127668463|NCT04529538|459407248|FG005|Overall Study|Lost to Follow-up|1|||
127668464|NCT04529538|459407249|FG006|Overall Study|Lost to Follow-up|2|||
127668465|NCT04529538|459407250|FG007|Overall Study|Lost to Follow-up|0|||
127668466|NCT04529538|459407243|FG000|Overall Study|Not eligible at enrollment|0|||
127668467|NCT04529538|459407244|FG001|Overall Study|Not eligible at enrollment|1|||
127668468|NCT04529538|459407245|FG002|Overall Study|Not eligible at enrollment|2|||
127668469|NCT04529538|459407246|FG003|Overall Study|Not eligible at enrollment|1|||
127668470|NCT04529538|459407247|FG004|Overall Study|Not eligible at enrollment|0|||
127668471|NCT04529538|459407248|FG005|Overall Study|Not eligible at enrollment|0|||
127668472|NCT04529538|459407249|FG006|Overall Study|Not eligible at enrollment|0|||
127668473|NCT04529538|459407250|FG007|Overall Study|Not eligible at enrollment|1|||
127668474|NCT04529538|459407243|FG000|Overall Study|Withdrawal by Subject|0|||
127668475|NCT04529538|459407244|FG001|Overall Study|Withdrawal by Subject|1|||
127668476|NCT04529538|459407245|FG002|Overall Study|Withdrawal by Subject|1|||
127668477|NCT04529538|459407246|FG003|Overall Study|Withdrawal by Subject|2|||
127668478|NCT04529538|459407247|FG004|Overall Study|Withdrawal by Subject|0|||
127668479|NCT04529538|459407248|FG005|Overall Study|Withdrawal by Subject|2|||
127668480|NCT04529538|459407249|FG006|Overall Study|Withdrawal by Subject|3|||
127668481|NCT04529538|459407250|FG007|Overall Study|Withdrawal by Subject|0|||
127668482|NCT04529538|459407243|FG000|Overall Study|Other|0|||
127668483|NCT04529538|459407244|FG001|Overall Study|Other|1|||
127668484|NCT04529538|459407245|FG002|Overall Study|Other|0|||
127668485|NCT04529538|459407246|FG003|Overall Study|Other|0|||
127668486|NCT04529538|459407247|FG004|Overall Study|Other|0|||
127668487|NCT04529538|459407248|FG005|Overall Study|Other|0|||
127668488|NCT04529538|459407249|FG006|Overall Study|Other|0|||
127668489|NCT04529538|459407250|FG007|Overall Study|Other|0|||
127668490|NCT04529538|459407243|FG000|Overall Study|Adverse Event|0|||
127668491|NCT04529538|459407244|FG001|Overall Study|Adverse Event|0|||
127668492|NCT04529538|459407245|FG002|Overall Study|Adverse Event|0|||
127668493|NCT04529538|459407246|FG003|Overall Study|Adverse Event|1|||
127668494|NCT04529538|459407247|FG004|Overall Study|Adverse Event|0|||
127668495|NCT04529538|459407248|FG005|Overall Study|Adverse Event|0|||
127668496|NCT04529538|459407249|FG006|Overall Study|Adverse Event|0|||
127668497|NCT04529538|459407250|FG007|Overall Study|Adverse Event|0|||
127668498|NCT04529538|459407243|FG000|Overall Study|Protocol Deviation|0|||
127668499|NCT04529538|459407244|FG001|Overall Study|Protocol Deviation|0|||
127668500|NCT04529538|459407245|FG002|Overall Study|Protocol Deviation|0|||
127668501|NCT04529538|459407246|FG003|Overall Study|Protocol Deviation|1|||
127668502|NCT04529538|459407247|FG004|Overall Study|Protocol Deviation|0|||
127668503|NCT04529538|459407248|FG005|Overall Study|Protocol Deviation|0|||
127668504|NCT04529538|459407249|FG006|Overall Study|Protocol Deviation|0|||
127668505|NCT04529538|459407250|FG007|Overall Study|Protocol Deviation|0|||
127668506|NCT04529538|459407243|FG000|Overall Study|Physician Decision|0|||
127668507|NCT04529538|459407244|FG001|Overall Study|Physician Decision|0|||
127668508|NCT04529538|459407245|FG002|Overall Study|Physician Decision|0|||
128001818|NCT00069264|460633477|FG000|Overall Study|Withdrawal by Subject|3|||
128001819|NCT00069264|460633477|FG000|Overall Study|Discon Therapy|3|||
128001820|NCT05547386|460633478|FG000|Overall Study|Withdrawal by Subject|7|||
127668509|NCT04529538|459407246|FG003|Overall Study|Physician Decision|0|||
127668510|NCT04529538|459407247|FG004|Overall Study|Physician Decision|0|||
127668511|NCT04529538|459407248|FG005|Overall Study|Physician Decision|1|||
127668512|NCT04529538|459407249|FG006|Overall Study|Physician Decision|0|||
128001821|NCT04622969|460633479|FG000|Overall Study|Withdrawal by Subject|2|||
128001822|NCT04622969|460633480|FG001|Overall Study|Withdrawal by Subject|3|||
127668513|NCT04529538|459407250|FG007|Overall Study|Physician Decision|1|||
127668514|NCT00235495|459407253|FG000|Overall Study|Death|52|||
127668515|NCT00235495|459407254|FG001|Overall Study|Death|42|||
127668516|NCT00235495|459407253|FG000|Overall Study|Withdrawal by Subject|5|||
127668517|NCT00235495|459407254|FG001|Overall Study|Withdrawal by Subject|3|||
127668518|NCT00235495|459407253|FG000|Overall Study|Lost to Follow-up|11|||
127668519|NCT00235495|459407254|FG001|Overall Study|Lost to Follow-up|13|||
127668520|NCT00235495|459407253|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
127668521|NCT00235495|459407254|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
127668522|NCT02234310|459407255|FG000|Overall Study|Physician Decision|1|||
127668523|NCT02234310|459407255|FG000|Overall Study|Adverse Event|1|||
127668524|NCT02234310|459407255|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
128001823|NCT04467515|460633481|FG000|Overall Study|Lost to Follow-up|1|||
128001824|NCT04467515|460633482|FG001|Overall Study|Lost to Follow-up|0|||
128001825|NCT04467515|460633483|FG002|Overall Study|Lost to Follow-up|0|||
128001826|NCT04467515|460633481|FG000|Overall Study|Withdrawal by Subject|1|||
128001827|NCT04467515|460633482|FG001|Overall Study|Withdrawal by Subject|0|||
128001828|NCT04467515|460633483|FG002|Overall Study|Withdrawal by Subject|1|||
128001829|NCT04467515|460633481|FG000|Overall Study|Progressive Disease|0|||
128001830|NCT04467515|460633482|FG001|Overall Study|Progressive Disease|1|||
128001831|NCT04467515|460633483|FG002|Overall Study|Progressive Disease|3|||
128001832|NCT04467515|460633481|FG000|Overall Study|Death|0|||
127668525|NCT02234310|459407255|FG000|Overall Study|Withdrawal by Subject|2|||
127668526|NCT03289455|459407257|FG000|Overall Study|Death|1|||
127668527|NCT03289455|459407258|FG001|Overall Study|Death|0|||
127668528|NCT03289455|459407259|FG002|Overall Study|Death|0|||
127668529|NCT03289455|459407257|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
127668530|NCT03289455|459407258|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
127668531|NCT03289455|459407259|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
127668532|NCT03289455|459407257|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
127668533|NCT03289455|459407258|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
127668534|NCT03289455|459407259|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
127668535|NCT03289455|459407257|FG000|Overall Study|Progressive disease|3|||
127668536|NCT03289455|459407258|FG001|Overall Study|Progressive disease|4|||
127668537|NCT03289455|459407259|FG002|Overall Study|Progressive disease|5|||
127668538|NCT02192359|459407262|FG000|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
127668539|NCT02192359|459407263|FG001|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
127668540|NCT02192359|459407264|FG002|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|1|||
127668541|NCT02192359|459407265|FG003|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
127668542|NCT02192359|459407262|FG000|Overall Study|Could not receive irinotecan due to low KPS score post surgery|1|||
127668543|NCT02192359|459407263|FG001|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
127668544|NCT02192359|459407264|FG002|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
127668545|NCT02192359|459407265|FG003|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
127668546|NCT02192359|459407262|FG000|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
127668547|NCT02192359|459407263|FG001|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
127668548|NCT02192359|459407264|FG002|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
127668549|NCT02192359|459407265|FG003|Overall Study|Taken off study treatment to catheter infection not related to treatment|1|||
127668550|NCT05567952|459408973|FG000|Overall Study|Lost to Follow-up|3|||
127668551|NCT05567952|459408974|FG001|Overall Study|Lost to Follow-up|2|||
127668552|NCT05567952|459408973|FG000|Overall Study|Withdrawal by Subject|6|||
127668553|NCT05567952|459408974|FG001|Overall Study|Withdrawal by Subject|3|||
127668554|NCT05567952|459408973|FG000|Overall Study|Other|3|||
127668555|NCT05567952|459408974|FG001|Overall Study|Other|1|||
127668556|NCT00777803|459408975|FG000|Overall Study|Lost to Follow-up|12|||
127668557|NCT00777803|459408976|FG001|Overall Study|Lost to Follow-up|5|||
127668558|NCT00777803|459408975|FG000|Overall Study|Adverse Event|1|||
127668559|NCT00777803|459408976|FG001|Overall Study|Adverse Event|0|||
127668560|NCT00777803|459408975|FG000|Overall Study|Non-compliance|2|||
127668561|NCT00777803|459408976|FG001|Overall Study|Non-compliance|2|||
127668562|NCT00432159|459408983|FG000|Overall Study|Death|0|||
127668563|NCT00432159|459408984|FG001|Overall Study|Death|1|||
127668564|NCT00432159|459408985|FG002|Overall Study|Death|0|||
127668565|NCT00432159|459408986|FG003|Overall Study|Death|0|||
127668566|NCT00432159|459408987|FG004|Overall Study|Death|0|||
127668567|NCT00432159|459408983|FG000|Overall Study|Failure|9|||
127668568|NCT00432159|459408984|FG001|Overall Study|Failure|5|||
127668569|NCT00432159|459408985|FG002|Overall Study|Failure|3|||
127668570|NCT00432159|459408986|FG003|Overall Study|Failure|2|||
127668571|NCT00432159|459408987|FG004|Overall Study|Failure|3|||
127668572|NCT00432159|459408983|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
127668573|NCT00432159|459408984|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
127668574|NCT00432159|459408985|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
127668575|NCT00432159|459408986|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
127668576|NCT00432159|459408987|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
127668577|NCT01852162|459408991|FG000|Overall Study|Adverse Event|1|||
127668578|NCT01852162|459408992|FG001|Overall Study|Adverse Event|0|||
127668579|NCT01852162|459408991|FG000|Overall Study|Withdrawal by Subject|3|||
127668580|NCT01852162|459408992|FG001|Overall Study|Withdrawal by Subject|1|||
127668581|NCT01021878|459408999|FG000|Overall Study|Lost to Follow-up|4|||
127668582|NCT01021878|459409000|FG001|Overall Study|Lost to Follow-up|3|||
128001833|NCT04467515|460633482|FG001|Overall Study|Death|1|||
128001834|NCT04467515|460633483|FG002|Overall Study|Death|0|||
128001835|NCT05616013|460633486|FG000|Overall Study|Adverse Event|6|||
127668583|NCT01021878|459408999|FG000|Overall Study|Death|0|||
127668584|NCT01021878|459409000|FG001|Overall Study|Death|1|||
127668585|NCT01021878|459408999|FG000|Overall Study|Adverse Event|6|||
127668586|NCT01021878|459409000|FG001|Overall Study|Adverse Event|5|||
127668587|NCT01021878|459408999|FG000|Overall Study|Transplantation|6|||
127668588|NCT01021878|459409000|FG001|Overall Study|Transplantation|1|||
127668589|NCT05305040|459409004|FG000|Overall Study|Not Dosed|37|||
128001836|NCT05616013|460633487|FG001|Overall Study|Adverse Event|12|||
128001837|NCT05616013|460633488|FG002|Overall Study|Adverse Event|8|||
128001838|NCT05616013|460633489|FG003|Overall Study|Adverse Event|4|||
128001839|NCT05616013|460633490|FG004|Overall Study|Adverse Event|6|||
128001840|NCT05616013|460633491|FG005|Overall Study|Adverse Event|8|||
128001841|NCT05616013|460633492|FG006|Overall Study|Adverse Event|3|||
128001842|NCT05616013|460633493|FG007|Overall Study|Adverse Event|6|||
128001843|NCT05616013|460633494|FG008|Overall Study|Adverse Event|1|||
128001844|NCT05616013|460633486|FG000|Overall Study|Lost to Follow-up|5|||
128001845|NCT05616013|460633487|FG001|Overall Study|Lost to Follow-up|4|||
128001846|NCT05616013|460633488|FG002|Overall Study|Lost to Follow-up|3|||
128001847|NCT05616013|460633489|FG003|Overall Study|Lost to Follow-up|2|||
128001848|NCT05616013|460633490|FG004|Overall Study|Lost to Follow-up|0|||
128001849|NCT05616013|460633491|FG005|Overall Study|Lost to Follow-up|5|||
128001850|NCT05616013|460633492|FG006|Overall Study|Lost to Follow-up|2|||
128001851|NCT05616013|460633493|FG007|Overall Study|Lost to Follow-up|1|||
128001852|NCT05616013|460633494|FG008|Overall Study|Lost to Follow-up|2|||
128001853|NCT05616013|460633486|FG000|Overall Study|Non-compliance with study requirements|2|||
128001854|NCT05616013|460633487|FG001|Overall Study|Non-compliance with study requirements|2|||
128001855|NCT05616013|460633488|FG002|Overall Study|Non-compliance with study requirements|2|||
128001856|NCT05616013|460633489|FG003|Overall Study|Non-compliance with study requirements|3|||
128001857|NCT05616013|460633490|FG004|Overall Study|Non-compliance with study requirements|0|||
128001858|NCT05616013|460633491|FG005|Overall Study|Non-compliance with study requirements|2|||
128001859|NCT05616013|460633492|FG006|Overall Study|Non-compliance with study requirements|1|||
128001860|NCT05616013|460633493|FG007|Overall Study|Non-compliance with study requirements|1|||
128001861|NCT05616013|460633494|FG008|Overall Study|Non-compliance with study requirements|4|||
128001862|NCT05616013|460633486|FG000|Overall Study|Withdrawal by Subject|11|||
128001863|NCT05616013|460633487|FG001|Overall Study|Withdrawal by Subject|9|||
128001864|NCT05616013|460633488|FG002|Overall Study|Withdrawal by Subject|8|||
128001865|NCT05616013|460633489|FG003|Overall Study|Withdrawal by Subject|6|||
128001866|NCT05616013|460633490|FG004|Overall Study|Withdrawal by Subject|3|||
128001867|NCT05616013|460633491|FG005|Overall Study|Withdrawal by Subject|4|||
128001868|NCT05616013|460633492|FG006|Overall Study|Withdrawal by Subject|6|||
128001869|NCT05616013|460633493|FG007|Overall Study|Withdrawal by Subject|5|||
128001870|NCT05616013|460633494|FG008|Overall Study|Withdrawal by Subject|4|||
128001871|NCT05616013|460633486|FG000|Overall Study|Physician Decision|0|||
128001872|NCT05616013|460633487|FG001|Overall Study|Physician Decision|0|||
128001873|NCT05616013|460633488|FG002|Overall Study|Physician Decision|1|||
128001874|NCT05616013|460633489|FG003|Overall Study|Physician Decision|0|||
128001875|NCT05616013|460633490|FG004|Overall Study|Physician Decision|0|||
128001876|NCT05616013|460633491|FG005|Overall Study|Physician Decision|1|||
128001877|NCT05616013|460633492|FG006|Overall Study|Physician Decision|3|||
128001878|NCT05616013|460633493|FG007|Overall Study|Physician Decision|0|||
128001879|NCT05616013|460633494|FG008|Overall Study|Physician Decision|0|||
128001880|NCT05616013|460633486|FG000|Overall Study|Protocol Violation|0|||
128001881|NCT05616013|460633487|FG001|Overall Study|Protocol Violation|0|||
128001882|NCT05616013|460633488|FG002|Overall Study|Protocol Violation|0|||
128001883|NCT05616013|460633489|FG003|Overall Study|Protocol Violation|0|||
128001884|NCT05616013|460633490|FG004|Overall Study|Protocol Violation|0|||
128001885|NCT05616013|460633491|FG005|Overall Study|Protocol Violation|0|||
128001886|NCT05616013|460633492|FG006|Overall Study|Protocol Violation|1|||
128001887|NCT05616013|460633493|FG007|Overall Study|Protocol Violation|0|||
128001888|NCT05616013|460633494|FG008|Overall Study|Protocol Violation|2|||
128001889|NCT05616013|460633486|FG000|Overall Study|Did not Fulfill Enrollment criteria|1|||
128001890|NCT05616013|460633487|FG001|Overall Study|Did not Fulfill Enrollment criteria|0|||
128001891|NCT05616013|460633488|FG002|Overall Study|Did not Fulfill Enrollment criteria|0|||
128001892|NCT05616013|460633489|FG003|Overall Study|Did not Fulfill Enrollment criteria|0|||
128001893|NCT05616013|460633490|FG004|Overall Study|Did not Fulfill Enrollment criteria|0|||
128001894|NCT05616013|460633491|FG005|Overall Study|Did not Fulfill Enrollment criteria|0|||
128001895|NCT05616013|460633492|FG006|Overall Study|Did not Fulfill Enrollment criteria|0|||
128001896|NCT05616013|460633493|FG007|Overall Study|Did not Fulfill Enrollment criteria|0|||
128001897|NCT05616013|460633494|FG008|Overall Study|Did not Fulfill Enrollment criteria|0|||
128001898|NCT05616013|460633486|FG000|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|1|||
128001899|NCT05616013|460633487|FG001|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
128001900|NCT05616013|460633488|FG002|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
128001901|NCT05616013|460633489|FG003|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
127668590|NCT05305040|459409005|FG001|Overall Study|Not Dosed|37|||
127668591|NCT05305040|459409004|FG000|Overall Study|Study Closure|34|||
128001902|NCT05616013|460633490|FG004|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
128001903|NCT05616013|460633491|FG005|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
128001904|NCT05616013|460633492|FG006|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
128001905|NCT05616013|460633493|FG007|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
128001906|NCT05616013|460633494|FG008|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
128001907|NCT05616013|460633486|FG000|Overall Study|Participant Withdrawal due to use of Restricted Medication|1|||
128001908|NCT05616013|460633487|FG001|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
128001909|NCT05616013|460633488|FG002|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
128001910|NCT05616013|460633489|FG003|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
128001911|NCT05616013|460633490|FG004|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
128001912|NCT05616013|460633491|FG005|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
128001913|NCT05616013|460633492|FG006|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
128001914|NCT05616013|460633493|FG007|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
128001915|NCT05616013|460633494|FG008|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
128001916|NCT05616013|460633486|FG000|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
128001917|NCT05616013|460633487|FG001|Overall Study|Participant Cannot Continue study due to Work Commitments|1|||
128001918|NCT05616013|460633488|FG002|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
128001919|NCT05616013|460633489|FG003|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
128001920|NCT05616013|460633490|FG004|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
128001921|NCT05616013|460633491|FG005|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
128001922|NCT05616013|460633492|FG006|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
128001923|NCT05616013|460633493|FG007|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
128001924|NCT05616013|460633494|FG008|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
128001925|NCT05616013|460633486|FG000|Overall Study|Participant Decision, Time Constraints|0|||
128001926|NCT05616013|460633487|FG001|Overall Study|Participant Decision, Time Constraints|1|||
128001927|NCT05616013|460633488|FG002|Overall Study|Participant Decision, Time Constraints|0|||
128001928|NCT05616013|460633489|FG003|Overall Study|Participant Decision, Time Constraints|0|||
127668592|NCT05305040|459409005|FG001|Overall Study|Study Closure|46|||
128001929|NCT05616013|460633490|FG004|Overall Study|Participant Decision, Time Constraints|0|||
128001930|NCT05616013|460633491|FG005|Overall Study|Participant Decision, Time Constraints|0|||
128001931|NCT05616013|460633492|FG006|Overall Study|Participant Decision, Time Constraints|0|||
128001932|NCT05616013|460633493|FG007|Overall Study|Participant Decision, Time Constraints|0|||
128001933|NCT05616013|460633494|FG008|Overall Study|Participant Decision, Time Constraints|0|||
128001934|NCT05616013|460633486|FG000|Overall Study|Prohibited Concomitant Medication|0|||
128001935|NCT05616013|460633487|FG001|Overall Study|Prohibited Concomitant Medication|0|||
128001936|NCT05616013|460633488|FG002|Overall Study|Prohibited Concomitant Medication|1|||
128001937|NCT05616013|460633489|FG003|Overall Study|Prohibited Concomitant Medication|0|||
128001938|NCT05616013|460633490|FG004|Overall Study|Prohibited Concomitant Medication|0|||
128001939|NCT05616013|460633491|FG005|Overall Study|Prohibited Concomitant Medication|0|||
128001940|NCT05616013|460633492|FG006|Overall Study|Prohibited Concomitant Medication|0|||
128001941|NCT05616013|460633493|FG007|Overall Study|Prohibited Concomitant Medication|0|||
128001942|NCT05616013|460633494|FG008|Overall Study|Prohibited Concomitant Medication|0|||
127668593|NCT05305040|459409004|FG000|Overall Study|Death|14|||
127668594|NCT05305040|459409005|FG001|Overall Study|Death|13|||
127668595|NCT05305040|459409004|FG000|Overall Study|Withdrawal by Subject|15|||
127668596|NCT05305040|459409005|FG001|Overall Study|Withdrawal by Subject|10|||
127668597|NCT05305040|459409004|FG000|Overall Study|Other|13|||
127668598|NCT05305040|459409005|FG001|Overall Study|Other|10|||
127668599|NCT05305040|459409004|FG000|Overall Study|Primary Malignancy Relapse|3|||
127668600|NCT05305040|459409005|FG001|Overall Study|Primary Malignancy Relapse|4|||
127668601|NCT05305040|459409004|FG000|Overall Study|Adverse Event|3|||
127668602|NCT05305040|459409005|FG001|Overall Study|Adverse Event|3|||
127668603|NCT05305040|459409004|FG000|Overall Study|Lost to Follow-up|2|||
127668604|NCT05305040|459409005|FG001|Overall Study|Lost to Follow-up|1|||
127668605|NCT05305040|459409004|FG000|Overall Study|Graft versus host disease|2|||
127668606|NCT05305040|459409005|FG001|Overall Study|Graft versus host disease|0|||
127668607|NCT05305040|459409004|FG000|Overall Study|Investigator's Decision|1|||
127668608|NCT05305040|459409005|FG001|Overall Study|Investigator's Decision|1|||
127668609|NCT05305040|459409004|FG000|Overall Study|COVID-19 Reasons|1|||
127668610|NCT05305040|459409005|FG001|Overall Study|COVID-19 Reasons|0|||
127668611|NCT02123966|459409006|FG000|Overall Study|Intercurrent Illness|1|||
127668612|NCT01460381|459409007|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
127668613|NCT01460381|459409008|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
127668614|NCT01333943|459409013|FG000|Overall Study|Known neuropathy|1|||
127668615|NCT01333943|459409014|FG001|Overall Study|Known neuropathy|0|||
127668616|NCT01237678|459409022|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
127668617|NCT01237678|459409023|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
128001943|NCT05616013|460633486|FG000|Overall Study|Medical history condition Requiring Further Treatment|0|||
127543435|NCT03253796|458956543|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
127543436|NCT03253796|458956544|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
127543437|NCT03253796|458956545|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
127543438|NCT03253796|458956546|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
127543439|NCT03253796|458956542|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
127543440|NCT03253796|458956543|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
127543441|NCT03253796|458956544|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
127543442|NCT03253796|458956545|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
127543443|NCT03253796|458956546|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
127543444|NCT02285855|458956547|FG000|Overall Study|Withdrawal by Subject|2|||
127543445|NCT02285855|458956548|FG001|Overall Study|Withdrawal by Subject|1|||
127543446|NCT00528112|458956549|FG000|Treatment up to 3 Years|Adverse Event|313|||
127543447|NCT00528112|458956550|FG001|Treatment up to 3 Years|Adverse Event|278|||
127543448|NCT00528112|458956549|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
127543449|NCT00528112|458956550|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
127543450|NCT00528112|458956549|FG000|Treatment up to 3 Years|Protocol Violation|16|||
127543451|NCT00528112|458956550|FG001|Treatment up to 3 Years|Protocol Violation|16|||
127543452|NCT00528112|458956549|FG000|Treatment up to 3 Years|Death|0|||
127543453|NCT00528112|458956550|FG001|Treatment up to 3 Years|Death|1|||
127543454|NCT00528112|458956549|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
127543455|NCT00528112|458956550|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
127543456|NCT00528112|458956549|FG000|Treatment up to 3 Years|Pregnancy|9|||
127543457|NCT00528112|458956550|FG001|Treatment up to 3 Years|Pregnancy|10|||
127543458|NCT00528112|458956549|FG000|Treatment up to 3 Years|Other reasons|186|||
127543459|NCT00528112|458956550|FG001|Treatment up to 3 Years|Other reasons|186|||
127543460|NCT00528112|458956549|FG000|Extension Phase|Withdrawal by Subject|0|||
127543461|NCT00528112|458956550|FG001|Extension Phase|Withdrawal by Subject|3|||
127543462|NCT00528112|458956549|FG000|Extension Phase|Other reasons|0|||
127543463|NCT00528112|458956550|FG001|Extension Phase|Other reasons|100|||
127543464|NCT00528112|458956549|FG000|Extension Phase|Pregnancy|0|||
127543465|NCT00528112|458956550|FG001|Extension Phase|Pregnancy|3|||
127543466|NCT00528112|458956549|FG000|Extension Phase|Lost to Follow-up|0|||
127543467|NCT00528112|458956550|FG001|Extension Phase|Lost to Follow-up|12|||
127543468|NCT00528112|458956549|FG000|Extension Phase|Death|0|||
127543469|NCT00528112|458956550|FG001|Extension Phase|Death|1|||
127543470|NCT00528112|458956549|FG000|Extension Phase|Adverse Event|0|||
127543471|NCT00528112|458956550|FG001|Extension Phase|Adverse Event|36|||
127543472|NCT00528112|458956549|FG000|Extension Phase|Protocol Violation|0|||
127543473|NCT00528112|458956550|FG001|Extension Phase|Protocol Violation|2|||
127543474|NCT02718898|458956551|FG000|Blinded Treatment Period|Adverse Event|5|||
127543475|NCT02718898|458956552|FG001|Blinded Treatment Period|Adverse Event|1|||
127543476|NCT02718898|458956553|FG002|Blinded Treatment Period|Adverse Event|0|||
127543477|NCT02718898|458956554|FG003|Blinded Treatment Period|Adverse Event|0|||
127543478|NCT02718898|458956555|FG004|Blinded Treatment Period|Adverse Event|0|||
127543479|NCT02718898|458956556|FG005|Blinded Treatment Period|Adverse Event|0|||
127543480|NCT02718898|458956557|FG006|Blinded Treatment Period|Adverse Event|0|||
127543481|NCT02718898|458956551|FG000|Blinded Treatment Period|Physician Decision|1|||
127543482|NCT02718898|458956552|FG001|Blinded Treatment Period|Physician Decision|0|||
127543483|NCT02718898|458956553|FG002|Blinded Treatment Period|Physician Decision|0|||
127543484|NCT02718898|458956554|FG003|Blinded Treatment Period|Physician Decision|0|||
127543485|NCT02718898|458956555|FG004|Blinded Treatment Period|Physician Decision|0|||
127543486|NCT02718898|458956556|FG005|Blinded Treatment Period|Physician Decision|0|||
127543487|NCT02718898|458956557|FG006|Blinded Treatment Period|Physician Decision|0|||
127543488|NCT02718898|458956551|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
127543489|NCT02718898|458956552|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
127543490|NCT02718898|458956553|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
127543491|NCT02718898|458956554|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
127543492|NCT02718898|458956555|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
127543493|NCT02718898|458956556|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
127543494|NCT02718898|458956557|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
127543495|NCT02718898|458956551|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
127543496|NCT02718898|458956552|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
127543497|NCT02718898|458956553|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
127543498|NCT02718898|458956554|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
127543499|NCT02718898|458956555|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
127543500|NCT02718898|458956556|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
127543501|NCT02718898|458956557|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
127543502|NCT02718898|458956551|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
127543503|NCT02718898|458956552|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
127543504|NCT02718898|458956553|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
127668618|NCT01237678|459409024|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
127668619|NCT01237678|459409022|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
127668620|NCT01237678|459409023|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
127668621|NCT01237678|459409024|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
127668622|NCT01237678|459409022|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
127668623|NCT01237678|459409023|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
127668624|NCT01237678|459409024|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
127668625|NCT01237678|459409022|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
127668626|NCT01237678|459409023|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
127668627|NCT01237678|459409024|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
127668628|NCT01237678|459409022|FG000|Phase II|Adverse Event|0|||
127668629|NCT01237678|459409023|FG001|Phase II|Adverse Event|39|||
127668630|NCT01237678|459409024|FG002|Phase II|Adverse Event|9|||
127668631|NCT01237678|459409022|FG000|Phase II|Death|0|||
127668632|NCT01237678|459409023|FG001|Phase II|Death|0|||
127668633|NCT01237678|459409024|FG002|Phase II|Death|2|||
127668634|NCT01237678|459409022|FG000|Phase II|Lack of Efficacy|0|||
127668635|NCT01237678|459409023|FG001|Phase II|Lack of Efficacy|25|||
127668636|NCT01237678|459409024|FG002|Phase II|Lack of Efficacy|3|||
127668637|NCT01237678|459409022|FG000|Phase II|Withdrawal by Subject|0|||
127668638|NCT01237678|459409023|FG001|Phase II|Withdrawal by Subject|1|||
127668639|NCT01237678|459409024|FG002|Phase II|Withdrawal by Subject|5|||
127668640|NCT01237678|459409022|FG000|Phase II|Completed Cycles 4-6|0|||
127668641|NCT01237678|459409023|FG001|Phase II|Completed Cycles 4-6|11|||
127668642|NCT01237678|459409024|FG002|Phase II|Completed Cycles 4-6|21|||
127668643|NCT01237678|459409022|FG000|Phase II|Sponsor Decision/Study Closed|0|||
127668644|NCT01237678|459409023|FG001|Phase II|Sponsor Decision/Study Closed|18|||
127668645|NCT01237678|459409024|FG002|Phase II|Sponsor Decision/Study Closed|7|||
127668646|NCT01237678|459409022|FG000|Phase II|Randomized but were not treated|0|||
127668647|NCT01237678|459409023|FG001|Phase II|Randomized but were not treated|4|||
127668648|NCT01237678|459409024|FG002|Phase II|Randomized but were not treated|3|||
127668649|NCT01818700|459409025|FG000|Overall Study|Adverse Event|67|||
127668650|NCT01818700|459409025|FG000|Overall Study|Lack of Efficacy|2|||
127668651|NCT01818700|459409025|FG000|Overall Study|Lost to Follow-up|5|||
127668652|NCT01818700|459409025|FG000|Overall Study|Withdrawal by Subject|27|||
127668653|NCT01818700|459409025|FG000|Overall Study|Protocol Violation|2|||
127668654|NCT01818700|459409025|FG000|Overall Study|Other|1|||
127668655|NCT01657682|459409026|FG000|Overall Study|Lost to Follow-up|1|||
127668656|NCT01657682|459409027|FG001|Overall Study|Lost to Follow-up|0|||
127668657|NCT01657682|459409028|FG002|Overall Study|Lost to Follow-up|0|||
127668658|NCT01657682|459409026|FG000|Overall Study|Withdrawal by Subject|0|||
127668659|NCT01657682|459409027|FG001|Overall Study|Withdrawal by Subject|1|||
127668660|NCT01657682|459409028|FG002|Overall Study|Withdrawal by Subject|1|||
127668661|NCT01657682|459409026|FG000|Overall Study|Adverse Event|0|||
127668662|NCT01657682|459409027|FG001|Overall Study|Adverse Event|1|||
127668663|NCT01657682|459409028|FG002|Overall Study|Adverse Event|0|||
127668664|NCT01719861|459409029|FG000|Cycle 1|Death|4|||
127668665|NCT01719861|459409029|FG000|Cycle 2|Death|1|||
127668666|NCT00087490|459409030|FG000|Overall Study|Death|6|||
127668667|NCT00087490|459409031|FG001|Overall Study|Death|4|||
127668668|NCT00087490|459409030|FG000|Overall Study|Adverse Event|3|||
127668669|NCT00087490|459409031|FG001|Overall Study|Adverse Event|8|||
127668670|NCT00087490|459409030|FG000|Overall Study|Lack of Efficacy|0|||
127668671|NCT00087490|459409031|FG001|Overall Study|Lack of Efficacy|2|||
127668672|NCT00087490|459409030|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
127668673|NCT00087490|459409031|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
127668674|NCT00087490|459409030|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
127668675|NCT00087490|459409031|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
127668676|NCT00087490|459409030|FG000|Overall Study|Randomized but not treated|7|||
127668677|NCT00087490|459409031|FG001|Overall Study|Randomized but not treated|18|||
127668678|NCT02034435|459409032|FG000|Overall Study|Withdrawal by Subject|1|||
127668679|NCT02034435|459409033|FG001|Overall Study|Withdrawal by Subject|0|||
127668680|NCT02034435|459409034|FG002|Overall Study|Withdrawal by Subject|0|||
128001944|NCT05616013|460633487|FG001|Overall Study|Medical history condition Requiring Further Treatment|0|||
127668681|NCT02034435|459409035|FG003|Overall Study|Withdrawal by Subject|0|||
127668682|NCT02034435|459409032|FG000|Overall Study|Illness|0|||
128001945|NCT05616013|460633488|FG002|Overall Study|Medical history condition Requiring Further Treatment|1|||
128001946|NCT05616013|460633489|FG003|Overall Study|Medical history condition Requiring Further Treatment|0|||
127668683|NCT02034435|459409033|FG001|Overall Study|Illness|2|||
127668684|NCT02034435|459409034|FG002|Overall Study|Illness|0|||
127668685|NCT02034435|459409035|FG003|Overall Study|Illness|0|||
127668686|NCT02034435|459409032|FG000|Overall Study|Inadequate IV access|1|||
127668687|NCT02034435|459409033|FG001|Overall Study|Inadequate IV access|0|||
127668688|NCT02034435|459409034|FG002|Overall Study|Inadequate IV access|0|||
127668689|NCT02034435|459409035|FG003|Overall Study|Inadequate IV access|1|||
127668690|NCT00630539|459409036|FG000|Overall Study|Adverse Event|1|||
127668691|NCT00630539|459409037|FG001|Overall Study|Adverse Event|3|||
127668692|NCT00630539|459409038|FG002|Overall Study|Adverse Event|1|||
127668693|NCT00630539|459409039|FG003|Overall Study|Adverse Event|2|||
127668694|NCT00630539|459409036|FG000|Overall Study|Withdrawal by Subject|0|||
127668695|NCT00630539|459409037|FG001|Overall Study|Withdrawal by Subject|1|||
127668696|NCT00630539|459409038|FG002|Overall Study|Withdrawal by Subject|0|||
127668697|NCT00630539|459409039|FG003|Overall Study|Withdrawal by Subject|1|||
127668698|NCT01700530|459409042|FG000|Overall Study|Withdrawal by Subject|0|||
127668699|NCT01700530|459409043|FG001|Overall Study|Withdrawal by Subject|3|||
127668700|NCT01700530|459409044|FG002|Overall Study|Withdrawal by Subject|1|||
127668701|NCT04833855|459409053|FG000|Overall Study|Decision by sponsor|0|||
127668702|NCT04833855|459409054|FG001|Overall Study|Decision by sponsor|1|||
127668703|NCT04833855|459409055|FG002|Overall Study|Decision by sponsor|0|||
127668704|NCT04833855|459409056|FG003|Overall Study|Decision by sponsor|0|||
127668705|NCT04833855|459409053|FG000|Overall Study|Withdrawal by Subject|4|||
127668706|NCT04833855|459409054|FG001|Overall Study|Withdrawal by Subject|1|||
127668707|NCT04833855|459409055|FG002|Overall Study|Withdrawal by Subject|3|||
127668708|NCT04833855|459409056|FG003|Overall Study|Withdrawal by Subject|1|||
127668709|NCT04833855|459409053|FG000|Overall Study|Lost to Follow-up|1|||
127668710|NCT04833855|459409054|FG001|Overall Study|Lost to Follow-up|0|||
127668711|NCT04833855|459409055|FG002|Overall Study|Lost to Follow-up|2|||
127668712|NCT04833855|459409056|FG003|Overall Study|Lost to Follow-up|2|||
127668713|NCT04833855|459409053|FG000|Overall Study|Protocol specified criteria|0|||
127668714|NCT04833855|459409054|FG001|Overall Study|Protocol specified criteria|0|||
127668715|NCT04833855|459409055|FG002|Overall Study|Protocol specified criteria|2|||
127668716|NCT04833855|459409056|FG003|Overall Study|Protocol specified criteria|1|||
127668717|NCT03682536|459409058|FG000|Randomization|Withdrawal by Subject|0|||
127668718|NCT03682536|459409059|FG001|Randomization|Withdrawal by Subject|2|||
127668719|NCT03682536|459409058|FG000|Treatment|Other Reasons|8|||
127668720|NCT03682536|459409059|FG001|Treatment|Other Reasons|7|||
127668721|NCT03682536|459409058|FG000|Treatment|Physician Decision|5|||
127668722|NCT03682536|459409059|FG001|Treatment|Physician Decision|5|||
127668723|NCT03682536|459409058|FG000|Treatment|Protocol Violation|1|||
127668724|NCT03682536|459409059|FG001|Treatment|Protocol Violation|0|||
127668725|NCT03682536|459409058|FG000|Treatment|Study Terminated by Sponsor|1|||
127668726|NCT03682536|459409059|FG001|Treatment|Study Terminated by Sponsor|2|||
127668727|NCT03682536|459409058|FG000|Treatment|Lost to Follow-up|0|||
127668728|NCT03682536|459409059|FG001|Treatment|Lost to Follow-up|1|||
127668729|NCT03682536|459409058|FG000|Treatment|Withdrawal by Subject|16|||
127668730|NCT03682536|459409059|FG001|Treatment|Withdrawal by Subject|18|||
127668731|NCT03682536|459409058|FG000|Treatment|Lack of Efficacy|41|||
127668732|NCT03682536|459409059|FG001|Treatment|Lack of Efficacy|68|||
127668733|NCT03682536|459409058|FG000|Treatment|Disease Progression|9|||
127668734|NCT03682536|459409059|FG001|Treatment|Disease Progression|7|||
127668735|NCT03682536|459409058|FG000|Treatment|Adverse Event|9|||
127668736|NCT03682536|459409059|FG001|Treatment|Adverse Event|5|||
127668737|NCT03682536|459409058|FG000|Treatment|Death|14|||
127668738|NCT03682536|459409059|FG001|Treatment|Death|13|||
127668739|NCT03008122|459409060|FG000|Overall Study|Physician Decision|3|||
127668740|NCT03008122|459409061|FG001|Overall Study|Physician Decision|2|||
127668741|NCT03008122|459409062|FG002|Overall Study|Physician Decision|0|||
127668742|NCT03008122|459409060|FG000|Overall Study|Withdrawal by Subject|1|||
127668743|NCT03008122|459409061|FG001|Overall Study|Withdrawal by Subject|3|||
127668744|NCT03008122|459409062|FG002|Overall Study|Withdrawal by Subject|0|||
128001947|NCT05616013|460633490|FG004|Overall Study|Medical history condition Requiring Further Treatment|0|||
128001948|NCT05616013|460633491|FG005|Overall Study|Medical history condition Requiring Further Treatment|0|||
128001949|NCT05616013|460633492|FG006|Overall Study|Medical history condition Requiring Further Treatment|0|||
128001950|NCT05616013|460633493|FG007|Overall Study|Medical history condition Requiring Further Treatment|0|||
128001951|NCT05616013|460633494|FG008|Overall Study|Medical history condition Requiring Further Treatment|0|||
127668745|NCT03008122|459409060|FG000|Overall Study|Lost to Follow-up|4|||
127668746|NCT03008122|459409061|FG001|Overall Study|Lost to Follow-up|8|||
127668747|NCT03008122|459409062|FG002|Overall Study|Lost to Follow-up|3|||
127668748|NCT03008122|459409060|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
127668749|NCT03008122|459409061|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
127668750|NCT03008122|459409062|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
127668751|NCT03008122|459409060|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
127668752|NCT03008122|459409061|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
127668753|NCT03008122|459409062|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
127668754|NCT03008122|459409060|FG000|Overall Study|Death|0|||
127668755|NCT03008122|459409061|FG001|Overall Study|Death|0|||
127668756|NCT03008122|459409062|FG002|Overall Study|Death|1|||
127668757|NCT02338609|459409063|FG000|Overall Study|Physician Decision|1|||
127668758|NCT02338609|459409063|FG000|Overall Study|Death|1|||
127668759|NCT02223182|459409066|FG000|Double-Blind Period|Adverse Event|0|||
127668760|NCT02223182|459409067|FG001|Double-Blind Period|Adverse Event|2|||
127668761|NCT02223182|459409068|FG002|Double-Blind Period|Adverse Event|1|||
128001952|NCT05616013|460633486|FG000|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
128001953|NCT05616013|460633487|FG001|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
128001954|NCT05616013|460633488|FG002|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
128001955|NCT05616013|460633489|FG003|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|1|||
128001956|NCT05616013|460633490|FG004|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
128001957|NCT05616013|460633491|FG005|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
128001958|NCT05616013|460633492|FG006|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
128001959|NCT05616013|460633493|FG007|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
128001960|NCT05616013|460633494|FG008|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
128001961|NCT05616013|460633486|FG000|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
128001962|NCT05616013|460633487|FG001|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
128001963|NCT05616013|460633488|FG002|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
127668762|NCT02223182|459409069|FG003|Double-Blind Period|Adverse Event|0|||
127668763|NCT02223182|459409066|FG000|Double-Blind Period|Withdrawal by Subject|1|||
128001964|NCT05616013|460633489|FG003|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
128001965|NCT05616013|460633490|FG004|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
128001966|NCT05616013|460633491|FG005|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
128001967|NCT05616013|460633492|FG006|Overall Study|Withdrawn due to Elevated Blood Pressure|1|||
128001968|NCT05616013|460633493|FG007|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
128001969|NCT05616013|460633494|FG008|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
128001970|NCT05616013|460633486|FG000|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
128001971|NCT05616013|460633487|FG001|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
128001972|NCT05616013|460633488|FG002|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
128001973|NCT05616013|460633489|FG003|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
128001974|NCT05616013|460633490|FG004|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
128001975|NCT05616013|460633491|FG005|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
128001976|NCT05616013|460633492|FG006|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
128001977|NCT05616013|460633493|FG007|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
128001978|NCT05616013|460633494|FG008|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|1|||
128001979|NCT05616013|460633486|FG000|Overall Study|Unable to Visit site as Participant Moved town|0|||
128001980|NCT05616013|460633487|FG001|Overall Study|Unable to Visit site as Participant Moved town|0|||
128001981|NCT05616013|460633488|FG002|Overall Study|Unable to Visit site as Participant Moved town|0|||
128001982|NCT05616013|460633489|FG003|Overall Study|Unable to Visit site as Participant Moved town|0|||
128001983|NCT05616013|460633490|FG004|Overall Study|Unable to Visit site as Participant Moved town|0|||
128001984|NCT05616013|460633491|FG005|Overall Study|Unable to Visit site as Participant Moved town|0|||
128001985|NCT05616013|460633492|FG006|Overall Study|Unable to Visit site as Participant Moved town|0|||
128001986|NCT05616013|460633493|FG007|Overall Study|Unable to Visit site as Participant Moved town|0|||
128001987|NCT05616013|460633494|FG008|Overall Study|Unable to Visit site as Participant Moved town|1|||
128001988|NCT05116202|460633495|FG000|Overall Study|Study Terminated by Sponsor|21|||
128001989|NCT05116202|460633496|FG001|Overall Study|Study Terminated by Sponsor|38|||
128001990|NCT05116202|460633497|FG002|Overall Study|Study Terminated by Sponsor|17|||
128001991|NCT05116202|460633498|FG003|Overall Study|Study Terminated by Sponsor|18|||
128001992|NCT05116202|460633499|FG004|Overall Study|Study Terminated by Sponsor|0|||
128001993|NCT05116202|460633495|FG000|Overall Study|Withdrawal by Subject|0|||
128001994|NCT05116202|460633496|FG001|Overall Study|Withdrawal by Subject|1|||
128001995|NCT05116202|460633497|FG002|Overall Study|Withdrawal by Subject|1|||
128001996|NCT05116202|460633498|FG003|Overall Study|Withdrawal by Subject|1|||
128001997|NCT05116202|460633499|FG004|Overall Study|Withdrawal by Subject|1|||
128001998|NCT05116202|460633495|FG000|Overall Study|Lost to Follow-up|0|||
128001999|NCT05116202|460633496|FG001|Overall Study|Lost to Follow-up|0|||
127668764|NCT02223182|459409067|FG001|Double-Blind Period|Withdrawal by Subject|1|||
127668765|NCT02223182|459409068|FG002|Double-Blind Period|Withdrawal by Subject|1|||
127668766|NCT02223182|459409069|FG003|Double-Blind Period|Withdrawal by Subject|0|||
127668767|NCT02223182|459409066|FG000|Double-Blind Period|Lost to Follow-up|0|||
127668768|NCT02223182|459409067|FG001|Double-Blind Period|Lost to Follow-up|1|||
127668769|NCT02223182|459409068|FG002|Double-Blind Period|Lost to Follow-up|0|||
128002000|NCT05116202|460633497|FG002|Overall Study|Lost to Follow-up|0|||
128002001|NCT05116202|460633498|FG003|Overall Study|Lost to Follow-up|0|||
128002002|NCT05116202|460633499|FG004|Overall Study|Lost to Follow-up|2|||
128002003|NCT05116202|460633495|FG000|Overall Study|Death|1|||
128002004|NCT05116202|460633496|FG001|Overall Study|Death|1|||
128002005|NCT05116202|460633497|FG002|Overall Study|Death|2|||
127668770|NCT02223182|459409069|FG003|Double-Blind Period|Lost to Follow-up|0|||
127668771|NCT02223182|459409066|FG000|Double-Blind Period|Non Compliance|0|||
127668772|NCT02223182|459409067|FG001|Double-Blind Period|Non Compliance|0|||
127668773|NCT02223182|459409068|FG002|Double-Blind Period|Non Compliance|0|||
127668774|NCT02223182|459409069|FG003|Double-Blind Period|Non Compliance|1|||
127668775|NCT02223182|459409066|FG000|Double-Blind Period|Sponsor or Regulatory Authorities Decision|1|||
127668776|NCT02223182|459409067|FG001|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
127668777|NCT02223182|459409068|FG002|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
127668778|NCT02223182|459409069|FG003|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
127668779|NCT02223182|459409066|FG000|Open-Label 500 Period|Adverse Event|1|||
127668780|NCT02223182|459409067|FG001|Open-Label 500 Period|Adverse Event|0|||
127668781|NCT02223182|459409068|FG002|Open-Label 500 Period|Adverse Event|2|||
127668782|NCT02223182|459409069|FG003|Open-Label 500 Period|Adverse Event|1|||
127668783|NCT02223182|459409066|FG000|Open-Label 500 Period|Withdrawal by Subject|5|||
127668784|NCT02223182|459409067|FG001|Open-Label 500 Period|Withdrawal by Subject|2|||
127668785|NCT02223182|459409068|FG002|Open-Label 500 Period|Withdrawal by Subject|9|||
127668786|NCT02223182|459409069|FG003|Open-Label 500 Period|Withdrawal by Subject|8|||
127668787|NCT02223182|459409066|FG000|Open-Label 500 Period|Physician Decision|0|||
127668788|NCT02223182|459409067|FG001|Open-Label 500 Period|Physician Decision|0|||
127668789|NCT02223182|459409068|FG002|Open-Label 500 Period|Physician Decision|0|||
127668790|NCT02223182|459409069|FG003|Open-Label 500 Period|Physician Decision|1|||
127668791|NCT02223182|459409066|FG000|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
127668792|NCT02223182|459409067|FG001|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
127668793|NCT02223182|459409068|FG002|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|1|||
127668794|NCT02223182|459409069|FG003|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
127668795|NCT02223182|459409066|FG000|Open-Label 300 Period|Withdrawal by Subject|10|||
127668796|NCT02223182|459409067|FG001|Open-Label 300 Period|Withdrawal by Subject|13|||
127668797|NCT02223182|459409068|FG002|Open-Label 300 Period|Withdrawal by Subject|13|||
127668798|NCT02223182|459409069|FG003|Open-Label 300 Period|Withdrawal by Subject|15|||
127668799|NCT02223182|459409066|FG000|Open-Label 300 Period|Lost to Follow-up|1|||
127668800|NCT02223182|459409067|FG001|Open-Label 300 Period|Lost to Follow-up|0|||
127668801|NCT02223182|459409068|FG002|Open-Label 300 Period|Lost to Follow-up|1|||
127668802|NCT02223182|459409069|FG003|Open-Label 300 Period|Lost to Follow-up|0|||
127668803|NCT02223182|459409066|FG000|Open-Label 300 Period|Non Compliance|0|||
127668804|NCT02223182|459409067|FG001|Open-Label 300 Period|Non Compliance|2|||
127668805|NCT02223182|459409068|FG002|Open-Label 300 Period|Non Compliance|1|||
127668806|NCT02223182|459409069|FG003|Open-Label 300 Period|Non Compliance|0|||
127668807|NCT03714022|459409070|FG000|Overall Study|Adverse Event|1|||
127668808|NCT03714022|459409071|FG001|Overall Study|Adverse Event|0|||
127668809|NCT03714022|459409070|FG000|Overall Study|Consent withdrawal|0|||
127668810|NCT03714022|459409071|FG001|Overall Study|Consent withdrawal|1|||
127668811|NCT03714022|459409070|FG000|Overall Study|Lost to Follow-up|3|||
127668812|NCT03714022|459409071|FG001|Overall Study|Lost to Follow-up|2|||
127668813|NCT00114959|459409080|FG000|Overall Study|Lack of Efficacy|6|||
127668814|NCT00114959|459409080|FG000|Overall Study|Physician Decision|1|||
127668815|NCT00114959|459409080|FG000|Overall Study|Death|1|||
127668816|NCT03251378|459409083|FG000|Overall Study|Death|3|||
127668817|NCT03251378|459409084|FG001|Overall Study|Death|2|||
127668818|NCT03251378|459409085|FG002|Overall Study|Death|3|||
127668819|NCT03251378|459409086|FG003|Overall Study|Death|30|||
127668820|NCT03251378|459409087|FG004|Overall Study|Death|24|||
127668821|NCT03251378|459409088|FG005|Overall Study|Death|12|||
127668822|NCT03251378|459409089|FG006|Overall Study|Death|12|||
127668823|NCT03251378|459409083|FG000|Overall Study|Lost to Follow-up|0|||
127668824|NCT03251378|459409084|FG001|Overall Study|Lost to Follow-up|0|||
127668825|NCT03251378|459409085|FG002|Overall Study|Lost to Follow-up|1|||
127668826|NCT03251378|459409086|FG003|Overall Study|Lost to Follow-up|3|||
127668827|NCT03251378|459409087|FG004|Overall Study|Lost to Follow-up|0|||
127668828|NCT03251378|459409088|FG005|Overall Study|Lost to Follow-up|0|||
127668829|NCT03251378|459409089|FG006|Overall Study|Lost to Follow-up|0|||
127668830|NCT03251378|459409083|FG000|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
127668831|NCT03251378|459409084|FG001|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
127668832|NCT03251378|459409085|FG002|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
127668833|NCT03251378|459409086|FG003|Overall Study|Patient withdrew consent and refused to provide follow-up information|3|||
127668834|NCT03251378|459409087|FG004|Overall Study|Patient withdrew consent and refused to provide follow-up information|2|||
127668835|NCT03251378|459409088|FG005|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
127668836|NCT03251378|459409089|FG006|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
127668837|NCT03251378|459409083|FG000|Overall Study|Progressive disease|2|||
127668838|NCT03251378|459409084|FG001|Overall Study|Progressive disease|0|||
127668839|NCT03251378|459409085|FG002|Overall Study|Progressive disease|0|||
127668840|NCT03251378|459409086|FG003|Overall Study|Progressive disease|1|||
127668841|NCT03251378|459409087|FG004|Overall Study|Progressive disease|0|||
127668842|NCT03251378|459409088|FG005|Overall Study|Progressive disease|0|||
127668843|NCT03251378|459409089|FG006|Overall Study|Progressive disease|0|||
127668844|NCT03251378|459409083|FG000|Overall Study|Physician Decision|0|||
127668845|NCT03251378|459409084|FG001|Overall Study|Physician Decision|2|||
127668846|NCT03251378|459409085|FG002|Overall Study|Physician Decision|0|||
127668847|NCT03251378|459409086|FG003|Overall Study|Physician Decision|0|||
127668848|NCT03251378|459409087|FG004|Overall Study|Physician Decision|0|||
127668849|NCT03251378|459409088|FG005|Overall Study|Physician Decision|0|||
127668850|NCT03251378|459409089|FG006|Overall Study|Physician Decision|0|||
128002006|NCT05116202|460633498|FG003|Overall Study|Death|1|||
128002007|NCT05116202|460633499|FG004|Overall Study|Death|5|||
128002008|NCT03834506|460633500|FG000|Overall Study|Death|336|||
128002009|NCT03834506|460633501|FG001|Overall Study|Death|326|||
128002010|NCT03834506|460633500|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
128002011|NCT03834506|460633501|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
128002012|NCT03834506|460633500|FG000|Overall Study|Withdrawal by Subject|10|||
128002013|NCT03834506|460633501|FG001|Overall Study|Withdrawal by Subject|8|||
128002014|NCT03834506|460633500|FG000|Overall Study|Sponsor decision|165|||
128002015|NCT03834506|460633501|FG001|Overall Study|Sponsor decision|178|||
128002016|NCT03834506|460633500|FG000|Overall Study|Physician Decision|3|||
128002017|NCT03834506|460633501|FG001|Overall Study|Physician Decision|1|||
128002018|NCT03834506|460633500|FG000|Overall Study|Lost to Follow-up|0|||
128002019|NCT03834506|460633501|FG001|Overall Study|Lost to Follow-up|1|||
128002020|NCT05067972|460633502|FG000|Part 1: Treatment|Global Deterioration of Health Status|0|||
128002021|NCT05067972|460633503|FG001|Part 1: Treatment|Global Deterioration of Health Status|1|||
128002022|NCT05067972|460633504|FG002|Part 1: Treatment|Global Deterioration of Health Status|0|||
128002023|NCT05067972|460633505|FG003|Part 1: Treatment|Global Deterioration of Health Status|1|||
128002024|NCT05067972|460633506|FG004|Part 1: Treatment|Global Deterioration of Health Status|0|||
128002025|NCT05067972|460633507|FG005|Part 1: Treatment|Global Deterioration of Health Status|0|||
128002026|NCT05067972|460633508|FG006|Part 1: Treatment|Global Deterioration of Health Status|1|||
128002027|NCT05067972|460633502|FG000|Part 1: Treatment|Withdrawal by Subject|0|||
128002028|NCT05067972|460633503|FG001|Part 1: Treatment|Withdrawal by Subject|0|||
128002029|NCT05067972|460633504|FG002|Part 1: Treatment|Withdrawal by Subject|0|||
128002030|NCT05067972|460633505|FG003|Part 1: Treatment|Withdrawal by Subject|0|||
128002031|NCT05067972|460633506|FG004|Part 1: Treatment|Withdrawal by Subject|1|||
128002032|NCT05067972|460633507|FG005|Part 1: Treatment|Withdrawal by Subject|2|||
128002033|NCT05067972|460633508|FG006|Part 1: Treatment|Withdrawal by Subject|1|||
128002034|NCT05067972|460633502|FG000|Part 1: Treatment|Progressive Disease|3|||
128002035|NCT05067972|460633503|FG001|Part 1: Treatment|Progressive Disease|3|||
128002036|NCT05067972|460633504|FG002|Part 1: Treatment|Progressive Disease|4|||
128002037|NCT05067972|460633505|FG003|Part 1: Treatment|Progressive Disease|2|||
128002038|NCT05067972|460633506|FG004|Part 1: Treatment|Progressive Disease|3|||
128002039|NCT05067972|460633507|FG005|Part 1: Treatment|Progressive Disease|0|||
128002040|NCT05067972|460633508|FG006|Part 1: Treatment|Progressive Disease|2|||
128002041|NCT05067972|460633502|FG000|Part 1: Treatment|Physician Decision|0|||
127668851|NCT03251378|459409083|FG000|Overall Study|Other|2|||
128002042|NCT05067972|460633503|FG001|Part 1: Treatment|Physician Decision|0|||
128002043|NCT05067972|460633504|FG002|Part 1: Treatment|Physician Decision|0|||
128002044|NCT05067972|460633505|FG003|Part 1: Treatment|Physician Decision|1|||
128002045|NCT05067972|460633506|FG004|Part 1: Treatment|Physician Decision|0|||
128002046|NCT05067972|460633507|FG005|Part 1: Treatment|Physician Decision|0|||
128002047|NCT05067972|460633508|FG006|Part 1: Treatment|Physician Decision|0|||
128002048|NCT05067972|460633502|FG000|Part 1: Treatment|Death|0|||
128002049|NCT05067972|460633503|FG001|Part 1: Treatment|Death|0|||
128002050|NCT05067972|460633504|FG002|Part 1: Treatment|Death|0|||
128002051|NCT05067972|460633505|FG003|Part 1: Treatment|Death|2|||
128002052|NCT05067972|460633506|FG004|Part 1: Treatment|Death|0|||
128002053|NCT05067972|460633507|FG005|Part 1: Treatment|Death|0|||
128002054|NCT05067972|460633508|FG006|Part 1: Treatment|Death|0|||
128002055|NCT05067972|460633502|FG000|Part 1: Treatment|Adverse Event|0|||
128002056|NCT05067972|460633503|FG001|Part 1: Treatment|Adverse Event|0|||
128002057|NCT05067972|460633504|FG002|Part 1: Treatment|Adverse Event|0|||
127668852|NCT03251378|459409084|FG001|Overall Study|Other|3|||
128002058|NCT05067972|460633505|FG003|Part 1: Treatment|Adverse Event|0|||
128002059|NCT05067972|460633506|FG004|Part 1: Treatment|Adverse Event|0|||
128002060|NCT05067972|460633507|FG005|Part 1: Treatment|Adverse Event|2|||
128002061|NCT05067972|460633508|FG006|Part 1: Treatment|Adverse Event|1|||
128002062|NCT05067972|460633502|FG000|Part 1: Follow-up|Adverse Event|0|||
128002063|NCT05067972|460633503|FG001|Part 1: Follow-up|Adverse Event|0|||
128002064|NCT05067972|460633504|FG002|Part 1: Follow-up|Adverse Event|0|||
128002065|NCT05067972|460633505|FG003|Part 1: Follow-up|Adverse Event|0|||
128002066|NCT05067972|460633506|FG004|Part 1: Follow-up|Adverse Event|0|||
128002067|NCT05067972|460633507|FG005|Part 1: Follow-up|Adverse Event|1|||
128002068|NCT05067972|460633508|FG006|Part 1: Follow-up|Adverse Event|0|||
128002069|NCT05067972|460633502|FG000|Part 1: Follow-up|Withdrawal by Subject|0|||
128002070|NCT05067972|460633503|FG001|Part 1: Follow-up|Withdrawal by Subject|0|||
128002071|NCT05067972|460633504|FG002|Part 1: Follow-up|Withdrawal by Subject|0|||
128002072|NCT05067972|460633505|FG003|Part 1: Follow-up|Withdrawal by Subject|0|||
128002073|NCT05067972|460633506|FG004|Part 1: Follow-up|Withdrawal by Subject|0|||
127668853|NCT03251378|459409085|FG002|Overall Study|Other|2|||
127668854|NCT03251378|459409086|FG003|Overall Study|Other|0|||
128002074|NCT05067972|460633507|FG005|Part 1: Follow-up|Withdrawal by Subject|0|||
128002075|NCT05067972|460633508|FG006|Part 1: Follow-up|Withdrawal by Subject|1|||
128002076|NCT05067972|460633502|FG000|Part 1: Follow-up|Study Terminated by Sponsor|0|||
128002077|NCT05067972|460633503|FG001|Part 1: Follow-up|Study Terminated by Sponsor|0|||
128002078|NCT05067972|460633504|FG002|Part 1: Follow-up|Study Terminated by Sponsor|0|||
128002079|NCT05067972|460633505|FG003|Part 1: Follow-up|Study Terminated by Sponsor|0|||
128002080|NCT05067972|460633506|FG004|Part 1: Follow-up|Study Terminated by Sponsor|0|||
127668855|NCT03251378|459409087|FG004|Overall Study|Other|1|||
127668856|NCT03251378|459409088|FG005|Overall Study|Other|1|||
127668857|NCT03251378|459409089|FG006|Overall Study|Other|1|||
127668858|NCT03251378|459409083|FG000|Overall Study|Other|0|||
127668859|NCT03251378|459409084|FG001|Overall Study|Other|0|||
127668860|NCT03251378|459409085|FG002|Overall Study|Other|0|||
127668861|NCT03251378|459409086|FG003|Overall Study|Other|4|||
127668862|NCT03251378|459409087|FG004|Overall Study|Other|13|||
127668863|NCT03251378|459409088|FG005|Overall Study|Other|0|||
127668864|NCT03251378|459409089|FG006|Overall Study|Other|0|||
127668865|NCT04482855|459409097|FG000|Overall Study|Lost to Follow-up|1|||
127668866|NCT04482855|459409098|FG001|Overall Study|Lost to Follow-up|0|||
127668867|NCT04482855|459409097|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|1|||
127668868|NCT04482855|459409098|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|0|||
127668869|NCT04482855|459409097|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|1|||
127668870|NCT04482855|459409098|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|0|||
127668871|NCT03212365|459409099|FG000|Overall Study|Discharged prior to Xa level|12|||
127668872|NCT03212365|459409100|FG001|Overall Study|Discharged prior to Xa level|8|||
127668873|NCT03212365|459409099|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
127668874|NCT03212365|459409100|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
127668875|NCT03212365|459409099|FG000|Overall Study|Refused study medication|3|||
127668876|NCT03212365|459409100|FG001|Overall Study|Refused study medication|0|||
127668877|NCT03212365|459409099|FG000|Overall Study|Initiated heparin infusion on floor|1|||
127668878|NCT03212365|459409100|FG001|Overall Study|Initiated heparin infusion on floor|1|||
127668879|NCT03212365|459409099|FG000|Overall Study|Unexpected return to OR|1|||
127668880|NCT03212365|459409100|FG001|Overall Study|Unexpected return to OR|1|||
127668881|NCT03212365|459409099|FG000|Overall Study|Medication distribution error|1|||
127668882|NCT03212365|459409100|FG001|Overall Study|Medication distribution error|0|||
127668883|NCT03212365|459409099|FG000|Overall Study|Required epidural placement|1|||
127668884|NCT03212365|459409100|FG001|Overall Study|Required epidural placement|0|||
127668885|NCT03212365|459409099|FG000|Overall Study|Withdrawal by Subject|0|||
127668886|NCT03212365|459409100|FG001|Overall Study|Withdrawal by Subject|1|||
127668887|NCT03212365|459409099|FG000|Overall Study|developed acute renal failure|0|||
127668888|NCT03212365|459409100|FG001|Overall Study|developed acute renal failure|1|||
127668889|NCT02753530|459409108|FG000|Overall Study|Adverse Event|7|||
127668890|NCT02753530|459409109|FG001|Overall Study|Adverse Event|1|||
127668891|NCT02753530|459409108|FG000|Overall Study|Death|0|||
127668892|NCT02753530|459409109|FG001|Overall Study|Death|1|||
127668893|NCT02753530|459409108|FG000|Overall Study|Physician Decision|0|||
127668894|NCT02753530|459409109|FG001|Overall Study|Physician Decision|1|||
127668895|NCT02753530|459409108|FG000|Overall Study|Protocol Violation|1|||
127668896|NCT02753530|459409109|FG001|Overall Study|Protocol Violation|0|||
127668897|NCT02753530|459409108|FG000|Overall Study|Withdrawal by Subject|4|||
127668898|NCT02753530|459409109|FG001|Overall Study|Withdrawal by Subject|3|||
127668899|NCT00429793|459409114|FG000|Overall Study|Improper pre-protocol treatment|3|||
127668900|NCT00429793|459409114|FG000|Overall Study|Required test not done|1|||
127668901|NCT00429793|459409114|FG000|Overall Study|Never treated|1|||
127668902|NCT00429793|459409114|FG000|Overall Study|Non-measurable|1|||
127668903|NCT01641861|459409115|FG000|Overall Study|Lost to Follow-up|21|||
127668904|NCT01641861|459409116|FG001|Overall Study|Lost to Follow-up|16|||
128002081|NCT05067972|460633507|FG005|Part 1: Follow-up|Study Terminated by Sponsor|1|||
127668905|NCT01641861|459409115|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
127668906|NCT01641861|459409116|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
127668907|NCT01641861|459409115|FG000|Overall Study|Died due to drowning|0|||
127668908|NCT01641861|459409116|FG001|Overall Study|Died due to drowning|1|||
127668909|NCT00465361|459411268|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
127668910|NCT05406791|459411269|FG000|Overall Study|Lost to Follow-up|13|||
127668911|NCT05406791|459411270|FG001|Overall Study|Lost to Follow-up|10|||
127668912|NCT02652130|459411273|FG000|Overall Study|Death|1|||
127668913|NCT00354029|459411274|FG000|Overall Study|Protocol Violation|4|||
127668914|NCT00354029|459411275|FG001|Overall Study|Protocol Violation|2|||
127668915|NCT00826280|459411276|FG000|Overall Study|Randomized but drug not received|1|||
127668916|NCT00826280|459411277|FG001|Overall Study|Randomized but drug not received|0|||
127668917|NCT00826280|459411278|FG002|Overall Study|Randomized but drug not received|1|||
128002082|NCT05067972|460633508|FG006|Part 1: Follow-up|Study Terminated by Sponsor|0|||
127668918|NCT00826280|459411276|FG000|Overall Study|Adverse Event|1|||
127668919|NCT00826280|459411277|FG001|Overall Study|Adverse Event|3|||
127668920|NCT00826280|459411278|FG002|Overall Study|Adverse Event|0|||
127668921|NCT00826280|459411276|FG000|Overall Study|Lost to Follow-up|0|||
127668922|NCT00826280|459411277|FG001|Overall Study|Lost to Follow-up|1|||
127668923|NCT00826280|459411278|FG002|Overall Study|Lost to Follow-up|0|||
127668924|NCT00826280|459411276|FG000|Overall Study|Sponsor discontinued subject or study|1|||
127668925|NCT00826280|459411277|FG001|Overall Study|Sponsor discontinued subject or study|0|||
127668926|NCT00826280|459411278|FG002|Overall Study|Sponsor discontinued subject or study|0|||
127668927|NCT00826280|459411276|FG000|Overall Study|Reversible ischemic defect not present|43|||
127668928|NCT00826280|459411277|FG001|Overall Study|Reversible ischemic defect not present|40|||
127668929|NCT00826280|459411278|FG002|Overall Study|Reversible ischemic defect not present|44|||
127668930|NCT00826280|459411276|FG000|Overall Study|Interpretation Failure|1|||
127668931|NCT00826280|459411277|FG001|Overall Study|Interpretation Failure|0|||
127668932|NCT00826280|459411278|FG002|Overall Study|Interpretation Failure|0|||
127668933|NCT00826280|459411276|FG000|Overall Study|Machine Failure|1|||
127668934|NCT00826280|459411277|FG001|Overall Study|Machine Failure|1|||
127668935|NCT00826280|459411278|FG002|Overall Study|Machine Failure|0|||
127668936|NCT00826280|459411276|FG000|Overall Study|One or more non-interpretable scan|0|||
127668937|NCT00826280|459411277|FG001|Overall Study|One or more non-interpretable scan|1|||
127668938|NCT00826280|459411278|FG002|Overall Study|One or more non-interpretable scan|1|||
127668939|NCT03201757|459411279|FG000|Overall Study|Withdrawal by Subject|133|||
127668940|NCT03201757|459411279|FG000|Overall Study|Adverse Event|44|||
127668941|NCT03201757|459411279|FG000|Overall Study|Lost to Follow-up|37|||
127668942|NCT03201757|459411279|FG000|Overall Study|Pregnancy|2|||
127668943|NCT03201757|459411279|FG000|Overall Study|Lack of Efficacy|1|||
127668944|NCT03201757|459411279|FG000|Overall Study|Protocol Violation|20|||
127668945|NCT03201757|459411279|FG000|Overall Study|Study Terminated at Site by Sponsor Due to Regional War|1|||
127668946|NCT03201757|459411279|FG000|Overall Study|Not Yet Determined|5|||
127668947|NCT03201757|459411279|FG000|Overall Study|Logistical Difficulties Due to Regional Wars & COVID-19|72|||
127668948|NCT03201757|459411279|FG000|Overall Study|Other|20|||
127668949|NCT02297503|459411280|FG000|Overall Study|Withdrawal by Subject|1|||
127668950|NCT02297503|459411281|FG001|Overall Study|Withdrawal by Subject|1|||
127668951|NCT02297503|459411280|FG000|Overall Study|Protocol Violation|1|||
127668952|NCT02297503|459411281|FG001|Overall Study|Protocol Violation|0|||
127668953|NCT02297503|459411280|FG000|Overall Study|Pregnancy|0|||
127668954|NCT02297503|459411281|FG001|Overall Study|Pregnancy|1|||
127668955|NCT02297503|459411280|FG000|Overall Study|Lost to Follow-up|0|||
127668956|NCT02297503|459411281|FG001|Overall Study|Lost to Follow-up|1|||
127668957|NCT02297503|459411280|FG000|Overall Study|Medical reason|0|||
127668958|NCT02297503|459411281|FG001|Overall Study|Medical reason|1|||
127668959|NCT02263885|459411283|FG000|Overall Study|Withdrawal by Subject|7|||
127668960|NCT02263885|459411283|FG000|Overall Study|Alternative Treatment|3|||
127668961|NCT01427907|459411287|FG000|Overall Study|Withdrawal by Subject|3|||
127668962|NCT01427907|459411288|FG001|Overall Study|Withdrawal by Subject|4|||
127668963|NCT02179918|459411289|FG000|Overall Study|Death|0|||
127668964|NCT02179918|459411290|FG001|Overall Study|Death|0|||
127668965|NCT02179918|459411291|FG002|Overall Study|Death|0|||
127668966|NCT02179918|459411292|FG003|Overall Study|Death|1|||
127668967|NCT02179918|459411293|FG004|Overall Study|Death|0|||
127668968|NCT02179918|459411289|FG000|Overall Study|Lost to Follow-up|0|||
127668969|NCT02179918|459411290|FG001|Overall Study|Lost to Follow-up|0|||
127668970|NCT02179918|459411291|FG002|Overall Study|Lost to Follow-up|1|||
127668971|NCT02179918|459411292|FG003|Overall Study|Lost to Follow-up|0|||
127668972|NCT02179918|459411293|FG004|Overall Study|Lost to Follow-up|0|||
127668973|NCT02179918|459411289|FG000|Overall Study|Progressive Disease|4|||
127668974|NCT02179918|459411290|FG001|Overall Study|Progressive Disease|1|||
127668975|NCT02179918|459411291|FG002|Overall Study|Progressive Disease|1|||
127668976|NCT02179918|459411292|FG003|Overall Study|Progressive Disease|2|||
127668977|NCT02179918|459411293|FG004|Overall Study|Progressive Disease|6|||
127668978|NCT02179918|459411289|FG000|Overall Study|Other|0|||
127668979|NCT02179918|459411290|FG001|Overall Study|Other|1|||
127668980|NCT02179918|459411291|FG002|Overall Study|Other|0|||
127668981|NCT02179918|459411292|FG003|Overall Study|Other|0|||
127668982|NCT02179918|459411293|FG004|Overall Study|Other|1|||
127668983|NCT02179918|459411289|FG000|Overall Study|Subject refused further follow-up|0|||
127668984|NCT02179918|459411290|FG001|Overall Study|Subject refused further follow-up|1|||
127668985|NCT02179918|459411291|FG002|Overall Study|Subject refused further follow-up|0|||
127668986|NCT02179918|459411292|FG003|Overall Study|Subject refused further follow-up|0|||
127668987|NCT02179918|459411293|FG004|Overall Study|Subject refused further follow-up|1|||
127668988|NCT04337489|459411298|FG000|Overall Study|Withdrawal by Subject|1|||
127668989|NCT00972543|459411299|FG000|Overall Study|Adverse Event|1|||
127668990|NCT00972543|459411300|FG001|Overall Study|Adverse Event|0|||
127668991|NCT00972543|459411299|FG000|Overall Study|Early study termination by sponsor|4|||
127668992|NCT00972543|459411300|FG001|Overall Study|Early study termination by sponsor|1|||
127668993|NCT04537949|459411303|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
127668994|NCT04537949|459411304|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
128002083|NCT05067972|460633502|FG000|Part 1: Follow-up|Physician Decision|0|||
128002084|NCT05067972|460633503|FG001|Part 1: Follow-up|Physician Decision|0|||
128002085|NCT05067972|460633504|FG002|Part 1: Follow-up|Physician Decision|0|||
128002086|NCT05067972|460633505|FG003|Part 1: Follow-up|Physician Decision|1|||
128002087|NCT05067972|460633506|FG004|Part 1: Follow-up|Physician Decision|0|||
128002088|NCT05067972|460633507|FG005|Part 1: Follow-up|Physician Decision|0|||
128002089|NCT05067972|460633508|FG006|Part 1: Follow-up|Physician Decision|0|||
128002090|NCT05067972|460633502|FG000|Part 1: Follow-up|Death|1|||
128002091|NCT05067972|460633503|FG001|Part 1: Follow-up|Death|2|||
128002092|NCT05067972|460633504|FG002|Part 1: Follow-up|Death|1|||
128002093|NCT05067972|460633505|FG003|Part 1: Follow-up|Death|0|||
128002094|NCT05067972|460633506|FG004|Part 1: Follow-up|Death|1|||
128002095|NCT05067972|460633507|FG005|Part 1: Follow-up|Death|0|||
128002096|NCT05067972|460633508|FG006|Part 1: Follow-up|Death|1|||
128002097|NCT04391842|460633509|FG000|Overall Study|Withdrawal by Subject|2|||
128002098|NCT02283658|460633528|FG000|Overall Study|Withdrawal by Subject|1|||
128002099|NCT00689338|460633529|FG000|Overall Study|Death|65|||
128002100|NCT00689338|460633529|FG000|Overall Study|Adverse Event|13|||
128002101|NCT00689338|460633529|FG000|Overall Study|Insufficient Clinical Response|1|||
128002102|NCT00689338|460633529|FG000|Overall Study|Lack of Efficacy|6|||
128002103|NCT00689338|460633529|FG000|Overall Study|Other|8|||
128002104|NCT00689338|460633529|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
128002105|NCT00689338|460633529|FG000|Overall Study|Lost to Follow-up|5|||
128002106|NCT00689338|460633529|FG000|Overall Study|Withdrawal by Subject|3|||
128002107|NCT00689338|460633529|FG000|Overall Study|Protocol Violation|15|||
128002108|NCT01789047|460633530|FG000|Overall Study|Adverse Event|3|||
128002109|NCT01789047|460633531|FG001|Overall Study|Adverse Event|2|||
128002110|NCT01789047|460633530|FG000|Overall Study|Withdrawal by Subject|1|||
128002111|NCT01789047|460633531|FG001|Overall Study|Withdrawal by Subject|2|||
128002112|NCT02668640|460633536|FG000|Overall Study|Lost to Follow-up|13|||
128002113|NCT02668640|460633536|FG000|Overall Study|Other, not specified|1|||
128002114|NCT02481050|460635132|FG000|Overall Study|Adverse Event|1|||
128002115|NCT02481050|460635132|FG000|Overall Study|Disease Progression|47|||
128002116|NCT02481050|460635132|FG000|Overall Study|Withdrawal by Subject|7|||
128002117|NCT02481050|460635132|FG000|Overall Study|Other|3|||
128002118|NCT03246347|460635135|FG000|Overall Study|On Study|23|||
128002119|NCT04113694|460635136|FG000|Overall Study|Adverse Event|2|||
128002120|NCT04113694|460635136|FG000|Overall Study|Lost to Follow-up|2|||
128002121|NCT04113694|460635136|FG000|Overall Study|Withdrawal by Subject|6|||
128002122|NCT04113694|460635136|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
128002123|NCT00329108|460635142|FG000|Overall Study|Adverse Event|2|||
128002124|NCT00329108|460635143|FG001|Overall Study|Adverse Event|2|||
128002125|NCT00329108|460635142|FG000|Overall Study|Lack of Efficacy|3|||
128002126|NCT00329108|460635143|FG001|Overall Study|Lack of Efficacy|3|||
128002127|NCT00329108|460635142|FG000|Overall Study|Withdrawal by Subject|0|||
128002128|NCT00329108|460635143|FG001|Overall Study|Withdrawal by Subject|2|||
128002129|NCT00329108|460635142|FG000|Overall Study|symptomatic deterioration|1|||
128002130|NCT00329108|460635143|FG001|Overall Study|symptomatic deterioration|1|||
128002131|NCT00329108|460635142|FG000|Overall Study|Subject no longer willing to participate|2|||
128002132|NCT00329108|460635143|FG001|Overall Study|Subject no longer willing to participate|2|||
128002133|NCT00329108|460635142|FG000|Overall Study|study terminated by sponsor|1|||
128002134|NCT00329108|460635143|FG001|Overall Study|study terminated by sponsor|0|||
128002135|NCT00329108|460635142|FG000|Overall Study|withdrew patient after SAE resolved|1|||
128002136|NCT00329108|460635143|FG001|Overall Study|withdrew patient after SAE resolved|0|||
128002137|NCT00329108|460635142|FG000|Overall Study|Protocol Violation|0|||
128002138|NCT00329108|460635143|FG001|Overall Study|Protocol Violation|2|||
128002139|NCT00903201|460635144|FG000|Overall Study|Adverse Event|1|||
128002140|NCT00903201|460635145|FG001|Overall Study|Adverse Event|4|||
128002141|NCT00903201|460635146|FG002|Overall Study|Adverse Event|0|||
128002142|NCT00903201|460635144|FG000|Overall Study|Protocol Violation|2|||
128002143|NCT00903201|460635145|FG001|Overall Study|Protocol Violation|1|||
128002144|NCT00903201|460635146|FG002|Overall Study|Protocol Violation|0|||
128002145|NCT00903201|460635144|FG000|Overall Study|Lost to Follow-up|0|||
128002146|NCT00903201|460635145|FG001|Overall Study|Lost to Follow-up|1|||
128002147|NCT00903201|460635146|FG002|Overall Study|Lost to Follow-up|0|||
128002148|NCT00903201|460635144|FG000|Overall Study|Physician Decision|1|||
128002149|NCT00903201|460635145|FG001|Overall Study|Physician Decision|0|||
128002150|NCT00903201|460635146|FG002|Overall Study|Physician Decision|1|||
128002151|NCT00903201|460635144|FG000|Overall Study|Withdrawal by Subject|1|||
128002152|NCT00903201|460635145|FG001|Overall Study|Withdrawal by Subject|0|||
127880896|NCT00566631|460186057|FG000|Part 2: Extension Phase|Adverse Event|11|||
128002153|NCT00903201|460635146|FG002|Overall Study|Withdrawal by Subject|1|||
128002154|NCT02611882|460635147|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
128002155|NCT02611882|460635148|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
128002156|NCT02611882|460635149|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
128002157|NCT01389232|460635150|FG000|Overall Study|Had scaffold removed|15|||
128002158|NCT01389232|460635150|FG000|Overall Study|Personal reasons|2|||
127668995|NCT04537949|459411305|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
127668996|NCT04537949|459411306|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
127668997|NCT04537949|459411307|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
127668998|NCT04537949|459411308|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
127668999|NCT04537949|459411309|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
127669000|NCT04537949|459411310|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
127669001|NCT04537949|459411303|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
127669002|NCT04537949|459411304|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
127669003|NCT04537949|459411305|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
127669004|NCT04537949|459411306|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
127669005|NCT04537949|459411307|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
127669006|NCT04537949|459411308|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
127669007|NCT04537949|459411309|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
127669008|NCT04537949|459411310|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
127669009|NCT04537949|459411303|FG000|Follow-up Phase|Lost to Follow-up|0|||
127669010|NCT04537949|459411304|FG001|Follow-up Phase|Lost to Follow-up|3|||
127669011|NCT04537949|459411305|FG002|Follow-up Phase|Lost to Follow-up|0|||
127669012|NCT04537949|459411306|FG003|Follow-up Phase|Lost to Follow-up|0|||
127669013|NCT04537949|459411307|FG004|Follow-up Phase|Lost to Follow-up|0|||
127669014|NCT04537949|459411308|FG005|Follow-up Phase|Lost to Follow-up|0|||
127669015|NCT04537949|459411309|FG006|Follow-up Phase|Lost to Follow-up|0|||
127669016|NCT04537949|459411310|FG007|Follow-up Phase|Lost to Follow-up|0|||
127669017|NCT04537949|459411303|FG000|Follow-up Phase|personal reasons|0|||
127669018|NCT04537949|459411304|FG001|Follow-up Phase|personal reasons|0|||
127669019|NCT04537949|459411305|FG002|Follow-up Phase|personal reasons|0|||
127669020|NCT04537949|459411306|FG003|Follow-up Phase|personal reasons|1|||
127669021|NCT04537949|459411307|FG004|Follow-up Phase|personal reasons|1|||
127669022|NCT04537949|459411308|FG005|Follow-up Phase|personal reasons|0|||
127669023|NCT04537949|459411309|FG006|Follow-up Phase|personal reasons|0|||
127669024|NCT04537949|459411310|FG007|Follow-up Phase|personal reasons|0|||
127669025|NCT04537949|459411303|FG000|Follow-up Phase|Withdrawal by Subject|0|||
127669026|NCT04537949|459411304|FG001|Follow-up Phase|Withdrawal by Subject|0|||
127669027|NCT04537949|459411305|FG002|Follow-up Phase|Withdrawal by Subject|0|||
127669028|NCT04537949|459411306|FG003|Follow-up Phase|Withdrawal by Subject|0|||
127669029|NCT04537949|459411307|FG004|Follow-up Phase|Withdrawal by Subject|1|||
127669030|NCT04537949|459411308|FG005|Follow-up Phase|Withdrawal by Subject|0|||
127669031|NCT04537949|459411309|FG006|Follow-up Phase|Withdrawal by Subject|0|||
127669032|NCT04537949|459411310|FG007|Follow-up Phase|Withdrawal by Subject|0|||
127669033|NCT04003974|459411312|FG000|Overall Study|Missing|1|||
127669034|NCT04003974|459411313|FG001|Overall Study|Missing|0|||
127669035|NCT04003974|459411312|FG000|Overall Study|Withdrawal by Subject|0|||
127669036|NCT04003974|459411313|FG001|Overall Study|Withdrawal by Subject|2|||
127669037|NCT04296942|459411314|FG000|Overall Study|Study closure by sponsor|1|||
127669038|NCT04296942|459411315|FG001|Overall Study|Study closure by sponsor|0|||
127669039|NCT04296942|459411316|FG002|Overall Study|Study closure by sponsor|0|||
127669040|NCT02412761|459411319|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
127669041|NCT02412761|459411320|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
127669042|NCT02412761|459411321|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
127669043|NCT02412761|459411322|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
127669044|NCT02412761|459411323|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
127669045|NCT02412761|459411324|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
127669046|NCT02240680|459411325|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
127669047|NCT02240680|459411326|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
127669048|NCT02240680|459411327|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
127669049|NCT02240680|459411328|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
127669050|NCT02240680|459411325|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
127669051|NCT02240680|459411326|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
127669052|NCT02240680|459411327|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
128002159|NCT01389232|460635150|FG000|Overall Study|Adverse Event|1|||
128002160|NCT01389232|460635150|FG000|Overall Study|Death|1|||
127543505|NCT02718898|458956554|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
127543506|NCT02718898|458956555|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
127669053|NCT02240680|459411328|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
127669054|NCT02240680|459411325|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
127669055|NCT02240680|459411326|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
127669056|NCT02240680|459411327|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
127669057|NCT02240680|459411328|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
127669058|NCT02240680|459411325|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
127669059|NCT02240680|459411326|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
127669060|NCT02240680|459411327|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
127669061|NCT02240680|459411328|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
127669062|NCT02240680|459411325|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
128002161|NCT03205150|460635153|FG000|Overall Study|Protocol deviation|1|||
128002162|NCT03205150|460635154|FG001|Overall Study|Protocol deviation|3|||
128002163|NCT03205150|460635155|FG002|Overall Study|Protocol deviation|0|||
128002164|NCT03205150|460635153|FG000|Overall Study|Patient/guardian decision|0|||
128002165|NCT03205150|460635154|FG001|Overall Study|Patient/guardian decision|3|||
128002166|NCT03205150|460635155|FG002|Overall Study|Patient/guardian decision|0|||
128002167|NCT03205150|460635153|FG000|Overall Study|Adverse Event|1|||
128002168|NCT03205150|460635154|FG001|Overall Study|Adverse Event|1|||
128002169|NCT03205150|460635155|FG002|Overall Study|Adverse Event|1|||
128002170|NCT03205150|460635153|FG000|Overall Study|Lost to Follow-up|0|||
128002171|NCT03205150|460635154|FG001|Overall Study|Lost to Follow-up|0|||
128002172|NCT03205150|460635155|FG002|Overall Study|Lost to Follow-up|1|||
128002173|NCT00789321|460635162|FG000|Overall Study|Adverse Event|0|||
128002174|NCT00789321|460635163|FG001|Overall Study|Adverse Event|1|||
128002175|NCT00830219|460635164|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
128002176|NCT00830219|460635165|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
128002177|NCT01294423|460635166|FG000|Overall Study|Adverse Event|1|||
128002178|NCT01294423|460635167|FG001|Overall Study|Adverse Event|2|||
128002179|NCT01294423|460635168|FG002|Overall Study|Adverse Event|3|||
128002180|NCT01294423|460635166|FG000|Overall Study|Withdrawal by Subject|1|||
128002181|NCT01294423|460635167|FG001|Overall Study|Withdrawal by Subject|2|||
128002182|NCT01294423|460635168|FG002|Overall Study|Withdrawal by Subject|2|||
128002183|NCT01294423|460635166|FG000|Overall Study|subject no longer meets study criteria|2|||
128002184|NCT01294423|460635167|FG001|Overall Study|subject no longer meets study criteria|5|||
128002185|NCT01294423|460635168|FG002|Overall Study|subject no longer meets study criteria|2|||
128002186|NCT01294423|460635166|FG000|Overall Study|poor/non-compliance|1|||
128002187|NCT01294423|460635167|FG001|Overall Study|poor/non-compliance|0|||
128002188|NCT01294423|460635168|FG002|Overall Study|poor/non-compliance|1|||
128002189|NCT01145482|460635169|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
128002190|NCT01145482|460635170|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
128002191|NCT01699750|460635174|FG000|Overall Study|Withdrew Consent|0|||
128002192|NCT01699750|460635175|FG001|Overall Study|Withdrew Consent|1|||
128002193|NCT01699750|460635174|FG000|Overall Study|Other|0|||
128002194|NCT01699750|460635175|FG001|Overall Study|Other|2|||
128002195|NCT02119299|460635176|FG000|Overall Study|Withdrawal by Subject|7|||
128002196|NCT02119299|460635176|FG000|Overall Study|Lack of Efficacy|1|||
128002197|NCT02119299|460635176|FG000|Overall Study|Pregnancy|1|||
128002198|NCT02026141|460635177|FG000|Overall Study|Protocol Violation|0|||
128002199|NCT02026141|460635178|FG001|Overall Study|Protocol Violation|1|||
128002200|NCT01783743|460635183|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
128002201|NCT01783743|460635184|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
128002202|NCT01783743|460635183|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
128002203|NCT01783743|460635184|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
128002204|NCT01783743|460635183|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
128002205|NCT01783743|460635184|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
128002206|NCT02771275|460635185|FG000|Overall Study|Reoperation|3|||
128002207|NCT02771275|460635185|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
128002208|NCT00728494|460635198|FG000|Overall Study|Adverse Event|7|||
128002209|NCT00728494|460635199|FG001|Overall Study|Adverse Event|0|||
128002210|NCT00728494|460635198|FG000|Overall Study|Withdrawal by Subject|0|||
128002211|NCT00728494|460635199|FG001|Overall Study|Withdrawal by Subject|2|||
128002212|NCT00728494|460635198|FG000|Overall Study|Lack of Efficacy|2|||
128002213|NCT00728494|460635199|FG001|Overall Study|Lack of Efficacy|4|||
128002214|NCT00728494|460635198|FG000|Overall Study|No data available|0|||
128002215|NCT00728494|460635199|FG001|Overall Study|No data available|1|||
128002216|NCT03439137|460635200|FG000|Overall Study|Adverse Event|16|||
128002217|NCT03439137|460635201|FG001|Overall Study|Adverse Event|12|||
128002218|NCT03439137|460635200|FG000|Overall Study|Physician Decision|0|||
128002219|NCT03439137|460635201|FG001|Overall Study|Physician Decision|5|||
128002220|NCT03439137|460635200|FG000|Overall Study|Withdrawal by Subject|14|||
128002221|NCT03439137|460635201|FG001|Overall Study|Withdrawal by Subject|4|||
128002222|NCT03439137|460635200|FG000|Overall Study|Conducting rescue therapy|2|||
128002223|NCT03439137|460635201|FG001|Overall Study|Conducting rescue therapy|1|||
128002224|NCT03439137|460635200|FG000|Overall Study|Difficult to control Hb|10|||
128002225|NCT03439137|460635201|FG001|Overall Study|Difficult to control Hb|2|||
128002226|NCT03439137|460635200|FG000|Overall Study|Initiation of a renal transplant|0|||
128002227|NCT03439137|460635201|FG001|Overall Study|Initiation of a renal transplant|2|||
128002228|NCT00748241|460635202|FG000|Overall Study|Implant failure|1|||
128002229|NCT00748241|460635202|FG000|Overall Study|Lost to Follow-up|5|||
128002230|NCT00748241|460635202|FG000|Overall Study|Death|2|||
128002231|NCT01240382|460635203|FG000|Overall Study|Adverse Event|2|||
128002232|NCT01240382|460635204|FG001|Overall Study|Adverse Event|1|||
127669063|NCT02240680|459411326|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
128002233|NCT01240382|460635203|FG000|Overall Study|Lack of Efficacy|0|||
128002234|NCT01240382|460635204|FG001|Overall Study|Lack of Efficacy|2|||
128002235|NCT01240382|460635203|FG000|Overall Study|Fear of adverse events|0|||
128002236|NCT01240382|460635204|FG001|Overall Study|Fear of adverse events|1|||
128002237|NCT02456727|460635212|FG000|Overall Study|Lost to Follow-up|63|||
128002238|NCT02456727|460635213|FG001|Overall Study|Lost to Follow-up|65|||
128002239|NCT02456727|460635212|FG000|Overall Study|Death|2|||
128002240|NCT02456727|460635213|FG001|Overall Study|Death|1|||
128002241|NCT02456727|460635212|FG000|Overall Study|Withdrawal by Subject|1|||
128002242|NCT02456727|460635213|FG001|Overall Study|Withdrawal by Subject|10|||
128002243|NCT02456727|460635212|FG000|Overall Study|Never Initiated Treatment|43|||
128002244|NCT02456727|460635213|FG001|Overall Study|Never Initiated Treatment|30|||
128002245|NCT02643693|460635214|FG000|Overall Study|Physician Decision|0|||
128002246|NCT02643693|460635215|FG001|Overall Study|Physician Decision|1|||
128002247|NCT02643693|460635216|FG002|Overall Study|Physician Decision|0|||
128002248|NCT02643693|460635217|FG003|Overall Study|Physician Decision|0|||
128002249|NCT02643693|460635218|FG004|Overall Study|Physician Decision|0|||
128002250|NCT02643693|460635219|FG005|Overall Study|Physician Decision|0|||
128002251|NCT02643693|460635214|FG000|Overall Study|Withdrawal by Subject|0|||
127642810|NCT02677116|459313157|FG003|Overall Study|Physician Decision|2|||
127642811|NCT02677116|459313158|FG004|Overall Study|Physician Decision|1|||
127642812|NCT02677116|459313159|FG005|Overall Study|Physician Decision|3|||
127642813|NCT02677116|459313160|FG006|Overall Study|Physician Decision|1|||
127642814|NCT02677116|459313161|FG007|Overall Study|Physician Decision|1|||
127642815|NCT02677116|459313162|FG008|Overall Study|Physician Decision|2|||
127642816|NCT02677116|459313154|FG000|Overall Study|Withdrawal by parent or guardian|2|||
127642817|NCT02677116|459313155|FG001|Overall Study|Withdrawal by parent or guardian|1|||
127642818|NCT02677116|459313156|FG002|Overall Study|Withdrawal by parent or guardian|0|||
127642819|NCT02677116|459313157|FG003|Overall Study|Withdrawal by parent or guardian|1|||
127642820|NCT02677116|459313158|FG004|Overall Study|Withdrawal by parent or guardian|0|||
127642821|NCT02677116|459313159|FG005|Overall Study|Withdrawal by parent or guardian|0|||
127642822|NCT02677116|459313160|FG006|Overall Study|Withdrawal by parent or guardian|2|||
127642823|NCT02677116|459313161|FG007|Overall Study|Withdrawal by parent or guardian|1|||
127642824|NCT02677116|459313162|FG008|Overall Study|Withdrawal by parent or guardian|0|||
127642825|NCT02677116|459313154|FG000|Overall Study|Withdrawal by Subject|1|||
127642826|NCT02677116|459313155|FG001|Overall Study|Withdrawal by Subject|0|||
127642827|NCT02677116|459313156|FG002|Overall Study|Withdrawal by Subject|0|||
127642828|NCT02677116|459313157|FG003|Overall Study|Withdrawal by Subject|0|||
127642829|NCT02677116|459313158|FG004|Overall Study|Withdrawal by Subject|0|||
127642830|NCT02677116|459313159|FG005|Overall Study|Withdrawal by Subject|0|||
127642831|NCT02677116|459313160|FG006|Overall Study|Withdrawal by Subject|0|||
127642832|NCT02677116|459313161|FG007|Overall Study|Withdrawal by Subject|0|||
127642833|NCT02677116|459313162|FG008|Overall Study|Withdrawal by Subject|0|||
127642834|NCT03182868|459313163|FG000|Overall Study|Protocol Violation|3|||
127642835|NCT03182868|459313164|FG001|Overall Study|Protocol Violation|0|||
127642836|NCT03182868|459313165|FG002|Overall Study|Protocol Violation|4|||
127642837|NCT03182868|459313166|FG003|Overall Study|Protocol Violation|1|||
127642838|NCT03182868|459313167|FG004|Overall Study|Protocol Violation|8|||
127642839|NCT02363946|459313168|FG000|Overall Study|Lost to Follow-up|0|||
127642840|NCT02363946|459313169|FG001|Overall Study|Lost to Follow-up|0|||
127642841|NCT02363946|459313170|FG002|Overall Study|Lost to Follow-up|0|||
127642842|NCT02363946|459313171|FG003|Overall Study|Lost to Follow-up|0|||
127642843|NCT02363946|459313172|FG004|Overall Study|Lost to Follow-up|0|||
127642844|NCT02363946|459313173|FG005|Overall Study|Lost to Follow-up|0|||
127642845|NCT02363946|459313174|FG006|Overall Study|Lost to Follow-up|0|||
127642846|NCT02363946|459313175|FG007|Overall Study|Lost to Follow-up|1|||
127642847|NCT02363946|459313176|FG008|Overall Study|Lost to Follow-up|0|||
127642848|NCT02363946|459313177|FG009|Overall Study|Lost to Follow-up|0|||
127642849|NCT02363946|459313178|FG010|Overall Study|Lost to Follow-up|0|||
127642850|NCT02363946|459313179|FG011|Overall Study|Lost to Follow-up|0|||
127642851|NCT02363946|459313180|FG012|Overall Study|Lost to Follow-up|0|||
127642852|NCT01967732|459313181|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
127642853|NCT01967732|459313182|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
127642854|NCT01967732|459313183|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
127642855|NCT01967732|459313184|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
127642856|NCT01967732|459313181|FG000|First Intervention (Day 1)|Poor venous access|0|||
127642857|NCT01967732|459313182|FG001|First Intervention (Day 1)|Poor venous access|1|||
127642858|NCT01967732|459313183|FG002|First Intervention (Day 1)|Poor venous access|0|||
127642859|NCT01967732|459313184|FG003|First Intervention (Day 1)|Poor venous access|0|||
127642860|NCT03342638|459313185|FG000|Overall Study|Withdrawal by Subject|1|||
127642861|NCT03342638|459313186|FG001|Overall Study|Withdrawal by Subject|0|||
127642862|NCT03342638|459313185|FG000|Overall Study|Physician Decision|0|||
127642863|NCT03342638|459313186|FG001|Overall Study|Physician Decision|1|||
127642864|NCT00113568|459313202|FG000|Overall Study|Adverse Event|97|||
127642865|NCT00113568|459313202|FG000|Overall Study|Death|1|||
127642866|NCT00113568|459313202|FG000|Overall Study|Lack of Efficacy|30|||
127642867|NCT00113568|459313202|FG000|Overall Study|Lost to Follow-up|156|||
127642868|NCT00113568|459313202|FG000|Overall Study|Protocol Violation|32|||
128002252|NCT02643693|460635215|FG001|Overall Study|Withdrawal by Subject|1|||
128002253|NCT02643693|460635216|FG002|Overall Study|Withdrawal by Subject|0|||
128002254|NCT02643693|460635217|FG003|Overall Study|Withdrawal by Subject|0|||
128002255|NCT02643693|460635218|FG004|Overall Study|Withdrawal by Subject|0|||
128002256|NCT02643693|460635219|FG005|Overall Study|Withdrawal by Subject|0|||
128002257|NCT02643693|460635214|FG000|Overall Study|Protocol Adherence Issues|2|||
128002258|NCT02643693|460635215|FG001|Overall Study|Protocol Adherence Issues|0|||
128002259|NCT02643693|460635216|FG002|Overall Study|Protocol Adherence Issues|1|||
128002260|NCT02643693|460635217|FG003|Overall Study|Protocol Adherence Issues|0|||
128002261|NCT02643693|460635218|FG004|Overall Study|Protocol Adherence Issues|0|||
128002262|NCT02643693|460635219|FG005|Overall Study|Protocol Adherence Issues|1|||
128002263|NCT02974868|460635222|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
128002264|NCT02974868|460635223|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
128002265|NCT02974868|460635224|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
128002266|NCT02974868|460635225|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
127669064|NCT02240680|459411327|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
127669065|NCT02240680|459411328|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
127669066|NCT02240680|459411325|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
127669067|NCT02240680|459411326|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
127669068|NCT02240680|459411327|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
127669069|NCT02240680|459411328|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
127669070|NCT02240680|459411325|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
127669071|NCT02240680|459411326|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
127669072|NCT02240680|459411327|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
127669073|NCT02240680|459411328|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
128002267|NCT02974868|460635222|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
128002268|NCT02974868|460635223|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
128002269|NCT02974868|460635224|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
128002270|NCT02974868|460635225|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
128002271|NCT02974868|460635222|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
128002272|NCT02974868|460635223|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
128002273|NCT02974868|460635224|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
128002274|NCT02974868|460635225|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
128002275|NCT02974868|460635222|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
128002276|NCT02974868|460635223|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
128002277|NCT02974868|460635224|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
128002278|NCT02974868|460635225|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
128002279|NCT03575702|460635228|FG000|Overall Study|Withdrawal by Subject|1|||
128002280|NCT03575702|460635229|FG001|Overall Study|Withdrawal by Subject|1|||
128002281|NCT03575702|460635228|FG000|Overall Study|Lost to Follow-up|1|||
128002282|NCT03575702|460635229|FG001|Overall Study|Lost to Follow-up|2|||
128002283|NCT03575702|460635228|FG000|Overall Study|Protocol Violation|0|||
128002284|NCT03575702|460635229|FG001|Overall Study|Protocol Violation|1|||
128002285|NCT03575702|460635228|FG000|Overall Study|Patient non compliance|4|||
128002286|NCT03575702|460635229|FG001|Overall Study|Patient non compliance|0|||
128002287|NCT03903172|460635230|FG000|Overall Study|screen fail|4|||
128002288|NCT03903172|460635231|FG001|Overall Study|screen fail|1|||
128002289|NCT01545388|460635232|FG000|Overall Study|Adverse Event|2|||
128002290|NCT01545388|460635233|FG001|Overall Study|Adverse Event|4|||
128002291|NCT01545388|460635234|FG002|Overall Study|Adverse Event|1|||
128002292|NCT01545388|460635232|FG000|Overall Study|Lack of Efficacy|3|||
128002293|NCT01545388|460635233|FG001|Overall Study|Lack of Efficacy|2|||
128002294|NCT01545388|460635234|FG002|Overall Study|Lack of Efficacy|5|||
128002295|NCT01545388|460635232|FG000|Overall Study|Participant moved or relocated|1|||
128002296|NCT01545388|460635233|FG001|Overall Study|Participant moved or relocated|0|||
128002297|NCT01545388|460635234|FG002|Overall Study|Participant moved or relocated|0|||
128002298|NCT01545388|460635232|FG000|Overall Study|Withdrawal by Subject|1|||
128002299|NCT01545388|460635233|FG001|Overall Study|Withdrawal by Subject|4|||
128002300|NCT01545388|460635234|FG002|Overall Study|Withdrawal by Subject|2|||
128002301|NCT01545388|460635232|FG000|Overall Study|Other|1|||
128002302|NCT01545388|460635233|FG001|Overall Study|Other|1|||
128002303|NCT01545388|460635234|FG002|Overall Study|Other|0|||
128002304|NCT01255163|460635235|FG000|Overall Study|Withdrawal by Subject|1|||
128002305|NCT01255163|460635236|FG001|Overall Study|Withdrawal by Subject|0|||
128002306|NCT01255163|460635235|FG000|Overall Study|Lost to Follow-up|2|||
128002307|NCT01255163|460635236|FG001|Overall Study|Lost to Follow-up|0|||
128002308|NCT01255163|460635235|FG000|Overall Study|Adverse Event|0|||
128002309|NCT01255163|460635236|FG001|Overall Study|Adverse Event|2|||
128002310|NCT01255163|460635235|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
128002311|NCT01255163|460635236|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
128002312|NCT02495389|460635237|FG000|Overall Study|Withdrawal by Subject|40|||
128002313|NCT01802385|460635241|FG000|Overall Study|Death|106|||
128002314|NCT01802385|460635242|FG001|Overall Study|Death|120|||
127669074|NCT02240680|459411325|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
127669075|NCT02240680|459411326|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
127669076|NCT02240680|459411327|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
127669077|NCT02240680|459411328|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
128002315|NCT05559905|460635243|FG000|Overall Study|Withdrawal by Subject|1|||
127669078|NCT00562965|459411329|FG000|Overall Study|Withdrawal by Subject|0|||
127669079|NCT00562965|459411330|FG001|Overall Study|Withdrawal by Subject|1|||
127669080|NCT00562965|459411329|FG000|Overall Study|Death|2|||
127669081|NCT00562965|459411330|FG001|Overall Study|Death|4|||
127669082|NCT00562965|459411329|FG000|Overall Study|Lost to Follow-up|1|||
127669083|NCT00562965|459411330|FG001|Overall Study|Lost to Follow-up|0|||
127669084|NCT00562965|459411329|FG000|Overall Study|Other|0|||
127669085|NCT00562965|459411330|FG001|Overall Study|Other|1|||
127669086|NCT00965484|459411334|FG000|Overall Study|Protocol Violation|1|||
127669087|NCT00965484|459411334|FG000|Overall Study|Withdrawal by Subject|1|||
127669088|NCT00848211|459411335|FG000|Overall Study|Protocol Violation|0|||
127669089|NCT00848211|459411336|FG001|Overall Study|Protocol Violation|1|||
127669090|NCT00848211|459411337|FG002|Overall Study|Protocol Violation|1|||
127669091|NCT00848211|459411338|FG003|Overall Study|Protocol Violation|0|||
127669092|NCT00848211|459411335|FG000|Overall Study|Adverse Event|0|||
127669093|NCT00848211|459411336|FG001|Overall Study|Adverse Event|0|||
127669094|NCT00848211|459411337|FG002|Overall Study|Adverse Event|0|||
127669095|NCT00848211|459411338|FG003|Overall Study|Adverse Event|0|||
127669096|NCT01124617|459411339|FG000|Overall Study|Adverse Event|5|||
127669097|NCT01124617|459411340|FG001|Overall Study|Adverse Event|2|||
127669098|NCT01124617|459411339|FG000|Overall Study|Lack of Efficacy|2|||
127669099|NCT01124617|459411340|FG001|Overall Study|Lack of Efficacy|1|||
127669100|NCT01124617|459411339|FG000|Overall Study|Protocol Violation|1|||
127669101|NCT01124617|459411340|FG001|Overall Study|Protocol Violation|1|||
127669102|NCT01124617|459411339|FG000|Overall Study|Withdrawal by Subject|9|||
127669103|NCT01124617|459411340|FG001|Overall Study|Withdrawal by Subject|1|||
127669104|NCT01124617|459411339|FG000|Overall Study|Other|2|||
127669105|NCT01124617|459411340|FG001|Overall Study|Other|1|||
127669106|NCT00945477|459411341|FG000|Overall Study|Adverse Event|3|||
127669107|NCT00945477|459411341|FG000|Overall Study|Lack of Efficacy|2|||
127669108|NCT00945477|459411341|FG000|Overall Study|Withdrawal by Subject|1|||
127669109|NCT00619151|459411342|FG000|Overall Study|Study terminated prior to followup|1|||
127669110|NCT00619151|459411343|FG001|Overall Study|Study terminated prior to followup|0|||
127669111|NCT02825043|459411344|FG000|Overall Study|Lost to Follow-up|4|||
127669112|NCT03582137|459411347|FG000|Overall Study|Adverse Event|1|||
127669113|NCT03582137|459411348|FG001|Overall Study|Adverse Event|0|||
127669114|NCT01982760|459411350|FG000|Overall Study|Physician Decision|1|||
127669115|NCT01982760|459411351|FG001|Overall Study|Physician Decision|0|||
127669116|NCT03704298|459411352|FG000|Overall Study|Death|3|||
127669117|NCT03704298|459411353|FG001|Overall Study|Death|1|||
127669118|NCT03704298|459411354|FG002|Overall Study|Death|1|||
127669119|NCT03704298|459411355|FG003|Overall Study|Death|0|||
127669120|NCT03704298|459411352|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|1|||
127669121|NCT03704298|459411353|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
127669122|NCT03704298|459411354|FG002|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
127669123|NCT03704298|459411355|FG003|Overall Study|Rollover to Long-term Follow-up Study Criteria|3|||
127669124|NCT03704298|459411352|FG000|Overall Study|Withdrawal by Subject|1|||
127669125|NCT03704298|459411353|FG001|Overall Study|Withdrawal by Subject|0|||
127669126|NCT03704298|459411354|FG002|Overall Study|Withdrawal by Subject|0|||
127669127|NCT03704298|459411355|FG003|Overall Study|Withdrawal by Subject|0|||
127669128|NCT03704298|459411352|FG000|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
127669129|NCT03704298|459411353|FG001|Overall Study|Developed Other Infection Before Starting the Treatment|1|||
127669130|NCT03704298|459411354|FG002|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
127669131|NCT03704298|459411355|FG003|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
127669132|NCT02303574|459411358|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
128002316|NCT05559905|460635244|FG001|Overall Study|Withdrawal by Subject|0|||
128002317|NCT05559905|460635245|FG002|Overall Study|Withdrawal by Subject|0|||
128002318|NCT05559905|460635243|FG000|Overall Study|Not Reported|1|||
127669133|NCT02303574|459411359|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
127669134|NCT02303574|459411360|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
127669135|NCT02303574|459411361|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
127669136|NCT02303574|459411362|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
127669137|NCT02303574|459411363|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
127669138|NCT02303574|459411364|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
127669139|NCT02303574|459411365|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
127669140|NCT02303574|459411366|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
127669141|NCT02303574|459411367|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
127669142|NCT02303574|459411358|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
128002319|NCT05559905|460635244|FG001|Overall Study|Not Reported|0|||
127669143|NCT02303574|459411359|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
128002320|NCT05559905|460635245|FG002|Overall Study|Not Reported|0|||
128002321|NCT04003103|460635246|FG000|Overall Study|Death|1|||
128002322|NCT04003103|460635247|FG001|Overall Study|Death|0|||
128002323|NCT04003103|460635248|FG002|Overall Study|Death|0|||
128002324|NCT04003103|460635246|FG000|Overall Study|Lost to Follow-up|4|||
128002325|NCT04003103|460635247|FG001|Overall Study|Lost to Follow-up|3|||
128002326|NCT04003103|460635248|FG002|Overall Study|Lost to Follow-up|2|||
128002327|NCT04003103|460635246|FG000|Overall Study|Withdrawal by Subject|10|||
128002328|NCT04003103|460635247|FG001|Overall Study|Withdrawal by Subject|1|||
128002329|NCT04003103|460635248|FG002|Overall Study|Withdrawal by Subject|1|||
128002330|NCT04003103|460635246|FG000|Overall Study|Status not recorded|0|||
128002331|NCT04003103|460635247|FG001|Overall Study|Status not recorded|2|||
128002332|NCT04003103|460635248|FG002|Overall Study|Status not recorded|0|||
128002333|NCT03669588|460635249|FG000|Overall Study|Adverse Event|1|||
128002334|NCT03669588|460635250|FG001|Overall Study|Adverse Event|0|||
128002335|NCT03669588|460635249|FG000|Overall Study|Physician Decision|0|||
128002336|NCT03669588|460635250|FG001|Overall Study|Physician Decision|1|||
128002337|NCT03669588|460635249|FG000|Overall Study|Protocol Violation|1|||
127669144|NCT02303574|459411360|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
128002338|NCT03669588|460635250|FG001|Overall Study|Protocol Violation|0|||
128002339|NCT03669588|460635249|FG000|Overall Study|Sponsor Decision|1|||
128002340|NCT03669588|460635250|FG001|Overall Study|Sponsor Decision|1|||
128002341|NCT03669588|460635249|FG000|Overall Study|Withdrawal by Subject|1|||
128002342|NCT03669588|460635250|FG001|Overall Study|Withdrawal by Subject|4|||
128002343|NCT03669588|460635249|FG000|Overall Study|Rescue Therapy Needed|0|||
128002344|NCT03669588|460635250|FG001|Overall Study|Rescue Therapy Needed|1|||
128002345|NCT00369343|460635252|FG000|Double-blind Phase|Adverse Event|19|||
128002346|NCT00369343|460635253|FG001|Double-blind Phase|Adverse Event|4|||
128002347|NCT00369343|460635252|FG000|Double-blind Phase|Failed to return|2|||
128002348|NCT00369343|460635253|FG001|Double-blind Phase|Failed to return|0|||
128002349|NCT00369343|460635252|FG000|Double-blind Phase|Lost to Follow-up|9|||
128002350|NCT00369343|460635253|FG001|Double-blind Phase|Lost to Follow-up|2|||
127669145|NCT02303574|459411361|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
127669146|NCT02303574|459411362|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
127669147|NCT02303574|459411363|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
128002351|NCT00369343|460635252|FG000|Double-blind Phase|Protocol Violation|2|||
128002352|NCT00369343|460635253|FG001|Double-blind Phase|Protocol Violation|0|||
127669148|NCT02303574|459411364|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
127669149|NCT02303574|459411365|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
127669150|NCT02303574|459411366|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
127669151|NCT02303574|459411367|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
127669152|NCT00859014|459411368|FG000|Overall Study|Death|4|||
127669153|NCT00859014|459411368|FG000|Overall Study|Lost to Follow-up|1|||
127669154|NCT04796935|459411369|FG000|Overall Study|Withdrawal by Subject|0|||
127669155|NCT04796935|459411370|FG001|Overall Study|Withdrawal by Subject|1|||
127669156|NCT04796935|459411369|FG000|Overall Study|Physician Decision|0|||
127669157|NCT04796935|459411370|FG001|Overall Study|Physician Decision|1|||
127669158|NCT04796935|459411369|FG000|Overall Study|Device not available|1|||
127669159|NCT04796935|459411370|FG001|Overall Study|Device not available|0|||
127669160|NCT04796935|459411369|FG000|Overall Study|Trained provider not available|1|||
127669161|NCT04796935|459411370|FG001|Overall Study|Trained provider not available|0|||
127669162|NCT00783718|459411371|FG000|Induction Phase|Adverse Event|4|||
127669163|NCT00783718|459411372|FG001|Induction Phase|Adverse Event|0|||
127669164|NCT00783718|459411373|FG002|Induction Phase|Adverse Event|7|||
127669165|NCT00783718|459411374|FG003|Induction Phase|Adverse Event|0|||
127669166|NCT00783718|459411375|FG004|Induction Phase|Adverse Event|0|||
127669167|NCT00783718|459411376|FG005|Induction Phase|Adverse Event|0|||
127669168|NCT00783718|459411377|FG006|Induction Phase|Adverse Event|0|||
127669169|NCT00783718|459411371|FG000|Induction Phase|Protocol Violation|1|||
127669170|NCT00783718|459411372|FG001|Induction Phase|Protocol Violation|1|||
128002353|NCT00369343|460635252|FG000|Double-blind Phase|Withdrawal by Subject|8|||
128002354|NCT00369343|460635253|FG001|Double-blind Phase|Withdrawal by Subject|6|||
128002355|NCT00369343|460635252|FG000|Double-blind Phase|Lack of Efficacy|0|||
128002356|NCT00369343|460635253|FG001|Double-blind Phase|Lack of Efficacy|4|||
128002357|NCT00369343|460635252|FG000|Double-blind Phase|Protocol deviation|4|||
128002358|NCT00369343|460635253|FG001|Double-blind Phase|Protocol deviation|0|||
128002359|NCT00369343|460635252|FG000|Open-label Phase|Adverse Event|19|||
128002360|NCT00369343|460635253|FG001|Open-label Phase|Adverse Event|7|||
128002361|NCT00369343|460635252|FG000|Open-label Phase|Failed to return|4|||
127543507|NCT02718898|458956556|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
127669171|NCT00783718|459411373|FG002|Induction Phase|Protocol Violation|6|||
128002362|NCT00369343|460635253|FG001|Open-label Phase|Failed to return|0|||
127669172|NCT00783718|459411374|FG003|Induction Phase|Protocol Violation|0|||
127669173|NCT00783718|459411375|FG004|Induction Phase|Protocol Violation|0|||
128002363|NCT00369343|460635252|FG000|Open-label Phase|Physician Decision|2|||
128002364|NCT00369343|460635253|FG001|Open-label Phase|Physician Decision|0|||
128002365|NCT00369343|460635252|FG000|Open-label Phase|Lost to Follow-up|5|||
127669174|NCT00783718|459411376|FG005|Induction Phase|Protocol Violation|0|||
127669175|NCT00783718|459411377|FG006|Induction Phase|Protocol Violation|0|||
127669176|NCT00783718|459411371|FG000|Induction Phase|Lack of Efficacy|5|||
127669177|NCT00783718|459411372|FG001|Induction Phase|Lack of Efficacy|2|||
127669178|NCT00783718|459411373|FG002|Induction Phase|Lack of Efficacy|14|||
127669179|NCT00783718|459411374|FG003|Induction Phase|Lack of Efficacy|0|||
127669180|NCT00783718|459411375|FG004|Induction Phase|Lack of Efficacy|0|||
127669181|NCT00783718|459411376|FG005|Induction Phase|Lack of Efficacy|0|||
127669182|NCT00783718|459411377|FG006|Induction Phase|Lack of Efficacy|0|||
127669183|NCT00783718|459411371|FG000|Induction Phase|Withdrawal by Subject|3|||
127669184|NCT00783718|459411372|FG001|Induction Phase|Withdrawal by Subject|4|||
127669185|NCT00783718|459411373|FG002|Induction Phase|Withdrawal by Subject|8|||
127669186|NCT00783718|459411374|FG003|Induction Phase|Withdrawal by Subject|0|||
127669187|NCT00783718|459411375|FG004|Induction Phase|Withdrawal by Subject|0|||
127669188|NCT00783718|459411376|FG005|Induction Phase|Withdrawal by Subject|0|||
127669189|NCT00783718|459411377|FG006|Induction Phase|Withdrawal by Subject|0|||
127669190|NCT00783718|459411371|FG000|Induction Phase|Lost to Follow-up|1|||
127669191|NCT00783718|459411372|FG001|Induction Phase|Lost to Follow-up|0|||
127669192|NCT00783718|459411373|FG002|Induction Phase|Lost to Follow-up|1|||
127669193|NCT00783718|459411374|FG003|Induction Phase|Lost to Follow-up|0|||
127669194|NCT00783718|459411375|FG004|Induction Phase|Lost to Follow-up|0|||
127669195|NCT00783718|459411376|FG005|Induction Phase|Lost to Follow-up|0|||
127669196|NCT00783718|459411377|FG006|Induction Phase|Lost to Follow-up|0|||
127669197|NCT00783718|459411371|FG000|Maintenance Phase|Adverse Event|12|||
127669198|NCT00783718|459411372|FG001|Maintenance Phase|Adverse Event|0|||
127669199|NCT00783718|459411373|FG002|Maintenance Phase|Adverse Event|0|||
127669200|NCT00783718|459411374|FG003|Maintenance Phase|Adverse Event|15|||
127669201|NCT00783718|459411375|FG004|Maintenance Phase|Adverse Event|7|||
127669202|NCT00783718|459411376|FG005|Maintenance Phase|Adverse Event|6|||
127669203|NCT00783718|459411377|FG006|Maintenance Phase|Adverse Event|16|||
127669204|NCT00783718|459411371|FG000|Maintenance Phase|Protocol Violation|1|||
127669205|NCT00783718|459411372|FG001|Maintenance Phase|Protocol Violation|0|||
127669206|NCT00783718|459411373|FG002|Maintenance Phase|Protocol Violation|0|||
127669207|NCT00783718|459411374|FG003|Maintenance Phase|Protocol Violation|0|||
127669208|NCT00783718|459411375|FG004|Maintenance Phase|Protocol Violation|0|||
127669209|NCT00783718|459411376|FG005|Maintenance Phase|Protocol Violation|0|||
127669210|NCT00783718|459411377|FG006|Maintenance Phase|Protocol Violation|2|||
127669211|NCT00783718|459411371|FG000|Maintenance Phase|Lack of Efficacy|83|||
127669212|NCT00783718|459411372|FG001|Maintenance Phase|Lack of Efficacy|0|||
127669213|NCT00783718|459411373|FG002|Maintenance Phase|Lack of Efficacy|0|||
127669214|NCT00783718|459411374|FG003|Maintenance Phase|Lack of Efficacy|61|||
127669215|NCT00783718|459411375|FG004|Maintenance Phase|Lack of Efficacy|31|||
127669216|NCT00783718|459411376|FG005|Maintenance Phase|Lack of Efficacy|33|||
127669217|NCT00783718|459411377|FG006|Maintenance Phase|Lack of Efficacy|155|||
127669218|NCT00783718|459411371|FG000|Maintenance Phase|Withdrawal by Subject|6|||
127669219|NCT00783718|459411372|FG001|Maintenance Phase|Withdrawal by Subject|0|||
127669220|NCT00783718|459411373|FG002|Maintenance Phase|Withdrawal by Subject|0|||
127669221|NCT00783718|459411374|FG003|Maintenance Phase|Withdrawal by Subject|2|||
127669222|NCT00783718|459411375|FG004|Maintenance Phase|Withdrawal by Subject|5|||
127669223|NCT00783718|459411376|FG005|Maintenance Phase|Withdrawal by Subject|2|||
127669224|NCT00783718|459411377|FG006|Maintenance Phase|Withdrawal by Subject|20|||
127669225|NCT00783718|459411371|FG000|Maintenance Phase|Lost to Follow-up|3|||
127669226|NCT00783718|459411372|FG001|Maintenance Phase|Lost to Follow-up|0|||
127669227|NCT00783718|459411373|FG002|Maintenance Phase|Lost to Follow-up|0|||
127669228|NCT00783718|459411374|FG003|Maintenance Phase|Lost to Follow-up|0|||
127669229|NCT00783718|459411375|FG004|Maintenance Phase|Lost to Follow-up|2|||
127669230|NCT00783718|459411376|FG005|Maintenance Phase|Lost to Follow-up|0|||
127669231|NCT00783718|459411377|FG006|Maintenance Phase|Lost to Follow-up|2|||
127669232|NCT01027871|459411379|FG000|Overall Study|Physician Decision|1|||
127669233|NCT01027871|459411380|FG001|Overall Study|Physician Decision|5|||
127669234|NCT01027871|459411381|FG002|Overall Study|Physician Decision|0|||
127669235|NCT01027871|459411379|FG000|Overall Study|Protocol Violation|0|||
127669236|NCT01027871|459411380|FG001|Overall Study|Protocol Violation|2|||
127669237|NCT01027871|459411381|FG002|Overall Study|Protocol Violation|2|||
127669238|NCT01027871|459411379|FG000|Overall Study|Withdrawal by Subject|1|||
127669239|NCT01027871|459411380|FG001|Overall Study|Withdrawal by Subject|2|||
127669240|NCT01027871|459411381|FG002|Overall Study|Withdrawal by Subject|2|||
127669241|NCT01027871|459411379|FG000|Overall Study|Adverse Event|0|||
127669242|NCT01027871|459411380|FG001|Overall Study|Adverse Event|2|||
127669243|NCT01027871|459411381|FG002|Overall Study|Adverse Event|2|||
127669244|NCT01027871|459411379|FG000|Overall Study|Sponsor Decision|0|||
127669245|NCT01027871|459411380|FG001|Overall Study|Sponsor Decision|2|||
127669246|NCT01027871|459411381|FG002|Overall Study|Sponsor Decision|0|||
127669247|NCT01027871|459411379|FG000|Overall Study|Discontinued Prior to Treatment|0|||
127669248|NCT01027871|459411380|FG001|Overall Study|Discontinued Prior to Treatment|0|||
127669249|NCT01027871|459411381|FG002|Overall Study|Discontinued Prior to Treatment|1|||
127669250|NCT04159896|459411387|FG000|Overall Study|Lack of Efficacy|7|||
127669251|NCT04159896|459411387|FG000|Overall Study|Withdrawal by Subject|1|||
128002366|NCT00369343|460635253|FG001|Open-label Phase|Lost to Follow-up|3|||
127669252|NCT04159896|459411387|FG000|Overall Study|Adverse Event|1|||
128002367|NCT00369343|460635252|FG000|Open-label Phase|inadvertently reported study completers|3|||
128002368|NCT00369343|460635253|FG001|Open-label Phase|inadvertently reported study completers|2|||
128002369|NCT00369343|460635252|FG000|Open-label Phase|Protocol Violation|1|||
128002370|NCT00369343|460635253|FG001|Open-label Phase|Protocol Violation|3|||
128002371|NCT00369343|460635252|FG000|Open-label Phase|Withdrawal by Subject|15|||
127669253|NCT04159896|459411387|FG000|Overall Study|A transient ischaemic attack|1|||
127669254|NCT05705167|459411388|FG000|Overall Study|Randomised but not Treated|0|||
127669255|NCT05705167|459411389|FG001|Overall Study|Randomised but not Treated|2|||
128002372|NCT00369343|460635253|FG001|Open-label Phase|Withdrawal by Subject|6|||
128002373|NCT00369343|460635252|FG000|Open-label Phase|Lack of Efficacy|4|||
128002374|NCT00369343|460635253|FG001|Open-label Phase|Lack of Efficacy|3|||
128002375|NCT00369343|460635252|FG000|Open-label Phase|Lack of continuance tolerability|3|||
127669256|NCT05705167|459411390|FG002|Overall Study|Randomised but not Treated|0|||
127669257|NCT05705167|459411391|FG003|Overall Study|Randomised but not Treated|7|||
127669258|NCT05705167|459411392|FG004|Overall Study|Randomised but not Treated|0|||
127669259|NCT05705167|459411393|FG005|Overall Study|Randomised but not Treated|0|||
127669260|NCT05705167|459411394|FG006|Overall Study|Randomised but not Treated|0|||
127669261|NCT05705167|459411388|FG000|Overall Study|Death|0|||
127669262|NCT05705167|459411389|FG001|Overall Study|Death|0|||
127669263|NCT05705167|459411390|FG002|Overall Study|Death|3|||
127669264|NCT05705167|459411391|FG003|Overall Study|Death|0|||
127669265|NCT05705167|459411392|FG004|Overall Study|Death|1|||
127669266|NCT05705167|459411393|FG005|Overall Study|Death|1|||
127669267|NCT05705167|459411394|FG006|Overall Study|Death|1|||
127669268|NCT05705167|459411388|FG000|Overall Study|Discontinued Prior to FAS Eligibility|0|||
127669269|NCT05705167|459411389|FG001|Overall Study|Discontinued Prior to FAS Eligibility|0|||
127669270|NCT05705167|459411390|FG002|Overall Study|Discontinued Prior to FAS Eligibility|1|||
127669271|NCT05705167|459411391|FG003|Overall Study|Discontinued Prior to FAS Eligibility|1|||
127669272|NCT05705167|459411392|FG004|Overall Study|Discontinued Prior to FAS Eligibility|0|||
127669273|NCT05705167|459411393|FG005|Overall Study|Discontinued Prior to FAS Eligibility|0|||
127669274|NCT05705167|459411394|FG006|Overall Study|Discontinued Prior to FAS Eligibility|1|||
127669275|NCT02099539|459411395|FG000|Overall Study|Progressive Disease|3|||
127669276|NCT02099539|459411396|FG001|Overall Study|Progressive Disease|2|||
127669277|NCT02099539|459411397|FG002|Overall Study|Progressive Disease|2|||
127669278|NCT02099539|459411398|FG003|Overall Study|Progressive Disease|1|||
127669279|NCT02099539|459411399|FG004|Overall Study|Progressive Disease|4|||
127669280|NCT02099539|459411400|FG005|Overall Study|Progressive Disease|2|||
127669281|NCT02099539|459411401|FG006|Overall Study|Progressive Disease|0|||
127669282|NCT02099539|459411395|FG000|Overall Study|Adverse Event|0|||
127669283|NCT02099539|459411396|FG001|Overall Study|Adverse Event|0|||
127669284|NCT02099539|459411397|FG002|Overall Study|Adverse Event|1|||
127669285|NCT02099539|459411398|FG003|Overall Study|Adverse Event|1|||
127669286|NCT02099539|459411399|FG004|Overall Study|Adverse Event|0|||
127669287|NCT02099539|459411400|FG005|Overall Study|Adverse Event|0|||
127669288|NCT02099539|459411401|FG006|Overall Study|Adverse Event|0|||
127669289|NCT02099539|459411395|FG000|Overall Study|Physician Decision|0|||
127669290|NCT02099539|459411396|FG001|Overall Study|Physician Decision|0|||
127669291|NCT02099539|459411397|FG002|Overall Study|Physician Decision|0|||
127669292|NCT02099539|459411398|FG003|Overall Study|Physician Decision|0|||
127669293|NCT02099539|459411399|FG004|Overall Study|Physician Decision|0|||
127669294|NCT02099539|459411400|FG005|Overall Study|Physician Decision|1|||
127669295|NCT02099539|459411401|FG006|Overall Study|Physician Decision|0|||
127669296|NCT04060680|459411404|FG000|Overall Study|Unsuccessful implant|17|||
127669297|NCT04060680|459411405|FG001|Overall Study|Unsuccessful implant|2|||
127669298|NCT04060680|459411404|FG000|Overall Study|Adverse Event|3|||
127669299|NCT04060680|459411405|FG001|Overall Study|Adverse Event|0|||
127669300|NCT04060680|459411404|FG000|Overall Study|Death|2|||
127669301|NCT04060680|459411405|FG001|Overall Study|Death|0|||
127669302|NCT04060680|459411404|FG000|Overall Study|Study product no longer in use|1|||
127669303|NCT04060680|459411405|FG001|Overall Study|Study product no longer in use|0|||
127669304|NCT04060680|459411404|FG000|Overall Study|Withdrawal by Subject|1|||
127669305|NCT04060680|459411405|FG001|Overall Study|Withdrawal by Subject|0|||
127669306|NCT02322775|459411409|FG000|Overall Study|Adverse Event|1|||
128002376|NCT00369343|460635253|FG001|Open-label Phase|Lack of continuance tolerability|4|||
128002377|NCT00369343|460635252|FG000|Open-label Phase|did not take study drug|1|||
128002378|NCT00369343|460635253|FG001|Open-label Phase|did not take study drug|2|||
127669307|NCT02322775|459411410|FG001|Overall Study|Adverse Event|0|||
127669308|NCT02322775|459411409|FG000|Overall Study|Lost to Follow-up|0|||
127669309|NCT02322775|459411410|FG001|Overall Study|Lost to Follow-up|1|||
127669310|NCT02322775|459411409|FG000|Overall Study|Protocol Violation|1|||
127669311|NCT02322775|459411410|FG001|Overall Study|Protocol Violation|0|||
127669312|NCT02322775|459411409|FG000|Overall Study|Withdrawal by Subject|3|||
127669313|NCT02322775|459411410|FG001|Overall Study|Withdrawal by Subject|4|||
128002379|NCT01100502|460635254|FG000|Overall Study|Withdrawal by Subject|18|||
127669314|NCT02322775|459411409|FG000|Overall Study|Not willing to perform all FU visits|0|||
127669315|NCT02322775|459411410|FG001|Overall Study|Not willing to perform all FU visits|1|||
127669316|NCT04739423|459411415|FG000|Overall Study|Protocol Violation|0|||
127669317|NCT04739423|459411416|FG001|Overall Study|Protocol Violation|1|||
127669318|NCT04739423|459411417|FG002|Overall Study|Protocol Violation|0|||
127669319|NCT04739423|459411418|FG003|Overall Study|Protocol Violation|0|||
127669320|NCT04739423|459411419|FG004|Overall Study|Protocol Violation|0|||
127669321|NCT04739423|459411420|FG005|Overall Study|Protocol Violation|0|||
127669322|NCT04739423|459411415|FG000|Overall Study|Adverse Event|0|||
127669323|NCT04739423|459411416|FG001|Overall Study|Adverse Event|0|||
127669324|NCT04739423|459411417|FG002|Overall Study|Adverse Event|1|||
127669325|NCT04739423|459411418|FG003|Overall Study|Adverse Event|0|||
127669326|NCT04739423|459411419|FG004|Overall Study|Adverse Event|1|||
127669327|NCT04739423|459411420|FG005|Overall Study|Adverse Event|0|||
127669328|NCT04739423|459411415|FG000|Overall Study|Withdrawal by Subject|0|||
127669329|NCT04739423|459411416|FG001|Overall Study|Withdrawal by Subject|0|||
127669330|NCT04739423|459411417|FG002|Overall Study|Withdrawal by Subject|0|||
127669331|NCT04739423|459411418|FG003|Overall Study|Withdrawal by Subject|0|||
127669332|NCT04739423|459411419|FG004|Overall Study|Withdrawal by Subject|0|||
127669333|NCT04739423|459411420|FG005|Overall Study|Withdrawal by Subject|1|||
127669334|NCT01007552|459411421|FG000|Overall Study|Withdrawal by Subject|1|||
127669335|NCT02507219|459411427|FG000|Overall Study|Physician Decision|1|||
127669336|NCT02507219|459411428|FG001|Overall Study|Physician Decision|0|||
127669337|NCT02507219|459411429|FG002|Overall Study|Physician Decision|0|||
127669338|NCT02507219|459411430|FG003|Overall Study|Physician Decision|0|||
127669339|NCT02507219|459411431|FG004|Overall Study|Physician Decision|0|||
127669340|NCT02507219|459411432|FG005|Overall Study|Physician Decision|0|||
127669341|NCT02507219|459411427|FG000|Overall Study|Withdrawal by Subject|0|||
127669342|NCT02507219|459411428|FG001|Overall Study|Withdrawal by Subject|0|||
127669343|NCT02507219|459411429|FG002|Overall Study|Withdrawal by Subject|0|||
127669344|NCT02507219|459411430|FG003|Overall Study|Withdrawal by Subject|0|||
127669345|NCT02507219|459411431|FG004|Overall Study|Withdrawal by Subject|1|||
127669346|NCT02507219|459411432|FG005|Overall Study|Withdrawal by Subject|0|||
127669347|NCT05174065|459411433|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
127669348|NCT05174065|459411434|FG001|Placebo-controlled Period|Withdrawal by Subject|0|||
127669349|NCT05174065|459411435|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
127669350|NCT05174065|459411433|FG000|Placebo-controlled Period|Other|0|||
127669351|NCT05174065|459411434|FG001|Placebo-controlled Period|Other|1|||
127669352|NCT05174065|459411435|FG002|Placebo-controlled Period|Other|0|||
127669353|NCT05174065|459411433|FG000|Placebo-controlled Period|Adverse Event|1|||
127669354|NCT05174065|459411434|FG001|Placebo-controlled Period|Adverse Event|1|||
127669355|NCT05174065|459411435|FG002|Placebo-controlled Period|Adverse Event|0|||
127669356|NCT05174065|459411433|FG000|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
127669357|NCT05174065|459411434|FG001|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
127669358|NCT05174065|459411435|FG002|Apremilast Active Treatment Period|Withdrawal by Subject|3|||
127669359|NCT05174065|459411433|FG000|Apremilast Active Treatment Period|Protocol Violation|0|||
127669360|NCT05174065|459411434|FG001|Apremilast Active Treatment Period|Protocol Violation|0|||
127669361|NCT05174065|459411435|FG002|Apremilast Active Treatment Period|Protocol Violation|1|||
127669362|NCT05174065|459411433|FG000|Apremilast Active Treatment Period|Adverse Event|0|||
127669363|NCT05174065|459411434|FG001|Apremilast Active Treatment Period|Adverse Event|0|||
127669364|NCT05174065|459411435|FG002|Apremilast Active Treatment Period|Adverse Event|4|||
127669365|NCT01342887|459411438|FG000|Overall Study|Death|2|||
127669366|NCT00209274|459411439|FG000|Overall Study|Missed visit|3|||
127669367|NCT00209274|459411440|FG001|Overall Study|Missed visit|2|||
127669368|NCT00209274|459411439|FG000|Overall Study|Death|32|||
127669369|NCT00209274|459411440|FG001|Overall Study|Death|15|||
127669370|NCT00209274|459411439|FG000|Overall Study|Withdrawal by Subject|30|||
127669371|NCT00209274|459411440|FG001|Overall Study|Withdrawal by Subject|15|||
127669372|NCT00209274|459411439|FG000|Overall Study|Randomized not treated (RNT)|6|||
127669373|NCT00209274|459411440|FG001|Overall Study|Randomized not treated (RNT)|15|||
127669374|NCT00097370|459411445|FG000|Stage 1|Adverse Event|3|||
127669375|NCT00097370|459411445|FG000|Stage 1|Withdrawal by Subject|1|||
127669376|NCT00097370|459411445|FG000|Stage 1|Lack of Efficacy|2|||
127669377|NCT00097370|459411445|FG000|Stage 2|Adverse Event|5|||
127669378|NCT00097370|459411445|FG000|Stage 2|Withdrawal by Subject|1|||
127669379|NCT00097370|459411445|FG000|Stage 2|Lack of Efficacy|3|||
127669380|NCT00097370|459411445|FG000|Stage 2|Pregnancy|1|||
127669381|NCT00097370|459411445|FG000|Stage 2|Sponsor Terminated Study|2|||
127669382|NCT00097370|459411445|FG000|Stage 2|Lost to Follow-up|1|||
127669383|NCT00097370|459411445|FG000|Stage 3|Adverse Event|2|||
127669384|NCT00097370|459411445|FG000|Stage 3|Withdrawal by Subject|3|||
127669385|NCT00097370|459411445|FG000|Stage 3|Lack of Efficacy|1|||
127669386|NCT00097370|459411445|FG000|Stage 3|Sponsor Terminated Study|52|||
127669387|NCT00097370|459411445|FG000|Stage 3|Lost to Follow-up|1|||
127669388|NCT02337361|459411446|FG000|3-month Follow-up|Lost to Follow-up|19|||
127669389|NCT02337361|459411447|FG001|3-month Follow-up|Lost to Follow-up|14|||
127669390|NCT02337361|459411446|FG000|6-month Follow-up|Lost to Follow-up|2|||
127669391|NCT02337361|459411447|FG001|6-month Follow-up|Lost to Follow-up|4|||
127669392|NCT02419755|459411449|FG000|Overall Study|Death|1|||
127669393|NCT02419755|459411450|FG001|Overall Study|Death|3|||
127669394|NCT02419755|459411449|FG000|Overall Study|Relapse|0|||
127669395|NCT02419755|459411450|FG001|Overall Study|Relapse|1|||
127669396|NCT02419755|459411449|FG000|Overall Study|Ineligible|1|||
128002380|NCT01100502|460635255|FG001|Overall Study|Withdrawal by Subject|25|||
128002381|NCT01100502|460635254|FG000|Overall Study|Lost to Follow-up|13|||
128002382|NCT01100502|460635255|FG001|Overall Study|Lost to Follow-up|28|||
128002383|NCT01100502|460635254|FG000|Overall Study|Site request to end participation in study|0|||
128002384|NCT01100502|460635255|FG001|Overall Study|Site request to end participation in study|1|||
128002385|NCT01100502|460635254|FG000|Overall Study|Death|45|||
128002386|NCT01100502|460635255|FG001|Overall Study|Death|40|||
128002387|NCT02322749|460635256|FG000|Period 2|Adverse Event|0|||
128002388|NCT02322749|460635257|FG001|Period 2|Adverse Event|0|||
128002389|NCT02322749|460635258|FG002|Period 2|Adverse Event|0|||
128002390|NCT02322749|460635259|FG003|Period 2|Adverse Event|1|||
128002391|NCT02322749|460635260|FG004|Period 2|Adverse Event|0|||
128002392|NCT02322749|460635261|FG005|Period 2|Adverse Event|0|||
128002393|NCT02322749|460635256|FG000|Period 2|Withdrawal by Subject|0|||
128002394|NCT02322749|460635257|FG001|Period 2|Withdrawal by Subject|0|||
128002395|NCT02322749|460635258|FG002|Period 2|Withdrawal by Subject|0|||
128002396|NCT02322749|460635259|FG003|Period 2|Withdrawal by Subject|1|||
128002397|NCT02322749|460635260|FG004|Period 2|Withdrawal by Subject|0|||
128002398|NCT02322749|460635261|FG005|Period 2|Withdrawal by Subject|0|||
128002399|NCT02322749|460635256|FG000|Period 3|Withdrawal by Subject|0|||
128002400|NCT02322749|460635257|FG001|Period 3|Withdrawal by Subject|0|||
128002401|NCT02322749|460635258|FG002|Period 3|Withdrawal by Subject|1|||
128002402|NCT02322749|460635259|FG003|Period 3|Withdrawal by Subject|0|||
128002403|NCT02322749|460635260|FG004|Period 3|Withdrawal by Subject|0|||
128002404|NCT02322749|460635261|FG005|Period 3|Withdrawal by Subject|0|||
128002405|NCT01190813|460635266|FG000|Overall Study|Lost to Follow-up|1|||
128002406|NCT01190813|460635267|FG001|Overall Study|Lost to Follow-up|2|||
128002407|NCT01190813|460635266|FG000|Overall Study|Withdrawal by Subject|2|||
128002408|NCT01190813|460635267|FG001|Overall Study|Withdrawal by Subject|1|||
128002409|NCT01190813|460635266|FG000|Overall Study|Refused study treatment after randomized|1|||
128002410|NCT01190813|460635267|FG001|Overall Study|Refused study treatment after randomized|0|||
128002411|NCT01190813|460635266|FG000|Overall Study|Adverse Event|0|||
128002412|NCT01190813|460635267|FG001|Overall Study|Adverse Event|1|||
128002413|NCT05158140|460635274|FG000|Overall Study|Death|0|||
128002414|NCT05158140|460635275|FG001|Overall Study|Death|0|||
128002415|NCT05158140|460635276|FG002|Overall Study|Death|0|||
128002416|NCT05158140|460635277|FG003|Overall Study|Death|1|||
128002417|NCT05158140|460635274|FG000|Overall Study|Lost to Follow-up|3|||
128002418|NCT05158140|460635275|FG001|Overall Study|Lost to Follow-up|6|||
128002419|NCT05158140|460635276|FG002|Overall Study|Lost to Follow-up|4|||
128002420|NCT05158140|460635277|FG003|Overall Study|Lost to Follow-up|3|||
128002421|NCT05158140|460635274|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
128002422|NCT05158140|460635275|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
128002423|NCT05158140|460635276|FG002|Overall Study|Randomized By Mistake Without Study Treatment|4|||
128002424|NCT05158140|460635277|FG003|Overall Study|Randomized By Mistake Without Study Treatment|1|||
128002425|NCT05158140|460635274|FG000|Overall Study|Withdrawal by Subject|3|||
128002426|NCT05158140|460635275|FG001|Overall Study|Withdrawal by Subject|7|||
128002427|NCT05158140|460635276|FG002|Overall Study|Withdrawal by Subject|3|||
128002428|NCT05158140|460635277|FG003|Overall Study|Withdrawal by Subject|7|||
128002429|NCT04414787|460635282|FG000|Overall Study|Patient Death|18|||
128002430|NCT04414787|460635283|FG001|Overall Study|Patient Death|18|||
128002431|NCT04414787|460635284|FG002|Overall Study|Patient Death|15|||
128002432|NCT04414787|460635285|FG003|Overall Study|Patient Death|15|||
128002433|NCT04414787|460635282|FG000|Overall Study|Patient Hospitalization|1|||
128002434|NCT04414787|460635283|FG001|Overall Study|Patient Hospitalization|1|||
128002435|NCT04414787|460635284|FG002|Overall Study|Patient Hospitalization|2|||
128002436|NCT04414787|460635285|FG003|Overall Study|Patient Hospitalization|2|||
128002437|NCT04414787|460635282|FG000|Overall Study|Lost to Follow-up|7|||
128002438|NCT04414787|460635283|FG001|Overall Study|Lost to Follow-up|7|||
127669397|NCT02419755|459411450|FG001|Overall Study|Ineligible|0|||
128002439|NCT04414787|460635284|FG002|Overall Study|Lost to Follow-up|5|||
128002440|NCT04414787|460635285|FG003|Overall Study|Lost to Follow-up|5|||
127543508|NCT02718898|458956557|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
127669398|NCT02419755|459411449|FG000|Overall Study|Withdrawal by Subject|1|||
128002441|NCT04414787|460635282|FG000|Overall Study|Residence in post-acute care facility|3|||
128002442|NCT04414787|460635283|FG001|Overall Study|Residence in post-acute care facility|3|||
128002443|NCT04414787|460635284|FG002|Overall Study|Residence in post-acute care facility|5|||
128002444|NCT04414787|460635285|FG003|Overall Study|Residence in post-acute care facility|5|||
128002445|NCT00807365|460635286|FG000|Overall Study|Study Terminated|5|||
128002446|NCT01526785|460635287|FG000|Overall Study|Study Terminated by Sponsor|8|||
128002447|NCT01526785|460635287|FG000|Overall Study|Death|2|||
128002448|NCT01526785|460635287|FG000|Overall Study|Physician Decision|1|||
128002449|NCT01526785|460635287|FG000|Overall Study|Withdrawal by Subject|2|||
128002450|NCT04194814|460635294|FG000|Overall Study|Physician Decision|3|||
127669399|NCT02419755|459411450|FG001|Overall Study|Withdrawal by Subject|0|||
127669400|NCT02427646|459411451|FG000|Overall Study|Lack of Efficacy|2|||
127669401|NCT02427646|459411452|FG001|Overall Study|Lack of Efficacy|3|||
127669402|NCT02427646|459411451|FG000|Overall Study|Physician Decision|1|||
127669403|NCT02427646|459411452|FG001|Overall Study|Physician Decision|4|||
127669404|NCT02427646|459411451|FG000|Overall Study|Protocol Violation|3|||
127669405|NCT02427646|459411452|FG001|Overall Study|Protocol Violation|3|||
127669406|NCT02427646|459411451|FG000|Overall Study|Bothersome hand weakness|2|||
127669407|NCT02427646|459411452|FG001|Overall Study|Bothersome hand weakness|4|||
127669408|NCT01101542|459411453|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
127669409|NCT01101542|459411453|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
127669410|NCT01101542|459411453|FG000|Year 4 Surveillance Period|Other|287|||
127669411|NCT01101542|459411453|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
127669412|NCT01101542|459411453|FG000|Year 5 Surveillance Period|Pregnancy|1|||
127669413|NCT01101542|459411453|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
127669414|NCT01101542|459411453|FG000|Year 6 Surveillance Period|Pregnancy|1|||
127669415|NCT01101542|459411453|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
127669416|NCT00901485|459411454|FG000|Overall Study|Lack of Efficacy|0|||
127669417|NCT00901485|459411455|FG001|Overall Study|Lack of Efficacy|2|||
127669418|NCT00901485|459411454|FG000|Overall Study|Withdrawal by Subject|1|||
127669419|NCT00901485|459411455|FG001|Overall Study|Withdrawal by Subject|2|||
127669420|NCT01929993|459413093|FG000|Overall Study|Protocol Violation|4|||
127669421|NCT01929993|459413094|FG001|Overall Study|Protocol Violation|6|||
127669422|NCT01929993|459413093|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
127669423|NCT01929993|459413094|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
127669424|NCT01256476|459413095|FG000|Overall Study|Adverse Event|2|||
127669425|NCT01256476|459413096|FG001|Overall Study|Adverse Event|1|||
127669426|NCT01256476|459413095|FG000|Overall Study|Withdrawal by Subject|2|||
127669427|NCT01256476|459413096|FG001|Overall Study|Withdrawal by Subject|1|||
127669428|NCT01256476|459413095|FG000|Overall Study|Lost to Follow-up|1|||
127669429|NCT01256476|459413096|FG001|Overall Study|Lost to Follow-up|2|||
127669430|NCT01256476|459413095|FG000|Overall Study|Persistent ALT or AST elevation|1|||
127669431|NCT01256476|459413096|FG001|Overall Study|Persistent ALT or AST elevation|0|||
127669432|NCT01256476|459413095|FG000|Overall Study|Physician Decision|0|||
127669433|NCT01256476|459413096|FG001|Overall Study|Physician Decision|1|||
127669434|NCT01256476|459413095|FG000|Overall Study|Subject non-compliance|0|||
127669435|NCT01256476|459413096|FG001|Overall Study|Subject non-compliance|1|||
127669436|NCT01256476|459413095|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
127669437|NCT01256476|459413096|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
127669438|NCT02268396|459413100|FG000|Overall Study|Adverse Event|3|||
127669439|NCT02268396|459413100|FG000|Overall Study|Administrative|2|||
127669440|NCT02268396|459413100|FG000|Overall Study|Withdrawal by Subject|1|||
127669441|NCT02268396|459413100|FG000|Overall Study|Lost to Follow-up|2|||
127669442|NCT02268396|459413100|FG000|Overall Study|Protocol-Specified Criteria|2|||
127669443|NCT02268396|459413100|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
127669444|NCT00163215|459413101|FG000|Overall Study|Lack of Efficacy|3|||
127669445|NCT00163215|459413101|FG000|Overall Study|Withdrawal by Subject|5|||
127669446|NCT00163215|459413101|FG000|Overall Study|Other|7|||
127669447|NCT03660943|459413102|FG000|Overall Study|Adverse Event|5|||
127669448|NCT03660943|459413103|FG001|Overall Study|Adverse Event|3|||
127669449|NCT03660943|459413102|FG000|Overall Study|Death|0|||
127669450|NCT03660943|459413103|FG001|Overall Study|Death|2|||
127669451|NCT03660943|459413102|FG000|Overall Study|Lost to Follow-up|7|||
127669452|NCT03660943|459413103|FG001|Overall Study|Lost to Follow-up|3|||
127669453|NCT03660943|459413102|FG000|Overall Study|Protocol Violation|3|||
127669454|NCT03660943|459413103|FG001|Overall Study|Protocol Violation|5|||
127669455|NCT03660943|459413102|FG000|Overall Study|Withdrawal by Subject|8|||
127669456|NCT03660943|459413103|FG001|Overall Study|Withdrawal by Subject|15|||
127669457|NCT03660943|459413102|FG000|Overall Study|Lack of Efficacy|9|||
127669458|NCT03660943|459413103|FG001|Overall Study|Lack of Efficacy|12|||
128002451|NCT04194814|460635295|FG001|Overall Study|Physician Decision|0|||
127669459|NCT03660943|459413102|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
127669460|NCT03660943|459413103|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
127669461|NCT00231179|459413104|FG000|Overall Study|Lost to Follow-up|21|||
127669462|NCT00231179|459413105|FG001|Overall Study|Lost to Follow-up|21|||
127669463|NCT00231179|459413104|FG000|Overall Study|Withdrawal by Subject|3|||
127669464|NCT00231179|459413105|FG001|Overall Study|Withdrawal by Subject|3|||
127669465|NCT02491411|459413108|FG000|Overall Study|Physician Decision|4|||
127669466|NCT04034238|459413109|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
127669467|NCT04034238|459413110|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
127669468|NCT04034238|459413111|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
127669469|NCT04034238|459413112|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
128002452|NCT04194814|460635294|FG000|Overall Study|Withdrawal by Subject|0|||
128002453|NCT04194814|460635295|FG001|Overall Study|Withdrawal by Subject|2|||
128002454|NCT02188160|460636981|FG000|Overall Study|Adverse Event|1|||
128002455|NCT02188160|460636982|FG001|Overall Study|Adverse Event|0|||
128002456|NCT02188160|460636981|FG000|Overall Study|Use of an excluded medication|0|||
128002457|NCT02188160|460636982|FG001|Overall Study|Use of an excluded medication|1|||
127669470|NCT04034238|459413109|FG000|Dose Escalation Phase|Screen failures|0|||
127669471|NCT04034238|459413110|FG001|Dose Escalation Phase|Screen failures|0|||
127669472|NCT04034238|459413111|FG002|Dose Escalation Phase|Screen failures|0|||
127669473|NCT04034238|459413112|FG003|Dose Escalation Phase|Screen failures|2|||
127669474|NCT04034238|459413109|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
127669475|NCT04034238|459413110|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
127669476|NCT04034238|459413111|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
127669477|NCT04034238|459413112|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
127669478|NCT04034238|459413109|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
127669479|NCT04034238|459413110|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
127669480|NCT04034238|459413111|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
127669481|NCT04034238|459413112|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
127669482|NCT01939158|459413113|FG000|Overall Study|Adverse Event|1|||
127669483|NCT01939158|459413114|FG001|Overall Study|Adverse Event|0|||
127669484|NCT01939158|459413115|FG002|Overall Study|Adverse Event|0|||
127669485|NCT01939158|459413116|FG003|Overall Study|Adverse Event|0|||
127669486|NCT01939158|459413113|FG000|Overall Study|Withdrawal by Subject|22|||
127669487|NCT01939158|459413114|FG001|Overall Study|Withdrawal by Subject|25|||
127669488|NCT01939158|459413115|FG002|Overall Study|Withdrawal by Subject|15|||
127669489|NCT01939158|459413116|FG003|Overall Study|Withdrawal by Subject|17|||
127669490|NCT01939158|459413113|FG000|Overall Study|Migrated/moved from study area|5|||
127669491|NCT01939158|459413114|FG001|Overall Study|Migrated/moved from study area|7|||
127669492|NCT01939158|459413115|FG002|Overall Study|Migrated/moved from study area|3|||
127669493|NCT01939158|459413116|FG003|Overall Study|Migrated/moved from study area|6|||
127669494|NCT01939158|459413113|FG000|Overall Study|Lost to Follow-up|18|||
127669495|NCT01939158|459413114|FG001|Overall Study|Lost to Follow-up|17|||
127669496|NCT01939158|459413115|FG002|Overall Study|Lost to Follow-up|17|||
127669497|NCT01939158|459413116|FG003|Overall Study|Lost to Follow-up|17|||
127669498|NCT01939158|459413113|FG000|Overall Study|Death|0|||
127669499|NCT01939158|459413114|FG001|Overall Study|Death|0|||
127669500|NCT01939158|459413115|FG002|Overall Study|Death|1|||
127669501|NCT01939158|459413116|FG003|Overall Study|Death|1|||
127669502|NCT01939158|459413113|FG000|Overall Study|No longer meets eligibility criteria|0|||
127669503|NCT01939158|459413114|FG001|Overall Study|No longer meets eligibility criteria|0|||
127669504|NCT01939158|459413115|FG002|Overall Study|No longer meets eligibility criteria|1|||
127669505|NCT01939158|459413116|FG003|Overall Study|No longer meets eligibility criteria|0|||
127669506|NCT01939158|459413113|FG000|Overall Study|Other|1|||
127669507|NCT01939158|459413114|FG001|Overall Study|Other|3|||
127669508|NCT01939158|459413115|FG002|Overall Study|Other|4|||
127669509|NCT01939158|459413116|FG003|Overall Study|Other|3|||
127669510|NCT02065245|459413117|FG000|Infusion 1|Lost to Follow-up|0|||
127669511|NCT02065245|459413118|FG001|Infusion 1|Lost to Follow-up|0|||
127669512|NCT02065245|459413119|FG002|Infusion 1|Lost to Follow-up|0|||
127669513|NCT02065245|459413120|FG003|Infusion 1|Lost to Follow-up|0|||
127669514|NCT02065245|459413121|FG004|Infusion 1|Lost to Follow-up|0|||
127669515|NCT02065245|459413122|FG005|Infusion 1|Lost to Follow-up|0|||
127669516|NCT02065245|459413123|FG006|Infusion 1|Lost to Follow-up|1|||
127669517|NCT02065245|459413117|FG000|Infusion 1|Death|0|||
127669518|NCT02065245|459413118|FG001|Infusion 1|Death|0|||
127669519|NCT02065245|459413119|FG002|Infusion 1|Death|1|||
127669520|NCT02065245|459413120|FG003|Infusion 1|Death|0|||
127669521|NCT02065245|459413121|FG004|Infusion 1|Death|1|||
127669522|NCT02065245|459413122|FG005|Infusion 1|Death|0|||
127669523|NCT02065245|459413123|FG006|Infusion 1|Death|0|||
127669524|NCT02065245|459413117|FG000|Infusion 2|Death|0|||
128002458|NCT03638128|460636985|FG000|Overall Study|Withdrawal by Subject|1|||
128002459|NCT03638128|460636986|FG001|Overall Study|Withdrawal by Subject|7|||
128002460|NCT03638128|460636987|FG002|Overall Study|Withdrawal by Subject|6|||
127669525|NCT02065245|459413118|FG001|Infusion 2|Death|0|||
127669526|NCT02065245|459413119|FG002|Infusion 2|Death|0|||
127669527|NCT02065245|459413120|FG003|Infusion 2|Death|0|||
127669528|NCT02065245|459413121|FG004|Infusion 2|Death|0|||
127669529|NCT02065245|459413122|FG005|Infusion 2|Death|0|||
127669530|NCT02065245|459413123|FG006|Infusion 2|Death|1|||
127669531|NCT02065245|459413117|FG000|Infusion 3|Lost to Follow-up|1|||
127669532|NCT02065245|459413118|FG001|Infusion 3|Lost to Follow-up|1|||
127669533|NCT02065245|459413119|FG002|Infusion 3|Lost to Follow-up|0|||
127669534|NCT02065245|459413120|FG003|Infusion 3|Lost to Follow-up|0|||
127669535|NCT02065245|459413121|FG004|Infusion 3|Lost to Follow-up|0|||
127669536|NCT02065245|459413122|FG005|Infusion 3|Lost to Follow-up|0|||
127669537|NCT02065245|459413123|FG006|Infusion 3|Lost to Follow-up|0|||
127669538|NCT01304706|459413124|FG000|Overall Study|Adverse Event|2|||
128002461|NCT03638128|460636985|FG000|Overall Study|Sponsor Decision|15|||
127669539|NCT01304706|459413124|FG000|Overall Study|Lack of Efficacy|1|||
127669540|NCT01304706|459413124|FG000|Overall Study|Death|3|||
127669541|NCT01304706|459413124|FG000|Overall Study|Withdrawal by Subject|3|||
127669542|NCT01304706|459413124|FG000|Overall Study|Lost to Follow-up|7|||
127669543|NCT01304706|459413124|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
127669544|NCT02892409|459413125|FG000|Overall Study|Adverse Event|1|||
127669545|NCT02892409|459413126|FG001|Overall Study|Adverse Event|0|||
127669546|NCT02892409|459413125|FG000|Overall Study|Withdrawal by Subject|2|||
127669547|NCT02892409|459413126|FG001|Overall Study|Withdrawal by Subject|1|||
127669548|NCT01345292|459413131|FG000|Overall Study|Withdrawal by Subject|2|||
127669549|NCT01345292|459413132|FG001|Overall Study|Withdrawal by Subject|0|||
127669550|NCT01345292|459413133|FG002|Overall Study|Withdrawal by Subject|1|||
127669551|NCT04822298|459413136|FG000|Overall Study|Death|3|||
127669552|NCT01033643|459413137|FG000|Overall Study|Withdrew Consent|0|||
127669553|NCT01033643|459413138|FG001|Overall Study|Withdrew Consent|3|||
127669554|NCT01033643|459413139|FG002|Overall Study|Withdrew Consent|0|||
127669555|NCT01033643|459413140|FG003|Overall Study|Withdrew Consent|0|||
127669556|NCT01033643|459413141|FG004|Overall Study|Withdrew Consent|0|||
127669557|NCT01033643|459413142|FG005|Overall Study|Withdrew Consent|1|||
127669558|NCT01789203|459413145|FG000|Overall Study|Adverse Event|2|||
128002462|NCT03638128|460636986|FG001|Overall Study|Sponsor Decision|12|||
127669559|NCT01789203|459413146|FG001|Overall Study|Adverse Event|2|||
127669560|NCT01789203|459413145|FG000|Overall Study|Withdrawal by Subject|1|||
127669561|NCT01789203|459413146|FG001|Overall Study|Withdrawal by Subject|0|||
127669562|NCT01789203|459413145|FG000|Overall Study|Death|1|||
127669563|NCT01789203|459413146|FG001|Overall Study|Death|0|||
127669564|NCT01789203|459413145|FG000|Overall Study|Protocol Violation|2|||
127669565|NCT01789203|459413146|FG001|Overall Study|Protocol Violation|1|||
127669566|NCT01789203|459413145|FG000|Overall Study|Other|1|||
127669567|NCT01789203|459413146|FG001|Overall Study|Other|1|||
127669568|NCT01789203|459413145|FG000|Overall Study|patient non-adherent|2|||
127669569|NCT01789203|459413146|FG001|Overall Study|patient non-adherent|0|||
127669570|NCT00515086|459413147|FG000|Overall Study|Adverse Event|1|||
127669571|NCT00515086|459413148|FG001|Overall Study|Adverse Event|1|||
127669572|NCT00515086|459413149|FG002|Overall Study|Adverse Event|2|||
127669573|NCT00515086|459413150|FG003|Overall Study|Adverse Event|3|||
127669574|NCT00515086|459413147|FG000|Overall Study|Administrative|1|||
127669575|NCT00515086|459413148|FG001|Overall Study|Administrative|1|||
127669576|NCT00515086|459413149|FG002|Overall Study|Administrative|0|||
127669577|NCT00515086|459413150|FG003|Overall Study|Administrative|0|||
127669578|NCT00515086|459413147|FG000|Overall Study|Withdrawal by Subject|1|||
127669579|NCT00515086|459413148|FG001|Overall Study|Withdrawal by Subject|0|||
127669580|NCT00515086|459413149|FG002|Overall Study|Withdrawal by Subject|0|||
127669581|NCT00515086|459413150|FG003|Overall Study|Withdrawal by Subject|1|||
127669582|NCT00515086|459413147|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
127669583|NCT00515086|459413148|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
127669584|NCT00515086|459413149|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
127669585|NCT00515086|459413150|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
127669586|NCT00515086|459413147|FG000|Overall Study|Lost to Follow-up|1|||
127669587|NCT00515086|459413148|FG001|Overall Study|Lost to Follow-up|0|||
127669588|NCT00515086|459413149|FG002|Overall Study|Lost to Follow-up|0|||
127669589|NCT00515086|459413150|FG003|Overall Study|Lost to Follow-up|0|||
127669590|NCT00515086|459413147|FG000|Overall Study|Study drug no longer required|0|||
127669591|NCT00515086|459413148|FG001|Overall Study|Study drug no longer required|1|||
127669592|NCT00515086|459413149|FG002|Overall Study|Study drug no longer required|0|||
127669593|NCT00515086|459413150|FG003|Overall Study|Study drug no longer required|0|||
127669594|NCT00515086|459413147|FG000|Overall Study|Death|2|||
127669595|NCT00515086|459413148|FG001|Overall Study|Death|0|||
128002463|NCT03638128|460636987|FG002|Overall Study|Sponsor Decision|19|||
128002464|NCT03638128|460636985|FG000|Overall Study|Lost to Follow-up|0|||
128002465|NCT03638128|460636986|FG001|Overall Study|Lost to Follow-up|0|||
128002466|NCT03638128|460636987|FG002|Overall Study|Lost to Follow-up|1|||
128002467|NCT02371616|460636988|FG000|Overall Study|Protocol Violation|2|||
128002468|NCT02371616|460636989|FG001|Overall Study|Protocol Violation|1|||
127669596|NCT00515086|459413149|FG002|Overall Study|Death|0|||
127669597|NCT00515086|459413150|FG003|Overall Study|Death|0|||
127669598|NCT02028884|459413151|FG000|Double-blind Period|Adverse Event|5|||
127669599|NCT02028884|459413152|FG001|Double-blind Period|Adverse Event|3|||
127669600|NCT02028884|459413153|FG002|Double-blind Period|Adverse Event|0|||
127543509|NCT02718898|458956551|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
127669601|NCT02028884|459413151|FG000|Double-blind Period|Eligibility Violation|1|||
127669602|NCT02028884|459413152|FG001|Double-blind Period|Eligibility Violation|0|||
127669603|NCT02028884|459413153|FG002|Double-blind Period|Eligibility Violation|0|||
127669604|NCT02028884|459413151|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
127669605|NCT02028884|459413152|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
127669606|NCT02028884|459413153|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
127669607|NCT02028884|459413151|FG000|Double-blind Period|Withdrawal by Subject|2|||
128002469|NCT02371616|460636988|FG000|Overall Study|Adverse Event|0|||
128002470|NCT02371616|460636989|FG001|Overall Study|Adverse Event|1|||
128002471|NCT02371616|460636988|FG000|Overall Study|Withdrawal of Consent|1|||
128002472|NCT02371616|460636989|FG001|Overall Study|Withdrawal of Consent|0|||
128002473|NCT02371616|460636988|FG000|Overall Study|Other (Not specified)|1|||
128002474|NCT02371616|460636989|FG001|Overall Study|Other (Not specified)|5|||
128002475|NCT00754741|460636990|FG000|Overall Study|Died or disenrolled|57|||
128002476|NCT00754741|460636991|FG001|Overall Study|Died or disenrolled|69|||
128002477|NCT00754741|460636992|FG002|Overall Study|Died or disenrolled|54|||
128002478|NCT03028142|460636993|FG000|Overall Study|Adverse Event|1|||
127669608|NCT02028884|459413152|FG001|Double-blind Period|Withdrawal by Subject|0|||
127669609|NCT02028884|459413153|FG002|Double-blind Period|Withdrawal by Subject|0|||
127669610|NCT02028884|459413151|FG000|Open-label Extension Period|Adverse Event|3|||
127669611|NCT02028884|459413152|FG001|Open-label Extension Period|Adverse Event|1|||
127669612|NCT02028884|459413153|FG002|Open-label Extension Period|Adverse Event|0|||
127669613|NCT02028884|459413151|FG000|Open-label Extension Period|Lack of Efficacy|3|||
127669614|NCT02028884|459413152|FG001|Open-label Extension Period|Lack of Efficacy|0|||
127669615|NCT02028884|459413153|FG002|Open-label Extension Period|Lack of Efficacy|0|||
127669616|NCT02028884|459413151|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
127669617|NCT02028884|459413152|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
127669618|NCT02028884|459413153|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
127669619|NCT02028884|459413151|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
127669620|NCT02028884|459413152|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
127669621|NCT02028884|459413153|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
127669622|NCT02028884|459413151|FG000|Open-label Extension Period|Switched to another treatment option|3|||
127669623|NCT02028884|459413152|FG001|Open-label Extension Period|Switched to another treatment option|0|||
127669624|NCT02028884|459413153|FG002|Open-label Extension Period|Switched to another treatment option|0|||
127669625|NCT02373813|459413154|FG000|Run-In Period|Other, Not Specified|5|||
127669626|NCT02373813|459413155|FG001|Run-In Period|Other, Not Specified|0|||
127669627|NCT02373813|459413156|FG002|Run-In Period|Other, Not Specified|0|||
127669628|NCT02373813|459413157|FG003|Run-In Period|Other, Not Specified|0|||
127669629|NCT02373813|459413154|FG000|Run-In Period|Withdrawal by Subject|16|||
127669630|NCT02373813|459413155|FG001|Run-In Period|Withdrawal by Subject|0|||
127669631|NCT02373813|459413156|FG002|Run-In Period|Withdrawal by Subject|0|||
127669632|NCT02373813|459413157|FG003|Run-In Period|Withdrawal by Subject|0|||
127669633|NCT02373813|459413154|FG000|Run-In Period|Decision by Sponsor|11|||
127669634|NCT02373813|459413155|FG001|Run-In Period|Decision by Sponsor|0|||
127669635|NCT02373813|459413156|FG002|Run-In Period|Decision by Sponsor|0|||
127669636|NCT02373813|459413157|FG003|Run-In Period|Decision by Sponsor|0|||
127669637|NCT02373813|459413154|FG000|Run-In Period|Protocol Violation|75|||
127669638|NCT02373813|459413155|FG001|Run-In Period|Protocol Violation|0|||
127669639|NCT02373813|459413156|FG002|Run-In Period|Protocol Violation|0|||
127669640|NCT02373813|459413157|FG003|Run-In Period|Protocol Violation|0|||
127669641|NCT02373813|459413154|FG000|Run-In Period|Lost to Follow-up|2|||
127669642|NCT02373813|459413155|FG001|Run-In Period|Lost to Follow-up|0|||
127669643|NCT02373813|459413156|FG002|Run-In Period|Lost to Follow-up|0|||
127669644|NCT02373813|459413157|FG003|Run-In Period|Lost to Follow-up|0|||
127669645|NCT02373813|459413154|FG000|Run-In Period|Adverse Event|3|||
127669646|NCT02373813|459413155|FG001|Run-In Period|Adverse Event|0|||
127669647|NCT02373813|459413156|FG002|Run-In Period|Adverse Event|0|||
127669648|NCT02373813|459413157|FG003|Run-In Period|Adverse Event|0|||
127669649|NCT02373813|459413154|FG000|Run-In Period|Noncompliance|1|||
127669650|NCT02373813|459413155|FG001|Run-In Period|Noncompliance|0|||
127669651|NCT02373813|459413156|FG002|Run-In Period|Noncompliance|0|||
127669652|NCT02373813|459413157|FG003|Run-In Period|Noncompliance|0|||
127669653|NCT02373813|459413154|FG000|Run-In Period|Ineligibility Determined|3|||
127669654|NCT02373813|459413155|FG001|Run-In Period|Ineligibility Determined|0|||
127669655|NCT02373813|459413156|FG002|Run-In Period|Ineligibility Determined|0|||
127669656|NCT02373813|459413157|FG003|Run-In Period|Ineligibility Determined|0|||
127669657|NCT02373813|459413154|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
127669658|NCT02373813|459413155|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
127669659|NCT02373813|459413156|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
127669660|NCT02373813|459413157|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
127669661|NCT02373813|459413154|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
127669662|NCT02373813|459413155|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
127669663|NCT02373813|459413156|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
127669664|NCT02373813|459413157|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
127669665|NCT02373813|459413154|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
127669666|NCT02373813|459413155|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
127669667|NCT02373813|459413156|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
127669668|NCT02373813|459413157|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
127669669|NCT02373813|459413154|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
127669670|NCT02373813|459413155|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
127669671|NCT02373813|459413156|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
128002479|NCT03028142|460636994|FG001|Overall Study|Adverse Event|1|||
128002480|NCT03028142|460636995|FG002|Overall Study|Adverse Event|0|||
127669672|NCT02373813|459413157|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
127669673|NCT00723294|459413158|FG000|Overall Study|Lobular histology|2|||
127669674|NCT00723294|459413158|FG000|Overall Study|>25% intraductal component|1|||
127669675|NCT00723294|459413158|FG000|Overall Study|No MRI tumor enhancement|1|||
127669676|NCT00723294|459413158|FG000|Overall Study|1.0-Tesla MRI|1|||
127669677|NCT00723294|459413158|FG000|Overall Study|No cryoabalation|2|||
127669678|NCT00723294|459413158|FG000|Overall Study|Did not undergo surgery|1|||
127669679|NCT00723294|459413158|FG000|Overall Study|Treated prior to registration|1|||
127669680|NCT00723294|459413158|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
127669681|NCT00723294|459413158|FG000|Overall Study|Benign lesion|1|||
127669682|NCT00723294|459413158|FG000|Overall Study|Withdrawal by Subject|1|||
127669683|NCT00723294|459413158|FG000|Overall Study|No treatment due to probe failure|1|||
127669684|NCT01254305|459413159|FG000|Overall Study|Adverse Event|6|||
127669685|NCT01254305|459413160|FG001|Overall Study|Adverse Event|3|||
127669686|NCT01254305|459413161|FG002|Overall Study|Adverse Event|2|||
127669687|NCT01254305|459413159|FG000|Overall Study|Lack of Efficacy|1|||
127669688|NCT01254305|459413160|FG001|Overall Study|Lack of Efficacy|0|||
127669689|NCT01254305|459413161|FG002|Overall Study|Lack of Efficacy|1|||
127669690|NCT01254305|459413159|FG000|Overall Study|Protocol Violation|1|||
127669691|NCT01254305|459413160|FG001|Overall Study|Protocol Violation|7|||
127669692|NCT01254305|459413161|FG002|Overall Study|Protocol Violation|3|||
127669693|NCT01254305|459413159|FG000|Overall Study|Withdrawal by Subject|4|||
127669694|NCT01254305|459413160|FG001|Overall Study|Withdrawal by Subject|2|||
127669695|NCT01254305|459413161|FG002|Overall Study|Withdrawal by Subject|4|||
127669696|NCT01254305|459413159|FG000|Overall Study|Lost to Follow-up|10|||
127669697|NCT01254305|459413160|FG001|Overall Study|Lost to Follow-up|6|||
127669698|NCT01254305|459413161|FG002|Overall Study|Lost to Follow-up|5|||
127669699|NCT01254305|459413159|FG000|Overall Study|Other Reasons|0|||
127669700|NCT01254305|459413160|FG001|Overall Study|Other Reasons|0|||
127669701|NCT01254305|459413161|FG002|Overall Study|Other Reasons|2|||
127669702|NCT02788656|459413162|FG000|Overall Study|Withdrawal by Subject|1|||
127669703|NCT02788656|459413163|FG001|Overall Study|Withdrawal by Subject|0|||
127669704|NCT01403987|459413170|FG000|Overall Study|Residents forgot their secret PIN|18|||
128002481|NCT03028142|460636996|FG003|Overall Study|Adverse Event|0|||
128002482|NCT03028142|460636997|FG004|Overall Study|Adverse Event|0|||
128002483|NCT03028142|460636998|FG005|Overall Study|Adverse Event|1|||
128002484|NCT03028142|460636993|FG000|Overall Study|Withdrawal by Subject|0|||
128002485|NCT03028142|460636994|FG001|Overall Study|Withdrawal by Subject|0|||
128002486|NCT03028142|460636995|FG002|Overall Study|Withdrawal by Subject|0|||
128002487|NCT03028142|460636996|FG003|Overall Study|Withdrawal by Subject|0|||
128002488|NCT03028142|460636997|FG004|Overall Study|Withdrawal by Subject|1|||
128002489|NCT03028142|460636998|FG005|Overall Study|Withdrawal by Subject|0|||
128002490|NCT02810418|460636999|FG000|Arm A Dose Escalation|Adverse Event|2|||
128002491|NCT02810418|460637000|FG001|Arm A Dose Escalation|Adverse Event|1|||
128002492|NCT02810418|460637001|FG002|Arm A Dose Escalation|Adverse Event|0|||
128002493|NCT02810418|460637002|FG003|Arm A Dose Escalation|Adverse Event|0|||
128002494|NCT02810418|460637003|FG004|Arm A Dose Escalation|Adverse Event|0|||
128002495|NCT02810418|460637004|FG005|Arm A Dose Escalation|Adverse Event|0|||
128002496|NCT02810418|460637005|FG006|Arm A Dose Escalation|Adverse Event|0|||
128002497|NCT02810418|460636999|FG000|Dose Expansion|Adverse Event|0|||
128002498|NCT02810418|460637000|FG001|Dose Expansion|Adverse Event|1|||
128002499|NCT02810418|460637001|FG002|Dose Expansion|Adverse Event|1|||
128002500|NCT02810418|460637002|FG003|Dose Expansion|Adverse Event|0|||
128002501|NCT02810418|460637003|FG004|Dose Expansion|Adverse Event|0|||
128002502|NCT02810418|460637004|FG005|Dose Expansion|Adverse Event|0|||
128002503|NCT02810418|460637005|FG006|Dose Expansion|Adverse Event|0|||
128002504|NCT02810418|460636999|FG000|Dose Expansion|Physician Decision|0|||
128002505|NCT02810418|460637000|FG001|Dose Expansion|Physician Decision|0|||
128002506|NCT02810418|460637001|FG002|Dose Expansion|Physician Decision|2|||
128002507|NCT02810418|460637002|FG003|Dose Expansion|Physician Decision|0|||
128002508|NCT02810418|460637003|FG004|Dose Expansion|Physician Decision|0|||
128002509|NCT02810418|460637004|FG005|Dose Expansion|Physician Decision|0|||
128002510|NCT02810418|460637005|FG006|Dose Expansion|Physician Decision|0|||
128002511|NCT02810418|460636999|FG000|Arm B Dose Escalation|Adverse Event|0|||
128002512|NCT02810418|460637000|FG001|Arm B Dose Escalation|Adverse Event|0|||
128002513|NCT02810418|460637001|FG002|Arm B Dose Escalation|Adverse Event|0|||
128002514|NCT02810418|460637002|FG003|Arm B Dose Escalation|Adverse Event|0|||
127669705|NCT01403987|459413171|FG001|Overall Study|Residents forgot their secret PIN|17|||
127669706|NCT01403987|459413172|FG002|Overall Study|Residents forgot their secret PIN|18|||
127669707|NCT00751790|459413174|FG000|Overall Study|Lost to Follow-up|1|||
128002515|NCT02810418|460637003|FG004|Arm B Dose Escalation|Adverse Event|1|||
128002516|NCT02810418|460637004|FG005|Arm B Dose Escalation|Adverse Event|2|||
128002517|NCT02810418|460637005|FG006|Arm B Dose Escalation|Adverse Event|0|||
128002518|NCT01965327|460637009|FG000|Overall Study|Physician Decision|2|||
128002519|NCT01162343|460637010|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
128002520|NCT01162343|460637010|FG000|Overall Study|Refused psychiatrist assessment|12|||
128002521|NCT04635839|460637028|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
128002522|NCT04635839|460637029|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
127669708|NCT00751790|459413174|FG000|Overall Study|Death|3|||
127669709|NCT00751790|459413174|FG000|Overall Study|Withdrawal by Subject|1|||
127669710|NCT00180674|459413175|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
127669711|NCT00180674|459413175|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
127669712|NCT01106976|459413176|FG000|Overall Study|Lost to Follow-up|8|||
127669713|NCT03606460|459413180|FG000|Overall Study|Lost to Follow-up|1|||
127669714|NCT03606460|459413181|FG001|Overall Study|Lost to Follow-up|8|||
127669715|NCT04170023|459413182|FG000|LTE Period|Withdrawal by Subject|1|||
127669716|NCT04170023|459413183|FG001|LTE Period|Withdrawal by Subject|0|||
127669717|NCT04170023|459413184|FG002|LTE Period|Withdrawal by Subject|0|||
127669718|NCT04170023|459413182|FG000|LTE Period|Study Termination|11|||
127669719|NCT04170023|459413183|FG001|LTE Period|Study Termination|11|||
127669720|NCT04170023|459413184|FG002|LTE Period|Study Termination|5|||
127669721|NCT03836664|459413185|FG000|Overall Study|Didn't complete forms and lost drug|3|||
127669722|NCT03836664|459413186|FG001|Overall Study|Didn't complete forms and lost drug|3|||
127669723|NCT00335153|459413187|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
127669724|NCT00335153|459413187|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
127669725|NCT00335153|459413187|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
127669726|NCT00335153|459413187|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
127669727|NCT00335153|459413187|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
127669728|NCT00335153|459413187|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
127669729|NCT00335153|459413187|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
127669730|NCT00335153|459413187|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
127669731|NCT00335153|459413187|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
128002523|NCT02737358|460637030|FG000|Overall Study|Withdrawal by Subject|7|||
128002524|NCT02737358|460637031|FG001|Overall Study|Withdrawal by Subject|12|||
128002525|NCT02737358|460637030|FG000|Overall Study|Lost to Follow-up|2|||
128002526|NCT02737358|460637031|FG001|Overall Study|Lost to Follow-up|3|||
128002527|NCT02870868|460637032|FG000|Overall Study|Withdrawal by Subject|2|||
128002528|NCT02870868|460637033|FG001|Overall Study|Withdrawal by Subject|1|||
128002529|NCT00744939|460637034|FG000|Overall Study|Withdrawal by Subject|9|||
128002530|NCT00744939|460637034|FG000|Overall Study|Protocol Violation|13|||
128002531|NCT00744939|460637034|FG000|Overall Study|Death|24|||
128002532|NCT00744939|460637034|FG000|Overall Study|distance|4|||
128002533|NCT00744939|460637034|FG000|Overall Study|Lost to Follow-up|12|||
128002534|NCT00744939|460637034|FG000|Overall Study|Medical history exclusionary|1|||
128002535|NCT00744939|460637034|FG000|Overall Study|Did not receive Magnevist|7|||
128002536|NCT00744939|460637034|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
128002537|NCT00744939|460637034|FG000|Overall Study|coma|1|||
128002538|NCT00744939|460637034|FG000|Overall Study|incorrect race|1|||
128002539|NCT01868646|460637035|FG000|Overall Study|Do not meet inclusion criteria|3|||
128002540|NCT01868646|460637036|FG001|Overall Study|Do not meet inclusion criteria|5|||
128002541|NCT03191799|460637041|FG000|Overall Study|Withdrawal by Subject|4|||
128002542|NCT03191799|460637041|FG000|Overall Study|Physician Decision|2|||
128002543|NCT03191799|460637041|FG000|Overall Study|Lost to Follow-up|1|||
128002544|NCT03191799|460637041|FG000|Overall Study|Death|2|||
128002545|NCT00492297|460637052|FG000|Treatment|Death|2|||
128002546|NCT00492297|460637052|FG000|Treatment|Study terminated by sponsor|3|||
128002547|NCT00492297|460637052|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
128002548|NCT00492297|460637052|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
128002549|NCT00492297|460637052|FG000|Survival Only Follow-up|Death|46|||
128002550|NCT00492297|460637052|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
128002551|NCT00492297|460637052|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
128002552|NCT01408706|460637054|FG000|Overall Study|Physician Decision|1|||
128002553|NCT01408706|460637055|FG001|Overall Study|Physician Decision|0|||
128002554|NCT00888654|460637056|FG000|Overall Study|Problems swallowing oral meds.|1|||
128002555|NCT00888654|460637056|FG000|Overall Study|Not enough oral meds before surgery|3|||
128002556|NCT00888654|460637056|FG000|Overall Study|Surgery aborted|2|||
128002557|NCT00888654|460637056|FG000|Overall Study|Withdrawal by Subject|1|||
128002558|NCT00888654|460637056|FG000|Overall Study|Inelig. due to contraindication of med|1|||
128002559|NCT00888654|460637056|FG000|Overall Study|Change in surg date|1|||
128002560|NCT00888654|460637056|FG000|Overall Study|Stopped meds due to headaches|1|||
128002561|NCT03669549|460637057|FG000|Overall Study|Adverse Event|4|||
128002562|NCT03669549|460637057|FG000|Overall Study|Withdrawal by Subject|1|||
128002563|NCT03669549|460637057|FG000|Overall Study|Study terminated by the Sponsor|1|||
128002564|NCT00698815|460637058|FG000|Overall Study|Death|1|||
128002565|NCT00698815|460637059|FG001|Overall Study|Death|2|||
127669732|NCT00335153|459413187|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
127669733|NCT02478359|459413190|FG000|Overall Study|Disenrolled from health plan|106|||
128002566|NCT00698815|460637060|FG002|Overall Study|Death|4|||
128002567|NCT00698815|460637058|FG000|Overall Study|Withdrawal by Subject|6|||
128002568|NCT00698815|460637059|FG001|Overall Study|Withdrawal by Subject|3|||
128002569|NCT00698815|460637060|FG002|Overall Study|Withdrawal by Subject|2|||
128002570|NCT00698815|460637058|FG000|Overall Study|MD discretion|2|||
127669734|NCT02478359|459413191|FG001|Overall Study|Disenrolled from health plan|65|||
127669735|NCT00372528|459413192|FG000|Overall Study|Lack of Efficacy|1|||
127669736|NCT00372528|459413192|FG000|Overall Study|Adverse Event|1|||
127669737|NCT00372528|459413192|FG000|Overall Study|Study Terminated by Sponsor|18|||
127669738|NCT00372528|459413192|FG000|Overall Study|Other|1|||
127669739|NCT01414166|459413201|FG000|Overall Study|Adverse Event|10|||
127669740|NCT01414166|459413202|FG001|Overall Study|Adverse Event|2|||
127669741|NCT01414166|459413201|FG000|Overall Study|Lost to Follow-up|4|||
127669742|NCT01414166|459413202|FG001|Overall Study|Lost to Follow-up|1|||
127669743|NCT01414166|459413201|FG000|Overall Study|Non-compliance with study drug|2|||
127669744|NCT01414166|459413202|FG001|Overall Study|Non-compliance with study drug|0|||
127669745|NCT01414166|459413201|FG000|Overall Study|Physician Decision|2|||
127669746|NCT01414166|459413202|FG001|Overall Study|Physician Decision|0|||
127669747|NCT01414166|459413201|FG000|Overall Study|Protocol Violation|2|||
127669748|NCT01414166|459413202|FG001|Overall Study|Protocol Violation|0|||
127669749|NCT01414166|459413201|FG000|Overall Study|Study terminated by Sponsor|68|||
127669750|NCT01414166|459413202|FG001|Overall Study|Study terminated by Sponsor|75|||
127669751|NCT01414166|459413201|FG000|Overall Study|Withdrawal by Subject|3|||
127669752|NCT01414166|459413202|FG001|Overall Study|Withdrawal by Subject|5|||
127669753|NCT03782727|459413203|FG000|Overall Study|Lost to Follow-up|32|||
127669754|NCT02084082|459413204|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
127669755|NCT02084082|459413205|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
127669756|NCT02084082|459413206|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
127669757|NCT02084082|459413207|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
127669758|NCT02084082|459413204|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
127669759|NCT02084082|459413205|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
127669760|NCT02084082|459413206|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
127669761|NCT02084082|459413207|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
127669762|NCT04736056|459413208|FG000|Overall Study|Death|0|||
127669763|NCT04736056|459413209|FG001|Overall Study|Death|0|||
127669764|NCT04736056|459413210|FG002|Overall Study|Death|0|||
127669765|NCT04736056|459413211|FG003|Overall Study|Death|1|||
127669766|NCT04736056|459413208|FG000|Overall Study|Lost to Follow-up|1|||
127669767|NCT04736056|459413209|FG001|Overall Study|Lost to Follow-up|0|||
127669768|NCT04736056|459413210|FG002|Overall Study|Lost to Follow-up|1|||
127669769|NCT04736056|459413211|FG003|Overall Study|Lost to Follow-up|1|||
127669770|NCT04736056|459413208|FG000|Overall Study|Withdrawal by Subject|2|||
127669771|NCT04736056|459413209|FG001|Overall Study|Withdrawal by Subject|0|||
127669772|NCT04736056|459413210|FG002|Overall Study|Withdrawal by Subject|0|||
127669773|NCT04736056|459413211|FG003|Overall Study|Withdrawal by Subject|0|||
127669774|NCT04736056|459413208|FG000|Overall Study|Physician Decision|1|||
127669775|NCT04736056|459413209|FG001|Overall Study|Physician Decision|0|||
127669776|NCT04736056|459413210|FG002|Overall Study|Physician Decision|1|||
127669777|NCT04736056|459413211|FG003|Overall Study|Physician Decision|0|||
127669778|NCT02956967|459413218|FG000|Overall Study|Adverse Event|3|||
127669779|NCT02956967|459413218|FG000|Overall Study|Reason non-related to neutropenia|10|||
127669780|NCT02956967|459413218|FG000|Overall Study|Lost to Follow-up|5|||
127669781|NCT02956967|459413218|FG000|Overall Study|Missing|1|||
127669782|NCT02956967|459413218|FG000|Overall Study|Termination of Nivestim administration|29|||
127669783|NCT00819234|459413219|FG000|Overall Study|Withdrawal by Subject|8|||
127669784|NCT00819234|459413220|FG001|Overall Study|Withdrawal by Subject|13|||
127669785|NCT00819234|459413221|FG002|Overall Study|Withdrawal by Subject|6|||
127669786|NCT00819234|459413222|FG003|Overall Study|Withdrawal by Subject|3|||
127669787|NCT00819234|459413223|FG004|Overall Study|Withdrawal by Subject|0|||
127669788|NCT00819234|459413224|FG005|Overall Study|Withdrawal by Subject|4|||
127669789|NCT00819234|459413225|FG006|Overall Study|Withdrawal by Subject|4|||
127669790|NCT00819234|459413226|FG007|Overall Study|Withdrawal by Subject|8|||
127669791|NCT00819234|459413227|FG008|Overall Study|Withdrawal by Subject|5|||
127669792|NCT00819234|459413228|FG009|Overall Study|Withdrawal by Subject|3|||
127669793|NCT00819234|459413219|FG000|Overall Study|Adverse Event|0|||
127669794|NCT00819234|459413220|FG001|Overall Study|Adverse Event|0|||
127669795|NCT00819234|459413221|FG002|Overall Study|Adverse Event|1|||
127669796|NCT00819234|459413222|FG003|Overall Study|Adverse Event|0|||
128002571|NCT00698815|460637059|FG001|Overall Study|MD discretion|7|||
128002572|NCT00698815|460637060|FG002|Overall Study|MD discretion|2|||
127669797|NCT00819234|459413223|FG004|Overall Study|Adverse Event|0|||
127669798|NCT00819234|459413224|FG005|Overall Study|Adverse Event|2|||
127669799|NCT00819234|459413225|FG006|Overall Study|Adverse Event|0|||
127543510|NCT02718898|458956552|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
127669800|NCT00819234|459413226|FG007|Overall Study|Adverse Event|0|||
127669801|NCT00819234|459413227|FG008|Overall Study|Adverse Event|0|||
127669802|NCT00819234|459413228|FG009|Overall Study|Adverse Event|0|||
127669803|NCT00819234|459413219|FG000|Overall Study|Physician Decision|0|||
127669804|NCT00819234|459413220|FG001|Overall Study|Physician Decision|0|||
127669805|NCT00819234|459413221|FG002|Overall Study|Physician Decision|0|||
127669806|NCT00819234|459413222|FG003|Overall Study|Physician Decision|1|||
127669807|NCT00819234|459413223|FG004|Overall Study|Physician Decision|0|||
127669808|NCT00819234|459413224|FG005|Overall Study|Physician Decision|0|||
127669809|NCT00819234|459413225|FG006|Overall Study|Physician Decision|0|||
127669810|NCT00819234|459413226|FG007|Overall Study|Physician Decision|0|||
127669811|NCT00819234|459413227|FG008|Overall Study|Physician Decision|0|||
127669812|NCT00819234|459413228|FG009|Overall Study|Physician Decision|2|||
127669813|NCT00819234|459413219|FG000|Overall Study|Protocol Violation|0|||
127669814|NCT00819234|459413220|FG001|Overall Study|Protocol Violation|0|||
127669815|NCT00819234|459413221|FG002|Overall Study|Protocol Violation|1|||
127669816|NCT00819234|459413222|FG003|Overall Study|Protocol Violation|0|||
127669817|NCT00819234|459413223|FG004|Overall Study|Protocol Violation|0|||
127669818|NCT00819234|459413224|FG005|Overall Study|Protocol Violation|0|||
127669819|NCT00819234|459413225|FG006|Overall Study|Protocol Violation|0|||
127669820|NCT00819234|459413226|FG007|Overall Study|Protocol Violation|0|||
127669821|NCT00819234|459413227|FG008|Overall Study|Protocol Violation|0|||
127669822|NCT00819234|459413228|FG009|Overall Study|Protocol Violation|0|||
127669823|NCT00819234|459413219|FG000|Overall Study|Lost to Follow-up|2|||
127669824|NCT00819234|459413220|FG001|Overall Study|Lost to Follow-up|2|||
127669825|NCT00819234|459413221|FG002|Overall Study|Lost to Follow-up|0|||
127669826|NCT00819234|459413222|FG003|Overall Study|Lost to Follow-up|2|||
127669827|NCT00819234|459413223|FG004|Overall Study|Lost to Follow-up|1|||
127669828|NCT00819234|459413224|FG005|Overall Study|Lost to Follow-up|1|||
127669829|NCT00819234|459413225|FG006|Overall Study|Lost to Follow-up|1|||
127669830|NCT00819234|459413226|FG007|Overall Study|Lost to Follow-up|1|||
127669831|NCT00819234|459413227|FG008|Overall Study|Lost to Follow-up|1|||
127669832|NCT00819234|459413228|FG009|Overall Study|Lost to Follow-up|2|||
127669833|NCT01823341|459413229|FG000|Overall Study|Failed run-in|7|||
127669834|NCT01823341|459413229|FG000|Overall Study|Withdrawal by Subject|7|||
127669835|NCT01823341|459413229|FG000|Overall Study|Adverse Event|1|||
127669836|NCT00924560|459413230|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
127669837|NCT00924560|459413231|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
127669838|NCT00924560|459413232|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
127669839|NCT00924560|459413230|FG000|Overall Study|Non Compliance with the Protocol|20|||
127669840|NCT00924560|459413231|FG001|Overall Study|Non Compliance with the Protocol|15|||
127669841|NCT00924560|459413232|FG002|Overall Study|Non Compliance with the Protocol|4|||
127669842|NCT00924560|459413230|FG000|Overall Study|Physician Decision|2|||
127669843|NCT00924560|459413231|FG001|Overall Study|Physician Decision|3|||
127669844|NCT00924560|459413232|FG002|Overall Study|Physician Decision|4|||
127669845|NCT00924560|459413230|FG000|Overall Study|Withdrawal by Subject|50|||
127669846|NCT00924560|459413231|FG001|Overall Study|Withdrawal by Subject|44|||
127669847|NCT00924560|459413232|FG002|Overall Study|Withdrawal by Subject|18|||
127669848|NCT00924560|459413230|FG000|Overall Study|Adverse Event|39|||
127669849|NCT00924560|459413231|FG001|Overall Study|Adverse Event|33|||
127669850|NCT00924560|459413232|FG002|Overall Study|Adverse Event|0|||
127669851|NCT00924560|459413230|FG000|Overall Study|Pregnancy|5|||
127669852|NCT00924560|459413231|FG001|Overall Study|Pregnancy|7|||
127669853|NCT00924560|459413232|FG002|Overall Study|Pregnancy|1|||
127669854|NCT00924560|459413230|FG000|Overall Study|Lost to Follow-up|78|||
127669855|NCT00924560|459413231|FG001|Overall Study|Lost to Follow-up|94|||
127669856|NCT00924560|459413232|FG002|Overall Study|Lost to Follow-up|45|||
127669857|NCT00924560|459413230|FG000|Overall Study|Miscellaneous Reasons|13|||
127669858|NCT00924560|459413231|FG001|Overall Study|Miscellaneous Reasons|10|||
127669859|NCT00924560|459413232|FG002|Overall Study|Miscellaneous Reasons|10|||
127669860|NCT02696226|459413234|FG000|Overall Study|Study terminated - lack of enrollment|1|||
127669861|NCT02696226|459413235|FG001|Overall Study|Study terminated - lack of enrollment|0|||
127669862|NCT02696226|459413236|FG002|Overall Study|Study terminated - lack of enrollment|2|||
127669863|NCT02696226|459413237|FG003|Overall Study|Study terminated - lack of enrollment|0|||
127669864|NCT02909101|459413245|FG000|Overall Study|Lost to Follow-up|1|||
128002573|NCT00698815|460637058|FG000|Overall Study|Did not receive protocol treatment|1|||
128002574|NCT00698815|460637059|FG001|Overall Study|Did not receive protocol treatment|2|||
128002575|NCT00698815|460637060|FG002|Overall Study|Did not receive protocol treatment|2|||
127669865|NCT02909101|459413246|FG001|Overall Study|Lost to Follow-up|1|||
127669866|NCT03073005|459413247|FG000|Overall Study|Death|6|||
127669867|NCT03073005|459413248|FG001|Overall Study|Death|0|||
127669868|NCT03073005|459413249|FG002|Overall Study|Death|7|||
127669869|NCT03073005|459413250|FG003|Overall Study|Death|0|||
127669870|NCT03073005|459413247|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
127669871|NCT03073005|459413248|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
127669872|NCT03073005|459413249|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
127669873|NCT03073005|459413250|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
127669874|NCT03073005|459413247|FG000|Overall Study|Lost to Follow-up|2|||
127669875|NCT03073005|459413248|FG001|Overall Study|Lost to Follow-up|2|||
127669876|NCT03073005|459413249|FG002|Overall Study|Lost to Follow-up|1|||
127669877|NCT03073005|459413250|FG003|Overall Study|Lost to Follow-up|2|||
127669878|NCT03073005|459413247|FG000|Overall Study|Withdrawal by Subject|0|||
127669879|NCT03073005|459413248|FG001|Overall Study|Withdrawal by Subject|4|||
127669880|NCT03073005|459413249|FG002|Overall Study|Withdrawal by Subject|4|||
127669881|NCT03073005|459413250|FG003|Overall Study|Withdrawal by Subject|4|||
127669882|NCT01290094|459413251|FG000|Overall Study|Withdrawal by Subject|1|||
128002576|NCT00297648|460637061|FG000|Overall Study|Adverse Event|13|||
127669883|NCT01290094|459413251|FG000|Overall Study|Lost to Follow-up|5|||
127669884|NCT04091672|459415205|FG000|Overall Study|Death|6|||
127669885|NCT04091672|459415206|FG001|Overall Study|Death|6|||
127669886|NCT04091672|459415205|FG000|Overall Study|Lost to Follow-up|7|||
127669887|NCT04091672|459415206|FG001|Overall Study|Lost to Follow-up|7|||
127669888|NCT04091672|459415205|FG000|Overall Study|Withdrawal by Subject|3|||
127669889|NCT04091672|459415206|FG001|Overall Study|Withdrawal by Subject|3|||
127669890|NCT04091672|459415205|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
127669891|NCT04091672|459415206|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
127669892|NCT05296629|459415207|FG000|Overall Study|Withdrawal by Subject|3|||
127669893|NCT05296629|459415208|FG001|Overall Study|Withdrawal by Subject|10|||
127669894|NCT05296629|459415209|FG002|Overall Study|Withdrawal by Subject|4|||
127669895|NCT05296629|459415207|FG000|Overall Study|Lost to Follow-up|2|||
127669896|NCT05296629|459415208|FG001|Overall Study|Lost to Follow-up|7|||
127669897|NCT05296629|459415209|FG002|Overall Study|Lost to Follow-up|1|||
128002577|NCT00297648|460637061|FG000|Overall Study|Lack of Efficacy|18|||
128002578|NCT00297648|460637061|FG000|Overall Study|Lost to Follow-up|1|||
128002579|NCT00297648|460637061|FG000|Overall Study|Withdrawal by Subject|3|||
128002580|NCT00297648|460637061|FG000|Overall Study|Other: Incompliance|1|||
128002581|NCT01663402|460637062|FG000|Overall Study|Randomized but not treated|19|||
128002582|NCT01663402|460637063|FG001|Overall Study|Randomized but not treated|11|||
128002583|NCT01663402|460637062|FG000|Overall Study|Adverse Event|347|||
128002584|NCT01663402|460637063|FG001|Overall Study|Adverse Event|362|||
128002585|NCT01663402|460637062|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
128002586|NCT01663402|460637063|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
128002587|NCT01663402|460637062|FG000|Overall Study|Poor compliance to protocol|529|||
128002588|NCT01663402|460637063|FG001|Overall Study|Poor compliance to protocol|454|||
128002589|NCT01663402|460637062|FG000|Overall Study|Physician Decision|77|||
128002590|NCT01663402|460637063|FG001|Overall Study|Physician Decision|62|||
128002591|NCT01663402|460637062|FG000|Overall Study|Site terminated by sponsor|1|||
128002592|NCT01663402|460637063|FG001|Overall Study|Site terminated by sponsor|3|||
128002593|NCT01663402|460637062|FG000|Overall Study|Participant moved|139|||
127669898|NCT05296629|459415207|FG000|Overall Study|Adverse Event|0|||
128002594|NCT01663402|460637063|FG001|Overall Study|Participant moved|104|||
128002595|NCT01663402|460637062|FG000|Overall Study|Withdrawal by Subject|118|||
128002596|NCT01663402|460637063|FG001|Overall Study|Withdrawal by Subject|91|||
128002597|NCT01663402|460637062|FG000|Overall Study|Related to study drug administration|96|||
128002598|NCT01663402|460637063|FG001|Overall Study|Related to study drug administration|105|||
128002599|NCT01663402|460637062|FG000|Overall Study|Lost to Follow-up|17|||
128002600|NCT01663402|460637063|FG001|Overall Study|Lost to Follow-up|15|||
128002601|NCT01663402|460637062|FG000|Overall Study|Other than specified above|172|||
128002602|NCT01663402|460637063|FG001|Overall Study|Other than specified above|147|||
128002603|NCT02277028|460637066|FG000|Overall Study|Lost to Follow-up|1|||
128002604|NCT02277028|460637067|FG001|Overall Study|Lost to Follow-up|0|||
128002605|NCT02277028|460637066|FG000|Overall Study|Withdrawal by Subject|0|||
128002606|NCT02277028|460637067|FG001|Overall Study|Withdrawal by Subject|1|||
127669899|NCT05296629|459415208|FG001|Overall Study|Adverse Event|4|||
127669900|NCT05296629|459415209|FG002|Overall Study|Adverse Event|2|||
127669901|NCT05296629|459415207|FG000|Overall Study|Protocol Violation|0|||
127669902|NCT05296629|459415208|FG001|Overall Study|Protocol Violation|2|||
127669903|NCT05296629|459415209|FG002|Overall Study|Protocol Violation|0|||
127669904|NCT02401529|459415210|FG000|Overall Study|Lost to Follow-up|2|||
127669905|NCT02401529|459415211|FG001|Overall Study|Lost to Follow-up|1|||
127669906|NCT02401529|459415210|FG000|Overall Study|Physician Decision|2|||
127669907|NCT02401529|459415211|FG001|Overall Study|Physician Decision|6|||
127669908|NCT02401529|459415210|FG000|Overall Study|Protocol Violation|5|||
127669909|NCT02401529|459415211|FG001|Overall Study|Protocol Violation|0|||
127669910|NCT01518257|459415212|FG000|Overall Study|Lost to Follow-up|1|||
127669911|NCT01518257|459415213|FG001|Overall Study|Lost to Follow-up|0|||
127669912|NCT01518257|459415212|FG000|Overall Study|Other Miscellaneous Reason|1|||
127669913|NCT01518257|459415213|FG001|Overall Study|Other Miscellaneous Reason|0|||
128002607|NCT05002972|460637068|FG000|Overall Study|Withdrawal by Subject|2|||
128002608|NCT05518539|460637072|FG000|Overall Study|Lost to Follow-up|6|||
127669914|NCT00924664|459415214|FG000|Overall Study|Adverse Event|23|||
127669915|NCT00924664|459415215|FG001|Overall Study|Adverse Event|39|||
128002609|NCT02053493|460637075|FG000|Overall Study|Withdrawal by Subject|1|||
127669916|NCT00924664|459415214|FG000|Overall Study|Lack of Efficacy|10|||
127669917|NCT00924664|459415215|FG001|Overall Study|Lack of Efficacy|15|||
127669918|NCT00924664|459415214|FG000|Overall Study|Lost to Follow-up|10|||
127669919|NCT00924664|459415215|FG001|Overall Study|Lost to Follow-up|12|||
127669920|NCT00924664|459415214|FG000|Overall Study|Withdrawal by Subject|47|||
127669921|NCT00924664|459415215|FG001|Overall Study|Withdrawal by Subject|71|||
127669922|NCT00924664|459415214|FG000|Overall Study|Protocol Violation|2|||
128002610|NCT02053493|460637076|FG001|Overall Study|Withdrawal by Subject|1|||
128002611|NCT04613518|460637079|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
128002612|NCT04613518|460637080|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
127543511|NCT02718898|458956553|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
127669923|NCT00924664|459415215|FG001|Overall Study|Protocol Violation|5|||
128002613|NCT04613518|460637081|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
128002614|NCT04613518|460637079|FG000|Double-Blind Treatment Period|Adverse Event|2|||
128002615|NCT04613518|460637080|FG001|Double-Blind Treatment Period|Adverse Event|0|||
128002616|NCT04613518|460637081|FG002|Double-Blind Treatment Period|Adverse Event|1|||
128002617|NCT04613518|460637079|FG000|Double-Blind Treatment Period|Participant request to discontinue treatment|1|||
128002618|NCT04613518|460637080|FG001|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
128002619|NCT04613518|460637081|FG002|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
128002620|NCT04613518|460637079|FG000|Double-Blind Treatment Period|Participant withdrew consent|1|||
128002621|NCT04613518|460637080|FG001|Double-Blind Treatment Period|Participant withdrew consent|1|||
128002622|NCT04613518|460637081|FG002|Double-Blind Treatment Period|Participant withdrew consent|0|||
128002623|NCT04613518|460637079|FG000|Double-Blind Treatment Period|Other Reasons|2|||
128002624|NCT04613518|460637080|FG001|Double-Blind Treatment Period|Other Reasons|0|||
128002625|NCT04613518|460637081|FG002|Double-Blind Treatment Period|Other Reasons|0|||
128002626|NCT04613518|460637079|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
128002627|NCT04613518|460637080|FG001|Open-Label Treatment Period|Lack of Efficacy|3|||
128002628|NCT04613518|460637081|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
128002629|NCT04613518|460637079|FG000|Open-Label Treatment Period|Adverse Event|1|||
128002630|NCT04613518|460637080|FG001|Open-Label Treatment Period|Adverse Event|0|||
128002631|NCT04613518|460637081|FG002|Open-Label Treatment Period|Adverse Event|3|||
128002632|NCT04613518|460637079|FG000|Open-Label Treatment Period|Participant request to discontinue treatment|1|||
128002633|NCT04613518|460637080|FG001|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
128002634|NCT04613518|460637081|FG002|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
128002635|NCT04613518|460637079|FG000|Open-Label Treatment Period|Participant withdrew consent|1|||
128002636|NCT04613518|460637080|FG001|Open-Label Treatment Period|Participant withdrew consent|0|||
128002637|NCT04613518|460637081|FG002|Open-Label Treatment Period|Participant withdrew consent|3|||
128002638|NCT04613518|460637079|FG000|Open-Label Treatment Period|Administrative reason by sponsor|4|||
128002639|NCT04613518|460637080|FG001|Open-Label Treatment Period|Administrative reason by sponsor|0|||
128002640|NCT04613518|460637081|FG002|Open-Label Treatment Period|Administrative reason by sponsor|0|||
128002641|NCT04613518|460637079|FG000|Open-Label Treatment Period|Other reasons|1|||
128002642|NCT04613518|460637080|FG001|Open-Label Treatment Period|Other reasons|0|||
128002643|NCT04613518|460637081|FG002|Open-Label Treatment Period|Other reasons|0|||
128002644|NCT01619865|460637084|FG000|Overall Study|Adverse Event|1|||
128002645|NCT01619865|460637084|FG000|Overall Study|Death|2|||
128002646|NCT01619865|460637084|FG000|Overall Study|subject not able to comply|1|||
128002647|NCT01494818|460637085|FG000|Overall Study|Relocation|1|||
128002648|NCT01494818|460637086|FG001|Overall Study|Relocation|2|||
128002649|NCT01494818|460637085|FG000|Overall Study|Lost to Follow-up|1|||
128002650|NCT01494818|460637086|FG001|Overall Study|Lost to Follow-up|0|||
128002651|NCT00791999|460637087|FG000|Overall Study|Protocol planed withdrawal|14|||
128002652|NCT00791999|460637088|FG001|Overall Study|Protocol planed withdrawal|11|||
128002653|NCT00791999|460637089|FG002|Overall Study|Protocol planed withdrawal|11|||
128002654|NCT00791999|460637090|FG003|Overall Study|Protocol planed withdrawal|45|||
128002655|NCT00791999|460637087|FG000|Overall Study|Withdrawal by Subject|0|||
128002656|NCT00791999|460637088|FG001|Overall Study|Withdrawal by Subject|1|||
128002657|NCT00791999|460637089|FG002|Overall Study|Withdrawal by Subject|0|||
128002658|NCT00791999|460637090|FG003|Overall Study|Withdrawal by Subject|2|||
128002659|NCT00791999|460637087|FG000|Overall Study|Protocol Violation|3|||
128002660|NCT00791999|460637088|FG001|Overall Study|Protocol Violation|0|||
128002661|NCT00791999|460637089|FG002|Overall Study|Protocol Violation|1|||
128002662|NCT00791999|460637090|FG003|Overall Study|Protocol Violation|0|||
128002663|NCT00791999|460637087|FG000|Overall Study|Adverse Event|3|||
128002664|NCT00791999|460637088|FG001|Overall Study|Adverse Event|3|||
128002665|NCT00791999|460637089|FG002|Overall Study|Adverse Event|7|||
128002666|NCT00791999|460637090|FG003|Overall Study|Adverse Event|3|||
128002667|NCT00791999|460637087|FG000|Overall Study|Lack of Efficacy|0|||
127669924|NCT00924664|459415214|FG000|Overall Study|Pregnancy|1|||
127669925|NCT00924664|459415215|FG001|Overall Study|Pregnancy|1|||
127669926|NCT00924664|459415214|FG000|Overall Study|Death|0|||
127669927|NCT00924664|459415215|FG001|Overall Study|Death|2|||
127669928|NCT00924664|459415214|FG000|Overall Study|Study terminated by sponsor|199|||
127669929|NCT00924664|459415215|FG001|Overall Study|Study terminated by sponsor|330|||
127669930|NCT00924664|459415214|FG000|Overall Study|Other|29|||
127669931|NCT00924664|459415215|FG001|Overall Study|Other|52|||
127669932|NCT00924664|459415214|FG000|Overall Study|Randomized but not Treated|1|||
127669933|NCT00924664|459415215|FG001|Overall Study|Randomized but not Treated|0|||
128002668|NCT00791999|460637088|FG001|Overall Study|Lack of Efficacy|1|||
127669934|NCT00093795|459415216|FG000|Overall Study|No follow up data|20|||
128002669|NCT00791999|460637089|FG002|Overall Study|Lack of Efficacy|0|||
128002670|NCT00791999|460637090|FG003|Overall Study|Lack of Efficacy|2|||
128002671|NCT00791999|460637087|FG000|Overall Study|Reason other than those above|1|||
127669935|NCT00093795|459415217|FG001|Overall Study|No follow up data|16|||
127669936|NCT00093795|459415218|FG002|Overall Study|No follow up data|17|||
127669937|NCT01106287|459415222|FG000|Overall Study|Adverse Event|1|||
128002672|NCT00791999|460637088|FG001|Overall Study|Reason other than those above|0|||
128002673|NCT00791999|460637089|FG002|Overall Study|Reason other than those above|1|||
128002674|NCT00791999|460637090|FG003|Overall Study|Reason other than those above|0|||
128002675|NCT01077323|460637091|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
128002676|NCT01077323|460637092|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
128002677|NCT01077323|460637093|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
128002678|NCT01077323|460637091|FG000|Overall Study|Dispensing of drug in baseline period|0|||
128002679|NCT01077323|460637092|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
128002680|NCT01077323|460637093|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
128002681|NCT01077323|460637091|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
128002682|NCT01077323|460637092|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
128002683|NCT01077323|460637093|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
128002684|NCT00427908|460637094|FG000|Primary Phase|Lost to Follow-up|4|||
128002685|NCT00427908|460637095|FG001|Primary Phase|Lost to Follow-up|0|||
128002686|NCT00427908|460637096|FG002|Primary Phase|Lost to Follow-up|2|||
128002687|NCT00427908|460637097|FG003|Primary Phase|Lost to Follow-up|0|||
128002688|NCT00427908|460637094|FG000|Primary Phase|Withdrawal by Subject|1|||
128002689|NCT00427908|460637095|FG001|Primary Phase|Withdrawal by Subject|2|||
128002690|NCT00427908|460637096|FG002|Primary Phase|Withdrawal by Subject|1|||
128002691|NCT00427908|460637097|FG003|Primary Phase|Withdrawal by Subject|0|||
127669938|NCT01106287|459415223|FG001|Overall Study|Adverse Event|0|||
127669939|NCT01106287|459415224|FG002|Overall Study|Adverse Event|0|||
127669940|NCT01106287|459415225|FG003|Overall Study|Adverse Event|0|||
127669941|NCT04730947|459415226|FG000|Overall Study|Withdrawal by Subject|0|||
127669942|NCT04730947|459415227|FG001|Overall Study|Withdrawal by Subject|1|||
127669943|NCT00940017|459415228|FG000|Overall Study|did not meet entrance criteria|3|||
127669944|NCT00940017|459415228|FG000|Overall Study|Adverse Event|1|||
127669945|NCT02949271|459415229|FG000|Overall Study|Lack of Efficacy|5|||
127669946|NCT02949271|459415230|FG001|Overall Study|Lack of Efficacy|4|||
127669947|NCT02949271|459415229|FG000|Overall Study|Lost to Follow-up|3|||
127669948|NCT02949271|459415230|FG001|Overall Study|Lost to Follow-up|6|||
127669949|NCT02949271|459415229|FG000|Overall Study|Physician Decision|5|||
127669950|NCT02949271|459415230|FG001|Overall Study|Physician Decision|5|||
127669951|NCT02949271|459415229|FG000|Overall Study|Protocol Violation|6|||
127669952|NCT02949271|459415230|FG001|Overall Study|Protocol Violation|3|||
127669953|NCT02949271|459415229|FG000|Overall Study|Withdrawal by Subject|1|||
127669954|NCT02949271|459415230|FG001|Overall Study|Withdrawal by Subject|0|||
127669955|NCT02949271|459415229|FG000|Overall Study|Delivered prior to intervention|7|||
127669956|NCT02949271|459415230|FG001|Overall Study|Delivered prior to intervention|9|||
127669957|NCT02949271|459415229|FG000|Overall Study|Outside the window for cervical dilation|2|||
127669958|NCT02949271|459415230|FG001|Overall Study|Outside the window for cervical dilation|3|||
127669959|NCT01097655|459415231|FG000|Overall Study|Withdrawal by Subject|1|||
127669960|NCT01097655|459415231|FG000|Overall Study|Subject Documented Twice|1|||
127669961|NCT01097655|459415231|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
127669962|NCT05458102|459415233|FG000|Overall Study|Withdrew consent|2|||
127669963|NCT05458102|459415234|FG001|Overall Study|Withdrew consent|0|||
127669964|NCT05458102|459415233|FG000|Overall Study|Adverse Event|1|||
127669965|NCT05458102|459415234|FG001|Overall Study|Adverse Event|0|||
127669966|NCT05458102|459415233|FG000|Overall Study|Enrolled but never treated|1|||
127669967|NCT05458102|459415234|FG001|Overall Study|Enrolled but never treated|0|||
127669968|NCT05458102|459415233|FG000|Overall Study|Protocol Violation|1|||
127669969|NCT05458102|459415234|FG001|Overall Study|Protocol Violation|0|||
127669970|NCT03303105|459415235|FG000|Overall Study|Adverse Event|0|||
127669971|NCT03303105|459415236|FG001|Overall Study|Adverse Event|2|||
127669972|NCT03303105|459415235|FG000|Overall Study|Lack of Efficacy|1|||
127669973|NCT03303105|459415236|FG001|Overall Study|Lack of Efficacy|0|||
127669974|NCT03303105|459415235|FG000|Overall Study|Protocol Violation|1|||
127669975|NCT03303105|459415236|FG001|Overall Study|Protocol Violation|0|||
127669976|NCT03303105|459415235|FG000|Overall Study|Withdrawal by Subject|0|||
127669977|NCT03303105|459415236|FG001|Overall Study|Withdrawal by Subject|2|||
127669978|NCT00852475|459415243|FG000|Overall Study|Lost to Follow-up|3|||
127669979|NCT00852475|459415244|FG001|Overall Study|Lost to Follow-up|4|||
127669980|NCT02403674|459415245|FG000|Base Study|Death|1|||
127669981|NCT02403674|459415246|FG001|Base Study|Death|4|||
127669982|NCT02403674|459415245|FG000|Base Study|Adverse Event|11|||
127669983|NCT02403674|459415246|FG001|Base Study|Adverse Event|26|||
127669984|NCT02403674|459415245|FG000|Base Study|Lack of Efficacy|31|||
127669985|NCT02403674|459415246|FG001|Base Study|Lack of Efficacy|23|||
127669986|NCT02403674|459415245|FG000|Base Study|Lost to Follow-up|6|||
127669987|NCT02403674|459415246|FG001|Base Study|Lost to Follow-up|8|||
127669988|NCT02403674|459415245|FG000|Base Study|Withdrawal by Subject|10|||
128002692|NCT00427908|460637094|FG000|Primary Phase|Adverse Event|0|||
128002693|NCT00427908|460637095|FG001|Primary Phase|Adverse Event|1|||
127669989|NCT02403674|459415246|FG001|Base Study|Withdrawal by Subject|17|||
127669990|NCT02403674|459415245|FG000|Base Study|Physician Decision|2|||
127669991|NCT02403674|459415246|FG001|Base Study|Physician Decision|2|||
127669992|NCT02403674|459415245|FG000|Base Study|Pregnancy|2|||
127669993|NCT02403674|459415246|FG001|Base Study|Pregnancy|2|||
128002694|NCT00427908|460637096|FG002|Primary Phase|Adverse Event|0|||
128002695|NCT00427908|460637097|FG003|Primary Phase|Adverse Event|0|||
128002696|NCT01710020|460637098|FG000|Period 1|Protocol Violation|1|||
128002697|NCT02984982|460637099|FG000|Overall Study|Adverse Event|2|||
128002698|NCT02984982|460637100|FG001|Overall Study|Adverse Event|5|||
128002699|NCT02984982|460637099|FG000|Overall Study|Poor Compliance to Protocol|4|||
128002700|NCT02984982|460637100|FG001|Overall Study|Poor Compliance to Protocol|4|||
128002701|NCT02984982|460637099|FG000|Overall Study|Withdrawal by Subject|2|||
127669994|NCT02403674|459415245|FG000|Base Study|Protocol Violation|8|||
127669995|NCT02403674|459415246|FG001|Base Study|Protocol Violation|4|||
127669996|NCT02403674|459415245|FG000|Base Study|Non-Compliance with study drug|1|||
127669997|NCT02403674|459415246|FG001|Base Study|Non-Compliance with study drug|4|||
127669998|NCT02403674|459415245|FG000|Study Extension 1 (Open-Label)|Adverse Event|1|||
127669999|NCT02403674|459415246|FG001|Study Extension 1 (Open-Label)|Adverse Event|4|||
127670000|NCT02403674|459415245|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|10|||
127670001|NCT02403674|459415246|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|13|||
127670002|NCT02403674|459415245|FG000|Study Extension 1 (Open-Label)|Lost to Follow-up|8|||
127670003|NCT02403674|459415246|FG001|Study Extension 1 (Open-Label)|Lost to Follow-up|5|||
127670004|NCT02403674|459415245|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|11|||
127670005|NCT02403674|459415246|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|13|||
127670006|NCT02403674|459415245|FG000|Study Extension 1 (Open-Label)|Physician Decision|2|||
127670007|NCT02403674|459415246|FG001|Study Extension 1 (Open-Label)|Physician Decision|5|||
127670008|NCT02403674|459415245|FG000|Study Extension 1 (Open-Label)|Pregnancy|4|||
127670009|NCT02403674|459415246|FG001|Study Extension 1 (Open-Label)|Pregnancy|2|||
127670010|NCT02403674|459415245|FG000|Study Extension 1 (Open-Label)|Death|1|||
127670011|NCT02403674|459415246|FG001|Study Extension 1 (Open-Label)|Death|0|||
127670012|NCT02403674|459415245|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|22|||
127670013|NCT02403674|459415246|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|19|||
127670014|NCT02403674|459415245|FG000|Study Extension 1 (Open-Label)|Non-Compliance|2|||
127670015|NCT02403674|459415246|FG001|Study Extension 1 (Open-Label)|Non-Compliance|3|||
127670016|NCT02403674|459415245|FG000|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
127670017|NCT02403674|459415246|FG001|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
127670018|NCT02403674|459415245|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
127670019|NCT02403674|459415246|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|7|||
127670020|NCT02403674|459415245|FG000|Study Extension 2 (Open-Label)|Withdrawal by Subject|8|||
127670021|NCT02403674|459415246|FG001|Study Extension 2 (Open-Label)|Withdrawal by Subject|6|||
127670022|NCT02403674|459415245|FG000|Study Extension 2 (Open-Label)|Physician Decision|1|||
127670023|NCT02403674|459415246|FG001|Study Extension 2 (Open-Label)|Physician Decision|1|||
127670024|NCT02403674|459415245|FG000|Study Extension 2 (Open-Label)|Pregnancy|0|||
127670025|NCT02403674|459415246|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
127670026|NCT02403674|459415245|FG000|Study Extension 2 (Open-Label)|Death|2|||
127670027|NCT02403674|459415246|FG001|Study Extension 2 (Open-Label)|Death|2|||
127670028|NCT02403674|459415245|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|27|||
127670029|NCT02403674|459415246|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|23|||
127670030|NCT02403674|459415245|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|2|||
127670031|NCT02403674|459415246|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
127670032|NCT02403674|459415245|FG000|Study Extension 3 (Open-Label)|Lost to Follow-up|5|||
127670033|NCT02403674|459415246|FG001|Study Extension 3 (Open-Label)|Lost to Follow-up|4|||
127670034|NCT02403674|459415245|FG000|Study Extension 3 (Open-Label)|Withdrawal by Subject|1|||
127670035|NCT02403674|459415246|FG001|Study Extension 3 (Open-Label)|Withdrawal by Subject|3|||
127670036|NCT02403674|459415245|FG000|Study Extension 3 (Open-Label)|Physician Decision|1|||
127670037|NCT02403674|459415246|FG001|Study Extension 3 (Open-Label)|Physician Decision|5|||
127670038|NCT02403674|459415245|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
127670039|NCT02403674|459415246|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
127670040|NCT02403674|459415245|FG000|Study Extension 3 (Open-Label)|Availability of study drug locally|14|||
127670041|NCT02403674|459415246|FG001|Study Extension 3 (Open-Label)|Availability of study drug locally|13|||
127670042|NCT02703532|459415251|FG000|Overall Study|Withdrawal by Subject|0|||
127670043|NCT02703532|459415252|FG001|Overall Study|Withdrawal by Subject|1|||
128002702|NCT02984982|460637100|FG001|Overall Study|Withdrawal by Subject|0|||
128002703|NCT02984982|460637099|FG000|Overall Study|Randomized but not treated|0|||
127670044|NCT02703532|459415253|FG002|Overall Study|Withdrawal by Subject|0|||
127670045|NCT02703532|459415254|FG003|Overall Study|Withdrawal by Subject|1|||
127670046|NCT02703532|459415251|FG000|Overall Study|Lost to Follow-up|2|||
127670047|NCT02703532|459415252|FG001|Overall Study|Lost to Follow-up|0|||
127670048|NCT02703532|459415253|FG002|Overall Study|Lost to Follow-up|2|||
128002704|NCT02984982|460637100|FG001|Overall Study|Randomized but not treated|1|||
127670049|NCT02703532|459415254|FG003|Overall Study|Lost to Follow-up|0|||
127670050|NCT03738241|459415258|FG000|Overall Study|Withdrawal by Subject|0|||
127670051|NCT03738241|459415259|FG001|Overall Study|Withdrawal by Subject|0|||
127670052|NCT03738241|459415260|FG002|Overall Study|Withdrawal by Subject|0|||
127670053|NCT03738241|459415261|FG003|Overall Study|Withdrawal by Subject|0|||
127670054|NCT03738241|459415262|FG004|Overall Study|Withdrawal by Subject|0|||
127670055|NCT03738241|459415263|FG005|Overall Study|Withdrawal by Subject|0|||
127670056|NCT03738241|459415264|FG006|Overall Study|Withdrawal by Subject|0|||
127670057|NCT03738241|459415265|FG007|Overall Study|Withdrawal by Subject|0|||
127670058|NCT03738241|459415266|FG008|Overall Study|Withdrawal by Subject|0|||
127670059|NCT03738241|459415267|FG009|Overall Study|Withdrawal by Subject|1|||
128002705|NCT02153918|460637101|FG000|Overall Study|Refused further treatment|1|||
128002706|NCT02616783|460637102|FG000|Overall Study|Randomized but Not Treated|1|||
128002707|NCT02616783|460637103|FG001|Overall Study|Randomized but Not Treated|0|||
128002708|NCT02616783|460637102|FG000|Overall Study|Adverse Event|1|||
128002709|NCT02616783|460637103|FG001|Overall Study|Adverse Event|0|||
128002710|NCT02616783|460637102|FG000|Overall Study|Death|1|||
128002711|NCT02616783|460637103|FG001|Overall Study|Death|0|||
128002712|NCT02616783|460637102|FG000|Overall Study|Non-Compliance with Study Drug|1|||
128002713|NCT02616783|460637103|FG001|Overall Study|Non-Compliance with Study Drug|0|||
128002714|NCT02616783|460637102|FG000|Overall Study|Protocol Violation|1|||
128002715|NCT02616783|460637103|FG001|Overall Study|Protocol Violation|1|||
128002716|NCT02616783|460637102|FG000|Overall Study|Withdrew Consent|1|||
128002717|NCT02616783|460637103|FG001|Overall Study|Withdrew Consent|1|||
128002718|NCT04344301|460637104|FG000|Overall Study|Withdrawal by Subject|1|||
128002719|NCT04344301|460637105|FG001|Overall Study|Withdrawal by Subject|0|||
128002720|NCT04344301|460637104|FG000|Overall Study|Death|0|||
128002721|NCT04344301|460637105|FG001|Overall Study|Death|1|||
128002722|NCT01747499|460637106|FG000|Overall Study|Steroid refractory aGvHD|1|||
128002723|NCT01747499|460637107|FG001|Overall Study|Steroid refractory aGvHD|0|||
128002724|NCT01747499|460637108|FG002|Overall Study|Steroid refractory aGvHD|0|||
128002725|NCT01747499|460637109|FG003|Overall Study|Steroid refractory aGvHD|1|||
128002726|NCT01747499|460637110|FG004|Overall Study|Steroid refractory aGvHD|4|||
128002727|NCT01747499|460637106|FG000|Overall Study|Physician Decision|0|||
128002728|NCT01747499|460637107|FG001|Overall Study|Physician Decision|1|||
128002729|NCT01747499|460637108|FG002|Overall Study|Physician Decision|0|||
128002730|NCT01747499|460637109|FG003|Overall Study|Physician Decision|0|||
128002731|NCT01747499|460637110|FG004|Overall Study|Physician Decision|2|||
128002732|NCT01747499|460637106|FG000|Overall Study|Death|0|||
128002733|NCT01747499|460637107|FG001|Overall Study|Death|0|||
128002734|NCT01747499|460637108|FG002|Overall Study|Death|0|||
128002735|NCT01747499|460637109|FG003|Overall Study|Death|1|||
128002736|NCT01747499|460637110|FG004|Overall Study|Death|1|||
128002737|NCT01747499|460637106|FG000|Overall Study|Withdrawal by Subject|0|||
128002738|NCT01747499|460637107|FG001|Overall Study|Withdrawal by Subject|0|||
128002739|NCT01747499|460637108|FG002|Overall Study|Withdrawal by Subject|0|||
128002740|NCT01747499|460637109|FG003|Overall Study|Withdrawal by Subject|0|||
128002741|NCT01747499|460637110|FG004|Overall Study|Withdrawal by Subject|6|||
128002742|NCT01747499|460637106|FG000|Overall Study|Developed AML and death|0|||
128002743|NCT01747499|460637107|FG001|Overall Study|Developed AML and death|0|||
128002744|NCT01747499|460637108|FG002|Overall Study|Developed AML and death|0|||
128002745|NCT01747499|460637109|FG003|Overall Study|Developed AML and death|0|||
128002746|NCT01747499|460637110|FG004|Overall Study|Developed AML and death|1|||
128002747|NCT01747499|460637106|FG000|Overall Study|Determined not to be eligible|0|||
128002748|NCT01747499|460637107|FG001|Overall Study|Determined not to be eligible|0|||
128002749|NCT01747499|460637108|FG002|Overall Study|Determined not to be eligible|0|||
128002750|NCT01747499|460637109|FG003|Overall Study|Determined not to be eligible|0|||
128002751|NCT01747499|460637110|FG004|Overall Study|Determined not to be eligible|1|||
127543512|NCT02718898|458956554|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
127670060|NCT03738241|459415258|FG000|Overall Study|Physician Decision|0|||
127670061|NCT03738241|459415259|FG001|Overall Study|Physician Decision|0|||
127670062|NCT03738241|459415260|FG002|Overall Study|Physician Decision|0|||
127670063|NCT03738241|459415261|FG003|Overall Study|Physician Decision|0|||
127670064|NCT03738241|459415262|FG004|Overall Study|Physician Decision|0|||
127670065|NCT03738241|459415263|FG005|Overall Study|Physician Decision|0|||
127670066|NCT03738241|459415264|FG006|Overall Study|Physician Decision|0|||
127670067|NCT03738241|459415265|FG007|Overall Study|Physician Decision|0|||
127670068|NCT03738241|459415266|FG008|Overall Study|Physician Decision|1|||
127670069|NCT03738241|459415267|FG009|Overall Study|Physician Decision|0|||
127670070|NCT03738241|459415258|FG000|Overall Study|Adverse Event|1|||
127670071|NCT03738241|459415259|FG001|Overall Study|Adverse Event|0|||
127670072|NCT03738241|459415260|FG002|Overall Study|Adverse Event|0|||
127670073|NCT03738241|459415261|FG003|Overall Study|Adverse Event|0|||
127670074|NCT03738241|459415262|FG004|Overall Study|Adverse Event|0|||
128002752|NCT05214118|460637113|FG000|Overall Study|Lost to Follow-up|0|||
128002753|NCT05214118|460637114|FG001|Overall Study|Lost to Follow-up|2|||
128002754|NCT05214118|460637113|FG000|Overall Study|delivered late preterm 34 wks gestation|1|||
128002755|NCT05214118|460637114|FG001|Overall Study|delivered late preterm 34 wks gestation|1|||
128002756|NCT05214118|460637113|FG000|Overall Study|moved|1|||
128002757|NCT05214118|460637114|FG001|Overall Study|moved|0|||
128002758|NCT04010461|460637115|FG000|Overall Study|COVID based withdrawal|5|||
128002759|NCT04010461|460637115|FG000|Overall Study|Withdrawal by Subject|5|||
128002760|NCT04010461|460637115|FG000|Overall Study|Adverse Event|1|||
128002761|NCT04010461|460637115|FG000|Overall Study|No Motor Threshold obtainable|1|||
128002762|NCT04010461|460637115|FG000|Overall Study|Physician Decision|1|||
128002763|NCT03797898|460637116|FG000|Overall Study|Lost to Follow-up|60|||
128002764|NCT03797898|460637117|FG001|Overall Study|Lost to Follow-up|69|||
128002765|NCT03797898|460637116|FG000|Overall Study|Withdrawal by Subject|9|||
128002766|NCT03797898|460637117|FG001|Overall Study|Withdrawal by Subject|7|||
128002767|NCT03797898|460637116|FG000|Overall Study|Became ineligible|5|||
128002768|NCT03797898|460637117|FG001|Overall Study|Became ineligible|2|||
128002769|NCT00086190|460637118|FG000|Overall Study|Adverse Event|6|||
128002770|NCT00086190|460637119|FG001|Overall Study|Adverse Event|2|||
128002771|NCT00086190|460637120|FG002|Overall Study|Adverse Event|2|||
128002772|NCT00086190|460637118|FG000|Overall Study|Withdrawal by Subject|0|||
128002773|NCT00086190|460637119|FG001|Overall Study|Withdrawal by Subject|2|||
128002774|NCT00086190|460637120|FG002|Overall Study|Withdrawal by Subject|2|||
128002775|NCT00086190|460637118|FG000|Overall Study|Protocol Violation|1|||
128002776|NCT00086190|460637119|FG001|Overall Study|Protocol Violation|0|||
128002777|NCT00086190|460637120|FG002|Overall Study|Protocol Violation|0|||
128002778|NCT00086190|460637118|FG000|Overall Study|Moved|1|||
128002779|NCT00086190|460637119|FG001|Overall Study|Moved|0|||
128002780|NCT00086190|460637120|FG002|Overall Study|Moved|0|||
128002781|NCT00086190|460637118|FG000|Overall Study|Worsening depression|0|||
128002782|NCT00086190|460637119|FG001|Overall Study|Worsening depression|0|||
128002783|NCT00086190|460637120|FG002|Overall Study|Worsening depression|2|||
128002784|NCT03902613|460637124|FG000|Overall Study|Physician Decision|1|||
128002785|NCT02027025|460637125|FG000|Overall Study|Adverse Event|0|||
128002786|NCT02027025|460637126|FG001|Overall Study|Adverse Event|1|||
128002787|NCT02027025|460637127|FG002|Overall Study|Adverse Event|1|||
128002788|NCT02027025|460637125|FG000|Overall Study|Protocol Violation|1|||
128002789|NCT02027025|460637126|FG001|Overall Study|Protocol Violation|0|||
128002790|NCT02027025|460637127|FG002|Overall Study|Protocol Violation|0|||
128002791|NCT02027025|460637125|FG000|Overall Study|Lost to Follow-up|0|||
128002792|NCT02027025|460637126|FG001|Overall Study|Lost to Follow-up|2|||
128002793|NCT02027025|460637127|FG002|Overall Study|Lost to Follow-up|0|||
128002794|NCT02027025|460637125|FG000|Overall Study|Withdrawal by Subject|0|||
128002795|NCT02027025|460637126|FG001|Overall Study|Withdrawal by Subject|1|||
128002796|NCT02027025|460637127|FG002|Overall Study|Withdrawal by Subject|0|||
128002797|NCT02027025|460637125|FG000|Overall Study|Sponsor's decision|0|||
128002798|NCT02027025|460637126|FG001|Overall Study|Sponsor's decision|1|||
128002799|NCT02027025|460637127|FG002|Overall Study|Sponsor's decision|0|||
128002800|NCT04350827|460637136|FG000|Overall Study|Lost to Follow-up|1|||
128002801|NCT04350827|460637137|FG001|Overall Study|Lost to Follow-up|2|||
128002802|NCT00916578|460639304|FG000|Overall Study|Physician Decision|2|||
128002803|NCT00916578|460639304|FG000|Overall Study|Withdrawal by Subject|3|||
128002804|NCT00916578|460639304|FG000|Overall Study|Insurance Denial|2|||
128002805|NCT01655901|460639307|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
128002806|NCT01655901|460639308|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
128002807|NCT01655901|460639309|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
128002808|NCT01655901|460639310|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
128002809|NCT01655901|460639311|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
128002810|NCT01655901|460639312|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
128002811|NCT00945243|460639315|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
128002812|NCT03256578|460639316|FG000|Overall Study|Excluded Post Randomization|66|||
128002813|NCT03256578|460639317|FG001|Overall Study|Excluded Post Randomization|56|||
128002814|NCT00922636|460639320|FG000|Overall Study|Adverse Event|3|||
128002815|NCT00922636|460639321|FG001|Overall Study|Adverse Event|3|||
128002816|NCT00922636|460639322|FG002|Overall Study|Adverse Event|2|||
128002817|NCT00922636|460639323|FG003|Overall Study|Adverse Event|3|||
128002818|NCT00922636|460639324|FG004|Overall Study|Adverse Event|2|||
128002819|NCT00922636|460639320|FG000|Overall Study|Lack of Efficacy|1|||
128002820|NCT00922636|460639321|FG001|Overall Study|Lack of Efficacy|7|||
128002821|NCT00922636|460639322|FG002|Overall Study|Lack of Efficacy|3|||
128002822|NCT00922636|460639323|FG003|Overall Study|Lack of Efficacy|2|||
128002823|NCT00922636|460639324|FG004|Overall Study|Lack of Efficacy|4|||
128002824|NCT00922636|460639320|FG000|Overall Study|Sponsor Decision|0|||
128002825|NCT00922636|460639321|FG001|Overall Study|Sponsor Decision|0|||
128002826|NCT00922636|460639322|FG002|Overall Study|Sponsor Decision|2|||
128002827|NCT00922636|460639323|FG003|Overall Study|Sponsor Decision|0|||
128002828|NCT00922636|460639324|FG004|Overall Study|Sponsor Decision|0|||
128002829|NCT00922636|460639320|FG000|Overall Study|Withdrawal by Subject|0|||
128002830|NCT00922636|460639321|FG001|Overall Study|Withdrawal by Subject|0|||
128002831|NCT00922636|460639322|FG002|Overall Study|Withdrawal by Subject|5|||
127670075|NCT03738241|459415263|FG005|Overall Study|Adverse Event|0|||
128002832|NCT00922636|460639323|FG003|Overall Study|Withdrawal by Subject|2|||
128002833|NCT00922636|460639324|FG004|Overall Study|Withdrawal by Subject|4|||
128002834|NCT00922636|460639320|FG000|Overall Study|Protocol Violation|0|||
128002835|NCT00922636|460639321|FG001|Overall Study|Protocol Violation|0|||
127670076|NCT03738241|459415264|FG006|Overall Study|Adverse Event|0|||
127670077|NCT03738241|459415265|FG007|Overall Study|Adverse Event|0|||
127670078|NCT03738241|459415266|FG008|Overall Study|Adverse Event|0|||
127670079|NCT03738241|459415267|FG009|Overall Study|Adverse Event|0|||
127670080|NCT03169361|459415268|FG000|Overall Study|Protocol Violation|32|||
127670081|NCT02271594|459415269|FG000|Overall Study|Study closed; recruiting failure|19|||
127670082|NCT02271594|459415270|FG001|Overall Study|Study closed; recruiting failure|12|||
127670083|NCT00088465|459415271|FG000|Overall Study|Withdrawal by Subject|290|||
127670084|NCT00088465|459415271|FG000|Overall Study|Adverse Event|77|||
127670085|NCT00088465|459415271|FG000|Overall Study|Lost to Follow-up|57|||
127670086|NCT00088465|459415271|FG000|Overall Study|Physician Decision|45|||
127670087|NCT00088465|459415271|FG000|Overall Study|Sponsor Decision|37|||
127670088|NCT00088465|459415271|FG000|Overall Study|Lack of Efficacy|27|||
127670089|NCT00088465|459415271|FG000|Overall Study|Protocol Violation|17|||
127670090|NCT00088465|459415271|FG000|Overall Study|Death|11|||
127670091|NCT00495469|459415272|FG000|Overall Study|Adverse Event|0|||
127670092|NCT00495469|459415273|FG001|Overall Study|Adverse Event|1|||
127670093|NCT00495469|459415274|FG002|Overall Study|Adverse Event|3|||
127670094|NCT00495469|459415275|FG003|Overall Study|Adverse Event|0|||
127670095|NCT00495469|459415276|FG004|Overall Study|Adverse Event|1|||
127670096|NCT00495469|459415277|FG005|Overall Study|Adverse Event|1|||
127670097|NCT00495469|459415278|FG006|Overall Study|Adverse Event|1|||
127670098|NCT00495469|459415272|FG000|Overall Study|Lost to Follow-up|1|||
127670099|NCT00495469|459415273|FG001|Overall Study|Lost to Follow-up|1|||
127670100|NCT00495469|459415274|FG002|Overall Study|Lost to Follow-up|3|||
127670101|NCT00495469|459415275|FG003|Overall Study|Lost to Follow-up|1|||
127670102|NCT00495469|459415276|FG004|Overall Study|Lost to Follow-up|0|||
127670103|NCT00495469|459415277|FG005|Overall Study|Lost to Follow-up|0|||
127670104|NCT00495469|459415278|FG006|Overall Study|Lost to Follow-up|0|||
127670105|NCT00495469|459415272|FG000|Overall Study|Protocol Violation|0|||
127670106|NCT00495469|459415273|FG001|Overall Study|Protocol Violation|0|||
127670107|NCT00495469|459415274|FG002|Overall Study|Protocol Violation|0|||
127670108|NCT00495469|459415275|FG003|Overall Study|Protocol Violation|0|||
127670109|NCT00495469|459415276|FG004|Overall Study|Protocol Violation|1|||
127670110|NCT00495469|459415277|FG005|Overall Study|Protocol Violation|2|||
127670111|NCT00495469|459415278|FG006|Overall Study|Protocol Violation|0|||
127670112|NCT00495469|459415272|FG000|Overall Study|Withdrawal by Subject|5|||
127670113|NCT00495469|459415273|FG001|Overall Study|Withdrawal by Subject|3|||
127670114|NCT00495469|459415274|FG002|Overall Study|Withdrawal by Subject|1|||
127670115|NCT00495469|459415275|FG003|Overall Study|Withdrawal by Subject|3|||
127670116|NCT00495469|459415276|FG004|Overall Study|Withdrawal by Subject|3|||
127670117|NCT00495469|459415277|FG005|Overall Study|Withdrawal by Subject|2|||
127670118|NCT00495469|459415278|FG006|Overall Study|Withdrawal by Subject|3|||
127670119|NCT00495469|459415272|FG000|Overall Study|Lack of Efficacy|0|||
127670120|NCT00495469|459415273|FG001|Overall Study|Lack of Efficacy|0|||
127670121|NCT00495469|459415274|FG002|Overall Study|Lack of Efficacy|0|||
127670122|NCT00495469|459415275|FG003|Overall Study|Lack of Efficacy|0|||
127670123|NCT00495469|459415276|FG004|Overall Study|Lack of Efficacy|0|||
127670124|NCT00495469|459415277|FG005|Overall Study|Lack of Efficacy|0|||
127670125|NCT00495469|459415278|FG006|Overall Study|Lack of Efficacy|1|||
127670126|NCT00495469|459415272|FG000|Overall Study|Liver function test abnormality|0|||
127670127|NCT00495469|459415273|FG001|Overall Study|Liver function test abnormality|1|||
127670128|NCT00495469|459415274|FG002|Overall Study|Liver function test abnormality|0|||
127670129|NCT00495469|459415275|FG003|Overall Study|Liver function test abnormality|0|||
127670130|NCT00495469|459415276|FG004|Overall Study|Liver function test abnormality|0|||
127670131|NCT00495469|459415277|FG005|Overall Study|Liver function test abnormality|0|||
127670132|NCT00495469|459415278|FG006|Overall Study|Liver function test abnormality|0|||
127670133|NCT00495469|459415272|FG000|Overall Study|ST depression at randomisation in ECG|0|||
127670134|NCT00495469|459415273|FG001|Overall Study|ST depression at randomisation in ECG|1|||
127670135|NCT00495469|459415274|FG002|Overall Study|ST depression at randomisation in ECG|0|||
127670136|NCT00495469|459415275|FG003|Overall Study|ST depression at randomisation in ECG|0|||
128002836|NCT00922636|460639322|FG002|Overall Study|Protocol Violation|2|||
128002837|NCT00922636|460639323|FG003|Overall Study|Protocol Violation|2|||
127670137|NCT00495469|459415276|FG004|Overall Study|ST depression at randomisation in ECG|0|||
127670138|NCT00495469|459415277|FG005|Overall Study|ST depression at randomisation in ECG|0|||
127670139|NCT00495469|459415278|FG006|Overall Study|ST depression at randomisation in ECG|0|||
127670140|NCT00448864|459415281|FG000|Overall Study|Death|1|||
127670141|NCT00448864|459415282|FG001|Overall Study|Death|0|||
127670142|NCT00448864|459415283|FG002|Overall Study|Death|0|||
127670143|NCT00448864|459415281|FG000|Overall Study|Lost to Follow-up|3|||
127670144|NCT00448864|459415282|FG001|Overall Study|Lost to Follow-up|1|||
127670145|NCT00448864|459415283|FG002|Overall Study|Lost to Follow-up|0|||
127670146|NCT00448864|459415281|FG000|Overall Study|Physician Decision|1|||
127670147|NCT00448864|459415282|FG001|Overall Study|Physician Decision|0|||
127670148|NCT00448864|459415283|FG002|Overall Study|Physician Decision|1|||
127670149|NCT00448864|459415281|FG000|Overall Study|Withdrawal by Subject|0|||
127670150|NCT00448864|459415282|FG001|Overall Study|Withdrawal by Subject|2|||
128002838|NCT00922636|460639324|FG004|Overall Study|Protocol Violation|0|||
127670151|NCT00448864|459415283|FG002|Overall Study|Withdrawal by Subject|0|||
127670152|NCT00448864|459415281|FG000|Overall Study|Protocol Violation|0|||
127670153|NCT00448864|459415282|FG001|Overall Study|Protocol Violation|2|||
127670154|NCT00448864|459415283|FG002|Overall Study|Protocol Violation|0|||
127670155|NCT01323660|459415286|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
127670156|NCT01323660|459415287|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
127670157|NCT01323660|459415288|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
127670158|NCT01323660|459415289|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
127670159|NCT01323660|459415290|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
127670160|NCT01323660|459415291|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
127670161|NCT01323660|459415286|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
127670162|NCT01323660|459415287|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
127670163|NCT01323660|459415288|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
127670164|NCT01323660|459415289|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
127670165|NCT01323660|459415290|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
127670166|NCT01323660|459415291|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
127670167|NCT01323660|459415286|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
127670168|NCT01323660|459415287|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
127670169|NCT01323660|459415288|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
127670170|NCT01323660|459415289|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
127670171|NCT01323660|459415290|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
127670172|NCT01323660|459415291|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
127670173|NCT01323660|459415286|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
127670174|NCT01323660|459415287|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
127670175|NCT01323660|459415288|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
127670176|NCT01323660|459415289|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
127670177|NCT01323660|459415290|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
127670178|NCT01323660|459415291|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
127670179|NCT01323660|459415286|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
127670180|NCT01323660|459415287|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
127670181|NCT01323660|459415288|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
127670182|NCT01323660|459415289|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
127670183|NCT01323660|459415290|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
127670184|NCT01323660|459415291|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
127670185|NCT01323660|459415286|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
127670186|NCT01323660|459415287|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
127670187|NCT01323660|459415288|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
127670188|NCT01323660|459415289|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
127670189|NCT01323660|459415290|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
127670190|NCT01323660|459415291|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
127670191|NCT01323660|459415286|FG000|Washout Period (14 Days)|Adverse Event|0|||
127670192|NCT01323660|459415287|FG001|Washout Period (14 Days)|Adverse Event|0|||
127670193|NCT01323660|459415288|FG002|Washout Period (14 Days)|Adverse Event|0|||
127670194|NCT01323660|459415289|FG003|Washout Period (14 Days)|Adverse Event|0|||
127670195|NCT01323660|459415290|FG004|Washout Period (14 Days)|Adverse Event|1|||
127670196|NCT01323660|459415291|FG005|Washout Period (14 Days)|Adverse Event|0|||
127670197|NCT01323660|459415286|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
127670198|NCT01323660|459415287|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
127670199|NCT01323660|459415288|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
127670200|NCT01323660|459415289|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
127670201|NCT01323660|459415290|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
127670202|NCT01323660|459415291|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
127670203|NCT01323660|459415286|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
127670204|NCT01323660|459415287|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
127670205|NCT01323660|459415288|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
127670206|NCT01323660|459415289|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
127670207|NCT01323660|459415290|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
127670208|NCT01323660|459415291|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
127670209|NCT01323660|459415286|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
127670210|NCT01323660|459415287|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
127670211|NCT01323660|459415288|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
127670212|NCT01323660|459415289|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
127670213|NCT01323660|459415290|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
127670214|NCT01323660|459415291|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
127670215|NCT01323660|459415286|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
127670216|NCT01323660|459415287|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
127670217|NCT01323660|459415288|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
127670218|NCT01323660|459415289|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
128002839|NCT00922636|460639320|FG000|Overall Study|Entry Criteria Not Met|0|||
128002840|NCT00922636|460639321|FG001|Overall Study|Entry Criteria Not Met|0|||
128002841|NCT00922636|460639322|FG002|Overall Study|Entry Criteria Not Met|1|||
128002842|NCT00922636|460639323|FG003|Overall Study|Entry Criteria Not Met|1|||
128002843|NCT00922636|460639324|FG004|Overall Study|Entry Criteria Not Met|0|||
128002844|NCT00922636|460639320|FG000|Overall Study|Parent/Caregiver Decision|2|||
128002845|NCT00922636|460639321|FG001|Overall Study|Parent/Caregiver Decision|4|||
128002846|NCT00922636|460639322|FG002|Overall Study|Parent/Caregiver Decision|3|||
128002847|NCT00922636|460639323|FG003|Overall Study|Parent/Caregiver Decision|5|||
128002848|NCT00922636|460639324|FG004|Overall Study|Parent/Caregiver Decision|2|||
128002849|NCT00922636|460639320|FG000|Overall Study|Lost to Follow-up|1|||
128002850|NCT00922636|460639321|FG001|Overall Study|Lost to Follow-up|2|||
128002851|NCT00922636|460639322|FG002|Overall Study|Lost to Follow-up|2|||
128002852|NCT00922636|460639323|FG003|Overall Study|Lost to Follow-up|2|||
128002853|NCT00922636|460639324|FG004|Overall Study|Lost to Follow-up|4|||
128002854|NCT04969289|460639325|FG000|Overall Study|Lost to Follow-up|13|||
127670219|NCT01323660|459415290|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
127670220|NCT01323660|459415291|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
127670221|NCT01323660|459415286|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
127670222|NCT01323660|459415287|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
127670223|NCT01323660|459415288|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
127670224|NCT01323660|459415289|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
127670225|NCT01323660|459415290|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
128002855|NCT04969289|460639326|FG001|Overall Study|Lost to Follow-up|9|||
128002856|NCT00557466|460639327|FG000|Overall Study|Adverse Event|3|||
128002857|NCT00557466|460639328|FG001|Overall Study|Adverse Event|1|||
127670226|NCT01323660|459415291|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
127670227|NCT01323660|459415286|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
127670228|NCT01323660|459415287|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
127670229|NCT01323660|459415288|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
127670230|NCT01323660|459415289|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
127670231|NCT01323660|459415290|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
127670232|NCT01323660|459415291|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
127670233|NCT04531540|459415294|FG000|Overall Study|Adverse Event|1|||
127670234|NCT04531540|459415294|FG000|Overall Study|Protocol Violation|3|||
127670235|NCT04531540|459415294|FG000|Overall Study|Withdrawal by Subject|4|||
127670236|NCT04531540|459415294|FG000|Overall Study|Found to be Ineligible|1|||
127670237|NCT02688621|459415295|FG000|Overall Study|Pregnancy|1|||
127670238|NCT02688621|459415296|FG001|Overall Study|Pregnancy|3|||
127670239|NCT02688621|459415295|FG000|Overall Study|Lost to Follow-up|38|||
127670240|NCT02688621|459415296|FG001|Overall Study|Lost to Follow-up|15|||
127670241|NCT02688621|459415295|FG000|Overall Study|Withdrawal by Subject|1|||
127670242|NCT02688621|459415296|FG001|Overall Study|Withdrawal by Subject|0|||
127670243|NCT03239210|459415297|FG000|Overall Study|Lost to Follow-up|2|||
127670244|NCT03239210|459415298|FG001|Overall Study|Lost to Follow-up|2|||
127670245|NCT03239210|459415297|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
127670246|NCT03239210|459415298|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
127670247|NCT03239210|459415297|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
127670248|NCT03239210|459415298|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
127670249|NCT01575860|459415299|FG000|Overall Study|Withdrawal by Subject|1|||
127670250|NCT01575860|459415299|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
127670251|NCT00278564|459415301|FG000|Overall Study|Lack of Efficacy|4|||
127670252|NCT01094743|459415302|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
127670253|NCT02851511|459415303|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
127670254|NCT02851511|459415304|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
127670255|NCT02851511|459415305|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
127670256|NCT02851511|459415306|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
127670257|NCT02851511|459415303|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
127670258|NCT02851511|459415304|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
127670259|NCT02851511|459415305|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
127670260|NCT02851511|459415306|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
127670261|NCT02851511|459415303|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
127670262|NCT02851511|459415304|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
127670263|NCT02851511|459415305|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
127670264|NCT02851511|459415306|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
127670265|NCT02851511|459415303|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
128002858|NCT00557466|460639329|FG002|Overall Study|Adverse Event|4|||
128002859|NCT00557466|460639330|FG003|Overall Study|Adverse Event|1|||
128002860|NCT00557466|460639331|FG004|Overall Study|Adverse Event|2|||
127670266|NCT02851511|459415304|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
128002861|NCT00557466|460639332|FG005|Overall Study|Adverse Event|4|||
128002862|NCT00557466|460639327|FG000|Overall Study|Abnormal laboratory value(s)|1|||
127670267|NCT02851511|459415305|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
127670268|NCT02851511|459415306|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
127670269|NCT02851511|459415303|FG000|Phase I|Physician Decision|0|||
127670270|NCT02851511|459415304|FG001|Phase I|Physician Decision|0|||
127670271|NCT02851511|459415305|FG002|Phase I|Physician Decision|0|||
127670272|NCT02851511|459415306|FG003|Phase I|Physician Decision|1|||
127670273|NCT02851511|459415303|FG000|Phase I|Withdrawal by Subject|2|||
127670274|NCT02851511|459415304|FG001|Phase I|Withdrawal by Subject|1|||
127670275|NCT02851511|459415305|FG002|Phase I|Withdrawal by Subject|0|||
127670276|NCT02851511|459415306|FG003|Phase I|Withdrawal by Subject|3|||
127670277|NCT02851511|459415303|FG000|Phase II|Physician Decision|18|||
127670278|NCT02851511|459415304|FG001|Phase II|Physician Decision|16|||
127670279|NCT02851511|459415305|FG002|Phase II|Physician Decision|0|||
127670280|NCT02851511|459415306|FG003|Phase II|Physician Decision|0|||
127670281|NCT02851511|459415303|FG000|Phase II|Withdrawal by Subject|18|||
127670282|NCT02851511|459415304|FG001|Phase II|Withdrawal by Subject|16|||
127670283|NCT02851511|459415305|FG002|Phase II|Withdrawal by Subject|0|||
127670284|NCT02851511|459415306|FG003|Phase II|Withdrawal by Subject|0|||
127670285|NCT02851511|459415303|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
127670286|NCT02851511|459415304|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
128002863|NCT00557466|460639328|FG001|Overall Study|Abnormal laboratory value(s)|2|||
128002864|NCT00557466|460639329|FG002|Overall Study|Abnormal laboratory value(s)|0|||
128002865|NCT00557466|460639330|FG003|Overall Study|Abnormal laboratory value(s)|0|||
128002866|NCT00557466|460639331|FG004|Overall Study|Abnormal laboratory value(s)|0|||
128002867|NCT00557466|460639332|FG005|Overall Study|Abnormal laboratory value(s)|0|||
128002868|NCT00557466|460639327|FG000|Overall Study|Protocol deviation|0|||
128002869|NCT00557466|460639328|FG001|Overall Study|Protocol deviation|1|||
128002870|NCT00557466|460639329|FG002|Overall Study|Protocol deviation|0|||
128002871|NCT00557466|460639330|FG003|Overall Study|Protocol deviation|2|||
128002872|NCT00557466|460639331|FG004|Overall Study|Protocol deviation|0|||
128002873|NCT00557466|460639332|FG005|Overall Study|Protocol deviation|0|||
128002874|NCT00557466|460639327|FG000|Overall Study|Subject withdrew consent|0|||
128002875|NCT00557466|460639328|FG001|Overall Study|Subject withdrew consent|0|||
128002876|NCT00557466|460639329|FG002|Overall Study|Subject withdrew consent|0|||
128002877|NCT00557466|460639330|FG003|Overall Study|Subject withdrew consent|0|||
128002878|NCT00557466|460639331|FG004|Overall Study|Subject withdrew consent|1|||
128002879|NCT00557466|460639332|FG005|Overall Study|Subject withdrew consent|2|||
128002880|NCT00557466|460639327|FG000|Overall Study|Administrative problems|0|||
128002881|NCT00557466|460639328|FG001|Overall Study|Administrative problems|1|||
128002882|NCT00557466|460639329|FG002|Overall Study|Administrative problems|1|||
128002883|NCT00557466|460639330|FG003|Overall Study|Administrative problems|0|||
128002884|NCT00557466|460639331|FG004|Overall Study|Administrative problems|0|||
128002885|NCT00557466|460639332|FG005|Overall Study|Administrative problems|0|||
128002886|NCT00557466|460639327|FG000|Overall Study|Abnormal test procedure results|0|||
128002887|NCT00557466|460639328|FG001|Overall Study|Abnormal test procedure results|0|||
128002888|NCT00557466|460639329|FG002|Overall Study|Abnormal test procedure results|1|||
128002889|NCT00557466|460639330|FG003|Overall Study|Abnormal test procedure results|0|||
128002890|NCT00557466|460639331|FG004|Overall Study|Abnormal test procedure results|0|||
128002891|NCT00557466|460639332|FG005|Overall Study|Abnormal test procedure results|0|||
128002892|NCT00557466|460639327|FG000|Overall Study|Lost to Follow-up|0|||
128002893|NCT00557466|460639328|FG001|Overall Study|Lost to Follow-up|0|||
128002894|NCT00557466|460639329|FG002|Overall Study|Lost to Follow-up|0|||
128002895|NCT00557466|460639330|FG003|Overall Study|Lost to Follow-up|1|||
128002896|NCT00557466|460639331|FG004|Overall Study|Lost to Follow-up|0|||
128002897|NCT00557466|460639332|FG005|Overall Study|Lost to Follow-up|0|||
128002898|NCT01251952|460639335|FG000|Overall Study|Adverse Event|1|||
128002899|NCT02486692|460639336|FG000|Overall Study|did not login for randomization|4|||
128002900|NCT02486692|460639337|FG001|Overall Study|did not login for randomization|7|||
128002901|NCT02224625|460639340|FG000|Irritation|Adverse Event|6|||
128002902|NCT02224625|460639340|FG000|Sensitization|Adverse Event|55|||
128002903|NCT01307787|460639341|FG000|Overall Study|Withdrawal by Subject|2|||
127670287|NCT02851511|459415305|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
127670288|NCT02851511|459415306|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
127670289|NCT02851511|459415303|FG000|Phase II|Lost to Follow-up|0|||
128002904|NCT01307787|460639342|FG001|Overall Study|Withdrawal by Subject|0|||
128002905|NCT03342001|460639346|FG000|Overall Study|Adverse Event|1|||
128002906|NCT03342001|460639346|FG000|Overall Study|Lost to Follow-up|1|||
128002907|NCT04161391|460639352|FG000|Overall Study|Adverse Event|0|||
128002908|NCT04161391|460639353|FG001|Overall Study|Adverse Event|1|||
127670290|NCT02851511|459415304|FG001|Phase II|Lost to Follow-up|1|||
127670291|NCT02851511|459415305|FG002|Phase II|Lost to Follow-up|0|||
127670292|NCT02851511|459415306|FG003|Phase II|Lost to Follow-up|0|||
128002909|NCT04161391|460639354|FG002|Overall Study|Adverse Event|0|||
128002910|NCT04161391|460639355|FG003|Overall Study|Adverse Event|1|||
128002911|NCT04161391|460639356|FG004|Overall Study|Adverse Event|0|||
127670293|NCT00051311|459415307|FG000|Overall Study|Starting new study|0|||
127670294|NCT00051311|459415308|FG001|Overall Study|Starting new study|1|||
127670295|NCT00051311|459415307|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
127670296|NCT00051311|459415308|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
127670297|NCT00051311|459415307|FG000|Overall Study|Death of recipient|8|||
127670298|NCT00051311|459415308|FG001|Overall Study|Death of recipient|8|||
127670299|NCT00051311|459415307|FG000|Overall Study|Recipient taken off study|4|||
127670300|NCT00051311|459415308|FG001|Overall Study|Recipient taken off study|4|||
127670301|NCT00372567|459415316|FG000|Phase 3 Study|Adverse Event|5|||
127670302|NCT00372567|459415317|FG001|Phase 3 Study|Adverse Event|1|||
127670303|NCT00372567|459415318|FG002|Phase 3 Study|Adverse Event|1|||
127670304|NCT00372567|459415316|FG000|Phase 3 Study|Death|1|||
127670305|NCT00372567|459415317|FG001|Phase 3 Study|Death|1|||
127670306|NCT00372567|459415318|FG002|Phase 3 Study|Death|0|||
127670307|NCT00372567|459415316|FG000|Phase 3 Study|Protocol Violation|0|||
127670308|NCT00372567|459415317|FG001|Phase 3 Study|Protocol Violation|0|||
127670309|NCT00372567|459415318|FG002|Phase 3 Study|Protocol Violation|1|||
127670310|NCT00372567|459415316|FG000|Phase 3 Study|Objective progression or relapse|10|||
127670311|NCT00372567|459415317|FG001|Phase 3 Study|Objective progression or relapse|13|||
127670312|NCT00372567|459415318|FG002|Phase 3 Study|Objective progression or relapse|4|||
127670313|NCT00372567|459415316|FG000|Phase 3 Study|Global deterioration of health status|0|||
127670314|NCT00372567|459415317|FG001|Phase 3 Study|Global deterioration of health status|1|||
127670315|NCT00372567|459415318|FG002|Phase 3 Study|Global deterioration of health status|0|||
127670316|NCT00372567|459415316|FG000|Phase 3 Study|Other|2|||
127670317|NCT00372567|459415317|FG001|Phase 3 Study|Other|2|||
127670318|NCT00372567|459415318|FG002|Phase 3 Study|Other|1|||
127670319|NCT00372567|459415316|FG000|Phase 3 Study|study terminated by sponsor|13|||
127670320|NCT00372567|459415317|FG001|Phase 3 Study|study terminated by sponsor|8|||
127670321|NCT00372567|459415318|FG002|Phase 3 Study|study terminated by sponsor|5|||
127670322|NCT00303303|459415322|FG000|Overall Study|Withdrawal by Subject|0|||
127670323|NCT00303303|459415323|FG001|Overall Study|Withdrawal by Subject|0|||
127670324|NCT00303303|459415324|FG002|Overall Study|Withdrawal by Subject|1|||
127670325|NCT00582790|459415327|FG000|Overall Study|Rapid progression of disease|1|||
127670326|NCT00480441|459415328|FG000|Screening|Not Eligible|37|||
127670327|NCT00480441|459415329|FG001|Screening|Not Eligible|0|||
127670328|NCT00480441|459415330|FG002|Screening|Not Eligible|0|||
127670329|NCT00480441|459415328|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
127670330|NCT00480441|459415329|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
127670331|NCT00480441|459415330|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
127670332|NCT00480441|459415328|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
127670333|NCT00480441|459415329|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
127670334|NCT00480441|459415330|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
127670335|NCT00480441|459415328|FG000|Baseline Functional MRI|physical contraindication|4|||
127670336|NCT00480441|459415329|FG001|Baseline Functional MRI|physical contraindication|0|||
127670337|NCT00480441|459415330|FG002|Baseline Functional MRI|physical contraindication|0|||
127670338|NCT00480441|459415328|FG000|Randomization|Lost to Follow-up|0|||
127670339|NCT00480441|459415329|FG001|Randomization|Lost to Follow-up|7|||
127670340|NCT00480441|459415330|FG002|Randomization|Lost to Follow-up|2|||
127670341|NCT01004263|459415342|FG000|Overall Study|Adverse Event|15|||
128002912|NCT04161391|460639357|FG005|Overall Study|Adverse Event|0|||
128002913|NCT04161391|460639358|FG006|Overall Study|Adverse Event|0|||
128002914|NCT04161391|460639359|FG007|Overall Study|Adverse Event|3|||
128002915|NCT04161391|460639360|FG008|Overall Study|Adverse Event|0|||
128002916|NCT04161391|460639352|FG000|Overall Study|Death|0|||
128002917|NCT04161391|460639353|FG001|Overall Study|Death|0|||
128002918|NCT04161391|460639354|FG002|Overall Study|Death|0|||
128002919|NCT04161391|460639355|FG003|Overall Study|Death|0|||
128002920|NCT04161391|460639356|FG004|Overall Study|Death|0|||
128002921|NCT04161391|460639357|FG005|Overall Study|Death|0|||
128002922|NCT04161391|460639358|FG006|Overall Study|Death|0|||
128002923|NCT04161391|460639359|FG007|Overall Study|Death|1|||
128002924|NCT04161391|460639360|FG008|Overall Study|Death|0|||
128002925|NCT04161391|460639352|FG000|Overall Study|Physician Decision|0|||
128002926|NCT04161391|460639353|FG001|Overall Study|Physician Decision|0|||
128002927|NCT04161391|460639354|FG002|Overall Study|Physician Decision|1|||
128002928|NCT04161391|460639355|FG003|Overall Study|Physician Decision|2|||
128002929|NCT04161391|460639356|FG004|Overall Study|Physician Decision|0|||
127670342|NCT01004263|459415342|FG000|Overall Study|Withdrawal by Subject|58|||
127670343|NCT01004263|459415342|FG000|Overall Study|Protocol Violation|10|||
127670344|NCT01004263|459415342|FG000|Overall Study|Lost to Follow-up|64|||
127670345|NCT01004263|459415342|FG000|Overall Study|Lack of Efficacy|13|||
128002930|NCT04161391|460639357|FG005|Overall Study|Physician Decision|0|||
127670346|NCT01004263|459415342|FG000|Overall Study|Pregnancy|2|||
128002931|NCT04161391|460639358|FG006|Overall Study|Physician Decision|2|||
127670347|NCT01004263|459415342|FG000|Overall Study|Physician Decision|15|||
127670348|NCT01004263|459415342|FG000|Overall Study|Lack of Qualifying Event|2|||
127670349|NCT00958009|459415343|FG000|Overall Study|Adverse Event|1|||
128002932|NCT04161391|460639359|FG007|Overall Study|Physician Decision|0|||
128002933|NCT04161391|460639360|FG008|Overall Study|Physician Decision|0|||
128002934|NCT04161391|460639352|FG000|Overall Study|Progressive Disease|4|||
127670350|NCT00958009|459415343|FG000|Overall Study|Subject found device difficult to use|1|||
127670351|NCT00558753|459415344|FG000|Overall Study|Lost to Follow-up|5|||
127670352|NCT00558753|459415345|FG001|Overall Study|Lost to Follow-up|7|||
127670353|NCT00578227|459415348|FG000|Overall Study|Lost to Follow-up|0|||
127670354|NCT00578227|459415349|FG001|Overall Study|Lost to Follow-up|1|||
127670355|NCT00578227|459415350|FG002|Overall Study|Lost to Follow-up|1|||
127670356|NCT00578227|459415348|FG000|Overall Study|Withdrawal by Subject|5|||
127670357|NCT00578227|459415349|FG001|Overall Study|Withdrawal by Subject|1|||
127670358|NCT00578227|459415350|FG002|Overall Study|Withdrawal by Subject|3|||
127670359|NCT04668144|459415351|FG000|Overall Study|Protocol Violation|0|||
127670360|NCT04668144|459415352|FG001|Overall Study|Protocol Violation|1|||
127670361|NCT04668144|459415353|FG002|Overall Study|Protocol Violation|2|||
127670362|NCT00577629|459415354|FG000|Treatment Period|Death|1|||
127670363|NCT00577629|459415354|FG000|Long Term Follow-Up|Death|15|||
127670364|NCT00577629|459415354|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
127670365|NCT00577629|459415354|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
127670366|NCT00577629|459415354|FG000|Long Term Follow-Up|Physician Decision|1|||
127670367|NCT02929108|459415355|FG000|Overall Study|Hospice patient death|100|||
127670368|NCT02929108|459415356|FG001|Overall Study|Hospice patient death|64|||
127670369|NCT02929108|459415357|FG002|Overall Study|Hospice patient death|28|||
128002935|NCT04161391|460639353|FG001|Overall Study|Progressive Disease|3|||
128002936|NCT04161391|460639354|FG002|Overall Study|Progressive Disease|3|||
128002937|NCT04161391|460639355|FG003|Overall Study|Progressive Disease|5|||
128002938|NCT04161391|460639356|FG004|Overall Study|Progressive Disease|3|||
128002939|NCT04161391|460639357|FG005|Overall Study|Progressive Disease|3|||
128002940|NCT04161391|460639358|FG006|Overall Study|Progressive Disease|5|||
128002941|NCT04161391|460639359|FG007|Overall Study|Progressive Disease|2|||
128002942|NCT04161391|460639360|FG008|Overall Study|Progressive Disease|2|||
128002943|NCT02579629|460639361|FG000|Overall Study|Withdrawal by Subject|0|||
128002944|NCT02579629|460639362|FG001|Overall Study|Withdrawal by Subject|1|||
128002945|NCT02579629|460639363|FG002|Overall Study|Withdrawal by Subject|0|||
128002946|NCT02579629|460639361|FG000|Overall Study|Screen Failure|2|||
128002947|NCT02579629|460639362|FG001|Overall Study|Screen Failure|0|||
128002948|NCT02579629|460639363|FG002|Overall Study|Screen Failure|2|||
128002949|NCT02351934|460639364|FG000|Allocation|POD weight<pre-op weight|3|||
128002950|NCT02351934|460639365|FG001|Allocation|POD weight<pre-op weight|0|||
128002951|NCT02351934|460639364|FG000|Allocation|Hypotension preventing administration|2|||
127670370|NCT02929108|459415358|FG003|Overall Study|Hospice patient death|46|||
127670371|NCT02929108|459415359|FG004|Overall Study|Hospice patient death|55|||
127670372|NCT02929108|459415360|FG005|Overall Study|Hospice patient death|28|||
127670373|NCT02929108|459415361|FG006|Overall Study|Hospice patient death|78|||
127670374|NCT03590743|459415364|FG000|Overall Study|Withdrawal by Subject|0|||
127670375|NCT03590743|459415365|FG001|Overall Study|Withdrawal by Subject|1|||
127670376|NCT00604786|459415366|FG000|Overall Study|Lost to Follow-up|2|||
127670377|NCT00604786|459415367|FG001|Overall Study|Lost to Follow-up|0|||
127670378|NCT01221181|459415368|FG000|Overall Study|Lost to Follow-up|1|||
127670379|NCT02698436|459415369|FG000|Overall Study|Adverse Event|1|||
127670380|NCT02698436|459415370|FG001|Overall Study|Adverse Event|0|||
127670381|NCT02698436|459415369|FG000|Overall Study|Withdrawal by Subject|3|||
127670382|NCT02698436|459415370|FG001|Overall Study|Withdrawal by Subject|3|||
127670383|NCT02698436|459415369|FG000|Overall Study|Lost to Follow-up|2|||
127670384|NCT02698436|459415370|FG001|Overall Study|Lost to Follow-up|4|||
127670385|NCT02698436|459415369|FG000|Overall Study|Non-compliance with study regimen|1|||
127670386|NCT02698436|459415370|FG001|Overall Study|Non-compliance with study regimen|0|||
127670387|NCT03158948|459417265|FG000|Overall Study|Death|1|||
127670388|NCT03158948|459417266|FG001|Overall Study|Death|1|||
127670389|NCT03158948|459417267|FG002|Overall Study|Death|3|||
127670390|NCT03158948|459417268|FG003|Overall Study|Death|2|||
127670391|NCT03158948|459417265|FG000|Overall Study|Physician Decision|0|||
127670392|NCT03158948|459417266|FG001|Overall Study|Physician Decision|0|||
127670393|NCT03158948|459417267|FG002|Overall Study|Physician Decision|0|||
127670394|NCT03158948|459417268|FG003|Overall Study|Physician Decision|1|||
127670395|NCT01876043|459417269|FG000|Overall Study|Death|1|||
127670396|NCT01876043|459417269|FG000|Overall Study|Withdrawal by Subject|1|||
128002952|NCT02351934|460639365|FG001|Allocation|Hypotension preventing administration|0|||
128002953|NCT02351934|460639364|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
127670397|NCT00079937|459417270|FG000|Overall Study|Adverse Event|2|||
127670398|NCT00079937|459417271|FG001|Overall Study|Adverse Event|1|||
127670399|NCT00079937|459417270|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
127670400|NCT00079937|459417271|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
127670401|NCT00079937|459417270|FG000|Overall Study|Subject no longer requires study drug|3|||
127670402|NCT00079937|459417271|FG001|Overall Study|Subject no longer requires study drug|0|||
127670403|NCT00079937|459417270|FG000|Overall Study|Protocol Violation|8|||
128002954|NCT02351934|460639365|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
127670404|NCT00079937|459417271|FG001|Overall Study|Protocol Violation|6|||
127670405|NCT00079937|459417270|FG000|Overall Study|Withdrawal by Subject|21|||
127670406|NCT00079937|459417271|FG001|Overall Study|Withdrawal by Subject|7|||
127670407|NCT00079937|459417270|FG000|Overall Study|Lost to Follow-up|12|||
127670408|NCT00079937|459417271|FG001|Overall Study|Lost to Follow-up|5|||
127670409|NCT00079937|459417270|FG000|Overall Study|Administrative problems|22|||
127670410|NCT00079937|459417271|FG001|Overall Study|Administrative problems|11|||
127670411|NCT02206685|459417272|FG000|Overall Study|Surgery cancelled/changed|2|||
127670412|NCT02206685|459417273|FG001|Overall Study|Surgery cancelled/changed|3|||
127670413|NCT02206685|459417272|FG000|Overall Study|Withdrawal by Subject|1|||
127670414|NCT02206685|459417273|FG001|Overall Study|Withdrawal by Subject|2|||
127670415|NCT02206685|459417272|FG000|Overall Study|Protocol Violation|2|||
127670416|NCT02206685|459417273|FG001|Overall Study|Protocol Violation|2|||
127670417|NCT01616563|459417274|FG000|Overall Study|Lost to Follow-up|40|||
127670418|NCT01195675|459417275|FG000|Overall Study|Adverse Event|1|||
127670419|NCT01195675|459417275|FG000|Overall Study|Withdrawal by Subject|2|||
127670420|NCT00072475|459417276|FG000|Overall Study|Adverse Event|44|||
127670421|NCT00072475|459417276|FG000|Overall Study|Death|3|||
127670422|NCT00072475|459417276|FG000|Overall Study|Withdrawal by Subject|46|||
127670423|NCT00072475|459417276|FG000|Overall Study|Patient/Investigator Decision|4|||
127670424|NCT01450943|459417279|FG000|Overall Study|Screen failure, loss to follow-up|2|||
127670425|NCT01450943|459417280|FG001|Overall Study|Screen failure, loss to follow-up|7|||
127670426|NCT01450943|459417281|FG002|Overall Study|Screen failure, loss to follow-up|6|||
127670427|NCT04454567|459417287|FG000|Overall Study|Study Terminated by Sponsor|1|||
127670428|NCT04454567|459417288|FG001|Overall Study|Study Terminated by Sponsor|1|||
127670429|NCT01175707|459417291|FG000|Overall Study|Adverse Event|4|||
127670430|NCT01175707|459417292|FG001|Overall Study|Adverse Event|6|||
127670431|NCT00003377|459417296|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
127670432|NCT00003377|459417297|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
127670433|NCT00003377|459417298|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
127670434|NCT00003377|459417299|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
127670435|NCT00003377|459417300|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
127670436|NCT00003377|459417296|FG000|Period II|Ureteral stent complications|0|||
127670437|NCT00003377|459417297|FG001|Period II|Ureteral stent complications|0|||
127670438|NCT00003377|459417298|FG002|Period II|Ureteral stent complications|0|||
127670439|NCT00003377|459417299|FG003|Period II|Ureteral stent complications|0|||
127670440|NCT00003377|459417300|FG004|Period II|Ureteral stent complications|1|||
127670441|NCT02256969|459417301|FG000|Overall Study|Screenfailed or withdrew|2|||
127670442|NCT02256969|459417302|FG001|Overall Study|Screenfailed or withdrew|1|||
127670443|NCT02256969|459417303|FG002|Overall Study|Screenfailed or withdrew|1|||
127670444|NCT02347943|459417304|FG000|Overall Study|Study was cancelled|140|||
127670445|NCT02347943|459417305|FG001|Overall Study|Study was cancelled|67|||
127670446|NCT02347943|459417306|FG002|Overall Study|Study was cancelled|45|||
127670447|NCT03566680|459417310|FG000|Overall Study|Pregnancy|1|||
127670448|NCT03566680|459417310|FG000|Overall Study|Lost to Follow-up|13|||
127670449|NCT03566680|459417310|FG000|Overall Study|Withdrawal by Subject|3|||
128002955|NCT02351934|460639364|FG000|Follow-Up|POD weight<pre-op weight|3|||
128002956|NCT02351934|460639365|FG001|Follow-Up|POD weight<pre-op weight|0|||
128002957|NCT02351934|460639364|FG000|Follow-Up|Acute Kidney Injury|1|||
128002958|NCT02351934|460639365|FG001|Follow-Up|Acute Kidney Injury|0|||
128002959|NCT02351934|460639364|FG000|Follow-Up|Early dismissal|3|||
128002960|NCT02351934|460639365|FG001|Follow-Up|Early dismissal|0|||
128002961|NCT02351934|460639364|FG000|Follow-Up|Hypotension|3|||
128002962|NCT02351934|460639365|FG001|Follow-Up|Hypotension|0|||
128002963|NCT02351934|460639364|FG000|Follow-Up|No documentation|2|||
128002964|NCT02351934|460639365|FG001|Follow-Up|No documentation|0|||
128002965|NCT02351934|460639364|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
128002966|NCT02351934|460639365|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
128002967|NCT02351934|460639364|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
128002968|NCT02351934|460639365|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
128002969|NCT00896493|460639366|FG000|Overall Study|Early disease relapse|3|||
128002970|NCT01739335|460639368|FG000|Overall Study|Lost to Follow-up|7|||
128002971|NCT01739335|460639369|FG001|Overall Study|Lost to Follow-up|4|||
128002972|NCT01739335|460639368|FG000|Overall Study|Ineligible patient randomized|0|||
128002973|NCT01739335|460639369|FG001|Overall Study|Ineligible patient randomized|1|||
128002974|NCT01674725|460639375|FG000|Overall Study|Adverse Event|1|||
128002975|NCT01674725|460639376|FG001|Overall Study|Adverse Event|0|||
128002976|NCT01674725|460639375|FG000|Overall Study|Did not receive study drug|1|||
127670450|NCT02374957|459417313|FG000|Overall Study|Patient did not complete forms correctly|1|||
127670451|NCT02374957|459417314|FG001|Overall Study|Patient did not complete forms correctly|0|||
127670452|NCT01687270|459417315|FG000|Overall Study|Lack of Efficacy|11|||
127670453|NCT01687270|459417315|FG000|Overall Study|Lost to Follow-up|1|||
127670454|NCT05349084|459417316|FG000|Overall Study|Radiotracer production failed. Patient received an intervention so did not qualify to come back.|1|||
127670455|NCT00821236|459417318|FG000|Overall Study|Lost to Follow-up|3|||
127670456|NCT01605136|459417321|FG000|Study Period|Withdrawal by Subject|2|||
127670457|NCT01605136|459417322|FG001|Study Period|Withdrawal by Subject|0|||
127670458|NCT01605136|459417321|FG000|Study Period|Physician Decision|1|||
128002977|NCT01674725|460639376|FG001|Overall Study|Did not receive study drug|0|||
128002978|NCT01674725|460639375|FG000|Overall Study|Withdrawal by Subject|1|||
128002979|NCT01674725|460639376|FG001|Overall Study|Withdrawal by Subject|0|||
128002980|NCT01674725|460639375|FG000|Overall Study|Lost to Follow-up|0|||
128002981|NCT01674725|460639376|FG001|Overall Study|Lost to Follow-up|1|||
127670459|NCT01605136|459417322|FG001|Study Period|Physician Decision|1|||
127670460|NCT01605136|459417321|FG000|Study Period|Lost to Follow-up|0|||
127670461|NCT01605136|459417322|FG001|Study Period|Lost to Follow-up|2|||
127670462|NCT01605136|459417321|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
127670463|NCT01605136|459417322|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
127670464|NCT01072929|459417323|FG000|Overall Study|Adverse Event|8|||
127670465|NCT01072929|459417324|FG001|Overall Study|Adverse Event|11|||
127670466|NCT01072929|459417325|FG002|Overall Study|Adverse Event|2|||
127670467|NCT01072929|459417323|FG000|Overall Study|Lack of Efficacy|7|||
127670468|NCT01072929|459417324|FG001|Overall Study|Lack of Efficacy|4|||
127670469|NCT01072929|459417325|FG002|Overall Study|Lack of Efficacy|0|||
127670470|NCT01072929|459417323|FG000|Overall Study|Withdrawal by Subject|7|||
127670471|NCT01072929|459417324|FG001|Overall Study|Withdrawal by Subject|15|||
127670472|NCT01072929|459417325|FG002|Overall Study|Withdrawal by Subject|3|||
127670473|NCT01072929|459417323|FG000|Overall Study|Protocol Violation|13|||
127670474|NCT01072929|459417324|FG001|Overall Study|Protocol Violation|11|||
127670475|NCT01072929|459417325|FG002|Overall Study|Protocol Violation|2|||
127670476|NCT01072929|459417323|FG000|Overall Study|Lost to Follow-up|8|||
127670477|NCT01072929|459417324|FG001|Overall Study|Lost to Follow-up|4|||
127670478|NCT01072929|459417325|FG002|Overall Study|Lost to Follow-up|1|||
127670479|NCT01072929|459417323|FG000|Overall Study|Noncompliance with study medication|0|||
128002982|NCT02900352|460639377|FG000|Overall Study|Lost to Follow-up|28|||
128002983|NCT02900352|460639378|FG001|Overall Study|Lost to Follow-up|17|||
128002984|NCT03074695|460639379|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
128002985|NCT03074695|460639380|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
128002986|NCT03074695|460639379|FG000|Overall Study|Research staff not available|1|||
128002987|NCT03074695|460639380|FG001|Overall Study|Research staff not available|2|||
128002988|NCT03074695|460639379|FG000|Overall Study|Did not receive neuraxial block|2|||
128002989|NCT03074695|460639380|FG001|Overall Study|Did not receive neuraxial block|2|||
128002990|NCT01232790|460639383|FG000|Randomization|Withdrawal by Subject|2|||
128002991|NCT01232790|460639384|FG001|Randomization|Withdrawal by Subject|0|||
128002992|NCT01232790|460639383|FG000|Randomization|Protocol Violation|0|||
128002993|NCT01232790|460639384|FG001|Randomization|Protocol Violation|1|||
128002994|NCT01232790|460639383|FG000|Randomization|Physician Decision|0|||
128002995|NCT01232790|460639384|FG001|Randomization|Physician Decision|1|||
128002996|NCT01232790|460639383|FG000|Initial Assessment|Withdrawal by Subject|0|||
128002997|NCT01232790|460639384|FG001|Initial Assessment|Withdrawal by Subject|1|||
128002998|NCT01232790|460639383|FG000|First Crossover|Withdrawal by Subject|1|||
128002999|NCT01232790|460639384|FG001|First Crossover|Withdrawal by Subject|0|||
128003000|NCT01232790|460639383|FG000|Second Crossover|Withdrawal by Subject|1|||
128003001|NCT01232790|460639384|FG001|Second Crossover|Withdrawal by Subject|2|||
128003002|NCT01239797|460639385|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
128003003|NCT01239797|460639386|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
128003004|NCT01239797|460639385|FG000|Randomized Participants|Participant withdrew consent|1|||
128003005|NCT01239797|460639386|FG001|Randomized Participants|Participant withdrew consent|7|||
128003006|NCT01239797|460639385|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
128003007|NCT01239797|460639386|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
128003008|NCT01239797|460639385|FG000|Treated Participants|Disease progression|185|||
128003009|NCT01239797|460639386|FG001|Treated Participants|Disease progression|185|||
128003010|NCT01239797|460639385|FG000|Treated Participants|Study drug toxicity|39|||
128003011|NCT01239797|460639386|FG001|Treated Participants|Study drug toxicity|45|||
128003012|NCT01239797|460639385|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
128003013|NCT01239797|460639386|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
128003014|NCT01239797|460639385|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
128003015|NCT01239797|460639386|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
128003016|NCT01239797|460639385|FG000|Treated Participants|Administrative reason by sponsor|13|||
128003017|NCT01239797|460639386|FG001|Treated Participants|Administrative reason by sponsor|4|||
128003018|NCT01239797|460639385|FG000|Treated Participants|Other reasons|14|||
128003019|NCT01239797|460639386|FG001|Treated Participants|Other reasons|14|||
128003020|NCT01239797|460639385|FG000|Treated Participants|Participant withdrew consent|6|||
128003021|NCT01239797|460639386|FG001|Treated Participants|Participant withdrew consent|11|||
128003022|NCT01239797|460639385|FG000|Treated Participants|Death|1|||
128003023|NCT01239797|460639386|FG001|Treated Participants|Death|1|||
127670480|NCT01072929|459417324|FG001|Overall Study|Noncompliance with study medication|3|||
127670481|NCT01072929|459417325|FG002|Overall Study|Noncompliance with study medication|0|||
127670482|NCT01072929|459417323|FG000|Overall Study|Noncompliance with study procedures|1|||
127670483|NCT01072929|459417324|FG001|Overall Study|Noncompliance with study procedures|0|||
127670484|NCT01072929|459417325|FG002|Overall Study|Noncompliance with study procedures|1|||
127670485|NCT01072929|459417323|FG000|Overall Study|Other|0|||
128003024|NCT01239797|460639385|FG000|Treated Participants|Participant no longer meets study criteria|1|||
128003025|NCT01239797|460639386|FG001|Treated Participants|Participant no longer meets study criteria|1|||
128003026|NCT01239797|460639385|FG000|Treated Participants|Poor/non-compliance|0|||
128003027|NCT01239797|460639386|FG001|Treated Participants|Poor/non-compliance|1|||
128003028|NCT02051296|460639390|FG000|Overall Study|Lost to Follow-up|1|||
128003029|NCT02051296|460639391|FG001|Overall Study|Lost to Follow-up|2|||
128003030|NCT02051296|460639390|FG000|Overall Study|withdraw prior to treatment|7|||
128003031|NCT02051296|460639391|FG001|Overall Study|withdraw prior to treatment|7|||
128003032|NCT02631941|460639392|FG000|Overall Study|Physician Decision|0|||
128003033|NCT02631941|460639393|FG001|Overall Study|Physician Decision|1|||
128003034|NCT02631941|460639394|FG002|Overall Study|Physician Decision|0|||
128003035|NCT02631941|460639395|FG003|Overall Study|Physician Decision|0|||
128003036|NCT02631941|460639396|FG004|Overall Study|Physician Decision|0|||
128003037|NCT02631941|460639397|FG005|Overall Study|Physician Decision|0|||
128003038|NCT02631941|460639398|FG006|Overall Study|Physician Decision|0|||
128003039|NCT02631941|460639399|FG007|Overall Study|Physician Decision|0|||
128003040|NCT02631941|460639400|FG008|Overall Study|Physician Decision|0|||
128003041|NCT02631941|460639401|FG009|Overall Study|Physician Decision|0|||
128003042|NCT02631941|460639392|FG000|Overall Study|Adverse Event|0|||
127670486|NCT01072929|459417324|FG001|Overall Study|Other|3|||
127670487|NCT01072929|459417325|FG002|Overall Study|Other|0|||
127670488|NCT00052962|459417328|FG000|Overall Study|Not evaluable|0|||
127670489|NCT00052962|459417329|FG001|Overall Study|Not evaluable|2|||
127670490|NCT00052962|459417328|FG000|Overall Study|Not randomized/not evaluable|1|||
127670491|NCT00052962|459417329|FG001|Overall Study|Not randomized/not evaluable|0|||
127670492|NCT01723774|459417332|FG000|Neoadjuvant|Ki67 > 10%|4|||
127670493|NCT01723774|459417333|FG001|Neoadjuvant|Ki67 > 10%|0|||
127670494|NCT01723774|459417334|FG002|Neoadjuvant|Ki67 > 10%|10|||
127670495|NCT01723774|459417335|FG003|Neoadjuvant|Ki67 > 10%|0|||
127670496|NCT01723774|459417332|FG000|Neoadjuvant|Withdrawal by Subject|3|||
127670497|NCT01723774|459417333|FG001|Neoadjuvant|Withdrawal by Subject|1|||
127670498|NCT01723774|459417334|FG002|Neoadjuvant|Withdrawal by Subject|0|||
127670499|NCT01723774|459417335|FG003|Neoadjuvant|Withdrawal by Subject|0|||
127670500|NCT01723774|459417332|FG000|Neoadjuvant|Disease progression|0|||
127670501|NCT01723774|459417333|FG001|Neoadjuvant|Disease progression|1|||
127670502|NCT01723774|459417334|FG002|Neoadjuvant|Disease progression|1|||
127670503|NCT01723774|459417335|FG003|Neoadjuvant|Disease progression|0|||
127670504|NCT01723774|459417332|FG000|Neoadjuvant|Adverse Event|0|||
127670505|NCT01723774|459417333|FG001|Neoadjuvant|Adverse Event|1|||
127670506|NCT01723774|459417334|FG002|Neoadjuvant|Adverse Event|2|||
127670507|NCT01723774|459417335|FG003|Neoadjuvant|Adverse Event|0|||
127670508|NCT01723774|459417332|FG000|Neoadjuvant|High estradiol|0|||
127670509|NCT01723774|459417333|FG001|Neoadjuvant|High estradiol|1|||
127670510|NCT01723774|459417334|FG002|Neoadjuvant|High estradiol|0|||
127670511|NCT01723774|459417335|FG003|Neoadjuvant|High estradiol|0|||
127670512|NCT02487446|459417341|FG000|Period 1|Physician Decision|0|||
127670513|NCT02487446|459417342|FG001|Period 1|Physician Decision|1|||
127670514|NCT02487446|459417341|FG000|Period 1|Lack of Efficacy|1|||
127670515|NCT02487446|459417342|FG001|Period 1|Lack of Efficacy|0|||
127670516|NCT02487446|459417341|FG000|Period 1|Protocol deviation|3|||
127670517|NCT02487446|459417342|FG001|Period 1|Protocol deviation|2|||
127670518|NCT02487446|459417341|FG000|Period 1|Lost to Follow-up|2|||
127670519|NCT02487446|459417342|FG001|Period 1|Lost to Follow-up|0|||
127670520|NCT02487446|459417341|FG000|Period 1|Withdrawal by Subject|2|||
127670521|NCT02487446|459417342|FG001|Period 1|Withdrawal by Subject|0|||
127670522|NCT02487446|459417341|FG000|Period 1|Adverse Event|5|||
127670523|NCT02487446|459417342|FG001|Period 1|Adverse Event|5|||
127670524|NCT02487446|459417341|FG000|Washout|Lost to Follow-up|0|||
127670525|NCT02487446|459417342|FG001|Washout|Lost to Follow-up|2|||
127670526|NCT02487446|459417341|FG000|Washout|Withdrawal by Subject|1|||
127670527|NCT02487446|459417342|FG001|Washout|Withdrawal by Subject|4|||
127670528|NCT02487446|459417341|FG000|Washout|Adverse Event|2|||
127670529|NCT02487446|459417342|FG001|Washout|Adverse Event|2|||
127670530|NCT02487446|459417341|FG000|Period 2|Protocol deviation|0|||
127670531|NCT02487446|459417342|FG001|Period 2|Protocol deviation|1|||
127670532|NCT02487446|459417341|FG000|Period 2|Lost to Follow-up|1|||
127670533|NCT02487446|459417342|FG001|Period 2|Lost to Follow-up|1|||
127670534|NCT02487446|459417341|FG000|Period 2|Withdrawal by Subject|1|||
127670535|NCT02487446|459417342|FG001|Period 2|Withdrawal by Subject|1|||
128003043|NCT02631941|460639393|FG001|Overall Study|Adverse Event|1|||
127670536|NCT02487446|459417341|FG000|Period 2|Adverse Event|6|||
128003044|NCT02631941|460639394|FG002|Overall Study|Adverse Event|0|||
128003045|NCT02631941|460639395|FG003|Overall Study|Adverse Event|0|||
127670537|NCT02487446|459417342|FG001|Period 2|Adverse Event|2|||
127670538|NCT01822821|459417343|FG000|Overall Study|Eligible surgery cancelled|1|||
127670539|NCT01822821|459417344|FG001|Overall Study|Eligible surgery cancelled|1|||
127670540|NCT01822821|459417343|FG000|Overall Study|Other reasons|1|||
127670541|NCT01822821|459417344|FG001|Overall Study|Other reasons|0|||
127670542|NCT05780047|459417345|FG000|Overall Study|Did not submit baseline urine test kit|226|||
127670543|NCT05780047|459417345|FG000|Overall Study|Lost to Follow-up|34|||
127670544|NCT05780047|459417345|FG000|Overall Study|Did not submit second urine test kit|124|||
127670545|NCT04438785|459417350|FG000|Overall Study|change of weight, give up intervention|2|||
127670546|NCT04438785|459417351|FG001|Overall Study|change of weight, give up intervention|10|||
127670547|NCT04011033|459417352|FG000|Overall Study|Physician Decision|2|||
127670548|NCT04011033|459417353|FG001|Overall Study|Physician Decision|3|||
127670549|NCT04011033|459417352|FG000|Overall Study|Withdrawal by Subject|1|||
127670550|NCT04011033|459417353|FG001|Overall Study|Withdrawal by Subject|0|||
127670551|NCT02027935|459417354|FG000|Overall Study|Death|1|||
127670552|NCT02027935|459417354|FG000|Overall Study|Lack of Efficacy|5|||
127670553|NCT02027935|459417354|FG000|Overall Study|Study Closure|1|||
127670554|NCT00689104|459417355|FG000|Overall Study|Eligibility criterion not met|5|||
127670555|NCT00689104|459417356|FG001|Overall Study|Eligibility criterion not met|8|||
127670556|NCT00689104|459417357|FG002|Overall Study|Eligibility criterion not met|0|||
127670557|NCT00689104|459417358|FG003|Overall Study|Eligibility criterion not met|4|||
127670558|NCT00689104|459417355|FG000|Overall Study|Adverse Event|13|||
127670559|NCT00689104|459417356|FG001|Overall Study|Adverse Event|25|||
127670560|NCT00689104|459417357|FG002|Overall Study|Adverse Event|16|||
127670561|NCT00689104|459417358|FG003|Overall Study|Adverse Event|24|||
127670562|NCT00689104|459417355|FG000|Overall Study|Lack of Efficacy|5|||
127670563|NCT00689104|459417356|FG001|Overall Study|Lack of Efficacy|6|||
127670564|NCT00689104|459417357|FG002|Overall Study|Lack of Efficacy|2|||
127670565|NCT00689104|459417358|FG003|Overall Study|Lack of Efficacy|3|||
127670566|NCT00689104|459417355|FG000|Overall Study|Withdrawal by Subject|12|||
127670567|NCT00689104|459417356|FG001|Overall Study|Withdrawal by Subject|11|||
127670568|NCT00689104|459417357|FG002|Overall Study|Withdrawal by Subject|18|||
127670569|NCT00689104|459417358|FG003|Overall Study|Withdrawal by Subject|11|||
127670570|NCT00689104|459417355|FG000|Overall Study|Lost to Follow-up|4|||
128003046|NCT02631941|460639396|FG004|Overall Study|Adverse Event|0|||
128003047|NCT02631941|460639397|FG005|Overall Study|Adverse Event|0|||
128003048|NCT02631941|460639398|FG006|Overall Study|Adverse Event|0|||
128003049|NCT02631941|460639399|FG007|Overall Study|Adverse Event|0|||
128003050|NCT02631941|460639400|FG008|Overall Study|Adverse Event|0|||
128003051|NCT02631941|460639401|FG009|Overall Study|Adverse Event|0|||
128003052|NCT02631941|460639392|FG000|Overall Study|Withdrawal by Subject|0|||
128003053|NCT02631941|460639393|FG001|Overall Study|Withdrawal by Subject|0|||
128003054|NCT02631941|460639394|FG002|Overall Study|Withdrawal by Subject|0|||
128003055|NCT02631941|460639395|FG003|Overall Study|Withdrawal by Subject|0|||
128003056|NCT02631941|460639396|FG004|Overall Study|Withdrawal by Subject|1|||
128003057|NCT02631941|460639397|FG005|Overall Study|Withdrawal by Subject|0|||
128003058|NCT02631941|460639398|FG006|Overall Study|Withdrawal by Subject|0|||
128003059|NCT02631941|460639399|FG007|Overall Study|Withdrawal by Subject|1|||
128003060|NCT02631941|460639400|FG008|Overall Study|Withdrawal by Subject|0|||
128003061|NCT02631941|460639401|FG009|Overall Study|Withdrawal by Subject|0|||
128003062|NCT02631941|460639392|FG000|Overall Study|Lost to Follow-up|0|||
128003063|NCT02631941|460639393|FG001|Overall Study|Lost to Follow-up|0|||
128003064|NCT02631941|460639394|FG002|Overall Study|Lost to Follow-up|0|||
128003065|NCT02631941|460639395|FG003|Overall Study|Lost to Follow-up|0|||
128003066|NCT02631941|460639396|FG004|Overall Study|Lost to Follow-up|0|||
128003067|NCT02631941|460639397|FG005|Overall Study|Lost to Follow-up|0|||
128003068|NCT02631941|460639398|FG006|Overall Study|Lost to Follow-up|0|||
128003069|NCT02631941|460639399|FG007|Overall Study|Lost to Follow-up|0|||
128003070|NCT02631941|460639400|FG008|Overall Study|Lost to Follow-up|1|||
128003071|NCT02631941|460639401|FG009|Overall Study|Lost to Follow-up|0|||
128003072|NCT01225549|460639402|FG000|Period 4 - Washout|Disallowed medication|0|||
128003073|NCT01225549|460639403|FG001|Period 4 - Washout|Disallowed medication|1|||
128003074|NCT01225549|460639404|FG002|Period 4 - Washout|Disallowed medication|0|||
128003075|NCT01225549|460639405|FG003|Period 4 - Washout|Disallowed medication|0|||
128003076|NCT01225549|460639406|FG004|Period 4 - Washout|Disallowed medication|0|||
128003077|NCT01225549|460639407|FG005|Period 4 - Washout|Disallowed medication|0|||
128003078|NCT01225549|460639408|FG006|Period 4 - Washout|Disallowed medication|0|||
128003079|NCT01225549|460639409|FG007|Period 4 - Washout|Disallowed medication|0|||
128003080|NCT01225549|460639410|FG008|Period 4 - Washout|Disallowed medication|0|||
128003081|NCT01225549|460639411|FG009|Period 4 - Washout|Disallowed medication|0|||
128003082|NCT01225549|460639402|FG000|Period 6 - Washout|Disallowed medication|0|||
128003083|NCT01225549|460639403|FG001|Period 6 - Washout|Disallowed medication|0|||
128003084|NCT01225549|460639404|FG002|Period 6 - Washout|Disallowed medication|0|||
127670571|NCT00689104|459417356|FG001|Overall Study|Lost to Follow-up|3|||
128003085|NCT01225549|460639405|FG003|Period 6 - Washout|Disallowed medication|1|||
128003086|NCT01225549|460639406|FG004|Period 6 - Washout|Disallowed medication|0|||
128003087|NCT01225549|460639407|FG005|Period 6 - Washout|Disallowed medication|0|||
128003088|NCT01225549|460639408|FG006|Period 6 - Washout|Disallowed medication|0|||
127670572|NCT00689104|459417357|FG002|Overall Study|Lost to Follow-up|2|||
127670573|NCT00689104|459417358|FG003|Overall Study|Lost to Follow-up|5|||
127670574|NCT00689104|459417355|FG000|Overall Study|Protocol Violation|2|||
127670575|NCT00689104|459417356|FG001|Overall Study|Protocol Violation|3|||
128003089|NCT01225549|460639409|FG007|Period 6 - Washout|Disallowed medication|0|||
128003090|NCT01225549|460639410|FG008|Period 6 - Washout|Disallowed medication|0|||
128003091|NCT01225549|460639411|FG009|Period 6 - Washout|Disallowed medication|0|||
127670576|NCT00689104|459417357|FG002|Overall Study|Protocol Violation|5|||
127670577|NCT00689104|459417358|FG003|Overall Study|Protocol Violation|3|||
127670578|NCT00689104|459417355|FG000|Overall Study|Randomized but never received study drug|2|||
127670579|NCT00689104|459417356|FG001|Overall Study|Randomized but never received study drug|1|||
127670580|NCT00689104|459417357|FG002|Overall Study|Randomized but never received study drug|1|||
127670581|NCT00689104|459417358|FG003|Overall Study|Randomized but never received study drug|0|||
127670582|NCT00689104|459417355|FG000|Overall Study|Physician Decision|1|||
127670583|NCT00689104|459417356|FG001|Overall Study|Physician Decision|0|||
127670584|NCT00689104|459417357|FG002|Overall Study|Physician Decision|0|||
127670585|NCT00689104|459417358|FG003|Overall Study|Physician Decision|0|||
127670586|NCT00689104|459417355|FG000|Overall Study|Non-compliance with study procedures|0|||
127670587|NCT00689104|459417356|FG001|Overall Study|Non-compliance with study procedures|0|||
127670588|NCT00689104|459417357|FG002|Overall Study|Non-compliance with study procedures|1|||
127670589|NCT00689104|459417358|FG003|Overall Study|Non-compliance with study procedures|0|||
127670590|NCT04873817|459417359|FG000|Overall Study|Subject and/or Family Request Withdrew Consent|3|||
127670591|NCT04873817|459417359|FG000|Overall Study|Lost to Follow-up|4|||
127670592|NCT04873817|459417359|FG000|Overall Study|Unsuccessful RFA Procedure|1|||
127670593|NCT04873817|459417359|FG000|Overall Study|Additional Chronic Pain Treatment for The Same Anatomical Region|8|||
127670594|NCT04873817|459417359|FG000|Overall Study|Other Reasons|3|||
127670595|NCT00665561|459417362|FG000|Overall Study|Death recorded on subject summary pages|75|||
127670596|NCT00665561|459417363|FG001|Overall Study|Death recorded on subject summary pages|75|||
127670597|NCT00665561|459417362|FG000|Overall Study|Does not meet entrance criteria|19|||
127670598|NCT00665561|459417363|FG001|Overall Study|Does not meet entrance criteria|21|||
127670599|NCT00665561|459417362|FG000|Overall Study|Lost to Follow-up|203|||
127670600|NCT00665561|459417363|FG001|Overall Study|Lost to Follow-up|264|||
127670601|NCT00665561|459417362|FG000|Overall Study|Withdrawal by Subject|74|||
127670602|NCT00665561|459417363|FG001|Overall Study|Withdrawal by Subject|65|||
127670603|NCT00665561|459417362|FG000|Overall Study|Other|123|||
127670604|NCT00665561|459417363|FG001|Overall Study|Other|108|||
127670605|NCT00665561|459417362|FG000|Overall Study|Site closed|8|||
127670606|NCT00665561|459417363|FG001|Overall Study|Site closed|0|||
127670607|NCT00665561|459417362|FG000|Overall Study|Withdrawn due to pregnancy|0|||
127670608|NCT00665561|459417363|FG001|Overall Study|Withdrawn due to pregnancy|1|||
127670609|NCT01394991|459417364|FG000|Overall Study|Adverse Event|0|||
127670610|NCT01394991|459417365|FG001|Overall Study|Adverse Event|4|||
127670611|NCT01394991|459417364|FG000|Overall Study|Lack of Efficacy|5|||
127670612|NCT01394991|459417365|FG001|Overall Study|Lack of Efficacy|7|||
127670613|NCT01394991|459417364|FG000|Overall Study|Lost to Follow-up|6|||
127670614|NCT01394991|459417365|FG001|Overall Study|Lost to Follow-up|8|||
127670615|NCT01394991|459417364|FG000|Overall Study|Physician Decision|1|||
127670616|NCT01394991|459417365|FG001|Overall Study|Physician Decision|3|||
127670617|NCT01394991|459417364|FG000|Overall Study|Protocol Violation|1|||
127670618|NCT01394991|459417365|FG001|Overall Study|Protocol Violation|1|||
127670619|NCT01394991|459417364|FG000|Overall Study|Withdrawal by Subject|20|||
127670620|NCT01394991|459417365|FG001|Overall Study|Withdrawal by Subject|17|||
127670621|NCT01394991|459417364|FG000|Overall Study|Chemotherapy Termination|10|||
127670622|NCT01394991|459417365|FG001|Overall Study|Chemotherapy Termination|15|||
127670623|NCT01394991|459417364|FG000|Overall Study|Disease Progression|7|||
127670624|NCT01394991|459417365|FG001|Overall Study|Disease Progression|7|||
127670625|NCT01394991|459417364|FG000|Overall Study|Prematurely Termination of Trial|9|||
127670626|NCT01394991|459417365|FG001|Overall Study|Prematurely Termination of Trial|10|||
127670627|NCT01734811|459417375|FG000|Overall Study|Lost to Follow-up|2|||
127670628|NCT01734811|459417376|FG001|Overall Study|Lost to Follow-up|3|||
127670629|NCT01734811|459417375|FG000|Overall Study|Withdrawal by Subject|2|||
127670630|NCT01734811|459417376|FG001|Overall Study|Withdrawal by Subject|0|||
127670631|NCT00062868|459417377|FG000|Dose Level 1|Death|2|||
127670632|NCT00062868|459417378|FG001|Dose Level 1|Death|0|||
127670633|NCT00062868|459417379|FG002|Dose Level 1|Death|0|||
127670634|NCT00062868|459417380|FG003|Dose Level 1|Death|2|||
127670635|NCT00062868|459417381|FG004|Dose Level 1|Death|0|||
127670636|NCT00062868|459417382|FG005|Dose Level 1|Death|0|||
127670637|NCT00062868|459417383|FG006|Dose Level 1|Death|3|||
127670638|NCT00062868|459417384|FG007|Dose Level 1|Death|0|||
127670639|NCT00062868|459417385|FG008|Dose Level 1|Death|0|||
127670640|NCT00062868|459417386|FG009|Dose Level 1|Death|0|||
127670641|NCT00062868|459417387|FG010|Dose Level 1|Death|0|||
127670642|NCT00062868|459417388|FG011|Dose Level 1|Death|0|||
127670643|NCT00062868|459417389|FG012|Dose Level 1|Death|0|||
127670644|NCT00062868|459417390|FG013|Dose Level 1|Death|0|||
127670645|NCT00062868|459417391|FG014|Dose Level 1|Death|0|||
127670646|NCT00062868|459417392|FG015|Dose Level 1|Death|0|||
127670647|NCT00062868|459417393|FG016|Dose Level 1|Death|0|||
127670648|NCT00062868|459417394|FG017|Dose Level 1|Death|0|||
127670649|NCT00062868|459417395|FG018|Dose Level 1|Death|7|||
127670650|NCT00062868|459417396|FG019|Dose Level 1|Death|0|||
127670651|NCT00062868|459417397|FG020|Dose Level 1|Death|1|||
127670652|NCT00062868|459417377|FG000|Dose Level 1|Lost to Follow-up|0|||
127670653|NCT00062868|459417378|FG001|Dose Level 1|Lost to Follow-up|0|||
127670654|NCT00062868|459417379|FG002|Dose Level 1|Lost to Follow-up|0|||
127670655|NCT00062868|459417380|FG003|Dose Level 1|Lost to Follow-up|0|||
127670656|NCT00062868|459417381|FG004|Dose Level 1|Lost to Follow-up|0|||
127670657|NCT00062868|459417382|FG005|Dose Level 1|Lost to Follow-up|0|||
127670658|NCT00062868|459417383|FG006|Dose Level 1|Lost to Follow-up|0|||
127670659|NCT00062868|459417384|FG007|Dose Level 1|Lost to Follow-up|0|||
127670660|NCT00062868|459417385|FG008|Dose Level 1|Lost to Follow-up|0|||
127670661|NCT00062868|459417386|FG009|Dose Level 1|Lost to Follow-up|0|||
127670662|NCT00062868|459417387|FG010|Dose Level 1|Lost to Follow-up|0|||
127670663|NCT00062868|459417388|FG011|Dose Level 1|Lost to Follow-up|0|||
127670664|NCT00062868|459417389|FG012|Dose Level 1|Lost to Follow-up|1|||
127670665|NCT00062868|459417390|FG013|Dose Level 1|Lost to Follow-up|0|||
127670666|NCT00062868|459417391|FG014|Dose Level 1|Lost to Follow-up|0|||
127670667|NCT00062868|459417392|FG015|Dose Level 1|Lost to Follow-up|0|||
128003092|NCT02858401|460639413|FG000|Overall Study|Withdrew Consent|0|||
128003093|NCT02858401|460639414|FG001|Overall Study|Withdrew Consent|0|||
127670668|NCT00062868|459417393|FG016|Dose Level 1|Lost to Follow-up|0|||
127670669|NCT00062868|459417394|FG017|Dose Level 1|Lost to Follow-up|0|||
127670670|NCT00062868|459417395|FG018|Dose Level 1|Lost to Follow-up|2|||
127670671|NCT00062868|459417396|FG019|Dose Level 1|Lost to Follow-up|0|||
127670672|NCT00062868|459417397|FG020|Dose Level 1|Lost to Follow-up|1|||
127670673|NCT00062868|459417377|FG000|Dose Level 2|Death|0|||
127670674|NCT00062868|459417378|FG001|Dose Level 2|Death|3|||
127670675|NCT00062868|459417379|FG002|Dose Level 2|Death|0|||
127670676|NCT00062868|459417380|FG003|Dose Level 2|Death|0|||
127670677|NCT00062868|459417381|FG004|Dose Level 2|Death|2|||
127670678|NCT00062868|459417382|FG005|Dose Level 2|Death|0|||
127670679|NCT00062868|459417383|FG006|Dose Level 2|Death|0|||
127670680|NCT00062868|459417384|FG007|Dose Level 2|Death|0|||
127670681|NCT00062868|459417385|FG008|Dose Level 2|Death|0|||
127670682|NCT00062868|459417386|FG009|Dose Level 2|Death|0|||
127670683|NCT00062868|459417387|FG010|Dose Level 2|Death|1|||
127670684|NCT00062868|459417388|FG011|Dose Level 2|Death|0|||
127670685|NCT00062868|459417389|FG012|Dose Level 2|Death|0|||
127670686|NCT00062868|459417390|FG013|Dose Level 2|Death|0|||
127670687|NCT00062868|459417391|FG014|Dose Level 2|Death|0|||
127670688|NCT00062868|459417392|FG015|Dose Level 2|Death|0|||
127670689|NCT00062868|459417393|FG016|Dose Level 2|Death|2|||
127670690|NCT00062868|459417394|FG017|Dose Level 2|Death|0|||
127670691|NCT00062868|459417395|FG018|Dose Level 2|Death|0|||
128003094|NCT02858401|460639415|FG002|Overall Study|Withdrew Consent|0|||
128003095|NCT02858401|460639416|FG003|Overall Study|Withdrew Consent|0|||
128003096|NCT02858401|460639417|FG004|Overall Study|Withdrew Consent|0|||
128003097|NCT02858401|460639418|FG005|Overall Study|Withdrew Consent|1|||
128003098|NCT02858401|460639419|FG006|Overall Study|Withdrew Consent|0|||
128003099|NCT02858401|460639413|FG000|Overall Study|Lost to Follow-up|0|||
128003100|NCT02858401|460639414|FG001|Overall Study|Lost to Follow-up|1|||
128003101|NCT02858401|460639415|FG002|Overall Study|Lost to Follow-up|0|||
128003102|NCT02858401|460639416|FG003|Overall Study|Lost to Follow-up|0|||
128003103|NCT02858401|460639417|FG004|Overall Study|Lost to Follow-up|0|||
128003104|NCT02858401|460639418|FG005|Overall Study|Lost to Follow-up|0|||
128003105|NCT02858401|460639419|FG006|Overall Study|Lost to Follow-up|0|||
128003106|NCT02513550|460639420|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
128003107|NCT02513550|460639421|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
128003108|NCT02513550|460639422|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
128003109|NCT02513550|460639423|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
128003110|NCT02513550|460639424|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
128003111|NCT02513550|460639425|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
128003112|NCT02513550|460639420|FG000|Double Blind Treatment Period|Adverse Event|5|||
128003113|NCT02513550|460639421|FG001|Double Blind Treatment Period|Adverse Event|13|||
128003114|NCT02513550|460639422|FG002|Double Blind Treatment Period|Adverse Event|17|||
128003115|NCT02513550|460639423|FG003|Double Blind Treatment Period|Adverse Event|0|||
128003116|NCT02513550|460639424|FG004|Double Blind Treatment Period|Adverse Event|1|||
127670692|NCT00062868|459417396|FG019|Dose Level 2|Death|0|||
127670693|NCT00062868|459417397|FG020|Dose Level 2|Death|0|||
127670694|NCT00062868|459417377|FG000|Dose Level 2|Lost to Follow-up|0|||
127670695|NCT00062868|459417378|FG001|Dose Level 2|Lost to Follow-up|0|||
127670696|NCT00062868|459417379|FG002|Dose Level 2|Lost to Follow-up|0|||
127670697|NCT00062868|459417380|FG003|Dose Level 2|Lost to Follow-up|0|||
127670698|NCT00062868|459417381|FG004|Dose Level 2|Lost to Follow-up|0|||
127670699|NCT00062868|459417382|FG005|Dose Level 2|Lost to Follow-up|0|||
127670700|NCT00062868|459417383|FG006|Dose Level 2|Lost to Follow-up|0|||
128003117|NCT02513550|460639425|FG005|Double Blind Treatment Period|Adverse Event|0|||
128003118|NCT02513550|460639420|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
127670701|NCT00062868|459417384|FG007|Dose Level 2|Lost to Follow-up|0|||
127670702|NCT00062868|459417385|FG008|Dose Level 2|Lost to Follow-up|0|||
127670703|NCT00062868|459417386|FG009|Dose Level 2|Lost to Follow-up|0|||
127670704|NCT00062868|459417387|FG010|Dose Level 2|Lost to Follow-up|0|||
127670705|NCT00062868|459417388|FG011|Dose Level 2|Lost to Follow-up|0|||
128003119|NCT02513550|460639421|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
127670706|NCT00062868|459417389|FG012|Dose Level 2|Lost to Follow-up|0|||
127670707|NCT00062868|459417390|FG013|Dose Level 2|Lost to Follow-up|1|||
127670708|NCT00062868|459417391|FG014|Dose Level 2|Lost to Follow-up|0|||
127670709|NCT00062868|459417392|FG015|Dose Level 2|Lost to Follow-up|0|||
127670710|NCT00062868|459417393|FG016|Dose Level 2|Lost to Follow-up|1|||
127670711|NCT00062868|459417394|FG017|Dose Level 2|Lost to Follow-up|0|||
127670712|NCT00062868|459417395|FG018|Dose Level 2|Lost to Follow-up|0|||
127670713|NCT00062868|459417396|FG019|Dose Level 2|Lost to Follow-up|0|||
127670714|NCT00062868|459417397|FG020|Dose Level 2|Lost to Follow-up|0|||
127670715|NCT00062868|459417377|FG000|Dose Level 3|Death|0|||
127670716|NCT00062868|459417378|FG001|Dose Level 3|Death|0|||
127670717|NCT00062868|459417379|FG002|Dose Level 3|Death|0|||
127670718|NCT00062868|459417380|FG003|Dose Level 3|Death|0|||
127670719|NCT00062868|459417381|FG004|Dose Level 3|Death|0|||
127670720|NCT00062868|459417382|FG005|Dose Level 3|Death|0|||
127670721|NCT00062868|459417383|FG006|Dose Level 3|Death|0|||
127670722|NCT00062868|459417384|FG007|Dose Level 3|Death|0|||
127670723|NCT00062868|459417385|FG008|Dose Level 3|Death|0|||
127670724|NCT00062868|459417386|FG009|Dose Level 3|Death|0|||
127670725|NCT00062868|459417387|FG010|Dose Level 3|Death|0|||
127670726|NCT00062868|459417388|FG011|Dose Level 3|Death|1|||
127670727|NCT00062868|459417389|FG012|Dose Level 3|Death|0|||
127670728|NCT00062868|459417390|FG013|Dose Level 3|Death|0|||
127670729|NCT00062868|459417391|FG014|Dose Level 3|Death|0|||
127670730|NCT00062868|459417392|FG015|Dose Level 3|Death|0|||
127670731|NCT00062868|459417393|FG016|Dose Level 3|Death|0|||
127670732|NCT00062868|459417394|FG017|Dose Level 3|Death|1|||
127670733|NCT00062868|459417395|FG018|Dose Level 3|Death|0|||
127670734|NCT00062868|459417396|FG019|Dose Level 3|Death|0|||
127670735|NCT00062868|459417397|FG020|Dose Level 3|Death|0|||
127670736|NCT00062868|459417377|FG000|Dose Level 3|Lost to Follow-up|0|||
127670737|NCT00062868|459417378|FG001|Dose Level 3|Lost to Follow-up|0|||
127670738|NCT00062868|459417379|FG002|Dose Level 3|Lost to Follow-up|0|||
127670739|NCT00062868|459417380|FG003|Dose Level 3|Lost to Follow-up|0|||
127670740|NCT00062868|459417381|FG004|Dose Level 3|Lost to Follow-up|0|||
127670741|NCT00062868|459417382|FG005|Dose Level 3|Lost to Follow-up|0|||
127670742|NCT00062868|459417383|FG006|Dose Level 3|Lost to Follow-up|0|||
127670743|NCT00062868|459417384|FG007|Dose Level 3|Lost to Follow-up|0|||
127670744|NCT00062868|459417385|FG008|Dose Level 3|Lost to Follow-up|0|||
127670745|NCT00062868|459417386|FG009|Dose Level 3|Lost to Follow-up|0|||
127670746|NCT00062868|459417387|FG010|Dose Level 3|Lost to Follow-up|0|||
127670747|NCT00062868|459417388|FG011|Dose Level 3|Lost to Follow-up|0|||
127670748|NCT00062868|459417389|FG012|Dose Level 3|Lost to Follow-up|0|||
127670749|NCT00062868|459417390|FG013|Dose Level 3|Lost to Follow-up|0|||
127670750|NCT00062868|459417391|FG014|Dose Level 3|Lost to Follow-up|1|||
127670751|NCT00062868|459417392|FG015|Dose Level 3|Lost to Follow-up|0|||
127670752|NCT00062868|459417393|FG016|Dose Level 3|Lost to Follow-up|0|||
127670753|NCT00062868|459417394|FG017|Dose Level 3|Lost to Follow-up|0|||
127670754|NCT00062868|459417395|FG018|Dose Level 3|Lost to Follow-up|0|||
127670755|NCT00062868|459417396|FG019|Dose Level 3|Lost to Follow-up|0|||
127670756|NCT00062868|459417397|FG020|Dose Level 3|Lost to Follow-up|0|||
127670757|NCT00062868|459417377|FG000|Dose Level 3|Withdrew|0|||
127670758|NCT00062868|459417378|FG001|Dose Level 3|Withdrew|0|||
127670759|NCT00062868|459417379|FG002|Dose Level 3|Withdrew|2|||
127670760|NCT00062868|459417380|FG003|Dose Level 3|Withdrew|0|||
127670761|NCT00062868|459417381|FG004|Dose Level 3|Withdrew|0|||
127670762|NCT00062868|459417382|FG005|Dose Level 3|Withdrew|0|||
127670763|NCT00062868|459417383|FG006|Dose Level 3|Withdrew|0|||
127670764|NCT00062868|459417384|FG007|Dose Level 3|Withdrew|0|||
127670765|NCT00062868|459417385|FG008|Dose Level 3|Withdrew|0|||
127670766|NCT00062868|459417386|FG009|Dose Level 3|Withdrew|0|||
127670767|NCT00062868|459417387|FG010|Dose Level 3|Withdrew|0|||
127670768|NCT00062868|459417388|FG011|Dose Level 3|Withdrew|0|||
127670769|NCT00062868|459417389|FG012|Dose Level 3|Withdrew|0|||
127670770|NCT00062868|459417390|FG013|Dose Level 3|Withdrew|0|||
127670771|NCT00062868|459417391|FG014|Dose Level 3|Withdrew|0|||
127670772|NCT00062868|459417392|FG015|Dose Level 3|Withdrew|0|||
127670773|NCT00062868|459417393|FG016|Dose Level 3|Withdrew|0|||
127670774|NCT00062868|459417394|FG017|Dose Level 3|Withdrew|0|||
127670775|NCT00062868|459417395|FG018|Dose Level 3|Withdrew|0|||
127670776|NCT00062868|459417396|FG019|Dose Level 3|Withdrew|0|||
127670777|NCT00062868|459417397|FG020|Dose Level 3|Withdrew|0|||
127670778|NCT00725010|459417400|FG000|Overall Study|Toxicity|9|||
127670779|NCT00725010|459417400|FG000|Overall Study|Tumor Progression|7|||
127670780|NCT00725010|459417400|FG000|Overall Study|Withdrawal by Subject|2|||
127670781|NCT00725010|459417400|FG000|Overall Study|Death|1|||
127670782|NCT00725010|459417400|FG000|Overall Study|Lost to Follow-up|1|||
127670783|NCT00725010|459417400|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
127670784|NCT00725010|459417400|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
127670785|NCT00725010|459417400|FG000|Overall Study|No further documentation|1|||
127670786|NCT00725010|459417400|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
127670787|NCT02414828|459417401|FG000|Overall Study|Lost to Follow-up|0|||
127670788|NCT02414828|459417402|FG001|Overall Study|Lost to Follow-up|1|||
127670789|NCT02414828|459417403|FG002|Overall Study|Lost to Follow-up|1|||
127670790|NCT02414828|459417404|FG003|Overall Study|Lost to Follow-up|2|||
127670791|NCT04949399|459417409|FG000|Overall Study|Lost to Follow-up|11|||
127670792|NCT04949399|459417410|FG001|Overall Study|Lost to Follow-up|6|||
127670793|NCT04949399|459417409|FG000|Overall Study|Withdrawal by Subject|2|||
127670794|NCT04949399|459417410|FG001|Overall Study|Withdrawal by Subject|3|||
127670795|NCT00814489|459417436|FG000|Overall Study|Other|2|||
127670796|NCT00814489|459417437|FG001|Overall Study|Other|0|||
127670797|NCT00814489|459417438|FG002|Overall Study|Other|1|||
127670798|NCT01866917|459417445|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
127670799|NCT01866917|459417446|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
127670800|NCT01712685|459417447|FG000|Overall Study|pt declined to participate before trmt|1|||
127670801|NCT00662909|459417452|FG000|Overall Study|Adverse Event|17|||
127670802|NCT00662909|459417453|FG001|Overall Study|Adverse Event|18|||
127670803|NCT00662909|459417454|FG002|Overall Study|Adverse Event|19|||
127670804|NCT00662909|459417452|FG000|Overall Study|Lack of Efficacy|9|||
127670805|NCT00662909|459417453|FG001|Overall Study|Lack of Efficacy|1|||
127670806|NCT00662909|459417454|FG002|Overall Study|Lack of Efficacy|5|||
127670807|NCT00662909|459417452|FG000|Overall Study|Withdrawal by Subject|29|||
127670808|NCT00662909|459417453|FG001|Overall Study|Withdrawal by Subject|22|||
128003120|NCT02513550|460639422|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
128003121|NCT02513550|460639423|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
127670809|NCT00662909|459417454|FG002|Overall Study|Withdrawal by Subject|16|||
127670810|NCT00662909|459417452|FG000|Overall Study|Lost to Follow-up|2|||
127670811|NCT00662909|459417453|FG001|Overall Study|Lost to Follow-up|9|||
127670812|NCT00662909|459417454|FG002|Overall Study|Lost to Follow-up|3|||
127670813|NCT00662909|459417452|FG000|Overall Study|Protocol Violation|7|||
127670814|NCT00662909|459417453|FG001|Overall Study|Protocol Violation|4|||
127670815|NCT00662909|459417454|FG002|Overall Study|Protocol Violation|5|||
127670816|NCT00662909|459417452|FG000|Overall Study|Randomized- never received study drug|1|||
127670817|NCT00662909|459417453|FG001|Overall Study|Randomized- never received study drug|0|||
127670818|NCT00662909|459417454|FG002|Overall Study|Randomized- never received study drug|0|||
127670819|NCT00662909|459417452|FG000|Overall Study|Non-compliance with study procedures|3|||
127670820|NCT00662909|459417453|FG001|Overall Study|Non-compliance with study procedures|3|||
127670821|NCT00662909|459417454|FG002|Overall Study|Non-compliance with study procedures|2|||
127670822|NCT00662909|459417452|FG000|Overall Study|Physician Decision|1|||
127670823|NCT00662909|459417453|FG001|Overall Study|Physician Decision|1|||
127670824|NCT00662909|459417454|FG002|Overall Study|Physician Decision|2|||
127670825|NCT00662909|459417452|FG000|Overall Study|Eligibility criterion not met|0|||
128003122|NCT02513550|460639424|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
128003123|NCT02513550|460639425|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
128003124|NCT02513550|460639420|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
128003125|NCT02513550|460639421|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
128003126|NCT02513550|460639422|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
128003127|NCT02513550|460639423|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
128003128|NCT02513550|460639424|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
128003129|NCT02513550|460639425|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
128003130|NCT02513550|460639420|FG000|Double Blind Treatment Period|Protocol Violation|1|||
128003131|NCT02513550|460639421|FG001|Double Blind Treatment Period|Protocol Violation|1|||
128003132|NCT02513550|460639422|FG002|Double Blind Treatment Period|Protocol Violation|4|||
128003133|NCT02513550|460639423|FG003|Double Blind Treatment Period|Protocol Violation|0|||
128003134|NCT02513550|460639424|FG004|Double Blind Treatment Period|Protocol Violation|0|||
128003135|NCT02513550|460639425|FG005|Double Blind Treatment Period|Protocol Violation|0|||
128003136|NCT02513550|460639420|FG000|Double Blind Treatment Period|Physician Decision|2|||
128003137|NCT02513550|460639421|FG001|Double Blind Treatment Period|Physician Decision|0|||
127670826|NCT00662909|459417453|FG001|Overall Study|Eligibility criterion not met|1|||
127670827|NCT00662909|459417454|FG002|Overall Study|Eligibility criterion not met|1|||
127670828|NCT04610684|459419499|FG000|Study Treatment|Withdrawal by Subject|1|||
127670829|NCT04610684|459419499|FG000|Study Treatment|Disease Progression|2|||
127670830|NCT04610684|459419499|FG000|Follow up|Death|2|||
127670831|NCT04610684|459419499|FG000|Follow up|Withdrawal by Subject|1|||
127670832|NCT04978363|459419503|FG000|Overall Study|Other medical issues unrelated to the study|0|||
127670833|NCT04978363|459419504|FG001|Overall Study|Other medical issues unrelated to the study|0|||
127670834|NCT04978363|459419505|FG002|Overall Study|Other medical issues unrelated to the study|0|||
127670835|NCT04978363|459419506|FG003|Overall Study|Other medical issues unrelated to the study|0|||
127670836|NCT04978363|459419507|FG004|Overall Study|Other medical issues unrelated to the study|1|||
127670837|NCT04978363|459419508|FG005|Overall Study|Other medical issues unrelated to the study|0|||
127670838|NCT04978363|459419509|FG006|Overall Study|Other medical issues unrelated to the study|0|||
127670839|NCT04978363|459419510|FG007|Overall Study|Other medical issues unrelated to the study|0|||
128003138|NCT02513550|460639422|FG002|Double Blind Treatment Period|Physician Decision|4|||
128003139|NCT02513550|460639423|FG003|Double Blind Treatment Period|Physician Decision|0|||
128003140|NCT02513550|460639424|FG004|Double Blind Treatment Period|Physician Decision|0|||
128003141|NCT02513550|460639425|FG005|Double Blind Treatment Period|Physician Decision|0|||
128003142|NCT02513550|460639420|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
128003143|NCT02513550|460639421|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
128003144|NCT02513550|460639422|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
128003145|NCT02513550|460639423|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
128003146|NCT02513550|460639424|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
128003147|NCT02513550|460639425|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
128003148|NCT02513550|460639420|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
128003149|NCT02513550|460639421|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
128003150|NCT02513550|460639422|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
128003151|NCT02513550|460639423|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
128003152|NCT02513550|460639424|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
128003153|NCT02513550|460639425|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
128003154|NCT02513550|460639420|FG000|Double Blind Treatment Period|Due to personal business|2|||
128003155|NCT02513550|460639421|FG001|Double Blind Treatment Period|Due to personal business|0|||
128003156|NCT02513550|460639422|FG002|Double Blind Treatment Period|Due to personal business|1|||
128003157|NCT02513550|460639423|FG003|Double Blind Treatment Period|Due to personal business|0|||
128003158|NCT02513550|460639424|FG004|Double Blind Treatment Period|Due to personal business|0|||
128003159|NCT02513550|460639425|FG005|Double Blind Treatment Period|Due to personal business|0|||
128003160|NCT02513550|460639420|FG000|Double Blind Treatment Period|Death|1|||
128003161|NCT02513550|460639421|FG001|Double Blind Treatment Period|Death|0|||
128003162|NCT02513550|460639422|FG002|Double Blind Treatment Period|Death|2|||
128003163|NCT02513550|460639423|FG003|Double Blind Treatment Period|Death|0|||
128003164|NCT02513550|460639424|FG004|Double Blind Treatment Period|Death|0|||
128003165|NCT02513550|460639425|FG005|Double Blind Treatment Period|Death|0|||
128003166|NCT02513550|460639420|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
128003167|NCT02513550|460639421|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
128003168|NCT02513550|460639422|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
128003169|NCT02513550|460639423|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
128003170|NCT02513550|460639424|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
128003171|NCT02513550|460639425|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
128003172|NCT02513550|460639420|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
128003173|NCT02513550|460639421|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
128003174|NCT02513550|460639422|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
128003175|NCT02513550|460639423|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
128003176|NCT02513550|460639424|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
128003177|NCT02513550|460639425|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
128003178|NCT02513550|460639420|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
127670840|NCT04978363|459419511|FG008|Overall Study|Other medical issues unrelated to the study|0|||
127670841|NCT04978363|459419512|FG009|Overall Study|Other medical issues unrelated to the study|0|||
127670842|NCT04978363|459419513|FG010|Overall Study|Other medical issues unrelated to the study|0|||
127670843|NCT04978363|459419503|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
127670844|NCT04978363|459419504|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
127670845|NCT04978363|459419505|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
127670846|NCT04978363|459419506|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
127670847|NCT04978363|459419507|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
127670848|NCT04978363|459419508|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
127670849|NCT04978363|459419509|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
127670850|NCT04978363|459419510|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
127670851|NCT04978363|459419511|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
127670852|NCT04978363|459419512|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
127670853|NCT04978363|459419513|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
127670854|NCT04978363|459419503|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
127670855|NCT04978363|459419504|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
127670856|NCT04978363|459419505|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
127670857|NCT04978363|459419506|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
127670858|NCT04978363|459419507|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
127670859|NCT04978363|459419508|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
127670860|NCT04978363|459419509|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
127670861|NCT04978363|459419510|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
127670862|NCT04978363|459419511|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
127670863|NCT04978363|459419512|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
127670864|NCT04978363|459419513|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
127670865|NCT01251614|459419514|FG000|Overall Study|Adverse Event|1|||
127670866|NCT01251614|459419515|FG001|Overall Study|Adverse Event|0|||
127670867|NCT01251614|459419516|FG002|Overall Study|Adverse Event|1|||
127670868|NCT01251614|459419514|FG000|Overall Study|Lack of Efficacy|1|||
127670869|NCT01251614|459419515|FG001|Overall Study|Lack of Efficacy|9|||
127670870|NCT01251614|459419516|FG002|Overall Study|Lack of Efficacy|4|||
127670871|NCT01251614|459419514|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
127670872|NCT01251614|459419515|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
127670873|NCT01251614|459419516|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
127670874|NCT01251614|459419514|FG000|Overall Study|Pregnancy|0|||
127670875|NCT01251614|459419515|FG001|Overall Study|Pregnancy|0|||
127670876|NCT01251614|459419516|FG002|Overall Study|Pregnancy|2|||
128003179|NCT02513550|460639421|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
128003180|NCT02513550|460639422|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
128003181|NCT02513550|460639423|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
128003182|NCT02513550|460639424|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
128003183|NCT02513550|460639425|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
127670877|NCT01251614|459419514|FG000|Overall Study|Loss of Disease Control|0|||
127670878|NCT01251614|459419515|FG001|Overall Study|Loss of Disease Control|1|||
127670879|NCT01251614|459419516|FG002|Overall Study|Loss of Disease Control|0|||
127670880|NCT01251614|459419514|FG000|Overall Study|Withdrawal by Subject|0|||
127670881|NCT01251614|459419515|FG001|Overall Study|Withdrawal by Subject|2|||
127670882|NCT01251614|459419516|FG002|Overall Study|Withdrawal by Subject|1|||
127670883|NCT01251614|459419514|FG000|Overall Study|Lost to Follow-up|0|||
127670884|NCT01251614|459419515|FG001|Overall Study|Lost to Follow-up|1|||
127670885|NCT01251614|459419516|FG002|Overall Study|Lost to Follow-up|0|||
127670886|NCT02153788|459419517|FG000|Overall Study|Physician Decision|2|||
127670887|NCT02153788|459419518|FG001|Overall Study|Physician Decision|1|||
127670888|NCT04672460|459419519|FG000|Bioequivalence Phase: Period 1 (28 Days)|Death|1|||
127670889|NCT04672460|459419520|FG001|Bioequivalence Phase: Period 1 (28 Days)|Death|2|||
127670890|NCT04672460|459419519|FG000|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|2|||
127670891|NCT04672460|459419520|FG001|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|4|||
127670892|NCT04672460|459419519|FG000|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|0|||
127670893|NCT04672460|459419520|FG001|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|3|||
127670894|NCT04672460|459419519|FG000|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|0|||
128003184|NCT02513550|460639420|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
128003185|NCT02513550|460639421|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
128003186|NCT02513550|460639422|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
128003187|NCT02513550|460639423|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
128003188|NCT02513550|460639424|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
128003189|NCT02513550|460639425|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
128003190|NCT02513550|460639420|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
128003191|NCT02513550|460639421|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
128003192|NCT02513550|460639422|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
128003193|NCT02513550|460639423|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
128003194|NCT02513550|460639424|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
128003195|NCT02513550|460639425|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
128003196|NCT02513550|460639420|FG000|Post-Treatment Follow-up Period|Death|0|||
128003197|NCT02513550|460639421|FG001|Post-Treatment Follow-up Period|Death|0|||
128003198|NCT02513550|460639422|FG002|Post-Treatment Follow-up Period|Death|1|||
128003199|NCT02513550|460639423|FG003|Post-Treatment Follow-up Period|Death|0|||
128003200|NCT02513550|460639424|FG004|Post-Treatment Follow-up Period|Death|0|||
128003201|NCT02513550|460639425|FG005|Post-Treatment Follow-up Period|Death|0|||
128003202|NCT02513550|460639420|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
128003203|NCT02513550|460639421|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
128003204|NCT02513550|460639422|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
127670895|NCT04672460|459419520|FG001|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|1|||
127670896|NCT04672460|459419519|FG000|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|3|||
127670897|NCT04672460|459419520|FG001|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|0|||
127670898|NCT04672460|459419519|FG000|Bioequivalence Phase: Period 1 (28 Days)|Other|1|||
127670899|NCT04672460|459419520|FG001|Bioequivalence Phase: Period 1 (28 Days)|Other|0|||
127670900|NCT04672460|459419519|FG000|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|1|||
127670901|NCT04672460|459419520|FG001|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|5|||
127670902|NCT04672460|459419519|FG000|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|1|||
128003205|NCT02513550|460639423|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
127670903|NCT04672460|459419520|FG001|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|0|||
127670904|NCT04672460|459419519|FG000|Food Effect Phase: Period 3 (21 Days)|Adverse Event|1|||
127670905|NCT04672460|459419520|FG001|Food Effect Phase: Period 3 (21 Days)|Adverse Event|0|||
127670906|NCT04672460|459419519|FG000|Food Effect Phase: Period 3 (21 Days)|Progressive disease|3|||
127670907|NCT04672460|459419520|FG001|Food Effect Phase: Period 3 (21 Days)|Progressive disease|1|||
128003206|NCT02513550|460639424|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
127670908|NCT04672460|459419519|FG000|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|0|||
127670909|NCT04672460|459419520|FG001|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|1|||
127670910|NCT04672460|459419519|FG000|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|0|||
127670911|NCT04672460|459419520|FG001|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|1|||
127670912|NCT04672460|459419519|FG000|Food Effect Phase: Period 3 (21 Days)|Other|1|||
127670913|NCT04672460|459419520|FG001|Food Effect Phase: Period 3 (21 Days)|Other|0|||
127670914|NCT04672460|459419519|FG000|Maintenance Phase: Period 4 (28 Days)|Adverse Event|1|||
127670915|NCT04672460|459419520|FG001|Maintenance Phase: Period 4 (28 Days)|Adverse Event|0|||
127670916|NCT04672460|459419519|FG000|Maintenance Phase: Period 4 (28 Days)|Progressive disease|10|||
127670917|NCT04672460|459419520|FG001|Maintenance Phase: Period 4 (28 Days)|Progressive disease|12|||
127670918|NCT04672460|459419519|FG000|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|1|||
127670919|NCT04672460|459419520|FG001|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|0|||
127670920|NCT04672460|459419519|FG000|Maintenance Phase: Period 4 (28 Days)|Other|9|||
127670921|NCT04672460|459419520|FG001|Maintenance Phase: Period 4 (28 Days)|Other|8|||
127670922|NCT00049517|459419524|FG000|Induction|Disease progression|0|||
127670923|NCT00049517|459419525|FG001|Induction|Disease progression|0|||
127670924|NCT00049517|459419526|FG002|Induction|Disease progression|0|||
127670925|NCT00049517|459419527|FG003|Induction|Disease progression|0|||
127670926|NCT00049517|459419528|FG004|Induction|Disease progression|18|||
127670927|NCT00049517|459419529|FG005|Induction|Disease progression|11|||
127670928|NCT00049517|459419524|FG000|Induction|Adverse Event|0|||
127670929|NCT00049517|459419525|FG001|Induction|Adverse Event|0|||
127670930|NCT00049517|459419526|FG002|Induction|Adverse Event|0|||
127670931|NCT00049517|459419527|FG003|Induction|Adverse Event|0|||
127670932|NCT00049517|459419528|FG004|Induction|Adverse Event|5|||
127670933|NCT00049517|459419529|FG005|Induction|Adverse Event|7|||
127670934|NCT00049517|459419524|FG000|Induction|Death|0|||
127670935|NCT00049517|459419525|FG001|Induction|Death|0|||
127670936|NCT00049517|459419526|FG002|Induction|Death|0|||
127670937|NCT00049517|459419527|FG003|Induction|Death|0|||
127670938|NCT00049517|459419528|FG004|Induction|Death|9|||
127670939|NCT00049517|459419529|FG005|Induction|Death|6|||
127670940|NCT00049517|459419524|FG000|Induction|Withdrawal by Subject|0|||
127670941|NCT00049517|459419525|FG001|Induction|Withdrawal by Subject|0|||
127670942|NCT00049517|459419526|FG002|Induction|Withdrawal by Subject|0|||
127670943|NCT00049517|459419527|FG003|Induction|Withdrawal by Subject|0|||
127670944|NCT00049517|459419528|FG004|Induction|Withdrawal by Subject|1|||
127670945|NCT00049517|459419529|FG005|Induction|Withdrawal by Subject|3|||
127670946|NCT00049517|459419524|FG000|Induction|Alternative therapy|0|||
127670947|NCT00049517|459419525|FG001|Induction|Alternative therapy|0|||
127670948|NCT00049517|459419526|FG002|Induction|Alternative therapy|0|||
127670949|NCT00049517|459419527|FG003|Induction|Alternative therapy|0|||
127670950|NCT00049517|459419528|FG004|Induction|Alternative therapy|2|||
127670951|NCT00049517|459419529|FG005|Induction|Alternative therapy|2|||
127670952|NCT00049517|459419524|FG000|Induction|Other complicating disease|0|||
127670953|NCT00049517|459419525|FG001|Induction|Other complicating disease|0|||
127670954|NCT00049517|459419526|FG002|Induction|Other complicating disease|0|||
127670955|NCT00049517|459419527|FG003|Induction|Other complicating disease|0|||
127670956|NCT00049517|459419528|FG004|Induction|Other complicating disease|3|||
127670957|NCT00049517|459419529|FG005|Induction|Other complicating disease|0|||
127670958|NCT00049517|459419524|FG000|Induction|Reasons not reported|0|||
127670959|NCT00049517|459419525|FG001|Induction|Reasons not reported|0|||
127670960|NCT00049517|459419526|FG002|Induction|Reasons not reported|0|||
127670961|NCT00049517|459419527|FG003|Induction|Reasons not reported|0|||
127670962|NCT00049517|459419528|FG004|Induction|Reasons not reported|22|||
127670963|NCT00049517|459419529|FG005|Induction|Reasons not reported|25|||
128003207|NCT02513550|460639425|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
128003208|NCT02513550|460639420|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
128003209|NCT02513550|460639421|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
128003210|NCT02513550|460639422|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
128003211|NCT02513550|460639423|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
128003212|NCT02513550|460639424|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
128003213|NCT02513550|460639425|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
128003214|NCT02513550|460639420|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
128003215|NCT02513550|460639421|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
128003216|NCT02513550|460639422|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
128003217|NCT02513550|460639423|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
128003218|NCT02513550|460639424|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
128003219|NCT02513550|460639425|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
127670964|NCT00049517|459419524|FG000|Conditioning/Transplant|Disease progression|14|||
127670965|NCT00049517|459419525|FG001|Conditioning/Transplant|Disease progression|6|||
127670966|NCT00049517|459419526|FG002|Conditioning/Transplant|Disease progression|10|||
127670967|NCT00049517|459419527|FG003|Conditioning/Transplant|Disease progression|6|||
127670968|NCT00049517|459419528|FG004|Conditioning/Transplant|Disease progression|0|||
128003220|NCT02204917|460639430|FG000|Overall Study|Protocol Violation|1|||
128003221|NCT03834493|460639438|FG000|Overall Study|Participants Ongoing|311|||
128003222|NCT03834493|460639439|FG001|Overall Study|Participants Ongoing|324|||
128003223|NCT03834493|460639438|FG000|Overall Study|Withdrawal by Subject|20|||
128003224|NCT03834493|460639439|FG001|Overall Study|Withdrawal by Subject|17|||
128003225|NCT03834493|460639438|FG000|Overall Study|Physician Decision|1|||
128003226|NCT03834493|460639439|FG001|Overall Study|Physician Decision|0|||
128003227|NCT03834493|460639438|FG000|Overall Study|Death|289|||
128003228|NCT03834493|460639439|FG001|Overall Study|Death|282|||
128003229|NCT03829462|460639443|FG000|Overall Study|No tumoral evaluation due to progression disease|6|||
128003230|NCT03829462|460639444|FG001|Overall Study|No tumoral evaluation due to progression disease|3|||
128003231|NCT03829462|460639443|FG000|Overall Study|No treatment due to progression disease|0|||
128003232|NCT03829462|460639444|FG001|Overall Study|No treatment due to progression disease|1|||
128003233|NCT02718911|460639446|FG000|Overall Study|Adverse Event|0|||
128003234|NCT02718911|460639447|FG001|Overall Study|Adverse Event|0|||
128003235|NCT02718911|460639448|FG002|Overall Study|Adverse Event|0|||
128003236|NCT02718911|460639449|FG003|Overall Study|Adverse Event|0|||
128003237|NCT02718911|460639450|FG004|Overall Study|Adverse Event|0|||
128003238|NCT02718911|460639451|FG005|Overall Study|Adverse Event|0|||
128003239|NCT02718911|460639452|FG006|Overall Study|Adverse Event|0|||
128003240|NCT02718911|460639453|FG007|Overall Study|Adverse Event|0|||
127670969|NCT00049517|459419529|FG005|Conditioning/Transplant|Disease progression|0|||
127670970|NCT00049517|459419524|FG000|Conditioning/Transplant|Adverse Event|2|||
127670971|NCT00049517|459419525|FG001|Conditioning/Transplant|Adverse Event|1|||
127670972|NCT00049517|459419526|FG002|Conditioning/Transplant|Adverse Event|4|||
127670973|NCT00049517|459419527|FG003|Conditioning/Transplant|Adverse Event|8|||
127670974|NCT00049517|459419528|FG004|Conditioning/Transplant|Adverse Event|0|||
127670975|NCT00049517|459419529|FG005|Conditioning/Transplant|Adverse Event|0|||
127670976|NCT00049517|459419524|FG000|Conditioning/Transplant|Death|1|||
127670977|NCT00049517|459419525|FG001|Conditioning/Transplant|Death|0|||
127670978|NCT00049517|459419526|FG002|Conditioning/Transplant|Death|0|||
127670979|NCT00049517|459419527|FG003|Conditioning/Transplant|Death|2|||
127670980|NCT00049517|459419528|FG004|Conditioning/Transplant|Death|0|||
127670981|NCT00049517|459419529|FG005|Conditioning/Transplant|Death|0|||
127670982|NCT00049517|459419524|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
127670983|NCT00049517|459419525|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
127670984|NCT00049517|459419526|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
127670985|NCT00049517|459419527|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
127670986|NCT00049517|459419528|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
127670987|NCT00049517|459419529|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
127670988|NCT00049517|459419524|FG000|Conditioning/Transplant|Alternative therapy|4|||
127670989|NCT00049517|459419525|FG001|Conditioning/Transplant|Alternative therapy|4|||
127670990|NCT00049517|459419526|FG002|Conditioning/Transplant|Alternative therapy|2|||
127670991|NCT00049517|459419527|FG003|Conditioning/Transplant|Alternative therapy|1|||
127670992|NCT00049517|459419528|FG004|Conditioning/Transplant|Alternative therapy|1|||
127670993|NCT00049517|459419529|FG005|Conditioning/Transplant|Alternative therapy|0|||
127670994|NCT00049517|459419524|FG000|Conditioning/Transplant|Other complicating disease|2|||
127670995|NCT00049517|459419525|FG001|Conditioning/Transplant|Other complicating disease|0|||
127670996|NCT00049517|459419526|FG002|Conditioning/Transplant|Other complicating disease|0|||
127670997|NCT00049517|459419527|FG003|Conditioning/Transplant|Other complicating disease|4|||
127670998|NCT00049517|459419528|FG004|Conditioning/Transplant|Other complicating disease|0|||
127670999|NCT00049517|459419529|FG005|Conditioning/Transplant|Other complicating disease|1|||
127671000|NCT00049517|459419524|FG000|Conditioning/Transplant|Reasons not reported|25|||
127671001|NCT00049517|459419525|FG001|Conditioning/Transplant|Reasons not reported|31|||
127671002|NCT00049517|459419526|FG002|Conditioning/Transplant|Reasons not reported|18|||
127671003|NCT00049517|459419527|FG003|Conditioning/Transplant|Reasons not reported|15|||
127671004|NCT00049517|459419528|FG004|Conditioning/Transplant|Reasons not reported|5|||
127671005|NCT00049517|459419529|FG005|Conditioning/Transplant|Reasons not reported|5|||
127671006|NCT01684046|459419532|FG000|Period 1, First 30 Days|Adverse Event|0|||
127671007|NCT01684046|459419533|FG001|Period 1, First 30 Days|Adverse Event|2|||
127671008|NCT02790606|459419544|FG000|Overall Study|Death|27|||
127671009|NCT02790606|459419544|FG000|Overall Study|Lost to Follow-up|4|||
127671010|NCT02790606|459419544|FG000|Overall Study|Physician Decision|3|||
128003241|NCT02718911|460639454|FG008|Overall Study|Adverse Event|0|||
128003242|NCT02718911|460639455|FG009|Overall Study|Adverse Event|2|||
127671011|NCT02790606|459419544|FG000|Overall Study|Withdrawal by Subject|1|||
127671012|NCT02735915|459419545|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
127671013|NCT02735915|459419545|FG000|Overall Study|Withdrawal following SAE|2|||
127671014|NCT02735915|459419545|FG000|Overall Study|Withdrawal by Subject|1|||
127671015|NCT05328973|459419546|FG000|Overall Study|Withdrawal by Subject|0|||
128003243|NCT02718911|460639446|FG000|Overall Study|Death|2|||
128003244|NCT02718911|460639447|FG001|Overall Study|Death|3|||
128003245|NCT02718911|460639448|FG002|Overall Study|Death|1|||
128003246|NCT02718911|460639449|FG003|Overall Study|Death|0|||
128003247|NCT02718911|460639450|FG004|Overall Study|Death|1|||
127671016|NCT05328973|459419547|FG001|Overall Study|Withdrawal by Subject|1|||
127671017|NCT00946114|459419548|FG000|Overall Study|Death|5|||
127671018|NCT00946114|459419549|FG001|Overall Study|Death|2|||
127671019|NCT00946114|459419548|FG000|Overall Study|Other|1|||
127671020|NCT00946114|459419549|FG001|Overall Study|Other|0|||
127671021|NCT00946114|459419548|FG000|Overall Study|Withdrawal by Subject|2|||
127671022|NCT00946114|459419549|FG001|Overall Study|Withdrawal by Subject|0|||
127671023|NCT01764386|459419551|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
127671024|NCT01764386|459419552|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
127671025|NCT01764386|459419551|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
127671026|NCT01764386|459419552|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
127671027|NCT01764386|459419551|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
127671028|NCT01764386|459419552|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
127671029|NCT01764386|459419551|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
127671030|NCT01764386|459419552|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
127671031|NCT01764386|459419551|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
127671032|NCT01764386|459419552|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
127671033|NCT01764386|459419551|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
127671034|NCT01764386|459419552|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
127671035|NCT01764386|459419551|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
127671036|NCT01764386|459419552|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
127671037|NCT01764386|459419551|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
127671038|NCT01764386|459419552|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
127671039|NCT03929302|459419553|FG000|Intervention - myTAP Mouth Shield|Withdrawal by Subject|5|||
127671040|NCT03929302|459419554|FG001|Intervention - myTAP Mouth Shield|Withdrawal by Subject|8|||
127671041|NCT03929302|459419555|FG002|Intervention - myTAP Mouth Shield|Withdrawal by Subject|4|||
127671042|NCT03929302|459419553|FG000|Intervention - myTAP Mouth Shield|Time constraints|3|||
127671043|NCT03929302|459419554|FG001|Intervention - myTAP Mouth Shield|Time constraints|0|||
127671044|NCT03929302|459419555|FG002|Intervention - myTAP Mouth Shield|Time constraints|0|||
127671045|NCT03929302|459419553|FG000|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
127671046|NCT03929302|459419554|FG001|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
127671047|NCT03929302|459419555|FG002|Intervention - myTAP Mouth Shield|Device didnot fit|1|||
127671048|NCT01123161|459419556|FG000|Overall Study|Lost to Follow-up|1|||
127671049|NCT01123161|459419557|FG001|Overall Study|Lost to Follow-up|0|||
127671050|NCT01123161|459419556|FG000|Overall Study|Withdrawal by Subject|1|||
127671051|NCT01123161|459419557|FG001|Overall Study|Withdrawal by Subject|0|||
127671052|NCT02757885|459419558|FG000|Overall Study|Screen Failures|4|||
127671053|NCT01360840|459419565|FG000|Overall Study|Ongoing at data cut-off|10|||
127671054|NCT01360840|459419566|FG001|Overall Study|Ongoing at data cut-off|10|||
127671055|NCT01360840|459419567|FG002|Overall Study|Ongoing at data cut-off|9|||
127671056|NCT00463151|459419569|FG000|Overall Study|Adverse Event|0|||
127671057|NCT00463151|459419570|FG001|Overall Study|Adverse Event|0|||
127671058|NCT00463151|459419571|FG002|Overall Study|Adverse Event|1|||
127671059|NCT00463151|459419572|FG003|Overall Study|Adverse Event|0|||
127671060|NCT00463151|459419569|FG000|Overall Study|Lack of Efficacy|2|||
127671061|NCT00463151|459419570|FG001|Overall Study|Lack of Efficacy|5|||
127671062|NCT00463151|459419571|FG002|Overall Study|Lack of Efficacy|2|||
127671063|NCT00463151|459419572|FG003|Overall Study|Lack of Efficacy|5|||
127671064|NCT00463151|459419569|FG000|Overall Study|Protocol Violation|0|||
127671065|NCT00463151|459419570|FG001|Overall Study|Protocol Violation|0|||
127671066|NCT00463151|459419571|FG002|Overall Study|Protocol Violation|0|||
127671067|NCT00463151|459419572|FG003|Overall Study|Protocol Violation|1|||
127671068|NCT00463151|459419569|FG000|Overall Study|Withdrawal by Subject|0|||
127671069|NCT00463151|459419570|FG001|Overall Study|Withdrawal by Subject|0|||
127671070|NCT00463151|459419571|FG002|Overall Study|Withdrawal by Subject|0|||
127671071|NCT00463151|459419572|FG003|Overall Study|Withdrawal by Subject|1|||
127671072|NCT00293462|459419573|FG000|Overall Study|Withdrawal by Subject|4|||
127671073|NCT00293462|459419574|FG001|Overall Study|Withdrawal by Subject|3|||
127671074|NCT00293462|459419575|FG002|Overall Study|Withdrawal by Subject|8|||
127671075|NCT00293462|459419573|FG000|Overall Study|Death|1|||
127671076|NCT00293462|459419574|FG001|Overall Study|Death|0|||
127671077|NCT00293462|459419575|FG002|Overall Study|Death|0|||
127671078|NCT00293462|459419573|FG000|Overall Study|Lost to Follow-up|0|||
127671079|NCT00293462|459419574|FG001|Overall Study|Lost to Follow-up|1|||
127671080|NCT00293462|459419575|FG002|Overall Study|Lost to Follow-up|0|||
127671081|NCT00293462|459419573|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
127671082|NCT00293462|459419574|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
127671083|NCT00293462|459419575|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
127671084|NCT00293462|459419573|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
127671085|NCT00293462|459419574|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
127671086|NCT00293462|459419575|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
127671087|NCT00293462|459419573|FG000|Overall Study|Refuse Radiation Treatment|1|||
128003248|NCT02718911|460639451|FG005|Overall Study|Death|3|||
128003249|NCT02718911|460639452|FG006|Overall Study|Death|1|||
128003250|NCT02718911|460639453|FG007|Overall Study|Death|1|||
128003251|NCT02718911|460639454|FG008|Overall Study|Death|4|||
128003252|NCT02718911|460639455|FG009|Overall Study|Death|3|||
128003253|NCT02718911|460639446|FG000|Overall Study|Lost to Follow-up|0|||
127671088|NCT00293462|459419574|FG001|Overall Study|Refuse Radiation Treatment|0|||
127671089|NCT00293462|459419575|FG002|Overall Study|Refuse Radiation Treatment|0|||
127671090|NCT00293462|459419573|FG000|Overall Study|No Show|0|||
127671091|NCT00293462|459419574|FG001|Overall Study|No Show|0|||
127671092|NCT00293462|459419575|FG002|Overall Study|No Show|1|||
127671093|NCT00293462|459419573|FG000|Overall Study|Went back to his home country|0|||
127671094|NCT00293462|459419574|FG001|Overall Study|Went back to his home country|0|||
127671095|NCT00293462|459419575|FG002|Overall Study|Went back to his home country|1|||
127671096|NCT00293462|459419573|FG000|Overall Study|Blood clot after chemotherapy|0|||
127671097|NCT00293462|459419574|FG001|Overall Study|Blood clot after chemotherapy|0|||
127671098|NCT00293462|459419575|FG002|Overall Study|Blood clot after chemotherapy|1|||
127671099|NCT00293462|459419573|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
127671100|NCT00293462|459419574|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
127671101|NCT00293462|459419575|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
127671102|NCT00293462|459419573|FG000|Overall Study|Possible Tracheostomy leakage|0|||
127671103|NCT00293462|459419574|FG001|Overall Study|Possible Tracheostomy leakage|1|||
127671104|NCT00293462|459419575|FG002|Overall Study|Possible Tracheostomy leakage|0|||
127671105|NCT00293462|459419573|FG000|Overall Study|Low radiation dose in oral cavity|0|||
127671106|NCT00293462|459419574|FG001|Overall Study|Low radiation dose in oral cavity|1|||
127671107|NCT00293462|459419575|FG002|Overall Study|Low radiation dose in oral cavity|0|||
127671108|NCT00293462|459419573|FG000|Overall Study|Physician Decision|0|||
127671109|NCT00293462|459419574|FG001|Overall Study|Physician Decision|1|||
127671110|NCT00293462|459419575|FG002|Overall Study|Physician Decision|0|||
127671111|NCT00688688|459419576|FG000|Overall Study|Eligibility criterion not met|7|||
127671112|NCT00688688|459419577|FG001|Overall Study|Eligibility criterion not met|7|||
127671113|NCT00688688|459419578|FG002|Overall Study|Eligibility criterion not met|10|||
127671114|NCT00688688|459419576|FG000|Overall Study|Adverse Event|52|||
127671115|NCT00688688|459419577|FG001|Overall Study|Adverse Event|51|||
127671116|NCT00688688|459419578|FG002|Overall Study|Adverse Event|50|||
127671117|NCT00688688|459419576|FG000|Overall Study|Lack of Efficacy|34|||
127671118|NCT00688688|459419577|FG001|Overall Study|Lack of Efficacy|25|||
127671119|NCT00688688|459419578|FG002|Overall Study|Lack of Efficacy|45|||
127671120|NCT00688688|459419576|FG000|Overall Study|Withdrawal by Subject|66|||
127671121|NCT00688688|459419577|FG001|Overall Study|Withdrawal by Subject|75|||
127671122|NCT00688688|459419578|FG002|Overall Study|Withdrawal by Subject|65|||
127671123|NCT00688688|459419576|FG000|Overall Study|Lost to Follow-up|14|||
127671124|NCT00688688|459419577|FG001|Overall Study|Lost to Follow-up|7|||
127671125|NCT00688688|459419578|FG002|Overall Study|Lost to Follow-up|7|||
127671126|NCT00688688|459419576|FG000|Overall Study|Protocol Violation|6|||
127671127|NCT00688688|459419577|FG001|Overall Study|Protocol Violation|9|||
127671128|NCT00688688|459419578|FG002|Overall Study|Protocol Violation|11|||
127671129|NCT00688688|459419576|FG000|Overall Study|Randomized but never received study drug|1|||
127671130|NCT00688688|459419577|FG001|Overall Study|Randomized but never received study drug|0|||
127671131|NCT00688688|459419578|FG002|Overall Study|Randomized but never received study drug|0|||
127671132|NCT00688688|459419576|FG000|Overall Study|Non-compliance with study procedures|5|||
127671133|NCT00688688|459419577|FG001|Overall Study|Non-compliance with study procedures|3|||
127671134|NCT00688688|459419578|FG002|Overall Study|Non-compliance with study procedures|4|||
127671135|NCT00688688|459419576|FG000|Overall Study|Taking exclusionary medications|1|||
127671136|NCT00688688|459419577|FG001|Overall Study|Taking exclusionary medications|0|||
127671137|NCT00688688|459419578|FG002|Overall Study|Taking exclusionary medications|0|||
127671138|NCT00688688|459419576|FG000|Overall Study|Site closure|0|||
127671139|NCT00688688|459419577|FG001|Overall Study|Site closure|1|||
127671140|NCT00688688|459419578|FG002|Overall Study|Site closure|0|||
127671141|NCT00688688|459419576|FG000|Overall Study|Violation of exclusion criterion|0|||
127671142|NCT00688688|459419577|FG001|Overall Study|Violation of exclusion criterion|1|||
127671143|NCT00688688|459419578|FG002|Overall Study|Violation of exclusion criterion|0|||
127671144|NCT03283553|459419581|FG000|Patient Participant Flow|Death|5|||
127671145|NCT03283553|459419582|FG001|Patient Participant Flow|Death|10|||
127671146|NCT03283553|459419581|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
127671147|NCT03283553|459419582|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
127671148|NCT03283553|459419581|FG000|Patient Participant Flow|Lost to Follow-up|1|||
127671149|NCT03283553|459419582|FG001|Patient Participant Flow|Lost to Follow-up|1|||
127671150|NCT03283553|459419581|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
127671151|NCT03283553|459419582|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
127671152|NCT03283553|459419581|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
127671153|NCT03283553|459419582|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
128003254|NCT02718911|460639447|FG001|Overall Study|Lost to Follow-up|0|||
128003255|NCT02718911|460639448|FG002|Overall Study|Lost to Follow-up|0|||
128003256|NCT02718911|460639449|FG003|Overall Study|Lost to Follow-up|0|||
127671154|NCT03283553|459419581|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
127671155|NCT03283553|459419582|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
127671156|NCT03686683|459419583|FG000|Overall Study|Withdrawal by Subject|52|||
127671157|NCT03686683|459419584|FG001|Overall Study|Withdrawal by Subject|32|||
127671158|NCT03686683|459419583|FG000|Overall Study|Lost to Follow-up|23|||
127671159|NCT03686683|459419584|FG001|Overall Study|Lost to Follow-up|19|||
127671160|NCT03686683|459419583|FG000|Overall Study|Adverse Event|1|||
127671161|NCT03686683|459419584|FG001|Overall Study|Adverse Event|0|||
127671162|NCT03686683|459419583|FG000|Overall Study|Death|10|||
127671163|NCT03686683|459419584|FG001|Overall Study|Death|5|||
127671164|NCT03686683|459419583|FG000|Overall Study|Progressive Disease|1|||
127671165|NCT03686683|459419584|FG001|Overall Study|Progressive Disease|1|||
127671166|NCT03686683|459419583|FG000|Overall Study|Noncompliance|1|||
127671167|NCT03686683|459419584|FG001|Overall Study|Noncompliance|0|||
127671168|NCT03686683|459419583|FG000|Overall Study|Physician Decision|1|||
127671169|NCT03686683|459419584|FG001|Overall Study|Physician Decision|1|||
127671170|NCT03686683|459419583|FG000|Overall Study|Screen fail post-randomization|1|||
127671171|NCT03686683|459419584|FG001|Overall Study|Screen fail post-randomization|0|||
127671172|NCT03686683|459419583|FG000|Overall Study|Protocol Violation|3|||
127671173|NCT03686683|459419584|FG001|Overall Study|Protocol Violation|0|||
127671174|NCT03686683|459419583|FG000|Overall Study|No data available|1|||
127671175|NCT03686683|459419584|FG001|Overall Study|No data available|0|||
127671176|NCT03255941|459419585|FG000|Overall Study|Not eligible or refused injection|37|||
127671177|NCT03255941|459419586|FG001|Overall Study|Not eligible or refused injection|44|||
127671178|NCT03255941|459419587|FG002|Overall Study|Not eligible or refused injection|5|||
127671179|NCT03255941|459419588|FG003|Overall Study|Not eligible or refused injection|6|||
127671180|NCT03255941|459419585|FG000|Overall Study|Did not complete exit interview|1|||
127671181|NCT03255941|459419586|FG001|Overall Study|Did not complete exit interview|2|||
127671182|NCT03255941|459419587|FG002|Overall Study|Did not complete exit interview|0|||
127671183|NCT03255941|459419588|FG003|Overall Study|Did not complete exit interview|0|||
127671184|NCT00372060|459419589|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
127671185|NCT00372060|459419590|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
127671186|NCT00372060|459419589|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
127671187|NCT00372060|459419590|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
127671188|NCT00372060|459419589|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
127671189|NCT00372060|459419590|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
127671190|NCT00372060|459419589|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
127671191|NCT00372060|459419590|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
127671192|NCT00372060|459419589|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
127671193|NCT00372060|459419590|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
127671194|NCT00372060|459419589|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
127671195|NCT00372060|459419590|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
127671196|NCT01579578|459419591|FG000|Overall Study|Death|4|||
127671197|NCT01579578|459419592|FG001|Overall Study|Death|1|||
127671198|NCT01579578|459419591|FG000|Overall Study|Lost to Follow-up|1|||
127671199|NCT01579578|459419592|FG001|Overall Study|Lost to Follow-up|1|||
127671200|NCT01579578|459419591|FG000|Overall Study|Withdrawal by Subject|2|||
127671201|NCT01579578|459419592|FG001|Overall Study|Withdrawal by Subject|1|||
127671202|NCT01579578|459419591|FG000|Overall Study|Eligibility criteria|3|||
127671203|NCT01579578|459419592|FG001|Overall Study|Eligibility criteria|9|||
127671204|NCT01579578|459419591|FG000|Overall Study|Ongoing|3|||
128003257|NCT02718911|460639450|FG004|Overall Study|Lost to Follow-up|0|||
128003258|NCT02718911|460639451|FG005|Overall Study|Lost to Follow-up|0|||
127671205|NCT01579578|459419592|FG001|Overall Study|Ongoing|0|||
127671206|NCT01528709|459419593|FG000|Overall Study|Death|2|||
127671207|NCT01528709|459419594|FG001|Overall Study|Death|0|||
128003259|NCT02718911|460639452|FG006|Overall Study|Lost to Follow-up|0|||
128003260|NCT02718911|460639453|FG007|Overall Study|Lost to Follow-up|0|||
128003261|NCT02718911|460639454|FG008|Overall Study|Lost to Follow-up|1|||
128003262|NCT02718911|460639455|FG009|Overall Study|Lost to Follow-up|0|||
128003263|NCT02718911|460639446|FG000|Overall Study|Physician Decision|2|||
127671208|NCT01528709|459419593|FG000|Overall Study|Withdrawal by Subject|10|||
127671209|NCT01528709|459419594|FG001|Overall Study|Withdrawal by Subject|15|||
127671210|NCT01528709|459419593|FG000|Overall Study|allergy|1|||
127671211|NCT01528709|459419594|FG001|Overall Study|allergy|0|||
127671212|NCT05124899|459419598|FG000|Overall Study|Lost to Follow-up|3|||
127671213|NCT01417000|459419606|FG000|Overall Study|Death|59|||
127671214|NCT01417000|459419607|FG001|Overall Study|Death|28|||
127671215|NCT01417000|459419606|FG000|Overall Study|Lost to Follow-up|1|||
127671216|NCT01417000|459419607|FG001|Overall Study|Lost to Follow-up|0|||
127671217|NCT01417000|459419606|FG000|Overall Study|Study Terminated by Sponsor|1|||
127671218|NCT01417000|459419607|FG001|Overall Study|Study Terminated by Sponsor|1|||
127671219|NCT00647348|459419608|FG000|Overall Study|Lost to Follow-up|3|||
127671220|NCT00647348|459419609|FG001|Overall Study|Lost to Follow-up|6|||
128003264|NCT02718911|460639447|FG001|Overall Study|Physician Decision|0|||
128003265|NCT02718911|460639448|FG002|Overall Study|Physician Decision|1|||
127671221|NCT02397889|459419616|FG000|Overall Study|Physician Decision|1|||
127671222|NCT02397889|459419617|FG001|Overall Study|Physician Decision|0|||
127671223|NCT00797225|459419622|FG000|Weeks 1 to 12|Adverse Event|0|||
127671224|NCT00797225|459419623|FG001|Weeks 1 to 12|Adverse Event|0|||
127671225|NCT00797225|459419624|FG002|Weeks 1 to 12|Adverse Event|1|||
127671226|NCT00797225|459419625|FG003|Weeks 1 to 12|Adverse Event|0|||
127671227|NCT00797225|459419626|FG004|Weeks 1 to 12|Adverse Event|0|||
127671228|NCT00797225|459419627|FG005|Weeks 1 to 12|Adverse Event|0|||
127671229|NCT00797225|459419628|FG006|Weeks 1 to 12|Adverse Event|0|||
127671230|NCT00797225|459419629|FG007|Weeks 1 to 12|Adverse Event|0|||
127671231|NCT00797225|459419622|FG000|Weeks 1 to 12|Non-compliance|0|||
127671232|NCT00797225|459419623|FG001|Weeks 1 to 12|Non-compliance|1|||
127671233|NCT00797225|459419624|FG002|Weeks 1 to 12|Non-compliance|0|||
127671234|NCT00797225|459419625|FG003|Weeks 1 to 12|Non-compliance|0|||
127671235|NCT00797225|459419626|FG004|Weeks 1 to 12|Non-compliance|0|||
127671236|NCT00797225|459419627|FG005|Weeks 1 to 12|Non-compliance|0|||
127671237|NCT00797225|459419628|FG006|Weeks 1 to 12|Non-compliance|0|||
127671238|NCT00797225|459419629|FG007|Weeks 1 to 12|Non-compliance|0|||
127671239|NCT00797225|459419622|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
127671240|NCT00797225|459419623|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
127671241|NCT00797225|459419624|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
127671242|NCT00797225|459419625|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
127671243|NCT00797225|459419626|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
127671244|NCT00797225|459419627|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
127671245|NCT00797225|459419628|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
127671246|NCT00797225|459419629|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
127671247|NCT00797225|459419622|FG000|Weeks 1 to 12|Sponsor Decision|1|||
127671248|NCT00797225|459419623|FG001|Weeks 1 to 12|Sponsor Decision|0|||
127671249|NCT00797225|459419624|FG002|Weeks 1 to 12|Sponsor Decision|0|||
127671250|NCT00797225|459419625|FG003|Weeks 1 to 12|Sponsor Decision|0|||
127671251|NCT00797225|459419626|FG004|Weeks 1 to 12|Sponsor Decision|0|||
127671252|NCT00797225|459419627|FG005|Weeks 1 to 12|Sponsor Decision|0|||
127671253|NCT00797225|459419628|FG006|Weeks 1 to 12|Sponsor Decision|0|||
127671254|NCT00797225|459419629|FG007|Weeks 1 to 12|Sponsor Decision|0|||
127671255|NCT00797225|459419622|FG000|Weeks 13 to 24|Non-compliance|0|||
127671256|NCT00797225|459419623|FG001|Weeks 13 to 24|Non-compliance|2|||
127671257|NCT00797225|459419624|FG002|Weeks 13 to 24|Non-compliance|0|||
127671258|NCT00797225|459419625|FG003|Weeks 13 to 24|Non-compliance|0|||
127671259|NCT00797225|459419626|FG004|Weeks 13 to 24|Non-compliance|0|||
127671260|NCT00797225|459419627|FG005|Weeks 13 to 24|Non-compliance|0|||
127671261|NCT00797225|459419628|FG006|Weeks 13 to 24|Non-compliance|0|||
127671262|NCT00797225|459419629|FG007|Weeks 13 to 24|Non-compliance|0|||
127671263|NCT00797225|459419622|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
127671264|NCT00797225|459419623|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
127671265|NCT00797225|459419624|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
127671266|NCT00797225|459419625|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
127671267|NCT00797225|459419626|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
127671268|NCT00797225|459419627|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
127671269|NCT00797225|459419628|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
127671270|NCT00797225|459419629|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
127671271|NCT00797225|459419622|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
127671272|NCT00797225|459419623|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
127671273|NCT00797225|459419624|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
127671274|NCT00797225|459419625|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
127671275|NCT00797225|459419626|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
127671276|NCT00797225|459419627|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
127671277|NCT00797225|459419628|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
127671278|NCT00797225|459419629|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
127671279|NCT00797225|459419622|FG000|Weeks 13 to 24|Adverse Event|0|||
127671280|NCT00797225|459419623|FG001|Weeks 13 to 24|Adverse Event|1|||
127671281|NCT00797225|459419624|FG002|Weeks 13 to 24|Adverse Event|0|||
127671282|NCT00797225|459419625|FG003|Weeks 13 to 24|Adverse Event|0|||
127671283|NCT00797225|459419626|FG004|Weeks 13 to 24|Adverse Event|0|||
127671284|NCT00797225|459419627|FG005|Weeks 13 to 24|Adverse Event|0|||
127671285|NCT00797225|459419628|FG006|Weeks 13 to 24|Adverse Event|1|||
127671286|NCT00797225|459419629|FG007|Weeks 13 to 24|Adverse Event|0|||
127671287|NCT00797225|459419622|FG000|Weeks 13 to 24|Sponsor Decision|0|||
127671288|NCT00797225|459419623|FG001|Weeks 13 to 24|Sponsor Decision|0|||
127671289|NCT00797225|459419624|FG002|Weeks 13 to 24|Sponsor Decision|0|||
127671290|NCT00797225|459419625|FG003|Weeks 13 to 24|Sponsor Decision|0|||
127671291|NCT00797225|459419626|FG004|Weeks 13 to 24|Sponsor Decision|0|||
127671292|NCT00797225|459419627|FG005|Weeks 13 to 24|Sponsor Decision|0|||
127671293|NCT00797225|459419628|FG006|Weeks 13 to 24|Sponsor Decision|1|||
127671294|NCT00797225|459419629|FG007|Weeks 13 to 24|Sponsor Decision|0|||
127671295|NCT01352507|459419632|FG000|Treatment Period 1|Adverse Event|3|||
127671296|NCT01352507|459419633|FG001|Treatment Period 1|Adverse Event|0|||
127671297|NCT01352507|459419632|FG000|Treatment Period 1|Lost to Follow-up|3|||
127671298|NCT01352507|459419633|FG001|Treatment Period 1|Lost to Follow-up|4|||
127671299|NCT01352507|459419632|FG000|Treatment Period 1|Withdrawal by Subject|7|||
127671300|NCT01352507|459419633|FG001|Treatment Period 1|Withdrawal by Subject|5|||
128003266|NCT02718911|460639449|FG003|Overall Study|Physician Decision|1|||
128003267|NCT02718911|460639450|FG004|Overall Study|Physician Decision|0|||
128003268|NCT02718911|460639451|FG005|Overall Study|Physician Decision|0|||
128003269|NCT02718911|460639452|FG006|Overall Study|Physician Decision|0|||
128003270|NCT02718911|460639453|FG007|Overall Study|Physician Decision|1|||
128003271|NCT02718911|460639454|FG008|Overall Study|Physician Decision|2|||
128003272|NCT02718911|460639455|FG009|Overall Study|Physician Decision|1|||
128003273|NCT02718911|460639446|FG000|Overall Study|Withdrawal by Subject|0|||
128003274|NCT02718911|460639447|FG001|Overall Study|Withdrawal by Subject|0|||
128003275|NCT02718911|460639448|FG002|Overall Study|Withdrawal by Subject|0|||
128003276|NCT02718911|460639449|FG003|Overall Study|Withdrawal by Subject|0|||
128003277|NCT02718911|460639450|FG004|Overall Study|Withdrawal by Subject|1|||
128003278|NCT02718911|460639451|FG005|Overall Study|Withdrawal by Subject|0|||
128003279|NCT02718911|460639452|FG006|Overall Study|Withdrawal by Subject|0|||
128003280|NCT02718911|460639453|FG007|Overall Study|Withdrawal by Subject|0|||
128003281|NCT02718911|460639454|FG008|Overall Study|Withdrawal by Subject|1|||
128003282|NCT02718911|460639455|FG009|Overall Study|Withdrawal by Subject|4|||
128003283|NCT02718911|460639446|FG000|Overall Study|Reason Not Collected|0|||
127671301|NCT01352507|459419632|FG000|Treatment Period 1|Physician Decision|1|||
127671302|NCT01352507|459419633|FG001|Treatment Period 1|Physician Decision|0|||
127671303|NCT01352507|459419632|FG000|Washout Period|Withdrawal by Subject|0|||
127671304|NCT01352507|459419633|FG001|Washout Period|Withdrawal by Subject|1|||
127671305|NCT01352507|459419632|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
127671306|NCT01352507|459419633|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
127671307|NCT01352507|459419632|FG000|Treatment Period 2|Withdrawal by Subject|4|||
127671308|NCT01352507|459419633|FG001|Treatment Period 2|Withdrawal by Subject|3|||
127671309|NCT01352507|459419632|FG000|Treatment Period 2|Lack of Efficacy|1|||
127671310|NCT01352507|459419633|FG001|Treatment Period 2|Lack of Efficacy|0|||
127671311|NCT02096003|459419634|FG000|Overall Study|Protocol Violation|0|||
127671312|NCT02096003|459419635|FG001|Overall Study|Protocol Violation|2|||
127671313|NCT02096003|459419634|FG000|Overall Study|additional surgery|2|||
127671314|NCT02096003|459419635|FG001|Overall Study|additional surgery|1|||
127671315|NCT01511250|459419636|FG000|Overall Study|Withdrawal of Consent|1|||
127671316|NCT01511250|459419637|FG001|Overall Study|Withdrawal of Consent|0|||
127671317|NCT01511250|459419638|FG002|Overall Study|Withdrawal of Consent|0|||
127671318|NCT01511250|459419639|FG003|Overall Study|Withdrawal of Consent|0|||
127671319|NCT01511250|459419640|FG004|Overall Study|Withdrawal of Consent|0|||
127671320|NCT01511250|459419641|FG005|Overall Study|Withdrawal of Consent|0|||
127671321|NCT01511250|459419642|FG006|Overall Study|Withdrawal of Consent|0|||
127671322|NCT01511250|459419643|FG007|Overall Study|Withdrawal of Consent|1|||
127671323|NCT01511250|459419644|FG008|Overall Study|Withdrawal of Consent|1|||
127671324|NCT01511250|459419645|FG009|Overall Study|Withdrawal of Consent|0|||
127671325|NCT01511250|459419636|FG000|Overall Study|Sponsor/Investigator Decision|1|||
127671326|NCT01511250|459419637|FG001|Overall Study|Sponsor/Investigator Decision|0|||
127671327|NCT01511250|459419638|FG002|Overall Study|Sponsor/Investigator Decision|0|||
127671328|NCT01511250|459419639|FG003|Overall Study|Sponsor/Investigator Decision|0|||
127671329|NCT01511250|459419640|FG004|Overall Study|Sponsor/Investigator Decision|0|||
127671330|NCT01511250|459419641|FG005|Overall Study|Sponsor/Investigator Decision|0|||
127671331|NCT01511250|459419642|FG006|Overall Study|Sponsor/Investigator Decision|0|||
127671332|NCT01511250|459419643|FG007|Overall Study|Sponsor/Investigator Decision|0|||
127671333|NCT01511250|459419644|FG008|Overall Study|Sponsor/Investigator Decision|0|||
127671334|NCT01511250|459419645|FG009|Overall Study|Sponsor/Investigator Decision|0|||
127671335|NCT01511250|459419636|FG000|Overall Study|Lost to Follow-up|7|||
127671336|NCT01511250|459419637|FG001|Overall Study|Lost to Follow-up|3|||
127671337|NCT01511250|459419638|FG002|Overall Study|Lost to Follow-up|3|||
127671338|NCT01511250|459419639|FG003|Overall Study|Lost to Follow-up|3|||
127671339|NCT01511250|459419640|FG004|Overall Study|Lost to Follow-up|0|||
127671340|NCT01511250|459419641|FG005|Overall Study|Lost to Follow-up|0|||
127671341|NCT01511250|459419642|FG006|Overall Study|Lost to Follow-up|2|||
127671342|NCT01511250|459419643|FG007|Overall Study|Lost to Follow-up|3|||
127671343|NCT01511250|459419644|FG008|Overall Study|Lost to Follow-up|13|||
127671344|NCT01511250|459419645|FG009|Overall Study|Lost to Follow-up|5|||
127671345|NCT01511250|459419636|FG000|Overall Study|Protocol Violation|0|||
127671346|NCT01511250|459419637|FG001|Overall Study|Protocol Violation|2|||
127671347|NCT01511250|459419638|FG002|Overall Study|Protocol Violation|1|||
127671348|NCT01511250|459419639|FG003|Overall Study|Protocol Violation|0|||
127671349|NCT01511250|459419640|FG004|Overall Study|Protocol Violation|0|||
127671350|NCT01511250|459419641|FG005|Overall Study|Protocol Violation|0|||
127671351|NCT01511250|459419642|FG006|Overall Study|Protocol Violation|0|||
127671352|NCT01511250|459419643|FG007|Overall Study|Protocol Violation|0|||
127671353|NCT01511250|459419644|FG008|Overall Study|Protocol Violation|0|||
127671354|NCT01511250|459419645|FG009|Overall Study|Protocol Violation|0|||
127671355|NCT00916006|459419651|FG000|Overall Study|Adverse Event|1|||
127671356|NCT00916006|459419652|FG001|Overall Study|Adverse Event|1|||
128003284|NCT02718911|460639447|FG001|Overall Study|Reason Not Collected|0|||
128003285|NCT02718911|460639448|FG002|Overall Study|Reason Not Collected|1|||
128003286|NCT02718911|460639449|FG003|Overall Study|Reason Not Collected|0|||
127671357|NCT00916006|459419651|FG000|Overall Study|Withdrawal by Subject|2|||
127671358|NCT00916006|459419652|FG001|Overall Study|Withdrawal by Subject|5|||
127671359|NCT00916006|459419651|FG000|Overall Study|Protocol Violation|0|||
127671360|NCT00916006|459419652|FG001|Overall Study|Protocol Violation|1|||
127671361|NCT05487703|459419653|FG000|Overall Study|Other|19|||
127671362|NCT05487703|459419653|FG000|Overall Study|Participant not well|5|||
127671363|NCT05487703|459419653|FG000|Overall Study|Insurance Reasons|6|||
127671364|NCT05487703|459419653|FG000|Overall Study|Physician Decision|19|||
127671365|NCT05487703|459419653|FG000|Overall Study|Lack of Efficacy|60|||
127671366|NCT04824131|459419654|FG000|CAB LA Oral Phase|Adverse Event|1|||
127671367|NCT04824131|459419654|FG000|CAB LA Oral Phase|Withdrawal by Subject|1|||
127671368|NCT04824131|459419654|FG000|Step 3|Withdrawal by Subject|2|||
127671369|NCT05489224|459419655|FG000|Treatment Period I|Withdrawal by Subject|6|||
127671370|NCT05489224|459419656|FG001|Treatment Period I|Withdrawal by Subject|5|||
127671371|NCT05489224|459419657|FG002|Treatment Period I|Withdrawal by Subject|0|||
127671372|NCT05489224|459419655|FG000|Treatment Period I|Adverse Event|3|||
127671373|NCT05489224|459419656|FG001|Treatment Period I|Adverse Event|11|||
127671374|NCT05489224|459419657|FG002|Treatment Period I|Adverse Event|0|||
127671375|NCT05489224|459419655|FG000|Treatment Period I|Lost to Follow-up|0|||
127671376|NCT05489224|459419656|FG001|Treatment Period I|Lost to Follow-up|1|||
127671377|NCT05489224|459419657|FG002|Treatment Period I|Lost to Follow-up|0|||
127671378|NCT05489224|459419655|FG000|Treatment Period I|Physician Decision|0|||
127671379|NCT05489224|459419656|FG001|Treatment Period I|Physician Decision|1|||
127671380|NCT05489224|459419657|FG002|Treatment Period I|Physician Decision|0|||
127671381|NCT05489224|459419655|FG000|Treatment Period II up to Week 32|Ongoing|222|||
127671382|NCT05489224|459419656|FG001|Treatment Period II up to Week 32|Ongoing|107|||
127671383|NCT05489224|459419657|FG002|Treatment Period II up to Week 32|Ongoing|107|||
127671384|NCT05489224|459419655|FG000|Treatment Period II up to Week 32|Adverse Event|3|||
127671385|NCT05489224|459419656|FG001|Treatment Period II up to Week 32|Adverse Event|0|||
127671386|NCT05489224|459419657|FG002|Treatment Period II up to Week 32|Adverse Event|1|||
127671387|NCT05489224|459419655|FG000|Treatment Period II up to Week 32|Withdrawal by Subject|0|||
127671388|NCT05489224|459419656|FG001|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
127671389|NCT05489224|459419657|FG002|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
127671390|NCT04887285|459419659|FG000|Overall Study|Lost to Follow-up|0|||
127671391|NCT04887285|459419660|FG001|Overall Study|Lost to Follow-up|2|||
127671392|NCT04887285|459419661|FG002|Overall Study|Lost to Follow-up|3|||
127671393|NCT04640571|459419662|FG000|Overall Study|Withdrawal by Subject|0|||
127671394|NCT04640571|459419663|FG001|Overall Study|Withdrawal by Subject|0|||
127671395|NCT04640571|459419664|FG002|Overall Study|Withdrawal by Subject|0|||
127671396|NCT04640571|459419665|FG003|Overall Study|Withdrawal by Subject|0|||
127671397|NCT04640571|459419666|FG004|Overall Study|Withdrawal by Subject|0|||
127671398|NCT04640571|459419667|FG005|Overall Study|Withdrawal by Subject|2|||
127671399|NCT00832780|459419672|FG000|Overall Study|Death|16|||
128003287|NCT02718911|460639450|FG004|Overall Study|Reason Not Collected|0|||
128003288|NCT02718911|460639451|FG005|Overall Study|Reason Not Collected|0|||
128003289|NCT02718911|460639452|FG006|Overall Study|Reason Not Collected|2|||
128003290|NCT02718911|460639453|FG007|Overall Study|Reason Not Collected|1|||
128003291|NCT02718911|460639454|FG008|Overall Study|Reason Not Collected|4|||
128003292|NCT02718911|460639455|FG009|Overall Study|Reason Not Collected|9|||
128003293|NCT01172873|460639458|FG000|Overall Study|Withdrawal by Subject|3|||
128003294|NCT01172873|460639459|FG001|Overall Study|Withdrawal by Subject|2|||
128003295|NCT00983372|460639460|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
128003296|NCT00983372|460639460|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
128003297|NCT00983372|460639460|FG000|Diltiazem ER Alone|Adverse Event|1|||
128003298|NCT00617357|460639467|FG000|Overall Study|Lost to Follow-up|7|||
128003299|NCT00617357|460639467|FG000|Overall Study|Death|5|||
128003300|NCT00617357|460639467|FG000|Overall Study|insurance concerns|2|||
128003301|NCT00617357|460639467|FG000|Overall Study|Withdrawal by Subject|1|||
128003302|NCT00617357|460639467|FG000|Overall Study|Physician Decision|1|||
128003303|NCT01764841|460639468|FG000|Overall Study|Logistical Difficulties|0|||
128003304|NCT01764841|460639469|FG001|Overall Study|Logistical Difficulties|1|||
128003305|NCT01764841|460639470|FG002|Overall Study|Logistical Difficulties|0|||
128003306|NCT01764841|460639471|FG003|Overall Study|Logistical Difficulties|0|||
127671400|NCT00832780|459419672|FG000|Overall Study|Lost to Follow-up|4|||
127671401|NCT00832780|459419672|FG000|Overall Study|no reason given|2|||
127671402|NCT00832780|459419672|FG000|Overall Study|other complicating condition|2|||
127671403|NCT00832780|459419672|FG000|Overall Study|Physician Decision|1|||
128003307|NCT01764841|460639468|FG000|Overall Study|Death|3|||
128003308|NCT01764841|460639469|FG001|Overall Study|Death|0|||
128003309|NCT01764841|460639470|FG002|Overall Study|Death|1|||
128003310|NCT01764841|460639471|FG003|Overall Study|Death|4|||
128003311|NCT01764841|460639468|FG000|Overall Study|No Follow Up|1|||
127671404|NCT04319094|459419677|FG000|Baseline|Lost to Follow-up|4|||
127671405|NCT04319094|459419678|FG001|Baseline|Lost to Follow-up|5|||
127671406|NCT04319094|459419677|FG000|Baseline|Protocol Violation|0|||
127671407|NCT04319094|459419678|FG001|Baseline|Protocol Violation|3|||
127671408|NCT04319094|459419677|FG000|Baseline|Withdrawal by Subject|2|||
127671409|NCT04319094|459419678|FG001|Baseline|Withdrawal by Subject|1|||
127671410|NCT04319094|459419677|FG000|Post-Intervention|Death|0|||
127671411|NCT04319094|459419678|FG001|Post-Intervention|Death|1|||
127671412|NCT04319094|459419677|FG000|Post-Intervention|Lost to Follow-up|4|||
127671413|NCT04319094|459419678|FG001|Post-Intervention|Lost to Follow-up|4|||
127671414|NCT04319094|459419677|FG000|Post-Intervention|Withdrawal by Subject|8|||
127671415|NCT04319094|459419678|FG001|Post-Intervention|Withdrawal by Subject|5|||
127671416|NCT04319094|459419677|FG000|Post-Intervention|Incomplete Data Collection|1|||
127671417|NCT04319094|459419678|FG001|Post-Intervention|Incomplete Data Collection|3|||
127671418|NCT04319094|459419677|FG000|3-month|Death|1|||
127671419|NCT04319094|459419678|FG001|3-month|Death|0|||
127671420|NCT04319094|459419677|FG000|3-month|Lost to Follow-up|2|||
127671421|NCT04319094|459419678|FG001|3-month|Lost to Follow-up|2|||
127671422|NCT04319094|459419677|FG000|3-month|Withdrawal by Subject|0|||
127671423|NCT04319094|459419678|FG001|3-month|Withdrawal by Subject|3|||
127671424|NCT04319094|459419677|FG000|3-month|Incomplete data collection|9|||
127671425|NCT04319094|459419678|FG001|3-month|Incomplete data collection|7|||
127671426|NCT04319094|459419677|FG000|6-month|Lost to Follow-up|1|||
127671427|NCT04319094|459419678|FG001|6-month|Lost to Follow-up|1|||
127671428|NCT04319094|459419677|FG000|6-month|Withdrawal by Subject|0|||
127671429|NCT04319094|459419678|FG001|6-month|Withdrawal by Subject|3|||
127671430|NCT04319094|459419677|FG000|6-month|Incomplete data collection|14|||
127671431|NCT04319094|459419678|FG001|6-month|Incomplete data collection|9|||
127671432|NCT04319094|459419677|FG000|9-month|Lost to Follow-up|8|||
127671433|NCT04319094|459419678|FG001|9-month|Lost to Follow-up|4|||
127671434|NCT04319094|459419677|FG000|9-month|Withdrawal by Subject|0|||
127671435|NCT04319094|459419678|FG001|9-month|Withdrawal by Subject|1|||
127671436|NCT04319094|459419677|FG000|9-month|Incomplete data collection|8|||
127671437|NCT04319094|459419678|FG001|9-month|Incomplete data collection|5|||
127671438|NCT04319094|459419677|FG000|12-month|Lost to Follow-up|11|||
127671439|NCT04319094|459419678|FG001|12-month|Lost to Follow-up|8|||
127671440|NCT04956692|459419679|FG000|Overall Study|Death|115|||
127671441|NCT04956692|459419680|FG001|Overall Study|Death|47|||
127671442|NCT04956692|459419679|FG000|Overall Study|Lost to Follow-up|0|||
127671443|NCT04956692|459419680|FG001|Overall Study|Lost to Follow-up|1|||
127671444|NCT04956692|459419679|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
127671445|NCT04956692|459419680|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
127671446|NCT04956692|459419679|FG000|Overall Study|Withdrawal by Subject|5|||
127671447|NCT04956692|459419680|FG001|Overall Study|Withdrawal by Subject|2|||
127671448|NCT04956692|459419679|FG000|Overall Study|Ongoing in Study|236|||
127671449|NCT04956692|459419680|FG001|Overall Study|Ongoing in Study|123|||
127671450|NCT04863898|459419682|FG000|Overall Study|Away from study clinic during intervention training period|2|||
127671451|NCT04863898|459419682|FG000|Overall Study|Preferred not to answer on endline survey why they did not participate in the training|1|||
127671452|NCT04863898|459419682|FG000|Overall Study|Lost to Follow-up|3|||
127671453|NCT04863898|459419682|FG000|Overall Study|Self reported at endline that they had not received information about the training|1|||
127671454|NCT04863898|459419682|FG000|Overall Study|No longer employed at clinic|3|||
127671455|NCT00770211|459419683|FG000|Overall Study|Lost to Follow-up|1|||
127671456|NCT00770211|459419684|FG001|Overall Study|Lost to Follow-up|0|||
127671457|NCT00770211|459419683|FG000|Overall Study|Withdrawal by Subject|0|||
127671458|NCT00770211|459419684|FG001|Overall Study|Withdrawal by Subject|2|||
127671459|NCT00764868|459419685|FG000|Overall Study|Adverse Event|18|||
127671460|NCT00764868|459419685|FG000|Overall Study|Withdrawal by Subject|31|||
127671461|NCT00764868|459419685|FG000|Overall Study|Non-compliance|16|||
127671462|NCT00764868|459419685|FG000|Overall Study|Lost to Follow-up|25|||
127671463|NCT00764868|459419685|FG000|Overall Study|Lack of Efficacy|5|||
127671464|NCT00764868|459419685|FG000|Overall Study|Subject moved|7|||
127671465|NCT00764868|459419685|FG000|Overall Study|Pregnancy|3|||
127671466|NCT00764868|459419685|FG000|Overall Study|Prohibited medication|1|||
127671467|NCT00764868|459419685|FG000|Overall Study|Out of town|1|||
127671468|NCT00764868|459419685|FG000|Overall Study|Misuse and compliance of study drug|1|||
127671469|NCT00764868|459419685|FG000|Overall Study|Subject sent to boarding school|1|||
127671470|NCT00764868|459419685|FG000|Overall Study|Met an exclusion criteria|1|||
127671471|NCT00764868|459419685|FG000|Overall Study|Positive drug screen|2|||
127671472|NCT00764868|459419685|FG000|Overall Study|Sponsor requested withdrawal|1|||
127671473|NCT01515319|459419688|FG000|Overall Study|Withdrawal by Subject|0|||
127671474|NCT01515319|459419689|FG001|Overall Study|Withdrawal by Subject|0|||
127671475|NCT01515319|459419690|FG002|Overall Study|Withdrawal by Subject|0|||
127671476|NCT01515319|459419691|FG003|Overall Study|Withdrawal by Subject|0|||
127671477|NCT01515319|459419692|FG004|Overall Study|Withdrawal by Subject|0|||
127671478|NCT01515319|459419693|FG005|Overall Study|Withdrawal by Subject|0|||
127671479|NCT01515319|459419694|FG006|Overall Study|Withdrawal by Subject|1|||
127671480|NCT01515319|459419695|FG007|Overall Study|Withdrawal by Subject|0|||
127671481|NCT01515319|459419696|FG008|Overall Study|Withdrawal by Subject|0|||
127671482|NCT01515319|459419697|FG009|Overall Study|Withdrawal by Subject|0|||
127671483|NCT01515319|459419688|FG000|Overall Study|Adverse Event|0|||
127671484|NCT01515319|459419689|FG001|Overall Study|Adverse Event|0|||
127671485|NCT01515319|459419690|FG002|Overall Study|Adverse Event|0|||
128003312|NCT01764841|460639469|FG001|Overall Study|No Follow Up|0|||
128003313|NCT01764841|460639470|FG002|Overall Study|No Follow Up|1|||
128003314|NCT01764841|460639471|FG003|Overall Study|No Follow Up|0|||
128003315|NCT01764841|460639468|FG000|Overall Study|Protocol Violation|0|||
128003316|NCT01764841|460639469|FG001|Overall Study|Protocol Violation|1|||
128003317|NCT01764841|460639470|FG002|Overall Study|Protocol Violation|0|||
128003318|NCT01764841|460639471|FG003|Overall Study|Protocol Violation|0|||
128003319|NCT01764841|460639468|FG000|Overall Study|Withdrawal by Subject|16|||
128003320|NCT01764841|460639469|FG001|Overall Study|Withdrawal by Subject|24|||
128003321|NCT01764841|460639470|FG002|Overall Study|Withdrawal by Subject|11|||
128003322|NCT01764841|460639471|FG003|Overall Study|Withdrawal by Subject|15|||
128003323|NCT01764841|460639468|FG000|Overall Study|Lost to Follow-up|3|||
128003324|NCT01764841|460639469|FG001|Overall Study|Lost to Follow-up|0|||
128003325|NCT01764841|460639470|FG002|Overall Study|Lost to Follow-up|1|||
128003326|NCT01764841|460639471|FG003|Overall Study|Lost to Follow-up|0|||
128003327|NCT01103323|460639473|FG000|Without/Before Drug Switch|Adverse Event|50|||
128003328|NCT01103323|460639474|FG001|Without/Before Drug Switch|Adverse Event|7|||
128003329|NCT01103323|460639473|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
128003330|NCT01103323|460639474|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
128003331|NCT01103323|460639473|FG000|Without/Before Drug Switch|Protocol Violation|2|||
128003332|NCT01103323|460639474|FG001|Without/Before Drug Switch|Protocol Violation|0|||
128003333|NCT01103323|460639473|FG000|Without/Before Drug Switch|Physician Decision|2|||
128003334|NCT01103323|460639474|FG001|Without/Before Drug Switch|Physician Decision|0|||
127671486|NCT01515319|459419691|FG003|Overall Study|Adverse Event|0|||
127671487|NCT01515319|459419692|FG004|Overall Study|Adverse Event|0|||
127671488|NCT01515319|459419693|FG005|Overall Study|Adverse Event|0|||
127671489|NCT01515319|459419694|FG006|Overall Study|Adverse Event|0|||
127671490|NCT01515319|459419695|FG007|Overall Study|Adverse Event|0|||
127671491|NCT01515319|459419696|FG008|Overall Study|Adverse Event|3|||
127671492|NCT01515319|459419697|FG009|Overall Study|Adverse Event|0|||
127671493|NCT01515319|459419688|FG000|Overall Study|Protocol Violation|0|||
127671494|NCT01515319|459419689|FG001|Overall Study|Protocol Violation|0|||
127671495|NCT01515319|459419690|FG002|Overall Study|Protocol Violation|0|||
127671496|NCT01515319|459419691|FG003|Overall Study|Protocol Violation|0|||
127671497|NCT01515319|459419692|FG004|Overall Study|Protocol Violation|0|||
127671498|NCT01515319|459419693|FG005|Overall Study|Protocol Violation|0|||
127671499|NCT01515319|459419694|FG006|Overall Study|Protocol Violation|0|||
127671500|NCT01515319|459419695|FG007|Overall Study|Protocol Violation|0|||
127671501|NCT01515319|459419696|FG008|Overall Study|Protocol Violation|2|||
128003335|NCT01103323|460639473|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
128003336|NCT01103323|460639474|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
128003337|NCT01103323|460639473|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
128003338|NCT01103323|460639474|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
128003339|NCT01103323|460639473|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
128003340|NCT01103323|460639474|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
128003341|NCT00732069|460639475|FG000|Washout After First Study Drug|Adverse Event|1|||
128003342|NCT00732069|460639476|FG001|Washout After First Study Drug|Adverse Event|0|||
128003343|NCT00732069|460639477|FG002|Washout After First Study Drug|Adverse Event|0|||
128003344|NCT00732069|460639478|FG003|Washout After First Study Drug|Adverse Event|0|||
128003345|NCT00732069|460639479|FG004|Washout After First Study Drug|Adverse Event|0|||
128003346|NCT00732069|460639480|FG005|Washout After First Study Drug|Adverse Event|0|||
128003347|NCT00577317|460639481|FG000|Overall Study|Study Terminated|0|||
128003348|NCT00577317|460639482|FG001|Overall Study|Study Terminated|2|||
128003349|NCT04460326|460639483|FG000|Completed at Least 4 Meals|Early discharge|5|||
128003350|NCT04460326|460639484|FG001|Completed at Least 4 Meals|Early discharge|5|||
128003351|NCT04460326|460639483|FG000|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
128003352|NCT04460326|460639484|FG001|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
128003353|NCT04460326|460639483|FG000|Completed at Least 4 Meals|Nutrition method changed|1|||
128003354|NCT04460326|460639484|FG001|Completed at Least 4 Meals|Nutrition method changed|0|||
128003355|NCT04460326|460639483|FG000|Completed at Least 4 Meals|Transfer to ICU|0|||
127671502|NCT01515319|459419697|FG009|Overall Study|Protocol Violation|0|||
127671503|NCT01959880|459419698|FG000|Overall Study|Withdrawal by Subject|11|||
128003356|NCT04460326|460639484|FG001|Completed at Least 4 Meals|Transfer to ICU|1|||
128003357|NCT04460326|460639483|FG000|Completed at Least 4 Meals|Bleeding at CGM site|0|||
128003358|NCT04460326|460639484|FG001|Completed at Least 4 Meals|Bleeding at CGM site|1|||
128003359|NCT04460326|460639483|FG000|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|5|||
128003360|NCT04460326|460639484|FG001|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|12|||
128003361|NCT03160716|460639485|FG000|Overall Study|Lost to Follow-up|1|||
128003362|NCT04794751|460639487|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
127671504|NCT01959880|459419699|FG001|Overall Study|Withdrawal by Subject|13|||
127671505|NCT01959880|459419700|FG002|Overall Study|Withdrawal by Subject|8|||
127671506|NCT01959880|459419701|FG003|Overall Study|Withdrawal by Subject|7|||
127671507|NCT01959880|459419698|FG000|Overall Study|Death|1|||
127671508|NCT01959880|459419699|FG001|Overall Study|Death|10|||
128003363|NCT04794751|460639488|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
128003364|NCT04794751|460639487|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
128003365|NCT04794751|460639488|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
128003366|NCT04794751|460639487|FG000|Period 1|Protocol Violation|0|||
128003367|NCT04794751|460639488|FG001|Period 1|Protocol Violation|2|||
128003368|NCT04794751|460639487|FG000|Period 1|Withdrawal by Subject|0|||
128003369|NCT04794751|460639488|FG001|Period 1|Withdrawal by Subject|1|||
128003370|NCT04794751|460639487|FG000|Period 2|Withdrawal by Subject|0|||
128003371|NCT04794751|460639488|FG001|Period 2|Withdrawal by Subject|1|||
128003372|NCT04794751|460639487|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
128003373|NCT04794751|460639488|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
128003374|NCT04794751|460639487|FG000|Period 2|Protocol Violation|1|||
128003375|NCT04794751|460639488|FG001|Period 2|Protocol Violation|0|||
128003376|NCT00875810|460639491|FG000|Overall Study|Withdrawal by Subject|1|||
128003377|NCT00875810|460639491|FG000|Overall Study|Physician Decision|3|||
128003378|NCT00875810|460639491|FG000|Overall Study|Lost to Follow-up|39|||
128003379|NCT00875810|460639491|FG000|Overall Study|Patient enroled but not implanted|2|||
128003380|NCT00875810|460639491|FG000|Overall Study|Device explanted|1|||
128003381|NCT00780975|460639492|FG000|Overall Study|Progressive disease|3|||
128003382|NCT00780975|460639492|FG000|Overall Study|Toxicity|5|||
128003383|NCT01939314|460639495|FG000|Overall Study|Withdrawal by Subject|3|||
128003384|NCT01939314|460639496|FG001|Overall Study|Withdrawal by Subject|1|||
128003385|NCT01939314|460639495|FG000|Overall Study|Protocol Violation|1|||
128003386|NCT01939314|460639496|FG001|Overall Study|Protocol Violation|0|||
128003387|NCT01939314|460639495|FG000|Overall Study|Pregnancy|0|||
128003388|NCT01939314|460639496|FG001|Overall Study|Pregnancy|1|||
128003389|NCT01939314|460639495|FG000|Overall Study|Lost to Follow-up|5|||
128003390|NCT01939314|460639496|FG001|Overall Study|Lost to Follow-up|6|||
128003391|NCT00969228|460639500|FG000|Overall Study|Adverse Event|1|||
128003392|NCT00969228|460639501|FG001|Overall Study|Adverse Event|0|||
128003393|NCT00969228|460639500|FG000|Overall Study|Withdrawal by Subject|4|||
128003394|NCT00969228|460639501|FG001|Overall Study|Withdrawal by Subject|0|||
128003395|NCT00969228|460639500|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
128003396|NCT00969228|460639501|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
128003397|NCT02563899|460639502|FG000|Overall Study|Protocol Violation|1|||
128003398|NCT02563899|460639503|FG001|Overall Study|Protocol Violation|0|||
128003399|NCT02563899|460639504|FG002|Overall Study|Protocol Violation|0|||
128003400|NCT02563899|460639505|FG003|Overall Study|Protocol Violation|0|||
128003401|NCT02563899|460639502|FG000|Overall Study|Withdrawal by Subject|0|||
128003402|NCT02563899|460639503|FG001|Overall Study|Withdrawal by Subject|0|||
128003403|NCT02563899|460639504|FG002|Overall Study|Withdrawal by Subject|1|||
128003404|NCT02563899|460639505|FG003|Overall Study|Withdrawal by Subject|0|||
128003405|NCT00794664|460639506|FG000|Treatment Period|Withdrawal by Subject|0|||
128003406|NCT00794664|460639507|FG001|Treatment Period|Withdrawal by Subject|2|||
128003407|NCT00794664|460639506|FG000|Treatment Period|Protocol non-compliance|0|||
128003408|NCT00794664|460639507|FG001|Treatment Period|Protocol non-compliance|1|||
128003409|NCT00794664|460639506|FG000|Treatment Period|Other|0|||
128003410|NCT00794664|460639507|FG001|Treatment Period|Other|1|||
128003411|NCT00794664|460639506|FG000|Treatment Period|Adverse Event|1|||
128003412|NCT00794664|460639507|FG001|Treatment Period|Adverse Event|8|||
128003413|NCT00794664|460639506|FG000|Follow-up Period|Other|1|||
128003414|NCT00794664|460639507|FG001|Follow-up Period|Other|2|||
128003415|NCT00794664|460639506|FG000|Follow-up Period|Withdrawal by Subject|0|||
128003416|NCT00794664|460639507|FG001|Follow-up Period|Withdrawal by Subject|2|||
128003417|NCT00794664|460639506|FG000|Follow-up Period|Protocol non-compliance|0|||
128003418|NCT00794664|460639507|FG001|Follow-up Period|Protocol non-compliance|1|||
128003419|NCT01305564|460639510|FG000|Overall Study|Death|21|||
128003420|NCT01305564|460639510|FG000|Overall Study|Lost to Follow-up|12|||
128003421|NCT01305564|460639510|FG000|Overall Study|Withdrawal by Subject|1|||
128003422|NCT01305564|460639510|FG000|Overall Study|Physician Decision|3|||
128003423|NCT00496769|460641448|FG000|Double Blind|>=1 reason assigned per patient|558|||
128003424|NCT00496769|460641449|FG001|Double Blind|>=1 reason assigned per patient|649|||
128003425|NCT00496769|460641450|FG002|Double Blind|>=1 reason assigned per patient|0|||
128003426|NCT00496769|460641448|FG000|Open Label|>=1 reason assigned per patient|0|||
128003427|NCT00496769|460641449|FG001|Open Label|>=1 reason assigned per patient|0|||
128003428|NCT00496769|460641450|FG002|Open Label|>=1 reason assigned per patient|1011|||
128003429|NCT02812186|460641451|FG000|Period 1|Post randomization screen failure|5|||
128003430|NCT02812186|460641452|FG001|Period 1|Post randomization screen failure|9|||
128003431|NCT02812186|460641451|FG000|Period 1|nonevaluable data sets|6|||
128003432|NCT02812186|460641452|FG001|Period 1|nonevaluable data sets|6|||
128003433|NCT01573000|460641455|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
128003434|NCT01573000|460641456|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
128003435|NCT01573000|460641455|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
128003436|NCT01573000|460641456|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
128003437|NCT01573000|460641455|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
128003438|NCT01573000|460641456|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
128003439|NCT01573000|460641455|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
128003440|NCT01573000|460641456|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
128003441|NCT01573000|460641455|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
128003442|NCT01573000|460641456|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
128003443|NCT01573000|460641455|FG000|Crossover Phase|Lack of Efficacy|0|||
128003444|NCT01573000|460641456|FG001|Crossover Phase|Lack of Efficacy|13|||
128003445|NCT01573000|460641455|FG000|Crossover Phase|Lost to Follow-up|0|||
128003446|NCT01573000|460641456|FG001|Crossover Phase|Lost to Follow-up|2|||
128003447|NCT01573000|460641455|FG000|Crossover Phase|Death|0|||
128003448|NCT01573000|460641456|FG001|Crossover Phase|Death|3|||
128003449|NCT01573000|460641455|FG000|Long-Term Follow-Up|Death|3|||
128003450|NCT01573000|460641456|FG001|Long-Term Follow-Up|Death|0|||
128003451|NCT01573000|460641455|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
128003452|NCT01573000|460641456|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
128003453|NCT03353792|460641457|FG000|Overall Study|Lost to Follow-up|1|||
128003454|NCT03353792|460641458|FG001|Overall Study|Lost to Follow-up|0|||
128003455|NCT03353792|460641457|FG000|Overall Study|Participant Unable to Manage Device|1|||
128003456|NCT03353792|460641458|FG001|Overall Study|Participant Unable to Manage Device|0|||
128003457|NCT01433159|460641461|FG000|Overall Study|Adverse Event|1|||
128003458|NCT01433159|460641462|FG001|Overall Study|Adverse Event|0|||
128003459|NCT01433159|460641461|FG000|Overall Study|Physician Decision|1|||
128003460|NCT01433159|460641462|FG001|Overall Study|Physician Decision|0|||
128003461|NCT01433159|460641461|FG000|Overall Study|Protocol Violation|0|||
128003462|NCT01433159|460641462|FG001|Overall Study|Protocol Violation|1|||
128003463|NCT01100853|460641463|FG000|Overall Study|Lost to Follow-up|11|||
128003464|NCT01100853|460641464|FG001|Overall Study|Lost to Follow-up|6|||
128003465|NCT01100853|460641463|FG000|Overall Study|Received <4 study injections|10|||
128003466|NCT01100853|460641464|FG001|Overall Study|Received <4 study injections|13|||
128003467|NCT01100853|460641463|FG000|Overall Study|Withdrawal by Subject|6|||
128003468|NCT01100853|460641464|FG001|Overall Study|Withdrawal by Subject|4|||
128003469|NCT01190891|460641465|FG000|Overall Study|Protocol Violation|1|||
128003470|NCT01190891|460641466|FG001|Overall Study|Protocol Violation|0|||
128003471|NCT01190891|460641465|FG000|Overall Study|Withdrawal by Subject|5|||
128003472|NCT01190891|460641466|FG001|Overall Study|Withdrawal by Subject|0|||
128003473|NCT00266708|460641467|FG000|Overall Study|No renal function|1|||
128003474|NCT00266708|460641468|FG001|Overall Study|No renal function|1|||
128003475|NCT00266708|460641467|FG000|Overall Study|Refused biopsy|3|||
128003476|NCT00266708|460641468|FG001|Overall Study|Refused biopsy|6|||
128003477|NCT00266708|460641467|FG000|Overall Study|Asthma|0|||
128003478|NCT00266708|460641468|FG001|Overall Study|Asthma|2|||
128003479|NCT01926028|460641469|FG000|Overall Study|Lost to Follow-up|7|||
128003480|NCT01926028|460641470|FG001|Overall Study|Lost to Follow-up|6|||
128003481|NCT01926028|460641471|FG002|Overall Study|Lost to Follow-up|0|||
128003482|NCT01926028|460641469|FG000|Overall Study|Physician Decision|1|||
128003483|NCT01926028|460641470|FG001|Overall Study|Physician Decision|5|||
128003484|NCT01926028|460641471|FG002|Overall Study|Physician Decision|0|||
128003485|NCT01926028|460641469|FG000|Overall Study|Withdrawal by Subject|9|||
128003486|NCT01926028|460641470|FG001|Overall Study|Withdrawal by Subject|9|||
128003487|NCT01926028|460641471|FG002|Overall Study|Withdrawal by Subject|2|||
128003488|NCT01926028|460641469|FG000|Overall Study|Non compliance or other reasons|4|||
128003489|NCT01926028|460641470|FG001|Overall Study|Non compliance or other reasons|2|||
128003490|NCT01926028|460641471|FG002|Overall Study|Non compliance or other reasons|0|||
128003491|NCT01130272|460641472|FG000|Overall Study|Adverse Event|2|||
128003492|NCT01130272|460641473|FG001|Overall Study|Adverse Event|5|||
128003493|NCT01130272|460641474|FG002|Overall Study|Adverse Event|6|||
128003494|NCT01130272|460641475|FG003|Overall Study|Adverse Event|22|||
128003495|NCT01130272|460641476|FG004|Overall Study|Adverse Event|7|||
128003496|NCT01130272|460641472|FG000|Overall Study|IVRS-confirmed constipation|0|||
127671509|NCT01959880|459419700|FG002|Overall Study|Death|1|||
127671510|NCT01959880|459419701|FG003|Overall Study|Death|2|||
127671511|NCT01959880|459419698|FG000|Overall Study|Lost to Follow-up|95|||
128003497|NCT01130272|460641473|FG001|Overall Study|IVRS-confirmed constipation|1|||
128003498|NCT01130272|460641474|FG002|Overall Study|IVRS-confirmed constipation|1|||
128003499|NCT01130272|460641475|FG003|Overall Study|IVRS-confirmed constipation|2|||
128003500|NCT01130272|460641476|FG004|Overall Study|IVRS-confirmed constipation|0|||
128003501|NCT01130272|460641472|FG000|Overall Study|Rescue medications due to diarrhea|3|||
128003502|NCT01130272|460641473|FG001|Overall Study|Rescue medications due to diarrhea|5|||
128003503|NCT01130272|460641474|FG002|Overall Study|Rescue medications due to diarrhea|8|||
128003504|NCT01130272|460641475|FG003|Overall Study|Rescue medications due to diarrhea|8|||
128003505|NCT01130272|460641476|FG004|Overall Study|Rescue medications due to diarrhea|6|||
128003506|NCT01130272|460641472|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
128003507|NCT01130272|460641473|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
128003508|NCT01130272|460641474|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
128003509|NCT01130272|460641475|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
128003510|NCT01130272|460641476|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
127671512|NCT01959880|459419699|FG001|Overall Study|Lost to Follow-up|18|||
128003511|NCT01130272|460641472|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
128003512|NCT01130272|460641473|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
128003513|NCT01130272|460641474|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
128003514|NCT01130272|460641475|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
128003515|NCT01130272|460641476|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
128003516|NCT01130272|460641472|FG000|Overall Study|Protocol Violation|0|||
128003517|NCT01130272|460641473|FG001|Overall Study|Protocol Violation|0|||
127671513|NCT01959880|459419700|FG002|Overall Study|Lost to Follow-up|15|||
127671514|NCT01959880|459419701|FG003|Overall Study|Lost to Follow-up|8|||
127671515|NCT01959880|459419698|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
127671516|NCT01959880|459419699|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
127671517|NCT01959880|459419700|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
127671518|NCT01959880|459419701|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
127671519|NCT01959880|459419698|FG000|Overall Study|Study completed early-FDA approved|1003|||
128003518|NCT01130272|460641474|FG002|Overall Study|Protocol Violation|3|||
128003519|NCT01130272|460641475|FG003|Overall Study|Protocol Violation|5|||
128003520|NCT01130272|460641476|FG004|Overall Study|Protocol Violation|5|||
128003521|NCT01130272|460641472|FG000|Overall Study|Lost to Follow-up|4|||
128003522|NCT01130272|460641473|FG001|Overall Study|Lost to Follow-up|3|||
128003523|NCT01130272|460641474|FG002|Overall Study|Lost to Follow-up|4|||
128003524|NCT01130272|460641475|FG003|Overall Study|Lost to Follow-up|7|||
128003525|NCT01130272|460641476|FG004|Overall Study|Lost to Follow-up|6|||
128003526|NCT01130272|460641472|FG000|Overall Study|Withdrawal by Subject|4|||
128003527|NCT01130272|460641473|FG001|Overall Study|Withdrawal by Subject|11|||
128003528|NCT01130272|460641474|FG002|Overall Study|Withdrawal by Subject|10|||
128003529|NCT01130272|460641475|FG003|Overall Study|Withdrawal by Subject|9|||
128003530|NCT01130272|460641476|FG004|Overall Study|Withdrawal by Subject|8|||
128003531|NCT01130272|460641472|FG000|Overall Study|Physician Decision|1|||
128003532|NCT01130272|460641473|FG001|Overall Study|Physician Decision|1|||
128003533|NCT01130272|460641474|FG002|Overall Study|Physician Decision|0|||
128003534|NCT01130272|460641475|FG003|Overall Study|Physician Decision|1|||
128003535|NCT01130272|460641476|FG004|Overall Study|Physician Decision|2|||
128003536|NCT01130272|460641472|FG000|Overall Study|Sponsor decision|6|||
128003537|NCT01130272|460641473|FG001|Overall Study|Sponsor decision|15|||
128003538|NCT01130272|460641474|FG002|Overall Study|Sponsor decision|16|||
128003539|NCT01130272|460641475|FG003|Overall Study|Sponsor decision|13|||
128003540|NCT01130272|460641476|FG004|Overall Study|Sponsor decision|16|||
128003541|NCT01130272|460641472|FG000|Overall Study|Study arm discontinued|38|||
128003542|NCT01130272|460641473|FG001|Overall Study|Study arm discontinued|0|||
128003543|NCT01130272|460641474|FG002|Overall Study|Study arm discontinued|0|||
128003544|NCT01130272|460641475|FG003|Overall Study|Study arm discontinued|0|||
128003545|NCT01130272|460641476|FG004|Overall Study|Study arm discontinued|0|||
128003546|NCT01548404|460641477|FG000|Overall Study|Adverse Event|3|||
128003547|NCT01548404|460641478|FG001|Overall Study|Adverse Event|1|||
128003548|NCT01548404|460641477|FG000|Overall Study|Physician Decision|2|||
128003549|NCT01548404|460641478|FG001|Overall Study|Physician Decision|1|||
128003550|NCT01548404|460641477|FG000|Overall Study|Inadequate response to study treatment|23|||
128003551|NCT01548404|460641478|FG001|Overall Study|Inadequate response to study treatment|7|||
127671520|NCT01959880|459419699|FG001|Overall Study|Study completed early-FDA approved|311|||
127671521|NCT01959880|459419700|FG002|Overall Study|Study completed early-FDA approved|179|||
127671522|NCT01959880|459419701|FG003|Overall Study|Study completed early-FDA approved|152|||
127671523|NCT01919619|459419702|FG000|Overall Study|Physician Decision|1|||
127671524|NCT01919619|459419703|FG001|Overall Study|Physician Decision|1|||
127671525|NCT03253653|459419704|FG000|Overall Study|Withdrawal by Subject|4|||
127671526|NCT03253653|459419705|FG001|Overall Study|Withdrawal by Subject|1|||
127671527|NCT03253653|459419704|FG000|Overall Study|Protocol Violation|0|||
127671528|NCT03253653|459419705|FG001|Overall Study|Protocol Violation|5|||
127671529|NCT00498186|459420976|FG000|Overall Study|Protocol Violation|10|||
128003552|NCT01548404|460641477|FG000|Overall Study|Lost to Follow-up|2|||
128003553|NCT01548404|460641478|FG001|Overall Study|Lost to Follow-up|0|||
128003554|NCT01548404|460641477|FG000|Overall Study|Withdrawal by Subject|0|||
128003555|NCT01548404|460641478|FG001|Overall Study|Withdrawal by Subject|3|||
128003556|NCT01548404|460641477|FG000|Overall Study|Other than specified above|0|||
128003557|NCT01548404|460641478|FG001|Overall Study|Other than specified above|2|||
128003558|NCT00641056|460641479|FG000|Overall Study|Adverse Event|12|||
128003559|NCT00641056|460641480|FG001|Overall Study|Adverse Event|2|||
128003560|NCT00641056|460641479|FG000|Overall Study|Lost to Follow-up|2|||
128003561|NCT00641056|460641480|FG001|Overall Study|Lost to Follow-up|1|||
128003562|NCT00641056|460641479|FG000|Overall Study|Physician Decision|3|||
127671530|NCT00498186|459420976|FG000|Overall Study|Lack of Efficacy|31|||
127671531|NCT00498186|459420976|FG000|Overall Study|Adverse Event|89|||
127671532|NCT00498186|459420976|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
127671533|NCT00498186|459420976|FG000|Overall Study|Withdrawal by Subject|18|||
128003563|NCT00641056|460641480|FG001|Overall Study|Physician Decision|1|||
128003564|NCT00641056|460641479|FG000|Overall Study|Protocol Violation|2|||
127671534|NCT00498186|459420976|FG000|Overall Study|Lost to Follow-up|3|||
128003565|NCT00641056|460641480|FG001|Overall Study|Protocol Violation|0|||
128003566|NCT00641056|460641479|FG000|Overall Study|Entry Criteria Not Met|3|||
128003567|NCT00641056|460641480|FG001|Overall Study|Entry Criteria Not Met|0|||
128003568|NCT00641056|460641479|FG000|Overall Study|Subject Decision|6|||
127671535|NCT00498186|459420976|FG000|Overall Study|Other|10|||
127671536|NCT00886613|459420978|FG000|Overall Study|Protocol deviation (Part B)|1|||
128003569|NCT00641056|460641480|FG001|Overall Study|Subject Decision|19|||
128003570|NCT00641056|460641479|FG000|Overall Study|Sponsor Decision|1|||
128003571|NCT00641056|460641480|FG001|Overall Study|Sponsor Decision|2|||
128003572|NCT00737048|460641481|FG000|Overall Study|Physician Decision|0|||
127671537|NCT00886613|459420979|FG001|Overall Study|Protocol deviation (Part B)|0|||
127671538|NCT00886613|459420980|FG002|Overall Study|Protocol deviation (Part B)|0|||
127671539|NCT00886613|459420978|FG000|Overall Study|Lost to follow-up (Part B)|1|||
128003573|NCT00737048|460641482|FG001|Overall Study|Physician Decision|0|||
128003574|NCT00737048|460641483|FG002|Overall Study|Physician Decision|1|||
128003575|NCT00737048|460641481|FG000|Overall Study|Adverse Event|0|||
128003576|NCT00737048|460641482|FG001|Overall Study|Adverse Event|1|||
128003577|NCT00737048|460641483|FG002|Overall Study|Adverse Event|0|||
128003578|NCT00737048|460641481|FG000|Overall Study|Worsening of the symptoms|3|||
128003579|NCT00737048|460641482|FG001|Overall Study|Worsening of the symptoms|5|||
128003580|NCT00737048|460641483|FG002|Overall Study|Worsening of the symptoms|3|||
128003581|NCT04040439|460641485|FG000|Overall Study|Invalid registration|11|||
128003582|NCT04040439|460641485|FG000|Overall Study|No IC* on publication of study results|2|||
128003583|NCT01309386|460641486|FG000|Overall Study|Other|2|||
128003584|NCT01309386|460641487|FG001|Overall Study|Other|0|||
128003585|NCT01309386|460641486|FG000|Overall Study|Withdrawal by Subject|2|||
128003586|NCT01309386|460641487|FG001|Overall Study|Withdrawal by Subject|0|||
128003587|NCT01309386|460641486|FG000|Overall Study|Progressive disease|9|||
128003588|NCT01309386|460641487|FG001|Overall Study|Progressive disease|11|||
128003589|NCT01309386|460641486|FG000|Overall Study|Physician Decision|1|||
128003590|NCT01309386|460641487|FG001|Overall Study|Physician Decision|1|||
128003591|NCT01309386|460641486|FG000|Overall Study|Lack of Efficacy|3|||
128003592|NCT01309386|460641487|FG001|Overall Study|Lack of Efficacy|1|||
128003593|NCT01309386|460641486|FG000|Overall Study|Adverse Event|5|||
128003594|NCT01309386|460641487|FG001|Overall Study|Adverse Event|8|||
128003595|NCT02062437|460641488|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
128003596|NCT02062437|460641488|FG000|Overall Study|Patient not available for the 2y visit|18|||
128003597|NCT02062437|460641488|FG000|Overall Study|Death|2|||
128003598|NCT02062437|460641488|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
128003599|NCT01774981|460641489|FG000|Overall Study|Adverse Event|0|||
128003600|NCT01774981|460641490|FG001|Overall Study|Adverse Event|0|||
128003601|NCT01774981|460641491|FG002|Overall Study|Adverse Event|0|||
128003602|NCT01774981|460641492|FG003|Overall Study|Adverse Event|0|||
128003603|NCT01774981|460641493|FG004|Overall Study|Adverse Event|0|||
128003604|NCT01774981|460641494|FG005|Overall Study|Adverse Event|1|||
128003605|NCT01774981|460641495|FG006|Overall Study|Adverse Event|0|||
128003606|NCT01774981|460641496|FG007|Overall Study|Adverse Event|0|||
128003607|NCT01774981|460641489|FG000|Overall Study|Withdrawal by Subject|0|||
128003608|NCT01774981|460641490|FG001|Overall Study|Withdrawal by Subject|0|||
128003609|NCT01774981|460641491|FG002|Overall Study|Withdrawal by Subject|0|||
128003610|NCT01774981|460641492|FG003|Overall Study|Withdrawal by Subject|0|||
128003611|NCT01774981|460641493|FG004|Overall Study|Withdrawal by Subject|0|||
128003612|NCT01774981|460641494|FG005|Overall Study|Withdrawal by Subject|0|||
128003613|NCT01774981|460641495|FG006|Overall Study|Withdrawal by Subject|0|||
128003614|NCT01774981|460641496|FG007|Overall Study|Withdrawal by Subject|1|||
128003615|NCT01774981|460641489|FG000|Overall Study|Death|0|||
128003616|NCT01774981|460641490|FG001|Overall Study|Death|0|||
128003617|NCT01774981|460641491|FG002|Overall Study|Death|0|||
128003618|NCT01774981|460641492|FG003|Overall Study|Death|0|||
128003619|NCT01774981|460641493|FG004|Overall Study|Death|1|||
128003620|NCT01774981|460641494|FG005|Overall Study|Death|0|||
128003621|NCT01774981|460641495|FG006|Overall Study|Death|0|||
128003622|NCT01774981|460641496|FG007|Overall Study|Death|0|||
127671540|NCT00886613|459420979|FG001|Overall Study|Lost to follow-up (Part B)|0|||
127671541|NCT00886613|459420980|FG002|Overall Study|Lost to follow-up (Part B)|1|||
128003623|NCT00960193|460641497|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
128003624|NCT01324102|460641498|FG000|Overall Study|illness|1|||
128003625|NCT01324102|460641499|FG001|Overall Study|illness|6|||
128003626|NCT00386334|460641504|FG000|Double Blind Period|Adverse Event|9|||
128003627|NCT00386334|460641505|FG001|Double Blind Period|Adverse Event|14|||
128003628|NCT00386334|460641504|FG000|Double Blind Period|Protocol Violation|1|||
128003629|NCT00386334|460641505|FG001|Double Blind Period|Protocol Violation|1|||
128003630|NCT00386334|460641504|FG000|Double Blind Period|Withdrawal by Subject|9|||
128003631|NCT00386334|460641505|FG001|Double Blind Period|Withdrawal by Subject|13|||
128003632|NCT00386334|460641504|FG000|Double Blind Period|Lack of Efficacy|20|||
128003633|NCT00386334|460641505|FG001|Double Blind Period|Lack of Efficacy|11|||
128003634|NCT00386334|460641504|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
128003635|NCT00386334|460641505|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
128003636|NCT00386334|460641504|FG000|Double Blind Period|Other|3|||
128003637|NCT00386334|460641505|FG001|Double Blind Period|Other|3|||
128003638|NCT00386334|460641504|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
128003639|NCT00386334|460641505|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
128003640|NCT00902577|460641508|FG000|Overall Study|Withdrawal by Subject|6|||
128003641|NCT00902577|460641508|FG000|Overall Study|FMISO production failure|2|||
128003642|NCT00785356|460641509|FG000|Overall Study|Study prematurely terminated|8|||
128003643|NCT03238417|460641511|FG000|Overall|non-response|955|||
128003644|NCT03238417|460641512|FG001|Overall|non-response|1920|||
128003645|NCT03238417|460641511|FG000|Overall|partial completion|48|||
128003646|NCT03238417|460641512|FG001|Overall|partial completion|68|||
128003647|NCT03238417|460641511|FG000|Baseline|Partial completion|17|||
128003648|NCT03238417|460641512|FG001|Baseline|Partial completion|48|||
128003649|NCT03238417|460641511|FG000|Baseline|non-response|372|||
128003650|NCT03238417|460641512|FG001|Baseline|non-response|669|||
128003651|NCT03238417|460641511|FG000|12-month|non-response|296|||
128003652|NCT03238417|460641512|FG001|12-month|non-response|669|||
128003653|NCT03238417|460641511|FG000|12-month|partial completion|23|||
128003654|NCT03238417|460641512|FG001|12-month|partial completion|37|||
128003655|NCT03238417|460641511|FG000|24-month|non-response|287|||
128003656|NCT03238417|460641512|FG001|24-month|non-response|594|||
128003657|NCT03238417|460641511|FG000|24-month|partial completion|8|||
128003658|NCT03238417|460641512|FG001|24-month|partial completion|31|||
128003659|NCT00083915|460641513|FG000|Overall Study|Death|6|||
128003660|NCT00083915|460641514|FG001|Overall Study|Death|3|||
128003661|NCT00083915|460641513|FG000|Overall Study|Physician Decision|11|||
128003662|NCT00083915|460641514|FG001|Overall Study|Physician Decision|6|||
128003663|NCT00083915|460641513|FG000|Overall Study|Withdrawal by Subject|8|||
128003664|NCT00083915|460641514|FG001|Overall Study|Withdrawal by Subject|3|||
128003665|NCT00083915|460641513|FG000|Overall Study|disease progression|18|||
128003666|NCT00083915|460641514|FG001|Overall Study|disease progression|23|||
128003667|NCT00083915|460641513|FG000|Overall Study|Failure to collect|3|||
128003668|NCT00083915|460641514|FG001|Overall Study|Failure to collect|0|||
128003669|NCT00083915|460641513|FG000|Overall Study|No response|3|||
128003670|NCT00083915|460641514|FG001|Overall Study|No response|1|||
128003671|NCT00083915|460641513|FG000|Overall Study|Insurance issues|1|||
128003672|NCT00083915|460641514|FG001|Overall Study|Insurance issues|1|||
128003673|NCT00853762|460641515|FG000|Overall Study|Premature Termination|16|||
128003674|NCT00853762|460641516|FG001|Overall Study|Premature Termination|15|||
128003675|NCT00853762|460641517|FG002|Overall Study|Premature Termination|14|||
128003676|NCT00853762|460641518|FG003|Overall Study|Premature Termination|21|||
128003677|NCT00853762|460641515|FG000|Overall Study|Protocol Violation|0|||
128003678|NCT00853762|460641516|FG001|Overall Study|Protocol Violation|0|||
128003679|NCT00853762|460641517|FG002|Overall Study|Protocol Violation|0|||
128003680|NCT00853762|460641518|FG003|Overall Study|Protocol Violation|1|||
128003681|NCT00853762|460641515|FG000|Overall Study|Withdrawal by Subject|0|||
128003682|NCT00853762|460641516|FG001|Overall Study|Withdrawal by Subject|0|||
128003683|NCT00853762|460641517|FG002|Overall Study|Withdrawal by Subject|1|||
128003684|NCT00853762|460641518|FG003|Overall Study|Withdrawal by Subject|0|||
128003685|NCT00853762|460641515|FG000|Overall Study|Other|0|||
128003686|NCT00853762|460641516|FG001|Overall Study|Other|2|||
128003687|NCT00853762|460641517|FG002|Overall Study|Other|0|||
128003688|NCT00853762|460641518|FG003|Overall Study|Other|0|||
128003689|NCT00853762|460641515|FG000|Overall Study|Randomised but not Treated|0|||
128003690|NCT00853762|460641516|FG001|Overall Study|Randomised but not Treated|2|||
128003691|NCT00853762|460641517|FG002|Overall Study|Randomised but not Treated|2|||
128003692|NCT00853762|460641518|FG003|Overall Study|Randomised but not Treated|0|||
128003693|NCT02000921|460641521|FG000|Overall Study|Withdrawal by Subject|3|||
128003694|NCT02000921|460641522|FG001|Overall Study|Withdrawal by Subject|10|||
128003695|NCT02000921|460641523|FG002|Overall Study|Withdrawal by Subject|5|||
128003696|NCT02000921|460641521|FG000|Overall Study|Lost to Follow-up|2|||
128003697|NCT02000921|460641522|FG001|Overall Study|Lost to Follow-up|4|||
128003698|NCT02000921|460641523|FG002|Overall Study|Lost to Follow-up|5|||
128003699|NCT02000921|460641521|FG000|Overall Study|Physician Decision|0|||
128003700|NCT02000921|460641522|FG001|Overall Study|Physician Decision|2|||
127671542|NCT00886613|459420978|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
128003701|NCT02000921|460641523|FG002|Overall Study|Physician Decision|0|||
128003702|NCT00106002|460641524|FG000|Overall Study|Did not take any study drug|1|||
128003703|NCT00106002|460641524|FG000|Overall Study|Ineligible after Registration|1|||
128003704|NCT01245101|460641527|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
128003705|NCT01245101|460641528|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
128003706|NCT01245101|460641527|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
128003707|NCT01245101|460641528|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
128003708|NCT01245101|460641527|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
128003709|NCT01245101|460641528|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
128003710|NCT04456686|460641531|FG000|Overall Study|Adverse Event|2|||
128003711|NCT04456686|460641532|FG001|Overall Study|Adverse Event|1|||
128003712|NCT04456686|460641531|FG000|Overall Study|Lack of Efficacy|3|||
128003713|NCT04456686|460641532|FG001|Overall Study|Lack of Efficacy|1|||
128003714|NCT04456686|460641531|FG000|Overall Study|Withdrew consent|3|||
128003715|NCT04456686|460641532|FG001|Overall Study|Withdrew consent|1|||
128003716|NCT04456686|460641531|FG000|Overall Study|Physician Decision|2|||
128003717|NCT04456686|460641532|FG001|Overall Study|Physician Decision|2|||
128003718|NCT04456686|460641531|FG000|Overall Study|Withdrawal by Subject|5|||
128003719|NCT04456686|460641532|FG001|Overall Study|Withdrawal by Subject|1|||
128003720|NCT04456686|460641531|FG000|Overall Study|Protocol Violation|0|||
128003721|NCT04456686|460641532|FG001|Overall Study|Protocol Violation|1|||
128003722|NCT00891813|460641533|FG000|Overall Study|Adverse Event|3|||
128003723|NCT00891813|460641533|FG000|Overall Study|Withdrawal by Subject|1|||
128003724|NCT00891813|460641533|FG000|Overall Study|Patient Noncompliance|6|||
128003725|NCT00891813|460641533|FG000|Overall Study|Protocol Violation|2|||
128003726|NCT00473083|460641538|FG000|Overall Study|Adverse Event|1|||
128003727|NCT00473083|460641539|FG001|Overall Study|Adverse Event|0|||
128003728|NCT00473083|460641540|FG002|Overall Study|Adverse Event|0|||
128003729|NCT02915835|460641541|FG000|Overall Study|Physician Decision|1|||
128003730|NCT02915835|460641542|FG001|Overall Study|Physician Decision|0|||
128003731|NCT02915835|460641541|FG000|Overall Study|Withdrawal by Subject|0|||
128003732|NCT02915835|460641542|FG001|Overall Study|Withdrawal by Subject|1|||
128003733|NCT03722576|460641543|FG000|Overall Study|Withdrawal by Subject|3|||
128003734|NCT03722576|460641543|FG000|Overall Study|Adverse Event|2|||
128003735|NCT03722576|460641543|FG000|Overall Study|Physician Decision|1|||
128003736|NCT03722576|460641543|FG000|Overall Study|Lost to Follow-up|1|||
128003737|NCT00192114|460641546|FG000|Overall Study|Objective Tumor Progression|19|||
128003738|NCT00192114|460641546|FG000|Overall Study|Adverse Event|2|||
128003739|NCT00192114|460641546|FG000|Overall Study|Clinical Progression|2|||
128003740|NCT00192114|460641546|FG000|Overall Study|Death|1|||
128003741|NCT00113607|460641547|FG000|Overall Study|Adverse Event|40|||
128003742|NCT00113607|460641548|FG001|Overall Study|Adverse Event|71|||
128003743|NCT00113607|460641547|FG000|Overall Study|Death|8|||
128003744|NCT00113607|460641548|FG001|Overall Study|Death|8|||
128003745|NCT00113607|460641547|FG000|Overall Study|Withdrawal by Subject|50|||
128003746|NCT00113607|460641548|FG001|Overall Study|Withdrawal by Subject|58|||
128003747|NCT00113607|460641547|FG000|Overall Study|Lost to Follow-up|0|||
128003748|NCT00113607|460641548|FG001|Overall Study|Lost to Follow-up|2|||
128003749|NCT00113607|460641547|FG000|Overall Study|Disease Progression|180|||
128003750|NCT00113607|460641548|FG001|Overall Study|Disease Progression|142|||
128003751|NCT00113607|460641547|FG000|Overall Study|Complete Response (Confirmed)|14|||
128003752|NCT00113607|460641548|FG001|Overall Study|Complete Response (Confirmed)|24|||
128003753|NCT00113607|460641547|FG000|Overall Study|Other|43|||
127671543|NCT00886613|459420979|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
127671544|NCT00886613|459420980|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
127671545|NCT04541186|459420982|FG000|Main Study|Adverse Event|0|||
127671546|NCT04541186|459420983|FG001|Main Study|Adverse Event|0|||
127671547|NCT04541186|459420984|FG002|Main Study|Adverse Event|4|||
127671548|NCT04541186|459420985|FG003|Main Study|Adverse Event|0|||
127671549|NCT04541186|459420986|FG004|Main Study|Adverse Event|0|||
127671550|NCT04541186|459420982|FG000|Main Study|Investigator Decision|0|||
127671551|NCT04541186|459420983|FG001|Main Study|Investigator Decision|0|||
127671552|NCT04541186|459420984|FG002|Main Study|Investigator Decision|1|||
127671553|NCT04541186|459420985|FG003|Main Study|Investigator Decision|1|||
127671554|NCT04541186|459420986|FG004|Main Study|Investigator Decision|0|||
127671555|NCT04541186|459420982|FG000|Main Study|Withdrawal by Subject|1|||
127671556|NCT04541186|459420983|FG001|Main Study|Withdrawal by Subject|1|||
127671557|NCT04541186|459420984|FG002|Main Study|Withdrawal by Subject|0|||
127671558|NCT04541186|459420985|FG003|Main Study|Withdrawal by Subject|0|||
127671559|NCT04541186|459420986|FG004|Main Study|Withdrawal by Subject|0|||
127671560|NCT04541186|459420982|FG000|Main Study|COVID-19-related Dose Interruption|0|||
127671561|NCT04541186|459420983|FG001|Main Study|COVID-19-related Dose Interruption|0|||
127671562|NCT04541186|459420984|FG002|Main Study|COVID-19-related Dose Interruption|0|||
127671563|NCT04541186|459420985|FG003|Main Study|COVID-19-related Dose Interruption|0|||
127671564|NCT04541186|459420986|FG004|Main Study|COVID-19-related Dose Interruption|1|||
128003754|NCT00113607|460641548|FG001|Overall Study|Other|32|||
128003755|NCT01222104|460641549|FG000|Overall Study|Lost to Follow-up|37|||
128003756|NCT01222104|460641549|FG000|Overall Study|Death|10|||
128003757|NCT01418339|460641550|FG000|Overall Study|Adverse Event|5|||
128003758|NCT01418339|460641551|FG001|Overall Study|Adverse Event|2|||
128003759|NCT01418339|460641550|FG000|Overall Study|Subject Withdrew Consent|1|||
128003760|NCT01418339|460641551|FG001|Overall Study|Subject Withdrew Consent|2|||
128003761|NCT01418339|460641550|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
128003762|NCT01418339|460641551|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
128003763|NCT03885908|460641552|FG000|Overall Study|Patient deemed to be ineligible due to language preference|1|||
128003764|NCT03885908|460641553|FG001|Overall Study|Patient deemed to be ineligible due to language preference|0|||
128003765|NCT03885908|460641552|FG000|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|1|||
127671565|NCT04541186|459420982|FG000|Main Study|Randomized in Error Not Treated|0|||
127671566|NCT04541186|459420983|FG001|Main Study|Randomized in Error Not Treated|0|||
127671567|NCT04541186|459420984|FG002|Main Study|Randomized in Error Not Treated|1|||
128003766|NCT03885908|460641553|FG001|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|0|||
128003767|NCT03885908|460641552|FG000|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
128003768|NCT03885908|460641553|FG001|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
128003769|NCT03885908|460641552|FG000|Overall Study|Patient unable to complete appointment - withdrawn from study|0|||
128003770|NCT03885908|460641553|FG001|Overall Study|Patient unable to complete appointment - withdrawn from study|1|||
128003771|NCT00909844|460641554|FG000|Overall Study|Adverse Event|1|||
128003772|NCT00909844|460641554|FG000|Overall Study|Withdrawal by Subject|1|||
128003773|NCT00909844|460641554|FG000|Overall Study|Lost to Follow-up|2|||
128003774|NCT00706004|460641555|FG000|Overall Study|Did not meet eligibility criteria|2|||
127671568|NCT04541186|459420985|FG003|Main Study|Randomized in Error Not Treated|0|||
127671569|NCT04541186|459420986|FG004|Main Study|Randomized in Error Not Treated|0|||
128003775|NCT01064479|460641556|FG000|Overall Study|Death|10|||
128003776|NCT01064479|460641557|FG001|Overall Study|Death|11|||
128003777|NCT01064479|460641556|FG000|Overall Study|Withdrawal by Subject|2|||
128003778|NCT01064479|460641557|FG001|Overall Study|Withdrawal by Subject|2|||
128003779|NCT01064479|460641556|FG000|Overall Study|Disease progression|1|||
128003780|NCT01064479|460641557|FG001|Overall Study|Disease progression|1|||
128003781|NCT01064479|460641556|FG000|Overall Study|Toxicity|1|||
128003782|NCT01064479|460641557|FG001|Overall Study|Toxicity|1|||
128003783|NCT01064479|460641556|FG000|Overall Study|Other|1|||
128003784|NCT01064479|460641557|FG001|Overall Study|Other|2|||
128003785|NCT00749398|460641558|FG000|Overall Study|Lack of Efficacy|7|||
128003786|NCT00749398|460641558|FG000|Overall Study|Adverse Event|4|||
128003787|NCT00749398|460641558|FG000|Overall Study|Serious adverse event|11|||
128003788|NCT00749398|460641558|FG000|Overall Study|Withdrawal by Subject|17|||
128003789|NCT00749398|460641558|FG000|Overall Study|Lost to Follow-up|11|||
128003790|NCT00749398|460641558|FG000|Overall Study|Reason not specified|2|||
128003791|NCT00749398|460641558|FG000|Overall Study|Unknown reason|1|||
128003792|NCT03093181|460641562|FG000|Overall Study|Withdrawal by Subject|2|||
128003793|NCT03093181|460641563|FG001|Overall Study|Withdrawal by Subject|1|||
128003794|NCT03093181|460641564|FG002|Overall Study|Withdrawal by Subject|2|||
127671570|NCT04541186|459420982|FG000|Fibrate Expansion Study|Other than Specified|0|||
127671571|NCT04541186|459420983|FG001|Fibrate Expansion Study|Other than Specified|0|||
127671572|NCT04541186|459420984|FG002|Fibrate Expansion Study|Other than Specified|0|||
127671573|NCT04541186|459420985|FG003|Fibrate Expansion Study|Other than Specified|0|||
127671574|NCT04541186|459420986|FG004|Fibrate Expansion Study|Other than Specified|1|||
127671575|NCT00691028|459420987|FG000|Open-label Period|Adverse Event|0|||
127671576|NCT00691028|459420988|FG001|Open-label Period|Adverse Event|0|||
127671577|NCT00691028|459420989|FG002|Open-label Period|Adverse Event|0|||
127671578|NCT00691028|459420990|FG003|Open-label Period|Adverse Event|16|||
127671579|NCT00691028|459420987|FG000|Open-label Period|Withdrawal by Subject|0|||
127671580|NCT00691028|459420988|FG001|Open-label Period|Withdrawal by Subject|0|||
127671581|NCT00691028|459420989|FG002|Open-label Period|Withdrawal by Subject|0|||
127671582|NCT00691028|459420990|FG003|Open-label Period|Withdrawal by Subject|3|||
127671583|NCT00691028|459420987|FG000|Open-label Period|not come to a hospital|0|||
127671584|NCT00691028|459420988|FG001|Open-label Period|not come to a hospital|0|||
127671585|NCT00691028|459420989|FG002|Open-label Period|not come to a hospital|0|||
127671586|NCT00691028|459420990|FG003|Open-label Period|not come to a hospital|1|||
127671587|NCT00691028|459420987|FG000|Double-blind Period|Adverse Event|8|||
127671588|NCT00691028|459420988|FG001|Double-blind Period|Adverse Event|9|||
127671589|NCT00691028|459420989|FG002|Double-blind Period|Adverse Event|6|||
127671590|NCT00691028|459420990|FG003|Double-blind Period|Adverse Event|0|||
127671591|NCT00691028|459420987|FG000|Double-blind Period|Lack of Efficacy|4|||
127671592|NCT00691028|459420988|FG001|Double-blind Period|Lack of Efficacy|3|||
127671593|NCT00691028|459420989|FG002|Double-blind Period|Lack of Efficacy|2|||
127671594|NCT00691028|459420990|FG003|Double-blind Period|Lack of Efficacy|0|||
127671595|NCT00691028|459420987|FG000|Double-blind Period|Withdrawal by Subject|1|||
127671596|NCT00691028|459420988|FG001|Double-blind Period|Withdrawal by Subject|0|||
127671597|NCT00691028|459420989|FG002|Double-blind Period|Withdrawal by Subject|1|||
127671598|NCT00691028|459420990|FG003|Double-blind Period|Withdrawal by Subject|0|||
127671599|NCT00691028|459420987|FG000|Double-blind Period|not come to a hospital.|0|||
127671600|NCT00691028|459420988|FG001|Double-blind Period|not come to a hospital.|1|||
127671601|NCT00691028|459420989|FG002|Double-blind Period|not come to a hospital.|0|||
127671602|NCT00691028|459420990|FG003|Double-blind Period|not come to a hospital.|0|||
127671603|NCT03255018|459420994|FG000|Overall Study|Death on study|0|||
127671604|NCT03255018|459420995|FG001|Overall Study|Death on study|5|||
127671605|NCT03255018|459420994|FG000|Overall Study|Withdrawal by Subject|0|||
127671606|NCT03255018|459420995|FG001|Overall Study|Withdrawal by Subject|2|||
127671607|NCT00748969|459420996|FG000|Overall Study|Withdrawal by Subject|1|||
128003795|NCT03093181|460641562|FG000|Overall Study|Other (Not specified)|1|||
128003796|NCT03093181|460641563|FG001|Overall Study|Other (Not specified)|0|||
128003797|NCT03093181|460641564|FG002|Overall Study|Other (Not specified)|0|||
128003798|NCT03093181|460641562|FG000|Overall Study|Adverse Event|0|||
128003799|NCT03093181|460641563|FG001|Overall Study|Adverse Event|1|||
128003800|NCT03093181|460641564|FG002|Overall Study|Adverse Event|0|||
127671608|NCT00748969|459420997|FG001|Overall Study|Withdrawal by Subject|0|||
127671609|NCT00748969|459420996|FG000|Overall Study|Withdrawal by Subject|0|||
127671610|NCT00748969|459420997|FG001|Overall Study|Withdrawal by Subject|1|||
127671611|NCT02334306|459420998|FG000|Double-blind Period|Adverse Event|0|||
127671612|NCT02334306|459420999|FG001|Double-blind Period|Adverse Event|1|||
127671613|NCT02334306|459420998|FG000|Double-blind Period|Withdrawal by Subject|1|||
127671614|NCT02334306|459420999|FG001|Double-blind Period|Withdrawal by Subject|1|||
127671615|NCT00465985|459421000|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
127671616|NCT00465985|459421001|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
127671617|NCT00465985|459421000|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
127671618|NCT00465985|459421001|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
127671619|NCT00465985|459421000|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
127671620|NCT00465985|459421001|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
127671621|NCT00465985|459421000|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
127671622|NCT00465985|459421001|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
127671623|NCT03532178|459421002|FG000|First Period|Withdrawal by Subject|1|||
127671624|NCT03532178|459421003|FG001|First Period|Withdrawal by Subject|3|||
127671625|NCT03532178|459421002|FG000|First Period|technical issues in data collection Technical issues|0|||
127671626|NCT03532178|459421003|FG001|First Period|technical issues in data collection Technical issues|1|||
128003801|NCT03093181|460641562|FG000|Overall Study|Other (Protocol violation)|0|||
127671627|NCT03532178|459421002|FG000|Second Period|Withdrawal by Subject|1|||
127671628|NCT03532178|459421003|FG001|Second Period|Withdrawal by Subject|1|||
127671629|NCT03532178|459421002|FG000|Second Period|Technical issues|0|||
127671630|NCT03532178|459421003|FG001|Second Period|Technical issues|1|||
127671631|NCT03302156|459421004|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
127671632|NCT03302156|459421005|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
127671633|NCT03302156|459421006|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
127671634|NCT02390557|459421007|FG000|Wave 2|Survey non-respondent|72|||
127671635|NCT02390557|459421008|FG001|Wave 2|Survey non-respondent|41|||
127671636|NCT02390557|459421009|FG002|Wave 2|Survey non-respondent|23|||
127671637|NCT03278028|459421013|FG000|Overall Study|Lost to Follow-up|1|||
127671638|NCT03278028|459421014|FG001|Overall Study|Lost to Follow-up|0|||
127671639|NCT03278028|459421013|FG000|Overall Study|Withdrawal by Subject|3|||
127671640|NCT03278028|459421014|FG001|Overall Study|Withdrawal by Subject|1|||
127671641|NCT03278028|459421013|FG000|Overall Study|Pregnancy|0|||
127671642|NCT03278028|459421014|FG001|Overall Study|Pregnancy|1|||
127671643|NCT01813422|459421016|FG000|Overall Study|Withdrawal by Subject|14|||
127671644|NCT01813422|459421017|FG001|Overall Study|Withdrawal by Subject|8|||
127671645|NCT01813422|459421016|FG000|Overall Study|Death|2|||
127671646|NCT01813422|459421017|FG001|Overall Study|Death|3|||
127671647|NCT01813422|459421016|FG000|Overall Study|Sponsor Decision|2|||
127671648|NCT01813422|459421017|FG001|Overall Study|Sponsor Decision|1|||
127671649|NCT01813422|459421016|FG000|Overall Study|Lost to Follow-up|2|||
127671650|NCT01813422|459421017|FG001|Overall Study|Lost to Follow-up|4|||
127671651|NCT01653743|459421018|FG000|Overall Study|Withdrawal by Subject|1|||
127671652|NCT01653743|459421019|FG001|Overall Study|Withdrawal by Subject|0|||
127671653|NCT01653743|459421018|FG000|Overall Study|Investigator discretion|3|||
127671654|NCT01653743|459421019|FG001|Overall Study|Investigator discretion|0|||
127671655|NCT04889118|459421021|FG000|Overall Study|Death|33|||
127671656|NCT04889118|459421022|FG001|Overall Study|Death|37|||
127671657|NCT04889118|459421021|FG000|Overall Study|Ongoing in Study|31|||
127671658|NCT04889118|459421022|FG001|Overall Study|Ongoing in Study|30|||
127671659|NCT01763047|459421037|FG000|Period 1|Test Article Not Available|4|||
128003802|NCT03093181|460641563|FG001|Overall Study|Other (Protocol violation)|0|||
128003803|NCT03093181|460641564|FG002|Overall Study|Other (Protocol violation)|1|||
128003804|NCT04210986|460641565|FG000|Overall Study|Lost to Follow-up|5|||
128003805|NCT04210986|460641566|FG001|Overall Study|Lost to Follow-up|2|||
128003806|NCT04210986|460641565|FG000|Overall Study|Withdrawal by Subject|3|||
128003807|NCT04210986|460641566|FG001|Overall Study|Withdrawal by Subject|1|||
128003808|NCT04210986|460641565|FG000|Overall Study|Protocol Violation|1|||
128003809|NCT04210986|460641566|FG001|Overall Study|Protocol Violation|1|||
128003810|NCT04210986|460641565|FG000|Overall Study|Physician Decision|0|||
128003811|NCT04210986|460641566|FG001|Overall Study|Physician Decision|1|||
127671660|NCT01763047|459421038|FG001|Period 1|Test Article Not Available|1|||
127671661|NCT01763047|459421037|FG000|Period 1|Protocol Violation|4|||
127671662|NCT01763047|459421038|FG001|Period 1|Protocol Violation|4|||
127671663|NCT01763047|459421037|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
127671664|NCT01763047|459421038|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
127671665|NCT01763047|459421037|FG000|Period 1|Adverse Event|0|||
127671666|NCT01763047|459421038|FG001|Period 1|Adverse Event|1|||
127671667|NCT01763047|459421037|FG000|Period 1|Unsatisfactory Visual Response|0|||
127671668|NCT01763047|459421038|FG001|Period 1|Unsatisfactory Visual Response|3|||
128003812|NCT02378662|460641567|FG000|Overall Study|Early Discontinuation|2|||
127543513|NCT02718898|458956555|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
127671669|NCT01763047|459421037|FG000|Period 1|Lens Power Not Available|0|||
128003813|NCT02378662|460641568|FG001|Overall Study|Early Discontinuation|0|||
128003814|NCT01701245|460641569|FG000|Overall Study|Protocol Violation|1|||
128003815|NCT01701245|460641570|FG001|Overall Study|Protocol Violation|3|||
128003816|NCT01701245|460641569|FG000|Overall Study|Did not complete the open label period|11|||
128003817|NCT01701245|460641570|FG001|Overall Study|Did not complete the open label period|12|||
128003818|NCT01159574|460641571|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
127671670|NCT01763047|459421038|FG001|Period 1|Lens Power Not Available|1|||
127671671|NCT01763047|459421037|FG000|Period 1|Study Site office Closed|0|||
127671672|NCT01763047|459421038|FG001|Period 1|Study Site office Closed|1|||
127671673|NCT01763047|459421037|FG000|Period 2|Lens Discomfort|1|||
127671674|NCT01763047|459421038|FG001|Period 2|Lens Discomfort|0|||
127671675|NCT01763047|459421037|FG000|Period 2|No longer meets Eligibility Criteria|1|||
127671676|NCT01763047|459421038|FG001|Period 2|No longer meets Eligibility Criteria|0|||
127671677|NCT01763047|459421037|FG000|Period 2|Study Site office Closed|1|||
127671678|NCT01763047|459421038|FG001|Period 2|Study Site office Closed|1|||
127671679|NCT01763047|459421037|FG000|Period 2|Unsatisfactory Visual Response|1|||
127671680|NCT01763047|459421038|FG001|Period 2|Unsatisfactory Visual Response|1|||
127671681|NCT01763047|459421037|FG000|Period 2|Protocol Violation|0|||
127671682|NCT01763047|459421038|FG001|Period 2|Protocol Violation|2|||
127671683|NCT01763047|459421037|FG000|Period 2|Unsatisfactory lens Fitting|0|||
127671684|NCT01763047|459421038|FG001|Period 2|Unsatisfactory lens Fitting|1|||
127671685|NCT03124108|459421041|FG000|Overall Study|Adverse Event|0|||
127671686|NCT03124108|459421042|FG001|Overall Study|Adverse Event|1|||
127671687|NCT03124108|459421043|FG002|Overall Study|Adverse Event|0|||
127671688|NCT03686384|459421044|FG000|Overall Study|Lack of Efficacy|4|||
127671689|NCT03686384|459421045|FG001|Overall Study|Lack of Efficacy|13|||
127671690|NCT03686384|459421044|FG000|Overall Study|Lost to Follow-up|3|||
127671691|NCT03686384|459421045|FG001|Overall Study|Lost to Follow-up|0|||
127671692|NCT03686384|459421044|FG000|Overall Study|Physician Decision|0|||
127671693|NCT03686384|459421045|FG001|Overall Study|Physician Decision|1|||
127671694|NCT03686384|459421044|FG000|Overall Study|Took prohibited medication|0|||
127671695|NCT03686384|459421045|FG001|Overall Study|Took prohibited medication|1|||
127671696|NCT02820051|459421048|FG000|Overall Study|Lost to Follow-up|7|||
127671697|NCT02820051|459421049|FG001|Overall Study|Lost to Follow-up|4|||
127671698|NCT01222247|459421050|FG000|Overall Study|Lost to Follow-up|2|||
127671699|NCT01222247|459421051|FG001|Overall Study|Lost to Follow-up|2|||
127671700|NCT01767909|459421052|FG000|Overall Study|Withdrawal by Subject|4|||
127671701|NCT01767909|459421053|FG001|Overall Study|Withdrawal by Subject|7|||
127671702|NCT01767909|459421052|FG000|Overall Study|Adverse Event|3|||
127671703|NCT01767909|459421053|FG001|Overall Study|Adverse Event|1|||
127671704|NCT01767909|459421052|FG000|Overall Study|Withdrawal by Study Partner|3|||
127671705|NCT01767909|459421053|FG001|Overall Study|Withdrawal by Study Partner|1|||
127671706|NCT01767909|459421052|FG000|Overall Study|Non-Compliance|2|||
127671707|NCT01767909|459421053|FG001|Overall Study|Non-Compliance|0|||
127671708|NCT01767909|459421052|FG000|Overall Study|Perceived Lack of Efficacy|1|||
127671709|NCT01767909|459421053|FG001|Overall Study|Perceived Lack of Efficacy|0|||
127671710|NCT01767909|459421052|FG000|Overall Study|Investigator Recommendation|0|||
127671711|NCT01767909|459421053|FG001|Overall Study|Investigator Recommendation|1|||
127671712|NCT01767909|459421052|FG000|Overall Study|Lost to Follow-up|0|||
127671713|NCT01767909|459421053|FG001|Overall Study|Lost to Follow-up|1|||
127671714|NCT01767909|459421052|FG000|Overall Study|LP uncessessful|0|||
127671715|NCT01767909|459421053|FG001|Overall Study|LP uncessessful|1|||
127671716|NCT04939428|459421054|FG000|Overall Study|Death|0|||
127671717|NCT04939428|459421055|FG001|Overall Study|Death|1|||
127671718|NCT04939428|459421056|FG002|Overall Study|Death|0|||
127671719|NCT04939428|459421054|FG000|Overall Study|Lost to Follow-up|0|||
127671720|NCT04939428|459421055|FG001|Overall Study|Lost to Follow-up|5|||
127671721|NCT04939428|459421056|FG002|Overall Study|Lost to Follow-up|0|||
127671722|NCT04939428|459421054|FG000|Overall Study|Physician Decision|1|||
127671723|NCT04939428|459421055|FG001|Overall Study|Physician Decision|0|||
128003819|NCT01159574|460641571|FG000|Treatment Phase|Adverse Event|3|||
128003820|NCT01159574|460641571|FG000|Treatment Phase|Death|6|||
127671724|NCT04939428|459421056|FG002|Overall Study|Physician Decision|0|||
127671725|NCT04939428|459421054|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
127671726|NCT04939428|459421055|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
127671727|NCT04939428|459421056|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
127671728|NCT04939428|459421054|FG000|Overall Study|Withdrawal by Subject|10|||
127671729|NCT04939428|459421055|FG001|Overall Study|Withdrawal by Subject|11|||
127671730|NCT04939428|459421056|FG002|Overall Study|Withdrawal by Subject|0|||
127671731|NCT04939428|459421054|FG000|Overall Study|Unkown|6|||
127671732|NCT04939428|459421055|FG001|Overall Study|Unkown|3|||
127671733|NCT04939428|459421056|FG002|Overall Study|Unkown|0|||
127671734|NCT04939428|459421054|FG000|Overall Study|Discotinued per protocol|0|||
128003821|NCT01159574|460641571|FG000|Treatment Phase|Physician Decision|2|||
128003822|NCT01159574|460641571|FG000|Treatment Phase|Withdrawal by Subject|7|||
127671735|NCT04939428|459421055|FG001|Overall Study|Discotinued per protocol|0|||
127671736|NCT04939428|459421056|FG002|Overall Study|Discotinued per protocol|902|||
127671737|NCT04639947|459421059|FG000|Overall Study|Screen fail|1|||
128003823|NCT01159574|460641571|FG000|Treatment Phase|still on treatment|2|||
128003824|NCT01159574|460641571|FG000|Follow Up Phase|Lost to Follow-up|2|||
128003825|NCT01159574|460641571|FG000|Follow Up Phase|still being followed for overall surviva|18|||
128003826|NCT02666222|460641573|FG000|Overall Study|Death|2|||
128003827|NCT01474486|460641575|FG000|Overall Study|Death|2|||
128003828|NCT01474486|460641575|FG000|Overall Study|Withdrawal by Subject|4|||
128003829|NCT01474486|460641575|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
128003830|NCT03504917|460641576|FG000|Blinded Treatment Period|Protocol Violation|1|||
128003831|NCT03504917|460641577|FG001|Blinded Treatment Period|Protocol Violation|0|||
128003832|NCT03504917|460641576|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
128003833|NCT03504917|460641577|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
128003834|NCT03504917|460641576|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
128003835|NCT03504917|460641577|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
128003836|NCT03504917|460641576|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
128003837|NCT03504917|460641577|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
128003838|NCT03504917|460641576|FG000|Blinded Treatment Period|Adverse Event|4|||
128003839|NCT03504917|460641577|FG001|Blinded Treatment Period|Adverse Event|4|||
128003840|NCT03504917|460641576|FG000|Blinded Treatment Period|Physician Decision|1|||
128003841|NCT03504917|460641577|FG001|Blinded Treatment Period|Physician Decision|0|||
128003842|NCT03504917|460641576|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
128003843|NCT03504917|460641577|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
128003844|NCT03504917|460641576|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
128003845|NCT03504917|460641577|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
128003846|NCT03504917|460641576|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
128003847|NCT03504917|460641577|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
128003848|NCT03504917|460641576|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
128003849|NCT03504917|460641577|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
128003850|NCT03504917|460641576|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
127671738|NCT02696785|459421062|FG000|Blinded Treatment Period|Adverse Event|0|||
127671739|NCT02696785|459421063|FG001|Blinded Treatment Period|Adverse Event|1|||
127671740|NCT02696785|459421064|FG002|Blinded Treatment Period|Adverse Event|3|||
127671741|NCT02696785|459421065|FG003|Blinded Treatment Period|Adverse Event|0|||
127671742|NCT02696785|459421062|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
127671743|NCT02696785|459421063|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
127671744|NCT02696785|459421064|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
127671745|NCT02696785|459421065|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
127671746|NCT02696785|459421062|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
127671747|NCT02696785|459421063|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
127671748|NCT02696785|459421064|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
127671749|NCT02696785|459421065|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
127671750|NCT02696785|459421062|FG000|Blinded Treatment Period|Screen Failure|1|||
127671751|NCT02696785|459421063|FG001|Blinded Treatment Period|Screen Failure|0|||
127671752|NCT02696785|459421064|FG002|Blinded Treatment Period|Screen Failure|0|||
127671753|NCT02696785|459421065|FG003|Blinded Treatment Period|Screen Failure|0|||
127671754|NCT02696785|459421062|FG000|Washout Period|Withdrawal by Subject|0|||
127671755|NCT02696785|459421063|FG001|Washout Period|Withdrawal by Subject|1|||
127671756|NCT02696785|459421064|FG002|Washout Period|Withdrawal by Subject|0|||
127671757|NCT02696785|459421065|FG003|Washout Period|Withdrawal by Subject|0|||
127671758|NCT02696785|459421062|FG000|Washout Period|Lack of Efficacy|0|||
127671759|NCT02696785|459421063|FG001|Washout Period|Lack of Efficacy|1|||
127671760|NCT02696785|459421064|FG002|Washout Period|Lack of Efficacy|0|||
127671761|NCT02696785|459421065|FG003|Washout Period|Lack of Efficacy|0|||
127671762|NCT02696785|459421062|FG000|Extended Treatment Period|Adverse Event|2|||
127671763|NCT02696785|459421063|FG001|Extended Treatment Period|Adverse Event|3|||
127671764|NCT02696785|459421064|FG002|Extended Treatment Period|Adverse Event|2|||
127671765|NCT02696785|459421065|FG003|Extended Treatment Period|Adverse Event|1|||
127671766|NCT02696785|459421062|FG000|Extended Treatment Period|Lack of Efficacy|0|||
127671767|NCT02696785|459421063|FG001|Extended Treatment Period|Lack of Efficacy|1|||
127671768|NCT02696785|459421064|FG002|Extended Treatment Period|Lack of Efficacy|0|||
127671769|NCT02696785|459421065|FG003|Extended Treatment Period|Lack of Efficacy|0|||
127671770|NCT02696785|459421062|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
127671771|NCT02696785|459421063|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
127671772|NCT02696785|459421064|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
127671773|NCT02696785|459421065|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
127671774|NCT02696785|459421062|FG000|Follow-up Period|Adverse Event|0|||
128003851|NCT03504917|460641577|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
128003852|NCT03504917|460641576|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
127671775|NCT02696785|459421063|FG001|Follow-up Period|Adverse Event|0|||
127671776|NCT02696785|459421064|FG002|Follow-up Period|Adverse Event|8|||
127671777|NCT02696785|459421065|FG003|Follow-up Period|Adverse Event|2|||
127671778|NCT02696785|459421062|FG000|Follow-up Period|Lost to Follow-up|0|||
127671779|NCT02696785|459421063|FG001|Follow-up Period|Lost to Follow-up|0|||
127671780|NCT02696785|459421064|FG002|Follow-up Period|Lost to Follow-up|0|||
127671781|NCT02696785|459421065|FG003|Follow-up Period|Lost to Follow-up|1|||
127671782|NCT02696785|459421062|FG000|Follow-up Period|Lack of Efficacy|0|||
127671783|NCT02696785|459421063|FG001|Follow-up Period|Lack of Efficacy|0|||
127671784|NCT02696785|459421064|FG002|Follow-up Period|Lack of Efficacy|0|||
127671785|NCT02696785|459421065|FG003|Follow-up Period|Lack of Efficacy|1|||
128003853|NCT03504917|460641577|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
128003854|NCT03504917|460641576|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
128003855|NCT03504917|460641577|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
128003856|NCT03504917|460641576|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
128003857|NCT03504917|460641577|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
128003858|NCT03504917|460641576|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
128003859|NCT03504917|460641577|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
128003860|NCT03504917|460641576|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
128003861|NCT03504917|460641577|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
128003862|NCT04219189|460641578|FG000|Overall Study|Withdrawal by Subject|1|||
128003863|NCT04219189|460641579|FG001|Overall Study|Withdrawal by Subject|2|||
128003864|NCT04219189|460641578|FG000|Overall Study|Protocol Violation|0|||
128003865|NCT04219189|460641579|FG001|Overall Study|Protocol Violation|1|||
128003866|NCT04219189|460641578|FG000|Overall Study|Lost to Follow-up|0|||
128003867|NCT04219189|460641579|FG001|Overall Study|Lost to Follow-up|1|||
128003868|NCT04219189|460641578|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
128003869|NCT04219189|460641579|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
128003870|NCT03101020|460641580|FG000|Overall Study|Lack of time to participate|1|||
127543514|NCT02718898|458956556|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
127543515|NCT02718898|458956557|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
127543516|NCT02718898|458956551|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
127543517|NCT02718898|458956552|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
127543518|NCT02718898|458956553|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
127543519|NCT02718898|458956554|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
127543520|NCT02718898|458956555|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
127543521|NCT02718898|458956556|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
127543522|NCT02718898|458956557|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
127543523|NCT02718898|458956551|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
127543524|NCT02718898|458956552|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
127543525|NCT02718898|458956553|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
127543526|NCT02718898|458956554|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
127543527|NCT02718898|458956555|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
127543528|NCT02718898|458956556|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
127543529|NCT02718898|458956557|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
127543530|NCT02718898|458956551|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
127671786|NCT02696785|459421062|FG000|Follow-up Period|Withdrawal by Subject|1|||
127671787|NCT02696785|459421063|FG001|Follow-up Period|Withdrawal by Subject|0|||
128003871|NCT03101020|460641581|FG001|Overall Study|Lack of time to participate|0|||
128003872|NCT03101020|460641580|FG000|Overall Study|Ran over by a car|0|||
128003873|NCT03101020|460641581|FG001|Overall Study|Ran over by a car|1|||
128003874|NCT03101020|460641580|FG000|Overall Study|Withdrawal by Subject|0|||
128003875|NCT03101020|460641581|FG001|Overall Study|Withdrawal by Subject|2|||
128003876|NCT04233879|460641582|FG000|Overall Study|Death|2|||
128003877|NCT04233879|460641583|FG001|Overall Study|Death|0|||
128003878|NCT04233879|460641582|FG000|Overall Study|Lost to Follow-up|3|||
128003879|NCT04233879|460641583|FG001|Overall Study|Lost to Follow-up|8|||
128003880|NCT04233879|460641582|FG000|Overall Study|Physician Decision|4|||
128003881|NCT04233879|460641583|FG001|Overall Study|Physician Decision|4|||
128003882|NCT04233879|460641582|FG000|Overall Study|Withdrawal by Subject|7|||
128003883|NCT04233879|460641583|FG001|Overall Study|Withdrawal by Subject|10|||
128003884|NCT04233879|460641582|FG000|Overall Study|Other|281|||
128003885|NCT04233879|460641583|FG001|Overall Study|Other|279|||
128003886|NCT03585270|460641586|FG000|Overall Study|Withdrawal by Subject|2|||
128003887|NCT03585270|460641587|FG001|Overall Study|Withdrawal by Subject|6|||
128003888|NCT03585270|460641586|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
128003889|NCT03585270|460641587|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
128003890|NCT03585270|460641586|FG000|Overall Study|Adverse Event|5|||
128003891|NCT03585270|460641587|FG001|Overall Study|Adverse Event|2|||
128003892|NCT03585270|460641586|FG000|Overall Study|Lost to Follow-up|1|||
128003893|NCT03585270|460641587|FG001|Overall Study|Lost to Follow-up|4|||
128003894|NCT03585270|460641586|FG000|Overall Study|Death|5|||
127543531|NCT02718898|458956552|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
128003895|NCT03585270|460641587|FG001|Overall Study|Death|3|||
127671788|NCT02696785|459421064|FG002|Follow-up Period|Withdrawal by Subject|5|||
127671789|NCT02696785|459421065|FG003|Follow-up Period|Withdrawal by Subject|4|||
127671790|NCT00614744|459421067|FG000|Overall Study|Lost to Follow-up|5|||
127671791|NCT00614744|459421068|FG001|Overall Study|Lost to Follow-up|4|||
127671792|NCT00614744|459421067|FG000|Overall Study|Incomplete for Behavior Issues|0|||
127671793|NCT00614744|459421068|FG001|Overall Study|Incomplete for Behavior Issues|2|||
127671794|NCT00877851|459421069|FG000|Overall Study|Lost to Follow-up|5|||
127671795|NCT00877851|459421070|FG001|Overall Study|Lost to Follow-up|5|||
127671796|NCT00877851|459421069|FG000|Overall Study|computer problem|3|||
127671797|NCT00877851|459421070|FG001|Overall Study|computer problem|0|||
127671798|NCT00877851|459421069|FG000|Overall Study|no longer interested in participating|1|||
127671799|NCT00877851|459421070|FG001|Overall Study|no longer interested in participating|0|||
127671800|NCT03424239|459421071|FG000|Overall Study|Withdrawal by Subject|2|||
127671801|NCT03005288|459421081|FG000|Overall Study|Withdrawal by Subject|7|||
127671802|NCT03005288|459421082|FG001|Overall Study|Withdrawal by Subject|5|||
127671803|NCT03005288|459421081|FG000|Overall Study|Lost to Follow-up|0|||
127671804|NCT03005288|459421082|FG001|Overall Study|Lost to Follow-up|1|||
127671805|NCT03005288|459421081|FG000|Overall Study|Adverse Event|5|||
127671806|NCT03005288|459421082|FG001|Overall Study|Adverse Event|0|||
127671807|NCT03005288|459421081|FG000|Overall Study|Protocol deviation|0|||
127671808|NCT03005288|459421082|FG001|Overall Study|Protocol deviation|1|||
127671809|NCT03005288|459421081|FG000|Overall Study|Physician Decision|0|||
127671810|NCT03005288|459421082|FG001|Overall Study|Physician Decision|1|||
127671811|NCT03824236|459421084|FG000|Overall Study|Lost to Follow-up|0|||
127671812|NCT03824236|459421085|FG001|Overall Study|Lost to Follow-up|0|||
127671813|NCT03824236|459421086|FG002|Overall Study|Lost to Follow-up|1|||
127671814|NCT00701311|459421087|FG000|Overall Study|Lack of Efficacy|3|||
127671815|NCT00701311|459421087|FG000|Overall Study|Adverse Event|3|||
127671816|NCT00701311|459421087|FG000|Overall Study|Withdrawal by Subject|2|||
127671817|NCT00670540|459421090|FG000|Overall Study|ineligible|17|||
127671818|NCT00670540|459421090|FG000|Overall Study|not living in France|348|||
127671819|NCT00670540|459421090|FG000|Overall Study|refused to participate|189|||
128003896|NCT03585270|460641586|FG000|Overall Study|Other reasons|2|||
128003897|NCT03585270|460641587|FG001|Overall Study|Other reasons|2|||
128003898|NCT03292016|460641588|FG000|Second Washout|Adverse Event|0|||
127671820|NCT00670540|459421090|FG000|Overall Study|controls randomised for no follow up|2770|||
127671821|NCT00670540|459421090|FG000|Overall Study|missing information inclusion criteria|1|||
128003899|NCT03292016|460641589|FG001|Second Washout|Adverse Event|1|||
128003900|NCT03292016|460641590|FG002|Second Washout|Adverse Event|0|||
128003901|NCT03292016|460641591|FG003|Second Washout|Adverse Event|0|||
128003902|NCT03292016|460641592|FG004|Second Washout|Adverse Event|0|||
128003903|NCT03292016|460641593|FG005|Second Washout|Adverse Event|0|||
128003904|NCT01076543|460641598|FG000|Overall Study|Withdrawal by Subject|2|||
128003905|NCT01076543|460641599|FG001|Overall Study|Withdrawal by Subject|0|||
128003906|NCT01076543|460641600|FG002|Overall Study|Withdrawal by Subject|0|||
128003907|NCT01076543|460641601|FG003|Overall Study|Withdrawal by Subject|0|||
128003908|NCT01076543|460641602|FG004|Overall Study|Withdrawal by Subject|0|||
128003909|NCT01076543|460641603|FG005|Overall Study|Withdrawal by Subject|0|||
128003910|NCT00338741|460641604|FG000|Overall Study|Lost to Follow-up|2|||
128003911|NCT00338741|460641605|FG001|Overall Study|Lost to Follow-up|0|||
128003912|NCT01791985|460641606|FG000|Overall Study|Adverse Event|7|||
128003913|NCT01791985|460641606|FG000|Overall Study|Withdrawal by Subject|1|||
128003914|NCT00372424|460641607|FG000|Overall Study|Adverse Event|2|||
128003915|NCT00372424|460641607|FG000|Overall Study|Withdrawal by Subject|1|||
128003916|NCT00372424|460641607|FG000|Overall Study|Death|1|||
128003917|NCT00372424|460641607|FG000|Overall Study|Objective Progression or Relapse|14|||
128003918|NCT00372424|460641607|FG000|Overall Study|Other|7|||
128003919|NCT00372424|460641607|FG000|Overall Study|Enrolled, Not Treated|1|||
128003920|NCT00072410|460641608|FG000|Overall Study|Progressive disease|0|||
128003921|NCT00072410|460641609|FG001|Overall Study|Progressive disease|3|||
128003922|NCT01204671|460641611|FG000|Overall Study|Adverse Event|4|||
128003923|NCT01204671|460641612|FG001|Overall Study|Adverse Event|3|||
128003924|NCT01204671|460641613|FG002|Overall Study|Adverse Event|3|||
128003925|NCT01204671|460641614|FG003|Overall Study|Adverse Event|3|||
128003926|NCT01204671|460641615|FG004|Overall Study|Adverse Event|1|||
128003927|NCT01204671|460641611|FG000|Overall Study|Withdrawal by Subject|2|||
127543532|NCT02718898|458956553|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
127671822|NCT01140347|459421091|FG000|Overall Study|Lost to Follow-up|5|||
127671823|NCT01140347|459421092|FG001|Overall Study|Lost to Follow-up|6|||
127671824|NCT01140347|459421091|FG000|Overall Study|Withdrawal by Subject|13|||
127671825|NCT01140347|459421092|FG001|Overall Study|Withdrawal by Subject|8|||
127671826|NCT00828919|459421093|FG000|Overall Study|Death|0|||
127671827|NCT00828919|459421094|FG001|Overall Study|Death|1|||
127671828|NCT00828919|459421095|FG002|Overall Study|Death|2|||
127671829|NCT00828919|459421096|FG003|Overall Study|Death|0|||
127671830|NCT00828919|459421097|FG004|Overall Study|Death|0|||
128003928|NCT01204671|460641612|FG001|Overall Study|Withdrawal by Subject|3|||
128003929|NCT01204671|460641613|FG002|Overall Study|Withdrawal by Subject|4|||
128003930|NCT01204671|460641614|FG003|Overall Study|Withdrawal by Subject|5|||
128003931|NCT01204671|460641615|FG004|Overall Study|Withdrawal by Subject|3|||
128003932|NCT01204671|460641611|FG000|Overall Study|Lost to Follow-up|7|||
128003933|NCT01204671|460641612|FG001|Overall Study|Lost to Follow-up|8|||
128003934|NCT01204671|460641613|FG002|Overall Study|Lost to Follow-up|6|||
128003935|NCT01204671|460641614|FG003|Overall Study|Lost to Follow-up|4|||
127671831|NCT00828919|459421093|FG000|Overall Study|Adverse Event|2|||
127671832|NCT00828919|459421094|FG001|Overall Study|Adverse Event|2|||
127671833|NCT00828919|459421095|FG002|Overall Study|Adverse Event|2|||
127671834|NCT00828919|459421096|FG003|Overall Study|Adverse Event|1|||
127671835|NCT00828919|459421097|FG004|Overall Study|Adverse Event|3|||
127671836|NCT00828919|459421093|FG000|Overall Study|Objective progression or relapse|4|||
127671837|NCT00828919|459421094|FG001|Overall Study|Objective progression or relapse|4|||
127671838|NCT00828919|459421095|FG002|Overall Study|Objective progression or relapse|11|||
127671839|NCT00828919|459421096|FG003|Overall Study|Objective progression or relapse|0|||
127671840|NCT00828919|459421097|FG004|Overall Study|Objective progression or relapse|5|||
127671841|NCT00828919|459421093|FG000|Overall Study|No longer willing to participate in study|0|||
127671842|NCT00828919|459421094|FG001|Overall Study|No longer willing to participate in study|0|||
127671843|NCT00828919|459421095|FG002|Overall Study|No longer willing to participate in study|2|||
127671844|NCT00828919|459421096|FG003|Overall Study|No longer willing to participate in study|0|||
127671845|NCT00828919|459421097|FG004|Overall Study|No longer willing to participate in study|0|||
127671846|NCT00828919|459421093|FG000|Overall Study|Insufficient Clinical Response|0|||
127671847|NCT00828919|459421094|FG001|Overall Study|Insufficient Clinical Response|1|||
127671848|NCT00828919|459421095|FG002|Overall Study|Insufficient Clinical Response|2|||
127671849|NCT00828919|459421096|FG003|Overall Study|Insufficient Clinical Response|0|||
127671850|NCT00828919|459421097|FG004|Overall Study|Insufficient Clinical Response|0|||
127671851|NCT00828919|459421093|FG000|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
127671852|NCT00828919|459421094|FG001|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
127671853|NCT00828919|459421095|FG002|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
127671854|NCT00828919|459421096|FG003|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
127671855|NCT00828919|459421097|FG004|Overall Study|Subject refused continued treatment for reason other than adverse event|3|||
127671856|NCT00828919|459421093|FG000|Overall Study|Other|1|||
127671857|NCT00828919|459421094|FG001|Overall Study|Other|0|||
127671858|NCT00828919|459421095|FG002|Overall Study|Other|1|||
127671859|NCT00828919|459421096|FG003|Overall Study|Other|1|||
127671860|NCT00828919|459421097|FG004|Overall Study|Other|0|||
127671861|NCT00828919|459421093|FG000|Overall Study|Lost to Follow-up|0|||
127671862|NCT00828919|459421094|FG001|Overall Study|Lost to Follow-up|1|||
127671863|NCT00828919|459421095|FG002|Overall Study|Lost to Follow-up|0|||
127671864|NCT00828919|459421096|FG003|Overall Study|Lost to Follow-up|0|||
127671865|NCT00828919|459421097|FG004|Overall Study|Lost to Follow-up|0|||
127671866|NCT01449929|459421098|FG000|Randomization Phase 96 Week|Adverse Event|5|||
127671867|NCT01449929|459421099|FG001|Randomization Phase 96 Week|Adverse Event|13|||
127671868|NCT01449929|459421100|FG002|Randomization Phase 96 Week|Adverse Event|0|||
127671869|NCT01449929|459421098|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
127671870|NCT01449929|459421099|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
127671871|NCT01449929|459421100|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
127671872|NCT01449929|459421098|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
127671873|NCT01449929|459421099|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
127671874|NCT01449929|459421100|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
127671875|NCT01449929|459421098|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
127671876|NCT01449929|459421099|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
127671877|NCT01449929|459421100|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
127671878|NCT01449929|459421098|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
127671879|NCT01449929|459421099|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
127671880|NCT01449929|459421100|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
127671881|NCT01449929|459421098|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
127671882|NCT01449929|459421099|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
127671883|NCT01449929|459421100|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
127671884|NCT01449929|459421098|FG000|Randomization Phase 96 Week|Physician Decision|2|||
127671885|NCT01449929|459421099|FG001|Randomization Phase 96 Week|Physician Decision|3|||
127671886|NCT01449929|459421100|FG002|Randomization Phase 96 Week|Physician Decision|0|||
127671887|NCT01449929|459421098|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
127671888|NCT01449929|459421099|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
127671889|NCT01449929|459421100|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
128003936|NCT01204671|460641615|FG004|Overall Study|Lost to Follow-up|0|||
128003937|NCT01204671|460641611|FG000|Overall Study|Unknown Completion Status|1|||
127671890|NCT01449929|459421098|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
127671891|NCT01449929|459421099|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
128003938|NCT01204671|460641612|FG001|Overall Study|Unknown Completion Status|1|||
128003939|NCT01204671|460641613|FG002|Overall Study|Unknown Completion Status|0|||
128003940|NCT01204671|460641614|FG003|Overall Study|Unknown Completion Status|0|||
128003941|NCT01204671|460641615|FG004|Overall Study|Unknown Completion Status|0|||
127671892|NCT01449929|459421100|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
128003942|NCT01204671|460641611|FG000|Overall Study|Physician Decision|0|||
128003943|NCT01204671|460641612|FG001|Overall Study|Physician Decision|0|||
128003944|NCT01204671|460641613|FG002|Overall Study|Physician Decision|0|||
128003945|NCT01204671|460641614|FG003|Overall Study|Physician Decision|1|||
128003946|NCT01204671|460641615|FG004|Overall Study|Physician Decision|0|||
128003947|NCT01814007|460641621|FG000|Overall Study|Withdrawal by Subject|1|||
128003948|NCT02357459|460643449|FG000|Overall Study|Adverse Event|0|||
128003949|NCT02357459|460643450|FG001|Overall Study|Adverse Event|1|||
128003950|NCT02357459|460643451|FG002|Overall Study|Adverse Event|1|||
128003951|NCT02357459|460643449|FG000|Overall Study|Withdrawal by Subject|5|||
128003952|NCT02357459|460643450|FG001|Overall Study|Withdrawal by Subject|3|||
128003953|NCT02357459|460643451|FG002|Overall Study|Withdrawal by Subject|3|||
128003954|NCT02357459|460643449|FG000|Overall Study|Physician Decision|0|||
128003955|NCT02357459|460643450|FG001|Overall Study|Physician Decision|2|||
128003956|NCT02357459|460643451|FG002|Overall Study|Physician Decision|0|||
128003957|NCT02357459|460643449|FG000|Overall Study|Protocol Violation|1|||
128003958|NCT02357459|460643450|FG001|Overall Study|Protocol Violation|1|||
128003959|NCT02357459|460643451|FG002|Overall Study|Protocol Violation|0|||
128003960|NCT02357459|460643449|FG000|Overall Study|Lost to Follow-up|1|||
128003961|NCT02357459|460643450|FG001|Overall Study|Lost to Follow-up|3|||
128003962|NCT02357459|460643451|FG002|Overall Study|Lost to Follow-up|0|||
128003963|NCT02357459|460643449|FG000|Overall Study|Lack of Efficacy|7|||
128003964|NCT02357459|460643450|FG001|Overall Study|Lack of Efficacy|4|||
128003965|NCT02357459|460643451|FG002|Overall Study|Lack of Efficacy|4|||
128003966|NCT02357459|460643449|FG000|Overall Study|Patient Relocated|2|||
128003967|NCT02357459|460643450|FG001|Overall Study|Patient Relocated|0|||
128003968|NCT02357459|460643451|FG002|Overall Study|Patient Relocated|0|||
128003969|NCT02357459|460643449|FG000|Overall Study|Instruction from PCP|1|||
128003970|NCT02357459|460643450|FG001|Overall Study|Instruction from PCP|0|||
128003971|NCT02357459|460643451|FG002|Overall Study|Instruction from PCP|0|||
128003972|NCT02357459|460643449|FG000|Overall Study|Incarceration|0|||
128003973|NCT02357459|460643450|FG001|Overall Study|Incarceration|0|||
128003974|NCT02357459|460643451|FG002|Overall Study|Incarceration|1|||
128003975|NCT02357459|460643449|FG000|Overall Study|Pre-planned Knee surgery|0|||
128003976|NCT02357459|460643450|FG001|Overall Study|Pre-planned Knee surgery|0|||
128003977|NCT02357459|460643451|FG002|Overall Study|Pre-planned Knee surgery|2|||
128003978|NCT02357459|460643449|FG000|Overall Study|Job Commitments|0|||
128003979|NCT02357459|460643450|FG001|Overall Study|Job Commitments|0|||
128003980|NCT02357459|460643451|FG002|Overall Study|Job Commitments|1|||
128003981|NCT01548599|460643452|FG000|Overall Study|Lost to Follow-up|0|||
128003982|NCT01548599|460643453|FG001|Overall Study|Lost to Follow-up|1|||
128003983|NCT01548599|460643452|FG000|Overall Study|Withdrawal by Subject|4|||
128003984|NCT01548599|460643453|FG001|Overall Study|Withdrawal by Subject|0|||
128003985|NCT01548599|460643452|FG000|Overall Study|Death|2|||
128003986|NCT01548599|460643453|FG001|Overall Study|Death|1|||
128003987|NCT05630196|460643454|FG000|Overall Study|Adverse Event|2|||
128003988|NCT05630196|460643455|FG001|Overall Study|Adverse Event|1|||
128003989|NCT05630196|460643454|FG000|Overall Study|Lost to Follow-up|1|||
128003990|NCT05630196|460643455|FG001|Overall Study|Lost to Follow-up|1|||
128003991|NCT05630196|460643454|FG000|Overall Study|Protocol Violation|2|||
128003992|NCT05630196|460643455|FG001|Overall Study|Protocol Violation|3|||
127671893|NCT01449929|459421098|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
127671894|NCT01449929|459421099|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
127671895|NCT01449929|459421100|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
127671896|NCT01449929|459421098|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
127671897|NCT01449929|459421099|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
127671898|NCT01449929|459421100|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
128003993|NCT05630196|460643454|FG000|Overall Study|Physician Decision|1|||
128003994|NCT05630196|460643455|FG001|Overall Study|Physician Decision|0|||
128003995|NCT05630196|460643454|FG000|Overall Study|Withdrawal by Subject|3|||
128003996|NCT05630196|460643455|FG001|Overall Study|Withdrawal by Subject|4|||
128003997|NCT00352118|460643457|FG000|Overall Study|Physician Decision|4|||
128003998|NCT02990000|460643458|FG000|Overall Study|Failed to provide data beyond baseline|36|||
128003999|NCT02990000|460643459|FG001|Overall Study|Failed to provide data beyond baseline|34|||
128004000|NCT02308046|460643460|FG000|Overall Study|Negative yeast culture at Baseline|32|||
127671899|NCT01871285|459421101|FG000|First Intervention (1 Day)|Adverse Event|1|||
128004001|NCT02308046|460643461|FG001|Overall Study|Negative yeast culture at Baseline|33|||
128004002|NCT02308046|460643460|FG000|Overall Study|Positive for STD at Baseline|1|||
128004003|NCT02308046|460643461|FG001|Overall Study|Positive for STD at Baseline|2|||
128004004|NCT02308046|460643460|FG000|Overall Study|Lost to Follow-up|1|||
128004005|NCT02308046|460643461|FG001|Overall Study|Lost to Follow-up|3|||
128004006|NCT00883181|460643462|FG000|Overall Study|Hematological Adverse Event|26|||
128004007|NCT00883181|460643462|FG000|Overall Study|Non-hematological Adverse Event|55|||
128004008|NCT00883181|460643462|FG000|Overall Study|Disease Progression|94|||
128004009|NCT00883181|460643462|FG000|Overall Study|Administrative Reason|24|||
128004010|NCT00883181|460643462|FG000|Overall Study|Withdrawal by Subject|4|||
128004011|NCT00883181|460643462|FG000|Overall Study|Death|31|||
128004012|NCT00883181|460643462|FG000|Overall Study|Other|38|||
128004013|NCT00883181|460643462|FG000|Overall Study|Protocol Deviation|3|||
128004014|NCT00883181|460643462|FG000|Overall Study|Noncompliance|3|||
128004015|NCT01587885|460643465|FG000|Treatment Period 1|Failure to Return|0|||
128004016|NCT01587885|460643466|FG001|Treatment Period 1|Failure to Return|1|||
128004017|NCT01587885|460643465|FG000|Treatment Period 1|Protocol Violation|0|||
128004018|NCT01587885|460643466|FG001|Treatment Period 1|Protocol Violation|2|||
128004019|NCT00752089|460643471|FG000|Overall Study|Adverse Event|1|||
128004020|NCT00752089|460643471|FG000|Overall Study|Protocol Deviation|2|||
128004021|NCT00752089|460643471|FG000|Overall Study|Could not attend visit 9|1|||
128004022|NCT00752089|460643471|FG000|Overall Study|Not capable of wearing partial denture|1|||
128004023|NCT00752089|460643471|FG000|Overall Study|Cannot continue the study|1|||
128004024|NCT00001566|460643472|FG000|Overall Study|patients' choice to discontinue protocol|3|||
128004025|NCT00001566|460643472|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
128004026|NCT00001566|460643472|FG000|Overall Study|Death|13|||
128004027|NCT00001566|460643472|FG000|Overall Study|Lost to Follow-up|1|||
128004028|NCT00001566|460643472|FG000|Overall Study|unable to complete initial apheresis|1|||
128004029|NCT02914834|460643473|FG000|Overall Study|Study halted due to COVID|1|||
128004030|NCT02914834|460643474|FG001|Overall Study|Study halted due to COVID|1|||
128004031|NCT02914834|460643473|FG000|Overall Study|1 subject withdrew|0|||
128004032|NCT02914834|460643474|FG001|Overall Study|1 subject withdrew|1|||
128004033|NCT00975416|460643477|FG000|Overall Study|early discharge from tx|3|||
128004034|NCT00975416|460643478|FG001|Overall Study|early discharge from tx|5|||
128004035|NCT01249131|460643483|FG000|Washout Period of 10 Days|Adverse Event|0|||
128004036|NCT01249131|460643484|FG001|Washout Period of 10 Days|Adverse Event|0|||
127671900|NCT01871285|459421102|FG001|First Intervention (1 Day)|Adverse Event|0|||
127671901|NCT01871285|459421103|FG002|First Intervention (1 Day)|Adverse Event|0|||
128004037|NCT01249131|460643485|FG002|Washout Period of 10 Days|Adverse Event|0|||
128004038|NCT01249131|460643486|FG003|Washout Period of 10 Days|Adverse Event|0|||
128004039|NCT01249131|460643487|FG004|Washout Period of 10 Days|Adverse Event|1|||
128004040|NCT01249131|460643488|FG005|Washout Period of 10 Days|Adverse Event|0|||
128004041|NCT01774591|460643489|FG000|Overall Study|Physician Decision|1|||
128004042|NCT01774591|460643490|FG001|Overall Study|Physician Decision|1|||
128004043|NCT01774591|460643489|FG000|Overall Study|Withdrawal by Subject|0|||
128004044|NCT01774591|460643490|FG001|Overall Study|Withdrawal by Subject|1|||
128004045|NCT01774591|460643489|FG000|Overall Study|Adverse Event|0|||
128004046|NCT01774591|460643490|FG001|Overall Study|Adverse Event|2|||
128004047|NCT03555149|460643495|FG000|Overall Study|Death|18|||
128004048|NCT03555149|460643496|FG001|Overall Study|Death|15|||
128004049|NCT03555149|460643497|FG002|Overall Study|Death|15|||
128004050|NCT03555149|460643498|FG003|Overall Study|Death|4|||
128004051|NCT03555149|460643499|FG004|Overall Study|Death|4|||
128004052|NCT03555149|460643500|FG005|Overall Study|Death|11|||
128004053|NCT03555149|460643501|FG006|Overall Study|Death|12|||
128004054|NCT03555149|460643502|FG007|Overall Study|Death|1|||
128004055|NCT03555149|460643495|FG000|Overall Study|Lost to Follow-up|1|||
128004056|NCT03555149|460643496|FG001|Overall Study|Lost to Follow-up|0|||
128004057|NCT03555149|460643497|FG002|Overall Study|Lost to Follow-up|0|||
128004058|NCT03555149|460643498|FG003|Overall Study|Lost to Follow-up|0|||
128004059|NCT03555149|460643499|FG004|Overall Study|Lost to Follow-up|0|||
128004060|NCT03555149|460643500|FG005|Overall Study|Lost to Follow-up|1|||
128004061|NCT03555149|460643501|FG006|Overall Study|Lost to Follow-up|0|||
128004062|NCT03555149|460643502|FG007|Overall Study|Lost to Follow-up|0|||
128004063|NCT03555149|460643495|FG000|Overall Study|Physician Decision|1|||
128004064|NCT03555149|460643496|FG001|Overall Study|Physician Decision|0|||
128004065|NCT03555149|460643497|FG002|Overall Study|Physician Decision|0|||
128004066|NCT03555149|460643498|FG003|Overall Study|Physician Decision|0|||
128004067|NCT03555149|460643499|FG004|Overall Study|Physician Decision|0|||
127671902|NCT01871285|459421104|FG003|First Intervention (1 Day)|Adverse Event|0|||
127671903|NCT01871285|459421101|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
127671904|NCT01871285|459421102|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
128004068|NCT03555149|460643500|FG005|Overall Study|Physician Decision|0|||
128004069|NCT03555149|460643501|FG006|Overall Study|Physician Decision|0|||
128004070|NCT03555149|460643502|FG007|Overall Study|Physician Decision|0|||
128004071|NCT03555149|460643495|FG000|Overall Study|Study Terminated By Sponsor|1|||
128004072|NCT03555149|460643496|FG001|Overall Study|Study Terminated By Sponsor|0|||
128004073|NCT03555149|460643497|FG002|Overall Study|Study Terminated By Sponsor|0|||
127671905|NCT01871285|459421103|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
128004074|NCT03555149|460643498|FG003|Overall Study|Study Terminated By Sponsor|0|||
127671906|NCT01871285|459421104|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
128004075|NCT03555149|460643499|FG004|Overall Study|Study Terminated By Sponsor|0|||
128004076|NCT03555149|460643500|FG005|Overall Study|Study Terminated By Sponsor|2|||
128004077|NCT03555149|460643501|FG006|Overall Study|Study Terminated By Sponsor|3|||
128004078|NCT03555149|460643502|FG007|Overall Study|Study Terminated By Sponsor|1|||
128004079|NCT03555149|460643495|FG000|Overall Study|Withdrawal by Subject|3|||
127671907|NCT01211665|459422490|FG000|Overall Study|Withdrawal by Subject|1|||
127671908|NCT01211665|459422491|FG001|Overall Study|Withdrawal by Subject|0|||
127671909|NCT01211665|459422490|FG000|Overall Study|Death|1|||
127671910|NCT01211665|459422491|FG001|Overall Study|Death|0|||
127671911|NCT01390857|459422494|FG000|Overall Study|Protocol Violation|2|||
127671912|NCT01390857|459422494|FG000|Overall Study|Lost to Follow-up|1|||
127671913|NCT01390857|459422494|FG000|Overall Study|No Visit after the First Visit|7|||
127671914|NCT03085017|459422503|FG000|Overall Study|Death|0|||
127671915|NCT03085017|459422504|FG001|Overall Study|Death|3|||
127671916|NCT00058058|459422512|FG000|Overall Study|Withdrawal by Subject|4|||
127671917|NCT00058058|459422512|FG000|Overall Study|Ineligible|20|||
127671918|NCT00058058|459422512|FG000|Overall Study|Claustrophobic|5|||
127671919|NCT00058058|459422512|FG000|Overall Study|technical issues|6|||
127671920|NCT00058058|459422512|FG000|Overall Study|Poor positioning, illness,pain|3|||
127671921|NCT03681691|459422516|FG000|Overall Study|COVID|1|||
127671922|NCT03681691|459422517|FG001|Overall Study|COVID|0|||
127671923|NCT03681691|459422516|FG000|Overall Study|prolonged bleeding|1|||
128004080|NCT03555149|460643496|FG001|Overall Study|Withdrawal by Subject|0|||
128004081|NCT03555149|460643497|FG002|Overall Study|Withdrawal by Subject|0|||
128004082|NCT03555149|460643498|FG003|Overall Study|Withdrawal by Subject|2|||
128004083|NCT03555149|460643499|FG004|Overall Study|Withdrawal by Subject|0|||
127671924|NCT03681691|459422517|FG001|Overall Study|prolonged bleeding|0|||
127671925|NCT03681691|459422516|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
127671926|NCT03681691|459422517|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
127671927|NCT01582243|459422520|FG000|Overall Study|Withdrawal by Subject|1|||
127671928|NCT01582243|459422520|FG000|Overall Study|Adverse Event|1|||
127671929|NCT01582243|459422520|FG000|Overall Study|Lost to Follow-up|1|||
127671930|NCT01928940|459422523|FG000|Overall Study|Adverse Event|0|||
127671931|NCT01928940|459422524|FG001|Overall Study|Adverse Event|1|||
127671932|NCT02954055|459422525|FG000|Overall Study|Did not initiate therapy|6|||
127671933|NCT02954055|459422526|FG001|Overall Study|Did not initiate therapy|1|||
127671934|NCT01119703|459422529|FG000|Overall Study|Adverse Event|0|||
127671935|NCT01119703|459422530|FG001|Overall Study|Adverse Event|1|||
127671936|NCT03178201|459422531|FG000|Overall Study|Off study|5|||
127671937|NCT02282527|459422533|FG000|Overall Study|Lost to Follow-up|0|||
127671938|NCT02282527|459422534|FG001|Overall Study|Lost to Follow-up|1|||
127671939|NCT02282527|459422533|FG000|Overall Study|Lack of home health aid|1|||
127671940|NCT02282527|459422534|FG001|Overall Study|Lack of home health aid|0|||
127671941|NCT00941031|459422535|FG000|Induction Period|Lack of Efficacy|2|||
127671942|NCT00941031|459422536|FG001|Induction Period|Lack of Efficacy|1|||
127671943|NCT00941031|459422537|FG002|Induction Period|Lack of Efficacy|0|||
127671944|NCT00941031|459422538|FG003|Induction Period|Lack of Efficacy|5|||
127671945|NCT00941031|459422539|FG004|Induction Period|Lack of Efficacy|0|||
127671946|NCT00941031|459422540|FG005|Induction Period|Lack of Efficacy|0|||
127671947|NCT00941031|459422541|FG006|Induction Period|Lack of Efficacy|0|||
127671948|NCT00941031|459422535|FG000|Induction Period|Withdrawal by Subject|1|||
127671949|NCT00941031|459422536|FG001|Induction Period|Withdrawal by Subject|2|||
128004084|NCT03555149|460643500|FG005|Overall Study|Withdrawal by Subject|1|||
128004085|NCT03555149|460643501|FG006|Overall Study|Withdrawal by Subject|0|||
128004086|NCT03555149|460643502|FG007|Overall Study|Withdrawal by Subject|0|||
128004087|NCT05817669|460643506|FG000|Overall Study|Prohibited medication used|1|||
128004088|NCT05817669|460643507|FG001|Overall Study|Prohibited medication used|2|||
128004089|NCT05817669|460643506|FG000|Overall Study|Adverse Event|1|||
128004090|NCT05817669|460643507|FG001|Overall Study|Adverse Event|0|||
128004091|NCT05817669|460643506|FG000|Overall Study|Withdrawal by Subject|1|||
128004092|NCT05817669|460643507|FG001|Overall Study|Withdrawal by Subject|2|||
128004093|NCT03786380|460643508|FG000|Overall Study|Adverse Event|1|||
128004094|NCT03786380|460643509|FG001|Overall Study|Adverse Event|0|||
128004095|NCT03786380|460643510|FG002|Overall Study|Adverse Event|0|||
128004096|NCT03786380|460643511|FG003|Overall Study|Adverse Event|3|||
128004097|NCT03786380|460643512|FG004|Overall Study|Adverse Event|1|||
128004098|NCT03786380|460643508|FG000|Overall Study|Lack of Efficacy|0|||
128004099|NCT03786380|460643509|FG001|Overall Study|Lack of Efficacy|0|||
128004100|NCT03786380|460643510|FG002|Overall Study|Lack of Efficacy|0|||
128004101|NCT03786380|460643511|FG003|Overall Study|Lack of Efficacy|0|||
128004102|NCT03786380|460643512|FG004|Overall Study|Lack of Efficacy|1|||
128004103|NCT03786380|460643508|FG000|Overall Study|Withdrawal by Subject|1|||
127671950|NCT00941031|459422537|FG002|Induction Period|Withdrawal by Subject|2|||
127671951|NCT00941031|459422538|FG003|Induction Period|Withdrawal by Subject|2|||
127671952|NCT00941031|459422539|FG004|Induction Period|Withdrawal by Subject|0|||
127671953|NCT00941031|459422540|FG005|Induction Period|Withdrawal by Subject|0|||
127671954|NCT00941031|459422541|FG006|Induction Period|Withdrawal by Subject|0|||
127671955|NCT00941031|459422535|FG000|Induction Period|Adminstative Problems|1|||
127671956|NCT00941031|459422536|FG001|Induction Period|Adminstative Problems|1|||
128004104|NCT03786380|460643509|FG001|Overall Study|Withdrawal by Subject|2|||
128004105|NCT03786380|460643510|FG002|Overall Study|Withdrawal by Subject|2|||
127671957|NCT00941031|459422537|FG002|Induction Period|Adminstative Problems|1|||
127671958|NCT00941031|459422538|FG003|Induction Period|Adminstative Problems|0|||
128004106|NCT03786380|460643511|FG003|Overall Study|Withdrawal by Subject|1|||
128004107|NCT03786380|460643512|FG004|Overall Study|Withdrawal by Subject|2|||
128004108|NCT03786380|460643508|FG000|Overall Study|Lost to Follow-up|3|||
128004109|NCT03786380|460643509|FG001|Overall Study|Lost to Follow-up|0|||
128004110|NCT03786380|460643510|FG002|Overall Study|Lost to Follow-up|1|||
128004111|NCT03786380|460643511|FG003|Overall Study|Lost to Follow-up|2|||
128004112|NCT03786380|460643512|FG004|Overall Study|Lost to Follow-up|0|||
128004113|NCT03786380|460643508|FG000|Overall Study|Physician Decision|0|||
128004114|NCT03786380|460643509|FG001|Overall Study|Physician Decision|0|||
128004115|NCT03786380|460643510|FG002|Overall Study|Physician Decision|1|||
128004116|NCT03786380|460643511|FG003|Overall Study|Physician Decision|0|||
128004117|NCT03786380|460643512|FG004|Overall Study|Physician Decision|0|||
128004118|NCT03786380|460643508|FG000|Overall Study|Study Terminated by the Sponsor|30|||
128004119|NCT03786380|460643509|FG001|Overall Study|Study Terminated by the Sponsor|20|||
128004120|NCT03786380|460643510|FG002|Overall Study|Study Terminated by the Sponsor|50|||
128004121|NCT03786380|460643511|FG003|Overall Study|Study Terminated by the Sponsor|57|||
128004122|NCT03786380|460643512|FG004|Overall Study|Study Terminated by the Sponsor|23|||
128004123|NCT03786380|460643508|FG000|Overall Study|Reason Not Specified|0|||
128004124|NCT03786380|460643509|FG001|Overall Study|Reason Not Specified|0|||
128004125|NCT03786380|460643510|FG002|Overall Study|Reason Not Specified|0|||
128004126|NCT03786380|460643511|FG003|Overall Study|Reason Not Specified|0|||
128004127|NCT03786380|460643512|FG004|Overall Study|Reason Not Specified|1|||
128004128|NCT01664091|460643513|FG000|Overall Study|Death|1|||
127671959|NCT00941031|459422539|FG004|Induction Period|Adminstative Problems|0|||
127671960|NCT00941031|459422540|FG005|Induction Period|Adminstative Problems|0|||
127671961|NCT00941031|459422541|FG006|Induction Period|Adminstative Problems|0|||
127671962|NCT00941031|459422535|FG000|Induction Period|Adverse Event|1|||
127671963|NCT00941031|459422536|FG001|Induction Period|Adverse Event|0|||
127671964|NCT00941031|459422537|FG002|Induction Period|Adverse Event|3|||
127671965|NCT00941031|459422538|FG003|Induction Period|Adverse Event|2|||
127671966|NCT00941031|459422539|FG004|Induction Period|Adverse Event|0|||
127671967|NCT00941031|459422540|FG005|Induction Period|Adverse Event|0|||
127671968|NCT00941031|459422541|FG006|Induction Period|Adverse Event|0|||
127671969|NCT00941031|459422535|FG000|Maintenance Period|Withdrawal by Subject|0|||
127671970|NCT00941031|459422536|FG001|Maintenance Period|Withdrawal by Subject|0|||
127671971|NCT00941031|459422537|FG002|Maintenance Period|Withdrawal by Subject|0|||
127671972|NCT00941031|459422538|FG003|Maintenance Period|Withdrawal by Subject|0|||
127671973|NCT00941031|459422539|FG004|Maintenance Period|Withdrawal by Subject|6|||
127671974|NCT00941031|459422540|FG005|Maintenance Period|Withdrawal by Subject|2|||
127671975|NCT00941031|459422541|FG006|Maintenance Period|Withdrawal by Subject|13|||
127671976|NCT00941031|459422535|FG000|Maintenance Period|Administrative Problems|0|||
127671977|NCT00941031|459422536|FG001|Maintenance Period|Administrative Problems|0|||
127671978|NCT00941031|459422537|FG002|Maintenance Period|Administrative Problems|0|||
127671979|NCT00941031|459422538|FG003|Maintenance Period|Administrative Problems|0|||
127671980|NCT00941031|459422539|FG004|Maintenance Period|Administrative Problems|1|||
127671981|NCT00941031|459422540|FG005|Maintenance Period|Administrative Problems|0|||
127671982|NCT00941031|459422541|FG006|Maintenance Period|Administrative Problems|1|||
127671983|NCT00941031|459422535|FG000|Maintenance Period|Protocol Violation|0|||
127671984|NCT00941031|459422536|FG001|Maintenance Period|Protocol Violation|0|||
127671985|NCT00941031|459422537|FG002|Maintenance Period|Protocol Violation|0|||
127671986|NCT00941031|459422538|FG003|Maintenance Period|Protocol Violation|0|||
127671987|NCT00941031|459422539|FG004|Maintenance Period|Protocol Violation|0|||
127671988|NCT00941031|459422540|FG005|Maintenance Period|Protocol Violation|0|||
127671989|NCT00941031|459422541|FG006|Maintenance Period|Protocol Violation|1|||
127671990|NCT00941031|459422535|FG000|Maintenance Period|Adverse Event|0|||
127671991|NCT00941031|459422536|FG001|Maintenance Period|Adverse Event|0|||
127671992|NCT00941031|459422537|FG002|Maintenance Period|Adverse Event|0|||
127671993|NCT00941031|459422538|FG003|Maintenance Period|Adverse Event|0|||
127671994|NCT00941031|459422539|FG004|Maintenance Period|Adverse Event|0|||
128004129|NCT01664091|460643513|FG000|Overall Study|Disease Progression|2|||
128004130|NCT01664091|460643513|FG000|Overall Study|Lost to Follow-up|2|||
128004131|NCT01664091|460643513|FG000|Overall Study|Withdrawal by Subject|1|||
128004132|NCT01038687|460643514|FG000|Overall Study|Adverse Event|0|||
127671995|NCT00941031|459422540|FG005|Maintenance Period|Adverse Event|2|||
127671996|NCT00941031|459422541|FG006|Maintenance Period|Adverse Event|8|||
127671997|NCT00941031|459422535|FG000|Maintenance Period|Lost to Follow-up|0|||
127671998|NCT00941031|459422536|FG001|Maintenance Period|Lost to Follow-up|0|||
127671999|NCT00941031|459422537|FG002|Maintenance Period|Lost to Follow-up|0|||
127672000|NCT00941031|459422538|FG003|Maintenance Period|Lost to Follow-up|0|||
127672001|NCT00941031|459422539|FG004|Maintenance Period|Lost to Follow-up|2|||
127672002|NCT00941031|459422540|FG005|Maintenance Period|Lost to Follow-up|2|||
127672003|NCT00941031|459422541|FG006|Maintenance Period|Lost to Follow-up|7|||
127672004|NCT00941031|459422535|FG000|Maintenance Period|Lack of Efficacy|0|||
128004133|NCT01038687|460643515|FG001|Overall Study|Adverse Event|2|||
128004134|NCT01038687|460643516|FG002|Overall Study|Adverse Event|1|||
127672005|NCT00941031|459422536|FG001|Maintenance Period|Lack of Efficacy|0|||
128004135|NCT05222880|460643518|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
128004136|NCT05222880|460643518|FG000|Overall Study|Withdrew Consent during Study|1|||
128004137|NCT05222880|460643518|FG000|Overall Study|COVID-19 Related|1|||
128004138|NCT02314728|460643527|FG000|Overall Study|Protocol Violation|1|||
128004139|NCT02314728|460643528|FG001|Overall Study|Protocol Violation|0|||
128004140|NCT02314728|460643527|FG000|Overall Study|Lost to Follow-up|0|||
128004141|NCT02314728|460643528|FG001|Overall Study|Lost to Follow-up|1|||
128004142|NCT01791595|460643529|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
128004143|NCT01791595|460643530|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
128004144|NCT01791595|460643531|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
128004145|NCT01791595|460643532|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
128004146|NCT01791595|460643533|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
128004147|NCT01791595|460643534|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
128004148|NCT01791595|460643535|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
128004149|NCT01791595|460643529|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
128004150|NCT01791595|460643530|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
128004151|NCT01791595|460643531|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
128004152|NCT01791595|460643532|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
128004153|NCT01791595|460643533|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
128004154|NCT01791595|460643534|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
128004155|NCT01791595|460643535|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
128004156|NCT01791595|460643529|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
128004157|NCT01791595|460643530|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
128004158|NCT01791595|460643531|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
128004159|NCT01791595|460643532|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
128004160|NCT01791595|460643533|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
128004161|NCT01791595|460643534|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
128004162|NCT01791595|460643535|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
128004163|NCT01791595|460643529|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
128004164|NCT01791595|460643530|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
128004165|NCT01791595|460643531|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
128004166|NCT01791595|460643532|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
128004167|NCT01791595|460643533|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
128004168|NCT01791595|460643534|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
128004169|NCT01791595|460643535|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
128004170|NCT01791595|460643529|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
128004171|NCT01791595|460643530|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
128004172|NCT01791595|460643531|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
128004173|NCT01791595|460643532|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
128004174|NCT01791595|460643533|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
128004175|NCT01791595|460643534|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
128004176|NCT01791595|460643535|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
128004177|NCT01791595|460643529|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
128004178|NCT01791595|460643530|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
128004179|NCT01791595|460643531|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
128004180|NCT01791595|460643532|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
128004181|NCT01791595|460643533|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
128004182|NCT01791595|460643534|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
128004183|NCT01791595|460643535|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
128004184|NCT01791595|460643529|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
128004185|NCT01791595|460643530|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
128004186|NCT01791595|460643531|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
128004187|NCT01791595|460643532|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
128004188|NCT01791595|460643533|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
128004189|NCT01791595|460643534|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
128004190|NCT01791595|460643535|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
128004191|NCT01791595|460643529|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
128004192|NCT01791595|460643530|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
128004193|NCT01791595|460643531|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
128004194|NCT01791595|460643532|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
128004195|NCT01791595|460643533|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
128004196|NCT01791595|460643534|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
128004197|NCT01791595|460643535|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
128004198|NCT01791595|460643529|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
128004199|NCT01791595|460643530|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
128004200|NCT01791595|460643531|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
128004201|NCT01791595|460643532|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
128004202|NCT01791595|460643533|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
128004203|NCT01791595|460643534|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
128004204|NCT01791595|460643535|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
128004205|NCT01791595|460643529|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
128004206|NCT01791595|460643530|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
128004207|NCT01791595|460643531|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
128004208|NCT01791595|460643532|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
128004209|NCT01791595|460643533|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
128004210|NCT01791595|460643534|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
128004211|NCT01791595|460643535|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
128004212|NCT01791595|460643529|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
128004213|NCT01791595|460643530|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
128004214|NCT01791595|460643531|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
128004215|NCT01791595|460643532|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
128004216|NCT01791595|460643533|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
128004217|NCT01791595|460643534|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
128004218|NCT01791595|460643535|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
128004219|NCT01791595|460643529|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
128004220|NCT01791595|460643530|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
128004221|NCT01791595|460643531|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
128004222|NCT01791595|460643532|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
128004223|NCT01791595|460643533|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
128004224|NCT01791595|460643534|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
128004225|NCT01791595|460643535|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
128004226|NCT01791595|460643529|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
128004227|NCT01791595|460643530|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
128004228|NCT01791595|460643531|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
128004229|NCT01791595|460643532|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
128004230|NCT01791595|460643533|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
128004231|NCT01791595|460643534|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
128004232|NCT01791595|460643535|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
128004233|NCT01791595|460643529|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
128004234|NCT01791595|460643530|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
128004235|NCT01791595|460643531|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
128004236|NCT01791595|460643532|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
128004237|NCT01791595|460643533|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
128004238|NCT01791595|460643534|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
128004239|NCT01791595|460643535|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
128004240|NCT01791595|460643529|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
128004241|NCT01791595|460643530|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
128004242|NCT01791595|460643531|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
128004243|NCT01791595|460643532|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
128004244|NCT01791595|460643533|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
128004245|NCT01791595|460643534|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
128004246|NCT01791595|460643535|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
128004247|NCT01791595|460643529|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
128004248|NCT01791595|460643530|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
128004249|NCT01791595|460643531|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
128004250|NCT01791595|460643532|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
128004251|NCT01791595|460643533|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
128004252|NCT01791595|460643534|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
128004253|NCT01791595|460643535|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
128004254|NCT01791595|460643529|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
128004255|NCT01791595|460643530|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
128004256|NCT01791595|460643531|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
128004257|NCT01791595|460643532|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
128004258|NCT01791595|460643533|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
128004259|NCT01791595|460643534|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
128004260|NCT01791595|460643535|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
128004261|NCT01791595|460643529|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
127672006|NCT00941031|459422537|FG002|Maintenance Period|Lack of Efficacy|0|||
127672007|NCT00941031|459422538|FG003|Maintenance Period|Lack of Efficacy|0|||
128004262|NCT01791595|460643530|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
128004263|NCT01791595|460643531|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
128004264|NCT01791595|460643532|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
128004265|NCT01791595|460643533|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
128004266|NCT01791595|460643534|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
128004267|NCT01791595|460643535|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
128004268|NCT03118934|460643536|FG000|Overall Study|Adverse Event|0|||
128004269|NCT03118934|460643537|FG001|Overall Study|Adverse Event|0|||
128004270|NCT03118934|460643538|FG002|Overall Study|Adverse Event|0|||
128004271|NCT03118934|460643539|FG003|Overall Study|Adverse Event|0|||
128004272|NCT03118934|460643540|FG004|Overall Study|Adverse Event|0|||
128004273|NCT03118934|460643541|FG005|Overall Study|Adverse Event|1|||
128004274|NCT03118934|460643536|FG000|Overall Study|Physician Decision|0|||
128004275|NCT03118934|460643537|FG001|Overall Study|Physician Decision|0|||
128004276|NCT03118934|460643538|FG002|Overall Study|Physician Decision|0|||
128004277|NCT03118934|460643539|FG003|Overall Study|Physician Decision|0|||
128004278|NCT03118934|460643540|FG004|Overall Study|Physician Decision|0|||
128004279|NCT03118934|460643541|FG005|Overall Study|Physician Decision|1|||
128004280|NCT03118934|460643536|FG000|Overall Study|Discontinued prior to exposure|0|||
128004281|NCT03118934|460643537|FG001|Overall Study|Discontinued prior to exposure|1|||
128004282|NCT03118934|460643538|FG002|Overall Study|Discontinued prior to exposure|1|||
128004283|NCT03118934|460643539|FG003|Overall Study|Discontinued prior to exposure|1|||
128004284|NCT03118934|460643540|FG004|Overall Study|Discontinued prior to exposure|2|||
128004285|NCT03118934|460643541|FG005|Overall Study|Discontinued prior to exposure|0|||
128004286|NCT01614470|460643542|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
128004287|NCT01614470|460643543|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
128004288|NCT01614470|460643544|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
128004289|NCT01614470|460643542|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
128004290|NCT01614470|460643543|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
128004291|NCT01614470|460643544|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
128004292|NCT03217591|460643545|FG000|Overall Study|Adverse Event|1|||
128004293|NCT03217591|460643546|FG001|Overall Study|Adverse Event|2|||
128004294|NCT03217591|460643547|FG002|Overall Study|Adverse Event|6|||
128004295|NCT03217591|460643545|FG000|Overall Study|Withdrawal by Subject|0|||
128004296|NCT03217591|460643546|FG001|Overall Study|Withdrawal by Subject|1|||
128004297|NCT03217591|460643547|FG002|Overall Study|Withdrawal by Subject|3|||
128004298|NCT03217591|460643545|FG000|Overall Study|Lost to Follow-up|1|||
128004299|NCT03217591|460643546|FG001|Overall Study|Lost to Follow-up|0|||
128004300|NCT03217591|460643547|FG002|Overall Study|Lost to Follow-up|0|||
128004301|NCT03217591|460643545|FG000|Overall Study|Protocol Violation|1|||
128004302|NCT03217591|460643546|FG001|Overall Study|Protocol Violation|0|||
128004303|NCT03217591|460643547|FG002|Overall Study|Protocol Violation|1|||
128004304|NCT00249834|460643558|FG000|Overall Study|Ovarian stimulation failed|1|||
127672008|NCT00941031|459422539|FG004|Maintenance Period|Lack of Efficacy|0|||
127672009|NCT00941031|459422540|FG005|Maintenance Period|Lack of Efficacy|0|||
127672010|NCT00941031|459422541|FG006|Maintenance Period|Lack of Efficacy|13|||
127672011|NCT01872611|459422542|FG000|Overall Study|Adverse Event|3|||
127672012|NCT01872611|459422543|FG001|Overall Study|Adverse Event|1|||
127672013|NCT01872611|459422542|FG000|Overall Study|Adverse Event, prior to treatment|0|||
127672014|NCT01872611|459422543|FG001|Overall Study|Adverse Event, prior to treatment|1|||
127672015|NCT01872611|459422542|FG000|Overall Study|Death|0|||
127672016|NCT01872611|459422543|FG001|Overall Study|Death|1|||
127672017|NCT01872611|459422542|FG000|Overall Study|Death, prior to treatment|0|||
127672018|NCT01872611|459422543|FG001|Overall Study|Death, prior to treatment|1|||
127672019|NCT01872611|459422542|FG000|Overall Study|Lost to Follow-up|8|||
127672020|NCT01872611|459422543|FG001|Overall Study|Lost to Follow-up|1|||
127672021|NCT01872611|459422542|FG000|Overall Study|Physician Decision|1|||
127672022|NCT01872611|459422543|FG001|Overall Study|Physician Decision|0|||
127672023|NCT01872611|459422542|FG000|Overall Study|Withdrawal by Subject|6|||
127672024|NCT01872611|459422543|FG001|Overall Study|Withdrawal by Subject|1|||
127672025|NCT01872611|459422542|FG000|Overall Study|Reason not provided|6|||
127672026|NCT01872611|459422543|FG001|Overall Study|Reason not provided|6|||
127672027|NCT00631917|459422544|FG000|Overall Study|Adverse Event|34|||
127672028|NCT00631917|459422545|FG001|Overall Study|Adverse Event|45|||
128004305|NCT00249834|460643559|FG001|Overall Study|Ovarian stimulation failed|0|||
128004306|NCT00249834|460643560|FG002|Overall Study|Ovarian stimulation failed|0|||
128004307|NCT00249834|460643561|FG003|Overall Study|Ovarian stimulation failed|0|||
127672029|NCT00631917|459422544|FG000|Overall Study|Abnormal laboratory value(s)|2|||
127672030|NCT00631917|459422545|FG001|Overall Study|Abnormal laboratory value(s)|1|||
127672031|NCT00631917|459422544|FG000|Overall Study|Abnormal test procedure result(s)|3|||
127672032|NCT00631917|459422545|FG001|Overall Study|Abnormal test procedure result(s)|2|||
127672033|NCT00631917|459422544|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
127672034|NCT00631917|459422545|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
127672035|NCT00631917|459422544|FG000|Overall Study|No longer required study drug|0|||
128004308|NCT00249834|460643562|FG004|Overall Study|Ovarian stimulation failed|0|||
128004309|NCT00249834|460643563|FG005|Overall Study|Ovarian stimulation failed|0|||
128004310|NCT00249834|460643564|FG006|Overall Study|Ovarian stimulation failed|0|||
128004311|NCT00249834|460643565|FG007|Overall Study|Ovarian stimulation failed|0|||
128004312|NCT00249834|460643558|FG000|Overall Study|Failure of down-regulation|0|||
128004313|NCT00249834|460643559|FG001|Overall Study|Failure of down-regulation|0|||
128004314|NCT00249834|460643560|FG002|Overall Study|Failure of down-regulation|0|||
128004315|NCT00249834|460643561|FG003|Overall Study|Failure of down-regulation|0|||
128004316|NCT00249834|460643562|FG004|Overall Study|Failure of down-regulation|0|||
128004317|NCT00249834|460643563|FG005|Overall Study|Failure of down-regulation|0|||
128004318|NCT00249834|460643564|FG006|Overall Study|Failure of down-regulation|1|||
128004319|NCT00249834|460643565|FG007|Overall Study|Failure of down-regulation|0|||
128004320|NCT00249834|460643558|FG000|Overall Study|Protocol Violation|0|||
128004321|NCT00249834|460643559|FG001|Overall Study|Protocol Violation|19|||
128004322|NCT00249834|460643560|FG002|Overall Study|Protocol Violation|14|||
128004323|NCT00249834|460643561|FG003|Overall Study|Protocol Violation|8|||
128004324|NCT00249834|460643562|FG004|Overall Study|Protocol Violation|5|||
128004325|NCT00249834|460643563|FG005|Overall Study|Protocol Violation|2|||
128004326|NCT00249834|460643564|FG006|Overall Study|Protocol Violation|0|||
128004327|NCT00249834|460643565|FG007|Overall Study|Protocol Violation|0|||
128004328|NCT02895347|460643567|FG000|Overall Study|Withdrawal by Subject|3|||
128004329|NCT02895347|460643568|FG001|Overall Study|Withdrawal by Subject|1|||
128004330|NCT01673178|460643572|FG000|Overall Study|Lost to Follow-up|0|||
128004331|NCT01673178|460643573|FG001|Overall Study|Lost to Follow-up|1|||
128004332|NCT01673178|460643574|FG002|Overall Study|Lost to Follow-up|0|||
128004333|NCT01673178|460643575|FG003|Overall Study|Lost to Follow-up|0|||
128004334|NCT01673178|460643576|FG004|Overall Study|Lost to Follow-up|0|||
128004335|NCT01673178|460643572|FG000|Overall Study|Withdrawal by Subject|0|||
128004336|NCT01673178|460643573|FG001|Overall Study|Withdrawal by Subject|0|||
128004337|NCT01673178|460643574|FG002|Overall Study|Withdrawal by Subject|1|||
128004338|NCT01673178|460643575|FG003|Overall Study|Withdrawal by Subject|4|||
128004339|NCT01673178|460643576|FG004|Overall Study|Withdrawal by Subject|2|||
128004340|NCT01673178|460643572|FG000|Overall Study|Protocol Violation|1|||
128004341|NCT01673178|460643573|FG001|Overall Study|Protocol Violation|1|||
128004342|NCT01673178|460643574|FG002|Overall Study|Protocol Violation|0|||
128004343|NCT01673178|460643575|FG003|Overall Study|Protocol Violation|1|||
128004344|NCT01673178|460643576|FG004|Overall Study|Protocol Violation|0|||
128004345|NCT01673178|460643572|FG000|Overall Study|Adverse Event|1|||
128004346|NCT01673178|460643573|FG001|Overall Study|Adverse Event|0|||
128004347|NCT01673178|460643574|FG002|Overall Study|Adverse Event|0|||
128004348|NCT01673178|460643575|FG003|Overall Study|Adverse Event|2|||
128004349|NCT01673178|460643576|FG004|Overall Study|Adverse Event|0|||
128004350|NCT01673178|460643572|FG000|Overall Study|Other|1|||
128004351|NCT01673178|460643573|FG001|Overall Study|Other|0|||
128004352|NCT01673178|460643574|FG002|Overall Study|Other|2|||
128004353|NCT01673178|460643575|FG003|Overall Study|Other|1|||
128004354|NCT01673178|460643576|FG004|Overall Study|Other|0|||
128004355|NCT03177148|460643577|FG000|Overall Study|Lost to Follow-up|50|||
128004356|NCT03177148|460643578|FG001|Overall Study|Lost to Follow-up|1|||
127672036|NCT00631917|459422545|FG001|Overall Study|No longer required study drug|1|||
127672037|NCT00631917|459422544|FG000|Overall Study|Protocol deviation|6|||
127672038|NCT00631917|459422545|FG001|Overall Study|Protocol deviation|5|||
127672039|NCT00631917|459422544|FG000|Overall Study|Subject withdrew consent|25|||
127672040|NCT00631917|459422545|FG001|Overall Study|Subject withdrew consent|33|||
127672041|NCT00631917|459422544|FG000|Overall Study|Lost to Follow-up|7|||
127672042|NCT00631917|459422545|FG001|Overall Study|Lost to Follow-up|7|||
127672043|NCT00631917|459422544|FG000|Overall Study|Administrative problems|2|||
127672044|NCT00631917|459422545|FG001|Overall Study|Administrative problems|0|||
127672045|NCT00631917|459422544|FG000|Overall Study|Death|1|||
127672046|NCT00631917|459422545|FG001|Overall Study|Death|0|||
127672047|NCT05650333|459422546|FG000|Treatment Period (7 Days)|Adverse Event|1|||
127672048|NCT02616263|459422547|FG000|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|0|||
127672049|NCT02616263|459422548|FG001|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|3|||
127672050|NCT02616263|459422547|FG000|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|1|||
127672051|NCT02616263|459422548|FG001|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|0|||
127672052|NCT02616263|459422547|FG000|6 Month to 1.5 Year|Death|1|||
128004357|NCT03177148|460643577|FG000|Overall Study|Death|1|||
127672053|NCT02616263|459422548|FG001|6 Month to 1.5 Year|Death|0|||
127672054|NCT02616263|459422547|FG000|6 Month to 1.5 Year|Lost to Follow-up|0|||
127672055|NCT02616263|459422548|FG001|6 Month to 1.5 Year|Lost to Follow-up|2|||
128004358|NCT03177148|460643578|FG001|Overall Study|Death|0|||
127672056|NCT02616263|459422547|FG000|6 Month to 1.5 Year|Withdrawal by Subject|1|||
127672057|NCT02616263|459422548|FG001|6 Month to 1.5 Year|Withdrawal by Subject|1|||
127672058|NCT02616263|459422547|FG000|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|4|||
128004359|NCT01419314|460643581|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
128004360|NCT01419314|460643582|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
128004361|NCT01419314|460643581|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
127672059|NCT02616263|459422548|FG001|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|2|||
127672060|NCT02939183|459422551|FG000|Overall Study|Death|0|||
127672061|NCT02939183|459422552|FG001|Overall Study|Death|0|||
127672062|NCT02939183|459422553|FG002|Overall Study|Death|1|||
127672063|NCT02939183|459422554|FG003|Overall Study|Death|0|||
127672064|NCT02939183|459422555|FG004|Overall Study|Death|0|||
127672065|NCT02939183|459422556|FG005|Overall Study|Death|2|||
127672066|NCT02939183|459422557|FG006|Overall Study|Death|1|||
127672067|NCT02939183|459422558|FG007|Overall Study|Death|0|||
127672068|NCT02939183|459422559|FG008|Overall Study|Death|0|||
127672069|NCT02939183|459422551|FG000|Overall Study|Sponsor decision|0|||
127672070|NCT02939183|459422552|FG001|Overall Study|Sponsor decision|1|||
127672071|NCT02939183|459422553|FG002|Overall Study|Sponsor decision|0|||
127672072|NCT02939183|459422554|FG003|Overall Study|Sponsor decision|1|||
127672073|NCT02939183|459422555|FG004|Overall Study|Sponsor decision|2|||
127672074|NCT02939183|459422556|FG005|Overall Study|Sponsor decision|0|||
127672075|NCT02939183|459422557|FG006|Overall Study|Sponsor decision|3|||
127672076|NCT02939183|459422558|FG007|Overall Study|Sponsor decision|1|||
127672077|NCT02939183|459422559|FG008|Overall Study|Sponsor decision|4|||
127672078|NCT02939183|459422551|FG000|Overall Study|Withdrawal by Subject|0|||
127672079|NCT02939183|459422552|FG001|Overall Study|Withdrawal by Subject|2|||
127672080|NCT02939183|459422553|FG002|Overall Study|Withdrawal by Subject|0|||
127672081|NCT02939183|459422554|FG003|Overall Study|Withdrawal by Subject|1|||
127672082|NCT02939183|459422555|FG004|Overall Study|Withdrawal by Subject|0|||
127672083|NCT02939183|459422556|FG005|Overall Study|Withdrawal by Subject|0|||
127672084|NCT02939183|459422557|FG006|Overall Study|Withdrawal by Subject|2|||
127672085|NCT02939183|459422558|FG007|Overall Study|Withdrawal by Subject|2|||
127672086|NCT02939183|459422559|FG008|Overall Study|Withdrawal by Subject|2|||
127672087|NCT02939183|459422551|FG000|Overall Study|Not treated due to adverse event|0|||
127672088|NCT02939183|459422552|FG001|Overall Study|Not treated due to adverse event|0|||
128004362|NCT01419314|460643582|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
128004363|NCT01419314|460643581|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
128004364|NCT01419314|460643582|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
128004365|NCT00887484|460643596|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
128004366|NCT00887484|460643596|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
128004367|NCT00887484|460643596|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
128004368|NCT03044314|460643597|FG000|Overall Study|Physician Decision|2|||
128004369|NCT03044314|460643597|FG000|Overall Study|Withdrawal by Subject|1|||
128004370|NCT03044314|460643597|FG000|Overall Study|Connector tubing not available|1|||
128004371|NCT01316224|460643598|FG000|Overall Study|Protocol Violation|3|||
128004372|NCT01316224|460643598|FG000|Overall Study|Adverse Event|3|||
128004373|NCT01316224|460643598|FG000|Overall Study|Lack of Efficacy|1|||
128004374|NCT01316224|460643598|FG000|Overall Study|Withdrawal by Subject|1|||
128004375|NCT01316224|460643598|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
128004376|NCT01316224|460643598|FG000|Overall Study|Other|1|||
128004377|NCT03106077|460643599|FG000|Overall Study|Screen Failure|94|||
127672089|NCT02939183|459422553|FG002|Overall Study|Not treated due to adverse event|0|||
127672090|NCT02939183|459422554|FG003|Overall Study|Not treated due to adverse event|1|||
127672091|NCT02939183|459422555|FG004|Overall Study|Not treated due to adverse event|0|||
127672092|NCT02939183|459422556|FG005|Overall Study|Not treated due to adverse event|0|||
127672093|NCT02939183|459422557|FG006|Overall Study|Not treated due to adverse event|1|||
127672094|NCT02939183|459422558|FG007|Overall Study|Not treated due to adverse event|0|||
127672095|NCT02939183|459422559|FG008|Overall Study|Not treated due to adverse event|0|||
127672096|NCT01446003|459422564|FG000|Period 1|Protocol Violation|2|||
127672097|NCT01446003|459422565|FG001|Period 1|Protocol Violation|0|||
127672098|NCT01446003|459422564|FG000|Period 2|Adverse Event|1|||
127672099|NCT01446003|459422565|FG001|Period 2|Adverse Event|0|||
127672100|NCT00318656|459422566|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
127672101|NCT00318656|459422567|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
127672102|NCT00318656|459422566|FG000|Overall Study|Did not receive any treatment|0|||
127672103|NCT00318656|459422567|FG001|Overall Study|Did not receive any treatment|1|||
127672104|NCT03905135|459422568|FG000|Dose Escalation|Adverse Event|1|||
128004378|NCT03106077|460643600|FG001|Overall Study|Screen Failure|0|||
127543533|NCT02718898|458956554|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
127672105|NCT03905135|459422569|FG001|Dose Escalation|Adverse Event|1|||
127672106|NCT03905135|459422568|FG000|Dose Escalation|Progressive disease|3|||
127672107|NCT03905135|459422569|FG001|Dose Escalation|Progressive disease|1|||
128004379|NCT00606307|460643603|FG000|Overall Study|Adverse Event|2|||
128004380|NCT00606307|460643603|FG000|Overall Study|Withdrawal by Subject|2|||
127672108|NCT03905135|459422568|FG000|Dose Escalation|Intercurrent illness|1|||
127672109|NCT03905135|459422569|FG001|Dose Escalation|Intercurrent illness|0|||
127672110|NCT00490555|459422570|FG000|Overall Study|noncompliant with drug administration|0|||
127672111|NCT00490555|459422571|FG001|Overall Study|noncompliant with drug administration|0|||
127672112|NCT00490555|459422572|FG002|Overall Study|noncompliant with drug administration|2|||
127672113|NCT00490555|459422573|FG003|Overall Study|noncompliant with drug administration|0|||
127672114|NCT02042443|459422576|FG000|Overall Study|Adverse Event|2|||
128004381|NCT00606307|460643603|FG000|Overall Study|Disease progression|6|||
128004382|NCT00606307|460643603|FG000|Overall Study|QTc prolongation|1|||
128004383|NCT01274533|460643604|FG000|Overall Study|Withdrawal by Subject|1|||
128004384|NCT01274533|460643604|FG000|Overall Study|Non-compliance|1|||
128004385|NCT01274533|460643604|FG000|Overall Study|Disease progression|2|||
128004386|NCT02008526|460643614|FG000|Overall Study|Death|0|||
128004387|NCT02008526|460643615|FG001|Overall Study|Death|2|||
128004388|NCT02008526|460643616|FG002|Overall Study|Death|1|||
128004389|NCT02008526|460643614|FG000|Overall Study|Withdrawal by Subject|3|||
128004390|NCT02008526|460643615|FG001|Overall Study|Withdrawal by Subject|3|||
128004391|NCT02008526|460643616|FG002|Overall Study|Withdrawal by Subject|2|||
128004392|NCT02008526|460643614|FG000|Overall Study|Lost to Follow-up|5|||
128004393|NCT02008526|460643615|FG001|Overall Study|Lost to Follow-up|9|||
128004394|NCT02008526|460643616|FG002|Overall Study|Lost to Follow-up|6|||
128004395|NCT01118052|460643617|FG000|Overall Study|Never treated|2|||
128004396|NCT02949947|460643618|FG000|Overall Study|Non Compliance|0|||
127543534|NCT02718898|458956555|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
127672115|NCT02042443|459422577|FG001|Overall Study|Adverse Event|1|||
127672116|NCT02042443|459422576|FG000|Overall Study|Withdrawal by Subject|0|||
127672117|NCT02042443|459422577|FG001|Overall Study|Withdrawal by Subject|1|||
127672118|NCT02042443|459422576|FG000|Overall Study|Progression|21|||
127672119|NCT02042443|459422577|FG001|Overall Study|Progression|17|||
127672120|NCT02042443|459422576|FG000|Overall Study|not protocol specified|1|||
127672121|NCT02042443|459422577|FG001|Overall Study|not protocol specified|1|||
127672122|NCT02042443|459422576|FG000|Overall Study|Not eligible/not analyzable|3|||
127672123|NCT02042443|459422577|FG001|Overall Study|Not eligible/not analyzable|6|||
127672124|NCT01007149|459422580|FG000|Overall Study|Administrative problems|0|||
127672125|NCT01007149|459422581|FG001|Overall Study|Administrative problems|1|||
127672126|NCT01913340|459422582|FG000|Overall Study|Death|2|||
127672127|NCT01913340|459422583|FG001|Overall Study|Death|5|||
127672128|NCT01913340|459422582|FG000|Overall Study|Lost to Follow-up|1|||
127672129|NCT01913340|459422583|FG001|Overall Study|Lost to Follow-up|1|||
127672130|NCT02784704|459422584|FG000|Overall Study|Adverse Event|4|||
127672131|NCT02784704|459422585|FG001|Overall Study|Adverse Event|2|||
127672132|NCT02784704|459422584|FG000|Overall Study|Lost to Follow-up|6|||
127672133|NCT02784704|459422585|FG001|Overall Study|Lost to Follow-up|4|||
127672134|NCT02784704|459422584|FG000|Overall Study|Withdrawal by Subject|1|||
127672135|NCT02784704|459422585|FG001|Overall Study|Withdrawal by Subject|3|||
127672136|NCT02784704|459422584|FG000|Overall Study|Subject Non Compliance|2|||
127672137|NCT02784704|459422585|FG001|Overall Study|Subject Non Compliance|0|||
127672138|NCT02320253|459422586|FG000|Overall Study|Withdrawal by Subject|3|||
127672139|NCT02320253|459422587|FG001|Overall Study|Withdrawal by Subject|0|||
127672140|NCT02320253|459422588|FG002|Overall Study|Withdrawal by Subject|0|||
127672141|NCT02320253|459422586|FG000|Overall Study|Lost to Follow-up|2|||
127672142|NCT02320253|459422587|FG001|Overall Study|Lost to Follow-up|2|||
127672143|NCT02320253|459422588|FG002|Overall Study|Lost to Follow-up|1|||
127672144|NCT02320253|459422586|FG000|Overall Study|Death|1|||
127672145|NCT02320253|459422587|FG001|Overall Study|Death|0|||
127672146|NCT02320253|459422588|FG002|Overall Study|Death|1|||
127672147|NCT00603538|459422589|FG000|Overall Study|Adverse Event|0|||
127672148|NCT00603538|459422590|FG001|Overall Study|Adverse Event|4|||
127672149|NCT00603538|459422591|FG002|Overall Study|Adverse Event|2|||
127672150|NCT00603538|459422589|FG000|Overall Study|Objective progression or relapse|3|||
127672151|NCT00603538|459422590|FG001|Overall Study|Objective progression or relapse|0|||
127672152|NCT00603538|459422591|FG002|Overall Study|Objective progression or relapse|0|||
127672153|NCT05750745|459422593|FG000|Overall Study|Adverse Event|1|||
127672154|NCT05750745|459422594|FG001|Overall Study|Adverse Event|0|||
127672155|NCT05750745|459422595|FG002|Overall Study|Adverse Event|0|||
127672156|NCT05750745|459422593|FG000|Overall Study|Protocol Violation|1|||
127672157|NCT05750745|459422594|FG001|Overall Study|Protocol Violation|0|||
127672158|NCT05750745|459422595|FG002|Overall Study|Protocol Violation|0|||
127672159|NCT05750745|459422593|FG000|Overall Study|Withdrawal by Subject|0|||
127672160|NCT05750745|459422594|FG001|Overall Study|Withdrawal by Subject|1|||
127672161|NCT05750745|459422595|FG002|Overall Study|Withdrawal by Subject|0|||
127672162|NCT00783692|459422597|FG000|Induction Phase|Adverse Event|7|||
127672163|NCT00783692|459422598|FG001|Induction Phase|Adverse Event|9|||
127672164|NCT00783692|459422599|FG002|Induction Phase|Adverse Event|24|||
127672165|NCT00783692|459422600|FG003|Induction Phase|Adverse Event|0|||
127672166|NCT00783692|459422601|FG004|Induction Phase|Adverse Event|0|||
127672167|NCT00783692|459422602|FG005|Induction Phase|Adverse Event|0|||
127672168|NCT00783692|459422603|FG006|Induction Phase|Adverse Event|0|||
127672169|NCT00783692|459422597|FG000|Induction Phase|Protocol Violation|0|||
127672170|NCT00783692|459422598|FG001|Induction Phase|Protocol Violation|0|||
128004397|NCT02949947|460643619|FG001|Overall Study|Non Compliance|1|||
128004398|NCT02949947|460643618|FG000|Overall Study|Insurance change|1|||
128004399|NCT02949947|460643619|FG001|Overall Study|Insurance change|0|||
127672171|NCT00783692|459422599|FG002|Induction Phase|Protocol Violation|1|||
127672172|NCT00783692|459422600|FG003|Induction Phase|Protocol Violation|0|||
128004400|NCT00492726|460643621|FG000|Overall Study|Adverse Event|10|||
128004401|NCT00492726|460643622|FG001|Overall Study|Adverse Event|6|||
128004402|NCT00492726|460643621|FG000|Overall Study|Death|7|||
128004403|NCT00492726|460643622|FG001|Overall Study|Death|2|||
128004404|NCT00492726|460643621|FG000|Overall Study|Lack of Efficacy|0|||
128004405|NCT00492726|460643622|FG001|Overall Study|Lack of Efficacy|2|||
128004406|NCT00492726|460643621|FG000|Overall Study|Lost to Follow-up|27|||
128004407|NCT00492726|460643622|FG001|Overall Study|Lost to Follow-up|19|||
127672173|NCT00783692|459422601|FG004|Induction Phase|Protocol Violation|0|||
127672174|NCT00783692|459422602|FG005|Induction Phase|Protocol Violation|0|||
127672175|NCT00783692|459422603|FG006|Induction Phase|Protocol Violation|0|||
128004408|NCT00492726|460643621|FG000|Overall Study|Physician Decision|0|||
128004409|NCT00492726|460643622|FG001|Overall Study|Physician Decision|1|||
128004410|NCT00492726|460643621|FG000|Overall Study|Withdrawal by Subject|6|||
128004411|NCT00492726|460643622|FG001|Overall Study|Withdrawal by Subject|3|||
128004412|NCT00492726|460643621|FG000|Overall Study|Non compliant with study medication|0|||
128004413|NCT00492726|460643622|FG001|Overall Study|Non compliant with study medication|3|||
128004414|NCT04386902|460643623|FG000|Overall Study|Withdrawal by Subject|5|||
128004415|NCT04386902|460643623|FG000|Overall Study|Technical problems in the recording|5|||
128004416|NCT00828711|460643624|FG000|Overall Study|Lost to Follow-up|1|||
128004417|NCT00828711|460643625|FG001|Overall Study|Lost to Follow-up|0|||
128004418|NCT00828711|460643626|FG002|Overall Study|Lost to Follow-up|0|||
128004419|NCT02230891|460643627|FG000|Baseline|Did not meet inclusion|0|||
128004420|NCT02230891|460643628|FG001|Baseline|Did not meet inclusion|1|||
128004421|NCT02230891|460643629|FG002|Baseline|Did not meet inclusion|1|||
128004422|NCT02230891|460643627|FG000|2 Week|Withdrawal by Subject|2|||
128004423|NCT02230891|460643628|FG001|2 Week|Withdrawal by Subject|2|||
128004424|NCT02230891|460643629|FG002|2 Week|Withdrawal by Subject|0|||
128004425|NCT02230891|460643627|FG000|2 Week|Consent withdrawn|1|||
128004426|NCT02230891|460643628|FG001|2 Week|Consent withdrawn|0|||
128004427|NCT02230891|460643629|FG002|2 Week|Consent withdrawn|0|||
128004428|NCT02230891|460643627|FG000|6 Month|Withdrawal by Subject|1|||
128004429|NCT02230891|460643628|FG001|6 Month|Withdrawal by Subject|1|||
128004430|NCT02230891|460643629|FG002|6 Month|Withdrawal by Subject|1|||
128004431|NCT02230891|460643627|FG000|6 Month|Physician Decision|0|||
128004432|NCT02230891|460643628|FG001|6 Month|Physician Decision|2|||
128004433|NCT02230891|460643629|FG002|6 Month|Physician Decision|0|||
128004434|NCT02230891|460643627|FG000|12 Month|Death|1|||
128004435|NCT02230891|460643628|FG001|12 Month|Death|0|||
128004436|NCT02230891|460643629|FG002|12 Month|Death|0|||
128004437|NCT02230891|460643627|FG000|12 Month|Lost to Follow-up|0|||
128004438|NCT02230891|460643628|FG001|12 Month|Lost to Follow-up|1|||
128004439|NCT02230891|460643629|FG002|12 Month|Lost to Follow-up|0|||
128004440|NCT02230891|460643627|FG000|12 Month|Withdrawal by Subject|0|||
128004441|NCT02230891|460643628|FG001|12 Month|Withdrawal by Subject|2|||
128004442|NCT02230891|460643629|FG002|12 Month|Withdrawal by Subject|0|||
128004443|NCT02230891|460643627|FG000|18 Month End of Study|Death|0|||
128004444|NCT02230891|460643628|FG001|18 Month End of Study|Death|0|||
128004445|NCT02230891|460643629|FG002|18 Month End of Study|Death|1|||
128004446|NCT02230891|460643627|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
128004447|NCT02230891|460643628|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
128004448|NCT02230891|460643629|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
128004449|NCT02404545|460643630|FG000|Overall Study|Sponsor Termination|6|||
128004450|NCT02404545|460643631|FG001|Overall Study|Sponsor Termination|6|||
128004451|NCT02370511|460643632|FG000|Overall Study|Death|10|||
128004452|NCT02370511|460643633|FG001|Overall Study|Death|7|||
128004453|NCT02370511|460643634|FG002|Overall Study|Death|1|||
128004454|NCT02370511|460643632|FG000|Overall Study|Withdrawal by Subject|2|||
128004455|NCT02370511|460643633|FG001|Overall Study|Withdrawal by Subject|0|||
128004456|NCT02370511|460643634|FG002|Overall Study|Withdrawal by Subject|0|||
127672176|NCT00783692|459422597|FG000|Induction Phase|Lack of Efficacy|1|||
127672177|NCT00783692|459422598|FG001|Induction Phase|Lack of Efficacy|3|||
127672178|NCT00783692|459422599|FG002|Induction Phase|Lack of Efficacy|28|||
127672179|NCT00783692|459422600|FG003|Induction Phase|Lack of Efficacy|0|||
128004457|NCT02370511|460643632|FG000|Overall Study|Lost to Follow-up|0|||
127672180|NCT00783692|459422601|FG004|Induction Phase|Lack of Efficacy|0|||
128004458|NCT02370511|460643633|FG001|Overall Study|Lost to Follow-up|4|||
128004459|NCT02370511|460643634|FG002|Overall Study|Lost to Follow-up|0|||
128004460|NCT03882918|460643635|FG000|Overall Study|Study terminated by sponsor|98|||
128004461|NCT03882918|460643635|FG000|Overall Study|Protocol Violation|1|||
128004462|NCT03882918|460643635|FG000|Overall Study|Other|9|||
128004463|NCT03882918|460643635|FG000|Overall Study|Lack of Efficacy|14|||
128004464|NCT03882918|460643635|FG000|Overall Study|Adverse Event|13|||
128004465|NCT03882918|460643635|FG000|Overall Study|Withdrawal by Subject|5|||
128004466|NCT02100124|460643636|FG000|Overall Study|Lost to Follow-up|5|||
128004467|NCT02100124|460643637|FG001|Overall Study|Lost to Follow-up|11|||
127543535|NCT02718898|458956556|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
128004468|NCT02100124|460643638|FG002|Overall Study|Lost to Follow-up|3|||
128004469|NCT02100124|460643636|FG000|Overall Study|Withdrawal by Subject|1|||
128004470|NCT02100124|460643637|FG001|Overall Study|Withdrawal by Subject|0|||
128004471|NCT02100124|460643638|FG002|Overall Study|Withdrawal by Subject|0|||
128004472|NCT01712516|460644908|FG000|Overall Study|Technical problems|0|||
128004473|NCT01712516|460644909|FG001|Overall Study|Technical problems|0|||
128004474|NCT01712516|460644910|FG002|Overall Study|Technical problems|0|||
128004475|NCT01712516|460644911|FG003|Overall Study|Technical problems|2|||
128004476|NCT01712516|460644908|FG000|Overall Study|Lost to Follow-up|0|||
128004477|NCT01712516|460644909|FG001|Overall Study|Lost to Follow-up|0|||
128004478|NCT01712516|460644910|FG002|Overall Study|Lost to Follow-up|2|||
128004479|NCT01712516|460644911|FG003|Overall Study|Lost to Follow-up|1|||
128004480|NCT01712516|460644908|FG000|Overall Study|Death|0|||
128004481|NCT01712516|460644909|FG001|Overall Study|Death|1|||
128004482|NCT01712516|460644910|FG002|Overall Study|Death|0|||
128004483|NCT01712516|460644911|FG003|Overall Study|Death|0|||
128004484|NCT01712516|460644908|FG000|Overall Study|Protocol deviation|1|||
128004485|NCT01712516|460644909|FG001|Overall Study|Protocol deviation|0|||
128004486|NCT01712516|460644910|FG002|Overall Study|Protocol deviation|1|||
128004487|NCT01712516|460644911|FG003|Overall Study|Protocol deviation|0|||
128004488|NCT01712516|460644908|FG000|Overall Study|Physician Decision|2|||
128004489|NCT01712516|460644909|FG001|Overall Study|Physician Decision|0|||
128004490|NCT01712516|460644910|FG002|Overall Study|Physician Decision|0|||
128004491|NCT01712516|460644911|FG003|Overall Study|Physician Decision|1|||
128004492|NCT01712516|460644908|FG000|Overall Study|Withdrawal by Subject|3|||
128004493|NCT01712516|460644909|FG001|Overall Study|Withdrawal by Subject|9|||
128004494|NCT01712516|460644910|FG002|Overall Study|Withdrawal by Subject|3|||
128004495|NCT01712516|460644911|FG003|Overall Study|Withdrawal by Subject|9|||
128004496|NCT01181167|460644915|FG000|Overall Study|Adverse Event|11|||
128004497|NCT01181167|460644916|FG001|Overall Study|Adverse Event|21|||
128004498|NCT01181167|460644915|FG000|Overall Study|Lost to Follow-up|1|||
128004499|NCT01181167|460644916|FG001|Overall Study|Lost to Follow-up|0|||
128004500|NCT01181167|460644915|FG000|Overall Study|Physician Decision|2|||
128004501|NCT01181167|460644916|FG001|Overall Study|Physician Decision|3|||
128004502|NCT01181167|460644915|FG000|Overall Study|Protocol Violation|3|||
128004503|NCT01181167|460644916|FG001|Overall Study|Protocol Violation|0|||
128004504|NCT01181167|460644915|FG000|Overall Study|Withdrawal by Subject|6|||
128004505|NCT01181167|460644916|FG001|Overall Study|Withdrawal by Subject|8|||
128004506|NCT00161213|460644917|FG000|Overall Study|Withdrawal by Subject|1|||
128004507|NCT00161213|460644917|FG000|Overall Study|Evaluable for toxicity but not response|1|||
128004508|NCT03103503|460644918|FG000|Overall Study|Death|64|||
128004509|NCT03103503|460644918|FG000|Overall Study|Physician Decision|57|||
128004510|NCT03103503|460644918|FG000|Overall Study|Withdrawal by Subject|10|||
128004511|NCT03103503|460644918|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
128004512|NCT03103503|460644918|FG000|Overall Study|Lost to Follow-up|3|||
128004513|NCT03103503|460644918|FG000|Overall Study|Study Closure|757|||
128004514|NCT01384877|460644919|FG000|Treatment 2|Lost to Follow-up|2|||
128004515|NCT01384877|460644920|FG001|Treatment 2|Lost to Follow-up|2|||
128004516|NCT03630393|460644921|FG000|Overall Study|Death|1|||
128004517|NCT03630393|460644922|FG001|Overall Study|Death|0|||
128004518|NCT00408499|460644923|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
128004519|NCT00408499|460644924|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
128004520|NCT00408499|460644925|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
128004521|NCT00408499|460644926|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
128004522|NCT00408499|460644927|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
128004523|NCT00408499|460644923|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
128004524|NCT00408499|460644924|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
128004525|NCT00408499|460644925|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
128004526|NCT00408499|460644926|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
128004527|NCT00408499|460644927|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
128004528|NCT00408499|460644923|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
128004529|NCT00408499|460644924|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
128004530|NCT00408499|460644925|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
128004531|NCT00408499|460644926|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
128004532|NCT00408499|460644927|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
127672181|NCT00783692|459422602|FG005|Induction Phase|Lack of Efficacy|0|||
127672182|NCT00783692|459422603|FG006|Induction Phase|Lack of Efficacy|0|||
127672183|NCT00783692|459422597|FG000|Induction Phase|Withdrawal by Subject|3|||
127672184|NCT00783692|459422598|FG001|Induction Phase|Withdrawal by Subject|9|||
127672185|NCT00783692|459422599|FG002|Induction Phase|Withdrawal by Subject|16|||
127672186|NCT00783692|459422600|FG003|Induction Phase|Withdrawal by Subject|0|||
128004533|NCT00408499|460644923|FG000|Phase II- MTD Expansion|Adverse Event|0|||
128004534|NCT00408499|460644924|FG001|Phase II- MTD Expansion|Adverse Event|0|||
128004535|NCT00408499|460644925|FG002|Phase II- MTD Expansion|Adverse Event|0|||
128004536|NCT00408499|460644926|FG003|Phase II- MTD Expansion|Adverse Event|0|||
128004537|NCT00408499|460644927|FG004|Phase II- MTD Expansion|Adverse Event|9|||
128004538|NCT00408499|460644923|FG000|Phase II- MTD Expansion|Death|0|||
128004539|NCT00408499|460644924|FG001|Phase II- MTD Expansion|Death|0|||
128004540|NCT00408499|460644925|FG002|Phase II- MTD Expansion|Death|0|||
128004541|NCT00408499|460644926|FG003|Phase II- MTD Expansion|Death|0|||
128004542|NCT00408499|460644927|FG004|Phase II- MTD Expansion|Death|2|||
128004543|NCT00408499|460644923|FG000|Phase II- MTD Expansion|Physician Decision|0|||
128004544|NCT00408499|460644924|FG001|Phase II- MTD Expansion|Physician Decision|0|||
128004545|NCT00408499|460644925|FG002|Phase II- MTD Expansion|Physician Decision|0|||
128004546|NCT00408499|460644926|FG003|Phase II- MTD Expansion|Physician Decision|0|||
128004547|NCT00408499|460644927|FG004|Phase II- MTD Expansion|Physician Decision|1|||
128004548|NCT00408499|460644923|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
128004549|NCT00408499|460644924|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
128004550|NCT00408499|460644925|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
128004551|NCT00408499|460644926|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
128004552|NCT00408499|460644927|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
128004553|NCT00408499|460644923|FG000|Phase II- MTD Expansion|treatment delay|0|||
128004554|NCT00408499|460644924|FG001|Phase II- MTD Expansion|treatment delay|0|||
128004555|NCT00408499|460644925|FG002|Phase II- MTD Expansion|treatment delay|0|||
128004556|NCT00408499|460644926|FG003|Phase II- MTD Expansion|treatment delay|0|||
128004557|NCT00408499|460644927|FG004|Phase II- MTD Expansion|treatment delay|3|||
127672187|NCT00783692|459422601|FG004|Induction Phase|Withdrawal by Subject|0|||
128004558|NCT00997334|460644931|FG000|Overall Study|still on therapy|12|||
128004559|NCT00997334|460644931|FG000|Overall Study|Adverse Event|3|||
128004560|NCT00997334|460644931|FG000|Overall Study|Patient non-compliance|1|||
128004561|NCT00997334|460644931|FG000|Overall Study|Withdrawal by Subject|3|||
128004562|NCT00997334|460644931|FG000|Overall Study|Death|2|||
128004563|NCT00997334|460644931|FG000|Overall Study|Urgent Palliative Care|2|||
128004564|NCT00997334|460644931|FG000|Overall Study|No lesion amenable|1|||
128004565|NCT00997334|460644931|FG000|Overall Study|Ineligible|1|||
128004566|NCT01586195|460644932|FG000|Overall Study|Death|11|||
128004567|NCT01586195|460644932|FG000|Overall Study|Withdrawal of Consent|5|||
128004568|NCT01586195|460644932|FG000|Overall Study|Started new anti-melanoma therapy|1|||
128004569|NCT01586195|460644932|FG000|Overall Study|Reason not specified|9|||
128004570|NCT02683109|460644936|FG000|Overall Study|Adverse Event|1|||
128004571|NCT02683109|460644937|FG001|Overall Study|Adverse Event|0|||
128004572|NCT00183430|460644938|FG000|Overall Study|Adverse Event|1|||
128004573|NCT00183430|460644939|FG001|Overall Study|Adverse Event|0|||
128004574|NCT00183430|460644938|FG000|Overall Study|Lost to Follow-up|3|||
128004575|NCT00183430|460644939|FG001|Overall Study|Lost to Follow-up|0|||
128004576|NCT00183430|460644938|FG000|Overall Study|did not meet inclusion criteria|1|||
128004577|NCT00183430|460644939|FG001|Overall Study|did not meet inclusion criteria|0|||
128004578|NCT00183430|460644938|FG000|Overall Study|Withdrawal by Subject|1|||
128004579|NCT00183430|460644939|FG001|Overall Study|Withdrawal by Subject|0|||
128004580|NCT00426270|460644944|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
128004581|NCT00426270|460644944|FG000|Overall Study|Adverse Event|5|||
128004582|NCT03102762|460644945|FG000|Overall Study|Lost to Follow-up|1|||
128004583|NCT03102762|460644946|FG001|Overall Study|Lost to Follow-up|0|||
128004584|NCT00958074|460644947|FG000|Overall Study|Withdrawal by Subject|0|||
128004585|NCT00958074|460644948|FG001|Overall Study|Withdrawal by Subject|1|||
128004586|NCT02709746|460644949|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
128004587|NCT02709746|460644950|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
128004588|NCT02709746|460644951|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
128004589|NCT02709746|460644952|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
128004590|NCT02709746|460644953|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
128004591|NCT02709746|460644949|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
128004592|NCT02709746|460644950|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
128004593|NCT02709746|460644951|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
127672188|NCT00783692|459422602|FG005|Induction Phase|Withdrawal by Subject|0|||
128004594|NCT02709746|460644952|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
128004595|NCT02709746|460644953|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
128004596|NCT02709746|460644949|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
128004597|NCT02709746|460644950|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
128004598|NCT02709746|460644951|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
128004599|NCT02709746|460644952|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
128004600|NCT02709746|460644953|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
128004601|NCT02709746|460644949|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
128004602|NCT02709746|460644950|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
128004603|NCT02709746|460644951|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
127672189|NCT00783692|459422603|FG006|Induction Phase|Withdrawal by Subject|0|||
127672190|NCT00783692|459422597|FG000|Induction Phase|Lost to Follow-up|0|||
128004604|NCT02709746|460644952|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
128004605|NCT02709746|460644953|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
128004606|NCT02709746|460644949|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
128004607|NCT02709746|460644950|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
128004608|NCT02709746|460644951|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
127672191|NCT00783692|459422598|FG001|Induction Phase|Lost to Follow-up|0|||
127672192|NCT00783692|459422599|FG002|Induction Phase|Lost to Follow-up|3|||
128004609|NCT02709746|460644952|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
128004610|NCT02709746|460644953|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
128004611|NCT02709746|460644949|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
128004612|NCT02709746|460644950|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
128004613|NCT02709746|460644951|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
128004614|NCT02709746|460644952|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
128004615|NCT02709746|460644953|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
128004616|NCT02709746|460644949|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
128004617|NCT02709746|460644950|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
128004618|NCT02709746|460644951|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
128004619|NCT02709746|460644952|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
128004620|NCT02709746|460644953|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
128004621|NCT02709746|460644949|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
128004622|NCT02709746|460644950|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
128004623|NCT02709746|460644951|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
128004624|NCT02709746|460644952|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
128004625|NCT02709746|460644953|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
128004626|NCT02709746|460644949|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
128004627|NCT02709746|460644950|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
128004628|NCT02709746|460644951|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
128004629|NCT02709746|460644952|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
128004630|NCT02709746|460644953|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
128004631|NCT02709746|460644949|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
128004632|NCT02709746|460644950|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
128004633|NCT02709746|460644951|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
128004634|NCT02709746|460644952|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
128004635|NCT02709746|460644953|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
128004636|NCT02709746|460644949|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
128004637|NCT02709746|460644950|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
128004638|NCT02709746|460644951|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
128004639|NCT02709746|460644952|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
128004640|NCT02709746|460644953|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
128004641|NCT02709746|460644949|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
128004642|NCT02709746|460644950|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
128004643|NCT02709746|460644951|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
128004644|NCT02709746|460644952|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
128004645|NCT02709746|460644953|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
128004646|NCT02709746|460644949|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
128004647|NCT02709746|460644950|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
128004648|NCT02709746|460644951|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
128004649|NCT02709746|460644952|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
128004650|NCT02709746|460644953|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
128004651|NCT02709746|460644949|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
128004652|NCT02709746|460644950|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
128004653|NCT02709746|460644951|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
128004654|NCT02709746|460644952|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
128004655|NCT02709746|460644953|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
128004656|NCT02709746|460644949|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
128004657|NCT02709746|460644950|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
128004658|NCT02709746|460644951|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
128004659|NCT02709746|460644952|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
128004660|NCT02709746|460644953|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
128004661|NCT02709746|460644949|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
128004662|NCT02709746|460644950|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
128004663|NCT02709746|460644951|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
128004664|NCT02709746|460644952|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
128004665|NCT02709746|460644953|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
128004666|NCT02709746|460644949|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
128004667|NCT02709746|460644950|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
128004668|NCT02709746|460644951|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
128004669|NCT02709746|460644952|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
127672193|NCT00783692|459422600|FG003|Induction Phase|Lost to Follow-up|0|||
128004670|NCT02709746|460644953|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
127672194|NCT00783692|459422601|FG004|Induction Phase|Lost to Follow-up|0|||
127672195|NCT00783692|459422602|FG005|Induction Phase|Lost to Follow-up|0|||
127672196|NCT00783692|459422603|FG006|Induction Phase|Lost to Follow-up|0|||
127672197|NCT00783692|459422597|FG000|Induction Phase|Other|0|||
127672198|NCT00783692|459422598|FG001|Induction Phase|Other|0|||
127672199|NCT00783692|459422599|FG002|Induction Phase|Other|2|||
127672200|NCT00783692|459422600|FG003|Induction Phase|Other|0|||
127672201|NCT00783692|459422601|FG004|Induction Phase|Other|0|||
127672202|NCT00783692|459422602|FG005|Induction Phase|Other|0|||
127672203|NCT00783692|459422603|FG006|Induction Phase|Other|0|||
127672204|NCT00783692|459422597|FG000|Maintenance Phase|Adverse Event|7|||
128004671|NCT00551369|460644954|FG000|Overall Study|Protocol Violation|5|||
128004672|NCT00551369|460644954|FG000|Overall Study|Withdrawal by Subject|1|||
128004673|NCT00551369|460644954|FG000|Overall Study|Not treated per protocol and re|1|||
128004674|NCT00719901|460644955|FG000|Overall Study|Adverse Event|5|||
128004675|NCT00719901|460644955|FG000|Overall Study|Withdrawal by Subject|1|||
128004676|NCT00719901|460644955|FG000|Overall Study|Alternate Treatment|1|||
128004677|NCT00719901|460644955|FG000|Overall Study|Disease Progression|3|||
128004678|NCT00719901|460644955|FG000|Overall Study|Availability of Study Drug|1|||
128004679|NCT01122173|460644956|FG000|Overall Study|Lost to Follow-up|3|||
128004680|NCT01122173|460644956|FG000|Overall Study|Withdrawal by Subject|3|||
128004681|NCT01122173|460644956|FG000|Overall Study|Left study for other reasons|3|||
128004682|NCT01184872|460644957|FG000|Overall Study|Adverse Event|3|||
128004683|NCT01184872|460644958|FG001|Overall Study|Adverse Event|4|||
128004684|NCT01184872|460644957|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
128004685|NCT01184872|460644958|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
128004686|NCT01184872|460644957|FG000|Overall Study|Withdrawal by Subject|2|||
128004687|NCT01184872|460644958|FG001|Overall Study|Withdrawal by Subject|0|||
128004688|NCT01184872|460644957|FG000|Overall Study|Lost to Follow-up|0|||
128004689|NCT01184872|460644958|FG001|Overall Study|Lost to Follow-up|1|||
128004690|NCT01184872|460644957|FG000|Overall Study|Administrative problems|1|||
128004691|NCT01184872|460644958|FG001|Overall Study|Administrative problems|1|||
128004692|NCT01184872|460644957|FG000|Overall Study|Protocol deviation|1|||
128004693|NCT01184872|460644958|FG001|Overall Study|Protocol deviation|0|||
128004694|NCT03426345|460644959|FG000|Overall Study|Adverse Event|4|||
128004695|NCT03426345|460644960|FG001|Overall Study|Adverse Event|4|||
128004696|NCT03426345|460644959|FG000|Overall Study|Lack of Efficacy|1|||
128004697|NCT03426345|460644960|FG001|Overall Study|Lack of Efficacy|0|||
128004698|NCT03426345|460644959|FG000|Overall Study|Withdrawal by Subject|5|||
127672205|NCT00783692|459422598|FG001|Maintenance Phase|Adverse Event|0|||
127672206|NCT00783692|459422599|FG002|Maintenance Phase|Adverse Event|0|||
127672207|NCT00783692|459422600|FG003|Maintenance Phase|Adverse Event|15|||
128004699|NCT03426345|460644960|FG001|Overall Study|Withdrawal by Subject|6|||
128004700|NCT03426345|460644959|FG000|Overall Study|Lost to Follow-up|3|||
128004701|NCT03426345|460644960|FG001|Overall Study|Lost to Follow-up|1|||
128004702|NCT03426345|460644959|FG000|Overall Study|Protocol Deviation|3|||
128004703|NCT03426345|460644960|FG001|Overall Study|Protocol Deviation|4|||
128004704|NCT03426345|460644959|FG000|Overall Study|Reason Not Specified|1|||
128004705|NCT03426345|460644960|FG001|Overall Study|Reason Not Specified|2|||
128004706|NCT03426345|460644959|FG000|Overall Study|Missing Completion Status|1|||
128004707|NCT03426345|460644960|FG001|Overall Study|Missing Completion Status|0|||
128004708|NCT02497469|460644961|FG000|Overall Study|Randomized but not Treated|0|||
128004709|NCT02497469|460644962|FG001|Overall Study|Randomized but not Treated|2|||
128004710|NCT02497469|460644961|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
127672208|NCT00783692|459422601|FG004|Maintenance Phase|Adverse Event|12|||
127672209|NCT00783692|459422602|FG005|Maintenance Phase|Adverse Event|9|||
127672210|NCT00783692|459422603|FG006|Maintenance Phase|Adverse Event|38|||
128004711|NCT02497469|460644962|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
128004712|NCT02497469|460644961|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
128004713|NCT02497469|460644962|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
128004714|NCT02497469|460644961|FG000|Overall Study|Significant Protocol Deviation|4|||
128004715|NCT02497469|460644962|FG001|Overall Study|Significant Protocol Deviation|5|||
127672211|NCT00783692|459422597|FG000|Maintenance Phase|Protocol Violation|0|||
128004716|NCT02497469|460644961|FG000|Overall Study|Lost to Follow-up|14|||
128004717|NCT02497469|460644962|FG001|Overall Study|Lost to Follow-up|4|||
128004718|NCT02497469|460644961|FG000|Overall Study|Voluntary Withdrawal|39|||
127672212|NCT00783692|459422598|FG001|Maintenance Phase|Protocol Violation|0|||
128004719|NCT02497469|460644962|FG001|Overall Study|Voluntary Withdrawal|41|||
128004720|NCT02497469|460644961|FG000|Overall Study|Pregnancy|1|||
127672213|NCT00783692|459422599|FG002|Maintenance Phase|Protocol Violation|0|||
127672214|NCT00783692|459422600|FG003|Maintenance Phase|Protocol Violation|1|||
127672215|NCT00783692|459422601|FG004|Maintenance Phase|Protocol Violation|2|||
127672216|NCT00783692|459422602|FG005|Maintenance Phase|Protocol Violation|3|||
127672217|NCT00783692|459422603|FG006|Maintenance Phase|Protocol Violation|4|||
127672218|NCT00783692|459422597|FG000|Maintenance Phase|Lack of Efficacy|79|||
128004721|NCT02497469|460644962|FG001|Overall Study|Pregnancy|1|||
128004722|NCT02497469|460644961|FG000|Overall Study|Lack of Efficacy|86|||
128004723|NCT02497469|460644962|FG001|Overall Study|Lack of Efficacy|40|||
128004724|NCT02497469|460644961|FG000|Overall Study|Reason not Specified|6|||
128004725|NCT02497469|460644962|FG001|Overall Study|Reason not Specified|6|||
128004726|NCT04076917|460644963|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
128004727|NCT04076917|460644963|FG000|Overall Study|Study closure|13|||
128004728|NCT04076917|460644963|FG000|Overall Study|Physician Decision|3|||
128004729|NCT04076917|460644963|FG000|Overall Study|Death|1|||
128004730|NCT04076917|460644963|FG000|Overall Study|Lost to Follow-up|1|||
128004731|NCT04076917|460644963|FG000|Overall Study|Withdrawal by Subject|1|||
128004732|NCT04076917|460644963|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
128004733|NCT00630916|460644967|FG000|Overall Study|Death|110|||
128004734|NCT00630916|460644967|FG000|Overall Study|Explant|8|||
128004735|NCT00630916|460644967|FG000|Overall Study|Lost to Follow-up|5|||
128004736|NCT00630916|460644967|FG000|Overall Study|Withdrawal by Subject|30|||
128004737|NCT00630916|460644967|FG000|Overall Study|Protocol Violation|7|||
128004738|NCT00630916|460644967|FG000|Overall Study|Physician Decision|47|||
128004739|NCT00630916|460644967|FG000|Overall Study|Lack of Efficacy|3|||
128004740|NCT03863353|460644973|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
128004741|NCT03863353|460644974|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
128004742|NCT01299584|460644975|FG000|Overall Study|Protocol Violation|9|||
128004743|NCT03810183|460644978|FG000|Overall Study|Study terminated by Sponsor|2|||
128004744|NCT03810183|460644979|FG001|Overall Study|Study terminated by Sponsor|1|||
128004745|NCT00323063|460644981|FG000|Overall Study|Adverse Event|1|||
128004746|NCT00323063|460644982|FG001|Overall Study|Adverse Event|0|||
128004747|NCT00323063|460644981|FG000|Overall Study|brain mets discovered prior to treatment|1|||
128004748|NCT00323063|460644982|FG001|Overall Study|brain mets discovered prior to treatment|0|||
128004749|NCT03167242|460644983|FG000|Overall Study|Patient/Guardian Decision|0|||
128004750|NCT03167242|460644984|FG001|Overall Study|Patient/Guardian Decision|1|||
128004751|NCT03167242|460644985|FG002|Overall Study|Patient/Guardian Decision|2|||
128004752|NCT03167242|460644986|FG003|Overall Study|Patient/Guardian Decision|1|||
128004753|NCT03167242|460644987|FG004|Overall Study|Patient/Guardian Decision|1|||
128004754|NCT03167242|460644988|FG005|Overall Study|Patient/Guardian Decision|1|||
128004755|NCT03167242|460644989|FG006|Overall Study|Patient/Guardian Decision|0|||
128004756|NCT03167242|460644990|FG007|Overall Study|Patient/Guardian Decision|0|||
128004757|NCT03167242|460644991|FG008|Overall Study|Patient/Guardian Decision|0|||
128004758|NCT03167242|460644992|FG009|Overall Study|Patient/Guardian Decision|0|||
128004759|NCT03167242|460644993|FG010|Overall Study|Patient/Guardian Decision|1|||
128004760|NCT03167242|460644994|FG011|Overall Study|Patient/Guardian Decision|0|||
128004761|NCT03167242|460644983|FG000|Overall Study|Lost to Follow-up|0|||
128004762|NCT03167242|460644984|FG001|Overall Study|Lost to Follow-up|0|||
128004763|NCT03167242|460644985|FG002|Overall Study|Lost to Follow-up|1|||
128004764|NCT03167242|460644986|FG003|Overall Study|Lost to Follow-up|0|||
128004765|NCT03167242|460644987|FG004|Overall Study|Lost to Follow-up|0|||
128004766|NCT03167242|460644988|FG005|Overall Study|Lost to Follow-up|1|||
128004767|NCT03167242|460644989|FG006|Overall Study|Lost to Follow-up|2|||
128004768|NCT03167242|460644990|FG007|Overall Study|Lost to Follow-up|1|||
128004769|NCT03167242|460644991|FG008|Overall Study|Lost to Follow-up|0|||
128004770|NCT03167242|460644992|FG009|Overall Study|Lost to Follow-up|0|||
128004771|NCT03167242|460644993|FG010|Overall Study|Lost to Follow-up|1|||
128004772|NCT03167242|460644994|FG011|Overall Study|Lost to Follow-up|1|||
128004773|NCT03167242|460644983|FG000|Overall Study|Reason not provided|0|||
128004774|NCT03167242|460644984|FG001|Overall Study|Reason not provided|0|||
128004775|NCT03167242|460644985|FG002|Overall Study|Reason not provided|0|||
128004776|NCT03167242|460644986|FG003|Overall Study|Reason not provided|0|||
128004777|NCT03167242|460644987|FG004|Overall Study|Reason not provided|0|||
128004778|NCT03167242|460644988|FG005|Overall Study|Reason not provided|0|||
128004779|NCT03167242|460644989|FG006|Overall Study|Reason not provided|0|||
128004780|NCT03167242|460644990|FG007|Overall Study|Reason not provided|0|||
128004781|NCT03167242|460644991|FG008|Overall Study|Reason not provided|1|||
128004782|NCT03167242|460644992|FG009|Overall Study|Reason not provided|0|||
128004783|NCT03167242|460644993|FG010|Overall Study|Reason not provided|0|||
128004784|NCT03167242|460644994|FG011|Overall Study|Reason not provided|0|||
128004785|NCT02144701|460645001|FG000|Overall Study|development of relapse, GVHD or death|9|||
128004786|NCT02144701|460645002|FG001|Overall Study|development of relapse, GVHD or death|3|||
128004787|NCT01218802|460645004|FG000|Overall Study|Lost to Follow-up|5|||
128004788|NCT01218802|460645005|FG001|Overall Study|Lost to Follow-up|6|||
128004789|NCT01218802|460645004|FG000|Overall Study|Withdrawal by Subject|3|||
128004790|NCT01218802|460645005|FG001|Overall Study|Withdrawal by Subject|10|||
127672219|NCT00783692|459422598|FG001|Maintenance Phase|Lack of Efficacy|0|||
128004791|NCT01218802|460645004|FG000|Overall Study|Adverse Event|0|||
128004792|NCT01218802|460645005|FG001|Overall Study|Adverse Event|2|||
128004793|NCT01218802|460645004|FG000|Overall Study|Incarcerated|2|||
128004794|NCT01218802|460645005|FG001|Overall Study|Incarcerated|0|||
128004795|NCT03327324|460645006|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
128004796|NCT03327324|460645007|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
128004797|NCT03327324|460645008|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
128004798|NCT03327324|460645009|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
128004799|NCT03327324|460645010|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
128004800|NCT03327324|460645011|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
128004801|NCT03327324|460645006|FG000|Baseline (Month 0-Month 3)|Refused|0|||
128004802|NCT03327324|460645007|FG001|Baseline (Month 0-Month 3)|Refused|0|||
128004803|NCT03327324|460645008|FG002|Baseline (Month 0-Month 3)|Refused|0|||
128004804|NCT03327324|460645009|FG003|Baseline (Month 0-Month 3)|Refused|0|||
128004805|NCT03327324|460645010|FG004|Baseline (Month 0-Month 3)|Refused|1|||
128004806|NCT03327324|460645011|FG005|Baseline (Month 0-Month 3)|Refused|0|||
128004807|NCT03327324|460645006|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
128004808|NCT03327324|460645007|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
128004809|NCT03327324|460645008|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
128004810|NCT03327324|460645009|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
128004811|NCT03327324|460645010|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
128004812|NCT03327324|460645011|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
128004813|NCT03327324|460645006|FG000|Baseline (Month 0-Month 3)|Death|0|||
128004814|NCT03327324|460645007|FG001|Baseline (Month 0-Month 3)|Death|0|||
128004815|NCT03327324|460645008|FG002|Baseline (Month 0-Month 3)|Death|0|||
128004816|NCT03327324|460645009|FG003|Baseline (Month 0-Month 3)|Death|0|||
128004817|NCT03327324|460645010|FG004|Baseline (Month 0-Month 3)|Death|1|||
128004818|NCT03327324|460645011|FG005|Baseline (Month 0-Month 3)|Death|0|||
128004819|NCT03327324|460645006|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
128004820|NCT03327324|460645007|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
128004821|NCT03327324|460645008|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
128004822|NCT03327324|460645009|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
128004823|NCT03327324|460645010|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
128004824|NCT03327324|460645011|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
128004825|NCT03327324|460645006|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
128004826|NCT03327324|460645007|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
128004827|NCT03327324|460645008|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
128004828|NCT03327324|460645009|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
128004829|NCT03327324|460645010|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
128004830|NCT03327324|460645011|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
128004831|NCT03327324|460645006|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
128004832|NCT03327324|460645007|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
128004833|NCT03327324|460645008|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
128004834|NCT03327324|460645009|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
127672220|NCT00783692|459422599|FG002|Maintenance Phase|Lack of Efficacy|0|||
127672221|NCT00783692|459422600|FG003|Maintenance Phase|Lack of Efficacy|64|||
127672222|NCT00783692|459422601|FG004|Maintenance Phase|Lack of Efficacy|58|||
127672223|NCT00783692|459422602|FG005|Maintenance Phase|Lack of Efficacy|48|||
127672224|NCT00783692|459422603|FG006|Maintenance Phase|Lack of Efficacy|177|||
127672225|NCT00783692|459422597|FG000|Maintenance Phase|Withdrawal by Subject|7|||
127672226|NCT00783692|459422598|FG001|Maintenance Phase|Withdrawal by Subject|0|||
127672227|NCT00783692|459422599|FG002|Maintenance Phase|Withdrawal by Subject|0|||
127672228|NCT00783692|459422600|FG003|Maintenance Phase|Withdrawal by Subject|7|||
127672229|NCT00783692|459422601|FG004|Maintenance Phase|Withdrawal by Subject|6|||
127672230|NCT00783692|459422602|FG005|Maintenance Phase|Withdrawal by Subject|9|||
127672231|NCT00783692|459422603|FG006|Maintenance Phase|Withdrawal by Subject|24|||
127672232|NCT00783692|459422597|FG000|Maintenance Phase|Lost to Follow-up|2|||
127672233|NCT00783692|459422598|FG001|Maintenance Phase|Lost to Follow-up|0|||
127672234|NCT00783692|459422599|FG002|Maintenance Phase|Lost to Follow-up|0|||
127672235|NCT00783692|459422600|FG003|Maintenance Phase|Lost to Follow-up|1|||
127672236|NCT00783692|459422601|FG004|Maintenance Phase|Lost to Follow-up|3|||
127672237|NCT00783692|459422602|FG005|Maintenance Phase|Lost to Follow-up|2|||
127672238|NCT00783692|459422603|FG006|Maintenance Phase|Lost to Follow-up|5|||
127672239|NCT00783692|459422597|FG000|Maintenance Phase|Other|0|||
127672240|NCT00783692|459422598|FG001|Maintenance Phase|Other|0|||
127672241|NCT00783692|459422599|FG002|Maintenance Phase|Other|0|||
127672242|NCT00783692|459422600|FG003|Maintenance Phase|Other|1|||
127672243|NCT00783692|459422601|FG004|Maintenance Phase|Other|0|||
127672244|NCT00783692|459422602|FG005|Maintenance Phase|Other|1|||
127672245|NCT00783692|459422603|FG006|Maintenance Phase|Other|1|||
127672246|NCT00768066|459422606|FG000|Overall Study|Did not receive study product injection.|3|||
127672247|NCT00768066|459422607|FG001|Overall Study|Did not receive study product injection.|3|||
127672248|NCT00768066|459422608|FG002|Overall Study|Did not receive study product injection.|0|||
127672249|NCT04831775|459422609|FG000|Overall Study|Lost to Follow-up|11|||
127672250|NCT04831775|459422610|FG001|Overall Study|Lost to Follow-up|13|||
127672251|NCT05550337|459422613|FG000|Overall Study|Lack of Efficacy|0|||
127672252|NCT05550337|459422614|FG001|Overall Study|Lack of Efficacy|0|||
127672253|NCT05550337|459422615|FG002|Overall Study|Lack of Efficacy|1|||
127672254|NCT05550337|459422613|FG000|Overall Study|Adverse Event|1|||
127672255|NCT05550337|459422614|FG001|Overall Study|Adverse Event|5|||
127672256|NCT05550337|459422615|FG002|Overall Study|Adverse Event|0|||
127672257|NCT05550337|459422613|FG000|Overall Study|Withdrawal by Subject|8|||
127672258|NCT05550337|459422614|FG001|Overall Study|Withdrawal by Subject|14|||
127672259|NCT05550337|459422615|FG002|Overall Study|Withdrawal by Subject|10|||
127672260|NCT05550337|459422613|FG000|Overall Study|Pregnancy|0|||
127672261|NCT05550337|459422614|FG001|Overall Study|Pregnancy|0|||
127672262|NCT05550337|459422615|FG002|Overall Study|Pregnancy|1|||
127672263|NCT05550337|459422613|FG000|Overall Study|Protocol Violation|1|||
128004835|NCT03327324|460645010|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
128004836|NCT03327324|460645011|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
128004837|NCT03327324|460645006|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
128004838|NCT03327324|460645007|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
128004839|NCT03327324|460645008|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
128004840|NCT03327324|460645009|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
128004841|NCT03327324|460645010|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
128004842|NCT03327324|460645011|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
128004843|NCT03327324|460645006|FG000|Intervention (Month 3-Month 6)|Death|1|||
128004844|NCT03327324|460645007|FG001|Intervention (Month 3-Month 6)|Death|0|||
128004845|NCT03327324|460645008|FG002|Intervention (Month 3-Month 6)|Death|1|||
128004846|NCT03327324|460645009|FG003|Intervention (Month 3-Month 6)|Death|1|||
128004847|NCT03327324|460645010|FG004|Intervention (Month 3-Month 6)|Death|1|||
128004848|NCT03327324|460645011|FG005|Intervention (Month 3-Month 6)|Death|0|||
128004849|NCT03327324|460645006|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
128004850|NCT03327324|460645007|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
128004851|NCT03327324|460645008|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
128004852|NCT03327324|460645009|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
128004853|NCT03327324|460645010|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
128004854|NCT03327324|460645011|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
128004855|NCT03327324|460645006|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
128004856|NCT03327324|460645007|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
128004857|NCT03327324|460645008|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
128004858|NCT03327324|460645009|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
128004859|NCT03327324|460645010|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
128004860|NCT03327324|460645011|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
128004861|NCT03327324|460645006|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
128004862|NCT03327324|460645007|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
128004863|NCT03327324|460645008|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
128004864|NCT03327324|460645009|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
128004865|NCT03327324|460645010|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
128004866|NCT03327324|460645011|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
128004867|NCT03327324|460645006|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
128004868|NCT03327324|460645007|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
128004869|NCT03327324|460645008|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
128004870|NCT03327324|460645009|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
128004871|NCT03327324|460645010|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
128004872|NCT03327324|460645011|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
127672264|NCT05550337|459422614|FG001|Overall Study|Protocol Violation|3|||
127672265|NCT05550337|459422615|FG002|Overall Study|Protocol Violation|4|||
127672266|NCT05550337|459422613|FG000|Overall Study|Physician Decision|2|||
127672267|NCT05550337|459422614|FG001|Overall Study|Physician Decision|1|||
127672268|NCT05550337|459422615|FG002|Overall Study|Physician Decision|1|||
128004873|NCT03327324|460645006|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
128004874|NCT03327324|460645007|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
128004875|NCT03327324|460645008|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
128004876|NCT03327324|460645009|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
128004877|NCT03327324|460645010|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
128004878|NCT03327324|460645011|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
128004879|NCT03327324|460645006|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
128004880|NCT03327324|460645007|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
128004881|NCT03327324|460645008|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
128004882|NCT03327324|460645009|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
128004883|NCT03327324|460645010|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
128004884|NCT03327324|460645011|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
128004885|NCT03327324|460645006|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
128004886|NCT03327324|460645007|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
128004887|NCT03327324|460645008|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
128004888|NCT03327324|460645009|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
128004889|NCT03327324|460645010|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
128004890|NCT03327324|460645011|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
128004891|NCT00269152|460645012|FG000|Overall Study|Adverse Event|9|||
128004892|NCT00269152|460645013|FG001|Overall Study|Adverse Event|3|||
128004893|NCT00269152|460645012|FG000|Overall Study|Withdrawal by Subject|7|||
128004894|NCT00269152|460645013|FG001|Overall Study|Withdrawal by Subject|3|||
128004895|NCT00269152|460645012|FG000|Overall Study|Physician Decision|2|||
128004896|NCT00269152|460645013|FG001|Overall Study|Physician Decision|3|||
128004897|NCT00269152|460645012|FG000|Overall Study|Protocol Violation|0|||
128004898|NCT00269152|460645013|FG001|Overall Study|Protocol Violation|1|||
128004899|NCT04249427|460645014|FG000|Overall Study|Adverse Event|3|||
128004900|NCT04249427|460645015|FG001|Overall Study|Adverse Event|1|||
128004901|NCT04249427|460645014|FG000|Overall Study|Lack of Efficacy|0|||
128004902|NCT04249427|460645015|FG001|Overall Study|Lack of Efficacy|1|||
128004903|NCT04249427|460645014|FG000|Overall Study|Withdrawal by Subject|1|||
128004904|NCT04249427|460645015|FG001|Overall Study|Withdrawal by Subject|2|||
128004905|NCT02557399|460645016|FG000|Overall Study|Adverse Event|6|||
128004906|NCT02557399|460645017|FG001|Overall Study|Adverse Event|5|||
128004907|NCT02557399|460645016|FG000|Overall Study|Protocol Violation|0|||
128004908|NCT02557399|460645017|FG001|Overall Study|Protocol Violation|1|||
128004909|NCT02557399|460645016|FG000|Overall Study|Protocol-defined stopping criteria|0|||
128004910|NCT02557399|460645017|FG001|Overall Study|Protocol-defined stopping criteria|1|||
128004911|NCT02557399|460645016|FG000|Overall Study|Withdrawal by Subject|1|||
128004912|NCT02557399|460645017|FG001|Overall Study|Withdrawal by Subject|1|||
128004913|NCT02848664|460645018|FG000|Overall Study|Withdrawal by Subject|2|||
128004914|NCT02848664|460645018|FG000|Overall Study|Adverse Event|1|||
128004915|NCT02848664|460645018|FG000|Overall Study|no assistance for device training|1|||
128004916|NCT00402727|460645019|FG000|Overall Study|Adverse Event|10|||
128004917|NCT00402727|460645020|FG001|Overall Study|Adverse Event|6|||
128004918|NCT00402727|460645019|FG000|Overall Study|Death|1|||
128004919|NCT00402727|460645020|FG001|Overall Study|Death|0|||
128004920|NCT00402727|460645019|FG000|Overall Study|Lack of Efficacy|1|||
128004921|NCT00402727|460645020|FG001|Overall Study|Lack of Efficacy|3|||
128004922|NCT00402727|460645019|FG000|Overall Study|Lost to Follow-up|24|||
128004923|NCT00402727|460645020|FG001|Overall Study|Lost to Follow-up|11|||
128004924|NCT00402727|460645019|FG000|Overall Study|Physician Decision|1|||
128004925|NCT00402727|460645020|FG001|Overall Study|Physician Decision|1|||
128004926|NCT00402727|460645019|FG000|Overall Study|Protocol Violation|0|||
128004927|NCT00402727|460645020|FG001|Overall Study|Protocol Violation|4|||
128004928|NCT00402727|460645019|FG000|Overall Study|Withdrawal by Subject|3|||
128004929|NCT00402727|460645020|FG001|Overall Study|Withdrawal by Subject|7|||
128004930|NCT00402727|460645019|FG000|Overall Study|supply problems|2|||
128004931|NCT00402727|460645020|FG001|Overall Study|supply problems|1|||
128004932|NCT00402727|460645019|FG000|Overall Study|non-compliance|0|||
127672269|NCT05550337|459422613|FG000|Overall Study|Lost to Follow-up|16|||
127672270|NCT05550337|459422614|FG001|Overall Study|Lost to Follow-up|11|||
127672271|NCT05550337|459422615|FG002|Overall Study|Lost to Follow-up|11|||
127672272|NCT03115346|459422616|FG000|Overall Study|Did not have AAA surgery|28|||
127672273|NCT03115346|459422617|FG001|Overall Study|Did not have AAA surgery|15|||
127672274|NCT03115346|459422616|FG000|Overall Study|Death|3|||
128004933|NCT00402727|460645020|FG001|Overall Study|non-compliance|1|||
128004934|NCT03188055|460645021|FG000|Overall Study|Unavailable for training|0|||
128004935|NCT03188055|460645022|FG001|Overall Study|Unavailable for training|0|||
128004936|NCT03188055|460645023|FG002|Overall Study|Unavailable for training|19|||
127672275|NCT03115346|459422617|FG001|Overall Study|Death|1|||
128004937|NCT03188055|460645024|FG003|Overall Study|Unavailable for training|0|||
128004938|NCT03188055|460645025|FG004|Overall Study|Unavailable for training|0|||
128004939|NCT03188055|460645026|FG005|Overall Study|Unavailable for training|0|||
128004940|NCT03188055|460645021|FG000|Overall Study|Lost to Follow-up|0|||
128004941|NCT03188055|460645022|FG001|Overall Study|Lost to Follow-up|18|||
128004942|NCT03188055|460645023|FG002|Overall Study|Lost to Follow-up|0|||
128004943|NCT03188055|460645024|FG003|Overall Study|Lost to Follow-up|11|||
128004944|NCT03188055|460645025|FG004|Overall Study|Lost to Follow-up|0|||
128004945|NCT03188055|460645026|FG005|Overall Study|Lost to Follow-up|0|||
128004946|NCT03188055|460645021|FG000|Overall Study|Withdrawal by Subject|0|||
128004947|NCT03188055|460645022|FG001|Overall Study|Withdrawal by Subject|1|||
128004948|NCT03188055|460645023|FG002|Overall Study|Withdrawal by Subject|0|||
128004949|NCT03188055|460645024|FG003|Overall Study|Withdrawal by Subject|1|||
128004950|NCT03188055|460645025|FG004|Overall Study|Withdrawal by Subject|0|||
128004951|NCT03188055|460645026|FG005|Overall Study|Withdrawal by Subject|0|||
128004952|NCT01405898|460645027|FG000|Overall Study|Withdrawal by Subject|2|||
128004953|NCT01405898|460645028|FG001|Overall Study|Withdrawal by Subject|2|||
128004954|NCT00264147|460645031|FG000|Treatment I Period|Adverse Event|3|||
128004955|NCT00264147|460645032|FG001|Treatment I Period|Adverse Event|6|||
128004956|NCT00264147|460645033|FG002|Treatment I Period|Adverse Event|3|||
128004957|NCT00264147|460645034|FG003|Treatment I Period|Adverse Event|5|||
128004958|NCT00264147|460645035|FG004|Treatment I Period|Adverse Event|7|||
128004959|NCT00264147|460645036|FG005|Treatment I Period|Adverse Event|0|||
128004960|NCT00264147|460645031|FG000|Treatment I Period|Laboratory Adverse Event|0|||
128004961|NCT00264147|460645032|FG001|Treatment I Period|Laboratory Adverse Event|0|||
128004962|NCT00264147|460645033|FG002|Treatment I Period|Laboratory Adverse Event|0|||
128004963|NCT00264147|460645034|FG003|Treatment I Period|Laboratory Adverse Event|1|||
128004964|NCT00264147|460645035|FG004|Treatment I Period|Laboratory Adverse Event|0|||
128004965|NCT00264147|460645036|FG005|Treatment I Period|Laboratory Adverse Event|0|||
128004966|NCT00264147|460645031|FG000|Treatment I Period|Lack of Efficacy|6|||
128004967|NCT00264147|460645032|FG001|Treatment I Period|Lack of Efficacy|2|||
128004968|NCT00264147|460645033|FG002|Treatment I Period|Lack of Efficacy|8|||
128004969|NCT00264147|460645034|FG003|Treatment I Period|Lack of Efficacy|0|||
128004970|NCT00264147|460645035|FG004|Treatment I Period|Lack of Efficacy|1|||
128004971|NCT00264147|460645036|FG005|Treatment I Period|Lack of Efficacy|0|||
128004972|NCT00264147|460645031|FG000|Treatment I Period|Lost to Follow-up|1|||
128004973|NCT00264147|460645032|FG001|Treatment I Period|Lost to Follow-up|0|||
128004974|NCT00264147|460645033|FG002|Treatment I Period|Lost to Follow-up|0|||
128004975|NCT00264147|460645034|FG003|Treatment I Period|Lost to Follow-up|1|||
128004976|NCT00264147|460645035|FG004|Treatment I Period|Lost to Follow-up|1|||
128004977|NCT00264147|460645036|FG005|Treatment I Period|Lost to Follow-up|0|||
128004978|NCT00264147|460645031|FG000|Treatment I Period|Protocol Violation|2|||
128004979|NCT00264147|460645032|FG001|Treatment I Period|Protocol Violation|2|||
128004980|NCT00264147|460645033|FG002|Treatment I Period|Protocol Violation|0|||
128004981|NCT00264147|460645034|FG003|Treatment I Period|Protocol Violation|0|||
128004982|NCT00264147|460645035|FG004|Treatment I Period|Protocol Violation|0|||
128004983|NCT00264147|460645036|FG005|Treatment I Period|Protocol Violation|0|||
128004984|NCT00264147|460645031|FG000|Treatment I Period|Withdrawal by Subject|2|||
128004985|NCT00264147|460645032|FG001|Treatment I Period|Withdrawal by Subject|0|||
128004986|NCT00264147|460645033|FG002|Treatment I Period|Withdrawal by Subject|0|||
128004987|NCT00264147|460645034|FG003|Treatment I Period|Withdrawal by Subject|2|||
128004988|NCT00264147|460645035|FG004|Treatment I Period|Withdrawal by Subject|2|||
128004989|NCT00264147|460645036|FG005|Treatment I Period|Withdrawal by Subject|0|||
128004990|NCT00264147|460645031|FG000|Treatment I Period|Patient out of town for an extended time|0|||
128004991|NCT00264147|460645032|FG001|Treatment I Period|Patient out of town for an extended time|1|||
128004992|NCT00264147|460645033|FG002|Treatment I Period|Patient out of town for an extended time|0|||
128004993|NCT00264147|460645034|FG003|Treatment I Period|Patient out of town for an extended time|0|||
128004994|NCT00264147|460645035|FG004|Treatment I Period|Patient out of town for an extended time|0|||
128004995|NCT00264147|460645036|FG005|Treatment I Period|Patient out of town for an extended time|0|||
128004996|NCT00264147|460645031|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
128004997|NCT00264147|460645032|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
128004998|NCT00264147|460645033|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
128004999|NCT00264147|460645034|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
128005000|NCT00264147|460645035|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
128005001|NCT00264147|460645036|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
128005002|NCT00264147|460645031|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
128005003|NCT00264147|460645032|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
128005004|NCT00264147|460645033|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
128005005|NCT00264147|460645034|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
128005006|NCT00264147|460645035|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
128005007|NCT00264147|460645036|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
128005008|NCT00264147|460645031|FG000|Treatment II Period|Adverse Event|0|||
128005009|NCT00264147|460645032|FG001|Treatment II Period|Adverse Event|0|||
128005010|NCT00264147|460645033|FG002|Treatment II Period|Adverse Event|0|||
128005011|NCT00264147|460645034|FG003|Treatment II Period|Adverse Event|0|||
128005012|NCT00264147|460645035|FG004|Treatment II Period|Adverse Event|9|||
128005013|NCT00264147|460645036|FG005|Treatment II Period|Adverse Event|9|||
128005014|NCT00264147|460645031|FG000|Treatment II Period|Laboratory Adverse Event|0|||
128005015|NCT00264147|460645032|FG001|Treatment II Period|Laboratory Adverse Event|0|||
128005016|NCT00264147|460645033|FG002|Treatment II Period|Laboratory Adverse Event|0|||
128005017|NCT00264147|460645034|FG003|Treatment II Period|Laboratory Adverse Event|0|||
128005018|NCT00264147|460645035|FG004|Treatment II Period|Laboratory Adverse Event|0|||
128005019|NCT00264147|460645036|FG005|Treatment II Period|Laboratory Adverse Event|1|||
128005020|NCT00264147|460645031|FG000|Treatment II Period|Lack of Efficacy|0|||
127672276|NCT03115346|459422616|FG000|Overall Study|Withdrawal by Subject|0|||
127672277|NCT03115346|459422617|FG001|Overall Study|Withdrawal by Subject|3|||
127672278|NCT03115346|459422616|FG000|Overall Study|Lost to Follow-up|0|||
127672279|NCT03115346|459422617|FG001|Overall Study|Lost to Follow-up|3|||
127672280|NCT01737268|459422619|FG000|Overall Study|Adverse Event|6|||
127672281|NCT01737268|459422619|FG000|Overall Study|Worsening of Target Disease|2|||
128005021|NCT00264147|460645032|FG001|Treatment II Period|Lack of Efficacy|0|||
128005022|NCT00264147|460645033|FG002|Treatment II Period|Lack of Efficacy|0|||
128005023|NCT00264147|460645034|FG003|Treatment II Period|Lack of Efficacy|0|||
128005024|NCT00264147|460645035|FG004|Treatment II Period|Lack of Efficacy|20|||
128005025|NCT00264147|460645036|FG005|Treatment II Period|Lack of Efficacy|19|||
128005026|NCT00264147|460645031|FG000|Treatment II Period|Lost to Follow-up|0|||
128005027|NCT00264147|460645032|FG001|Treatment II Period|Lost to Follow-up|0|||
128005028|NCT00264147|460645033|FG002|Treatment II Period|Lost to Follow-up|0|||
128005029|NCT00264147|460645034|FG003|Treatment II Period|Lost to Follow-up|0|||
128005030|NCT00264147|460645035|FG004|Treatment II Period|Lost to Follow-up|1|||
128005031|NCT00264147|460645036|FG005|Treatment II Period|Lost to Follow-up|1|||
128005032|NCT00264147|460645031|FG000|Treatment II Period|Withdrawal by Subject|0|||
128005033|NCT00264147|460645032|FG001|Treatment II Period|Withdrawal by Subject|0|||
128005034|NCT00264147|460645033|FG002|Treatment II Period|Withdrawal by Subject|0|||
128005035|NCT00264147|460645034|FG003|Treatment II Period|Withdrawal by Subject|0|||
128005036|NCT00264147|460645035|FG004|Treatment II Period|Withdrawal by Subject|3|||
128005037|NCT00264147|460645036|FG005|Treatment II Period|Withdrawal by Subject|2|||
128005038|NCT00264147|460645031|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
128005039|NCT00264147|460645032|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
128005040|NCT00264147|460645033|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
128005041|NCT00264147|460645034|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
128005042|NCT00264147|460645035|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
128005043|NCT00264147|460645036|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
128005044|NCT03234465|460645037|FG000|Overall Study|Adverse Event|4|||
128005045|NCT03234465|460645038|FG001|Overall Study|Adverse Event|2|||
128005046|NCT03234465|460645037|FG000|Overall Study|Death|0|||
127672282|NCT01737268|459422619|FG000|Overall Study|In consideration of the patient's safety|1|||
127672283|NCT05567159|459422625|FG000|Overall Study|Adverse Event|4|||
127672284|NCT05567159|459422625|FG000|Overall Study|Physician Decision|3|||
127672285|NCT05567159|459422625|FG000|Overall Study|Protocol deviation|1|||
127672286|NCT02501811|459422628|FG000|Overall Study|Death|1|||
127672287|NCT02501811|459422629|FG001|Overall Study|Death|3|||
127672288|NCT02501811|459422630|FG002|Overall Study|Death|2|||
127672289|NCT02501811|459422631|FG003|Overall Study|Death|3|||
127672290|NCT02501811|459422628|FG000|Overall Study|Withdrawal by Subject|3|||
127672291|NCT02501811|459422629|FG001|Overall Study|Withdrawal by Subject|3|||
127672292|NCT02501811|459422630|FG002|Overall Study|Withdrawal by Subject|2|||
127672293|NCT02501811|459422631|FG003|Overall Study|Withdrawal by Subject|3|||
127672294|NCT02501811|459422628|FG000|Overall Study|Lost to Follow-up|0|||
127672295|NCT02501811|459422629|FG001|Overall Study|Lost to Follow-up|0|||
127672296|NCT02501811|459422630|FG002|Overall Study|Lost to Follow-up|2|||
127672297|NCT02501811|459422631|FG003|Overall Study|Lost to Follow-up|1|||
127672298|NCT00359619|459424470|FG000|Overall Study|Adverse Event|0|||
127672299|NCT00359619|459424471|FG001|Overall Study|Adverse Event|0|||
127672300|NCT00359619|459424472|FG002|Overall Study|Adverse Event|1|||
127672301|NCT00359619|459424473|FG003|Overall Study|Adverse Event|0|||
127672302|NCT00359619|459424474|FG004|Overall Study|Adverse Event|0|||
127672303|NCT00359619|459424475|FG005|Overall Study|Adverse Event|0|||
127672304|NCT00359619|459424476|FG006|Overall Study|Adverse Event|1|||
127672305|NCT00359619|459424470|FG000|Overall Study|Withdrawal by Subject|3|||
127672306|NCT00359619|459424471|FG001|Overall Study|Withdrawal by Subject|1|||
127672307|NCT00359619|459424472|FG002|Overall Study|Withdrawal by Subject|4|||
127672308|NCT00359619|459424473|FG003|Overall Study|Withdrawal by Subject|2|||
127672309|NCT00359619|459424474|FG004|Overall Study|Withdrawal by Subject|2|||
127672310|NCT00359619|459424475|FG005|Overall Study|Withdrawal by Subject|0|||
127672311|NCT00359619|459424476|FG006|Overall Study|Withdrawal by Subject|3|||
127672312|NCT00359619|459424470|FG000|Overall Study|Other|1|||
128005047|NCT03234465|460645038|FG001|Overall Study|Death|1|||
128005048|NCT03234465|460645037|FG000|Overall Study|Lost to Follow-up|1|||
128005049|NCT03234465|460645038|FG001|Overall Study|Lost to Follow-up|1|||
128005050|NCT03234465|460645037|FG000|Overall Study|Withdrawal by Subject|12|||
128005051|NCT03234465|460645038|FG001|Overall Study|Withdrawal by Subject|27|||
128005052|NCT03234465|460645037|FG000|Overall Study|Symptomatic deterioration|0|||
128005053|NCT03234465|460645038|FG001|Overall Study|Symptomatic deterioration|1|||
128005054|NCT03234465|460645037|FG000|Overall Study|Non-compliance|2|||
128005055|NCT03234465|460645038|FG001|Overall Study|Non-compliance|0|||
128005056|NCT03234465|460645037|FG000|Overall Study|Other|14|||
128005057|NCT03234465|460645038|FG001|Overall Study|Other|8|||
128005058|NCT00449163|460645039|FG000|Overall Study|Physician Decision|3|||
128005059|NCT02033759|460645041|FG000|Overall Study|Withdrawal by Subject|2|||
128005060|NCT02033759|460645042|FG001|Overall Study|Withdrawal by Subject|1|||
128005061|NCT02033759|460645041|FG000|Overall Study|Protocol Violation|1|||
128005062|NCT02033759|460645042|FG001|Overall Study|Protocol Violation|1|||
128005063|NCT01419535|460645052|FG000|Overall Study|could not maintain iv line|1|||
128005064|NCT01419535|460645053|FG001|Overall Study|could not maintain iv line|1|||
128005065|NCT01419535|460645052|FG000|Overall Study|Withdrawal by Subject|0|||
128005066|NCT01419535|460645053|FG001|Overall Study|Withdrawal by Subject|1|||
128005067|NCT00870727|460647281|FG000|Overall Study|Lost to Follow-up|0|||
128005068|NCT00870727|460647282|FG001|Overall Study|Lost to Follow-up|1|||
128005069|NCT00870727|460647281|FG000|Overall Study|Lack of Efficacy|1|||
128005070|NCT00870727|460647282|FG001|Overall Study|Lack of Efficacy|3|||
128005071|NCT00870727|460647281|FG000|Overall Study|Adverse Event|0|||
128005072|NCT00870727|460647282|FG001|Overall Study|Adverse Event|1|||
128005073|NCT00720278|460647283|FG000|Overall Study|Adverse Event|5|||
128005074|NCT00720278|460647284|FG001|Overall Study|Adverse Event|3|||
128005075|NCT00720278|460647285|FG002|Overall Study|Adverse Event|4|||
128005076|NCT00720278|460647283|FG000|Overall Study|Withdrawal by Subject|0|||
128005077|NCT00720278|460647284|FG001|Overall Study|Withdrawal by Subject|1|||
128005078|NCT00720278|460647285|FG002|Overall Study|Withdrawal by Subject|0|||
128005079|NCT00720278|460647283|FG000|Overall Study|Lost to Follow-up|0|||
128005080|NCT00720278|460647284|FG001|Overall Study|Lost to Follow-up|0|||
128005081|NCT00720278|460647285|FG002|Overall Study|Lost to Follow-up|1|||
128005082|NCT00720278|460647283|FG000|Overall Study|Non-compliance|1|||
128005083|NCT00720278|460647284|FG001|Overall Study|Non-compliance|0|||
128005084|NCT00720278|460647285|FG002|Overall Study|Non-compliance|0|||
128005085|NCT00720278|460647283|FG000|Overall Study|eligibility criteria violation|1|||
128005086|NCT00720278|460647284|FG001|Overall Study|eligibility criteria violation|0|||
128005087|NCT00720278|460647285|FG002|Overall Study|eligibility criteria violation|1|||
128005088|NCT03408899|460647286|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
128005089|NCT00606008|460647287|FG000|Overall Study|Adverse Event|1|||
128005090|NCT00606008|460647287|FG000|Overall Study|Withdrawal by Subject|4|||
128005091|NCT01248455|460647290|FG000|Overall Study|switched to alternate treatment|1|||
128005092|NCT01117870|460647292|FG000|Overall Study|Inability to place needle|1|||
128005093|NCT01117870|460647293|FG001|Overall Study|Inability to place needle|0|||
128005094|NCT03322293|460647299|FG000|Overall Study|Lost to Follow-up|0|||
128005095|NCT03322293|460647300|FG001|Overall Study|Lost to Follow-up|0|||
128005096|NCT03322293|460647301|FG002|Overall Study|Lost to Follow-up|1|||
128005097|NCT01178294|460647302|FG000|Overall Study|Adverse Event|4|||
128005098|NCT01178294|460647302|FG000|Overall Study|Lost to Follow-up|2|||
128005099|NCT01178294|460647302|FG000|Overall Study|Lack of Efficacy|1|||
128005100|NCT01178294|460647302|FG000|Overall Study|Death|1|||
127672313|NCT00359619|459424471|FG001|Overall Study|Other|0|||
127672314|NCT00359619|459424472|FG002|Overall Study|Other|0|||
127672315|NCT00359619|459424473|FG003|Overall Study|Other|0|||
127672316|NCT00359619|459424474|FG004|Overall Study|Other|0|||
127672317|NCT00359619|459424475|FG005|Overall Study|Other|0|||
127672318|NCT00359619|459424476|FG006|Overall Study|Other|0|||
127672319|NCT00359619|459424470|FG000|Overall Study|Lost to Follow-up|4|||
127672320|NCT00359619|459424471|FG001|Overall Study|Lost to Follow-up|4|||
127672321|NCT00359619|459424472|FG002|Overall Study|Lost to Follow-up|2|||
127672322|NCT00359619|459424473|FG003|Overall Study|Lost to Follow-up|1|||
127672323|NCT00359619|459424474|FG004|Overall Study|Lost to Follow-up|1|||
127672324|NCT00359619|459424475|FG005|Overall Study|Lost to Follow-up|5|||
128005101|NCT01178294|460647302|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
128005102|NCT01178294|460647302|FG000|Overall Study|Subject status is terminal|1|||
128005103|NCT01178294|460647302|FG000|Overall Study|Completion status could not be verified|1|||
128005104|NCT02089347|460647303|FG000|Overall Study|Protocol Violation|1|||
128005105|NCT02089347|460647304|FG001|Overall Study|Protocol Violation|0|||
128005106|NCT02783066|460647305|FG000|Overall Study|Withdrawal by Subject|13|||
128005107|NCT03176771|460647307|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
128005108|NCT03176771|460647308|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
127672325|NCT00359619|459424476|FG006|Overall Study|Lost to Follow-up|0|||
127672326|NCT00256308|459424479|FG000|Overall Study|Death|2|||
127672327|NCT01419717|459424480|FG000|Overall Study|Protocol-specified Criteria|62|||
128005109|NCT03176771|460647309|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
128005110|NCT03176771|460647310|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
128005111|NCT03176771|460647311|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
128005112|NCT03176771|460647307|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
128005113|NCT03176771|460647308|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
128005114|NCT03176771|460647309|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
128005115|NCT03176771|460647310|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
128005116|NCT03176771|460647311|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
128005117|NCT03176771|460647307|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
128005118|NCT03176771|460647308|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
128005119|NCT03176771|460647309|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
128005120|NCT03176771|460647310|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
128005121|NCT03176771|460647311|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
128005122|NCT03176771|460647307|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
128005123|NCT03176771|460647308|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
128005124|NCT03176771|460647309|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
127672328|NCT01419717|459424480|FG000|Overall Study|Adverse Event|19|||
127672329|NCT01419717|459424480|FG000|Overall Study|Death|17|||
127672330|NCT01419717|459424480|FG000|Overall Study|Withdrawal by Subject|10|||
127672331|NCT01419717|459424480|FG000|Overall Study|Disease Progression|9|||
127672332|NCT01419717|459424480|FG000|Overall Study|Other|4|||
127672333|NCT01419717|459424480|FG000|Overall Study|Lost to Follow-up|2|||
127672334|NCT01419717|459424480|FG000|Overall Study|Administrative Decision|1|||
127672335|NCT01419717|459424480|FG000|Overall Study|Noncompliance|1|||
127672336|NCT02857283|459424481|FG000|First Exposure|Withdrawal by Subject|1|||
127672337|NCT02857283|459424482|FG001|First Exposure|Withdrawal by Subject|0|||
127672338|NCT05074498|459424487|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
127672339|NCT05074498|459424488|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
127672340|NCT05074498|459424489|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
128005125|NCT03176771|460647310|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
128005126|NCT03176771|460647311|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
128005127|NCT03176771|460647307|FG000|Double-Blind Extension Period|Adverse Event|0|||
128005128|NCT03176771|460647308|FG001|Double-Blind Extension Period|Adverse Event|0|||
128005129|NCT03176771|460647309|FG002|Double-Blind Extension Period|Adverse Event|0|||
128005130|NCT03176771|460647310|FG003|Double-Blind Extension Period|Adverse Event|15|||
128005131|NCT03176771|460647311|FG004|Double-Blind Extension Period|Adverse Event|18|||
128005132|NCT03176771|460647307|FG000|Double-Blind Extension Period|Death|0|||
128005133|NCT03176771|460647308|FG001|Double-Blind Extension Period|Death|0|||
128005134|NCT03176771|460647309|FG002|Double-Blind Extension Period|Death|0|||
128005135|NCT03176771|460647310|FG003|Double-Blind Extension Period|Death|3|||
128005136|NCT03176771|460647311|FG004|Double-Blind Extension Period|Death|4|||
128005137|NCT03176771|460647307|FG000|Double-Blind Extension Period|Physician Decision|0|||
128005138|NCT03176771|460647308|FG001|Double-Blind Extension Period|Physician Decision|0|||
128005139|NCT03176771|460647309|FG002|Double-Blind Extension Period|Physician Decision|0|||
128005140|NCT03176771|460647310|FG003|Double-Blind Extension Period|Physician Decision|3|||
128005141|NCT03176771|460647311|FG004|Double-Blind Extension Period|Physician Decision|1|||
128005142|NCT03176771|460647307|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
128005143|NCT03176771|460647308|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
128005144|NCT03176771|460647309|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
128005145|NCT03176771|460647310|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
128005146|NCT03176771|460647311|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
128005147|NCT02732639|460647313|FG000|Overall Study|Lost to Follow-up|1|||
128005148|NCT00116142|460647314|FG000|Overall Study|Adverse Event|8|||
128005149|NCT00116142|460647315|FG001|Overall Study|Adverse Event|7|||
128005150|NCT00116142|460647314|FG000|Overall Study|Protocol Violation|2|||
128005151|NCT00116142|460647315|FG001|Overall Study|Protocol Violation|1|||
128005152|NCT00116142|460647314|FG000|Overall Study|Withdrawal by Subject|5|||
128005153|NCT00116142|460647315|FG001|Overall Study|Withdrawal by Subject|5|||
128005154|NCT00116142|460647314|FG000|Overall Study|Physician Decision|3|||
128005155|NCT00116142|460647315|FG001|Overall Study|Physician Decision|1|||
128005156|NCT00116142|460647314|FG000|Overall Study|Delayed Radiation Therapy|1|||
128005157|NCT00116142|460647315|FG001|Overall Study|Delayed Radiation Therapy|0|||
128005158|NCT00116142|460647314|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
128005159|NCT00116142|460647315|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
127672341|NCT05074498|459424490|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
127672342|NCT05074498|459424491|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
127672343|NCT05074498|459424492|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
128005160|NCT00116142|460647314|FG000|Overall Study|Patient stopped due to depression|0|||
128005161|NCT00116142|460647315|FG001|Overall Study|Patient stopped due to depression|1|||
128005162|NCT00116142|460647314|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
128005163|NCT00116142|460647315|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
128005164|NCT00116142|460647314|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
127672344|NCT05074498|459424487|FG000|Part 1 (Upto Day 104)|Other|1|||
127672345|NCT05074498|459424488|FG001|Part 1 (Upto Day 104)|Other|0|||
127672346|NCT05074498|459424489|FG002|Part 1 (Upto Day 104)|Other|0|||
127672347|NCT05074498|459424490|FG003|Part 1 (Upto Day 104)|Other|0|||
127672348|NCT05074498|459424491|FG004|Part 1 (Upto Day 104)|Other|0|||
127672349|NCT05074498|459424492|FG005|Part 1 (Upto Day 104)|Other|0|||
128005165|NCT00116142|460647315|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
128005166|NCT00116142|460647314|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
128005167|NCT00116142|460647315|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
128005168|NCT00644059|460647316|FG000|Overall Study|Lost to Follow-up|37|||
128005169|NCT00644059|460647317|FG001|Overall Study|Lost to Follow-up|34|||
128005170|NCT00644059|460647318|FG002|Overall Study|Lost to Follow-up|16|||
128005171|NCT00644059|460647316|FG000|Overall Study|Withdrawal by Subject|52|||
128005172|NCT00644059|460647317|FG001|Overall Study|Withdrawal by Subject|60|||
128005173|NCT00644059|460647318|FG002|Overall Study|Withdrawal by Subject|30|||
128005174|NCT00644059|460647316|FG000|Overall Study|Adverse Event|8|||
128005175|NCT00644059|460647317|FG001|Overall Study|Adverse Event|5|||
128005176|NCT00644059|460647318|FG002|Overall Study|Adverse Event|1|||
128005177|NCT00644059|460647316|FG000|Overall Study|Inappropriate Enrollment|1|||
128005178|NCT00644059|460647317|FG001|Overall Study|Inappropriate Enrollment|3|||
128005179|NCT00644059|460647318|FG002|Overall Study|Inappropriate Enrollment|0|||
128005180|NCT00644059|460647316|FG000|Overall Study|Protocol Deviation/violation|20|||
128005181|NCT00644059|460647317|FG001|Overall Study|Protocol Deviation/violation|19|||
128005182|NCT00644059|460647318|FG002|Overall Study|Protocol Deviation/violation|15|||
128005183|NCT00644059|460647316|FG000|Overall Study|Unable to classify|6|||
128005184|NCT00644059|460647317|FG001|Overall Study|Unable to classify|2|||
128005185|NCT00644059|460647318|FG002|Overall Study|Unable to classify|3|||
128005186|NCT02133508|460647319|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
128005187|NCT02133508|460647319|FG000|Overall Study|Death|12|||
128005188|NCT02133508|460647319|FG000|Overall Study|Lost to Follow-up|2|||
128005189|NCT02662569|460647328|FG000|Overall Study|Withdrawal by Subject|6|||
128005190|NCT02662569|460647329|FG001|Overall Study|Withdrawal by Subject|1|||
128005191|NCT02662569|460647330|FG002|Overall Study|Withdrawal by Subject|6|||
128005192|NCT02662569|460647331|FG003|Overall Study|Withdrawal by Subject|4|||
128005193|NCT02662569|460647328|FG000|Overall Study|Lost to Follow-up|1|||
128005194|NCT02662569|460647329|FG001|Overall Study|Lost to Follow-up|0|||
128005195|NCT02662569|460647330|FG002|Overall Study|Lost to Follow-up|0|||
128005196|NCT02662569|460647331|FG003|Overall Study|Lost to Follow-up|0|||
128005197|NCT01787552|460647334|FG000|Overall Study|Withdrawal by Subject|2|||
128005198|NCT01787552|460647335|FG001|Overall Study|Withdrawal by Subject|0|||
128005199|NCT01787552|460647336|FG002|Overall Study|Withdrawal by Subject|0|||
128005200|NCT01787552|460647337|FG003|Overall Study|Withdrawal by Subject|4|||
128005201|NCT01787552|460647334|FG000|Overall Study|Physician Decision|2|||
128005202|NCT01787552|460647335|FG001|Overall Study|Physician Decision|2|||
128005203|NCT01787552|460647336|FG002|Overall Study|Physician Decision|1|||
128005204|NCT01787552|460647337|FG003|Overall Study|Physician Decision|2|||
128005205|NCT01787552|460647334|FG000|Overall Study|Death|0|||
128005206|NCT01787552|460647335|FG001|Overall Study|Death|0|||
128005207|NCT01787552|460647336|FG002|Overall Study|Death|0|||
128005208|NCT01787552|460647337|FG003|Overall Study|Death|1|||
128005209|NCT01787552|460647334|FG000|Overall Study|Adverse Event|2|||
128005210|NCT01787552|460647335|FG001|Overall Study|Adverse Event|5|||
128005211|NCT01787552|460647336|FG002|Overall Study|Adverse Event|2|||
128005212|NCT01787552|460647337|FG003|Overall Study|Adverse Event|16|||
128005213|NCT01787552|460647334|FG000|Overall Study|Study terminated by Sponsor|0|||
128005214|NCT01787552|460647335|FG001|Overall Study|Study terminated by Sponsor|0|||
128005215|NCT01787552|460647336|FG002|Overall Study|Study terminated by Sponsor|1|||
128005216|NCT01787552|460647337|FG003|Overall Study|Study terminated by Sponsor|3|||
128005217|NCT01787552|460647334|FG000|Overall Study|Progressive Disease|2|||
128005218|NCT01787552|460647335|FG001|Overall Study|Progressive Disease|2|||
128005219|NCT01787552|460647336|FG002|Overall Study|Progressive Disease|1|||
128005220|NCT01787552|460647337|FG003|Overall Study|Progressive Disease|1|||
128005221|NCT02295644|460647342|FG000|Overall Study|Did not meet inclusion criterion|0|||
128005222|NCT02295644|460647343|FG001|Overall Study|Did not meet inclusion criterion|0|||
128005223|NCT02295644|460647344|FG002|Overall Study|Did not meet inclusion criterion|1|||
128005224|NCT02295644|460647345|FG003|Overall Study|Did not meet inclusion criterion|2|||
128005225|NCT04079790|460647347|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
128005226|NCT04079790|460647348|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
128005227|NCT04079790|460647349|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
128005228|NCT04079790|460647350|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
128005229|NCT04079790|460647347|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
128005230|NCT04079790|460647348|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
127672350|NCT05074498|459424487|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
128005231|NCT04079790|460647349|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
128005232|NCT04079790|460647350|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
128005233|NCT04079790|460647347|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
127672351|NCT05074498|459424488|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
127672352|NCT05074498|459424489|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
128005234|NCT04079790|460647348|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
128005235|NCT04079790|460647349|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
128005236|NCT04079790|460647350|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
128005237|NCT00324155|460647351|FG000|Enrolled and Randomized|No longer met study criteria|3|||
128005238|NCT00324155|460647352|FG001|Enrolled and Randomized|No longer met study criteria|0|||
128005239|NCT00324155|460647351|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
128005240|NCT00324155|460647352|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
128005241|NCT00324155|460647351|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
128005242|NCT00324155|460647352|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
128005243|NCT00324155|460647351|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
128005244|NCT00324155|460647352|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
128005245|NCT00324155|460647351|FG000|Received Treatment in Induction Phase|Death|8|||
128005246|NCT00324155|460647352|FG001|Received Treatment in Induction Phase|Death|15|||
128005247|NCT00324155|460647351|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
128005248|NCT00324155|460647352|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
128005249|NCT00324155|460647351|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
128005250|NCT00324155|460647352|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
128005251|NCT00324155|460647351|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
128005252|NCT00324155|460647352|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
128005253|NCT00324155|460647351|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
128005254|NCT00324155|460647352|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
128005255|NCT00324155|460647351|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
128005256|NCT00324155|460647352|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
128005257|NCT00324155|460647351|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
128005258|NCT00324155|460647352|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
128005259|NCT00324155|460647351|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
128005260|NCT00324155|460647352|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
128005261|NCT00324155|460647351|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
128005262|NCT00324155|460647352|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
128005263|NCT00324155|460647351|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
128005264|NCT00324155|460647352|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
128005265|NCT00324155|460647351|FG000|Follow-up Phase|On-going participants still on drug|11|||
128005266|NCT00324155|460647352|FG001|Follow-up Phase|On-going participants still on drug|6|||
128005267|NCT00390689|460647353|FG000|Overall Study|Adverse Event|2|||
128005268|NCT00390689|460647354|FG001|Overall Study|Adverse Event|5|||
128005269|NCT00390689|460647355|FG002|Overall Study|Adverse Event|2|||
128005270|NCT00390689|460647353|FG000|Overall Study|Lack of Efficacy|0|||
128005271|NCT00390689|460647354|FG001|Overall Study|Lack of Efficacy|0|||
128005272|NCT00390689|460647355|FG002|Overall Study|Lack of Efficacy|1|||
128005273|NCT00390689|460647353|FG000|Overall Study|Protocol Violation|1|||
128005274|NCT00390689|460647354|FG001|Overall Study|Protocol Violation|0|||
128005275|NCT00390689|460647355|FG002|Overall Study|Protocol Violation|0|||
128005276|NCT00390689|460647353|FG000|Overall Study|Investigator's judgement|2|||
128005277|NCT00390689|460647354|FG001|Overall Study|Investigator's judgement|0|||
128005278|NCT00390689|460647355|FG002|Overall Study|Investigator's judgement|0|||
128005279|NCT01253161|460647356|FG000|Overall Study|Adverse Event|1|||
128005280|NCT01924533|460647358|FG000|Overall Study|Death|181|||
128005281|NCT01924533|460647359|FG001|Overall Study|Death|200|||
128005282|NCT01924533|460647358|FG000|Overall Study|Lost to Follow-up|0|||
128005283|NCT01924533|460647359|FG001|Overall Study|Lost to Follow-up|1|||
128005284|NCT01924533|460647358|FG000|Overall Study|Withdrawal by Subject|7|||
128005285|NCT01924533|460647359|FG001|Overall Study|Withdrawal by Subject|3|||
128005286|NCT01924533|460647358|FG000|Overall Study|Other Eligibility criteria|1|||
128005287|NCT01924533|460647359|FG001|Overall Study|Other Eligibility criteria|1|||
128005288|NCT02747927|460647360|FG000|Overall Study|Adverse Event|5|||
128005289|NCT02747927|460647361|FG001|Overall Study|Adverse Event|14|||
128005290|NCT02747927|460647360|FG000|Overall Study|Lost to Follow-up|22|||
128005291|NCT02747927|460647361|FG001|Overall Study|Lost to Follow-up|43|||
128005292|NCT02747927|460647360|FG000|Overall Study|Pregnancy|34|||
128005293|NCT02747927|460647361|FG001|Overall Study|Pregnancy|66|||
128005294|NCT02747927|460647360|FG000|Overall Study|Protocol Violation|2|||
128005295|NCT02747927|460647361|FG001|Overall Study|Protocol Violation|4|||
128005296|NCT02747927|460647360|FG000|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|147|||
128005297|NCT02747927|460647361|FG001|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|304|||
127672353|NCT05074498|459424490|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
127672354|NCT05074498|459424491|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
127672355|NCT05074498|459424492|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
128005298|NCT02747927|460647360|FG000|Overall Study|Reason not Specified|11|||
127672356|NCT05074498|459424487|FG000|Part 2 (Upto Day 104)|Death|0|||
128005299|NCT02747927|460647361|FG001|Overall Study|Reason not Specified|27|||
128005300|NCT05412134|460647362|FG000|Overall Study|Lost to Follow-up|2|||
128005301|NCT05412134|460647363|FG001|Overall Study|Lost to Follow-up|0|||
128005302|NCT04275336|460647365|FG000|Overall Study|First venipuncture failed|4|||
128005303|NCT04275336|460647366|FG001|Overall Study|First venipuncture failed|6|||
128005304|NCT04275336|460647367|FG002|Overall Study|First venipuncture failed|5|||
128005305|NCT04275336|460647365|FG000|Overall Study|Unscheduled venipuncture|9|||
128005306|NCT04275336|460647366|FG001|Overall Study|Unscheduled venipuncture|13|||
128005307|NCT04275336|460647367|FG002|Overall Study|Unscheduled venipuncture|7|||
128005308|NCT04275336|460647365|FG000|Overall Study|Failed specimen of saliva|4|||
128005309|NCT04275336|460647366|FG001|Overall Study|Failed specimen of saliva|3|||
128005310|NCT04275336|460647367|FG002|Overall Study|Failed specimen of saliva|4|||
128005311|NCT03055936|460647368|FG000|Overall Study|Adverse Event|0|||
128005312|NCT03055936|460647369|FG001|Overall Study|Adverse Event|1|||
128005313|NCT03055936|460647370|FG002|Overall Study|Adverse Event|1|||
128005314|NCT03055936|460647371|FG003|Overall Study|Adverse Event|1|||
128005315|NCT03055936|460647368|FG000|Overall Study|Personal reason|2|||
128005316|NCT03055936|460647369|FG001|Overall Study|Personal reason|0|||
128005317|NCT03055936|460647370|FG002|Overall Study|Personal reason|1|||
128005318|NCT03055936|460647371|FG003|Overall Study|Personal reason|0|||
128005319|NCT00423046|460647378|FG000|Overall Study|Other|340|||
128005320|NCT00423046|460647379|FG001|Overall Study|Other|345|||
128005321|NCT01909804|460647380|FG000|Overall Study|Randomized but Never Treated|0|||
128005322|NCT01909804|460647381|FG001|Overall Study|Randomized but Never Treated|0|||
128005323|NCT01909804|460647382|FG002|Overall Study|Randomized but Never Treated|0|||
128005324|NCT01909804|460647383|FG003|Overall Study|Randomized but Never Treated|0|||
128005325|NCT01909804|460647384|FG004|Overall Study|Randomized but Never Treated|0|||
128005326|NCT01909804|460647385|FG005|Overall Study|Randomized but Never Treated|0|||
128005327|NCT01909804|460647386|FG006|Overall Study|Randomized but Never Treated|1|||
128005328|NCT01909804|460647387|FG007|Overall Study|Randomized but Never Treated|0|||
128005329|NCT01909804|460647388|FG008|Overall Study|Randomized but Never Treated|0|||
128005330|NCT01909804|460647389|FG009|Overall Study|Randomized but Never Treated|0|||
128005331|NCT01909804|460647390|FG010|Overall Study|Randomized but Never Treated|0|||
128005332|NCT01909804|460647391|FG011|Overall Study|Randomized but Never Treated|1|||
128005333|NCT01909804|460647380|FG000|Overall Study|Death|0|||
128005334|NCT01909804|460647381|FG001|Overall Study|Death|0|||
128005335|NCT01909804|460647382|FG002|Overall Study|Death|0|||
128005336|NCT01909804|460647383|FG003|Overall Study|Death|0|||
128005337|NCT01909804|460647384|FG004|Overall Study|Death|0|||
128005338|NCT01909804|460647385|FG005|Overall Study|Death|0|||
128005339|NCT01909804|460647386|FG006|Overall Study|Death|0|||
128005340|NCT01909804|460647387|FG007|Overall Study|Death|0|||
128005341|NCT01909804|460647388|FG008|Overall Study|Death|0|||
128005342|NCT01909804|460647389|FG009|Overall Study|Death|0|||
128005343|NCT01909804|460647390|FG010|Overall Study|Death|1|||
128005344|NCT01909804|460647391|FG011|Overall Study|Death|0|||
128005345|NCT01909804|460647380|FG000|Overall Study|Lack of Efficacy|4|||
128005346|NCT01909804|460647381|FG001|Overall Study|Lack of Efficacy|1|||
128005347|NCT01909804|460647382|FG002|Overall Study|Lack of Efficacy|0|||
128005348|NCT01909804|460647383|FG003|Overall Study|Lack of Efficacy|0|||
128005349|NCT01909804|460647384|FG004|Overall Study|Lack of Efficacy|7|||
128005350|NCT01909804|460647385|FG005|Overall Study|Lack of Efficacy|3|||
128005351|NCT01909804|460647386|FG006|Overall Study|Lack of Efficacy|1|||
128005352|NCT01909804|460647387|FG007|Overall Study|Lack of Efficacy|1|||
128005353|NCT01909804|460647388|FG008|Overall Study|Lack of Efficacy|0|||
128005354|NCT01909804|460647389|FG009|Overall Study|Lack of Efficacy|1|||
128005355|NCT01909804|460647390|FG010|Overall Study|Lack of Efficacy|0|||
128005356|NCT01909804|460647391|FG011|Overall Study|Lack of Efficacy|1|||
128005357|NCT01909804|460647380|FG000|Overall Study|Withdrew Consent|0|||
128005358|NCT01909804|460647381|FG001|Overall Study|Withdrew Consent|0|||
128005359|NCT01909804|460647382|FG002|Overall Study|Withdrew Consent|0|||
127672357|NCT05074498|459424488|FG001|Part 2 (Upto Day 104)|Death|0|||
128005360|NCT01909804|460647383|FG003|Overall Study|Withdrew Consent|0|||
128005361|NCT01909804|460647384|FG004|Overall Study|Withdrew Consent|1|||
128005362|NCT01909804|460647385|FG005|Overall Study|Withdrew Consent|1|||
128005363|NCT01909804|460647386|FG006|Overall Study|Withdrew Consent|0|||
128005364|NCT01909804|460647387|FG007|Overall Study|Withdrew Consent|0|||
128005365|NCT01909804|460647388|FG008|Overall Study|Withdrew Consent|0|||
128005366|NCT01909804|460647389|FG009|Overall Study|Withdrew Consent|0|||
128005367|NCT01909804|460647390|FG010|Overall Study|Withdrew Consent|0|||
128005368|NCT01909804|460647391|FG011|Overall Study|Withdrew Consent|0|||
128005369|NCT01909804|460647380|FG000|Overall Study|Protocol Violation|0|||
128005370|NCT01909804|460647381|FG001|Overall Study|Protocol Violation|0|||
128005371|NCT01909804|460647382|FG002|Overall Study|Protocol Violation|0|||
128005372|NCT01909804|460647383|FG003|Overall Study|Protocol Violation|0|||
128005373|NCT01909804|460647384|FG004|Overall Study|Protocol Violation|0|||
128005374|NCT01909804|460647385|FG005|Overall Study|Protocol Violation|0|||
128005375|NCT01909804|460647386|FG006|Overall Study|Protocol Violation|0|||
128005376|NCT01909804|460647387|FG007|Overall Study|Protocol Violation|0|||
128005377|NCT01909804|460647388|FG008|Overall Study|Protocol Violation|0|||
128005378|NCT01909804|460647389|FG009|Overall Study|Protocol Violation|0|||
128005379|NCT01909804|460647390|FG010|Overall Study|Protocol Violation|0|||
128005380|NCT01909804|460647391|FG011|Overall Study|Protocol Violation|1|||
128005381|NCT00830128|460647393|FG000|Overall Study|Adverse Event|5|||
128005382|NCT00830128|460647393|FG000|Overall Study|Lack of Efficacy|7|||
128005383|NCT00830128|460647393|FG000|Overall Study|Protocol Violation|1|||
128005384|NCT00830128|460647393|FG000|Overall Study|Withdrawal by Subject|2|||
128005385|NCT00830128|460647393|FG000|Overall Study|Family obligation|1|||
128005386|NCT00830128|460647393|FG000|Overall Study|Relocation|1|||
128005387|NCT00830128|460647393|FG000|Overall Study|Work obligation|1|||
128005388|NCT00830128|460647393|FG000|Overall Study|Operating a vehicle|1|||
128005389|NCT05401565|460647394|FG000|Overall Study|Lost to Follow-up|1|||
128005390|NCT05401565|460647395|FG001|Overall Study|Lost to Follow-up|0|||
128005391|NCT05401565|460647394|FG000|Overall Study|Adverse Event|2|||
128005392|NCT05401565|460647395|FG001|Overall Study|Adverse Event|0|||
128005393|NCT00726609|460647398|FG000|Overall Study|Adverse Event|10|||
128005394|NCT00726609|460647398|FG000|Overall Study|Withdrawal by Subject|2|||
128005395|NCT00726609|460647398|FG000|Overall Study|Lack of Efficacy|25|||
128005396|NCT00726609|460647398|FG000|Overall Study|Other|16|||
128005397|NCT00726609|460647398|FG000|Overall Study|Missing|42|||
128005398|NCT00726609|460647398|FG000|Overall Study|Other|3|||
128005399|NCT03080935|460647408|FG000|Overall Study|Death|34|||
128005400|NCT03080935|460647409|FG001|Overall Study|Death|50|||
128005401|NCT03080935|460647408|FG000|Overall Study|Lost to Follow-up|5|||
128005402|NCT03080935|460647409|FG001|Overall Study|Lost to Follow-up|4|||
128005403|NCT03080935|460647408|FG000|Overall Study|Withdrawal by Subject|11|||
128005404|NCT03080935|460647409|FG001|Overall Study|Withdrawal by Subject|15|||
128005405|NCT02175121|460647410|FG000|Overall Study|Lack of Efficacy|1|||
128005406|NCT02175121|460647411|FG001|Overall Study|Lack of Efficacy|0|||
128005407|NCT02175121|460647412|FG002|Overall Study|Lack of Efficacy|0|||
128005408|NCT02175121|460647413|FG003|Overall Study|Lack of Efficacy|0|||
128005409|NCT02175121|460647414|FG004|Overall Study|Lack of Efficacy|0|||
128005410|NCT02175121|460647410|FG000|Overall Study|Lost to Follow-up|0|||
128005411|NCT02175121|460647411|FG001|Overall Study|Lost to Follow-up|1|||
128005412|NCT02175121|460647412|FG002|Overall Study|Lost to Follow-up|0|||
128005413|NCT02175121|460647413|FG003|Overall Study|Lost to Follow-up|1|||
128005414|NCT02175121|460647414|FG004|Overall Study|Lost to Follow-up|0|||
128005415|NCT02175121|460647410|FG000|Overall Study|Personal emergency|0|||
128005416|NCT02175121|460647411|FG001|Overall Study|Personal emergency|0|||
128005417|NCT02175121|460647412|FG002|Overall Study|Personal emergency|0|||
128005418|NCT02175121|460647413|FG003|Overall Study|Personal emergency|0|||
128005419|NCT02175121|460647414|FG004|Overall Study|Personal emergency|1|||
128005420|NCT02175121|460647410|FG000|Overall Study|Schedule conflict|0|||
128005421|NCT02175121|460647411|FG001|Overall Study|Schedule conflict|0|||
128005422|NCT02175121|460647412|FG002|Overall Study|Schedule conflict|1|||
128005423|NCT02175121|460647413|FG003|Overall Study|Schedule conflict|0|||
128005424|NCT02175121|460647414|FG004|Overall Study|Schedule conflict|0|||
128005425|NCT02175121|460647410|FG000|Overall Study|Time issues|0|||
128005426|NCT02175121|460647411|FG001|Overall Study|Time issues|0|||
128005427|NCT02175121|460647412|FG002|Overall Study|Time issues|1|||
128005428|NCT02175121|460647413|FG003|Overall Study|Time issues|0|||
128005429|NCT02175121|460647414|FG004|Overall Study|Time issues|0|||
128005430|NCT03329885|460647415|FG000|Overall Study|Sponsor discontinued the study early|0|||
128005431|NCT03329885|460647416|FG001|Overall Study|Sponsor discontinued the study early|0|||
128005432|NCT03329885|460647417|FG002|Overall Study|Sponsor discontinued the study early|0|||
128005433|NCT03329885|460647418|FG003|Overall Study|Sponsor discontinued the study early|0|||
128005434|NCT03329885|460647419|FG004|Overall Study|Sponsor discontinued the study early|0|||
128005435|NCT03329885|460647420|FG005|Overall Study|Sponsor discontinued the study early|0|||
128005436|NCT03329885|460647421|FG006|Overall Study|Sponsor discontinued the study early|1|||
128005437|NCT03329885|460647422|FG007|Overall Study|Sponsor discontinued the study early|1|||
128005438|NCT03329885|460647423|FG008|Overall Study|Sponsor discontinued the study early|0|||
128005439|NCT03886272|460647430|FG000|Period 1|Withdrawal by Subject|0|||
128005440|NCT03886272|460647431|FG001|Period 1|Withdrawal by Subject|0|||
128005441|NCT03886272|460647432|FG002|Period 1|Withdrawal by Subject|0|||
128005442|NCT03886272|460647433|FG003|Period 1|Withdrawal by Subject|0|||
128005443|NCT03886272|460647434|FG004|Period 1|Withdrawal by Subject|0|||
128005444|NCT03886272|460647435|FG005|Period 1|Withdrawal by Subject|1|||
127672358|NCT05074498|459424489|FG002|Part 2 (Upto Day 104)|Death|0|||
127672359|NCT05074498|459424490|FG003|Part 2 (Upto Day 104)|Death|0|||
127672360|NCT05074498|459424491|FG004|Part 2 (Upto Day 104)|Death|1|||
128005445|NCT03886272|460647436|FG006|Period 1|Withdrawal by Subject|0|||
128005446|NCT00931632|460647437|FG000|Overall Study|Withdrawal by Subject|2|||
128005447|NCT00931632|460647438|FG001|Overall Study|Withdrawal by Subject|3|||
128005448|NCT00931632|460647437|FG000|Overall Study|Adverse Event|19|||
128005449|NCT00931632|460647438|FG001|Overall Study|Adverse Event|15|||
128005450|NCT01687218|460647441|FG000|Overall Study|Withdrawal by Subject|2|||
128005451|NCT01687218|460647442|FG001|Overall Study|Withdrawal by Subject|3|||
127672361|NCT05074498|459424492|FG005|Part 2 (Upto Day 104)|Death|0|||
128005452|NCT01687218|460647443|FG002|Overall Study|Withdrawal by Subject|0|||
128005453|NCT01687218|460647444|FG003|Overall Study|Withdrawal by Subject|1|||
128005454|NCT01687218|460647445|FG004|Overall Study|Withdrawal by Subject|1|||
128005455|NCT01687218|460647446|FG005|Overall Study|Withdrawal by Subject|0|||
128005456|NCT01687218|460647441|FG000|Overall Study|Relocated, no follow-up planned|1|||
128005457|NCT01687218|460647442|FG001|Overall Study|Relocated, no follow-up planned|0|||
128005458|NCT01687218|460647443|FG002|Overall Study|Relocated, no follow-up planned|1|||
128005459|NCT01687218|460647444|FG003|Overall Study|Relocated, no follow-up planned|1|||
128005460|NCT01687218|460647445|FG004|Overall Study|Relocated, no follow-up planned|0|||
128005461|NCT01687218|460647446|FG005|Overall Study|Relocated, no follow-up planned|0|||
128005462|NCT03139552|460647452|FG000|Overall Study|unable to attend tasting due to schedule|3|||
128005463|NCT03368807|460647461|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
128005464|NCT03368807|460647461|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
128005465|NCT03368807|460647461|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
128005466|NCT03368807|460647461|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
128005467|NCT01973218|460647462|FG000|Overall Study|Adverse Event|1|||
128005468|NCT01973218|460647463|FG001|Overall Study|Adverse Event|0|||
127672362|NCT05074498|459424487|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
127672363|NCT05074498|459424488|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
127672364|NCT05074498|459424489|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
127672365|NCT05074498|459424490|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
128005469|NCT01973218|460647462|FG000|Overall Study|Withdrawal by Subject|1|||
128005470|NCT01973218|460647463|FG001|Overall Study|Withdrawal by Subject|0|||
128005471|NCT02247466|460647464|FG000|Overall Study|Procedure changed to open surgery|0|||
128005472|NCT02247466|460647465|FG001|Overall Study|Procedure changed to open surgery|3|||
128005473|NCT01618968|460647466|FG000|Overall Study|Adverse Event|1|||
128005474|NCT01618968|460647467|FG001|Overall Study|Adverse Event|0|||
128005475|NCT01618968|460647468|FG002|Overall Study|Adverse Event|0|||
128005476|NCT01618968|460647469|FG003|Overall Study|Adverse Event|0|||
128005477|NCT01618968|460647466|FG000|Overall Study|Death|0|||
128005478|NCT01618968|460647467|FG001|Overall Study|Death|0|||
128005479|NCT01618968|460647468|FG002|Overall Study|Death|0|||
128005480|NCT01618968|460647469|FG003|Overall Study|Death|1|||
128005481|NCT04356937|460647472|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
128005482|NCT04356937|460647473|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
128005483|NCT03533751|460647474|FG000|Overall Study|Withdrawal by Subject|12|||
128005484|NCT03533751|460647475|FG001|Overall Study|Withdrawal by Subject|6|||
128005485|NCT03533751|460647476|FG002|Overall Study|Withdrawal by Subject|11|||
128005486|NCT03533751|460647477|FG003|Overall Study|Withdrawal by Subject|9|||
128005487|NCT03533751|460647478|FG004|Overall Study|Withdrawal by Subject|10|||
128005488|NCT03533751|460647474|FG000|Overall Study|Adverse Event|4|||
128005489|NCT03533751|460647475|FG001|Overall Study|Adverse Event|7|||
128005490|NCT03533751|460647476|FG002|Overall Study|Adverse Event|2|||
128005491|NCT03533751|460647477|FG003|Overall Study|Adverse Event|4|||
128005492|NCT03533751|460647478|FG004|Overall Study|Adverse Event|5|||
128005493|NCT03533751|460647474|FG000|Overall Study|Physician Decision|0|||
128005494|NCT03533751|460647475|FG001|Overall Study|Physician Decision|2|||
128005495|NCT03533751|460647476|FG002|Overall Study|Physician Decision|1|||
128005496|NCT03533751|460647477|FG003|Overall Study|Physician Decision|2|||
128005497|NCT03533751|460647478|FG004|Overall Study|Physician Decision|1|||
128005498|NCT03533751|460647474|FG000|Overall Study|Sponsor Decision|0|||
128005499|NCT03533751|460647475|FG001|Overall Study|Sponsor Decision|0|||
128005500|NCT03533751|460647476|FG002|Overall Study|Sponsor Decision|1|||
128005501|NCT03533751|460647477|FG003|Overall Study|Sponsor Decision|1|||
128005502|NCT03533751|460647478|FG004|Overall Study|Sponsor Decision|0|||
128005503|NCT03533751|460647474|FG000|Overall Study|Lost to Follow-up|3|||
128005504|NCT03533751|460647475|FG001|Overall Study|Lost to Follow-up|7|||
128005505|NCT03533751|460647476|FG002|Overall Study|Lost to Follow-up|6|||
128005506|NCT03533751|460647477|FG003|Overall Study|Lost to Follow-up|4|||
127672366|NCT05074498|459424491|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
127672367|NCT05074498|459424492|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
127672368|NCT05074498|459424487|FG000|Part 2 (Upto Day 104)|Other|0|||
127672369|NCT05074498|459424488|FG001|Part 2 (Upto Day 104)|Other|0|||
127672370|NCT05074498|459424489|FG002|Part 2 (Upto Day 104)|Other|0|||
127672371|NCT05074498|459424490|FG003|Part 2 (Upto Day 104)|Other|0|||
127672372|NCT05074498|459424491|FG004|Part 2 (Upto Day 104)|Other|1|||
127672373|NCT05074498|459424492|FG005|Part 2 (Upto Day 104)|Other|0|||
128005507|NCT03533751|460647478|FG004|Overall Study|Lost to Follow-up|3|||
128005508|NCT03533751|460647474|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
128005509|NCT03533751|460647475|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
128005510|NCT03533751|460647476|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
128005511|NCT03533751|460647477|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
127672374|NCT01240356|459424493|FG000|Overall Study|Withdrawal by Subject|2|||
127672375|NCT01240356|459424494|FG001|Overall Study|Withdrawal by Subject|0|||
128005512|NCT03533751|460647478|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
128005513|NCT03533751|460647474|FG000|Overall Study|Other|0|||
128005514|NCT03533751|460647475|FG001|Overall Study|Other|2|||
128005515|NCT03533751|460647476|FG002|Overall Study|Other|1|||
128005516|NCT03533751|460647477|FG003|Overall Study|Other|0|||
128005517|NCT03533751|460647478|FG004|Overall Study|Other|3|||
128005518|NCT05117060|460647479|FG000|Overall Study|Adverse Event|3|||
128005519|NCT05117060|460647480|FG001|Overall Study|Adverse Event|5|||
128005520|NCT05117060|460647481|FG002|Overall Study|Adverse Event|6|||
128005521|NCT05117060|460647482|FG003|Overall Study|Adverse Event|1|||
128005522|NCT05117060|460647479|FG000|Overall Study|Lost to Follow-up|0|||
128005523|NCT05117060|460647480|FG001|Overall Study|Lost to Follow-up|0|||
128005524|NCT05117060|460647481|FG002|Overall Study|Lost to Follow-up|0|||
128005525|NCT05117060|460647482|FG003|Overall Study|Lost to Follow-up|1|||
128005526|NCT05117060|460647479|FG000|Overall Study|Lack of Efficacy|4|||
128005527|NCT05117060|460647480|FG001|Overall Study|Lack of Efficacy|5|||
128005528|NCT05117060|460647481|FG002|Overall Study|Lack of Efficacy|2|||
128005529|NCT05117060|460647482|FG003|Overall Study|Lack of Efficacy|6|||
128005530|NCT05117060|460647479|FG000|Overall Study|Withdrawal by Subject|8|||
128005531|NCT05117060|460647480|FG001|Overall Study|Withdrawal by Subject|5|||
128005532|NCT05117060|460647481|FG002|Overall Study|Withdrawal by Subject|5|||
128005533|NCT05117060|460647482|FG003|Overall Study|Withdrawal by Subject|6|||
128005534|NCT05117060|460647479|FG000|Overall Study|Other|2|||
128005535|NCT05117060|460647480|FG001|Overall Study|Other|1|||
128005536|NCT05117060|460647481|FG002|Overall Study|Other|3|||
128005537|NCT05117060|460647482|FG003|Overall Study|Other|1|||
128005538|NCT03141359|460647483|FG000|Overall Study|Death|32|||
128005539|NCT03141359|460647483|FG000|Overall Study|Still On Study (in follow up)|29|||
128005540|NCT01081626|460647484|FG000|Overall Study|Dosing error|1|||
128005541|NCT01081626|460647485|FG001|Overall Study|Dosing error|1|||
128005542|NCT01081626|460647484|FG000|Overall Study|Missing Estradiol|25|||
128005543|NCT01081626|460647485|FG001|Overall Study|Missing Estradiol|28|||
128005544|NCT01081626|460647484|FG000|Overall Study|Low antral follicle count|1|||
128005545|NCT01081626|460647485|FG001|Overall Study|Low antral follicle count|0|||
128005546|NCT01081626|460647484|FG000|Overall Study|Overstimulation|0|||
128005547|NCT01081626|460647485|FG001|Overall Study|Overstimulation|1|||
128005548|NCT01081626|460647484|FG000|Overall Study|Lost to Follow-up|0|||
128005549|NCT01081626|460647485|FG001|Overall Study|Lost to Follow-up|1|||
128005550|NCT01081626|460647484|FG000|Overall Study|Other|33|||
128005551|NCT01081626|460647485|FG001|Overall Study|Other|30|||
128005552|NCT04158219|460647486|FG000|Overall Study|Lost to Follow-up|1|||
128005553|NCT02074514|460647487|FG000|Overall Study|Lack of Efficacy|3|||
128005554|NCT02074514|460647488|FG001|Overall Study|Lack of Efficacy|2|||
128005555|NCT02074514|460647487|FG000|Overall Study|Lost to Follow-up|0|||
128005556|NCT02074514|460647488|FG001|Overall Study|Lost to Follow-up|1|||
128005557|NCT02074514|460647487|FG000|Overall Study|Withdrew Consent|0|||
128005558|NCT02074514|460647488|FG001|Overall Study|Withdrew Consent|1|||
128005559|NCT00368251|460648727|FG000|Overall Study|SAE, non-fatal|1|||
128005560|NCT00368251|460648728|FG001|Overall Study|SAE, non-fatal|0|||
128005561|NCT00368251|460648729|FG002|Overall Study|SAE, non-fatal|0|||
128005562|NCT00368251|460648727|FG000|Overall Study|AE, non-serious non-fatal|0|||
128005563|NCT00368251|460648728|FG001|Overall Study|AE, non-serious non-fatal|0|||
128005564|NCT00368251|460648729|FG002|Overall Study|AE, non-serious non-fatal|1|||
128005565|NCT03312738|460648731|FG000|Overall Study|Progressive disease|58|||
128005566|NCT03312738|460648732|FG001|Overall Study|Progressive disease|67|||
128005567|NCT03312738|460648731|FG000|Overall Study|Patient/guardian decision|13|||
128005568|NCT03312738|460648732|FG001|Overall Study|Patient/guardian decision|5|||
128005569|NCT03312738|460648731|FG000|Overall Study|Adverse Event|5|||
128005570|NCT03312738|460648732|FG001|Overall Study|Adverse Event|3|||
128005571|NCT03312738|460648731|FG000|Overall Study|Protocol deviation|2|||
128005572|NCT03312738|460648732|FG001|Overall Study|Protocol deviation|0|||
128005573|NCT03312738|460648731|FG000|Overall Study|Technical problems|0|||
128005574|NCT03312738|460648732|FG001|Overall Study|Technical problems|1|||
128005575|NCT03312738|460648731|FG000|Overall Study|Physician Decision|2|||
128005576|NCT03312738|460648732|FG001|Overall Study|Physician Decision|3|||
128005577|NCT02466399|460648739|FG000|Overall Study|Adverse Event|1|||
128005578|NCT02466399|460648740|FG001|Overall Study|Adverse Event|0|||
128005579|NCT02466399|460648739|FG000|Overall Study|Early exit due to family emergency|1|||
127672376|NCT01240356|459424493|FG000|Overall Study|MRI contraindication|1|||
127672377|NCT01240356|459424494|FG001|Overall Study|MRI contraindication|0|||
127672378|NCT03613129|459424495|FG000|Pre-treatment Assessment|Protocol Violation|2|||
128005580|NCT02466399|460648740|FG001|Overall Study|Early exit due to family emergency|0|||
128005581|NCT00607893|460648741|FG000|Overall Study|Lost to Follow-up|4|||
128005582|NCT00607893|460648742|FG001|Overall Study|Lost to Follow-up|0|||
128005583|NCT00607893|460648741|FG000|Overall Study|withdrew due to loss of interest|0|||
128005584|NCT00607893|460648742|FG001|Overall Study|withdrew due to loss of interest|1|||
128005585|NCT00607893|460648741|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
128005586|NCT00607893|460648742|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
128005587|NCT00607893|460648741|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
128005588|NCT00607893|460648742|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
127672379|NCT03613129|459424496|FG001|Pre-treatment Assessment|Protocol Violation|0|||
128005589|NCT00607893|460648741|FG000|Overall Study|Declined to be treated|1|||
128005590|NCT00607893|460648742|FG001|Overall Study|Declined to be treated|0|||
128005591|NCT00607893|460648741|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
128005592|NCT00607893|460648742|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
128005593|NCT02669849|460648743|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
128005594|NCT02669849|460648744|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
128005595|NCT02669849|460648745|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
128005596|NCT02669849|460648743|FG000|Overall Study|Lost to Follow-up|1|||
128005597|NCT02669849|460648744|FG001|Overall Study|Lost to Follow-up|0|||
128005598|NCT02669849|460648745|FG002|Overall Study|Lost to Follow-up|3|||
128005599|NCT02669849|460648743|FG000|Overall Study|Death|1|||
128005600|NCT02669849|460648744|FG001|Overall Study|Death|1|||
128005601|NCT02669849|460648745|FG002|Overall Study|Death|2|||
128005602|NCT02669849|460648743|FG000|Overall Study|Study terminated by sponsor|16|||
128005603|NCT02669849|460648744|FG001|Overall Study|Study terminated by sponsor|1|||
128005604|NCT02669849|460648745|FG002|Overall Study|Study terminated by sponsor|14|||
128005605|NCT02669849|460648743|FG000|Overall Study|Other|0|||
128005606|NCT02669849|460648744|FG001|Overall Study|Other|0|||
128005607|NCT02669849|460648745|FG002|Overall Study|Other|2|||
128005608|NCT04745351|460648751|FG000|Overall Study|Death|51|||
128005609|NCT04745351|460648752|FG001|Overall Study|Death|25|||
128005610|NCT04745351|460648751|FG000|Overall Study|Lost to Follow-up|9|||
128005611|NCT04745351|460648752|FG001|Overall Study|Lost to Follow-up|3|||
128005612|NCT04745351|460648751|FG000|Overall Study|Randomized but Never Treated|3|||
128005613|NCT04745351|460648752|FG001|Overall Study|Randomized but Never Treated|3|||
128005614|NCT04745351|460648751|FG000|Overall Study|Adverse Event|4|||
128005615|NCT04745351|460648752|FG001|Overall Study|Adverse Event|0|||
128005616|NCT04745351|460648751|FG000|Overall Study|Withdrew Consent|1|||
128005617|NCT04745351|460648752|FG001|Overall Study|Withdrew Consent|2|||
128005618|NCT04745351|460648751|FG000|Overall Study|Investigator's Discretion|2|||
128005619|NCT04745351|460648752|FG001|Overall Study|Investigator's Discretion|0|||
128005620|NCT04745351|460648751|FG000|Overall Study|Protocol Violation|1|||
128005621|NCT04745351|460648752|FG001|Overall Study|Protocol Violation|0|||
128005622|NCT01863771|460648755|FG000|Induction Phase|Adverse Event|9|||
128005623|NCT01863771|460648756|FG001|Induction Phase|Adverse Event|0|||
128005624|NCT01863771|460648757|FG002|Induction Phase|Adverse Event|0|||
128005625|NCT01863771|460648758|FG003|Induction Phase|Adverse Event|0|||
128005626|NCT01863771|460648755|FG000|Induction Phase|Lack of Efficacy|10|||
128005627|NCT01863771|460648756|FG001|Induction Phase|Lack of Efficacy|0|||
128005628|NCT01863771|460648757|FG002|Induction Phase|Lack of Efficacy|0|||
128005629|NCT01863771|460648758|FG003|Induction Phase|Lack of Efficacy|0|||
128005630|NCT01863771|460648755|FG000|Induction Phase|Withdrawal by Subject|2|||
128005631|NCT01863771|460648756|FG001|Induction Phase|Withdrawal by Subject|0|||
128005632|NCT01863771|460648757|FG002|Induction Phase|Withdrawal by Subject|0|||
128005633|NCT01863771|460648758|FG003|Induction Phase|Withdrawal by Subject|0|||
128005634|NCT01863771|460648755|FG000|Maintenance Phase|Adverse Event|0|||
128005635|NCT01863771|460648756|FG001|Maintenance Phase|Adverse Event|0|||
128005636|NCT01863771|460648757|FG002|Maintenance Phase|Adverse Event|1|||
128005637|NCT01863771|460648758|FG003|Maintenance Phase|Adverse Event|1|||
128005638|NCT01863771|460648755|FG000|Maintenance Phase|Lack of Efficacy|0|||
128005639|NCT01863771|460648756|FG001|Maintenance Phase|Lack of Efficacy|3|||
128005640|NCT01863771|460648757|FG002|Maintenance Phase|Lack of Efficacy|7|||
128005641|NCT01863771|460648758|FG003|Maintenance Phase|Lack of Efficacy|38|||
128005642|NCT01863771|460648755|FG000|Maintenance Phase|Physician Decision|0|||
128005643|NCT01863771|460648756|FG001|Maintenance Phase|Physician Decision|0|||
128005644|NCT01863771|460648757|FG002|Maintenance Phase|Physician Decision|2|||
128005645|NCT01863771|460648758|FG003|Maintenance Phase|Physician Decision|1|||
128005646|NCT01863771|460648755|FG000|Maintenance Phase|Pregnancy|0|||
128005647|NCT01863771|460648756|FG001|Maintenance Phase|Pregnancy|1|||
128005648|NCT01863771|460648757|FG002|Maintenance Phase|Pregnancy|0|||
128005649|NCT01863771|460648758|FG003|Maintenance Phase|Pregnancy|0|||
128005650|NCT01863771|460648755|FG000|Maintenance Phase|Withdrawal by Subject|0|||
128005651|NCT01863771|460648756|FG001|Maintenance Phase|Withdrawal by Subject|1|||
128005652|NCT01863771|460648757|FG002|Maintenance Phase|Withdrawal by Subject|2|||
128005653|NCT01863771|460648758|FG003|Maintenance Phase|Withdrawal by Subject|3|||
128005654|NCT02014272|460648759|FG000|Intervention Period 1|Withdrawal by Subject|1|||
127672380|NCT03613129|459424497|FG002|Pre-treatment Assessment|Protocol Violation|0|||
127672381|NCT03613129|459424498|FG003|Pre-treatment Assessment|Protocol Violation|0|||
127672382|NCT03613129|459424499|FG004|Pre-treatment Assessment|Protocol Violation|0|||
128005655|NCT02014272|460648760|FG001|Intervention Period 1|Withdrawal by Subject|0|||
127672383|NCT03613129|459424495|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
127672384|NCT03613129|459424496|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
128005656|NCT02014272|460648759|FG000|Intervention Period 1|Adverse Event|0|||
128005657|NCT02014272|460648760|FG001|Intervention Period 1|Adverse Event|1|||
128005658|NCT03499795|460648761|FG000|Overall Study|Adverse Event|1|||
128005659|NCT03499795|460648761|FG000|Overall Study|Lost to Follow-up|1|||
128005660|NCT03636256|460648762|FG000|Overall Study|Lost to Follow-up|3|||
128005661|NCT03636256|460648763|FG001|Overall Study|Lost to Follow-up|0|||
128005662|NCT03636256|460648764|FG002|Overall Study|Lost to Follow-up|2|||
128005663|NCT03636256|460648765|FG003|Overall Study|Lost to Follow-up|1|||
128005664|NCT03636256|460648766|FG004|Overall Study|Lost to Follow-up|0|||
128005665|NCT03636256|460648767|FG005|Overall Study|Lost to Follow-up|4|||
128005666|NCT03636256|460648768|FG006|Overall Study|Lost to Follow-up|2|||
128005667|NCT03636256|460648769|FG007|Overall Study|Lost to Follow-up|0|||
128005668|NCT03636256|460648770|FG008|Overall Study|Lost to Follow-up|4|||
128005669|NCT03636256|460648762|FG000|Overall Study|Withdrawal by Subject|0|||
128005670|NCT03636256|460648763|FG001|Overall Study|Withdrawal by Subject|0|||
128005671|NCT03636256|460648764|FG002|Overall Study|Withdrawal by Subject|0|||
128005672|NCT03636256|460648765|FG003|Overall Study|Withdrawal by Subject|0|||
128005673|NCT03636256|460648766|FG004|Overall Study|Withdrawal by Subject|0|||
128005674|NCT03636256|460648767|FG005|Overall Study|Withdrawal by Subject|0|||
128005675|NCT03636256|460648768|FG006|Overall Study|Withdrawal by Subject|0|||
128005676|NCT03636256|460648769|FG007|Overall Study|Withdrawal by Subject|0|||
128005677|NCT03636256|460648770|FG008|Overall Study|Withdrawal by Subject|1|||
128005678|NCT01218308|460648773|FG000|Overall Study|Adverse Event|1|||
128005679|NCT01218308|460648774|FG001|Overall Study|Adverse Event|2|||
128005680|NCT01218308|460648773|FG000|Overall Study|Protocol Violation|0|||
128005681|NCT01218308|460648774|FG001|Overall Study|Protocol Violation|2|||
128005682|NCT01218308|460648773|FG000|Overall Study|Withdrawal by Subject|61|||
128005683|NCT01218308|460648774|FG001|Overall Study|Withdrawal by Subject|64|||
128005684|NCT01218308|460648773|FG000|Overall Study|Lost to Follow-up|27|||
128005685|NCT01218308|460648774|FG001|Overall Study|Lost to Follow-up|31|||
128005686|NCT01218308|460648773|FG000|Overall Study|Other|14|||
128005687|NCT01218308|460648774|FG001|Overall Study|Other|21|||
128005688|NCT00547339|460648777|FG000|Overall Study|Physician Decision|0|||
128005689|NCT00547339|460648778|FG001|Overall Study|Physician Decision|0|||
128005690|NCT00547339|460648779|FG002|Overall Study|Physician Decision|1|||
128005691|NCT00547339|460648780|FG003|Overall Study|Physician Decision|0|||
128005692|NCT01516216|460648781|FG000|Overall Study|Adverse Event|2|||
128005693|NCT01516216|460648782|FG001|Overall Study|Adverse Event|4|||
128005694|NCT01516216|460648781|FG000|Overall Study|Disease Progression|38|||
128005695|NCT01516216|460648782|FG001|Overall Study|Disease Progression|34|||
128005696|NCT01516216|460648781|FG000|Overall Study|Withdrawal by Subject|9|||
127672385|NCT03613129|459424497|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
128005697|NCT01516216|460648782|FG001|Overall Study|Withdrawal by Subject|11|||
128005698|NCT01516216|460648781|FG000|Overall Study|Potentially Curative Resection|6|||
128005699|NCT01516216|460648782|FG001|Overall Study|Potentially Curative Resection|12|||
128005700|NCT01516216|460648781|FG000|Overall Study|Nonadherence|2|||
128005701|NCT01516216|460648782|FG001|Overall Study|Nonadherence|3|||
128005702|NCT01516216|460648781|FG000|Overall Study|Physician Decision|6|||
128005703|NCT01516216|460648782|FG001|Overall Study|Physician Decision|3|||
128005704|NCT01516216|460648781|FG000|Overall Study|Prolonged Treatment Delay|5|||
128005705|NCT01516216|460648782|FG001|Overall Study|Prolonged Treatment Delay|1|||
128005706|NCT01516216|460648781|FG000|Overall Study|Intercurrent Illness|1|||
128005707|NCT01516216|460648782|FG001|Overall Study|Intercurrent Illness|0|||
128005708|NCT01516216|460648781|FG000|Overall Study|Death|1|||
128005709|NCT01516216|460648782|FG001|Overall Study|Death|1|||
127672386|NCT03613129|459424498|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
127672387|NCT03613129|459424499|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
127672388|NCT01770860|459424500|FG000|Overall Study|Withdrawal by Subject|4|||
127672389|NCT01770860|459424500|FG000|Overall Study|Lost to Follow-up|1|||
127672390|NCT01770860|459424500|FG000|Overall Study|Administrative decision made by the PI|1|||
127672391|NCT03432533|459424501|FG000|Overall Study|Lost to Follow-up|1|||
127672392|NCT03432533|459424502|FG001|Overall Study|Lost to Follow-up|2|||
127672393|NCT03432533|459424501|FG000|Overall Study|Withdrawal by Subject|14|||
127672394|NCT03432533|459424502|FG001|Overall Study|Withdrawal by Subject|9|||
127672395|NCT02095158|459424508|FG000|Overall Study|Adverse Event|14|||
127672396|NCT02095158|459424508|FG000|Overall Study|Lack of Efficacy|3|||
127672397|NCT02095158|459424508|FG000|Overall Study|Pregnancy|1|||
127672398|NCT02095158|459424508|FG000|Overall Study|Lost to Follow-up|20|||
127672399|NCT02095158|459424508|FG000|Overall Study|Personal Reasons|35|||
127672400|NCT02095158|459424508|FG000|Overall Study|Protocol Violation|1|||
127672401|NCT02095158|459424508|FG000|Overall Study|Other Miscellaneous Reasons|1|||
127672402|NCT01008748|459424509|FG000|Overall Study|Lost to Follow-up|80|||
128005710|NCT01603602|460648783|FG000|Overall Study|Adverse Event|1|||
128005711|NCT01603602|460648784|FG001|Overall Study|Adverse Event|0|||
128005712|NCT01603602|460648785|FG002|Overall Study|Adverse Event|0|||
128005713|NCT01603602|460648783|FG000|Overall Study|Personal Reasons|1|||
128005714|NCT01603602|460648784|FG001|Overall Study|Personal Reasons|0|||
128005715|NCT01603602|460648785|FG002|Overall Study|Personal Reasons|1|||
128005716|NCT04748718|460648788|FG000|Overall Study|Lost to Follow-up|50|||
128005717|NCT01065818|460648789|FG000|Overall Study|Withdrawal by Subject|1|||
127672403|NCT01008748|459424509|FG000|Overall Study|Other|1|||
127672404|NCT02775435|459424510|FG000|Overall Study|Adverse Event|32|||
127672405|NCT02775435|459424511|FG001|Overall Study|Adverse Event|27|||
128005718|NCT01065818|460648789|FG000|Overall Study|Not a candidate for surgery|1|||
128005719|NCT01450813|460648790|FG000|Overall Study|Physician Decision|1|||
128005720|NCT01450813|460648791|FG001|Overall Study|Physician Decision|1|||
128005721|NCT01450813|460648792|FG002|Overall Study|Physician Decision|0|||
128005722|NCT01450813|460648793|FG003|Overall Study|Physician Decision|3|||
128005723|NCT01935089|460648794|FG000|Overall Study|Adverse Event|2|||
128005724|NCT01935089|460648794|FG000|Overall Study|Withdrawal by Subject|1|||
128005725|NCT00723229|460648798|FG000|First Intervention|Lost to Follow-up|7|||
128005726|NCT00723229|460648799|FG001|First Intervention|Lost to Follow-up|3|||
128005727|NCT02337491|460648800|FG000|Overall Study|Death|1|||
128005728|NCT02337491|460648801|FG001|Overall Study|Death|1|||
128005729|NCT02337491|460648800|FG000|Overall Study|Adverse Event|0|||
128005730|NCT02337491|460648801|FG001|Overall Study|Adverse Event|1|||
128005731|NCT02337491|460648800|FG000|Overall Study|Withdrawal by Subject|3|||
128005732|NCT02337491|460648801|FG001|Overall Study|Withdrawal by Subject|0|||
128005733|NCT02337491|460648800|FG000|Overall Study|Progressive Disease|44|||
127672406|NCT02775435|459424510|FG000|Overall Study|Lost to Follow-up|2|||
127672407|NCT02775435|459424511|FG001|Overall Study|Lost to Follow-up|2|||
127672408|NCT02775435|459424510|FG000|Overall Study|Sponsor decision|44|||
127672409|NCT02775435|459424511|FG001|Overall Study|Sponsor decision|19|||
127672410|NCT02775435|459424510|FG000|Overall Study|Withdrawal by Subject|4|||
127672411|NCT02775435|459424511|FG001|Overall Study|Withdrawal by Subject|9|||
127672412|NCT02775435|459424510|FG000|Overall Study|Death|196|||
127672413|NCT02775435|459424511|FG001|Overall Study|Death|224|||
127672414|NCT03537651|459424522|FG000|Part A (Up to 96 Weeks)|Adverse Event|2|||
127672415|NCT03537651|459424522|FG000|Part A (Up to 96 Weeks)|Withdrawal of Consent (not due to AE)|2|||
127672416|NCT03537651|459424522|FG000|Part A (Up to 96 Weeks)|Commercial Drug is Available for Participant|56|||
127672417|NCT03537651|459424522|FG000|Part A (Up to 96 Weeks)|Other|1|||
127672418|NCT03537651|459424522|FG000|Part B (Up to 192 Weeks)|Adverse Event|1|||
127672419|NCT03537651|459424522|FG000|Part B (Up to 192 Weeks)|Withdrawal of Consent (not due to AE)|1|||
127672420|NCT03537651|459424522|FG000|Part B (Up to 192 Weeks)|Commercial Drug is available for Participant|56|||
127672421|NCT03537651|459424522|FG000|Part B (Up to 192 Weeks)|Other|1|||
127672422|NCT02403323|459424523|FG000|Part 1: Open Label Extension Period|Adverse Event|26|||
127672423|NCT02403323|459424524|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
127672424|NCT02403323|459424525|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
127672425|NCT02403323|459424523|FG000|Part 1: Open Label Extension Period|Death|3|||
127672426|NCT02403323|459424524|FG001|Part 1: Open Label Extension Period|Death|0|||
127672427|NCT02403323|459424525|FG002|Part 1: Open Label Extension Period|Death|0|||
127672428|NCT02403323|459424523|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|23|||
127672429|NCT02403323|459424524|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
127672430|NCT02403323|459424525|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
127672431|NCT02403323|459424523|FG000|Part 1: Open Label Extension Period|Non-Compliance|2|||
127672432|NCT02403323|459424524|FG001|Part 1: Open Label Extension Period|Non-Compliance|0|||
127672433|NCT02403323|459424525|FG002|Part 1: Open Label Extension Period|Non-Compliance|0|||
127672434|NCT02403323|459424523|FG000|Part 1: Open Label Extension Period|Reason Not Specified|59|||
127672435|NCT02403323|459424524|FG001|Part 1: Open Label Extension Period|Reason Not Specified|0|||
127672436|NCT02403323|459424525|FG002|Part 1: Open Label Extension Period|Reason Not Specified|0|||
127672437|NCT02403323|459424523|FG000|Part 1: Open Label Extension Period|Physician Decision|61|||
127672438|NCT02403323|459424524|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
127672439|NCT02403323|459424525|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
127672440|NCT02403323|459424523|FG000|Part 1: Open Label Extension Period|Study Terminated By Sponsor|19|||
127672441|NCT02403323|459424524|FG001|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
127672442|NCT02403323|459424525|FG002|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
127672443|NCT02403323|459424523|FG000|Part 1: Open Label Extension Period|Other|1|||
127672444|NCT02403323|459424524|FG001|Part 1: Open Label Extension Period|Other|0|||
127672445|NCT02403323|459424525|FG002|Part 1: Open Label Extension Period|Other|0|||
127672446|NCT02403323|459424523|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|232|||
127672447|NCT02403323|459424524|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
127672448|NCT02403323|459424525|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
127672449|NCT02403323|459424523|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
127672450|NCT02403323|459424524|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|4|||
127672451|NCT02403323|459424525|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
127672452|NCT02403323|459424523|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
127672453|NCT02403323|459424524|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
127672454|NCT02403323|459424525|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
127672455|NCT02403323|459424523|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
127672456|NCT02403323|459424524|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|9|||
127672457|NCT02403323|459424525|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
127672458|NCT02403323|459424523|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
127672459|NCT02403323|459424524|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
127672460|NCT02403323|459424525|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
127672461|NCT02403323|459424523|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
128005734|NCT02337491|460648801|FG001|Overall Study|Progressive Disease|28|||
128005735|NCT02337491|460648800|FG000|Overall Study|On Treatment|2|||
128005736|NCT02337491|460648801|FG001|Overall Study|On Treatment|0|||
128005737|NCT01483118|460648806|FG000|Overall Study|Lost to Follow-up|12|||
128005738|NCT01483118|460648807|FG001|Overall Study|Lost to Follow-up|16|||
128005739|NCT01079780|460648809|FG000|Overall Study|Disease progression|43|||
128005740|NCT01079780|460648810|FG001|Overall Study|Disease progression|7|||
128005741|NCT01079780|460648811|FG002|Overall Study|Disease progression|31|||
128005742|NCT01079780|460648809|FG000|Overall Study|Adverse Event|13|||
128005743|NCT01079780|460648810|FG001|Overall Study|Adverse Event|5|||
128005744|NCT01079780|460648811|FG002|Overall Study|Adverse Event|7|||
128005745|NCT01079780|460648809|FG000|Overall Study|Death|2|||
128005746|NCT01079780|460648810|FG001|Overall Study|Death|0|||
128005747|NCT01079780|460648811|FG002|Overall Study|Death|2|||
128005748|NCT01079780|460648809|FG000|Overall Study|Withdrawal by Subject|6|||
128005749|NCT01079780|460648810|FG001|Overall Study|Withdrawal by Subject|4|||
128005750|NCT01079780|460648811|FG002|Overall Study|Withdrawal by Subject|4|||
128005751|NCT01079780|460648809|FG000|Overall Study|Alternative therapy|2|||
128005752|NCT01079780|460648810|FG001|Overall Study|Alternative therapy|0|||
128005753|NCT01079780|460648811|FG002|Overall Study|Alternative therapy|2|||
128005754|NCT01079780|460648809|FG000|Overall Study|Physician Decision|1|||
128005755|NCT01079780|460648810|FG001|Overall Study|Physician Decision|0|||
127672462|NCT02403323|459424524|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
127672463|NCT02403323|459424525|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|1|||
127672464|NCT02403323|459424523|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
127672465|NCT02403323|459424524|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|7|||
127672466|NCT02403323|459424525|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
128005756|NCT01079780|460648811|FG002|Overall Study|Physician Decision|1|||
128005757|NCT01079780|460648809|FG000|Overall Study|Error made in lesion measurement|1|||
128005758|NCT01079780|460648810|FG001|Overall Study|Error made in lesion measurement|0|||
128005759|NCT01079780|460648811|FG002|Overall Study|Error made in lesion measurement|0|||
128005760|NCT01079780|460648809|FG000|Overall Study|Patient had surgery|1|||
128005761|NCT01079780|460648810|FG001|Overall Study|Patient had surgery|0|||
128005762|NCT01079780|460648811|FG002|Overall Study|Patient had surgery|0|||
128005763|NCT01079780|460648809|FG000|Overall Study|Treatment cycle delay|0|||
128005764|NCT01079780|460648810|FG001|Overall Study|Treatment cycle delay|0|||
128005765|NCT01079780|460648811|FG002|Overall Study|Treatment cycle delay|1|||
128005766|NCT01079780|460648809|FG000|Overall Study|Never started treatment|1|||
128005767|NCT01079780|460648810|FG001|Overall Study|Never started treatment|0|||
128005768|NCT01079780|460648811|FG002|Overall Study|Never started treatment|2|||
128005769|NCT03435055|460648812|FG000|Screening|Physician Decision|2|||
128005770|NCT03435055|460648812|FG000|Received Intervention|Did not complete nitrous administration|3|||
128005771|NCT03712280|460648813|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
128005772|NCT03712280|460648814|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
128005773|NCT03712280|460648815|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
128005774|NCT03712280|460648816|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
128005775|NCT03712280|460648813|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
127672467|NCT02403323|459424523|FG000|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
127672468|NCT02403323|459424524|FG001|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|167|||
127672469|NCT02403323|459424525|FG002|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
128005776|NCT03712280|460648814|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
128005777|NCT03712280|460648815|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
127672470|NCT02403323|459424523|FG000|Part 2: PML Safety Monitoring Period|Other|0|||
127672471|NCT02403323|459424524|FG001|Part 2: PML Safety Monitoring Period|Other|1|||
127672472|NCT02403323|459424525|FG002|Part 2: PML Safety Monitoring Period|Other|0|||
127672473|NCT02403323|459424523|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
127672474|NCT02403323|459424524|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|12|||
127672475|NCT02403323|459424525|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|2|||
127672476|NCT03852433|459424526|FG000|Overall Study|Withdrawal of consent|5|||
127672477|NCT03852433|459424527|FG001|Overall Study|Withdrawal of consent|8|||
127672478|NCT03852433|459424528|FG002|Overall Study|Withdrawal of consent|1|||
127672479|NCT03852433|459424529|FG003|Overall Study|Withdrawal of consent|1|||
127672480|NCT03852433|459424526|FG000|Overall Study|Adverse Event|1|||
127672481|NCT03852433|459424527|FG001|Overall Study|Adverse Event|1|||
127672482|NCT03852433|459424528|FG002|Overall Study|Adverse Event|1|||
127672483|NCT03852433|459424529|FG003|Overall Study|Adverse Event|1|||
127672484|NCT03852433|459424526|FG000|Overall Study|Lost to Follow-up|0|||
127672485|NCT03852433|459424527|FG001|Overall Study|Lost to Follow-up|1|||
128005778|NCT03712280|460648816|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
128005779|NCT03712280|460648813|FG000|Overall Study|Adverse Event|0|||
128005780|NCT03712280|460648814|FG001|Overall Study|Adverse Event|0|||
128005781|NCT03712280|460648815|FG002|Overall Study|Adverse Event|1|||
128005782|NCT03712280|460648816|FG003|Overall Study|Adverse Event|0|||
128005783|NCT05379920|460648824|FG000|Overall Study|Lost to Follow-up|0|||
128005784|NCT05379920|460648825|FG001|Overall Study|Lost to Follow-up|5|||
128005785|NCT05379920|460648826|FG002|Overall Study|Lost to Follow-up|0|||
128005786|NCT05379920|460648827|FG003|Overall Study|Lost to Follow-up|0|||
128005787|NCT03530293|460648830|FG000|Pre-randomization|Adverse Event|12|||
128005788|NCT03530293|460648831|FG001|Pre-randomization|Adverse Event|0|||
128005789|NCT03530293|460648832|FG002|Pre-randomization|Adverse Event|0|||
128005790|NCT03530293|460648830|FG000|Pre-randomization|Protocol Violation|2|||
128005791|NCT03530293|460648831|FG001|Pre-randomization|Protocol Violation|0|||
128005792|NCT03530293|460648832|FG002|Pre-randomization|Protocol Violation|0|||
128005793|NCT03530293|460648830|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
128005794|NCT03530293|460648831|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
128005795|NCT03530293|460648832|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
128005796|NCT03530293|460648830|FG000|Pre-randomization|Withdrawal by Subject|5|||
128005797|NCT03530293|460648831|FG001|Pre-randomization|Withdrawal by Subject|0|||
128005798|NCT03530293|460648832|FG002|Pre-randomization|Withdrawal by Subject|0|||
128005799|NCT03530293|460648830|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
128005800|NCT03530293|460648831|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
128005801|NCT03530293|460648832|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
128005802|NCT03530293|460648830|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
128005803|NCT03530293|460648831|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
128005804|NCT03530293|460648832|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
128005805|NCT03530293|460648830|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
128005806|NCT03530293|460648831|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
128005807|NCT03530293|460648832|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
128005808|NCT03530293|460648830|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
128005809|NCT03530293|460648831|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
128005810|NCT03530293|460648832|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
128005811|NCT03530293|460648830|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
128005812|NCT03530293|460648831|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
128005813|NCT03530293|460648832|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
128005814|NCT01668797|460648835|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
128005815|NCT01668797|460648836|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
128005816|NCT01668797|460648837|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
128005817|NCT01668797|460648838|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
128005818|NCT01668797|460648835|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
128005819|NCT01668797|460648836|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
128005820|NCT01668797|460648837|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
128005821|NCT01668797|460648838|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
128005822|NCT01668797|460648835|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
128005823|NCT01668797|460648836|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
128005824|NCT01668797|460648837|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
128005825|NCT01668797|460648838|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
128005826|NCT01668797|460648835|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
128005827|NCT01668797|460648836|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
128005828|NCT01668797|460648837|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
128005829|NCT01668797|460648838|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
128005830|NCT01668797|460648835|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
128005831|NCT01668797|460648836|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
128005832|NCT01668797|460648837|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
128005833|NCT01668797|460648838|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
128005834|NCT01668797|460648835|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
128005835|NCT01668797|460648836|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
128005836|NCT01668797|460648837|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
128005837|NCT01668797|460648838|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
128005838|NCT01668797|460648835|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
128005839|NCT01668797|460648836|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
128005840|NCT01668797|460648837|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
128005841|NCT01668797|460648838|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
128005842|NCT01668797|460648835|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
128005843|NCT01668797|460648836|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
128005844|NCT01668797|460648837|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
128005845|NCT01668797|460648838|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
128005846|NCT01668797|460648835|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
128005847|NCT01668797|460648836|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
128005848|NCT01668797|460648837|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
128005849|NCT01668797|460648838|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
128005850|NCT01668797|460648835|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
128005851|NCT01668797|460648836|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
128005852|NCT01668797|460648837|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
128005853|NCT01668797|460648838|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
128005854|NCT01668797|460648835|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
128005855|NCT01668797|460648836|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
128005856|NCT01668797|460648837|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
128005857|NCT01668797|460648838|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
128005858|NCT01668797|460648835|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
128005859|NCT01668797|460648836|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
128005860|NCT01668797|460648837|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
128005861|NCT01668797|460648838|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
128005862|NCT01668797|460648835|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
128005863|NCT01668797|460648836|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
128005864|NCT01668797|460648837|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
128005865|NCT01668797|460648838|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
128005866|NCT01668797|460648835|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
128005867|NCT01668797|460648836|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
128005868|NCT01668797|460648837|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
128005869|NCT01668797|460648838|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
128005870|NCT01668797|460648835|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
127672486|NCT03852433|459424528|FG002|Overall Study|Lost to Follow-up|0|||
127672487|NCT03852433|459424529|FG003|Overall Study|Lost to Follow-up|1|||
127672488|NCT03852433|459424526|FG000|Overall Study|Pregnancy|0|||
128005871|NCT01668797|460648836|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
128005872|NCT01668797|460648837|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
128005873|NCT01668797|460648838|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
128005874|NCT01668797|460648835|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
128005875|NCT01668797|460648836|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
128005876|NCT01668797|460648837|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
128005877|NCT01668797|460648838|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
128005878|NCT01668797|460648835|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
128005879|NCT01668797|460648836|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
128005880|NCT01668797|460648837|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
128005881|NCT01668797|460648838|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
128005882|NCT01668797|460648835|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
128005883|NCT01668797|460648836|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
128005884|NCT01668797|460648837|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
128005885|NCT01668797|460648838|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
128005886|NCT01668797|460648835|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
128005887|NCT01668797|460648836|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
128005888|NCT01668797|460648837|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
128005889|NCT01668797|460648838|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
128005890|NCT01668797|460648835|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
128005891|NCT01668797|460648836|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
128005892|NCT01668797|460648837|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
128005893|NCT01668797|460648838|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
128005894|NCT01668797|460648835|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
128005895|NCT01668797|460648836|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
128005896|NCT01668797|460648837|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
128005897|NCT01668797|460648838|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
128005898|NCT01668797|460648835|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
128005899|NCT01668797|460648836|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
128005900|NCT01668797|460648837|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
128005901|NCT01668797|460648838|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
128005902|NCT01668797|460648835|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
128005903|NCT01668797|460648836|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
128005904|NCT01668797|460648837|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
128005905|NCT01668797|460648838|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
128005906|NCT01668797|460648835|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
128005907|NCT01668797|460648836|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
128005908|NCT01668797|460648837|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
128005909|NCT01668797|460648838|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
127672489|NCT03852433|459424527|FG001|Overall Study|Pregnancy|1|||
127672490|NCT03852433|459424528|FG002|Overall Study|Pregnancy|1|||
127672491|NCT03852433|459424529|FG003|Overall Study|Pregnancy|0|||
127672492|NCT03852433|459424526|FG000|Overall Study|Protocol Violation|0|||
127672493|NCT03852433|459424527|FG001|Overall Study|Protocol Violation|0|||
127672494|NCT03852433|459424528|FG002|Overall Study|Protocol Violation|1|||
127672495|NCT03852433|459424529|FG003|Overall Study|Protocol Violation|1|||
127672496|NCT03852433|459424526|FG000|Overall Study|Death|0|||
127672497|NCT03852433|459424527|FG001|Overall Study|Death|0|||
127672498|NCT03852433|459424528|FG002|Overall Study|Death|1|||
127672499|NCT03852433|459424529|FG003|Overall Study|Death|0|||
127672500|NCT03852433|459424526|FG000|Overall Study|Lack of Efficacy|0|||
127672501|NCT03852433|459424527|FG001|Overall Study|Lack of Efficacy|1|||
127672502|NCT03852433|459424528|FG002|Overall Study|Lack of Efficacy|0|||
127672503|NCT03852433|459424529|FG003|Overall Study|Lack of Efficacy|0|||
127672504|NCT03852433|459424526|FG000|Overall Study|Non-compliance with study drug|0|||
127672505|NCT03852433|459424527|FG001|Overall Study|Non-compliance with study drug|0|||
127672506|NCT03852433|459424528|FG002|Overall Study|Non-compliance with study drug|0|||
127672507|NCT03852433|459424529|FG003|Overall Study|Non-compliance with study drug|1|||
127672508|NCT03852433|459424526|FG000|Overall Study|Physician Decision|1|||
127672509|NCT03852433|459424527|FG001|Overall Study|Physician Decision|0|||
127672510|NCT03852433|459424528|FG002|Overall Study|Physician Decision|0|||
128005910|NCT01668797|460648835|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
128005911|NCT01668797|460648836|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
128005912|NCT01668797|460648837|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
128005913|NCT01668797|460648838|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
128005914|NCT02530385|460648839|FG000|Overall Study|Withdrawal by Subject|0|||
128005915|NCT02530385|460648840|FG001|Overall Study|Withdrawal by Subject|1|||
128005916|NCT01569022|460648842|FG000|First Intervention|Lost to Follow-up|2|||
128005917|NCT01569022|460648843|FG001|First Intervention|Lost to Follow-up|1|||
128005918|NCT01569022|460648842|FG000|Second Intervention|Lost to Follow-up|2|||
128005919|NCT01569022|460648843|FG001|Second Intervention|Lost to Follow-up|2|||
128005920|NCT02111083|460648848|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
128005921|NCT02111083|460648849|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
128005922|NCT00433836|460648850|FG000|Overall Study|Adverse Event|7|||
128005923|NCT00433836|460648851|FG001|Overall Study|Adverse Event|0|||
128005924|NCT00433836|460648850|FG000|Overall Study|Lost to Follow-up|3|||
128005925|NCT00433836|460648851|FG001|Overall Study|Lost to Follow-up|0|||
128005926|NCT00433836|460648850|FG000|Overall Study|Withdrawal by Subject|2|||
128005927|NCT00433836|460648851|FG001|Overall Study|Withdrawal by Subject|1|||
128005928|NCT00433836|460648850|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
128005929|NCT00433836|460648851|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
128005930|NCT00433836|460648850|FG000|Overall Study|Protocol Violation|0|||
128005931|NCT00433836|460648851|FG001|Overall Study|Protocol Violation|2|||
128005932|NCT00433836|460648850|FG000|Overall Study|Condition no longer requires study drug|0|||
128005933|NCT00433836|460648851|FG001|Overall Study|Condition no longer requires study drug|1|||
128005934|NCT00433836|460648850|FG000|Overall Study|Abnormal laboratory values|0|||
128005935|NCT00433836|460648851|FG001|Overall Study|Abnormal laboratory values|1|||
128005936|NCT02446691|460648852|FG000|Overall Study|Withdrawal by Subject|2|||
128005937|NCT02446691|460648852|FG000|Overall Study|Lost to Follow-up|8|||
128005938|NCT02446691|460648852|FG000|Overall Study|Protocol Violation|1|||
128005939|NCT00472420|460648853|FG000|Induction Treatment Period|Physician Decision|9|||
128005940|NCT00472420|460648853|FG000|Induction Treatment Period|Adverse Event|3|||
128005941|NCT00472420|460648853|FG000|Induction Treatment Period|Non-compliance|1|||
128005942|NCT00472420|460648853|FG000|Induction Treatment Period|Death|3|||
128005943|NCT00472420|460648853|FG000|Follow-up Period|Death|5|||
128005944|NCT00472420|460648853|FG000|Follow-up Period|Physician Decision|9|||
128005945|NCT00472420|460648853|FG000|Follow-up Period|Lost to Follow-up|2|||
128005946|NCT00472420|460648853|FG000|Follow-up Period|Protocol Violation|1|||
128005947|NCT01026493|460648856|FG000|Overall Study|Protocol Violation|0|||
128005948|NCT01026493|460648857|FG001|Overall Study|Protocol Violation|1|||
128005949|NCT01026493|460648858|FG002|Overall Study|Protocol Violation|0|||
128005950|NCT01026493|460648859|FG003|Overall Study|Protocol Violation|0|||
128005951|NCT01026493|460648860|FG004|Overall Study|Protocol Violation|2|||
128005952|NCT01026493|460648861|FG005|Overall Study|Protocol Violation|3|||
128005953|NCT01026493|460648862|FG006|Overall Study|Protocol Violation|4|||
128005954|NCT01026493|460648863|FG007|Overall Study|Protocol Violation|1|||
128005955|NCT02674516|460648864|FG000|Overall Study|Lost to Follow-up|3|||
127672511|NCT03852433|459424529|FG003|Overall Study|Physician Decision|0|||
127672512|NCT03852433|459424526|FG000|Overall Study|Randomized but never treated|1|||
128005956|NCT02674516|460648865|FG001|Overall Study|Lost to Follow-up|0|||
128005957|NCT02674516|460648864|FG000|Overall Study|Protocol Violation|0|||
128005958|NCT02674516|460648865|FG001|Overall Study|Protocol Violation|4|||
128005959|NCT02674516|460648864|FG000|Overall Study|Knowledge of study hypothesis|1|||
128005960|NCT02674516|460648865|FG001|Overall Study|Knowledge of study hypothesis|0|||
127672513|NCT03852433|459424527|FG001|Overall Study|Randomized but never treated|0|||
127672514|NCT03852433|459424528|FG002|Overall Study|Randomized but never treated|0|||
127672515|NCT03852433|459424529|FG003|Overall Study|Randomized but never treated|0|||
128005961|NCT03307174|460648867|FG000|Overall Study|Unplanned ICU Administrion|5|||
128005962|NCT03307174|460648868|FG001|Overall Study|Unplanned ICU Administrion|3|||
128005963|NCT03307174|460648867|FG000|Overall Study|Aborted Surgery|1|||
128005964|NCT03307174|460648868|FG001|Overall Study|Aborted Surgery|2|||
128005965|NCT03307174|460648867|FG000|Overall Study|Hypotension|6|||
128005966|NCT03307174|460648868|FG001|Overall Study|Hypotension|0|||
128005967|NCT03307174|460648867|FG000|Overall Study|Nonfunctional epidural|1|||
128005968|NCT03307174|460648868|FG001|Overall Study|Nonfunctional epidural|1|||
128005969|NCT03307174|460648867|FG000|Overall Study|Planned epidural removal|1|||
128005970|NCT03307174|460648868|FG001|Overall Study|Planned epidural removal|0|||
128005971|NCT03307174|460648867|FG000|Overall Study|Intrathecal catheter placement|0|||
128005972|NCT03307174|460648868|FG001|Overall Study|Intrathecal catheter placement|1|||
128005973|NCT00721799|460648874|FG000|Overall Study|Withdrawal by Subject|7|||
128005974|NCT00721799|460648874|FG000|Overall Study|withdraw by subject after scan 1|1|||
128005975|NCT05965752|460648875|FG000|Overall Study|Adverse Event|0|||
128005976|NCT05965752|460648876|FG001|Overall Study|Adverse Event|1|||
128005977|NCT05965752|460648877|FG002|Overall Study|Adverse Event|0|||
128005978|NCT05965752|460648878|FG003|Overall Study|Adverse Event|1|||
128005979|NCT05965752|460648879|FG004|Overall Study|Adverse Event|3|||
128005980|NCT05965752|460648875|FG000|Overall Study|Lost to Follow-up|2|||
128005981|NCT05965752|460648876|FG001|Overall Study|Lost to Follow-up|0|||
128005982|NCT05965752|460648877|FG002|Overall Study|Lost to Follow-up|1|||
128005983|NCT05965752|460648878|FG003|Overall Study|Lost to Follow-up|1|||
128005984|NCT05965752|460648879|FG004|Overall Study|Lost to Follow-up|1|||
128005985|NCT05965752|460648875|FG000|Overall Study|Withdrawal by Subject|2|||
128005986|NCT05965752|460648876|FG001|Overall Study|Withdrawal by Subject|2|||
128005987|NCT05965752|460648877|FG002|Overall Study|Withdrawal by Subject|1|||
128005988|NCT05965752|460648878|FG003|Overall Study|Withdrawal by Subject|5|||
128005989|NCT05965752|460648879|FG004|Overall Study|Withdrawal by Subject|0|||
128005990|NCT05965752|460648875|FG000|Overall Study|Disease Relapse|1|||
128005991|NCT05965752|460648876|FG001|Overall Study|Disease Relapse|0|||
128005992|NCT05965752|460648877|FG002|Overall Study|Disease Relapse|1|||
128005993|NCT05965752|460648878|FG003|Overall Study|Disease Relapse|0|||
128005994|NCT05965752|460648879|FG004|Overall Study|Disease Relapse|0|||
128005995|NCT05965752|460648875|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
128005996|NCT05965752|460648876|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
128005997|NCT05965752|460648877|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
128005998|NCT05965752|460648878|FG003|Overall Study|Failure to Meet Randomization Criteria|1|||
128005999|NCT05965752|460648879|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
128006000|NCT05965752|460648875|FG000|Overall Study|Unable to Return for Study Visits|0|||
128006001|NCT05965752|460648876|FG001|Overall Study|Unable to Return for Study Visits|1|||
128006002|NCT05965752|460648877|FG002|Overall Study|Unable to Return for Study Visits|0|||
128006003|NCT05965752|460648878|FG003|Overall Study|Unable to Return for Study Visits|3|||
128006004|NCT05965752|460648879|FG004|Overall Study|Unable to Return for Study Visits|1|||
128006005|NCT05965752|460648875|FG000|Overall Study|Early Termination|0|||
128006006|NCT05965752|460648876|FG001|Overall Study|Early Termination|0|||
128006007|NCT05965752|460648877|FG002|Overall Study|Early Termination|1|||
128006008|NCT05965752|460648878|FG003|Overall Study|Early Termination|0|||
128006009|NCT05965752|460648879|FG004|Overall Study|Early Termination|0|||
128006010|NCT05965752|460648875|FG000|Overall Study|Reported Unwanted Symptoms|0|||
128006011|NCT05965752|460648876|FG001|Overall Study|Reported Unwanted Symptoms|0|||
128006012|NCT05965752|460648877|FG002|Overall Study|Reported Unwanted Symptoms|0|||
128006013|NCT05965752|460648878|FG003|Overall Study|Reported Unwanted Symptoms|0|||
128006014|NCT05965752|460648879|FG004|Overall Study|Reported Unwanted Symptoms|1|||
128006015|NCT05965752|460648875|FG000|Overall Study|Did Not Want to be Randomized to Intervention|0|||
128006016|NCT05965752|460648876|FG001|Overall Study|Did Not Want to be Randomized to Intervention|0|||
128006017|NCT05965752|460648877|FG002|Overall Study|Did Not Want to be Randomized to Intervention|0|||
128006018|NCT05965752|460648878|FG003|Overall Study|Did Not Want to be Randomized to Intervention|0|||
128006019|NCT05965752|460648879|FG004|Overall Study|Did Not Want to be Randomized to Intervention|1|||
128006020|NCT02873689|460650612|FG000|Overall Study|Lack of Efficacy|1|||
128006021|NCT02873689|460650613|FG001|Overall Study|Lack of Efficacy|0|||
128006022|NCT02873689|460650612|FG000|Overall Study|Withdrawal by Subject|2|||
128006023|NCT02873689|460650613|FG001|Overall Study|Withdrawal by Subject|2|||
128006024|NCT02873689|460650612|FG000|Overall Study|Protocol Violation|1|||
128006025|NCT02873689|460650613|FG001|Overall Study|Protocol Violation|0|||
128006026|NCT02873689|460650612|FG000|Overall Study|Adverse Event|2|||
128006027|NCT02873689|460650613|FG001|Overall Study|Adverse Event|2|||
128006028|NCT02873689|460650612|FG000|Overall Study|Randomized but not Treated|1|||
128006029|NCT02873689|460650613|FG001|Overall Study|Randomized but not Treated|1|||
128006030|NCT00350545|460650614|FG000|Overall Study|Withdrawal by Subject|2|||
128006031|NCT02997163|460650625|FG000|Overall Study|Adverse Event|1|||
128006032|NCT02997163|460650626|FG001|Overall Study|Adverse Event|0|||
128006033|NCT02997163|460650627|FG002|Overall Study|Adverse Event|0|||
128006034|NCT02997163|460650628|FG003|Overall Study|Adverse Event|1|||
128006035|NCT02337764|460650629|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
128006036|NCT02337764|460650629|FG000|Overall Study|Voluntary Withdrawal|12|||
128006037|NCT02337764|460650629|FG000|Overall Study|Lack of Efficacy|2|||
128006038|NCT00903968|460650639|FG000|Overall Study|Adverse Event|0|||
128006039|NCT00903968|460650640|FG001|Overall Study|Adverse Event|0|||
128006040|NCT00903968|460650641|FG002|Overall Study|Adverse Event|0|||
128006041|NCT00903968|460650642|FG003|Overall Study|Adverse Event|0|||
128006042|NCT00903968|460650643|FG004|Overall Study|Adverse Event|0|||
128006043|NCT00903968|460650644|FG005|Overall Study|Adverse Event|0|||
128006044|NCT00903968|460650645|FG006|Overall Study|Adverse Event|1|||
128006045|NCT00903968|460650646|FG007|Overall Study|Adverse Event|8|||
128006046|NCT00903968|460650639|FG000|Overall Study|DLT|0|||
128006047|NCT00903968|460650640|FG001|Overall Study|DLT|0|||
128006048|NCT00903968|460650641|FG002|Overall Study|DLT|0|||
128006049|NCT00903968|460650642|FG003|Overall Study|DLT|0|||
128006050|NCT00903968|460650643|FG004|Overall Study|DLT|0|||
128006051|NCT00903968|460650644|FG005|Overall Study|DLT|0|||
128006052|NCT00903968|460650645|FG006|Overall Study|DLT|2|||
128006053|NCT00903968|460650646|FG007|Overall Study|DLT|0|||
128006054|NCT00903968|460650639|FG000|Overall Study|Withdrawal by Subject|1|||
128006055|NCT00903968|460650640|FG001|Overall Study|Withdrawal by Subject|0|||
128006056|NCT00903968|460650641|FG002|Overall Study|Withdrawal by Subject|1|||
128006057|NCT00903968|460650642|FG003|Overall Study|Withdrawal by Subject|0|||
128006058|NCT00903968|460650643|FG004|Overall Study|Withdrawal by Subject|1|||
128006059|NCT00903968|460650644|FG005|Overall Study|Withdrawal by Subject|1|||
128006060|NCT00903968|460650645|FG006|Overall Study|Withdrawal by Subject|0|||
128006061|NCT00903968|460650646|FG007|Overall Study|Withdrawal by Subject|4|||
128006062|NCT00903968|460650639|FG000|Overall Study|Non-Compliance|0|||
128006063|NCT00903968|460650640|FG001|Overall Study|Non-Compliance|0|||
128006064|NCT00903968|460650641|FG002|Overall Study|Non-Compliance|0|||
128006065|NCT00903968|460650642|FG003|Overall Study|Non-Compliance|0|||
128006066|NCT00903968|460650643|FG004|Overall Study|Non-Compliance|0|||
128006067|NCT00903968|460650644|FG005|Overall Study|Non-Compliance|1|||
128006068|NCT00903968|460650645|FG006|Overall Study|Non-Compliance|0|||
128006069|NCT00903968|460650646|FG007|Overall Study|Non-Compliance|0|||
128006070|NCT00903968|460650639|FG000|Overall Study|Physician Decision|0|||
128006071|NCT00903968|460650640|FG001|Overall Study|Physician Decision|0|||
128006072|NCT00903968|460650641|FG002|Overall Study|Physician Decision|0|||
128006073|NCT00903968|460650642|FG003|Overall Study|Physician Decision|0|||
128006074|NCT00903968|460650643|FG004|Overall Study|Physician Decision|0|||
128006075|NCT00903968|460650644|FG005|Overall Study|Physician Decision|1|||
128006076|NCT00903968|460650645|FG006|Overall Study|Physician Decision|0|||
128006077|NCT00903968|460650646|FG007|Overall Study|Physician Decision|0|||
128006078|NCT00903968|460650639|FG000|Overall Study|Progressive Disease|2|||
128006079|NCT00903968|460650640|FG001|Overall Study|Progressive Disease|3|||
128006080|NCT00903968|460650641|FG002|Overall Study|Progressive Disease|2|||
128006081|NCT00903968|460650642|FG003|Overall Study|Progressive Disease|3|||
128006082|NCT00903968|460650643|FG004|Overall Study|Progressive Disease|3|||
128006083|NCT00903968|460650644|FG005|Overall Study|Progressive Disease|3|||
128006084|NCT00903968|460650645|FG006|Overall Study|Progressive Disease|0|||
128006085|NCT00903968|460650646|FG007|Overall Study|Progressive Disease|18|||
128006086|NCT00903968|460650639|FG000|Overall Study|Lack of Efficacy|0|||
128006087|NCT00903968|460650640|FG001|Overall Study|Lack of Efficacy|0|||
128006088|NCT00903968|460650641|FG002|Overall Study|Lack of Efficacy|0|||
128006089|NCT00903968|460650642|FG003|Overall Study|Lack of Efficacy|0|||
128006090|NCT00903968|460650643|FG004|Overall Study|Lack of Efficacy|0|||
128006091|NCT00903968|460650644|FG005|Overall Study|Lack of Efficacy|0|||
128006092|NCT00903968|460650645|FG006|Overall Study|Lack of Efficacy|0|||
128006093|NCT00903968|460650646|FG007|Overall Study|Lack of Efficacy|3|||
128006094|NCT04539275|460650647|FG000|Overall Study|Death|2|||
128006095|NCT04539275|460650648|FG001|Overall Study|Death|4|||
128006096|NCT04539275|460650647|FG000|Overall Study|Lost to Follow-up|1|||
128006097|NCT04539275|460650648|FG001|Overall Study|Lost to Follow-up|1|||
128006098|NCT04539275|460650647|FG000|Overall Study|Withdrawal by Subject|3|||
128006099|NCT04539275|460650648|FG001|Overall Study|Withdrawal by Subject|0|||
128006100|NCT03736967|460650649|FG000|Overall Study|Withdrawal by Subject|26|||
128006101|NCT03736967|460650650|FG001|Overall Study|Withdrawal by Subject|25|||
128006102|NCT03736967|460650651|FG002|Overall Study|Withdrawal by Subject|23|||
128006103|NCT03736967|460650652|FG003|Overall Study|Withdrawal by Subject|26|||
128006104|NCT03736967|460650649|FG000|Overall Study|Lost to Follow-up|3|||
128006105|NCT03736967|460650650|FG001|Overall Study|Lost to Follow-up|2|||
128006106|NCT03736967|460650651|FG002|Overall Study|Lost to Follow-up|1|||
128006107|NCT03736967|460650652|FG003|Overall Study|Lost to Follow-up|1|||
128006108|NCT03736967|460650649|FG000|Overall Study|Physician Decision|1|||
128006109|NCT03736967|460650650|FG001|Overall Study|Physician Decision|0|||
128006110|NCT03736967|460650651|FG002|Overall Study|Physician Decision|0|||
128006111|NCT03736967|460650652|FG003|Overall Study|Physician Decision|1|||
128006112|NCT03736967|460650649|FG000|Overall Study|Adverse Event|0|||
128006113|NCT03736967|460650650|FG001|Overall Study|Adverse Event|1|||
128006114|NCT03736967|460650651|FG002|Overall Study|Adverse Event|0|||
128006115|NCT03736967|460650652|FG003|Overall Study|Adverse Event|1|||
128006116|NCT03736967|460650649|FG000|Overall Study|Death|0|||
128006117|NCT03736967|460650650|FG001|Overall Study|Death|0|||
128006118|NCT03736967|460650651|FG002|Overall Study|Death|0|||
128006119|NCT03736967|460650652|FG003|Overall Study|Death|1|||
128006120|NCT03736967|460650649|FG000|Overall Study|Randomized but never treated|1|||
128006121|NCT03736967|460650650|FG001|Overall Study|Randomized but never treated|0|||
128006122|NCT03736967|460650651|FG002|Overall Study|Randomized but never treated|0|||
128006123|NCT03736967|460650652|FG003|Overall Study|Randomized but never treated|0|||
128006124|NCT02419807|460650653|FG000|Overall Study|Withdrawal by Subject|4|||
128006125|NCT02419807|460650653|FG000|Overall Study|Physician Decision|1|||
128006126|NCT02419807|460650653|FG000|Overall Study|Protocol Violation|5|||
128006127|NCT01458587|460650654|FG000|Overall Study|Withdrawal by Subject|1|||
128006128|NCT01458587|460650655|FG001|Overall Study|Withdrawal by Subject|0|||
128006129|NCT02932943|460650657|FG000|Overall Study|Lost to Follow-up|0|||
128006130|NCT02932943|460650658|FG001|Overall Study|Lost to Follow-up|2|||
128006131|NCT02932943|460650657|FG000|Overall Study|Adverse Event|2|||
128006132|NCT02932943|460650658|FG001|Overall Study|Adverse Event|2|||
128006133|NCT02932943|460650657|FG000|Overall Study|Withdrawal by Subject|3|||
128006134|NCT02932943|460650658|FG001|Overall Study|Withdrawal by Subject|3|||
128006135|NCT01663623|460650661|FG000|Overall Study|Adverse Event|3|||
128006136|NCT01663623|460650662|FG001|Overall Study|Adverse Event|7|||
128006137|NCT01663623|460650661|FG000|Overall Study|Lack of Efficacy|5|||
128006138|NCT01663623|460650662|FG001|Overall Study|Lack of Efficacy|6|||
128006139|NCT01663623|460650661|FG000|Overall Study|Protocol Violation|0|||
128006140|NCT01663623|460650662|FG001|Overall Study|Protocol Violation|1|||
128006141|NCT01663623|460650661|FG000|Overall Study|Other-Study closed/terminated|1|||
128006142|NCT01663623|460650662|FG001|Overall Study|Other-Study closed/terminated|1|||
128006143|NCT01663623|460650661|FG000|Overall Study|Physician Decision|1|||
128006144|NCT01663623|460650662|FG001|Overall Study|Physician Decision|4|||
128006145|NCT01663623|460650661|FG000|Overall Study|Withdrawal by Subject|2|||
128006146|NCT01663623|460650662|FG001|Overall Study|Withdrawal by Subject|1|||
128006147|NCT00856180|460650666|FG000|Overall Study|Adverse Event|4|||
128006148|NCT00856180|460650666|FG000|Overall Study|Progressive Disease|16|||
128006149|NCT02265510|460650667|FG000|Overall Study|Withdrawal by Subject|1|||
128006150|NCT02265510|460650668|FG001|Overall Study|Withdrawal by Subject|1|||
128006151|NCT02265510|460650669|FG002|Overall Study|Withdrawal by Subject|2|||
128006152|NCT02265510|460650670|FG003|Overall Study|Withdrawal by Subject|1|||
128006153|NCT02265510|460650671|FG004|Overall Study|Withdrawal by Subject|0|||
128006154|NCT02265510|460650672|FG005|Overall Study|Withdrawal by Subject|2|||
128006155|NCT02265510|460650673|FG006|Overall Study|Withdrawal by Subject|0|||
128006156|NCT02265510|460650674|FG007|Overall Study|Withdrawal by Subject|2|||
128006157|NCT02265510|460650675|FG008|Overall Study|Withdrawal by Subject|0|||
128006158|NCT02265510|460650676|FG009|Overall Study|Withdrawal by Subject|0|||
128006159|NCT02265510|460650677|FG010|Overall Study|Withdrawal by Subject|0|||
128006160|NCT02265510|460650678|FG011|Overall Study|Withdrawal by Subject|0|||
128006161|NCT02265510|460650679|FG012|Overall Study|Withdrawal by Subject|1|||
128006162|NCT02265510|460650680|FG013|Overall Study|Withdrawal by Subject|0|||
128006163|NCT02265510|460650667|FG000|Overall Study|Disease Progression|0|||
128006164|NCT02265510|460650668|FG001|Overall Study|Disease Progression|1|||
128006165|NCT02265510|460650669|FG002|Overall Study|Disease Progression|2|||
128006166|NCT02265510|460650670|FG003|Overall Study|Disease Progression|1|||
128006167|NCT02265510|460650671|FG004|Overall Study|Disease Progression|1|||
128006168|NCT02265510|460650672|FG005|Overall Study|Disease Progression|0|||
128006169|NCT02265510|460650673|FG006|Overall Study|Disease Progression|0|||
128006170|NCT02265510|460650674|FG007|Overall Study|Disease Progression|0|||
128006171|NCT02265510|460650675|FG008|Overall Study|Disease Progression|0|||
128006172|NCT02265510|460650676|FG009|Overall Study|Disease Progression|0|||
128006173|NCT02265510|460650677|FG010|Overall Study|Disease Progression|0|||
128006174|NCT02265510|460650678|FG011|Overall Study|Disease Progression|0|||
128006175|NCT02265510|460650679|FG012|Overall Study|Disease Progression|0|||
128006176|NCT02265510|460650680|FG013|Overall Study|Disease Progression|0|||
128006177|NCT02265510|460650667|FG000|Overall Study|Death|2|||
128006178|NCT02265510|460650668|FG001|Overall Study|Death|0|||
128006179|NCT02265510|460650669|FG002|Overall Study|Death|2|||
128006180|NCT02265510|460650670|FG003|Overall Study|Death|2|||
128006181|NCT02265510|460650671|FG004|Overall Study|Death|1|||
128006182|NCT02265510|460650672|FG005|Overall Study|Death|3|||
128006183|NCT02265510|460650673|FG006|Overall Study|Death|2|||
128006184|NCT02265510|460650674|FG007|Overall Study|Death|1|||
128006185|NCT02265510|460650675|FG008|Overall Study|Death|3|||
128006186|NCT02265510|460650676|FG009|Overall Study|Death|3|||
128006187|NCT02265510|460650677|FG010|Overall Study|Death|4|||
128006188|NCT02265510|460650678|FG011|Overall Study|Death|12|||
128006189|NCT02265510|460650679|FG012|Overall Study|Death|7|||
128006190|NCT02265510|460650680|FG013|Overall Study|Death|6|||
128006191|NCT02265510|460650667|FG000|Overall Study|Lost to Follow-up|0|||
128006192|NCT02265510|460650668|FG001|Overall Study|Lost to Follow-up|0|||
128006193|NCT02265510|460650669|FG002|Overall Study|Lost to Follow-up|0|||
128006194|NCT02265510|460650670|FG003|Overall Study|Lost to Follow-up|0|||
128006195|NCT02265510|460650671|FG004|Overall Study|Lost to Follow-up|1|||
128006196|NCT02265510|460650672|FG005|Overall Study|Lost to Follow-up|0|||
128006197|NCT02265510|460650673|FG006|Overall Study|Lost to Follow-up|0|||
128006198|NCT02265510|460650674|FG007|Overall Study|Lost to Follow-up|0|||
128006199|NCT02265510|460650675|FG008|Overall Study|Lost to Follow-up|0|||
128006200|NCT02265510|460650676|FG009|Overall Study|Lost to Follow-up|2|||
128006201|NCT02265510|460650677|FG010|Overall Study|Lost to Follow-up|0|||
128006202|NCT02265510|460650678|FG011|Overall Study|Lost to Follow-up|0|||
128006203|NCT02265510|460650679|FG012|Overall Study|Lost to Follow-up|0|||
128006204|NCT02265510|460650680|FG013|Overall Study|Lost to Follow-up|2|||
128006205|NCT02265510|460650667|FG000|Overall Study|Other|0|||
128006206|NCT02265510|460650668|FG001|Overall Study|Other|1|||
128006207|NCT02265510|460650669|FG002|Overall Study|Other|0|||
128006208|NCT02265510|460650670|FG003|Overall Study|Other|0|||
128006209|NCT02265510|460650671|FG004|Overall Study|Other|0|||
128006210|NCT02265510|460650672|FG005|Overall Study|Other|0|||
128006211|NCT02265510|460650673|FG006|Overall Study|Other|0|||
128006212|NCT02265510|460650674|FG007|Overall Study|Other|0|||
128006213|NCT02265510|460650675|FG008|Overall Study|Other|0|||
128006214|NCT02265510|460650676|FG009|Overall Study|Other|0|||
128006215|NCT02265510|460650677|FG010|Overall Study|Other|0|||
128006216|NCT02265510|460650678|FG011|Overall Study|Other|0|||
128006217|NCT02265510|460650679|FG012|Overall Study|Other|0|||
128006218|NCT02265510|460650680|FG013|Overall Study|Other|0|||
128006219|NCT02265510|460650667|FG000|Overall Study|Study Terminated by Sponsor|0|||
128006220|NCT02265510|460650668|FG001|Overall Study|Study Terminated by Sponsor|0|||
128006221|NCT02265510|460650669|FG002|Overall Study|Study Terminated by Sponsor|0|||
128006222|NCT02265510|460650670|FG003|Overall Study|Study Terminated by Sponsor|0|||
128006223|NCT02265510|460650671|FG004|Overall Study|Study Terminated by Sponsor|0|||
128006224|NCT02265510|460650672|FG005|Overall Study|Study Terminated by Sponsor|1|||
128006225|NCT02265510|460650673|FG006|Overall Study|Study Terminated by Sponsor|1|||
128006226|NCT02265510|460650674|FG007|Overall Study|Study Terminated by Sponsor|1|||
128006227|NCT02265510|460650675|FG008|Overall Study|Study Terminated by Sponsor|1|||
128006228|NCT02265510|460650676|FG009|Overall Study|Study Terminated by Sponsor|2|||
128006229|NCT02265510|460650677|FG010|Overall Study|Study Terminated by Sponsor|1|||
128006230|NCT02265510|460650678|FG011|Overall Study|Study Terminated by Sponsor|4|||
128006231|NCT02265510|460650679|FG012|Overall Study|Study Terminated by Sponsor|1|||
128006232|NCT02265510|460650680|FG013|Overall Study|Study Terminated by Sponsor|2|||
128006233|NCT01004614|460650681|FG000|Washout|Withdrawal by Subject|0|||
128006234|NCT01004614|460650682|FG001|Washout|Withdrawal by Subject|1|||
128006235|NCT01004614|460650683|FG002|Washout|Withdrawal by Subject|0|||
128006236|NCT01004614|460650684|FG003|Washout|Withdrawal by Subject|0|||
128006237|NCT00368550|460650685|FG000|Overall Study|Adverse Event|7|||
128006238|NCT00368550|460650686|FG001|Overall Study|Adverse Event|4|||
128006239|NCT00368550|460650685|FG000|Overall Study|Lack of Efficacy|4|||
128006240|NCT00368550|460650686|FG001|Overall Study|Lack of Efficacy|9|||
128006241|NCT00368550|460650685|FG000|Overall Study|Withdrawal by Subject|17|||
128006242|NCT00368550|460650686|FG001|Overall Study|Withdrawal by Subject|10|||
128006243|NCT00486044|460650687|FG000|Overall Study|Withdrawal by Subject|2|||
128006244|NCT00486044|460650688|FG001|Overall Study|Withdrawal by Subject|1|||
128006245|NCT00486044|460650687|FG000|Overall Study|Adverse Event|0|||
128006246|NCT00486044|460650688|FG001|Overall Study|Adverse Event|1|||
128006247|NCT00486044|460650687|FG000|Overall Study|Lost to Follow-up|0|||
128006248|NCT00486044|460650688|FG001|Overall Study|Lost to Follow-up|1|||
128006249|NCT01670292|460650693|FG000|Overall Study|Lost to Follow-up|14|||
128006250|NCT01603277|460650694|FG000|Overall Study|Adverse Event|1|||
128006251|NCT01603277|460650695|FG001|Overall Study|Adverse Event|2|||
128006252|NCT01603277|460650694|FG000|Overall Study|Physician Decision|0|||
128006253|NCT01603277|460650695|FG001|Overall Study|Physician Decision|1|||
128006254|NCT01603277|460650694|FG000|Overall Study|Protocol Violation|6|||
128006255|NCT01603277|460650695|FG001|Overall Study|Protocol Violation|10|||
128006256|NCT01603277|460650694|FG000|Overall Study|Withdrawal by Subject|5|||
128006257|NCT01603277|460650695|FG001|Overall Study|Withdrawal by Subject|4|||
128006258|NCT01603277|460650694|FG000|Overall Study|Non-Compliance|2|||
128006259|NCT01603277|460650695|FG001|Overall Study|Non-Compliance|1|||
128006260|NCT04494646|460650698|FG000|Overall Study|Adverse Event|0|||
128006261|NCT04494646|460650699|FG001|Overall Study|Adverse Event|1|||
128006262|NCT04494646|460650698|FG000|Overall Study|Withdrawal by Subject|0|||
128006263|NCT04494646|460650699|FG001|Overall Study|Withdrawal by Subject|1|||
128006264|NCT02785939|460650702|FG000|Overall Study|Progression|25|||
128006265|NCT02785939|460650703|FG001|Overall Study|Progression|8|||
128006266|NCT02785939|460650702|FG000|Overall Study|Adverse Event|3|||
128006267|NCT02785939|460650703|FG001|Overall Study|Adverse Event|1|||
128006268|NCT02785939|460650702|FG000|Overall Study|Death|1|||
128006269|NCT02785939|460650703|FG001|Overall Study|Death|0|||
128006270|NCT02785939|460650702|FG000|Overall Study|Refusal|1|||
128006271|NCT02785939|460650703|FG001|Overall Study|Refusal|0|||
128006272|NCT02785939|460650702|FG000|Overall Study|Deteriorating health|1|||
128006273|NCT02785939|460650703|FG001|Overall Study|Deteriorating health|0|||
128006274|NCT02785939|460650702|FG000|Overall Study|Not protocol specified|0|||
128006275|NCT02785939|460650703|FG001|Overall Study|Not protocol specified|1|||
128006276|NCT02391337|460650707|FG000|6 Months Follow-up|Death|5|||
128006277|NCT02391337|460650708|FG001|6 Months Follow-up|Death|4|||
128006278|NCT02391337|460650707|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
128006279|NCT02391337|460650708|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
128006280|NCT02391337|460650707|FG000|12 Months Follow-up|Death|2|||
128006281|NCT02391337|460650708|FG001|12 Months Follow-up|Death|0|||
128006282|NCT02391337|460650707|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
128006283|NCT02391337|460650708|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
128006284|NCT02391337|460650707|FG000|12 Months Follow-up|Lost to Follow-up|0|||
128006285|NCT02391337|460650708|FG001|12 Months Follow-up|Lost to Follow-up|2|||
128006286|NCT00846053|460650711|FG000|Overall Study|Physician Decision|3|||
128006287|NCT00846053|460650712|FG001|Overall Study|Physician Decision|0|||
128006288|NCT00111761|460650713|FG000|Part 1|Physician Decision|0|||
128006289|NCT00111761|460650714|FG001|Part 1|Physician Decision|1|||
128006290|NCT00111761|460650713|FG000|Part 1|Death|0|||
128006291|NCT00111761|460650714|FG001|Part 1|Death|2|||
128006292|NCT00111761|460650713|FG000|Part 1|Other|0|||
128006293|NCT00111761|460650714|FG001|Part 1|Other|1|||
128006294|NCT00111761|460650713|FG000|Part 1|Withdrawal by Subject|0|||
128006295|NCT00111761|460650714|FG001|Part 1|Withdrawal by Subject|1|||
128006296|NCT00111761|460650713|FG000|Part 2|Adverse Event|1|||
128006297|NCT00111761|460650714|FG001|Part 2|Adverse Event|0|||
128006298|NCT00111761|460650713|FG000|Part 2|Physician Decision|1|||
128006299|NCT00111761|460650714|FG001|Part 2|Physician Decision|0|||
128006300|NCT00111761|460650713|FG000|Part 2|Death|1|||
128006301|NCT00111761|460650714|FG001|Part 2|Death|0|||
128006302|NCT00111761|460650713|FG000|Part 2|Disease progression|3|||
128006303|NCT00111761|460650714|FG001|Part 2|Disease progression|0|||
128006304|NCT00111761|460650713|FG000|Part 2|Protocol-specified criteria|1|||
128006305|NCT00111761|460650714|FG001|Part 2|Protocol-specified criteria|0|||
128006306|NCT00111761|460650713|FG000|Part 2|Other|1|||
128006307|NCT00111761|460650714|FG001|Part 2|Other|0|||
128006308|NCT00746551|460650715|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
128006309|NCT00746551|460650716|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
128006310|NCT00746551|460650715|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
128006311|NCT00746551|460650716|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
128006312|NCT00746551|460650715|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
128006313|NCT00746551|460650716|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
128006314|NCT03372798|460650718|FG000|Overall Study|Patient not attending post-procedural CT scan|1|||
128006315|NCT03372798|460650719|FG001|Overall Study|Patient not attending post-procedural CT scan|0|||
128006316|NCT03372798|460650718|FG000|Overall Study|Failure of imaging probe|0|||
128006317|NCT03372798|460650719|FG001|Overall Study|Failure of imaging probe|1|||
128006318|NCT00843492|460650739|FG000|Overall Study|Adverse Event|0|||
128006319|NCT00843492|460650740|FG001|Overall Study|Adverse Event|3|||
128006320|NCT00843492|460650739|FG000|Overall Study|Lost to Follow-up|4|||
128006321|NCT00843492|460650740|FG001|Overall Study|Lost to Follow-up|4|||
128006322|NCT00843492|460650739|FG000|Overall Study|Withdrawal by Subject|0|||
128006323|NCT00843492|460650740|FG001|Overall Study|Withdrawal by Subject|4|||
128006324|NCT00843492|460650739|FG000|Overall Study|Immobilization Stopped|1|||
128006325|NCT00843492|460650740|FG001|Overall Study|Immobilization Stopped|0|||
128006326|NCT00843492|460650739|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
128006327|NCT00843492|460650740|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
128006328|NCT00843492|460650739|FG000|Overall Study|Orthopedic Surgery|0|||
128006329|NCT00843492|460650740|FG001|Overall Study|Orthopedic Surgery|2|||
128006330|NCT00843492|460650739|FG000|Overall Study|Visit Not Performed|1|||
128006331|NCT00843492|460650740|FG001|Overall Study|Visit Not Performed|0|||
128006332|NCT00843492|460650739|FG000|Overall Study|Deep-vein Thrombosis|1|||
128006333|NCT00843492|460650740|FG001|Overall Study|Deep-vein Thrombosis|0|||
128006334|NCT01677741|460650742|FG000|Overall Study|Death|0|||
128006335|NCT01677741|460650743|FG001|Overall Study|Death|0|||
128006336|NCT01677741|460650744|FG002|Overall Study|Death|0|||
128006337|NCT01677741|460650745|FG003|Overall Study|Death|1|||
128006338|NCT01677741|460650746|FG004|Overall Study|Death|0|||
128006339|NCT01677741|460650747|FG005|Overall Study|Death|1|||
128006340|NCT01677741|460650748|FG006|Overall Study|Death|0|||
128006341|NCT01677741|460650749|FG007|Overall Study|Death|0|||
128006342|NCT01677741|460650742|FG000|Overall Study|Withdrawal by Subject|2|||
128006343|NCT01677741|460650743|FG001|Overall Study|Withdrawal by Subject|7|||
128006344|NCT01677741|460650744|FG002|Overall Study|Withdrawal by Subject|5|||
128006345|NCT01677741|460650745|FG003|Overall Study|Withdrawal by Subject|4|||
128006346|NCT01677741|460650746|FG004|Overall Study|Withdrawal by Subject|11|||
128006347|NCT01677741|460650747|FG005|Overall Study|Withdrawal by Subject|20|||
128006348|NCT01677741|460650748|FG006|Overall Study|Withdrawal by Subject|4|||
128006349|NCT01677741|460650749|FG007|Overall Study|Withdrawal by Subject|2|||
128006350|NCT01677741|460650742|FG000|Overall Study|Enrolled in a rollover study|0|||
128006351|NCT01677741|460650743|FG001|Overall Study|Enrolled in a rollover study|3|||
128006352|NCT01677741|460650744|FG002|Overall Study|Enrolled in a rollover study|2|||
128006353|NCT01677741|460650745|FG003|Overall Study|Enrolled in a rollover study|1|||
128006354|NCT01677741|460650746|FG004|Overall Study|Enrolled in a rollover study|6|||
128006355|NCT01677741|460650747|FG005|Overall Study|Enrolled in a rollover study|6|||
128006356|NCT01677741|460650748|FG006|Overall Study|Enrolled in a rollover study|7|||
128006357|NCT01677741|460650749|FG007|Overall Study|Enrolled in a rollover study|0|||
128006358|NCT01677741|460650742|FG000|Overall Study|Progressive disease|1|||
128006359|NCT01677741|460650743|FG001|Overall Study|Progressive disease|0|||
128006360|NCT01677741|460650744|FG002|Overall Study|Progressive disease|1|||
128006361|NCT01677741|460650745|FG003|Overall Study|Progressive disease|0|||
128006362|NCT01677741|460650746|FG004|Overall Study|Progressive disease|0|||
128006363|NCT01677741|460650747|FG005|Overall Study|Progressive disease|1|||
128006364|NCT01677741|460650748|FG006|Overall Study|Progressive disease|0|||
128006365|NCT01677741|460650749|FG007|Overall Study|Progressive disease|0|||
128006366|NCT00720499|460650750|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
128006367|NCT00720499|460650751|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
128006368|NCT00720499|460650750|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
128006369|NCT00720499|460650751|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
128006370|NCT00720499|460650750|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
128006371|NCT00720499|460650751|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
128006372|NCT03641508|460650762|FG000|First Injection|Lost to Follow-up|2|||
128006373|NCT03641508|460650763|FG001|First Injection|Lost to Follow-up|0|||
128006374|NCT03642990|460650764|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
128006375|NCT03642990|460650764|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
128006376|NCT00855218|460650765|FG000|Overall Study|Adverse Event|43|||
128006377|NCT00855218|460650766|FG001|Overall Study|Adverse Event|27|||
128006378|NCT00855218|460650765|FG000|Overall Study|Withdrawal by Subject|10|||
128006379|NCT00855218|460650766|FG001|Overall Study|Withdrawal by Subject|6|||
128006380|NCT00855218|460650765|FG000|Overall Study|Physician Decision|18|||
128006381|NCT00855218|460650766|FG001|Overall Study|Physician Decision|11|||
128006382|NCT00855218|460650765|FG000|Overall Study|Lost to Follow-up|0|||
128006383|NCT00855218|460650766|FG001|Overall Study|Lost to Follow-up|1|||
128006384|NCT00855218|460650765|FG000|Overall Study|Protocol Violation|5|||
128006385|NCT00855218|460650766|FG001|Overall Study|Protocol Violation|9|||
128006386|NCT00855218|460650765|FG000|Overall Study|non-compliant with study drug|3|||
128006387|NCT00855218|460650766|FG001|Overall Study|non-compliant with study drug|1|||
128006388|NCT00855218|460650765|FG000|Overall Study|patient convenience|2|||
128006389|NCT00855218|460650766|FG001|Overall Study|patient convenience|0|||
128006390|NCT00855218|460650765|FG000|Overall Study|technical problems|2|||
128006391|NCT00855218|460650766|FG001|Overall Study|technical problems|1|||
128006392|NCT00855218|460650765|FG000|Overall Study|Still treated with study medication|0|||
128006393|NCT00855218|460650766|FG001|Overall Study|Still treated with study medication|1|||
128006394|NCT00855218|460650765|FG000|Overall Study|Untreatable disease progression|54|||
128006395|NCT00855218|460650766|FG001|Overall Study|Untreatable disease progression|67|||
128006396|NCT00855218|460650765|FG000|Overall Study|Second malignancy|0|||
128006397|NCT00855218|460650766|FG001|Overall Study|Second malignancy|1|||
128006398|NCT00855218|460650765|FG000|Overall Study|Progression measurement proven|7|||
128006399|NCT00855218|460650766|FG001|Overall Study|Progression measurement proven|15|||
128006400|NCT00855218|460650765|FG000|Overall Study|Clinical endpoint reached|10|||
128006401|NCT00855218|460650766|FG001|Overall Study|Clinical endpoint reached|13|||
128006402|NCT00764790|460650767|FG000|Overall Study|Protocol Violation|0|||
128006403|NCT00764790|460650768|FG001|Overall Study|Protocol Violation|0|||
128006404|NCT00764790|460650769|FG002|Overall Study|Protocol Violation|1|||
128006405|NCT00764790|460650767|FG000|Overall Study|Withdrawal by Subject|10|||
128006406|NCT00764790|460650768|FG001|Overall Study|Withdrawal by Subject|12|||
128006407|NCT00764790|460650769|FG002|Overall Study|Withdrawal by Subject|6|||
128006408|NCT00764790|460650767|FG000|Overall Study|Lost to Follow-up|28|||
128006409|NCT00764790|460650768|FG001|Overall Study|Lost to Follow-up|29|||
128006410|NCT00764790|460650769|FG002|Overall Study|Lost to Follow-up|23|||
128006411|NCT03191552|460650770|FG000|Overall Study|Lost to Follow-up|1|||
128006412|NCT03191552|460650771|FG001|Overall Study|Lost to Follow-up|0|||
128006413|NCT03191552|460650772|FG002|Overall Study|Lost to Follow-up|0|||
128006414|NCT03191552|460650770|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
128006415|NCT03191552|460650771|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
128006416|NCT03191552|460650772|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
128006417|NCT01441973|460650773|FG000|Overall Study|Disease progression|8|||
128006418|NCT01441973|460650774|FG001|Overall Study|Disease progression|6|||
127672516|NCT01076335|459424530|FG000|Overall Study|Withdrawal by Subject|3|||
127672517|NCT01076335|459424530|FG000|Overall Study|Withdrawal without treatment|1|||
128006419|NCT01441973|460650773|FG000|Overall Study|Adverse event unrelated to study drug|3|||
127672518|NCT00654238|459424533|FG000|Overall Study|Screen Failures|4|||
128006420|NCT01441973|460650774|FG001|Overall Study|Adverse event unrelated to study drug|2|||
128006421|NCT01441973|460650773|FG000|Overall Study|Participant request to discontinue|1|||
128006422|NCT01441973|460650774|FG001|Overall Study|Participant request to discontinue|1|||
128006423|NCT01441973|460650773|FG000|Overall Study|Poor compliance/noncompliance|0|||
128006424|NCT01441973|460650774|FG001|Overall Study|Poor compliance/noncompliance|1|||
128006425|NCT01441973|460650773|FG000|Overall Study|Administrative reason by sponsor|3|||
128006426|NCT01441973|460650774|FG001|Overall Study|Administrative reason by sponsor|5|||
128006427|NCT01441973|460650773|FG000|Overall Study|Participant withdrew consent|0|||
128006428|NCT01441973|460650774|FG001|Overall Study|Participant withdrew consent|1|||
127672519|NCT01740557|459424534|FG000|Overall Study|Ineligible|1|||
128006429|NCT01149655|460650775|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
128006430|NCT01149655|460650776|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
128006431|NCT01149655|460650777|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
128006432|NCT01149655|460650778|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
128006433|NCT01149655|460650775|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
128006434|NCT01149655|460650776|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
128006435|NCT01149655|460650777|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
128006436|NCT01149655|460650778|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
128006437|NCT01149655|460650775|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
128006438|NCT01149655|460650776|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
128006439|NCT01149655|460650777|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
128006440|NCT01149655|460650778|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
128006441|NCT01149655|460650775|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
128006442|NCT01149655|460650776|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
128006443|NCT01149655|460650777|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
128006444|NCT01149655|460650778|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
128006445|NCT01149655|460650775|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
128006446|NCT01149655|460650776|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
128006447|NCT01149655|460650777|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
128006448|NCT01149655|460650778|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
128006449|NCT01149655|460650775|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
128006450|NCT01149655|460650776|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
128006451|NCT01149655|460650777|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
128006452|NCT01149655|460650778|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
128006453|NCT01149655|460650775|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
128006454|NCT01149655|460650776|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
128006455|NCT01149655|460650777|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
128006456|NCT01149655|460650778|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
128006457|NCT01149655|460650775|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
128006458|NCT01149655|460650776|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
128006459|NCT01149655|460650777|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
128006460|NCT01149655|460650778|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
128006461|NCT01149655|460650775|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
128006462|NCT01149655|460650776|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
128006463|NCT01149655|460650777|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
128006464|NCT01149655|460650778|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
128006465|NCT01149655|460650775|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
128006466|NCT01149655|460650776|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
128006467|NCT01149655|460650777|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
128006468|NCT01149655|460650778|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
128006469|NCT01149655|460650775|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
128006470|NCT01149655|460650776|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
128006471|NCT01149655|460650777|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
128006472|NCT01149655|460650778|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
127672520|NCT01740557|459424534|FG000|Overall Study|Screen failure|1|||
127672521|NCT01268566|459424539|FG000|Overall Study|Lost to Follow-up|1|||
127672522|NCT01268566|459424539|FG000|Overall Study|Withdrawal by Subject|12|||
127672523|NCT01268566|459424539|FG000|Overall Study|Death|30|||
127672524|NCT02138916|459424545|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
127672525|NCT02138916|459424546|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
127672526|NCT02138916|459424547|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
127672527|NCT02138916|459424545|FG000|Overall Study|Death|14|||
127672528|NCT02138916|459424546|FG001|Overall Study|Death|11|||
127672529|NCT02138916|459424547|FG002|Overall Study|Death|12|||
127672530|NCT02138916|459424545|FG000|Overall Study|Withdrawal by Subject|27|||
127672531|NCT02138916|459424546|FG001|Overall Study|Withdrawal by Subject|31|||
127672532|NCT02138916|459424547|FG002|Overall Study|Withdrawal by Subject|32|||
127672533|NCT02138916|459424545|FG000|Overall Study|Study specific withdrawal criteria|0|||
127672534|NCT02138916|459424546|FG001|Overall Study|Study specific withdrawal criteria|0|||
127672535|NCT02138916|459424547|FG002|Overall Study|Study specific withdrawal criteria|1|||
127672536|NCT02138916|459424545|FG000|Overall Study|incorrect enrolment|1|||
128006473|NCT01149655|460650775|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
128006474|NCT01149655|460650776|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
128006475|NCT01149655|460650777|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
128006476|NCT01149655|460650778|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
128006477|NCT01149655|460650775|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
128006478|NCT01149655|460650776|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
127672537|NCT02138916|459424546|FG001|Overall Study|incorrect enrolment|1|||
127672538|NCT02138916|459424547|FG002|Overall Study|incorrect enrolment|0|||
128006479|NCT01149655|460650777|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
128006480|NCT01149655|460650778|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
128006481|NCT01149655|460650775|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
128006482|NCT01149655|460650776|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
128006483|NCT01149655|460650777|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
128006484|NCT01149655|460650778|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
128006485|NCT01149655|460650775|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
128006486|NCT01149655|460650776|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
128006487|NCT01149655|460650777|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
128006488|NCT01149655|460650778|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
128006489|NCT01149655|460650775|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
128006490|NCT01149655|460650776|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
128006491|NCT01149655|460650777|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
128006492|NCT01149655|460650778|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
128006493|NCT05079321|460650779|FG000|Overall Study|Withdrawal by Subject|2|||
128006494|NCT05079321|460650780|FG001|Overall Study|Withdrawal by Subject|2|||
128006495|NCT05079321|460650779|FG000|Overall Study|Lost to Follow-up|0|||
128006496|NCT05079321|460650780|FG001|Overall Study|Lost to Follow-up|1|||
128006497|NCT02003144|460650781|FG000|Open Label Maintenance Phase|Other than specified|2|||
128006498|NCT02003144|460650782|FG001|Open Label Maintenance Phase|Other than specified|4|||
128006499|NCT02003144|460650781|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
128006500|NCT02003144|460650782|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
128006501|NCT02003144|460650781|FG000|Open Label Maintenance Phase|Pregnancy|0|||
128006502|NCT02003144|460650782|FG001|Open Label Maintenance Phase|Pregnancy|2|||
128006503|NCT02003144|460650781|FG000|Open Label Maintenance Phase|Physician Decision|1|||
128006504|NCT02003144|460650782|FG001|Open Label Maintenance Phase|Physician Decision|1|||
128006505|NCT02003144|460650781|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
128006506|NCT02003144|460650782|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
128006507|NCT02003144|460650781|FG000|Open Label Maintenance Phase|Adverse Event|2|||
128006508|NCT02003144|460650782|FG001|Open Label Maintenance Phase|Adverse Event|1|||
128006509|NCT01324947|460650783|FG000|Overall Study|Adverse Event|7|||
128006510|NCT01324947|460650783|FG000|Overall Study|Death|10|||
128006511|NCT01324947|460650783|FG000|Overall Study|Other|3|||
128006512|NCT01324947|460650783|FG000|Overall Study|Progressive Disease|50|||
128006513|NCT01324947|460650783|FG000|Overall Study|Withdrawal by Subject|3|||
128006514|NCT01324947|460650783|FG000|Overall Study|1 discontinued before starting drug|1|||
128006515|NCT01274351|460650784|FG000|Overall Study|Lost to Follow-up|1|||
128006516|NCT01274351|460650784|FG000|Overall Study|patient not compliant with the protocol|1|||
128006517|NCT01274351|460650784|FG000|Overall Study|Pregnancy|1|||
128006518|NCT01274351|460650784|FG000|Overall Study|Death|2|||
128006519|NCT01274351|460650784|FG000|Overall Study|Withdrawal by Subject|3|||
128006520|NCT01274351|460650784|FG000|Overall Study|Adverse Event|8|||
128006521|NCT01274351|460650784|FG000|Overall Study|progression of disease|3|||
128006522|NCT01274351|460650784|FG000|Overall Study|hospitalization|1|||
128006523|NCT01296412|460650788|FG000|Overall Study|Adverse Event|8|||
128006524|NCT01296412|460650789|FG001|Overall Study|Adverse Event|29|||
128006525|NCT01296412|460650788|FG000|Overall Study|Lack of Efficacy|1|||
128006526|NCT01296412|460650789|FG001|Overall Study|Lack of Efficacy|0|||
128006527|NCT01296412|460650788|FG000|Overall Study|Lost to Follow-up|10|||
128006528|NCT01296412|460650789|FG001|Overall Study|Lost to Follow-up|7|||
128006529|NCT01296412|460650788|FG000|Overall Study|Non-compliance with study drug|1|||
128006530|NCT01296412|460650789|FG001|Overall Study|Non-compliance with study drug|2|||
128006531|NCT01296412|460650788|FG000|Overall Study|Other reason not specified|20|||
128006532|NCT01296412|460650789|FG001|Overall Study|Other reason not specified|15|||
128006533|NCT01296412|460650788|FG000|Overall Study|Physician Decision|1|||
128006534|NCT01296412|460650789|FG001|Overall Study|Physician Decision|3|||
128006535|NCT01296412|460650788|FG000|Overall Study|Pregnancy|0|||
128006536|NCT01296412|460650789|FG001|Overall Study|Pregnancy|1|||
128006537|NCT01296412|460650788|FG000|Overall Study|Withdrawal by Subject|10|||
128006538|NCT01296412|460650789|FG001|Overall Study|Withdrawal by Subject|13|||
128006539|NCT02160626|460650790|FG000|Overall Study|Adverse Event|1|||
128006540|NCT02160626|460650791|FG001|Overall Study|Adverse Event|0|||
128006541|NCT02160626|460650792|FG002|Overall Study|Adverse Event|0|||
128006542|NCT02160626|460650790|FG000|Overall Study|Schedule not conducive to study visits|0|||
128006543|NCT02160626|460650791|FG001|Overall Study|Schedule not conducive to study visits|0|||
128006544|NCT02160626|460650792|FG002|Overall Study|Schedule not conducive to study visits|1|||
128006545|NCT02160626|460650790|FG000|Overall Study|Withdrawal by Subject|0|||
128006546|NCT02160626|460650791|FG001|Overall Study|Withdrawal by Subject|1|||
128006547|NCT02160626|460650792|FG002|Overall Study|Withdrawal by Subject|0|||
128006548|NCT04239924|460650793|FG000|Overall Study|Lost to Follow-up|2|||
128006549|NCT00753519|460653057|FG000|Overall Study|Withdrawal by Subject|0|||
128006550|NCT00753519|460653058|FG001|Overall Study|Withdrawal by Subject|2|||
128006551|NCT00434252|460653059|FG000|Overall Study|Lack of Efficacy|50|||
128006552|NCT00434252|460653060|FG001|Overall Study|Lack of Efficacy|100|||
128006553|NCT00434252|460653059|FG000|Overall Study|Adverse Event|6|||
128006554|NCT00434252|460653060|FG001|Overall Study|Adverse Event|13|||
128006555|NCT00434252|460653059|FG000|Overall Study|Death|1|||
128006556|NCT00434252|460653060|FG001|Overall Study|Death|2|||
128006557|NCT00434252|460653059|FG000|Overall Study|Lost to Follow-up|0|||
128006558|NCT00434252|460653060|FG001|Overall Study|Lost to Follow-up|1|||
128006559|NCT00434252|460653059|FG000|Overall Study|Physician Decision|4|||
128006560|NCT00434252|460653060|FG001|Overall Study|Physician Decision|8|||
128006561|NCT00434252|460653059|FG000|Overall Study|Withdrawal by Subject|3|||
128006562|NCT00434252|460653060|FG001|Overall Study|Withdrawal by Subject|7|||
128006563|NCT02807259|460653061|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
128006564|NCT02807259|460653062|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
128006565|NCT02807259|460653061|FG000|Midline (3 Months)|migration, refusal, not available|30|||
128006566|NCT02807259|460653062|FG001|Midline (3 Months)|migration, refusal, not available|34|||
128006567|NCT02807259|460653061|FG000|Endline (3 Months)|migration, refusal, not available|35|||
128006568|NCT02807259|460653062|FG001|Endline (3 Months)|migration, refusal, not available|87|||
128006569|NCT03861039|460653063|FG000|Overall Study|Adverse Event|2|||
128006570|NCT03861039|460653064|FG001|Overall Study|Adverse Event|5|||
128006571|NCT03861039|460653065|FG002|Overall Study|Adverse Event|11|||
128006572|NCT03861039|460653063|FG000|Overall Study|Withdrawal by Subject|1|||
128006573|NCT03861039|460653064|FG001|Overall Study|Withdrawal by Subject|3|||
128006574|NCT03861039|460653065|FG002|Overall Study|Withdrawal by Subject|4|||
128006575|NCT01855958|460653086|FG000|Overall Study|Withdrawal by Subject|1|||
128006576|NCT01855958|460653087|FG001|Overall Study|Withdrawal by Subject|0|||
128006577|NCT00296244|460653088|FG000|Overall Study|Underwent retransplant|0|||
128006578|NCT00296244|460653089|FG001|Overall Study|Underwent retransplant|1|||
128006579|NCT00427934|460653090|FG000|Overall Study|Adverse Event|1|||
128006580|NCT00427934|460653091|FG001|Overall Study|Adverse Event|0|||
128006581|NCT00427934|460653092|FG002|Overall Study|Adverse Event|5|||
128006582|NCT00427934|460653093|FG003|Overall Study|Adverse Event|4|||
128006583|NCT00427934|460653090|FG000|Overall Study|Lack of Efficacy|0|||
128006584|NCT00427934|460653091|FG001|Overall Study|Lack of Efficacy|0|||
128006585|NCT00427934|460653092|FG002|Overall Study|Lack of Efficacy|5|||
128006586|NCT00427934|460653093|FG003|Overall Study|Lack of Efficacy|2|||
128006587|NCT00427934|460653090|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
127672539|NCT02138916|459424545|FG000|Overall Study|Severe non-compliance|1|||
127672540|NCT02138916|459424546|FG001|Overall Study|Severe non-compliance|2|||
127672541|NCT02138916|459424547|FG002|Overall Study|Severe non-compliance|1|||
127672542|NCT02138916|459424545|FG000|Overall Study|Lost to Follow-up|4|||
127672543|NCT02138916|459424546|FG001|Overall Study|Lost to Follow-up|2|||
127672544|NCT02138916|459424547|FG002|Overall Study|Lost to Follow-up|3|||
127672545|NCT02138916|459424545|FG000|Overall Study|Adverse Event|4|||
127672546|NCT02138916|459424546|FG001|Overall Study|Adverse Event|4|||
128006588|NCT00427934|460653091|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
128006589|NCT00427934|460653092|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
128006590|NCT00427934|460653093|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
128006591|NCT00427934|460653090|FG000|Overall Study|Other|0|||
128006592|NCT00427934|460653091|FG001|Overall Study|Other|0|||
128006593|NCT00427934|460653092|FG002|Overall Study|Other|11|||
128006594|NCT00427934|460653093|FG003|Overall Study|Other|5|||
128006595|NCT00427934|460653090|FG000|Overall Study|Withdrawal by Subject|0|||
128006596|NCT00427934|460653091|FG001|Overall Study|Withdrawal by Subject|0|||
128006597|NCT00427934|460653092|FG002|Overall Study|Withdrawal by Subject|1|||
128006598|NCT00427934|460653093|FG003|Overall Study|Withdrawal by Subject|3|||
128006599|NCT00499122|460653094|FG000|Overall Study|Withdrawal by Subject|2|||
128006600|NCT01373164|460653095|FG000|Overall Study|Lost to Follow-up|0|||
128006601|NCT01373164|460653096|FG001|Overall Study|Lost to Follow-up|0|||
128006602|NCT01373164|460653097|FG002|Overall Study|Lost to Follow-up|1|||
128006603|NCT01373164|460653098|FG003|Overall Study|Lost to Follow-up|2|||
128006604|NCT01373164|460653099|FG004|Overall Study|Lost to Follow-up|0|||
128006605|NCT01373164|460653095|FG000|Overall Study|Withdrawal by Subject|0|||
128006606|NCT01373164|460653096|FG001|Overall Study|Withdrawal by Subject|1|||
128006607|NCT01373164|460653097|FG002|Overall Study|Withdrawal by Subject|0|||
128006608|NCT01373164|460653098|FG003|Overall Study|Withdrawal by Subject|10|||
128006609|NCT01373164|460653099|FG004|Overall Study|Withdrawal by Subject|2|||
127672547|NCT02138916|459424547|FG002|Overall Study|Adverse Event|3|||
127672548|NCT01348087|459424548|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
128006610|NCT01006629|460653119|FG000|Overall Study|Adverse Event|1|||
128006611|NCT01006629|460653119|FG000|Overall Study|Parent refused to continue participation|1|||
128006612|NCT01006629|460653119|FG000|Overall Study|Parent unable to perform site visit|4|||
128006613|NCT00095979|460653120|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
128006614|NCT02251275|460653121|FG000|Overall Study|Adverse Event|23|||
128006615|NCT02251275|460653122|FG001|Overall Study|Adverse Event|60|||
128006616|NCT02251275|460653123|FG002|Overall Study|Adverse Event|28|||
127672549|NCT01348087|459424548|FG000|Overall Study|Administrative problems|79|||
128006617|NCT02251275|460653124|FG003|Overall Study|Adverse Event|0|||
128006618|NCT02251275|460653125|FG004|Overall Study|Adverse Event|0|||
128006619|NCT02251275|460653121|FG000|Overall Study|Lost to Follow-up|5|||
128006620|NCT02251275|460653122|FG001|Overall Study|Lost to Follow-up|6|||
128006621|NCT02251275|460653123|FG002|Overall Study|Lost to Follow-up|4|||
128006622|NCT02251275|460653124|FG003|Overall Study|Lost to Follow-up|0|||
128006623|NCT02251275|460653125|FG004|Overall Study|Lost to Follow-up|0|||
128006624|NCT02251275|460653121|FG000|Overall Study|Physician Decision|19|||
128006625|NCT02251275|460653122|FG001|Overall Study|Physician Decision|30|||
128006626|NCT02251275|460653123|FG002|Overall Study|Physician Decision|26|||
128006627|NCT02251275|460653124|FG003|Overall Study|Physician Decision|0|||
128006628|NCT02251275|460653125|FG004|Overall Study|Physician Decision|1|||
128006629|NCT02251275|460653121|FG000|Overall Study|Protocol Deviation|0|||
128006630|NCT02251275|460653122|FG001|Overall Study|Protocol Deviation|0|||
128006631|NCT02251275|460653123|FG002|Overall Study|Protocol Deviation|1|||
128006632|NCT02251275|460653124|FG003|Overall Study|Protocol Deviation|0|||
128006633|NCT02251275|460653125|FG004|Overall Study|Protocol Deviation|0|||
128006634|NCT02251275|460653121|FG000|Overall Study|Withdrawal by Subject|25|||
128006635|NCT02251275|460653122|FG001|Overall Study|Withdrawal by Subject|51|||
128006636|NCT02251275|460653123|FG002|Overall Study|Withdrawal by Subject|35|||
128006637|NCT02251275|460653124|FG003|Overall Study|Withdrawal by Subject|1|||
128006638|NCT02251275|460653125|FG004|Overall Study|Withdrawal by Subject|0|||
128006639|NCT00686972|460653126|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
128006640|NCT01462942|460653127|FG000|Overall Study|Adverse Event|7|||
128006641|NCT01462942|460653128|FG001|Overall Study|Adverse Event|12|||
128006642|NCT01462942|460653129|FG002|Overall Study|Adverse Event|10|||
128006643|NCT01462942|460653130|FG003|Overall Study|Adverse Event|11|||
128006644|NCT01462942|460653131|FG004|Overall Study|Adverse Event|11|||
128006645|NCT01462942|460653127|FG000|Overall Study|Other, including COPD exacerbation|3|||
128006646|NCT01462942|460653128|FG001|Overall Study|Other, including COPD exacerbation|5|||
128006647|NCT01462942|460653129|FG002|Overall Study|Other, including COPD exacerbation|2|||
128006648|NCT01462942|460653130|FG003|Overall Study|Other, including COPD exacerbation|8|||
128006649|NCT01462942|460653131|FG004|Overall Study|Other, including COPD exacerbation|5|||
128006650|NCT01462942|460653127|FG000|Overall Study|Withdrawal by Subject|14|||
128006651|NCT01462942|460653128|FG001|Overall Study|Withdrawal by Subject|10|||
128006652|NCT01462942|460653129|FG002|Overall Study|Withdrawal by Subject|14|||
128006653|NCT01462942|460653130|FG003|Overall Study|Withdrawal by Subject|16|||
128006654|NCT01462942|460653131|FG004|Overall Study|Withdrawal by Subject|19|||
128006655|NCT01462942|460653127|FG000|Overall Study|Lack of Efficacy|6|||
128006656|NCT01462942|460653128|FG001|Overall Study|Lack of Efficacy|0|||
128006657|NCT01462942|460653129|FG002|Overall Study|Lack of Efficacy|4|||
128006658|NCT01462942|460653130|FG003|Overall Study|Lack of Efficacy|5|||
128006659|NCT01462942|460653131|FG004|Overall Study|Lack of Efficacy|3|||
128006660|NCT01462942|460653127|FG000|Overall Study|Lost to Follow-up|0|||
128006661|NCT01462942|460653128|FG001|Overall Study|Lost to Follow-up|1|||
128006662|NCT01462942|460653129|FG002|Overall Study|Lost to Follow-up|1|||
128006663|NCT01462942|460653130|FG003|Overall Study|Lost to Follow-up|1|||
128006664|NCT01462942|460653131|FG004|Overall Study|Lost to Follow-up|1|||
128006665|NCT01462942|460653127|FG000|Overall Study|Protocol Violation|4|||
128006666|NCT01462942|460653128|FG001|Overall Study|Protocol Violation|6|||
128006667|NCT01462942|460653129|FG002|Overall Study|Protocol Violation|9|||
128006668|NCT01462942|460653130|FG003|Overall Study|Protocol Violation|9|||
128006669|NCT01462942|460653131|FG004|Overall Study|Protocol Violation|6|||
128006670|NCT01027845|460653132|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
128006671|NCT01027845|460653133|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
128006672|NCT01027845|460653134|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
128006673|NCT01027845|460653135|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
128006674|NCT01027845|460653132|FG000|Primary Vaccination Phase|Adverse Event|1|||
128006675|NCT01027845|460653133|FG001|Primary Vaccination Phase|Adverse Event|0|||
128006676|NCT01027845|460653134|FG002|Primary Vaccination Phase|Adverse Event|0|||
128006677|NCT01027845|460653135|FG003|Primary Vaccination Phase|Adverse Event|0|||
128006678|NCT01027845|460653132|FG000|Primary Vaccination Phase|Protocol Violation|1|||
128006679|NCT01027845|460653133|FG001|Primary Vaccination Phase|Protocol Violation|0|||
128006680|NCT01027845|460653134|FG002|Primary Vaccination Phase|Protocol Violation|0|||
128006681|NCT01027845|460653135|FG003|Primary Vaccination Phase|Protocol Violation|0|||
128006682|NCT01027845|460653132|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
128006683|NCT01027845|460653133|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
128006684|NCT01027845|460653134|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
128006685|NCT01027845|460653135|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
128006686|NCT01027845|460653132|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
128006687|NCT01027845|460653133|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
128006688|NCT01027845|460653134|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
128006689|NCT01027845|460653135|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
128006690|NCT01027845|460653132|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
128006691|NCT01027845|460653133|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
128006692|NCT01027845|460653134|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
128006693|NCT01027845|460653135|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
128006694|NCT03154086|460653138|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
128006695|NCT03154086|460653139|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
127672550|NCT01348087|459424548|FG000|Overall Study|protocol deviation|1|||
127672551|NCT01348087|459424548|FG000|Overall Study|Lost to Follow-up|1|||
128006696|NCT03154086|460653140|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
128006697|NCT03154086|460653141|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
128006698|NCT03154086|460653142|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
128006699|NCT03154086|460653143|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
128006700|NCT03154086|460653144|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
128006701|NCT03154086|460653145|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
128006702|NCT03154086|460653146|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
128006703|NCT03154086|460653147|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
128006704|NCT03154086|460653148|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
128006705|NCT03154086|460653149|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
128006706|NCT03154086|460653150|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
128006707|NCT03154086|460653151|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
128006708|NCT03154086|460653152|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
128006709|NCT03154086|460653138|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
128006710|NCT03154086|460653139|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
128006711|NCT03154086|460653140|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
128006712|NCT03154086|460653141|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
128006713|NCT03154086|460653142|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
128006714|NCT03154086|460653143|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
128006715|NCT03154086|460653144|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
128006716|NCT03154086|460653145|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
128006717|NCT03154086|460653146|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
128006718|NCT03154086|460653147|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
128006719|NCT03154086|460653148|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
128006720|NCT03154086|460653149|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
128006721|NCT03154086|460653150|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
128006722|NCT03154086|460653151|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
128006723|NCT03154086|460653152|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
128006724|NCT03154086|460653138|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
128006725|NCT03154086|460653139|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
128006726|NCT03154086|460653140|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
128006727|NCT03154086|460653141|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
128006728|NCT03154086|460653142|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
128006729|NCT03154086|460653143|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
128006730|NCT03154086|460653144|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
128006731|NCT03154086|460653145|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
128006732|NCT03154086|460653146|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
128006733|NCT03154086|460653147|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
128006734|NCT03154086|460653148|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
128006735|NCT03154086|460653149|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
128006736|NCT03154086|460653150|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
128006737|NCT03154086|460653151|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
128006738|NCT03154086|460653152|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
128006739|NCT03154086|460653138|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
128006740|NCT03154086|460653139|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
128006741|NCT03154086|460653140|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
128006742|NCT03154086|460653141|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
128006743|NCT03154086|460653142|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
128006744|NCT03154086|460653143|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
128006745|NCT03154086|460653144|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
128006746|NCT03154086|460653145|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
128006747|NCT03154086|460653146|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
128006748|NCT03154086|460653147|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
128006749|NCT03154086|460653148|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
128006750|NCT03154086|460653149|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
128006751|NCT03154086|460653150|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
128006752|NCT03154086|460653151|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
127672552|NCT01348087|459424548|FG000|Overall Study|Subject withdrew consent|7|||
128006753|NCT03154086|460653152|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
127672553|NCT01348087|459424548|FG000|Overall Study|Adverse Event|25|||
127672554|NCT04794179|459424549|FG000|Overall Study|This participant didn't meet criteria after screening|1|||
128006754|NCT03154086|460653138|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
127672555|NCT04794179|459424550|FG001|Overall Study|This participant didn't meet criteria after screening|0|||
127672556|NCT04678830|459424558|FG000|Overall Study|Lack of Efficacy|2|||
128006755|NCT03154086|460653139|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
128006756|NCT03154086|460653140|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
127672557|NCT04678830|459424559|FG001|Overall Study|Lack of Efficacy|0|||
127672558|NCT04678830|459424558|FG000|Overall Study|Withdrawal by Subject|0|||
127672559|NCT04678830|459424559|FG001|Overall Study|Withdrawal by Subject|1|||
127672560|NCT01190176|459424560|FG000|Overall Study|Withdrawal by Subject|1|||
127672561|NCT01190176|459424560|FG000|Overall Study|Lost to Follow-up|1|||
127672562|NCT03697460|459424561|FG000|Overall Study|Withdrawal by Subject|3|||
127672563|NCT03499600|459424563|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
127672564|NCT03499600|459424564|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
127672565|NCT00445692|459424565|FG000|Overall Study|Adverse Event|11|||
127672566|NCT00445692|459424565|FG000|Overall Study|Lack of Efficacy|5|||
127672567|NCT03425539|459424567|FG000|Overall Study|Randomized but not treated|0|||
127672568|NCT03425539|459424568|FG001|Overall Study|Randomized but not treated|1|||
127672569|NCT03425539|459424567|FG000|Overall Study|Adverse Event|2|||
127672570|NCT03425539|459424568|FG001|Overall Study|Adverse Event|2|||
127672571|NCT03425539|459424567|FG000|Overall Study|Withdrawal by Subject|3|||
127672572|NCT03425539|459424568|FG001|Overall Study|Withdrawal by Subject|0|||
127672573|NCT03425539|459424567|FG000|Overall Study|Lost to Follow-up|0|||
128006757|NCT03154086|460653141|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
128006758|NCT03154086|460653142|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
128006759|NCT03154086|460653143|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
128006760|NCT03154086|460653144|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
128006761|NCT03154086|460653145|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
128006762|NCT03154086|460653146|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
128006763|NCT03154086|460653147|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
128006764|NCT03154086|460653148|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
128006765|NCT03154086|460653149|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
128006766|NCT03154086|460653150|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
128006767|NCT03154086|460653151|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
128006768|NCT03154086|460653152|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
128006769|NCT03154086|460653138|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
128006770|NCT03154086|460653139|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
128006771|NCT03154086|460653140|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
128006772|NCT03154086|460653141|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
128006773|NCT03154086|460653142|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
128006774|NCT03154086|460653143|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
128006775|NCT03154086|460653144|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
128006776|NCT03154086|460653145|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
128006777|NCT03154086|460653146|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
128006778|NCT03154086|460653147|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
128006779|NCT03154086|460653148|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
128006780|NCT03154086|460653149|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
128006781|NCT03154086|460653150|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
128006782|NCT03154086|460653151|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
128006783|NCT03154086|460653152|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
128006784|NCT03154086|460653138|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
128006785|NCT03154086|460653139|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
128006786|NCT03154086|460653140|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
128006787|NCT03154086|460653141|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
128006788|NCT03154086|460653142|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
128006789|NCT03154086|460653143|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
128006790|NCT03154086|460653144|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
128006791|NCT03154086|460653145|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
128006792|NCT03154086|460653146|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
128006793|NCT03154086|460653147|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
128006794|NCT03154086|460653148|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
128006795|NCT03154086|460653149|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
128006796|NCT03154086|460653150|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
128006797|NCT03154086|460653151|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
127672574|NCT03425539|459424568|FG001|Overall Study|Lost to Follow-up|1|||
127672575|NCT01137292|459424569|FG000|Overall Study|Death|30|||
128006798|NCT03154086|460653152|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
128006799|NCT04465422|460653155|FG000|Overall Study|Lost to Follow-up|0|||
127672576|NCT01137292|459424569|FG000|Overall Study|Adverse Event|3|||
127672577|NCT01137292|459424569|FG000|Overall Study|Lack of Efficacy|13|||
127672578|NCT01137292|459424569|FG000|Overall Study|Lost to Follow-up|1|||
127672579|NCT01137292|459424569|FG000|Overall Study|Other|7|||
127672580|NCT02040844|459424570|FG000|Overall Study|Adverse Event|0|||
127672581|NCT02040844|459424571|FG001|Overall Study|Adverse Event|0|||
127672582|NCT02040844|459424572|FG002|Overall Study|Adverse Event|1|||
127672583|NCT02040844|459424570|FG000|Overall Study|Withdrawal by Subject|16|||
127672584|NCT02040844|459424571|FG001|Overall Study|Withdrawal by Subject|22|||
127672585|NCT02040844|459424572|FG002|Overall Study|Withdrawal by Subject|25|||
127672586|NCT02040844|459424570|FG000|Overall Study|Lost to Follow-up|12|||
127672587|NCT02040844|459424571|FG001|Overall Study|Lost to Follow-up|9|||
127672588|NCT02040844|459424572|FG002|Overall Study|Lost to Follow-up|13|||
127672589|NCT02040844|459424570|FG000|Overall Study|Missing|13|||
127672590|NCT02040844|459424571|FG001|Overall Study|Missing|3|||
127672591|NCT02040844|459424572|FG002|Overall Study|Missing|2|||
127672592|NCT02040844|459424570|FG000|Overall Study|Non-specified|8|||
127672593|NCT02040844|459424571|FG001|Overall Study|Non-specified|2|||
127672594|NCT02040844|459424572|FG002|Overall Study|Non-specified|5|||
127672595|NCT02040844|459424570|FG000|Overall Study|Concomitant medication|1|||
127672596|NCT02040844|459424571|FG001|Overall Study|Concomitant medication|3|||
127672597|NCT02040844|459424572|FG002|Overall Study|Concomitant medication|1|||
127672598|NCT02014558|459424577|FG000|Overall Study|Never Received Study Drug|0|||
127672599|NCT02014558|459424578|FG001|Overall Study|Never Received Study Drug|0|||
127672600|NCT02014558|459424579|FG002|Overall Study|Never Received Study Drug|0|||
127672601|NCT02014558|459424580|FG003|Overall Study|Never Received Study Drug|0|||
127672602|NCT02014558|459424581|FG004|Overall Study|Never Received Study Drug|1|||
127672603|NCT02014558|459424582|FG005|Overall Study|Never Received Study Drug|0|||
127672604|NCT02014558|459424583|FG006|Overall Study|Never Received Study Drug|1|||
127672605|NCT02014558|459424584|FG007|Overall Study|Never Received Study Drug|0|||
127672606|NCT02014558|459424585|FG008|Overall Study|Never Received Study Drug|2|||
127672607|NCT02014558|459424586|FG009|Overall Study|Never Received Study Drug|0|||
128006800|NCT04465422|460653156|FG001|Overall Study|Lost to Follow-up|2|||
128006801|NCT02147626|460653159|FG000|Overall Study|Lost to Follow-up|4|||
128006802|NCT02147626|460653160|FG001|Overall Study|Lost to Follow-up|4|||
128006803|NCT02147626|460653159|FG000|Overall Study|Pregnancy|1|||
128006804|NCT02147626|460653160|FG001|Overall Study|Pregnancy|2|||
128006805|NCT02147626|460653159|FG000|Overall Study|Withdrawal by Subject|0|||
128006806|NCT02147626|460653160|FG001|Overall Study|Withdrawal by Subject|1|||
128006807|NCT00572832|460653161|FG000|Overall Study|Lost to Follow-up|0|||
128006808|NCT00572832|460653162|FG001|Overall Study|Lost to Follow-up|11|||
128006809|NCT00572832|460653161|FG000|Overall Study|Pregnancy|0|||
128006810|NCT00572832|460653162|FG001|Overall Study|Pregnancy|1|||
128006811|NCT01704261|460653163|FG000|Overall Study|Withdrawal by Subject|12|||
128006812|NCT01704261|460653164|FG001|Overall Study|Withdrawal by Subject|15|||
128006813|NCT01704261|460653163|FG000|Overall Study|Lost to Follow-up|1|||
128006814|NCT01704261|460653164|FG001|Overall Study|Lost to Follow-up|0|||
128006815|NCT02722967|460653165|FG000|Overall Study|Adverse Event|1|||
128006816|NCT02722967|460653166|FG001|Overall Study|Adverse Event|0|||
128006817|NCT02722967|460653167|FG002|Overall Study|Adverse Event|0|||
128006818|NCT02722967|460653165|FG000|Overall Study|Lost to Follow-up|0|||
128006819|NCT02722967|460653166|FG001|Overall Study|Lost to Follow-up|1|||
128006820|NCT02722967|460653167|FG002|Overall Study|Lost to Follow-up|0|||
128006821|NCT02722967|460653165|FG000|Overall Study|Non-compliance with patch wearing|2|||
128006822|NCT02722967|460653166|FG001|Overall Study|Non-compliance with patch wearing|1|||
128006823|NCT02722967|460653167|FG002|Overall Study|Non-compliance with patch wearing|1|||
128006824|NCT02722967|460653165|FG000|Overall Study|Withdrawal by Subject|1|||
128006825|NCT02722967|460653166|FG001|Overall Study|Withdrawal by Subject|0|||
128006826|NCT02722967|460653167|FG002|Overall Study|Withdrawal by Subject|1|||
128006827|NCT02722967|460653165|FG000|Overall Study|Physician Decision|1|||
128006828|NCT02722967|460653166|FG001|Overall Study|Physician Decision|0|||
128006829|NCT02722967|460653167|FG002|Overall Study|Physician Decision|0|||
128006830|NCT02722967|460653165|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
128006831|NCT02722967|460653166|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
128006832|NCT02722967|460653167|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
128006833|NCT00467519|460653170|FG000|Overall Study|Protocol Violation|8|||
128006834|NCT00467519|460653171|FG001|Overall Study|Protocol Violation|4|||
128006835|NCT00467519|460653170|FG000|Overall Study|Lost to Follow-up|2|||
127672608|NCT02014558|459424587|FG010|Overall Study|Never Received Study Drug|2|||
127672609|NCT02014558|459424588|FG011|Overall Study|Never Received Study Drug|2|||
127672610|NCT02014558|459424589|FG012|Overall Study|Never Received Study Drug|0|||
127672611|NCT02014558|459424577|FG000|Overall Study|Adverse Event|0|||
127672612|NCT02014558|459424578|FG001|Overall Study|Adverse Event|0|||
127672613|NCT02014558|459424579|FG002|Overall Study|Adverse Event|0|||
127672614|NCT02014558|459424580|FG003|Overall Study|Adverse Event|0|||
128006836|NCT00467519|460653171|FG001|Overall Study|Lost to Follow-up|9|||
128006837|NCT00467519|460653170|FG000|Overall Study|Withdrawal by Subject|4|||
128006838|NCT00467519|460653171|FG001|Overall Study|Withdrawal by Subject|10|||
128006839|NCT00062166|460653174|FG000|Overall Study|Withdrawal by Subject|6|||
128006840|NCT00833755|460653175|FG000|Overall Study|Physician Decision|4|||
127672615|NCT02014558|459424581|FG004|Overall Study|Adverse Event|1|||
127672616|NCT02014558|459424582|FG005|Overall Study|Adverse Event|0|||
127672617|NCT02014558|459424583|FG006|Overall Study|Adverse Event|0|||
127672618|NCT02014558|459424584|FG007|Overall Study|Adverse Event|0|||
127672619|NCT02014558|459424585|FG008|Overall Study|Adverse Event|2|||
127672620|NCT02014558|459424586|FG009|Overall Study|Adverse Event|2|||
127672621|NCT02014558|459424587|FG010|Overall Study|Adverse Event|5|||
127672622|NCT02014558|459424588|FG011|Overall Study|Adverse Event|21|||
127672623|NCT02014558|459424589|FG012|Overall Study|Adverse Event|3|||
127672624|NCT02014558|459424577|FG000|Overall Study|Death|1|||
127672625|NCT02014558|459424578|FG001|Overall Study|Death|0|||
127672626|NCT02014558|459424579|FG002|Overall Study|Death|0|||
127672627|NCT02014558|459424580|FG003|Overall Study|Death|0|||
127672628|NCT02014558|459424581|FG004|Overall Study|Death|0|||
127672629|NCT02014558|459424582|FG005|Overall Study|Death|0|||
127672630|NCT02014558|459424583|FG006|Overall Study|Death|1|||
127672631|NCT02014558|459424584|FG007|Overall Study|Death|1|||
127672632|NCT02014558|459424585|FG008|Overall Study|Death|2|||
127672633|NCT02014558|459424586|FG009|Overall Study|Death|5|||
127672634|NCT02014558|459424587|FG010|Overall Study|Death|5|||
127672635|NCT02014558|459424588|FG011|Overall Study|Death|19|||
127672636|NCT02014558|459424589|FG012|Overall Study|Death|2|||
127672637|NCT02014558|459424577|FG000|Overall Study|Lack of Efficacy|1|||
127672638|NCT02014558|459424578|FG001|Overall Study|Lack of Efficacy|2|||
127672639|NCT02014558|459424579|FG002|Overall Study|Lack of Efficacy|1|||
127672640|NCT02014558|459424580|FG003|Overall Study|Lack of Efficacy|1|||
127672641|NCT02014558|459424581|FG004|Overall Study|Lack of Efficacy|0|||
127672642|NCT02014558|459424582|FG005|Overall Study|Lack of Efficacy|0|||
127672643|NCT02014558|459424583|FG006|Overall Study|Lack of Efficacy|1|||
127672644|NCT02014558|459424584|FG007|Overall Study|Lack of Efficacy|3|||
127672645|NCT02014558|459424585|FG008|Overall Study|Lack of Efficacy|3|||
127672646|NCT02014558|459424586|FG009|Overall Study|Lack of Efficacy|3|||
127672647|NCT02014558|459424587|FG010|Overall Study|Lack of Efficacy|16|||
127672648|NCT02014558|459424588|FG011|Overall Study|Lack of Efficacy|8|||
127672649|NCT02014558|459424589|FG012|Overall Study|Lack of Efficacy|5|||
127672650|NCT02014558|459424577|FG000|Overall Study|Lost to Follow-up|0|||
127672651|NCT02014558|459424578|FG001|Overall Study|Lost to Follow-up|0|||
127672652|NCT02014558|459424579|FG002|Overall Study|Lost to Follow-up|0|||
127672653|NCT02014558|459424580|FG003|Overall Study|Lost to Follow-up|0|||
127672654|NCT02014558|459424581|FG004|Overall Study|Lost to Follow-up|0|||
127672655|NCT02014558|459424582|FG005|Overall Study|Lost to Follow-up|0|||
127672656|NCT02014558|459424583|FG006|Overall Study|Lost to Follow-up|0|||
127672657|NCT02014558|459424584|FG007|Overall Study|Lost to Follow-up|0|||
127672658|NCT02014558|459424585|FG008|Overall Study|Lost to Follow-up|0|||
127672659|NCT02014558|459424586|FG009|Overall Study|Lost to Follow-up|0|||
127672660|NCT02014558|459424587|FG010|Overall Study|Lost to Follow-up|1|||
127672661|NCT02014558|459424588|FG011|Overall Study|Lost to Follow-up|0|||
127672662|NCT02014558|459424589|FG012|Overall Study|Lost to Follow-up|0|||
127672663|NCT02014558|459424577|FG000|Overall Study|Progressive Disease|1|||
128006841|NCT00833755|460653176|FG001|Overall Study|Physician Decision|4|||
128006842|NCT00833755|460653177|FG002|Overall Study|Physician Decision|2|||
128006843|NCT00833755|460653178|FG003|Overall Study|Physician Decision|6|||
128006844|NCT00833755|460653175|FG000|Overall Study|Subject had scheduling issues|0|||
128006845|NCT00833755|460653176|FG001|Overall Study|Subject had scheduling issues|1|||
128006846|NCT00833755|460653177|FG002|Overall Study|Subject had scheduling issues|0|||
128006847|NCT00833755|460653178|FG003|Overall Study|Subject had scheduling issues|0|||
128006848|NCT01776554|460653182|FG000|Overall Study|Adverse Event|1|||
128006849|NCT01776554|460653183|FG001|Overall Study|Adverse Event|0|||
128006850|NCT01776554|460653182|FG000|Overall Study|Withdrawal by Subject|3|||
128006851|NCT01776554|460653183|FG001|Overall Study|Withdrawal by Subject|8|||
128006852|NCT01776554|460653182|FG000|Overall Study|Lost to Follow-up|6|||
128006853|NCT01776554|460653183|FG001|Overall Study|Lost to Follow-up|9|||
128006854|NCT01776554|460653182|FG000|Overall Study|Administrative Reason|2|||
128006855|NCT01776554|460653183|FG001|Overall Study|Administrative Reason|5|||
128006856|NCT01776554|460653182|FG000|Overall Study|Protocol Violation|1|||
128006857|NCT01776554|460653183|FG001|Overall Study|Protocol Violation|0|||
128006858|NCT01776554|460653182|FG000|Overall Study|Unclassified|4|||
128006859|NCT01776554|460653183|FG001|Overall Study|Unclassified|1|||
127672664|NCT02014558|459424578|FG001|Overall Study|Progressive Disease|0|||
128006860|NCT02475369|460653184|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
128006861|NCT02475369|460653185|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
128006862|NCT03608826|460653189|FG000|Overall Study|Death|3|||
128006863|NCT03608826|460653189|FG000|Overall Study|Heart Transplant|3|||
127672665|NCT02014558|459424579|FG002|Overall Study|Progressive Disease|1|||
127672666|NCT02014558|459424580|FG003|Overall Study|Progressive Disease|1|||
127672667|NCT02014558|459424581|FG004|Overall Study|Progressive Disease|1|||
127672668|NCT02014558|459424582|FG005|Overall Study|Progressive Disease|2|||
127672669|NCT02014558|459424583|FG006|Overall Study|Progressive Disease|1|||
127672670|NCT02014558|459424584|FG007|Overall Study|Progressive Disease|6|||
127672671|NCT02014558|459424585|FG008|Overall Study|Progressive Disease|5|||
128006864|NCT03608826|460653189|FG000|Overall Study|Physician Decision|4|||
128006865|NCT03122171|460653190|FG000|Overall Study|Withdrawal by Subject|1|||
128006866|NCT01326871|460653201|FG000|Overall Study|Major surgery|0|||
127672672|NCT02014558|459424586|FG009|Overall Study|Progressive Disease|6|||
127672673|NCT02014558|459424587|FG010|Overall Study|Progressive Disease|22|||
127672674|NCT02014558|459424588|FG011|Overall Study|Progressive Disease|31|||
127672675|NCT02014558|459424589|FG012|Overall Study|Progressive Disease|6|||
127672676|NCT02014558|459424577|FG000|Overall Study|Withdrawal by Subject|0|||
127672677|NCT02014558|459424578|FG001|Overall Study|Withdrawal by Subject|0|||
127672678|NCT02014558|459424579|FG002|Overall Study|Withdrawal by Subject|0|||
127672679|NCT02014558|459424580|FG003|Overall Study|Withdrawal by Subject|0|||
127672680|NCT02014558|459424581|FG004|Overall Study|Withdrawal by Subject|1|||
127672681|NCT02014558|459424582|FG005|Overall Study|Withdrawal by Subject|0|||
127672682|NCT02014558|459424583|FG006|Overall Study|Withdrawal by Subject|0|||
127672683|NCT02014558|459424584|FG007|Overall Study|Withdrawal by Subject|0|||
127672684|NCT02014558|459424585|FG008|Overall Study|Withdrawal by Subject|0|||
127672685|NCT02014558|459424586|FG009|Overall Study|Withdrawal by Subject|2|||
127672686|NCT02014558|459424587|FG010|Overall Study|Withdrawal by Subject|6|||
127672687|NCT02014558|459424588|FG011|Overall Study|Withdrawal by Subject|10|||
127672688|NCT02014558|459424589|FG012|Overall Study|Withdrawal by Subject|0|||
128006867|NCT01326871|460653202|FG001|Overall Study|Major surgery|1|||
128006868|NCT01326871|460653203|FG002|Overall Study|Major surgery|0|||
128006869|NCT01326871|460653201|FG000|Overall Study|SAE and death|0|||
128006870|NCT01326871|460653202|FG001|Overall Study|SAE and death|2|||
128006871|NCT01326871|460653203|FG002|Overall Study|SAE and death|0|||
128006872|NCT01326871|460653201|FG000|Overall Study|Physician decision and decreased performance status|0|||
128006873|NCT01326871|460653202|FG001|Overall Study|Physician decision and decreased performance status|1|||
128006874|NCT01326871|460653203|FG002|Overall Study|Physician decision and decreased performance status|0|||
128006875|NCT01326871|460653201|FG000|Overall Study|Disease progression|0|||
128006876|NCT01326871|460653202|FG001|Overall Study|Disease progression|11|||
128006877|NCT01326871|460653203|FG002|Overall Study|Disease progression|5|||
127672689|NCT02014558|459424577|FG000|Overall Study|Miscellaneous|2|||
127672690|NCT02014558|459424578|FG001|Overall Study|Miscellaneous|1|||
127672691|NCT02014558|459424579|FG002|Overall Study|Miscellaneous|1|||
127672692|NCT02014558|459424580|FG003|Overall Study|Miscellaneous|1|||
127672693|NCT02014558|459424581|FG004|Overall Study|Miscellaneous|0|||
127672694|NCT02014558|459424582|FG005|Overall Study|Miscellaneous|1|||
127672695|NCT02014558|459424583|FG006|Overall Study|Miscellaneous|0|||
127672696|NCT02014558|459424584|FG007|Overall Study|Miscellaneous|1|||
127672697|NCT02014558|459424585|FG008|Overall Study|Miscellaneous|1|||
127672698|NCT02014558|459424586|FG009|Overall Study|Miscellaneous|3|||
127672699|NCT02014558|459424587|FG010|Overall Study|Miscellaneous|12|||
127672700|NCT02014558|459424588|FG011|Overall Study|Miscellaneous|11|||
127672701|NCT02014558|459424589|FG012|Overall Study|Miscellaneous|1|||
127672702|NCT01560949|459424592|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
127672703|NCT01560949|459424592|FG000|Surgery Phase|Physician Decision|3|||
127672704|NCT04580407|459424593|FG000|Overall Study|Judged to be Required to Receive Prophylactic Treatment with Emicizumab|1|||
127672705|NCT00681811|459424598|FG000|Overall Study|Adverse Event|1|||
127672706|NCT00681811|459424599|FG001|Overall Study|Adverse Event|1|||
127672707|NCT00681811|459424598|FG000|Overall Study|Withdrawal by Subject|2|||
127672708|NCT00681811|459424599|FG001|Overall Study|Withdrawal by Subject|2|||
127672709|NCT00681811|459424598|FG000|Overall Study|Non-compliance|0|||
127672710|NCT00681811|459424599|FG001|Overall Study|Non-compliance|1|||
127672711|NCT02068885|459424600|FG000|Overall Study|Withdrew|3|||
127672712|NCT02068885|459424601|FG001|Overall Study|Withdrew|5|||
127672713|NCT02068885|459424602|FG002|Overall Study|Withdrew|8|||
127672714|NCT01562743|459424612|FG000|Overall Study|Adverse Event|29|||
127672715|NCT01562743|459424612|FG000|Overall Study|Lack of Efficacy|3|||
127672716|NCT01562743|459424612|FG000|Overall Study|Withdrawal by Subject|13|||
127672717|NCT01562743|459424612|FG000|Overall Study|Protocol Violation|1|||
127672718|NCT01562743|459424612|FG000|Overall Study|Discontinuation criteria|2|||
127672719|NCT01562743|459424612|FG000|Overall Study|Lost to Follow-up|2|||
127672720|NCT01562743|459424612|FG000|Overall Study|Physician Decision|2|||
127672721|NCT03015740|459424614|FG000|Overall Study|Adverse Event|1|||
127672722|NCT03015740|459424615|FG001|Overall Study|Adverse Event|0|||
127672723|NCT03015740|459424616|FG002|Overall Study|Adverse Event|0|||
127672724|NCT03015740|459424614|FG000|Overall Study|Death|3|||
127672725|NCT03015740|459424615|FG001|Overall Study|Death|5|||
127672726|NCT03015740|459424616|FG002|Overall Study|Death|0|||
127672727|NCT03015740|459424614|FG000|Overall Study|Withdrawal by Subject|2|||
127672728|NCT03015740|459424615|FG001|Overall Study|Withdrawal by Subject|0|||
127672729|NCT03015740|459424616|FG002|Overall Study|Withdrawal by Subject|0|||
127672730|NCT02449044|459424617|FG000|Overall Study|Lost to Follow-up|2|||
127672731|NCT02449044|459424617|FG000|Overall Study|Withdrawal by Subject|13|||
127672732|NCT02449044|459424617|FG000|Overall Study|Adverse Event|30|||
127672733|NCT02449044|459424617|FG000|Overall Study|Met Withdrawal Criteria|7|||
127672734|NCT02449044|459424617|FG000|Overall Study|Physician Decision|9|||
128006878|NCT01326871|460653201|FG000|Overall Study|Did not qualify or consent for repeat treatment|0|||
128006879|NCT01326871|460653202|FG001|Overall Study|Did not qualify or consent for repeat treatment|1|||
128006880|NCT01326871|460653203|FG002|Overall Study|Did not qualify or consent for repeat treatment|0|||
128006881|NCT01326871|460653201|FG000|Overall Study|Subject decision to continue survival follow-up only|0|||
128006882|NCT01326871|460653202|FG001|Overall Study|Subject decision to continue survival follow-up only|4|||
128006883|NCT01326871|460653203|FG002|Overall Study|Subject decision to continue survival follow-up only|1|||
128006884|NCT01326871|460653201|FG000|Overall Study|Withdrawal by Subject|0|||
128006885|NCT01326871|460653202|FG001|Overall Study|Withdrawal by Subject|1|||
128006886|NCT01326871|460653203|FG002|Overall Study|Withdrawal by Subject|0|||
128006887|NCT01326871|460653201|FG000|Overall Study|DLT|0|||
128006888|NCT01326871|460653202|FG001|Overall Study|DLT|2|||
128006889|NCT01326871|460653203|FG002|Overall Study|DLT|0|||
128006890|NCT01326871|460653201|FG000|Overall Study|SAE, disease progression and subject decision|0|||
128006891|NCT01326871|460653202|FG001|Overall Study|SAE, disease progression and subject decision|1|||
128006892|NCT01326871|460653203|FG002|Overall Study|SAE, disease progression and subject decision|0|||
128006893|NCT01326871|460653201|FG000|Overall Study|Death|0|||
128006894|NCT01326871|460653202|FG001|Overall Study|Death|1|||
128006895|NCT01326871|460653203|FG002|Overall Study|Death|0|||
128006896|NCT01326871|460653201|FG000|Overall Study|Other|0|||
128006897|NCT01326871|460653202|FG001|Overall Study|Other|3|||
128006898|NCT01326871|460653203|FG002|Overall Study|Other|0|||
128006899|NCT01326871|460653201|FG000|Overall Study|SAE and disease progression|0|||
128006900|NCT01326871|460653202|FG001|Overall Study|SAE and disease progression|0|||
128006901|NCT01326871|460653203|FG002|Overall Study|SAE and disease progression|1|||
128006902|NCT01326871|460653201|FG000|Overall Study|SAE and physician decision|0|||
128006903|NCT01326871|460653202|FG001|Overall Study|SAE and physician decision|0|||
128006904|NCT01326871|460653203|FG002|Overall Study|SAE and physician decision|1|||
128006905|NCT01326871|460653201|FG000|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
128006906|NCT01326871|460653202|FG001|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
128006907|NCT01326871|460653203|FG002|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|1|||
128006908|NCT01326871|460653201|FG000|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
128006909|NCT01326871|460653202|FG001|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
128006910|NCT01326871|460653203|FG002|Overall Study|Did not qualify or consent for repeat treatment and disease progression|1|||
128006911|NCT01326871|460653201|FG000|Overall Study|Physician decision, AEs and subject compliance|0|||
128006912|NCT01326871|460653202|FG001|Overall Study|Physician decision, AEs and subject compliance|0|||
128006913|NCT01326871|460653203|FG002|Overall Study|Physician decision, AEs and subject compliance|1|||
128006914|NCT01326871|460653201|FG000|Overall Study|Physician Decision|0|||
128006915|NCT01326871|460653202|FG001|Overall Study|Physician Decision|0|||
128006916|NCT01326871|460653203|FG002|Overall Study|Physician Decision|1|||
128006917|NCT01326871|460653201|FG000|Overall Study|SAE|0|||
128006918|NCT01326871|460653202|FG001|Overall Study|SAE|0|||
128006919|NCT01326871|460653203|FG002|Overall Study|SAE|1|||
128006920|NCT01326871|460653201|FG000|Overall Study|Disease progression and death|0|||
128006921|NCT01326871|460653202|FG001|Overall Study|Disease progression and death|0|||
128006922|NCT01326871|460653203|FG002|Overall Study|Disease progression and death|1|||
128006923|NCT01326871|460653201|FG000|Overall Study|Subject decision|0|||
128006924|NCT01326871|460653202|FG001|Overall Study|Subject decision|0|||
128006925|NCT01326871|460653203|FG002|Overall Study|Subject decision|1|||
128006926|NCT01200329|460653204|FG000|Overall Study|Lack of financial coverage|2|||
128006927|NCT01200329|460653204|FG000|Overall Study|Progressive disease|1|||
128006928|NCT03087058|460653208|FG000|Overall Study|Withdrawal by Subject|2|||
128006929|NCT03087058|460653209|FG001|Overall Study|Withdrawal by Subject|0|||
128006930|NCT03087058|460653210|FG002|Overall Study|Withdrawal by Subject|0|||
128006931|NCT02717195|460653211|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
128006932|NCT02717195|460653212|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
127672735|NCT02449044|459424617|FG000|Overall Study|Sponsor Discontinued Trial|3|||
127672736|NCT00587288|459426378|FG000|Overall Study|Adverse Event|0|||
127672737|NCT00587288|459426379|FG001|Overall Study|Adverse Event|1|||
127672738|NCT00587288|459426378|FG000|Overall Study|Lack of Efficacy|2|||
127672739|NCT00587288|459426379|FG001|Overall Study|Lack of Efficacy|8|||
127672740|NCT00587288|459426378|FG000|Overall Study|Protocol Violation|1|||
127672741|NCT00587288|459426379|FG001|Overall Study|Protocol Violation|0|||
127672742|NCT01244984|459426382|FG000|Overall Study|Adverse Event|2|||
127672743|NCT01244984|459426383|FG001|Overall Study|Adverse Event|11|||
127672744|NCT01244984|459426384|FG002|Overall Study|Adverse Event|2|||
127672745|NCT01244984|459426382|FG000|Overall Study|Protocol Violation|1|||
128006933|NCT02717195|460653213|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
128006934|NCT02717195|460653214|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
128006935|NCT02717195|460653215|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
128006936|NCT02717195|460653211|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
127672746|NCT01244984|459426383|FG001|Overall Study|Protocol Violation|0|||
128006937|NCT02717195|460653212|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
128006938|NCT02717195|460653213|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
128006939|NCT02717195|460653214|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
128006940|NCT02717195|460653215|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
128006941|NCT02717195|460653211|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
128006942|NCT02717195|460653212|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
128006943|NCT02717195|460653213|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
128006944|NCT02717195|460653214|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
128006945|NCT02717195|460653215|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
128006946|NCT02717195|460653211|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
128006947|NCT02717195|460653212|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
128006948|NCT02717195|460653213|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
128006949|NCT02717195|460653214|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
128006950|NCT02717195|460653215|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
128006951|NCT02717195|460653211|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
128006952|NCT02717195|460653212|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
128006953|NCT02717195|460653213|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
128006954|NCT02717195|460653214|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
128006955|NCT02717195|460653215|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
128006956|NCT02717195|460653211|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
128006957|NCT02717195|460653212|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
128006958|NCT02717195|460653213|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
128006959|NCT02717195|460653214|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
128006960|NCT02717195|460653215|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
128006961|NCT02717195|460653211|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
128006962|NCT02717195|460653212|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
128006963|NCT02717195|460653213|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
128006964|NCT02717195|460653214|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
128006965|NCT02717195|460653215|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
128006966|NCT02717195|460653211|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
128006967|NCT02717195|460653212|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
128006968|NCT02717195|460653213|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
128006969|NCT02717195|460653214|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
128006970|NCT02717195|460653215|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
128006971|NCT02717195|460653211|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
128006972|NCT02717195|460653212|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
128006973|NCT02717195|460653213|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
128006974|NCT02717195|460653214|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
128006975|NCT02717195|460653215|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
128006976|NCT02717195|460653211|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
128006977|NCT02717195|460653212|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
128006978|NCT02717195|460653213|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
128006979|NCT02717195|460653214|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
128006980|NCT02717195|460653215|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
128006981|NCT02717195|460653211|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
128006982|NCT02717195|460653212|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
128006983|NCT02717195|460653213|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
128006984|NCT02717195|460653214|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
128006985|NCT02717195|460653215|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
128006986|NCT02717195|460653211|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
128006987|NCT02717195|460653212|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
128006988|NCT02717195|460653213|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
128006989|NCT02717195|460653214|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
128006990|NCT02717195|460653215|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
128006991|NCT02717195|460653211|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
127672747|NCT01244984|459426384|FG002|Overall Study|Protocol Violation|0|||
128006992|NCT02717195|460653212|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
128006993|NCT02717195|460653213|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
128006994|NCT02717195|460653214|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
128006995|NCT02717195|460653215|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
127672748|NCT01244984|459426382|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
127672749|NCT01244984|459426383|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
127672750|NCT01244984|459426384|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
127672751|NCT01244984|459426382|FG000|Overall Study|Withdrawal by Subject|1|||
127672752|NCT01244984|459426383|FG001|Overall Study|Withdrawal by Subject|2|||
127672753|NCT01244984|459426384|FG002|Overall Study|Withdrawal by Subject|2|||
127672754|NCT02072226|459426385|FG000|Overall Study|Lost to Follow-up|11|||
127672755|NCT02072226|459426386|FG001|Overall Study|Lost to Follow-up|7|||
127672756|NCT02072226|459426385|FG000|Overall Study|Patient Non-compliance|2|||
127672757|NCT02072226|459426386|FG001|Overall Study|Patient Non-compliance|3|||
127672758|NCT02072226|459426385|FG000|Overall Study|Death|1|||
127672759|NCT02072226|459426386|FG001|Overall Study|Death|0|||
127672760|NCT02072226|459426385|FG000|Overall Study|Patient Withdrawal of Consent|1|||
127672761|NCT02072226|459426386|FG001|Overall Study|Patient Withdrawal of Consent|0|||
127672762|NCT01124162|459426391|FG000|First Intervention|Adverse Event|2|||
128006996|NCT02717195|460653211|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
128006997|NCT02717195|460653212|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
128006998|NCT02717195|460653213|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
128006999|NCT02717195|460653214|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
128007000|NCT02717195|460653215|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
128007001|NCT02717195|460653211|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
128007002|NCT02717195|460653212|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
128007003|NCT02717195|460653213|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
128007004|NCT02717195|460653214|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
128007005|NCT02717195|460653215|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
128007006|NCT02717195|460653211|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
128007007|NCT02717195|460653212|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
128007008|NCT02717195|460653213|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
128007009|NCT02717195|460653214|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
128007010|NCT02717195|460653215|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
128007011|NCT02717195|460653211|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
128007012|NCT02717195|460653212|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
128007013|NCT02717195|460653213|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
128007014|NCT02717195|460653214|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
128007015|NCT02717195|460653215|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
128007016|NCT02717195|460653211|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
128007017|NCT02717195|460653212|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
128007018|NCT02717195|460653213|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
128007019|NCT02717195|460653214|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
128007020|NCT02717195|460653215|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
128007021|NCT02717195|460653211|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
128007022|NCT02717195|460653212|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
128007023|NCT02717195|460653213|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
128007024|NCT02717195|460653214|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
128007025|NCT02717195|460653215|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
128007026|NCT02717195|460653211|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
128007027|NCT02717195|460653212|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
128007028|NCT02717195|460653213|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
128007029|NCT02717195|460653214|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
128007030|NCT02717195|460653215|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
128007031|NCT02717195|460653211|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
128007032|NCT02717195|460653212|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
128007033|NCT02717195|460653213|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
128007034|NCT02717195|460653214|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
128007035|NCT02717195|460653215|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
128007036|NCT02717195|460653211|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
128007037|NCT02717195|460653212|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
128007038|NCT02717195|460653213|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
128007039|NCT02717195|460653214|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
128007040|NCT02717195|460653215|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
128007041|NCT02717195|460653211|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
128007042|NCT02717195|460653212|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
128007043|NCT02717195|460653213|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
127672763|NCT01124162|459426392|FG001|First Intervention|Adverse Event|0|||
128007044|NCT02717195|460653214|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
127672764|NCT01124162|459426391|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
127672765|NCT01124162|459426392|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
127672766|NCT02680756|459426393|FG000|Overall Study|Adverse Event|10|||
128007045|NCT02717195|460653215|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
128007046|NCT02717195|460653211|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
128007047|NCT02717195|460653212|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
128007048|NCT02717195|460653213|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
128007049|NCT02717195|460653214|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
128007050|NCT02717195|460653215|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
128007051|NCT02717195|460653211|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
128007052|NCT02717195|460653212|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
128007053|NCT02717195|460653213|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
128007054|NCT02717195|460653214|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
128007055|NCT02717195|460653215|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
128007056|NCT02717195|460653211|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
128007057|NCT02717195|460653212|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
128007058|NCT02717195|460653213|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
128007059|NCT02717195|460653214|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
128007060|NCT02717195|460653215|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
128007061|NCT02717195|460653211|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
128007062|NCT02717195|460653212|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
128007063|NCT02717195|460653213|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
128007064|NCT02717195|460653214|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
128007065|NCT02717195|460653215|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
128007066|NCT02717195|460653211|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
128007067|NCT02717195|460653212|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
128007068|NCT02717195|460653213|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
128007069|NCT02717195|460653214|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
127672767|NCT02680756|459426394|FG001|Overall Study|Adverse Event|2|||
127672768|NCT02680756|459426393|FG000|Overall Study|Lost to Follow-up|7|||
127672769|NCT02680756|459426394|FG001|Overall Study|Lost to Follow-up|6|||
127672770|NCT02680756|459426393|FG000|Overall Study|Withdrawal by Subject|5|||
127672771|NCT02680756|459426394|FG001|Overall Study|Withdrawal by Subject|5|||
127672772|NCT02680756|459426393|FG000|Overall Study|Physician Decision|4|||
127672773|NCT02680756|459426394|FG001|Overall Study|Physician Decision|1|||
127672774|NCT02680756|459426393|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
127672775|NCT02680756|459426394|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
127672776|NCT02680756|459426393|FG000|Overall Study|Blood transfusion for any reason|0|||
127672777|NCT02680756|459426394|FG001|Overall Study|Blood transfusion for any reason|1|||
127672778|NCT02680756|459426393|FG000|Overall Study|Death|1|||
127672779|NCT02680756|459426394|FG001|Overall Study|Death|0|||
127672780|NCT02680756|459426393|FG000|Overall Study|Protocol Violation|1|||
127672781|NCT02680756|459426394|FG001|Overall Study|Protocol Violation|0|||
127672782|NCT02680756|459426393|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
127672783|NCT02680756|459426394|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
127672784|NCT02680756|459426393|FG000|Overall Study|None of above or not recorded|3|||
127672785|NCT02680756|459426394|FG001|Overall Study|None of above or not recorded|2|||
127672786|NCT01516892|459426396|FG000|Overall Study|Adverse Event|25|||
127672787|NCT01516892|459426396|FG000|Overall Study|Lack of Efficacy|35|||
127672788|NCT01516892|459426396|FG000|Overall Study|Pregnancy|5|||
127672789|NCT01516892|459426396|FG000|Overall Study|Lost to Follow-up|82|||
127672790|NCT01516892|459426396|FG000|Overall Study|Subject Withdrew Consent|92|||
127672791|NCT01516892|459426396|FG000|Overall Study|Protocol Violation|60|||
127672792|NCT01516892|459426396|FG000|Overall Study|Other Miscellaneous Reasons|43|||
127672793|NCT01516892|459426396|FG000|Overall Study|Missing|1|||
127672794|NCT03635112|459426397|FG000|Overall Study|Adverse Event|5|||
127672795|NCT03635112|459426398|FG001|Overall Study|Adverse Event|9|||
127672796|NCT03635112|459426399|FG002|Overall Study|Adverse Event|14|||
127672797|NCT03635112|459426397|FG000|Overall Study|Lost to Follow-up|1|||
127672798|NCT03635112|459426398|FG001|Overall Study|Lost to Follow-up|0|||
127672799|NCT03635112|459426399|FG002|Overall Study|Lost to Follow-up|1|||
127672800|NCT03635112|459426397|FG000|Overall Study|Physician Decision|5|||
127672801|NCT03635112|459426398|FG001|Overall Study|Physician Decision|7|||
127672802|NCT03635112|459426399|FG002|Overall Study|Physician Decision|5|||
127672803|NCT03635112|459426397|FG000|Overall Study|Protocol Violation|0|||
128007070|NCT02717195|460653215|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
128007071|NCT02717195|460653211|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
127672804|NCT03635112|459426398|FG001|Overall Study|Protocol Violation|0|||
127672805|NCT03635112|459426399|FG002|Overall Study|Protocol Violation|1|||
127672806|NCT03635112|459426397|FG000|Overall Study|Study Terminated by Sponsor|11|||
127672807|NCT03635112|459426398|FG001|Overall Study|Study Terminated by Sponsor|17|||
127672808|NCT03635112|459426399|FG002|Overall Study|Study Terminated by Sponsor|21|||
127672809|NCT03635112|459426397|FG000|Overall Study|Withdrawal by Subject|4|||
127672810|NCT03635112|459426398|FG001|Overall Study|Withdrawal by Subject|9|||
127672811|NCT03635112|459426399|FG002|Overall Study|Withdrawal by Subject|7|||
128007072|NCT02717195|460653212|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
128007073|NCT02717195|460653213|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
128007074|NCT02717195|460653214|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
128007075|NCT02717195|460653215|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
128007076|NCT02717195|460653211|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
128007077|NCT02717195|460653212|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
128007078|NCT02717195|460653213|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
128007079|NCT02717195|460653214|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
128007080|NCT02717195|460653215|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
128007081|NCT02717195|460653211|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
128007082|NCT02717195|460653212|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
128007083|NCT02717195|460653213|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
128007084|NCT02717195|460653214|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
128007085|NCT02717195|460653215|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
128007086|NCT02717195|460653211|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
128007087|NCT02717195|460653212|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
128007088|NCT02717195|460653213|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
128007089|NCT02717195|460653214|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
128007090|NCT02717195|460653215|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
128007091|NCT02717195|460653211|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
128007092|NCT02717195|460653212|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
128007093|NCT02717195|460653213|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
128007094|NCT02717195|460653214|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
128007095|NCT02717195|460653215|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
128007096|NCT02717195|460653211|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
128007097|NCT02717195|460653212|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
128007098|NCT02717195|460653213|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
128007099|NCT02717195|460653214|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
128007100|NCT02717195|460653215|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
128007101|NCT02717195|460653211|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
128007102|NCT02717195|460653212|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
128007103|NCT02717195|460653213|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
128007104|NCT02717195|460653214|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
128007105|NCT02717195|460653215|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
128007106|NCT02717195|460653211|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
128007107|NCT02717195|460653212|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
128007108|NCT02717195|460653213|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
128007109|NCT02717195|460653214|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
127672812|NCT03635112|459426397|FG000|Overall Study|Miscellaneous|0|||
127672813|NCT03635112|459426398|FG001|Overall Study|Miscellaneous|0|||
127672814|NCT03635112|459426399|FG002|Overall Study|Miscellaneous|1|||
127672815|NCT02950545|459426403|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
127672816|NCT02950545|459426404|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
127672817|NCT02950545|459426405|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
128007110|NCT02717195|460653215|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
128007111|NCT02577029|460653216|FG000|Overall Study|Adverse Event|1|||
128007112|NCT02577029|460653217|FG001|Overall Study|Adverse Event|0|||
128007113|NCT02577029|460653218|FG002|Overall Study|Adverse Event|2|||
128007114|NCT02577029|460653219|FG003|Overall Study|Adverse Event|0|||
128007115|NCT02577029|460653220|FG004|Overall Study|Adverse Event|1|||
128007116|NCT02577029|460653221|FG005|Overall Study|Adverse Event|0|||
128007117|NCT02577029|460653222|FG006|Overall Study|Adverse Event|0|||
128007118|NCT02577029|460653223|FG007|Overall Study|Adverse Event|0|||
128007119|NCT02577029|460653216|FG000|Overall Study|Withdrawal by Subject|0|||
128007120|NCT02577029|460653217|FG001|Overall Study|Withdrawal by Subject|0|||
128007121|NCT02577029|460653218|FG002|Overall Study|Withdrawal by Subject|0|||
128007122|NCT02577029|460653219|FG003|Overall Study|Withdrawal by Subject|0|||
128007123|NCT02577029|460653220|FG004|Overall Study|Withdrawal by Subject|0|||
127672818|NCT02950545|459426406|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
127672819|NCT02950545|459426407|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
128007124|NCT02577029|460653221|FG005|Overall Study|Withdrawal by Subject|1|||
128007125|NCT02577029|460653222|FG006|Overall Study|Withdrawal by Subject|0|||
128007126|NCT02577029|460653223|FG007|Overall Study|Withdrawal by Subject|0|||
128007127|NCT02577029|460653216|FG000|Overall Study|Sponsor Termination of the Study|9|||
128007128|NCT02577029|460653217|FG001|Overall Study|Sponsor Termination of the Study|2|||
128007129|NCT02577029|460653218|FG002|Overall Study|Sponsor Termination of the Study|5|||
128007130|NCT02577029|460653219|FG003|Overall Study|Sponsor Termination of the Study|12|||
128007131|NCT02577029|460653220|FG004|Overall Study|Sponsor Termination of the Study|10|||
127672820|NCT02950545|459426408|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
127672821|NCT02950545|459426403|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
127672822|NCT02950545|459426404|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
128007132|NCT02577029|460653221|FG005|Overall Study|Sponsor Termination of the Study|12|||
128007133|NCT02577029|460653222|FG006|Overall Study|Sponsor Termination of the Study|12|||
128007134|NCT02577029|460653223|FG007|Overall Study|Sponsor Termination of the Study|12|||
128007135|NCT02078817|460653224|FG000|Overall Study|Withdrawal by Subject|1|||
128007136|NCT01420536|460653225|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
128007137|NCT01420536|460653226|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
128007138|NCT01265498|460653231|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
128007139|NCT01265498|460653232|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
128007140|NCT01652690|460653234|FG000|Overall Study|Withdrawal by Subject|16|||
128007141|NCT01652690|460653235|FG001|Overall Study|Withdrawal by Subject|4|||
128007142|NCT01652690|460653234|FG000|Overall Study|Other|8|||
128007143|NCT01652690|460653235|FG001|Overall Study|Other|9|||
128007144|NCT01652690|460653234|FG000|Overall Study|Lost to Follow-up|6|||
128007145|NCT01652690|460653235|FG001|Overall Study|Lost to Follow-up|6|||
128007146|NCT01652690|460653234|FG000|Overall Study|Death|5|||
128007147|NCT01652690|460653235|FG001|Overall Study|Death|2|||
128007148|NCT00617279|460653236|FG000|Overall Study|Study terminated by Sponsor|10|||
128007149|NCT00617279|460653237|FG001|Overall Study|Study terminated by Sponsor|15|||
128007150|NCT00617279|460653236|FG000|Overall Study|Graft abandonment|2|||
128007151|NCT00617279|460653237|FG001|Overall Study|Graft abandonment|0|||
128007152|NCT00617279|460653236|FG000|Overall Study|Lost to Follow-up|1|||
128007153|NCT00617279|460653237|FG001|Overall Study|Lost to Follow-up|0|||
128007154|NCT00617279|460653236|FG000|Overall Study|Death|1|||
128007155|NCT00617279|460653237|FG001|Overall Study|Death|2|||
128007156|NCT00921024|460653242|FG000|Overall Study|Lost to Follow-up|2|||
128007157|NCT00921024|460653243|FG001|Overall Study|Lost to Follow-up|0|||
128007158|NCT00921024|460653242|FG000|Overall Study|Received concomittant therapy|2|||
128007159|NCT00921024|460653243|FG001|Overall Study|Received concomittant therapy|0|||
128007160|NCT00921024|460653242|FG000|Overall Study|Withdrawal by Subject|0|||
128007161|NCT00921024|460653243|FG001|Overall Study|Withdrawal by Subject|3|||
128007162|NCT03225287|460653244|FG000|Overall Study|Adverse Event|0|||
128007163|NCT03225287|460653245|FG001|Overall Study|Adverse Event|0|||
128007164|NCT03225287|460653246|FG002|Overall Study|Adverse Event|1|||
128007165|NCT03225287|460653244|FG000|Overall Study|Protocol non-compliance|0|||
128007166|NCT03225287|460653245|FG001|Overall Study|Protocol non-compliance|0|||
128007167|NCT03225287|460653246|FG002|Overall Study|Protocol non-compliance|1|||
128007168|NCT03225287|460653244|FG000|Overall Study|Subject withdraws consent|3|||
128007169|NCT03225287|460653245|FG001|Overall Study|Subject withdraws consent|0|||
128007170|NCT03225287|460653246|FG002|Overall Study|Subject withdraws consent|0|||
128007171|NCT03225287|460653244|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
128007172|NCT03225287|460653245|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
128007173|NCT03225287|460653246|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
128007174|NCT03225287|460653244|FG000|Overall Study|Trial drug not effective|0|||
128007175|NCT03225287|460653245|FG001|Overall Study|Trial drug not effective|1|||
128007176|NCT03225287|460653246|FG002|Overall Study|Trial drug not effective|0|||
128007177|NCT03225287|460653244|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
128007178|NCT03225287|460653245|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
128007179|NCT03225287|460653246|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
128007180|NCT03225287|460653244|FG000|Overall Study|Stem cell transplantation|0|||
128007181|NCT03225287|460653245|FG001|Overall Study|Stem cell transplantation|1|||
128007182|NCT03225287|460653246|FG002|Overall Study|Stem cell transplantation|0|||
128007183|NCT03415178|460653248|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
128007184|NCT03415178|460653249|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
128007185|NCT03415178|460653248|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
128007186|NCT03415178|460653249|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
128007187|NCT04030598|460653250|FG000|Overall Study|Voluntary Withdrawal|0|||
128007188|NCT04030598|460653251|FG001|Overall Study|Voluntary Withdrawal|1|||
128007189|NCT04030598|460653252|FG002|Overall Study|Voluntary Withdrawal|0|||
128007190|NCT02791269|460655287|FG000|Overall Study|Lost to Follow-up|0|||
128007191|NCT02791269|460655288|FG001|Overall Study|Lost to Follow-up|1|||
128007192|NCT01799941|460655291|FG000|Overall Study|Adverse Event|34|||
128007193|NCT01799941|460655291|FG000|Overall Study|Withdrawal by Subject|21|||
128007194|NCT01799941|460655291|FG000|Overall Study|Death|2|||
128007195|NCT01799941|460655291|FG000|Overall Study|Investigator Decision|4|||
128007196|NCT01799941|460655291|FG000|Overall Study|Lack of Efficacy|3|||
128007197|NCT01799941|460655291|FG000|Overall Study|Lost to Follow-up|17|||
128007198|NCT01799941|460655291|FG000|Overall Study|Other|15|||
128007199|NCT00420745|460655292|FG000|Overall Study|Adverse Event|2|||
128007200|NCT00420745|460655293|FG001|Overall Study|Adverse Event|2|||
128007201|NCT00420745|460655292|FG000|Overall Study|Lost to Follow-up|10|||
128007202|NCT00420745|460655293|FG001|Overall Study|Lost to Follow-up|2|||
128007203|NCT00420745|460655292|FG000|Overall Study|Protocol Violation|1|||
128007204|NCT00420745|460655293|FG001|Overall Study|Protocol Violation|0|||
128007205|NCT00420745|460655292|FG000|Overall Study|Physician Decision|1|||
128007206|NCT00420745|460655293|FG001|Overall Study|Physician Decision|1|||
128007207|NCT00420745|460655292|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
128007208|NCT00420745|460655293|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
128007209|NCT00420745|460655292|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
128007210|NCT00420745|460655293|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
128007211|NCT01125930|460655294|FG000|Overall Study|Adverse Event|0|||
128007212|NCT01125930|460655295|FG001|Overall Study|Adverse Event|1|||
128007213|NCT01125930|460655294|FG000|Overall Study|Withdrawal by Subject|1|||
128007214|NCT01125930|460655295|FG001|Overall Study|Withdrawal by Subject|6|||
128007215|NCT01125930|460655294|FG000|Overall Study|Protocol Violation|0|||
128007216|NCT01125930|460655295|FG001|Overall Study|Protocol Violation|1|||
128007217|NCT01125930|460655294|FG000|Overall Study|Lost to Follow-up|0|||
128007218|NCT01125930|460655295|FG001|Overall Study|Lost to Follow-up|2|||
128007219|NCT03098979|460655296|FG000|Overall Study|Adverse Event|1|||
128007220|NCT03098979|460655297|FG001|Overall Study|Adverse Event|0|||
128007221|NCT03098979|460655298|FG002|Overall Study|Adverse Event|1|||
128007222|NCT03098979|460655299|FG003|Overall Study|Adverse Event|4|||
128007223|NCT03098979|460655300|FG004|Overall Study|Adverse Event|6|||
128007224|NCT03098979|460655301|FG005|Overall Study|Adverse Event|1|||
128007225|NCT03098979|460655296|FG000|Overall Study|Withdrawal by Subject|2|||
128007226|NCT03098979|460655297|FG001|Overall Study|Withdrawal by Subject|1|||
128007227|NCT03098979|460655298|FG002|Overall Study|Withdrawal by Subject|1|||
128007228|NCT03098979|460655299|FG003|Overall Study|Withdrawal by Subject|1|||
128007229|NCT03098979|460655300|FG004|Overall Study|Withdrawal by Subject|2|||
128007230|NCT03098979|460655301|FG005|Overall Study|Withdrawal by Subject|1|||
128007231|NCT03098979|460655296|FG000|Overall Study|Death|1|||
128007232|NCT03098979|460655297|FG001|Overall Study|Death|0|||
128007233|NCT03098979|460655298|FG002|Overall Study|Death|2|||
128007234|NCT03098979|460655299|FG003|Overall Study|Death|0|||
128007235|NCT03098979|460655300|FG004|Overall Study|Death|1|||
128007236|NCT03098979|460655301|FG005|Overall Study|Death|0|||
128007237|NCT03098979|460655296|FG000|Overall Study|Physician Decision|2|||
128007238|NCT03098979|460655297|FG001|Overall Study|Physician Decision|1|||
128007239|NCT03098979|460655298|FG002|Overall Study|Physician Decision|0|||
128007240|NCT03098979|460655299|FG003|Overall Study|Physician Decision|0|||
128007241|NCT03098979|460655300|FG004|Overall Study|Physician Decision|0|||
128007242|NCT03098979|460655301|FG005|Overall Study|Physician Decision|0|||
128007243|NCT03098979|460655296|FG000|Overall Study|Non-compliance|0|||
128007244|NCT03098979|460655297|FG001|Overall Study|Non-compliance|0|||
128007245|NCT03098979|460655298|FG002|Overall Study|Non-compliance|0|||
128007246|NCT03098979|460655299|FG003|Overall Study|Non-compliance|0|||
128007247|NCT03098979|460655300|FG004|Overall Study|Non-compliance|0|||
128007248|NCT03098979|460655301|FG005|Overall Study|Non-compliance|1|||
128007249|NCT03098979|460655296|FG000|Overall Study|Protocol Violation|0|||
128007250|NCT03098979|460655297|FG001|Overall Study|Protocol Violation|0|||
128007251|NCT03098979|460655298|FG002|Overall Study|Protocol Violation|0|||
128007252|NCT03098979|460655299|FG003|Overall Study|Protocol Violation|0|||
128007253|NCT03098979|460655300|FG004|Overall Study|Protocol Violation|0|||
128007254|NCT03098979|460655301|FG005|Overall Study|Protocol Violation|1|||
128007255|NCT02369653|460655302|FG000|Overall Study|Lost to Follow-up|0|||
128007256|NCT02369653|460655303|FG001|Overall Study|Lost to Follow-up|1|||
128007257|NCT02369653|460655302|FG000|Overall Study|Administrative reason by sponsor|0|||
128007258|NCT02369653|460655303|FG001|Overall Study|Administrative reason by sponsor|1|||
128007259|NCT02369653|460655302|FG000|Overall Study|Death|1|||
128007260|NCT02369653|460655303|FG001|Overall Study|Death|2|||
128007261|NCT02369653|460655302|FG000|Overall Study|Participant withdrew consent|13|||
128007262|NCT02369653|460655303|FG001|Overall Study|Participant withdrew consent|3|||
128007263|NCT03157089|460655304|FG000|Overall Study|Treated only with pembrolizumab|1|||
128007264|NCT03157089|460655305|FG001|Overall Study|Treated only with pembrolizumab|0|||
128007265|NCT03157089|460655304|FG000|Overall Study|Adverse Event|5|||
128007266|NCT03157089|460655305|FG001|Overall Study|Adverse Event|4|||
128007267|NCT03157089|460655304|FG000|Overall Study|Progressive disease|6|||
128007268|NCT03157089|460655305|FG001|Overall Study|Progressive disease|8|||
128007269|NCT02300610|460655308|FG000|Overall Study|Withdrawal by Subject|1|||
128007270|NCT02300610|460655309|FG001|Overall Study|Withdrawal by Subject|0|||
128007271|NCT02300610|460655310|FG002|Overall Study|Withdrawal by Subject|1|||
128007272|NCT01302899|460655317|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
128007273|NCT01302899|460655318|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
128007274|NCT01302899|460655317|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
128007275|NCT01302899|460655318|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
128007276|NCT02834975|460655319|FG000|Overall Study|Physician Decision|2|||
128007277|NCT02834975|460655319|FG000|Overall Study|Adverse Event|1|||
128007278|NCT02834975|460655319|FG000|Overall Study|Withdrawal by Subject|1|||
128007279|NCT02834975|460655319|FG000|Overall Study|Lack of Efficacy|1|||
128007280|NCT03558516|460655325|FG000|Overall Study|Protocol Violation|2|||
128007281|NCT03558516|460655326|FG001|Overall Study|Protocol Violation|2|||
128007282|NCT03363906|460655327|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
128007283|NCT03363906|460655328|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
128007284|NCT03363906|460655327|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
128007285|NCT03363906|460655328|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
128007286|NCT03363906|460655327|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
128007287|NCT03363906|460655328|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
128007288|NCT03363906|460655327|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
128007289|NCT03363906|460655328|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
128007290|NCT00929669|460655330|FG000|Overall Study|elevated glucose levels|1|||
128007291|NCT02714153|460655331|FG000|Overall Study|Death|1|||
128007292|NCT00087178|460655340|FG000|Overall Study|No follow up data|5|||
128007293|NCT00087178|460655341|FG001|Overall Study|No follow up data|15|||
128007294|NCT00087178|460655340|FG000|Overall Study|No clinical assessment|1|||
128007295|NCT00087178|460655341|FG001|Overall Study|No clinical assessment|2|||
128007296|NCT00087178|460655340|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
128007297|NCT00087178|460655341|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
128007298|NCT01692119|460655356|FG000|Overall Study|Protocol Violation|3|||
128007299|NCT01692119|460655357|FG001|Overall Study|Protocol Violation|1|||
128007300|NCT01692119|460655356|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
128007301|NCT01692119|460655357|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
128007302|NCT00997893|460655358|FG000|Overall Study|Adverse Event|1|||
128007303|NCT00997893|460655359|FG001|Overall Study|Adverse Event|0|||
128007304|NCT00997893|460655360|FG002|Overall Study|Adverse Event|0|||
128007305|NCT00997893|460655358|FG000|Overall Study|Unable to meet study timelines|1|||
128007306|NCT00997893|460655359|FG001|Overall Study|Unable to meet study timelines|0|||
128007307|NCT00997893|460655360|FG002|Overall Study|Unable to meet study timelines|0|||
128007308|NCT00997893|460655358|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
128007309|NCT00997893|460655359|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
128007310|NCT00997893|460655360|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
128007311|NCT00112957|460655361|FG000|Overall Study|Progressive disease|18|||
128007312|NCT00112957|460655361|FG000|Overall Study|Physician Decision|1|||
128007313|NCT03444584|460655369|FG000|Overall Study|Withdrawal by Subject|0|||
128007314|NCT03444584|460655370|FG001|Overall Study|Withdrawal by Subject|1|||
128007315|NCT03444584|460655369|FG000|Overall Study|Other|0|||
128007316|NCT03444584|460655370|FG001|Overall Study|Other|1|||
128007317|NCT01142336|460655371|FG000|Overall Study|Adverse Event|1|||
128007318|NCT01142336|460655372|FG001|Overall Study|Adverse Event|1|||
128007319|NCT01142336|460655371|FG000|Overall Study|Lost to Follow-up|0|||
128007320|NCT01142336|460655372|FG001|Overall Study|Lost to Follow-up|1|||
128007321|NCT03704064|460655373|FG000|Overall Study|Lost to Follow-up|8|||
128007322|NCT03704064|460655374|FG001|Overall Study|Lost to Follow-up|4|||
128007323|NCT03704064|460655373|FG000|Overall Study|Withdrawal by Subject|1|||
128007324|NCT03704064|460655374|FG001|Overall Study|Withdrawal by Subject|1|||
128007325|NCT03704064|460655373|FG000|Overall Study|No longer available for study visits|0|||
128007326|NCT03704064|460655374|FG001|Overall Study|No longer available for study visits|1|||
128007327|NCT03704064|460655373|FG000|Overall Study|Censoring event|1|||
128007328|NCT03704064|460655374|FG001|Overall Study|Censoring event|0|||
128007329|NCT00289276|460655377|FG000|Second Part of FAST Study (Expansion)|Death|0|||
128007330|NCT00289276|460655378|FG001|Second Part of FAST Study (Expansion)|Death|2|||
128007331|NCT00289276|460655377|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
128007332|NCT00289276|460655378|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
128007333|NCT02029417|460655379|FG000|Overall Study|Death|1|||
128007334|NCT02029417|460655379|FG000|Overall Study|Adverse Event|1|||
127672823|NCT02950545|459426405|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
128007335|NCT02783911|460655380|FG000|Overall Study|Lost to Follow-up|3|||
128007336|NCT02783911|460655381|FG001|Overall Study|Lost to Follow-up|32|||
128007337|NCT00071981|460655382|FG000|Overall Study|Lack of Efficacy|37|||
128007338|NCT00071981|460655383|FG001|Overall Study|Lack of Efficacy|29|||
128007339|NCT00071981|460655384|FG002|Overall Study|Lack of Efficacy|30|||
128007340|NCT00071981|460655385|FG003|Overall Study|Lack of Efficacy|43|||
128007341|NCT00071981|460655382|FG000|Overall Study|Adverse Event|4|||
128007342|NCT00071981|460655383|FG001|Overall Study|Adverse Event|4|||
128007343|NCT00071981|460655384|FG002|Overall Study|Adverse Event|3|||
128007344|NCT00071981|460655385|FG003|Overall Study|Adverse Event|1|||
127672824|NCT02950545|459426406|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
127672825|NCT02950545|459426407|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
127672826|NCT02950545|459426408|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
128007345|NCT00071981|460655382|FG000|Overall Study|Death|0|||
128007346|NCT00071981|460655383|FG001|Overall Study|Death|0|||
128007347|NCT00071981|460655384|FG002|Overall Study|Death|1|||
128007348|NCT00071981|460655385|FG003|Overall Study|Death|1|||
128007349|NCT00071981|460655382|FG000|Overall Study|Withdrawal by Subject|3|||
128007350|NCT00071981|460655383|FG001|Overall Study|Withdrawal by Subject|1|||
128007351|NCT00071981|460655384|FG002|Overall Study|Withdrawal by Subject|0|||
128007352|NCT00071981|460655385|FG003|Overall Study|Withdrawal by Subject|0|||
128007353|NCT00071981|460655382|FG000|Overall Study|No protocol therapy|2|||
128007354|NCT00071981|460655383|FG001|Overall Study|No protocol therapy|5|||
128007355|NCT00071981|460655384|FG002|Overall Study|No protocol therapy|1|||
128007356|NCT00071981|460655385|FG003|Overall Study|No protocol therapy|0|||
128007357|NCT00071981|460655382|FG000|Overall Study|others (not specified in the study)|0|||
128007358|NCT00071981|460655383|FG001|Overall Study|others (not specified in the study)|2|||
128007359|NCT00071981|460655384|FG002|Overall Study|others (not specified in the study)|2|||
128007360|NCT00071981|460655385|FG003|Overall Study|others (not specified in the study)|0|||
128007361|NCT01123655|460655386|FG000|Overall Study|Medication for RA had to be changed|1|||
128007362|NCT01123655|460655387|FG001|Overall Study|Medication for RA had to be changed|0|||
128007363|NCT01123655|460655388|FG002|Overall Study|Medication for RA had to be changed|0|||
128007364|NCT01123655|460655386|FG000|Overall Study|new illness|0|||
128007365|NCT01123655|460655387|FG001|Overall Study|new illness|1|||
128007366|NCT01123655|460655388|FG002|Overall Study|new illness|0|||
128007367|NCT01123655|460655386|FG000|Overall Study|began prohibitive drug|0|||
128007368|NCT01123655|460655387|FG001|Overall Study|began prohibitive drug|0|||
128007369|NCT01123655|460655388|FG002|Overall Study|began prohibitive drug|1|||
128007370|NCT00171249|460655391|FG000|Overall Study|Withdrawal by Subject|2|||
128007371|NCT00171249|460655392|FG001|Overall Study|Withdrawal by Subject|0|||
128007372|NCT00171249|460655393|FG002|Overall Study|Withdrawal by Subject|0|||
128007373|NCT00171249|460655394|FG003|Overall Study|Withdrawal by Subject|6|||
128007374|NCT00171249|460655395|FG004|Overall Study|Withdrawal by Subject|0|||
128007375|NCT00171249|460655396|FG005|Overall Study|Withdrawal by Subject|0|||
128007376|NCT00171249|460655397|FG006|Overall Study|Withdrawal by Subject|0|||
128007377|NCT00171249|460655391|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
128007378|NCT00171249|460655392|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
128007379|NCT00171249|460655393|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
128007380|NCT00171249|460655394|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
128007381|NCT00171249|460655395|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
128007382|NCT00171249|460655396|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
128007383|NCT00171249|460655397|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
128007384|NCT00171249|460655391|FG000|Overall Study|Death|7|||
128007385|NCT00171249|460655392|FG001|Overall Study|Death|1|||
128007386|NCT00171249|460655393|FG002|Overall Study|Death|0|||
128007387|NCT00171249|460655394|FG003|Overall Study|Death|4|||
128007388|NCT00171249|460655395|FG004|Overall Study|Death|0|||
128007389|NCT00171249|460655396|FG005|Overall Study|Death|3|||
128007390|NCT00171249|460655397|FG006|Overall Study|Death|1|||
128007391|NCT00171249|460655391|FG000|Overall Study|Other|10|||
128007392|NCT00171249|460655392|FG001|Overall Study|Other|0|||
128007393|NCT00171249|460655393|FG002|Overall Study|Other|0|||
128007394|NCT00171249|460655394|FG003|Overall Study|Other|43|||
128007395|NCT00171249|460655395|FG004|Overall Study|Other|0|||
128007396|NCT00171249|460655396|FG005|Overall Study|Other|2|||
128007397|NCT00171249|460655397|FG006|Overall Study|Other|0|||
128007398|NCT00171249|460655391|FG000|Overall Study|No Longer Requires Study Drug|4|||
128007399|NCT00171249|460655392|FG001|Overall Study|No Longer Requires Study Drug|0|||
128007400|NCT00171249|460655393|FG002|Overall Study|No Longer Requires Study Drug|0|||
128007401|NCT00171249|460655394|FG003|Overall Study|No Longer Requires Study Drug|3|||
128007402|NCT00171249|460655395|FG004|Overall Study|No Longer Requires Study Drug|0|||
128007403|NCT00171249|460655396|FG005|Overall Study|No Longer Requires Study Drug|5|||
128007404|NCT00171249|460655397|FG006|Overall Study|No Longer Requires Study Drug|0|||
128007405|NCT00171249|460655391|FG000|Overall Study|Administrative Problems|1|||
127672827|NCT02950545|459426403|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
127672828|NCT02950545|459426404|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
127672829|NCT02950545|459426405|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
128007406|NCT00171249|460655392|FG001|Overall Study|Administrative Problems|0|||
128007407|NCT00171249|460655393|FG002|Overall Study|Administrative Problems|0|||
127672830|NCT02950545|459426406|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
127672831|NCT02950545|459426407|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
128007408|NCT00171249|460655394|FG003|Overall Study|Administrative Problems|2|||
128007409|NCT00171249|460655395|FG004|Overall Study|Administrative Problems|0|||
128007410|NCT00171249|460655396|FG005|Overall Study|Administrative Problems|0|||
128007411|NCT00171249|460655397|FG006|Overall Study|Administrative Problems|0|||
128007412|NCT00171249|460655391|FG000|Overall Study|Adverse Event|3|||
127672832|NCT02950545|459426408|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
127672833|NCT02950545|459426403|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
127672834|NCT02950545|459426404|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
127672835|NCT02950545|459426405|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
128007413|NCT00171249|460655392|FG001|Overall Study|Adverse Event|1|||
128007414|NCT00171249|460655393|FG002|Overall Study|Adverse Event|0|||
128007415|NCT00171249|460655394|FG003|Overall Study|Adverse Event|15|||
128007416|NCT00171249|460655395|FG004|Overall Study|Adverse Event|0|||
128007417|NCT00171249|460655396|FG005|Overall Study|Adverse Event|2|||
128007418|NCT00171249|460655397|FG006|Overall Study|Adverse Event|0|||
128007419|NCT00171249|460655391|FG000|Overall Study|Lost to Follow-up|5|||
128007420|NCT00171249|460655392|FG001|Overall Study|Lost to Follow-up|0|||
128007421|NCT00171249|460655393|FG002|Overall Study|Lost to Follow-up|0|||
128007422|NCT00171249|460655394|FG003|Overall Study|Lost to Follow-up|9|||
128007423|NCT00171249|460655395|FG004|Overall Study|Lost to Follow-up|0|||
128007424|NCT00171249|460655396|FG005|Overall Study|Lost to Follow-up|0|||
128007425|NCT00171249|460655397|FG006|Overall Study|Lost to Follow-up|0|||
128007426|NCT01041859|460655398|FG000|Open-Label Titration|Adverse Event|69|||
128007427|NCT01041859|460655399|FG001|Open-Label Titration|Adverse Event|0|||
128007428|NCT01041859|460655400|FG002|Open-Label Titration|Adverse Event|0|||
128007429|NCT01041859|460655398|FG000|Open-Label Titration|Lack of Efficacy|3|||
128007430|NCT01041859|460655399|FG001|Open-Label Titration|Lack of Efficacy|0|||
128007431|NCT01041859|460655400|FG002|Open-Label Titration|Lack of Efficacy|0|||
128007432|NCT01041859|460655398|FG000|Open-Label Titration|Lost to Follow-up|1|||
128007433|NCT01041859|460655399|FG001|Open-Label Titration|Lost to Follow-up|0|||
128007434|NCT01041859|460655400|FG002|Open-Label Titration|Lost to Follow-up|0|||
128007435|NCT01041859|460655398|FG000|Open-Label Titration|Physician Decision|1|||
128007436|NCT01041859|460655399|FG001|Open-Label Titration|Physician Decision|0|||
128007437|NCT01041859|460655400|FG002|Open-Label Titration|Physician Decision|0|||
128007438|NCT01041859|460655398|FG000|Open-Label Titration|Protocol Violation|1|||
128007439|NCT01041859|460655399|FG001|Open-Label Titration|Protocol Violation|0|||
128007440|NCT01041859|460655400|FG002|Open-Label Titration|Protocol Violation|0|||
128007441|NCT01041859|460655398|FG000|Open-Label Titration|Other|7|||
128007442|NCT01041859|460655399|FG001|Open-Label Titration|Other|0|||
128007443|NCT01041859|460655400|FG002|Open-Label Titration|Other|0|||
128007444|NCT01041859|460655398|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
128007445|NCT01041859|460655399|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
128007446|NCT01041859|460655400|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
128007447|NCT01041859|460655398|FG000|Open-Label Titration|Withdrawal by Subject|11|||
128007448|NCT01041859|460655399|FG001|Open-Label Titration|Withdrawal by Subject|0|||
128007449|NCT01041859|460655400|FG002|Open-Label Titration|Withdrawal by Subject|0|||
128007450|NCT01041859|460655398|FG000|Double-Blind Maintenance|Adverse Event|0|||
128007451|NCT01041859|460655399|FG001|Double-Blind Maintenance|Adverse Event|23|||
128007452|NCT01041859|460655400|FG002|Double-Blind Maintenance|Adverse Event|13|||
128007453|NCT01041859|460655398|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
128007454|NCT01041859|460655399|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
128007455|NCT01041859|460655400|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
128007456|NCT01041859|460655398|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
128007457|NCT01041859|460655399|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
128007458|NCT01041859|460655400|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
128007459|NCT01041859|460655398|FG000|Double-Blind Maintenance|Physician Decision|0|||
128007460|NCT01041859|460655399|FG001|Double-Blind Maintenance|Physician Decision|2|||
128007461|NCT01041859|460655400|FG002|Double-Blind Maintenance|Physician Decision|1|||
128007462|NCT01041859|460655398|FG000|Double-Blind Maintenance|Protocol Violation|0|||
128007463|NCT01041859|460655399|FG001|Double-Blind Maintenance|Protocol Violation|1|||
128007464|NCT01041859|460655400|FG002|Double-Blind Maintenance|Protocol Violation|3|||
128007465|NCT01041859|460655398|FG000|Double-Blind Maintenance|Other|0|||
128007466|NCT01041859|460655399|FG001|Double-Blind Maintenance|Other|6|||
128007467|NCT01041859|460655400|FG002|Double-Blind Maintenance|Other|2|||
128007468|NCT01041859|460655398|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
128007469|NCT01041859|460655399|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
128007470|NCT01041859|460655400|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
128007471|NCT01041859|460655398|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
128007472|NCT01041859|460655399|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
128007473|NCT01041859|460655400|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
128007474|NCT02908347|460655406|FG000|Overall Study|Adverse Event|0|||
128007475|NCT02908347|460655407|FG001|Overall Study|Adverse Event|1|||
128007476|NCT02908347|460655406|FG000|Overall Study|Lost to Follow-up|1|||
127672836|NCT02950545|459426406|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
127672837|NCT02950545|459426407|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
128007477|NCT02908347|460655407|FG001|Overall Study|Lost to Follow-up|0|||
128007478|NCT00885118|460655408|FG000|Overall Study|Adverse Event|1|||
128007479|NCT00885118|460655409|FG001|Overall Study|Adverse Event|0|||
127672838|NCT02950545|459426408|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
127672839|NCT02950545|459426403|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
127672840|NCT02950545|459426404|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
128007480|NCT00885118|460655410|FG002|Overall Study|Adverse Event|0|||
128007481|NCT00885118|460655411|FG003|Overall Study|Adverse Event|0|||
128007482|NCT00885118|460655412|FG004|Overall Study|Adverse Event|0|||
128007483|NCT00885118|460655408|FG000|Overall Study|Withdrawal by Subject|0|||
128007484|NCT00885118|460655409|FG001|Overall Study|Withdrawal by Subject|0|||
128007485|NCT00885118|460655410|FG002|Overall Study|Withdrawal by Subject|0|||
128007486|NCT00885118|460655411|FG003|Overall Study|Withdrawal by Subject|0|||
128007487|NCT00885118|460655412|FG004|Overall Study|Withdrawal by Subject|1|||
128007488|NCT00885118|460655408|FG000|Overall Study|Other reason not defined above|0|||
128007489|NCT00885118|460655409|FG001|Overall Study|Other reason not defined above|0|||
128007490|NCT00885118|460655410|FG002|Overall Study|Other reason not defined above|1|||
128007491|NCT00885118|460655411|FG003|Overall Study|Other reason not defined above|0|||
128007492|NCT00885118|460655412|FG004|Overall Study|Other reason not defined above|0|||
128007493|NCT03054428|460655417|FG000|Overall Study|Physician Decision|0|||
128007494|NCT03054428|460655418|FG001|Overall Study|Physician Decision|1|||
128007495|NCT03054428|460655419|FG002|Overall Study|Physician Decision|1|||
128007496|NCT03054428|460655417|FG000|Overall Study|Lack of Efficacy|3|||
128007497|NCT03054428|460655418|FG001|Overall Study|Lack of Efficacy|1|||
128007498|NCT03054428|460655419|FG002|Overall Study|Lack of Efficacy|0|||
128007499|NCT03054428|460655417|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
128007500|NCT03054428|460655418|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
128007501|NCT03054428|460655419|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
128007502|NCT03054428|460655417|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
128007503|NCT03054428|460655418|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
128007504|NCT03054428|460655419|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
128007505|NCT03054428|460655417|FG000|Overall Study|Transitioned to OLE study|76|||
128007506|NCT03054428|460655418|FG001|Overall Study|Transitioned to OLE study|76|||
128007507|NCT03054428|460655419|FG002|Overall Study|Transitioned to OLE study|73|||
128007508|NCT03054428|460655417|FG000|Overall Study|Withdrawal by Subject|3|||
128007509|NCT03054428|460655418|FG001|Overall Study|Withdrawal by Subject|2|||
128007510|NCT03054428|460655419|FG002|Overall Study|Withdrawal by Subject|3|||
128007511|NCT03054428|460655417|FG000|Overall Study|Lost to Follow-up|0|||
128007512|NCT03054428|460655418|FG001|Overall Study|Lost to Follow-up|0|||
128007513|NCT03054428|460655419|FG002|Overall Study|Lost to Follow-up|1|||
128007514|NCT01884597|460655421|FG000|Overall Study|Adverse Event|0|||
128007515|NCT01884597|460655422|FG001|Overall Study|Adverse Event|0|||
128007516|NCT01884597|460655423|FG002|Overall Study|Adverse Event|1|||
128007517|NCT01884597|460655421|FG000|Overall Study|Lack of Efficacy|1|||
128007518|NCT01884597|460655422|FG001|Overall Study|Lack of Efficacy|0|||
128007519|NCT01884597|460655423|FG002|Overall Study|Lack of Efficacy|0|||
128007520|NCT01884597|460655421|FG000|Overall Study|Death|0|||
128007521|NCT01884597|460655422|FG001|Overall Study|Death|1|||
128007522|NCT01884597|460655423|FG002|Overall Study|Death|0|||
128007523|NCT02097823|460655424|FG000|Overall Study|Withdrawal by Subject|1|||
128007524|NCT02097823|460655425|FG001|Overall Study|Withdrawal by Subject|1|||
128007525|NCT03082729|460655426|FG000|Overall Study|Lost to Follow-up|7|||
128007526|NCT03082729|460655426|FG000|Overall Study|Physician Decision|2|||
128007527|NCT03082729|460655426|FG000|Overall Study|Withdrawal by Subject|1|||
128007528|NCT03082729|460655426|FG000|Overall Study|Lack of Efficacy|9|||
128007529|NCT03082729|460655426|FG000|Overall Study|Adverse Event|4|||
128007530|NCT03082729|460655426|FG000|Overall Study|Protocol Violation|6|||
128007531|NCT03082729|460655426|FG000|Overall Study|Fear of study procedure|1|||
128007532|NCT03082729|460655426|FG000|Overall Study|Scheduling conflict|1|||
128007533|NCT01093846|460655427|FG000|Overall Study|Adverse Event|0|||
128007534|NCT01093846|460655428|FG001|Overall Study|Adverse Event|0|||
128007535|NCT01093846|460655429|FG002|Overall Study|Adverse Event|1|||
128007536|NCT01093846|460655427|FG000|Overall Study|Lack of Efficacy|0|||
128007537|NCT01093846|460655428|FG001|Overall Study|Lack of Efficacy|0|||
128007538|NCT01093846|460655429|FG002|Overall Study|Lack of Efficacy|4|||
128007539|NCT01093846|460655427|FG000|Overall Study|Condition no longer required study drug|1|||
128007540|NCT01093846|460655428|FG001|Overall Study|Condition no longer required study drug|1|||
128007541|NCT01093846|460655429|FG002|Overall Study|Condition no longer required study drug|1|||
128007542|NCT01093846|460655427|FG000|Overall Study|Administrative Problems|18|||
128007543|NCT01093846|460655428|FG001|Overall Study|Administrative Problems|17|||
128007544|NCT01093846|460655429|FG002|Overall Study|Administrative Problems|15|||
128007545|NCT01416571|460655430|FG000|Overall Study|Lost to Follow-up|2|||
128007546|NCT00959751|460656521|FG000|Overall Study|Lost to Follow-up|2|||
128007547|NCT00959751|460656522|FG001|Overall Study|Lost to Follow-up|3|||
128007548|NCT00959751|460656521|FG000|Overall Study|Consent Withdrawn|0|||
128007549|NCT00959751|460656522|FG001|Overall Study|Consent Withdrawn|1|||
128007550|NCT00959751|460656521|FG000|Overall Study|Non-compliance to Study Procedures|0|||
128007551|NCT00959751|460656522|FG001|Overall Study|Non-compliance to Study Procedures|1|||
128007552|NCT00959751|460656521|FG000|Overall Study|No migraine headache without aura|7|||
128007553|NCT00959751|460656522|FG001|Overall Study|No migraine headache without aura|7|||
128007554|NCT01715831|460656523|FG000|Overall Study|Adverse Event|1|||
128007555|NCT00900562|460656524|FG000|Overall Study|Progressive disease|9|||
128007556|NCT00900562|460656525|FG001|Overall Study|Progressive disease|5|||
128007557|NCT00900562|460656524|FG000|Overall Study|Toxicity|1|||
128007558|NCT00900562|460656525|FG001|Overall Study|Toxicity|0|||
128007559|NCT00900562|460656524|FG000|Overall Study|Death|1|||
128007560|NCT00900562|460656525|FG001|Overall Study|Death|1|||
128007561|NCT00900562|460656524|FG000|Overall Study|Withdrawal by Subject|0|||
128007562|NCT00900562|460656525|FG001|Overall Study|Withdrawal by Subject|1|||
128007563|NCT00900562|460656524|FG000|Overall Study|Unrelated adverse event|1|||
128007564|NCT00900562|460656525|FG001|Overall Study|Unrelated adverse event|0|||
128007565|NCT02426684|460656526|FG000|Overall Study|Physician Decision|1|||
128007566|NCT03587636|460656527|FG000|Overall Study|Lost to Follow-up|2|||
128007567|NCT03587636|460656528|FG001|Overall Study|Lost to Follow-up|5|||
128007568|NCT01118299|460656531|FG000|Overall Study|Death|7|||
128007569|NCT01118299|460656532|FG001|Overall Study|Death|5|||
128007570|NCT01118299|460656531|FG000|Overall Study|Withdrawal by Subject|8|||
128007571|NCT01118299|460656532|FG001|Overall Study|Withdrawal by Subject|8|||
128007572|NCT01118299|460656531|FG000|Overall Study|Lost to Follow-up|2|||
128007573|NCT01118299|460656532|FG001|Overall Study|Lost to Follow-up|1|||
128007574|NCT01118299|460656531|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
128007575|NCT01118299|460656532|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
128007576|NCT04459338|460656533|FG000|Overall Study|Loss of IV during study|1|||
128007577|NCT04459338|460656534|FG001|Overall Study|Loss of IV during study|0|||
128007578|NCT01454284|460656535|FG000|Overall Study|Adverse Event|20|||
128007579|NCT01454284|460656536|FG001|Overall Study|Adverse Event|7|||
128007580|NCT01454284|460656535|FG000|Overall Study|Death|0|||
128007581|NCT01454284|460656536|FG001|Overall Study|Death|3|||
128007582|NCT01454284|460656535|FG000|Overall Study|Lost to Follow-up|13|||
128007583|NCT01454284|460656536|FG001|Overall Study|Lost to Follow-up|8|||
128007584|NCT01454284|460656535|FG000|Overall Study|Protocol Violation|9|||
128007585|NCT01454284|460656536|FG001|Overall Study|Protocol Violation|6|||
128007586|NCT01454284|460656535|FG000|Overall Study|Withdrawal by Subject|58|||
128007587|NCT01454284|460656536|FG001|Overall Study|Withdrawal by Subject|36|||
128007588|NCT01454284|460656535|FG000|Overall Study|Physician Decision|16|||
128007589|NCT01454284|460656536|FG001|Overall Study|Physician Decision|11|||
128007590|NCT01454284|460656535|FG000|Overall Study|Sponsor Decision|0|||
128007591|NCT01454284|460656536|FG001|Overall Study|Sponsor Decision|2|||
128007592|NCT02665117|460656537|FG000|Overall Study|Physician Decision|1|||
128007593|NCT02665117|460656538|FG001|Overall Study|Physician Decision|0|||
128007594|NCT03248037|460656543|FG000|Overall Study|Withdrawal by Subject|6|||
128007595|NCT03248037|460656544|FG001|Overall Study|Withdrawal by Subject|9|||
128007596|NCT03248037|460656543|FG000|Overall Study|Adverse Event|15|||
128007597|NCT03248037|460656544|FG001|Overall Study|Adverse Event|0|||
128007598|NCT03743194|460656546|FG000|Overall Study|Protocol Violation|7|||
128007599|NCT03743194|460656547|FG001|Overall Study|Protocol Violation|7|||
128007600|NCT03743194|460656546|FG000|Overall Study|Physician Decision|0|||
128007601|NCT03743194|460656547|FG001|Overall Study|Physician Decision|2|||
128007602|NCT02897349|460656550|FG000|Overall Study|Lost to Follow-up|2|||
128007603|NCT02897349|460656551|FG001|Overall Study|Lost to Follow-up|2|||
128007604|NCT02897349|460656550|FG000|Overall Study|Adverse Event|3|||
128007605|NCT02897349|460656551|FG001|Overall Study|Adverse Event|3|||
128007606|NCT02897349|460656550|FG000|Overall Study|Other than listed above|0|||
128007607|NCT02897349|460656551|FG001|Overall Study|Other than listed above|1|||
128007608|NCT01829347|460656552|FG000|VTI-210|Death|5|||
128007609|NCT01829347|460656553|FG001|VTI-210|Death|3|||
128007610|NCT01829347|460656552|FG000|VTI-210|Withdrawal by Subject|1|||
128007611|NCT01829347|460656553|FG001|VTI-210|Withdrawal by Subject|0|||
128007612|NCT01829347|460656552|FG000|VTI-210E|Death|2|||
128007613|NCT01829347|460656553|FG001|VTI-210E|Death|1|||
128007614|NCT01829347|460656552|FG000|VTI-210E|Study terminated prematurely|1|||
128007615|NCT01829347|460656553|FG001|VTI-210E|Study terminated prematurely|5|||
128007616|NCT04018066|460656558|FG000|Overall Study|participants started taking medications during the study period|3|||
128007617|NCT04018066|460656558|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
128007618|NCT03817528|460656559|FG000|Overall Study|Withdrawal by Subject|1|||
128007619|NCT03817528|460656559|FG000|Overall Study|Adverse Event|2|||
128007620|NCT01027949|460656565|FG000|Overall Study|Death|174|||
128007621|NCT01027949|460656565|FG000|Overall Study|Progressive Disease|163|||
128007622|NCT01027949|460656565|FG000|Overall Study|Adverse Event|172|||
128007623|NCT01027949|460656565|FG000|Overall Study|Withdrawal by Subject|113|||
128007624|NCT01027949|460656565|FG000|Overall Study|Lost to Follow-up|17|||
128007625|NCT01027949|460656565|FG000|Overall Study|Protocol Violation|13|||
128007626|NCT01027949|460656565|FG000|Overall Study|PI Decision|8|||
128007627|NCT01027949|460656565|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
128007628|NCT01027949|460656565|FG000|Overall Study|Non-compliance with Study Procedures|7|||
128007629|NCT01027949|460656565|FG000|Overall Study|Lung Transplant|5|||
128007630|NCT01027949|460656565|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
128007631|NCT01027949|460656565|FG000|Overall Study|Use of Excluded Medication|2|||
128007632|NCT01027949|460656565|FG000|Overall Study|Patient Self-discontinuation|1|||
128007633|NCT01027949|460656565|FG000|Overall Study|Pregnancy|1|||
128007634|NCT01027949|460656565|FG000|Overall Study|Surgery|1|||
128007635|NCT00671749|460656570|FG000|Overall Study|Adverse Event|2|||
128007636|NCT00671749|460656570|FG000|Overall Study|Withdrawal by Subject|4|||
128007637|NCT00671749|460656570|FG000|Overall Study|Protocol Violation|1|||
128007638|NCT00671749|460656570|FG000|Overall Study|Lost to Follow-up|1|||
128007639|NCT02515227|460656571|FG000|Overall Study|Adverse Event|0|||
127543536|NCT02718898|458956557|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
128007640|NCT02515227|460656572|FG001|Overall Study|Adverse Event|2|||
128007641|NCT02515227|460656571|FG000|Overall Study|Progressive disease|2|||
128007642|NCT02515227|460656572|FG001|Overall Study|Progressive disease|9|||
128007643|NCT01259245|460656580|FG000|Overall Study|Withdrawal by Subject|27|||
128007644|NCT01259245|460656581|FG001|Overall Study|Withdrawal by Subject|24|||
128007645|NCT01259245|460656580|FG000|Overall Study|Death|1|||
128007646|NCT01259245|460656581|FG001|Overall Study|Death|2|||
128007647|NCT02152007|460656582|FG000|Overall Study|Withdrawal by Subject|1|||
128007648|NCT03451071|460656585|FG000|First Vaccine|Withdrawal by Subject|1|||
128007649|NCT03451071|460656585|FG000|Second Vaccine|Lost to Follow-up|19|||
128007650|NCT03451071|460656585|FG000|Third Vaccine|Lost to Follow-up|22|||
127672841|NCT02950545|459426405|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
127672842|NCT02950545|459426406|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
127672843|NCT02950545|459426407|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
127672844|NCT02950545|459426408|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
127672845|NCT03101592|459426409|FG000|Overall Study|participant files could not be located|111|||
127672846|NCT03101592|459426410|FG001|Overall Study|participant files could not be located|170|||
128007651|NCT03451071|460656585|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
128007652|NCT02065557|460656586|FG000|Induction Period|Withdrawal by Subject|2|||
128007653|NCT02065557|460656587|FG001|Induction Period|Withdrawal by Subject|1|||
128007654|NCT02065557|460656588|FG002|Induction Period|Withdrawal by Subject|0|||
128007655|NCT02065557|460656589|FG003|Induction Period|Withdrawal by Subject|0|||
128007656|NCT02065557|460656590|FG004|Induction Period|Withdrawal by Subject|0|||
128007657|NCT02065557|460656591|FG005|Induction Period|Withdrawal by Subject|0|||
128007658|NCT02065557|460656586|FG000|Induction Period|Lack of Efficacy|2|||
128007659|NCT02065557|460656587|FG001|Induction Period|Lack of Efficacy|1|||
128007660|NCT02065557|460656588|FG002|Induction Period|Lack of Efficacy|1|||
128007661|NCT02065557|460656589|FG003|Induction Period|Lack of Efficacy|0|||
128007662|NCT02065557|460656590|FG004|Induction Period|Lack of Efficacy|0|||
128007663|NCT02065557|460656591|FG005|Induction Period|Lack of Efficacy|0|||
128007664|NCT02065557|460656586|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
128007665|NCT02065557|460656587|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
128007666|NCT02065557|460656588|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
128007667|NCT02065557|460656589|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
128007668|NCT02065557|460656590|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
128007669|NCT02065557|460656591|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
128007670|NCT02065557|460656586|FG000|Induction Period|Non-Responder at Week 8|4|||
128007671|NCT02065557|460656587|FG001|Induction Period|Non-Responder at Week 8|4|||
128007672|NCT02065557|460656588|FG002|Induction Period|Non-Responder at Week 8|0|||
128007673|NCT02065557|460656589|FG003|Induction Period|Non-Responder at Week 8|0|||
128007674|NCT02065557|460656590|FG004|Induction Period|Non-Responder at Week 8|0|||
128007675|NCT02065557|460656591|FG005|Induction Period|Non-Responder at Week 8|0|||
128007676|NCT02065557|460656586|FG000|Induction Period|Adverse Event|1|||
128007677|NCT02065557|460656587|FG001|Induction Period|Adverse Event|1|||
128007678|NCT02065557|460656588|FG002|Induction Period|Adverse Event|0|||
128007679|NCT02065557|460656589|FG003|Induction Period|Adverse Event|0|||
128007680|NCT02065557|460656590|FG004|Induction Period|Adverse Event|0|||
128007681|NCT02065557|460656591|FG005|Induction Period|Adverse Event|0|||
128007682|NCT02065557|460656586|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
128007683|NCT02065557|460656587|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
128007684|NCT02065557|460656588|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
128007685|NCT02065557|460656589|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
128007686|NCT02065557|460656590|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
128007687|NCT02065557|460656591|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
128007688|NCT02065557|460656586|FG000|Maintenance Period|Withdrawal by Subject|0|||
128007689|NCT02065557|460656587|FG001|Maintenance Period|Withdrawal by Subject|0|||
128007690|NCT02065557|460656588|FG002|Maintenance Period|Withdrawal by Subject|0|||
128007691|NCT02065557|460656589|FG003|Maintenance Period|Withdrawal by Subject|0|||
128007692|NCT02065557|460656590|FG004|Maintenance Period|Withdrawal by Subject|2|||
128007693|NCT02065557|460656591|FG005|Maintenance Period|Withdrawal by Subject|1|||
128007694|NCT02065557|460656586|FG000|Maintenance Period|Lack of Efficacy|0|||
128007695|NCT02065557|460656587|FG001|Maintenance Period|Lack of Efficacy|0|||
128007696|NCT02065557|460656588|FG002|Maintenance Period|Lack of Efficacy|0|||
128007697|NCT02065557|460656589|FG003|Maintenance Period|Lack of Efficacy|0|||
128007698|NCT02065557|460656590|FG004|Maintenance Period|Lack of Efficacy|5|||
128007699|NCT02065557|460656591|FG005|Maintenance Period|Lack of Efficacy|2|||
128007700|NCT02065557|460656586|FG000|Maintenance Period|Subject Non-Compliance|0|||
128007701|NCT02065557|460656587|FG001|Maintenance Period|Subject Non-Compliance|0|||
128007702|NCT02065557|460656588|FG002|Maintenance Period|Subject Non-Compliance|0|||
128007703|NCT02065557|460656589|FG003|Maintenance Period|Subject Non-Compliance|0|||
128007704|NCT02065557|460656590|FG004|Maintenance Period|Subject Non-Compliance|0|||
128007705|NCT02065557|460656591|FG005|Maintenance Period|Subject Non-Compliance|1|||
128007706|NCT00250588|460656592|FG000|Overall Study|Withdrawal by Subject|3|||
128007707|NCT00250588|460656593|FG001|Overall Study|Withdrawal by Subject|6|||
128007708|NCT00250588|460656594|FG002|Overall Study|Withdrawal by Subject|0|||
128007709|NCT00250588|460656592|FG000|Overall Study|Lost to Follow-up|6|||
128007710|NCT00250588|460656593|FG001|Overall Study|Lost to Follow-up|13|||
127672847|NCT03101592|459426411|FG002|Overall Study|participant files could not be located|118|||
128007711|NCT00250588|460656594|FG002|Overall Study|Lost to Follow-up|13|||
128007712|NCT00706797|460656595|FG000|Overall Study|Lack of Efficacy|3|||
128007713|NCT00706797|460656596|FG001|Overall Study|Lack of Efficacy|0|||
128007714|NCT00706797|460656595|FG000|Overall Study|Adverse Event|0|||
128007715|NCT00706797|460656596|FG001|Overall Study|Adverse Event|3|||
128007716|NCT00706797|460656595|FG000|Overall Study|Withdrawal by Subject|8|||
128007717|NCT00706797|460656596|FG001|Overall Study|Withdrawal by Subject|1|||
128007718|NCT00706797|460656595|FG000|Overall Study|Death|1|||
128007719|NCT00706797|460656596|FG001|Overall Study|Death|0|||
128007720|NCT00706797|460656595|FG000|Overall Study|Discontinuation of study by sponsor|52|||
128007721|NCT00706797|460656596|FG001|Overall Study|Discontinuation of study by sponsor|63|||
128007722|NCT00706797|460656595|FG000|Overall Study|Protocol Violation|3|||
128007723|NCT00706797|460656596|FG001|Overall Study|Protocol Violation|2|||
128007724|NCT00706797|460656595|FG000|Overall Study|Lost to Follow-up|1|||
128007725|NCT00706797|460656596|FG001|Overall Study|Lost to Follow-up|2|||
128007726|NCT00706797|460656595|FG000|Overall Study|Other|1|||
128007727|NCT00706797|460656596|FG001|Overall Study|Other|0|||
128007728|NCT03502798|460656597|FG000|Overall Study|equipment failure|0|||
128007729|NCT03502798|460656598|FG001|Overall Study|equipment failure|7|||
128007730|NCT00485303|460656600|FG000|Overall Study|Adverse Event|5|||
128007731|NCT00485303|460656600|FG000|Overall Study|Progressive Disease|44|||
128007732|NCT00485303|460656600|FG000|Overall Study|Other|3|||
128007733|NCT00485303|460656600|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
128007734|NCT00485303|460656600|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
128007735|NCT00296335|460656602|FG000|Overall Study|Recurrence|3|||
128007736|NCT00296335|460656603|FG001|Overall Study|Recurrence|51|||
128007737|NCT00296335|460656602|FG000|Overall Study|Adverse Event|17|||
128007738|NCT00296335|460656603|FG001|Overall Study|Adverse Event|27|||
128007739|NCT00296335|460656602|FG000|Overall Study|Lost to Follow-up|7|||
128007740|NCT00296335|460656603|FG001|Overall Study|Lost to Follow-up|33|||
128007741|NCT00296335|460656602|FG000|Overall Study|Physician Decision|3|||
128007742|NCT00296335|460656603|FG001|Overall Study|Physician Decision|11|||
128007743|NCT01401322|460656604|FG000|Overall Study|Withdrawal by Subject|1|||
128007744|NCT01401322|460656604|FG000|Overall Study|Physician Decision|1|||
128007745|NCT02737722|460656605|FG000|Overall Study|Physician Decision|0|||
128007746|NCT02737722|460656606|FG001|Overall Study|Physician Decision|0|||
128007747|NCT02737722|460656607|FG002|Overall Study|Physician Decision|1|||
128007748|NCT02737722|460656608|FG003|Overall Study|Physician Decision|0|||
128007749|NCT03451045|460656617|FG000|Overall Study|Lack of Efficacy|3|||
127672848|NCT03398356|459426414|FG000|Before Treatment|Lost to Follow-up|1|||
127672849|NCT03398356|459426415|FG001|Before Treatment|Lost to Follow-up|2|||
127672850|NCT03398356|459426416|FG002|Before Treatment|Lost to Follow-up|0|||
127672851|NCT03398356|459426414|FG000|Before Treatment|drug intolerance|2|||
127672852|NCT03398356|459426415|FG001|Before Treatment|drug intolerance|1|||
127672853|NCT03398356|459426416|FG002|Before Treatment|drug intolerance|0|||
127672854|NCT03398356|459426414|FG000|Before Treatment|Withdrawal by Subject|0|||
127672855|NCT03398356|459426415|FG001|Before Treatment|Withdrawal by Subject|5|||
127672856|NCT03398356|459426416|FG002|Before Treatment|Withdrawal by Subject|0|||
127672857|NCT03398356|459426414|FG000|Before Treatment|Physician Decision|0|||
127672858|NCT03398356|459426415|FG001|Before Treatment|Physician Decision|0|||
127672859|NCT03398356|459426416|FG002|Before Treatment|Physician Decision|11|||
127672860|NCT03398356|459426414|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
127672861|NCT03398356|459426415|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
127672862|NCT03398356|459426416|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
127672863|NCT01648283|459426419|FG000|Overall Study|Withdrawal by Subject|14|||
127672864|NCT00601640|459426424|FG000|Overall Study|Withdrawal by Subject|3|||
127672865|NCT00601640|459426425|FG001|Overall Study|Withdrawal by Subject|0|||
127672866|NCT00601640|459426426|FG002|Overall Study|Withdrawal by Subject|7|||
127672867|NCT00601640|459426424|FG000|Overall Study|Death|1|||
127672868|NCT00601640|459426425|FG001|Overall Study|Death|0|||
127672869|NCT00601640|459426426|FG002|Overall Study|Death|0|||
127672870|NCT00601640|459426424|FG000|Overall Study|Adverse Event|0|||
127672871|NCT00601640|459426425|FG001|Overall Study|Adverse Event|4|||
127672872|NCT00601640|459426426|FG002|Overall Study|Adverse Event|2|||
127672873|NCT00601640|459426424|FG000|Overall Study|intercurrent illness|1|||
127672874|NCT00601640|459426425|FG001|Overall Study|intercurrent illness|0|||
127672875|NCT00601640|459426426|FG002|Overall Study|intercurrent illness|0|||
128007750|NCT03451045|460656618|FG001|Overall Study|Lack of Efficacy|2|||
128007751|NCT03451045|460656619|FG002|Overall Study|Lack of Efficacy|2|||
128007752|NCT03451045|460656617|FG000|Overall Study|Physician Decision|1|||
128007753|NCT03451045|460656618|FG001|Overall Study|Physician Decision|1|||
127672876|NCT00601640|459426424|FG000|Overall Study|change in eligibility status|0|||
127672877|NCT00601640|459426425|FG001|Overall Study|change in eligibility status|1|||
127672878|NCT00601640|459426426|FG002|Overall Study|change in eligibility status|1|||
127672879|NCT00530777|459426427|FG000|Overall Study|Lost to Follow-up|0|||
127672880|NCT00530777|459426428|FG001|Overall Study|Lost to Follow-up|1|||
127672881|NCT00530777|459426427|FG000|Overall Study|Death|1|||
128007754|NCT03451045|460656619|FG002|Overall Study|Physician Decision|1|||
128007755|NCT03451045|460656617|FG000|Overall Study|Withdrawal by Subject|4|||
127672882|NCT00530777|459426428|FG001|Overall Study|Death|2|||
127672883|NCT00530777|459426427|FG000|Overall Study|Physician Decision|1|||
127672884|NCT00530777|459426428|FG001|Overall Study|Physician Decision|0|||
127672885|NCT00530777|459426427|FG000|Overall Study|Withdrawal by Subject|0|||
127672886|NCT00530777|459426428|FG001|Overall Study|Withdrawal by Subject|1|||
127672887|NCT00530777|459426427|FG000|Overall Study|Unable to adhere to visit schedule|5|||
127672888|NCT00530777|459426428|FG001|Overall Study|Unable to adhere to visit schedule|1|||
127672889|NCT03382821|459426435|FG000|Overall Study|Did not receive allocated intervention.|0|||
127672890|NCT03382821|459426436|FG001|Overall Study|Did not receive allocated intervention.|3|||
127672891|NCT00282438|459426437|FG000|Overall Study|Lack of Efficacy|1|||
127672892|NCT00282438|459426438|FG001|Overall Study|Lack of Efficacy|0|||
127672893|NCT00282438|459426437|FG000|Overall Study|Death|0|||
127672894|NCT00282438|459426438|FG001|Overall Study|Death|1|||
127672895|NCT01674569|459426439|FG000|Overall Study|Adverse Event|0|||
127672896|NCT01674569|459426440|FG001|Overall Study|Adverse Event|2|||
127672897|NCT01674569|459426441|FG002|Overall Study|Adverse Event|0|||
127672898|NCT01674569|459426442|FG003|Overall Study|Adverse Event|1|||
127672899|NCT01674569|459426443|FG004|Overall Study|Adverse Event|2|||
127672900|NCT01674569|459426444|FG005|Overall Study|Adverse Event|2|||
127672901|NCT01674569|459426439|FG000|Overall Study|Protocol Violation|0|||
127672902|NCT01674569|459426440|FG001|Overall Study|Protocol Violation|1|||
127672903|NCT01674569|459426441|FG002|Overall Study|Protocol Violation|1|||
127672904|NCT01674569|459426442|FG003|Overall Study|Protocol Violation|0|||
127672905|NCT01674569|459426443|FG004|Overall Study|Protocol Violation|0|||
127672906|NCT01674569|459426444|FG005|Overall Study|Protocol Violation|0|||
127672907|NCT01674569|459426439|FG000|Overall Study|Withdrawal by Subject|0|||
127672908|NCT01674569|459426440|FG001|Overall Study|Withdrawal by Subject|0|||
127672909|NCT01674569|459426441|FG002|Overall Study|Withdrawal by Subject|1|||
127672910|NCT01674569|459426442|FG003|Overall Study|Withdrawal by Subject|0|||
127672911|NCT01674569|459426443|FG004|Overall Study|Withdrawal by Subject|0|||
127672912|NCT01674569|459426444|FG005|Overall Study|Withdrawal by Subject|0|||
127672913|NCT01941316|459426452|FG000|Overall Study|Adverse Event|0|||
127672914|NCT01941316|459426453|FG001|Overall Study|Adverse Event|1|||
127672915|NCT01941316|459426454|FG002|Overall Study|Adverse Event|0|||
127672916|NCT01941316|459426455|FG003|Overall Study|Adverse Event|7|||
127672917|NCT01941316|459426452|FG000|Overall Study|Progressive Disease|3|||
127672918|NCT01941316|459426453|FG001|Overall Study|Progressive Disease|6|||
127672919|NCT01941316|459426454|FG002|Overall Study|Progressive Disease|2|||
127672920|NCT01941316|459426455|FG003|Overall Study|Progressive Disease|29|||
127672921|NCT01941316|459426452|FG000|Overall Study|Withdrawal by Subject|0|||
127672922|NCT01941316|459426453|FG001|Overall Study|Withdrawal by Subject|2|||
127672923|NCT01941316|459426454|FG002|Overall Study|Withdrawal by Subject|1|||
127672924|NCT01941316|459426455|FG003|Overall Study|Withdrawal by Subject|8|||
127672925|NCT01941316|459426452|FG000|Overall Study|Death|0|||
127672926|NCT01941316|459426453|FG001|Overall Study|Death|0|||
127672927|NCT01941316|459426454|FG002|Overall Study|Death|0|||
127672928|NCT01941316|459426455|FG003|Overall Study|Death|3|||
127672929|NCT01941316|459426452|FG000|Overall Study|Physician Decision|0|||
127672930|NCT01941316|459426453|FG001|Overall Study|Physician Decision|0|||
127672931|NCT01941316|459426454|FG002|Overall Study|Physician Decision|0|||
127672932|NCT01941316|459426455|FG003|Overall Study|Physician Decision|3|||
127672933|NCT01941316|459426452|FG000|Overall Study|Protocol Violation|0|||
127672934|NCT01941316|459426453|FG001|Overall Study|Protocol Violation|0|||
127672935|NCT01941316|459426454|FG002|Overall Study|Protocol Violation|0|||
127672936|NCT01941316|459426455|FG003|Overall Study|Protocol Violation|3|||
127672937|NCT01941316|459426452|FG000|Overall Study|Intercurrent illness|0|||
127672938|NCT01941316|459426453|FG001|Overall Study|Intercurrent illness|0|||
127672939|NCT01941316|459426454|FG002|Overall Study|Intercurrent illness|0|||
127672940|NCT01941316|459426455|FG003|Overall Study|Intercurrent illness|1|||
127672941|NCT01941316|459426452|FG000|Overall Study|Other, not specified|0|||
127672942|NCT01941316|459426453|FG001|Overall Study|Other, not specified|0|||
127672943|NCT01941316|459426454|FG002|Overall Study|Other, not specified|0|||
127672944|NCT01941316|459426455|FG003|Overall Study|Other, not specified|1|||
127672945|NCT03885596|459426456|FG000|Overall Study|Withdrawal by Subject|2|||
127672946|NCT03885596|459426457|FG001|Overall Study|Withdrawal by Subject|1|||
127672947|NCT03885596|459426458|FG002|Overall Study|Withdrawal by Subject|0|||
127672948|NCT03885596|459426459|FG003|Overall Study|Withdrawal by Subject|0|||
127672949|NCT00117988|459426466|FG000|Overall Study|Death|3|||
127672950|NCT00117988|459426466|FG000|Overall Study|Adverse Event|1|||
127672951|NCT05196737|459426467|FG000|Non-intervention Week|Lost to Follow-up|2|||
127672952|NCT05196737|459426467|FG000|Dry Needling Reflex Measurment Week|Protocol Violation|1|||
127672953|NCT05096884|459426468|FG000|Overall Study|Excluded based on negative tilt table test|4|||
127672954|NCT01096056|459426469|FG000|Overall Study|Lost to Follow-up|0|||
127672955|NCT01096056|459426470|FG001|Overall Study|Lost to Follow-up|1|||
127672956|NCT03781804|459426471|FG000|Overall Study|Adverse Event|2|||
127672957|NCT03781804|459426472|FG001|Overall Study|Adverse Event|2|||
127672958|NCT03781804|459426473|FG002|Overall Study|Adverse Event|3|||
127672959|NCT03781804|459426471|FG000|Overall Study|Lost to Follow-up|1|||
127672960|NCT03781804|459426472|FG001|Overall Study|Lost to Follow-up|1|||
127672961|NCT03781804|459426473|FG002|Overall Study|Lost to Follow-up|2|||
127672962|NCT03781804|459426471|FG000|Overall Study|Lack of Efficacy|4|||
127672963|NCT03781804|459426472|FG001|Overall Study|Lack of Efficacy|2|||
127672964|NCT03781804|459426473|FG002|Overall Study|Lack of Efficacy|9|||
127672965|NCT03781804|459426471|FG000|Overall Study|Protocol Violation|0|||
127672966|NCT03781804|459426472|FG001|Overall Study|Protocol Violation|0|||
127672967|NCT03781804|459426473|FG002|Overall Study|Protocol Violation|1|||
127672968|NCT03781804|459426471|FG000|Overall Study|Withdrawal by Subject|0|||
127672969|NCT03781804|459426472|FG001|Overall Study|Withdrawal by Subject|1|||
127672970|NCT03781804|459426473|FG002|Overall Study|Withdrawal by Subject|1|||
127672971|NCT03781804|459426471|FG000|Overall Study|Reason not provided|2|||
127672972|NCT03781804|459426472|FG001|Overall Study|Reason not provided|2|||
127672973|NCT03781804|459426473|FG002|Overall Study|Reason not provided|0|||
127672974|NCT01836458|459426475|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
127672975|NCT01836458|459426476|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
127672976|NCT01836458|459426477|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
127672977|NCT01836458|459426478|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
127672978|NCT02189863|459426479|FG000|First 2 Weeks|Motion Sickness|4|||
127672979|NCT02189863|459426480|FG001|First 2 Weeks|Motion Sickness|2|||
127672980|NCT01458275|459426481|FG000|Overall Study|Adverse Event|3|||
127672981|NCT01458275|459426482|FG001|Overall Study|Adverse Event|4|||
127672982|NCT01458275|459426483|FG002|Overall Study|Adverse Event|1|||
127672983|NCT01458275|459426481|FG000|Overall Study|Lost to Follow-up|3|||
127672984|NCT01458275|459426482|FG001|Overall Study|Lost to Follow-up|2|||
127672985|NCT01458275|459426483|FG002|Overall Study|Lost to Follow-up|5|||
127672986|NCT01458275|459426481|FG000|Overall Study|Protocol Violation|5|||
127672987|NCT01458275|459426482|FG001|Overall Study|Protocol Violation|5|||
127672988|NCT01458275|459426483|FG002|Overall Study|Protocol Violation|2|||
127672989|NCT01458275|459426481|FG000|Overall Study|Withdrawal by Subject|3|||
127672990|NCT01458275|459426482|FG001|Overall Study|Withdrawal by Subject|2|||
127672991|NCT01458275|459426483|FG002|Overall Study|Withdrawal by Subject|1|||
127672992|NCT03369951|459426485|FG000|Overall Study|Withdrawal by Subject|3|||
127672993|NCT03369951|459426485|FG000|Overall Study|Death|1|||
127672994|NCT03369951|459426485|FG000|Overall Study|Lost to Follow-up|1|||
127672995|NCT03369951|459426485|FG000|Overall Study|Protocol Violation|1|||
127672996|NCT02926937|459426489|FG000|Overall Study|Adverse Event|0|||
127672997|NCT02926937|459426490|FG001|Overall Study|Adverse Event|1|||
127672998|NCT02926937|459426491|FG002|Overall Study|Adverse Event|1|||
127672999|NCT02926937|459426489|FG000|Overall Study|Poor Compliance to Protocol|1|||
127673000|NCT02926937|459426490|FG001|Overall Study|Poor Compliance to Protocol|0|||
127673001|NCT02926937|459426491|FG002|Overall Study|Poor Compliance to Protocol|0|||
127673002|NCT02926937|459426489|FG000|Overall Study|Lost to Follow-up|4|||
127673003|NCT02926937|459426490|FG001|Overall Study|Lost to Follow-up|5|||
127673004|NCT02926937|459426491|FG002|Overall Study|Lost to Follow-up|0|||
127673005|NCT02926937|459426489|FG000|Overall Study|At the Participant's own Request|11|||
127673006|NCT02926937|459426490|FG001|Overall Study|At the Participant's own Request|5|||
127673007|NCT02926937|459426491|FG002|Overall Study|At the Participant's own Request|8|||
127673008|NCT02926937|459426489|FG000|Overall Study|Reason not Specified|3|||
127673009|NCT02926937|459426490|FG001|Overall Study|Reason not Specified|4|||
127673010|NCT02926937|459426491|FG002|Overall Study|Reason not Specified|2|||
127673011|NCT03677375|459426492|FG000|Overall Study|Incomplete procedure|8|||
127673012|NCT03677375|459426492|FG000|Overall Study|Adverse Event|3|||
127673013|NCT03677375|459426492|FG000|Overall Study|Physician Decision|1|||
127673014|NCT00561574|459426498|FG000|Overall Study|Adverse Event|21|||
127673015|NCT00561574|459426499|FG001|Overall Study|Adverse Event|24|||
127673016|NCT00561574|459426498|FG000|Overall Study|Lack of Efficacy|11|||
127673017|NCT00561574|459426499|FG001|Overall Study|Lack of Efficacy|21|||
127673018|NCT00561574|459426498|FG000|Overall Study|Withdrawal by Subject|4|||
127673019|NCT00561574|459426499|FG001|Overall Study|Withdrawal by Subject|4|||
127673020|NCT00561574|459426498|FG000|Overall Study|Reason Unrelated to Trial|6|||
127673021|NCT00561574|459426499|FG001|Overall Study|Reason Unrelated to Trial|2|||
127673022|NCT00561574|459426498|FG000|Overall Study|Lost to Follow-up|1|||
127673023|NCT00561574|459426499|FG001|Overall Study|Lost to Follow-up|0|||
127673024|NCT00561574|459426498|FG000|Overall Study|Other|5|||
127673025|NCT00561574|459426499|FG001|Overall Study|Other|7|||
127673026|NCT03971357|459426500|FG000|Overall Study|Lack of Efficacy|0|||
127673027|NCT03971357|459426501|FG001|Overall Study|Lack of Efficacy|1|||
127673028|NCT00124982|459426508|FG000|Short-term Period|Death|1|||
127673029|NCT00124982|459426509|FG001|Short-term Period|Death|1|||
127673030|NCT00124982|459426510|FG002|Short-term Period|Death|0|||
127673031|NCT00124982|459426508|FG000|Short-term Period|Adverse Event|17|||
127673032|NCT00124982|459426509|FG001|Short-term Period|Adverse Event|22|||
127673033|NCT00124982|459426510|FG002|Short-term Period|Adverse Event|0|||
127673034|NCT00124982|459426508|FG000|Short-term Period|Lack of Efficacy|32|||
127673035|NCT00124982|459426509|FG001|Short-term Period|Lack of Efficacy|73|||
127673036|NCT00124982|459426510|FG002|Short-term Period|Lack of Efficacy|0|||
127673037|NCT00124982|459426508|FG000|Short-term Period|Lost to Follow-up|8|||
127673038|NCT00124982|459426509|FG001|Short-term Period|Lost to Follow-up|5|||
127673039|NCT00124982|459426510|FG002|Short-term Period|Lost to Follow-up|0|||
127673040|NCT00124982|459426508|FG000|Short-term Period|Withdrawal of Consent|7|||
127673041|NCT00124982|459426509|FG001|Short-term Period|Withdrawal of Consent|9|||
127673042|NCT00124982|459426510|FG002|Short-term Period|Withdrawal of Consent|0|||
127673043|NCT00124982|459426508|FG000|Short-term Period|Poor/Non-compliance|3|||
127673044|NCT00124982|459426509|FG001|Short-term Period|Poor/Non-compliance|1|||
127673045|NCT00124982|459426510|FG002|Short-term Period|Poor/Non-compliance|0|||
127673046|NCT00124982|459426508|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
127673047|NCT00124982|459426509|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
127673048|NCT00124982|459426510|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
127673049|NCT00124982|459426508|FG000|Short-term Period|Participant Decision|1|||
127673050|NCT00124982|459426509|FG001|Short-term Period|Participant Decision|0|||
127673051|NCT00124982|459426510|FG002|Short-term Period|Participant Decision|0|||
127673052|NCT00124982|459426508|FG000|Short-term Period|Participant Chose Own Doctor|0|||
127673053|NCT00124982|459426509|FG001|Short-term Period|Participant Chose Own Doctor|1|||
127673054|NCT00124982|459426510|FG002|Short-term Period|Participant Chose Own Doctor|0|||
127673055|NCT00124982|459426508|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
127673056|NCT00124982|459426509|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
127673057|NCT00124982|459426510|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
127673058|NCT00124982|459426508|FG000|Short-term Period|Participant Had Lymphopenia|1|||
127673059|NCT00124982|459426509|FG001|Short-term Period|Participant Had Lymphopenia|0|||
127673060|NCT00124982|459426510|FG002|Short-term Period|Participant Had Lymphopenia|0|||
127673061|NCT00124982|459426508|FG000|Long-term Period|Death|0|||
127673062|NCT00124982|459426509|FG001|Long-term Period|Death|0|||
127673063|NCT00124982|459426510|FG002|Long-term Period|Death|1|||
127673064|NCT00124982|459426508|FG000|Long-term Period|Adverse Event|0|||
127673065|NCT00124982|459426509|FG001|Long-term Period|Adverse Event|0|||
127673066|NCT00124982|459426510|FG002|Long-term Period|Adverse Event|17|||
127673067|NCT00124982|459426508|FG000|Long-term Period|Lack of Efficacy|0|||
127673068|NCT00124982|459426509|FG001|Long-term Period|Lack of Efficacy|0|||
127673069|NCT00124982|459426510|FG002|Long-term Period|Lack of Efficacy|46|||
127673070|NCT00124982|459426508|FG000|Long-term Period|Lost to Follow-up|0|||
127673071|NCT00124982|459426509|FG001|Long-term Period|Lost to Follow-up|0|||
127673072|NCT00124982|459426510|FG002|Long-term Period|Lost to Follow-up|4|||
127673073|NCT00124982|459426508|FG000|Long-term Period|Withdrawal by Subject|0|||
127673074|NCT00124982|459426509|FG001|Long-term Period|Withdrawal by Subject|0|||
127673075|NCT00124982|459426510|FG002|Long-term Period|Withdrawal by Subject|16|||
127673076|NCT00124982|459426508|FG000|Long-term Period|Pregnancy|0|||
127673077|NCT00124982|459426509|FG001|Long-term Period|Pregnancy|0|||
127673078|NCT00124982|459426510|FG002|Long-term Period|Pregnancy|1|||
127673079|NCT00124982|459426508|FG000|Long-term Period|Poor/Non-compliance|0|||
127673080|NCT00124982|459426509|FG001|Long-term Period|Poor/Non-compliance|0|||
127673081|NCT00124982|459426510|FG002|Long-term Period|Poor/Non-compliance|2|||
127673082|NCT00124982|459426508|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
127673083|NCT00124982|459426509|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
127673084|NCT00124982|459426510|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
127673085|NCT00124982|459426508|FG000|Long-term Period|Neurologist Recommendation|0|||
127673086|NCT00124982|459426509|FG001|Long-term Period|Neurologist Recommendation|0|||
127673087|NCT00124982|459426510|FG002|Long-term Period|Neurologist Recommendation|1|||
127673088|NCT00630864|459426511|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
127673089|NCT00630864|459426511|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
127673090|NCT00430677|459426512|FG000|Short-term Period|Death|1|||
127673091|NCT00430677|459426513|FG001|Short-term Period|Death|1|||
127673092|NCT00430677|459426514|FG002|Short-term Period|Death|5|||
127673093|NCT00430677|459426512|FG000|Short-term Period|Adverse Event|15|||
127673094|NCT00430677|459426513|FG001|Short-term Period|Adverse Event|13|||
127673095|NCT00430677|459426514|FG002|Short-term Period|Adverse Event|9|||
127673096|NCT00430677|459426512|FG000|Short-term Period|Lack of Efficacy|5|||
127673097|NCT00430677|459426513|FG001|Short-term Period|Lack of Efficacy|6|||
127673098|NCT00430677|459426514|FG002|Short-term Period|Lack of Efficacy|4|||
127673099|NCT00430677|459426512|FG000|Short-term Period|Withdrawal by Subject|1|||
127673100|NCT00430677|459426513|FG001|Short-term Period|Withdrawal by Subject|1|||
127673101|NCT00430677|459426514|FG002|Short-term Period|Withdrawal by Subject|2|||
127673102|NCT00430677|459426512|FG000|Short-term Period|Participant no longer met study criteria|1|||
127673103|NCT00430677|459426513|FG001|Short-term Period|Participant no longer met study criteria|1|||
127673104|NCT00430677|459426514|FG002|Short-term Period|Participant no longer met study criteria|2|||
127673105|NCT00430677|459426512|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
127673106|NCT00430677|459426513|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
127673107|NCT00430677|459426514|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
127673108|NCT00430677|459426512|FG000|Short-term Period|Pregnancy|0|||
127673109|NCT00430677|459426513|FG001|Short-term Period|Pregnancy|2|||
127673110|NCT00430677|459426514|FG002|Short-term Period|Pregnancy|0|||
127673111|NCT00430677|459426512|FG000|Long-term Extension Period|Death|1|||
127673112|NCT00430677|459426513|FG001|Long-term Extension Period|Death|0|||
127673113|NCT00430677|459426514|FG002|Long-term Extension Period|Death|0|||
127673114|NCT00430677|459426512|FG000|Long-term Extension Period|Adverse Event|3|||
127673115|NCT00430677|459426513|FG001|Long-term Extension Period|Adverse Event|2|||
127673116|NCT00430677|459426514|FG002|Long-term Extension Period|Adverse Event|5|||
127673117|NCT00430677|459426512|FG000|Long-term Extension Period|Lack of Efficacy|5|||
127673118|NCT00430677|459426513|FG001|Long-term Extension Period|Lack of Efficacy|3|||
127673119|NCT00430677|459426514|FG002|Long-term Extension Period|Lack of Efficacy|8|||
127673120|NCT00430677|459426512|FG000|Long-term Extension Period|Lost to Follow-up|1|||
127673121|NCT00430677|459426513|FG001|Long-term Extension Period|Lost to Follow-up|1|||
127673122|NCT00430677|459426514|FG002|Long-term Extension Period|Lost to Follow-up|1|||
127673123|NCT00430677|459426512|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
127673124|NCT00430677|459426513|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
127673125|NCT00430677|459426514|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
127673126|NCT00430677|459426512|FG000|Long-term Extension Period|Pregnancy|1|||
127673127|NCT00430677|459426513|FG001|Long-term Extension Period|Pregnancy|1|||
127673128|NCT00430677|459426514|FG002|Long-term Extension Period|Pregnancy|0|||
127673129|NCT00430677|459426512|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
127673130|NCT00430677|459426513|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
127673131|NCT00430677|459426514|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
127673132|NCT00430677|459426512|FG000|Long-term Extension Period|Other|2|||
127673133|NCT00430677|459426513|FG001|Long-term Extension Period|Other|1|||
127673134|NCT00430677|459426514|FG002|Long-term Extension Period|Other|1|||
127673135|NCT00430677|459426512|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
127673136|NCT00430677|459426513|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
127673137|NCT00430677|459426514|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
127673138|NCT01555762|459426515|FG000|Overall Study|No information on Bevacizumab intake|11|||
127673139|NCT01555762|459426515|FG000|Overall Study|Missing start date of infusion|8|||
127673140|NCT01555762|459426515|FG000|Overall Study|75 years old or more ticked No|1|||
127673141|NCT01555762|459426515|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
127673142|NCT01555762|459426515|FG000|Overall Study|Death linked to progression of disease|165|||
127673143|NCT01555762|459426515|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
127673144|NCT01555762|459426515|FG000|Overall Study|Investigator's decision|10|||
127673145|NCT01555762|459426515|FG000|Overall Study|Participant not wishing to continue|5|||
127673146|NCT01555762|459426515|FG000|Overall Study|Missing data|1|||
127673147|NCT01555762|459426515|FG000|Overall Study|Death linked to an adverse event|14|||
127673148|NCT01333514|459426516|FG000|Overall Study|Withdrawal by Subject|1|||
127673149|NCT01333514|459426517|FG001|Overall Study|Withdrawal by Subject|0|||
127673150|NCT00836810|459426518|FG000|Overall Study|New diagnosis|1|||
127673151|NCT00836810|459426519|FG001|Overall Study|New diagnosis|0|||
127673152|NCT00389519|459426522|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
127673153|NCT00389519|459426523|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
127673154|NCT00389519|459426524|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
127673155|NCT00389519|459426525|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
127673156|NCT00389519|459426522|FG000|Placebo Run-In|Withdrawal by Subject|19|||
127673157|NCT00389519|459426523|FG001|Placebo Run-In|Withdrawal by Subject|0|||
127673158|NCT00389519|459426524|FG002|Placebo Run-In|Withdrawal by Subject|0|||
127673159|NCT00389519|459426525|FG003|Placebo Run-In|Withdrawal by Subject|0|||
127673160|NCT00389519|459426522|FG000|Placebo Run-In|Reason not specified|40|||
127673161|NCT00389519|459426523|FG001|Placebo Run-In|Reason not specified|0|||
127673162|NCT00389519|459426524|FG002|Placebo Run-In|Reason not specified|0|||
127673163|NCT00389519|459426525|FG003|Placebo Run-In|Reason not specified|0|||
127673164|NCT00389519|459426522|FG000|Randomized|Did not receive study drug|2|||
127673165|NCT00389519|459426523|FG001|Randomized|Did not receive study drug|0|||
127673166|NCT00389519|459426524|FG002|Randomized|Did not receive study drug|0|||
127673167|NCT00389519|459426525|FG003|Randomized|Did not receive study drug|0|||
127673168|NCT00389519|459426522|FG000|Treated|Adverse Event|1|||
127673169|NCT00389519|459426523|FG001|Treated|Adverse Event|0|||
127673170|NCT00389519|459426524|FG002|Treated|Adverse Event|0|||
127673171|NCT00389519|459426525|FG003|Treated|Adverse Event|2|||
127673172|NCT00389519|459426522|FG000|Treated|Reason not specified|1|||
127673173|NCT00389519|459426523|FG001|Treated|Reason not specified|1|||
127673174|NCT00389519|459426524|FG002|Treated|Reason not specified|0|||
127673175|NCT00389519|459426525|FG003|Treated|Reason not specified|2|||
127673176|NCT00946192|459426526|FG000|Overall Study|Lost to Follow-up|6|||
127673177|NCT00946192|459426527|FG001|Overall Study|Lost to Follow-up|11|||
127673178|NCT00946192|459426528|FG002|Overall Study|Lost to Follow-up|9|||
127673179|NCT00946192|459426526|FG000|Overall Study|Withdrawal by Subject|10|||
127673180|NCT00946192|459426527|FG001|Overall Study|Withdrawal by Subject|7|||
127673181|NCT00946192|459426528|FG002|Overall Study|Withdrawal by Subject|3|||
127673182|NCT00946192|459426526|FG000|Overall Study|Did not start medication|2|||
127673183|NCT00946192|459426527|FG001|Overall Study|Did not start medication|0|||
127673184|NCT00946192|459426528|FG002|Overall Study|Did not start medication|0|||
127673185|NCT01080131|459426529|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
127673186|NCT01080131|459426530|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
128007756|NCT03451045|460656618|FG001|Overall Study|Withdrawal by Subject|0|||
127673187|NCT01080131|459426529|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
127673188|NCT01080131|459426530|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
127673189|NCT01080131|459426529|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
127673190|NCT01080131|459426530|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
127673191|NCT01080131|459426529|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
127673192|NCT01080131|459426530|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
127673193|NCT01080131|459426529|FG000|Core Study (0- 12 Weeks)|Death|1|||
127673194|NCT01080131|459426530|FG001|Core Study (0- 12 Weeks)|Death|0|||
127673195|NCT01080131|459426529|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
127673196|NCT01080131|459426530|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
127673197|NCT01080131|459426529|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
127673198|NCT01080131|459426530|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
127673199|NCT01080131|459426529|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
127673200|NCT01080131|459426530|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
127673201|NCT01080131|459426529|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
127673202|NCT01080131|459426530|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
127673203|NCT01080131|459426529|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
127673204|NCT01080131|459426530|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
127673205|NCT01080131|459426529|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
127673206|NCT01080131|459426530|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
127673207|NCT01080131|459426529|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
127673208|NCT01080131|459426530|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
127673209|NCT01080131|459426529|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
127673210|NCT01080131|459426530|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
127673211|NCT04155424|459426531|FG000|Overall Study|Other than specified|3|||
127673212|NCT04155424|459426531|FG000|Overall Study|Withdrawal by Subject|1|||
127673213|NCT04155424|459426531|FG000|Overall Study|Adverse Event|1|||
127673214|NCT04159506|459426532|FG000|Overall Study|Lost to Follow-up|2|||
127673215|NCT04159506|459426533|FG001|Overall Study|Lost to Follow-up|5|||
127673216|NCT02624778|459428034|FG000|Overall Study|Lost to Follow-up|0|||
127673217|NCT02624778|459428035|FG001|Overall Study|Lost to Follow-up|0|||
127673218|NCT02624778|459428036|FG002|Overall Study|Lost to Follow-up|1|||
127673219|NCT02624778|459428037|FG003|Overall Study|Lost to Follow-up|0|||
127673220|NCT02624778|459428038|FG004|Overall Study|Lost to Follow-up|0|||
127673221|NCT02624778|459428039|FG005|Overall Study|Lost to Follow-up|0|||
127673222|NCT02624778|459428040|FG006|Overall Study|Lost to Follow-up|0|||
127673223|NCT02624778|459428041|FG007|Overall Study|Lost to Follow-up|0|||
127673224|NCT02624778|459428042|FG008|Overall Study|Lost to Follow-up|0|||
127673225|NCT02624778|459428034|FG000|Overall Study|Withdrawal by Subject|0|||
127673226|NCT02624778|459428035|FG001|Overall Study|Withdrawal by Subject|1|||
127673227|NCT02624778|459428036|FG002|Overall Study|Withdrawal by Subject|0|||
127673228|NCT02624778|459428037|FG003|Overall Study|Withdrawal by Subject|0|||
127673229|NCT02624778|459428038|FG004|Overall Study|Withdrawal by Subject|0|||
127673230|NCT02624778|459428039|FG005|Overall Study|Withdrawal by Subject|1|||
127673231|NCT02624778|459428040|FG006|Overall Study|Withdrawal by Subject|1|||
127673232|NCT02624778|459428041|FG007|Overall Study|Withdrawal by Subject|1|||
127673233|NCT02624778|459428042|FG008|Overall Study|Withdrawal by Subject|1|||
127673234|NCT02624778|459428034|FG000|Overall Study|Adverse Event|0|||
127673235|NCT02624778|459428035|FG001|Overall Study|Adverse Event|0|||
127673236|NCT02624778|459428036|FG002|Overall Study|Adverse Event|0|||
127673237|NCT02624778|459428037|FG003|Overall Study|Adverse Event|0|||
127673238|NCT02624778|459428038|FG004|Overall Study|Adverse Event|0|||
127673239|NCT02624778|459428039|FG005|Overall Study|Adverse Event|0|||
127673240|NCT02624778|459428040|FG006|Overall Study|Adverse Event|0|||
127673241|NCT02624778|459428041|FG007|Overall Study|Adverse Event|0|||
127673242|NCT02624778|459428042|FG008|Overall Study|Adverse Event|2|||
127673243|NCT02624778|459428034|FG000|Overall Study|Death|0|||
127673244|NCT02624778|459428035|FG001|Overall Study|Death|0|||
127673245|NCT02624778|459428036|FG002|Overall Study|Death|0|||
127673246|NCT02624778|459428037|FG003|Overall Study|Death|0|||
127673247|NCT02624778|459428038|FG004|Overall Study|Death|0|||
127673248|NCT02624778|459428039|FG005|Overall Study|Death|0|||
127673249|NCT02624778|459428040|FG006|Overall Study|Death|1|||
127673250|NCT02624778|459428041|FG007|Overall Study|Death|0|||
127673251|NCT02624778|459428042|FG008|Overall Study|Death|0|||
127673252|NCT02624778|459428034|FG000|Overall Study|Physician Decision|0|||
127673253|NCT02624778|459428035|FG001|Overall Study|Physician Decision|0|||
127673254|NCT02624778|459428036|FG002|Overall Study|Physician Decision|0|||
127673255|NCT02624778|459428037|FG003|Overall Study|Physician Decision|0|||
127673256|NCT02624778|459428038|FG004|Overall Study|Physician Decision|0|||
127673257|NCT02624778|459428039|FG005|Overall Study|Physician Decision|0|||
127673258|NCT02624778|459428040|FG006|Overall Study|Physician Decision|0|||
127673259|NCT02624778|459428041|FG007|Overall Study|Physician Decision|3|||
127673260|NCT02624778|459428042|FG008|Overall Study|Physician Decision|3|||
127673261|NCT01537133|459428048|FG000|Overall Study|Withdrawal by Subject|2|||
127673262|NCT01537133|459428049|FG001|Overall Study|Withdrawal by Subject|0|||
127673263|NCT01537133|459428050|FG002|Overall Study|Withdrawal by Subject|0|||
127673264|NCT01537133|459428051|FG003|Overall Study|Withdrawal by Subject|0|||
127673265|NCT01537133|459428048|FG000|Overall Study|Lost to Follow-up|1|||
127673266|NCT01537133|459428049|FG001|Overall Study|Lost to Follow-up|0|||
127673267|NCT01537133|459428050|FG002|Overall Study|Lost to Follow-up|0|||
127673268|NCT01537133|459428051|FG003|Overall Study|Lost to Follow-up|0|||
127673269|NCT00531479|459428052|FG000|Overall Study|Death|68|||
127673270|NCT00531479|459428053|FG001|Overall Study|Death|71|||
127673271|NCT00531479|459428052|FG000|Overall Study|Lost to Follow-up|0|||
127673272|NCT00531479|459428053|FG001|Overall Study|Lost to Follow-up|2|||
127673273|NCT00531479|459428052|FG000|Overall Study|Other|0|||
127673274|NCT00531479|459428053|FG001|Overall Study|Other|1|||
127673275|NCT00531479|459428052|FG000|Overall Study|Withdrawal by Subject|6|||
127673276|NCT00531479|459428053|FG001|Overall Study|Withdrawal by Subject|6|||
127673277|NCT00531479|459428052|FG000|Overall Study|Did not receive treatment|2|||
127673278|NCT00531479|459428053|FG001|Overall Study|Did not receive treatment|3|||
127673279|NCT02501629|459428058|FG000|Overall Study|Death|0|||
127673280|NCT02501629|459428059|FG001|Overall Study|Death|1|||
127673281|NCT02501629|459428058|FG000|Overall Study|Withdrawn from study by sponsor|1|||
127673282|NCT02501629|459428059|FG001|Overall Study|Withdrawn from study by sponsor|0|||
127673283|NCT02501629|459428058|FG000|Overall Study|Early termination by sponsor|1|||
127673284|NCT02501629|459428059|FG001|Overall Study|Early termination by sponsor|0|||
127673285|NCT02501629|459428058|FG000|Overall Study|Withdrawal by Subject|3|||
127673286|NCT02501629|459428059|FG001|Overall Study|Withdrawal by Subject|5|||
127673287|NCT02501629|459428058|FG000|Overall Study|Subject did not return to site|0|||
127673288|NCT02501629|459428059|FG001|Overall Study|Subject did not return to site|1|||
127673289|NCT00868231|459428062|FG000|Treatment Period 1|Adverse Event|0|||
127673290|NCT00868231|459428063|FG001|Treatment Period 1|Adverse Event|0|||
127673291|NCT00868231|459428064|FG002|Treatment Period 1|Adverse Event|0|||
127673292|NCT00868231|459428065|FG003|Treatment Period 1|Adverse Event|0|||
127673293|NCT00868231|459428066|FG004|Treatment Period 1|Adverse Event|1|||
127673294|NCT00868231|459428067|FG005|Treatment Period 1|Adverse Event|0|||
127673295|NCT00868231|459428062|FG000|Treatment Period 2|Adverse Event|1|||
127673296|NCT00868231|459428063|FG001|Treatment Period 2|Adverse Event|0|||
127673297|NCT00868231|459428064|FG002|Treatment Period 2|Adverse Event|0|||
127673298|NCT00868231|459428065|FG003|Treatment Period 2|Adverse Event|0|||
127673299|NCT00868231|459428066|FG004|Treatment Period 2|Adverse Event|0|||
127673300|NCT00868231|459428067|FG005|Treatment Period 2|Adverse Event|0|||
127673301|NCT00868231|459428062|FG000|Treatment Period 3|Adverse Event|0|||
127673302|NCT00868231|459428063|FG001|Treatment Period 3|Adverse Event|0|||
127673303|NCT00868231|459428064|FG002|Treatment Period 3|Adverse Event|1|||
127673304|NCT00868231|459428065|FG003|Treatment Period 3|Adverse Event|0|||
127673305|NCT00868231|459428066|FG004|Treatment Period 3|Adverse Event|0|||
127673306|NCT00868231|459428067|FG005|Treatment Period 3|Adverse Event|0|||
127673307|NCT02321540|459428073|FG000|Overall Study|Death|0|||
127673308|NCT02321540|459428074|FG001|Overall Study|Death|1|||
127673309|NCT02321540|459428073|FG000|Overall Study|Progression|3|||
127673310|NCT02321540|459428074|FG001|Overall Study|Progression|9|||
127673311|NCT00530335|459428075|FG000|Overall Study|Adverse Event|3|||
127673312|NCT00530335|459428075|FG000|Overall Study|Protocol Violation|1|||
127673313|NCT00530335|459428075|FG000|Overall Study|Withdrawal by Subject|1|||
127673314|NCT00530335|459428075|FG000|Overall Study|Physician Decision|1|||
127673315|NCT04577183|459428076|FG000|Overall Study|Death|1|||
127673316|NCT04577183|459428076|FG000|Overall Study|Withdrawal by Subject|3|||
127673317|NCT04577183|459428076|FG000|Overall Study|Early termination|2|||
127673318|NCT01168401|459428077|FG000|Overall Study|Lost to Follow-up|1|||
127673319|NCT01168401|459428078|FG001|Overall Study|Lost to Follow-up|1|||
127673320|NCT01168401|459428079|FG002|Overall Study|Lost to Follow-up|2|||
127673321|NCT01168401|459428080|FG003|Overall Study|Lost to Follow-up|1|||
127673322|NCT01168401|459428081|FG004|Overall Study|Lost to Follow-up|0|||
127673323|NCT01168401|459428082|FG005|Overall Study|Lost to Follow-up|0|||
127673324|NCT01168401|459428083|FG006|Overall Study|Lost to Follow-up|0|||
127673325|NCT01168401|459428084|FG007|Overall Study|Lost to Follow-up|0|||
127673326|NCT01168401|459428085|FG008|Overall Study|Lost to Follow-up|0|||
127673327|NCT01168401|459428086|FG009|Overall Study|Lost to Follow-up|0|||
127673328|NCT01168401|459428087|FG010|Overall Study|Lost to Follow-up|0|||
127673329|NCT01168401|459428077|FG000|Overall Study|Withdrawal by Subject|0|||
127673330|NCT01168401|459428078|FG001|Overall Study|Withdrawal by Subject|0|||
127673331|NCT01168401|459428079|FG002|Overall Study|Withdrawal by Subject|0|||
127673332|NCT01168401|459428080|FG003|Overall Study|Withdrawal by Subject|1|||
127673333|NCT01168401|459428081|FG004|Overall Study|Withdrawal by Subject|0|||
127673334|NCT01168401|459428082|FG005|Overall Study|Withdrawal by Subject|0|||
127673335|NCT01168401|459428083|FG006|Overall Study|Withdrawal by Subject|0|||
127673336|NCT01168401|459428084|FG007|Overall Study|Withdrawal by Subject|0|||
127673337|NCT01168401|459428085|FG008|Overall Study|Withdrawal by Subject|0|||
127673338|NCT01168401|459428086|FG009|Overall Study|Withdrawal by Subject|0|||
127673339|NCT01168401|459428087|FG010|Overall Study|Withdrawal by Subject|0|||
127673340|NCT00672256|459428092|FG000|Overall Study|PI dropped, bad data|44|||
127673341|NCT01268891|459428095|FG000|Overall Study|Adverse Event|3|||
127673342|NCT01268891|459428096|FG001|Overall Study|Adverse Event|7|||
127673343|NCT01268891|459428095|FG000|Overall Study|Lack of Efficacy|1|||
127673344|NCT01268891|459428096|FG001|Overall Study|Lack of Efficacy|0|||
127673345|NCT01268891|459428095|FG000|Overall Study|Withdrawal of Consent|3|||
127673346|NCT01268891|459428096|FG001|Overall Study|Withdrawal of Consent|1|||
127673347|NCT01268891|459428095|FG000|Overall Study|Administrative or other reason(s)|1|||
127673348|NCT01268891|459428096|FG001|Overall Study|Administrative or other reason(s)|0|||
127673349|NCT01720043|459428098|FG000|Overall Study|Withdrawal by Subject|1|||
127673350|NCT00938340|459428102|FG000|Overall Study|Withdrawal by Subject|3|||
127673351|NCT00938340|459428102|FG000|Overall Study|Protocol Violation|1|||
127673352|NCT00938340|459428102|FG000|Overall Study|Adverse Event|1|||
127673353|NCT02534896|459428103|FG000|Overall Study|Adverse Event|2|||
127673354|NCT02534896|459428104|FG001|Overall Study|Adverse Event|1|||
127673355|NCT02534896|459428105|FG002|Overall Study|Adverse Event|1|||
127673356|NCT02534896|459428103|FG000|Overall Study|Insufficient therapeutic response|2|||
127673357|NCT02534896|459428104|FG001|Overall Study|Insufficient therapeutic response|0|||
127673358|NCT02534896|459428105|FG002|Overall Study|Insufficient therapeutic response|0|||
127673359|NCT01107626|459428110|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
127673360|NCT01107626|459428111|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
127673361|NCT01107626|459428112|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
127673362|NCT01107626|459428113|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
127673363|NCT01107626|459428110|FG000|Step 1: Induction Therapy|Adverse Event|198|||
127673364|NCT01107626|459428111|FG001|Step 1: Induction Therapy|Adverse Event|0|||
127673365|NCT01107626|459428112|FG002|Step 1: Induction Therapy|Adverse Event|0|||
127673366|NCT01107626|459428113|FG003|Step 1: Induction Therapy|Adverse Event|0|||
127673367|NCT01107626|459428110|FG000|Step 1: Induction Therapy|Death|62|||
127673368|NCT01107626|459428111|FG001|Step 1: Induction Therapy|Death|0|||
127673369|NCT01107626|459428112|FG002|Step 1: Induction Therapy|Death|0|||
127673370|NCT01107626|459428113|FG003|Step 1: Induction Therapy|Death|0|||
127673371|NCT01107626|459428110|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
127673372|NCT01107626|459428111|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
127673373|NCT01107626|459428112|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
127673374|NCT01107626|459428113|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
127673375|NCT01107626|459428110|FG000|Step 1: Induction Therapy|Complicating disease|13|||
127673376|NCT01107626|459428111|FG001|Step 1: Induction Therapy|Complicating disease|0|||
127673377|NCT01107626|459428112|FG002|Step 1: Induction Therapy|Complicating disease|0|||
127673378|NCT01107626|459428113|FG003|Step 1: Induction Therapy|Complicating disease|0|||
127673379|NCT01107626|459428110|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
127673380|NCT01107626|459428111|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
127673381|NCT01107626|459428112|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
127673382|NCT01107626|459428113|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
127673383|NCT01107626|459428110|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
127673384|NCT01107626|459428111|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
127673385|NCT01107626|459428112|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
127673386|NCT01107626|459428113|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
127673387|NCT01107626|459428110|FG000|Step 1: Induction Therapy|Non-compliance|4|||
127673388|NCT01107626|459428111|FG001|Step 1: Induction Therapy|Non-compliance|0|||
127673389|NCT01107626|459428112|FG002|Step 1: Induction Therapy|Non-compliance|0|||
127673390|NCT01107626|459428113|FG003|Step 1: Induction Therapy|Non-compliance|0|||
127673391|NCT01107626|459428110|FG000|Step 1: Induction Therapy|Pain|4|||
127673392|NCT01107626|459428111|FG001|Step 1: Induction Therapy|Pain|0|||
127673393|NCT01107626|459428112|FG002|Step 1: Induction Therapy|Pain|0|||
127673394|NCT01107626|459428113|FG003|Step 1: Induction Therapy|Pain|0|||
127673395|NCT01107626|459428110|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
127673396|NCT01107626|459428111|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
127673397|NCT01107626|459428112|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
127673398|NCT01107626|459428113|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
127673399|NCT01107626|459428110|FG000|Step 1: Induction Therapy|Hospice care|1|||
127673400|NCT01107626|459428111|FG001|Step 1: Induction Therapy|Hospice care|0|||
127673401|NCT01107626|459428112|FG002|Step 1: Induction Therapy|Hospice care|0|||
127673402|NCT01107626|459428113|FG003|Step 1: Induction Therapy|Hospice care|0|||
127673403|NCT01107626|459428110|FG000|Step 1: Induction Therapy|Physician Decision|1|||
127673404|NCT01107626|459428111|FG001|Step 1: Induction Therapy|Physician Decision|0|||
127673405|NCT01107626|459428112|FG002|Step 1: Induction Therapy|Physician Decision|0|||
127673406|NCT01107626|459428113|FG003|Step 1: Induction Therapy|Physician Decision|0|||
127673407|NCT01107626|459428110|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
127673408|NCT01107626|459428111|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
127673409|NCT01107626|459428112|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
127673410|NCT01107626|459428113|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
127673411|NCT01107626|459428110|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
127673412|NCT01107626|459428111|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
127673413|NCT01107626|459428112|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
127673414|NCT01107626|459428113|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
127673415|NCT01107626|459428110|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
127673416|NCT01107626|459428111|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
127673417|NCT01107626|459428112|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
127673418|NCT01107626|459428113|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
127673419|NCT01107626|459428110|FG000|Step 2: Maintenance Therapy|Death|0|||
127673420|NCT01107626|459428111|FG001|Step 2: Maintenance Therapy|Death|8|||
127673421|NCT01107626|459428112|FG002|Step 2: Maintenance Therapy|Death|2|||
127673422|NCT01107626|459428113|FG003|Step 2: Maintenance Therapy|Death|13|||
127673423|NCT01107626|459428110|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
127673424|NCT01107626|459428111|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
127673425|NCT01107626|459428112|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
127673426|NCT01107626|459428113|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
127673427|NCT01107626|459428110|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
127673428|NCT01107626|459428111|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
127673429|NCT01107626|459428112|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
127673430|NCT01107626|459428113|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
127673431|NCT01107626|459428110|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
127673432|NCT01107626|459428111|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
127673433|NCT01107626|459428112|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
127673434|NCT01107626|459428113|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
127673435|NCT01107626|459428110|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
127673436|NCT01107626|459428111|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
127673437|NCT01107626|459428112|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
127673438|NCT01107626|459428113|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
127673439|NCT01107626|459428110|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
127673440|NCT01107626|459428111|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
127673441|NCT01107626|459428112|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
127673442|NCT01107626|459428113|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
127673443|NCT01107626|459428110|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
127673444|NCT01107626|459428111|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
127673445|NCT01107626|459428112|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
127673446|NCT01107626|459428113|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
127673447|NCT01107626|459428110|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
127673448|NCT01107626|459428111|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
127673449|NCT01107626|459428112|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
127673450|NCT01107626|459428113|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
127673451|NCT01107626|459428110|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
127673452|NCT01107626|459428111|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
127673453|NCT01107626|459428112|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
127673454|NCT01107626|459428113|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
127673455|NCT01107626|459428110|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
127673456|NCT01107626|459428111|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
127673457|NCT01107626|459428112|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
127673458|NCT01107626|459428113|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
127673459|NCT01107626|459428110|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
127673460|NCT01107626|459428111|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
127673461|NCT01107626|459428112|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
127673462|NCT01107626|459428113|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
127673463|NCT01107626|459428110|FG000|Step 2: Maintenance Therapy|Pain|0|||
127673464|NCT01107626|459428111|FG001|Step 2: Maintenance Therapy|Pain|0|||
127673465|NCT01107626|459428112|FG002|Step 2: Maintenance Therapy|Pain|0|||
127673466|NCT01107626|459428113|FG003|Step 2: Maintenance Therapy|Pain|1|||
127673467|NCT01107626|459428110|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
127673468|NCT01107626|459428111|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
127673469|NCT01107626|459428112|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
127673470|NCT01107626|459428113|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
127673471|NCT04381494|459428114|FG000|Overall Study|Early termination of trial|19|||
127673472|NCT04381494|459428114|FG000|Overall Study|Investigator's discretion|1|||
127673473|NCT04381494|459428114|FG000|Overall Study|Withdrawal by Subject|9|||
127673474|NCT04381494|459428114|FG000|Overall Study|NSCLC disease progression|4|||
127673475|NCT04381494|459428114|FG000|Overall Study|Device-Related Adverse Event|2|||
127673476|NCT04310579|459428115|FG000|Overall Study|Adverse Event|0|||
127673477|NCT04310579|459428116|FG001|Overall Study|Adverse Event|0|||
127673478|NCT04310579|459428117|FG002|Overall Study|Adverse Event|0|||
127673479|NCT04310579|459428118|FG003|Overall Study|Adverse Event|0|||
127673480|NCT04310579|459428119|FG004|Overall Study|Adverse Event|0|||
127673481|NCT04310579|459428120|FG005|Overall Study|Adverse Event|0|||
127673482|NCT04310579|459428121|FG006|Overall Study|Adverse Event|2|||
127673483|NCT04310579|459428122|FG007|Overall Study|Adverse Event|0|||
127673484|NCT04310579|459428123|FG008|Overall Study|Adverse Event|1|||
127673485|NCT04310579|459428124|FG009|Overall Study|Adverse Event|1|||
127673486|NCT04310579|459428125|FG010|Overall Study|Adverse Event|0|||
127673487|NCT04310579|459428115|FG000|Overall Study|Withdrawal by Subject|0|||
127673488|NCT04310579|459428116|FG001|Overall Study|Withdrawal by Subject|0|||
127673489|NCT04310579|459428117|FG002|Overall Study|Withdrawal by Subject|0|||
127673490|NCT04310579|459428118|FG003|Overall Study|Withdrawal by Subject|0|||
127673491|NCT04310579|459428119|FG004|Overall Study|Withdrawal by Subject|0|||
127673492|NCT04310579|459428120|FG005|Overall Study|Withdrawal by Subject|1|||
127673493|NCT04310579|459428121|FG006|Overall Study|Withdrawal by Subject|0|||
127673494|NCT04310579|459428122|FG007|Overall Study|Withdrawal by Subject|0|||
127673495|NCT04310579|459428123|FG008|Overall Study|Withdrawal by Subject|0|||
127673496|NCT04310579|459428124|FG009|Overall Study|Withdrawal by Subject|0|||
127673497|NCT04310579|459428125|FG010|Overall Study|Withdrawal by Subject|0|||
127673498|NCT04310579|459428115|FG000|Overall Study|Positive COVID-19 test|0|||
127673499|NCT04310579|459428116|FG001|Overall Study|Positive COVID-19 test|0|||
127673500|NCT04310579|459428117|FG002|Overall Study|Positive COVID-19 test|0|||
127673501|NCT04310579|459428118|FG003|Overall Study|Positive COVID-19 test|0|||
127673502|NCT04310579|459428119|FG004|Overall Study|Positive COVID-19 test|0|||
127673503|NCT04310579|459428120|FG005|Overall Study|Positive COVID-19 test|0|||
127673504|NCT04310579|459428121|FG006|Overall Study|Positive COVID-19 test|0|||
127673505|NCT04310579|459428122|FG007|Overall Study|Positive COVID-19 test|0|||
127673506|NCT04310579|459428123|FG008|Overall Study|Positive COVID-19 test|0|||
127673507|NCT04310579|459428124|FG009|Overall Study|Positive COVID-19 test|0|||
127673508|NCT04310579|459428125|FG010|Overall Study|Positive COVID-19 test|1|||
127673509|NCT04353037|459428126|FG000|Overall Study|Lost to Follow-up|0|||
127673510|NCT04353037|459428127|FG001|Overall Study|Lost to Follow-up|1|||
127673511|NCT04353037|459428128|FG002|Overall Study|Lost to Follow-up|2|||
127673512|NCT04353037|459428129|FG003|Overall Study|Lost to Follow-up|3|||
127673513|NCT04353037|459428126|FG000|Overall Study|Withdrawal by Subject|0|||
127673514|NCT04353037|459428127|FG001|Overall Study|Withdrawal by Subject|2|||
127673515|NCT04353037|459428128|FG002|Overall Study|Withdrawal by Subject|3|||
127673516|NCT04353037|459428129|FG003|Overall Study|Withdrawal by Subject|5|||
127673517|NCT04353037|459428126|FG000|Overall Study|Adverse Event|0|||
127673518|NCT04353037|459428127|FG001|Overall Study|Adverse Event|0|||
127673519|NCT04353037|459428128|FG002|Overall Study|Adverse Event|2|||
127673520|NCT04353037|459428129|FG003|Overall Study|Adverse Event|0|||
127673521|NCT04353037|459428126|FG000|Overall Study|Exposure Change|0|||
127673522|NCT04353037|459428127|FG001|Overall Study|Exposure Change|0|||
127673523|NCT04353037|459428128|FG002|Overall Study|Exposure Change|0|||
127673524|NCT04353037|459428129|FG003|Overall Study|Exposure Change|2|||
127673525|NCT03710564|459428130|FG000|Overall Study|Study Terminated by Sponsor|104|||
127673526|NCT03710564|459428131|FG001|Overall Study|Study Terminated by Sponsor|55|||
127673527|NCT03710564|459428130|FG000|Overall Study|Withdrawal by Subject|57|||
127673528|NCT03710564|459428131|FG001|Overall Study|Withdrawal by Subject|25|||
127673529|NCT03710564|459428130|FG000|Overall Study|Death|10|||
127673530|NCT03710564|459428131|FG001|Overall Study|Death|4|||
127673531|NCT03710564|459428130|FG000|Overall Study|Lost to Follow-up|5|||
127673532|NCT03710564|459428131|FG001|Overall Study|Lost to Follow-up|4|||
127673533|NCT03710564|459428130|FG000|Overall Study|Protocol Violation|3|||
127673534|NCT03710564|459428131|FG001|Overall Study|Protocol Violation|2|||
127673535|NCT03710564|459428130|FG000|Overall Study|Adverse Event|3|||
127673536|NCT03710564|459428131|FG001|Overall Study|Adverse Event|0|||
127673537|NCT03710564|459428130|FG000|Overall Study|Physician Decision|2|||
127673538|NCT03710564|459428131|FG001|Overall Study|Physician Decision|3|||
127673539|NCT03006341|459428132|FG000|Overall Study|Not linked in the EMR|25069|||
127673540|NCT03006341|459428133|FG001|Overall Study|Not linked in the EMR|67505|||
127673541|NCT03006341|459428134|FG002|Overall Study|Not linked in the EMR|30993|||
127673542|NCT03006341|459428135|FG003|Overall Study|Not linked in the EMR|10685|||
127673543|NCT00003656|459428136|FG000|Overall Study|Adverse Event|0|||
127673544|NCT00003656|459428137|FG001|Overall Study|Adverse Event|1|||
127673545|NCT03168438|459428143|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
127673546|NCT03168438|459428144|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
127673547|NCT05015478|459428147|FG000|Second Experimental Condition|Withdrawal by Subject|0|||
127673548|NCT05015478|459428148|FG001|Second Experimental Condition|Withdrawal by Subject|0|||
127673549|NCT05015478|459428149|FG002|Second Experimental Condition|Withdrawal by Subject|0|||
127673550|NCT05015478|459428150|FG003|Second Experimental Condition|Withdrawal by Subject|1|||
127673551|NCT04927975|459428153|FG000|Period 1 (Baseline-Week 24)|Withdrawal by Subject|2|||
127673552|NCT04927975|459428154|FG001|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
127673553|NCT04927975|459428155|FG002|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
127673554|NCT04927975|459428156|FG003|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
127673555|NCT04927975|459428157|FG004|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
127673556|NCT04927975|459428158|FG005|Period 1 (Baseline-Week 24)|Withdrawal by Subject|4|||
127673557|NCT04927975|459428153|FG000|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
127673558|NCT04927975|459428154|FG001|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
127673559|NCT04927975|459428155|FG002|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
127673560|NCT04927975|459428156|FG003|Period 1 (Baseline-Week 24)|Lost to Follow-up|2|||
127673561|NCT04927975|459428157|FG004|Period 1 (Baseline-Week 24)|Lost to Follow-up|1|||
127673562|NCT04927975|459428158|FG005|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
127673563|NCT04927975|459428153|FG000|Period 1 (Baseline-Week 24)|Death|0|||
127673564|NCT04927975|459428154|FG001|Period 1 (Baseline-Week 24)|Death|0|||
127673565|NCT04927975|459428155|FG002|Period 1 (Baseline-Week 24)|Death|0|||
127673566|NCT04927975|459428156|FG003|Period 1 (Baseline-Week 24)|Death|0|||
127673567|NCT04927975|459428157|FG004|Period 1 (Baseline-Week 24)|Death|0|||
127673568|NCT04927975|459428158|FG005|Period 1 (Baseline-Week 24)|Death|1|||
127673569|NCT04927975|459428153|FG000|Period 2 (Week 24-52)|Lost to Follow-up|0|||
127673570|NCT04927975|459428154|FG001|Period 2 (Week 24-52)|Lost to Follow-up|1|||
127673571|NCT04927975|459428155|FG002|Period 2 (Week 24-52)|Lost to Follow-up|0|||
127673572|NCT04927975|459428156|FG003|Period 2 (Week 24-52)|Lost to Follow-up|2|||
127673573|NCT04927975|459428157|FG004|Period 2 (Week 24-52)|Lost to Follow-up|6|||
127673574|NCT04927975|459428158|FG005|Period 2 (Week 24-52)|Lost to Follow-up|2|||
127673575|NCT04927975|459428153|FG000|Period 2 (Week 24-52)|Withdrawal by Subject|0|||
127673576|NCT04927975|459428154|FG001|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
127673577|NCT04927975|459428155|FG002|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
127673578|NCT04927975|459428156|FG003|Period 2 (Week 24-52)|Withdrawal by Subject|4|||
127673579|NCT04927975|459428157|FG004|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
127673580|NCT04927975|459428158|FG005|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
127673581|NCT03568162|459428160|FG000|Overall Study|Adverse Event|0|||
127673582|NCT03568162|459428161|FG001|Overall Study|Adverse Event|1|||
127761720|NCT03122223|459752072|FG002|Overall Study|Participant unable to adhere|1|||
127761721|NCT03122223|459752073|FG003|Overall Study|Participant unable to adhere|0|||
127761722|NCT01820585|459752074|FG000|Overall Study|Adverse Event|9|||
127761723|NCT01820585|459752075|FG001|Overall Study|Adverse Event|13|||
127761724|NCT01820585|459752076|FG002|Overall Study|Adverse Event|23|||
127761725|NCT01820585|459752077|FG003|Overall Study|Adverse Event|34|||
127761726|NCT01820585|459752074|FG000|Overall Study|Lack of Efficacy|9|||
127761727|NCT01820585|459752075|FG001|Overall Study|Lack of Efficacy|7|||
127761728|NCT01820585|459752076|FG002|Overall Study|Lack of Efficacy|5|||
127761729|NCT01820585|459752077|FG003|Overall Study|Lack of Efficacy|1|||
127761730|NCT01820585|459752074|FG000|Overall Study|Withdrawal by Subject|3|||
127761731|NCT01820585|459752075|FG001|Overall Study|Withdrawal by Subject|7|||
127761732|NCT01820585|459752076|FG002|Overall Study|Withdrawal by Subject|3|||
127761733|NCT01820585|459752077|FG003|Overall Study|Withdrawal by Subject|8|||
127761734|NCT01820585|459752074|FG000|Overall Study|Lost to Follow-up|3|||
127761735|NCT01820585|459752075|FG001|Overall Study|Lost to Follow-up|3|||
127761736|NCT01820585|459752076|FG002|Overall Study|Lost to Follow-up|0|||
127761737|NCT01820585|459752077|FG003|Overall Study|Lost to Follow-up|3|||
127761738|NCT01820585|459752074|FG000|Overall Study|Protocol Violation|3|||
127761739|NCT01820585|459752075|FG001|Overall Study|Protocol Violation|1|||
127761740|NCT01820585|459752076|FG002|Overall Study|Protocol Violation|1|||
127761741|NCT01820585|459752077|FG003|Overall Study|Protocol Violation|1|||
127761742|NCT01820585|459752074|FG000|Overall Study|Subject non-compliance|0|||
127761743|NCT01820585|459752075|FG001|Overall Study|Subject non-compliance|0|||
127761744|NCT01820585|459752076|FG002|Overall Study|Subject non-compliance|1|||
127761745|NCT01820585|459752077|FG003|Overall Study|Subject non-compliance|2|||
127673583|NCT03568162|459428162|FG002|Overall Study|Adverse Event|2|||
127673584|NCT03568162|459428163|FG003|Overall Study|Adverse Event|0|||
127673585|NCT03568162|459428164|FG004|Overall Study|Adverse Event|0|||
127673586|NCT03568162|459428165|FG005|Overall Study|Adverse Event|1|||
127673587|NCT03568162|459428160|FG000|Overall Study|Death|0|||
127673588|NCT03568162|459428161|FG001|Overall Study|Death|0|||
127673589|NCT03568162|459428162|FG002|Overall Study|Death|0|||
127673590|NCT03568162|459428163|FG003|Overall Study|Death|0|||
127673591|NCT03568162|459428164|FG004|Overall Study|Death|1|||
127673592|NCT03568162|459428165|FG005|Overall Study|Death|0|||
127673593|NCT03568162|459428160|FG000|Overall Study|Lost to Follow-up|3|||
127673594|NCT03568162|459428161|FG001|Overall Study|Lost to Follow-up|2|||
127761746|NCT01820585|459752074|FG000|Overall Study|at sponsor request|0|||
127673595|NCT03568162|459428162|FG002|Overall Study|Lost to Follow-up|4|||
127673596|NCT03568162|459428163|FG003|Overall Study|Lost to Follow-up|2|||
127673597|NCT03568162|459428164|FG004|Overall Study|Lost to Follow-up|3|||
127673598|NCT03568162|459428165|FG005|Overall Study|Lost to Follow-up|2|||
127673599|NCT03568162|459428160|FG000|Overall Study|Physician Decision|0|||
127673600|NCT03568162|459428161|FG001|Overall Study|Physician Decision|1|||
127673601|NCT03568162|459428162|FG002|Overall Study|Physician Decision|1|||
127673602|NCT03568162|459428163|FG003|Overall Study|Physician Decision|0|||
127673603|NCT03568162|459428164|FG004|Overall Study|Physician Decision|1|||
127673604|NCT03568162|459428165|FG005|Overall Study|Physician Decision|0|||
127673605|NCT03568162|459428160|FG000|Overall Study|Pregnancy|0|||
127673606|NCT03568162|459428161|FG001|Overall Study|Pregnancy|0|||
127673607|NCT03568162|459428162|FG002|Overall Study|Pregnancy|0|||
127673608|NCT03568162|459428163|FG003|Overall Study|Pregnancy|1|||
127761747|NCT01820585|459752075|FG001|Overall Study|at sponsor request|0|||
127761748|NCT01820585|459752076|FG002|Overall Study|at sponsor request|1|||
127761749|NCT01820585|459752077|FG003|Overall Study|at sponsor request|0|||
127673609|NCT03568162|459428164|FG004|Overall Study|Pregnancy|0|||
127673610|NCT03568162|459428165|FG005|Overall Study|Pregnancy|0|||
127673611|NCT03568162|459428160|FG000|Overall Study|Protocol Violation|1|||
127673612|NCT03568162|459428161|FG001|Overall Study|Protocol Violation|0|||
127673613|NCT03568162|459428162|FG002|Overall Study|Protocol Violation|1|||
127673614|NCT03568162|459428163|FG003|Overall Study|Protocol Violation|1|||
127673615|NCT03568162|459428164|FG004|Overall Study|Protocol Violation|1|||
127673616|NCT03568162|459428165|FG005|Overall Study|Protocol Violation|1|||
127673617|NCT03568162|459428160|FG000|Overall Study|Withdrawal by Subject|15|||
127673618|NCT03568162|459428161|FG001|Overall Study|Withdrawal by Subject|15|||
127673619|NCT03568162|459428162|FG002|Overall Study|Withdrawal by Subject|26|||
127673620|NCT03568162|459428163|FG003|Overall Study|Withdrawal by Subject|22|||
127673621|NCT03568162|459428164|FG004|Overall Study|Withdrawal by Subject|6|||
127673622|NCT03568162|459428165|FG005|Overall Study|Withdrawal by Subject|9|||
127673623|NCT03568162|459428160|FG000|Overall Study|Others|3|||
127673624|NCT03568162|459428161|FG001|Overall Study|Others|4|||
127673625|NCT03568162|459428162|FG002|Overall Study|Others|1|||
127673626|NCT03568162|459428163|FG003|Overall Study|Others|4|||
127673627|NCT03568162|459428164|FG004|Overall Study|Others|2|||
127673628|NCT03568162|459428165|FG005|Overall Study|Others|1|||
127673629|NCT03717194|459428166|FG000|Overall Study|Withdrawal by Subject|2|||
127673630|NCT03717194|459428167|FG001|Overall Study|Withdrawal by Subject|4|||
127673631|NCT03717194|459428166|FG000|Overall Study|Adverse Event|1|||
127673632|NCT03717194|459428167|FG001|Overall Study|Adverse Event|1|||
127673633|NCT00337818|459428168|FG000|Overall Study|Lost to Follow-up|289|||
127673634|NCT00337818|459428169|FG001|Overall Study|Lost to Follow-up|91|||
127673635|NCT00337818|459428170|FG002|Overall Study|Lost to Follow-up|107|||
127673636|NCT03563053|459428173|FG000|Overall Study|Withdrawal by Subject|17|||
127673637|NCT03563053|459428173|FG000|Overall Study|Due to the COVID-19 pandemic|12|||
127673638|NCT03563053|459428173|FG000|Overall Study|Adverse Event|3|||
127673639|NCT03563053|459428173|FG000|Overall Study|Physician Decision|1|||
127673640|NCT03563053|459428173|FG000|Overall Study|study terminated by sponsor|71|||
127673641|NCT02081391|459428174|FG000|12-hour Treatment|Withdrawal by Subject|3|||
127673642|NCT02081391|459428175|FG001|12-hour Treatment|Withdrawal by Subject|2|||
127673643|NCT02081391|459428176|FG002|12-hour Treatment|Withdrawal by Subject|0|||
127673644|NCT02081391|459428177|FG003|12-hour Treatment|Withdrawal by Subject|0|||
127673645|NCT02081391|459428174|FG000|12-hour Treatment|Physician Decision|4|||
127673646|NCT02081391|459428175|FG001|12-hour Treatment|Physician Decision|1|||
127673647|NCT02081391|459428176|FG002|12-hour Treatment|Physician Decision|0|||
127673648|NCT02081391|459428177|FG003|12-hour Treatment|Physician Decision|0|||
127673649|NCT02081391|459428174|FG000|12-hour Treatment|Lack of Efficacy|3|||
127673650|NCT02081391|459428175|FG001|12-hour Treatment|Lack of Efficacy|0|||
127673651|NCT02081391|459428176|FG002|12-hour Treatment|Lack of Efficacy|0|||
127673652|NCT02081391|459428177|FG003|12-hour Treatment|Lack of Efficacy|0|||
127673653|NCT02081391|459428174|FG000|12-hour Treatment|Adverse Event|4|||
127673654|NCT02081391|459428175|FG001|12-hour Treatment|Adverse Event|2|||
127673655|NCT02081391|459428176|FG002|12-hour Treatment|Adverse Event|0|||
127673656|NCT02081391|459428177|FG003|12-hour Treatment|Adverse Event|0|||
127673657|NCT02081391|459428174|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
127673658|NCT02081391|459428175|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
127673659|NCT02081391|459428176|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
127673660|NCT02081391|459428177|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
127673661|NCT02081391|459428174|FG000|12-hour Treatment|Further reasons|2|||
127673662|NCT02081391|459428175|FG001|12-hour Treatment|Further reasons|1|||
127673663|NCT02081391|459428176|FG002|12-hour Treatment|Further reasons|0|||
127673664|NCT02081391|459428177|FG003|12-hour Treatment|Further reasons|0|||
127673665|NCT02081391|459428174|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
127673666|NCT02081391|459428175|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
127673667|NCT02081391|459428176|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
127673668|NCT02081391|459428177|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
127673669|NCT02081391|459428174|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
127761750|NCT01820585|459752074|FG000|Overall Study|Pregnancy|0|||
127761751|NCT01820585|459752075|FG001|Overall Study|Pregnancy|1|||
127761752|NCT01820585|459752076|FG002|Overall Study|Pregnancy|0|||
127761753|NCT01820585|459752077|FG003|Overall Study|Pregnancy|0|||
127761754|NCT01712659|459752078|FG000|Dose Escalation|Physician Decision|0|||
127761755|NCT01712659|459752079|FG001|Dose Escalation|Physician Decision|1|||
127761756|NCT01712659|459752080|FG002|Dose Escalation|Physician Decision|0|||
127761757|NCT01712659|459752081|FG003|Dose Escalation|Physician Decision|0|||
127761758|NCT01712659|459752082|FG004|Dose Escalation|Physician Decision|0|||
127761759|NCT01712659|459752078|FG000|Dose Escalation|Unable to take study drug|0|||
127673670|NCT02081391|459428175|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
127673671|NCT02081391|459428176|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
127673672|NCT02081391|459428177|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
127673673|NCT02081391|459428174|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
127761760|NCT01712659|459752079|FG001|Dose Escalation|Unable to take study drug|1|||
127761761|NCT01712659|459752080|FG002|Dose Escalation|Unable to take study drug|0|||
127761762|NCT01712659|459752081|FG003|Dose Escalation|Unable to take study drug|0|||
127761763|NCT01712659|459752082|FG004|Dose Escalation|Unable to take study drug|0|||
127761764|NCT01712659|459752078|FG000|Dose Expansion|Early disease progression|1|||
127761765|NCT01712659|459752079|FG001|Dose Expansion|Early disease progression|0|||
127761766|NCT01712659|459752080|FG002|Dose Expansion|Early disease progression|0|||
127761767|NCT01712659|459752081|FG003|Dose Expansion|Early disease progression|0|||
127761768|NCT01712659|459752082|FG004|Dose Expansion|Early disease progression|0|||
127761769|NCT01712659|459752078|FG000|Dose Expansion|Physician Decision|1|||
127761770|NCT01712659|459752079|FG001|Dose Expansion|Physician Decision|0|||
127761771|NCT01712659|459752080|FG002|Dose Expansion|Physician Decision|0|||
127761772|NCT01712659|459752081|FG003|Dose Expansion|Physician Decision|0|||
127761773|NCT01712659|459752082|FG004|Dose Expansion|Physician Decision|0|||
127761774|NCT00548262|459752083|FG000|Overall Study|Death|21|||
127761775|NCT00548262|459752083|FG000|Overall Study|Adverse Event|2|||
127761776|NCT00548262|459752083|FG000|Overall Study|Lack of Efficacy|4|||
127761777|NCT00548262|459752083|FG000|Overall Study|Lost to Follow-up|1|||
127761778|NCT00548262|459752083|FG000|Overall Study|Other|3|||
127761779|NCT00548262|459752083|FG000|Overall Study|Withdrawal by Subject|1|||
127761780|NCT01080716|459752086|FG000|Part 1|Physician Decision|1|||
127761781|NCT01080716|459752087|FG001|Part 1|Physician Decision|0|||
127673674|NCT02081391|459428175|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
127673675|NCT02081391|459428176|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
127673676|NCT02081391|459428177|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
127673677|NCT02081391|459428174|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
127673678|NCT02081391|459428175|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
127673679|NCT02081391|459428176|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
127673680|NCT02081391|459428177|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
127673681|NCT02081391|459428174|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
127673682|NCT02081391|459428175|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
127673683|NCT02081391|459428176|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
127673684|NCT02081391|459428177|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
127673685|NCT02081391|459428174|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
127673686|NCT02081391|459428175|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
127673687|NCT02081391|459428176|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
127673688|NCT02081391|459428177|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
127673689|NCT03102242|459428180|FG000|Overall Study|Adverse Event|2|||
127673690|NCT01311713|459428183|FG000|Overall Study|Death|0|||
127673691|NCT01311713|459428184|FG001|Overall Study|Death|0|||
127673692|NCT01311713|459428185|FG002|Overall Study|Death|1|||
127673693|NCT01311713|459428186|FG003|Overall Study|Death|1|||
127673694|NCT01311713|459428187|FG004|Overall Study|Death|0|||
127673695|NCT01311713|459428188|FG005|Overall Study|Death|1|||
127673696|NCT01311713|459428189|FG006|Overall Study|Death|0|||
127673697|NCT01311713|459428183|FG000|Overall Study|Adverse Event|0|||
127673698|NCT01311713|459428184|FG001|Overall Study|Adverse Event|1|||
127673699|NCT01311713|459428185|FG002|Overall Study|Adverse Event|0|||
127673700|NCT01311713|459428186|FG003|Overall Study|Adverse Event|2|||
127673701|NCT01311713|459428187|FG004|Overall Study|Adverse Event|0|||
127673702|NCT01311713|459428188|FG005|Overall Study|Adverse Event|0|||
127673703|NCT01311713|459428189|FG006|Overall Study|Adverse Event|2|||
127673704|NCT01311713|459428183|FG000|Overall Study|Withdrawal by Subject|0|||
127673705|NCT01311713|459428184|FG001|Overall Study|Withdrawal by Subject|1|||
127673706|NCT01311713|459428185|FG002|Overall Study|Withdrawal by Subject|1|||
127673707|NCT01311713|459428186|FG003|Overall Study|Withdrawal by Subject|0|||
127673708|NCT01311713|459428187|FG004|Overall Study|Withdrawal by Subject|0|||
127673709|NCT01311713|459428188|FG005|Overall Study|Withdrawal by Subject|1|||
127673710|NCT01311713|459428189|FG006|Overall Study|Withdrawal by Subject|2|||
127673711|NCT01311713|459428183|FG000|Overall Study|Disease progression|3|||
127673712|NCT01311713|459428184|FG001|Overall Study|Disease progression|4|||
127673713|NCT01311713|459428185|FG002|Overall Study|Disease progression|3|||
127673714|NCT01311713|459428186|FG003|Overall Study|Disease progression|2|||
127673715|NCT01311713|459428187|FG004|Overall Study|Disease progression|4|||
127673716|NCT01311713|459428188|FG005|Overall Study|Disease progression|4|||
127673717|NCT01311713|459428189|FG006|Overall Study|Disease progression|5|||
127673718|NCT01311713|459428183|FG000|Overall Study|Lost to Follow-up|0|||
127673719|NCT01311713|459428184|FG001|Overall Study|Lost to Follow-up|0|||
127673720|NCT01311713|459428185|FG002|Overall Study|Lost to Follow-up|1|||
127673721|NCT01311713|459428186|FG003|Overall Study|Lost to Follow-up|0|||
127673722|NCT01311713|459428187|FG004|Overall Study|Lost to Follow-up|0|||
127673723|NCT01311713|459428188|FG005|Overall Study|Lost to Follow-up|0|||
127673724|NCT01311713|459428189|FG006|Overall Study|Lost to Follow-up|0|||
127673725|NCT01311713|459428183|FG000|Overall Study|Stopped taking study medication|0|||
127673726|NCT01311713|459428184|FG001|Overall Study|Stopped taking study medication|0|||
127673727|NCT01311713|459428185|FG002|Overall Study|Stopped taking study medication|0|||
127761782|NCT01080716|459752088|FG002|Part 1|Physician Decision|0|||
127673728|NCT01311713|459428186|FG003|Overall Study|Stopped taking study medication|1|||
127673729|NCT01311713|459428187|FG004|Overall Study|Stopped taking study medication|1|||
127673730|NCT01311713|459428188|FG005|Overall Study|Stopped taking study medication|0|||
127673731|NCT01311713|459428189|FG006|Overall Study|Stopped taking study medication|0|||
127673732|NCT01311713|459428183|FG000|Overall Study|Enrolled but not treated|0|||
127673733|NCT01311713|459428184|FG001|Overall Study|Enrolled but not treated|0|||
127673734|NCT01311713|459428185|FG002|Overall Study|Enrolled but not treated|1|||
127673735|NCT01311713|459428186|FG003|Overall Study|Enrolled but not treated|0|||
127673736|NCT01311713|459428187|FG004|Overall Study|Enrolled but not treated|0|||
127673737|NCT01311713|459428188|FG005|Overall Study|Enrolled but not treated|0|||
127673738|NCT01311713|459428189|FG006|Overall Study|Enrolled but not treated|0|||
127673739|NCT01311713|459428183|FG000|Overall Study|Other than specified|0|||
127673740|NCT01311713|459428184|FG001|Overall Study|Other than specified|1|||
127673741|NCT01311713|459428185|FG002|Overall Study|Other than specified|2|||
127673742|NCT01311713|459428186|FG003|Overall Study|Other than specified|0|||
127673743|NCT01311713|459428187|FG004|Overall Study|Other than specified|0|||
127673744|NCT01311713|459428188|FG005|Overall Study|Other than specified|0|||
127673745|NCT01311713|459428189|FG006|Overall Study|Other than specified|0|||
127673746|NCT00797862|459430392|FG000|Overall Study|Adverse Event|86|||
127673747|NCT00797862|459430393|FG001|Overall Study|Adverse Event|44|||
127673748|NCT00797862|459430394|FG002|Overall Study|Adverse Event|58|||
127673749|NCT00797862|459430392|FG000|Overall Study|Abnormal Test Procedure Result|0|||
127673750|NCT00797862|459430393|FG001|Overall Study|Abnormal Test Procedure Result|1|||
127673751|NCT00797862|459430394|FG002|Overall Study|Abnormal Test Procedure Result|1|||
127673752|NCT00797862|459430392|FG000|Overall Study|Lack of Efficacy|1|||
127673753|NCT00797862|459430393|FG001|Overall Study|Lack of Efficacy|7|||
127673754|NCT00797862|459430394|FG002|Overall Study|Lack of Efficacy|6|||
127673755|NCT00797862|459430392|FG000|Overall Study|No longer required study medication|1|||
127673756|NCT00797862|459430393|FG001|Overall Study|No longer required study medication|0|||
127673757|NCT00797862|459430394|FG002|Overall Study|No longer required study medication|0|||
127673758|NCT00797862|459430392|FG000|Overall Study|Withdrawal by Subject|14|||
127673759|NCT00797862|459430393|FG001|Overall Study|Withdrawal by Subject|7|||
127673760|NCT00797862|459430394|FG002|Overall Study|Withdrawal by Subject|7|||
127673761|NCT00797862|459430392|FG000|Overall Study|Lost to Follow-up|11|||
127673762|NCT00797862|459430393|FG001|Overall Study|Lost to Follow-up|0|||
127673763|NCT00797862|459430394|FG002|Overall Study|Lost to Follow-up|5|||
127673764|NCT00797862|459430392|FG000|Overall Study|Administrative Problem|4|||
127673765|NCT00797862|459430393|FG001|Overall Study|Administrative Problem|0|||
127673766|NCT00797862|459430394|FG002|Overall Study|Administrative Problem|0|||
127673767|NCT00797862|459430392|FG000|Overall Study|Protocol Violation|4|||
127673768|NCT00797862|459430393|FG001|Overall Study|Protocol Violation|6|||
127673769|NCT00797862|459430394|FG002|Overall Study|Protocol Violation|8|||
127673770|NCT00797862|459430392|FG000|Overall Study|Mis-randomized|3|||
127673771|NCT00797862|459430393|FG001|Overall Study|Mis-randomized|3|||
127673772|NCT00797862|459430394|FG002|Overall Study|Mis-randomized|1|||
127673773|NCT00409708|459430400|FG000|Treatment|Abnormal test procedure result(s)|1|||
127673774|NCT00409708|459430401|FG001|Treatment|Abnormal test procedure result(s)|0|||
127673775|NCT00409708|459430400|FG000|Treatment|Lack of Efficacy|0|||
127673776|NCT00409708|459430401|FG001|Treatment|Lack of Efficacy|1|||
127673777|NCT00409708|459430400|FG000|Treatment|Protocol Violation|6|||
127673778|NCT00409708|459430401|FG001|Treatment|Protocol Violation|2|||
127673779|NCT00409708|459430400|FG000|Treatment|Withdrawal by Subject|3|||
127673780|NCT00409708|459430401|FG001|Treatment|Withdrawal by Subject|8|||
127673781|NCT00409708|459430400|FG000|Treatment|Lost to Follow-up|0|||
127673782|NCT00409708|459430401|FG001|Treatment|Lost to Follow-up|6|||
127673783|NCT00409708|459430400|FG000|Treatment|Administrative problems|5|||
127673784|NCT00409708|459430401|FG001|Treatment|Administrative problems|0|||
127673785|NCT00409708|459430400|FG000|Washout|Lack of Efficacy|9|||
127673786|NCT00409708|459430401|FG001|Washout|Lack of Efficacy|1|||
127673787|NCT00409708|459430400|FG000|Washout|Protocol Violation|0|||
127673788|NCT00409708|459430401|FG001|Washout|Protocol Violation|1|||
127673789|NCT00409708|459430400|FG000|Washout|Withdrawal by Subject|11|||
127673790|NCT00409708|459430401|FG001|Washout|Withdrawal by Subject|5|||
127673791|NCT00409708|459430400|FG000|Washout|Lost to Follow-up|1|||
127673792|NCT00409708|459430401|FG001|Washout|Lost to Follow-up|3|||
127673793|NCT01474538|459430404|FG000|Treatment Period 1|Death|1|||
127673794|NCT01474538|459430405|FG001|Treatment Period 1|Death|0|||
127673795|NCT01474538|459430404|FG000|Treatment Period 1|Physician Decision|1|||
127673796|NCT01474538|459430405|FG001|Treatment Period 1|Physician Decision|0|||
127673797|NCT01474538|459430404|FG000|Treatment Period 1|Withdrawal by Subject|1|||
127673798|NCT01474538|459430405|FG001|Treatment Period 1|Withdrawal by Subject|3|||
127673799|NCT01474538|459430404|FG000|Treatment Period 1|Protocol Violation|0|||
127673800|NCT01474538|459430405|FG001|Treatment Period 1|Protocol Violation|1|||
127673801|NCT01474538|459430404|FG000|Treatment Period 2|Death|1|||
127673802|NCT01474538|459430405|FG001|Treatment Period 2|Death|0|||
127673803|NCT01474538|459430404|FG000|Treatment Period 2|Adverse Event|1|||
127673804|NCT01474538|459430405|FG001|Treatment Period 2|Adverse Event|1|||
127673805|NCT01474538|459430404|FG000|Treatment Period 2|Withdrawal by Subject|2|||
127673806|NCT01474538|459430405|FG001|Treatment Period 2|Withdrawal by Subject|0|||
127673807|NCT01474538|459430404|FG000|Treatment Period 2|Sponsor decision|1|||
127673808|NCT01474538|459430405|FG001|Treatment Period 2|Sponsor decision|0|||
127673809|NCT01474538|459430404|FG000|Treatment Period 2|Physician Decision|0|||
127673810|NCT01474538|459430405|FG001|Treatment Period 2|Physician Decision|1|||
127673811|NCT01474538|459430404|FG000|Treatment Period 2|Protocol Violation|1|||
127673812|NCT01474538|459430405|FG001|Treatment Period 2|Protocol Violation|0|||
127761783|NCT01080716|459752089|FG003|Part 1|Physician Decision|0|||
127761784|NCT01993927|459752090|FG000|Overall Study|Case Report Forms Uncollected|18|||
127761785|NCT01993927|459752090|FG000|Overall Study|Protocol Violation|11|||
127761786|NCT00895154|459752091|FG000|Overall Study|Lost to Follow-up|1|||
127673813|NCT01456780|459430409|FG000|Overall Study|Lost to Follow-up|3|||
127673814|NCT01456780|459430410|FG001|Overall Study|Lost to Follow-up|3|||
127673815|NCT01456780|459430411|FG002|Overall Study|Lost to Follow-up|0|||
127673816|NCT03120676|459430414|FG000|Overall Study|Not treated|1|||
127673817|NCT00926393|459430415|FG000|Overall Study|Withdrawal by Subject|1|||
127673818|NCT00926393|459430416|FG001|Overall Study|Withdrawal by Subject|2|||
127673819|NCT00926393|459430415|FG000|Overall Study|Adverse Event|1|||
127673820|NCT00926393|459430416|FG001|Overall Study|Adverse Event|1|||
127673821|NCT05349864|459430417|FG000|Period 2 (5 Days)|Withdrawal by Subject|1|||
127673822|NCT05349864|459430418|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
127673823|NCT02333630|459430419|FG000|Overall Study|Lost to Follow-up|5|||
127673824|NCT02333630|459430420|FG001|Overall Study|Lost to Follow-up|2|||
127673825|NCT02223793|459430421|FG000|Overall Study|Lost to Follow-up|10|||
127673826|NCT02223793|459430422|FG001|Overall Study|Lost to Follow-up|1|||
127673827|NCT02223793|459430423|FG002|Overall Study|Lost to Follow-up|2|||
127673828|NCT02223793|459430421|FG000|Overall Study|Withdrawal by Subject|3|||
127673829|NCT02223793|459430422|FG001|Overall Study|Withdrawal by Subject|2|||
127673830|NCT02223793|459430423|FG002|Overall Study|Withdrawal by Subject|3|||
127673831|NCT02223793|459430421|FG000|Overall Study|Moved/studycenter unable to participate|4|||
127673832|NCT02223793|459430422|FG001|Overall Study|Moved/studycenter unable to participate|6|||
127673833|NCT02223793|459430423|FG002|Overall Study|Moved/studycenter unable to participate|8|||
127673834|NCT01704846|459430424|FG000|Treatment Period 2|Withdrawal by Subject|0|||
127673835|NCT01704846|459430425|FG001|Treatment Period 2|Withdrawal by Subject|1|||
127673836|NCT01688973|459430432|FG000|Overall Study|Ineligible|2|||
127673837|NCT01688973|459430433|FG001|Overall Study|Ineligible|3|||
127673838|NCT01149681|459430434|FG000|Overall Study|Withdrawal by Subject|7|||
127673839|NCT01149681|459430434|FG000|Overall Study|Progressive disease|1|||
127673840|NCT01149681|459430434|FG000|Overall Study|Physician Decision|2|||
127673841|NCT01149681|459430434|FG000|Overall Study|adverse events nonrelated study drug|2|||
127673842|NCT02993471|459430435|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
127673843|NCT02993471|459430435|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
127673844|NCT00588666|459430437|FG000|Overall Study|Adverse Event|4|||
127673845|NCT04582877|459430440|FG000|Overall Study|Did not use device measurement|5|||
127673846|NCT04582877|459430440|FG000|Overall Study|No fractional flow reserve test results|2|||
127673847|NCT04582877|459430440|FG000|Overall Study|Protocol Violation|1|||
127673848|NCT03055767|459430441|FG000|Open-Label Period|Lost to Follow-up|0|||
127673849|NCT03055767|459430442|FG001|Open-Label Period|Lost to Follow-up|0|||
127673850|NCT03055767|459430443|FG002|Open-Label Period|Lost to Follow-up|2|||
127673851|NCT03055767|459430444|FG003|Open-Label Period|Lost to Follow-up|0|||
127673852|NCT03055767|459430441|FG000|Open-Label Period|Withdrawal by Subject|0|||
127673853|NCT03055767|459430442|FG001|Open-Label Period|Withdrawal by Subject|0|||
127673854|NCT03055767|459430443|FG002|Open-Label Period|Withdrawal by Subject|0|||
127673855|NCT03055767|459430444|FG003|Open-Label Period|Withdrawal by Subject|1|||
127673856|NCT02759731|459430445|FG000|Overall Study|Did not complete treatment.|8|||
127673857|NCT00763282|459430448|FG000|Overall Study|Withdrawal by Subject|6|||
127673858|NCT00763282|459430449|FG001|Overall Study|Withdrawal by Subject|5|||
127673859|NCT00763282|459430448|FG000|Overall Study|Death|4|||
127673860|NCT00763282|459430449|FG001|Overall Study|Death|3|||
127673861|NCT00763282|459430448|FG000|Overall Study|Lost to Follow-up|22|||
127673862|NCT00763282|459430449|FG001|Overall Study|Lost to Follow-up|26|||
127673863|NCT00335556|459430452|FG000|Overall Study|Death|0|||
127673864|NCT00335556|459430453|FG001|Overall Study|Death|5|||
127761787|NCT00895154|459752092|FG001|Overall Study|Lost to Follow-up|1|||
127761788|NCT00895154|459752091|FG000|Overall Study|Withdrawal by Subject|0|||
127761789|NCT00895154|459752092|FG001|Overall Study|Withdrawal by Subject|1|||
127673865|NCT00335556|459430454|FG002|Overall Study|Death|0|||
127761790|NCT00287690|459752093|FG000|Overall Study|Protocol Violation|20|||
127761791|NCT00287690|459752094|FG001|Overall Study|Protocol Violation|26|||
127761792|NCT02729831|459752096|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
127761793|NCT02729831|459752097|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
127761794|NCT02729831|459752098|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
127761795|NCT02729831|459752099|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
127761796|NCT02729831|459752096|FG000|1 Week Post-visit|Lost to Follow-up|43|||
127761797|NCT02729831|459752097|FG001|1 Week Post-visit|Lost to Follow-up|40|||
127673866|NCT00335556|459430455|FG003|Overall Study|Death|0|||
127673867|NCT00335556|459430456|FG004|Overall Study|Death|1|||
127673868|NCT00335556|459430457|FG005|Overall Study|Death|0|||
127673869|NCT00335556|459430452|FG000|Overall Study|Lack of Efficacy|0|||
127673870|NCT00335556|459430453|FG001|Overall Study|Lack of Efficacy|19|||
127673871|NCT00335556|459430454|FG002|Overall Study|Lack of Efficacy|3|||
127673872|NCT00335556|459430455|FG003|Overall Study|Lack of Efficacy|3|||
127673873|NCT00335556|459430456|FG004|Overall Study|Lack of Efficacy|0|||
127673874|NCT00335556|459430457|FG005|Overall Study|Lack of Efficacy|1|||
127673875|NCT00335556|459430452|FG000|Overall Study|Physician Decision|0|||
127673876|NCT00335556|459430453|FG001|Overall Study|Physician Decision|6|||
127673877|NCT00335556|459430454|FG002|Overall Study|Physician Decision|2|||
127673878|NCT00335556|459430455|FG003|Overall Study|Physician Decision|1|||
127673879|NCT00335556|459430456|FG004|Overall Study|Physician Decision|0|||
127673880|NCT00335556|459430457|FG005|Overall Study|Physician Decision|0|||
127673881|NCT00335556|459430452|FG000|Overall Study|Ineligible|2|||
127673882|NCT00335556|459430453|FG001|Overall Study|Ineligible|0|||
127673883|NCT00335556|459430454|FG002|Overall Study|Ineligible|0|||
127673884|NCT00335556|459430455|FG003|Overall Study|Ineligible|0|||
127673885|NCT00335556|459430456|FG004|Overall Study|Ineligible|0|||
127673886|NCT00335556|459430457|FG005|Overall Study|Ineligible|0|||
127673887|NCT00335556|459430452|FG000|Overall Study|Refusal of further protocol therapy|0|||
127761798|NCT02729831|459752098|FG002|1 Week Post-visit|Lost to Follow-up|38|||
127761799|NCT02729831|459752099|FG003|1 Week Post-visit|Lost to Follow-up|36|||
127761800|NCT02729831|459752096|FG000|6 Month Follow-up|Lost to Follow-up|54|||
127543537|NCT02718898|458956551|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
127673888|NCT00335556|459430453|FG001|Overall Study|Refusal of further protocol therapy|4|||
127673889|NCT00335556|459430454|FG002|Overall Study|Refusal of further protocol therapy|0|||
127673890|NCT00335556|459430455|FG003|Overall Study|Refusal of further protocol therapy|1|||
127673891|NCT00335556|459430456|FG004|Overall Study|Refusal of further protocol therapy|0|||
127673892|NCT00335556|459430457|FG005|Overall Study|Refusal of further protocol therapy|0|||
127673893|NCT01878890|459430458|FG000|Overall Study|Protocol Violation|0|||
127673894|NCT01878890|459430459|FG001|Overall Study|Protocol Violation|1|||
127673895|NCT01878890|459430460|FG002|Overall Study|Protocol Violation|0|||
127673896|NCT01878890|459430461|FG003|Overall Study|Protocol Violation|0|||
127673897|NCT02974010|459430462|FG000|Overall Study|Lost to Follow-up|3|||
127673898|NCT02974010|459430463|FG001|Overall Study|Lost to Follow-up|1|||
127673899|NCT02974010|459430464|FG002|Overall Study|Lost to Follow-up|0|||
127673900|NCT02974010|459430465|FG003|Overall Study|Lost to Follow-up|0|||
127673901|NCT02974010|459430462|FG000|Overall Study|Withdrawal by Subject|2|||
127673902|NCT02974010|459430463|FG001|Overall Study|Withdrawal by Subject|1|||
127673903|NCT02974010|459430464|FG002|Overall Study|Withdrawal by Subject|0|||
127673904|NCT02974010|459430465|FG003|Overall Study|Withdrawal by Subject|0|||
127673905|NCT02974010|459430462|FG000|Overall Study|Adverse Event|0|||
127673906|NCT02974010|459430463|FG001|Overall Study|Adverse Event|1|||
127673907|NCT02974010|459430464|FG002|Overall Study|Adverse Event|0|||
127673908|NCT02974010|459430465|FG003|Overall Study|Adverse Event|0|||
127673909|NCT02974010|459430462|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
127673910|NCT02974010|459430463|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
127673911|NCT02974010|459430464|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
127673912|NCT02974010|459430465|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
127673913|NCT02974010|459430462|FG000|Overall Study|Lack of Efficacy|0|||
127673914|NCT02974010|459430463|FG001|Overall Study|Lack of Efficacy|0|||
127673915|NCT02974010|459430464|FG002|Overall Study|Lack of Efficacy|1|||
127673916|NCT02974010|459430465|FG003|Overall Study|Lack of Efficacy|0|||
127673917|NCT00320489|459430466|FG000|Overall Study|Adverse Event|26|||
127673918|NCT00320489|459430467|FG001|Overall Study|Adverse Event|25|||
127673919|NCT00320489|459430466|FG000|Overall Study|Clinical Relapse|26|||
127673920|NCT00320489|459430467|FG001|Overall Study|Clinical Relapse|20|||
127673921|NCT00320489|459430466|FG000|Overall Study|Death|0|||
127673922|NCT00320489|459430467|FG001|Overall Study|Death|2|||
127673923|NCT00320489|459430466|FG000|Overall Study|Entry Criteria Exclusion|2|||
127673924|NCT00320489|459430467|FG001|Overall Study|Entry Criteria Exclusion|4|||
127673925|NCT00320489|459430466|FG000|Overall Study|Lack of Efficacy|16|||
127673926|NCT00320489|459430467|FG001|Overall Study|Lack of Efficacy|7|||
127673927|NCT00320489|459430466|FG000|Overall Study|Lost to Follow-up|21|||
127673928|NCT00320489|459430467|FG001|Overall Study|Lost to Follow-up|22|||
127673929|NCT00320489|459430466|FG000|Overall Study|Physician Decision|8|||
127673930|NCT00320489|459430467|FG001|Overall Study|Physician Decision|8|||
127673931|NCT00320489|459430466|FG000|Overall Study|Protocol Violation|4|||
127673932|NCT00320489|459430467|FG001|Overall Study|Protocol Violation|4|||
127673933|NCT00320489|459430466|FG000|Overall Study|Sponsor Decision|3|||
127673934|NCT00320489|459430467|FG001|Overall Study|Sponsor Decision|3|||
127673935|NCT00320489|459430466|FG000|Overall Study|Withdrawal by Subject|39|||
127673936|NCT00320489|459430467|FG001|Overall Study|Withdrawal by Subject|41|||
127673937|NCT04555044|459430478|FG000|Overall Study|Adverse Event|0|||
127673938|NCT04555044|459430479|FG001|Overall Study|Adverse Event|1|||
127673939|NCT04088188|459430481|FG000|Overall Study|Withdrawal by Subject|2|||
127673940|NCT04088188|459430482|FG001|Overall Study|Withdrawal by Subject|0|||
127673941|NCT04088188|459430481|FG000|Overall Study|Adverse Event|2|||
127673942|NCT04088188|459430482|FG001|Overall Study|Adverse Event|0|||
127673943|NCT00580801|459430486|FG000|Overall Study|Physician Decision|1|||
127673944|NCT00580801|459430487|FG001|Overall Study|Physician Decision|0|||
127673945|NCT00580801|459430488|FG002|Overall Study|Physician Decision|0|||
127673946|NCT00580801|459430486|FG000|Overall Study|Adverse Event|2|||
127673947|NCT00580801|459430487|FG001|Overall Study|Adverse Event|0|||
127673948|NCT00580801|459430488|FG002|Overall Study|Adverse Event|0|||
127673949|NCT00580801|459430486|FG000|Overall Study|Lost to Follow-up|2|||
127673950|NCT00580801|459430487|FG001|Overall Study|Lost to Follow-up|0|||
127673951|NCT00580801|459430488|FG002|Overall Study|Lost to Follow-up|0|||
127673952|NCT00580801|459430486|FG000|Overall Study|Reached a virologic endpoint|0|||
127673953|NCT00580801|459430487|FG001|Overall Study|Reached a virologic endpoint|1|||
127673954|NCT00580801|459430488|FG002|Overall Study|Reached a virologic endpoint|2|||
127673955|NCT00580801|459430486|FG000|Overall Study|Participant non-compliant|0|||
127673956|NCT00580801|459430487|FG001|Overall Study|Participant non-compliant|0|||
127673957|NCT00580801|459430488|FG002|Overall Study|Participant non-compliant|1|||
127673958|NCT00580801|459430486|FG000|Overall Study|Travel|1|||
127673959|NCT00580801|459430487|FG001|Overall Study|Travel|0|||
127673960|NCT00580801|459430488|FG002|Overall Study|Travel|0|||
127673961|NCT01670019|459430489|FG000|Overall Study|Adverse Event|3|||
127673962|NCT01670019|459430490|FG001|Overall Study|Adverse Event|0|||
127673963|NCT01670019|459430489|FG000|Overall Study|Withdrawal by Subject|6|||
127673964|NCT01670019|459430490|FG001|Overall Study|Withdrawal by Subject|0|||
127673965|NCT00502593|459430491|FG000|Overall Study|Withdrawn unspecified reason|1|||
127673966|NCT00502593|459430492|FG001|Overall Study|Withdrawn unspecified reason|1|||
127673967|NCT00502593|459430493|FG002|Overall Study|Withdrawn unspecified reason|3|||
127673968|NCT00502593|459430494|FG003|Overall Study|Withdrawn unspecified reason|1|||
127673969|NCT00502593|459430495|FG004|Overall Study|Withdrawn unspecified reason|2|||
127673970|NCT00502593|459430496|FG005|Overall Study|Withdrawn unspecified reason|0|||
127673971|NCT00502593|459430497|FG006|Overall Study|Withdrawn unspecified reason|2|||
127673972|NCT00502593|459430498|FG007|Overall Study|Withdrawn unspecified reason|0|||
127673973|NCT00502593|459430499|FG008|Overall Study|Withdrawn unspecified reason|0|||
127673974|NCT00502593|459430500|FG009|Overall Study|Withdrawn unspecified reason|0|||
127673975|NCT00502593|459430501|FG010|Overall Study|Withdrawn unspecified reason|0|||
127673976|NCT00502593|459430502|FG011|Overall Study|Withdrawn unspecified reason|0|||
127673977|NCT00502593|459430491|FG000|Overall Study|Withdrawal by Subject|0|||
127673978|NCT00502593|459430492|FG001|Overall Study|Withdrawal by Subject|0|||
127673979|NCT00502593|459430493|FG002|Overall Study|Withdrawal by Subject|6|||
127673980|NCT00502593|459430494|FG003|Overall Study|Withdrawal by Subject|2|||
127673981|NCT00502593|459430495|FG004|Overall Study|Withdrawal by Subject|2|||
127673982|NCT00502593|459430496|FG005|Overall Study|Withdrawal by Subject|0|||
127673983|NCT00502593|459430497|FG006|Overall Study|Withdrawal by Subject|3|||
127673984|NCT00502593|459430498|FG007|Overall Study|Withdrawal by Subject|0|||
127673985|NCT00502593|459430499|FG008|Overall Study|Withdrawal by Subject|3|||
127673986|NCT00502593|459430500|FG009|Overall Study|Withdrawal by Subject|0|||
127761801|NCT02729831|459752097|FG001|6 Month Follow-up|Lost to Follow-up|51|||
127761802|NCT02729831|459752098|FG002|6 Month Follow-up|Lost to Follow-up|48|||
127761803|NCT02729831|459752099|FG003|6 Month Follow-up|Lost to Follow-up|42|||
127761804|NCT02729831|459752096|FG000|6 Month Follow-up|Death|1|||
127761805|NCT02729831|459752097|FG001|6 Month Follow-up|Death|3|||
127761806|NCT02729831|459752098|FG002|6 Month Follow-up|Death|0|||
127761807|NCT02729831|459752099|FG003|6 Month Follow-up|Death|1|||
127761808|NCT05017103|459752100|FG000|Overall Study|Death|2|||
127761809|NCT01747551|459752101|FG000|Overall Study|Progressive Disease|24|||
127761810|NCT01747551|459752102|FG001|Overall Study|Progressive Disease|17|||
127761811|NCT01747551|459752101|FG000|Overall Study|Death|3|||
127761812|NCT01747551|459752102|FG001|Overall Study|Death|1|||
127761813|NCT01747551|459752101|FG000|Overall Study|Adverse Event|7|||
127761814|NCT01747551|459752102|FG001|Overall Study|Adverse Event|1|||
127761815|NCT01747551|459752101|FG000|Overall Study|Prolonged Treatment Delay|2|||
127761816|NCT01747551|459752102|FG001|Overall Study|Prolonged Treatment Delay|0|||
127761817|NCT01747551|459752101|FG000|Overall Study|Withdrawal by Subject|3|||
127761818|NCT01747551|459752102|FG001|Overall Study|Withdrawal by Subject|1|||
127761819|NCT01747551|459752101|FG000|Overall Study|Physician Decision|2|||
127761820|NCT01747551|459752102|FG001|Overall Study|Physician Decision|1|||
127761821|NCT01747551|459752101|FG000|Overall Study|Other|2|||
127673987|NCT00502593|459430501|FG010|Overall Study|Withdrawal by Subject|1|||
127673988|NCT00502593|459430502|FG011|Overall Study|Withdrawal by Subject|0|||
127673989|NCT00502593|459430491|FG000|Overall Study|Lost to Follow-up|2|||
127673990|NCT00502593|459430492|FG001|Overall Study|Lost to Follow-up|1|||
127673991|NCT00502593|459430493|FG002|Overall Study|Lost to Follow-up|1|||
127673992|NCT00502593|459430494|FG003|Overall Study|Lost to Follow-up|1|||
127673993|NCT00502593|459430495|FG004|Overall Study|Lost to Follow-up|0|||
127673994|NCT00502593|459430496|FG005|Overall Study|Lost to Follow-up|0|||
127673995|NCT00502593|459430497|FG006|Overall Study|Lost to Follow-up|0|||
127673996|NCT00502593|459430498|FG007|Overall Study|Lost to Follow-up|0|||
127761822|NCT01747551|459752102|FG001|Overall Study|Other|0|||
127761823|NCT01142115|459752103|FG000|First Intervention|Lack of Efficacy|1|||
127761824|NCT01142115|459752104|FG001|First Intervention|Lack of Efficacy|1|||
127761825|NCT01142115|459752103|FG000|First Intervention|Adverse Event|1|||
127761826|NCT01142115|459752104|FG001|First Intervention|Adverse Event|0|||
127761827|NCT03406078|459752105|FG000|Overall Study|Death|1|||
127761828|NCT03406078|459752106|FG001|Overall Study|Death|0|||
127761829|NCT03406078|459752105|FG000|Overall Study|Lost to Follow-up|0|||
127761830|NCT03406078|459752106|FG001|Overall Study|Lost to Follow-up|1|||
127761831|NCT03406078|459752105|FG000|Overall Study|Withdrawal by Subject|5|||
127761832|NCT03406078|459752106|FG001|Overall Study|Withdrawal by Subject|2|||
127761833|NCT02091206|459752107|FG000|Treatment Period|Adverse Event|0|||
127761834|NCT02091206|459752108|FG001|Treatment Period|Adverse Event|1|||
127761835|NCT02091206|459752109|FG002|Treatment Period|Adverse Event|0|||
127761836|NCT02091206|459752110|FG003|Treatment Period|Adverse Event|0|||
127761837|NCT02091206|459752107|FG000|Treatment Period|Met withdrawal criteria|0|||
127761838|NCT02091206|459752108|FG001|Treatment Period|Met withdrawal criteria|0|||
127761839|NCT02091206|459752109|FG002|Treatment Period|Met withdrawal criteria|1|||
127761840|NCT02091206|459752110|FG003|Treatment Period|Met withdrawal criteria|0|||
127761841|NCT02091206|459752107|FG000|Taper Period|Participant refused study drug|1|||
127761842|NCT02091206|459752108|FG001|Taper Period|Participant refused study drug|0|||
127761843|NCT02091206|459752109|FG002|Taper Period|Participant refused study drug|0|||
127761844|NCT02091206|459752110|FG003|Taper Period|Participant refused study drug|1|||
127761845|NCT02091206|459752107|FG000|Taper Period|Lost to Follow-up|0|||
127761846|NCT02091206|459752108|FG001|Taper Period|Lost to Follow-up|0|||
127761847|NCT02091206|459752109|FG002|Taper Period|Lost to Follow-up|0|||
127761848|NCT02091206|459752110|FG003|Taper Period|Lost to Follow-up|1|||
127761849|NCT00700778|459752111|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
127761850|NCT00350103|459752112|FG000|Overall Study|Adverse Event|12|||
127761851|NCT00350103|459752113|FG001|Overall Study|Adverse Event|29|||
127761852|NCT00350103|459752114|FG002|Overall Study|Adverse Event|17|||
127761853|NCT00350103|459752112|FG000|Overall Study|Lack of Efficacy|5|||
127761854|NCT00350103|459752113|FG001|Overall Study|Lack of Efficacy|1|||
127761855|NCT00350103|459752114|FG002|Overall Study|Lack of Efficacy|3|||
127761856|NCT00350103|459752112|FG000|Overall Study|Withdrawal by Subject|6|||
127761857|NCT00350103|459752113|FG001|Overall Study|Withdrawal by Subject|6|||
127761858|NCT00350103|459752114|FG002|Overall Study|Withdrawal by Subject|8|||
127761859|NCT00350103|459752112|FG000|Overall Study|Protocol Violation|0|||
127761860|NCT00350103|459752113|FG001|Overall Study|Protocol Violation|0|||
127761861|NCT00350103|459752114|FG002|Overall Study|Protocol Violation|1|||
127761862|NCT00350103|459752112|FG000|Overall Study|Unsatisfactory Compliance|2|||
127761863|NCT00350103|459752113|FG001|Overall Study|Unsatisfactory Compliance|2|||
127761864|NCT00350103|459752114|FG002|Overall Study|Unsatisfactory Compliance|1|||
127761865|NCT00350103|459752112|FG000|Overall Study|Investigator´s decision|1|||
127761866|NCT00350103|459752113|FG001|Overall Study|Investigator´s decision|1|||
127761867|NCT00350103|459752114|FG002|Overall Study|Investigator´s decision|0|||
127761868|NCT00350103|459752112|FG000|Overall Study|Exclusion criteria met|0|||
127761869|NCT00350103|459752113|FG001|Overall Study|Exclusion criteria met|0|||
127761870|NCT00350103|459752114|FG002|Overall Study|Exclusion criteria met|1|||
127761871|NCT00350103|459752112|FG000|Overall Study|Patient relocated|0|||
127761872|NCT00350103|459752113|FG001|Overall Study|Patient relocated|0|||
127761873|NCT00350103|459752114|FG002|Overall Study|Patient relocated|1|||
127761874|NCT00350103|459752112|FG000|Overall Study|Need for prohibited medication|1|||
127761875|NCT00350103|459752113|FG001|Overall Study|Need for prohibited medication|0|||
127761876|NCT00350103|459752114|FG002|Overall Study|Need for prohibited medication|0|||
127761877|NCT00350103|459752112|FG000|Overall Study|Personal reasons|0|||
127761878|NCT00350103|459752113|FG001|Overall Study|Personal reasons|0|||
127761879|NCT00350103|459752114|FG002|Overall Study|Personal reasons|1|||
127761880|NCT00350103|459752112|FG000|Overall Study|Patient stopped feeling pain|1|||
127761881|NCT00350103|459752113|FG001|Overall Study|Patient stopped feeling pain|0|||
127761882|NCT00350103|459752114|FG002|Overall Study|Patient stopped feeling pain|0|||
127761883|NCT00350103|459752112|FG000|Overall Study|PR greater than 250ms|0|||
127761884|NCT00350103|459752113|FG001|Overall Study|PR greater than 250ms|0|||
127761885|NCT00350103|459752114|FG002|Overall Study|PR greater than 250ms|1|||
127761886|NCT00350103|459752112|FG000|Overall Study|Wrong calculation of QT interval|0|||
127761887|NCT00350103|459752113|FG001|Overall Study|Wrong calculation of QT interval|0|||
127761888|NCT00350103|459752114|FG002|Overall Study|Wrong calculation of QT interval|1|||
127761889|NCT00350103|459752112|FG000|Overall Study|Sponsor mistake|1|||
127761890|NCT00350103|459752113|FG001|Overall Study|Sponsor mistake|0|||
127761891|NCT00350103|459752114|FG002|Overall Study|Sponsor mistake|0|||
127761892|NCT00350103|459752112|FG000|Overall Study|Randomization mistake|0|||
127761893|NCT00350103|459752113|FG001|Overall Study|Randomization mistake|1|||
127761894|NCT00350103|459752114|FG002|Overall Study|Randomization mistake|1|||
127761895|NCT00350103|459752112|FG000|Overall Study|Sponsor´s decision|0|||
127761896|NCT00350103|459752113|FG001|Overall Study|Sponsor´s decision|1|||
127761897|NCT00350103|459752114|FG002|Overall Study|Sponsor´s decision|0|||
127761898|NCT00350103|459752112|FG000|Overall Study|Lost, Reason unknown|1|||
127761899|NCT00350103|459752113|FG001|Overall Study|Lost, Reason unknown|1|||
127673997|NCT00502593|459430499|FG008|Overall Study|Lost to Follow-up|3|||
127761900|NCT00350103|459752114|FG002|Overall Study|Lost, Reason unknown|0|||
127761901|NCT00760474|459752115|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
127761902|NCT00760474|459752116|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
127761903|NCT00760474|459752115|FG000|Placebo Washout Period|Other|0|||
127761904|NCT00760474|459752116|FG001|Placebo Washout Period|Other|1|||
127761905|NCT00760474|459752115|FG000|Period 2 (P2)|Lost to Follow-up|1|||
127761906|NCT00760474|459752116|FG001|Period 2 (P2)|Lost to Follow-up|0|||
127761907|NCT00760474|459752115|FG000|Period 2 (P2)|Adverse Event|0|||
127761908|NCT00760474|459752116|FG001|Period 2 (P2)|Adverse Event|1|||
127761909|NCT01011153|459752117|FG000|Overall Study|Less than 78 cases completed|8|||
127761910|NCT01011153|459752118|FG001|Overall Study|Less than 78 cases completed|11|||
127761911|NCT01011153|459752119|FG002|Overall Study|Less than 78 cases completed|9|||
127761912|NCT03014479|459752120|FG000|Overall Study|Adverse Event|0|||
127761913|NCT03014479|459752121|FG001|Overall Study|Adverse Event|1|||
127761914|NCT03014479|459752120|FG000|Overall Study|Voluntary Withdrawal|0|||
127761915|NCT03014479|459752121|FG001|Overall Study|Voluntary Withdrawal|2|||
127761916|NCT03014479|459752120|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
127761917|NCT03014479|459752121|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
127761918|NCT01394978|459752122|FG000|Overall Study|Withdrawal by Subject|2|||
127761919|NCT01394978|459752123|FG001|Overall Study|Withdrawal by Subject|4|||
127761920|NCT01394978|459752122|FG000|Overall Study|Lost to Follow-up|13|||
127761921|NCT01394978|459752123|FG001|Overall Study|Lost to Follow-up|20|||
127761922|NCT01394978|459752122|FG000|Overall Study|Death|6|||
127761923|NCT01394978|459752123|FG001|Overall Study|Death|7|||
127761924|NCT02631577|459752124|FG000|Overall Study|Death|1|||
127761925|NCT02631577|459752125|FG001|Overall Study|Death|7|||
127761926|NCT02631577|459752124|FG000|Overall Study|Withdrawal by Subject|0|||
127761927|NCT02631577|459752125|FG001|Overall Study|Withdrawal by Subject|3|||
127761928|NCT03981861|459752131|FG000|Overall Study|Withdrawal by Subject|3|||
127761929|NCT05618912|459752132|FG000|Overall Study|Lost to Follow-up|14|||
127761930|NCT05618912|459752133|FG001|Overall Study|Lost to Follow-up|19|||
127761931|NCT00432666|459754045|FG000|Main Period|Adverse Event|1|||
127761932|NCT00432666|459754046|FG001|Main Period|Adverse Event|1|||
127761933|NCT00432666|459754045|FG000|Main Period|Consent Withdrawn|1|||
127761934|NCT00432666|459754046|FG001|Main Period|Consent Withdrawn|0|||
127761935|NCT00432666|459754045|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
127761936|NCT00432666|459754046|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
127761937|NCT00432666|459754045|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
127761938|NCT00432666|459754046|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
127761939|NCT00432666|459754045|FG000|Open-Label Extension Period|Adverse Event|5|||
127761940|NCT00432666|459754046|FG001|Open-Label Extension Period|Adverse Event|0|||
127761941|NCT00432666|459754045|FG000|Open-Label Extension Period|Consent withdrawn|10|||
127761942|NCT00432666|459754046|FG001|Open-Label Extension Period|Consent withdrawn|0|||
127761943|NCT00432666|459754045|FG000|Open-Label Extension Period|Physician Decision|3|||
127761944|NCT00432666|459754046|FG001|Open-Label Extension Period|Physician Decision|0|||
127761945|NCT00978627|459754047|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
127761946|NCT00978627|459754048|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
127761947|NCT00978627|459754047|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
127761948|NCT00978627|459754048|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
127761949|NCT00978627|459754047|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
127761950|NCT00978627|459754048|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
127761951|NCT00978627|459754047|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
127761952|NCT00978627|459754048|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
127761953|NCT00978627|459754047|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
127761954|NCT00978627|459754048|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
127761955|NCT00978627|459754047|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
127761956|NCT00978627|459754048|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
127761957|NCT00978627|459754047|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
127761958|NCT00978627|459754048|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
127761959|NCT00978627|459754047|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
127761960|NCT00978627|459754048|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
127673998|NCT00502593|459430500|FG009|Overall Study|Lost to Follow-up|0|||
127673999|NCT00502593|459430501|FG010|Overall Study|Lost to Follow-up|1|||
127674000|NCT00502593|459430502|FG011|Overall Study|Lost to Follow-up|0|||
127674001|NCT03601507|459430503|FG000|Overall Study|Adverse Event|1|||
127674002|NCT01664104|459430504|FG000|Overall Study|Adverse Event|6|||
127674003|NCT01664104|459430504|FG000|Overall Study|Lack of Efficacy|2|||
127674004|NCT01664104|459430504|FG000|Overall Study|Withdrawal by Subject|1|||
127761961|NCT00978627|459754047|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
127761962|NCT00978627|459754048|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
127761963|NCT02516332|459754051|FG000|Overall Study|Withdrawal by Subject|2|||
127761964|NCT02516332|459754052|FG001|Overall Study|Withdrawal by Subject|1|||
127674005|NCT01664104|459430504|FG000|Overall Study|Lost to Follow-up|4|||
127674006|NCT01664104|459430504|FG000|Overall Study|Other|1|||
127674007|NCT01664104|459430504|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
127674008|NCT02107014|459430507|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
127674009|NCT03761784|459430509|FG000|Overall Study|Adverse Event|4|||
127674010|NCT03761784|459430510|FG001|Overall Study|Adverse Event|0|||
127674011|NCT03761784|459430509|FG000|Overall Study|Lost to Follow-up|10|||
127674012|NCT03761784|459430510|FG001|Overall Study|Lost to Follow-up|7|||
127674013|NCT03761784|459430509|FG000|Overall Study|Pregnancy|1|||
127674014|NCT03761784|459430510|FG001|Overall Study|Pregnancy|0|||
127674015|NCT03761784|459430509|FG000|Overall Study|Protocol Violation|2|||
127674016|NCT03761784|459430510|FG001|Overall Study|Protocol Violation|0|||
127674017|NCT03761784|459430509|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
127674018|NCT03761784|459430510|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
127674019|NCT03761784|459430509|FG000|Overall Study|Withdrawal by Subject|9|||
127674020|NCT03761784|459430510|FG001|Overall Study|Withdrawal by Subject|4|||
127674021|NCT03761784|459430509|FG000|Overall Study|Physician Decision|1|||
127674022|NCT03761784|459430510|FG001|Overall Study|Physician Decision|0|||
127674023|NCT03761784|459430509|FG000|Overall Study|Other Than Specified|1|||
127674024|NCT03761784|459430510|FG001|Overall Study|Other Than Specified|0|||
127674025|NCT00586339|459430511|FG000|Overall Study|Withdrawal by Subject|1|||
127674026|NCT00586339|459430512|FG001|Overall Study|Withdrawal by Subject|3|||
127674027|NCT00586339|459430513|FG002|Overall Study|Withdrawal by Subject|1|||
127674028|NCT00586339|459430511|FG000|Overall Study|Migrated/moved from study area|3|||
127761965|NCT02516332|459754053|FG002|Overall Study|Withdrawal by Subject|2|||
127761966|NCT01342341|459754054|FG000|Overall Study|Lost to Follow-up|4|||
127761967|NCT01342341|459754055|FG001|Overall Study|Lost to Follow-up|4|||
127761968|NCT02366468|459754056|FG000|Overall Study|Adverse Event|2|||
127761969|NCT02366468|459754057|FG001|Overall Study|Adverse Event|0|||
127761970|NCT02366468|459754056|FG000|Overall Study|Withdrawal by Subject|1|||
128007757|NCT03451045|460656619|FG002|Overall Study|Withdrawal by Subject|5|||
128007758|NCT03451045|460656617|FG000|Overall Study|Pregnancy|0|||
128007759|NCT03451045|460656618|FG001|Overall Study|Pregnancy|0|||
128007760|NCT03451045|460656619|FG002|Overall Study|Pregnancy|2|||
128007761|NCT03451045|460656617|FG000|Overall Study|Adverse Event|7|||
128007762|NCT03451045|460656618|FG001|Overall Study|Adverse Event|1|||
128007763|NCT03451045|460656619|FG002|Overall Study|Adverse Event|3|||
128007764|NCT03451045|460656617|FG000|Overall Study|Non-compliance with study|2|||
128007765|NCT03451045|460656618|FG001|Overall Study|Non-compliance with study|0|||
128007766|NCT03451045|460656619|FG002|Overall Study|Non-compliance with study|1|||
128007767|NCT03451045|460656617|FG000|Overall Study|any other reason|10|||
128007768|NCT03451045|460656618|FG001|Overall Study|any other reason|2|||
128007769|NCT03451045|460656619|FG002|Overall Study|any other reason|13|||
128007770|NCT00863707|460656620|FG000|Overall Study|Randomized, but drug not received|4|||
128007771|NCT00863707|460656621|FG001|Overall Study|Randomized, but drug not received|3|||
128007772|NCT04142242|460656622|FG000|Stage I|Non-compliance with the protocol|1|||
128007773|NCT04142242|460656623|FG001|Stage I|Non-compliance with the protocol|0|||
128007774|NCT04142242|460656624|FG002|Stage I|Non-compliance with the protocol|0|||
128007775|NCT04142242|460656625|FG003|Stage I|Non-compliance with the protocol|0|||
128007776|NCT04142242|460656626|FG004|Stage I|Non-compliance with the protocol|0|||
128007777|NCT04142242|460656627|FG005|Stage I|Non-compliance with the protocol|1|||
128007778|NCT04142242|460656622|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
128007779|NCT04142242|460656623|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
128007780|NCT04142242|460656624|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
128007781|NCT04142242|460656625|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
128007782|NCT04142242|460656626|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
128007783|NCT04142242|460656627|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
128007784|NCT04142242|460656622|FG000|Stage II|Non-compliance with the protocol|0|||
128007785|NCT04142242|460656623|FG001|Stage II|Non-compliance with the protocol|0|||
128007786|NCT04142242|460656624|FG002|Stage II|Non-compliance with the protocol|0|||
128007787|NCT04142242|460656625|FG003|Stage II|Non-compliance with the protocol|2|||
128007788|NCT04142242|460656626|FG004|Stage II|Non-compliance with the protocol|0|||
128007789|NCT04142242|460656627|FG005|Stage II|Non-compliance with the protocol|0|||
128007790|NCT04142242|460656622|FG000|Stage II|Lost to Follow-up|0|||
128007791|NCT04142242|460656623|FG001|Stage II|Lost to Follow-up|0|||
128007792|NCT04142242|460656624|FG002|Stage II|Lost to Follow-up|1|||
128007793|NCT04142242|460656625|FG003|Stage II|Lost to Follow-up|2|||
128007794|NCT04142242|460656626|FG004|Stage II|Lost to Follow-up|0|||
128007795|NCT04142242|460656627|FG005|Stage II|Lost to Follow-up|0|||
128007796|NCT04142242|460656622|FG000|Stage II|Withdrawal by Subject|0|||
128007797|NCT04142242|460656623|FG001|Stage II|Withdrawal by Subject|0|||
127543538|NCT02718898|458956552|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
127674029|NCT00586339|459430512|FG001|Overall Study|Migrated/moved from study area|2|||
127761971|NCT02366468|459754057|FG001|Overall Study|Withdrawal by Subject|5|||
127674030|NCT00586339|459430513|FG002|Overall Study|Migrated/moved from study area|4|||
127674031|NCT00586339|459430511|FG000|Overall Study|Lost to Follow-up|3|||
127761972|NCT02366468|459754056|FG000|Overall Study|Lost to Follow-up|2|||
128007798|NCT04142242|460656624|FG002|Stage II|Withdrawal by Subject|5|||
128007799|NCT04142242|460656625|FG003|Stage II|Withdrawal by Subject|9|||
128007800|NCT04142242|460656626|FG004|Stage II|Withdrawal by Subject|0|||
128007801|NCT04142242|460656627|FG005|Stage II|Withdrawal by Subject|0|||
128007802|NCT03040726|460656628|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
128007803|NCT03040726|460656629|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
128007804|NCT03040726|460656628|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
128007805|NCT03040726|460656629|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
128007806|NCT03040726|460656628|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
128007807|NCT03040726|460656629|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
128007808|NCT03040726|460656628|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
128007809|NCT03040726|460656629|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
128007810|NCT03040726|460656628|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
128007811|NCT03040726|460656629|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
128007812|NCT05219162|460656632|FG000|Overall Study|Meet exclusion criterion or did not meet inclusion criteria|6|||
128007813|NCT05219162|460656632|FG000|Overall Study|Withdrawal by Subject|23|||
128007814|NCT06996301|460656640|FG000|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
128007815|NCT06996301|460656641|FG001|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
128007816|NCT06996301|460656640|FG000|Overall Study|Patients with discordant diagnostic results|107|||
128007817|NCT06996301|460656641|FG001|Overall Study|Patients with discordant diagnostic results|90|||
128007818|NCT06996301|460656640|FG000|Overall Study|Lost to Follow-up|31|||
128007819|NCT06996301|460656641|FG001|Overall Study|Lost to Follow-up|56|||
128007820|NCT06996301|460656640|FG000|Overall Study|Withdrawal by Subject|12|||
128007821|NCT06996301|460656641|FG001|Overall Study|Withdrawal by Subject|7|||
128007822|NCT03321721|460656646|FG000|Overall Study|Lost to Follow-up|4|||
128007823|NCT03321721|460656647|FG001|Overall Study|Lost to Follow-up|8|||
128007824|NCT03321721|460656648|FG002|Overall Study|Lost to Follow-up|11|||
128007825|NCT03353220|460656649|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
128007826|NCT03353220|460656650|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
128007827|NCT00661388|460656657|FG000|Overall Study|Adverse Event|14|||
128007828|NCT00661388|460656657|FG000|Overall Study|Protocol Violation|7|||
128007829|NCT00661388|460656657|FG000|Overall Study|Renal transplantation|1|||
128007830|NCT00661388|460656657|FG000|Overall Study|Dialysis initiation|1|||
128007831|NCT00661388|460656657|FG000|Overall Study|Administrative reasons|1|||
128007832|NCT02934178|460658646|FG000|Received Vaccination 2|Death|0|||
128007833|NCT02934178|460658647|FG001|Received Vaccination 2|Death|1|||
128007834|NCT02934178|460658646|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
128007835|NCT02934178|460658647|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
128007836|NCT01898078|460658650|FG000|Overall Study|Progressive Disease|1|||
128007837|NCT01898078|460658651|FG001|Overall Study|Progressive Disease|5|||
128007838|NCT01898078|460658650|FG000|Overall Study|Adverse Event|2|||
128007839|NCT01898078|460658651|FG001|Overall Study|Adverse Event|1|||
128007840|NCT01898078|460658650|FG000|Overall Study|Withdrawal by Subject|1|||
128007841|NCT01898078|460658651|FG001|Overall Study|Withdrawal by Subject|1|||
128007842|NCT01898078|460658650|FG000|Overall Study|Symptomatic Deterioration|2|||
128007843|NCT01898078|460658651|FG001|Overall Study|Symptomatic Deterioration|0|||
128007844|NCT01898078|460658650|FG000|Overall Study|Reason not Specified|0|||
128007845|NCT01898078|460658651|FG001|Overall Study|Reason not Specified|1|||
128007846|NCT01075048|460658653|FG000|Overall Study|Death|4|||
128007847|NCT01075048|460658654|FG001|Overall Study|Death|17|||
128007848|NCT01075048|460658655|FG002|Overall Study|Death|12|||
128007849|NCT01075048|460658653|FG000|Overall Study|Start of other or new therapy|4|||
128007850|NCT01075048|460658654|FG001|Overall Study|Start of other or new therapy|36|||
128007851|NCT01075048|460658655|FG002|Overall Study|Start of other or new therapy|46|||
128007852|NCT01075048|460658653|FG000|Overall Study|Withdrawal by Subject|1|||
128007853|NCT01075048|460658654|FG001|Overall Study|Withdrawal by Subject|6|||
128007854|NCT01075048|460658655|FG002|Overall Study|Withdrawal by Subject|3|||
128007855|NCT01075048|460658653|FG000|Overall Study|Lost to Follow-up|0|||
128007856|NCT01075048|460658654|FG001|Overall Study|Lost to Follow-up|1|||
128007857|NCT01075048|460658655|FG002|Overall Study|Lost to Follow-up|1|||
128007858|NCT01287936|460658659|FG000|Overall Study|Lost to Follow-up|0|||
128007859|NCT01287936|460658660|FG001|Overall Study|Lost to Follow-up|1|||
128007860|NCT01287936|460658661|FG002|Overall Study|Lost to Follow-up|1|||
128007861|NCT01140906|460658662|FG000|Overall Study|Adverse Event|7|||
128007862|NCT01140906|460658663|FG001|Overall Study|Adverse Event|10|||
128007863|NCT01140906|460658664|FG002|Overall Study|Adverse Event|17|||
128007864|NCT01140906|460658665|FG003|Overall Study|Adverse Event|7|||
128007865|NCT01140906|460658662|FG000|Overall Study|Lack of Efficacy|6|||
128007866|NCT01140906|460658663|FG001|Overall Study|Lack of Efficacy|8|||
128007867|NCT01140906|460658664|FG002|Overall Study|Lack of Efficacy|2|||
128007868|NCT01140906|460658665|FG003|Overall Study|Lack of Efficacy|1|||
128007869|NCT01140906|460658662|FG000|Overall Study|Non-compliance|0|||
128007870|NCT01140906|460658663|FG001|Overall Study|Non-compliance|1|||
128007871|NCT01140906|460658664|FG002|Overall Study|Non-compliance|0|||
128007872|NCT01140906|460658665|FG003|Overall Study|Non-compliance|1|||
128007873|NCT01140906|460658662|FG000|Overall Study|Protocol Violation|5|||
128007874|NCT01140906|460658663|FG001|Overall Study|Protocol Violation|3|||
128007875|NCT01140906|460658664|FG002|Overall Study|Protocol Violation|2|||
128007876|NCT01140906|460658665|FG003|Overall Study|Protocol Violation|1|||
128007877|NCT01140906|460658662|FG000|Overall Study|Withdrawal of consent|6|||
128007878|NCT01140906|460658663|FG001|Overall Study|Withdrawal of consent|6|||
128007879|NCT01140906|460658664|FG002|Overall Study|Withdrawal of consent|2|||
128007880|NCT01140906|460658665|FG003|Overall Study|Withdrawal of consent|2|||
128007881|NCT01140906|460658662|FG000|Overall Study|Lost to Follow-up|1|||
128007882|NCT01140906|460658663|FG001|Overall Study|Lost to Follow-up|1|||
128007883|NCT01140906|460658664|FG002|Overall Study|Lost to Follow-up|0|||
128007884|NCT01140906|460658665|FG003|Overall Study|Lost to Follow-up|2|||
128007885|NCT01140906|460658662|FG000|Overall Study|Administrative or other reason|0|||
128007886|NCT01140906|460658663|FG001|Overall Study|Administrative or other reason|5|||
128007887|NCT01140906|460658664|FG002|Overall Study|Administrative or other reason|3|||
128007888|NCT01140906|460658665|FG003|Overall Study|Administrative or other reason|2|||
128007889|NCT00703534|460658666|FG000|Overall Study|Adverse Event|14|||
128007890|NCT00703534|460658667|FG001|Overall Study|Adverse Event|3|||
128007891|NCT00703534|460658666|FG000|Overall Study|Withdrawal by Subject|8|||
128007892|NCT00703534|460658667|FG001|Overall Study|Withdrawal by Subject|7|||
128007893|NCT00703534|460658666|FG000|Overall Study|Incorrect Enrollment|6|||
128007894|NCT00703534|460658667|FG001|Overall Study|Incorrect Enrollment|6|||
128007895|NCT00703534|460658666|FG000|Overall Study|Lost to Follow-up|1|||
128007896|NCT00703534|460658667|FG001|Overall Study|Lost to Follow-up|4|||
128007897|NCT00703534|460658666|FG000|Overall Study|Severe Non Compliance|1|||
128007898|NCT00703534|460658667|FG001|Overall Study|Severe Non Compliance|5|||
128007899|NCT00336544|460658668|FG000|Overall Study|Lack of Efficacy|8|||
128007900|NCT00336544|460658669|FG001|Overall Study|Lack of Efficacy|5|||
128007901|NCT00336544|460658668|FG000|Overall Study|Adverse Event|4|||
128007902|NCT00336544|460658669|FG001|Overall Study|Adverse Event|9|||
128007903|NCT00336544|460658668|FG000|Overall Study|Withdrawal by Subject|4|||
128007904|NCT00336544|460658669|FG001|Overall Study|Withdrawal by Subject|3|||
128007905|NCT00336544|460658668|FG000|Overall Study|Other|3|||
128007906|NCT00336544|460658669|FG001|Overall Study|Other|5|||
128007907|NCT01649765|460658670|FG000|Overall Study|Adverse Event|5|||
128007908|NCT01649765|460658671|FG001|Overall Study|Adverse Event|3|||
128007909|NCT01649765|460658670|FG000|Overall Study|Lack of Efficacy|1|||
128007910|NCT01649765|460658671|FG001|Overall Study|Lack of Efficacy|1|||
128007911|NCT01649765|460658670|FG000|Overall Study|Physician Decision|0|||
128007912|NCT01649765|460658671|FG001|Overall Study|Physician Decision|3|||
128007913|NCT01649765|460658670|FG000|Overall Study|Protocol Violation|1|||
128007914|NCT01649765|460658671|FG001|Overall Study|Protocol Violation|0|||
128007915|NCT01649765|460658670|FG000|Overall Study|Withdrawal by Subject|2|||
128007916|NCT01649765|460658671|FG001|Overall Study|Withdrawal by Subject|1|||
128007917|NCT01648764|460658672|FG000|Overall Study|Progressive Disease|0|||
127674032|NCT00586339|459430512|FG001|Overall Study|Lost to Follow-up|2|||
127674033|NCT00586339|459430513|FG002|Overall Study|Lost to Follow-up|1|||
127674034|NCT00197236|459430518|FG000|Overall Study|Adverse Event|1|||
127674035|NCT00197236|459430519|FG001|Overall Study|Adverse Event|0|||
127674036|NCT00197236|459430520|FG002|Overall Study|Adverse Event|1|||
127674037|NCT00197236|459430518|FG000|Overall Study|Lost to Follow-up|5|||
127674038|NCT00197236|459430519|FG001|Overall Study|Lost to Follow-up|14|||
127674039|NCT00197236|459430520|FG002|Overall Study|Lost to Follow-up|6|||
127674040|NCT00197236|459430518|FG000|Overall Study|Protocol Violation|0|||
127674041|NCT00197236|459430519|FG001|Overall Study|Protocol Violation|0|||
127674042|NCT00197236|459430520|FG002|Overall Study|Protocol Violation|1|||
127674043|NCT00197236|459430518|FG000|Overall Study|Withdrawal by Subject|7|||
127674044|NCT00197236|459430519|FG001|Overall Study|Withdrawal by Subject|3|||
127674045|NCT00197236|459430520|FG002|Overall Study|Withdrawal by Subject|11|||
127674046|NCT00197236|459430518|FG000|Overall Study|Study drug/medication expiration|1|||
128007918|NCT01648764|460658673|FG001|Overall Study|Progressive Disease|1|||
128007919|NCT01648764|460658674|FG002|Overall Study|Progressive Disease|0|||
128007920|NCT01648764|460658675|FG003|Overall Study|Progressive Disease|0|||
128007921|NCT01648764|460658676|FG004|Overall Study|Progressive Disease|0|||
128007922|NCT01648764|460658677|FG005|Overall Study|Progressive Disease|1|||
128007923|NCT01648764|460658678|FG006|Overall Study|Progressive Disease|1|||
128007924|NCT01648764|460658679|FG007|Overall Study|Progressive Disease|0|||
128007925|NCT01648764|460658680|FG008|Overall Study|Progressive Disease|0|||
128007926|NCT01648764|460658681|FG009|Overall Study|Progressive Disease|2|||
128007927|NCT01648764|460658682|FG010|Overall Study|Progressive Disease|0|||
128007928|NCT01648764|460658683|FG011|Overall Study|Progressive Disease|1|||
128007929|NCT01648764|460658684|FG012|Overall Study|Progressive Disease|2|||
128007930|NCT01648764|460658685|FG013|Overall Study|Progressive Disease|1|||
128007931|NCT01648764|460658672|FG000|Overall Study|Adverse Event|0|||
128007932|NCT01648764|460658673|FG001|Overall Study|Adverse Event|0|||
128007933|NCT01648764|460658674|FG002|Overall Study|Adverse Event|0|||
128007934|NCT01648764|460658675|FG003|Overall Study|Adverse Event|0|||
128007935|NCT01648764|460658676|FG004|Overall Study|Adverse Event|0|||
128007936|NCT01648764|460658677|FG005|Overall Study|Adverse Event|1|||
128007937|NCT01648764|460658678|FG006|Overall Study|Adverse Event|0|||
128007938|NCT01648764|460658679|FG007|Overall Study|Adverse Event|0|||
128007939|NCT01648764|460658680|FG008|Overall Study|Adverse Event|0|||
128007940|NCT01648764|460658681|FG009|Overall Study|Adverse Event|1|||
128007941|NCT01648764|460658682|FG010|Overall Study|Adverse Event|0|||
128007942|NCT01648764|460658683|FG011|Overall Study|Adverse Event|3|||
128007943|NCT01648764|460658684|FG012|Overall Study|Adverse Event|1|||
128007944|NCT01648764|460658685|FG013|Overall Study|Adverse Event|1|||
128007945|NCT01648764|460658672|FG000|Overall Study|Death|0|||
128007946|NCT01648764|460658673|FG001|Overall Study|Death|0|||
128007947|NCT01648764|460658674|FG002|Overall Study|Death|0|||
128007948|NCT01648764|460658675|FG003|Overall Study|Death|0|||
128007949|NCT01648764|460658676|FG004|Overall Study|Death|0|||
128007950|NCT01648764|460658677|FG005|Overall Study|Death|0|||
128007951|NCT01648764|460658678|FG006|Overall Study|Death|1|||
128007952|NCT01648764|460658679|FG007|Overall Study|Death|0|||
127674047|NCT00197236|459430519|FG001|Overall Study|Study drug/medication expiration|0|||
127674048|NCT00197236|459430520|FG002|Overall Study|Study drug/medication expiration|3|||
128007953|NCT01648764|460658680|FG008|Overall Study|Death|0|||
128007954|NCT01648764|460658681|FG009|Overall Study|Death|0|||
128007955|NCT01648764|460658682|FG010|Overall Study|Death|0|||
128007956|NCT01648764|460658683|FG011|Overall Study|Death|0|||
128007957|NCT01648764|460658684|FG012|Overall Study|Death|0|||
128007958|NCT01648764|460658685|FG013|Overall Study|Death|1|||
128007959|NCT01648764|460658672|FG000|Overall Study|Withdrawal by Subject|0|||
128007960|NCT01648764|460658673|FG001|Overall Study|Withdrawal by Subject|0|||
128007961|NCT01648764|460658674|FG002|Overall Study|Withdrawal by Subject|0|||
128007962|NCT01648764|460658675|FG003|Overall Study|Withdrawal by Subject|0|||
128007963|NCT01648764|460658676|FG004|Overall Study|Withdrawal by Subject|0|||
128007964|NCT01648764|460658677|FG005|Overall Study|Withdrawal by Subject|0|||
128007965|NCT01648764|460658678|FG006|Overall Study|Withdrawal by Subject|2|||
128007966|NCT01648764|460658679|FG007|Overall Study|Withdrawal by Subject|0|||
128007967|NCT01648764|460658680|FG008|Overall Study|Withdrawal by Subject|0|||
128007968|NCT01648764|460658681|FG009|Overall Study|Withdrawal by Subject|0|||
128007969|NCT01648764|460658682|FG010|Overall Study|Withdrawal by Subject|0|||
128007970|NCT01648764|460658683|FG011|Overall Study|Withdrawal by Subject|0|||
128007971|NCT01648764|460658684|FG012|Overall Study|Withdrawal by Subject|1|||
128007972|NCT01648764|460658685|FG013|Overall Study|Withdrawal by Subject|0|||
128007973|NCT01648764|460658672|FG000|Overall Study|Investigator Decision|0|||
128007974|NCT01648764|460658673|FG001|Overall Study|Investigator Decision|0|||
128007975|NCT01648764|460658674|FG002|Overall Study|Investigator Decision|0|||
128007976|NCT01648764|460658675|FG003|Overall Study|Investigator Decision|0|||
128007977|NCT01648764|460658676|FG004|Overall Study|Investigator Decision|0|||
128007978|NCT01648764|460658677|FG005|Overall Study|Investigator Decision|0|||
128007979|NCT01648764|460658678|FG006|Overall Study|Investigator Decision|1|||
128007980|NCT01648764|460658679|FG007|Overall Study|Investigator Decision|0|||
128007981|NCT01648764|460658680|FG008|Overall Study|Investigator Decision|0|||
128007982|NCT01648764|460658681|FG009|Overall Study|Investigator Decision|0|||
128007983|NCT01648764|460658682|FG010|Overall Study|Investigator Decision|0|||
128007984|NCT01648764|460658683|FG011|Overall Study|Investigator Decision|1|||
127674049|NCT00197236|459430518|FG000|Overall Study|Returned out of specified time window|0|||
127674050|NCT00197236|459430519|FG001|Overall Study|Returned out of specified time window|0|||
127674051|NCT00197236|459430520|FG002|Overall Study|Returned out of specified time window|1|||
127674052|NCT00746330|459430521|FG000|Period 1|Abnormal test procedure result|0|||
127674053|NCT00746330|459430522|FG001|Period 1|Abnormal test procedure result|0|||
127674054|NCT00746330|459430523|FG002|Period 1|Abnormal test procedure result|1|||
127674055|NCT00746330|459430524|FG003|Period 1|Abnormal test procedure result|0|||
127674056|NCT01981850|459430525|FG000|Main Phase Stage 1|Death|2|||
127674057|NCT01981850|459430526|FG001|Main Phase Stage 1|Death|0|||
127674058|NCT01981850|459430527|FG002|Main Phase Stage 1|Death|0|||
127674059|NCT01981850|459430528|FG003|Main Phase Stage 1|Death|0|||
128007985|NCT01648764|460658684|FG012|Overall Study|Investigator Decision|0|||
128007986|NCT01648764|460658685|FG013|Overall Study|Investigator Decision|0|||
128007987|NCT00715208|460658686|FG000|Overall Study|Withdrawal by Subject|1|||
127674060|NCT01981850|459430529|FG004|Main Phase Stage 1|Death|0|||
127674061|NCT01981850|459430530|FG005|Main Phase Stage 1|Death|0|||
128007988|NCT00715208|460658687|FG001|Overall Study|Withdrawal by Subject|1|||
128007989|NCT00715208|460658686|FG000|Overall Study|Adverse Event|0|||
128007990|NCT00715208|460658687|FG001|Overall Study|Adverse Event|6|||
128007991|NCT00715208|460658686|FG000|Overall Study|Lack of Efficacy|0|||
128007992|NCT00715208|460658687|FG001|Overall Study|Lack of Efficacy|2|||
127674062|NCT01981850|459430531|FG006|Main Phase Stage 1|Death|0|||
127674063|NCT01981850|459430532|FG007|Main Phase Stage 1|Death|0|||
128007993|NCT01316614|460658688|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
128007994|NCT01316614|460658688|FG000|Overall Study|Cytology slides not available for review|4|||
128007995|NCT01316614|460658688|FG000|Overall Study|Cystic lesion|5|||
127761973|NCT02366468|459754057|FG001|Overall Study|Lost to Follow-up|0|||
127761974|NCT02366468|459754056|FG000|Overall Study|Death|1|||
127761975|NCT02366468|459754057|FG001|Overall Study|Death|2|||
127761976|NCT02366468|459754056|FG000|Overall Study|Other|0|||
127761977|NCT02366468|459754057|FG001|Overall Study|Other|2|||
127761978|NCT01552603|459754058|FG000|Overall Study|Physician Decision|1|||
127761979|NCT04797650|459754063|FG000|Overall Study|Reason Not Specified|5|||
127761980|NCT04797650|459754064|FG001|Overall Study|Reason Not Specified|12|||
127761981|NCT04797650|459754065|FG002|Overall Study|Reason Not Specified|5|||
127761982|NCT04797650|459754063|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
127761983|NCT04797650|459754064|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
127761984|NCT04797650|459754065|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
127761985|NCT04797650|459754063|FG000|Overall Study|Lack of Efficacy|1|||
127761986|NCT04797650|459754064|FG001|Overall Study|Lack of Efficacy|0|||
127761987|NCT04797650|459754065|FG002|Overall Study|Lack of Efficacy|1|||
127761988|NCT04797650|459754063|FG000|Overall Study|Non-compliance with Study Drug|0|||
127761989|NCT04797650|459754064|FG001|Overall Study|Non-compliance with Study Drug|0|||
127761990|NCT04797650|459754065|FG002|Overall Study|Non-compliance with Study Drug|2|||
128007996|NCT01316614|460658688|FG000|Overall Study|Inadequate number of passes|2|||
128007997|NCT01316614|460658688|FG000|Overall Study|Medically unstable|1|||
128007998|NCT00076570|460658689|FG000|Overall Study|Drug intolerance|8|||
128007999|NCT00076570|460658690|FG001|Overall Study|Drug intolerance|8|||
128008000|NCT03427411|460658691|FG000|Overall Study|Screen failure - platelets too low|0|||
128008001|NCT03427411|460658692|FG001|Overall Study|Screen failure - platelets too low|1|||
128008002|NCT04889040|460658693|FG000|Overall Study|Withdrawal by Subject|3|||
128008003|NCT04889040|460658694|FG001|Overall Study|Withdrawal by Subject|3|||
128008004|NCT04889040|460658693|FG000|Overall Study|Lost to Follow-up|0|||
128008005|NCT04889040|460658694|FG001|Overall Study|Lost to Follow-up|1|||
128008006|NCT04889040|460658693|FG000|Overall Study|Adverse Event|2|||
128008007|NCT04889040|460658694|FG001|Overall Study|Adverse Event|1|||
128008008|NCT02058095|460658695|FG000|Overall Study|Adverse Event|1|||
128008009|NCT02058095|460658696|FG001|Overall Study|Adverse Event|0|||
128008010|NCT00998946|460658697|FG000|Overall Study|Lost to Follow-up|1|||
128008011|NCT00998946|460658697|FG000|Overall Study|Withdrawal by Subject|1|||
128008012|NCT00998946|460658697|FG000|Overall Study|Death|2|||
128008013|NCT00998946|460658697|FG000|Overall Study|Reason Unspecified|3|||
128008014|NCT00998946|460658697|FG000|Overall Study|Enrolled but not Dosed|2|||
128008015|NCT00316004|460658700|FG000|Overall Study|Subject was not given study fluid.|14|||
128008016|NCT00316004|460658701|FG001|Overall Study|Subject was not given study fluid.|14|||
128008017|NCT00316004|460658702|FG002|Overall Study|Subject was not given study fluid.|21|||
128008018|NCT00977197|460658703|FG000|Overall Study|Withdrawal by Subject|3|||
128008019|NCT00977197|460658704|FG001|Overall Study|Withdrawal by Subject|4|||
128008020|NCT00977197|460658703|FG000|Overall Study|Adverse Event|3|||
128008021|NCT00977197|460658704|FG001|Overall Study|Adverse Event|1|||
128008022|NCT00977197|460658703|FG000|Overall Study|Lack of Efficacy|1|||
128008023|NCT00977197|460658704|FG001|Overall Study|Lack of Efficacy|0|||
128008024|NCT00977197|460658703|FG000|Overall Study|Lost to Follow-up|1|||
128008025|NCT00977197|460658704|FG001|Overall Study|Lost to Follow-up|3|||
128008026|NCT00977197|460658703|FG000|Overall Study|Nonadherence|1|||
128008027|NCT00977197|460658704|FG001|Overall Study|Nonadherence|1|||
128008028|NCT00784875|460658705|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
128008029|NCT00784875|460658706|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
128008030|NCT00784875|460658707|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
128008031|NCT00784875|460658708|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
128008032|NCT00784875|460658705|FG000|Period A - Baseline|Adverse Event|0|||
128008033|NCT00784875|460658706|FG001|Period A - Baseline|Adverse Event|0|||
128008034|NCT00784875|460658707|FG002|Period A - Baseline|Adverse Event|0|||
128008035|NCT00784875|460658708|FG003|Period A - Baseline|Adverse Event|8|||
128008036|NCT00784875|460658705|FG000|Period A - Baseline|Protocol Violation|0|||
128008037|NCT00784875|460658706|FG001|Period A - Baseline|Protocol Violation|0|||
128008038|NCT00784875|460658707|FG002|Period A - Baseline|Protocol Violation|0|||
128008039|NCT00784875|460658708|FG003|Period A - Baseline|Protocol Violation|25|||
128008040|NCT00784875|460658705|FG000|Period A - Baseline|Withdrawal by Subject|0|||
128008041|NCT00784875|460658706|FG001|Period A - Baseline|Withdrawal by Subject|0|||
128008042|NCT00784875|460658707|FG002|Period A - Baseline|Withdrawal by Subject|0|||
128008043|NCT00784875|460658708|FG003|Period A - Baseline|Withdrawal by Subject|27|||
128008044|NCT00784875|460658705|FG000|Period A - Baseline|Physician Decision|0|||
128008045|NCT00784875|460658706|FG001|Period A - Baseline|Physician Decision|0|||
128008046|NCT00784875|460658707|FG002|Period A - Baseline|Physician Decision|0|||
127761991|NCT04797650|459754063|FG000|Overall Study|Lost to Follow-up|4|||
127761992|NCT04797650|459754064|FG001|Overall Study|Lost to Follow-up|6|||
127761993|NCT04797650|459754065|FG002|Overall Study|Lost to Follow-up|1|||
128008047|NCT00784875|460658708|FG003|Period A - Baseline|Physician Decision|2|||
128008048|NCT00784875|460658705|FG000|Period A - Baseline|Sponsor Decision|0|||
128008049|NCT00784875|460658706|FG001|Period A - Baseline|Sponsor Decision|0|||
128008050|NCT00784875|460658707|FG002|Period A - Baseline|Sponsor Decision|0|||
128008051|NCT00784875|460658708|FG003|Period A - Baseline|Sponsor Decision|113|||
127761994|NCT00446043|459754066|FG000|Overall Study|Adverse Event|9|||
128008052|NCT00784875|460658705|FG000|Period A - Baseline|Lost to Follow-up|0|||
128008053|NCT00784875|460658706|FG001|Period A - Baseline|Lost to Follow-up|0|||
128008054|NCT00784875|460658707|FG002|Period A - Baseline|Lost to Follow-up|0|||
128008055|NCT00784875|460658708|FG003|Period A - Baseline|Lost to Follow-up|2|||
128008056|NCT00784875|460658705|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
128008057|NCT00784875|460658706|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
128008058|NCT00784875|460658707|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
128008059|NCT00784875|460658708|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
127674064|NCT01981850|459430533|FG008|Main Phase Stage 1|Death|0|||
127674065|NCT01981850|459430534|FG009|Main Phase Stage 1|Death|0|||
127674066|NCT01981850|459430525|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
127674067|NCT01981850|459430526|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
127674068|NCT01981850|459430527|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
127674069|NCT01981850|459430528|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
127674070|NCT01981850|459430529|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
127674071|NCT01981850|459430530|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
127674072|NCT01981850|459430531|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
127674073|NCT01981850|459430532|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
127674074|NCT01981850|459430533|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
127674075|NCT01981850|459430534|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
127674076|NCT01981850|459430525|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
127674077|NCT01981850|459430526|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
127674078|NCT01981850|459430527|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
127674079|NCT01981850|459430528|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
127674080|NCT01981850|459430529|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
127674081|NCT01981850|459430530|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
127674082|NCT01981850|459430531|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
127674083|NCT01981850|459430532|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
127674084|NCT01981850|459430533|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
127674085|NCT01981850|459430534|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
127674086|NCT01981850|459430525|FG000|Main Phase Stage 1|Various reasons|0|||
127674087|NCT01981850|459430526|FG001|Main Phase Stage 1|Various reasons|0|||
127674088|NCT01981850|459430527|FG002|Main Phase Stage 1|Various reasons|2|||
127674089|NCT01981850|459430528|FG003|Main Phase Stage 1|Various reasons|0|||
127674090|NCT01981850|459430529|FG004|Main Phase Stage 1|Various reasons|0|||
127674091|NCT01981850|459430530|FG005|Main Phase Stage 1|Various reasons|0|||
127674092|NCT01981850|459430531|FG006|Main Phase Stage 1|Various reasons|0|||
127674093|NCT01981850|459430532|FG007|Main Phase Stage 1|Various reasons|0|||
127674094|NCT01981850|459430533|FG008|Main Phase Stage 1|Various reasons|0|||
127674095|NCT01981850|459430534|FG009|Main Phase Stage 1|Various reasons|0|||
127674096|NCT01981850|459430525|FG000|Main Phase Stage 2|Adverse Event|0|||
127674097|NCT01981850|459430526|FG001|Main Phase Stage 2|Adverse Event|0|||
127674098|NCT01981850|459430527|FG002|Main Phase Stage 2|Adverse Event|0|||
127674099|NCT01981850|459430528|FG003|Main Phase Stage 2|Adverse Event|0|||
127674100|NCT01981850|459430529|FG004|Main Phase Stage 2|Adverse Event|6|||
127674101|NCT01981850|459430530|FG005|Main Phase Stage 2|Adverse Event|5|||
127674102|NCT01981850|459430531|FG006|Main Phase Stage 2|Adverse Event|7|||
127674103|NCT01981850|459430532|FG007|Main Phase Stage 2|Adverse Event|0|||
127674104|NCT01981850|459430533|FG008|Main Phase Stage 2|Adverse Event|0|||
127674105|NCT01981850|459430534|FG009|Main Phase Stage 2|Adverse Event|0|||
127674106|NCT01981850|459430525|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
127674107|NCT01981850|459430526|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
127674108|NCT01981850|459430527|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
127674109|NCT01981850|459430528|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
127674110|NCT01981850|459430529|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
127674111|NCT01981850|459430530|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
127674112|NCT01981850|459430531|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
127674113|NCT01981850|459430532|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
127674114|NCT01981850|459430533|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
127674115|NCT01981850|459430534|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
127674116|NCT01981850|459430525|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
127674117|NCT01981850|459430526|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
127674118|NCT01981850|459430527|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
127674119|NCT01981850|459430528|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
127674120|NCT01981850|459430529|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
127674121|NCT01981850|459430530|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
127674122|NCT01981850|459430531|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
127674123|NCT01981850|459430532|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
127674124|NCT01981850|459430533|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
127674125|NCT01981850|459430534|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
127674126|NCT01981850|459430525|FG000|Main Phase Stage 2|Various reasons|0|||
127674127|NCT01981850|459430526|FG001|Main Phase Stage 2|Various reasons|0|||
127674128|NCT01981850|459430527|FG002|Main Phase Stage 2|Various reasons|0|||
127761995|NCT00446043|459754066|FG000|Overall Study|Withdrawal by Subject|70|||
127761996|NCT00446043|459754066|FG000|Overall Study|Protocol Violation|2|||
127761997|NCT00446043|459754066|FG000|Overall Study|Lost to Follow-up|42|||
127761998|NCT00446043|459754066|FG000|Overall Study|Pregnancy|2|||
127761999|NCT00657020|459754069|FG000|PERIOD 1|Adverse Event|0|||
127762000|NCT00657020|459754070|FG001|PERIOD 1|Adverse Event|1|||
127762001|NCT04772898|459754073|FG000|Overall Study|Withdrawal by Subject|0|||
127762002|NCT04772898|459754074|FG001|Overall Study|Withdrawal by Subject|1|||
128008060|NCT00784875|460658705|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
128008061|NCT00784875|460658706|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
128008062|NCT00784875|460658707|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
128008063|NCT00784875|460658708|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
128008064|NCT00784875|460658705|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
128008065|NCT00784875|460658706|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
128008066|NCT00784875|460658707|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
128008067|NCT00784875|460658708|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
128008068|NCT00784875|460658705|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
128008069|NCT00784875|460658706|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
128008070|NCT00784875|460658707|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
128008071|NCT00784875|460658708|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
128008072|NCT00784875|460658705|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
128008073|NCT00784875|460658706|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
128008074|NCT00784875|460658707|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
128008075|NCT00784875|460658708|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
128008076|NCT00784875|460658705|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
128008077|NCT00784875|460658706|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
128008078|NCT00784875|460658707|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
128008079|NCT00784875|460658708|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
128008080|NCT00784875|460658705|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
128008081|NCT00784875|460658706|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
128008082|NCT00784875|460658707|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
128008083|NCT00784875|460658708|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
128008084|NCT00784875|460658705|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
128008085|NCT00784875|460658706|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
128008086|NCT00784875|460658707|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
128008087|NCT00784875|460658708|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
128008088|NCT00784875|460658705|FG000|Period C|Adverse Event|1|||
128008089|NCT00784875|460658706|FG001|Period C|Adverse Event|0|||
128008090|NCT00784875|460658707|FG002|Period C|Adverse Event|4|||
128008091|NCT00784875|460658708|FG003|Period C|Adverse Event|2|||
128008092|NCT00784875|460658705|FG000|Period C|Protocol Violation|0|||
128008093|NCT00784875|460658706|FG001|Period C|Protocol Violation|0|||
128008094|NCT00784875|460658707|FG002|Period C|Protocol Violation|1|||
128008095|NCT00784875|460658708|FG003|Period C|Protocol Violation|2|||
128008096|NCT00784875|460658705|FG000|Period C|Lack of Efficacy|0|||
128008097|NCT00784875|460658706|FG001|Period C|Lack of Efficacy|0|||
128008098|NCT00784875|460658707|FG002|Period C|Lack of Efficacy|1|||
128008099|NCT00784875|460658708|FG003|Period C|Lack of Efficacy|0|||
128008100|NCT00784875|460658705|FG000|Period C|Withdrawal by Subject|1|||
128008101|NCT00784875|460658706|FG001|Period C|Withdrawal by Subject|1|||
128008102|NCT00784875|460658707|FG002|Period C|Withdrawal by Subject|2|||
128008103|NCT00784875|460658708|FG003|Period C|Withdrawal by Subject|0|||
128008104|NCT00784875|460658705|FG000|Period C|Physician Decision|0|||
128008105|NCT00784875|460658706|FG001|Period C|Physician Decision|0|||
128008106|NCT00784875|460658707|FG002|Period C|Physician Decision|1|||
128008107|NCT00784875|460658708|FG003|Period C|Physician Decision|1|||
128008108|NCT00784875|460658705|FG000|Period C|Sponsor Decision|5|||
128008109|NCT00784875|460658706|FG001|Period C|Sponsor Decision|5|||
128008110|NCT00784875|460658707|FG002|Period C|Sponsor Decision|4|||
128008111|NCT00784875|460658708|FG003|Period C|Sponsor Decision|2|||
128008112|NCT00784875|460658705|FG000|Period D|Adverse Event|0|||
128008113|NCT00784875|460658706|FG001|Period D|Adverse Event|2|||
128008114|NCT00784875|460658707|FG002|Period D|Adverse Event|2|||
128008115|NCT00784875|460658708|FG003|Period D|Adverse Event|0|||
128008116|NCT00784875|460658705|FG000|Period D|Protocol Violation|1|||
128008117|NCT00784875|460658706|FG001|Period D|Protocol Violation|0|||
128008118|NCT00784875|460658707|FG002|Period D|Protocol Violation|0|||
128008119|NCT00784875|460658708|FG003|Period D|Protocol Violation|0|||
128008120|NCT00784875|460658705|FG000|Period D|Withdrawal by Subject|2|||
128008121|NCT00784875|460658706|FG001|Period D|Withdrawal by Subject|0|||
128008122|NCT00784875|460658707|FG002|Period D|Withdrawal by Subject|2|||
128008123|NCT00784875|460658708|FG003|Period D|Withdrawal by Subject|0|||
128008124|NCT00784875|460658705|FG000|Period D|Physician Decision|0|||
128008125|NCT00784875|460658706|FG001|Period D|Physician Decision|1|||
127762003|NCT01144052|459754075|FG000|Overall Study|Withdrawal by Subject|1|||
128008126|NCT00784875|460658707|FG002|Period D|Physician Decision|0|||
127762004|NCT01144052|459754076|FG001|Overall Study|Withdrawal by Subject|1|||
128008127|NCT00784875|460658708|FG003|Period D|Physician Decision|0|||
128008128|NCT00784875|460658705|FG000|Period D|Sponsor Decision|1|||
128008129|NCT00784875|460658706|FG001|Period D|Sponsor Decision|1|||
128008130|NCT00784875|460658707|FG002|Period D|Sponsor Decision|1|||
128008131|NCT00784875|460658708|FG003|Period D|Sponsor Decision|0|||
128008132|NCT00784875|460658705|FG000|Period D|Lost to Follow-up|1|||
128008133|NCT00784875|460658706|FG001|Period D|Lost to Follow-up|0|||
128008134|NCT00784875|460658707|FG002|Period D|Lost to Follow-up|1|||
128008135|NCT00784875|460658708|FG003|Period D|Lost to Follow-up|1|||
128008136|NCT02842866|460658709|FG000|Overall Study|Serious Adverse Event|0|||
128008137|NCT02842866|460658710|FG001|Overall Study|Serious Adverse Event|1|||
128008138|NCT02842866|460658709|FG000|Overall Study|Protocol Violation|4|||
128008139|NCT02842866|460658710|FG001|Overall Study|Protocol Violation|2|||
128008140|NCT02842866|460658709|FG000|Overall Study|Lost to Follow-up|2|||
128008141|NCT02842866|460658710|FG001|Overall Study|Lost to Follow-up|0|||
128008142|NCT02842866|460658709|FG000|Overall Study|Withdrawal by Subject|1|||
128008143|NCT02842866|460658710|FG001|Overall Study|Withdrawal by Subject|0|||
128008144|NCT00676143|460658711|FG000|Overall Study|Adverse Event|34|||
128008145|NCT00676143|460658712|FG001|Overall Study|Adverse Event|60|||
128008146|NCT00676143|460658711|FG000|Overall Study|Death|4|||
128008147|NCT00676143|460658712|FG001|Overall Study|Death|4|||
128008148|NCT00676143|460658711|FG000|Overall Study|Lack of Efficacy|0|||
128008149|NCT00676143|460658712|FG001|Overall Study|Lack of Efficacy|6|||
128008150|NCT00676143|460658711|FG000|Overall Study|Lost to Follow-up|0|||
128008151|NCT00676143|460658712|FG001|Overall Study|Lost to Follow-up|13|||
128008152|NCT00676143|460658711|FG000|Overall Study|Physician Decision|5|||
128008153|NCT00676143|460658712|FG001|Overall Study|Physician Decision|8|||
128008154|NCT00676143|460658711|FG000|Overall Study|Protocol Violation|4|||
128008155|NCT00676143|460658712|FG001|Overall Study|Protocol Violation|8|||
128008156|NCT00676143|460658711|FG000|Overall Study|Withdrawal by Subject|24|||
128008157|NCT00676143|460658712|FG001|Overall Study|Withdrawal by Subject|42|||
128008158|NCT00676143|460658711|FG000|Overall Study|Discontinuation of study by sponsor|65|||
128008159|NCT00676143|460658712|FG001|Overall Study|Discontinuation of study by sponsor|88|||
128008160|NCT00676143|460658711|FG000|Overall Study|Failed to return|2|||
128008161|NCT00676143|460658712|FG001|Overall Study|Failed to return|1|||
128008162|NCT00676143|460658711|FG000|Overall Study|Loss of caregiver|5|||
128008163|NCT00676143|460658712|FG001|Overall Study|Loss of caregiver|3|||
128008164|NCT00676143|460658711|FG000|Overall Study|Other|11|||
128008165|NCT00676143|460658712|FG001|Overall Study|Other|20|||
128008166|NCT00676143|460658711|FG000|Overall Study|Participant participation unknown|1|||
128008167|NCT00676143|460658712|FG001|Overall Study|Participant participation unknown|4|||
128008168|NCT00676143|460658711|FG000|Overall Study|Vasogenic edema recurrence|1|||
128008169|NCT00676143|460658712|FG001|Overall Study|Vasogenic edema recurrence|3|||
128008170|NCT01901185|460658713|FG000|Overall Study|Withdrawal by Subject|2|||
128008171|NCT02309359|460658718|FG000|Overall Study|Adverse Event|4|||
128008172|NCT02309359|460658719|FG001|Overall Study|Adverse Event|5|||
128008173|NCT02309359|460658720|FG002|Overall Study|Adverse Event|5|||
128008174|NCT02309359|460658721|FG003|Overall Study|Adverse Event|4|||
128008175|NCT02309359|460658722|FG004|Overall Study|Adverse Event|4|||
128008176|NCT02309359|460658718|FG000|Overall Study|Death|1|||
128008177|NCT02309359|460658719|FG001|Overall Study|Death|0|||
128008178|NCT02309359|460658720|FG002|Overall Study|Death|0|||
128008179|NCT02309359|460658721|FG003|Overall Study|Death|0|||
128008180|NCT02309359|460658722|FG004|Overall Study|Death|0|||
128008181|NCT02309359|460658718|FG000|Overall Study|Withdrawal by Subject|2|||
128008182|NCT02309359|460658719|FG001|Overall Study|Withdrawal by Subject|2|||
128008183|NCT02309359|460658720|FG002|Overall Study|Withdrawal by Subject|4|||
128008184|NCT02309359|460658721|FG003|Overall Study|Withdrawal by Subject|4|||
128008185|NCT02309359|460658722|FG004|Overall Study|Withdrawal by Subject|0|||
128008186|NCT02309359|460658718|FG000|Overall Study|Lack of Efficacy|3|||
128008187|NCT02309359|460658719|FG001|Overall Study|Lack of Efficacy|1|||
128008188|NCT02309359|460658720|FG002|Overall Study|Lack of Efficacy|0|||
128008189|NCT02309359|460658721|FG003|Overall Study|Lack of Efficacy|0|||
128008190|NCT02309359|460658722|FG004|Overall Study|Lack of Efficacy|3|||
127674129|NCT01981850|459430528|FG003|Main Phase Stage 2|Various reasons|0|||
127674130|NCT01981850|459430529|FG004|Main Phase Stage 2|Various reasons|2|||
127674131|NCT01981850|459430530|FG005|Main Phase Stage 2|Various reasons|0|||
127674132|NCT01981850|459430531|FG006|Main Phase Stage 2|Various reasons|1|||
127674133|NCT01981850|459430532|FG007|Main Phase Stage 2|Various reasons|0|||
128008191|NCT02309359|460658718|FG000|Overall Study|Lost to Follow-up|0|||
128008192|NCT02309359|460658719|FG001|Overall Study|Lost to Follow-up|0|||
128008193|NCT02309359|460658720|FG002|Overall Study|Lost to Follow-up|0|||
128008194|NCT02309359|460658721|FG003|Overall Study|Lost to Follow-up|1|||
128008195|NCT02309359|460658722|FG004|Overall Study|Lost to Follow-up|0|||
128008196|NCT02309359|460658718|FG000|Overall Study|Other|2|||
128008197|NCT02309359|460658719|FG001|Overall Study|Other|0|||
127674134|NCT01981850|459430533|FG008|Main Phase Stage 2|Various reasons|0|||
128008198|NCT02309359|460658720|FG002|Overall Study|Other|2|||
128008199|NCT02309359|460658721|FG003|Overall Study|Other|3|||
128008200|NCT02309359|460658722|FG004|Overall Study|Other|2|||
128008201|NCT00701363|460658723|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
128008202|NCT00701363|460658724|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
128008203|NCT00701363|460658725|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
128008204|NCT00701363|460658726|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
128008205|NCT00701363|460658723|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
128008206|NCT00701363|460658724|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
128008207|NCT00701363|460658725|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
128008208|NCT00701363|460658726|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
128008209|NCT00701363|460658723|FG000|Treatment Phase 1|Adverse Event|7|||
128008210|NCT00701363|460658724|FG001|Treatment Phase 1|Adverse Event|0|||
128008211|NCT00701363|460658725|FG002|Treatment Phase 1|Adverse Event|0|||
128008212|NCT00701363|460658726|FG003|Treatment Phase 1|Adverse Event|0|||
128008213|NCT00701363|460658723|FG000|Treatment Phase 1|Protocol Violation|1|||
128008214|NCT00701363|460658724|FG001|Treatment Phase 1|Protocol Violation|0|||
128008215|NCT00701363|460658725|FG002|Treatment Phase 1|Protocol Violation|0|||
128008216|NCT00701363|460658726|FG003|Treatment Phase 1|Protocol Violation|0|||
128008217|NCT00701363|460658723|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
128008218|NCT00701363|460658724|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
128008219|NCT00701363|460658725|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
128008220|NCT00701363|460658726|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
128008221|NCT00701363|460658723|FG000|Treatment Phase 1|Lack of Efficacy|1|||
128008222|NCT00701363|460658724|FG001|Treatment Phase 1|Lack of Efficacy|0|||
128008223|NCT00701363|460658725|FG002|Treatment Phase 1|Lack of Efficacy|0|||
128008224|NCT00701363|460658726|FG003|Treatment Phase 1|Lack of Efficacy|0|||
128008225|NCT00701363|460658723|FG000|Treatment Phase 2|Adverse Event|0|||
128008226|NCT00701363|460658724|FG001|Treatment Phase 2|Adverse Event|0|||
128008227|NCT00701363|460658725|FG002|Treatment Phase 2|Adverse Event|1|||
127674135|NCT01981850|459430534|FG009|Main Phase Stage 2|Various reasons|0|||
127674136|NCT01981850|459430525|FG000|Main Phase Stage 2|Progressive Disease|0|||
127674137|NCT01981850|459430526|FG001|Main Phase Stage 2|Progressive Disease|0|||
127674138|NCT01981850|459430527|FG002|Main Phase Stage 2|Progressive Disease|0|||
127674139|NCT01981850|459430528|FG003|Main Phase Stage 2|Progressive Disease|0|||
127674140|NCT01981850|459430529|FG004|Main Phase Stage 2|Progressive Disease|0|||
127674141|NCT01981850|459430530|FG005|Main Phase Stage 2|Progressive Disease|6|||
127674142|NCT01981850|459430531|FG006|Main Phase Stage 2|Progressive Disease|6|||
127674143|NCT01981850|459430532|FG007|Main Phase Stage 2|Progressive Disease|0|||
127674144|NCT01981850|459430533|FG008|Main Phase Stage 2|Progressive Disease|0|||
127674145|NCT01981850|459430534|FG009|Main Phase Stage 2|Progressive Disease|0|||
127674146|NCT01981850|459430525|FG000|Open Label Extension (OLE)|Adverse Event|0|||
127674147|NCT01981850|459430526|FG001|Open Label Extension (OLE)|Adverse Event|0|||
127674148|NCT01981850|459430527|FG002|Open Label Extension (OLE)|Adverse Event|0|||
127674149|NCT01981850|459430528|FG003|Open Label Extension (OLE)|Adverse Event|0|||
127674150|NCT01981850|459430529|FG004|Open Label Extension (OLE)|Adverse Event|0|||
127674151|NCT01981850|459430530|FG005|Open Label Extension (OLE)|Adverse Event|0|||
127674152|NCT01981850|459430531|FG006|Open Label Extension (OLE)|Adverse Event|0|||
127674153|NCT01981850|459430532|FG007|Open Label Extension (OLE)|Adverse Event|2|||
127674154|NCT01981850|459430533|FG008|Open Label Extension (OLE)|Adverse Event|1|||
127674155|NCT01981850|459430534|FG009|Open Label Extension (OLE)|Adverse Event|8|||
127674156|NCT01981850|459430525|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
127674157|NCT01981850|459430526|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
127674158|NCT01981850|459430527|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
127674159|NCT01981850|459430528|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
127674160|NCT01981850|459430529|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
127674161|NCT01981850|459430530|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
127674162|NCT01981850|459430531|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
127674163|NCT01981850|459430532|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
127674164|NCT01981850|459430533|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
127674165|NCT01981850|459430534|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
127674166|NCT01981850|459430525|FG000|Open Label Extension (OLE)|Various reasons|0|||
127674167|NCT01981850|459430526|FG001|Open Label Extension (OLE)|Various reasons|0|||
127674168|NCT01981850|459430527|FG002|Open Label Extension (OLE)|Various reasons|0|||
127674169|NCT01981850|459430528|FG003|Open Label Extension (OLE)|Various reasons|0|||
127674170|NCT01981850|459430529|FG004|Open Label Extension (OLE)|Various reasons|0|||
127674171|NCT01981850|459430530|FG005|Open Label Extension (OLE)|Various reasons|0|||
127674172|NCT01981850|459430531|FG006|Open Label Extension (OLE)|Various reasons|0|||
127674173|NCT01981850|459430532|FG007|Open Label Extension (OLE)|Various reasons|3|||
127674174|NCT01981850|459430533|FG008|Open Label Extension (OLE)|Various reasons|1|||
127674175|NCT01981850|459430534|FG009|Open Label Extension (OLE)|Various reasons|3|||
128008228|NCT00701363|460658726|FG003|Treatment Phase 2|Adverse Event|0|||
127674176|NCT01981850|459430525|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
127674177|NCT01981850|459430526|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
128008229|NCT00701363|460658723|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
128008230|NCT00701363|460658724|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
128008231|NCT00701363|460658725|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
128008232|NCT00701363|460658726|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
128008233|NCT00284856|460658727|FG000|Overall Study|Adverse Event|3|||
128008234|NCT00284856|460658728|FG001|Overall Study|Adverse Event|3|||
128008235|NCT00284856|460658729|FG002|Overall Study|Adverse Event|3|||
128008236|NCT00284856|460658727|FG000|Overall Study|Lack of Efficacy|2|||
128008237|NCT00284856|460658728|FG001|Overall Study|Lack of Efficacy|1|||
128008238|NCT00284856|460658729|FG002|Overall Study|Lack of Efficacy|8|||
128008239|NCT00284856|460658727|FG000|Overall Study|Lost to Follow-up|25|||
128008240|NCT00284856|460658728|FG001|Overall Study|Lost to Follow-up|21|||
128008241|NCT00284856|460658729|FG002|Overall Study|Lost to Follow-up|22|||
128008242|NCT00284856|460658727|FG000|Overall Study|Protocol Violation|5|||
128008243|NCT00284856|460658728|FG001|Overall Study|Protocol Violation|4|||
128008244|NCT00284856|460658729|FG002|Overall Study|Protocol Violation|5|||
128008245|NCT00284856|460658727|FG000|Overall Study|Withdrawal by Subject|12|||
128008246|NCT00284856|460658728|FG001|Overall Study|Withdrawal by Subject|16|||
128008247|NCT00284856|460658729|FG002|Overall Study|Withdrawal by Subject|18|||
128008248|NCT00284856|460658727|FG000|Overall Study|Other|4|||
128008249|NCT00284856|460658728|FG001|Overall Study|Other|5|||
128008250|NCT00284856|460658729|FG002|Overall Study|Other|4|||
128008251|NCT01192815|460658730|FG000|Overall Study|Withdrawal by Subject|1|||
128008252|NCT01192815|460658730|FG000|Overall Study|Lack of Efficacy|1|||
128008253|NCT01286129|460658733|FG000|Overall Study|Withdrawal by Subject|4|||
128008254|NCT01286129|460658734|FG001|Overall Study|Withdrawal by Subject|1|||
128008255|NCT01286129|460658733|FG000|Overall Study|Could not comply with study requirements|4|||
128008256|NCT01286129|460658734|FG001|Overall Study|Could not comply with study requirements|4|||
128008257|NCT00465179|460658735|FG000|Overall Study|Adverse Event|4|||
128008258|NCT00465179|460658735|FG000|Overall Study|Withdrawal by Subject|2|||
128008259|NCT00465179|460658735|FG000|Overall Study|Progression of Disease|47|||
128008260|NCT02187783|460658738|FG000|Overall Study|Adverse Event|8|||
128008261|NCT02187783|460658738|FG000|Overall Study|Death|3|||
128008262|NCT02187783|460658738|FG000|Overall Study|Progressive disease|80|||
128008263|NCT02187783|460658738|FG000|Overall Study|Protocol Violation|3|||
128008264|NCT02187783|460658738|FG000|Overall Study|Physician Decision|2|||
128008265|NCT02187783|460658738|FG000|Overall Study|Withdrawal by Subject|9|||
128008266|NCT02187783|460658738|FG000|Overall Study|Study terminated by sponsor|1|||
128008267|NCT01654276|460658739|FG000|Overall Study|Lack of Efficacy|1|||
128008268|NCT01654276|460658739|FG000|Overall Study|Lost to Follow-up|4|||
128008269|NCT01654276|460658739|FG000|Overall Study|Withdrawal by Subject|1|||
128008270|NCT04609514|460658740|FG000|Overall Study|Lost to Follow-up|5|||
128008271|NCT04609514|460658741|FG001|Overall Study|Lost to Follow-up|4|||
128008272|NCT04609514|460658740|FG000|Overall Study|Withdrawal by PI|0|||
128008273|NCT04609514|460658741|FG001|Overall Study|Withdrawal by PI|2|||
128008274|NCT01316575|460658744|FG000|Overall Study|Withdrawal by Subject|2|||
128008275|NCT01316575|460658745|FG001|Overall Study|Withdrawal by Subject|0|||
128008276|NCT01316575|460658744|FG000|Overall Study|Required alternate treatment|0|||
128008277|NCT01316575|460658745|FG001|Overall Study|Required alternate treatment|1|||
128008278|NCT00402831|460658746|FG000|Overall Study|Lost to Follow-up|1|||
128008279|NCT00402831|460658747|FG001|Overall Study|Lost to Follow-up|2|||
128008280|NCT00402831|460658746|FG000|Overall Study|Non-compliance with protocol|0|||
128008281|NCT00402831|460658747|FG001|Overall Study|Non-compliance with protocol|1|||
128008282|NCT01114724|460658750|FG000|Overall Study|Death|8|||
128008283|NCT01114724|460658750|FG000|Overall Study|Lost to Follow-up|1|||
128008284|NCT01114724|460658750|FG000|Overall Study|Withdrawal by Subject|1|||
128008285|NCT03883386|460658756|FG000|First Assignment|Lost to Follow-up|1|||
128008286|NCT03883386|460658757|FG001|First Assignment|Lost to Follow-up|0|||
128008287|NCT03883386|460658756|FG000|First Assignment|Withdrawal by Subject|1|||
127674178|NCT01981850|459430527|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
128008288|NCT03883386|460658757|FG001|First Assignment|Withdrawal by Subject|1|||
128008289|NCT02814526|460658758|FG000|Overall Study|Adverse Event|4|||
128008290|NCT02814526|460658759|FG001|Overall Study|Adverse Event|3|||
127674179|NCT01981850|459430528|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
127674180|NCT01981850|459430529|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
127674181|NCT01981850|459430530|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
127674182|NCT01981850|459430531|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
127674183|NCT01981850|459430532|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
127674184|NCT01981850|459430533|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
128008291|NCT02814526|460658758|FG000|Overall Study|Death|1|||
128008292|NCT02814526|460658759|FG001|Overall Study|Death|1|||
127674185|NCT01981850|459430534|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
128008293|NCT02814526|460658758|FG000|Overall Study|Lost to Follow-up|3|||
128008294|NCT02814526|460658759|FG001|Overall Study|Lost to Follow-up|4|||
128008295|NCT02814526|460658758|FG000|Overall Study|non site physician decision|1|||
127674186|NCT01981850|459430525|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
128008296|NCT02814526|460658759|FG001|Overall Study|non site physician decision|0|||
128008297|NCT02814526|460658758|FG000|Overall Study|participant noncompliance|1|||
128008298|NCT02814526|460658759|FG001|Overall Study|participant noncompliance|1|||
128008299|NCT02814526|460658758|FG000|Overall Study|Withdrawal by Subject|20|||
127762005|NCT02947087|459754077|FG000|Overall Study|Withdrawal by Subject|3|||
127762006|NCT02947087|459754078|FG001|Overall Study|Withdrawal by Subject|2|||
127762007|NCT01879722|459754082|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
127762008|NCT01879722|459754083|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
127762009|NCT01879722|459754084|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
127762010|NCT01879722|459754085|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
127762011|NCT01879722|459754086|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
127762012|NCT01879722|459754087|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
127762013|NCT01879722|459754088|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
127762014|NCT01879722|459754089|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
127762015|NCT01879722|459754090|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
128008300|NCT02814526|460658759|FG001|Overall Study|Withdrawal by Subject|14|||
128008301|NCT02814526|460658758|FG000|Overall Study|safety risk|2|||
128008302|NCT02814526|460658759|FG001|Overall Study|safety risk|1|||
128008303|NCT02814526|460658758|FG000|Overall Study|early termination-study terminated|1|||
128008304|NCT02814526|460658759|FG001|Overall Study|early termination-study terminated|2|||
128008305|NCT02814526|460658758|FG000|Overall Study|Other|0|||
128008306|NCT02814526|460658759|FG001|Overall Study|Other|4|||
128008307|NCT00251758|460658760|FG000|Overall Study|Adverse Event|7|||
128008308|NCT00251758|460658761|FG001|Overall Study|Adverse Event|9|||
128008309|NCT00251758|460658762|FG002|Overall Study|Adverse Event|11|||
128008310|NCT00251758|460658760|FG000|Overall Study|Lost to Follow-up|4|||
128008311|NCT00251758|460658761|FG001|Overall Study|Lost to Follow-up|2|||
128008312|NCT00251758|460658762|FG002|Overall Study|Lost to Follow-up|5|||
128008313|NCT00251758|460658760|FG000|Overall Study|Withdrawal by Subject|13|||
128008314|NCT00251758|460658761|FG001|Overall Study|Withdrawal by Subject|7|||
128008315|NCT00251758|460658762|FG002|Overall Study|Withdrawal by Subject|3|||
128008316|NCT00251758|460658760|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
128008317|NCT00251758|460658761|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
128008318|NCT00251758|460658762|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
128008319|NCT00251758|460658760|FG000|Overall Study|Lack of Efficacy|3|||
128008320|NCT00251758|460658761|FG001|Overall Study|Lack of Efficacy|0|||
128008321|NCT00251758|460658762|FG002|Overall Study|Lack of Efficacy|0|||
128008322|NCT00251758|460658760|FG000|Overall Study|Noncompliant|0|||
128008323|NCT00251758|460658761|FG001|Overall Study|Noncompliant|2|||
128008324|NCT00251758|460658762|FG002|Overall Study|Noncompliant|2|||
128008325|NCT00251758|460658760|FG000|Overall Study|Pregnancy|0|||
128008326|NCT00251758|460658761|FG001|Overall Study|Pregnancy|1|||
128008327|NCT00251758|460658762|FG002|Overall Study|Pregnancy|0|||
128008328|NCT00251758|460658760|FG000|Overall Study|Per Subject Request|0|||
128008329|NCT00251758|460658761|FG001|Overall Study|Per Subject Request|0|||
128008330|NCT00251758|460658762|FG002|Overall Study|Per Subject Request|1|||
128008331|NCT00251758|460658760|FG000|Overall Study|Per Investigator Request|1|||
128008332|NCT00251758|460658761|FG001|Overall Study|Per Investigator Request|0|||
128008333|NCT00251758|460658762|FG002|Overall Study|Per Investigator Request|0|||
128008334|NCT01387269|460658763|FG000|Overall Study|Death|38|||
128008335|NCT01387269|460658764|FG001|Overall Study|Death|20|||
128008336|NCT01387269|460658763|FG000|Overall Study|Other|8|||
128008337|NCT01387269|460658764|FG001|Overall Study|Other|7|||
128008338|NCT01387269|460658763|FG000|Overall Study|Unrelated AE|12|||
128008339|NCT01387269|460658764|FG001|Overall Study|Unrelated AE|3|||
128008340|NCT01387269|460658763|FG000|Overall Study|Withdrawal by patient|32|||
128008341|NCT01387269|460658764|FG001|Overall Study|Withdrawal by patient|10|||
128008342|NCT01387269|460658763|FG000|Overall Study|Study drug-related AE|1|||
128008343|NCT01387269|460658764|FG001|Overall Study|Study drug-related AE|0|||
128008344|NCT01387269|460658763|FG000|Overall Study|Lost to Follow-up|1|||
128008345|NCT01387269|460658764|FG001|Overall Study|Lost to Follow-up|0|||
128008346|NCT01981616|460658770|FG000|Overall Study|Adverse Event|0|||
128008347|NCT01981616|460658771|FG001|Overall Study|Adverse Event|1|||
128008348|NCT01981616|460658770|FG000|Overall Study|Protocol Violation|1|||
128008349|NCT01981616|460658771|FG001|Overall Study|Protocol Violation|0|||
128008350|NCT01020123|460658772|FG000|Main Period|Withdrawal by Subject|6|||
128008351|NCT01020123|460658773|FG001|Main Period|Withdrawal by Subject|5|||
128008352|NCT01020123|460658774|FG002|Main Period|Withdrawal by Subject|3|||
128008353|NCT01020123|460658775|FG003|Main Period|Withdrawal by Subject|1|||
128008354|NCT01020123|460658776|FG004|Main Period|Withdrawal by Subject|6|||
128008355|NCT01020123|460658777|FG005|Main Period|Withdrawal by Subject|3|||
128008356|NCT01020123|460658778|FG006|Main Period|Withdrawal by Subject|2|||
128008357|NCT01020123|460658772|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
127762016|NCT01879722|459754091|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
128008358|NCT01020123|460658773|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
128008359|NCT01020123|460658774|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
128008360|NCT01020123|460658775|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
128008361|NCT01020123|460658776|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
128008362|NCT01020123|460658777|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
128008363|NCT01020123|460658778|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
128008364|NCT01020123|460658772|FG000|Main Period|Adverse Event|5|||
128008365|NCT01020123|460658773|FG001|Main Period|Adverse Event|2|||
127762017|NCT01879722|459754082|FG000|Overall Study|Voluntary Withdrawal|0|||
127762018|NCT01879722|459754083|FG001|Overall Study|Voluntary Withdrawal|0|||
127762019|NCT01879722|459754084|FG002|Overall Study|Voluntary Withdrawal|0|||
128008366|NCT01020123|460658774|FG002|Main Period|Adverse Event|2|||
128008367|NCT01020123|460658775|FG003|Main Period|Adverse Event|1|||
128008368|NCT01020123|460658776|FG004|Main Period|Adverse Event|1|||
128008369|NCT01020123|460658777|FG005|Main Period|Adverse Event|2|||
128008370|NCT01020123|460658778|FG006|Main Period|Adverse Event|1|||
128008371|NCT01020123|460658772|FG000|Main Period|Protocol Violation|4|||
128008372|NCT01020123|460658773|FG001|Main Period|Protocol Violation|4|||
128008373|NCT01020123|460658774|FG002|Main Period|Protocol Violation|2|||
128008374|NCT01020123|460658775|FG003|Main Period|Protocol Violation|5|||
128008375|NCT01020123|460658776|FG004|Main Period|Protocol Violation|2|||
128008376|NCT01020123|460658777|FG005|Main Period|Protocol Violation|3|||
128008377|NCT01020123|460658778|FG006|Main Period|Protocol Violation|2|||
128008378|NCT01020123|460658772|FG000|Main Period|Lost to Follow-up|0|||
128008379|NCT01020123|460658773|FG001|Main Period|Lost to Follow-up|2|||
128008380|NCT01020123|460658774|FG002|Main Period|Lost to Follow-up|0|||
128008381|NCT01020123|460658775|FG003|Main Period|Lost to Follow-up|0|||
128008382|NCT01020123|460658776|FG004|Main Period|Lost to Follow-up|0|||
128008383|NCT01020123|460658777|FG005|Main Period|Lost to Follow-up|0|||
128008384|NCT01020123|460658778|FG006|Main Period|Lost to Follow-up|0|||
128008385|NCT01020123|460658772|FG000|Main Period|Unclasified|2|||
128008386|NCT01020123|460658773|FG001|Main Period|Unclasified|0|||
128008387|NCT01020123|460658774|FG002|Main Period|Unclasified|1|||
128008388|NCT01020123|460658775|FG003|Main Period|Unclasified|0|||
128008389|NCT01020123|460658776|FG004|Main Period|Unclasified|1|||
128008390|NCT01020123|460658777|FG005|Main Period|Unclasified|3|||
128008391|NCT01020123|460658778|FG006|Main Period|Unclasified|6|||
128008392|NCT01020123|460658772|FG000|Extention Period|Withdrawal by Subject|2|||
128008393|NCT01020123|460658773|FG001|Extention Period|Withdrawal by Subject|1|||
128008394|NCT01020123|460658774|FG002|Extention Period|Withdrawal by Subject|1|||
128008395|NCT01020123|460658775|FG003|Extention Period|Withdrawal by Subject|0|||
128008396|NCT01020123|460658776|FG004|Extention Period|Withdrawal by Subject|0|||
128008397|NCT01020123|460658777|FG005|Extention Period|Withdrawal by Subject|0|||
128008398|NCT01020123|460658778|FG006|Extention Period|Withdrawal by Subject|0|||
128008399|NCT01020123|460658772|FG000|Extention Period|Adverse Event|0|||
128008400|NCT01020123|460658773|FG001|Extention Period|Adverse Event|0|||
128008401|NCT01020123|460658774|FG002|Extention Period|Adverse Event|0|||
128008402|NCT01020123|460658775|FG003|Extention Period|Adverse Event|1|||
128008403|NCT01020123|460658776|FG004|Extention Period|Adverse Event|0|||
128008404|NCT01020123|460658777|FG005|Extention Period|Adverse Event|0|||
128008405|NCT01020123|460658778|FG006|Extention Period|Adverse Event|0|||
128008406|NCT01020123|460658772|FG000|Extention Period|Protocol Violation|1|||
128008407|NCT01020123|460658773|FG001|Extention Period|Protocol Violation|1|||
128008408|NCT01020123|460658774|FG002|Extention Period|Protocol Violation|1|||
128008409|NCT01020123|460658775|FG003|Extention Period|Protocol Violation|0|||
128008410|NCT01020123|460658776|FG004|Extention Period|Protocol Violation|0|||
128008411|NCT01020123|460658777|FG005|Extention Period|Protocol Violation|0|||
128008412|NCT01020123|460658778|FG006|Extention Period|Protocol Violation|1|||
128008413|NCT01020123|460658772|FG000|Extention Period|Lost to Follow-up|0|||
128008414|NCT01020123|460658773|FG001|Extention Period|Lost to Follow-up|0|||
128008415|NCT01020123|460658774|FG002|Extention Period|Lost to Follow-up|0|||
128008416|NCT01020123|460658775|FG003|Extention Period|Lost to Follow-up|0|||
128008417|NCT01020123|460658776|FG004|Extention Period|Lost to Follow-up|0|||
128008418|NCT01020123|460658777|FG005|Extention Period|Lost to Follow-up|2|||
128008419|NCT01020123|460658778|FG006|Extention Period|Lost to Follow-up|0|||
128008420|NCT04711005|460658783|FG000|Overall Study|Withdrawal by Subject|0|||
128008421|NCT04711005|460658784|FG001|Overall Study|Withdrawal by Subject|0|||
128008422|NCT04711005|460658785|FG002|Overall Study|Withdrawal by Subject|0|||
127762020|NCT01879722|459754085|FG003|Overall Study|Voluntary Withdrawal|0|||
128008423|NCT04711005|460658786|FG003|Overall Study|Withdrawal by Subject|0|||
128008424|NCT04711005|460658787|FG004|Overall Study|Withdrawal by Subject|0|||
128008425|NCT04711005|460658788|FG005|Overall Study|Withdrawal by Subject|0|||
127762021|NCT01879722|459754086|FG004|Overall Study|Voluntary Withdrawal|0|||
127762022|NCT01879722|459754087|FG005|Overall Study|Voluntary Withdrawal|0|||
127762023|NCT01879722|459754088|FG006|Overall Study|Voluntary Withdrawal|0|||
127762024|NCT01879722|459754089|FG007|Overall Study|Voluntary Withdrawal|0|||
128008426|NCT04711005|460658789|FG006|Overall Study|Withdrawal by Subject|0|||
128008427|NCT04711005|460658790|FG007|Overall Study|Withdrawal by Subject|1|||
128008428|NCT04711005|460658791|FG008|Overall Study|Withdrawal by Subject|0|||
128008429|NCT04711005|460658792|FG009|Overall Study|Withdrawal by Subject|0|||
128008430|NCT04711005|460658783|FG000|Overall Study|Physician Decision|0|||
128008431|NCT04711005|460658784|FG001|Overall Study|Physician Decision|0|||
128008432|NCT04711005|460658785|FG002|Overall Study|Physician Decision|0|||
128008433|NCT04711005|460658786|FG003|Overall Study|Physician Decision|0|||
128008434|NCT04711005|460658787|FG004|Overall Study|Physician Decision|0|||
128008435|NCT04711005|460658788|FG005|Overall Study|Physician Decision|0|||
128008436|NCT04711005|460658789|FG006|Overall Study|Physician Decision|0|||
128008437|NCT04711005|460658790|FG007|Overall Study|Physician Decision|2|||
128008438|NCT04711005|460658791|FG008|Overall Study|Physician Decision|1|||
128008439|NCT04711005|460658792|FG009|Overall Study|Physician Decision|0|||
128008440|NCT03824561|460658800|FG000|Overall Study|Protocol Violation|19|||
128008441|NCT03573297|460658802|FG000|Open Label Treatment Period|Adverse Event|67|||
128008442|NCT03573297|460658803|FG001|Open Label Treatment Period|Adverse Event|0|||
128008443|NCT03573297|460658804|FG002|Open Label Treatment Period|Adverse Event|0|||
128008444|NCT03573297|460658805|FG003|Open Label Treatment Period|Adverse Event|0|||
128008445|NCT03573297|460658802|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
128008446|NCT03573297|460658803|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
128008447|NCT03573297|460658804|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
128008448|NCT03573297|460658805|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
128008449|NCT03573297|460658802|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
128008450|NCT03573297|460658803|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
128008451|NCT03573297|460658804|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
128008452|NCT03573297|460658805|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
128008453|NCT03573297|460658802|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
128008454|NCT03573297|460658803|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
128008455|NCT03573297|460658804|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
128008456|NCT03573297|460658805|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
128008457|NCT03573297|460658802|FG000|Open Label Treatment Period|Pregnancy|1|||
128008458|NCT03573297|460658803|FG001|Open Label Treatment Period|Pregnancy|0|||
128008459|NCT03573297|460658804|FG002|Open Label Treatment Period|Pregnancy|0|||
128008460|NCT03573297|460658805|FG003|Open Label Treatment Period|Pregnancy|0|||
128008461|NCT03573297|460658802|FG000|Open Label Treatment Period|Protocol Violation|17|||
128008462|NCT03573297|460658803|FG001|Open Label Treatment Period|Protocol Violation|0|||
128008463|NCT03573297|460658804|FG002|Open Label Treatment Period|Protocol Violation|0|||
128008464|NCT03573297|460658805|FG003|Open Label Treatment Period|Protocol Violation|0|||
128008465|NCT03573297|460658802|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
128008466|NCT03573297|460658803|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
128008467|NCT03573297|460658804|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
128008468|NCT03573297|460658805|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
128008469|NCT03573297|460658802|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
127674187|NCT01981850|459430526|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
128008470|NCT03573297|460658803|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
128008471|NCT03573297|460658804|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
128008472|NCT03573297|460658805|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
128008473|NCT03573297|460658802|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
128008474|NCT03573297|460658803|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
128008475|NCT03573297|460658804|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
128008476|NCT03573297|460658805|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
128008477|NCT03573297|460658802|FG000|Open Label Treatment Period|Other, Not Specified|7|||
128008478|NCT03573297|460658803|FG001|Open Label Treatment Period|Other, Not Specified|0|||
128008479|NCT03573297|460658804|FG002|Open Label Treatment Period|Other, Not Specified|0|||
128008480|NCT03573297|460658805|FG003|Open Label Treatment Period|Other, Not Specified|0|||
128008481|NCT03573297|460658802|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
128008482|NCT03573297|460658803|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
128008483|NCT03573297|460658804|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
128008484|NCT03573297|460658805|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
128008485|NCT03573297|460658802|FG000|Double-Blind Treatment Period|Adverse Event|0|||
128008486|NCT03573297|460658803|FG001|Double-Blind Treatment Period|Adverse Event|1|||
128008487|NCT03573297|460658804|FG002|Double-Blind Treatment Period|Adverse Event|5|||
128008488|NCT03573297|460658805|FG003|Double-Blind Treatment Period|Adverse Event|1|||
128008489|NCT03573297|460658802|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
128008490|NCT03573297|460658803|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
128008491|NCT03573297|460658804|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
128008492|NCT03573297|460658805|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
128008493|NCT03573297|460658802|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
128008494|NCT03573297|460658803|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
128008495|NCT03573297|460658804|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
128008496|NCT03573297|460658805|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
128008497|NCT03573297|460658802|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
128008498|NCT03573297|460658803|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
128008499|NCT03573297|460658804|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
128008500|NCT03573297|460658805|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
127674188|NCT01981850|459430527|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
127674189|NCT01981850|459430528|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
127674190|NCT01981850|459430529|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
128008501|NCT03573297|460658802|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
128008502|NCT03573297|460658803|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
128008503|NCT03573297|460658804|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
128008504|NCT03573297|460658805|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
128008505|NCT03573297|460658802|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
128008506|NCT03573297|460658803|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
128008507|NCT03573297|460658804|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
128008508|NCT03573297|460658805|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
128008509|NCT03573297|460658802|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
128008510|NCT03573297|460658803|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
128008511|NCT03573297|460658804|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
128008512|NCT03573297|460658805|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
128008513|NCT01499810|460658806|FG000|Overall Study|Lost to Follow-up|10|||
128008514|NCT01499810|460658806|FG000|Overall Study|Protocol Violation|1|||
128008515|NCT01499810|460658806|FG000|Overall Study|Withdrawal by Subject|1|||
128008516|NCT02273167|460658810|FG000|Overall Study|Adverse Event|1|||
128008517|NCT02273167|460658811|FG001|Overall Study|Adverse Event|0|||
128008518|NCT02273167|460658812|FG002|Overall Study|Adverse Event|0|||
128008519|NCT02273167|460658810|FG000|Overall Study|Protocol Violation|3|||
128008520|NCT02273167|460658811|FG001|Overall Study|Protocol Violation|1|||
128008521|NCT02273167|460658812|FG002|Overall Study|Protocol Violation|1|||
128008522|NCT02273167|460658810|FG000|Overall Study|Lost to Follow-up|0|||
128008523|NCT02273167|460658811|FG001|Overall Study|Lost to Follow-up|1|||
128008524|NCT02273167|460658812|FG002|Overall Study|Lost to Follow-up|1|||
128008525|NCT02273167|460658810|FG000|Overall Study|Withdrawal by Subject|10|||
128008526|NCT02273167|460658811|FG001|Overall Study|Withdrawal by Subject|12|||
128008527|NCT02273167|460658812|FG002|Overall Study|Withdrawal by Subject|11|||
128008528|NCT02273167|460658810|FG000|Overall Study|Various|10|||
128008529|NCT02273167|460658811|FG001|Overall Study|Various|9|||
128008530|NCT02273167|460658812|FG002|Overall Study|Various|8|||
128008531|NCT02781324|460658813|FG000|Overall Study|Withdrawal by Subject|1|||
128008532|NCT02781324|460658814|FG001|Overall Study|Withdrawal by Subject|0|||
128008533|NCT02781324|460658813|FG000|Overall Study|Physician Decision|1|||
128008534|NCT02781324|460658814|FG001|Overall Study|Physician Decision|2|||
128008535|NCT00666237|460658816|FG000|Overall Study|Death|5|||
128008536|NCT00666237|460658817|FG001|Overall Study|Death|5|||
128008537|NCT00666237|460658816|FG000|Overall Study|Lost to Follow-up|29|||
128008538|NCT00666237|460658817|FG001|Overall Study|Lost to Follow-up|25|||
128008539|NCT03370172|460660511|FG000|Overall Study|Withdrawal by Subject|0|||
128008540|NCT03370172|460660512|FG001|Overall Study|Withdrawal by Subject|1|||
128008541|NCT01171534|460660519|FG000|Overall Study|Lost to Follow-up|0|||
128008542|NCT01171534|460660520|FG001|Overall Study|Lost to Follow-up|2|||
128008543|NCT01171534|460660519|FG000|Overall Study|screen failure|0|||
128008544|NCT01171534|460660520|FG001|Overall Study|screen failure|1|||
128008545|NCT00849056|460660521|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
128008546|NCT00849056|460660522|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
128008547|NCT00849056|460660521|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
128008548|NCT00849056|460660522|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
128008549|NCT00849056|460660521|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
128008550|NCT00849056|460660522|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
128008551|NCT00849056|460660521|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
128008552|NCT00849056|460660522|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
128008553|NCT00849056|460660521|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
128008554|NCT00849056|460660522|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
128008555|NCT00849056|460660521|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
128008556|NCT00849056|460660522|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
128008557|NCT00849056|460660521|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
128008558|NCT00849056|460660522|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
128008559|NCT00849056|460660521|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
128008560|NCT00849056|460660522|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
128008561|NCT00849056|460660521|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
128008562|NCT00849056|460660522|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
128008563|NCT00849056|460660521|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
128008564|NCT00849056|460660522|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
128008565|NCT00849056|460660521|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
128008566|NCT00849056|460660522|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
128008567|NCT00849056|460660521|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
127674191|NCT01981850|459430530|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
128008568|NCT00849056|460660522|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
128008569|NCT00849056|460660521|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
128008570|NCT00849056|460660522|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
128008571|NCT00849056|460660521|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
127762025|NCT01879722|459754090|FG008|Overall Study|Voluntary Withdrawal|1|||
127762026|NCT01879722|459754091|FG009|Overall Study|Voluntary Withdrawal|0|||
127762027|NCT00434213|459754092|FG000|Overall Study|Adverse Event|12|||
127762028|NCT00434213|459754092|FG000|Overall Study|Lack of Efficacy|9|||
127762029|NCT00434213|459754092|FG000|Overall Study|Lost to Follow-up|14|||
127762030|NCT00434213|459754092|FG000|Overall Study|Withdrawal by Subject|7|||
127762031|NCT00434213|459754092|FG000|Overall Study|Protocol Violation|3|||
127762032|NCT00434213|459754092|FG000|Overall Study|Unable to comply with study visit window|2|||
127762033|NCT00434213|459754092|FG000|Overall Study|Application site reaction|1|||
127762034|NCT00434213|459754092|FG000|Overall Study|Non-compliant to study schedule|1|||
128008572|NCT00849056|460660522|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
128008573|NCT00849056|460660521|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
128008574|NCT00849056|460660522|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
128008575|NCT00849056|460660521|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
128008576|NCT00849056|460660522|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
128008577|NCT02711137|460660523|FG000|Overall Study|Death|1|||
128008578|NCT02711137|460660524|FG001|Overall Study|Death|4|||
128008579|NCT02711137|460660525|FG002|Overall Study|Death|5|||
128008580|NCT02711137|460660526|FG003|Overall Study|Death|5|||
128008581|NCT02711137|460660527|FG004|Overall Study|Death|3|||
128008582|NCT02711137|460660528|FG005|Overall Study|Death|1|||
128008583|NCT02711137|460660529|FG006|Overall Study|Death|61|||
128008584|NCT02711137|460660530|FG007|Overall Study|Death|3|||
128008585|NCT02711137|460660531|FG008|Overall Study|Death|0|||
128008586|NCT02711137|460660532|FG009|Overall Study|Death|1|||
128008587|NCT02711137|460660533|FG010|Overall Study|Death|1|||
128008588|NCT02711137|460660534|FG011|Overall Study|Death|1|||
128008589|NCT02711137|460660535|FG012|Overall Study|Death|0|||
128008590|NCT02711137|460660536|FG013|Overall Study|Death|0|||
128008591|NCT02711137|460660537|FG014|Overall Study|Death|0|||
128008592|NCT02711137|460660523|FG000|Overall Study|Study Terminated by Sponsor|0|||
128008593|NCT02711137|460660524|FG001|Overall Study|Study Terminated by Sponsor|0|||
128008594|NCT02711137|460660525|FG002|Overall Study|Study Terminated by Sponsor|1|||
128008595|NCT02711137|460660526|FG003|Overall Study|Study Terminated by Sponsor|0|||
128008596|NCT02711137|460660527|FG004|Overall Study|Study Terminated by Sponsor|0|||
128008597|NCT02711137|460660528|FG005|Overall Study|Study Terminated by Sponsor|0|||
128008598|NCT02711137|460660529|FG006|Overall Study|Study Terminated by Sponsor|1|||
128008599|NCT02711137|460660530|FG007|Overall Study|Study Terminated by Sponsor|0|||
128008600|NCT02711137|460660531|FG008|Overall Study|Study Terminated by Sponsor|0|||
128008601|NCT02711137|460660532|FG009|Overall Study|Study Terminated by Sponsor|0|||
128008602|NCT02711137|460660533|FG010|Overall Study|Study Terminated by Sponsor|0|||
128008603|NCT02711137|460660534|FG011|Overall Study|Study Terminated by Sponsor|0|||
128008604|NCT02711137|460660535|FG012|Overall Study|Study Terminated by Sponsor|0|||
128008605|NCT02711137|460660536|FG013|Overall Study|Study Terminated by Sponsor|0|||
128008606|NCT02711137|460660537|FG014|Overall Study|Study Terminated by Sponsor|0|||
128008607|NCT02711137|460660523|FG000|Overall Study|Physician Decision|1|||
128008608|NCT02711137|460660524|FG001|Overall Study|Physician Decision|0|||
128008609|NCT02711137|460660525|FG002|Overall Study|Physician Decision|2|||
128008610|NCT02711137|460660526|FG003|Overall Study|Physician Decision|1|||
128008611|NCT02711137|460660527|FG004|Overall Study|Physician Decision|1|||
128008612|NCT02711137|460660528|FG005|Overall Study|Physician Decision|0|||
128008613|NCT02711137|460660529|FG006|Overall Study|Physician Decision|12|||
128008614|NCT02711137|460660530|FG007|Overall Study|Physician Decision|2|||
128008615|NCT02711137|460660531|FG008|Overall Study|Physician Decision|1|||
128008616|NCT02711137|460660532|FG009|Overall Study|Physician Decision|1|||
128008617|NCT02711137|460660533|FG010|Overall Study|Physician Decision|3|||
128008618|NCT02711137|460660534|FG011|Overall Study|Physician Decision|2|||
128008619|NCT02711137|460660535|FG012|Overall Study|Physician Decision|1|||
128008620|NCT02711137|460660536|FG013|Overall Study|Physician Decision|1|||
128008621|NCT02711137|460660537|FG014|Overall Study|Physician Decision|2|||
128008622|NCT02711137|460660523|FG000|Overall Study|Other|0|||
128008623|NCT02711137|460660524|FG001|Overall Study|Other|1|||
128008624|NCT02711137|460660525|FG002|Overall Study|Other|0|||
128008625|NCT02711137|460660526|FG003|Overall Study|Other|0|||
128008626|NCT02711137|460660527|FG004|Overall Study|Other|0|||
128008627|NCT02711137|460660528|FG005|Overall Study|Other|0|||
128008628|NCT02711137|460660529|FG006|Overall Study|Other|3|||
127762035|NCT01327495|459754095|FG000|Overall Study|Adverse Event|2|||
127762036|NCT01327495|459754096|FG001|Overall Study|Adverse Event|1|||
128008629|NCT02711137|460660530|FG007|Overall Study|Other|0|||
128008630|NCT02711137|460660531|FG008|Overall Study|Other|0|||
128008631|NCT02711137|460660532|FG009|Overall Study|Other|0|||
128008632|NCT02711137|460660533|FG010|Overall Study|Other|0|||
128008633|NCT02711137|460660534|FG011|Overall Study|Other|0|||
128008634|NCT02711137|460660535|FG012|Overall Study|Other|0|||
128008635|NCT02711137|460660536|FG013|Overall Study|Other|0|||
127762037|NCT01327495|459754097|FG002|Overall Study|Adverse Event|1|||
128008636|NCT02711137|460660537|FG014|Overall Study|Other|1|||
128008637|NCT02711137|460660523|FG000|Overall Study|Withdrawal by Subject|1|||
128008638|NCT02711137|460660524|FG001|Overall Study|Withdrawal by Subject|0|||
128008639|NCT02711137|460660525|FG002|Overall Study|Withdrawal by Subject|0|||
128008640|NCT02711137|460660526|FG003|Overall Study|Withdrawal by Subject|1|||
128008641|NCT02711137|460660527|FG004|Overall Study|Withdrawal by Subject|1|||
128008642|NCT02711137|460660528|FG005|Overall Study|Withdrawal by Subject|0|||
128008643|NCT02711137|460660529|FG006|Overall Study|Withdrawal by Subject|7|||
128008644|NCT02711137|460660530|FG007|Overall Study|Withdrawal by Subject|0|||
128008645|NCT02711137|460660531|FG008|Overall Study|Withdrawal by Subject|0|||
128008646|NCT02711137|460660532|FG009|Overall Study|Withdrawal by Subject|0|||
128008647|NCT02711137|460660533|FG010|Overall Study|Withdrawal by Subject|0|||
128008648|NCT02711137|460660534|FG011|Overall Study|Withdrawal by Subject|0|||
128008649|NCT02711137|460660535|FG012|Overall Study|Withdrawal by Subject|0|||
127674192|NCT01981850|459430531|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
127674193|NCT01981850|459430532|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
127674194|NCT01981850|459430533|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
127674195|NCT01981850|459430534|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
127674196|NCT01981850|459430525|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
127674197|NCT01981850|459430526|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
127674198|NCT01981850|459430527|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
127674199|NCT01981850|459430528|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
127674200|NCT01981850|459430529|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
127674201|NCT01981850|459430530|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
127674202|NCT01981850|459430531|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
127674203|NCT01981850|459430532|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
127674204|NCT01981850|459430533|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
127674205|NCT01981850|459430534|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
127674206|NCT02524288|459430535|FG000|Overall Study|Adverse Event|115|||
127674207|NCT02524288|459430535|FG000|Overall Study|Lost to Follow-up|216|||
127674208|NCT02524288|459430535|FG000|Overall Study|Non-Compliance With Protocol|32|||
127674209|NCT02524288|459430535|FG000|Overall Study|Non-Compliance With Study Drug|14|||
127674210|NCT02524288|459430535|FG000|Overall Study|Pregnancy Wish|6|||
127674211|NCT02524288|459430535|FG000|Overall Study|Protocol Violation|6|||
127674212|NCT02524288|459430535|FG000|Overall Study|Screen Failure|2|||
127674213|NCT02524288|459430535|FG000|Overall Study|Site Discontinued Study Participation|1|||
127674214|NCT02524288|459430535|FG000|Overall Study|Study Terminated By Sponsor|1417|||
127674215|NCT02524288|459430535|FG000|Overall Study|Subject Moved|32|||
127674216|NCT02524288|459430535|FG000|Overall Study|Withdrawal by Subject|76|||
127674217|NCT02524288|459430535|FG000|Overall Study|Pregnancy|22|||
127674218|NCT02524288|459430535|FG000|Overall Study|Physician Decision|2|||
127674219|NCT00517933|459430536|FG000|Period 1|Death|2|||
127674220|NCT00517933|459430537|FG001|Period 1|Death|1|||
127674221|NCT00517933|459430536|FG000|Period 1|Adverse Event|4|||
127674222|NCT00517933|459430537|FG001|Period 1|Adverse Event|4|||
127674223|NCT00517933|459430536|FG000|Period 1|Lost to Follow-up|2|||
127674224|NCT00517933|459430537|FG001|Period 1|Lost to Follow-up|0|||
127674225|NCT00517933|459430536|FG000|Period 1|Underwent lung transplant|0|||
127674226|NCT00517933|459430537|FG001|Period 1|Underwent lung transplant|1|||
127674227|NCT00517933|459430536|FG000|Period 2|Death|2|||
127674228|NCT00517933|459430537|FG001|Period 2|Death|4|||
127674229|NCT00517933|459430536|FG000|Period 2|Adverse Event|2|||
127674230|NCT00517933|459430537|FG001|Period 2|Adverse Event|4|||
127674231|NCT00517933|459430536|FG000|Period 2|Physician Decision|1|||
127674232|NCT00517933|459430537|FG001|Period 2|Physician Decision|0|||
127674233|NCT00517933|459430536|FG000|Period 2|Withdrawal by Subject|1|||
127674234|NCT00517933|459430537|FG001|Period 2|Withdrawal by Subject|3|||
127674235|NCT00517933|459430536|FG000|Period 2|Underwent lung transplant|0|||
127674236|NCT00517933|459430537|FG001|Period 2|Underwent lung transplant|2|||
127674237|NCT01835899|459430538|FG000|Overall Study|Adverse Event|0|||
127674238|NCT01835899|459430539|FG001|Overall Study|Adverse Event|0|||
127674239|NCT01835899|459430540|FG002|Overall Study|Adverse Event|1|||
127674240|NCT01835899|459430538|FG000|Overall Study|Other than stated above|0|||
128008650|NCT02711137|460660536|FG013|Overall Study|Withdrawal by Subject|1|||
128008651|NCT02711137|460660537|FG014|Overall Study|Withdrawal by Subject|0|||
128008652|NCT02711137|460660523|FG000|Overall Study|Lost to Follow-up|1|||
128008653|NCT02711137|460660524|FG001|Overall Study|Lost to Follow-up|0|||
127674241|NCT01835899|459430539|FG001|Overall Study|Other than stated above|1|||
127674242|NCT01835899|459430540|FG002|Overall Study|Other than stated above|0|||
127674243|NCT04305912|459430543|FG000|First Intervention|COVID-19 Suspension|2|||
127674244|NCT04305912|459430544|FG001|First Intervention|COVID-19 Suspension|0|||
127674245|NCT04305912|459430543|FG000|First Intervention|Withdrawal by Subject|0|||
127674246|NCT04305912|459430544|FG001|First Intervention|Withdrawal by Subject|1|||
127674247|NCT04305912|459430543|FG000|Second Intervention|Adverse Event|0|||
127674248|NCT04305912|459430544|FG001|Second Intervention|Adverse Event|1|||
127674249|NCT01649427|459430545|FG000|Overall Study|Adverse Event|1|||
127674250|NCT01649427|459430546|FG001|Overall Study|Adverse Event|1|||
127674251|NCT01649427|459430545|FG000|Overall Study|Withdrawal by Subject|8|||
127674252|NCT01649427|459430546|FG001|Overall Study|Withdrawal by Subject|7|||
127674253|NCT01649427|459430545|FG000|Overall Study|Lost to Follow-up|0|||
128008654|NCT02711137|460660525|FG002|Overall Study|Lost to Follow-up|0|||
128008655|NCT02711137|460660526|FG003|Overall Study|Lost to Follow-up|0|||
128008656|NCT02711137|460660527|FG004|Overall Study|Lost to Follow-up|0|||
128008657|NCT02711137|460660528|FG005|Overall Study|Lost to Follow-up|0|||
127674254|NCT01649427|459430546|FG001|Overall Study|Lost to Follow-up|1|||
127674255|NCT01649427|459430545|FG000|Overall Study|Graft loss|0|||
127674256|NCT01649427|459430546|FG001|Overall Study|Graft loss|1|||
127674257|NCT01649427|459430545|FG000|Overall Study|Surgical problems during nephrectomy|2|||
127674258|NCT01649427|459430546|FG001|Overall Study|Surgical problems during nephrectomy|2|||
127674259|NCT04888585|459430547|FG000|Placebo-Controlled (Baseline-Week 12)|Other|4|||
127674260|NCT04888585|459430548|FG001|Placebo-Controlled (Baseline-Week 12)|Other|4|||
127674261|NCT04888585|459430549|FG002|Placebo-Controlled (Baseline-Week 12)|Other|4|||
127674262|NCT04888585|459430550|FG003|Placebo-Controlled (Baseline-Week 12)|Other|2|||
127674263|NCT04888585|459430551|FG004|Placebo-Controlled (Baseline-Week 12)|Other|1|||
127674264|NCT04888585|459430552|FG005|Placebo-Controlled (Baseline-Week 12)|Other|0|||
127674265|NCT04888585|459430553|FG006|Placebo-Controlled (Baseline-Week 12)|Other|0|||
127674266|NCT04888585|459430554|FG007|Placebo-Controlled (Baseline-Week 12)|Other|0|||
127674267|NCT04888585|459430555|FG008|Placebo-Controlled (Baseline-Week 12)|Other|0|||
127674268|NCT04888585|459430556|FG009|Placebo-Controlled (Baseline-Week 12)|Other|0|||
127674269|NCT04888585|459430557|FG010|Placebo-Controlled (Baseline-Week 12)|Other|0|||
127674270|NCT04888585|459430547|FG000|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
127674271|NCT04888585|459430548|FG001|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|1|||
127674272|NCT04888585|459430549|FG002|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|4|||
127674273|NCT04888585|459430550|FG003|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
127674274|NCT04888585|459430551|FG004|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
127674275|NCT04888585|459430552|FG005|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
127674276|NCT04888585|459430553|FG006|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
127674277|NCT04888585|459430554|FG007|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
127674278|NCT04888585|459430555|FG008|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
127674279|NCT04888585|459430556|FG009|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
127674280|NCT04888585|459430557|FG010|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
127674281|NCT04888585|459430547|FG000|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
127674282|NCT04888585|459430548|FG001|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
127674283|NCT04888585|459430549|FG002|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
127674284|NCT04888585|459430550|FG003|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
127674285|NCT04888585|459430551|FG004|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
127674286|NCT04888585|459430552|FG005|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
127674287|NCT04888585|459430553|FG006|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
127674288|NCT04888585|459430554|FG007|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
127674289|NCT04888585|459430555|FG008|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
127674290|NCT04888585|459430556|FG009|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
127674291|NCT04888585|459430557|FG010|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
127674292|NCT04888585|459430547|FG000|Long Term Extension (Wk 13-End of Study)|Death|0|||
127674293|NCT04888585|459430548|FG001|Long Term Extension (Wk 13-End of Study)|Death|0|||
127674294|NCT04888585|459430549|FG002|Long Term Extension (Wk 13-End of Study)|Death|0|||
127674295|NCT04888585|459430550|FG003|Long Term Extension (Wk 13-End of Study)|Death|0|||
127674296|NCT04888585|459430551|FG004|Long Term Extension (Wk 13-End of Study)|Death|0|||
127674297|NCT04888585|459430552|FG005|Long Term Extension (Wk 13-End of Study)|Death|0|||
127674298|NCT04888585|459430553|FG006|Long Term Extension (Wk 13-End of Study)|Death|0|||
127674299|NCT04888585|459430554|FG007|Long Term Extension (Wk 13-End of Study)|Death|1|||
127674300|NCT04888585|459430555|FG008|Long Term Extension (Wk 13-End of Study)|Death|0|||
127674301|NCT04888585|459430556|FG009|Long Term Extension (Wk 13-End of Study)|Death|0|||
127674302|NCT04888585|459430557|FG010|Long Term Extension (Wk 13-End of Study)|Death|3|||
127674303|NCT04888585|459430547|FG000|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
127674304|NCT04888585|459430548|FG001|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
127674305|NCT04888585|459430549|FG002|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
127674306|NCT04888585|459430550|FG003|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
127674307|NCT04888585|459430551|FG004|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
127674308|NCT04888585|459430552|FG005|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
127674309|NCT04888585|459430553|FG006|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
127674310|NCT04888585|459430554|FG007|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
127674311|NCT04888585|459430555|FG008|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
127674312|NCT04888585|459430556|FG009|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
127674313|NCT04888585|459430557|FG010|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|11|||
127674314|NCT04888585|459430547|FG000|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
127674315|NCT04888585|459430548|FG001|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
127705132|NCT01928394|459551581|FG014|Treatment Period|Poor/non-compliance|1|||
128008658|NCT02711137|460660529|FG006|Overall Study|Lost to Follow-up|2|||
128008659|NCT02711137|460660530|FG007|Overall Study|Lost to Follow-up|0|||
127762038|NCT01327495|459754098|FG003|Overall Study|Adverse Event|0|||
127762039|NCT01327495|459754099|FG004|Overall Study|Adverse Event|0|||
127762040|NCT01327495|459754100|FG005|Overall Study|Adverse Event|2|||
127762041|NCT01327495|459754095|FG000|Overall Study|Withdrawal by Subject|0|||
127762042|NCT01327495|459754096|FG001|Overall Study|Withdrawal by Subject|1|||
127762043|NCT01327495|459754097|FG002|Overall Study|Withdrawal by Subject|1|||
127762044|NCT01327495|459754098|FG003|Overall Study|Withdrawal by Subject|0|||
127762045|NCT01327495|459754099|FG004|Overall Study|Withdrawal by Subject|1|||
127762046|NCT01327495|459754100|FG005|Overall Study|Withdrawal by Subject|0|||
127762047|NCT01327495|459754095|FG000|Overall Study|Physician Decision|0|||
127762048|NCT01327495|459754096|FG001|Overall Study|Physician Decision|0|||
127762049|NCT01327495|459754097|FG002|Overall Study|Physician Decision|0|||
127762050|NCT01327495|459754098|FG003|Overall Study|Physician Decision|0|||
127762051|NCT01327495|459754099|FG004|Overall Study|Physician Decision|2|||
127762052|NCT01327495|459754100|FG005|Overall Study|Physician Decision|0|||
127762053|NCT01631227|459754108|FG000|Overall Study|withdrawn consent|27|||
127762054|NCT01631227|459754109|FG001|Overall Study|withdrawn consent|21|||
127762055|NCT01631227|459754108|FG000|Overall Study|Adverse Event|1|||
127762056|NCT01631227|459754109|FG001|Overall Study|Adverse Event|0|||
127762057|NCT01631227|459754108|FG000|Overall Study|administrative|2|||
127762058|NCT01631227|459754109|FG001|Overall Study|administrative|1|||
127762059|NCT00766363|459754110|FG000|Overall Study|Withdrawal by Subject|1|||
127762060|NCT00766363|459754111|FG001|Overall Study|Withdrawal by Subject|0|||
127762061|NCT00766363|459754112|FG002|Overall Study|Withdrawal by Subject|0|||
127762062|NCT00766363|459754113|FG003|Overall Study|Withdrawal by Subject|0|||
127762063|NCT00766363|459754110|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
127762064|NCT00766363|459754111|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
127762065|NCT00766363|459754112|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
127762066|NCT00766363|459754113|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
127762067|NCT03020576|459754114|FG000|Overall Study|Withdrawal by Subject|1|||
127762068|NCT03020576|459754115|FG001|Overall Study|Withdrawal by Subject|2|||
127762069|NCT01177800|459754117|FG000|Overall Study|Adverse Event|9|||
127762070|NCT01177800|459754118|FG001|Overall Study|Adverse Event|3|||
127762071|NCT01177800|459754117|FG000|Overall Study|Protocol Violation|0|||
127762072|NCT01177800|459754118|FG001|Overall Study|Protocol Violation|1|||
127762073|NCT01177800|459754117|FG000|Overall Study|Physician Decision|1|||
127762074|NCT01177800|459754118|FG001|Overall Study|Physician Decision|0|||
127762075|NCT01177800|459754117|FG000|Overall Study|Withdrawal of informed consent|0|||
127762076|NCT01177800|459754118|FG001|Overall Study|Withdrawal of informed consent|1|||
127762077|NCT03527550|459754119|FG000|Overall Study|Lost to Follow-up|4|||
127762078|NCT03527550|459754120|FG001|Overall Study|Lost to Follow-up|2|||
127762079|NCT03527550|459754119|FG000|Overall Study|Withdrawal by Subject|4|||
127762080|NCT03527550|459754120|FG001|Overall Study|Withdrawal by Subject|1|||
127762081|NCT03527550|459754119|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
127762082|NCT03527550|459754120|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
127762083|NCT00911937|459754121|FG000|Overall Study|Death|1|||
127762084|NCT00911937|459754122|FG001|Overall Study|Death|0|||
127762085|NCT00911937|459754121|FG000|Overall Study|Lost to Follow-up|8|||
127762086|NCT00911937|459754122|FG001|Overall Study|Lost to Follow-up|5|||
127762087|NCT00911937|459754121|FG000|Overall Study|Withdrawal by Subject|10|||
128008660|NCT02711137|460660531|FG008|Overall Study|Lost to Follow-up|0|||
128008661|NCT02711137|460660532|FG009|Overall Study|Lost to Follow-up|0|||
128008662|NCT02711137|460660533|FG010|Overall Study|Lost to Follow-up|0|||
128008663|NCT02711137|460660534|FG011|Overall Study|Lost to Follow-up|0|||
128008664|NCT02711137|460660535|FG012|Overall Study|Lost to Follow-up|0|||
128008665|NCT02711137|460660536|FG013|Overall Study|Lost to Follow-up|0|||
128008666|NCT02711137|460660537|FG014|Overall Study|Lost to Follow-up|0|||
128008667|NCT00548327|460660538|FG000|Overall Study|Adverse Event|0|||
128008668|NCT00548327|460660539|FG001|Overall Study|Adverse Event|1|||
128008669|NCT01673386|460660540|FG000|Overall Study|Study terminated by sponsor|16|||
128008670|NCT01673386|460660541|FG001|Overall Study|Study terminated by sponsor|22|||
128008671|NCT01673386|460660540|FG000|Overall Study|Adverse Event|5|||
128008672|NCT01673386|460660541|FG001|Overall Study|Adverse Event|2|||
128008673|NCT01673386|460660540|FG000|Overall Study|Progressive disease|4|||
128008674|NCT01673386|460660541|FG001|Overall Study|Progressive disease|1|||
128008675|NCT01673386|460660540|FG000|Overall Study|Withdrawal by Subject|0|||
127762088|NCT00911937|459754122|FG001|Overall Study|Withdrawal by Subject|7|||
127762089|NCT00911937|459754121|FG000|Overall Study|Withdrawn due to pregnancy|1|||
127762090|NCT00911937|459754122|FG001|Overall Study|Withdrawn due to pregnancy|0|||
127762091|NCT00911937|459754121|FG000|Overall Study|Adverse Event|11|||
127762092|NCT00911937|459754122|FG001|Overall Study|Adverse Event|25|||
127762093|NCT00911937|459754121|FG000|Overall Study|Lack of Efficacy|11|||
127762094|NCT00911937|459754122|FG001|Overall Study|Lack of Efficacy|6|||
128008676|NCT01673386|460660541|FG001|Overall Study|Withdrawal by Subject|2|||
128008677|NCT01721798|460660542|FG000|Overall Study|Death|0|||
128008678|NCT01721798|460660543|FG001|Overall Study|Death|0|||
128008679|NCT01721798|460660544|FG002|Overall Study|Death|1|||
128008680|NCT01721798|460660545|FG003|Overall Study|Death|1|||
128008681|NCT01721798|460660542|FG000|Overall Study|Lost to Follow-up|2|||
128008682|NCT01721798|460660543|FG001|Overall Study|Lost to Follow-up|2|||
128008683|NCT01721798|460660544|FG002|Overall Study|Lost to Follow-up|9|||
127674316|NCT04888585|459430549|FG002|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
127674317|NCT04888585|459430550|FG003|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
127674318|NCT04888585|459430551|FG004|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
127674319|NCT04888585|459430552|FG005|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|37|||
127674320|NCT04888585|459430553|FG006|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|36|||
127674321|NCT04888585|459430554|FG007|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|78|||
127674322|NCT04888585|459430555|FG008|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
127674323|NCT04888585|459430556|FG009|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
127674324|NCT04888585|459430557|FG010|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|72|||
127674325|NCT04888585|459430547|FG000|Long Term Extension (Wk 13-End of Study)|Other|0|||
127674326|NCT04888585|459430548|FG001|Long Term Extension (Wk 13-End of Study)|Other|0|||
127674327|NCT04888585|459430549|FG002|Long Term Extension (Wk 13-End of Study)|Other|0|||
127674328|NCT04888585|459430550|FG003|Long Term Extension (Wk 13-End of Study)|Other|0|||
127674329|NCT04888585|459430551|FG004|Long Term Extension (Wk 13-End of Study)|Other|0|||
127674330|NCT04888585|459430552|FG005|Long Term Extension (Wk 13-End of Study)|Other|3|||
127674331|NCT04888585|459430553|FG006|Long Term Extension (Wk 13-End of Study)|Other|1|||
127674332|NCT04888585|459430554|FG007|Long Term Extension (Wk 13-End of Study)|Other|4|||
127674333|NCT04888585|459430555|FG008|Long Term Extension (Wk 13-End of Study)|Other|5|||
127674334|NCT04888585|459430556|FG009|Long Term Extension (Wk 13-End of Study)|Other|5|||
127674335|NCT04888585|459430557|FG010|Long Term Extension (Wk 13-End of Study)|Other|3|||
127674336|NCT04888585|459430547|FG000|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
127674337|NCT04888585|459430548|FG001|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
127674338|NCT04888585|459430549|FG002|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
127674339|NCT04888585|459430550|FG003|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
127674340|NCT04888585|459430551|FG004|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
127674341|NCT04888585|459430552|FG005|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
127674342|NCT04888585|459430553|FG006|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|4|||
127674343|NCT04888585|459430554|FG007|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
127674344|NCT04888585|459430555|FG008|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
127674345|NCT04888585|459430556|FG009|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|1|||
127674346|NCT04888585|459430557|FG010|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
127674347|NCT01559090|459430558|FG000|Stage I|Withdrawal by Subject|2|||
127674348|NCT01559090|459430559|FG001|Stage I|Withdrawal by Subject|2|||
127674349|NCT01559090|459430560|FG002|Stage I|Withdrawal by Subject|3|||
127674350|NCT01559090|459430558|FG000|Stage II|Withdrawal by Subject|1|||
127674351|NCT01559090|459430559|FG001|Stage II|Withdrawal by Subject|0|||
127674352|NCT01559090|459430560|FG002|Stage II|Withdrawal by Subject|0|||
127674353|NCT03722446|459430561|FG000|Overall Study|Protocol Violation|15|||
127674354|NCT03722446|459430562|FG001|Overall Study|Protocol Violation|2|||
127674355|NCT02908464|459430563|FG000|Overall Study|Withdrawal by Subject|2|||
127674356|NCT02908464|459430564|FG001|Overall Study|Withdrawal by Subject|1|||
127674357|NCT02908464|459430563|FG000|Overall Study|Found ineligible after randomization|0|||
127674358|NCT02908464|459430564|FG001|Overall Study|Found ineligible after randomization|2|||
127674359|NCT05273801|459430565|FG000|Overall Study|Physician Decision|1|||
127674360|NCT00349908|459432526|FG000|Overall Study|Withdrawal by Subject|0|||
127674361|NCT00349908|459432527|FG001|Overall Study|Withdrawal by Subject|4|||
127674362|NCT04565249|459432528|FG000|Overall Study|Death|0|||
127674363|NCT04565249|459432529|FG001|Overall Study|Death|0|||
127674364|NCT04565249|459432530|FG002|Overall Study|Death|0|||
127674365|NCT04565249|459432531|FG003|Overall Study|Death|1|||
127674366|NCT00984282|459432532|FG000|Double Blind Treatment|Adverse Event|40|||
127674367|NCT00984282|459432533|FG001|Double Blind Treatment|Adverse Event|6|||
127674368|NCT00984282|459432532|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
127674369|NCT00984282|459432533|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
127674370|NCT00984282|459432532|FG000|Double Blind Treatment|Physician Decision|1|||
127674371|NCT00984282|459432533|FG001|Double Blind Treatment|Physician Decision|2|||
127674372|NCT00984282|459432532|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
127674373|NCT00984282|459432533|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
127674374|NCT00984282|459432532|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
127674375|NCT00984282|459432533|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
127674376|NCT00984282|459432532|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
127674377|NCT00984282|459432533|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
127674378|NCT00984282|459432532|FG000|Double Blind Treatment|Lost to Follow-up|3|||
128008684|NCT01721798|460660545|FG003|Overall Study|Lost to Follow-up|9|||
128008685|NCT01721798|460660542|FG000|Overall Study|Pregnancy|0|||
128008686|NCT01721798|460660543|FG001|Overall Study|Pregnancy|0|||
128008687|NCT01721798|460660544|FG002|Overall Study|Pregnancy|1|||
128008688|NCT01721798|460660545|FG003|Overall Study|Pregnancy|1|||
128008689|NCT01721798|460660542|FG000|Overall Study|Withdrawal by Subject|1|||
128008690|NCT01721798|460660543|FG001|Overall Study|Withdrawal by Subject|0|||
128008691|NCT01721798|460660544|FG002|Overall Study|Withdrawal by Subject|2|||
128008692|NCT01721798|460660545|FG003|Overall Study|Withdrawal by Subject|1|||
128008693|NCT01721798|460660542|FG000|Overall Study|Not eligible for 24 month visit|1|||
128008694|NCT01721798|460660543|FG001|Overall Study|Not eligible for 24 month visit|0|||
128008695|NCT01721798|460660544|FG002|Overall Study|Not eligible for 24 month visit|8|||
128008696|NCT01721798|460660545|FG003|Overall Study|Not eligible for 24 month visit|7|||
128008697|NCT00577408|460660546|FG000|Overall Study|Stopped attending study visits|9|||
128008698|NCT00577408|460660547|FG001|Overall Study|Stopped attending study visits|11|||
128008699|NCT00577408|460660546|FG000|Overall Study|Continued opioid use|3|||
128008700|NCT00577408|460660547|FG001|Overall Study|Continued opioid use|2|||
128008701|NCT00577408|460660546|FG000|Overall Study|Non-compliance with study meds|0|||
128008702|NCT00577408|460660547|FG001|Overall Study|Non-compliance with study meds|3|||
128008703|NCT00577408|460660546|FG000|Overall Study|Refused Oral Naltrexone|0|||
128008704|NCT00577408|460660547|FG001|Overall Study|Refused Oral Naltrexone|1|||
128008705|NCT00577408|460660546|FG000|Overall Study|Moved out of state|0|||
128008706|NCT00577408|460660547|FG001|Overall Study|Moved out of state|1|||
128008707|NCT00577408|460660546|FG000|Overall Study|Scheduling Issues|0|||
128008708|NCT00577408|460660547|FG001|Overall Study|Scheduling Issues|3|||
127674379|NCT00984282|459432533|FG001|Double Blind Treatment|Lost to Follow-up|0|||
127674380|NCT00984282|459432532|FG000|Double Blind Treatment|Death|8|||
127674381|NCT00984282|459432533|FG001|Double Blind Treatment|Death|4|||
127674382|NCT00984282|459432532|FG000|Double Blind Treatment|Not treated|0|||
127674383|NCT00984282|459432533|FG001|Double Blind Treatment|Not treated|1|||
127674384|NCT00984282|459432532|FG000|Double Blind Treatment|Switched to commercial drug|6|||
127674385|NCT00984282|459432533|FG001|Double Blind Treatment|Switched to commercial drug|1|||
127674386|NCT00984282|459432532|FG000|Double Blind Treatment|protocol driven decision point|1|||
127674387|NCT00984282|459432533|FG001|Double Blind Treatment|protocol driven decision point|1|||
127674388|NCT00984282|459432532|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
127674389|NCT00984282|459432533|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
127674390|NCT00984282|459432532|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
127674391|NCT00984282|459432533|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
127674392|NCT00984282|459432532|FG000|Open-label Treatment|Adverse Event|20|||
127674393|NCT00984282|459432533|FG001|Open-label Treatment|Adverse Event|30|||
127674394|NCT00984282|459432532|FG000|Open-label Treatment|Withdrawal by Subject|6|||
127674395|NCT00984282|459432533|FG001|Open-label Treatment|Withdrawal by Subject|21|||
127674396|NCT00984282|459432532|FG000|Open-label Treatment|Death|7|||
127674397|NCT00984282|459432533|FG001|Open-label Treatment|Death|15|||
127674398|NCT00984282|459432532|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
127674399|NCT00984282|459432533|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
127674400|NCT00984282|459432532|FG000|Open-label Treatment|Lost to Follow-up|1|||
127674401|NCT00984282|459432533|FG001|Open-label Treatment|Lost to Follow-up|1|||
127674402|NCT00984282|459432532|FG000|Open-label Treatment|Patient convenience|1|||
127674403|NCT00984282|459432533|FG001|Open-label Treatment|Patient convenience|0|||
127674404|NCT00984282|459432532|FG000|Open-label Treatment|Non-compliant with study medication|1|||
127674405|NCT00984282|459432533|FG001|Open-label Treatment|Non-compliant with study medication|0|||
127674406|NCT00984282|459432532|FG000|Open-label Treatment|Target lesion removed|0|||
127674407|NCT00984282|459432533|FG001|Open-label Treatment|Target lesion removed|1|||
127674408|NCT00984282|459432532|FG000|Open-label Treatment|Protocol driven decision point|1|||
127674409|NCT00984282|459432533|FG001|Open-label Treatment|Protocol driven decision point|1|||
127674410|NCT00984282|459432532|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
127674411|NCT00984282|459432533|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
127674412|NCT00984282|459432532|FG000|Open-label Treatment|Switched to commercial drug|6|||
127674413|NCT00984282|459432533|FG001|Open-label Treatment|Switched to commercial drug|7|||
127674414|NCT00984282|459432532|FG000|Open-label Treatment|Physician Decision|1|||
127674415|NCT00984282|459432533|FG001|Open-label Treatment|Physician Decision|0|||
127674416|NCT00984282|459432532|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
127674417|NCT00984282|459432533|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
127674418|NCT00984282|459432532|FG000|Long Term Follow-up|Death|27|||
127674419|NCT00984282|459432533|FG001|Long Term Follow-up|Death|68|||
127674420|NCT00984282|459432532|FG000|Long Term Follow-up|Lost to Follow-up|3|||
127674421|NCT00984282|459432533|FG001|Long Term Follow-up|Lost to Follow-up|6|||
127674422|NCT00984282|459432532|FG000|Long Term Follow-up|Protocol driven decision point|25|||
127674423|NCT00984282|459432533|FG001|Long Term Follow-up|Protocol driven decision point|26|||
127674424|NCT00984282|459432532|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
128008709|NCT00577408|460660546|FG000|Overall Study|Death|0|||
128008710|NCT00577408|460660547|FG001|Overall Study|Death|1|||
128008711|NCT00577408|460660546|FG000|Overall Study|Psychiatric hospitalization|0|||
128008712|NCT00577408|460660547|FG001|Overall Study|Psychiatric hospitalization|1|||
128008713|NCT00656617|460660548|FG000|Overall Study|Adverse Event|1|||
128008714|NCT00656617|460660548|FG000|Overall Study|Death|2|||
128008715|NCT00656617|460660548|FG000|Overall Study|Insurance Issues|2|||
128008716|NCT00656617|460660548|FG000|Overall Study|Move to different clinical trial|2|||
128008717|NCT02349386|460660558|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
128008718|NCT02349386|460660559|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
128008719|NCT02349386|460660560|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
128008720|NCT02349386|460660561|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
128008721|NCT02349386|460660558|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
128008722|NCT02349386|460660559|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
128008723|NCT02349386|460660560|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
128008724|NCT02349386|460660561|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
128008725|NCT02349386|460660558|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
128008726|NCT02349386|460660559|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
128008727|NCT02349386|460660560|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
128008728|NCT02349386|460660561|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
128008729|NCT02349386|460660558|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
128008730|NCT02349386|460660559|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
128008731|NCT02349386|460660560|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
128008732|NCT02349386|460660561|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
128008733|NCT02349386|460660558|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
128008734|NCT02349386|460660559|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
128008735|NCT02349386|460660560|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
128008736|NCT02349386|460660561|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
128008737|NCT02349386|460660558|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
128008738|NCT02349386|460660559|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
128008739|NCT02349386|460660560|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
128008740|NCT02349386|460660561|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
128008741|NCT01712178|460660562|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
128008742|NCT01712178|460660563|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
128008743|NCT01712178|460660562|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
128008744|NCT01712178|460660563|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
128008745|NCT01712178|460660562|FG000|Overall Study|Lost to Follow-up|0|||
128008746|NCT01712178|460660563|FG001|Overall Study|Lost to Follow-up|1|||
128008747|NCT00091819|460660564|FG000|Overall Study|Adverse Event|1|||
128008748|NCT00091819|460660565|FG001|Overall Study|Adverse Event|1|||
128008749|NCT00091819|460660564|FG000|Overall Study|Death|4|||
128008750|NCT00091819|460660565|FG001|Overall Study|Death|5|||
128008751|NCT00091819|460660564|FG000|Overall Study|Lost to Follow-up|26|||
128008752|NCT00091819|460660565|FG001|Overall Study|Lost to Follow-up|23|||
128008753|NCT00091819|460660564|FG000|Overall Study|Withdrawal by Subject|5|||
128008754|NCT00091819|460660565|FG001|Overall Study|Withdrawal by Subject|8|||
128008755|NCT00091819|460660564|FG000|Overall Study|Protocol Violation|1|||
128008756|NCT00091819|460660565|FG001|Overall Study|Protocol Violation|2|||
128008757|NCT00091819|460660564|FG000|Overall Study|Other|2|||
128008758|NCT00091819|460660565|FG001|Overall Study|Other|3|||
127674425|NCT00984282|459432533|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
127674426|NCT00984282|459432532|FG000|Long Term Follow-up|Switched to commercial drug|4|||
127674427|NCT00984282|459432533|FG001|Long Term Follow-up|Switched to commercial drug|2|||
127674428|NCT00984282|459432532|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
127674429|NCT00984282|459432533|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
127674430|NCT00315055|459432534|FG000|Overall Study|Protocol Violation|2|||
127674431|NCT00315055|459432535|FG001|Overall Study|Protocol Violation|4|||
127674432|NCT00315055|459432534|FG000|Overall Study|Lost to Follow-up|1|||
127674433|NCT00315055|459432535|FG001|Overall Study|Lost to Follow-up|1|||
127674434|NCT02359435|459432536|FG000|Overall Study|Lost to Follow-up|4|||
127674435|NCT02359435|459432537|FG001|Overall Study|Lost to Follow-up|4|||
127674436|NCT01289119|459432542|FG000|Overall Study|Adverse Event|2|||
127674437|NCT01289119|459432543|FG001|Overall Study|Adverse Event|1|||
127674438|NCT01289119|459432544|FG002|Overall Study|Adverse Event|0|||
127674439|NCT01289119|459432545|FG003|Overall Study|Adverse Event|2|||
127674440|NCT01289119|459432546|FG004|Overall Study|Adverse Event|1|||
127674441|NCT01289119|459432547|FG005|Overall Study|Adverse Event|0|||
128008759|NCT00091819|460660564|FG000|Overall Study|Never received study treatment|3|||
128008760|NCT00091819|460660565|FG001|Overall Study|Never received study treatment|4|||
128008761|NCT04759131|460660566|FG000|Overall Study|Investigator's discretion|1|||
128008762|NCT04759131|460660567|FG001|Overall Study|Investigator's discretion|0|||
128008763|NCT04759131|460660566|FG000|Overall Study|Subject withdrawal|1|||
127674442|NCT01289119|459432542|FG000|Overall Study|Major Protocol Deviation|2|||
127674443|NCT01289119|459432543|FG001|Overall Study|Major Protocol Deviation|1|||
128008764|NCT04759131|460660567|FG001|Overall Study|Subject withdrawal|0|||
128008765|NCT05144945|460660568|FG000|Overall Study|Withdrawal by Subject|1|||
128008766|NCT05144945|460660569|FG001|Overall Study|Withdrawal by Subject|0|||
128008767|NCT03692949|460660570|FG000|Overall Study|Lost to Follow-up|0|||
128008768|NCT03692949|460660571|FG001|Overall Study|Lost to Follow-up|0|||
128008769|NCT03692949|460660572|FG002|Overall Study|Lost to Follow-up|0|||
128008770|NCT03692949|460660573|FG003|Overall Study|Lost to Follow-up|0|||
128008771|NCT03692949|460660574|FG004|Overall Study|Lost to Follow-up|0|||
128008772|NCT03692949|460660575|FG005|Overall Study|Lost to Follow-up|0|||
128008773|NCT03692949|460660576|FG006|Overall Study|Lost to Follow-up|0|||
128008774|NCT03692949|460660577|FG007|Overall Study|Lost to Follow-up|1|||
128008775|NCT02592824|460660578|FG000|Overall Study|Protocol Violation|5|||
128008776|NCT02592824|460660579|FG001|Overall Study|Protocol Violation|3|||
128008777|NCT02592824|460660578|FG000|Overall Study|Lost to Follow-up|2|||
128008778|NCT02592824|460660579|FG001|Overall Study|Lost to Follow-up|1|||
128008779|NCT00869960|460660580|FG000|Overall Study|Lost to Follow-up|2|||
128008780|NCT01394276|460660582|FG000|Overall Study|Related Adverse event (AEs)|15|||
128008781|NCT01394276|460660582|FG000|Overall Study|Not related AEs|9|||
128008782|NCT01394276|460660582|FG000|Overall Study|Remission of disease|2|||
128008783|NCT01394276|460660582|FG000|Overall Study|Insufficient therapeutic effect|17|||
128008784|NCT01394276|460660582|FG000|Overall Study|Insufficient compliance|9|||
128008785|NCT01394276|460660582|FG000|Overall Study|Lost to Follow-up|5|||
128008786|NCT01394276|460660582|FG000|Overall Study|Participant moved to another site|1|||
128008787|NCT01394276|460660582|FG000|Overall Study|Pregnancy|1|||
128008788|NCT01394276|460660582|FG000|Overall Study|unavailability of drug at the Hospital|2|||
128008789|NCT01394276|460660582|FG000|Overall Study|Symptoms of concurrent diseases|1|||
128008790|NCT00262925|460660584|FG000|Overall Study|Lack of Efficacy|3|||
128008791|NCT00262925|460660584|FG000|Overall Study|Adverse Event|4|||
128008792|NCT00262925|460660584|FG000|Overall Study|Death|2|||
128008793|NCT00262925|460660584|FG000|Overall Study|alternative therapy|1|||
128008794|NCT00262925|460660584|FG000|Overall Study|Other|1|||
128008795|NCT04682301|460660586|FG000|Overall Study|Participant enrolled in Aim I only.|60|||
128008796|NCT04682301|460660586|FG000|Overall Study|Death|2|||
128008797|NCT00560404|460660587|FG000|Overall Study|Adverse Event|2|||
128008798|NCT00560404|460660588|FG001|Overall Study|Adverse Event|3|||
128008799|NCT00560404|460660587|FG000|Overall Study|Death|3|||
128008800|NCT00560404|460660588|FG001|Overall Study|Death|3|||
128008801|NCT00560404|460660587|FG000|Overall Study|Protocol Violation|12|||
128008802|NCT00560404|460660588|FG001|Overall Study|Protocol Violation|7|||
128008803|NCT00560404|460660587|FG000|Overall Study|Administrative Reasons|1|||
127674444|NCT01289119|459432544|FG002|Overall Study|Major Protocol Deviation|3|||
127674445|NCT01289119|459432545|FG003|Overall Study|Major Protocol Deviation|0|||
127674446|NCT01289119|459432546|FG004|Overall Study|Major Protocol Deviation|2|||
127674447|NCT01289119|459432547|FG005|Overall Study|Major Protocol Deviation|1|||
127674448|NCT01289119|459432542|FG000|Overall Study|Lost to Follow-up|0|||
127674449|NCT01289119|459432543|FG001|Overall Study|Lost to Follow-up|3|||
127674450|NCT01289119|459432544|FG002|Overall Study|Lost to Follow-up|0|||
127674451|NCT01289119|459432545|FG003|Overall Study|Lost to Follow-up|0|||
127674452|NCT01289119|459432546|FG004|Overall Study|Lost to Follow-up|0|||
127674453|NCT01289119|459432547|FG005|Overall Study|Lost to Follow-up|1|||
127674454|NCT01289119|459432542|FG000|Overall Study|Withdrawal by Subject|4|||
127674455|NCT01289119|459432543|FG001|Overall Study|Withdrawal by Subject|2|||
127674456|NCT01289119|459432544|FG002|Overall Study|Withdrawal by Subject|4|||
127674457|NCT01289119|459432545|FG003|Overall Study|Withdrawal by Subject|3|||
127674458|NCT01289119|459432546|FG004|Overall Study|Withdrawal by Subject|1|||
127674459|NCT01289119|459432547|FG005|Overall Study|Withdrawal by Subject|1|||
127674460|NCT01289119|459432542|FG000|Overall Study|Pregnancy|0|||
127674461|NCT01289119|459432543|FG001|Overall Study|Pregnancy|1|||
128008804|NCT00560404|460660588|FG001|Overall Study|Administrative Reasons|1|||
128008805|NCT00560404|460660587|FG000|Overall Study|Withdrew Consent|4|||
128008806|NCT00560404|460660588|FG001|Overall Study|Withdrew Consent|0|||
128008807|NCT00560404|460660587|FG000|Overall Study|Failure to return|1|||
128008808|NCT00560404|460660588|FG001|Overall Study|Failure to return|2|||
128008809|NCT00560404|460660587|FG000|Overall Study|Other withdrawal reason|13|||
128008810|NCT00560404|460660588|FG001|Overall Study|Other withdrawal reason|5|||
128008811|NCT00471497|460660595|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
128008812|NCT00471497|460660596|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
127674462|NCT01289119|459432544|FG002|Overall Study|Pregnancy|0|||
127674463|NCT01289119|459432545|FG003|Overall Study|Pregnancy|0|||
127674464|NCT01289119|459432546|FG004|Overall Study|Pregnancy|0|||
128008813|NCT00471497|460660597|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
128008814|NCT00471497|460660595|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
128008815|NCT00471497|460660596|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
128008816|NCT00471497|460660597|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
128008817|NCT00471497|460660595|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
128008818|NCT00471497|460660596|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
128008819|NCT00471497|460660597|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
127674465|NCT01289119|459432547|FG005|Overall Study|Pregnancy|0|||
128008820|NCT00471497|460660595|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
128008821|NCT00471497|460660596|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
128008822|NCT00471497|460660597|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
128008823|NCT00471497|460660595|FG000|Core Treatment Phase|Lost to Follow-up|6|||
128008824|NCT00471497|460660596|FG001|Core Treatment Phase|Lost to Follow-up|6|||
128008825|NCT00471497|460660597|FG002|Core Treatment Phase|Lost to Follow-up|3|||
128008826|NCT00471497|460660595|FG000|Core Treatment Phase|Death|3|||
128008827|NCT00471497|460660596|FG001|Core Treatment Phase|Death|9|||
128008828|NCT00471497|460660597|FG002|Core Treatment Phase|Death|3|||
128008829|NCT00471497|460660595|FG000|Core Treatment Phase|Disease Progression|10|||
128008830|NCT00471497|460660596|FG001|Core Treatment Phase|Disease Progression|2|||
128008831|NCT00471497|460660597|FG002|Core Treatment Phase|Disease Progression|4|||
128008832|NCT00471497|460660595|FG000|Core Treatment Phase|Protocol Violation|6|||
128008833|NCT00471497|460660596|FG001|Core Treatment Phase|Protocol Violation|15|||
128008834|NCT00471497|460660597|FG002|Core Treatment Phase|Protocol Violation|11|||
128008835|NCT00471497|460660595|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
128008836|NCT00471497|460660596|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
128008837|NCT00471497|460660597|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
128008838|NCT00471497|460660595|FG000|Core Treatment Phase|Administrative problems|14|||
128008839|NCT00471497|460660596|FG001|Core Treatment Phase|Administrative problems|14|||
128008840|NCT00471497|460660597|FG002|Core Treatment Phase|Administrative problems|12|||
128008841|NCT00471497|460660595|FG000|Core Treatment Phase|Adverse Event|43|||
128008842|NCT00471497|460660596|FG001|Core Treatment Phase|Adverse Event|53|||
128008843|NCT00471497|460660597|FG002|Core Treatment Phase|Adverse Event|89|||
128008844|NCT00471497|460660595|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
128008845|NCT00471497|460660596|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
128008846|NCT00471497|460660597|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
128008847|NCT00471497|460660595|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
128008848|NCT00471497|460660596|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
128008849|NCT00471497|460660597|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
128008850|NCT00471497|460660595|FG000|Extension Phase|Adverse Event|9|||
128008851|NCT00471497|460660596|FG001|Extension Phase|Adverse Event|5|||
128008852|NCT00471497|460660597|FG002|Extension Phase|Adverse Event|1|||
128008853|NCT00471497|460660595|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
128008854|NCT00471497|460660596|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
128008855|NCT00471497|460660597|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
127543539|NCT02718898|458956553|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
127674466|NCT01289119|459432542|FG000|Overall Study|Lack of Efficacy|0|||
127674467|NCT01289119|459432543|FG001|Overall Study|Lack of Efficacy|1|||
127674468|NCT01289119|459432544|FG002|Overall Study|Lack of Efficacy|1|||
127674469|NCT01289119|459432545|FG003|Overall Study|Lack of Efficacy|1|||
127674470|NCT01289119|459432546|FG004|Overall Study|Lack of Efficacy|1|||
127674471|NCT01289119|459432547|FG005|Overall Study|Lack of Efficacy|1|||
127674472|NCT01289119|459432542|FG000|Overall Study|Other|1|||
127674473|NCT01289119|459432543|FG001|Overall Study|Other|0|||
127674474|NCT01289119|459432544|FG002|Overall Study|Other|1|||
127674475|NCT01289119|459432545|FG003|Overall Study|Other|0|||
127674476|NCT01289119|459432546|FG004|Overall Study|Other|0|||
127674477|NCT01289119|459432547|FG005|Overall Study|Other|0|||
127674478|NCT01649791|459432550|FG000|Overall Study|Disease Progression|2|||
127674479|NCT01649791|459432550|FG000|Overall Study|Adverse Event|1|||
127674480|NCT00991276|459432554|FG000|First Intervention Period|Adverse Event|0|||
127674481|NCT00991276|459432555|FG001|First Intervention Period|Adverse Event|1|||
127674482|NCT00991276|459432556|FG002|First Intervention Period|Adverse Event|0|||
127674483|NCT00991276|459432557|FG003|First Intervention Period|Adverse Event|1|||
127674484|NCT00991276|459432558|FG004|First Intervention Period|Adverse Event|0|||
127674485|NCT00991276|459432559|FG005|First Intervention Period|Adverse Event|0|||
127674486|NCT00991276|459432554|FG000|First Intervention Period|Protocol Violation|0|||
127674487|NCT00991276|459432555|FG001|First Intervention Period|Protocol Violation|0|||
127674488|NCT00991276|459432556|FG002|First Intervention Period|Protocol Violation|0|||
127674489|NCT00991276|459432557|FG003|First Intervention Period|Protocol Violation|0|||
127674490|NCT00991276|459432558|FG004|First Intervention Period|Protocol Violation|2|||
127674491|NCT00991276|459432559|FG005|First Intervention Period|Protocol Violation|0|||
127674492|NCT00991276|459432554|FG000|First Intervention Period|Insufficient clinical response|0|||
127674493|NCT00991276|459432555|FG001|First Intervention Period|Insufficient clinical response|0|||
127674494|NCT00991276|459432556|FG002|First Intervention Period|Insufficient clinical response|0|||
127674495|NCT00991276|459432557|FG003|First Intervention Period|Insufficient clinical response|0|||
127674496|NCT00991276|459432558|FG004|First Intervention Period|Insufficient clinical response|1|||
127674497|NCT00991276|459432559|FG005|First Intervention Period|Insufficient clinical response|0|||
128008856|NCT00471497|460660595|FG000|Extension Phase|Withdrawal by Subject|3|||
128008857|NCT00471497|460660596|FG001|Extension Phase|Withdrawal by Subject|1|||
128008858|NCT00471497|460660597|FG002|Extension Phase|Withdrawal by Subject|0|||
128008859|NCT00471497|460660595|FG000|Extension Phase|Lost to Follow-up|2|||
128008860|NCT00471497|460660596|FG001|Extension Phase|Lost to Follow-up|0|||
128008861|NCT00471497|460660597|FG002|Extension Phase|Lost to Follow-up|0|||
128008862|NCT00471497|460660595|FG000|Extension Phase|Death|1|||
128008863|NCT00471497|460660596|FG001|Extension Phase|Death|0|||
128008864|NCT00471497|460660597|FG002|Extension Phase|Death|0|||
128008865|NCT00471497|460660595|FG000|Extension Phase|Disease progression|2|||
128008866|NCT00471497|460660596|FG001|Extension Phase|Disease progression|0|||
128008867|NCT00471497|460660597|FG002|Extension Phase|Disease progression|0|||
128008868|NCT00471497|460660595|FG000|Extension Phase|Protocol Violation|2|||
128008869|NCT00471497|460660596|FG001|Extension Phase|Protocol Violation|2|||
128008870|NCT00471497|460660597|FG002|Extension Phase|Protocol Violation|0|||
128008871|NCT00392223|460660598|FG000|Overall Study|Adverse Event|5|||
127674498|NCT00991276|459432554|FG000|First Intervention Period|Other|0|||
127762095|NCT00911937|459754121|FG000|Overall Study|Did not meet inclusion criteria|9|||
127762096|NCT00911937|459754122|FG001|Overall Study|Did not meet inclusion criteria|11|||
127762097|NCT00911937|459754121|FG000|Overall Study|Protocol Violation|14|||
127762098|NCT00911937|459754122|FG001|Overall Study|Protocol Violation|23|||
127762099|NCT00911937|459754121|FG000|Overall Study|Randomized but not treated|13|||
127762100|NCT00911937|459754122|FG001|Overall Study|Randomized but not treated|13|||
127762101|NCT00911937|459754121|FG000|Overall Study|Other|9|||
127762102|NCT00911937|459754122|FG001|Overall Study|Other|5|||
127762103|NCT01844687|459754129|FG000|Visit 1|Protocol Violation|3|||
127762104|NCT01844687|459754129|FG000|Visit 1|Lost to Follow-up|5|||
127762105|NCT01844687|459754129|FG000|Visit 2|Withdrawal by Subject|1|||
127762106|NCT01844687|459754129|FG000|Visit 2|Protocol Violation|1|||
127762107|NCT01844687|459754129|FG000|Visit 3|Lost to Follow-up|1|||
127762108|NCT01844687|459754129|FG000|Visit 3|Withdrawal by Subject|3|||
127762109|NCT01844687|459754129|FG000|Visit 3|child care problems|1|||
127762110|NCT01844687|459754129|FG000|Visit 4|Pregnancy|1|||
127762111|NCT01844687|459754129|FG000|Visit 4|Lost to Follow-up|1|||
127762112|NCT01844687|459754129|FG000|Visit 4|Withdrawal by Subject|2|||
127762113|NCT03047395|459754132|FG000|Overall Study|Adverse Event|142|||
127762114|NCT03047395|459754132|FG000|Overall Study|Withdrawal by Subject|155|||
127762115|NCT03047395|459754132|FG000|Overall Study|Lost to Follow-up|144|||
127762116|NCT03047395|459754132|FG000|Overall Study|COVID-19 Infection|2|||
127762117|NCT03047395|459754132|FG000|Overall Study|COVID-19 Logistical Restrictions|9|||
127762118|NCT03047395|459754132|FG000|Overall Study|Other, Not Specified|117|||
127762119|NCT00635427|459754137|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
127762120|NCT00635427|459754138|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
127762121|NCT00635427|459754139|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
127762122|NCT00635427|459754140|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
127762123|NCT00635427|459754141|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
127762124|NCT00635427|459754137|FG000|Overall Study|Death|0|||
127674499|NCT00991276|459432555|FG001|First Intervention Period|Other|0|||
127674500|NCT00991276|459432556|FG002|First Intervention Period|Other|0|||
127674501|NCT00991276|459432557|FG003|First Intervention Period|Other|1|||
127674502|NCT00991276|459432558|FG004|First Intervention Period|Other|1|||
127674503|NCT00991276|459432559|FG005|First Intervention Period|Other|0|||
127674504|NCT00991276|459432554|FG000|First Intervention Period|Withdrawal by Subject|0|||
127674505|NCT00991276|459432555|FG001|First Intervention Period|Withdrawal by Subject|1|||
127674506|NCT00991276|459432556|FG002|First Intervention Period|Withdrawal by Subject|0|||
127674507|NCT00991276|459432557|FG003|First Intervention Period|Withdrawal by Subject|1|||
127674508|NCT00991276|459432558|FG004|First Intervention Period|Withdrawal by Subject|0|||
127674509|NCT00991276|459432559|FG005|First Intervention Period|Withdrawal by Subject|1|||
127674510|NCT00991276|459432554|FG000|First Intervention Period|Lost to Follow-up|0|||
127674511|NCT00991276|459432555|FG001|First Intervention Period|Lost to Follow-up|1|||
127674512|NCT00991276|459432556|FG002|First Intervention Period|Lost to Follow-up|0|||
127674513|NCT00991276|459432557|FG003|First Intervention Period|Lost to Follow-up|1|||
127674514|NCT00991276|459432558|FG004|First Intervention Period|Lost to Follow-up|0|||
127674515|NCT00991276|459432559|FG005|First Intervention Period|Lost to Follow-up|0|||
127674516|NCT00991276|459432554|FG000|Second Intervention Period|Adverse Event|0|||
127674517|NCT00991276|459432555|FG001|Second Intervention Period|Adverse Event|2|||
127674518|NCT00991276|459432556|FG002|Second Intervention Period|Adverse Event|0|||
127674519|NCT00991276|459432557|FG003|Second Intervention Period|Adverse Event|1|||
127762125|NCT00635427|459754138|FG001|Overall Study|Death|0|||
127762126|NCT00635427|459754139|FG002|Overall Study|Death|0|||
127674520|NCT00991276|459432558|FG004|Second Intervention Period|Adverse Event|1|||
127674521|NCT00991276|459432559|FG005|Second Intervention Period|Adverse Event|0|||
127762127|NCT00635427|459754140|FG003|Overall Study|Death|1|||
127762128|NCT00635427|459754141|FG004|Overall Study|Death|0|||
127762129|NCT00635427|459754137|FG000|Overall Study|Termination Of Study By Sponsor|12|||
127762130|NCT00635427|459754138|FG001|Overall Study|Termination Of Study By Sponsor|6|||
127762131|NCT00635427|459754139|FG002|Overall Study|Termination Of Study By Sponsor|10|||
127762132|NCT00635427|459754140|FG003|Overall Study|Termination Of Study By Sponsor|6|||
128008872|NCT00392223|460660599|FG001|Overall Study|Adverse Event|4|||
128008873|NCT00392223|460660598|FG000|Overall Study|Lost to Follow-up|1|||
128008874|NCT00392223|460660599|FG001|Overall Study|Lost to Follow-up|4|||
127674522|NCT00991276|459432554|FG000|Second Intervention Period|Protocol Violation|1|||
127674523|NCT00991276|459432555|FG001|Second Intervention Period|Protocol Violation|0|||
127674524|NCT00991276|459432556|FG002|Second Intervention Period|Protocol Violation|0|||
127674525|NCT00991276|459432557|FG003|Second Intervention Period|Protocol Violation|0|||
127674526|NCT00991276|459432558|FG004|Second Intervention Period|Protocol Violation|0|||
127674527|NCT00991276|459432559|FG005|Second Intervention Period|Protocol Violation|0|||
127674528|NCT00991276|459432554|FG000|Second Intervention Period|Other|0|||
127674529|NCT00991276|459432555|FG001|Second Intervention Period|Other|0|||
127674530|NCT00991276|459432556|FG002|Second Intervention Period|Other|0|||
127674531|NCT00991276|459432557|FG003|Second Intervention Period|Other|1|||
127674532|NCT00991276|459432558|FG004|Second Intervention Period|Other|0|||
127674533|NCT00991276|459432559|FG005|Second Intervention Period|Other|1|||
127674534|NCT00991276|459432554|FG000|Third Intervention Period|Protocol Violation|1|||
127674535|NCT00991276|459432555|FG001|Third Intervention Period|Protocol Violation|0|||
127674536|NCT00991276|459432556|FG002|Third Intervention Period|Protocol Violation|0|||
127674537|NCT00991276|459432557|FG003|Third Intervention Period|Protocol Violation|0|||
127674538|NCT00991276|459432558|FG004|Third Intervention Period|Protocol Violation|0|||
127674539|NCT00991276|459432559|FG005|Third Intervention Period|Protocol Violation|0|||
127674540|NCT00991276|459432554|FG000|Third Intervention Period|Other|0|||
127674541|NCT00991276|459432555|FG001|Third Intervention Period|Other|0|||
127674542|NCT00991276|459432556|FG002|Third Intervention Period|Other|0|||
127674543|NCT00991276|459432557|FG003|Third Intervention Period|Other|0|||
127674544|NCT00991276|459432558|FG004|Third Intervention Period|Other|0|||
127674545|NCT00991276|459432559|FG005|Third Intervention Period|Other|1|||
127674546|NCT00991276|459432554|FG000|Third Intervention Period|Adverse Event|0|||
127674547|NCT00991276|459432555|FG001|Third Intervention Period|Adverse Event|0|||
127674548|NCT00991276|459432556|FG002|Third Intervention Period|Adverse Event|1|||
127674549|NCT00991276|459432557|FG003|Third Intervention Period|Adverse Event|0|||
127674550|NCT00991276|459432558|FG004|Third Intervention Period|Adverse Event|0|||
127674551|NCT00991276|459432559|FG005|Third Intervention Period|Adverse Event|0|||
127674552|NCT00991276|459432554|FG000|Third Intervention Period|Withdrawal by Subject|0|||
127674553|NCT00991276|459432555|FG001|Third Intervention Period|Withdrawal by Subject|0|||
127674554|NCT00991276|459432556|FG002|Third Intervention Period|Withdrawal by Subject|0|||
127674555|NCT00991276|459432557|FG003|Third Intervention Period|Withdrawal by Subject|1|||
127674556|NCT00991276|459432558|FG004|Third Intervention Period|Withdrawal by Subject|0|||
127674557|NCT00991276|459432559|FG005|Third Intervention Period|Withdrawal by Subject|0|||
127674558|NCT00711646|459432562|FG000|Overall Study|Adverse Event|6|||
127674559|NCT00711646|459432563|FG001|Overall Study|Adverse Event|1|||
127674560|NCT00711646|459432562|FG000|Overall Study|Withdrawal by Subject|4|||
127674561|NCT00711646|459432563|FG001|Overall Study|Withdrawal by Subject|0|||
127674562|NCT00711646|459432562|FG000|Overall Study|Protocol Violation|0|||
127674563|NCT00711646|459432563|FG001|Overall Study|Protocol Violation|1|||
127674564|NCT00711646|459432562|FG000|Overall Study|Lost to Follow-up|1|||
127674565|NCT00711646|459432563|FG001|Overall Study|Lost to Follow-up|0|||
127674566|NCT00711646|459432562|FG000|Overall Study|administrative decision|0|||
127674567|NCT00711646|459432563|FG001|Overall Study|administrative decision|1|||
127674568|NCT00711646|459432562|FG000|Overall Study|patient non-compliance|1|||
127674569|NCT00711646|459432563|FG001|Overall Study|patient non-compliance|0|||
127674570|NCT03467724|459432564|FG000|Overall Study|Lost to Follow-up|5|||
127674571|NCT03467724|459432564|FG000|Overall Study|Withdrawal by Subject|1|||
127674572|NCT03467724|459432564|FG000|Overall Study|Protocol Violation|1|||
127674573|NCT03467724|459432564|FG000|Overall Study|Adverse Event|1|||
127674574|NCT03721016|459432565|FG000|Overall Study|Adverse Event|0|||
127674575|NCT03721016|459432566|FG001|Overall Study|Adverse Event|1|||
127674576|NCT03721016|459432567|FG002|Overall Study|Adverse Event|1|||
127674577|NCT03721016|459432565|FG000|Overall Study|Withdrawal by Subject|8|||
127674578|NCT03721016|459432566|FG001|Overall Study|Withdrawal by Subject|16|||
127674579|NCT03721016|459432567|FG002|Overall Study|Withdrawal by Subject|13|||
127674580|NCT03721016|459432565|FG000|Overall Study|Lost to Follow-up|4|||
127674581|NCT03721016|459432566|FG001|Overall Study|Lost to Follow-up|6|||
127674582|NCT03721016|459432567|FG002|Overall Study|Lost to Follow-up|5|||
127674583|NCT03721016|459432565|FG000|Overall Study|Physician Decision|0|||
127674584|NCT03721016|459432566|FG001|Overall Study|Physician Decision|1|||
127674585|NCT03721016|459432567|FG002|Overall Study|Physician Decision|2|||
127674586|NCT03721016|459432565|FG000|Overall Study|Protocol Violation|0|||
127674587|NCT03721016|459432566|FG001|Overall Study|Protocol Violation|1|||
127674588|NCT03721016|459432567|FG002|Overall Study|Protocol Violation|0|||
127674589|NCT03721016|459432565|FG000|Overall Study|Site terminated by sponsor|3|||
127674590|NCT03721016|459432566|FG001|Overall Study|Site terminated by sponsor|7|||
127762133|NCT00635427|459754141|FG004|Overall Study|Termination Of Study By Sponsor|6|||
127674591|NCT03721016|459432567|FG002|Overall Study|Site terminated by sponsor|6|||
127674592|NCT03721016|459432565|FG000|Overall Study|Subject exited early due to COVID-19|1|||
127674593|NCT03721016|459432566|FG001|Overall Study|Subject exited early due to COVID-19|0|||
127674594|NCT03721016|459432567|FG002|Overall Study|Subject exited early due to COVID-19|0|||
127674595|NCT02232178|459432570|FG000|Overall Study|Lost to Follow-up|0|||
127674596|NCT02232178|459432571|FG001|Overall Study|Lost to Follow-up|1|||
127674597|NCT02232178|459432572|FG002|Overall Study|Lost to Follow-up|0|||
127674598|NCT02232178|459432570|FG000|Overall Study|ineligibility|0|||
127674599|NCT02232178|459432571|FG001|Overall Study|ineligibility|0|||
127674600|NCT02232178|459432572|FG002|Overall Study|ineligibility|1|||
127674601|NCT02232178|459432570|FG000|Overall Study|surgical complication|1|||
127674602|NCT02232178|459432571|FG001|Overall Study|surgical complication|0|||
127674603|NCT02232178|459432572|FG002|Overall Study|surgical complication|0|||
127674604|NCT00817635|459432573|FG000|Overall Study|Adverse Event|1|||
127674605|NCT00817635|459432574|FG001|Overall Study|Adverse Event|0|||
127674606|NCT00817635|459432575|FG002|Overall Study|Adverse Event|0|||
127674607|NCT00817635|459432576|FG003|Overall Study|Adverse Event|1|||
127674608|NCT00817635|459432577|FG004|Overall Study|Adverse Event|1|||
127674609|NCT00817635|459432573|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
127674610|NCT00817635|459432574|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
127674611|NCT00817635|459432575|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
127674612|NCT00817635|459432576|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
127674613|NCT00817635|459432577|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
127674614|NCT00817635|459432573|FG000|Overall Study|Withdrawal by Subject|2|||
127674615|NCT00817635|459432574|FG001|Overall Study|Withdrawal by Subject|1|||
127674616|NCT00817635|459432575|FG002|Overall Study|Withdrawal by Subject|0|||
127674617|NCT00817635|459432576|FG003|Overall Study|Withdrawal by Subject|1|||
127674618|NCT00817635|459432577|FG004|Overall Study|Withdrawal by Subject|2|||
127674619|NCT00817635|459432573|FG000|Overall Study|Lost to Follow-up|0|||
127674620|NCT00817635|459432574|FG001|Overall Study|Lost to Follow-up|1|||
127674621|NCT00817635|459432575|FG002|Overall Study|Lost to Follow-up|0|||
127674622|NCT00817635|459432576|FG003|Overall Study|Lost to Follow-up|1|||
127674623|NCT00817635|459432577|FG004|Overall Study|Lost to Follow-up|0|||
127674624|NCT00817635|459432573|FG000|Overall Study|Administrative Problems|0|||
127674625|NCT00817635|459432574|FG001|Overall Study|Administrative Problems|0|||
127674626|NCT00817635|459432575|FG002|Overall Study|Administrative Problems|0|||
127674627|NCT00817635|459432576|FG003|Overall Study|Administrative Problems|0|||
127674628|NCT00817635|459432577|FG004|Overall Study|Administrative Problems|1|||
127674629|NCT00817635|459432573|FG000|Overall Study|Protocol Violation|5|||
127674630|NCT00817635|459432574|FG001|Overall Study|Protocol Violation|1|||
127674631|NCT00817635|459432575|FG002|Overall Study|Protocol Violation|3|||
127674632|NCT00817635|459432576|FG003|Overall Study|Protocol Violation|2|||
127674633|NCT00817635|459432577|FG004|Overall Study|Protocol Violation|3|||
127674634|NCT01020838|459432582|FG000|Overall Study|Death|90|||
127674635|NCT01020838|459432582|FG000|Overall Study|Adverse Event|1|||
127674636|NCT01020838|459432582|FG000|Overall Study|Withdrawal by Subject|9|||
127674637|NCT01020838|459432582|FG000|Overall Study|Lost to Follow-up|6|||
127674638|NCT01020838|459432582|FG000|Overall Study|Most common: Study ended by sponsor|77|||
127674639|NCT01908634|459432584|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
127674640|NCT01908634|459432584|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
127674641|NCT04176458|459432585|FG000|Overall Study|Covid 19|4|||
127674642|NCT01570751|459432586|FG000|Period A (16 Weeks)|Protocol Violation|1|||
127674643|NCT01570751|459432587|FG001|Period A (16 Weeks)|Protocol Violation|1|||
127674644|NCT01570751|459432586|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
127674645|NCT01570751|459432587|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
127674646|NCT01570751|459432586|FG000|Period A (16 Weeks)|Unclassified|2|||
127674647|NCT01570751|459432587|FG001|Period A (16 Weeks)|Unclassified|3|||
127674648|NCT01570751|459432586|FG000|Period B (16 Weeks)|Adverse Event|1|||
127674649|NCT01570751|459432587|FG001|Period B (16 Weeks)|Adverse Event|0|||
127674650|NCT01570751|459432586|FG000|Period B (16 Weeks)|Protocol Violation|0|||
127762134|NCT00635427|459754137|FG000|Overall Study|Withdrawal Of Consent|0|||
127762135|NCT00635427|459754138|FG001|Overall Study|Withdrawal Of Consent|0|||
127762136|NCT00635427|459754139|FG002|Overall Study|Withdrawal Of Consent|0|||
127762137|NCT00635427|459754140|FG003|Overall Study|Withdrawal Of Consent|2|||
127762138|NCT00635427|459754141|FG004|Overall Study|Withdrawal Of Consent|2|||
127762139|NCT03484273|459754142|FG000|Overall Study|Equipment Malfunction|1|||
127762140|NCT03484273|459754142|FG000|Overall Study|Data excluded from analysis|1|||
127762141|NCT02706899|459754147|FG000|Overall Study|Withdrawal by Subject|1|||
127762142|NCT02706899|459754148|FG001|Overall Study|Withdrawal by Subject|0|||
127762143|NCT02706899|459754147|FG000|Overall Study|Death|8|||
127762144|NCT02706899|459754148|FG001|Overall Study|Death|0|||
127762145|NCT02706899|459754147|FG000|Overall Study|Study Termination by Sponsor|4|||
127762146|NCT02706899|459754148|FG001|Overall Study|Study Termination by Sponsor|6|||
127762147|NCT00324675|459754149|FG000|Overall Study|Adverse Event|1|||
127762148|NCT00324675|459754150|FG001|Overall Study|Adverse Event|0|||
127762149|NCT01801735|459754153|FG000|Overall Study|Adverse Event|79|||
127762150|NCT01801735|459754153|FG000|Overall Study|Lack of Efficacy|28|||
127674651|NCT01570751|459432587|FG001|Period B (16 Weeks)|Protocol Violation|1|||
127674652|NCT00930813|459432588|FG000|Overall Study|Death|4|||
127674653|NCT00930813|459432589|FG001|Overall Study|Death|5|||
127674654|NCT00930813|459432588|FG000|Overall Study|Withdrawal by Subject|2|||
127674655|NCT00930813|459432589|FG001|Overall Study|Withdrawal by Subject|5|||
127674656|NCT00930813|459432588|FG000|Overall Study|Lost to Follow-up|2|||
127762151|NCT01801735|459754153|FG000|Overall Study|Withdrawal by Subject|27|||
127762152|NCT01801735|459754153|FG000|Overall Study|Protocol Violation|25|||
127762153|NCT01801735|459754153|FG000|Overall Study|Lost to Follow-up|15|||
127762154|NCT01801735|459754153|FG000|Overall Study|Non-compliance with Trial Drug|13|||
127762155|NCT01801735|459754153|FG000|Overall Study|Physician Decision|3|||
127762156|NCT01801735|459754153|FG000|Overall Study|Death|1|||
127762157|NCT01801735|459754153|FG000|Overall Study|Other, including site closure|19|||
127762158|NCT01435616|459754154|FG000|Overall Study|Adverse Event|39|||
127762159|NCT01435616|459754155|FG001|Overall Study|Adverse Event|21|||
127762160|NCT01435616|459754154|FG000|Overall Study|Death|7|||
127762161|NCT01435616|459754155|FG001|Overall Study|Death|2|||
127762162|NCT01435616|459754154|FG000|Overall Study|Lost to Follow-up|22|||
127762163|NCT01435616|459754155|FG001|Overall Study|Lost to Follow-up|13|||
127762164|NCT01435616|459754154|FG000|Overall Study|Protocol Violation|16|||
127762165|NCT01435616|459754155|FG001|Overall Study|Protocol Violation|13|||
127762166|NCT01435616|459754154|FG000|Overall Study|Withdrawal by Subject|66|||
127762167|NCT01435616|459754155|FG001|Overall Study|Withdrawal by Subject|24|||
127762168|NCT01435616|459754154|FG000|Overall Study|Physician Decision|20|||
127762169|NCT01435616|459754155|FG001|Overall Study|Physician Decision|7|||
127762170|NCT01435616|459754154|FG000|Overall Study|Sponsor Decision|1|||
127762171|NCT01435616|459754155|FG001|Overall Study|Sponsor Decision|0|||
127762172|NCT04860297|459754156|FG000|Part A (Primary Series)|Withdrawal by Subject|0|||
127762173|NCT04860297|459754157|FG001|Part A (Primary Series)|Withdrawal by Subject|1|||
127762174|NCT04860297|459754158|FG002|Part A (Primary Series)|Withdrawal by Subject|0|||
127762175|NCT04860297|459754159|FG003|Part A (Primary Series)|Withdrawal by Subject|1|||
127762176|NCT04860297|459754160|FG004|Part A (Primary Series)|Withdrawal by Subject|0|||
127762177|NCT04860297|459754161|FG005|Part A (Primary Series)|Withdrawal by Subject|0|||
127762178|NCT04860297|459754162|FG006|Part A (Primary Series)|Withdrawal by Subject|0|||
127762179|NCT04860297|459754163|FG007|Part A (Primary Series)|Withdrawal by Subject|0|||
127762180|NCT04860297|459754156|FG000|Part A (Primary Series)|Lost to Follow-up|1|||
127762181|NCT04860297|459754157|FG001|Part A (Primary Series)|Lost to Follow-up|0|||
127762182|NCT04860297|459754158|FG002|Part A (Primary Series)|Lost to Follow-up|0|||
127762183|NCT04860297|459754159|FG003|Part A (Primary Series)|Lost to Follow-up|2|||
127762184|NCT04860297|459754160|FG004|Part A (Primary Series)|Lost to Follow-up|0|||
127762185|NCT04860297|459754161|FG005|Part A (Primary Series)|Lost to Follow-up|0|||
127762186|NCT04860297|459754162|FG006|Part A (Primary Series)|Lost to Follow-up|0|||
127762187|NCT04860297|459754163|FG007|Part A (Primary Series)|Lost to Follow-up|0|||
127762188|NCT04860297|459754156|FG000|Part B (Booster Dose)|Protocol Deviation|0|||
127762189|NCT04860297|459754157|FG001|Part B (Booster Dose)|Protocol Deviation|0|||
127762190|NCT04860297|459754158|FG002|Part B (Booster Dose)|Protocol Deviation|0|||
127762191|NCT04860297|459754159|FG003|Part B (Booster Dose)|Protocol Deviation|0|||
127762192|NCT04860297|459754160|FG004|Part B (Booster Dose)|Protocol Deviation|0|||
127762193|NCT04860297|459754161|FG005|Part B (Booster Dose)|Protocol Deviation|0|||
127762194|NCT04860297|459754162|FG006|Part B (Booster Dose)|Protocol Deviation|1|||
127762195|NCT04860297|459754163|FG007|Part B (Booster Dose)|Protocol Deviation|0|||
128008875|NCT00392223|460660598|FG000|Overall Study|Protocol Violation|0|||
128008876|NCT00392223|460660599|FG001|Overall Study|Protocol Violation|3|||
128008877|NCT00392223|460660598|FG000|Overall Study|Withdrawal by Subject|3|||
128008878|NCT00392223|460660599|FG001|Overall Study|Withdrawal by Subject|2|||
127762196|NCT04860297|459754156|FG000|Part B (Booster Dose)|Other Than Specified|0|||
128008879|NCT01991795|460660600|FG000|Overall Study|Lost to Follow-up|6|||
128008880|NCT01991795|460660601|FG001|Overall Study|Lost to Follow-up|4|||
128008881|NCT01991795|460660600|FG000|Overall Study|Withdrawal by Subject|117|||
128008882|NCT01991795|460660601|FG001|Overall Study|Withdrawal by Subject|94|||
128008883|NCT01991795|460660600|FG000|Overall Study|Site prematurely closed by sponsor|26|||
128008884|NCT01991795|460660601|FG001|Overall Study|Site prematurely closed by sponsor|25|||
128008885|NCT03344757|460660602|FG000|Overall Study|Withdrawal by Subject|18|||
128008886|NCT03344757|460660603|FG001|Overall Study|Withdrawal by Subject|16|||
128008887|NCT03344757|460660602|FG000|Overall Study|Lost to Follow-up|0|||
128008888|NCT03344757|460660603|FG001|Overall Study|Lost to Follow-up|2|||
128008889|NCT03104374|460660607|FG000|Period 1|Adverse Event|7|||
128008890|NCT03104374|460660608|FG001|Period 1|Adverse Event|7|||
128008891|NCT03104374|460660609|FG002|Period 1|Adverse Event|12|||
127762197|NCT04860297|459754157|FG001|Part B (Booster Dose)|Other Than Specified|0|||
127762198|NCT04860297|459754158|FG002|Part B (Booster Dose)|Other Than Specified|0|||
127762199|NCT04860297|459754159|FG003|Part B (Booster Dose)|Other Than Specified|0|||
127762200|NCT04860297|459754160|FG004|Part B (Booster Dose)|Other Than Specified|0|||
128008892|NCT03104374|460660610|FG003|Period 1|Adverse Event|14|||
127762201|NCT04860297|459754161|FG005|Part B (Booster Dose)|Other Than Specified|1|||
127762202|NCT04860297|459754162|FG006|Part B (Booster Dose)|Other Than Specified|1|||
127762203|NCT04860297|459754163|FG007|Part B (Booster Dose)|Other Than Specified|0|||
127762204|NCT04860297|459754156|FG000|Part B (Booster Dose)|Withdrawal by Subject|0|||
128008893|NCT03104374|460660607|FG000|Period 1|Withdrawal by Subject|18|||
128008894|NCT03104374|460660608|FG001|Period 1|Withdrawal by Subject|9|||
128008895|NCT03104374|460660609|FG002|Period 1|Withdrawal by Subject|10|||
128008896|NCT03104374|460660610|FG003|Period 1|Withdrawal by Subject|17|||
128008897|NCT03104374|460660607|FG000|Period 1|Lost to Follow-up|4|||
128008898|NCT03104374|460660608|FG001|Period 1|Lost to Follow-up|4|||
128008899|NCT03104374|460660609|FG002|Period 1|Lost to Follow-up|6|||
128008900|NCT03104374|460660610|FG003|Period 1|Lost to Follow-up|8|||
128008901|NCT03104374|460660607|FG000|Period 1|Lack of Efficacy|6|||
128008902|NCT03104374|460660608|FG001|Period 1|Lack of Efficacy|7|||
128008903|NCT03104374|460660609|FG002|Period 1|Lack of Efficacy|12|||
128008904|NCT03104374|460660610|FG003|Period 1|Lack of Efficacy|6|||
128008905|NCT03104374|460660607|FG000|Period 1|Other|2|||
128008906|NCT03104374|460660608|FG001|Period 1|Other|2|||
128008907|NCT03104374|460660609|FG002|Period 1|Other|4|||
128008908|NCT03104374|460660610|FG003|Period 1|Other|7|||
128008909|NCT03104374|460660607|FG000|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
128008910|NCT03104374|460660608|FG001|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
128008911|NCT03104374|460660609|FG002|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
128008912|NCT03104374|460660610|FG003|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|1|||
128008913|NCT03104374|460660607|FG000|Period 2|Adverse Event|4|||
128008914|NCT03104374|460660608|FG001|Period 2|Adverse Event|7|||
128008915|NCT03104374|460660609|FG002|Period 2|Adverse Event|10|||
127674657|NCT00930813|459432589|FG001|Overall Study|Lost to Follow-up|4|||
127762205|NCT04860297|459754157|FG001|Part B (Booster Dose)|Withdrawal by Subject|0|||
127674658|NCT05790408|459432594|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
127674659|NCT02145182|459432596|FG000|Overall Study|Adverse Event|4|||
127674660|NCT02145182|459432597|FG001|Overall Study|Adverse Event|1|||
127674661|NCT02145182|459432596|FG000|Overall Study|Death|7|||
127674662|NCT02145182|459432597|FG001|Overall Study|Death|7|||
127674663|NCT02145182|459432596|FG000|Overall Study|Lost to Follow-up|2|||
127674664|NCT02145182|459432597|FG001|Overall Study|Lost to Follow-up|2|||
127674665|NCT02145182|459432596|FG000|Overall Study|Pre-transplant Withdrawal|0|||
127674666|NCT02145182|459432597|FG001|Overall Study|Pre-transplant Withdrawal|2|||
127674667|NCT02145182|459432596|FG000|Overall Study|Withdrawal by Subject|5|||
127674668|NCT02145182|459432597|FG001|Overall Study|Withdrawal by Subject|4|||
127674669|NCT03999554|459432598|FG000|Overall Study|Lost to Follow-up|4|||
127674670|NCT03999554|459432599|FG001|Overall Study|Lost to Follow-up|5|||
127674671|NCT03999554|459432600|FG002|Overall Study|Lost to Follow-up|4|||
127674672|NCT03999554|459432601|FG003|Overall Study|Lost to Follow-up|5|||
127674673|NCT03999554|459432602|FG004|Overall Study|Lost to Follow-up|8|||
127674674|NCT03999554|459432598|FG000|Overall Study|Protocol Violation|0|||
127674675|NCT03999554|459432599|FG001|Overall Study|Protocol Violation|0|||
127674676|NCT03999554|459432600|FG002|Overall Study|Protocol Violation|5|||
127674677|NCT03999554|459432601|FG003|Overall Study|Protocol Violation|0|||
127674678|NCT03999554|459432602|FG004|Overall Study|Protocol Violation|0|||
127674679|NCT03999554|459432598|FG000|Overall Study|Pregnancy|0|||
127674680|NCT03999554|459432599|FG001|Overall Study|Pregnancy|0|||
127674681|NCT03999554|459432600|FG002|Overall Study|Pregnancy|1|||
127674682|NCT03999554|459432601|FG003|Overall Study|Pregnancy|0|||
127674683|NCT03999554|459432602|FG004|Overall Study|Pregnancy|0|||
127674684|NCT03999554|459432598|FG000|Overall Study|Withdrawal by Subject|2|||
127674685|NCT03999554|459432599|FG001|Overall Study|Withdrawal by Subject|2|||
127674686|NCT03999554|459432600|FG002|Overall Study|Withdrawal by Subject|2|||
127674687|NCT03999554|459432601|FG003|Overall Study|Withdrawal by Subject|1|||
127674688|NCT03999554|459432602|FG004|Overall Study|Withdrawal by Subject|1|||
127674689|NCT03999554|459432598|FG000|Overall Study|failure to comply with protocol requirements|0|||
127674690|NCT03999554|459432599|FG001|Overall Study|failure to comply with protocol requirements|0|||
127674691|NCT03999554|459432600|FG002|Overall Study|failure to comply with protocol requirements|0|||
127674692|NCT03999554|459432601|FG003|Overall Study|failure to comply with protocol requirements|1|||
127674693|NCT03999554|459432602|FG004|Overall Study|failure to comply with protocol requirements|0|||
127674694|NCT02274493|459432605|FG000|Overall Study|Withdrawal by Subject|1|||
127674695|NCT00558363|459432606|FG000|Overall Study|Physician Decision|18|||
127674696|NCT00558363|459432607|FG001|Overall Study|Physician Decision|4|||
127674697|NCT00558363|459432606|FG000|Overall Study|Withdrawal by Subject|11|||
127674698|NCT00558363|459432607|FG001|Overall Study|Withdrawal by Subject|4|||
127674699|NCT00558363|459432606|FG000|Overall Study|Adverse Event|5|||
127674700|NCT00558363|459432607|FG001|Overall Study|Adverse Event|5|||
127674701|NCT00558363|459432606|FG000|Overall Study|Lack of Efficacy|2|||
127674702|NCT00558363|459432607|FG001|Overall Study|Lack of Efficacy|2|||
127674703|NCT00558363|459432606|FG000|Overall Study|Protocol Violation|2|||
127674704|NCT00558363|459432607|FG001|Overall Study|Protocol Violation|1|||
127762206|NCT04860297|459754158|FG002|Part B (Booster Dose)|Withdrawal by Subject|0|||
128008916|NCT03104374|460660610|FG003|Period 2|Adverse Event|10|||
128008917|NCT03104374|460660607|FG000|Period 2|Withdrawal by Subject|3|||
128008918|NCT03104374|460660608|FG001|Period 2|Withdrawal by Subject|7|||
127674705|NCT00558363|459432606|FG000|Overall Study|Lost to Follow-up|0|||
127674706|NCT00558363|459432607|FG001|Overall Study|Lost to Follow-up|1|||
127674707|NCT00558363|459432606|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
127674708|NCT00558363|459432607|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
128008919|NCT03104374|460660609|FG002|Period 2|Withdrawal by Subject|13|||
128008920|NCT03104374|460660610|FG003|Period 2|Withdrawal by Subject|16|||
128008921|NCT03104374|460660607|FG000|Period 2|Lost to Follow-up|2|||
128008922|NCT03104374|460660608|FG001|Period 2|Lost to Follow-up|2|||
128008923|NCT03104374|460660609|FG002|Period 2|Lost to Follow-up|3|||
127674709|NCT00558363|459432606|FG000|Overall Study|Randomized in Error|1|||
127674710|NCT00558363|459432607|FG001|Overall Study|Randomized in Error|2|||
127674711|NCT00558363|459432606|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
127674712|NCT00558363|459432607|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
127674713|NCT03102710|459432608|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
127674714|NCT03102710|459432609|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
127674715|NCT03102710|459432610|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
127674716|NCT03102710|459432608|FG000|Overall Study|Technical issues during final MRI scan|0|||
127674717|NCT03102710|459432609|FG001|Overall Study|Technical issues during final MRI scan|1|||
127674718|NCT03102710|459432610|FG002|Overall Study|Technical issues during final MRI scan|0|||
127674719|NCT03102710|459432608|FG000|Overall Study|Nausea during MRI scan|0|||
127674720|NCT03102710|459432609|FG001|Overall Study|Nausea during MRI scan|1|||
127674721|NCT03102710|459432610|FG002|Overall Study|Nausea during MRI scan|0|||
127674722|NCT03102710|459432608|FG000|Overall Study|Subject unable to attend final session|0|||
127674723|NCT03102710|459432609|FG001|Overall Study|Subject unable to attend final session|1|||
127674724|NCT03102710|459432610|FG002|Overall Study|Subject unable to attend final session|0|||
127674725|NCT04012853|459432611|FG000|Overall Study|Withdrawal by Subject|1|||
127674726|NCT04012853|459432612|FG001|Overall Study|Withdrawal by Subject|1|||
127674727|NCT04012853|459432611|FG000|Overall Study|Protocol Violation|1|||
127674728|NCT04012853|459432612|FG001|Overall Study|Protocol Violation|0|||
127674729|NCT04012853|459432611|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
127674730|NCT04012853|459432612|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
127674731|NCT00742274|459432615|FG000|Overall Study|Death|1|||
127674732|NCT00742274|459432616|FG001|Overall Study|Death|0|||
127674733|NCT00742274|459432615|FG000|Overall Study|Withdrawal by Subject|1|||
127674734|NCT00742274|459432616|FG001|Overall Study|Withdrawal by Subject|2|||
127674735|NCT00742274|459432615|FG000|Overall Study|Removed for medical reasons|1|||
127674736|NCT00742274|459432616|FG001|Overall Study|Removed for medical reasons|1|||
127674737|NCT01101165|459432617|FG000|Period 1|Adverse Event|1|||
127674738|NCT01101165|459432618|FG001|Period 1|Adverse Event|2|||
127674739|NCT01101165|459432617|FG000|Period 1|Withdrawal by Subject|0|||
127674740|NCT01101165|459432618|FG001|Period 1|Withdrawal by Subject|2|||
127674741|NCT01101165|459432617|FG000|Period 1|Positive Drug Screen|0|||
127674742|NCT01101165|459432618|FG001|Period 1|Positive Drug Screen|1|||
127674743|NCT01101165|459432617|FG000|Period 1|Lost to Follow-up|1|||
127674744|NCT01101165|459432618|FG001|Period 1|Lost to Follow-up|0|||
127674745|NCT01101165|459432617|FG000|Period 2|Withdrawal by Subject|3|||
127674746|NCT01101165|459432618|FG001|Period 2|Withdrawal by Subject|1|||
127674747|NCT01101165|459432617|FG000|Period 2|Adverse Event|1|||
127674748|NCT01101165|459432618|FG001|Period 2|Adverse Event|0|||
127674749|NCT00015457|459432619|FG000|First Intervention|Adverse Event|0|||
127674750|NCT00015457|459432620|FG001|First Intervention|Adverse Event|2|||
127674751|NCT00015457|459432619|FG000|First Intervention|Lack of Efficacy|0|||
127674752|NCT00015457|459432620|FG001|First Intervention|Lack of Efficacy|1|||
127674753|NCT00015457|459432619|FG000|Second Intervention|Withdrawal by Subject|1|||
127674754|NCT00015457|459432620|FG001|Second Intervention|Withdrawal by Subject|0|||
127674755|NCT02317705|459432621|FG000|Overall Study|Withdrawal by Subject|3|||
127674756|NCT02317705|459432621|FG000|Overall Study|Physician Decision|1|||
127674757|NCT02317705|459432621|FG000|Overall Study|Drug not usable|1|||
127674758|NCT02219490|459432622|FG000|Overall Study|Adverse Event|24|||
127674759|NCT02219490|459432622|FG000|Overall Study|Withdrew consent|96|||
127674760|NCT02219490|459432622|FG000|Overall Study|Lost to Follow-up|126|||
127674761|NCT02219490|459432622|FG000|Overall Study|COVID-19 infection|2|||
127674762|NCT02219490|459432622|FG000|Overall Study|COVID-19 logistical restrictions|33|||
127674763|NCT02219490|459432622|FG000|Overall Study|Other, not specified|57|||
127674764|NCT01599325|459432623|FG000|Primary Parent Phase|Adverse Event|5|||
127674765|NCT01599325|459432623|FG000|Primary Parent Phase|Disease Progression|7|||
127674766|NCT01599325|459432623|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
127674767|NCT01599325|459432623|FG000|Primary Parent Phase|Death|13|||
127674768|NCT01599325|459432623|FG000|Primary Parent Phase|Protocol Violation|1|||
127674769|NCT01599325|459432623|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
127674770|NCT01599325|459432623|FG000|Primary Parent Phase|Other|2|||
127674771|NCT01599325|459432623|FG000|Extension Phase|Study Closure|1|||
127674772|NCT01599325|459432623|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
127674773|NCT01599325|459432623|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
128008924|NCT03104374|460660610|FG003|Period 2|Lost to Follow-up|5|||
127674774|NCT01599325|459432623|FG000|Extension Phase|Disease Progression|1|||
127674775|NCT01599325|459432623|FG000|Extension Phase|Withdrawal by Subject|8|||
127674776|NCT02365298|459432626|FG000|Period 2|incorrect Rx dispensed|1|||
127674777|NCT02365298|459432627|FG001|Period 2|incorrect Rx dispensed|0|||
127674778|NCT02365298|459432626|FG000|Period 2|Discontinued at request of Sponsor|1|||
127762207|NCT04860297|459754159|FG003|Part B (Booster Dose)|Withdrawal by Subject|0|||
127762208|NCT04860297|459754160|FG004|Part B (Booster Dose)|Withdrawal by Subject|0|||
127762209|NCT04860297|459754161|FG005|Part B (Booster Dose)|Withdrawal by Subject|2|||
127762210|NCT04860297|459754162|FG006|Part B (Booster Dose)|Withdrawal by Subject|0|||
127762211|NCT04860297|459754163|FG007|Part B (Booster Dose)|Withdrawal by Subject|1|||
127762212|NCT04860297|459754156|FG000|Part B (Booster Dose)|Death|0|||
127762213|NCT04860297|459754157|FG001|Part B (Booster Dose)|Death|0|||
127762214|NCT04860297|459754158|FG002|Part B (Booster Dose)|Death|0|||
127762215|NCT04860297|459754159|FG003|Part B (Booster Dose)|Death|0|||
127762216|NCT04860297|459754160|FG004|Part B (Booster Dose)|Death|1|||
127762217|NCT04860297|459754161|FG005|Part B (Booster Dose)|Death|2|||
127762218|NCT04860297|459754162|FG006|Part B (Booster Dose)|Death|1|||
127762219|NCT04860297|459754163|FG007|Part B (Booster Dose)|Death|0|||
127762220|NCT04860297|459754156|FG000|Part B (Booster Dose)|Lost to Follow-up|0|||
127762221|NCT04860297|459754157|FG001|Part B (Booster Dose)|Lost to Follow-up|0|||
127762222|NCT04860297|459754158|FG002|Part B (Booster Dose)|Lost to Follow-up|0|||
127762223|NCT04860297|459754159|FG003|Part B (Booster Dose)|Lost to Follow-up|0|||
127762224|NCT04860297|459754160|FG004|Part B (Booster Dose)|Lost to Follow-up|3|||
128008925|NCT03104374|460660607|FG000|Period 2|Lack of Efficacy|2|||
128008926|NCT03104374|460660608|FG001|Period 2|Lack of Efficacy|4|||
128008927|NCT03104374|460660609|FG002|Period 2|Lack of Efficacy|7|||
127674779|NCT02365298|459432627|FG001|Period 2|Discontinued at request of Sponsor|0|||
127674780|NCT02365298|459432626|FG000|Period 2|Test Article longer available|0|||
127674781|NCT02365298|459432627|FG001|Period 2|Test Article longer available|1|||
127674782|NCT02365298|459432626|FG000|Period 2|Protocol Violation|0|||
127674783|NCT02365298|459432627|FG001|Period 2|Protocol Violation|1|||
127674784|NCT03404843|459432629|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
127674785|NCT03404843|459432630|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
127674786|NCT00567164|459432631|FG000|Overall Study|Withdrawal by Subject|171|||
127674787|NCT00567164|459432632|FG001|Overall Study|Withdrawal by Subject|21|||
127674788|NCT00567164|459432633|FG002|Overall Study|Withdrawal by Subject|17|||
127674789|NCT00567164|459432631|FG000|Overall Study|Protocol Violation|23|||
127674790|NCT00567164|459432632|FG001|Overall Study|Protocol Violation|4|||
127674791|NCT00567164|459432633|FG002|Overall Study|Protocol Violation|2|||
127674792|NCT00567164|459432631|FG000|Overall Study|Adverse Event|92|||
127674793|NCT00567164|459432632|FG001|Overall Study|Adverse Event|13|||
127674794|NCT00567164|459432633|FG002|Overall Study|Adverse Event|9|||
127674795|NCT00567164|459432631|FG000|Overall Study|Death|0|||
127674796|NCT00567164|459432632|FG001|Overall Study|Death|0|||
127674797|NCT00567164|459432633|FG002|Overall Study|Death|1|||
127674798|NCT00567164|459432631|FG000|Overall Study|Lost to Follow-up|202|||
127674799|NCT00567164|459432632|FG001|Overall Study|Lost to Follow-up|23|||
127674800|NCT00567164|459432633|FG002|Overall Study|Lost to Follow-up|21|||
127674801|NCT00567164|459432631|FG000|Overall Study|Pregnancy|20|||
127674802|NCT00567164|459432632|FG001|Overall Study|Pregnancy|4|||
127674803|NCT00567164|459432633|FG002|Overall Study|Pregnancy|6|||
127674804|NCT00567164|459432631|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
127674805|NCT00567164|459432632|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
127674806|NCT00567164|459432633|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
127674807|NCT00567164|459432631|FG000|Overall Study|Missing|1|||
127674808|NCT00567164|459432632|FG001|Overall Study|Missing|0|||
127674809|NCT00567164|459432633|FG002|Overall Study|Missing|0|||
127674810|NCT03441984|459432634|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
127674811|NCT03441984|459432635|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
127674812|NCT03441984|459432636|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
127674813|NCT03441984|459432637|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
127674814|NCT03441984|459432638|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
127674815|NCT03441984|459432639|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
127674816|NCT03441984|459432640|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
127674817|NCT03441984|459432641|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
127674818|NCT03441984|459432642|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
127674819|NCT03441984|459432643|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
127674820|NCT03441984|459432644|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
127674821|NCT03441984|459432645|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
127762225|NCT04860297|459754161|FG005|Part B (Booster Dose)|Lost to Follow-up|5|||
127762226|NCT04860297|459754162|FG006|Part B (Booster Dose)|Lost to Follow-up|1|||
127762227|NCT04860297|459754163|FG007|Part B (Booster Dose)|Lost to Follow-up|2|||
127762228|NCT04811131|459754167|FG000|Overall Study|Adverse Event|0|||
128008928|NCT03104374|460660610|FG003|Period 2|Lack of Efficacy|4|||
128008929|NCT03104374|460660607|FG000|Period 2|COVID-19 Infection|0|||
127674822|NCT02430532|459432646|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
127674823|NCT02430532|459432647|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
127674824|NCT02430532|459432646|FG000|Overall Study|Consent Withdrawn|0|||
127674825|NCT02430532|459432647|FG001|Overall Study|Consent Withdrawn|2|||
127762229|NCT04811131|459754168|FG001|Overall Study|Adverse Event|0|||
127762230|NCT04811131|459754169|FG002|Overall Study|Adverse Event|1|||
127762231|NCT04811131|459754170|FG003|Overall Study|Adverse Event|0|||
127762232|NCT04811131|459754167|FG000|Overall Study|Lack of Efficacy|0|||
127762233|NCT04811131|459754168|FG001|Overall Study|Lack of Efficacy|0|||
127762234|NCT04811131|459754169|FG002|Overall Study|Lack of Efficacy|0|||
127762235|NCT04811131|459754170|FG003|Overall Study|Lack of Efficacy|1|||
127762236|NCT04811131|459754167|FG000|Overall Study|Lost to Follow-up|0|||
127762237|NCT04811131|459754168|FG001|Overall Study|Lost to Follow-up|1|||
127762238|NCT04811131|459754169|FG002|Overall Study|Lost to Follow-up|0|||
127762239|NCT04811131|459754170|FG003|Overall Study|Lost to Follow-up|0|||
127762240|NCT04811131|459754167|FG000|Overall Study|Sponsor request|31|||
127762241|NCT04811131|459754168|FG001|Overall Study|Sponsor request|35|||
127762242|NCT04811131|459754169|FG002|Overall Study|Sponsor request|27|||
127762243|NCT04811131|459754170|FG003|Overall Study|Sponsor request|10|||
127762244|NCT04811131|459754167|FG000|Overall Study|Withdrawal by Subject|3|||
127762245|NCT04811131|459754168|FG001|Overall Study|Withdrawal by Subject|1|||
127762246|NCT04811131|459754169|FG002|Overall Study|Withdrawal by Subject|3|||
127762247|NCT04811131|459754170|FG003|Overall Study|Withdrawal by Subject|1|||
127762248|NCT00371683|459754172|FG000|DB Treatment Period-Randomized Patients|Death|1|||
127762249|NCT00371683|459754173|FG001|DB Treatment Period-Randomized Patients|Death|1|||
127762250|NCT00371683|459754172|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
127762251|NCT00371683|459754173|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
127762252|NCT00371683|459754172|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
127762253|NCT00371683|459754173|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
127762254|NCT00371683|459754172|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
127762255|NCT00371683|459754173|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
127762256|NCT00371683|459754172|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
127762257|NCT00371683|459754173|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
127762258|NCT00371683|459754172|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
127762259|NCT00371683|459754173|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
127762260|NCT00371683|459754172|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
127762261|NCT00371683|459754173|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
127762262|NCT00371683|459754172|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
127762263|NCT00371683|459754173|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
127762264|NCT00371683|459754172|FG000|Follow-Up Period - Randomized Patients|Death|0|||
127762265|NCT00371683|459754173|FG001|Follow-Up Period - Randomized Patients|Death|2|||
127762266|NCT00371683|459754172|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
127762267|NCT00371683|459754173|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
127762268|NCT00371683|459754172|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
127762269|NCT00371683|459754173|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
127762270|NCT03181789|459754175|FG000|Overall Study|Withdrawal by Subject|0|||
127762271|NCT03181789|459754176|FG001|Overall Study|Withdrawal by Subject|1|||
127762272|NCT03181789|459754177|FG002|Overall Study|Withdrawal by Subject|1|||
127762273|NCT03181789|459754178|FG003|Overall Study|Withdrawal by Subject|0|||
127762274|NCT03181789|459754175|FG000|Overall Study|Lost to Follow-up|7|||
127762275|NCT03181789|459754176|FG001|Overall Study|Lost to Follow-up|1|||
127762276|NCT03181789|459754177|FG002|Overall Study|Lost to Follow-up|0|||
127762277|NCT03181789|459754178|FG003|Overall Study|Lost to Follow-up|0|||
127762278|NCT03181789|459754175|FG000|Overall Study|Participant unable to adhere to visit|0|||
127762279|NCT03181789|459754176|FG001|Overall Study|Participant unable to adhere to visit|1|||
127762280|NCT03181789|459754177|FG002|Overall Study|Participant unable to adhere to visit|0|||
127762281|NCT03181789|459754178|FG003|Overall Study|Participant unable to adhere to visit|0|||
127762282|NCT01151410|459754179|FG000|Overall Study|Withdrawal by Subject|3|||
127762283|NCT01151410|459754180|FG001|Overall Study|Withdrawal by Subject|5|||
127762284|NCT01151410|459754179|FG000|Overall Study|Lost to Follow-up|3|||
127762285|NCT01151410|459754180|FG001|Overall Study|Lost to Follow-up|4|||
127762286|NCT01151410|459754179|FG000|Overall Study|Adverse Event|1|||
127762287|NCT01151410|459754180|FG001|Overall Study|Adverse Event|2|||
127762288|NCT01151410|459754179|FG000|Overall Study|Protocol deviation|2|||
127762289|NCT01151410|459754180|FG001|Overall Study|Protocol deviation|1|||
127762290|NCT01151410|459754179|FG000|Overall Study|Administrative problems|1|||
127762291|NCT01151410|459754180|FG001|Overall Study|Administrative problems|1|||
127762292|NCT01151410|459754179|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
128008930|NCT03104374|460660608|FG001|Period 2|COVID-19 Infection|0|||
127762293|NCT01151410|459754180|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
127762294|NCT01151410|459754179|FG000|Overall Study|Abnormal laboratory value(s)|0|||
127762295|NCT01151410|459754180|FG001|Overall Study|Abnormal laboratory value(s)|1|||
127762296|NCT00735475|459754181|FG000|Overall Study|Adverse Event|0|||
127762297|NCT00735475|459754182|FG001|Overall Study|Adverse Event|1|||
127762298|NCT00735475|459754181|FG000|Overall Study|Death|1|||
128008931|NCT03104374|460660609|FG002|Period 2|COVID-19 Infection|1|||
127762299|NCT00735475|459754182|FG001|Overall Study|Death|1|||
128008932|NCT03104374|460660610|FG003|Period 2|COVID-19 Infection|0|||
128008933|NCT03104374|460660607|FG000|Period 2|Other|3|||
127674826|NCT02430532|459432646|FG000|Overall Study|Adverse Event|0|||
127674827|NCT02430532|459432647|FG001|Overall Study|Adverse Event|1|||
127674828|NCT03256344|459432648|FG000|Overall Study|Death|6|||
127674829|NCT03256344|459432649|FG001|Overall Study|Death|22|||
127674830|NCT03256344|459432648|FG000|Overall Study|Withdrawal by Subject|3|||
127674831|NCT03256344|459432649|FG001|Overall Study|Withdrawal by Subject|3|||
127674832|NCT03256344|459432648|FG000|Overall Study|Sponsor Decision|1|||
127674833|NCT03256344|459432649|FG001|Overall Study|Sponsor Decision|0|||
127674834|NCT03586167|459432658|FG000|Overall Study|Other|1|||
127674835|NCT03586167|459432659|FG001|Overall Study|Other|0|||
127674836|NCT04163458|459432662|FG000|Overall Study|Protocol Deviation|7|||
127674837|NCT04163458|459432663|FG001|Overall Study|Protocol Deviation|13|||
127674838|NCT04163458|459432662|FG000|Overall Study|Adverse Event|5|||
127674839|NCT04163458|459432663|FG001|Overall Study|Adverse Event|8|||
127674840|NCT04163458|459432662|FG000|Overall Study|Due to COVID-19 pandemic|4|||
127674841|NCT04163458|459432663|FG001|Overall Study|Due to COVID-19 pandemic|2|||
127674842|NCT04163458|459432662|FG000|Overall Study|Participant withdrew consent|2|||
127674843|NCT04163458|459432663|FG001|Overall Study|Participant withdrew consent|3|||
127674844|NCT04163458|459432662|FG000|Overall Study|Randomization failure|2|||
127674845|NCT04163458|459432663|FG001|Overall Study|Randomization failure|2|||
127674846|NCT04163458|459432662|FG000|Overall Study|Other|4|||
127674847|NCT04163458|459432663|FG001|Overall Study|Other|2|||
127674848|NCT01467700|459432664|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
127674849|NCT01467700|459432665|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
127674850|NCT01467700|459432666|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
127674851|NCT01467700|459432667|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
127674852|NCT01467700|459432664|FG000|Overall Study|Major Protocol Deviation|3|||
127674853|NCT01467700|459432665|FG001|Overall Study|Major Protocol Deviation|3|||
127674854|NCT01467700|459432666|FG002|Overall Study|Major Protocol Deviation|2|||
127674855|NCT01467700|459432667|FG003|Overall Study|Major Protocol Deviation|3|||
127674856|NCT01467700|459432664|FG000|Overall Study|Lost to Follow-up|6|||
127674857|NCT01467700|459432665|FG001|Overall Study|Lost to Follow-up|5|||
127674858|NCT01467700|459432666|FG002|Overall Study|Lost to Follow-up|2|||
127674859|NCT01467700|459432667|FG003|Overall Study|Lost to Follow-up|3|||
127674860|NCT01467700|459432664|FG000|Overall Study|Voluntary Withdrawal|5|||
127674861|NCT01467700|459432665|FG001|Overall Study|Voluntary Withdrawal|7|||
127674862|NCT01467700|459432666|FG002|Overall Study|Voluntary Withdrawal|6|||
127674863|NCT01467700|459432667|FG003|Overall Study|Voluntary Withdrawal|2|||
127674864|NCT01467700|459432664|FG000|Overall Study|Study Termination|6|||
127674865|NCT01467700|459432665|FG001|Overall Study|Study Termination|5|||
127674866|NCT01467700|459432666|FG002|Overall Study|Study Termination|10|||
127674867|NCT01467700|459432667|FG003|Overall Study|Study Termination|7|||
127674868|NCT01467700|459432664|FG000|Overall Study|Pregnancy|0|||
127674869|NCT01467700|459432665|FG001|Overall Study|Pregnancy|1|||
127674870|NCT01467700|459432666|FG002|Overall Study|Pregnancy|1|||
127674871|NCT01467700|459432667|FG003|Overall Study|Pregnancy|0|||
127674872|NCT01467700|459432664|FG000|Overall Study|Lack of Efficacy|2|||
127674873|NCT01467700|459432665|FG001|Overall Study|Lack of Efficacy|0|||
127674874|NCT01467700|459432666|FG002|Overall Study|Lack of Efficacy|2|||
127674875|NCT01467700|459432667|FG003|Overall Study|Lack of Efficacy|1|||
127674876|NCT01467700|459432664|FG000|Overall Study|Reason not Specified|1|||
127674877|NCT01467700|459432665|FG001|Overall Study|Reason not Specified|3|||
127674878|NCT01467700|459432666|FG002|Overall Study|Reason not Specified|2|||
127674879|NCT01467700|459432667|FG003|Overall Study|Reason not Specified|8|||
127674880|NCT00121199|459432669|FG000|Overall Study|Adverse Event|11|||
127674881|NCT00121199|459432669|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
127674882|NCT00121199|459432669|FG000|Overall Study|Progression/Relapse|1|||
127674883|NCT00121199|459432669|FG000|Overall Study|Death|3|||
127674884|NCT00121199|459432669|FG000|Overall Study|Other - Not Protocol Specified|3|||
127674885|NCT00121199|459432669|FG000|Overall Study|Ineligible|9|||
127674886|NCT04109118|459432672|FG000|Overall Study|Lost to Follow-up|3|||
127674887|NCT03235349|459432675|FG000|Overall Study|Adverse Event|1|||
127674888|NCT03235349|459432675|FG000|Overall Study|Other|1|||
127674889|NCT03396913|459432677|FG000|Overall Study|Lost to Follow-up|0|||
127674890|NCT03396913|459432678|FG001|Overall Study|Lost to Follow-up|6|||
127674891|NCT00819910|459432679|FG000|Overall Study|Adverse Event|0|||
127674892|NCT00819910|459432680|FG001|Overall Study|Adverse Event|0|||
127674893|NCT00819910|459432681|FG002|Overall Study|Adverse Event|2|||
127674894|NCT00819910|459432682|FG003|Overall Study|Adverse Event|1|||
127674895|NCT00819910|459432679|FG000|Overall Study|Withdrawal by Subject|1|||
127674896|NCT00819910|459432680|FG001|Overall Study|Withdrawal by Subject|1|||
127674897|NCT00819910|459432681|FG002|Overall Study|Withdrawal by Subject|1|||
127674898|NCT00819910|459432682|FG003|Overall Study|Withdrawal by Subject|0|||
127674899|NCT00819910|459432679|FG000|Overall Study|Lost to Follow-up|1|||
127674900|NCT00819910|459432680|FG001|Overall Study|Lost to Follow-up|0|||
127674901|NCT00819910|459432681|FG002|Overall Study|Lost to Follow-up|0|||
127674902|NCT00819910|459432682|FG003|Overall Study|Lost to Follow-up|0|||
128008934|NCT03104374|460660608|FG001|Period 2|Other|2|||
127762300|NCT00735475|459754181|FG000|Overall Study|Lost to Follow-up|3|||
127762301|NCT00735475|459754182|FG001|Overall Study|Lost to Follow-up|3|||
127762302|NCT00735475|459754181|FG000|Overall Study|Physician Decision|0|||
127762303|NCT00735475|459754182|FG001|Overall Study|Physician Decision|1|||
128008935|NCT03104374|460660609|FG002|Period 2|Other|2|||
128008936|NCT03104374|460660610|FG003|Period 2|Other|4|||
128008937|NCT02121210|460660613|FG000|Overall Study|Adverse Event|5|||
128008938|NCT02121210|460660614|FG001|Overall Study|Adverse Event|7|||
128008939|NCT02121210|460660613|FG000|Overall Study|Lack of Efficacy|2|||
128008940|NCT02121210|460660614|FG001|Overall Study|Lack of Efficacy|0|||
128008941|NCT02121210|460660613|FG000|Overall Study|Other than specified above|0|||
128008942|NCT02121210|460660614|FG001|Overall Study|Other than specified above|2|||
128008943|NCT00909870|460660615|FG000|Overall Study|Adverse Event|13|||
128008944|NCT00909870|460660616|FG001|Overall Study|Adverse Event|7|||
127674903|NCT00299702|459432683|FG000|Overall Study|Death|1|||
127674904|NCT00299702|459432684|FG001|Overall Study|Death|0|||
127674905|NCT00299702|459432683|FG000|Overall Study|Adverse Event|0|||
127674906|NCT00299702|459432684|FG001|Overall Study|Adverse Event|4|||
127674907|NCT00299702|459432683|FG000|Overall Study|Lost to Follow-up|18|||
127674908|NCT00299702|459432684|FG001|Overall Study|Lost to Follow-up|10|||
127674909|NCT00299702|459432683|FG000|Overall Study|Withdrawal by Subject|25|||
127674910|NCT00299702|459432684|FG001|Overall Study|Withdrawal by Subject|23|||
127674911|NCT00299702|459432683|FG000|Overall Study|Pregnancy|0|||
127674912|NCT00299702|459432684|FG001|Overall Study|Pregnancy|1|||
127674913|NCT00299702|459432683|FG000|Overall Study|Insufficient Response|4|||
127674914|NCT00299702|459432684|FG001|Overall Study|Insufficient Response|3|||
127674915|NCT00299702|459432683|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
127674916|NCT00299702|459432684|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
127674917|NCT00751036|459432685|FG000|Overall Study|Disease Progression|28|||
127674918|NCT00751036|459432686|FG001|Overall Study|Disease Progression|29|||
127674919|NCT00751036|459432685|FG000|Overall Study|Adverse Event|6|||
127674920|NCT00751036|459432686|FG001|Overall Study|Adverse Event|4|||
127674921|NCT00751036|459432685|FG000|Overall Study|Administrative Problems|3|||
127674922|NCT00751036|459432686|FG001|Overall Study|Administrative Problems|4|||
127674923|NCT00751036|459432685|FG000|Overall Study|Withdrawal by Subject|5|||
127674924|NCT00751036|459432686|FG001|Overall Study|Withdrawal by Subject|2|||
127674925|NCT00751036|459432685|FG000|Overall Study|Death|3|||
127674926|NCT00751036|459432686|FG001|Overall Study|Death|3|||
127674927|NCT00751036|459432685|FG000|Overall Study|Lost to Follow-up|0|||
127674928|NCT00751036|459432686|FG001|Overall Study|Lost to Follow-up|1|||
127674929|NCT00751036|459432685|FG000|Overall Study|Protocol Violation|1|||
127674930|NCT00751036|459432686|FG001|Overall Study|Protocol Violation|0|||
127674931|NCT00751036|459432685|FG000|Overall Study|Missing end of Treatment Page|2|||
127674932|NCT00751036|459432686|FG001|Overall Study|Missing end of Treatment Page|3|||
127674933|NCT05460663|459432687|FG000|Overall Study|Withdrawal by Subject|2|||
127674934|NCT05460663|459432688|FG001|Overall Study|Withdrawal by Subject|5|||
127705133|NCT01928394|459551582|FG015|Treatment Period|Poor/non-compliance|0|||
127705134|NCT01928394|459551583|FG016|Treatment Period|Poor/non-compliance|0|||
127705135|NCT01928394|459551584|FG017|Treatment Period|Poor/non-compliance|1|||
127705136|NCT01928394|459551585|FG018|Treatment Period|Poor/non-compliance|0|||
127705137|NCT01928394|459551586|FG019|Treatment Period|Poor/non-compliance|1|||
127705138|NCT01928394|459551587|FG020|Treatment Period|Poor/non-compliance|0|||
127705139|NCT01928394|459551588|FG021|Treatment Period|Poor/non-compliance|0|||
127705140|NCT01928394|459551589|FG022|Treatment Period|Poor/non-compliance|0|||
127705141|NCT01928394|459551567|FG000|Treatment Period|other reason|0|||
127705142|NCT01928394|459551568|FG001|Treatment Period|other reason|0|||
127705143|NCT01928394|459551569|FG002|Treatment Period|other reason|0|||
127705144|NCT01928394|459551570|FG003|Treatment Period|other reason|0|||
127705145|NCT01928394|459551571|FG004|Treatment Period|other reason|0|||
127705146|NCT01928394|459551572|FG005|Treatment Period|other reason|0|||
127705147|NCT01928394|459551573|FG006|Treatment Period|other reason|0|||
127705148|NCT01928394|459551574|FG007|Treatment Period|other reason|0|||
127705149|NCT01928394|459551575|FG008|Treatment Period|other reason|0|||
127705150|NCT01928394|459551576|FG009|Treatment Period|other reason|0|||
127762304|NCT00735475|459754181|FG000|Overall Study|Withdrawal by Subject|4|||
128008945|NCT00909870|460660615|FG000|Overall Study|Protocol Violation|1|||
127705151|NCT01928394|459551577|FG010|Treatment Period|other reason|1|||
127762305|NCT00735475|459754182|FG001|Overall Study|Withdrawal by Subject|5|||
128008946|NCT00909870|460660616|FG001|Overall Study|Protocol Violation|2|||
128008947|NCT00909870|460660615|FG000|Overall Study|Withdrawal by Subject|5|||
128008948|NCT00909870|460660616|FG001|Overall Study|Withdrawal by Subject|8|||
127705152|NCT01928394|459551578|FG011|Treatment Period|other reason|1|||
127705153|NCT01928394|459551579|FG012|Treatment Period|other reason|1|||
127705154|NCT01928394|459551580|FG013|Treatment Period|other reason|0|||
127705155|NCT01928394|459551581|FG014|Treatment Period|other reason|1|||
127705156|NCT01928394|459551582|FG015|Treatment Period|other reason|0|||
127705157|NCT01928394|459551583|FG016|Treatment Period|other reason|0|||
127705158|NCT01928394|459551584|FG017|Treatment Period|other reason|0|||
127705159|NCT01928394|459551585|FG018|Treatment Period|other reason|2|||
127762306|NCT02442336|459754183|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
127762307|NCT02442336|459754183|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
127762308|NCT02442336|459754183|FG000|Overall Study|Lost to Follow-up|11|||
127762309|NCT00844532|459754185|FG000|Overall Study|Death|16|||
127762310|NCT00844532|459754185|FG000|Overall Study|Withdrawal by Subject|16|||
127762311|NCT00844532|459754185|FG000|Overall Study|Lost to Follow-up|7|||
127762312|NCT01237587|459754188|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
127762313|NCT01237587|459754189|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
127762314|NCT01237587|459754188|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
127762315|NCT01237587|459754189|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
127762316|NCT01237587|459754188|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
127762317|NCT01237587|459754189|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
127762318|NCT01237587|459754188|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
127762319|NCT01237587|459754189|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
127762320|NCT01237587|459754188|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
127762321|NCT01237587|459754189|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
127762322|NCT01237587|459754188|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
127762323|NCT01237587|459754189|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
127762324|NCT01237587|459754188|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
127762325|NCT01237587|459754189|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
127762326|NCT01237587|459754188|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
127762327|NCT01237587|459754189|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
127762328|NCT01237587|459754188|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
127762329|NCT01237587|459754189|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
127762330|NCT01237587|459754188|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
127762331|NCT01237587|459754189|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
127762332|NCT01237587|459754188|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
127762333|NCT01237587|459754189|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
127762334|NCT01237587|459754188|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
127762335|NCT01237587|459754189|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
127762336|NCT01237587|459754188|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
127762337|NCT01237587|459754189|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
127762338|NCT01237587|459754188|FG000|Taper Phase|Adverse Event|0|||
127762339|NCT01237587|459754189|FG001|Taper Phase|Adverse Event|2|||
127762340|NCT01237587|459754188|FG000|Taper Phase|Protocol Violation|2|||
127762341|NCT01237587|459754189|FG001|Taper Phase|Protocol Violation|0|||
127762342|NCT01237587|459754188|FG000|Taper Phase|Lack of Efficacy|2|||
127762343|NCT01237587|459754189|FG001|Taper Phase|Lack of Efficacy|5|||
127762344|NCT01237587|459754188|FG000|Taper Phase|Parent/Guardian Decision|0|||
127762345|NCT01237587|459754189|FG001|Taper Phase|Parent/Guardian Decision|2|||
127762346|NCT01237587|459754188|FG000|Taper Phase|Sponsor Decision|1|||
127762347|NCT01237587|459754189|FG001|Taper Phase|Sponsor Decision|0|||
127762348|NCT01237587|459754188|FG000|Taper Phase|Withdrawal by Subject|0|||
127762349|NCT01237587|459754189|FG001|Taper Phase|Withdrawal by Subject|1|||
127762350|NCT03208036|459754194|FG000|Baseline Assessment|Withdrawal by Subject|1|||
127762351|NCT03208036|459754195|FG001|Baseline Assessment|Withdrawal by Subject|1|||
127762352|NCT03208036|459754194|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
127762353|NCT03208036|459754195|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
127762354|NCT03208036|459754194|FG000|Intervention|Withdrawal by Subject|3|||
127762355|NCT03208036|459754195|FG001|Intervention|Withdrawal by Subject|2|||
127762356|NCT03208036|459754194|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
127762357|NCT03208036|459754195|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
127762358|NCT02217501|459754201|FG000|Overall Study|Death|3|||
127762359|NCT02217501|459754202|FG001|Overall Study|Death|4|||
127762360|NCT02245737|459755987|FG000|Overall Study|Adverse Event|23|||
127762361|NCT02245737|459755988|FG001|Overall Study|Adverse Event|26|||
127762362|NCT02245737|459755989|FG002|Overall Study|Adverse Event|33|||
127762363|NCT02245737|459755987|FG000|Overall Study|Condition Worsened|9|||
127762364|NCT02245737|459755988|FG001|Overall Study|Condition Worsened|10|||
127762365|NCT02245737|459755989|FG002|Overall Study|Condition Worsened|9|||
127762366|NCT02245737|459755987|FG000|Overall Study|Death|2|||
127762367|NCT02245737|459755988|FG001|Overall Study|Death|4|||
127762368|NCT02245737|459755989|FG002|Overall Study|Death|4|||
127762369|NCT02245737|459755987|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
127762370|NCT02245737|459755988|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
127762371|NCT02245737|459755989|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
128008949|NCT00909870|460660615|FG000|Overall Study|Lost to Follow-up|3|||
127543540|NCT02718898|458956554|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
127543541|NCT02718898|458956555|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
127543542|NCT02718898|458956556|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
127543543|NCT02718898|458956557|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
127543544|NCT02718898|458956551|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
127543545|NCT02718898|458956552|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
127674935|NCT05526911|459434281|FG000|Overall Study|Adverse Event|2|||
127762372|NCT02245737|459755987|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
127762373|NCT02245737|459755988|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
127762374|NCT02245737|459755989|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
127762375|NCT02245737|459755987|FG000|Overall Study|Lost to Follow-up|2|||
127762376|NCT02245737|459755988|FG001|Overall Study|Lost to Follow-up|5|||
127762377|NCT02245737|459755989|FG002|Overall Study|Lost to Follow-up|4|||
127762378|NCT02245737|459755987|FG000|Overall Study|Other-determined by Investigator|9|||
127762379|NCT02245737|459755988|FG001|Overall Study|Other-determined by Investigator|10|||
127762380|NCT02245737|459755989|FG002|Overall Study|Other-determined by Investigator|10|||
127762381|NCT02245737|459755987|FG000|Overall Study|Physician Decision|6|||
127762382|NCT02245737|459755988|FG001|Overall Study|Physician Decision|3|||
127762383|NCT02245737|459755989|FG002|Overall Study|Physician Decision|6|||
127762384|NCT02245737|459755987|FG000|Overall Study|Protocol Violation|3|||
127762385|NCT02245737|459755988|FG001|Overall Study|Protocol Violation|2|||
127762386|NCT02245737|459755989|FG002|Overall Study|Protocol Violation|3|||
127762387|NCT02245737|459755987|FG000|Overall Study|Withdrawal by Subject|40|||
127762388|NCT02245737|459755988|FG001|Overall Study|Withdrawal by Subject|41|||
127762389|NCT02245737|459755989|FG002|Overall Study|Withdrawal by Subject|44|||
127762390|NCT02245737|459755987|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
127762391|NCT02245737|459755988|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
127762392|NCT02245737|459755989|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
127762393|NCT02245737|459755987|FG000|Overall Study|Sponsor Decision|445|||
127762394|NCT02245737|459755988|FG001|Overall Study|Sponsor Decision|430|||
127762395|NCT02245737|459755989|FG002|Overall Study|Sponsor Decision|432|||
127762396|NCT01983254|459755991|FG000|Overall Study|Death|6|||
127762397|NCT01983254|459755992|FG001|Overall Study|Death|6|||
127762398|NCT01983254|459755991|FG000|Overall Study|Lost to Follow-up|17|||
127762399|NCT01983254|459755992|FG001|Overall Study|Lost to Follow-up|16|||
127762400|NCT01983254|459755991|FG000|Overall Study|too ill|11|||
127762401|NCT01983254|459755992|FG001|Overall Study|too ill|8|||
127762402|NCT04988867|459755995|FG000|Overall Study|Study terminated by Sponsor|12|||
127762403|NCT04988867|459755995|FG000|Overall Study|Adverse Event|2|||
127762404|NCT04988867|459755995|FG000|Overall Study|Study drug noncompliance|1|||
127762405|NCT01253304|459755996|FG000|Overall Study|Adverse Event|0|||
127762406|NCT01253304|459755997|FG001|Overall Study|Adverse Event|0|||
127762407|NCT01253304|459755998|FG002|Overall Study|Adverse Event|0|||
127762408|NCT01253304|459755999|FG003|Overall Study|Adverse Event|1|||
127762409|NCT01699503|459756002|FG000|Overall Study|Death|31|||
127762410|NCT01699503|459756003|FG001|Overall Study|Death|40|||
127762411|NCT01699503|459756002|FG000|Overall Study|Withdrawal by Subject|65|||
127762412|NCT01699503|459756003|FG001|Overall Study|Withdrawal by Subject|57|||
127762413|NCT01699503|459756002|FG000|Overall Study|Lost to Follow-up|121|||
127762414|NCT01699503|459756003|FG001|Overall Study|Lost to Follow-up|117|||
127762415|NCT01699503|459756002|FG000|Overall Study|Excluded due to quality|783|||
127762416|NCT01699503|459756003|FG001|Overall Study|Excluded due to quality|791|||
127762417|NCT00768079|459756008|FG000|Overall Study|Lost to Follow-up|2|||
127762418|NCT00768079|459756009|FG001|Overall Study|Lost to Follow-up|0|||
127762419|NCT00768079|459756010|FG002|Overall Study|Lost to Follow-up|4|||
127762420|NCT00768079|459756008|FG000|Overall Study|Participant incarcerated|0|||
127762421|NCT00768079|459756009|FG001|Overall Study|Participant incarcerated|1|||
127762422|NCT00768079|459756010|FG002|Overall Study|Participant incarcerated|0|||
127674936|NCT05025449|459434282|FG000|Overall Study|Withdrawal by Subject|1|||
127674937|NCT05025449|459434282|FG000|Overall Study|Patient emergently taken to operating room|1|||
127674938|NCT00613301|459434283|FG000|Overall Study|Adverse Event|49|||
127674939|NCT00613301|459434283|FG000|Overall Study|Lost to Follow-up|88|||
127674940|NCT00613301|459434283|FG000|Overall Study|Withdrawal by Subject|5|||
127674941|NCT00613301|459434283|FG000|Overall Study|Death|6|||
127674942|NCT00613301|459434283|FG000|Overall Study|Lack of Efficacy|13|||
127674943|NCT00613301|459434283|FG000|Overall Study|Physician Decision|2|||
127674944|NCT00613301|459434283|FG000|Overall Study|No data was collected|53|||
127762423|NCT01097707|459756011|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
127762424|NCT01097707|459756012|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
127762425|NCT01097707|459756013|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
127762426|NCT01097707|459756014|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
127762427|NCT01097707|459756015|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
127762428|NCT01097707|459756011|FG000|Overall Study|Adverse Event|4|||
127762429|NCT01097707|459756012|FG001|Overall Study|Adverse Event|2|||
127762430|NCT01097707|459756013|FG002|Overall Study|Adverse Event|3|||
127762431|NCT01097707|459756014|FG003|Overall Study|Adverse Event|1|||
127674945|NCT00613301|459434283|FG000|Overall Study|Irregularly enrolled patients|12|||
127762432|NCT01097707|459756015|FG004|Overall Study|Adverse Event|3|||
127762433|NCT01097707|459756011|FG000|Overall Study|Entry Criteria Not Met|2|||
127762434|NCT01097707|459756012|FG001|Overall Study|Entry Criteria Not Met|1|||
127762435|NCT01097707|459756013|FG002|Overall Study|Entry Criteria Not Met|1|||
127762436|NCT01097707|459756014|FG003|Overall Study|Entry Criteria Not Met|0|||
127762437|NCT01097707|459756015|FG004|Overall Study|Entry Criteria Not Met|1|||
127762438|NCT01097707|459756011|FG000|Overall Study|Lack of Efficacy|1|||
127762439|NCT01097707|459756012|FG001|Overall Study|Lack of Efficacy|0|||
127762440|NCT01097707|459756013|FG002|Overall Study|Lack of Efficacy|0|||
127762441|NCT01097707|459756014|FG003|Overall Study|Lack of Efficacy|1|||
127762442|NCT01097707|459756015|FG004|Overall Study|Lack of Efficacy|0|||
127762443|NCT01097707|459756011|FG000|Overall Study|Lost to Follow-up|1|||
127762444|NCT01097707|459756012|FG001|Overall Study|Lost to Follow-up|1|||
127762445|NCT01097707|459756013|FG002|Overall Study|Lost to Follow-up|2|||
127762446|NCT01097707|459756014|FG003|Overall Study|Lost to Follow-up|0|||
127762447|NCT01097707|459756015|FG004|Overall Study|Lost to Follow-up|3|||
127762448|NCT01097707|459756011|FG000|Overall Study|Protocol Violation|2|||
127762449|NCT01097707|459756012|FG001|Overall Study|Protocol Violation|2|||
127762450|NCT01097707|459756013|FG002|Overall Study|Protocol Violation|3|||
127762451|NCT01097707|459756014|FG003|Overall Study|Protocol Violation|2|||
127762452|NCT01097707|459756015|FG004|Overall Study|Protocol Violation|2|||
127762453|NCT01097707|459756011|FG000|Overall Study|Sponsor Decision|31|||
127762454|NCT01097707|459756012|FG001|Overall Study|Sponsor Decision|31|||
127762455|NCT01097707|459756013|FG002|Overall Study|Sponsor Decision|34|||
127762456|NCT01097707|459756014|FG003|Overall Study|Sponsor Decision|35|||
127762457|NCT01097707|459756015|FG004|Overall Study|Sponsor Decision|36|||
127762458|NCT01097707|459756011|FG000|Overall Study|Withdrawal by Subject|3|||
127762459|NCT01097707|459756012|FG001|Overall Study|Withdrawal by Subject|6|||
127762460|NCT01097707|459756013|FG002|Overall Study|Withdrawal by Subject|1|||
128008950|NCT00909870|460660616|FG001|Overall Study|Lost to Follow-up|3|||
128008951|NCT00909870|460660615|FG000|Overall Study|Physician Decision|0|||
127762461|NCT01097707|459756014|FG003|Overall Study|Withdrawal by Subject|4|||
127762462|NCT01097707|459756015|FG004|Overall Study|Withdrawal by Subject|3|||
127762463|NCT01097707|459756011|FG000|Overall Study|Reason unknown|0|||
127762464|NCT01097707|459756012|FG001|Overall Study|Reason unknown|0|||
127762465|NCT01097707|459756013|FG002|Overall Study|Reason unknown|0|||
127762466|NCT01097707|459756014|FG003|Overall Study|Reason unknown|0|||
127762467|NCT01097707|459756015|FG004|Overall Study|Reason unknown|1|||
127762468|NCT02207569|459756016|FG000|1-Month|Death|6|||
127762469|NCT02207569|459756016|FG000|1-Month|Withdrawal by Subject|2|||
127762470|NCT02207569|459756016|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
127762471|NCT02207569|459756016|FG000|6-Month|Death|8|||
127762472|NCT02207569|459756016|FG000|6-Month|Withdrawal by Subject|2|||
127762473|NCT02207569|459756016|FG000|12-Month|Death|14|||
127762474|NCT02207569|459756016|FG000|12-Month|Withdrawal by Subject|2|||
127762475|NCT02207569|459756016|FG000|24-Month|Death|23|||
127762476|NCT02207569|459756016|FG000|24-Month|Withdrawal by Subject|3|||
127762477|NCT02207569|459756016|FG000|36-Month|Death|23|||
127762478|NCT02207569|459756016|FG000|36-Month|Withdrawal by Subject|4|||
127762479|NCT02207569|459756016|FG000|48-Month|Death|25|||
127762480|NCT02207569|459756016|FG000|48-Month|Withdrawal by Subject|2|||
127762481|NCT02207569|459756016|FG000|48-Month|Lost to Follow-up|4|||
127762482|NCT02207569|459756016|FG000|60-Month|Death|1|||
127762483|NCT02207569|459756016|FG000|60-Month|Lost to Follow-up|1|||
127762484|NCT02207569|459756016|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
127762485|NCT02207569|459756016|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
127762486|NCT01236534|459756018|FG000|Overall Study|Adverse Event|3|||
127762487|NCT01236534|459756019|FG001|Overall Study|Adverse Event|0|||
127762488|NCT05383508|459756028|FG000|Overall Study|Withdrawal by Subject|1|||
127762489|NCT05383508|459756029|FG001|Overall Study|Withdrawal by Subject|0|||
127762490|NCT05383508|459756030|FG002|Overall Study|Withdrawal by Subject|1|||
127762491|NCT05383508|459756031|FG003|Overall Study|Withdrawal by Subject|1|||
127762492|NCT05383508|459756032|FG004|Overall Study|Withdrawal by Subject|2|||
128008952|NCT00909870|460660616|FG001|Overall Study|Physician Decision|2|||
128008953|NCT00909870|460660615|FG000|Overall Study|Other|1|||
128008954|NCT00909870|460660616|FG001|Overall Study|Other|5|||
128008955|NCT01232283|460660617|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
128008956|NCT01232283|460660618|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
127762493|NCT05383508|459756033|FG005|Overall Study|Withdrawal by Subject|0|||
127762494|NCT03412747|459756036|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
127762495|NCT03412747|459756037|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
127762496|NCT03412747|459756038|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
127762497|NCT03412747|459756036|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
127762498|NCT03412747|459756037|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
127762499|NCT03412747|459756038|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
127762500|NCT03412747|459756036|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
127762501|NCT03412747|459756037|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
127762502|NCT03412747|459756038|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
128008957|NCT01232283|460660619|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
128008958|NCT01232283|460660620|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
127762503|NCT03412747|459756036|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
127762504|NCT03412747|459756037|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
127762505|NCT03412747|459756038|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
127762506|NCT03412747|459756036|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
127762507|NCT03412747|459756037|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
127762508|NCT03412747|459756038|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
127762509|NCT03412747|459756036|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
127762510|NCT03412747|459756037|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
127762511|NCT03412747|459756038|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
127762512|NCT03412747|459756036|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
127762513|NCT03412747|459756037|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
127762514|NCT03412747|459756038|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
127762515|NCT03412747|459756036|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
127762516|NCT03412747|459756037|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
127762517|NCT03412747|459756038|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
127762518|NCT03412747|459756036|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
127762519|NCT03412747|459756037|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
127762520|NCT03412747|459756038|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
127762521|NCT03412747|459756036|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
127762522|NCT03412747|459756037|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
127762523|NCT03412747|459756038|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
127762524|NCT03412747|459756036|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
127762525|NCT03412747|459756037|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
127762526|NCT03412747|459756038|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
127762527|NCT03412747|459756036|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
127762528|NCT03412747|459756037|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
127762529|NCT03412747|459756038|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
127762530|NCT03412747|459756036|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
127762531|NCT03412747|459756037|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
127762532|NCT03412747|459756038|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
127762533|NCT03412747|459756036|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
127762534|NCT03412747|459756037|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
127762535|NCT03412747|459756038|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
127762536|NCT03412747|459756036|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
127762537|NCT03412747|459756037|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
127762538|NCT03412747|459756038|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
127762539|NCT03412747|459756036|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
127762540|NCT03412747|459756037|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
127762541|NCT03412747|459756038|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
127762542|NCT02081417|459756039|FG000|Overall Study|Lost to Follow-up|26|||
127762543|NCT02081417|459756040|FG001|Overall Study|Lost to Follow-up|23|||
127762544|NCT02081417|459756039|FG000|Overall Study|Moved Away|1|||
127762545|NCT02081417|459756040|FG001|Overall Study|Moved Away|2|||
127762546|NCT02081417|459756039|FG000|Overall Study|Incarcerated|2|||
127762547|NCT02081417|459756040|FG001|Overall Study|Incarcerated|2|||
127762548|NCT02081417|459756039|FG000|Overall Study|Death|4|||
127762549|NCT02081417|459756040|FG001|Overall Study|Death|3|||
127762550|NCT02081417|459756039|FG000|Overall Study|Withdrawal by Subject|4|||
127762551|NCT02081417|459756040|FG001|Overall Study|Withdrawal by Subject|0|||
127762552|NCT02081417|459756039|FG000|Overall Study|Admitted to Residential Treatment|2|||
127762553|NCT02081417|459756040|FG001|Overall Study|Admitted to Residential Treatment|0|||
127762554|NCT02081417|459756039|FG000|Overall Study|Did not start treatment|17|||
127762555|NCT02081417|459756040|FG001|Overall Study|Did not start treatment|21|||
127762556|NCT01157676|459756043|FG000|Randomization|Death|1|||
127762557|NCT01157676|459756044|FG001|Randomization|Death|1|||
127762558|NCT01157676|459756043|FG000|Randomization|unresectable|2|||
127762559|NCT01157676|459756044|FG001|Randomization|unresectable|3|||
127762560|NCT01157676|459756043|FG000|Randomization|Withdrawal by Subject|17|||
127762561|NCT01157676|459756044|FG001|Randomization|Withdrawal by Subject|13|||
128008959|NCT01232283|460660621|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
128008960|NCT01232283|460660622|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
128008961|NCT01232283|460660623|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
128008962|NCT01232283|460660624|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
128008963|NCT01232283|460660625|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
128008964|NCT01232283|460660626|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
127762562|NCT01157676|459756043|FG000|Randomization|Physician Decision|1|||
127762563|NCT01157676|459756044|FG001|Randomization|Physician Decision|0|||
127762564|NCT01157676|459756043|FG000|Surgery|underwent open cystectomy|0|||
127762565|NCT01157676|459756044|FG001|Surgery|underwent open cystectomy|4|||
128008965|NCT01232283|460660617|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
127674946|NCT00569946|459434284|FG000|Overall Study|Adverse Event|16|||
127674947|NCT00569946|459434284|FG000|Overall Study|Objective Progression or Relapse|42|||
127674948|NCT00569946|459434284|FG000|Overall Study|Global Deterioration of Health Status|1|||
127674949|NCT00762463|459434286|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
127674950|NCT00762463|459434287|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
127674951|NCT00762463|459434288|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
127674952|NCT00762463|459434289|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
127674953|NCT00762463|459434286|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
127674954|NCT00762463|459434287|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
127674955|NCT00762463|459434288|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
127674956|NCT00762463|459434289|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
127674957|NCT00762463|459434286|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
127674958|NCT00762463|459434287|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
127674959|NCT00762463|459434288|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
127674960|NCT00762463|459434289|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
127674961|NCT00762463|459434286|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
127674962|NCT00762463|459434287|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
127674963|NCT00762463|459434288|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
127674964|NCT00762463|459434289|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
127674965|NCT00762463|459434286|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
127674966|NCT00762463|459434287|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
127674967|NCT00762463|459434288|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
127674968|NCT00762463|459434289|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
127674969|NCT00762463|459434286|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
127674970|NCT00762463|459434287|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
127674971|NCT00762463|459434288|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
127674972|NCT00762463|459434289|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
127674973|NCT00762463|459434286|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
127674974|NCT00762463|459434287|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
127674975|NCT00762463|459434288|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
127674976|NCT00762463|459434289|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
127674977|NCT00762463|459434286|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
127674978|NCT00762463|459434287|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
127674979|NCT00762463|459434288|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
127674980|NCT00762463|459434289|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
127674981|NCT01306331|459434290|FG000|Overall Study|Adverse Event|28|||
127674982|NCT01306331|459434291|FG001|Overall Study|Adverse Event|25|||
127674983|NCT01306331|459434290|FG000|Overall Study|Lost to Follow-up|321|||
127674984|NCT01306331|459434291|FG001|Overall Study|Lost to Follow-up|323|||
127674985|NCT01306331|459434290|FG000|Overall Study|Physician Decision|26|||
127674986|NCT01306331|459434291|FG001|Overall Study|Physician Decision|22|||
127674987|NCT01306331|459434290|FG000|Overall Study|Pregnancy|136|||
127674988|NCT01306331|459434291|FG001|Overall Study|Pregnancy|151|||
127674989|NCT01306331|459434290|FG000|Overall Study|Protocol Violation|154|||
127674990|NCT01306331|459434291|FG001|Overall Study|Protocol Violation|124|||
127674991|NCT01306331|459434290|FG000|Overall Study|Withdrawal by Subject|163|||
127674992|NCT01306331|459434291|FG001|Overall Study|Withdrawal by Subject|152|||
127674993|NCT01306331|459434290|FG000|Overall Study|Not sexually active|29|||
127674994|NCT01306331|459434291|FG001|Overall Study|Not sexually active|28|||
127674995|NCT01306331|459434290|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
127674996|NCT01306331|459434291|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
127674997|NCT01306331|459434290|FG000|Overall Study|Other|34|||
127674998|NCT01306331|459434291|FG001|Overall Study|Other|32|||
127674999|NCT04048135|459434294|FG000|Overall Study|Withdrawal by Subject|1|||
127675000|NCT04048135|459434295|FG001|Overall Study|Withdrawal by Subject|1|||
127675001|NCT04048135|459434296|FG002|Overall Study|Withdrawal by Subject|1|||
127675002|NCT04048135|459434297|FG003|Overall Study|Withdrawal by Subject|2|||
127675003|NCT04048135|459434298|FG004|Overall Study|Withdrawal by Subject|0|||
127675004|NCT04048135|459434299|FG005|Overall Study|Withdrawal by Subject|0|||
127675005|NCT04048135|459434300|FG006|Overall Study|Withdrawal by Subject|1|||
127675006|NCT04048135|459434301|FG007|Overall Study|Withdrawal by Subject|1|||
127675007|NCT04048135|459434294|FG000|Overall Study|Adverse Event|0|||
127675008|NCT04048135|459434295|FG001|Overall Study|Adverse Event|0|||
127675009|NCT04048135|459434296|FG002|Overall Study|Adverse Event|0|||
127675010|NCT04048135|459434297|FG003|Overall Study|Adverse Event|1|||
127762566|NCT01157676|459756043|FG000|Surgery|converted to open procedure|0|||
127762567|NCT01157676|459756044|FG001|Surgery|converted to open procedure|5|||
127762568|NCT01157676|459756043|FG000|Surgery|underwent robotic cystectomy|1|||
127675011|NCT04048135|459434298|FG004|Overall Study|Adverse Event|1|||
127675012|NCT04048135|459434299|FG005|Overall Study|Adverse Event|0|||
127675013|NCT04048135|459434300|FG006|Overall Study|Adverse Event|0|||
127675014|NCT04048135|459434301|FG007|Overall Study|Adverse Event|0|||
127675015|NCT04048135|459434294|FG000|Overall Study|Protocol Violation|0|||
127675016|NCT04048135|459434295|FG001|Overall Study|Protocol Violation|0|||
127675017|NCT04048135|459434296|FG002|Overall Study|Protocol Violation|0|||
127675018|NCT04048135|459434297|FG003|Overall Study|Protocol Violation|0|||
127675019|NCT04048135|459434298|FG004|Overall Study|Protocol Violation|0|||
127675020|NCT04048135|459434299|FG005|Overall Study|Protocol Violation|1|||
127675021|NCT04048135|459434300|FG006|Overall Study|Protocol Violation|0|||
127675022|NCT04048135|459434301|FG007|Overall Study|Protocol Violation|0|||
127675023|NCT00172185|459434302|FG000|Overall Study|Adverse Event|0|||
127675024|NCT00172185|459434303|FG001|Overall Study|Adverse Event|1|||
127675025|NCT00172185|459434304|FG002|Overall Study|Adverse Event|3|||
127675026|NCT00172185|459434305|FG003|Overall Study|Adverse Event|4|||
127675027|NCT00172185|459434302|FG000|Overall Study|Physician Decision|0|||
127675028|NCT00172185|459434303|FG001|Overall Study|Physician Decision|0|||
127675029|NCT00172185|459434304|FG002|Overall Study|Physician Decision|1|||
127675030|NCT00172185|459434305|FG003|Overall Study|Physician Decision|0|||
127675031|NCT00172185|459434302|FG000|Overall Study|SPONSOR Decision|0|||
127675032|NCT00172185|459434303|FG001|Overall Study|SPONSOR Decision|1|||
127675033|NCT00172185|459434304|FG002|Overall Study|SPONSOR Decision|0|||
127675034|NCT00172185|459434305|FG003|Overall Study|SPONSOR Decision|0|||
127675035|NCT00172185|459434302|FG000|Overall Study|Withdrawal by Subject|0|||
127675036|NCT00172185|459434303|FG001|Overall Study|Withdrawal by Subject|0|||
127675037|NCT00172185|459434304|FG002|Overall Study|Withdrawal by Subject|1|||
127675038|NCT00172185|459434305|FG003|Overall Study|Withdrawal by Subject|0|||
127675039|NCT00151996|459434312|FG000|Overall Study|Adverse Event|3|||
127675040|NCT00151996|459434313|FG001|Overall Study|Adverse Event|2|||
127675041|NCT00151996|459434312|FG000|Overall Study|Withdrawal by Subject|1|||
127675042|NCT00151996|459434313|FG001|Overall Study|Withdrawal by Subject|1|||
127675043|NCT00151996|459434312|FG000|Overall Study|Protocol Violation|1|||
127675044|NCT00151996|459434313|FG001|Overall Study|Protocol Violation|2|||
127675045|NCT00151996|459434312|FG000|Overall Study|Sponsor's decision|0|||
127675046|NCT00151996|459434313|FG001|Overall Study|Sponsor's decision|2|||
127705160|NCT01928394|459551586|FG019|Treatment Period|other reason|2|||
127705161|NCT01928394|459551587|FG020|Treatment Period|other reason|0|||
127705162|NCT01928394|459551588|FG021|Treatment Period|other reason|0|||
127705163|NCT01928394|459551589|FG022|Treatment Period|other reason|0|||
127705164|NCT01928394|459551567|FG000|Treatment Period|Maximum clinical benefit|0|||
127705165|NCT01928394|459551568|FG001|Treatment Period|Maximum clinical benefit|0|||
127705166|NCT01928394|459551569|FG002|Treatment Period|Maximum clinical benefit|0|||
127705167|NCT01928394|459551570|FG003|Treatment Period|Maximum clinical benefit|0|||
127705168|NCT01928394|459551571|FG004|Treatment Period|Maximum clinical benefit|0|||
127705169|NCT01928394|459551572|FG005|Treatment Period|Maximum clinical benefit|0|||
127705170|NCT01928394|459551573|FG006|Treatment Period|Maximum clinical benefit|0|||
127705171|NCT01928394|459551574|FG007|Treatment Period|Maximum clinical benefit|0|||
127705172|NCT01928394|459551575|FG008|Treatment Period|Maximum clinical benefit|0|||
127705173|NCT01928394|459551576|FG009|Treatment Period|Maximum clinical benefit|0|||
127705174|NCT01928394|459551577|FG010|Treatment Period|Maximum clinical benefit|1|||
127705175|NCT01928394|459551578|FG011|Treatment Period|Maximum clinical benefit|1|||
127705176|NCT01928394|459551579|FG012|Treatment Period|Maximum clinical benefit|0|||
127705177|NCT01928394|459551580|FG013|Treatment Period|Maximum clinical benefit|0|||
127705178|NCT01928394|459551581|FG014|Treatment Period|Maximum clinical benefit|1|||
127705179|NCT01928394|459551582|FG015|Treatment Period|Maximum clinical benefit|0|||
127705180|NCT01928394|459551583|FG016|Treatment Period|Maximum clinical benefit|0|||
127705181|NCT01928394|459551584|FG017|Treatment Period|Maximum clinical benefit|1|||
127705182|NCT01928394|459551585|FG018|Treatment Period|Maximum clinical benefit|1|||
127705183|NCT01928394|459551586|FG019|Treatment Period|Maximum clinical benefit|0|||
127705184|NCT01928394|459551587|FG020|Treatment Period|Maximum clinical benefit|2|||
127705185|NCT01928394|459551588|FG021|Treatment Period|Maximum clinical benefit|0|||
127705186|NCT01928394|459551589|FG022|Treatment Period|Maximum clinical benefit|0|||
127705187|NCT01928394|459551567|FG000|Treatment Period|Lost to Follow-up|0|||
127705188|NCT01928394|459551568|FG001|Treatment Period|Lost to Follow-up|0|||
127705189|NCT01928394|459551569|FG002|Treatment Period|Lost to Follow-up|0|||
127705190|NCT01928394|459551570|FG003|Treatment Period|Lost to Follow-up|0|||
127705191|NCT01928394|459551571|FG004|Treatment Period|Lost to Follow-up|0|||
127705192|NCT01928394|459551572|FG005|Treatment Period|Lost to Follow-up|0|||
127705193|NCT01928394|459551573|FG006|Treatment Period|Lost to Follow-up|0|||
127705194|NCT01928394|459551574|FG007|Treatment Period|Lost to Follow-up|0|||
127705195|NCT01928394|459551575|FG008|Treatment Period|Lost to Follow-up|0|||
127705196|NCT01928394|459551576|FG009|Treatment Period|Lost to Follow-up|0|||
127705197|NCT01928394|459551577|FG010|Treatment Period|Lost to Follow-up|0|||
127705198|NCT01928394|459551578|FG011|Treatment Period|Lost to Follow-up|0|||
127705199|NCT01928394|459551579|FG012|Treatment Period|Lost to Follow-up|0|||
128008966|NCT01232283|460660618|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
128008967|NCT01232283|460660619|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
128008968|NCT01232283|460660620|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
128008969|NCT01232283|460660621|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
128008970|NCT01232283|460660622|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
128008971|NCT01232283|460660623|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
128008972|NCT01232283|460660624|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
128008973|NCT01232283|460660625|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
128008974|NCT01232283|460660626|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
128008975|NCT01232283|460660617|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
128008976|NCT01232283|460660618|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
128008977|NCT01232283|460660619|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
128008978|NCT01232283|460660620|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
127675047|NCT01801930|459434314|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
127675048|NCT01801930|459434315|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
127675049|NCT01801930|459434316|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
127675050|NCT01801930|459434317|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
127675051|NCT01801930|459434314|FG000|Overall Study|DLT occurs|0|||
127675052|NCT01801930|459434315|FG001|Overall Study|DLT occurs|1|||
127675053|NCT01801930|459434316|FG002|Overall Study|DLT occurs|0|||
127675054|NCT01801930|459434317|FG003|Overall Study|DLT occurs|0|||
127675055|NCT03441360|459434321|FG000|Overall Study|Radiological disease progression|5|||
127675056|NCT03441360|459434322|FG001|Overall Study|Radiological disease progression|6|||
127675057|NCT03441360|459434323|FG002|Overall Study|Radiological disease progression|4|||
127675058|NCT03441360|459434321|FG000|Overall Study|Clinical disease progression|2|||
127675059|NCT03441360|459434322|FG001|Overall Study|Clinical disease progression|2|||
127675060|NCT03441360|459434323|FG002|Overall Study|Clinical disease progression|0|||
127675061|NCT03441360|459434321|FG000|Overall Study|Adverse Event|1|||
127675062|NCT03441360|459434322|FG001|Overall Study|Adverse Event|0|||
127675063|NCT03441360|459434323|FG002|Overall Study|Adverse Event|1|||
127675064|NCT00269399|459434324|FG000|Overall Study|Lack of Efficacy|27|||
127675065|NCT00269399|459434325|FG001|Overall Study|Lack of Efficacy|10|||
127675066|NCT00269399|459434324|FG000|Overall Study|Adverse Event|10|||
127675067|NCT00269399|459434325|FG001|Overall Study|Adverse Event|4|||
127675068|NCT00269399|459434324|FG000|Overall Study|Withdrawal by Subject|2|||
127675069|NCT00269399|459434325|FG001|Overall Study|Withdrawal by Subject|5|||
127675070|NCT00269399|459434324|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
127675071|NCT00269399|459434325|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
127675072|NCT00269399|459434324|FG000|Overall Study|Other|0|||
127675073|NCT00269399|459434325|FG001|Overall Study|Other|4|||
127675074|NCT00269399|459434324|FG000|Overall Study|Development of exclusion criteria|0|||
127675075|NCT00269399|459434325|FG001|Overall Study|Development of exclusion criteria|1|||
127675076|NCT03396835|459434327|FG000|Overall Study|Withdrawn prior to completion|1|||
127675077|NCT03396835|459434327|FG000|Overall Study|Did not meet criteria for data analysis|1|||
127675078|NCT03439124|459434334|FG000|Overall Study|Adverse Event|2|||
127675079|NCT03439124|459434335|FG001|Overall Study|Adverse Event|0|||
127675080|NCT03439124|459434334|FG000|Overall Study|Lost to Follow-up|1|||
127675081|NCT03439124|459434335|FG001|Overall Study|Lost to Follow-up|0|||
127675082|NCT03439124|459434334|FG000|Overall Study|Other reasons|1|||
127675083|NCT03439124|459434335|FG001|Overall Study|Other reasons|0|||
127675084|NCT02236559|459434339|FG000|Overall Study|Met Exclusion|3|||
127675085|NCT02236559|459434340|FG001|Overall Study|Met Exclusion|6|||
127675086|NCT02236559|459434339|FG000|Overall Study|Did not Meet Inclusion|3|||
127675087|NCT02236559|459434340|FG001|Overall Study|Did not Meet Inclusion|3|||
127675088|NCT02236559|459434339|FG000|Overall Study|Subject Did Not Consent|4|||
127675089|NCT02236559|459434340|FG001|Overall Study|Subject Did Not Consent|2|||
127675090|NCT02236559|459434339|FG000|Overall Study|Physician Decision|1|||
127675091|NCT02236559|459434340|FG001|Overall Study|Physician Decision|1|||
127675092|NCT02236559|459434339|FG000|Overall Study|Withdrawal by Subject|1|||
127675093|NCT02236559|459434340|FG001|Overall Study|Withdrawal by Subject|0|||
127675094|NCT02049866|459434341|FG000|Overall Study|Withdrawal by Subject|1|||
127675095|NCT01117480|459434343|FG000|Overall Study|Protocol Violation|8|||
127675096|NCT01117480|459434343|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
127675097|NCT02955069|459434344|FG000|Overall Study|Adverse Event|7|||
127762569|NCT01157676|459756044|FG001|Surgery|underwent robotic cystectomy|0|||
127762570|NCT00468104|459756048|FG000|First Intervention|Protocol Violation|2|||
127675098|NCT02955069|459434345|FG001|Overall Study|Adverse Event|2|||
127675099|NCT02955069|459434344|FG000|Overall Study|Death|7|||
127675100|NCT02955069|459434345|FG001|Overall Study|Death|3|||
127675101|NCT02955069|459434344|FG000|Overall Study|Physician Decision|10|||
127675102|NCT02955069|459434345|FG001|Overall Study|Physician Decision|2|||
127675103|NCT02955069|459434344|FG000|Overall Study|Progressive disease|64|||
127675104|NCT02955069|459434345|FG001|Overall Study|Progressive disease|13|||
127762571|NCT00468104|459756049|FG001|First Intervention|Protocol Violation|1|||
127762572|NCT00468104|459756048|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
127762573|NCT00468104|459756049|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
127762574|NCT00468104|459756048|FG000|First Intervention|died within 3 weeks|1|||
127762575|NCT00468104|459756049|FG001|First Intervention|died within 3 weeks|0|||
127762576|NCT00468104|459756048|FG000|First Intervention|malposition/blocked chest tube tube|2|||
127762577|NCT00468104|459756049|FG001|First Intervention|malposition/blocked chest tube tube|0|||
127762578|NCT00468104|459756048|FG000|First Intervention|large lung mass with minimal effusion|1|||
127762579|NCT00468104|459756049|FG001|First Intervention|large lung mass with minimal effusion|0|||
127762580|NCT00468104|459756048|FG000|First Intervention|associated prolonged pneumothorax|1|||
127762581|NCT00468104|459756049|FG001|First Intervention|associated prolonged pneumothorax|0|||
127762582|NCT00468104|459756048|FG000|First Intervention|trapped lung|1|||
127762583|NCT00468104|459756049|FG001|First Intervention|trapped lung|0|||
127762584|NCT00468104|459756048|FG000|Second Intervention|Withdrawal by Subject|5|||
127762585|NCT00468104|459756049|FG001|Second Intervention|Withdrawal by Subject|2|||
127762586|NCT00468104|459756048|FG000|Second Intervention|discarded for malposition of chest tube|0|||
127762587|NCT00468104|459756049|FG001|Second Intervention|discarded for malposition of chest tube|2|||
127762588|NCT01263665|459756050|FG000|Overall Study|Withdrew Consent|1|||
127762589|NCT01263665|459756050|FG000|Overall Study|Lost to Follow-up|3|||
127762590|NCT01263665|459756050|FG000|Overall Study|Death|2|||
127762591|NCT01263665|459756050|FG000|Overall Study|Amputation above the ankle|1|||
127762592|NCT01263665|459756050|FG000|Overall Study|Surgical Bypass|2|||
127762593|NCT01528345|459756058|FG000|Overall Study|Adverse Event|10|||
127762594|NCT01528345|459756059|FG001|Overall Study|Adverse Event|1|||
127762595|NCT01528345|459756058|FG000|Overall Study|Death|1|||
127762596|NCT01528345|459756059|FG001|Overall Study|Death|1|||
127762597|NCT01528345|459756058|FG000|Overall Study|Non-compliance with study treatment|1|||
127762598|NCT01528345|459756059|FG001|Overall Study|Non-compliance with study treatment|0|||
127762599|NCT01528345|459756058|FG000|Overall Study|Progressive Disease|26|||
127762600|NCT01528345|459756059|FG001|Overall Study|Progressive Disease|40|||
127762601|NCT01528345|459756058|FG000|Overall Study|Study Terminated by Sponsor|4|||
127762602|NCT01528345|459756059|FG001|Overall Study|Study Terminated by Sponsor|8|||
127762603|NCT01528345|459756058|FG000|Overall Study|Subject/Guardian Decision|5|||
127762604|NCT01528345|459756059|FG001|Overall Study|Subject/Guardian Decision|0|||
127762605|NCT02624791|459756060|FG000|Overall Study|Withdrawal by Subject|2|||
127762606|NCT02624791|459756061|FG001|Overall Study|Withdrawal by Subject|0|||
127762607|NCT02624791|459756062|FG002|Overall Study|Withdrawal by Subject|0|||
127762608|NCT02624791|459756063|FG003|Overall Study|Withdrawal by Subject|0|||
127762609|NCT02624791|459756064|FG004|Overall Study|Withdrawal by Subject|0|||
127762610|NCT02624791|459756065|FG005|Overall Study|Withdrawal by Subject|0|||
127762611|NCT02656329|459756070|FG000|Overall Study|Lost to Follow-up|2|||
127762612|NCT02656329|459756071|FG001|Overall Study|Lost to Follow-up|3|||
127762613|NCT02656329|459756070|FG000|Overall Study|Withdrawal by Subject|7|||
127762614|NCT02656329|459756071|FG001|Overall Study|Withdrawal by Subject|6|||
127762615|NCT02656329|459756070|FG000|Overall Study|Study termination by Sponsor|150|||
127762616|NCT02656329|459756071|FG001|Overall Study|Study termination by Sponsor|142|||
127762617|NCT02656329|459756070|FG000|Overall Study|Other than specified above|5|||
127762618|NCT02656329|459756071|FG001|Overall Study|Other than specified above|6|||
127762619|NCT01139580|459756072|FG000|Overall Study|Adverse Event|5|||
127762620|NCT01139580|459756073|FG001|Overall Study|Adverse Event|4|||
127762621|NCT01139580|459756072|FG000|Overall Study|Lost to Follow-up|9|||
127762622|NCT01139580|459756073|FG001|Overall Study|Lost to Follow-up|1|||
127762623|NCT01139580|459756072|FG000|Overall Study|Lack of Efficacy|0|||
127762624|NCT01139580|459756073|FG001|Overall Study|Lack of Efficacy|2|||
127762625|NCT01139580|459756072|FG000|Overall Study|Withdrawal by Subject|6|||
127762626|NCT01139580|459756073|FG001|Overall Study|Withdrawal by Subject|9|||
127762627|NCT01139580|459756072|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
127762628|NCT01139580|459756073|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
127762629|NCT01139580|459756072|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
127762630|NCT01139580|459756073|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
127762631|NCT01139580|459756072|FG000|Overall Study|Misrandomized|1|||
127762632|NCT01139580|459756073|FG001|Overall Study|Misrandomized|0|||
127762633|NCT01139580|459756072|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
127762634|NCT01139580|459756073|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
127762635|NCT01139580|459756072|FG000|Overall Study|Participant Randomization in Error|0|||
128008979|NCT01232283|460660621|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
127762636|NCT01139580|459756073|FG001|Overall Study|Participant Randomization in Error|1|||
127762637|NCT00633880|459756074|FG000|Open Label Titration|Lack of Efficacy|1|||
127762638|NCT00633880|459756075|FG001|Open Label Titration|Lack of Efficacy|0|||
127762639|NCT00633880|459756076|FG002|Open Label Titration|Lack of Efficacy|0|||
127762640|NCT00633880|459756074|FG000|Open Label Titration|Adverse Event|13|||
127762641|NCT00633880|459756075|FG001|Open Label Titration|Adverse Event|0|||
127762642|NCT00633880|459756076|FG002|Open Label Titration|Adverse Event|0|||
127762643|NCT00633880|459756074|FG000|Open Label Titration|Treatment Failure|55|||
128008980|NCT01232283|460660622|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
128008981|NCT01232283|460660623|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
128008982|NCT01232283|460660624|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
128008983|NCT01232283|460660625|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
128008984|NCT01232283|460660626|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
128008985|NCT01232283|460660617|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
128008986|NCT01232283|460660618|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
128008987|NCT01232283|460660619|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
128008988|NCT01232283|460660620|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
128008989|NCT01232283|460660621|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
128008990|NCT01232283|460660622|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
128008991|NCT01232283|460660623|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
128008992|NCT01232283|460660624|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
127675105|NCT02955069|459434344|FG000|Overall Study|Study terminated by sponsor|4|||
127675106|NCT02955069|459434345|FG001|Overall Study|Study terminated by sponsor|0|||
127675107|NCT02955069|459434344|FG000|Overall Study|Subject/Guardian decision|3|||
127675108|NCT02955069|459434345|FG001|Overall Study|Subject/Guardian decision|1|||
127675109|NCT04148937|459434347|FG000|Overall Study|Withdrawal by Subject|0|||
127675110|NCT04148937|459434348|FG001|Overall Study|Withdrawal by Subject|0|||
127675111|NCT04148937|459434349|FG002|Overall Study|Withdrawal by Subject|0|||
127675112|NCT04148937|459434350|FG003|Overall Study|Withdrawal by Subject|1|||
127675113|NCT04148937|459434351|FG004|Overall Study|Withdrawal by Subject|0|||
127675114|NCT04148937|459434352|FG005|Overall Study|Withdrawal by Subject|1|||
127675115|NCT04148937|459434353|FG006|Overall Study|Withdrawal by Subject|1|||
127675116|NCT04148937|459434354|FG007|Overall Study|Withdrawal by Subject|0|||
127675117|NCT04148937|459434347|FG000|Overall Study|Lost to Follow-up|0|||
127675118|NCT04148937|459434348|FG001|Overall Study|Lost to Follow-up|0|||
127675119|NCT04148937|459434349|FG002|Overall Study|Lost to Follow-up|1|||
127675120|NCT04148937|459434350|FG003|Overall Study|Lost to Follow-up|0|||
127675121|NCT04148937|459434351|FG004|Overall Study|Lost to Follow-up|0|||
127675122|NCT04148937|459434352|FG005|Overall Study|Lost to Follow-up|2|||
127675123|NCT04148937|459434353|FG006|Overall Study|Lost to Follow-up|0|||
127675124|NCT04148937|459434354|FG007|Overall Study|Lost to Follow-up|0|||
127675125|NCT01167426|459434355|FG000|Overall Study|Lost to Follow-up|6|||
127675126|NCT01167426|459434355|FG000|Overall Study|Protocol Violation|1|||
127675127|NCT01167426|459434355|FG000|Overall Study|Withdrawal by Subject|2|||
127675128|NCT01167426|459434355|FG000|Overall Study|Sponsor Decision|1|||
127675129|NCT00544440|459434360|FG000|Overall Study|Other|1|||
127675130|NCT00544440|459434360|FG000|Overall Study|Adverse Event|1|||
127675131|NCT00544440|459434360|FG000|Overall Study|Withdrawal by Subject|2|||
127675132|NCT00544440|459434360|FG000|Overall Study|Subject Non-compliance|1|||
127675133|NCT00544440|459434360|FG000|Overall Study|Progressive Disease|47|||
127675134|NCT00544440|459434360|FG000|Overall Study|Other|5|||
127675135|NCT00591838|459434362|FG000|Overall Study|Withdrawal by Subject|0|||
127675136|NCT00591838|459434363|FG001|Overall Study|Withdrawal by Subject|0|||
127675137|NCT00591838|459434364|FG002|Overall Study|Withdrawal by Subject|0|||
127675138|NCT00591838|459434365|FG003|Overall Study|Withdrawal by Subject|1|||
127675139|NCT00591838|459434366|FG004|Overall Study|Withdrawal by Subject|0|||
127675140|NCT00881335|459434368|FG000|Overall Study|Lost to Follow-up|3|||
127675141|NCT00881335|459434369|FG001|Overall Study|Lost to Follow-up|2|||
127675142|NCT05824351|459434372|FG000|Overall Study|Adverse Event|6|||
127675143|NCT00828945|459434373|FG000|Overall Study|Death|4|||
127675144|NCT00828945|459434373|FG000|Overall Study|Participant was missing|1|||
127675145|NCT00828945|459434373|FG000|Overall Study|Other|36|||
127675146|NCT02482233|459434378|FG000|Overall Study|Lost to Follow-up|1|||
127675147|NCT02482233|459434379|FG001|Overall Study|Lost to Follow-up|1|||
127675148|NCT03822351|459434380|FG000|Overall Study|Death|27|||
127675149|NCT03822351|459434381|FG001|Overall Study|Death|23|||
127675150|NCT03822351|459434382|FG002|Overall Study|Death|24|||
127675151|NCT03822351|459434380|FG000|Overall Study|Lost to Follow-up|6|||
127675152|NCT03822351|459434381|FG001|Overall Study|Lost to Follow-up|2|||
128008993|NCT01232283|460660625|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
128008994|NCT01232283|460660626|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
127675153|NCT03822351|459434382|FG002|Overall Study|Lost to Follow-up|1|||
127675154|NCT03822351|459434380|FG000|Overall Study|Withdrawal by Subject|10|||
127675155|NCT03822351|459434381|FG001|Overall Study|Withdrawal by Subject|4|||
127675156|NCT03822351|459434382|FG002|Overall Study|Withdrawal by Subject|6|||
127675157|NCT03822351|459434380|FG000|Overall Study|Progressive Disease|2|||
127675158|NCT03822351|459434381|FG001|Overall Study|Progressive Disease|1|||
127675159|NCT03822351|459434382|FG002|Overall Study|Progressive Disease|0|||
127675160|NCT03822351|459434380|FG000|Overall Study|Not Treated|1|||
127675161|NCT03822351|459434381|FG001|Overall Study|Not Treated|1|||
127675162|NCT03822351|459434382|FG002|Overall Study|Not Treated|1|||
127675163|NCT00462943|459434383|FG000|Overall Study|Failure to achieve a response|5|||
128008995|NCT01232283|460660617|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
128008996|NCT01232283|460660618|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
128008997|NCT01232283|460660619|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
128008998|NCT01232283|460660620|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
128008999|NCT01232283|460660621|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
128009000|NCT01232283|460660622|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
128009001|NCT01232283|460660623|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
128009002|NCT01232283|460660624|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
128009003|NCT01232283|460660625|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
128009004|NCT01232283|460660626|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
128009005|NCT01232283|460660617|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
128009006|NCT01232283|460660618|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
128009007|NCT01232283|460660619|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
128009008|NCT01232283|460660620|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
128009009|NCT01232283|460660621|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
128009010|NCT01232283|460660622|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
128009011|NCT01232283|460660623|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
128009012|NCT01232283|460660624|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
128009013|NCT01232283|460660625|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
128009014|NCT01232283|460660626|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
128009015|NCT01232283|460660617|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
127762644|NCT00633880|459756075|FG001|Open Label Titration|Treatment Failure|0|||
127762645|NCT00633880|459756076|FG002|Open Label Titration|Treatment Failure|0|||
127762646|NCT00633880|459756074|FG000|Open Label Titration|Protocol Violation|6|||
127762647|NCT00633880|459756075|FG001|Open Label Titration|Protocol Violation|0|||
127762648|NCT00633880|459756076|FG002|Open Label Titration|Protocol Violation|0|||
127762649|NCT00633880|459756074|FG000|Open Label Titration|Physician Decision|1|||
127762650|NCT00633880|459756075|FG001|Open Label Titration|Physician Decision|0|||
127762651|NCT00633880|459756076|FG002|Open Label Titration|Physician Decision|0|||
127762652|NCT00633880|459756074|FG000|Open Label Titration|Withdrawal by Subject|4|||
128009016|NCT01232283|460660618|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
128009017|NCT01232283|460660619|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
128009018|NCT01232283|460660620|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
128009019|NCT01232283|460660621|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
128009020|NCT01232283|460660622|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
128009021|NCT01232283|460660623|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
127762653|NCT00633880|459756075|FG001|Open Label Titration|Withdrawal by Subject|0|||
127762654|NCT00633880|459756076|FG002|Open Label Titration|Withdrawal by Subject|0|||
127762655|NCT00591851|459756078|FG000|Overall Study|Withdrawal by Subject|3|||
127762656|NCT00591851|459756078|FG000|Overall Study|Adverse Event|2|||
127762657|NCT00591851|459756078|FG000|Overall Study|Progressive Disease|1|||
127762658|NCT00515853|459756081|FG000|Overall Study|Lost to Follow-up|9|||
127762659|NCT00515853|459756082|FG001|Overall Study|Lost to Follow-up|13|||
127762660|NCT00515853|459756081|FG000|Overall Study|Withdrawal by Subject|6|||
127762661|NCT00515853|459756082|FG001|Overall Study|Withdrawal by Subject|4|||
127762662|NCT00589121|459756085|FG000|Overall Study|Protocol Violation|2|||
127762663|NCT00589121|459756086|FG001|Overall Study|Protocol Violation|6|||
127762664|NCT00589121|459756085|FG000|Overall Study|No protocol treatment received|0|||
127762665|NCT00589121|459756086|FG001|Overall Study|No protocol treatment received|1|||
127762666|NCT00847808|459756088|FG000|Overall Study|Adverse Event|7|||
127762667|NCT00847808|459756088|FG000|Overall Study|Protocol Violation|1|||
127762668|NCT00847808|459756088|FG000|Overall Study|Lost to Follow-up|1|||
127762669|NCT00847808|459756088|FG000|Overall Study|Withdrawal by Subject|4|||
127762670|NCT00847808|459756088|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
127762671|NCT00847808|459756088|FG000|Overall Study|Participant Took Excluded Medication|1|||
127762672|NCT01758900|459756095|FG000|Overall Study|difficulty for further intubation|7|||
127762673|NCT01758900|459756096|FG001|Overall Study|difficulty for further intubation|8|||
127762674|NCT01892540|459756098|FG000|Overall Study|Did not complete PET/MRI|0|||
127762675|NCT01892540|459756099|FG001|Overall Study|Did not complete PET/MRI|0|||
127762676|NCT01892540|459756100|FG002|Overall Study|Did not complete PET/MRI|2|||
127762677|NCT01892540|459756098|FG000|Overall Study|Did not fit in scanner|0|||
127762678|NCT01892540|459756099|FG001|Overall Study|Did not fit in scanner|0|||
127762679|NCT01892540|459756100|FG002|Overall Study|Did not fit in scanner|1|||
128009022|NCT01232283|460660624|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
128009023|NCT01232283|460660625|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
128009024|NCT01232283|460660626|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
127762680|NCT01370590|459756101|FG000|Period 1|Adverse Event|8|||
127762681|NCT01370590|459756102|FG001|Period 1|Adverse Event|4|||
127762682|NCT01370590|459756101|FG000|Period 1|Lost to Follow-up|2|||
127762683|NCT01370590|459756102|FG001|Period 1|Lost to Follow-up|2|||
127762684|NCT01370590|459756101|FG000|Period 1|Protocol Violation|2|||
127762685|NCT01370590|459756102|FG001|Period 1|Protocol Violation|2|||
128009025|NCT01232283|460660617|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
128009026|NCT01232283|460660618|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
128009027|NCT01232283|460660619|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
128009028|NCT01232283|460660620|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
128009029|NCT01232283|460660621|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
128009030|NCT01232283|460660622|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
128009031|NCT01232283|460660623|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
128009032|NCT01232283|460660624|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
128009033|NCT01232283|460660625|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
128009034|NCT01232283|460660626|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
128009035|NCT01232283|460660617|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
128009036|NCT01232283|460660618|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
127675164|NCT00462943|459434384|FG001|Overall Study|Failure to achieve a response|5|||
127675165|NCT00462943|459434385|FG002|Overall Study|Failure to achieve a response|1|||
127675166|NCT00462943|459434383|FG000|Overall Study|Adverse Event|6|||
127675167|NCT00462943|459434384|FG001|Overall Study|Adverse Event|4|||
127675168|NCT00462943|459434385|FG002|Overall Study|Adverse Event|1|||
127675169|NCT00462943|459434383|FG000|Overall Study|Protocol Violation|1|||
127675170|NCT00462943|459434384|FG001|Overall Study|Protocol Violation|0|||
127675171|NCT00462943|459434385|FG002|Overall Study|Protocol Violation|0|||
127675172|NCT00462943|459434383|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
127675173|NCT00462943|459434384|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
127675174|NCT00462943|459434385|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
127675175|NCT00462943|459434383|FG000|Overall Study|Disease Progression|15|||
127675176|NCT00462943|459434384|FG001|Overall Study|Disease Progression|15|||
127675177|NCT00462943|459434385|FG002|Overall Study|Disease Progression|9|||
127675178|NCT00462943|459434383|FG000|Overall Study|Death|5|||
127675179|NCT00462943|459434384|FG001|Overall Study|Death|2|||
127675180|NCT00462943|459434385|FG002|Overall Study|Death|7|||
127675181|NCT00462943|459434383|FG000|Overall Study|Stem Cell Transplant|1|||
127675182|NCT00462943|459434384|FG001|Overall Study|Stem Cell Transplant|1|||
127675183|NCT00462943|459434385|FG002|Overall Study|Stem Cell Transplant|0|||
127675184|NCT00462943|459434383|FG000|Overall Study|Bone Marrow Transplant|1|||
127675185|NCT00462943|459434384|FG001|Overall Study|Bone Marrow Transplant|0|||
127675186|NCT00462943|459434385|FG002|Overall Study|Bone Marrow Transplant|0|||
127675187|NCT00462943|459434383|FG000|Overall Study|Required Lymphocyte Infusion|1|||
127675188|NCT00462943|459434384|FG001|Overall Study|Required Lymphocyte Infusion|0|||
127675189|NCT00462943|459434385|FG002|Overall Study|Required Lymphocyte Infusion|0|||
127675190|NCT00462943|459434383|FG000|Overall Study|Transplant - not specified|1|||
127675191|NCT00462943|459434384|FG001|Overall Study|Transplant - not specified|0|||
127675192|NCT00462943|459434385|FG002|Overall Study|Transplant - not specified|1|||
127675193|NCT00462943|459434383|FG000|Overall Study|Physician Decision|1|||
127675194|NCT00462943|459434384|FG001|Overall Study|Physician Decision|0|||
127675195|NCT00462943|459434385|FG002|Overall Study|Physician Decision|0|||
127675196|NCT00462943|459434383|FG000|Overall Study|Withdrawal by Subject|0|||
127675197|NCT00462943|459434384|FG001|Overall Study|Withdrawal by Subject|1|||
127675198|NCT00462943|459434385|FG002|Overall Study|Withdrawal by Subject|0|||
127675199|NCT00813488|459434391|FG000|Titration Period 1|Adverse Event|6|||
127675200|NCT00813488|459434392|FG001|Titration Period 1|Adverse Event|1|||
127675201|NCT00813488|459434391|FG000|Titration Period 1|Lack of Efficacy|9|||
127675202|NCT00813488|459434392|FG001|Titration Period 1|Lack of Efficacy|7|||
127675203|NCT00813488|459434391|FG000|Titration Period 1|Withdrawal by Subject|2|||
127675204|NCT00813488|459434392|FG001|Titration Period 1|Withdrawal by Subject|2|||
127675205|NCT00813488|459434391|FG000|Titration Period 1|Protocol Violation|4|||
127675206|NCT00813488|459434392|FG001|Titration Period 1|Protocol Violation|3|||
127675207|NCT00813488|459434391|FG000|Titration Period 1|Non-compliance to study medication|4|||
127675208|NCT00813488|459434392|FG001|Titration Period 1|Non-compliance to study medication|1|||
127675209|NCT00813488|459434391|FG000|Titration Period 1|Non-compliance to study procedures|2|||
127675210|NCT00813488|459434392|FG001|Titration Period 1|Non-compliance to study procedures|2|||
127675211|NCT00813488|459434391|FG000|Titration Period 1|Technical Difficulties|0|||
127675212|NCT00813488|459434392|FG001|Titration Period 1|Technical Difficulties|1|||
127675213|NCT00813488|459434391|FG000|Titration Period 2|Adverse Event|2|||
127675214|NCT00813488|459434392|FG001|Titration Period 2|Adverse Event|3|||
127675215|NCT00813488|459434391|FG000|Titration Period 2|Lack of Efficacy|8|||
127675216|NCT00813488|459434392|FG001|Titration Period 2|Lack of Efficacy|4|||
127675217|NCT00813488|459434391|FG000|Titration Period 2|Protocol Violation|3|||
127675218|NCT00813488|459434392|FG001|Titration Period 2|Protocol Violation|2|||
127675219|NCT00813488|459434391|FG000|Titration Period 2|Lost to Follow-up|1|||
127675220|NCT00813488|459434392|FG001|Titration Period 2|Lost to Follow-up|0|||
127675221|NCT00813488|459434391|FG000|Titration Period 2|Non-compliance with study procedures|2|||
127675222|NCT00813488|459434392|FG001|Titration Period 2|Non-compliance with study procedures|1|||
127675223|NCT00813488|459434391|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
127675224|NCT00813488|459434392|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
127762686|NCT01370590|459756101|FG000|Period 1|Withdrawal by Subject|4|||
128009037|NCT01232283|460660619|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
128009038|NCT01232283|460660620|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
128009039|NCT01232283|460660621|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
128009040|NCT01232283|460660622|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
128009041|NCT01232283|460660623|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
128009042|NCT01232283|460660624|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
128009043|NCT01232283|460660625|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
128009044|NCT01232283|460660626|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
128009045|NCT01232283|460660617|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
128009046|NCT01232283|460660618|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
128009047|NCT01232283|460660619|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
128009048|NCT01232283|460660620|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
128009049|NCT01232283|460660621|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
128009050|NCT01232283|460660622|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
128009051|NCT01232283|460660623|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
128009052|NCT01232283|460660624|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
128009053|NCT01232283|460660625|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
128009054|NCT01232283|460660626|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
128009055|NCT01232283|460660617|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
128009056|NCT01232283|460660618|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
128009057|NCT01232283|460660619|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
128009058|NCT01232283|460660620|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
128009059|NCT01232283|460660621|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
128009060|NCT01232283|460660622|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
128009061|NCT01232283|460660623|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
128009062|NCT01232283|460660624|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
128009063|NCT01232283|460660625|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
128009064|NCT01232283|460660626|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
128009065|NCT01232283|460660617|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
128009066|NCT01232283|460660618|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
127762687|NCT01370590|459756102|FG001|Period 1|Withdrawal by Subject|2|||
127762688|NCT01370590|459756101|FG000|Period 1|Could not access randomization system|0|||
127762689|NCT01370590|459756102|FG001|Period 1|Could not access randomization system|1|||
127762690|NCT01370590|459756101|FG000|Crossover Washout Period|Adverse Event|1|||
127762691|NCT01370590|459756102|FG001|Crossover Washout Period|Adverse Event|4|||
127762692|NCT01370590|459756101|FG000|Crossover Washout Period|Lost to Follow-up|2|||
127762693|NCT01370590|459756102|FG001|Crossover Washout Period|Lost to Follow-up|0|||
127762694|NCT01370590|459756101|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
127762695|NCT01370590|459756102|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
127762696|NCT01370590|459756101|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
127762697|NCT01370590|459756102|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
127762698|NCT01370590|459756101|FG000|Period 2|Adverse Event|0|||
127762699|NCT01370590|459756102|FG001|Period 2|Adverse Event|1|||
127762700|NCT01370590|459756101|FG000|Period 2|Withdrawal by Subject|1|||
127762701|NCT01370590|459756102|FG001|Period 2|Withdrawal by Subject|1|||
127762702|NCT05172050|459756103|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
127762703|NCT05172050|459756104|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
127762704|NCT05172050|459756105|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
127762705|NCT05172050|459756103|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
127762706|NCT05172050|459756104|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
127762707|NCT05172050|459756105|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
127762708|NCT05172050|459756103|FG000|Overall Study|Other|2|||
127762709|NCT05172050|459756104|FG001|Overall Study|Other|2|||
127762710|NCT05172050|459756105|FG002|Overall Study|Other|1|||
127762711|NCT00604825|459756106|FG000|Overall Study|Adverse Event|2|||
127762712|NCT00604825|459756107|FG001|Overall Study|Adverse Event|6|||
127762713|NCT00604825|459756108|FG002|Overall Study|Adverse Event|7|||
127762714|NCT00604825|459756109|FG003|Overall Study|Adverse Event|4|||
127762715|NCT00604825|459756106|FG000|Overall Study|Lost to Follow-up|0|||
127762716|NCT00604825|459756107|FG001|Overall Study|Lost to Follow-up|3|||
127543546|NCT02718898|458956553|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
127543547|NCT02718898|458956554|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
127762717|NCT00604825|459756108|FG002|Overall Study|Lost to Follow-up|1|||
127762718|NCT00604825|459756109|FG003|Overall Study|Lost to Follow-up|0|||
127762719|NCT00604825|459756106|FG000|Overall Study|Protocol Violation|0|||
128009067|NCT01232283|460660619|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
128009068|NCT01232283|460660620|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
127762720|NCT00604825|459756107|FG001|Overall Study|Protocol Violation|1|||
127762721|NCT00604825|459756108|FG002|Overall Study|Protocol Violation|0|||
127762722|NCT00604825|459756109|FG003|Overall Study|Protocol Violation|0|||
127762723|NCT00604825|459756106|FG000|Overall Study|Withdrawal by Subject|4|||
128009069|NCT01232283|460660621|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
127762724|NCT00604825|459756107|FG001|Overall Study|Withdrawal by Subject|3|||
127762725|NCT00604825|459756108|FG002|Overall Study|Withdrawal by Subject|5|||
127762726|NCT00604825|459756109|FG003|Overall Study|Withdrawal by Subject|5|||
127762727|NCT00604825|459756106|FG000|Overall Study|Lack of Efficacy|3|||
127762728|NCT00604825|459756107|FG001|Overall Study|Lack of Efficacy|2|||
127762729|NCT00604825|459756108|FG002|Overall Study|Lack of Efficacy|1|||
127762730|NCT00604825|459756109|FG003|Overall Study|Lack of Efficacy|0|||
127762731|NCT00604825|459756106|FG000|Overall Study|Did not meet eligibility criteria|0|||
127762732|NCT00604825|459756107|FG001|Overall Study|Did not meet eligibility criteria|0|||
127762733|NCT00604825|459756108|FG002|Overall Study|Did not meet eligibility criteria|2|||
127762734|NCT00604825|459756109|FG003|Overall Study|Did not meet eligibility criteria|0|||
127762735|NCT00604825|459756106|FG000|Overall Study|Physician Decision|0|||
127762736|NCT00604825|459756107|FG001|Overall Study|Physician Decision|0|||
127762737|NCT00604825|459756108|FG002|Overall Study|Physician Decision|0|||
127762738|NCT00604825|459756109|FG003|Overall Study|Physician Decision|1|||
127762739|NCT00604825|459756106|FG000|Overall Study|Exclusion criterion met|0|||
127762740|NCT00604825|459756107|FG001|Overall Study|Exclusion criterion met|0|||
127762741|NCT00604825|459756108|FG002|Overall Study|Exclusion criterion met|0|||
127762742|NCT00604825|459756109|FG003|Overall Study|Exclusion criterion met|1|||
127762743|NCT04617275|459756110|FG000|Treatment Period|Adverse Event|1|||
127762744|NCT04617275|459756111|FG001|Treatment Period|Adverse Event|6|||
127762745|NCT04617275|459756112|FG002|Treatment Period|Adverse Event|4|||
127762746|NCT04617275|459756113|FG003|Treatment Period|Adverse Event|6|||
127762747|NCT04617275|459756114|FG004|Treatment Period|Adverse Event|7|||
127762748|NCT04617275|459756115|FG005|Treatment Period|Adverse Event|8|||
127762749|NCT04617275|459756116|FG006|Treatment Period|Adverse Event|0|||
127762750|NCT04617275|459756117|FG007|Treatment Period|Adverse Event|12|||
127762751|NCT04617275|459756110|FG000|Treatment Period|Lost to Follow-up|0|||
127762752|NCT04617275|459756111|FG001|Treatment Period|Lost to Follow-up|0|||
127762753|NCT04617275|459756112|FG002|Treatment Period|Lost to Follow-up|2|||
127762754|NCT04617275|459756113|FG003|Treatment Period|Lost to Follow-up|0|||
127762755|NCT04617275|459756114|FG004|Treatment Period|Lost to Follow-up|0|||
127762756|NCT04617275|459756115|FG005|Treatment Period|Lost to Follow-up|3|||
128009070|NCT01232283|460660622|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
128009071|NCT01232283|460660623|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
128009072|NCT01232283|460660624|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
128009073|NCT01232283|460660625|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
128009074|NCT01232283|460660626|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
128009075|NCT01232283|460660617|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
128009076|NCT01232283|460660618|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
128009077|NCT01232283|460660619|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
128009078|NCT01232283|460660620|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
128009079|NCT01232283|460660621|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
127675225|NCT00813488|459434391|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
127675226|NCT00813488|459434392|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
127675227|NCT00813488|459434391|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
127675228|NCT00813488|459434392|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
127675229|NCT00813488|459434391|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
127675230|NCT00813488|459434392|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
127675231|NCT00813488|459434391|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
127675232|NCT00813488|459434392|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
127675233|NCT00813488|459434391|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
127675234|NCT00813488|459434392|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
127675235|NCT00813488|459434391|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
127675236|NCT00813488|459434392|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
127675237|NCT00813488|459434391|FG000|Double-blind Treatment Period 2|Other|1|||
127675238|NCT00813488|459434392|FG001|Double-blind Treatment Period 2|Other|0|||
127675239|NCT00813488|459434391|FG000|Open-label Extension|Adverse Event|1|||
127675240|NCT00813488|459434392|FG001|Open-label Extension|Adverse Event|2|||
127675241|NCT00813488|459434391|FG000|Open-label Extension|Lack of Efficacy|3|||
127675242|NCT00813488|459434392|FG001|Open-label Extension|Lack of Efficacy|0|||
127675243|NCT00813488|459434391|FG000|Open-label Extension|Withdrawal by Subject|0|||
127675244|NCT00813488|459434392|FG001|Open-label Extension|Withdrawal by Subject|2|||
127675245|NCT00813488|459434391|FG000|Open-label Extension|Protocol Violation|1|||
127675246|NCT00813488|459434392|FG001|Open-label Extension|Protocol Violation|2|||
127675247|NCT00813488|459434391|FG000|Open-label Extension|Non-compliance study medication|4|||
127675248|NCT00813488|459434392|FG001|Open-label Extension|Non-compliance study medication|0|||
127675249|NCT00813488|459434391|FG000|Open-label Extension|Non-compliance study procedures|2|||
127675250|NCT00813488|459434392|FG001|Open-label Extension|Non-compliance study procedures|1|||
127762757|NCT04617275|459756116|FG006|Treatment Period|Lost to Follow-up|0|||
127762758|NCT04617275|459756117|FG007|Treatment Period|Lost to Follow-up|2|||
127762759|NCT04617275|459756110|FG000|Treatment Period|No longer meets eligibility criteria|0|||
128009080|NCT01232283|460660622|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
128009081|NCT01232283|460660623|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
128009082|NCT01232283|460660624|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
128009083|NCT01232283|460660625|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
128009084|NCT01232283|460660626|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
128009085|NCT01232283|460660617|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
128009086|NCT01232283|460660618|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
128009087|NCT01232283|460660619|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
128009088|NCT01232283|460660620|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
128009089|NCT01232283|460660621|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
128009090|NCT01232283|460660622|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
128009091|NCT01232283|460660623|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
128009092|NCT01232283|460660624|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
128009093|NCT01232283|460660625|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
128009094|NCT01232283|460660626|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
128009095|NCT01232283|460660617|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
127762760|NCT04617275|459756111|FG001|Treatment Period|No longer meets eligibility criteria|0|||
127762761|NCT04617275|459756112|FG002|Treatment Period|No longer meets eligibility criteria|0|||
127762762|NCT04617275|459756113|FG003|Treatment Period|No longer meets eligibility criteria|1|||
128009096|NCT01232283|460660618|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
128009097|NCT01232283|460660619|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
128009098|NCT01232283|460660620|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
128009099|NCT01232283|460660621|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
127675251|NCT00813488|459434391|FG000|Open-label Extension|Other|1|||
127675252|NCT00813488|459434392|FG001|Open-label Extension|Other|0|||
127675253|NCT01729871|459434394|FG000|Overall Study|Adverse Event|7|||
127675254|NCT01729871|459434395|FG001|Overall Study|Adverse Event|7|||
127675255|NCT01729871|459434394|FG000|Overall Study|Death|0|||
127675256|NCT01729871|459434395|FG001|Overall Study|Death|1|||
127675257|NCT01729871|459434394|FG000|Overall Study|Lack of Efficacy|0|||
127675258|NCT01729871|459434395|FG001|Overall Study|Lack of Efficacy|1|||
127675259|NCT01729871|459434394|FG000|Overall Study|Physician Decision|0|||
127675260|NCT01729871|459434395|FG001|Overall Study|Physician Decision|2|||
127675261|NCT01729871|459434394|FG000|Overall Study|Protocol Violation|1|||
127675262|NCT01729871|459434395|FG001|Overall Study|Protocol Violation|0|||
127675263|NCT01729871|459434394|FG000|Overall Study|Withdrawal by Subject|0|||
127675264|NCT01729871|459434395|FG001|Overall Study|Withdrawal by Subject|3|||
127675265|NCT01729871|459434394|FG000|Overall Study|Other|4|||
127675266|NCT01729871|459434395|FG001|Overall Study|Other|9|||
127675267|NCT01143077|459434396|FG000|Overall Study|Lack of Efficacy|0|||
127675268|NCT01143077|459434397|FG001|Overall Study|Lack of Efficacy|2|||
127675269|NCT01143077|459434398|FG002|Overall Study|Lack of Efficacy|1|||
127675270|NCT01143077|459434396|FG000|Overall Study|Adverse Event|5|||
127675271|NCT01143077|459434397|FG001|Overall Study|Adverse Event|6|||
127675272|NCT01143077|459434398|FG002|Overall Study|Adverse Event|5|||
127675273|NCT01143077|459434396|FG000|Overall Study|Lost to Follow-up|2|||
127675274|NCT01143077|459434397|FG001|Overall Study|Lost to Follow-up|3|||
127675275|NCT01143077|459434398|FG002|Overall Study|Lost to Follow-up|4|||
127675276|NCT01143077|459434396|FG000|Overall Study|Protocol Violation|2|||
127675277|NCT01143077|459434397|FG001|Overall Study|Protocol Violation|0|||
127675278|NCT01143077|459434398|FG002|Overall Study|Protocol Violation|0|||
127675279|NCT01143077|459434396|FG000|Overall Study|Withdrawal by Subject|4|||
127675280|NCT01143077|459434397|FG001|Overall Study|Withdrawal by Subject|3|||
127675281|NCT01143077|459434398|FG002|Overall Study|Withdrawal by Subject|3|||
127675282|NCT01143077|459434396|FG000|Overall Study|Non-compliance with study drug|0|||
127675283|NCT01143077|459434397|FG001|Overall Study|Non-compliance with study drug|1|||
127675284|NCT01143077|459434398|FG002|Overall Study|Non-compliance with study drug|1|||
127675285|NCT01143077|459434396|FG000|Overall Study|Administrative|1|||
127675286|NCT01143077|459434397|FG001|Overall Study|Administrative|0|||
127675287|NCT01143077|459434398|FG002|Overall Study|Administrative|0|||
127675288|NCT01143077|459434396|FG000|Overall Study|Principal Investigator Decision|2|||
127675289|NCT01143077|459434397|FG001|Overall Study|Principal Investigator Decision|0|||
127675290|NCT01143077|459434398|FG002|Overall Study|Principal Investigator Decision|1|||
127675291|NCT00871429|459434403|FG000|Overall Study|Lost to Follow-up|6|||
127675292|NCT00871429|459434403|FG000|Overall Study|Withdrawal by Subject|17|||
127675293|NCT00871429|459434403|FG000|Overall Study|Questionnaire not completed|1|||
127675294|NCT01772719|459434407|FG000|Overall Study|Withdrawal by Subject|3|||
127675295|NCT01772719|459434407|FG000|Overall Study|Adverse Event|2|||
127675296|NCT01772719|459434407|FG000|Overall Study|Protocol Violation|1|||
127675297|NCT01772719|459434407|FG000|Overall Study|Lost to Follow-up|1|||
127675298|NCT00477412|459434408|FG000|Overall Study|Death|0|||
127675299|NCT00477412|459434409|FG001|Overall Study|Death|0|||
127675300|NCT00477412|459434410|FG002|Overall Study|Death|0|||
127675301|NCT00477412|459434411|FG003|Overall Study|Death|4|||
127675302|NCT00477412|459434408|FG000|Overall Study|Lost to Follow-up|0|||
128009100|NCT01232283|460660622|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
128009101|NCT01232283|460660623|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
128009102|NCT01232283|460660624|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
128009103|NCT01232283|460660625|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
128009104|NCT01232283|460660626|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
128009105|NCT01232283|460660617|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
128009106|NCT01232283|460660618|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
128009107|NCT01232283|460660619|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
128009108|NCT01232283|460660620|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
128009109|NCT01232283|460660621|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
128009110|NCT01232283|460660622|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
128009111|NCT01232283|460660623|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
128009112|NCT01232283|460660624|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
128009113|NCT01232283|460660625|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
128009114|NCT01232283|460660626|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
128009115|NCT01232283|460660617|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
128009116|NCT01232283|460660618|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
128009117|NCT01232283|460660619|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
128009118|NCT01232283|460660620|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
127762763|NCT04617275|459756114|FG004|Treatment Period|No longer meets eligibility criteria|0|||
127762764|NCT04617275|459756115|FG005|Treatment Period|No longer meets eligibility criteria|0|||
127762765|NCT04617275|459756116|FG006|Treatment Period|No longer meets eligibility criteria|0|||
127762766|NCT04617275|459756117|FG007|Treatment Period|No longer meets eligibility criteria|0|||
127762767|NCT04617275|459756110|FG000|Treatment Period|Other|0|||
127762768|NCT04617275|459756111|FG001|Treatment Period|Other|1|||
127762769|NCT04617275|459756112|FG002|Treatment Period|Other|0|||
127762770|NCT04617275|459756113|FG003|Treatment Period|Other|0|||
127762771|NCT04617275|459756114|FG004|Treatment Period|Other|0|||
127762772|NCT04617275|459756115|FG005|Treatment Period|Other|0|||
127762773|NCT04617275|459756116|FG006|Treatment Period|Other|0|||
127762774|NCT04617275|459756117|FG007|Treatment Period|Other|0|||
127762775|NCT04617275|459756110|FG000|Treatment Period|Withdrawal by Subject|2|||
127762776|NCT04617275|459756111|FG001|Treatment Period|Withdrawal by Subject|0|||
127762777|NCT04617275|459756112|FG002|Treatment Period|Withdrawal by Subject|0|||
127762778|NCT04617275|459756113|FG003|Treatment Period|Withdrawal by Subject|2|||
127762779|NCT04617275|459756114|FG004|Treatment Period|Withdrawal by Subject|2|||
127762780|NCT04617275|459756115|FG005|Treatment Period|Withdrawal by Subject|0|||
127762781|NCT04617275|459756116|FG006|Treatment Period|Withdrawal by Subject|1|||
127762782|NCT04617275|459756117|FG007|Treatment Period|Withdrawal by Subject|2|||
127762783|NCT04617275|459756110|FG000|Follow-up Period|Adverse Event|1|||
127762784|NCT04617275|459756111|FG001|Follow-up Period|Adverse Event|1|||
127762785|NCT04617275|459756112|FG002|Follow-up Period|Adverse Event|2|||
127762786|NCT04617275|459756113|FG003|Follow-up Period|Adverse Event|3|||
127762787|NCT04617275|459756114|FG004|Follow-up Period|Adverse Event|4|||
127762788|NCT04617275|459756115|FG005|Follow-up Period|Adverse Event|3|||
127762789|NCT04617275|459756116|FG006|Follow-up Period|Adverse Event|0|||
127762790|NCT04617275|459756117|FG007|Follow-up Period|Adverse Event|3|||
127762791|NCT04617275|459756110|FG000|Follow-up Period|Lost to Follow-up|0|||
127762792|NCT04617275|459756111|FG001|Follow-up Period|Lost to Follow-up|1|||
127762793|NCT04617275|459756112|FG002|Follow-up Period|Lost to Follow-up|2|||
128009119|NCT01232283|460660621|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
128009120|NCT01232283|460660622|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
128009121|NCT01232283|460660623|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
128009122|NCT01232283|460660624|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
128009123|NCT01232283|460660625|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
128009124|NCT01232283|460660626|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
128009125|NCT01232283|460660617|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
128009126|NCT01232283|460660618|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
128009127|NCT01232283|460660619|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
128009128|NCT01232283|460660620|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
128009129|NCT01232283|460660621|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
128009130|NCT01232283|460660622|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
127543548|NCT02718898|458956555|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
127543549|NCT02718898|458956556|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
127762794|NCT04617275|459756113|FG003|Follow-up Period|Lost to Follow-up|0|||
127762795|NCT04617275|459756114|FG004|Follow-up Period|Lost to Follow-up|0|||
127762796|NCT04617275|459756115|FG005|Follow-up Period|Lost to Follow-up|4|||
127762797|NCT04617275|459756116|FG006|Follow-up Period|Lost to Follow-up|0|||
127762798|NCT04617275|459756117|FG007|Follow-up Period|Lost to Follow-up|3|||
127762799|NCT04617275|459756110|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
127762800|NCT04617275|459756111|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
128009131|NCT01232283|460660623|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
128009132|NCT01232283|460660624|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
128009133|NCT01232283|460660625|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
128009134|NCT01232283|460660626|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
128009135|NCT01232283|460660617|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
128009136|NCT01232283|460660618|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
128009137|NCT01232283|460660619|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
128009138|NCT01232283|460660620|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
128009139|NCT01232283|460660621|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
128009140|NCT01232283|460660622|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
128009141|NCT01232283|460660623|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
128009142|NCT01232283|460660624|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
128009143|NCT01232283|460660625|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
128009144|NCT01232283|460660626|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
128009145|NCT01232283|460660617|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
128009146|NCT01232283|460660618|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
128009147|NCT01232283|460660619|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
128009148|NCT01232283|460660620|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
128009149|NCT01232283|460660621|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
128009150|NCT01232283|460660622|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
128009151|NCT01232283|460660623|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
128009152|NCT01232283|460660624|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
128009153|NCT01232283|460660625|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
128009154|NCT01232283|460660626|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
128009155|NCT01232283|460660617|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
128009156|NCT01232283|460660618|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
128009157|NCT01232283|460660619|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
128009158|NCT01232283|460660620|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
128009159|NCT01232283|460660621|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
128009160|NCT01232283|460660622|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
128009161|NCT01232283|460660623|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
128009162|NCT01232283|460660624|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
128009163|NCT01232283|460660625|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
128009164|NCT01232283|460660626|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
128009165|NCT01232283|460660617|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
128009166|NCT01232283|460660618|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
128009167|NCT01232283|460660619|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
128009168|NCT01232283|460660620|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
128009169|NCT01232283|460660621|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
128009170|NCT01232283|460660622|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
128009171|NCT01232283|460660623|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
128009172|NCT01232283|460660624|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
128009173|NCT01232283|460660625|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
128009174|NCT01232283|460660626|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
128009175|NCT01232283|460660617|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
128009176|NCT01232283|460660618|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
128009177|NCT01232283|460660619|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
128009178|NCT01232283|460660620|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
128009179|NCT01232283|460660621|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
128009180|NCT01232283|460660622|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
128009181|NCT01232283|460660623|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
128009182|NCT01232283|460660624|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
128009183|NCT01232283|460660625|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
128009184|NCT01232283|460660626|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
128009185|NCT01232283|460660617|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
128009186|NCT01232283|460660618|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
128009187|NCT01232283|460660619|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
128009188|NCT01232283|460660620|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
128009189|NCT01232283|460660621|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
128009190|NCT01232283|460660622|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
128009191|NCT01232283|460660623|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
128009192|NCT01232283|460660624|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
128009193|NCT01232283|460660625|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
128009194|NCT01232283|460660626|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
128009195|NCT01232283|460660617|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
128009196|NCT01232283|460660618|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
127675303|NCT00477412|459434409|FG001|Overall Study|Lost to Follow-up|0|||
127675304|NCT00477412|459434410|FG002|Overall Study|Lost to Follow-up|0|||
127675305|NCT00477412|459434411|FG003|Overall Study|Lost to Follow-up|1|||
127675306|NCT00477412|459434408|FG000|Overall Study|Withdrawal by Subject|0|||
127675307|NCT00477412|459434409|FG001|Overall Study|Withdrawal by Subject|0|||
127675308|NCT00477412|459434410|FG002|Overall Study|Withdrawal by Subject|0|||
127675309|NCT00477412|459434411|FG003|Overall Study|Withdrawal by Subject|2|||
127675310|NCT00477412|459434408|FG000|Overall Study|Second Malignancy|0|||
127675311|NCT00477412|459434409|FG001|Overall Study|Second Malignancy|0|||
127675312|NCT00477412|459434410|FG002|Overall Study|Second Malignancy|0|||
127675313|NCT00477412|459434411|FG003|Overall Study|Second Malignancy|1|||
127675314|NCT00477412|459434408|FG000|Overall Study|Adverse Event|1|||
127675315|NCT00477412|459434409|FG001|Overall Study|Adverse Event|0|||
127675316|NCT00477412|459434410|FG002|Overall Study|Adverse Event|1|||
127675317|NCT00477412|459434411|FG003|Overall Study|Adverse Event|0|||
127675318|NCT03820986|459434413|FG000|Overall Study|Death|177|||
127675319|NCT03820986|459434414|FG001|Overall Study|Death|156|||
127675320|NCT03820986|459434413|FG000|Overall Study|Lost to Follow-up|0|||
127675321|NCT03820986|459434414|FG001|Overall Study|Lost to Follow-up|1|||
127675322|NCT03820986|459434413|FG000|Overall Study|Withdrawal by Subject|8|||
127675323|NCT03820986|459434414|FG001|Overall Study|Withdrawal by Subject|3|||
127675324|NCT03820986|459434413|FG000|Overall Study|Ongoing|149|||
127675325|NCT03820986|459434414|FG001|Overall Study|Ongoing|180|||
127675326|NCT01677936|459435763|FG000|Overall Study|Lost to Follow-up|4|||
127675327|NCT01677936|459435764|FG001|Overall Study|Lost to Follow-up|1|||
127675328|NCT01677936|459435763|FG000|Overall Study|Protocol Violation|3|||
127675329|NCT01677936|459435764|FG001|Overall Study|Protocol Violation|0|||
127675330|NCT01677936|459435763|FG000|Overall Study|Adverse Event|1|||
127675331|NCT01677936|459435764|FG001|Overall Study|Adverse Event|0|||
127675332|NCT01677936|459435763|FG000|Overall Study|Lost to Follow-up|1|||
127675333|NCT01677936|459435764|FG001|Overall Study|Lost to Follow-up|0|||
127675334|NCT01677936|459435763|FG000|Overall Study|Protocol Violation|0|||
127675335|NCT01677936|459435764|FG001|Overall Study|Protocol Violation|4|||
127675336|NCT04358549|459435765|FG000|Overall Study|Adverse Event|0|||
127675337|NCT04358549|459435766|FG001|Overall Study|Adverse Event|1|||
127675338|NCT04358549|459435765|FG000|Overall Study|Death|1|||
127675339|NCT04358549|459435766|FG001|Overall Study|Death|0|||
127675340|NCT04358549|459435765|FG000|Overall Study|Lost to Follow-up|2|||
127675341|NCT04358549|459435766|FG001|Overall Study|Lost to Follow-up|1|||
127675342|NCT04358549|459435765|FG000|Overall Study|Withdrawal by Subject|6|||
127675343|NCT04358549|459435766|FG001|Overall Study|Withdrawal by Subject|6|||
127675344|NCT04358549|459435765|FG000|Overall Study|Start remdesivir|1|||
127675345|NCT04358549|459435766|FG001|Overall Study|Start remdesivir|0|||
127675346|NCT01118377|459435767|FG000|Overall Study|Did Not Receive Study Medication|1|||
127675347|NCT01118377|459435767|FG000|Overall Study|Death|38|||
127675348|NCT01118377|459435767|FG000|Overall Study|Failure to Return|3|||
127675349|NCT04867902|459435768|FG000|Overall Study|Lost to Follow-up|1|||
127675350|NCT04867902|459435768|FG000|Overall Study|Withdrawal by Subject|2|||
127675351|NCT04867902|459435768|FG000|Overall Study|Protocol Violation|1|||
127675352|NCT00470626|459435771|FG000|Overall Study|Lost to Follow-up|10|||
127675353|NCT00470626|459435771|FG000|Overall Study|Withdrawal by Subject|7|||
127675354|NCT01729819|459435774|FG000|Overall Study|Adverse Event|2|||
127675355|NCT01729819|459435775|FG001|Overall Study|Adverse Event|4|||
127675356|NCT01729819|459435774|FG000|Overall Study|Lack of Efficacy|1|||
127675357|NCT01729819|459435775|FG001|Overall Study|Lack of Efficacy|0|||
127675358|NCT01729819|459435774|FG000|Overall Study|Lost to Follow-up|2|||
127675359|NCT01729819|459435775|FG001|Overall Study|Lost to Follow-up|0|||
127675360|NCT01729819|459435774|FG000|Overall Study|Other reason|1|||
127675361|NCT01729819|459435775|FG001|Overall Study|Other reason|0|||
127675362|NCT01729819|459435774|FG000|Overall Study|Protocol Violation|0|||
127675363|NCT01729819|459435775|FG001|Overall Study|Protocol Violation|1|||
127675364|NCT01729819|459435774|FG000|Overall Study|Withdrawal by Subject|0|||
127675365|NCT01729819|459435775|FG001|Overall Study|Withdrawal by Subject|2|||
127675366|NCT00943605|459435776|FG000|Overall Study|Study termination|30|||
127675367|NCT00943605|459435777|FG001|Overall Study|Study termination|30|||
127675368|NCT03107611|459435781|FG000|Overall Study|Adverse Event|1|||
127762801|NCT04617275|459756112|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
127675369|NCT03107611|459435782|FG001|Overall Study|Adverse Event|0|||
127675370|NCT03107611|459435783|FG002|Overall Study|Adverse Event|2|||
127675371|NCT03107611|459435781|FG000|Overall Study|Lost to Follow-up|3|||
127675372|NCT03107611|459435782|FG001|Overall Study|Lost to Follow-up|3|||
127675373|NCT03107611|459435783|FG002|Overall Study|Lost to Follow-up|3|||
127675374|NCT03107611|459435781|FG000|Overall Study|Protocol Violation|0|||
127675375|NCT03107611|459435782|FG001|Overall Study|Protocol Violation|0|||
127675376|NCT03107611|459435783|FG002|Overall Study|Protocol Violation|1|||
127675377|NCT03107611|459435781|FG000|Overall Study|Withdrawal by Subject|1|||
127675378|NCT03107611|459435782|FG001|Overall Study|Withdrawal by Subject|0|||
127762802|NCT04617275|459756113|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
127762803|NCT04617275|459756114|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
127762804|NCT04617275|459756115|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
127762805|NCT04617275|459756116|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
127762806|NCT04617275|459756117|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
127762807|NCT04617275|459756110|FG000|Follow-up Period|Other|0|||
127762808|NCT04617275|459756111|FG001|Follow-up Period|Other|1|||
127762809|NCT04617275|459756112|FG002|Follow-up Period|Other|0|||
127762810|NCT04617275|459756113|FG003|Follow-up Period|Other|0|||
127762811|NCT04617275|459756114|FG004|Follow-up Period|Other|0|||
127762812|NCT04617275|459756115|FG005|Follow-up Period|Other|0|||
127762813|NCT04617275|459756116|FG006|Follow-up Period|Other|0|||
127762814|NCT04617275|459756117|FG007|Follow-up Period|Other|0|||
127762815|NCT04617275|459756110|FG000|Follow-up Period|Withdrawal by Subject|2|||
127762816|NCT04617275|459756111|FG001|Follow-up Period|Withdrawal by Subject|0|||
127762817|NCT04617275|459756112|FG002|Follow-up Period|Withdrawal by Subject|0|||
127762818|NCT04617275|459756113|FG003|Follow-up Period|Withdrawal by Subject|2|||
127762819|NCT04617275|459756114|FG004|Follow-up Period|Withdrawal by Subject|2|||
127762820|NCT04617275|459756115|FG005|Follow-up Period|Withdrawal by Subject|0|||
127762821|NCT04617275|459756116|FG006|Follow-up Period|Withdrawal by Subject|1|||
127762822|NCT04617275|459756117|FG007|Follow-up Period|Withdrawal by Subject|2|||
127762823|NCT04927884|459756125|FG000|Overall Study|Progressive Disease|2|||
127762824|NCT05593445|459756126|FG000|12-Week DBVC Period|Adverse Event|1|||
127762825|NCT05593445|459756127|FG001|12-Week DBVC Period|Adverse Event|0|||
127762826|NCT05593445|459756128|FG002|12-Week DBVC Period|Adverse Event|0|||
127762827|NCT05593445|459756129|FG003|12-Week DBVC Period|Adverse Event|0|||
128009197|NCT01232283|460660619|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
128009198|NCT01232283|460660620|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
127762828|NCT05593445|459756126|FG000|12-Week DBVC Period|Physician Decision|0|||
127762829|NCT05593445|459756127|FG001|12-Week DBVC Period|Physician Decision|1|||
127762830|NCT05593445|459756128|FG002|12-Week DBVC Period|Physician Decision|0|||
127762831|NCT05593445|459756129|FG003|12-Week DBVC Period|Physician Decision|0|||
127762832|NCT05593445|459756126|FG000|12-Week DBVC Period|Protocol Violation|0|||
127762833|NCT05593445|459756127|FG001|12-Week DBVC Period|Protocol Violation|1|||
127762834|NCT05593445|459756128|FG002|12-Week DBVC Period|Protocol Violation|0|||
127762835|NCT05593445|459756129|FG003|12-Week DBVC Period|Protocol Violation|0|||
127762836|NCT05593445|459756126|FG000|12-Week DBVC Period|Withdrawal by Subject|0|||
127762837|NCT05593445|459756127|FG001|12-Week DBVC Period|Withdrawal by Subject|1|||
127762838|NCT05593445|459756128|FG002|12-Week DBVC Period|Withdrawal by Subject|0|||
127762839|NCT05593445|459756129|FG003|12-Week DBVC Period|Withdrawal by Subject|0|||
127762840|NCT05593445|459756126|FG000|12-Week DBVC Period|Did Not Meet Eligibility Criteria|1|||
127762841|NCT05593445|459756127|FG001|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
127762842|NCT05593445|459756128|FG002|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
127762843|NCT05593445|459756129|FG003|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
127762844|NCT05593445|459756126|FG000|12-Week Open-Label Extension Period|Adverse Event|0|||
127762845|NCT05593445|459756127|FG001|12-Week Open-Label Extension Period|Adverse Event|0|||
127762846|NCT05593445|459756128|FG002|12-Week Open-Label Extension Period|Adverse Event|1|||
127762847|NCT05593445|459756129|FG003|12-Week Open-Label Extension Period|Adverse Event|1|||
127762848|NCT05593445|459756126|FG000|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
127762849|NCT05593445|459756127|FG001|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
127762850|NCT05593445|459756128|FG002|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
128009199|NCT01232283|460660621|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
128009200|NCT01232283|460660622|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
128009201|NCT01232283|460660623|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
128009202|NCT01232283|460660624|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
128009203|NCT01232283|460660625|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
128009204|NCT01232283|460660626|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
128009205|NCT01232283|460660617|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
127762851|NCT05593445|459756129|FG003|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
127762852|NCT05593445|459756126|FG000|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
127762853|NCT05593445|459756127|FG001|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
127762854|NCT05593445|459756128|FG002|12-Week Open-Label Extension Period|Withdrawal by Subject|1|||
127762855|NCT05593445|459756129|FG003|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
127762856|NCT05559476|459756130|FG000|Overall Study|Adverse Event|2|||
128009206|NCT01232283|460660618|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
128009207|NCT01232283|460660619|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
127762857|NCT05559476|459756131|FG001|Overall Study|Adverse Event|0|||
127762858|NCT05559476|459756130|FG000|Overall Study|Lost to Follow-up|13|||
127762859|NCT05559476|459756131|FG001|Overall Study|Lost to Follow-up|12|||
127762860|NCT05559476|459756130|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|8|||
127762861|NCT05559476|459756131|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|14|||
127762862|NCT05559476|459756130|FG000|Overall Study|Other|0|||
128009208|NCT01232283|460660620|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
128009209|NCT01232283|460660621|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
128009210|NCT01232283|460660622|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
128009211|NCT01232283|460660623|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
127675379|NCT03107611|459435783|FG002|Overall Study|Withdrawal by Subject|1|||
127675380|NCT03107611|459435781|FG000|Overall Study|Worsening signs/symptoms|2|||
127675381|NCT03107611|459435782|FG001|Overall Study|Worsening signs/symptoms|1|||
127675382|NCT03107611|459435783|FG002|Overall Study|Worsening signs/symptoms|2|||
127675383|NCT01720446|459435784|FG000|Overall Study|Lost to Follow-up|12|||
127675384|NCT01720446|459435785|FG001|Overall Study|Lost to Follow-up|6|||
127675385|NCT01720446|459435786|FG002|Overall Study|Lost to Follow-up|16|||
127675386|NCT01720446|459435787|FG003|Overall Study|Lost to Follow-up|16|||
127675387|NCT01720446|459435784|FG000|Overall Study|Withdrawal by Subject|2|||
127675388|NCT01720446|459435785|FG001|Overall Study|Withdrawal by Subject|5|||
127675389|NCT01720446|459435786|FG002|Overall Study|Withdrawal by Subject|4|||
127675390|NCT01720446|459435787|FG003|Overall Study|Withdrawal by Subject|4|||
127675391|NCT04464421|459435788|FG000|Overall Study|Lost to Follow-up|2|||
127675392|NCT04464421|459435789|FG001|Overall Study|Lost to Follow-up|2|||
127675393|NCT01072357|459435792|FG000|Overall Study|Lost to Follow-up|0|||
127675394|NCT01072357|459435793|FG001|Overall Study|Lost to Follow-up|1|||
127675395|NCT00891618|459435794|FG000|Overall Study|Withdrawal by Subject|1|||
127675396|NCT01313182|459435795|FG000|Overall Study|Protocol Violation|66|||
127675397|NCT01313182|459435796|FG001|Overall Study|Protocol Violation|92|||
127675398|NCT01695317|459435797|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
127675399|NCT01695317|459435798|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
127675400|NCT01695317|459435797|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
127675401|NCT01695317|459435798|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
127675402|NCT00957229|459435800|FG000|Study Start|Adverse Event|0|||
127675403|NCT00957229|459435801|FG001|Study Start|Adverse Event|3|||
127675404|NCT00957229|459435800|FG000|Study Start|Disease Progression|1|||
127675405|NCT00957229|459435801|FG001|Study Start|Disease Progression|0|||
127675406|NCT00957229|459435800|FG000|Reallocated to or Continued Vismodegib|Death|1|||
127675407|NCT00957229|459435801|FG001|Reallocated to or Continued Vismodegib|Death|1|||
127675408|NCT00957229|459435800|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
127675409|NCT00957229|459435801|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
127675410|NCT00606580|459435802|FG000|Overall Study|Lost to Follow-up|1|||
127675411|NCT00606580|459435803|FG001|Overall Study|Lost to Follow-up|1|||
127675412|NCT00606580|459435804|FG002|Overall Study|Lost to Follow-up|4|||
127675413|NCT00606580|459435802|FG000|Overall Study|Clinical failures|1|||
127675414|NCT00606580|459435803|FG001|Overall Study|Clinical failures|0|||
127675415|NCT00606580|459435804|FG002|Overall Study|Clinical failures|12|||
127675416|NCT00606580|459435802|FG000|Overall Study|Withdrawal by investigator|0|||
127675417|NCT00606580|459435803|FG001|Overall Study|Withdrawal by investigator|1|||
127675418|NCT00606580|459435804|FG002|Overall Study|Withdrawal by investigator|6|||
127675419|NCT00606580|459435802|FG000|Overall Study|Withdrawal by Subject|0|||
127675420|NCT00606580|459435803|FG001|Overall Study|Withdrawal by Subject|1|||
127675421|NCT00606580|459435804|FG002|Overall Study|Withdrawal by Subject|0|||
127675422|NCT01250002|459435809|FG000|Overall Study|Change to open surgical procedure|4|||
127675423|NCT01250002|459435810|FG001|Overall Study|Change to open surgical procedure|3|||
127675424|NCT04044664|459435825|FG000|Stage 1|Adverse Event|3|||
127675425|NCT04044664|459435826|FG001|Stage 1|Adverse Event|3|||
127675426|NCT04044664|459435827|FG002|Stage 1|Adverse Event|1|||
127675427|NCT04044664|459435825|FG000|Stage 1|Lost to Follow-up|3|||
127675428|NCT04044664|459435826|FG001|Stage 1|Lost to Follow-up|2|||
127675429|NCT04044664|459435827|FG002|Stage 1|Lost to Follow-up|2|||
127675430|NCT04044664|459435825|FG000|Stage 1|Withdrawal by Subject|9|||
127675431|NCT04044664|459435826|FG001|Stage 1|Withdrawal by Subject|1|||
127675432|NCT04044664|459435827|FG002|Stage 1|Withdrawal by Subject|0|||
127675433|NCT04044664|459435825|FG000|Stage 1|noncompliance, personal reason|2|||
127675434|NCT04044664|459435826|FG001|Stage 1|noncompliance, personal reason|0|||
127675435|NCT04044664|459435827|FG002|Stage 1|noncompliance, personal reason|0|||
127675436|NCT04044664|459435825|FG000|Stage 1|randomization error|0|||
127675437|NCT04044664|459435826|FG001|Stage 1|randomization error|1|||
128009212|NCT01232283|460660624|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
128009213|NCT01232283|460660625|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
127675438|NCT04044664|459435827|FG002|Stage 1|randomization error|0|||
127675439|NCT04044664|459435825|FG000|Stage 2|Adverse Event|2|||
127675440|NCT04044664|459435826|FG001|Stage 2|Adverse Event|0|||
127675441|NCT04044664|459435827|FG002|Stage 2|Adverse Event|0|||
127675442|NCT04044664|459435825|FG000|Stage 2|Lost to Follow-up|3|||
127675443|NCT04044664|459435826|FG001|Stage 2|Lost to Follow-up|2|||
127675444|NCT04044664|459435827|FG002|Stage 2|Lost to Follow-up|1|||
127675445|NCT04044664|459435825|FG000|Stage 2|Withdrawal by Subject|3|||
127675446|NCT04044664|459435826|FG001|Stage 2|Withdrawal by Subject|0|||
127675447|NCT04044664|459435827|FG002|Stage 2|Withdrawal by Subject|0|||
127675448|NCT04044664|459435825|FG000|Stage 2|protocol deviation|1|||
127675449|NCT04044664|459435826|FG001|Stage 2|protocol deviation|0|||
127675450|NCT04044664|459435827|FG002|Stage 2|protocol deviation|0|||
127762863|NCT05559476|459756131|FG001|Overall Study|Other|2|||
127762864|NCT00727311|459756132|FG000|Overall Study|Did not receive drug|316|||
127762865|NCT00727311|459756132|FG000|Overall Study|Missing end of therapy data|205|||
127762866|NCT00727311|459756132|FG000|Overall Study|Adverse Event|58|||
127762867|NCT00727311|459756132|FG000|Overall Study|Lack of Efficacy|242|||
127762868|NCT00727311|459756132|FG000|Overall Study|Lost to Follow-up|73|||
127762869|NCT00727311|459756132|FG000|Overall Study|Withdrawal by Subject|77|||
127762870|NCT00727311|459756132|FG000|Overall Study|Other|97|||
127762871|NCT00727311|459756132|FG000|Overall Study|Multiple reasons|39|||
127762872|NCT00565851|459757428|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
127762873|NCT00565851|459757429|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
127762874|NCT00565851|459757430|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
127762875|NCT00565851|459757431|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
127762876|NCT00565851|459757432|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
127762877|NCT00565851|459757433|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
127762878|NCT00565851|459757434|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
127762879|NCT00565851|459757435|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
127762880|NCT00565851|459757428|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
127762881|NCT00565851|459757429|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
127762882|NCT00565851|459757430|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
127762883|NCT00565851|459757431|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
127762884|NCT00565851|459757432|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
127762885|NCT00565851|459757433|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
127762886|NCT00565851|459757434|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
127762887|NCT00565851|459757435|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
127762888|NCT00775463|459757438|FG000|Overall Study|Withdrawal by Subject|0|||
127762889|NCT00775463|459757439|FG001|Overall Study|Withdrawal by Subject|1|||
127762890|NCT00775463|459757438|FG000|Overall Study|Adverse Event|7|||
127762891|NCT00775463|459757439|FG001|Overall Study|Adverse Event|9|||
127762892|NCT00775463|459757438|FG000|Overall Study|Protocol Violation|2|||
127762893|NCT00775463|459757439|FG001|Overall Study|Protocol Violation|2|||
127762894|NCT00775463|459757438|FG000|Overall Study|Lost to Follow-up|1|||
127762895|NCT00775463|459757439|FG001|Overall Study|Lost to Follow-up|0|||
127762896|NCT00775463|459757438|FG000|Overall Study|Lack of Efficacy|1|||
127762897|NCT00775463|459757439|FG001|Overall Study|Lack of Efficacy|1|||
127762898|NCT00969709|459757440|FG000|Overall Study|Adverse Event|3|||
127762899|NCT00969709|459757441|FG001|Overall Study|Adverse Event|13|||
127762900|NCT00969709|459757442|FG002|Overall Study|Adverse Event|26|||
127762901|NCT00969709|459757443|FG003|Overall Study|Adverse Event|12|||
127762902|NCT00969709|459757440|FG000|Overall Study|Lack of Efficacy|7|||
127762903|NCT00969709|459757441|FG001|Overall Study|Lack of Efficacy|4|||
127762904|NCT00969709|459757442|FG002|Overall Study|Lack of Efficacy|1|||
127762905|NCT00969709|459757443|FG003|Overall Study|Lack of Efficacy|3|||
127762906|NCT00969709|459757440|FG000|Overall Study|Protocol Violation|9|||
127762907|NCT00969709|459757441|FG001|Overall Study|Protocol Violation|5|||
127762908|NCT00969709|459757442|FG002|Overall Study|Protocol Violation|9|||
127762909|NCT00969709|459757443|FG003|Overall Study|Protocol Violation|10|||
127762910|NCT00969709|459757440|FG000|Overall Study|Withdrawal by Subject|9|||
127762911|NCT00969709|459757441|FG001|Overall Study|Withdrawal by Subject|12|||
127762912|NCT00969709|459757442|FG002|Overall Study|Withdrawal by Subject|11|||
127762913|NCT00969709|459757443|FG003|Overall Study|Withdrawal by Subject|23|||
127762914|NCT00969709|459757440|FG000|Overall Study|Lost to Follow-up|10|||
127762915|NCT00969709|459757441|FG001|Overall Study|Lost to Follow-up|14|||
127762916|NCT00969709|459757442|FG002|Overall Study|Lost to Follow-up|8|||
127762917|NCT00969709|459757443|FG003|Overall Study|Lost to Follow-up|15|||
127762918|NCT00969709|459757440|FG000|Overall Study|Other reasons|0|||
127762919|NCT00969709|459757441|FG001|Overall Study|Other reasons|0|||
127762920|NCT00969709|459757442|FG002|Overall Study|Other reasons|3|||
127762921|NCT00969709|459757443|FG003|Overall Study|Other reasons|0|||
127762922|NCT01238900|459757444|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
127762923|NCT01238900|459757444|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
128009214|NCT01232283|460660626|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
128009215|NCT01232283|460660617|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
128009216|NCT01232283|460660618|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
127762924|NCT00266227|459757447|FG000|Initial Treatment|Adverse Event|0|||
127762925|NCT00266227|459757448|FG001|Initial Treatment|Adverse Event|0|||
127762926|NCT00266227|459757449|FG002|Initial Treatment|Adverse Event|13|||
127762927|NCT00266227|459757447|FG000|Initial Treatment|Lost to Follow-up|0|||
127762928|NCT00266227|459757448|FG001|Initial Treatment|Lost to Follow-up|0|||
127762929|NCT00266227|459757449|FG002|Initial Treatment|Lost to Follow-up|6|||
127762930|NCT00266227|459757447|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
127762931|NCT00266227|459757448|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
127762932|NCT00266227|459757449|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
127762933|NCT00266227|459757447|FG000|Initial Treatment|Physician decision to withdraw|0|||
127762934|NCT00266227|459757448|FG001|Initial Treatment|Physician decision to withdraw|0|||
128009217|NCT01232283|460660619|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
128009218|NCT01232283|460660620|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
128009219|NCT01232283|460660621|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
128009220|NCT01232283|460660622|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
127675451|NCT03736785|459435829|FG000|Overall Study|Adverse Event|1|||
127675452|NCT03736785|459435830|FG001|Overall Study|Adverse Event|1|||
127675453|NCT03736785|459435831|FG002|Overall Study|Adverse Event|1|||
127675454|NCT03736785|459435829|FG000|Overall Study|Death|1|||
127675455|NCT03736785|459435830|FG001|Overall Study|Death|0|||
127675456|NCT03736785|459435831|FG002|Overall Study|Death|1|||
127675457|NCT03736785|459435829|FG000|Overall Study|Lost to Follow-up|0|||
127675458|NCT03736785|459435830|FG001|Overall Study|Lost to Follow-up|2|||
127675459|NCT03736785|459435831|FG002|Overall Study|Lost to Follow-up|3|||
127675460|NCT03736785|459435829|FG000|Overall Study|Non compliance with study drug|1|||
127675461|NCT03736785|459435830|FG001|Overall Study|Non compliance with study drug|1|||
127675462|NCT03736785|459435831|FG002|Overall Study|Non compliance with study drug|0|||
127675463|NCT03736785|459435829|FG000|Overall Study|Physician Decision|0|||
127675464|NCT03736785|459435830|FG001|Overall Study|Physician Decision|1|||
127675465|NCT03736785|459435831|FG002|Overall Study|Physician Decision|1|||
127675466|NCT03736785|459435829|FG000|Overall Study|Protocol Violation|1|||
127675467|NCT03736785|459435830|FG001|Overall Study|Protocol Violation|4|||
127675468|NCT03736785|459435831|FG002|Overall Study|Protocol Violation|3|||
127675469|NCT03736785|459435829|FG000|Overall Study|Sponsor Decision|1|||
127675470|NCT03736785|459435830|FG001|Overall Study|Sponsor Decision|0|||
127675471|NCT03736785|459435831|FG002|Overall Study|Sponsor Decision|0|||
127675472|NCT03736785|459435829|FG000|Overall Study|Unknown/Missing data|3|||
127675473|NCT03736785|459435830|FG001|Overall Study|Unknown/Missing data|2|||
127675474|NCT03736785|459435831|FG002|Overall Study|Unknown/Missing data|1|||
127675475|NCT03736785|459435829|FG000|Overall Study|Withdrawal by Subject|9|||
127675476|NCT03736785|459435830|FG001|Overall Study|Withdrawal by Subject|6|||
127675477|NCT03736785|459435831|FG002|Overall Study|Withdrawal by Subject|4|||
127675478|NCT01744691|459435832|FG000|Overall Study|Progressive Disease|18|||
127675479|NCT01744691|459435832|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
127675480|NCT01744691|459435832|FG000|Overall Study|Withdrawal of consent for treatment|3|||
127675481|NCT01744691|459435832|FG000|Overall Study|Physician Decision|4|||
127675482|NCT04588480|459435833|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
127675483|NCT04588480|459435834|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
127675484|NCT04588480|459435835|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
127675485|NCT04588480|459435833|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
127675486|NCT04588480|459435834|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
127675487|NCT04588480|459435835|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
127675488|NCT01549652|459435836|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
127675489|NCT01549652|459435837|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
127675490|NCT01549652|459435838|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
127675491|NCT01549652|459435839|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
127675492|NCT01549652|459435836|FG000|Overall Study|Study Drug Titration Failure|5|||
127675493|NCT01549652|459435837|FG001|Overall Study|Study Drug Titration Failure|6|||
127675494|NCT01549652|459435838|FG002|Overall Study|Study Drug Titration Failure|0|||
127675495|NCT01549652|459435839|FG003|Overall Study|Study Drug Titration Failure|0|||
127675496|NCT01549652|459435836|FG000|Overall Study|Withdrawal Effect|0|||
127675497|NCT01549652|459435837|FG001|Overall Study|Withdrawal Effect|2|||
127675498|NCT01549652|459435838|FG002|Overall Study|Withdrawal Effect|0|||
127675499|NCT01549652|459435839|FG003|Overall Study|Withdrawal Effect|0|||
127675500|NCT01549652|459435836|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
127675501|NCT01549652|459435837|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
127675502|NCT01549652|459435838|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
127675503|NCT01549652|459435839|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
127675504|NCT01549652|459435836|FG000|Overall Study|Problem with Infusion|1|||
127675505|NCT01549652|459435837|FG001|Overall Study|Problem with Infusion|0|||
127675506|NCT01549652|459435838|FG002|Overall Study|Problem with Infusion|0|||
127675507|NCT01549652|459435839|FG003|Overall Study|Problem with Infusion|0|||
127675508|NCT01549652|459435836|FG000|Overall Study|Titration Non-Compliance|1|||
127675509|NCT01549652|459435837|FG001|Overall Study|Titration Non-Compliance|3|||
127675510|NCT01549652|459435838|FG002|Overall Study|Titration Non-Compliance|4|||
127675511|NCT01549652|459435839|FG003|Overall Study|Titration Non-Compliance|5|||
127675512|NCT01549652|459435836|FG000|Overall Study|Titration Side Effects|0|||
127675513|NCT01549652|459435837|FG001|Overall Study|Titration Side Effects|0|||
127675514|NCT01549652|459435838|FG002|Overall Study|Titration Side Effects|6|||
127675515|NCT01549652|459435839|FG003|Overall Study|Titration Side Effects|3|||
127675516|NCT01549652|459435836|FG000|Overall Study|Withdrawal by Subject|0|||
127675517|NCT01549652|459435837|FG001|Overall Study|Withdrawal by Subject|0|||
127675518|NCT01549652|459435838|FG002|Overall Study|Withdrawal by Subject|5|||
127675519|NCT01549652|459435839|FG003|Overall Study|Withdrawal by Subject|3|||
127675520|NCT02512042|459435840|FG000|Overall Study|Adverse Event|0|||
127762935|NCT00266227|459757449|FG002|Initial Treatment|Physician decision to withdraw|12|||
127762936|NCT00266227|459757447|FG000|Initial Treatment|Pregnancy|0|||
127762937|NCT00266227|459757448|FG001|Initial Treatment|Pregnancy|0|||
127762938|NCT00266227|459757449|FG002|Initial Treatment|Pregnancy|1|||
127762939|NCT00266227|459757447|FG000|Retreatment: Up to Week 48|Death|1|||
127762940|NCT00266227|459757448|FG001|Retreatment: Up to Week 48|Death|0|||
127762941|NCT00266227|459757449|FG002|Retreatment: Up to Week 48|Death|0|||
127762942|NCT00266227|459757447|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
127762943|NCT00266227|459757448|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
127762944|NCT00266227|459757449|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
127762945|NCT00266227|459757447|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
127762946|NCT00266227|459757448|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
127762947|NCT00266227|459757449|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
127762948|NCT00266227|459757447|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
127762949|NCT00266227|459757448|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
127762950|NCT00266227|459757449|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
127762951|NCT00266227|459757447|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
127762952|NCT00266227|459757448|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
127762953|NCT00266227|459757449|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
127762954|NCT00266227|459757447|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
127762955|NCT00266227|459757448|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
127762956|NCT00266227|459757449|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
127762957|NCT00266227|459757447|FG000|Retreatment: Week 48 to Week 72|Death|1|||
127762958|NCT00266227|459757448|FG001|Retreatment: Week 48 to Week 72|Death|1|||
127762959|NCT00266227|459757449|FG002|Retreatment: Week 48 to Week 72|Death|0|||
128009221|NCT01232283|460660623|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
128009222|NCT01232283|460660624|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
128009223|NCT01232283|460660625|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
128009224|NCT01232283|460660626|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
128009225|NCT01232283|460660617|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
127675521|NCT02512042|459435841|FG001|Overall Study|Adverse Event|4|||
127675522|NCT02512042|459435840|FG000|Overall Study|Withdrawal by Subject|6|||
127675523|NCT02512042|459435841|FG001|Overall Study|Withdrawal by Subject|6|||
127675524|NCT02512042|459435840|FG000|Overall Study|Non-compliance with study drug|1|||
127675525|NCT02512042|459435841|FG001|Overall Study|Non-compliance with study drug|2|||
127675526|NCT02512042|459435840|FG000|Overall Study|Lost to Follow-up|5|||
127675527|NCT02512042|459435841|FG001|Overall Study|Lost to Follow-up|2|||
127675528|NCT02512042|459435840|FG000|Overall Study|Other|11|||
127675529|NCT02512042|459435841|FG001|Overall Study|Other|11|||
127675530|NCT03523962|459435843|FG000|Closed Fractures|Death|86|||
127675531|NCT03523962|459435844|FG001|Closed Fractures|Death|71|||
127675532|NCT03523962|459435845|FG002|Closed Fractures|Death|0|||
127675533|NCT03523962|459435846|FG003|Closed Fractures|Death|0|||
127675534|NCT03523962|459435843|FG000|Closed Fractures|Lost to Follow-up|62|||
127675535|NCT03523962|459435844|FG001|Closed Fractures|Lost to Follow-up|36|||
127675536|NCT03523962|459435845|FG002|Closed Fractures|Lost to Follow-up|0|||
127675537|NCT03523962|459435846|FG003|Closed Fractures|Lost to Follow-up|0|||
127675538|NCT03523962|459435843|FG000|Closed Fractures|Withdrawal by Subject|19|||
127675539|NCT03523962|459435844|FG001|Closed Fractures|Withdrawal by Subject|29|||
127675540|NCT03523962|459435845|FG002|Closed Fractures|Withdrawal by Subject|0|||
127675541|NCT03523962|459435846|FG003|Closed Fractures|Withdrawal by Subject|0|||
127675542|NCT03523962|459435843|FG000|Closed Fractures|Incarceration|1|||
127675543|NCT03523962|459435844|FG001|Closed Fractures|Incarceration|4|||
127675544|NCT03523962|459435845|FG002|Closed Fractures|Incarceration|0|||
127675545|NCT03523962|459435846|FG003|Closed Fractures|Incarceration|0|||
127675546|NCT03523962|459435843|FG000|Open Fractures|Death|0|||
127675547|NCT03523962|459435844|FG001|Open Fractures|Death|0|||
127675548|NCT03523962|459435845|FG002|Open Fractures|Death|11|||
127675549|NCT03523962|459435846|FG003|Open Fractures|Death|6|||
127675550|NCT03523962|459435843|FG000|Open Fractures|Lost to Follow-up|0|||
127675551|NCT03523962|459435844|FG001|Open Fractures|Lost to Follow-up|0|||
127675552|NCT03523962|459435845|FG002|Open Fractures|Lost to Follow-up|15|||
127675553|NCT03523962|459435846|FG003|Open Fractures|Lost to Follow-up|8|||
127675554|NCT03523962|459435843|FG000|Open Fractures|Withdrawal by Subject|0|||
127675555|NCT03523962|459435844|FG001|Open Fractures|Withdrawal by Subject|0|||
127675556|NCT03523962|459435845|FG002|Open Fractures|Withdrawal by Subject|6|||
127762960|NCT00266227|459757447|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
127762961|NCT00266227|459757448|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
127675557|NCT03523962|459435846|FG003|Open Fractures|Withdrawal by Subject|2|||
127675558|NCT03523962|459435843|FG000|Open Fractures|Incarceration|0|||
127675559|NCT03523962|459435844|FG001|Open Fractures|Incarceration|0|||
127675560|NCT03523962|459435845|FG002|Open Fractures|Incarceration|1|||
127675561|NCT03523962|459435846|FG003|Open Fractures|Incarceration|0|||
127675562|NCT01081145|459435857|FG000|Open-Label Phase|Lack of Efficacy|56|||
127675563|NCT01081145|459435858|FG001|Open-Label Phase|Lack of Efficacy|0|||
127762962|NCT00266227|459757449|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
127762963|NCT00266227|459757447|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
127762964|NCT00266227|459757448|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
127762965|NCT00266227|459757449|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
127762966|NCT00266227|459757447|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
127762967|NCT00266227|459757448|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
127762968|NCT00266227|459757449|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
127762969|NCT00266227|459757447|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
127762970|NCT00266227|459757448|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
127762971|NCT00266227|459757449|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
127762972|NCT03725085|459757454|FG000|Overall Study|Lost to Follow-up|2|||
127762973|NCT01227577|459757455|FG000|Overall Study|Protocol deviation|3|||
127762974|NCT01227577|459757455|FG000|Overall Study|Death|3|||
127762975|NCT01227577|459757455|FG000|Overall Study|Administrative problems|2|||
127762976|NCT01227577|459757455|FG000|Overall Study|Lost to Follow-up|1|||
128009226|NCT01232283|460660618|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
128009227|NCT01232283|460660619|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
127675564|NCT01081145|459435857|FG000|Open-Label Phase|Response criteria not met|46|||
127675565|NCT01081145|459435858|FG001|Open-Label Phase|Response criteria not met|0|||
127675566|NCT01081145|459435857|FG000|Open-Label Phase|Adverse Event|42|||
127675567|NCT01081145|459435858|FG001|Open-Label Phase|Adverse Event|0|||
127675568|NCT01081145|459435857|FG000|Open-Label Phase|Withdrawal by Subject|41|||
127675569|NCT01081145|459435858|FG001|Open-Label Phase|Withdrawal by Subject|0|||
127675570|NCT01081145|459435857|FG000|Open-Label Phase|Other|12|||
127675571|NCT01081145|459435858|FG001|Open-Label Phase|Other|0|||
127675572|NCT01081145|459435857|FG000|Open-Label Phase|Lost to Follow-up|11|||
127675573|NCT01081145|459435858|FG001|Open-Label Phase|Lost to Follow-up|0|||
127675574|NCT01081145|459435857|FG000|Open-Label Phase|Protocol Violation|4|||
127675575|NCT01081145|459435858|FG001|Open-Label Phase|Protocol Violation|0|||
127675576|NCT01081145|459435857|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
127675577|NCT01081145|459435858|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
127675578|NCT01081145|459435857|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
127675579|NCT01081145|459435858|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
127675580|NCT01081145|459435857|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
127675581|NCT01081145|459435858|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
127675582|NCT01081145|459435857|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
127675583|NCT01081145|459435858|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
127675584|NCT01081145|459435857|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
127675585|NCT01081145|459435858|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
127675586|NCT01081145|459435857|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
127675587|NCT01081145|459435858|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
127675588|NCT01081145|459435857|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
127675589|NCT01081145|459435858|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
127675590|NCT01253226|459435859|FG000|Overall Study|Adverse Event|0|||
127675591|NCT01253226|459435860|FG001|Overall Study|Adverse Event|0|||
127675592|NCT01253226|459435861|FG002|Overall Study|Adverse Event|1|||
127675593|NCT01253226|459435862|FG003|Overall Study|Adverse Event|0|||
127675594|NCT01253226|459435863|FG004|Overall Study|Adverse Event|0|||
127675595|NCT01253226|459435859|FG000|Overall Study|Death|0|||
127675596|NCT01253226|459435860|FG001|Overall Study|Death|1|||
127675597|NCT01253226|459435861|FG002|Overall Study|Death|0|||
127675598|NCT01253226|459435862|FG003|Overall Study|Death|0|||
127675599|NCT01253226|459435863|FG004|Overall Study|Death|0|||
127675600|NCT01253226|459435859|FG000|Overall Study|Physician Decision|0|||
127675601|NCT01253226|459435860|FG001|Overall Study|Physician Decision|0|||
127675602|NCT01253226|459435861|FG002|Overall Study|Physician Decision|0|||
127675603|NCT01253226|459435862|FG003|Overall Study|Physician Decision|0|||
127675604|NCT01253226|459435863|FG004|Overall Study|Physician Decision|2|||
128009228|NCT01232283|460660620|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
128009229|NCT01232283|460660621|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
128009230|NCT01232283|460660622|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
128009231|NCT01232283|460660623|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
128009232|NCT01232283|460660624|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
128009233|NCT01232283|460660625|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
127675605|NCT01253226|459435859|FG000|Overall Study|Withdrawal by Subject|0|||
127675606|NCT01253226|459435860|FG001|Overall Study|Withdrawal by Subject|0|||
127675607|NCT01253226|459435861|FG002|Overall Study|Withdrawal by Subject|0|||
127675608|NCT01253226|459435862|FG003|Overall Study|Withdrawal by Subject|1|||
127675609|NCT01253226|459435863|FG004|Overall Study|Withdrawal by Subject|0|||
127675610|NCT00988637|459435864|FG000|Overall Study|Lost to Follow-up|2|||
127675611|NCT00988637|459435865|FG001|Overall Study|Lost to Follow-up|1|||
127762977|NCT01227577|459757455|FG000|Overall Study|Withdrawal by Subject|4|||
127762978|NCT01227577|459757455|FG000|Overall Study|Lack of Efficacy|5|||
127762979|NCT01227577|459757455|FG000|Overall Study|Adverse Event|17|||
127762980|NCT00852540|459757456|FG000|Overall Study|Adverse Event|10|||
127762981|NCT00852540|459757457|FG001|Overall Study|Adverse Event|3|||
127762982|NCT00852540|459757456|FG000|Overall Study|Lack of Efficacy|15|||
127762983|NCT00852540|459757457|FG001|Overall Study|Lack of Efficacy|3|||
127762984|NCT00852540|459757456|FG000|Overall Study|Protocol Violation|1|||
127762985|NCT00852540|459757457|FG001|Overall Study|Protocol Violation|2|||
127762986|NCT00852540|459757456|FG000|Overall Study|Lost to Follow-up|2|||
127762987|NCT00852540|459757457|FG001|Overall Study|Lost to Follow-up|3|||
127762988|NCT00852540|459757456|FG000|Overall Study|Investigator Discretion|2|||
127762989|NCT00852540|459757457|FG001|Overall Study|Investigator Discretion|3|||
127762990|NCT00852540|459757456|FG000|Overall Study|Withdrawal by Subject|3|||
127762991|NCT00852540|459757457|FG001|Overall Study|Withdrawal by Subject|1|||
127762992|NCT00852540|459757456|FG000|Overall Study|Did Not Receive Study Drug|3|||
127762993|NCT00852540|459757457|FG001|Overall Study|Did Not Receive Study Drug|3|||
128009234|NCT01232283|460660626|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
128009235|NCT02792504|460660629|FG000|Overall Study|Lost to Follow-up|24|||
128009236|NCT02792504|460660629|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
128009237|NCT00848497|460660636|FG000|Overall Study|Screen failure|2|||
128009238|NCT00848497|460660637|FG001|Overall Study|Screen failure|0|||
128009239|NCT00848497|460660636|FG000|Overall Study|Withdrawal by Subject|0|||
128009240|NCT00848497|460660637|FG001|Overall Study|Withdrawal by Subject|1|||
128009241|NCT02966834|460660638|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
128009242|NCT02966834|460660639|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
128009243|NCT02966834|460660640|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
128009244|NCT02966834|460660641|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
128009245|NCT02966834|460660642|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
128009246|NCT02966834|460660643|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
128009247|NCT02966834|460660638|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
128009248|NCT02966834|460660639|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
128009249|NCT02966834|460660640|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
128009250|NCT02966834|460660641|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
128009251|NCT02966834|460660642|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
128009252|NCT02966834|460660643|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
128009253|NCT02966834|460660638|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
128009254|NCT02966834|460660639|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
128009255|NCT02966834|460660640|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
128009256|NCT02966834|460660641|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
128009257|NCT02966834|460660642|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
128009258|NCT02966834|460660643|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
128009259|NCT02966834|460660638|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
128009260|NCT02966834|460660639|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
128009261|NCT02966834|460660640|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
128009262|NCT02966834|460660641|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
128009263|NCT02966834|460660642|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
128009264|NCT02966834|460660643|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
128009265|NCT02966834|460660638|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
128009266|NCT02966834|460660639|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
128009267|NCT02966834|460660640|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
128009268|NCT02966834|460660641|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
128009269|NCT02966834|460660642|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
128009270|NCT02966834|460660643|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
128009271|NCT02966834|460660638|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
128009272|NCT02966834|460660639|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
128009273|NCT02966834|460660640|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
128009274|NCT02966834|460660641|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
128009275|NCT02966834|460660642|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
128009276|NCT02966834|460660643|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
128009277|NCT00094445|460660644|FG000|Overall Study|Withdrawal by Subject|3|||
128009278|NCT00094445|460660644|FG000|Overall Study|Lost to Follow-up|1|||
128009279|NCT00094445|460660644|FG000|Overall Study|Progressive Disease|2|||
128009280|NCT00769561|460660645|FG000|Overall Study|Withdrawal by Subject|2|||
127762994|NCT01119105|459757458|FG000|Overall Study|Withdrawal by Subject|1|||
127762995|NCT01119105|459757459|FG001|Overall Study|Withdrawal by Subject|1|||
127762996|NCT01119105|459757460|FG002|Overall Study|Withdrawal by Subject|1|||
127762997|NCT01119105|459757458|FG000|Overall Study|Lost to Follow-up|0|||
127762998|NCT01119105|459757459|FG001|Overall Study|Lost to Follow-up|2|||
127762999|NCT01119105|459757460|FG002|Overall Study|Lost to Follow-up|5|||
127763000|NCT01119105|459757458|FG000|Overall Study|Adverse Event|1|||
127763001|NCT01119105|459757459|FG001|Overall Study|Adverse Event|0|||
127763002|NCT01119105|459757460|FG002|Overall Study|Adverse Event|1|||
127763003|NCT01119105|459757458|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
127763004|NCT01119105|459757459|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
128009281|NCT00769561|460660646|FG001|Overall Study|Withdrawal by Subject|2|||
128009282|NCT00769561|460660645|FG000|Overall Study|Lost to Follow-up|1|||
128009283|NCT00769561|460660646|FG001|Overall Study|Lost to Follow-up|3|||
128009284|NCT01773928|460660647|FG000|Overall Study|Adverse Event|0|||
128009285|NCT01773928|460660648|FG001|Overall Study|Adverse Event|0|||
128009286|NCT01773928|460660649|FG002|Overall Study|Adverse Event|0|||
128009287|NCT01773928|460660650|FG003|Overall Study|Adverse Event|0|||
128009288|NCT01773928|460660651|FG004|Overall Study|Adverse Event|0|||
128009289|NCT01773928|460660652|FG005|Overall Study|Adverse Event|0|||
128009290|NCT01773928|460660653|FG006|Overall Study|Adverse Event|0|||
128009291|NCT01773928|460660654|FG007|Overall Study|Adverse Event|1|||
128009292|NCT01773928|460660655|FG008|Overall Study|Adverse Event|0|||
128009293|NCT01773928|460660647|FG000|Overall Study|Physician Decision|0|||
128009294|NCT01773928|460660648|FG001|Overall Study|Physician Decision|0|||
128009295|NCT01773928|460660649|FG002|Overall Study|Physician Decision|0|||
128009296|NCT01773928|460660650|FG003|Overall Study|Physician Decision|1|||
128009297|NCT01773928|460660651|FG004|Overall Study|Physician Decision|0|||
128009298|NCT01773928|460660652|FG005|Overall Study|Physician Decision|0|||
128009299|NCT01773928|460660653|FG006|Overall Study|Physician Decision|0|||
128009300|NCT01773928|460660654|FG007|Overall Study|Physician Decision|0|||
127763005|NCT01119105|459757460|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
127763006|NCT01119105|459757458|FG000|Overall Study|Other|1|||
127763007|NCT01119105|459757459|FG001|Overall Study|Other|1|||
127763008|NCT01119105|459757460|FG002|Overall Study|Other|0|||
127763009|NCT01639495|459757461|FG000|Overall Study|Lost to Follow-up|6|||
127763010|NCT01639495|459757461|FG000|Overall Study|Consented but didn't have study catheter|4|||
127763011|NCT01639495|459757461|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
127763012|NCT01639495|459757461|FG000|Overall Study|No radiofrequency energy applied|2|||
127763013|NCT01775475|459757462|FG000|Overall Study|Death|3|||
127763014|NCT01775475|459757463|FG001|Overall Study|Death|3|||
127763015|NCT00618618|459757464|FG000|Overall Study|Patient Request|0|||
127763016|NCT00618618|459757465|FG001|Overall Study|Patient Request|0|||
127763017|NCT00618618|459757466|FG002|Overall Study|Patient Request|2|||
127763018|NCT00618618|459757467|FG003|Overall Study|Patient Request|0|||
127763019|NCT00618618|459757464|FG000|Overall Study|Inability to Complete Study Procedures|0|||
127763020|NCT00618618|459757465|FG001|Overall Study|Inability to Complete Study Procedures|1|||
127763021|NCT00618618|459757466|FG002|Overall Study|Inability to Complete Study Procedures|0|||
127763022|NCT00618618|459757467|FG003|Overall Study|Inability to Complete Study Procedures|0|||
127763023|NCT00618618|459757464|FG000|Overall Study|Lost to Follow-up|3|||
127763024|NCT00618618|459757465|FG001|Overall Study|Lost to Follow-up|0|||
127763025|NCT00618618|459757466|FG002|Overall Study|Lost to Follow-up|0|||
127763026|NCT00618618|459757467|FG003|Overall Study|Lost to Follow-up|1|||
127763027|NCT00618618|459757464|FG000|Overall Study|Non-compliance|1|||
127763028|NCT00618618|459757465|FG001|Overall Study|Non-compliance|1|||
127763029|NCT00618618|459757466|FG002|Overall Study|Non-compliance|0|||
127763030|NCT00618618|459757467|FG003|Overall Study|Non-compliance|0|||
127763031|NCT00618618|459757464|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
127763032|NCT00618618|459757465|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
127763033|NCT00618618|459757466|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
127763034|NCT00618618|459757467|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
127763035|NCT00618618|459757464|FG000|Overall Study|Death|0|||
127763036|NCT00618618|459757465|FG001|Overall Study|Death|1|||
127763037|NCT00618618|459757466|FG002|Overall Study|Death|0|||
127763038|NCT00618618|459757467|FG003|Overall Study|Death|0|||
127763039|NCT02929329|459757468|FG000|Overall Study|Withdrawal by Subject|24|||
128009301|NCT01773928|460660655|FG008|Overall Study|Physician Decision|0|||
128009302|NCT01773928|460660647|FG000|Overall Study|Withdrawal by Subject|5|||
128009303|NCT01773928|460660648|FG001|Overall Study|Withdrawal by Subject|4|||
128009304|NCT01773928|460660649|FG002|Overall Study|Withdrawal by Subject|4|||
128009305|NCT01773928|460660650|FG003|Overall Study|Withdrawal by Subject|4|||
128009306|NCT01773928|460660651|FG004|Overall Study|Withdrawal by Subject|7|||
127763040|NCT02929329|459757469|FG001|Overall Study|Withdrawal by Subject|21|||
128009307|NCT01773928|460660652|FG005|Overall Study|Withdrawal by Subject|1|||
128009308|NCT01773928|460660653|FG006|Overall Study|Withdrawal by Subject|0|||
127763041|NCT02929329|459757468|FG000|Overall Study|Lost to Follow-up|26|||
127763042|NCT02929329|459757469|FG001|Overall Study|Lost to Follow-up|20|||
127763043|NCT02929329|459757468|FG000|Overall Study|Death|1054|||
127763044|NCT02929329|459757469|FG001|Overall Study|Death|1051|||
127763045|NCT01183234|459757470|FG000|First Intervention|Adverse Event|1|||
127763046|NCT01183234|459757471|FG001|First Intervention|Adverse Event|0|||
127763047|NCT00309959|459757480|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
127763048|NCT03836716|459757483|FG000|Overall Study|Adverse Event|3|||
127763049|NCT03836716|459757483|FG000|Overall Study|Death|22|||
128009309|NCT01773928|460660654|FG007|Overall Study|Withdrawal by Subject|0|||
128009310|NCT01773928|460660655|FG008|Overall Study|Withdrawal by Subject|1|||
128009311|NCT01773928|460660647|FG000|Overall Study|Lost to Follow-up|0|||
128009312|NCT01773928|460660648|FG001|Overall Study|Lost to Follow-up|0|||
128009313|NCT01773928|460660649|FG002|Overall Study|Lost to Follow-up|0|||
128009314|NCT01773928|460660650|FG003|Overall Study|Lost to Follow-up|0|||
128009315|NCT01773928|460660651|FG004|Overall Study|Lost to Follow-up|0|||
128009316|NCT01773928|460660652|FG005|Overall Study|Lost to Follow-up|1|||
128009317|NCT01773928|460660653|FG006|Overall Study|Lost to Follow-up|0|||
128009318|NCT01773928|460660654|FG007|Overall Study|Lost to Follow-up|0|||
128009319|NCT01773928|460660655|FG008|Overall Study|Lost to Follow-up|0|||
128009320|NCT01773928|460660647|FG000|Overall Study|Subject misrepresented age|0|||
128009321|NCT01773928|460660648|FG001|Overall Study|Subject misrepresented age|1|||
128009322|NCT01773928|460660649|FG002|Overall Study|Subject misrepresented age|0|||
127763050|NCT03836716|459757483|FG000|Overall Study|Withdrawal by Subject|8|||
127763051|NCT03836716|459757483|FG000|Overall Study|Study terminated by sponsor|87|||
127763052|NCT00037830|459757484|FG000|Overall Study|Adverse Event|2|||
127763053|NCT00037830|459757485|FG001|Overall Study|Adverse Event|0|||
127763054|NCT00037830|459757486|FG002|Overall Study|Adverse Event|0|||
127763055|NCT00037830|459757484|FG000|Overall Study|Withdrawal by Subject|4|||
127763056|NCT00037830|459757485|FG001|Overall Study|Withdrawal by Subject|5|||
127763057|NCT00037830|459757486|FG002|Overall Study|Withdrawal by Subject|1|||
127763058|NCT00037830|459757484|FG000|Overall Study|Protocol Violation|2|||
127763059|NCT00037830|459757485|FG001|Overall Study|Protocol Violation|2|||
127763060|NCT00037830|459757486|FG002|Overall Study|Protocol Violation|0|||
127763061|NCT00037830|459757484|FG000|Overall Study|Unrelated Medical Problem|2|||
127763062|NCT00037830|459757485|FG001|Overall Study|Unrelated Medical Problem|0|||
127763063|NCT00037830|459757486|FG002|Overall Study|Unrelated Medical Problem|0|||
127763064|NCT03292432|459757489|FG000|Overall Study|Lost to Follow-up|11|||
127763065|NCT03292432|459757490|FG001|Overall Study|Lost to Follow-up|8|||
127763066|NCT03292432|459757489|FG000|Overall Study|Death|2|||
127763067|NCT03292432|459757490|FG001|Overall Study|Death|1|||
127763068|NCT03292432|459757489|FG000|Overall Study|Withdrawal by Subject|1|||
127763069|NCT03292432|459757490|FG001|Overall Study|Withdrawal by Subject|2|||
127763070|NCT03292432|459757489|FG000|Overall Study|Site closed before any data collected|1|||
127763071|NCT03292432|459757490|FG001|Overall Study|Site closed before any data collected|0|||
127763072|NCT01014143|459757494|FG000|Second Intervention|Lost to Follow-up|2|||
127763073|NCT01014143|459757495|FG001|Second Intervention|Lost to Follow-up|0|||
127763074|NCT01014143|459757496|FG002|Second Intervention|Lost to Follow-up|0|||
127763075|NCT04638920|459757501|FG000|Overall Study|Withdrawal by Subject|5|||
127763076|NCT03775434|459757502|FG000|Overall Study|Adverse Event|2|||
127763077|NCT03775434|459757502|FG000|Overall Study|Withdrawal by Subject|1|||
127763078|NCT01859988|459757503|FG000|Overall Study|Withdrawal by Subject|6|||
127763079|NCT01859988|459757504|FG001|Overall Study|Withdrawal by Subject|3|||
127763080|NCT01859988|459757505|FG002|Overall Study|Withdrawal by Subject|4|||
127763081|NCT01859988|459757506|FG003|Overall Study|Withdrawal by Subject|3|||
127763082|NCT01859988|459757507|FG004|Overall Study|Withdrawal by Subject|2|||
127763083|NCT01859988|459757508|FG005|Overall Study|Withdrawal by Subject|2|||
127763084|NCT01859988|459757503|FG000|Overall Study|Lack of Efficacy|1|||
127763085|NCT01859988|459757504|FG001|Overall Study|Lack of Efficacy|1|||
127763086|NCT01859988|459757505|FG002|Overall Study|Lack of Efficacy|5|||
127763087|NCT01859988|459757506|FG003|Overall Study|Lack of Efficacy|0|||
127763088|NCT01859988|459757507|FG004|Overall Study|Lack of Efficacy|7|||
127763089|NCT01859988|459757508|FG005|Overall Study|Lack of Efficacy|9|||
127763090|NCT01859988|459757503|FG000|Overall Study|Physician Decision|1|||
127763091|NCT01859988|459757504|FG001|Overall Study|Physician Decision|3|||
127763092|NCT01859988|459757505|FG002|Overall Study|Physician Decision|1|||
127763093|NCT01859988|459757506|FG003|Overall Study|Physician Decision|3|||
127763094|NCT01859988|459757507|FG004|Overall Study|Physician Decision|4|||
127763095|NCT01859988|459757508|FG005|Overall Study|Physician Decision|1|||
127763096|NCT01859988|459757503|FG000|Overall Study|Adverse Event|2|||
127763097|NCT01859988|459757504|FG001|Overall Study|Adverse Event|1|||
128009323|NCT01773928|460660650|FG003|Overall Study|Subject misrepresented age|0|||
128009324|NCT01773928|460660651|FG004|Overall Study|Subject misrepresented age|0|||
127763098|NCT01859988|459757505|FG002|Overall Study|Adverse Event|3|||
127763099|NCT01859988|459757506|FG003|Overall Study|Adverse Event|1|||
127763100|NCT01859988|459757507|FG004|Overall Study|Adverse Event|2|||
127763101|NCT01859988|459757508|FG005|Overall Study|Adverse Event|2|||
127763102|NCT01859988|459757503|FG000|Overall Study|Lost to Follow-up|1|||
127763103|NCT01859988|459757504|FG001|Overall Study|Lost to Follow-up|2|||
127763104|NCT01859988|459757505|FG002|Overall Study|Lost to Follow-up|3|||
127763105|NCT01859988|459757506|FG003|Overall Study|Lost to Follow-up|0|||
127763106|NCT01859988|459757507|FG004|Overall Study|Lost to Follow-up|3|||
127763107|NCT01859988|459757508|FG005|Overall Study|Lost to Follow-up|2|||
127763108|NCT01859988|459757503|FG000|Overall Study|Protocol Violation|0|||
127763109|NCT01859988|459757504|FG001|Overall Study|Protocol Violation|0|||
127763110|NCT01859988|459757505|FG002|Overall Study|Protocol Violation|1|||
128009325|NCT01773928|460660652|FG005|Overall Study|Subject misrepresented age|0|||
128009326|NCT01773928|460660653|FG006|Overall Study|Subject misrepresented age|0|||
127763111|NCT01859988|459757506|FG003|Overall Study|Protocol Violation|0|||
127763112|NCT01859988|459757507|FG004|Overall Study|Protocol Violation|0|||
127763113|NCT01859988|459757508|FG005|Overall Study|Protocol Violation|0|||
127763114|NCT01859988|459757503|FG000|Overall Study|Other than specified above|0|||
127763115|NCT01859988|459757504|FG001|Overall Study|Other than specified above|2|||
127763116|NCT01859988|459757505|FG002|Overall Study|Other than specified above|11|||
127763117|NCT01859988|459757506|FG003|Overall Study|Other than specified above|3|||
127763118|NCT01859988|459757507|FG004|Overall Study|Other than specified above|5|||
127763119|NCT01859988|459757508|FG005|Overall Study|Other than specified above|3|||
127763120|NCT01871805|459757511|FG000|Phase I|Death|7|||
127763121|NCT01871805|459757512|FG001|Phase I|Death|4|||
127763122|NCT01871805|459757513|FG002|Phase I|Death|6|||
127763123|NCT01871805|459757514|FG003|Phase I|Death|2|||
127763124|NCT01871805|459757515|FG004|Phase I|Death|9|||
127763125|NCT01871805|459757516|FG005|Phase I|Death|0|||
127763126|NCT01871805|459757511|FG000|Phase I|Alive in Survival Follow-up|0|||
127763127|NCT01871805|459757512|FG001|Phase I|Alive in Survival Follow-up|2|||
127763128|NCT01871805|459757513|FG002|Phase I|Alive in Survival Follow-up|4|||
127763129|NCT01871805|459757514|FG003|Phase I|Alive in Survival Follow-up|5|||
127763130|NCT01871805|459757515|FG004|Phase I|Alive in Survival Follow-up|4|||
127763131|NCT01871805|459757516|FG005|Phase I|Alive in Survival Follow-up|0|||
127763132|NCT01871805|459757511|FG000|Phase I|Lost to Follow-up|0|||
127763133|NCT01871805|459757512|FG001|Phase I|Lost to Follow-up|1|||
127763134|NCT01871805|459757513|FG002|Phase I|Lost to Follow-up|3|||
127763135|NCT01871805|459757514|FG003|Phase I|Lost to Follow-up|0|||
127763136|NCT01871805|459757515|FG004|Phase I|Lost to Follow-up|0|||
127763137|NCT01871805|459757516|FG005|Phase I|Lost to Follow-up|0|||
127763138|NCT01871805|459757511|FG000|Phase II|Death|0|||
127763139|NCT01871805|459757512|FG001|Phase II|Death|0|||
127763140|NCT01871805|459757513|FG002|Phase II|Death|0|||
127763141|NCT01871805|459757514|FG003|Phase II|Death|0|||
127763142|NCT01871805|459757515|FG004|Phase II|Death|0|||
127763143|NCT01871805|459757516|FG005|Phase II|Death|45|||
127763144|NCT01871805|459757511|FG000|Phase II|Alive in Survival Follow-up|0|||
127763145|NCT01871805|459757512|FG001|Phase II|Alive in Survival Follow-up|0|||
127763146|NCT01871805|459757513|FG002|Phase II|Alive in Survival Follow-up|0|||
127763147|NCT01871805|459757514|FG003|Phase II|Alive in Survival Follow-up|0|||
127763148|NCT01871805|459757515|FG004|Phase II|Alive in Survival Follow-up|0|||
127763149|NCT01871805|459757516|FG005|Phase II|Alive in Survival Follow-up|29|||
127763150|NCT01871805|459757511|FG000|Phase II|Lost to Follow-up|0|||
127763151|NCT01871805|459757512|FG001|Phase II|Lost to Follow-up|0|||
127763152|NCT01871805|459757513|FG002|Phase II|Lost to Follow-up|0|||
127763153|NCT01871805|459757514|FG003|Phase II|Lost to Follow-up|0|||
127763154|NCT01871805|459757515|FG004|Phase II|Lost to Follow-up|0|||
127763155|NCT01871805|459757516|FG005|Phase II|Lost to Follow-up|13|||
127763156|NCT00381615|459757519|FG000|Overall Study|Withdrawal by Subject|1|||
127763157|NCT00381615|459757520|FG001|Overall Study|Withdrawal by Subject|3|||
127763158|NCT00381615|459757521|FG002|Overall Study|Withdrawal by Subject|0|||
127763159|NCT00381615|459757522|FG003|Overall Study|Withdrawal by Subject|1|||
127763160|NCT00381615|459757519|FG000|Overall Study|Lost to Follow-up|3|||
127763161|NCT00381615|459757520|FG001|Overall Study|Lost to Follow-up|2|||
127763162|NCT00381615|459757521|FG002|Overall Study|Lost to Follow-up|0|||
127763163|NCT00381615|459757522|FG003|Overall Study|Lost to Follow-up|1|||
127763164|NCT00381615|459757519|FG000|Overall Study|Protocol Violation|0|||
127763165|NCT00381615|459757520|FG001|Overall Study|Protocol Violation|0|||
128009327|NCT01773928|460660654|FG007|Overall Study|Subject misrepresented age|0|||
128009328|NCT01773928|460660655|FG008|Overall Study|Subject misrepresented age|0|||
128009329|NCT01773928|460660647|FG000|Overall Study|Subject met exclusion criteria|0|||
128009330|NCT01773928|460660648|FG001|Overall Study|Subject met exclusion criteria|0|||
128009331|NCT01773928|460660649|FG002|Overall Study|Subject met exclusion criteria|0|||
128009332|NCT01773928|460660650|FG003|Overall Study|Subject met exclusion criteria|0|||
128009333|NCT01773928|460660651|FG004|Overall Study|Subject met exclusion criteria|0|||
128009334|NCT01773928|460660652|FG005|Overall Study|Subject met exclusion criteria|0|||
128009335|NCT01773928|460660653|FG006|Overall Study|Subject met exclusion criteria|0|||
128009336|NCT01773928|460660654|FG007|Overall Study|Subject met exclusion criteria|0|||
128009337|NCT01773928|460660655|FG008|Overall Study|Subject met exclusion criteria|1|||
128009338|NCT01773928|460660647|FG000|Overall Study|Randomized, had to leave, never returned|0|||
127763166|NCT00381615|459757521|FG002|Overall Study|Protocol Violation|1|||
127763167|NCT00381615|459757522|FG003|Overall Study|Protocol Violation|0|||
127763168|NCT00468559|459757523|FG000|Open-label Treatment Phase|Adverse Event|5|||
127763169|NCT00468559|459757524|FG001|Open-label Treatment Phase|Adverse Event|0|||
127763170|NCT00468559|459757525|FG002|Open-label Treatment Phase|Adverse Event|0|||
127763171|NCT00468559|459757523|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
127763172|NCT00468559|459757524|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
127763173|NCT00468559|459757525|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
127763174|NCT00468559|459757523|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
127763175|NCT00468559|459757524|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
127763176|NCT00468559|459757525|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
128009339|NCT01773928|460660648|FG001|Overall Study|Randomized, had to leave, never returned|0|||
128009340|NCT01773928|460660649|FG002|Overall Study|Randomized, had to leave, never returned|0|||
128009341|NCT01773928|460660650|FG003|Overall Study|Randomized, had to leave, never returned|1|||
128009342|NCT01773928|460660651|FG004|Overall Study|Randomized, had to leave, never returned|0|||
128009343|NCT01773928|460660652|FG005|Overall Study|Randomized, had to leave, never returned|0|||
128009344|NCT01773928|460660653|FG006|Overall Study|Randomized, had to leave, never returned|0|||
128009345|NCT01773928|460660654|FG007|Overall Study|Randomized, had to leave, never returned|0|||
128009346|NCT01773928|460660655|FG008|Overall Study|Randomized, had to leave, never returned|0|||
128009347|NCT01773928|460660647|FG000|Overall Study|Refused vaccine, withdrew consent|0|||
128009348|NCT01773928|460660648|FG001|Overall Study|Refused vaccine, withdrew consent|0|||
127675612|NCT00988637|459435864|FG000|Overall Study|Withdrawal by Subject|1|||
127675613|NCT00988637|459435865|FG001|Overall Study|Withdrawal by Subject|1|||
127675614|NCT00988637|459435864|FG000|Overall Study|non-compliance with study drug|0|||
127675615|NCT00988637|459435865|FG001|Overall Study|non-compliance with study drug|1|||
127675616|NCT03593070|459435867|FG000|Overall Study|administrative withdrawal|1|||
127675617|NCT03593070|459435868|FG001|Overall Study|administrative withdrawal|1|||
127675618|NCT03394027|459435871|FG000|Overall Study|Ineligible|3|||
127675619|NCT03394027|459435872|FG001|Overall Study|Ineligible|1|||
127675620|NCT03394027|459435873|FG002|Overall Study|Ineligible|3|||
127675621|NCT03394027|459435871|FG000|Overall Study|Participant declined to participate before treatment started|0|||
127675622|NCT03394027|459435872|FG001|Overall Study|Participant declined to participate before treatment started|0|||
127675623|NCT03394027|459435873|FG002|Overall Study|Participant declined to participate before treatment started|1|||
127675624|NCT02197234|459435874|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
127675625|NCT02197234|459435874|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
127675626|NCT02197234|459435874|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
127675627|NCT02197234|459435874|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
127675628|NCT02197234|459435874|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
127675629|NCT02197234|459435874|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
127675630|NCT01018511|459435876|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
127675631|NCT01018511|459435877|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
127675632|NCT01018511|459435878|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
127675633|NCT01018511|459435879|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
127675634|NCT01018511|459435876|FG000|Overall Study|Adverse Event|5|||
127675635|NCT01018511|459435877|FG001|Overall Study|Adverse Event|9|||
127675636|NCT01018511|459435878|FG002|Overall Study|Adverse Event|13|||
127675637|NCT01018511|459435879|FG003|Overall Study|Adverse Event|10|||
127675638|NCT01018511|459435876|FG000|Overall Study|Lack of Efficacy|4|||
127675639|NCT01018511|459435877|FG001|Overall Study|Lack of Efficacy|1|||
127675640|NCT01018511|459435878|FG002|Overall Study|Lack of Efficacy|1|||
127675641|NCT01018511|459435879|FG003|Overall Study|Lack of Efficacy|2|||
127675642|NCT01018511|459435876|FG000|Overall Study|Withdrawal by Subject|6|||
127675643|NCT01018511|459435877|FG001|Overall Study|Withdrawal by Subject|5|||
127675644|NCT01018511|459435878|FG002|Overall Study|Withdrawal by Subject|11|||
127675645|NCT01018511|459435879|FG003|Overall Study|Withdrawal by Subject|9|||
127675646|NCT01018511|459435876|FG000|Overall Study|Lost to Follow-up|0|||
127675647|NCT01018511|459435877|FG001|Overall Study|Lost to Follow-up|0|||
127675648|NCT01018511|459435878|FG002|Overall Study|Lost to Follow-up|1|||
127675649|NCT01018511|459435879|FG003|Overall Study|Lost to Follow-up|0|||
127675650|NCT01018511|459435876|FG000|Overall Study|Protocol Violation|5|||
127675651|NCT01018511|459435877|FG001|Overall Study|Protocol Violation|8|||
127675652|NCT01018511|459435878|FG002|Overall Study|Protocol Violation|7|||
127675653|NCT01018511|459435879|FG003|Overall Study|Protocol Violation|9|||
127675654|NCT01018511|459435876|FG000|Overall Study|Miscellaneous|0|||
127675655|NCT01018511|459435877|FG001|Overall Study|Miscellaneous|2|||
127675656|NCT01018511|459435878|FG002|Overall Study|Miscellaneous|0|||
127675657|NCT01018511|459435879|FG003|Overall Study|Miscellaneous|0|||
127675658|NCT04523181|459435880|FG000|Overall Study|Withdrawal by Subject|4|||
127675659|NCT04523181|459435881|FG001|Overall Study|Withdrawal by Subject|5|||
127675660|NCT04523181|459435880|FG000|Overall Study|Lost to Follow-up|2|||
127675661|NCT04523181|459435881|FG001|Overall Study|Lost to Follow-up|3|||
127675662|NCT04523181|459435880|FG000|Overall Study|Physician Decision|1|||
127675663|NCT04523181|459435881|FG001|Overall Study|Physician Decision|0|||
127675664|NCT04523181|459435880|FG000|Overall Study|Transferred to external facility.|1|||
128009349|NCT01773928|460660649|FG002|Overall Study|Refused vaccine, withdrew consent|0|||
127675665|NCT04523181|459435881|FG001|Overall Study|Transferred to external facility.|1|||
127675666|NCT04550039|459435882|FG000|Overall Study|discharge to acute care prior to completion of study|2|||
127675667|NCT04550039|459435883|FG001|Overall Study|discharge to acute care prior to completion of study|1|||
127675668|NCT04550039|459435882|FG000|Overall Study|patient self-withdrew from study|0|||
127675669|NCT04550039|459435883|FG001|Overall Study|patient self-withdrew from study|1|||
127675670|NCT04391309|459435884|FG000|Overall Study|Death|1|||
127675671|NCT04391309|459435885|FG001|Overall Study|Death|1|||
127675672|NCT04391309|459435884|FG000|Overall Study|Lost to Follow-up|3|||
128009350|NCT01773928|460660650|FG003|Overall Study|Refused vaccine, withdrew consent|0|||
128009351|NCT01773928|460660651|FG004|Overall Study|Refused vaccine, withdrew consent|1|||
128009352|NCT01773928|460660652|FG005|Overall Study|Refused vaccine, withdrew consent|0|||
128009353|NCT01773928|460660653|FG006|Overall Study|Refused vaccine, withdrew consent|0|||
128009354|NCT01773928|460660654|FG007|Overall Study|Refused vaccine, withdrew consent|0|||
128009355|NCT01773928|460660655|FG008|Overall Study|Refused vaccine, withdrew consent|0|||
128009356|NCT03092752|460660656|FG000|Overall Study|Aged <40 years|14209|||
128009357|NCT03092752|460660656|FG000|Overall Study|At least one claim with T2DM|61299|||
128009358|NCT03092752|460660656|FG000|Overall Study|Having no claim of study drugs|29282|||
128009359|NCT03092752|460660656|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
128009360|NCT03092752|460660656|FG000|Overall Study|<6 month history|245900|||
128009361|NCT00834041|460660664|FG000|Overall Study|Withdrawal by Subject|1|||
128009362|NCT00834041|460660665|FG001|Overall Study|Withdrawal by Subject|0|||
128009363|NCT00834041|460660664|FG000|Overall Study|Lost to Follow-up|0|||
128009364|NCT00834041|460660665|FG001|Overall Study|Lost to Follow-up|1|||
128009365|NCT03427892|460662714|FG000|Overall Study|Lost to Follow-up|2|||
128009366|NCT00274456|460662715|FG000|Overall Study|Still on treatment|2|||
127675673|NCT04391309|459435885|FG001|Overall Study|Lost to Follow-up|2|||
127675674|NCT04391309|459435884|FG000|Overall Study|Withdrawal by Subject|2|||
127675675|NCT04391309|459435885|FG001|Overall Study|Withdrawal by Subject|2|||
127675676|NCT04771273|459435891|FG000|Dose Escalation Period|Not treated with trial medication|0|||
127675677|NCT04771273|459435892|FG001|Dose Escalation Period|Not treated with trial medication|1|||
127675678|NCT04771273|459435893|FG002|Dose Escalation Period|Not treated with trial medication|1|||
127675679|NCT04771273|459435894|FG003|Dose Escalation Period|Not treated with trial medication|0|||
127675680|NCT04771273|459435891|FG000|Dose Escalation Period|Other reasons than listed|2|||
127675681|NCT04771273|459435892|FG001|Dose Escalation Period|Other reasons than listed|0|||
127675682|NCT04771273|459435893|FG002|Dose Escalation Period|Other reasons than listed|2|||
127675683|NCT04771273|459435894|FG003|Dose Escalation Period|Other reasons than listed|1|||
127675684|NCT04771273|459435891|FG000|Dose Escalation Period|Protocol Violation|0|||
127675685|NCT04771273|459435892|FG001|Dose Escalation Period|Protocol Violation|0|||
127675686|NCT04771273|459435893|FG002|Dose Escalation Period|Protocol Violation|3|||
127675687|NCT04771273|459435894|FG003|Dose Escalation Period|Protocol Violation|1|||
127675688|NCT04771273|459435891|FG000|Dose Escalation Period|Burden of study procedures|1|||
127675689|NCT04771273|459435892|FG001|Dose Escalation Period|Burden of study procedures|0|||
127675690|NCT04771273|459435893|FG002|Dose Escalation Period|Burden of study procedures|0|||
127675691|NCT04771273|459435894|FG003|Dose Escalation Period|Burden of study procedures|0|||
127675692|NCT04771273|459435891|FG000|Dose Escalation Period|Change of residence|0|||
127675693|NCT04771273|459435892|FG001|Dose Escalation Period|Change of residence|0|||
127675694|NCT04771273|459435893|FG002|Dose Escalation Period|Change of residence|0|||
127675695|NCT04771273|459435894|FG003|Dose Escalation Period|Change of residence|1|||
127675696|NCT04771273|459435891|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
127675697|NCT04771273|459435892|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
127675698|NCT04771273|459435893|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
127675699|NCT04771273|459435894|FG003|Dose Escalation Period|Perceived lack of efficacy|1|||
127675700|NCT04771273|459435891|FG000|Dose Escalation Period|Adverse Event|8|||
127675701|NCT04771273|459435892|FG001|Dose Escalation Period|Adverse Event|9|||
127675702|NCT04771273|459435893|FG002|Dose Escalation Period|Adverse Event|12|||
127675703|NCT04771273|459435894|FG003|Dose Escalation Period|Adverse Event|2|||
127675704|NCT04771273|459435891|FG000|Maintenance Period|Other than listed|4|||
127675705|NCT04771273|459435892|FG001|Maintenance Period|Other than listed|2|||
127675706|NCT04771273|459435893|FG002|Maintenance Period|Other than listed|0|||
127675707|NCT04771273|459435894|FG003|Maintenance Period|Other than listed|3|||
127675708|NCT04771273|459435891|FG000|Maintenance Period|Burden of study procedures|1|||
127675709|NCT04771273|459435892|FG001|Maintenance Period|Burden of study procedures|0|||
127675710|NCT04771273|459435893|FG002|Maintenance Period|Burden of study procedures|0|||
127675711|NCT04771273|459435894|FG003|Maintenance Period|Burden of study procedures|0|||
127675712|NCT04771273|459435891|FG000|Maintenance Period|Change of residence|0|||
127675713|NCT04771273|459435892|FG001|Maintenance Period|Change of residence|1|||
127675714|NCT04771273|459435893|FG002|Maintenance Period|Change of residence|3|||
127675715|NCT04771273|459435894|FG003|Maintenance Period|Change of residence|0|||
127675716|NCT04771273|459435891|FG000|Maintenance Period|Perceived lack of efficacy|0|||
127675717|NCT04771273|459435892|FG001|Maintenance Period|Perceived lack of efficacy|0|||
127675718|NCT04771273|459435893|FG002|Maintenance Period|Perceived lack of efficacy|0|||
127675719|NCT04771273|459435894|FG003|Maintenance Period|Perceived lack of efficacy|1|||
127675720|NCT04771273|459435891|FG000|Maintenance Period|Adverse Event|4|||
127675721|NCT04771273|459435892|FG001|Maintenance Period|Adverse Event|5|||
127675722|NCT04771273|459435893|FG002|Maintenance Period|Adverse Event|5|||
127675723|NCT04771273|459435894|FG003|Maintenance Period|Adverse Event|0|||
127675724|NCT02465359|459435896|FG000|Overall Study|Lack of Efficacy|1|||
127675725|NCT02465359|459435896|FG000|Overall Study|Withdrawal by Subject|1|||
127675726|NCT02465359|459435896|FG000|Overall Study|Adverse Event|1|||
127675727|NCT00708097|459435897|FG000|Period 1|Protocol Violation|0|||
128009367|NCT00274456|460662716|FG001|Overall Study|Still on treatment|3|||
127763177|NCT00468559|459757523|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
127763178|NCT00468559|459757524|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
127763179|NCT00468559|459757525|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
127763180|NCT00468559|459757523|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
127763181|NCT00468559|459757524|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
127763182|NCT00468559|459757525|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
127763183|NCT01131182|459757526|FG000|Overall Study|Withdrawal by Subject|1|||
127763184|NCT01131182|459757527|FG001|Overall Study|Withdrawal by Subject|1|||
127763185|NCT01131182|459757526|FG000|Overall Study|Lost to Follow-up|14|||
127763186|NCT01131182|459757527|FG001|Overall Study|Lost to Follow-up|15|||
127763187|NCT01131182|459757526|FG000|Overall Study|Other Reason|1|||
127763188|NCT01131182|459757527|FG001|Overall Study|Other Reason|0|||
127763189|NCT04602221|459757530|FG000|Overall Study|Discontinuation of trial treatment|0|||
127763190|NCT04602221|459757531|FG001|Overall Study|Discontinuation of trial treatment|0|||
127763191|NCT04602221|459757532|FG002|Overall Study|Discontinuation of trial treatment|1|||
127763192|NCT04602221|459757533|FG003|Overall Study|Discontinuation of trial treatment|0|||
127763193|NCT04602221|459757534|FG004|Overall Study|Discontinuation of trial treatment|0|||
127763194|NCT04602221|459757535|FG005|Overall Study|Discontinuation of trial treatment|0|||
127763195|NCT04602221|459757536|FG006|Overall Study|Discontinuation of trial treatment|0|||
127763196|NCT04602221|459757537|FG007|Overall Study|Discontinuation of trial treatment|0|||
127763197|NCT04602221|459757538|FG008|Overall Study|Discontinuation of trial treatment|0|||
127763198|NCT04602221|459757539|FG009|Overall Study|Discontinuation of trial treatment|0|||
127763199|NCT04602221|459757540|FG010|Overall Study|Discontinuation of trial treatment|0|||
127763200|NCT04602221|459757541|FG011|Overall Study|Discontinuation of trial treatment|0|||
127763201|NCT04602221|459757542|FG012|Overall Study|Discontinuation of trial treatment|0|||
127763202|NCT04602221|459757543|FG013|Overall Study|Discontinuation of trial treatment|0|||
127763203|NCT04602221|459757544|FG014|Overall Study|Discontinuation of trial treatment|0|||
127763204|NCT04602221|459757545|FG015|Overall Study|Discontinuation of trial treatment|0|||
127763205|NCT04602221|459757546|FG016|Overall Study|Discontinuation of trial treatment|0|||
127763206|NCT04602221|459757547|FG017|Overall Study|Discontinuation of trial treatment|0|||
127763207|NCT04602221|459757530|FG000|Overall Study|Other than listed|0|||
127763208|NCT04602221|459757531|FG001|Overall Study|Other than listed|0|||
127763209|NCT04602221|459757532|FG002|Overall Study|Other than listed|0|||
127763210|NCT04602221|459757533|FG003|Overall Study|Other than listed|0|||
127763211|NCT04602221|459757534|FG004|Overall Study|Other than listed|0|||
127763212|NCT04602221|459757535|FG005|Overall Study|Other than listed|0|||
127763213|NCT04602221|459757536|FG006|Overall Study|Other than listed|0|||
127763214|NCT04602221|459757537|FG007|Overall Study|Other than listed|0|||
127763215|NCT04602221|459757538|FG008|Overall Study|Other than listed|0|||
127763216|NCT04602221|459757539|FG009|Overall Study|Other than listed|0|||
127763217|NCT04602221|459757540|FG010|Overall Study|Other than listed|0|||
127763218|NCT04602221|459757541|FG011|Overall Study|Other than listed|0|||
127763219|NCT04602221|459757542|FG012|Overall Study|Other than listed|0|||
127763220|NCT04602221|459757543|FG013|Overall Study|Other than listed|0|||
127763221|NCT04602221|459757544|FG014|Overall Study|Other than listed|0|||
127763222|NCT04602221|459757545|FG015|Overall Study|Other than listed|1|||
127763223|NCT04602221|459757546|FG016|Overall Study|Other than listed|0|||
127763224|NCT04602221|459757547|FG017|Overall Study|Other than listed|1|||
127763225|NCT04602221|459757530|FG000|Overall Study|Withdrawal by Subject|0|||
127763226|NCT04602221|459757531|FG001|Overall Study|Withdrawal by Subject|0|||
127763227|NCT04602221|459757532|FG002|Overall Study|Withdrawal by Subject|0|||
127763228|NCT04602221|459757533|FG003|Overall Study|Withdrawal by Subject|0|||
127763229|NCT04602221|459757534|FG004|Overall Study|Withdrawal by Subject|0|||
127763230|NCT04602221|459757535|FG005|Overall Study|Withdrawal by Subject|0|||
127763231|NCT04602221|459757536|FG006|Overall Study|Withdrawal by Subject|0|||
127763232|NCT04602221|459757537|FG007|Overall Study|Withdrawal by Subject|0|||
127763233|NCT04602221|459757538|FG008|Overall Study|Withdrawal by Subject|0|||
127763234|NCT04602221|459757539|FG009|Overall Study|Withdrawal by Subject|0|||
127763235|NCT04602221|459757540|FG010|Overall Study|Withdrawal by Subject|0|||
128009368|NCT00274456|460662717|FG002|Overall Study|Still on treatment|5|||
128009369|NCT00274456|460662718|FG003|Overall Study|Still on treatment|1|||
128009370|NCT00274456|460662715|FG000|Overall Study|Unacceptable toxicity|10|||
128009371|NCT00274456|460662716|FG001|Overall Study|Unacceptable toxicity|5|||
128009372|NCT00274456|460662717|FG002|Overall Study|Unacceptable toxicity|12|||
128009373|NCT00274456|460662718|FG003|Overall Study|Unacceptable toxicity|16|||
128009374|NCT00274456|460662715|FG000|Overall Study|Adverse Event|0|||
127763236|NCT04602221|459757541|FG011|Overall Study|Withdrawal by Subject|0|||
127763237|NCT04602221|459757542|FG012|Overall Study|Withdrawal by Subject|1|||
127763238|NCT04602221|459757543|FG013|Overall Study|Withdrawal by Subject|0|||
127763239|NCT04602221|459757544|FG014|Overall Study|Withdrawal by Subject|0|||
127763240|NCT04602221|459757545|FG015|Overall Study|Withdrawal by Subject|0|||
127763241|NCT04602221|459757546|FG016|Overall Study|Withdrawal by Subject|0|||
127763242|NCT04602221|459757547|FG017|Overall Study|Withdrawal by Subject|0|||
128009375|NCT00274456|460662716|FG001|Overall Study|Adverse Event|1|||
128009376|NCT00274456|460662717|FG002|Overall Study|Adverse Event|2|||
127763243|NCT04602221|459757530|FG000|Overall Study|Lost to Follow-up|0|||
127763244|NCT04602221|459757531|FG001|Overall Study|Lost to Follow-up|0|||
127763245|NCT04602221|459757532|FG002|Overall Study|Lost to Follow-up|0|||
127763246|NCT04602221|459757533|FG003|Overall Study|Lost to Follow-up|0|||
127763247|NCT04602221|459757534|FG004|Overall Study|Lost to Follow-up|0|||
127763248|NCT04602221|459757535|FG005|Overall Study|Lost to Follow-up|1|||
127763249|NCT04602221|459757536|FG006|Overall Study|Lost to Follow-up|0|||
127763250|NCT04602221|459757537|FG007|Overall Study|Lost to Follow-up|0|||
127763251|NCT04602221|459757538|FG008|Overall Study|Lost to Follow-up|0|||
127763252|NCT04602221|459757539|FG009|Overall Study|Lost to Follow-up|0|||
127763253|NCT04602221|459757540|FG010|Overall Study|Lost to Follow-up|0|||
127763254|NCT04602221|459757541|FG011|Overall Study|Lost to Follow-up|0|||
127763255|NCT04602221|459757542|FG012|Overall Study|Lost to Follow-up|0|||
127763256|NCT04602221|459757543|FG013|Overall Study|Lost to Follow-up|0|||
127763257|NCT04602221|459757544|FG014|Overall Study|Lost to Follow-up|0|||
127763258|NCT04602221|459757545|FG015|Overall Study|Lost to Follow-up|0|||
127763259|NCT04602221|459757546|FG016|Overall Study|Lost to Follow-up|0|||
127763260|NCT04602221|459757547|FG017|Overall Study|Lost to Follow-up|0|||
127763261|NCT01146782|459757548|FG000|Screening Cohort|Screen Failure|187|||
127763262|NCT01146782|459757548|FG000|Screening Cohort|Lost to Follow-up|4|||
127763263|NCT01146782|459757548|FG000|Screening Cohort|Physician Decision|1|||
127763264|NCT01146782|459757548|FG000|Screening Cohort|Withdrawal by Subject|29|||
127763265|NCT01146782|459757548|FG000|Safety Cohort|Screen Failure|61|||
127763266|NCT01146782|459757548|FG000|Safety Cohort|Withdrawal by Subject|4|||
127763267|NCT01146782|459757548|FG000|Safety Cohort|Control AHI <5|4|||
127763268|NCT01146782|459757548|FG000|Safety Cohort|TST <4 hrs|14|||
127763269|NCT01146782|459757548|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
127763270|NCT01146782|459757548|FG000|Primary Endpoint Cohort|Physician Decision|1|||
127763271|NCT02270515|459757549|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
127763272|NCT02270515|459757549|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
127763273|NCT02270515|459757549|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
127763274|NCT02270515|459757549|FG000|Intervention Period 1: 0-6 Months|Death|7|||
127763275|NCT02270515|459757549|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
127763276|NCT02270515|459757549|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
127763277|NCT02270515|459757549|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
127763278|NCT02270515|459757549|FG000|Intervention Period 2: 6-12 Months|Death|5|||
127763279|NCT02270515|459757549|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
127763280|NCT02270515|459757549|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
127763281|NCT02270515|459757549|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
127763282|NCT02270515|459757549|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
127763283|NCT02270515|459757549|FG000|Intervention Period 3: 12-18 Months|Death|3|||
127763284|NCT02270515|459757549|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
127763285|NCT00911768|459757551|FG000|Overall Study|Protocol Violation|5|||
127763286|NCT00911768|459757552|FG001|Overall Study|Protocol Violation|4|||
127763287|NCT00911768|459757551|FG000|Overall Study|Withdrawal by Subject|1|||
127763288|NCT00911768|459757552|FG001|Overall Study|Withdrawal by Subject|0|||
127763289|NCT03538301|459757555|FG000|Overall Study|Adverse Event|1|||
127763290|NCT03538301|459757556|FG001|Overall Study|Adverse Event|4|||
127763291|NCT03538301|459757557|FG002|Overall Study|Adverse Event|4|||
127763292|NCT03538301|459757555|FG000|Overall Study|Death|1|||
127763293|NCT03538301|459757556|FG001|Overall Study|Death|1|||
127763294|NCT03538301|459757557|FG002|Overall Study|Death|0|||
127763295|NCT03538301|459757555|FG000|Overall Study|Physician Decision|0|||
127763296|NCT03538301|459757556|FG001|Overall Study|Physician Decision|1|||
127763297|NCT03538301|459757557|FG002|Overall Study|Physician Decision|0|||
127763298|NCT03538301|459757555|FG000|Overall Study|Protocol Violation|0|||
127763299|NCT03538301|459757556|FG001|Overall Study|Protocol Violation|0|||
127763300|NCT03538301|459757557|FG002|Overall Study|Protocol Violation|1|||
127763301|NCT03538301|459757555|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
127763302|NCT03538301|459757556|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
127763303|NCT03538301|459757557|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
127763304|NCT02842151|459757560|FG000|Overall Study|Adverse Event|1|||
127763305|NCT02842151|459757560|FG000|Overall Study|Subject moved too far away|1|||
127763306|NCT01879553|459757561|FG000|Overall Study|Withdrawal by Subject|1|||
127763307|NCT01879553|459757562|FG001|Overall Study|Withdrawal by Subject|0|||
127763308|NCT02559895|459757564|FG000|Overall Study|Adverse Event|3|||
127763309|NCT02559895|459757565|FG001|Overall Study|Adverse Event|3|||
127763310|NCT02559895|459757566|FG002|Overall Study|Adverse Event|2|||
127763311|NCT02559895|459757567|FG003|Overall Study|Adverse Event|1|||
127763312|NCT02559895|459757564|FG000|Overall Study|Lack of Efficacy|2|||
127763313|NCT02559895|459757565|FG001|Overall Study|Lack of Efficacy|3|||
127763314|NCT02559895|459757566|FG002|Overall Study|Lack of Efficacy|2|||
127763315|NCT02559895|459757567|FG003|Overall Study|Lack of Efficacy|8|||
127763316|NCT02559895|459757564|FG000|Overall Study|Lost to Follow-up|22|||
127763317|NCT02559895|459757565|FG001|Overall Study|Lost to Follow-up|16|||
127763318|NCT02559895|459757566|FG002|Overall Study|Lost to Follow-up|12|||
128009377|NCT00274456|460662718|FG003|Overall Study|Adverse Event|2|||
128009378|NCT00274456|460662715|FG000|Overall Study|Physician Decision|7|||
128009379|NCT00274456|460662716|FG001|Overall Study|Physician Decision|5|||
128009380|NCT00274456|460662717|FG002|Overall Study|Physician Decision|6|||
128009381|NCT00274456|460662718|FG003|Overall Study|Physician Decision|13|||
128009382|NCT00274456|460662715|FG000|Overall Study|Lost to Follow-up|0|||
128009383|NCT00274456|460662716|FG001|Overall Study|Lost to Follow-up|0|||
128009384|NCT00274456|460662717|FG002|Overall Study|Lost to Follow-up|1|||
128009385|NCT00274456|460662718|FG003|Overall Study|Lost to Follow-up|0|||
128009386|NCT00274456|460662715|FG000|Overall Study|Withdrawal by Subject|18|||
128009387|NCT00274456|460662716|FG001|Overall Study|Withdrawal by Subject|13|||
128009388|NCT00274456|460662717|FG002|Overall Study|Withdrawal by Subject|9|||
128009389|NCT00274456|460662718|FG003|Overall Study|Withdrawal by Subject|13|||
128009390|NCT03255187|460662722|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
127543550|NCT02718898|458956557|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
127675728|NCT00708097|459435898|FG001|Period 1|Protocol Violation|1|||
127675729|NCT00708097|459435899|FG002|Period 1|Protocol Violation|0|||
127675730|NCT00708097|459435900|FG003|Period 1|Protocol Violation|2|||
127675731|NCT00708097|459435901|FG004|Period 1|Protocol Violation|0|||
127675732|NCT00708097|459435897|FG000|Period 1|Other Reason|0|||
127675733|NCT00708097|459435898|FG001|Period 1|Other Reason|0|||
127675734|NCT00708097|459435899|FG002|Period 1|Other Reason|0|||
127675735|NCT00708097|459435900|FG003|Period 1|Other Reason|0|||
127675736|NCT00708097|459435901|FG004|Period 1|Other Reason|1|||
127675737|NCT00708097|459435897|FG000|Period 2|Protocol Violation|0|||
127675738|NCT00708097|459435898|FG001|Period 2|Protocol Violation|1|||
127675739|NCT00708097|459435899|FG002|Period 2|Protocol Violation|1|||
127675740|NCT00708097|459435900|FG003|Period 2|Protocol Violation|1|||
127675741|NCT00708097|459435901|FG004|Period 2|Protocol Violation|0|||
127675742|NCT03895034|459437509|FG000|Overall Study|Lost to Follow-up|2|||
127675743|NCT03837028|459437510|FG000|Overall Study|Lost to Follow-up|4|||
127675744|NCT03837028|459437511|FG001|Overall Study|Lost to Follow-up|0|||
127675745|NCT03837028|459437512|FG002|Overall Study|Lost to Follow-up|2|||
127675746|NCT03837028|459437513|FG003|Overall Study|Lost to Follow-up|0|||
127675747|NCT03837028|459437510|FG000|Overall Study|Withdrawal by Subject|12|||
127675748|NCT03837028|459437511|FG001|Overall Study|Withdrawal by Subject|11|||
127675749|NCT03837028|459437512|FG002|Overall Study|Withdrawal by Subject|11|||
127675750|NCT03837028|459437513|FG003|Overall Study|Withdrawal by Subject|7|||
127675751|NCT03784963|459437514|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
127675752|NCT03784963|459437515|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
127675753|NCT03784963|459437516|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
127675754|NCT03784963|459437517|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
127675755|NCT00157014|459437518|FG000|Overall Study|Death|4|||
127675756|NCT00157014|459437519|FG001|Overall Study|Death|2|||
127675757|NCT00157014|459437520|FG002|Overall Study|Death|1|||
127675758|NCT00157014|459437521|FG003|Overall Study|Death|1|||
127675759|NCT00157014|459437518|FG000|Overall Study|Physician Decision|0|||
127675760|NCT00157014|459437519|FG001|Overall Study|Physician Decision|1|||
127675761|NCT00157014|459437520|FG002|Overall Study|Physician Decision|0|||
127675762|NCT00157014|459437521|FG003|Overall Study|Physician Decision|0|||
127675763|NCT00157014|459437518|FG000|Overall Study|Medications withdrawn on family request|0|||
127675764|NCT00157014|459437519|FG001|Overall Study|Medications withdrawn on family request|1|||
127675765|NCT00157014|459437520|FG002|Overall Study|Medications withdrawn on family request|0|||
127675766|NCT00157014|459437521|FG003|Overall Study|Medications withdrawn on family request|0|||
127675767|NCT00157014|459437518|FG000|Overall Study|Patient withdrawn by investigator|1|||
127675768|NCT00157014|459437519|FG001|Overall Study|Patient withdrawn by investigator|0|||
127675769|NCT00157014|459437520|FG002|Overall Study|Patient withdrawn by investigator|0|||
127675770|NCT00157014|459437521|FG003|Overall Study|Patient withdrawn by investigator|0|||
127675771|NCT00157014|459437518|FG000|Overall Study|Patient unable to return in nursing home|1|||
127675772|NCT00157014|459437519|FG001|Overall Study|Patient unable to return in nursing home|0|||
127675773|NCT00157014|459437520|FG002|Overall Study|Patient unable to return in nursing home|0|||
127675774|NCT00157014|459437521|FG003|Overall Study|Patient unable to return in nursing home|0|||
127675775|NCT00157014|459437518|FG000|Overall Study|Patient would not receive transplant|0|||
127675776|NCT00157014|459437519|FG001|Overall Study|Patient would not receive transplant|1|||
127675777|NCT00157014|459437520|FG002|Overall Study|Patient would not receive transplant|0|||
127675778|NCT00157014|459437521|FG003|Overall Study|Patient would not receive transplant|0|||
127675779|NCT00157014|459437518|FG000|Overall Study|Withdrawal by Subject|1|||
127675780|NCT00157014|459437519|FG001|Overall Study|Withdrawal by Subject|0|||
127675781|NCT00157014|459437520|FG002|Overall Study|Withdrawal by Subject|0|||
127675782|NCT00157014|459437521|FG003|Overall Study|Withdrawal by Subject|0|||
127675783|NCT01362491|459437522|FG000|Overall Study|Ineligible|1|||
128009391|NCT03255187|460662723|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
128009392|NCT03255187|460662722|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
128009393|NCT03255187|460662723|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
128009394|NCT00375752|460662724|FG000|Overall Study|Lack of Efficacy|4|||
128009395|NCT00375752|460662725|FG001|Overall Study|Lack of Efficacy|4|||
128009396|NCT00375752|460662724|FG000|Overall Study|Adverse Event|1|||
128009397|NCT00375752|460662725|FG001|Overall Study|Adverse Event|6|||
128009398|NCT00375752|460662724|FG000|Overall Study|Withdrawal by Subject|6|||
128009399|NCT00375752|460662725|FG001|Overall Study|Withdrawal by Subject|1|||
128009400|NCT00375752|460662724|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
127675784|NCT01362491|459437523|FG001|Overall Study|Ineligible|0|||
127675785|NCT01362491|459437524|FG002|Overall Study|Ineligible|0|||
127675786|NCT03181958|459437525|FG000|Overall Study|Lost to Follow-up|17|||
127675787|NCT03181958|459437526|FG001|Overall Study|Lost to Follow-up|21|||
127675788|NCT03181958|459437527|FG002|Overall Study|Lost to Follow-up|15|||
127675789|NCT01257503|459437528|FG000|Overall Study|Lost to Follow-up|7|||
127675790|NCT01257503|459437529|FG001|Overall Study|Lost to Follow-up|10|||
127675791|NCT01257503|459437528|FG000|Overall Study|Over 5 years old at enrollment|0|||
127675792|NCT01257503|459437529|FG001|Overall Study|Over 5 years old at enrollment|1|||
127675793|NCT01257503|459437528|FG000|Overall Study|strep culture positive at enrollment|1|||
127675794|NCT01257503|459437529|FG001|Overall Study|strep culture positive at enrollment|0|||
127675795|NCT05355116|459437530|FG000|Overall Study|Withdrawal by Subject|2|||
127675796|NCT01090024|459437531|FG000|Period 1|Met exclusion criteria|0|||
127675797|NCT01090024|459437532|FG001|Period 1|Met exclusion criteria|0|||
127675798|NCT01090024|459437533|FG002|Period 1|Met exclusion criteria|0|||
127675799|NCT01090024|459437534|FG003|Period 1|Met exclusion criteria|0|||
127675800|NCT01090024|459437535|FG004|Period 1|Met exclusion criteria|0|||
127675801|NCT01090024|459437536|FG005|Period 1|Met exclusion criteria|0|||
127675802|NCT01090024|459437537|FG006|Period 1|Met exclusion criteria|0|||
127675803|NCT01090024|459437538|FG007|Period 1|Met exclusion criteria|0|||
127675804|NCT01090024|459437539|FG008|Period 1|Met exclusion criteria|0|||
127675805|NCT01090024|459437540|FG009|Period 1|Met exclusion criteria|0|||
127675806|NCT01090024|459437541|FG010|Period 1|Met exclusion criteria|0|||
127675807|NCT01090024|459437542|FG011|Period 1|Met exclusion criteria|0|||
127675808|NCT01090024|459437543|FG012|Period 1|Met exclusion criteria|0|||
127675809|NCT01090024|459437544|FG013|Period 1|Met exclusion criteria|0|||
127675810|NCT01090024|459437545|FG014|Period 1|Met exclusion criteria|1|||
127675811|NCT01090024|459437546|FG015|Period 1|Met exclusion criteria|0|||
127675812|NCT01090024|459437547|FG016|Period 1|Met exclusion criteria|0|||
127675813|NCT01090024|459437548|FG017|Period 1|Met exclusion criteria|0|||
127675814|NCT01090024|459437531|FG000|Period 1|Adverse Event|0|||
127675815|NCT01090024|459437532|FG001|Period 1|Adverse Event|0|||
127675816|NCT01090024|459437533|FG002|Period 1|Adverse Event|0|||
127675817|NCT01090024|459437534|FG003|Period 1|Adverse Event|0|||
127675818|NCT01090024|459437535|FG004|Period 1|Adverse Event|0|||
127675819|NCT01090024|459437536|FG005|Period 1|Adverse Event|0|||
127675820|NCT01090024|459437537|FG006|Period 1|Adverse Event|0|||
127675821|NCT01090024|459437538|FG007|Period 1|Adverse Event|0|||
127675822|NCT01090024|459437539|FG008|Period 1|Adverse Event|0|||
127675823|NCT01090024|459437540|FG009|Period 1|Adverse Event|1|||
127675824|NCT01090024|459437541|FG010|Period 1|Adverse Event|0|||
127675825|NCT01090024|459437542|FG011|Period 1|Adverse Event|1|||
127675826|NCT01090024|459437543|FG012|Period 1|Adverse Event|0|||
127675827|NCT01090024|459437544|FG013|Period 1|Adverse Event|0|||
127675828|NCT01090024|459437545|FG014|Period 1|Adverse Event|0|||
127675829|NCT01090024|459437546|FG015|Period 1|Adverse Event|0|||
127675830|NCT01090024|459437547|FG016|Period 1|Adverse Event|0|||
127675831|NCT01090024|459437548|FG017|Period 1|Adverse Event|1|||
127675832|NCT01090024|459437531|FG000|Period 1|Withdrawal by Subject|0|||
127675833|NCT01090024|459437532|FG001|Period 1|Withdrawal by Subject|0|||
127675834|NCT01090024|459437533|FG002|Period 1|Withdrawal by Subject|0|||
127675835|NCT01090024|459437534|FG003|Period 1|Withdrawal by Subject|1|||
127675836|NCT01090024|459437535|FG004|Period 1|Withdrawal by Subject|0|||
127675837|NCT01090024|459437536|FG005|Period 1|Withdrawal by Subject|0|||
127675838|NCT01090024|459437537|FG006|Period 1|Withdrawal by Subject|0|||
127675839|NCT01090024|459437538|FG007|Period 1|Withdrawal by Subject|0|||
127675840|NCT01090024|459437539|FG008|Period 1|Withdrawal by Subject|0|||
127675841|NCT01090024|459437540|FG009|Period 1|Withdrawal by Subject|0|||
127675842|NCT01090024|459437541|FG010|Period 1|Withdrawal by Subject|0|||
127675843|NCT01090024|459437542|FG011|Period 1|Withdrawal by Subject|0|||
127675844|NCT01090024|459437543|FG012|Period 1|Withdrawal by Subject|0|||
127675845|NCT01090024|459437544|FG013|Period 1|Withdrawal by Subject|0|||
127675846|NCT01090024|459437545|FG014|Period 1|Withdrawal by Subject|0|||
127675847|NCT01090024|459437546|FG015|Period 1|Withdrawal by Subject|0|||
127675848|NCT01090024|459437547|FG016|Period 1|Withdrawal by Subject|0|||
127675849|NCT01090024|459437548|FG017|Period 1|Withdrawal by Subject|0|||
127675850|NCT01090024|459437531|FG000|Period 1|Lost to Follow-up|0|||
127675851|NCT01090024|459437532|FG001|Period 1|Lost to Follow-up|1|||
127675852|NCT01090024|459437533|FG002|Period 1|Lost to Follow-up|0|||
127675853|NCT01090024|459437534|FG003|Period 1|Lost to Follow-up|0|||
127675854|NCT01090024|459437535|FG004|Period 1|Lost to Follow-up|0|||
127763319|NCT02559895|459757567|FG003|Overall Study|Lost to Follow-up|17|||
127763320|NCT02559895|459757564|FG000|Overall Study|Physician Decision|1|||
127763321|NCT02559895|459757565|FG001|Overall Study|Physician Decision|1|||
127763322|NCT02559895|459757566|FG002|Overall Study|Physician Decision|3|||
127763323|NCT02559895|459757567|FG003|Overall Study|Physician Decision|0|||
127763324|NCT02559895|459757564|FG000|Overall Study|Withdrawal by Subject|16|||
127763325|NCT02559895|459757565|FG001|Overall Study|Withdrawal by Subject|9|||
127763326|NCT02559895|459757566|FG002|Overall Study|Withdrawal by Subject|20|||
127763327|NCT02559895|459757567|FG003|Overall Study|Withdrawal by Subject|9|||
127763328|NCT02559895|459757564|FG000|Overall Study|Study Burden|10|||
127763329|NCT02559895|459757565|FG001|Overall Study|Study Burden|16|||
127763330|NCT02559895|459757566|FG002|Overall Study|Study Burden|12|||
127763331|NCT02559895|459757567|FG003|Overall Study|Study Burden|22|||
127763332|NCT02559895|459757564|FG000|Overall Study|Other|1|||
127763333|NCT02559895|459757565|FG001|Overall Study|Other|5|||
127763334|NCT02559895|459757566|FG002|Overall Study|Other|3|||
127763335|NCT02559895|459757567|FG003|Overall Study|Other|3|||
127763336|NCT04540887|459757573|FG000|Overall Study|Withdrawal by Subject|2|||
128009401|NCT00375752|460662725|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
128009402|NCT00375752|460662724|FG000|Overall Study|Protocol Violation|0|||
128009403|NCT00375752|460662725|FG001|Overall Study|Protocol Violation|2|||
128009404|NCT00375752|460662724|FG000|Overall Study|Administrative Problems|0|||
128009405|NCT00375752|460662725|FG001|Overall Study|Administrative Problems|1|||
128009406|NCT02034006|460662726|FG000|Overall Study|Withdrawal by Subject|7|||
128009407|NCT02034006|460662726|FG000|Overall Study|Lost to Follow-up|5|||
128009408|NCT02034006|460662726|FG000|Overall Study|Death|1|||
128009409|NCT02034006|460662726|FG000|Overall Study|Pregnancy|1|||
128009410|NCT00109343|460662730|FG000|Overall Study|Adverse Event|1|||
128009411|NCT00109343|460662731|FG001|Overall Study|Adverse Event|0|||
128009412|NCT00109343|460662732|FG002|Overall Study|Adverse Event|2|||
128009413|NCT00109343|460662730|FG000|Overall Study|Lack of Efficacy|1|||
128009414|NCT00109343|460662731|FG001|Overall Study|Lack of Efficacy|0|||
128009415|NCT00109343|460662732|FG002|Overall Study|Lack of Efficacy|0|||
127763337|NCT01262027|459757574|FG000|Overall Study|Adverse Event|1|||
127763338|NCT01262027|459757574|FG000|Overall Study|Withdrawal by Subject|3|||
127763339|NCT01262027|459757574|FG000|Overall Study|Protocol Violation|1|||
127763340|NCT03695237|459758845|FG000|Overall Study|Withdrawal by Subject|1|||
127763341|NCT03695237|459758846|FG001|Overall Study|Withdrawal by Subject|3|||
127763342|NCT03695237|459758845|FG000|Overall Study|Lost to Follow-up|1|||
127763343|NCT03695237|459758846|FG001|Overall Study|Lost to Follow-up|2|||
127763344|NCT03695237|459758845|FG000|Overall Study|Other, Not Specified|8|||
127763345|NCT03695237|459758846|FG001|Overall Study|Other, Not Specified|2|||
127763346|NCT01789567|459758849|FG000|Overall Study|Death|6|||
127763347|NCT00091169|459758850|FG000|Overall Study|Disease progression|3|||
127763348|NCT00091169|459758851|FG001|Overall Study|Disease progression|1|||
127763349|NCT00091169|459758850|FG000|Overall Study|Adverse Event|11|||
127763350|NCT00091169|459758851|FG001|Overall Study|Adverse Event|17|||
127763351|NCT00091169|459758850|FG000|Overall Study|Death|4|||
127763352|NCT00091169|459758851|FG001|Overall Study|Death|1|||
128009416|NCT00109343|460662730|FG000|Overall Study|Lost to Follow-up|35|||
128009417|NCT00109343|460662731|FG001|Overall Study|Lost to Follow-up|20|||
128009418|NCT00109343|460662732|FG002|Overall Study|Lost to Follow-up|14|||
128009419|NCT00109343|460662730|FG000|Overall Study|Protocol Violation|1|||
128009420|NCT00109343|460662731|FG001|Overall Study|Protocol Violation|2|||
128009421|NCT00109343|460662732|FG002|Overall Study|Protocol Violation|2|||
128009422|NCT00109343|460662730|FG000|Overall Study|Withdrawal by Subject|15|||
128009423|NCT00109343|460662731|FG001|Overall Study|Withdrawal by Subject|11|||
127763353|NCT00091169|459758850|FG000|Overall Study|Withdrawal by Subject|10|||
127763354|NCT00091169|459758851|FG001|Overall Study|Withdrawal by Subject|13|||
128009424|NCT00109343|460662732|FG002|Overall Study|Withdrawal by Subject|10|||
128009425|NCT00109343|460662730|FG000|Overall Study|Subject Moved|6|||
128009426|NCT00109343|460662731|FG001|Overall Study|Subject Moved|2|||
128009427|NCT00109343|460662732|FG002|Overall Study|Subject Moved|1|||
128009428|NCT00109343|460662730|FG000|Overall Study|Other|5|||
127763355|NCT00091169|459758850|FG000|Overall Study|Other|3|||
127763356|NCT00091169|459758851|FG001|Overall Study|Other|4|||
128009429|NCT00109343|460662731|FG001|Overall Study|Other|2|||
128009430|NCT00109343|460662732|FG002|Overall Study|Other|1|||
127763357|NCT00091169|459758850|FG000|Overall Study|Not start protocol therapy|26|||
127763358|NCT00091169|459758851|FG001|Overall Study|Not start protocol therapy|17|||
128009431|NCT00750269|460662733|FG000|Overall Study|Protocol Violation|0|||
128009432|NCT00750269|460662734|FG001|Overall Study|Protocol Violation|1|||
127763359|NCT00872989|459758852|FG000|Overall Study|Adverse Event|7|||
127763360|NCT00872989|459758853|FG001|Overall Study|Adverse Event|15|||
127763361|NCT00872989|459758852|FG000|Overall Study|Withdrawal by Subject|8|||
127763362|NCT00872989|459758853|FG001|Overall Study|Withdrawal by Subject|5|||
127763363|NCT00872989|459758852|FG000|Overall Study|Progression/relapse|47|||
128009433|NCT00750269|460662735|FG002|Overall Study|Protocol Violation|1|||
128009434|NCT00750269|460662736|FG003|Overall Study|Protocol Violation|2|||
128009435|NCT00750269|460662737|FG004|Overall Study|Protocol Violation|4|||
128009436|NCT00750269|460662733|FG000|Overall Study|Withdrawal by Subject|0|||
128009437|NCT00750269|460662734|FG001|Overall Study|Withdrawal by Subject|0|||
128009438|NCT00750269|460662735|FG002|Overall Study|Withdrawal by Subject|2|||
128009439|NCT00750269|460662736|FG003|Overall Study|Withdrawal by Subject|2|||
128009440|NCT00750269|460662737|FG004|Overall Study|Withdrawal by Subject|2|||
128009441|NCT00750269|460662733|FG000|Overall Study|Physician Decision|0|||
128009442|NCT00750269|460662734|FG001|Overall Study|Physician Decision|0|||
128009443|NCT00750269|460662735|FG002|Overall Study|Physician Decision|0|||
128009444|NCT00750269|460662736|FG003|Overall Study|Physician Decision|0|||
128009445|NCT00750269|460662737|FG004|Overall Study|Physician Decision|2|||
128009446|NCT00750269|460662733|FG000|Overall Study|Patient too large for positioning|0|||
128009447|NCT00750269|460662734|FG001|Overall Study|Patient too large for positioning|0|||
128009448|NCT00750269|460662735|FG002|Overall Study|Patient too large for positioning|1|||
128009449|NCT00750269|460662736|FG003|Overall Study|Patient too large for positioning|0|||
128009450|NCT00750269|460662737|FG004|Overall Study|Patient too large for positioning|0|||
128009451|NCT00750269|460662733|FG000|Overall Study|Site error|0|||
128009452|NCT00750269|460662734|FG001|Overall Study|Site error|0|||
128009453|NCT00750269|460662735|FG002|Overall Study|Site error|0|||
128009454|NCT00750269|460662736|FG003|Overall Study|Site error|1|||
128009455|NCT00750269|460662737|FG004|Overall Study|Site error|0|||
128009456|NCT00750269|460662733|FG000|Overall Study|SBRT plan could not be drawn|0|||
128009457|NCT00750269|460662734|FG001|Overall Study|SBRT plan could not be drawn|0|||
128009458|NCT00750269|460662735|FG002|Overall Study|SBRT plan could not be drawn|0|||
128009459|NCT00750269|460662736|FG003|Overall Study|SBRT plan could not be drawn|0|||
127763364|NCT00872989|459758853|FG001|Overall Study|Progression/relapse|35|||
127763365|NCT00872989|459758852|FG000|Overall Study|Not protocol specified|3|||
127763366|NCT00872989|459758853|FG001|Overall Study|Not protocol specified|8|||
127763367|NCT02407990|459758854|FG000|Overall Study|Death|2|||
127763368|NCT02407990|459758855|FG001|Overall Study|Death|22|||
128009460|NCT00750269|460662737|FG004|Overall Study|SBRT plan could not be drawn|1|||
128009461|NCT00750269|460662733|FG000|Overall Study|Fiducials could not be placed|0|||
128009462|NCT00750269|460662734|FG001|Overall Study|Fiducials could not be placed|0|||
127763369|NCT02407990|459758856|FG002|Overall Study|Death|23|||
127763370|NCT02407990|459758857|FG003|Overall Study|Death|7|||
127763371|NCT02407990|459758858|FG004|Overall Study|Death|17|||
127763372|NCT02407990|459758859|FG005|Overall Study|Death|16|||
127763373|NCT02407990|459758860|FG006|Overall Study|Death|10|||
127763374|NCT02407990|459758861|FG007|Overall Study|Death|248|||
127763375|NCT02407990|459758854|FG000|Overall Study|Lost to Follow-up|0|||
127763376|NCT02407990|459758855|FG001|Overall Study|Lost to Follow-up|1|||
127763377|NCT02407990|459758856|FG002|Overall Study|Lost to Follow-up|0|||
127763378|NCT02407990|459758857|FG003|Overall Study|Lost to Follow-up|0|||
127763379|NCT02407990|459758858|FG004|Overall Study|Lost to Follow-up|0|||
127763380|NCT02407990|459758859|FG005|Overall Study|Lost to Follow-up|0|||
127763381|NCT02407990|459758860|FG006|Overall Study|Lost to Follow-up|0|||
127763382|NCT02407990|459758861|FG007|Overall Study|Lost to Follow-up|17|||
127763383|NCT02407990|459758854|FG000|Overall Study|Progressive Disease|0|||
127763384|NCT02407990|459758855|FG001|Overall Study|Progressive Disease|0|||
127763385|NCT02407990|459758856|FG002|Overall Study|Progressive Disease|0|||
127763386|NCT02407990|459758857|FG003|Overall Study|Progressive Disease|0|||
127763387|NCT02407990|459758858|FG004|Overall Study|Progressive Disease|0|||
127763388|NCT02407990|459758859|FG005|Overall Study|Progressive Disease|0|||
127763389|NCT02407990|459758860|FG006|Overall Study|Progressive Disease|0|||
127763390|NCT02407990|459758861|FG007|Overall Study|Progressive Disease|1|||
127763391|NCT02407990|459758854|FG000|Overall Study|Withdrawal by Subject|0|||
127763392|NCT02407990|459758855|FG001|Overall Study|Withdrawal by Subject|0|||
127763393|NCT02407990|459758856|FG002|Overall Study|Withdrawal by Subject|0|||
127763394|NCT02407990|459758857|FG003|Overall Study|Withdrawal by Subject|0|||
127763395|NCT02407990|459758858|FG004|Overall Study|Withdrawal by Subject|1|||
128009463|NCT00750269|460662735|FG002|Overall Study|Fiducials could not be placed|0|||
128009464|NCT00750269|460662736|FG003|Overall Study|Fiducials could not be placed|0|||
128009465|NCT00750269|460662737|FG004|Overall Study|Fiducials could not be placed|1|||
128009466|NCT03944616|460662740|FG000|Overall Study|Lost to Follow-up|0|||
128009467|NCT03944616|460662741|FG001|Overall Study|Lost to Follow-up|2|||
128009468|NCT00961064|460662742|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
127763396|NCT02407990|459758859|FG005|Overall Study|Withdrawal by Subject|0|||
127763397|NCT02407990|459758860|FG006|Overall Study|Withdrawal by Subject|0|||
127763398|NCT02407990|459758861|FG007|Overall Study|Withdrawal by Subject|30|||
127763399|NCT02407990|459758854|FG000|Overall Study|Study Terminated by Sponsor|1|||
127763400|NCT02407990|459758855|FG001|Overall Study|Study Terminated by Sponsor|3|||
127763401|NCT02407990|459758856|FG002|Overall Study|Study Terminated by Sponsor|3|||
128009469|NCT00961064|460662742|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
128009470|NCT00961064|460662742|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
128009471|NCT00961064|460662742|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
127763402|NCT02407990|459758857|FG003|Overall Study|Study Terminated by Sponsor|0|||
127763403|NCT02407990|459758858|FG004|Overall Study|Study Terminated by Sponsor|3|||
127763404|NCT02407990|459758859|FG005|Overall Study|Study Terminated by Sponsor|4|||
128009472|NCT00961064|460662742|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
128009473|NCT00961064|460662742|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
128009474|NCT00961064|460662742|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
128009475|NCT00961064|460662742|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
128009476|NCT00576758|460662743|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
128009477|NCT00576758|460662744|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
128009478|NCT00576758|460662743|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
128009479|NCT00576758|460662744|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
127763405|NCT02407990|459758860|FG006|Overall Study|Study Terminated by Sponsor|3|||
127763406|NCT02407990|459758861|FG007|Overall Study|Study Terminated by Sponsor|37|||
127763407|NCT02407990|459758854|FG000|Overall Study|Logistics|0|||
127763408|NCT02407990|459758855|FG001|Overall Study|Logistics|0|||
127763409|NCT02407990|459758856|FG002|Overall Study|Logistics|0|||
127763410|NCT02407990|459758857|FG003|Overall Study|Logistics|0|||
127763411|NCT02407990|459758858|FG004|Overall Study|Logistics|0|||
127763412|NCT02407990|459758859|FG005|Overall Study|Logistics|0|||
127763413|NCT02407990|459758860|FG006|Overall Study|Logistics|0|||
127763414|NCT02407990|459758861|FG007|Overall Study|Logistics|1|||
127763415|NCT02407990|459758854|FG000|Overall Study|Rolled into long-term extension study|0|||
127763416|NCT02407990|459758855|FG001|Overall Study|Rolled into long-term extension study|0|||
127763417|NCT02407990|459758856|FG002|Overall Study|Rolled into long-term extension study|0|||
127763418|NCT02407990|459758857|FG003|Overall Study|Rolled into long-term extension study|0|||
127763419|NCT02407990|459758858|FG004|Overall Study|Rolled into long-term extension study|0|||
127763420|NCT02407990|459758859|FG005|Overall Study|Rolled into long-term extension study|0|||
127763421|NCT02407990|459758860|FG006|Overall Study|Rolled into long-term extension study|0|||
127763422|NCT02407990|459758861|FG007|Overall Study|Rolled into long-term extension study|1|||
127763423|NCT00734097|459758862|FG000|Screening|Protocol Violation|12|||
127763424|NCT00734097|459758862|FG000|Screening|Withdrawal by Subject|5|||
127763425|NCT00734097|459758862|FG000|Screening|Lost to Follow-up|2|||
127763426|NCT00734097|459758862|FG000|Screening|Unconfirmed pregnancy|1|||
127763427|NCT00734097|459758862|FG000|Open Label|Lost to Follow-up|7|||
127763428|NCT00734097|459758862|FG000|Open Label|Withdrawal by Subject|5|||
127763429|NCT00734097|459758862|FG000|Open Label|Protocol Violation|4|||
127763430|NCT02233543|459758867|FG000|Period 1|Withdrawal by Subject|1|||
127763431|NCT02233543|459758868|FG001|Period 1|Withdrawal by Subject|0|||
127763432|NCT02233543|459758867|FG000|Period 1|Participants required other treatment.|2|||
127763433|NCT02233543|459758868|FG001|Period 1|Participants required other treatment.|3|||
127763434|NCT02233543|459758867|FG000|Period 2|Adverse Event|1|||
127763435|NCT02233543|459758868|FG001|Period 2|Adverse Event|0|||
127763436|NCT02233543|459758867|FG000|Period 2|Participant required other treatment.|0|||
127763437|NCT02233543|459758868|FG001|Period 2|Participant required other treatment.|1|||
127763438|NCT02233543|459758867|FG000|Period 2|COPD exacerbation|1|||
127763439|NCT02233543|459758868|FG001|Period 2|COPD exacerbation|0|||
127763440|NCT00616902|459758869|FG000|Overall Study|Termination of study|6|||
127763441|NCT00616902|459758870|FG001|Overall Study|Termination of study|6|||
127763442|NCT03573583|459758871|FG000|Overall Study|Lost to Follow-up|1|||
127763443|NCT03573583|459758872|FG001|Overall Study|Lost to Follow-up|0|||
127763444|NCT03573583|459758871|FG000|Overall Study|Withdrawal by Subject|1|||
127763445|NCT03573583|459758872|FG001|Overall Study|Withdrawal by Subject|1|||
127763446|NCT04343872|459758877|FG000|Overall Study|Lost to Follow-up|6|||
127763447|NCT04343872|459758878|FG001|Overall Study|Lost to Follow-up|3|||
127763448|NCT03730480|459758879|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
127763449|NCT02480153|459758880|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
127763450|NCT02480153|459758881|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
127763451|NCT02480153|459758882|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
127763452|NCT02480153|459758880|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
127763453|NCT02480153|459758881|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
127763454|NCT02480153|459758882|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
127763455|NCT02480153|459758880|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
127763456|NCT02480153|459758881|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
127763457|NCT02480153|459758882|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
127763458|NCT02480153|459758880|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
127763459|NCT02480153|459758881|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
128009480|NCT00576758|460662743|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
128009481|NCT00576758|460662744|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
128009482|NCT00576758|460662743|FG000|Induction Treatment Period|Death|1|||
128009483|NCT00576758|460662744|FG001|Induction Treatment Period|Death|0|||
127763460|NCT02480153|459758882|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
127763461|NCT02480153|459758880|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
127763462|NCT02480153|459758881|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
127763463|NCT02480153|459758882|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
127763464|NCT02480153|459758880|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
127763465|NCT02480153|459758881|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
128009484|NCT00576758|460662743|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
128009485|NCT00576758|460662744|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
128009486|NCT00576758|460662743|FG000|Induction Treatment Period|Withdrew consent|1|||
128009487|NCT00576758|460662744|FG001|Induction Treatment Period|Withdrew consent|0|||
127763466|NCT02480153|459758882|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
127763467|NCT02480153|459758880|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
127763468|NCT02480153|459758881|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
128009488|NCT00576758|460662743|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
128009489|NCT00576758|460662744|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
128009490|NCT00576758|460662743|FG000|Extension Treatment Period|Death|1|||
128009491|NCT00576758|460662744|FG001|Extension Treatment Period|Death|1|||
128009492|NCT00576758|460662743|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
128009493|NCT00576758|460662744|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
128009494|NCT00576758|460662743|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
128009495|NCT00576758|460662744|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
128009496|NCT00576758|460662743|FG000|Extension Treatment Period|Administrative/Other|3|||
128009497|NCT00576758|460662744|FG001|Extension Treatment Period|Administrative/Other|1|||
128009498|NCT00576758|460662743|FG000|Follow-up Period|Administrative/Other|6|||
128009499|NCT00576758|460662744|FG001|Follow-up Period|Administrative/Other|8|||
128009500|NCT00576758|460662743|FG000|Follow-up Period|Death|3|||
127763469|NCT02480153|459758882|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
127763470|NCT02480153|459758880|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
127763471|NCT02480153|459758881|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
127763472|NCT02480153|459758882|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
127763473|NCT02480153|459758880|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
127763474|NCT02480153|459758881|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
127763475|NCT02480153|459758882|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
127763476|NCT02480153|459758880|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
127763477|NCT02480153|459758881|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
127763478|NCT02480153|459758882|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
127763479|NCT02480153|459758880|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
127763480|NCT02480153|459758881|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
127763481|NCT02480153|459758882|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
127763482|NCT02480153|459758880|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
127763483|NCT02480153|459758881|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
127763484|NCT02480153|459758882|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
127763485|NCT02480153|459758880|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
127763486|NCT02480153|459758881|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
127763487|NCT02480153|459758882|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
127763488|NCT02480153|459758880|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
127763489|NCT02480153|459758881|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
127763490|NCT02480153|459758882|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
127763491|NCT02480153|459758880|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
127763492|NCT02480153|459758881|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
127763493|NCT02480153|459758882|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
127763494|NCT02480153|459758880|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
127763495|NCT02480153|459758881|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
127763496|NCT02480153|459758882|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
127763497|NCT02480153|459758880|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
127763498|NCT02480153|459758881|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
127763499|NCT02480153|459758882|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
127763500|NCT02480153|459758880|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
127763501|NCT02480153|459758881|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
127763502|NCT02480153|459758882|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
127763503|NCT00495586|459758883|FG000|Overall Study|Withdrawal by Subject|4|||
127763504|NCT00495586|459758884|FG001|Overall Study|Withdrawal by Subject|4|||
127763505|NCT02038543|459758885|FG000|Overall Study|Screen Failure|0|||
127763506|NCT02038543|459758886|FG001|Overall Study|Screen Failure|0|||
127763507|NCT02038543|459758887|FG002|Overall Study|Screen Failure|0|||
127763508|NCT02038543|459758888|FG003|Overall Study|Screen Failure|1|||
127763509|NCT02038543|459758885|FG000|Overall Study|Withdrawal by Subject|0|||
127763510|NCT02038543|459758886|FG001|Overall Study|Withdrawal by Subject|0|||
127763511|NCT02038543|459758887|FG002|Overall Study|Withdrawal by Subject|0|||
128009501|NCT00576758|460662744|FG001|Follow-up Period|Death|3|||
128009502|NCT00576758|460662743|FG000|Follow-up Period|Insufficient therapeutic response|16|||
128009503|NCT00576758|460662744|FG001|Follow-up Period|Insufficient therapeutic response|5|||
128009504|NCT00576758|460662743|FG000|Follow-up Period|Withdrew consent|2|||
128009505|NCT00576758|460662744|FG001|Follow-up Period|Withdrew consent|1|||
128009506|NCT01294046|460662745|FG000|Overall Study|Infection and surgical explant|1|||
128009507|NCT01294046|460662745|FG000|Overall Study|Eligibility criteria expanded|1|||
128009508|NCT01294046|460662745|FG000|Overall Study|Stimulation response inadqequate|1|||
128009509|NCT00761319|460662746|FG000|Overall Study|Protocol Violation|21|||
128009510|NCT00761319|460662747|FG001|Overall Study|Protocol Violation|14|||
128009511|NCT00761319|460662746|FG000|Overall Study|Adverse Event|11|||
128009512|NCT00761319|460662747|FG001|Overall Study|Adverse Event|7|||
128009513|NCT00761319|460662746|FG000|Overall Study|Withdrawal by Subject|8|||
128009514|NCT00761319|460662747|FG001|Overall Study|Withdrawal by Subject|7|||
128009515|NCT00761319|460662746|FG000|Overall Study|Noncompliance|4|||
128009516|NCT00761319|460662747|FG001|Overall Study|Noncompliance|3|||
128009517|NCT00761319|460662746|FG000|Overall Study|Lost to Follow-up|1|||
128009518|NCT00761319|460662747|FG001|Overall Study|Lost to Follow-up|1|||
128009519|NCT00761319|460662746|FG000|Overall Study|Nonspecified|2|||
128009520|NCT00761319|460662747|FG001|Overall Study|Nonspecified|2|||
128009521|NCT00761319|460662746|FG000|Overall Study|Missing|1|||
128009522|NCT00761319|460662747|FG001|Overall Study|Missing|0|||
128009523|NCT01715298|460662750|FG000|Overall Study|Lost to Follow-up|0|||
128009524|NCT01715298|460662751|FG001|Overall Study|Lost to Follow-up|2|||
128009525|NCT01715298|460662750|FG000|Overall Study|Patient/guardian decision|7|||
128009526|NCT01715298|460662751|FG001|Overall Study|Patient/guardian decision|9|||
128009527|NCT01499511|460662756|FG000|Overall Study|Death|1|||
128009528|NCT01499511|460662757|FG001|Overall Study|Death|0|||
128009529|NCT00726453|460662759|FG000|Primary Enrollment Group|Death|18|||
128009530|NCT00726453|460662760|FG001|Primary Enrollment Group|Death|0|||
128009531|NCT00726453|460662759|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
128009532|NCT00726453|460662760|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
128009533|NCT00726453|460662759|FG000|38 mm Length Group|Death|0|||
128009534|NCT00726453|460662760|FG001|38 mm Length Group|Death|3|||
128009535|NCT01432951|460662761|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
128009536|NCT00853385|460662762|FG000|Overall Study|Death|0|||
128009537|NCT00853385|460662763|FG001|Overall Study|Death|0|||
128009538|NCT00853385|460662764|FG002|Overall Study|Death|0|||
128009539|NCT00853385|460662765|FG003|Overall Study|Death|0|||
128009540|NCT00853385|460662766|FG004|Overall Study|Death|1|||
128009541|NCT00853385|460662762|FG000|Overall Study|Adverse Event|24|||
128009542|NCT00853385|460662763|FG001|Overall Study|Adverse Event|24|||
128009543|NCT00853385|460662764|FG002|Overall Study|Adverse Event|2|||
128009544|NCT00853385|460662765|FG003|Overall Study|Adverse Event|5|||
128009545|NCT00853385|460662766|FG004|Overall Study|Adverse Event|22|||
128009546|NCT00853385|460662762|FG000|Overall Study|Lack of Efficacy|6|||
128009547|NCT00853385|460662763|FG001|Overall Study|Lack of Efficacy|7|||
128009548|NCT00853385|460662764|FG002|Overall Study|Lack of Efficacy|3|||
128009549|NCT00853385|460662765|FG003|Overall Study|Lack of Efficacy|3|||
128009550|NCT00853385|460662766|FG004|Overall Study|Lack of Efficacy|6|||
128009551|NCT00853385|460662762|FG000|Overall Study|Lost to Follow-up|2|||
128009552|NCT00853385|460662763|FG001|Overall Study|Lost to Follow-up|1|||
128009553|NCT00853385|460662764|FG002|Overall Study|Lost to Follow-up|0|||
128009554|NCT00853385|460662765|FG003|Overall Study|Lost to Follow-up|0|||
128009555|NCT00853385|460662766|FG004|Overall Study|Lost to Follow-up|0|||
128009556|NCT00853385|460662762|FG000|Overall Study|Withdrawal by Subject|4|||
128009557|NCT00853385|460662763|FG001|Overall Study|Withdrawal by Subject|2|||
128009558|NCT00853385|460662764|FG002|Overall Study|Withdrawal by Subject|0|||
128009559|NCT00853385|460662765|FG003|Overall Study|Withdrawal by Subject|1|||
128009560|NCT00853385|460662766|FG004|Overall Study|Withdrawal by Subject|1|||
128009561|NCT00853385|460662762|FG000|Overall Study|Other|18|||
128009562|NCT00853385|460662763|FG001|Overall Study|Other|9|||
127675855|NCT01090024|459437536|FG005|Period 1|Lost to Follow-up|0|||
127675856|NCT01090024|459437537|FG006|Period 1|Lost to Follow-up|0|||
127675857|NCT01090024|459437538|FG007|Period 1|Lost to Follow-up|0|||
127675858|NCT01090024|459437539|FG008|Period 1|Lost to Follow-up|0|||
128009563|NCT00853385|460662764|FG002|Overall Study|Other|4|||
128009564|NCT00853385|460662765|FG003|Overall Study|Other|4|||
128009565|NCT00853385|460662766|FG004|Overall Study|Other|12|||
128009566|NCT00915525|460662769|FG000|Overall Study|Protocol Violation|9|||
128009567|NCT00915525|460662770|FG001|Overall Study|Protocol Violation|4|||
128009568|NCT00915525|460662769|FG000|Overall Study|Withdrawal by Subject|59|||
127675859|NCT01090024|459437540|FG009|Period 1|Lost to Follow-up|0|||
128009569|NCT00915525|460662770|FG001|Overall Study|Withdrawal by Subject|21|||
128009570|NCT00915525|460662769|FG000|Overall Study|Lost to Follow-up|27|||
128009571|NCT00915525|460662770|FG001|Overall Study|Lost to Follow-up|16|||
128009572|NCT00915525|460662769|FG000|Overall Study|Pregnancy|2|||
128009573|NCT00915525|460662770|FG001|Overall Study|Pregnancy|0|||
128009574|NCT00915525|460662769|FG000|Overall Study|Lack of Efficacy|15|||
128009575|NCT00915525|460662770|FG001|Overall Study|Lack of Efficacy|32|||
127675860|NCT01090024|459437541|FG010|Period 1|Lost to Follow-up|0|||
128009576|NCT00915525|460662769|FG000|Overall Study|Adverse Event|29|||
128009577|NCT00915525|460662770|FG001|Overall Study|Adverse Event|13|||
128009578|NCT00915525|460662769|FG000|Overall Study|Missing|12|||
127763512|NCT02038543|459758888|FG003|Overall Study|Withdrawal by Subject|1|||
127763513|NCT00158860|459758889|FG000|Overall Study|Adverse Event|3|||
127763514|NCT00158860|459758890|FG001|Overall Study|Adverse Event|6|||
127763515|NCT00158860|459758889|FG000|Overall Study|Lost to Follow-up|11|||
127763516|NCT00158860|459758890|FG001|Overall Study|Lost to Follow-up|17|||
127763517|NCT00158860|459758889|FG000|Overall Study|Protocol Violation|8|||
127763518|NCT00158860|459758890|FG001|Overall Study|Protocol Violation|23|||
127763519|NCT00158860|459758889|FG000|Overall Study|Withdrawal by Subject|7|||
127763520|NCT00158860|459758890|FG001|Overall Study|Withdrawal by Subject|17|||
127763521|NCT00158860|459758889|FG000|Overall Study|MOVING OUT OF STATE|1|||
127763522|NCT00158860|459758890|FG001|Overall Study|MOVING OUT OF STATE|0|||
127763523|NCT00158860|459758889|FG000|Overall Study|Pregnancy|3|||
127763524|NCT00158860|459758890|FG001|Overall Study|Pregnancy|3|||
127763525|NCT00158860|459758889|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
127763526|NCT00158860|459758890|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
127763527|NCT00158860|459758889|FG000|Overall Study|SPONSOR REQUEST|0|||
127763528|NCT00158860|459758890|FG001|Overall Study|SPONSOR REQUEST|1|||
127763529|NCT00158860|459758889|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
127763530|NCT00158860|459758890|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
127763531|NCT00158860|459758889|FG000|Overall Study|Closed per sponsor|0|||
127763532|NCT00158860|459758890|FG001|Overall Study|Closed per sponsor|1|||
127763533|NCT01029652|459758891|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
127763534|NCT01029652|459758892|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
127763535|NCT01029652|459758891|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
127763536|NCT01029652|459758892|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
127763537|NCT01029652|459758891|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
127763538|NCT01029652|459758892|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
127763539|NCT01029652|459758891|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
127763540|NCT01029652|459758892|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
127763541|NCT01029652|459758891|FG000|Core Study (0-12 Weeks)|Death|0|||
127763542|NCT01029652|459758892|FG001|Core Study (0-12 Weeks)|Death|1|||
127763543|NCT01029652|459758891|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
127763544|NCT01029652|459758892|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
127763545|NCT01029652|459758891|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
127763546|NCT01029652|459758892|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
127763547|NCT01029652|459758891|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
127763548|NCT01029652|459758892|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
127763549|NCT01029652|459758891|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
127763550|NCT01029652|459758892|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
127763551|NCT01029652|459758891|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
127763552|NCT01029652|459758892|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
127763553|NCT01029652|459758891|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
127763554|NCT01029652|459758892|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
127763555|NCT01029652|459758891|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
127763556|NCT01029652|459758892|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
127763557|NCT02095951|459758893|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
127763558|NCT02095951|459758894|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
127763559|NCT00964886|459758895|FG000|Overall Study|Lost to Follow-up|2|||
127763560|NCT00964886|459758896|FG001|Overall Study|Lost to Follow-up|2|||
127763561|NCT00964886|459758897|FG002|Overall Study|Lost to Follow-up|6|||
127763562|NCT00964886|459758898|FG003|Overall Study|Lost to Follow-up|4|||
127763563|NCT00964886|459758895|FG000|Overall Study|Withdrawal by Subject|6|||
127763564|NCT00964886|459758896|FG001|Overall Study|Withdrawal by Subject|2|||
127763565|NCT00964886|459758897|FG002|Overall Study|Withdrawal by Subject|5|||
127763566|NCT00964886|459758898|FG003|Overall Study|Withdrawal by Subject|3|||
127763567|NCT00964886|459758895|FG000|Overall Study|Adverse Event|3|||
127763568|NCT00964886|459758896|FG001|Overall Study|Adverse Event|1|||
127763569|NCT00964886|459758897|FG002|Overall Study|Adverse Event|5|||
127763570|NCT00964886|459758898|FG003|Overall Study|Adverse Event|2|||
127763571|NCT00964886|459758895|FG000|Overall Study|Protocol Violation|0|||
127763572|NCT00964886|459758896|FG001|Overall Study|Protocol Violation|2|||
127763573|NCT00964886|459758897|FG002|Overall Study|Protocol Violation|0|||
127763574|NCT00964886|459758898|FG003|Overall Study|Protocol Violation|0|||
127763575|NCT01621568|459758902|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
127763576|NCT01621568|459758903|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
127763577|NCT01621568|459758902|FG000|Week 5-6 No Treatment|Death|1|||
127763578|NCT01621568|459758903|FG001|Week 5-6 No Treatment|Death|0|||
127763579|NCT02334423|459758904|FG000|Overall Study|Protocol Violation|10|||
127763580|NCT02334423|459758905|FG001|Overall Study|Protocol Violation|3|||
127763581|NCT02930226|459758906|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
127763582|NCT02930226|459758907|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
127763583|NCT02930226|459758908|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
127763584|NCT02930226|459758909|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
127763585|NCT02930226|459758910|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
127763586|NCT02930226|459758911|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
127763587|NCT00652327|459758912|FG000|Overall Study|Adverse Event|0|||
127763588|NCT00652327|459758913|FG001|Overall Study|Adverse Event|2|||
127763589|NCT00652327|459758912|FG000|Overall Study|Lost to Follow-up|0|||
127763590|NCT00652327|459758913|FG001|Overall Study|Lost to Follow-up|3|||
127763591|NCT01076647|459758914|FG000|Overall Study|Adverse Event|4|||
127763592|NCT01076647|459758915|FG001|Overall Study|Adverse Event|1|||
127763593|NCT01076647|459758914|FG000|Overall Study|Lack of Efficacy|0|||
127763594|NCT01076647|459758915|FG001|Overall Study|Lack of Efficacy|1|||
127763595|NCT01076647|459758914|FG000|Overall Study|Protocol Violation|7|||
127763596|NCT01076647|459758915|FG001|Overall Study|Protocol Violation|9|||
127763597|NCT01076647|459758914|FG000|Overall Study|Withdrawal criteria|2|||
127763598|NCT01076647|459758915|FG001|Overall Study|Withdrawal criteria|2|||
127763599|NCT01076647|459758914|FG000|Overall Study|Unclassified|12|||
127763600|NCT01076647|459758915|FG001|Overall Study|Unclassified|12|||
127763601|NCT00564889|459758921|FG000|Overall Study|Death|7|||
127763602|NCT00564889|459758921|FG000|Overall Study|Adverse Event|12|||
127763603|NCT00564889|459758921|FG000|Overall Study|Alternative treatment|3|||
127763604|NCT00564889|459758921|FG000|Overall Study|Disease progression|3|||
127763605|NCT00564889|459758921|FG000|Overall Study|Other, not specified|4|||
127763606|NCT03500159|459758922|FG000|Overall Study|Study Terminated|2|||
127763607|NCT03500159|459758923|FG001|Overall Study|Study Terminated|1|||
127763608|NCT02292927|459758928|FG000|Overall Study|Protocol Violation|13|||
127763609|NCT02292927|459758929|FG001|Overall Study|Protocol Violation|7|||
127763610|NCT00141219|459758933|FG000|Overall Study|Protocol violations|5|||
127763611|NCT00141219|459758934|FG001|Overall Study|Protocol violations|4|||
127763612|NCT00141219|459758933|FG000|Overall Study|Adverse Event|8|||
127763613|NCT00141219|459758934|FG001|Overall Study|Adverse Event|6|||
127763614|NCT00141219|459758933|FG000|Overall Study|Lack of Efficacy|5|||
127763615|NCT00141219|459758934|FG001|Overall Study|Lack of Efficacy|4|||
127763616|NCT00141219|459758933|FG000|Overall Study|Withdrawal by Subject|6|||
127763617|NCT00141219|459758934|FG001|Overall Study|Withdrawal by Subject|2|||
127763618|NCT02224690|459758935|FG000|Overall Study|Adverse Event|8|||
127763619|NCT02224690|459758936|FG001|Overall Study|Adverse Event|1|||
127763620|NCT02224690|459758935|FG000|Overall Study|Met Withdrawal Criteria|4|||
127763621|NCT02224690|459758936|FG001|Overall Study|Met Withdrawal Criteria|0|||
127763622|NCT02224690|459758935|FG000|Overall Study|Use of G-tube|1|||
127763623|NCT02224690|459758936|FG001|Overall Study|Use of G-tube|0|||
127763624|NCT02224690|459758935|FG000|Overall Study|Did not meet eligibility criteria|1|||
127763625|NCT02224690|459758936|FG001|Overall Study|Did not meet eligibility criteria|0|||
127763626|NCT00122460|459758938|FG000|Overall Study|investigational study phase ongoing|7|||
127763627|NCT00122460|459758939|FG001|Overall Study|investigational study phase ongoing|1|||
127763628|NCT02595073|459758940|FG000|Overall Study|Progressive Disease|0|||
127763629|NCT02595073|459758941|FG001|Overall Study|Progressive Disease|1|||
127763630|NCT02595073|459758940|FG000|Overall Study|Protocol Violation|2|||
127763631|NCT02595073|459758941|FG001|Overall Study|Protocol Violation|0|||
127763632|NCT02962960|459758942|FG000|Overall Study|Withdrawal by Subject|1|||
127763633|NCT02962960|459758943|FG001|Overall Study|Withdrawal by Subject|1|||
127763634|NCT02962960|459758944|FG002|Overall Study|Withdrawal by Subject|0|||
127763635|NCT02962960|459758942|FG000|Overall Study|Adverse Event|1|||
127763636|NCT02962960|459758943|FG001|Overall Study|Adverse Event|1|||
127763637|NCT02962960|459758944|FG002|Overall Study|Adverse Event|0|||
127763638|NCT02962960|459758942|FG000|Overall Study|Protocol Violation|1|||
127763639|NCT02962960|459758943|FG001|Overall Study|Protocol Violation|0|||
127763640|NCT02962960|459758944|FG002|Overall Study|Protocol Violation|0|||
127763641|NCT01103362|459758945|FG000|Overall Study|study terminated|596|||
127763642|NCT02665338|459758947|FG000|Overall Study|Withdrawal by Subject|0|||
127763643|NCT02665338|459758948|FG001|Overall Study|Withdrawal by Subject|1|||
127763644|NCT05326815|459758952|FG000|Overall Study|Withdrawal by Subject|3|||
127763645|NCT05326815|459758952|FG000|Overall Study|Did not complete required labs|6|||
127763646|NCT05326815|459758952|FG000|Overall Study|Screen fail- abnormal labs|5|||
127543551|NCT02718898|458956551|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
127763647|NCT03562975|459758953|FG000|Overall Study|Death|1|||
127763648|NCT03562975|459758953|FG000|Overall Study|Lost to Follow-up|1|||
127763649|NCT03562975|459758953|FG000|Overall Study|Withdrawal by Subject|1|||
127763650|NCT02545933|459758954|FG000|Overall Study|Adverse Event|3|||
127763651|NCT02545933|459758955|FG001|Overall Study|Adverse Event|0|||
127763652|NCT02545933|459758956|FG002|Overall Study|Adverse Event|0|||
127763653|NCT02545933|459758954|FG000|Overall Study|Withdrawal by Subject|2|||
127763654|NCT02545933|459758955|FG001|Overall Study|Withdrawal by Subject|3|||
127763655|NCT02545933|459758956|FG002|Overall Study|Withdrawal by Subject|3|||
127763656|NCT02545933|459758954|FG000|Overall Study|Protocol Violation|1|||
127763657|NCT02545933|459758955|FG001|Overall Study|Protocol Violation|0|||
127763658|NCT02545933|459758956|FG002|Overall Study|Protocol Violation|1|||
127543552|NCT02718898|458956552|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
127763659|NCT00935818|459758959|FG000|Overall Study|Withdrawal by Subject|45|||
127763660|NCT00935818|459758960|FG001|Overall Study|Withdrawal by Subject|50|||
127675861|NCT01090024|459437542|FG011|Period 1|Lost to Follow-up|0|||
127675862|NCT01090024|459437543|FG012|Period 1|Lost to Follow-up|0|||
127675863|NCT01090024|459437544|FG013|Period 1|Lost to Follow-up|0|||
127675864|NCT01090024|459437545|FG014|Period 1|Lost to Follow-up|0|||
127675865|NCT01090024|459437546|FG015|Period 1|Lost to Follow-up|0|||
127675866|NCT01090024|459437547|FG016|Period 1|Lost to Follow-up|0|||
127675867|NCT01090024|459437548|FG017|Period 1|Lost to Follow-up|0|||
127675868|NCT01090024|459437531|FG000|Period 2|Lost to Follow-up|0|||
127675869|NCT01090024|459437532|FG001|Period 2|Lost to Follow-up|0|||
127675870|NCT01090024|459437533|FG002|Period 2|Lost to Follow-up|0|||
127675871|NCT01090024|459437534|FG003|Period 2|Lost to Follow-up|1|||
127675872|NCT01090024|459437535|FG004|Period 2|Lost to Follow-up|0|||
127675873|NCT01090024|459437536|FG005|Period 2|Lost to Follow-up|0|||
127675874|NCT01090024|459437537|FG006|Period 2|Lost to Follow-up|0|||
127675875|NCT01090024|459437538|FG007|Period 2|Lost to Follow-up|0|||
127675876|NCT01090024|459437539|FG008|Period 2|Lost to Follow-up|0|||
127675877|NCT01090024|459437540|FG009|Period 2|Lost to Follow-up|0|||
127675878|NCT01090024|459437541|FG010|Period 2|Lost to Follow-up|0|||
127675879|NCT01090024|459437542|FG011|Period 2|Lost to Follow-up|0|||
127675880|NCT01090024|459437543|FG012|Period 2|Lost to Follow-up|0|||
127675881|NCT01090024|459437544|FG013|Period 2|Lost to Follow-up|0|||
127675882|NCT01090024|459437545|FG014|Period 2|Lost to Follow-up|0|||
127675883|NCT01090024|459437546|FG015|Period 2|Lost to Follow-up|0|||
127675884|NCT01090024|459437547|FG016|Period 2|Lost to Follow-up|0|||
127675885|NCT01090024|459437548|FG017|Period 2|Lost to Follow-up|0|||
127675886|NCT01090024|459437531|FG000|Period 2|Adverse Event|1|||
127675887|NCT01090024|459437532|FG001|Period 2|Adverse Event|0|||
127675888|NCT01090024|459437533|FG002|Period 2|Adverse Event|0|||
127675889|NCT01090024|459437534|FG003|Period 2|Adverse Event|0|||
127675890|NCT01090024|459437535|FG004|Period 2|Adverse Event|0|||
127675891|NCT01090024|459437536|FG005|Period 2|Adverse Event|0|||
127675892|NCT01090024|459437537|FG006|Period 2|Adverse Event|0|||
127675893|NCT01090024|459437538|FG007|Period 2|Adverse Event|0|||
127675894|NCT01090024|459437539|FG008|Period 2|Adverse Event|0|||
127675895|NCT01090024|459437540|FG009|Period 2|Adverse Event|0|||
127675896|NCT01090024|459437541|FG010|Period 2|Adverse Event|0|||
127675897|NCT01090024|459437542|FG011|Period 2|Adverse Event|0|||
127675898|NCT01090024|459437543|FG012|Period 2|Adverse Event|0|||
127675899|NCT01090024|459437544|FG013|Period 2|Adverse Event|0|||
127675900|NCT01090024|459437545|FG014|Period 2|Adverse Event|0|||
127675901|NCT01090024|459437546|FG015|Period 2|Adverse Event|0|||
127675902|NCT01090024|459437547|FG016|Period 2|Adverse Event|0|||
127675903|NCT01090024|459437548|FG017|Period 2|Adverse Event|0|||
127675904|NCT01090024|459437531|FG000|Period 3|Withdrawal by Subject|0|||
127675905|NCT01090024|459437532|FG001|Period 3|Withdrawal by Subject|0|||
127675906|NCT01090024|459437533|FG002|Period 3|Withdrawal by Subject|0|||
127675907|NCT01090024|459437534|FG003|Period 3|Withdrawal by Subject|0|||
127675908|NCT01090024|459437535|FG004|Period 3|Withdrawal by Subject|0|||
127675909|NCT01090024|459437536|FG005|Period 3|Withdrawal by Subject|0|||
127675910|NCT01090024|459437537|FG006|Period 3|Withdrawal by Subject|0|||
127675911|NCT01090024|459437538|FG007|Period 3|Withdrawal by Subject|0|||
127675912|NCT01090024|459437539|FG008|Period 3|Withdrawal by Subject|0|||
127675913|NCT01090024|459437540|FG009|Period 3|Withdrawal by Subject|0|||
127675914|NCT01090024|459437541|FG010|Period 3|Withdrawal by Subject|0|||
127675915|NCT01090024|459437542|FG011|Period 3|Withdrawal by Subject|0|||
127675916|NCT01090024|459437543|FG012|Period 3|Withdrawal by Subject|0|||
127675917|NCT01090024|459437544|FG013|Period 3|Withdrawal by Subject|0|||
127675918|NCT01090024|459437545|FG014|Period 3|Withdrawal by Subject|0|||
127675919|NCT01090024|459437546|FG015|Period 3|Withdrawal by Subject|1|||
127675920|NCT01090024|459437547|FG016|Period 3|Withdrawal by Subject|0|||
127675921|NCT01090024|459437548|FG017|Period 3|Withdrawal by Subject|0|||
127675922|NCT01090024|459437531|FG000|Period 3|Protocol Violation|0|||
127675923|NCT01090024|459437532|FG001|Period 3|Protocol Violation|0|||
127675924|NCT01090024|459437533|FG002|Period 3|Protocol Violation|0|||
127675925|NCT01090024|459437534|FG003|Period 3|Protocol Violation|0|||
127675926|NCT01090024|459437535|FG004|Period 3|Protocol Violation|0|||
127675927|NCT01090024|459437536|FG005|Period 3|Protocol Violation|0|||
127675928|NCT01090024|459437537|FG006|Period 3|Protocol Violation|0|||
127763661|NCT00935818|459758959|FG000|Overall Study|Lost to Follow-up|40|||
127675929|NCT01090024|459437538|FG007|Period 3|Protocol Violation|0|||
127675930|NCT01090024|459437539|FG008|Period 3|Protocol Violation|1|||
127675931|NCT01090024|459437540|FG009|Period 3|Protocol Violation|0|||
127675932|NCT01090024|459437541|FG010|Period 3|Protocol Violation|0|||
127675933|NCT01090024|459437542|FG011|Period 3|Protocol Violation|0|||
127675934|NCT01090024|459437543|FG012|Period 3|Protocol Violation|0|||
127543553|NCT02718898|458956553|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
127675935|NCT01090024|459437544|FG013|Period 3|Protocol Violation|0|||
127675936|NCT01090024|459437545|FG014|Period 3|Protocol Violation|0|||
127675937|NCT01090024|459437546|FG015|Period 3|Protocol Violation|0|||
127675938|NCT01090024|459437547|FG016|Period 3|Protocol Violation|0|||
127675939|NCT01090024|459437548|FG017|Period 3|Protocol Violation|0|||
127675940|NCT01090024|459437531|FG000|Period 3|Adverse Event|0|||
127675941|NCT01090024|459437532|FG001|Period 3|Adverse Event|0|||
127763662|NCT00935818|459758960|FG001|Overall Study|Lost to Follow-up|42|||
127763663|NCT00935818|459758959|FG000|Overall Study|Adverse Event|6|||
127763664|NCT00935818|459758960|FG001|Overall Study|Adverse Event|7|||
127763665|NCT00935818|459758959|FG000|Overall Study|Physician Decision|0|||
127763666|NCT00935818|459758960|FG001|Overall Study|Physician Decision|1|||
127763667|NCT00979134|459758961|FG000|Overall Study|Disease progression|18|||
127763668|NCT00979134|459758962|FG001|Overall Study|Disease progression|2|||
127763669|NCT00979134|459758963|FG002|Overall Study|Disease progression|5|||
127763670|NCT00979134|459758961|FG000|Overall Study|Adverse Event|0|||
127763671|NCT00979134|459758962|FG001|Overall Study|Adverse Event|0|||
127763672|NCT00979134|459758963|FG002|Overall Study|Adverse Event|2|||
127763673|NCT00979134|459758961|FG000|Overall Study|Withdrawal by Subject|1|||
127763674|NCT00979134|459758962|FG001|Overall Study|Withdrawal by Subject|1|||
127763675|NCT00979134|459758963|FG002|Overall Study|Withdrawal by Subject|2|||
127763676|NCT00979134|459758961|FG000|Overall Study|Lost to Follow-up|2|||
127763677|NCT00979134|459758962|FG001|Overall Study|Lost to Follow-up|2|||
127763678|NCT00979134|459758963|FG002|Overall Study|Lost to Follow-up|0|||
127763679|NCT00979134|459758961|FG000|Overall Study|Death|4|||
127763680|NCT00979134|459758962|FG001|Overall Study|Death|0|||
127763681|NCT00979134|459758963|FG002|Overall Study|Death|26|||
127763682|NCT00979134|459758961|FG000|Overall Study|Other|8|||
127763683|NCT00979134|459758962|FG001|Overall Study|Other|1|||
127763684|NCT00979134|459758963|FG002|Overall Study|Other|5|||
127763685|NCT05180500|459758966|FG000|Overall Study|Adverse Event|1|||
127763686|NCT05180500|459758967|FG001|Overall Study|Adverse Event|0|||
127763687|NCT05180500|459758966|FG000|Overall Study|Withdrawal by Subject|2|||
127763688|NCT05180500|459758967|FG001|Overall Study|Withdrawal by Subject|0|||
127763689|NCT00867308|459758968|FG000|Overall Study|Death|1|||
127763690|NCT00867308|459758969|FG001|Overall Study|Death|0|||
127763691|NCT00867308|459758968|FG000|Overall Study|Adverse Event|1|||
127763692|NCT00867308|459758969|FG001|Overall Study|Adverse Event|4|||
127763693|NCT00867308|459758968|FG000|Overall Study|Lack of Efficacy|6|||
127763694|NCT00867308|459758969|FG001|Overall Study|Lack of Efficacy|12|||
127763695|NCT00867308|459758968|FG000|Overall Study|Withdrawal by Subject|1|||
127763696|NCT00867308|459758969|FG001|Overall Study|Withdrawal by Subject|2|||
127763697|NCT05917470|459758975|FG000|Overall Study|Progressive Disease|1|||
127763698|NCT05917470|459758976|FG001|Overall Study|Progressive Disease|1|||
127763699|NCT05917470|459758977|FG002|Overall Study|Progressive Disease|2|||
127763700|NCT05917470|459758978|FG003|Overall Study|Progressive Disease|3|||
127763701|NCT05917470|459758979|FG004|Overall Study|Progressive Disease|1|||
127763702|NCT05917470|459758980|FG005|Overall Study|Progressive Disease|1|||
127763703|NCT05917470|459758981|FG006|Overall Study|Progressive Disease|0|||
127763704|NCT05917470|459758982|FG007|Overall Study|Progressive Disease|0|||
127763705|NCT05917470|459758975|FG000|Overall Study|Withdrawal by Subject|0|||
127763706|NCT05917470|459758976|FG001|Overall Study|Withdrawal by Subject|0|||
127763707|NCT05917470|459758977|FG002|Overall Study|Withdrawal by Subject|1|||
127763708|NCT05917470|459758978|FG003|Overall Study|Withdrawal by Subject|0|||
127763709|NCT05917470|459758979|FG004|Overall Study|Withdrawal by Subject|0|||
127763710|NCT05917470|459758980|FG005|Overall Study|Withdrawal by Subject|0|||
127763711|NCT05917470|459758981|FG006|Overall Study|Withdrawal by Subject|0|||
127763712|NCT05917470|459758982|FG007|Overall Study|Withdrawal by Subject|0|||
127763713|NCT05917470|459758975|FG000|Overall Study|Sponsor Decision|0|||
127763714|NCT05917470|459758976|FG001|Overall Study|Sponsor Decision|0|||
127763715|NCT05917470|459758977|FG002|Overall Study|Sponsor Decision|1|||
127763716|NCT05917470|459758978|FG003|Overall Study|Sponsor Decision|0|||
127763717|NCT05917470|459758979|FG004|Overall Study|Sponsor Decision|2|||
127763718|NCT05917470|459758980|FG005|Overall Study|Sponsor Decision|1|||
127763719|NCT05917470|459758981|FG006|Overall Study|Sponsor Decision|3|||
127763720|NCT05917470|459758982|FG007|Overall Study|Sponsor Decision|3|||
127763721|NCT05917470|459758975|FG000|Overall Study|Adverse Event|0|||
127763722|NCT05917470|459758976|FG001|Overall Study|Adverse Event|0|||
127763723|NCT05917470|459758977|FG002|Overall Study|Adverse Event|0|||
127763724|NCT05917470|459758978|FG003|Overall Study|Adverse Event|0|||
127763725|NCT05917470|459758979|FG004|Overall Study|Adverse Event|0|||
127763726|NCT05917470|459758980|FG005|Overall Study|Adverse Event|1|||
127763727|NCT05917470|459758981|FG006|Overall Study|Adverse Event|0|||
127763728|NCT05917470|459758982|FG007|Overall Study|Adverse Event|0|||
127763729|NCT02317432|459758983|FG000|Overall Study|Death|4|||
127763730|NCT02317432|459758984|FG001|Overall Study|Death|1|||
127763731|NCT02317432|459758983|FG000|Overall Study|Lost to Follow-up|0|||
127763732|NCT02317432|459758984|FG001|Overall Study|Lost to Follow-up|5|||
127763733|NCT02317432|459758983|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
127763734|NCT02317432|459758984|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
127763735|NCT03992846|459758989|FG000|Overall Study|Adverse Event|8|||
127763736|NCT03992846|459758990|FG001|Overall Study|Adverse Event|6|||
127763737|NCT03992846|459758991|FG002|Overall Study|Adverse Event|3|||
127763738|NCT03992846|459758989|FG000|Overall Study|Lost to Follow-up|0|||
127763739|NCT03992846|459758990|FG001|Overall Study|Lost to Follow-up|1|||
127763740|NCT03992846|459758991|FG002|Overall Study|Lost to Follow-up|1|||
127763741|NCT03992846|459758989|FG000|Overall Study|Pregnancy|2|||
127763742|NCT03992846|459758990|FG001|Overall Study|Pregnancy|0|||
127763743|NCT03992846|459758991|FG002|Overall Study|Pregnancy|1|||
127763744|NCT03992846|459758989|FG000|Overall Study|Protocol Violation|1|||
127763745|NCT03992846|459758990|FG001|Overall Study|Protocol Violation|2|||
127763746|NCT03992846|459758991|FG002|Overall Study|Protocol Violation|0|||
127763747|NCT03992846|459758989|FG000|Overall Study|Withdrawal by Subject|8|||
127763748|NCT03992846|459758990|FG001|Overall Study|Withdrawal by Subject|10|||
127763749|NCT03992846|459758991|FG002|Overall Study|Withdrawal by Subject|20|||
127763750|NCT03992846|459758989|FG000|Overall Study|Sponsor decided to exclude the patient|1|||
127763751|NCT03992846|459758990|FG001|Overall Study|Sponsor decided to exclude the patient|0|||
127763752|NCT03992846|459758991|FG002|Overall Study|Sponsor decided to exclude the patient|0|||
127763753|NCT03647488|459761437|FG000|Overall Study|Progressive disease|10|||
127763754|NCT03647488|459761438|FG001|Overall Study|Progressive disease|0|||
127763755|NCT03647488|459761439|FG002|Overall Study|Progressive disease|0|||
127763756|NCT03647488|459761437|FG000|Overall Study|Adverse Event|5|||
127763757|NCT03647488|459761438|FG001|Overall Study|Adverse Event|0|||
127763758|NCT03647488|459761439|FG002|Overall Study|Adverse Event|0|||
127763759|NCT03647488|459761437|FG000|Overall Study|Clinical progression|2|||
127763760|NCT03647488|459761438|FG001|Overall Study|Clinical progression|0|||
127763761|NCT03647488|459761439|FG002|Overall Study|Clinical progression|0|||
127763762|NCT03647488|459761437|FG000|Overall Study|Participant refused to take investigational product|1|||
127763763|NCT03647488|459761438|FG001|Overall Study|Participant refused to take investigational product|0|||
127763764|NCT03647488|459761439|FG002|Overall Study|Participant refused to take investigational product|0|||
127763765|NCT03694275|459761440|FG000|Overall Study|Adverse Event|0|||
127763766|NCT03694275|459761441|FG001|Overall Study|Adverse Event|1|||
127763767|NCT03694275|459761440|FG000|Overall Study|Reason not Specified|0|||
127763768|NCT03694275|459761441|FG001|Overall Study|Reason not Specified|1|||
127763769|NCT03541174|459761442|FG000|Part 1 Double-Blind|Adverse Event|6|||
127763770|NCT03541174|459761443|FG001|Part 1 Double-Blind|Adverse Event|5|||
127763771|NCT03541174|459761444|FG002|Part 1 Double-Blind|Adverse Event|2|||
127763772|NCT03541174|459761445|FG003|Part 1 Double-Blind|Adverse Event|0|||
127763773|NCT03541174|459761446|FG004|Part 1 Double-Blind|Adverse Event|0|||
127763774|NCT03541174|459761447|FG005|Part 1 Double-Blind|Adverse Event|0|||
127763775|NCT03541174|459761442|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
127763776|NCT03541174|459761443|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
127763777|NCT03541174|459761444|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
127763778|NCT03541174|459761445|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
127763779|NCT03541174|459761446|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
127763780|NCT03541174|459761447|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
127763781|NCT03541174|459761442|FG000|Part 1 Double-Blind|Other reasons|3|||
127763782|NCT03541174|459761443|FG001|Part 1 Double-Blind|Other reasons|2|||
127763783|NCT03541174|459761444|FG002|Part 1 Double-Blind|Other reasons|3|||
127763784|NCT03541174|459761445|FG003|Part 1 Double-Blind|Other reasons|0|||
127763785|NCT03541174|459761446|FG004|Part 1 Double-Blind|Other reasons|0|||
127763786|NCT03541174|459761447|FG005|Part 1 Double-Blind|Other reasons|0|||
127763787|NCT03541174|459761442|FG000|Part 2 Single-Blind|Adverse Event|0|||
127763788|NCT03541174|459761443|FG001|Part 2 Single-Blind|Adverse Event|0|||
127763789|NCT03541174|459761444|FG002|Part 2 Single-Blind|Adverse Event|0|||
127763790|NCT03541174|459761445|FG003|Part 2 Single-Blind|Adverse Event|25|||
127763791|NCT03541174|459761446|FG004|Part 2 Single-Blind|Adverse Event|0|||
127763792|NCT03541174|459761447|FG005|Part 2 Single-Blind|Adverse Event|0|||
127763793|NCT03541174|459761442|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
127763794|NCT03541174|459761443|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
127763795|NCT03541174|459761444|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
127763796|NCT03541174|459761445|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
127763797|NCT03541174|459761446|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
127763798|NCT03541174|459761447|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
127763799|NCT03541174|459761442|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
127763800|NCT03541174|459761443|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
127763801|NCT03541174|459761444|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
127763802|NCT03541174|459761445|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
128009579|NCT00915525|460662770|FG001|Overall Study|Missing|1|||
128009580|NCT00915525|460662769|FG000|Overall Study|Other Reason|35|||
128009581|NCT00915525|460662770|FG001|Overall Study|Other Reason|12|||
128009582|NCT00915525|460662769|FG000|Overall Study|Site Closed|27|||
127763803|NCT03541174|459761446|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
127763804|NCT03541174|459761447|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
128009583|NCT00915525|460662770|FG001|Overall Study|Site Closed|9|||
127763805|NCT03541174|459761442|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
127763806|NCT03541174|459761443|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
127763807|NCT03541174|459761444|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
128009584|NCT00915525|460662769|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
127763808|NCT03541174|459761445|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
127763809|NCT03541174|459761446|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
127763810|NCT03541174|459761447|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
127763811|NCT03541174|459761442|FG000|Part 2 Single-Blind|Death|0|||
128009585|NCT00915525|460662770|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
127763812|NCT03541174|459761443|FG001|Part 2 Single-Blind|Death|0|||
127763813|NCT03541174|459761444|FG002|Part 2 Single-Blind|Death|0|||
127763814|NCT03541174|459761445|FG003|Part 2 Single-Blind|Death|5|||
127763815|NCT03541174|459761446|FG004|Part 2 Single-Blind|Death|0|||
127763816|NCT03541174|459761447|FG005|Part 2 Single-Blind|Death|0|||
127763817|NCT03541174|459761442|FG000|Part 2 Single-Blind|Pregnancy|0|||
127763818|NCT03541174|459761443|FG001|Part 2 Single-Blind|Pregnancy|0|||
127763819|NCT03541174|459761444|FG002|Part 2 Single-Blind|Pregnancy|0|||
127763820|NCT03541174|459761445|FG003|Part 2 Single-Blind|Pregnancy|1|||
127763821|NCT03541174|459761446|FG004|Part 2 Single-Blind|Pregnancy|0|||
127763822|NCT03541174|459761447|FG005|Part 2 Single-Blind|Pregnancy|0|||
127763823|NCT03541174|459761442|FG000|Part 2 Single-Blind|Other reasons|0|||
127763824|NCT03541174|459761443|FG001|Part 2 Single-Blind|Other reasons|0|||
127763825|NCT03541174|459761444|FG002|Part 2 Single-Blind|Other reasons|0|||
127763826|NCT03541174|459761445|FG003|Part 2 Single-Blind|Other reasons|32|||
127763827|NCT03541174|459761446|FG004|Part 2 Single-Blind|Other reasons|0|||
127763828|NCT03541174|459761447|FG005|Part 2 Single-Blind|Other reasons|0|||
127763829|NCT03541174|459761442|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
127763830|NCT03541174|459761443|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
127763831|NCT03541174|459761444|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
127763832|NCT03541174|459761445|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
127763833|NCT03541174|459761446|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
127763834|NCT03541174|459761447|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
127763835|NCT03541174|459761442|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
127763836|NCT03541174|459761443|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
127763837|NCT03541174|459761444|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
127763838|NCT03541174|459761445|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
127763839|NCT03541174|459761446|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
127763840|NCT03541174|459761447|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
127763841|NCT03541174|459761442|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
127763842|NCT03541174|459761443|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
127763843|NCT03541174|459761444|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
127763844|NCT03541174|459761445|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
127763845|NCT03541174|459761446|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
127763846|NCT03541174|459761447|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
127763847|NCT03541174|459761442|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
127763848|NCT03541174|459761443|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
127763849|NCT03541174|459761444|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
127763850|NCT03541174|459761445|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
127763851|NCT03541174|459761446|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
127763852|NCT03541174|459761447|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
127763853|NCT03541174|459761442|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
127763854|NCT03541174|459761443|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
127763855|NCT03541174|459761444|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
127763856|NCT03541174|459761445|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
127763857|NCT03541174|459761446|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
127763858|NCT03541174|459761447|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
127763859|NCT02217332|459761450|FG000|Overall Study|Adverse Event|3|||
127763860|NCT02217332|459761450|FG000|Overall Study|Dose interruption >1 month|1|||
127763861|NCT02217332|459761450|FG000|Overall Study|Protocol Violation (eligibility)|1|||
127763862|NCT02217332|459761450|FG000|Overall Study|Withdrawal by Subject|1|||
127763863|NCT02217332|459761450|FG000|Overall Study|Lost to Follow-up|1|||
127763864|NCT04058366|459761451|FG000|Overall Study|Adverse Event|14|||
127763865|NCT04058366|459761451|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
127763866|NCT04058366|459761451|FG000|Overall Study|Commercial drug is available for participants|6|||
127763867|NCT04058366|459761451|FG000|Overall Study|Death|1|||
127763868|NCT04058366|459761451|FG000|Overall Study|Other non-compliance|2|||
127763869|NCT04058366|459761451|FG000|Overall Study|Other|6|||
127763870|NCT00603304|459761452|FG000|Overall Study|Lost to Follow-up|5|||
127763871|NCT00603304|459761453|FG001|Overall Study|Lost to Follow-up|7|||
127763872|NCT00603304|459761452|FG000|Overall Study|Withdrawal by Subject|8|||
127763873|NCT00603304|459761453|FG001|Overall Study|Withdrawal by Subject|5|||
127763874|NCT00603304|459761452|FG000|Overall Study|Protocol Violation|1|||
127763875|NCT00603304|459761453|FG001|Overall Study|Protocol Violation|0|||
127763876|NCT00603304|459761452|FG000|Overall Study|Adverse Event|4|||
127763877|NCT00603304|459761453|FG001|Overall Study|Adverse Event|2|||
127763878|NCT00603304|459761452|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
127763879|NCT00603304|459761453|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
127763880|NCT00603304|459761452|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
127763881|NCT00603304|459761453|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
127763882|NCT00603304|459761452|FG000|Overall Study|Exclusionary Medication|2|||
127763883|NCT00603304|459761453|FG001|Overall Study|Exclusionary Medication|3|||
127763884|NCT00603304|459761452|FG000|Overall Study|Non-Compliant|0|||
128009586|NCT00915525|460662769|FG000|Overall Study|Study Burden|28|||
128009587|NCT00915525|460662770|FG001|Overall Study|Study Burden|12|||
128009588|NCT00915525|460662769|FG000|Overall Study|Non-Compliance|3|||
128009589|NCT00915525|460662770|FG001|Overall Study|Non-Compliance|1|||
128009590|NCT00915525|460662769|FG000|Overall Study|Patient Moved|15|||
128009591|NCT00915525|460662770|FG001|Overall Study|Patient Moved|9|||
128009592|NCT02765035|460662775|FG000|First Intervention (90 Days)|Adverse Event|1|||
128009593|NCT02765035|460662776|FG001|First Intervention (90 Days)|Adverse Event|1|||
128009594|NCT02765035|460662775|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
128009595|NCT02765035|460662776|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
128009596|NCT00984867|460662784|FG000|Overall Study|Adverse Event|3|||
127675942|NCT01090024|459437533|FG002|Period 3|Adverse Event|0|||
127675943|NCT01090024|459437534|FG003|Period 3|Adverse Event|0|||
127675944|NCT01090024|459437535|FG004|Period 3|Adverse Event|0|||
127675945|NCT01090024|459437536|FG005|Period 3|Adverse Event|1|||
127675946|NCT01090024|459437537|FG006|Period 3|Adverse Event|0|||
127675947|NCT01090024|459437538|FG007|Period 3|Adverse Event|0|||
127675948|NCT01090024|459437539|FG008|Period 3|Adverse Event|0|||
127675949|NCT01090024|459437540|FG009|Period 3|Adverse Event|0|||
127675950|NCT01090024|459437541|FG010|Period 3|Adverse Event|0|||
127675951|NCT01090024|459437542|FG011|Period 3|Adverse Event|0|||
127675952|NCT01090024|459437543|FG012|Period 3|Adverse Event|0|||
127675953|NCT01090024|459437544|FG013|Period 3|Adverse Event|0|||
127675954|NCT01090024|459437545|FG014|Period 3|Adverse Event|0|||
127675955|NCT01090024|459437546|FG015|Period 3|Adverse Event|0|||
127675956|NCT01090024|459437547|FG016|Period 3|Adverse Event|0|||
127675957|NCT01090024|459437548|FG017|Period 3|Adverse Event|0|||
127675958|NCT00567879|459437551|FG000|Overall Study|Adverse Event|2|||
127675959|NCT00567879|459437552|FG001|Overall Study|Adverse Event|0|||
127675960|NCT00567879|459437553|FG002|Overall Study|Adverse Event|1|||
127675961|NCT00567879|459437554|FG003|Overall Study|Adverse Event|0|||
127675962|NCT00567879|459437555|FG004|Overall Study|Adverse Event|1|||
127675963|NCT00567879|459437556|FG005|Overall Study|Adverse Event|0|||
127675964|NCT00567879|459437551|FG000|Overall Study|Abnormal test procedure(s)|0|||
127675965|NCT00567879|459437552|FG001|Overall Study|Abnormal test procedure(s)|0|||
127675966|NCT00567879|459437553|FG002|Overall Study|Abnormal test procedure(s)|1|||
127675967|NCT00567879|459437554|FG003|Overall Study|Abnormal test procedure(s)|0|||
127675968|NCT00567879|459437555|FG004|Overall Study|Abnormal test procedure(s)|0|||
127675969|NCT00567879|459437556|FG005|Overall Study|Abnormal test procedure(s)|0|||
127675970|NCT00567879|459437551|FG000|Overall Study|Withdrawal by Subject|0|||
127675971|NCT00567879|459437552|FG001|Overall Study|Withdrawal by Subject|0|||
127675972|NCT00567879|459437553|FG002|Overall Study|Withdrawal by Subject|3|||
127675973|NCT00567879|459437554|FG003|Overall Study|Withdrawal by Subject|1|||
127675974|NCT00567879|459437555|FG004|Overall Study|Withdrawal by Subject|0|||
127675975|NCT00567879|459437556|FG005|Overall Study|Withdrawal by Subject|0|||
127675976|NCT00567879|459437551|FG000|Overall Study|New cancer therapy|0|||
127675977|NCT00567879|459437552|FG001|Overall Study|New cancer therapy|0|||
127675978|NCT00567879|459437553|FG002|Overall Study|New cancer therapy|1|||
127675979|NCT00567879|459437554|FG003|Overall Study|New cancer therapy|0|||
127675980|NCT00567879|459437555|FG004|Overall Study|New cancer therapy|0|||
127675981|NCT00567879|459437556|FG005|Overall Study|New cancer therapy|0|||
127675982|NCT00567879|459437551|FG000|Overall Study|Disease progression|5|||
127675983|NCT00567879|459437552|FG001|Overall Study|Disease progression|7|||
127675984|NCT00567879|459437553|FG002|Overall Study|Disease progression|15|||
127675985|NCT00567879|459437554|FG003|Overall Study|Disease progression|5|||
127675986|NCT00567879|459437555|FG004|Overall Study|Disease progression|11|||
127675987|NCT00567879|459437556|FG005|Overall Study|Disease progression|3|||
127675988|NCT00777556|459437557|FG000|Overall Study|Inappropriate self-selection|34|||
127675989|NCT00777556|459437557|FG000|Overall Study|Dispensed but did not use product|12|||
127675990|NCT00777556|459437557|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
127675991|NCT02380742|459437558|FG000|Overall Study|Withdrawal by Subject|1|||
127675992|NCT02380742|459437559|FG001|Overall Study|Withdrawal by Subject|0|||
127675993|NCT03646669|459437565|FG000|Overall Study|Withdrawal by Subject|5|||
127675994|NCT03646669|459437566|FG001|Overall Study|Withdrawal by Subject|0|||
127675995|NCT01451814|459437573|FG000|Overall Study|Withdrawal by Subject|1|||
127675996|NCT01451814|459437574|FG001|Overall Study|Withdrawal by Subject|1|||
127675997|NCT01451814|459437573|FG000|Overall Study|Lost to Follow-up|5|||
127675998|NCT01451814|459437574|FG001|Overall Study|Lost to Follow-up|4|||
127675999|NCT01956669|459437575|FG000|Overall Study|Disease Progression|12|||
127676000|NCT01956669|459437576|FG001|Overall Study|Disease Progression|7|||
127676001|NCT01956669|459437577|FG002|Overall Study|Disease Progression|7|||
127676002|NCT01956669|459437578|FG003|Overall Study|Disease Progression|8|||
127676003|NCT01956669|459437579|FG004|Overall Study|Disease Progression|4|||
127676004|NCT01956669|459437580|FG005|Overall Study|Disease Progression|3|||
127676005|NCT01956669|459437581|FG006|Overall Study|Disease Progression|5|||
127676006|NCT01956669|459437575|FG000|Overall Study|Adverse Event|0|||
127676007|NCT01956669|459437576|FG001|Overall Study|Adverse Event|2|||
127676008|NCT01956669|459437577|FG002|Overall Study|Adverse Event|2|||
128009597|NCT00984867|460662785|FG001|Overall Study|Adverse Event|7|||
128009598|NCT00984867|460662784|FG000|Overall Study|Death|1|||
127763885|NCT00603304|459761453|FG001|Overall Study|Non-Compliant|1|||
127763886|NCT00603304|459761452|FG000|Overall Study|Moved Away|0|||
127763887|NCT00603304|459761453|FG001|Overall Study|Moved Away|2|||
127763888|NCT00603304|459761452|FG000|Overall Study|Other|2|||
127763889|NCT00603304|459761453|FG001|Overall Study|Other|0|||
127763890|NCT00603304|459761452|FG000|Overall Study|Patient Decision|2|||
127763891|NCT00603304|459761453|FG001|Overall Study|Patient Decision|0|||
127763892|NCT00512317|459761454|FG000|Overall Study|Insufficient clinical response|36|||
127763893|NCT00512317|459761454|FG000|Overall Study|Withdrawal by Subject|23|||
127763894|NCT00512317|459761454|FG000|Overall Study|Sponsor closure of study|21|||
127763895|NCT00512317|459761454|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
127763896|NCT00512317|459761454|FG000|Overall Study|Adverse Event|13|||
127763897|NCT00512317|459761454|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
127763898|NCT00512317|459761454|FG000|Overall Study|Lost to Follow-up|2|||
127676009|NCT01956669|459437578|FG003|Overall Study|Adverse Event|1|||
127676010|NCT01956669|459437579|FG004|Overall Study|Adverse Event|0|||
127676011|NCT01956669|459437580|FG005|Overall Study|Adverse Event|0|||
127676012|NCT01956669|459437581|FG006|Overall Study|Adverse Event|0|||
127676013|NCT01956669|459437575|FG000|Overall Study|Physician Decision|0|||
127676014|NCT01956669|459437576|FG001|Overall Study|Physician Decision|2|||
127676015|NCT01956669|459437577|FG002|Overall Study|Physician Decision|0|||
127676016|NCT01956669|459437578|FG003|Overall Study|Physician Decision|0|||
127676017|NCT01956669|459437579|FG004|Overall Study|Physician Decision|0|||
127676018|NCT01956669|459437580|FG005|Overall Study|Physician Decision|1|||
127676019|NCT01956669|459437581|FG006|Overall Study|Physician Decision|0|||
127676020|NCT01956669|459437575|FG000|Overall Study|Withdrawal by Subject|0|||
127676021|NCT01956669|459437576|FG001|Overall Study|Withdrawal by Subject|0|||
127676022|NCT01956669|459437577|FG002|Overall Study|Withdrawal by Subject|1|||
127676023|NCT01956669|459437578|FG003|Overall Study|Withdrawal by Subject|1|||
127676024|NCT01956669|459437579|FG004|Overall Study|Withdrawal by Subject|0|||
127676025|NCT01956669|459437580|FG005|Overall Study|Withdrawal by Subject|0|||
127676026|NCT01956669|459437581|FG006|Overall Study|Withdrawal by Subject|1|||
127676027|NCT02131324|459437582|FG000|Overall Study|Withdrawal by Subject|1|||
127676028|NCT02131324|459437583|FG001|Overall Study|Withdrawal by Subject|2|||
127676029|NCT02131324|459437582|FG000|Overall Study|Lost to Follow-up|1|||
127676030|NCT02131324|459437583|FG001|Overall Study|Lost to Follow-up|1|||
127676031|NCT01693614|459437584|FG000|Overall Study|Adverse Event|7|||
127676032|NCT01693614|459437585|FG001|Overall Study|Adverse Event|11|||
127676033|NCT01693614|459437586|FG002|Overall Study|Adverse Event|5|||
127676034|NCT01693614|459437584|FG000|Overall Study|Disease progression|11|||
127676035|NCT01693614|459437585|FG001|Overall Study|Disease progression|8|||
127676036|NCT01693614|459437586|FG002|Overall Study|Disease progression|7|||
127676037|NCT01693614|459437584|FG000|Overall Study|Protocol Violation|5|||
127676038|NCT01693614|459437585|FG001|Overall Study|Protocol Violation|2|||
127676039|NCT01693614|459437586|FG002|Overall Study|Protocol Violation|1|||
127676040|NCT01693614|459437584|FG000|Overall Study|Death|1|||
127676041|NCT01693614|459437585|FG001|Overall Study|Death|0|||
127676042|NCT01693614|459437586|FG002|Overall Study|Death|0|||
127676043|NCT01693614|459437584|FG000|Overall Study|Physician Decision|1|||
127676044|NCT01693614|459437585|FG001|Overall Study|Physician Decision|1|||
127676045|NCT01693614|459437586|FG002|Overall Study|Physician Decision|4|||
127676046|NCT01693614|459437584|FG000|Overall Study|Withdrawal by subject/guardian|0|||
127676047|NCT01693614|459437585|FG001|Overall Study|Withdrawal by subject/guardian|0|||
127676048|NCT01693614|459437586|FG002|Overall Study|Withdrawal by subject/guardian|2|||
127676049|NCT01693614|459437584|FG000|Overall Study|Withdrawal by Subject|1|||
127676050|NCT01693614|459437585|FG001|Overall Study|Withdrawal by Subject|0|||
127676051|NCT01693614|459437586|FG002|Overall Study|Withdrawal by Subject|5|||
127676052|NCT01048788|459437587|FG000|Overall Study|Adverse Event|5|||
127676053|NCT01048788|459437588|FG001|Overall Study|Adverse Event|1|||
127676054|NCT01048788|459437589|FG002|Overall Study|Adverse Event|1|||
127676055|NCT01048788|459437587|FG000|Overall Study|Lack of Efficacy|0|||
127676056|NCT01048788|459437588|FG001|Overall Study|Lack of Efficacy|0|||
127676057|NCT01048788|459437589|FG002|Overall Study|Lack of Efficacy|1|||
127676058|NCT01048788|459437587|FG000|Overall Study|Withdrawal by Subject|0|||
127676059|NCT01048788|459437588|FG001|Overall Study|Withdrawal by Subject|1|||
127676060|NCT01048788|459437589|FG002|Overall Study|Withdrawal by Subject|0|||
127676061|NCT00420316|459437590|FG000|Overall Study|Withdrawal by Subject|0|||
127676062|NCT00420316|459437591|FG001|Overall Study|Withdrawal by Subject|1|||
127676063|NCT00420316|459437590|FG000|Overall Study|Lost to Follow-up|12|||
127676064|NCT00420316|459437591|FG001|Overall Study|Lost to Follow-up|8|||
127676065|NCT05419557|459437592|FG000|Overall Study|Lost to Follow-up|11|||
127763899|NCT00512317|459761454|FG000|Overall Study|Other|2|||
127763900|NCT04433585|459761455|FG000|Overall Study|Withdrawal by Subject|15|||
127763901|NCT04433585|459761456|FG001|Overall Study|Withdrawal by Subject|3|||
127676066|NCT05419557|459437593|FG001|Overall Study|Lost to Follow-up|4|||
127676067|NCT01196988|459437594|FG000|Overall Study|Adverse Event|1|||
127676068|NCT01196988|459437595|FG001|Overall Study|Adverse Event|2|||
127676069|NCT01196988|459437596|FG002|Overall Study|Adverse Event|0|||
127763902|NCT04433585|459761457|FG002|Overall Study|Withdrawal by Subject|15|||
127763903|NCT04433585|459761458|FG003|Overall Study|Withdrawal by Subject|6|||
127763904|NCT04433585|459761455|FG000|Overall Study|Adverse Event|10|||
127763905|NCT04433585|459761456|FG001|Overall Study|Adverse Event|4|||
127763906|NCT04433585|459761457|FG002|Overall Study|Adverse Event|1|||
127763907|NCT04433585|459761458|FG003|Overall Study|Adverse Event|0|||
127763908|NCT04433585|459761455|FG000|Overall Study|Due to the conflict in Ukraine|2|||
127763909|NCT04433585|459761456|FG001|Overall Study|Due to the conflict in Ukraine|1|||
127763910|NCT04433585|459761457|FG002|Overall Study|Due to the conflict in Ukraine|1|||
127763911|NCT04433585|459761458|FG003|Overall Study|Due to the conflict in Ukraine|2|||
127763912|NCT04433585|459761455|FG000|Overall Study|Physician Decision|1|||
127763913|NCT04433585|459761456|FG001|Overall Study|Physician Decision|2|||
127763914|NCT04433585|459761457|FG002|Overall Study|Physician Decision|0|||
127763915|NCT04433585|459761458|FG003|Overall Study|Physician Decision|0|||
127763916|NCT04433585|459761455|FG000|Overall Study|Lost to Follow-up|1|||
127763917|NCT04433585|459761456|FG001|Overall Study|Lost to Follow-up|1|||
127763918|NCT04433585|459761457|FG002|Overall Study|Lost to Follow-up|1|||
127763919|NCT04433585|459761458|FG003|Overall Study|Lost to Follow-up|0|||
127763920|NCT04433585|459761455|FG000|Overall Study|Lack of Efficacy|0|||
127763921|NCT04433585|459761456|FG001|Overall Study|Lack of Efficacy|1|||
127763922|NCT04433585|459761457|FG002|Overall Study|Lack of Efficacy|1|||
127763923|NCT04433585|459761458|FG003|Overall Study|Lack of Efficacy|1|||
127763924|NCT04433585|459761455|FG000|Overall Study|Death|0|||
127763925|NCT04433585|459761456|FG001|Overall Study|Death|1|||
127763926|NCT04433585|459761457|FG002|Overall Study|Death|0|||
127763927|NCT04433585|459761458|FG003|Overall Study|Death|0|||
127763928|NCT04875676|459761459|FG000|Overall Study|Lost to Follow-up|1|||
127763929|NCT04875676|459761460|FG001|Overall Study|Lost to Follow-up|0|||
127763930|NCT04875676|459761461|FG002|Overall Study|Lost to Follow-up|0|||
127763931|NCT02937454|459761462|FG000|Overall Study|Adverse Event|0|||
127763932|NCT02937454|459761463|FG001|Overall Study|Adverse Event|1|||
127763933|NCT02937454|459761462|FG000|Overall Study|Death|98|||
127763934|NCT02937454|459761463|FG001|Overall Study|Death|95|||
127763935|NCT02937454|459761462|FG000|Overall Study|Lost to Follow-up|1|||
127763936|NCT02937454|459761463|FG001|Overall Study|Lost to Follow-up|1|||
127763937|NCT02937454|459761462|FG000|Overall Study|Physician Decision|0|||
127763938|NCT02937454|459761463|FG001|Overall Study|Physician Decision|1|||
127763939|NCT02937454|459761462|FG000|Overall Study|Protocol Violation|6|||
127763940|NCT02937454|459761463|FG001|Overall Study|Protocol Violation|10|||
127763941|NCT02937454|459761462|FG000|Overall Study|Withdrawal by Subject|27|||
127763942|NCT02937454|459761463|FG001|Overall Study|Withdrawal by Subject|15|||
127763943|NCT02937454|459761462|FG000|Overall Study|Other|8|||
127763944|NCT02937454|459761463|FG001|Overall Study|Other|5|||
127763945|NCT01004848|459761464|FG000|Overall Study|Lost to Follow-up|55|||
127763946|NCT01004848|459761465|FG001|Overall Study|Lost to Follow-up|45|||
127763947|NCT01639560|459761466|FG000|Overall Study|Withdrawal by Subject|9|||
127763948|NCT01639560|459761467|FG001|Overall Study|Withdrawal by Subject|14|||
127763949|NCT01639560|459761466|FG000|Overall Study|Lack of Efficacy|1|||
127763950|NCT01639560|459761467|FG001|Overall Study|Lack of Efficacy|2|||
127763951|NCT01639560|459761466|FG000|Overall Study|Lost to Follow-up|9|||
127763952|NCT01639560|459761467|FG001|Overall Study|Lost to Follow-up|11|||
127763953|NCT01639560|459761466|FG000|Overall Study|Adverse Event|0|||
127763954|NCT01639560|459761467|FG001|Overall Study|Adverse Event|2|||
127763955|NCT01160289|459761468|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
127763956|NCT01160289|459761469|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
127763957|NCT01160289|459761470|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
127763958|NCT01160289|459761471|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
127763959|NCT01160289|459761472|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
127763960|NCT01160289|459761473|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
127763961|NCT01160289|459761468|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
127763962|NCT01160289|459761469|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
127763963|NCT01160289|459761470|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
128009599|NCT00984867|460662785|FG001|Overall Study|Death|0|||
128009600|NCT00984867|460662784|FG000|Overall Study|Withdrawal by Subject|13|||
127763964|NCT01160289|459761471|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
127763965|NCT01160289|459761472|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
127763966|NCT01160289|459761473|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
127763967|NCT01160289|459761468|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
127763968|NCT01160289|459761469|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
127763969|NCT01160289|459761470|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
127763970|NCT01160289|459761471|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
127763971|NCT01160289|459761472|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
128009601|NCT00984867|460662785|FG001|Overall Study|Withdrawal by Subject|4|||
128009602|NCT00984867|460662784|FG000|Overall Study|Lost to Follow-up|3|||
128009603|NCT00984867|460662785|FG001|Overall Study|Lost to Follow-up|4|||
127763972|NCT01160289|459761473|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
128009604|NCT00984867|460662784|FG000|Overall Study|Poor/non-compliance|0|||
128009605|NCT00984867|460662785|FG001|Overall Study|Poor/non-compliance|1|||
128009606|NCT00984867|460662784|FG000|Overall Study|Subject no longer meets study criteria|1|||
128009607|NCT00984867|460662785|FG001|Overall Study|Subject no longer meets study criteria|1|||
128009608|NCT00984867|460662784|FG000|Overall Study|site closing|1|||
128009609|NCT00984867|460662785|FG001|Overall Study|site closing|0|||
127676070|NCT01196988|459437597|FG003|Overall Study|Adverse Event|0|||
127676071|NCT01196988|459437594|FG000|Overall Study|Withdrawal by Subject|5|||
127676072|NCT01196988|459437595|FG001|Overall Study|Withdrawal by Subject|1|||
127676073|NCT01196988|459437596|FG002|Overall Study|Withdrawal by Subject|4|||
127676074|NCT01196988|459437597|FG003|Overall Study|Withdrawal by Subject|0|||
127676075|NCT01196988|459437594|FG000|Overall Study|Lost to Follow-up|16|||
127676076|NCT01196988|459437595|FG001|Overall Study|Lost to Follow-up|29|||
127676077|NCT01196988|459437596|FG002|Overall Study|Lost to Follow-up|21|||
127676078|NCT01196988|459437597|FG003|Overall Study|Lost to Follow-up|1|||
127676079|NCT01196988|459437594|FG000|Overall Study|Other|2|||
127676080|NCT01196988|459437595|FG001|Overall Study|Other|0|||
127676081|NCT01196988|459437596|FG002|Overall Study|Other|0|||
127676082|NCT01196988|459437597|FG003|Overall Study|Other|0|||
127676083|NCT00920686|459437599|FG000|Overall Study|Lost to Follow-up|2|||
127676084|NCT00920686|459437600|FG001|Overall Study|Lost to Follow-up|3|||
127676085|NCT00920686|459437601|FG002|Overall Study|Lost to Follow-up|1|||
127676086|NCT00920686|459437599|FG000|Overall Study|Study drug dosing criteria not met|17|||
127676087|NCT00920686|459437600|FG001|Overall Study|Study drug dosing criteria not met|19|||
127676088|NCT00920686|459437601|FG002|Overall Study|Study drug dosing criteria not met|12|||
127676089|NCT00868192|459437602|FG000|Overall Study|Ineligible|4|||
127676090|NCT04304534|459437603|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
127676091|NCT04304534|459437604|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
127676092|NCT04304534|459437605|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
127676093|NCT04304534|459437606|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
127676094|NCT04304534|459437603|FG000|Overall Study|Non-Compliance with study drug|0|||
127676095|NCT04304534|459437604|FG001|Overall Study|Non-Compliance with study drug|1|||
127676096|NCT04304534|459437605|FG002|Overall Study|Non-Compliance with study drug|1|||
127676097|NCT04304534|459437606|FG003|Overall Study|Non-Compliance with study drug|1|||
127676098|NCT04304534|459437603|FG000|Overall Study|Lost to Follow-up|0|||
127676099|NCT04304534|459437604|FG001|Overall Study|Lost to Follow-up|1|||
127676100|NCT04304534|459437605|FG002|Overall Study|Lost to Follow-up|2|||
127676101|NCT04304534|459437606|FG003|Overall Study|Lost to Follow-up|3|||
127676102|NCT04304534|459437603|FG000|Overall Study|Unspecific|4|||
127676103|NCT04304534|459437604|FG001|Overall Study|Unspecific|2|||
127676104|NCT04304534|459437605|FG002|Overall Study|Unspecific|2|||
127676105|NCT04304534|459437606|FG003|Overall Study|Unspecific|2|||
127676106|NCT04304534|459437603|FG000|Overall Study|Technical Problems|2|||
127676107|NCT04304534|459437604|FG001|Overall Study|Technical Problems|2|||
127676108|NCT04304534|459437605|FG002|Overall Study|Technical Problems|3|||
127676109|NCT04304534|459437606|FG003|Overall Study|Technical Problems|4|||
127676110|NCT04304534|459437603|FG000|Overall Study|Death|7|||
127676111|NCT04304534|459437604|FG001|Overall Study|Death|2|||
127676112|NCT04304534|459437605|FG002|Overall Study|Death|4|||
127676113|NCT04304534|459437606|FG003|Overall Study|Death|3|||
127676114|NCT04304534|459437603|FG000|Overall Study|Withdrawal by Subject|7|||
127676115|NCT04304534|459437604|FG001|Overall Study|Withdrawal by Subject|2|||
127676116|NCT04304534|459437605|FG002|Overall Study|Withdrawal by Subject|7|||
127676117|NCT04304534|459437606|FG003|Overall Study|Withdrawal by Subject|4|||
127676118|NCT04304534|459437603|FG000|Overall Study|Physician Decision|4|||
127676119|NCT04304534|459437604|FG001|Overall Study|Physician Decision|9|||
127676120|NCT04304534|459437605|FG002|Overall Study|Physician Decision|9|||
127676121|NCT04304534|459437606|FG003|Overall Study|Physician Decision|5|||
127676122|NCT04304534|459437603|FG000|Overall Study|Subject Decision|34|||
127676123|NCT04304534|459437604|FG001|Overall Study|Subject Decision|25|||
127676124|NCT04304534|459437605|FG002|Overall Study|Subject Decision|25|||
127676125|NCT04304534|459437606|FG003|Overall Study|Subject Decision|26|||
127676126|NCT04304534|459437603|FG000|Overall Study|Adverse Event|35|||
127676127|NCT04304534|459437604|FG001|Overall Study|Adverse Event|40|||
127676128|NCT04304534|459437605|FG002|Overall Study|Adverse Event|39|||
127676129|NCT04304534|459437606|FG003|Overall Study|Adverse Event|44|||
127676130|NCT00464672|459437607|FG000|Overall Study|withdrawal of consent|0|||
127676131|NCT00464672|459437608|FG001|Overall Study|withdrawal of consent|0|||
127676132|NCT00464672|459437609|FG002|Overall Study|withdrawal of consent|0|||
127676133|NCT00464672|459437610|FG003|Overall Study|withdrawal of consent|1|||
127676134|NCT00464672|459437611|FG004|Overall Study|withdrawal of consent|9|||
127676135|NCT00464672|459437612|FG005|Overall Study|withdrawal of consent|4|||
127676136|NCT00464672|459437607|FG000|Overall Study|Lost to Follow-up|25|||
127676137|NCT00464672|459437608|FG001|Overall Study|Lost to Follow-up|10|||
127676138|NCT00464672|459437609|FG002|Overall Study|Lost to Follow-up|0|||
127676139|NCT00464672|459437610|FG003|Overall Study|Lost to Follow-up|0|||
127676140|NCT00464672|459437611|FG004|Overall Study|Lost to Follow-up|1|||
127676141|NCT00464672|459437612|FG005|Overall Study|Lost to Follow-up|0|||
127676142|NCT00001575|459437613|FG000|Overall Study|Screening failures-Ph I portion|22|||
128009610|NCT00984867|460662784|FG000|Overall Study|lack of efficacy and subject compliance|1|||
128009611|NCT00984867|460662785|FG001|Overall Study|lack of efficacy and subject compliance|0|||
128009612|NCT00634504|460662790|FG000|Overall Study|Protocol Violation|1|||
128009613|NCT00634504|460662791|FG001|Overall Study|Protocol Violation|0|||
128009614|NCT05001620|460662794|FG000|Overall Study|Didn't complete the telehealth Palliative Care Consultation|1|||
128009615|NCT05001620|460662795|FG001|Overall Study|Didn't complete the telehealth Palliative Care Consultation|0|||
128009616|NCT00481676|460662796|FG000|Overall Study|Adverse Event|0|||
128009617|NCT00481676|460662797|FG001|Overall Study|Adverse Event|1|||
128009618|NCT00481676|460662796|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
128009619|NCT00481676|460662797|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
128009620|NCT00481676|460662796|FG000|Overall Study|Administrative problem|1|||
128009621|NCT00481676|460662797|FG001|Overall Study|Administrative problem|0|||
128009622|NCT03937778|460662798|FG000|Overall Study|Withdrawal by Subject|1|||
128009623|NCT03937778|460662798|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
128009624|NCT00819039|460662799|FG000|Overall Study|Physician Decision|1|||
128009625|NCT00819039|460662800|FG001|Overall Study|Physician Decision|0|||
128009626|NCT00819039|460662801|FG002|Overall Study|Physician Decision|1|||
128009627|NCT00819039|460662799|FG000|Overall Study|Protocol Violation|1|||
128009628|NCT00819039|460662800|FG001|Overall Study|Protocol Violation|0|||
128009629|NCT00819039|460662801|FG002|Overall Study|Protocol Violation|0|||
128009630|NCT01240694|460662802|FG000|Overall Study|Adverse Event|9|||
128009631|NCT01240694|460662802|FG000|Overall Study|Lack of Efficacy|6|||
128009632|NCT01240694|460662802|FG000|Overall Study|Withdrawal by Subject|6|||
128009633|NCT01240694|460662802|FG000|Overall Study|Protocol Violation|2|||
128009634|NCT01240694|460662802|FG000|Overall Study|Lost to Follow-up|2|||
128009635|NCT01240694|460662802|FG000|Overall Study|Other than specified|3|||
128009636|NCT01240694|460662802|FG000|Overall Study|Withdrawn due to early study termination|107|||
128009637|NCT01513590|460662803|FG000|Overall Study|Adverse Event|2|||
128009638|NCT01513590|460662804|FG001|Overall Study|Adverse Event|3|||
128009639|NCT01513590|460662803|FG000|Overall Study|Withdrawal Criteria|3|||
128009640|NCT01513590|460662804|FG001|Overall Study|Withdrawal Criteria|0|||
128009641|NCT01513590|460662803|FG000|Overall Study|Unclassified|5|||
128009642|NCT01513590|460662804|FG001|Overall Study|Unclassified|10|||
128009643|NCT03834350|460662805|FG000|Overall Study|Withdrawal by Subject|1|||
128009644|NCT02765165|460662806|FG000|Treatment Period|Progressive disease|3|||
128009645|NCT02765165|460662807|FG001|Treatment Period|Progressive disease|2|||
128009646|NCT02765165|460662808|FG002|Treatment Period|Progressive disease|3|||
127676143|NCT00001575|459437613|FG000|Overall Study|Withdrawn/deaths|23|||
127676144|NCT02701361|459437623|FG000|Overall Study|Lost to Follow-up|5|||
127676145|NCT02701361|459437624|FG001|Overall Study|Lost to Follow-up|2|||
127676146|NCT02701361|459437625|FG002|Overall Study|Lost to Follow-up|1|||
127676147|NCT02701361|459437623|FG000|Overall Study|Withdrawal by Subject|4|||
127676148|NCT02701361|459437624|FG001|Overall Study|Withdrawal by Subject|0|||
127676149|NCT02701361|459437625|FG002|Overall Study|Withdrawal by Subject|0|||
127676150|NCT02701361|459437623|FG000|Overall Study|timed out in rehab center|0|||
127676151|NCT02701361|459437624|FG001|Overall Study|timed out in rehab center|1|||
127676152|NCT02701361|459437625|FG002|Overall Study|timed out in rehab center|0|||
127676153|NCT02701361|459437623|FG000|Overall Study|incarceration|0|||
127676154|NCT02701361|459437624|FG001|Overall Study|incarceration|0|||
127676155|NCT02701361|459437625|FG002|Overall Study|incarceration|1|||
127676156|NCT01190150|459437630|FG000|First Treatment|Withdrawal by Subject|1|||
127676157|NCT01190150|459437631|FG001|First Treatment|Withdrawal by Subject|0|||
127676158|NCT01190150|459437630|FG000|Washout|Withdrawal by Subject|0|||
127676159|NCT01190150|459437631|FG001|Washout|Withdrawal by Subject|1|||
127676160|NCT01190150|459437630|FG000|Washout|Difficulty in adherence|0|||
127676161|NCT01190150|459437631|FG001|Washout|Difficulty in adherence|1|||
127676162|NCT00843193|459437635|FG000|Overall Study|Adverse Event|2|||
127676163|NCT00843193|459437636|FG001|Overall Study|Adverse Event|4|||
127676164|NCT00843193|459437635|FG000|Overall Study|Lack of Efficacy|1|||
127676165|NCT00843193|459437636|FG001|Overall Study|Lack of Efficacy|1|||
127676166|NCT00843193|459437635|FG000|Overall Study|Protocol Violation|1|||
127676167|NCT00843193|459437636|FG001|Overall Study|Protocol Violation|2|||
127676168|NCT00843193|459437635|FG000|Overall Study|Lost to Follow-up|1|||
127676169|NCT00843193|459437636|FG001|Overall Study|Lost to Follow-up|0|||
127676170|NCT00843193|459437635|FG000|Overall Study|Physician Decision|0|||
127676171|NCT00843193|459437636|FG001|Overall Study|Physician Decision|1|||
127676172|NCT00843193|459437635|FG000|Overall Study|Withdrawal by Subject|3|||
127676173|NCT00843193|459437636|FG001|Overall Study|Withdrawal by Subject|3|||
127676174|NCT04511650|459437637|FG000|Overall Study|Lost to Follow-up|1|||
127676175|NCT04511650|459437638|FG001|Overall Study|Lost to Follow-up|0|||
127676176|NCT04511650|459437639|FG002|Overall Study|Lost to Follow-up|0|||
127676177|NCT04511650|459437637|FG000|Overall Study|Withdrawal by Subject|1|||
127676178|NCT04511650|459437638|FG001|Overall Study|Withdrawal by Subject|0|||
127676179|NCT04511650|459437639|FG002|Overall Study|Withdrawal by Subject|0|||
127763973|NCT01160289|459761468|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
128009647|NCT02765165|460662809|FG003|Treatment Period|Progressive disease|3|||
128009648|NCT02765165|460662810|FG004|Treatment Period|Progressive disease|4|||
128009649|NCT02765165|460662811|FG005|Treatment Period|Progressive disease|2|||
128009650|NCT02765165|460662812|FG006|Treatment Period|Progressive disease|2|||
127763974|NCT01160289|459761469|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
128009651|NCT02765165|460662806|FG000|Treatment Period|Physician Decision|0|||
128009652|NCT02765165|460662807|FG001|Treatment Period|Physician Decision|1|||
128009653|NCT02765165|460662808|FG002|Treatment Period|Physician Decision|0|||
128009654|NCT02765165|460662809|FG003|Treatment Period|Physician Decision|0|||
128009655|NCT02765165|460662810|FG004|Treatment Period|Physician Decision|0|||
128009656|NCT02765165|460662811|FG005|Treatment Period|Physician Decision|0|||
128009657|NCT02765165|460662812|FG006|Treatment Period|Physician Decision|0|||
128009658|NCT02765165|460662806|FG000|Treatment Period|Adverse Event|0|||
128009659|NCT02765165|460662807|FG001|Treatment Period|Adverse Event|1|||
128009660|NCT02765165|460662808|FG002|Treatment Period|Adverse Event|0|||
128009661|NCT02765165|460662809|FG003|Treatment Period|Adverse Event|0|||
128009662|NCT02765165|460662810|FG004|Treatment Period|Adverse Event|0|||
128009663|NCT02765165|460662811|FG005|Treatment Period|Adverse Event|0|||
128009664|NCT02765165|460662812|FG006|Treatment Period|Adverse Event|0|||
128009665|NCT02765165|460662806|FG000|Treatment Period|Withdrawal by Subject|0|||
128009666|NCT02765165|460662807|FG001|Treatment Period|Withdrawal by Subject|0|||
128009667|NCT02765165|460662808|FG002|Treatment Period|Withdrawal by Subject|0|||
128009668|NCT02765165|460662809|FG003|Treatment Period|Withdrawal by Subject|0|||
128009669|NCT02765165|460662810|FG004|Treatment Period|Withdrawal by Subject|2|||
128009670|NCT02765165|460662811|FG005|Treatment Period|Withdrawal by Subject|0|||
128009671|NCT02765165|460662812|FG006|Treatment Period|Withdrawal by Subject|0|||
128009672|NCT02765165|460662806|FG000|Treatment Period|Study terminated|0|||
128009673|NCT02765165|460662807|FG001|Treatment Period|Study terminated|0|||
128009674|NCT02765165|460662808|FG002|Treatment Period|Study terminated|0|||
128009675|NCT02765165|460662809|FG003|Treatment Period|Study terminated|0|||
128009676|NCT02765165|460662810|FG004|Treatment Period|Study terminated|0|||
128009677|NCT02765165|460662811|FG005|Treatment Period|Study terminated|1|||
128009678|NCT02765165|460662812|FG006|Treatment Period|Study terminated|2|||
128009679|NCT02765165|460662806|FG000|Post-treatment Follow-up|Death|1|||
128009680|NCT02765165|460662807|FG001|Post-treatment Follow-up|Death|2|||
128009681|NCT02765165|460662808|FG002|Post-treatment Follow-up|Death|1|||
128009682|NCT02765165|460662809|FG003|Post-treatment Follow-up|Death|1|||
127763975|NCT01160289|459761470|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
127763976|NCT01160289|459761471|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
127763977|NCT01160289|459761472|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
127763978|NCT01160289|459761473|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
128009683|NCT02765165|460662810|FG004|Post-treatment Follow-up|Death|1|||
128009684|NCT02765165|460662811|FG005|Post-treatment Follow-up|Death|1|||
127763979|NCT01160289|459761468|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
127763980|NCT01160289|459761469|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
127763981|NCT01160289|459761470|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
127763982|NCT01160289|459761471|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
127763983|NCT01160289|459761472|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
127763984|NCT01160289|459761473|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
127763985|NCT01160289|459761468|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
127763986|NCT01160289|459761469|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
127763987|NCT01160289|459761470|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
127763988|NCT01160289|459761471|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
127763989|NCT01160289|459761472|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
127763990|NCT01160289|459761473|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
127763991|NCT01160289|459761468|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
127763992|NCT01160289|459761469|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
127763993|NCT01160289|459761470|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
127763994|NCT01160289|459761471|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
127763995|NCT01160289|459761472|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
127763996|NCT01160289|459761473|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
127763997|NCT01160289|459761468|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
127763998|NCT01160289|459761469|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
127763999|NCT01160289|459761470|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
127764000|NCT01160289|459761471|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
127764001|NCT01160289|459761472|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
128009685|NCT02765165|460662812|FG006|Post-treatment Follow-up|Death|0|||
128009686|NCT02765165|460662806|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
128009687|NCT02765165|460662807|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
128009688|NCT02765165|460662808|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
128009689|NCT02765165|460662809|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
128009690|NCT02765165|460662810|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
128009691|NCT02765165|460662811|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
128009692|NCT02765165|460662812|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
128009693|NCT02765165|460662806|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
128009694|NCT02765165|460662807|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
128009695|NCT02765165|460662808|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
128009696|NCT02765165|460662809|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
128009697|NCT02765165|460662810|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
128009698|NCT02765165|460662811|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
128009699|NCT02765165|460662812|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
128009700|NCT02765165|460662806|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
128009701|NCT02765165|460662807|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
128009702|NCT02765165|460662808|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
128009703|NCT02765165|460662809|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
128009704|NCT02765165|460662810|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
128009705|NCT02765165|460662811|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
128009706|NCT02765165|460662812|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
128009707|NCT02765165|460662806|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
128009708|NCT02765165|460662807|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
128009709|NCT02765165|460662808|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
128009710|NCT02765165|460662809|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
128009711|NCT02765165|460662810|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
128009712|NCT02765165|460662811|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
128009713|NCT02765165|460662812|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
128009714|NCT02765165|460662806|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
128009715|NCT02765165|460662807|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
128009716|NCT02765165|460662808|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
128009717|NCT02765165|460662809|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
128009718|NCT02765165|460662810|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
128009719|NCT02765165|460662811|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
128009720|NCT02765165|460662812|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
128009721|NCT01206764|460662813|FG000|Overall Study|Adverse Event|20|||
128009722|NCT01206764|460662813|FG000|Overall Study|Abnormal laboratory value|2|||
128009723|NCT01206764|460662813|FG000|Overall Study|Abnormal test procedure result|1|||
128009724|NCT01206764|460662813|FG000|Overall Study|Patient withdrew consent|5|||
128009725|NCT01206764|460662813|FG000|Overall Study|Lost to Follow-up|6|||
128009726|NCT01206764|460662813|FG000|Overall Study|Death|11|||
128009727|NCT01206764|460662813|FG000|Overall Study|New cancer therapy|2|||
128009728|NCT01206764|460662813|FG000|Overall Study|Disease progression|88|||
128009729|NCT01206764|460662813|FG000|Overall Study|Protocol deviation|3|||
128009730|NCT02567188|460662814|FG000|Overall Study|Death|10|||
128009731|NCT02567188|460662814|FG000|Overall Study|Terminated Mircera Treatment|9|||
128009732|NCT02567188|460662814|FG000|Overall Study|Lost to Follow-up|5|||
128009733|NCT02567188|460662814|FG000|Overall Study|Adverse Event|1|||
128009734|NCT02567188|460662814|FG000|Overall Study|Withdrawal by Subject|1|||
128009735|NCT02567188|460662814|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
128009736|NCT02567188|460662814|FG000|Overall Study|Moved and Changed Clinic|1|||
128009737|NCT02567188|460662814|FG000|Overall Study|Started Hemodialysis|2|||
128009738|NCT02567188|460662814|FG000|Overall Study|Protocol Violation|5|||
128009739|NCT00321763|460662816|FG000|Overall Study|Adverse Event|1|||
128009740|NCT00321763|460662817|FG001|Overall Study|Adverse Event|1|||
128009741|NCT00321763|460662818|FG002|Overall Study|Adverse Event|0|||
128009742|NCT00321763|460662819|FG003|Overall Study|Adverse Event|1|||
127764002|NCT01160289|459761473|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
127764003|NCT01160289|459761468|FG000|Post-Randomization Period|Adverse Event|0|||
127764004|NCT01160289|459761469|FG001|Post-Randomization Period|Adverse Event|4|||
127764005|NCT01160289|459761470|FG002|Post-Randomization Period|Adverse Event|4|||
127764006|NCT01160289|459761471|FG003|Post-Randomization Period|Adverse Event|2|||
127764007|NCT01160289|459761472|FG004|Post-Randomization Period|Adverse Event|0|||
128009743|NCT00321763|460662816|FG000|Overall Study|Withdrawal by Subject|2|||
128009744|NCT00321763|460662817|FG001|Overall Study|Withdrawal by Subject|0|||
128009745|NCT00321763|460662818|FG002|Overall Study|Withdrawal by Subject|1|||
128009746|NCT00321763|460662819|FG003|Overall Study|Withdrawal by Subject|0|||
128009747|NCT00321763|460662816|FG000|Overall Study|Lost to Follow-up|3|||
128009748|NCT00321763|460662817|FG001|Overall Study|Lost to Follow-up|1|||
128009749|NCT00321763|460662818|FG002|Overall Study|Lost to Follow-up|5|||
128009750|NCT00321763|460662819|FG003|Overall Study|Lost to Follow-up|4|||
128009751|NCT00410163|460662820|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
128009752|NCT00410163|460662821|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
128009753|NCT00410163|460662820|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
128009754|NCT00410163|460662821|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
128009755|NCT00410163|460662820|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
128009756|NCT00410163|460662821|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
128009757|NCT00410163|460662820|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
128009758|NCT00410163|460662821|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
128009759|NCT00410163|460662820|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
128009760|NCT00410163|460662821|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
128009761|NCT00410163|460662820|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
127676180|NCT04511650|459437637|FG000|Overall Study|reason not provided|0|||
127676181|NCT04511650|459437638|FG001|Overall Study|reason not provided|0|||
127676182|NCT04511650|459437639|FG002|Overall Study|reason not provided|1|||
127676183|NCT04511650|459437637|FG000|Overall Study|Death|1|||
127676184|NCT04511650|459437638|FG001|Overall Study|Death|1|||
127676185|NCT04511650|459437639|FG002|Overall Study|Death|1|||
127676186|NCT02982213|459437640|FG000|Overall Study|Did not complete follow up questionnaire|5|||
127676187|NCT02982213|459437641|FG001|Overall Study|Did not complete follow up questionnaire|1|||
127676188|NCT01972152|459437642|FG000|First Treatment Visit|Lost to Follow-up|0|||
127676189|NCT01972152|459437643|FG001|First Treatment Visit|Lost to Follow-up|1|||
127676190|NCT01972152|459437644|FG002|First Treatment Visit|Lost to Follow-up|0|||
127676191|NCT01972152|459437645|FG003|First Treatment Visit|Lost to Follow-up|0|||
127676192|NCT01972152|459437646|FG004|First Treatment Visit|Lost to Follow-up|0|||
127676193|NCT01972152|459437647|FG005|First Treatment Visit|Lost to Follow-up|0|||
127676194|NCT01972152|459437642|FG000|Second Treatment Visit|Protocol Violation|0|||
127676195|NCT01972152|459437643|FG001|Second Treatment Visit|Protocol Violation|1|||
127676196|NCT01972152|459437644|FG002|Second Treatment Visit|Protocol Violation|0|||
127676197|NCT01972152|459437645|FG003|Second Treatment Visit|Protocol Violation|0|||
127676198|NCT01972152|459437646|FG004|Second Treatment Visit|Protocol Violation|0|||
127676199|NCT01972152|459437647|FG005|Second Treatment Visit|Protocol Violation|0|||
127676200|NCT01194258|459437650|FG000|Titration Period|Withdrawal by Subject|6|||
127676201|NCT01194258|459437651|FG001|Titration Period|Withdrawal by Subject|0|||
127676202|NCT01194258|459437652|FG002|Titration Period|Withdrawal by Subject|0|||
127676203|NCT01194258|459437653|FG003|Titration Period|Withdrawal by Subject|0|||
127676204|NCT01194258|459437654|FG004|Titration Period|Withdrawal by Subject|0|||
127676205|NCT01194258|459437650|FG000|Titration Period|Lost to Follow-up|2|||
127676206|NCT01194258|459437651|FG001|Titration Period|Lost to Follow-up|0|||
127676207|NCT01194258|459437652|FG002|Titration Period|Lost to Follow-up|0|||
127676208|NCT01194258|459437653|FG003|Titration Period|Lost to Follow-up|0|||
127676209|NCT01194258|459437654|FG004|Titration Period|Lost to Follow-up|0|||
127676210|NCT01194258|459437650|FG000|Titration Period|Titration failure|3|||
127676211|NCT01194258|459437651|FG001|Titration Period|Titration failure|0|||
127676212|NCT01194258|459437652|FG002|Titration Period|Titration failure|0|||
127676213|NCT01194258|459437653|FG003|Titration Period|Titration failure|0|||
127676214|NCT01194258|459437654|FG004|Titration Period|Titration failure|0|||
127676215|NCT01194258|459437650|FG000|Period 1 (12 Weeks)|Death|0|||
127676216|NCT01194258|459437651|FG001|Period 1 (12 Weeks)|Death|0|||
127676217|NCT01194258|459437652|FG002|Period 1 (12 Weeks)|Death|0|||
127676218|NCT01194258|459437653|FG003|Period 1 (12 Weeks)|Death|0|||
127676219|NCT01194258|459437654|FG004|Period 1 (12 Weeks)|Death|1|||
127676220|NCT01194258|459437650|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
127676221|NCT01194258|459437651|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
127676222|NCT01194258|459437652|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
127676223|NCT01194258|459437653|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
127676224|NCT01194258|459437654|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
127676225|NCT01194258|459437650|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
127676226|NCT01194258|459437651|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
127676227|NCT01194258|459437652|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
127676228|NCT01194258|459437653|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
127676229|NCT01194258|459437654|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
127676230|NCT01194258|459437650|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
127676231|NCT01194258|459437651|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
127676232|NCT01194258|459437652|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
127676233|NCT01194258|459437653|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
127676234|NCT01194258|459437654|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
127676235|NCT01582945|459437657|FG000|Overall Study|Intolerable side-effects|1|||
127676236|NCT01582945|459437657|FG000|Overall Study|Scheduling conflicts|1|||
127676237|NCT03310983|459437658|FG000|Overall Study|Lost to Follow-up|15|||
127676238|NCT03310983|459437659|FG001|Overall Study|Lost to Follow-up|17|||
127676239|NCT01656304|459437664|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
127676240|NCT05826431|459437665|FG000|Overall Study|Withdrawal by Subject|1|||
127676241|NCT02163915|459437666|FG000|Overall Study|Withdrawal by Subject|2|||
127543554|NCT02718898|458956554|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
127676242|NCT02163915|459437667|FG001|Overall Study|Withdrawal by Subject|0|||
127676243|NCT02163915|459437668|FG002|Overall Study|Withdrawal by Subject|2|||
127676244|NCT02163915|459437669|FG003|Overall Study|Withdrawal by Subject|2|||
127676245|NCT02163915|459437670|FG004|Overall Study|Withdrawal by Subject|2|||
127676246|NCT02163915|459437666|FG000|Overall Study|Study termination|1|||
127676247|NCT02163915|459437667|FG001|Overall Study|Study termination|0|||
127676248|NCT02163915|459437668|FG002|Overall Study|Study termination|0|||
127676249|NCT02163915|459437669|FG003|Overall Study|Study termination|0|||
127764008|NCT01160289|459761473|FG005|Post-Randomization Period|Adverse Event|0|||
127764009|NCT01160289|459761468|FG000|Post-Randomization Period|Death|0|||
127764010|NCT01160289|459761469|FG001|Post-Randomization Period|Death|0|||
127764011|NCT01160289|459761470|FG002|Post-Randomization Period|Death|0|||
127764012|NCT01160289|459761471|FG003|Post-Randomization Period|Death|1|||
127764013|NCT01160289|459761472|FG004|Post-Randomization Period|Death|0|||
127764014|NCT01160289|459761473|FG005|Post-Randomization Period|Death|0|||
127764015|NCT01160289|459761468|FG000|Post-Randomization Period|Lack of Efficacy|0|||
127764016|NCT01160289|459761469|FG001|Post-Randomization Period|Lack of Efficacy|1|||
127764017|NCT01160289|459761470|FG002|Post-Randomization Period|Lack of Efficacy|0|||
127764018|NCT01160289|459761471|FG003|Post-Randomization Period|Lack of Efficacy|3|||
127764019|NCT01160289|459761472|FG004|Post-Randomization Period|Lack of Efficacy|0|||
127764020|NCT01160289|459761473|FG005|Post-Randomization Period|Lack of Efficacy|0|||
127764021|NCT01160289|459761468|FG000|Post-Randomization Period|Lost to Follow-up|0|||
127764022|NCT01160289|459761469|FG001|Post-Randomization Period|Lost to Follow-up|3|||
127764023|NCT01160289|459761470|FG002|Post-Randomization Period|Lost to Follow-up|2|||
127764024|NCT01160289|459761471|FG003|Post-Randomization Period|Lost to Follow-up|5|||
127764025|NCT01160289|459761472|FG004|Post-Randomization Period|Lost to Follow-up|3|||
127764026|NCT01160289|459761473|FG005|Post-Randomization Period|Lost to Follow-up|4|||
127764027|NCT01160289|459761468|FG000|Post-Randomization Period|Physician Decision|0|||
127764028|NCT01160289|459761469|FG001|Post-Randomization Period|Physician Decision|0|||
127764029|NCT01160289|459761470|FG002|Post-Randomization Period|Physician Decision|1|||
127764030|NCT01160289|459761471|FG003|Post-Randomization Period|Physician Decision|0|||
127764031|NCT01160289|459761472|FG004|Post-Randomization Period|Physician Decision|0|||
127764032|NCT01160289|459761473|FG005|Post-Randomization Period|Physician Decision|0|||
127764033|NCT01160289|459761468|FG000|Post-Randomization Period|Protocol Violation|0|||
127764034|NCT01160289|459761469|FG001|Post-Randomization Period|Protocol Violation|4|||
127764035|NCT01160289|459761470|FG002|Post-Randomization Period|Protocol Violation|2|||
127764036|NCT01160289|459761471|FG003|Post-Randomization Period|Protocol Violation|0|||
127764037|NCT01160289|459761472|FG004|Post-Randomization Period|Protocol Violation|1|||
127764038|NCT01160289|459761473|FG005|Post-Randomization Period|Protocol Violation|3|||
127764039|NCT01160289|459761468|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
127764040|NCT01160289|459761469|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
127764041|NCT01160289|459761470|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
127764042|NCT01160289|459761471|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
127764043|NCT01160289|459761472|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
127764044|NCT01160289|459761473|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
127764045|NCT01160289|459761468|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
127764046|NCT01160289|459761469|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
127764047|NCT01160289|459761470|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
127764048|NCT01160289|459761471|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
127764049|NCT01160289|459761472|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
127764050|NCT01160289|459761473|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
127764051|NCT01160289|459761468|FG000|Post-Randomization Period|Sponsor Decision|0|||
127764052|NCT01160289|459761469|FG001|Post-Randomization Period|Sponsor Decision|1|||
127764053|NCT01160289|459761470|FG002|Post-Randomization Period|Sponsor Decision|0|||
127764054|NCT01160289|459761471|FG003|Post-Randomization Period|Sponsor Decision|0|||
127764055|NCT01160289|459761472|FG004|Post-Randomization Period|Sponsor Decision|0|||
127764056|NCT01160289|459761473|FG005|Post-Randomization Period|Sponsor Decision|0|||
127764057|NCT01156792|459761475|FG000|Overall Study|Adverse Event|1|||
127764058|NCT01156792|459761475|FG000|Overall Study|Lack of Efficacy|36|||
127764059|NCT01156792|459761475|FG000|Overall Study|Protocol Violation|6|||
127764060|NCT01156792|459761475|FG000|Overall Study|Lost to Follow-up|3|||
127764061|NCT01156792|459761475|FG000|Overall Study|Physician Decision|3|||
127764062|NCT01156792|459761475|FG000|Overall Study|Withdrawal by Subject|9|||
128009762|NCT00410163|460662821|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
127764063|NCT01156792|459761475|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
127764064|NCT01474434|459761476|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
127764065|NCT01474434|459761477|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
127764066|NCT01474434|459761478|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
127764067|NCT01474434|459761479|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
128009763|NCT00410163|460662820|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
128009764|NCT00410163|460662821|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
127764068|NCT01474434|459761476|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
127764069|NCT01474434|459761477|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
127764070|NCT01474434|459761478|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
127764071|NCT01474434|459761479|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
127764072|NCT01474434|459761476|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
127764073|NCT01474434|459761477|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
127764074|NCT01474434|459761478|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
128009765|NCT00410163|460662820|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
127764075|NCT01474434|459761479|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
127764076|NCT00993668|459761481|FG000|Single-Blind Period|Adverse Event|1|||
127764077|NCT00993668|459761482|FG001|Single-Blind Period|Adverse Event|1|||
127764078|NCT00993668|459761481|FG000|Single-Blind Period|Lack of Efficacy|0|||
127764079|NCT00993668|459761482|FG001|Single-Blind Period|Lack of Efficacy|1|||
127764080|NCT00993668|459761481|FG000|Single-Blind Period|Lost to Follow-up|3|||
127764081|NCT00993668|459761482|FG001|Single-Blind Period|Lost to Follow-up|1|||
127764082|NCT00993668|459761481|FG000|Open-Label Period|Adverse Event|9|||
127764083|NCT00993668|459761482|FG001|Open-Label Period|Adverse Event|8|||
127764084|NCT00993668|459761481|FG000|Open-Label Period|Lack of Efficacy|4|||
127764085|NCT00993668|459761482|FG001|Open-Label Period|Lack of Efficacy|3|||
127764086|NCT00993668|459761481|FG000|Open-Label Period|Withdrawal by Subject|4|||
127764087|NCT00993668|459761482|FG001|Open-Label Period|Withdrawal by Subject|3|||
127764088|NCT00993668|459761481|FG000|Open-Label Period|Lost to Follow-up|6|||
127764089|NCT00993668|459761482|FG001|Open-Label Period|Lost to Follow-up|1|||
127764090|NCT03606668|459761485|FG000|Overall Study|Screen Failure|1|||
127764091|NCT03606668|459761485|FG000|Overall Study|Lost to Follow-up|1|||
127764092|NCT02057523|459761489|FG000|Overall Study|Withdrawal by Subject|1|||
127764093|NCT02057523|459761489|FG000|Overall Study|Lack of Efficacy|1|||
127764094|NCT03618823|459761493|FG000|Overall Study|Lost to Follow-up|63|||
127764095|NCT03618823|459761494|FG001|Overall Study|Lost to Follow-up|61|||
127764096|NCT00523640|459761495|FG000|Overall Study|Death|1|||
127764097|NCT02399254|459761496|FG000|Overall Study|Physician Decision|2|||
127764098|NCT01506609|459761497|FG000|Overall Study|Adverse Event Related to Progression|0|||
127764099|NCT01506609|459761498|FG001|Overall Study|Adverse Event Related to Progression|0|||
127764100|NCT01506609|459761499|FG002|Overall Study|Adverse Event Related to Progression|0|||
127764101|NCT01506609|459761500|FG003|Overall Study|Adverse Event Related to Progression|3|||
127764102|NCT01506609|459761501|FG004|Overall Study|Adverse Event Related to Progression|7|||
127764103|NCT01506609|459761502|FG005|Overall Study|Adverse Event Related to Progression|3|||
127764104|NCT01506609|459761497|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
127764105|NCT01506609|459761498|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
127764106|NCT01506609|459761499|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
127764107|NCT01506609|459761500|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
127764108|NCT01506609|459761501|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
127764109|NCT01506609|459761502|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
127764110|NCT01506609|459761497|FG000|Overall Study|Withdrawal by Subject|0|||
127764111|NCT01506609|459761498|FG001|Overall Study|Withdrawal by Subject|0|||
127764112|NCT01506609|459761499|FG002|Overall Study|Withdrawal by Subject|0|||
127764113|NCT01506609|459761500|FG003|Overall Study|Withdrawal by Subject|9|||
127764114|NCT01506609|459761501|FG004|Overall Study|Withdrawal by Subject|7|||
127764115|NCT01506609|459761502|FG005|Overall Study|Withdrawal by Subject|7|||
127764116|NCT01506609|459761497|FG000|Overall Study|Lost to Follow-up|0|||
127764117|NCT01506609|459761498|FG001|Overall Study|Lost to Follow-up|0|||
127764118|NCT01506609|459761499|FG002|Overall Study|Lost to Follow-up|0|||
127764119|NCT01506609|459761500|FG003|Overall Study|Lost to Follow-up|1|||
127764120|NCT01506609|459761501|FG004|Overall Study|Lost to Follow-up|2|||
127764121|NCT01506609|459761502|FG005|Overall Study|Lost to Follow-up|0|||
127764122|NCT01506609|459761497|FG000|Overall Study|Sponsor Discontinued Study|0|||
127764123|NCT01506609|459761498|FG001|Overall Study|Sponsor Discontinued Study|0|||
127764124|NCT01506609|459761499|FG002|Overall Study|Sponsor Discontinued Study|0|||
127764125|NCT01506609|459761500|FG003|Overall Study|Sponsor Discontinued Study|2|||
127764126|NCT01506609|459761501|FG004|Overall Study|Sponsor Discontinued Study|2|||
127764127|NCT01506609|459761502|FG005|Overall Study|Sponsor Discontinued Study|0|||
127764128|NCT01506609|459761497|FG000|Overall Study|Progressive Disease per Protocol|1|||
127764129|NCT01506609|459761498|FG001|Overall Study|Progressive Disease per Protocol|0|||
127764130|NCT01506609|459761499|FG002|Overall Study|Progressive Disease per Protocol|0|||
127764131|NCT01506609|459761500|FG003|Overall Study|Progressive Disease per Protocol|64|||
127764132|NCT01506609|459761501|FG004|Overall Study|Progressive Disease per Protocol|57|||
127764133|NCT01506609|459761502|FG005|Overall Study|Progressive Disease per Protocol|74|||
127764134|NCT01506609|459761497|FG000|Overall Study|Other, Not Specified|0|||
127764135|NCT01506609|459761498|FG001|Overall Study|Other, Not Specified|0|||
128009766|NCT00410163|460662821|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
128009767|NCT00410163|460662820|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
128009768|NCT00410163|460662821|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
127764136|NCT01506609|459761499|FG002|Overall Study|Other, Not Specified|0|||
128009769|NCT00410163|460662820|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
127764137|NCT01506609|459761500|FG003|Overall Study|Other, Not Specified|10|||
127764138|NCT01506609|459761501|FG004|Overall Study|Other, Not Specified|7|||
127764139|NCT01506609|459761502|FG005|Overall Study|Other, Not Specified|3|||
127764140|NCT01506609|459761497|FG000|Overall Study|Missing / Unknown Reason|1|||
127676250|NCT02163915|459437670|FG004|Overall Study|Study termination|2|||
127676251|NCT02163915|459437666|FG000|Overall Study|Physician Decision|0|||
127676252|NCT02163915|459437667|FG001|Overall Study|Physician Decision|0|||
127676253|NCT02163915|459437668|FG002|Overall Study|Physician Decision|0|||
127676254|NCT02163915|459437669|FG003|Overall Study|Physician Decision|1|||
127676255|NCT02163915|459437670|FG004|Overall Study|Physician Decision|0|||
127676256|NCT02952261|459437674|FG000|Overall Study|Withdrawal by Subject|4|||
127676257|NCT02952261|459437675|FG001|Overall Study|Withdrawal by Subject|5|||
127676258|NCT02952261|459437674|FG000|Overall Study|Protocol Violation|1|||
127676259|NCT02952261|459437675|FG001|Overall Study|Protocol Violation|0|||
127676260|NCT05233085|459437676|FG000|Overall Study|Adverse Event|1|||
127676261|NCT05233085|459437677|FG001|Overall Study|Adverse Event|0|||
127676262|NCT05233085|459437678|FG002|Overall Study|Adverse Event|0|||
127676263|NCT05233085|459437679|FG003|Overall Study|Adverse Event|0|||
127676264|NCT00798265|459437680|FG000|Overall Study|Lost to Follow-up|1|||
127676265|NCT00798265|459437681|FG001|Overall Study|Lost to Follow-up|10|||
127676266|NCT00798265|459437680|FG000|Overall Study|Study closing|7|||
127676267|NCT00798265|459437681|FG001|Overall Study|Study closing|6|||
127676268|NCT00798265|459437680|FG000|Overall Study|Withdrawal by Subject|0|||
127676269|NCT00798265|459437681|FG001|Overall Study|Withdrawal by Subject|1|||
127676270|NCT00798265|459437680|FG000|Overall Study|Screen failure|0|||
127676271|NCT00798265|459437681|FG001|Overall Study|Screen failure|1|||
127676272|NCT01838200|459437682|FG000|Overall Study|Adverse Event|0|||
127676273|NCT01838200|459437683|FG001|Overall Study|Adverse Event|2|||
127676274|NCT01838200|459437682|FG000|Overall Study|Progressive disease|3|||
127676275|NCT01838200|459437683|FG001|Overall Study|Progressive disease|0|||
127676276|NCT01311648|459439034|FG000|Main Study|Protocol Violation|0|||
127676277|NCT01311648|459439035|FG001|Main Study|Protocol Violation|1|||
127676278|NCT01311648|459439034|FG000|Main Study|Adverse Event|0|||
127676279|NCT01311648|459439035|FG001|Main Study|Adverse Event|1|||
127676280|NCT01311648|459439034|FG000|Main Study|Inhibitor management|0|||
127676281|NCT01311648|459439035|FG001|Main Study|Inhibitor management|17|||
127676282|NCT01311648|459439034|FG000|Main Study|Withdrawal by Subject|0|||
127676283|NCT01311648|459439035|FG001|Main Study|Withdrawal by Subject|2|||
127676284|NCT01311648|459439034|FG000|Extension Study|Physician Decision|0|||
127676285|NCT01311648|459439035|FG001|Extension Study|Physician Decision|1|||
127676286|NCT01311648|459439034|FG000|Extension Study|ITI therapy with marketed product|0|||
127676287|NCT01311648|459439035|FG001|Extension Study|ITI therapy with marketed product|1|||
127676288|NCT01311648|459439034|FG000|Extension Study|Incorrect visit planning|0|||
127764141|NCT01506609|459761498|FG001|Overall Study|Missing / Unknown Reason|0|||
127764142|NCT01506609|459761499|FG002|Overall Study|Missing / Unknown Reason|1|||
127764143|NCT01506609|459761500|FG003|Overall Study|Missing / Unknown Reason|4|||
127764144|NCT01506609|459761501|FG004|Overall Study|Missing / Unknown Reason|4|||
127764145|NCT01506609|459761502|FG005|Overall Study|Missing / Unknown Reason|2|||
127764146|NCT02971761|459761503|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
127764147|NCT02424734|459761504|FG000|Overall Study|Treatment stopped to be discharged home|2|||
127764148|NCT02424734|459761505|FG001|Overall Study|Treatment stopped to be discharged home|2|||
127764149|NCT02424734|459761506|FG002|Overall Study|Treatment stopped to be discharged home|0|||
127764150|NCT00116753|459761507|FG000|Overall Study|Adverse Event|16|||
128009770|NCT00410163|460662821|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
128009771|NCT00410163|460662820|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
127676289|NCT01311648|459439035|FG001|Extension Study|Incorrect visit planning|1|||
127676290|NCT01311648|459439034|FG000|Extension Study|Family's decision|0|||
127676291|NCT01311648|459439035|FG001|Extension Study|Family's decision|1|||
127676292|NCT01311648|459439034|FG000|Extension Study|Failure of ITI therapy|0|||
127676293|NCT01311648|459439035|FG001|Extension Study|Failure of ITI therapy|3|||
127676294|NCT01311648|459439034|FG000|Extension Study|Long travel|0|||
127676295|NCT01311648|459439035|FG001|Extension Study|Long travel|1|||
127676296|NCT01311648|459439034|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
127676297|NCT01311648|459439035|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
127676298|NCT01311648|459439034|FG000|Extension Study|Withdrawal by Subject|0|||
127676299|NCT01311648|459439035|FG001|Extension Study|Withdrawal by Subject|1|||
127676300|NCT01311648|459439034|FG000|Extension Study|Inhibitor management|0|||
127676301|NCT01311648|459439035|FG001|Extension Study|Inhibitor management|2|||
127676302|NCT03712930|459439036|FG000|Overall Study|Death|7|||
127676303|NCT03712930|459439036|FG000|Overall Study|Physician Decision|1|||
127676304|NCT03712930|459439036|FG000|Overall Study|Study Terminated by Sponsor|3|||
127676305|NCT03712930|459439036|FG000|Overall Study|Progressive Disease|2|||
127676306|NCT00739102|459439041|FG000|Overall Study|Death|5|||
127676307|NCT00739102|459439041|FG000|Overall Study|Withdrawal by Subject|10|||
127676308|NCT01091454|459439044|FG000|Overall Study|Ineligible|1|||
127676309|NCT01510912|459439045|FG000|Overall Study|Adverse Event|99|||
127676310|NCT01510912|459439045|FG000|Overall Study|Lack of Efficacy|12|||
127676311|NCT01510912|459439045|FG000|Overall Study|Non-compliance with trial drug|23|||
127676312|NCT01510912|459439045|FG000|Overall Study|Withdrawal by Subject|49|||
127764151|NCT00116753|459761508|FG001|Overall Study|Adverse Event|10|||
127764152|NCT00116753|459761509|FG002|Overall Study|Adverse Event|7|||
127764153|NCT00116753|459761507|FG000|Overall Study|Withdrawal by Subject|11|||
127764154|NCT00116753|459761508|FG001|Overall Study|Withdrawal by Subject|12|||
127764155|NCT00116753|459761509|FG002|Overall Study|Withdrawal by Subject|8|||
127764156|NCT00116753|459761507|FG000|Overall Study|Lost to Follow-up|0|||
127764157|NCT00116753|459761508|FG001|Overall Study|Lost to Follow-up|2|||
127764158|NCT00116753|459761509|FG002|Overall Study|Lost to Follow-up|1|||
127764159|NCT00116753|459761507|FG000|Overall Study|Protocol Violation|0|||
127764160|NCT00116753|459761508|FG001|Overall Study|Protocol Violation|0|||
127764161|NCT00116753|459761509|FG002|Overall Study|Protocol Violation|1|||
127764162|NCT00116753|459761507|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
127764163|NCT00116753|459761508|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
127764164|NCT00116753|459761509|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
127764165|NCT00116753|459761507|FG000|Overall Study|Disease Progression|3|||
127764166|NCT00116753|459761508|FG001|Overall Study|Disease Progression|4|||
127764167|NCT00116753|459761509|FG002|Overall Study|Disease Progression|3|||
127764168|NCT00116753|459761507|FG000|Overall Study|Abnormal Echocardiogram|0|||
127764169|NCT00116753|459761508|FG001|Overall Study|Abnormal Echocardiogram|0|||
127764170|NCT00116753|459761509|FG002|Overall Study|Abnormal Echocardiogram|1|||
127764171|NCT00116753|459761507|FG000|Overall Study|Progressive Parkinson's Disease|1|||
127764172|NCT00116753|459761508|FG001|Overall Study|Progressive Parkinson's Disease|0|||
127764173|NCT00116753|459761509|FG002|Overall Study|Progressive Parkinson's Disease|0|||
127764174|NCT00116753|459761507|FG000|Overall Study|Dosing Error|0|||
127764175|NCT00116753|459761508|FG001|Overall Study|Dosing Error|1|||
127764176|NCT00116753|459761509|FG002|Overall Study|Dosing Error|0|||
127764177|NCT01642251|459761510|FG000|Overall Study|Progressive disease|0|||
127764178|NCT01642251|459761511|FG001|Overall Study|Progressive disease|0|||
127764179|NCT01642251|459761512|FG002|Overall Study|Progressive disease|3|||
127764180|NCT01642251|459761513|FG003|Overall Study|Progressive disease|3|||
127764181|NCT01642251|459761510|FG000|Overall Study|Adverse Event|0|||
127764182|NCT01642251|459761511|FG001|Overall Study|Adverse Event|0|||
127764183|NCT01642251|459761512|FG002|Overall Study|Adverse Event|5|||
127764184|NCT01642251|459761513|FG003|Overall Study|Adverse Event|4|||
127764185|NCT01642251|459761510|FG000|Overall Study|Death|0|||
127764186|NCT01642251|459761511|FG001|Overall Study|Death|0|||
127764187|NCT01642251|459761512|FG002|Overall Study|Death|1|||
127764188|NCT01642251|459761513|FG003|Overall Study|Death|3|||
127764189|NCT01642251|459761510|FG000|Overall Study|Withdrawal by Subject|0|||
127764190|NCT01642251|459761511|FG001|Overall Study|Withdrawal by Subject|0|||
127764191|NCT01642251|459761512|FG002|Overall Study|Withdrawal by Subject|1|||
127764192|NCT01642251|459761513|FG003|Overall Study|Withdrawal by Subject|3|||
127764193|NCT01642251|459761510|FG000|Overall Study|Alternative therapy|0|||
127764194|NCT01642251|459761511|FG001|Overall Study|Alternative therapy|0|||
127764195|NCT01642251|459761512|FG002|Overall Study|Alternative therapy|0|||
127764196|NCT01642251|459761513|FG003|Overall Study|Alternative therapy|2|||
127764197|NCT01642251|459761510|FG000|Overall Study|Other complicating disease|0|||
127764198|NCT01642251|459761511|FG001|Overall Study|Other complicating disease|0|||
127764199|NCT01642251|459761512|FG002|Overall Study|Other complicating disease|1|||
127764200|NCT01642251|459761513|FG003|Overall Study|Other complicating disease|0|||
127764201|NCT01642251|459761510|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
127764202|NCT01642251|459761511|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
127764203|NCT01642251|459761512|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
127764204|NCT01642251|459761513|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
127764205|NCT01445301|459761514|FG000|Overall Study|Adverse Event|15|||
127764206|NCT01445301|459761515|FG001|Overall Study|Adverse Event|25|||
127764207|NCT01445301|459761516|FG002|Overall Study|Adverse Event|4|||
127764208|NCT01445301|459761514|FG000|Overall Study|Lack of Efficacy|0|||
127764209|NCT01445301|459761515|FG001|Overall Study|Lack of Efficacy|1|||
127764210|NCT01445301|459761516|FG002|Overall Study|Lack of Efficacy|0|||
127764211|NCT01445301|459761514|FG000|Overall Study|Protocol Violation|1|||
127764212|NCT01445301|459761515|FG001|Overall Study|Protocol Violation|0|||
127764213|NCT01445301|459761516|FG002|Overall Study|Protocol Violation|0|||
127764214|NCT01445301|459761514|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
127764215|NCT01445301|459761515|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
127764216|NCT01445301|459761516|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
127764217|NCT01445301|459761514|FG000|Overall Study|Physician Decision|0|||
127764218|NCT01445301|459761515|FG001|Overall Study|Physician Decision|2|||
127764219|NCT01445301|459761516|FG002|Overall Study|Physician Decision|0|||
127764220|NCT01445301|459761514|FG000|Overall Study|Withdrawal by Subject|5|||
127764221|NCT01445301|459761515|FG001|Overall Study|Withdrawal by Subject|6|||
127764222|NCT01445301|459761516|FG002|Overall Study|Withdrawal by Subject|4|||
127764223|NCT00752557|459761517|FG000|Overall Study|Withdrawal by Subject|4|||
127764224|NCT00752557|459761518|FG001|Overall Study|Withdrawal by Subject|3|||
127764225|NCT00752557|459761519|FG002|Overall Study|Withdrawal by Subject|3|||
127764226|NCT00752557|459761517|FG000|Overall Study|Unspecified resaons|0|||
127764227|NCT00752557|459761518|FG001|Overall Study|Unspecified resaons|2|||
127764228|NCT00752557|459761519|FG002|Overall Study|Unspecified resaons|2|||
127764229|NCT00752557|459761517|FG000|Overall Study|Lost to Follow-up|1|||
127764230|NCT00752557|459761518|FG001|Overall Study|Lost to Follow-up|0|||
128009772|NCT00410163|460662821|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
128009773|NCT00410163|460662820|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
128009774|NCT00410163|460662821|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
128009775|NCT00410163|460662820|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
127676313|NCT01510912|459439045|FG000|Overall Study|Physician Decision|1|||
127676314|NCT01510912|459439045|FG000|Overall Study|Protocol Violation|27|||
127676315|NCT01510912|459439045|FG000|Overall Study|Lost to Follow-up|26|||
127676316|NCT01510912|459439045|FG000|Overall Study|Other, including joint replacement|5|||
127676317|NCT03179787|459439046|FG000|Overall Study|Lost to Follow-up|15|||
127676318|NCT03179787|459439046|FG000|Overall Study|Case report failures|2|||
127676319|NCT03179787|459439046|FG000|Overall Study|Treatment not administered|1|||
127676320|NCT02030028|459439047|FG000|Overall Study|Withdrawal by Subject|4|||
127676321|NCT02030028|459439047|FG000|Overall Study|lack of transportation|1|||
127676322|NCT02930343|459439048|FG000|Overall Study|Lost to Follow-up|9|||
127676323|NCT02930343|459439049|FG001|Overall Study|Lost to Follow-up|7|||
127676324|NCT02987543|459439052|FG000|Overall Study|Ongoing study at data cut off|49|||
127676325|NCT02987543|459439053|FG001|Overall Study|Ongoing study at data cut off|21|||
127676326|NCT02987543|459439054|FG002|Overall Study|Ongoing study at data cut off|19|||
127676327|NCT02987543|459439055|FG003|Overall Study|Ongoing study at data cut off|12|||
127676328|NCT02987543|459439052|FG000|Overall Study|Death|88|||
127676329|NCT02987543|459439053|FG001|Overall Study|Death|54|||
127676330|NCT02987543|459439054|FG002|Overall Study|Death|67|||
127676331|NCT02987543|459439055|FG003|Overall Study|Death|28|||
127676332|NCT02987543|459439052|FG000|Overall Study|Lost to Follow-up|3|||
127676333|NCT02987543|459439053|FG001|Overall Study|Lost to Follow-up|0|||
127676334|NCT02987543|459439054|FG002|Overall Study|Lost to Follow-up|1|||
127676335|NCT02987543|459439055|FG003|Overall Study|Lost to Follow-up|0|||
127676336|NCT02987543|459439052|FG000|Overall Study|Screen failure|0|||
127676337|NCT02987543|459439053|FG001|Overall Study|Screen failure|0|||
127676338|NCT02987543|459439054|FG002|Overall Study|Screen failure|0|||
127676339|NCT02987543|459439055|FG003|Overall Study|Screen failure|1|||
127676340|NCT02987543|459439052|FG000|Overall Study|Withdrawal by Subject|21|||
127676341|NCT02987543|459439053|FG001|Overall Study|Withdrawal by Subject|7|||
127676342|NCT02987543|459439054|FG002|Overall Study|Withdrawal by Subject|7|||
127676343|NCT02987543|459439055|FG003|Overall Study|Withdrawal by Subject|6|||
127676344|NCT02987543|459439052|FG000|Overall Study|Study terminated by sponsor|1|||
127676345|NCT02987543|459439053|FG001|Overall Study|Study terminated by sponsor|0|||
127676346|NCT02987543|459439054|FG002|Overall Study|Study terminated by sponsor|0|||
127676347|NCT02987543|459439055|FG003|Overall Study|Study terminated by sponsor|0|||
127676348|NCT02987543|459439052|FG000|Overall Study|Investigator decision|0|||
127676349|NCT02987543|459439053|FG001|Overall Study|Investigator decision|1|||
127676350|NCT02987543|459439054|FG002|Overall Study|Investigator decision|0|||
127676351|NCT02987543|459439055|FG003|Overall Study|Investigator decision|0|||
127676352|NCT02987543|459439052|FG000|Overall Study|Disease progression|0|||
127676353|NCT02987543|459439053|FG001|Overall Study|Disease progression|0|||
127676354|NCT02987543|459439054|FG002|Overall Study|Disease progression|0|||
127676355|NCT02987543|459439055|FG003|Overall Study|Disease progression|1|||
127676356|NCT01977612|459439056|FG000|Overall Study|Lost to Follow-up|1|||
127676357|NCT01977612|459439057|FG001|Overall Study|Lost to Follow-up|1|||
127676358|NCT01280591|459439058|FG000|Overall Study|Withdrawal by Subject|0|||
127676359|NCT01280591|459439059|FG001|Overall Study|Withdrawal by Subject|0|||
127676360|NCT01280591|459439060|FG002|Overall Study|Withdrawal by Subject|0|||
127676361|NCT01280591|459439061|FG003|Overall Study|Withdrawal by Subject|2|||
127676362|NCT01280591|459439058|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
127676363|NCT01280591|459439059|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
127676364|NCT01280591|459439060|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
127676365|NCT01280591|459439061|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
127676366|NCT01883492|459439064|FG000|Overall Study|Lost to Follow-up|3|||
127676367|NCT01883492|459439065|FG001|Overall Study|Lost to Follow-up|4|||
127676368|NCT01883492|459439064|FG000|Overall Study|Surgery on contra-lateral hip|0|||
128009776|NCT00410163|460662821|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
127676369|NCT01883492|459439065|FG001|Overall Study|Surgery on contra-lateral hip|1|||
127676370|NCT01883492|459439064|FG000|Overall Study|Poor X-ray quality|7|||
127676371|NCT01883492|459439065|FG001|Overall Study|Poor X-ray quality|4|||
127676372|NCT01883492|459439064|FG000|Overall Study|Withdrawal by Subject|1|||
127676373|NCT01883492|459439065|FG001|Overall Study|Withdrawal by Subject|0|||
127676374|NCT01883492|459439064|FG000|Overall Study|inappropriate implant used|1|||
127676375|NCT01883492|459439065|FG001|Overall Study|inappropriate implant used|1|||
127676376|NCT01883492|459439064|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
127676377|NCT01883492|459439065|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
127676378|NCT01259102|459439066|FG000|Overall Study|Adverse Event|1|||
127676379|NCT01259102|459439067|FG001|Overall Study|Adverse Event|0|||
127676380|NCT01259102|459439068|FG002|Overall Study|Adverse Event|1|||
127676381|NCT01259102|459439069|FG003|Overall Study|Adverse Event|1|||
127676382|NCT01259102|459439070|FG004|Overall Study|Adverse Event|0|||
127676383|NCT01259102|459439066|FG000|Overall Study|Other|0|||
128009777|NCT00410163|460662820|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
128009778|NCT00410163|460662821|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
128009779|NCT00797563|460662823|FG000|Overall Study|Adverse Event|1|||
128009780|NCT00688597|460662824|FG000|Overall Study|Adverse Event|2|||
128009781|NCT00688597|460662825|FG001|Overall Study|Adverse Event|0|||
128009782|NCT00688597|460662826|FG002|Overall Study|Adverse Event|0|||
128009783|NCT00688597|460662824|FG000|Overall Study|Physician Decision|1|||
128009784|NCT00688597|460662825|FG001|Overall Study|Physician Decision|0|||
127676384|NCT01259102|459439067|FG001|Overall Study|Other|0|||
127676385|NCT01259102|459439068|FG002|Overall Study|Other|1|||
127676386|NCT01259102|459439069|FG003|Overall Study|Other|1|||
127676387|NCT01259102|459439070|FG004|Overall Study|Other|1|||
127676388|NCT01876511|459439072|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
127676389|NCT01876511|459439073|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
127676390|NCT01876511|459439074|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
127676391|NCT01876511|459439072|FG000|Overall Study|Death (unrelated)|3|||
127676392|NCT01876511|459439073|FG001|Overall Study|Death (unrelated)|0|||
127676393|NCT01876511|459439074|FG002|Overall Study|Death (unrelated)|2|||
127676394|NCT01876511|459439072|FG000|Overall Study|Drug-related Toxicity|5|||
127676395|NCT01876511|459439073|FG001|Overall Study|Drug-related Toxicity|1|||
127676396|NCT01876511|459439074|FG002|Overall Study|Drug-related Toxicity|6|||
127676397|NCT01876511|459439072|FG000|Overall Study|Patient Decision|3|||
127676398|NCT01876511|459439073|FG001|Overall Study|Patient Decision|0|||
127676399|NCT01876511|459439074|FG002|Overall Study|Patient Decision|6|||
127676400|NCT01876511|459439072|FG000|Overall Study|Physician Decision|1|||
127676401|NCT01876511|459439073|FG001|Overall Study|Physician Decision|0|||
127676402|NCT01876511|459439074|FG002|Overall Study|Physician Decision|1|||
127676403|NCT01233050|459439077|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
127676404|NCT01233050|459439078|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
127676405|NCT01064817|459439079|FG000|Study Completion|Physician Decision|1|||
127676406|NCT01064817|459439080|FG001|Study Completion|Physician Decision|0|||
127676407|NCT01064817|459439079|FG000|Study Completion|Withdrawal by Subject|1|||
127676408|NCT01064817|459439080|FG001|Study Completion|Withdrawal by Subject|0|||
127676409|NCT01466881|459439082|FG000|Overall Study|Ineligible|5|||
127676410|NCT01466881|459439082|FG000|Overall Study|Adverse Event|6|||
127676411|NCT01466881|459439082|FG000|Overall Study|Progression/relapse|20|||
127676412|NCT01466881|459439082|FG000|Overall Study|Death|4|||
127676413|NCT01466881|459439082|FG000|Overall Study|Other reason not protocol specified|5|||
127676414|NCT04580303|459439085|FG000|Overall Study|Adverse Event|0|||
127676415|NCT04580303|459439086|FG001|Overall Study|Adverse Event|1|||
127676416|NCT04580303|459439087|FG002|Overall Study|Adverse Event|0|||
127676417|NCT04580303|459439088|FG003|Overall Study|Adverse Event|0|||
127676418|NCT04580303|459439085|FG000|Overall Study|Withdrawal by Subject|0|||
127676419|NCT04580303|459439086|FG001|Overall Study|Withdrawal by Subject|0|||
127676420|NCT04580303|459439087|FG002|Overall Study|Withdrawal by Subject|1|||
127676421|NCT04580303|459439088|FG003|Overall Study|Withdrawal by Subject|0|||
127676422|NCT02299635|459439092|FG000|Overall Study|Adverse Event|2|||
127676423|NCT02299635|459439092|FG000|Overall Study|Death|1|||
127676424|NCT02299635|459439092|FG000|Overall Study|Global deterioration of health status|1|||
127676425|NCT02299635|459439092|FG000|Overall Study|Objective progression or relapse|10|||
127676426|NCT02299635|459439092|FG000|Overall Study|Withdrawal by Subject|2|||
127676427|NCT02299635|459439092|FG000|Overall Study|Other|3|||
127676428|NCT00927823|459439093|FG000|Continuous Dosing Period|Death|0|||
127676429|NCT00927823|459439094|FG001|Continuous Dosing Period|Death|0|||
127676430|NCT00927823|459439095|FG002|Continuous Dosing Period|Death|6|||
127676431|NCT00927823|459439096|FG003|Continuous Dosing Period|Death|0|||
127676432|NCT00927823|459439093|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
127676433|NCT00927823|459439094|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
127676434|NCT00927823|459439095|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
127676435|NCT00927823|459439096|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
127676436|NCT00927823|459439093|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
127676437|NCT00927823|459439094|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
127676438|NCT00927823|459439095|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
127676439|NCT00927823|459439096|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
127676440|NCT00927823|459439093|FG000|Continuous Dosing Period|Other|1|||
127676441|NCT00927823|459439094|FG001|Continuous Dosing Period|Other|2|||
127676442|NCT00927823|459439095|FG002|Continuous Dosing Period|Other|9|||
127676443|NCT00927823|459439096|FG003|Continuous Dosing Period|Other|3|||
127676444|NCT00828672|459439097|FG000|Study Treatment|Lost to Follow-up|1|||
127676445|NCT00828672|459439098|FG001|Study Treatment|Lost to Follow-up|0|||
127676446|NCT00828672|459439097|FG000|Study Treatment|Adverse Event|0|||
127676447|NCT00828672|459439098|FG001|Study Treatment|Adverse Event|1|||
127676448|NCT00828672|459439097|FG000|Study Treatment|Complete response, no surgery|1|||
127676449|NCT00828672|459439098|FG001|Study Treatment|Complete response, no surgery|1|||
127676450|NCT00828672|459439097|FG000|Post-surgery (<30 Days)|No central review materials|0|||
128009785|NCT00688597|460662826|FG002|Overall Study|Physician Decision|0|||
128009786|NCT00961415|460662827|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
128009787|NCT00961415|460662828|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
128009788|NCT00961415|460662829|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
128009789|NCT00961415|460662827|FG000|Induction Treatment Phase|Death|77|||
128009790|NCT00961415|460662828|FG001|Induction Treatment Phase|Death|0|||
128009791|NCT00961415|460662829|FG002|Induction Treatment Phase|Death|0|||
128009792|NCT00961415|460662827|FG000|Induction Treatment Phase|Protocol Violation|1|||
128009793|NCT00961415|460662828|FG001|Induction Treatment Phase|Protocol Violation|0|||
128009794|NCT00961415|460662829|FG002|Induction Treatment Phase|Protocol Violation|0|||
128009795|NCT00961415|460662827|FG000|Induction Treatment Phase|Physician Decision|2|||
128009796|NCT00961415|460662828|FG001|Induction Treatment Phase|Physician Decision|0|||
128009797|NCT00961415|460662829|FG002|Induction Treatment Phase|Physician Decision|0|||
128009798|NCT00961415|460662827|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
128009799|NCT00961415|460662828|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
128009800|NCT00961415|460662829|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
128009801|NCT00961415|460662827|FG000|Induction Treatment Phase|Other Reason|5|||
128009802|NCT00961415|460662828|FG001|Induction Treatment Phase|Other Reason|0|||
128009803|NCT00961415|460662829|FG002|Induction Treatment Phase|Other Reason|0|||
128009804|NCT00961415|460662827|FG000|Maintenance Treatment Phase|Death|0|||
128009805|NCT00961415|460662828|FG001|Maintenance Treatment Phase|Death|42|||
128009806|NCT00961415|460662829|FG002|Maintenance Treatment Phase|Death|34|||
128009807|NCT00961415|460662827|FG000|Maintenance Treatment Phase|Investigators decision|0|||
128009808|NCT00961415|460662828|FG001|Maintenance Treatment Phase|Investigators decision|2|||
128009809|NCT00961415|460662829|FG002|Maintenance Treatment Phase|Investigators decision|0|||
128009810|NCT00961415|460662827|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
128009811|NCT00961415|460662828|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
128009812|NCT00961415|460662829|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
128009813|NCT00961415|460662827|FG000|Maintenance Treatment Phase|Other reason|0|||
128009814|NCT00961415|460662828|FG001|Maintenance Treatment Phase|Other reason|1|||
128009815|NCT00961415|460662829|FG002|Maintenance Treatment Phase|Other reason|3|||
128009816|NCT05853120|460662833|FG000|Overall Study|Lost to Follow-up|4|||
128009817|NCT05853120|460662834|FG001|Overall Study|Lost to Follow-up|4|||
128009818|NCT05853120|460662833|FG000|Overall Study|Physician Decision|3|||
128009819|NCT05853120|460662834|FG001|Overall Study|Physician Decision|0|||
128009820|NCT05853120|460662833|FG000|Overall Study|Withdrawal by Subject|5|||
128009821|NCT05853120|460662834|FG001|Overall Study|Withdrawal by Subject|2|||
128009822|NCT03426878|460662840|FG000|Overall Study|Did not return saliva sample to laboratory|126|||
128009823|NCT03426878|460662840|FG000|Overall Study|DNA extraction and sequencing was not successful|14|||
128009824|NCT03426878|460662840|FG000|Overall Study|Declined to receive results|3|||
128009825|NCT03426878|460662840|FG000|Overall Study|Received negative results by mailed letter|65|||
128009826|NCT03426878|460662840|FG000|Overall Study|Lost to Follow-up|177|||
128009827|NCT02855268|460662841|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
127676451|NCT00828672|459439098|FG001|Post-surgery (<30 Days)|No central review materials|1|||
127676452|NCT00831792|459439107|FG000|Overall Study|Not Eligible|3|||
127676453|NCT00831792|459439107|FG000|Overall Study|Adverse Event|1|||
127676454|NCT00831792|459439107|FG000|Overall Study|Death|1|||
128009828|NCT02855268|460662842|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
128009829|NCT02855268|460662841|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
128009830|NCT02855268|460662842|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
128009831|NCT02855268|460662841|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
128009832|NCT02855268|460662842|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
128009833|NCT02855268|460662841|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
127676455|NCT00831792|459439107|FG000|Overall Study|Lack of Efficacy|1|||
127676456|NCT02469064|459439115|FG000|Overall Study|Request not to receive intervention.|1|||
127676457|NCT02469064|459439116|FG001|Overall Study|Request not to receive intervention.|3|||
127676458|NCT02155829|459439117|FG000|Overall Study|Adverse Event|1|||
127676459|NCT02155829|459439118|FG001|Overall Study|Adverse Event|0|||
127676460|NCT02155829|459439117|FG000|Overall Study|Withdrawal by Subject|3|||
127676461|NCT02155829|459439118|FG001|Overall Study|Withdrawal by Subject|3|||
127676462|NCT02155829|459439117|FG000|Overall Study|Protocol Violation|2|||
127676463|NCT02155829|459439118|FG001|Overall Study|Protocol Violation|0|||
127676464|NCT00678795|459439119|FG000|Overall Study|Adverse Event|7|||
127676465|NCT00678795|459439120|FG001|Overall Study|Adverse Event|3|||
128009834|NCT02855268|460662842|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
128009835|NCT02855268|460662841|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
127676466|NCT00678795|459439119|FG000|Overall Study|Withdrawal by Subject|3|||
127676467|NCT00678795|459439120|FG001|Overall Study|Withdrawal by Subject|0|||
127676468|NCT00678795|459439119|FG000|Overall Study|Protocol Violation|0|||
127676469|NCT00678795|459439120|FG001|Overall Study|Protocol Violation|1|||
128009836|NCT02855268|460662842|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
128009837|NCT02855268|460662841|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
128009838|NCT02855268|460662842|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
128009839|NCT00465517|460662843|FG000|Overall Study|Adverse Event|7|||
128009840|NCT00465517|460662844|FG001|Overall Study|Adverse Event|3|||
128009841|NCT00465517|460662843|FG000|Overall Study|Lost to Follow-up|1|||
128009842|NCT00465517|460662844|FG001|Overall Study|Lost to Follow-up|0|||
128009843|NCT00465517|460662843|FG000|Overall Study|Withdrawal by Subject|4|||
127676470|NCT00678795|459439119|FG000|Overall Study|Lost to Follow-up|0|||
127676471|NCT00678795|459439120|FG001|Overall Study|Lost to Follow-up|1|||
127676472|NCT00678795|459439119|FG000|Overall Study|Lack of Efficacy|1|||
127676473|NCT00678795|459439120|FG001|Overall Study|Lack of Efficacy|1|||
127676474|NCT02750709|459439121|FG000|Treatment Period 1|Adverse Event|0|||
127676475|NCT02750709|459439122|FG001|Treatment Period 1|Adverse Event|0|||
127676476|NCT02750709|459439123|FG002|Treatment Period 1|Adverse Event|0|||
127676477|NCT02750709|459439124|FG003|Treatment Period 1|Adverse Event|0|||
127676478|NCT02750709|459439125|FG004|Treatment Period 1|Adverse Event|0|||
127676479|NCT02750709|459439126|FG005|Treatment Period 1|Adverse Event|1|||
127676480|NCT00404079|459439127|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
127676481|NCT00404079|459439128|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
127676482|NCT01120275|459439129|FG000|Overall Study|Adverse Event|3|||
127676483|NCT01120275|459439129|FG000|Overall Study|Progression|27|||
127676484|NCT01120275|459439129|FG000|Overall Study|Ineligible|3|||
127676485|NCT01120275|459439129|FG000|Overall Study|Withdrawal by Subject|1|||
127676486|NCT01120275|459439129|FG000|Overall Study|Refusal|1|||
127676487|NCT01120275|459439129|FG000|Overall Study|Not specific|1|||
127676488|NCT00290732|459439130|FG000|Overall Study|Inability to instill drug intraductally.|0|||
127676489|NCT00290732|459439131|FG001|Overall Study|Inability to instill drug intraductally.|1|||
127676490|NCT00290732|459439132|FG002|Overall Study|Inability to instill drug intraductally.|1|||
127676491|NCT00290732|459439133|FG003|Overall Study|Inability to instill drug intraductally.|0|||
127676492|NCT00290732|459439134|FG004|Overall Study|Inability to instill drug intraductally.|0|||
127676493|NCT02595398|459439135|FG000|Overall Study|Non-compliance|1|||
127676494|NCT02595398|459439136|FG001|Overall Study|Non-compliance|0|||
127676495|NCT02595398|459439135|FG000|Overall Study|Withdrawal by Subject|2|||
127676496|NCT02595398|459439136|FG001|Overall Study|Withdrawal by Subject|1|||
127676497|NCT02595398|459439135|FG000|Overall Study|Lost to Follow-up|1|||
127676498|NCT02595398|459439136|FG001|Overall Study|Lost to Follow-up|0|||
127676499|NCT00542386|459439137|FG000|Overall Study|Adverse Event|1|||
127676500|NCT00542386|459439138|FG001|Overall Study|Adverse Event|7|||
127676501|NCT00542386|459439139|FG002|Overall Study|Adverse Event|7|||
127676502|NCT00542386|459439140|FG003|Overall Study|Adverse Event|8|||
127676503|NCT00542386|459439141|FG004|Overall Study|Adverse Event|13|||
127676504|NCT00542386|459439142|FG005|Overall Study|Adverse Event|4|||
127676505|NCT00542386|459439137|FG000|Overall Study|Death|0|||
127676506|NCT00542386|459439138|FG001|Overall Study|Death|0|||
127676507|NCT00542386|459439139|FG002|Overall Study|Death|1|||
127676508|NCT00542386|459439140|FG003|Overall Study|Death|2|||
127676509|NCT00542386|459439141|FG004|Overall Study|Death|1|||
127676510|NCT00542386|459439142|FG005|Overall Study|Death|2|||
127676511|NCT00542386|459439137|FG000|Overall Study|Lack of Efficacy|32|||
127676512|NCT00542386|459439138|FG001|Overall Study|Lack of Efficacy|12|||
127676513|NCT00542386|459439139|FG002|Overall Study|Lack of Efficacy|10|||
127676514|NCT00542386|459439140|FG003|Overall Study|Lack of Efficacy|13|||
127676515|NCT00542386|459439141|FG004|Overall Study|Lack of Efficacy|7|||
127676516|NCT00542386|459439142|FG005|Overall Study|Lack of Efficacy|31|||
127676517|NCT00542386|459439137|FG000|Overall Study|Physician Decision|1|||
127676518|NCT00542386|459439138|FG001|Overall Study|Physician Decision|0|||
127676519|NCT00542386|459439139|FG002|Overall Study|Physician Decision|0|||
127676520|NCT00542386|459439140|FG003|Overall Study|Physician Decision|1|||
127676521|NCT00542386|459439141|FG004|Overall Study|Physician Decision|0|||
127676522|NCT00542386|459439142|FG005|Overall Study|Physician Decision|0|||
127676523|NCT00542386|459439137|FG000|Overall Study|Protocol Violation|0|||
127676524|NCT00542386|459439138|FG001|Overall Study|Protocol Violation|0|||
127676525|NCT00542386|459439139|FG002|Overall Study|Protocol Violation|1|||
127676526|NCT00542386|459439140|FG003|Overall Study|Protocol Violation|0|||
127676527|NCT00542386|459439141|FG004|Overall Study|Protocol Violation|0|||
127676528|NCT00542386|459439142|FG005|Overall Study|Protocol Violation|4|||
127676529|NCT00542386|459439137|FG000|Overall Study|Withdrawal by Subject|5|||
127676530|NCT00542386|459439138|FG001|Overall Study|Withdrawal by Subject|8|||
127676531|NCT00542386|459439139|FG002|Overall Study|Withdrawal by Subject|10|||
127676532|NCT00542386|459439140|FG003|Overall Study|Withdrawal by Subject|11|||
128009844|NCT00465517|460662844|FG001|Overall Study|Withdrawal by Subject|1|||
127676533|NCT00542386|459439141|FG004|Overall Study|Withdrawal by Subject|15|||
127676534|NCT00542386|459439142|FG005|Overall Study|Withdrawal by Subject|7|||
127676535|NCT00542386|459439137|FG000|Overall Study|Other Reasons|4|||
127676536|NCT00542386|459439138|FG001|Overall Study|Other Reasons|1|||
127676537|NCT00542386|459439139|FG002|Overall Study|Other Reasons|4|||
127676538|NCT00542386|459439140|FG003|Overall Study|Other Reasons|3|||
127676539|NCT00542386|459439141|FG004|Overall Study|Other Reasons|4|||
127676540|NCT00542386|459439142|FG005|Overall Study|Other Reasons|2|||
127676541|NCT00197015|459439143|FG000|Overall Study|Adverse Event|3|||
127676542|NCT00197015|459439144|FG001|Overall Study|Adverse Event|0|||
127676543|NCT00197015|459439145|FG002|Overall Study|Adverse Event|1|||
128009845|NCT05233761|460662851|FG000|Treatment Period A|Withdrawal by Subject|12|||
128009846|NCT05233761|460662852|FG001|Treatment Period A|Withdrawal by Subject|10|||
128009847|NCT05233761|460662851|FG000|Treatment Period A|Lost to Follow-up|6|||
128009848|NCT05233761|460662852|FG001|Treatment Period A|Lost to Follow-up|12|||
128009849|NCT05233761|460662851|FG000|Treatment Period A|Protocol Violation|8|||
128009850|NCT05233761|460662852|FG001|Treatment Period A|Protocol Violation|15|||
128009851|NCT01604785|460662853|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
128009852|NCT01604785|460662854|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
128009853|NCT04798027|460662857|FG000|Overall Study|Protocol Violation|0|||
128009854|NCT04798027|460662858|FG001|Overall Study|Protocol Violation|0|||
128009855|NCT04798027|460662859|FG002|Overall Study|Protocol Violation|0|||
128009856|NCT04798027|460662860|FG003|Overall Study|Protocol Violation|0|||
128009857|NCT04798027|460662861|FG004|Overall Study|Protocol Violation|1|||
127676544|NCT00197015|459439143|FG000|Overall Study|Protocol Violation|0|||
127676545|NCT00197015|459439144|FG001|Overall Study|Protocol Violation|3|||
127764231|NCT00752557|459761519|FG002|Overall Study|Lost to Follow-up|1|||
127764232|NCT01605916|459761524|FG000|Overall Study|Adverse Event|1|||
127764233|NCT01605916|459761525|FG001|Overall Study|Adverse Event|0|||
127676546|NCT00197015|459439145|FG002|Overall Study|Protocol Violation|3|||
127676547|NCT00197015|459439143|FG000|Overall Study|Withdrawal by Subject|17|||
127676548|NCT00197015|459439144|FG001|Overall Study|Withdrawal by Subject|37|||
127676549|NCT00197015|459439145|FG002|Overall Study|Withdrawal by Subject|34|||
127676550|NCT00197015|459439143|FG000|Overall Study|Lost to Follow-up|28|||
127676551|NCT00197015|459439144|FG001|Overall Study|Lost to Follow-up|46|||
127676552|NCT00197015|459439145|FG002|Overall Study|Lost to Follow-up|37|||
127676553|NCT00197015|459439143|FG000|Overall Study|Other|2|||
127676554|NCT00197015|459439144|FG001|Overall Study|Other|3|||
127676555|NCT00197015|459439145|FG002|Overall Study|Other|2|||
127676556|NCT00880906|459439148|FG000|Overall Study|Lost to Follow-up|0|||
127676557|NCT00880906|459439149|FG001|Overall Study|Lost to Follow-up|1|||
127676558|NCT00880906|459439148|FG000|Overall Study|Did not meet criteria following patholog|12|||
127676559|NCT00880906|459439149|FG001|Overall Study|Did not meet criteria following patholog|6|||
127676560|NCT00559949|459439154|FG000|Overall Study|Progressive Disease during cycle 1|1|||
127676561|NCT00559949|459439154|FG000|Overall Study|Adverse Event|1|||
127676562|NCT00559949|459439154|FG000|Overall Study|Withdrawal by Subject|4|||
127676563|NCT00559949|459439154|FG000|Overall Study|No disease evaluation per protocol|1|||
127676564|NCT00414648|459439155|FG000|Overall Study|Adverse Event|5|||
127676565|NCT00414648|459439156|FG001|Overall Study|Adverse Event|5|||
127676566|NCT00414648|459439155|FG000|Overall Study|Death|0|||
127676567|NCT00414648|459439156|FG001|Overall Study|Death|1|||
127676568|NCT00414648|459439155|FG000|Overall Study|Lack of Efficacy|0|||
127676569|NCT00414648|459439156|FG001|Overall Study|Lack of Efficacy|2|||
127676570|NCT00414648|459439155|FG000|Overall Study|Withdrawal by Subject|0|||
127676571|NCT00414648|459439156|FG001|Overall Study|Withdrawal by Subject|1|||
127676572|NCT03643211|459439157|FG000|Overall Study|Contract violation/deficiency|12|||
127676573|NCT03643211|459439157|FG000|Overall Study|Invalid registration|3|||
127676574|NCT03643211|459439157|FG000|Overall Study|No treatment information|2|||
127676575|NCT03643211|459439157|FG000|Overall Study|No adverse event information - No revisit|4|||
127676576|NCT04858425|459439158|FG000|Overall Study|Adverse Event|2|||
127676577|NCT04858425|459439159|FG001|Overall Study|Adverse Event|2|||
127676578|NCT04858425|459439158|FG000|Overall Study|Withdrawal by Subject|3|||
127676579|NCT04858425|459439159|FG001|Overall Study|Withdrawal by Subject|1|||
127676580|NCT04858425|459439158|FG000|Overall Study|Lost to Follow-up|4|||
127676581|NCT04858425|459439159|FG001|Overall Study|Lost to Follow-up|2|||
127676582|NCT04858425|459439158|FG000|Overall Study|Lost to Follow-up|1|||
127676583|NCT04858425|459439159|FG001|Overall Study|Lost to Follow-up|0|||
127676584|NCT01155869|459439161|FG000|Overall Study|Lost to Follow-up|3|||
127676585|NCT01155869|459439162|FG001|Overall Study|Lost to Follow-up|1|||
127676586|NCT02824432|459439163|FG000|Overall Study|Major Protocol Deviation|1|||
127676587|NCT02824432|459439164|FG001|Overall Study|Major Protocol Deviation|0|||
127676588|NCT04436120|459439169|FG000|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
127676589|NCT04436120|459439170|FG001|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
127676590|NCT04436120|459439171|FG002|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
127764234|NCT01605916|459761526|FG002|Overall Study|Adverse Event|0|||
128009858|NCT04798027|460662862|FG005|Overall Study|Protocol Violation|0|||
128009859|NCT04798027|460662863|FG006|Overall Study|Protocol Violation|0|||
128009860|NCT04798027|460662864|FG007|Overall Study|Protocol Violation|1|||
127676591|NCT04436120|459439172|FG003|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
127676592|NCT04436120|459439173|FG004|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
127676593|NCT04436120|459439174|FG005|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
127676594|NCT04436120|459439175|FG006|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
127676595|NCT02357784|459439176|FG000|Overall Study|Withdrawal by Subject|1|||
128009861|NCT04798027|460662865|FG008|Overall Study|Protocol Violation|0|||
128009862|NCT04798027|460662857|FG000|Overall Study|Withdrawal by Subject|1|||
128009863|NCT04798027|460662858|FG001|Overall Study|Withdrawal by Subject|0|||
128009864|NCT04798027|460662859|FG002|Overall Study|Withdrawal by Subject|1|||
128009865|NCT04798027|460662860|FG003|Overall Study|Withdrawal by Subject|1|||
128009866|NCT04798027|460662861|FG004|Overall Study|Withdrawal by Subject|1|||
128009867|NCT04798027|460662862|FG005|Overall Study|Withdrawal by Subject|1|||
128009868|NCT04798027|460662863|FG006|Overall Study|Withdrawal by Subject|3|||
128009869|NCT04798027|460662864|FG007|Overall Study|Withdrawal by Subject|2|||
128009870|NCT04798027|460662865|FG008|Overall Study|Withdrawal by Subject|2|||
128009871|NCT04798027|460662857|FG000|Overall Study|Lost to Follow-up|1|||
128009872|NCT04798027|460662858|FG001|Overall Study|Lost to Follow-up|3|||
128009873|NCT04798027|460662859|FG002|Overall Study|Lost to Follow-up|0|||
128009874|NCT04798027|460662860|FG003|Overall Study|Lost to Follow-up|0|||
128009875|NCT04798027|460662861|FG004|Overall Study|Lost to Follow-up|0|||
128009876|NCT04798027|460662862|FG005|Overall Study|Lost to Follow-up|1|||
128009877|NCT04798027|460662863|FG006|Overall Study|Lost to Follow-up|0|||
127764235|NCT01605916|459761527|FG003|Overall Study|Adverse Event|1|||
127764236|NCT01605916|459761528|FG004|Overall Study|Adverse Event|0|||
127764237|NCT01605916|459761524|FG000|Overall Study|Lack of Efficacy|2|||
127764238|NCT01605916|459761525|FG001|Overall Study|Lack of Efficacy|3|||
127764239|NCT01605916|459761526|FG002|Overall Study|Lack of Efficacy|3|||
127764240|NCT01605916|459761527|FG003|Overall Study|Lack of Efficacy|5|||
127764241|NCT01605916|459761528|FG004|Overall Study|Lack of Efficacy|4|||
127764242|NCT01605916|459761524|FG000|Overall Study|Withdrawal by Subject|1|||
127764243|NCT01605916|459761525|FG001|Overall Study|Withdrawal by Subject|1|||
127764244|NCT01605916|459761526|FG002|Overall Study|Withdrawal by Subject|0|||
127764245|NCT01605916|459761527|FG003|Overall Study|Withdrawal by Subject|0|||
127764246|NCT01605916|459761528|FG004|Overall Study|Withdrawal by Subject|2|||
127764247|NCT00470366|459761531|FG000|Overall Study|Adverse Event|3|||
127764248|NCT00470366|459761531|FG000|Overall Study|Poor compliance|1|||
127764249|NCT02996474|459761532|FG000|Overall Study|Physician Decision|5|||
127764250|NCT04493502|459761533|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
127764251|NCT04493502|459761534|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
127764252|NCT04493502|459761533|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
127764253|NCT04493502|459761534|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
127764254|NCT04493502|459761533|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
127764255|NCT04493502|459761534|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
127764256|NCT04493502|459761533|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
127764257|NCT04493502|459761534|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
127764258|NCT04493502|459761533|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
127764259|NCT04493502|459761534|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
127764260|NCT04493502|459761533|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
127764261|NCT04493502|459761534|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
127764262|NCT04493502|459761533|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
127764263|NCT04493502|459761534|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
127764264|NCT04493502|459761533|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
127764265|NCT04493502|459761534|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
127764266|NCT04493502|459761533|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
128009878|NCT04798027|460662864|FG007|Overall Study|Lost to Follow-up|0|||
128009879|NCT04798027|460662865|FG008|Overall Study|Lost to Follow-up|1|||
128009880|NCT04798027|460662857|FG000|Overall Study|Withdrawal by Sponsor|8|||
128009881|NCT04798027|460662858|FG001|Overall Study|Withdrawal by Sponsor|22|||
128009882|NCT04798027|460662859|FG002|Overall Study|Withdrawal by Sponsor|9|||
128009883|NCT04798027|460662860|FG003|Overall Study|Withdrawal by Sponsor|26|||
128009884|NCT04798027|460662861|FG004|Overall Study|Withdrawal by Sponsor|24|||
128009885|NCT04798027|460662862|FG005|Overall Study|Withdrawal by Sponsor|11|||
128009886|NCT04798027|460662863|FG006|Overall Study|Withdrawal by Sponsor|25|||
128009887|NCT04798027|460662864|FG007|Overall Study|Withdrawal by Sponsor|26|||
128009888|NCT04798027|460662865|FG008|Overall Study|Withdrawal by Sponsor|11|||
127676596|NCT01543685|459439177|FG000|Overall Study|Lack of Efficacy|1|||
127676597|NCT01543685|459439178|FG001|Overall Study|Lack of Efficacy|2|||
127676598|NCT01543685|459439179|FG002|Overall Study|Lack of Efficacy|2|||
127676599|NCT01543685|459439180|FG003|Overall Study|Lack of Efficacy|0|||
127676600|NCT01543685|459439181|FG004|Overall Study|Lack of Efficacy|2|||
127676601|NCT01543685|459439177|FG000|Overall Study|Adverse Event|2|||
127676602|NCT01543685|459439178|FG001|Overall Study|Adverse Event|1|||
127676603|NCT01543685|459439179|FG002|Overall Study|Adverse Event|0|||
127676604|NCT01543685|459439180|FG003|Overall Study|Adverse Event|0|||
127676605|NCT01543685|459439181|FG004|Overall Study|Adverse Event|2|||
127676606|NCT04776213|459439182|FG000|Overall Study|Other|1|||
127676607|NCT04776213|459439182|FG000|Overall Study|Withdrawal by Subject|7|||
127676608|NCT04776213|459439182|FG000|Overall Study|Protocol Violation|1|||
127676609|NCT04776213|459439182|FG000|Overall Study|Lost to Follow-up|2|||
127676610|NCT02931396|459439183|FG000|Overall Study|Lost to Follow-up|3|||
127676611|NCT02931396|459439184|FG001|Overall Study|Lost to Follow-up|0|||
127676612|NCT02931396|459439183|FG000|Overall Study|Withdrawal by Subject|2|||
127676613|NCT02931396|459439184|FG001|Overall Study|Withdrawal by Subject|0|||
127676614|NCT02013037|459439185|FG000|Overall Study|Death|6|||
127676615|NCT02013037|459439185|FG000|Overall Study|Withdrawal by Subject|1|||
127676616|NCT02013037|459439185|FG000|Overall Study|Awaiting Transplantation|7|||
127676617|NCT02013037|459439185|FG000|Overall Study|Transplanted without DSA|2|||
127676618|NCT01304147|459439186|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
127676619|NCT01304147|459439187|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
127676620|NCT01244828|459439188|FG000|Overall Study|Adverse Event|37|||
127676621|NCT01244828|459439188|FG000|Overall Study|Withdrawal by Subject|31|||
127676622|NCT01244828|459439188|FG000|Overall Study|Lack of Efficacy|7|||
127676623|NCT01244828|459439188|FG000|Overall Study|Lost to Follow-up|2|||
127676624|NCT01244828|459439188|FG000|Overall Study|Other reason (not specified)|1|||
127676625|NCT01278862|459439189|FG000|Overall Study|Lost to Follow-up|1|||
127676626|NCT01278862|459439190|FG001|Overall Study|Lost to Follow-up|1|||
127676627|NCT00603447|459439191|FG000|Overall Study|Adverse Event|0|||
127676628|NCT00603447|459439192|FG001|Overall Study|Adverse Event|1|||
127676629|NCT00603447|459439193|FG002|Overall Study|Adverse Event|1|||
127676630|NCT00603447|459439194|FG003|Overall Study|Adverse Event|2|||
127676631|NCT00603447|459439195|FG004|Overall Study|Adverse Event|1|||
127676632|NCT00603447|459439196|FG005|Overall Study|Adverse Event|2|||
127676633|NCT00603447|459439197|FG006|Overall Study|Adverse Event|10|||
127676634|NCT00603447|459439191|FG000|Overall Study|Other|0|||
127676635|NCT00603447|459439192|FG001|Overall Study|Other|0|||
127676636|NCT00603447|459439193|FG002|Overall Study|Other|1|||
127676637|NCT00603447|459439194|FG003|Overall Study|Other|0|||
127676638|NCT00603447|459439195|FG004|Overall Study|Other|3|||
127676639|NCT00603447|459439196|FG005|Overall Study|Other|0|||
127676640|NCT00603447|459439197|FG006|Overall Study|Other|13|||
127676641|NCT00603447|459439191|FG000|Overall Study|Withdrew Consent|0|||
127676642|NCT00603447|459439192|FG001|Overall Study|Withdrew Consent|2|||
127676643|NCT00603447|459439193|FG002|Overall Study|Withdrew Consent|0|||
127676644|NCT00603447|459439194|FG003|Overall Study|Withdrew Consent|0|||
127676645|NCT00603447|459439195|FG004|Overall Study|Withdrew Consent|1|||
127676646|NCT00603447|459439196|FG005|Overall Study|Withdrew Consent|0|||
127676647|NCT00603447|459439197|FG006|Overall Study|Withdrew Consent|1|||
127676648|NCT02738840|459440998|FG000|Overall Study|MRI Scan not Performed|5|||
127676649|NCT02738840|459440998|FG000|Overall Study|Lost to Follow-up|1|||
127676650|NCT02738840|459440998|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
127676651|NCT02738840|459440998|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
127676652|NCT01645111|459441000|FG000|Overall Study|Did not require Clevidipine|15|||
127676653|NCT04057196|459441002|FG000|Overall Study|Withdrawal by Subject|3|||
127676654|NCT04057196|459441002|FG000|Overall Study|Death|3|||
127676655|NCT02466516|459441004|FG000|Overall Study|Adverse Event|1|||
127676656|NCT02466516|459441005|FG001|Overall Study|Adverse Event|1|||
127676657|NCT02466516|459441006|FG002|Overall Study|Adverse Event|0|||
127676658|NCT02466516|459441007|FG003|Overall Study|Adverse Event|0|||
127676659|NCT02466516|459441008|FG004|Overall Study|Adverse Event|0|||
127676660|NCT02466516|459441004|FG000|Overall Study|Withdrew Consent|1|||
127676661|NCT02466516|459441005|FG001|Overall Study|Withdrew Consent|0|||
127676662|NCT02466516|459441006|FG002|Overall Study|Withdrew Consent|0|||
127676663|NCT02466516|459441007|FG003|Overall Study|Withdrew Consent|0|||
127676664|NCT02466516|459441008|FG004|Overall Study|Withdrew Consent|0|||
127676665|NCT02466516|459441004|FG000|Overall Study|Lost to Follow-up|2|||
127676666|NCT02466516|459441005|FG001|Overall Study|Lost to Follow-up|0|||
127676667|NCT02466516|459441006|FG002|Overall Study|Lost to Follow-up|1|||
127676668|NCT02466516|459441007|FG003|Overall Study|Lost to Follow-up|0|||
127676669|NCT02466516|459441008|FG004|Overall Study|Lost to Follow-up|0|||
127676670|NCT01331824|459441009|FG000|Overall Study|Adverse Event|2|||
127676671|NCT01331824|459441009|FG000|Overall Study|Death|1|||
127676672|NCT01331824|459441009|FG000|Overall Study|Disease Progression|9|||
127676673|NCT01331824|459441009|FG000|Overall Study|Withdrawal by Subject|1|||
127676674|NCT00646451|459441010|FG000|Overall Study|Adverse Event|3|||
127676675|NCT00646451|459441011|FG001|Overall Study|Adverse Event|0|||
127676676|NCT00646451|459441010|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
127676677|NCT00646451|459441011|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
127676678|NCT01249092|459441013|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
127676679|NCT01249092|459441013|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
127676680|NCT03357341|459441016|FG000|Overall Study|Withdrawal by Subject|3|||
127676681|NCT03357341|459441017|FG001|Overall Study|Withdrawal by Subject|6|||
127676682|NCT03357341|459441016|FG000|Overall Study|Lost to Follow-up|4|||
127676683|NCT03357341|459441017|FG001|Overall Study|Lost to Follow-up|5|||
127676684|NCT03357341|459441016|FG000|Overall Study|Death|0|||
127676685|NCT03357341|459441017|FG001|Overall Study|Death|1|||
127764267|NCT04493502|459761534|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
127764268|NCT04493502|459761533|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
127764269|NCT04493502|459761534|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
127764270|NCT04493502|459761533|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
127764271|NCT04493502|459761534|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
127764272|NCT04493502|459761533|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
127764273|NCT04493502|459761534|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
127764274|NCT04493502|459761533|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
127764275|NCT04493502|459761534|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
127764276|NCT00540046|459761535|FG000|Overall Study|Lost to Follow-up|33|||
127764277|NCT00540046|459761536|FG001|Overall Study|Lost to Follow-up|23|||
127764278|NCT02891837|459761537|FG000|Overall Study|Lost to Follow-up|2|||
127764279|NCT02891837|459761538|FG001|Overall Study|Lost to Follow-up|0|||
127764280|NCT02891837|459761537|FG000|Overall Study|Withdrawal by Subject|1|||
127764281|NCT02891837|459761538|FG001|Overall Study|Withdrawal by Subject|0|||
127764282|NCT02751320|459761546|FG000|Overall Study|Adverse Event|2|||
127764283|NCT02751320|459761546|FG000|Overall Study|Withdrawal by Subject|1|||
127764284|NCT01021215|459761547|FG000|Overall Study|Lost to Follow-up|3|||
127764285|NCT01021215|459761548|FG001|Overall Study|Lost to Follow-up|0|||
127764286|NCT02549196|459761549|FG000|Overall Study|Protocol Violation|0|||
127764287|NCT02549196|459761550|FG001|Overall Study|Protocol Violation|0|||
127764288|NCT02549196|459761551|FG002|Overall Study|Protocol Violation|0|||
127764289|NCT02549196|459761552|FG003|Overall Study|Protocol Violation|1|||
127764290|NCT02549196|459761549|FG000|Overall Study|Withdrawal by Subject|1|||
127764291|NCT02549196|459761550|FG001|Overall Study|Withdrawal by Subject|0|||
127764292|NCT02549196|459761551|FG002|Overall Study|Withdrawal by Subject|1|||
127764293|NCT02549196|459761552|FG003|Overall Study|Withdrawal by Subject|0|||
127764294|NCT00185965|459761555|FG000|Overall Study|Adverse Event|0|||
127764295|NCT00185965|459761556|FG001|Overall Study|Adverse Event|1|||
127764296|NCT02533531|459761557|FG000|Overall Study|Device did not turn on|1|||
127764297|NCT02047903|459761558|FG000|Overall Study|Adverse Event|14|||
127764298|NCT02047903|459761558|FG000|Overall Study|Serious adverse event|10|||
127764299|NCT02047903|459761558|FG000|Overall Study|Withdrawal by Subject|16|||
127764300|NCT02047903|459761558|FG000|Overall Study|Lost to Follow-up|4|||
127764301|NCT02047903|459761558|FG000|Overall Study|Reason not listed|6|||
127764302|NCT02047903|459761558|FG000|Overall Study|Not Treated|9|||
127764303|NCT01014533|459761559|FG000|Overall Study|Protocol Violation|3|||
127764304|NCT01014533|459761560|FG001|Overall Study|Protocol Violation|2|||
127764305|NCT01014533|459761559|FG000|Overall Study|Withdrawal by Subject|2|||
127764306|NCT01014533|459761560|FG001|Overall Study|Withdrawal by Subject|0|||
127764307|NCT01014533|459761559|FG000|Overall Study|unable to come to appointment|0|||
127764308|NCT01014533|459761560|FG001|Overall Study|unable to come to appointment|3|||
127764309|NCT01011387|459761567|FG000|Overall Study|Withdrawal by Subject|3|||
127764310|NCT01011387|459761567|FG000|Overall Study|Adverse Event|2|||
127764311|NCT01011387|459761567|FG000|Overall Study|Protocol Violation|1|||
127764312|NCT02433340|459761568|FG000|Overall Study|Adverse Event|0|||
127764313|NCT02433340|459761569|FG001|Overall Study|Adverse Event|0|||
127764314|NCT02433340|459761570|FG002|Overall Study|Adverse Event|1|||
127764315|NCT02433340|459761571|FG003|Overall Study|Adverse Event|0|||
127764316|NCT02433340|459761568|FG000|Overall Study|Withdrawal by Subject|1|||
127764317|NCT02433340|459761569|FG001|Overall Study|Withdrawal by Subject|0|||
127764318|NCT02433340|459761570|FG002|Overall Study|Withdrawal by Subject|1|||
127764319|NCT02433340|459761571|FG003|Overall Study|Withdrawal by Subject|2|||
127764320|NCT02433340|459761568|FG000|Overall Study|Lost to Follow-up|0|||
127764321|NCT02433340|459761569|FG001|Overall Study|Lost to Follow-up|1|||
127764322|NCT02433340|459761570|FG002|Overall Study|Lost to Follow-up|0|||
127764323|NCT02433340|459761571|FG003|Overall Study|Lost to Follow-up|0|||
127764324|NCT02433340|459761568|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
127764325|NCT02433340|459761569|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
127764326|NCT02433340|459761570|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
127764327|NCT02433340|459761571|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
127764328|NCT02433340|459761568|FG000|Overall Study|Other|0|||
127764329|NCT02433340|459761569|FG001|Overall Study|Other|1|||
127764330|NCT02433340|459761570|FG002|Overall Study|Other|0|||
128009889|NCT03729362|460663895|FG000|Overall Study|Withdrawal by Subject|2|||
127764331|NCT02433340|459761571|FG003|Overall Study|Other|0|||
127764332|NCT01226095|459761572|FG000|Overall Study|Poor compliance|1|||
127764333|NCT04822597|459761573|FG000|Overall Study|Withdrawal by Subject|0|||
127764334|NCT04822597|459761574|FG001|Overall Study|Withdrawal by Subject|1|||
127764335|NCT04822597|459761575|FG002|Overall Study|Withdrawal by Subject|1|||
127764336|NCT04822597|459761576|FG003|Overall Study|Withdrawal by Subject|0|||
127764337|NCT04822597|459761573|FG000|Overall Study|Physician Decision|0|||
127764338|NCT04822597|459761574|FG001|Overall Study|Physician Decision|0|||
127764339|NCT04822597|459761575|FG002|Overall Study|Physician Decision|1|||
127764340|NCT04822597|459761576|FG003|Overall Study|Physician Decision|1|||
127764341|NCT04822597|459761573|FG000|Overall Study|Subject withdrawn after enrollment|0|||
127764342|NCT04822597|459761574|FG001|Overall Study|Subject withdrawn after enrollment|1|||
127764343|NCT04822597|459761575|FG002|Overall Study|Subject withdrawn after enrollment|0|||
127764344|NCT04822597|459761576|FG003|Overall Study|Subject withdrawn after enrollment|1|||
127764345|NCT04822597|459761573|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
127764346|NCT04822597|459761574|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
127764347|NCT04822597|459761575|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
127764348|NCT04822597|459761576|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
127764349|NCT03265938|459761577|FG000|Overall Study|Withdrawal by Subject|1|||
127764350|NCT03265938|459761577|FG000|Overall Study|Physician Decision|1|||
127764351|NCT03265938|459761577|FG000|Overall Study|friable mass|6|||
127764352|NCT02679508|459761578|FG000|Healing Phase|Protocol Violation|1|||
127764353|NCT02679508|459761579|FG001|Healing Phase|Protocol Violation|1|||
127764354|NCT02679508|459761578|FG000|Healing Phase|Lost to Follow-up|1|||
127764355|NCT02679508|459761579|FG001|Healing Phase|Lost to Follow-up|0|||
127764356|NCT02679508|459761578|FG000|Maintenance Phase|Adverse Event|12|||
127764357|NCT02679508|459761579|FG001|Maintenance Phase|Adverse Event|2|||
127764358|NCT02679508|459761578|FG000|Maintenance Phase|Lost to Follow-up|0|||
127764359|NCT02679508|459761579|FG001|Maintenance Phase|Lost to Follow-up|1|||
127764360|NCT02679508|459761578|FG000|Maintenance Phase|Withdrawal by Subject|15|||
127764361|NCT02679508|459761579|FG001|Maintenance Phase|Withdrawal by Subject|8|||
127764362|NCT02679508|459761578|FG000|Maintenance Phase|Other|5|||
127764363|NCT02679508|459761579|FG001|Maintenance Phase|Other|4|||
127764364|NCT03143166|459761580|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
127764365|NCT05000931|459761589|FG000|Overall Study|Lost to Follow-up|1|||
127764366|NCT00925132|459761590|FG000|Overall Study|Withdrawal by Subject|2|||
127764367|NCT00925132|459761591|FG001|Overall Study|Withdrawal by Subject|0|||
127764368|NCT00925132|459761592|FG002|Overall Study|Withdrawal by Subject|0|||
127764369|NCT00925132|459761593|FG003|Overall Study|Withdrawal by Subject|0|||
127764370|NCT00925132|459761594|FG004|Overall Study|Withdrawal by Subject|1|||
127764371|NCT00925132|459761590|FG000|Overall Study|Removed due to disease progression|0|||
127764372|NCT00925132|459761591|FG001|Overall Study|Removed due to disease progression|0|||
127764373|NCT00925132|459761592|FG002|Overall Study|Removed due to disease progression|0|||
127764374|NCT00925132|459761593|FG003|Overall Study|Removed due to disease progression|0|||
127764375|NCT00925132|459761594|FG004|Overall Study|Removed due to disease progression|4|||
127764376|NCT01034176|459763398|FG000|Overall Study|Physician Decision|2|||
127764377|NCT01034176|459763399|FG001|Overall Study|Physician Decision|0|||
127764378|NCT01034176|459763398|FG000|Overall Study|Withdrawal by Subject|0|||
127764379|NCT01034176|459763399|FG001|Overall Study|Withdrawal by Subject|1|||
127764380|NCT01034176|459763398|FG000|Overall Study|Lost to Follow-up|0|||
127764381|NCT01034176|459763399|FG001|Overall Study|Lost to Follow-up|1|||
127764382|NCT05087979|459763402|FG000|Overall Study|Converted to general anesthesia|1|||
127764383|NCT05087979|459763403|FG001|Overall Study|Converted to general anesthesia|0|||
127764384|NCT03207009|459763404|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
127764385|NCT02924428|459763405|FG000|Overall Study|Adverse Event|1|||
127764386|NCT02924428|459763406|FG001|Overall Study|Adverse Event|0|||
127764387|NCT02924428|459763405|FG000|Overall Study|Physician Decision|1|||
127764388|NCT02924428|459763406|FG001|Overall Study|Physician Decision|0|||
127764389|NCT02924428|459763405|FG000|Overall Study|Lost to Follow-up|2|||
128009890|NCT03729362|460663896|FG001|Overall Study|Withdrawal by Subject|0|||
128009891|NCT03729362|460663895|FG000|Overall Study|Physician Decision|1|||
128009892|NCT03729362|460663896|FG001|Overall Study|Physician Decision|0|||
127764390|NCT02924428|459763406|FG001|Overall Study|Lost to Follow-up|4|||
127764391|NCT02924428|459763405|FG000|Overall Study|Pregnancy|0|||
127764392|NCT02924428|459763406|FG001|Overall Study|Pregnancy|1|||
127764393|NCT01850446|459763407|FG000|Overall Study|Lack of Efficacy|1|||
127764394|NCT01850446|459763408|FG001|Overall Study|Lack of Efficacy|0|||
127764395|NCT01850446|459763407|FG000|Overall Study|Withdrawal by Subject|4|||
127764396|NCT01850446|459763408|FG001|Overall Study|Withdrawal by Subject|0|||
127764397|NCT01850446|459763407|FG000|Overall Study|Protocol Violation|0|||
127764398|NCT01850446|459763408|FG001|Overall Study|Protocol Violation|2|||
127764399|NCT00759915|459763409|FG000|Overall Study|Withdrawal by Subject|1|||
127764400|NCT00759915|459763410|FG001|Overall Study|Withdrawal by Subject|0|||
128009893|NCT03729362|460663895|FG000|Overall Study|COVID-19 Pandemic|1|||
127764401|NCT00759915|459763409|FG000|Overall Study|Adverse Event|0|||
127764402|NCT00759915|459763410|FG001|Overall Study|Adverse Event|1|||
128009894|NCT03729362|460663896|FG001|Overall Study|COVID-19 Pandemic|0|||
127764403|NCT03241225|459763413|FG000|Overall Study|Lost to Follow-up|2|||
127764404|NCT03241225|459763414|FG001|Overall Study|Lost to Follow-up|1|||
128009895|NCT03729362|460663895|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
127764405|NCT03241225|459763413|FG000|Overall Study|Protocol Violation|4|||
128009896|NCT03729362|460663896|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
127764406|NCT03241225|459763414|FG001|Overall Study|Protocol Violation|1|||
128009897|NCT03729362|460663895|FG000|Overall Study|Adverse Event|0|||
127764407|NCT03241225|459763413|FG000|Overall Study|Withdrawal by Subject|1|||
127764408|NCT03241225|459763414|FG001|Overall Study|Withdrawal by Subject|0|||
128009898|NCT03729362|460663896|FG001|Overall Study|Adverse Event|1|||
127764409|NCT01635920|459763417|FG000|Overall Study|Adverse Event|1|||
127676686|NCT01710514|459441021|FG000|Overall Study|Adverse Event|6|||
127676687|NCT01710514|459441022|FG001|Overall Study|Adverse Event|7|||
127676688|NCT01710514|459441021|FG000|Overall Study|Withdrawal by Subject|1|||
127676689|NCT01710514|459441022|FG001|Overall Study|Withdrawal by Subject|0|||
127676690|NCT02846415|459441023|FG000|Overall Study|Lost to Follow-up|2|||
127676691|NCT02846415|459441024|FG001|Overall Study|Lost to Follow-up|0|||
127676692|NCT02846415|459441023|FG000|Overall Study|Withdrawal by Subject|1|||
127676693|NCT02846415|459441024|FG001|Overall Study|Withdrawal by Subject|1|||
127676694|NCT03383887|459441025|FG000|Overall Study|Lost to Follow-up|0|||
127676695|NCT03383887|459441026|FG001|Overall Study|Lost to Follow-up|1|||
127676696|NCT01242085|459441029|FG000|Overall Study|Withdrawal by Subject|4|||
127676697|NCT01242085|459441030|FG001|Overall Study|Withdrawal by Subject|2|||
127676698|NCT01242085|459441031|FG002|Overall Study|Withdrawal by Subject|0|||
127676699|NCT01242085|459441029|FG000|Overall Study|medically unable to have surgery|4|||
127676700|NCT01242085|459441030|FG001|Overall Study|medically unable to have surgery|5|||
127676701|NCT01242085|459441031|FG002|Overall Study|medically unable to have surgery|0|||
127676702|NCT02596035|459441036|FG000|Overall Study|Disease Progression|64|||
127676703|NCT02596035|459441037|FG001|Overall Study|Disease Progression|32|||
127676704|NCT02596035|459441038|FG002|Overall Study|Disease Progression|1|||
127676705|NCT02596035|459441036|FG000|Overall Study|study drug toxicity|12|||
127676706|NCT02596035|459441037|FG001|Overall Study|study drug toxicity|3|||
127676707|NCT02596035|459441038|FG002|Overall Study|study drug toxicity|0|||
127676708|NCT02596035|459441036|FG000|Overall Study|AE unrelated to study drug|5|||
127676709|NCT02596035|459441037|FG001|Overall Study|AE unrelated to study drug|2|||
127676710|NCT02596035|459441038|FG002|Overall Study|AE unrelated to study drug|0|||
127676711|NCT02596035|459441036|FG000|Overall Study|participant request to discontinue study treatment|2|||
127676712|NCT02596035|459441037|FG001|Overall Study|participant request to discontinue study treatment|0|||
127676713|NCT02596035|459441038|FG002|Overall Study|participant request to discontinue study treatment|0|||
127676714|NCT02596035|459441036|FG000|Overall Study|participant withdrew consent|2|||
127676715|NCT02596035|459441037|FG001|Overall Study|participant withdrew consent|2|||
127676716|NCT02596035|459441038|FG002|Overall Study|participant withdrew consent|0|||
127676717|NCT02596035|459441036|FG000|Overall Study|Poor/Non Comlpiance|0|||
127676718|NCT02596035|459441037|FG001|Overall Study|Poor/Non Comlpiance|1|||
127676719|NCT02596035|459441038|FG002|Overall Study|Poor/Non Comlpiance|0|||
127676720|NCT02596035|459441036|FG000|Overall Study|participant no longer meets study criteria|1|||
127676721|NCT02596035|459441037|FG001|Overall Study|participant no longer meets study criteria|0|||
127676722|NCT02596035|459441038|FG002|Overall Study|participant no longer meets study criteria|0|||
127676723|NCT02596035|459441036|FG000|Overall Study|other reasons|11|||
127676724|NCT02596035|459441037|FG001|Overall Study|other reasons|4|||
127676725|NCT02596035|459441038|FG002|Overall Study|other reasons|0|||
127676726|NCT01235949|459441043|FG000|Primary Phase|Migrated/moved from study area|1|||
127676727|NCT01235949|459441044|FG001|Primary Phase|Migrated/moved from study area|1|||
127676728|NCT01235949|459441045|FG002|Primary Phase|Migrated/moved from study area|0|||
127676729|NCT01235949|459441046|FG003|Primary Phase|Migrated/moved from study area|0|||
127676730|NCT01235949|459441047|FG004|Primary Phase|Migrated/moved from study area|1|||
127676731|NCT01235949|459441048|FG005|Primary Phase|Migrated/moved from study area|2|||
127676732|NCT01235949|459441049|FG006|Primary Phase|Migrated/moved from study area|0|||
127676733|NCT01235949|459441050|FG007|Primary Phase|Migrated/moved from study area|0|||
127676734|NCT01235949|459441051|FG008|Primary Phase|Migrated/moved from study area|0|||
127676735|NCT01235949|459441052|FG009|Primary Phase|Migrated/moved from study area|0|||
127676736|NCT01235949|459441053|FG010|Primary Phase|Migrated/moved from study area|0|||
127676737|NCT01235949|459441054|FG011|Primary Phase|Migrated/moved from study area|0|||
127676738|NCT01235949|459441055|FG012|Primary Phase|Migrated/moved from study area|0|||
127676739|NCT01235949|459441056|FG013|Primary Phase|Migrated/moved from study area|0|||
127676740|NCT01235949|459441057|FG014|Primary Phase|Migrated/moved from study area|0|||
127676741|NCT01235949|459441058|FG015|Primary Phase|Migrated/moved from study area|0|||
127764410|NCT01635920|459763418|FG001|Overall Study|Adverse Event|0|||
127764411|NCT01635920|459763417|FG000|Overall Study|Lost to Follow-up|0|||
127676742|NCT01235949|459441059|FG016|Primary Phase|Migrated/moved from study area|0|||
127676743|NCT01235949|459441060|FG017|Primary Phase|Migrated/moved from study area|0|||
127676744|NCT01235949|459441043|FG000|Primary Phase|Adverse Event|0|||
127676745|NCT01235949|459441044|FG001|Primary Phase|Adverse Event|0|||
127676746|NCT01235949|459441045|FG002|Primary Phase|Adverse Event|0|||
127676747|NCT01235949|459441046|FG003|Primary Phase|Adverse Event|1|||
127676748|NCT01235949|459441047|FG004|Primary Phase|Adverse Event|0|||
127676749|NCT01235949|459441048|FG005|Primary Phase|Adverse Event|0|||
127676750|NCT01235949|459441049|FG006|Primary Phase|Adverse Event|0|||
127676751|NCT01235949|459441050|FG007|Primary Phase|Adverse Event|0|||
127676752|NCT01235949|459441051|FG008|Primary Phase|Adverse Event|0|||
127676753|NCT01235949|459441052|FG009|Primary Phase|Adverse Event|0|||
127676754|NCT01235949|459441053|FG010|Primary Phase|Adverse Event|0|||
127676755|NCT01235949|459441054|FG011|Primary Phase|Adverse Event|0|||
127764412|NCT01635920|459763418|FG001|Overall Study|Lost to Follow-up|1|||
127764413|NCT01635920|459763417|FG000|Overall Study|Subject decision|2|||
127764414|NCT01635920|459763418|FG001|Overall Study|Subject decision|0|||
127764415|NCT00007345|459763419|FG000|Overall Study|Refused further treatment|0|||
127764416|NCT00007345|459763420|FG001|Overall Study|Refused further treatment|7|||
127764417|NCT00007345|459763419|FG000|Overall Study|Switched to alternative treatment|0|||
127764418|NCT00007345|459763420|FG001|Overall Study|Switched to alternative treatment|3|||
127764419|NCT00007345|459763419|FG000|Overall Study|Intercurrent illness|1|||
127764420|NCT00007345|459763420|FG001|Overall Study|Intercurrent illness|0|||
127764421|NCT00007345|459763419|FG000|Overall Study|Death on study|1|||
127764422|NCT00007345|459763420|FG001|Overall Study|Death on study|1|||
127764423|NCT02074553|459763421|FG000|Intervention Period 1|Family Emergency|0|||
127764424|NCT02074553|459763422|FG001|Intervention Period 1|Family Emergency|0|||
127764425|NCT02074553|459763423|FG002|Intervention Period 1|Family Emergency|0|||
127764426|NCT02074553|459763424|FG003|Intervention Period 1|Family Emergency|1|||
127764427|NCT02074553|459763425|FG004|Intervention Period 1|Family Emergency|0|||
127764428|NCT02074553|459763426|FG005|Intervention Period 1|Family Emergency|0|||
127764429|NCT02074553|459763427|FG006|Intervention Period 1|Family Emergency|0|||
127764430|NCT02074553|459763428|FG007|Intervention Period 1|Family Emergency|0|||
127764431|NCT02074553|459763421|FG000|Washout Period 1|Adverse Event|1|||
127764432|NCT02074553|459763422|FG001|Washout Period 1|Adverse Event|0|||
127764433|NCT02074553|459763423|FG002|Washout Period 1|Adverse Event|0|||
127764434|NCT02074553|459763424|FG003|Washout Period 1|Adverse Event|0|||
127764435|NCT02074553|459763425|FG004|Washout Period 1|Adverse Event|0|||
127764436|NCT02074553|459763426|FG005|Washout Period 1|Adverse Event|0|||
127764437|NCT02074553|459763427|FG006|Washout Period 1|Adverse Event|0|||
127764438|NCT02074553|459763428|FG007|Washout Period 1|Adverse Event|0|||
127764439|NCT02074553|459763421|FG000|Washout Period 1|Physician Decision|0|||
127764440|NCT02074553|459763422|FG001|Washout Period 1|Physician Decision|0|||
128009899|NCT03729362|460663895|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
127764441|NCT02074553|459763423|FG002|Washout Period 1|Physician Decision|0|||
127764442|NCT02074553|459763424|FG003|Washout Period 1|Physician Decision|1|||
127764443|NCT02074553|459763425|FG004|Washout Period 1|Physician Decision|0|||
127764444|NCT02074553|459763426|FG005|Washout Period 1|Physician Decision|0|||
127764445|NCT02074553|459763427|FG006|Washout Period 1|Physician Decision|0|||
127764446|NCT02074553|459763428|FG007|Washout Period 1|Physician Decision|0|||
127764447|NCT02074553|459763421|FG000|Washout Period 1|Other|0|||
127764448|NCT02074553|459763422|FG001|Washout Period 1|Other|0|||
127764449|NCT02074553|459763423|FG002|Washout Period 1|Other|0|||
127764450|NCT02074553|459763424|FG003|Washout Period 1|Other|0|||
128009900|NCT03729362|460663896|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
128009901|NCT01113749|460663897|FG000|Overall Study|Lost to Follow-up|1|||
128009902|NCT01113749|460663898|FG001|Overall Study|Lost to Follow-up|2|||
128009903|NCT00362232|460663899|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
128009904|NCT00362232|460663900|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
128009905|NCT00362232|460663899|FG000|Treatment (12 +/- 2 Days)|Death|1|||
128009906|NCT00362232|460663900|FG001|Treatment (12 +/- 2 Days)|Death|3|||
127764451|NCT02074553|459763425|FG004|Washout Period 1|Other|0|||
127764452|NCT02074553|459763426|FG005|Washout Period 1|Other|1|||
128009907|NCT00362232|460663899|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
128009908|NCT00362232|460663900|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
128009909|NCT00362232|460663899|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
128009910|NCT00362232|460663900|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
128009911|NCT00362232|460663899|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
127764453|NCT02074553|459763427|FG006|Washout Period 1|Other|0|||
127764454|NCT02074553|459763428|FG007|Washout Period 1|Other|0|||
127764455|NCT02074553|459763421|FG000|Washout Period 2|Adverse Event|0|||
127764456|NCT02074553|459763422|FG001|Washout Period 2|Adverse Event|0|||
127764457|NCT02074553|459763423|FG002|Washout Period 2|Adverse Event|0|||
127764458|NCT02074553|459763424|FG003|Washout Period 2|Adverse Event|0|||
127764459|NCT02074553|459763425|FG004|Washout Period 2|Adverse Event|0|||
128009912|NCT00362232|460663900|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
128009913|NCT00362232|460663899|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
128009914|NCT00362232|460663900|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
128009915|NCT00362232|460663899|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
127764460|NCT02074553|459763426|FG005|Washout Period 2|Adverse Event|0|||
127764461|NCT02074553|459763427|FG006|Washout Period 2|Adverse Event|1|||
128009916|NCT00362232|460663900|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
127764462|NCT02074553|459763428|FG007|Washout Period 2|Adverse Event|0|||
127764463|NCT02074553|459763421|FG000|Washout Period 2|Physician Decision|0|||
127764464|NCT02074553|459763422|FG001|Washout Period 2|Physician Decision|0|||
127764465|NCT02074553|459763423|FG002|Washout Period 2|Physician Decision|0|||
127764466|NCT02074553|459763424|FG003|Washout Period 2|Physician Decision|0|||
127764467|NCT02074553|459763425|FG004|Washout Period 2|Physician Decision|0|||
127764468|NCT02074553|459763426|FG005|Washout Period 2|Physician Decision|1|||
127764469|NCT02074553|459763427|FG006|Washout Period 2|Physician Decision|0|||
127764470|NCT02074553|459763428|FG007|Washout Period 2|Physician Decision|0|||
127676756|NCT01235949|459441055|FG012|Primary Phase|Adverse Event|0|||
127676757|NCT01235949|459441056|FG013|Primary Phase|Adverse Event|0|||
127676758|NCT01235949|459441057|FG014|Primary Phase|Adverse Event|0|||
127676759|NCT01235949|459441058|FG015|Primary Phase|Adverse Event|0|||
127676760|NCT01235949|459441059|FG016|Primary Phase|Adverse Event|0|||
127676761|NCT01235949|459441060|FG017|Primary Phase|Adverse Event|0|||
127676762|NCT01235949|459441043|FG000|Primary Phase|Withdrawal by Subject|3|||
127676763|NCT01235949|459441044|FG001|Primary Phase|Withdrawal by Subject|2|||
127676764|NCT01235949|459441045|FG002|Primary Phase|Withdrawal by Subject|2|||
127676765|NCT01235949|459441046|FG003|Primary Phase|Withdrawal by Subject|0|||
127676766|NCT01235949|459441047|FG004|Primary Phase|Withdrawal by Subject|0|||
127676767|NCT01235949|459441048|FG005|Primary Phase|Withdrawal by Subject|3|||
127676768|NCT01235949|459441049|FG006|Primary Phase|Withdrawal by Subject|0|||
127676769|NCT01235949|459441050|FG007|Primary Phase|Withdrawal by Subject|0|||
127676770|NCT01235949|459441051|FG008|Primary Phase|Withdrawal by Subject|0|||
127676771|NCT01235949|459441052|FG009|Primary Phase|Withdrawal by Subject|0|||
127676772|NCT01235949|459441053|FG010|Primary Phase|Withdrawal by Subject|0|||
127676773|NCT01235949|459441054|FG011|Primary Phase|Withdrawal by Subject|0|||
127676774|NCT01235949|459441055|FG012|Primary Phase|Withdrawal by Subject|0|||
127676775|NCT01235949|459441056|FG013|Primary Phase|Withdrawal by Subject|0|||
127676776|NCT01235949|459441057|FG014|Primary Phase|Withdrawal by Subject|0|||
127676777|NCT01235949|459441058|FG015|Primary Phase|Withdrawal by Subject|0|||
127676778|NCT01235949|459441059|FG016|Primary Phase|Withdrawal by Subject|0|||
127676779|NCT01235949|459441060|FG017|Primary Phase|Withdrawal by Subject|0|||
127676780|NCT01235949|459441043|FG000|Primary Phase|Lost to Follow-up|0|||
127676781|NCT01235949|459441044|FG001|Primary Phase|Lost to Follow-up|0|||
127676782|NCT01235949|459441045|FG002|Primary Phase|Lost to Follow-up|1|||
127676783|NCT01235949|459441046|FG003|Primary Phase|Lost to Follow-up|1|||
127676784|NCT01235949|459441047|FG004|Primary Phase|Lost to Follow-up|0|||
127676785|NCT01235949|459441048|FG005|Primary Phase|Lost to Follow-up|2|||
127676786|NCT01235949|459441049|FG006|Primary Phase|Lost to Follow-up|0|||
127676787|NCT01235949|459441050|FG007|Primary Phase|Lost to Follow-up|0|||
127676788|NCT01235949|459441051|FG008|Primary Phase|Lost to Follow-up|0|||
127676789|NCT01235949|459441052|FG009|Primary Phase|Lost to Follow-up|0|||
127676790|NCT01235949|459441053|FG010|Primary Phase|Lost to Follow-up|0|||
127676791|NCT01235949|459441054|FG011|Primary Phase|Lost to Follow-up|0|||
127676792|NCT01235949|459441055|FG012|Primary Phase|Lost to Follow-up|0|||
127676793|NCT01235949|459441056|FG013|Primary Phase|Lost to Follow-up|0|||
127676794|NCT01235949|459441057|FG014|Primary Phase|Lost to Follow-up|0|||
127676795|NCT01235949|459441058|FG015|Primary Phase|Lost to Follow-up|0|||
127676796|NCT01235949|459441059|FG016|Primary Phase|Lost to Follow-up|0|||
127676797|NCT01235949|459441060|FG017|Primary Phase|Lost to Follow-up|0|||
127676798|NCT01235949|459441043|FG000|Booster Phase|Migrated/moved from study area|0|||
127676799|NCT01235949|459441044|FG001|Booster Phase|Migrated/moved from study area|0|||
127676800|NCT01235949|459441045|FG002|Booster Phase|Migrated/moved from study area|0|||
127676801|NCT01235949|459441046|FG003|Booster Phase|Migrated/moved from study area|0|||
127676802|NCT01235949|459441047|FG004|Booster Phase|Migrated/moved from study area|0|||
127676803|NCT01235949|459441048|FG005|Booster Phase|Migrated/moved from study area|0|||
127676804|NCT01235949|459441049|FG006|Booster Phase|Migrated/moved from study area|0|||
127676805|NCT01235949|459441050|FG007|Booster Phase|Migrated/moved from study area|0|||
127676806|NCT01235949|459441051|FG008|Booster Phase|Migrated/moved from study area|0|||
127676807|NCT01235949|459441052|FG009|Booster Phase|Migrated/moved from study area|0|||
127676808|NCT01235949|459441053|FG010|Booster Phase|Migrated/moved from study area|0|||
127676809|NCT01235949|459441054|FG011|Booster Phase|Migrated/moved from study area|1|||
127676810|NCT01235949|459441055|FG012|Booster Phase|Migrated/moved from study area|1|||
127676811|NCT01235949|459441056|FG013|Booster Phase|Migrated/moved from study area|0|||
127676812|NCT01235949|459441057|FG014|Booster Phase|Migrated/moved from study area|0|||
127676813|NCT01235949|459441058|FG015|Booster Phase|Migrated/moved from study area|0|||
127676814|NCT01235949|459441059|FG016|Booster Phase|Migrated/moved from study area|0|||
127676815|NCT01235949|459441060|FG017|Booster Phase|Migrated/moved from study area|1|||
127676816|NCT01235949|459441043|FG000|Booster Phase|Adverse Event|0|||
127676817|NCT01235949|459441044|FG001|Booster Phase|Adverse Event|0|||
127676818|NCT01235949|459441045|FG002|Booster Phase|Adverse Event|0|||
127676819|NCT01235949|459441046|FG003|Booster Phase|Adverse Event|0|||
127676820|NCT01235949|459441047|FG004|Booster Phase|Adverse Event|0|||
127676821|NCT01235949|459441048|FG005|Booster Phase|Adverse Event|0|||
127676822|NCT01235949|459441049|FG006|Booster Phase|Adverse Event|0|||
127676823|NCT01235949|459441050|FG007|Booster Phase|Adverse Event|0|||
127676824|NCT01235949|459441051|FG008|Booster Phase|Adverse Event|0|||
127676825|NCT01235949|459441052|FG009|Booster Phase|Adverse Event|0|||
127676826|NCT01235949|459441053|FG010|Booster Phase|Adverse Event|0|||
127676827|NCT01235949|459441054|FG011|Booster Phase|Adverse Event|0|||
127676828|NCT01235949|459441055|FG012|Booster Phase|Adverse Event|0|||
127676829|NCT01235949|459441056|FG013|Booster Phase|Adverse Event|0|||
127676830|NCT01235949|459441057|FG014|Booster Phase|Adverse Event|0|||
127676831|NCT01235949|459441058|FG015|Booster Phase|Adverse Event|1|||
127676832|NCT01235949|459441059|FG016|Booster Phase|Adverse Event|0|||
128009917|NCT00362232|460663899|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
128009918|NCT00362232|460663900|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
128009919|NCT00362232|460663899|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
128009920|NCT00362232|460663900|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
128009921|NCT00362232|460663899|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
128009922|NCT00362232|460663900|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
128009923|NCT00362232|460663899|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
128009924|NCT00362232|460663900|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
128009925|NCT00362232|460663899|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
128009926|NCT00362232|460663900|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
128009927|NCT00362232|460663899|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
128009928|NCT00362232|460663900|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
128009929|NCT01799889|460663901|FG000|Overall Study|Adverse Event|4|||
128009930|NCT01799889|460663902|FG001|Overall Study|Adverse Event|4|||
128009931|NCT01799889|460663903|FG002|Overall Study|Adverse Event|5|||
128009932|NCT01799889|460663904|FG003|Overall Study|Adverse Event|1|||
128009933|NCT01799889|460663905|FG004|Overall Study|Adverse Event|11|||
128009934|NCT01799889|460663906|FG005|Overall Study|Adverse Event|1|||
128009935|NCT01799889|460663907|FG006|Overall Study|Adverse Event|5|||
128009936|NCT01799889|460663908|FG007|Overall Study|Adverse Event|2|||
128009937|NCT01799889|460663909|FG008|Overall Study|Adverse Event|3|||
128009938|NCT01799889|460663910|FG009|Overall Study|Adverse Event|1|||
128009939|NCT01799889|460663911|FG010|Overall Study|Adverse Event|1|||
128009940|NCT01799889|460663912|FG011|Overall Study|Adverse Event|0|||
128009941|NCT01799889|460663901|FG000|Overall Study|Death|1|||
128009942|NCT01799889|460663902|FG001|Overall Study|Death|0|||
128009943|NCT01799889|460663903|FG002|Overall Study|Death|5|||
128009944|NCT01799889|460663904|FG003|Overall Study|Death|3|||
128009945|NCT01799889|460663905|FG004|Overall Study|Death|1|||
128009946|NCT01799889|460663906|FG005|Overall Study|Death|0|||
128009947|NCT01799889|460663907|FG006|Overall Study|Death|0|||
128009948|NCT01799889|460663908|FG007|Overall Study|Death|0|||
128009949|NCT01799889|460663909|FG008|Overall Study|Death|1|||
128009950|NCT01799889|460663910|FG009|Overall Study|Death|0|||
128009951|NCT01799889|460663911|FG010|Overall Study|Death|1|||
128009952|NCT01799889|460663912|FG011|Overall Study|Death|0|||
128009953|NCT01799889|460663901|FG000|Overall Study|Lack of Efficacy|1|||
128009954|NCT01799889|460663902|FG001|Overall Study|Lack of Efficacy|1|||
128009955|NCT01799889|460663903|FG002|Overall Study|Lack of Efficacy|0|||
128009956|NCT01799889|460663904|FG003|Overall Study|Lack of Efficacy|1|||
128009957|NCT01799889|460663905|FG004|Overall Study|Lack of Efficacy|2|||
128009958|NCT01799889|460663906|FG005|Overall Study|Lack of Efficacy|2|||
128009959|NCT01799889|460663907|FG006|Overall Study|Lack of Efficacy|0|||
128009960|NCT01799889|460663908|FG007|Overall Study|Lack of Efficacy|0|||
128009961|NCT01799889|460663909|FG008|Overall Study|Lack of Efficacy|2|||
128009962|NCT01799889|460663910|FG009|Overall Study|Lack of Efficacy|0|||
128009963|NCT01799889|460663911|FG010|Overall Study|Lack of Efficacy|1|||
128009964|NCT01799889|460663912|FG011|Overall Study|Lack of Efficacy|0|||
128009965|NCT01799889|460663901|FG000|Overall Study|Lost to Follow-up|0|||
128009966|NCT01799889|460663902|FG001|Overall Study|Lost to Follow-up|1|||
128009967|NCT01799889|460663903|FG002|Overall Study|Lost to Follow-up|0|||
128009968|NCT01799889|460663904|FG003|Overall Study|Lost to Follow-up|0|||
128009969|NCT01799889|460663905|FG004|Overall Study|Lost to Follow-up|0|||
128009970|NCT01799889|460663906|FG005|Overall Study|Lost to Follow-up|0|||
128009971|NCT01799889|460663907|FG006|Overall Study|Lost to Follow-up|0|||
128009972|NCT01799889|460663908|FG007|Overall Study|Lost to Follow-up|0|||
128009973|NCT01799889|460663909|FG008|Overall Study|Lost to Follow-up|0|||
128009974|NCT01799889|460663910|FG009|Overall Study|Lost to Follow-up|0|||
128009975|NCT01799889|460663911|FG010|Overall Study|Lost to Follow-up|0|||
128009976|NCT01799889|460663912|FG011|Overall Study|Lost to Follow-up|0|||
128009977|NCT01799889|460663901|FG000|Overall Study|Physician Decision|3|||
127676833|NCT01235949|459441060|FG017|Booster Phase|Adverse Event|0|||
127676834|NCT01235949|459441043|FG000|Booster Phase|Withdrawal by Subject|0|||
127676835|NCT01235949|459441044|FG001|Booster Phase|Withdrawal by Subject|0|||
128009978|NCT01799889|460663902|FG001|Overall Study|Physician Decision|2|||
128009979|NCT01799889|460663903|FG002|Overall Study|Physician Decision|4|||
128009980|NCT01799889|460663904|FG003|Overall Study|Physician Decision|4|||
128009981|NCT01799889|460663905|FG004|Overall Study|Physician Decision|5|||
128009982|NCT01799889|460663906|FG005|Overall Study|Physician Decision|5|||
128009983|NCT01799889|460663907|FG006|Overall Study|Physician Decision|5|||
128009984|NCT01799889|460663908|FG007|Overall Study|Physician Decision|2|||
128009985|NCT01799889|460663909|FG008|Overall Study|Physician Decision|6|||
128009986|NCT01799889|460663910|FG009|Overall Study|Physician Decision|0|||
128009987|NCT01799889|460663911|FG010|Overall Study|Physician Decision|0|||
128009988|NCT01799889|460663912|FG011|Overall Study|Physician Decision|1|||
128009989|NCT01799889|460663901|FG000|Overall Study|Progressive Disease|30|||
128009990|NCT01799889|460663902|FG001|Overall Study|Progressive Disease|26|||
128009991|NCT01799889|460663903|FG002|Overall Study|Progressive Disease|25|||
128009992|NCT01799889|460663904|FG003|Overall Study|Progressive Disease|30|||
128009993|NCT01799889|460663905|FG004|Overall Study|Progressive Disease|23|||
127764471|NCT02074553|459763421|FG000|Washout Period 2|Lost to Follow-up|0|||
127764472|NCT02074553|459763422|FG001|Washout Period 2|Lost to Follow-up|0|||
128009994|NCT01799889|460663906|FG005|Overall Study|Progressive Disease|9|||
128009995|NCT01799889|460663907|FG006|Overall Study|Progressive Disease|8|||
128009996|NCT01799889|460663908|FG007|Overall Study|Progressive Disease|13|||
128009997|NCT01799889|460663909|FG008|Overall Study|Progressive Disease|18|||
128009998|NCT01799889|460663910|FG009|Overall Study|Progressive Disease|5|||
128009999|NCT01799889|460663911|FG010|Overall Study|Progressive Disease|3|||
128010000|NCT01799889|460663912|FG011|Overall Study|Progressive Disease|1|||
128010001|NCT01799889|460663901|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
128010002|NCT01799889|460663902|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
128010003|NCT01799889|460663903|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
128010004|NCT01799889|460663904|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
128010005|NCT01799889|460663905|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
128010006|NCT01799889|460663906|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
128010007|NCT01799889|460663907|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
128010008|NCT01799889|460663908|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
128010009|NCT01799889|460663909|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
128010010|NCT01799889|460663910|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
128010011|NCT01799889|460663911|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
128010012|NCT01799889|460663912|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
128010013|NCT01799889|460663901|FG000|Overall Study|Study Terminated By Sponsor|1|||
128010014|NCT01799889|460663902|FG001|Overall Study|Study Terminated By Sponsor|0|||
128010015|NCT01799889|460663903|FG002|Overall Study|Study Terminated By Sponsor|0|||
128010016|NCT01799889|460663904|FG003|Overall Study|Study Terminated By Sponsor|0|||
128010017|NCT01799889|460663905|FG004|Overall Study|Study Terminated By Sponsor|2|||
128010018|NCT01799889|460663906|FG005|Overall Study|Study Terminated By Sponsor|1|||
128010019|NCT01799889|460663907|FG006|Overall Study|Study Terminated By Sponsor|0|||
128010020|NCT01799889|460663908|FG007|Overall Study|Study Terminated By Sponsor|2|||
127764473|NCT02074553|459763423|FG002|Washout Period 2|Lost to Follow-up|1|||
127764474|NCT02074553|459763424|FG003|Washout Period 2|Lost to Follow-up|0|||
127764475|NCT02074553|459763425|FG004|Washout Period 2|Lost to Follow-up|0|||
127764476|NCT02074553|459763426|FG005|Washout Period 2|Lost to Follow-up|0|||
127764477|NCT02074553|459763427|FG006|Washout Period 2|Lost to Follow-up|0|||
127764478|NCT02074553|459763428|FG007|Washout Period 2|Lost to Follow-up|0|||
127764479|NCT02074553|459763421|FG000|Washout Period 3|Physician Decision|0|||
127764480|NCT02074553|459763422|FG001|Washout Period 3|Physician Decision|0|||
127764481|NCT02074553|459763423|FG002|Washout Period 3|Physician Decision|0|||
127764482|NCT02074553|459763424|FG003|Washout Period 3|Physician Decision|0|||
127764483|NCT02074553|459763425|FG004|Washout Period 3|Physician Decision|0|||
128010021|NCT01799889|460663909|FG008|Overall Study|Study Terminated By Sponsor|1|||
128010022|NCT01799889|460663910|FG009|Overall Study|Study Terminated By Sponsor|1|||
128010023|NCT01799889|460663911|FG010|Overall Study|Study Terminated By Sponsor|0|||
128010024|NCT01799889|460663912|FG011|Overall Study|Study Terminated By Sponsor|0|||
128010025|NCT01799889|460663901|FG000|Overall Study|Withdrawal by Subject|1|||
128010026|NCT01799889|460663902|FG001|Overall Study|Withdrawal by Subject|6|||
128010027|NCT01799889|460663903|FG002|Overall Study|Withdrawal by Subject|4|||
128010028|NCT01799889|460663904|FG003|Overall Study|Withdrawal by Subject|0|||
128010029|NCT01799889|460663905|FG004|Overall Study|Withdrawal by Subject|5|||
128010030|NCT01799889|460663906|FG005|Overall Study|Withdrawal by Subject|1|||
128010031|NCT01799889|460663907|FG006|Overall Study|Withdrawal by Subject|3|||
128010032|NCT01799889|460663908|FG007|Overall Study|Withdrawal by Subject|1|||
128010033|NCT01799889|460663909|FG008|Overall Study|Withdrawal by Subject|2|||
128010034|NCT01799889|460663910|FG009|Overall Study|Withdrawal by Subject|1|||
128010035|NCT01799889|460663911|FG010|Overall Study|Withdrawal by Subject|1|||
128010036|NCT01799889|460663912|FG011|Overall Study|Withdrawal by Subject|1|||
128010037|NCT01799889|460663901|FG000|Overall Study|Non-Compliance With Study Drug|0|||
128010038|NCT01799889|460663902|FG001|Overall Study|Non-Compliance With Study Drug|0|||
128010039|NCT01799889|460663903|FG002|Overall Study|Non-Compliance With Study Drug|0|||
128010040|NCT01799889|460663904|FG003|Overall Study|Non-Compliance With Study Drug|0|||
128010041|NCT01799889|460663905|FG004|Overall Study|Non-Compliance With Study Drug|0|||
128010042|NCT01799889|460663906|FG005|Overall Study|Non-Compliance With Study Drug|1|||
128010043|NCT01799889|460663907|FG006|Overall Study|Non-Compliance With Study Drug|0|||
128010044|NCT01799889|460663908|FG007|Overall Study|Non-Compliance With Study Drug|0|||
128010045|NCT01799889|460663909|FG008|Overall Study|Non-Compliance With Study Drug|0|||
128010046|NCT01799889|460663910|FG009|Overall Study|Non-Compliance With Study Drug|0|||
128010047|NCT01799889|460663911|FG010|Overall Study|Non-Compliance With Study Drug|0|||
128010048|NCT01799889|460663912|FG011|Overall Study|Non-Compliance With Study Drug|0|||
128010049|NCT02100631|460663913|FG000|Overall Study|Withdrawal by Subject|1|||
127764484|NCT02074553|459763426|FG005|Washout Period 3|Physician Decision|0|||
128010050|NCT02100631|460663914|FG001|Overall Study|Withdrawal by Subject|0|||
128010051|NCT02100631|460663915|FG002|Overall Study|Withdrawal by Subject|0|||
128010052|NCT02100631|460663913|FG000|Overall Study|Lost to Follow-up|3|||
128010053|NCT02100631|460663914|FG001|Overall Study|Lost to Follow-up|4|||
128010054|NCT02100631|460663915|FG002|Overall Study|Lost to Follow-up|0|||
128010055|NCT02100631|460663913|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
128010056|NCT02100631|460663914|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
128010057|NCT02100631|460663915|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
128010058|NCT00941928|460663917|FG000|Overall Study|Withdrawal by Subject|1|||
128010059|NCT00941928|460663917|FG000|Overall Study|Disease Progression|1|||
128010060|NCT03482024|460663920|FG000|Overall Study|Physician Decision|1|||
128010061|NCT03482024|460663921|FG001|Overall Study|Physician Decision|0|||
128010062|NCT03482024|460663922|FG002|Overall Study|Physician Decision|0|||
128010063|NCT03482024|460663923|FG003|Overall Study|Physician Decision|0|||
128010064|NCT03482024|460663924|FG004|Overall Study|Physician Decision|0|||
128010065|NCT01056276|460663925|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
128010066|NCT01056276|460663926|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
128010067|NCT01056276|460663925|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
128010068|NCT01056276|460663926|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
128010069|NCT01056276|460663925|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
128010070|NCT01056276|460663926|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
128010071|NCT01056276|460663925|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
128010072|NCT01056276|460663926|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
128010073|NCT01056276|460663925|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
128010074|NCT01056276|460663926|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
128010075|NCT01056276|460663925|FG000|Treatment Period-Cycles 1-8|Death|3|||
128010076|NCT01056276|460663926|FG001|Treatment Period-Cycles 1-8|Death|1|||
128010077|NCT01056276|460663925|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
128010078|NCT01056276|460663926|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
128010079|NCT01056276|460663925|FG000|Maintenance Therapy|Toxicity|0|||
128010080|NCT01056276|460663926|FG001|Maintenance Therapy|Toxicity|2|||
128010081|NCT01056276|460663925|FG000|Maintenance Therapy|Progressive Disease|0|||
128010082|NCT01056276|460663926|FG001|Maintenance Therapy|Progressive Disease|9|||
128010083|NCT01056276|460663925|FG000|Maintenance Therapy|Physician Decision|0|||
128010084|NCT01056276|460663926|FG001|Maintenance Therapy|Physician Decision|1|||
128010085|NCT01056276|460663925|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
128010086|NCT01056276|460663926|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
128010087|NCT01056276|460663925|FG000|Maintenance Therapy|Intercurrent Illness|0|||
128010088|NCT01056276|460663926|FG001|Maintenance Therapy|Intercurrent Illness|1|||
128010089|NCT01056276|460663925|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
128010090|NCT01056276|460663926|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
128010091|NCT01881425|460663927|FG000|Overall Study|Death|5|||
128010092|NCT01881425|460663928|FG001|Overall Study|Death|1|||
128010093|NCT01881425|460663927|FG000|Overall Study|Withdrawal by Subject|8|||
128010094|NCT01881425|460663928|FG001|Overall Study|Withdrawal by Subject|3|||
128010095|NCT01881425|460663927|FG000|Overall Study|Physician Decision|2|||
128010096|NCT01881425|460663928|FG001|Overall Study|Physician Decision|1|||
128010097|NCT01881425|460663927|FG000|Overall Study|Adverse Event|3|||
128010098|NCT01881425|460663928|FG001|Overall Study|Adverse Event|0|||
128010099|NCT01881425|460663927|FG000|Overall Study|General Anesthesia panic attack|0|||
128010100|NCT01881425|460663928|FG001|Overall Study|General Anesthesia panic attack|1|||
128010101|NCT01881425|460663927|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
128010102|NCT01881425|460663928|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
128010103|NCT01881425|460663927|FG000|Overall Study|Lost to Follow-up|7|||
128010104|NCT01881425|460663928|FG001|Overall Study|Lost to Follow-up|2|||
128010105|NCT01200355|460663935|FG000|Overall Study|Death|7|||
128010106|NCT01200355|460663936|FG001|Overall Study|Death|2|||
128010107|NCT04424901|460663937|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
128010108|NCT04424901|460663938|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
128010109|NCT00147238|460663939|FG000|Overall Study|Inevaluable|8|||
128010110|NCT00297167|460663940|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
128010111|NCT00297167|460663941|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
128010112|NCT00297167|460663942|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
128010113|NCT00297167|460663940|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
128010114|NCT00297167|460663941|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
128010115|NCT00297167|460663942|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
128010116|NCT03185208|460663946|FG000|Overall Study|Did not start study medication|0|||
128010117|NCT03185208|460663947|FG001|Overall Study|Did not start study medication|3|||
128010118|NCT02410629|460663948|FG000|Overall Study|Family cannot commit to the study|2|||
128010119|NCT02410629|460663949|FG001|Overall Study|Family cannot commit to the study|1|||
128010120|NCT02410629|460663948|FG000|Overall Study|Subject returned to work|1|||
128010121|NCT02410629|460663949|FG001|Overall Study|Subject returned to work|0|||
128010122|NCT02410629|460663948|FG000|Overall Study|Subject moved back to home country|0|||
128010123|NCT02410629|460663949|FG001|Overall Study|Subject moved back to home country|1|||
128010124|NCT02410629|460663948|FG000|Overall Study|Subject underwent heart surgery|0|||
128010125|NCT02410629|460663949|FG001|Overall Study|Subject underwent heart surgery|1|||
128010126|NCT02701634|460663950|FG000|Overall Study|Adverse Event|2|||
128010127|NCT02701634|460663951|FG001|Overall Study|Adverse Event|3|||
128010128|NCT02701634|460663950|FG000|Overall Study|Death|1|||
128010129|NCT02701634|460663951|FG001|Overall Study|Death|0|||
128010130|NCT02701634|460663950|FG000|Overall Study|Investigator's Discretion|7|||
128010131|NCT02701634|460663951|FG001|Overall Study|Investigator's Discretion|4|||
128010132|NCT02701634|460663950|FG000|Overall Study|Study terminated by Sponsor|15|||
128010133|NCT02701634|460663951|FG001|Overall Study|Study terminated by Sponsor|17|||
128010134|NCT02701634|460663950|FG000|Overall Study|Withdrew Consent|6|||
128010135|NCT02701634|460663951|FG001|Overall Study|Withdrew Consent|7|||
128010136|NCT02701634|460663950|FG000|Overall Study|Randomized but not treated|1|||
128010137|NCT02701634|460663951|FG001|Overall Study|Randomized but not treated|0|||
128010138|NCT01186770|460663952|FG000|Overall Study|Ineligibility|0|||
128010139|NCT01186770|460663953|FG001|Overall Study|Ineligibility|0|||
128010140|NCT01186770|460663954|FG002|Overall Study|Ineligibility|2|||
128010141|NCT01186770|460663955|FG003|Overall Study|Ineligibility|0|||
128010142|NCT01186770|460663952|FG000|Overall Study|Protocol Violation|7|||
128010143|NCT01186770|460663953|FG001|Overall Study|Protocol Violation|9|||
128010144|NCT01186770|460663954|FG002|Overall Study|Protocol Violation|12|||
128010145|NCT01186770|460663955|FG003|Overall Study|Protocol Violation|14|||
128010146|NCT01186770|460663952|FG000|Overall Study|Adverse Event|2|||
127676836|NCT01235949|459441045|FG002|Booster Phase|Withdrawal by Subject|0|||
127676837|NCT01235949|459441046|FG003|Booster Phase|Withdrawal by Subject|0|||
127676838|NCT01235949|459441047|FG004|Booster Phase|Withdrawal by Subject|0|||
127676839|NCT01235949|459441048|FG005|Booster Phase|Withdrawal by Subject|0|||
127676840|NCT01235949|459441049|FG006|Booster Phase|Withdrawal by Subject|0|||
127676841|NCT01235949|459441050|FG007|Booster Phase|Withdrawal by Subject|1|||
127676842|NCT01235949|459441051|FG008|Booster Phase|Withdrawal by Subject|1|||
127676843|NCT01235949|459441052|FG009|Booster Phase|Withdrawal by Subject|0|||
127676844|NCT01235949|459441053|FG010|Booster Phase|Withdrawal by Subject|1|||
127676845|NCT01235949|459441054|FG011|Booster Phase|Withdrawal by Subject|1|||
127676846|NCT01235949|459441055|FG012|Booster Phase|Withdrawal by Subject|2|||
127676847|NCT01235949|459441056|FG013|Booster Phase|Withdrawal by Subject|0|||
127676848|NCT01235949|459441057|FG014|Booster Phase|Withdrawal by Subject|2|||
127676849|NCT01235949|459441058|FG015|Booster Phase|Withdrawal by Subject|0|||
127676850|NCT01235949|459441059|FG016|Booster Phase|Withdrawal by Subject|0|||
127676851|NCT01235949|459441060|FG017|Booster Phase|Withdrawal by Subject|0|||
127676852|NCT01235949|459441043|FG000|Booster Phase|Lost to Follow-up|0|||
127676853|NCT01235949|459441044|FG001|Booster Phase|Lost to Follow-up|0|||
127676854|NCT01235949|459441045|FG002|Booster Phase|Lost to Follow-up|0|||
127676855|NCT01235949|459441046|FG003|Booster Phase|Lost to Follow-up|0|||
127676856|NCT01235949|459441047|FG004|Booster Phase|Lost to Follow-up|0|||
127676857|NCT01235949|459441048|FG005|Booster Phase|Lost to Follow-up|0|||
127676858|NCT01235949|459441049|FG006|Booster Phase|Lost to Follow-up|0|||
127676859|NCT01235949|459441050|FG007|Booster Phase|Lost to Follow-up|0|||
127676860|NCT01235949|459441051|FG008|Booster Phase|Lost to Follow-up|1|||
127676861|NCT01235949|459441052|FG009|Booster Phase|Lost to Follow-up|1|||
127676862|NCT01235949|459441053|FG010|Booster Phase|Lost to Follow-up|1|||
127676863|NCT01235949|459441054|FG011|Booster Phase|Lost to Follow-up|1|||
127676864|NCT01235949|459441055|FG012|Booster Phase|Lost to Follow-up|0|||
127676865|NCT01235949|459441056|FG013|Booster Phase|Lost to Follow-up|0|||
127676866|NCT01235949|459441057|FG014|Booster Phase|Lost to Follow-up|0|||
127676867|NCT01235949|459441058|FG015|Booster Phase|Lost to Follow-up|0|||
127676868|NCT01235949|459441059|FG016|Booster Phase|Lost to Follow-up|0|||
127676869|NCT01235949|459441060|FG017|Booster Phase|Lost to Follow-up|1|||
127676870|NCT04173572|459441061|FG000|Overall Study|Withdrawal by Subject|1|||
127676871|NCT04173572|459441062|FG001|Overall Study|Withdrawal by Subject|5|||
127676872|NCT04173572|459441061|FG000|Overall Study|Lost to Follow-up|3|||
127676873|NCT04173572|459441062|FG001|Overall Study|Lost to Follow-up|1|||
127676874|NCT00383188|459441063|FG000|Overall Study|Adverse Event|4|||
127676875|NCT00383188|459441064|FG001|Overall Study|Adverse Event|7|||
127676876|NCT00383188|459441065|FG002|Overall Study|Adverse Event|9|||
127676877|NCT00383188|459441066|FG003|Overall Study|Adverse Event|8|||
127676878|NCT00383188|459441067|FG004|Overall Study|Adverse Event|8|||
127676879|NCT00383188|459441063|FG000|Overall Study|Lack of Efficacy|9|||
127676880|NCT00383188|459441064|FG001|Overall Study|Lack of Efficacy|3|||
127676881|NCT00383188|459441065|FG002|Overall Study|Lack of Efficacy|3|||
127676882|NCT00383188|459441066|FG003|Overall Study|Lack of Efficacy|2|||
127676883|NCT00383188|459441067|FG004|Overall Study|Lack of Efficacy|6|||
127676884|NCT00383188|459441063|FG000|Overall Study|Other|3|||
128010147|NCT01186770|460663953|FG001|Overall Study|Adverse Event|9|||
127676885|NCT00383188|459441064|FG001|Overall Study|Other|1|||
127676886|NCT00383188|459441065|FG002|Overall Study|Other|0|||
127676887|NCT00383188|459441066|FG003|Overall Study|Other|2|||
128010148|NCT01186770|460663954|FG002|Overall Study|Adverse Event|7|||
127676888|NCT00383188|459441067|FG004|Overall Study|Other|6|||
127676889|NCT00383188|459441063|FG000|Overall Study|No longer willing to participate|1|||
127676890|NCT00383188|459441064|FG001|Overall Study|No longer willing to participate|0|||
127676891|NCT00383188|459441065|FG002|Overall Study|No longer willing to participate|1|||
127676892|NCT00383188|459441066|FG003|Overall Study|No longer willing to participate|0|||
127676893|NCT00383188|459441067|FG004|Overall Study|No longer willing to participate|2|||
127676894|NCT00383188|459441063|FG000|Overall Study|Lost to Follow-up|0|||
127676895|NCT00383188|459441064|FG001|Overall Study|Lost to Follow-up|0|||
127676896|NCT00383188|459441065|FG002|Overall Study|Lost to Follow-up|0|||
127676897|NCT00383188|459441066|FG003|Overall Study|Lost to Follow-up|0|||
127676898|NCT00383188|459441067|FG004|Overall Study|Lost to Follow-up|1|||
127676899|NCT00835380|459441072|FG000|Overall Study|Withdrawal by Subject|2|||
127676900|NCT03247543|459441073|FG000|Overall Study|Adverse Event|3|||
127676901|NCT03247543|459441074|FG001|Overall Study|Adverse Event|6|||
127676902|NCT03247543|459441075|FG002|Overall Study|Adverse Event|4|||
127676903|NCT03247543|459441073|FG000|Overall Study|Lost to Follow-up|10|||
127676904|NCT03247543|459441074|FG001|Overall Study|Lost to Follow-up|7|||
127676905|NCT03247543|459441075|FG002|Overall Study|Lost to Follow-up|8|||
127676906|NCT03247543|459441073|FG000|Overall Study|Consent withdrawn by caregiver|2|||
127676907|NCT03247543|459441074|FG001|Overall Study|Consent withdrawn by caregiver|2|||
127676908|NCT03247543|459441075|FG002|Overall Study|Consent withdrawn by caregiver|9|||
127676909|NCT03247543|459441073|FG000|Overall Study|Withdrawal by Subject|0|||
127676910|NCT03247543|459441074|FG001|Overall Study|Withdrawal by Subject|0|||
127676911|NCT03247543|459441075|FG002|Overall Study|Withdrawal by Subject|1|||
127676912|NCT03247543|459441073|FG000|Overall Study|Failure to Follow study procedures|1|||
127676913|NCT03247543|459441074|FG001|Overall Study|Failure to Follow study procedures|3|||
127676914|NCT03247543|459441075|FG002|Overall Study|Failure to Follow study procedures|1|||
127676915|NCT03247543|459441073|FG000|Overall Study|Lack of Efficacy|1|||
127676916|NCT03247543|459441074|FG001|Overall Study|Lack of Efficacy|0|||
127676917|NCT03247543|459441075|FG002|Overall Study|Lack of Efficacy|0|||
127676918|NCT03247543|459441073|FG000|Overall Study|Non-compliance with study visits|0|||
127676919|NCT03247543|459441074|FG001|Overall Study|Non-compliance with study visits|1|||
127676920|NCT03247543|459441075|FG002|Overall Study|Non-compliance with study visits|0|||
127676921|NCT02059980|459441078|FG000|Overall Study|Lost to Follow-up|2|||
127676922|NCT02059980|459441079|FG001|Overall Study|Lost to Follow-up|1|||
127676923|NCT01104415|459441080|FG000|Core Phase|Consent withdrawn by subjects|1|||
127676924|NCT01104415|459441081|FG001|Core Phase|Consent withdrawn by subjects|0|||
127676925|NCT01104415|459441080|FG000|Extension Period|Progressive disease|0|||
127676926|NCT01104415|459441081|FG001|Extension Period|Progressive disease|4|||
127676927|NCT01104415|459441080|FG000|Extension Period|Death|0|||
127676928|NCT01104415|459441081|FG001|Extension Period|Death|1|||
127676929|NCT01104415|459441080|FG000|Extension Period|Physician Decision|0|||
127676930|NCT01104415|459441081|FG001|Extension Period|Physician Decision|1|||
127676931|NCT01104415|459441080|FG000|Extension Period|Transition to Study LX1606.302|0|||
127676932|NCT01104415|459441081|FG001|Extension Period|Transition to Study LX1606.302|4|||
127676933|NCT01104415|459441080|FG000|Extension Period|Heart surgery/feeling miserable|0|||
127676934|NCT01104415|459441081|FG001|Extension Period|Heart surgery/feeling miserable|1|||
127676935|NCT02341625|459441086|FG000|Overall Study|Disease Progression|2|||
127676936|NCT02341625|459441087|FG001|Overall Study|Disease Progression|2|||
127676937|NCT02341625|459441088|FG002|Overall Study|Disease Progression|3|||
127676938|NCT02341625|459441089|FG003|Overall Study|Disease Progression|6|||
127676939|NCT02341625|459441090|FG004|Overall Study|Disease Progression|7|||
127676940|NCT02341625|459441091|FG005|Overall Study|Disease Progression|7|||
127676941|NCT02341625|459441092|FG006|Overall Study|Disease Progression|28|||
127676942|NCT02341625|459441093|FG007|Overall Study|Disease Progression|5|||
127676943|NCT02341625|459441094|FG008|Overall Study|Disease Progression|4|||
127676944|NCT02341625|459441095|FG009|Overall Study|Disease Progression|19|||
127676945|NCT02341625|459441086|FG000|Overall Study|Study Drug Toxicity|0|||
127676946|NCT02341625|459441087|FG001|Overall Study|Study Drug Toxicity|0|||
127676947|NCT02341625|459441088|FG002|Overall Study|Study Drug Toxicity|0|||
127676948|NCT02341625|459441089|FG003|Overall Study|Study Drug Toxicity|1|||
127676949|NCT02341625|459441090|FG004|Overall Study|Study Drug Toxicity|0|||
127676950|NCT02341625|459441091|FG005|Overall Study|Study Drug Toxicity|3|||
127676951|NCT02341625|459441092|FG006|Overall Study|Study Drug Toxicity|10|||
127676952|NCT02341625|459441093|FG007|Overall Study|Study Drug Toxicity|0|||
127676953|NCT02341625|459441094|FG008|Overall Study|Study Drug Toxicity|0|||
127676954|NCT02341625|459441095|FG009|Overall Study|Study Drug Toxicity|3|||
127676955|NCT02341625|459441086|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
127676956|NCT02341625|459441087|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
127676957|NCT02341625|459441088|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
127676958|NCT02341625|459441089|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
127676959|NCT02341625|459441090|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
127676960|NCT02341625|459441091|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
127676961|NCT02341625|459441092|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
127676962|NCT02341625|459441093|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
127676963|NCT02341625|459441094|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
127676964|NCT02341625|459441095|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
127676965|NCT02341625|459441086|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
128010149|NCT01186770|460663955|FG003|Overall Study|Adverse Event|9|||
128010150|NCT01186770|460663952|FG000|Overall Study|Withdrawal by Subject|15|||
128010151|NCT01186770|460663953|FG001|Overall Study|Withdrawal by Subject|13|||
128010152|NCT01186770|460663954|FG002|Overall Study|Withdrawal by Subject|11|||
128010153|NCT01186770|460663955|FG003|Overall Study|Withdrawal by Subject|17|||
128010154|NCT01186770|460663952|FG000|Overall Study|Lost to Follow-up|10|||
128010155|NCT01186770|460663953|FG001|Overall Study|Lost to Follow-up|6|||
128010156|NCT01186770|460663954|FG002|Overall Study|Lost to Follow-up|14|||
128010157|NCT01186770|460663955|FG003|Overall Study|Lost to Follow-up|9|||
128010158|NCT01186770|460663952|FG000|Overall Study|Insufficient response to treatment|7|||
128010159|NCT01186770|460663953|FG001|Overall Study|Insufficient response to treatment|8|||
128010160|NCT01186770|460663954|FG002|Overall Study|Insufficient response to treatment|5|||
128010161|NCT01186770|460663955|FG003|Overall Study|Insufficient response to treatment|7|||
128010162|NCT01186770|460663952|FG000|Overall Study|Other than specified|0|||
128010163|NCT01186770|460663953|FG001|Overall Study|Other than specified|1|||
127676966|NCT02341625|459441087|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
127676967|NCT02341625|459441088|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
127676968|NCT02341625|459441089|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
127676969|NCT02341625|459441090|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
127676970|NCT02341625|459441091|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
127676971|NCT02341625|459441092|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
127676972|NCT02341625|459441093|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
127676973|NCT02341625|459441094|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
127676974|NCT02341625|459441095|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
127676975|NCT02341625|459441086|FG000|Overall Study|Participant Withdrew Consent|0|||
127676976|NCT02341625|459441087|FG001|Overall Study|Participant Withdrew Consent|0|||
127676977|NCT02341625|459441088|FG002|Overall Study|Participant Withdrew Consent|0|||
127676978|NCT02341625|459441089|FG003|Overall Study|Participant Withdrew Consent|1|||
127676979|NCT02341625|459441090|FG004|Overall Study|Participant Withdrew Consent|0|||
127676980|NCT02341625|459441091|FG005|Overall Study|Participant Withdrew Consent|0|||
127676981|NCT02341625|459441092|FG006|Overall Study|Participant Withdrew Consent|0|||
127676982|NCT02341625|459441093|FG007|Overall Study|Participant Withdrew Consent|0|||
127676983|NCT02341625|459441094|FG008|Overall Study|Participant Withdrew Consent|0|||
127676984|NCT02341625|459441095|FG009|Overall Study|Participant Withdrew Consent|0|||
127676985|NCT02341625|459441086|FG000|Overall Study|Completed Treatment as per Protocol|0|||
127676986|NCT02341625|459441087|FG001|Overall Study|Completed Treatment as per Protocol|0|||
127676987|NCT02341625|459441088|FG002|Overall Study|Completed Treatment as per Protocol|0|||
127676988|NCT02341625|459441089|FG003|Overall Study|Completed Treatment as per Protocol|0|||
127676989|NCT02341625|459441090|FG004|Overall Study|Completed Treatment as per Protocol|0|||
127676990|NCT02341625|459441091|FG005|Overall Study|Completed Treatment as per Protocol|0|||
127676991|NCT02341625|459441092|FG006|Overall Study|Completed Treatment as per Protocol|0|||
127676992|NCT02341625|459441093|FG007|Overall Study|Completed Treatment as per Protocol|0|||
127676993|NCT02341625|459441094|FG008|Overall Study|Completed Treatment as per Protocol|0|||
127676994|NCT02341625|459441095|FG009|Overall Study|Completed Treatment as per Protocol|1|||
127676995|NCT02341625|459441086|FG000|Overall Study|Other Reasons|0|||
127676996|NCT02341625|459441087|FG001|Overall Study|Other Reasons|0|||
127676997|NCT02341625|459441088|FG002|Overall Study|Other Reasons|0|||
127676998|NCT02341625|459441089|FG003|Overall Study|Other Reasons|0|||
127676999|NCT02341625|459441090|FG004|Overall Study|Other Reasons|1|||
127677000|NCT02341625|459441091|FG005|Overall Study|Other Reasons|0|||
127677001|NCT02341625|459441092|FG006|Overall Study|Other Reasons|5|||
127677002|NCT02341625|459441093|FG007|Overall Study|Other Reasons|0|||
127677003|NCT02341625|459441094|FG008|Overall Study|Other Reasons|0|||
127677004|NCT02341625|459441095|FG009|Overall Study|Other Reasons|2|||
127677005|NCT02341625|459441086|FG000|Overall Study|Not Reported|0|||
127677006|NCT02341625|459441087|FG001|Overall Study|Not Reported|0|||
127677007|NCT02341625|459441088|FG002|Overall Study|Not Reported|0|||
127677008|NCT02341625|459441089|FG003|Overall Study|Not Reported|0|||
127677009|NCT02341625|459441090|FG004|Overall Study|Not Reported|0|||
127677010|NCT02341625|459441091|FG005|Overall Study|Not Reported|0|||
127677011|NCT02341625|459441092|FG006|Overall Study|Not Reported|0|||
127677012|NCT02341625|459441093|FG007|Overall Study|Not Reported|0|||
128010164|NCT01186770|460663954|FG002|Overall Study|Other than specified|1|||
128010165|NCT01186770|460663955|FG003|Overall Study|Other than specified|2|||
128010166|NCT01033136|460663958|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
128010167|NCT01033136|460663959|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
127677013|NCT02341625|459441094|FG008|Overall Study|Not Reported|0|||
127677014|NCT02341625|459441095|FG009|Overall Study|Not Reported|3|||
127677015|NCT01839877|459441099|FG000|Overall Study|Protocol Violation|1|||
127677016|NCT03098030|459441100|FG000|Overall Study|Death|10|||
127677017|NCT03098030|459441101|FG001|Overall Study|Death|156|||
127677018|NCT03098030|459441102|FG002|Overall Study|Death|156|||
127677019|NCT03098030|459441103|FG003|Overall Study|Death|82|||
127677020|NCT03098030|459441100|FG000|Overall Study|Withdrawal by Subject|0|||
128010168|NCT01572792|460663964|FG000|Lead-in Study|Lost to Follow-up|5|||
128010169|NCT01572792|460663965|FG001|Lead-in Study|Lost to Follow-up|9|||
128010170|NCT01572792|460663966|FG002|Lead-in Study|Lost to Follow-up|4|||
128010171|NCT01572792|460663967|FG003|Lead-in Study|Lost to Follow-up|2|||
128010172|NCT01572792|460663968|FG004|Lead-in Study|Lost to Follow-up|4|||
128010173|NCT01572792|460663964|FG000|Lead-in Study|Withdrawal by Subject|22|||
128010174|NCT01572792|460663965|FG001|Lead-in Study|Withdrawal by Subject|11|||
128010175|NCT01572792|460663966|FG002|Lead-in Study|Withdrawal by Subject|12|||
128010176|NCT01572792|460663967|FG003|Lead-in Study|Withdrawal by Subject|24|||
128010177|NCT01572792|460663968|FG004|Lead-in Study|Withdrawal by Subject|11|||
128010178|NCT01572792|460663964|FG000|Lead-in Study|Protocol Violation|19|||
128010179|NCT01572792|460663965|FG001|Lead-in Study|Protocol Violation|10|||
128010180|NCT01572792|460663966|FG002|Lead-in Study|Protocol Violation|12|||
128010181|NCT01572792|460663967|FG003|Lead-in Study|Protocol Violation|13|||
128010182|NCT01572792|460663968|FG004|Lead-in Study|Protocol Violation|21|||
128010183|NCT01572792|460663964|FG000|Lead-in Study|Lack of Efficacy|20|||
128010184|NCT01572792|460663965|FG001|Lead-in Study|Lack of Efficacy|5|||
128010185|NCT01572792|460663966|FG002|Lead-in Study|Lack of Efficacy|4|||
128010186|NCT01572792|460663967|FG003|Lead-in Study|Lack of Efficacy|8|||
128010187|NCT01572792|460663968|FG004|Lead-in Study|Lack of Efficacy|10|||
128010188|NCT01572792|460663964|FG000|Lead-in Study|Adverse Event|21|||
128010189|NCT01572792|460663965|FG001|Lead-in Study|Adverse Event|21|||
128010190|NCT01572792|460663966|FG002|Lead-in Study|Adverse Event|22|||
128010191|NCT01572792|460663967|FG003|Lead-in Study|Adverse Event|16|||
128010192|NCT01572792|460663968|FG004|Lead-in Study|Adverse Event|14|||
128010193|NCT01572792|460663964|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
128010194|NCT01572792|460663965|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
128010195|NCT01572792|460663966|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
128010196|NCT01572792|460663967|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
128010197|NCT01572792|460663968|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
128010198|NCT01572792|460663964|FG000|Extension Study|Lost to Follow-up|6|||
128010199|NCT01572792|460663965|FG001|Extension Study|Lost to Follow-up|2|||
128010200|NCT01572792|460663966|FG002|Extension Study|Lost to Follow-up|0|||
128010201|NCT01572792|460663967|FG003|Extension Study|Lost to Follow-up|3|||
128010202|NCT01572792|460663968|FG004|Extension Study|Lost to Follow-up|3|||
128010203|NCT01572792|460663964|FG000|Extension Study|Withdrawal by Subject|7|||
128010204|NCT01572792|460663965|FG001|Extension Study|Withdrawal by Subject|6|||
128010205|NCT01572792|460663966|FG002|Extension Study|Withdrawal by Subject|11|||
128010206|NCT01572792|460663967|FG003|Extension Study|Withdrawal by Subject|8|||
128010207|NCT01572792|460663968|FG004|Extension Study|Withdrawal by Subject|14|||
128010208|NCT01572792|460663964|FG000|Extension Study|Protocol Violation|0|||
128010209|NCT01572792|460663965|FG001|Extension Study|Protocol Violation|4|||
128010210|NCT01572792|460663966|FG002|Extension Study|Protocol Violation|3|||
128010211|NCT01572792|460663967|FG003|Extension Study|Protocol Violation|4|||
128010212|NCT01572792|460663968|FG004|Extension Study|Protocol Violation|3|||
128010213|NCT01572792|460663964|FG000|Extension Study|Lack of Efficacy|2|||
128010214|NCT01572792|460663965|FG001|Extension Study|Lack of Efficacy|3|||
128010215|NCT01572792|460663966|FG002|Extension Study|Lack of Efficacy|3|||
128010216|NCT01572792|460663967|FG003|Extension Study|Lack of Efficacy|2|||
128010217|NCT01572792|460663968|FG004|Extension Study|Lack of Efficacy|2|||
128010218|NCT01572792|460663964|FG000|Extension Study|Adverse Event|7|||
128010219|NCT01572792|460663965|FG001|Extension Study|Adverse Event|6|||
128010220|NCT01572792|460663966|FG002|Extension Study|Adverse Event|5|||
128010221|NCT01572792|460663967|FG003|Extension Study|Adverse Event|6|||
128010222|NCT01572792|460663968|FG004|Extension Study|Adverse Event|4|||
128010223|NCT01572792|460663964|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
128010224|NCT01572792|460663965|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
127677021|NCT03098030|459441101|FG001|Overall Study|Withdrawal by Subject|7|||
127677022|NCT03098030|459441102|FG002|Overall Study|Withdrawal by Subject|8|||
127677023|NCT03098030|459441103|FG003|Overall Study|Withdrawal by Subject|2|||
127677024|NCT03098030|459441100|FG000|Overall Study|Lost to Follow-up|0|||
127677025|NCT03098030|459441101|FG001|Overall Study|Lost to Follow-up|0|||
127677026|NCT03098030|459441102|FG002|Overall Study|Lost to Follow-up|2|||
127677027|NCT03098030|459441103|FG003|Overall Study|Lost to Follow-up|1|||
128010225|NCT01572792|460663966|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
128010226|NCT01572792|460663967|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
128010227|NCT01572792|460663968|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
128010228|NCT03530696|460663969|FG000|Overall Study|Excluded for not meeting eligibility criteria upon further review|1|||
128010229|NCT03530696|460663970|FG001|Overall Study|Excluded for not meeting eligibility criteria upon further review|2|||
128010230|NCT02472353|460663971|FG000|Overall Study|Lost to Follow-up|1|||
128010231|NCT02472353|460663972|FG001|Overall Study|Lost to Follow-up|1|||
128010232|NCT02472353|460663971|FG000|Overall Study|Withdrawal by Subject|2|||
128010233|NCT02472353|460663972|FG001|Overall Study|Withdrawal by Subject|1|||
128010234|NCT02472353|460663971|FG000|Overall Study|Study Termination|1|||
128010235|NCT02472353|460663972|FG001|Overall Study|Study Termination|4|||
128010236|NCT01129128|460663973|FG000|Overall Study|Lost to Follow-up|2|||
127764485|NCT02074553|459763427|FG006|Washout Period 3|Physician Decision|0|||
127764486|NCT02074553|459763428|FG007|Washout Period 3|Physician Decision|1|||
127764487|NCT00194987|459763429|FG000|Overall Study|Withdrawal by Subject|0|||
127764488|NCT00194987|459763430|FG001|Overall Study|Withdrawal by Subject|3|||
127764489|NCT01664598|459763431|FG000|Overall Study|Sponsor Decision|1|||
127764490|NCT01664598|459763431|FG000|Overall Study|Withdrawal of Informed Consent|4|||
128010237|NCT01129128|460663974|FG001|Overall Study|Lost to Follow-up|2|||
128010238|NCT01129128|460663975|FG002|Overall Study|Lost to Follow-up|1|||
128010239|NCT01129128|460663973|FG000|Overall Study|Protocol Violation|0|||
128010240|NCT01129128|460663974|FG001|Overall Study|Protocol Violation|1|||
128010241|NCT01129128|460663975|FG002|Overall Study|Protocol Violation|0|||
128010242|NCT01129128|460663973|FG000|Overall Study|Withdrawal by Subject|0|||
128010243|NCT01129128|460663974|FG001|Overall Study|Withdrawal by Subject|1|||
128010244|NCT01129128|460663975|FG002|Overall Study|Withdrawal by Subject|3|||
128010245|NCT01129128|460663973|FG000|Overall Study|Physician Decision|1|||
128010246|NCT01129128|460663974|FG001|Overall Study|Physician Decision|0|||
128010247|NCT01129128|460663975|FG002|Overall Study|Physician Decision|0|||
128010248|NCT00639509|460663991|FG000|Overall Study|Death|1|||
128010249|NCT05049122|460663992|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
128010250|NCT05049122|460663992|FG000|Overall Study|Participant moved|1|||
128010251|NCT05049122|460663992|FG000|Overall Study|At the direction of the doctor|1|||
128010252|NCT05722015|460663993|FG000|Overall Study|Death|57|||
128010253|NCT05722015|460663994|FG001|Overall Study|Death|37|||
128010254|NCT05722015|460663993|FG000|Overall Study|Lost to Follow-up|1|||
128010255|NCT05722015|460663994|FG001|Overall Study|Lost to Follow-up|0|||
128010256|NCT05722015|460663993|FG000|Overall Study|Withdrawal by Subject|5|||
128010257|NCT05722015|460663994|FG001|Overall Study|Withdrawal by Subject|1|||
128010258|NCT05722015|460663993|FG000|Overall Study|Participants Ongoing|188|||
128010259|NCT05722015|460663994|FG001|Overall Study|Participants Ongoing|88|||
128010260|NCT04513366|460663995|FG000|Treatment Phase|Withdrawal by Subject|6|||
128010261|NCT04513366|460663996|FG001|Treatment Phase|Withdrawal by Subject|8|||
128010262|NCT04513366|460663997|FG002|Treatment Phase|Withdrawal by Subject|3|||
128010263|NCT04513366|460663995|FG000|Treatment Phase|Lost to Follow-up|1|||
128010264|NCT04513366|460663996|FG001|Treatment Phase|Lost to Follow-up|2|||
128010265|NCT04513366|460663997|FG002|Treatment Phase|Lost to Follow-up|5|||
128010266|NCT04513366|460663995|FG000|Treatment Phase|Other than Specified|1|||
128010267|NCT04513366|460663996|FG001|Treatment Phase|Other than Specified|0|||
128010268|NCT04513366|460663997|FG002|Treatment Phase|Other than Specified|2|||
128010269|NCT04513366|460663995|FG000|Treatment Phase|Physician Decision|2|||
127677028|NCT01726023|459441104|FG000|Overall Study|Death|1|||
127677029|NCT01726023|459441105|FG001|Overall Study|Death|1|||
127677030|NCT01726023|459441104|FG000|Overall Study|Lost to Follow-up|5|||
127677031|NCT01726023|459441105|FG001|Overall Study|Lost to Follow-up|10|||
127677032|NCT01726023|459441104|FG000|Overall Study|Other Eligibility criteria|7|||
127677033|NCT01726023|459441105|FG001|Overall Study|Other Eligibility criteria|7|||
127677034|NCT01726023|459441104|FG000|Overall Study|Withdrawal by Subject|16|||
127677035|NCT01726023|459441105|FG001|Overall Study|Withdrawal by Subject|8|||
127677036|NCT04536077|459441110|FG000|Overall Study|Did not start treatment due to surgery needing to occur urgently|1|||
127677037|NCT04536077|459441111|FG001|Overall Study|Did not start treatment due to surgery needing to occur urgently|0|||
127677038|NCT04536077|459441110|FG000|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|0|||
127677039|NCT04536077|459441111|FG001|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|1|||
127677040|NCT03368001|459441112|FG000|Allocation|Lost to Pretest|16|||
127677041|NCT03368001|459441113|FG001|Allocation|Lost to Pretest|25|||
127677042|NCT03368001|459441112|FG000|Allocation|Completed Pretest but 0 Intervention sessions|8|||
127677043|NCT03368001|459441113|FG001|Allocation|Completed Pretest but 0 Intervention sessions|9|||
127677044|NCT03368001|459441112|FG000|Posttest|Lost to Posttest|7|||
127677045|NCT03368001|459441113|FG001|Posttest|Lost to Posttest|11|||
127677046|NCT03368001|459441112|FG000|Posttest|Discontinued Intervention|6|||
127677047|NCT03368001|459441113|FG001|Posttest|Discontinued Intervention|19|||
127677048|NCT03368001|459441112|FG000|Follow-up|Lost to Follow-up|6|||
127677049|NCT03368001|459441113|FG001|Follow-up|Lost to Follow-up|3|||
127677050|NCT00554801|459441114|FG000|Overall Study|left area before completion|5|||
127677051|NCT00554801|459441115|FG001|Overall Study|left area before completion|0|||
127677052|NCT00554801|459441114|FG000|Overall Study|Withdrawal by Subject|14|||
128010270|NCT04513366|460663996|FG001|Treatment Phase|Physician Decision|0|||
128010271|NCT04513366|460663997|FG002|Treatment Phase|Physician Decision|0|||
127677053|NCT00554801|459441115|FG001|Overall Study|Withdrawal by Subject|0|||
127677054|NCT02698241|459441119|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
127764491|NCT01664598|459763431|FG000|Overall Study|Adverse Event|1|||
127764492|NCT01658150|459763432|FG000|Overall Study|Withdrawal by Subject|1|||
128010272|NCT04513366|460663995|FG000|Treatment Phase|Adverse Event|0|||
128010273|NCT04513366|460663996|FG001|Treatment Phase|Adverse Event|1|||
127677055|NCT02698241|459441119|FG000|Overall Study|Screening not met|7|||
127677056|NCT02698241|459441119|FG000|Overall Study|Withdrawal by Subject|7|||
128010274|NCT04513366|460663997|FG002|Treatment Phase|Adverse Event|1|||
128010275|NCT04513366|460663995|FG000|Extension Phase|Withdrawal by Subject|3|||
128010276|NCT04513366|460663996|FG001|Extension Phase|Withdrawal by Subject|1|||
128010277|NCT04513366|460663997|FG002|Extension Phase|Withdrawal by Subject|1|||
128010278|NCT04513366|460663995|FG000|Extension Phase|Other than Specified|4|||
128010279|NCT04513366|460663996|FG001|Extension Phase|Other than Specified|0|||
128010280|NCT04513366|460663997|FG002|Extension Phase|Other than Specified|1|||
128010281|NCT04513366|460663995|FG000|Extension Phase|Lost to Follow-up|1|||
127764493|NCT02342743|459763433|FG000|Baseline Period|Withdrawal by Subject|3|||
127764494|NCT02342743|459763433|FG000|Baseline Period|Lost to Follow-up|2|||
127764495|NCT02342743|459763433|FG000|Baseline Period|Change in prophylactic medication|3|||
127764496|NCT02342743|459763433|FG000|Baseline Period|Screening failure regarding baseline|7|||
127764497|NCT02342743|459763433|FG000|Treatment Period|Withdrawal by Subject|2|||
127764498|NCT02342743|459763433|FG000|Treatment Period|Lost to Follow-up|8|||
127764499|NCT02342743|459763433|FG000|Treatment Period|Change in prophylactic medication|1|||
127764500|NCT04187989|459763434|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
127764501|NCT04187989|459763435|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
127764502|NCT04187989|459763434|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
127764503|NCT04187989|459763435|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
127764504|NCT03602066|459763436|FG000|Overall Study|Withdrawal by Subject|2|||
127764505|NCT03602066|459763437|FG001|Overall Study|Withdrawal by Subject|0|||
127764506|NCT03602066|459763436|FG000|Overall Study|Physician Decision|1|||
127764507|NCT03602066|459763437|FG001|Overall Study|Physician Decision|0|||
127764508|NCT03646656|459763438|FG000|Overall Study|Lost to Follow-up|1|||
127764509|NCT03646656|459763439|FG001|Overall Study|Lost to Follow-up|0|||
127764510|NCT03646656|459763438|FG000|Overall Study|Withdrawal by Subject|2|||
127764511|NCT03646656|459763439|FG001|Overall Study|Withdrawal by Subject|0|||
127764512|NCT00092495|459763440|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
127764513|NCT00092495|459763441|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
127764514|NCT00092495|459763442|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
127764515|NCT00092495|459763443|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
127764516|NCT00092495|459763444|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
127764517|NCT00092495|459763440|FG000|Base Study Vaccination Period|Extended|0|||
127764518|NCT00092495|459763441|FG001|Base Study Vaccination Period|Extended|0|||
127764519|NCT00092495|459763442|FG002|Base Study Vaccination Period|Extended|0|||
127764520|NCT00092495|459763443|FG003|Base Study Vaccination Period|Extended|1|||
127764521|NCT00092495|459763444|FG004|Base Study Vaccination Period|Extended|0|||
127764522|NCT00092495|459763440|FG000|Base Study Vaccination Period|*Clinical AE|1|||
127764523|NCT00092495|459763441|FG001|Base Study Vaccination Period|*Clinical AE|0|||
127764524|NCT00092495|459763442|FG002|Base Study Vaccination Period|*Clinical AE|1|||
127764525|NCT00092495|459763443|FG003|Base Study Vaccination Period|*Clinical AE|2|||
128010282|NCT04513366|460663996|FG001|Extension Phase|Lost to Follow-up|1|||
128010283|NCT04513366|460663997|FG002|Extension Phase|Lost to Follow-up|1|||
128010284|NCT04513366|460663995|FG000|Extension Phase|Sponsor Decision|0|||
128010285|NCT04513366|460663996|FG001|Extension Phase|Sponsor Decision|1|||
128010286|NCT04513366|460663997|FG002|Extension Phase|Sponsor Decision|0|||
128010287|NCT04513366|460663995|FG000|Extension Phase|Death|0|||
128010288|NCT04513366|460663996|FG001|Extension Phase|Death|1|||
128010289|NCT04513366|460663997|FG002|Extension Phase|Death|0|||
128010290|NCT04513366|460663995|FG000|Extension Phase|Adverse Event|0|||
128010291|NCT04513366|460663996|FG001|Extension Phase|Adverse Event|0|||
127764526|NCT00092495|459763444|FG004|Base Study Vaccination Period|*Clinical AE|0|||
127764527|NCT00092495|459763440|FG000|Base Study Vaccination Period|*Other reasons|1|||
127764528|NCT00092495|459763441|FG001|Base Study Vaccination Period|*Other reasons|0|||
127764529|NCT00092495|459763442|FG002|Base Study Vaccination Period|*Other reasons|0|||
127764530|NCT00092495|459763443|FG003|Base Study Vaccination Period|*Other reasons|1|||
127764531|NCT00092495|459763444|FG004|Base Study Vaccination Period|*Other reasons|0|||
127764532|NCT00092495|459763440|FG000|Base Study Vaccination Period|*Pregnancy|0|||
127764533|NCT00092495|459763441|FG001|Base Study Vaccination Period|*Pregnancy|2|||
127764534|NCT00092495|459763442|FG002|Base Study Vaccination Period|*Pregnancy|5|||
127764535|NCT00092495|459763443|FG003|Base Study Vaccination Period|*Pregnancy|7|||
127764536|NCT00092495|459763444|FG004|Base Study Vaccination Period|*Pregnancy|0|||
127764537|NCT00092495|459763440|FG000|Base Study Vaccination Period|Adverse Event|1|||
128010292|NCT04513366|460663997|FG002|Extension Phase|Adverse Event|1|||
128010293|NCT04478266|460664001|FG000|Overall Study|Adverse Event|20|||
127764538|NCT00092495|459763441|FG001|Base Study Vaccination Period|Adverse Event|0|||
128010294|NCT04478266|460664002|FG001|Overall Study|Adverse Event|21|||
128010295|NCT04478266|460664001|FG000|Overall Study|Progressive disease|146|||
128010296|NCT04478266|460664002|FG001|Overall Study|Progressive disease|168|||
128010297|NCT04478266|460664001|FG000|Overall Study|Poor compliance to protocol|1|||
128010298|NCT04478266|460664002|FG001|Overall Study|Poor compliance to protocol|0|||
128010299|NCT04478266|460664001|FG000|Overall Study|Withdrawal by Subject|19|||
128010300|NCT04478266|460664002|FG001|Overall Study|Withdrawal by Subject|16|||
127764539|NCT00092495|459763442|FG002|Base Study Vaccination Period|Adverse Event|0|||
128010301|NCT04478266|460664001|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
128010302|NCT04478266|460664002|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
128010303|NCT04478266|460664001|FG000|Overall Study|Study terminated by sponsor|33|||
128010304|NCT04478266|460664002|FG001|Overall Study|Study terminated by sponsor|35|||
128010305|NCT04478266|460664001|FG000|Overall Study|Other: unspecified|5|||
128010306|NCT04478266|460664002|FG001|Overall Study|Other: unspecified|7|||
128010307|NCT04478266|460664001|FG000|Overall Study|Randomized but not treated|1|||
128010308|NCT04478266|460664002|FG001|Overall Study|Randomized but not treated|1|||
128010309|NCT04058717|460664003|FG000|Randomization Period|Lost to Follow-up|2|||
128010310|NCT04058717|460664004|FG001|Randomization Period|Lost to Follow-up|3|||
128010311|NCT04058717|460664005|FG002|Randomization Period|Lost to Follow-up|4|||
128010312|NCT04058717|460664006|FG003|Randomization Period|Lost to Follow-up|4|||
128010313|NCT04058717|460664003|FG000|Randomization Period|Withdrawal by Subject|1|||
128010314|NCT04058717|460664004|FG001|Randomization Period|Withdrawal by Subject|3|||
128010315|NCT04058717|460664005|FG002|Randomization Period|Withdrawal by Subject|3|||
128010316|NCT04058717|460664006|FG003|Randomization Period|Withdrawal by Subject|3|||
128010317|NCT04058717|460664003|FG000|Randomization Period|PI decision|0|||
128010318|NCT04058717|460664004|FG001|Randomization Period|PI decision|1|||
128010319|NCT04058717|460664005|FG002|Randomization Period|PI decision|0|||
128010320|NCT04058717|460664006|FG003|Randomization Period|PI decision|0|||
128010321|NCT00671788|460664007|FG000|Overall Study|Adverse Event|8|||
128010322|NCT00671788|460664007|FG000|Overall Study|Refused further treatment|3|||
127677057|NCT02698241|459441119|FG000|Overall Study|Physician Decision|2|||
127677058|NCT02698241|459441119|FG000|Overall Study|Subject underwent system modification|2|||
127677059|NCT02698241|459441119|FG000|Overall Study|Lost to Follow-up|3|||
127677060|NCT02698241|459441119|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
127677061|NCT02698241|459441119|FG000|Overall Study|geographic and licensing issue|1|||
127677062|NCT02698241|459441119|FG000|Overall Study|Death|2|||
127677063|NCT00604721|459441120|FG000|Overall Study|Physician Decision|1|||
127677064|NCT00604721|459441120|FG000|Overall Study|Withdrawal by Subject|1|||
127677065|NCT01838551|459441124|FG000|Overall Study|Adverse Event|16|||
127677066|NCT01838551|459441124|FG000|Overall Study|Death|1|||
127677067|NCT01838551|459441124|FG000|Overall Study|Lack of Efficacy|10|||
127677068|NCT01838551|459441124|FG000|Overall Study|Physician Decision|4|||
127677069|NCT01838551|459441124|FG000|Overall Study|Withdrawal by Subject|10|||
127677070|NCT01838551|459441124|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
127677071|NCT00906282|459441125|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
127677072|NCT00906282|459441125|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
127677073|NCT00906282|459441125|FG000|Preoperative Chemotherapy|Progressive disease|6|||
127677074|NCT00906282|459441125|FG000|Preoperative Chemotherapy|Toxicity|1|||
127677075|NCT02289560|459441126|FG000|Overall Study|Lost to Follow-up|6|||
127677076|NCT02289560|459441126|FG000|Overall Study|Alternative Treatment|4|||
127677077|NCT02289560|459441126|FG000|Overall Study|Inadequate Treatment|2|||
127677078|NCT02289560|459441126|FG000|Overall Study|Withdrawal by Subject|23|||
127677079|NCT02540213|459441127|FG000|Overall Study|Death/adverse event|18|||
127677080|NCT02540213|459441127|FG000|Overall Study|Administrative reasons|3|||
127677081|NCT02540213|459441127|FG000|Overall Study|Kidney transplant|3|||
127677082|NCT02540213|459441127|FG000|Overall Study|Lack of Efficacy|6|||
127677083|NCT02540213|459441127|FG000|Overall Study|Consent withdrawn|7|||
127677084|NCT02540213|459441127|FG000|Overall Study|Enrolled but not treated|2|||
127677085|NCT01981356|459441135|FG000|Overall Study|Lost to Follow-up|4|||
127677086|NCT01981356|459441136|FG001|Overall Study|Lost to Follow-up|1|||
127677087|NCT01981356|459441135|FG000|Overall Study|Withdrawal by Subject|1|||
127677088|NCT01981356|459441136|FG001|Overall Study|Withdrawal by Subject|1|||
127677089|NCT01981356|459441135|FG000|Overall Study|Protocol Violation|2|||
127677090|NCT01981356|459441136|FG001|Overall Study|Protocol Violation|0|||
127677091|NCT02317016|459441137|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
127677092|NCT02317016|459441137|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
127677093|NCT02317016|459441137|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
127677094|NCT02317016|459441137|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
127677095|NCT02317016|459441137|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
127677096|NCT02317016|459441137|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
127677097|NCT02317016|459441137|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
127677098|NCT00536380|459441138|FG000|Overall Study|Adverse Event|0|||
127677099|NCT00536380|459441139|FG001|Overall Study|Adverse Event|2|||
127677100|NCT00536380|459441140|FG002|Overall Study|Adverse Event|2|||
127677101|NCT00536380|459441138|FG000|Overall Study|Lost to Follow-up|0|||
128010323|NCT00671788|460664007|FG000|Overall Study|Ineligible|1|||
127677102|NCT00536380|459441139|FG001|Overall Study|Lost to Follow-up|0|||
127677103|NCT00536380|459441140|FG002|Overall Study|Lost to Follow-up|1|||
127677104|NCT00536380|459441138|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
128010324|NCT00671788|460664007|FG000|Overall Study|MD Decision|1|||
128010325|NCT00671788|460664007|FG000|Overall Study|Other|1|||
127677105|NCT00536380|459441139|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
128010326|NCT01832766|460664008|FG000|Washout|Lost to Follow-up|0|||
128010327|NCT01832766|460664009|FG001|Washout|Lost to Follow-up|1|||
128010328|NCT03074500|460664014|FG000|Overall Study|Lost to Follow-up|1|||
128010329|NCT03074500|460664015|FG001|Overall Study|Lost to Follow-up|0|||
128010330|NCT03074500|460664016|FG002|Overall Study|Lost to Follow-up|0|||
128010331|NCT03074500|460664014|FG000|Overall Study|Lack of Efficacy|0|||
128010332|NCT03074500|460664015|FG001|Overall Study|Lack of Efficacy|1|||
128010333|NCT03074500|460664016|FG002|Overall Study|Lack of Efficacy|0|||
128010334|NCT03074500|460664014|FG000|Overall Study|Adverse Event|0|||
128010335|NCT03074500|460664015|FG001|Overall Study|Adverse Event|0|||
128010336|NCT03074500|460664016|FG002|Overall Study|Adverse Event|1|||
128010337|NCT02233413|460665524|FG000|Overall Study|Lost to Follow-up|7|||
128010338|NCT02233413|460665525|FG001|Overall Study|Lost to Follow-up|9|||
128010339|NCT02233413|460665524|FG000|Overall Study|Withdrawal by Subject|4|||
128010340|NCT02233413|460665525|FG001|Overall Study|Withdrawal by Subject|5|||
128010341|NCT00090103|460665526|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
128010342|NCT00090103|460665527|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
128010343|NCT00090103|460665528|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
128010344|NCT00090103|460665526|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
128010345|NCT00090103|460665527|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
128010346|NCT00090103|460665528|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
128010347|NCT00090103|460665526|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
128010348|NCT00090103|460665527|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
128010349|NCT00090103|460665528|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
128010350|NCT00090103|460665526|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
128010351|NCT00090103|460665527|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
128010352|NCT00090103|460665528|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
128010353|NCT00090103|460665526|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
128010354|NCT00090103|460665527|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
128010355|NCT00090103|460665528|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
128010356|NCT00090103|460665526|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
128010357|NCT00090103|460665527|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
128010358|NCT00090103|460665528|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
128010359|NCT00090103|460665526|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
128010360|NCT00090103|460665527|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
128010361|NCT00090103|460665528|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
128010362|NCT00090103|460665526|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
128010363|NCT00090103|460665527|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
128010364|NCT00090103|460665528|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
128010365|NCT00090103|460665526|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
128010366|NCT00090103|460665527|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
128010367|NCT00090103|460665528|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
128010368|NCT00090103|460665526|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
128010369|NCT00090103|460665527|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
128010370|NCT00090103|460665528|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
128010371|NCT00090103|460665526|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
128010372|NCT00090103|460665527|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
128010373|NCT00090103|460665528|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
128010374|NCT00090103|460665526|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
128010375|NCT00090103|460665527|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
128010376|NCT00090103|460665528|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
128010377|NCT00090103|460665526|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
128010378|NCT00090103|460665527|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
128010379|NCT00090103|460665528|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
128010380|NCT00090103|460665526|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
128010381|NCT00090103|460665527|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
128010382|NCT00090103|460665528|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
128010383|NCT00090103|460665526|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
128010384|NCT00090103|460665527|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
128010385|NCT00090103|460665528|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
128010386|NCT00090103|460665526|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
128010387|NCT00090103|460665527|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
128010388|NCT00090103|460665528|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
128010389|NCT00090103|460665526|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
128010390|NCT00090103|460665527|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
128010391|NCT00090103|460665528|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
127764540|NCT00092495|459763443|FG003|Base Study Vaccination Period|Adverse Event|3|||
127764541|NCT00092495|459763444|FG004|Base Study Vaccination Period|Adverse Event|0|||
127764542|NCT00092495|459763440|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
127764543|NCT00092495|459763441|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
127764544|NCT00092495|459763442|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
127764545|NCT00092495|459763443|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
127764546|NCT00092495|459763444|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
127764547|NCT00092495|459763440|FG000|Base Study Vaccination Period|Moved|3|||
127764548|NCT00092495|459763441|FG001|Base Study Vaccination Period|Moved|1|||
127764549|NCT00092495|459763442|FG002|Base Study Vaccination Period|Moved|2|||
127764550|NCT00092495|459763443|FG003|Base Study Vaccination Period|Moved|2|||
127764551|NCT00092495|459763444|FG004|Base Study Vaccination Period|Moved|0|||
127764552|NCT00092495|459763440|FG000|Base Study Vaccination Period|Other|1|||
127764553|NCT00092495|459763441|FG001|Base Study Vaccination Period|Other|1|||
127764554|NCT00092495|459763442|FG002|Base Study Vaccination Period|Other|0|||
127764555|NCT00092495|459763443|FG003|Base Study Vaccination Period|Other|2|||
127764556|NCT00092495|459763444|FG004|Base Study Vaccination Period|Other|0|||
127764557|NCT00092495|459763440|FG000|Base Study Vaccination Period|Pregnancy|2|||
127764558|NCT00092495|459763441|FG001|Base Study Vaccination Period|Pregnancy|0|||
128010392|NCT00090103|460665526|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
127677106|NCT00536380|459441140|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
127677107|NCT00536380|459441138|FG000|Overall Study|Withdrawal related to study drug|7|||
127677108|NCT00536380|459441139|FG001|Overall Study|Withdrawal related to study drug|5|||
127677109|NCT00536380|459441140|FG002|Overall Study|Withdrawal related to study drug|2|||
127677110|NCT00536380|459441138|FG000|Overall Study|Noncompliance with protocol|3|||
127677111|NCT00536380|459441139|FG001|Overall Study|Noncompliance with protocol|2|||
127677112|NCT00536380|459441140|FG002|Overall Study|Noncompliance with protocol|2|||
127677113|NCT00536380|459441138|FG000|Overall Study|Did not meet protocol eligibility|0|||
127677114|NCT00536380|459441139|FG001|Overall Study|Did not meet protocol eligibility|0|||
127677115|NCT00536380|459441140|FG002|Overall Study|Did not meet protocol eligibility|1|||
127677116|NCT00536380|459441138|FG000|Overall Study|Administrative|0|||
127677117|NCT00536380|459441139|FG001|Overall Study|Administrative|0|||
127677118|NCT00536380|459441140|FG002|Overall Study|Administrative|1|||
127677119|NCT00290706|459441144|FG000|Overall Study|Withdrawal by Subject|2|||
127677120|NCT00290706|459441145|FG001|Overall Study|Withdrawal by Subject|0|||
127677121|NCT00290706|459441146|FG002|Overall Study|Withdrawal by Subject|0|||
127677122|NCT00290706|459441147|FG003|Overall Study|Withdrawal by Subject|0|||
127677123|NCT00290706|459441144|FG000|Overall Study|Progressive Disease|3|||
127677124|NCT00290706|459441145|FG001|Overall Study|Progressive Disease|5|||
127677125|NCT00290706|459441146|FG002|Overall Study|Progressive Disease|4|||
127677126|NCT00290706|459441147|FG003|Overall Study|Progressive Disease|10|||
127677127|NCT00290706|459441144|FG000|Overall Study|Adverse Event|0|||
127677128|NCT00290706|459441145|FG001|Overall Study|Adverse Event|1|||
127677129|NCT00290706|459441146|FG002|Overall Study|Adverse Event|2|||
127677130|NCT00290706|459441147|FG003|Overall Study|Adverse Event|0|||
127677131|NCT00290706|459441144|FG000|Overall Study|Receive auto transplant or radiation|0|||
127677132|NCT00290706|459441145|FG001|Overall Study|Receive auto transplant or radiation|0|||
127677133|NCT00290706|459441146|FG002|Overall Study|Receive auto transplant or radiation|0|||
127677134|NCT00290706|459441147|FG003|Overall Study|Receive auto transplant or radiation|1|||
127677135|NCT00290706|459441144|FG000|Overall Study|Physician Decision|0|||
127677136|NCT00290706|459441145|FG001|Overall Study|Physician Decision|0|||
127677137|NCT00290706|459441146|FG002|Overall Study|Physician Decision|0|||
127677138|NCT00290706|459441147|FG003|Overall Study|Physician Decision|1|||
127677139|NCT01768676|459441150|FG000|Overall Study|Adverse Event|3|||
127677140|NCT01768676|459441151|FG001|Overall Study|Adverse Event|3|||
127677141|NCT01768676|459441150|FG000|Overall Study|Lost to Follow-up|13|||
127677142|NCT01768676|459441151|FG001|Overall Study|Lost to Follow-up|16|||
127677143|NCT01768676|459441150|FG000|Overall Study|Protocol Violation|1|||
127677144|NCT01768676|459441151|FG001|Overall Study|Protocol Violation|1|||
127677145|NCT01768676|459441150|FG000|Overall Study|Physician Decision|4|||
127677146|NCT01768676|459441151|FG001|Overall Study|Physician Decision|1|||
127677147|NCT01768676|459441150|FG000|Overall Study|Withdrawal by Subject|3|||
127764559|NCT00092495|459763442|FG002|Base Study Vaccination Period|Pregnancy|0|||
127764560|NCT00092495|459763443|FG003|Base Study Vaccination Period|Pregnancy|0|||
127764561|NCT00092495|459763444|FG004|Base Study Vaccination Period|Pregnancy|0|||
127764562|NCT00092495|459763440|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
128010393|NCT00090103|460665527|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
127677148|NCT01768676|459441151|FG001|Overall Study|Withdrawal by Subject|10|||
127677149|NCT03395353|459441153|FG000|Overall Study|Adverse Event|20|||
127677150|NCT03395353|459441153|FG000|Overall Study|Protocol Violation|1|||
127677151|NCT03395353|459441153|FG000|Overall Study|Lack of Efficacy|3|||
127677152|NCT03395353|459441153|FG000|Overall Study|Withdrawal by Subject|24|||
127677153|NCT03395353|459441153|FG000|Overall Study|Discontinued visit|1|||
127677154|NCT03395353|459441153|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
127677155|NCT03395353|459441153|FG000|Overall Study|Physician Decision|4|||
128010394|NCT00090103|460665528|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
128010395|NCT00090103|460665526|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
128010396|NCT00090103|460665527|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
128010397|NCT00090103|460665528|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
128010398|NCT00090103|460665526|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
128010399|NCT00090103|460665527|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
128010400|NCT00090103|460665528|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
128010401|NCT00090103|460665526|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
128010402|NCT00090103|460665527|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
128010403|NCT00090103|460665528|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
128010404|NCT00090103|460665526|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
128010405|NCT00090103|460665527|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
128010406|NCT00090103|460665528|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
128010407|NCT00090103|460665526|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
128010408|NCT00090103|460665527|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
128010409|NCT00090103|460665528|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
128010410|NCT00090103|460665526|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
128010411|NCT00090103|460665527|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
128010412|NCT00090103|460665528|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
128010413|NCT00090103|460665526|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
128010414|NCT00090103|460665527|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
128010415|NCT00090103|460665528|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
128010416|NCT00090103|460665526|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
128010417|NCT00090103|460665527|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
128010418|NCT00090103|460665528|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
128010419|NCT00090103|460665526|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
128010420|NCT00090103|460665527|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
128010421|NCT00090103|460665528|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
128010422|NCT00090103|460665526|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
128010423|NCT00090103|460665527|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
128010424|NCT00090103|460665528|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
128010425|NCT00090103|460665526|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
128010426|NCT00090103|460665527|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
128010427|NCT00090103|460665528|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
128010428|NCT00090103|460665526|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
128010429|NCT00090103|460665527|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
128010430|NCT00090103|460665528|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
128010431|NCT00090103|460665526|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
128010432|NCT00090103|460665527|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
128010433|NCT00090103|460665528|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
128010434|NCT00090103|460665526|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
128010435|NCT00090103|460665527|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
128010436|NCT00090103|460665528|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
128010437|NCT00090103|460665526|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
128010438|NCT00090103|460665527|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
128010439|NCT00090103|460665528|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
128010440|NCT00090103|460665526|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
128010441|NCT00090103|460665527|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
128010442|NCT00090103|460665528|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
128010443|NCT00090103|460665526|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
128010444|NCT00090103|460665527|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
128010445|NCT00090103|460665528|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
128010446|NCT00090103|460665526|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
128010447|NCT00090103|460665527|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
128010448|NCT00090103|460665528|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
128010449|NCT00090103|460665526|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
128010450|NCT00090103|460665527|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
128010451|NCT00090103|460665528|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
128010452|NCT00090103|460665526|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
128010453|NCT00090103|460665527|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
128010454|NCT00090103|460665528|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
128010455|NCT00090103|460665526|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
128010456|NCT00090103|460665527|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
128010457|NCT00090103|460665528|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
128010458|NCT00090103|460665526|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
128010459|NCT00090103|460665527|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
128010460|NCT00090103|460665528|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
128010461|NCT00090103|460665526|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
128010462|NCT00090103|460665527|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
128010463|NCT00090103|460665528|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
128010464|NCT00090103|460665526|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
128010465|NCT00090103|460665527|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
128010466|NCT00090103|460665528|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
128010467|NCT00090103|460665526|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
128010468|NCT00090103|460665527|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
128010469|NCT00090103|460665528|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
128010470|NCT00090103|460665526|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
128010471|NCT00090103|460665527|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
128010472|NCT00090103|460665528|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
128010473|NCT00090103|460665526|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
128010474|NCT00090103|460665527|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
128010475|NCT00090103|460665528|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
128010476|NCT00090103|460665526|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
128010477|NCT00090103|460665527|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
127764563|NCT00092495|459763441|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
127764564|NCT00092495|459763442|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
127764565|NCT00092495|459763443|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
127764566|NCT00092495|459763444|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
127764567|NCT00092495|459763440|FG000|Base Study Vaccination Period|Protocol Violation|1|||
128010478|NCT00090103|460665528|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
128010479|NCT00090103|460665526|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
127764568|NCT00092495|459763441|FG001|Base Study Vaccination Period|Protocol Violation|0|||
127764569|NCT00092495|459763442|FG002|Base Study Vaccination Period|Protocol Violation|0|||
127764570|NCT00092495|459763443|FG003|Base Study Vaccination Period|Protocol Violation|0|||
127764571|NCT00092495|459763444|FG004|Base Study Vaccination Period|Protocol Violation|0|||
128010480|NCT00090103|460665527|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
127764572|NCT00092495|459763440|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
127764573|NCT00092495|459763441|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
127764574|NCT00092495|459763442|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
127764575|NCT00092495|459763443|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
127764576|NCT00092495|459763444|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
127764577|NCT00092495|459763440|FG000|Base Study Follow-up Period|Extended|0|||
127764578|NCT00092495|459763441|FG001|Base Study Follow-up Period|Extended|0|||
127764579|NCT00092495|459763442|FG002|Base Study Follow-up Period|Extended|1|||
127764580|NCT00092495|459763443|FG003|Base Study Follow-up Period|Extended|2|||
127764581|NCT00092495|459763444|FG004|Base Study Follow-up Period|Extended|0|||
127764582|NCT00092495|459763440|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
127764583|NCT00092495|459763441|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
127764584|NCT00092495|459763442|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
128010481|NCT00090103|460665528|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
128010482|NCT00090103|460665526|FG000|16-Week Safety Follow-up Period|Death|1|||
128010483|NCT00090103|460665527|FG001|16-Week Safety Follow-up Period|Death|0|||
128010484|NCT00090103|460665528|FG002|16-Week Safety Follow-up Period|Death|1|||
128010485|NCT00090103|460665526|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
127764585|NCT00092495|459763443|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
127764586|NCT00092495|459763444|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
127764587|NCT00092495|459763440|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
127764588|NCT00092495|459763441|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
127764589|NCT00092495|459763442|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
128010486|NCT00090103|460665527|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
128010487|NCT00090103|460665528|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
128010488|NCT00090103|460665526|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
128010489|NCT00090103|460665527|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
128010490|NCT00090103|460665528|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
128010491|NCT00090103|460665526|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
128010492|NCT00090103|460665527|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
127764590|NCT00092495|459763443|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
127764591|NCT00092495|459763444|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
127764592|NCT02630693|459763452|FG000|Overall Study|No receive treatment|0|||
127764593|NCT02630693|459763453|FG001|Overall Study|No receive treatment|1|||
128010493|NCT00090103|460665528|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
128010494|NCT00090103|460665526|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
128010495|NCT00090103|460665527|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
128010496|NCT00090103|460665528|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
128010497|NCT00090103|460665526|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
128010498|NCT00090103|460665527|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
128010499|NCT00090103|460665528|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
128010500|NCT00090103|460665526|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
128010501|NCT00090103|460665527|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
128010502|NCT00090103|460665528|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
128010503|NCT00090103|460665526|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
128010504|NCT00090103|460665527|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
128010505|NCT00090103|460665528|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
128010506|NCT00090103|460665526|FG000|16-Week Safety Follow-up Period|Depression|0|||
128010507|NCT00090103|460665527|FG001|16-Week Safety Follow-up Period|Depression|1|||
128010508|NCT00090103|460665528|FG002|16-Week Safety Follow-up Period|Depression|0|||
128010509|NCT00090103|460665526|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
128010510|NCT00090103|460665527|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
128010511|NCT00090103|460665528|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
128010512|NCT00090103|460665526|FG000|16-Week Safety Follow-up Period|Jailed|0|||
128010513|NCT00090103|460665527|FG001|16-Week Safety Follow-up Period|Jailed|1|||
128010514|NCT00090103|460665528|FG002|16-Week Safety Follow-up Period|Jailed|0|||
128010515|NCT00090103|460665526|FG000|16-Week Safety Follow-up Period|Other|0|||
128010516|NCT00090103|460665527|FG001|16-Week Safety Follow-up Period|Other|1|||
128010517|NCT00090103|460665528|FG002|16-Week Safety Follow-up Period|Other|0|||
128010518|NCT02194465|460665533|FG000|Overall Study|Adverse Event|6|||
128010519|NCT02194465|460665534|FG001|Overall Study|Adverse Event|1|||
127764594|NCT03932812|459763458|FG000|Overall Study|Lost to Follow-up|12|||
127764595|NCT03932812|459763459|FG001|Overall Study|Lost to Follow-up|14|||
127764596|NCT03932812|459763458|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
127764597|NCT03932812|459763459|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
127764598|NCT02585232|459763464|FG000|Overall Study|Lost to Follow-up|8|||
127764599|NCT02585232|459763465|FG001|Overall Study|Lost to Follow-up|8|||
127764600|NCT02585232|459763464|FG000|Overall Study|Withdrawal by Subject|4|||
127764601|NCT02585232|459763465|FG001|Overall Study|Withdrawal by Subject|8|||
127764602|NCT03215810|459763466|FG000|Overall Study|Still responding to nivolumab|1|||
127764603|NCT03215810|459763466|FG000|Overall Study|Insufficient TIL growth|1|||
127764604|NCT03215810|459763466|FG000|Overall Study|Decline in performance status|1|||
127764605|NCT03215810|459763466|FG000|Overall Study|Withdrawal by Subject|1|||
127764606|NCT02313233|459763467|FG000|Overall Study|Withdrawal by Subject|1|||
127764607|NCT02313233|459763468|FG001|Overall Study|Withdrawal by Subject|2|||
127764608|NCT02313233|459763467|FG000|Overall Study|Administrative reason|1|||
127764609|NCT02313233|459763468|FG001|Overall Study|Administrative reason|1|||
127764610|NCT01656733|459763471|FG000|Overall Study|No permission to collect birth outcomes|0|||
127764611|NCT01656733|459763472|FG001|Overall Study|No permission to collect birth outcomes|1|||
127764612|NCT01656733|459763471|FG000|Overall Study|Delivery at another hospital|0|||
127764613|NCT01656733|459763472|FG001|Overall Study|Delivery at another hospital|2|||
127764614|NCT01656733|459763471|FG000|Overall Study|Spontaneous abortion|0|||
127764615|NCT01656733|459763472|FG001|Overall Study|Spontaneous abortion|1|||
127764616|NCT02679573|459763476|FG000|Overall Study|Adverse Event|13|||
127764617|NCT02679573|459763477|FG001|Overall Study|Adverse Event|6|||
127764618|NCT02679573|459763476|FG000|Overall Study|Lack of Efficacy|12|||
127764619|NCT02679573|459763477|FG001|Overall Study|Lack of Efficacy|15|||
127764620|NCT02679573|459763476|FG000|Overall Study|Could not complete required study visits|6|||
127764621|NCT02679573|459763477|FG001|Overall Study|Could not complete required study visits|2|||
127764622|NCT02679573|459763476|FG000|Overall Study|Withdrawal by Subject|2|||
127764623|NCT02679573|459763477|FG001|Overall Study|Withdrawal by Subject|9|||
127764624|NCT02679573|459763476|FG000|Overall Study|Death|2|||
127764625|NCT02679573|459763477|FG001|Overall Study|Death|0|||
127764626|NCT02679573|459763476|FG000|Overall Study|Physician Decision|2|||
127764627|NCT02679573|459763477|FG001|Overall Study|Physician Decision|4|||
127764628|NCT02679573|459763476|FG000|Overall Study|Lost to Follow-up|0|||
127764629|NCT02679573|459763477|FG001|Overall Study|Lost to Follow-up|3|||
127764630|NCT03545503|459763478|FG000|Overall Study|Protocol Violation|14|||
128010520|NCT02194465|460665535|FG002|Overall Study|Adverse Event|4|||
128010521|NCT02194465|460665536|FG003|Overall Study|Adverse Event|4|||
128010522|NCT02194465|460665537|FG004|Overall Study|Adverse Event|4|||
128010523|NCT02194465|460665538|FG005|Overall Study|Adverse Event|2|||
128010524|NCT02194465|460665539|FG006|Overall Study|Adverse Event|0|||
127764631|NCT03545503|459763479|FG001|Overall Study|Protocol Violation|16|||
127764632|NCT00682890|459763480|FG000|Overall Study|Lost to Follow-up|1|||
128010525|NCT02194465|460665533|FG000|Overall Study|Lost to Follow-up|0|||
128010526|NCT02194465|460665534|FG001|Overall Study|Lost to Follow-up|0|||
128010527|NCT02194465|460665535|FG002|Overall Study|Lost to Follow-up|0|||
127677156|NCT03395353|459441153|FG000|Overall Study|Early termination of overall study|33|||
127677157|NCT01196429|459441154|FG000|Overall Study|Ineligible - inadequate pathology|1|||
127677158|NCT01196429|459441155|FG001|Overall Study|Ineligible - inadequate pathology|0|||
127677159|NCT01196429|459441154|FG000|Overall Study|Ineligible - wrong cell type|1|||
127677160|NCT01196429|459441155|FG001|Overall Study|Ineligible - wrong cell type|0|||
127677161|NCT01196429|459441154|FG000|Overall Study|Refused - Never Treated|1|||
127677162|NCT01196429|459441155|FG001|Overall Study|Refused - Never Treated|0|||
127677163|NCT02486588|459441156|FG000|Overall Study|Randomized in error- ineligible|738|||
127677164|NCT02486588|459441157|FG001|Overall Study|Randomized in error- ineligible|750|||
127677165|NCT02486588|459441158|FG002|Overall Study|Randomized in error- ineligible|755|||
127677166|NCT02486588|459441159|FG003|Overall Study|Randomized in error- ineligible|738|||
127677167|NCT02486588|459441160|FG004|Overall Study|Randomized in error- ineligible|746|||
127677168|NCT02486588|459441161|FG005|Overall Study|Randomized in error- ineligible|746|||
127677169|NCT04248829|459441164|FG000|Overall Study|Disease progression|44|||
127677170|NCT04248829|459441165|FG001|Overall Study|Disease progression|109|||
127677171|NCT04248829|459441164|FG000|Overall Study|Adverse Event|19|||
127677172|NCT04248829|459441165|FG001|Overall Study|Adverse Event|18|||
127677173|NCT04248829|459441164|FG000|Overall Study|Withdrawal by Subject|11|||
127677174|NCT04248829|459441165|FG001|Overall Study|Withdrawal by Subject|2|||
127677175|NCT04248829|459441164|FG000|Overall Study|Lost to Follow-up|0|||
127677176|NCT04248829|459441165|FG001|Overall Study|Lost to Follow-up|1|||
127677177|NCT04248829|459441164|FG000|Overall Study|Death|12|||
127677178|NCT04248829|459441165|FG001|Overall Study|Death|14|||
127677179|NCT04248829|459441164|FG000|Overall Study|Physician Decision|2|||
127677180|NCT04248829|459441165|FG001|Overall Study|Physician Decision|4|||
127677181|NCT04248829|459441164|FG000|Overall Study|Any reason not specifically recorded|0|||
127677182|NCT04248829|459441165|FG001|Overall Study|Any reason not specifically recorded|2|||
127677183|NCT02685033|459441166|FG000|Overall Study|Withdrawal of Consent|0|||
127677184|NCT02685033|459441167|FG001|Overall Study|Withdrawal of Consent|1|||
127677185|NCT02685033|459441166|FG000|Overall Study|Lost to Follow-up|2|||
127677186|NCT02685033|459441167|FG001|Overall Study|Lost to Follow-up|1|||
127677187|NCT02685033|459441166|FG000|Overall Study|Adverse Event|1|||
127677188|NCT02685033|459441167|FG001|Overall Study|Adverse Event|0|||
127677189|NCT02132702|459441168|FG000|Overall Study|Protocol Violation|2|||
127677190|NCT02132702|459441168|FG000|Overall Study|Adverse Event|3|||
127677191|NCT02132702|459441168|FG000|Overall Study|Withdrawal by Subject|3|||
127677192|NCT02960659|459442672|FG000|Overall Study|Withdrawal by Subject|1|||
127677193|NCT02960659|459442673|FG001|Overall Study|Withdrawal by Subject|0|||
127677194|NCT02960659|459442672|FG000|Overall Study|Poor compliance|0|||
127677195|NCT02960659|459442673|FG001|Overall Study|Poor compliance|1|||
127677196|NCT03068468|459442676|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
127677197|NCT03068468|459442677|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
127677198|NCT03068468|459442678|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
127677199|NCT03068468|459442679|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
127677200|NCT03068468|459442676|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
127677201|NCT03068468|459442677|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
127677202|NCT03068468|459442678|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
127677203|NCT03068468|459442679|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
127677204|NCT03068468|459442676|FG000|Placebo-Controlled Period|Adverse Event|16|||
127677205|NCT03068468|459442677|FG001|Placebo-Controlled Period|Adverse Event|21|||
128010528|NCT02194465|460665536|FG003|Overall Study|Lost to Follow-up|1|||
128010529|NCT02194465|460665537|FG004|Overall Study|Lost to Follow-up|0|||
128010530|NCT02194465|460665538|FG005|Overall Study|Lost to Follow-up|1|||
128010531|NCT02194465|460665539|FG006|Overall Study|Lost to Follow-up|0|||
128010532|NCT02194465|460665533|FG000|Overall Study|Physician Decision|1|||
128010533|NCT02194465|460665534|FG001|Overall Study|Physician Decision|0|||
128010534|NCT02194465|460665535|FG002|Overall Study|Physician Decision|0|||
128010535|NCT02194465|460665536|FG003|Overall Study|Physician Decision|0|||
128010536|NCT02194465|460665537|FG004|Overall Study|Physician Decision|0|||
128010537|NCT02194465|460665538|FG005|Overall Study|Physician Decision|0|||
128010538|NCT02194465|460665539|FG006|Overall Study|Physician Decision|0|||
128010539|NCT02194465|460665533|FG000|Overall Study|Protocol Violation|1|||
128010540|NCT02194465|460665534|FG001|Overall Study|Protocol Violation|1|||
127677206|NCT03068468|459442678|FG002|Placebo-Controlled Period|Adverse Event|0|||
127677207|NCT03068468|459442679|FG003|Placebo-Controlled Period|Adverse Event|0|||
127677208|NCT03068468|459442676|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
127677209|NCT03068468|459442677|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
127677210|NCT03068468|459442678|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
127677211|NCT03068468|459442679|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
127677212|NCT03068468|459442676|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
127677213|NCT03068468|459442677|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
128010541|NCT02194465|460665535|FG002|Overall Study|Protocol Violation|2|||
128010542|NCT02194465|460665536|FG003|Overall Study|Protocol Violation|1|||
128010543|NCT02194465|460665537|FG004|Overall Study|Protocol Violation|1|||
128010544|NCT02194465|460665538|FG005|Overall Study|Protocol Violation|0|||
128010545|NCT02194465|460665539|FG006|Overall Study|Protocol Violation|0|||
128010546|NCT02194465|460665533|FG000|Overall Study|Withdrawal by Subject|1|||
128010547|NCT02194465|460665534|FG001|Overall Study|Withdrawal by Subject|3|||
128010548|NCT02194465|460665535|FG002|Overall Study|Withdrawal by Subject|1|||
128010549|NCT02194465|460665536|FG003|Overall Study|Withdrawal by Subject|2|||
128010550|NCT02194465|460665537|FG004|Overall Study|Withdrawal by Subject|2|||
128010551|NCT02194465|460665538|FG005|Overall Study|Withdrawal by Subject|1|||
128010552|NCT02194465|460665539|FG006|Overall Study|Withdrawal by Subject|2|||
128010553|NCT02194465|460665533|FG000|Overall Study|Discontinued follow-up period|0|||
128010554|NCT02194465|460665534|FG001|Overall Study|Discontinued follow-up period|2|||
128010555|NCT02194465|460665535|FG002|Overall Study|Discontinued follow-up period|1|||
128010556|NCT02194465|460665536|FG003|Overall Study|Discontinued follow-up period|0|||
128010557|NCT02194465|460665537|FG004|Overall Study|Discontinued follow-up period|2|||
128010558|NCT02194465|460665538|FG005|Overall Study|Discontinued follow-up period|0|||
128010559|NCT02194465|460665539|FG006|Overall Study|Discontinued follow-up period|0|||
128010560|NCT01408641|460665540|FG000|Overall Study|Physician Decision|1|||
128010561|NCT01408641|460665541|FG001|Overall Study|Physician Decision|0|||
128010562|NCT03979313|460665542|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|3|||
128010563|NCT03979313|460665543|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|9|||
128010564|NCT03979313|460665542|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|3|||
128010565|NCT03979313|460665543|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|4|||
128010566|NCT03979313|460665542|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Death|0|||
128010567|NCT03979313|460665543|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Death|4|||
128010568|NCT03979313|460665542|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|14|||
128010569|NCT03979313|460665543|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|20|||
128010570|NCT03979313|460665542|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|1|||
128010571|NCT03979313|460665543|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|3|||
128010572|NCT03979313|460665542|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|432|||
128010573|NCT03979313|460665543|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|865|||
128010574|NCT03979313|460665542|FG000|All Subjects|Any Other Reason|16|||
128010575|NCT03979313|460665543|FG001|All Subjects|Any Other Reason|23|||
128010576|NCT03979313|460665542|FG000|All Subjects|Covid-19|1|||
128010577|NCT03979313|460665543|FG001|All Subjects|Covid-19|3|||
128010578|NCT03979313|460665542|FG000|All Subjects|Withdrawal by Subject|35|||
128010579|NCT03979313|460665543|FG001|All Subjects|Withdrawal by Subject|44|||
128010580|NCT03979313|460665542|FG000|All Subjects|Death|0|||
127677214|NCT03068468|459442678|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
127677215|NCT03068468|459442679|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
127677216|NCT03068468|459442676|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
127677217|NCT03068468|459442677|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
127677218|NCT03068468|459442678|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
127677219|NCT03068468|459442679|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
127677220|NCT03068468|459442676|FG000|Placebo-Controlled Period|Death|0|||
127677221|NCT03068468|459442677|FG001|Placebo-Controlled Period|Death|1|||
127677222|NCT03068468|459442678|FG002|Placebo-Controlled Period|Death|0|||
127677223|NCT03068468|459442679|FG003|Placebo-Controlled Period|Death|0|||
127677224|NCT03068468|459442676|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
127677225|NCT03068468|459442677|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
127677226|NCT03068468|459442678|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
127677227|NCT03068468|459442679|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
127677228|NCT03068468|459442676|FG000|Open-Label Extension Period|Adverse Event|0|||
127677229|NCT03068468|459442677|FG001|Open-Label Extension Period|Adverse Event|0|||
127677230|NCT03068468|459442678|FG002|Open-Label Extension Period|Adverse Event|13|||
127677231|NCT03068468|459442679|FG003|Open-Label Extension Period|Adverse Event|17|||
127677232|NCT03068468|459442676|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
127677233|NCT03068468|459442677|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
127677234|NCT03068468|459442678|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
127677235|NCT03068468|459442679|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
127677236|NCT03068468|459442676|FG000|Open-Label Extension Period|Death|0|||
127677237|NCT03068468|459442677|FG001|Open-Label Extension Period|Death|0|||
127677238|NCT03068468|459442678|FG002|Open-Label Extension Period|Death|0|||
127677239|NCT03068468|459442679|FG003|Open-Label Extension Period|Death|1|||
127677240|NCT03068468|459442676|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
127677241|NCT03068468|459442677|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
127677242|NCT03068468|459442678|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
127677243|NCT03068468|459442679|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
128010581|NCT03979313|460665543|FG001|All Subjects|Death|5|||
128010582|NCT03979313|460665542|FG000|All Subjects|Lost to Follow-up|28|||
128010583|NCT03979313|460665543|FG001|All Subjects|Lost to Follow-up|61|||
128010584|NCT00089648|460665544|FG000|Overall Study|Adverse Event|7|||
128010585|NCT00089648|460665544|FG000|Overall Study|Withdrawal by Subject|1|||
128010586|NCT00089648|460665544|FG000|Overall Study|Lack of Efficacy|33|||
128010587|NCT00300053|460665545|FG000|Overall Study|Patient/Caregiver Preference|2|||
128010588|NCT00300053|460665546|FG001|Overall Study|Patient/Caregiver Preference|2|||
128010589|NCT00300053|460665547|FG002|Overall Study|Patient/Caregiver Preference|3|||
128010590|NCT00300053|460665545|FG000|Overall Study|Death|0|||
128010591|NCT00300053|460665546|FG001|Overall Study|Death|0|||
128010592|NCT00300053|460665547|FG002|Overall Study|Death|3|||
128010593|NCT00300053|460665545|FG000|Overall Study|Lost to Follow-up|0|||
128010594|NCT00300053|460665546|FG001|Overall Study|Lost to Follow-up|1|||
128010595|NCT00300053|460665547|FG002|Overall Study|Lost to Follow-up|0|||
128010596|NCT00423605|460665548|FG000|Overall Study|Adverse Event|129|||
128010597|NCT00423605|460665548|FG000|Overall Study|Withdrawal by Subject|36|||
128010598|NCT00423605|460665548|FG000|Overall Study|Lost to Follow-up|15|||
128010599|NCT00423605|460665548|FG000|Overall Study|Lack of Efficacy|38|||
128010600|NCT00423605|460665548|FG000|Overall Study|Sponsor Decision|3|||
128010601|NCT00423605|460665548|FG000|Overall Study|Physician Decision|8|||
128010602|NCT00423605|460665548|FG000|Overall Study|Protocol Violation|7|||
128010603|NCT00423605|460665548|FG000|Overall Study|Not one of the pre-specified options|5|||
128010604|NCT03183908|460665551|FG000|Overall Study|Missing Symptom Diary Data|0|||
128010605|NCT03183908|460665552|FG001|Overall Study|Missing Symptom Diary Data|2|||
128010606|NCT01240746|460665556|FG000|Overall Study|Adverse Event|2|||
128010607|NCT01240746|460665557|FG001|Overall Study|Adverse Event|0|||
128010608|NCT01240746|460665558|FG002|Overall Study|Adverse Event|10|||
128010609|NCT01240746|460665556|FG000|Overall Study|Lost to Follow-up|23|||
128010610|NCT01240746|460665557|FG001|Overall Study|Lost to Follow-up|20|||
128010611|NCT01240746|460665558|FG002|Overall Study|Lost to Follow-up|102|||
128010612|NCT01240746|460665556|FG000|Overall Study|Protocol Violation|24|||
128010613|NCT01240746|460665557|FG001|Overall Study|Protocol Violation|15|||
128010614|NCT01240746|460665558|FG002|Overall Study|Protocol Violation|72|||
128010615|NCT01240746|460665556|FG000|Overall Study|Withdrawal by Subject|10|||
128010616|NCT01240746|460665557|FG001|Overall Study|Withdrawal by Subject|13|||
128010617|NCT01240746|460665558|FG002|Overall Study|Withdrawal by Subject|59|||
128010618|NCT03738696|460665559|FG000|Overall Study|Withdrawal by Subject|0|||
128010619|NCT03738696|460665560|FG001|Overall Study|Withdrawal by Subject|1|||
128010620|NCT03738696|460665559|FG000|Overall Study|Lost to Follow-up|8|||
128010621|NCT03738696|460665560|FG001|Overall Study|Lost to Follow-up|14|||
128010622|NCT02566005|460665561|FG000|Overall Study|vaginal bleeding|0|||
128010623|NCT02566005|460665562|FG001|Overall Study|vaginal bleeding|1|||
128010624|NCT02566005|460665561|FG000|Overall Study|received foley|8|||
128010625|NCT02566005|460665562|FG001|Overall Study|received foley|0|||
128010626|NCT02566005|460665561|FG000|Overall Study|did not receive foley|0|||
128010627|NCT02566005|460665562|FG001|Overall Study|did not receive foley|1|||
128010628|NCT02566005|460665561|FG000|Overall Study|labor after randomization|0|||
128010629|NCT02566005|460665562|FG001|Overall Study|labor after randomization|4|||
128010630|NCT02472405|460665563|FG000|Overall Study|Lost to Follow-up|9|||
128010631|NCT02472405|460665563|FG000|Overall Study|Adverse Event|1|||
128010632|NCT03617588|460665564|FG000|Overall Study|Withdrawal by Subject|1|||
128010633|NCT03617588|460665565|FG001|Overall Study|Withdrawal by Subject|0|||
128010634|NCT03261401|460665566|FG000|Overall Study|Withdrawal by Subject|0|||
128010635|NCT03261401|460665567|FG001|Overall Study|Withdrawal by Subject|0|||
128010636|NCT03261401|460665568|FG002|Overall Study|Withdrawal by Subject|0|||
128010637|NCT03261401|460665569|FG003|Overall Study|Withdrawal by Subject|0|||
128010638|NCT03261401|460665570|FG004|Overall Study|Withdrawal by Subject|0|||
128010639|NCT03261401|460665571|FG005|Overall Study|Withdrawal by Subject|1|||
128010640|NCT03261401|460665572|FG006|Overall Study|Withdrawal by Subject|0|||
128010641|NCT03261401|460665573|FG007|Overall Study|Withdrawal by Subject|0|||
128010642|NCT03261401|460665574|FG008|Overall Study|Withdrawal by Subject|0|||
128010643|NCT03261401|460665575|FG009|Overall Study|Withdrawal by Subject|0|||
128010644|NCT03261401|460665576|FG010|Overall Study|Withdrawal by Subject|0|||
128010645|NCT03261401|460665577|FG011|Overall Study|Withdrawal by Subject|0|||
128010646|NCT03261401|460665578|FG012|Overall Study|Withdrawal by Subject|0|||
128010647|NCT03261401|460665566|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
128010648|NCT03261401|460665567|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
128010649|NCT03261401|460665568|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
128010650|NCT03261401|460665569|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
128010651|NCT03261401|460665570|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
128010652|NCT03261401|460665571|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
128010653|NCT03261401|460665572|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
128010654|NCT03261401|460665573|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
128010655|NCT03261401|460665574|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
128010656|NCT03261401|460665575|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
128010657|NCT03261401|460665576|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
128010658|NCT03261401|460665577|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
128010659|NCT03261401|460665578|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
128010660|NCT01294514|460665579|FG000|Overall Study|Excluded due to Arrhythmia|1|||
128010661|NCT02690727|460665580|FG000|Overall Study|Adverse Event|2|||
128010662|NCT02690727|460665581|FG001|Overall Study|Adverse Event|2|||
128010663|NCT00785629|460665588|FG000|Overall Study|Adverse Event|2|||
128010664|NCT00785629|460665589|FG001|Overall Study|Adverse Event|1|||
128010665|NCT00785629|460665590|FG002|Overall Study|Adverse Event|1|||
128010666|NCT00785629|460665591|FG003|Overall Study|Adverse Event|5|||
128010667|NCT00785629|460665588|FG000|Overall Study|Protocol Violation|1|||
128010668|NCT00785629|460665589|FG001|Overall Study|Protocol Violation|2|||
128010669|NCT00785629|460665590|FG002|Overall Study|Protocol Violation|4|||
128010670|NCT00785629|460665591|FG003|Overall Study|Protocol Violation|5|||
128010671|NCT00785629|460665588|FG000|Overall Study|administrative decision|5|||
128010672|NCT00785629|460665589|FG001|Overall Study|administrative decision|1|||
128010673|NCT00785629|460665590|FG002|Overall Study|administrative decision|3|||
128010674|NCT00785629|460665591|FG003|Overall Study|administrative decision|4|||
128010675|NCT00785629|460665588|FG000|Overall Study|Withdrawal by Subject|0|||
128010676|NCT00785629|460665589|FG001|Overall Study|Withdrawal by Subject|1|||
128010677|NCT00785629|460665590|FG002|Overall Study|Withdrawal by Subject|2|||
128010678|NCT00785629|460665591|FG003|Overall Study|Withdrawal by Subject|2|||
128010679|NCT00851591|460665592|FG000|Overall Study|Withdrawal by Subject|2|||
128010680|NCT00851591|460665593|FG001|Overall Study|Withdrawal by Subject|0|||
128010681|NCT04796415|460665595|FG000|Overall Study|not interested|12|||
128010682|NCT04796415|460665595|FG000|Overall Study|health issue|8|||
128010683|NCT04796415|460665595|FG000|Overall Study|Other|4|||
128010684|NCT04796415|460665595|FG000|Overall Study|discharged from home health service|3|||
128010685|NCT04796415|460665595|FG000|Overall Study|re-hospitalization|2|||
128010686|NCT04796415|460665595|FG000|Overall Study|moving to nursing home|1|||
128010687|NCT04796415|460665595|FG000|Overall Study|lost contact|1|||
128010688|NCT02469857|460665596|FG000|Overall Study|Death|24|||
128010689|NCT02469857|460665597|FG001|Overall Study|Death|29|||
128010690|NCT02469857|460665596|FG000|Overall Study|Discontinuation|1|||
128010691|NCT02469857|460665597|FG001|Overall Study|Discontinuation|3|||
128010692|NCT02110693|460665598|FG000|Overall Study|Withdrawal by Subject|6|||
128010693|NCT02110693|460665599|FG001|Overall Study|Withdrawal by Subject|7|||
128010694|NCT02110693|460665598|FG000|Overall Study|skipped assessment|15|||
128010695|NCT02110693|460665599|FG001|Overall Study|skipped assessment|18|||
128010696|NCT02110693|460665598|FG000|Overall Study|technical difficulties|6|||
128010697|NCT02110693|460665599|FG001|Overall Study|technical difficulties|4|||
128010698|NCT02110693|460665598|FG000|Overall Study|Other|1|||
128010699|NCT02110693|460665599|FG001|Overall Study|Other|0|||
128010700|NCT04009837|460665603|FG000|Overall Study|Withdrawal by Subject|5|||
128010701|NCT04009837|460665604|FG001|Overall Study|Withdrawal by Subject|4|||
128010702|NCT04009837|460665603|FG000|Overall Study|Did not complete any aspect of of 8-week assessment|3|||
128010703|NCT04009837|460665604|FG001|Overall Study|Did not complete any aspect of of 8-week assessment|7|||
128010704|NCT02763566|460665607|FG000|Overall Study|Lost to Follow-up|1|||
128010705|NCT02763566|460665608|FG001|Overall Study|Lost to Follow-up|4|||
128010706|NCT02763566|460665609|FG002|Overall Study|Lost to Follow-up|0|||
128010707|NCT02763566|460665610|FG003|Overall Study|Lost to Follow-up|1|||
128010708|NCT02763566|460665607|FG000|Overall Study|On study treatment at study conclusion|114|||
128010709|NCT02763566|460665608|FG001|Overall Study|On study treatment at study conclusion|34|||
128010710|NCT02763566|460665609|FG002|Overall Study|On study treatment at study conclusion|54|||
128010711|NCT02763566|460665610|FG003|Overall Study|On study treatment at study conclusion|13|||
128010712|NCT02763566|460665607|FG000|Overall Study|Withdrawal by Subject|3|||
128010713|NCT02763566|460665608|FG001|Overall Study|Withdrawal by Subject|1|||
128010714|NCT02763566|460665609|FG002|Overall Study|Withdrawal by Subject|0|||
128010715|NCT02763566|460665610|FG003|Overall Study|Withdrawal by Subject|0|||
128010716|NCT01933594|460665615|FG000|Overall Study|Lost to Follow-up|1|||
128010717|NCT01933594|460665616|FG001|Overall Study|Lost to Follow-up|0|||
128010718|NCT01933594|460665617|FG002|Overall Study|Lost to Follow-up|0|||
128010719|NCT01933594|460665618|FG003|Overall Study|Lost to Follow-up|0|||
128010720|NCT01933594|460665619|FG004|Overall Study|Lost to Follow-up|1|||
128010721|NCT01933594|460665620|FG005|Overall Study|Lost to Follow-up|0|||
128010722|NCT01933594|460665615|FG000|Overall Study|Ineligible for subsequent study step|0|||
128010723|NCT01933594|460665616|FG001|Overall Study|Ineligible for subsequent study step|0|||
128010724|NCT01933594|460665617|FG002|Overall Study|Ineligible for subsequent study step|0|||
128010725|NCT01933594|460665618|FG003|Overall Study|Ineligible for subsequent study step|0|||
128010726|NCT01933594|460665619|FG004|Overall Study|Ineligible for subsequent study step|1|||
128010727|NCT01933594|460665620|FG005|Overall Study|Ineligible for subsequent study step|0|||
128010728|NCT02657551|460665629|FG000|Overall Study|Adverse Event|2|||
127677244|NCT03068468|459442676|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
127677245|NCT03068468|459442677|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
127677246|NCT03068468|459442678|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
127677247|NCT03068468|459442679|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
127677248|NCT03068468|459442676|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
127677249|NCT03068468|459442677|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
127677250|NCT03068468|459442678|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
127677251|NCT03068468|459442679|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
127677252|NCT03068468|459442676|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
128010729|NCT02657551|460665629|FG000|Overall Study|Withdrawal by Subject|1|||
128010730|NCT02657551|460665629|FG000|Overall Study|Non-Compliance|1|||
128010731|NCT02657551|460665629|FG000|Overall Study|Progression / Relapse|4|||
128010732|NCT00315445|460665630|FG000|Overall Study|Adverse Event|7|||
128010733|NCT00315445|460665631|FG001|Overall Study|Adverse Event|12|||
127764633|NCT00682890|459763481|FG001|Overall Study|Lost to Follow-up|1|||
127764634|NCT00682890|459763480|FG000|Overall Study|subject moved away|0|||
127764635|NCT00682890|459763481|FG001|Overall Study|subject moved away|1|||
127764636|NCT00682890|459763480|FG000|Overall Study|heavy menstrual bleeding|1|||
127764637|NCT00682890|459763481|FG001|Overall Study|heavy menstrual bleeding|0|||
127764638|NCT00862719|459763484|FG000|Overall Study|Disease Progression|5|||
127764639|NCT00862719|459763485|FG001|Overall Study|Disease Progression|0|||
127764640|NCT00862719|459763486|FG002|Overall Study|Disease Progression|1|||
127764641|NCT00862719|459763487|FG003|Overall Study|Disease Progression|0|||
127764642|NCT00862719|459763484|FG000|Overall Study|Death|5|||
127764643|NCT00862719|459763485|FG001|Overall Study|Death|6|||
127764644|NCT00862719|459763486|FG002|Overall Study|Death|1|||
127764645|NCT00862719|459763487|FG003|Overall Study|Death|1|||
127764646|NCT00862719|459763484|FG000|Overall Study|Engraftment failure|0|||
127764647|NCT00862719|459763485|FG001|Overall Study|Engraftment failure|0|||
127764648|NCT00862719|459763486|FG002|Overall Study|Engraftment failure|1|||
127764649|NCT00862719|459763487|FG003|Overall Study|Engraftment failure|0|||
127764650|NCT00862719|459763484|FG000|Overall Study|Veno-Occlusive Disease|0|||
127764651|NCT00862719|459763485|FG001|Overall Study|Veno-Occlusive Disease|0|||
127764652|NCT00862719|459763486|FG002|Overall Study|Veno-Occlusive Disease|1|||
127764653|NCT00862719|459763487|FG003|Overall Study|Veno-Occlusive Disease|0|||
127764654|NCT00324116|459763488|FG000|Overall Study|Adverse Event|5|||
127764655|NCT00324116|459763488|FG000|Overall Study|Lack of Efficacy|17|||
127764656|NCT00324116|459763488|FG000|Overall Study|Withdrawal by Subject|5|||
127764657|NCT00324116|459763488|FG000|Overall Study|Other|5|||
127764658|NCT01806623|459763489|FG000|Overall Study|Withdrawal by Subject|1|||
127764659|NCT01806623|459763489|FG000|Overall Study|Adverse Event|1|||
127764660|NCT01806623|459763489|FG000|Overall Study|Did not meet the inclusion criteria|56|||
128010734|NCT00315445|460665632|FG002|Overall Study|Adverse Event|15|||
128010735|NCT00315445|460665630|FG000|Overall Study|Lack of Efficacy|16|||
128010736|NCT00315445|460665631|FG001|Overall Study|Lack of Efficacy|1|||
128010737|NCT00315445|460665632|FG002|Overall Study|Lack of Efficacy|7|||
128010738|NCT00315445|460665630|FG000|Overall Study|Lost to Follow-up|1|||
127677253|NCT03068468|459442677|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
127677254|NCT03068468|459442678|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
127677255|NCT03068468|459442679|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
127677256|NCT03068468|459442676|FG000|Open-Label Extension Period|Reason not Specified|0|||
127677257|NCT03068468|459442677|FG001|Open-Label Extension Period|Reason not Specified|0|||
127677258|NCT03068468|459442678|FG002|Open-Label Extension Period|Reason not Specified|1|||
127677259|NCT03068468|459442679|FG003|Open-Label Extension Period|Reason not Specified|4|||
127677260|NCT01062126|459442680|FG000|Overall Study|Death|209|||
127677261|NCT01062126|459442680|FG000|Overall Study|All Withdrawals|324|||
127677262|NCT00486759|459442682|FG000|Treatment|Adverse event/intercurrent illness|86|||
127677263|NCT00486759|459442683|FG001|Treatment|Adverse event/intercurrent illness|39|||
127677264|NCT00486759|459442682|FG000|Treatment|Insufficient therapeutic response|37|||
127677265|NCT00486759|459442683|FG001|Treatment|Insufficient therapeutic response|39|||
127677266|NCT00486759|459442682|FG000|Treatment|Death|17|||
127677267|NCT00486759|459442683|FG001|Treatment|Death|10|||
127677268|NCT00486759|459442682|FG000|Treatment|Withdrew consent|15|||
127677269|NCT00486759|459442683|FG001|Treatment|Withdrew consent|12|||
127677270|NCT00486759|459442682|FG000|Treatment|Administrative/reason not specified|17|||
127677271|NCT00486759|459442683|FG001|Treatment|Administrative/reason not specified|21|||
127677272|NCT00486759|459442682|FG000|Treatment|Refused treatment|10|||
127677273|NCT00486759|459442683|FG001|Treatment|Refused treatment|7|||
127677274|NCT00486759|459442682|FG000|Treatment|Violation of selection criteria at entry|3|||
127677275|NCT00486759|459442683|FG001|Treatment|Violation of selection criteria at entry|3|||
127677276|NCT00486759|459442682|FG000|Treatment|Other protocol violation|1|||
127677277|NCT00486759|459442683|FG001|Treatment|Other protocol violation|5|||
127677278|NCT00486759|459442682|FG000|Treatment|Failure to return|1|||
127677279|NCT00486759|459442683|FG001|Treatment|Failure to return|1|||
127677280|NCT00486759|459442682|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
127677281|NCT00486759|459442683|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
127677282|NCT00486759|459442682|FG000|Safety Follow-up|Death|40|||
127677283|NCT00486759|459442683|FG001|Safety Follow-up|Death|29|||
127677284|NCT00486759|459442682|FG000|Safety Follow-up|Withdrew consent|32|||
127677285|NCT00486759|459442683|FG001|Safety Follow-up|Withdrew consent|23|||
127764661|NCT01737827|459763490|FG000|Overall Study|Adverse Event|3|||
127764662|NCT01737827|459763491|FG001|Overall Study|Adverse Event|6|||
127764663|NCT01737827|459763492|FG002|Overall Study|Adverse Event|0|||
127764664|NCT01737827|459763490|FG000|Overall Study|Lost to Follow-up|0|||
127764665|NCT01737827|459763491|FG001|Overall Study|Lost to Follow-up|1|||
127764666|NCT01737827|459763492|FG002|Overall Study|Lost to Follow-up|0|||
128010739|NCT00315445|460665631|FG001|Overall Study|Lost to Follow-up|0|||
128010740|NCT00315445|460665632|FG002|Overall Study|Lost to Follow-up|1|||
128010741|NCT00315445|460665630|FG000|Overall Study|Protocol Violation|2|||
128010742|NCT00315445|460665631|FG001|Overall Study|Protocol Violation|0|||
128010743|NCT00315445|460665632|FG002|Overall Study|Protocol Violation|1|||
128010744|NCT00315445|460665630|FG000|Overall Study|Other|1|||
128010745|NCT00315445|460665631|FG001|Overall Study|Other|3|||
128010746|NCT00315445|460665632|FG002|Overall Study|Other|0|||
128010747|NCT01035138|460665633|FG000|Overall Study|Adverse Event|4|||
128010748|NCT01035138|460665634|FG001|Overall Study|Adverse Event|0|||
128010749|NCT01035138|460665635|FG002|Overall Study|Adverse Event|2|||
128010750|NCT01035138|460665633|FG000|Overall Study|Caregiver Decision|2|||
128010751|NCT01035138|460665634|FG001|Overall Study|Caregiver Decision|0|||
128010752|NCT01035138|460665635|FG002|Overall Study|Caregiver Decision|1|||
128010753|NCT01035138|460665633|FG000|Overall Study|Withdrawal by Subject|1|||
128010754|NCT01035138|460665634|FG001|Overall Study|Withdrawal by Subject|0|||
128010755|NCT01035138|460665635|FG002|Overall Study|Withdrawal by Subject|0|||
128010756|NCT01035138|460665633|FG000|Overall Study|Physician Decision|0|||
128010757|NCT01035138|460665634|FG001|Overall Study|Physician Decision|0|||
128010758|NCT01035138|460665635|FG002|Overall Study|Physician Decision|1|||
128010759|NCT01035138|460665633|FG000|Overall Study|Sponsor Decision|66|||
128010760|NCT01035138|460665634|FG001|Overall Study|Sponsor Decision|60|||
128010761|NCT01035138|460665635|FG002|Overall Study|Sponsor Decision|42|||
128010762|NCT01035138|460665633|FG000|Overall Study|Lost to Follow-up|0|||
128010763|NCT01035138|460665634|FG001|Overall Study|Lost to Follow-up|0|||
128010764|NCT01035138|460665635|FG002|Overall Study|Lost to Follow-up|1|||
128010765|NCT02916927|460665636|FG000|Overall Study|Discharged prior to study drug receipt|0|||
128010766|NCT02916927|460665637|FG001|Overall Study|Discharged prior to study drug receipt|2|||
128010767|NCT02916927|460665636|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
128010768|NCT02916927|460665637|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
128010769|NCT02916927|460665636|FG000|Overall Study|Withdrawal before first time point|1|||
128010770|NCT02916927|460665637|FG001|Overall Study|Withdrawal before first time point|0|||
128010771|NCT00655889|460665638|FG000|Overall Study|Inadequate cell growth|1|||
128010772|NCT00655889|460665638|FG000|Overall Study|Protocol Violation|1|||
128010773|NCT04585893|460665641|FG000|Overall Study|Death|1|||
128010774|NCT04585893|460665642|FG001|Overall Study|Death|0|||
128010775|NCT02598661|460665643|FG000|Overall Study|Death|27|||
128010776|NCT02598661|460665644|FG001|Overall Study|Death|34|||
128010777|NCT02598661|460665645|FG002|Overall Study|Death|14|||
128010778|NCT02598661|460665646|FG003|Overall Study|Death|1|||
128010779|NCT02598661|460665647|FG004|Overall Study|Death|0|||
128010780|NCT02598661|460665643|FG000|Overall Study|Lost to Follow-up|2|||
128010781|NCT02598661|460665644|FG001|Overall Study|Lost to Follow-up|3|||
128010782|NCT02598661|460665645|FG002|Overall Study|Lost to Follow-up|2|||
128010783|NCT02598661|460665646|FG003|Overall Study|Lost to Follow-up|0|||
128010784|NCT02598661|460665647|FG004|Overall Study|Lost to Follow-up|0|||
128010785|NCT02598661|460665643|FG000|Overall Study|Withdrawal by Subject|13|||
128010786|NCT02598661|460665644|FG001|Overall Study|Withdrawal by Subject|24|||
128010787|NCT02598661|460665645|FG002|Overall Study|Withdrawal by Subject|14|||
128010788|NCT02598661|460665646|FG003|Overall Study|Withdrawal by Subject|1|||
128010789|NCT02598661|460665647|FG004|Overall Study|Withdrawal by Subject|1|||
128010790|NCT02598661|460665643|FG000|Overall Study|Adverse Event|0|||
128010791|NCT02598661|460665644|FG001|Overall Study|Adverse Event|0|||
128010792|NCT02598661|460665645|FG002|Overall Study|Adverse Event|1|||
128010793|NCT02598661|460665646|FG003|Overall Study|Adverse Event|0|||
128010794|NCT02598661|460665647|FG004|Overall Study|Adverse Event|0|||
128010795|NCT02598661|460665643|FG000|Overall Study|Randomized, Never Treated|0|||
128010796|NCT02598661|460665644|FG001|Overall Study|Randomized, Never Treated|0|||
128010797|NCT02598661|460665645|FG002|Overall Study|Randomized, Never Treated|0|||
128010798|NCT02598661|460665646|FG003|Overall Study|Randomized, Never Treated|0|||
128010799|NCT02598661|460665647|FG004|Overall Study|Randomized, Never Treated|1|||
128010800|NCT01366092|460665648|FG000|Overall Study|Progressive cGVHD|2|||
128010801|NCT01366092|460665648|FG000|Overall Study|Physician Decision|1|||
128010802|NCT01366092|460665648|FG000|Overall Study|Withdrawal by Subject|1|||
128010803|NCT03608163|460665649|FG000|2nd Intervention (2 Days)|Physician Decision|0|||
128010804|NCT03608163|460665650|FG001|2nd Intervention (2 Days)|Physician Decision|1|||
128010805|NCT05399680|460667139|FG000|Overall Study|Lost to Follow-up|1|||
128010806|NCT05399680|460667140|FG001|Overall Study|Lost to Follow-up|0|||
128010807|NCT05399680|460667139|FG000|Overall Study|Death|0|||
128010808|NCT05399680|460667140|FG001|Overall Study|Death|1|||
128010809|NCT02659865|460667141|FG000|Period 1|Withdrawal by Subject|1|||
128010810|NCT02659865|460667142|FG001|Period 1|Withdrawal by Subject|0|||
128010811|NCT02659865|460667143|FG002|Period 1|Withdrawal by Subject|0|||
128010812|NCT02659865|460667144|FG003|Period 1|Withdrawal by Subject|0|||
128010813|NCT02659865|460667145|FG004|Period 1|Withdrawal by Subject|0|||
128010814|NCT02659865|460667141|FG000|Period 1|Adverse Event|0|||
128010815|NCT02659865|460667142|FG001|Period 1|Adverse Event|0|||
128010816|NCT02659865|460667143|FG002|Period 1|Adverse Event|0|||
128010817|NCT02659865|460667144|FG003|Period 1|Adverse Event|0|||
128010818|NCT02659865|460667145|FG004|Period 1|Adverse Event|1|||
128010819|NCT01288430|460667147|FG000|Part 1|Progressive disease|2|||
127764667|NCT01737827|459763490|FG000|Overall Study|Physician Decision|0|||
127764668|NCT01737827|459763491|FG001|Overall Study|Physician Decision|2|||
127764669|NCT01737827|459763492|FG002|Overall Study|Physician Decision|0|||
127764670|NCT01737827|459763490|FG000|Overall Study|Progressive Disease|5|||
127764671|NCT01737827|459763491|FG001|Overall Study|Progressive Disease|16|||
127764672|NCT01737827|459763492|FG002|Overall Study|Progressive Disease|2|||
127764673|NCT01737827|459763490|FG000|Overall Study|Study Terminated by Sponsor|0|||
127764674|NCT01737827|459763491|FG001|Overall Study|Study Terminated by Sponsor|1|||
127764675|NCT01737827|459763492|FG002|Overall Study|Study Terminated by Sponsor|0|||
127764676|NCT01737827|459763490|FG000|Overall Study|Subject/Guardian Decision|0|||
127764677|NCT01737827|459763491|FG001|Overall Study|Subject/Guardian Decision|2|||
127764678|NCT01737827|459763492|FG002|Overall Study|Subject/Guardian Decision|0|||
127677286|NCT00486759|459442682|FG000|Safety Follow-up|Failure to return|9|||
127677287|NCT00486759|459442683|FG001|Safety Follow-up|Failure to return|6|||
127677288|NCT00486759|459442682|FG000|Safety Follow-up|Administrative/not specified|8|||
127677289|NCT00486759|459442683|FG001|Safety Follow-up|Administrative/not specified|6|||
127677290|NCT00486759|459442682|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
127677291|NCT00486759|459442683|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
127677292|NCT00486759|459442682|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
127677293|NCT00486759|459442683|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
127677294|NCT01185522|459442684|FG000|Overall Study|Lack of Efficacy|28|||
127677295|NCT01185522|459442684|FG000|Overall Study|Lost to Follow-up|19|||
127764679|NCT01451827|459763493|FG000|Overall Study|Adverse Event|2|||
127764680|NCT01451827|459763494|FG001|Overall Study|Adverse Event|0|||
127764681|NCT01451827|459763495|FG002|Overall Study|Adverse Event|1|||
127764682|NCT01451827|459763496|FG003|Overall Study|Adverse Event|1|||
127764683|NCT01451827|459763493|FG000|Overall Study|Protocol deviation|1|||
127764684|NCT01451827|459763494|FG001|Overall Study|Protocol deviation|0|||
127764685|NCT01451827|459763495|FG002|Overall Study|Protocol deviation|0|||
127764686|NCT01451827|459763496|FG003|Overall Study|Protocol deviation|0|||
127764687|NCT01451827|459763493|FG000|Overall Study|Lost to Follow-up|0|||
127764688|NCT01451827|459763494|FG001|Overall Study|Lost to Follow-up|3|||
127764689|NCT01451827|459763495|FG002|Overall Study|Lost to Follow-up|0|||
127764690|NCT01451827|459763496|FG003|Overall Study|Lost to Follow-up|2|||
127764691|NCT01451827|459763493|FG000|Overall Study|Participant met withdrawal criteria|0|||
127764692|NCT01451827|459763494|FG001|Overall Study|Participant met withdrawal criteria|2|||
127764693|NCT01451827|459763495|FG002|Overall Study|Participant met withdrawal criteria|0|||
127764694|NCT01451827|459763496|FG003|Overall Study|Participant met withdrawal criteria|0|||
127764695|NCT01451827|459763493|FG000|Overall Study|Withdrawal by Subject|0|||
127764696|NCT01451827|459763494|FG001|Overall Study|Withdrawal by Subject|0|||
128010820|NCT01288430|460667148|FG001|Part 1|Progressive disease|1|||
127677296|NCT01185522|459442684|FG000|Overall Study|Withdrawal by Subject|10|||
127677297|NCT01185522|459442684|FG000|Overall Study|Poor tolerance|39|||
127677298|NCT01185522|459442684|FG000|Overall Study|Other reasons|12|||
127677299|NCT00109967|459442685|FG000|Overall Study|Cancel Prior to Treatment|2|||
127677300|NCT00109967|459442686|FG001|Overall Study|Cancel Prior to Treatment|0|||
127677301|NCT00109967|459442685|FG000|Overall Study|Adverse Event|12|||
127677302|NCT00109967|459442686|FG001|Overall Study|Adverse Event|1|||
127677303|NCT00109967|459442685|FG000|Overall Study|Withdrawal by Subject|5|||
127677304|NCT00109967|459442686|FG001|Overall Study|Withdrawal by Subject|0|||
127677305|NCT00109967|459442685|FG000|Overall Study|Physician Decision|1|||
127677306|NCT00109967|459442686|FG001|Overall Study|Physician Decision|3|||
127677307|NCT00109967|459442685|FG000|Overall Study|Death|0|||
127677308|NCT00109967|459442686|FG001|Overall Study|Death|2|||
127677309|NCT00918957|459442693|FG000|Overall Study|Adverse Event|2|||
127677310|NCT00918957|459442694|FG001|Overall Study|Adverse Event|0|||
127677311|NCT00918957|459442693|FG000|Overall Study|Withdrawal by Subject|1|||
127677312|NCT00918957|459442694|FG001|Overall Study|Withdrawal by Subject|0|||
127677313|NCT01803646|459442697|FG000|Overall Study|Protocol Violation|1|||
127764697|NCT01451827|459763495|FG002|Overall Study|Withdrawal by Subject|1|||
128010821|NCT01288430|460667149|FG002|Part 1|Progressive disease|1|||
128010822|NCT01288430|460667150|FG003|Part 1|Progressive disease|6|||
128010823|NCT01288430|460667151|FG004|Part 1|Progressive disease|2|||
128010824|NCT01288430|460667152|FG005|Part 1|Progressive disease|4|||
128010825|NCT01288430|460667153|FG006|Part 1|Progressive disease|2|||
128010826|NCT01288430|460667154|FG007|Part 1|Progressive disease|0|||
127677314|NCT01803646|459442698|FG001|Overall Study|Protocol Violation|0|||
127677315|NCT01803646|459442697|FG000|Overall Study|Adverse Event|1|||
127677316|NCT01803646|459442698|FG001|Overall Study|Adverse Event|1|||
127677317|NCT01803646|459442697|FG000|Overall Study|Withdrawal by Subject|9|||
127677318|NCT01803646|459442698|FG001|Overall Study|Withdrawal by Subject|6|||
128010827|NCT01288430|460667155|FG008|Part 1|Progressive disease|0|||
127764698|NCT01451827|459763496|FG003|Overall Study|Withdrawal by Subject|1|||
127764699|NCT00296400|459763497|FG000|Overall Study|Adverse Event|7|||
127764700|NCT00296400|459763498|FG001|Overall Study|Adverse Event|7|||
127764701|NCT00296400|459763499|FG002|Overall Study|Adverse Event|7|||
127764702|NCT00296400|459763497|FG000|Overall Study|Withdrawal by Subject|5|||
128010828|NCT01288430|460667156|FG009|Part 1|Progressive disease|0|||
127677319|NCT01803646|459442697|FG000|Overall Study|Randomization error|1|||
127677320|NCT01803646|459442698|FG001|Overall Study|Randomization error|2|||
127677321|NCT01803646|459442697|FG000|Overall Study|Lost to Follow-up|5|||
127677322|NCT01803646|459442698|FG001|Overall Study|Lost to Follow-up|1|||
127677323|NCT01131494|459442699|FG000|Overall Study|Withdrawal by Subject|2|||
127677324|NCT01368406|459442700|FG000|Overall Study|Lost to Follow-up|8|||
127677325|NCT01368406|459442701|FG001|Overall Study|Lost to Follow-up|4|||
127677326|NCT01368406|459442700|FG000|Overall Study|Withdrawal by Subject|8|||
127677327|NCT01368406|459442701|FG001|Overall Study|Withdrawal by Subject|4|||
127677328|NCT01368406|459442700|FG000|Overall Study|relapse of the disease|3|||
127677329|NCT01368406|459442701|FG001|Overall Study|relapse of the disease|2|||
127677330|NCT01368406|459442700|FG000|Overall Study|started working|2|||
127677331|NCT01368406|459442701|FG001|Overall Study|started working|3|||
127677332|NCT03670602|459442708|FG000|Overall Study|Lost to Follow-up|1|||
127677333|NCT03670602|459442709|FG001|Overall Study|Lost to Follow-up|0|||
127677334|NCT03670602|459442708|FG000|Overall Study|Withdrawal by Subject|0|||
127677335|NCT03670602|459442709|FG001|Overall Study|Withdrawal by Subject|3|||
127677336|NCT01456936|459442710|FG000|Overall Study|Other reason|41|||
127677337|NCT01456936|459442711|FG001|Overall Study|Other reason|30|||
127677338|NCT01456936|459442712|FG002|Overall Study|Other reason|36|||
127677339|NCT01456936|459442713|FG003|Overall Study|Other reason|33|||
128010829|NCT01288430|460667147|FG000|Part 1|Clinical disease progression|0|||
128010830|NCT01288430|460667148|FG001|Part 1|Clinical disease progression|0|||
128010831|NCT01288430|460667149|FG002|Part 1|Clinical disease progression|1|||
128010832|NCT01288430|460667150|FG003|Part 1|Clinical disease progression|0|||
128010833|NCT01288430|460667151|FG004|Part 1|Clinical disease progression|0|||
128010834|NCT01288430|460667152|FG005|Part 1|Clinical disease progression|2|||
128010835|NCT01288430|460667153|FG006|Part 1|Clinical disease progression|2|||
128010836|NCT01288430|460667154|FG007|Part 1|Clinical disease progression|0|||
128010837|NCT01288430|460667155|FG008|Part 1|Clinical disease progression|0|||
128010838|NCT01288430|460667156|FG009|Part 1|Clinical disease progression|0|||
128010839|NCT01288430|460667147|FG000|Part 1|Death due to disease progression|0|||
128010840|NCT01288430|460667148|FG001|Part 1|Death due to disease progression|0|||
128010841|NCT01288430|460667149|FG002|Part 1|Death due to disease progression|0|||
128010842|NCT01288430|460667150|FG003|Part 1|Death due to disease progression|0|||
128010843|NCT01288430|460667151|FG004|Part 1|Death due to disease progression|1|||
128010844|NCT01288430|460667152|FG005|Part 1|Death due to disease progression|0|||
128010845|NCT01288430|460667153|FG006|Part 1|Death due to disease progression|0|||
128010846|NCT01288430|460667154|FG007|Part 1|Death due to disease progression|0|||
128010847|NCT01288430|460667155|FG008|Part 1|Death due to disease progression|0|||
128010848|NCT01288430|460667156|FG009|Part 1|Death due to disease progression|0|||
128010849|NCT01288430|460667147|FG000|Part 1|Adverse Event|0|||
128010850|NCT01288430|460667148|FG001|Part 1|Adverse Event|0|||
128010851|NCT01288430|460667149|FG002|Part 1|Adverse Event|3|||
128010852|NCT01288430|460667150|FG003|Part 1|Adverse Event|1|||
128010853|NCT01288430|460667151|FG004|Part 1|Adverse Event|0|||
128010854|NCT01288430|460667152|FG005|Part 1|Adverse Event|0|||
128010855|NCT01288430|460667153|FG006|Part 1|Adverse Event|2|||
128010856|NCT01288430|460667154|FG007|Part 1|Adverse Event|0|||
128010857|NCT01288430|460667155|FG008|Part 1|Adverse Event|0|||
128010858|NCT01288430|460667156|FG009|Part 1|Adverse Event|0|||
128010859|NCT01288430|460667147|FG000|Part 1|Other|0|||
128010860|NCT01288430|460667148|FG001|Part 1|Other|2|||
128010861|NCT01288430|460667149|FG002|Part 1|Other|0|||
128010862|NCT01288430|460667150|FG003|Part 1|Other|0|||
128010863|NCT01288430|460667151|FG004|Part 1|Other|0|||
128010864|NCT01288430|460667152|FG005|Part 1|Other|0|||
128010865|NCT01288430|460667153|FG006|Part 1|Other|1|||
128010866|NCT01288430|460667154|FG007|Part 1|Other|0|||
128010867|NCT01288430|460667155|FG008|Part 1|Other|0|||
128010868|NCT01288430|460667156|FG009|Part 1|Other|0|||
128010869|NCT01288430|460667147|FG000|Part 2|Progressive disease|0|||
128010870|NCT01288430|460667148|FG001|Part 2|Progressive disease|0|||
127677340|NCT01456936|459442710|FG000|Overall Study|No longer meets eligibility criteria|4|||
127677341|NCT01456936|459442711|FG001|Overall Study|No longer meets eligibility criteria|8|||
128010871|NCT01288430|460667149|FG002|Part 2|Progressive disease|0|||
128010872|NCT01288430|460667150|FG003|Part 2|Progressive disease|0|||
128010873|NCT01288430|460667151|FG004|Part 2|Progressive disease|0|||
128010874|NCT01288430|460667152|FG005|Part 2|Progressive disease|0|||
128010875|NCT01288430|460667153|FG006|Part 2|Progressive disease|0|||
127543555|NCT02718898|458956555|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
128010876|NCT01288430|460667154|FG007|Part 2|Progressive disease|8|||
128010877|NCT01288430|460667155|FG008|Part 2|Progressive disease|7|||
127677342|NCT01456936|459442712|FG002|Overall Study|No longer meets eligibility criteria|6|||
127677343|NCT01456936|459442713|FG003|Overall Study|No longer meets eligibility criteria|5|||
128010878|NCT01288430|460667156|FG009|Part 2|Progressive disease|2|||
128010879|NCT01288430|460667147|FG000|Part 2|Clinical disease progression|0|||
128010880|NCT01288430|460667148|FG001|Part 2|Clinical disease progression|0|||
128010881|NCT01288430|460667149|FG002|Part 2|Clinical disease progression|0|||
128010882|NCT01288430|460667150|FG003|Part 2|Clinical disease progression|0|||
127764703|NCT00296400|459763498|FG001|Overall Study|Withdrawal by Subject|6|||
127764704|NCT00296400|459763499|FG002|Overall Study|Withdrawal by Subject|2|||
127764705|NCT00296400|459763497|FG000|Overall Study|Incorrect enrollment|2|||
127764706|NCT00296400|459763498|FG001|Overall Study|Incorrect enrollment|0|||
127764707|NCT00296400|459763499|FG002|Overall Study|Incorrect enrollment|0|||
127764708|NCT00296400|459763497|FG000|Overall Study|Protocol Violation|1|||
127764709|NCT00296400|459763498|FG001|Overall Study|Protocol Violation|1|||
127764710|NCT00296400|459763499|FG002|Overall Study|Protocol Violation|1|||
127764711|NCT00296400|459763497|FG000|Overall Study|Lost to Follow-up|1|||
127764712|NCT00296400|459763498|FG001|Overall Study|Lost to Follow-up|1|||
127764713|NCT00296400|459763499|FG002|Overall Study|Lost to Follow-up|2|||
127764714|NCT00296400|459763497|FG000|Overall Study|Study specific discontinuation criteria|0|||
127764715|NCT00296400|459763498|FG001|Overall Study|Study specific discontinuation criteria|0|||
127764716|NCT00296400|459763499|FG002|Overall Study|Study specific discontinuation criteria|1|||
127764717|NCT00296400|459763497|FG000|Overall Study|Visit 10 was performed earlier|0|||
127764718|NCT00296400|459763498|FG001|Overall Study|Visit 10 was performed earlier|1|||
127764719|NCT00296400|459763499|FG002|Overall Study|Visit 10 was performed earlier|0|||
127764720|NCT00296400|459763497|FG000|Overall Study|Pregnancy|1|||
127764721|NCT00296400|459763498|FG001|Overall Study|Pregnancy|2|||
127764722|NCT00296400|459763499|FG002|Overall Study|Pregnancy|0|||
127764723|NCT00412061|459763500|FG000|Double Blind Phase|Disease Progression|101|||
127764724|NCT00412061|459763501|FG001|Double Blind Phase|Disease Progression|154|||
127764725|NCT00412061|459763500|FG000|Double Blind Phase|Adverse Event|61|||
127764726|NCT00412061|459763501|FG001|Double Blind Phase|Adverse Event|16|||
127764727|NCT00412061|459763500|FG000|Double Blind Phase|Final Primary Analysis|26|||
127764728|NCT00412061|459763501|FG001|Double Blind Phase|Final Primary Analysis|14|||
127764729|NCT00412061|459763500|FG000|Double Blind Phase|Withdrawal by Subject|18|||
127764730|NCT00412061|459763501|FG001|Double Blind Phase|Withdrawal by Subject|20|||
127764731|NCT00412061|459763500|FG000|Double Blind Phase|Death|6|||
127764732|NCT00412061|459763501|FG001|Double Blind Phase|Death|3|||
127764733|NCT00412061|459763500|FG000|Double Blind Phase|Protocol Violation|3|||
127764734|NCT00412061|459763501|FG001|Double Blind Phase|Protocol Violation|4|||
127764735|NCT00412061|459763500|FG000|Double Blind Phase|New Cander Therapy|1|||
127764736|NCT00412061|459763501|FG001|Double Blind Phase|New Cander Therapy|1|||
127764737|NCT00412061|459763500|FG000|Double Blind Phase|Lost to Follow-up|0|||
127764738|NCT00412061|459763501|FG001|Double Blind Phase|Lost to Follow-up|1|||
127764739|NCT00412061|459763500|FG000|Open Label Phase|Disease Progression|0|||
127764740|NCT00412061|459763501|FG001|Open Label Phase|Disease Progression|86|||
127764741|NCT00412061|459763500|FG000|Open Label Phase|Adverse Event|0|||
127764742|NCT00412061|459763501|FG001|Open Label Phase|Adverse Event|46|||
127764743|NCT00412061|459763500|FG000|Open Label Phase|Withdrawal by Subject|0|||
127764744|NCT00412061|459763501|FG001|Open Label Phase|Withdrawal by Subject|15|||
127764745|NCT00412061|459763500|FG000|Open Label Phase|Administrative Problems|0|||
128010883|NCT01288430|460667151|FG004|Part 2|Clinical disease progression|0|||
128010884|NCT01288430|460667152|FG005|Part 2|Clinical disease progression|0|||
128010885|NCT01288430|460667153|FG006|Part 2|Clinical disease progression|0|||
128010886|NCT01288430|460667154|FG007|Part 2|Clinical disease progression|2|||
128010887|NCT01288430|460667155|FG008|Part 2|Clinical disease progression|0|||
128010888|NCT01288430|460667156|FG009|Part 2|Clinical disease progression|0|||
128010889|NCT01288430|460667147|FG000|Part 2|Withdrawal by Subject|0|||
128010890|NCT01288430|460667148|FG001|Part 2|Withdrawal by Subject|0|||
128010891|NCT01288430|460667149|FG002|Part 2|Withdrawal by Subject|0|||
128010892|NCT01288430|460667150|FG003|Part 2|Withdrawal by Subject|0|||
128010893|NCT01288430|460667151|FG004|Part 2|Withdrawal by Subject|0|||
128010894|NCT01288430|460667152|FG005|Part 2|Withdrawal by Subject|0|||
128010895|NCT01288430|460667153|FG006|Part 2|Withdrawal by Subject|0|||
128010896|NCT01288430|460667154|FG007|Part 2|Withdrawal by Subject|1|||
128010897|NCT01288430|460667155|FG008|Part 2|Withdrawal by Subject|4|||
128010898|NCT01288430|460667156|FG009|Part 2|Withdrawal by Subject|0|||
128010899|NCT01288430|460667147|FG000|Part 2|Adverse Event|0|||
128010900|NCT01288430|460667148|FG001|Part 2|Adverse Event|0|||
127764746|NCT00412061|459763501|FG001|Open Label Phase|Administrative Problems|13|||
127764747|NCT00412061|459763500|FG000|Open Label Phase|Death|0|||
127764748|NCT00412061|459763501|FG001|Open Label Phase|Death|7|||
128010901|NCT01288430|460667149|FG002|Part 2|Adverse Event|0|||
127543556|NCT02718898|458956556|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
127543557|NCT02718898|458956557|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
127764749|NCT00412061|459763500|FG000|Open Label Phase|Lost to Follow-up|0|||
127764750|NCT00412061|459763501|FG001|Open Label Phase|Lost to Follow-up|2|||
127764751|NCT00412061|459763500|FG000|Open Label Phase|New Cancer Therapy|0|||
127764752|NCT00412061|459763501|FG001|Open Label Phase|New Cancer Therapy|1|||
127764753|NCT01942590|459763503|FG000|Overall Study|Withdrawal by Subject|0|||
128010902|NCT01288430|460667150|FG003|Part 2|Adverse Event|0|||
127764754|NCT01942590|459763504|FG001|Overall Study|Withdrawal by Subject|1|||
127764755|NCT01942590|459763503|FG000|Overall Study|Adverse Event|1|||
127764756|NCT01942590|459763504|FG001|Overall Study|Adverse Event|0|||
127764757|NCT01178385|459763506|FG000|Overall Study|Withdrawal by Subject|2|||
127764758|NCT01178385|459763507|FG001|Overall Study|Withdrawal by Subject|0|||
127677344|NCT01456936|459442710|FG000|Overall Study|Protocol Violation|4|||
127677345|NCT01456936|459442711|FG001|Overall Study|Protocol Violation|2|||
127677346|NCT01456936|459442712|FG002|Overall Study|Protocol Violation|5|||
127677347|NCT01456936|459442713|FG003|Overall Study|Protocol Violation|5|||
127677348|NCT01456936|459442710|FG000|Overall Study|Pregnancy|1|||
127677349|NCT01456936|459442711|FG001|Overall Study|Pregnancy|0|||
127677350|NCT01456936|459442712|FG002|Overall Study|Pregnancy|0|||
127677351|NCT01456936|459442713|FG003|Overall Study|Pregnancy|1|||
127677352|NCT01456936|459442710|FG000|Overall Study|Insufficient clinical response|4|||
127677353|NCT01456936|459442711|FG001|Overall Study|Insufficient clinical response|4|||
127677354|NCT01456936|459442712|FG002|Overall Study|Insufficient clinical response|14|||
128010903|NCT01288430|460667151|FG004|Part 2|Adverse Event|0|||
128010904|NCT01288430|460667152|FG005|Part 2|Adverse Event|0|||
128010905|NCT01288430|460667153|FG006|Part 2|Adverse Event|0|||
128010906|NCT01288430|460667154|FG007|Part 2|Adverse Event|1|||
127677355|NCT01456936|459442713|FG003|Overall Study|Insufficient clinical response|13|||
127677356|NCT01456936|459442710|FG000|Overall Study|No longer willing to participate|195|||
127677357|NCT01456936|459442711|FG001|Overall Study|No longer willing to participate|218|||
127677358|NCT01456936|459442712|FG002|Overall Study|No longer willing to participate|224|||
127677359|NCT01456936|459442713|FG003|Overall Study|No longer willing to participate|248|||
127677360|NCT01456936|459442710|FG000|Overall Study|Lost to Follow-up|135|||
127677361|NCT01456936|459442711|FG001|Overall Study|Lost to Follow-up|126|||
127677362|NCT01456936|459442712|FG002|Overall Study|Lost to Follow-up|144|||
127677363|NCT01456936|459442713|FG003|Overall Study|Lost to Follow-up|127|||
127677364|NCT01456936|459442710|FG000|Overall Study|Medication error|0|||
127677365|NCT01456936|459442711|FG001|Overall Study|Medication error|1|||
127677366|NCT01456936|459442712|FG002|Overall Study|Medication error|0|||
127677367|NCT01456936|459442713|FG003|Overall Study|Medication error|1|||
127677368|NCT01456936|459442710|FG000|Overall Study|Adverse event (study drug)|25|||
127677369|NCT01456936|459442711|FG001|Overall Study|Adverse event (study drug)|21|||
127677370|NCT01456936|459442712|FG002|Overall Study|Adverse event (study drug)|26|||
127677371|NCT01456936|459442713|FG003|Overall Study|Adverse event (study drug)|17|||
127677372|NCT01456936|459442710|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
127677373|NCT01456936|459442711|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
127677374|NCT01456936|459442712|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
127677375|NCT01456936|459442713|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
127677376|NCT01456936|459442710|FG000|Overall Study|Death|0|||
127677377|NCT01456936|459442711|FG001|Overall Study|Death|3|||
127677378|NCT01456936|459442712|FG002|Overall Study|Death|1|||
127677379|NCT01456936|459442713|FG003|Overall Study|Death|3|||
127677380|NCT01456936|459442710|FG000|Overall Study|Randomized but not treated|21|||
127677381|NCT01456936|459442711|FG001|Overall Study|Randomized but not treated|28|||
127677382|NCT01456936|459442712|FG002|Overall Study|Randomized but not treated|16|||
127677383|NCT01456936|459442713|FG003|Overall Study|Randomized but not treated|21|||
127677384|NCT00543725|459442714|FG000|Overall Study|Adverse Event|18|||
127677385|NCT00543725|459442715|FG001|Overall Study|Adverse Event|27|||
127677386|NCT00543725|459442714|FG000|Overall Study|Sponsor's Decision|0|||
127677387|NCT00543725|459442715|FG001|Overall Study|Sponsor's Decision|1|||
127677388|NCT00543725|459442714|FG000|Overall Study|Subject Non-Compliant|4|||
127677389|NCT00543725|459442715|FG001|Overall Study|Subject Non-Compliant|4|||
128010907|NCT01288430|460667155|FG008|Part 2|Adverse Event|1|||
128010908|NCT01288430|460667156|FG009|Part 2|Adverse Event|0|||
128010909|NCT01288430|460667147|FG000|Part 2|Other|0|||
128010910|NCT01288430|460667148|FG001|Part 2|Other|0|||
128010911|NCT01288430|460667149|FG002|Part 2|Other|0|||
128010912|NCT01288430|460667150|FG003|Part 2|Other|0|||
128010913|NCT01288430|460667151|FG004|Part 2|Other|0|||
128010914|NCT01288430|460667152|FG005|Part 2|Other|0|||
127677390|NCT00543725|459442714|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
127677391|NCT00543725|459442715|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
127677392|NCT00543725|459442714|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
127677393|NCT00543725|459442715|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
127677394|NCT00543725|459442714|FG000|Overall Study|Protocol Violation|0|||
127677395|NCT00543725|459442715|FG001|Overall Study|Protocol Violation|1|||
127677396|NCT00543725|459442714|FG000|Overall Study|Withdrawal by Subject|4|||
127677397|NCT00543725|459442715|FG001|Overall Study|Withdrawal by Subject|13|||
127677398|NCT00543725|459442714|FG000|Overall Study|Lost to Follow-up|15|||
127677399|NCT00543725|459442715|FG001|Overall Study|Lost to Follow-up|11|||
127677400|NCT00543725|459442714|FG000|Overall Study|Other|3|||
127677401|NCT00543725|459442715|FG001|Overall Study|Other|3|||
127677402|NCT00906698|459442716|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
128010915|NCT01288430|460667153|FG006|Part 2|Other|0|||
128010916|NCT01288430|460667154|FG007|Part 2|Other|0|||
128010917|NCT01288430|460667155|FG008|Part 2|Other|0|||
128010918|NCT01288430|460667156|FG009|Part 2|Other|1|||
127677403|NCT00906698|459442717|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
127677404|NCT00906698|459442718|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
128010919|NCT03836053|460667162|FG000|Overall Study|Protocol-specified criteria|0|||
128010920|NCT03836053|460667163|FG001|Overall Study|Protocol-specified criteria|2|||
127764759|NCT01688830|459763510|FG000|Overall Study|Lost to Follow-up|0|||
127764760|NCT01688830|459763511|FG001|Overall Study|Lost to Follow-up|0|||
127764761|NCT01688830|459763512|FG002|Overall Study|Lost to Follow-up|0|||
127764762|NCT01688830|459763513|FG003|Overall Study|Lost to Follow-up|0|||
127764763|NCT01688830|459763514|FG004|Overall Study|Lost to Follow-up|0|||
127764764|NCT01688830|459763515|FG005|Overall Study|Lost to Follow-up|0|||
127764765|NCT01688830|459763516|FG006|Overall Study|Lost to Follow-up|0|||
127764766|NCT01688830|459763517|FG007|Overall Study|Lost to Follow-up|0|||
127764767|NCT01688830|459763518|FG008|Overall Study|Lost to Follow-up|0|||
127764768|NCT01688830|459763519|FG009|Overall Study|Lost to Follow-up|0|||
127764769|NCT01688830|459763520|FG010|Overall Study|Lost to Follow-up|1|||
127764770|NCT01688830|459763521|FG011|Overall Study|Lost to Follow-up|0|||
127764771|NCT01688830|459763522|FG012|Overall Study|Lost to Follow-up|0|||
127764772|NCT01688830|459763523|FG013|Overall Study|Lost to Follow-up|0|||
127764773|NCT01688830|459763524|FG014|Overall Study|Lost to Follow-up|0|||
127764774|NCT01688830|459763525|FG015|Overall Study|Lost to Follow-up|0|||
127764775|NCT01688830|459763526|FG016|Overall Study|Lost to Follow-up|0|||
127764776|NCT01688830|459763527|FG017|Overall Study|Lost to Follow-up|0|||
127764777|NCT01688830|459763528|FG018|Overall Study|Lost to Follow-up|0|||
127764778|NCT01688830|459763529|FG019|Overall Study|Lost to Follow-up|0|||
127764779|NCT01688830|459763530|FG020|Overall Study|Lost to Follow-up|0|||
127764780|NCT01285609|459763531|FG000|Randomized|Progressive Disease|41|||
127764781|NCT01285609|459763532|FG001|Randomized|Progressive Disease|61|||
127764782|NCT01285609|459763531|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
127764783|NCT01285609|459763532|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
127764784|NCT01285609|459763531|FG000|Randomized|Study Drug Toxicity|13|||
127764785|NCT01285609|459763532|FG001|Randomized|Study Drug Toxicity|14|||
127764786|NCT01285609|459763531|FG000|Randomized|Death|5|||
127764787|NCT01285609|459763532|FG001|Randomized|Death|7|||
127764788|NCT01285609|459763531|FG000|Randomized|Withdrawal by Subject|8|||
127764789|NCT01285609|459763532|FG001|Randomized|Withdrawal by Subject|11|||
127764790|NCT01285609|459763531|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
127764791|NCT01285609|459763532|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
127764792|NCT01285609|459763531|FG000|Randomized|Undisclosed Reasons|1|||
127764793|NCT01285609|459763532|FG001|Randomized|Undisclosed Reasons|0|||
127764794|NCT01285609|459763531|FG000|Randomized|Randomized but not Treated|4|||
127764795|NCT01285609|459763532|FG001|Randomized|Randomized but not Treated|4|||
127764796|NCT01285609|459763531|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
127764797|NCT01285609|459763532|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
127764798|NCT01285609|459763531|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
127764799|NCT01285609|459763532|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
127764800|NCT01285609|459763531|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
127764801|NCT01285609|459763532|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
127764802|NCT01285609|459763531|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
127764803|NCT01285609|459763532|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
127764804|NCT01285609|459763531|FG000|Treated With Blinded Therapy|Death|11|||
127764805|NCT01285609|459763532|FG001|Treated With Blinded Therapy|Death|3|||
127764806|NCT01285609|459763531|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
127764807|NCT01285609|459763532|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
127764808|NCT01285609|459763531|FG000|Treated With Blinded Therapy|Not Reported|0|||
127764809|NCT01285609|459763532|FG001|Treated With Blinded Therapy|Not Reported|2|||
127764810|NCT01285609|459763531|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
127764811|NCT01285609|459763532|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
127764812|NCT01285609|459763531|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
127764813|NCT01285609|459763532|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
127764814|NCT01285609|459763531|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
127764815|NCT01285609|459763532|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
127764816|NCT01285609|459763531|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
127764817|NCT01285609|459763532|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
128010921|NCT03836053|460667164|FG002|Overall Study|Protocol-specified criteria|1|||
128010922|NCT03836053|460667162|FG000|Overall Study|Death|1|||
128010923|NCT03836053|460667163|FG001|Overall Study|Death|6|||
128010924|NCT03836053|460667164|FG002|Overall Study|Death|4|||
127543558|NCT02718898|458956551|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
127764818|NCT01285609|459763531|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
127764819|NCT01285609|459763532|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
127764820|NCT01285609|459763531|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
127764821|NCT01285609|459763532|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
127764822|NCT01285609|459763531|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
127764823|NCT01285609|459763532|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
127764824|NCT01285609|459763531|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
127764825|NCT01285609|459763532|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
127543559|NCT02718898|458956552|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
127543560|NCT02718898|458956553|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
127543561|NCT02718898|458956554|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
127543562|NCT02718898|458956555|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
127543563|NCT02718898|458956556|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
127543564|NCT02718898|458956557|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
127543565|NCT00894803|458956558|FG000|Overall Study|Death|20|||
127543566|NCT00894803|458956559|FG001|Overall Study|Death|4|||
127543567|NCT00894803|458956558|FG000|Overall Study|Lost to Follow-up|0|||
127543568|NCT00894803|458956559|FG001|Overall Study|Lost to Follow-up|1|||
127543569|NCT03337308|458956561|FG000|Overall Study|Adverse Event|2|||
127543570|NCT03337308|458956562|FG001|Overall Study|Adverse Event|3|||
127543571|NCT03337308|458956563|FG002|Overall Study|Adverse Event|3|||
127543572|NCT03337308|458956564|FG003|Overall Study|Adverse Event|1|||
127543573|NCT03337308|458956561|FG000|Overall Study|Lost to Follow-up|1|||
127543574|NCT03337308|458956562|FG001|Overall Study|Lost to Follow-up|2|||
127543575|NCT03337308|458956563|FG002|Overall Study|Lost to Follow-up|0|||
127543576|NCT03337308|458956564|FG003|Overall Study|Lost to Follow-up|0|||
127543577|NCT03337308|458956561|FG000|Overall Study|Withdrawal by Subject|2|||
127543578|NCT03337308|458956562|FG001|Overall Study|Withdrawal by Subject|1|||
127543579|NCT03337308|458956563|FG002|Overall Study|Withdrawal by Subject|2|||
127543580|NCT03337308|458956564|FG003|Overall Study|Withdrawal by Subject|1|||
127543581|NCT03337308|458956561|FG000|Overall Study|Protocol Violation|0|||
127543582|NCT03337308|458956562|FG001|Overall Study|Protocol Violation|1|||
127543583|NCT03337308|458956563|FG002|Overall Study|Protocol Violation|0|||
127543584|NCT03337308|458956564|FG003|Overall Study|Protocol Violation|0|||
128010925|NCT03836053|460667162|FG000|Overall Study|Withdrawal of consent from study|0|||
128010926|NCT03836053|460667163|FG001|Overall Study|Withdrawal of consent from study|0|||
128010927|NCT03836053|460667164|FG002|Overall Study|Withdrawal of consent from study|1|||
128010928|NCT03836053|460667162|FG000|Overall Study|Decision by sponsor|0|||
128010929|NCT03836053|460667163|FG001|Overall Study|Decision by sponsor|2|||
128010930|NCT03836053|460667164|FG002|Overall Study|Decision by sponsor|4|||
128010931|NCT04006457|460667165|FG000|Main Study: Treatment Period 1|Adverse Event|26|||
128010932|NCT04006457|460667166|FG001|Main Study: Treatment Period 1|Adverse Event|36|||
128010933|NCT04006457|460667167|FG002|Main Study: Treatment Period 1|Adverse Event|0|||
128010934|NCT04006457|460667165|FG000|Main Study: Treatment Period 1|Death|1|||
128010935|NCT04006457|460667166|FG001|Main Study: Treatment Period 1|Death|1|||
128010936|NCT04006457|460667167|FG002|Main Study: Treatment Period 1|Death|0|||
128010937|NCT04006457|460667165|FG000|Main Study: Treatment Period 1|Lack of Efficacy|27|||
128010938|NCT04006457|460667166|FG001|Main Study: Treatment Period 1|Lack of Efficacy|79|||
128010939|NCT04006457|460667167|FG002|Main Study: Treatment Period 1|Lack of Efficacy|0|||
128010940|NCT04006457|460667165|FG000|Main Study: Treatment Period 1|Lost to Follow-up|22|||
128010941|NCT04006457|460667166|FG001|Main Study: Treatment Period 1|Lost to Follow-up|17|||
128010942|NCT04006457|460667167|FG002|Main Study: Treatment Period 1|Lost to Follow-up|0|||
128010943|NCT04006457|460667165|FG000|Main Study: Treatment Period 1|Non-Compliance with Study Drug|4|||
128010944|NCT04006457|460667166|FG001|Main Study: Treatment Period 1|Non-Compliance with Study Drug|1|||
128010945|NCT04006457|460667167|FG002|Main Study: Treatment Period 1|Non-Compliance with Study Drug|0|||
128010946|NCT04006457|460667165|FG000|Main Study: Treatment Period 1|Physician Decision|3|||
128010947|NCT04006457|460667166|FG001|Main Study: Treatment Period 1|Physician Decision|0|||
128010948|NCT04006457|460667167|FG002|Main Study: Treatment Period 1|Physician Decision|0|||
128010949|NCT04006457|460667165|FG000|Main Study: Treatment Period 1|Pregnancy|8|||
128010950|NCT04006457|460667166|FG001|Main Study: Treatment Period 1|Pregnancy|8|||
128010951|NCT04006457|460667167|FG002|Main Study: Treatment Period 1|Pregnancy|0|||
128010952|NCT04006457|460667165|FG000|Main Study: Treatment Period 1|Withdrawal by Subject|41|||
128010953|NCT04006457|460667166|FG001|Main Study: Treatment Period 1|Withdrawal by Subject|57|||
128010954|NCT04006457|460667167|FG002|Main Study: Treatment Period 1|Withdrawal by Subject|0|||
128010955|NCT04006457|460667165|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|14|||
128010956|NCT04006457|460667166|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|29|||
128010957|NCT04006457|460667167|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|0|||
128010958|NCT04006457|460667165|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|4|||
128010959|NCT04006457|460667166|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|2|||
128010960|NCT04006457|460667167|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|0|||
128010961|NCT04006457|460667165|FG000|Main Study: Treatment Period 1|Other|10|||
127764826|NCT01285609|459763531|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
127764827|NCT01285609|459763532|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
127764828|NCT01285609|459763531|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
127764829|NCT01285609|459763532|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
127764830|NCT03616977|459763542|FG000|Period 1|Physician Decision|0|||
127543585|NCT01668784|458956565|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
127543586|NCT01668784|458956566|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
127543587|NCT01668784|458956565|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
127764831|NCT03616977|459763543|FG001|Period 1|Physician Decision|1|||
127764832|NCT03616977|459763542|FG000|Period 3|Adverse Event|1|||
127764833|NCT03616977|459763543|FG001|Period 3|Adverse Event|1|||
127764834|NCT03683823|459763544|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
127764835|NCT03683823|459763545|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
127764836|NCT03683823|459763544|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
127764837|NCT03683823|459763545|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
127764838|NCT03683823|459763544|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
127764839|NCT03683823|459763545|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
127764840|NCT01323972|459763547|FG000|Overall Study|Withdrawal by Subject|1|||
127764841|NCT01323972|459763548|FG001|Overall Study|Withdrawal by Subject|0|||
127764842|NCT01323972|459763549|FG002|Overall Study|Withdrawal by Subject|1|||
127764843|NCT01323972|459763550|FG003|Overall Study|Withdrawal by Subject|0|||
127764844|NCT01323972|459763547|FG000|Overall Study|Migrated/moved from study area|1|||
127764845|NCT01323972|459763548|FG001|Overall Study|Migrated/moved from study area|2|||
127764846|NCT01323972|459763549|FG002|Overall Study|Migrated/moved from study area|0|||
127764847|NCT01323972|459763550|FG003|Overall Study|Migrated/moved from study area|0|||
127764848|NCT01323972|459763547|FG000|Overall Study|Lost to Follow-up|0|||
127764849|NCT01323972|459763548|FG001|Overall Study|Lost to Follow-up|1|||
127764850|NCT01323972|459763549|FG002|Overall Study|Lost to Follow-up|1|||
127764851|NCT01323972|459763550|FG003|Overall Study|Lost to Follow-up|1|||
127764852|NCT02008877|459763551|FG000|Overall Study|Inevaluable|0|||
127764853|NCT02008877|459763552|FG001|Overall Study|Inevaluable|1|||
127764854|NCT02008877|459763553|FG002|Overall Study|Inevaluable|0|||
127764855|NCT02412371|459763554|FG000|Overall Study|Withdrawal by Subject|0|||
127764856|NCT02412371|459763555|FG001|Overall Study|Withdrawal by Subject|2|||
127764857|NCT02412371|459763556|FG002|Overall Study|Withdrawal by Subject|0|||
127764858|NCT02412371|459763557|FG003|Overall Study|Withdrawal by Subject|1|||
127764859|NCT02412371|459763558|FG004|Overall Study|Withdrawal by Subject|1|||
127764860|NCT02412371|459763559|FG005|Overall Study|Withdrawal by Subject|0|||
127764861|NCT02412371|459763554|FG000|Overall Study|Sponsor Discontinued Study|1|||
127764862|NCT02412371|459763555|FG001|Overall Study|Sponsor Discontinued Study|4|||
127764863|NCT02412371|459763556|FG002|Overall Study|Sponsor Discontinued Study|6|||
127764864|NCT02412371|459763557|FG003|Overall Study|Sponsor Discontinued Study|4|||
127764865|NCT02412371|459763558|FG004|Overall Study|Sponsor Discontinued Study|5|||
127764866|NCT02412371|459763559|FG005|Overall Study|Sponsor Discontinued Study|0|||
127764867|NCT02412371|459763554|FG000|Overall Study|Death|4|||
127764868|NCT02412371|459763555|FG001|Overall Study|Death|2|||
127764869|NCT02412371|459763556|FG002|Overall Study|Death|1|||
127764870|NCT02412371|459763557|FG003|Overall Study|Death|3|||
127764871|NCT02412371|459763558|FG004|Overall Study|Death|5|||
127764872|NCT02412371|459763559|FG005|Overall Study|Death|2|||
127764873|NCT02412371|459763554|FG000|Overall Study|Other|2|||
127764874|NCT02412371|459763555|FG001|Overall Study|Other|1|||
127764875|NCT02412371|459763556|FG002|Overall Study|Other|0|||
127764876|NCT02412371|459763557|FG003|Overall Study|Other|0|||
127764877|NCT02412371|459763558|FG004|Overall Study|Other|1|||
127764878|NCT02412371|459763559|FG005|Overall Study|Other|3|||
127764879|NCT02053792|459763560|FG000|Overall Study|Physician Decision|0|||
128010962|NCT04006457|460667166|FG001|Main Study: Treatment Period 1|Other|4|||
127764880|NCT02053792|459763561|FG001|Overall Study|Physician Decision|1|||
127764881|NCT02053792|459763560|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
127764882|NCT02053792|459763561|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
127764883|NCT02053792|459763560|FG000|Overall Study|Lack of Efficacy|1|||
127764884|NCT02053792|459763561|FG001|Overall Study|Lack of Efficacy|0|||
127764885|NCT02053792|459763560|FG000|Overall Study|Adverse Event|1|||
128010963|NCT04006457|460667167|FG002|Main Study: Treatment Period 1|Other|0|||
128010964|NCT04006457|460667165|FG000|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
128010965|NCT04006457|460667166|FG001|Main Study: Treatment Period 1|Approved Drug Available For Indication|37|||
127764886|NCT02053792|459763561|FG001|Overall Study|Adverse Event|0|||
127764887|NCT02053792|459763560|FG000|Overall Study|Withdrawal by Subject|2|||
127764888|NCT02053792|459763561|FG001|Overall Study|Withdrawal by Subject|2|||
127543588|NCT01668784|458956566|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
127764889|NCT02053792|459763560|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
127764890|NCT02053792|459763561|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
127764891|NCT02053792|459763560|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
127764892|NCT02053792|459763561|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
127764893|NCT03149549|459763562|FG000|Study Discontinuation--Treatment Period|Death|0|||
127764894|NCT03149549|459763563|FG001|Study Discontinuation--Treatment Period|Death|0|||
127764895|NCT03149549|459763564|FG002|Study Discontinuation--Treatment Period|Death|0|||
127764896|NCT03149549|459763565|FG003|Study Discontinuation--Treatment Period|Death|1|||
127764897|NCT03149549|459763566|FG004|Study Discontinuation--Treatment Period|Death|2|||
127764898|NCT03149549|459763567|FG005|Study Discontinuation--Treatment Period|Death|1|||
127764899|NCT03149549|459763568|FG006|Study Discontinuation--Treatment Period|Death|1|||
128010966|NCT04006457|460667167|FG002|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
128010967|NCT04006457|460667165|FG000|Main Study: Treatment Period 2|Adverse Event|2|||
128010968|NCT04006457|460667166|FG001|Main Study: Treatment Period 2|Adverse Event|2|||
128010969|NCT04006457|460667167|FG002|Main Study: Treatment Period 2|Adverse Event|0|||
128010970|NCT04006457|460667165|FG000|Main Study: Treatment Period 2|Lack of Efficacy|7|||
128010971|NCT04006457|460667166|FG001|Main Study: Treatment Period 2|Lack of Efficacy|0|||
128010972|NCT04006457|460667167|FG002|Main Study: Treatment Period 2|Lack of Efficacy|0|||
128010973|NCT04006457|460667165|FG000|Main Study: Treatment Period 2|Lost to Follow-up|2|||
128010974|NCT04006457|460667166|FG001|Main Study: Treatment Period 2|Lost to Follow-up|1|||
128010975|NCT04006457|460667167|FG002|Main Study: Treatment Period 2|Lost to Follow-up|0|||
128010976|NCT04006457|460667165|FG000|Main Study: Treatment Period 2|Protocol Violation|3|||
128010977|NCT04006457|460667166|FG001|Main Study: Treatment Period 2|Protocol Violation|1|||
128010978|NCT04006457|460667167|FG002|Main Study: Treatment Period 2|Protocol Violation|0|||
128010979|NCT04006457|460667165|FG000|Main Study: Treatment Period 2|Withdrawal by Subject|8|||
128010980|NCT04006457|460667166|FG001|Main Study: Treatment Period 2|Withdrawal by Subject|7|||
128010981|NCT04006457|460667167|FG002|Main Study: Treatment Period 2|Withdrawal by Subject|0|||
127677405|NCT00906698|459442719|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
127677406|NCT00906698|459442720|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
127677407|NCT00906698|459442721|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
127677408|NCT00906698|459442716|FG000|Overall Study|Adverse Event|0|||
127677409|NCT00906698|459442717|FG001|Overall Study|Adverse Event|0|||
127677410|NCT00906698|459442718|FG002|Overall Study|Adverse Event|2|||
127677411|NCT00906698|459442719|FG003|Overall Study|Adverse Event|0|||
127677412|NCT00906698|459442720|FG004|Overall Study|Adverse Event|4|||
127677413|NCT00906698|459442721|FG005|Overall Study|Adverse Event|1|||
127677414|NCT00906698|459442716|FG000|Overall Study|Disease progression|3|||
127677415|NCT00906698|459442717|FG001|Overall Study|Disease progression|12|||
127677416|NCT00906698|459442718|FG002|Overall Study|Disease progression|4|||
127677417|NCT00906698|459442719|FG003|Overall Study|Disease progression|4|||
127677418|NCT00906698|459442720|FG004|Overall Study|Disease progression|12|||
127677419|NCT00906698|459442721|FG005|Overall Study|Disease progression|4|||
127677420|NCT00906698|459442716|FG000|Overall Study|Withdrawal by Subject|0|||
127677421|NCT00906698|459442717|FG001|Overall Study|Withdrawal by Subject|0|||
127677422|NCT00906698|459442718|FG002|Overall Study|Withdrawal by Subject|0|||
127677423|NCT00906698|459442719|FG003|Overall Study|Withdrawal by Subject|0|||
127677424|NCT00906698|459442720|FG004|Overall Study|Withdrawal by Subject|1|||
127677425|NCT00906698|459442721|FG005|Overall Study|Withdrawal by Subject|0|||
127677426|NCT00906698|459442716|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
127677427|NCT00906698|459442717|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
127677428|NCT00906698|459442718|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
127677429|NCT00906698|459442719|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
127677430|NCT00906698|459442720|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
127677431|NCT00906698|459442721|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
127677432|NCT03095508|459442722|FG000|Overall Study|Adverse Event|0|||
127677433|NCT03095508|459442723|FG001|Overall Study|Adverse Event|1|||
127677434|NCT03201809|459442724|FG000|Overall Study|Lost to Follow-up|2|||
127677435|NCT03201809|459442725|FG001|Overall Study|Lost to Follow-up|0|||
127677436|NCT00246012|459442727|FG000|Overall Study|Adverse Event|0|||
127677437|NCT00246012|459442728|FG001|Overall Study|Adverse Event|0|||
127677438|NCT00246012|459442729|FG002|Overall Study|Adverse Event|0|||
127677439|NCT00246012|459442730|FG003|Overall Study|Adverse Event|0|||
127677440|NCT00246012|459442731|FG004|Overall Study|Adverse Event|0|||
127677441|NCT00246012|459442732|FG005|Overall Study|Adverse Event|1|||
127677442|NCT00246012|459442733|FG006|Overall Study|Adverse Event|0|||
127677443|NCT00246012|459442734|FG007|Overall Study|Adverse Event|0|||
127677444|NCT00246012|459442735|FG008|Overall Study|Adverse Event|2|||
127677445|NCT00246012|459442727|FG000|Overall Study|Withdrawal by Subject|0|||
127677446|NCT00246012|459442728|FG001|Overall Study|Withdrawal by Subject|0|||
127677447|NCT00246012|459442729|FG002|Overall Study|Withdrawal by Subject|0|||
127677448|NCT00246012|459442730|FG003|Overall Study|Withdrawal by Subject|0|||
127677449|NCT00246012|459442731|FG004|Overall Study|Withdrawal by Subject|0|||
127677450|NCT00246012|459442732|FG005|Overall Study|Withdrawal by Subject|1|||
127677451|NCT00246012|459442733|FG006|Overall Study|Withdrawal by Subject|0|||
127677452|NCT00246012|459442734|FG007|Overall Study|Withdrawal by Subject|0|||
127677453|NCT00246012|459442735|FG008|Overall Study|Withdrawal by Subject|0|||
127677454|NCT00246012|459442727|FG000|Overall Study|Disease progression|3|||
127677455|NCT00246012|459442728|FG001|Overall Study|Disease progression|1|||
127677456|NCT00246012|459442729|FG002|Overall Study|Disease progression|2|||
127677457|NCT00246012|459442730|FG003|Overall Study|Disease progression|3|||
128010982|NCT04006457|460667165|FG000|Main Study: Treatment Period 2|Other|2|||
127677458|NCT00246012|459442731|FG004|Overall Study|Disease progression|3|||
127677459|NCT00246012|459442732|FG005|Overall Study|Disease progression|25|||
127677460|NCT00246012|459442733|FG006|Overall Study|Disease progression|30|||
127677461|NCT00246012|459442734|FG007|Overall Study|Disease progression|27|||
127677462|NCT00246012|459442735|FG008|Overall Study|Disease progression|26|||
127764900|NCT03149549|459763569|FG007|Study Discontinuation--Treatment Period|Death|2|||
127764901|NCT03149549|459763570|FG008|Study Discontinuation--Treatment Period|Death|4|||
127764902|NCT03149549|459763571|FG009|Study Discontinuation--Treatment Period|Death|1|||
127764903|NCT03149549|459763572|FG010|Study Discontinuation--Treatment Period|Death|0|||
127764904|NCT03149549|459763573|FG011|Study Discontinuation--Treatment Period|Death|0|||
127764905|NCT03149549|459763574|FG012|Study Discontinuation--Treatment Period|Death|1|||
127764906|NCT03149549|459763562|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
127764907|NCT03149549|459763563|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
127764908|NCT03149549|459763564|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
128010983|NCT04006457|460667166|FG001|Main Study: Treatment Period 2|Other|3|||
128010984|NCT04006457|460667167|FG002|Main Study: Treatment Period 2|Other|0|||
128010985|NCT04006457|460667165|FG000|Main Study: Treatment Period 2|Approved Drug Available For Indication|179|||
128010986|NCT04006457|460667166|FG001|Main Study: Treatment Period 2|Approved Drug Available For Indication|222|||
128010987|NCT04006457|460667167|FG002|Main Study: Treatment Period 2|Approved Drug Available For Indication|0|||
128010988|NCT04006457|460667165|FG000|Main Study: Treatment Period 2|Ongoing|86|||
128010989|NCT04006457|460667166|FG001|Main Study: Treatment Period 2|Ongoing|96|||
128010990|NCT04006457|460667167|FG002|Main Study: Treatment Period 2|Ongoing|0|||
128010991|NCT04006457|460667165|FG000|Main Study Observation Period|Adverse Event|1|||
127764909|NCT03149549|459763565|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
127764910|NCT03149549|459763566|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
127764911|NCT03149549|459763567|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
127764912|NCT03149549|459763568|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
127764913|NCT03149549|459763569|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
127764914|NCT03149549|459763570|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
127764915|NCT03149549|459763571|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
127764916|NCT03149549|459763572|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
128010992|NCT04006457|460667166|FG001|Main Study Observation Period|Adverse Event|1|||
128010993|NCT04006457|460667167|FG002|Main Study Observation Period|Adverse Event|0|||
128010994|NCT04006457|460667165|FG000|Main Study Observation Period|Lost to Follow-up|0|||
128010995|NCT04006457|460667166|FG001|Main Study Observation Period|Lost to Follow-up|1|||
128010996|NCT04006457|460667167|FG002|Main Study Observation Period|Lost to Follow-up|0|||
128010997|NCT04006457|460667165|FG000|Main Study Observation Period|Pregnancy|1|||
128010998|NCT04006457|460667166|FG001|Main Study Observation Period|Pregnancy|0|||
128010999|NCT04006457|460667167|FG002|Main Study Observation Period|Pregnancy|0|||
128011000|NCT04006457|460667165|FG000|Main Study Observation Period|Withdrawal by Subject|10|||
128011001|NCT04006457|460667166|FG001|Main Study Observation Period|Withdrawal by Subject|14|||
128011002|NCT04006457|460667167|FG002|Main Study Observation Period|Withdrawal by Subject|0|||
128011003|NCT04006457|460667165|FG000|Main Study Observation Period|Other|8|||
128011004|NCT04006457|460667166|FG001|Main Study Observation Period|Other|16|||
128011005|NCT04006457|460667167|FG002|Main Study Observation Period|Other|0|||
128011006|NCT04006457|460667165|FG000|Main Study Observation Period|Approved Drug Available For Indication|6|||
128011007|NCT04006457|460667166|FG001|Main Study Observation Period|Approved Drug Available For Indication|9|||
128011008|NCT04006457|460667167|FG002|Main Study Observation Period|Approved Drug Available For Indication|0|||
128011009|NCT04006457|460667165|FG000|Main Study Observation Period|Ongoing|2|||
128011010|NCT04006457|460667166|FG001|Main Study Observation Period|Ongoing|1|||
128011011|NCT04006457|460667167|FG002|Main Study Observation Period|Ongoing|0|||
128011012|NCT04006457|460667165|FG000|Vaccine Sub Study|Withdrawal by Subject|0|||
128011013|NCT04006457|460667166|FG001|Vaccine Sub Study|Withdrawal by Subject|0|||
128011014|NCT04006457|460667167|FG002|Vaccine Sub Study|Withdrawal by Subject|1|||
128011015|NCT04486716|460667168|FG000|Core Phase|Subject decision|6|||
128011016|NCT04486716|460667168|FG000|Core Phase|Adverse Event|5|||
128011017|NCT04486716|460667168|FG000|Core Phase|Lost to Follow-up|1|||
128011018|NCT04486716|460667168|FG000|Core Phase|Physician Decision|1|||
128011019|NCT04486716|460667168|FG000|Core Phase|Enrolled subjects not treated|9|||
128011020|NCT02332707|460667169|FG000|Overall Study|Adverse Event|0|||
128011021|NCT02332707|460667170|FG001|Overall Study|Adverse Event|0|||
128011022|NCT02332707|460667171|FG002|Overall Study|Adverse Event|0|||
128011023|NCT02332707|460667172|FG003|Overall Study|Adverse Event|0|||
128011024|NCT02332707|460667173|FG004|Overall Study|Adverse Event|0|||
128011025|NCT02332707|460667174|FG005|Overall Study|Adverse Event|0|||
128011026|NCT02332707|460667175|FG006|Overall Study|Adverse Event|0|||
128011027|NCT02332707|460667176|FG007|Overall Study|Adverse Event|0|||
128011028|NCT02332707|460667177|FG008|Overall Study|Adverse Event|0|||
128011029|NCT02332707|460667178|FG009|Overall Study|Adverse Event|0|||
128011030|NCT02332707|460667179|FG010|Overall Study|Adverse Event|0|||
128011031|NCT02332707|460667180|FG011|Overall Study|Adverse Event|0|||
128011032|NCT02332707|460667181|FG012|Overall Study|Adverse Event|1|||
128011033|NCT02332707|460667182|FG013|Overall Study|Adverse Event|0|||
128011034|NCT02332707|460667183|FG014|Overall Study|Adverse Event|0|||
127764917|NCT03149549|459763573|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
127764918|NCT03149549|459763574|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
128011035|NCT02332707|460667184|FG015|Overall Study|Adverse Event|0|||
128011036|NCT02332707|460667185|FG016|Overall Study|Adverse Event|0|||
128011037|NCT02332707|460667186|FG017|Overall Study|Adverse Event|0|||
128011038|NCT02332707|460667169|FG000|Overall Study|Lost to Follow-up|0|||
128011039|NCT02332707|460667170|FG001|Overall Study|Lost to Follow-up|0|||
128011040|NCT02332707|460667171|FG002|Overall Study|Lost to Follow-up|0|||
128011041|NCT02332707|460667172|FG003|Overall Study|Lost to Follow-up|0|||
128011042|NCT02332707|460667173|FG004|Overall Study|Lost to Follow-up|0|||
128011043|NCT02332707|460667174|FG005|Overall Study|Lost to Follow-up|1|||
128011044|NCT02332707|460667175|FG006|Overall Study|Lost to Follow-up|0|||
128011045|NCT02332707|460667176|FG007|Overall Study|Lost to Follow-up|0|||
128011046|NCT02332707|460667177|FG008|Overall Study|Lost to Follow-up|0|||
128011047|NCT02332707|460667178|FG009|Overall Study|Lost to Follow-up|0|||
128011048|NCT02332707|460667179|FG010|Overall Study|Lost to Follow-up|2|||
128011049|NCT02332707|460667180|FG011|Overall Study|Lost to Follow-up|0|||
128011050|NCT02332707|460667181|FG012|Overall Study|Lost to Follow-up|3|||
128011051|NCT02332707|460667182|FG013|Overall Study|Lost to Follow-up|0|||
128011052|NCT02332707|460667183|FG014|Overall Study|Lost to Follow-up|0|||
128011053|NCT02332707|460667184|FG015|Overall Study|Lost to Follow-up|0|||
128011054|NCT02332707|460667185|FG016|Overall Study|Lost to Follow-up|0|||
128011055|NCT02332707|460667186|FG017|Overall Study|Lost to Follow-up|0|||
128011056|NCT02332707|460667169|FG000|Overall Study|Physician Decision|0|||
128011057|NCT02332707|460667170|FG001|Overall Study|Physician Decision|0|||
128011058|NCT02332707|460667171|FG002|Overall Study|Physician Decision|0|||
128011059|NCT02332707|460667172|FG003|Overall Study|Physician Decision|1|||
128011060|NCT02332707|460667173|FG004|Overall Study|Physician Decision|0|||
128011061|NCT02332707|460667174|FG005|Overall Study|Physician Decision|0|||
128011062|NCT02332707|460667175|FG006|Overall Study|Physician Decision|0|||
128011063|NCT02332707|460667176|FG007|Overall Study|Physician Decision|0|||
128011064|NCT02332707|460667177|FG008|Overall Study|Physician Decision|0|||
128011065|NCT02332707|460667178|FG009|Overall Study|Physician Decision|0|||
128011066|NCT02332707|460667179|FG010|Overall Study|Physician Decision|0|||
128011067|NCT02332707|460667180|FG011|Overall Study|Physician Decision|0|||
128011068|NCT02332707|460667181|FG012|Overall Study|Physician Decision|1|||
128011069|NCT02332707|460667182|FG013|Overall Study|Physician Decision|0|||
128011070|NCT02332707|460667183|FG014|Overall Study|Physician Decision|0|||
128011071|NCT02332707|460667184|FG015|Overall Study|Physician Decision|0|||
128011072|NCT02332707|460667185|FG016|Overall Study|Physician Decision|0|||
128011073|NCT02332707|460667186|FG017|Overall Study|Physician Decision|0|||
128011074|NCT02332707|460667169|FG000|Overall Study|Withdrawal by Subject|0|||
128011075|NCT02332707|460667170|FG001|Overall Study|Withdrawal by Subject|0|||
128011076|NCT02332707|460667171|FG002|Overall Study|Withdrawal by Subject|1|||
128011077|NCT02332707|460667172|FG003|Overall Study|Withdrawal by Subject|0|||
128011078|NCT02332707|460667173|FG004|Overall Study|Withdrawal by Subject|0|||
128011079|NCT02332707|460667174|FG005|Overall Study|Withdrawal by Subject|0|||
128011080|NCT02332707|460667175|FG006|Overall Study|Withdrawal by Subject|0|||
128011081|NCT02332707|460667176|FG007|Overall Study|Withdrawal by Subject|0|||
128011082|NCT02332707|460667177|FG008|Overall Study|Withdrawal by Subject|0|||
128011083|NCT02332707|460667178|FG009|Overall Study|Withdrawal by Subject|3|||
128011084|NCT02332707|460667179|FG010|Overall Study|Withdrawal by Subject|0|||
128011085|NCT02332707|460667180|FG011|Overall Study|Withdrawal by Subject|0|||
128011086|NCT02332707|460667181|FG012|Overall Study|Withdrawal by Subject|0|||
128011087|NCT02332707|460667182|FG013|Overall Study|Withdrawal by Subject|0|||
128011088|NCT02332707|460667183|FG014|Overall Study|Withdrawal by Subject|0|||
128011089|NCT02332707|460667184|FG015|Overall Study|Withdrawal by Subject|0|||
128011090|NCT02332707|460667185|FG016|Overall Study|Withdrawal by Subject|0|||
128011091|NCT02332707|460667186|FG017|Overall Study|Withdrawal by Subject|0|||
128011092|NCT00947544|460667193|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
128011093|NCT00947544|460667194|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
128011094|NCT02471183|460667198|FG000|Main Treatment Period|Adverse Event|1|||
128011095|NCT02471183|460667198|FG000|Main Treatment Period|Withdrawal by Subject|1|||
128011096|NCT02471183|460667198|FG000|Extended Treatment Period|Lack of Efficacy|1|||
128011097|NCT01983930|460667199|FG000|Overall Study|Withdrawal by Subject|9|||
128011098|NCT01983930|460667200|FG001|Overall Study|Withdrawal by Subject|8|||
128011099|NCT01983930|460667199|FG000|Overall Study|Adverse Event|0|||
128011100|NCT01983930|460667200|FG001|Overall Study|Adverse Event|1|||
127677463|NCT00246012|459442727|FG000|Overall Study|Other|0|||
127677464|NCT00246012|459442728|FG001|Overall Study|Other|0|||
127677465|NCT00246012|459442729|FG002|Overall Study|Other|0|||
128011101|NCT00141921|460667202|FG000|Overall Study|Remain on Study|28|||
128011102|NCT00141921|460667202|FG000|Overall Study|Withdrawal by Subject|42|||
127677466|NCT00246012|459442730|FG003|Overall Study|Other|0|||
128011103|NCT00141921|460667202|FG000|Overall Study|Lost to Follow-up|19|||
127677467|NCT00246012|459442731|FG004|Overall Study|Other|0|||
128011104|NCT00141921|460667202|FG000|Overall Study|Noncompliance|17|||
128011105|NCT00141921|460667202|FG000|Overall Study|Disease Progression|7|||
128011106|NCT00141921|460667202|FG000|Overall Study|Protocol Deviation|7|||
128011107|NCT00141921|460667202|FG000|Overall Study|Adverse Event|5|||
128011108|NCT00141921|460667202|FG000|Overall Study|Administrative Decision|2|||
128011109|NCT00141921|460667202|FG000|Overall Study|Pregnancy|4|||
128011110|NCT00141921|460667202|FG000|Overall Study|Ineligibility Determined|2|||
128011111|NCT00141921|460667202|FG000|Overall Study|Other|8|||
128011112|NCT02471339|460667204|FG000|Overall Study|Did not provide follow-up data|2|||
128011113|NCT02471339|460667205|FG001|Overall Study|Did not provide follow-up data|0|||
128011114|NCT00626639|460667213|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
128011115|NCT00626639|460667214|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
128011116|NCT00827567|460667215|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
128011117|NCT01461551|460667216|FG000|Overall Study|Physician Decision|2|||
128011118|NCT01461551|460667217|FG001|Overall Study|Physician Decision|1|||
128011119|NCT01461551|460667218|FG002|Overall Study|Physician Decision|2|||
128011120|NCT01155141|460667219|FG000|Overall Study|Withdrawal by Subject|1|||
128011121|NCT01155141|460667219|FG000|Overall Study|Screen Failure|1|||
128011122|NCT00303186|460667221|FG000|Overall Study|Other|52|||
128011123|NCT03473197|460667222|FG000|Overall Study|Adverse Event|4|||
128011124|NCT03473197|460667222|FG000|Overall Study|Lost to Follow-up|1|||
128011125|NCT03473197|460667222|FG000|Overall Study|Withdrawal by Subject|5|||
128011126|NCT02326883|460667225|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
128011127|NCT02326883|460667226|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
128011128|NCT02326883|460667227|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
128011129|NCT02736617|460667228|FG000|Treatment|Adverse Event|1|||
128011130|NCT02736617|460667228|FG000|Treatment|Lack of Efficacy|1|||
128011131|NCT02736617|460667228|FG000|Treatment|Withdrawal by Subject|1|||
128011132|NCT02736617|460667228|FG000|Maintenance|Lack of Efficacy|4|||
128011133|NCT02736617|460667228|FG000|Maintenance|Physician Decision|1|||
128011134|NCT02911116|460667233|FG000|Overall Study|Insufficient Therapeutic Response|1|||
128011135|NCT02911116|460667234|FG001|Overall Study|Insufficient Therapeutic Response|0|||
128011136|NCT02911116|460667233|FG000|Overall Study|Lost to Follow-up|0|||
128011137|NCT02911116|460667234|FG001|Overall Study|Lost to Follow-up|1|||
128011138|NCT04810962|460667235|FG000|Overall Study|Adverse Event|0|||
128011139|NCT04810962|460667236|FG001|Overall Study|Adverse Event|1|||
128011140|NCT04810962|460667235|FG000|Overall Study|Lost to Follow-up|2|||
128011141|NCT04810962|460667236|FG001|Overall Study|Lost to Follow-up|1|||
128011142|NCT04810962|460667235|FG000|Overall Study|Physician Decision|1|||
128011143|NCT04810962|460667236|FG001|Overall Study|Physician Decision|0|||
128011144|NCT04810962|460667235|FG000|Overall Study|Withdrawal by Subject|1|||
128011145|NCT04810962|460667236|FG001|Overall Study|Withdrawal by Subject|3|||
128011146|NCT04810962|460667235|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
128011147|NCT04810962|460667236|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
128011148|NCT00630292|460667237|FG000|Overall Study|Withdrawal by Subject|1|||
128011149|NCT00142415|460667238|FG000|Overall Study|Physician Decision|0|||
128011150|NCT00142415|460667239|FG001|Overall Study|Physician Decision|0|||
128011151|NCT00142415|460667240|FG002|Overall Study|Physician Decision|0|||
128011152|NCT00142415|460667241|FG003|Overall Study|Physician Decision|0|||
128011153|NCT00142415|460667242|FG004|Overall Study|Physician Decision|1|||
128011154|NCT00142415|460667243|FG005|Overall Study|Physician Decision|2|||
128011155|NCT01189266|460667244|FG000|Overall Study|Adverse Event|1|||
128011156|NCT01189266|460667245|FG001|Overall Study|Adverse Event|0|||
128011157|NCT01189266|460667246|FG002|Overall Study|Adverse Event|5|||
128011158|NCT01189266|460667244|FG000|Overall Study|Death|0|||
128011159|NCT01189266|460667245|FG001|Overall Study|Death|0|||
128011160|NCT01189266|460667246|FG002|Overall Study|Death|5|||
128011161|NCT01189266|460667244|FG000|Overall Study|Lack of Efficacy|4|||
128011162|NCT01189266|460667245|FG001|Overall Study|Lack of Efficacy|5|||
128011163|NCT01189266|460667246|FG002|Overall Study|Lack of Efficacy|44|||
128011164|NCT01189266|460667244|FG000|Overall Study|Physician Decision|0|||
128011165|NCT01189266|460667245|FG001|Overall Study|Physician Decision|0|||
128011166|NCT01189266|460667246|FG002|Overall Study|Physician Decision|1|||
128011167|NCT01189266|460667244|FG000|Overall Study|Protocol Violation|0|||
128011168|NCT01189266|460667245|FG001|Overall Study|Protocol Violation|1|||
128011169|NCT01189266|460667246|FG002|Overall Study|Protocol Violation|1|||
128011170|NCT01189266|460667244|FG000|Overall Study|Withdrawal by Subject|0|||
128011171|NCT01189266|460667245|FG001|Overall Study|Withdrawal by Subject|0|||
128011172|NCT01189266|460667246|FG002|Overall Study|Withdrawal by Subject|1|||
128011173|NCT01189266|460667244|FG000|Overall Study|Patient refuses further therapy|1|||
128011174|NCT01189266|460667245|FG001|Overall Study|Patient refuses further therapy|0|||
128011175|NCT01189266|460667246|FG002|Overall Study|Patient refuses further therapy|7|||
128011176|NCT01189266|460667244|FG000|Overall Study|No treatment|0|||
128011177|NCT01189266|460667245|FG001|Overall Study|No treatment|0|||
128011178|NCT01189266|460667246|FG002|Overall Study|No treatment|1|||
128011179|NCT03620162|460667247|FG000|Overall Study|Physician Decision|4|||
128011180|NCT03620162|460667248|FG001|Overall Study|Physician Decision|0|||
128011181|NCT03620162|460667249|FG002|Overall Study|Physician Decision|1|||
128011182|NCT03620162|460667250|FG003|Overall Study|Physician Decision|0|||
128011183|NCT03620162|460667251|FG004|Overall Study|Physician Decision|2|||
127764919|NCT03149549|459763562|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
127764920|NCT03149549|459763563|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
127764921|NCT03149549|459763564|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
127764922|NCT03149549|459763565|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
127764923|NCT03149549|459763566|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
127764924|NCT03149549|459763567|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
127764925|NCT03149549|459763568|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
127764926|NCT03149549|459763569|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
127764927|NCT03149549|459763570|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
127764928|NCT03149549|459763571|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
127764929|NCT03149549|459763572|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
127764930|NCT03149549|459763573|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
127764931|NCT03149549|459763574|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
127764932|NCT03149549|459763562|FG000|Study Discontinuation--Treatment Period|Other|0|||
127764933|NCT03149549|459763563|FG001|Study Discontinuation--Treatment Period|Other|0|||
128011184|NCT03620162|460667247|FG000|Overall Study|Lost to Follow-up|2|||
128011185|NCT03620162|460667248|FG001|Overall Study|Lost to Follow-up|6|||
128011186|NCT03620162|460667249|FG002|Overall Study|Lost to Follow-up|7|||
127543589|NCT01668784|458956565|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
127543590|NCT01668784|458956566|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
128011187|NCT03620162|460667250|FG003|Overall Study|Lost to Follow-up|3|||
128011188|NCT03620162|460667251|FG004|Overall Study|Lost to Follow-up|2|||
128011189|NCT03620162|460667247|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
128011190|NCT03620162|460667248|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
128011191|NCT03620162|460667249|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
127543591|NCT01668784|458956565|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
127543592|NCT01668784|458956566|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
127543593|NCT01668784|458956565|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
127543594|NCT01668784|458956566|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
128011192|NCT03620162|460667250|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
128011193|NCT03620162|460667251|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
128011194|NCT03416179|460667254|FG000|Overall Study|Death|90|||
128011195|NCT03416179|460667255|FG001|Overall Study|Death|87|||
128011196|NCT03416179|460667256|FG002|Overall Study|Death|117|||
128011197|NCT03416179|460667257|FG003|Overall Study|Death|113|||
128011198|NCT03416179|460667254|FG000|Overall Study|Withdrawal by Subject|15|||
128011199|NCT03416179|460667255|FG001|Overall Study|Withdrawal by Subject|20|||
128011200|NCT03416179|460667256|FG002|Overall Study|Withdrawal by Subject|6|||
128011201|NCT03416179|460667257|FG003|Overall Study|Withdrawal by Subject|9|||
128011202|NCT03416179|460667254|FG000|Overall Study|Lost to Follow-up|1|||
128011203|NCT03416179|460667255|FG001|Overall Study|Lost to Follow-up|1|||
128011204|NCT03416179|460667256|FG002|Overall Study|Lost to Follow-up|0|||
128011205|NCT03416179|460667257|FG003|Overall Study|Lost to Follow-up|3|||
128011206|NCT03416179|460667254|FG000|Overall Study|Study participation terminated by Sponsor|93|||
128011207|NCT03416179|460667255|FG001|Overall Study|Study participation terminated by Sponsor|91|||
128011208|NCT03416179|460667256|FG002|Overall Study|Study participation terminated by Sponsor|26|||
128011209|NCT03416179|460667257|FG003|Overall Study|Study participation terminated by Sponsor|31|||
128011210|NCT03416179|460667254|FG000|Overall Study|Other|2|||
128011211|NCT03416179|460667255|FG001|Overall Study|Other|3|||
128011212|NCT03416179|460667256|FG002|Overall Study|Other|1|||
128011213|NCT03416179|460667257|FG003|Overall Study|Other|0|||
128011214|NCT01682031|460667260|FG000|Overall Study|Withdrawal by Subject|0|||
128011215|NCT01682031|460667261|FG001|Overall Study|Withdrawal by Subject|1|||
128011216|NCT01682031|460667260|FG000|Overall Study|Adverse Event|0|||
128011217|NCT01682031|460667261|FG001|Overall Study|Adverse Event|2|||
128011218|NCT01682031|460667260|FG000|Overall Study|MRI results indicate increased nodul|0|||
128011219|NCT01682031|460667261|FG001|Overall Study|MRI results indicate increased nodul|1|||
128011220|NCT01682031|460667260|FG000|Overall Study|Patient could not swallow tablets|1|||
128011221|NCT01682031|460667261|FG001|Overall Study|Patient could not swallow tablets|0|||
128011222|NCT01682031|460667260|FG000|Overall Study|Patient stopped selenium on his own|0|||
128011223|NCT01682031|460667261|FG001|Overall Study|Patient stopped selenium on his own|1|||
128011224|NCT01056536|460667263|FG000|Overall Study|Lost to Follow-up|202|||
127543595|NCT01668784|458956565|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
127543596|NCT01668784|458956566|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
127543597|NCT01668784|458956565|FG000|Treatment Period|Disease Progression|316|||
128011225|NCT01056536|460667264|FG001|Overall Study|Lost to Follow-up|116|||
128011226|NCT01056536|460667265|FG002|Overall Study|Lost to Follow-up|248|||
128011227|NCT03805841|460667266|FG000|Overall Study|Clinical Progression|2|||
128011228|NCT03805841|460667267|FG001|Overall Study|Clinical Progression|0|||
128011229|NCT03805841|460667268|FG002|Overall Study|Clinical Progression|0|||
128011230|NCT03805841|460667266|FG000|Overall Study|Death|0|||
127543598|NCT01668784|458956566|FG001|Treatment Period|Disease Progression|293|||
127543599|NCT01668784|458956565|FG000|Treatment Period|Study Drug Toxicity|46|||
127543600|NCT01668784|458956566|FG001|Treatment Period|Study Drug Toxicity|53|||
127543601|NCT01668784|458956565|FG000|Treatment Period|Death|1|||
127543602|NCT01668784|458956566|FG001|Treatment Period|Death|1|||
127543603|NCT01668784|458956565|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
127543604|NCT01668784|458956566|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
127543605|NCT01668784|458956565|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
127543606|NCT01668784|458956566|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
127543607|NCT01668784|458956565|FG000|Treatment Period|Withdrawal by Subject|5|||
127543608|NCT01668784|458956566|FG001|Treatment Period|Withdrawal by Subject|3|||
127543609|NCT01668784|458956565|FG000|Treatment Period|Maximal Clinical Benefit|3|||
127543610|NCT01668784|458956566|FG001|Treatment Period|Maximal Clinical Benefit|3|||
127543611|NCT01668784|458956565|FG000|Treatment Period|Other|2|||
127543612|NCT01668784|458956566|FG001|Treatment Period|Other|8|||
127543613|NCT01668784|458956565|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
127543614|NCT01668784|458956566|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
127543615|NCT02783690|458956572|FG000|Overall Study|Withdrawal by Subject|3|||
127543616|NCT02783690|458956573|FG001|Overall Study|Withdrawal by Subject|3|||
127543617|NCT05138653|458956579|FG000|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|1|||
127543618|NCT05138653|458956580|FG001|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
127543619|NCT05138653|458956581|FG002|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
127543620|NCT05138653|458956582|FG003|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
127543621|NCT05138653|458956583|FG004|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
127543622|NCT05138653|458956584|FG005|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
127543623|NCT05138653|458956585|FG006|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
127543624|NCT05138653|458956586|FG007|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
127543625|NCT05138653|458956587|FG008|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
127543626|NCT05138653|458956588|FG009|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
127543627|NCT05138653|458956589|FG010|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
127543628|NCT05138653|458956590|FG011|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
127543629|NCT05138653|458956591|FG012|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
127543630|NCT05138653|458956592|FG013|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
127543631|NCT05138653|458956593|FG014|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
127543632|NCT05138653|458956594|FG015|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
127543633|NCT05138653|458956579|FG000|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
128011231|NCT03805841|460667267|FG001|Overall Study|Death|3|||
128011232|NCT03805841|460667268|FG002|Overall Study|Death|1|||
128011233|NCT03805841|460667266|FG000|Overall Study|Lost to Follow-up|0|||
128011234|NCT03805841|460667267|FG001|Overall Study|Lost to Follow-up|0|||
128011235|NCT03805841|460667268|FG002|Overall Study|Lost to Follow-up|1|||
128011236|NCT03805841|460667266|FG000|Overall Study|Withdrawal by Subject|2|||
128011237|NCT03805841|460667267|FG001|Overall Study|Withdrawal by Subject|3|||
128011238|NCT03805841|460667268|FG002|Overall Study|Withdrawal by Subject|0|||
127543634|NCT05138653|458956580|FG001|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
127543635|NCT05138653|458956581|FG002|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
127543636|NCT05138653|458956582|FG003|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
127543637|NCT05138653|458956583|FG004|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
127543638|NCT05138653|458956584|FG005|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
127543639|NCT05138653|458956585|FG006|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
127543640|NCT05138653|458956586|FG007|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
127543641|NCT05138653|458956587|FG008|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
127543642|NCT05138653|458956588|FG009|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
127543643|NCT05138653|458956589|FG010|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
127543644|NCT05138653|458956590|FG011|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
128011239|NCT03805841|460667266|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
128011240|NCT03805841|460667267|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
128011241|NCT03805841|460667268|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
128011242|NCT02164916|460667269|FG000|Overall Study|Adverse Event|3|||
128011243|NCT02164916|460667270|FG001|Overall Study|Adverse Event|8|||
128011244|NCT02164916|460667269|FG000|Overall Study|Death|1|||
128011245|NCT02164916|460667270|FG001|Overall Study|Death|1|||
128011246|NCT02164916|460667269|FG000|Overall Study|Refusal unrelated to adverse event|3|||
127543645|NCT05138653|458956591|FG012|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
128011247|NCT02164916|460667270|FG001|Overall Study|Refusal unrelated to adverse event|7|||
128011248|NCT02164916|460667269|FG000|Overall Study|Progression|37|||
127543646|NCT05138653|458956592|FG013|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
127543647|NCT05138653|458956593|FG014|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
127677468|NCT00246012|459442732|FG005|Overall Study|Other|0|||
127543648|NCT05138653|458956594|FG015|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
127543649|NCT05138653|458956579|FG000|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
127543650|NCT05138653|458956580|FG001|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
127543651|NCT05138653|458956581|FG002|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
127543652|NCT05138653|458956582|FG003|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
127543653|NCT05138653|458956583|FG004|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
127543654|NCT05138653|458956584|FG005|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
127543655|NCT05138653|458956585|FG006|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
127543656|NCT05138653|458956586|FG007|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
127543657|NCT05138653|458956587|FG008|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
127543658|NCT05138653|458956588|FG009|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
127543659|NCT05138653|458956589|FG010|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
127543660|NCT05138653|458956590|FG011|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
127543661|NCT05138653|458956591|FG012|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
127543662|NCT05138653|458956592|FG013|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
127543663|NCT05138653|458956593|FG014|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
127543664|NCT05138653|458956594|FG015|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
127543665|NCT05138653|458956579|FG000|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
127543666|NCT05138653|458956580|FG001|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
127543667|NCT05138653|458956581|FG002|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
127543668|NCT05138653|458956582|FG003|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
127543669|NCT05138653|458956583|FG004|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
127543670|NCT05138653|458956584|FG005|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
127543671|NCT05138653|458956585|FG006|Single Ascending Dose (Up to 13 Weeks)|Other|1|||
127543672|NCT05138653|458956586|FG007|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
127543673|NCT05138653|458956587|FG008|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
127543674|NCT05138653|458956588|FG009|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
127543675|NCT05138653|458956589|FG010|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
127543676|NCT05138653|458956590|FG011|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
127543677|NCT05138653|458956591|FG012|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
127543678|NCT05138653|458956592|FG013|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
127543679|NCT05138653|458956593|FG014|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
127543680|NCT05138653|458956594|FG015|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
127543681|NCT05138653|458956579|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
127543682|NCT05138653|458956580|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
127543683|NCT05138653|458956581|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
127543684|NCT05138653|458956582|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
127543685|NCT05138653|458956583|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
127543686|NCT05138653|458956584|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
127543687|NCT05138653|458956585|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
127543688|NCT05138653|458956586|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
127543689|NCT05138653|458956587|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
127543690|NCT05138653|458956588|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
127543691|NCT05138653|458956589|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
127543692|NCT05138653|458956590|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
127543693|NCT05138653|458956591|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
127543694|NCT05138653|458956592|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
127543695|NCT05138653|458956593|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
127543696|NCT05138653|458956594|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
127543697|NCT05138653|458956579|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
127543698|NCT05138653|458956580|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
127543699|NCT05138653|458956581|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
127543700|NCT05138653|458956582|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
127543701|NCT05138653|458956583|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
127543702|NCT05138653|458956584|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
127543703|NCT05138653|458956585|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
128011249|NCT02164916|460667270|FG001|Overall Study|Progression|26|||
128011250|NCT02164916|460667269|FG000|Overall Study|Not protocol specified|5|||
128011251|NCT02164916|460667270|FG001|Overall Study|Not protocol specified|1|||
128011252|NCT02164916|460667269|FG000|Overall Study|Reason under review|1|||
128011253|NCT02164916|460667270|FG001|Overall Study|Reason under review|6|||
128011254|NCT02164916|460667269|FG000|Overall Study|Not eligible|2|||
128011255|NCT02164916|460667270|FG001|Overall Study|Not eligible|5|||
128011256|NCT00596635|460667273|FG000|Overall Study|Lost to Follow-up|0|||
128011257|NCT00596635|460667274|FG001|Overall Study|Lost to Follow-up|2|||
128011258|NCT00596635|460667275|FG002|Overall Study|Lost to Follow-up|0|||
128011259|NCT00596635|460667273|FG000|Overall Study|Treatment for symptomatic UTI|4|||
128011260|NCT00596635|460667274|FG001|Overall Study|Treatment for symptomatic UTI|6|||
128011261|NCT00596635|460667275|FG002|Overall Study|Treatment for symptomatic UTI|3|||
128011262|NCT00596635|460667273|FG000|Overall Study|Hip fracture|2|||
128011263|NCT00596635|460667274|FG001|Overall Study|Hip fracture|3|||
128011264|NCT00596635|460667275|FG002|Overall Study|Hip fracture|3|||
128011265|NCT00596635|460667273|FG000|Overall Study|Could not provide urine specimen|1|||
128011266|NCT00596635|460667274|FG001|Overall Study|Could not provide urine specimen|2|||
128011267|NCT00596635|460667275|FG002|Overall Study|Could not provide urine specimen|2|||
128011268|NCT01101178|460667279|FG000|Period 1|Withdrawal by Subject|1|||
128011269|NCT01101178|460667280|FG001|Period 1|Withdrawal by Subject|2|||
128011270|NCT01101178|460667279|FG000|Period 1|Positive drug screen|1|||
128011271|NCT01101178|460667280|FG001|Period 1|Positive drug screen|1|||
128011272|NCT01101178|460667279|FG000|Period 1|Adverse Event|2|||
128011273|NCT01101178|460667280|FG001|Period 1|Adverse Event|1|||
128011274|NCT01101178|460667279|FG000|Period 2|Withdrawal by Subject|0|||
128011275|NCT01101178|460667280|FG001|Period 2|Withdrawal by Subject|1|||
128011276|NCT01850641|460667281|FG000|Overall Study|Physician Decision|1|||
128011277|NCT01850641|460667281|FG000|Overall Study|Decrease in serum phosphorus|1|||
128011278|NCT01850641|460667281|FG000|Overall Study|Decrease in serum calcium|2|||
128011279|NCT01850641|460667281|FG000|Overall Study|Increase in serum ferritin|1|||
128011280|NCT00141817|460667282|FG000|Overall Study|Protocol Violation|0|||
128011281|NCT00141817|460667283|FG001|Overall Study|Protocol Violation|0|||
128011282|NCT00141817|460667284|FG002|Overall Study|Protocol Violation|1|||
128011283|NCT00141817|460667285|FG003|Overall Study|Protocol Violation|0|||
128011284|NCT00141817|460667282|FG000|Overall Study|Parent request|1|||
128011285|NCT00141817|460667283|FG001|Overall Study|Parent request|0|||
128011286|NCT00141817|460667284|FG002|Overall Study|Parent request|0|||
128011287|NCT00141817|460667285|FG003|Overall Study|Parent request|0|||
128011288|NCT00127803|460667288|FG000|Overall Study|Adverse Event|2|||
128011289|NCT00127803|460667289|FG001|Overall Study|Adverse Event|0|||
128011290|NCT00127803|460667290|FG002|Overall Study|Adverse Event|0|||
128011291|NCT00127803|460667291|FG003|Overall Study|Adverse Event|0|||
128011292|NCT00127803|460667288|FG000|Overall Study|Withdrawal by Subject|1|||
128011293|NCT00127803|460667289|FG001|Overall Study|Withdrawal by Subject|0|||
128011294|NCT00127803|460667290|FG002|Overall Study|Withdrawal by Subject|0|||
128011295|NCT00127803|460667291|FG003|Overall Study|Withdrawal by Subject|0|||
128011296|NCT00127803|460667288|FG000|Overall Study|Lost to Follow-up|0|||
128011297|NCT00127803|460667289|FG001|Overall Study|Lost to Follow-up|0|||
128011298|NCT00127803|460667290|FG002|Overall Study|Lost to Follow-up|0|||
128011299|NCT00127803|460667291|FG003|Overall Study|Lost to Follow-up|1|||
128011300|NCT00846365|460667296|FG000|Overall Study|Adverse Event|20|||
128011301|NCT00846365|460667297|FG001|Overall Study|Adverse Event|30|||
128011302|NCT00846365|460667298|FG002|Overall Study|Adverse Event|11|||
128011303|NCT00846365|460667296|FG000|Overall Study|Protocol Violation|5|||
128011304|NCT00846365|460667297|FG001|Overall Study|Protocol Violation|4|||
128011305|NCT00846365|460667298|FG002|Overall Study|Protocol Violation|0|||
128011306|NCT00846365|460667296|FG000|Overall Study|Lost to Follow-up|8|||
128011307|NCT00846365|460667297|FG001|Overall Study|Lost to Follow-up|2|||
128011308|NCT00846365|460667298|FG002|Overall Study|Lost to Follow-up|5|||
128011309|NCT00846365|460667296|FG000|Overall Study|Withdrawal by Subject|11|||
128011310|NCT00846365|460667297|FG001|Overall Study|Withdrawal by Subject|11|||
128011311|NCT00846365|460667298|FG002|Overall Study|Withdrawal by Subject|9|||
128011312|NCT00846365|460667296|FG000|Overall Study|Pregnancy|1|||
128011313|NCT00846365|460667297|FG001|Overall Study|Pregnancy|0|||
128011314|NCT00846365|460667298|FG002|Overall Study|Pregnancy|0|||
128011315|NCT00846365|460667296|FG000|Overall Study|Lack of Efficacy|1|||
128011316|NCT00846365|460667297|FG001|Overall Study|Lack of Efficacy|1|||
127677469|NCT00246012|459442733|FG006|Overall Study|Other|0|||
127677470|NCT00246012|459442734|FG007|Overall Study|Other|1|||
127677471|NCT00246012|459442735|FG008|Overall Study|Other|0|||
127677472|NCT00246012|459442727|FG000|Overall Study|Randomly assigned but not treated|0|||
127677473|NCT00246012|459442728|FG001|Overall Study|Randomly assigned but not treated|0|||
127677474|NCT00246012|459442729|FG002|Overall Study|Randomly assigned but not treated|0|||
127677475|NCT00246012|459442730|FG003|Overall Study|Randomly assigned but not treated|0|||
127677476|NCT00246012|459442731|FG004|Overall Study|Randomly assigned but not treated|0|||
128011317|NCT00846365|460667298|FG002|Overall Study|Lack of Efficacy|2|||
128011318|NCT00846365|460667296|FG000|Overall Study|Other|9|||
128011319|NCT00846365|460667297|FG001|Overall Study|Other|1|||
128011320|NCT00846365|460667298|FG002|Overall Study|Other|6|||
128011321|NCT01925417|460667299|FG000|Overall Study|Withdrawal by Subject|2|||
127677477|NCT00246012|459442732|FG005|Overall Study|Randomly assigned but not treated|1|||
127677478|NCT00246012|459442733|FG006|Overall Study|Randomly assigned but not treated|1|||
128011322|NCT01925417|460667299|FG000|Overall Study|Death|1|||
128011323|NCT03479905|460667300|FG000|Overall Study|Other airway method used|4|||
128011324|NCT03479905|460667301|FG001|Overall Study|Other airway method used|5|||
128011325|NCT03479905|460667302|FG002|Overall Study|Other airway method used|5|||
128011326|NCT00720759|460667303|FG000|Overall Study|Lost to Follow-up|0|||
128011327|NCT00720759|460667304|FG001|Overall Study|Lost to Follow-up|1|||
128011328|NCT00720759|460667305|FG002|Overall Study|Lost to Follow-up|1|||
127543704|NCT05138653|458956586|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
127543705|NCT05138653|458956587|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
127543706|NCT05138653|458956588|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
127543707|NCT05138653|458956589|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
127543708|NCT05138653|458956590|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
127543709|NCT05138653|458956591|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
127543710|NCT05138653|458956592|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
127764934|NCT03149549|459763564|FG002|Study Discontinuation--Treatment Period|Other|0|||
127764935|NCT03149549|459763565|FG003|Study Discontinuation--Treatment Period|Other|0|||
127764936|NCT03149549|459763566|FG004|Study Discontinuation--Treatment Period|Other|0|||
127764937|NCT03149549|459763567|FG005|Study Discontinuation--Treatment Period|Other|0|||
127764938|NCT03149549|459763568|FG006|Study Discontinuation--Treatment Period|Other|0|||
127764939|NCT03149549|459763569|FG007|Study Discontinuation--Treatment Period|Other|1|||
127764940|NCT03149549|459763570|FG008|Study Discontinuation--Treatment Period|Other|0|||
127764941|NCT03149549|459763571|FG009|Study Discontinuation--Treatment Period|Other|1|||
127543711|NCT05138653|458956593|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
127543712|NCT05138653|458956594|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|1|||
127677479|NCT00246012|459442734|FG007|Overall Study|Randomly assigned but not treated|0|||
127677480|NCT00246012|459442735|FG008|Overall Study|Randomly assigned but not treated|0|||
127764942|NCT03149549|459763572|FG010|Study Discontinuation--Treatment Period|Other|0|||
127764943|NCT03149549|459763573|FG011|Study Discontinuation--Treatment Period|Other|0|||
127764944|NCT03149549|459763574|FG012|Study Discontinuation--Treatment Period|Other|0|||
127764945|NCT03149549|459763562|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
127764946|NCT03149549|459763563|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
127764947|NCT03149549|459763564|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
127764948|NCT03149549|459763565|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
128011329|NCT00720759|460667306|FG003|Overall Study|Lost to Follow-up|0|||
128011330|NCT02318940|460667307|FG000|Overall Study|lost the record|1|||
128011331|NCT02318940|460667308|FG001|Overall Study|lost the record|0|||
128011332|NCT01047319|460667309|FG000|Overall Study|Teva requested participant withdrawal|3|||
127677481|NCT01178762|459442736|FG000|Overall Study|Lost to Follow-up|15|||
127677482|NCT02322216|459442737|FG000|Overall Study|Adverse Event|1|||
127677483|NCT02322216|459442738|FG001|Overall Study|Adverse Event|0|||
127677484|NCT02322216|459442737|FG000|Overall Study|Withdrawal by Subject|1|||
127677485|NCT02322216|459442738|FG001|Overall Study|Withdrawal by Subject|4|||
127677486|NCT01651949|459442739|FG000|Overall Study|Unknown status|4|||
127677487|NCT01651949|459442740|FG001|Overall Study|Unknown status|4|||
127677488|NCT01651949|459442741|FG002|Overall Study|Unknown status|0|||
127677489|NCT01651949|459442739|FG000|Overall Study|Lost to Follow-up|30|||
127677490|NCT01651949|459442740|FG001|Overall Study|Lost to Follow-up|56|||
127677491|NCT01651949|459442741|FG002|Overall Study|Lost to Follow-up|20|||
127677492|NCT01651949|459442739|FG000|Overall Study|Protocol Violation|0|||
127677493|NCT01651949|459442740|FG001|Overall Study|Protocol Violation|2|||
127677494|NCT01651949|459442741|FG002|Overall Study|Protocol Violation|1|||
127677495|NCT01651949|459442739|FG000|Overall Study|Physician Decision|0|||
127677496|NCT01651949|459442740|FG001|Overall Study|Physician Decision|2|||
127677497|NCT01651949|459442741|FG002|Overall Study|Physician Decision|0|||
127677498|NCT01651949|459442739|FG000|Overall Study|Adverse Event|0|||
127677499|NCT01651949|459442740|FG001|Overall Study|Adverse Event|2|||
127677500|NCT01651949|459442741|FG002|Overall Study|Adverse Event|1|||
127677501|NCT01651949|459442739|FG000|Overall Study|Screen failure|2|||
127677502|NCT01651949|459442740|FG001|Overall Study|Screen failure|2|||
127677503|NCT01651949|459442741|FG002|Overall Study|Screen failure|0|||
127677504|NCT01651949|459442739|FG000|Overall Study|Withdrawal by Subject|17|||
127677505|NCT01651949|459442740|FG001|Overall Study|Withdrawal by Subject|18|||
127677506|NCT01651949|459442741|FG002|Overall Study|Withdrawal by Subject|9|||
127677507|NCT01806714|459442742|FG000|Overall Study|No functioning phone number|200|||
127677508|NCT01806714|459442743|FG001|Overall Study|No functioning phone number|170|||
127677509|NCT01585038|459442744|FG000|Overall Study|Adverse Event|2|||
127677510|NCT01585038|459442745|FG001|Overall Study|Adverse Event|2|||
127677511|NCT04107805|459442746|FG000|Overall Study|Adverse Event|0|||
127677512|NCT04107805|459442747|FG001|Overall Study|Adverse Event|0|||
127677513|NCT04107805|459442748|FG002|Overall Study|Adverse Event|0|||
127677514|NCT04107805|459442749|FG003|Overall Study|Adverse Event|1|||
127677515|NCT04107805|459442750|FG004|Overall Study|Adverse Event|0|||
127677516|NCT04107805|459442751|FG005|Overall Study|Adverse Event|1|||
127677517|NCT04107805|459442752|FG006|Overall Study|Adverse Event|0|||
127677518|NCT04107805|459442753|FG007|Overall Study|Adverse Event|0|||
127677519|NCT04107805|459442754|FG008|Overall Study|Adverse Event|1|||
127677520|NCT00853827|459442760|FG000|Single Blind Period (1 Week)|Other|4|||
127764949|NCT03149549|459763566|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
127764950|NCT03149549|459763567|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
127677521|NCT00853827|459442761|FG001|Single Blind Period (1 Week)|Other|0|||
128011333|NCT01047319|460667310|FG001|Overall Study|Teva requested participant withdrawal|0|||
128011334|NCT01047319|460667311|FG002|Overall Study|Teva requested participant withdrawal|1|||
128011335|NCT01047319|460667309|FG000|Overall Study|Protocol Violation|3|||
128011336|NCT01047319|460667310|FG001|Overall Study|Protocol Violation|2|||
127677522|NCT00853827|459442760|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
127677523|NCT00853827|459442761|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
127677524|NCT00853827|459442760|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
127677525|NCT00853827|459442761|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
127677526|NCT00853827|459442760|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
127677527|NCT00853827|459442761|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
127677528|NCT00853827|459442760|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
127677529|NCT00853827|459442761|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
127677530|NCT00853827|459442760|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
127677531|NCT00853827|459442761|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
127677532|NCT00853827|459442760|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
127677533|NCT00853827|459442761|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
127677534|NCT00853827|459442760|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
127677535|NCT00853827|459442761|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
127677536|NCT00853827|459442760|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
127677537|NCT00853827|459442761|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
127677538|NCT00853827|459442760|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
127677539|NCT00853827|459442761|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
127677540|NCT00853827|459442760|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
127677541|NCT00853827|459442761|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
127677542|NCT00853827|459442760|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
127677543|NCT00853827|459442761|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
127677544|NCT00853827|459442760|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
127677545|NCT00853827|459442761|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
127677546|NCT00853827|459442760|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
127677547|NCT00853827|459442761|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
127677548|NCT00853827|459442760|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
127677549|NCT00853827|459442761|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
127677550|NCT00853827|459442760|FG000|Double Blind Period (103 Weeks)|Death|1|||
127677551|NCT00853827|459442761|FG001|Double Blind Period (103 Weeks)|Death|6|||
127677552|NCT01156116|459442767|FG000|Overall Study|Withdrawal by Subject|3|||
127677553|NCT01156116|459442768|FG001|Overall Study|Withdrawal by Subject|1|||
127677554|NCT01156116|459442767|FG000|Overall Study|CPAP intolerance|2|||
127677555|NCT01156116|459442768|FG001|Overall Study|CPAP intolerance|0|||
127677556|NCT01191788|459442769|FG000|Overall Study|Lost to Follow-up|21|||
127677557|NCT01191788|459442770|FG001|Overall Study|Lost to Follow-up|22|||
127677558|NCT00509769|459442772|FG000|Overall Study|Progressive disease|77|||
127677559|NCT00509769|459442772|FG000|Overall Study|Adverse Event|4|||
127677560|NCT00509769|459442772|FG000|Overall Study|Patient's decision|1|||
127677561|NCT00509769|459442772|FG000|Overall Study|Physician Decision|8|||
127677562|NCT00509769|459442772|FG000|Overall Study|Use of prohibited therapies during study|1|||
127677563|NCT00754936|459442773|FG000|Overall Study|Lost to Follow-up|3|||
127677564|NCT00754936|459442773|FG000|Overall Study|Physician Decision|1|||
127677565|NCT00754936|459442773|FG000|Overall Study|Withdrawal by Subject|2|||
127677566|NCT00754936|459442773|FG000|Overall Study|Side Effects|3|||
127677567|NCT00754936|459442773|FG000|Overall Study|Inter-current medical events|3|||
127677568|NCT01227707|459442777|FG000|Overall Study|Adverse Event|10|||
127677569|NCT01227707|459442777|FG000|Overall Study|Progression of disease|3|||
127677570|NCT01227707|459442777|FG000|Overall Study|Withdrawal by Subject|1|||
127677571|NCT01227707|459442777|FG000|Overall Study|Patient non-compliance|3|||
127677572|NCT01227707|459442777|FG000|Overall Study|Medical decision|6|||
127677573|NCT01227707|459442777|FG000|Overall Study|Death|1|||
127677574|NCT05484726|459442780|FG000|Overall Study|Protocol Violation|3|||
127677575|NCT05484726|459442781|FG001|Overall Study|Protocol Violation|3|||
127677576|NCT05484726|459442780|FG000|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|4|||
127677577|NCT05484726|459442781|FG001|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|2|||
127677578|NCT05484726|459442780|FG000|Overall Study|HsPDA requiring antifailure therapy|1|||
127677579|NCT05484726|459442781|FG001|Overall Study|HsPDA requiring antifailure therapy|2|||
127677580|NCT05484726|459442780|FG000|Overall Study|continued need of mechanical ventilation|2|||
127677581|NCT05484726|459442781|FG001|Overall Study|continued need of mechanical ventilation|3|||
127677582|NCT05484726|459442780|FG000|Overall Study|Withdrawal by Subject|2|||
127677583|NCT05484726|459442781|FG001|Overall Study|Withdrawal by Subject|3|||
127677584|NCT05484726|459442780|FG000|Overall Study|IVH (G III & IV)|2|||
127677585|NCT05484726|459442781|FG001|Overall Study|IVH (G III & IV)|1|||
127677586|NCT05484726|459442780|FG000|Overall Study|NEC (stage II & III)|2|||
127677587|NCT05484726|459442781|FG001|Overall Study|NEC (stage II & III)|3|||
127677588|NCT01093534|459442784|FG000|Overall Study|Adverse Event|2|||
128011337|NCT01047319|460667311|FG002|Overall Study|Protocol Violation|4|||
128011338|NCT01047319|460667309|FG000|Overall Study|Lack of Efficacy|4|||
128011339|NCT01047319|460667310|FG001|Overall Study|Lack of Efficacy|3|||
128011340|NCT01047319|460667311|FG002|Overall Study|Lack of Efficacy|3|||
128011341|NCT01047319|460667309|FG000|Overall Study|Death|5|||
128011342|NCT01047319|460667310|FG001|Overall Study|Death|1|||
128011343|NCT01047319|460667311|FG002|Overall Study|Death|5|||
128011344|NCT01047319|460667309|FG000|Overall Study|Pregnancy|13|||
128011345|NCT01047319|460667310|FG001|Overall Study|Pregnancy|8|||
128011346|NCT01047319|460667311|FG002|Overall Study|Pregnancy|8|||
128011347|NCT01047319|460667309|FG000|Overall Study|Physician Decision|12|||
128011348|NCT01047319|460667310|FG001|Overall Study|Physician Decision|9|||
128011349|NCT01047319|460667311|FG002|Overall Study|Physician Decision|10|||
128011350|NCT01047319|460667309|FG000|Overall Study|Lost to Follow-up|14|||
128011351|NCT01047319|460667310|FG001|Overall Study|Lost to Follow-up|10|||
128011352|NCT01047319|460667311|FG002|Overall Study|Lost to Follow-up|10|||
128011353|NCT01047319|460667309|FG000|Overall Study|Adverse Event|16|||
128011354|NCT01047319|460667310|FG001|Overall Study|Adverse Event|27|||
128011355|NCT01047319|460667311|FG002|Overall Study|Adverse Event|21|||
128011356|NCT01047319|460667309|FG000|Overall Study|Withdrawal by Subject|77|||
128011357|NCT01047319|460667310|FG001|Overall Study|Withdrawal by Subject|75|||
128011358|NCT01047319|460667311|FG002|Overall Study|Withdrawal by Subject|87|||
128011359|NCT01047319|460667309|FG000|Overall Study|Study terminated by Sponsor|198|||
128011360|NCT01047319|460667310|FG001|Overall Study|Study terminated by Sponsor|215|||
128011361|NCT01047319|460667311|FG002|Overall Study|Study terminated by Sponsor|203|||
128011362|NCT00857389|460667313|FG000|Overall Study|Did not proceed to transplant|2|||
128011363|NCT01157845|460667314|FG000|Overall Study|Lost to Follow-up|5|||
128011364|NCT01157845|460667314|FG000|Overall Study|Withdrawal by Subject|12|||
128011365|NCT01157845|460667314|FG000|Overall Study|Physician Decision|3|||
128011366|NCT01157845|460667314|FG000|Overall Study|Protocol Violation|13|||
127677589|NCT01093534|459442785|FG001|Overall Study|Adverse Event|5|||
127677590|NCT01093534|459442786|FG002|Overall Study|Adverse Event|2|||
127677591|NCT01093534|459442784|FG000|Overall Study|Lack of Efficacy|2|||
127677592|NCT01093534|459442785|FG001|Overall Study|Lack of Efficacy|1|||
127677593|NCT01093534|459442786|FG002|Overall Study|Lack of Efficacy|1|||
127677594|NCT01093534|459442784|FG000|Overall Study|Withdrawal by Subject|5|||
127677595|NCT01093534|459442785|FG001|Overall Study|Withdrawal by Subject|7|||
127677596|NCT01093534|459442786|FG002|Overall Study|Withdrawal by Subject|2|||
127677597|NCT01093534|459442784|FG000|Overall Study|Other|1|||
127677598|NCT01093534|459442785|FG001|Overall Study|Other|3|||
127677599|NCT01093534|459442786|FG002|Overall Study|Other|4|||
127677600|NCT01837641|459442795|FG000|Overall Study|Sponsor decision|1|||
127677601|NCT01837641|459442796|FG001|Overall Study|Sponsor decision|0|||
127677602|NCT01837641|459442797|FG002|Overall Study|Sponsor decision|0|||
127677603|NCT01837641|459442798|FG003|Overall Study|Sponsor decision|0|||
127677604|NCT01837641|459442799|FG004|Overall Study|Sponsor decision|0|||
127677605|NCT01837641|459442800|FG005|Overall Study|Sponsor decision|1|||
127677606|NCT01837641|459442801|FG006|Overall Study|Sponsor decision|0|||
127677607|NCT01837641|459442802|FG007|Overall Study|Sponsor decision|0|||
127677608|NCT01837641|459442795|FG000|Overall Study|Adverse Event|0|||
127677609|NCT01837641|459442796|FG001|Overall Study|Adverse Event|0|||
127677610|NCT01837641|459442797|FG002|Overall Study|Adverse Event|0|||
127677611|NCT01837641|459442798|FG003|Overall Study|Adverse Event|0|||
127677612|NCT01837641|459442799|FG004|Overall Study|Adverse Event|0|||
127677613|NCT01837641|459442800|FG005|Overall Study|Adverse Event|1|||
127677614|NCT01837641|459442801|FG006|Overall Study|Adverse Event|0|||
127677615|NCT01837641|459442802|FG007|Overall Study|Adverse Event|0|||
127677616|NCT01837641|459442795|FG000|Overall Study|Withdrawal by Subject|0|||
127677617|NCT01837641|459442796|FG001|Overall Study|Withdrawal by Subject|0|||
127677618|NCT01837641|459442797|FG002|Overall Study|Withdrawal by Subject|0|||
127677619|NCT01837641|459442798|FG003|Overall Study|Withdrawal by Subject|0|||
127677620|NCT01837641|459442799|FG004|Overall Study|Withdrawal by Subject|1|||
127677621|NCT01837641|459442800|FG005|Overall Study|Withdrawal by Subject|0|||
127677622|NCT01837641|459442801|FG006|Overall Study|Withdrawal by Subject|1|||
127677623|NCT01837641|459442802|FG007|Overall Study|Withdrawal by Subject|0|||
127677624|NCT00605033|459442809|FG000|Overall Study|Adverse Event|2|||
127677625|NCT00605033|459442810|FG001|Overall Study|Adverse Event|2|||
127677626|NCT00605033|459442809|FG000|Overall Study|Lost to Follow-up|1|||
127677627|NCT00605033|459442810|FG001|Overall Study|Lost to Follow-up|1|||
127677628|NCT00605033|459442809|FG000|Overall Study|Withdrawal by Subject|3|||
127677629|NCT00605033|459442810|FG001|Overall Study|Withdrawal by Subject|4|||
127677630|NCT00605033|459442809|FG000|Overall Study|Protocol Violation|1|||
127764951|NCT03149549|459763568|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
128011367|NCT01157845|460667314|FG000|Overall Study|Study was ended|1|||
128011368|NCT01157845|460667314|FG000|Overall Study|Device malfunction|1|||
128011369|NCT03311555|460667315|FG000|Overall Study|Adverse Event|1|||
127677631|NCT00605033|459442810|FG001|Overall Study|Protocol Violation|1|||
128011370|NCT03737994|460668812|FG000|Overall Study|Withdrawal by Subject|0|||
128011371|NCT03737994|460668813|FG001|Overall Study|Withdrawal by Subject|0|||
128011372|NCT03737994|460668814|FG002|Overall Study|Withdrawal by Subject|0|||
127764952|NCT03149549|459763569|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
127764953|NCT03149549|459763570|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
127764954|NCT03149549|459763571|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
127764955|NCT03149549|459763572|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
127543713|NCT05138653|458956579|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
127543714|NCT05138653|458956580|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
127543715|NCT05138653|458956581|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
127543716|NCT05138653|458956582|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
127543717|NCT05138653|458956583|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
127543718|NCT05138653|458956584|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
127543719|NCT05138653|458956585|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
127543720|NCT05138653|458956586|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
127543721|NCT05138653|458956587|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
127543722|NCT05138653|458956588|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
127543723|NCT05138653|458956589|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
127543724|NCT05138653|458956590|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
127543725|NCT05138653|458956591|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
127543726|NCT05138653|458956592|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|1|||
127764956|NCT03149549|459763573|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
127543727|NCT05138653|458956593|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
127543728|NCT05138653|458956594|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
127543729|NCT04825574|458956596|FG000|Overall Study|Commercial treatment became available|1|||
127543730|NCT04825574|458956596|FG000|Overall Study|Disease progression|1|||
127543731|NCT04272242|458956599|FG000|Overall Study|Withdrawal by Subject|3|||
127543732|NCT04272242|458956599|FG000|Overall Study|Lost to Follow-up|1|||
127543733|NCT04272242|458956599|FG000|Overall Study|Adverse Event|1|||
127543734|NCT02702492|458956600|FG000|Overall Study|Disease progression|3|||
127543735|NCT02702492|458956601|FG001|Overall Study|Disease progression|3|||
127543736|NCT02702492|458956602|FG002|Overall Study|Disease progression|2|||
127543737|NCT02702492|458956603|FG003|Overall Study|Disease progression|4|||
127543738|NCT02702492|458956604|FG004|Overall Study|Disease progression|4|||
127543739|NCT02702492|458956605|FG005|Overall Study|Disease progression|1|||
128011373|NCT03737994|460668815|FG003|Overall Study|Withdrawal by Subject|0|||
128011374|NCT03737994|460668816|FG004|Overall Study|Withdrawal by Subject|0|||
128011375|NCT03737994|460668817|FG005|Overall Study|Withdrawal by Subject|0|||
128011376|NCT03737994|460668818|FG006|Overall Study|Withdrawal by Subject|1|||
128011377|NCT01473134|460668819|FG000|Overall Study|Lost to Follow-up|21|||
128011378|NCT01473134|460668820|FG001|Overall Study|Lost to Follow-up|13|||
128011379|NCT01473134|460668819|FG000|Overall Study|Protocol Violation|32|||
128011380|NCT01473134|460668820|FG001|Overall Study|Protocol Violation|19|||
128011381|NCT01473134|460668819|FG000|Overall Study|Withdrawal by Subject|1|||
128011382|NCT01473134|460668820|FG001|Overall Study|Withdrawal by Subject|2|||
128011383|NCT01473134|460668819|FG000|Overall Study|Death|0|||
128011384|NCT01473134|460668820|FG001|Overall Study|Death|1|||
128011385|NCT01473134|460668819|FG000|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|1|||
128011386|NCT01473134|460668820|FG001|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|0|||
128011387|NCT04761822|460668823|FG000|Overall Study|Adverse Event|3|||
128011388|NCT04761822|460668824|FG001|Overall Study|Adverse Event|1|||
128011389|NCT04761822|460668825|FG002|Overall Study|Adverse Event|1|||
128011390|NCT04761822|460668826|FG003|Overall Study|Adverse Event|3|||
128011391|NCT04761822|460668823|FG000|Overall Study|Lost to Follow-up|1|||
128011392|NCT04761822|460668824|FG001|Overall Study|Lost to Follow-up|0|||
128011393|NCT04761822|460668825|FG002|Overall Study|Lost to Follow-up|2|||
128011394|NCT04761822|460668826|FG003|Overall Study|Lost to Follow-up|3|||
128011395|NCT04761822|460668823|FG000|Overall Study|Physician Decision|0|||
128011396|NCT04761822|460668824|FG001|Overall Study|Physician Decision|1|||
128011397|NCT04761822|460668825|FG002|Overall Study|Physician Decision|0|||
128011398|NCT04761822|460668826|FG003|Overall Study|Physician Decision|0|||
128011399|NCT04761822|460668823|FG000|Overall Study|Withdrawal by Subject|3|||
128011400|NCT04761822|460668824|FG001|Overall Study|Withdrawal by Subject|8|||
128011401|NCT04761822|460668825|FG002|Overall Study|Withdrawal by Subject|1|||
128011402|NCT04761822|460668826|FG003|Overall Study|Withdrawal by Subject|11|||
128011403|NCT04761822|460668823|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
128011404|NCT04761822|460668824|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
128011405|NCT04761822|460668825|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
128011406|NCT04761822|460668826|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
128011407|NCT04761822|460668823|FG000|Overall Study|Participant requested unblinding|0|||
127543740|NCT02702492|458956606|FG006|Overall Study|Disease progression|2|||
127543741|NCT02702492|458956607|FG007|Overall Study|Disease progression|8|||
127543742|NCT02702492|458956608|FG008|Overall Study|Disease progression|5|||
128011408|NCT04761822|460668824|FG001|Overall Study|Participant requested unblinding|0|||
128011409|NCT04761822|460668825|FG002|Overall Study|Participant requested unblinding|0|||
128011410|NCT04761822|460668826|FG003|Overall Study|Participant requested unblinding|1|||
128011411|NCT04476043|460668827|FG000|Overall Study|Withdrawal by Subject|1|||
128011412|NCT04476043|460668828|FG001|Overall Study|Withdrawal by Subject|3|||
128011413|NCT04476043|460668829|FG002|Overall Study|Withdrawal by Subject|4|||
128011414|NCT04476043|460668830|FG003|Overall Study|Withdrawal by Subject|1|||
128011415|NCT04476043|460668827|FG000|Overall Study|Lost to Follow-up|1|||
128011416|NCT04476043|460668828|FG001|Overall Study|Lost to Follow-up|1|||
128011417|NCT04476043|460668829|FG002|Overall Study|Lost to Follow-up|2|||
128011418|NCT04476043|460668830|FG003|Overall Study|Lost to Follow-up|1|||
128011419|NCT04476043|460668827|FG000|Overall Study|Adverse Event|2|||
128011420|NCT04476043|460668828|FG001|Overall Study|Adverse Event|0|||
128011421|NCT04476043|460668829|FG002|Overall Study|Adverse Event|1|||
128011422|NCT04476043|460668830|FG003|Overall Study|Adverse Event|0|||
128011423|NCT04476043|460668827|FG000|Overall Study|Protocol Violation|0|||
127543743|NCT02702492|458956609|FG009|Overall Study|Disease progression|1|||
127543744|NCT02702492|458956610|FG010|Overall Study|Disease progression|0|||
127543745|NCT02702492|458956611|FG011|Overall Study|Disease progression|3|||
128011424|NCT04476043|460668828|FG001|Overall Study|Protocol Violation|1|||
128011425|NCT04476043|460668829|FG002|Overall Study|Protocol Violation|0|||
128011426|NCT04476043|460668830|FG003|Overall Study|Protocol Violation|0|||
128011427|NCT06217380|460668831|FG000|Overall Study|Death: Unrelated to the device. The subject was enrolled but did not start any study activities|1|||
128011428|NCT06217380|460668831|FG000|Overall Study|Physician Decision|1|||
128011429|NCT06217380|460668831|FG000|Overall Study|Withdrawal by Subject|2|||
128011430|NCT06633965|460668832|FG000|Overall Study|Withdrawal by Subject|0|||
128011431|NCT06633965|460668833|FG001|Overall Study|Withdrawal by Subject|1|||
128011432|NCT01963611|460668840|FG000|Overall Study|Adverse Event|1|||
128011433|NCT01963611|460668841|FG001|Overall Study|Adverse Event|1|||
128011434|NCT01963611|460668842|FG002|Overall Study|Adverse Event|3|||
128011435|NCT01963611|460668843|FG003|Overall Study|Adverse Event|4|||
128011436|NCT01963611|460668844|FG004|Overall Study|Adverse Event|3|||
128011437|NCT01963611|460668840|FG000|Overall Study|Protocol Violation|0|||
128011438|NCT01963611|460668841|FG001|Overall Study|Protocol Violation|0|||
128011439|NCT01963611|460668842|FG002|Overall Study|Protocol Violation|0|||
128011440|NCT01963611|460668843|FG003|Overall Study|Protocol Violation|1|||
128011441|NCT01963611|460668844|FG004|Overall Study|Protocol Violation|0|||
128011442|NCT01963611|460668840|FG000|Overall Study|Lack of Efficacy|0|||
128011443|NCT01963611|460668841|FG001|Overall Study|Lack of Efficacy|0|||
128011444|NCT01963611|460668842|FG002|Overall Study|Lack of Efficacy|0|||
128011445|NCT01963611|460668843|FG003|Overall Study|Lack of Efficacy|1|||
128011446|NCT01963611|460668844|FG004|Overall Study|Lack of Efficacy|0|||
128011447|NCT01963611|460668840|FG000|Overall Study|Withdrawal by Subject|3|||
128011448|NCT01963611|460668841|FG001|Overall Study|Withdrawal by Subject|2|||
128011449|NCT01963611|460668842|FG002|Overall Study|Withdrawal by Subject|1|||
128011450|NCT01963611|460668843|FG003|Overall Study|Withdrawal by Subject|1|||
128011451|NCT01963611|460668844|FG004|Overall Study|Withdrawal by Subject|3|||
128011452|NCT01963611|460668840|FG000|Overall Study|Other|47|||
128011453|NCT01963611|460668841|FG001|Overall Study|Other|46|||
128011454|NCT01963611|460668842|FG002|Overall Study|Other|48|||
127543746|NCT02702492|458956612|FG012|Overall Study|Disease progression|2|||
127543747|NCT02702492|458956600|FG000|Overall Study|Clinical progression|0|||
127543748|NCT02702492|458956601|FG001|Overall Study|Clinical progression|0|||
127543749|NCT02702492|458956602|FG002|Overall Study|Clinical progression|2|||
127543750|NCT02702492|458956603|FG003|Overall Study|Clinical progression|1|||
127543751|NCT02702492|458956604|FG004|Overall Study|Clinical progression|0|||
127543752|NCT02702492|458956605|FG005|Overall Study|Clinical progression|2|||
127543753|NCT02702492|458956606|FG006|Overall Study|Clinical progression|1|||
127543754|NCT02702492|458956607|FG007|Overall Study|Clinical progression|4|||
127543755|NCT02702492|458956608|FG008|Overall Study|Clinical progression|0|||
128011455|NCT01963611|460668843|FG003|Overall Study|Other|45|||
128011456|NCT01963611|460668844|FG004|Overall Study|Other|45|||
128011457|NCT01126424|460668845|FG000|Overall Study|Adverse Event|0|||
127543756|NCT02702492|458956609|FG009|Overall Study|Clinical progression|0|||
127543757|NCT02702492|458956610|FG010|Overall Study|Clinical progression|1|||
128011458|NCT01126424|460668846|FG001|Overall Study|Adverse Event|0|||
128011459|NCT01126424|460668847|FG002|Overall Study|Adverse Event|0|||
128011460|NCT01126424|460668848|FG003|Overall Study|Adverse Event|0|||
128011461|NCT01126424|460668849|FG004|Overall Study|Adverse Event|1|||
127543758|NCT02702492|458956611|FG011|Overall Study|Clinical progression|2|||
128011462|NCT01126424|460668850|FG005|Overall Study|Adverse Event|0|||
128011463|NCT01126424|460668845|FG000|Overall Study|Withdrawal by Subject|0|||
128011464|NCT01126424|460668846|FG001|Overall Study|Withdrawal by Subject|0|||
128011465|NCT01126424|460668847|FG002|Overall Study|Withdrawal by Subject|1|||
127543759|NCT02702492|458956612|FG012|Overall Study|Clinical progression|0|||
127543760|NCT02702492|458956600|FG000|Overall Study|Adverse Event|0|||
127543761|NCT02702492|458956601|FG001|Overall Study|Adverse Event|0|||
128011466|NCT01126424|460668848|FG003|Overall Study|Withdrawal by Subject|3|||
128011467|NCT01126424|460668849|FG004|Overall Study|Withdrawal by Subject|1|||
128011468|NCT01126424|460668850|FG005|Overall Study|Withdrawal by Subject|0|||
127543762|NCT02702492|458956602|FG002|Overall Study|Adverse Event|1|||
127543763|NCT02702492|458956603|FG003|Overall Study|Adverse Event|2|||
127543764|NCT02702492|458956604|FG004|Overall Study|Adverse Event|1|||
127543765|NCT02702492|458956605|FG005|Overall Study|Adverse Event|0|||
127543766|NCT02702492|458956606|FG006|Overall Study|Adverse Event|1|||
127543767|NCT02702492|458956607|FG007|Overall Study|Adverse Event|0|||
127543768|NCT02702492|458956608|FG008|Overall Study|Adverse Event|2|||
127543769|NCT02702492|458956609|FG009|Overall Study|Adverse Event|0|||
127543770|NCT02702492|458956610|FG010|Overall Study|Adverse Event|0|||
127543771|NCT02702492|458956611|FG011|Overall Study|Adverse Event|0|||
127543772|NCT02702492|458956612|FG012|Overall Study|Adverse Event|1|||
127543773|NCT02702492|458956600|FG000|Overall Study|Other|0|||
127543774|NCT02702492|458956601|FG001|Overall Study|Other|0|||
127543775|NCT02702492|458956602|FG002|Overall Study|Other|0|||
127543776|NCT02702492|458956603|FG003|Overall Study|Other|0|||
127543777|NCT02702492|458956604|FG004|Overall Study|Other|0|||
127543778|NCT02702492|458956605|FG005|Overall Study|Other|0|||
127543779|NCT02702492|458956606|FG006|Overall Study|Other|0|||
127543780|NCT02702492|458956607|FG007|Overall Study|Other|0|||
127543781|NCT02702492|458956608|FG008|Overall Study|Other|0|||
127543782|NCT02702492|458956609|FG009|Overall Study|Other|0|||
127543783|NCT02702492|458956610|FG010|Overall Study|Other|0|||
127543784|NCT02702492|458956611|FG011|Overall Study|Other|0|||
127543785|NCT02702492|458956612|FG012|Overall Study|Other|1|||
127543786|NCT00781768|458958297|FG000|Overall Study|Not transplanted.|0|||
127543787|NCT00781768|458958298|FG001|Overall Study|Not transplanted.|2|||
127543788|NCT00079417|458958299|FG000|Overall Study|Physician Decision|2|||
127543789|NCT00079417|458958299|FG000|Overall Study|Ineligible|7|||
127543790|NCT02458313|458958300|FG000|Overall Study|Withdrawal by Subject|6|||
127543791|NCT02458313|458958301|FG001|Overall Study|Withdrawal by Subject|8|||
127543792|NCT02458313|458958300|FG000|Overall Study|Excluded for motion during MRI|1|||
127543793|NCT02458313|458958301|FG001|Overall Study|Excluded for motion during MRI|2|||
127543794|NCT00904969|458958302|FG000|Overall Study|Lost to Follow-up|4|||
127543795|NCT00904969|458958302|FG000|Overall Study|Withdrawal by Subject|3|||
127543796|NCT00904969|458958302|FG000|Overall Study|Additional Treatments|11|||
127543797|NCT00904969|458958302|FG000|Overall Study|Case Aborted; Subject Exited|1|||
127543798|NCT00199381|458958303|FG000|Overall Study|Withdrawal by Subject|38|||
127543799|NCT00199381|458958303|FG000|Overall Study|Adverse Event|73|||
127543800|NCT00199381|458958303|FG000|Overall Study|Protocol Violation|6|||
127543801|NCT00199381|458958303|FG000|Overall Study|Lack of Efficacy|27|||
127543802|NCT00199381|458958303|FG000|Overall Study|Not including due to early termination|37|||
127543803|NCT00199381|458958303|FG000|Overall Study|Study termination by Sponsor|323|||
127543804|NCT04944992|458958304|FG000|Overall Study|Lost to Follow-up|1|||
127543805|NCT04944992|458958305|FG001|Overall Study|Lost to Follow-up|1|||
127543806|NCT04944992|458958304|FG000|Overall Study|Physician Decision|1|||
127543807|NCT04944992|458958305|FG001|Overall Study|Physician Decision|0|||
127764957|NCT03149549|459763574|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
127764958|NCT03149549|459763562|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
127764959|NCT03149549|459763563|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
127764960|NCT03149549|459763564|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
128011469|NCT03801252|460668852|FG000|Overall Study|Protocol Violation|1|||
128011470|NCT03801252|460668853|FG001|Overall Study|Protocol Violation|2|||
127543808|NCT04944992|458958304|FG000|Overall Study|Withdrawal by Subject|6|||
127543809|NCT04944992|458958305|FG001|Overall Study|Withdrawal by Subject|1|||
127543810|NCT01295814|458958306|FG000|Overall Study|Lack of Efficacy|0|||
127543811|NCT01295814|458958307|FG001|Overall Study|Lack of Efficacy|2|||
127543812|NCT01295814|458958306|FG000|Overall Study|Withdrawal by Subject|2|||
127543813|NCT01295814|458958307|FG001|Overall Study|Withdrawal by Subject|0|||
128011471|NCT01134042|460668854|FG000|Overall Study|Adverse Event|3|||
128011472|NCT01134042|460668855|FG001|Overall Study|Adverse Event|7|||
127543814|NCT03414983|458958308|FG000|Pre-Treatment|Other reasons|1|||
127543815|NCT03414983|458958309|FG001|Pre-Treatment|Other reasons|0|||
127543816|NCT03414983|458958308|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
128011473|NCT01134042|460668856|FG002|Overall Study|Adverse Event|2|||
128011474|NCT01134042|460668854|FG000|Overall Study|Lack of Efficacy|21|||
127543817|NCT03414983|458958309|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
127543818|NCT03414983|458958308|FG000|Pre-Treatment|Participant withdrew consent|1|||
127543819|NCT03414983|458958309|FG001|Pre-Treatment|Participant withdrew consent|3|||
127543820|NCT03414983|458958308|FG000|Treatment|Participant withdrew consent|4|||
127543821|NCT03414983|458958309|FG001|Treatment|Participant withdrew consent|3|||
127543822|NCT03414983|458958308|FG000|Treatment|Participant request to discontinue study treatment|8|||
127543823|NCT03414983|458958309|FG001|Treatment|Participant request to discontinue study treatment|10|||
127543824|NCT03414983|458958308|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
127543825|NCT03414983|458958309|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
127543826|NCT03414983|458958308|FG000|Treatment|Death|0|||
127543827|NCT03414983|458958309|FG001|Treatment|Death|1|||
127543828|NCT03414983|458958308|FG000|Treatment|Study Drug Toxicity|10|||
127543829|NCT03414983|458958309|FG001|Treatment|Study Drug Toxicity|5|||
127543830|NCT03414983|458958308|FG000|Treatment|Disease Progression|75|||
127543831|NCT03414983|458958309|FG001|Treatment|Disease Progression|29|||
127543832|NCT03414983|458958308|FG000|Treatment|Not reported|1|||
127543833|NCT03414983|458958309|FG001|Treatment|Not reported|0|||
127543834|NCT03414983|458958308|FG000|Treatment|Other reasons|3|||
127543835|NCT03414983|458958309|FG001|Treatment|Other reasons|2|||
127543836|NCT03414983|458958308|FG000|Treatment|Poor/non-compliance|2|||
127543837|NCT03414983|458958309|FG001|Treatment|Poor/non-compliance|0|||
127543838|NCT03414983|458958308|FG000|Treatment|Maximum clinical benefit|5|||
127543839|NCT03414983|458958309|FG001|Treatment|Maximum clinical benefit|9|||
127543840|NCT03414983|458958308|FG000|Treatment|Lost to Follow-up|0|||
127543841|NCT03414983|458958309|FG001|Treatment|Lost to Follow-up|1|||
127543842|NCT03414983|458958308|FG000|Treatment|Administrative reasons by sponsor|1|||
127543843|NCT03414983|458958309|FG001|Treatment|Administrative reasons by sponsor|0|||
127543844|NCT00303069|458958310|FG000|Overall Study|Lost to Follow-up|1|||
127543845|NCT00303069|458958311|FG001|Overall Study|Lost to Follow-up|0|||
127543846|NCT00303069|458958312|FG002|Overall Study|Lost to Follow-up|0|||
127543847|NCT00303069|458958313|FG003|Overall Study|Lost to Follow-up|2|||
127543848|NCT00303069|458958310|FG000|Overall Study|subject moved|1|||
127543849|NCT00303069|458958311|FG001|Overall Study|subject moved|0|||
127543850|NCT00303069|458958312|FG002|Overall Study|subject moved|0|||
127543851|NCT00303069|458958313|FG003|Overall Study|subject moved|0|||
127543852|NCT00303069|458958310|FG000|Overall Study|Recruitment into Army Reserves|0|||
127543853|NCT00303069|458958311|FG001|Overall Study|Recruitment into Army Reserves|0|||
127543854|NCT00303069|458958312|FG002|Overall Study|Recruitment into Army Reserves|1|||
127543855|NCT00303069|458958313|FG003|Overall Study|Recruitment into Army Reserves|0|||
127543856|NCT00092417|458958314|FG000|Overall Study|Lost to Follow-up|2|||
127543857|NCT00092417|458958315|FG001|Overall Study|Lost to Follow-up|0|||
127543858|NCT00092417|458958314|FG000|Overall Study|Withdrawal by Subject|2|||
127543859|NCT00092417|458958315|FG001|Overall Study|Withdrawal by Subject|1|||
127543860|NCT00092417|458958314|FG000|Overall Study|Other|1|||
127543861|NCT00092417|458958315|FG001|Overall Study|Other|0|||
127543862|NCT00751296|458958317|FG000|Overall Study|Adverse Event|2|||
127543863|NCT03780244|458958327|FG000|Overall Study|Lost to Follow-up|1|||
127543864|NCT03780244|458958328|FG001|Overall Study|Lost to Follow-up|0|||
127543865|NCT00804908|458958331|FG000|Overall Study|Other|115|||
127543866|NCT00804908|458958332|FG001|Overall Study|Other|116|||
127543867|NCT00804908|458958333|FG002|Overall Study|Other|114|||
127543868|NCT01280903|458958334|FG000|Overall Study|Lost to Follow-up|23|||
127543869|NCT01280903|458958335|FG001|Overall Study|Lost to Follow-up|16|||
127543870|NCT03453164|458958336|FG000|Overall Study|Lack of Efficacy|16|||
127543871|NCT03453164|458958336|FG000|Overall Study|3 cases did not meet the criteria for nivolumab initiation.|3|||
127543872|NCT01428258|458958337|FG000|Intervention 1|Withdrawal by Subject|2|||
127543873|NCT01428258|458958338|FG001|Intervention 1|Withdrawal by Subject|0|||
127543874|NCT03459079|458958340|FG000|Overall Study|Adverse Event|4|||
127543875|NCT03459079|458958341|FG001|Overall Study|Adverse Event|2|||
127543876|NCT03459079|458958342|FG002|Overall Study|Adverse Event|0|||
127543877|NCT03459079|458958340|FG000|Overall Study|Withdrawal by Subject|2|||
127543878|NCT03459079|458958341|FG001|Overall Study|Withdrawal by Subject|2|||
127543879|NCT03459079|458958342|FG002|Overall Study|Withdrawal by Subject|0|||
127543880|NCT01112917|458958343|FG000|Overall Study|Death|2|||
127543881|NCT01112917|458958344|FG001|Overall Study|Death|11|||
127543882|NCT01112917|458958343|FG000|Overall Study|Lost to Follow-up|1|||
127543883|NCT01112917|458958344|FG001|Overall Study|Lost to Follow-up|1|||
127543884|NCT01112917|458958343|FG000|Overall Study|Withdrawal by Subject|1|||
127543885|NCT01112917|458958344|FG001|Overall Study|Withdrawal by Subject|3|||
127543886|NCT01112917|458958343|FG000|Overall Study|Unable to Convert Filter|3|||
127543887|NCT01112917|458958344|FG001|Overall Study|Unable to Convert Filter|0|||
127543888|NCT02177123|458958345|FG000|Overall Study|Lost to Follow-up|6|||
127543889|NCT02177123|458958345|FG000|Overall Study|Withdrawal by Subject|4|||
127543890|NCT02177123|458958345|FG000|Overall Study|Adverse Event|4|||
127543891|NCT02177123|458958345|FG000|Overall Study|Physician Decision|3|||
127543892|NCT02177123|458958345|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
127543893|NCT02177123|458958345|FG000|Overall Study|Excluded for medical reasons|2|||
127543894|NCT02177123|458958345|FG000|Overall Study|Death|1|||
128011475|NCT01134042|460668855|FG001|Overall Study|Lack of Efficacy|6|||
128011476|NCT01134042|460668856|FG002|Overall Study|Lack of Efficacy|18|||
127543895|NCT02177123|458958345|FG000|Overall Study|Other|1|||
127543896|NCT02177123|458958345|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
127543897|NCT02766023|458958348|FG000|Overall Study|Lost to Follow-up|23|||
127543898|NCT02766023|458958349|FG001|Overall Study|Lost to Follow-up|11|||
127543899|NCT02766023|458958348|FG000|Overall Study|Pregnancy|1|||
127543900|NCT02766023|458958349|FG001|Overall Study|Pregnancy|0|||
127543901|NCT02766023|458958348|FG000|Overall Study|Adverse Event|1|||
127543902|NCT02766023|458958349|FG001|Overall Study|Adverse Event|0|||
127543903|NCT02766023|458958348|FG000|Overall Study|Withdrawal by Subject|4|||
127543904|NCT02766023|458958349|FG001|Overall Study|Withdrawal by Subject|5|||
127543905|NCT02766023|458958348|FG000|Overall Study|Physician Decision|1|||
128011477|NCT01134042|460668854|FG000|Overall Study|Protocol Violation|5|||
127677632|NCT03354390|459442811|FG000|Level 1|Death|2|||
127677633|NCT03354390|459442812|FG001|Level 1|Death|0|||
127677634|NCT03354390|459442813|FG002|Level 1|Death|0|||
127677635|NCT03354390|459442814|FG003|Level 1|Death|0|||
127677636|NCT03354390|459442811|FG000|Level 1|Physician Decision|1|||
127677637|NCT03354390|459442812|FG001|Level 1|Physician Decision|0|||
127677638|NCT03354390|459442813|FG002|Level 1|Physician Decision|0|||
127677639|NCT03354390|459442814|FG003|Level 1|Physician Decision|0|||
127677640|NCT03354390|459442811|FG000|Level 2|Physician Decision|0|||
127677641|NCT03354390|459442812|FG001|Level 2|Physician Decision|2|||
127677642|NCT03354390|459442813|FG002|Level 2|Physician Decision|0|||
127677643|NCT03354390|459442814|FG003|Level 2|Physician Decision|0|||
127677644|NCT03354390|459442811|FG000|Level 2|Lack of Efficacy|0|||
127677645|NCT03354390|459442812|FG001|Level 2|Lack of Efficacy|1|||
127677646|NCT03354390|459442813|FG002|Level 2|Lack of Efficacy|0|||
127677647|NCT03354390|459442814|FG003|Level 2|Lack of Efficacy|0|||
127677648|NCT03354390|459442811|FG000|Level 2|Lost to Follow-up|0|||
127677649|NCT03354390|459442812|FG001|Level 2|Lost to Follow-up|1|||
127677650|NCT03354390|459442813|FG002|Level 2|Lost to Follow-up|0|||
127677651|NCT03354390|459442814|FG003|Level 2|Lost to Follow-up|0|||
127677652|NCT03354390|459442811|FG000|Level 3|Death|0|||
127677653|NCT03354390|459442812|FG001|Level 3|Death|0|||
127677654|NCT03354390|459442813|FG002|Level 3|Death|1|||
127677655|NCT03354390|459442814|FG003|Level 3|Death|0|||
127677656|NCT03354390|459442811|FG000|Level 3|Physician Decision|0|||
127677657|NCT03354390|459442812|FG001|Level 3|Physician Decision|0|||
127677658|NCT03354390|459442813|FG002|Level 3|Physician Decision|2|||
127677659|NCT03354390|459442814|FG003|Level 3|Physician Decision|0|||
127677660|NCT03354390|459442811|FG000|Level 4|Death|0|||
127677661|NCT03354390|459442812|FG001|Level 4|Death|0|||
127677662|NCT03354390|459442813|FG002|Level 4|Death|0|||
127677663|NCT03354390|459442814|FG003|Level 4|Death|3|||
127677664|NCT01066923|459442815|FG000|Overall Study|Withdrawal by Subject|3|||
127677665|NCT01066923|459442816|FG001|Overall Study|Withdrawal by Subject|3|||
127677666|NCT01066923|459442817|FG002|Overall Study|Withdrawal by Subject|8|||
127677667|NCT01066923|459442818|FG003|Overall Study|Withdrawal by Subject|8|||
127677668|NCT03140176|459444475|FG000|Overall Study|Reason missing|23|||
127677669|NCT03140176|459444475|FG000|Overall Study|Death|33|||
127677670|NCT03140176|459444475|FG000|Overall Study|Disease progression|1|||
127677671|NCT03140176|459444475|FG000|Overall Study|Physician Decision|1|||
127677672|NCT03140176|459444475|FG000|Overall Study|Withdrawal by Subject|1|||
127677673|NCT03140176|459444475|FG000|Overall Study|Lost to Follow-up|15|||
127677674|NCT00954707|459444482|FG000|Overall Study|Death|34|||
127677675|NCT00954707|459444482|FG000|Overall Study|Withdrawal by Subject|100|||
127677676|NCT00954707|459444482|FG000|Overall Study|Lost to Follow-up|33|||
127677677|NCT02001623|459444483|FG000|Overall Study|Disease Progression|2|||
127677678|NCT02001623|459444484|FG001|Overall Study|Disease Progression|2|||
127677679|NCT02001623|459444485|FG002|Overall Study|Disease Progression|3|||
127677680|NCT02001623|459444486|FG003|Overall Study|Disease Progression|2|||
127677681|NCT02001623|459444487|FG004|Overall Study|Disease Progression|3|||
127677682|NCT02001623|459444488|FG005|Overall Study|Disease Progression|2|||
127677683|NCT02001623|459444489|FG006|Overall Study|Disease Progression|3|||
127677684|NCT02001623|459444490|FG007|Overall Study|Disease Progression|3|||
127677685|NCT02001623|459444491|FG008|Overall Study|Disease Progression|7|||
127677686|NCT02001623|459444492|FG009|Overall Study|Disease Progression|40|||
127677687|NCT02001623|459444493|FG010|Overall Study|Disease Progression|5|||
127677688|NCT02001623|459444494|FG011|Overall Study|Disease Progression|9|||
127677689|NCT02001623|459444495|FG012|Overall Study|Disease Progression|9|||
127677690|NCT02001623|459444496|FG013|Overall Study|Disease Progression|20|||
127677691|NCT02001623|459444497|FG014|Overall Study|Disease Progression|9|||
127677692|NCT02001623|459444483|FG000|Overall Study|Physician Decision|0|||
127677693|NCT02001623|459444484|FG001|Overall Study|Physician Decision|0|||
127677694|NCT02001623|459444485|FG002|Overall Study|Physician Decision|0|||
127677695|NCT02001623|459444486|FG003|Overall Study|Physician Decision|0|||
127677696|NCT02001623|459444487|FG004|Overall Study|Physician Decision|0|||
127677697|NCT02001623|459444488|FG005|Overall Study|Physician Decision|0|||
127677698|NCT02001623|459444489|FG006|Overall Study|Physician Decision|0|||
127677699|NCT02001623|459444490|FG007|Overall Study|Physician Decision|0|||
127677700|NCT02001623|459444491|FG008|Overall Study|Physician Decision|3|||
127677701|NCT02001623|459444492|FG009|Overall Study|Physician Decision|2|||
127543906|NCT02766023|458958349|FG001|Overall Study|Physician Decision|0|||
127677702|NCT02001623|459444493|FG010|Overall Study|Physician Decision|3|||
127677703|NCT02001623|459444494|FG011|Overall Study|Physician Decision|3|||
127677704|NCT02001623|459444495|FG012|Overall Study|Physician Decision|1|||
127677705|NCT02001623|459444496|FG013|Overall Study|Physician Decision|2|||
127677706|NCT02001623|459444497|FG014|Overall Study|Physician Decision|1|||
127677707|NCT02001623|459444483|FG000|Overall Study|Death|0|||
127677708|NCT02001623|459444484|FG001|Overall Study|Death|1|||
127677709|NCT02001623|459444485|FG002|Overall Study|Death|0|||
127677710|NCT02001623|459444486|FG003|Overall Study|Death|0|||
127677711|NCT02001623|459444487|FG004|Overall Study|Death|0|||
127677712|NCT02001623|459444488|FG005|Overall Study|Death|0|||
127677713|NCT02001623|459444489|FG006|Overall Study|Death|0|||
127677714|NCT02001623|459444490|FG007|Overall Study|Death|0|||
127543907|NCT02766023|458958348|FG000|Overall Study|Not Eligible at Enrollment|0|||
127543908|NCT02766023|458958349|FG001|Overall Study|Not Eligible at Enrollment|1|||
127543909|NCT06271993|458958350|FG000|Overall Study|Not reactive to histamine|5|||
127543910|NCT06271993|458958351|FG001|Overall Study|Not reactive to histamine|5|||
127543911|NCT06271993|458958352|FG002|Overall Study|Not reactive to histamine|5|||
127543912|NCT04026113|458958357|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
127543913|NCT04026113|458958358|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|2|||
127543914|NCT04026113|458958359|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
127543915|NCT04026113|458958360|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
127543916|NCT04026113|458958357|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
127543917|NCT04026113|458958358|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
128011478|NCT01134042|460668855|FG001|Overall Study|Protocol Violation|3|||
128011479|NCT01134042|460668856|FG002|Overall Study|Protocol Violation|5|||
128011480|NCT01134042|460668854|FG000|Overall Study|Lost to Follow-up|2|||
128011481|NCT01134042|460668855|FG001|Overall Study|Lost to Follow-up|0|||
128011482|NCT01134042|460668856|FG002|Overall Study|Lost to Follow-up|1|||
128011483|NCT01134042|460668854|FG000|Overall Study|Physician Decision|4|||
128011484|NCT01134042|460668855|FG001|Overall Study|Physician Decision|8|||
128011485|NCT01134042|460668856|FG002|Overall Study|Physician Decision|1|||
128011486|NCT01134042|460668854|FG000|Overall Study|Withdrawal by Subject|13|||
128011487|NCT01134042|460668855|FG001|Overall Study|Withdrawal by Subject|4|||
128011488|NCT01134042|460668856|FG002|Overall Study|Withdrawal by Subject|7|||
128011489|NCT00393367|460668857|FG000|Overall Study|Protocol Violation|2|||
128011490|NCT00393367|460668858|FG001|Overall Study|Protocol Violation|5|||
128011491|NCT00393367|460668857|FG000|Overall Study|Withdrawal by Subject|0|||
128011492|NCT00393367|460668858|FG001|Overall Study|Withdrawal by Subject|2|||
128011493|NCT03286504|460668859|FG000|Overall Study|Lost to Follow-up|19|||
128011494|NCT03286504|460668860|FG001|Overall Study|Lost to Follow-up|16|||
128011495|NCT01432327|460668861|FG000|Posttest 3 Months|depression|3|||
128011496|NCT01432327|460668862|FG001|Posttest 3 Months|depression|0|||
128011497|NCT01432327|460668863|FG002|Posttest 3 Months|depression|0|||
128011498|NCT01432327|460668864|FG003|Posttest 3 Months|depression|0|||
128011499|NCT01432327|460668861|FG000|Posttest 3 Months|Lost to Follow-up|1|||
128011500|NCT01432327|460668862|FG001|Posttest 3 Months|Lost to Follow-up|0|||
128011501|NCT01432327|460668863|FG002|Posttest 3 Months|Lost to Follow-up|2|||
128011502|NCT01432327|460668864|FG003|Posttest 3 Months|Lost to Follow-up|1|||
128011503|NCT01432327|460668861|FG000|Posttest 3 Months|Allergic reaction|0|||
128011504|NCT01432327|460668862|FG001|Posttest 3 Months|Allergic reaction|2|||
128011505|NCT01432327|460668863|FG002|Posttest 3 Months|Allergic reaction|0|||
128011506|NCT01432327|460668864|FG003|Posttest 3 Months|Allergic reaction|0|||
128011507|NCT01432327|460668861|FG000|Posttest 6 Months|Lost to Follow-up|0|||
128011508|NCT01432327|460668862|FG001|Posttest 6 Months|Lost to Follow-up|0|||
128011509|NCT01432327|460668863|FG002|Posttest 6 Months|Lost to Follow-up|3|||
128011510|NCT01432327|460668864|FG003|Posttest 6 Months|Lost to Follow-up|2|||
128011511|NCT01432327|460668861|FG000|Posttest 6 Months|Allergic reaction|0|||
127677715|NCT02001623|459444491|FG008|Overall Study|Death|0|||
127677716|NCT02001623|459444492|FG009|Overall Study|Death|0|||
127677717|NCT02001623|459444493|FG010|Overall Study|Death|0|||
127677718|NCT02001623|459444494|FG011|Overall Study|Death|0|||
127677719|NCT02001623|459444495|FG012|Overall Study|Death|0|||
127677720|NCT02001623|459444496|FG013|Overall Study|Death|0|||
127677721|NCT02001623|459444497|FG014|Overall Study|Death|0|||
127677722|NCT02001623|459444483|FG000|Overall Study|Adverse Event|0|||
127677723|NCT02001623|459444484|FG001|Overall Study|Adverse Event|0|||
127677724|NCT02001623|459444485|FG002|Overall Study|Adverse Event|0|||
127677725|NCT02001623|459444486|FG003|Overall Study|Adverse Event|0|||
127677726|NCT02001623|459444487|FG004|Overall Study|Adverse Event|0|||
127677727|NCT02001623|459444488|FG005|Overall Study|Adverse Event|1|||
128011512|NCT01432327|460668862|FG001|Posttest 6 Months|Allergic reaction|0|||
127677728|NCT02001623|459444489|FG006|Overall Study|Adverse Event|0|||
127677729|NCT02001623|459444490|FG007|Overall Study|Adverse Event|3|||
127677730|NCT02001623|459444491|FG008|Overall Study|Adverse Event|4|||
127677731|NCT02001623|459444492|FG009|Overall Study|Adverse Event|6|||
128011513|NCT01432327|460668863|FG002|Posttest 6 Months|Allergic reaction|1|||
128011514|NCT01432327|460668864|FG003|Posttest 6 Months|Allergic reaction|0|||
128011515|NCT01432327|460668861|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
128011516|NCT01432327|460668862|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
128011517|NCT01432327|460668863|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
128011518|NCT01432327|460668864|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
128011519|NCT01432327|460668861|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
128011520|NCT01432327|460668862|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
127677732|NCT02001623|459444493|FG010|Overall Study|Adverse Event|4|||
127677733|NCT02001623|459444494|FG011|Overall Study|Adverse Event|0|||
128011521|NCT01432327|460668863|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
128011522|NCT01432327|460668864|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
128011523|NCT01432327|460668861|FG000|Posttest 1 Year|Lost to Follow-up|0|||
128011524|NCT01432327|460668862|FG001|Posttest 1 Year|Lost to Follow-up|0|||
128011525|NCT01432327|460668863|FG002|Posttest 1 Year|Lost to Follow-up|4|||
128011526|NCT01432327|460668864|FG003|Posttest 1 Year|Lost to Follow-up|2|||
128011527|NCT01432327|460668861|FG000|Posttest 1 Year|Allergic reaction|0|||
128011528|NCT01432327|460668862|FG001|Posttest 1 Year|Allergic reaction|0|||
128011529|NCT01432327|460668863|FG002|Posttest 1 Year|Allergic reaction|1|||
128011530|NCT01432327|460668864|FG003|Posttest 1 Year|Allergic reaction|1|||
128011531|NCT02030600|460668869|FG000|Treatment Period 1|Adverse Event|5|||
128011532|NCT02030600|460668870|FG001|Treatment Period 1|Adverse Event|7|||
128011533|NCT02030600|460668869|FG000|Treatment Period 1|Lack of Efficacy|0|||
127677734|NCT02001623|459444495|FG012|Overall Study|Adverse Event|3|||
127677735|NCT02001623|459444496|FG013|Overall Study|Adverse Event|5|||
127677736|NCT02001623|459444497|FG014|Overall Study|Adverse Event|6|||
127677737|NCT02001623|459444483|FG000|Overall Study|Other - Miscellaneous|0|||
127677738|NCT02001623|459444484|FG001|Overall Study|Other - Miscellaneous|0|||
127677739|NCT02001623|459444485|FG002|Overall Study|Other - Miscellaneous|0|||
127677740|NCT02001623|459444486|FG003|Overall Study|Other - Miscellaneous|0|||
127677741|NCT02001623|459444487|FG004|Overall Study|Other - Miscellaneous|0|||
127677742|NCT02001623|459444488|FG005|Overall Study|Other - Miscellaneous|0|||
127677743|NCT02001623|459444489|FG006|Overall Study|Other - Miscellaneous|0|||
127677744|NCT02001623|459444490|FG007|Overall Study|Other - Miscellaneous|0|||
127677745|NCT02001623|459444491|FG008|Overall Study|Other - Miscellaneous|0|||
127677746|NCT02001623|459444492|FG009|Overall Study|Other - Miscellaneous|1|||
127677747|NCT02001623|459444493|FG010|Overall Study|Other - Miscellaneous|0|||
127677748|NCT02001623|459444494|FG011|Overall Study|Other - Miscellaneous|0|||
127677749|NCT02001623|459444495|FG012|Overall Study|Other - Miscellaneous|0|||
127677750|NCT02001623|459444496|FG013|Overall Study|Other - Miscellaneous|1|||
127677751|NCT02001623|459444497|FG014|Overall Study|Other - Miscellaneous|0|||
127677752|NCT02001623|459444483|FG000|Overall Study|Withdrawal by Subject|1|||
127677753|NCT02001623|459444484|FG001|Overall Study|Withdrawal by Subject|0|||
127677754|NCT02001623|459444485|FG002|Overall Study|Withdrawal by Subject|0|||
127677755|NCT02001623|459444486|FG003|Overall Study|Withdrawal by Subject|0|||
127677756|NCT02001623|459444487|FG004|Overall Study|Withdrawal by Subject|0|||
127677757|NCT02001623|459444488|FG005|Overall Study|Withdrawal by Subject|0|||
127677758|NCT02001623|459444489|FG006|Overall Study|Withdrawal by Subject|0|||
127677759|NCT02001623|459444490|FG007|Overall Study|Withdrawal by Subject|0|||
127677760|NCT02001623|459444491|FG008|Overall Study|Withdrawal by Subject|1|||
127677761|NCT02001623|459444492|FG009|Overall Study|Withdrawal by Subject|3|||
127677762|NCT02001623|459444493|FG010|Overall Study|Withdrawal by Subject|2|||
127677763|NCT02001623|459444494|FG011|Overall Study|Withdrawal by Subject|2|||
127677764|NCT02001623|459444495|FG012|Overall Study|Withdrawal by Subject|1|||
127677765|NCT02001623|459444496|FG013|Overall Study|Withdrawal by Subject|5|||
127677766|NCT02001623|459444497|FG014|Overall Study|Withdrawal by Subject|2|||
127677767|NCT02001623|459444483|FG000|Overall Study|Lost to Follow-up|0|||
127677768|NCT02001623|459444484|FG001|Overall Study|Lost to Follow-up|0|||
127677769|NCT02001623|459444485|FG002|Overall Study|Lost to Follow-up|0|||
127677770|NCT02001623|459444486|FG003|Overall Study|Lost to Follow-up|0|||
127677771|NCT02001623|459444487|FG004|Overall Study|Lost to Follow-up|0|||
127677772|NCT02001623|459444488|FG005|Overall Study|Lost to Follow-up|0|||
127677773|NCT02001623|459444489|FG006|Overall Study|Lost to Follow-up|0|||
127677774|NCT02001623|459444490|FG007|Overall Study|Lost to Follow-up|0|||
127677775|NCT02001623|459444491|FG008|Overall Study|Lost to Follow-up|0|||
127677776|NCT02001623|459444492|FG009|Overall Study|Lost to Follow-up|1|||
128011534|NCT02030600|460668870|FG001|Treatment Period 1|Lack of Efficacy|1|||
128011535|NCT02030600|460668869|FG000|Treatment Period 1|Lost to Follow-up|11|||
128011536|NCT02030600|460668870|FG001|Treatment Period 1|Lost to Follow-up|3|||
128011537|NCT02030600|460668869|FG000|Treatment Period 1|Protocol Violation|22|||
128011538|NCT02030600|460668870|FG001|Treatment Period 1|Protocol Violation|17|||
127677777|NCT02001623|459444493|FG010|Overall Study|Lost to Follow-up|0|||
127677778|NCT02001623|459444494|FG011|Overall Study|Lost to Follow-up|0|||
127677779|NCT02001623|459444495|FG012|Overall Study|Lost to Follow-up|0|||
127677780|NCT02001623|459444496|FG013|Overall Study|Lost to Follow-up|0|||
127677781|NCT02001623|459444497|FG014|Overall Study|Lost to Follow-up|0|||
127677782|NCT02001623|459444483|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
127677783|NCT02001623|459444484|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
127677784|NCT02001623|459444485|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
127677785|NCT02001623|459444486|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
127677786|NCT02001623|459444487|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
127677787|NCT02001623|459444488|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
127677788|NCT02001623|459444489|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
128011539|NCT02030600|460668869|FG000|Treatment Period 1|Withdrawal by Subject|13|||
128011540|NCT02030600|460668870|FG001|Treatment Period 1|Withdrawal by Subject|17|||
127677789|NCT02001623|459444490|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
128011541|NCT02030600|460668869|FG000|Treatment Period 1|Casebook Unsigned|1|||
128011542|NCT02030600|460668870|FG001|Treatment Period 1|Casebook Unsigned|0|||
128011543|NCT02030600|460668869|FG000|Treatment Period 1|Unclassified|1|||
128011544|NCT02030600|460668870|FG001|Treatment Period 1|Unclassified|0|||
128011545|NCT02030600|460668869|FG000|Treatment Period 2|Adverse Event|4|||
128011546|NCT02030600|460668870|FG001|Treatment Period 2|Adverse Event|4|||
128011547|NCT02030600|460668869|FG000|Treatment Period 2|Lack of Efficacy|2|||
128011548|NCT02030600|460668870|FG001|Treatment Period 2|Lack of Efficacy|1|||
128011549|NCT02030600|460668869|FG000|Treatment Period 2|Lost to Follow-up|4|||
128011550|NCT02030600|460668870|FG001|Treatment Period 2|Lost to Follow-up|2|||
128011551|NCT02030600|460668869|FG000|Treatment Period 2|Protocol Violation|1|||
128011552|NCT02030600|460668870|FG001|Treatment Period 2|Protocol Violation|2|||
128011553|NCT02030600|460668869|FG000|Treatment Period 2|Withdrawal by Subject|13|||
128011554|NCT02030600|460668870|FG001|Treatment Period 2|Withdrawal by Subject|9|||
128011555|NCT02030600|460668869|FG000|Treatment Period 2|Unclassified|1|||
128011556|NCT02030600|460668870|FG001|Treatment Period 2|Unclassified|0|||
128011557|NCT01155323|460668871|FG000|First Intervention|exclusion criteria|1|||
128011558|NCT01155323|460668872|FG001|First Intervention|exclusion criteria|1|||
128011559|NCT01155323|460668871|FG000|Second Intervention|Lost to Follow-up|1|||
128011560|NCT01155323|460668872|FG001|Second Intervention|Lost to Follow-up|1|||
128011561|NCT00937950|460668875|FG000|Overall Study|Withdrawal by Subject|23|||
128011562|NCT00937950|460668875|FG000|Overall Study|Migrated/moved from study area|27|||
128011563|NCT00937950|460668875|FG000|Overall Study|Lost to Follow-up|144|||
128011564|NCT00937950|460668875|FG000|Overall Study|Missing confirmed|4|||
128011565|NCT00937950|460668875|FG000|Overall Study|Other|18|||
128011566|NCT04154956|460668876|FG000|Overall Study|Death|109|||
128011567|NCT04154956|460668877|FG001|Overall Study|Death|110|||
128011568|NCT04154956|460668876|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
128011569|NCT04154956|460668877|FG001|Overall Study|Not related to Coronavirus disease 2019|1|||
128011570|NCT04154956|460668876|FG000|Overall Study|Withdrawal by Subject|1|||
128011571|NCT04154956|460668877|FG001|Overall Study|Withdrawal by Subject|7|||
128011572|NCT04154956|460668876|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|36|||
128011573|NCT04154956|460668877|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|25|||
128011574|NCT00805532|460668878|FG000|Overall Study|invalid data|0|||
128011575|NCT00805532|460668879|FG001|Overall Study|invalid data|1|||
128011576|NCT01859741|460668880|FG000|Overall Study|Death|3|||
128011577|NCT01859741|460668881|FG001|Overall Study|Death|2|||
128011578|NCT01859741|460668882|FG002|Overall Study|Death|4|||
128011579|NCT01859741|460668883|FG003|Overall Study|Death|3|||
128011580|NCT01859741|460668884|FG004|Overall Study|Death|5|||
128011581|NCT01859741|460668885|FG005|Overall Study|Death|4|||
128011582|NCT01859741|460668886|FG006|Overall Study|Death|51|||
128011583|NCT01859741|460668887|FG007|Overall Study|Death|51|||
128011584|NCT01859741|460668880|FG000|Overall Study|Lost to Follow-up|0|||
128011585|NCT01859741|460668881|FG001|Overall Study|Lost to Follow-up|0|||
128011586|NCT01859741|460668882|FG002|Overall Study|Lost to Follow-up|0|||
128011587|NCT01859741|460668883|FG003|Overall Study|Lost to Follow-up|0|||
128011588|NCT01859741|460668884|FG004|Overall Study|Lost to Follow-up|0|||
128011589|NCT01859741|460668885|FG005|Overall Study|Lost to Follow-up|1|||
128011590|NCT01859741|460668886|FG006|Overall Study|Lost to Follow-up|0|||
128011591|NCT01859741|460668887|FG007|Overall Study|Lost to Follow-up|4|||
128011592|NCT01859741|460668880|FG000|Overall Study|Withdrawal by Subject|0|||
128011593|NCT01859741|460668881|FG001|Overall Study|Withdrawal by Subject|1|||
128011594|NCT01859741|460668882|FG002|Overall Study|Withdrawal by Subject|2|||
128011595|NCT01859741|460668883|FG003|Overall Study|Withdrawal by Subject|0|||
128011596|NCT01859741|460668884|FG004|Overall Study|Withdrawal by Subject|0|||
128011597|NCT01859741|460668885|FG005|Overall Study|Withdrawal by Subject|1|||
128011598|NCT01859741|460668886|FG006|Overall Study|Withdrawal by Subject|1|||
128011599|NCT01859741|460668887|FG007|Overall Study|Withdrawal by Subject|1|||
128011600|NCT01859741|460668880|FG000|Overall Study|Study Terminated by Sponsor|0|||
128011601|NCT01859741|460668881|FG001|Overall Study|Study Terminated by Sponsor|0|||
128011602|NCT01859741|460668882|FG002|Overall Study|Study Terminated by Sponsor|0|||
128011603|NCT01859741|460668883|FG003|Overall Study|Study Terminated by Sponsor|0|||
127543918|NCT04026113|458958359|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
128011604|NCT01859741|460668884|FG004|Overall Study|Study Terminated by Sponsor|1|||
128011605|NCT01859741|460668885|FG005|Overall Study|Study Terminated by Sponsor|0|||
128011606|NCT01859741|460668886|FG006|Overall Study|Study Terminated by Sponsor|16|||
128011607|NCT01859741|460668887|FG007|Overall Study|Study Terminated by Sponsor|14|||
128011608|NCT01859741|460668880|FG000|Overall Study|Other|0|||
128011609|NCT01859741|460668881|FG001|Overall Study|Other|0|||
128011610|NCT01859741|460668882|FG002|Overall Study|Other|0|||
128011611|NCT01859741|460668883|FG003|Overall Study|Other|0|||
128011612|NCT01859741|460668884|FG004|Overall Study|Other|0|||
128011613|NCT01859741|460668885|FG005|Overall Study|Other|0|||
128011614|NCT01859741|460668886|FG006|Overall Study|Other|2|||
128011615|NCT01859741|460668887|FG007|Overall Study|Other|0|||
128011616|NCT02412657|460668889|FG000|Overall Study|Lost to Follow-up|1|||
128011617|NCT02412657|460668890|FG001|Overall Study|Lost to Follow-up|0|||
127543919|NCT04026113|458958360|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
127543920|NCT04026113|458958357|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|4|||
127543921|NCT04026113|458958358|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
127543922|NCT04026113|458958359|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
127543923|NCT04026113|458958360|FG003|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
127764961|NCT03149549|459763565|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
127764962|NCT03149549|459763566|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
127764963|NCT03149549|459763567|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
127764964|NCT03149549|459763568|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
128011618|NCT02412657|460668891|FG002|Overall Study|Lost to Follow-up|0|||
127543924|NCT04026113|458958357|FG000|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
127543925|NCT04026113|458958358|FG001|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
127543926|NCT04026113|458958359|FG002|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
127543927|NCT04026113|458958360|FG003|Double-Blind Treatment Period (12 Weeks)|Physician Decision|0|||
127543928|NCT04026113|458958357|FG000|Double-Blind Treatment Period (12 Weeks)|Other, not specified|4|||
127543929|NCT04026113|458958358|FG001|Double-Blind Treatment Period (12 Weeks)|Other, not specified|3|||
127543930|NCT04026113|458958359|FG002|Double-Blind Treatment Period (12 Weeks)|Other, not specified|0|||
127543931|NCT04026113|458958360|FG003|Double-Blind Treatment Period (12 Weeks)|Other, not specified|1|||
127543932|NCT04026113|458958357|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
127543933|NCT04026113|458958358|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
127543934|NCT04026113|458958359|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
127543935|NCT04026113|458958360|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
127543936|NCT04026113|458958357|FG000|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
127543937|NCT04026113|458958358|FG001|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|4|||
127543938|NCT04026113|458958359|FG002|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
127543939|NCT04026113|458958360|FG003|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
127543940|NCT04026113|458958357|FG000|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
127543941|NCT04026113|458958358|FG001|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|1|||
127543942|NCT04026113|458958359|FG002|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
127543943|NCT04026113|458958360|FG003|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
127543944|NCT04026113|458958357|FG000|Post-Intervention Period (1 Week)|Other, not specified|1|||
127543945|NCT04026113|458958358|FG001|Post-Intervention Period (1 Week)|Other, not specified|0|||
127543946|NCT04026113|458958359|FG002|Post-Intervention Period (1 Week)|Other, not specified|1|||
127543947|NCT04026113|458958360|FG003|Post-Intervention Period (1 Week)|Other, not specified|0|||
127543948|NCT04613362|458958362|FG000|3 Month Follow-up|Lost to Follow-up|1|||
127543949|NCT04613362|458958363|FG001|3 Month Follow-up|Lost to Follow-up|2|||
127543950|NCT04613362|458958362|FG000|6 Month Follow-up|Lost to Follow-up|0|||
127543951|NCT04613362|458958363|FG001|6 Month Follow-up|Lost to Follow-up|1|||
127543952|NCT02218372|458958364|FG000|Overall Study|Adverse Event|1|||
127543953|NCT02218372|458958365|FG001|Overall Study|Adverse Event|1|||
127543954|NCT02218372|458958364|FG000|Overall Study|Miscellaneous|2|||
127543955|NCT02218372|458958365|FG001|Overall Study|Miscellaneous|1|||
127543956|NCT02218372|458958364|FG000|Overall Study|Randomized but did not receive treatment|2|||
127543957|NCT02218372|458958365|FG001|Overall Study|Randomized but did not receive treatment|3|||
127543958|NCT02218372|458958364|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
127543959|NCT02218372|458958365|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
127543960|NCT00671658|458958374|FG000|Overall Study|Physician Decision|5|||
127543961|NCT01921205|458958375|FG000|Overall Study|Adverse Event|12|||
127543962|NCT01921205|458958376|FG001|Overall Study|Adverse Event|7|||
127543963|NCT01921205|458958375|FG000|Overall Study|Lack of Efficacy|1|||
127543964|NCT01921205|458958376|FG001|Overall Study|Lack of Efficacy|0|||
127543965|NCT01921205|458958375|FG000|Overall Study|Protocol Violation|1|||
127543966|NCT01921205|458958376|FG001|Overall Study|Protocol Violation|3|||
127543967|NCT01921205|458958375|FG000|Overall Study|Lost to Follow-up|1|||
127543968|NCT01921205|458958376|FG001|Overall Study|Lost to Follow-up|1|||
127543969|NCT01921205|458958375|FG000|Overall Study|Withdrawal by Subject|6|||
127543970|NCT01921205|458958376|FG001|Overall Study|Withdrawal by Subject|5|||
127543971|NCT01921205|458958375|FG000|Overall Study|Use Of Prohibited Medication|0|||
127543972|NCT01921205|458958376|FG001|Overall Study|Use Of Prohibited Medication|1|||
127543973|NCT01921205|458958375|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
127543974|NCT01921205|458958376|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
127543975|NCT01921205|458958375|FG000|Overall Study|Non Compliance Of The Parent|0|||
128011619|NCT02412657|460668889|FG000|Overall Study|Protocol Violation|0|||
128011620|NCT02412657|460668890|FG001|Overall Study|Protocol Violation|2|||
128011621|NCT02412657|460668891|FG002|Overall Study|Protocol Violation|3|||
128011622|NCT00460798|460668892|FG000|Overall Study|Death|59|||
128011623|NCT00460798|460668892|FG000|Overall Study|Adverse Event|27|||
128011624|NCT00460798|460668892|FG000|Overall Study|Lost to Follow-up|19|||
128011625|NCT00460798|460668892|FG000|Overall Study|Progressive Disease|99|||
127543976|NCT01921205|458958376|FG001|Overall Study|Non Compliance Of The Parent|1|||
127543977|NCT01921205|458958375|FG000|Overall Study|Non Compliance Of Child|0|||
127543978|NCT01921205|458958376|FG001|Overall Study|Non Compliance Of Child|1|||
127543979|NCT00456846|458958378|FG000|Overall Study|Adverse Event|2|||
127543980|NCT00456846|458958379|FG001|Overall Study|Adverse Event|15|||
127543981|NCT00456846|458958378|FG000|Overall Study|Physician Decision|11|||
127543982|NCT00456846|458958379|FG001|Overall Study|Physician Decision|6|||
127543983|NCT00456846|458958378|FG000|Overall Study|Protocol Deviation|2|||
127543984|NCT00456846|458958379|FG001|Overall Study|Protocol Deviation|0|||
127543985|NCT00456846|458958378|FG000|Overall Study|Participant Discretion|1|||
127543986|NCT00456846|458958379|FG001|Overall Study|Participant Discretion|5|||
127543987|NCT00456846|458958378|FG000|Overall Study|Other|0|||
127543988|NCT00456846|458958379|FG001|Overall Study|Other|2|||
127543989|NCT03379818|458958380|FG000|Overall Study|Closures due to the Covid-19 pandemic|2|||
127543990|NCT03379818|458958381|FG001|Overall Study|Closures due to the Covid-19 pandemic|2|||
127543991|NCT03379818|458958380|FG000|Overall Study|Withdrawal by Subject|2|||
127543992|NCT03379818|458958381|FG001|Overall Study|Withdrawal by Subject|3|||
127543993|NCT03379818|458958380|FG000|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|1|||
127543994|NCT03379818|458958381|FG001|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|2|||
127543995|NCT03199976|458958383|FG000|Overall Study|Lack of Efficacy|3|||
127543996|NCT03199976|458958384|FG001|Overall Study|Lack of Efficacy|6|||
127543997|NCT03199976|458958385|FG002|Overall Study|Lack of Efficacy|13|||
127543998|NCT03199976|458958383|FG000|Overall Study|Withdrawal by Subject|1|||
127764965|NCT03149549|459763569|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
127764966|NCT03149549|459763570|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
127764967|NCT03149549|459763571|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
127764968|NCT03149549|459763572|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
127764969|NCT03149549|459763573|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
128011626|NCT00460798|460668892|FG000|Overall Study|Other|27|||
128011627|NCT00460798|460668892|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
128011628|NCT00460798|460668892|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
127764970|NCT03149549|459763574|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
127764971|NCT03149549|459763562|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
127764972|NCT03149549|459763563|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
127764973|NCT03149549|459763564|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
127764974|NCT03149549|459763565|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
127764975|NCT03149549|459763566|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
127764976|NCT03149549|459763567|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
127764977|NCT03149549|459763568|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
128011629|NCT01898130|460668893|FG000|Treatment|Withdrawal by Subject|2|||
128011630|NCT01898130|460668893|FG000|Treatment|Progressive Disease|4|||
128011631|NCT01898130|460668893|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
128011632|NCT01281306|460668900|FG000|Overall Study|Lack of Efficacy|0|||
128011633|NCT01281306|460668901|FG001|Overall Study|Lack of Efficacy|1|||
127543999|NCT03199976|458958384|FG001|Overall Study|Withdrawal by Subject|0|||
127544000|NCT03199976|458958385|FG002|Overall Study|Withdrawal by Subject|0|||
127544001|NCT03199976|458958383|FG000|Overall Study|Lost to Follow-up|0|||
127544002|NCT03199976|458958384|FG001|Overall Study|Lost to Follow-up|1|||
127544003|NCT03199976|458958385|FG002|Overall Study|Lost to Follow-up|1|||
127544004|NCT01780506|458958392|FG000|Double-Blind Phase|Randomized but not Treated|3|||
127544005|NCT01780506|458958393|FG001|Double-Blind Phase|Randomized but not Treated|2|||
127544006|NCT01780506|458958392|FG000|Double-Blind Phase|Adverse Event|4|||
127544007|NCT01780506|458958393|FG001|Double-Blind Phase|Adverse Event|14|||
127544008|NCT01780506|458958392|FG000|Double-Blind Phase|Death|1|||
127544009|NCT01780506|458958393|FG001|Double-Blind Phase|Death|2|||
127544010|NCT01780506|458958392|FG000|Double-Blind Phase|Pregnancy|2|||
127544011|NCT01780506|458958393|FG001|Double-Blind Phase|Pregnancy|1|||
127544012|NCT01780506|458958392|FG000|Double-Blind Phase|Lack of Efficacy|1|||
128011634|NCT01281306|460668902|FG002|Overall Study|Lack of Efficacy|3|||
128011635|NCT01281306|460668903|FG003|Overall Study|Lack of Efficacy|0|||
128011636|NCT01281306|460668904|FG004|Overall Study|Lack of Efficacy|2|||
127544013|NCT01780506|458958393|FG001|Double-Blind Phase|Lack of Efficacy|1|||
128011637|NCT01281306|460668905|FG005|Overall Study|Lack of Efficacy|0|||
127544014|NCT01780506|458958392|FG000|Double-Blind Phase|Investigator's Discretion|5|||
127544015|NCT01780506|458958393|FG001|Double-Blind Phase|Investigator's Discretion|2|||
127544016|NCT01780506|458958392|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
127544017|NCT01780506|458958393|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
127544018|NCT01780506|458958392|FG000|Double-Blind Phase|Protocol Violation|4|||
127544019|NCT01780506|458958393|FG001|Double-Blind Phase|Protocol Violation|3|||
127544020|NCT01780506|458958392|FG000|Double-Blind Phase|Withdrew Consent|23|||
127544021|NCT01780506|458958393|FG001|Double-Blind Phase|Withdrew Consent|24|||
127544022|NCT01780506|458958392|FG000|Double-Blind Phase|Lost to Follow-up|23|||
127544023|NCT01780506|458958393|FG001|Double-Blind Phase|Lost to Follow-up|26|||
128011638|NCT01281306|460668906|FG006|Overall Study|Lack of Efficacy|1|||
128011639|NCT01281306|460668900|FG000|Overall Study|Withdrawal by Subject|1|||
128011640|NCT01281306|460668901|FG001|Overall Study|Withdrawal by Subject|0|||
128011641|NCT01281306|460668902|FG002|Overall Study|Withdrawal by Subject|2|||
128011642|NCT01281306|460668903|FG003|Overall Study|Withdrawal by Subject|4|||
128011643|NCT01281306|460668904|FG004|Overall Study|Withdrawal by Subject|1|||
128011644|NCT01281306|460668905|FG005|Overall Study|Withdrawal by Subject|3|||
128011645|NCT01281306|460668906|FG006|Overall Study|Withdrawal by Subject|1|||
128011646|NCT01281306|460668900|FG000|Overall Study|Protocol deviation|0|||
128011647|NCT01281306|460668901|FG001|Overall Study|Protocol deviation|1|||
128011648|NCT01281306|460668902|FG002|Overall Study|Protocol deviation|1|||
128011649|NCT01281306|460668903|FG003|Overall Study|Protocol deviation|1|||
128011650|NCT01281306|460668904|FG004|Overall Study|Protocol deviation|1|||
128011651|NCT01281306|460668905|FG005|Overall Study|Protocol deviation|0|||
128011652|NCT01281306|460668906|FG006|Overall Study|Protocol deviation|0|||
128011653|NCT01281306|460668900|FG000|Overall Study|Condition no longer requires study drug|1|||
128011654|NCT01281306|460668901|FG001|Overall Study|Condition no longer requires study drug|0|||
128011655|NCT01281306|460668902|FG002|Overall Study|Condition no longer requires study drug|0|||
128011656|NCT01281306|460668903|FG003|Overall Study|Condition no longer requires study drug|0|||
128011657|NCT01281306|460668904|FG004|Overall Study|Condition no longer requires study drug|0|||
128011658|NCT01281306|460668905|FG005|Overall Study|Condition no longer requires study drug|1|||
128011659|NCT01281306|460668906|FG006|Overall Study|Condition no longer requires study drug|1|||
128011660|NCT01281306|460668900|FG000|Overall Study|Lost to Follow-up|1|||
128011661|NCT01281306|460668901|FG001|Overall Study|Lost to Follow-up|0|||
128011662|NCT01281306|460668902|FG002|Overall Study|Lost to Follow-up|0|||
128011663|NCT01281306|460668903|FG003|Overall Study|Lost to Follow-up|2|||
128011664|NCT01281306|460668904|FG004|Overall Study|Lost to Follow-up|0|||
128011665|NCT01281306|460668905|FG005|Overall Study|Lost to Follow-up|0|||
128011666|NCT01281306|460668906|FG006|Overall Study|Lost to Follow-up|1|||
128011667|NCT01281306|460668900|FG000|Overall Study|Death|1|||
128011668|NCT01281306|460668901|FG001|Overall Study|Death|0|||
128011669|NCT01281306|460668902|FG002|Overall Study|Death|0|||
128011670|NCT01281306|460668903|FG003|Overall Study|Death|0|||
127544024|NCT01780506|458958392|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
127544025|NCT01780506|458958393|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
127544026|NCT05236270|458958394|FG000|Overall Study|Lost to Follow-up|3|||
127544027|NCT05236270|458958395|FG001|Overall Study|Lost to Follow-up|2|||
127544028|NCT05236270|458958396|FG002|Overall Study|Lost to Follow-up|0|||
127544029|NCT05236270|458958397|FG003|Overall Study|Lost to Follow-up|0|||
127544030|NCT05236270|458958398|FG004|Overall Study|Lost to Follow-up|2|||
127544031|NCT05236270|458958399|FG005|Overall Study|Lost to Follow-up|0|||
127544032|NCT05236270|458958400|FG006|Overall Study|Lost to Follow-up|1|||
127544033|NCT05236270|458958401|FG007|Overall Study|Lost to Follow-up|3|||
127544034|NCT01499940|458958402|FG000|Overall Study|Study was withdrawn before completion.|9|||
127544035|NCT00412984|458958403|FG000|Overall Study|Death|331|||
127544036|NCT00412984|458958404|FG001|Overall Study|Death|349|||
127544037|NCT00412984|458958403|FG000|Overall Study|Adverse Event|679|||
127544038|NCT00412984|458958404|FG001|Overall Study|Adverse Event|738|||
127544039|NCT00412984|458958403|FG000|Overall Study|Withdrawal by Subject|921|||
127544040|NCT00412984|458958404|FG001|Overall Study|Withdrawal by Subject|989|||
127544041|NCT00412984|458958403|FG000|Overall Study|Lost to Follow-up|51|||
127544042|NCT00412984|458958404|FG001|Overall Study|Lost to Follow-up|39|||
127544043|NCT00412984|458958403|FG000|Overall Study|Poor/Noncompliance|57|||
127544044|NCT00412984|458958404|FG001|Overall Study|Poor/Noncompliance|77|||
127544045|NCT00412984|458958403|FG000|Overall Study|Pregnancy|1|||
127544046|NCT00412984|458958404|FG001|Overall Study|Pregnancy|0|||
127544047|NCT00412984|458958403|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
127544048|NCT00412984|458958404|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
127544049|NCT00412984|458958403|FG000|Overall Study|Administrative Reason by Sponsor|11|||
127544050|NCT00412984|458958404|FG001|Overall Study|Administrative Reason by Sponsor|8|||
127544051|NCT00412984|458958403|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
127544052|NCT00412984|458958404|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
127544053|NCT00412984|458958403|FG000|Overall Study|Other Reason|80|||
127544054|NCT00412984|458958404|FG001|Overall Study|Other Reason|92|||
127544055|NCT00412984|458958403|FG000|Overall Study|Not Reported|11|||
127544056|NCT00412984|458958404|FG001|Overall Study|Not Reported|12|||
128011671|NCT01281306|460668904|FG004|Overall Study|Death|0|||
128011672|NCT01281306|460668905|FG005|Overall Study|Death|0|||
128011673|NCT01281306|460668906|FG006|Overall Study|Death|0|||
128011674|NCT01281306|460668900|FG000|Overall Study|Adverse Event|3|||
128011675|NCT01281306|460668901|FG001|Overall Study|Adverse Event|2|||
128011676|NCT01281306|460668902|FG002|Overall Study|Adverse Event|2|||
128011677|NCT01281306|460668903|FG003|Overall Study|Adverse Event|3|||
127544057|NCT04914364|458958405|FG000|Overall Study|No longer eligible for study|1|||
127544058|NCT04914364|458958405|FG000|Overall Study|Lost to Follow-up|2|||
127544059|NCT04097678|458958406|FG000|Overall Study|No Radiographs Obtained During Surgery|17|||
128011678|NCT01281306|460668904|FG004|Overall Study|Adverse Event|5|||
127544060|NCT04097678|458958407|FG001|Overall Study|No Radiographs Obtained During Surgery|18|||
127544061|NCT03694678|458958408|FG000|Overall Study|Withdrawal by Subject|2|||
127544062|NCT03694678|458958409|FG001|Overall Study|Withdrawal by Subject|0|||
127544063|NCT03694678|458958408|FG000|Overall Study|Lost to Follow-up|2|||
127544064|NCT03694678|458958409|FG001|Overall Study|Lost to Follow-up|3|||
127544065|NCT05966142|458958419|FG000|Overall Study|Death|3|||
127544066|NCT05966142|458958420|FG001|Overall Study|Death|3|||
127544067|NCT05966142|458958419|FG000|Overall Study|Lost to Follow-up|55|||
127544068|NCT05966142|458958420|FG001|Overall Study|Lost to Follow-up|52|||
127544069|NCT05966142|458958419|FG000|Overall Study|Physician Decision|1|||
127544070|NCT05966142|458958420|FG001|Overall Study|Physician Decision|0|||
127544071|NCT05966142|458958419|FG000|Overall Study|Withdrawal by Subject|9|||
127544072|NCT05966142|458958420|FG001|Overall Study|Withdrawal by Subject|8|||
127544073|NCT05966142|458958419|FG000|Overall Study|Duplicate Enrollment|1|||
127544074|NCT05966142|458958420|FG001|Overall Study|Duplicate Enrollment|0|||
127544075|NCT05966142|458958419|FG000|Overall Study|Study Logistical Reason|1|||
127544076|NCT05966142|458958420|FG001|Overall Study|Study Logistical Reason|0|||
127544077|NCT05966142|458958419|FG000|Overall Study|Unable to complete follow up due to change in health|1|||
127544078|NCT05966142|458958420|FG001|Overall Study|Unable to complete follow up due to change in health|1|||
128011679|NCT01281306|460668905|FG005|Overall Study|Adverse Event|3|||
127544079|NCT04852302|458958426|FG000|Overall Study|Withdrawal by Subject|2|||
127544080|NCT04852302|458958426|FG000|Overall Study|Did not complete CALM therapy.|2|||
128011680|NCT01281306|460668906|FG006|Overall Study|Adverse Event|3|||
128011681|NCT01281306|460668900|FG000|Overall Study|Randomized in error|1|||
128011682|NCT01281306|460668901|FG001|Overall Study|Randomized in error|0|||
128011683|NCT01281306|460668902|FG002|Overall Study|Randomized in error|0|||
128011684|NCT01281306|460668903|FG003|Overall Study|Randomized in error|1|||
128011685|NCT01281306|460668904|FG004|Overall Study|Randomized in error|0|||
128011686|NCT01281306|460668905|FG005|Overall Study|Randomized in error|0|||
128011687|NCT01281306|460668906|FG006|Overall Study|Randomized in error|0|||
128011688|NCT02320396|460668907|FG000|Overall Study|Adverse Event|2|||
128011689|NCT02320396|460668908|FG001|Overall Study|Adverse Event|2|||
128011690|NCT02320396|460668907|FG000|Overall Study|Pregnancy|0|||
128011691|NCT02320396|460668908|FG001|Overall Study|Pregnancy|1|||
128011692|NCT02320396|460668907|FG000|Overall Study|Protocol Violation|0|||
128011693|NCT02320396|460668908|FG001|Overall Study|Protocol Violation|1|||
128011694|NCT02320396|460668907|FG000|Overall Study|Withdrawal by Subject|2|||
128011695|NCT02320396|460668908|FG001|Overall Study|Withdrawal by Subject|0|||
128011696|NCT03331562|460668909|FG000|Overall Study|Adverse Event|2|||
128011697|NCT03331562|460668910|FG001|Overall Study|Adverse Event|0|||
128011698|NCT03331562|460668909|FG000|Overall Study|Death|1|||
128011699|NCT03331562|460668910|FG001|Overall Study|Death|0|||
128011700|NCT03718000|460668911|FG000|Overall Study|Relocation|2|||
128011701|NCT03718000|460668912|FG001|Overall Study|Relocation|4|||
128011702|NCT03718000|460668911|FG000|Overall Study|Pregnancy|0|||
128011703|NCT03718000|460668912|FG001|Overall Study|Pregnancy|1|||
128011704|NCT01838876|460668913|FG000|Overall Study|Adverse Event|49|||
128011705|NCT01838876|460668913|FG000|Overall Study|Insufficient Therapeutic Response|10|||
128011706|NCT01838876|460668913|FG000|Overall Study|Protocol Violation|34|||
128011707|NCT01838876|460668913|FG000|Overall Study|Withdrawal of Consent|33|||
128011708|NCT01838876|460668913|FG000|Overall Study|Lost to Follow-up|21|||
128011709|NCT01838876|460668913|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
128011710|NCT01838876|460668913|FG000|Overall Study|Reason not Specified|7|||
128011711|NCT01838876|460668913|FG000|Overall Study|Did not meet eligibility criteria|78|||
128011712|NCT02101294|460668914|FG000|Overall Study|Withdrawal by Subject|5|||
128011713|NCT02101294|460668914|FG000|Overall Study|Lost to Follow-up|6|||
128011714|NCT00844519|460668919|FG000|Overall Study|Withdrawal by Subject|1|||
128011715|NCT00844519|460668920|FG001|Overall Study|Withdrawal by Subject|1|||
128011716|NCT00844519|460668919|FG000|Overall Study|Adverse Event|1|||
128011717|NCT00844519|460668920|FG001|Overall Study|Adverse Event|0|||
128011718|NCT06438601|460668921|FG000|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|1|||
127544081|NCT04711850|458958427|FG000|Overall Study|Graft loss|2|||
127544082|NCT04711850|458958428|FG001|Overall Study|Graft loss|1|||
127544083|NCT04711850|458958427|FG000|Overall Study|Patient not eligible as no AMR in feeder trial|1|||
127544084|NCT04711850|458958428|FG001|Overall Study|Patient not eligible as no AMR in feeder trial|0|||
128011719|NCT06438601|460668922|FG001|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|0|||
128011720|NCT06438601|460668921|FG000|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|1|||
128011721|NCT06438601|460668922|FG001|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|0|||
128011722|NCT00924898|460668930|FG000|Overall Study|Withdrawal by Subject|2|||
128011723|NCT01285518|460668931|FG000|Overall Study|Lost to Follow-up|0|||
128011724|NCT01285518|460668932|FG001|Overall Study|Lost to Follow-up|0|||
128011725|NCT01285518|460668933|FG002|Overall Study|Lost to Follow-up|0|||
127544085|NCT04711850|458958427|FG000|Overall Study|Study terminated by sponsor|5|||
127544086|NCT04711850|458958428|FG001|Overall Study|Study terminated by sponsor|3|||
128011726|NCT01285518|460668934|FG003|Overall Study|Lost to Follow-up|0|||
128011727|NCT01285518|460668935|FG004|Overall Study|Lost to Follow-up|0|||
128011728|NCT01285518|460668936|FG005|Overall Study|Lost to Follow-up|1|||
127544087|NCT04711850|458958427|FG000|Overall Study|Sponsor decision|0|||
127544088|NCT04711850|458958428|FG001|Overall Study|Sponsor decision|2|||
127544089|NCT03267277|458958429|FG000|Overall Study|Withdrawal by Subject|1|||
127544090|NCT03521570|458958430|FG000|Overall Study|Not eligible|11|||
128011729|NCT01285518|460668937|FG006|Overall Study|Lost to Follow-up|0|||
128011730|NCT01285518|460668938|FG007|Overall Study|Lost to Follow-up|0|||
128011731|NCT01910441|460668944|FG000|Overall Study|Sponsor decision|0|||
128011732|NCT01910441|460668945|FG001|Overall Study|Sponsor decision|2|||
128011733|NCT01910441|460668944|FG000|Overall Study|Lost to Follow-up|6|||
128011734|NCT01910441|460668945|FG001|Overall Study|Lost to Follow-up|5|||
128011735|NCT01910441|460668944|FG000|Overall Study|Withdrawal by Subject|0|||
128011736|NCT01910441|460668945|FG001|Overall Study|Withdrawal by Subject|1|||
127544091|NCT04531176|458958433|FG000|Overall Study|Study was stopped early|24|||
127544092|NCT04531176|458958434|FG001|Overall Study|Study was stopped early|26|||
127544093|NCT04531176|458958435|FG002|Overall Study|Study was stopped early|24|||
127544094|NCT03605667|458958443|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
127544095|NCT03605667|458958444|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
127544096|NCT03605667|458958443|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
127544097|NCT03605667|458958444|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
127544098|NCT03605667|458958443|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
127544099|NCT03605667|458958444|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
127544100|NCT03605667|458958443|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
127544101|NCT03605667|458958444|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
128011737|NCT01910441|460668944|FG000|Overall Study|Non-compliance|0|||
128011738|NCT01910441|460668945|FG001|Overall Study|Non-compliance|1|||
128011739|NCT01910441|460668944|FG000|Overall Study|Adverse Event|1|||
128011740|NCT01910441|460668945|FG001|Overall Study|Adverse Event|0|||
128011741|NCT01910441|460668944|FG000|Overall Study|Physician Decision|0|||
128011742|NCT01910441|460668945|FG001|Overall Study|Physician Decision|1|||
128011743|NCT01811238|460668946|FG000|Overall Study|Withdrawal by Subject|42|||
128011744|NCT01811238|460668946|FG000|Overall Study|Adverse Event|25|||
128011745|NCT01811238|460668946|FG000|Overall Study|Protocol Violation|4|||
128011746|NCT01811238|460668946|FG000|Overall Study|Lack of Efficacy|4|||
128011747|NCT01811238|460668946|FG000|Overall Study|subject refused study medication|6|||
128011748|NCT01192178|460668947|FG000|Overall Study|Withdrawal by Subject|6|||
128011749|NCT01192178|460668948|FG001|Overall Study|Withdrawal by Subject|10|||
127544102|NCT03605667|458958443|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
127544103|NCT03605667|458958444|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
127544104|NCT03605667|458958443|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
127544105|NCT03605667|458958444|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
127544106|NCT03605667|458958443|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
127544107|NCT03605667|458958444|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
127544108|NCT03605667|458958443|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
127544109|NCT03605667|458958444|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
127544110|NCT03605667|458958443|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
127544111|NCT03605667|458958444|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
127544112|NCT03605667|458958443|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
127544113|NCT03605667|458958444|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
127544114|NCT03605667|458958443|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
127544115|NCT03605667|458958444|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
127544116|NCT03605667|458958443|FG000|OLE Phase (48 Weeks)|Other|6|||
127544117|NCT03605667|458958444|FG001|OLE Phase (48 Weeks)|Other|8|||
127544118|NCT03605667|458958443|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
127544119|NCT03605667|458958444|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
127544120|NCT03605667|458958443|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
127544121|NCT03605667|458958444|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
127544122|NCT03605667|458958443|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
127544123|NCT03605667|458958444|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
127544124|NCT03605667|458958443|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
127544125|NCT03605667|458958444|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
127544126|NCT03605667|458958443|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
127544127|NCT03605667|458958444|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
127544128|NCT03605667|458958443|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
127544129|NCT03605667|458958444|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
127544130|NCT03605667|458958443|FG000|OLE Phase (48 Weeks)|Death|0|||
127544131|NCT03605667|458958444|FG001|OLE Phase (48 Weeks)|Death|2|||
127544132|NCT03605667|458958443|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
128011750|NCT01192178|460668947|FG000|Overall Study|Protocol Violation|10|||
128011751|NCT01192178|460668948|FG001|Overall Study|Protocol Violation|3|||
127544133|NCT03605667|458958444|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
128011752|NCT01192178|460668947|FG000|Overall Study|Physician Decision|2|||
127544134|NCT03312231|458958450|FG000|Overall Study|Lost to Follow-up|2|||
128011753|NCT01192178|460668948|FG001|Overall Study|Physician Decision|4|||
127544135|NCT03312231|458958451|FG001|Overall Study|Lost to Follow-up|6|||
127544136|NCT03312231|458958452|FG002|Overall Study|Lost to Follow-up|1|||
127544137|NCT03312231|458958453|FG003|Overall Study|Lost to Follow-up|3|||
127544138|NCT03312231|458958454|FG004|Overall Study|Lost to Follow-up|1|||
127544139|NCT03312231|458958450|FG000|Overall Study|Withdrawal by Subject|0|||
127544140|NCT03312231|458958451|FG001|Overall Study|Withdrawal by Subject|3|||
127544141|NCT03312231|458958452|FG002|Overall Study|Withdrawal by Subject|1|||
127544142|NCT03312231|458958453|FG003|Overall Study|Withdrawal by Subject|0|||
127544143|NCT03312231|458958454|FG004|Overall Study|Withdrawal by Subject|0|||
127544144|NCT03312231|458958450|FG000|Overall Study|Death|0|||
127544145|NCT03312231|458958451|FG001|Overall Study|Death|1|||
127544146|NCT03312231|458958452|FG002|Overall Study|Death|1|||
127544147|NCT03312231|458958453|FG003|Overall Study|Death|0|||
127544148|NCT03312231|458958454|FG004|Overall Study|Death|0|||
127544149|NCT03312231|458958450|FG000|Overall Study|Study Vaccination not Received|1|||
127544150|NCT03312231|458958451|FG001|Overall Study|Study Vaccination not Received|1|||
127544151|NCT03312231|458958452|FG002|Overall Study|Study Vaccination not Received|1|||
127544152|NCT03312231|458958453|FG003|Overall Study|Study Vaccination not Received|0|||
127544153|NCT03312231|458958454|FG004|Overall Study|Study Vaccination not Received|0|||
127544154|NCT03157830|458958455|FG000|Overall Study|Lost to Follow-up|1|||
127544155|NCT03157830|458958455|FG000|Overall Study|Withdrawal by Subject|1|||
127544156|NCT00400179|458958456|FG000|Overall Study|Adverse Event|2|||
127544157|NCT00400179|458958457|FG001|Overall Study|Adverse Event|2|||
127544158|NCT00400179|458958456|FG000|Overall Study|Death|1|||
127544159|NCT00400179|458958457|FG001|Overall Study|Death|2|||
127544160|NCT00400179|458958456|FG000|Overall Study|Withdrew Consent|1|||
127544161|NCT00400179|458958457|FG001|Overall Study|Withdrew Consent|5|||
127544162|NCT00400179|458958456|FG000|Overall Study|Disease progression|1|||
127544163|NCT00400179|458958457|FG001|Overall Study|Disease progression|1|||
127544164|NCT00400179|458958456|FG000|Overall Study|Intercurrent illness|0|||
127544165|NCT00400179|458958457|FG001|Overall Study|Intercurrent illness|1|||
127544166|NCT00400179|458958456|FG000|Overall Study|Investigator judgment|0|||
127544167|NCT00400179|458958457|FG001|Overall Study|Investigator judgment|1|||
127544168|NCT00400179|458958456|FG000|Overall Study|Randomization error/patient ineligible|1|||
127544169|NCT00400179|458958457|FG001|Overall Study|Randomization error/patient ineligible|6|||
127544170|NCT01972217|458960614|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
127544171|NCT01972217|458960615|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
127544172|NCT01972217|458960616|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
127544173|NCT01972217|458960617|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
127544174|NCT01972217|458960614|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
127544175|NCT01972217|458960615|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
127544176|NCT01972217|458960616|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
127544177|NCT01972217|458960617|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
127544178|NCT01972217|458960614|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
127544179|NCT01972217|458960615|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
127544180|NCT01972217|458960616|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
127544181|NCT01972217|458960617|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
128011754|NCT01192178|460668947|FG000|Overall Study|Lost to Follow-up|3|||
127544182|NCT01972217|458960614|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
127544183|NCT01972217|458960615|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
127544184|NCT01972217|458960616|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
127544185|NCT01972217|458960617|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
127544186|NCT01972217|458960614|FG000|Part B Double-blind, Randomised Period|Death|0|||
127544187|NCT01972217|458960615|FG001|Part B Double-blind, Randomised Period|Death|0|||
128011755|NCT01192178|460668948|FG001|Overall Study|Lost to Follow-up|3|||
128011756|NCT01192178|460668947|FG000|Overall Study|Adverse Event|2|||
128011757|NCT01192178|460668948|FG001|Overall Study|Adverse Event|1|||
128011758|NCT01192178|460668947|FG000|Overall Study|Lack of Efficacy|1|||
128011759|NCT01192178|460668948|FG001|Overall Study|Lack of Efficacy|2|||
128011760|NCT01977846|460668951|FG000|Total Study - Prospective|Death|0|||
128011761|NCT01977846|460668952|FG001|Total Study - Prospective|Death|1|||
128011762|NCT01977846|460668951|FG000|Total Study - Prospective|Lost to Follow-up|0|||
128011763|NCT01977846|460668952|FG001|Total Study - Prospective|Lost to Follow-up|8|||
128011764|NCT01977846|460668951|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
127544188|NCT01972217|458960616|FG002|Part B Double-blind, Randomised Period|Death|43|||
127544189|NCT01972217|458960617|FG003|Part B Double-blind, Randomised Period|Death|44|||
127544190|NCT01972217|458960614|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
127544191|NCT01972217|458960615|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
127544192|NCT01972217|458960616|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
127544193|NCT01972217|458960617|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
127544194|NCT01972217|458960614|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
128011765|NCT01977846|460668952|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
128011766|NCT01977846|460668951|FG000|Total Study - Prospective|Not available at time of visit|0|||
128011767|NCT01977846|460668952|FG001|Total Study - Prospective|Not available at time of visit|5|||
128011768|NCT01977846|460668951|FG000|Total Study - Prospective|No show|0|||
128011769|NCT01977846|460668952|FG001|Total Study - Prospective|No show|1|||
128011770|NCT01977846|460668951|FG000|Total Study - Prospective|Protocol Violation|0|||
128011771|NCT01977846|460668952|FG001|Total Study - Prospective|Protocol Violation|1|||
128011772|NCT02460289|460668953|FG000|Overall Study|Adverse Event|1|||
128011773|NCT02460289|460668953|FG000|Overall Study|Withdrawal by Subject|8|||
128011774|NCT02460289|460668953|FG000|Overall Study|Lost to Follow-up|1|||
128011775|NCT00862992|460668960|FG000|Overall Study|Adverse Event|2|||
128011776|NCT00862992|460668961|FG001|Overall Study|Adverse Event|1|||
128011777|NCT00862992|460668962|FG002|Overall Study|Adverse Event|1|||
128011778|NCT00862992|460668960|FG000|Overall Study|Physician Decision|1|||
128011779|NCT00862992|460668961|FG001|Overall Study|Physician Decision|0|||
128011780|NCT00862992|460668962|FG002|Overall Study|Physician Decision|0|||
128011781|NCT00862992|460668960|FG000|Overall Study|Withdrawal by Subject|0|||
128011782|NCT00862992|460668961|FG001|Overall Study|Withdrawal by Subject|0|||
128011783|NCT00862992|460668962|FG002|Overall Study|Withdrawal by Subject|2|||
128011784|NCT01277861|460668964|FG000|Overall Study|Physician Decision|2|||
128011785|NCT01277861|460668965|FG001|Overall Study|Physician Decision|2|||
128011786|NCT02696798|460668966|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
128011787|NCT02696798|460668967|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
128011788|NCT02696798|460668968|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
128011789|NCT02696798|460668966|FG000|Blinded Treatment Dosing Period|Death|0|||
128011790|NCT02696798|460668967|FG001|Blinded Treatment Dosing Period|Death|0|||
128011791|NCT02696798|460668968|FG002|Blinded Treatment Dosing Period|Death|1|||
128011792|NCT02696798|460668966|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
128011793|NCT02696798|460668967|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
128011794|NCT02696798|460668968|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
128011795|NCT02696798|460668966|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
128011796|NCT02696798|460668967|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
128011797|NCT02696798|460668968|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
128011798|NCT02696798|460668966|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
128011799|NCT02696798|460668967|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
128011800|NCT02696798|460668968|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
128011801|NCT02696798|460668966|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
128011802|NCT02696798|460668967|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
128011803|NCT02696798|460668968|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
128011804|NCT02696798|460668966|FG000|Extended Treatment Period|Adverse Event|1|||
128011805|NCT02696798|460668967|FG001|Extended Treatment Period|Adverse Event|4|||
128011806|NCT02696798|460668968|FG002|Extended Treatment Period|Adverse Event|5|||
128011807|NCT02696798|460668966|FG000|Extended Treatment Period|Lack of Efficacy|7|||
128011808|NCT02696798|460668967|FG001|Extended Treatment Period|Lack of Efficacy|2|||
128011809|NCT02696798|460668968|FG002|Extended Treatment Period|Lack of Efficacy|2|||
128011810|NCT02696798|460668966|FG000|Extended Treatment Period|Lost to Follow-up|1|||
128011811|NCT02696798|460668967|FG001|Extended Treatment Period|Lost to Follow-up|0|||
128011812|NCT02696798|460668968|FG002|Extended Treatment Period|Lost to Follow-up|0|||
128011813|NCT02696798|460668966|FG000|Extended Treatment Period|Physician Decision|0|||
128011814|NCT02696798|460668967|FG001|Extended Treatment Period|Physician Decision|1|||
128011815|NCT02696798|460668968|FG002|Extended Treatment Period|Physician Decision|0|||
128011816|NCT02696798|460668966|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
128011817|NCT02696798|460668967|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
128011818|NCT02696798|460668968|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
128011819|NCT02696798|460668966|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
128011820|NCT02696798|460668967|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
128011821|NCT02696798|460668968|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
128011822|NCT02696798|460668966|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
128011823|NCT02696798|460668967|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
128011824|NCT02696798|460668968|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
128011825|NCT02696798|460668966|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
128011826|NCT02696798|460668967|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
128011827|NCT02696798|460668968|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
128011828|NCT02696798|460668966|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
128011829|NCT02696798|460668967|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
128011830|NCT02696798|460668968|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
128011831|NCT02696798|460668966|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
128011832|NCT02696798|460668967|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
128011833|NCT02696798|460668968|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
128011834|NCT02696798|460668966|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
128011835|NCT02696798|460668967|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
128011836|NCT02696798|460668968|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
127544195|NCT01972217|458960615|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
127544196|NCT01972217|458960616|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
127544197|NCT01972217|458960617|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
127544198|NCT01972217|458960614|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
127544199|NCT01972217|458960615|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
127544200|NCT01972217|458960616|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
127544201|NCT01972217|458960617|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
127544202|NCT01972217|458960614|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
127544203|NCT01972217|458960615|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
127544204|NCT01972217|458960616|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
127544205|NCT01972217|458960617|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
127544206|NCT02318706|458960618|FG000|Double-blind Phase|Adverse Event|7|||
127544207|NCT02318706|458960619|FG001|Double-blind Phase|Adverse Event|4|||
127544208|NCT02318706|458960620|FG002|Double-blind Phase|Adverse Event|3|||
127544209|NCT02318706|458960621|FG003|Double-blind Phase|Adverse Event|10|||
127544210|NCT02318706|458960622|FG004|Double-blind Phase|Adverse Event|0|||
127544211|NCT02318706|458960618|FG000|Double-blind Phase|Lost to Follow-up|1|||
127544212|NCT02318706|458960619|FG001|Double-blind Phase|Lost to Follow-up|0|||
127544213|NCT02318706|458960620|FG002|Double-blind Phase|Lost to Follow-up|0|||
127544214|NCT02318706|458960621|FG003|Double-blind Phase|Lost to Follow-up|0|||
127544215|NCT02318706|458960622|FG004|Double-blind Phase|Lost to Follow-up|0|||
127544216|NCT02318706|458960618|FG000|Double-blind Phase|Protocol Violation|4|||
127544217|NCT02318706|458960619|FG001|Double-blind Phase|Protocol Violation|2|||
127544218|NCT02318706|458960620|FG002|Double-blind Phase|Protocol Violation|4|||
127544219|NCT02318706|458960621|FG003|Double-blind Phase|Protocol Violation|3|||
127544220|NCT02318706|458960622|FG004|Double-blind Phase|Protocol Violation|0|||
127764978|NCT03149549|459763569|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
127764979|NCT03149549|459763570|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
127764980|NCT03149549|459763571|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
127764981|NCT03149549|459763572|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
128011837|NCT03454555|460671308|FG000|Overall Study|Death|6|||
128011838|NCT03454555|460671309|FG001|Overall Study|Death|6|||
127544221|NCT02318706|458960618|FG000|Double-blind Phase|Withdrawal by Subject|9|||
128011839|NCT03454555|460671308|FG000|Overall Study|Lost to Follow-up|31|||
128011840|NCT03454555|460671309|FG001|Overall Study|Lost to Follow-up|12|||
128011841|NCT03454555|460671308|FG000|Overall Study|Physician Decision|2|||
128011842|NCT03454555|460671309|FG001|Overall Study|Physician Decision|6|||
128011843|NCT03454555|460671308|FG000|Overall Study|Withdrawal by Subject|34|||
128011844|NCT03454555|460671309|FG001|Overall Study|Withdrawal by Subject|5|||
128011845|NCT03454555|460671308|FG000|Overall Study|Ineligible|1|||
128011846|NCT03454555|460671309|FG001|Overall Study|Ineligible|5|||
128011847|NCT04530630|460671310|FG000|Overall Study|Physician Decision|1|||
128011848|NCT03675308|460671313|FG000|Overall Study|Adverse Event|3|||
128011849|NCT03675308|460671314|FG001|Overall Study|Adverse Event|2|||
128011850|NCT03675308|460671313|FG000|Overall Study|Withdrawal by Subject|6|||
128011851|NCT03675308|460671314|FG001|Overall Study|Withdrawal by Subject|4|||
128011852|NCT03675308|460671313|FG000|Overall Study|Lost to Follow-up|3|||
128011853|NCT03675308|460671314|FG001|Overall Study|Lost to Follow-up|0|||
128011854|NCT03675308|460671313|FG000|Overall Study|Lack of Efficacy|1|||
128011855|NCT03675308|460671314|FG001|Overall Study|Lack of Efficacy|1|||
128011856|NCT03675308|460671313|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
128011857|NCT03675308|460671314|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
128011858|NCT03675308|460671313|FG000|Overall Study|Other|0|||
128011859|NCT03675308|460671314|FG001|Overall Study|Other|1|||
128011860|NCT01386385|460671317|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
128011861|NCT01386385|460671318|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
128011862|NCT01386385|460671319|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
128011863|NCT01386385|460671320|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
128011864|NCT01386385|460671321|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
128011865|NCT01386385|460671322|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
128011866|NCT01386385|460671323|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
128011867|NCT01386385|460671324|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
128011868|NCT01386385|460671317|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
128011869|NCT01386385|460671318|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
128011870|NCT01386385|460671319|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
127544222|NCT02318706|458960619|FG001|Double-blind Phase|Withdrawal by Subject|5|||
127544223|NCT02318706|458960620|FG002|Double-blind Phase|Withdrawal by Subject|7|||
128011871|NCT01386385|460671320|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
128011872|NCT01386385|460671321|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
127544224|NCT02318706|458960621|FG003|Double-blind Phase|Withdrawal by Subject|10|||
127544225|NCT02318706|458960622|FG004|Double-blind Phase|Withdrawal by Subject|0|||
127544226|NCT02318706|458960618|FG000|Double-blind Phase|Other|4|||
127544227|NCT02318706|458960619|FG001|Double-blind Phase|Other|1|||
127544228|NCT02318706|458960620|FG002|Double-blind Phase|Other|2|||
127544229|NCT02318706|458960621|FG003|Double-blind Phase|Other|1|||
127544230|NCT02318706|458960622|FG004|Double-blind Phase|Other|0|||
127544231|NCT02318706|458960618|FG000|Double-blind Phase|Death|0|||
127544232|NCT02318706|458960619|FG001|Double-blind Phase|Death|0|||
127544233|NCT02318706|458960620|FG002|Double-blind Phase|Death|2|||
127544234|NCT02318706|458960621|FG003|Double-blind Phase|Death|0|||
127544235|NCT02318706|458960622|FG004|Double-blind Phase|Death|0|||
127544236|NCT02318706|458960618|FG000|Open-label Extension Phase|Adverse Event|0|||
127544237|NCT02318706|458960619|FG001|Open-label Extension Phase|Adverse Event|0|||
127544238|NCT02318706|458960620|FG002|Open-label Extension Phase|Adverse Event|0|||
127544239|NCT02318706|458960621|FG003|Open-label Extension Phase|Adverse Event|0|||
127544240|NCT02318706|458960622|FG004|Open-label Extension Phase|Adverse Event|21|||
127544241|NCT02318706|458960618|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
127544242|NCT02318706|458960619|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
127544243|NCT02318706|458960620|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
127544244|NCT02318706|458960621|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
127544245|NCT02318706|458960622|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
127544246|NCT02318706|458960618|FG000|Open-label Extension Phase|Death|0|||
127544247|NCT02318706|458960619|FG001|Open-label Extension Phase|Death|0|||
127544248|NCT02318706|458960620|FG002|Open-label Extension Phase|Death|0|||
127544249|NCT02318706|458960621|FG003|Open-label Extension Phase|Death|0|||
127544250|NCT02318706|458960622|FG004|Open-label Extension Phase|Death|1|||
127544251|NCT02318706|458960618|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
127544252|NCT02318706|458960619|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
127544253|NCT02318706|458960620|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
127544254|NCT02318706|458960621|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
127544255|NCT02318706|458960622|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
127544256|NCT00992108|458960632|FG000|Overall Study|Lost to Follow-up|0|||
127544257|NCT00992108|458960633|FG001|Overall Study|Lost to Follow-up|1|||
127544258|NCT01702311|458960634|FG000|Overall Study|Withdrawal by Subject|3|||
127544259|NCT01702311|458960635|FG001|Overall Study|Withdrawal by Subject|2|||
127544260|NCT01702311|458960634|FG000|Overall Study|Discharge less than 24 hours|10|||
127544261|NCT01702311|458960635|FG001|Overall Study|Discharge less than 24 hours|7|||
127544262|NCT01702311|458960634|FG000|Overall Study|Physician Decision|3|||
127544263|NCT01702311|458960635|FG001|Overall Study|Physician Decision|4|||
127544264|NCT04106557|458960637|FG000|Overall Study|Physician Decision|0|||
127544265|NCT04106557|458960638|FG001|Overall Study|Physician Decision|1|||
127544266|NCT04106557|458960639|FG002|Overall Study|Physician Decision|0|||
127544267|NCT04106557|458960637|FG000|Overall Study|Protocol Violation|0|||
127544268|NCT04106557|458960638|FG001|Overall Study|Protocol Violation|1|||
127544269|NCT04106557|458960639|FG002|Overall Study|Protocol Violation|0|||
127544270|NCT01209689|458960640|FG000|Overall Study|Insufficient Therapeutic Response|7|||
127544271|NCT01209689|458960641|FG001|Overall Study|Insufficient Therapeutic Response|2|||
127544272|NCT01209689|458960640|FG000|Overall Study|Refused Treatment|8|||
127544273|NCT01209689|458960641|FG001|Overall Study|Refused Treatment|3|||
127544274|NCT01209689|458960640|FG000|Overall Study|Adverse Event|4|||
127544275|NCT01209689|458960641|FG001|Overall Study|Adverse Event|0|||
127544276|NCT01209689|458960640|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
127544277|NCT01209689|458960641|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
127544278|NCT01209689|458960640|FG000|Overall Study|Failure to Return|3|||
127544279|NCT01209689|458960641|FG001|Overall Study|Failure to Return|0|||
127544280|NCT01209689|458960640|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
127544281|NCT01209689|458960641|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
127544282|NCT03175367|458960642|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
127544283|NCT03175367|458960643|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
127544284|NCT03175367|458960644|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
127544285|NCT03175367|458960645|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
127544286|NCT03175367|458960646|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
127544287|NCT03175367|458960647|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
127544288|NCT03175367|458960648|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
128011873|NCT01386385|460671322|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
128011874|NCT01386385|460671323|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
127544289|NCT03175367|458960642|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
127544290|NCT03175367|458960643|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
127544291|NCT03175367|458960644|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
127544292|NCT03175367|458960645|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
127544293|NCT03175367|458960646|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
127544294|NCT03175367|458960647|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
128011875|NCT01386385|460671324|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
127544295|NCT03175367|458960648|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
127544296|NCT03175367|458960642|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
128011876|NCT01386385|460671317|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
128011877|NCT01386385|460671318|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
128011878|NCT01386385|460671319|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
128011879|NCT01386385|460671320|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
128011880|NCT01386385|460671321|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
128011881|NCT01386385|460671322|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
128011882|NCT01386385|460671323|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
128011883|NCT01386385|460671324|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
128011884|NCT01386385|460671317|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
128011885|NCT01386385|460671318|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
128011886|NCT01386385|460671319|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
128011887|NCT01386385|460671320|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
128011888|NCT01386385|460671321|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
128011889|NCT01386385|460671322|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
128011890|NCT01386385|460671323|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
128011891|NCT01386385|460671324|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
128011892|NCT01386385|460671317|FG000|Phase II Concurrent CRT|Adverse Event|0|||
128011893|NCT01386385|460671318|FG001|Phase II Concurrent CRT|Adverse Event|0|||
128011894|NCT01386385|460671319|FG002|Phase II Concurrent CRT|Adverse Event|0|||
128011895|NCT01386385|460671320|FG003|Phase II Concurrent CRT|Adverse Event|0|||
128011896|NCT01386385|460671321|FG004|Phase II Concurrent CRT|Adverse Event|0|||
128011897|NCT01386385|460671322|FG005|Phase II Concurrent CRT|Adverse Event|0|||
128011898|NCT01386385|460671323|FG006|Phase II Concurrent CRT|Adverse Event|3|||
128011899|NCT01386385|460671324|FG007|Phase II Concurrent CRT|Adverse Event|3|||
128011900|NCT01386385|460671317|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
128011901|NCT01386385|460671318|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
128011902|NCT01386385|460671319|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
128011903|NCT01386385|460671320|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
128011904|NCT01386385|460671321|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
128011905|NCT01386385|460671322|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
128011906|NCT01386385|460671323|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
128011907|NCT01386385|460671324|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
128011908|NCT01386385|460671317|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
128011909|NCT01386385|460671318|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
128011910|NCT01386385|460671319|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
128011911|NCT01386385|460671320|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
128011912|NCT01386385|460671321|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
128011913|NCT01386385|460671322|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
128011914|NCT01386385|460671323|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
128011915|NCT01386385|460671324|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
128011916|NCT01386385|460671317|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
128011917|NCT01386385|460671318|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
128011918|NCT01386385|460671319|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
128011919|NCT01386385|460671320|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
128011920|NCT01386385|460671321|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
128011921|NCT01386385|460671322|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
128011922|NCT01386385|460671323|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
128011923|NCT01386385|460671324|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
127544297|NCT03175367|458960643|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
127544298|NCT03175367|458960644|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
127544299|NCT03175367|458960645|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
127544300|NCT03175367|458960646|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
128011924|NCT01386385|460671317|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
128011925|NCT01386385|460671318|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
128011926|NCT01386385|460671319|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
128011927|NCT01386385|460671320|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
128011928|NCT01386385|460671321|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
128011929|NCT01386385|460671322|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
128011930|NCT01386385|460671323|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
128011931|NCT01386385|460671324|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
128011932|NCT00788671|460671326|FG000|Overall Study|Death|2|||
128011933|NCT00788671|460671326|FG000|Overall Study|Unable to biopsy|1|||
128011934|NCT00788671|460671326|FG000|Overall Study|Withdrawal by Subject|4|||
128011935|NCT00788671|460671326|FG000|Overall Study|IUD expulsed|1|||
128011936|NCT00788671|460671326|FG000|Overall Study|Lost to follow up|2|||
128011937|NCT03405870|460671327|FG000|Overall Study|Withdrawal|1|||
128011938|NCT03405870|460671328|FG001|Overall Study|Withdrawal|0|||
128011939|NCT03405870|460671329|FG002|Overall Study|Withdrawal|1|||
127544301|NCT03175367|458960647|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
128011940|NCT03405870|460671330|FG003|Overall Study|Withdrawal|0|||
127677790|NCT02001623|459444491|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
127677791|NCT02001623|459444492|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
127677792|NCT02001623|459444493|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
127677793|NCT02001623|459444494|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
127677794|NCT02001623|459444495|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
127677795|NCT02001623|459444496|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
127677796|NCT02001623|459444497|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
127677797|NCT02001623|459444483|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
127677798|NCT02001623|459444484|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
127677799|NCT02001623|459444485|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
127677800|NCT02001623|459444486|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
127677801|NCT02001623|459444487|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
127677802|NCT02001623|459444488|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
127677803|NCT02001623|459444489|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
127677804|NCT02001623|459444490|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
127677805|NCT02001623|459444491|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
127677806|NCT02001623|459444492|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
127677807|NCT02001623|459444493|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
127677808|NCT02001623|459444494|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
127677809|NCT02001623|459444495|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
127677810|NCT02001623|459444496|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
127677811|NCT02001623|459444497|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
127677812|NCT00309452|459444498|FG000|Overall Study|Withdrawal by Subject|3|||
127677813|NCT00309452|459444499|FG001|Overall Study|Withdrawal by Subject|0|||
127677814|NCT00771667|459444500|FG000|Induction Phase|Adverse Event|5|||
127677815|NCT00771667|459444501|FG001|Induction Phase|Adverse Event|2|||
127677816|NCT00771667|459444502|FG002|Induction Phase|Adverse Event|4|||
127677817|NCT00771667|459444503|FG003|Induction Phase|Adverse Event|1|||
127677818|NCT00771667|459444504|FG004|Induction Phase|Adverse Event|0|||
127677819|NCT00771667|459444505|FG005|Induction Phase|Adverse Event|0|||
127677820|NCT00771667|459444506|FG006|Induction Phase|Adverse Event|0|||
127677821|NCT00771667|459444507|FG007|Induction Phase|Adverse Event|0|||
127677822|NCT00771667|459444508|FG008|Induction Phase|Adverse Event|0|||
127677823|NCT00771667|459444509|FG009|Induction Phase|Adverse Event|0|||
127677824|NCT00771667|459444500|FG000|Induction Phase|Lack of Efficacy|9|||
127677825|NCT00771667|459444501|FG001|Induction Phase|Lack of Efficacy|2|||
127677826|NCT00771667|459444502|FG002|Induction Phase|Lack of Efficacy|4|||
127677827|NCT00771667|459444503|FG003|Induction Phase|Lack of Efficacy|3|||
127677828|NCT00771667|459444504|FG004|Induction Phase|Lack of Efficacy|0|||
127677829|NCT00771667|459444505|FG005|Induction Phase|Lack of Efficacy|0|||
127677830|NCT00771667|459444506|FG006|Induction Phase|Lack of Efficacy|0|||
127677831|NCT00771667|459444507|FG007|Induction Phase|Lack of Efficacy|0|||
127677832|NCT00771667|459444508|FG008|Induction Phase|Lack of Efficacy|0|||
127677833|NCT00771667|459444509|FG009|Induction Phase|Lack of Efficacy|0|||
127677834|NCT00771667|459444500|FG000|Induction Phase|Lost to Follow-up|1|||
127677835|NCT00771667|459444501|FG001|Induction Phase|Lost to Follow-up|0|||
127677836|NCT00771667|459444502|FG002|Induction Phase|Lost to Follow-up|1|||
127677837|NCT00771667|459444503|FG003|Induction Phase|Lost to Follow-up|0|||
127677838|NCT00771667|459444504|FG004|Induction Phase|Lost to Follow-up|0|||
127677839|NCT00771667|459444505|FG005|Induction Phase|Lost to Follow-up|0|||
127677840|NCT00771667|459444506|FG006|Induction Phase|Lost to Follow-up|0|||
127677841|NCT00771667|459444507|FG007|Induction Phase|Lost to Follow-up|0|||
127677842|NCT00771667|459444508|FG008|Induction Phase|Lost to Follow-up|0|||
127677843|NCT00771667|459444509|FG009|Induction Phase|Lost to Follow-up|0|||
127677844|NCT00771667|459444500|FG000|Induction Phase|Other|4|||
127677845|NCT00771667|459444501|FG001|Induction Phase|Other|6|||
127677846|NCT00771667|459444502|FG002|Induction Phase|Other|3|||
127677847|NCT00771667|459444503|FG003|Induction Phase|Other|4|||
127677848|NCT00771667|459444504|FG004|Induction Phase|Other|0|||
127677849|NCT00771667|459444505|FG005|Induction Phase|Other|0|||
127677850|NCT00771667|459444506|FG006|Induction Phase|Other|0|||
127677851|NCT00771667|459444507|FG007|Induction Phase|Other|0|||
127677852|NCT00771667|459444508|FG008|Induction Phase|Other|0|||
127677853|NCT00771667|459444509|FG009|Induction Phase|Other|0|||
127677854|NCT00771667|459444500|FG000|Maintenance Phase|Adverse Event|0|||
127677855|NCT00771667|459444501|FG001|Maintenance Phase|Adverse Event|0|||
127677856|NCT00771667|459444502|FG002|Maintenance Phase|Adverse Event|0|||
127677857|NCT00771667|459444503|FG003|Maintenance Phase|Adverse Event|0|||
127677858|NCT00771667|459444504|FG004|Maintenance Phase|Adverse Event|1|||
127677859|NCT00771667|459444505|FG005|Maintenance Phase|Adverse Event|3|||
127677860|NCT00771667|459444506|FG006|Maintenance Phase|Adverse Event|5|||
127677861|NCT00771667|459444507|FG007|Maintenance Phase|Adverse Event|1|||
127677862|NCT00771667|459444508|FG008|Maintenance Phase|Adverse Event|8|||
127677863|NCT00771667|459444509|FG009|Maintenance Phase|Adverse Event|7|||
127677864|NCT00771667|459444500|FG000|Maintenance Phase|Lack of Efficacy|0|||
127677865|NCT00771667|459444501|FG001|Maintenance Phase|Lack of Efficacy|0|||
127677866|NCT00771667|459444502|FG002|Maintenance Phase|Lack of Efficacy|0|||
127677867|NCT00771667|459444503|FG003|Maintenance Phase|Lack of Efficacy|0|||
127677868|NCT00771667|459444504|FG004|Maintenance Phase|Lack of Efficacy|1|||
127544302|NCT03175367|458960648|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
127544303|NCT03175367|458960642|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
127544304|NCT03175367|458960643|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
127544305|NCT03175367|458960644|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
127544306|NCT03175367|458960645|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
127544307|NCT03175367|458960646|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
127544308|NCT03175367|458960647|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
127544309|NCT03175367|458960648|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
127544310|NCT03175367|458960642|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
127544311|NCT03175367|458960643|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
128011941|NCT03405870|460671331|FG004|Overall Study|Withdrawal|0|||
128011942|NCT03405870|460671332|FG005|Overall Study|Withdrawal|0|||
128011943|NCT03405870|460671333|FG006|Overall Study|Withdrawal|1|||
128011944|NCT03405870|460671334|FG007|Overall Study|Withdrawal|0|||
128011945|NCT05172609|460671335|FG000|Time 3|Elected not to continue with study due to time constraints|1|||
127544312|NCT03175367|458960644|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
127544313|NCT03175367|458960645|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
127544314|NCT03175367|458960646|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
127544315|NCT03175367|458960647|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
127544316|NCT03175367|458960648|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
127544317|NCT03175367|458960642|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
127544318|NCT03175367|458960643|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
127544319|NCT03175367|458960644|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
127544320|NCT03175367|458960645|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
127544321|NCT03175367|458960646|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
127544322|NCT03175367|458960647|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
127544323|NCT03175367|458960648|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
127544324|NCT03175367|458960642|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
127544325|NCT03175367|458960643|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
127544326|NCT03175367|458960644|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
127544327|NCT03175367|458960645|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
127544328|NCT03175367|458960646|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
127544329|NCT03175367|458960647|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
127544330|NCT03175367|458960648|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
127544331|NCT02151058|458960649|FG000|Overall Study|Withdrawal by Subject|1|||
127544332|NCT02151058|458960650|FG001|Overall Study|Withdrawal by Subject|1|||
127544333|NCT02151058|458960651|FG002|Overall Study|Withdrawal by Subject|3|||
127544334|NCT02151058|458960649|FG000|Overall Study|Lost to Follow-up|1|||
127544335|NCT02151058|458960650|FG001|Overall Study|Lost to Follow-up|0|||
127544336|NCT02151058|458960651|FG002|Overall Study|Lost to Follow-up|2|||
127544337|NCT03181932|458960653|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
128011946|NCT05172609|460671336|FG001|Time 3|Elected not to continue with study due to time constraints|1|||
127544338|NCT03181932|458960654|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
127544339|NCT03181932|458960653|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
127544340|NCT03181932|458960654|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
127544341|NCT03181932|458960653|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
127544342|NCT03181932|458960654|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
127544343|NCT03181932|458960653|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
127544344|NCT03181932|458960654|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
128011947|NCT05172609|460671335|FG000|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|1|||
128011948|NCT05172609|460671336|FG001|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|0|||
128011949|NCT05172609|460671335|FG000|Time 4|Elected not to continue with study due to time constraints|0|||
128011950|NCT05172609|460671336|FG001|Time 4|Elected not to continue with study due to time constraints|1|||
127677869|NCT00771667|459444505|FG005|Maintenance Phase|Lack of Efficacy|3|||
127677870|NCT00771667|459444506|FG006|Maintenance Phase|Lack of Efficacy|3|||
127677871|NCT00771667|459444507|FG007|Maintenance Phase|Lack of Efficacy|2|||
127677872|NCT00771667|459444508|FG008|Maintenance Phase|Lack of Efficacy|11|||
127677873|NCT00771667|459444509|FG009|Maintenance Phase|Lack of Efficacy|7|||
127544345|NCT03181932|458960653|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
127544346|NCT03181932|458960654|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
128011951|NCT03846479|460671337|FG000|Overall Study|Death|8|||
127544347|NCT03181932|458960653|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
127544348|NCT03181932|458960654|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
127544349|NCT03181932|458960653|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
127544350|NCT03181932|458960654|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
127677874|NCT00771667|459444500|FG000|Maintenance Phase|Other|0|||
127677875|NCT00771667|459444501|FG001|Maintenance Phase|Other|0|||
127677876|NCT00771667|459444502|FG002|Maintenance Phase|Other|0|||
127677877|NCT00771667|459444503|FG003|Maintenance Phase|Other|0|||
128011952|NCT03846479|460671337|FG000|Overall Study|Lost to Follow-up|1|||
128011953|NCT05020015|460671338|FG000|Overall Study|Ongoing on study|1|||
128011954|NCT05020015|460671339|FG001|Overall Study|Ongoing on study|3|||
128011955|NCT05020015|460671340|FG002|Overall Study|Ongoing on study|4|||
128011956|NCT05020015|460671341|FG003|Overall Study|Ongoing on study|7|||
128011957|NCT05020015|460671338|FG000|Overall Study|Death|2|||
128011958|NCT05020015|460671339|FG001|Overall Study|Death|3|||
128011959|NCT05020015|460671340|FG002|Overall Study|Death|4|||
128011960|NCT05020015|460671341|FG003|Overall Study|Death|0|||
128011961|NCT05020015|460671338|FG000|Overall Study|Withdrawal by Subject|0|||
128011962|NCT05020015|460671339|FG001|Overall Study|Withdrawal by Subject|0|||
128011963|NCT05020015|460671340|FG002|Overall Study|Withdrawal by Subject|1|||
128011964|NCT05020015|460671341|FG003|Overall Study|Withdrawal by Subject|0|||
128011965|NCT05020015|460671338|FG000|Overall Study|Reason Not Specified|0|||
128011966|NCT05020015|460671339|FG001|Overall Study|Reason Not Specified|0|||
128011967|NCT05020015|460671340|FG002|Overall Study|Reason Not Specified|2|||
128011968|NCT05020015|460671341|FG003|Overall Study|Reason Not Specified|0|||
128011969|NCT00614393|460671348|FG000|Overall Study|Adverse Event|20|||
128011970|NCT00614393|460671349|FG001|Overall Study|Adverse Event|2|||
128011971|NCT00614393|460671350|FG002|Overall Study|Adverse Event|3|||
128011972|NCT00614393|460671351|FG003|Overall Study|Adverse Event|13|||
128011973|NCT00614393|460671352|FG004|Overall Study|Adverse Event|21|||
128011974|NCT00614393|460671348|FG000|Overall Study|Lost to Follow-up|0|||
128011975|NCT00614393|460671349|FG001|Overall Study|Lost to Follow-up|0|||
128011976|NCT00614393|460671350|FG002|Overall Study|Lost to Follow-up|0|||
128011977|NCT00614393|460671351|FG003|Overall Study|Lost to Follow-up|1|||
128011978|NCT00614393|460671352|FG004|Overall Study|Lost to Follow-up|2|||
128011979|NCT00614393|460671348|FG000|Overall Study|Physician Decision|17|||
128011980|NCT00614393|460671349|FG001|Overall Study|Physician Decision|0|||
128011981|NCT00614393|460671350|FG002|Overall Study|Physician Decision|1|||
128011982|NCT00614393|460671351|FG003|Overall Study|Physician Decision|8|||
128011983|NCT00614393|460671352|FG004|Overall Study|Physician Decision|9|||
128011984|NCT00614393|460671348|FG000|Overall Study|Progressive Disease|118|||
128011985|NCT00614393|460671349|FG001|Overall Study|Progressive Disease|5|||
128011986|NCT00614393|460671350|FG002|Overall Study|Progressive Disease|5|||
128011987|NCT00614393|460671351|FG003|Overall Study|Progressive Disease|138|||
128011988|NCT00614393|460671352|FG004|Overall Study|Progressive Disease|130|||
128011989|NCT00614393|460671348|FG000|Overall Study|Protocol Violation|1|||
128011990|NCT00614393|460671349|FG001|Overall Study|Protocol Violation|0|||
128011991|NCT00614393|460671350|FG002|Overall Study|Protocol Violation|0|||
128011992|NCT00614393|460671351|FG003|Overall Study|Protocol Violation|0|||
128011993|NCT00614393|460671352|FG004|Overall Study|Protocol Violation|0|||
128011994|NCT00614393|460671348|FG000|Overall Study|Terminated by Sponsor|0|||
128011995|NCT00614393|460671349|FG001|Overall Study|Terminated by Sponsor|0|||
128011996|NCT00614393|460671350|FG002|Overall Study|Terminated by Sponsor|0|||
128011997|NCT00614393|460671351|FG003|Overall Study|Terminated by Sponsor|0|||
128011998|NCT00614393|460671352|FG004|Overall Study|Terminated by Sponsor|1|||
127544351|NCT03181932|458960653|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
127544352|NCT03181932|458960654|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
127544353|NCT03181932|458960653|FG000|Period 2 (Open-label Period)|Reason missing|2|||
127544354|NCT03181932|458960654|FG001|Period 2 (Open-label Period)|Reason missing|0|||
127544355|NCT00853307|458960655|FG000|Overall Study|Adverse Event|1|||
127544356|NCT00853307|458960656|FG001|Overall Study|Adverse Event|2|||
127544357|NCT00853307|458960655|FG000|Overall Study|Withdrawal by Subject|1|||
127544358|NCT00853307|458960656|FG001|Overall Study|Withdrawal by Subject|2|||
127544359|NCT00853307|458960655|FG000|Overall Study|Reason Not Specified|0|||
127544360|NCT00853307|458960656|FG001|Overall Study|Reason Not Specified|1|||
127544361|NCT00674817|458960657|FG000|Period 1|Withdrawal by Subject|2|||
127544362|NCT00674817|458960657|FG000|Period 1|Protocol Violation|1|||
127544363|NCT00674817|458960657|FG000|Period 3|Adverse Event|1|||
127544364|NCT00674817|458960657|FG000|Period 3|Protocol Violation|1|||
128011999|NCT00614393|460671348|FG000|Overall Study|Withdrawal by Subject|20|||
128012000|NCT00614393|460671349|FG001|Overall Study|Withdrawal by Subject|1|||
128012001|NCT00614393|460671350|FG002|Overall Study|Withdrawal by Subject|1|||
128012002|NCT00614393|460671351|FG003|Overall Study|Withdrawal by Subject|16|||
128012003|NCT00614393|460671352|FG004|Overall Study|Withdrawal by Subject|13|||
128012004|NCT00614393|460671348|FG000|Overall Study|Other|4|||
128012005|NCT00614393|460671349|FG001|Overall Study|Other|0|||
128012006|NCT00614393|460671350|FG002|Overall Study|Other|0|||
128012007|NCT00614393|460671351|FG003|Overall Study|Other|4|||
128012008|NCT00614393|460671352|FG004|Overall Study|Other|2|||
128012009|NCT00614393|460671348|FG000|Overall Study|Not Treated|0|||
128012010|NCT00614393|460671349|FG001|Overall Study|Not Treated|0|||
128012011|NCT00614393|460671350|FG002|Overall Study|Not Treated|0|||
127544365|NCT00674817|458960657|FG000|Period 4|Adverse Event|1|||
127544366|NCT03697252|458960658|FG000|Overall Study|Adverse Event|3|||
127544367|NCT03697252|458960659|FG001|Overall Study|Adverse Event|2|||
128012012|NCT00614393|460671351|FG003|Overall Study|Not Treated|0|||
128012013|NCT00614393|460671352|FG004|Overall Study|Not Treated|2|||
128012014|NCT02328105|460671353|FG000|Overall Study|Death|6|||
127544368|NCT03697252|458960658|FG000|Overall Study|Withdrawal by Subject|14|||
127544369|NCT03697252|458960659|FG001|Overall Study|Withdrawal by Subject|14|||
127544370|NCT03697252|458960658|FG000|Overall Study|Lost to Follow-up|0|||
127544371|NCT03697252|458960659|FG001|Overall Study|Lost to Follow-up|1|||
127544372|NCT03697252|458960658|FG000|Overall Study|Physician Decision|1|||
127544373|NCT03697252|458960659|FG001|Overall Study|Physician Decision|1|||
127544374|NCT03697252|458960658|FG000|Overall Study|Other|0|||
127544375|NCT03697252|458960659|FG001|Overall Study|Other|1|||
127544376|NCT04030143|458960660|FG000|Overall Study|Adverse Event|5|||
127544377|NCT04030143|458960661|FG001|Overall Study|Adverse Event|10|||
127544378|NCT04030143|458960660|FG000|Overall Study|Lost to Follow-up|3|||
127544379|NCT04030143|458960661|FG001|Overall Study|Lost to Follow-up|7|||
127544380|NCT04030143|458960660|FG000|Overall Study|Protocol Deviation|2|||
127544381|NCT04030143|458960661|FG001|Overall Study|Protocol Deviation|2|||
127544382|NCT04030143|458960660|FG000|Overall Study|Withdrawal by Subject|16|||
127544383|NCT04030143|458960661|FG001|Overall Study|Withdrawal by Subject|18|||
127544384|NCT04030143|458960660|FG000|Overall Study|Physician Decision|1|||
127544385|NCT04030143|458960661|FG001|Overall Study|Physician Decision|1|||
127544386|NCT04030143|458960660|FG000|Overall Study|Due to Covid-19|2|||
127544387|NCT04030143|458960661|FG001|Overall Study|Due to Covid-19|3|||
127544388|NCT04030143|458960660|FG000|Overall Study|Not Due to Covid-19|1|||
127544389|NCT04030143|458960661|FG001|Overall Study|Not Due to Covid-19|1|||
128012015|NCT02328105|460671353|FG000|Overall Study|Withdrawal by Subject|1|||
128012016|NCT02328105|460671353|FG000|Overall Study|Still On Study in Follow-Up|4|||
128012017|NCT01588509|460671357|FG000|Overall Study|Lost to Follow-up|1|||
128012018|NCT01588509|460671358|FG001|Overall Study|Lost to Follow-up|0|||
128012019|NCT00855582|460671359|FG000|Overall Study|Adverse Event|2|||
128012020|NCT00855582|460671360|FG001|Overall Study|Adverse Event|6|||
128012021|NCT00855582|460671361|FG002|Overall Study|Adverse Event|3|||
128012022|NCT00855582|460671359|FG000|Overall Study|Death|1|||
128012023|NCT00855582|460671360|FG001|Overall Study|Death|0|||
128012024|NCT00855582|460671361|FG002|Overall Study|Death|0|||
128012025|NCT00855582|460671359|FG000|Overall Study|Lack of Efficacy|1|||
128012026|NCT00855582|460671360|FG001|Overall Study|Lack of Efficacy|3|||
128012027|NCT00855582|460671361|FG002|Overall Study|Lack of Efficacy|8|||
128012028|NCT00855582|460671359|FG000|Overall Study|Lost to Follow-up|1|||
127544390|NCT02383576|458960662|FG000|Overall Study|Death|53|||
127544391|NCT02383576|458960663|FG001|Overall Study|Death|33|||
127544392|NCT02383576|458960662|FG000|Overall Study|Lost to Follow-up|7|||
127544393|NCT02383576|458960663|FG001|Overall Study|Lost to Follow-up|1|||
127544394|NCT02383576|458960662|FG000|Overall Study|Withdrew Consent|1|||
127544395|NCT02383576|458960663|FG001|Overall Study|Withdrew Consent|6|||
127544396|NCT02383576|458960662|FG000|Overall Study|Investigator's Decision|0|||
127544397|NCT02383576|458960663|FG001|Overall Study|Investigator's Decision|1|||
127544398|NCT02383576|458960662|FG000|Overall Study|Administrative/Other|2|||
127544399|NCT02383576|458960663|FG001|Overall Study|Administrative/Other|4|||
127544400|NCT02435212|458960664|FG000|Core Phase|Adverse Event|8|||
127544401|NCT02435212|458960665|FG001|Core Phase|Adverse Event|5|||
127544402|NCT02435212|458960664|FG000|Core Phase|Withdrawal by Subject|3|||
127544403|NCT02435212|458960665|FG001|Core Phase|Withdrawal by Subject|0|||
127544404|NCT02435212|458960664|FG000|Core Phase|Withdrawal by parent/guardian|9|||
127544405|NCT02435212|458960665|FG001|Core Phase|Withdrawal by parent/guardian|4|||
127544406|NCT02435212|458960664|FG000|Core Phase|Protocol Violation|1|||
127544407|NCT02435212|458960665|FG001|Core Phase|Protocol Violation|2|||
127544408|NCT02435212|458960664|FG000|Core Phase|Physician Decision|3|||
127544409|NCT02435212|458960665|FG001|Core Phase|Physician Decision|0|||
127544410|NCT02435212|458960664|FG000|Core Phase|Lost to Follow-up|0|||
127544411|NCT02435212|458960665|FG001|Core Phase|Lost to Follow-up|1|||
127544412|NCT02435212|458960664|FG000|Core Phase|Lack of Efficacy|0|||
128012029|NCT00855582|460671360|FG001|Overall Study|Lost to Follow-up|3|||
128012030|NCT00855582|460671361|FG002|Overall Study|Lost to Follow-up|1|||
128012031|NCT00855582|460671359|FG000|Overall Study|Physician Decision|0|||
128012032|NCT00855582|460671360|FG001|Overall Study|Physician Decision|0|||
128012033|NCT00855582|460671361|FG002|Overall Study|Physician Decision|1|||
127544413|NCT02435212|458960665|FG001|Core Phase|Lack of Efficacy|1|||
127544414|NCT02435212|458960664|FG000|Core Phase|Recovery|1|||
127544415|NCT02435212|458960665|FG001|Core Phase|Recovery|0|||
127544416|NCT02435212|458960664|FG000|Optional Extension Phase|Adverse Event|3|||
128012034|NCT00855582|460671359|FG000|Overall Study|Protocol Violation|6|||
127544417|NCT02435212|458960665|FG001|Optional Extension Phase|Adverse Event|9|||
127544418|NCT02435212|458960664|FG000|Optional Extension Phase|Physician Decision|6|||
127544419|NCT02435212|458960665|FG001|Optional Extension Phase|Physician Decision|8|||
127544420|NCT02435212|458960664|FG000|Optional Extension Phase|Withdrawal by parent/guardian|10|||
127544421|NCT02435212|458960665|FG001|Optional Extension Phase|Withdrawal by parent/guardian|7|||
127544422|NCT02435212|458960664|FG000|Optional Extension Phase|Lack of Efficacy|2|||
127544423|NCT02435212|458960665|FG001|Optional Extension Phase|Lack of Efficacy|3|||
127544424|NCT02435212|458960664|FG000|Optional Extension Phase|Withdrawal by Subject|2|||
127544425|NCT02435212|458960665|FG001|Optional Extension Phase|Withdrawal by Subject|2|||
128012035|NCT00855582|460671360|FG001|Overall Study|Protocol Violation|2|||
128012036|NCT00855582|460671361|FG002|Overall Study|Protocol Violation|6|||
127544426|NCT02435212|458960664|FG000|Optional Extension Phase|Protocol Violation|0|||
127544427|NCT02435212|458960665|FG001|Optional Extension Phase|Protocol Violation|1|||
127544428|NCT02435212|458960664|FG000|Optional Extension Phase|Recovery|1|||
127764982|NCT03149549|459763573|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
127764983|NCT03149549|459763574|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
127764984|NCT03149549|459763562|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
127764985|NCT03149549|459763563|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
127764986|NCT03149549|459763564|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
127764987|NCT03149549|459763565|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
127764988|NCT03149549|459763566|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
127764989|NCT03149549|459763567|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
127764990|NCT03149549|459763568|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
127764991|NCT03149549|459763569|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
127764992|NCT03149549|459763570|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
127764993|NCT03149549|459763571|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
127764994|NCT03149549|459763572|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
127764995|NCT03149549|459763573|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
127764996|NCT03149549|459763574|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
127764997|NCT03149549|459763562|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
127544429|NCT02435212|458960665|FG001|Optional Extension Phase|Recovery|1|||
127544430|NCT02435212|458960664|FG000|Optional Extension Phase|Death|1|||
127544431|NCT02435212|458960665|FG001|Optional Extension Phase|Death|0|||
127544432|NCT02435212|458960664|FG000|Optional Extension Phase|Technical problems|2|||
127544433|NCT02435212|458960665|FG001|Optional Extension Phase|Technical problems|0|||
127544434|NCT04849364|458960666|FG000|Overall Study|Eligibility criteria not meet|0|||
127544435|NCT04849364|458960667|FG001|Overall Study|Eligibility criteria not meet|1|||
127544436|NCT04849364|458960668|FG002|Overall Study|Eligibility criteria not meet|0|||
127544437|NCT03279081|458960680|FG000|Overall Study|Withdrawal by Subject|12|||
127544438|NCT03279081|458960681|FG001|Overall Study|Withdrawal by Subject|20|||
127544439|NCT03279081|458960680|FG000|Overall Study|Physician Decision|4|||
127544440|NCT03279081|458960681|FG001|Overall Study|Physician Decision|1|||
127544441|NCT03279081|458960680|FG000|Overall Study|Lost to Follow-up|8|||
127544442|NCT03279081|458960681|FG001|Overall Study|Lost to Follow-up|8|||
127544443|NCT03279081|458960680|FG000|Overall Study|Death|0|||
127544444|NCT03279081|458960681|FG001|Overall Study|Death|1|||
127544445|NCT03279081|458960680|FG000|Overall Study|Adverse Event|1|||
127544446|NCT03279081|458960681|FG001|Overall Study|Adverse Event|0|||
127544447|NCT03279081|458960680|FG000|Overall Study|Reason not Specified|14|||
127544448|NCT03279081|458960681|FG001|Overall Study|Reason not Specified|4|||
127544449|NCT01345240|458960692|FG000|Overall Study|Adverse Event|3|||
127544450|NCT01345240|458960693|FG001|Overall Study|Adverse Event|5|||
127544451|NCT01345240|458960694|FG002|Overall Study|Adverse Event|4|||
127544452|NCT01345240|458960695|FG003|Overall Study|Adverse Event|2|||
127544453|NCT01345240|458960696|FG004|Overall Study|Adverse Event|1|||
127544454|NCT01345240|458960692|FG000|Overall Study|Lost to Follow-up|8|||
127544455|NCT01345240|458960693|FG001|Overall Study|Lost to Follow-up|9|||
127544456|NCT01345240|458960694|FG002|Overall Study|Lost to Follow-up|14|||
127544457|NCT01345240|458960695|FG003|Overall Study|Lost to Follow-up|7|||
127544458|NCT01345240|458960696|FG004|Overall Study|Lost to Follow-up|9|||
127544459|NCT04298697|458960697|FG000|Overall Study|Lost to Follow-up|5|||
127544460|NCT04298697|458960698|FG001|Overall Study|Lost to Follow-up|5|||
127544461|NCT04298697|458960699|FG002|Overall Study|Lost to Follow-up|1|||
127544462|NCT04298697|458960700|FG003|Overall Study|Lost to Follow-up|0|||
127544463|NCT04298697|458960697|FG000|Overall Study|Withdrawal by Subject|0|||
127544464|NCT04298697|458960698|FG001|Overall Study|Withdrawal by Subject|3|||
127544465|NCT04298697|458960699|FG002|Overall Study|Withdrawal by Subject|2|||
127544466|NCT04298697|458960700|FG003|Overall Study|Withdrawal by Subject|3|||
128012037|NCT00855582|460671359|FG000|Overall Study|Entry Criteria Not Met|8|||
127544467|NCT00449696|458960701|FG000|Overall Study|Other Treatment Required|6|||
127544468|NCT00449696|458960702|FG001|Overall Study|Other Treatment Required|1|||
127544469|NCT00449696|458960701|FG000|Overall Study|Withdrawal by Subject|5|||
127544470|NCT00449696|458960702|FG001|Overall Study|Withdrawal by Subject|5|||
127544471|NCT00449696|458960701|FG000|Overall Study|Lost to Follow-up|2|||
127544472|NCT00449696|458960702|FG001|Overall Study|Lost to Follow-up|3|||
127544473|NCT00449696|458960701|FG000|Overall Study|Others|7|||
127544474|NCT00449696|458960702|FG001|Overall Study|Others|0|||
127544475|NCT00774046|458960707|FG000|Screening|Not eligible|56|||
127544476|NCT00774046|458960707|FG000|Enrollment|Desired other therapy/refused|28|||
127764998|NCT03149549|459763563|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
127764999|NCT03149549|459763564|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
127765000|NCT03149549|459763565|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
127544477|NCT00774046|458960707|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
127544478|NCT00888134|458960720|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
127544479|NCT00888134|458960720|FG000|Follow-up|being followed for long-term survival|1|||
127544480|NCT01903460|458960724|FG000|Overall Study|Adverse Event|0|||
128012038|NCT00855582|460671360|FG001|Overall Study|Entry Criteria Not Met|6|||
128012039|NCT00855582|460671361|FG002|Overall Study|Entry Criteria Not Met|3|||
128012040|NCT00855582|460671359|FG000|Overall Study|Withdrawal by Subject|7|||
128012041|NCT00855582|460671360|FG001|Overall Study|Withdrawal by Subject|4|||
128012042|NCT00855582|460671361|FG002|Overall Study|Withdrawal by Subject|8|||
128012043|NCT03345004|460671362|FG000|Overall Study|Physician Decision|1|||
128012044|NCT03345004|460671363|FG001|Overall Study|Physician Decision|0|||
128012045|NCT03345004|460671362|FG000|Overall Study|Withdrawal by Subject|0|||
128012046|NCT03345004|460671363|FG001|Overall Study|Withdrawal by Subject|1|||
128012047|NCT01013753|460671364|FG000|Overall Study|Adverse Event|8|||
128012048|NCT01013753|460671364|FG000|Overall Study|Protocol Violation|3|||
128012049|NCT01013753|460671364|FG000|Overall Study|Lost to Follow-up|1|||
128012050|NCT01013753|460671364|FG000|Overall Study|Withdrawal by Subject|2|||
128012051|NCT01013753|460671364|FG000|Overall Study|Other|2|||
128012052|NCT03320369|460671371|FG000|Overall Study|Adverse Event|1|||
128012053|NCT03320369|460671371|FG000|Overall Study|Withdrawal by Subject|2|||
128012054|NCT01732692|460671372|FG000|Overall Study|Adverse Event|0|||
128012055|NCT01732692|460671373|FG001|Overall Study|Adverse Event|1|||
128012056|NCT01137786|460671374|FG000|Overall Study|Lost to Follow-up|0|||
128012057|NCT01137786|460671375|FG001|Overall Study|Lost to Follow-up|2|||
128012058|NCT01137786|460671374|FG000|Overall Study|Withdrawal by Subject|1|||
128012059|NCT01137786|460671375|FG001|Overall Study|Withdrawal by Subject|1|||
128012060|NCT00435942|460671376|FG000|Overall Study|Death|17|||
128012061|NCT00435942|460671377|FG001|Overall Study|Death|10|||
128012062|NCT00435942|460671376|FG000|Overall Study|Withdrawal by Subject|2|||
128012063|NCT00435942|460671377|FG001|Overall Study|Withdrawal by Subject|0|||
128012064|NCT00435942|460671376|FG000|Overall Study|Lost to Follow-up|0|||
128012065|NCT00435942|460671377|FG001|Overall Study|Lost to Follow-up|16|||
128012066|NCT00435942|460671376|FG000|Overall Study|Conversion to Open Repair|1|||
128012067|NCT00435942|460671377|FG001|Overall Study|Conversion to Open Repair|0|||
128012068|NCT00435942|460671376|FG000|Overall Study|Technical Failure|3|||
128012069|NCT00435942|460671377|FG001|Overall Study|Technical Failure|0|||
128012070|NCT00435942|460671376|FG000|Overall Study|Other|0|||
128012071|NCT00435942|460671377|FG001|Overall Study|Other|1|||
128012072|NCT04491994|460671378|FG000|Overall Study|Withdrawal by Subject|10|||
128012073|NCT04491994|460671379|FG001|Overall Study|Withdrawal by Subject|5|||
128012074|NCT04491994|460671378|FG000|Overall Study|developed fever > 3 days|4|||
128012075|NCT04491994|460671379|FG001|Overall Study|developed fever > 3 days|1|||
128012076|NCT04491994|460671378|FG000|Overall Study|Protocol Violation|11|||
128012077|NCT04491994|460671379|FG001|Overall Study|Protocol Violation|2|||
128012078|NCT04491994|460671378|FG000|Overall Study|Lost to Follow-up|4|||
128012079|NCT04491994|460671379|FG001|Overall Study|Lost to Follow-up|3|||
128012080|NCT04167462|460671387|FG000|Overall Study|Other reasons|3|||
128012081|NCT04167462|460671388|FG001|Overall Study|Other reasons|2|||
128012082|NCT04167462|460671387|FG000|Overall Study|Withdrawal by Subject|6|||
128012083|NCT04167462|460671388|FG001|Overall Study|Withdrawal by Subject|7|||
128012084|NCT04167462|460671387|FG000|Overall Study|Adverse Event|4|||
128012085|NCT04167462|460671388|FG001|Overall Study|Adverse Event|0|||
128012086|NCT04167462|460671387|FG000|Overall Study|Pregnancy|1|||
128012087|NCT04167462|460671388|FG001|Overall Study|Pregnancy|0|||
128012088|NCT04167462|460671387|FG000|Overall Study|Lack of Efficacy|0|||
128012089|NCT04167462|460671388|FG001|Overall Study|Lack of Efficacy|1|||
128012090|NCT02606253|460671389|FG000|Overall Study|Adverse Event|2|||
128012091|NCT02606253|460671390|FG001|Overall Study|Adverse Event|0|||
128012092|NCT02606253|460671391|FG002|Overall Study|Adverse Event|0|||
128012093|NCT02606253|460671389|FG000|Overall Study|Protocol Violation|2|||
128012094|NCT02606253|460671390|FG001|Overall Study|Protocol Violation|1|||
128012095|NCT02606253|460671391|FG002|Overall Study|Protocol Violation|0|||
128012096|NCT02606253|460671389|FG000|Overall Study|Physician Decision|1|||
128012097|NCT02606253|460671390|FG001|Overall Study|Physician Decision|1|||
128012098|NCT02606253|460671391|FG002|Overall Study|Physician Decision|0|||
128012099|NCT02475213|460671392|FG000|Overall Study|Adverse Event|2|||
128012100|NCT02475213|460671393|FG001|Overall Study|Adverse Event|0|||
128012101|NCT02475213|460671394|FG002|Overall Study|Adverse Event|0|||
128012102|NCT02475213|460671395|FG003|Overall Study|Adverse Event|1|||
128012103|NCT02475213|460671396|FG004|Overall Study|Adverse Event|1|||
128012104|NCT02475213|460671397|FG005|Overall Study|Adverse Event|4|||
128012105|NCT02475213|460671398|FG006|Overall Study|Adverse Event|6|||
128012106|NCT02475213|460671399|FG007|Overall Study|Adverse Event|2|||
128012107|NCT02475213|460671392|FG000|Overall Study|Physician Decision|1|||
128012108|NCT02475213|460671393|FG001|Overall Study|Physician Decision|1|||
128012109|NCT02475213|460671394|FG002|Overall Study|Physician Decision|1|||
128012110|NCT02475213|460671395|FG003|Overall Study|Physician Decision|0|||
128012111|NCT02475213|460671396|FG004|Overall Study|Physician Decision|0|||
128012112|NCT02475213|460671397|FG005|Overall Study|Physician Decision|1|||
128012113|NCT02475213|460671398|FG006|Overall Study|Physician Decision|4|||
128012114|NCT02475213|460671399|FG007|Overall Study|Physician Decision|0|||
128012115|NCT02475213|460671392|FG000|Overall Study|Progressive Disease|3|||
128012116|NCT02475213|460671393|FG001|Overall Study|Progressive Disease|2|||
128012117|NCT02475213|460671394|FG002|Overall Study|Progressive Disease|2|||
127544481|NCT01903460|458960725|FG001|Overall Study|Adverse Event|0|||
127544482|NCT01903460|458960726|FG002|Overall Study|Adverse Event|0|||
127544483|NCT01903460|458960727|FG003|Overall Study|Adverse Event|1|||
127544484|NCT02246530|458960728|FG000|Overall Study|Lost to Follow-up|4|||
127544485|NCT02246530|458960729|FG001|Overall Study|Lost to Follow-up|0|||
127544486|NCT00888173|458960730|FG000|Overall Study|Wrong Primary|1|||
127544487|NCT00888173|458960730|FG000|Overall Study|Ineligible: required test not done|1|||
127544488|NCT01488890|458960733|FG000|Overall Study|Serious adverse event|2|||
127544489|NCT01488890|458960734|FG001|Overall Study|Serious adverse event|0|||
127544490|NCT01488890|458960735|FG002|Overall Study|Serious adverse event|0|||
127544491|NCT01488890|458960736|FG003|Overall Study|Serious adverse event|0|||
127544492|NCT01488890|458960733|FG000|Overall Study|Protocol Violation|3|||
127544493|NCT01488890|458960734|FG001|Overall Study|Protocol Violation|0|||
127544494|NCT01488890|458960735|FG002|Overall Study|Protocol Violation|4|||
127544495|NCT01488890|458960736|FG003|Overall Study|Protocol Violation|0|||
127544496|NCT01488890|458960733|FG000|Overall Study|Lost to Follow-up|13|||
127544497|NCT01488890|458960734|FG001|Overall Study|Lost to Follow-up|10|||
127544498|NCT01488890|458960735|FG002|Overall Study|Lost to Follow-up|20|||
127544499|NCT01488890|458960736|FG003|Overall Study|Lost to Follow-up|3|||
127544500|NCT01488890|458960733|FG000|Overall Study|Withdrawal by Subject|14|||
127544501|NCT01488890|458960734|FG001|Overall Study|Withdrawal by Subject|10|||
127544502|NCT01488890|458960735|FG002|Overall Study|Withdrawal by Subject|11|||
127544503|NCT01488890|458960736|FG003|Overall Study|Withdrawal by Subject|2|||
127544504|NCT05712460|458960737|FG000|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
127765001|NCT03149549|459763566|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
128012118|NCT02475213|460671395|FG003|Overall Study|Progressive Disease|13|||
128012119|NCT02475213|460671396|FG004|Overall Study|Progressive Disease|15|||
128012120|NCT02475213|460671397|FG005|Overall Study|Progressive Disease|25|||
128012121|NCT02475213|460671398|FG006|Overall Study|Progressive Disease|30|||
127765002|NCT03149549|459763567|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
127765003|NCT03149549|459763568|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
127765004|NCT03149549|459763569|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
128012122|NCT02475213|460671399|FG007|Overall Study|Progressive Disease|10|||
128012123|NCT02475213|460671392|FG000|Overall Study|Death|0|||
128012124|NCT02475213|460671393|FG001|Overall Study|Death|0|||
128012125|NCT02475213|460671394|FG002|Overall Study|Death|0|||
128012126|NCT02475213|460671395|FG003|Overall Study|Death|0|||
128012127|NCT02475213|460671396|FG004|Overall Study|Death|0|||
128012128|NCT02475213|460671397|FG005|Overall Study|Death|4|||
128012129|NCT02475213|460671398|FG006|Overall Study|Death|1|||
128012130|NCT02475213|460671399|FG007|Overall Study|Death|0|||
128012131|NCT02475213|460671392|FG000|Overall Study|Protocol Violation|0|||
128012132|NCT02475213|460671393|FG001|Overall Study|Protocol Violation|0|||
128012133|NCT02475213|460671394|FG002|Overall Study|Protocol Violation|0|||
128012134|NCT02475213|460671395|FG003|Overall Study|Protocol Violation|0|||
128012135|NCT02475213|460671396|FG004|Overall Study|Protocol Violation|1|||
128012136|NCT02475213|460671397|FG005|Overall Study|Protocol Violation|0|||
128012137|NCT02475213|460671398|FG006|Overall Study|Protocol Violation|0|||
128012138|NCT02475213|460671399|FG007|Overall Study|Protocol Violation|0|||
128012139|NCT02475213|460671392|FG000|Overall Study|Withdrawal by Subject|0|||
128012140|NCT02475213|460671393|FG001|Overall Study|Withdrawal by Subject|0|||
128012141|NCT02475213|460671394|FG002|Overall Study|Withdrawal by Subject|0|||
127765005|NCT03149549|459763570|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
127765006|NCT03149549|459763571|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
127765007|NCT03149549|459763572|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
127765008|NCT03149549|459763573|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
127765009|NCT03149549|459763574|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
127765010|NCT03141905|459763577|FG000|Overall Study|Death|3|||
127765011|NCT03141905|459763578|FG001|Overall Study|Death|2|||
127765012|NCT03141905|459763577|FG000|Overall Study|Withdrawal by Subject|1|||
127765013|NCT03141905|459763578|FG001|Overall Study|Withdrawal by Subject|0|||
128012142|NCT02475213|460671395|FG003|Overall Study|Withdrawal by Subject|1|||
127677878|NCT00771667|459444504|FG004|Maintenance Phase|Other|0|||
127677879|NCT00771667|459444505|FG005|Maintenance Phase|Other|1|||
127677880|NCT00771667|459444506|FG006|Maintenance Phase|Other|2|||
127677881|NCT00771667|459444507|FG007|Maintenance Phase|Other|2|||
127677882|NCT00771667|459444508|FG008|Maintenance Phase|Other|3|||
127677883|NCT00771667|459444509|FG009|Maintenance Phase|Other|3|||
127677884|NCT00628862|459444510|FG000|Overall Study|Adverse Event|6|||
127765014|NCT03141905|459763577|FG000|Overall Study|Lost to Follow-up|3|||
127544505|NCT05712460|458960738|FG001|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
128012143|NCT02475213|460671396|FG004|Overall Study|Withdrawal by Subject|0|||
128012144|NCT02475213|460671397|FG005|Overall Study|Withdrawal by Subject|2|||
127677885|NCT00628862|459444511|FG001|Overall Study|Adverse Event|8|||
127677886|NCT00628862|459444512|FG002|Overall Study|Adverse Event|10|||
127677887|NCT00628862|459444510|FG000|Overall Study|Withdrawal by Subject|4|||
127765015|NCT03141905|459763578|FG001|Overall Study|Lost to Follow-up|7|||
128012145|NCT02475213|460671398|FG006|Overall Study|Withdrawal by Subject|2|||
128012146|NCT02475213|460671399|FG007|Overall Study|Withdrawal by Subject|0|||
128012147|NCT02475213|460671392|FG000|Overall Study|Other|0|||
128012148|NCT02475213|460671393|FG001|Overall Study|Other|0|||
128012149|NCT02475213|460671394|FG002|Overall Study|Other|0|||
128012150|NCT02475213|460671395|FG003|Overall Study|Other|1|||
128012151|NCT02475213|460671396|FG004|Overall Study|Other|3|||
128012152|NCT02475213|460671397|FG005|Overall Study|Other|1|||
128012153|NCT02475213|460671398|FG006|Overall Study|Other|0|||
128012154|NCT02475213|460671399|FG007|Overall Study|Other|0|||
128012155|NCT00505921|460671400|FG000|Overall Study|Ineligible|1|||
128012156|NCT00505921|460671400|FG000|Overall Study|Failed to Mobilize|8|||
128012157|NCT02441283|460671401|FG000|Overall Study|Withdrew consent|15|||
128012158|NCT02441283|460671401|FG000|Overall Study|Lost to Follow-up|42|||
128012159|NCT02441283|460671401|FG000|Overall Study|Death|1|||
128012160|NCT02441283|460671401|FG000|Overall Study|Other, not specified|32|||
128012161|NCT02382939|460671407|FG000|Overall Study|Adverse Event|1|||
128012162|NCT02382939|460671408|FG001|Overall Study|Adverse Event|1|||
128012163|NCT02382939|460671407|FG000|Overall Study|Withdrawal by Subject|2|||
128012164|NCT02382939|460671408|FG001|Overall Study|Withdrawal by Subject|2|||
128012165|NCT00537277|460671411|FG000|Overall Study|Adverse Event|1|||
128012166|NCT00537277|460671411|FG000|Overall Study|Lack of Efficacy|2|||
128012167|NCT00537277|460671411|FG000|Overall Study|Lost to Follow-up|12|||
128012168|NCT00537277|460671411|FG000|Overall Study|Protocol Violation|11|||
128012169|NCT00537277|460671411|FG000|Overall Study|Unclassified|4|||
128012170|NCT00537277|460671411|FG000|Overall Study|Inability to tolerate trial medication|4|||
128012171|NCT00537277|460671411|FG000|Overall Study|Non-compliance with trial procedures|15|||
128012172|NCT05383209|460671412|FG000|Overall Study|Adverse Event: Non-ocular|0|||
128012173|NCT05383209|460671413|FG001|Overall Study|Adverse Event: Non-ocular|1|||
128012174|NCT05383209|460671414|FG002|Overall Study|Adverse Event: Non-ocular|0|||
128012175|NCT05383209|460671412|FG000|Overall Study|Lost to Follow-up|2|||
128012176|NCT05383209|460671413|FG001|Overall Study|Lost to Follow-up|1|||
128012177|NCT05383209|460671414|FG002|Overall Study|Lost to Follow-up|4|||
128012178|NCT05383209|460671412|FG000|Overall Study|Withdrawal by Subject|2|||
128012179|NCT05383209|460671413|FG001|Overall Study|Withdrawal by Subject|0|||
128012180|NCT05383209|460671414|FG002|Overall Study|Withdrawal by Subject|1|||
128012181|NCT05383209|460671412|FG000|Overall Study|Death|1|||
128012182|NCT05383209|460671413|FG001|Overall Study|Death|0|||
128012183|NCT05383209|460671414|FG002|Overall Study|Death|0|||
128012184|NCT05383209|460671412|FG000|Overall Study|Other|0|||
128012185|NCT05383209|460671413|FG001|Overall Study|Other|1|||
128012186|NCT05383209|460671414|FG002|Overall Study|Other|0|||
128012187|NCT00716417|460671415|FG000|Overall Study|Adverse Event|0|||
128012188|NCT00716417|460671416|FG001|Overall Study|Adverse Event|0|||
128012189|NCT00716417|460671417|FG002|Overall Study|Adverse Event|2|||
128012190|NCT00716417|460671418|FG003|Overall Study|Adverse Event|1|||
128012191|NCT00716417|460671419|FG004|Overall Study|Adverse Event|0|||
128012192|NCT00716417|460671420|FG005|Overall Study|Adverse Event|0|||
128012193|NCT00716417|460671421|FG006|Overall Study|Adverse Event|3|||
128012194|NCT00716417|460671422|FG007|Overall Study|Adverse Event|1|||
128012195|NCT00716417|460671423|FG008|Overall Study|Adverse Event|0|||
128012196|NCT00716417|460671424|FG009|Overall Study|Adverse Event|3|||
127544506|NCT05712460|458960739|FG002|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
127544507|NCT05712460|458960740|FG003|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
127544508|NCT05712460|458960741|FG004|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
127544509|NCT05712460|458960742|FG005|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
127544510|NCT05712460|458960743|FG006|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
127544511|NCT05712460|458960744|FG007|Part 1 Period 3 (4 Days)|Refused further treatment|1|||
127544512|NCT05712460|458960745|FG008|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
127544513|NCT05712460|458960746|FG009|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
128012197|NCT00716417|460671415|FG000|Overall Study|Withdrawal by Subject|0|||
128012198|NCT00716417|460671416|FG001|Overall Study|Withdrawal by Subject|1|||
128012199|NCT00716417|460671417|FG002|Overall Study|Withdrawal by Subject|0|||
128012200|NCT00716417|460671418|FG003|Overall Study|Withdrawal by Subject|2|||
128012201|NCT00716417|460671419|FG004|Overall Study|Withdrawal by Subject|0|||
128012202|NCT00716417|460671420|FG005|Overall Study|Withdrawal by Subject|0|||
128012203|NCT00716417|460671421|FG006|Overall Study|Withdrawal by Subject|1|||
128012204|NCT00716417|460671422|FG007|Overall Study|Withdrawal by Subject|0|||
128012205|NCT00716417|460671423|FG008|Overall Study|Withdrawal by Subject|0|||
128012206|NCT00716417|460671424|FG009|Overall Study|Withdrawal by Subject|0|||
128012207|NCT00716417|460671415|FG000|Overall Study|Progressive disease|3|||
128012208|NCT00716417|460671416|FG001|Overall Study|Progressive disease|5|||
128012209|NCT00716417|460671417|FG002|Overall Study|Progressive disease|3|||
127765016|NCT03141905|459763577|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
128012210|NCT00716417|460671418|FG003|Overall Study|Progressive disease|8|||
128012211|NCT00716417|460671419|FG004|Overall Study|Progressive disease|0|||
128012212|NCT00716417|460671420|FG005|Overall Study|Progressive disease|3|||
128012213|NCT00716417|460671421|FG006|Overall Study|Progressive disease|3|||
128012214|NCT00716417|460671422|FG007|Overall Study|Progressive disease|1|||
128012215|NCT00716417|460671423|FG008|Overall Study|Progressive disease|5|||
127544514|NCT05712460|458960747|FG010|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
127544515|NCT05712460|458960748|FG011|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
127544516|NCT00829426|458960752|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
127544517|NCT00829426|458960753|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
127544518|NCT05135767|458960756|FG000|Baseline|Lost to Follow-up|1|||
127544519|NCT05135767|458960757|FG001|Baseline|Lost to Follow-up|1|||
127544520|NCT05135767|458960756|FG000|Baseline|Withdrawal by Subject|0|||
127544521|NCT05135767|458960757|FG001|Baseline|Withdrawal by Subject|2|||
127544522|NCT05135767|458960756|FG000|Active Study Phase|Lost to Follow-up|2|||
127544523|NCT05135767|458960757|FG001|Active Study Phase|Lost to Follow-up|0|||
127544524|NCT02260934|458960758|FG000|Overall Study|Lost to Follow-up|2|||
127544525|NCT02260934|458960759|FG001|Overall Study|Lost to Follow-up|1|||
127544526|NCT02260934|458960758|FG000|Overall Study|Withdrawal by Subject|0|||
127544527|NCT02260934|458960759|FG001|Overall Study|Withdrawal by Subject|2|||
127544528|NCT02260934|458960758|FG000|Overall Study|Participant Relocated|1|||
127544529|NCT02260934|458960759|FG001|Overall Study|Participant Relocated|0|||
127544530|NCT02260934|458960758|FG000|Overall Study|Site error|0|||
127544531|NCT02260934|458960759|FG001|Overall Study|Site error|1|||
127544532|NCT03597347|458960760|FG000|Overall Study|Withdrawal by Subject|1|||
127544533|NCT03597347|458960761|FG001|Overall Study|Withdrawal by Subject|1|||
127544534|NCT03597347|458960762|FG002|Overall Study|Withdrawal by Subject|0|||
127544535|NCT03597347|458960760|FG000|Overall Study|Withdrawal due to Covid-19|3|||
127544536|NCT03597347|458960761|FG001|Overall Study|Withdrawal due to Covid-19|0|||
127544537|NCT03597347|458960762|FG002|Overall Study|Withdrawal due to Covid-19|0|||
127544538|NCT03597347|458960760|FG000|Overall Study|Sponsor decision to terminate study|3|||
127544539|NCT03597347|458960761|FG001|Overall Study|Sponsor decision to terminate study|2|||
127544540|NCT03597347|458960762|FG002|Overall Study|Sponsor decision to terminate study|4|||
127544541|NCT00107653|458960763|FG000|Overall Study|Adverse Event|24|||
127544542|NCT00107653|458960764|FG001|Overall Study|Adverse Event|43|||
127544543|NCT00107653|458960763|FG000|Overall Study|Insufficient Therapeutic Response|25|||
127765017|NCT03141905|459763578|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
127765018|NCT02502799|459765543|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
127765019|NCT02502799|459765544|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
127765020|NCT02502799|459765545|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
127544544|NCT00107653|458960764|FG001|Overall Study|Insufficient Therapeutic Response|11|||
127544545|NCT00107653|458960763|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
127544546|NCT00107653|458960764|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
127544547|NCT00107653|458960763|FG000|Overall Study|Protocol Violation|1|||
127544548|NCT00107653|458960764|FG001|Overall Study|Protocol Violation|0|||
127544549|NCT00107653|458960763|FG000|Overall Study|Withdrawal by Subject|12|||
127544550|NCT00107653|458960764|FG001|Overall Study|Withdrawal by Subject|13|||
127544551|NCT00107653|458960763|FG000|Overall Study|Lost to Follow-up|13|||
127544552|NCT00107653|458960764|FG001|Overall Study|Lost to Follow-up|5|||
127544553|NCT00107653|458960763|FG000|Overall Study|Administrative Reasons|3|||
127544554|NCT00107653|458960764|FG001|Overall Study|Administrative Reasons|3|||
127544555|NCT02532517|458960765|FG000|Overall Study|Did not complete 24-Month visit|4|||
127544556|NCT02532517|458960765|FG000|Overall Study|Failed Angiographic eligibility|1|||
127544557|NCT02532517|458960765|FG000|Overall Study|Lost to Follow-up|4|||
127765021|NCT02502799|459765546|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
128012216|NCT00716417|460671424|FG009|Overall Study|Progressive disease|0|||
128012217|NCT00716417|460671415|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
128012218|NCT00716417|460671416|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
128012219|NCT00716417|460671417|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
128012220|NCT00716417|460671418|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
128012221|NCT00716417|460671419|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
128012222|NCT00716417|460671420|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
128012223|NCT00716417|460671421|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
128012224|NCT00716417|460671422|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
128012225|NCT00716417|460671423|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
128012226|NCT00716417|460671424|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
128012227|NCT00716417|460671415|FG000|Overall Study|On patient request due to toxicities|0|||
128012228|NCT00716417|460671416|FG001|Overall Study|On patient request due to toxicities|0|||
128012229|NCT00716417|460671417|FG002|Overall Study|On patient request due to toxicities|0|||
128012230|NCT00716417|460671418|FG003|Overall Study|On patient request due to toxicities|0|||
128012231|NCT00716417|460671419|FG004|Overall Study|On patient request due to toxicities|0|||
128012232|NCT00716417|460671420|FG005|Overall Study|On patient request due to toxicities|0|||
128012233|NCT00716417|460671421|FG006|Overall Study|On patient request due to toxicities|0|||
127765022|NCT02502799|459765543|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
127765023|NCT02502799|459765544|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
127765024|NCT02502799|459765545|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
128012234|NCT00716417|460671422|FG007|Overall Study|On patient request due to toxicities|1|||
128012235|NCT00716417|460671423|FG008|Overall Study|On patient request due to toxicities|0|||
128012236|NCT00716417|460671424|FG009|Overall Study|On patient request due to toxicities|0|||
128012237|NCT01553851|460671425|FG000|Overall Study|Adverse Event|2|||
128012238|NCT01553851|460671425|FG000|Overall Study|constipation|1|||
128012239|NCT01369433|460671426|FG000|Overall Study|Adverse Event|31|||
128012240|NCT01369433|460671427|FG001|Overall Study|Adverse Event|1|||
128012241|NCT01369433|460671426|FG000|Overall Study|Required significant surgical procedure|1|||
128012242|NCT01369433|460671427|FG001|Overall Study|Required significant surgical procedure|0|||
128012243|NCT01369433|460671426|FG000|Overall Study|Non-compliance|1|||
128012244|NCT01369433|460671427|FG001|Overall Study|Non-compliance|0|||
128012245|NCT01369433|460671426|FG000|Overall Study|Withdrawal by Subject|5|||
128012246|NCT01369433|460671427|FG001|Overall Study|Withdrawal by Subject|2|||
128012247|NCT01369433|460671426|FG000|Overall Study|Study terminated by Sponsor|67|||
128012248|NCT01369433|460671427|FG001|Overall Study|Study terminated by Sponsor|0|||
128012249|NCT01369433|460671426|FG000|Overall Study|Lost to Follow-up|1|||
128012250|NCT01369433|460671427|FG001|Overall Study|Lost to Follow-up|0|||
128012251|NCT01369433|460671426|FG000|Overall Study|Death|5|||
128012252|NCT01369433|460671427|FG001|Overall Study|Death|0|||
128012253|NCT01369433|460671426|FG000|Overall Study|Investigator discretion|6|||
128012254|NCT01369433|460671427|FG001|Overall Study|Investigator discretion|1|||
128012255|NCT01369433|460671426|FG000|Overall Study|Progressive Disease|92|||
128012256|NCT01369433|460671427|FG001|Overall Study|Progressive Disease|12|||
128012257|NCT04666298|460671434|FG000|Overall Study|Subject decision|1|||
128012258|NCT04666298|460671435|FG001|Overall Study|Subject decision|0|||
128012259|NCT04666298|460671436|FG002|Overall Study|Subject decision|0|||
128012260|NCT04666298|460671437|FG003|Overall Study|Subject decision|2|||
128012261|NCT04666298|460671434|FG000|Overall Study|Death|1|||
128012262|NCT04666298|460671435|FG001|Overall Study|Death|0|||
128012263|NCT04666298|460671436|FG002|Overall Study|Death|0|||
128012264|NCT04666298|460671437|FG003|Overall Study|Death|0|||
128012265|NCT04666298|460671434|FG000|Overall Study|Lost to Follow-up|0|||
128012266|NCT04666298|460671435|FG001|Overall Study|Lost to Follow-up|0|||
128012267|NCT04666298|460671436|FG002|Overall Study|Lost to Follow-up|0|||
128012268|NCT04666298|460671437|FG003|Overall Study|Lost to Follow-up|1|||
128012269|NCT04666298|460671434|FG000|Overall Study|Physician Decision|0|||
128012270|NCT04666298|460671435|FG001|Overall Study|Physician Decision|0|||
128012271|NCT04666298|460671436|FG002|Overall Study|Physician Decision|0|||
128012272|NCT04666298|460671437|FG003|Overall Study|Physician Decision|1|||
128012273|NCT04666298|460671434|FG000|Overall Study|Protocol deviation|0|||
128012274|NCT04666298|460671435|FG001|Overall Study|Protocol deviation|0|||
128012275|NCT04666298|460671436|FG002|Overall Study|Protocol deviation|1|||
128012276|NCT04666298|460671437|FG003|Overall Study|Protocol deviation|0|||
128012277|NCT00226655|460671438|FG000|Overall Study|Death|13|||
128012278|NCT00226655|460671438|FG000|Overall Study|Withdrawal by Subject|15|||
128012279|NCT00226655|460671438|FG000|Overall Study|Adverse Event|35|||
128012280|NCT00226655|460671438|FG000|Overall Study|Physician Decision|6|||
128012281|NCT00226655|460671438|FG000|Overall Study|Clinical deterioration|10|||
128012282|NCT01311661|460671441|FG000|Overall Study|Adverse Event|2|||
128012283|NCT01311661|460671441|FG000|Overall Study|Protocol Violation|3|||
128012284|NCT01311661|460671441|FG000|Overall Study|Withdrawal by Subject|2|||
128012285|NCT00207740|460671442|FG000|Overall Study|Adverse Event|4|||
128012286|NCT00207740|460671443|FG001|Overall Study|Adverse Event|14|||
128012287|NCT00207740|460671444|FG002|Overall Study|Adverse Event|14|||
128012288|NCT00207740|460671445|FG003|Overall Study|Adverse Event|11|||
128012289|NCT00207740|460671442|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
128012290|NCT00207740|460671443|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
128012291|NCT00207740|460671444|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
128012292|NCT00207740|460671445|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
128012293|NCT00207740|460671442|FG000|Overall Study|Lost to Follow-up|0|||
128012294|NCT00207740|460671443|FG001|Overall Study|Lost to Follow-up|2|||
128012295|NCT00207740|460671444|FG002|Overall Study|Lost to Follow-up|1|||
128012296|NCT00207740|460671445|FG003|Overall Study|Lost to Follow-up|1|||
128012297|NCT00207740|460671442|FG000|Overall Study|Death|0|||
128012298|NCT00207740|460671443|FG001|Overall Study|Death|0|||
128012299|NCT00207740|460671444|FG002|Overall Study|Death|0|||
128012300|NCT00207740|460671445|FG003|Overall Study|Death|1|||
128012301|NCT00207740|460671442|FG000|Overall Study|Sponsor Directive|22|||
128012302|NCT00207740|460671443|FG001|Overall Study|Sponsor Directive|15|||
128012303|NCT00207740|460671444|FG002|Overall Study|Sponsor Directive|16|||
128012304|NCT00207740|460671445|FG003|Overall Study|Sponsor Directive|21|||
128012305|NCT00207740|460671442|FG000|Overall Study|Other|2|||
128012306|NCT00207740|460671443|FG001|Overall Study|Other|10|||
128012307|NCT00207740|460671444|FG002|Overall Study|Other|7|||
128012308|NCT00207740|460671445|FG003|Overall Study|Other|5|||
128012309|NCT00390013|460671446|FG000|Phase 1|tired|0|||
128012310|NCT00390013|460671447|FG001|Phase 1|tired|0|||
128012311|NCT00390013|460671448|FG002|Phase 1|tired|0|||
128012312|NCT00390013|460671449|FG003|Phase 1|tired|1|||
128012313|NCT00390013|460671446|FG000|Phase 2 First Treatment|tired|1|||
128012314|NCT00390013|460671447|FG001|Phase 2 First Treatment|tired|0|||
128012315|NCT00390013|460671448|FG002|Phase 2 First Treatment|tired|0|||
128012316|NCT00390013|460671449|FG003|Phase 2 First Treatment|tired|0|||
127765025|NCT02502799|459765546|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
127765026|NCT02502799|459765543|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
127765027|NCT02502799|459765544|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
127765028|NCT02502799|459765545|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
127765029|NCT02502799|459765546|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
127765030|NCT02502799|459765543|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
127765031|NCT02502799|459765544|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
127765032|NCT02502799|459765545|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
127765033|NCT02502799|459765546|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
127765034|NCT02502799|459765543|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
127765035|NCT02502799|459765544|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
127765036|NCT02502799|459765545|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
127765037|NCT02502799|459765546|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
127765038|NCT01076192|459765549|FG000|Overall Study|Other|197|||
127765039|NCT02680002|459765550|FG000|Overall Study|Lost to Follow-up|5|||
127765040|NCT02680002|459765551|FG001|Overall Study|Lost to Follow-up|1|||
127765041|NCT02680002|459765552|FG002|Overall Study|Lost to Follow-up|4|||
127544558|NCT02532517|458960765|FG000|Overall Study|Withdrawal by Subject|4|||
127544559|NCT02532517|458960765|FG000|Overall Study|Death|4|||
127544560|NCT05720897|458960767|FG000|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|2|||
127544561|NCT05720897|458960768|FG001|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|0|||
127544562|NCT04780061|458960769|FG000|Overall Study|Withdrawal by Subject|5|||
127544563|NCT04780061|458960770|FG001|Overall Study|Withdrawal by Subject|8|||
127544564|NCT04780061|458960769|FG000|Overall Study|Adverse Event|2|||
127544565|NCT04780061|458960770|FG001|Overall Study|Adverse Event|2|||
127544566|NCT04780061|458960769|FG000|Overall Study|Lost to Follow-up|1|||
127544567|NCT04780061|458960770|FG001|Overall Study|Lost to Follow-up|5|||
127544568|NCT01824836|458960771|FG000|Overall Study|Adverse Event|48|||
127544569|NCT01824836|458960771|FG000|Overall Study|Withdrawal by Subject|63|||
127544570|NCT01824836|458960771|FG000|Overall Study|Other complicating disease|116|||
127544571|NCT01824836|458960771|FG000|Overall Study|Disease progression|5|||
127544572|NCT01824836|458960771|FG000|Overall Study|Alternative therapy|2|||
127544573|NCT01824836|458960771|FG000|Overall Study|Depression|1|||
127544574|NCT01824836|458960771|FG000|Overall Study|Non-compliance|3|||
127544575|NCT01824836|458960771|FG000|Overall Study|Patient regained ovarian function|3|||
127544576|NCT01824836|458960771|FG000|Overall Study|Lost to Follow-up|8|||
127544577|NCT01824836|458960771|FG000|Overall Study|Physician Decision|2|||
127544578|NCT01824836|458960771|FG000|Overall Study|Research office was closed|3|||
127544579|NCT01824836|458960771|FG000|Overall Study|Relocation|3|||
127544580|NCT01824836|458960771|FG000|Overall Study|Insurance-related issue|1|||
127544581|NCT01824836|458960771|FG000|Overall Study|Transportation issue|1|||
127544582|NCT01824836|458960771|FG000|Overall Study|Patient transferred care|1|||
127544583|NCT01824836|458960771|FG000|Overall Study|Unknown reasons|4|||
127544584|NCT01824836|458960771|FG000|Overall Study|Never started treatment|16|||
127544585|NCT02608684|458962409|FG000|Overall Study|Physician Decision|2|||
127544586|NCT02608684|458962409|FG000|Overall Study|Withdrawal by Subject|1|||
127544587|NCT01456039|458962411|FG000|Phase 1 (First Step)|Disease Progression|1|||
127544588|NCT01456039|458962412|FG001|Phase 1 (First Step)|Disease Progression|1|||
127544589|NCT01456039|458962413|FG002|Phase 1 (First Step)|Disease Progression|0|||
127544590|NCT01456039|458962411|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
127544591|NCT01456039|458962412|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
127544592|NCT01456039|458962413|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
127544593|NCT01456039|458962411|FG000|Phase 1 (First Step)|Adverse Event|0|||
127544594|NCT01456039|458962412|FG001|Phase 1 (First Step)|Adverse Event|3|||
127544595|NCT01456039|458962413|FG002|Phase 1 (First Step)|Adverse Event|0|||
127765042|NCT02680002|459765553|FG003|Overall Study|Lost to Follow-up|2|||
127765043|NCT02680002|459765554|FG004|Overall Study|Lost to Follow-up|0|||
127765044|NCT02680002|459765555|FG005|Overall Study|Lost to Follow-up|2|||
127765045|NCT02680002|459765550|FG000|Overall Study|Physician Decision|5|||
127765046|NCT02680002|459765551|FG001|Overall Study|Physician Decision|1|||
127765047|NCT02680002|459765552|FG002|Overall Study|Physician Decision|1|||
127765048|NCT02680002|459765553|FG003|Overall Study|Physician Decision|1|||
127765049|NCT02680002|459765554|FG004|Overall Study|Physician Decision|1|||
127765050|NCT02680002|459765555|FG005|Overall Study|Physician Decision|1|||
127544596|NCT01456039|458962411|FG000|Phase 1 (First Step)|Other|0|||
127544597|NCT01456039|458962412|FG001|Phase 1 (First Step)|Other|1|||
127544598|NCT01456039|458962413|FG002|Phase 1 (First Step)|Other|0|||
127544599|NCT01456039|458962411|FG000|Phase 2 (Second Step)|Disease Progression|0|||
127544600|NCT01456039|458962412|FG001|Phase 2 (Second Step)|Disease Progression|0|||
127544601|NCT01456039|458962413|FG002|Phase 2 (Second Step)|Disease Progression|17|||
127544602|NCT01456039|458962411|FG000|Phase 2 (Second Step)|Adverse Event|0|||
127544603|NCT01456039|458962412|FG001|Phase 2 (Second Step)|Adverse Event|0|||
127544604|NCT01456039|458962413|FG002|Phase 2 (Second Step)|Adverse Event|10|||
127544605|NCT01456039|458962411|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
128012317|NCT00390013|460671446|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
128012318|NCT00390013|460671447|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
128012319|NCT00390013|460671448|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
128012320|NCT00390013|460671449|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
128012321|NCT03188822|460671450|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
128012322|NCT03188822|460671450|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
128012323|NCT00294658|460671451|FG000|Overall Study|Death|0|||
128012324|NCT00294658|460671452|FG001|Overall Study|Death|1|||
128012325|NCT00294658|460671451|FG000|Overall Study|Lost to Follow-up|4|||
128012326|NCT00294658|460671452|FG001|Overall Study|Lost to Follow-up|0|||
128012327|NCT00294658|460671451|FG000|Overall Study|Physician Decision|1|||
128012328|NCT00294658|460671452|FG001|Overall Study|Physician Decision|2|||
128012329|NCT00294658|460671451|FG000|Overall Study|Pregnancy|0|||
128012330|NCT00294658|460671452|FG001|Overall Study|Pregnancy|1|||
128012331|NCT00294658|460671451|FG000|Overall Study|Withdrawal by Subject|0|||
128012332|NCT00294658|460671452|FG001|Overall Study|Withdrawal by Subject|4|||
128012333|NCT00294658|460671451|FG000|Overall Study|Found to have invasive thymoma|1|||
128012334|NCT00294658|460671452|FG001|Overall Study|Found to have invasive thymoma|0|||
128012335|NCT00294658|460671451|FG000|Overall Study|Patient and family were not satisfied|0|||
128012336|NCT00294658|460671452|FG001|Overall Study|Patient and family were not satisfied|1|||
128012337|NCT02340949|460671453|FG000|Overall Study|Adverse Event|4|||
128012338|NCT02340949|460671454|FG001|Overall Study|Adverse Event|2|||
128012339|NCT02340949|460671453|FG000|Overall Study|Withdrawal by Subject|2|||
128012340|NCT02340949|460671454|FG001|Overall Study|Withdrawal by Subject|0|||
128012341|NCT02340949|460671453|FG000|Overall Study|Progression disease|6|||
128012342|NCT02340949|460671454|FG001|Overall Study|Progression disease|2|||
128012343|NCT02340949|460671453|FG000|Overall Study|Death|3|||
128012344|NCT02340949|460671454|FG001|Overall Study|Death|0|||
128012345|NCT02340949|460671453|FG000|Overall Study|Physician Decision|1|||
128012346|NCT02340949|460671454|FG001|Overall Study|Physician Decision|0|||
128012347|NCT01155570|460671455|FG000|Overall Study|Adverse Event|39|||
128012348|NCT01155570|460671455|FG000|Overall Study|Lack of Efficacy|46|||
128012349|NCT01155570|460671455|FG000|Overall Study|Participant's Economic Reasons|17|||
128012350|NCT01155570|460671455|FG000|Overall Study|No Hospital Visits|7|||
128012351|NCT01155570|460671455|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
128012352|NCT01155570|460671455|FG000|Overall Study|Adverse Event + Other Reasons|7|||
128012353|NCT01155570|460671455|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
127544606|NCT01456039|458962412|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
127765051|NCT02680002|459765550|FG000|Overall Study|Protocol Violation|1|||
127765052|NCT02680002|459765551|FG001|Overall Study|Protocol Violation|0|||
127765053|NCT02680002|459765552|FG002|Overall Study|Protocol Violation|1|||
127765054|NCT02680002|459765553|FG003|Overall Study|Protocol Violation|0|||
127765055|NCT02680002|459765554|FG004|Overall Study|Protocol Violation|1|||
127765056|NCT02680002|459765555|FG005|Overall Study|Protocol Violation|2|||
127765057|NCT02680002|459765550|FG000|Overall Study|Withdrawal by Subject|0|||
127765058|NCT02680002|459765551|FG001|Overall Study|Withdrawal by Subject|0|||
127765059|NCT02680002|459765552|FG002|Overall Study|Withdrawal by Subject|1|||
127765060|NCT02680002|459765553|FG003|Overall Study|Withdrawal by Subject|0|||
127765061|NCT02680002|459765554|FG004|Overall Study|Withdrawal by Subject|2|||
127765062|NCT02680002|459765555|FG005|Overall Study|Withdrawal by Subject|2|||
127765063|NCT02680002|459765550|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
127765064|NCT02680002|459765551|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
127765065|NCT02680002|459765552|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
127765066|NCT02680002|459765553|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
127765067|NCT02680002|459765554|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
127765068|NCT02680002|459765555|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
128012354|NCT01155570|460671455|FG000|Overall Study|Other Reasons|23|||
128012355|NCT00296517|460671456|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
128012356|NCT00296517|460671457|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
128012357|NCT00296517|460671456|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
128012358|NCT00296517|460671457|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
128012359|NCT00296517|460671456|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
128012360|NCT00296517|460671457|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
128012361|NCT00296517|460671456|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
128012362|NCT00296517|460671457|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
128012363|NCT00296517|460671456|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
128012364|NCT00296517|460671457|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
128012365|NCT00296517|460671456|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
128012366|NCT00296517|460671457|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
127765069|NCT02680002|459765550|FG000|Overall Study|Other|0|||
127765070|NCT02680002|459765551|FG001|Overall Study|Other|1|||
127765071|NCT02680002|459765552|FG002|Overall Study|Other|0|||
128012367|NCT00296517|460671456|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
128012368|NCT00296517|460671457|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
128012369|NCT00296517|460671456|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
127544607|NCT01456039|458962413|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
127544608|NCT01456039|458962411|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
127544609|NCT01456039|458962412|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
127544610|NCT01456039|458962413|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
127544611|NCT01456039|458962411|FG000|Phase 2 (Second Step)|Other|0|||
127544612|NCT01456039|458962412|FG001|Phase 2 (Second Step)|Other|0|||
127544613|NCT01456039|458962413|FG002|Phase 2 (Second Step)|Other|1|||
127544614|NCT00755183|458962414|FG000|Overall Study|Adverse Event|5|||
127544615|NCT00755183|458962415|FG001|Overall Study|Adverse Event|2|||
127544616|NCT00755183|458962414|FG000|Overall Study|Protocol Violation|0|||
127544617|NCT00755183|458962415|FG001|Overall Study|Protocol Violation|1|||
127544618|NCT00755183|458962414|FG000|Overall Study|Withdrawal by Subject|0|||
127544619|NCT00755183|458962415|FG001|Overall Study|Withdrawal by Subject|2|||
127765072|NCT02680002|459765553|FG003|Overall Study|Other|0|||
127765073|NCT02680002|459765554|FG004|Overall Study|Other|1|||
127765074|NCT02680002|459765555|FG005|Overall Study|Other|0|||
127765075|NCT02680002|459765550|FG000|Overall Study|Adverse Event|0|||
127765076|NCT02680002|459765551|FG001|Overall Study|Adverse Event|0|||
127765077|NCT02680002|459765552|FG002|Overall Study|Adverse Event|0|||
127765078|NCT02680002|459765553|FG003|Overall Study|Adverse Event|0|||
127765079|NCT02680002|459765554|FG004|Overall Study|Adverse Event|1|||
127765080|NCT02680002|459765555|FG005|Overall Study|Adverse Event|2|||
127765081|NCT03527173|459765558|FG000|Overall Study|Lost to Follow-up|4|||
127765082|NCT03527173|459765559|FG001|Overall Study|Lost to Follow-up|2|||
127765083|NCT03527173|459765558|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
127765084|NCT03527173|459765559|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
127765085|NCT03527173|459765558|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
127765086|NCT03527173|459765559|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
127765087|NCT03527173|459765558|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
127765088|NCT03527173|459765559|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
127765089|NCT01248780|459765564|FG000|Overall Study|Lack of Efficacy|2|||
127765090|NCT01248780|459765565|FG001|Overall Study|Lack of Efficacy|0|||
127765091|NCT01248780|459765564|FG000|Overall Study|Lost to Follow-up|0|||
127765092|NCT01248780|459765565|FG001|Overall Study|Lost to Follow-up|1|||
127765093|NCT01248780|459765564|FG000|Overall Study|Death|0|||
127765094|NCT01248780|459765565|FG001|Overall Study|Death|1|||
127765095|NCT01248780|459765564|FG000|Overall Study|Adverse Event|2|||
127765096|NCT01248780|459765565|FG001|Overall Study|Adverse Event|7|||
127765097|NCT01248780|459765564|FG000|Overall Study|Protocol Violation|1|||
127544620|NCT00755183|458962414|FG000|Overall Study|Administrative|2|||
127544621|NCT00755183|458962415|FG001|Overall Study|Administrative|1|||
127544622|NCT00148317|458962416|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
127544623|NCT00148317|458962416|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
127544624|NCT00148317|458962416|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
127544625|NCT00335777|458962417|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
127544626|NCT00335777|458962417|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
127544627|NCT00335777|458962417|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
127544628|NCT00335777|458962417|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
127544629|NCT00335777|458962417|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
127544630|NCT04639245|458962418|FG000|Overall Study|Death|1|||
127544631|NCT03829228|458962422|FG000|Overall Study|Protocol Violation|1|||
127544632|NCT03337477|458962423|FG000|Overall Study|not categorized into the listed ones|11|||
127544633|NCT03337477|458962424|FG001|Overall Study|not categorized into the listed ones|9|||
127544634|NCT03337477|458962423|FG000|Overall Study|Withdrawal by Subject|0|||
127544635|NCT03337477|458962424|FG001|Overall Study|Withdrawal by Subject|1|||
127544636|NCT03337477|458962423|FG000|Overall Study|Death|0|||
127544637|NCT03337477|458962424|FG001|Overall Study|Death|1|||
127544638|NCT03337477|458962423|FG000|Overall Study|Lost to Follow-up|0|||
127544639|NCT03337477|458962424|FG001|Overall Study|Lost to Follow-up|2|||
127544640|NCT01462370|458962431|FG000|Overall Study|Lack of Qualifying Event|1|||
127544641|NCT01462370|458962432|FG001|Overall Study|Lack of Qualifying Event|1|||
127544642|NCT01462370|458962431|FG000|Overall Study|Physician Decision|0|||
127544643|NCT01462370|458962432|FG001|Overall Study|Physician Decision|1|||
127544644|NCT01462370|458962431|FG000|Overall Study|Withdrawal by Subject|0|||
127544645|NCT01462370|458962432|FG001|Overall Study|Withdrawal by Subject|3|||
127544646|NCT02220920|458962433|FG000|Overall Study|Adverse Event|1|||
127544647|NCT02220920|458962434|FG001|Overall Study|Adverse Event|0|||
127544648|NCT02220920|458962433|FG000|Overall Study|Lack of Efficacy|0|||
127544649|NCT02220920|458962434|FG001|Overall Study|Lack of Efficacy|1|||
127544650|NCT02220920|458962433|FG000|Overall Study|Withdrawal by Subject|1|||
127544651|NCT02220920|458962434|FG001|Overall Study|Withdrawal by Subject|0|||
127544652|NCT02220920|458962433|FG000|Overall Study|Conflict with the stopping criteria|1|||
127544653|NCT02220920|458962434|FG001|Overall Study|Conflict with the stopping criteria|2|||
127544654|NCT00473564|458962435|FG000|Overall Study|robot surgery aborted in OR|23|||
127544655|NCT02118584|458962441|FG000|Part 1: Open Label Extension Period|Adverse Event|79|||
127765098|NCT01248780|459765565|FG001|Overall Study|Protocol Violation|1|||
128012370|NCT00296517|460671457|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
128012371|NCT00296517|460671456|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
128012372|NCT00296517|460671457|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
128012373|NCT00964782|460671461|FG000|Overall Study|Lost to Follow-up|1|||
128012374|NCT00964782|460671462|FG001|Overall Study|Lost to Follow-up|0|||
128012375|NCT01143324|460671468|FG000|Overall Study|Lost to Follow-up|11|||
128012376|NCT01143324|460671468|FG000|Overall Study|Withdrawal by Subject|4|||
128012377|NCT01143324|460671468|FG000|Overall Study|Explant of the device|4|||
128012378|NCT02774889|460671478|FG000|Overall Study|Lost to Follow-up|2|||
128012379|NCT02774889|460671479|FG001|Overall Study|Lost to Follow-up|1|||
128012380|NCT00858988|460671480|FG000|Analysis|Lactulose unable to be detected in urine|2|||
128012381|NCT00858988|460671481|FG001|Analysis|Lactulose unable to be detected in urine|1|||
128012382|NCT01349595|460671482|FG000|Overall Study|Lack of funding|2|||
128012383|NCT01349595|460671483|FG001|Overall Study|Lack of funding|2|||
128012384|NCT04584788|460671508|FG000|Overall Study|Physician Decision|8|||
128012385|NCT04584788|460671508|FG000|Overall Study|Withdrawal by Subject|1|||
128012386|NCT04584788|460671508|FG000|Overall Study|Adverse Event|3|||
128012387|NCT05399485|460673240|FG000|DBT Phase|Other|6|||
128012388|NCT05399485|460673241|FG001|DBT Phase|Other|5|||
128012389|NCT05399485|460673240|FG000|DBT Phase|Protocol-specified withdrawal criterion met|1|||
128012390|NCT05399485|460673241|FG001|DBT Phase|Protocol-specified withdrawal criterion met|1|||
128012391|NCT05399485|460673240|FG000|DBT Phase|Withdrawal by Subject|3|||
128012392|NCT05399485|460673241|FG001|DBT Phase|Withdrawal by Subject|2|||
128012393|NCT05399485|460673240|FG000|DBT Phase|Protocol Violation|2|||
128012394|NCT05399485|460673241|FG001|DBT Phase|Protocol Violation|1|||
128012395|NCT05399485|460673240|FG000|DBT Phase|Physician Decision|0|||
128012396|NCT05399485|460673241|FG001|DBT Phase|Physician Decision|1|||
128012397|NCT05399485|460673240|FG000|DBT Phase|Adverse Event|2|||
128012398|NCT05399485|460673241|FG001|DBT Phase|Adverse Event|1|||
128012399|NCT05399485|460673240|FG000|OLE Phase|Not reported|0|||
128012400|NCT05399485|460673241|FG001|OLE Phase|Not reported|1|||
128012401|NCT05399485|460673240|FG000|OLE Phase|Other|3|||
127677888|NCT00628862|459444511|FG001|Overall Study|Withdrawal by Subject|6|||
127677889|NCT00628862|459444512|FG002|Overall Study|Withdrawal by Subject|11|||
127677890|NCT00628862|459444510|FG000|Overall Study|Lost to Follow-up|0|||
127677891|NCT00628862|459444511|FG001|Overall Study|Lost to Follow-up|2|||
127677892|NCT00628862|459444512|FG002|Overall Study|Lost to Follow-up|1|||
127677893|NCT00628862|459444510|FG000|Overall Study|Protocol Violation|1|||
127677894|NCT00628862|459444511|FG001|Overall Study|Protocol Violation|0|||
127677895|NCT00628862|459444512|FG002|Overall Study|Protocol Violation|0|||
127677896|NCT00628862|459444510|FG000|Overall Study|COPD Exacerbation|0|||
127677897|NCT00628862|459444511|FG001|Overall Study|COPD Exacerbation|1|||
127677898|NCT00628862|459444512|FG002|Overall Study|COPD Exacerbation|0|||
127677899|NCT01063036|459444513|FG000|Participants Treated With Study Drug|Adverse Event|1|||
127677900|NCT01063036|459444513|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
127677901|NCT01063036|459444513|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
127677902|NCT01063036|459444513|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
127677903|NCT01063036|459444513|FG000|Participants Treated With Study Drug|Pregnancy|1|||
127677904|NCT01063036|459444513|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
127677905|NCT01063036|459444513|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
127677906|NCT01063036|459444513|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
127677907|NCT02715258|459444514|FG000|Overall Study|Withdrawal by Subject|6|||
127677908|NCT02715258|459444515|FG001|Overall Study|Withdrawal by Subject|1|||
127677909|NCT02715258|459444514|FG000|Overall Study|Lost to Follow-up|7|||
127677910|NCT02715258|459444515|FG001|Overall Study|Lost to Follow-up|1|||
127677911|NCT02715258|459444514|FG000|Overall Study|Terminated by Sponsor|0|||
127677912|NCT02715258|459444515|FG001|Overall Study|Terminated by Sponsor|1|||
127677913|NCT02715258|459444514|FG000|Overall Study|Death|0|||
127677914|NCT02715258|459444515|FG001|Overall Study|Death|1|||
127677915|NCT02715258|459444514|FG000|Overall Study|Subject non-compliant|1|||
127677916|NCT02715258|459444515|FG001|Overall Study|Subject non-compliant|1|||
127677917|NCT02715258|459444514|FG000|Overall Study|GCP violation|2|||
127677918|NCT02715258|459444515|FG001|Overall Study|GCP violation|1|||
127677919|NCT02814643|459444516|FG000|Overall Study|Lost to Follow-up|0|||
127677920|NCT02814643|459444517|FG001|Overall Study|Lost to Follow-up|1|||
127677921|NCT02814643|459444516|FG000|Overall Study|Withdrawal by Subject|1|||
127677922|NCT02814643|459444517|FG001|Overall Study|Withdrawal by Subject|2|||
127677923|NCT02263508|459444518|FG000|Overall Study|Withdrawal by Subject|1|||
127677924|NCT02263508|459444519|FG001|Overall Study|Withdrawal by Subject|23|||
127677925|NCT02263508|459444520|FG002|Overall Study|Withdrawal by Subject|17|||
128012402|NCT05399485|460673241|FG001|OLE Phase|Other|3|||
128012403|NCT05399485|460673240|FG000|OLE Phase|Withdrawal by Subject|8|||
128012404|NCT05399485|460673241|FG001|OLE Phase|Withdrawal by Subject|5|||
128012405|NCT05399485|460673240|FG000|OLE Phase|Pregnancy|0|||
128012406|NCT05399485|460673241|FG001|OLE Phase|Pregnancy|1|||
128012407|NCT05399485|460673240|FG000|OLE Phase|Physician Decision|2|||
128012408|NCT05399485|460673241|FG001|OLE Phase|Physician Decision|0|||
128012409|NCT05399485|460673240|FG000|OLE Phase|Adverse Event|0|||
128012410|NCT05399485|460673241|FG001|OLE Phase|Adverse Event|1|||
128012411|NCT05399485|460673240|FG000|OLE Phase|Ongoing in the OLE Phase|141|||
128012412|NCT05399485|460673241|FG001|OLE Phase|Ongoing in the OLE Phase|140|||
128012413|NCT00549055|460673244|FG000|Overall Study|Adverse Event|4|||
128012414|NCT00549055|460673244|FG000|Overall Study|Lack of Efficacy|18|||
128012415|NCT00549055|460673244|FG000|Overall Study|Stabilization|5|||
128012416|NCT00549055|460673244|FG000|Overall Study|Progression to fibrosis|2|||
127544656|NCT02118584|458962442|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
127544657|NCT02118584|458962443|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
128012417|NCT00549055|460673244|FG000|Overall Study|Decrease of size|1|||
128012418|NCT00549055|460673244|FG000|Overall Study|Active choroidal neovascula increased|1|||
128012419|NCT00549055|460673244|FG000|Overall Study|Vitreous hemorrhage|1|||
128012420|NCT00549055|460673244|FG000|Overall Study|Growth choroidal neovascularisation|1|||
128012421|NCT00549055|460673244|FG000|Overall Study|Choroidal neovascularization|1|||
128012422|NCT00549055|460673244|FG000|Overall Study|Very low visual acuity (VA)|1|||
128012423|NCT00770809|460673249|FG000|Overall Study|Adverse Event|9|||
128012424|NCT00770809|460673250|FG001|Overall Study|Adverse Event|1|||
128012425|NCT00770809|460673251|FG002|Overall Study|Adverse Event|12|||
128012426|NCT00770809|460673249|FG000|Overall Study|Death|1|||
128012427|NCT00770809|460673250|FG001|Overall Study|Death|0|||
128012428|NCT00770809|460673251|FG002|Overall Study|Death|0|||
128012429|NCT00770809|460673249|FG000|Overall Study|Withdrawal by Subject|3|||
128012430|NCT00770809|460673250|FG001|Overall Study|Withdrawal by Subject|3|||
128012431|NCT00770809|460673251|FG002|Overall Study|Withdrawal by Subject|7|||
128012432|NCT00770809|460673249|FG000|Overall Study|Progression|2|||
128012433|NCT00770809|460673250|FG001|Overall Study|Progression|2|||
128012434|NCT00770809|460673251|FG002|Overall Study|Progression|0|||
128012435|NCT00770809|460673249|FG000|Overall Study|Complicating illness|0|||
128012436|NCT00770809|460673250|FG001|Overall Study|Complicating illness|0|||
128012437|NCT00770809|460673251|FG002|Overall Study|Complicating illness|1|||
128012438|NCT00770809|460673249|FG000|Overall Study|Other Medical Reasons|2|||
128012439|NCT00770809|460673250|FG001|Overall Study|Other Medical Reasons|4|||
128012440|NCT00770809|460673251|FG002|Overall Study|Other Medical Reasons|3|||
128012441|NCT03474107|460673256|FG000|Overall Study|Adverse Event|42|||
128012442|NCT03474107|460673257|FG001|Overall Study|Adverse Event|46|||
128012443|NCT03474107|460673256|FG000|Overall Study|Death|2|||
128012444|NCT03474107|460673257|FG001|Overall Study|Death|2|||
128012445|NCT03474107|460673256|FG000|Overall Study|Lost to Follow-up|0|||
128012446|NCT03474107|460673257|FG001|Overall Study|Lost to Follow-up|1|||
128012447|NCT03474107|460673256|FG000|Overall Study|Progressive Disease|177|||
128012448|NCT03474107|460673257|FG001|Overall Study|Progressive Disease|180|||
128012449|NCT03474107|460673256|FG000|Overall Study|Protocol Violation|1|||
128012450|NCT03474107|460673257|FG001|Overall Study|Protocol Violation|1|||
128012451|NCT03474107|460673256|FG000|Overall Study|Withdrawal by Subject|15|||
128012452|NCT03474107|460673257|FG001|Overall Study|Withdrawal by Subject|27|||
128012453|NCT03474107|460673256|FG000|Overall Study|Physician Decision|7|||
128012454|NCT03474107|460673257|FG001|Overall Study|Physician Decision|22|||
128012455|NCT03474107|460673256|FG000|Overall Study|Miscellaneous|1|||
128012456|NCT03474107|460673257|FG001|Overall Study|Miscellaneous|6|||
128012457|NCT03095287|460673258|FG000|Overall Study|Treatment Failure|1|||
128012458|NCT03095287|460673258|FG000|Overall Study|Adverse Event|1|||
128012459|NCT02127671|460673261|FG000|Overall Study|Death|2|||
128012460|NCT02127671|460673262|FG001|Overall Study|Death|2|||
128012461|NCT02127671|460673261|FG000|Overall Study|Lost to Follow-up|4|||
128012462|NCT02127671|460673262|FG001|Overall Study|Lost to Follow-up|2|||
128012463|NCT02127671|460673261|FG000|Overall Study|Physician Decision|1|||
128012464|NCT02127671|460673262|FG001|Overall Study|Physician Decision|0|||
128012465|NCT02127671|460673261|FG000|Overall Study|incarceration|0|||
128012466|NCT02127671|460673262|FG001|Overall Study|incarceration|1|||
128012467|NCT02127671|460673261|FG000|Overall Study|Did not have full Framingham risk score measured|1|||
128012468|NCT02127671|460673262|FG001|Overall Study|Did not have full Framingham risk score measured|0|||
128012469|NCT02394275|460673263|FG000|Overall Study|Adverse Event|22|||
128012470|NCT02394275|460673263|FG000|Overall Study|Lost to Follow-up|7|||
128012471|NCT04757636|460673269|FG000|Overall Study|Adverse Event|25|||
128012472|NCT04757636|460673270|FG001|Overall Study|Adverse Event|8|||
128012473|NCT04757636|460673271|FG002|Overall Study|Adverse Event|11|||
128012474|NCT04757636|460673269|FG000|Overall Study|Death|9|||
128012475|NCT04757636|460673270|FG001|Overall Study|Death|12|||
128012476|NCT04757636|460673271|FG002|Overall Study|Death|6|||
128012477|NCT04757636|460673269|FG000|Overall Study|Lack of Efficacy|2|||
128012478|NCT04757636|460673270|FG001|Overall Study|Lack of Efficacy|0|||
128012479|NCT04757636|460673271|FG002|Overall Study|Lack of Efficacy|0|||
128012480|NCT04757636|460673269|FG000|Overall Study|Lost to Follow-up|1|||
128012481|NCT04757636|460673270|FG001|Overall Study|Lost to Follow-up|6|||
128012482|NCT04757636|460673271|FG002|Overall Study|Lost to Follow-up|7|||
128012483|NCT04757636|460673269|FG000|Overall Study|Physician Decision|1|||
128012484|NCT04757636|460673270|FG001|Overall Study|Physician Decision|3|||
128012485|NCT04757636|460673271|FG002|Overall Study|Physician Decision|4|||
128012486|NCT04757636|460673269|FG000|Overall Study|Withdrawal by Subject|20|||
128012487|NCT04757636|460673270|FG001|Overall Study|Withdrawal by Subject|23|||
128012488|NCT04757636|460673271|FG002|Overall Study|Withdrawal by Subject|18|||
128012489|NCT04757636|460673269|FG000|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
128012490|NCT04757636|460673270|FG001|Overall Study|Discontinued Study Treatment at or prior to Week 52|1|||
128012491|NCT04757636|460673271|FG002|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
128012492|NCT04757636|460673269|FG000|Overall Study|Study Terminated by Sponsor|103|||
128012493|NCT04757636|460673270|FG001|Overall Study|Study Terminated by Sponsor|104|||
128012494|NCT04757636|460673271|FG002|Overall Study|Study Terminated by Sponsor|114|||
128012495|NCT04757636|460673269|FG000|Overall Study|Sponsor Decision|0|||
128012496|NCT04757636|460673270|FG001|Overall Study|Sponsor Decision|0|||
128012497|NCT04757636|460673271|FG002|Overall Study|Sponsor Decision|1|||
128012498|NCT04757636|460673269|FG000|Overall Study|Randomized in Error|0|||
128012499|NCT04757636|460673270|FG001|Overall Study|Randomized in Error|0|||
128012500|NCT04757636|460673271|FG002|Overall Study|Randomized in Error|2|||
128012501|NCT05350423|460673273|FG000|Overall Study|Lost to Follow-up|3|||
128012502|NCT05350423|460673274|FG001|Overall Study|Lost to Follow-up|3|||
128012503|NCT05350423|460673273|FG000|Overall Study|screen failure|5|||
128012504|NCT05350423|460673274|FG001|Overall Study|screen failure|6|||
128012505|NCT02097277|460673277|FG000|Overall Study|Subject no longer meets study criteria|0|||
128012506|NCT02097277|460673278|FG001|Overall Study|Subject no longer meets study criteria|1|||
128012507|NCT02097277|460673279|FG002|Overall Study|Subject no longer meets study criteria|0|||
128012508|NCT02097277|460673280|FG003|Overall Study|Subject no longer meets study criteria|1|||
128012509|NCT02097277|460673281|FG004|Overall Study|Subject no longer meets study criteria|0|||
128012510|NCT02097277|460673277|FG000|Overall Study|Subject request to discontinue treatment|0|||
128012511|NCT02097277|460673278|FG001|Overall Study|Subject request to discontinue treatment|0|||
128012512|NCT02097277|460673279|FG002|Overall Study|Subject request to discontinue treatment|0|||
128012513|NCT02097277|460673280|FG003|Overall Study|Subject request to discontinue treatment|0|||
128012514|NCT02097277|460673281|FG004|Overall Study|Subject request to discontinue treatment|1|||
128012515|NCT02097277|460673277|FG000|Overall Study|Lost to Follow-up|0|||
128012516|NCT02097277|460673278|FG001|Overall Study|Lost to Follow-up|1|||
128012517|NCT02097277|460673279|FG002|Overall Study|Lost to Follow-up|1|||
128012518|NCT02097277|460673280|FG003|Overall Study|Lost to Follow-up|0|||
128012519|NCT02097277|460673281|FG004|Overall Study|Lost to Follow-up|0|||
128012520|NCT02097277|460673277|FG000|Overall Study|Withdrawal by Subject|2|||
128012521|NCT02097277|460673278|FG001|Overall Study|Withdrawal by Subject|1|||
128012522|NCT02097277|460673279|FG002|Overall Study|Withdrawal by Subject|0|||
128012523|NCT02097277|460673280|FG003|Overall Study|Withdrawal by Subject|1|||
128012524|NCT02097277|460673281|FG004|Overall Study|Withdrawal by Subject|0|||
127677926|NCT02263508|459444518|FG000|Overall Study|Sponsor Decision|12|||
127677927|NCT02263508|459444519|FG001|Overall Study|Sponsor Decision|165|||
127677928|NCT02263508|459444520|FG002|Overall Study|Sponsor Decision|182|||
127677929|NCT02263508|459444518|FG000|Overall Study|Lost to Follow-up|2|||
127677930|NCT02263508|459444519|FG001|Overall Study|Lost to Follow-up|7|||
127677931|NCT02263508|459444520|FG002|Overall Study|Lost to Follow-up|7|||
127677932|NCT02263508|459444518|FG000|Overall Study|Death|6|||
127677933|NCT02263508|459444519|FG001|Overall Study|Death|151|||
127677934|NCT02263508|459444520|FG002|Overall Study|Death|140|||
127677935|NCT03265210|459444523|FG000|Overall Study|Withdrawal by Subject|7|||
127677936|NCT03265210|459444524|FG001|Overall Study|Withdrawal by Subject|9|||
127677937|NCT03265210|459444523|FG000|Overall Study|Lost to Follow-up|2|||
127677938|NCT03265210|459444524|FG001|Overall Study|Lost to Follow-up|0|||
127677939|NCT03265210|459444523|FG000|Overall Study|Physician Decision|2|||
127677940|NCT03265210|459444524|FG001|Overall Study|Physician Decision|0|||
127677941|NCT03265210|459444523|FG000|Overall Study|Adverse Event|1|||
127677942|NCT03265210|459444524|FG001|Overall Study|Adverse Event|0|||
127677943|NCT00686517|459444525|FG000|Treatment|Serious Adverse Event|1|||
127677944|NCT00686517|459444526|FG001|Treatment|Serious Adverse Event|2|||
127677945|NCT00686517|459444527|FG002|Treatment|Serious Adverse Event|1|||
127677946|NCT00686517|459444525|FG000|Treatment|Adverse Event|2|||
127677947|NCT00686517|459444526|FG001|Treatment|Adverse Event|0|||
127677948|NCT00686517|459444527|FG002|Treatment|Adverse Event|0|||
127677949|NCT00686517|459444525|FG000|Treatment|Poor Protocol Compliance|1|||
127677950|NCT00686517|459444526|FG001|Treatment|Poor Protocol Compliance|0|||
127677951|NCT00686517|459444527|FG002|Treatment|Poor Protocol Compliance|0|||
127677952|NCT00686517|459444525|FG000|Treatment|Protocol Violation|2|||
127677953|NCT00686517|459444526|FG001|Treatment|Protocol Violation|1|||
127677954|NCT00686517|459444527|FG002|Treatment|Protocol Violation|0|||
127677955|NCT02281318|459444528|FG000|Overall Study|Adverse Event|2|||
127677956|NCT02281318|459444529|FG001|Overall Study|Adverse Event|2|||
127677957|NCT02281318|459444528|FG000|Overall Study|Lack of Efficacy|2|||
127677958|NCT02281318|459444529|FG001|Overall Study|Lack of Efficacy|0|||
127677959|NCT02281318|459444528|FG000|Overall Study|Lost to Follow-up|2|||
127677960|NCT02281318|459444529|FG001|Overall Study|Lost to Follow-up|1|||
127677961|NCT02281318|459444528|FG000|Overall Study|Physician Decision|2|||
127677962|NCT02281318|459444529|FG001|Overall Study|Physician Decision|0|||
127677963|NCT02281318|459444528|FG000|Overall Study|Withdrawal by Subject|6|||
127677964|NCT02281318|459444529|FG001|Overall Study|Withdrawal by Subject|2|||
127544658|NCT02118584|458962441|FG000|Part 1: Open Label Extension Period|Death|9|||
127544659|NCT02118584|458962442|FG001|Part 1: Open Label Extension Period|Death|0|||
127544660|NCT02118584|458962443|FG002|Part 1: Open Label Extension Period|Death|0|||
127544661|NCT02118584|458962441|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|53|||
127544662|NCT02118584|458962442|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
127544663|NCT02118584|458962443|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
127544664|NCT02118584|458962441|FG000|Part 1: Open Label Extension Period|Non-compliance|12|||
127544665|NCT02118584|458962442|FG001|Part 1: Open Label Extension Period|Non-compliance|0|||
127544666|NCT02118584|458962443|FG002|Part 1: Open Label Extension Period|Non-compliance|0|||
127544667|NCT02118584|458962441|FG000|Part 1: Open Label Extension Period|Other|135|||
127544668|NCT02118584|458962442|FG001|Part 1: Open Label Extension Period|Other|0|||
127544669|NCT02118584|458962443|FG002|Part 1: Open Label Extension Period|Other|0|||
127544670|NCT02118584|458962441|FG000|Part 1: Open Label Extension Period|Physician Decision|128|||
127544671|NCT02118584|458962442|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
127544672|NCT02118584|458962443|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
127544673|NCT02118584|458962441|FG000|Part 1: Open Label Extension Period|Protocol Violation|1|||
127544674|NCT02118584|458962442|FG001|Part 1: Open Label Extension Period|Protocol Violation|0|||
127544675|NCT02118584|458962443|FG002|Part 1: Open Label Extension Period|Protocol Violation|0|||
127544676|NCT02118584|458962441|FG000|Part 1: Open Label Extension Period|Study Terminated by Sponsor|29|||
127544677|NCT02118584|458962442|FG001|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
127544678|NCT02118584|458962443|FG002|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
127544679|NCT02118584|458962441|FG000|Part 1: Open Label Extension Period|Other|3|||
127544680|NCT02118584|458962442|FG001|Part 1: Open Label Extension Period|Other|0|||
128012525|NCT02097277|460673277|FG000|Overall Study|Adverse Event|0|||
128012526|NCT02097277|460673278|FG001|Overall Study|Adverse Event|0|||
128012527|NCT02097277|460673279|FG002|Overall Study|Adverse Event|1|||
128012528|NCT02097277|460673280|FG003|Overall Study|Adverse Event|2|||
128012529|NCT02097277|460673281|FG004|Overall Study|Adverse Event|0|||
128012530|NCT01091259|460673282|FG000|Overall Study|Adverse Event|3|||
128012531|NCT01091259|460673282|FG000|Overall Study|Lack of Efficacy|2|||
128012532|NCT00770367|460673283|FG000|First Intervention|Withdrawal by Subject|0|||
128012533|NCT00770367|460673284|FG001|First Intervention|Withdrawal by Subject|2|||
128012534|NCT00770367|460673283|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
128012535|NCT00770367|460673284|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
128012536|NCT00770367|460673283|FG000|Second Intervention|Lost to Follow-up|2|||
128012537|NCT00770367|460673284|FG001|Second Intervention|Lost to Follow-up|0|||
128012538|NCT00920816|460673285|FG000|Overall Study|Death|116|||
128012539|NCT00920816|460673286|FG001|Overall Study|Death|63|||
128012540|NCT00920816|460673287|FG002|Overall Study|Death|8|||
128012541|NCT00920816|460673288|FG003|Overall Study|Death|3|||
128012542|NCT00920816|460673285|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
128012543|NCT00920816|460673286|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
128012544|NCT00920816|460673287|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
128012545|NCT00920816|460673288|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
128012546|NCT00920816|460673285|FG000|Overall Study|Global deterioration of health status|2|||
128012547|NCT00920816|460673286|FG001|Overall Study|Global deterioration of health status|0|||
128012548|NCT00920816|460673287|FG002|Overall Study|Global deterioration of health status|0|||
128012549|NCT00920816|460673288|FG003|Overall Study|Global deterioration of health status|0|||
128012550|NCT00920816|460673285|FG000|Overall Study|Objective progression or relapse|6|||
128012551|NCT00920816|460673286|FG001|Overall Study|Objective progression or relapse|2|||
128012552|NCT00920816|460673287|FG002|Overall Study|Objective progression or relapse|0|||
128012553|NCT00920816|460673288|FG003|Overall Study|Objective progression or relapse|0|||
128012554|NCT00920816|460673285|FG000|Overall Study|Other|26|||
128012555|NCT00920816|460673286|FG001|Overall Study|Other|15|||
128012556|NCT00920816|460673287|FG002|Overall Study|Other|1|||
128012557|NCT00920816|460673288|FG003|Overall Study|Other|2|||
128012558|NCT00920816|460673285|FG000|Overall Study|Lost to Follow-up|11|||
128012559|NCT00920816|460673286|FG001|Overall Study|Lost to Follow-up|2|||
128012560|NCT00920816|460673287|FG002|Overall Study|Lost to Follow-up|0|||
128012561|NCT00920816|460673288|FG003|Overall Study|Lost to Follow-up|0|||
128012562|NCT00920816|460673285|FG000|Overall Study|Adverse Event|1|||
128012563|NCT00920816|460673286|FG001|Overall Study|Adverse Event|1|||
128012564|NCT00920816|460673287|FG002|Overall Study|Adverse Event|1|||
128012565|NCT00920816|460673288|FG003|Overall Study|Adverse Event|0|||
128012566|NCT00920816|460673285|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
128012567|NCT00920816|460673286|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
128012568|NCT00920816|460673287|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
128012569|NCT00920816|460673288|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
128012570|NCT00920816|460673285|FG000|Overall Study|Randomized but not treated|3|||
128012571|NCT00920816|460673286|FG001|Overall Study|Randomized but not treated|0|||
128012572|NCT00920816|460673287|FG002|Overall Study|Randomized but not treated|0|||
128012573|NCT00920816|460673288|FG003|Overall Study|Randomized but not treated|0|||
128012574|NCT01180777|460673289|FG000|Overall Study|Protocol Violation|6|||
128012575|NCT01180777|460673289|FG000|Overall Study|Poor lens fit|4|||
128012576|NCT01180777|460673289|FG000|Overall Study|Lost to Follow-up|1|||
128012577|NCT01180777|460673289|FG000|Overall Study|Adverse Event|1|||
128012578|NCT05522751|460673296|FG000|Overall Study|Adverse Event|1|||
128012579|NCT01138046|460673301|FG000|Overall Study|Withdrawal due to death|6|||
128012580|NCT01900314|460673302|FG000|Overall Study|Lost to Follow-up|1|||
128012581|NCT01900314|460673303|FG001|Overall Study|Lost to Follow-up|0|||
128012582|NCT01900314|460673302|FG000|Overall Study|Protocol Violation|0|||
128012583|NCT01900314|460673303|FG001|Overall Study|Protocol Violation|1|||
128012584|NCT01900314|460673302|FG000|Overall Study|Withdrawal by Subject|3|||
128012585|NCT01900314|460673303|FG001|Overall Study|Withdrawal by Subject|3|||
128012586|NCT01104766|460673304|FG000|Overall Study|Did not meet inc/exc criteria|1|||
128012587|NCT01104766|460673305|FG001|Overall Study|Did not meet inc/exc criteria|0|||
128012588|NCT01104766|460673306|FG002|Overall Study|Did not meet inc/exc criteria|0|||
128012589|NCT01104766|460673307|FG003|Overall Study|Did not meet inc/exc criteria|0|||
128012590|NCT01104766|460673304|FG000|Overall Study|Adverse Event|17|||
128012591|NCT01104766|460673305|FG001|Overall Study|Adverse Event|15|||
128012592|NCT01104766|460673306|FG002|Overall Study|Adverse Event|20|||
128012593|NCT01104766|460673307|FG003|Overall Study|Adverse Event|14|||
127544681|NCT02118584|458962443|FG002|Part 1: Open Label Extension Period|Other|0|||
127544682|NCT02118584|458962441|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|568|||
127544683|NCT02118584|458962442|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
127544684|NCT02118584|458962443|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
127544685|NCT02118584|458962441|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
127544686|NCT02118584|458962442|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|5|||
127544687|NCT02118584|458962443|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
128012594|NCT01104766|460673304|FG000|Overall Study|Lack of Efficacy|20|||
128012595|NCT01104766|460673305|FG001|Overall Study|Lack of Efficacy|15|||
128012596|NCT01104766|460673306|FG002|Overall Study|Lack of Efficacy|14|||
127544688|NCT02118584|458962441|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
127765099|NCT01248780|459765564|FG000|Overall Study|Withdrawal by Subject|4|||
127765100|NCT01248780|459765565|FG001|Overall Study|Withdrawal by Subject|4|||
127544689|NCT02118584|458962442|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
127544690|NCT02118584|458962443|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
127544691|NCT02118584|458962441|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
127544692|NCT02118584|458962442|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|22|||
127544693|NCT02118584|458962443|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
127765101|NCT01248780|459765564|FG000|Overall Study|Not treated|0|||
127765102|NCT01248780|459765565|FG001|Overall Study|Not treated|1|||
127765103|NCT02134977|459765566|FG000|Overall Study|Protocol Deviation|102|||
127765104|NCT04097301|459765567|FG000|Overall Study|Death|1|||
127765105|NCT04097301|459765567|FG000|Overall Study|Withdrawal by Subject|1|||
127765106|NCT04097301|459765567|FG000|Overall Study|Screening Failure|5|||
127765107|NCT01773291|459765568|FG000|Overall Study|Protocol Violation|1|||
127765108|NCT01773291|459765569|FG001|Overall Study|Protocol Violation|0|||
127765109|NCT01773291|459765570|FG002|Overall Study|Protocol Violation|0|||
127765110|NCT01773291|459765568|FG000|Overall Study|Withdrawal by Subject|0|||
127765111|NCT01773291|459765569|FG001|Overall Study|Withdrawal by Subject|0|||
127765112|NCT01773291|459765570|FG002|Overall Study|Withdrawal by Subject|1|||
127765113|NCT00203476|459765571|FG000|Overall Study|Lost to Follow-up|1|||
127765114|NCT00203476|459765572|FG001|Overall Study|Lost to Follow-up|0|||
127544694|NCT02118584|458962441|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
127544695|NCT02118584|458962442|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
127544696|NCT02118584|458962443|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
127544697|NCT02118584|458962441|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
127544698|NCT02118584|458962442|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
127544699|NCT02118584|458962443|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
127544700|NCT02118584|458962441|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
127544701|NCT02118584|458962442|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|10|||
127544702|NCT02118584|458962443|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|1|||
127544703|NCT02118584|458962441|FG000|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
127544704|NCT02118584|458962442|FG001|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|354|||
127544705|NCT02118584|458962443|FG002|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
127544706|NCT02118584|458962441|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
127765115|NCT00203476|459765573|FG002|Overall Study|Lost to Follow-up|0|||
127765116|NCT00203476|459765571|FG000|Overall Study|Withdrawal by Subject|0|||
128012597|NCT01104766|460673307|FG003|Overall Study|Lack of Efficacy|8|||
128012598|NCT01104766|460673304|FG000|Overall Study|Protocol Violation|2|||
128012599|NCT01104766|460673305|FG001|Overall Study|Protocol Violation|0|||
128012600|NCT01104766|460673306|FG002|Overall Study|Protocol Violation|0|||
128012601|NCT01104766|460673307|FG003|Overall Study|Protocol Violation|0|||
128012602|NCT01104766|460673304|FG000|Overall Study|Withdrawal by Subject|17|||
127765117|NCT00203476|459765572|FG001|Overall Study|Withdrawal by Subject|1|||
127765118|NCT00203476|459765573|FG002|Overall Study|Withdrawal by Subject|0|||
127765119|NCT01190514|459765574|FG000|First Intervention (Period 1)|Adverse Event|1|||
127765120|NCT01190514|459765575|FG001|First Intervention (Period 1)|Adverse Event|0|||
127765121|NCT01190514|459765576|FG002|First Intervention (Period 1)|Adverse Event|0|||
127765122|NCT01190514|459765577|FG003|First Intervention (Period 1)|Adverse Event|0|||
127765123|NCT01190514|459765574|FG000|Third Intervention (Period 3)|Adverse Event|1|||
127765124|NCT01190514|459765575|FG001|Third Intervention (Period 3)|Adverse Event|0|||
127765125|NCT01190514|459765576|FG002|Third Intervention (Period 3)|Adverse Event|0|||
127765126|NCT01190514|459765577|FG003|Third Intervention (Period 3)|Adverse Event|0|||
127765127|NCT00107120|459765579|FG000|Overall Study|Adverse Event|4|||
127765128|NCT00107120|459765580|FG001|Overall Study|Adverse Event|1|||
127765129|NCT00107120|459765579|FG000|Overall Study|Lack of Efficacy|5|||
127765130|NCT00107120|459765580|FG001|Overall Study|Lack of Efficacy|5|||
127765131|NCT00107120|459765579|FG000|Overall Study|Protocol Violation|3|||
127765132|NCT00107120|459765580|FG001|Overall Study|Protocol Violation|0|||
127765133|NCT00107120|459765579|FG000|Overall Study|Withdrawal by Subject|8|||
127765134|NCT00107120|459765580|FG001|Overall Study|Withdrawal by Subject|9|||
127765135|NCT00107120|459765579|FG000|Overall Study|Lost to Follow-up|8|||
127765136|NCT00107120|459765580|FG001|Overall Study|Lost to Follow-up|6|||
127765137|NCT00107120|459765579|FG000|Overall Study|Pregnancy|0|||
127765138|NCT00107120|459765580|FG001|Overall Study|Pregnancy|1|||
127765139|NCT00107120|459765579|FG000|Overall Study|moving away from site|1|||
128012603|NCT01104766|460673305|FG001|Overall Study|Withdrawal by Subject|19|||
128012604|NCT01104766|460673306|FG002|Overall Study|Withdrawal by Subject|25|||
128012605|NCT01104766|460673307|FG003|Overall Study|Withdrawal by Subject|15|||
127765140|NCT00107120|459765580|FG001|Overall Study|moving away from site|1|||
127765141|NCT00107120|459765579|FG000|Overall Study|death of parent|0|||
127765142|NCT00107120|459765580|FG001|Overall Study|death of parent|1|||
127765143|NCT01813929|459765581|FG000|Overall Study|Withdrawal by Subject|0|||
127765144|NCT01813929|459765582|FG001|Overall Study|Withdrawal by Subject|1|||
127765145|NCT00938470|459765585|FG000|Overall Study|Disease Progression|3|||
127765146|NCT00938470|459765586|FG001|Overall Study|Disease Progression|0|||
127765147|NCT00938470|459765585|FG000|Overall Study|Alternate Treatment|1|||
127765148|NCT00938470|459765586|FG001|Overall Study|Alternate Treatment|0|||
127765149|NCT00938470|459765585|FG000|Overall Study|Death|3|||
127765150|NCT00938470|459765586|FG001|Overall Study|Death|2|||
127765151|NCT00938470|459765585|FG000|Overall Study|Other Reason|0|||
127765152|NCT00938470|459765586|FG001|Overall Study|Other Reason|1|||
127765153|NCT04279392|459765587|FG000|Overall Study|Physician Decision|1|||
127765154|NCT04279392|459765588|FG001|Overall Study|Physician Decision|0|||
127765155|NCT01171807|459765589|FG000|Overall Study|Treatment failure|2|||
127765156|NCT01171807|459765590|FG001|Overall Study|Treatment failure|4|||
127765157|NCT01171807|459765589|FG000|Overall Study|Non compliance|1|||
127765158|NCT01171807|459765590|FG001|Overall Study|Non compliance|0|||
127765159|NCT01171807|459765589|FG000|Overall Study|Lost to Follow-up|3|||
127765160|NCT01171807|459765590|FG001|Overall Study|Lost to Follow-up|0|||
127765161|NCT04101318|459765595|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
127765162|NCT04101318|459765596|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
127765163|NCT04101318|459765595|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
127765164|NCT04101318|459765596|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
127765165|NCT04101318|459765595|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
127765166|NCT04101318|459765596|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
127765167|NCT04289051|459765597|FG000|Overall Study|Lost to Follow-up|0|||
127765168|NCT04289051|459765598|FG001|Overall Study|Lost to Follow-up|0|||
128012606|NCT01104766|460673304|FG000|Overall Study|Lost to Follow-up|1|||
128012607|NCT01104766|460673305|FG001|Overall Study|Lost to Follow-up|2|||
128012608|NCT01104766|460673306|FG002|Overall Study|Lost to Follow-up|1|||
128012609|NCT01104766|460673307|FG003|Overall Study|Lost to Follow-up|1|||
128012610|NCT04225832|460673309|FG000|Overall Study|No longer eligible (e.g., seroconversion)|6|||
127765169|NCT04289051|459765599|FG002|Overall Study|Lost to Follow-up|2|||
127765170|NCT01901341|459765600|FG000|Overall Study|Adverse Event|4|||
127765171|NCT01901341|459765601|FG001|Overall Study|Adverse Event|2|||
127765172|NCT01901341|459765600|FG000|Overall Study|Lack of Efficacy|0|||
127765173|NCT01901341|459765601|FG001|Overall Study|Lack of Efficacy|2|||
127765174|NCT01901341|459765600|FG000|Overall Study|Lost to Follow-up|0|||
128012611|NCT04225832|460673310|FG001|Overall Study|No longer eligible (e.g., seroconversion)|3|||
128012612|NCT04225832|460673309|FG000|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|36|||
128012613|NCT04225832|460673310|FG001|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|5|||
128012614|NCT03965923|460673311|FG000|Overall Study|Withdrawal by Subject|1|||
127765175|NCT01901341|459765601|FG001|Overall Study|Lost to Follow-up|1|||
127765176|NCT01901341|459765600|FG000|Overall Study|Protocol Violation|2|||
127765177|NCT01901341|459765601|FG001|Overall Study|Protocol Violation|0|||
127765178|NCT01901341|459765600|FG000|Overall Study|Study Terminated by Sponsor|13|||
128012615|NCT03965923|460673312|FG001|Overall Study|Withdrawal by Subject|2|||
127765179|NCT01901341|459765601|FG001|Overall Study|Study Terminated by Sponsor|15|||
128012616|NCT03965923|460673313|FG002|Overall Study|Withdrawal by Subject|3|||
128012617|NCT03965923|460673314|FG003|Overall Study|Withdrawal by Subject|1|||
128012618|NCT03965923|460673315|FG004|Overall Study|Withdrawal by Subject|2|||
128012619|NCT03965923|460673316|FG005|Overall Study|Withdrawal by Subject|0|||
128012620|NCT03965923|460673317|FG006|Overall Study|Withdrawal by Subject|4|||
128012621|NCT03965923|460673318|FG007|Overall Study|Withdrawal by Subject|3|||
128012622|NCT03965923|460673319|FG008|Overall Study|Withdrawal by Subject|4|||
128012623|NCT03965923|460673320|FG009|Overall Study|Withdrawal by Subject|0|||
128012624|NCT03965923|460673321|FG010|Overall Study|Withdrawal by Subject|2|||
128012625|NCT03965923|460673322|FG011|Overall Study|Withdrawal by Subject|0|||
128012626|NCT03965923|460673311|FG000|Overall Study|Lost to Follow-up|2|||
128012627|NCT03965923|460673312|FG001|Overall Study|Lost to Follow-up|1|||
128012628|NCT03965923|460673313|FG002|Overall Study|Lost to Follow-up|1|||
128012629|NCT03965923|460673314|FG003|Overall Study|Lost to Follow-up|0|||
128012630|NCT03965923|460673315|FG004|Overall Study|Lost to Follow-up|2|||
128012631|NCT03965923|460673316|FG005|Overall Study|Lost to Follow-up|1|||
128012632|NCT03965923|460673317|FG006|Overall Study|Lost to Follow-up|2|||
128012633|NCT03965923|460673318|FG007|Overall Study|Lost to Follow-up|1|||
128012634|NCT03965923|460673319|FG008|Overall Study|Lost to Follow-up|0|||
128012635|NCT03965923|460673320|FG009|Overall Study|Lost to Follow-up|2|||
128012636|NCT03965923|460673321|FG010|Overall Study|Lost to Follow-up|0|||
128012637|NCT03965923|460673322|FG011|Overall Study|Lost to Follow-up|0|||
128012638|NCT03965923|460673311|FG000|Overall Study|Death|0|||
128012639|NCT03965923|460673312|FG001|Overall Study|Death|0|||
128012640|NCT03965923|460673313|FG002|Overall Study|Death|0|||
128012641|NCT03965923|460673314|FG003|Overall Study|Death|0|||
128012642|NCT03965923|460673315|FG004|Overall Study|Death|0|||
128012643|NCT03965923|460673316|FG005|Overall Study|Death|0|||
128012644|NCT03965923|460673317|FG006|Overall Study|Death|0|||
128012645|NCT03965923|460673318|FG007|Overall Study|Death|1|||
128012646|NCT03965923|460673319|FG008|Overall Study|Death|4|||
128012647|NCT03965923|460673320|FG009|Overall Study|Death|0|||
128012648|NCT03965923|460673321|FG010|Overall Study|Death|4|||
128012649|NCT03965923|460673322|FG011|Overall Study|Death|0|||
128012650|NCT03965923|460673311|FG000|Overall Study|Other reason|0|||
128012651|NCT03965923|460673312|FG001|Overall Study|Other reason|0|||
128012652|NCT03965923|460673313|FG002|Overall Study|Other reason|0|||
128012653|NCT03965923|460673314|FG003|Overall Study|Other reason|1|||
128012654|NCT03965923|460673315|FG004|Overall Study|Other reason|0|||
128012655|NCT03965923|460673316|FG005|Overall Study|Other reason|0|||
128012656|NCT03965923|460673317|FG006|Overall Study|Other reason|0|||
128012657|NCT03965923|460673318|FG007|Overall Study|Other reason|0|||
128012658|NCT03965923|460673319|FG008|Overall Study|Other reason|0|||
128012659|NCT03965923|460673320|FG009|Overall Study|Other reason|0|||
128012660|NCT03965923|460673321|FG010|Overall Study|Other reason|2|||
128012661|NCT03965923|460673322|FG011|Overall Study|Other reason|0|||
128012662|NCT03282097|460673323|FG000|Randomized and Completed Baseline|Randomized no Baseline|1|||
128012663|NCT03282097|460673324|FG001|Randomized and Completed Baseline|Randomized no Baseline|1|||
128012664|NCT03282097|460673323|FG000|Intervention Visit Complete|Patient Death|13|||
128012665|NCT03282097|460673324|FG001|Intervention Visit Complete|Patient Death|15|||
128012666|NCT03282097|460673323|FG000|Intervention Visit Complete|Caregiver Death|0|||
128012667|NCT03282097|460673324|FG001|Intervention Visit Complete|Caregiver Death|3|||
128012668|NCT03282097|460673323|FG000|Intervention Visit Complete|Withdrawal by Subject|14|||
128012669|NCT03282097|460673324|FG001|Intervention Visit Complete|Withdrawal by Subject|13|||
128012670|NCT03282097|460673323|FG000|Intervention Visit Complete|Became Ineligible before PCP Index visit|12|||
128012671|NCT03282097|460673324|FG001|Intervention Visit Complete|Became Ineligible before PCP Index visit|21|||
128012672|NCT03282097|460673323|FG000|Intervention Visit Complete|PCP Index Visit Not Completed|3|||
128012673|NCT03282097|460673324|FG001|Intervention Visit Complete|PCP Index Visit Not Completed|7|||
128012674|NCT03282097|460673323|FG000|Primary Outcome Data Collection Complete|Missing|2|||
128012675|NCT03282097|460673324|FG001|Primary Outcome Data Collection Complete|Missing|3|||
128012676|NCT03282097|460673323|FG000|Primary Outcome Data Collection Complete|Withdrawal by Subject|1|||
128012677|NCT03282097|460673324|FG001|Primary Outcome Data Collection Complete|Withdrawal by Subject|0|||
128012678|NCT03282097|460673323|FG000|15 Month Follow-up Complete|Withdrawal by Subject|0|||
128012679|NCT03282097|460673324|FG001|15 Month Follow-up Complete|Withdrawal by Subject|1|||
128012680|NCT03282097|460673323|FG000|15 Month Follow-up Complete|Lost to Follow-up|6|||
128012681|NCT03282097|460673324|FG001|15 Month Follow-up Complete|Lost to Follow-up|8|||
128012682|NCT06001021|460673328|FG000|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
128012683|NCT06001021|460673329|FG001|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
128012684|NCT06001021|460673330|FG002|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
128012685|NCT06001021|460673331|FG003|15 August 2023 to 30 September 2023|Withdrawal by Subject|8|||
128012686|NCT06001021|460673332|FG004|15 August 2023 to 30 September 2023|Withdrawal by Subject|6|||
128012687|NCT06001021|460673333|FG005|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
128012688|NCT06001021|460673334|FG006|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
128012689|NCT06001021|460673328|FG000|1 October 2023 to 28 October 2023)|Withdrawal by Subject|14|||
128012690|NCT06001021|460673329|FG001|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
128012691|NCT06001021|460673330|FG002|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
128012692|NCT06001021|460673331|FG003|1 October 2023 to 28 October 2023)|Withdrawal by Subject|8|||
128012693|NCT06001021|460673332|FG004|1 October 2023 to 28 October 2023)|Withdrawal by Subject|10|||
128012694|NCT06001021|460673333|FG005|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
128012695|NCT06001021|460673334|FG006|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
128012696|NCT02755090|460673335|FG000|Overall Study|equipment malfunction|1|||
128012697|NCT02755090|460673336|FG001|Overall Study|equipment malfunction|0|||
128012698|NCT04797169|460673338|FG000|Overall Study|Lost to Follow-up|84|||
128012699|NCT04797169|460673339|FG001|Overall Study|Lost to Follow-up|67|||
128012700|NCT04797169|460673338|FG000|Overall Study|Pregnancy|1|||
128012701|NCT04797169|460673339|FG001|Overall Study|Pregnancy|3|||
128012702|NCT04797169|460673338|FG000|Overall Study|Withdrawal by Subject|27|||
128012703|NCT04797169|460673339|FG001|Overall Study|Withdrawal by Subject|35|||
128012704|NCT03839641|460673348|FG000|Overall Study|Withdrawal by Subject|1|||
128012705|NCT03839641|460673349|FG001|Overall Study|Withdrawal by Subject|1|||
128012706|NCT04221490|460673350|FG000|At 30 Days Follow-up|Death|7|||
128012707|NCT04221490|460673350|FG000|At 30 Days Follow-up|Missed Visit|4|||
128012708|NCT04221490|460673350|FG000|At 30 Days Follow-up|Exited for Other Reasons|1|||
128012709|NCT04221490|460673350|FG000|At 6 Months Follow-up|Death|9|||
128012710|NCT04221490|460673350|FG000|At 6 Months Follow-up|Physician Decision|1|||
128012711|NCT04221490|460673350|FG000|At 6 Months Follow-up|Missed Visit|8|||
128012712|NCT04221490|460673350|FG000|At 6 Months Follow-up|Exited for Other Reasons|8|||
128012713|NCT03034967|460673351|FG000|Overall Study|Withdrawal by Subject|9|||
128012714|NCT03034967|460673352|FG001|Overall Study|Withdrawal by Subject|2|||
128012715|NCT03034967|460673353|FG002|Overall Study|Withdrawal by Subject|6|||
128012716|NCT03034967|460673354|FG003|Overall Study|Withdrawal by Subject|6|||
128012717|NCT03034967|460673355|FG004|Overall Study|Withdrawal by Subject|9|||
128012718|NCT03034967|460673356|FG005|Overall Study|Withdrawal by Subject|2|||
128012719|NCT03034967|460673351|FG000|Overall Study|Physician Decision|1|||
128012720|NCT03034967|460673352|FG001|Overall Study|Physician Decision|0|||
128012721|NCT03034967|460673353|FG002|Overall Study|Physician Decision|1|||
128012722|NCT03034967|460673354|FG003|Overall Study|Physician Decision|1|||
128012723|NCT03034967|460673355|FG004|Overall Study|Physician Decision|1|||
128012724|NCT03034967|460673356|FG005|Overall Study|Physician Decision|0|||
128012725|NCT03034967|460673351|FG000|Overall Study|Lost to Follow-up|0|||
128012726|NCT03034967|460673352|FG001|Overall Study|Lost to Follow-up|0|||
128012727|NCT03034967|460673353|FG002|Overall Study|Lost to Follow-up|0|||
128012728|NCT03034967|460673354|FG003|Overall Study|Lost to Follow-up|1|||
128012729|NCT03034967|460673355|FG004|Overall Study|Lost to Follow-up|0|||
128012730|NCT03034967|460673356|FG005|Overall Study|Lost to Follow-up|2|||
128012731|NCT03034967|460673351|FG000|Overall Study|Liver function test abnormality|0|||
128012732|NCT03034967|460673352|FG001|Overall Study|Liver function test abnormality|0|||
128012733|NCT03034967|460673353|FG002|Overall Study|Liver function test abnormality|1|||
128012734|NCT03034967|460673354|FG003|Overall Study|Liver function test abnormality|0|||
128012735|NCT03034967|460673355|FG004|Overall Study|Liver function test abnormality|0|||
127677965|NCT02614560|459444532|FG000|Overall Study|Death|6|||
127677966|NCT02614560|459444533|FG001|Overall Study|Death|2|||
127677967|NCT00703911|459444536|FG000|Overall Study|Death|1|||
127677968|NCT00703911|459444536|FG000|Overall Study|Physician Decision|6|||
127677969|NCT00703911|459444536|FG000|Overall Study|Lost to Follow-up|1|||
127677970|NCT00703911|459444536|FG000|Overall Study|Withdrawal by Subject|2|||
127677971|NCT02174562|459444539|FG000|Overall Study|Withdrawal by Subject|7|||
127677972|NCT02174562|459444540|FG001|Overall Study|Withdrawal by Subject|2|||
127677973|NCT02174562|459444539|FG000|Overall Study|Death|2|||
127677974|NCT02174562|459444540|FG001|Overall Study|Death|0|||
127677975|NCT02174562|459444539|FG000|Overall Study|Lost to Follow-up|0|||
127677976|NCT02174562|459444540|FG001|Overall Study|Lost to Follow-up|3|||
127677977|NCT05193318|459444541|FG000|Acute Intervention (Weeks 1-9 of Study)|Physician Decision|1|||
127677978|NCT05193318|459444541|FG000|Follow-up Phase (Through Week 16)|Lost to Follow-up|1|||
127677979|NCT00798096|459444542|FG000|Overall Study|Ongoing|2|||
127677980|NCT01833065|459444543|FG000|Overall Study|Adverse Event|6|||
127677981|NCT01833065|459444544|FG001|Overall Study|Adverse Event|1|||
127677982|NCT01833065|459444545|FG002|Overall Study|Adverse Event|0|||
127677983|NCT01833065|459444546|FG003|Overall Study|Adverse Event|2|||
127677984|NCT01833065|459444547|FG004|Overall Study|Adverse Event|3|||
127677985|NCT01833065|459444543|FG000|Overall Study|Protocol Violation|1|||
127677986|NCT01833065|459444544|FG001|Overall Study|Protocol Violation|0|||
127677987|NCT01833065|459444545|FG002|Overall Study|Protocol Violation|0|||
127677988|NCT01833065|459444546|FG003|Overall Study|Protocol Violation|0|||
127677989|NCT01833065|459444547|FG004|Overall Study|Protocol Violation|2|||
127677990|NCT01833065|459444543|FG000|Overall Study|Lost to Follow-up|1|||
127677991|NCT01833065|459444544|FG001|Overall Study|Lost to Follow-up|0|||
127677992|NCT01833065|459444545|FG002|Overall Study|Lost to Follow-up|0|||
127677993|NCT01833065|459444546|FG003|Overall Study|Lost to Follow-up|0|||
128012736|NCT03034967|460673356|FG005|Overall Study|Liver function test abnormality|0|||
127677994|NCT01833065|459444547|FG004|Overall Study|Lost to Follow-up|3|||
127677995|NCT01833065|459444543|FG000|Overall Study|Withdrawal by Subject|6|||
128012737|NCT03034967|460673351|FG000|Overall Study|Protocol Violation|1|||
128012738|NCT03034967|460673352|FG001|Overall Study|Protocol Violation|0|||
128012739|NCT03034967|460673353|FG002|Overall Study|Protocol Violation|0|||
128012740|NCT03034967|460673354|FG003|Overall Study|Protocol Violation|0|||
128012741|NCT03034967|460673355|FG004|Overall Study|Protocol Violation|0|||
128012742|NCT03034967|460673356|FG005|Overall Study|Protocol Violation|2|||
128012743|NCT03034967|460673351|FG000|Overall Study|Lack of Efficacy|0|||
128012744|NCT03034967|460673352|FG001|Overall Study|Lack of Efficacy|1|||
128012745|NCT03034967|460673353|FG002|Overall Study|Lack of Efficacy|2|||
128012746|NCT03034967|460673354|FG003|Overall Study|Lack of Efficacy|1|||
128012747|NCT03034967|460673355|FG004|Overall Study|Lack of Efficacy|1|||
128012748|NCT03034967|460673356|FG005|Overall Study|Lack of Efficacy|0|||
128012749|NCT03034967|460673351|FG000|Overall Study|Adverse Event, non-fatal|3|||
128012750|NCT03034967|460673352|FG001|Overall Study|Adverse Event, non-fatal|1|||
128012751|NCT03034967|460673353|FG002|Overall Study|Adverse Event, non-fatal|2|||
128012752|NCT03034967|460673354|FG003|Overall Study|Adverse Event, non-fatal|0|||
128012753|NCT03034967|460673355|FG004|Overall Study|Adverse Event, non-fatal|2|||
128012754|NCT03034967|460673356|FG005|Overall Study|Adverse Event, non-fatal|8|||
128012755|NCT03034967|460673351|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
128012756|NCT03034967|460673352|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
128012757|NCT03034967|460673353|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
128012758|NCT03034967|460673354|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
127765180|NCT01901341|459765600|FG000|Overall Study|Withdrawal by Subject|1|||
127765181|NCT01901341|459765601|FG001|Overall Study|Withdrawal by Subject|1|||
127765182|NCT01981473|459765602|FG000|Overall Study|Incorrect diagnosis of RA|0|||
127765183|NCT01981473|459765603|FG001|Overall Study|Incorrect diagnosis of RA|0|||
127765184|NCT01981473|459765604|FG002|Overall Study|Incorrect diagnosis of RA|1|||
127765185|NCT01981473|459765602|FG000|Overall Study|Received treatment for < 6 months|0|||
128012759|NCT03034967|460673355|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
128012760|NCT03034967|460673356|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
128012761|NCT02550795|460673363|FG000|Overall Study|Physician Decision|0|||
128012762|NCT02550795|460673364|FG001|Overall Study|Physician Decision|1|||
128012763|NCT02550795|460673365|FG002|Overall Study|Physician Decision|0|||
128012764|NCT00879658|460673366|FG000|Overall Study|Abnormal laboratory value(s)|3|||
128012765|NCT00879658|460673367|FG001|Overall Study|Abnormal laboratory value(s)|0|||
128012766|NCT00879658|460673368|FG002|Overall Study|Abnormal laboratory value(s)|0|||
128012767|NCT00879658|460673369|FG003|Overall Study|Abnormal laboratory value(s)|1|||
128012768|NCT00879658|460673370|FG004|Overall Study|Abnormal laboratory value(s)|0|||
128012769|NCT00879658|460673371|FG005|Overall Study|Abnormal laboratory value(s)|0|||
128012770|NCT00879658|460673372|FG006|Overall Study|Abnormal laboratory value(s)|0|||
128012771|NCT00879658|460673366|FG000|Overall Study|Administrative problems|2|||
128012772|NCT00879658|460673367|FG001|Overall Study|Administrative problems|1|||
128012773|NCT00879658|460673368|FG002|Overall Study|Administrative problems|0|||
128012774|NCT00879658|460673369|FG003|Overall Study|Administrative problems|1|||
128012775|NCT00879658|460673370|FG004|Overall Study|Administrative problems|0|||
128012776|NCT00879658|460673371|FG005|Overall Study|Administrative problems|0|||
128012777|NCT00879658|460673372|FG006|Overall Study|Administrative problems|0|||
128012778|NCT00879658|460673366|FG000|Overall Study|Adverse Event|6|||
128012779|NCT00879658|460673367|FG001|Overall Study|Adverse Event|4|||
128012780|NCT00879658|460673368|FG002|Overall Study|Adverse Event|3|||
128012781|NCT00879658|460673369|FG003|Overall Study|Adverse Event|1|||
128012782|NCT00879658|460673370|FG004|Overall Study|Adverse Event|2|||
128012783|NCT00879658|460673371|FG005|Overall Study|Adverse Event|0|||
128012784|NCT00879658|460673372|FG006|Overall Study|Adverse Event|0|||
128012785|NCT00879658|460673366|FG000|Overall Study|Protocol Violation|1|||
128012786|NCT00879658|460673367|FG001|Overall Study|Protocol Violation|0|||
128012787|NCT00879658|460673368|FG002|Overall Study|Protocol Violation|0|||
128012788|NCT00879658|460673369|FG003|Overall Study|Protocol Violation|0|||
128012789|NCT00879658|460673370|FG004|Overall Study|Protocol Violation|0|||
128012790|NCT00879658|460673371|FG005|Overall Study|Protocol Violation|0|||
128012791|NCT00879658|460673372|FG006|Overall Study|Protocol Violation|0|||
128012792|NCT00879658|460673366|FG000|Overall Study|Withdrawal by Subject|3|||
128012793|NCT00879658|460673367|FG001|Overall Study|Withdrawal by Subject|0|||
128012794|NCT00879658|460673368|FG002|Overall Study|Withdrawal by Subject|2|||
128012795|NCT00879658|460673369|FG003|Overall Study|Withdrawal by Subject|0|||
128012796|NCT00879658|460673370|FG004|Overall Study|Withdrawal by Subject|0|||
128012797|NCT00879658|460673371|FG005|Overall Study|Withdrawal by Subject|1|||
128012798|NCT00879658|460673372|FG006|Overall Study|Withdrawal by Subject|0|||
128012799|NCT00879658|460673366|FG000|Overall Study|Lack of Efficacy|0|||
128012800|NCT00879658|460673367|FG001|Overall Study|Lack of Efficacy|0|||
128012801|NCT00879658|460673368|FG002|Overall Study|Lack of Efficacy|2|||
128012802|NCT00879658|460673369|FG003|Overall Study|Lack of Efficacy|0|||
128012803|NCT00879658|460673370|FG004|Overall Study|Lack of Efficacy|0|||
127765186|NCT01981473|459765603|FG001|Overall Study|Received treatment for < 6 months|0|||
127765187|NCT01981473|459765604|FG002|Overall Study|Received treatment for < 6 months|1|||
128012804|NCT00879658|460673371|FG005|Overall Study|Lack of Efficacy|0|||
128012805|NCT00879658|460673372|FG006|Overall Study|Lack of Efficacy|0|||
128012806|NCT00879658|460673366|FG000|Overall Study|misrandomized (never received study med)|0|||
128012807|NCT00879658|460673367|FG001|Overall Study|misrandomized (never received study med)|0|||
128012808|NCT00879658|460673368|FG002|Overall Study|misrandomized (never received study med)|0|||
128012809|NCT00879658|460673369|FG003|Overall Study|misrandomized (never received study med)|1|||
128012810|NCT00879658|460673370|FG004|Overall Study|misrandomized (never received study med)|0|||
128012811|NCT00879658|460673371|FG005|Overall Study|misrandomized (never received study med)|0|||
128012812|NCT00879658|460673372|FG006|Overall Study|misrandomized (never received study med)|0|||
128012813|NCT00580840|460673373|FG000|Run-in|Adverse Event|17|||
128012814|NCT00580840|460673374|FG001|Run-in|Adverse Event|0|||
128012815|NCT00580840|460673375|FG002|Run-in|Adverse Event|0|||
128012816|NCT00580840|460673376|FG003|Run-in|Adverse Event|0|||
128012817|NCT00580840|460673373|FG000|Run-in|Lack of Efficacy|93|||
128012818|NCT00580840|460673374|FG001|Run-in|Lack of Efficacy|0|||
128012819|NCT00580840|460673375|FG002|Run-in|Lack of Efficacy|0|||
128012820|NCT00580840|460673376|FG003|Run-in|Lack of Efficacy|0|||
128012821|NCT00580840|460673373|FG000|Run-in|Loss of Efficacy|1|||
128012822|NCT00580840|460673374|FG001|Run-in|Loss of Efficacy|0|||
128012823|NCT00580840|460673375|FG002|Run-in|Loss of Efficacy|0|||
128012824|NCT00580840|460673376|FG003|Run-in|Loss of Efficacy|0|||
128012825|NCT00580840|460673373|FG000|Run-in|Lost to Follow-up|4|||
128012826|NCT00580840|460673374|FG001|Run-in|Lost to Follow-up|0|||
128012827|NCT00580840|460673375|FG002|Run-in|Lost to Follow-up|0|||
128012828|NCT00580840|460673376|FG003|Run-in|Lost to Follow-up|0|||
128012829|NCT00580840|460673373|FG000|Run-in|Withdrawal by Subject|5|||
128012830|NCT00580840|460673374|FG001|Run-in|Withdrawal by Subject|0|||
128012831|NCT00580840|460673375|FG002|Run-in|Withdrawal by Subject|0|||
128012832|NCT00580840|460673376|FG003|Run-in|Withdrawal by Subject|0|||
128012833|NCT00580840|460673373|FG000|Run-in|Other: Per Sponsor Request|2|||
128012834|NCT00580840|460673374|FG001|Run-in|Other: Per Sponsor Request|0|||
128012835|NCT00580840|460673375|FG002|Run-in|Other: Per Sponsor Request|0|||
128012836|NCT00580840|460673376|FG003|Run-in|Other: Per Sponsor Request|0|||
128012837|NCT00580840|460673373|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
128012838|NCT00580840|460673374|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
128012839|NCT00580840|460673375|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
128012840|NCT00580840|460673376|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
128012841|NCT00580840|460673373|FG000|Run-in|Other: Exclusionary Lab Value|1|||
128012842|NCT00580840|460673374|FG001|Run-in|Other: Exclusionary Lab Value|0|||
128012843|NCT00580840|460673375|FG002|Run-in|Other: Exclusionary Lab Value|0|||
127677996|NCT01833065|459444544|FG001|Overall Study|Withdrawal by Subject|2|||
127677997|NCT01833065|459444545|FG002|Overall Study|Withdrawal by Subject|4|||
127677998|NCT01833065|459444546|FG003|Overall Study|Withdrawal by Subject|3|||
127677999|NCT01833065|459444547|FG004|Overall Study|Withdrawal by Subject|11|||
127678000|NCT01833065|459444543|FG000|Overall Study|Subject's substantial non-compliance|0|||
127678001|NCT01833065|459444544|FG001|Overall Study|Subject's substantial non-compliance|1|||
127678002|NCT01833065|459444545|FG002|Overall Study|Subject's substantial non-compliance|0|||
127678003|NCT01833065|459444546|FG003|Overall Study|Subject's substantial non-compliance|0|||
127678004|NCT01833065|459444547|FG004|Overall Study|Subject's substantial non-compliance|0|||
127678005|NCT01833065|459444543|FG000|Overall Study|Trial terminated by sponsor|8|||
127678006|NCT01833065|459444544|FG001|Overall Study|Trial terminated by sponsor|8|||
127678007|NCT01833065|459444545|FG002|Overall Study|Trial terminated by sponsor|7|||
127678008|NCT01833065|459444546|FG003|Overall Study|Trial terminated by sponsor|3|||
127678009|NCT01833065|459444547|FG004|Overall Study|Trial terminated by sponsor|13|||
127678010|NCT01833065|459444543|FG000|Overall Study|Others|2|||
127678011|NCT01833065|459444544|FG001|Overall Study|Others|1|||
127678012|NCT01833065|459444545|FG002|Overall Study|Others|1|||
127678013|NCT01833065|459444546|FG003|Overall Study|Others|1|||
127678014|NCT01833065|459444547|FG004|Overall Study|Others|4|||
127678015|NCT00094809|459444552|FG000|Overall Study|Protocol deviation|2|||
127678016|NCT00094809|459444553|FG001|Overall Study|Protocol deviation|2|||
127678017|NCT00094809|459444552|FG000|Overall Study|Noncompliance|1|||
127678018|NCT00094809|459444553|FG001|Overall Study|Noncompliance|0|||
127678019|NCT00094809|459444552|FG000|Overall Study|Adverse Event|3|||
127678020|NCT00094809|459444553|FG001|Overall Study|Adverse Event|1|||
127678021|NCT00094809|459444552|FG000|Overall Study|Withdrawal by Subject|8|||
127678022|NCT00094809|459444553|FG001|Overall Study|Withdrawal by Subject|9|||
127678023|NCT00094809|459444552|FG000|Overall Study|Disease progression|3|||
127678024|NCT00094809|459444553|FG001|Overall Study|Disease progression|3|||
127678025|NCT00094809|459444552|FG000|Overall Study|Physician Decision|3|||
127678026|NCT00094809|459444553|FG001|Overall Study|Physician Decision|5|||
127678027|NCT00094809|459444552|FG000|Overall Study|Lost to Follow-up|6|||
127678028|NCT00094809|459444553|FG001|Overall Study|Lost to Follow-up|6|||
127678029|NCT00094809|459444552|FG000|Overall Study|Death|19|||
127678030|NCT00094809|459444553|FG001|Overall Study|Death|25|||
127678031|NCT00094809|459444552|FG000|Overall Study|Protocol-specified criteria|1|||
127678032|NCT00094809|459444553|FG001|Overall Study|Protocol-specified criteria|1|||
127678033|NCT00094809|459444552|FG000|Overall Study|Other|2|||
127678034|NCT00094809|459444553|FG001|Overall Study|Other|4|||
127678035|NCT00094809|459444552|FG000|Overall Study|Informed consent signed after treatment|1|||
127765188|NCT01981473|459765602|FG000|Overall Study|Received treatment for >24 months|2|||
127765189|NCT01981473|459765603|FG001|Overall Study|Received treatment for >24 months|0|||
127765190|NCT01981473|459765604|FG002|Overall Study|Received treatment for >24 months|6|||
127765191|NCT01888900|459765608|FG000|Overall Study|failed treatment|0|||
127765192|NCT01888900|459765609|FG001|Overall Study|failed treatment|2|||
127765193|NCT02257567|459765616|FG000|Overall Study|Adverse Event|0|||
127765194|NCT02257567|459765617|FG001|Overall Study|Adverse Event|0|||
127765195|NCT02257567|459765618|FG002|Overall Study|Adverse Event|0|||
127765196|NCT02257567|459765619|FG003|Overall Study|Adverse Event|1|||
127765197|NCT02257567|459765620|FG004|Overall Study|Adverse Event|1|||
127765198|NCT02257567|459765621|FG005|Overall Study|Adverse Event|0|||
127765199|NCT02257567|459765622|FG006|Overall Study|Adverse Event|0|||
127765200|NCT02257567|459765623|FG007|Overall Study|Adverse Event|0|||
127765201|NCT02257567|459765624|FG008|Overall Study|Adverse Event|1|||
127765202|NCT02257567|459765625|FG009|Overall Study|Adverse Event|0|||
127765203|NCT02257567|459765626|FG010|Overall Study|Adverse Event|0|||
127765204|NCT02257567|459765616|FG000|Overall Study|Death|2|||
127765205|NCT02257567|459765617|FG001|Overall Study|Death|2|||
127765206|NCT02257567|459765618|FG002|Overall Study|Death|2|||
127765207|NCT02257567|459765619|FG003|Overall Study|Death|4|||
127765208|NCT02257567|459765620|FG004|Overall Study|Death|15|||
127765209|NCT02257567|459765621|FG005|Overall Study|Death|11|||
127765210|NCT02257567|459765622|FG006|Overall Study|Death|26|||
127765211|NCT02257567|459765623|FG007|Overall Study|Death|30|||
127765212|NCT02257567|459765624|FG008|Overall Study|Death|2|||
127765213|NCT02257567|459765625|FG009|Overall Study|Death|18|||
127765214|NCT02257567|459765626|FG010|Overall Study|Death|65|||
127765215|NCT02257567|459765616|FG000|Overall Study|Lost to Follow-up|0|||
127765216|NCT02257567|459765617|FG001|Overall Study|Lost to Follow-up|0|||
127765217|NCT02257567|459765618|FG002|Overall Study|Lost to Follow-up|0|||
127765218|NCT02257567|459765619|FG003|Overall Study|Lost to Follow-up|0|||
127765219|NCT02257567|459765620|FG004|Overall Study|Lost to Follow-up|2|||
127765220|NCT02257567|459765621|FG005|Overall Study|Lost to Follow-up|2|||
127765221|NCT02257567|459765622|FG006|Overall Study|Lost to Follow-up|0|||
127765222|NCT02257567|459765623|FG007|Overall Study|Lost to Follow-up|0|||
127765223|NCT02257567|459765624|FG008|Overall Study|Lost to Follow-up|0|||
127765224|NCT02257567|459765625|FG009|Overall Study|Lost to Follow-up|1|||
127765225|NCT02257567|459765626|FG010|Overall Study|Lost to Follow-up|1|||
127765226|NCT02257567|459765616|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
127765227|NCT02257567|459765617|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
127765228|NCT02257567|459765618|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
127765229|NCT02257567|459765619|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
127765230|NCT02257567|459765620|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
127765231|NCT02257567|459765621|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
127765232|NCT02257567|459765622|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
127765233|NCT02257567|459765623|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
127765234|NCT02257567|459765624|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
127765235|NCT02257567|459765625|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
127765236|NCT02257567|459765626|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
127765237|NCT02257567|459765616|FG000|Overall Study|Physician Decision|0|||
127765238|NCT02257567|459765617|FG001|Overall Study|Physician Decision|0|||
127765239|NCT02257567|459765618|FG002|Overall Study|Physician Decision|0|||
127765240|NCT02257567|459765619|FG003|Overall Study|Physician Decision|0|||
127765241|NCT02257567|459765620|FG004|Overall Study|Physician Decision|0|||
127765242|NCT02257567|459765621|FG005|Overall Study|Physician Decision|0|||
127765243|NCT02257567|459765622|FG006|Overall Study|Physician Decision|0|||
127765244|NCT02257567|459765623|FG007|Overall Study|Physician Decision|2|||
127765245|NCT02257567|459765624|FG008|Overall Study|Physician Decision|0|||
128012844|NCT00580840|460673376|FG003|Run-in|Other: Exclusionary Lab Value|0|||
128012845|NCT00580840|460673373|FG000|Double-Blind|Adverse Event|0|||
128012846|NCT00580840|460673374|FG001|Double-Blind|Adverse Event|3|||
128012847|NCT00580840|460673375|FG002|Double-Blind|Adverse Event|4|||
127678036|NCT00094809|459444553|FG001|Overall Study|Informed consent signed after treatment|0|||
127678037|NCT00094809|459444552|FG000|Overall Study|Study drug not received|2|||
127678038|NCT00094809|459444553|FG001|Overall Study|Study drug not received|8|||
127678039|NCT00094809|459444552|FG000|Overall Study|Other|1|||
127678040|NCT00094809|459444553|FG001|Overall Study|Other|1|||
127678041|NCT04889664|459444554|FG000|Screen|Lost to Follow-up|1|||
127678042|NCT04889664|459444554|FG000|Screen|Failed to meet screening criteria|1|||
127678043|NCT04889664|459444554|FG000|Study Treatment|Exited by study team due to inappropriate behavior|1|||
127678044|NCT01191086|459444569|FG000|Overall Study|Adverse Event|20|||
127765246|NCT02257567|459765625|FG009|Overall Study|Physician Decision|1|||
127765247|NCT02257567|459765626|FG010|Overall Study|Physician Decision|0|||
127765248|NCT02257567|459765616|FG000|Overall Study|Withdrawal by Subject|0|||
127765249|NCT02257567|459765617|FG001|Overall Study|Withdrawal by Subject|0|||
127765250|NCT02257567|459765618|FG002|Overall Study|Withdrawal by Subject|2|||
127765251|NCT02257567|459765619|FG003|Overall Study|Withdrawal by Subject|0|||
127765252|NCT02257567|459765620|FG004|Overall Study|Withdrawal by Subject|0|||
127765253|NCT02257567|459765621|FG005|Overall Study|Withdrawal by Subject|6|||
127765254|NCT02257567|459765622|FG006|Overall Study|Withdrawal by Subject|6|||
127765255|NCT02257567|459765623|FG007|Overall Study|Withdrawal by Subject|6|||
127765256|NCT02257567|459765624|FG008|Overall Study|Withdrawal by Subject|1|||
127765257|NCT02257567|459765625|FG009|Overall Study|Withdrawal by Subject|1|||
127765258|NCT02257567|459765626|FG010|Overall Study|Withdrawal by Subject|10|||
127765259|NCT01065844|459765633|FG000|Overall Study|Adverse Event|5|||
127765260|NCT02884908|459765638|FG000|Overall Study|Lost to Follow-up|13|||
127765261|NCT02884908|459765639|FG001|Overall Study|Lost to Follow-up|18|||
127765262|NCT01502631|459765642|FG000|Overall Study|Adverse Event|5|||
127765263|NCT01502631|459765643|FG001|Overall Study|Adverse Event|8|||
127765264|NCT01502631|459765642|FG000|Overall Study|Lost to Follow-up|2|||
127765265|NCT01502631|459765643|FG001|Overall Study|Lost to Follow-up|2|||
127765266|NCT01502631|459765642|FG000|Overall Study|Participant withdrew consent|2|||
127765267|NCT01502631|459765643|FG001|Overall Study|Participant withdrew consent|4|||
127765268|NCT01502631|459765642|FG000|Overall Study|Participant non-compliant|1|||
127765269|NCT01502631|459765643|FG001|Overall Study|Participant non-compliant|0|||
127765270|NCT01502631|459765642|FG000|Overall Study|Investigator's decision|0|||
127765271|NCT01502631|459765643|FG001|Overall Study|Investigator's decision|1|||
127765272|NCT01502631|459765642|FG000|Overall Study|Other|10|||
127765273|NCT01502631|459765643|FG001|Overall Study|Other|5|||
127765274|NCT02084056|459765644|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
127765275|NCT02084056|459765645|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
127765276|NCT02084056|459765646|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
127765277|NCT02084056|459765647|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
127765278|NCT02084056|459765644|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
127765279|NCT02084056|459765645|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
127765280|NCT02084056|459765646|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
127765281|NCT02084056|459765647|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
127765282|NCT01293487|459765649|FG000|Overall Study|Lost to Follow-up|0|||
127765283|NCT01293487|459765650|FG001|Overall Study|Lost to Follow-up|0|||
127765284|NCT01293487|459765651|FG002|Overall Study|Lost to Follow-up|0|||
127765285|NCT01293487|459765652|FG003|Overall Study|Lost to Follow-up|1|||
127765286|NCT01293487|459765653|FG004|Overall Study|Lost to Follow-up|0|||
127765287|NCT01293487|459765654|FG005|Overall Study|Lost to Follow-up|0|||
127765288|NCT01293487|459765655|FG006|Overall Study|Lost to Follow-up|0|||
127765289|NCT01293487|459765656|FG007|Overall Study|Lost to Follow-up|0|||
127765290|NCT01293487|459765649|FG000|Overall Study|Withdrawal by Subject|0|||
127765291|NCT01293487|459765650|FG001|Overall Study|Withdrawal by Subject|0|||
127765292|NCT01293487|459765651|FG002|Overall Study|Withdrawal by Subject|0|||
127765293|NCT01293487|459765652|FG003|Overall Study|Withdrawal by Subject|0|||
127765294|NCT01293487|459765653|FG004|Overall Study|Withdrawal by Subject|0|||
127765295|NCT01293487|459765654|FG005|Overall Study|Withdrawal by Subject|0|||
127765296|NCT01293487|459765655|FG006|Overall Study|Withdrawal by Subject|0|||
127765297|NCT01293487|459765656|FG007|Overall Study|Withdrawal by Subject|2|||
127765298|NCT00395460|459765657|FG000|Overall Study|Withdrawal by Subject|1|||
127765299|NCT00395460|459765658|FG001|Overall Study|Withdrawal by Subject|0|||
127765300|NCT01605019|459765661|FG000|Overall Study|pt did not meet transplant endpoint|3|||
127765301|NCT01605019|459765662|FG001|Overall Study|pt did not meet transplant endpoint|0|||
127765302|NCT04223830|459765667|FG000|Overall Study|Lost to Follow-up|9|||
127765303|NCT04223830|459765667|FG000|Overall Study|Adverse Event|1|||
127765304|NCT01964924|459765668|FG000|Trametinib Monotherapy|Progression|19|||
127765305|NCT01964924|459765669|FG001|Trametinib Monotherapy|Progression|0|||
127765306|NCT01153958|459765670|FG000|Overall Study|Study Terminated|36|||
127765307|NCT01153958|459765671|FG001|Overall Study|Study Terminated|32|||
127765308|NCT01034163|459765672|FG000|Overall Study|Treatment completed as per protocol|8|||
127765309|NCT01034163|459765673|FG001|Overall Study|Treatment completed as per protocol|7|||
127765310|NCT01034163|459765672|FG000|Overall Study|Withdrawal by Subject|8|||
127765311|NCT01034163|459765673|FG001|Overall Study|Withdrawal by Subject|2|||
127765312|NCT01034163|459765672|FG000|Overall Study|Protocol deviation|1|||
127765313|NCT01034163|459765673|FG001|Overall Study|Protocol deviation|0|||
127765314|NCT01034163|459765672|FG000|Overall Study|Disease progression|3|||
127765315|NCT01034163|459765673|FG001|Overall Study|Disease progression|4|||
127765316|NCT01034163|459765672|FG000|Overall Study|Adverse Event|6|||
127765317|NCT01034163|459765673|FG001|Overall Study|Adverse Event|0|||
127765318|NCT01034163|459765672|FG000|Overall Study|Administrative problems|0|||
127765319|NCT01034163|459765673|FG001|Overall Study|Administrative problems|1|||
127765320|NCT01034163|459765672|FG000|Overall Study|Abnormal laboratory value|1|||
127765321|NCT01034163|459765673|FG001|Overall Study|Abnormal laboratory value|0|||
128012848|NCT00580840|460673376|FG003|Double-Blind|Adverse Event|1|||
128012849|NCT00580840|460673373|FG000|Double-Blind|Loss of Efficacy|0|||
127678045|NCT01191086|459444569|FG000|Overall Study|Lack of Efficacy|10|||
127678046|NCT01191086|459444569|FG000|Overall Study|Lost to Follow-up|4|||
127678047|NCT01191086|459444569|FG000|Overall Study|Physician Decision|2|||
127678048|NCT01191086|459444569|FG000|Overall Study|Withdrawal by Subject|24|||
127678049|NCT01191086|459444569|FG000|Overall Study|Discontinuation criterion met|1|||
127678050|NCT01191086|459444569|FG000|Overall Study|Other|1|||
127678051|NCT00771849|459444570|FG000|Overall Study|Lost to Follow-up|1|||
127678052|NCT00771849|459444571|FG001|Overall Study|Lost to Follow-up|2|||
127678053|NCT00771849|459444570|FG000|Overall Study|Withdrawal by Subject|1|||
127678054|NCT00771849|459444571|FG001|Overall Study|Withdrawal by Subject|1|||
127678055|NCT00771849|459444570|FG000|Overall Study|Not vaccinated|0|||
127678056|NCT00771849|459444571|FG001|Overall Study|Not vaccinated|1|||
127678057|NCT02046616|459444574|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
127678058|NCT02046616|459444574|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
127678059|NCT02046616|459444574|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
127678060|NCT02046616|459444574|FG000|24-Week Treatment Period|Physician Decision|3|||
127678061|NCT02046616|459444574|FG000|24-Week Treatment Period|Other|1|||
127678062|NCT02046616|459444574|FG000|8-Week FU Period|Lost to Follow-up|1|||
127678063|NCT02736799|459444575|FG000|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
127678064|NCT02736799|459444576|FG001|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
127678065|NCT02736799|459444577|FG002|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
127678066|NCT02736799|459444578|FG003|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|1|||
127678067|NCT00344019|459444581|FG000|Overall Study|did not meet final inclusion criteria|0|||
127678068|NCT00344019|459444582|FG001|Overall Study|did not meet final inclusion criteria|0|||
127678069|NCT00344019|459444583|FG002|Overall Study|did not meet final inclusion criteria|74|||
127678070|NCT02057718|459444584|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
127678071|NCT02057718|459444585|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
127678072|NCT02057718|459444584|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
127678073|NCT02057718|459444585|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
127678074|NCT02057718|459444584|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
127678075|NCT02057718|459444585|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
127678076|NCT02057718|459444584|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
127678077|NCT02057718|459444585|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
127678078|NCT02057718|459444584|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
127678079|NCT02057718|459444585|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
127678080|NCT02057718|459444584|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
127678081|NCT02057718|459444585|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
127678082|NCT02057718|459444584|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
127678083|NCT02057718|459444585|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
127678084|NCT02057718|459444584|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
127678085|NCT02057718|459444585|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
127678086|NCT02057718|459444584|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
127678087|NCT02057718|459444585|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
127678088|NCT02057718|459444584|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
127678089|NCT02057718|459444585|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
127678090|NCT02057718|459444584|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
127678091|NCT02057718|459444585|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
127678092|NCT02503202|459444586|FG000|Base Study: Up to Month 6|Death|1|||
127678093|NCT02503202|459444587|FG001|Base Study: Up to Month 6|Death|1|||
127678094|NCT02503202|459444588|FG002|Base Study: Up to Month 6|Death|0|||
127678095|NCT02503202|459444589|FG003|Base Study: Up to Month 6|Death|0|||
127678096|NCT02503202|459444590|FG004|Base Study: Up to Month 6|Death|0|||
127678097|NCT02503202|459444586|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
127678098|NCT02503202|459444587|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
127678099|NCT02503202|459444588|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
127678100|NCT02503202|459444589|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
127678101|NCT02503202|459444590|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
127678102|NCT02503202|459444586|FG000|Base Study: Up to Month 6|Physician Decision|0|||
127678103|NCT02503202|459444587|FG001|Base Study: Up to Month 6|Physician Decision|0|||
127678104|NCT02503202|459444588|FG002|Base Study: Up to Month 6|Physician Decision|0|||
127678105|NCT02503202|459444589|FG003|Base Study: Up to Month 6|Physician Decision|0|||
128012850|NCT00580840|460673374|FG001|Double-Blind|Loss of Efficacy|1|||
127678106|NCT02503202|459444590|FG004|Base Study: Up to Month 6|Physician Decision|1|||
127678107|NCT02503202|459444586|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
127678108|NCT02503202|459444587|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
127765322|NCT00528645|459765674|FG000|Overall Study|Adverse Event|3|||
128012851|NCT00580840|460673375|FG002|Double-Blind|Loss of Efficacy|2|||
127765323|NCT02150343|459765675|FG000|Overall Study|Adverse Event|2|||
127765324|NCT02150343|459765676|FG001|Overall Study|Adverse Event|0|||
127765325|NCT02150343|459765677|FG002|Overall Study|Adverse Event|1|||
127765326|NCT02150343|459765678|FG003|Overall Study|Adverse Event|1|||
127765327|NCT02150343|459765675|FG000|Overall Study|Withdrawal by Subject|13|||
127765328|NCT02150343|459765676|FG001|Overall Study|Withdrawal by Subject|10|||
127765329|NCT02150343|459765677|FG002|Overall Study|Withdrawal by Subject|9|||
127765330|NCT02150343|459765678|FG003|Overall Study|Withdrawal by Subject|4|||
127765331|NCT02150343|459765675|FG000|Overall Study|Lost to Follow-up|4|||
127765332|NCT02150343|459765676|FG001|Overall Study|Lost to Follow-up|4|||
127765333|NCT02150343|459765677|FG002|Overall Study|Lost to Follow-up|2|||
127765334|NCT02150343|459765678|FG003|Overall Study|Lost to Follow-up|3|||
127765335|NCT02150343|459765675|FG000|Overall Study|Other|2|||
127765336|NCT02150343|459765676|FG001|Overall Study|Other|6|||
127765337|NCT02150343|459765677|FG002|Overall Study|Other|0|||
127765338|NCT02150343|459765678|FG003|Overall Study|Other|2|||
127765339|NCT02729753|459765679|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
127765340|NCT02729753|459765680|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
127765341|NCT00190749|459765681|FG000|Overall Study|Lost to Follow-up|8|||
127765342|NCT00190749|459765682|FG001|Overall Study|Lost to Follow-up|11|||
127765343|NCT00190749|459765681|FG000|Overall Study|Withdrawal by Subject|10|||
127765344|NCT00190749|459765682|FG001|Overall Study|Withdrawal by Subject|6|||
127765345|NCT00190749|459765681|FG000|Overall Study|Protocol Violation|5|||
127765346|NCT00190749|459765682|FG001|Overall Study|Protocol Violation|4|||
127765347|NCT00190749|459765681|FG000|Overall Study|Adverse Event|0|||
127765348|NCT00190749|459765682|FG001|Overall Study|Adverse Event|5|||
127765349|NCT00190749|459765681|FG000|Overall Study|Lack of Efficacy|2|||
127765350|NCT00190749|459765682|FG001|Overall Study|Lack of Efficacy|3|||
127765351|NCT00190749|459765681|FG000|Overall Study|Reason Not Specified|0|||
127765352|NCT00190749|459765682|FG001|Overall Study|Reason Not Specified|2|||
127765353|NCT00190749|459765681|FG000|Overall Study|Sponsor Decision|1|||
127765354|NCT00190749|459765682|FG001|Overall Study|Sponsor Decision|0|||
127765355|NCT01090427|459765683|FG000|After Controlled Period|Death|0|||
127765356|NCT01090427|459765684|FG001|After Controlled Period|Death|0|||
127765357|NCT01090427|459765685|FG002|After Controlled Period|Death|0|||
127765358|NCT01090427|459765686|FG003|After Controlled Period|Death|0|||
127765359|NCT01090427|459765687|FG004|After Controlled Period|Death|0|||
127765360|NCT01090427|459765688|FG005|After Controlled Period|Death|1|||
127765361|NCT01090427|459765689|FG006|After Controlled Period|Death|0|||
127765362|NCT01090427|459765683|FG000|After Controlled Period|Lack of Efficacy|0|||
127765363|NCT01090427|459765684|FG001|After Controlled Period|Lack of Efficacy|0|||
127765364|NCT01090427|459765685|FG002|After Controlled Period|Lack of Efficacy|0|||
127765365|NCT01090427|459765686|FG003|After Controlled Period|Lack of Efficacy|0|||
127765366|NCT01090427|459765687|FG004|After Controlled Period|Lack of Efficacy|0|||
127765367|NCT01090427|459765688|FG005|After Controlled Period|Lack of Efficacy|3|||
127765368|NCT01090427|459765689|FG006|After Controlled Period|Lack of Efficacy|2|||
127765369|NCT01090427|459765683|FG000|After Controlled Period|Adverse Event|0|||
127765370|NCT01090427|459765684|FG001|After Controlled Period|Adverse Event|0|||
127765371|NCT01090427|459765685|FG002|After Controlled Period|Adverse Event|0|||
127765372|NCT01090427|459765686|FG003|After Controlled Period|Adverse Event|2|||
127765373|NCT01090427|459765687|FG004|After Controlled Period|Adverse Event|0|||
127765374|NCT01090427|459765688|FG005|After Controlled Period|Adverse Event|1|||
127765375|NCT01090427|459765689|FG006|After Controlled Period|Adverse Event|0|||
127765376|NCT01200589|459765690|FG000|Overall Study|Withdrawal by Subject|13|||
127765377|NCT01200589|459765691|FG001|Overall Study|Withdrawal by Subject|11|||
127765378|NCT01200589|459765690|FG000|Overall Study|Physician Decision|2|||
127765379|NCT01200589|459765691|FG001|Overall Study|Physician Decision|2|||
127765380|NCT01200589|459765690|FG000|Overall Study|Lost to Follow-up|5|||
127765381|NCT01200589|459765691|FG001|Overall Study|Lost to Follow-up|4|||
127765382|NCT01200589|459765690|FG000|Overall Study|Study terminated|170|||
127765383|NCT01200589|459765691|FG001|Overall Study|Study terminated|172|||
127765384|NCT01154010|459765692|FG000|Overall Study|Lost to Follow-up|0|||
127765385|NCT01154010|459765693|FG001|Overall Study|Lost to Follow-up|1|||
127765386|NCT00439231|459765694|FG000|Overall Study|Lack of Efficacy|28|||
127765387|NCT02413333|459765695|FG000|Period 1|Adverse Event|1|||
127765388|NCT02413333|459765696|FG001|Period 1|Adverse Event|0|||
127765389|NCT02413333|459765695|FG000|Period 1|Reason Not Specified|0|||
127765390|NCT02413333|459765696|FG001|Period 1|Reason Not Specified|1|||
127765391|NCT02413333|459765695|FG000|Period 2|Protocol Deviation|1|||
127765392|NCT02413333|459765696|FG001|Period 2|Protocol Deviation|0|||
127765393|NCT01049217|459765697|FG000|Overall Study|Adverse Event|2|||
127765394|NCT01049217|459765698|FG001|Overall Study|Adverse Event|1|||
127765395|NCT01049217|459765697|FG000|Overall Study|Lack of Efficacy|1|||
127765396|NCT01049217|459765698|FG001|Overall Study|Lack of Efficacy|1|||
127765397|NCT01049217|459765697|FG000|Overall Study|Lost to Follow-up|3|||
127765398|NCT01049217|459765698|FG001|Overall Study|Lost to Follow-up|8|||
127765399|NCT01049217|459765697|FG000|Overall Study|Withdrawal by Subject|4|||
127765400|NCT01049217|459765698|FG001|Overall Study|Withdrawal by Subject|3|||
127765401|NCT01049217|459765697|FG000|Overall Study|Protocol Violation|1|||
127765402|NCT01049217|459765698|FG001|Overall Study|Protocol Violation|3|||
127765403|NCT01049217|459765697|FG000|Overall Study|Pregnancy|1|||
127765404|NCT01049217|459765698|FG001|Overall Study|Pregnancy|0|||
127765405|NCT01049217|459765697|FG000|Overall Study|Study Terminated by Sponsor|43|||
127765406|NCT01049217|459765698|FG001|Overall Study|Study Terminated by Sponsor|43|||
127765407|NCT01049217|459765697|FG000|Overall Study|Other|1|||
127765408|NCT01049217|459765698|FG001|Overall Study|Other|2|||
127765409|NCT01049217|459765697|FG000|Overall Study|Randomized but not Treated|0|||
127765410|NCT01049217|459765698|FG001|Overall Study|Randomized but not Treated|2|||
127765411|NCT00903682|459765699|FG000|Overall Study|Adverse Event|6|||
127765412|NCT00903682|459765700|FG001|Overall Study|Adverse Event|13|||
128012852|NCT00580840|460673376|FG003|Double-Blind|Loss of Efficacy|10|||
128012853|NCT00580840|460673373|FG000|Double-Blind|Lost to Follow-up|0|||
128012854|NCT00580840|460673374|FG001|Double-Blind|Lost to Follow-up|1|||
128012855|NCT00580840|460673375|FG002|Double-Blind|Lost to Follow-up|0|||
128012856|NCT00580840|460673376|FG003|Double-Blind|Lost to Follow-up|2|||
128012857|NCT00580840|460673373|FG000|Double-Blind|Withdrawal by Subject|0|||
128012858|NCT00580840|460673374|FG001|Double-Blind|Withdrawal by Subject|1|||
128012859|NCT00580840|460673375|FG002|Double-Blind|Withdrawal by Subject|2|||
128012860|NCT00580840|460673376|FG003|Double-Blind|Withdrawal by Subject|2|||
128012861|NCT00580840|460673373|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
128012862|NCT00580840|460673374|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
128012863|NCT00580840|460673375|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
128012864|NCT00580840|460673376|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
128012865|NCT00580840|460673373|FG000|Double-Blind|Other: Forbidden Medication|0|||
128012866|NCT00580840|460673374|FG001|Double-Blind|Other: Forbidden Medication|0|||
128012867|NCT00580840|460673375|FG002|Double-Blind|Other: Forbidden Medication|1|||
128012868|NCT00580840|460673376|FG003|Double-Blind|Other: Forbidden Medication|0|||
128012869|NCT01551173|460673377|FG000|Overall Study|Withdrawal by Subject|11|||
128012870|NCT01551173|460673378|FG001|Overall Study|Withdrawal by Subject|16|||
128012871|NCT01551173|460673377|FG000|Overall Study|Adverse Event|7|||
128012872|NCT01551173|460673378|FG001|Overall Study|Adverse Event|6|||
128012873|NCT01551173|460673377|FG000|Overall Study|Lost to Follow-up|5|||
128012874|NCT01551173|460673378|FG001|Overall Study|Lost to Follow-up|7|||
128012875|NCT01551173|460673377|FG000|Overall Study|Other|5|||
127765413|NCT00903682|459765699|FG000|Overall Study|Lost to Follow-up|1|||
127765414|NCT00903682|459765700|FG001|Overall Study|Lost to Follow-up|0|||
127765415|NCT00903682|459765699|FG000|Overall Study|Withdrawal by Subject|5|||
127765416|NCT00903682|459765700|FG001|Overall Study|Withdrawal by Subject|0|||
127765417|NCT00903682|459765699|FG000|Overall Study|Pregnancy|0|||
127765418|NCT00903682|459765700|FG001|Overall Study|Pregnancy|1|||
127765419|NCT00903682|459765699|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
127765420|NCT00903682|459765700|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
127765421|NCT00903682|459765699|FG000|Overall Study|Subject Non-Compliant|1|||
127765422|NCT00903682|459765700|FG001|Overall Study|Subject Non-Compliant|0|||
127765423|NCT00903682|459765699|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
127765424|NCT00903682|459765700|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
127765425|NCT00903682|459765699|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
127765426|NCT00903682|459765700|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
127765427|NCT02495792|459765701|FG000|Overall Study|Lost to Follow-up|5|||
127765428|NCT02495792|459765702|FG001|Overall Study|Lost to Follow-up|9|||
127765429|NCT02495792|459765701|FG000|Overall Study|Protocol Violation|32|||
127765430|NCT02495792|459765702|FG001|Overall Study|Protocol Violation|31|||
127765431|NCT01028027|459765703|FG000|Overall Study|Lost to Follow-up|4|||
127765432|NCT01028027|459765704|FG001|Overall Study|Lost to Follow-up|1|||
127765433|NCT01028027|459765703|FG000|Overall Study|Withdrawal by Subject|5|||
127765434|NCT01028027|459765704|FG001|Overall Study|Withdrawal by Subject|3|||
127765435|NCT01028027|459765703|FG000|Overall Study|Adverse Event|4|||
127765436|NCT01028027|459765704|FG001|Overall Study|Adverse Event|7|||
127765437|NCT01028027|459765703|FG000|Overall Study|Protocol Violation|3|||
127765438|NCT01028027|459765704|FG001|Overall Study|Protocol Violation|1|||
127765439|NCT01028027|459765703|FG000|Overall Study|Lack of Efficacy|0|||
127765440|NCT01028027|459765704|FG001|Overall Study|Lack of Efficacy|1|||
127765441|NCT00686725|459767776|FG000|Overall Study|Adverse Event|1|||
127765442|NCT00686725|459767777|FG001|Overall Study|Adverse Event|1|||
128012876|NCT01551173|460673378|FG001|Overall Study|Other|3|||
128012877|NCT04530344|460673379|FG000|Overall Study|Lost to Follow-up|3|||
128012878|NCT04530344|460673380|FG001|Overall Study|Lost to Follow-up|3|||
128012879|NCT04530344|460673381|FG002|Overall Study|Lost to Follow-up|3|||
128012880|NCT04530344|460673382|FG003|Overall Study|Lost to Follow-up|10|||
128012881|NCT04530344|460673379|FG000|Overall Study|Withdrawal by Subject|14|||
128012882|NCT04530344|460673380|FG001|Overall Study|Withdrawal by Subject|5|||
127765443|NCT00686725|459767776|FG000|Overall Study|Progressive Disease|17|||
127765444|NCT00686725|459767777|FG001|Overall Study|Progressive Disease|23|||
127765445|NCT00686725|459767776|FG000|Overall Study|Lost to Follow-up|7|||
127765446|NCT00686725|459767777|FG001|Overall Study|Lost to Follow-up|5|||
128012883|NCT04530344|460673381|FG002|Overall Study|Withdrawal by Subject|18|||
128012884|NCT04530344|460673382|FG003|Overall Study|Withdrawal by Subject|33|||
127678109|NCT02503202|459444588|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
127678110|NCT02503202|459444589|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
127678111|NCT02503202|459444590|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
127678112|NCT02503202|459444586|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
127678113|NCT02503202|459444587|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
127678114|NCT02503202|459444588|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
127678115|NCT02503202|459444589|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
127678116|NCT02503202|459444590|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
127678117|NCT02503202|459444586|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
127678118|NCT02503202|459444587|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
127678119|NCT02503202|459444588|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
127678120|NCT02503202|459444589|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
127678121|NCT02503202|459444590|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
127678122|NCT02503202|459444586|FG000|Extension: Month 6 to 24|Death|1|||
127678123|NCT02503202|459444587|FG001|Extension: Month 6 to 24|Death|0|||
127678124|NCT02503202|459444588|FG002|Extension: Month 6 to 24|Death|0|||
127678125|NCT02503202|459444589|FG003|Extension: Month 6 to 24|Death|0|||
127678126|NCT02503202|459444590|FG004|Extension: Month 6 to 24|Death|0|||
127678127|NCT02503202|459444586|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
127678128|NCT02503202|459444587|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
127678129|NCT02503202|459444588|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
127678130|NCT02503202|459444589|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
127678131|NCT02503202|459444590|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
127678132|NCT02503202|459444586|FG000|Extension: Month 6 to 24|Physician Decision|1|||
127678133|NCT02503202|459444587|FG001|Extension: Month 6 to 24|Physician Decision|0|||
127678134|NCT02503202|459444588|FG002|Extension: Month 6 to 24|Physician Decision|1|||
127678135|NCT02503202|459444589|FG003|Extension: Month 6 to 24|Physician Decision|3|||
127678136|NCT02503202|459444590|FG004|Extension: Month 6 to 24|Physician Decision|0|||
127678137|NCT02503202|459444586|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
127678138|NCT02503202|459444587|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
127678139|NCT02503202|459444588|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
127678140|NCT02503202|459444589|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
127678141|NCT02503202|459444590|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
127678142|NCT00906035|459444596|FG000|Overall Study|Withdrawal by Subject|2|||
127678143|NCT00906035|459444597|FG001|Overall Study|Withdrawal by Subject|3|||
127678144|NCT00906035|459444598|FG002|Overall Study|Withdrawal by Subject|0|||
127678145|NCT03058991|459444599|FG000|Overall Study|Lost to Follow-up|17|||
127678146|NCT03058991|459444600|FG001|Overall Study|Lost to Follow-up|12|||
127678147|NCT03058991|459444601|FG002|Overall Study|Lost to Follow-up|12|||
127678148|NCT03058991|459444599|FG000|Overall Study|Withdrawal by Subject|1|||
127678149|NCT03058991|459444600|FG001|Overall Study|Withdrawal by Subject|0|||
127678150|NCT03058991|459444601|FG002|Overall Study|Withdrawal by Subject|0|||
127678151|NCT00130637|459444602|FG000|Overall Study|Adverse Event|2|||
127678152|NCT00130637|459444602|FG000|Overall Study|Withdrawal by Subject|1|||
127678153|NCT01460342|459444604|FG000|Overall Study|Adverse Event|5|||
127678154|NCT01460342|459444605|FG001|Overall Study|Adverse Event|4|||
127678155|NCT01460342|459444604|FG000|Overall Study|Lost to Follow-up|1|||
127678156|NCT01460342|459444605|FG001|Overall Study|Lost to Follow-up|2|||
127678157|NCT01460342|459444604|FG000|Overall Study|Protocol Violation|0|||
127678158|NCT01460342|459444605|FG001|Overall Study|Protocol Violation|1|||
127678159|NCT01460342|459444604|FG000|Overall Study|Withdrawal by Subject|3|||
127678160|NCT01460342|459444605|FG001|Overall Study|Withdrawal by Subject|4|||
127678161|NCT01460342|459444604|FG000|Overall Study|Physician Decision|1|||
127678162|NCT01460342|459444605|FG001|Overall Study|Physician Decision|3|||
127678163|NCT01460342|459444604|FG000|Overall Study|Lack of Efficacy|1|||
127678164|NCT01460342|459444605|FG001|Overall Study|Lack of Efficacy|0|||
127678165|NCT01689519|459444606|FG000|Intent to Treat|Death|157|||
127678166|NCT01689519|459444607|FG001|Intent to Treat|Death|167|||
127678167|NCT01689519|459444606|FG000|Intent to Treat|Lost to Follow-up|4|||
127678168|NCT01689519|459444607|FG001|Intent to Treat|Lost to Follow-up|8|||
127678169|NCT01689519|459444606|FG000|Intent to Treat|Other|2|||
127678170|NCT01689519|459444607|FG001|Intent to Treat|Other|4|||
127678171|NCT01689519|459444606|FG000|Intent to Treat|Physician Decision|4|||
127678172|NCT01689519|459444607|FG001|Intent to Treat|Physician Decision|1|||
127678173|NCT01689519|459444606|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
127678174|NCT01689519|459444607|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
127678175|NCT01689519|459444606|FG000|Intent to Treat|Withdrawal by Subject|21|||
127678176|NCT01689519|459444607|FG001|Intent to Treat|Withdrawal by Subject|20|||
127678177|NCT01689519|459444606|FG000|Safety Population|Death|158|||
127678178|NCT01689519|459444607|FG001|Safety Population|Death|165|||
127678179|NCT01689519|459444606|FG000|Safety Population|Lost to Follow-up|4|||
127678180|NCT01689519|459444607|FG001|Safety Population|Lost to Follow-up|8|||
127678181|NCT01689519|459444606|FG000|Safety Population|Other|2|||
127678182|NCT01689519|459444607|FG001|Safety Population|Other|4|||
127678183|NCT01689519|459444606|FG000|Safety Population|Physician Decision|4|||
127765447|NCT00686725|459767776|FG000|Overall Study|Death|6|||
127765448|NCT00686725|459767777|FG001|Overall Study|Death|3|||
127765449|NCT00686725|459767776|FG000|Overall Study|Withdrawal by Subject|13|||
127765450|NCT00686725|459767777|FG001|Overall Study|Withdrawal by Subject|4|||
127765451|NCT00686725|459767776|FG000|Overall Study|Protocol Violation|1|||
127765452|NCT00686725|459767777|FG001|Overall Study|Protocol Violation|3|||
127765453|NCT00686725|459767776|FG000|Overall Study|Other|1|||
127765454|NCT00686725|459767777|FG001|Overall Study|Other|3|||
127765455|NCT03064035|459767780|FG000|Overall Study|Did not receive allocated intervention|4|||
127765456|NCT03064035|459767781|FG001|Overall Study|Did not receive allocated intervention|2|||
127765457|NCT03064035|459767780|FG000|Overall Study|Lost to Follow-up|1|||
127765458|NCT03064035|459767781|FG001|Overall Study|Lost to Follow-up|1|||
127765459|NCT03103763|459767782|FG000|Overall Study|Death|15|||
127765460|NCT03103763|459767783|FG001|Overall Study|Death|5|||
127765461|NCT03103763|459767784|FG002|Overall Study|Death|5|||
127765462|NCT03103763|459767782|FG000|Overall Study|Withdrawal by Subject|0|||
127765463|NCT03103763|459767783|FG001|Overall Study|Withdrawal by Subject|3|||
127765464|NCT03103763|459767784|FG002|Overall Study|Withdrawal by Subject|2|||
127765465|NCT01970345|459767785|FG000|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
127765466|NCT01970345|459767786|FG001|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
127765467|NCT01970345|459767785|FG000|Second Treatment Phase 12 Weeks|Withdrawal by Subject|0|||
127765468|NCT01970345|459767786|FG001|Second Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
127765469|NCT00558259|459767791|FG000|Overall Study|Adverse Event|50|||
127765470|NCT00558259|459767792|FG001|Overall Study|Adverse Event|81|||
127765471|NCT00558259|459767791|FG000|Overall Study|Protocol Violation|9|||
127765472|NCT00558259|459767792|FG001|Overall Study|Protocol Violation|5|||
127765473|NCT00558259|459767791|FG000|Overall Study|Withdrawal by Subject|12|||
127765474|NCT00558259|459767792|FG001|Overall Study|Withdrawal by Subject|13|||
127765475|NCT02874924|459767793|FG000|Overall Study|Adverse Event|2|||
127765476|NCT02874924|459767794|FG001|Overall Study|Adverse Event|0|||
127765477|NCT02874924|459767795|FG002|Overall Study|Adverse Event|0|||
127765478|NCT02874924|459767793|FG000|Overall Study|Withdrawal by Subject|1|||
127765479|NCT02874924|459767794|FG001|Overall Study|Withdrawal by Subject|0|||
127765480|NCT02874924|459767795|FG002|Overall Study|Withdrawal by Subject|0|||
127765481|NCT02029846|459767800|FG000|Overall Study|n=1 each arm|1|||
127765482|NCT02029846|459767801|FG001|Overall Study|n=1 each arm|1|||
127765483|NCT02966301|459767802|FG000|Overall Study|Death|2|||
127765484|NCT02966301|459767802|FG000|Overall Study|Withdrawal by Subject|1|||
127765485|NCT00822172|459767806|FG000|Overall Study|Adverse Event|10|||
127765486|NCT00822172|459767807|FG001|Overall Study|Adverse Event|12|||
127765487|NCT00822172|459767806|FG000|Overall Study|Death|1|||
127765488|NCT00822172|459767807|FG001|Overall Study|Death|0|||
127765489|NCT00822172|459767806|FG000|Overall Study|Lost to Follow-up|3|||
127765490|NCT00822172|459767807|FG001|Overall Study|Lost to Follow-up|1|||
127765491|NCT00822172|459767806|FG000|Overall Study|Withdrawal by Subject|1|||
127765492|NCT00822172|459767807|FG001|Overall Study|Withdrawal by Subject|4|||
127765493|NCT00822172|459767806|FG000|Overall Study|site closed|0|||
127765494|NCT00822172|459767807|FG001|Overall Study|site closed|1|||
127765495|NCT00822172|459767806|FG000|Overall Study|Other|0|||
127765496|NCT00822172|459767807|FG001|Overall Study|Other|1|||
127765497|NCT00700258|459767808|FG000|Overall Study|Premature discontinuation of documentation|136|||
127765498|NCT00700258|459767808|FG000|Overall Study|Type of study end not documented|1|||
127765499|NCT00700258|459767808|FG000|Overall Study|Lost to Follow-up|81|||
127765500|NCT00700258|459767808|FG000|Overall Study|Premature discontinuation of therapy|1013|||
127765501|NCT01874431|459767810|FG000|Overall Study|Physician Decision|0|||
127765502|NCT01874431|459767811|FG001|Overall Study|Physician Decision|0|||
127765503|NCT01874431|459767812|FG002|Overall Study|Physician Decision|1|||
127765504|NCT01874431|459767813|FG003|Overall Study|Physician Decision|0|||
127765505|NCT01874431|459767814|FG004|Overall Study|Physician Decision|0|||
127765506|NCT01874431|459767815|FG005|Overall Study|Physician Decision|0|||
127765507|NCT01874431|459767816|FG006|Overall Study|Physician Decision|0|||
128012885|NCT04530344|460673379|FG000|Overall Study|Adverse Event|0|||
128012886|NCT04530344|460673380|FG001|Overall Study|Adverse Event|0|||
128012887|NCT04530344|460673381|FG002|Overall Study|Adverse Event|0|||
128012888|NCT04530344|460673382|FG003|Overall Study|Adverse Event|1|||
128012889|NCT04530344|460673379|FG000|Overall Study|Lack of Efficacy|0|||
128012890|NCT04530344|460673380|FG001|Overall Study|Lack of Efficacy|0|||
128012891|NCT04530344|460673381|FG002|Overall Study|Lack of Efficacy|0|||
128012892|NCT04530344|460673382|FG003|Overall Study|Lack of Efficacy|1|||
128012893|NCT04530344|460673379|FG000|Overall Study|Physician Decision|0|||
127765508|NCT01874431|459767817|FG007|Overall Study|Physician Decision|0|||
127765509|NCT01874431|459767810|FG000|Overall Study|Adverse Event|5|||
127765510|NCT01874431|459767811|FG001|Overall Study|Adverse Event|4|||
127765511|NCT01874431|459767812|FG002|Overall Study|Adverse Event|6|||
127765512|NCT01874431|459767813|FG003|Overall Study|Adverse Event|5|||
127765513|NCT01874431|459767814|FG004|Overall Study|Adverse Event|2|||
127765514|NCT01874431|459767815|FG005|Overall Study|Adverse Event|8|||
127765515|NCT01874431|459767816|FG006|Overall Study|Adverse Event|2|||
127765516|NCT01874431|459767817|FG007|Overall Study|Adverse Event|3|||
128012894|NCT04530344|460673380|FG001|Overall Study|Physician Decision|0|||
128012895|NCT04530344|460673381|FG002|Overall Study|Physician Decision|1|||
128012896|NCT04530344|460673382|FG003|Overall Study|Physician Decision|1|||
128012897|NCT04530344|460673379|FG000|Overall Study|Pregnancy|0|||
128012898|NCT04530344|460673380|FG001|Overall Study|Pregnancy|0|||
128012899|NCT04530344|460673381|FG002|Overall Study|Pregnancy|2|||
128012900|NCT04530344|460673382|FG003|Overall Study|Pregnancy|1|||
128012901|NCT04530344|460673379|FG000|Overall Study|Protocol Violation|0|||
128012902|NCT04530344|460673380|FG001|Overall Study|Protocol Violation|0|||
128012903|NCT04530344|460673381|FG002|Overall Study|Protocol Violation|0|||
128012904|NCT04530344|460673382|FG003|Overall Study|Protocol Violation|1|||
127678184|NCT01689519|459444607|FG001|Safety Population|Physician Decision|1|||
127678185|NCT01689519|459444606|FG000|Safety Population|Study Terminated By Sponsor|60|||
127678186|NCT01689519|459444607|FG001|Safety Population|Study Terminated By Sponsor|47|||
127678187|NCT01689519|459444606|FG000|Safety Population|Withdrawal by Subject|20|||
127678188|NCT01689519|459444607|FG001|Safety Population|Withdrawal by Subject|20|||
127678189|NCT01713530|459444611|FG000|Overall Study|Adverse Event|0|||
127678190|NCT01713530|459444612|FG001|Overall Study|Adverse Event|5|||
127678191|NCT01713530|459444611|FG000|Overall Study|Withdrawal criteria|21|||
127678192|NCT01713530|459444612|FG001|Overall Study|Withdrawal criteria|12|||
127678193|NCT01713530|459444611|FG000|Overall Study|Unclassified|4|||
127678194|NCT01713530|459444612|FG001|Overall Study|Unclassified|2|||
127678195|NCT05046132|459444613|FG000|Overall Study|Adverse Event|4|||
127678196|NCT05046132|459444614|FG001|Overall Study|Adverse Event|0|||
127678197|NCT05046132|459444615|FG002|Overall Study|Adverse Event|0|||
127678198|NCT05046132|459444613|FG000|Overall Study|Withdrawal by Subject|3|||
127678199|NCT05046132|459444614|FG001|Overall Study|Withdrawal by Subject|0|||
127678200|NCT05046132|459444615|FG002|Overall Study|Withdrawal by Subject|0|||
127678201|NCT05046132|459444613|FG000|Overall Study|Positive Covid19 Result.|0|||
127678202|NCT05046132|459444614|FG001|Overall Study|Positive Covid19 Result.|1|||
127678203|NCT05046132|459444615|FG002|Overall Study|Positive Covid19 Result.|0|||
127678204|NCT01959412|459444616|FG000|Overall Study|Protocol deviation|1|||
127678205|NCT01959412|459444617|FG001|Overall Study|Protocol deviation|1|||
127678206|NCT01959412|459444618|FG002|Overall Study|Protocol deviation|0|||
127678207|NCT01959412|459444619|FG003|Overall Study|Protocol deviation|1|||
127678208|NCT01959412|459444620|FG004|Overall Study|Protocol deviation|3|||
127678209|NCT01959412|459444621|FG005|Overall Study|Protocol deviation|0|||
127678210|NCT01959412|459444616|FG000|Overall Study|Adverse Event|0|||
127678211|NCT01959412|459444617|FG001|Overall Study|Adverse Event|0|||
127678212|NCT01959412|459444618|FG002|Overall Study|Adverse Event|0|||
127678213|NCT01959412|459444619|FG003|Overall Study|Adverse Event|1|||
127678214|NCT01959412|459444620|FG004|Overall Study|Adverse Event|0|||
127678215|NCT01959412|459444621|FG005|Overall Study|Adverse Event|0|||
127678216|NCT00619645|459444623|FG000|Overall Study|Adverse Event|1|||
127678217|NCT04364269|459444624|FG000|Overall Study|Adverse Event|1|||
127678218|NCT04364269|459444625|FG001|Overall Study|Adverse Event|0|||
127678219|NCT04364269|459444626|FG002|Overall Study|Adverse Event|0|||
127678220|NCT04364269|459444624|FG000|Overall Study|Withdrawal by Subject|0|||
127678221|NCT04364269|459444625|FG001|Overall Study|Withdrawal by Subject|1|||
127678222|NCT04364269|459444626|FG002|Overall Study|Withdrawal by Subject|0|||
127678223|NCT04246762|459444627|FG000|Period 1: Cocktail Alone|Protocol Violation|1|||
127678224|NCT00597519|459444628|FG000|Overall Study|Death|1|||
127678225|NCT00741988|459444632|FG000|Overall Study|Adverse Event|2|||
127678226|NCT00741988|459444633|FG001|Overall Study|Adverse Event|4|||
127678227|NCT00741988|459444632|FG000|Overall Study|Lack of Efficacy|2|||
127678228|NCT00741988|459444633|FG001|Overall Study|Lack of Efficacy|0|||
127678229|NCT02104765|459444634|FG000|Overall Study|Lost to Follow-up|0|||
127678230|NCT02104765|459444635|FG001|Overall Study|Lost to Follow-up|0|||
127678231|NCT02104765|459444636|FG002|Overall Study|Lost to Follow-up|1|||
127678232|NCT02104765|459444637|FG003|Overall Study|Lost to Follow-up|0|||
127678233|NCT02104765|459444638|FG004|Overall Study|Lost to Follow-up|0|||
127678234|NCT02104765|459444639|FG005|Overall Study|Lost to Follow-up|0|||
128012905|NCT04530344|460673379|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
127678235|NCT02104765|459444640|FG006|Overall Study|Lost to Follow-up|0|||
127678236|NCT02104765|459444634|FG000|Overall Study|Withdrawal by Subject|0|||
127678237|NCT02104765|459444635|FG001|Overall Study|Withdrawal by Subject|0|||
128012906|NCT04530344|460673380|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
128012907|NCT04530344|460673381|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
128012908|NCT04530344|460673382|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
127678238|NCT02104765|459444636|FG002|Overall Study|Withdrawal by Subject|0|||
127678239|NCT02104765|459444637|FG003|Overall Study|Withdrawal by Subject|1|||
127678240|NCT02104765|459444638|FG004|Overall Study|Withdrawal by Subject|1|||
127678241|NCT02104765|459444639|FG005|Overall Study|Withdrawal by Subject|0|||
127678242|NCT02104765|459444640|FG006|Overall Study|Withdrawal by Subject|1|||
127678243|NCT00995709|459444643|FG000|Overall Study|Adverse Event|4|||
127678244|NCT00995709|459444644|FG001|Overall Study|Adverse Event|2|||
127678245|NCT00995709|459444645|FG002|Overall Study|Adverse Event|0|||
127678246|NCT00995709|459444643|FG000|Overall Study|Lack of Efficacy|0|||
127678247|NCT00995709|459444644|FG001|Overall Study|Lack of Efficacy|1|||
127765517|NCT01874431|459767810|FG000|Overall Study|Protocol Violation|1|||
127765518|NCT01874431|459767811|FG001|Overall Study|Protocol Violation|1|||
127765519|NCT01874431|459767812|FG002|Overall Study|Protocol Violation|1|||
127765520|NCT01874431|459767813|FG003|Overall Study|Protocol Violation|0|||
127765521|NCT01874431|459767814|FG004|Overall Study|Protocol Violation|3|||
127765522|NCT01874431|459767815|FG005|Overall Study|Protocol Violation|2|||
127765523|NCT01874431|459767816|FG006|Overall Study|Protocol Violation|1|||
127765524|NCT01874431|459767817|FG007|Overall Study|Protocol Violation|1|||
127765525|NCT01874431|459767810|FG000|Overall Study|Non-compliance|0|||
127765526|NCT01874431|459767811|FG001|Overall Study|Non-compliance|0|||
127765527|NCT01874431|459767812|FG002|Overall Study|Non-compliance|0|||
127765528|NCT01874431|459767813|FG003|Overall Study|Non-compliance|0|||
127765529|NCT01874431|459767814|FG004|Overall Study|Non-compliance|1|||
127765530|NCT01874431|459767815|FG005|Overall Study|Non-compliance|0|||
127765531|NCT01874431|459767816|FG006|Overall Study|Non-compliance|1|||
127765532|NCT01874431|459767817|FG007|Overall Study|Non-compliance|0|||
127765533|NCT01874431|459767810|FG000|Overall Study|Logistical difficulties|0|||
127765534|NCT01874431|459767811|FG001|Overall Study|Logistical difficulties|0|||
127765535|NCT01874431|459767812|FG002|Overall Study|Logistical difficulties|0|||
127765536|NCT01874431|459767813|FG003|Overall Study|Logistical difficulties|0|||
127765537|NCT01874431|459767814|FG004|Overall Study|Logistical difficulties|0|||
127765538|NCT01874431|459767815|FG005|Overall Study|Logistical difficulties|0|||
127765539|NCT01874431|459767816|FG006|Overall Study|Logistical difficulties|1|||
127765540|NCT01874431|459767817|FG007|Overall Study|Logistical difficulties|0|||
127765541|NCT01874431|459767810|FG000|Overall Study|Withdrawal by Subject|0|||
127765542|NCT01874431|459767811|FG001|Overall Study|Withdrawal by Subject|0|||
127765543|NCT01874431|459767812|FG002|Overall Study|Withdrawal by Subject|1|||
127765544|NCT01874431|459767813|FG003|Overall Study|Withdrawal by Subject|2|||
127765545|NCT01874431|459767814|FG004|Overall Study|Withdrawal by Subject|1|||
127765546|NCT01874431|459767815|FG005|Overall Study|Withdrawal by Subject|1|||
127765547|NCT01874431|459767816|FG006|Overall Study|Withdrawal by Subject|3|||
127765548|NCT01874431|459767817|FG007|Overall Study|Withdrawal by Subject|0|||
127765549|NCT01874431|459767810|FG000|Overall Study|Sponsor decision|0|||
127765550|NCT01874431|459767811|FG001|Overall Study|Sponsor decision|0|||
127765551|NCT01874431|459767812|FG002|Overall Study|Sponsor decision|0|||
128012909|NCT04530344|460673379|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
128012910|NCT04530344|460673380|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
128012911|NCT04530344|460673381|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
128012912|NCT04530344|460673382|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
128012913|NCT04530344|460673379|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
128012914|NCT04530344|460673380|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
128012915|NCT04530344|460673381|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
128012916|NCT04530344|460673382|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
128012917|NCT04530344|460673379|FG000|Overall Study|Personal Reasons|0|||
128012918|NCT04530344|460673380|FG001|Overall Study|Personal Reasons|0|||
128012919|NCT04530344|460673381|FG002|Overall Study|Personal Reasons|0|||
128012920|NCT04530344|460673382|FG003|Overall Study|Personal Reasons|1|||
128012921|NCT04530344|460673379|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
128012922|NCT04530344|460673380|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
128012923|NCT04530344|460673381|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
128012924|NCT04530344|460673382|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
128012925|NCT01402700|460673383|FG000|Overall Study|Death|3|||
128012926|NCT01402700|460673383|FG000|Overall Study|Withdrawal by Subject|3|||
128012927|NCT01402700|460673383|FG000|Overall Study|Missed Visit|1|||
128012928|NCT00764517|460675145|FG000|Overall Study|Adverse Event|9|||
128012929|NCT00764517|460675146|FG001|Overall Study|Adverse Event|3|||
128012930|NCT00764517|460675145|FG000|Overall Study|Death|3|||
128012931|NCT00764517|460675146|FG001|Overall Study|Death|11|||
128012932|NCT00764517|460675145|FG000|Overall Study|Physician Decision|3|||
128012933|NCT00764517|460675146|FG001|Overall Study|Physician Decision|0|||
128012934|NCT03813654|460675153|FG000|Overall Study|Protocol Violation|0|||
128012935|NCT03813654|460675154|FG001|Overall Study|Protocol Violation|1|||
128012936|NCT03813654|460675155|FG002|Overall Study|Protocol Violation|2|||
128012937|NCT03813654|460675153|FG000|Overall Study|Withdrawal by Subject|1|||
128012938|NCT03813654|460675154|FG001|Overall Study|Withdrawal by Subject|0|||
128012939|NCT03813654|460675155|FG002|Overall Study|Withdrawal by Subject|0|||
127765552|NCT01874431|459767813|FG003|Overall Study|Sponsor decision|0|||
127765553|NCT01874431|459767814|FG004|Overall Study|Sponsor decision|1|||
127765554|NCT01874431|459767815|FG005|Overall Study|Sponsor decision|0|||
128012940|NCT01208051|460675157|FG000|Total Enrollment|Withdrawal by Subject|0|||
128012941|NCT01208051|460675158|FG001|Total Enrollment|Withdrawal by Subject|1|||
128012942|NCT01208051|460675159|FG002|Total Enrollment|Withdrawal by Subject|0|||
128012943|NCT01208051|460675160|FG003|Total Enrollment|Withdrawal by Subject|0|||
127765555|NCT01874431|459767816|FG006|Overall Study|Sponsor decision|0|||
127765556|NCT01874431|459767817|FG007|Overall Study|Sponsor decision|0|||
127765557|NCT01874431|459767810|FG000|Overall Study|Lost to Follow-up|0|||
128012944|NCT01208051|460675161|FG004|Total Enrollment|Withdrawal by Subject|2|||
128012945|NCT01208051|460675157|FG000|Total Enrollment|Brain metastases|0|||
128012946|NCT01208051|460675158|FG001|Total Enrollment|Brain metastases|0|||
128012947|NCT01208051|460675159|FG002|Total Enrollment|Brain metastases|1|||
128012948|NCT01208051|460675160|FG003|Total Enrollment|Brain metastases|0|||
128012949|NCT01208051|460675161|FG004|Total Enrollment|Brain metastases|0|||
127678248|NCT00995709|459444645|FG002|Overall Study|Lack of Efficacy|4|||
127678249|NCT00995709|459444643|FG000|Overall Study|Withdrawal by Subject|0|||
127678250|NCT00995709|459444644|FG001|Overall Study|Withdrawal by Subject|4|||
127678251|NCT00995709|459444645|FG002|Overall Study|Withdrawal by Subject|1|||
127678252|NCT00995709|459444643|FG000|Overall Study|Lost to Follow-up|1|||
127678253|NCT00995709|459444644|FG001|Overall Study|Lost to Follow-up|0|||
127678254|NCT00995709|459444645|FG002|Overall Study|Lost to Follow-up|0|||
127678255|NCT00995709|459444643|FG000|Overall Study|Death|0|||
127678256|NCT00995709|459444644|FG001|Overall Study|Death|1|||
127678257|NCT00995709|459444645|FG002|Overall Study|Death|0|||
127678258|NCT00995709|459444643|FG000|Overall Study|Protocol Violation|2|||
127678259|NCT00995709|459444644|FG001|Overall Study|Protocol Violation|1|||
127678260|NCT00995709|459444645|FG002|Overall Study|Protocol Violation|0|||
127678261|NCT01697319|459444646|FG000|Primary Phase|Withdrawal by Subject|1|||
127678262|NCT01697319|459444646|FG000|Extension Phase|Terminated by Sponsor|15|||
127678263|NCT04222959|459444647|FG000|Overall Study|Lost to Follow-up|76|||
127678264|NCT04222959|459444648|FG001|Overall Study|Lost to Follow-up|28|||
127678265|NCT03008915|459444649|FG000|Treatment 1|Withdrawal by Subject|0|||
127678266|NCT03008915|459444650|FG001|Treatment 1|Withdrawal by Subject|1|||
127678267|NCT00712166|459444651|FG000|Overall Study|Noncompliance|0|||
127678268|NCT00712166|459444652|FG001|Overall Study|Noncompliance|1|||
127678269|NCT01769391|459444653|FG000|Overall Study|Death|10|||
127678270|NCT01769391|459444654|FG001|Overall Study|Death|1|||
127678271|NCT01769391|459444653|FG000|Overall Study|Adverse Event|0|||
127678272|NCT01769391|459444654|FG001|Overall Study|Adverse Event|3|||
127678273|NCT01769391|459444653|FG000|Overall Study|Progressive Disease|1|||
127678274|NCT01769391|459444654|FG001|Overall Study|Progressive Disease|2|||
127678275|NCT01769391|459444653|FG000|Overall Study|Withdrawal by Subject|4|||
127678276|NCT01769391|459444654|FG001|Overall Study|Withdrawal by Subject|3|||
127678277|NCT01769391|459444653|FG000|Overall Study|Investigator Decision|2|||
127678278|NCT01769391|459444654|FG001|Overall Study|Investigator Decision|0|||
127678279|NCT03227757|459446418|FG000|Overall Study|Death|25|||
127678280|NCT03227757|459446418|FG000|Overall Study|Withdrawal|10|||
127678281|NCT03227757|459446418|FG000|Overall Study|Missed visits|1|||
127678282|NCT03227757|459446418|FG000|Overall Study|Lost to Follow-up|2|||
127678283|NCT01144468|459446419|FG000|Overall Study|Lost to Follow-up|4|||
127678284|NCT01144468|459446420|FG001|Overall Study|Lost to Follow-up|7|||
127678285|NCT01144468|459446419|FG000|Overall Study|Adverse Event|3|||
127678286|NCT01144468|459446420|FG001|Overall Study|Adverse Event|2|||
127678287|NCT01144468|459446419|FG000|Overall Study|did not reach 2 year follow up at time of clinical cut off|45|||
127678288|NCT01144468|459446420|FG001|Overall Study|did not reach 2 year follow up at time of clinical cut off|48|||
127678289|NCT01875250|459446423|FG000|Overall Study|Adverse Event|2|||
127678290|NCT01875250|459446424|FG001|Overall Study|Adverse Event|0|||
127678291|NCT00149630|459446430|FG000|Overall Study|Incarceration|2|||
127678292|NCT00149630|459446431|FG001|Overall Study|Incarceration|0|||
127678293|NCT00149630|459446430|FG000|Overall Study|Treatment Programs|4|||
127678294|NCT00149630|459446431|FG001|Overall Study|Treatment Programs|5|||
127678295|NCT00149630|459446430|FG000|Overall Study|Adverse Event|2|||
127678296|NCT00149630|459446431|FG001|Overall Study|Adverse Event|0|||
127678297|NCT05298111|459446433|FG000|Washout (3 Days)|Withdrawal by Subject|3|||
127678298|NCT05298111|459446434|FG001|Washout (3 Days)|Withdrawal by Subject|3|||
127678299|NCT02689349|459446435|FG000|Overall Study|Not implanted|4|||
127678300|NCT02689349|459446436|FG001|Overall Study|Not implanted|0|||
127678301|NCT02689349|459446435|FG000|Overall Study|Withdrawal by Subject|9|||
127678302|NCT02689349|459446436|FG001|Overall Study|Withdrawal by Subject|0|||
127678303|NCT03518112|459446437|FG000|Overall Study|Withdrawal by Subject|1|||
127678304|NCT01546155|459446438|FG000|Overall Study|could not tolerate long scan duration|3|||
127678305|NCT02034916|459446439|FG000|Overall Study|Death|39|||
127678306|NCT02034916|459446440|FG001|Overall Study|Death|28|||
127678307|NCT02034916|459446439|FG000|Overall Study|Withdrawal by Subject|2|||
127678308|NCT02034916|459446440|FG001|Overall Study|Withdrawal by Subject|1|||
127678309|NCT02034916|459446439|FG000|Overall Study|Lost to Follow-up|4|||
127678310|NCT02034916|459446440|FG001|Overall Study|Lost to Follow-up|1|||
127678311|NCT02034916|459446439|FG000|Overall Study|Study terminated by sponsor|4|||
127678312|NCT02034916|459446440|FG001|Overall Study|Study terminated by sponsor|5|||
127678313|NCT01616654|459446445|FG000|Overall Study|Lack of Efficacy|1|||
127678314|NCT01616654|459446446|FG001|Overall Study|Lack of Efficacy|0|||
127678315|NCT01616654|459446447|FG002|Overall Study|Lack of Efficacy|0|||
127678316|NCT01616654|459446448|FG003|Overall Study|Lack of Efficacy|0|||
127678317|NCT01616654|459446449|FG004|Overall Study|Lack of Efficacy|1|||
127765558|NCT01874431|459767811|FG001|Overall Study|Lost to Follow-up|0|||
127765559|NCT01874431|459767812|FG002|Overall Study|Lost to Follow-up|1|||
127765560|NCT01874431|459767813|FG003|Overall Study|Lost to Follow-up|0|||
127765561|NCT01874431|459767814|FG004|Overall Study|Lost to Follow-up|0|||
127765562|NCT01874431|459767815|FG005|Overall Study|Lost to Follow-up|0|||
127765563|NCT01874431|459767816|FG006|Overall Study|Lost to Follow-up|0|||
127765564|NCT01874431|459767817|FG007|Overall Study|Lost to Follow-up|0|||
127765565|NCT00738582|459767820|FG000|Combination Therapy|Completed Combination Therapy|1|||
127765566|NCT00738582|459767821|FG001|Combination Therapy|Completed Combination Therapy|0|||
127765567|NCT00738582|459767820|FG000|Combination Therapy|Physician Decision|1|||
127765568|NCT00738582|459767821|FG001|Combination Therapy|Physician Decision|0|||
127765569|NCT00738582|459767820|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
127765570|NCT00738582|459767821|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
127765571|NCT00738582|459767820|FG000|Combination Therapy|Other|5|||
127765572|NCT00738582|459767821|FG001|Combination Therapy|Other|0|||
127765573|NCT00738582|459767820|FG000|Combination Therapy|Adverse Event|16|||
127765574|NCT00738582|459767821|FG001|Combination Therapy|Adverse Event|0|||
127765575|NCT00738582|459767820|FG000|Combination Therapy|Progressive Disease|9|||
127765576|NCT00738582|459767821|FG001|Combination Therapy|Progressive Disease|0|||
127765577|NCT00738582|459767820|FG000|Maintenance Therapy|Other|0|||
127765578|NCT00738582|459767821|FG001|Maintenance Therapy|Other|2|||
127765579|NCT00738582|459767820|FG000|Maintenance Therapy|Adverse Event|0|||
127765580|NCT00738582|459767821|FG001|Maintenance Therapy|Adverse Event|6|||
127765581|NCT00738582|459767820|FG000|Maintenance Therapy|Progressive Disease|0|||
127765582|NCT00738582|459767821|FG001|Maintenance Therapy|Progressive Disease|47|||
127765583|NCT00738582|459767820|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
127765584|NCT00738582|459767821|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
127765585|NCT00642772|459767822|FG000|Overall Study|Lost to Follow-up|3|||
127765586|NCT00642772|459767822|FG000|Overall Study|Withdrawal by Subject|7|||
127765587|NCT00545051|459767823|FG000|Overall Study|Adverse Event|7|||
127765588|NCT00545051|459767824|FG001|Overall Study|Adverse Event|3|||
127765589|NCT00545051|459767823|FG000|Overall Study|Death|1|||
127765590|NCT00545051|459767824|FG001|Overall Study|Death|0|||
127765591|NCT00545051|459767823|FG000|Overall Study|Violation of inclusion/exclusion|0|||
127765592|NCT00545051|459767824|FG001|Overall Study|Violation of inclusion/exclusion|2|||
127765593|NCT00545051|459767823|FG000|Overall Study|Protocol Violation|1|||
127765594|NCT00545051|459767824|FG001|Overall Study|Protocol Violation|0|||
127765595|NCT00545051|459767823|FG000|Overall Study|Withdrawal by Subject|0|||
127765596|NCT00545051|459767824|FG001|Overall Study|Withdrawal by Subject|1|||
127765597|NCT00545051|459767823|FG000|Overall Study|Administrative reasons|0|||
127765598|NCT00545051|459767824|FG001|Overall Study|Administrative reasons|1|||
127765599|NCT00903006|459767825|FG000|Overall Study|Withdrawal by Subject|2|||
127765600|NCT00903006|459767826|FG001|Overall Study|Withdrawal by Subject|0|||
127765601|NCT00903006|459767827|FG002|Overall Study|Withdrawal by Subject|0|||
127765602|NCT00903006|459767828|FG003|Overall Study|Withdrawal by Subject|0|||
127765603|NCT00903006|459767825|FG000|Overall Study|Progressive Disease|0|||
128012950|NCT00973973|460675166|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
128012951|NCT00973973|460675167|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
128012952|NCT00973973|460675166|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
128012953|NCT00973973|460675167|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
128012954|NCT00973973|460675166|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
128012955|NCT00973973|460675167|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
128012956|NCT00973973|460675166|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
128012957|NCT00973973|460675167|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
128012958|NCT00973973|460675166|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
128012959|NCT00973973|460675167|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
128012960|NCT00973973|460675166|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
128012961|NCT00973973|460675167|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
128012962|NCT00973973|460675166|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
128012963|NCT00973973|460675167|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
128012964|NCT00973973|460675166|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
128012965|NCT00973973|460675167|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
128012966|NCT00973973|460675166|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
128012967|NCT00973973|460675167|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
127765604|NCT00903006|459767826|FG001|Overall Study|Progressive Disease|3|||
127765605|NCT00903006|459767827|FG002|Overall Study|Progressive Disease|1|||
127765606|NCT00903006|459767828|FG003|Overall Study|Progressive Disease|0|||
127765607|NCT03271021|459767832|FG000|Overall Study|Adverse Event|3|||
127765608|NCT03271021|459767833|FG001|Overall Study|Adverse Event|2|||
127765609|NCT03271021|459767832|FG000|Overall Study|Withdrawal by Subject|36|||
127765610|NCT03271021|459767833|FG001|Overall Study|Withdrawal by Subject|53|||
127765611|NCT03271021|459767832|FG000|Overall Study|Lost to Follow-up|34|||
127765612|NCT03271021|459767833|FG001|Overall Study|Lost to Follow-up|39|||
127765613|NCT03271021|459767832|FG000|Overall Study|Protocol Violation|6|||
128012968|NCT00973973|460675166|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
128012969|NCT00973973|460675167|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
128012970|NCT00973973|460675166|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
128012971|NCT00973973|460675167|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
128012972|NCT00973973|460675166|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
128012973|NCT00973973|460675167|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
128012974|NCT00671060|460675168|FG000|Overall Study|Protocol Violation|1|||
128012975|NCT00671060|460675169|FG001|Overall Study|Protocol Violation|0|||
128012976|NCT00671060|460675168|FG000|Overall Study|Physician Decision|0|||
128012977|NCT00671060|460675169|FG001|Overall Study|Physician Decision|1|||
128012978|NCT06057064|460675170|FG000|Overall Study|Death|2|||
128012979|NCT06057064|460675171|FG001|Overall Study|Death|0|||
128012980|NCT06057064|460675170|FG000|Overall Study|Physician Decision|1|||
128012981|NCT06057064|460675171|FG001|Overall Study|Physician Decision|0|||
127765614|NCT03271021|459767833|FG001|Overall Study|Protocol Violation|4|||
127765615|NCT03271021|459767832|FG000|Overall Study|Abnormal Lab Results|1|||
127765616|NCT03271021|459767833|FG001|Overall Study|Abnormal Lab Results|0|||
128012982|NCT06057064|460675170|FG000|Overall Study|Withdrawal by Subject|1|||
127678318|NCT01616654|459446445|FG000|Overall Study|Adverse Event|0|||
127678319|NCT01616654|459446446|FG001|Overall Study|Adverse Event|1|||
127678320|NCT01616654|459446447|FG002|Overall Study|Adverse Event|2|||
127678321|NCT01616654|459446448|FG003|Overall Study|Adverse Event|1|||
127678322|NCT01616654|459446449|FG004|Overall Study|Adverse Event|0|||
127678323|NCT01616654|459446445|FG000|Overall Study|Withdrawal by Subject|2|||
127678324|NCT01616654|459446446|FG001|Overall Study|Withdrawal by Subject|2|||
127678325|NCT01616654|459446447|FG002|Overall Study|Withdrawal by Subject|3|||
127678326|NCT01616654|459446448|FG003|Overall Study|Withdrawal by Subject|1|||
127678327|NCT01616654|459446449|FG004|Overall Study|Withdrawal by Subject|5|||
127678328|NCT01616654|459446445|FG000|Overall Study|Protocol Violation|0|||
127678329|NCT01616654|459446446|FG001|Overall Study|Protocol Violation|5|||
127678330|NCT01616654|459446447|FG002|Overall Study|Protocol Violation|2|||
127678331|NCT01616654|459446448|FG003|Overall Study|Protocol Violation|4|||
127678332|NCT01616654|459446449|FG004|Overall Study|Protocol Violation|4|||
127678333|NCT01616654|459446445|FG000|Overall Study|Lost to Follow-up|1|||
127678334|NCT01616654|459446446|FG001|Overall Study|Lost to Follow-up|0|||
127678335|NCT01616654|459446447|FG002|Overall Study|Lost to Follow-up|3|||
127678336|NCT01616654|459446448|FG003|Overall Study|Lost to Follow-up|2|||
127678337|NCT01616654|459446449|FG004|Overall Study|Lost to Follow-up|1|||
127678338|NCT01616654|459446445|FG000|Overall Study|Pregnancy|1|||
127678339|NCT01616654|459446446|FG001|Overall Study|Pregnancy|0|||
127678340|NCT01616654|459446447|FG002|Overall Study|Pregnancy|0|||
127678341|NCT01616654|459446448|FG003|Overall Study|Pregnancy|0|||
127678342|NCT01616654|459446449|FG004|Overall Study|Pregnancy|1|||
127678343|NCT02057692|459446453|FG000|Overall Study|Adverse Event|1|||
127678344|NCT02057692|459446454|FG001|Overall Study|Adverse Event|0|||
127678345|NCT02057692|459446455|FG002|Overall Study|Adverse Event|0|||
127678346|NCT02057692|459446456|FG003|Overall Study|Adverse Event|0|||
127678347|NCT02057692|459446453|FG000|Overall Study|Lost to Follow-up|0|||
127678348|NCT02057692|459446454|FG001|Overall Study|Lost to Follow-up|0|||
127678349|NCT02057692|459446455|FG002|Overall Study|Lost to Follow-up|0|||
127678350|NCT02057692|459446456|FG003|Overall Study|Lost to Follow-up|1|||
127678351|NCT00864682|459446457|FG000|Overall Study|Protocol Violation|2|||
127678352|NCT00864682|459446458|FG001|Overall Study|Protocol Violation|1|||
127678353|NCT00864682|459446459|FG002|Overall Study|Protocol Violation|2|||
127678354|NCT00545844|459446460|FG000|Overall Study|Lost to Follow-up|9|||
127678355|NCT00545844|459446460|FG000|Overall Study|Protocol Violation|1|||
127678356|NCT00545844|459446460|FG000|Overall Study|Withdrawal by Subject|2|||
127678357|NCT00957658|459446461|FG000|Overall Study|Death|1|||
127678358|NCT00957658|459446461|FG000|Overall Study|Lost to Follow-up|4|||
127678359|NCT00957658|459446461|FG000|Overall Study|Withdrawal by Subject|12|||
127678360|NCT00957658|459446461|FG000|Overall Study|Revision|1|||
127678361|NCT00957658|459446461|FG000|Overall Study|Incomplete 2 yr data|28|||
127678362|NCT00957658|459446461|FG000|Overall Study|Site termination|10|||
127678363|NCT00957658|459446461|FG000|Overall Study|unwilling/unable to return|2|||
127678364|NCT00957658|459446461|FG000|Overall Study|surgery cancelled|2|||
127678365|NCT00957658|459446461|FG000|Overall Study|Protocol Violation|5|||
127765617|NCT03271021|459767832|FG000|Overall Study|Miscellaneous|9|||
128012983|NCT06057064|460675171|FG001|Overall Study|Withdrawal by Subject|1|||
128012984|NCT01541748|460675172|FG000|Overall Study|Lost to Follow-up|17|||
128012985|NCT01541748|460675172|FG000|Overall Study|Moved out of state|1|||
127678366|NCT00975806|459446462|FG000|Overall Study|Adverse Event|2|||
127678367|NCT00975806|459446463|FG001|Overall Study|Adverse Event|1|||
127678368|NCT00975806|459446464|FG002|Overall Study|Adverse Event|2|||
127678369|NCT00975806|459446462|FG000|Overall Study|Disease Progression|1|||
127678370|NCT00975806|459446463|FG001|Overall Study|Disease Progression|5|||
127678371|NCT00975806|459446464|FG002|Overall Study|Disease Progression|1|||
127678372|NCT00975806|459446462|FG000|Overall Study|Withdrawal by Subject|1|||
127678373|NCT00975806|459446463|FG001|Overall Study|Withdrawal by Subject|0|||
127678374|NCT00975806|459446464|FG002|Overall Study|Withdrawal by Subject|0|||
128012986|NCT01541748|460675172|FG000|Overall Study|Withdrawal by Subject|7|||
128012987|NCT01541748|460675172|FG000|Overall Study|Screen failure|5|||
128012988|NCT01541748|460675172|FG000|Overall Study|Did not receive study device|1|||
128012989|NCT02020941|460675173|FG000|Overall Study|Adverse Event|1|||
128012990|NCT02020941|460675173|FG000|Overall Study|Physician Decision|2|||
128012991|NCT02020941|460675173|FG000|Overall Study|Withdrawal by Subject|1|||
128012992|NCT02020941|460675173|FG000|Overall Study|Disease Progression|4|||
128012993|NCT02832037|460675174|FG000|Overall Study|Administrative reasons|0|||
128012994|NCT02832037|460675175|FG001|Overall Study|Administrative reasons|0|||
128012995|NCT02832037|460675176|FG002|Overall Study|Administrative reasons|1|||
128012996|NCT02832037|460675177|FG003|Overall Study|Administrative reasons|0|||
128012997|NCT02832037|460675178|FG004|Overall Study|Administrative reasons|0|||
128012998|NCT02832037|460675174|FG000|Overall Study|Protocol Violation|3|||
128012999|NCT02832037|460675175|FG001|Overall Study|Protocol Violation|0|||
128013000|NCT02832037|460675176|FG002|Overall Study|Protocol Violation|4|||
128013001|NCT02832037|460675177|FG003|Overall Study|Protocol Violation|1|||
128013002|NCT02832037|460675178|FG004|Overall Study|Protocol Violation|2|||
128013003|NCT02832037|460675174|FG000|Overall Study|Lost to Follow-up|2|||
128013004|NCT02832037|460675175|FG001|Overall Study|Lost to Follow-up|0|||
128013005|NCT02832037|460675176|FG002|Overall Study|Lost to Follow-up|3|||
128013006|NCT02832037|460675177|FG003|Overall Study|Lost to Follow-up|0|||
128013007|NCT02832037|460675178|FG004|Overall Study|Lost to Follow-up|5|||
128013008|NCT02832037|460675174|FG000|Overall Study|Withdrawal by Subject|9|||
128013009|NCT02832037|460675175|FG001|Overall Study|Withdrawal by Subject|8|||
128013010|NCT02832037|460675176|FG002|Overall Study|Withdrawal by Subject|0|||
128013011|NCT02832037|460675177|FG003|Overall Study|Withdrawal by Subject|4|||
128013012|NCT02832037|460675178|FG004|Overall Study|Withdrawal by Subject|8|||
128013013|NCT02832037|460675174|FG000|Overall Study|Adverse Event|5|||
128013014|NCT02832037|460675175|FG001|Overall Study|Adverse Event|4|||
128013015|NCT02832037|460675176|FG002|Overall Study|Adverse Event|0|||
128013016|NCT02832037|460675177|FG003|Overall Study|Adverse Event|2|||
128013017|NCT02832037|460675178|FG004|Overall Study|Adverse Event|4|||
128013018|NCT02107898|460675182|FG000|Overall Study|Adverse Event|4|||
128013019|NCT02107898|460675183|FG001|Overall Study|Adverse Event|7|||
128013020|NCT02107898|460675182|FG000|Overall Study|Poor compliance to protocol|0|||
128013021|NCT02107898|460675183|FG001|Overall Study|Poor compliance to protocol|1|||
128013022|NCT02107898|460675182|FG000|Overall Study|Participant moved|0|||
128013023|NCT02107898|460675183|FG001|Overall Study|Participant moved|2|||
127765618|NCT03271021|459767833|FG001|Overall Study|Miscellaneous|8|||
127765619|NCT01383499|459767834|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
127765620|NCT01383499|459767835|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
127765621|NCT01383499|459767836|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
127765622|NCT01383499|459767837|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
127765623|NCT04275089|459767840|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
127765624|NCT01079663|459767841|FG000|Overall Study|Adverse Event|0|||
127765625|NCT01079663|459767842|FG001|Overall Study|Adverse Event|2|||
127765626|NCT01079663|459767841|FG000|Overall Study|Protocol Violation|0|||
127765627|NCT01079663|459767842|FG001|Overall Study|Protocol Violation|2|||
127765628|NCT00297232|459767843|FG000|Overall Study|Lack of Efficacy|7|||
127765629|NCT00297232|459767843|FG000|Overall Study|Lost to Follow-up|10|||
127765630|NCT00297232|459767843|FG000|Overall Study|Adverse Event|63|||
127765631|NCT00297232|459767843|FG000|Overall Study|Voluntary Withdrawal|120|||
127765632|NCT00297232|459767843|FG000|Overall Study|Subject was Noncompliant|9|||
127765633|NCT00297232|459767843|FG000|Overall Study|Death|9|||
127765634|NCT00297232|459767843|FG000|Overall Study|Anti-natalizumab Positive|8|||
127765635|NCT00297232|459767843|FG000|Overall Study|Switched to Commercial Tysabri|22|||
127765636|NCT00297232|459767843|FG000|Overall Study|Disease Progression|8|||
127765637|NCT00297232|459767843|FG000|Overall Study|Fear of PML|10|||
127765638|NCT00297232|459767843|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
127765639|NCT00297232|459767843|FG000|Overall Study|Miscellaneous|5|||
127765640|NCT00297232|459767843|FG000|Overall Study|Sponsor Decision|34|||
127765641|NCT00297232|459767843|FG000|Overall Study|Subject Relocated|7|||
127765642|NCT00297232|459767843|FG000|Overall Study|Subject Withdrew Consent|37|||
128013024|NCT02107898|460675182|FG000|Overall Study|Consent withdrawn by participant|2|||
128013025|NCT02107898|460675183|FG001|Overall Study|Consent withdrawn by participant|1|||
128013026|NCT02107898|460675182|FG000|Overall Study|Randomized but not treated|0|||
127765643|NCT00297232|459767843|FG000|Overall Study|Persistently Positive Antibodies|11|||
128013027|NCT02107898|460675183|FG001|Overall Study|Randomized but not treated|1|||
128013028|NCT03329989|460675184|FG000|Overall Study|Withdrawal by Subject|9|||
128013029|NCT03329989|460675184|FG000|Overall Study|Lost to Follow-up|8|||
127765644|NCT00297232|459767843|FG000|Overall Study|Investigator Withdrew From Program|19|||
127765645|NCT00297232|459767843|FG000|Overall Study|Did Not Enroll to Week 264|34|||
127765646|NCT00297232|459767843|FG000|Overall Study|Did Not Enroll to Week 480|17|||
127765647|NCT00297232|459767843|FG000|Overall Study|No data available after Week 264|161|||
127765648|NCT00297232|459767843|FG000|Overall Study|Other|1|||
127765649|NCT03038438|459767844|FG000|Overall Study|Death|3|||
128013030|NCT03329989|460675184|FG000|Overall Study|Adverse Event|5|||
128013031|NCT03329989|460675184|FG000|Overall Study|Protocol Violation|1|||
128013032|NCT01283386|460675189|FG000|Overall Study|Death|2|||
128013033|NCT01283386|460675190|FG001|Overall Study|Death|0|||
128013034|NCT01283386|460675189|FG000|Overall Study|Withdrawal by Subject|2|||
128013035|NCT01283386|460675190|FG001|Overall Study|Withdrawal by Subject|1|||
128013036|NCT01283386|460675189|FG000|Overall Study|Relapse of underlying disease|1|||
128013037|NCT01283386|460675190|FG001|Overall Study|Relapse of underlying disease|3|||
128013038|NCT01283386|460675189|FG000|Overall Study|Progression of underlying disease|2|||
128013039|NCT01283386|460675190|FG001|Overall Study|Progression of underlying disease|7|||
128013040|NCT01283386|460675189|FG000|Overall Study|Reason not specified|1|||
128013041|NCT01283386|460675190|FG001|Overall Study|Reason not specified|0|||
128013042|NCT01283386|460675189|FG000|Overall Study|Protocol Violation|0|||
128013043|NCT01283386|460675190|FG001|Overall Study|Protocol Violation|1|||
128013044|NCT01531153|460675193|FG000|Overall Study|Withdrawal by Subject|10|||
128013045|NCT01531153|460675194|FG001|Overall Study|Withdrawal by Subject|9|||
128013046|NCT01531153|460675195|FG002|Overall Study|Withdrawal by Subject|15|||
128013047|NCT03517137|460675197|FG000|Overall Study|Lack of Efficacy|1|||
128013048|NCT03517137|460675197|FG000|Overall Study|Adverse Event|2|||
127678375|NCT00975806|459446462|FG000|Overall Study|Death|0|||
127678376|NCT00975806|459446463|FG001|Overall Study|Death|1|||
127678377|NCT00975806|459446464|FG002|Overall Study|Death|0|||
127678378|NCT00975806|459446462|FG000|Overall Study|Physician decision and disease related|1|||
127678379|NCT00975806|459446463|FG001|Overall Study|Physician decision and disease related|0|||
127678380|NCT00975806|459446464|FG002|Overall Study|Physician decision and disease related|1|||
127678381|NCT02377362|459446465|FG000|Part A Second Treatment|Protocol Violation|0|||
127678382|NCT02377362|459446466|FG001|Part A Second Treatment|Protocol Violation|0|||
127678383|NCT02377362|459446467|FG002|Part A Second Treatment|Protocol Violation|0|||
127678384|NCT02377362|459446468|FG003|Part A Second Treatment|Protocol Violation|0|||
127678385|NCT02377362|459446469|FG004|Part A Second Treatment|Protocol Violation|1|||
127678386|NCT02377362|459446470|FG005|Part A Second Treatment|Protocol Violation|0|||
127678387|NCT02377362|459446471|FG006|Part A Second Treatment|Protocol Violation|0|||
127678388|NCT02377362|459446472|FG007|Part A Second Treatment|Protocol Violation|0|||
127678389|NCT02377362|459446473|FG008|Part A Second Treatment|Protocol Violation|0|||
127678390|NCT02377362|459446474|FG009|Part A Second Treatment|Protocol Violation|0|||
127678391|NCT02377362|459446475|FG010|Part A Second Treatment|Protocol Violation|0|||
127678392|NCT02377362|459446476|FG011|Part A Second Treatment|Protocol Violation|0|||
127678393|NCT02377362|459446477|FG012|Part A Second Treatment|Protocol Violation|0|||
127678394|NCT02377362|459446465|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
127678395|NCT02377362|459446466|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
127678396|NCT02377362|459446467|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
127678397|NCT02377362|459446468|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
127678398|NCT02377362|459446469|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
127678399|NCT02377362|459446470|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
127678400|NCT02377362|459446471|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
127678401|NCT02377362|459446472|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
127678402|NCT02377362|459446473|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
127678403|NCT02377362|459446474|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
127678404|NCT02377362|459446475|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
127678405|NCT02377362|459446476|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
127678406|NCT02377362|459446477|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
127678407|NCT02377362|459446465|FG000|Part B Overall|Protocol Violation|0|||
127678408|NCT02377362|459446466|FG001|Part B Overall|Protocol Violation|0|||
127678409|NCT02377362|459446467|FG002|Part B Overall|Protocol Violation|0|||
127678410|NCT02377362|459446468|FG003|Part B Overall|Protocol Violation|0|||
127678411|NCT02377362|459446469|FG004|Part B Overall|Protocol Violation|0|||
127678412|NCT02377362|459446470|FG005|Part B Overall|Protocol Violation|0|||
127678413|NCT02377362|459446471|FG006|Part B Overall|Protocol Violation|0|||
127678414|NCT02377362|459446472|FG007|Part B Overall|Protocol Violation|0|||
127678415|NCT02377362|459446473|FG008|Part B Overall|Protocol Violation|0|||
127678416|NCT02377362|459446474|FG009|Part B Overall|Protocol Violation|1|||
127678417|NCT02377362|459446475|FG010|Part B Overall|Protocol Violation|0|||
127678418|NCT02377362|459446476|FG011|Part B Overall|Protocol Violation|0|||
127678419|NCT02377362|459446477|FG012|Part B Overall|Protocol Violation|0|||
127678420|NCT02377362|459446465|FG000|Part B Overall|Adverse Event|0|||
127678421|NCT02377362|459446466|FG001|Part B Overall|Adverse Event|0|||
127678422|NCT02377362|459446467|FG002|Part B Overall|Adverse Event|0|||
127678423|NCT02377362|459446468|FG003|Part B Overall|Adverse Event|0|||
127678424|NCT02377362|459446469|FG004|Part B Overall|Adverse Event|0|||
128013049|NCT03517137|460675197|FG000|Overall Study|Withdrawal by Subject|2|||
128013050|NCT03517137|460675197|FG000|Overall Study|Poor therapy tolerance, ineligibility, AE, error in treatment administration|4|||
128013051|NCT01582451|460675198|FG000|Overall Study|Adverse Event|1|||
127678425|NCT02377362|459446470|FG005|Part B Overall|Adverse Event|0|||
127678426|NCT02377362|459446471|FG006|Part B Overall|Adverse Event|1|||
127678427|NCT02377362|459446472|FG007|Part B Overall|Adverse Event|1|||
127678428|NCT02377362|459446473|FG008|Part B Overall|Adverse Event|0|||
127765650|NCT03038438|459767844|FG000|Overall Study|Lost to Follow-up|8|||
127765651|NCT03038438|459767844|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
127765652|NCT03038438|459767844|FG000|Overall Study|Withdrawal by Subject|5|||
127765653|NCT03038438|459767844|FG000|Overall Study|No 36-Month Follow-Up|18|||
127765654|NCT03625895|459767845|FG000|Overall Study|Protocol Violation|585|||
127765655|NCT02476279|459767846|FG000|Overall Study|Lost to Follow-up|1|||
127765656|NCT02476279|459767847|FG001|Overall Study|Lost to Follow-up|1|||
127765657|NCT00577473|459767848|FG000|Overall Study|Protocol Violation|1|||
127765658|NCT00577473|459767849|FG001|Overall Study|Protocol Violation|4|||
127765659|NCT00577473|459767848|FG000|Overall Study|Adverse Event|8|||
127765660|NCT00577473|459767849|FG001|Overall Study|Adverse Event|5|||
127765661|NCT00577473|459767848|FG000|Overall Study|Withdrawal by Subject|2|||
127765662|NCT00577473|459767849|FG001|Overall Study|Withdrawal by Subject|6|||
127765663|NCT00577473|459767848|FG000|Overall Study|Physician Decision|2|||
127765664|NCT00577473|459767849|FG001|Overall Study|Physician Decision|2|||
127765665|NCT00577473|459767848|FG000|Overall Study|Lack of Efficacy|8|||
127765666|NCT00577473|459767849|FG001|Overall Study|Lack of Efficacy|7|||
127765667|NCT00577577|459767851|FG000|Overall Study|Adverse Event|3|||
127765668|NCT00577577|459767852|FG001|Overall Study|Adverse Event|2|||
127765669|NCT00577577|459767851|FG000|Overall Study|Lost to Follow-up|1|||
127765670|NCT00577577|459767852|FG001|Overall Study|Lost to Follow-up|0|||
127765671|NCT00577577|459767851|FG000|Overall Study|Protocol Violation|0|||
127765672|NCT00577577|459767852|FG001|Overall Study|Protocol Violation|3|||
127765673|NCT00577577|459767851|FG000|Overall Study|Transportation|1|||
127765674|NCT00577577|459767852|FG001|Overall Study|Transportation|0|||
127765675|NCT00232544|459767857|FG000|Overall Study|Lost to Follow-up|20|||
127765676|NCT00232544|459767858|FG001|Overall Study|Lost to Follow-up|15|||
127765677|NCT00986973|459767859|FG000|Overall Study|Withdrawn by study team|1|||
127765678|NCT01465347|459767860|FG000|Overall Study|Withdrawal by Subject|1|||
127765679|NCT01465347|459767861|FG001|Overall Study|Withdrawal by Subject|1|||
127765680|NCT01465347|459767860|FG000|Overall Study|Physician Decision|0|||
127765681|NCT01465347|459767861|FG001|Overall Study|Physician Decision|1|||
127765682|NCT01465347|459767860|FG000|Overall Study|Admitted to hospice|0|||
127765683|NCT01465347|459767861|FG001|Overall Study|Admitted to hospice|1|||
127765684|NCT01590082|459767862|FG000|Overall Study|Withdrawal by Subject|1|||
127765685|NCT01590082|459767863|FG001|Overall Study|Withdrawal by Subject|0|||
127765686|NCT01590082|459767862|FG000|Overall Study|Ineligible|1|||
127765687|NCT01590082|459767863|FG001|Overall Study|Ineligible|0|||
127765688|NCT02414932|459767864|FG000|Overall Study|Withdrawal by Subject|2|||
127765689|NCT02414932|459767865|FG001|Overall Study|Withdrawal by Subject|3|||
127765690|NCT02414932|459767864|FG000|Overall Study|Adverse Event|1|||
127765691|NCT02414932|459767865|FG001|Overall Study|Adverse Event|0|||
127765692|NCT01210664|459767867|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
127765693|NCT01210664|459767868|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
127765694|NCT01210664|459767869|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
127765695|NCT01210664|459767870|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
127765696|NCT01210664|459767867|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
127765697|NCT01210664|459767868|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
127765698|NCT01210664|459767869|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
128013052|NCT01582451|460675199|FG001|Overall Study|Adverse Event|3|||
127765699|NCT01210664|459767870|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
127765700|NCT01210664|459767867|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
127765701|NCT01210664|459767868|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
127765702|NCT01210664|459767869|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
128013053|NCT01582451|460675198|FG000|Overall Study|Death|3|||
128013054|NCT01582451|460675199|FG001|Overall Study|Death|3|||
128013055|NCT01582451|460675198|FG000|Overall Study|Lost to Follow-up|0|||
127765703|NCT01210664|459767870|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
127765704|NCT01853644|459767871|FG000|Registration and Treatment Start|Did not start treatment|1|||
127765705|NCT01853644|459767871|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
127765706|NCT01853644|459767871|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
127765707|NCT01853644|459767871|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
128013056|NCT01582451|460675199|FG001|Overall Study|Lost to Follow-up|2|||
128013057|NCT01582451|460675198|FG000|Overall Study|Protocol Violation|11|||
128013058|NCT01582451|460675199|FG001|Overall Study|Protocol Violation|3|||
127765708|NCT01853644|459767871|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
127765709|NCT01853644|459767871|FG000|Continued Treatment After First Response|Adverse Event|2|||
127765710|NCT01853644|459767871|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
127765711|NCT02891408|459767872|FG000|Overall Study|Lost to Follow-up|0|||
127765712|NCT02891408|459767873|FG001|Overall Study|Lost to Follow-up|0|||
127765713|NCT02891408|459767874|FG002|Overall Study|Lost to Follow-up|1|||
128013059|NCT01582451|460675198|FG000|Overall Study|Withdrawal by Subject|13|||
128013060|NCT01582451|460675199|FG001|Overall Study|Withdrawal by Subject|9|||
127765714|NCT02891408|459767875|FG003|Overall Study|Lost to Follow-up|0|||
128013061|NCT01582451|460675198|FG000|Overall Study|Physician Decision|3|||
127678429|NCT02377362|459446474|FG009|Part B Overall|Adverse Event|0|||
127678430|NCT02377362|459446475|FG010|Part B Overall|Adverse Event|0|||
127678431|NCT02377362|459446476|FG011|Part B Overall|Adverse Event|0|||
127678432|NCT02377362|459446477|FG012|Part B Overall|Adverse Event|0|||
127678433|NCT02377362|459446465|FG000|Part B Overall|Withdrawal by Subject|0|||
127678434|NCT02377362|459446466|FG001|Part B Overall|Withdrawal by Subject|0|||
127678435|NCT02377362|459446467|FG002|Part B Overall|Withdrawal by Subject|0|||
127678436|NCT02377362|459446468|FG003|Part B Overall|Withdrawal by Subject|0|||
127678437|NCT02377362|459446469|FG004|Part B Overall|Withdrawal by Subject|0|||
127678438|NCT02377362|459446470|FG005|Part B Overall|Withdrawal by Subject|0|||
127678439|NCT02377362|459446471|FG006|Part B Overall|Withdrawal by Subject|1|||
127678440|NCT02377362|459446472|FG007|Part B Overall|Withdrawal by Subject|0|||
127678441|NCT02377362|459446473|FG008|Part B Overall|Withdrawal by Subject|0|||
127678442|NCT02377362|459446474|FG009|Part B Overall|Withdrawal by Subject|0|||
127678443|NCT02377362|459446475|FG010|Part B Overall|Withdrawal by Subject|0|||
127678444|NCT02377362|459446476|FG011|Part B Overall|Withdrawal by Subject|1|||
127678445|NCT02377362|459446477|FG012|Part B Overall|Withdrawal by Subject|0|||
127678446|NCT01833832|459446478|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
127678447|NCT01050569|459446479|FG000|Overall Study|Lost to Follow-up|20|||
127678448|NCT01050569|459446480|FG001|Overall Study|Lost to Follow-up|14|||
127678449|NCT01050569|459446481|FG002|Overall Study|Lost to Follow-up|16|||
127678450|NCT01050569|459446479|FG000|Overall Study|Withdrawal by Subject|9|||
127678451|NCT01050569|459446480|FG001|Overall Study|Withdrawal by Subject|3|||
127678452|NCT01050569|459446481|FG002|Overall Study|Withdrawal by Subject|11|||
127678453|NCT01050569|459446479|FG000|Overall Study|Lack of Efficacy|5|||
127678454|NCT01050569|459446480|FG001|Overall Study|Lack of Efficacy|4|||
127678455|NCT01050569|459446481|FG002|Overall Study|Lack of Efficacy|3|||
127678456|NCT01050569|459446479|FG000|Overall Study|Adverse Event|1|||
127678457|NCT01050569|459446480|FG001|Overall Study|Adverse Event|0|||
127678458|NCT01050569|459446481|FG002|Overall Study|Adverse Event|0|||
127678459|NCT01050569|459446479|FG000|Overall Study|Physician Decision|3|||
127678460|NCT01050569|459446480|FG001|Overall Study|Physician Decision|3|||
127678461|NCT01050569|459446481|FG002|Overall Study|Physician Decision|3|||
127678462|NCT03525119|459446482|FG000|Overall Study|Adverse Event|0|||
127678463|NCT03525119|459446483|FG001|Overall Study|Adverse Event|1|||
127678464|NCT03525119|459446484|FG002|Overall Study|Adverse Event|0|||
127678465|NCT03525119|459446482|FG000|Overall Study|Lost to Follow-up|32|||
127678466|NCT03525119|459446483|FG001|Overall Study|Lost to Follow-up|33|||
127678467|NCT03525119|459446484|FG002|Overall Study|Lost to Follow-up|37|||
127678468|NCT03525119|459446482|FG000|Overall Study|Withdrawal by Subject|5|||
127678469|NCT03525119|459446483|FG001|Overall Study|Withdrawal by Subject|4|||
127678470|NCT03525119|459446484|FG002|Overall Study|Withdrawal by Subject|2|||
127678471|NCT03525119|459446482|FG000|Overall Study|Reason not Specified|2|||
127678472|NCT03525119|459446483|FG001|Overall Study|Reason not Specified|1|||
127678473|NCT03525119|459446484|FG002|Overall Study|Reason not Specified|2|||
127678474|NCT03525119|459446482|FG000|Overall Study|Randomized but not Vaccinated|1|||
127678475|NCT03525119|459446483|FG001|Overall Study|Randomized but not Vaccinated|0|||
127678476|NCT03525119|459446484|FG002|Overall Study|Randomized but not Vaccinated|2|||
127678477|NCT01186848|459446485|FG000|Overall Study|Lost to Follow-up|4|||
127678478|NCT01186848|459446485|FG000|Overall Study|Withdrawal by Subject|2|||
127678479|NCT01186848|459446485|FG000|Overall Study|Adverse Event|2|||
127678480|NCT01183780|459446496|FG000|Overall Study|Withdrawal by Subject|25|||
127678481|NCT01183780|459446497|FG001|Overall Study|Withdrawal by Subject|14|||
127678482|NCT01183780|459446496|FG000|Overall Study|Lost to Follow-up|6|||
127678483|NCT01183780|459446497|FG001|Overall Study|Lost to Follow-up|11|||
127678484|NCT02148133|459446501|FG000|Overall Study|Investigator discretion|1|||
127678485|NCT02148133|459446501|FG000|Overall Study|Lack of Efficacy|1|||
127678486|NCT02148133|459446501|FG000|Overall Study|Protocol deviation|1|||
127678487|NCT02148133|459446501|FG000|Overall Study|Protocol-defined stopping criteria|2|||
127678488|NCT00079183|459446507|FG000|Overall Study|Withdrawal by Subject|4|||
127678489|NCT00079183|459446507|FG000|Overall Study|Study medication non-compliance|2|||
127678490|NCT00079183|459446507|FG000|Overall Study|Specimen collection non-compliance|1|||
128013062|NCT01582451|460675199|FG001|Overall Study|Physician Decision|0|||
128013063|NCT01582451|460675198|FG000|Overall Study|Sponsor Decision|1|||
128013064|NCT01582451|460675199|FG001|Overall Study|Sponsor Decision|0|||
128013065|NCT00717886|460675202|FG000|Overall Study|Withdrawal by Subject|3|||
128013066|NCT00717886|460675202|FG000|Overall Study|Treatment Failure|1|||
127678491|NCT02613364|459446508|FG000|Overall Study|Other|19|||
127678492|NCT02613364|459446509|FG001|Overall Study|Other|29|||
127678493|NCT02613364|459446510|FG002|Overall Study|Other|17|||
127678494|NCT02613364|459446508|FG000|Overall Study|Too time consuming|21|||
127678495|NCT02613364|459446509|FG001|Overall Study|Too time consuming|26|||
127678496|NCT02613364|459446510|FG002|Overall Study|Too time consuming|26|||
127678497|NCT02613364|459446508|FG000|Overall Study|Withdrawal by Subject|13|||
127678498|NCT02613364|459446509|FG001|Overall Study|Withdrawal by Subject|18|||
127678499|NCT02613364|459446510|FG002|Overall Study|Withdrawal by Subject|17|||
127678500|NCT02613364|459446508|FG000|Overall Study|Medical|12|||
127678501|NCT02613364|459446509|FG001|Overall Study|Medical|13|||
127765715|NCT02891408|459767876|FG004|Overall Study|Lost to Follow-up|0|||
127765716|NCT02891408|459767877|FG005|Overall Study|Lost to Follow-up|0|||
127765717|NCT02891408|459767878|FG006|Overall Study|Lost to Follow-up|0|||
127765718|NCT02951767|459767879|FG000|Overall Study|Study Terminated By Sponsor|9|||
127765719|NCT02951767|459767879|FG000|Overall Study|Withdrawal by Subject|11|||
127765720|NCT02951767|459767879|FG000|Overall Study|Death|96|||
127765721|NCT02951767|459767879|FG000|Overall Study|Lost to Follow-up|2|||
127765722|NCT02951767|459767879|FG000|Overall Study|Physician Decision|1|||
127765723|NCT00709852|459767880|FG000|Period 1|Adverse Event|2|||
127765724|NCT00709852|459767881|FG001|Period 1|Adverse Event|0|||
127765725|NCT00709852|459767880|FG000|Period 1|Withdrawal by Subject|4|||
127765726|NCT00709852|459767881|FG001|Period 1|Withdrawal by Subject|2|||
127765727|NCT00709852|459767880|FG000|Period 1|Protocol Violation|1|||
127765728|NCT00709852|459767881|FG001|Period 1|Protocol Violation|0|||
127765729|NCT00709852|459767880|FG000|Period 1|Defective scanner|0|||
127765730|NCT00709852|459767881|FG001|Period 1|Defective scanner|1|||
127765731|NCT00709852|459767880|FG000|Period 1|Lost to Follow-up|1|||
127765732|NCT00709852|459767881|FG001|Period 1|Lost to Follow-up|0|||
127765733|NCT00709852|459767880|FG000|Period 2|Protocol Violation|4|||
127765734|NCT00709852|459767881|FG001|Period 2|Protocol Violation|1|||
127765735|NCT00709852|459767880|FG000|Period 2|Adverse Event|1|||
127765736|NCT00709852|459767881|FG001|Period 2|Adverse Event|1|||
127765737|NCT00709852|459767880|FG000|Period 2|Lost to Follow-up|1|||
127765738|NCT00709852|459767881|FG001|Period 2|Lost to Follow-up|0|||
127765739|NCT00709852|459767880|FG000|Period 2|No 72-hour follow-up|3|||
127765740|NCT00709852|459767881|FG001|Period 2|No 72-hour follow-up|0|||
127765741|NCT01442779|459767882|FG000|Overall Study|Withdrawal by Subject|3|||
127765742|NCT01442779|459767882|FG000|Overall Study|Death|3|||
127765743|NCT01442779|459767882|FG000|Overall Study|Non-compliance|1|||
127765744|NCT01048671|459767883|FG000|Overall Study|Protocol Violation|0|||
127765745|NCT01048671|459767884|FG001|Overall Study|Protocol Violation|1|||
127765746|NCT01048671|459767885|FG002|Overall Study|Protocol Violation|1|||
127765747|NCT03814187|459767886|FG000|Overall Study|Sponsor's Administrative Decision|0|||
127765748|NCT03814187|459767887|FG001|Overall Study|Sponsor's Administrative Decision|0|||
127765749|NCT03814187|459767888|FG002|Overall Study|Sponsor's Administrative Decision|272|||
127765750|NCT03814187|459767886|FG000|Overall Study|Death|80|||
127765751|NCT03814187|459767887|FG001|Overall Study|Death|81|||
127765752|NCT03814187|459767888|FG002|Overall Study|Death|4|||
127765753|NCT03814187|459767886|FG000|Overall Study|Withdrew Consent|77|||
127765754|NCT03814187|459767887|FG001|Overall Study|Withdrew Consent|78|||
127765755|NCT03814187|459767888|FG002|Overall Study|Withdrew Consent|2|||
127765756|NCT03814187|459767886|FG000|Overall Study|Lost to Follow-up|47|||
127765757|NCT03814187|459767887|FG001|Overall Study|Lost to Follow-up|52|||
127765758|NCT03814187|459767888|FG002|Overall Study|Lost to Follow-up|1|||
127765759|NCT03814187|459767886|FG000|Overall Study|Adverse Event|22|||
127765760|NCT03814187|459767887|FG001|Overall Study|Adverse Event|23|||
127765761|NCT03814187|459767888|FG002|Overall Study|Adverse Event|0|||
127765762|NCT03814187|459767886|FG000|Overall Study|Physician Decision|7|||
127765763|NCT03814187|459767887|FG001|Overall Study|Physician Decision|4|||
127765764|NCT03814187|459767888|FG002|Overall Study|Physician Decision|2|||
127765765|NCT03814187|459767886|FG000|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
127765766|NCT03814187|459767887|FG001|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
127765767|NCT03814187|459767888|FG002|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|1|||
127765768|NCT03814187|459767886|FG000|Overall Study|Other reasons|34|||
127765769|NCT03814187|459767887|FG001|Overall Study|Other reasons|40|||
127765770|NCT03814187|459767888|FG002|Overall Study|Other reasons|2|||
127765771|NCT00196976|459767889|FG000|Primary Study|Migrated from study area|0|||
127765772|NCT00196976|459767890|FG001|Primary Study|Migrated from study area|0|||
127765773|NCT00196976|459767891|FG002|Primary Study|Migrated from study area|0|||
127765774|NCT00196976|459767892|FG003|Primary Study|Migrated from study area|0|||
127765775|NCT00196976|459767893|FG004|Primary Study|Migrated from study area|0|||
127765776|NCT00196976|459767894|FG005|Primary Study|Migrated from study area|0|||
127765777|NCT00196976|459767895|FG006|Primary Study|Migrated from study area|0|||
127765778|NCT00196976|459767896|FG007|Primary Study|Migrated from study area|1|||
127765779|NCT00196976|459767897|FG008|Primary Study|Migrated from study area|0|||
127765780|NCT00196976|459767898|FG009|Primary Study|Migrated from study area|0|||
127765781|NCT00196976|459767899|FG010|Primary Study|Migrated from study area|0|||
127765782|NCT00196976|459767900|FG011|Primary Study|Migrated from study area|0|||
127765783|NCT00196976|459767901|FG012|Primary Study|Migrated from study area|0|||
128013067|NCT00487188|460675204|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
127765784|NCT00196976|459767902|FG013|Primary Study|Migrated from study area|0|||
127765785|NCT00196976|459767889|FG000|Primary Study|Protocol Violation|0|||
127765786|NCT00196976|459767890|FG001|Primary Study|Protocol Violation|1|||
127765787|NCT00196976|459767891|FG002|Primary Study|Protocol Violation|1|||
127765788|NCT00196976|459767892|FG003|Primary Study|Protocol Violation|0|||
127765789|NCT00196976|459767893|FG004|Primary Study|Protocol Violation|0|||
127765790|NCT00196976|459767894|FG005|Primary Study|Protocol Violation|0|||
127765791|NCT00196976|459767895|FG006|Primary Study|Protocol Violation|0|||
127765792|NCT00196976|459767896|FG007|Primary Study|Protocol Violation|0|||
127765793|NCT00196976|459767897|FG008|Primary Study|Protocol Violation|0|||
127765794|NCT00196976|459767898|FG009|Primary Study|Protocol Violation|0|||
127765795|NCT00196976|459767899|FG010|Primary Study|Protocol Violation|0|||
127765796|NCT00196976|459767900|FG011|Primary Study|Protocol Violation|0|||
127765797|NCT00196976|459767901|FG012|Primary Study|Protocol Violation|0|||
127765798|NCT00196976|459767902|FG013|Primary Study|Protocol Violation|0|||
127765799|NCT00196976|459767889|FG000|Primary Study|Withdrawal by Subject|1|||
127765800|NCT00196976|459767890|FG001|Primary Study|Withdrawal by Subject|0|||
127765801|NCT00196976|459767891|FG002|Primary Study|Withdrawal by Subject|1|||
127765802|NCT00196976|459767892|FG003|Primary Study|Withdrawal by Subject|1|||
127765803|NCT00196976|459767893|FG004|Primary Study|Withdrawal by Subject|2|||
127765804|NCT00196976|459767894|FG005|Primary Study|Withdrawal by Subject|1|||
127765805|NCT00196976|459767895|FG006|Primary Study|Withdrawal by Subject|0|||
127765806|NCT00196976|459767896|FG007|Primary Study|Withdrawal by Subject|0|||
127765807|NCT00196976|459767897|FG008|Primary Study|Withdrawal by Subject|0|||
127765808|NCT00196976|459767898|FG009|Primary Study|Withdrawal by Subject|1|||
127765809|NCT00196976|459767899|FG010|Primary Study|Withdrawal by Subject|0|||
128013068|NCT00487188|460675205|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
128013069|NCT00487188|460675206|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
128013070|NCT00487188|460675204|FG000|Induction Phase|Adverse Event|5|||
127765810|NCT00196976|459767900|FG011|Primary Study|Withdrawal by Subject|0|||
127765811|NCT00196976|459767901|FG012|Primary Study|Withdrawal by Subject|0|||
127765812|NCT00196976|459767902|FG013|Primary Study|Withdrawal by Subject|0|||
127765813|NCT00196976|459767889|FG000|Primary Study|Lost to Follow-up|0|||
127765814|NCT00196976|459767890|FG001|Primary Study|Lost to Follow-up|0|||
127765815|NCT00196976|459767891|FG002|Primary Study|Lost to Follow-up|0|||
127765816|NCT00196976|459767892|FG003|Primary Study|Lost to Follow-up|0|||
127765817|NCT00196976|459767893|FG004|Primary Study|Lost to Follow-up|1|||
127765818|NCT00196976|459767894|FG005|Primary Study|Lost to Follow-up|1|||
127765819|NCT00196976|459767895|FG006|Primary Study|Lost to Follow-up|0|||
127765820|NCT00196976|459767896|FG007|Primary Study|Lost to Follow-up|2|||
127765821|NCT00196976|459767897|FG008|Primary Study|Lost to Follow-up|0|||
127765822|NCT00196976|459767898|FG009|Primary Study|Lost to Follow-up|0|||
127765823|NCT00196976|459767899|FG010|Primary Study|Lost to Follow-up|0|||
127765824|NCT00196976|459767900|FG011|Primary Study|Lost to Follow-up|0|||
127765825|NCT00196976|459767901|FG012|Primary Study|Lost to Follow-up|0|||
127765826|NCT00196976|459767902|FG013|Primary Study|Lost to Follow-up|0|||
127765827|NCT00196976|459767889|FG000|Primary Study|Other|0|||
127765828|NCT00196976|459767890|FG001|Primary Study|Other|0|||
127765829|NCT00196976|459767891|FG002|Primary Study|Other|2|||
127765830|NCT00196976|459767892|FG003|Primary Study|Other|0|||
127765831|NCT00196976|459767893|FG004|Primary Study|Other|0|||
127765832|NCT00196976|459767894|FG005|Primary Study|Other|0|||
127765833|NCT00196976|459767895|FG006|Primary Study|Other|0|||
127765834|NCT00196976|459767896|FG007|Primary Study|Other|0|||
127765835|NCT00196976|459767897|FG008|Primary Study|Other|0|||
127765836|NCT00196976|459767898|FG009|Primary Study|Other|0|||
127765837|NCT00196976|459767899|FG010|Primary Study|Other|0|||
127765838|NCT00196976|459767900|FG011|Primary Study|Other|0|||
127765839|NCT00196976|459767901|FG012|Primary Study|Other|0|||
127765840|NCT00196976|459767902|FG013|Primary Study|Other|0|||
127765841|NCT00196976|459767889|FG000|Booster Study|Withdrawal by Subject|0|||
127765842|NCT00196976|459767890|FG001|Booster Study|Withdrawal by Subject|0|||
127765843|NCT00196976|459767891|FG002|Booster Study|Withdrawal by Subject|0|||
127765844|NCT00196976|459767892|FG003|Booster Study|Withdrawal by Subject|0|||
127765845|NCT00196976|459767893|FG004|Booster Study|Withdrawal by Subject|0|||
127765846|NCT00196976|459767894|FG005|Booster Study|Withdrawal by Subject|0|||
127765847|NCT00196976|459767895|FG006|Booster Study|Withdrawal by Subject|0|||
127765848|NCT00196976|459767896|FG007|Booster Study|Withdrawal by Subject|0|||
127765849|NCT00196976|459767897|FG008|Booster Study|Withdrawal by Subject|0|||
128013071|NCT00487188|460675205|FG001|Induction Phase|Adverse Event|0|||
128013072|NCT00487188|460675206|FG002|Induction Phase|Adverse Event|0|||
128013073|NCT00487188|460675204|FG000|Induction Phase|Lack of Efficacy|0|||
127765850|NCT00196976|459767898|FG009|Booster Study|Withdrawal by Subject|0|||
127765851|NCT00196976|459767899|FG010|Booster Study|Withdrawal by Subject|1|||
127765852|NCT00196976|459767900|FG011|Booster Study|Withdrawal by Subject|0|||
127765853|NCT00196976|459767901|FG012|Booster Study|Withdrawal by Subject|0|||
127765854|NCT00196976|459767902|FG013|Booster Study|Withdrawal by Subject|0|||
127765855|NCT00196976|459767889|FG000|Booster Study|Lost to Follow-up|0|||
127765856|NCT00196976|459767890|FG001|Booster Study|Lost to Follow-up|0|||
127765857|NCT00196976|459767891|FG002|Booster Study|Lost to Follow-up|0|||
127765858|NCT00196976|459767892|FG003|Booster Study|Lost to Follow-up|0|||
127765859|NCT00196976|459767893|FG004|Booster Study|Lost to Follow-up|0|||
127765860|NCT00196976|459767894|FG005|Booster Study|Lost to Follow-up|0|||
127765861|NCT00196976|459767895|FG006|Booster Study|Lost to Follow-up|0|||
127765862|NCT00196976|459767896|FG007|Booster Study|Lost to Follow-up|0|||
127765863|NCT00196976|459767897|FG008|Booster Study|Lost to Follow-up|0|||
127765864|NCT00196976|459767898|FG009|Booster Study|Lost to Follow-up|0|||
127765865|NCT00196976|459767899|FG010|Booster Study|Lost to Follow-up|1|||
127765866|NCT00196976|459767900|FG011|Booster Study|Lost to Follow-up|2|||
128013074|NCT00487188|460675205|FG001|Induction Phase|Lack of Efficacy|1|||
128013075|NCT00487188|460675206|FG002|Induction Phase|Lack of Efficacy|0|||
128013076|NCT00487188|460675204|FG000|Induction Phase|Protocol Violation|1|||
128013077|NCT00487188|460675205|FG001|Induction Phase|Protocol Violation|0|||
128013078|NCT00487188|460675206|FG002|Induction Phase|Protocol Violation|0|||
128013079|NCT00487188|460675204|FG000|Induction Phase|Refused Treatment|1|||
128013080|NCT00487188|460675205|FG001|Induction Phase|Refused Treatment|2|||
128013081|NCT00487188|460675206|FG002|Induction Phase|Refused Treatment|0|||
128013082|NCT00487188|460675204|FG000|Induction Phase|Lost to Follow-up|2|||
128013083|NCT00487188|460675205|FG001|Induction Phase|Lost to Follow-up|2|||
128013084|NCT00487188|460675206|FG002|Induction Phase|Lost to Follow-up|0|||
127678502|NCT02613364|459446510|FG002|Overall Study|Medical|9|||
127678503|NCT02613364|459446508|FG000|Overall Study|Disliked Study Procedure|1|||
127678504|NCT02613364|459446509|FG001|Overall Study|Disliked Study Procedure|1|||
127678505|NCT02613364|459446510|FG002|Overall Study|Disliked Study Procedure|4|||
127678506|NCT02613364|459446508|FG000|Overall Study|Disliked Intervention|0|||
127678507|NCT02613364|459446509|FG001|Overall Study|Disliked Intervention|3|||
127678508|NCT02613364|459446510|FG002|Overall Study|Disliked Intervention|3|||
127678509|NCT00371566|459446513|FG000|Treatment Phase|Withdrawal by Subject|0|||
127678510|NCT00371566|459446514|FG001|Treatment Phase|Withdrawal by Subject|1|||
127678511|NCT00371566|459446513|FG000|Treatment Phase|Adverse Event|0|||
127678512|NCT00371566|459446514|FG001|Treatment Phase|Adverse Event|1|||
127678513|NCT00371566|459446513|FG000|Treatment Phase|Protocol Violation|0|||
127678514|NCT00371566|459446514|FG001|Treatment Phase|Protocol Violation|1|||
127678515|NCT00371566|459446513|FG000|Chemoradiation Phase|Physician Decision|2|||
127678516|NCT00371566|459446514|FG001|Chemoradiation Phase|Physician Decision|0|||
127678517|NCT00371566|459446513|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
127678518|NCT00371566|459446514|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
127678519|NCT00371566|459446513|FG000|Chemoradiation Phase|Non compliant|0|||
127678520|NCT00371566|459446514|FG001|Chemoradiation Phase|Non compliant|1|||
127678521|NCT00371566|459446513|FG000|Chemoradiation Phase|Progressive Disease|1|||
127678522|NCT00371566|459446514|FG001|Chemoradiation Phase|Progressive Disease|1|||
127678523|NCT00371566|459446513|FG000|Chemoradiation Phase|Death|2|||
127678524|NCT00371566|459446514|FG001|Chemoradiation Phase|Death|0|||
127678525|NCT00371566|459446513|FG000|Follow Up Phase|Death|0|||
127678526|NCT00371566|459446514|FG001|Follow Up Phase|Death|5|||
127678527|NCT00371566|459446513|FG000|Follow Up Phase|Disease progression|1|||
127678528|NCT00371566|459446514|FG001|Follow Up Phase|Disease progression|0|||
127678529|NCT00371566|459446513|FG000|Follow Up Phase|Withdrawal by Subject|0|||
127678530|NCT00371566|459446514|FG001|Follow Up Phase|Withdrawal by Subject|1|||
127678531|NCT00371566|459446513|FG000|Follow Up Phase|Physician Decision|1|||
127678532|NCT00371566|459446514|FG001|Follow Up Phase|Physician Decision|1|||
127678533|NCT00371566|459446513|FG000|Follow Up Phase|Lost to Follow-up|1|||
127678534|NCT00371566|459446514|FG001|Follow Up Phase|Lost to Follow-up|0|||
127678535|NCT02873754|459446515|FG000|Overall Study|Lost to Follow-up|5|||
127678536|NCT02873754|459446515|FG000|Overall Study|Couldn't complete study procedures|1|||
127678537|NCT00972504|459446516|FG000|Overall Study|Adverse Event|2|||
127678538|NCT00972504|459446516|FG000|Overall Study|Investigator discretion|1|||
127678539|NCT00410124|459446517|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
127678540|NCT00410124|459446518|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
127678541|NCT00410124|459446517|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
127678542|NCT00410124|459446518|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
127678543|NCT00410124|459446517|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
127678544|NCT00410124|459446518|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
127678545|NCT00410124|459446517|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
127678546|NCT00410124|459446518|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
127678547|NCT00410124|459446517|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
127678548|NCT00410124|459446518|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
127678549|NCT00410124|459446517|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
127678550|NCT00410124|459446518|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
127678551|NCT00410124|459446517|FG000|Core Phase Double Blind (15 Months)|Death|7|||
127678552|NCT00410124|459446518|FG001|Core Phase Double Blind (15 Months)|Death|4|||
127765867|NCT00196976|459767901|FG012|Booster Study|Lost to Follow-up|0|||
128013085|NCT00487188|460675204|FG000|Induction Phase|Administrative|0|||
128013086|NCT00487188|460675205|FG001|Induction Phase|Administrative|1|||
127678553|NCT00410124|459446517|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
127678554|NCT00410124|459446518|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
127678555|NCT00410124|459446517|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
127678556|NCT00410124|459446518|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
127678557|NCT00410124|459446517|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
127678558|NCT00410124|459446518|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
127678559|NCT00410124|459446517|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
128013087|NCT00487188|460675206|FG002|Induction Phase|Administrative|0|||
128013088|NCT00487188|460675204|FG000|Maintenance Phase|Adverse Event|1|||
127765868|NCT00196976|459767902|FG013|Booster Study|Lost to Follow-up|0|||
127765869|NCT02689518|459767903|FG000|Overall Study|Withdrawal by Subject|3|||
127765870|NCT00825825|459767908|FG000|First Medication Period (14 Days)|Adverse Event|1|||
127765871|NCT00825825|459767909|FG001|First Medication Period (14 Days)|Adverse Event|0|||
127765872|NCT00825825|459767910|FG002|First Medication Period (14 Days)|Adverse Event|0|||
127765873|NCT00825825|459767911|FG003|First Medication Period (14 Days)|Adverse Event|0|||
127765874|NCT00825825|459767912|FG004|First Medication Period (14 Days)|Adverse Event|0|||
127765875|NCT00825825|459767913|FG005|First Medication Period (14 Days)|Adverse Event|1|||
127765876|NCT00825825|459767908|FG000|First Medication Period (14 Days)|Physician Decision|2|||
127765877|NCT00825825|459767909|FG001|First Medication Period (14 Days)|Physician Decision|0|||
127765878|NCT00825825|459767910|FG002|First Medication Period (14 Days)|Physician Decision|1|||
127765879|NCT00825825|459767911|FG003|First Medication Period (14 Days)|Physician Decision|0|||
127765880|NCT00825825|459767912|FG004|First Medication Period (14 Days)|Physician Decision|0|||
127765881|NCT00825825|459767913|FG005|First Medication Period (14 Days)|Physician Decision|1|||
127765882|NCT00825825|459767908|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
127765883|NCT00825825|459767909|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
127765884|NCT00825825|459767910|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
127765885|NCT00825825|459767911|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
127765886|NCT00825825|459767912|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
127765887|NCT00825825|459767913|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
127765888|NCT00825825|459767908|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
127765889|NCT00825825|459767909|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
127765890|NCT00825825|459767910|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
127765891|NCT00825825|459767911|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
127765892|NCT00825825|459767912|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
127765893|NCT00825825|459767913|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
127765894|NCT00825825|459767908|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
127765895|NCT00825825|459767909|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
127765896|NCT00825825|459767910|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
127765897|NCT00825825|459767911|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
127765898|NCT00825825|459767912|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
127765899|NCT00825825|459767913|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
127765900|NCT00825825|459767908|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
127765901|NCT00825825|459767909|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
127765902|NCT00825825|459767910|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
127765903|NCT00825825|459767911|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
127765904|NCT00825825|459767912|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
127765905|NCT00825825|459767913|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
127765906|NCT00825825|459767908|FG000|Third Medication Period (14 Days)|poor data quality|0|||
127765907|NCT00825825|459767909|FG001|Third Medication Period (14 Days)|poor data quality|1|||
127765908|NCT00825825|459767910|FG002|Third Medication Period (14 Days)|poor data quality|0|||
127765909|NCT00825825|459767911|FG003|Third Medication Period (14 Days)|poor data quality|0|||
127765910|NCT00825825|459767912|FG004|Third Medication Period (14 Days)|poor data quality|0|||
127765911|NCT00825825|459767913|FG005|Third Medication Period (14 Days)|poor data quality|0|||
127765912|NCT01920854|459767917|FG000|Overall Study|Withdrawal by Subject|1|||
127765913|NCT01920854|459767918|FG001|Overall Study|Withdrawal by Subject|0|||
127765914|NCT01920854|459767919|FG002|Overall Study|Withdrawal by Subject|0|||
127765915|NCT01920854|459767920|FG003|Overall Study|Withdrawal by Subject|0|||
127765916|NCT01920854|459767921|FG004|Overall Study|Withdrawal by Subject|1|||
127765917|NCT01920854|459767922|FG005|Overall Study|Withdrawal by Subject|0|||
127765918|NCT01920854|459767923|FG006|Overall Study|Withdrawal by Subject|1|||
127765919|NCT00757783|459767924|FG000|Overall Study|Adverse Event|0|||
127765920|NCT00757783|459767925|FG001|Overall Study|Adverse Event|2|||
127765921|NCT00757783|459767924|FG000|Overall Study|Lost to Follow-up|1|||
127765922|NCT00757783|459767925|FG001|Overall Study|Lost to Follow-up|1|||
128013089|NCT00487188|460675205|FG001|Maintenance Phase|Adverse Event|0|||
128013090|NCT00487188|460675206|FG002|Maintenance Phase|Adverse Event|0|||
128013091|NCT00487188|460675204|FG000|Maintenance Phase|Death|1|||
128013092|NCT00487188|460675205|FG001|Maintenance Phase|Death|0|||
128013093|NCT00487188|460675206|FG002|Maintenance Phase|Death|0|||
128013094|NCT00487188|460675204|FG000|Maintenance Phase|Lost to Follow-up|1|||
128013095|NCT00487188|460675205|FG001|Maintenance Phase|Lost to Follow-up|0|||
128013096|NCT00487188|460675206|FG002|Maintenance Phase|Lost to Follow-up|0|||
128013097|NCT00487188|460675204|FG000|Maintenance Phase|Administrative|0|||
128013098|NCT00487188|460675205|FG001|Maintenance Phase|Administrative|0|||
128013099|NCT00487188|460675206|FG002|Maintenance Phase|Administrative|1|||
128013100|NCT03881371|460675209|FG000|Overall Study|Adverse Event|8|||
127765923|NCT00757783|459767924|FG000|Overall Study|Protocol Violation|1|||
127765924|NCT00757783|459767925|FG001|Overall Study|Protocol Violation|0|||
128013101|NCT03881371|460675210|FG001|Overall Study|Adverse Event|9|||
128013102|NCT03881371|460675209|FG000|Overall Study|Death|1|||
128013103|NCT03881371|460675210|FG001|Overall Study|Death|0|||
128013104|NCT03881371|460675209|FG000|Overall Study|Lost to Follow-up|1|||
128013105|NCT03881371|460675210|FG001|Overall Study|Lost to Follow-up|0|||
128013106|NCT03881371|460675209|FG000|Overall Study|Non-Compliance with Study Drug|0|||
128013107|NCT03881371|460675210|FG001|Overall Study|Non-Compliance with Study Drug|2|||
128013108|NCT03881371|460675209|FG000|Overall Study|Physician Decision|3|||
128013109|NCT03881371|460675210|FG001|Overall Study|Physician Decision|3|||
128013110|NCT03881371|460675209|FG000|Overall Study|Withdrawal by Subject|2|||
128013111|NCT03881371|460675210|FG001|Overall Study|Withdrawal by Subject|10|||
128013112|NCT03881371|460675209|FG000|Overall Study|Discontinuation from Study|1|||
128013113|NCT03881371|460675210|FG001|Overall Study|Discontinuation from Study|0|||
128013114|NCT00933933|460675214|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
128013115|NCT00933933|460675215|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
128013116|NCT00933933|460675216|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
128013117|NCT00933933|460675214|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
128013118|NCT00933933|460675215|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
128013119|NCT00933933|460675216|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
128013120|NCT03822416|460675217|FG000|Overall Study|Lost to Follow-up|1|||
128013121|NCT03822416|460675218|FG001|Overall Study|Lost to Follow-up|0|||
128013122|NCT03822416|460675217|FG000|Overall Study|Withdrawal by Subject|0|||
128013123|NCT03822416|460675218|FG001|Overall Study|Withdrawal by Subject|1|||
128013124|NCT01995201|460675221|FG000|From Baseline Until Week 24|Adverse Event|4|||
128013125|NCT01995201|460675222|FG001|From Baseline Until Week 24|Adverse Event|15|||
128013126|NCT01995201|460675223|FG002|From Baseline Until Week 24|Adverse Event|0|||
128013127|NCT01995201|460675224|FG003|From Baseline Until Week 24|Adverse Event|0|||
128013128|NCT01995201|460675225|FG004|From Baseline Until Week 24|Adverse Event|0|||
128013129|NCT01995201|460675226|FG005|From Baseline Until Week 24|Adverse Event|0|||
128013130|NCT01995201|460675227|FG006|From Baseline Until Week 24|Adverse Event|0|||
128013131|NCT01995201|460675221|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
128013132|NCT01995201|460675222|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
128013133|NCT01995201|460675223|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
128013134|NCT01995201|460675224|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
128013135|NCT01995201|460675225|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
128013136|NCT01995201|460675226|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
128013137|NCT01995201|460675227|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
128013138|NCT01995201|460675221|FG000|From Baseline Until Week 24|Death|0|||
128013139|NCT01995201|460675222|FG001|From Baseline Until Week 24|Death|1|||
128013140|NCT01995201|460675223|FG002|From Baseline Until Week 24|Death|0|||
128013141|NCT01995201|460675224|FG003|From Baseline Until Week 24|Death|0|||
128013142|NCT01995201|460675225|FG004|From Baseline Until Week 24|Death|0|||
128013143|NCT01995201|460675226|FG005|From Baseline Until Week 24|Death|0|||
128013144|NCT01995201|460675227|FG006|From Baseline Until Week 24|Death|0|||
127678560|NCT00410124|459446518|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
127678561|NCT00410124|459446517|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
127678562|NCT00410124|459446518|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
127678563|NCT00410124|459446517|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
127678564|NCT00410124|459446518|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
127678565|NCT00410124|459446517|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
127678566|NCT00410124|459446518|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
127678567|NCT00410124|459446517|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
127678568|NCT00410124|459446518|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
127678569|NCT00410124|459446517|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
127678570|NCT00410124|459446518|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
127678571|NCT02807493|459446519|FG000|Overall Study|Adverse Event|5|||
127678572|NCT02807493|459446520|FG001|Overall Study|Adverse Event|2|||
127678573|NCT02807493|459446519|FG000|Overall Study|Lost to Follow-up|6|||
127678574|NCT02807493|459446520|FG001|Overall Study|Lost to Follow-up|0|||
127678575|NCT02807493|459446519|FG000|Overall Study|Physician Decision|4|||
127678576|NCT02807493|459446520|FG001|Overall Study|Physician Decision|1|||
127678577|NCT02807493|459446519|FG000|Overall Study|Protocol Violation|7|||
127678578|NCT02807493|459446520|FG001|Overall Study|Protocol Violation|0|||
127678579|NCT02807493|459446519|FG000|Overall Study|Withdrawal by Subject|17|||
127678580|NCT02807493|459446520|FG001|Overall Study|Withdrawal by Subject|10|||
127678581|NCT02807493|459446519|FG000|Overall Study|Other withdrawal|17|||
127678582|NCT02807493|459446520|FG001|Overall Study|Other withdrawal|0|||
127678583|NCT02807493|459446519|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
128013145|NCT01995201|460675221|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
128013146|NCT01995201|460675222|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
128013147|NCT01995201|460675223|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
128013148|NCT01995201|460675224|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
127678584|NCT02807493|459446520|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
127765925|NCT00757783|459767924|FG000|Overall Study|Withdrawal by Subject|2|||
128013149|NCT01995201|460675225|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
128013150|NCT01995201|460675226|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
128013151|NCT01995201|460675227|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
127765926|NCT00757783|459767925|FG001|Overall Study|Withdrawal by Subject|1|||
127765927|NCT00757783|459767924|FG000|Overall Study|Other|1|||
127765928|NCT00757783|459767925|FG001|Overall Study|Other|2|||
127765929|NCT02372136|459767930|FG000|Overall Study|Death|3|||
127765930|NCT02372136|459767931|FG001|Overall Study|Death|1|||
127765931|NCT00985946|459767932|FG000|Overall Study|Lost to Follow-up|6|||
127765932|NCT00985946|459767932|FG000|Overall Study|Withdrawal by Subject|1|||
127765933|NCT02471833|459767933|FG000|Overall Study|Lost to Follow-up|1|||
127765934|NCT02471833|459767934|FG001|Overall Study|Lost to Follow-up|0|||
127765935|NCT02471833|459767935|FG002|Overall Study|Lost to Follow-up|0|||
127765936|NCT02471833|459767933|FG000|Overall Study|Withdrawal by Subject|2|||
127765937|NCT02471833|459767934|FG001|Overall Study|Withdrawal by Subject|1|||
127765938|NCT02471833|459767935|FG002|Overall Study|Withdrawal by Subject|5|||
127765939|NCT02673515|459767939|FG000|Overall Study|Lack of motivation|2|||
127765940|NCT02673515|459767940|FG001|Overall Study|Lack of motivation|1|||
127765941|NCT03965351|459767942|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
127765942|NCT03965351|459767943|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
127765943|NCT03965351|459767942|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
127765944|NCT03965351|459767943|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
127765945|NCT00490724|459767944|FG000|Period I|Physician Decision|0|||
127765946|NCT00490724|459767945|FG001|Period I|Physician Decision|0|||
127765947|NCT00490724|459767946|FG002|Period I|Physician Decision|1|||
127765948|NCT00490724|459767944|FG000|Period II|Treatment Discontinuation|3|||
127765949|NCT00490724|459767945|FG001|Period II|Treatment Discontinuation|1|||
127765950|NCT00490724|459767946|FG002|Period II|Treatment Discontinuation|3|||
127765951|NCT00994682|459767947|FG000|Double Bilnd|Withdrawal by Subject|5|||
127765952|NCT00994682|459767948|FG001|Double Bilnd|Withdrawal by Subject|6|||
127765953|NCT00994682|459767947|FG000|Double Bilnd|Lost to Follow-up|3|||
127765954|NCT00994682|459767948|FG001|Double Bilnd|Lost to Follow-up|3|||
127765955|NCT00994682|459767947|FG000|Double Bilnd|Adverse Event|1|||
127765956|NCT00994682|459767948|FG001|Double Bilnd|Adverse Event|0|||
127765957|NCT00994682|459767947|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
127765958|NCT00994682|459767948|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
127765959|NCT00994682|459767947|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
127765960|NCT00994682|459767948|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
127765961|NCT00994682|459767947|FG000|Pioglitazone Open Label|Physician Decision|6|||
127765962|NCT00994682|459767948|FG001|Pioglitazone Open Label|Physician Decision|1|||
127765963|NCT00812331|459770066|FG000|Overall Study|Adverse Event|1|||
127765964|NCT00812331|459770067|FG001|Overall Study|Adverse Event|0|||
127765965|NCT00812331|459770068|FG002|Overall Study|Adverse Event|0|||
127765966|NCT00812331|459770069|FG003|Overall Study|Adverse Event|0|||
127765967|NCT00812331|459770070|FG004|Overall Study|Adverse Event|0|||
127765968|NCT01506453|459770071|FG000|Overall Study|Withdrawal prior to treatment|0|||
127765969|NCT01506453|459770072|FG001|Overall Study|Withdrawal prior to treatment|2|||
127765970|NCT00055601|459770080|FG000|Overall Study|Protocol Violation|1|||
127765971|NCT00055601|459770081|FG001|Overall Study|Protocol Violation|1|||
127765972|NCT00055601|459770080|FG000|Overall Study|No protocol treatment received|1|||
128013152|NCT01995201|460675221|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
128013153|NCT01995201|460675222|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
128013154|NCT01995201|460675223|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
128013155|NCT01995201|460675224|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
128013156|NCT01995201|460675225|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
128013157|NCT01995201|460675226|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
128013158|NCT01995201|460675227|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
127765973|NCT00055601|459770081|FG001|Overall Study|No protocol treatment received|1|||
128013159|NCT01995201|460675221|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
128013160|NCT01995201|460675222|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
128013161|NCT01995201|460675223|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
127765974|NCT00117845|459770082|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
127765975|NCT01022268|459770083|FG000|Overall Study|Withdrawal by Subject|1|||
127765976|NCT01022268|459770084|FG001|Overall Study|Withdrawal by Subject|0|||
127765977|NCT01022268|459770083|FG000|Overall Study|Withdrawal by Subject|1|||
127765978|NCT01022268|459770084|FG001|Overall Study|Withdrawal by Subject|0|||
127765979|NCT00910689|459770085|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
127765980|NCT00910689|459770086|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
127765981|NCT00910689|459770087|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
128013162|NCT01995201|460675224|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
128013163|NCT01995201|460675225|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
128013164|NCT01995201|460675226|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
127765982|NCT00910689|459770088|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
128013165|NCT01995201|460675227|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
128013166|NCT01995201|460675221|FG000|From Baseline Until Week 24|Physician Decision|0|||
128013167|NCT01995201|460675222|FG001|From Baseline Until Week 24|Physician Decision|2|||
128013168|NCT01995201|460675223|FG002|From Baseline Until Week 24|Physician Decision|0|||
128013169|NCT01995201|460675224|FG003|From Baseline Until Week 24|Physician Decision|0|||
128013170|NCT01995201|460675225|FG004|From Baseline Until Week 24|Physician Decision|0|||
128013171|NCT01995201|460675226|FG005|From Baseline Until Week 24|Physician Decision|0|||
128013172|NCT01995201|460675227|FG006|From Baseline Until Week 24|Physician Decision|0|||
128013173|NCT01995201|460675221|FG000|From Baseline Until Week 24|Protocol Violation|0|||
128013174|NCT01995201|460675222|FG001|From Baseline Until Week 24|Protocol Violation|9|||
128013175|NCT01995201|460675223|FG002|From Baseline Until Week 24|Protocol Violation|0|||
128013176|NCT01995201|460675224|FG003|From Baseline Until Week 24|Protocol Violation|0|||
128013177|NCT01995201|460675225|FG004|From Baseline Until Week 24|Protocol Violation|0|||
128013178|NCT01995201|460675226|FG005|From Baseline Until Week 24|Protocol Violation|0|||
128013179|NCT01995201|460675227|FG006|From Baseline Until Week 24|Protocol Violation|0|||
128013180|NCT01995201|460675221|FG000|From Week 24 Until Week 48|Adverse Event|0|||
128013181|NCT01995201|460675222|FG001|From Week 24 Until Week 48|Adverse Event|0|||
128013182|NCT01995201|460675223|FG002|From Week 24 Until Week 48|Adverse Event|2|||
127678585|NCT00811057|459446521|FG000|Overall Study|Protocol Violation|5|||
127678586|NCT00811057|459446522|FG001|Overall Study|Protocol Violation|10|||
127678587|NCT00811057|459446523|FG002|Overall Study|Protocol Violation|10|||
127678588|NCT00768651|459446528|FG000|Overall Study|Withdrawal by Subject|1|||
127678589|NCT01773122|459446533|FG000|Overall Study|Due to amended age eligibility criteria|3|||
127678590|NCT01773122|459446534|FG001|Overall Study|Due to amended age eligibility criteria|1|||
127678591|NCT01773122|459446535|FG002|Overall Study|Due to amended age eligibility criteria|0|||
127678592|NCT01773122|459446536|FG003|Overall Study|Due to amended age eligibility criteria|1|||
127678593|NCT01264718|459446537|FG000|Overall Study|Lost to Follow-up|3|||
127678594|NCT01264718|459446538|FG001|Overall Study|Lost to Follow-up|2|||
127678595|NCT01264718|459446537|FG000|Overall Study|Withdrawal by Subject|9|||
127678596|NCT01264718|459446538|FG001|Overall Study|Withdrawal by Subject|15|||
127678597|NCT01264718|459446537|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
127678598|NCT01264718|459446538|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
127678599|NCT01144182|459446542|FG000|Overall Study|Death|5|||
127678600|NCT01144182|459446543|FG001|Overall Study|Death|6|||
127678601|NCT01144182|459446542|FG000|Overall Study|Withdrawal by Subject|3|||
127678602|NCT01144182|459446543|FG001|Overall Study|Withdrawal by Subject|6|||
127678603|NCT01144182|459446542|FG000|Overall Study|Lost to Follow-up|9|||
127678604|NCT01144182|459446543|FG001|Overall Study|Lost to Follow-up|9|||
127678605|NCT03538054|459446548|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
127678606|NCT03538054|459446548|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
127678607|NCT03538054|459446548|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
127678608|NCT03264456|459446549|FG000|Overall Study|Withdrawal by Subject|3|||
127678609|NCT03264456|459446549|FG000|Overall Study|Lost to Follow-up|1|||
127678610|NCT03254394|459446552|FG000|Overall Study|Withdrawal by Subject|0|||
127678611|NCT03254394|459446553|FG001|Overall Study|Withdrawal by Subject|2|||
127678612|NCT02351180|459446554|FG000|Overall Study|Withdrawal by Subject|1|||
127678613|NCT02351180|459446555|FG001|Overall Study|Withdrawal by Subject|0|||
127678614|NCT01123083|459446562|FG000|Overall Study|Investigator recommendation|1|||
127678615|NCT01123083|459446563|FG001|Overall Study|Investigator recommendation|1|||
127678616|NCT01123083|459446562|FG000|Overall Study|Administrative reasons|0|||
127678617|NCT01123083|459446563|FG001|Overall Study|Administrative reasons|4|||
127678618|NCT01123083|459446562|FG000|Overall Study|Lost to Follow-up|2|||
127678619|NCT01123083|459446563|FG001|Overall Study|Lost to Follow-up|6|||
127678620|NCT01123083|459446562|FG000|Overall Study|Adverse Event|1|||
127678621|NCT01123083|459446563|FG001|Overall Study|Adverse Event|0|||
127678622|NCT01123083|459446562|FG000|Overall Study|Withdrew for another reason not covered|0|||
127678623|NCT01123083|459446563|FG001|Overall Study|Withdrew for another reason not covered|1|||
127678624|NCT01123083|459446562|FG000|Overall Study|Participant/legal representative request|7|||
127678625|NCT01123083|459446563|FG001|Overall Study|Participant/legal representative request|3|||
127678626|NCT03418324|459446564|FG000|Overall Study|Death|0|||
127678627|NCT03418324|459446565|FG001|Overall Study|Death|1|||
127678628|NCT03418324|459446564|FG000|Overall Study|Physician Decision|1|||
127678629|NCT03418324|459446565|FG001|Overall Study|Physician Decision|1|||
127678630|NCT01751724|459446566|FG000|Overall Study|extubated bef.start assigned treatment|1|||
127678631|NCT01751724|459446567|FG001|Overall Study|extubated bef.start assigned treatment|0|||
127678632|NCT01751724|459446566|FG000|Overall Study|withdrawn by parent|0|||
128013183|NCT01995201|460675224|FG003|From Week 24 Until Week 48|Adverse Event|1|||
128013184|NCT01995201|460675225|FG004|From Week 24 Until Week 48|Adverse Event|1|||
128013185|NCT01995201|460675226|FG005|From Week 24 Until Week 48|Adverse Event|3|||
127678633|NCT01751724|459446567|FG001|Overall Study|withdrawn by parent|2|||
127678634|NCT03121950|459446569|FG000|Overall Study|Withdrawal by Subject|11|||
127678635|NCT03121950|459446570|FG001|Overall Study|Withdrawal by Subject|2|||
128013186|NCT01995201|460675227|FG006|From Week 24 Until Week 48|Adverse Event|1|||
128013187|NCT01995201|460675221|FG000|From Week 24 Until Week 48|Death|0|||
127678636|NCT01867580|459446571|FG000|Overall Study|Withdrawal by Subject|2|||
127678637|NCT01867580|459446572|FG001|Overall Study|Withdrawal by Subject|3|||
127678638|NCT01867580|459446571|FG000|Overall Study|Physician Decision|17|||
127678639|NCT01867580|459446572|FG001|Overall Study|Physician Decision|12|||
127678640|NCT01867580|459446571|FG000|Overall Study|Lost to Follow-up|3|||
127678641|NCT01867580|459446572|FG001|Overall Study|Lost to Follow-up|5|||
127678642|NCT01867580|459446571|FG000|Overall Study|Sponsor terminated study|1|||
127678643|NCT01867580|459446572|FG001|Overall Study|Sponsor terminated study|0|||
127678644|NCT01867580|459446571|FG000|Overall Study|Missed follow-up assessment|2|||
127678645|NCT01867580|459446572|FG001|Overall Study|Missed follow-up assessment|1|||
127678646|NCT01867580|459446571|FG000|Overall Study|Interruption to therapy|3|||
127678647|NCT01867580|459446572|FG001|Overall Study|Interruption to therapy|0|||
127678648|NCT01867580|459446571|FG000|Overall Study|Osteomyelitis|0|||
127678649|NCT01867580|459446572|FG001|Overall Study|Osteomyelitis|1|||
127678650|NCT01867580|459446571|FG000|Overall Study|Continuation of therapy|0|||
127678651|NCT01867580|459446572|FG001|Overall Study|Continuation of therapy|1|||
127678652|NCT01867580|459446571|FG000|Overall Study|Wound recurrence|0|||
127678653|NCT01867580|459446572|FG001|Overall Study|Wound recurrence|1|||
127678654|NCT03141788|459446573|FG000|Overall Study|Lost to Follow-up|1|||
127678655|NCT03141788|459446573|FG000|Overall Study|Protocol Violation|3|||
127678656|NCT03141788|459446573|FG000|Overall Study|Withdrawal by Subject|4|||
127678657|NCT01025843|459447744|FG000|Washout 4|Withdrawal by Subject|0|||
127678658|NCT01025843|459447745|FG001|Washout 4|Withdrawal by Subject|0|||
127678659|NCT01025843|459447746|FG002|Washout 4|Withdrawal by Subject|1|||
127678660|NCT01025843|459447747|FG003|Washout 4|Withdrawal by Subject|1|||
127678661|NCT01025843|459447748|FG004|Washout 4|Withdrawal by Subject|0|||
127678662|NCT01025843|459447749|FG005|Washout 4|Withdrawal by Subject|0|||
127678663|NCT01025843|459447750|FG006|Washout 4|Withdrawal by Subject|0|||
128013188|NCT01995201|460675222|FG001|From Week 24 Until Week 48|Death|0|||
128013189|NCT01995201|460675223|FG002|From Week 24 Until Week 48|Death|0|||
128013190|NCT01995201|460675224|FG003|From Week 24 Until Week 48|Death|0|||
128013191|NCT01995201|460675225|FG004|From Week 24 Until Week 48|Death|0|||
128013192|NCT01995201|460675226|FG005|From Week 24 Until Week 48|Death|2|||
128013193|NCT01995201|460675227|FG006|From Week 24 Until Week 48|Death|0|||
128013194|NCT01995201|460675221|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
128013195|NCT01995201|460675222|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
128013196|NCT01995201|460675223|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
128013197|NCT01995201|460675224|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
128013198|NCT01995201|460675225|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
128013199|NCT01995201|460675226|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
128013200|NCT01995201|460675227|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
128013201|NCT01995201|460675221|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
128013202|NCT01995201|460675222|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
128013203|NCT01995201|460675223|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
128013204|NCT01995201|460675224|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
128013205|NCT01995201|460675225|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
128013206|NCT01995201|460675226|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
128013207|NCT01995201|460675227|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
128013208|NCT01995201|460675221|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
128013209|NCT01995201|460675222|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
128013210|NCT01995201|460675223|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
128013211|NCT01995201|460675224|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
128013212|NCT01995201|460675225|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
128013213|NCT01995201|460675226|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
128013214|NCT01995201|460675227|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
128013215|NCT01995201|460675221|FG000|From Week 24 Until Week 48|Physician Decision|0|||
128013216|NCT01995201|460675222|FG001|From Week 24 Until Week 48|Physician Decision|0|||
128013217|NCT01995201|460675223|FG002|From Week 24 Until Week 48|Physician Decision|0|||
128013218|NCT01995201|460675224|FG003|From Week 24 Until Week 48|Physician Decision|0|||
128013219|NCT01995201|460675225|FG004|From Week 24 Until Week 48|Physician Decision|1|||
128013220|NCT01995201|460675226|FG005|From Week 24 Until Week 48|Physician Decision|0|||
128013221|NCT01995201|460675227|FG006|From Week 24 Until Week 48|Physician Decision|0|||
128013222|NCT01995201|460675221|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
128013223|NCT01995201|460675222|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
128013224|NCT01995201|460675223|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
128013225|NCT01995201|460675224|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
127678664|NCT01025843|459447751|FG007|Washout 4|Withdrawal by Subject|0|||
127678665|NCT01025843|459447752|FG008|Washout 4|Withdrawal by Subject|0|||
127678666|NCT01025843|459447753|FG009|Washout 4|Withdrawal by Subject|0|||
127678667|NCT00377455|459447756|FG000|Overall Study|Withdrawal by Subject|1|||
128013226|NCT01995201|460675225|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
128013227|NCT01995201|460675226|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
128013228|NCT01995201|460675227|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
127678668|NCT01897233|459447759|FG000|Part B (24 Weeks)|Adverse Event|1|||
128013229|NCT03329001|460675228|FG000|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
128013230|NCT03329001|460675229|FG001|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
128013231|NCT03329001|460675230|FG002|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|5|||
128013232|NCT03329001|460675231|FG003|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|6|||
127765983|NCT00910689|459770085|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
127765984|NCT00910689|459770086|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
127765985|NCT00910689|459770087|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
127765986|NCT00910689|459770088|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
127765987|NCT00910689|459770085|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
127765988|NCT00910689|459770086|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
127765989|NCT00910689|459770087|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
127765990|NCT00910689|459770088|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
127765991|NCT00910689|459770085|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
127765992|NCT00910689|459770086|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
127765993|NCT00910689|459770087|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
128013233|NCT03329001|460675232|FG004|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
128013234|NCT03329001|460675233|FG005|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
127678669|NCT01897233|459447759|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
127678670|NCT01897233|459447759|FG000|Part B (24 Weeks)|Physician Decision|1|||
127678671|NCT01281813|459447766|FG000|Overall Study|Adverse Event|0|||
127678672|NCT01281813|459447767|FG001|Overall Study|Adverse Event|0|||
127678673|NCT01281813|459447768|FG002|Overall Study|Adverse Event|10|||
127678674|NCT01281813|459447766|FG000|Overall Study|Lost to Follow-up|0|||
127678675|NCT01281813|459447767|FG001|Overall Study|Lost to Follow-up|0|||
127678676|NCT01281813|459447768|FG002|Overall Study|Lost to Follow-up|31|||
127678677|NCT01281813|459447766|FG000|Overall Study|Withdrawal by Subject|0|||
127678678|NCT01281813|459447767|FG001|Overall Study|Withdrawal by Subject|0|||
127678679|NCT01281813|459447768|FG002|Overall Study|Withdrawal by Subject|13|||
127678680|NCT01281813|459447766|FG000|Overall Study|Subject Non-Compliant|0|||
127678681|NCT01281813|459447767|FG001|Overall Study|Subject Non-Compliant|0|||
127678682|NCT01281813|459447768|FG002|Overall Study|Subject Non-Compliant|6|||
127678683|NCT01281813|459447766|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
127678684|NCT01281813|459447767|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
127678685|NCT01281813|459447768|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
127678686|NCT01281813|459447766|FG000|Overall Study|Sponsor's Decision|4|||
127678687|NCT01281813|459447767|FG001|Overall Study|Sponsor's Decision|3|||
127678688|NCT01281813|459447768|FG002|Overall Study|Sponsor's Decision|7|||
127678689|NCT01281813|459447766|FG000|Overall Study|Switched to Commercially Available Medication|0|||
127678690|NCT01281813|459447767|FG001|Overall Study|Switched to Commercially Available Medication|0|||
127678691|NCT01281813|459447768|FG002|Overall Study|Switched to Commercially Available Medication|26|||
127678692|NCT01281813|459447766|FG000|Overall Study|Other|0|||
127678693|NCT01281813|459447767|FG001|Overall Study|Other|1|||
127678694|NCT01281813|459447768|FG002|Overall Study|Other|39|||
127678695|NCT03546907|459447769|FG000|Overall Study|Lack of Efficacy|1|||
127678696|NCT03546907|459447770|FG001|Overall Study|Lack of Efficacy|1|||
127678697|NCT03546907|459447769|FG000|Overall Study|Withdrawal by Subject|8|||
127678698|NCT03546907|459447770|FG001|Overall Study|Withdrawal by Subject|9|||
127678699|NCT03546907|459447769|FG000|Overall Study|Adverse events (AEs)|7|||
127678700|NCT03546907|459447770|FG001|Overall Study|Adverse events (AEs)|10|||
127678701|NCT03546907|459447769|FG000|Overall Study|Other-unspecified|1|||
127678702|NCT03546907|459447770|FG001|Overall Study|Other-unspecified|1|||
127678703|NCT02810080|459447771|FG000|Overall Study|Adverse Event|3|||
127678704|NCT02810080|459447772|FG001|Overall Study|Adverse Event|0|||
127678705|NCT02810080|459447771|FG000|Overall Study|Death|0|||
127678706|NCT02810080|459447772|FG001|Overall Study|Death|2|||
127678707|NCT02810080|459447771|FG000|Overall Study|Physician Decision|4|||
127678708|NCT02810080|459447772|FG001|Overall Study|Physician Decision|0|||
127678709|NCT02810080|459447771|FG000|Overall Study|Withdrawal by Subject|0|||
127678710|NCT02810080|459447772|FG001|Overall Study|Withdrawal by Subject|2|||
127678711|NCT04033432|459447775|FG000|Overall Study|Progressive Disease|8|||
127678712|NCT04033432|459447775|FG000|Overall Study|Adverse Event|4|||
127678713|NCT04033432|459447775|FG000|Overall Study|Death|1|||
127678714|NCT00393848|459447776|FG000|Overall Study|Surgical schedule|0|||
128013235|NCT03329001|460675234|FG006|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
127678715|NCT00393848|459447777|FG001|Overall Study|Surgical schedule|0|||
127678716|NCT00393848|459447778|FG002|Overall Study|Surgical schedule|0|||
127765994|NCT00910689|459770088|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
127765995|NCT00910689|459770085|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
127678717|NCT00393848|459447779|FG003|Overall Study|Surgical schedule|1|||
127678718|NCT00393848|459447776|FG000|Overall Study|Personal reasons|0|||
127678719|NCT00393848|459447777|FG001|Overall Study|Personal reasons|0|||
127678720|NCT00393848|459447778|FG002|Overall Study|Personal reasons|2|||
127678721|NCT00393848|459447779|FG003|Overall Study|Personal reasons|0|||
127765996|NCT00910689|459770086|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
127765997|NCT00910689|459770087|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
127765998|NCT00910689|459770088|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
127765999|NCT00910689|459770085|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
127766000|NCT00910689|459770086|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
127766001|NCT00910689|459770087|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
127766002|NCT00910689|459770088|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
127766003|NCT00910689|459770085|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
127766004|NCT00910689|459770086|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
127766005|NCT00910689|459770087|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
127766006|NCT00910689|459770088|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
127766007|NCT00910689|459770085|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
127766008|NCT00910689|459770086|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
127766009|NCT00910689|459770087|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
127766010|NCT00910689|459770088|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
127766011|NCT00910689|459770085|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
127766012|NCT00910689|459770086|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
127766013|NCT00910689|459770087|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
127766014|NCT00910689|459770088|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
127766015|NCT00910689|459770085|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
127766016|NCT00910689|459770086|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
127766017|NCT00910689|459770087|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
127766018|NCT00910689|459770088|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
127766019|NCT00910689|459770085|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
127766020|NCT00910689|459770086|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
127766021|NCT00910689|459770087|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
127766022|NCT00910689|459770088|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
127766023|NCT00910689|459770085|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
127766024|NCT00910689|459770086|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
127766025|NCT00910689|459770087|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
127766026|NCT00910689|459770088|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
127766027|NCT00910689|459770085|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
127766028|NCT00910689|459770086|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
127766029|NCT00910689|459770087|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
127766030|NCT00910689|459770088|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
127766031|NCT00910689|459770085|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
127766032|NCT00910689|459770086|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
127766033|NCT00910689|459770087|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
127766034|NCT00910689|459770088|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
127766035|NCT00910689|459770085|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
127766036|NCT00910689|459770086|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
127766037|NCT00910689|459770087|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
127766038|NCT00910689|459770088|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
127766039|NCT00910689|459770085|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
127766040|NCT00910689|459770086|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
127766041|NCT00910689|459770087|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
127766042|NCT00910689|459770088|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
127766043|NCT00910689|459770085|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
127766044|NCT00910689|459770086|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
127766045|NCT00910689|459770087|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
127766046|NCT00910689|459770088|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
127766047|NCT00910689|459770085|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
127766048|NCT00910689|459770086|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
127766049|NCT00910689|459770087|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
127766050|NCT00910689|459770088|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
127766051|NCT00910689|459770085|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
127766052|NCT00910689|459770086|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
127766053|NCT00910689|459770087|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
127766054|NCT00910689|459770088|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
127766055|NCT00910689|459770085|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
127766056|NCT00910689|459770086|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
128013236|NCT03329001|460675235|FG007|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
128013237|NCT03329001|460675228|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
128013238|NCT03329001|460675229|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
128013239|NCT03329001|460675230|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
128013240|NCT03329001|460675231|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|1|||
127766057|NCT00910689|459770087|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
128013241|NCT03329001|460675232|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
127678722|NCT02192606|459447783|FG000|Overall Study|surgery type was changed|1|||
127678723|NCT02192606|459447784|FG001|Overall Study|surgery type was changed|1|||
127678724|NCT02192606|459447783|FG000|Overall Study|Physician Decision|1|||
127678725|NCT02192606|459447784|FG001|Overall Study|Physician Decision|2|||
127678726|NCT02192606|459447783|FG000|Overall Study|3D equipment rep unable to join|0|||
127678727|NCT02192606|459447784|FG001|Overall Study|3D equipment rep unable to join|1|||
127678728|NCT01458210|459447785|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
127678729|NCT01458210|459447785|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
127678730|NCT01458210|459447785|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
127678731|NCT01458210|459447785|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
127678732|NCT03923491|459447786|FG000|Overall Study|Lost to Follow-up|5|||
127678733|NCT03923491|459447787|FG001|Overall Study|Lost to Follow-up|8|||
127678734|NCT03923491|459447786|FG000|Overall Study|Withdrawal by Subject|4|||
127678735|NCT03923491|459447787|FG001|Overall Study|Withdrawal by Subject|6|||
127678736|NCT00241644|459447791|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
127678737|NCT00241644|459447792|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
127678738|NCT00241644|459447793|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
127678739|NCT00241644|459447794|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
127678740|NCT00241644|459447791|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
127678741|NCT00241644|459447792|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
127678742|NCT00241644|459447793|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
127678743|NCT00241644|459447794|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
127678744|NCT00241644|459447791|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
127678745|NCT00241644|459447792|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
127678746|NCT00241644|459447793|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
127678747|NCT00241644|459447794|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
127678748|NCT00241644|459447791|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
127678749|NCT00241644|459447792|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
127678750|NCT00241644|459447793|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
127678751|NCT00241644|459447794|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
127678752|NCT00241644|459447791|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
127678753|NCT00241644|459447792|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
127678754|NCT00241644|459447793|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
127678755|NCT00241644|459447794|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
127678756|NCT00241644|459447791|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
127678757|NCT00241644|459447792|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
127678758|NCT00241644|459447793|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
127678759|NCT00241644|459447794|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
127678760|NCT00241644|459447791|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
127678761|NCT00241644|459447792|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
127678762|NCT00241644|459447793|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
127678763|NCT00241644|459447794|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
127678764|NCT00241644|459447791|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
127678765|NCT00241644|459447792|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
127678766|NCT00241644|459447793|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
127678767|NCT00241644|459447794|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
127678768|NCT00241644|459447791|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
127678769|NCT00241644|459447792|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
127678770|NCT00241644|459447793|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
127678771|NCT00241644|459447794|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
127678772|NCT00241644|459447791|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
127678773|NCT00241644|459447792|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
127678774|NCT00241644|459447793|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
127678775|NCT00241644|459447794|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
127678776|NCT00241644|459447791|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
127678777|NCT00241644|459447792|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
127678778|NCT00241644|459447793|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
127678779|NCT00241644|459447794|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
127678780|NCT00241644|459447791|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
127678781|NCT00241644|459447792|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
127678782|NCT00241644|459447793|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
127678783|NCT00241644|459447794|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
127678784|NCT00241644|459447791|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
127678785|NCT00241644|459447792|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
127678786|NCT00241644|459447793|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
127678787|NCT00241644|459447794|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
127678788|NCT01027286|459447795|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
127678789|NCT01027286|459447796|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
127766058|NCT00910689|459770088|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
127766059|NCT00910689|459770085|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
127766060|NCT00910689|459770086|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
127766061|NCT00910689|459770087|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
127766062|NCT00910689|459770088|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
127766063|NCT00484289|459770094|FG000|Long Term Phase|Adverse Event|1|||
127766064|NCT00484289|459770095|FG001|Long Term Phase|Adverse Event|17|||
127766065|NCT00484289|459770096|FG002|Long Term Phase|Adverse Event|5|||
127766066|NCT00484289|459770094|FG000|Long Term Phase|Withdrawal by Subject|0|||
127766067|NCT00484289|459770095|FG001|Long Term Phase|Withdrawal by Subject|7|||
127766068|NCT00484289|459770096|FG002|Long Term Phase|Withdrawal by Subject|6|||
127766069|NCT00484289|459770094|FG000|Long Term Phase|Inadequate response|2|||
127766070|NCT00484289|459770095|FG001|Long Term Phase|Inadequate response|7|||
127766071|NCT00484289|459770096|FG002|Long Term Phase|Inadequate response|4|||
127766072|NCT00484289|459770094|FG000|Long Term Phase|Other Reason|0|||
127766073|NCT00484289|459770095|FG001|Long Term Phase|Other Reason|5|||
127766074|NCT00484289|459770096|FG002|Long Term Phase|Other Reason|1|||
127766075|NCT00484289|459770094|FG000|Post Marketing Phase|Adverse Event|0|||
127766076|NCT00484289|459770095|FG001|Post Marketing Phase|Adverse Event|1|||
127766077|NCT00484289|459770096|FG002|Post Marketing Phase|Adverse Event|0|||
127766078|NCT02349425|459770097|FG000|Period 1|Adverse Event|1|||
127766079|NCT02349425|459770098|FG001|Period 1|Adverse Event|1|||
127766080|NCT02349425|459770099|FG002|Period 1|Adverse Event|0|||
127766081|NCT02349425|459770100|FG003|Period 1|Adverse Event|0|||
127766082|NCT02349425|459770097|FG000|Period 2|Adverse Event|0|||
127766083|NCT02349425|459770098|FG001|Period 2|Adverse Event|1|||
127766084|NCT02349425|459770099|FG002|Period 2|Adverse Event|1|||
127766085|NCT02349425|459770100|FG003|Period 2|Adverse Event|0|||
127766086|NCT02915302|459770101|FG000|Overall Study|Adverse Event|3|||
127766087|NCT02915302|459770102|FG001|Overall Study|Adverse Event|0|||
127766088|NCT02915302|459770101|FG000|Overall Study|Protocol Violation|20|||
127766089|NCT02915302|459770102|FG001|Overall Study|Protocol Violation|27|||
127766090|NCT02915302|459770101|FG000|Overall Study|Lost to Follow-up|19|||
127766091|NCT02915302|459770102|FG001|Overall Study|Lost to Follow-up|22|||
127766092|NCT02915302|459770101|FG000|Overall Study|Withdrawal by Subject|22|||
127766093|NCT02915302|459770102|FG001|Overall Study|Withdrawal by Subject|29|||
127766094|NCT02915302|459770101|FG000|Overall Study|Other|1|||
127766095|NCT02915302|459770102|FG001|Overall Study|Other|0|||
127766096|NCT01877837|459770103|FG000|Overall Study|Lost to Follow-up|1|||
127766097|NCT01877837|459770103|FG000|Overall Study|Ineligible|4|||
127766098|NCT00645801|459770105|FG000|Overall Study|unclear if patient took all the medication.|1|||
127766099|NCT00645801|459770106|FG001|Overall Study|unclear if patient took all the medication.|0|||
127766100|NCT00645801|459770105|FG000|Overall Study|Lost to Follow-up|19|||
127766101|NCT00645801|459770106|FG001|Overall Study|Lost to Follow-up|15|||
127766102|NCT00705679|459770107|FG000|Overall Study|Adverse Event|1|||
127766103|NCT00705679|459770108|FG001|Overall Study|Adverse Event|1|||
127766104|NCT00705679|459770109|FG002|Overall Study|Adverse Event|0|||
127766105|NCT00705679|459770110|FG003|Overall Study|Adverse Event|0|||
127766106|NCT00705679|459770111|FG004|Overall Study|Adverse Event|0|||
127766107|NCT00705679|459770107|FG000|Overall Study|Death|0|||
127766108|NCT00705679|459770108|FG001|Overall Study|Death|0|||
127766109|NCT00705679|459770109|FG002|Overall Study|Death|3|||
127766110|NCT00705679|459770110|FG003|Overall Study|Death|2|||
127766111|NCT00705679|459770111|FG004|Overall Study|Death|1|||
127766112|NCT00705679|459770107|FG000|Overall Study|Lost to Follow-up|32|||
127766113|NCT00705679|459770108|FG001|Overall Study|Lost to Follow-up|60|||
127766114|NCT00705679|459770109|FG002|Overall Study|Lost to Follow-up|44|||
127766115|NCT00705679|459770110|FG003|Overall Study|Lost to Follow-up|30|||
127766116|NCT00705679|459770111|FG004|Overall Study|Lost to Follow-up|35|||
127766117|NCT00705679|459770107|FG000|Overall Study|Physician Decision|0|||
127766118|NCT00705679|459770108|FG001|Overall Study|Physician Decision|1|||
127766119|NCT00705679|459770109|FG002|Overall Study|Physician Decision|0|||
128013242|NCT03329001|460675233|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
127766120|NCT00705679|459770110|FG003|Overall Study|Physician Decision|1|||
127766121|NCT00705679|459770111|FG004|Overall Study|Physician Decision|0|||
127766122|NCT00705679|459770107|FG000|Overall Study|Withdrawal by Subject|32|||
127766123|NCT00705679|459770108|FG001|Overall Study|Withdrawal by Subject|77|||
127766124|NCT00705679|459770109|FG002|Overall Study|Withdrawal by Subject|68|||
127766125|NCT00705679|459770110|FG003|Overall Study|Withdrawal by Subject|47|||
127766126|NCT00705679|459770111|FG004|Overall Study|Withdrawal by Subject|33|||
127766127|NCT00932113|459770112|FG000|Overall Study|Lost to Follow-up|1|||
127766128|NCT00932113|459770113|FG001|Overall Study|Lost to Follow-up|0|||
127766129|NCT01403610|459770114|FG000|Overall Study|Withdrawal by Subject|2|||
127766130|NCT01403610|459770115|FG001|Overall Study|Withdrawal by Subject|0|||
127766131|NCT01403610|459770116|FG002|Overall Study|Withdrawal by Subject|0|||
127766132|NCT01403610|459770117|FG003|Overall Study|Withdrawal by Subject|0|||
127766133|NCT01403610|459770114|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
127766134|NCT01403610|459770115|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
128013243|NCT03329001|460675234|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
128013244|NCT03329001|460675235|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
127766135|NCT01403610|459770116|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
127766136|NCT01403610|459770117|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
127766137|NCT00896051|459770121|FG000|Overall Study|Adverse Event|2|||
127766138|NCT00896051|459770122|FG001|Overall Study|Adverse Event|1|||
127766139|NCT00896051|459770121|FG000|Overall Study|Lost to Follow-up|3|||
127766140|NCT00896051|459770122|FG001|Overall Study|Lost to Follow-up|2|||
127766141|NCT00896051|459770121|FG000|Overall Study|Withdrawal by Subject|3|||
127766142|NCT00896051|459770122|FG001|Overall Study|Withdrawal by Subject|2|||
127766143|NCT00896051|459770121|FG000|Overall Study|Subject noncompliant|1|||
127766144|NCT00896051|459770122|FG001|Overall Study|Subject noncompliant|3|||
127766145|NCT00896051|459770121|FG000|Overall Study|Other|1|||
127766146|NCT00896051|459770122|FG001|Overall Study|Other|1|||
127766147|NCT02935452|459770123|FG000|Overall Study|work and life commintment|3|||
127766148|NCT02935452|459770124|FG001|Overall Study|work and life commintment|1|||
127766149|NCT00876928|459770125|FG000|Overall Study|Lost to Follow-up|2|||
127766150|NCT00876928|459770126|FG001|Overall Study|Lost to Follow-up|5|||
127766151|NCT00876928|459770125|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
127766152|NCT00876928|459770126|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
127766153|NCT01143038|459770131|FG000|Overall Study|Withdrawal by Subject|4|||
127766154|NCT01143038|459770131|FG000|Overall Study|Requirement for alternative therapy|5|||
127766155|NCT01143038|459770131|FG000|Overall Study|Adverse Event|3|||
127766156|NCT01143038|459770131|FG000|Overall Study|Lost to Follow-up|2|||
127766157|NCT01143038|459770131|FG000|Overall Study|Protocol Deviation|1|||
127766158|NCT01143038|459770131|FG000|Overall Study|Death|1|||
127766159|NCT01346475|459770135|FG000|First Intervention|Lost to Follow-up|4|||
127766160|NCT01346475|459770136|FG001|First Intervention|Lost to Follow-up|3|||
127766161|NCT00370331|459770137|FG000|Overall Study|Adverse Event|4|||
128013245|NCT03329001|460675228|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
127766162|NCT00370331|459770138|FG001|Overall Study|Adverse Event|13|||
127766163|NCT00370331|459770137|FG000|Overall Study|Withdrawal by Subject|2|||
127766164|NCT00370331|459770138|FG001|Overall Study|Withdrawal by Subject|4|||
127766165|NCT00370331|459770137|FG000|Overall Study|Lost to Follow-up|0|||
127766166|NCT00370331|459770138|FG001|Overall Study|Lost to Follow-up|3|||
127766167|NCT00370331|459770137|FG000|Overall Study|Lack of Efficacy|0|||
127766168|NCT00370331|459770138|FG001|Overall Study|Lack of Efficacy|1|||
127766169|NCT00370331|459770137|FG000|Overall Study|Non-compliance|0|||
127766170|NCT00370331|459770138|FG001|Overall Study|Non-compliance|1|||
127766171|NCT00370331|459770137|FG000|Overall Study|Protocol Violation|1|||
127766172|NCT00370331|459770138|FG001|Overall Study|Protocol Violation|1|||
127766173|NCT00757588|459770139|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
127766174|NCT00757588|459770140|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
127766175|NCT00757588|459770139|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
127766176|NCT00757588|459770140|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
127766177|NCT00757588|459770139|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
127766178|NCT00757588|459770140|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
127766179|NCT00757588|459770139|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
127766180|NCT00757588|459770140|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
127766181|NCT00757588|459770139|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
127766182|NCT00757588|459770140|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
127766183|NCT00757588|459770139|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
127766184|NCT00757588|459770140|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
127766185|NCT00757588|459770139|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
127766186|NCT00757588|459770140|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
127766187|NCT00757588|459770139|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
127766188|NCT00757588|459770140|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
127766189|NCT00757588|459770139|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
127766190|NCT00757588|459770140|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
127766191|NCT00757588|459770139|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
127766192|NCT00757588|459770140|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
128013246|NCT03329001|460675229|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
128013247|NCT03329001|460675230|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
128013248|NCT03329001|460675231|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|1|||
127766193|NCT00757588|459770139|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
127766194|NCT00757588|459770140|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
127766195|NCT00757588|459770139|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
127766196|NCT00757588|459770140|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
127766197|NCT00757588|459770139|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
127766198|NCT00757588|459770140|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
128013249|NCT03329001|460675232|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
128013250|NCT03329001|460675233|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
128013251|NCT03329001|460675234|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
128013252|NCT03329001|460675235|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
128013253|NCT03329001|460675228|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
128013254|NCT03329001|460675229|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
128013255|NCT03329001|460675230|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
128013256|NCT03329001|460675231|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|1|||
128013257|NCT03329001|460675232|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
127678790|NCT01027286|459447795|FG000|Overall Study|Lost to Follow-up|0|||
127678791|NCT01027286|459447796|FG001|Overall Study|Lost to Follow-up|1|||
127678792|NCT01563354|459447797|FG000|Core Phase|Adverse Event|5|||
127678793|NCT01563354|459447798|FG001|Core Phase|Adverse Event|15|||
127678794|NCT01563354|459447799|FG002|Core Phase|Adverse Event|13|||
127678795|NCT01563354|459447797|FG000|Core Phase|Withdrawal by Subject|1|||
127678796|NCT01563354|459447798|FG001|Core Phase|Withdrawal by Subject|0|||
127678797|NCT01563354|459447799|FG002|Core Phase|Withdrawal by Subject|3|||
127678798|NCT01563354|459447797|FG000|Core Phase|Lost to Follow-up|1|||
127678799|NCT01563354|459447798|FG001|Core Phase|Lost to Follow-up|0|||
127678800|NCT01563354|459447799|FG002|Core Phase|Lost to Follow-up|0|||
127678801|NCT01563354|459447797|FG000|Core Phase|Death|1|||
127678802|NCT01563354|459447798|FG001|Core Phase|Death|5|||
127678803|NCT01563354|459447799|FG002|Core Phase|Death|2|||
127678804|NCT01563354|459447797|FG000|Core Phase|Diseasse progression|18|||
127678805|NCT01563354|459447798|FG001|Core Phase|Diseasse progression|7|||
127678806|NCT01563354|459447799|FG002|Core Phase|Diseasse progression|8|||
127678807|NCT01563354|459447797|FG000|Core Phase|Protocol deviation|2|||
127678808|NCT01563354|459447798|FG001|Core Phase|Protocol deviation|0|||
127678809|NCT01563354|459447799|FG002|Core Phase|Protocol deviation|0|||
127678810|NCT01563354|459447797|FG000|Core Phase|PI decision - did not enter extension|0|||
127678811|NCT01563354|459447798|FG001|Core Phase|PI decision - did not enter extension|1|||
127678812|NCT01563354|459447799|FG002|Core Phase|PI decision - did not enter extension|0|||
127678813|NCT01563354|459447797|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
127678814|NCT01563354|459447798|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
127678815|NCT01563354|459447799|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
127678816|NCT01563354|459447797|FG000|Extension Phase|Adverse Event|0|||
127678817|NCT01563354|459447798|FG001|Extension Phase|Adverse Event|3|||
127678818|NCT01563354|459447799|FG002|Extension Phase|Adverse Event|2|||
127678819|NCT01563354|459447797|FG000|Extension Phase|Withdrawal by Subject|0|||
127678820|NCT01563354|459447798|FG001|Extension Phase|Withdrawal by Subject|1|||
127678821|NCT01563354|459447799|FG002|Extension Phase|Withdrawal by Subject|0|||
127678822|NCT01563354|459447797|FG000|Extension Phase|Administration problems|3|||
127678823|NCT01563354|459447798|FG001|Extension Phase|Administration problems|2|||
127678824|NCT01563354|459447799|FG002|Extension Phase|Administration problems|3|||
127678825|NCT01563354|459447797|FG000|Extension Phase|Disease progression|9|||
127678826|NCT01563354|459447798|FG001|Extension Phase|Disease progression|8|||
127678827|NCT01563354|459447799|FG002|Extension Phase|Disease progression|10|||
127678828|NCT01565928|459447800|FG000|Overall Study|Adverse Event|3|||
127678829|NCT01565928|459447800|FG000|Overall Study|Other|3|||
127678830|NCT01565928|459447800|FG000|Overall Study|Progressive Disease|13|||
127678831|NCT01565928|459447800|FG000|Overall Study|Withdrawal by Subject|1|||
127678832|NCT01565928|459447800|FG000|Overall Study|Death|2|||
127678833|NCT00608907|459447803|FG000|Overall Study|Adverse Event|6|||
127678834|NCT00608907|459447804|FG001|Overall Study|Adverse Event|0|||
127678835|NCT00608907|459447805|FG002|Overall Study|Adverse Event|1|||
127678836|NCT00608907|459447803|FG000|Overall Study|Death|1|||
127678837|NCT00608907|459447804|FG001|Overall Study|Death|0|||
127678838|NCT00608907|459447805|FG002|Overall Study|Death|0|||
127678839|NCT00608907|459447803|FG000|Overall Study|Withdrawal by Subject|4|||
127678840|NCT00608907|459447804|FG001|Overall Study|Withdrawal by Subject|0|||
127678841|NCT00608907|459447805|FG002|Overall Study|Withdrawal by Subject|0|||
127678842|NCT00608907|459447803|FG000|Overall Study|Progressive Disease|1|||
127678843|NCT00608907|459447804|FG001|Overall Study|Progressive Disease|0|||
127678844|NCT00608907|459447805|FG002|Overall Study|Progressive Disease|0|||
127678845|NCT01988233|459447808|FG000|Overall Study|Lost to Follow-up|64|||
127678846|NCT01988233|459447809|FG001|Overall Study|Lost to Follow-up|51|||
127678847|NCT03621761|459447814|FG000|Overall Study|Lost to Follow-up|1|||
127678848|NCT03621761|459447815|FG001|Overall Study|Lost to Follow-up|1|||
127678849|NCT03621761|459447816|FG002|Overall Study|Lost to Follow-up|2|||
127678850|NCT03621761|459447814|FG000|Overall Study|Withdrawal by Subject|2|||
127678851|NCT03621761|459447815|FG001|Overall Study|Withdrawal by Subject|1|||
127678852|NCT03621761|459447816|FG002|Overall Study|Withdrawal by Subject|1|||
127678853|NCT03621761|459447814|FG000|Overall Study|Became Ineligible|0|||
127678854|NCT03621761|459447815|FG001|Overall Study|Became Ineligible|2|||
127678855|NCT03621761|459447816|FG002|Overall Study|Became Ineligible|0|||
127678856|NCT03939819|459447817|FG000|Overall Study|Death|2|||
127766199|NCT00757588|459770139|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
127766200|NCT00757588|459770140|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
127766201|NCT00757588|459770139|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
127766202|NCT00757588|459770140|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
127766203|NCT00757588|459770139|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
127766204|NCT00757588|459770140|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
127766205|NCT01052103|459770141|FG000|Overall Study|Adverse Event|10|||
127766206|NCT01052103|459770142|FG001|Overall Study|Adverse Event|6|||
127766207|NCT01052103|459770141|FG000|Overall Study|Entry Criteria Not Met|3|||
127766208|NCT01052103|459770142|FG001|Overall Study|Entry Criteria Not Met|1|||
127766209|NCT01052103|459770141|FG000|Overall Study|Lost to Follow-up|3|||
127766210|NCT01052103|459770142|FG001|Overall Study|Lost to Follow-up|5|||
127766211|NCT01052103|459770141|FG000|Overall Study|Protocol Violation|10|||
127766212|NCT01052103|459770142|FG001|Overall Study|Protocol Violation|4|||
127766213|NCT01052103|459770141|FG000|Overall Study|Scheduling conflict|2|||
127766214|NCT01052103|459770142|FG001|Overall Study|Scheduling conflict|1|||
127766215|NCT01052103|459770141|FG000|Overall Study|Sponsor Decision|2|||
127766216|NCT01052103|459770142|FG001|Overall Study|Sponsor Decision|0|||
127766217|NCT01052103|459770141|FG000|Overall Study|Withdrawal by Subject|3|||
127766218|NCT01052103|459770142|FG001|Overall Study|Withdrawal by Subject|6|||
127766219|NCT01052103|459770141|FG000|Overall Study|Perceived Lack of Efficacy|1|||
127766220|NCT01052103|459770142|FG001|Overall Study|Perceived Lack of Efficacy|0|||
127766221|NCT05398237|459770146|FG000|Overall Study|Withdrawal by Subject|1|||
127766222|NCT00321373|459770151|FG000|Overall Study|Adverse Event|0|||
127766223|NCT00321373|459770152|FG001|Overall Study|Adverse Event|0|||
127766224|NCT00321373|459770153|FG002|Overall Study|Adverse Event|1|||
127766225|NCT00321373|459770151|FG000|Overall Study|Lost to Follow-up|1|||
127766226|NCT00321373|459770152|FG001|Overall Study|Lost to Follow-up|0|||
127766227|NCT00321373|459770153|FG002|Overall Study|Lost to Follow-up|1|||
127766228|NCT00321373|459770151|FG000|Overall Study|Withdrawal by Subject|1|||
127766229|NCT00321373|459770152|FG001|Overall Study|Withdrawal by Subject|0|||
127766230|NCT00321373|459770153|FG002|Overall Study|Withdrawal by Subject|0|||
127766231|NCT00321373|459770151|FG000|Overall Study|Other|0|||
127766232|NCT00321373|459770152|FG001|Overall Study|Other|0|||
127766233|NCT00321373|459770153|FG002|Overall Study|Other|1|||
127766234|NCT00552240|459770159|FG000|Overall Study|Adverse Event|9|||
127766235|NCT00552240|459770160|FG001|Overall Study|Adverse Event|9|||
127766236|NCT00552240|459770159|FG000|Overall Study|Protocol Violation|1|||
127766237|NCT00552240|459770160|FG001|Overall Study|Protocol Violation|1|||
127766238|NCT00552240|459770159|FG000|Overall Study|Lost to Follow-up|5|||
127766239|NCT00552240|459770160|FG001|Overall Study|Lost to Follow-up|6|||
127766240|NCT00552240|459770159|FG000|Overall Study|Withdrawal by Subject|2|||
127766241|NCT00552240|459770160|FG001|Overall Study|Withdrawal by Subject|2|||
127766242|NCT00552240|459770159|FG000|Overall Study|Lack of Efficacy|6|||
127766243|NCT00552240|459770160|FG001|Overall Study|Lack of Efficacy|0|||
127766244|NCT00552240|459770159|FG000|Overall Study|Other|1|||
127766245|NCT00552240|459770160|FG001|Overall Study|Other|0|||
127766246|NCT02783768|459770162|FG000|Overall Study|Lost to Follow-up|1|||
127766247|NCT02783768|459770163|FG001|Overall Study|Lost to Follow-up|0|||
127766248|NCT01323647|459770164|FG000|Overall Study|Migrated/moved from study area|2|||
127766249|NCT01323647|459770165|FG001|Overall Study|Migrated/moved from study area|0|||
127766250|NCT01323647|459770164|FG000|Overall Study|Withdrawal by Subject|5|||
127766251|NCT01323647|459770165|FG001|Overall Study|Withdrawal by Subject|0|||
127766252|NCT01323647|459770164|FG000|Overall Study|Lost to Follow-up|2|||
127766253|NCT01323647|459770165|FG001|Overall Study|Lost to Follow-up|0|||
127766254|NCT01945060|459770178|FG000|Overall Study|Lost to follow up|1|||
127766255|NCT01945060|459770179|FG001|Overall Study|Lost to follow up|0|||
127766256|NCT01945060|459770178|FG000|Overall Study|Distress related to IV access|0|||
127766257|NCT01945060|459770179|FG001|Overall Study|Distress related to IV access|1|||
127766258|NCT00402597|459770180|FG000|Overall Study|Death|15|||
127766259|NCT00402597|459770181|FG001|Overall Study|Death|7|||
127766260|NCT00402597|459770182|FG002|Overall Study|Death|6|||
128013258|NCT03329001|460675233|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
127766261|NCT00402597|459770183|FG003|Overall Study|Death|4|||
127766262|NCT00402597|459770184|FG004|Overall Study|Death|6|||
127766263|NCT00402597|459770180|FG000|Overall Study|Adverse Event|81|||
127766264|NCT00402597|459770181|FG001|Overall Study|Adverse Event|18|||
127766265|NCT00402597|459770182|FG002|Overall Study|Adverse Event|106|||
127766266|NCT00402597|459770183|FG003|Overall Study|Adverse Event|39|||
127766267|NCT00402597|459770184|FG004|Overall Study|Adverse Event|71|||
127766268|NCT00402597|459770180|FG000|Overall Study|Lost to Follow-up|8|||
127766269|NCT00402597|459770181|FG001|Overall Study|Lost to Follow-up|1|||
127766270|NCT00402597|459770182|FG002|Overall Study|Lost to Follow-up|8|||
127766271|NCT00402597|459770183|FG003|Overall Study|Lost to Follow-up|2|||
127766272|NCT00402597|459770184|FG004|Overall Study|Lost to Follow-up|3|||
127766273|NCT00402597|459770180|FG000|Overall Study|Withdrawal by Subject|57|||
127766274|NCT00402597|459770181|FG001|Overall Study|Withdrawal by Subject|16|||
127766275|NCT00402597|459770182|FG002|Overall Study|Withdrawal by Subject|65|||
128013259|NCT03329001|460675234|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
128013260|NCT03329001|460675235|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
128013261|NCT03329001|460675228|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
128013262|NCT03329001|460675229|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
128013263|NCT03329001|460675230|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|1|||
128013264|NCT03329001|460675231|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
128013265|NCT03329001|460675232|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
128013266|NCT03329001|460675233|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
128013267|NCT03329001|460675234|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
128013268|NCT03329001|460675235|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
128013269|NCT03329001|460675228|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
128013270|NCT03329001|460675229|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
128013271|NCT03329001|460675230|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|1|||
128013272|NCT03329001|460675231|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
128013273|NCT03329001|460675232|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
128013274|NCT03329001|460675233|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
128013275|NCT03329001|460675234|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
128013276|NCT03329001|460675235|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
128013277|NCT03329001|460675228|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
128013278|NCT03329001|460675229|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
128013279|NCT03329001|460675230|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|1|||
128013280|NCT03329001|460675231|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
128013281|NCT03329001|460675232|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
128013282|NCT03329001|460675233|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
128013283|NCT03329001|460675234|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
128013284|NCT03329001|460675235|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
128013285|NCT03329001|460675228|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
128013286|NCT03329001|460675229|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
128013287|NCT03329001|460675230|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|1|||
128013288|NCT03329001|460675231|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
128013289|NCT03329001|460675232|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
128013290|NCT03329001|460675233|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
128013291|NCT03329001|460675234|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
128013292|NCT03329001|460675235|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
128013293|NCT03329001|460675228|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
128013294|NCT03329001|460675229|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
128013295|NCT03329001|460675230|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
128013296|NCT03329001|460675231|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
128013297|NCT03329001|460675232|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
128013298|NCT03329001|460675233|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
128013299|NCT03329001|460675234|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
128013300|NCT03329001|460675235|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
128013301|NCT03329001|460675228|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
128013302|NCT03329001|460675229|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
128013303|NCT03329001|460675230|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|1|||
128013304|NCT03329001|460675231|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
128013305|NCT03329001|460675232|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
127678857|NCT03939819|459447818|FG001|Overall Study|Death|0|||
127678858|NCT04379713|459447819|FG000|Overall Study|Adverse Event|2|||
127678859|NCT04379713|459447820|FG001|Overall Study|Adverse Event|0|||
127678860|NCT04379713|459447819|FG000|Overall Study|Physician Decision|2|||
127678861|NCT04379713|459447820|FG001|Overall Study|Physician Decision|1|||
127678862|NCT04379713|459447819|FG000|Overall Study|Protocol Violation|11|||
128013306|NCT03329001|460675233|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
128013307|NCT03329001|460675234|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
128013308|NCT03329001|460675235|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
128013309|NCT03329001|460675228|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
127678863|NCT04379713|459447820|FG001|Overall Study|Protocol Violation|6|||
127678864|NCT04379713|459447819|FG000|Overall Study|No longer met eligibility criteria|14|||
127678865|NCT04379713|459447820|FG001|Overall Study|No longer met eligibility criteria|11|||
127678866|NCT04379713|459447819|FG000|Overall Study|Withdrawal by parent/guardian|36|||
127678867|NCT04379713|459447820|FG001|Overall Study|Withdrawal by parent/guardian|15|||
127678868|NCT04379713|459447819|FG000|Overall Study|Lost to Follow-up|31|||
127678869|NCT04379713|459447820|FG001|Overall Study|Lost to Follow-up|21|||
127678870|NCT03808883|459447822|FG000|Overall Study|Withdrawal by Subject|2|||
127678871|NCT03808883|459447823|FG001|Overall Study|Withdrawal by Subject|0|||
127678872|NCT03808883|459447822|FG000|Overall Study|Did not complete pre test or post test survey|4|||
127678873|NCT03808883|459447823|FG001|Overall Study|Did not complete pre test or post test survey|3|||
127678874|NCT00158054|459447825|FG000|Overall Study|Refused to continue|3|||
127678875|NCT00158054|459447826|FG001|Overall Study|Refused to continue|0|||
127678876|NCT00158054|459447825|FG000|Overall Study|Unavailable for follow up|7|||
127678877|NCT00158054|459447826|FG001|Overall Study|Unavailable for follow up|3|||
127678878|NCT00855465|459447827|FG000|Treatment Period|Adverse Event|4|||
127678879|NCT00855465|459447828|FG001|Treatment Period|Adverse Event|2|||
127678880|NCT00855465|459447827|FG000|Treatment Period|Death|2|||
127678881|NCT00855465|459447828|FG001|Treatment Period|Death|2|||
127678882|NCT00855465|459447827|FG000|Treatment Period|Lack of Efficacy|2|||
127678883|NCT00855465|459447828|FG001|Treatment Period|Lack of Efficacy|1|||
127678884|NCT00855465|459447827|FG000|Treatment Period|Non-compliance|1|||
127678885|NCT00855465|459447828|FG001|Treatment Period|Non-compliance|0|||
127678886|NCT00855465|459447827|FG000|Treatment Period|Protocol Violation|2|||
127678887|NCT00855465|459447828|FG001|Treatment Period|Protocol Violation|0|||
127678888|NCT00855465|459447827|FG000|Treatment Period|Withdrawal by Subject|2|||
127678889|NCT00855465|459447828|FG001|Treatment Period|Withdrawal by Subject|0|||
127678890|NCT00855465|459447827|FG000|Treatment Period|Not treated|1|||
127678891|NCT00855465|459447828|FG001|Treatment Period|Not treated|0|||
127678892|NCT00855465|459447827|FG000|Follow-up Period (FUP)|Adverse Event|0|||
127678893|NCT00855465|459447828|FG001|Follow-up Period (FUP)|Adverse Event|1|||
127678894|NCT00855465|459447827|FG000|Follow-up Period (FUP)|Death|0|||
127678895|NCT00855465|459447828|FG001|Follow-up Period (FUP)|Death|1|||
127678896|NCT00855465|459447827|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
127678897|NCT00855465|459447828|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
127678898|NCT00855465|459447827|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
127678899|NCT00855465|459447828|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
127678900|NCT00855465|459447827|FG000|Follow-up Period (FUP)|Missing|1|||
127678901|NCT00855465|459447828|FG001|Follow-up Period (FUP)|Missing|0|||
127678902|NCT04567888|459447839|FG000|Overall Study|Did Not Create Happify for Teens Account|22|||
127678903|NCT04567888|459447840|FG001|Overall Study|Did Not Create Happify for Teens Account|0|||
127678904|NCT04567888|459447839|FG000|Overall Study|Did Not Complete Any Happify for Teens Activities|22|||
127678905|NCT04567888|459447840|FG001|Overall Study|Did Not Complete Any Happify for Teens Activities|0|||
127678906|NCT04567888|459447839|FG000|Overall Study|Reported Unusual Birth Year|2|||
127678907|NCT04567888|459447840|FG001|Overall Study|Reported Unusual Birth Year|3|||
127678908|NCT04567888|459447839|FG000|Overall Study|Duplicate Responses|0|||
127678909|NCT04567888|459447840|FG001|Overall Study|Duplicate Responses|1|||
127678910|NCT00436644|459447842|FG000|Overall Study|Adverse Event|2|||
127678911|NCT00436644|459447842|FG000|Overall Study|Death|1|||
127678912|NCT01490580|459447847|FG000|Overall Study|Parents withdrew consent|0|||
127678913|NCT01490580|459447848|FG001|Overall Study|Parents withdrew consent|2|||
127678914|NCT00756730|459447849|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
127678915|NCT00756730|459447850|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
127678916|NCT00756730|459447849|FG000|Overall Study|persistent low-level viremmia|0|||
127678917|NCT00756730|459447850|FG001|Overall Study|persistent low-level viremmia|1|||
127678918|NCT01161498|459447851|FG000|Overall Study|Disease Progression|0|||
127678919|NCT01161498|459447852|FG001|Overall Study|Disease Progression|1|||
127678920|NCT05052983|459447864|FG000|Overall Study|Lack of Efficacy|3|||
127678921|NCT05052983|459447865|FG001|Overall Study|Lack of Efficacy|12|||
127678922|NCT05052983|459447864|FG000|Overall Study|Adverse Event|1|||
127678923|NCT05052983|459447865|FG001|Overall Study|Adverse Event|0|||
127678924|NCT03425643|459447866|FG000|Overall Study|Withdrawal by Subject|10|||
127678925|NCT03425643|459447867|FG001|Overall Study|Withdrawal by Subject|12|||
127678926|NCT03425643|459447866|FG000|Overall Study|Lost to Follow-up|2|||
127678927|NCT03425643|459447867|FG001|Overall Study|Lost to Follow-up|0|||
128013310|NCT03329001|460675229|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
127678928|NCT03425643|459447866|FG000|Overall Study|Death|109|||
127678929|NCT03425643|459447867|FG001|Overall Study|Death|141|||
127678930|NCT03425643|459447866|FG000|Overall Study|Ongoing in study|276|||
127678931|NCT03425643|459447867|FG001|Overall Study|Ongoing in study|247|||
127678932|NCT04133363|459447868|FG000|Overall Study|Lost to Follow-up|2|||
127766276|NCT00402597|459770183|FG003|Overall Study|Withdrawal by Subject|15|||
127766277|NCT00402597|459770184|FG004|Overall Study|Withdrawal by Subject|24|||
127766278|NCT00402597|459770180|FG000|Overall Study|reason not specified|30|||
127766279|NCT00402597|459770181|FG001|Overall Study|reason not specified|4|||
127766280|NCT00402597|459770182|FG002|Overall Study|reason not specified|27|||
127766281|NCT00402597|459770183|FG003|Overall Study|reason not specified|14|||
127766282|NCT00402597|459770184|FG004|Overall Study|reason not specified|20|||
127766283|NCT02319525|459770185|FG000|Overall Study|Withdrawal by Subject|2|||
127766284|NCT02319525|459770186|FG001|Overall Study|Withdrawal by Subject|1|||
127766285|NCT00938860|459770187|FG000|Overall Study|Adverse Event|2|||
127766286|NCT00938860|459770188|FG001|Overall Study|Adverse Event|1|||
128013311|NCT03329001|460675230|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
128013312|NCT03329001|460675231|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
128013313|NCT03329001|460675232|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
128013314|NCT03329001|460675233|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
128013315|NCT03329001|460675234|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
128013316|NCT03329001|460675235|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
127678933|NCT04133363|459447869|FG001|Overall Study|Lost to Follow-up|1|||
127678934|NCT04133363|459447870|FG002|Overall Study|Lost to Follow-up|4|||
127678935|NCT00849147|459447874|FG000|Overall Study|Withdrawal by Subject|1|||
127678936|NCT00849147|459447874|FG000|Overall Study|Protocol Violation|2|||
127678937|NCT00849147|459447874|FG000|Overall Study|Disease Relapse/Progression|2|||
127678938|NCT02631148|459450115|FG000|Overall Study|8 were ineligible|8|||
127678939|NCT02631148|459450116|FG001|Overall Study|8 were ineligible|0|||
127678940|NCT02631148|459450115|FG000|Overall Study|Withdrawal by Subject|1|||
127678941|NCT02631148|459450116|FG001|Overall Study|Withdrawal by Subject|0|||
127678942|NCT02631148|459450115|FG000|Overall Study|PAH not available to study participant|1|||
127678943|NCT02631148|459450116|FG001|Overall Study|PAH not available to study participant|0|||
127678944|NCT02525796|459450122|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
127678945|NCT02525796|459450123|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
127678946|NCT02525796|459450124|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
127678947|NCT02525796|459450122|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
127678948|NCT02525796|459450123|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
127678949|NCT02525796|459450124|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
127678950|NCT02525796|459450122|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
127678951|NCT02525796|459450123|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
127678952|NCT02525796|459450124|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
127678953|NCT02525796|459450122|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
127678954|NCT02525796|459450123|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
127678955|NCT02525796|459450124|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
127678956|NCT02525796|459450122|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
127678957|NCT02525796|459450123|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
127678958|NCT02525796|459450124|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
127678959|NCT02488980|459450125|FG000|Overall Study|Protocol Violation|2|||
127678960|NCT02488980|459450126|FG001|Overall Study|Protocol Violation|2|||
127678961|NCT02488980|459450127|FG002|Overall Study|Protocol Violation|2|||
127678962|NCT02385669|459450138|FG000|Overall Study|Adverse Event|2|||
127678963|NCT00970307|459450139|FG000|Overall Study|Serious Adverse Event|1|||
127678964|NCT00970307|459450140|FG001|Overall Study|Serious Adverse Event|0|||
127678965|NCT00970307|459450141|FG002|Overall Study|Serious Adverse Event|0|||
127678966|NCT00970307|459450139|FG000|Overall Study|Withdrawal by Subject|2|||
127678967|NCT00970307|459450140|FG001|Overall Study|Withdrawal by Subject|3|||
127678968|NCT00970307|459450141|FG002|Overall Study|Withdrawal by Subject|2|||
127678969|NCT00753012|459450147|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
127678970|NCT00753012|459450148|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
127678971|NCT00753012|459450147|FG000|Overall Study|Adverse Event|2|||
127678972|NCT00753012|459450148|FG001|Overall Study|Adverse Event|0|||
127678973|NCT00753012|459450147|FG000|Overall Study|Withdrawal by Subject|0|||
127678974|NCT00753012|459450148|FG001|Overall Study|Withdrawal by Subject|1|||
127678975|NCT00753012|459450147|FG000|Overall Study|Lost to Follow-up|4|||
127678976|NCT00753012|459450148|FG001|Overall Study|Lost to Follow-up|0|||
127678977|NCT00753012|459450147|FG000|Overall Study|Confounded endpoint data|1|||
127678978|NCT00753012|459450148|FG001|Overall Study|Confounded endpoint data|0|||
127678979|NCT00943735|459450151|FG000|Overall Study|Adverse Event|12|||
127766287|NCT00938860|459770187|FG000|Overall Study|Abnormal laboratory values|2|||
127766288|NCT00938860|459770188|FG001|Overall Study|Abnormal laboratory values|2|||
127766289|NCT00938860|459770187|FG000|Overall Study|Withdrawal by Subject|11|||
127678980|NCT00943735|459450151|FG000|Overall Study|Withdrawal by Subject|8|||
127678981|NCT00943735|459450151|FG000|Overall Study|Death|1|||
127678982|NCT00943735|459450151|FG000|Overall Study|Other|8|||
127678983|NCT00943735|459450151|FG000|Overall Study|Other|3|||
127678984|NCT03804918|459450152|FG000|Overall Study|Participant did not use the app|1|||
128013317|NCT03329001|460675228|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
128013318|NCT03329001|460675229|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
128013319|NCT03329001|460675230|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|5|||
128013320|NCT03329001|460675231|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|2|||
128013321|NCT03329001|460675232|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
128013322|NCT03329001|460675233|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
128013323|NCT03329001|460675234|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
128013324|NCT03329001|460675235|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
128013325|NCT03329001|460675228|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
128013326|NCT03329001|460675229|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
128013327|NCT03329001|460675230|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Death|1|||
128013328|NCT03329001|460675231|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Death|2|||
128013329|NCT03329001|460675232|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
128013330|NCT03329001|460675233|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
128013331|NCT03329001|460675234|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
128013332|NCT03329001|460675235|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
128013333|NCT03329001|460675228|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
128013334|NCT03329001|460675229|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
128013335|NCT03329001|460675230|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
128013336|NCT03329001|460675231|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|1|||
128013337|NCT03329001|460675232|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
128013338|NCT03329001|460675233|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
128013339|NCT03329001|460675234|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
128013340|NCT03329001|460675235|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
128013341|NCT03329001|460675228|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
128013342|NCT03329001|460675229|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
128013343|NCT03329001|460675230|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
128013344|NCT03329001|460675231|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|1|||
128013345|NCT03329001|460675232|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
128013346|NCT03329001|460675233|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
128013347|NCT03329001|460675234|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
128013348|NCT03329001|460675235|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
128013349|NCT03329001|460675228|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
128013350|NCT03329001|460675229|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
128013351|NCT03329001|460675230|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|1|||
128013352|NCT03329001|460675231|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
127678985|NCT01329328|459450153|FG000|Overall Study|Withdrawal by Subject|2|||
127678986|NCT01329328|459450154|FG001|Overall Study|Withdrawal by Subject|4|||
127678987|NCT01329328|459450155|FG002|Overall Study|Withdrawal by Subject|3|||
127678988|NCT04842604|459450162|FG000|Overall Study|Death|1|||
127678989|NCT04842604|459450163|FG001|Overall Study|Death|0|||
127678990|NCT04842604|459450162|FG000|Overall Study|Other|4|||
127678991|NCT04842604|459450163|FG001|Overall Study|Other|4|||
127678992|NCT04842604|459450162|FG000|Overall Study|Randomized but not treated|1|||
127678993|NCT04842604|459450163|FG001|Overall Study|Randomized but not treated|0|||
127678994|NCT01193153|459450164|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
127678995|NCT01193153|459450165|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
127678996|NCT01193153|459450164|FG000|Open-label Lead in Period|Pregnancy|1|||
127678997|NCT01193153|459450165|FG001|Open-label Lead in Period|Pregnancy|0|||
127678998|NCT01193153|459450164|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
127678999|NCT01193153|459450165|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
127679000|NCT01193153|459450164|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
127679001|NCT01193153|459450165|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
127679002|NCT01193153|459450164|FG000|Open-label Lead in Period|Other|14|||
127679003|NCT01193153|459450165|FG001|Open-label Lead in Period|Other|0|||
127679004|NCT01193153|459450164|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
127679005|NCT01193153|459450165|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
127679006|NCT01193153|459450164|FG000|Open-label Lead in Period|Adverse Event|41|||
127679007|NCT01193153|459450165|FG001|Open-label Lead in Period|Adverse Event|0|||
127679008|NCT01193153|459450164|FG000|Open-label Lead in Period|Death|1|||
127679009|NCT01193153|459450165|FG001|Open-label Lead in Period|Death|0|||
127679010|NCT01193153|459450164|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
128013353|NCT03329001|460675232|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
128013354|NCT03329001|460675233|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
128013355|NCT03329001|460675234|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
128013356|NCT03329001|460675235|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
127679011|NCT01193153|459450165|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
127679012|NCT01193153|459450164|FG000|Open-label Stabilization Period|Adverse Event|9|||
128013357|NCT03329001|460675228|FG000|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
128013358|NCT03329001|460675229|FG001|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
128013359|NCT03329001|460675230|FG002|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
128013360|NCT03329001|460675231|FG003|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
128013361|NCT03329001|460675232|FG004|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
128013362|NCT03329001|460675233|FG005|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
128013363|NCT03329001|460675234|FG006|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
128013364|NCT03329001|460675235|FG007|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
128013365|NCT03329001|460675228|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
128013366|NCT03329001|460675229|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
127679013|NCT01193153|459450165|FG001|Open-label Stabilization Period|Adverse Event|0|||
127679014|NCT01193153|459450164|FG000|Open-label Stabilization Period|Death|2|||
127679015|NCT01193153|459450165|FG001|Open-label Stabilization Period|Death|0|||
127679016|NCT01193153|459450164|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
127679017|NCT01193153|459450165|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
127679018|NCT01193153|459450164|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
127679019|NCT01193153|459450165|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
127679020|NCT01193153|459450164|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
127679021|NCT01193153|459450165|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
127679022|NCT01193153|459450164|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
127679023|NCT01193153|459450165|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
127679024|NCT01193153|459450164|FG000|Open-label Stabilization Period|Other|8|||
127679025|NCT01193153|459450165|FG001|Open-label Stabilization Period|Other|0|||
127679026|NCT01193153|459450164|FG000|Double Blind Relapse Prevention Period|Other|2|||
127679027|NCT01193153|459450165|FG001|Double Blind Relapse Prevention Period|Other|3|||
127679028|NCT01193153|459450164|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
127679029|NCT01193153|459450165|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
127679030|NCT01193153|459450164|FG000|Double Blind Relapse Prevention Period|Death|2|||
127679031|NCT01193153|459450165|FG001|Double Blind Relapse Prevention Period|Death|0|||
127679032|NCT01193153|459450164|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
127679033|NCT01193153|459450165|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
127679034|NCT01193153|459450164|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
127679035|NCT01193153|459450165|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
127679036|NCT01193153|459450164|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
127679037|NCT01193153|459450165|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
127679038|NCT01193153|459450164|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
127679039|NCT01193153|459450165|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
127679040|NCT01193153|459450164|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
127679041|NCT01193153|459450165|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
127679042|NCT01648140|459450166|FG000|Overall Study|Physician Decision|1|||
127679043|NCT01648140|459450167|FG001|Overall Study|Physician Decision|0|||
127679044|NCT01648140|459450168|FG002|Overall Study|Physician Decision|0|||
127679045|NCT01648140|459450169|FG003|Overall Study|Physician Decision|0|||
127679046|NCT01648140|459450166|FG000|Overall Study|Lack of Efficacy|4|||
127679047|NCT01648140|459450167|FG001|Overall Study|Lack of Efficacy|7|||
127679048|NCT01648140|459450168|FG002|Overall Study|Lack of Efficacy|1|||
127679049|NCT01648140|459450169|FG003|Overall Study|Lack of Efficacy|0|||
127679050|NCT01648140|459450166|FG000|Overall Study|Adverse Event|3|||
127679051|NCT01648140|459450167|FG001|Overall Study|Adverse Event|1|||
127679052|NCT01648140|459450168|FG002|Overall Study|Adverse Event|2|||
127679053|NCT01648140|459450169|FG003|Overall Study|Adverse Event|0|||
127679054|NCT01648140|459450166|FG000|Overall Study|Withdrawal by Subject|2|||
127679055|NCT01648140|459450167|FG001|Overall Study|Withdrawal by Subject|3|||
127679056|NCT01648140|459450168|FG002|Overall Study|Withdrawal by Subject|3|||
127679057|NCT01648140|459450169|FG003|Overall Study|Withdrawal by Subject|2|||
127679058|NCT01648140|459450166|FG000|Overall Study|Lost to Follow-up|2|||
127679059|NCT01648140|459450167|FG001|Overall Study|Lost to Follow-up|1|||
127679060|NCT01648140|459450168|FG002|Overall Study|Lost to Follow-up|2|||
127679061|NCT01648140|459450169|FG003|Overall Study|Lost to Follow-up|0|||
127679062|NCT01119950|459450170|FG000|Overall Study|Adverse Event|25|||
127679063|NCT01119950|459450170|FG000|Overall Study|Withdrawal by Subject|9|||
127679064|NCT01119950|459450170|FG000|Overall Study|Protocol Violation|5|||
127679065|NCT01119950|459450170|FG000|Overall Study|Lost to Follow-up|4|||
127679066|NCT01119950|459450170|FG000|Overall Study|Administrative|2|||
127679067|NCT01119950|459450170|FG000|Overall Study|Abnormal lab value|1|||
127679068|NCT01119950|459450170|FG000|Overall Study|Death|1|||
127679069|NCT00217672|459450174|FG000|Allocation|Ineligible|2|||
127679070|NCT00217672|459450175|FG001|Allocation|Ineligible|0|||
127679071|NCT00217672|459450174|FG000|Treatment|disease progression|33|||
127679072|NCT00217672|459450175|FG001|Treatment|disease progression|4|||
127679073|NCT00217672|459450174|FG000|Treatment|Adverse Event|18|||
128013367|NCT03329001|460675230|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|1|||
128013368|NCT03329001|460675231|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
128013369|NCT03329001|460675232|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
128013370|NCT03329001|460675233|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
128013371|NCT03329001|460675234|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
128013372|NCT03329001|460675235|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
128013373|NCT03329001|460675228|FG000|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
128013374|NCT03329001|460675229|FG001|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
128013375|NCT03329001|460675230|FG002|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|2|||
128013376|NCT03329001|460675231|FG003|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
128013377|NCT03329001|460675232|FG004|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
128013378|NCT03329001|460675233|FG005|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
128013379|NCT03329001|460675234|FG006|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
128013380|NCT03329001|460675235|FG007|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
128013381|NCT03329001|460675228|FG000|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
128013382|NCT03329001|460675229|FG001|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
128013383|NCT03329001|460675230|FG002|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
128013384|NCT03329001|460675231|FG003|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|2|||
128013385|NCT03329001|460675232|FG004|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
128013386|NCT03329001|460675233|FG005|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
127679074|NCT00217672|459450175|FG001|Treatment|Adverse Event|2|||
127679075|NCT00217672|459450174|FG000|Treatment|reqd treatment not permitted by protocol|6|||
127679076|NCT00217672|459450175|FG001|Treatment|reqd treatment not permitted by protocol|0|||
127679077|NCT00217672|459450174|FG000|Treatment|Physician Decision|6|||
127679078|NCT00217672|459450175|FG001|Treatment|Physician Decision|0|||
127679079|NCT00217672|459450174|FG000|Treatment|insurance issues|1|||
127679080|NCT00217672|459450175|FG001|Treatment|insurance issues|1|||
127679081|NCT00217672|459450174|FG000|Treatment|Death|2|||
127679082|NCT00217672|459450175|FG001|Treatment|Death|0|||
127679083|NCT00217672|459450174|FG000|Treatment|secondary malignancy|1|||
127679084|NCT00217672|459450175|FG001|Treatment|secondary malignancy|0|||
127679085|NCT00217672|459450174|FG000|Follow-up|Withdrawal by Subject|4|||
127679086|NCT00217672|459450175|FG001|Follow-up|Withdrawal by Subject|0|||
127679087|NCT00217672|459450174|FG000|Follow-up|Lost to Follow-up|1|||
127679088|NCT00217672|459450175|FG001|Follow-up|Lost to Follow-up|0|||
127679089|NCT01591616|459450183|FG000|Overall Study|Withdrawal by Subject|1|||
127679090|NCT00758602|459450184|FG000|Overall Study|Adverse Event|11|||
127679091|NCT00758602|459450185|FG001|Overall Study|Adverse Event|10|||
127679092|NCT00758602|459450184|FG000|Overall Study|Lost to Follow-up|4|||
127679093|NCT00758602|459450185|FG001|Overall Study|Lost to Follow-up|3|||
127679094|NCT00758602|459450184|FG000|Overall Study|Withdrawal by Subject|1|||
127679095|NCT00758602|459450185|FG001|Overall Study|Withdrawal by Subject|3|||
127679096|NCT00758602|459450184|FG000|Overall Study|Protocol Violation|0|||
127679097|NCT00758602|459450185|FG001|Overall Study|Protocol Violation|2|||
127679098|NCT00758602|459450184|FG000|Overall Study|Death|0|||
127679099|NCT00758602|459450185|FG001|Overall Study|Death|1|||
127679100|NCT00758602|459450184|FG000|Overall Study|Reason not specified|3|||
127679101|NCT00758602|459450185|FG001|Overall Study|Reason not specified|3|||
127679102|NCT02371746|459450188|FG000|Overall Study|Consent withdrawn|0|||
127679103|NCT02371746|459450189|FG001|Overall Study|Consent withdrawn|0|||
127679104|NCT02371746|459450190|FG002|Overall Study|Consent withdrawn|0|||
127679105|NCT02371746|459450191|FG003|Overall Study|Consent withdrawn|0|||
127679106|NCT02371746|459450192|FG004|Overall Study|Consent withdrawn|0|||
127679107|NCT02371746|459450193|FG005|Overall Study|Consent withdrawn|0|||
127679108|NCT02371746|459450194|FG006|Overall Study|Consent withdrawn|1|||
127679109|NCT01157182|459450195|FG000|Washout of 28 Days|Adverse Event|2|||
127679110|NCT01157182|459450196|FG001|Washout of 28 Days|Adverse Event|0|||
127679111|NCT03743246|459450197|FG000|Pre-Treatment Period|Failure to meet treatment criteria|0|||
127679112|NCT03743246|459450198|FG001|Pre-Treatment Period|Failure to meet treatment criteria|0|||
127679113|NCT03743246|459450199|FG002|Pre-Treatment Period|Failure to meet treatment criteria|2|||
127679114|NCT03743246|459450200|FG003|Pre-Treatment Period|Failure to meet treatment criteria|0|||
127679115|NCT03743246|459450197|FG000|Pre-Treatment Period|Death|0|||
127679116|NCT03743246|459450198|FG001|Pre-Treatment Period|Death|1|||
127679117|NCT03743246|459450199|FG002|Pre-Treatment Period|Death|0|||
127679118|NCT03743246|459450200|FG003|Pre-Treatment Period|Death|1|||
127679119|NCT03743246|459450197|FG000|Pre-Treatment Period|Study Drug Manufacturing Failure|1|||
127679120|NCT03743246|459450198|FG001|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
127679121|NCT03743246|459450199|FG002|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
127679122|NCT03743246|459450200|FG003|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
127766290|NCT00938860|459770188|FG001|Overall Study|Withdrawal by Subject|8|||
127766291|NCT00938860|459770187|FG000|Overall Study|Lost to Follow-up|4|||
127766292|NCT00938860|459770188|FG001|Overall Study|Lost to Follow-up|4|||
127766293|NCT00938860|459770187|FG000|Overall Study|Administration problems|2|||
127766294|NCT00938860|459770188|FG001|Overall Study|Administration problems|0|||
127766295|NCT00938860|459770187|FG000|Overall Study|Death|1|||
127766296|NCT00938860|459770188|FG001|Overall Study|Death|1|||
127766297|NCT00938860|459770187|FG000|Overall Study|Protocol Violation|3|||
127766298|NCT00938860|459770188|FG001|Overall Study|Protocol Violation|1|||
127766299|NCT01054170|459770192|FG000|Overall Study|Protocol Violation|1|||
127766300|NCT01054170|459770193|FG001|Overall Study|Protocol Violation|0|||
127679123|NCT03743246|459450197|FG000|Lymphodepleting Chemotherapy|Progressive Disease|1|||
127679124|NCT03743246|459450198|FG001|Lymphodepleting Chemotherapy|Progressive Disease|0|||
127679125|NCT03743246|459450199|FG002|Lymphodepleting Chemotherapy|Progressive Disease|0|||
127679126|NCT03743246|459450200|FG003|Lymphodepleting Chemotherapy|Progressive Disease|0|||
127679127|NCT03743246|459450197|FG000|Treatment Period (JCAR017 Infusion)|Other Reason|1|||
127766301|NCT01054170|459770192|FG000|Overall Study|Withdrawal by Subject|3|||
127766302|NCT01054170|459770193|FG001|Overall Study|Withdrawal by Subject|2|||
127766303|NCT01054170|459770192|FG000|Overall Study|Adverse Event|0|||
127766304|NCT01054170|459770193|FG001|Overall Study|Adverse Event|4|||
127766305|NCT05249829|459770194|FG000|Overall Study|Participant Relocation|0|||
127766306|NCT05249829|459770195|FG001|Overall Study|Participant Relocation|1|||
127766307|NCT05249829|459770196|FG002|Overall Study|Participant Relocation|2|||
127766308|NCT05249829|459770197|FG003|Overall Study|Participant Relocation|2|||
127766309|NCT05249829|459770194|FG000|Overall Study|Withdrawal by Subject|9|||
127766310|NCT05249829|459770195|FG001|Overall Study|Withdrawal by Subject|17|||
127766311|NCT05249829|459770196|FG002|Overall Study|Withdrawal by Subject|40|||
127766312|NCT05249829|459770197|FG003|Overall Study|Withdrawal by Subject|35|||
127766313|NCT05249829|459770194|FG000|Overall Study|Physician Decision|1|||
127766314|NCT05249829|459770195|FG001|Overall Study|Physician Decision|0|||
127766315|NCT05249829|459770196|FG002|Overall Study|Physician Decision|0|||
127766316|NCT05249829|459770197|FG003|Overall Study|Physician Decision|0|||
127766317|NCT05249829|459770194|FG000|Overall Study|Lost to Follow-up|16|||
127766318|NCT05249829|459770195|FG001|Overall Study|Lost to Follow-up|16|||
127766319|NCT05249829|459770196|FG002|Overall Study|Lost to Follow-up|57|||
127766320|NCT05249829|459770197|FG003|Overall Study|Lost to Follow-up|60|||
127766321|NCT05249829|459770194|FG000|Overall Study|Adverse Event|2|||
127766322|NCT05249829|459770195|FG001|Overall Study|Adverse Event|2|||
127766323|NCT05249829|459770196|FG002|Overall Study|Adverse Event|2|||
127766324|NCT05249829|459770197|FG003|Overall Study|Adverse Event|2|||
127766325|NCT05249829|459770194|FG000|Overall Study|COVID-19 Non-Infection Related|0|||
127766326|NCT05249829|459770195|FG001|Overall Study|COVID-19 Non-Infection Related|0|||
127766327|NCT05249829|459770196|FG002|Overall Study|COVID-19 Non-Infection Related|0|||
127766328|NCT05249829|459770197|FG003|Overall Study|COVID-19 Non-Infection Related|1|||
127766329|NCT05249829|459770194|FG000|Overall Study|Protocol Violation|2|||
127766330|NCT05249829|459770195|FG001|Overall Study|Protocol Violation|0|||
127679128|NCT03743246|459450198|FG001|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
127679129|NCT03743246|459450199|FG002|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
127679130|NCT03743246|459450200|FG003|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
127679131|NCT03743246|459450197|FG000|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
127679132|NCT03743246|459450198|FG001|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|1|||
127679133|NCT03743246|459450199|FG002|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
127679134|NCT03743246|459450200|FG003|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
127679135|NCT03743246|459450197|FG000|Treatment Period (JCAR017 Infusion)|Progressive Disease|1|||
127679136|NCT03743246|459450198|FG001|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
127679137|NCT03743246|459450199|FG002|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
127679138|NCT03743246|459450200|FG003|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
127679139|NCT03743246|459450197|FG000|Treatment Period (JCAR017 Infusion)|Death|1|||
127679140|NCT03743246|459450198|FG001|Treatment Period (JCAR017 Infusion)|Death|0|||
127679141|NCT03743246|459450199|FG002|Treatment Period (JCAR017 Infusion)|Death|0|||
127679142|NCT03743246|459450200|FG003|Treatment Period (JCAR017 Infusion)|Death|0|||
127679143|NCT03743246|459450197|FG000|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|1|||
127679144|NCT03743246|459450198|FG001|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
127679145|NCT03743246|459450199|FG002|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
127766331|NCT05249829|459770196|FG002|Overall Study|Protocol Violation|5|||
127766332|NCT05249829|459770197|FG003|Overall Study|Protocol Violation|3|||
127766333|NCT05249829|459770194|FG000|Overall Study|Death|0|||
127766334|NCT05249829|459770195|FG001|Overall Study|Death|1|||
127766335|NCT05249829|459770196|FG002|Overall Study|Death|2|||
128013387|NCT03329001|460675234|FG006|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
127766336|NCT05249829|459770197|FG003|Overall Study|Death|4|||
127766337|NCT00513604|459770198|FG000|Overall Study|Not treated|2|||
127679146|NCT03743246|459450200|FG003|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
127766338|NCT00513604|459770199|FG001|Overall Study|Not treated|0|||
127766339|NCT00513604|459770200|FG002|Overall Study|Not treated|1|||
128013388|NCT03329001|460675235|FG007|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
128013389|NCT03329001|460675228|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
128013390|NCT03329001|460675229|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
128013391|NCT03329001|460675230|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
128013392|NCT03329001|460675231|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
128013393|NCT03329001|460675232|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
128013394|NCT03329001|460675233|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|1|||
128013395|NCT03329001|460675234|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
128013396|NCT03329001|460675235|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
128013397|NCT03329001|460675228|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
128013398|NCT03329001|460675229|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
128013399|NCT03329001|460675230|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
128013400|NCT03329001|460675231|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
128013401|NCT03329001|460675232|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|1|||
128013402|NCT03329001|460675233|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
128013403|NCT03329001|460675234|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
128013404|NCT03329001|460675235|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
128013405|NCT03329001|460675228|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
128013406|NCT03329001|460675229|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
128013407|NCT03329001|460675230|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
128013408|NCT03329001|460675231|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
128013409|NCT03329001|460675232|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
128013410|NCT03329001|460675233|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
128013411|NCT03329001|460675234|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
128013412|NCT03329001|460675235|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
128013413|NCT03329001|460675228|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
128013414|NCT03329001|460675229|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
127679147|NCT00878722|459450202|FG000|Overall Study|Progressive disease|3|||
127679148|NCT00878722|459450203|FG001|Overall Study|Progressive disease|3|||
127679149|NCT00878722|459450204|FG002|Overall Study|Progressive disease|3|||
127679150|NCT00878722|459450205|FG003|Overall Study|Progressive disease|7|||
127679151|NCT00878722|459450206|FG004|Overall Study|Progressive disease|7|||
127679152|NCT00878722|459450207|FG005|Overall Study|Progressive disease|1|||
127679153|NCT00878722|459450208|FG006|Overall Study|Progressive disease|4|||
127679154|NCT00878722|459450209|FG007|Overall Study|Progressive disease|3|||
127679155|NCT00878722|459450202|FG000|Overall Study|Death|0|||
127679156|NCT00878722|459450203|FG001|Overall Study|Death|0|||
127679157|NCT00878722|459450204|FG002|Overall Study|Death|0|||
127679158|NCT00878722|459450205|FG003|Overall Study|Death|1|||
127679159|NCT00878722|459450206|FG004|Overall Study|Death|0|||
127679160|NCT00878722|459450207|FG005|Overall Study|Death|1|||
127679161|NCT00878722|459450208|FG006|Overall Study|Death|0|||
127679162|NCT00878722|459450209|FG007|Overall Study|Death|2|||
127679163|NCT00878722|459450202|FG000|Overall Study|Adverse Event|0|||
127679164|NCT00878722|459450203|FG001|Overall Study|Adverse Event|0|||
127679165|NCT00878722|459450204|FG002|Overall Study|Adverse Event|0|||
127679166|NCT00878722|459450205|FG003|Overall Study|Adverse Event|0|||
127679167|NCT00878722|459450206|FG004|Overall Study|Adverse Event|0|||
127679168|NCT00878722|459450207|FG005|Overall Study|Adverse Event|0|||
127679169|NCT00878722|459450208|FG006|Overall Study|Adverse Event|2|||
127679170|NCT00878722|459450209|FG007|Overall Study|Adverse Event|0|||
127679171|NCT00878722|459450202|FG000|Overall Study|Withdrawal by Subject|0|||
127679172|NCT00878722|459450203|FG001|Overall Study|Withdrawal by Subject|0|||
127679173|NCT00878722|459450204|FG002|Overall Study|Withdrawal by Subject|0|||
127679174|NCT00878722|459450205|FG003|Overall Study|Withdrawal by Subject|0|||
127679175|NCT00878722|459450206|FG004|Overall Study|Withdrawal by Subject|0|||
127679176|NCT00878722|459450207|FG005|Overall Study|Withdrawal by Subject|0|||
127679177|NCT00878722|459450208|FG006|Overall Study|Withdrawal by Subject|0|||
127679178|NCT00878722|459450209|FG007|Overall Study|Withdrawal by Subject|2|||
127679179|NCT00878722|459450202|FG000|Overall Study|Relapse|0|||
127679180|NCT00878722|459450203|FG001|Overall Study|Relapse|0|||
127679181|NCT00878722|459450204|FG002|Overall Study|Relapse|0|||
127679182|NCT00878722|459450205|FG003|Overall Study|Relapse|1|||
127679183|NCT00878722|459450206|FG004|Overall Study|Relapse|0|||
127679184|NCT00878722|459450207|FG005|Overall Study|Relapse|0|||
127679185|NCT00878722|459450208|FG006|Overall Study|Relapse|0|||
128013415|NCT03329001|460675230|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
127679186|NCT00878722|459450209|FG007|Overall Study|Relapse|0|||
127679187|NCT00949975|459450210|FG000|Overall Study|Voluntary discontinuation|6|||
127679188|NCT00949975|459450211|FG001|Overall Study|Voluntary discontinuation|5|||
127679189|NCT00949975|459450212|FG002|Overall Study|Voluntary discontinuation|3|||
127679190|NCT00949975|459450213|FG003|Overall Study|Voluntary discontinuation|6|||
127679191|NCT00949975|459450210|FG000|Overall Study|Adverse Event|11|||
127679192|NCT00949975|459450211|FG001|Overall Study|Adverse Event|11|||
127679193|NCT00949975|459450212|FG002|Overall Study|Adverse Event|10|||
128013416|NCT03329001|460675231|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
128013417|NCT03329001|460675232|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|1|||
128013418|NCT03329001|460675233|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
128013419|NCT03329001|460675234|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
128013420|NCT03329001|460675235|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
128013421|NCT03329001|460675228|FG000|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
128013422|NCT03329001|460675229|FG001|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
128013423|NCT03329001|460675230|FG002|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
128013424|NCT03329001|460675231|FG003|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
127679194|NCT00949975|459450213|FG003|Overall Study|Adverse Event|10|||
127679195|NCT00949975|459450210|FG000|Overall Study|Safety reason|0|||
127679196|NCT00949975|459450211|FG001|Overall Study|Safety reason|1|||
127679197|NCT00949975|459450212|FG002|Overall Study|Safety reason|0|||
127679198|NCT00949975|459450213|FG003|Overall Study|Safety reason|0|||
127679199|NCT00949975|459450210|FG000|Overall Study|Study-specific criteria|0|||
127679200|NCT00949975|459450211|FG001|Overall Study|Study-specific criteria|1|||
127679201|NCT00949975|459450212|FG002|Overall Study|Study-specific criteria|1|||
127679202|NCT00949975|459450213|FG003|Overall Study|Study-specific criteria|0|||
127679203|NCT00949975|459450210|FG000|Overall Study|Incorrect enrolment|5|||
127679204|NCT00949975|459450211|FG001|Overall Study|Incorrect enrolment|10|||
127679205|NCT00949975|459450212|FG002|Overall Study|Incorrect enrolment|4|||
127679206|NCT00949975|459450213|FG003|Overall Study|Incorrect enrolment|7|||
127679207|NCT00949975|459450210|FG000|Overall Study|Severe non-compliance|3|||
127679208|NCT00949975|459450211|FG001|Overall Study|Severe non-compliance|1|||
127679209|NCT00949975|459450212|FG002|Overall Study|Severe non-compliance|0|||
127679210|NCT00949975|459450213|FG003|Overall Study|Severe non-compliance|2|||
127679211|NCT00949975|459450210|FG000|Overall Study|Lost to Follow-up|1|||
127679212|NCT00949975|459450211|FG001|Overall Study|Lost to Follow-up|0|||
127679213|NCT00949975|459450212|FG002|Overall Study|Lost to Follow-up|1|||
127679214|NCT00949975|459450213|FG003|Overall Study|Lost to Follow-up|3|||
127679215|NCT00949975|459450210|FG000|Overall Study|Other|1|||
127679216|NCT00949975|459450211|FG001|Overall Study|Other|0|||
127679217|NCT00949975|459450212|FG002|Overall Study|Other|0|||
127679218|NCT00949975|459450213|FG003|Overall Study|Other|0|||
127679219|NCT00716144|459450226|FG000|Overall Study|Withdrawal by Subject|4|||
127679220|NCT00716144|459450227|FG001|Overall Study|Withdrawal by Subject|2|||
127679221|NCT00716144|459450228|FG002|Overall Study|Withdrawal by Subject|6|||
127679222|NCT00716144|459450229|FG003|Overall Study|Withdrawal by Subject|6|||
127679223|NCT00716144|459450226|FG000|Overall Study|Lost to Follow-up|2|||
127679224|NCT00716144|459450227|FG001|Overall Study|Lost to Follow-up|2|||
127679225|NCT00716144|459450228|FG002|Overall Study|Lost to Follow-up|1|||
127679226|NCT00716144|459450229|FG003|Overall Study|Lost to Follow-up|2|||
127679227|NCT00716144|459450226|FG000|Overall Study|Adverse Event|0|||
127679228|NCT00716144|459450227|FG001|Overall Study|Adverse Event|0|||
127679229|NCT00716144|459450228|FG002|Overall Study|Adverse Event|0|||
127679230|NCT00716144|459450229|FG003|Overall Study|Adverse Event|2|||
127679231|NCT00716144|459450226|FG000|Overall Study|Non-compliance|1|||
127679232|NCT00716144|459450227|FG001|Overall Study|Non-compliance|0|||
127679233|NCT00716144|459450228|FG002|Overall Study|Non-compliance|0|||
127679234|NCT00716144|459450229|FG003|Overall Study|Non-compliance|0|||
127679235|NCT00716144|459450226|FG000|Overall Study|Protocol Violation|2|||
127679236|NCT00716144|459450227|FG001|Overall Study|Protocol Violation|0|||
127679237|NCT00716144|459450228|FG002|Overall Study|Protocol Violation|1|||
127679238|NCT00716144|459450229|FG003|Overall Study|Protocol Violation|0|||
127679239|NCT00716144|459450226|FG000|Overall Study|Physician Decision|0|||
127679240|NCT00716144|459450227|FG001|Overall Study|Physician Decision|1|||
127679241|NCT00716144|459450228|FG002|Overall Study|Physician Decision|2|||
127679242|NCT00716144|459450229|FG003|Overall Study|Physician Decision|2|||
127679243|NCT00716144|459450226|FG000|Overall Study|Intercurrent illness|0|||
127679244|NCT00716144|459450227|FG001|Overall Study|Intercurrent illness|0|||
127679245|NCT00716144|459450228|FG002|Overall Study|Intercurrent illness|1|||
127679246|NCT00716144|459450229|FG003|Overall Study|Intercurrent illness|0|||
127679247|NCT00716144|459450226|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
127679248|NCT00716144|459450227|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
127679249|NCT00716144|459450228|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
127679250|NCT00716144|459450229|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
127679251|NCT00716144|459450226|FG000|Overall Study|Adverse event: left foot pain|0|||
127679252|NCT00716144|459450227|FG001|Overall Study|Adverse event: left foot pain|1|||
127679253|NCT00716144|459450228|FG002|Overall Study|Adverse event: left foot pain|0|||
127679254|NCT00716144|459450229|FG003|Overall Study|Adverse event: left foot pain|0|||
127679255|NCT00716144|459450226|FG000|Overall Study|Clinical Depression|0|||
127679256|NCT00716144|459450227|FG001|Overall Study|Clinical Depression|1|||
127679257|NCT00716144|459450228|FG002|Overall Study|Clinical Depression|0|||
127679258|NCT00716144|459450229|FG003|Overall Study|Clinical Depression|0|||
128013425|NCT03329001|460675232|FG004|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
128013426|NCT03329001|460675233|FG005|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
128013427|NCT03329001|460675234|FG006|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
128013428|NCT03329001|460675235|FG007|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
128013429|NCT03329001|460675228|FG000|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
128013430|NCT03329001|460675229|FG001|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
128013431|NCT03329001|460675230|FG002|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
128013432|NCT03329001|460675231|FG003|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
128013433|NCT03329001|460675232|FG004|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
128013434|NCT03329001|460675233|FG005|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
128013435|NCT03329001|460675234|FG006|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|22|||
128013436|NCT03329001|460675235|FG007|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|14|||
128013437|NCT03329001|460675228|FG000|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
128013438|NCT03329001|460675229|FG001|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
127679259|NCT00909363|459450230|FG000|Overall Study|Withdrawal by Subject|1|||
127679260|NCT00909363|459450231|FG001|Overall Study|Withdrawal by Subject|0|||
127679261|NCT00909363|459450232|FG002|Overall Study|Withdrawal by Subject|0|||
127679262|NCT00909363|459450230|FG000|Overall Study|Lack of Efficacy|1|||
127679263|NCT00909363|459450231|FG001|Overall Study|Lack of Efficacy|0|||
127679264|NCT00909363|459450232|FG002|Overall Study|Lack of Efficacy|0|||
127679265|NCT05641311|459450233|FG000|Dosing Period 1|Adverse Event|1|||
127679266|NCT05641311|459450234|FG001|Dosing Period 1|Adverse Event|0|||
127679267|NCT00082810|459450235|FG000|Overall Study|Adverse Event|3|||
127679268|NCT00082810|459450235|FG000|Overall Study|Progressive disease|24|||
127679269|NCT00082810|459450235|FG000|Overall Study|Withdrawal by Subject|4|||
127679270|NCT02950558|459450236|FG000|Overall Study|Lost to Follow-up|2|||
127679271|NCT02950558|459450237|FG001|Overall Study|Lost to Follow-up|0|||
127679272|NCT00319436|459450238|FG000|Overall Study|Withdrawal by Subject|6|||
127679273|NCT00319436|459450239|FG001|Overall Study|Withdrawal by Subject|7|||
127679274|NCT01321606|459450242|FG000|Overall Study|Lost to Follow-up|0|||
127679275|NCT01321606|459450243|FG001|Overall Study|Lost to Follow-up|0|||
127679276|NCT01321606|459450244|FG002|Overall Study|Lost to Follow-up|0|||
127679277|NCT01321606|459450245|FG003|Overall Study|Lost to Follow-up|1|||
127679278|NCT02914522|459450246|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
127679279|NCT02914522|459450247|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
127679280|NCT02914522|459450248|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
127679281|NCT02914522|459450249|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
127679282|NCT02914522|459450250|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
127679283|NCT02914522|459450251|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
127679284|NCT02914522|459450252|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
127679285|NCT02914522|459450253|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
127679286|NCT02914522|459450254|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
127679287|NCT02914522|459450255|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
127679288|NCT02914522|459450256|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
127679289|NCT02914522|459450246|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
127679290|NCT02914522|459450247|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
127679291|NCT02914522|459450248|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
127679292|NCT02914522|459450249|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
127679293|NCT02914522|459450250|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
127679294|NCT02914522|459450251|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
127679295|NCT02914522|459450252|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
127679296|NCT02914522|459450253|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
127679297|NCT02914522|459450254|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
127679298|NCT02914522|459450255|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
127679299|NCT02914522|459450256|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
127679300|NCT02914522|459450246|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
127679301|NCT02914522|459450247|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
127679302|NCT02914522|459450248|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
127679303|NCT02914522|459450249|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
127679304|NCT02914522|459450250|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
127679305|NCT02914522|459450251|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
127679306|NCT02914522|459450252|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
127679307|NCT02914522|459450253|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
127679308|NCT02914522|459450254|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
127679309|NCT02914522|459450255|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
127679310|NCT02914522|459450256|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
127679311|NCT02914522|459450246|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
127679312|NCT02914522|459450247|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
127766340|NCT00513604|459770201|FG003|Overall Study|Not treated|0|||
128013439|NCT03329001|460675230|FG002|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
128013440|NCT03329001|460675231|FG003|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
128013441|NCT03329001|460675232|FG004|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
128013442|NCT03329001|460675233|FG005|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
128013443|NCT03329001|460675234|FG006|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|4|||
128013444|NCT03329001|460675235|FG007|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
128013445|NCT03329001|460675228|FG000|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
128013446|NCT03329001|460675229|FG001|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
128013447|NCT03329001|460675230|FG002|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
128013448|NCT03329001|460675231|FG003|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
128013449|NCT03329001|460675232|FG004|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
128013450|NCT03329001|460675233|FG005|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
127679313|NCT02914522|459450248|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
127679314|NCT02914522|459450249|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
127679315|NCT02914522|459450250|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
127679316|NCT02914522|459450251|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
127679317|NCT02914522|459450252|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
127679318|NCT02914522|459450253|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
127679319|NCT02914522|459450254|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
127766341|NCT00513604|459770202|FG004|Overall Study|Not treated|0|||
127766342|NCT00513604|459770198|FG000|Overall Study|Death during treatment|0|||
127766343|NCT00513604|459770199|FG001|Overall Study|Death during treatment|3|||
127766344|NCT00513604|459770200|FG002|Overall Study|Death during treatment|2|||
127766345|NCT00513604|459770201|FG003|Overall Study|Death during treatment|0|||
127766346|NCT00513604|459770202|FG004|Overall Study|Death during treatment|0|||
127679320|NCT02914522|459450255|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
127679321|NCT02914522|459450256|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
127679322|NCT02914522|459450246|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
127679323|NCT02914522|459450247|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
127679324|NCT02914522|459450248|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
127679325|NCT02914522|459450249|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
127679326|NCT02914522|459450250|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
127679327|NCT02914522|459450251|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
127679328|NCT02914522|459450252|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
127679329|NCT02914522|459450253|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
127679330|NCT02914522|459450254|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
127679331|NCT02914522|459450255|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
127679332|NCT02914522|459450256|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
127679333|NCT02914522|459450246|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
127679334|NCT02914522|459450247|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
127679335|NCT02914522|459450248|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
127679336|NCT02914522|459450249|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
127679337|NCT02914522|459450250|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
127679338|NCT02914522|459450251|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
127679339|NCT02914522|459450252|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
127679340|NCT02914522|459450253|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
127679341|NCT02914522|459450254|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
127679342|NCT02914522|459450255|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
127679343|NCT02914522|459450256|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
127679344|NCT02914522|459450246|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
127679345|NCT02914522|459450247|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
127679346|NCT02914522|459450248|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
127679347|NCT02914522|459450249|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
127679348|NCT02914522|459450250|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
127679349|NCT02914522|459450251|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
127679350|NCT02914522|459450252|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
127679351|NCT02914522|459450253|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
127679352|NCT02914522|459450254|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
127679353|NCT02914522|459450255|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
127679354|NCT02914522|459450256|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
127766347|NCT01535560|459770207|FG000|Overall Study|Adverse Event|12|||
127766348|NCT01535560|459770208|FG001|Overall Study|Adverse Event|7|||
127766349|NCT01535560|459770207|FG000|Overall Study|Lost to Follow-up|1|||
127544707|NCT02118584|458962442|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|32|||
127544708|NCT02118584|458962443|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|1|||
127679355|NCT02914522|459450246|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
127679356|NCT02914522|459450247|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
127766350|NCT01535560|459770208|FG001|Overall Study|Lost to Follow-up|3|||
127766351|NCT01535560|459770207|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
127766352|NCT01535560|459770208|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
127766353|NCT01535560|459770207|FG000|Overall Study|Treatment Failure|21|||
127766354|NCT01535560|459770208|FG001|Overall Study|Treatment Failure|83|||
127766355|NCT01535560|459770207|FG000|Overall Study|Other|0|||
127766356|NCT01535560|459770208|FG001|Overall Study|Other|1|||
127766357|NCT01535560|459770207|FG000|Overall Study|Randomized in Error|0|||
127766358|NCT01535560|459770208|FG001|Overall Study|Randomized in Error|1|||
127766359|NCT02009761|459770209|FG000|Overall Study|Adverse Event|4|||
127766360|NCT02842827|459770210|FG000|Overall Study|Adverse Event|0|||
127766361|NCT02842827|459770211|FG001|Overall Study|Adverse Event|1|||
127766362|NCT02842827|459770212|FG002|Overall Study|Adverse Event|0|||
127766363|NCT02842827|459770213|FG003|Overall Study|Adverse Event|1|||
127766364|NCT02842827|459770214|FG004|Overall Study|Adverse Event|0|||
127766365|NCT02842827|459770215|FG005|Overall Study|Adverse Event|1|||
127766366|NCT02842827|459770216|FG006|Overall Study|Adverse Event|0|||
127766367|NCT02842827|459770217|FG007|Overall Study|Adverse Event|0|||
127766368|NCT02842827|459770210|FG000|Overall Study|Death|1|||
127766369|NCT02842827|459770211|FG001|Overall Study|Death|0|||
127766370|NCT02842827|459770212|FG002|Overall Study|Death|2|||
127766371|NCT02842827|459770213|FG003|Overall Study|Death|3|||
127679357|NCT02914522|459450248|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
127679358|NCT02914522|459450249|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
127679359|NCT02914522|459450250|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
127679360|NCT02914522|459450251|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
127679361|NCT02914522|459450252|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
127679362|NCT02914522|459450253|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
127679363|NCT02914522|459450254|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
127679364|NCT02914522|459450255|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
127679365|NCT02914522|459450256|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
127679366|NCT02914522|459450246|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
127679367|NCT02914522|459450247|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
127679368|NCT02914522|459450248|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
127679369|NCT02914522|459450249|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
127679370|NCT02914522|459450250|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
127679371|NCT02914522|459450251|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
127679372|NCT02914522|459450252|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
127679373|NCT02914522|459450253|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
127679374|NCT02914522|459450254|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
127679375|NCT02914522|459450255|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
127679376|NCT02914522|459450256|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
127679377|NCT02914522|459450246|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
127679378|NCT02914522|459450247|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
127679379|NCT02914522|459450248|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
127679380|NCT02914522|459450249|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
127679381|NCT02914522|459450250|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
127679382|NCT02914522|459450251|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
127679383|NCT02914522|459450252|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
127679384|NCT02914522|459450253|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
127679385|NCT02914522|459450254|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
127679386|NCT02914522|459450255|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
127679387|NCT02914522|459450256|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
127679388|NCT02914522|459450246|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
127679389|NCT02914522|459450247|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
127679390|NCT02914522|459450248|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
127679391|NCT02914522|459450249|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
127679392|NCT02914522|459450250|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
127679393|NCT02914522|459450251|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
127679394|NCT02914522|459450252|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
127679395|NCT02914522|459450253|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
127679396|NCT02914522|459450254|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
127679397|NCT02914522|459450255|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
127679398|NCT02914522|459450256|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
127766372|NCT02842827|459770214|FG004|Overall Study|Death|2|||
127766373|NCT02842827|459770215|FG005|Overall Study|Death|1|||
127766374|NCT02842827|459770216|FG006|Overall Study|Death|0|||
127766375|NCT02842827|459770217|FG007|Overall Study|Death|4|||
127766376|NCT02842827|459770210|FG000|Overall Study|Physician Decision|1|||
127766377|NCT02842827|459770211|FG001|Overall Study|Physician Decision|3|||
127766378|NCT02842827|459770212|FG002|Overall Study|Physician Decision|0|||
127766379|NCT02842827|459770213|FG003|Overall Study|Physician Decision|0|||
127766380|NCT02842827|459770214|FG004|Overall Study|Physician Decision|1|||
127766381|NCT02842827|459770215|FG005|Overall Study|Physician Decision|4|||
127766382|NCT02842827|459770216|FG006|Overall Study|Physician Decision|2|||
127766383|NCT02842827|459770217|FG007|Overall Study|Physician Decision|1|||
127766384|NCT02842827|459770210|FG000|Overall Study|Protocol Defined Disease Progression|0|||
127766385|NCT02842827|459770211|FG001|Overall Study|Protocol Defined Disease Progression|0|||
127766386|NCT02842827|459770212|FG002|Overall Study|Protocol Defined Disease Progression|0|||
127766387|NCT02842827|459770213|FG003|Overall Study|Protocol Defined Disease Progression|0|||
127766388|NCT02842827|459770214|FG004|Overall Study|Protocol Defined Disease Progression|0|||
127766389|NCT02842827|459770215|FG005|Overall Study|Protocol Defined Disease Progression|1|||
127766390|NCT02842827|459770216|FG006|Overall Study|Protocol Defined Disease Progression|0|||
127766391|NCT02842827|459770217|FG007|Overall Study|Protocol Defined Disease Progression|0|||
127766392|NCT02842827|459770210|FG000|Overall Study|Participant Withdrawal of Consent|1|||
127766393|NCT02842827|459770211|FG001|Overall Study|Participant Withdrawal of Consent|2|||
127766394|NCT02842827|459770212|FG002|Overall Study|Participant Withdrawal of Consent|2|||
127766395|NCT02842827|459770213|FG003|Overall Study|Participant Withdrawal of Consent|2|||
127766396|NCT02842827|459770214|FG004|Overall Study|Participant Withdrawal of Consent|2|||
127766397|NCT02842827|459770215|FG005|Overall Study|Participant Withdrawal of Consent|1|||
127766398|NCT02842827|459770216|FG006|Overall Study|Participant Withdrawal of Consent|2|||
127766399|NCT02842827|459770217|FG007|Overall Study|Participant Withdrawal of Consent|1|||
127766400|NCT00943111|459770220|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
127766401|NCT00943111|459770221|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
127766402|NCT00943111|459770222|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
127766403|NCT00943111|459770220|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
127766404|NCT00943111|459770221|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
127766405|NCT00943111|459770222|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
128013451|NCT03329001|460675234|FG006|Extension Phase(Approx 5 Years 5 Months)|Death|15|||
128013452|NCT03329001|460675235|FG007|Extension Phase(Approx 5 Years 5 Months)|Death|3|||
128013453|NCT03329001|460675228|FG000|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
128013454|NCT03329001|460675229|FG001|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
128013455|NCT03329001|460675230|FG002|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
128013456|NCT03329001|460675231|FG003|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
128013457|NCT03329001|460675232|FG004|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
128013458|NCT03329001|460675233|FG005|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
128013459|NCT03329001|460675234|FG006|Extension Phase(Approx 5 Years 5 Months)|Other reasons|30|||
128013460|NCT03329001|460675235|FG007|Extension Phase(Approx 5 Years 5 Months)|Other reasons|13|||
128013461|NCT02178956|460675236|FG000|Overall Study|Lost to Follow-up|4|||
128013462|NCT02178956|460675237|FG001|Overall Study|Lost to Follow-up|4|||
128013463|NCT02178956|460675236|FG000|Overall Study|Sponsor terminated study|49|||
128013464|NCT02178956|460675237|FG001|Overall Study|Sponsor terminated study|58|||
128013465|NCT02178956|460675236|FG000|Overall Study|Withdrawal by Subject|15|||
128013466|NCT02178956|460675237|FG001|Overall Study|Withdrawal by Subject|11|||
128013467|NCT02178956|460675236|FG000|Overall Study|Various Reasons|3|||
128013468|NCT02178956|460675237|FG001|Overall Study|Various Reasons|5|||
128013469|NCT02709369|460675241|FG000|Overall Study|Lost to Follow-up|15|||
128013470|NCT02709369|460675241|FG000|Overall Study|Withdrawal by Subject|10|||
128013471|NCT02709369|460675241|FG000|Overall Study|Did not received intervention|2|||
128013472|NCT00963235|460675242|FG000|Overall Study|Withdrawal by Subject|22|||
128013473|NCT00963235|460675242|FG000|Overall Study|Lost to Follow-up|14|||
128013474|NCT00963235|460675242|FG000|Overall Study|Failed to return|9|||
128013475|NCT00963235|460675242|FG000|Overall Study|Protocol Violation|7|||
127679399|NCT02914522|459450246|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
127679400|NCT02914522|459450247|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
127679401|NCT02914522|459450248|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
127679402|NCT02914522|459450249|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
127679403|NCT02914522|459450250|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
127679404|NCT02914522|459450251|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
127679405|NCT02914522|459450252|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
127679406|NCT02914522|459450253|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
127679407|NCT02914522|459450254|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
127766406|NCT00943111|459770220|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
127766407|NCT00943111|459770221|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
128013476|NCT00963235|460675242|FG000|Overall Study|Adverse Event|5|||
128013477|NCT00963235|460675242|FG000|Overall Study|Physician Decision|2|||
127679408|NCT02914522|459450255|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
127679409|NCT02914522|459450256|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
127766408|NCT00943111|459770222|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
127766409|NCT00943111|459770220|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
127766410|NCT00943111|459770221|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
127766411|NCT00943111|459770222|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
127766412|NCT00943111|459770220|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
127766413|NCT00943111|459770221|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
127766414|NCT00943111|459770222|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
127766415|NCT00943111|459770220|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
127766416|NCT00943111|459770221|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
127766417|NCT00943111|459770222|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
127766418|NCT00943111|459770220|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
127766419|NCT00943111|459770221|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
127766420|NCT00943111|459770222|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
127766421|NCT00943111|459770220|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
127766422|NCT00943111|459770221|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
127766423|NCT00943111|459770222|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
127766424|NCT01796548|459770223|FG000|Overall Study|Lost to Follow-up|1|||
127766425|NCT01796548|459770223|FG000|Overall Study|Other|2|||
127766426|NCT02859324|459770224|FG000|Overall Study|Death|4|||
127766427|NCT02859324|459770225|FG001|Overall Study|Death|6|||
127766428|NCT02859324|459770226|FG002|Overall Study|Death|5|||
127766429|NCT02859324|459770224|FG000|Overall Study|Other reasons|3|||
127766430|NCT02859324|459770225|FG001|Overall Study|Other reasons|3|||
127766431|NCT02859324|459770226|FG002|Overall Study|Other reasons|0|||
127766432|NCT04227704|459770232|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
127766433|NCT04227704|459770233|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
127766434|NCT04227704|459770234|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
127766435|NCT04227704|459770232|FG000|Overall Study|due to C/S being cancelled|1|||
127766436|NCT04227704|459770233|FG001|Overall Study|due to C/S being cancelled|0|||
127766437|NCT04227704|459770234|FG002|Overall Study|due to C/S being cancelled|0|||
127766438|NCT00112047|459770235|FG000|Randomized Phase|Lost to Follow-up|26|||
127766439|NCT00112047|459770236|FG001|Randomized Phase|Lost to Follow-up|33|||
127766440|NCT00112047|459770235|FG000|Randomized Phase|Adverse Event|10|||
127766441|NCT00112047|459770236|FG001|Randomized Phase|Adverse Event|10|||
127766442|NCT00112047|459770235|FG000|Randomized Phase|Withrawal of consent|10|||
128013478|NCT00963235|460675242|FG000|Overall Study|Other|1|||
128013479|NCT01341470|460675244|FG000|Overall Study|Sponsor decision|0|||
128013480|NCT01341470|460675245|FG001|Overall Study|Sponsor decision|0|||
128013481|NCT01341470|460675246|FG002|Overall Study|Sponsor decision|1|||
128013482|NCT01341470|460675247|FG003|Overall Study|Sponsor decision|1|||
128013483|NCT01341470|460675248|FG004|Overall Study|Sponsor decision|0|||
128013484|NCT01341470|460675249|FG005|Overall Study|Sponsor decision|1|||
128013485|NCT01136915|460675250|FG000|Overall Study|Lost to Follow-up|2|||
128013486|NCT01136915|460675251|FG001|Overall Study|Lost to Follow-up|0|||
128013487|NCT01136915|460675250|FG000|Overall Study|Exclusion criterion met|0|||
128013488|NCT01136915|460675251|FG001|Overall Study|Exclusion criterion met|1|||
128013489|NCT01756235|460675252|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
128013490|NCT05376358|460675255|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
128013491|NCT05376358|460675256|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|15|||
128013492|NCT05376358|460675255|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
128013493|NCT05376358|460675256|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
128013494|NCT05376358|460675255|FG000|3 Month Timepoint Data Collection|Lost to Follow-up|3|||
127679410|NCT02914522|459450246|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
127679411|NCT02914522|459450247|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
127679412|NCT02914522|459450248|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
127679413|NCT02914522|459450249|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
127679414|NCT02914522|459450250|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
127679415|NCT02914522|459450251|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
127679416|NCT02914522|459450252|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
127679417|NCT02914522|459450253|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
127679418|NCT02914522|459450254|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
127679419|NCT02914522|459450255|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
127679420|NCT02914522|459450256|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
127679421|NCT02914522|459450246|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
127679422|NCT02914522|459450247|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
127679423|NCT02914522|459450248|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
127679424|NCT02914522|459450249|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
127679425|NCT02914522|459450250|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
128013495|NCT05376358|460675256|FG001|3 Month Timepoint Data Collection|Lost to Follow-up|5|||
128013496|NCT05376358|460675255|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|14|||
128013497|NCT05376358|460675256|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
128013498|NCT05376358|460675255|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|1|||
128013499|NCT05376358|460675256|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|5|||
128013500|NCT05376358|460675255|FG000|6 Month Timepoint Data Collection|Lost to Follow-up|8|||
128013501|NCT05376358|460675256|FG001|6 Month Timepoint Data Collection|Lost to Follow-up|6|||
128013502|NCT00311168|460675257|FG000|First Intervention|Withdrawal by Subject|2|||
128013503|NCT00311168|460675258|FG001|First Intervention|Withdrawal by Subject|2|||
128013504|NCT00311168|460675257|FG000|First Intervention|Lost to Follow-up|1|||
128013505|NCT00311168|460675258|FG001|First Intervention|Lost to Follow-up|1|||
128013506|NCT00311168|460675257|FG000|First Intervention|Protocol Violation|1|||
128013507|NCT00311168|460675258|FG001|First Intervention|Protocol Violation|1|||
128013508|NCT00311168|460675257|FG000|First Intervention|Adverse Event|1|||
128013509|NCT00311168|460675258|FG001|First Intervention|Adverse Event|0|||
128013510|NCT00311168|460675257|FG000|First Intervention|Other|2|||
128013511|NCT00311168|460675258|FG001|First Intervention|Other|2|||
128013512|NCT00311168|460675257|FG000|Second Intervention|Lost to Follow-up|9|||
128013513|NCT00311168|460675258|FG001|Second Intervention|Lost to Follow-up|2|||
128013514|NCT00311168|460675257|FG000|Second Intervention|Withdrawal by Subject|0|||
128013515|NCT00311168|460675258|FG001|Second Intervention|Withdrawal by Subject|1|||
128013516|NCT00311168|460675257|FG000|Second Intervention|Other|1|||
128013517|NCT00311168|460675258|FG001|Second Intervention|Other|1|||
128013518|NCT02337829|460675261|FG000|Overall Study|Death|0|||
128013519|NCT02337829|460675262|FG001|Overall Study|Death|1|||
128013520|NCT02337829|460675263|FG002|Overall Study|Death|0|||
128013521|NCT02337829|460675264|FG003|Overall Study|Death|0|||
128013522|NCT02337829|460675261|FG000|Overall Study|Study terminated by sponsor|12|||
128013523|NCT02337829|460675262|FG001|Overall Study|Study terminated by sponsor|10|||
128013524|NCT02337829|460675263|FG002|Overall Study|Study terminated by sponsor|5|||
128013525|NCT02337829|460675264|FG003|Overall Study|Study terminated by sponsor|6|||
128013526|NCT02337829|460675261|FG000|Overall Study|discontinued for other reasons|6|||
128013527|NCT02337829|460675262|FG001|Overall Study|discontinued for other reasons|3|||
128013528|NCT02337829|460675263|FG002|Overall Study|discontinued for other reasons|1|||
128013529|NCT02337829|460675264|FG003|Overall Study|discontinued for other reasons|4|||
128013530|NCT04225039|460675277|FG000|Overall Study|Withdrawal by Subject|1|||
128013531|NCT04225039|460675278|FG001|Overall Study|Withdrawal by Subject|0|||
128013532|NCT04225039|460675279|FG002|Overall Study|Withdrawal by Subject|0|||
128013533|NCT04225039|460675280|FG003|Overall Study|Withdrawal by Subject|1|||
128013534|NCT04225039|460675277|FG000|Overall Study|Currently active on study treatment|0|||
128013535|NCT04225039|460675278|FG001|Overall Study|Currently active on study treatment|1|||
128013536|NCT04225039|460675279|FG002|Overall Study|Currently active on study treatment|0|||
128013537|NCT04225039|460675280|FG003|Overall Study|Currently active on study treatment|0|||
128013538|NCT04225039|460675277|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
128013539|NCT04225039|460675278|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
128013540|NCT04225039|460675279|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
128013541|NCT04225039|460675280|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
128013542|NCT04225039|460675277|FG000|Overall Study|Ineligible for treatment|0|||
128013543|NCT04225039|460675278|FG001|Overall Study|Ineligible for treatment|0|||
128013544|NCT04225039|460675279|FG002|Overall Study|Ineligible for treatment|0|||
128013545|NCT04225039|460675280|FG003|Overall Study|Ineligible for treatment|4|||
128013546|NCT02802228|460675284|FG000|Overall Study|Withdrawal by Subject|2|||
128013547|NCT02802228|460675285|FG001|Overall Study|Withdrawal by Subject|0|||
128013548|NCT02802228|460675284|FG000|Overall Study|Lost to Follow-up|1|||
127766443|NCT00112047|459770236|FG001|Randomized Phase|Withrawal of consent|18|||
127766444|NCT00112047|459770235|FG000|Randomized Phase|Sub-optimal virological response|3|||
127766445|NCT00112047|459770236|FG001|Randomized Phase|Sub-optimal virological response|13|||
127766446|NCT00112047|459770235|FG000|Randomized Phase|Noncompliance|8|||
127766447|NCT00112047|459770236|FG001|Randomized Phase|Noncompliance|4|||
127766448|NCT00112047|459770235|FG000|Randomized Phase|Protocol Violation|2|||
127766449|NCT00112047|459770236|FG001|Randomized Phase|Protocol Violation|0|||
127766450|NCT00112047|459770235|FG000|Randomized Phase|Pregnancy|3|||
128013549|NCT02802228|460675285|FG001|Overall Study|Lost to Follow-up|0|||
128013550|NCT02802228|460675284|FG000|Overall Study|Adverse Event|1|||
128013551|NCT02802228|460675285|FG001|Overall Study|Adverse Event|0|||
128013552|NCT02802228|460675284|FG000|Overall Study|Physician Decision|1|||
128013553|NCT02802228|460675285|FG001|Overall Study|Physician Decision|0|||
128013554|NCT00695019|460675286|FG000|Overall Study|Withdrawal by Subject|8|||
128013555|NCT00695019|460675287|FG001|Overall Study|Withdrawal by Subject|6|||
128013556|NCT00695019|460675288|FG002|Overall Study|Withdrawal by Subject|4|||
128013557|NCT00695019|460675286|FG000|Overall Study|Protocol Violation|1|||
127766451|NCT00112047|459770236|FG001|Randomized Phase|Pregnancy|1|||
128013558|NCT00695019|460675287|FG001|Overall Study|Protocol Violation|3|||
128013559|NCT00695019|460675288|FG002|Overall Study|Protocol Violation|1|||
128013560|NCT00695019|460675286|FG000|Overall Study|Lack of Efficacy|0|||
128013561|NCT00695019|460675287|FG001|Overall Study|Lack of Efficacy|0|||
128013562|NCT00695019|460675288|FG002|Overall Study|Lack of Efficacy|1|||
128013563|NCT00695019|460675286|FG000|Overall Study|Various|4|||
128013564|NCT00695019|460675287|FG001|Overall Study|Various|5|||
128013565|NCT00695019|460675288|FG002|Overall Study|Various|4|||
128013566|NCT02879695|460675291|FG000|Overall Study|Did not start study treatment|2|||
128013567|NCT02879695|460675292|FG001|Overall Study|Did not start study treatment|0|||
128013568|NCT02879695|460675293|FG002|Overall Study|Did not start study treatment|3|||
128013569|NCT02879695|460675294|FG003|Overall Study|Did not start study treatment|0|||
128013570|NCT05523297|460675299|FG000|Overall Study|Death|7|||
128013571|NCT05523297|460675300|FG001|Overall Study|Death|8|||
128013572|NCT05523297|460675299|FG000|Overall Study|Lost to Follow-up|2|||
128013573|NCT05523297|460675300|FG001|Overall Study|Lost to Follow-up|1|||
128013574|NCT03462680|460675301|FG000|Overall Study|Withdrawal by Subject|3|||
128013575|NCT03462680|460675302|FG001|Overall Study|Withdrawal by Subject|5|||
128013576|NCT02246777|460675303|FG000|Overall Study|Adverse Event|2|||
128013577|NCT02246777|460675303|FG000|Overall Study|Change of residence|1|||
128013578|NCT02401230|460675304|FG000|Overall Study|Adverse Event|3|||
128013579|NCT02401230|460675305|FG001|Overall Study|Adverse Event|2|||
128013580|NCT02401230|460675306|FG002|Overall Study|Adverse Event|0|||
128013581|NCT02401230|460675304|FG000|Overall Study|Withdrawal by Subject|2|||
128013582|NCT02401230|460675305|FG001|Overall Study|Withdrawal by Subject|1|||
128013583|NCT02401230|460675306|FG002|Overall Study|Withdrawal by Subject|1|||
128013584|NCT02401230|460675304|FG000|Overall Study|Lost to Follow-up|1|||
128013585|NCT02401230|460675305|FG001|Overall Study|Lost to Follow-up|3|||
128013586|NCT02401230|460675306|FG002|Overall Study|Lost to Follow-up|3|||
128013587|NCT04133909|460675307|FG000|Overall Study|Death|11|||
128013588|NCT04133909|460675308|FG001|Overall Study|Death|11|||
128013589|NCT04133909|460675307|FG000|Overall Study|Adverse Event|4|||
128013590|NCT04133909|460675308|FG001|Overall Study|Adverse Event|5|||
128013591|NCT04133909|460675307|FG000|Overall Study|Lost to Follow-up|3|||
128013592|NCT04133909|460675308|FG001|Overall Study|Lost to Follow-up|5|||
128013593|NCT04133909|460675307|FG000|Overall Study|Physician Decision|4|||
128013594|NCT04133909|460675308|FG001|Overall Study|Physician Decision|7|||
128013595|NCT04133909|460675307|FG000|Overall Study|Withdrawal by Subject|40|||
128013596|NCT04133909|460675308|FG001|Overall Study|Withdrawal by Subject|35|||
128013597|NCT04133909|460675307|FG000|Overall Study|Lack of Efficacy|2|||
128013598|NCT04133909|460675308|FG001|Overall Study|Lack of Efficacy|7|||
128013599|NCT04133909|460675307|FG000|Overall Study|Randomized in error|1|||
128013600|NCT04133909|460675308|FG001|Overall Study|Randomized in error|1|||
128013601|NCT00830765|460675309|FG000|Overall Study|Protocol Violation|3|||
128013602|NCT00830765|460675310|FG001|Overall Study|Protocol Violation|2|||
128013603|NCT01299909|460675311|FG000|Overall Study|Lost to Follow-up|22|||
128013604|NCT01299909|460675312|FG001|Overall Study|Lost to Follow-up|18|||
127679426|NCT02914522|459450251|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
127679427|NCT02914522|459450252|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
127679428|NCT02914522|459450253|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
127679429|NCT02914522|459450254|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
127679430|NCT02914522|459450255|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
127679431|NCT02914522|459450256|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
128013605|NCT01299909|460675313|FG002|Overall Study|Lost to Follow-up|17|||
127679432|NCT02914522|459450246|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
127679433|NCT02914522|459450247|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
127679434|NCT02914522|459450248|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
127679435|NCT02914522|459450249|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
127679436|NCT02914522|459450250|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
127679437|NCT02914522|459450251|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
127679438|NCT02914522|459450252|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
128013606|NCT04817410|460677986|FG000|Overall Study|Withdrawal by Subject|5|||
128013607|NCT04817410|460677986|FG000|Overall Study|Physician Decision|3|||
128013608|NCT03595748|460677988|FG000|Overall Study|Death|11|||
128013609|NCT03595748|460677989|FG001|Overall Study|Death|12|||
127679439|NCT02914522|459450253|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
128013610|NCT03595748|460677988|FG000|Overall Study|Withdrawal by Subject|28|||
128013611|NCT03595748|460677989|FG001|Overall Study|Withdrawal by Subject|29|||
128013612|NCT03595748|460677988|FG000|Overall Study|Protocol Violation|0|||
127679440|NCT02914522|459450254|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
128013613|NCT03595748|460677989|FG001|Overall Study|Protocol Violation|1|||
128013614|NCT04809974|460677991|FG000|Lead-in Phase|Withdrawal by Subject|3|||
128013615|NCT04809974|460677992|FG001|Lead-in Phase|Withdrawal by Subject|0|||
128013616|NCT04809974|460677993|FG002|Lead-in Phase|Withdrawal by Subject|0|||
128013617|NCT04809974|460677991|FG000|Lead-in Phase|No longer eligible|11|||
128013618|NCT04809974|460677992|FG001|Lead-in Phase|No longer eligible|0|||
128013619|NCT04809974|460677993|FG002|Lead-in Phase|No longer eligible|0|||
127766452|NCT00112047|459770235|FG000|Randomized Phase|Death|1|||
127766453|NCT00112047|459770236|FG001|Randomized Phase|Death|3|||
127766454|NCT00112047|459770235|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
127766455|NCT00112047|459770236|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
127766456|NCT00112047|459770235|FG000|Randomized Phase|Inability to swallow pills|0|||
127766457|NCT00112047|459770236|FG001|Randomized Phase|Inability to swallow pills|1|||
127766458|NCT00112047|459770235|FG000|Randomized Phase|Incarceration|3|||
127766459|NCT00112047|459770236|FG001|Randomized Phase|Incarceration|2|||
127766460|NCT00112047|459770235|FG000|Randomized Phase|Moved out of State|0|||
127766461|NCT00112047|459770236|FG001|Randomized Phase|Moved out of State|1|||
127766462|NCT00112047|459770235|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
127766463|NCT00112047|459770236|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
127766464|NCT00112047|459770235|FG000|Randomized Phase|High Hepatitis B DNA|0|||
127766465|NCT00112047|459770236|FG001|Randomized Phase|High Hepatitis B DNA|1|||
127766466|NCT00112047|459770235|FG000|Atripla Phase|Adverse Event|2|||
127766467|NCT00112047|459770236|FG001|Atripla Phase|Adverse Event|1|||
127766468|NCT00112047|459770235|FG000|Atripla Phase|Lost to Follow-up|5|||
127766469|NCT00112047|459770236|FG001|Atripla Phase|Lost to Follow-up|7|||
127766470|NCT00112047|459770235|FG000|Atripla Phase|Pregnancy|0|||
127766471|NCT00112047|459770236|FG001|Atripla Phase|Pregnancy|1|||
127766472|NCT00112047|459770235|FG000|Atripla Phase|Death|0|||
127766473|NCT00112047|459770236|FG001|Atripla Phase|Death|2|||
127766474|NCT00112047|459770235|FG000|Atripla Phase|Withdrew consent|7|||
127766475|NCT00112047|459770236|FG001|Atripla Phase|Withdrew consent|7|||
127766476|NCT00112047|459770235|FG000|Atripla Phase|Sub-optimal virological response|0|||
127766477|NCT00112047|459770236|FG001|Atripla Phase|Sub-optimal virological response|1|||
127766478|NCT00112047|459770235|FG000|Atripla Phase|Non-compliance|1|||
127766479|NCT00112047|459770236|FG001|Atripla Phase|Non-compliance|0|||
127766480|NCT00112047|459770235|FG000|Atripla Phase|Other|3|||
127766481|NCT00112047|459770236|FG001|Atripla Phase|Other|1|||
127766482|NCT01307579|459770237|FG000|Overall Study|Death|3|||
127766483|NCT01307579|459770238|FG001|Overall Study|Death|6|||
127766484|NCT01307579|459770237|FG000|Overall Study|Physician Decision|26|||
127766485|NCT01307579|459770238|FG001|Overall Study|Physician Decision|29|||
127766486|NCT01307579|459770237|FG000|Overall Study|Withdrawal by Subject|7|||
127766487|NCT01307579|459770238|FG001|Overall Study|Withdrawal by Subject|3|||
127766488|NCT01307579|459770237|FG000|Overall Study|Institutional diagnosis of IFD|21|||
127766489|NCT01307579|459770238|FG001|Overall Study|Institutional diagnosis of IFD|36|||
127766490|NCT01307579|459770237|FG000|Overall Study|Begin conditioning for HSCT|42|||
127766491|NCT01307579|459770238|FG001|Overall Study|Begin conditioning for HSCT|44|||
127766492|NCT01307579|459770237|FG000|Overall Study|Refractory or relapsed AML|38|||
128013620|NCT04809974|460677991|FG000|Randomized Phase|Lost to Follow-up|0|||
128013621|NCT04809974|460677992|FG001|Randomized Phase|Lost to Follow-up|1|||
128013622|NCT04809974|460677993|FG002|Randomized Phase|Lost to Follow-up|5|||
128013623|NCT04809974|460677991|FG000|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|0|||
128013624|NCT04809974|460677992|FG001|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|2|||
128013625|NCT04809974|460677993|FG002|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|8|||
128013626|NCT04809974|460677991|FG000|Randomized Phase|Adverse Event|0|||
128013627|NCT04809974|460677992|FG001|Randomized Phase|Adverse Event|1|||
128013628|NCT04809974|460677993|FG002|Randomized Phase|Adverse Event|4|||
128013629|NCT04809974|460677991|FG000|Randomized Phase|Withdrawal by Subject|0|||
128013630|NCT04809974|460677992|FG001|Randomized Phase|Withdrawal by Subject|0|||
128013631|NCT04809974|460677993|FG002|Randomized Phase|Withdrawal by Subject|5|||
128013632|NCT05493111|460677995|FG000|Overall Study|Adverse Event|3|||
128013633|NCT05493111|460677996|FG001|Overall Study|Adverse Event|4|||
128013634|NCT05493111|460677995|FG000|Overall Study|Withdrawal of Consent|19|||
128013635|NCT05493111|460677996|FG001|Overall Study|Withdrawal of Consent|10|||
128013636|NCT05493111|460677995|FG000|Overall Study|Non-compliance|1|||
128013637|NCT05493111|460677996|FG001|Overall Study|Non-compliance|1|||
128013638|NCT05493111|460677995|FG000|Overall Study|Lost to Follow-up|8|||
128013639|NCT05493111|460677996|FG001|Overall Study|Lost to Follow-up|1|||
128013640|NCT05493111|460677995|FG000|Overall Study|Disallowed Concurrent Treatment|1|||
128013641|NCT05493111|460677996|FG001|Overall Study|Disallowed Concurrent Treatment|0|||
128013642|NCT05493111|460677995|FG000|Overall Study|Withdrawal by Subject|1|||
127766493|NCT01307579|459770238|FG001|Overall Study|Refractory or relapsed AML|23|||
127766494|NCT01307579|459770237|FG000|Overall Study|Ineligible|3|||
127766495|NCT01307579|459770238|FG001|Overall Study|Ineligible|4|||
127766496|NCT00153062|459772014|FG000|Overall Study|Death|360|||
127766497|NCT00153062|459772015|FG001|Overall Study|Death|352|||
127766498|NCT00153062|459772016|FG002|Overall Study|Death|369|||
127766499|NCT00153062|459772017|FG003|Overall Study|Death|365|||
127766500|NCT00153062|459772014|FG000|Overall Study|Withdrawal by Subject|14|||
128013643|NCT05493111|460677996|FG001|Overall Study|Withdrawal by Subject|1|||
128013644|NCT06125964|460677997|FG000|Overall Study|Lost to Follow-up|0|||
128013645|NCT06125964|460677998|FG001|Overall Study|Lost to Follow-up|1|||
127766501|NCT00153062|459772015|FG001|Overall Study|Withdrawal by Subject|30|||
128013646|NCT06125964|460677999|FG002|Overall Study|Lost to Follow-up|0|||
128013647|NCT06125964|460678000|FG003|Overall Study|Lost to Follow-up|0|||
128013648|NCT02469233|460678001|FG000|Overall Study|Death|1|||
128013649|NCT02469233|460678002|FG001|Overall Study|Death|1|||
128013650|NCT02469233|460678001|FG000|Overall Study|Lost to post or 6 month follow up|7|||
128013651|NCT02469233|460678002|FG001|Overall Study|Lost to post or 6 month follow up|2|||
128013652|NCT01787838|460678003|FG000|Overall Study|refused|1413|||
128013653|NCT01431976|460678004|FG000|Overall Study|Adverse Event|6|||
128013654|NCT01431976|460678004|FG000|Overall Study|Lack of Efficacy|2|||
128013655|NCT01431976|460678004|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
128013656|NCT01431976|460678004|FG000|Overall Study|Physician Decision|1|||
128013657|NCT01431976|460678004|FG000|Overall Study|Withdrawal by Subject|1|||
128013658|NCT01136954|460678006|FG000|Overall Study|Adverse Event|3|||
128013659|NCT01136954|460678007|FG001|Overall Study|Adverse Event|2|||
128013660|NCT01136954|460678006|FG000|Overall Study|Withdrawal by Subject|6|||
128013661|NCT01136954|460678007|FG001|Overall Study|Withdrawal by Subject|2|||
128013662|NCT01136954|460678006|FG000|Overall Study|Lack of Efficacy|14|||
128013663|NCT01136954|460678007|FG001|Overall Study|Lack of Efficacy|13|||
128013664|NCT01136954|460678006|FG000|Overall Study|Physician Decision|0|||
128013665|NCT01136954|460678007|FG001|Overall Study|Physician Decision|1|||
128013666|NCT01136954|460678006|FG000|Overall Study|Other|1|||
128013667|NCT01136954|460678007|FG001|Overall Study|Other|3|||
128013668|NCT00782067|460678008|FG000|Overall Study|Adverse Event|35|||
128013669|NCT00782067|460678008|FG000|Overall Study|Subject withdrew consent|11|||
128013670|NCT00782067|460678008|FG000|Overall Study|Lost to Follow-up|2|||
128013671|NCT00782067|460678008|FG000|Overall Study|Administrative problems|14|||
128013672|NCT00782067|460678008|FG000|Overall Study|Death|9|||
128013673|NCT00782067|460678008|FG000|Overall Study|Disease progression|43|||
128013674|NCT00782067|460678008|FG000|Overall Study|Protocol deviation|2|||
128013675|NCT01970371|460678011|FG000|Overall Study|Death|8|||
128013676|NCT01970371|460678012|FG001|Overall Study|Death|13|||
128013677|NCT01970371|460678013|FG002|Overall Study|Death|12|||
128013678|NCT01970371|460678011|FG000|Overall Study|Lost to Follow-up|0|||
128013679|NCT01970371|460678012|FG001|Overall Study|Lost to Follow-up|0|||
128013680|NCT01970371|460678013|FG002|Overall Study|Lost to Follow-up|1|||
128013681|NCT02239328|460678014|FG000|Overall Study|Benign disease noted at time of surgery|6|||
128013682|NCT02239328|460678014|FG000|Overall Study|Equipment or website malfunction|2|||
128013683|NCT03483103|460678015|FG000|Pre-Treatment Phase|Other reasons|1|||
128013684|NCT03483103|460678015|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
128013685|NCT03483103|460678015|FG000|Pre-Treatment Phase|Disease-related complications|1|||
128013686|NCT03483103|460678015|FG000|Pre-Treatment Phase|Death|5|||
128013687|NCT03483103|460678015|FG000|Treatment Phase|Withdrawal by Subject|7|||
128013688|NCT03483103|460678015|FG000|Treatment Phase|Other reasons|1|||
128013689|NCT03483103|460678015|FG000|Treatment Phase|Death|23|||
128013690|NCT03483103|460678015|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
128013691|NCT03483103|460678015|FG000|Treatment Phase|Received nonconforming product|1|||
128013692|NCT01481779|460678016|FG000|Overall Study|Adverse Event|23|||
128013693|NCT01481779|460678017|FG001|Overall Study|Adverse Event|5|||
128013694|NCT01481779|460678016|FG000|Overall Study|Lost to Follow-up|3|||
128013695|NCT01481779|460678017|FG001|Overall Study|Lost to Follow-up|2|||
128013696|NCT01481779|460678016|FG000|Overall Study|Protocol Violation|2|||
128013697|NCT01481779|460678017|FG001|Overall Study|Protocol Violation|3|||
128013698|NCT01481779|460678016|FG000|Overall Study|Withdrawal by Subject|26|||
128013699|NCT01481779|460678017|FG001|Overall Study|Withdrawal by Subject|13|||
128013700|NCT01481779|460678016|FG000|Overall Study|Physician Decision|13|||
128013701|NCT01481779|460678017|FG001|Overall Study|Physician Decision|4|||
128013702|NCT01481779|460678016|FG000|Overall Study|Sponsor Decision|3|||
128013703|NCT01481779|460678017|FG001|Overall Study|Sponsor Decision|1|||
128013704|NCT02378181|460678018|FG000|Overall Study|Lost to Follow-up|2|||
128013705|NCT02378181|460678019|FG001|Overall Study|Lost to Follow-up|5|||
128013706|NCT02378181|460678018|FG000|Overall Study|Withdrawal by Subject|1|||
128013707|NCT02378181|460678019|FG001|Overall Study|Withdrawal by Subject|1|||
128013708|NCT02378181|460678018|FG000|Overall Study|Incarcerated|0|||
128013709|NCT02378181|460678019|FG001|Overall Study|Incarcerated|1|||
128013710|NCT04115059|460678023|FG000|Overall Study|Withdrawal by Subject|1|||
128013711|NCT04115059|460678023|FG000|Overall Study|Lack of Efficacy|2|||
128013712|NCT06420232|460678032|FG000|Overall Study|Withdrawal by Subject|3|||
128013713|NCT02313155|460678033|FG000|Overall Study|Lost to Follow-up|0|||
128013714|NCT02313155|460678034|FG001|Overall Study|Lost to Follow-up|1|||
128013715|NCT00689936|460678035|FG000|Active Treatment Phase|Adverse Event|68|||
128013716|NCT00689936|460678036|FG001|Active Treatment Phase|Adverse Event|71|||
128013717|NCT00689936|460678037|FG002|Active Treatment Phase|Adverse Event|76|||
128013718|NCT00689936|460678035|FG000|Active Treatment Phase|Disease Progression|273|||
128013719|NCT00689936|460678036|FG001|Active Treatment Phase|Disease Progression|362|||
128013720|NCT00689936|460678037|FG002|Active Treatment Phase|Disease Progression|339|||
128013721|NCT00689936|460678035|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
127544709|NCT03103542|458962446|FG000|Overall Study|Physician Decision|2|||
128013722|NCT00689936|460678036|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
128013723|NCT00689936|460678037|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
128013724|NCT00689936|460678035|FG000|Active Treatment Phase|Death|60|||
128013725|NCT00689936|460678036|FG001|Active Treatment Phase|Death|28|||
128013726|NCT00689936|460678037|FG002|Active Treatment Phase|Death|37|||
128013727|NCT00689936|460678035|FG000|Active Treatment Phase|Lost to Follow-up|0|||
128013728|NCT00689936|460678036|FG001|Active Treatment Phase|Lost to Follow-up|2|||
128013729|NCT00689936|460678037|FG002|Active Treatment Phase|Lost to Follow-up|2|||
128013730|NCT00689936|460678035|FG000|Active Treatment Phase|Protocol Violation|2|||
128013731|NCT00689936|460678036|FG001|Active Treatment Phase|Protocol Violation|2|||
128013732|NCT00689936|460678037|FG002|Active Treatment Phase|Protocol Violation|4|||
128013733|NCT00689936|460678035|FG000|Active Treatment Phase|Study Close Out|64|||
128013734|NCT00689936|460678036|FG001|Active Treatment Phase|Study Close Out|26|||
128013735|NCT00689936|460678037|FG002|Active Treatment Phase|Study Close Out|21|||
128013736|NCT00689936|460678035|FG000|Active Treatment Phase|Miscellaneous|52|||
128013737|NCT00689936|460678036|FG001|Active Treatment Phase|Miscellaneous|34|||
128013738|NCT00689936|460678037|FG002|Active Treatment Phase|Miscellaneous|47|||
128013739|NCT00689936|460678035|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
128013740|NCT00689936|460678036|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
128013741|NCT00689936|460678037|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
128013742|NCT01303419|460678038|FG000|Overall Study|Discontinuation of study|60|||
128013743|NCT01303419|460678038|FG000|Overall Study|Did not complete both imaging methods|5|||
128013744|NCT01303419|460678038|FG000|Overall Study|Did not meet all I/E after screening|31|||
128013745|NCT02213926|460678040|FG000|Overall Study|Death|59|||
128013746|NCT02213926|460678040|FG000|Overall Study|Withdrawal by Subject|10|||
128013747|NCT02213926|460678040|FG000|Overall Study|study terminated by sponsor|51|||
128013748|NCT02213926|460678040|FG000|Overall Study|Lost to Follow-up|3|||
128013749|NCT02213926|460678040|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
128013750|NCT02327078|460678047|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
128013751|NCT02327078|460678048|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
128013752|NCT02327078|460678049|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
128013753|NCT02327078|460678050|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
128013754|NCT02327078|460678051|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
128013755|NCT02327078|460678052|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
128013756|NCT02327078|460678053|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
128013757|NCT02327078|460678054|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
128013758|NCT02327078|460678055|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
128013759|NCT02327078|460678047|FG000|Overall Study|Death|2|||
128013760|NCT02327078|460678048|FG001|Overall Study|Death|4|||
128013761|NCT02327078|460678049|FG002|Overall Study|Death|10|||
128013762|NCT02327078|460678050|FG003|Overall Study|Death|6|||
128013763|NCT02327078|460678051|FG004|Overall Study|Death|4|||
128013764|NCT02327078|460678052|FG005|Overall Study|Death|3|||
128013765|NCT02327078|460678053|FG006|Overall Study|Death|2|||
128013766|NCT02327078|460678054|FG007|Overall Study|Death|51|||
128013767|NCT02327078|460678055|FG008|Overall Study|Death|97|||
128013768|NCT02327078|460678047|FG000|Overall Study|Lost to Follow-up|0|||
128013769|NCT02327078|460678048|FG001|Overall Study|Lost to Follow-up|1|||
128013770|NCT02327078|460678049|FG002|Overall Study|Lost to Follow-up|1|||
127766502|NCT00153062|459772016|FG002|Overall Study|Withdrawal by Subject|27|||
127766503|NCT00153062|459772017|FG003|Overall Study|Withdrawal by Subject|28|||
127766504|NCT00153062|459772014|FG000|Overall Study|Lost to Follow-up|12|||
127766505|NCT00153062|459772015|FG001|Overall Study|Lost to Follow-up|20|||
127766506|NCT00153062|459772016|FG002|Overall Study|Lost to Follow-up|15|||
127766507|NCT00153062|459772017|FG003|Overall Study|Lost to Follow-up|16|||
127766508|NCT00153062|459772014|FG000|Overall Study|Adverse Event|0|||
127766509|NCT00153062|459772015|FG001|Overall Study|Adverse Event|1|||
128013771|NCT02327078|460678050|FG003|Overall Study|Lost to Follow-up|0|||
128013772|NCT02327078|460678051|FG004|Overall Study|Lost to Follow-up|0|||
128013773|NCT02327078|460678052|FG005|Overall Study|Lost to Follow-up|0|||
128013774|NCT02327078|460678053|FG006|Overall Study|Lost to Follow-up|0|||
128013775|NCT02327078|460678054|FG007|Overall Study|Lost to Follow-up|2|||
128013776|NCT02327078|460678055|FG008|Overall Study|Lost to Follow-up|5|||
128013777|NCT02327078|460678047|FG000|Overall Study|Site Terminated by Sponsor|1|||
128013778|NCT02327078|460678048|FG001|Overall Study|Site Terminated by Sponsor|0|||
128013779|NCT02327078|460678049|FG002|Overall Study|Site Terminated by Sponsor|1|||
128013780|NCT02327078|460678050|FG003|Overall Study|Site Terminated by Sponsor|4|||
128013781|NCT02327078|460678051|FG004|Overall Study|Site Terminated by Sponsor|0|||
128013782|NCT02327078|460678052|FG005|Overall Study|Site Terminated by Sponsor|0|||
128013783|NCT02327078|460678053|FG006|Overall Study|Site Terminated by Sponsor|0|||
127766510|NCT00153062|459772016|FG002|Overall Study|Adverse Event|1|||
127766511|NCT00153062|459772017|FG003|Overall Study|Adverse Event|0|||
128013784|NCT02327078|460678054|FG007|Overall Study|Site Terminated by Sponsor|11|||
128013785|NCT02327078|460678055|FG008|Overall Study|Site Terminated by Sponsor|25|||
128013786|NCT02327078|460678047|FG000|Overall Study|Physician Decision|0|||
127766512|NCT00153062|459772014|FG000|Overall Study|Protocol Violation|0|||
127766513|NCT00153062|459772015|FG001|Overall Study|Protocol Violation|2|||
128013787|NCT02327078|460678048|FG001|Overall Study|Physician Decision|0|||
128013788|NCT02327078|460678049|FG002|Overall Study|Physician Decision|0|||
128013789|NCT02327078|460678050|FG003|Overall Study|Physician Decision|1|||
128013790|NCT02327078|460678051|FG004|Overall Study|Physician Decision|0|||
128013791|NCT02327078|460678052|FG005|Overall Study|Physician Decision|0|||
128013792|NCT02327078|460678053|FG006|Overall Study|Physician Decision|0|||
127766514|NCT00153062|459772016|FG002|Overall Study|Protocol Violation|1|||
127766515|NCT00153062|459772017|FG003|Overall Study|Protocol Violation|1|||
128013793|NCT02327078|460678054|FG007|Overall Study|Physician Decision|0|||
128013794|NCT02327078|460678055|FG008|Overall Study|Physician Decision|1|||
128013795|NCT02327078|460678047|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
128013796|NCT02327078|460678048|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
128013797|NCT02327078|460678049|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
127766516|NCT00153062|459772014|FG000|Overall Study|No disposition data available|1|||
127766517|NCT00153062|459772015|FG001|Overall Study|No disposition data available|1|||
127766518|NCT00153062|459772016|FG002|Overall Study|No disposition data available|1|||
127766519|NCT00153062|459772017|FG003|Overall Study|No disposition data available|1|||
128013798|NCT02327078|460678050|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
128013799|NCT02327078|460678051|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
128013800|NCT02327078|460678052|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
128013801|NCT02327078|460678053|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
128013802|NCT02327078|460678054|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
128013803|NCT02327078|460678055|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
128013804|NCT02327078|460678047|FG000|Overall Study|Reason not Specified|0|||
128013805|NCT02327078|460678048|FG001|Overall Study|Reason not Specified|0|||
128013806|NCT02327078|460678049|FG002|Overall Study|Reason not Specified|0|||
128013807|NCT02327078|460678050|FG003|Overall Study|Reason not Specified|0|||
128013808|NCT02327078|460678051|FG004|Overall Study|Reason not Specified|0|||
128013809|NCT02327078|460678052|FG005|Overall Study|Reason not Specified|0|||
128013810|NCT02327078|460678053|FG006|Overall Study|Reason not Specified|0|||
128013811|NCT02327078|460678054|FG007|Overall Study|Reason not Specified|5|||
128013812|NCT02327078|460678055|FG008|Overall Study|Reason not Specified|12|||
128013813|NCT05513950|460678056|FG000|Overall Study|Not treated due to technical reasons|0|||
128013814|NCT05513950|460678057|FG001|Overall Study|Not treated due to technical reasons|0|||
128013815|NCT05513950|460678058|FG002|Overall Study|Not treated due to technical reasons|1|||
128013816|NCT05513950|460678059|FG003|Overall Study|Not treated due to technical reasons|0|||
128013817|NCT06001866|460678060|FG000|Overall Study|Withdrawal by Subject|0|||
128013818|NCT06001866|460678061|FG001|Overall Study|Withdrawal by Subject|2|||
128013819|NCT06001866|460678060|FG000|Overall Study|Protocol Violation|0|||
128013820|NCT06001866|460678061|FG001|Overall Study|Protocol Violation|2|||
128013821|NCT02903914|460678062|FG000|Overall Study|Adverse Event|0|||
128013822|NCT02903914|460678063|FG001|Overall Study|Adverse Event|0|||
128013823|NCT02903914|460678064|FG002|Overall Study|Adverse Event|1|||
128013824|NCT02903914|460678065|FG003|Overall Study|Adverse Event|0|||
128013825|NCT02903914|460678066|FG004|Overall Study|Adverse Event|0|||
128013826|NCT02903914|460678067|FG005|Overall Study|Adverse Event|0|||
128013827|NCT02903914|460678068|FG006|Overall Study|Adverse Event|2|||
128013828|NCT02903914|460678069|FG007|Overall Study|Adverse Event|0|||
128013829|NCT02903914|460678062|FG000|Overall Study|Withdrawal by Subject|3|||
128013830|NCT02903914|460678063|FG001|Overall Study|Withdrawal by Subject|1|||
128013831|NCT02903914|460678064|FG002|Overall Study|Withdrawal by Subject|28|||
127679441|NCT02914522|459450255|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
127679442|NCT02914522|459450256|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
127679443|NCT02914522|459450246|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
127679444|NCT02914522|459450247|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
127679445|NCT02914522|459450248|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
127679446|NCT02914522|459450249|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
127679447|NCT02914522|459450250|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
127679448|NCT02914522|459450251|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
127679449|NCT02914522|459450252|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
127766520|NCT00153062|459772014|FG000|Overall Study|Other|0|||
128013832|NCT02903914|460678065|FG003|Overall Study|Withdrawal by Subject|0|||
128013833|NCT02903914|460678066|FG004|Overall Study|Withdrawal by Subject|1|||
128013834|NCT02903914|460678067|FG005|Overall Study|Withdrawal by Subject|2|||
128013835|NCT02903914|460678068|FG006|Overall Study|Withdrawal by Subject|12|||
128013836|NCT02903914|460678069|FG007|Overall Study|Withdrawal by Subject|0|||
128013837|NCT02903914|460678062|FG000|Overall Study|Progressive Disease|1|||
128013838|NCT02903914|460678063|FG001|Overall Study|Progressive Disease|0|||
128013839|NCT02903914|460678064|FG002|Overall Study|Progressive Disease|4|||
128013840|NCT02903914|460678065|FG003|Overall Study|Progressive Disease|0|||
127766521|NCT00153062|459772015|FG001|Overall Study|Other|0|||
127766522|NCT00153062|459772016|FG002|Overall Study|Other|1|||
127766523|NCT00153062|459772017|FG003|Overall Study|Other|0|||
127766524|NCT00275262|459772024|FG000|Overall Study|Adverse Event|2|||
127766525|NCT00275262|459772025|FG001|Overall Study|Adverse Event|0|||
127766526|NCT00275262|459772024|FG000|Overall Study|Disease progression|2|||
127766527|NCT00275262|459772025|FG001|Overall Study|Disease progression|5|||
127766528|NCT00275262|459772024|FG000|Overall Study|Lost to Follow-up|0|||
127766529|NCT00275262|459772025|FG001|Overall Study|Lost to Follow-up|2|||
127766530|NCT00275262|459772024|FG000|Overall Study|Protocol Violation|0|||
127766531|NCT00275262|459772025|FG001|Overall Study|Protocol Violation|2|||
127766532|NCT00275262|459772024|FG000|Overall Study|Death|1|||
127766533|NCT00275262|459772025|FG001|Overall Study|Death|0|||
127766534|NCT00275262|459772024|FG000|Overall Study|Started Chemotherapy|1|||
127766535|NCT00275262|459772025|FG001|Overall Study|Started Chemotherapy|0|||
127766536|NCT01589237|459772038|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
127766537|NCT01589237|459772039|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
127766538|NCT01589237|459772040|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
127766539|NCT01589237|459772041|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
127766540|NCT01589237|459772038|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
127766541|NCT01589237|459772039|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
127766542|NCT01589237|459772040|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
127766543|NCT01589237|459772041|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
127766544|NCT01589237|459772038|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
127766545|NCT01589237|459772039|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
127766546|NCT01589237|459772040|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
127766547|NCT01589237|459772041|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
127766548|NCT01589237|459772038|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
127766549|NCT01589237|459772039|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
127766550|NCT01589237|459772040|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
127766551|NCT01589237|459772041|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
127766552|NCT02594163|459772042|FG000|Treatment Period|Progressive disease|2|||
127766553|NCT02594163|459772043|FG001|Treatment Period|Progressive disease|3|||
127766554|NCT02594163|459772042|FG000|Treatment Period|Adverse Event|1|||
127766555|NCT02594163|459772043|FG001|Treatment Period|Adverse Event|5|||
127766556|NCT02594163|459772042|FG000|Treatment Period|Physician Decision|1|||
127766557|NCT02594163|459772043|FG001|Treatment Period|Physician Decision|3|||
127766558|NCT02594163|459772042|FG000|Treatment Period|Study termination by sponsor|2|||
127766559|NCT02594163|459772043|FG001|Treatment Period|Study termination by sponsor|1|||
127766560|NCT02594163|459772042|FG000|Treatment Period|Other, Non-AE|1|||
127766561|NCT02594163|459772043|FG001|Treatment Period|Other, Non-AE|0|||
127766562|NCT02594163|459772042|FG000|Follow-up Period|Withdrawal by Subject|0|||
127766563|NCT02594163|459772043|FG001|Follow-up Period|Withdrawal by Subject|1|||
127766564|NCT02594163|459772042|FG000|Follow-up Period|Study Termination by Sponsor|6|||
127766565|NCT02594163|459772043|FG001|Follow-up Period|Study Termination by Sponsor|4|||
127766566|NCT02594163|459772042|FG000|Follow-up Period|Lost to Follow-up|1|||
127766567|NCT02594163|459772043|FG001|Follow-up Period|Lost to Follow-up|0|||
127766568|NCT02594163|459772042|FG000|Follow-up Period|Death|2|||
127766569|NCT02594163|459772043|FG001|Follow-up Period|Death|5|||
127766570|NCT02594163|459772042|FG000|Follow-up Period|Adverse Event|0|||
127766571|NCT02594163|459772043|FG001|Follow-up Period|Adverse Event|1|||
127766572|NCT02594163|459772042|FG000|Follow-up Period|Progressive Disease|2|||
127766573|NCT02594163|459772043|FG001|Follow-up Period|Progressive Disease|0|||
127766574|NCT02594163|459772042|FG000|Follow-up Period|Physician Decision|0|||
127679450|NCT02914522|459450253|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
127679451|NCT02914522|459450254|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
127679452|NCT02914522|459450255|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
127679453|NCT02914522|459450256|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
127679454|NCT05382104|459450258|FG000|Period 2 (2 Days)|Adverse Event|0|||
127679455|NCT05382104|459450259|FG001|Period 2 (2 Days)|Adverse Event|1|||
127679456|NCT05382104|459450260|FG002|Period 2 (2 Days)|Adverse Event|0|||
127679457|NCT05382104|459450261|FG003|Period 2 (2 Days)|Adverse Event|0|||
127679458|NCT05382104|459450262|FG004|Period 2 (2 Days)|Adverse Event|0|||
127679459|NCT05382104|459450263|FG005|Period 2 (2 Days)|Adverse Event|0|||
127679460|NCT00639002|459450264|FG000|Overall Study|Death|1|||
127679461|NCT00639002|459450264|FG000|Overall Study|Adverse Event|1|||
127679462|NCT00639002|459450264|FG000|Overall Study|Protocol Violation|1|||
127679463|NCT00639002|459450264|FG000|Overall Study|Disease progression|3|||
127679464|NCT00639002|459450264|FG000|Overall Study|Physician Decision|6|||
127766575|NCT02594163|459772043|FG001|Follow-up Period|Physician Decision|1|||
127766576|NCT01290029|459772046|FG000|Overall Study|Other|2|||
127679465|NCT00639002|459450264|FG000|Overall Study|Lack of Efficacy|1|||
127679466|NCT05686421|459450272|FG000|Overall Study|Screen failure|22|||
127679467|NCT05686421|459450273|FG001|Overall Study|Screen failure|0|||
127766577|NCT00189488|459772047|FG000|Overall Study|Ineligibility determined|1|||
127766578|NCT00189488|459772048|FG001|Overall Study|Ineligibility determined|0|||
127766579|NCT00189488|459772047|FG000|Overall Study|Protocol deviation|2|||
127766580|NCT00189488|459772048|FG001|Overall Study|Protocol deviation|1|||
127766581|NCT00189488|459772047|FG000|Overall Study|Adverse Event|2|||
127766582|NCT00189488|459772048|FG001|Overall Study|Adverse Event|1|||
127766583|NCT00189488|459772047|FG000|Overall Study|Withdrawal by Subject|2|||
127766584|NCT00189488|459772048|FG001|Overall Study|Withdrawal by Subject|6|||
127766585|NCT00189488|459772047|FG000|Overall Study|Disease progression|2|||
127766586|NCT00189488|459772048|FG001|Overall Study|Disease progression|4|||
127766587|NCT00189488|459772047|FG000|Overall Study|Administrative Decision|0|||
127766588|NCT00189488|459772048|FG001|Overall Study|Administrative Decision|2|||
127766589|NCT00189488|459772047|FG000|Overall Study|Death|5|||
127766590|NCT00189488|459772048|FG001|Overall Study|Death|8|||
127766591|NCT00189488|459772047|FG000|Overall Study|Other|1|||
127766592|NCT00189488|459772048|FG001|Overall Study|Other|0|||
127766593|NCT02090959|459772052|FG000|Overall Study|Withdrawal by Subject|10|||
127766594|NCT02090959|459772052|FG000|Overall Study|Adverse Event|1|||
127766595|NCT02090959|459772052|FG000|Overall Study|Investigator decision|2|||
127766596|NCT02090959|459772052|FG000|Overall Study|Study termination|6|||
127766597|NCT02090959|459772052|FG000|Overall Study|Enrolled but not treated|1|||
127766598|NCT02090959|459772052|FG000|Overall Study|Transfer for compassionate use medicine|4|||
127766599|NCT02090959|459772052|FG000|Overall Study|Move to medical need program|3|||
127766600|NCT02090959|459772052|FG000|Overall Study|Entered in to other study|34|||
127766601|NCT02090959|459772052|FG000|Overall Study|Switched to commercial supply|88|||
127766602|NCT02090959|459772052|FG000|Overall Study|Other than specified|2|||
127766603|NCT01248065|459772054|FG000|Overall Study|Lost to Follow-up|3|||
127766604|NCT01248065|459772055|FG001|Overall Study|Lost to Follow-up|5|||
127766605|NCT01248065|459772054|FG000|Overall Study|Withdrawal by Subject|14|||
127766606|NCT01248065|459772055|FG001|Overall Study|Withdrawal by Subject|11|||
127766607|NCT01248065|459772054|FG000|Overall Study|Adverse Event|3|||
127766608|NCT01248065|459772055|FG001|Overall Study|Adverse Event|0|||
127766609|NCT01248065|459772054|FG000|Overall Study|Third treatment failure event|3|||
127766610|NCT01248065|459772055|FG001|Overall Study|Third treatment failure event|1|||
127766611|NCT01248065|459772054|FG000|Overall Study|Other|3|||
127766612|NCT01248065|459772055|FG001|Overall Study|Other|5|||
127766613|NCT03010176|459772059|FG000|Overall Study|Death|21|||
127766614|NCT03010176|459772060|FG001|Overall Study|Death|35|||
127766615|NCT03010176|459772061|FG002|Overall Study|Death|19|||
127766616|NCT03010176|459772062|FG003|Overall Study|Death|19|||
127766617|NCT03010176|459772063|FG004|Overall Study|Death|14|||
127766618|NCT03010176|459772064|FG005|Overall Study|Death|0|||
127766619|NCT03010176|459772059|FG000|Overall Study|Lost to Follow-up|0|||
127766620|NCT03010176|459772060|FG001|Overall Study|Lost to Follow-up|0|||
127766621|NCT03010176|459772061|FG002|Overall Study|Lost to Follow-up|0|||
127766622|NCT03010176|459772062|FG003|Overall Study|Lost to Follow-up|0|||
127766623|NCT03010176|459772063|FG004|Overall Study|Lost to Follow-up|1|||
127766624|NCT03010176|459772064|FG005|Overall Study|Lost to Follow-up|0|||
127766625|NCT03010176|459772059|FG000|Overall Study|Physician Decision|0|||
127766626|NCT03010176|459772060|FG001|Overall Study|Physician Decision|4|||
127766627|NCT03010176|459772061|FG002|Overall Study|Physician Decision|0|||
127766628|NCT03010176|459772062|FG003|Overall Study|Physician Decision|1|||
127766629|NCT03010176|459772063|FG004|Overall Study|Physician Decision|0|||
127766630|NCT03010176|459772064|FG005|Overall Study|Physician Decision|0|||
127766631|NCT03010176|459772059|FG000|Overall Study|Sponsor Decision|0|||
127766632|NCT03010176|459772060|FG001|Overall Study|Sponsor Decision|4|||
127766633|NCT03010176|459772061|FG002|Overall Study|Sponsor Decision|4|||
127766634|NCT03010176|459772062|FG003|Overall Study|Sponsor Decision|1|||
127766635|NCT03010176|459772063|FG004|Overall Study|Sponsor Decision|6|||
127766636|NCT03010176|459772064|FG005|Overall Study|Sponsor Decision|0|||
127766637|NCT03010176|459772059|FG000|Overall Study|Withdrawal by Subject|11|||
127766638|NCT03010176|459772060|FG001|Overall Study|Withdrawal by Subject|9|||
128013841|NCT02903914|460678066|FG004|Overall Study|Progressive Disease|0|||
128013842|NCT02903914|460678067|FG005|Overall Study|Progressive Disease|0|||
127766639|NCT03010176|459772061|FG002|Overall Study|Withdrawal by Subject|3|||
127766640|NCT03010176|459772062|FG003|Overall Study|Withdrawal by Subject|0|||
127766641|NCT03010176|459772063|FG004|Overall Study|Withdrawal by Subject|4|||
127766642|NCT03010176|459772064|FG005|Overall Study|Withdrawal by Subject|0|||
127766643|NCT04256629|459772065|FG000|Overall Study|Adverse Event|0|||
127766644|NCT04256629|459772066|FG001|Overall Study|Adverse Event|0|||
127766645|NCT04256629|459772067|FG002|Overall Study|Adverse Event|0|||
127766646|NCT04256629|459772068|FG003|Overall Study|Adverse Event|0|||
127766647|NCT04256629|459772069|FG004|Overall Study|Adverse Event|0|||
127766648|NCT04256629|459772070|FG005|Overall Study|Adverse Event|1|||
127766649|NCT04256629|459772065|FG000|Overall Study|Protocol Violation|0|||
127766650|NCT04256629|459772066|FG001|Overall Study|Protocol Violation|1|||
127766651|NCT04256629|459772067|FG002|Overall Study|Protocol Violation|0|||
127766652|NCT04256629|459772068|FG003|Overall Study|Protocol Violation|0|||
127766653|NCT04256629|459772069|FG004|Overall Study|Protocol Violation|0|||
127766654|NCT04256629|459772070|FG005|Overall Study|Protocol Violation|0|||
128013843|NCT02903914|460678068|FG006|Overall Study|Progressive Disease|2|||
128013844|NCT02903914|460678069|FG007|Overall Study|Progressive Disease|0|||
128013845|NCT02903914|460678062|FG000|Overall Study|Death|0|||
128013846|NCT02903914|460678063|FG001|Overall Study|Death|0|||
128013847|NCT02903914|460678064|FG002|Overall Study|Death|9|||
128013848|NCT02903914|460678065|FG003|Overall Study|Death|0|||
128013849|NCT02903914|460678066|FG004|Overall Study|Death|1|||
128013850|NCT02903914|460678067|FG005|Overall Study|Death|3|||
128013851|NCT02903914|460678068|FG006|Overall Study|Death|24|||
128013852|NCT02903914|460678069|FG007|Overall Study|Death|2|||
128013853|NCT02903914|460678062|FG000|Overall Study|Lost to Follow-up|0|||
128013854|NCT02903914|460678063|FG001|Overall Study|Lost to Follow-up|1|||
128013855|NCT02903914|460678064|FG002|Overall Study|Lost to Follow-up|0|||
127679468|NCT05686421|459450274|FG002|Overall Study|Screen failure|0|||
127679469|NCT05686421|459450275|FG003|Overall Study|Screen failure|0|||
127679470|NCT00367055|459450276|FG000|Overall Study|Adverse Event|6|||
127679471|NCT00367055|459450277|FG001|Overall Study|Adverse Event|3|||
127679472|NCT00367055|459450276|FG000|Overall Study|Patient's Willing|3|||
127679473|NCT00367055|459450277|FG001|Overall Study|Patient's Willing|2|||
127679474|NCT00367055|459450276|FG000|Overall Study|Lack of Efficacy|1|||
127679475|NCT00367055|459450277|FG001|Overall Study|Lack of Efficacy|2|||
127679476|NCT00367055|459450276|FG000|Overall Study|Lost to Follow-up|1|||
127679477|NCT00367055|459450277|FG001|Overall Study|Lost to Follow-up|1|||
127679478|NCT00367055|459450276|FG000|Overall Study|Protocol Violation|0|||
127679479|NCT00367055|459450277|FG001|Overall Study|Protocol Violation|1|||
127679480|NCT00367055|459450276|FG000|Overall Study|Stopping Criterion Met|0|||
127679481|NCT00367055|459450277|FG001|Overall Study|Stopping Criterion Met|1|||
127679482|NCT00367055|459450276|FG000|Overall Study|Participant Living too Far from Hospital|0|||
127679483|NCT00367055|459450277|FG001|Overall Study|Participant Living too Far from Hospital|1|||
127679484|NCT03612804|459450278|FG000|Overall Study|Death|0|||
127679485|NCT03612804|459450279|FG001|Overall Study|Death|7|||
127679486|NCT03612804|459450280|FG002|Overall Study|Death|0|||
127679487|NCT03612804|459450281|FG003|Overall Study|Death|8|||
127679488|NCT03612804|459450278|FG000|Overall Study|Medication copay coverage issues|0|||
127679489|NCT03612804|459450279|FG001|Overall Study|Medication copay coverage issues|0|||
127679490|NCT03612804|459450280|FG002|Overall Study|Medication copay coverage issues|0|||
127679491|NCT03612804|459450281|FG003|Overall Study|Medication copay coverage issues|17|||
127679492|NCT03612804|459450278|FG000|Overall Study|Not current smoker at time of screening|0|||
127679493|NCT03612804|459450279|FG001|Overall Study|Not current smoker at time of screening|1|||
127679494|NCT03612804|459450280|FG002|Overall Study|Not current smoker at time of screening|0|||
127679495|NCT03612804|459450281|FG003|Overall Study|Not current smoker at time of screening|3|||
127679496|NCT03612804|459450278|FG000|Overall Study|Non-veteran status|0|||
127679497|NCT03612804|459450279|FG001|Overall Study|Non-veteran status|1|||
127679498|NCT03612804|459450280|FG002|Overall Study|Non-veteran status|0|||
127679499|NCT03612804|459450281|FG003|Overall Study|Non-veteran status|0|||
127679500|NCT03612804|459450278|FG000|Overall Study|Misassignment to a proactive arm provider|0|||
127679501|NCT03612804|459450279|FG001|Overall Study|Misassignment to a proactive arm provider|1|||
127679502|NCT03612804|459450280|FG002|Overall Study|Misassignment to a proactive arm provider|0|||
127679503|NCT03612804|459450281|FG003|Overall Study|Misassignment to a proactive arm provider|0|||
127679504|NCT03612804|459450278|FG000|Overall Study|Provider retired from VA|0|||
127679505|NCT03612804|459450279|FG001|Overall Study|Provider retired from VA|0|||
127679506|NCT03612804|459450280|FG002|Overall Study|Provider retired from VA|2|||
127679507|NCT03612804|459450281|FG003|Overall Study|Provider retired from VA|0|||
127679508|NCT03612804|459450278|FG000|Overall Study|Withdrawal by Subject|0|||
127679509|NCT03612804|459450279|FG001|Overall Study|Withdrawal by Subject|0|||
127679510|NCT03612804|459450280|FG002|Overall Study|Withdrawal by Subject|7|||
127679511|NCT03612804|459450281|FG003|Overall Study|Withdrawal by Subject|0|||
127679512|NCT03612804|459450278|FG000|Overall Study|Provider involved with study activities|1|||
127679513|NCT03612804|459450279|FG001|Overall Study|Provider involved with study activities|0|||
127679514|NCT03612804|459450280|FG002|Overall Study|Provider involved with study activities|0|||
127679515|NCT03612804|459450281|FG003|Overall Study|Provider involved with study activities|0|||
127679516|NCT03386929|459450289|FG000|Overall Study|Death|0|||
127679517|NCT03386929|459450290|FG001|Overall Study|Death|0|||
127679518|NCT03386929|459450291|FG002|Overall Study|Death|1|||
127679519|NCT03386929|459450289|FG000|Overall Study|Withdrawal by Subject|0|||
128013856|NCT02903914|460678065|FG003|Overall Study|Lost to Follow-up|0|||
127679520|NCT03386929|459450290|FG001|Overall Study|Withdrawal by Subject|1|||
127679521|NCT03386929|459450291|FG002|Overall Study|Withdrawal by Subject|0|||
127679522|NCT03386929|459450289|FG000|Overall Study|Physician Decision|0|||
127679523|NCT03386929|459450290|FG001|Overall Study|Physician Decision|0|||
127679524|NCT03386929|459450291|FG002|Overall Study|Physician Decision|1|||
127679525|NCT03386929|459450289|FG000|Overall Study|Progression|4|||
128013857|NCT02903914|460678066|FG004|Overall Study|Lost to Follow-up|2|||
127679526|NCT03386929|459450290|FG001|Overall Study|Progression|4|||
127679527|NCT03386929|459450291|FG002|Overall Study|Progression|0|||
127679528|NCT03386929|459450289|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
128013858|NCT02903914|460678067|FG005|Overall Study|Lost to Follow-up|0|||
127766655|NCT01774487|459772071|FG000|Overall Study|Did not tolerate taste|4|||
127766656|NCT01774487|459772072|FG001|Overall Study|Did not tolerate taste|4|||
127766657|NCT00461032|459772073|FG000|Overall Study|Adverse Event|5|||
127766658|NCT00461032|459772074|FG001|Overall Study|Adverse Event|6|||
127766659|NCT00461032|459772073|FG000|Overall Study|Lack of Efficacy|5|||
127766660|NCT00461032|459772074|FG001|Overall Study|Lack of Efficacy|1|||
127766661|NCT00461032|459772073|FG000|Overall Study|Lost to Follow-up|7|||
127766662|NCT00461032|459772074|FG001|Overall Study|Lost to Follow-up|12|||
127766663|NCT00461032|459772073|FG000|Overall Study|Protocol Violation|4|||
127766664|NCT00461032|459772074|FG001|Overall Study|Protocol Violation|4|||
127766665|NCT00461032|459772073|FG000|Overall Study|Withdrawal by Subject|7|||
127766666|NCT00461032|459772074|FG001|Overall Study|Withdrawal by Subject|15|||
127766667|NCT00461032|459772073|FG000|Overall Study|Patient Moved or Relocated|2|||
127766668|NCT00461032|459772074|FG001|Overall Study|Patient Moved or Relocated|1|||
127766669|NCT00461032|459772073|FG000|Overall Study|Other|7|||
127766670|NCT00461032|459772074|FG001|Overall Study|Other|5|||
127766671|NCT04447846|459772075|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
127766672|NCT01878214|459772076|FG000|Overall Study|Withdrawal by Subject|18|||
127766673|NCT01878214|459772077|FG001|Overall Study|Withdrawal by Subject|7|||
127766674|NCT01878214|459772076|FG000|Overall Study|Death|0|||
127766675|NCT01878214|459772077|FG001|Overall Study|Death|1|||
127766676|NCT01878214|459772076|FG000|Overall Study|Lost to Follow-up|35|||
127766677|NCT01878214|459772077|FG001|Overall Study|Lost to Follow-up|36|||
127766678|NCT00946101|459772080|FG000|Overall Study|Lost to Follow-up|2|||
127766679|NCT00946101|459772081|FG001|Overall Study|Lost to Follow-up|1|||
127766680|NCT00946101|459772080|FG000|Overall Study|Withdrawal of consent|2|||
127766681|NCT00946101|459772081|FG001|Overall Study|Withdrawal of consent|0|||
127766682|NCT00946101|459772080|FG000|Overall Study|Physician Decision|0|||
127766683|NCT00946101|459772081|FG001|Overall Study|Physician Decision|1|||
127766684|NCT02647866|459772082|FG000|Overall Study|Adverse Event|0|||
127766685|NCT02647866|459772083|FG001|Overall Study|Adverse Event|0|||
127766686|NCT02647866|459772084|FG002|Overall Study|Adverse Event|2|||
127766687|NCT02647866|459772085|FG003|Overall Study|Adverse Event|2|||
127766688|NCT02647866|459772086|FG004|Overall Study|Adverse Event|1|||
127766689|NCT02647866|459772082|FG000|Overall Study|Disease Worsening|3|||
127766690|NCT02647866|459772083|FG001|Overall Study|Disease Worsening|1|||
127766691|NCT02647866|459772084|FG002|Overall Study|Disease Worsening|0|||
127766692|NCT02647866|459772085|FG003|Overall Study|Disease Worsening|0|||
127766693|NCT02647866|459772086|FG004|Overall Study|Disease Worsening|1|||
127766694|NCT02647866|459772082|FG000|Overall Study|Withdrawal by Subject|1|||
127766695|NCT02647866|459772083|FG001|Overall Study|Withdrawal by Subject|1|||
127766696|NCT02647866|459772084|FG002|Overall Study|Withdrawal by Subject|2|||
127766697|NCT02647866|459772085|FG003|Overall Study|Withdrawal by Subject|4|||
127766698|NCT02647866|459772086|FG004|Overall Study|Withdrawal by Subject|4|||
127766699|NCT02647866|459772082|FG000|Overall Study|Physician Decision|0|||
127766700|NCT02647866|459772083|FG001|Overall Study|Physician Decision|1|||
127766701|NCT02647866|459772084|FG002|Overall Study|Physician Decision|1|||
127766702|NCT02647866|459772085|FG003|Overall Study|Physician Decision|0|||
127766703|NCT02647866|459772086|FG004|Overall Study|Physician Decision|2|||
127766704|NCT02647866|459772082|FG000|Overall Study|Death|0|||
127766705|NCT02647866|459772083|FG001|Overall Study|Death|1|||
127766706|NCT02647866|459772084|FG002|Overall Study|Death|0|||
127766707|NCT02647866|459772085|FG003|Overall Study|Death|0|||
127766708|NCT02647866|459772086|FG004|Overall Study|Death|0|||
127766709|NCT02647866|459772082|FG000|Overall Study|Subject moved to different country|1|||
127766710|NCT02647866|459772083|FG001|Overall Study|Subject moved to different country|0|||
127766711|NCT02647866|459772084|FG002|Overall Study|Subject moved to different country|0|||
127766712|NCT02647866|459772085|FG003|Overall Study|Subject moved to different country|0|||
127766713|NCT02647866|459772086|FG004|Overall Study|Subject moved to different country|0|||
127766714|NCT00069108|459772090|FG000|Overall Study|Withdrawal by Subject|5|||
127766715|NCT00069108|459772091|FG001|Overall Study|Withdrawal by Subject|9|||
127766716|NCT00069108|459772090|FG000|Overall Study|Adverse Event|64|||
127766717|NCT00069108|459772091|FG001|Overall Study|Adverse Event|42|||
127766718|NCT00069108|459772090|FG000|Overall Study|Death|6|||
127766719|NCT00069108|459772091|FG001|Overall Study|Death|6|||
127766720|NCT00069108|459772090|FG000|Overall Study|Administration|15|||
127766721|NCT00069108|459772091|FG001|Overall Study|Administration|4|||
127766722|NCT00069108|459772090|FG000|Overall Study|Insufficient therapy|117|||
127766723|NCT00069108|459772091|FG001|Overall Study|Insufficient therapy|144|||
127766724|NCT00069108|459772090|FG000|Overall Study|Violation criteria|1|||
127766725|NCT00069108|459772091|FG001|Overall Study|Violation criteria|4|||
127766726|NCT00069108|459772090|FG000|Overall Study|Refused treatment|5|||
127766727|NCT00069108|459772091|FG001|Overall Study|Refused treatment|10|||
127766728|NCT01415531|459772092|FG000|Overall Study|Adverse Event|7|||
127766729|NCT01415531|459772093|FG001|Overall Study|Adverse Event|10|||
127766730|NCT01415531|459772092|FG000|Overall Study|Lack of Efficacy|3|||
127766731|NCT01415531|459772093|FG001|Overall Study|Lack of Efficacy|2|||
127766732|NCT01415531|459772092|FG000|Overall Study|Protocol Violation|0|||
127766733|NCT01415531|459772093|FG001|Overall Study|Protocol Violation|1|||
128013859|NCT02903914|460678068|FG006|Overall Study|Lost to Follow-up|1|||
128013860|NCT02903914|460678069|FG007|Overall Study|Lost to Follow-up|0|||
128013861|NCT02903914|460678062|FG000|Overall Study|Physician Decision|0|||
128013862|NCT02903914|460678063|FG001|Overall Study|Physician Decision|0|||
128013863|NCT02903914|460678064|FG002|Overall Study|Physician Decision|1|||
128013864|NCT02903914|460678065|FG003|Overall Study|Physician Decision|0|||
128013865|NCT02903914|460678066|FG004|Overall Study|Physician Decision|0|||
128013866|NCT02903914|460678067|FG005|Overall Study|Physician Decision|0|||
128013867|NCT02903914|460678068|FG006|Overall Study|Physician Decision|1|||
128013868|NCT02903914|460678069|FG007|Overall Study|Physician Decision|0|||
128013869|NCT02903914|460678062|FG000|Overall Study|Symptomatic Deterioration|0|||
128013870|NCT02903914|460678063|FG001|Overall Study|Symptomatic Deterioration|0|||
128013871|NCT02903914|460678064|FG002|Overall Study|Symptomatic Deterioration|1|||
128013872|NCT02903914|460678065|FG003|Overall Study|Symptomatic Deterioration|0|||
128013873|NCT02903914|460678066|FG004|Overall Study|Symptomatic Deterioration|0|||
128013874|NCT02903914|460678067|FG005|Overall Study|Symptomatic Deterioration|0|||
128013875|NCT02903914|460678068|FG006|Overall Study|Symptomatic Deterioration|0|||
128013876|NCT02903914|460678069|FG007|Overall Study|Symptomatic Deterioration|0|||
128013877|NCT02903914|460678062|FG000|Overall Study|New Cancer Therapy|2|||
128013878|NCT02903914|460678063|FG001|Overall Study|New Cancer Therapy|2|||
128013879|NCT02903914|460678064|FG002|Overall Study|New Cancer Therapy|21|||
128013880|NCT02903914|460678065|FG003|Overall Study|New Cancer Therapy|4|||
128013881|NCT02903914|460678066|FG004|Overall Study|New Cancer Therapy|3|||
128013882|NCT02903914|460678067|FG005|Overall Study|New Cancer Therapy|6|||
128013883|NCT02903914|460678068|FG006|Overall Study|New Cancer Therapy|56|||
128013884|NCT02903914|460678069|FG007|Overall Study|New Cancer Therapy|3|||
128013885|NCT02903914|460678062|FG000|Overall Study|Didn't Return to Site|1|||
128013886|NCT02903914|460678063|FG001|Overall Study|Didn't Return to Site|0|||
128013887|NCT02903914|460678064|FG002|Overall Study|Didn't Return to Site|1|||
128013888|NCT02903914|460678065|FG003|Overall Study|Didn't Return to Site|1|||
128013889|NCT02903914|460678066|FG004|Overall Study|Didn't Return to Site|0|||
128013890|NCT02903914|460678067|FG005|Overall Study|Didn't Return to Site|0|||
128013891|NCT02903914|460678068|FG006|Overall Study|Didn't Return to Site|2|||
128013892|NCT02903914|460678069|FG007|Overall Study|Didn't Return to Site|0|||
128013893|NCT02903914|460678062|FG000|Overall Study|Entered/Referred to Hospice Care|1|||
128013894|NCT02903914|460678063|FG001|Overall Study|Entered/Referred to Hospice Care|1|||
128013895|NCT02903914|460678064|FG002|Overall Study|Entered/Referred to Hospice Care|8|||
128013896|NCT02903914|460678065|FG003|Overall Study|Entered/Referred to Hospice Care|0|||
128013897|NCT02903914|460678066|FG004|Overall Study|Entered/Referred to Hospice Care|0|||
128013898|NCT02903914|460678067|FG005|Overall Study|Entered/Referred to Hospice Care|0|||
128013899|NCT02903914|460678068|FG006|Overall Study|Entered/Referred to Hospice Care|4|||
128013900|NCT02903914|460678069|FG007|Overall Study|Entered/Referred to Hospice Care|0|||
128013901|NCT02903914|460678062|FG000|Overall Study|Follow-up Did Not Occur|0|||
128013902|NCT02903914|460678063|FG001|Overall Study|Follow-up Did Not Occur|1|||
128013903|NCT02903914|460678064|FG002|Overall Study|Follow-up Did Not Occur|1|||
128013904|NCT02903914|460678065|FG003|Overall Study|Follow-up Did Not Occur|0|||
128013905|NCT02903914|460678066|FG004|Overall Study|Follow-up Did Not Occur|2|||
128013906|NCT02903914|460678067|FG005|Overall Study|Follow-up Did Not Occur|0|||
128013907|NCT02903914|460678068|FG006|Overall Study|Follow-up Did Not Occur|8|||
128013908|NCT02903914|460678069|FG007|Overall Study|Follow-up Did Not Occur|0|||
127679529|NCT03386929|459450290|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
127679530|NCT03386929|459450291|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
127679531|NCT03386929|459450289|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
127679532|NCT03386929|459450290|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
127679533|NCT03386929|459450291|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
127679534|NCT00387465|459450294|FG000|Overall Study|Withdrawal by Subject|0|||
127679535|NCT00387465|459450295|FG001|Overall Study|Withdrawal by Subject|1|||
127679536|NCT00387465|459450296|FG002|Overall Study|Withdrawal by Subject|0|||
127679537|NCT04257058|459451958|FG000|Overall Study|Lost to Follow-up|31|||
127679538|NCT04199728|459451967|FG000|Overall Study|Adverse Event|1|||
127679539|NCT04199728|459451968|FG001|Overall Study|Adverse Event|0|||
127679540|NCT04199728|459451967|FG000|Overall Study|Withdrawal by Subject|8|||
127679541|NCT04199728|459451968|FG001|Overall Study|Withdrawal by Subject|3|||
127679542|NCT04199728|459451967|FG000|Overall Study|Screen fail after consent|0|||
127679543|NCT04199728|459451968|FG001|Overall Study|Screen fail after consent|1|||
127679544|NCT04199728|459451967|FG000|Overall Study|Early withdraw criteria met|0|||
127679545|NCT04199728|459451968|FG001|Overall Study|Early withdraw criteria met|1|||
128013909|NCT02903914|460678062|FG000|Overall Study|Systemic Treatment Options Necessary|0|||
128013910|NCT02903914|460678063|FG001|Overall Study|Systemic Treatment Options Necessary|1|||
128013911|NCT02903914|460678064|FG002|Overall Study|Systemic Treatment Options Necessary|0|||
128013912|NCT02903914|460678065|FG003|Overall Study|Systemic Treatment Options Necessary|0|||
128013913|NCT02903914|460678066|FG004|Overall Study|Systemic Treatment Options Necessary|0|||
128013914|NCT02903914|460678067|FG005|Overall Study|Systemic Treatment Options Necessary|0|||
128013915|NCT02903914|460678068|FG006|Overall Study|Systemic Treatment Options Necessary|0|||
128013916|NCT02903914|460678069|FG007|Overall Study|Systemic Treatment Options Necessary|0|||
128013917|NCT02903914|460678062|FG000|Overall Study|Consented to/Considered Other Clinical Study|0|||
128013918|NCT02903914|460678063|FG001|Overall Study|Consented to/Considered Other Clinical Study|0|||
128013919|NCT02903914|460678064|FG002|Overall Study|Consented to/Considered Other Clinical Study|2|||
128013920|NCT02903914|460678065|FG003|Overall Study|Consented to/Considered Other Clinical Study|0|||
127679546|NCT04199728|459451967|FG000|Overall Study|Non-compliance/difficulty with staff|2|||
127766734|NCT01415531|459772092|FG000|Overall Study|Withdrawal by Subject|5|||
127766735|NCT01415531|459772093|FG001|Overall Study|Withdrawal by Subject|4|||
127679547|NCT04199728|459451968|FG001|Overall Study|Non-compliance/difficulty with staff|0|||
127679548|NCT00482729|459451969|FG000|Overall Study|Adverse Event|29|||
127679549|NCT00482729|459451970|FG001|Overall Study|Adverse Event|33|||
127679550|NCT00482729|459451969|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
127679551|NCT00482729|459451970|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
127679552|NCT00482729|459451969|FG000|Overall Study|Hyperglycemia Criteria|7|||
127679553|NCT00482729|459451970|FG001|Overall Study|Hyperglycemia Criteria|5|||
127679554|NCT00482729|459451969|FG000|Overall Study|Lack of Efficacy|4|||
127679555|NCT00482729|459451970|FG001|Overall Study|Lack of Efficacy|16|||
127679556|NCT00482729|459451969|FG000|Overall Study|Lost to Follow-up|86|||
127679557|NCT00482729|459451970|FG001|Overall Study|Lost to Follow-up|66|||
127679558|NCT00482729|459451969|FG000|Overall Study|Physician Decision|10|||
127679559|NCT00482729|459451970|FG001|Overall Study|Physician Decision|7|||
127679560|NCT00482729|459451969|FG000|Overall Study|Pregnancy|4|||
127679561|NCT00482729|459451970|FG001|Overall Study|Pregnancy|2|||
127679562|NCT00482729|459451969|FG000|Overall Study|Protocol Violation|10|||
127679563|NCT00482729|459451970|FG001|Overall Study|Protocol Violation|18|||
127679564|NCT00482729|459451969|FG000|Overall Study|Withdrawal by Subject|67|||
127679565|NCT00482729|459451970|FG001|Overall Study|Withdrawal by Subject|69|||
127679566|NCT00661778|459451979|FG000|Overall Study|Disease Progression|23|||
127679567|NCT00661778|459451979|FG000|Overall Study|Adverse Event|18|||
127679568|NCT00661778|459451979|FG000|Overall Study|Reason not Specified|6|||
127679569|NCT00661778|459451979|FG000|Overall Study|Protocol Violation|2|||
127679570|NCT00661778|459451979|FG000|Overall Study|Withdrawal of Consent|1|||
127679571|NCT01070888|459451980|FG000|First Intervention (14 Days)|Adverse Event|0|||
127679572|NCT01070888|459451981|FG001|First Intervention (14 Days)|Adverse Event|1|||
127679573|NCT01070888|459451980|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
127679574|NCT01070888|459451981|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
127679575|NCT01070888|459451980|FG000|Washout (14 Days)|Physician Decision|1|||
127679576|NCT01070888|459451981|FG001|Washout (14 Days)|Physician Decision|0|||
127679577|NCT02577523|459451985|FG000|Overall Study|Adverse Event|1|||
127679578|NCT02577523|459451986|FG001|Overall Study|Adverse Event|1|||
127679579|NCT02577523|459451985|FG000|Overall Study|Lack of Efficacy|1|||
127679580|NCT02577523|459451986|FG001|Overall Study|Lack of Efficacy|1|||
127679581|NCT02577523|459451985|FG000|Overall Study|Withdrawal by Subject|1|||
127679582|NCT02577523|459451986|FG001|Overall Study|Withdrawal by Subject|0|||
127679583|NCT04860258|459451988|FG000|Overall Study|Withdrawal by Subject|0|||
127679584|NCT04860258|459451989|FG001|Overall Study|Withdrawal by Subject|0|||
127679585|NCT04860258|459451990|FG002|Overall Study|Withdrawal by Subject|4|||
127679586|NCT04860258|459451991|FG003|Overall Study|Withdrawal by Subject|1|||
127679587|NCT04860258|459451992|FG004|Overall Study|Withdrawal by Subject|4|||
127679588|NCT04860258|459451993|FG005|Overall Study|Withdrawal by Subject|1|||
127679589|NCT04860258|459451994|FG006|Overall Study|Withdrawal by Subject|0|||
127679590|NCT00487578|459451995|FG000|Overall Study|Adverse Event|1|||
127679591|NCT00487578|459451996|FG001|Overall Study|Adverse Event|2|||
127679592|NCT00487578|459451995|FG000|Overall Study|Lack of Efficacy|0|||
127679593|NCT00487578|459451996|FG001|Overall Study|Lack of Efficacy|1|||
127679594|NCT00487578|459451995|FG000|Overall Study|Lost to Follow-up|0|||
127679595|NCT00487578|459451996|FG001|Overall Study|Lost to Follow-up|1|||
127679596|NCT00726999|459451999|FG000|Overall Study|Physician Decision|0|||
127679597|NCT00726999|459452000|FG001|Overall Study|Physician Decision|1|||
127766736|NCT01415531|459772092|FG000|Overall Study|Lost to Follow-up|6|||
128013921|NCT02903914|460678066|FG004|Overall Study|Consented to/Considered Other Clinical Study|0|||
128013922|NCT02903914|460678067|FG005|Overall Study|Consented to/Considered Other Clinical Study|2|||
127679598|NCT00726999|459451999|FG000|Overall Study|Withdrawal by Subject|2|||
127766737|NCT01415531|459772093|FG001|Overall Study|Lost to Follow-up|14|||
127679599|NCT00726999|459452000|FG001|Overall Study|Withdrawal by Subject|0|||
127679600|NCT00726999|459451999|FG000|Overall Study|Protocol Violation|1|||
127679601|NCT00726999|459452000|FG001|Overall Study|Protocol Violation|0|||
127679602|NCT00955825|459452001|FG000|Overall Study|Adverse Event|15|||
127679603|NCT00955825|459452002|FG001|Overall Study|Adverse Event|2|||
127679604|NCT00955825|459452001|FG000|Overall Study|Withdrawal by Subject|4|||
127679605|NCT00955825|459452002|FG001|Overall Study|Withdrawal by Subject|6|||
127679606|NCT00955825|459452001|FG000|Overall Study|Any other reason not above-mentioned|7|||
127679607|NCT00955825|459452002|FG001|Overall Study|Any other reason not above-mentioned|9|||
127679608|NCT01499134|459452003|FG000|Overall Study|Withdrawal by Subject|0|||
127766738|NCT01415531|459772092|FG000|Overall Study|Lack of Compliance|1|||
127766739|NCT01415531|459772093|FG001|Overall Study|Lack of Compliance|4|||
127766740|NCT01415531|459772092|FG000|Overall Study|Other Reasons|3|||
127766741|NCT01415531|459772093|FG001|Overall Study|Other Reasons|2|||
127766742|NCT01236339|459772094|FG000|Overall Study|Termination of study by sponsor|11|||
127766743|NCT01236339|459772095|FG001|Overall Study|Termination of study by sponsor|13|||
127766744|NCT02054741|459772096|FG000|Overall Study|Protocol Violation|13|||
127766745|NCT02054741|459772097|FG001|Overall Study|Protocol Violation|2|||
127766746|NCT02054741|459772096|FG000|Overall Study|Withdrawal by Subject|10|||
127766747|NCT02054741|459772097|FG001|Overall Study|Withdrawal by Subject|5|||
127766748|NCT02054741|459772096|FG000|Overall Study|Death|94|||
127766749|NCT02054741|459772097|FG001|Overall Study|Death|90|||
127766750|NCT02054741|459772096|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
127766751|NCT02054741|459772097|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
127766752|NCT00394082|459772100|FG000|Overall Study|Unacceptable toxicity|15|||
127766753|NCT00394082|459772100|FG000|Overall Study|Adverse Event|4|||
127766754|NCT00394082|459772100|FG000|Overall Study|Physician Decision|4|||
128013923|NCT02903914|460678068|FG006|Overall Study|Consented to/Considered Other Clinical Study|0|||
128013924|NCT02903914|460678069|FG007|Overall Study|Consented to/Considered Other Clinical Study|0|||
128013925|NCT02903914|460678062|FG000|Overall Study|Clinical Disease Progression|0|||
128013926|NCT02903914|460678063|FG001|Overall Study|Clinical Disease Progression|0|||
128013927|NCT02903914|460678064|FG002|Overall Study|Clinical Disease Progression|2|||
128013928|NCT02903914|460678065|FG003|Overall Study|Clinical Disease Progression|0|||
128013929|NCT02903914|460678066|FG004|Overall Study|Clinical Disease Progression|0|||
128013930|NCT02903914|460678067|FG005|Overall Study|Clinical Disease Progression|0|||
128013931|NCT02903914|460678068|FG006|Overall Study|Clinical Disease Progression|0|||
128013932|NCT02903914|460678069|FG007|Overall Study|Clinical Disease Progression|0|||
128013933|NCT02903914|460678062|FG000|Overall Study|Completed Follow-up Period|0|||
128013934|NCT02903914|460678063|FG001|Overall Study|Completed Follow-up Period|0|||
128013935|NCT02903914|460678064|FG002|Overall Study|Completed Follow-up Period|6|||
128013936|NCT02903914|460678065|FG003|Overall Study|Completed Follow-up Period|2|||
128013937|NCT02903914|460678066|FG004|Overall Study|Completed Follow-up Period|1|||
128013938|NCT02903914|460678067|FG005|Overall Study|Completed Follow-up Period|0|||
128013939|NCT02903914|460678068|FG006|Overall Study|Completed Follow-up Period|9|||
128013940|NCT02903914|460678069|FG007|Overall Study|Completed Follow-up Period|1|||
128013941|NCT02903914|460678062|FG000|Overall Study|Taken off Treatment per Protocol|0|||
128013942|NCT02903914|460678063|FG001|Overall Study|Taken off Treatment per Protocol|0|||
128013943|NCT02903914|460678064|FG002|Overall Study|Taken off Treatment per Protocol|0|||
128013944|NCT02903914|460678065|FG003|Overall Study|Taken off Treatment per Protocol|0|||
128013945|NCT02903914|460678066|FG004|Overall Study|Taken off Treatment per Protocol|0|||
128013946|NCT02903914|460678067|FG005|Overall Study|Taken off Treatment per Protocol|1|||
128013947|NCT02903914|460678068|FG006|Overall Study|Taken off Treatment per Protocol|0|||
128013948|NCT02903914|460678069|FG007|Overall Study|Taken off Treatment per Protocol|0|||
128013949|NCT02903914|460678062|FG000|Overall Study|Refused Further Treatment/Contact|0|||
128013950|NCT02903914|460678063|FG001|Overall Study|Refused Further Treatment/Contact|0|||
128013951|NCT02903914|460678064|FG002|Overall Study|Refused Further Treatment/Contact|0|||
128013952|NCT02903914|460678065|FG003|Overall Study|Refused Further Treatment/Contact|0|||
127679609|NCT01499134|459452004|FG001|Overall Study|Withdrawal by Subject|1|||
127679610|NCT01198275|459452005|FG000|Overall Study|Adverse Event|2|||
127679611|NCT01198275|459452006|FG001|Overall Study|Adverse Event|3|||
127679612|NCT01198275|459452005|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
127679613|NCT01198275|459452006|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
127679614|NCT00391846|459452007|FG000|Overall Study|Adverse Event|4|||
127679615|NCT00391846|459452008|FG001|Overall Study|Adverse Event|1|||
127679616|NCT00391846|459452007|FG000|Overall Study|Did not meet the required elig. crit|2|||
127679617|NCT00391846|459452008|FG001|Overall Study|Did not meet the required elig. crit|2|||
127679618|NCT00391846|459452007|FG000|Overall Study|Withdrawal by Subject|2|||
127679619|NCT00391846|459452008|FG001|Overall Study|Withdrawal by Subject|3|||
127679620|NCT00391846|459452007|FG000|Overall Study|Developed study specific DC criteria|0|||
127679621|NCT00391846|459452008|FG001|Overall Study|Developed study specific DC criteria|1|||
127679622|NCT00150176|459452009|FG000|Overall Study|Adverse Event|16|||
127679623|NCT00150176|459452010|FG001|Overall Study|Adverse Event|53|||
127679624|NCT00150176|459452009|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
127679625|NCT00150176|459452010|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
127679626|NCT00150176|459452009|FG000|Overall Study|Withdrawal by Subject|19|||
127679627|NCT00150176|459452010|FG001|Overall Study|Withdrawal by Subject|12|||
127679628|NCT00150176|459452009|FG000|Overall Study|Lost to Follow-up|3|||
127679629|NCT00150176|459452010|FG001|Overall Study|Lost to Follow-up|3|||
127679630|NCT00150176|459452009|FG000|Overall Study|OTHER|11|||
127679631|NCT00150176|459452010|FG001|Overall Study|OTHER|13|||
127679632|NCT05257798|459452012|FG000|Follow-up Phase|Lost to Follow-up|1|||
127766755|NCT00394082|459772100|FG000|Overall Study|Withdrawal by Subject|2|||
127766756|NCT00394082|459772100|FG000|Overall Study|Other|1|||
128013953|NCT02903914|460678066|FG004|Overall Study|Refused Further Treatment/Contact|0|||
127766757|NCT02344004|459772102|FG000|Overall Study|Adverse Event|11|||
127766758|NCT02344004|459772103|FG001|Overall Study|Adverse Event|1|||
127766759|NCT02344004|459772102|FG000|Overall Study|Death|9|||
127766760|NCT02344004|459772103|FG001|Overall Study|Death|7|||
127766761|NCT02344004|459772102|FG000|Overall Study|Physician Decision|4|||
127766762|NCT02344004|459772103|FG001|Overall Study|Physician Decision|1|||
127766763|NCT02344004|459772102|FG000|Overall Study|Withdrawal by Subject|22|||
127766764|NCT02344004|459772103|FG001|Overall Study|Withdrawal by Subject|5|||
127766765|NCT02344004|459772102|FG000|Overall Study|Rescue Medication|2|||
127766766|NCT02344004|459772103|FG001|Overall Study|Rescue Medication|0|||
127766767|NCT02344004|459772102|FG000|Overall Study|Other Not Specified|12|||
127766768|NCT02344004|459772103|FG001|Overall Study|Other Not Specified|0|||
127766769|NCT02344004|459772102|FG000|Overall Study|Protocol Violation|1|||
127766770|NCT02344004|459772103|FG001|Overall Study|Protocol Violation|0|||
127766771|NCT00336895|459772110|FG000|Overall Study|diarrhea|1|||
127766772|NCT00336895|459772110|FG000|Overall Study|nausea and upset stomach|1|||
127766773|NCT00336895|459772110|FG000|Overall Study|Physician Decision|1|||
127766774|NCT00336895|459772110|FG000|Overall Study|screen failed|1|||
128013954|NCT02903914|460678067|FG005|Overall Study|Refused Further Treatment/Contact|0|||
128013955|NCT02903914|460678068|FG006|Overall Study|Refused Further Treatment/Contact|1|||
127766775|NCT00598273|459772111|FG000|Overall Study|Adverse Event|4|||
127766776|NCT00598273|459772112|FG001|Overall Study|Adverse Event|5|||
127766777|NCT00598273|459772113|FG002|Overall Study|Adverse Event|2|||
127766778|NCT00598273|459772111|FG000|Overall Study|Death|6|||
127766779|NCT00598273|459772112|FG001|Overall Study|Death|12|||
127766780|NCT00598273|459772113|FG002|Overall Study|Death|8|||
127766781|NCT00598273|459772111|FG000|Overall Study|Lost to Follow-up|8|||
127766782|NCT00598273|459772112|FG001|Overall Study|Lost to Follow-up|3|||
127766783|NCT00598273|459772113|FG002|Overall Study|Lost to Follow-up|5|||
127766784|NCT00598273|459772111|FG000|Overall Study|Physician Decision|0|||
127766785|NCT00598273|459772112|FG001|Overall Study|Physician Decision|0|||
128013956|NCT02903914|460678069|FG007|Overall Study|Refused Further Treatment/Contact|0|||
128013957|NCT02903914|460678062|FG000|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
128013958|NCT02903914|460678063|FG001|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
128013959|NCT02903914|460678064|FG002|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
128013960|NCT02903914|460678065|FG003|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
128013961|NCT02903914|460678066|FG004|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
128013962|NCT02903914|460678067|FG005|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
128013963|NCT02903914|460678068|FG006|Overall Study|Discontinued per Sponsor/Participant Agreement|1|||
128013964|NCT02903914|460678069|FG007|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
128013965|NCT03765073|460678072|FG000|Stage 1|Lost to Follow-up|1|||
128013966|NCT03765073|460678073|FG001|Stage 1|Lost to Follow-up|0|||
128013967|NCT03765073|460678074|FG002|Stage 1|Lost to Follow-up|0|||
128013968|NCT03765073|460678075|FG003|Stage 1|Lost to Follow-up|0|||
128013969|NCT03765073|460678076|FG004|Stage 1|Lost to Follow-up|0|||
128013970|NCT03765073|460678077|FG005|Stage 1|Lost to Follow-up|0|||
128013971|NCT03765073|460678078|FG006|Stage 1|Lost to Follow-up|0|||
128013972|NCT03765073|460678079|FG007|Stage 1|Lost to Follow-up|0|||
128013973|NCT03765073|460678080|FG008|Stage 1|Lost to Follow-up|0|||
128013974|NCT03765073|460678081|FG009|Stage 1|Lost to Follow-up|0|||
128013975|NCT03765073|460678082|FG010|Stage 1|Lost to Follow-up|0|||
128013976|NCT03765073|460678083|FG011|Stage 1|Lost to Follow-up|0|||
128013977|NCT03765073|460678084|FG012|Stage 1|Lost to Follow-up|0|||
128013978|NCT03765073|460678085|FG013|Stage 1|Lost to Follow-up|0|||
128013979|NCT03765073|460678086|FG014|Stage 1|Lost to Follow-up|0|||
128013980|NCT03765073|460678087|FG015|Stage 1|Lost to Follow-up|0|||
128013981|NCT03765073|460678088|FG016|Stage 1|Lost to Follow-up|0|||
128013982|NCT03765073|460678089|FG017|Stage 1|Lost to Follow-up|0|||
128013983|NCT03765073|460678090|FG018|Stage 1|Lost to Follow-up|0|||
128013984|NCT03765073|460678091|FG019|Stage 1|Lost to Follow-up|0|||
128013985|NCT03765073|460678092|FG020|Stage 1|Lost to Follow-up|0|||
128013986|NCT03765073|460678072|FG000|Stage 1|Withdrawal by participant|0|||
128013987|NCT03765073|460678073|FG001|Stage 1|Withdrawal by participant|1|||
128013988|NCT03765073|460678074|FG002|Stage 1|Withdrawal by participant|0|||
128013989|NCT03765073|460678075|FG003|Stage 1|Withdrawal by participant|0|||
127766786|NCT00598273|459772113|FG002|Overall Study|Physician Decision|1|||
127766787|NCT00598273|459772111|FG000|Overall Study|Withdrawal by Subject|12|||
127766788|NCT00598273|459772112|FG001|Overall Study|Withdrawal by Subject|10|||
127766789|NCT00598273|459772113|FG002|Overall Study|Withdrawal by Subject|10|||
127766790|NCT00598273|459772111|FG000|Overall Study|Noncompliance|3|||
127766791|NCT00598273|459772112|FG001|Overall Study|Noncompliance|2|||
127766792|NCT00598273|459772113|FG002|Overall Study|Noncompliance|3|||
127766793|NCT00598273|459772111|FG000|Overall Study|Relocation|0|||
128013990|NCT03765073|460678076|FG004|Stage 1|Withdrawal by participant|0|||
128013991|NCT03765073|460678077|FG005|Stage 1|Withdrawal by participant|0|||
128013992|NCT03765073|460678078|FG006|Stage 1|Withdrawal by participant|0|||
128013993|NCT03765073|460678079|FG007|Stage 1|Withdrawal by participant|0|||
128013994|NCT03765073|460678080|FG008|Stage 1|Withdrawal by participant|0|||
127766794|NCT00598273|459772112|FG001|Overall Study|Relocation|2|||
127766795|NCT00598273|459772113|FG002|Overall Study|Relocation|4|||
127766796|NCT00598273|459772111|FG000|Overall Study|Renal transplant|1|||
127766797|NCT00598273|459772112|FG001|Overall Study|Renal transplant|0|||
127766798|NCT00598273|459772113|FG002|Overall Study|Renal transplant|1|||
127766799|NCT00598273|459772111|FG000|Overall Study|Site elected to close|1|||
127766800|NCT00598273|459772112|FG001|Overall Study|Site elected to close|0|||
128013995|NCT03765073|460678081|FG009|Stage 1|Withdrawal by participant|0|||
128013996|NCT03765073|460678082|FG010|Stage 1|Withdrawal by participant|0|||
128013997|NCT03765073|460678083|FG011|Stage 1|Withdrawal by participant|0|||
128013998|NCT03765073|460678084|FG012|Stage 1|Withdrawal by participant|0|||
128013999|NCT03765073|460678085|FG013|Stage 1|Withdrawal by participant|0|||
128014000|NCT03765073|460678086|FG014|Stage 1|Withdrawal by participant|0|||
127679633|NCT05257798|459452013|FG001|Follow-up Phase|Lost to Follow-up|0|||
127766801|NCT00598273|459772113|FG002|Overall Study|Site elected to close|0|||
127766802|NCT00598273|459772111|FG000|Overall Study|Started dialysis|6|||
127766803|NCT00598273|459772112|FG001|Overall Study|Started dialysis|4|||
127766804|NCT00598273|459772113|FG002|Overall Study|Started dialysis|5|||
127766805|NCT00906945|459772114|FG000|Overall Study|Found to be not eligible|0|||
127766806|NCT00906945|459772115|FG001|Overall Study|Found to be not eligible|0|||
127766807|NCT00906945|459772116|FG002|Overall Study|Found to be not eligible|0|||
127766808|NCT00906945|459772117|FG003|Overall Study|Found to be not eligible|1|||
127766809|NCT00906945|459772118|FG004|Overall Study|Found to be not eligible|1|||
127679634|NCT02082158|459452018|FG000|Overall Study|Withdrawal by Subject|0|||
127679635|NCT02082158|459452019|FG001|Overall Study|Withdrawal by Subject|0|||
127679636|NCT02082158|459452020|FG002|Overall Study|Withdrawal by Subject|0|||
127679637|NCT02082158|459452021|FG003|Overall Study|Withdrawal by Subject|0|||
127679638|NCT02082158|459452022|FG004|Overall Study|Withdrawal by Subject|1|||
127679639|NCT02082158|459452023|FG005|Overall Study|Withdrawal by Subject|0|||
127679640|NCT02082158|459452018|FG000|Overall Study|Failed Fit-testing|8|||
127679641|NCT02082158|459452019|FG001|Overall Study|Failed Fit-testing|8|||
127679642|NCT02082158|459452020|FG002|Overall Study|Failed Fit-testing|14|||
127679643|NCT02082158|459452021|FG003|Overall Study|Failed Fit-testing|4|||
127679644|NCT02082158|459452022|FG004|Overall Study|Failed Fit-testing|3|||
127679645|NCT02082158|459452023|FG005|Overall Study|Failed Fit-testing|7|||
127679646|NCT00738699|459452024|FG000|Overall Study|Withdrawal by Subject|5|||
127679647|NCT00738699|459452025|FG001|Overall Study|Withdrawal by Subject|0|||
127679648|NCT00738699|459452024|FG000|Overall Study|Lost to Follow-up|1|||
127679649|NCT00738699|459452025|FG001|Overall Study|Lost to Follow-up|0|||
127679650|NCT00738699|459452024|FG000|Overall Study|Death|144|||
127679651|NCT00738699|459452025|FG001|Overall Study|Death|68|||
127679652|NCT00738699|459452024|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
127679653|NCT00738699|459452025|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
127679654|NCT00738699|459452024|FG000|Overall Study|Other|2|||
127679655|NCT00738699|459452025|FG001|Overall Study|Other|0|||
127679656|NCT00549848|459452030|FG000|Overall Study|Death|1|||
127679657|NCT00549848|459452031|FG001|Overall Study|Death|4|||
127679658|NCT00549848|459452032|FG002|Overall Study|Death|13|||
127679659|NCT00549848|459452030|FG000|Overall Study|Physician Decision|0|||
127679660|NCT00549848|459452031|FG001|Overall Study|Physician Decision|0|||
127679661|NCT00549848|459452032|FG002|Overall Study|Physician Decision|4|||
127679662|NCT00549848|459452030|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
127679663|NCT00549848|459452031|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
127679664|NCT00549848|459452032|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
127679665|NCT00549848|459452030|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
127679666|NCT00549848|459452031|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
127679667|NCT00549848|459452032|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
127679668|NCT00549848|459452030|FG000|Overall Study|Participant/Family Withdraw|2|||
127679669|NCT00549848|459452031|FG001|Overall Study|Participant/Family Withdraw|3|||
127679670|NCT00549848|459452032|FG002|Overall Study|Participant/Family Withdraw|5|||
127679671|NCT00549848|459452030|FG000|Overall Study|Second Malignancy|1|||
127679672|NCT00549848|459452031|FG001|Overall Study|Second Malignancy|0|||
127679673|NCT00549848|459452032|FG002|Overall Study|Second Malignancy|0|||
127679674|NCT00549848|459452030|FG000|Overall Study|Transplant|3|||
127766810|NCT00906945|459772119|FG005|Overall Study|Found to be not eligible|1|||
127766811|NCT00906945|459772114|FG000|Overall Study|Physician Decision|0|||
128014001|NCT03765073|460678087|FG015|Stage 1|Withdrawal by participant|0|||
128014002|NCT03765073|460678088|FG016|Stage 1|Withdrawal by participant|0|||
128014003|NCT03765073|460678089|FG017|Stage 1|Withdrawal by participant|0|||
127679675|NCT00549848|459452031|FG001|Overall Study|Transplant|3|||
127679676|NCT00549848|459452032|FG002|Overall Study|Transplant|18|||
127679677|NCT00549848|459452030|FG000|Overall Study|Unacceptable Toxicity|1|||
127679678|NCT00549848|459452031|FG001|Overall Study|Unacceptable Toxicity|6|||
127679679|NCT00549848|459452032|FG002|Overall Study|Unacceptable Toxicity|6|||
127679680|NCT03262935|459452033|FG000|Overall Study|Withdrawal by Subject|6|||
127679681|NCT03262935|459452034|FG001|Overall Study|Withdrawal by Subject|7|||
127679682|NCT03262935|459452033|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
127679683|NCT03262935|459452034|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
128014004|NCT03765073|460678090|FG018|Stage 1|Withdrawal by participant|0|||
128014005|NCT03765073|460678091|FG019|Stage 1|Withdrawal by participant|0|||
127679684|NCT03262935|459452033|FG000|Overall Study|Death|181|||
127679685|NCT03262935|459452034|FG001|Overall Study|Death|94|||
127679686|NCT03262935|459452033|FG000|Overall Study|Lost to Follow-up|9|||
127679687|NCT03262935|459452034|FG001|Overall Study|Lost to Follow-up|4|||
127679688|NCT03262935|459452033|FG000|Overall Study|Other reason|5|||
127679689|NCT03262935|459452034|FG001|Overall Study|Other reason|0|||
127679690|NCT00419094|459452035|FG000|Overall Study|Adverse Event|3|||
127679691|NCT00419094|459452036|FG001|Overall Study|Adverse Event|7|||
127679692|NCT00419094|459452035|FG000|Overall Study|Lack of Efficacy|1|||
127679693|NCT00419094|459452036|FG001|Overall Study|Lack of Efficacy|0|||
127679694|NCT00419094|459452035|FG000|Overall Study|Lost to Follow-up|0|||
127679695|NCT00419094|459452036|FG001|Overall Study|Lost to Follow-up|2|||
127679696|NCT00419094|459452035|FG000|Overall Study|Protocol Violation|1|||
127679697|NCT00419094|459452036|FG001|Overall Study|Protocol Violation|14|||
127679698|NCT00419094|459452035|FG000|Overall Study|Withdrawal of consent|1|||
127679699|NCT00419094|459452036|FG001|Overall Study|Withdrawal of consent|5|||
127679700|NCT00419094|459452035|FG000|Overall Study|Other: Error determining exit criteria|1|||
127679701|NCT00419094|459452036|FG001|Overall Study|Other: Error determining exit criteria|0|||
127679702|NCT00419094|459452035|FG000|Overall Study|Other: Patient non-compliant|0|||
127679703|NCT00419094|459452036|FG001|Overall Study|Other: Patient non-compliant|1|||
127679704|NCT00419094|459452035|FG000|Overall Study|Other: No contact for extended period|0|||
127679705|NCT00419094|459452036|FG001|Overall Study|Other: No contact for extended period|1|||
127679706|NCT01811706|459452037|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
127679707|NCT01811706|459452038|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
127679708|NCT02224924|459452039|FG000|Overall Study|Withdrawal by Subject|7|||
127679709|NCT02224924|459452040|FG001|Overall Study|Withdrawal by Subject|6|||
127679710|NCT02224924|459452039|FG000|Overall Study|Biopsy cancelled|20|||
127679711|NCT02224924|459452040|FG001|Overall Study|Biopsy cancelled|14|||
127679712|NCT02224924|459452039|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
127679713|NCT02224924|459452040|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
127679714|NCT02224924|459452039|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
127679715|NCT02224924|459452040|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
127679716|NCT03020745|459452041|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
127679717|NCT03020745|459452042|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
127679718|NCT03020745|459452043|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
127679719|NCT03020745|459452044|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
127679720|NCT03020745|459452045|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
127679721|NCT03020745|459452046|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
127679722|NCT03020745|459452047|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
127679723|NCT03020745|459452048|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
127679724|NCT03020745|459452049|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
127679725|NCT03020745|459452050|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
127679726|NCT03020745|459452041|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
127679727|NCT03020745|459452042|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
127679728|NCT03020745|459452043|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
127679729|NCT03020745|459452044|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
127679730|NCT03020745|459452045|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
127679731|NCT03020745|459452046|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
127679732|NCT03020745|459452047|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
127679733|NCT03020745|459452048|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
127679734|NCT03020745|459452049|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
127679735|NCT03020745|459452050|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
127679736|NCT03020745|459452041|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
127679737|NCT03020745|459452042|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
127679738|NCT03020745|459452043|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
127679739|NCT03020745|459452044|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
127679740|NCT03020745|459452045|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
127679741|NCT03020745|459452046|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
127679742|NCT03020745|459452047|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
127679743|NCT03020745|459452048|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
127679744|NCT03020745|459452049|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
127679745|NCT03020745|459452050|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
127766812|NCT00906945|459772115|FG001|Overall Study|Physician Decision|0|||
127679746|NCT03020745|459452041|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
127679747|NCT03020745|459452042|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
127679748|NCT03020745|459452043|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
127679749|NCT03020745|459452044|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
127679750|NCT03020745|459452045|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
127679751|NCT03020745|459452046|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
127766813|NCT00906945|459772116|FG002|Overall Study|Physician Decision|0|||
128014006|NCT03765073|460678092|FG020|Stage 1|Withdrawal by participant|0|||
127679752|NCT03020745|459452047|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
127679753|NCT03020745|459452048|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
127679754|NCT03020745|459452049|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
127679755|NCT03020745|459452050|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
127679756|NCT00964366|459452054|FG000|Overall Study|Did not qualify at Day 1|1|||
127679757|NCT00964366|459452055|FG001|Overall Study|Did not qualify at Day 1|0|||
127679758|NCT00964366|459452054|FG000|Overall Study|Withdrawal by Subject|0|||
127679759|NCT00964366|459452055|FG001|Overall Study|Withdrawal by Subject|1|||
127679760|NCT01370694|459452056|FG000|Overall Study|Switched to rituximab|4|||
127679761|NCT01370694|459452056|FG000|Overall Study|Progressive disease|2|||
127679762|NCT02393716|459452057|FG000|Overall Study|Death|29|||
127679763|NCT02393716|459452057|FG000|Overall Study|Withdrawal by Subject|8|||
127679764|NCT02393716|459452057|FG000|Overall Study|Device Explanted|8|||
127679765|NCT02393716|459452057|FG000|Overall Study|Missed visit|16|||
127679766|NCT02957539|459452058|FG000|Baseline to Week 16|Lost to Follow-up|8|||
127679767|NCT02957539|459452059|FG001|Baseline to Week 16|Lost to Follow-up|10|||
127679768|NCT02957539|459452060|FG002|Baseline to Week 16|Lost to Follow-up|16|||
127679769|NCT02957539|459452058|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
127679770|NCT02957539|459452059|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
127679771|NCT02957539|459452060|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
127679772|NCT02957539|459452058|FG000|Week 16 to 32|Withdrawal by Subject|3|||
127679773|NCT02957539|459452059|FG001|Week 16 to 32|Withdrawal by Subject|3|||
127679774|NCT02957539|459452060|FG002|Week 16 to 32|Withdrawal by Subject|1|||
127679775|NCT02957539|459452058|FG000|Week 16 to 32|Lost to Follow-up|8|||
127679776|NCT02957539|459452059|FG001|Week 16 to 32|Lost to Follow-up|7|||
127679777|NCT02957539|459452060|FG002|Week 16 to 32|Lost to Follow-up|5|||
127679778|NCT02957539|459452058|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
127679779|NCT02957539|459452059|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
127679780|NCT02957539|459452060|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
127679781|NCT02957539|459452058|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
127679782|NCT02957539|459452059|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
127679783|NCT02957539|459452060|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
127679784|NCT03781336|459452063|FG000|Overall Study|Withdrawal by Subject|2|||
127679785|NCT03781336|459452064|FG001|Overall Study|Withdrawal by Subject|2|||
127679786|NCT01596504|459452065|FG000|Overall Study|Participant's Private Reason|0|||
127679787|NCT01596504|459452066|FG001|Overall Study|Participant's Private Reason|1|||
127679788|NCT01596504|459452067|FG002|Overall Study|Participant's Private Reason|0|||
127679789|NCT01596504|459452065|FG000|Overall Study|Adverse Event|1|||
127679790|NCT01596504|459452066|FG001|Overall Study|Adverse Event|2|||
127679791|NCT01596504|459452067|FG002|Overall Study|Adverse Event|1|||
127679792|NCT01596504|459452065|FG000|Overall Study|Withdrawal by Subject|1|||
127679793|NCT01596504|459452066|FG001|Overall Study|Withdrawal by Subject|0|||
127679794|NCT01596504|459452067|FG002|Overall Study|Withdrawal by Subject|0|||
127679795|NCT01901276|459452068|FG000|No PPI: Week 0 to Week 4|Withdrawal by Subject|0|||
127679796|NCT01901276|459452069|FG001|No PPI: Week 0 to Week 4|Withdrawal by Subject|2|||
127679797|NCT04347954|459452070|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
127679798|NCT04347954|459452071|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
127679799|NCT04347954|459452072|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
127679800|NCT04347954|459452070|FG000|Overall Study|Lost to Follow-up|0|||
127679801|NCT04347954|459452071|FG001|Overall Study|Lost to Follow-up|1|||
127679802|NCT04347954|459452072|FG002|Overall Study|Lost to Follow-up|0|||
127679803|NCT03257813|459452076|FG000|Overall Study|Protocol Violation|6|||
127679804|NCT03257813|459452077|FG001|Overall Study|Protocol Violation|3|||
127679805|NCT02878330|459452078|FG000|Overall Study|Death|3|||
127679806|NCT02878330|459452079|FG001|Overall Study|Death|2|||
127679807|NCT02878330|459452078|FG000|Overall Study|Lost to Follow-up|11|||
127679808|NCT02878330|459452079|FG001|Overall Study|Lost to Follow-up|26|||
127679809|NCT02878330|459452078|FG000|Overall Study|Withdrawal by Subject|11|||
127679810|NCT02878330|459452079|FG001|Overall Study|Withdrawal by Subject|21|||
127679811|NCT02878330|459452078|FG000|Overall Study|Other|4|||
127679812|NCT02878330|459452079|FG001|Overall Study|Other|7|||
127679813|NCT02459899|459452081|FG000|Overall Study|Adverse Event|1|||
127679814|NCT02459899|459452082|FG001|Overall Study|Adverse Event|1|||
127679815|NCT02459899|459452083|FG002|Overall Study|Adverse Event|0|||
127679816|NCT02459899|459452084|FG003|Overall Study|Adverse Event|0|||
127679817|NCT02459899|459452081|FG000|Overall Study|Lost to Follow-up|1|||
127679818|NCT02459899|459452082|FG001|Overall Study|Lost to Follow-up|2|||
127679819|NCT02459899|459452083|FG002|Overall Study|Lost to Follow-up|0|||
127679820|NCT02459899|459452084|FG003|Overall Study|Lost to Follow-up|1|||
127679821|NCT02459899|459452081|FG000|Overall Study|Non-compliance with the treatment|0|||
127679822|NCT02459899|459452082|FG001|Overall Study|Non-compliance with the treatment|0|||
127679823|NCT02459899|459452083|FG002|Overall Study|Non-compliance with the treatment|0|||
127679824|NCT02459899|459452084|FG003|Overall Study|Non-compliance with the treatment|1|||
127679825|NCT02459899|459452081|FG000|Overall Study|Withdrawal by Subject|1|||
127679826|NCT02459899|459452082|FG001|Overall Study|Withdrawal by Subject|3|||
127679827|NCT02459899|459452083|FG002|Overall Study|Withdrawal by Subject|0|||
128014007|NCT03765073|460678072|FG000|Stage 2|Death|0|||
128014008|NCT03765073|460678073|FG001|Stage 2|Death|0|||
128014009|NCT03765073|460678074|FG002|Stage 2|Death|0|||
128014010|NCT03765073|460678075|FG003|Stage 2|Death|0|||
128014011|NCT03765073|460678076|FG004|Stage 2|Death|0|||
128014012|NCT03765073|460678077|FG005|Stage 2|Death|0|||
128014013|NCT03765073|460678078|FG006|Stage 2|Death|0|||
127679828|NCT02459899|459452084|FG003|Overall Study|Withdrawal by Subject|0|||
127679829|NCT00940992|459452087|FG000|Overall Study|Adverse Event|2|||
127679830|NCT00940992|459452088|FG001|Overall Study|Adverse Event|0|||
127679831|NCT00940992|459452089|FG002|Overall Study|Adverse Event|1|||
127679832|NCT00940992|459452087|FG000|Overall Study|subject request|2|||
127679833|NCT00940992|459452088|FG001|Overall Study|subject request|1|||
127679834|NCT00940992|459452089|FG002|Overall Study|subject request|0|||
127679835|NCT00940992|459452087|FG000|Overall Study|Lost to Follow-up|0|||
127679836|NCT00940992|459452088|FG001|Overall Study|Lost to Follow-up|1|||
127679837|NCT00940992|459452089|FG002|Overall Study|Lost to Follow-up|1|||
127679838|NCT02781584|459452104|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
127679839|NCT02781584|459452105|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
127679840|NCT02781584|459452106|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
127679841|NCT02781584|459452107|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
127679842|NCT02781584|459452108|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
127679843|NCT02781584|459452109|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
127679844|NCT02781584|459452110|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
127679845|NCT02781584|459452111|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
127679846|NCT02781584|459452112|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
127679847|NCT02781584|459452113|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
127679848|NCT02781584|459452114|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
127679849|NCT02781584|459452115|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
127679850|NCT02781584|459452116|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
127679851|NCT02781584|459452104|FG000|Pre-treatment Phase|Adverse Event|0|||
127679852|NCT02781584|459452105|FG001|Pre-treatment Phase|Adverse Event|0|||
127679853|NCT02781584|459452106|FG002|Pre-treatment Phase|Adverse Event|0|||
127679854|NCT02781584|459452107|FG003|Pre-treatment Phase|Adverse Event|0|||
127679855|NCT02781584|459452108|FG004|Pre-treatment Phase|Adverse Event|0|||
127679856|NCT02781584|459452109|FG005|Pre-treatment Phase|Adverse Event|0|||
127679857|NCT02781584|459452110|FG006|Pre-treatment Phase|Adverse Event|0|||
127679858|NCT02781584|459452111|FG007|Pre-treatment Phase|Adverse Event|0|||
127679859|NCT02781584|459452112|FG008|Pre-treatment Phase|Adverse Event|0|||
127679860|NCT02781584|459452113|FG009|Pre-treatment Phase|Adverse Event|0|||
127679861|NCT02781584|459452114|FG010|Pre-treatment Phase|Adverse Event|0|||
127679862|NCT02781584|459452115|FG011|Pre-treatment Phase|Adverse Event|1|||
127679863|NCT02781584|459452116|FG012|Pre-treatment Phase|Adverse Event|0|||
127679864|NCT02781584|459452104|FG000|Treatment Phase|Withdrew Consent|0|||
127679865|NCT02781584|459452105|FG001|Treatment Phase|Withdrew Consent|0|||
127679866|NCT02781584|459452106|FG002|Treatment Phase|Withdrew Consent|0|||
127679867|NCT02781584|459452107|FG003|Treatment Phase|Withdrew Consent|0|||
127679868|NCT02781584|459452108|FG004|Treatment Phase|Withdrew Consent|0|||
127679869|NCT02781584|459452109|FG005|Treatment Phase|Withdrew Consent|1|||
127679870|NCT02781584|459452110|FG006|Treatment Phase|Withdrew Consent|0|||
127679871|NCT02781584|459452111|FG007|Treatment Phase|Withdrew Consent|0|||
127679872|NCT02781584|459452112|FG008|Treatment Phase|Withdrew Consent|0|||
127679873|NCT02781584|459452113|FG009|Treatment Phase|Withdrew Consent|0|||
127679874|NCT02781584|459452114|FG010|Treatment Phase|Withdrew Consent|1|||
127679875|NCT02781584|459452115|FG011|Treatment Phase|Withdrew Consent|2|||
127679876|NCT02781584|459452116|FG012|Treatment Phase|Withdrew Consent|0|||
127679877|NCT02781584|459452104|FG000|Treatment Phase|Adverse Event|0|||
127679878|NCT02781584|459452105|FG001|Treatment Phase|Adverse Event|0|||
127679879|NCT02781584|459452106|FG002|Treatment Phase|Adverse Event|0|||
127679880|NCT02781584|459452107|FG003|Treatment Phase|Adverse Event|0|||
127679881|NCT02781584|459452108|FG004|Treatment Phase|Adverse Event|0|||
127679882|NCT02781584|459452109|FG005|Treatment Phase|Adverse Event|0|||
127679883|NCT02781584|459452110|FG006|Treatment Phase|Adverse Event|0|||
127679884|NCT02781584|459452111|FG007|Treatment Phase|Adverse Event|1|||
127679885|NCT02781584|459452112|FG008|Treatment Phase|Adverse Event|0|||
127679886|NCT02781584|459452113|FG009|Treatment Phase|Adverse Event|0|||
127679887|NCT02781584|459452114|FG010|Treatment Phase|Adverse Event|0|||
127679888|NCT02781584|459452115|FG011|Treatment Phase|Adverse Event|0|||
127679889|NCT02781584|459452116|FG012|Treatment Phase|Adverse Event|0|||
127679890|NCT05019729|459452117|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
127679891|NCT05019729|459452118|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
127679892|NCT05019729|459452119|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
127679893|NCT05019729|459452120|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
127679894|NCT05019729|459452121|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
128014014|NCT03765073|460678079|FG007|Stage 2|Death|0|||
128014015|NCT03765073|460678080|FG008|Stage 2|Death|0|||
128014016|NCT03765073|460678081|FG009|Stage 2|Death|1|||
128014017|NCT03765073|460678082|FG010|Stage 2|Death|0|||
128014018|NCT03765073|460678083|FG011|Stage 2|Death|1|||
128014019|NCT03765073|460678084|FG012|Stage 2|Death|0|||
128014020|NCT03765073|460678085|FG013|Stage 2|Death|0|||
128014021|NCT03765073|460678086|FG014|Stage 2|Death|0|||
128014022|NCT03765073|460678087|FG015|Stage 2|Death|0|||
128014023|NCT03765073|460678088|FG016|Stage 2|Death|2|||
128014024|NCT03765073|460678089|FG017|Stage 2|Death|0|||
128014025|NCT03765073|460678090|FG018|Stage 2|Death|0|||
128014026|NCT03765073|460678091|FG019|Stage 2|Death|0|||
128014027|NCT03765073|460678092|FG020|Stage 2|Death|0|||
128014028|NCT03765073|460678072|FG000|Stage 2|Lost to Follow-up|0|||
128014029|NCT03765073|460678073|FG001|Stage 2|Lost to Follow-up|0|||
128014030|NCT03765073|460678074|FG002|Stage 2|Lost to Follow-up|0|||
128014031|NCT03765073|460678075|FG003|Stage 2|Lost to Follow-up|5|||
128014032|NCT03765073|460678076|FG004|Stage 2|Lost to Follow-up|1|||
128014033|NCT03765073|460678077|FG005|Stage 2|Lost to Follow-up|0|||
128014034|NCT03765073|460678078|FG006|Stage 2|Lost to Follow-up|3|||
128014035|NCT03765073|460678079|FG007|Stage 2|Lost to Follow-up|3|||
128014036|NCT03765073|460678080|FG008|Stage 2|Lost to Follow-up|1|||
128014037|NCT03765073|460678081|FG009|Stage 2|Lost to Follow-up|6|||
128014038|NCT03765073|460678082|FG010|Stage 2|Lost to Follow-up|5|||
128014039|NCT03765073|460678083|FG011|Stage 2|Lost to Follow-up|1|||
128014040|NCT03765073|460678084|FG012|Stage 2|Lost to Follow-up|1|||
128014041|NCT03765073|460678085|FG013|Stage 2|Lost to Follow-up|3|||
128014042|NCT03765073|460678086|FG014|Stage 2|Lost to Follow-up|3|||
128014043|NCT03765073|460678087|FG015|Stage 2|Lost to Follow-up|1|||
128014044|NCT03765073|460678088|FG016|Stage 2|Lost to Follow-up|6|||
128014045|NCT03765073|460678089|FG017|Stage 2|Lost to Follow-up|0|||
128014046|NCT03765073|460678090|FG018|Stage 2|Lost to Follow-up|0|||
128014047|NCT03765073|460678091|FG019|Stage 2|Lost to Follow-up|0|||
128014048|NCT03765073|460678092|FG020|Stage 2|Lost to Follow-up|0|||
128014049|NCT03765073|460678072|FG000|Stage 2|Other|0|||
128014050|NCT03765073|460678073|FG001|Stage 2|Other|0|||
128014051|NCT03765073|460678074|FG002|Stage 2|Other|0|||
128014052|NCT03765073|460678075|FG003|Stage 2|Other|0|||
128014053|NCT03765073|460678076|FG004|Stage 2|Other|0|||
128014054|NCT03765073|460678077|FG005|Stage 2|Other|0|||
128014055|NCT03765073|460678078|FG006|Stage 2|Other|0|||
128014056|NCT03765073|460678079|FG007|Stage 2|Other|1|||
128014057|NCT03765073|460678080|FG008|Stage 2|Other|1|||
128014058|NCT03765073|460678081|FG009|Stage 2|Other|3|||
128014059|NCT03765073|460678082|FG010|Stage 2|Other|0|||
128014060|NCT03765073|460678083|FG011|Stage 2|Other|0|||
127679895|NCT05019729|459452122|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
127679896|NCT00361283|459452131|FG000|Overall Study|Lost to Follow-up|27|||
127679897|NCT00038103|459452132|FG000|Overall Study|Adverse Event|5|||
127679898|NCT00038103|459452133|FG001|Overall Study|Adverse Event|6|||
127679899|NCT00038103|459452132|FG000|Overall Study|Lack of Efficacy|48|||
127679900|NCT00038103|459452133|FG001|Overall Study|Lack of Efficacy|41|||
127679901|NCT00038103|459452132|FG000|Overall Study|Withdrawal by Subject|0|||
127679902|NCT00038103|459452133|FG001|Overall Study|Withdrawal by Subject|3|||
127679903|NCT00038103|459452132|FG000|Overall Study|Lost to Follow-up|0|||
127679904|NCT00038103|459452133|FG001|Overall Study|Lost to Follow-up|3|||
127679905|NCT00038103|459452132|FG000|Overall Study|Protocol Violation|0|||
127679906|NCT00038103|459452133|FG001|Overall Study|Protocol Violation|2|||
127679907|NCT00038103|459452132|FG000|Overall Study|Sponsor Decision|0|||
127679908|NCT00038103|459452133|FG001|Overall Study|Sponsor Decision|1|||
127679909|NCT00038103|459452132|FG000|Overall Study|Randomized/never treated|2|||
127679910|NCT00038103|459452133|FG001|Overall Study|Randomized/never treated|0|||
127679911|NCT05147233|459453966|FG000|Overall Study|Adverse Event|0|||
127679912|NCT05147233|459453967|FG001|Overall Study|Adverse Event|1|||
127679913|NCT05147233|459453966|FG000|Overall Study|Lost to Follow-up|1|||
127679914|NCT05147233|459453967|FG001|Overall Study|Lost to Follow-up|1|||
128014061|NCT03765073|460678084|FG012|Stage 2|Other|0|||
128014062|NCT03765073|460678085|FG013|Stage 2|Other|0|||
128014063|NCT03765073|460678086|FG014|Stage 2|Other|0|||
127679915|NCT05147233|459453966|FG000|Overall Study|Protocol Violation|0|||
127679916|NCT05147233|459453967|FG001|Overall Study|Protocol Violation|1|||
127679917|NCT05147233|459453966|FG000|Overall Study|Withdrawal by Subject|2|||
127679918|NCT05147233|459453967|FG001|Overall Study|Withdrawal by Subject|1|||
127679919|NCT04517864|459453970|FG000|Placebo-Controlled Phase|Adverse Event|1|||
127766814|NCT00906945|459772117|FG003|Overall Study|Physician Decision|0|||
128014064|NCT03765073|460678087|FG015|Stage 2|Other|1|||
128014065|NCT03765073|460678088|FG016|Stage 2|Other|2|||
128014066|NCT03765073|460678089|FG017|Stage 2|Other|0|||
127544710|NCT03103542|458962446|FG000|Overall Study|Adverse Event|2|||
128014067|NCT03765073|460678090|FG018|Stage 2|Other|0|||
128014068|NCT03765073|460678091|FG019|Stage 2|Other|0|||
128014069|NCT03765073|460678092|FG020|Stage 2|Other|0|||
128014070|NCT03765073|460678072|FG000|Stage 2|Withdrawal by parent/guardian|0|||
128014071|NCT03765073|460678073|FG001|Stage 2|Withdrawal by parent/guardian|0|||
128014072|NCT03765073|460678074|FG002|Stage 2|Withdrawal by parent/guardian|0|||
128014073|NCT03765073|460678075|FG003|Stage 2|Withdrawal by parent/guardian|0|||
128014074|NCT03765073|460678076|FG004|Stage 2|Withdrawal by parent/guardian|0|||
128014075|NCT03765073|460678077|FG005|Stage 2|Withdrawal by parent/guardian|0|||
127766815|NCT00906945|459772118|FG004|Overall Study|Physician Decision|0|||
127766816|NCT00906945|459772119|FG005|Overall Study|Physician Decision|1|||
127766817|NCT02481947|459772120|FG000|Overall Study|Withdrawal by Subject|24|||
127766818|NCT02481947|459772121|FG001|Overall Study|Withdrawal by Subject|10|||
127766819|NCT02481947|459772120|FG000|Overall Study|Lost to Follow-up|11|||
127766820|NCT02481947|459772121|FG001|Overall Study|Lost to Follow-up|5|||
127766821|NCT02481947|459772120|FG000|Overall Study|Adverse Event|6|||
127766822|NCT02481947|459772121|FG001|Overall Study|Adverse Event|11|||
128014076|NCT03765073|460678078|FG006|Stage 2|Withdrawal by parent/guardian|0|||
128014077|NCT03765073|460678079|FG007|Stage 2|Withdrawal by parent/guardian|0|||
127766823|NCT02481947|459772120|FG000|Overall Study|Physician Decision|4|||
127766824|NCT02481947|459772121|FG001|Overall Study|Physician Decision|5|||
127766825|NCT02481947|459772120|FG000|Overall Study|Protocol Violation|1|||
127766826|NCT02481947|459772121|FG001|Overall Study|Protocol Violation|5|||
127766827|NCT03426605|459772122|FG000|Overall Study|AML relapse or progression|2|||
128014078|NCT03765073|460678080|FG008|Stage 2|Withdrawal by parent/guardian|0|||
128014079|NCT03765073|460678081|FG009|Stage 2|Withdrawal by parent/guardian|0|||
128014080|NCT03765073|460678082|FG010|Stage 2|Withdrawal by parent/guardian|3|||
128014081|NCT03765073|460678083|FG011|Stage 2|Withdrawal by parent/guardian|3|||
128014082|NCT03765073|460678084|FG012|Stage 2|Withdrawal by parent/guardian|3|||
127766828|NCT03426605|459772123|FG001|Overall Study|AML relapse or progression|1|||
127766829|NCT03426605|459772124|FG002|Overall Study|AML relapse or progression|2|||
127766830|NCT03426605|459772125|FG003|Overall Study|AML relapse or progression|2|||
127766831|NCT03426605|459772122|FG000|Overall Study|Treatment failure|3|||
127766832|NCT03426605|459772123|FG001|Overall Study|Treatment failure|2|||
127766833|NCT03426605|459772124|FG002|Overall Study|Treatment failure|0|||
127766834|NCT03426605|459772125|FG003|Overall Study|Treatment failure|0|||
127766835|NCT03426605|459772122|FG000|Overall Study|Adverse Event|1|||
127766836|NCT03426605|459772123|FG001|Overall Study|Adverse Event|0|||
127766837|NCT03426605|459772124|FG002|Overall Study|Adverse Event|1|||
127766838|NCT03426605|459772125|FG003|Overall Study|Adverse Event|1|||
127766839|NCT03426605|459772122|FG000|Overall Study|Withdrawal by Subject|0|||
127766840|NCT03426605|459772123|FG001|Overall Study|Withdrawal by Subject|0|||
127766841|NCT03426605|459772124|FG002|Overall Study|Withdrawal by Subject|1|||
127766842|NCT03426605|459772125|FG003|Overall Study|Withdrawal by Subject|1|||
127766843|NCT01815138|459772126|FG000|Overall Study|Withdrawal by Subject|0|||
127766844|NCT01815138|459772127|FG001|Overall Study|Withdrawal by Subject|1|||
127766845|NCT01815138|459772126|FG000|Overall Study|Physician Decision|8|||
127766846|NCT01815138|459772127|FG001|Overall Study|Physician Decision|5|||
127766847|NCT03426267|459772128|FG000|Overall Study|Physician Decision|1|||
127766848|NCT03426267|459772129|FG001|Overall Study|Physician Decision|4|||
127766849|NCT03426267|459772128|FG000|Overall Study|Lost to Follow-up|1|||
127766850|NCT03426267|459772129|FG001|Overall Study|Lost to Follow-up|0|||
128014083|NCT03765073|460678085|FG013|Stage 2|Withdrawal by parent/guardian|1|||
128014084|NCT03765073|460678086|FG014|Stage 2|Withdrawal by parent/guardian|1|||
128014085|NCT03765073|460678087|FG015|Stage 2|Withdrawal by parent/guardian|0|||
128014086|NCT03765073|460678088|FG016|Stage 2|Withdrawal by parent/guardian|3|||
128014087|NCT03765073|460678089|FG017|Stage 2|Withdrawal by parent/guardian|0|||
128014088|NCT03765073|460678090|FG018|Stage 2|Withdrawal by parent/guardian|0|||
128014089|NCT03765073|460678091|FG019|Stage 2|Withdrawal by parent/guardian|0|||
128014090|NCT03765073|460678092|FG020|Stage 2|Withdrawal by parent/guardian|0|||
128014091|NCT03765073|460678072|FG000|Stage 2|Withdrawal by Subject|0|||
128014092|NCT03765073|460678073|FG001|Stage 2|Withdrawal by Subject|0|||
128014093|NCT03765073|460678074|FG002|Stage 2|Withdrawal by Subject|0|||
128014094|NCT03765073|460678075|FG003|Stage 2|Withdrawal by Subject|3|||
128014095|NCT03765073|460678076|FG004|Stage 2|Withdrawal by Subject|3|||
128014096|NCT03765073|460678077|FG005|Stage 2|Withdrawal by Subject|3|||
128014097|NCT03765073|460678078|FG006|Stage 2|Withdrawal by Subject|0|||
128014098|NCT03765073|460678079|FG007|Stage 2|Withdrawal by Subject|1|||
128014099|NCT03765073|460678080|FG008|Stage 2|Withdrawal by Subject|0|||
128014100|NCT03765073|460678081|FG009|Stage 2|Withdrawal by Subject|5|||
128014101|NCT03765073|460678082|FG010|Stage 2|Withdrawal by Subject|0|||
128014102|NCT03765073|460678083|FG011|Stage 2|Withdrawal by Subject|0|||
127766851|NCT03426267|459772128|FG000|Overall Study|Withdrawal by Subject|4|||
128014103|NCT03765073|460678084|FG012|Stage 2|Withdrawal by Subject|0|||
128014104|NCT03765073|460678085|FG013|Stage 2|Withdrawal by Subject|0|||
128014105|NCT03765073|460678086|FG014|Stage 2|Withdrawal by Subject|0|||
128014106|NCT03765073|460678087|FG015|Stage 2|Withdrawal by Subject|0|||
128014107|NCT03765073|460678088|FG016|Stage 2|Withdrawal by Subject|0|||
128014108|NCT03765073|460678089|FG017|Stage 2|Withdrawal by Subject|0|||
128014109|NCT03765073|460678090|FG018|Stage 2|Withdrawal by Subject|0|||
128014110|NCT03765073|460678091|FG019|Stage 2|Withdrawal by Subject|0|||
128014111|NCT03765073|460678092|FG020|Stage 2|Withdrawal by Subject|0|||
127766852|NCT03426267|459772129|FG001|Overall Study|Withdrawal by Subject|10|||
127766853|NCT03426267|459772128|FG000|Overall Study|Protocol Violation|1|||
128014112|NCT03765073|460678072|FG000|Stage 3|Adverse Event|0|||
128014113|NCT03765073|460678073|FG001|Stage 3|Adverse Event|0|||
128014114|NCT03765073|460678074|FG002|Stage 3|Adverse Event|0|||
128014115|NCT03765073|460678075|FG003|Stage 3|Adverse Event|0|||
128014116|NCT03765073|460678076|FG004|Stage 3|Adverse Event|0|||
127679920|NCT04517864|459453971|FG001|Placebo-Controlled Phase|Adverse Event|0|||
127679921|NCT04517864|459453972|FG002|Placebo-Controlled Phase|Adverse Event|0|||
127679922|NCT04517864|459453970|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
128014117|NCT03765073|460678077|FG005|Stage 3|Adverse Event|0|||
128014118|NCT03765073|460678078|FG006|Stage 3|Adverse Event|0|||
128014119|NCT03765073|460678079|FG007|Stage 3|Adverse Event|0|||
128014120|NCT03765073|460678080|FG008|Stage 3|Adverse Event|0|||
128014121|NCT03765073|460678081|FG009|Stage 3|Adverse Event|0|||
128014122|NCT03765073|460678082|FG010|Stage 3|Adverse Event|0|||
128014123|NCT03765073|460678083|FG011|Stage 3|Adverse Event|0|||
128014124|NCT03765073|460678084|FG012|Stage 3|Adverse Event|0|||
128014125|NCT03765073|460678085|FG013|Stage 3|Adverse Event|0|||
128014126|NCT03765073|460678086|FG014|Stage 3|Adverse Event|0|||
128014127|NCT03765073|460678087|FG015|Stage 3|Adverse Event|0|||
128014128|NCT03765073|460678088|FG016|Stage 3|Adverse Event|0|||
128014129|NCT03765073|460678089|FG017|Stage 3|Adverse Event|0|||
128014130|NCT03765073|460678090|FG018|Stage 3|Adverse Event|1|||
128014131|NCT03765073|460678091|FG019|Stage 3|Adverse Event|0|||
128014132|NCT03765073|460678092|FG020|Stage 3|Adverse Event|0|||
128014133|NCT03765073|460678072|FG000|Stage 3|Death|0|||
128014134|NCT03765073|460678073|FG001|Stage 3|Death|0|||
127679923|NCT04517864|459453971|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
127679924|NCT04517864|459453972|FG002|Placebo-Controlled Phase|Lost to Follow-up|0|||
127679925|NCT04517864|459453970|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
127679926|NCT04517864|459453971|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
127679927|NCT04517864|459453972|FG002|Placebo-Controlled Phase|Protocol Violation|0|||
127679928|NCT04517864|459453970|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
127679929|NCT04517864|459453971|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
127679930|NCT04517864|459453972|FG002|Placebo-Controlled Phase|Withdrawal by Subject|0|||
127679931|NCT04517864|459453970|FG000|Active Therapy Extension Phase|Adverse Event|1|||
127679932|NCT04517864|459453971|FG001|Active Therapy Extension Phase|Adverse Event|0|||
127679933|NCT04517864|459453972|FG002|Active Therapy Extension Phase|Adverse Event|0|||
127679934|NCT04517864|459453970|FG000|Active Therapy Extension Phase|Lack of Efficacy|1|||
127679935|NCT04517864|459453971|FG001|Active Therapy Extension Phase|Lack of Efficacy|0|||
127679936|NCT04517864|459453972|FG002|Active Therapy Extension Phase|Lack of Efficacy|0|||
127679937|NCT04517864|459453970|FG000|Active Therapy Extension Phase|Lost to Follow-up|0|||
127679938|NCT04517864|459453971|FG001|Active Therapy Extension Phase|Lost to Follow-up|1|||
127679939|NCT04517864|459453972|FG002|Active Therapy Extension Phase|Lost to Follow-up|0|||
127679940|NCT04517864|459453970|FG000|Active Therapy Extension Phase|Physician Decision|1|||
127679941|NCT04517864|459453971|FG001|Active Therapy Extension Phase|Physician Decision|0|||
127679942|NCT04517864|459453972|FG002|Active Therapy Extension Phase|Physician Decision|0|||
127679943|NCT04517864|459453970|FG000|Active Therapy Extension Phase|Withdrawal by Subject|8|||
127679944|NCT04517864|459453971|FG001|Active Therapy Extension Phase|Withdrawal by Subject|8|||
127679945|NCT04517864|459453972|FG002|Active Therapy Extension Phase|Withdrawal by Subject|0|||
127679946|NCT04517864|459453970|FG000|Extension Phase|Adverse Event|0|||
127679947|NCT04517864|459453971|FG001|Extension Phase|Adverse Event|0|||
127679948|NCT04517864|459453972|FG002|Extension Phase|Adverse Event|1|||
127679949|NCT04517864|459453970|FG000|Extension Phase|Lack of Efficacy|0|||
127679950|NCT04517864|459453971|FG001|Extension Phase|Lack of Efficacy|0|||
127679951|NCT04517864|459453972|FG002|Extension Phase|Lack of Efficacy|2|||
127679952|NCT04517864|459453970|FG000|Extension Phase|Study Terminated By Sponsor|0|||
127679953|NCT04517864|459453971|FG001|Extension Phase|Study Terminated By Sponsor|0|||
127679954|NCT04517864|459453972|FG002|Extension Phase|Study Terminated By Sponsor|32|||
127679955|NCT04517864|459453970|FG000|Extension Phase|Withdrawal by Subject|0|||
127679956|NCT04517864|459453971|FG001|Extension Phase|Withdrawal by Subject|0|||
127679957|NCT04517864|459453972|FG002|Extension Phase|Withdrawal by Subject|3|||
127679958|NCT04517864|459453970|FG000|Extension Phase|Approved Drug Available for Indication|0|||
127679959|NCT04517864|459453971|FG001|Extension Phase|Approved Drug Available for Indication|0|||
127679960|NCT04517864|459453972|FG002|Extension Phase|Approved Drug Available for Indication|7|||
127679961|NCT04722003|459453973|FG000|Overall Study|Lost to Follow-up|2|||
127679962|NCT04722003|459453974|FG001|Overall Study|Lost to Follow-up|0|||
127679963|NCT04722003|459453973|FG000|Overall Study|Physician Decision|1|||
127679964|NCT04722003|459453974|FG001|Overall Study|Physician Decision|0|||
127679965|NCT01049503|459453975|FG000|Overall Study|Lost to Follow-up|11|||
127679966|NCT01049503|459453976|FG001|Overall Study|Lost to Follow-up|12|||
128014135|NCT03765073|460678074|FG002|Stage 3|Death|0|||
128014136|NCT03765073|460678075|FG003|Stage 3|Death|0|||
127766854|NCT03426267|459772129|FG001|Overall Study|Protocol Violation|3|||
128014137|NCT03765073|460678076|FG004|Stage 3|Death|0|||
128014138|NCT03765073|460678077|FG005|Stage 3|Death|0|||
127679967|NCT01049503|459453977|FG002|Overall Study|Lost to Follow-up|24|||
127679968|NCT01049503|459453978|FG003|Overall Study|Lost to Follow-up|26|||
128014139|NCT03765073|460678078|FG006|Stage 3|Death|0|||
127679969|NCT01049503|459453979|FG004|Overall Study|Lost to Follow-up|27|||
128014140|NCT03765073|460678079|FG007|Stage 3|Death|0|||
128014141|NCT03765073|460678080|FG008|Stage 3|Death|0|||
128014142|NCT03765073|460678081|FG009|Stage 3|Death|0|||
128014143|NCT03765073|460678082|FG010|Stage 3|Death|0|||
127679970|NCT01049503|459453980|FG005|Overall Study|Lost to Follow-up|8|||
127679971|NCT00726596|459453981|FG000|Overall Study|Adverse Event|2|||
127679972|NCT00726596|459453982|FG001|Overall Study|Adverse Event|1|||
127679973|NCT00726596|459453981|FG000|Overall Study|Withdrawal by Subject|3|||
127679974|NCT00726596|459453982|FG001|Overall Study|Withdrawal by Subject|3|||
127679975|NCT02974634|459453983|FG000|Overall Study|Advanced disease|12|||
127679976|NCT02974634|459453984|FG001|Overall Study|Advanced disease|3|||
127679977|NCT02974634|459453983|FG000|Overall Study|Noncompliance|3|||
127679978|NCT02974634|459453984|FG001|Overall Study|Noncompliance|7|||
127679979|NCT02974634|459453983|FG000|Overall Study|intervention technology related issues|5|||
127679980|NCT02974634|459453984|FG001|Overall Study|intervention technology related issues|0|||
127679981|NCT02974634|459453983|FG000|Overall Study|Death|8|||
127679982|NCT02974634|459453984|FG001|Overall Study|Death|11|||
127679983|NCT02962674|459453991|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
127679984|NCT00364286|459453992|FG000|Overall Study|Withdrawal by Subject|1|||
127679985|NCT00364286|459453992|FG000|Overall Study|Adverse Event|2|||
127679986|NCT00028769|459453995|FG000|Overall Study|Adverse Event|2|||
127679987|NCT00028769|459453995|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
127679988|NCT00028769|459453995|FG000|Overall Study|Progression or Death|31|||
127679989|NCT00028769|459453995|FG000|Overall Study|Other - Not Protocol Specified|1|||
127679990|NCT00028769|459453995|FG000|Overall Study|Ineligible|5|||
127679991|NCT00028769|459453995|FG000|Overall Study|Not Analyzable|1|||
127679992|NCT01134562|459453996|FG000|Overall Study|Adverse Event|0|||
127679993|NCT01134562|459453997|FG001|Overall Study|Adverse Event|1|||
127679994|NCT01134562|459453998|FG002|Overall Study|Adverse Event|0|||
127679995|NCT01134562|459453999|FG003|Overall Study|Adverse Event|0|||
127679996|NCT01134562|459454000|FG004|Overall Study|Adverse Event|0|||
127679997|NCT00357396|459454001|FG000|Overall Study|Adverse Event|1|||
127679998|NCT00357396|459454002|FG001|Overall Study|Adverse Event|0|||
127679999|NCT02496702|459454003|FG000|Overall Study|Lost to Follow-up|8|||
127680000|NCT02496702|459454004|FG001|Overall Study|Lost to Follow-up|6|||
128014144|NCT03765073|460678083|FG011|Stage 3|Death|0|||
128014145|NCT03765073|460678084|FG012|Stage 3|Death|0|||
127680001|NCT02496702|459454003|FG000|Overall Study|Only partially tested|0|||
127680002|NCT02496702|459454004|FG001|Overall Study|Only partially tested|2|||
127680003|NCT01227278|459454005|FG000|Overall Study|Withdrawal by Subject|4|||
127680004|NCT01227278|459454006|FG001|Overall Study|Withdrawal by Subject|4|||
128014146|NCT03765073|460678085|FG013|Stage 3|Death|0|||
128014147|NCT03765073|460678086|FG014|Stage 3|Death|0|||
128014148|NCT03765073|460678087|FG015|Stage 3|Death|0|||
128014149|NCT03765073|460678088|FG016|Stage 3|Death|0|||
128014150|NCT03765073|460678089|FG017|Stage 3|Death|0|||
128014151|NCT03765073|460678090|FG018|Stage 3|Death|0|||
128014152|NCT03765073|460678091|FG019|Stage 3|Death|3|||
128014153|NCT03765073|460678092|FG020|Stage 3|Death|2|||
128014154|NCT03765073|460678072|FG000|Stage 3|Lost to Follow-up|0|||
128014155|NCT03765073|460678073|FG001|Stage 3|Lost to Follow-up|0|||
128014156|NCT03765073|460678074|FG002|Stage 3|Lost to Follow-up|0|||
128014157|NCT03765073|460678075|FG003|Stage 3|Lost to Follow-up|0|||
128014158|NCT03765073|460678076|FG004|Stage 3|Lost to Follow-up|0|||
128014159|NCT03765073|460678077|FG005|Stage 3|Lost to Follow-up|0|||
128014160|NCT03765073|460678078|FG006|Stage 3|Lost to Follow-up|0|||
128014161|NCT03765073|460678079|FG007|Stage 3|Lost to Follow-up|0|||
128014162|NCT03765073|460678080|FG008|Stage 3|Lost to Follow-up|0|||
128014163|NCT03765073|460678081|FG009|Stage 3|Lost to Follow-up|0|||
128014164|NCT03765073|460678082|FG010|Stage 3|Lost to Follow-up|0|||
128014165|NCT03765073|460678083|FG011|Stage 3|Lost to Follow-up|0|||
128014166|NCT03765073|460678084|FG012|Stage 3|Lost to Follow-up|0|||
128014167|NCT03765073|460678085|FG013|Stage 3|Lost to Follow-up|0|||
128014168|NCT03765073|460678086|FG014|Stage 3|Lost to Follow-up|0|||
128014169|NCT03765073|460678087|FG015|Stage 3|Lost to Follow-up|0|||
128014170|NCT03765073|460678088|FG016|Stage 3|Lost to Follow-up|0|||
128014171|NCT03765073|460678089|FG017|Stage 3|Lost to Follow-up|8|||
128014172|NCT03765073|460678090|FG018|Stage 3|Lost to Follow-up|5|||
128014173|NCT03765073|460678091|FG019|Stage 3|Lost to Follow-up|7|||
128014174|NCT03765073|460678092|FG020|Stage 3|Lost to Follow-up|4|||
128014175|NCT03765073|460678072|FG000|Stage 3|No longer meets eligibility criteria|0|||
128014176|NCT03765073|460678073|FG001|Stage 3|No longer meets eligibility criteria|0|||
127680005|NCT01227278|459454005|FG000|Overall Study|Death|0|||
127680006|NCT01227278|459454006|FG001|Overall Study|Death|2|||
127680007|NCT01227278|459454005|FG000|Overall Study|Other|1|||
128014177|NCT03765073|460678074|FG002|Stage 3|No longer meets eligibility criteria|0|||
128014178|NCT03765073|460678075|FG003|Stage 3|No longer meets eligibility criteria|0|||
127680008|NCT01227278|459454006|FG001|Overall Study|Other|2|||
127680009|NCT04035668|459454007|FG000|Overall Study|Adverse Event|3|||
128014179|NCT03765073|460678076|FG004|Stage 3|No longer meets eligibility criteria|0|||
128014180|NCT03765073|460678077|FG005|Stage 3|No longer meets eligibility criteria|0|||
128014181|NCT03765073|460678078|FG006|Stage 3|No longer meets eligibility criteria|0|||
127680010|NCT04035668|459454008|FG001|Overall Study|Adverse Event|4|||
128014182|NCT03765073|460678079|FG007|Stage 3|No longer meets eligibility criteria|0|||
128014183|NCT03765073|460678080|FG008|Stage 3|No longer meets eligibility criteria|0|||
128014184|NCT03765073|460678081|FG009|Stage 3|No longer meets eligibility criteria|0|||
128014185|NCT03765073|460678082|FG010|Stage 3|No longer meets eligibility criteria|0|||
128014186|NCT03765073|460678083|FG011|Stage 3|No longer meets eligibility criteria|0|||
128014187|NCT03765073|460678084|FG012|Stage 3|No longer meets eligibility criteria|0|||
128014188|NCT03765073|460678085|FG013|Stage 3|No longer meets eligibility criteria|0|||
128014189|NCT03765073|460678086|FG014|Stage 3|No longer meets eligibility criteria|0|||
128014190|NCT03765073|460678087|FG015|Stage 3|No longer meets eligibility criteria|0|||
128014191|NCT03765073|460678088|FG016|Stage 3|No longer meets eligibility criteria|0|||
128014192|NCT03765073|460678089|FG017|Stage 3|No longer meets eligibility criteria|0|||
128014193|NCT03765073|460678090|FG018|Stage 3|No longer meets eligibility criteria|1|||
128014194|NCT03765073|460678091|FG019|Stage 3|No longer meets eligibility criteria|0|||
128014195|NCT03765073|460678092|FG020|Stage 3|No longer meets eligibility criteria|1|||
127680011|NCT04035668|459454009|FG002|Overall Study|Adverse Event|2|||
127680012|NCT04035668|459454007|FG000|Overall Study|Lost to Follow-up|0|||
127680013|NCT04035668|459454008|FG001|Overall Study|Lost to Follow-up|1|||
128014196|NCT03765073|460678072|FG000|Stage 3|Other|0|||
128014197|NCT03765073|460678073|FG001|Stage 3|Other|0|||
128014198|NCT03765073|460678074|FG002|Stage 3|Other|0|||
128014199|NCT03765073|460678075|FG003|Stage 3|Other|0|||
128014200|NCT03765073|460678076|FG004|Stage 3|Other|0|||
128014201|NCT03765073|460678077|FG005|Stage 3|Other|0|||
128014202|NCT03765073|460678078|FG006|Stage 3|Other|0|||
128014203|NCT03765073|460678079|FG007|Stage 3|Other|0|||
128014204|NCT03765073|460678080|FG008|Stage 3|Other|0|||
128014205|NCT03765073|460678081|FG009|Stage 3|Other|0|||
128014206|NCT03765073|460678082|FG010|Stage 3|Other|0|||
128014207|NCT03765073|460678083|FG011|Stage 3|Other|0|||
128014208|NCT03765073|460678084|FG012|Stage 3|Other|0|||
127680014|NCT04035668|459454009|FG002|Overall Study|Lost to Follow-up|0|||
128014209|NCT03765073|460678085|FG013|Stage 3|Other|0|||
128014210|NCT03765073|460678086|FG014|Stage 3|Other|0|||
128014211|NCT03765073|460678087|FG015|Stage 3|Other|0|||
128014212|NCT03765073|460678088|FG016|Stage 3|Other|0|||
128014213|NCT03765073|460678089|FG017|Stage 3|Other|1|||
128014214|NCT03765073|460678090|FG018|Stage 3|Other|2|||
128014215|NCT03765073|460678091|FG019|Stage 3|Other|2|||
128014216|NCT03765073|460678092|FG020|Stage 3|Other|2|||
128014217|NCT03765073|460678072|FG000|Stage 3|Withdrawal by parent/guardian|0|||
128014218|NCT03765073|460678073|FG001|Stage 3|Withdrawal by parent/guardian|0|||
128014219|NCT03765073|460678074|FG002|Stage 3|Withdrawal by parent/guardian|0|||
128014220|NCT03765073|460678075|FG003|Stage 3|Withdrawal by parent/guardian|0|||
128014221|NCT03765073|460678076|FG004|Stage 3|Withdrawal by parent/guardian|0|||
127680015|NCT04035668|459454007|FG000|Overall Study|Physician Decision|2|||
127680016|NCT04035668|459454008|FG001|Overall Study|Physician Decision|1|||
127680017|NCT04035668|459454009|FG002|Overall Study|Physician Decision|1|||
127680018|NCT04035668|459454007|FG000|Overall Study|Subject Decision|2|||
127680019|NCT04035668|459454008|FG001|Overall Study|Subject Decision|2|||
127680020|NCT04035668|459454009|FG002|Overall Study|Subject Decision|0|||
127680021|NCT00516386|459454012|FG000|Overall Study|not interested in the study|4|||
127680022|NCT00516386|459454012|FG000|Overall Study|Lost to Follow-up|2|||
127680023|NCT01376089|459454013|FG000|Overall Study|Patient received no contrast media|3|||
127680024|NCT01376089|459454014|FG001|Overall Study|Patient received no contrast media|4|||
127680025|NCT03823300|459454017|FG000|Overall Study|Withdrawal by Subject|16|||
127680026|NCT03823300|459454018|FG001|Overall Study|Withdrawal by Subject|22|||
127680027|NCT03823300|459454017|FG000|Overall Study|Death|10|||
127680028|NCT03823300|459454018|FG001|Overall Study|Death|14|||
127680029|NCT03823300|459454017|FG000|Overall Study|Adverse Event|3|||
127680030|NCT03823300|459454018|FG001|Overall Study|Adverse Event|5|||
128014222|NCT03765073|460678077|FG005|Stage 3|Withdrawal by parent/guardian|0|||
128014223|NCT03765073|460678078|FG006|Stage 3|Withdrawal by parent/guardian|0|||
128014224|NCT03765073|460678079|FG007|Stage 3|Withdrawal by parent/guardian|0|||
127680031|NCT03823300|459454017|FG000|Overall Study|Physician Decision|1|||
127680032|NCT03823300|459454018|FG001|Overall Study|Physician Decision|7|||
127680033|NCT03823300|459454017|FG000|Overall Study|Lost to Follow-up|1|||
128014225|NCT03765073|460678080|FG008|Stage 3|Withdrawal by parent/guardian|0|||
128014226|NCT03765073|460678081|FG009|Stage 3|Withdrawal by parent/guardian|0|||
128014227|NCT03765073|460678082|FG010|Stage 3|Withdrawal by parent/guardian|0|||
127680034|NCT03823300|459454018|FG001|Overall Study|Lost to Follow-up|3|||
127680035|NCT03823300|459454017|FG000|Overall Study|Protocol Violation|1|||
127680036|NCT03823300|459454018|FG001|Overall Study|Protocol Violation|1|||
127680037|NCT03823300|459454017|FG000|Overall Study|Lack of Efficacy|1|||
128014228|NCT03765073|460678083|FG011|Stage 3|Withdrawal by parent/guardian|0|||
128014229|NCT03765073|460678084|FG012|Stage 3|Withdrawal by parent/guardian|0|||
128014230|NCT03765073|460678085|FG013|Stage 3|Withdrawal by parent/guardian|0|||
128014231|NCT03765073|460678086|FG014|Stage 3|Withdrawal by parent/guardian|0|||
128014232|NCT03765073|460678087|FG015|Stage 3|Withdrawal by parent/guardian|0|||
128014233|NCT03765073|460678088|FG016|Stage 3|Withdrawal by parent/guardian|0|||
128014234|NCT03765073|460678089|FG017|Stage 3|Withdrawal by parent/guardian|0|||
128014235|NCT03765073|460678090|FG018|Stage 3|Withdrawal by parent/guardian|0|||
127680038|NCT03823300|459454018|FG001|Overall Study|Lack of Efficacy|1|||
128014236|NCT03765073|460678091|FG019|Stage 3|Withdrawal by parent/guardian|6|||
127680039|NCT03823300|459454017|FG000|Overall Study|Not Eligible|0|||
127680040|NCT03823300|459454018|FG001|Overall Study|Not Eligible|1|||
127680041|NCT03823300|459454017|FG000|Overall Study|Other|1|||
127680042|NCT03823300|459454018|FG001|Overall Study|Other|0|||
127680043|NCT00139737|459454024|FG000|Overall Study|Withdrawal by Subject|190|||
127680044|NCT00139737|459454024|FG000|Overall Study|Adverse Event|58|||
127680045|NCT00139737|459454024|FG000|Overall Study|Lack of Efficacy|40|||
127680046|NCT00139737|459454024|FG000|Overall Study|Lost to Follow-up|8|||
127680047|NCT00139737|459454024|FG000|Overall Study|Death|3|||
127680048|NCT00139737|459454024|FG000|Overall Study|Laboratory Abnormality|2|||
127680049|NCT00139737|459454024|FG000|Overall Study|Protocol Violation|18|||
127680050|NCT00139737|459454024|FG000|Overall Study|Withdrew During Screening Phase|8|||
127680051|NCT00139737|459454024|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
127680052|NCT00139737|459454024|FG000|Overall Study|Screened, Not Treated|13|||
127680053|NCT03460756|459454025|FG000|Overall Study|Adverse Event|0|||
127680054|NCT03460756|459454026|FG001|Overall Study|Adverse Event|0|||
127680055|NCT03460756|459454027|FG002|Overall Study|Adverse Event|0|||
127680056|NCT03460756|459454028|FG003|Overall Study|Adverse Event|1|||
127680057|NCT03460756|459454025|FG000|Overall Study|Lack of Efficacy|0|||
127680058|NCT03460756|459454026|FG001|Overall Study|Lack of Efficacy|0|||
127680059|NCT03460756|459454027|FG002|Overall Study|Lack of Efficacy|0|||
127680060|NCT03460756|459454028|FG003|Overall Study|Lack of Efficacy|2|||
127680061|NCT03460756|459454025|FG000|Overall Study|Lost to Follow-up|0|||
127680062|NCT03460756|459454026|FG001|Overall Study|Lost to Follow-up|1|||
127680063|NCT03460756|459454027|FG002|Overall Study|Lost to Follow-up|2|||
127680064|NCT03460756|459454028|FG003|Overall Study|Lost to Follow-up|1|||
127680065|NCT03460756|459454025|FG000|Overall Study|Pregnancy|0|||
127680066|NCT03460756|459454026|FG001|Overall Study|Pregnancy|0|||
127680067|NCT03460756|459454027|FG002|Overall Study|Pregnancy|0|||
127680068|NCT03460756|459454028|FG003|Overall Study|Pregnancy|1|||
127680069|NCT03460756|459454025|FG000|Overall Study|Protocol Violation|0|||
127680070|NCT03460756|459454026|FG001|Overall Study|Protocol Violation|0|||
127680071|NCT03460756|459454027|FG002|Overall Study|Protocol Violation|0|||
127680072|NCT03460756|459454028|FG003|Overall Study|Protocol Violation|1|||
127680073|NCT03460756|459454025|FG000|Overall Study|Withdrawal by Subject|0|||
127680074|NCT03460756|459454026|FG001|Overall Study|Withdrawal by Subject|4|||
127680075|NCT03460756|459454027|FG002|Overall Study|Withdrawal by Subject|7|||
127680076|NCT03460756|459454028|FG003|Overall Study|Withdrawal by Subject|3|||
127680077|NCT03987451|459454029|FG000|Overall Study|Lost to Follow-up|1|||
127680078|NCT03987451|459454030|FG001|Overall Study|Lost to Follow-up|0|||
127680079|NCT03987451|459454029|FG000|Overall Study|Withdrawal by Subject|1|||
127680080|NCT03987451|459454030|FG001|Overall Study|Withdrawal by Subject|1|||
127680081|NCT02441036|459454031|FG000|Overall Study|No tissue resected|0|||
127680082|NCT02441036|459454032|FG001|Overall Study|No tissue resected|1|||
127680083|NCT02441036|459454033|FG002|Overall Study|No tissue resected|0|||
127680084|NCT02441036|459454034|FG003|Overall Study|No tissue resected|1|||
127680085|NCT02441036|459454035|FG004|Overall Study|No tissue resected|0|||
127680086|NCT01194154|459454036|FG000|Overall Study|Adverse Event|12|||
127680087|NCT01194154|459454037|FG001|Overall Study|Adverse Event|7|||
127680088|NCT01194154|459454036|FG000|Overall Study|Lost to Follow-up|2|||
127680089|NCT01194154|459454037|FG001|Overall Study|Lost to Follow-up|3|||
127680090|NCT01194154|459454036|FG000|Overall Study|Protocol Violation|0|||
127680091|NCT01194154|459454037|FG001|Overall Study|Protocol Violation|1|||
127680092|NCT01194154|459454036|FG000|Overall Study|Withdrawal by Subject|5|||
127680093|NCT01194154|459454037|FG001|Overall Study|Withdrawal by Subject|6|||
127680094|NCT01194154|459454036|FG000|Overall Study|Blood pressure increase|5|||
127680095|NCT01194154|459454037|FG001|Overall Study|Blood pressure increase|3|||
127680096|NCT01194154|459454036|FG000|Overall Study|Hemoglobin decrease|0|||
127680097|NCT01194154|459454037|FG001|Overall Study|Hemoglobin decrease|1|||
127680098|NCT01194154|459454036|FG000|Overall Study|Hemoglobin increase|12|||
127680099|NCT01194154|459454037|FG001|Overall Study|Hemoglobin increase|3|||
127680100|NCT01194154|459454036|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
127680101|NCT01194154|459454037|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
127680102|NCT01194154|459454036|FG000|Overall Study|Treatment with prohibited medication|4|||
127680103|NCT01194154|459454037|FG001|Overall Study|Treatment with prohibited medication|5|||
127680104|NCT01194154|459454036|FG000|Overall Study|Other|4|||
127680105|NCT01194154|459454037|FG001|Overall Study|Other|0|||
127680106|NCT01194154|459454036|FG000|Overall Study|Did not receive study medication|2|||
127680107|NCT01194154|459454037|FG001|Overall Study|Did not receive study medication|4|||
127680108|NCT02026258|459454038|FG000|Randomized|Did not start treatment|2|||
127680109|NCT02026258|459454039|FG001|Randomized|Did not start treatment|1|||
127680110|NCT02026258|459454038|FG000|Randomized|Change in treatment plan|1|||
127680111|NCT02026258|459454039|FG001|Randomized|Change in treatment plan|0|||
127680112|NCT02026258|459454038|FG000|Randomized|Presence of periodontal disease|1|||
127680113|NCT02026258|459454039|FG001|Randomized|Presence of periodontal disease|1|||
127680114|NCT02026258|459454038|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
127680115|NCT02026258|459454039|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
127680116|NCT02026258|459454038|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
128014237|NCT03765073|460678092|FG020|Stage 3|Withdrawal by parent/guardian|9|||
128014238|NCT03765073|460678072|FG000|Stage 3|Withdrawal by Subject|0|||
128014239|NCT03765073|460678073|FG001|Stage 3|Withdrawal by Subject|0|||
128014240|NCT03765073|460678074|FG002|Stage 3|Withdrawal by Subject|0|||
128014241|NCT03765073|460678075|FG003|Stage 3|Withdrawal by Subject|0|||
128014242|NCT03765073|460678076|FG004|Stage 3|Withdrawal by Subject|0|||
128014243|NCT03765073|460678077|FG005|Stage 3|Withdrawal by Subject|0|||
128014244|NCT03765073|460678078|FG006|Stage 3|Withdrawal by Subject|0|||
128014245|NCT03765073|460678079|FG007|Stage 3|Withdrawal by Subject|0|||
128014246|NCT03765073|460678080|FG008|Stage 3|Withdrawal by Subject|0|||
128014247|NCT03765073|460678081|FG009|Stage 3|Withdrawal by Subject|0|||
128014248|NCT03765073|460678082|FG010|Stage 3|Withdrawal by Subject|0|||
128014249|NCT03765073|460678083|FG011|Stage 3|Withdrawal by Subject|0|||
128014250|NCT03765073|460678084|FG012|Stage 3|Withdrawal by Subject|0|||
128014251|NCT03765073|460678085|FG013|Stage 3|Withdrawal by Subject|0|||
128014252|NCT03765073|460678086|FG014|Stage 3|Withdrawal by Subject|0|||
128014253|NCT03765073|460678087|FG015|Stage 3|Withdrawal by Subject|0|||
128014254|NCT03765073|460678088|FG016|Stage 3|Withdrawal by Subject|0|||
128014255|NCT03765073|460678089|FG017|Stage 3|Withdrawal by Subject|8|||
128014256|NCT03765073|460678090|FG018|Stage 3|Withdrawal by Subject|11|||
128014257|NCT03765073|460678091|FG019|Stage 3|Withdrawal by Subject|0|||
128014258|NCT03765073|460678092|FG020|Stage 3|Withdrawal by Subject|0|||
128014259|NCT02225587|460678095|FG000|Overall Study|Adverse Event|5|||
128014260|NCT02225587|460678096|FG001|Overall Study|Adverse Event|5|||
128014261|NCT02225587|460678095|FG000|Overall Study|Lost to Follow-up|5|||
128014262|NCT02225587|460678096|FG001|Overall Study|Lost to Follow-up|5|||
128014263|NCT02225587|460678095|FG000|Overall Study|Non-Compliance With Study Drug|1|||
128014264|NCT02225587|460678096|FG001|Overall Study|Non-Compliance With Study Drug|0|||
128014265|NCT02225587|460678095|FG000|Overall Study|Physician Decision|2|||
128014266|NCT02225587|460678096|FG001|Overall Study|Physician Decision|0|||
128014267|NCT02225587|460678095|FG000|Overall Study|Protocol Violation|1|||
128014268|NCT02225587|460678096|FG001|Overall Study|Protocol Violation|0|||
128014269|NCT02225587|460678095|FG000|Overall Study|Participant Moved|1|||
128014270|NCT02225587|460678096|FG001|Overall Study|Participant Moved|0|||
128014271|NCT02225587|460678095|FG000|Overall Study|Withdrawal by Subject|13|||
128014272|NCT02225587|460678096|FG001|Overall Study|Withdrawal by Subject|28|||
128014273|NCT01925794|460678097|FG000|180 Days|Death|2|||
128014274|NCT01925794|460678097|FG000|180 Days|Withdrawal by Subject|2|||
128014275|NCT01925794|460678097|FG000|270 Days|Death|2|||
128014276|NCT01925794|460678097|FG000|270 Days|Protocol Violation|3|||
128014277|NCT03197129|460678104|FG000|Overall Study|did not answer the VPT: shyness|4|||
128014278|NCT03197129|460678105|FG001|Overall Study|did not answer the VPT: shyness|5|||
128014279|NCT01564407|460678106|FG000|Overall Study|Lost to Follow-up|0|||
128014280|NCT01564407|460678107|FG001|Overall Study|Lost to Follow-up|1|||
128014281|NCT01564407|460678108|FG002|Overall Study|Lost to Follow-up|0|||
128014282|NCT01564407|460678109|FG003|Overall Study|Lost to Follow-up|0|||
128014283|NCT01564407|460678110|FG004|Overall Study|Lost to Follow-up|0|||
128014284|NCT01564407|460678106|FG000|Overall Study|Withdrawal by Subject|0|||
128014285|NCT01564407|460678107|FG001|Overall Study|Withdrawal by Subject|1|||
128014286|NCT01564407|460678108|FG002|Overall Study|Withdrawal by Subject|0|||
128014287|NCT01564407|460678109|FG003|Overall Study|Withdrawal by Subject|0|||
128014288|NCT01564407|460678110|FG004|Overall Study|Withdrawal by Subject|0|||
128014289|NCT01564407|460678106|FG000|Overall Study|funding lost, study ended|0|||
128014290|NCT01564407|460678107|FG001|Overall Study|funding lost, study ended|0|||
128014291|NCT01564407|460678108|FG002|Overall Study|funding lost, study ended|0|||
128014292|NCT01564407|460678109|FG003|Overall Study|funding lost, study ended|1|||
128014293|NCT01564407|460678110|FG004|Overall Study|funding lost, study ended|0|||
128014294|NCT02442349|460678111|FG000|Overall Study|Death|95|||
128014295|NCT02442349|460678111|FG000|Overall Study|Withdrawal by Subject|27|||
128014296|NCT02442349|460678111|FG000|Overall Study|poor compliance after treatment discontinuation|2|||
128014297|NCT02442349|460678111|FG000|Overall Study|Lost to Follow-up|1|||
128014298|NCT00314145|460678112|FG000|Overall Study|Withdrawal by Subject|8|||
128014299|NCT00314145|460678113|FG001|Overall Study|Withdrawal by Subject|10|||
128014300|NCT00314145|460678112|FG000|Overall Study|Lost to Follow-up|5|||
128014301|NCT00314145|460678113|FG001|Overall Study|Lost to Follow-up|12|||
128014302|NCT00314145|460678112|FG000|Overall Study|Physician Decision|3|||
128014303|NCT00314145|460678113|FG001|Overall Study|Physician Decision|4|||
128014304|NCT00314145|460678112|FG000|Overall Study|Adverse Event|0|||
128014305|NCT00314145|460678113|FG001|Overall Study|Adverse Event|3|||
128014306|NCT00314145|460678112|FG000|Overall Study|Protocol Violation|3|||
128014307|NCT00314145|460678113|FG001|Overall Study|Protocol Violation|0|||
128014308|NCT00314145|460678112|FG000|Overall Study|Sponsor Decision|2|||
128014309|NCT00314145|460678113|FG001|Overall Study|Sponsor Decision|0|||
128014310|NCT03507790|460678114|FG000|Overall Study|Adverse Event|0|||
128014311|NCT03507790|460678115|FG001|Overall Study|Adverse Event|11|||
128014312|NCT03507790|460678116|FG002|Overall Study|Adverse Event|3|||
128014313|NCT03507790|460678114|FG000|Overall Study|Withdrawal by Subject|2|||
128014314|NCT03507790|460678115|FG001|Overall Study|Withdrawal by Subject|0|||
128014315|NCT03507790|460678116|FG002|Overall Study|Withdrawal by Subject|0|||
127766855|NCT03426267|459772128|FG000|Overall Study|Adverse Event|9|||
127766856|NCT03426267|459772129|FG001|Overall Study|Adverse Event|27|||
128014316|NCT03507790|460678114|FG000|Overall Study|Subject moved to another location|1|||
128014317|NCT03507790|460678115|FG001|Overall Study|Subject moved to another location|2|||
128014318|NCT03507790|460678116|FG002|Overall Study|Subject moved to another location|0|||
128014319|NCT03507790|460678114|FG000|Overall Study|Non-compliance with study drug|0|||
128014320|NCT03507790|460678115|FG001|Overall Study|Non-compliance with study drug|0|||
128014321|NCT03507790|460678116|FG002|Overall Study|Non-compliance with study drug|1|||
128014322|NCT03507790|460678114|FG000|Overall Study|COVID 19 Pandemic|0|||
128014323|NCT03507790|460678115|FG001|Overall Study|COVID 19 Pandemic|1|||
128014324|NCT03507790|460678116|FG002|Overall Study|COVID 19 Pandemic|0|||
128014325|NCT03507790|460678114|FG000|Overall Study|Lost to Follow-up|0|||
128014326|NCT03507790|460678115|FG001|Overall Study|Lost to Follow-up|1|||
128014327|NCT03507790|460678116|FG002|Overall Study|Lost to Follow-up|0|||
128014328|NCT03507790|460678114|FG000|Overall Study|Discontinuation of the trial at the site|1|||
128014329|NCT03507790|460678115|FG001|Overall Study|Discontinuation of the trial at the site|1|||
128014330|NCT03507790|460678116|FG002|Overall Study|Discontinuation of the trial at the site|0|||
128014331|NCT03507790|460678114|FG000|Overall Study|Randomized in error|0|||
128014332|NCT03507790|460678115|FG001|Overall Study|Randomized in error|0|||
128014333|NCT03507790|460678116|FG002|Overall Study|Randomized in error|1|||
128014334|NCT02296125|460678119|FG000|Overall Study|Withdrawal by Subject|18|||
128014335|NCT02296125|460678120|FG001|Overall Study|Withdrawal by Subject|8|||
128014336|NCT02296125|460678121|FG002|Overall Study|Withdrawal by Subject|6|||
128014337|NCT02296125|460678122|FG003|Overall Study|Withdrawal by Subject|2|||
128014338|NCT02296125|460678119|FG000|Overall Study|Adverse Event|41|||
128014339|NCT02296125|460678120|FG001|Overall Study|Adverse Event|52|||
128014340|NCT02296125|460678121|FG002|Overall Study|Adverse Event|9|||
128014341|NCT02296125|460678122|FG003|Overall Study|Adverse Event|4|||
128014342|NCT02296125|460678119|FG000|Overall Study|Severe non-compliance to protocol|0|||
128014343|NCT02296125|460678120|FG001|Overall Study|Severe non-compliance to protocol|1|||
128014344|NCT02296125|460678121|FG002|Overall Study|Severe non-compliance to protocol|0|||
128014345|NCT02296125|460678122|FG003|Overall Study|Severe non-compliance to protocol|0|||
128014346|NCT02296125|460678119|FG000|Overall Study|Condition under investigation worsened|153|||
128014347|NCT02296125|460678120|FG001|Overall Study|Condition under investigation worsened|199|||
128014348|NCT02296125|460678121|FG002|Overall Study|Condition under investigation worsened|39|||
128014349|NCT02296125|460678122|FG003|Overall Study|Condition under investigation worsened|56|||
128014350|NCT02296125|460678119|FG000|Overall Study|Any reason not specifically recorded|6|||
128014351|NCT02296125|460678120|FG001|Overall Study|Any reason not specifically recorded|4|||
128014352|NCT02296125|460678121|FG002|Overall Study|Any reason not specifically recorded|2|||
128014353|NCT02296125|460678122|FG003|Overall Study|Any reason not specifically recorded|0|||
128014354|NCT01160614|460678123|FG000|Overall Study|Withdrawal by Subject|0|||
128014355|NCT01160614|460678124|FG001|Overall Study|Withdrawal by Subject|2|||
128014356|NCT00157755|460678125|FG000|Overall Study|Death|2|||
128014357|NCT00157755|460678126|FG001|Overall Study|Death|3|||
128014358|NCT00157755|460678127|FG002|Overall Study|Death|3|||
128014359|NCT00157755|460678128|FG003|Overall Study|Death|2|||
128014360|NCT00157755|460678129|FG004|Overall Study|Death|0|||
128014361|NCT00157755|460678130|FG005|Overall Study|Death|0|||
128014362|NCT00157755|460678125|FG000|Overall Study|Lost to Follow-up|0|||
128014363|NCT00157755|460678126|FG001|Overall Study|Lost to Follow-up|0|||
128014364|NCT00157755|460678127|FG002|Overall Study|Lost to Follow-up|1|||
128014365|NCT00157755|460678128|FG003|Overall Study|Lost to Follow-up|0|||
128014366|NCT00157755|460678129|FG004|Overall Study|Lost to Follow-up|0|||
128014367|NCT00157755|460678130|FG005|Overall Study|Lost to Follow-up|0|||
128014368|NCT00157755|460678125|FG000|Overall Study|Withdrawal by Subject|0|||
128014369|NCT00157755|460678126|FG001|Overall Study|Withdrawal by Subject|0|||
128014370|NCT00157755|460678127|FG002|Overall Study|Withdrawal by Subject|1|||
128014371|NCT00157755|460678128|FG003|Overall Study|Withdrawal by Subject|1|||
128014372|NCT00157755|460678129|FG004|Overall Study|Withdrawal by Subject|1|||
128014373|NCT00157755|460678130|FG005|Overall Study|Withdrawal by Subject|2|||
128014374|NCT00157755|460678125|FG000|Overall Study|Explant due to infection|0|||
128014375|NCT00157755|460678126|FG001|Overall Study|Explant due to infection|0|||
128014376|NCT00157755|460678127|FG002|Overall Study|Explant due to infection|1|||
127766857|NCT03426267|459772128|FG000|Overall Study|Prohibited Treatment Intake|2|||
127766858|NCT03426267|459772129|FG001|Overall Study|Prohibited Treatment Intake|3|||
128014377|NCT00157755|460678128|FG003|Overall Study|Explant due to infection|0|||
128014378|NCT00157755|460678129|FG004|Overall Study|Explant due to infection|0|||
128014379|NCT00157755|460678130|FG005|Overall Study|Explant due to infection|0|||
128014380|NCT00157755|460678125|FG000|Overall Study|Medical reason|0|||
128014381|NCT00157755|460678126|FG001|Overall Study|Medical reason|0|||
128014382|NCT00157755|460678127|FG002|Overall Study|Medical reason|1|||
128014383|NCT00157755|460678128|FG003|Overall Study|Medical reason|1|||
128014384|NCT00157755|460678129|FG004|Overall Study|Medical reason|0|||
128014385|NCT00157755|460678130|FG005|Overall Study|Medical reason|0|||
128014386|NCT00157755|460678125|FG000|Overall Study|Study site closure|0|||
127766859|NCT03426267|459772128|FG000|Overall Study|Lack of Efficacy|0|||
127680117|NCT02026258|459454039|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
127680118|NCT02534350|459454040|FG000|Overall Study|Randomized But Not Treated|1|||
127680119|NCT02534350|459454041|FG001|Overall Study|Randomized But Not Treated|0|||
127680120|NCT02534350|459454040|FG000|Overall Study|Protocol Violation|1|||
127680121|NCT02534350|459454041|FG001|Overall Study|Protocol Violation|0|||
127680122|NCT02534350|459454040|FG000|Overall Study|Withdrew Consent|2|||
127680123|NCT02534350|459454041|FG001|Overall Study|Withdrew Consent|0|||
127680124|NCT02954848|459454048|FG000|Overall Study|Randomized but Not Treated|0|||
127680125|NCT02954848|459454049|FG001|Overall Study|Randomized but Not Treated|1|||
127680126|NCT02954848|459454048|FG000|Overall Study|Adverse Event|2|||
127680127|NCT02954848|459454049|FG001|Overall Study|Adverse Event|3|||
127680128|NCT02954848|459454048|FG000|Overall Study|Withdrawal by Participant|0|||
127680129|NCT02954848|459454049|FG001|Overall Study|Withdrawal by Participant|1|||
127680130|NCT01069341|459454050|FG000|Overall Study|Lost to Follow-up|1|||
127680131|NCT01802632|459454051|FG000|Overall Study|Death|28|||
127680132|NCT01802632|459454052|FG001|Overall Study|Death|1|||
127680133|NCT01802632|459454053|FG002|Overall Study|Death|38|||
127680134|NCT01802632|459454054|FG003|Overall Study|Death|0|||
127680135|NCT01802632|459454055|FG004|Overall Study|Death|2|||
127680136|NCT01802632|459454056|FG005|Overall Study|Death|0|||
127680137|NCT01802632|459454051|FG000|Overall Study|Withdrawal by Subject|4|||
127680138|NCT01802632|459454052|FG001|Overall Study|Withdrawal by Subject|2|||
127680139|NCT01802632|459454053|FG002|Overall Study|Withdrawal by Subject|7|||
127680140|NCT01802632|459454054|FG003|Overall Study|Withdrawal by Subject|3|||
127680141|NCT01802632|459454055|FG004|Overall Study|Withdrawal by Subject|0|||
127680142|NCT01802632|459454056|FG005|Overall Study|Withdrawal by Subject|1|||
127680143|NCT01802632|459454051|FG000|Overall Study|Objective Disease Progression|1|||
127680144|NCT01802632|459454052|FG001|Overall Study|Objective Disease Progression|12|||
127680145|NCT01802632|459454053|FG002|Overall Study|Objective Disease Progression|104|||
127680146|NCT01802632|459454054|FG003|Overall Study|Objective Disease Progression|6|||
127680147|NCT01802632|459454055|FG004|Overall Study|Objective Disease Progression|4|||
127680148|NCT01802632|459454056|FG005|Overall Study|Objective Disease Progression|4|||
127680149|NCT01802632|459454051|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
127680150|NCT01802632|459454052|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
127680151|NCT01802632|459454053|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
127680152|NCT01802632|459454054|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
127680153|NCT01802632|459454055|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
127766860|NCT03426267|459772129|FG001|Overall Study|Lack of Efficacy|25|||
128014387|NCT00157755|460678126|FG001|Overall Study|Study site closure|1|||
128014388|NCT00157755|460678127|FG002|Overall Study|Study site closure|0|||
128014389|NCT00157755|460678128|FG003|Overall Study|Study site closure|0|||
128014390|NCT00157755|460678129|FG004|Overall Study|Study site closure|0|||
128014391|NCT00157755|460678130|FG005|Overall Study|Study site closure|0|||
128014392|NCT00157755|460678125|FG000|Overall Study|Subject non-compliance|0|||
128014393|NCT00157755|460678126|FG001|Overall Study|Subject non-compliance|0|||
128014394|NCT00157755|460678127|FG002|Overall Study|Subject non-compliance|0|||
128014395|NCT00157755|460678128|FG003|Overall Study|Subject non-compliance|0|||
128014396|NCT00157755|460678129|FG004|Overall Study|Subject non-compliance|0|||
128014397|NCT00157755|460678130|FG005|Overall Study|Subject non-compliance|1|||
128014398|NCT00157755|460678125|FG000|Overall Study|Study completion|0|||
128014399|NCT00157755|460678126|FG001|Overall Study|Study completion|0|||
127766861|NCT03426267|459772128|FG000|Overall Study|other|3|||
127766862|NCT03426267|459772129|FG001|Overall Study|other|0|||
127766863|NCT00609765|459772132|FG000|Overall Study|Study ended prior to 12 months|1|||
127766864|NCT02649946|459772139|FG000|Overall Study|Withdrawal by Subject|1|||
127766865|NCT02649946|459772140|FG001|Overall Study|Withdrawal by Subject|1|||
127766866|NCT02649946|459772139|FG000|Overall Study|Death|7|||
127766867|NCT02649946|459772140|FG001|Overall Study|Death|9|||
127766868|NCT02649946|459772139|FG000|Overall Study|Physician Decision|1|||
127766869|NCT02649946|459772140|FG001|Overall Study|Physician Decision|0|||
127766870|NCT02649946|459772139|FG000|Overall Study|Lost to Follow-up|2|||
127766871|NCT02649946|459772140|FG001|Overall Study|Lost to Follow-up|1|||
127766872|NCT02649946|459772139|FG000|Overall Study|Erroneously enrolled|1|||
127766873|NCT02649946|459772140|FG001|Overall Study|Erroneously enrolled|0|||
127766874|NCT02649946|459772139|FG000|Overall Study|Missed 6-month follow-up visit|0|||
127766875|NCT02649946|459772140|FG001|Overall Study|Missed 6-month follow-up visit|4|||
127766876|NCT00950950|459772141|FG000|Overall Study|Adverse Event|1|||
127766877|NCT00950950|459772142|FG001|Overall Study|Adverse Event|0|||
127766878|NCT00950950|459772141|FG000|Overall Study|Withdrawal by Subject|0|||
127766879|NCT00950950|459772142|FG001|Overall Study|Withdrawal by Subject|1|||
127766880|NCT01047293|459772148|FG000|Overall Study|DLT criteria not fulfilled|1|||
127680154|NCT01802632|459454056|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
127766881|NCT01047293|459772149|FG001|Overall Study|DLT criteria not fulfilled|1|||
127766882|NCT01047293|459772150|FG002|Overall Study|DLT criteria not fulfilled|0|||
127766883|NCT01047293|459772151|FG003|Overall Study|DLT criteria not fulfilled|0|||
127766884|NCT02054520|459772152|FG000|Overall Study|Adverse Event|1|||
127766885|NCT02054520|459772153|FG001|Overall Study|Adverse Event|4|||
128014400|NCT00157755|460678127|FG002|Overall Study|Study completion|0|||
128014401|NCT00157755|460678128|FG003|Overall Study|Study completion|0|||
128014402|NCT00157755|460678129|FG004|Overall Study|Study completion|1|||
128014403|NCT00157755|460678130|FG005|Overall Study|Study completion|2|||
128014404|NCT03314935|460678133|FG000|Phase 1|Death|4|||
128014405|NCT03314935|460678134|FG001|Phase 1|Death|2|||
128014406|NCT03314935|460678135|FG002|Phase 1|Death|5|||
128014407|NCT03314935|460678136|FG003|Phase 1|Death|4|||
128014408|NCT03314935|460678137|FG004|Phase 1|Death|3|||
128014409|NCT03314935|460678138|FG005|Phase 1|Death|4|||
128014410|NCT03314935|460678139|FG006|Phase 1|Death|5|||
128014411|NCT03314935|460678140|FG007|Phase 1|Death|4|||
128014412|NCT03314935|460678141|FG008|Phase 1|Death|3|||
128014413|NCT03314935|460678142|FG009|Phase 1|Death|0|||
128014414|NCT03314935|460678143|FG010|Phase 1|Death|0|||
128014415|NCT03314935|460678144|FG011|Phase 1|Death|0|||
128014416|NCT03314935|460678145|FG012|Phase 1|Death|0|||
128014417|NCT03314935|460678146|FG013|Phase 1|Death|0|||
128014418|NCT03314935|460678147|FG014|Phase 1|Death|0|||
128014419|NCT03314935|460678133|FG000|Phase 1|Withdrawal by Subject|2|||
128014420|NCT03314935|460678134|FG001|Phase 1|Withdrawal by Subject|1|||
128014421|NCT03314935|460678135|FG002|Phase 1|Withdrawal by Subject|1|||
128014422|NCT03314935|460678136|FG003|Phase 1|Withdrawal by Subject|2|||
128014423|NCT03314935|460678137|FG004|Phase 1|Withdrawal by Subject|1|||
128014424|NCT03314935|460678138|FG005|Phase 1|Withdrawal by Subject|0|||
128014425|NCT03314935|460678139|FG006|Phase 1|Withdrawal by Subject|1|||
128014426|NCT03314935|460678140|FG007|Phase 1|Withdrawal by Subject|0|||
128014427|NCT03314935|460678141|FG008|Phase 1|Withdrawal by Subject|1|||
128014428|NCT03314935|460678142|FG009|Phase 1|Withdrawal by Subject|0|||
128014429|NCT03314935|460678143|FG010|Phase 1|Withdrawal by Subject|0|||
127766886|NCT02054520|459772154|FG002|Overall Study|Adverse Event|2|||
127766887|NCT02054520|459772155|FG003|Overall Study|Adverse Event|1|||
127766888|NCT02054520|459772156|FG004|Overall Study|Adverse Event|1|||
127766889|NCT02054520|459772157|FG005|Overall Study|Adverse Event|0|||
127766890|NCT02054520|459772152|FG000|Overall Study|Lack of Efficacy|7|||
127766891|NCT02054520|459772153|FG001|Overall Study|Lack of Efficacy|0|||
127766892|NCT02054520|459772154|FG002|Overall Study|Lack of Efficacy|2|||
127766893|NCT02054520|459772155|FG003|Overall Study|Lack of Efficacy|1|||
127766894|NCT02054520|459772156|FG004|Overall Study|Lack of Efficacy|3|||
127766895|NCT02054520|459772157|FG005|Overall Study|Lack of Efficacy|2|||
127766896|NCT02054520|459772152|FG000|Overall Study|Withdrawal by Subject|1|||
127766897|NCT02054520|459772153|FG001|Overall Study|Withdrawal by Subject|0|||
127766898|NCT02054520|459772154|FG002|Overall Study|Withdrawal by Subject|0|||
127766899|NCT02054520|459772155|FG003|Overall Study|Withdrawal by Subject|2|||
127766900|NCT02054520|459772156|FG004|Overall Study|Withdrawal by Subject|1|||
127766901|NCT02054520|459772157|FG005|Overall Study|Withdrawal by Subject|0|||
127766902|NCT02054520|459772152|FG000|Overall Study|Physician Decision|0|||
127766903|NCT02054520|459772153|FG001|Overall Study|Physician Decision|1|||
127766904|NCT02054520|459772154|FG002|Overall Study|Physician Decision|0|||
127766905|NCT02054520|459772155|FG003|Overall Study|Physician Decision|1|||
127766906|NCT02054520|459772156|FG004|Overall Study|Physician Decision|0|||
127766907|NCT02054520|459772157|FG005|Overall Study|Physician Decision|1|||
127766908|NCT02054520|459772152|FG000|Overall Study|Study terminated by Sponsor|0|||
127766909|NCT02054520|459772153|FG001|Overall Study|Study terminated by Sponsor|0|||
127766910|NCT02054520|459772154|FG002|Overall Study|Study terminated by Sponsor|2|||
127766911|NCT02054520|459772155|FG003|Overall Study|Study terminated by Sponsor|1|||
127766912|NCT02054520|459772156|FG004|Overall Study|Study terminated by Sponsor|0|||
127766913|NCT02054520|459772157|FG005|Overall Study|Study terminated by Sponsor|0|||
127766914|NCT01272804|459772158|FG000|Overall Study|Adverse Event|1|||
127766915|NCT01272804|459772159|FG001|Overall Study|Adverse Event|0|||
127766916|NCT01272804|459772160|FG002|Overall Study|Adverse Event|0|||
127766917|NCT01272804|459772161|FG003|Overall Study|Adverse Event|0|||
127766918|NCT01272804|459772162|FG004|Overall Study|Adverse Event|2|||
127766919|NCT01272804|459772163|FG005|Overall Study|Adverse Event|1|||
128014430|NCT03314935|460678144|FG011|Phase 1|Withdrawal by Subject|0|||
128014431|NCT03314935|460678145|FG012|Phase 1|Withdrawal by Subject|0|||
127766920|NCT02318797|459772164|FG000|Overall Study|Death|3|||
128014432|NCT03314935|460678146|FG013|Phase 1|Withdrawal by Subject|0|||
128014433|NCT03314935|460678147|FG014|Phase 1|Withdrawal by Subject|0|||
128014434|NCT03314935|460678133|FG000|Phase 1|Progressive Disease|2|||
128014435|NCT03314935|460678134|FG001|Phase 1|Progressive Disease|0|||
128014436|NCT03314935|460678135|FG002|Phase 1|Progressive Disease|0|||
127544711|NCT03103542|458962446|FG000|Overall Study|Other|2|||
127766921|NCT02318797|459772165|FG001|Overall Study|Death|6|||
127766922|NCT02318797|459772164|FG000|Overall Study|Lost to Follow-up|85|||
127766923|NCT02318797|459772165|FG001|Overall Study|Lost to Follow-up|96|||
127766924|NCT02308020|459772166|FG000|Overall Study|Lost to Follow-up|1|||
128014437|NCT03314935|460678136|FG003|Phase 1|Progressive Disease|1|||
128014438|NCT03314935|460678137|FG004|Phase 1|Progressive Disease|0|||
128014439|NCT03314935|460678138|FG005|Phase 1|Progressive Disease|0|||
128014440|NCT03314935|460678139|FG006|Phase 1|Progressive Disease|0|||
128014441|NCT03314935|460678140|FG007|Phase 1|Progressive Disease|0|||
128014442|NCT03314935|460678141|FG008|Phase 1|Progressive Disease|0|||
128014443|NCT03314935|460678142|FG009|Phase 1|Progressive Disease|0|||
128014444|NCT03314935|460678143|FG010|Phase 1|Progressive Disease|0|||
128014445|NCT03314935|460678144|FG011|Phase 1|Progressive Disease|0|||
128014446|NCT03314935|460678145|FG012|Phase 1|Progressive Disease|0|||
128014447|NCT03314935|460678146|FG013|Phase 1|Progressive Disease|0|||
128014448|NCT03314935|460678147|FG014|Phase 1|Progressive Disease|0|||
128014449|NCT03314935|460678133|FG000|Phase 1|Study Terminated by Sponsor|0|||
128014450|NCT03314935|460678134|FG001|Phase 1|Study Terminated by Sponsor|1|||
128014451|NCT03314935|460678135|FG002|Phase 1|Study Terminated by Sponsor|0|||
128014452|NCT03314935|460678136|FG003|Phase 1|Study Terminated by Sponsor|0|||
128014453|NCT03314935|460678137|FG004|Phase 1|Study Terminated by Sponsor|0|||
128014454|NCT03314935|460678138|FG005|Phase 1|Study Terminated by Sponsor|0|||
128014455|NCT03314935|460678139|FG006|Phase 1|Study Terminated by Sponsor|0|||
128014456|NCT03314935|460678140|FG007|Phase 1|Study Terminated by Sponsor|0|||
128014457|NCT03314935|460678141|FG008|Phase 1|Study Terminated by Sponsor|1|||
128014458|NCT03314935|460678142|FG009|Phase 1|Study Terminated by Sponsor|0|||
128014459|NCT03314935|460678143|FG010|Phase 1|Study Terminated by Sponsor|0|||
127766925|NCT02308020|459772167|FG001|Overall Study|Lost to Follow-up|7|||
127766926|NCT02308020|459772168|FG002|Overall Study|Lost to Follow-up|0|||
127766927|NCT02308020|459772169|FG003|Overall Study|Lost to Follow-up|0|||
127766928|NCT02308020|459772170|FG004|Overall Study|Lost to Follow-up|1|||
127766929|NCT02308020|459772171|FG005|Overall Study|Lost to Follow-up|2|||
127766930|NCT02308020|459772166|FG000|Overall Study|Sponsor Decision|0|||
127766931|NCT02308020|459772167|FG001|Overall Study|Sponsor Decision|8|||
127766932|NCT02308020|459772168|FG002|Overall Study|Sponsor Decision|0|||
127766933|NCT02308020|459772169|FG003|Overall Study|Sponsor Decision|2|||
127766934|NCT02308020|459772170|FG004|Overall Study|Sponsor Decision|2|||
127766935|NCT02308020|459772171|FG005|Overall Study|Sponsor Decision|1|||
127766936|NCT02308020|459772166|FG000|Overall Study|Withdrawal by Subject|3|||
127766937|NCT02308020|459772167|FG001|Overall Study|Withdrawal by Subject|5|||
127766938|NCT02308020|459772168|FG002|Overall Study|Withdrawal by Subject|3|||
127766939|NCT02308020|459772169|FG003|Overall Study|Withdrawal by Subject|2|||
127766940|NCT02308020|459772170|FG004|Overall Study|Withdrawal by Subject|1|||
127766941|NCT02308020|459772171|FG005|Overall Study|Withdrawal by Subject|2|||
127766942|NCT02232243|459772172|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
127766943|NCT02232243|459772173|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
127766944|NCT02232243|459772174|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
127766945|NCT00704405|459772175|FG000|Overall Study (NC Population)|Adverse Event|1|||
127766946|NCT00704405|459772176|FG001|Overall Study (NC Population)|Adverse Event|0|||
127766947|NCT00704405|459772177|FG002|Overall Study (NC Population)|Adverse Event|0|||
127766948|NCT00704405|459772178|FG003|Overall Study (NC Population)|Adverse Event|0|||
127766949|NCT00704405|459772179|FG004|Overall Study (NC Population)|Adverse Event|0|||
127766950|NCT00704405|459772175|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
127766951|NCT00704405|459772176|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
127766952|NCT00704405|459772177|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
127766953|NCT00704405|459772178|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
127766954|NCT00704405|459772179|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
127766955|NCT00704405|459772175|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
127766956|NCT00704405|459772176|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
127766957|NCT00704405|459772177|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
127766958|NCT00704405|459772178|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
127766959|NCT00704405|459772179|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
127766960|NCT00704405|459772175|FG000|Overall Study (NC Population)|Other|0|||
127766961|NCT00704405|459772176|FG001|Overall Study (NC Population)|Other|0|||
127766962|NCT00704405|459772177|FG002|Overall Study (NC Population)|Other|0|||
127766963|NCT00704405|459772178|FG003|Overall Study (NC Population)|Other|0|||
127766964|NCT00704405|459772179|FG004|Overall Study (NC Population)|Other|1|||
127766965|NCT00704405|459772175|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
127766966|NCT00704405|459772176|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
127766967|NCT00704405|459772177|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
128014460|NCT03314935|460678144|FG011|Phase 1|Study Terminated by Sponsor|0|||
127766968|NCT00704405|459772178|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
127766969|NCT00704405|459772179|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
127766970|NCT00704405|459772175|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
127766971|NCT00704405|459772176|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
127766972|NCT00704405|459772177|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
127766973|NCT00704405|459772178|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
127766974|NCT00704405|459772179|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
128014461|NCT03314935|460678145|FG012|Phase 1|Study Terminated by Sponsor|0|||
127766975|NCT01395888|459772180|FG000|2-week Run-in Period|Adverse Event|2|||
127766976|NCT01395888|459772181|FG001|2-week Run-in Period|Adverse Event|0|||
127766977|NCT01395888|459772182|FG002|2-week Run-in Period|Adverse Event|0|||
127544712|NCT03103542|458962446|FG000|Overall Study|Withdrawal by Subject|1|||
127680155|NCT01802632|459454051|FG000|Overall Study|Other (not specified)|0|||
127680156|NCT01802632|459454052|FG001|Overall Study|Other (not specified)|0|||
127680157|NCT01802632|459454053|FG002|Overall Study|Other (not specified)|7|||
127680158|NCT01802632|459454054|FG003|Overall Study|Other (not specified)|1|||
127680159|NCT01802632|459454055|FG004|Overall Study|Other (not specified)|0|||
127680160|NCT01802632|459454056|FG005|Overall Study|Other (not specified)|1|||
127680161|NCT02880241|459454069|FG000|Overall Study|Lack of Efficacy|1|||
127680162|NCT02880241|459454070|FG001|Overall Study|Lack of Efficacy|0|||
127680163|NCT02880241|459454071|FG002|Overall Study|Lack of Efficacy|0|||
127680164|NCT02880241|459454072|FG003|Overall Study|Lack of Efficacy|0|||
127680165|NCT02880241|459454073|FG004|Overall Study|Lack of Efficacy|0|||
127680166|NCT02880241|459454074|FG005|Overall Study|Lack of Efficacy|0|||
127680167|NCT02705586|459454076|FG000|Overall Study|Health Issues|2|||
127680168|NCT02705586|459454076|FG000|Overall Study|Transportation Difficulties|5|||
127680169|NCT02705586|459454076|FG000|Overall Study|Vacation/Planned Absence|1|||
127680170|NCT02194933|459454080|FG000|Overall Study|Lost to Follow-up|1|||
127680171|NCT02194933|459454081|FG001|Overall Study|Lost to Follow-up|2|||
127680172|NCT02194933|459454080|FG000|Overall Study|Participant met withdrawal criteria|1|||
127680173|NCT02194933|459454081|FG001|Overall Study|Participant met withdrawal criteria|3|||
127680174|NCT02194933|459454080|FG000|Overall Study|Withdrawal by Subject|0|||
127680175|NCT02194933|459454081|FG001|Overall Study|Withdrawal by Subject|2|||
127680176|NCT02194933|459454080|FG000|Overall Study|Lack of Efficacy|1|||
127680177|NCT02194933|459454081|FG001|Overall Study|Lack of Efficacy|2|||
127680178|NCT02045836|459454085|FG000|Overall Study|Adverse Event|4|||
127680179|NCT02045836|459454086|FG001|Overall Study|Adverse Event|4|||
127680180|NCT02045836|459454085|FG000|Overall Study|Withdrawal by Subject|1|||
127766978|NCT01395888|459772180|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
127766979|NCT01395888|459772181|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
127766980|NCT01395888|459772182|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
127766981|NCT01395888|459772180|FG000|2-week Run-in Period|Lost to Follow-up|1|||
127766982|NCT01395888|459772181|FG001|2-week Run-in Period|Lost to Follow-up|0|||
127766983|NCT01395888|459772182|FG002|2-week Run-in Period|Lost to Follow-up|0|||
127766984|NCT01395888|459772180|FG000|2-week Run-in Period|Protocol Violation|2|||
127766985|NCT01395888|459772181|FG001|2-week Run-in Period|Protocol Violation|0|||
127766986|NCT01395888|459772182|FG002|2-week Run-in Period|Protocol Violation|0|||
127766987|NCT01395888|459772180|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
127766988|NCT01395888|459772181|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
127766989|NCT01395888|459772182|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
127766990|NCT01395888|459772180|FG000|Treatment Period (TP)|Adverse Event|0|||
127766991|NCT01395888|459772181|FG001|Treatment Period (TP)|Adverse Event|7|||
127766992|NCT01395888|459772182|FG002|Treatment Period (TP)|Adverse Event|6|||
127766993|NCT01395888|459772180|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
127766994|NCT01395888|459772181|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
127766995|NCT01395888|459772182|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
127766996|NCT01395888|459772180|FG000|Treatment Period (TP)|Protocol Violation|0|||
128014462|NCT03314935|460678146|FG013|Phase 1|Study Terminated by Sponsor|0|||
128014463|NCT03314935|460678147|FG014|Phase 1|Study Terminated by Sponsor|0|||
128014464|NCT03314935|460678133|FG000|Phase 1|"Captured as Other in Database"|0|||
127766997|NCT01395888|459772181|FG001|Treatment Period (TP)|Protocol Violation|1|||
127766998|NCT01395888|459772182|FG002|Treatment Period (TP)|Protocol Violation|5|||
127766999|NCT01395888|459772180|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
127767000|NCT01395888|459772181|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
127767001|NCT01395888|459772182|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
127767002|NCT01395888|459772180|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
127767003|NCT01395888|459772181|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
127767004|NCT01395888|459772182|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
127767005|NCT03218397|459772183|FG000|Overall Study|Prior positive blood culture|8|||
127767006|NCT03218397|459772184|FG001|Overall Study|Prior positive blood culture|13|||
127767007|NCT03218397|459772183|FG000|Overall Study|Comfort care|8|||
127767008|NCT03218397|459772184|FG001|Overall Study|Comfort care|5|||
127767009|NCT03218397|459772183|FG000|Overall Study|Comfort care and positive blood culture|1|||
127767010|NCT03218397|459772184|FG001|Overall Study|Comfort care and positive blood culture|0|||
127767011|NCT03218397|459772183|FG000|Overall Study|Comfort care and mixed culture|0|||
127767012|NCT03218397|459772184|FG001|Overall Study|Comfort care and mixed culture|1|||
127767013|NCT03218397|459772183|FG000|Overall Study|Mixed culture|2|||
127767014|NCT03218397|459772184|FG001|Overall Study|Mixed culture|2|||
127767015|NCT03218397|459772183|FG000|Overall Study|Inaccessible hospital records|2|||
127767016|NCT03218397|459772184|FG001|Overall Study|Inaccessible hospital records|5|||
127767017|NCT03218397|459772183|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
127767018|NCT03218397|459772184|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
127767019|NCT03218397|459772183|FG000|Overall Study|Randomized during laboratory off hours|2|||
127767020|NCT03218397|459772184|FG001|Overall Study|Randomized during laboratory off hours|1|||
127680181|NCT02045836|459454086|FG001|Overall Study|Withdrawal by Subject|1|||
127680182|NCT02045836|459454085|FG000|Overall Study|Lost to Follow-up|4|||
127680183|NCT02045836|459454086|FG001|Overall Study|Lost to Follow-up|7|||
127680184|NCT02045836|459454085|FG000|Overall Study|Migrated from study area|0|||
127680185|NCT02045836|459454086|FG001|Overall Study|Migrated from study area|2|||
127680186|NCT03920215|459454090|FG000|Overall Study|Lost to Follow-up|1|||
127680187|NCT03920215|459454091|FG001|Overall Study|Lost to Follow-up|2|||
127680188|NCT03920215|459454092|FG002|Overall Study|Lost to Follow-up|0|||
127680189|NCT03920215|459454093|FG003|Overall Study|Lost to Follow-up|0|||
127680190|NCT03920215|459454090|FG000|Overall Study|Death|0|||
127680191|NCT03920215|459454091|FG001|Overall Study|Death|0|||
127680192|NCT03920215|459454092|FG002|Overall Study|Death|0|||
127680193|NCT03920215|459454093|FG003|Overall Study|Death|1|||
127680194|NCT02000817|459454094|FG000|Overall Study|Withdrawal by Subject|2|||
127767021|NCT01946438|459772185|FG000|Overall Study|Adverse Event|0|||
127767022|NCT01946438|459772186|FG001|Overall Study|Adverse Event|0|||
127680195|NCT02000817|459454095|FG001|Overall Study|Withdrawal by Subject|0|||
127680196|NCT02000817|459454096|FG002|Overall Study|Withdrawal by Subject|0|||
127680197|NCT02000817|459454097|FG003|Overall Study|Withdrawal by Subject|0|||
127680198|NCT02000817|459454094|FG000|Overall Study|Adverse Event|0|||
127680199|NCT02000817|459454095|FG001|Overall Study|Adverse Event|1|||
127680200|NCT02000817|459454096|FG002|Overall Study|Adverse Event|0|||
127680201|NCT02000817|459454097|FG003|Overall Study|Adverse Event|0|||
127680202|NCT02000817|459454094|FG000|Overall Study|Lost to Follow-up|0|||
127680203|NCT02000817|459454095|FG001|Overall Study|Lost to Follow-up|0|||
127680204|NCT02000817|459454096|FG002|Overall Study|Lost to Follow-up|1|||
127680205|NCT02000817|459454097|FG003|Overall Study|Lost to Follow-up|0|||
127680206|NCT00177216|459454098|FG000|Overall Study|Withdrawal by Subject|6|||
127680207|NCT00177216|459454099|FG001|Overall Study|Withdrawal by Subject|3|||
127680208|NCT00177216|459454100|FG002|Overall Study|Withdrawal by Subject|1|||
127680209|NCT03383146|459454101|FG000|Overall Study|Screen Failure|1|||
127680210|NCT03383146|459454102|FG001|Overall Study|Screen Failure|0|||
127680211|NCT03383146|459454101|FG000|Overall Study|Adverse Event|6|||
127680212|NCT03383146|459454102|FG001|Overall Study|Adverse Event|18|||
127680213|NCT03383146|459454101|FG000|Overall Study|Lack of Efficacy|0|||
127680214|NCT03383146|459454102|FG001|Overall Study|Lack of Efficacy|3|||
127680215|NCT03383146|459454101|FG000|Overall Study|Withdrawal by Subject|20|||
127680216|NCT03383146|459454102|FG001|Overall Study|Withdrawal by Subject|36|||
127680217|NCT03383146|459454101|FG000|Overall Study|Lost to Follow-up|5|||
127680218|NCT03383146|459454102|FG001|Overall Study|Lost to Follow-up|15|||
127680219|NCT03383146|459454101|FG000|Overall Study|Death|0|||
127680220|NCT03383146|459454102|FG001|Overall Study|Death|2|||
127680221|NCT03383146|459454101|FG000|Overall Study|Physician Decision|0|||
127680222|NCT03383146|459454102|FG001|Overall Study|Physician Decision|1|||
127680223|NCT03383146|459454101|FG000|Overall Study|Protocol Deviation|1|||
127680224|NCT03383146|459454102|FG001|Overall Study|Protocol Deviation|8|||
127680225|NCT03383146|459454101|FG000|Overall Study|Study Terminated by the Sponsor|48|||
127680226|NCT03383146|459454102|FG001|Overall Study|Study Terminated by the Sponsor|95|||
127680227|NCT03383146|459454101|FG000|Overall Study|Reason not Specified|4|||
127680228|NCT03383146|459454102|FG001|Overall Study|Reason not Specified|6|||
127680229|NCT02739035|459454107|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
127680230|NCT02739035|459454108|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
127680231|NCT02739035|459454107|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
127680232|NCT02739035|459454108|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
127680233|NCT02739035|459454107|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
127680234|NCT02739035|459454108|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
127680235|NCT02739035|459454107|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
127680236|NCT02739035|459454108|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
127680237|NCT03210402|459454109|FG000|Overall Study|Withdrawal by Subject|0|||
127680238|NCT03210402|459454110|FG001|Overall Study|Withdrawal by Subject|1|||
127680239|NCT02517307|459454113|FG000|Overall Study|Withdrawal by Subject|1|||
127680240|NCT02517307|459454114|FG001|Overall Study|Withdrawal by Subject|0|||
127680241|NCT02517307|459454115|FG002|Overall Study|Withdrawal by Subject|1|||
127680242|NCT02517307|459454116|FG003|Overall Study|Withdrawal by Subject|0|||
127680243|NCT02517307|459454113|FG000|Overall Study|Protocol Violation|0|||
127680244|NCT02517307|459454114|FG001|Overall Study|Protocol Violation|0|||
127680245|NCT02517307|459454115|FG002|Overall Study|Protocol Violation|1|||
127680246|NCT02517307|459454116|FG003|Overall Study|Protocol Violation|1|||
127680247|NCT00823979|459454117|FG000|Overall Study|Lack of Efficacy|13|||
127680248|NCT00823979|459454118|FG001|Overall Study|Lack of Efficacy|16|||
127680249|NCT00823979|459454119|FG002|Overall Study|Lack of Efficacy|9|||
127680250|NCT00823979|459454117|FG000|Overall Study|Lost to Follow-up|2|||
127680251|NCT00823979|459454118|FG001|Overall Study|Lost to Follow-up|1|||
127680252|NCT00823979|459454119|FG002|Overall Study|Lost to Follow-up|0|||
127680253|NCT00823979|459454117|FG000|Overall Study|Withdrawal by Subject|2|||
127680254|NCT00823979|459454118|FG001|Overall Study|Withdrawal by Subject|3|||
127680255|NCT00823979|459454119|FG002|Overall Study|Withdrawal by Subject|2|||
127680256|NCT00823979|459454117|FG000|Overall Study|Protocol Violation|1|||
127680257|NCT00823979|459454118|FG001|Overall Study|Protocol Violation|1|||
127680258|NCT00823979|459454119|FG002|Overall Study|Protocol Violation|0|||
127680259|NCT00823979|459454117|FG000|Overall Study|Pregnancy|0|||
127767023|NCT01946438|459772187|FG002|Overall Study|Adverse Event|0|||
127767024|NCT01946438|459772188|FG003|Overall Study|Adverse Event|1|||
127767025|NCT01946438|459772185|FG000|Overall Study|Serious Adverse event|1|||
127767026|NCT01946438|459772186|FG001|Overall Study|Serious Adverse event|0|||
127767027|NCT01946438|459772187|FG002|Overall Study|Serious Adverse event|0|||
127767028|NCT01946438|459772188|FG003|Overall Study|Serious Adverse event|0|||
127767029|NCT01946438|459772185|FG000|Overall Study|Protocol Violation|0|||
127767030|NCT01946438|459772186|FG001|Overall Study|Protocol Violation|0|||
127767031|NCT01946438|459772187|FG002|Overall Study|Protocol Violation|1|||
127767032|NCT01946438|459772188|FG003|Overall Study|Protocol Violation|0|||
127767033|NCT01946438|459772185|FG000|Overall Study|Withdrawal by Subject|1|||
127767034|NCT01946438|459772186|FG001|Overall Study|Withdrawal by Subject|0|||
127767035|NCT01946438|459772187|FG002|Overall Study|Withdrawal by Subject|0|||
127767036|NCT01946438|459772188|FG003|Overall Study|Withdrawal by Subject|0|||
127767037|NCT03432260|459772197|FG000|Overall Study|Lost to Follow-up|1|||
127767038|NCT03432260|459772198|FG001|Overall Study|Lost to Follow-up|1|||
127767039|NCT03432260|459772199|FG002|Overall Study|Lost to Follow-up|0|||
127767040|NCT03432260|459772200|FG003|Overall Study|Lost to Follow-up|0|||
127767041|NCT03432260|459772201|FG004|Overall Study|Lost to Follow-up|1|||
127767042|NCT00031551|459774316|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
127767043|NCT00031551|459774317|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
127767044|NCT00409773|459774318|FG000|Overall Study|Adverse Event|3|||
127767045|NCT00409773|459774319|FG001|Overall Study|Adverse Event|4|||
127767046|NCT00409773|459774320|FG002|Overall Study|Adverse Event|4|||
127767047|NCT00409773|459774321|FG003|Overall Study|Adverse Event|2|||
127767048|NCT00409773|459774322|FG004|Overall Study|Adverse Event|6|||
127767049|NCT00409773|459774318|FG000|Overall Study|Lost to Follow-up|6|||
127767050|NCT00409773|459774319|FG001|Overall Study|Lost to Follow-up|1|||
127767051|NCT00409773|459774320|FG002|Overall Study|Lost to Follow-up|2|||
127767052|NCT00409773|459774321|FG003|Overall Study|Lost to Follow-up|3|||
127767053|NCT00409773|459774322|FG004|Overall Study|Lost to Follow-up|1|||
127767054|NCT00409773|459774318|FG000|Overall Study|Physician Decision|0|||
127767055|NCT00409773|459774319|FG001|Overall Study|Physician Decision|0|||
127767056|NCT00409773|459774320|FG002|Overall Study|Physician Decision|0|||
127767057|NCT00409773|459774321|FG003|Overall Study|Physician Decision|2|||
127767058|NCT00409773|459774322|FG004|Overall Study|Physician Decision|0|||
127767059|NCT00409773|459774318|FG000|Overall Study|Protocol Violation|0|||
127767060|NCT00409773|459774319|FG001|Overall Study|Protocol Violation|2|||
127767061|NCT00409773|459774320|FG002|Overall Study|Protocol Violation|3|||
127767062|NCT00409773|459774321|FG003|Overall Study|Protocol Violation|3|||
127767063|NCT00409773|459774322|FG004|Overall Study|Protocol Violation|1|||
127767064|NCT00409773|459774318|FG000|Overall Study|Withdrawal by Subject|0|||
127767065|NCT00409773|459774319|FG001|Overall Study|Withdrawal by Subject|0|||
127767066|NCT00409773|459774320|FG002|Overall Study|Withdrawal by Subject|0|||
127767067|NCT00409773|459774321|FG003|Overall Study|Withdrawal by Subject|2|||
127767068|NCT00409773|459774322|FG004|Overall Study|Withdrawal by Subject|1|||
127767069|NCT00409773|459774318|FG000|Overall Study|Lack of Eligibility|0|||
127767070|NCT00409773|459774319|FG001|Overall Study|Lack of Eligibility|0|||
127767071|NCT00409773|459774320|FG002|Overall Study|Lack of Eligibility|0|||
127767072|NCT00409773|459774321|FG003|Overall Study|Lack of Eligibility|0|||
127767073|NCT00409773|459774322|FG004|Overall Study|Lack of Eligibility|1|||
127767074|NCT02359877|459774323|FG000|Overall Study|Withdrawal by Subject|1|||
127767075|NCT02359877|459774324|FG001|Overall Study|Withdrawal by Subject|0|||
127767076|NCT02359877|459774325|FG002|Overall Study|Withdrawal by Subject|0|||
127767077|NCT02359877|459774326|FG003|Overall Study|Withdrawal by Subject|2|||
127767078|NCT02359877|459774323|FG000|Overall Study|Adverse Event|0|||
127767079|NCT02359877|459774324|FG001|Overall Study|Adverse Event|0|||
127767080|NCT02359877|459774325|FG002|Overall Study|Adverse Event|0|||
127767081|NCT02359877|459774326|FG003|Overall Study|Adverse Event|1|||
127767082|NCT01919814|459774327|FG000|Overall Study|Adverse Event|1|||
127767083|NCT01919814|459774328|FG001|Overall Study|Adverse Event|0|||
127767084|NCT01919814|459774327|FG000|Overall Study|Protocol Violation|1|||
127767085|NCT01919814|459774328|FG001|Overall Study|Protocol Violation|0|||
127767086|NCT01919814|459774327|FG000|Overall Study|Withdrawal by Subject|1|||
127767087|NCT01919814|459774328|FG001|Overall Study|Withdrawal by Subject|0|||
127767088|NCT02164383|459774329|FG000|Overall Study|Lost to Follow-up|1|||
127767089|NCT02164383|459774330|FG001|Overall Study|Lost to Follow-up|0|||
128014465|NCT03314935|460678134|FG001|Phase 1|"Captured as Other in Database"|2|||
128014466|NCT03314935|460678135|FG002|Phase 1|"Captured as Other in Database"|0|||
127767090|NCT02831387|459774332|FG000|Overall Study|Withdrawal by Subject|1|||
127767091|NCT02831387|459774333|FG001|Overall Study|Withdrawal by Subject|1|||
127767092|NCT02831387|459774332|FG000|Overall Study|Discontinued due to stock recovery|0|||
127767093|NCT02831387|459774333|FG001|Overall Study|Discontinued due to stock recovery|1|||
127767094|NCT00192647|459774334|FG000|Overall Study|Death|1|||
127767095|NCT00192647|459774335|FG001|Overall Study|Death|1|||
128014467|NCT03314935|460678136|FG003|Phase 1|"Captured as Other in Database"|0|||
127767096|NCT00192647|459774334|FG000|Overall Study|Adverse Event|35|||
127767097|NCT00192647|459774335|FG001|Overall Study|Adverse Event|29|||
127767098|NCT00192647|459774334|FG000|Overall Study|Laboratory Test Abnormality|4|||
127680260|NCT00823979|459454118|FG001|Overall Study|Pregnancy|1|||
127680261|NCT00823979|459454119|FG002|Overall Study|Pregnancy|0|||
127680262|NCT00823979|459454117|FG000|Overall Study|Adverse Event|0|||
127680263|NCT00823979|459454118|FG001|Overall Study|Adverse Event|2|||
127680264|NCT00823979|459454119|FG002|Overall Study|Adverse Event|4|||
127680265|NCT00823979|459454117|FG000|Overall Study|Other|2|||
127680266|NCT00823979|459454118|FG001|Overall Study|Other|0|||
127680267|NCT00823979|459454119|FG002|Overall Study|Other|1|||
127680268|NCT00823979|459454117|FG000|Overall Study|Randomized but not Treated|4|||
127680269|NCT00823979|459454118|FG001|Overall Study|Randomized but not Treated|3|||
127680270|NCT00823979|459454119|FG002|Overall Study|Randomized but not Treated|1|||
127680271|NCT00823979|459454117|FG000|Overall Study|Study Terminated by Sponsor|5|||
127680272|NCT00823979|459454118|FG001|Overall Study|Study Terminated by Sponsor|5|||
127680273|NCT00823979|459454119|FG002|Overall Study|Study Terminated by Sponsor|7|||
127680274|NCT03586544|459454120|FG000|First Intervention|Adverse Event|0|||
127680275|NCT03586544|459454121|FG001|First Intervention|Adverse Event|1|||
127680276|NCT03586544|459454120|FG000|Second Intervention|Withdrawal by Subject|0|||
127680277|NCT03586544|459454121|FG001|Second Intervention|Withdrawal by Subject|1|||
127680278|NCT03523091|459454122|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
127680279|NCT03523091|459454123|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
127680280|NCT03523091|459454122|FG000|Overall Study|Withdrawal by Subject|0|||
127680281|NCT03523091|459454123|FG001|Overall Study|Withdrawal by Subject|3|||
127680282|NCT03523091|459454122|FG000|Overall Study|Increase Botox dose|0|||
127680283|NCT03523091|459454123|FG001|Overall Study|Increase Botox dose|1|||
127680284|NCT03863834|459454129|FG000|Overall Study|Lost to Follow-up|3|||
127680285|NCT02685488|459454130|FG000|Overall Study|Withdrawal by Subject|0|||
127680286|NCT02685488|459454131|FG001|Overall Study|Withdrawal by Subject|1|||
127680287|NCT00208767|459454134|FG000|Overall Study|Adverse Event|9|||
127680288|NCT00208767|459454135|FG001|Overall Study|Adverse Event|1|||
127680289|NCT00208767|459454134|FG000|Overall Study|Withdrawal by Subject|14|||
127680290|NCT00208767|459454135|FG001|Overall Study|Withdrawal by Subject|3|||
127680291|NCT00208767|459454134|FG000|Overall Study|Death|1|||
127680292|NCT00208767|459454135|FG001|Overall Study|Death|0|||
127680293|NCT00208767|459454134|FG000|Overall Study|Lost to Follow-up|3|||
127680294|NCT00208767|459454135|FG001|Overall Study|Lost to Follow-up|3|||
127680295|NCT03545984|459454136|FG000|Overall Study|CSF cases not present during rotation|11|||
127680296|NCT03545984|459454137|FG001|Overall Study|CSF cases not present during rotation|9|||
127680297|NCT01212757|459454138|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
127680298|NCT01212757|459454139|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
127680299|NCT01212757|459454140|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
127680300|NCT01212757|459454141|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
127680301|NCT01212757|459454142|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
127680302|NCT01212757|459454143|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
127680303|NCT01212757|459454144|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
127680304|NCT01212757|459454145|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
127680305|NCT01212757|459454146|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
127680306|NCT01212757|459454138|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
127680307|NCT01212757|459454139|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
127680308|NCT01212757|459454140|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
127680309|NCT01212757|459454141|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
127680310|NCT01212757|459454142|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
127680311|NCT01212757|459454143|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
127680312|NCT01212757|459454144|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
127680313|NCT01212757|459454145|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
127680314|NCT01212757|459454146|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
127680315|NCT01212757|459454138|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
127680316|NCT01212757|459454139|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
127680317|NCT01212757|459454140|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
127680318|NCT01212757|459454141|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
127680319|NCT01212757|459454142|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
127680320|NCT01212757|459454143|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
127680321|NCT01212757|459454144|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
127680322|NCT01212757|459454145|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
127680323|NCT01212757|459454146|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
127680324|NCT01212757|459454138|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
127680325|NCT01212757|459454139|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
127680326|NCT01212757|459454140|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
127680327|NCT01212757|459454141|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
127680328|NCT01212757|459454142|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
127767099|NCT00192647|459774335|FG001|Overall Study|Laboratory Test Abnormality|2|||
127767100|NCT00192647|459774334|FG000|Overall Study|Insufficient Therapeutic Response|53|||
127767101|NCT00192647|459774335|FG001|Overall Study|Insufficient Therapeutic Response|83|||
127767102|NCT00192647|459774334|FG000|Overall Study|Entry Criteria Violation|6|||
127767103|NCT00192647|459774335|FG001|Overall Study|Entry Criteria Violation|6|||
127767104|NCT00192647|459774334|FG000|Overall Study|Protocol Violation|3|||
127767105|NCT00192647|459774335|FG001|Overall Study|Protocol Violation|1|||
127767106|NCT00192647|459774334|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
128014468|NCT03314935|460678137|FG004|Phase 1|"Captured as Other in Database"|0|||
128014469|NCT03314935|460678138|FG005|Phase 1|"Captured as Other in Database"|0|||
128014470|NCT03314935|460678139|FG006|Phase 1|"Captured as Other in Database"|1|||
128014471|NCT03314935|460678140|FG007|Phase 1|"Captured as Other in Database"|1|||
127767107|NCT00192647|459774335|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
127767108|NCT00192647|459774334|FG000|Overall Study|Failure to Return|11|||
127767109|NCT00192647|459774335|FG001|Overall Study|Failure to Return|13|||
127767110|NCT00192647|459774334|FG000|Overall Study|Other/Administrative|5|||
127767111|NCT00192647|459774335|FG001|Overall Study|Other/Administrative|3|||
127767112|NCT01828073|459774336|FG000|Overall Study|Lost to Follow-up|1|||
127767113|NCT01828073|459774337|FG001|Overall Study|Lost to Follow-up|2|||
127767114|NCT00690443|459774338|FG000|Overall Study|Adverse Event|1|||
127767115|NCT00690443|459774339|FG001|Overall Study|Adverse Event|2|||
127767116|NCT01350336|459774340|FG000|Overall Study|Lost to Follow-up|31|||
127767117|NCT01350336|459774340|FG000|Overall Study|Withdrawal by Subject|14|||
127767118|NCT01350336|459774340|FG000|Overall Study|Physician Decision|8|||
127767119|NCT01350336|459774340|FG000|Overall Study|Death|4|||
127767120|NCT02079610|459774341|FG000|Overall Study|Withdrawal by Subject|1|||
127767121|NCT02079610|459774342|FG001|Overall Study|Withdrawal by Subject|1|||
127767122|NCT01111474|459774343|FG000|Overall Study|Lost to Follow-up|12|||
127767123|NCT01016977|459774344|FG000|Overall Study|Lost to Follow-up|1|||
127767124|NCT01016977|459774345|FG001|Overall Study|Lost to Follow-up|0|||
127767125|NCT01016977|459774344|FG000|Overall Study|Withdrawal by Subject|2|||
127767126|NCT01016977|459774345|FG001|Overall Study|Withdrawal by Subject|2|||
127767127|NCT02336178|459774346|FG000|Overall Study|Lost to Follow-up|1|||
127767128|NCT02336178|459774346|FG000|Overall Study|Protocol Violation|1|||
127767129|NCT02336178|459774346|FG000|Overall Study|Withdrawal by Subject|1|||
127767130|NCT02336178|459774346|FG000|Overall Study|Other|1|||
127767131|NCT00618982|459774347|FG000|Overall Study|Adverse Event|23|||
127767132|NCT00618982|459774347|FG000|Overall Study|Withdrawal by Subject|1|||
127767133|NCT00618982|459774347|FG000|Overall Study|Protocol Violation|1|||
127767134|NCT00618982|459774347|FG000|Overall Study|ongoing, still treated with study med.|25|||
127767135|NCT01776541|459774350|FG000|Overall Study|Administrative Reason|6|||
127767136|NCT01776541|459774351|FG001|Overall Study|Administrative Reason|2|||
127767137|NCT01776541|459774350|FG000|Overall Study|Death|4|||
127767138|NCT01776541|459774351|FG001|Overall Study|Death|0|||
127767139|NCT01776541|459774350|FG000|Overall Study|Lost to Follow-up|27|||
127767140|NCT01776541|459774351|FG001|Overall Study|Lost to Follow-up|48|||
127767141|NCT01776541|459774350|FG000|Overall Study|Unclassified|5|||
127767142|NCT01776541|459774351|FG001|Overall Study|Unclassified|4|||
127767143|NCT01776541|459774350|FG000|Overall Study|Protocol Violation|2|||
127767144|NCT01776541|459774351|FG001|Overall Study|Protocol Violation|1|||
127767145|NCT01776541|459774350|FG000|Overall Study|Withdrawal by Subject|12|||
127767146|NCT01776541|459774351|FG001|Overall Study|Withdrawal by Subject|20|||
127767147|NCT00156819|459774352|FG000|Overall Study|Lost to Follow-up|1|||
127767148|NCT00156819|459774353|FG001|Overall Study|Lost to Follow-up|1|||
127767149|NCT00156819|459774354|FG002|Overall Study|Lost to Follow-up|3|||
127767150|NCT00522873|459774357|FG000|Overall Study|Adverse Event|41|||
127767151|NCT00522873|459774358|FG001|Overall Study|Adverse Event|26|||
127767152|NCT00522873|459774357|FG000|Overall Study|Withdrawal by Subject|20|||
127767153|NCT00522873|459774358|FG001|Overall Study|Withdrawal by Subject|9|||
127767154|NCT00522873|459774357|FG000|Overall Study|Protocol Violation|14|||
127767155|NCT00522873|459774358|FG001|Overall Study|Protocol Violation|4|||
127767156|NCT00522873|459774357|FG000|Overall Study|Lost to Follow-up|11|||
127767157|NCT00522873|459774358|FG001|Overall Study|Lost to Follow-up|3|||
127767158|NCT00522873|459774357|FG000|Overall Study|Personal Reasons|8|||
127767159|NCT00522873|459774358|FG001|Overall Study|Personal Reasons|1|||
127767160|NCT00522873|459774357|FG000|Overall Study|Medication Errors|1|||
127767161|NCT00522873|459774358|FG001|Overall Study|Medication Errors|1|||
127767162|NCT00522873|459774357|FG000|Overall Study|Never Received Medication|1|||
127767163|NCT00522873|459774358|FG001|Overall Study|Never Received Medication|0|||
127767164|NCT00799513|459774359|FG000|Overall Study|Physician Decision|1|||
127767165|NCT00799513|459774359|FG000|Overall Study|Adverse Event|1|||
127767166|NCT00666679|459774362|FG000|First Intervention|Lost to Follow-up|1|||
127767167|NCT00666679|459774363|FG001|First Intervention|Lost to Follow-up|0|||
127767168|NCT00666679|459774362|FG000|First Intervention|Protocol Violation|1|||
127767169|NCT00666679|459774363|FG001|First Intervention|Protocol Violation|0|||
127767170|NCT00666679|459774362|FG000|First Intervention|Withdrawal by Subject|1|||
127767171|NCT00666679|459774363|FG001|First Intervention|Withdrawal by Subject|0|||
127767172|NCT00666679|459774362|FG000|First Intervention|Randomized did not start treatment|1|||
127767173|NCT00666679|459774363|FG001|First Intervention|Randomized did not start treatment|1|||
128014472|NCT03314935|460678141|FG008|Phase 1|"Captured as Other in Database"|1|||
128014473|NCT03314935|460678142|FG009|Phase 1|"Captured as Other in Database"|0|||
128014474|NCT03314935|460678143|FG010|Phase 1|"Captured as Other in Database"|0|||
128014475|NCT03314935|460678144|FG011|Phase 1|"Captured as Other in Database"|0|||
128014476|NCT03314935|460678145|FG012|Phase 1|"Captured as Other in Database"|0|||
128014477|NCT03314935|460678146|FG013|Phase 1|"Captured as Other in Database"|0|||
127767174|NCT00666679|459774362|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
127767175|NCT00666679|459774363|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
127767176|NCT00666679|459774362|FG000|Washout Period of 1 Week|Protocol Violation|0|||
127767177|NCT00666679|459774363|FG001|Washout Period of 1 Week|Protocol Violation|1|||
128014478|NCT03314935|460678147|FG014|Phase 1|"Captured as Other in Database"|0|||
128014479|NCT03314935|460678133|FG000|Phase 1|Lost to Follow-up|0|||
128014480|NCT03314935|460678134|FG001|Phase 1|Lost to Follow-up|0|||
128014481|NCT03314935|460678135|FG002|Phase 1|Lost to Follow-up|0|||
128014482|NCT03314935|460678136|FG003|Phase 1|Lost to Follow-up|0|||
127767178|NCT00666679|459774362|FG000|Second Intervention|Adverse Event|1|||
128014483|NCT03314935|460678137|FG004|Phase 1|Lost to Follow-up|0|||
128014484|NCT03314935|460678138|FG005|Phase 1|Lost to Follow-up|0|||
128014485|NCT03314935|460678139|FG006|Phase 1|Lost to Follow-up|0|||
128014486|NCT03314935|460678140|FG007|Phase 1|Lost to Follow-up|0|||
128014487|NCT03314935|460678141|FG008|Phase 1|Lost to Follow-up|1|||
128014488|NCT03314935|460678142|FG009|Phase 1|Lost to Follow-up|0|||
128014489|NCT03314935|460678143|FG010|Phase 1|Lost to Follow-up|0|||
128014490|NCT03314935|460678144|FG011|Phase 1|Lost to Follow-up|0|||
128014491|NCT03314935|460678145|FG012|Phase 1|Lost to Follow-up|0|||
128014492|NCT03314935|460678146|FG013|Phase 1|Lost to Follow-up|0|||
128014493|NCT03314935|460678147|FG014|Phase 1|Lost to Follow-up|0|||
128014494|NCT03314935|460678133|FG000|Phase 2|Death|0|||
128014495|NCT03314935|460678134|FG001|Phase 2|Death|0|||
128014496|NCT03314935|460678135|FG002|Phase 2|Death|0|||
128014497|NCT03314935|460678136|FG003|Phase 2|Death|0|||
128014498|NCT03314935|460678137|FG004|Phase 2|Death|0|||
128014499|NCT03314935|460678138|FG005|Phase 2|Death|0|||
128014500|NCT03314935|460678139|FG006|Phase 2|Death|0|||
128014501|NCT03314935|460678140|FG007|Phase 2|Death|0|||
128014502|NCT03314935|460678141|FG008|Phase 2|Death|0|||
127767179|NCT00666679|459774363|FG001|Second Intervention|Adverse Event|0|||
127767180|NCT00666679|459774362|FG000|Second Intervention|Death|0|||
127767181|NCT00666679|459774363|FG001|Second Intervention|Death|1|||
127767182|NCT05062759|459774367|FG000|Overall Study|Death|0|||
127767183|NCT05062759|459774368|FG001|Overall Study|Death|1|||
127767184|NCT05062759|459774367|FG000|Overall Study|Lost to Follow-up|1|||
127767185|NCT05062759|459774368|FG001|Overall Study|Lost to Follow-up|0|||
127767186|NCT02781844|459774369|FG000|Treatment Period 1|Adverse Event|0|||
127767187|NCT02781844|459774370|FG001|Treatment Period 1|Adverse Event|0|||
127767188|NCT02781844|459774371|FG002|Treatment Period 1|Adverse Event|0|||
127767189|NCT02781844|459774372|FG003|Treatment Period 1|Adverse Event|0|||
127767190|NCT02781844|459774373|FG004|Treatment Period 1|Adverse Event|0|||
128014503|NCT03314935|460678142|FG009|Phase 2|Death|5|||
128014504|NCT03314935|460678143|FG010|Phase 2|Death|20|||
128014505|NCT03314935|460678144|FG011|Phase 2|Death|6|||
128014506|NCT03314935|460678145|FG012|Phase 2|Death|7|||
128014507|NCT03314935|460678146|FG013|Phase 2|Death|6|||
128014508|NCT03314935|460678147|FG014|Phase 2|Death|17|||
128014509|NCT03314935|460678133|FG000|Phase 2|Withdrawal by Subject|0|||
127767191|NCT02781844|459774374|FG005|Treatment Period 1|Adverse Event|1|||
127767192|NCT02781844|459774375|FG006|Treatment Period 1|Adverse Event|0|||
127767193|NCT02781844|459774376|FG007|Treatment Period 1|Adverse Event|0|||
127767194|NCT02518490|459774379|FG000|Overall Study|Withdrawal by Subject|1|||
127767195|NCT02518490|459774380|FG001|Overall Study|Withdrawal by Subject|1|||
127767196|NCT00346632|459774381|FG000|Overall Study|Progressive Disease|2|||
128014510|NCT03314935|460678134|FG001|Phase 2|Withdrawal by Subject|0|||
128014511|NCT03314935|460678135|FG002|Phase 2|Withdrawal by Subject|0|||
128014512|NCT03314935|460678136|FG003|Phase 2|Withdrawal by Subject|0|||
128014513|NCT03314935|460678137|FG004|Phase 2|Withdrawal by Subject|0|||
128014514|NCT03314935|460678138|FG005|Phase 2|Withdrawal by Subject|0|||
128014515|NCT03314935|460678139|FG006|Phase 2|Withdrawal by Subject|0|||
128014516|NCT03314935|460678140|FG007|Phase 2|Withdrawal by Subject|0|||
128014517|NCT03314935|460678141|FG008|Phase 2|Withdrawal by Subject|0|||
128014518|NCT03314935|460678142|FG009|Phase 2|Withdrawal by Subject|1|||
128014519|NCT03314935|460678143|FG010|Phase 2|Withdrawal by Subject|4|||
128014520|NCT03314935|460678144|FG011|Phase 2|Withdrawal by Subject|0|||
128014521|NCT03314935|460678145|FG012|Phase 2|Withdrawal by Subject|1|||
128014522|NCT03314935|460678146|FG013|Phase 2|Withdrawal by Subject|0|||
128014523|NCT03314935|460678147|FG014|Phase 2|Withdrawal by Subject|1|||
128014524|NCT03314935|460678133|FG000|Phase 2|Progressive Disease|0|||
127767197|NCT00346632|459774382|FG001|Overall Study|Progressive Disease|2|||
127767198|NCT00346632|459774383|FG002|Overall Study|Progressive Disease|4|||
127767199|NCT00346632|459774384|FG003|Overall Study|Progressive Disease|3|||
127767200|NCT00346632|459774385|FG004|Overall Study|Progressive Disease|3|||
128014525|NCT03314935|460678134|FG001|Phase 2|Progressive Disease|0|||
128014526|NCT03314935|460678135|FG002|Phase 2|Progressive Disease|0|||
128014527|NCT03314935|460678136|FG003|Phase 2|Progressive Disease|0|||
128014528|NCT03314935|460678137|FG004|Phase 2|Progressive Disease|0|||
127680329|NCT01212757|459454143|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
127680330|NCT01212757|459454144|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
127680331|NCT01212757|459454145|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
127680332|NCT01212757|459454146|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
127680333|NCT01212757|459454138|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
127680334|NCT01212757|459454139|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
127680335|NCT01212757|459454140|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
127680336|NCT01212757|459454141|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
127680337|NCT01212757|459454142|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
127680338|NCT01212757|459454143|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
127680339|NCT01212757|459454144|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
127680340|NCT01212757|459454145|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
127680341|NCT01212757|459454146|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
127680342|NCT01212757|459454138|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
127680343|NCT01212757|459454139|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
127680344|NCT01212757|459454140|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
127680345|NCT01212757|459454141|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
127680346|NCT01212757|459454142|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
127680347|NCT01212757|459454143|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
127680348|NCT01212757|459454144|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
127680349|NCT01212757|459454145|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
127680350|NCT01212757|459454146|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
127680351|NCT01212757|459454138|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
127680352|NCT01212757|459454139|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
127680353|NCT01212757|459454140|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
127680354|NCT01212757|459454141|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
127680355|NCT01212757|459454142|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
127680356|NCT01212757|459454143|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
127680357|NCT01212757|459454144|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
127680358|NCT01212757|459454145|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
127680359|NCT01212757|459454146|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
127680360|NCT01212757|459454138|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
127680361|NCT01212757|459454139|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
127680362|NCT01212757|459454140|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
127680363|NCT01212757|459454141|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
127680364|NCT01212757|459454142|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
127680365|NCT01212757|459454143|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
127680366|NCT01212757|459454144|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
127680367|NCT01212757|459454145|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
127680368|NCT01212757|459454146|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
127680369|NCT01212757|459454138|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
127680370|NCT01212757|459454139|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
127680371|NCT01212757|459454140|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
127680372|NCT01212757|459454141|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
127680373|NCT01212757|459454142|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
127680374|NCT01212757|459454143|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
127680375|NCT01212757|459454144|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
127680376|NCT01212757|459454145|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
127680377|NCT01212757|459454146|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
127680378|NCT01212757|459454138|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
127680379|NCT01212757|459454139|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
127680380|NCT01212757|459454140|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
127680381|NCT01212757|459454141|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
127680382|NCT01212757|459454142|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
127680383|NCT01212757|459454143|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
127680384|NCT01212757|459454144|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
127680385|NCT01212757|459454145|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
127680386|NCT01212757|459454146|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
127680387|NCT01212757|459454138|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
127680388|NCT01212757|459454139|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
127680389|NCT01212757|459454140|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
127680390|NCT01212757|459454141|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
127680391|NCT01212757|459454142|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
127680392|NCT01212757|459454143|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
127767201|NCT00346632|459774386|FG005|Overall Study|Progressive Disease|1|||
127767202|NCT00346632|459774387|FG006|Overall Study|Progressive Disease|2|||
127767203|NCT00346632|459774388|FG007|Overall Study|Progressive Disease|2|||
127767204|NCT00346632|459774389|FG008|Overall Study|Progressive Disease|2|||
127767205|NCT00346632|459774390|FG009|Overall Study|Progressive Disease|2|||
127767206|NCT00346632|459774381|FG000|Overall Study|Adverse Event|0|||
127767207|NCT00346632|459774382|FG001|Overall Study|Adverse Event|0|||
127767208|NCT00346632|459774383|FG002|Overall Study|Adverse Event|0|||
127767209|NCT00346632|459774384|FG003|Overall Study|Adverse Event|0|||
127767210|NCT00346632|459774385|FG004|Overall Study|Adverse Event|1|||
127767211|NCT00346632|459774386|FG005|Overall Study|Adverse Event|1|||
127767212|NCT00346632|459774387|FG006|Overall Study|Adverse Event|1|||
127767213|NCT00346632|459774388|FG007|Overall Study|Adverse Event|0|||
127767214|NCT00346632|459774389|FG008|Overall Study|Adverse Event|0|||
127767215|NCT00346632|459774390|FG009|Overall Study|Adverse Event|0|||
127767216|NCT00346632|459774381|FG000|Overall Study|Death|0|||
127767217|NCT00346632|459774382|FG001|Overall Study|Death|0|||
127767218|NCT00346632|459774383|FG002|Overall Study|Death|1|||
127767219|NCT00346632|459774384|FG003|Overall Study|Death|0|||
127767220|NCT00346632|459774385|FG004|Overall Study|Death|0|||
127767221|NCT00346632|459774386|FG005|Overall Study|Death|0|||
127767222|NCT00346632|459774387|FG006|Overall Study|Death|0|||
127767223|NCT00346632|459774388|FG007|Overall Study|Death|0|||
127767224|NCT00346632|459774389|FG008|Overall Study|Death|0|||
127767225|NCT00346632|459774390|FG009|Overall Study|Death|0|||
127767226|NCT00346632|459774381|FG000|Overall Study|Protocol Violation|0|||
127767227|NCT00346632|459774382|FG001|Overall Study|Protocol Violation|0|||
127767228|NCT00346632|459774383|FG002|Overall Study|Protocol Violation|0|||
127767229|NCT00346632|459774384|FG003|Overall Study|Protocol Violation|0|||
127767230|NCT00346632|459774385|FG004|Overall Study|Protocol Violation|0|||
127767231|NCT00346632|459774386|FG005|Overall Study|Protocol Violation|0|||
127767232|NCT00346632|459774387|FG006|Overall Study|Protocol Violation|1|||
127767233|NCT00346632|459774388|FG007|Overall Study|Protocol Violation|0|||
127767234|NCT00346632|459774389|FG008|Overall Study|Protocol Violation|0|||
127767235|NCT00346632|459774390|FG009|Overall Study|Protocol Violation|0|||
127767236|NCT00346632|459774381|FG000|Overall Study|Withdrawal by Subject|0|||
127767237|NCT00346632|459774382|FG001|Overall Study|Withdrawal by Subject|0|||
127767238|NCT00346632|459774383|FG002|Overall Study|Withdrawal by Subject|0|||
127767239|NCT00346632|459774384|FG003|Overall Study|Withdrawal by Subject|0|||
127767240|NCT00346632|459774385|FG004|Overall Study|Withdrawal by Subject|0|||
127767241|NCT00346632|459774386|FG005|Overall Study|Withdrawal by Subject|0|||
127767242|NCT00346632|459774387|FG006|Overall Study|Withdrawal by Subject|1|||
127767243|NCT00346632|459774388|FG007|Overall Study|Withdrawal by Subject|0|||
127767244|NCT00346632|459774389|FG008|Overall Study|Withdrawal by Subject|0|||
127767245|NCT00346632|459774390|FG009|Overall Study|Withdrawal by Subject|0|||
127767246|NCT00346632|459774381|FG000|Overall Study|Switched to alternative treatment|0|||
127767247|NCT00346632|459774382|FG001|Overall Study|Switched to alternative treatment|0|||
127767248|NCT00346632|459774383|FG002|Overall Study|Switched to alternative treatment|1|||
127767249|NCT00346632|459774384|FG003|Overall Study|Switched to alternative treatment|0|||
127767250|NCT00346632|459774385|FG004|Overall Study|Switched to alternative treatment|0|||
127767251|NCT00346632|459774386|FG005|Overall Study|Switched to alternative treatment|0|||
127767252|NCT00346632|459774387|FG006|Overall Study|Switched to alternative treatment|0|||
127767253|NCT00346632|459774388|FG007|Overall Study|Switched to alternative treatment|0|||
127767254|NCT00346632|459774389|FG008|Overall Study|Switched to alternative treatment|0|||
127767255|NCT00346632|459774390|FG009|Overall Study|Switched to alternative treatment|0|||
127767256|NCT00346632|459774381|FG000|Overall Study|Not Stated|1|||
127767257|NCT00346632|459774382|FG001|Overall Study|Not Stated|1|||
127767258|NCT00346632|459774383|FG002|Overall Study|Not Stated|0|||
127767259|NCT00346632|459774384|FG003|Overall Study|Not Stated|0|||
127767260|NCT00346632|459774385|FG004|Overall Study|Not Stated|0|||
127767261|NCT00346632|459774386|FG005|Overall Study|Not Stated|0|||
127767262|NCT00346632|459774387|FG006|Overall Study|Not Stated|0|||
127767263|NCT00346632|459774388|FG007|Overall Study|Not Stated|2|||
127767264|NCT00346632|459774389|FG008|Overall Study|Not Stated|2|||
127767265|NCT00346632|459774390|FG009|Overall Study|Not Stated|1|||
128014529|NCT03314935|460678138|FG005|Phase 2|Progressive Disease|0|||
128014530|NCT03314935|460678139|FG006|Phase 2|Progressive Disease|0|||
127767266|NCT00918580|459774391|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
127767267|NCT00918580|459774391|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
127767268|NCT00918580|459774391|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
127767269|NCT00918580|459774391|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
128014531|NCT03314935|460678140|FG007|Phase 2|Progressive Disease|0|||
127767270|NCT00918580|459774391|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
127767271|NCT00918580|459774391|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
127767272|NCT00918580|459774391|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
127767273|NCT00477334|459774392|FG000|Overall Study|Discontinued prior to taking study drug|106|||
127767274|NCT00477334|459774393|FG001|Overall Study|Discontinued prior to taking study drug|53|||
127767275|NCT00477334|459774392|FG000|Overall Study|Adverse Event|1|||
127767276|NCT00477334|459774393|FG001|Overall Study|Adverse Event|2|||
127767277|NCT00477334|459774392|FG000|Overall Study|Withdrawal by Subject|2|||
127767278|NCT00477334|459774393|FG001|Overall Study|Withdrawal by Subject|1|||
127767279|NCT00477334|459774392|FG000|Overall Study|Lost to Follow-up|15|||
127767280|NCT00477334|459774393|FG001|Overall Study|Lost to Follow-up|4|||
128014532|NCT03314935|460678141|FG008|Phase 2|Progressive Disease|0|||
128014533|NCT03314935|460678142|FG009|Phase 2|Progressive Disease|1|||
128014534|NCT03314935|460678143|FG010|Phase 2|Progressive Disease|1|||
128014535|NCT03314935|460678144|FG011|Phase 2|Progressive Disease|1|||
128014536|NCT03314935|460678145|FG012|Phase 2|Progressive Disease|2|||
128014537|NCT03314935|460678146|FG013|Phase 2|Progressive Disease|0|||
128014538|NCT03314935|460678147|FG014|Phase 2|Progressive Disease|1|||
127767281|NCT00477334|459774392|FG000|Overall Study|Administrative Problems|39|||
127767282|NCT00477334|459774393|FG001|Overall Study|Administrative Problems|15|||
127767283|NCT00477334|459774392|FG000|Overall Study|Protocol Violation|7|||
127767284|NCT00477334|459774393|FG001|Overall Study|Protocol Violation|1|||
127767285|NCT03587974|459774394|FG000|Overall Study|caregiver demented, care recipient died|3|||
127767286|NCT03587974|459774395|FG001|Overall Study|caregiver demented, care recipient died|3|||
127767287|NCT03587974|459774394|FG000|Overall Study|Withdrawal by Subject|2|||
127767288|NCT03587974|459774395|FG001|Overall Study|Withdrawal by Subject|1|||
127767289|NCT02354508|459774397|FG000|Period 1: Core Phase|Adverse Event|1|||
127767290|NCT02354508|459774398|FG001|Period 1: Core Phase|Adverse Event|1|||
127767291|NCT02354508|459774399|FG002|Period 1: Core Phase|Adverse Event|2|||
127767292|NCT02354508|459774397|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
127767293|NCT02354508|459774398|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
127767294|NCT02354508|459774399|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
127767295|NCT02354508|459774397|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
127767296|NCT02354508|459774398|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
127767297|NCT02354508|459774399|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
127767298|NCT02354508|459774397|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
127767299|NCT02354508|459774398|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
127767300|NCT02354508|459774399|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
127767301|NCT02354508|459774397|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
127767302|NCT02354508|459774398|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
128014539|NCT03314935|460678133|FG000|Phase 2|Study Terminated by Sponsor|0|||
128014540|NCT03314935|460678134|FG001|Phase 2|Study Terminated by Sponsor|0|||
127680393|NCT01212757|459454144|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
127680394|NCT01212757|459454145|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
127680395|NCT01212757|459454146|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
127680396|NCT01212757|459454138|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
127680397|NCT01212757|459454139|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
127680398|NCT01212757|459454140|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
127680399|NCT01212757|459454141|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
127680400|NCT01212757|459454142|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
127680401|NCT01212757|459454143|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
127680402|NCT01212757|459454144|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
127680403|NCT01212757|459454145|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
127680404|NCT01212757|459454146|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
127680405|NCT01212757|459454138|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
127680406|NCT01212757|459454139|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
127680407|NCT01212757|459454140|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
127680408|NCT01212757|459454141|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
127680409|NCT01212757|459454142|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
127680410|NCT01212757|459454143|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
127680411|NCT01212757|459454144|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
127680412|NCT01212757|459454145|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
127680413|NCT01212757|459454146|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
127680414|NCT01212757|459454138|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
127680415|NCT01212757|459454139|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
127680416|NCT01212757|459454140|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
127680417|NCT01212757|459454141|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
127680418|NCT01212757|459454142|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
128014541|NCT03314935|460678135|FG002|Phase 2|Study Terminated by Sponsor|0|||
128014542|NCT03314935|460678136|FG003|Phase 2|Study Terminated by Sponsor|0|||
128014543|NCT03314935|460678137|FG004|Phase 2|Study Terminated by Sponsor|0|||
128014544|NCT03314935|460678138|FG005|Phase 2|Study Terminated by Sponsor|0|||
128014545|NCT03314935|460678139|FG006|Phase 2|Study Terminated by Sponsor|0|||
128014546|NCT03314935|460678140|FG007|Phase 2|Study Terminated by Sponsor|0|||
127680419|NCT01212757|459454143|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
127680420|NCT01212757|459454144|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
127767303|NCT02354508|459774399|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
127767304|NCT02354508|459774397|FG000|Period 2: Extension Phase|Physician Decision|5|||
127767305|NCT02354508|459774398|FG001|Period 2: Extension Phase|Physician Decision|0|||
127767306|NCT02354508|459774399|FG002|Period 2: Extension Phase|Physician Decision|1|||
127767307|NCT02354508|459774397|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
127767308|NCT02354508|459774398|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
127767309|NCT02354508|459774399|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
127767310|NCT02354508|459774397|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
127767311|NCT02354508|459774398|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
127767312|NCT02354508|459774399|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
127767313|NCT02354508|459774397|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
127767314|NCT02354508|459774398|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
127767315|NCT02354508|459774399|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
127767316|NCT03486457|459774402|FG000|Up to Month 3|Adverse Event|2|||
127767317|NCT03486457|459774403|FG001|Up to Month 3|Adverse Event|5|||
127767318|NCT03486457|459774402|FG000|Up to Month 3|Lack of Efficacy|1|||
128014547|NCT03314935|460678141|FG008|Phase 2|Study Terminated by Sponsor|0|||
128014548|NCT03314935|460678142|FG009|Phase 2|Study Terminated by Sponsor|0|||
128014549|NCT03314935|460678143|FG010|Phase 2|Study Terminated by Sponsor|7|||
128014550|NCT03314935|460678144|FG011|Phase 2|Study Terminated by Sponsor|2|||
128014551|NCT03314935|460678145|FG012|Phase 2|Study Terminated by Sponsor|1|||
128014552|NCT03314935|460678146|FG013|Phase 2|Study Terminated by Sponsor|4|||
128014553|NCT03314935|460678147|FG014|Phase 2|Study Terminated by Sponsor|4|||
128014554|NCT03314935|460678133|FG000|Phase 2|Lost to Follow-up|0|||
128014555|NCT03314935|460678134|FG001|Phase 2|Lost to Follow-up|0|||
128014556|NCT03314935|460678135|FG002|Phase 2|Lost to Follow-up|0|||
128014557|NCT03314935|460678136|FG003|Phase 2|Lost to Follow-up|0|||
128014558|NCT03314935|460678137|FG004|Phase 2|Lost to Follow-up|0|||
128014559|NCT03314935|460678138|FG005|Phase 2|Lost to Follow-up|0|||
128014560|NCT03314935|460678139|FG006|Phase 2|Lost to Follow-up|0|||
127680421|NCT01212757|459454145|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
127680422|NCT01212757|459454146|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
127767319|NCT03486457|459774403|FG001|Up to Month 3|Lack of Efficacy|0|||
127767320|NCT03486457|459774402|FG000|Up to Month 3|Withdrawal by Subject|1|||
127767321|NCT03486457|459774403|FG001|Up to Month 3|Withdrawal by Subject|0|||
127767322|NCT03486457|459774402|FG000|Up to Month 3|Failure to Meet Randomization Criteria|2|||
127767323|NCT03486457|459774403|FG001|Up to Month 3|Failure to Meet Randomization Criteria|0|||
127767324|NCT03486457|459774402|FG000|Up to Month 3|Other|1|||
127767325|NCT03486457|459774403|FG001|Up to Month 3|Other|0|||
127767326|NCT03486457|459774402|FG000|Month 3 to Month 6|Adverse Event|2|||
127767327|NCT03486457|459774403|FG001|Month 3 to Month 6|Adverse Event|0|||
127767328|NCT03486457|459774402|FG000|Month 3 to Month 6|Lost to Follow-up|0|||
127767329|NCT03486457|459774403|FG001|Month 3 to Month 6|Lost to Follow-up|1|||
127767330|NCT03486457|459774402|FG000|Month 3 to Month 6|Pregnancy|0|||
127767331|NCT03486457|459774403|FG001|Month 3 to Month 6|Pregnancy|1|||
127767332|NCT03486457|459774402|FG000|Month 3 to Month 6|Other|1|||
127767333|NCT03486457|459774403|FG001|Month 3 to Month 6|Other|0|||
127767334|NCT00372229|459774404|FG000|Study Phase|Graft loss|0|||
127767335|NCT00372229|459774405|FG001|Study Phase|Graft loss|3|||
127767336|NCT00372229|459774404|FG000|Study Phase|Protocol Violation|3|||
127767337|NCT00372229|459774405|FG001|Study Phase|Protocol Violation|4|||
127767338|NCT00372229|459774404|FG000|Study Phase|Consent withdrawn|16|||
127767339|NCT00372229|459774405|FG001|Study Phase|Consent withdrawn|14|||
127767340|NCT00372229|459774404|FG000|Study Phase|Refused treatment/did not cooperate|3|||
127767341|NCT00372229|459774405|FG001|Study Phase|Refused treatment/did not cooperate|1|||
127767342|NCT00372229|459774404|FG000|Study Phase|Death|3|||
127767343|NCT00372229|459774405|FG001|Study Phase|Death|2|||
127767344|NCT00372229|459774404|FG000|Study Phase|Reason not specified|3|||
127767345|NCT00372229|459774405|FG001|Study Phase|Reason not specified|2|||
127767346|NCT00372229|459774404|FG000|Study Phase|Lost to Follow-up|3|||
127767347|NCT00372229|459774405|FG001|Study Phase|Lost to Follow-up|3|||
127767348|NCT00372229|459774404|FG000|Follow-Up Phase|Graft loss|8|||
127767349|NCT00372229|459774405|FG001|Follow-Up Phase|Graft loss|7|||
127767350|NCT00372229|459774404|FG000|Follow-Up Phase|Consent withdrawn|13|||
127680423|NCT01212757|459454138|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
127680424|NCT01212757|459454139|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
127680425|NCT01212757|459454140|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
127680426|NCT01212757|459454141|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
127680427|NCT01212757|459454142|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
127680428|NCT01212757|459454143|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
127680429|NCT01212757|459454144|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
127767351|NCT00372229|459774405|FG001|Follow-Up Phase|Consent withdrawn|19|||
127767352|NCT00372229|459774404|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
127767353|NCT00372229|459774405|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
127767354|NCT00372229|459774404|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
128014561|NCT03314935|460678140|FG007|Phase 2|Lost to Follow-up|0|||
128014562|NCT03314935|460678141|FG008|Phase 2|Lost to Follow-up|0|||
128014563|NCT03314935|460678142|FG009|Phase 2|Lost to Follow-up|1|||
128014564|NCT03314935|460678143|FG010|Phase 2|Lost to Follow-up|0|||
128014565|NCT03314935|460678144|FG011|Phase 2|Lost to Follow-up|0|||
127680430|NCT01212757|459454145|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
127680431|NCT01212757|459454146|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
127680432|NCT01212757|459454138|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
127767355|NCT00372229|459774405|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
127767356|NCT00372229|459774404|FG000|Follow-Up Phase|Death|9|||
127767357|NCT00372229|459774405|FG001|Follow-Up Phase|Death|12|||
127767358|NCT00372229|459774404|FG000|Follow-Up Phase|Administrative|1|||
127767359|NCT00372229|459774405|FG001|Follow-Up Phase|Administrative|0|||
127767360|NCT00372229|459774404|FG000|Follow-Up Phase|Reason not specified|2|||
127767361|NCT00372229|459774405|FG001|Follow-Up Phase|Reason not specified|3|||
127767362|NCT00372229|459774404|FG000|Follow-Up Phase|Lost to Follow-up|12|||
127767363|NCT00372229|459774405|FG001|Follow-Up Phase|Lost to Follow-up|10|||
127767364|NCT00093808|459774406|FG000|Overall Study|Cancel participation before receiving tx|1|||
127767365|NCT00093808|459774406|FG000|Overall Study|Protocol Violation|1|||
127767366|NCT00262951|459774409|FG000|Overall Study|Progressive disease/relapse|3|||
127767367|NCT00262951|459774409|FG000|Overall Study|Adverse Event|7|||
127767368|NCT00262951|459774409|FG000|Overall Study|Death|1|||
127767369|NCT00262951|459774409|FG000|Overall Study|Withdrawal by Subject|1|||
127767370|NCT00262951|459774409|FG000|Overall Study|Alternative treatment|3|||
127767371|NCT00262951|459774409|FG000|Overall Study|Off treatment for other disease|1|||
127767372|NCT01602562|459774412|FG000|Overall Study|Adverse Event|3|||
127767373|NCT01602562|459774413|FG001|Overall Study|Adverse Event|1|||
127767374|NCT01602562|459774412|FG000|Overall Study|Physician Decision|1|||
128014566|NCT03314935|460678145|FG012|Phase 2|Lost to Follow-up|0|||
127680433|NCT01212757|459454139|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
127680434|NCT01212757|459454140|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
127680435|NCT01212757|459454141|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
127680436|NCT01212757|459454142|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
127680437|NCT01212757|459454143|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
127680438|NCT01212757|459454144|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
127680439|NCT01212757|459454145|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
127680440|NCT01212757|459454146|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
127680441|NCT01212757|459454138|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
127680442|NCT01212757|459454139|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
127680443|NCT01212757|459454140|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
127680444|NCT01212757|459454141|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
127680445|NCT01212757|459454142|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
127680446|NCT01212757|459454143|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
127680447|NCT01212757|459454144|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
127680448|NCT01212757|459454145|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
127680449|NCT01212757|459454146|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
127680450|NCT01212757|459454138|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
127680451|NCT01212757|459454139|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
127680452|NCT01212757|459454140|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
127680453|NCT01212757|459454141|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
127680454|NCT01212757|459454142|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
127680455|NCT01212757|459454143|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
127680456|NCT01212757|459454144|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
127680457|NCT01212757|459454145|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
127680458|NCT01212757|459454146|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
127680459|NCT01212757|459454138|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
127680460|NCT01212757|459454139|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
127680461|NCT01212757|459454140|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
127680462|NCT01212757|459454141|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
127680463|NCT01212757|459454142|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
127680464|NCT01212757|459454143|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
127680465|NCT01212757|459454144|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
127680466|NCT01212757|459454145|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
127767375|NCT01602562|459774413|FG001|Overall Study|Physician Decision|1|||
127767376|NCT01602562|459774412|FG000|Overall Study|Withdrawal by Subject|1|||
127767377|NCT01602562|459774413|FG001|Overall Study|Withdrawal by Subject|1|||
128014567|NCT03314935|460678146|FG013|Phase 2|Lost to Follow-up|0|||
128014568|NCT03314935|460678147|FG014|Phase 2|Lost to Follow-up|1|||
128014569|NCT03314935|460678133|FG000|Phase 2|Physician Decision|0|||
128014570|NCT03314935|460678134|FG001|Phase 2|Physician Decision|0|||
128014571|NCT03314935|460678135|FG002|Phase 2|Physician Decision|0|||
128014572|NCT03314935|460678136|FG003|Phase 2|Physician Decision|0|||
127767378|NCT03881553|459774414|FG000|Overall Study|Discharged prior to participation|1|||
127767379|NCT03881553|459774415|FG001|Overall Study|Discharged prior to participation|1|||
128014573|NCT03314935|460678137|FG004|Phase 2|Physician Decision|0|||
128014574|NCT03314935|460678138|FG005|Phase 2|Physician Decision|0|||
127767380|NCT03881553|459774416|FG002|Overall Study|Discharged prior to participation|0|||
127767381|NCT03881553|459774414|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
127767382|NCT03881553|459774415|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
127680467|NCT01212757|459454146|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
127680468|NCT01212757|459454138|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
127680469|NCT01212757|459454139|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
127680470|NCT01212757|459454140|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
127680471|NCT01212757|459454141|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
127680472|NCT01212757|459454142|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
127680473|NCT01212757|459454143|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
127680474|NCT01212757|459454144|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
127680475|NCT01212757|459454145|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
127680476|NCT01212757|459454146|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
127680477|NCT01212757|459454138|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
127680478|NCT01212757|459454139|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
127680479|NCT01212757|459454140|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
127680480|NCT01212757|459454141|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
127680481|NCT01212757|459454142|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
127680482|NCT01212757|459454143|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
127680483|NCT01212757|459454144|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
127680484|NCT01212757|459454145|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
127680485|NCT01212757|459454146|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
127680486|NCT01212757|459454138|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
127680487|NCT01212757|459454139|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
127680488|NCT01212757|459454140|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
127680489|NCT01212757|459454141|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
127680490|NCT01212757|459454142|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
127680491|NCT01212757|459454143|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
127680492|NCT01212757|459454144|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
127680493|NCT01212757|459454145|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
127680494|NCT01212757|459454146|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
127680495|NCT01212757|459454138|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
127680496|NCT01212757|459454139|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
127680497|NCT01212757|459454140|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
127680498|NCT01212757|459454141|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
127680499|NCT01212757|459454142|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
127680500|NCT01212757|459454143|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
127680501|NCT01212757|459454144|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
127680502|NCT01212757|459454145|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
127680503|NCT01212757|459454146|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
127680504|NCT01212757|459454138|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
127680505|NCT01212757|459454139|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
127680506|NCT01212757|459454140|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
127680507|NCT01212757|459454141|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
127680508|NCT01212757|459454142|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
127680509|NCT01212757|459454143|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
127680510|NCT01212757|459454144|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
127680511|NCT01212757|459454145|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
127680512|NCT01212757|459454146|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
127680513|NCT01212757|459454138|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
127680514|NCT01212757|459454139|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
127680515|NCT01212757|459454140|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
127680516|NCT01212757|459454141|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
127680517|NCT01212757|459454142|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
127680518|NCT01212757|459454143|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
127680519|NCT01212757|459454144|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
127680520|NCT01212757|459454145|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
127680521|NCT01212757|459454146|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
127680522|NCT01212757|459454138|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
127680523|NCT01212757|459454139|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
127680524|NCT01212757|459454140|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
127680525|NCT01212757|459454141|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
127680526|NCT01212757|459454142|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
127767383|NCT03881553|459774416|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
127767384|NCT01477333|459774417|FG000|Overall Study|Adverse Event|1|||
127767385|NCT01477333|459774417|FG000|Overall Study|Withdrawal by Subject|1|||
127767386|NCT01477333|459774417|FG000|Overall Study|Clinical Deterioration|1|||
127767387|NCT03801915|459774422|FG000|Overall Study|Screen failure|0|||
127767388|NCT03801915|459774423|FG001|Overall Study|Screen failure|0|||
127767389|NCT03801915|459774424|FG002|Overall Study|Screen failure|1|||
127767390|NCT03801915|459774422|FG000|Overall Study|Ineligible|1|||
127767391|NCT03801915|459774423|FG001|Overall Study|Ineligible|0|||
127767392|NCT03801915|459774424|FG002|Overall Study|Ineligible|0|||
127767393|NCT03801915|459774422|FG000|Overall Study|Physician Decision|2|||
127767394|NCT03801915|459774423|FG001|Overall Study|Physician Decision|1|||
127767395|NCT03801915|459774424|FG002|Overall Study|Physician Decision|0|||
127767396|NCT01211288|459774427|FG000|Overall Study|Lost to Follow-up|1|||
127767397|NCT01211288|459774428|FG001|Overall Study|Lost to Follow-up|1|||
127767398|NCT03333837|459774430|FG000|Overall Study|Adverse Event|2|||
127767399|NCT03333837|459774431|FG001|Overall Study|Adverse Event|1|||
127767400|NCT03333837|459774432|FG002|Overall Study|Adverse Event|1|||
127767401|NCT03333837|459774433|FG003|Overall Study|Adverse Event|1|||
128014575|NCT03314935|460678139|FG006|Phase 2|Physician Decision|0|||
127767402|NCT03333837|459774434|FG004|Overall Study|Adverse Event|0|||
127767403|NCT03333837|459774430|FG000|Overall Study|Caregiver withdrew|0|||
127767404|NCT03333837|459774431|FG001|Overall Study|Caregiver withdrew|2|||
127767405|NCT03333837|459774432|FG002|Overall Study|Caregiver withdrew|1|||
127767406|NCT03333837|459774433|FG003|Overall Study|Caregiver withdrew|0|||
127767407|NCT03333837|459774434|FG004|Overall Study|Caregiver withdrew|0|||
127767408|NCT03333837|459774430|FG000|Overall Study|Withdrawal by Subject|0|||
127767409|NCT03333837|459774431|FG001|Overall Study|Withdrawal by Subject|0|||
127767410|NCT03333837|459774432|FG002|Overall Study|Withdrawal by Subject|1|||
127767411|NCT03333837|459774433|FG003|Overall Study|Withdrawal by Subject|1|||
127767412|NCT03333837|459774434|FG004|Overall Study|Withdrawal by Subject|3|||
127767413|NCT03333837|459774430|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
127767414|NCT03333837|459774431|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
127767415|NCT03333837|459774432|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
127767416|NCT03333837|459774433|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
127767417|NCT03333837|459774434|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
127767418|NCT04217590|459774436|FG000|Overall Study|Other|1|||
127767419|NCT04217590|459774437|FG001|Overall Study|Other|1|||
127767420|NCT04217590|459774436|FG000|Overall Study|Withdrawal by Subject|3|||
127767421|NCT04217590|459774437|FG001|Overall Study|Withdrawal by Subject|1|||
127767422|NCT04217590|459774436|FG000|Overall Study|Death|0|||
127767423|NCT04217590|459774437|FG001|Overall Study|Death|1|||
127767424|NCT02003573|459774449|FG000|Overall Study|Progressive disease|2|||
127767425|NCT02003573|459774450|FG001|Overall Study|Progressive disease|0|||
127767426|NCT02003573|459774451|FG002|Overall Study|Progressive disease|1|||
127767427|NCT02003573|459774449|FG000|Overall Study|Other Adverse event|0|||
127767428|NCT02003573|459774450|FG001|Overall Study|Other Adverse event|1|||
127767429|NCT02003573|459774451|FG002|Overall Study|Other Adverse event|1|||
127767430|NCT02003573|459774449|FG000|Overall Study|Refuse to take trial medication|0|||
127767431|NCT02003573|459774450|FG001|Overall Study|Refuse to take trial medication|1|||
127767432|NCT02003573|459774451|FG002|Overall Study|Refuse to take trial medication|1|||
127767433|NCT02003573|459774449|FG000|Overall Study|Other than specified|1|||
127767434|NCT02003573|459774450|FG001|Overall Study|Other than specified|2|||
127767435|NCT02003573|459774451|FG002|Overall Study|Other than specified|3|||
127767436|NCT02112708|459774454|FG000|Baseline|Physician Decision|16|||
127767437|NCT02112708|459774455|FG001|Baseline|Physician Decision|11|||
127680527|NCT01212757|459454143|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
127680528|NCT01212757|459454144|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
127680529|NCT01212757|459454145|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
127680530|NCT01212757|459454146|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
127680531|NCT01212757|459454138|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
127680532|NCT01212757|459454139|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
127680533|NCT01212757|459454140|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
127680534|NCT01212757|459454141|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
127680535|NCT01212757|459454142|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
127680536|NCT01212757|459454143|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
127680537|NCT01212757|459454144|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
127680538|NCT01212757|459454145|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
127767438|NCT02112708|459774454|FG000|Baseline|Lost to Follow-up|12|||
127767439|NCT02112708|459774455|FG001|Baseline|Lost to Follow-up|0|||
127767440|NCT02112708|459774454|FG000|4 Month|Death|0|||
127767441|NCT02112708|459774455|FG001|4 Month|Death|1|||
127767442|NCT02112708|459774454|FG000|4 Month|Withdrawal by Subject|12|||
127767443|NCT02112708|459774455|FG001|4 Month|Withdrawal by Subject|0|||
128014576|NCT03314935|460678140|FG007|Phase 2|Physician Decision|0|||
127767444|NCT00928018|459774460|FG000|Overall Study|Withdrawal by Subject|1|||
127767445|NCT00928018|459774461|FG001|Overall Study|Withdrawal by Subject|0|||
127767446|NCT00126503|459774462|FG000|Overall Study|disease progression|23|||
127767447|NCT00126503|459774463|FG001|Overall Study|disease progression|14|||
127767448|NCT00126503|459774462|FG000|Overall Study|Withdrawal by Subject|0|||
127680539|NCT01212757|459454146|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
127680540|NCT01212757|459454138|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
128014577|NCT03314935|460678141|FG008|Phase 2|Physician Decision|0|||
128014578|NCT03314935|460678142|FG009|Phase 2|Physician Decision|0|||
128014579|NCT03314935|460678143|FG010|Phase 2|Physician Decision|1|||
128014580|NCT03314935|460678144|FG011|Phase 2|Physician Decision|0|||
128014581|NCT03314935|460678145|FG012|Phase 2|Physician Decision|0|||
128014582|NCT03314935|460678146|FG013|Phase 2|Physician Decision|0|||
128014583|NCT03314935|460678147|FG014|Phase 2|Physician Decision|0|||
128014584|NCT05845619|460678148|FG000|Overall Study|duplicate enrollment|2|||
128014585|NCT05845619|460678149|FG001|Overall Study|duplicate enrollment|2|||
128014586|NCT05845619|460678150|FG002|Overall Study|duplicate enrollment|1|||
128014587|NCT03636477|460678154|FG000|Overall Study|Adverse Event|0|||
128014588|NCT03636477|460678155|FG001|Overall Study|Adverse Event|0|||
128014589|NCT03636477|460678156|FG002|Overall Study|Adverse Event|1|||
128014590|NCT03621592|460678157|FG000|Overall Study|Lost to Follow-up|1|||
128014591|NCT03621592|460678158|FG001|Overall Study|Lost to Follow-up|0|||
128014592|NCT03621592|460678157|FG000|Overall Study|Lack of Improvement|1|||
128014593|NCT03621592|460678158|FG001|Overall Study|Lack of Improvement|0|||
128014594|NCT03621592|460678157|FG000|Overall Study|Preference to receive wound care closer to home|1|||
128014595|NCT03621592|460678158|FG001|Overall Study|Preference to receive wound care closer to home|0|||
128014596|NCT03621592|460678157|FG000|Overall Study|Lack of healing|0|||
128014597|NCT03621592|460678158|FG001|Overall Study|Lack of healing|2|||
128014598|NCT02382380|460678160|FG000|Overall Study|Withdrawal by Subject|2|||
128014599|NCT02382380|460678161|FG001|Overall Study|Withdrawal by Subject|2|||
128014600|NCT02382380|460678160|FG000|Overall Study|Lost to Follow-up|0|||
128014601|NCT02382380|460678161|FG001|Overall Study|Lost to Follow-up|1|||
128014602|NCT05168800|460678162|FG000|Time 1 Survey|Did not start T1 survey|182|||
128014603|NCT05168800|460678163|FG001|Time 1 Survey|Did not start T1 survey|150|||
128014604|NCT05168800|460678164|FG002|Time 1 Survey|Did not start T1 survey|140|||
128014605|NCT05168800|460678162|FG000|Time 1 Survey|Completed T1 survey outside window|18|||
128014606|NCT05168800|460678163|FG001|Time 1 Survey|Completed T1 survey outside window|21|||
128014607|NCT05168800|460678164|FG002|Time 1 Survey|Completed T1 survey outside window|13|||
127680541|NCT01212757|459454139|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
127680542|NCT01212757|459454140|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
127680543|NCT01212757|459454141|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
127680544|NCT01212757|459454142|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
127680545|NCT01212757|459454143|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
127680546|NCT01212757|459454144|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
127680547|NCT01212757|459454145|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
127680548|NCT01212757|459454146|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
127680549|NCT01212757|459454138|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
127680550|NCT01212757|459454139|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
127680551|NCT01212757|459454140|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
127680552|NCT01212757|459454141|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
127680553|NCT01212757|459454142|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
127680554|NCT01212757|459454143|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
127680555|NCT01212757|459454144|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
127680556|NCT01212757|459454145|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
127680557|NCT01212757|459454146|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
127680558|NCT01212757|459454138|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
127680559|NCT01212757|459454139|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
127680560|NCT01212757|459454140|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
127680561|NCT01212757|459454141|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
127680562|NCT01212757|459454142|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
127680563|NCT01212757|459454143|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
127680564|NCT01212757|459454144|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
127680565|NCT01212757|459454145|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
127680566|NCT01212757|459454146|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
127680567|NCT01212757|459454138|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
127680568|NCT01212757|459454139|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
127680569|NCT01212757|459454140|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
127680570|NCT01212757|459454141|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
127680571|NCT01212757|459454142|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
127680572|NCT01212757|459454143|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
127680573|NCT01212757|459454144|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
127680574|NCT01212757|459454145|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
127680575|NCT01212757|459454146|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
128014608|NCT05168800|460678162|FG000|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
128014609|NCT05168800|460678163|FG001|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|6|||
128014610|NCT05168800|460678164|FG002|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
127680576|NCT01212757|459454138|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
128014611|NCT05168800|460678162|FG000|Time 1 Survey|Failed verification, did not start Time 1 survey|221|||
128014612|NCT05168800|460678163|FG001|Time 1 Survey|Failed verification, did not start Time 1 survey|200|||
128014613|NCT05168800|460678164|FG002|Time 1 Survey|Failed verification, did not start Time 1 survey|220|||
128014614|NCT05168800|460678162|FG000|Time 1 Survey|Failed verification, did complete time 1 survey|23|||
128014615|NCT05168800|460678163|FG001|Time 1 Survey|Failed verification, did complete time 1 survey|24|||
128014616|NCT05168800|460678164|FG002|Time 1 Survey|Failed verification, did complete time 1 survey|16|||
128014617|NCT05168800|460678162|FG000|Time 1 Survey|Withdrawal by Subject|6|||
128014618|NCT05168800|460678163|FG001|Time 1 Survey|Withdrawal by Subject|3|||
128014619|NCT05168800|460678164|FG002|Time 1 Survey|Withdrawal by Subject|2|||
128014620|NCT05168800|460678162|FG000|Time 2 Survey|Already excluded at Time 1|228|||
128014621|NCT05168800|460678163|FG001|Time 2 Survey|Already excluded at Time 1|202|||
128014622|NCT05168800|460678164|FG002|Time 2 Survey|Already excluded at Time 1|173|||
128014623|NCT05168800|460678162|FG000|Time 2 Survey|Did not start Time 2 survey|31|||
128014624|NCT05168800|460678163|FG001|Time 2 Survey|Did not start Time 2 survey|26|||
128014625|NCT05168800|460678164|FG002|Time 2 Survey|Did not start Time 2 survey|45|||
128014626|NCT05168800|460678162|FG000|Time 2 Survey|Completed Time 2 survey outside window|10|||
128014627|NCT05168800|460678163|FG001|Time 2 Survey|Completed Time 2 survey outside window|15|||
128014628|NCT05168800|460678164|FG002|Time 2 Survey|Completed Time 2 survey outside window|9|||
128014629|NCT05168800|460678162|FG000|Time 2 Survey|Missing primary outcome data at Time 2|0|||
128014630|NCT05168800|460678163|FG001|Time 2 Survey|Missing primary outcome data at Time 2|1|||
128014631|NCT05168800|460678164|FG002|Time 2 Survey|Missing primary outcome data at Time 2|1|||
128014632|NCT05168800|460678162|FG000|Time 2 Survey|Withdrawal by Subject|1|||
128014633|NCT05168800|460678163|FG001|Time 2 Survey|Withdrawal by Subject|0|||
128014634|NCT05168800|460678164|FG002|Time 2 Survey|Withdrawal by Subject|1|||
128014635|NCT05168800|460678162|FG000|Time 3 Survey|Already excluded at Time 1|228|||
128014636|NCT05168800|460678163|FG001|Time 3 Survey|Already excluded at Time 1|200|||
128014637|NCT05168800|460678164|FG002|Time 3 Survey|Already excluded at Time 1|173|||
128014638|NCT05168800|460678162|FG000|Time 3 Survey|Did not start Time 3 survey|48|||
128014639|NCT05168800|460678163|FG001|Time 3 Survey|Did not start Time 3 survey|48|||
128014640|NCT05168800|460678164|FG002|Time 3 Survey|Did not start Time 3 survey|51|||
128014641|NCT05168800|460678162|FG000|Time 3 Survey|Completed Time 3 survey outside window|1|||
128014642|NCT05168800|460678163|FG001|Time 3 Survey|Completed Time 3 survey outside window|6|||
128014643|NCT05168800|460678164|FG002|Time 3 Survey|Completed Time 3 survey outside window|8|||
128014644|NCT05168800|460678162|FG000|Time 3 Survey|Missing primary outcome data at Time 3|0|||
128014645|NCT05168800|460678163|FG001|Time 3 Survey|Missing primary outcome data at Time 3|1|||
128014646|NCT05168800|460678164|FG002|Time 3 Survey|Missing primary outcome data at Time 3|0|||
128014647|NCT04556097|460678165|FG000|Overall Study|Death|0|||
128014648|NCT04556097|460678166|FG001|Overall Study|Death|5|||
128014649|NCT04556097|460678167|FG002|Overall Study|Death|0|||
128014650|NCT04556097|460678168|FG003|Overall Study|Death|0|||
128014651|NCT04556097|460678165|FG000|Overall Study|No caregiver|43|||
128014652|NCT04556097|460678166|FG001|Overall Study|No caregiver|53|||
128014653|NCT04556097|460678167|FG002|Overall Study|No caregiver|0|||
128014654|NCT04556097|460678168|FG003|Overall Study|No caregiver|0|||
128014655|NCT04556097|460678165|FG000|Overall Study|Ineligible, SNF|2|||
128014656|NCT04556097|460678166|FG001|Overall Study|Ineligible, SNF|2|||
128014657|NCT04556097|460678167|FG002|Overall Study|Ineligible, SNF|0|||
128014658|NCT04556097|460678168|FG003|Overall Study|Ineligible, SNF|0|||
128014659|NCT04556097|460678165|FG000|Overall Study|Ineligible, health|3|||
128014660|NCT04556097|460678166|FG001|Overall Study|Ineligible, health|4|||
128014661|NCT04556097|460678167|FG002|Overall Study|Ineligible, health|0|||
128014662|NCT04556097|460678168|FG003|Overall Study|Ineligible, health|0|||
128014663|NCT04556097|460678165|FG000|Overall Study|Ineligible, language|0|||
128014664|NCT04556097|460678166|FG001|Overall Study|Ineligible, language|1|||
128014665|NCT04556097|460678167|FG002|Overall Study|Ineligible, language|0|||
128014666|NCT04556097|460678168|FG003|Overall Study|Ineligible, language|0|||
128014667|NCT04556097|460678165|FG000|Overall Study|Ineligible, no longer in care management|0|||
128014668|NCT04556097|460678166|FG001|Overall Study|Ineligible, no longer in care management|2|||
127767449|NCT00126503|459774463|FG001|Overall Study|Withdrawal by Subject|1|||
127767450|NCT00126503|459774462|FG000|Overall Study|alternative therapy|1|||
127767451|NCT00126503|459774463|FG001|Overall Study|alternative therapy|1|||
127767452|NCT00126503|459774462|FG000|Overall Study|other complicating disease|4|||
127767453|NCT00126503|459774463|FG001|Overall Study|other complicating disease|1|||
127767454|NCT00126503|459774462|FG000|Overall Study|Death|3|||
127767455|NCT00126503|459774463|FG001|Overall Study|Death|0|||
128014669|NCT04556097|460678167|FG002|Overall Study|Ineligible, no longer in care management|1|||
128014670|NCT04556097|460678168|FG003|Overall Study|Ineligible, no longer in care management|0|||
128014671|NCT04556097|460678165|FG000|Overall Study|No dementia|13|||
128014672|NCT04556097|460678166|FG001|Overall Study|No dementia|3|||
128014673|NCT04556097|460678167|FG002|Overall Study|No dementia|0|||
128014674|NCT04556097|460678168|FG003|Overall Study|No dementia|0|||
128014675|NCT04556097|460678165|FG000|Overall Study|Missing identifier|2|||
128014676|NCT04556097|460678166|FG001|Overall Study|Missing identifier|4|||
127767456|NCT00126503|459774462|FG000|Overall Study|Adverse Event|13|||
128014677|NCT04556097|460678167|FG002|Overall Study|Missing identifier|0|||
128014678|NCT04556097|460678168|FG003|Overall Study|Missing identifier|0|||
128014679|NCT04556097|460678165|FG000|Overall Study|Did not have at least 1 member month in pre and post period|17|||
128014680|NCT04556097|460678166|FG001|Overall Study|Did not have at least 1 member month in pre and post period|8|||
128014681|NCT04556097|460678167|FG002|Overall Study|Did not have at least 1 member month in pre and post period|0|||
128014682|NCT04556097|460678168|FG003|Overall Study|Did not have at least 1 member month in pre and post period|0|||
128014683|NCT02516241|460678169|FG000|Overall Study|Death|255|||
128014684|NCT02516241|460678170|FG001|Overall Study|Death|262|||
128014685|NCT02516241|460678171|FG002|Overall Study|Death|270|||
128014686|NCT02516241|460678169|FG000|Overall Study|Lost to Follow-up|1|||
128014687|NCT02516241|460678170|FG001|Overall Study|Lost to Follow-up|1|||
128014688|NCT02516241|460678171|FG002|Overall Study|Lost to Follow-up|3|||
128014689|NCT02516241|460678169|FG000|Overall Study|Withdrawal by Subject|2|||
128014690|NCT02516241|460678170|FG001|Overall Study|Withdrawal by Subject|7|||
128014691|NCT02516241|460678171|FG002|Overall Study|Withdrawal by Subject|12|||
128014692|NCT02516241|460678169|FG000|Overall Study|participants ongoing at data cut-off|84|||
128014693|NCT02516241|460678170|FG001|Overall Study|participants ongoing at data cut-off|76|||
128014694|NCT02516241|460678171|FG002|Overall Study|participants ongoing at data cut-off|59|||
128014702|NCT00724945|460678173|FG000|Period 1|non-compliance|1|||
128014703|NCT00724945|460678174|FG001|Period 1|non-compliance|0|||
128014704|NCT00724945|460678173|FG000|Period 1|Adverse Event|1|||
128014705|NCT00724945|460678174|FG001|Period 1|Adverse Event|1|||
128014706|NCT00724945|460678173|FG000|Period 1|Lost to Follow-up|1|||
128014707|NCT00724945|460678174|FG001|Period 1|Lost to Follow-up|0|||
128014708|NCT00724945|460678173|FG000|Period 2|lens comfort issue|3|||
128014709|NCT00724945|460678174|FG001|Period 2|lens comfort issue|0|||
128014710|NCT00724945|460678173|FG000|Period 2|lens physiology issue|1|||
127767457|NCT00126503|459774463|FG001|Overall Study|Adverse Event|3|||
127767458|NCT00126503|459774462|FG000|Overall Study|non-compliant|1|||
127767459|NCT00126503|459774463|FG001|Overall Study|non-compliant|0|||
127767460|NCT00126503|459774462|FG000|Overall Study|Physician Decision|2|||
127767461|NCT00126503|459774463|FG001|Overall Study|Physician Decision|1|||
127767462|NCT02457559|459774464|FG000|Overall Study|Progressive Disease|1|||
127767463|NCT02457559|459774465|FG001|Overall Study|Progressive Disease|2|||
127767464|NCT02457559|459774466|FG002|Overall Study|Progressive Disease|3|||
127767465|NCT02457559|459774467|FG003|Overall Study|Progressive Disease|0|||
127767466|NCT02457559|459774468|FG004|Overall Study|Progressive Disease|0|||
127767467|NCT02457559|459774469|FG005|Overall Study|Progressive Disease|2|||
127767468|NCT02457559|459774470|FG006|Overall Study|Progressive Disease|1|||
127767469|NCT02457559|459774471|FG007|Overall Study|Progressive Disease|0|||
127767470|NCT02457559|459774472|FG008|Overall Study|Progressive Disease|1|||
127767471|NCT02457559|459774473|FG009|Overall Study|Progressive Disease|1|||
127767472|NCT02457559|459774474|FG010|Overall Study|Progressive Disease|1|||
127767473|NCT02457559|459774464|FG000|Overall Study|Investigator's Discretion|0|||
127767474|NCT02457559|459774465|FG001|Overall Study|Investigator's Discretion|0|||
127767475|NCT02457559|459774466|FG002|Overall Study|Investigator's Discretion|2|||
127767476|NCT02457559|459774467|FG003|Overall Study|Investigator's Discretion|0|||
127767477|NCT02457559|459774468|FG004|Overall Study|Investigator's Discretion|1|||
127767478|NCT02457559|459774469|FG005|Overall Study|Investigator's Discretion|0|||
128014711|NCT00724945|460678174|FG001|Period 2|lens physiology issue|0|||
127767479|NCT02457559|459774470|FG006|Overall Study|Investigator's Discretion|1|||
127767480|NCT02457559|459774471|FG007|Overall Study|Investigator's Discretion|0|||
127767481|NCT02457559|459774472|FG008|Overall Study|Investigator's Discretion|1|||
127680577|NCT01212757|459454139|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
127680578|NCT01212757|459454140|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
127680579|NCT01212757|459454141|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
127680580|NCT01212757|459454142|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
127680581|NCT01212757|459454143|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
127680582|NCT01212757|459454144|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
127680583|NCT01212757|459454145|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
128014712|NCT03069989|460678178|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
128014713|NCT03069989|460678179|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
128014714|NCT00620542|460679763|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
128014715|NCT00620542|460679764|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
128014716|NCT00620542|460679765|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
128014717|NCT00620542|460679766|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
128014718|NCT00620542|460679763|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
128014719|NCT00620542|460679764|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
128014720|NCT00620542|460679765|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
128014721|NCT00620542|460679766|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
128014722|NCT00620542|460679763|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
128014723|NCT00620542|460679764|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
128014724|NCT00620542|460679765|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
128014725|NCT00620542|460679766|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
128014726|NCT00620542|460679763|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
128014727|NCT00620542|460679764|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
128014728|NCT00620542|460679765|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
128014729|NCT00620542|460679766|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
128014730|NCT00620542|460679763|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
128014731|NCT00620542|460679764|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
128014732|NCT00620542|460679765|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
128014733|NCT00620542|460679766|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
128014734|NCT00620542|460679763|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
128014735|NCT00620542|460679764|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
128014736|NCT00620542|460679765|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
128014737|NCT00620542|460679766|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
128014738|NCT00620542|460679763|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
128014739|NCT00620542|460679764|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
128014740|NCT00620542|460679765|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
128014741|NCT00620542|460679766|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
128014742|NCT00620542|460679763|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
128014743|NCT00620542|460679764|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
128014744|NCT00620542|460679765|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
128014745|NCT00620542|460679766|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
128014746|NCT00620542|460679763|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
128014747|NCT00620542|460679764|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
128014748|NCT00620542|460679765|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
127680584|NCT01212757|459454146|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
127680585|NCT01212757|459454138|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
128014749|NCT00620542|460679766|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
128014750|NCT00620542|460679763|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
128014751|NCT00620542|460679764|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
128014752|NCT00620542|460679765|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
127680586|NCT01212757|459454139|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
127680587|NCT01212757|459454140|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
127680588|NCT01212757|459454141|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
127680589|NCT01212757|459454142|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
127680590|NCT01212757|459454143|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
127680591|NCT01212757|459454144|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
127680592|NCT01212757|459454145|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
127680593|NCT01212757|459454146|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
127680594|NCT01212757|459454138|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
127680595|NCT01212757|459454139|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
127680596|NCT01212757|459454140|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
127680597|NCT01212757|459454141|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
127680598|NCT01212757|459454142|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
127680599|NCT01212757|459454143|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
127680600|NCT01212757|459454144|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
127680601|NCT01212757|459454145|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
127680602|NCT01212757|459454146|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
127680603|NCT01212757|459454138|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
127680604|NCT01212757|459454139|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
127680605|NCT01212757|459454140|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
127767482|NCT02457559|459774473|FG009|Overall Study|Investigator's Discretion|0|||
127767483|NCT02457559|459774474|FG010|Overall Study|Investigator's Discretion|1|||
127767484|NCT02457559|459774464|FG000|Overall Study|Adverse Event|0|||
127767485|NCT02457559|459774465|FG001|Overall Study|Adverse Event|1|||
127767486|NCT02457559|459774466|FG002|Overall Study|Adverse Event|2|||
127767487|NCT02457559|459774467|FG003|Overall Study|Adverse Event|0|||
127767488|NCT02457559|459774468|FG004|Overall Study|Adverse Event|0|||
127767489|NCT02457559|459774469|FG005|Overall Study|Adverse Event|0|||
127680606|NCT01212757|459454141|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
127680607|NCT01212757|459454142|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
127680608|NCT01212757|459454143|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
127680609|NCT01212757|459454144|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
127680610|NCT01212757|459454145|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
127680611|NCT01212757|459454146|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
127767490|NCT02457559|459774470|FG006|Overall Study|Adverse Event|0|||
127767491|NCT02457559|459774471|FG007|Overall Study|Adverse Event|0|||
127767492|NCT02457559|459774472|FG008|Overall Study|Adverse Event|0|||
127767493|NCT02457559|459774473|FG009|Overall Study|Adverse Event|0|||
127767494|NCT02457559|459774474|FG010|Overall Study|Adverse Event|0|||
127767495|NCT02457559|459774464|FG000|Overall Study|Reason not Specified|1|||
127767496|NCT02457559|459774465|FG001|Overall Study|Reason not Specified|0|||
127767497|NCT02457559|459774466|FG002|Overall Study|Reason not Specified|0|||
127767498|NCT02457559|459774467|FG003|Overall Study|Reason not Specified|0|||
127767499|NCT02457559|459774468|FG004|Overall Study|Reason not Specified|0|||
127767500|NCT02457559|459774469|FG005|Overall Study|Reason not Specified|0|||
127767501|NCT02457559|459774470|FG006|Overall Study|Reason not Specified|0|||
127767502|NCT02457559|459774471|FG007|Overall Study|Reason not Specified|0|||
127767503|NCT02457559|459774472|FG008|Overall Study|Reason not Specified|0|||
127767504|NCT02457559|459774473|FG009|Overall Study|Reason not Specified|2|||
127767505|NCT02457559|459774474|FG010|Overall Study|Reason not Specified|0|||
127767506|NCT02457559|459774464|FG000|Overall Study|Death|0|||
127767507|NCT02457559|459774465|FG001|Overall Study|Death|0|||
127767508|NCT02457559|459774466|FG002|Overall Study|Death|0|||
127767509|NCT02457559|459774467|FG003|Overall Study|Death|0|||
127767510|NCT02457559|459774468|FG004|Overall Study|Death|0|||
127767511|NCT02457559|459774469|FG005|Overall Study|Death|0|||
127767512|NCT02457559|459774470|FG006|Overall Study|Death|0|||
127767513|NCT02457559|459774471|FG007|Overall Study|Death|0|||
127767514|NCT02457559|459774472|FG008|Overall Study|Death|1|||
127767515|NCT02457559|459774473|FG009|Overall Study|Death|1|||
127767516|NCT02457559|459774474|FG010|Overall Study|Death|0|||
127767517|NCT00998335|459774477|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
127767518|NCT00998335|459774478|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
128014753|NCT00620542|460679766|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
128014754|NCT00620542|460679763|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
128014755|NCT00620542|460679764|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
128014756|NCT00620542|460679765|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
128014757|NCT00620542|460679766|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
128014758|NCT00620542|460679763|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
127680612|NCT01212757|459454138|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
127680613|NCT01212757|459454139|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
127680614|NCT01212757|459454140|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
127680615|NCT01212757|459454141|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
127767519|NCT00790751|459774479|FG000|Overall Study|Protocol non-compliance|16|||
127767520|NCT00790751|459774480|FG001|Overall Study|Protocol non-compliance|16|||
127767521|NCT00790751|459774481|FG002|Overall Study|Protocol non-compliance|10|||
127767522|NCT00790751|459774482|FG003|Overall Study|Protocol non-compliance|11|||
127767523|NCT00790751|459774479|FG000|Overall Study|Lost to Follow-up|4|||
127767524|NCT00790751|459774480|FG001|Overall Study|Lost to Follow-up|9|||
128014759|NCT00620542|460679764|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
128014760|NCT00620542|460679765|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
127680616|NCT01212757|459454142|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
127767525|NCT00790751|459774481|FG002|Overall Study|Lost to Follow-up|4|||
127767526|NCT00790751|459774482|FG003|Overall Study|Lost to Follow-up|5|||
127767527|NCT00790751|459774479|FG000|Overall Study|Adverse Event|5|||
127767528|NCT00790751|459774480|FG001|Overall Study|Adverse Event|3|||
127767529|NCT00790751|459774481|FG002|Overall Study|Adverse Event|5|||
127767530|NCT00790751|459774482|FG003|Overall Study|Adverse Event|4|||
127767531|NCT00790751|459774479|FG000|Overall Study|Requirement for restricted medication|0|||
127767532|NCT00790751|459774480|FG001|Overall Study|Requirement for restricted medication|2|||
127767533|NCT00790751|459774481|FG002|Overall Study|Requirement for restricted medication|0|||
127767534|NCT00790751|459774482|FG003|Overall Study|Requirement for restricted medication|0|||
127767535|NCT00790751|459774479|FG000|Overall Study|Death|0|||
127767536|NCT00790751|459774480|FG001|Overall Study|Death|0|||
127767537|NCT00790751|459774481|FG002|Overall Study|Death|1|||
127767538|NCT00790751|459774482|FG003|Overall Study|Death|0|||
127767539|NCT00790751|459774479|FG000|Overall Study|Physician Decision|0|||
128014761|NCT00620542|460679766|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
128014762|NCT00620542|460679763|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
128014763|NCT00620542|460679764|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
128014764|NCT00620542|460679765|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
128014765|NCT00620542|460679766|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
127767540|NCT00790751|459774480|FG001|Overall Study|Physician Decision|0|||
127767541|NCT00790751|459774481|FG002|Overall Study|Physician Decision|0|||
127767542|NCT00790751|459774482|FG003|Overall Study|Physician Decision|1|||
127767543|NCT05330312|459774483|FG000|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
127767544|NCT05330312|459774484|FG001|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
127767545|NCT05330312|459774485|FG002|Pilot Investigation - Part 1|Withdrawal by Subject|1|||
127767546|NCT05330312|459774483|FG000|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
127767547|NCT05330312|459774484|FG001|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
127767548|NCT05330312|459774485|FG002|Pivotal Investigation - Part 2|Lost to Follow-up|0|||
127767549|NCT05330312|459774483|FG000|Pivotal Investigation - Part 2|Withdrawal by Subject|5|||
127767550|NCT05330312|459774484|FG001|Pivotal Investigation - Part 2|Withdrawal by Subject|2|||
127767551|NCT05330312|459774485|FG002|Pivotal Investigation - Part 2|Withdrawal by Subject|0|||
127767552|NCT05330312|459774483|FG000|Pivotal Investigation - Part 2|Death|1|||
127767553|NCT05330312|459774484|FG001|Pivotal Investigation - Part 2|Death|4|||
127767554|NCT05330312|459774485|FG002|Pivotal Investigation - Part 2|Death|0|||
127767555|NCT01078454|459774488|FG000|Overall Study|Adverse Event|1|||
127767556|NCT01078454|459774489|FG001|Overall Study|Adverse Event|1|||
127767557|NCT01078454|459774488|FG000|Overall Study|Death|0|||
127767558|NCT01078454|459774489|FG001|Overall Study|Death|1|||
127767559|NCT01775124|459774496|FG000|Core Period|Disease Progression|0|||
127767560|NCT01775124|459774497|FG001|Core Period|Disease Progression|1|||
127767561|NCT01775124|459774496|FG000|Core Period|Physician Decision|1|||
127767562|NCT01775124|459774497|FG001|Core Period|Physician Decision|1|||
127767563|NCT01775124|459774496|FG000|Core Period|Death|0|||
127767564|NCT01775124|459774497|FG001|Core Period|Death|1|||
127767565|NCT01775124|459774496|FG000|Core Period|Administrative problems|1|||
127767566|NCT01775124|459774497|FG001|Core Period|Administrative problems|0|||
128014766|NCT00620542|460679763|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
128014767|NCT00620542|460679764|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
128014768|NCT00620542|460679765|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
128014769|NCT00620542|460679766|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
128014770|NCT00620542|460679763|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
128014771|NCT00620542|460679764|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
128014772|NCT00620542|460679765|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
128014773|NCT00620542|460679766|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
128014774|NCT01348269|460679767|FG000|Follow-up (Until Week 12)|Surgical intervention - not study related|1|||
128014775|NCT01348269|460679768|FG001|Follow-up (Until Week 12)|Surgical intervention - not study related|0|||
128014776|NCT01348269|460679767|FG000|Follow-up (Until Week 12)|Subsequent follow-up treatment required|0|||
128014777|NCT01348269|460679768|FG001|Follow-up (Until Week 12)|Subsequent follow-up treatment required|1|||
127767567|NCT01775124|459774496|FG000|Core Period|Withdrawal by Subject|4|||
127767568|NCT01775124|459774497|FG001|Core Period|Withdrawal by Subject|2|||
127767569|NCT01775124|459774496|FG000|Core Period|Adverse Event|5|||
127767570|NCT01775124|459774497|FG001|Core Period|Adverse Event|5|||
127767571|NCT01775124|459774496|FG000|Extension Period|Adverse Event|3|||
127767572|NCT01775124|459774497|FG001|Extension Period|Adverse Event|2|||
127767573|NCT01775124|459774496|FG000|Extension Period|Physician Decision|0|||
127767574|NCT01775124|459774497|FG001|Extension Period|Physician Decision|2|||
127767575|NCT01775124|459774496|FG000|Extension Period|Administrative problems|0|||
127767576|NCT01775124|459774497|FG001|Extension Period|Administrative problems|1|||
128014778|NCT01348269|460679767|FG000|Follow-up (Until Week 12)|Adverse Event|1|||
128014779|NCT01348269|460679768|FG001|Follow-up (Until Week 12)|Adverse Event|0|||
128014780|NCT04727749|460679769|FG000|Overall Study|Lost to Follow-up|10|||
128014781|NCT04727749|460679770|FG001|Overall Study|Lost to Follow-up|3|||
128014782|NCT03575364|460679771|FG000|Overall Study|Death|45|||
128014783|NCT03575364|460679771|FG000|Overall Study|Lost to Follow-up|114|||
127767577|NCT01775124|459774496|FG000|Extension Period|Lost to Follow-up|0|||
127767578|NCT01775124|459774497|FG001|Extension Period|Lost to Follow-up|1|||
127767579|NCT01775124|459774496|FG000|Extension Period|Withdrawal by Subject|9|||
127767580|NCT01775124|459774497|FG001|Extension Period|Withdrawal by Subject|12|||
127767581|NCT00346268|459776570|FG000|Overall Study|Adverse Event|1|||
127767582|NCT00346268|459776571|FG001|Overall Study|Adverse Event|0|||
127767583|NCT00346268|459776570|FG000|Overall Study|Protocol Violation|1|||
127767584|NCT00346268|459776571|FG001|Overall Study|Protocol Violation|0|||
127767585|NCT00346268|459776570|FG000|Overall Study|Participant refused|0|||
127767586|NCT00346268|459776571|FG001|Overall Study|Participant refused|3|||
127767587|NCT02502097|459776576|FG000|Period 1|Adverse Event|0|||
127767588|NCT02502097|459776577|FG001|Period 1|Adverse Event|0|||
127767589|NCT02502097|459776578|FG002|Period 1|Adverse Event|1|||
127767590|NCT02502097|459776579|FG003|Period 1|Adverse Event|0|||
127767591|NCT02502097|459776576|FG000|Wash Out Period|Adverse Event|0|||
127767592|NCT02502097|459776577|FG001|Wash Out Period|Adverse Event|1|||
127767593|NCT02502097|459776578|FG002|Wash Out Period|Adverse Event|1|||
127767594|NCT02502097|459776579|FG003|Wash Out Period|Adverse Event|1|||
127767595|NCT02502097|459776576|FG000|Period 2|Adverse Event|0|||
127767596|NCT02502097|459776577|FG001|Period 2|Adverse Event|0|||
127767597|NCT02502097|459776578|FG002|Period 2|Adverse Event|1|||
127767598|NCT02502097|459776579|FG003|Period 2|Adverse Event|0|||
127767599|NCT02186223|459776580|FG000|Overall Study|Not eligible for device placement|6|||
127767600|NCT02186223|459776580|FG000|Overall Study|Unable to obtain femoral access|3|||
127767601|NCT02186223|459776580|FG000|Overall Study|Death|3|||
127767602|NCT02186223|459776580|FG000|Overall Study|Device in place less than 48 hours|9|||
127767603|NCT01201317|459776581|FG000|Overall Study|Withdrawal by Subject|5|||
127767604|NCT01201317|459776582|FG001|Overall Study|Withdrawal by Subject|0|||
127767605|NCT01201317|459776583|FG002|Overall Study|Withdrawal by Subject|3|||
127767606|NCT01201317|459776581|FG000|Overall Study|Adverse Event|2|||
127767607|NCT01201317|459776582|FG001|Overall Study|Adverse Event|2|||
128014784|NCT03575364|460679771|FG000|Overall Study|Withdrawal by Subject|21|||
128014785|NCT03575364|460679771|FG000|Overall Study|Physician Decision|11|||
128014786|NCT03575364|460679771|FG000|Overall Study|Subject Refused Follow-up|13|||
127767608|NCT01201317|459776583|FG002|Overall Study|Adverse Event|2|||
127767609|NCT01201317|459776581|FG000|Overall Study|Screen failure|1|||
127767610|NCT01201317|459776582|FG001|Overall Study|Screen failure|1|||
127767611|NCT01201317|459776583|FG002|Overall Study|Screen failure|0|||
127767612|NCT01201317|459776581|FG000|Overall Study|Protocol Violation|0|||
127767613|NCT01201317|459776582|FG001|Overall Study|Protocol Violation|1|||
127767614|NCT01201317|459776583|FG002|Overall Study|Protocol Violation|1|||
127767615|NCT01201317|459776581|FG000|Overall Study|Death|0|||
127767616|NCT01201317|459776582|FG001|Overall Study|Death|1|||
127767617|NCT01201317|459776583|FG002|Overall Study|Death|0|||
127767618|NCT01201317|459776581|FG000|Overall Study|Study-specific withdrawal criteria|0|||
127767619|NCT01201317|459776582|FG001|Overall Study|Study-specific withdrawal criteria|0|||
127767620|NCT01201317|459776583|FG002|Overall Study|Study-specific withdrawal criteria|1|||
127767621|NCT01201317|459776581|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
127767622|NCT01201317|459776582|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
127767623|NCT01201317|459776583|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
127767624|NCT01201317|459776581|FG000|Overall Study|Decrease in renal function|0|||
127767625|NCT01201317|459776582|FG001|Overall Study|Decrease in renal function|1|||
127767626|NCT01201317|459776583|FG002|Overall Study|Decrease in renal function|0|||
127767627|NCT01201317|459776581|FG000|Overall Study|Lack of Efficacy|1|||
127767628|NCT01201317|459776582|FG001|Overall Study|Lack of Efficacy|0|||
127767629|NCT01201317|459776583|FG002|Overall Study|Lack of Efficacy|0|||
127767630|NCT01201317|459776581|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
127767631|NCT01201317|459776582|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
127767632|NCT01201317|459776583|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
127767633|NCT00252733|459776584|FG000|Overall Study|Withdrawal by Subject|73|||
127767634|NCT00252733|459776585|FG001|Overall Study|Withdrawal by Subject|67|||
127767635|NCT00252733|459776584|FG000|Overall Study|Death|7|||
127767636|NCT00252733|459776585|FG001|Overall Study|Death|5|||
127767637|NCT00252733|459776584|FG000|Overall Study|Lost to Follow-up|12|||
127767638|NCT00252733|459776585|FG001|Overall Study|Lost to Follow-up|6|||
127767639|NCT00252733|459776584|FG000|Overall Study|Multiple Reasons|14|||
127767640|NCT00252733|459776585|FG001|Overall Study|Multiple Reasons|14|||
127767641|NCT01491672|459776586|FG000|Overall Study|Lost to Follow-up|0|||
127767642|NCT01491672|459776587|FG001|Overall Study|Lost to Follow-up|4|||
127767643|NCT01491672|459776588|FG002|Overall Study|Lost to Follow-up|1|||
127767644|NCT01491672|459776586|FG000|Overall Study|Withdrawal by Subject|6|||
127767645|NCT01491672|459776587|FG001|Overall Study|Withdrawal by Subject|7|||
127767646|NCT01491672|459776588|FG002|Overall Study|Withdrawal by Subject|0|||
127767647|NCT01491672|459776586|FG000|Overall Study|Adverse Event|8|||
127767648|NCT01491672|459776587|FG001|Overall Study|Adverse Event|10|||
127767649|NCT01491672|459776588|FG002|Overall Study|Adverse Event|4|||
127767650|NCT01491672|459776586|FG000|Overall Study|Disease progression|42|||
127767651|NCT01491672|459776587|FG001|Overall Study|Disease progression|34|||
127767652|NCT01491672|459776588|FG002|Overall Study|Disease progression|6|||
127767653|NCT01491672|459776586|FG000|Overall Study|Protocol deviation|0|||
127767654|NCT01491672|459776587|FG001|Overall Study|Protocol deviation|1|||
127767655|NCT01491672|459776588|FG002|Overall Study|Protocol deviation|0|||
127767656|NCT01491672|459776586|FG000|Overall Study|Death|0|||
127767657|NCT01491672|459776587|FG001|Overall Study|Death|4|||
127767658|NCT01491672|459776588|FG002|Overall Study|Death|0|||
127767659|NCT00706433|459776594|FG000|Overall Study|Lost to Follow-up|3|||
127767660|NCT00706433|459776595|FG001|Overall Study|Lost to Follow-up|1|||
127767661|NCT00706433|459776596|FG002|Overall Study|Lost to Follow-up|6|||
127767662|NCT00706433|459776597|FG003|Overall Study|Lost to Follow-up|0|||
127767663|NCT00706433|459776594|FG000|Overall Study|Withdrawal by Subject|1|||
127767664|NCT00706433|459776595|FG001|Overall Study|Withdrawal by Subject|2|||
127767665|NCT00706433|459776596|FG002|Overall Study|Withdrawal by Subject|3|||
127767666|NCT00706433|459776597|FG003|Overall Study|Withdrawal by Subject|1|||
127767667|NCT00706433|459776594|FG000|Overall Study|Adverse Event|0|||
127767668|NCT00706433|459776595|FG001|Overall Study|Adverse Event|0|||
127767669|NCT00706433|459776596|FG002|Overall Study|Adverse Event|1|||
127767670|NCT00706433|459776597|FG003|Overall Study|Adverse Event|0|||
127767671|NCT00706433|459776594|FG000|Overall Study|Protocol Violation|1|||
127767672|NCT00706433|459776595|FG001|Overall Study|Protocol Violation|0|||
127767673|NCT00706433|459776596|FG002|Overall Study|Protocol Violation|0|||
128014787|NCT03575364|460679771|FG000|Overall Study|Hospital Administration decision, Research department closed|6|||
128014788|NCT03575364|460679771|FG000|Overall Study|Patient moved out of the state|1|||
128014789|NCT03575364|460679771|FG000|Overall Study|Patient no longer has insurance, will not return to clinic.|1|||
128014790|NCT03575364|460679771|FG000|Overall Study|Patient is lost to follow up|1|||
128014791|NCT03575364|460679771|FG000|Overall Study|Patient was unable to get to the clinic due to health problems and transportation difficulties|1|||
128014792|NCT01697579|460679772|FG000|Base Study-Cycle 1|Adverse Event|1|||
127767674|NCT00706433|459776597|FG003|Overall Study|Protocol Violation|0|||
127767675|NCT00706433|459776594|FG000|Overall Study|new job|0|||
127767676|NCT00706433|459776595|FG001|Overall Study|new job|0|||
127767677|NCT00706433|459776596|FG002|Overall Study|new job|0|||
127767678|NCT00706433|459776597|FG003|Overall Study|new job|1|||
127767679|NCT01236365|459776598|FG000|Overall Study|Lost to Follow-up|0|||
128014793|NCT01697579|460679773|FG001|Base Study-Cycle 1|Adverse Event|0|||
128014794|NCT01697579|460679774|FG002|Base Study-Cycle 1|Adverse Event|0|||
128014795|NCT01697579|460679775|FG003|Base Study-Cycle 1|Adverse Event|0|||
128014796|NCT01697579|460679776|FG004|Base Study-Cycle 1|Adverse Event|0|||
128014797|NCT01697579|460679777|FG005|Base Study-Cycle 1|Adverse Event|0|||
128014798|NCT01697579|460679778|FG006|Base Study-Cycle 1|Adverse Event|0|||
127680617|NCT01212757|459454143|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
127680618|NCT01212757|459454144|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
127680619|NCT01212757|459454145|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
127680620|NCT01212757|459454146|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
127680621|NCT02812966|459454147|FG000|Overall Study|Death|1|||
127680622|NCT02812966|459454148|FG001|Overall Study|Death|0|||
127680623|NCT00708032|459456435|FG000|Overall Study|Adverse Event|0|||
127680624|NCT00708032|459456436|FG001|Overall Study|Adverse Event|2|||
127680625|NCT00708032|459456435|FG000|Overall Study|Lost to Follow-up|1|||
127680626|NCT00708032|459456436|FG001|Overall Study|Lost to Follow-up|2|||
127680627|NCT00708032|459456435|FG000|Overall Study|Pregnancy|0|||
127680628|NCT00708032|459456436|FG001|Overall Study|Pregnancy|1|||
127680629|NCT00708032|459456435|FG000|Overall Study|Poor vision|0|||
127680630|NCT00708032|459456436|FG001|Overall Study|Poor vision|6|||
127680631|NCT00708032|459456435|FG000|Overall Study|Visit out of range at month 12|4|||
127680632|NCT00708032|459456436|FG001|Overall Study|Visit out of range at month 12|1|||
127680633|NCT00708032|459456435|FG000|Overall Study|Did not meet protocol criteria|1|||
127680634|NCT00708032|459456436|FG001|Overall Study|Did not meet protocol criteria|2|||
127680635|NCT00708032|459456435|FG000|Overall Study|Protocol Violation|4|||
127680636|NCT00708032|459456436|FG001|Overall Study|Protocol Violation|1|||
127680637|NCT00708032|459456435|FG000|Overall Study|Withdrawal by Subject|0|||
127680638|NCT00708032|459456436|FG001|Overall Study|Withdrawal by Subject|1|||
127680639|NCT01400776|459456437|FG000|Overall Study|Adverse Event|7|||
127680640|NCT01400776|459456438|FG001|Overall Study|Adverse Event|2|||
127680641|NCT01400776|459456439|FG002|Overall Study|Adverse Event|9|||
127680642|NCT01400776|459456440|FG003|Overall Study|Adverse Event|2|||
127680643|NCT01400776|459456437|FG000|Overall Study|Lost to Follow-up|1|||
127680644|NCT01400776|459456438|FG001|Overall Study|Lost to Follow-up|0|||
127680645|NCT01400776|459456439|FG002|Overall Study|Lost to Follow-up|4|||
127680646|NCT01400776|459456440|FG003|Overall Study|Lost to Follow-up|1|||
127680647|NCT01400776|459456437|FG000|Overall Study|Withdrew Consent|4|||
127680648|NCT01400776|459456438|FG001|Overall Study|Withdrew Consent|2|||
127680649|NCT01400776|459456439|FG002|Overall Study|Withdrew Consent|6|||
127680650|NCT01400776|459456440|FG003|Overall Study|Withdrew Consent|1|||
127680651|NCT01400776|459456437|FG000|Overall Study|Protocol Deviation|6|||
127680652|NCT01400776|459456438|FG001|Overall Study|Protocol Deviation|1|||
127680653|NCT01400776|459456439|FG002|Overall Study|Protocol Deviation|5|||
127680654|NCT01400776|459456440|FG003|Overall Study|Protocol Deviation|2|||
127680655|NCT01400776|459456437|FG000|Overall Study|Reason not Specified|3|||
127680656|NCT01400776|459456438|FG001|Overall Study|Reason not Specified|0|||
127680657|NCT01400776|459456439|FG002|Overall Study|Reason not Specified|4|||
127680658|NCT01400776|459456440|FG003|Overall Study|Reason not Specified|3|||
127767680|NCT01236365|459776599|FG001|Overall Study|Lost to Follow-up|2|||
127767681|NCT01236365|459776598|FG000|Overall Study|Moved Out of State|1|||
127680659|NCT02320123|459456442|FG000|Overall Study|Lost to Follow-up|4|||
127680660|NCT02320123|459456443|FG001|Overall Study|Lost to Follow-up|6|||
127680661|NCT02320123|459456442|FG000|Overall Study|Death|6|||
127680662|NCT02320123|459456443|FG001|Overall Study|Death|5|||
127767682|NCT01236365|459776599|FG001|Overall Study|Moved Out of State|0|||
128014799|NCT01697579|460679772|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
128014800|NCT01697579|460679773|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
128014801|NCT01697579|460679774|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
128014802|NCT01697579|460679775|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
128014803|NCT01697579|460679776|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
128014804|NCT01697579|460679777|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
128014805|NCT01697579|460679778|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
127680663|NCT02477670|459456450|FG000|Stage 1|Adverse Event|2|||
127680664|NCT02477670|459456451|FG001|Stage 1|Adverse Event|7|||
127680665|NCT02477670|459456452|FG002|Stage 1|Adverse Event|0|||
127680666|NCT02477670|459456453|FG003|Stage 1|Adverse Event|0|||
127680667|NCT02477670|459456454|FG004|Stage 1|Adverse Event|0|||
127680668|NCT02477670|459456455|FG005|Stage 1|Adverse Event|0|||
127680669|NCT02477670|459456456|FG006|Stage 1|Adverse Event|0|||
127680670|NCT02477670|459456450|FG000|Stage 1|Lost to Follow-up|0|||
127680671|NCT02477670|459456451|FG001|Stage 1|Lost to Follow-up|2|||
127680672|NCT02477670|459456452|FG002|Stage 1|Lost to Follow-up|0|||
127680673|NCT02477670|459456453|FG003|Stage 1|Lost to Follow-up|0|||
127680674|NCT02477670|459456454|FG004|Stage 1|Lost to Follow-up|0|||
127680675|NCT02477670|459456455|FG005|Stage 1|Lost to Follow-up|0|||
127680676|NCT02477670|459456456|FG006|Stage 1|Lost to Follow-up|0|||
127680677|NCT02477670|459456450|FG000|Stage 1|Withdrawal by Subject|1|||
127680678|NCT02477670|459456451|FG001|Stage 1|Withdrawal by Subject|2|||
127680679|NCT02477670|459456452|FG002|Stage 1|Withdrawal by Subject|0|||
127680680|NCT02477670|459456453|FG003|Stage 1|Withdrawal by Subject|0|||
127680681|NCT02477670|459456454|FG004|Stage 1|Withdrawal by Subject|0|||
127680682|NCT02477670|459456455|FG005|Stage 1|Withdrawal by Subject|0|||
127680683|NCT02477670|459456456|FG006|Stage 1|Withdrawal by Subject|0|||
127680684|NCT02477670|459456450|FG000|Stage 1|Non-compliance with Study Drug|1|||
127680685|NCT02477670|459456451|FG001|Stage 1|Non-compliance with Study Drug|2|||
127680686|NCT02477670|459456452|FG002|Stage 1|Non-compliance with Study Drug|0|||
127680687|NCT02477670|459456453|FG003|Stage 1|Non-compliance with Study Drug|0|||
127680688|NCT02477670|459456454|FG004|Stage 1|Non-compliance with Study Drug|0|||
127680689|NCT02477670|459456455|FG005|Stage 1|Non-compliance with Study Drug|0|||
127680690|NCT02477670|459456456|FG006|Stage 1|Non-compliance with Study Drug|0|||
127680691|NCT02477670|459456450|FG000|Stage 2|Adverse Event|0|||
127680692|NCT02477670|459456451|FG001|Stage 2|Adverse Event|0|||
127680693|NCT02477670|459456452|FG002|Stage 2|Adverse Event|1|||
127680694|NCT02477670|459456453|FG003|Stage 2|Adverse Event|0|||
127680695|NCT02477670|459456454|FG004|Stage 2|Adverse Event|0|||
127680696|NCT02477670|459456455|FG005|Stage 2|Adverse Event|0|||
127680697|NCT02477670|459456456|FG006|Stage 2|Adverse Event|0|||
127680698|NCT02477670|459456450|FG000|Stage 2|Antipsychotic Medication Changed|0|||
127680699|NCT02477670|459456451|FG001|Stage 2|Antipsychotic Medication Changed|0|||
127680700|NCT02477670|459456452|FG002|Stage 2|Antipsychotic Medication Changed|1|||
127680701|NCT02477670|459456453|FG003|Stage 2|Antipsychotic Medication Changed|0|||
127680702|NCT02477670|459456454|FG004|Stage 2|Antipsychotic Medication Changed|0|||
127680703|NCT02477670|459456455|FG005|Stage 2|Antipsychotic Medication Changed|0|||
127680704|NCT02477670|459456456|FG006|Stage 2|Antipsychotic Medication Changed|0|||
127680705|NCT02477670|459456450|FG000|Stage 2|Withdrawal by Subject|0|||
127680706|NCT02477670|459456451|FG001|Stage 2|Withdrawal by Subject|0|||
127680707|NCT02477670|459456452|FG002|Stage 2|Withdrawal by Subject|0|||
127680708|NCT02477670|459456453|FG003|Stage 2|Withdrawal by Subject|1|||
127680709|NCT02477670|459456454|FG004|Stage 2|Withdrawal by Subject|0|||
127680710|NCT02477670|459456455|FG005|Stage 2|Withdrawal by Subject|0|||
127680711|NCT02477670|459456456|FG006|Stage 2|Withdrawal by Subject|0|||
127680712|NCT00446550|459456458|FG000|Overall Study|Adverse Event|1|||
127680713|NCT00446550|459456459|FG001|Overall Study|Adverse Event|0|||
127680714|NCT02937831|459456460|FG000|Overall Study|Protocol Violation|4|||
127680715|NCT02983617|459456461|FG000|Overall Study|Adverse Event|0|||
127680716|NCT02983617|459456462|FG001|Overall Study|Adverse Event|7|||
127680717|NCT02983617|459456461|FG000|Overall Study|Death|0|||
127680718|NCT02983617|459456462|FG001|Overall Study|Death|1|||
127680719|NCT02983617|459456461|FG000|Overall Study|Investigator's Discretion|0|||
127680720|NCT02983617|459456462|FG001|Overall Study|Investigator's Discretion|1|||
128014806|NCT01697579|460679772|FG000|Base Study-Cycle 1|Protocol Violation|0|||
128014807|NCT01697579|460679773|FG001|Base Study-Cycle 1|Protocol Violation|0|||
127680721|NCT03720210|459456467|FG000|Overall Study|Lost to Follow-up|1|||
127680722|NCT00114244|459456468|FG000|Overall Study|Adverse Event|2|||
127680723|NCT00114244|459456469|FG001|Overall Study|Adverse Event|5|||
127680724|NCT00114244|459456468|FG000|Overall Study|Withdrawal by Subject|0|||
127680725|NCT00114244|459456469|FG001|Overall Study|Withdrawal by Subject|2|||
127680726|NCT02698891|459456470|FG000|Overall Study|Withdrawal by Subject|2|||
127680727|NCT02698891|459456470|FG000|Overall Study|deemed ineligible|1|||
127680728|NCT02698891|459456470|FG000|Overall Study|Adverse Event|9|||
127680729|NCT00711958|459456471|FG000|Overall Study|Withdrawal by Subject|6|||
127680730|NCT00711958|459456472|FG001|Overall Study|Withdrawal by Subject|8|||
127680731|NCT00711958|459456471|FG000|Overall Study|Lack of Efficacy|3|||
127680732|NCT00711958|459456472|FG001|Overall Study|Lack of Efficacy|1|||
127680733|NCT00711958|459456471|FG000|Overall Study|Clinical deterioration|1|||
128014808|NCT01697579|460679774|FG002|Base Study-Cycle 1|Protocol Violation|0|||
128014809|NCT01697579|460679775|FG003|Base Study-Cycle 1|Protocol Violation|0|||
128014810|NCT01697579|460679776|FG004|Base Study-Cycle 1|Protocol Violation|3|||
128014811|NCT01697579|460679777|FG005|Base Study-Cycle 1|Protocol Violation|0|||
128014812|NCT01697579|460679778|FG006|Base Study-Cycle 1|Protocol Violation|0|||
128014813|NCT01697579|460679772|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
128014814|NCT01697579|460679773|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
128014815|NCT01697579|460679774|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
128014816|NCT01697579|460679775|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
128014817|NCT01697579|460679776|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
128014818|NCT01697579|460679777|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
128014819|NCT01697579|460679778|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
128014820|NCT01697579|460679772|FG000|Base Study-Cycle 1|Technical Problems|0|||
128014821|NCT01697579|460679773|FG001|Base Study-Cycle 1|Technical Problems|0|||
128014822|NCT01697579|460679774|FG002|Base Study-Cycle 1|Technical Problems|1|||
128014823|NCT01697579|460679775|FG003|Base Study-Cycle 1|Technical Problems|1|||
128014824|NCT01697579|460679776|FG004|Base Study-Cycle 1|Technical Problems|0|||
128014825|NCT01697579|460679777|FG005|Base Study-Cycle 1|Technical Problems|0|||
128014826|NCT01697579|460679778|FG006|Base Study-Cycle 1|Technical Problems|0|||
128014827|NCT01697579|460679772|FG000|Optional Extension-Cycles 2-6|Death|0|||
128014828|NCT01697579|460679773|FG001|Optional Extension-Cycles 2-6|Death|0|||
128014829|NCT01697579|460679774|FG002|Optional Extension-Cycles 2-6|Death|0|||
128014830|NCT01697579|460679775|FG003|Optional Extension-Cycles 2-6|Death|0|||
128014831|NCT01697579|460679776|FG004|Optional Extension-Cycles 2-6|Death|0|||
128014832|NCT01697579|460679777|FG005|Optional Extension-Cycles 2-6|Death|0|||
128014833|NCT01697579|460679778|FG006|Optional Extension-Cycles 2-6|Death|2|||
128014834|NCT01697579|460679772|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
128014835|NCT01697579|460679773|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
128014836|NCT01697579|460679774|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
128014837|NCT01697579|460679775|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
128014838|NCT01697579|460679776|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
128014839|NCT01697579|460679777|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
128014840|NCT01697579|460679778|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
128014841|NCT01697579|460679772|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
128014842|NCT01697579|460679773|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
128014843|NCT01697579|460679774|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
128014844|NCT01697579|460679775|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
128014845|NCT01697579|460679776|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
128014846|NCT01697579|460679777|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
128014847|NCT01697579|460679778|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
128014848|NCT01697579|460679772|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
127680734|NCT00711958|459456472|FG001|Overall Study|Clinical deterioration|0|||
127680735|NCT00711958|459456471|FG000|Overall Study|Adverse Event|9|||
127680736|NCT00711958|459456472|FG001|Overall Study|Adverse Event|7|||
127680737|NCT00711958|459456471|FG000|Overall Study|Protocol Violation|1|||
128014849|NCT01697579|460679773|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
128014850|NCT01697579|460679774|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
128014851|NCT01697579|460679775|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
128014852|NCT01697579|460679776|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
128014853|NCT01697579|460679777|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
128014854|NCT01697579|460679778|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
128014855|NCT01697579|460679772|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
128014856|NCT01697579|460679773|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
128014857|NCT01697579|460679774|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
127680738|NCT00711958|459456472|FG001|Overall Study|Protocol Violation|0|||
127680739|NCT00711958|459456471|FG000|Overall Study|Lost to Follow-up|2|||
127680740|NCT00711958|459456472|FG001|Overall Study|Lost to Follow-up|2|||
127680741|NCT00711958|459456471|FG000|Overall Study|Death|10|||
127680742|NCT00711958|459456472|FG001|Overall Study|Death|5|||
127680743|NCT00711958|459456471|FG000|Overall Study|Progression of disease|1|||
127680744|NCT00711958|459456472|FG001|Overall Study|Progression of disease|0|||
128014858|NCT01697579|460679775|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
128014859|NCT01697579|460679776|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
128014860|NCT01697579|460679777|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
128014861|NCT01697579|460679778|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
128014862|NCT01697579|460679772|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
127680745|NCT02694978|459456475|FG000|Overall Study|Adverse Event|10|||
127680746|NCT02694978|459456476|FG001|Overall Study|Adverse Event|9|||
127680747|NCT02694978|459456475|FG000|Overall Study|Withdrawal by Subject|22|||
127680748|NCT02694978|459456476|FG001|Overall Study|Withdrawal by Subject|19|||
128014863|NCT01697579|460679773|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
128014864|NCT01697579|460679774|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
128014865|NCT01697579|460679775|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
127680749|NCT02694978|459456475|FG000|Overall Study|Lost to Follow-up|14|||
127680750|NCT02694978|459456476|FG001|Overall Study|Lost to Follow-up|17|||
127680751|NCT02694978|459456475|FG000|Overall Study|Death|4|||
127680752|NCT02694978|459456476|FG001|Overall Study|Death|1|||
127680753|NCT02694978|459456475|FG000|Overall Study|Other-Decision of Participant|6|||
127680754|NCT02694978|459456476|FG001|Overall Study|Other-Decision of Participant|1|||
127680755|NCT02694978|459456475|FG000|Overall Study|Other-Investigator's decision|1|||
127680756|NCT02694978|459456476|FG001|Overall Study|Other-Investigator's decision|0|||
127680757|NCT02694978|459456475|FG000|Overall Study|Other-Unable to be reached|0|||
127680758|NCT02694978|459456476|FG001|Overall Study|Other-Unable to be reached|1|||
127680759|NCT02694978|459456475|FG000|Overall Study|Other-Protocol noncompliant|2|||
127680760|NCT02694978|459456476|FG001|Overall Study|Other-Protocol noncompliant|1|||
127680761|NCT02694978|459456475|FG000|Overall Study|Other-Personal reasons|3|||
127680762|NCT02694978|459456476|FG001|Overall Study|Other-Personal reasons|3|||
127680763|NCT02694978|459456475|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
127680764|NCT02694978|459456476|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
127680765|NCT01613716|459456477|FG000|Overall Study|screen failures|3|||
127680766|NCT01613716|459456477|FG000|Overall Study|Lost to Follow-up|4|||
127680767|NCT00818454|459456478|FG000|Treatment Period 1|Adverse Event|0|||
127680768|NCT00818454|459456479|FG001|Treatment Period 1|Adverse Event|1|||
127680769|NCT00818454|459456480|FG002|Treatment Period 1|Adverse Event|0|||
127680770|NCT00818454|459456481|FG003|Treatment Period 1|Adverse Event|0|||
127680771|NCT00818454|459456478|FG000|Treatment Period 1|Other|3|||
127680772|NCT00818454|459456479|FG001|Treatment Period 1|Other|0|||
127680773|NCT00818454|459456480|FG002|Treatment Period 1|Other|0|||
127680774|NCT00818454|459456481|FG003|Treatment Period 1|Other|0|||
127680775|NCT00818454|459456478|FG000|Washout Period of 1 Week|Adverse Event|1|||
127680776|NCT00818454|459456479|FG001|Washout Period of 1 Week|Adverse Event|1|||
127680777|NCT00818454|459456480|FG002|Washout Period of 1 Week|Adverse Event|0|||
127680778|NCT00818454|459456481|FG003|Washout Period of 1 Week|Adverse Event|0|||
127680779|NCT00818454|459456478|FG000|Washout Period of 1 Week|Protocol Violation|2|||
127680780|NCT00818454|459456479|FG001|Washout Period of 1 Week|Protocol Violation|0|||
127680781|NCT00818454|459456480|FG002|Washout Period of 1 Week|Protocol Violation|0|||
127680782|NCT00818454|459456481|FG003|Washout Period of 1 Week|Protocol Violation|0|||
127680783|NCT00818454|459456478|FG000|Washout Period of 1 Week|Other|1|||
127680784|NCT00818454|459456479|FG001|Washout Period of 1 Week|Other|2|||
127680785|NCT00818454|459456480|FG002|Washout Period of 1 Week|Other|0|||
127680786|NCT00818454|459456481|FG003|Washout Period of 1 Week|Other|0|||
127680787|NCT00818454|459456478|FG000|Treatment Period 2|Other|2|||
127680788|NCT00818454|459456479|FG001|Treatment Period 2|Other|1|||
127680789|NCT00818454|459456480|FG002|Treatment Period 2|Other|0|||
127680790|NCT00818454|459456481|FG003|Treatment Period 2|Other|0|||
127680791|NCT00818454|459456478|FG000|Treatment Period 3|Adverse Event|0|||
127680792|NCT00818454|459456479|FG001|Treatment Period 3|Adverse Event|0|||
127680793|NCT00818454|459456480|FG002|Treatment Period 3|Adverse Event|0|||
127680794|NCT00818454|459456481|FG003|Treatment Period 3|Adverse Event|1|||
127680795|NCT01171625|459456483|FG000|Overall Study|On-Protocol|67|||
127680796|NCT01171625|459456483|FG000|Overall Study|Death|38|||
127680797|NCT01171625|459456483|FG000|Overall Study|Withdrawal by Subject|31|||
127680798|NCT01171625|459456483|FG000|Overall Study|Explanted|10|||
127680799|NCT01171625|459456483|FG000|Overall Study|Lost to Follow-up|5|||
127680800|NCT01171625|459456483|FG000|Overall Study|Patient received valve-in-valve|3|||
127680801|NCT01171625|459456483|FG000|Overall Study|Other|1|||
127680802|NCT01171625|459456483|FG000|Overall Study|Consented but did not receive device|25|||
127680803|NCT05174013|459456490|FG000|Overall Study|Lost to Follow-up|0|||
127680804|NCT05174013|459456491|FG001|Overall Study|Lost to Follow-up|0|||
127680805|NCT05174013|459456492|FG002|Overall Study|Lost to Follow-up|0|||
127680806|NCT05174013|459456493|FG003|Overall Study|Lost to Follow-up|1|||
127680807|NCT05174013|459456494|FG004|Overall Study|Lost to Follow-up|0|||
127680808|NCT05174013|459456495|FG005|Overall Study|Lost to Follow-up|0|||
127680809|NCT05174013|459456490|FG000|Overall Study|Withdrawal by Subject|0|||
127680810|NCT05174013|459456491|FG001|Overall Study|Withdrawal by Subject|0|||
128014866|NCT01697579|460679776|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
127680811|NCT05174013|459456492|FG002|Overall Study|Withdrawal by Subject|1|||
127680812|NCT05174013|459456493|FG003|Overall Study|Withdrawal by Subject|0|||
127680813|NCT05174013|459456494|FG004|Overall Study|Withdrawal by Subject|0|||
127680814|NCT05174013|459456495|FG005|Overall Study|Withdrawal by Subject|0|||
127680815|NCT03287622|459456496|FG000|Overall Study|Withdrawal by Subject|1|||
127680816|NCT03287622|459456497|FG001|Overall Study|Withdrawal by Subject|0|||
127680817|NCT03287622|459456496|FG000|Overall Study|Lost to Follow-up|27|||
127680818|NCT03287622|459456497|FG001|Overall Study|Lost to Follow-up|15|||
127680819|NCT03287622|459456496|FG000|Overall Study|No prescripion after surgery|28|||
127680820|NCT03287622|459456497|FG001|Overall Study|No prescripion after surgery|31|||
128014867|NCT01697579|460679777|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
128014868|NCT01697579|460679778|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
128014869|NCT01697579|460679772|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
128014870|NCT01697579|460679773|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
128014871|NCT01697579|460679774|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
128014872|NCT01697579|460679775|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
128014873|NCT01697579|460679776|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
128014874|NCT01697579|460679777|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
128014875|NCT01697579|460679778|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
128014876|NCT01697579|460679772|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
128014877|NCT01697579|460679773|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
128014878|NCT01697579|460679774|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
128014879|NCT01697579|460679775|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
128014880|NCT01697579|460679776|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
128014881|NCT01697579|460679777|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
128014882|NCT01697579|460679778|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
128014883|NCT01697579|460679772|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
128014884|NCT01697579|460679773|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
128014885|NCT01697579|460679774|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
128014886|NCT01697579|460679775|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
128014887|NCT01697579|460679776|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
128014888|NCT01697579|460679777|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
127767683|NCT01236365|459776598|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
127767684|NCT01236365|459776599|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
127767685|NCT00717067|459776600|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
127767686|NCT00717067|459776601|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
127767687|NCT00717067|459776602|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
127767688|NCT00717067|459776603|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
127767689|NCT00717067|459776604|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
127767690|NCT01689337|459776605|FG000|Overall Study|Study Discontinuation|1|||
127767691|NCT00824161|459776606|FG000|Overall Study|Withdrawal by Subject|1|||
127767692|NCT00824161|459776606|FG000|Overall Study|Screen Failure|1|||
127767693|NCT04882995|459776607|FG000|Overall Study|Withdrawal by Subject|1|||
127767694|NCT04882995|459776608|FG001|Overall Study|Withdrawal by Subject|2|||
127767695|NCT04882995|459776607|FG000|Overall Study|Protocol Violation|4|||
127767696|NCT04882995|459776608|FG001|Overall Study|Protocol Violation|4|||
127767697|NCT04882995|459776607|FG000|Overall Study|Surgery postponed due to COVID|1|||
127767698|NCT04882995|459776608|FG001|Overall Study|Surgery postponed due to COVID|1|||
127767699|NCT02572882|459776609|FG000|Overall Study|Withdrawal by Subject|1|||
127767700|NCT02572882|459776609|FG000|Overall Study|Participant received kidney transplant|1|||
127767701|NCT04371198|459776613|FG000|Overall Study|inadequate sample|4|||
127767702|NCT03536143|459776614|FG000|Overall Study|Early termination, Sponsor decision|1|||
127767703|NCT04754477|459776615|FG000|Overall Study|Withdrawal by Subject|1|||
127767704|NCT01347762|459776616|FG000|Overall Study|Lost to Follow-up|0|||
127767705|NCT01347762|459776617|FG001|Overall Study|Lost to Follow-up|1|||
127767706|NCT01347762|459776618|FG002|Overall Study|Lost to Follow-up|6|||
127767707|NCT01347762|459776619|FG003|Overall Study|Lost to Follow-up|5|||
127767708|NCT01347762|459776616|FG000|Overall Study|Withdrawal by Subject|4|||
127767709|NCT01347762|459776617|FG001|Overall Study|Withdrawal by Subject|1|||
127767710|NCT01347762|459776618|FG002|Overall Study|Withdrawal by Subject|3|||
127767711|NCT01347762|459776619|FG003|Overall Study|Withdrawal by Subject|3|||
127767712|NCT03406260|459776620|FG000|Period 1|Adverse Event|0|||
127767713|NCT03406260|459776621|FG001|Period 1|Adverse Event|0|||
127767714|NCT03406260|459776622|FG002|Period 1|Adverse Event|0|||
127767715|NCT03406260|459776623|FG003|Period 1|Adverse Event|0|||
127767716|NCT03406260|459776624|FG004|Period 1|Adverse Event|1|||
127767717|NCT03406260|459776625|FG005|Period 1|Adverse Event|0|||
128014889|NCT01697579|460679778|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
128014890|NCT01697579|460679772|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
128014891|NCT01697579|460679773|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
128014892|NCT01697579|460679774|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
128014893|NCT01697579|460679775|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
127767718|NCT00871780|459776626|FG000|Overall Study|Enrolled But Not Treated|6|||
127767719|NCT00871780|459776626|FG000|Overall Study|Withdrawal by Subject|9|||
127767720|NCT00871780|459776626|FG000|Overall Study|Adverse Event|6|||
127767721|NCT00871780|459776626|FG000|Overall Study|Voluntary Discontinuation|4|||
127767722|NCT00871780|459776626|FG000|Overall Study|Death|1|||
127767723|NCT00871780|459776626|FG000|Overall Study|Physician Decision|1|||
127767724|NCT00701220|459776627|FG000|Overall Study|Withdrawal by Subject|0|||
127680821|NCT03287622|459456496|FG000|Overall Study|prolonged Length of stay|2|||
127680822|NCT03287622|459456497|FG001|Overall Study|prolonged Length of stay|0|||
127680823|NCT03287622|459456496|FG000|Overall Study|surgery related|0|||
127680824|NCT03287622|459456497|FG001|Overall Study|surgery related|2|||
127680825|NCT00854906|459456498|FG000|Overall Study|One person had no ocular history|1|||
127680826|NCT00507689|459456501|FG000|Pre-Randomization Period|Adverse Event|1|||
127680827|NCT00507689|459456502|FG001|Pre-Randomization Period|Adverse Event|0|||
127680828|NCT00507689|459456501|FG000|Pre-Randomization Period|Physician Decision|1|||
127680829|NCT00507689|459456502|FG001|Pre-Randomization Period|Physician Decision|0|||
127680830|NCT00507689|459456501|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
127680831|NCT00507689|459456502|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
127680832|NCT00507689|459456501|FG000|Randomized Period|Adverse Event|1|||
127680833|NCT00507689|459456502|FG001|Randomized Period|Adverse Event|1|||
127680834|NCT00507689|459456501|FG000|Randomized Period|Withdrawal by Subject|0|||
127680835|NCT00507689|459456502|FG001|Randomized Period|Withdrawal by Subject|1|||
127680836|NCT01786564|459456503|FG000|Overall Study|Lost to Follow-up|47|||
127680837|NCT01786564|459456503|FG000|Overall Study|Ineligible|17|||
127680838|NCT00486330|459456504|FG000|Overall Study|Adverse Event|2|||
127680839|NCT03184558|459456505|FG000|Overall Study|Withdrawal by Subject|2|||
127680840|NCT03184558|459456505|FG000|Overall Study|Death|16|||
127680841|NCT03184558|459456505|FG000|Overall Study|Lost to Follow-up|2|||
127680842|NCT03184558|459456505|FG000|Overall Study|Other|9|||
127680843|NCT02506257|459456506|FG000|Overall Study|Adverse Event|0|||
127680844|NCT02506257|459456507|FG001|Overall Study|Adverse Event|2|||
127680845|NCT02506257|459456508|FG002|Overall Study|Adverse Event|3|||
127680846|NCT02506257|459456509|FG003|Overall Study|Adverse Event|0|||
127680847|NCT02506257|459456506|FG000|Overall Study|Protocol Violation|0|||
127680848|NCT02506257|459456507|FG001|Overall Study|Protocol Violation|0|||
127680849|NCT02506257|459456508|FG002|Overall Study|Protocol Violation|1|||
127680850|NCT02506257|459456509|FG003|Overall Study|Protocol Violation|0|||
127680851|NCT01924767|459456512|FG000|Overall Study|Adverse Event|1|||
127680852|NCT01924767|459456513|FG001|Overall Study|Adverse Event|0|||
127680853|NCT01924767|459456514|FG002|Overall Study|Adverse Event|1|||
127680854|NCT01924767|459456515|FG003|Overall Study|Adverse Event|0|||
127680855|NCT01924767|459456516|FG004|Overall Study|Adverse Event|0|||
127680856|NCT00723450|459456522|FG000|Open-Label Phase|Adverse Event|26|||
127767725|NCT00701220|459776628|FG001|Overall Study|Withdrawal by Subject|2|||
127767726|NCT00701220|459776627|FG000|Overall Study|Protocol Violation|2|||
127767727|NCT00701220|459776628|FG001|Overall Study|Protocol Violation|0|||
127767728|NCT03235284|459776629|FG000|Overall Study|Adverse Event|1|||
128014894|NCT01697579|460679776|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
128014895|NCT01697579|460679777|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
128014896|NCT01697579|460679778|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
128014897|NCT01697579|460679772|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
128014898|NCT01697579|460679773|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
128014899|NCT01697579|460679774|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
128014900|NCT01697579|460679775|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
128014901|NCT01697579|460679776|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
128014902|NCT01697579|460679777|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
128014903|NCT01697579|460679778|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
128014904|NCT01697579|460679772|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
128014905|NCT01697579|460679773|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
128014906|NCT01697579|460679774|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
128014907|NCT01697579|460679775|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
128014908|NCT01697579|460679776|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
128014909|NCT01697579|460679777|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
128014910|NCT01697579|460679778|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
128014911|NCT01697579|460679772|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
128014912|NCT01697579|460679773|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
128014913|NCT01697579|460679774|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
128014914|NCT01697579|460679775|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
128014915|NCT01697579|460679776|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
128014916|NCT01697579|460679777|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
128014917|NCT01697579|460679778|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
128014918|NCT02452190|460679779|FG000|Overall Study|Withdrawal by Sponsor|1|||
128014919|NCT02452190|460679780|FG001|Overall Study|Withdrawal by Sponsor|3|||
127680857|NCT00723450|459456523|FG001|Open-Label Phase|Adverse Event|0|||
127680858|NCT00723450|459456524|FG002|Open-Label Phase|Adverse Event|0|||
127680859|NCT00723450|459456522|FG000|Open-Label Phase|Lack of Efficacy|18|||
127767729|NCT03235284|459776630|FG001|Overall Study|Adverse Event|2|||
127767730|NCT03235284|459776631|FG002|Overall Study|Adverse Event|1|||
128014920|NCT02452190|460679779|FG000|Overall Study|Pregnancy|1|||
127680860|NCT00723450|459456523|FG001|Open-Label Phase|Lack of Efficacy|0|||
127680861|NCT00723450|459456524|FG002|Open-Label Phase|Lack of Efficacy|0|||
127680862|NCT00723450|459456522|FG000|Open-Label Phase|Protocol Violation|35|||
127680863|NCT00723450|459456523|FG001|Open-Label Phase|Protocol Violation|0|||
127680864|NCT00723450|459456524|FG002|Open-Label Phase|Protocol Violation|0|||
127680865|NCT00723450|459456522|FG000|Open-Label Phase|Lost to Follow-up|7|||
127680866|NCT00723450|459456523|FG001|Open-Label Phase|Lost to Follow-up|0|||
127680867|NCT00723450|459456524|FG002|Open-Label Phase|Lost to Follow-up|0|||
127680868|NCT00723450|459456522|FG000|Open-Label Phase|Physician Decision|2|||
127680869|NCT00723450|459456523|FG001|Open-Label Phase|Physician Decision|0|||
127680870|NCT00723450|459456524|FG002|Open-Label Phase|Physician Decision|0|||
127680871|NCT00723450|459456522|FG000|Open-Label Phase|Withdrawal by Subject|37|||
127680872|NCT00723450|459456523|FG001|Open-Label Phase|Withdrawal by Subject|0|||
127680873|NCT00723450|459456524|FG002|Open-Label Phase|Withdrawal by Subject|0|||
127680874|NCT00723450|459456522|FG000|Randomized Phase|Adverse Event|0|||
127680875|NCT00723450|459456523|FG001|Randomized Phase|Adverse Event|26|||
127680876|NCT00723450|459456524|FG002|Randomized Phase|Adverse Event|17|||
127680877|NCT00723450|459456522|FG000|Randomized Phase|Lack of Efficacy|0|||
127680878|NCT00723450|459456523|FG001|Randomized Phase|Lack of Efficacy|11|||
127680879|NCT00723450|459456524|FG002|Randomized Phase|Lack of Efficacy|11|||
127680880|NCT00723450|459456522|FG000|Randomized Phase|Protocol Violation|0|||
127680881|NCT00723450|459456523|FG001|Randomized Phase|Protocol Violation|9|||
127680882|NCT00723450|459456524|FG002|Randomized Phase|Protocol Violation|13|||
127680883|NCT00723450|459456522|FG000|Randomized Phase|Lost to Follow-up|0|||
127680884|NCT00723450|459456523|FG001|Randomized Phase|Lost to Follow-up|2|||
127680885|NCT00723450|459456524|FG002|Randomized Phase|Lost to Follow-up|3|||
127680886|NCT00723450|459456522|FG000|Randomized Phase|Physician Decision|0|||
127680887|NCT00723450|459456523|FG001|Randomized Phase|Physician Decision|3|||
127680888|NCT00723450|459456524|FG002|Randomized Phase|Physician Decision|1|||
127680889|NCT00723450|459456522|FG000|Randomized Phase|Withdrawal by Subject|0|||
127680890|NCT00723450|459456523|FG001|Randomized Phase|Withdrawal by Subject|14|||
127680891|NCT00723450|459456524|FG002|Randomized Phase|Withdrawal by Subject|22|||
127680892|NCT00612586|459456525|FG000|Overall Study|Adverse Event|6|||
127680893|NCT00612586|459456526|FG001|Overall Study|Adverse Event|2|||
127680894|NCT00612586|459456525|FG000|Overall Study|Death|1|||
127680895|NCT00612586|459456526|FG001|Overall Study|Death|0|||
127680896|NCT00612586|459456525|FG000|Overall Study|Entry Criteria Not Met|0|||
127680897|NCT00612586|459456526|FG001|Overall Study|Entry Criteria Not Met|2|||
127680898|NCT00612586|459456525|FG000|Overall Study|Withdrawal by Subject|7|||
127680899|NCT00612586|459456526|FG001|Overall Study|Withdrawal by Subject|9|||
127680900|NCT00612586|459456525|FG000|Overall Study|Physician Decision|1|||
127680901|NCT00612586|459456526|FG001|Overall Study|Physician Decision|2|||
127680902|NCT00612586|459456525|FG000|Overall Study|Sponsor Decision|1|||
127680903|NCT00612586|459456526|FG001|Overall Study|Sponsor Decision|1|||
127680904|NCT00612586|459456525|FG000|Overall Study|Progressive Disease|26|||
127680905|NCT00612586|459456526|FG001|Overall Study|Progressive Disease|24|||
127680906|NCT00612586|459456525|FG000|Overall Study|Randomized and Not Treated|1|||
127680907|NCT00612586|459456526|FG001|Overall Study|Randomized and Not Treated|1|||
127680908|NCT01909336|459456527|FG000|Overall Study|Lost to Follow-up|4|||
127680909|NCT01909336|459456528|FG001|Overall Study|Lost to Follow-up|2|||
127680910|NCT01909336|459456529|FG002|Overall Study|Lost to Follow-up|2|||
127680911|NCT01909336|459456527|FG000|Overall Study|Physician Decision|0|||
127680912|NCT01909336|459456528|FG001|Overall Study|Physician Decision|1|||
127680913|NCT01909336|459456529|FG002|Overall Study|Physician Decision|1|||
127680914|NCT02314117|459456530|FG000|Overall Study|Lost to Follow-up|9|||
127680915|NCT02314117|459456531|FG001|Overall Study|Lost to Follow-up|14|||
127680916|NCT02314117|459456530|FG000|Overall Study|Withdrawal by Subject|3|||
127680917|NCT02314117|459456531|FG001|Overall Study|Withdrawal by Subject|2|||
127680918|NCT00530842|459456532|FG000|Overall Study|Adverse Event|10|||
127680919|NCT00530842|459456533|FG001|Overall Study|Adverse Event|6|||
127680920|NCT00530842|459456532|FG000|Overall Study|Lack of Efficacy|2|||
127680921|NCT00530842|459456533|FG001|Overall Study|Lack of Efficacy|1|||
127680922|NCT00530842|459456532|FG000|Overall Study|Lost to Follow-up|0|||
128014921|NCT02452190|460679780|FG001|Overall Study|Pregnancy|0|||
127680923|NCT00530842|459456533|FG001|Overall Study|Lost to Follow-up|4|||
127680924|NCT00530842|459456532|FG000|Overall Study|Protocol Violation|3|||
127680925|NCT00530842|459456533|FG001|Overall Study|Protocol Violation|2|||
127680926|NCT00530842|459456532|FG000|Overall Study|Withdrawal by Subject|4|||
127680927|NCT00530842|459456533|FG001|Overall Study|Withdrawal by Subject|5|||
127680928|NCT00530842|459456532|FG000|Overall Study|Individual different reasons|4|||
127680929|NCT00530842|459456533|FG001|Overall Study|Individual different reasons|3|||
127680930|NCT00530842|459456532|FG000|Period 1|Adverse Event|7|||
127680931|NCT00530842|459456533|FG001|Period 1|Adverse Event|3|||
127680932|NCT00530842|459456532|FG000|Period 1|Lack of Efficacy|1|||
127680933|NCT00530842|459456533|FG001|Period 1|Lack of Efficacy|1|||
127680934|NCT00530842|459456532|FG000|Period 1|Protocol Violation|2|||
127680935|NCT00530842|459456533|FG001|Period 1|Protocol Violation|1|||
127680936|NCT00530842|459456532|FG000|Period 1|Withdrawal by Subject|2|||
127680937|NCT00530842|459456533|FG001|Period 1|Withdrawal by Subject|3|||
127680938|NCT00530842|459456532|FG000|Period 1|Individual different reasons|2|||
127680939|NCT00530842|459456533|FG001|Period 1|Individual different reasons|3|||
127680940|NCT00530842|459456532|FG000|Period 2|Adverse Event|3|||
127767731|NCT00440999|459776632|FG000|Overall Study|Adverse Event|0|||
127767732|NCT00440999|459776633|FG001|Overall Study|Adverse Event|2|||
127767733|NCT00440999|459776632|FG000|Overall Study|Lack of Efficacy|6|||
127767734|NCT00440999|459776633|FG001|Overall Study|Lack of Efficacy|7|||
128014922|NCT02452190|460679779|FG000|Overall Study|Investigator's Decision|2|||
128014923|NCT02452190|460679780|FG001|Overall Study|Investigator's Decision|0|||
128014924|NCT02452190|460679779|FG000|Overall Study|Lack of Efficacy|3|||
128014925|NCT02452190|460679780|FG001|Overall Study|Lack of Efficacy|1|||
128014926|NCT02452190|460679779|FG000|Overall Study|Lost to Follow-up|4|||
128014927|NCT02452190|460679780|FG001|Overall Study|Lost to Follow-up|3|||
128014928|NCT02452190|460679779|FG000|Overall Study|Adverse Event|2|||
128014929|NCT02452190|460679780|FG001|Overall Study|Adverse Event|5|||
128014930|NCT02452190|460679779|FG000|Overall Study|Withdrawal by Subject|20|||
128014931|NCT02452190|460679780|FG001|Overall Study|Withdrawal by Subject|11|||
128014932|NCT02452190|460679779|FG000|Overall Study|Noncompliance with study drug|1|||
128014933|NCT02452190|460679780|FG001|Overall Study|Noncompliance with study drug|0|||
128014934|NCT02452190|460679779|FG000|Overall Study|Participant traveled abroad|1|||
128014935|NCT02452190|460679780|FG001|Overall Study|Participant traveled abroad|0|||
128014936|NCT02452190|460679779|FG000|Overall Study|Death|0|||
128014937|NCT02452190|460679780|FG001|Overall Study|Death|1|||
128014938|NCT01044498|460679781|FG000|Overall Study|Withdrew consent|1|||
128014939|NCT01044498|460679782|FG001|Overall Study|Withdrew consent|1|||
128014940|NCT01044498|460679781|FG000|Overall Study|Adverse Event|1|||
128014941|NCT01044498|460679782|FG001|Overall Study|Adverse Event|1|||
128014942|NCT01044498|460679781|FG000|Overall Study|Other|1|||
128014943|NCT01044498|460679782|FG001|Overall Study|Other|0|||
128014944|NCT03112603|460679786|FG000|End of Randomization Period|Lost to Follow-up|3|||
128014945|NCT03112603|460679787|FG001|End of Randomization Period|Lost to Follow-up|0|||
128014946|NCT03112603|460679788|FG002|End of Randomization Period|Lost to Follow-up|0|||
128014947|NCT03112603|460679786|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
128014948|NCT03112603|460679787|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
128014949|NCT03112603|460679788|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
128014950|NCT03112603|460679786|FG000|End of Randomization Period|Physician Decision|43|||
128014951|NCT03112603|460679787|FG001|End of Randomization Period|Physician Decision|18|||
128014952|NCT03112603|460679788|FG002|End of Randomization Period|Physician Decision|0|||
128014953|NCT03112603|460679786|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
128014954|NCT03112603|460679787|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
128014955|NCT03112603|460679788|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
128014956|NCT03112603|460679786|FG000|End of Randomization Period|Death|10|||
128014957|NCT03112603|460679787|FG001|End of Randomization Period|Death|7|||
128014958|NCT03112603|460679788|FG002|End of Randomization Period|Death|0|||
128014959|NCT03112603|460679786|FG000|End of Randomization Period|Disease Relapse|12|||
128014960|NCT03112603|460679787|FG001|End of Randomization Period|Disease Relapse|7|||
128014961|NCT03112603|460679788|FG002|End of Randomization Period|Disease Relapse|0|||
128014962|NCT03112603|460679786|FG000|End of Randomization Period|Lack of Efficacy|25|||
128014963|NCT03112603|460679787|FG001|End of Randomization Period|Lack of Efficacy|77|||
128014964|NCT03112603|460679788|FG002|End of Randomization Period|Lack of Efficacy|0|||
128014965|NCT03112603|460679786|FG000|End of Randomization Period|Adverse Event|32|||
128014966|NCT03112603|460679787|FG001|End of Randomization Period|Adverse Event|12|||
128014967|NCT03112603|460679788|FG002|End of Randomization Period|Adverse Event|0|||
128014968|NCT03112603|460679786|FG000|End of Cross Over Period|Death|0|||
128014969|NCT03112603|460679787|FG001|End of Cross Over Period|Death|0|||
128014970|NCT03112603|460679788|FG002|End of Cross Over Period|Death|2|||
128014971|NCT03112603|460679786|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
128014972|NCT03112603|460679787|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
128014973|NCT03112603|460679788|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
128014974|NCT03112603|460679786|FG000|End of Cross Over Period|Physician Decision|0|||
128014975|NCT03112603|460679787|FG001|End of Cross Over Period|Physician Decision|0|||
128014976|NCT03112603|460679788|FG002|End of Cross Over Period|Physician Decision|29|||
128014977|NCT03112603|460679786|FG000|End of Cross Over Period|Lack of Efficacy|0|||
128014978|NCT03112603|460679787|FG001|End of Cross Over Period|Lack of Efficacy|0|||
128014979|NCT03112603|460679788|FG002|End of Cross Over Period|Lack of Efficacy|8|||
128014980|NCT03112603|460679786|FG000|End of Cross Over Period|Adverse Event|0|||
128014981|NCT03112603|460679787|FG001|End of Cross Over Period|Adverse Event|0|||
128014982|NCT03112603|460679788|FG002|End of Cross Over Period|Adverse Event|6|||
128014983|NCT03112603|460679786|FG000|End of Cross Over Period|Disease Relapse|0|||
128014984|NCT03112603|460679787|FG001|End of Cross Over Period|Disease Relapse|0|||
128014985|NCT03112603|460679788|FG002|End of Cross Over Period|Disease Relapse|2|||
128014986|NCT03916926|460679792|FG000|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|51|||
128014987|NCT03916926|460679793|FG001|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|35|||
128014988|NCT03916926|460679792|FG000|26 Week Follow-Up Visit|Withdrawal by Subject|11|||
128014989|NCT03916926|460679793|FG001|26 Week Follow-Up Visit|Withdrawal by Subject|2|||
127767735|NCT00440999|459776632|FG000|Overall Study|Lost to Follow-up|19|||
127767736|NCT00440999|459776633|FG001|Overall Study|Lost to Follow-up|12|||
127767737|NCT00440999|459776632|FG000|Overall Study|Protocol Violation|1|||
127767738|NCT00440999|459776633|FG001|Overall Study|Protocol Violation|0|||
127767739|NCT00440999|459776632|FG000|Overall Study|Withdrawal by Subject|2|||
127767740|NCT00440999|459776633|FG001|Overall Study|Withdrawal by Subject|5|||
127767741|NCT00440999|459776632|FG000|Overall Study|Subjets missed the visit|1|||
127767742|NCT00440999|459776633|FG001|Overall Study|Subjets missed the visit|0|||
127767743|NCT00440999|459776632|FG000|Overall Study|Mixed infection at entry|1|||
127767744|NCT00440999|459776633|FG001|Overall Study|Mixed infection at entry|0|||
127767745|NCT00440999|459776632|FG000|Overall Study|P. falciparum malaria|5|||
127767746|NCT00440999|459776633|FG001|Overall Study|P. falciparum malaria|14|||
127767747|NCT00440999|459776632|FG000|Overall Study|Subj left hosp without inform staff|0|||
127767748|NCT00440999|459776633|FG001|Overall Study|Subj left hosp without inform staff|1|||
127767749|NCT05041101|459776634|FG000|Overall Study|Adverse Event|1|||
127767750|NCT05041101|459776635|FG001|Overall Study|Adverse Event|0|||
127767751|NCT05041101|459776636|FG002|Overall Study|Adverse Event|0|||
127767752|NCT05041101|459776634|FG000|Overall Study|Diease Progression|5|||
127767753|NCT05041101|459776635|FG001|Overall Study|Diease Progression|0|||
127767754|NCT05041101|459776636|FG002|Overall Study|Diease Progression|0|||
127767755|NCT01205152|459776637|FG000|Overall Study|Death|1|||
127767756|NCT00249002|459776638|FG000|Overall Study|Adverse Event|2|||
127767757|NCT00249002|459776638|FG000|Overall Study|Study cancellation|3|||
127767758|NCT00249002|459776638|FG000|Overall Study|Other|2|||
127767759|NCT00319839|459776640|FG000|Overall Study|Adverse Event|5|||
127767760|NCT00319839|459776640|FG000|Overall Study|Withdrawal by Subject|1|||
127767761|NCT01577745|459776641|FG000|Overall Study|Withdrawal by Subject|0|||
127767762|NCT01577745|459776642|FG001|Overall Study|Withdrawal by Subject|1|||
127767763|NCT01577745|459776643|FG002|Overall Study|Withdrawal by Subject|0|||
127767764|NCT01577745|459776644|FG003|Overall Study|Withdrawal by Subject|3|||
127767765|NCT01577745|459776645|FG004|Overall Study|Withdrawal by Subject|2|||
127767766|NCT01577745|459776646|FG005|Overall Study|Withdrawal by Subject|0|||
127767767|NCT01577745|459776641|FG000|Overall Study|Death|3|||
127767768|NCT01577745|459776642|FG001|Overall Study|Death|2|||
127767769|NCT01577745|459776643|FG002|Overall Study|Death|2|||
127767770|NCT01577745|459776644|FG003|Overall Study|Death|1|||
127767771|NCT01577745|459776645|FG004|Overall Study|Death|1|||
127767772|NCT01577745|459776646|FG005|Overall Study|Death|3|||
127767773|NCT01577745|459776641|FG000|Overall Study|Physician Decision|0|||
127767774|NCT01577745|459776642|FG001|Overall Study|Physician Decision|0|||
127767775|NCT01577745|459776643|FG002|Overall Study|Physician Decision|0|||
127767776|NCT01577745|459776644|FG003|Overall Study|Physician Decision|1|||
127767777|NCT01577745|459776645|FG004|Overall Study|Physician Decision|1|||
127767778|NCT01577745|459776646|FG005|Overall Study|Physician Decision|0|||
127767779|NCT01577745|459776641|FG000|Overall Study|Lost to Follow-up|0|||
127767780|NCT01577745|459776642|FG001|Overall Study|Lost to Follow-up|0|||
127767781|NCT01577745|459776643|FG002|Overall Study|Lost to Follow-up|0|||
127767782|NCT01577745|459776644|FG003|Overall Study|Lost to Follow-up|0|||
127767783|NCT01577745|459776645|FG004|Overall Study|Lost to Follow-up|0|||
127767784|NCT01577745|459776646|FG005|Overall Study|Lost to Follow-up|1|||
127767785|NCT01577745|459776641|FG000|Overall Study|Alternative Therapy|0|||
127767786|NCT01577745|459776642|FG001|Overall Study|Alternative Therapy|0|||
127767787|NCT01577745|459776643|FG002|Overall Study|Alternative Therapy|0|||
127767788|NCT01577745|459776644|FG003|Overall Study|Alternative Therapy|1|||
127767789|NCT01577745|459776645|FG004|Overall Study|Alternative Therapy|1|||
127767790|NCT01577745|459776646|FG005|Overall Study|Alternative Therapy|0|||
127767791|NCT02483585|459776647|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
127767792|NCT02483585|459776648|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
127767793|NCT02483585|459776647|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
127767794|NCT02483585|459776648|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
127767795|NCT02483585|459776647|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
127767796|NCT02483585|459776648|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
127767797|NCT02483585|459776647|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
127767798|NCT02483585|459776648|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
127767799|NCT02483585|459776647|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
127767800|NCT02483585|459776648|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
127767801|NCT02483585|459776647|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
128014990|NCT03916926|460679792|FG000|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|22|||
127767802|NCT02483585|459776648|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
127767803|NCT02483585|459776647|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
127767804|NCT02483585|459776648|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
127767805|NCT01324440|459776653|FG000|Overall Study|Subject moved|0|||
127767806|NCT01324440|459776654|FG001|Overall Study|Subject moved|1|||
128014991|NCT03916926|460679793|FG001|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|13|||
127767807|NCT00903630|459776655|FG000|Phase 2|Adverse Event|0|||
127767808|NCT00903630|459776656|FG001|Phase 2|Adverse Event|0|||
127767809|NCT00903630|459776657|FG002|Phase 2|Adverse Event|1|||
128014992|NCT03916926|460679792|FG000|52 Week Follow-Up Visit|Withdrawal by Subject|22|||
128014993|NCT03916926|460679793|FG001|52 Week Follow-Up Visit|Withdrawal by Subject|12|||
128014994|NCT04725188|460679794|FG000|Overall Study|Death|72|||
128014995|NCT04725188|460679795|FG001|Overall Study|Death|69|||
128014996|NCT04725188|460679796|FG002|Overall Study|Death|76|||
128014997|NCT04725188|460679794|FG000|Overall Study|Lost to Follow-up|1|||
128014998|NCT04725188|460679795|FG001|Overall Study|Lost to Follow-up|0|||
128014999|NCT04725188|460679796|FG002|Overall Study|Lost to Follow-up|1|||
128015000|NCT04725188|460679794|FG000|Overall Study|Withdrawal by Subject|2|||
128015001|NCT04725188|460679795|FG001|Overall Study|Withdrawal by Subject|2|||
128015002|NCT04725188|460679796|FG002|Overall Study|Withdrawal by Subject|1|||
128015003|NCT04725188|460679794|FG000|Overall Study|Sponsor Decision|12|||
128015004|NCT04725188|460679795|FG001|Overall Study|Sponsor Decision|12|||
128015005|NCT04725188|460679796|FG002|Overall Study|Sponsor Decision|7|||
128015006|NCT03330197|460679797|FG000|Overall Study|Adverse Event|0|||
128015007|NCT03330197|460679798|FG001|Overall Study|Adverse Event|1|||
128015008|NCT03330197|460679797|FG000|Overall Study|Withdrawal by Subject|0|||
128015009|NCT03330197|460679798|FG001|Overall Study|Withdrawal by Subject|1|||
128015010|NCT04537299|460679799|FG000|Overall Study|Withdrawal by Subject|2|||
128015011|NCT04537299|460679800|FG001|Overall Study|Withdrawal by Subject|0|||
128015012|NCT04537299|460679799|FG000|Overall Study|Protocol Violation|1|||
128015013|NCT04537299|460679800|FG001|Overall Study|Protocol Violation|1|||
128015014|NCT00876343|460679807|FG000|Overall Study|Adverse Event|7|||
128015015|NCT00876343|460679808|FG001|Overall Study|Adverse Event|8|||
128015016|NCT00876343|460679809|FG002|Overall Study|Adverse Event|2|||
128015017|NCT00876343|460679807|FG000|Overall Study|Withdrawal by Subject|4|||
127767810|NCT02325557|459776658|FG000|Overall Study|Progressive disease|1|||
127767811|NCT02325557|459776659|FG001|Overall Study|Progressive disease|0|||
127767812|NCT02325557|459776660|FG002|Overall Study|Progressive disease|0|||
127767813|NCT02325557|459776661|FG003|Overall Study|Progressive disease|0|||
127767814|NCT02325557|459776658|FG000|Overall Study|Withdrawal by Subject|4|||
127767815|NCT02325557|459776659|FG001|Overall Study|Withdrawal by Subject|0|||
127767816|NCT02325557|459776660|FG002|Overall Study|Withdrawal by Subject|0|||
128015018|NCT00876343|460679808|FG001|Overall Study|Withdrawal by Subject|4|||
127767817|NCT02325557|459776661|FG003|Overall Study|Withdrawal by Subject|15|||
127767818|NCT02325557|459776658|FG000|Overall Study|Death|5|||
127767819|NCT02325557|459776659|FG001|Overall Study|Death|1|||
127767820|NCT02325557|459776660|FG002|Overall Study|Death|1|||
127767821|NCT02325557|459776661|FG003|Overall Study|Death|16|||
127767822|NCT02325557|459776658|FG000|Overall Study|Lost to Follow-up|0|||
127767823|NCT02325557|459776659|FG001|Overall Study|Lost to Follow-up|0|||
127767824|NCT02325557|459776660|FG002|Overall Study|Lost to Follow-up|1|||
127767825|NCT02325557|459776661|FG003|Overall Study|Lost to Follow-up|1|||
127767826|NCT02325557|459776658|FG000|Overall Study|Other|0|||
127767827|NCT02325557|459776659|FG001|Overall Study|Other|0|||
127767828|NCT02325557|459776660|FG002|Overall Study|Other|0|||
127767829|NCT02325557|459776661|FG003|Overall Study|Other|5|||
127767830|NCT01136772|459776664|FG000|Overall Study|Adverse Event|15|||
127767831|NCT01136772|459776665|FG001|Overall Study|Adverse Event|14|||
127767832|NCT01136772|459776664|FG000|Overall Study|Lack of Efficacy|42|||
127767833|NCT01136772|459776665|FG001|Overall Study|Lack of Efficacy|39|||
127767834|NCT01136772|459776664|FG000|Overall Study|Administrative|14|||
127767835|NCT01136772|459776665|FG001|Overall Study|Administrative|12|||
127767836|NCT01136772|459776664|FG000|Overall Study|Withdrawal by Subject|33|||
127767837|NCT01136772|459776665|FG001|Overall Study|Withdrawal by Subject|36|||
127767838|NCT01136772|459776664|FG000|Overall Study|Did not receive injection|10|||
127767839|NCT01136772|459776665|FG001|Overall Study|Did not receive injection|7|||
127767840|NCT01136772|459776664|FG000|Overall Study|Did not follow up after first injection|2|||
127767841|NCT01136772|459776665|FG001|Overall Study|Did not follow up after first injection|2|||
127767842|NCT01959516|459776666|FG000|Epoch 1|Adverse Event|4|||
127767843|NCT01959516|459776667|FG001|Epoch 1|Adverse Event|1|||
127767844|NCT01959516|459776666|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
127767845|NCT01959516|459776667|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
127767846|NCT01959516|459776666|FG000|Epoch 1|Subject withdrew consent|3|||
127767847|NCT01959516|459776667|FG001|Epoch 1|Subject withdrew consent|2|||
127767848|NCT01959516|459776666|FG000|Epoch 1|Administrative problems|1|||
127767849|NCT01959516|459776667|FG001|Epoch 1|Administrative problems|0|||
127767850|NCT01959516|459776666|FG000|Epoch 1|Use of prohibited treatment|1|||
127767851|NCT01959516|459776667|FG001|Epoch 1|Use of prohibited treatment|0|||
127767852|NCT01959516|459776666|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
127767853|NCT01959516|459776667|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
127767854|NCT01959516|459776666|FG000|Epoch 1|Protocol deviation|0|||
128015019|NCT00876343|460679809|FG002|Overall Study|Withdrawal by Subject|3|||
128015020|NCT00876343|460679807|FG000|Overall Study|Lack of Efficacy|0|||
128015021|NCT00876343|460679808|FG001|Overall Study|Lack of Efficacy|0|||
128015022|NCT00876343|460679809|FG002|Overall Study|Lack of Efficacy|1|||
128015023|NCT00876343|460679807|FG000|Overall Study|Protocol Violation|4|||
127767855|NCT01959516|459776667|FG001|Epoch 1|Protocol deviation|1|||
128015024|NCT00876343|460679808|FG001|Overall Study|Protocol Violation|1|||
127767856|NCT01959516|459776666|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
127767857|NCT01959516|459776667|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
127767858|NCT01959516|459776666|FG000|Epoch 2|Subject withdrew consent|1|||
127767859|NCT01959516|459776667|FG001|Epoch 2|Subject withdrew consent|0|||
127767860|NCT01959516|459776666|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
127767861|NCT01959516|459776667|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
128015025|NCT00876343|460679809|FG002|Overall Study|Protocol Violation|1|||
128015026|NCT00876343|460679807|FG000|Overall Study|Physician Decision|0|||
128015027|NCT00876343|460679808|FG001|Overall Study|Physician Decision|1|||
128015028|NCT00876343|460679809|FG002|Overall Study|Physician Decision|1|||
128015029|NCT00876343|460679807|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
128015030|NCT00876343|460679808|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
128015031|NCT00876343|460679809|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
128015032|NCT00876343|460679807|FG000|Overall Study|Change of residence or other commitments|2|||
128015033|NCT00876343|460679808|FG001|Overall Study|Change of residence or other commitments|2|||
128015034|NCT00876343|460679809|FG002|Overall Study|Change of residence or other commitments|3|||
128015035|NCT01933932|460679814|FG000|Overall Study|Death|173|||
128015036|NCT01933932|460679815|FG001|Overall Study|Death|163|||
128015037|NCT01933932|460679814|FG000|Overall Study|Withdrawal by Subject|11|||
128015038|NCT01933932|460679815|FG001|Overall Study|Withdrawal by Subject|14|||
128015039|NCT01933932|460679814|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
128015040|NCT01933932|460679815|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
128015041|NCT00790036|460679823|FG000|Overall Study|Abnormal lab values|3|||
127680941|NCT00530842|459456533|FG001|Period 2|Adverse Event|3|||
127680942|NCT00530842|459456532|FG000|Period 2|Lack of Efficacy|1|||
127680943|NCT00530842|459456533|FG001|Period 2|Lack of Efficacy|0|||
127680944|NCT00530842|459456532|FG000|Period 2|Lost to Follow-up|0|||
127680945|NCT00530842|459456533|FG001|Period 2|Lost to Follow-up|4|||
127680946|NCT00530842|459456532|FG000|Period 2|Protocol Violation|1|||
127680947|NCT00530842|459456533|FG001|Period 2|Protocol Violation|0|||
127680948|NCT00530842|459456532|FG000|Period 2|Withdrawal by Subject|1|||
127680949|NCT00530842|459456533|FG001|Period 2|Withdrawal by Subject|2|||
127680950|NCT00530842|459456532|FG000|Period 2|Individual different reasons|2|||
127680951|NCT00530842|459456533|FG001|Period 2|Individual different reasons|0|||
127680952|NCT00922207|459456534|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
127680953|NCT00922207|459456535|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
127680954|NCT00922207|459456536|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
127680955|NCT00922207|459456534|FG000|Overall Study|Insufficient Therapeutic Response|0|||
127680956|NCT00922207|459456535|FG001|Overall Study|Insufficient Therapeutic Response|0|||
127680957|NCT00922207|459456536|FG002|Overall Study|Insufficient Therapeutic Response|1|||
127680958|NCT00922207|459456534|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
127680959|NCT00922207|459456535|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
127680960|NCT00922207|459456536|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
127680961|NCT00922207|459456534|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
127680962|NCT00922207|459456535|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
127680963|NCT00922207|459456536|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
127680964|NCT00922207|459456534|FG000|Overall Study|Withdrew Consent|2|||
127680965|NCT00922207|459456535|FG001|Overall Study|Withdrew Consent|5|||
127680966|NCT00922207|459456536|FG002|Overall Study|Withdrew Consent|2|||
127680967|NCT00922207|459456534|FG000|Overall Study|Abnormality of Laboratory Test|0|||
127680968|NCT00922207|459456535|FG001|Overall Study|Abnormality of Laboratory Test|1|||
127680969|NCT00922207|459456536|FG002|Overall Study|Abnormality of Laboratory Test|1|||
127680970|NCT04707313|459456549|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|4|||
127680971|NCT04707313|459456550|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|20|||
127680972|NCT04707313|459456551|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|23|||
127680973|NCT04707313|459456552|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|25|||
127680974|NCT04707313|459456553|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
127680975|NCT04707313|459456554|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|38|||
127680976|NCT04707313|459456555|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
127680977|NCT04707313|459456556|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|42|||
127680978|NCT04707313|459456557|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|16|||
127680979|NCT04707313|459456558|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
127680980|NCT04707313|459456559|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
127680981|NCT04707313|459456560|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
127680982|NCT04707313|459456561|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
127680983|NCT04707313|459456549|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|5|||
127680984|NCT04707313|459456550|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
127680985|NCT04707313|459456551|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
127680986|NCT04707313|459456552|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
127680987|NCT04707313|459456553|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
127680988|NCT04707313|459456554|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
128015042|NCT00790036|460679824|FG001|Overall Study|Abnormal lab values|2|||
128015043|NCT00790036|460679823|FG000|Overall Study|Administrative problems|5|||
128015044|NCT00790036|460679824|FG001|Overall Study|Administrative problems|9|||
128015045|NCT00790036|460679823|FG000|Overall Study|Adverse Event|113|||
128015046|NCT00790036|460679824|FG001|Overall Study|Adverse Event|44|||
128015047|NCT00790036|460679823|FG000|Overall Study|Death|1|||
128015048|NCT00790036|460679824|FG001|Overall Study|Death|0|||
128015049|NCT00790036|460679823|FG000|Overall Study|Disease progression|24|||
128015050|NCT00790036|460679824|FG001|Overall Study|Disease progression|48|||
128015051|NCT00790036|460679823|FG000|Overall Study|Lost to Follow-up|1|||
128015052|NCT00790036|460679824|FG001|Overall Study|Lost to Follow-up|2|||
128015053|NCT00790036|460679823|FG000|Overall Study|Protocol Violation|10|||
128015054|NCT00790036|460679824|FG001|Overall Study|Protocol Violation|2|||
128015055|NCT00790036|460679823|FG000|Overall Study|Withdrawal by Subject|18|||
128015056|NCT00790036|460679824|FG001|Overall Study|Withdrawal by Subject|7|||
128015057|NCT00790036|460679823|FG000|Overall Study|Subject/guardian decision|20|||
128015058|NCT00790036|460679824|FG001|Overall Study|Subject/guardian decision|7|||
128015059|NCT03126110|460679827|FG000|Phase 1|Death|2|||
128015060|NCT03126110|460679828|FG001|Phase 1|Death|2|||
128015061|NCT03126110|460679829|FG002|Phase 1|Death|4|||
127680989|NCT04707313|459456555|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
127680990|NCT04707313|459456556|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
128015062|NCT03126110|460679830|FG003|Phase 1|Death|3|||
128015063|NCT03126110|460679831|FG004|Phase 1|Death|4|||
128015064|NCT03126110|460679832|FG005|Phase 1|Death|4|||
127680991|NCT04707313|459456557|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
127680992|NCT04707313|459456558|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
127680993|NCT04707313|459456559|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
127680994|NCT04707313|459456560|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
127680995|NCT04707313|459456561|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
127680996|NCT04707313|459456549|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
127680997|NCT04707313|459456550|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
127680998|NCT04707313|459456551|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
127680999|NCT04707313|459456552|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
127681000|NCT04707313|459456553|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
127681001|NCT04707313|459456554|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
127681002|NCT04707313|459456555|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
127681003|NCT04707313|459456556|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
127681004|NCT04707313|459456557|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
127681005|NCT04707313|459456558|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
127681006|NCT04707313|459456559|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
127681007|NCT04707313|459456560|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
127681008|NCT04707313|459456561|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
127681009|NCT04707313|459456549|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
127681010|NCT04707313|459456550|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
127681011|NCT04707313|459456551|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|2|||
128015065|NCT03126110|460679833|FG006|Phase 1|Death|3|||
128015066|NCT03126110|460679834|FG007|Phase 1|Death|4|||
128015067|NCT03126110|460679835|FG008|Phase 1|Death|5|||
128015068|NCT03126110|460679836|FG009|Phase 1|Death|2|||
128015069|NCT03126110|460679837|FG010|Phase 1|Death|6|||
128015070|NCT03126110|460679838|FG011|Phase 1|Death|0|||
128015071|NCT03126110|460679839|FG012|Phase 1|Death|0|||
128015072|NCT03126110|460679840|FG013|Phase 1|Death|0|||
128015073|NCT03126110|460679841|FG014|Phase 1|Death|0|||
128015074|NCT03126110|460679842|FG015|Phase 1|Death|0|||
128015075|NCT03126110|460679843|FG016|Phase 1|Death|0|||
128015076|NCT03126110|460679827|FG000|Phase 1|Lost to Follow-up|0|||
128015077|NCT03126110|460679828|FG001|Phase 1|Lost to Follow-up|1|||
127681012|NCT04707313|459456552|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
127681013|NCT04707313|459456553|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
127681014|NCT04707313|459456554|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
127681015|NCT04707313|459456555|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
127681016|NCT04707313|459456556|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
127681017|NCT04707313|459456557|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
128015078|NCT03126110|460679829|FG002|Phase 1|Lost to Follow-up|0|||
128015079|NCT03126110|460679830|FG003|Phase 1|Lost to Follow-up|0|||
128015080|NCT03126110|460679831|FG004|Phase 1|Lost to Follow-up|0|||
128015081|NCT03126110|460679832|FG005|Phase 1|Lost to Follow-up|0|||
128015082|NCT03126110|460679833|FG006|Phase 1|Lost to Follow-up|0|||
128015083|NCT03126110|460679834|FG007|Phase 1|Lost to Follow-up|0|||
128015084|NCT03126110|460679835|FG008|Phase 1|Lost to Follow-up|1|||
128015085|NCT03126110|460679836|FG009|Phase 1|Lost to Follow-up|0|||
128015086|NCT03126110|460679837|FG010|Phase 1|Lost to Follow-up|0|||
128015087|NCT03126110|460679838|FG011|Phase 1|Lost to Follow-up|0|||
128015088|NCT03126110|460679839|FG012|Phase 1|Lost to Follow-up|0|||
128015089|NCT03126110|460679840|FG013|Phase 1|Lost to Follow-up|0|||
128015090|NCT03126110|460679841|FG014|Phase 1|Lost to Follow-up|0|||
128015091|NCT03126110|460679842|FG015|Phase 1|Lost to Follow-up|0|||
128015092|NCT03126110|460679843|FG016|Phase 1|Lost to Follow-up|0|||
127681018|NCT04707313|459456558|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
127681019|NCT04707313|459456559|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
127681020|NCT04707313|459456560|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
127681021|NCT04707313|459456561|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
127681022|NCT04707313|459456549|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
127681023|NCT04707313|459456550|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Other|4|||
127681024|NCT04707313|459456551|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
127681025|NCT04707313|459456552|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
127681026|NCT04707313|459456553|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Other|2|||
127681027|NCT04707313|459456554|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
127681028|NCT04707313|459456555|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
127681029|NCT04707313|459456556|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
127681030|NCT04707313|459456557|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
127681031|NCT04707313|459456558|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
127681032|NCT04707313|459456559|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
127681033|NCT04707313|459456560|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
127681034|NCT04707313|459456561|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
127681035|NCT04707313|459456549|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
127681036|NCT04707313|459456550|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
127681037|NCT04707313|459456551|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
127681038|NCT04707313|459456552|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
127681039|NCT04707313|459456553|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
127681040|NCT04707313|459456554|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
127681041|NCT04707313|459456555|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|2|||
127681042|NCT04707313|459456556|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
127681043|NCT04707313|459456557|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
127681044|NCT04707313|459456558|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
127681045|NCT04707313|459456559|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
127681046|NCT04707313|459456560|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
127681047|NCT04707313|459456561|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
127681048|NCT04707313|459456549|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|11|||
127681049|NCT04707313|459456550|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|5|||
127681050|NCT04707313|459456551|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
127681051|NCT04707313|459456552|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|7|||
127681052|NCT04707313|459456553|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
127681053|NCT04707313|459456554|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
127681054|NCT04707313|459456555|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|6|||
127681055|NCT04707313|459456556|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
127681056|NCT04707313|459456557|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
127681057|NCT04707313|459456558|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
127681058|NCT04707313|459456559|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
127681059|NCT04707313|459456560|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
127681060|NCT04707313|459456561|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
127681061|NCT04707313|459456549|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
127681062|NCT04707313|459456550|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
127681063|NCT04707313|459456551|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
127681064|NCT04707313|459456552|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
127681065|NCT04707313|459456553|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
127681066|NCT04707313|459456554|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
127681067|NCT04707313|459456555|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
127681068|NCT04707313|459456556|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
127681069|NCT04707313|459456557|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
127681070|NCT04707313|459456558|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
127681071|NCT04707313|459456559|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
127681072|NCT04707313|459456560|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
127681073|NCT04707313|459456561|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
127681074|NCT04707313|459456549|FG000|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
127681075|NCT04707313|459456550|FG001|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
127681076|NCT04707313|459456551|FG002|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
127681077|NCT04707313|459456552|FG003|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
127681078|NCT04707313|459456553|FG004|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
127681079|NCT04707313|459456554|FG005|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
127681080|NCT04707313|459456555|FG006|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
127681081|NCT04707313|459456556|FG007|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
127767862|NCT00928746|459776668|FG000|Overall Study|Adverse Event|2|||
127767863|NCT00928746|459776668|FG000|Overall Study|Protocol Violation|1|||
127767864|NCT00928746|459776668|FG000|Overall Study|Withdrawal by Subject|1|||
127767865|NCT00928746|459776668|FG000|Overall Study|Other|2|||
127767866|NCT02004353|459776674|FG000|Overall Study|Voluntary participation|1334|||
127767867|NCT02581631|459776675|FG000|Overall Study|Disease progression|29|||
127767868|NCT02581631|459776676|FG001|Overall Study|Disease progression|19|||
127767869|NCT02581631|459776677|FG002|Overall Study|Disease progression|13|||
127767870|NCT02581631|459776678|FG003|Overall Study|Disease progression|5|||
127767871|NCT02581631|459776679|FG004|Overall Study|Disease progression|8|||
127767872|NCT02581631|459776675|FG000|Overall Study|Study drug toxicity|4|||
127767873|NCT02581631|459776676|FG001|Overall Study|Study drug toxicity|6|||
127767874|NCT02581631|459776677|FG002|Overall Study|Study drug toxicity|7|||
127767875|NCT02581631|459776678|FG003|Overall Study|Study drug toxicity|0|||
127767876|NCT02581631|459776679|FG004|Overall Study|Study drug toxicity|3|||
127767877|NCT02581631|459776675|FG000|Overall Study|AE unrelated to study drug|3|||
127767878|NCT02581631|459776676|FG001|Overall Study|AE unrelated to study drug|1|||
127767879|NCT02581631|459776677|FG002|Overall Study|AE unrelated to study drug|1|||
128015093|NCT03126110|460679827|FG000|Phase 1|Withdrawal by Subject|1|||
128015094|NCT03126110|460679828|FG001|Phase 1|Withdrawal by Subject|0|||
128015095|NCT03126110|460679829|FG002|Phase 1|Withdrawal by Subject|0|||
128015096|NCT03126110|460679830|FG003|Phase 1|Withdrawal by Subject|1|||
128015097|NCT03126110|460679831|FG004|Phase 1|Withdrawal by Subject|1|||
128015098|NCT03126110|460679832|FG005|Phase 1|Withdrawal by Subject|0|||
128015099|NCT03126110|460679833|FG006|Phase 1|Withdrawal by Subject|0|||
128015100|NCT03126110|460679834|FG007|Phase 1|Withdrawal by Subject|0|||
128015101|NCT03126110|460679835|FG008|Phase 1|Withdrawal by Subject|2|||
128015102|NCT03126110|460679836|FG009|Phase 1|Withdrawal by Subject|1|||
128015103|NCT03126110|460679837|FG010|Phase 1|Withdrawal by Subject|0|||
128015104|NCT03126110|460679838|FG011|Phase 1|Withdrawal by Subject|0|||
128015105|NCT03126110|460679839|FG012|Phase 1|Withdrawal by Subject|0|||
128015106|NCT03126110|460679840|FG013|Phase 1|Withdrawal by Subject|0|||
128015107|NCT03126110|460679841|FG014|Phase 1|Withdrawal by Subject|0|||
128015108|NCT03126110|460679842|FG015|Phase 1|Withdrawal by Subject|0|||
128015109|NCT03126110|460679843|FG016|Phase 1|Withdrawal by Subject|0|||
128015110|NCT03126110|460679827|FG000|Phase 1|Safety follow-up no longer necessary|1|||
128015111|NCT03126110|460679828|FG001|Phase 1|Safety follow-up no longer necessary|0|||
128015112|NCT03126110|460679829|FG002|Phase 1|Safety follow-up no longer necessary|0|||
128015113|NCT03126110|460679830|FG003|Phase 1|Safety follow-up no longer necessary|0|||
127767880|NCT02581631|459776678|FG003|Overall Study|AE unrelated to study drug|0|||
127767881|NCT02581631|459776679|FG004|Overall Study|AE unrelated to study drug|2|||
127767882|NCT02581631|459776675|FG000|Overall Study|Request to discontinue|1|||
127767883|NCT02581631|459776676|FG001|Overall Study|Request to discontinue|0|||
127767884|NCT02581631|459776677|FG002|Overall Study|Request to discontinue|3|||
127767885|NCT02581631|459776678|FG003|Overall Study|Request to discontinue|0|||
127767886|NCT02581631|459776679|FG004|Overall Study|Request to discontinue|1|||
127767887|NCT02581631|459776675|FG000|Overall Study|participant withdrew consent|3|||
127767888|NCT02581631|459776676|FG001|Overall Study|participant withdrew consent|0|||
127767889|NCT02581631|459776677|FG002|Overall Study|participant withdrew consent|1|||
127767890|NCT02581631|459776678|FG003|Overall Study|participant withdrew consent|0|||
127767891|NCT02581631|459776679|FG004|Overall Study|participant withdrew consent|0|||
127767892|NCT02581631|459776675|FG000|Overall Study|Maximum clinical benefit|1|||
127767893|NCT02581631|459776676|FG001|Overall Study|Maximum clinical benefit|7|||
128015114|NCT03126110|460679831|FG004|Phase 1|Safety follow-up no longer necessary|0|||
128015115|NCT03126110|460679832|FG005|Phase 1|Safety follow-up no longer necessary|0|||
128015116|NCT03126110|460679833|FG006|Phase 1|Safety follow-up no longer necessary|0|||
128015117|NCT03126110|460679834|FG007|Phase 1|Safety follow-up no longer necessary|0|||
128015118|NCT03126110|460679835|FG008|Phase 1|Safety follow-up no longer necessary|0|||
128015119|NCT03126110|460679836|FG009|Phase 1|Safety follow-up no longer necessary|0|||
128015120|NCT03126110|460679837|FG010|Phase 1|Safety follow-up no longer necessary|0|||
128015121|NCT03126110|460679838|FG011|Phase 1|Safety follow-up no longer necessary|0|||
128015122|NCT03126110|460679839|FG012|Phase 1|Safety follow-up no longer necessary|0|||
128015123|NCT03126110|460679840|FG013|Phase 1|Safety follow-up no longer necessary|0|||
128015124|NCT03126110|460679841|FG014|Phase 1|Safety follow-up no longer necessary|0|||
128015125|NCT03126110|460679842|FG015|Phase 1|Safety follow-up no longer necessary|0|||
127767894|NCT02581631|459776677|FG002|Overall Study|Maximum clinical benefit|1|||
127767895|NCT02581631|459776678|FG003|Overall Study|Maximum clinical benefit|3|||
127767896|NCT02581631|459776679|FG004|Overall Study|Maximum clinical benefit|13|||
127767897|NCT02581631|459776675|FG000|Overall Study|Other Reasons|1|||
127767898|NCT02581631|459776676|FG001|Overall Study|Other Reasons|0|||
127767899|NCT02581631|459776677|FG002|Overall Study|Other Reasons|2|||
127767900|NCT02581631|459776678|FG003|Overall Study|Other Reasons|2|||
127767901|NCT02581631|459776679|FG004|Overall Study|Other Reasons|3|||
128015126|NCT03126110|460679843|FG016|Phase 1|Safety follow-up no longer necessary|0|||
128015127|NCT03126110|460679827|FG000|Phase 1|Survival follow-up no longer necessary|0|||
128015128|NCT03126110|460679828|FG001|Phase 1|Survival follow-up no longer necessary|0|||
128015129|NCT03126110|460679829|FG002|Phase 1|Survival follow-up no longer necessary|1|||
127767902|NCT02581631|459776675|FG000|Overall Study|Poor/Non-Compliance|0|||
127767903|NCT02581631|459776676|FG001|Overall Study|Poor/Non-Compliance|0|||
127767904|NCT02581631|459776677|FG002|Overall Study|Poor/Non-Compliance|1|||
127767905|NCT02581631|459776678|FG003|Overall Study|Poor/Non-Compliance|0|||
127767906|NCT02581631|459776679|FG004|Overall Study|Poor/Non-Compliance|0|||
127767907|NCT00819390|459776680|FG000|Overall Study|Lost to Follow-up|1|||
127767908|NCT00819390|459776681|FG001|Overall Study|Lost to Follow-up|1|||
127767909|NCT00819390|459776682|FG002|Overall Study|Lost to Follow-up|0|||
127767910|NCT00819390|459776683|FG003|Overall Study|Lost to Follow-up|0|||
127767911|NCT00819390|459776680|FG000|Overall Study|Withdrawal by Subject|2|||
127767912|NCT00819390|459776681|FG001|Overall Study|Withdrawal by Subject|0|||
127767913|NCT00819390|459776682|FG002|Overall Study|Withdrawal by Subject|0|||
127767914|NCT00819390|459776683|FG003|Overall Study|Withdrawal by Subject|0|||
127767915|NCT00819390|459776680|FG000|Overall Study|Adverse Event|0|||
127767916|NCT00819390|459776681|FG001|Overall Study|Adverse Event|0|||
127767917|NCT00819390|459776682|FG002|Overall Study|Adverse Event|1|||
127767918|NCT00819390|459776683|FG003|Overall Study|Adverse Event|0|||
127767919|NCT01270971|459776690|FG000|Overall Study|Withdrawal by Subject|24|||
127767920|NCT01270971|459776691|FG001|Overall Study|Withdrawal by Subject|11|||
127767921|NCT01270971|459776690|FG000|Overall Study|Lost to Follow-up|18|||
127767922|NCT01270971|459776691|FG001|Overall Study|Lost to Follow-up|5|||
127767923|NCT01270971|459776690|FG000|Overall Study|Adverse Event|1|||
127767924|NCT01270971|459776691|FG001|Overall Study|Adverse Event|2|||
127767925|NCT01270971|459776690|FG000|Overall Study|Non compliance|2|||
127767926|NCT01270971|459776691|FG001|Overall Study|Non compliance|2|||
127767927|NCT01270971|459776690|FG000|Overall Study|Non-specific|7|||
127767928|NCT01270971|459776691|FG001|Overall Study|Non-specific|3|||
127767929|NCT01242800|459776694|FG000|Overall Study|Patient refusal|0|||
127767930|NCT01242800|459776695|FG001|Overall Study|Patient refusal|10|||
127767931|NCT01242800|459776694|FG000|Overall Study|Physician Decision|0|||
127767932|NCT01242800|459776695|FG001|Overall Study|Physician Decision|1|||
127767933|NCT01242800|459776694|FG000|Overall Study|Disease progression|0|||
127767934|NCT01242800|459776695|FG001|Overall Study|Disease progression|3|||
127767935|NCT01242800|459776694|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
127767936|NCT01242800|459776695|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
127767937|NCT01242800|459776694|FG000|Overall Study|Reasons not reported|0|||
127767938|NCT01242800|459776695|FG001|Overall Study|Reasons not reported|4|||
127767939|NCT02640157|459776697|FG000|Overall Study|Adverse Event|2|||
127767940|NCT02640157|459776698|FG001|Overall Study|Adverse Event|2|||
127767941|NCT02640157|459776699|FG002|Overall Study|Adverse Event|1|||
127767942|NCT02640157|459776697|FG000|Overall Study|Withdrew consent|2|||
127767943|NCT02640157|459776698|FG001|Overall Study|Withdrew consent|0|||
127767944|NCT02640157|459776699|FG002|Overall Study|Withdrew consent|2|||
127767945|NCT02640157|459776697|FG000|Overall Study|Lost to Follow-up|9|||
127767946|NCT02640157|459776698|FG001|Overall Study|Lost to Follow-up|2|||
127767947|NCT02640157|459776699|FG002|Overall Study|Lost to Follow-up|7|||
127767948|NCT02640157|459776697|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
127767949|NCT02640157|459776698|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
127767950|NCT02640157|459776699|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
127767951|NCT01679405|459776701|FG000|Overall Study|Death|2|||
127767952|NCT01679405|459776702|FG001|Overall Study|Death|5|||
127767953|NCT04677179|459776703|FG000|Induction Treatment Period|Adverse Event|1|||
127767954|NCT04677179|459776704|FG001|Induction Treatment Period|Adverse Event|0|||
127767955|NCT04677179|459776705|FG002|Induction Treatment Period|Adverse Event|0|||
127767956|NCT04677179|459776706|FG003|Induction Treatment Period|Adverse Event|0|||
127767957|NCT04677179|459776707|FG004|Induction Treatment Period|Adverse Event|0|||
127767958|NCT04677179|459776708|FG005|Induction Treatment Period|Adverse Event|0|||
127767959|NCT04677179|459776709|FG006|Induction Treatment Period|Adverse Event|0|||
127767960|NCT04677179|459776710|FG007|Induction Treatment Period|Adverse Event|0|||
127767961|NCT04677179|459776711|FG008|Induction Treatment Period|Adverse Event|0|||
127767962|NCT04677179|459776712|FG009|Induction Treatment Period|Adverse Event|0|||
127767963|NCT04677179|459776703|FG000|Induction Treatment Period|Physician Decision|1|||
127767964|NCT04677179|459776704|FG001|Induction Treatment Period|Physician Decision|0|||
127767965|NCT04677179|459776705|FG002|Induction Treatment Period|Physician Decision|1|||
127767966|NCT04677179|459776706|FG003|Induction Treatment Period|Physician Decision|0|||
127767967|NCT04677179|459776707|FG004|Induction Treatment Period|Physician Decision|0|||
127767968|NCT04677179|459776708|FG005|Induction Treatment Period|Physician Decision|0|||
127767969|NCT04677179|459776709|FG006|Induction Treatment Period|Physician Decision|0|||
127767970|NCT04677179|459776710|FG007|Induction Treatment Period|Physician Decision|0|||
127767971|NCT04677179|459776711|FG008|Induction Treatment Period|Physician Decision|0|||
127767972|NCT04677179|459776712|FG009|Induction Treatment Period|Physician Decision|0|||
128015130|NCT03126110|460679830|FG003|Phase 1|Survival follow-up no longer necessary|0|||
127767973|NCT04677179|459776703|FG000|Induction Treatment Period|Protocol Violation|0|||
127767974|NCT04677179|459776704|FG001|Induction Treatment Period|Protocol Violation|1|||
127767975|NCT04677179|459776705|FG002|Induction Treatment Period|Protocol Violation|0|||
127767976|NCT04677179|459776706|FG003|Induction Treatment Period|Protocol Violation|0|||
128015131|NCT03126110|460679831|FG004|Phase 1|Survival follow-up no longer necessary|0|||
128015132|NCT03126110|460679832|FG005|Phase 1|Survival follow-up no longer necessary|0|||
128015133|NCT03126110|460679833|FG006|Phase 1|Survival follow-up no longer necessary|0|||
128015134|NCT03126110|460679834|FG007|Phase 1|Survival follow-up no longer necessary|0|||
128015135|NCT03126110|460679835|FG008|Phase 1|Survival follow-up no longer necessary|0|||
128015136|NCT03126110|460679836|FG009|Phase 1|Survival follow-up no longer necessary|0|||
128015137|NCT03126110|460679837|FG010|Phase 1|Survival follow-up no longer necessary|0|||
128015138|NCT03126110|460679838|FG011|Phase 1|Survival follow-up no longer necessary|0|||
128015139|NCT03126110|460679839|FG012|Phase 1|Survival follow-up no longer necessary|0|||
128015140|NCT03126110|460679840|FG013|Phase 1|Survival follow-up no longer necessary|0|||
128015141|NCT03126110|460679841|FG014|Phase 1|Survival follow-up no longer necessary|0|||
128015142|NCT03126110|460679842|FG015|Phase 1|Survival follow-up no longer necessary|0|||
127681082|NCT04707313|459456557|FG008|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
127681083|NCT04707313|459456558|FG009|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
127681084|NCT04707313|459456559|FG010|Cohort 3 (Week 0 to Week 32)|Adverse Event|9|||
127681085|NCT04707313|459456560|FG011|Cohort 3 (Week 0 to Week 32)|Adverse Event|16|||
127681086|NCT04707313|459456561|FG012|Cohort 3 (Week 0 to Week 32)|Adverse Event|18|||
127681087|NCT04707313|459456549|FG000|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
127681088|NCT04707313|459456550|FG001|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
127681089|NCT04707313|459456551|FG002|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
127681090|NCT04707313|459456552|FG003|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
127681091|NCT04707313|459456553|FG004|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
127681092|NCT04707313|459456554|FG005|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
127681093|NCT04707313|459456555|FG006|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
127681094|NCT04707313|459456556|FG007|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
127681095|NCT04707313|459456557|FG008|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
127681096|NCT04707313|459456558|FG009|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|3|||
127681097|NCT04707313|459456559|FG010|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
127681098|NCT04707313|459456560|FG011|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
127681099|NCT04707313|459456561|FG012|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
127681100|NCT04707313|459456549|FG000|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
127681101|NCT04707313|459456550|FG001|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
127681102|NCT04707313|459456551|FG002|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
127681103|NCT04707313|459456552|FG003|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
127681104|NCT04707313|459456553|FG004|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
127681105|NCT04707313|459456554|FG005|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
127681106|NCT04707313|459456555|FG006|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
127681107|NCT04707313|459456556|FG007|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
127681108|NCT04707313|459456557|FG008|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
127681109|NCT04707313|459456558|FG009|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
127681110|NCT04707313|459456559|FG010|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|5|||
127681111|NCT04707313|459456560|FG011|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|2|||
127681112|NCT04707313|459456561|FG012|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
127681113|NCT04707313|459456549|FG000|Cohort 3 (Week 0 to Week 32)|Other|0|||
127681114|NCT04707313|459456550|FG001|Cohort 3 (Week 0 to Week 32)|Other|0|||
127681115|NCT04707313|459456551|FG002|Cohort 3 (Week 0 to Week 32)|Other|0|||
127681116|NCT04707313|459456552|FG003|Cohort 3 (Week 0 to Week 32)|Other|0|||
127681117|NCT04707313|459456553|FG004|Cohort 3 (Week 0 to Week 32)|Other|0|||
127681118|NCT04707313|459456554|FG005|Cohort 3 (Week 0 to Week 32)|Other|0|||
127681119|NCT04707313|459456555|FG006|Cohort 3 (Week 0 to Week 32)|Other|0|||
127681120|NCT04707313|459456556|FG007|Cohort 3 (Week 0 to Week 32)|Other|0|||
127681121|NCT04707313|459456557|FG008|Cohort 3 (Week 0 to Week 32)|Other|0|||
127681122|NCT04707313|459456558|FG009|Cohort 3 (Week 0 to Week 32)|Other|0|||
127681123|NCT04707313|459456559|FG010|Cohort 3 (Week 0 to Week 32)|Other|1|||
127681124|NCT04707313|459456560|FG011|Cohort 3 (Week 0 to Week 32)|Other|0|||
127681125|NCT04707313|459456561|FG012|Cohort 3 (Week 0 to Week 32)|Other|1|||
127681126|NCT04707313|459456549|FG000|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
127681127|NCT04707313|459456550|FG001|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
127681128|NCT04707313|459456551|FG002|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
127681129|NCT04707313|459456552|FG003|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
127681130|NCT04707313|459456553|FG004|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
127681131|NCT04707313|459456554|FG005|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
127681132|NCT04707313|459456555|FG006|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
127767977|NCT04677179|459776707|FG004|Induction Treatment Period|Protocol Violation|0|||
128015143|NCT03126110|460679843|FG016|Phase 1|Survival follow-up no longer necessary|0|||
128015144|NCT03126110|460679827|FG000|Phase 2|Study terminated by the sponsor|0|||
128015145|NCT03126110|460679828|FG001|Phase 2|Study terminated by the sponsor|0|||
128015146|NCT03126110|460679829|FG002|Phase 2|Study terminated by the sponsor|0|||
128015147|NCT03126110|460679830|FG003|Phase 2|Study terminated by the sponsor|0|||
128015148|NCT03126110|460679831|FG004|Phase 2|Study terminated by the sponsor|0|||
128015149|NCT03126110|460679832|FG005|Phase 2|Study terminated by the sponsor|0|||
128015150|NCT03126110|460679833|FG006|Phase 2|Study terminated by the sponsor|0|||
128015151|NCT03126110|460679834|FG007|Phase 2|Study terminated by the sponsor|0|||
128015152|NCT03126110|460679835|FG008|Phase 2|Study terminated by the sponsor|0|||
128015153|NCT03126110|460679836|FG009|Phase 2|Study terminated by the sponsor|0|||
128015154|NCT03126110|460679837|FG010|Phase 2|Study terminated by the sponsor|0|||
128015155|NCT03126110|460679838|FG011|Phase 2|Study terminated by the sponsor|0|||
128015156|NCT03126110|460679839|FG012|Phase 2|Study terminated by the sponsor|0|||
128015157|NCT03126110|460679840|FG013|Phase 2|Study terminated by the sponsor|4|||
128015158|NCT03126110|460679841|FG014|Phase 2|Study terminated by the sponsor|0|||
128015159|NCT03126110|460679842|FG015|Phase 2|Study terminated by the sponsor|0|||
128015160|NCT03126110|460679843|FG016|Phase 2|Study terminated by the sponsor|0|||
128015161|NCT03126110|460679827|FG000|Phase 2|Withdrawal by Subject|0|||
128015162|NCT03126110|460679828|FG001|Phase 2|Withdrawal by Subject|0|||
128015163|NCT03126110|460679829|FG002|Phase 2|Withdrawal by Subject|0|||
128015164|NCT03126110|460679830|FG003|Phase 2|Withdrawal by Subject|0|||
128015165|NCT03126110|460679831|FG004|Phase 2|Withdrawal by Subject|0|||
128015166|NCT03126110|460679832|FG005|Phase 2|Withdrawal by Subject|0|||
128015167|NCT03126110|460679833|FG006|Phase 2|Withdrawal by Subject|0|||
128015168|NCT03126110|460679834|FG007|Phase 2|Withdrawal by Subject|0|||
128015169|NCT03126110|460679835|FG008|Phase 2|Withdrawal by Subject|0|||
128015170|NCT03126110|460679836|FG009|Phase 2|Withdrawal by Subject|0|||
128015171|NCT03126110|460679837|FG010|Phase 2|Withdrawal by Subject|0|||
128015172|NCT03126110|460679838|FG011|Phase 2|Withdrawal by Subject|1|||
128015173|NCT03126110|460679839|FG012|Phase 2|Withdrawal by Subject|3|||
128015174|NCT03126110|460679840|FG013|Phase 2|Withdrawal by Subject|3|||
128015175|NCT03126110|460679841|FG014|Phase 2|Withdrawal by Subject|2|||
128015176|NCT03126110|460679842|FG015|Phase 2|Withdrawal by Subject|1|||
128015177|NCT03126110|460679843|FG016|Phase 2|Withdrawal by Subject|0|||
128015178|NCT03126110|460679827|FG000|Phase 2|Lost to Follow-up|0|||
128015179|NCT03126110|460679828|FG001|Phase 2|Lost to Follow-up|0|||
128015180|NCT03126110|460679829|FG002|Phase 2|Lost to Follow-up|0|||
128015181|NCT03126110|460679830|FG003|Phase 2|Lost to Follow-up|0|||
128015182|NCT03126110|460679831|FG004|Phase 2|Lost to Follow-up|0|||
128015183|NCT03126110|460679832|FG005|Phase 2|Lost to Follow-up|0|||
128015184|NCT03126110|460679833|FG006|Phase 2|Lost to Follow-up|0|||
128015185|NCT03126110|460679834|FG007|Phase 2|Lost to Follow-up|0|||
128015186|NCT03126110|460679835|FG008|Phase 2|Lost to Follow-up|0|||
128015187|NCT03126110|460679836|FG009|Phase 2|Lost to Follow-up|0|||
128015188|NCT03126110|460679837|FG010|Phase 2|Lost to Follow-up|0|||
128015189|NCT03126110|460679838|FG011|Phase 2|Lost to Follow-up|1|||
128015190|NCT03126110|460679839|FG012|Phase 2|Lost to Follow-up|1|||
128015191|NCT03126110|460679840|FG013|Phase 2|Lost to Follow-up|1|||
128015192|NCT03126110|460679841|FG014|Phase 2|Lost to Follow-up|2|||
128015193|NCT03126110|460679842|FG015|Phase 2|Lost to Follow-up|0|||
128015194|NCT03126110|460679843|FG016|Phase 2|Lost to Follow-up|0|||
128015195|NCT03126110|460679827|FG000|Phase 2|Death|0|||
128015196|NCT03126110|460679828|FG001|Phase 2|Death|0|||
128015197|NCT03126110|460679829|FG002|Phase 2|Death|0|||
128015198|NCT03126110|460679830|FG003|Phase 2|Death|0|||
128015199|NCT03126110|460679831|FG004|Phase 2|Death|0|||
127681133|NCT04707313|459456556|FG007|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
127681134|NCT04707313|459456557|FG008|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
127681135|NCT04707313|459456558|FG009|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
127681136|NCT04707313|459456559|FG010|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
127681137|NCT04707313|459456560|FG011|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
127681138|NCT04707313|459456561|FG012|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
127681139|NCT04707313|459456549|FG000|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
127681140|NCT04707313|459456550|FG001|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
127681141|NCT04707313|459456551|FG002|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
127681142|NCT04707313|459456552|FG003|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
127681143|NCT04707313|459456553|FG004|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
127681144|NCT04707313|459456554|FG005|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
128015200|NCT03126110|460679832|FG005|Phase 2|Death|0|||
128015201|NCT03126110|460679833|FG006|Phase 2|Death|0|||
128015202|NCT03126110|460679834|FG007|Phase 2|Death|0|||
128015203|NCT03126110|460679835|FG008|Phase 2|Death|0|||
128015204|NCT03126110|460679836|FG009|Phase 2|Death|0|||
128015205|NCT03126110|460679837|FG010|Phase 2|Death|0|||
127681145|NCT04707313|459456555|FG006|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
128015206|NCT03126110|460679838|FG011|Phase 2|Death|6|||
128015207|NCT03126110|460679839|FG012|Phase 2|Death|12|||
128015208|NCT03126110|460679840|FG013|Phase 2|Death|25|||
128015209|NCT03126110|460679841|FG014|Phase 2|Death|11|||
127681146|NCT04707313|459456556|FG007|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
128015210|NCT03126110|460679842|FG015|Phase 2|Death|3|||
128015211|NCT03126110|460679843|FG016|Phase 2|Death|2|||
128015212|NCT03126110|460679827|FG000|Phase 2|Progressive Disease|0|||
128015213|NCT03126110|460679828|FG001|Phase 2|Progressive Disease|0|||
128015214|NCT03126110|460679829|FG002|Phase 2|Progressive Disease|0|||
128015215|NCT03126110|460679830|FG003|Phase 2|Progressive Disease|0|||
128015216|NCT03126110|460679831|FG004|Phase 2|Progressive Disease|0|||
128015217|NCT03126110|460679832|FG005|Phase 2|Progressive Disease|0|||
127767978|NCT04677179|459776708|FG005|Induction Treatment Period|Protocol Violation|0|||
127767979|NCT04677179|459776709|FG006|Induction Treatment Period|Protocol Violation|0|||
127767980|NCT04677179|459776710|FG007|Induction Treatment Period|Protocol Violation|0|||
127767981|NCT04677179|459776711|FG008|Induction Treatment Period|Protocol Violation|0|||
127767982|NCT04677179|459776712|FG009|Induction Treatment Period|Protocol Violation|0|||
127767983|NCT04677179|459776703|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
127767984|NCT04677179|459776704|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
127767985|NCT04677179|459776705|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
127767986|NCT04677179|459776706|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
127767987|NCT04677179|459776707|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
127767988|NCT04677179|459776708|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
127767989|NCT04677179|459776709|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
127767990|NCT04677179|459776710|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
127767991|NCT04677179|459776711|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
127767992|NCT04677179|459776712|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
127767993|NCT04677179|459776703|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
127767994|NCT04677179|459776704|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
128015218|NCT03126110|460679833|FG006|Phase 2|Progressive Disease|0|||
128015219|NCT03126110|460679834|FG007|Phase 2|Progressive Disease|0|||
128015220|NCT03126110|460679835|FG008|Phase 2|Progressive Disease|0|||
128015221|NCT03126110|460679836|FG009|Phase 2|Progressive Disease|0|||
128015222|NCT03126110|460679837|FG010|Phase 2|Progressive Disease|0|||
128015223|NCT03126110|460679838|FG011|Phase 2|Progressive Disease|0|||
128015224|NCT03126110|460679839|FG012|Phase 2|Progressive Disease|0|||
128015225|NCT03126110|460679840|FG013|Phase 2|Progressive Disease|1|||
128015226|NCT03126110|460679841|FG014|Phase 2|Progressive Disease|0|||
128015227|NCT03126110|460679842|FG015|Phase 2|Progressive Disease|0|||
128015228|NCT03126110|460679843|FG016|Phase 2|Progressive Disease|0|||
128015229|NCT03126110|460679827|FG000|Phase 2|Started new treatment|0|||
128015230|NCT03126110|460679828|FG001|Phase 2|Started new treatment|0|||
128015231|NCT03126110|460679829|FG002|Phase 2|Started new treatment|0|||
128015232|NCT03126110|460679830|FG003|Phase 2|Started new treatment|0|||
128015233|NCT03126110|460679831|FG004|Phase 2|Started new treatment|0|||
128015234|NCT03126110|460679832|FG005|Phase 2|Started new treatment|0|||
128015235|NCT03126110|460679833|FG006|Phase 2|Started new treatment|0|||
128015236|NCT03126110|460679834|FG007|Phase 2|Started new treatment|0|||
127767995|NCT04677179|459776705|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
127767996|NCT04677179|459776706|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
128015237|NCT03126110|460679835|FG008|Phase 2|Started new treatment|0|||
128015238|NCT03126110|460679836|FG009|Phase 2|Started new treatment|0|||
128015239|NCT03126110|460679837|FG010|Phase 2|Started new treatment|0|||
128015240|NCT03126110|460679838|FG011|Phase 2|Started new treatment|0|||
128015241|NCT03126110|460679839|FG012|Phase 2|Started new treatment|0|||
128015242|NCT03126110|460679840|FG013|Phase 2|Started new treatment|0|||
128015243|NCT03126110|460679841|FG014|Phase 2|Started new treatment|1|||
128015244|NCT03126110|460679842|FG015|Phase 2|Started new treatment|0|||
128015245|NCT03126110|460679843|FG016|Phase 2|Started new treatment|0|||
128015246|NCT03785366|460679857|FG000|Overall Study|Non-Menstrual Pelvic Pain|1|||
128015247|NCT03785366|460679858|FG001|Overall Study|Non-Menstrual Pelvic Pain|0|||
127767997|NCT04677179|459776707|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
127767998|NCT04677179|459776708|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
127767999|NCT04677179|459776709|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
127768000|NCT04677179|459776710|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
127768001|NCT04677179|459776711|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
127768002|NCT04677179|459776712|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
127768003|NCT04677179|459776703|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
127768004|NCT04677179|459776704|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
127768005|NCT04677179|459776705|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
127768006|NCT04677179|459776706|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
127768007|NCT04677179|459776707|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
127768008|NCT04677179|459776708|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
128015248|NCT03785366|460679857|FG000|Overall Study|Lost to Follow-up|1|||
128015249|NCT03785366|460679858|FG001|Overall Study|Lost to Follow-up|0|||
128015250|NCT03785366|460679857|FG000|Overall Study|Partial IUD Expulsion|0|||
128015251|NCT03785366|460679858|FG001|Overall Study|Partial IUD Expulsion|2|||
128015252|NCT03785366|460679857|FG000|Overall Study|Unsuccessful IUD Insertion|0|||
128015253|NCT03785366|460679858|FG001|Overall Study|Unsuccessful IUD Insertion|1|||
128015254|NCT03240874|460679859|FG000|Overall Study|Lost to Follow-up|0|||
128015255|NCT03240874|460679860|FG001|Overall Study|Lost to Follow-up|2|||
128015256|NCT03240874|460679861|FG002|Overall Study|Lost to Follow-up|4|||
128015257|NCT03240874|460679862|FG003|Overall Study|Lost to Follow-up|1|||
128015258|NCT04153864|460679863|FG000|Overall Study|Withdrawal by Subject|21|||
128015259|NCT04153864|460679864|FG001|Overall Study|Withdrawal by Subject|7|||
128015260|NCT04153864|460679865|FG002|Overall Study|Withdrawal by Subject|23|||
128015261|NCT04153864|460679866|FG003|Overall Study|Withdrawal by Subject|2|||
128015262|NCT04153864|460679863|FG000|Overall Study|Lost to Follow-up|4|||
128015263|NCT04153864|460679864|FG001|Overall Study|Lost to Follow-up|0|||
128015264|NCT04153864|460679865|FG002|Overall Study|Lost to Follow-up|3|||
128015265|NCT04153864|460679866|FG003|Overall Study|Lost to Follow-up|0|||
128015266|NCT04153864|460679863|FG000|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|28|||
128015267|NCT04153864|460679864|FG001|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|10|||
128015268|NCT04153864|460679865|FG002|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|26|||
128015269|NCT04153864|460679866|FG003|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|8|||
128015270|NCT04958707|460679867|FG000|Post Intervention|Withdrawal by Subject|1|||
128015271|NCT04958707|460679868|FG001|Post Intervention|Withdrawal by Subject|0|||
128015272|NCT04958707|460679869|FG002|Post Intervention|Withdrawal by Subject|0|||
128015273|NCT04958707|460679867|FG000|3 Months Follow- up|Lost to Follow-up|0|||
128015274|NCT04958707|460679868|FG001|3 Months Follow- up|Lost to Follow-up|3|||
128015275|NCT04958707|460679869|FG002|3 Months Follow- up|Lost to Follow-up|0|||
128015276|NCT04958707|460679867|FG000|3 Months Follow- up|Withdrawal by Subject|2|||
128015277|NCT04958707|460679868|FG001|3 Months Follow- up|Withdrawal by Subject|0|||
128015278|NCT04958707|460679869|FG002|3 Months Follow- up|Withdrawal by Subject|0|||
127681147|NCT04707313|459456557|FG008|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
127681148|NCT04707313|459456558|FG009|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|1|||
127681149|NCT04707313|459456559|FG010|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|7|||
127681150|NCT04707313|459456560|FG011|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
127681151|NCT04707313|459456561|FG012|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
127681152|NCT00324038|459456565|FG000|Overall Study|Adverse Event|38|||
127681153|NCT00324038|459456566|FG001|Overall Study|Adverse Event|23|||
127681154|NCT00324038|459456565|FG000|Overall Study|Lack of Efficacy|5|||
127681155|NCT00324038|459456566|FG001|Overall Study|Lack of Efficacy|13|||
127681156|NCT00324038|459456565|FG000|Overall Study|Lost to Follow-up|0|||
127681157|NCT00324038|459456566|FG001|Overall Study|Lost to Follow-up|2|||
127681158|NCT00324038|459456565|FG000|Overall Study|Other|6|||
127681159|NCT00324038|459456566|FG001|Overall Study|Other|13|||
127681160|NCT03070483|459456567|FG000|Overall Study|Lost to Follow-up|2|||
127681161|NCT02770248|459456568|FG000|Overall Study|Adverse Event|0|||
127681162|NCT02770248|459456569|FG001|Overall Study|Adverse Event|1|||
127681163|NCT02770248|459456568|FG000|Overall Study|Randomized in error, prior to treatment|0|||
127681164|NCT02770248|459456569|FG001|Overall Study|Randomized in error, prior to treatment|1|||
127681165|NCT01585558|459456572|FG000|Overall Study|Withdrawal by Subject|4|||
127681166|NCT01585558|459456573|FG001|Overall Study|Withdrawal by Subject|5|||
127681167|NCT01585558|459456574|FG002|Overall Study|Withdrawal by Subject|8|||
127681168|NCT01585558|459456572|FG000|Overall Study|Lost to Follow-up|2|||
127681169|NCT01585558|459456573|FG001|Overall Study|Lost to Follow-up|0|||
127681170|NCT01585558|459456574|FG002|Overall Study|Lost to Follow-up|3|||
127681171|NCT01585558|459456572|FG000|Overall Study|Adverse Event|3|||
127681172|NCT01585558|459456573|FG001|Overall Study|Adverse Event|4|||
127681173|NCT01585558|459456574|FG002|Overall Study|Adverse Event|1|||
127681174|NCT01585558|459456572|FG000|Overall Study|Protocol Violation|4|||
127681175|NCT01585558|459456573|FG001|Overall Study|Protocol Violation|3|||
127681176|NCT01585558|459456574|FG002|Overall Study|Protocol Violation|2|||
127681177|NCT01585558|459456572|FG000|Overall Study|Lack of Efficacy|0|||
127681178|NCT01585558|459456573|FG001|Overall Study|Lack of Efficacy|0|||
127681179|NCT01585558|459456574|FG002|Overall Study|Lack of Efficacy|1|||
127681180|NCT03768206|459456582|FG000|Overall Study|Lost to Follow-up|2|||
127681181|NCT03768206|459456583|FG001|Overall Study|Lost to Follow-up|1|||
127681182|NCT03768206|459456582|FG000|Overall Study|Withdrawal by Subject|0|||
127681183|NCT03768206|459456583|FG001|Overall Study|Withdrawal by Subject|1|||
127681184|NCT01713946|459456584|FG000|Overall Study|Death|0|||
127681185|NCT01713946|459456585|FG001|Overall Study|Death|2|||
127681186|NCT01713946|459456586|FG002|Overall Study|Death|2|||
127681187|NCT01713946|459456584|FG000|Overall Study|Adverse Event|19|||
127681188|NCT01713946|459456585|FG001|Overall Study|Adverse Event|14|||
127681189|NCT01713946|459456586|FG002|Overall Study|Adverse Event|13|||
127681190|NCT01713946|459456584|FG000|Overall Study|Withdrawal by Subject|12|||
127681191|NCT01713946|459456585|FG001|Overall Study|Withdrawal by Subject|12|||
127681192|NCT01713946|459456586|FG002|Overall Study|Withdrawal by Subject|8|||
127681193|NCT01713946|459456584|FG000|Overall Study|Lack of Efficacy|8|||
127681194|NCT01713946|459456585|FG001|Overall Study|Lack of Efficacy|8|||
127681195|NCT01713946|459456586|FG002|Overall Study|Lack of Efficacy|14|||
127681196|NCT01713946|459456584|FG000|Overall Study|Protocol Violation|2|||
128015279|NCT02629159|460679872|FG000|Overall Study|Adverse Event|17|||
128015280|NCT02629159|460679873|FG001|Overall Study|Adverse Event|20|||
128015281|NCT02629159|460679874|FG002|Overall Study|Adverse Event|22|||
127681197|NCT01713946|459456585|FG001|Overall Study|Protocol Violation|4|||
127681198|NCT01713946|459456586|FG002|Overall Study|Protocol Violation|1|||
127681199|NCT01713946|459456584|FG000|Overall Study|Lost to Follow-up|0|||
127681200|NCT01713946|459456585|FG001|Overall Study|Lost to Follow-up|0|||
128015282|NCT02629159|460679872|FG000|Overall Study|Withdrawal by Subject|22|||
128015283|NCT02629159|460679873|FG001|Overall Study|Withdrawal by Subject|11|||
128015284|NCT02629159|460679874|FG002|Overall Study|Withdrawal by Subject|15|||
128015285|NCT02629159|460679872|FG000|Overall Study|Lost to Follow-up|7|||
128015286|NCT02629159|460679873|FG001|Overall Study|Lost to Follow-up|4|||
128015287|NCT02629159|460679874|FG002|Overall Study|Lost to Follow-up|5|||
128015288|NCT02629159|460679872|FG000|Overall Study|Lack of Efficacy|4|||
128015289|NCT02629159|460679873|FG001|Overall Study|Lack of Efficacy|0|||
128015290|NCT02629159|460679874|FG002|Overall Study|Lack of Efficacy|1|||
128015291|NCT02629159|460679872|FG000|Overall Study|Other|6|||
128015292|NCT02629159|460679873|FG001|Overall Study|Other|4|||
128015293|NCT02629159|460679874|FG002|Overall Study|Other|8|||
128015294|NCT04717557|460679887|FG000|Overall Study|Withdrawal by Subject|2|||
128015295|NCT04717557|460679888|FG001|Overall Study|Withdrawal by Subject|0|||
128015296|NCT04717557|460679887|FG000|Overall Study|Death|1|||
128015297|NCT04717557|460679888|FG001|Overall Study|Death|0|||
128015298|NCT05352399|460679890|FG000|Overall Study|Discontinued intervention|6|||
128015299|NCT01802281|460679893|FG000|Overall Study|Death|1|||
128015300|NCT01802281|460679894|FG001|Overall Study|Death|2|||
128015301|NCT01802281|460679893|FG000|Overall Study|Withdrawal by Subject|2|||
128015302|NCT01802281|460679894|FG001|Overall Study|Withdrawal by Subject|1|||
128015303|NCT01802281|460679893|FG000|Overall Study|Ineligible|5|||
128015304|NCT01802281|460679894|FG001|Overall Study|Ineligible|3|||
128015305|NCT02685735|460679895|FG000|Overall Study|Surgery Cancelled|4|||
128015306|NCT02685735|460679896|FG001|Overall Study|Surgery Cancelled|9|||
128015307|NCT02685735|460679895|FG000|Overall Study|Adverse Event|10|||
128015308|NCT02685735|460679896|FG001|Overall Study|Adverse Event|3|||
128015309|NCT02685735|460679895|FG000|Overall Study|Preop testing found to be incomplete|2|||
128015310|NCT02685735|460679896|FG001|Overall Study|Preop testing found to be incomplete|2|||
128015311|NCT02685735|460679895|FG000|Overall Study|Withdrawal by Subject|1|||
128015312|NCT02685735|460679896|FG001|Overall Study|Withdrawal by Subject|2|||
128015313|NCT02685735|460679895|FG000|Overall Study|Death|1|||
128015314|NCT02685735|460679896|FG001|Overall Study|Death|0|||
128015315|NCT00927472|460679906|FG000|Overall Study|Withdrawal by Subject|10|||
128015316|NCT00927472|460679907|FG001|Overall Study|Withdrawal by Subject|11|||
127681201|NCT01713946|459456586|FG002|Overall Study|Lost to Follow-up|1|||
127681202|NCT01713946|459456584|FG000|Overall Study|Administrative problems|1|||
127681203|NCT01713946|459456585|FG001|Overall Study|Administrative problems|0|||
127681204|NCT01713946|459456586|FG002|Overall Study|Administrative problems|0|||
128015317|NCT00927472|460679906|FG000|Overall Study|Lost to Follow-up|1|||
128015318|NCT00927472|460679907|FG001|Overall Study|Lost to Follow-up|6|||
128015319|NCT00927472|460679906|FG000|Overall Study|Protocol Violation|0|||
127681205|NCT01713946|459456584|FG000|Overall Study|Did not continue in Ext|0|||
127681206|NCT01713946|459456585|FG001|Overall Study|Did not continue in Ext|3|||
127681207|NCT01713946|459456586|FG002|Overall Study|Did not continue in Ext|0|||
127681208|NCT01713946|459456584|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
127681209|NCT01713946|459456585|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
127681210|NCT01713946|459456586|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
127681211|NCT01713946|459456584|FG000|Overall Study|Patients never switched to everolimus|0|||
127681212|NCT01713946|459456585|FG001|Overall Study|Patients never switched to everolimus|0|||
127681213|NCT01713946|459456586|FG002|Overall Study|Patients never switched to everolimus|5|||
127681214|NCT03183518|459456587|FG000|Overall Study|Other (Not specified)|2|||
127681215|NCT03183518|459456587|FG000|Overall Study|Other (Withdrawal of consent)|1|||
127681216|NCT04493242|459456590|FG000|Overall Study|Death|10|||
127681217|NCT04493242|459456591|FG001|Overall Study|Death|14|||
127681218|NCT04493242|459456592|FG002|Overall Study|Death|16|||
127681219|NCT04493242|459456590|FG000|Overall Study|Lost to Follow-up|1|||
127681220|NCT04493242|459456591|FG001|Overall Study|Lost to Follow-up|1|||
127681221|NCT04493242|459456592|FG002|Overall Study|Lost to Follow-up|0|||
127681222|NCT04493242|459456590|FG000|Overall Study|Withdrawal by Subject|1|||
127681223|NCT04493242|459456591|FG001|Overall Study|Withdrawal by Subject|0|||
128015320|NCT00927472|460679907|FG001|Overall Study|Protocol Violation|1|||
128015321|NCT00927472|460679906|FG000|Overall Study|Post treatment Assessment out of window|0|||
127681224|NCT04493242|459456592|FG002|Overall Study|Withdrawal by Subject|0|||
128015322|NCT00927472|460679907|FG001|Overall Study|Post treatment Assessment out of window|4|||
128015323|NCT01081951|460680852|FG000|Overall Study|Death|54|||
128015324|NCT01081951|460680853|FG001|Overall Study|Death|47|||
128015325|NCT01081951|460680852|FG000|Overall Study|Withdrawal by Subject|2|||
128015326|NCT01081951|460680853|FG001|Overall Study|Withdrawal by Subject|6|||
128015327|NCT01081951|460680852|FG000|Overall Study|Allocated treatment but did not take it|0|||
128015328|NCT01081951|460680853|FG001|Overall Study|Allocated treatment but did not take it|1|||
128015329|NCT01081951|460680852|FG000|Overall Study|Lost to Follow-up|0|||
128015330|NCT01081951|460680853|FG001|Overall Study|Lost to Follow-up|1|||
128015331|NCT03806296|460680856|FG000|T1: Laboratory: 1 Week|Withdrawal by Subject|6|||
128015332|NCT03806296|460680857|FG001|T1: Laboratory: 1 Week|Withdrawal by Subject|1|||
128015333|NCT03806296|460680858|FG002|T1: Laboratory: 1 Week|Withdrawal by Subject|3|||
128015334|NCT03806296|460680856|FG000|T1: Laboratory: 1 Week|Lost to Follow-up|7|||
128015335|NCT03806296|460680857|FG001|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
128015336|NCT03806296|460680858|FG002|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
128015337|NCT03806296|460680856|FG000|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|1|||
128015338|NCT03806296|460680857|FG001|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
128015339|NCT03806296|460680858|FG002|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
128015340|NCT04896385|460680861|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
128015341|NCT04896385|460680862|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
128015342|NCT04896385|460680863|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
128015343|NCT04896385|460680864|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
128015344|NCT04896385|460680861|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
128015345|NCT04896385|460680862|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
128015346|NCT04896385|460680863|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
128015347|NCT04896385|460680864|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
128015348|NCT04896385|460680861|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
128015349|NCT04896385|460680862|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
128015350|NCT04896385|460680863|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
128015351|NCT04896385|460680864|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
128015352|NCT04896385|460680861|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
128015353|NCT04896385|460680862|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
128015354|NCT04896385|460680863|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
128015355|NCT04896385|460680864|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
128015356|NCT04896385|460680861|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
128015357|NCT04896385|460680862|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
128015358|NCT04896385|460680863|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
128015359|NCT04896385|460680864|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
128015360|NCT04896385|460680861|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
128015361|NCT04896385|460680862|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
128015362|NCT04896385|460680863|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
128015363|NCT04896385|460680864|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
128015364|NCT01931098|460680867|FG000|Overall Study|Withdrawal by Subject|0|||
128015365|NCT01931098|460680868|FG001|Overall Study|Withdrawal by Subject|1|||
128015366|NCT01931098|460680867|FG000|Overall Study|Enrolled in different protocol|0|||
128015367|NCT01931098|460680868|FG001|Overall Study|Enrolled in different protocol|1|||
128015368|NCT01931098|460680867|FG000|Overall Study|Unable to begin trmt:active infection|0|||
128015369|NCT01931098|460680868|FG001|Overall Study|Unable to begin trmt:active infection|1|||
128015370|NCT01931098|460680867|FG000|Overall Study|Refused further treatment|0|||
128015371|NCT01931098|460680868|FG001|Overall Study|Refused further treatment|1|||
128015372|NCT02278354|460680869|FG000|Overall Study|Lost to Follow-up|2|||
128015373|NCT02278354|460680870|FG001|Overall Study|Lost to Follow-up|2|||
128015374|NCT02278354|460680869|FG000|Overall Study|Withdrawal by Subject|0|||
128015375|NCT02278354|460680870|FG001|Overall Study|Withdrawal by Subject|1|||
128015376|NCT02278354|460680869|FG000|Overall Study|<10 professional fights|2|||
128015377|NCT02278354|460680870|FG001|Overall Study|<10 professional fights|0|||
128015378|NCT01901562|460680871|FG000|Overall Study|Protocol Violation|5|||
128015379|NCT01901562|460680871|FG000|Overall Study|Excluded intraoperatively|4|||
128015380|NCT04235374|460680872|FG000|Overall Study|Death|91|||
128015381|NCT04235374|460680873|FG001|Overall Study|Death|91|||
128015382|NCT04235374|460680872|FG000|Overall Study|Refused|2|||
128015383|NCT04235374|460680873|FG001|Overall Study|Refused|2|||
128015384|NCT04235374|460680872|FG000|Overall Study|Unavailable|12|||
128015385|NCT04235374|460680873|FG001|Overall Study|Unavailable|3|||
128015386|NCT04235374|460680872|FG000|Overall Study|Withdrawal by Subject|0|||
128015387|NCT04235374|460680873|FG001|Overall Study|Withdrawal by Subject|1|||
128015388|NCT04235374|460680872|FG000|Overall Study|Withdrawal by Legally Authorized Representative|10|||
128015389|NCT04235374|460680873|FG001|Overall Study|Withdrawal by Legally Authorized Representative|9|||
127681225|NCT04493242|459456590|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
127681226|NCT04493242|459456591|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
127681227|NCT04493242|459456592|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
127681228|NCT04493242|459456590|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
127681229|NCT04493242|459456591|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
127681230|NCT04493242|459456592|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
127681231|NCT04513522|459458343|FG000|Overall Study|Other reasons|1|||
128015390|NCT00088153|460680874|FG000|Overall Study|Physician Decision|3|||
128015391|NCT00088153|460680875|FG001|Overall Study|Physician Decision|3|||
128015392|NCT00088153|460680874|FG000|Overall Study|Withdrawal by Subject|10|||
128015393|NCT00088153|460680875|FG001|Overall Study|Withdrawal by Subject|10|||
128015394|NCT00088153|460680874|FG000|Overall Study|Lost to Follow-up|11|||
128015395|NCT00088153|460680875|FG001|Overall Study|Lost to Follow-up|12|||
128015396|NCT00976027|460680877|FG000|Overall Study|Serious Adverse Event|36|||
128015397|NCT00976027|460680878|FG001|Overall Study|Serious Adverse Event|17|||
128015398|NCT00976027|460680877|FG000|Overall Study|Adverse Event|0|||
128015399|NCT00976027|460680878|FG001|Overall Study|Adverse Event|2|||
128015400|NCT00976027|460680877|FG000|Overall Study|Protocol Violation|60|||
128015401|NCT00976027|460680878|FG001|Overall Study|Protocol Violation|27|||
128015402|NCT00976027|460680877|FG000|Overall Study|Lost to Follow-up|208|||
128015403|NCT00976027|460680878|FG001|Overall Study|Lost to Follow-up|103|||
128015404|NCT00976027|460680877|FG000|Overall Study|Withdrawal by Subject|107|||
128015405|NCT00976027|460680878|FG001|Overall Study|Withdrawal by Subject|66|||
128015406|NCT04435626|460680883|FG000|Overall Study|Lost to Follow-up|1|||
128015407|NCT04435626|460680884|FG001|Overall Study|Lost to Follow-up|5|||
128015408|NCT04435626|460680883|FG000|Overall Study|Withdrawal by Subject|6|||
128015409|NCT04435626|460680884|FG001|Overall Study|Withdrawal by Subject|7|||
128015410|NCT04435626|460680883|FG000|Overall Study|major GCP violations|8|||
128015411|NCT04435626|460680884|FG001|Overall Study|major GCP violations|7|||
128015412|NCT01771107|460680890|FG000|Overall Study|Adverse Event|1|||
128015413|NCT01771107|460680891|FG001|Overall Study|Adverse Event|3|||
128015414|NCT01771107|460680890|FG000|Overall Study|Withdrawal by Subject|0|||
128015415|NCT01771107|460680891|FG001|Overall Study|Withdrawal by Subject|2|||
128015416|NCT01771107|460680890|FG000|Overall Study|Lost to Follow-up|0|||
128015417|NCT01771107|460680891|FG001|Overall Study|Lost to Follow-up|1|||
128015418|NCT01771107|460680890|FG000|Overall Study|participant moved|0|||
128015419|NCT01771107|460680891|FG001|Overall Study|participant moved|1|||
128015420|NCT01771107|460680890|FG000|Overall Study|Other|0|||
128015421|NCT01771107|460680891|FG001|Overall Study|Other|1|||
128015422|NCT05248386|460680893|FG000|Overall Study|Technical problems|0|||
128015423|NCT05248386|460680894|FG001|Overall Study|Technical problems|1|||
128015424|NCT05248386|460680893|FG000|Overall Study|Withdrawal by Subject|15|||
128015425|NCT05248386|460680894|FG001|Overall Study|Withdrawal by Subject|10|||
128015426|NCT05248386|460680893|FG000|Overall Study|Physician Decision|0|||
128015427|NCT05248386|460680894|FG001|Overall Study|Physician Decision|1|||
128015428|NCT05248386|460680893|FG000|Overall Study|Adverse Event|2|||
128015429|NCT05248386|460680894|FG001|Overall Study|Adverse Event|4|||
128015430|NCT05248386|460680893|FG000|Overall Study|Other|1|||
128015431|NCT05248386|460680894|FG001|Overall Study|Other|0|||
128015432|NCT05248386|460680893|FG000|Overall Study|Lack of Efficacy|14|||
128015433|NCT05248386|460680894|FG001|Overall Study|Lack of Efficacy|12|||
128015434|NCT02864992|460680898|FG000|Overall Study|still on treatment|15|||
128015435|NCT02864992|460680899|FG001|Overall Study|still on treatment|1|||
128015436|NCT02864992|460680900|FG002|Overall Study|still on treatment|33|||
128015437|NCT04967222|460680901|FG000|Randomized|Lost to Follow-up|0|||
128015438|NCT04967222|460680902|FG001|Randomized|Lost to Follow-up|1|||
128015439|NCT04967222|460680903|FG002|Randomized|Lost to Follow-up|1|||
128015440|NCT04967222|460680901|FG000|Randomized|Physician Decision|0|||
128015441|NCT04967222|460680902|FG001|Randomized|Physician Decision|0|||
128015442|NCT04967222|460680903|FG002|Randomized|Physician Decision|1|||
127681232|NCT04513522|459458343|FG000|Overall Study|Adverse event unrelated to study drug|9|||
127681233|NCT04513522|459458343|FG000|Overall Study|Study drug toxicity|14|||
127681234|NCT04513522|459458343|FG000|Overall Study|Disease progression|39|||
127681235|NCT04513522|459458343|FG000|Overall Study|Participants withdrew consent|2|||
127681236|NCT00589667|459458346|FG000|Overall Study|Adverse Event|2|||
128015443|NCT04967222|460680901|FG000|Randomized|Withdrawal by Subject|0|||
128015444|NCT04967222|460680902|FG001|Randomized|Withdrawal by Subject|0|||
128015445|NCT04967222|460680903|FG002|Randomized|Withdrawal by Subject|2|||
128015446|NCT04967222|460680901|FG000|Randomized|abnormal finding in MRI|0|||
128015447|NCT04967222|460680902|FG001|Randomized|abnormal finding in MRI|2|||
128015448|NCT04967222|460680903|FG002|Randomized|abnormal finding in MRI|0|||
128015449|NCT01295944|460680904|FG000|Overall Study|Switched to alternative treatment|1|||
128015450|NCT01295944|460680904|FG000|Overall Study|Ineligible|9|||
128015451|NCT01295944|460680904|FG000|Overall Study|Withdrawal by Subject|1|||
128015452|NCT01295944|460680904|FG000|Overall Study|Participant chose to be treated in Peru|1|||
128015453|NCT01295944|460680904|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
128015454|NCT01295944|460680904|FG000|Overall Study|Physician Decision|1|||
128015455|NCT01295944|460680904|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
128015456|NCT01295944|460680904|FG000|Overall Study|Disease progression|4|||
128015457|NCT01295944|460680904|FG000|Overall Study|Transferred care before starting new treatment|1|||
128015458|NCT05252702|460680905|FG000|Overall Study|No attempted implant, subjects withdrawn|12|||
128015459|NCT05252702|460680905|FG000|Overall Study|Death|16|||
128015460|NCT05252702|460680905|FG000|Overall Study|System explant|5|||
128015461|NCT05252702|460680905|FG000|Overall Study|Lost to Follow-up|1|||
128015462|NCT05252702|460680905|FG000|Overall Study|Withdrawn by investigator|1|||
128015463|NCT05252702|460680905|FG000|Overall Study|Visit not due|306|||
128015464|NCT05252702|460680905|FG000|Overall Study|Visit within window but not completed|92|||
128015465|NCT05252702|460680905|FG000|Overall Study|Unsuccessful implant|1|||
128015466|NCT00569127|460680906|FG000|Overall Study|Adverse Event|57|||
128015467|NCT00569127|460680907|FG001|Overall Study|Adverse Event|47|||
128015468|NCT00569127|460680906|FG000|Overall Study|Withdrawal by Subject|13|||
128015469|NCT00569127|460680907|FG001|Overall Study|Withdrawal by Subject|27|||
128015470|NCT00569127|460680906|FG000|Overall Study|Progression|99|||
128015471|NCT00569127|460680907|FG001|Overall Study|Progression|100|||
128015472|NCT00569127|460680906|FG000|Overall Study|Death|4|||
128015473|NCT00569127|460680907|FG001|Overall Study|Death|3|||
128015474|NCT00569127|460680906|FG000|Overall Study|Other|20|||
128015475|NCT00569127|460680907|FG001|Overall Study|Other|19|||
128015476|NCT00569127|460680906|FG000|Overall Study|Lost to Follow-up|0|||
128015477|NCT00569127|460680907|FG001|Overall Study|Lost to Follow-up|3|||
127768009|NCT04677179|459776709|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
127768010|NCT04677179|459776710|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
127768011|NCT04677179|459776711|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
127768012|NCT04677179|459776712|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
128015478|NCT00569127|460680906|FG000|Overall Study|Not Eligible|14|||
128015479|NCT00569127|460680907|FG001|Overall Study|Not Eligible|11|||
128015480|NCT00569127|460680906|FG000|Overall Study|Still on Treatment|7|||
128015481|NCT00569127|460680907|FG001|Overall Study|Still on Treatment|3|||
128015482|NCT04279522|460680909|FG000|Period 1: Double Blind Phase|Lost to Follow-up|0|||
128015483|NCT04279522|460680910|FG001|Period 1: Double Blind Phase|Lost to Follow-up|1|||
128015484|NCT04279522|460680909|FG000|Period 1: Double Blind Phase|Withdrawal by Subject|10|||
128015485|NCT04279522|460680910|FG001|Period 1: Double Blind Phase|Withdrawal by Subject|8|||
128015486|NCT04279522|460680909|FG000|Period 1: Double Blind Phase|Protocol Violation|1|||
128015487|NCT04279522|460680910|FG001|Period 1: Double Blind Phase|Protocol Violation|0|||
128015488|NCT04279522|460680909|FG000|Period 2: Open Label Phase|Lost to Follow-up|1|||
128015489|NCT04279522|460680910|FG001|Period 2: Open Label Phase|Lost to Follow-up|1|||
128015490|NCT04279522|460680909|FG000|Period 2: Open Label Phase|Withdrawal by Subject|2|||
128015491|NCT04279522|460680910|FG001|Period 2: Open Label Phase|Withdrawal by Subject|2|||
128015492|NCT04279522|460680909|FG000|Period 2: Open Label Phase|Physician Decision|0|||
128015493|NCT04279522|460680910|FG001|Period 2: Open Label Phase|Physician Decision|3|||
128015494|NCT04279522|460680909|FG000|Period 2: Open Label Phase|Adverse Event|0|||
128015495|NCT04279522|460680910|FG001|Period 2: Open Label Phase|Adverse Event|1|||
128015496|NCT04279522|460680909|FG000|Period 2: Open Label Phase|Protocol Violation|1|||
128015497|NCT04279522|460680910|FG001|Period 2: Open Label Phase|Protocol Violation|0|||
128015498|NCT03036254|460680912|FG000|Overall Study|Adverse Event|6|||
128015499|NCT03036254|460680913|FG001|Overall Study|Adverse Event|4|||
128015500|NCT03036254|460680912|FG000|Overall Study|Death|3|||
128015501|NCT03036254|460680913|FG001|Overall Study|Death|1|||
128015502|NCT03036254|460680912|FG000|Overall Study|Lack of Efficacy|5|||
128015503|NCT03036254|460680913|FG001|Overall Study|Lack of Efficacy|1|||
128015504|NCT03036254|460680912|FG000|Overall Study|Withdrawal by Subject|3|||
128015505|NCT03036254|460680913|FG001|Overall Study|Withdrawal by Subject|5|||
128015506|NCT02783274|460680914|FG000|Overall Study|Withdrawal by Subject|16|||
128015507|NCT02783274|460680914|FG000|Overall Study|Physician Decision|6|||
128015508|NCT02783274|460680914|FG000|Overall Study|Death|9|||
128015509|NCT02783274|460680914|FG000|Overall Study|Lost to Follow-up|22|||
128015510|NCT02783274|460680914|FG000|Overall Study|Other|22|||
128015511|NCT05119569|460680919|FG000|Double Blind Treatment Phase|Withdrawal by Subject|2|||
128015512|NCT05119569|460680920|FG001|Double Blind Treatment Phase|Withdrawal by Subject|2|||
128015513|NCT05119569|460680921|FG002|Double Blind Treatment Phase|Withdrawal by Subject|0|||
128015514|NCT05119569|460680922|FG003|Double Blind Treatment Phase|Withdrawal by Subject|0|||
128015515|NCT05119569|460680919|FG000|Double Blind Treatment Phase|Adverse Event|6|||
128015516|NCT05119569|460680920|FG001|Double Blind Treatment Phase|Adverse Event|0|||
128015517|NCT05119569|460680921|FG002|Double Blind Treatment Phase|Adverse Event|0|||
128015518|NCT05119569|460680922|FG003|Double Blind Treatment Phase|Adverse Event|0|||
128015519|NCT05119569|460680919|FG000|Open Label Extension Phase|Ongoing in the study|0|||
128015520|NCT05119569|460680920|FG001|Open Label Extension Phase|Ongoing in the study|0|||
128015521|NCT05119569|460680921|FG002|Open Label Extension Phase|Ongoing in the study|65|||
128015522|NCT05119569|460680922|FG003|Open Label Extension Phase|Ongoing in the study|34|||
128015523|NCT01069939|460680928|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
128015524|NCT01069939|460680929|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
128015525|NCT01069939|460680928|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
128015526|NCT01069939|460680929|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
128015527|NCT01069939|460680928|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
128015528|NCT01069939|460680929|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
128015529|NCT01069939|460680928|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
128015530|NCT01069939|460680929|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
128015531|NCT01069939|460680928|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
128015532|NCT01069939|460680929|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
128015533|NCT01069939|460680928|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
128015534|NCT01069939|460680929|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
128015535|NCT01069939|460680928|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
128015536|NCT01069939|460680929|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
127681237|NCT00589667|459458346|FG000|Overall Study|Withdrawal by Subject|1|||
127681238|NCT03538041|459458347|FG000|12-Week Treatment Period|Adverse Event|1|||
128015537|NCT01069939|460680928|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
128015538|NCT01069939|460680929|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
128015539|NCT01069939|460680928|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
128015540|NCT01069939|460680929|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
128015541|NCT01069939|460680928|FG000|Randomised and Included in the Analyses|Removal|1|||
128015542|NCT01069939|460680929|FG001|Randomised and Included in the Analyses|Removal|0|||
128015543|NCT00385840|460680930|FG000|Overall Study|Adverse Event|1|||
128015544|NCT00385840|460680931|FG001|Overall Study|Adverse Event|1|||
128015545|NCT00385840|460680930|FG000|Overall Study|Lost to Follow-up|3|||
128015546|NCT00385840|460680931|FG001|Overall Study|Lost to Follow-up|13|||
128015547|NCT02101853|460680935|FG000|Block 1 Induction|Adverse Event|11|||
128015548|NCT02101853|460680936|FG001|Block 1 Induction|Adverse Event|0|||
128015549|NCT02101853|460680937|FG002|Block 1 Induction|Adverse Event|0|||
128015550|NCT02101853|460680938|FG003|Block 1 Induction|Adverse Event|0|||
128015551|NCT02101853|460680939|FG004|Block 1 Induction|Adverse Event|0|||
128015552|NCT02101853|460680940|FG005|Block 1 Induction|Adverse Event|0|||
128015553|NCT02101853|460680935|FG000|Block 1 Induction|Death|20|||
128015554|NCT02101853|460680936|FG001|Block 1 Induction|Death|0|||
128015555|NCT02101853|460680937|FG002|Block 1 Induction|Death|0|||
128015556|NCT02101853|460680938|FG003|Block 1 Induction|Death|0|||
128015557|NCT02101853|460680939|FG004|Block 1 Induction|Death|0|||
128015558|NCT02101853|460680940|FG005|Block 1 Induction|Death|0|||
128015559|NCT02101853|460680935|FG000|Block 1 Induction|Lack of Efficacy|6|||
128015560|NCT02101853|460680936|FG001|Block 1 Induction|Lack of Efficacy|0|||
128015561|NCT02101853|460680937|FG002|Block 1 Induction|Lack of Efficacy|0|||
128015562|NCT02101853|460680938|FG003|Block 1 Induction|Lack of Efficacy|0|||
128015563|NCT02101853|460680939|FG004|Block 1 Induction|Lack of Efficacy|0|||
128015564|NCT02101853|460680940|FG005|Block 1 Induction|Lack of Efficacy|0|||
128015565|NCT02101853|460680935|FG000|Block 1 Induction|Physician Decision|61|||
128015566|NCT02101853|460680936|FG001|Block 1 Induction|Physician Decision|0|||
128015567|NCT02101853|460680937|FG002|Block 1 Induction|Physician Decision|0|||
128015568|NCT02101853|460680938|FG003|Block 1 Induction|Physician Decision|0|||
128015569|NCT02101853|460680939|FG004|Block 1 Induction|Physician Decision|0|||
128015570|NCT02101853|460680940|FG005|Block 1 Induction|Physician Decision|0|||
128015571|NCT02101853|460680935|FG000|Block 1 Induction|Protocol Violation|2|||
128015572|NCT02101853|460680936|FG001|Block 1 Induction|Protocol Violation|0|||
128015573|NCT02101853|460680937|FG002|Block 1 Induction|Protocol Violation|0|||
128015574|NCT02101853|460680938|FG003|Block 1 Induction|Protocol Violation|0|||
128015575|NCT02101853|460680939|FG004|Block 1 Induction|Protocol Violation|0|||
128015576|NCT02101853|460680940|FG005|Block 1 Induction|Protocol Violation|0|||
128015577|NCT02101853|460680935|FG000|Block 1 Induction|Withdrawal by Subject|65|||
128015578|NCT02101853|460680936|FG001|Block 1 Induction|Withdrawal by Subject|0|||
128015579|NCT02101853|460680937|FG002|Block 1 Induction|Withdrawal by Subject|0|||
128015580|NCT02101853|460680938|FG003|Block 1 Induction|Withdrawal by Subject|0|||
128015581|NCT02101853|460680939|FG004|Block 1 Induction|Withdrawal by Subject|0|||
128015582|NCT02101853|460680940|FG005|Block 1 Induction|Withdrawal by Subject|0|||
128015583|NCT02101853|460680935|FG000|Block 1 Induction|Ineligible|8|||
128015584|NCT02101853|460680936|FG001|Block 1 Induction|Ineligible|0|||
128015585|NCT02101853|460680937|FG002|Block 1 Induction|Ineligible|0|||
128015586|NCT02101853|460680938|FG003|Block 1 Induction|Ineligible|0|||
128015587|NCT02101853|460680939|FG004|Block 1 Induction|Ineligible|0|||
128015588|NCT02101853|460680940|FG005|Block 1 Induction|Ineligible|0|||
128015589|NCT02101853|460680935|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
128015590|NCT02101853|460680936|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
128015591|NCT02101853|460680937|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
128015592|NCT02101853|460680938|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
128015593|NCT02101853|460680939|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
128015594|NCT02101853|460680940|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
128015595|NCT02101853|460680935|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
128015596|NCT02101853|460680936|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
128015597|NCT02101853|460680937|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
128015598|NCT02101853|460680938|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
128015599|NCT02101853|460680939|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
128015600|NCT02101853|460680940|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
128015601|NCT02101853|460680935|FG000|Post Induction Randomization|Adverse Event|0|||
128015602|NCT02101853|460680936|FG001|Post Induction Randomization|Adverse Event|3|||
127681239|NCT03538041|459458348|FG001|12-Week Treatment Period|Adverse Event|1|||
127544713|NCT03566511|458962447|FG000|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|1|||
127544714|NCT03566511|458962448|FG001|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|0|||
127544715|NCT02939287|458962454|FG000|Overall Study|met exclusion criteria|1|||
127544716|NCT02939287|458962455|FG001|Overall Study|met exclusion criteria|1|||
127544717|NCT02939287|458962456|FG002|Overall Study|met exclusion criteria|1|||
127544718|NCT02939287|458962454|FG000|Overall Study|Did not complete survey|2|||
127544719|NCT02939287|458962455|FG001|Overall Study|Did not complete survey|2|||
127544720|NCT02939287|458962456|FG002|Overall Study|Did not complete survey|0|||
127544721|NCT02939287|458962454|FG000|Overall Study|Withdrawal by Subject|1|||
127544722|NCT02939287|458962455|FG001|Overall Study|Withdrawal by Subject|1|||
127544723|NCT02939287|458962456|FG002|Overall Study|Withdrawal by Subject|0|||
127544724|NCT00981656|458962457|FG000|Overall Study|Protocol Violation|1|||
127544725|NCT00981656|458962457|FG000|Overall Study|Did not start protocol treatment|2|||
127544726|NCT00687596|458962458|FG000|Overall Study|Adverse Event (AE)|10|||
127544727|NCT00687596|458962459|FG001|Overall Study|Adverse Event (AE)|3|||
127544728|NCT00687596|458962458|FG000|Overall Study|Radiological Disease Progression|6|||
127544729|NCT00687596|458962459|FG001|Overall Study|Radiological Disease Progression|2|||
127544730|NCT00687596|458962458|FG000|Overall Study|Clinical Disease Progression|1|||
127544731|NCT00687596|458962459|FG001|Overall Study|Clinical Disease Progression|3|||
127768013|NCT04677179|459776703|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
127768014|NCT04677179|459776704|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
127768015|NCT04677179|459776705|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
127768016|NCT04677179|459776706|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
127768017|NCT04677179|459776707|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
127768018|NCT04677179|459776708|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
127768019|NCT04677179|459776709|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
127768020|NCT04677179|459776710|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
127768021|NCT04677179|459776711|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
127768022|NCT04677179|459776712|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
127768023|NCT04677179|459776703|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
127768024|NCT04677179|459776704|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
127768025|NCT04677179|459776705|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
127768026|NCT04677179|459776706|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
127768027|NCT04677179|459776707|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
127768028|NCT04677179|459776708|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
127768029|NCT04677179|459776709|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
127768030|NCT04677179|459776710|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
127768031|NCT04677179|459776711|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
127768032|NCT04677179|459776712|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
127768033|NCT04677179|459776703|FG000|Extension Treatment Period|Lack of Efficacy|0|||
127768034|NCT04677179|459776704|FG001|Extension Treatment Period|Lack of Efficacy|0|||
127768035|NCT04677179|459776705|FG002|Extension Treatment Period|Lack of Efficacy|0|||
127768036|NCT04677179|459776706|FG003|Extension Treatment Period|Lack of Efficacy|0|||
127768037|NCT04677179|459776707|FG004|Extension Treatment Period|Lack of Efficacy|0|||
127768038|NCT04677179|459776708|FG005|Extension Treatment Period|Lack of Efficacy|0|||
127768039|NCT04677179|459776709|FG006|Extension Treatment Period|Lack of Efficacy|6|||
127768040|NCT04677179|459776710|FG007|Extension Treatment Period|Lack of Efficacy|0|||
127768041|NCT04677179|459776711|FG008|Extension Treatment Period|Lack of Efficacy|0|||
127768042|NCT04677179|459776712|FG009|Extension Treatment Period|Lack of Efficacy|0|||
127768043|NCT04677179|459776703|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
127768044|NCT04677179|459776704|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
127768045|NCT04677179|459776705|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
127768046|NCT04677179|459776706|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
127768047|NCT04677179|459776707|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
127768048|NCT04677179|459776708|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
127768049|NCT04677179|459776709|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
127768050|NCT04677179|459776710|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
127768051|NCT04677179|459776711|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
127768052|NCT04677179|459776712|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
127768053|NCT04677179|459776703|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
127768054|NCT04677179|459776704|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
127768055|NCT04677179|459776705|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
127768056|NCT04677179|459776706|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
127768057|NCT04677179|459776707|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
127768058|NCT04677179|459776708|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
127544732|NCT00687596|458962458|FG000|Overall Study|Investigator Discretion|3|||
127544733|NCT00687596|458962459|FG001|Overall Study|Investigator Discretion|1|||
127544734|NCT00687596|458962458|FG000|Overall Study|Sponsor Terminated Study|6|||
127544735|NCT00687596|458962459|FG001|Overall Study|Sponsor Terminated Study|17|||
127544736|NCT03406780|458962460|FG000|Overall Study|Withdrawal by Subject|1|||
127544737|NCT03406780|458962461|FG001|Overall Study|Withdrawal by Subject|1|||
127681240|NCT03538041|459458347|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
127681241|NCT03538041|459458348|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
127681242|NCT03538041|459458347|FG000|Treatment Extension Period|Adverse Event|4|||
127681243|NCT03538041|459458348|FG001|Treatment Extension Period|Adverse Event|1|||
127681244|NCT03538041|459458347|FG000|Treatment Extension Period|Physician Decision|1|||
127681245|NCT03538041|459458348|FG001|Treatment Extension Period|Physician Decision|1|||
127681246|NCT03538041|459458347|FG000|Treatment Extension Period|Lack of Efficacy|1|||
127681247|NCT03538041|459458348|FG001|Treatment Extension Period|Lack of Efficacy|4|||
127681248|NCT03538041|459458347|FG000|Treatment Extension Period|Transitioned to Rollover Study|1|||
127681249|NCT03538041|459458348|FG001|Treatment Extension Period|Transitioned to Rollover Study|4|||
127681250|NCT03538041|459458347|FG000|Treatment Extension Period|Death|0|||
127681251|NCT03538041|459458348|FG001|Treatment Extension Period|Death|1|||
127681252|NCT01266265|459458349|FG000|Overall Study|Death|95|||
127681253|NCT01266265|459458350|FG001|Overall Study|Death|73|||
127681254|NCT01266265|459458349|FG000|Overall Study|Lost to Follow-up|23|||
127681255|NCT01266265|459458350|FG001|Overall Study|Lost to Follow-up|28|||
127681256|NCT01266265|459458349|FG000|Overall Study|Withdrawal by Subject|13|||
127681257|NCT01266265|459458350|FG001|Overall Study|Withdrawal by Subject|11|||
127681258|NCT01266265|459458349|FG000|Overall Study|Respiratory-related adverse event|2|||
127681259|NCT01266265|459458350|FG001|Overall Study|Respiratory-related adverse event|1|||
127681260|NCT01266265|459458349|FG000|Overall Study|Transferred care to another provider|22|||
127681261|NCT01266265|459458350|FG001|Overall Study|Transferred care to another provider|28|||
127681262|NCT01266265|459458349|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
127681263|NCT01266265|459458350|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
127681264|NCT01266265|459458349|FG000|Overall Study|Enrolled in another clinical study|15|||
127681265|NCT01266265|459458350|FG001|Overall Study|Enrolled in another clinical study|26|||
127681266|NCT01266265|459458349|FG000|Overall Study|Non-compliance|8|||
127681267|NCT01266265|459458350|FG001|Overall Study|Non-compliance|5|||
127681268|NCT01266265|459458349|FG000|Overall Study|Lung transplant|6|||
127681269|NCT01266265|459458350|FG001|Overall Study|Lung transplant|5|||
127681270|NCT01266265|459458349|FG000|Overall Study|Site closed early|4|||
127681271|NCT01266265|459458350|FG001|Overall Study|Site closed early|3|||
127681272|NCT01266265|459458349|FG000|Overall Study|Clinical worsening|1|||
127681273|NCT01266265|459458350|FG001|Overall Study|Clinical worsening|1|||
127681274|NCT01580293|459458351|FG000|Part A_Main Trial|Adverse Event|0|||
127681275|NCT01580293|459458352|FG001|Part A_Main Trial|Adverse Event|2|||
127681276|NCT01580293|459458353|FG002|Part A_Main Trial|Adverse Event|0|||
127681277|NCT01580293|459458351|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
127681278|NCT01580293|459458352|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
127681279|NCT01580293|459458353|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
127681280|NCT01580293|459458351|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
127681281|NCT01580293|459458352|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
127681282|NCT01580293|459458353|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
127681283|NCT01580293|459458351|FG000|Part A_Extension|Adverse Event|0|||
127681284|NCT01580293|459458352|FG001|Part A_Extension|Adverse Event|2|||
127681285|NCT01580293|459458353|FG002|Part A_Extension|Adverse Event|0|||
127681286|NCT01580293|459458351|FG000|Part A_Extension|Withdrawal by Subject|0|||
127681287|NCT01580293|459458352|FG001|Part A_Extension|Withdrawal by Subject|3|||
127681288|NCT01580293|459458353|FG002|Part A_Extension|Withdrawal by Subject|0|||
127681289|NCT01580293|459458351|FG000|Part A_Extension|Lost to Follow-up|0|||
127681290|NCT01580293|459458352|FG001|Part A_Extension|Lost to Follow-up|1|||
127681291|NCT01580293|459458353|FG002|Part A_Extension|Lost to Follow-up|0|||
127681292|NCT01580293|459458351|FG000|Part A_Extension|Other Reason|0|||
127681293|NCT01580293|459458352|FG001|Part A_Extension|Other Reason|1|||
127681294|NCT01580293|459458353|FG002|Part A_Extension|Other Reason|0|||
127681295|NCT01580293|459458351|FG000|Part A_Extension|Completed Japan only|0|||
127681296|NCT01580293|459458352|FG001|Part A_Extension|Completed Japan only|5|||
127681297|NCT01580293|459458353|FG002|Part A_Extension|Completed Japan only|0|||
127681298|NCT01580293|459458351|FG000|Part B|Withdrawal by Subject|0|||
127681299|NCT01580293|459458352|FG001|Part B|Withdrawal by Subject|0|||
127681300|NCT01580293|459458353|FG002|Part B|Withdrawal by Subject|1|||
127681301|NCT01580293|459458351|FG000|Part B|Other reason|0|||
127681302|NCT01580293|459458352|FG001|Part B|Other reason|0|||
127681303|NCT01580293|459458353|FG002|Part B|Other reason|1|||
127681304|NCT00768664|459458354|FG000|Overall Study|Death|57|||
127681305|NCT00768664|459458354|FG000|Overall Study|Lost to Follow-up|2|||
127681306|NCT00768664|459458354|FG000|Overall Study|Other|9|||
127681307|NCT00768664|459458354|FG000|Overall Study|Participant refused|1|||
127681308|NCT00423098|459458355|FG000|Overall Study|Adverse Event|1|||
127681309|NCT00423098|459458356|FG001|Overall Study|Adverse Event|2|||
127681310|NCT00423098|459458355|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
127681311|NCT00423098|459458356|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
127681312|NCT00423098|459458355|FG000|Overall Study|Administrative problems|0|||
127544738|NCT03406780|458962460|FG000|Overall Study|Other|0|||
128015603|NCT02101853|460680937|FG002|Post Induction Randomization|Adverse Event|8|||
128015604|NCT02101853|460680938|FG003|Post Induction Randomization|Adverse Event|4|||
128015605|NCT02101853|460680939|FG004|Post Induction Randomization|Adverse Event|4|||
128015606|NCT02101853|460680940|FG005|Post Induction Randomization|Adverse Event|0|||
128015607|NCT02101853|460680935|FG000|Post Induction Randomization|Death|0|||
128015608|NCT02101853|460680936|FG001|Post Induction Randomization|Death|9|||
128015609|NCT02101853|460680937|FG002|Post Induction Randomization|Death|2|||
128015610|NCT02101853|460680938|FG003|Post Induction Randomization|Death|2|||
128015611|NCT02101853|460680939|FG004|Post Induction Randomization|Death|0|||
128015612|NCT02101853|460680940|FG005|Post Induction Randomization|Death|0|||
128015613|NCT02101853|460680935|FG000|Post Induction Randomization|Lack of Efficacy|0|||
128015614|NCT02101853|460680936|FG001|Post Induction Randomization|Lack of Efficacy|14|||
128015615|NCT02101853|460680937|FG002|Post Induction Randomization|Lack of Efficacy|23|||
128015616|NCT02101853|460680938|FG003|Post Induction Randomization|Lack of Efficacy|18|||
128015617|NCT02101853|460680939|FG004|Post Induction Randomization|Lack of Efficacy|21|||
128015618|NCT02101853|460680940|FG005|Post Induction Randomization|Lack of Efficacy|0|||
128015619|NCT02101853|460680935|FG000|Post Induction Randomization|Physician Decision|0|||
128015620|NCT02101853|460680936|FG001|Post Induction Randomization|Physician Decision|43|||
128015621|NCT02101853|460680937|FG002|Post Induction Randomization|Physician Decision|23|||
128015622|NCT02101853|460680938|FG003|Post Induction Randomization|Physician Decision|14|||
128015623|NCT02101853|460680939|FG004|Post Induction Randomization|Physician Decision|14|||
128015624|NCT02101853|460680940|FG005|Post Induction Randomization|Physician Decision|0|||
128015625|NCT02101853|460680935|FG000|Post Induction Randomization|Protocol Violation|0|||
128015626|NCT02101853|460680936|FG001|Post Induction Randomization|Protocol Violation|3|||
128015627|NCT02101853|460680937|FG002|Post Induction Randomization|Protocol Violation|0|||
128015628|NCT02101853|460680938|FG003|Post Induction Randomization|Protocol Violation|0|||
128015629|NCT02101853|460680939|FG004|Post Induction Randomization|Protocol Violation|0|||
128015630|NCT02101853|460680940|FG005|Post Induction Randomization|Protocol Violation|0|||
128015631|NCT02101853|460680935|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
128015632|NCT02101853|460680936|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
128015633|NCT02101853|460680937|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
128015634|NCT02101853|460680938|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
128015635|NCT02101853|460680939|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
128015636|NCT02101853|460680940|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
128015637|NCT02101853|460680935|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
128015638|NCT02101853|460680936|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
128015639|NCT02101853|460680937|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
128015640|NCT02101853|460680938|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
128015641|NCT02101853|460680939|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
127681313|NCT00423098|459458356|FG001|Overall Study|Administrative problems|1|||
127681314|NCT00423098|459458355|FG000|Overall Study|Death|2|||
127681315|NCT00423098|459458356|FG001|Overall Study|Death|0|||
127681316|NCT00465816|459458358|FG000|Overall Study|Lost to Follow-up|0|||
127681317|NCT00465816|459458359|FG001|Overall Study|Lost to Follow-up|0|||
127681318|NCT00465816|459458360|FG002|Overall Study|Lost to Follow-up|2|||
127681319|NCT04480827|459458361|FG000|Overall Study|Adverse Event|0|||
127681320|NCT04480827|459458362|FG001|Overall Study|Adverse Event|0|||
127681321|NCT04480827|459458363|FG002|Overall Study|Adverse Event|0|||
127681322|NCT04480827|459458364|FG003|Overall Study|Adverse Event|0|||
127681323|NCT04480827|459458365|FG004|Overall Study|Adverse Event|0|||
127681324|NCT04480827|459458366|FG005|Overall Study|Adverse Event|1|||
127681325|NCT04480827|459458367|FG006|Overall Study|Adverse Event|0|||
127681326|NCT00941655|459458368|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
127681327|NCT00941655|459458369|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
127681328|NCT00941655|459458368|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
127681329|NCT00941655|459458369|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
127681330|NCT00941655|459458368|FG000|Overall Study|progressed while on chemo|0|||
127681331|NCT00941655|459458369|FG001|Overall Study|progressed while on chemo|2|||
127681332|NCT00941655|459458368|FG000|Overall Study|refused further treatment|0|||
127681333|NCT00941655|459458369|FG001|Overall Study|refused further treatment|1|||
127681334|NCT00941655|459458368|FG000|Overall Study|withdrew consent|0|||
127681335|NCT00941655|459458369|FG001|Overall Study|withdrew consent|1|||
127681336|NCT00941655|459458368|FG000|Overall Study|non-compliant|0|||
127681337|NCT00941655|459458369|FG001|Overall Study|non-compliant|1|||
127768059|NCT04677179|459776709|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
128015642|NCT02101853|460680940|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
127681338|NCT00004124|459458373|FG000|Overall Study|Received no protocol therapy|12|||
127681339|NCT00004124|459458374|FG001|Overall Study|Received no protocol therapy|20|||
127681340|NCT00807144|459458377|FG000|Overall Study|Lost to Follow-up|0|||
127768060|NCT04677179|459776710|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
127768061|NCT04677179|459776711|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
127768062|NCT04677179|459776712|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
127768063|NCT04677179|459776703|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
127768064|NCT04677179|459776704|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
127768065|NCT04677179|459776705|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
127768066|NCT04677179|459776706|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
127768067|NCT04677179|459776707|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
127768068|NCT04677179|459776708|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
127768069|NCT04677179|459776709|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
127768070|NCT04677179|459776710|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
127768071|NCT04677179|459776711|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
127768072|NCT04677179|459776712|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
127768073|NCT04677179|459776703|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
127768074|NCT04677179|459776704|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
127768075|NCT04677179|459776705|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
127768076|NCT04677179|459776706|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
127768077|NCT04677179|459776707|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
127768078|NCT04677179|459776708|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
128015643|NCT02101853|460680935|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
128015644|NCT02101853|460680936|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
128015645|NCT02101853|460680937|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
128015646|NCT02101853|460680938|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
128015647|NCT02101853|460680939|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
128015648|NCT02101853|460680940|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
128015649|NCT02101853|460680935|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
128015650|NCT02101853|460680936|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
128015651|NCT02101853|460680937|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
128015652|NCT02101853|460680938|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
128015653|NCT02101853|460680939|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
128015654|NCT02101853|460680940|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
128015655|NCT02101853|460680935|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
128015656|NCT02101853|460680936|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
128015657|NCT02101853|460680937|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
128015658|NCT02101853|460680938|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
128015659|NCT02101853|460680939|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
128015660|NCT02101853|460680940|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
128015661|NCT02101853|460680935|FG000|Blinatumomab Salvage Therapy|Death|0|||
128015662|NCT02101853|460680936|FG001|Blinatumomab Salvage Therapy|Death|0|||
127768079|NCT04677179|459776709|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
127768080|NCT04677179|459776710|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
127768081|NCT04677179|459776711|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
127768082|NCT04677179|459776712|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
127768083|NCT04677179|459776703|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
127768084|NCT04677179|459776704|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
127768085|NCT04677179|459776705|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
127768086|NCT04677179|459776706|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
127768087|NCT04677179|459776707|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
127768088|NCT04677179|459776708|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
127768089|NCT04677179|459776709|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
127768090|NCT04677179|459776710|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
127768091|NCT04677179|459776711|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
127768092|NCT04677179|459776712|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
127768093|NCT04677179|459776703|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
127768094|NCT04677179|459776704|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
127768095|NCT04677179|459776705|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
127768096|NCT04677179|459776706|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
127768097|NCT04677179|459776707|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
127768098|NCT04677179|459776708|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
127768099|NCT04677179|459776709|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
128015663|NCT02101853|460680937|FG002|Blinatumomab Salvage Therapy|Death|0|||
127768100|NCT04677179|459776710|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
127768101|NCT04677179|459776711|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
127768102|NCT04677179|459776712|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
127768103|NCT04677179|459776703|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
127544739|NCT03406780|458962461|FG001|Overall Study|Other|2|||
127544740|NCT00837434|458962467|FG000|Overall Study|Physician Decision|3|||
127544741|NCT00837434|458962468|FG001|Overall Study|Physician Decision|0|||
127544742|NCT00837434|458962467|FG000|Overall Study|Lost to Follow-up|1|||
127544743|NCT00837434|458962468|FG001|Overall Study|Lost to Follow-up|1|||
127544744|NCT00837434|458962467|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
127544745|NCT00837434|458962468|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
127544746|NCT00837434|458962467|FG000|Overall Study|Noncompliant|2|||
127544747|NCT00837434|458962468|FG001|Overall Study|Noncompliant|0|||
127544748|NCT00837434|458962467|FG000|Overall Study|Baseline assessments not done in time|1|||
127544749|NCT00837434|458962468|FG001|Overall Study|Baseline assessments not done in time|0|||
127544750|NCT00837434|458962467|FG000|Overall Study|Unable to obtain study drug|1|||
127544751|NCT00837434|458962468|FG001|Overall Study|Unable to obtain study drug|0|||
127544752|NCT03041038|458962489|FG000|Overall Study|Withdrawal by Subject|4|||
127544753|NCT03041038|458962490|FG001|Overall Study|Withdrawal by Subject|0|||
127544754|NCT03041038|458962489|FG000|Overall Study|Lost to Follow-up|1|||
127544755|NCT03041038|458962490|FG001|Overall Study|Lost to Follow-up|1|||
127544756|NCT03041038|458962489|FG000|Overall Study|Protocol Violation|1|||
127544757|NCT03041038|458962490|FG001|Overall Study|Protocol Violation|1|||
127544758|NCT03331315|458962491|FG000|Overall Study|Physician Decision|18|||
127544759|NCT03331315|458962492|FG001|Overall Study|Physician Decision|14|||
127544760|NCT00360230|458962495|FG000|Overall Study|Withdrawal by Subject|1|||
127544761|NCT00360230|458962496|FG001|Overall Study|Withdrawal by Subject|1|||
127544762|NCT00360230|458962497|FG002|Overall Study|Withdrawal by Subject|0|||
127544763|NCT00360230|458962498|FG003|Overall Study|Withdrawal by Subject|1|||
127544764|NCT00360230|458962499|FG004|Overall Study|Withdrawal by Subject|1|||
127544765|NCT00360230|458962500|FG005|Overall Study|Withdrawal by Subject|1|||
127544766|NCT00360230|458962501|FG006|Overall Study|Withdrawal by Subject|0|||
127544767|NCT00360230|458962495|FG000|Overall Study|Migrated|4|||
127544768|NCT00360230|458962496|FG001|Overall Study|Migrated|1|||
127544769|NCT00360230|458962497|FG002|Overall Study|Migrated|3|||
127544770|NCT00360230|458962498|FG003|Overall Study|Migrated|1|||
127544771|NCT00360230|458962499|FG004|Overall Study|Migrated|4|||
127544772|NCT00360230|458962500|FG005|Overall Study|Migrated|1|||
127544773|NCT00360230|458962501|FG006|Overall Study|Migrated|1|||
127544774|NCT00360230|458962495|FG000|Overall Study|Other|1|||
127544775|NCT00360230|458962496|FG001|Overall Study|Other|0|||
127544776|NCT00360230|458962497|FG002|Overall Study|Other|0|||
127544777|NCT00360230|458962498|FG003|Overall Study|Other|0|||
127544778|NCT00360230|458962499|FG004|Overall Study|Other|0|||
127544779|NCT00360230|458962500|FG005|Overall Study|Other|0|||
127544780|NCT00360230|458962501|FG006|Overall Study|Other|0|||
127544781|NCT00360230|458962495|FG000|Overall Study|Protocol Violation|0|||
127544782|NCT00360230|458962496|FG001|Overall Study|Protocol Violation|0|||
127681341|NCT00807144|459458378|FG001|Overall Study|Lost to Follow-up|1|||
127681342|NCT01290224|459458385|FG000|Overall Study|Adverse Event|1|||
127681343|NCT01290224|459458385|FG000|Overall Study|Refused Further Treatment|4|||
127681344|NCT01241292|459458386|FG000|Overall Study|Administrative Reason by Sponsor|1|||
128015664|NCT02101853|460680938|FG003|Blinatumomab Salvage Therapy|Death|0|||
128015665|NCT02101853|460680939|FG004|Blinatumomab Salvage Therapy|Death|0|||
128015666|NCT02101853|460680940|FG005|Blinatumomab Salvage Therapy|Death|2|||
128015667|NCT02101853|460680935|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
128015668|NCT02101853|460680936|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
128015669|NCT02101853|460680937|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
128015670|NCT02101853|460680938|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
128015671|NCT02101853|460680939|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
128015672|NCT02101853|460680940|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
128015673|NCT02101853|460680935|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
128015674|NCT02101853|460680936|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
128015675|NCT02101853|460680937|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
128015676|NCT02101853|460680938|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
128015677|NCT02101853|460680939|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
128015678|NCT02101853|460680940|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
128015679|NCT02101853|460680935|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
128015680|NCT02101853|460680936|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
128015681|NCT02101853|460680937|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
128015682|NCT02101853|460680938|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
127544783|NCT00360230|458962497|FG002|Overall Study|Protocol Violation|0|||
127544784|NCT00360230|458962498|FG003|Overall Study|Protocol Violation|0|||
127544785|NCT00360230|458962499|FG004|Overall Study|Protocol Violation|0|||
127544786|NCT00360230|458962500|FG005|Overall Study|Protocol Violation|1|||
127544787|NCT00360230|458962501|FG006|Overall Study|Protocol Violation|0|||
127544788|NCT00360230|458962495|FG000|Overall Study|Death|0|||
127544789|NCT00360230|458962496|FG001|Overall Study|Death|1|||
127544790|NCT00360230|458962497|FG002|Overall Study|Death|0|||
127544791|NCT00360230|458962498|FG003|Overall Study|Death|0|||
127544792|NCT00360230|458962499|FG004|Overall Study|Death|0|||
127544793|NCT00360230|458962500|FG005|Overall Study|Death|1|||
127544794|NCT00360230|458962501|FG006|Overall Study|Death|1|||
127544795|NCT00581308|458962502|FG000|Pre Discharge|Lost to Follow-up|1|||
127544796|NCT00581308|458962502|FG000|Pre Discharge|Device Removed|1|||
127544797|NCT00581308|458962502|FG000|Month 1|Lost to Follow-up|3|||
127544798|NCT00581308|458962502|FG000|Month 1|Withdrawal by Subject|2|||
127544799|NCT00581308|458962502|FG000|Month 1|Device Removed|2|||
127544800|NCT00581308|458962502|FG000|Month 1|Uknown|1|||
127544801|NCT00581308|458962502|FG000|Month 6|Lost to Follow-up|1|||
127544802|NCT00581308|458962502|FG000|Month 6|Withdrawal by Subject|2|||
127544803|NCT00581308|458962502|FG000|Month 12|Death|1|||
127544804|NCT00581308|458962502|FG000|Month 12|Lost to Follow-up|14|||
127544805|NCT00581308|458962502|FG000|Month 12|Withdrawal by Subject|3|||
127544806|NCT00581308|458962502|FG000|Month 12|Device Removed|1|||
127544807|NCT00581308|458962502|FG000|Month 12|Other|1|||
127544808|NCT03219723|458962503|FG000|Overall Study|Case Report Forms Uncollected|6|||
127544809|NCT03219723|458962503|FG000|Overall Study|Protocol Deviation|4|||
127544810|NCT00459316|458962504|FG000|Steps 1 & 2|Other eligibility failure|1|||
127544811|NCT00459316|458962505|FG001|Steps 1 & 2|Other eligibility failure|1|||
127544812|NCT00459316|458962506|FG002|Steps 1 & 2|Other eligibility failure|0|||
127544813|NCT00459316|458962504|FG000|Steps 1 & 2|Death|1|||
127544814|NCT00459316|458962505|FG001|Steps 1 & 2|Death|1|||
127544815|NCT00459316|458962506|FG002|Steps 1 & 2|Death|0|||
127544816|NCT00459316|458962504|FG000|Steps 1 & 2|Not able to get to clinic|7|||
127544817|NCT00459316|458962505|FG001|Steps 1 & 2|Not able to get to clinic|4|||
127544818|NCT00459316|458962506|FG002|Steps 1 & 2|Not able to get to clinic|0|||
127544819|NCT00459316|458962504|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
127544820|NCT00459316|458962505|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
127544821|NCT00459316|458962506|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
127544822|NCT00459316|458962504|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
127544823|NCT00459316|458962505|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
127544824|NCT00459316|458962506|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
127544825|NCT00459316|458962504|FG000|Steps 1 & 2|Lost to Follow-up|5|||
127544826|NCT00459316|458962505|FG001|Steps 1 & 2|Lost to Follow-up|0|||
127544827|NCT00459316|458962506|FG002|Steps 1 & 2|Lost to Follow-up|2|||
127544828|NCT00459316|458962504|FG000|Step 3|Withdrawal by Subject|3|||
127544829|NCT00459316|458962505|FG001|Step 3|Withdrawal by Subject|0|||
127544830|NCT00459316|458962506|FG002|Step 3|Withdrawal by Subject|1|||
127544831|NCT01614886|458962507|FG000|Overall Study|Adverse Event|15|||
127544832|NCT01614886|458962508|FG001|Overall Study|Adverse Event|20|||
127544833|NCT01614886|458962507|FG000|Overall Study|Withdrawal by Subject|4|||
127544834|NCT01614886|458962508|FG001|Overall Study|Withdrawal by Subject|4|||
127544835|NCT01614886|458962507|FG000|Overall Study|Death|1|||
127544836|NCT01614886|458962508|FG001|Overall Study|Death|0|||
127544837|NCT01614886|458962507|FG000|Overall Study|Protocol deviation|0|||
128015683|NCT02101853|460680939|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
128015684|NCT02101853|460680940|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
128015685|NCT04409002|460680941|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
128015686|NCT04835441|460680942|FG000|Overall Study|Physician Decision|4|||
128015687|NCT04835441|460680943|FG001|Overall Study|Physician Decision|4|||
128015688|NCT04835441|460680942|FG000|Overall Study|Other|1|||
128015689|NCT04835441|460680943|FG001|Overall Study|Other|1|||
128015690|NCT04835441|460680942|FG000|Overall Study|Lost to Follow-up|0|||
128015691|NCT04835441|460680943|FG001|Overall Study|Lost to Follow-up|1|||
128015692|NCT05032196|460680944|FG000|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
128015693|NCT05032196|460680945|FG001|Period 1 (Single Ascending Dose)|Withdrawal by Subject|1|||
128015694|NCT05032196|460680946|FG002|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
128015695|NCT05032196|460680947|FG003|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
128015696|NCT05032196|460680948|FG004|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
128015697|NCT05032196|460680949|FG005|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
128015698|NCT05032196|460680944|FG000|Period 1 (Single Ascending Dose)|Adverse Event|0|||
128015699|NCT05032196|460680945|FG001|Period 1 (Single Ascending Dose)|Adverse Event|0|||
128015700|NCT05032196|460680946|FG002|Period 1 (Single Ascending Dose)|Adverse Event|0|||
128015701|NCT05032196|460680947|FG003|Period 1 (Single Ascending Dose)|Adverse Event|1|||
128015702|NCT05032196|460680948|FG004|Period 1 (Single Ascending Dose)|Adverse Event|0|||
128015703|NCT05032196|460680949|FG005|Period 1 (Single Ascending Dose)|Adverse Event|0|||
128015704|NCT05032196|460680944|FG000|Period 2 (Multidose)|Physician Decision|0|||
128015705|NCT05032196|460680945|FG001|Period 2 (Multidose)|Physician Decision|0|||
127544838|NCT01614886|458962508|FG001|Overall Study|Protocol deviation|2|||
127544839|NCT03044106|458962510|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
127544840|NCT03044106|458962511|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
127544841|NCT01207414|458962512|FG000|Overall Study|Adverse Event|25|||
127544842|NCT01207414|458962513|FG001|Overall Study|Adverse Event|39|||
127544843|NCT01207414|458962512|FG000|Overall Study|Abnormal test procedure results|0|||
127544844|NCT01207414|458962513|FG001|Overall Study|Abnormal test procedure results|1|||
127544845|NCT01207414|458962512|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
128015706|NCT05032196|460680946|FG002|Period 2 (Multidose)|Physician Decision|0|||
128015707|NCT05032196|460680947|FG003|Period 2 (Multidose)|Physician Decision|0|||
127681345|NCT01241292|459458387|FG001|Overall Study|Administrative Reason by Sponsor|0|||
127681346|NCT01241292|459458386|FG000|Overall Study|Disease Progression|2|||
127681347|NCT01241292|459458387|FG001|Overall Study|Disease Progression|0|||
127681348|NCT01241292|459458386|FG000|Overall Study|Study Drug Toxicity|0|||
127681349|NCT01241292|459458387|FG001|Overall Study|Study Drug Toxicity|1|||
127681350|NCT01241292|459458386|FG000|Overall Study|Participant Discontinued Treatment|0|||
127681351|NCT01241292|459458387|FG001|Overall Study|Participant Discontinued Treatment|2|||
127681352|NCT00346333|459458388|FG000|Overall Study|Death|1|||
127681353|NCT00346333|459458389|FG001|Overall Study|Death|0|||
127681354|NCT00346333|459458388|FG000|Overall Study|unwilling or unable to continue|4|||
127681355|NCT00346333|459458389|FG001|Overall Study|unwilling or unable to continue|8|||
127681356|NCT01405924|459458390|FG000|Overall Study|Protocol Violation|8|||
127681357|NCT01405924|459458390|FG000|Overall Study|Missing/Incomplete Data|2|||
127681358|NCT00770965|459458393|FG000|Safety Set|Withdrawal by Subject|0|||
127681359|NCT00770965|459458394|FG001|Safety Set|Withdrawal by Subject|0|||
127681360|NCT00770965|459458395|FG002|Safety Set|Withdrawal by Subject|0|||
127681361|NCT00770965|459458396|FG003|Safety Set|Withdrawal by Subject|1|||
127681362|NCT00770965|459458393|FG000|Safety Set|Protocol deviation|0|||
127681363|NCT00770965|459458394|FG001|Safety Set|Protocol deviation|0|||
127681364|NCT00770965|459458395|FG002|Safety Set|Protocol deviation|1|||
127681365|NCT00770965|459458396|FG003|Safety Set|Protocol deviation|0|||
127681366|NCT00770965|459458393|FG000|Excluded Set|Administrative problems|14|||
127681367|NCT00770965|459458394|FG001|Excluded Set|Administrative problems|12|||
127681368|NCT00770965|459458395|FG002|Excluded Set|Administrative problems|12|||
128015708|NCT05032196|460680948|FG004|Period 2 (Multidose)|Physician Decision|1|||
128015709|NCT05032196|460680949|FG005|Period 2 (Multidose)|Physician Decision|0|||
128015710|NCT05260008|460680950|FG000|Overall Study|Physician Decision|0|||
128015711|NCT05260008|460680951|FG001|Overall Study|Physician Decision|1|||
128015712|NCT05260008|460680952|FG002|Overall Study|Physician Decision|0|||
128015713|NCT05260008|460680953|FG003|Overall Study|Physician Decision|0|||
128015714|NCT05977868|460682124|FG000|Overall Study|Withdrawal by Subject|1|||
128015715|NCT05977868|460682125|FG001|Overall Study|Withdrawal by Subject|2|||
128015716|NCT05977868|460682124|FG000|Overall Study|Transitioned to comfort care|1|||
128015717|NCT05977868|460682125|FG001|Overall Study|Transitioned to comfort care|0|||
128015718|NCT05696847|460682134|FG000|Overall Study|Withdrawal by Subject|1|||
128015719|NCT05696847|460682135|FG001|Overall Study|Withdrawal by Subject|0|||
128015720|NCT05696847|460682136|FG002|Overall Study|Withdrawal by Subject|0|||
128015721|NCT05696847|460682137|FG003|Overall Study|Withdrawal by Subject|0|||
128015722|NCT05696847|460682138|FG004|Overall Study|Withdrawal by Subject|0|||
128015723|NCT05696847|460682139|FG005|Overall Study|Withdrawal by Subject|0|||
128015724|NCT05696847|460682134|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
128015725|NCT05696847|460682135|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
128015726|NCT05696847|460682136|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
128015727|NCT05696847|460682137|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
128015728|NCT05696847|460682138|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
128015729|NCT05696847|460682139|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
128015730|NCT05696847|460682134|FG000|Overall Study|Adverse Event|0|||
128015731|NCT05696847|460682135|FG001|Overall Study|Adverse Event|0|||
128015732|NCT05696847|460682136|FG002|Overall Study|Adverse Event|0|||
128015733|NCT05696847|460682137|FG003|Overall Study|Adverse Event|0|||
128015734|NCT05696847|460682138|FG004|Overall Study|Adverse Event|0|||
128015735|NCT05696847|460682139|FG005|Overall Study|Adverse Event|1|||
128015736|NCT05696847|460682134|FG000|Overall Study|Sponsor Decision|0|||
128015737|NCT05696847|460682135|FG001|Overall Study|Sponsor Decision|0|||
128015738|NCT05696847|460682136|FG002|Overall Study|Sponsor Decision|0|||
128015739|NCT05696847|460682137|FG003|Overall Study|Sponsor Decision|1|||
128015740|NCT05696847|460682138|FG004|Overall Study|Sponsor Decision|0|||
128015741|NCT05696847|460682139|FG005|Overall Study|Sponsor Decision|0|||
128015742|NCT03323502|460682140|FG000|Overall Study|Resident could not be linked to CMS data|594|||
128015743|NCT03323502|460682141|FG001|Overall Study|Resident could not be linked to CMS data|435|||
128015744|NCT03323502|460682140|FG000|Overall Study|Resident cognitive status could not be determined from CMS data|6551|||
128015745|NCT03323502|460682141|FG001|Overall Study|Resident cognitive status could not be determined from CMS data|6426|||
128015746|NCT03323502|460682140|FG000|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|247|||
128015747|NCT03323502|460682141|FG001|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|260|||
128015748|NCT03323502|460682140|FG000|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|896|||
128015749|NCT03323502|460682141|FG001|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|573|||
128015750|NCT03323502|460682140|FG000|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8386|||
127681369|NCT00770965|459458396|FG003|Excluded Set|Administrative problems|10|||
127681370|NCT00770965|459458393|FG000|Excluded Set|Withdrawal by Subject|1|||
127681371|NCT00770965|459458394|FG001|Excluded Set|Withdrawal by Subject|1|||
127681372|NCT00770965|459458395|FG002|Excluded Set|Withdrawal by Subject|2|||
127681373|NCT00770965|459458396|FG003|Excluded Set|Withdrawal by Subject|3|||
127768104|NCT04677179|459776704|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
127768105|NCT04677179|459776705|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
127768106|NCT04677179|459776706|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
127768107|NCT04677179|459776707|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
127768108|NCT04677179|459776708|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
127768109|NCT04677179|459776709|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
127768110|NCT04677179|459776710|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
127768111|NCT04677179|459776711|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
127768112|NCT04677179|459776712|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
127768113|NCT02374671|459776714|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
127768114|NCT02374671|459776715|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
127768115|NCT02374671|459776716|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
127768116|NCT02374671|459776714|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
127768117|NCT02374671|459776715|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
127768118|NCT02374671|459776716|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
127768119|NCT02374671|459776714|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
127768120|NCT02374671|459776715|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
127768121|NCT02374671|459776716|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
127768122|NCT02374671|459776714|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
127768123|NCT02374671|459776715|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
127768124|NCT02374671|459776716|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
127768125|NCT02374671|459776714|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
127768126|NCT02374671|459776715|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
127768127|NCT02374671|459776716|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
127768128|NCT03866473|459776719|FG000|Phase 1|Death|1|||
127768129|NCT03866473|459776720|FG001|Phase 1|Death|0|||
127768130|NCT03866473|459776719|FG000|Phase 2|Death|0|||
127768131|NCT03866473|459776720|FG001|Phase 2|Death|2|||
127768132|NCT03866473|459776719|FG000|Phase 2|Dropped|1|||
127768133|NCT03866473|459776720|FG001|Phase 2|Dropped|1|||
127768134|NCT03866473|459776719|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
127768135|NCT03866473|459776720|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
127768136|NCT03169101|459776722|FG000|Lab Session 1 (Week 1)|Protocol Violation|0|||
127768137|NCT03169101|459776723|FG001|Lab Session 1 (Week 1)|Protocol Violation|0|||
127768138|NCT03169101|459776724|FG002|Lab Session 1 (Week 1)|Protocol Violation|0|||
127768139|NCT03169101|459776725|FG003|Lab Session 1 (Week 1)|Protocol Violation|4|||
127768140|NCT02641496|459776728|FG000|Overall Study|Lost to Follow-up|13|||
127768141|NCT02641496|459776729|FG001|Overall Study|Lost to Follow-up|12|||
127768142|NCT02641496|459776728|FG000|Overall Study|Withdrawal by Subject|1|||
127768143|NCT02641496|459776729|FG001|Overall Study|Withdrawal by Subject|0|||
127768144|NCT00600886|459776730|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
127768145|NCT00600886|459776731|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
127768146|NCT00600886|459776730|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
127768147|NCT00600886|459776731|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
127768148|NCT00600886|459776730|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
127768149|NCT00600886|459776731|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
128015751|NCT03323502|460682141|FG001|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8196|||
128015752|NCT04092777|460682142|FG000|Overall Study|Lost to Follow-up|28|||
128015753|NCT04092777|460682143|FG001|Overall Study|Lost to Follow-up|46|||
128015754|NCT04092777|460682142|FG000|Overall Study|Withdrawal by Subject|8|||
128015755|NCT04092777|460682143|FG001|Overall Study|Withdrawal by Subject|5|||
128015756|NCT05291689|460682147|FG000|Overall Study|Adverse Event|3|||
127544846|NCT01207414|458962513|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
127544847|NCT01207414|458962512|FG000|Overall Study|Patient withdrew consent|14|||
127544848|NCT01207414|458962513|FG001|Overall Study|Patient withdrew consent|11|||
127544849|NCT01207414|458962512|FG000|Overall Study|Lost to Follow-up|15|||
127544850|NCT01207414|458962513|FG001|Overall Study|Lost to Follow-up|17|||
127544851|NCT01207414|458962512|FG000|Overall Study|Administrative problems|1|||
127544852|NCT01207414|458962513|FG001|Overall Study|Administrative problems|1|||
127544853|NCT01207414|458962512|FG000|Overall Study|Protocol deviation|12|||
127544854|NCT01207414|458962513|FG001|Overall Study|Protocol deviation|9|||
127768150|NCT00600886|459776730|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
127768151|NCT00600886|459776731|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
127768152|NCT00600886|459776730|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
128015757|NCT05291689|460682147|FG000|Overall Study|Lack of Efficacy|10|||
127544855|NCT01207414|458962512|FG000|Overall Study|Randomized in error|1|||
127768153|NCT00600886|459776731|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
128015758|NCT05291689|460682147|FG000|Overall Study|Withdrawal by Subject|4|||
128015759|NCT02612155|460682148|FG000|Overall Study|Death|1|||
127544856|NCT01207414|458962513|FG001|Overall Study|Randomized in error|0|||
127544857|NCT01748292|458962514|FG000|Overall Study|Adverse Event|2|||
127544858|NCT01748292|458962515|FG001|Overall Study|Adverse Event|4|||
127544859|NCT01748292|458962514|FG000|Overall Study|Lost to Follow-up|0|||
127544860|NCT01748292|458962515|FG001|Overall Study|Lost to Follow-up|3|||
127544861|NCT01748292|458962514|FG000|Overall Study|Death|0|||
127544862|NCT01748292|458962515|FG001|Overall Study|Death|3|||
127681374|NCT03192046|459458398|FG000|Overall Study|Withdrawal by Subject|1|||
127681375|NCT03192046|459458399|FG001|Overall Study|Withdrawal by Subject|1|||
127681376|NCT00762606|459458400|FG000|Overall Study|Lost to Follow-up|18|||
127681377|NCT00762606|459458401|FG001|Overall Study|Lost to Follow-up|13|||
127681378|NCT01505881|459458402|FG000|Overall Study|Adverse Event|0|||
127681379|NCT01505881|459458403|FG001|Overall Study|Adverse Event|1|||
127681380|NCT01505881|459458402|FG000|Overall Study|Lost to Follow-up|2|||
127681381|NCT01505881|459458403|FG001|Overall Study|Lost to Follow-up|0|||
127681382|NCT01505881|459458402|FG000|Overall Study|Withdrawal by Subject|2|||
127681383|NCT01505881|459458403|FG001|Overall Study|Withdrawal by Subject|0|||
127681384|NCT00842257|459458404|FG000|Overall Study|Adverse Event|1|||
127681385|NCT00395018|459458405|FG000|On-Treatment|Death|4|||
127681386|NCT00395018|459458405|FG000|On-Treatment|Other Reason|2|||
127681387|NCT00395018|459458405|FG000|On-Treatment|Poor/non-compliance|2|||
127681388|NCT00395018|459458405|FG000|On-Treatment|Subject no longer meets study criteria|2|||
127681389|NCT00395018|459458405|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
127681390|NCT00395018|459458405|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
127681391|NCT00395018|459458405|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
127681392|NCT04439799|459458406|FG000|Overall Study|Lost to Follow-up|6|||
127681393|NCT04439799|459458407|FG001|Overall Study|Lost to Follow-up|6|||
127681394|NCT04439799|459458406|FG000|Overall Study|Withdrawal by Subject|2|||
127681395|NCT04439799|459458407|FG001|Overall Study|Withdrawal by Subject|6|||
127681396|NCT04439799|459458406|FG000|Overall Study|Adverse Event|2|||
127681397|NCT04439799|459458407|FG001|Overall Study|Adverse Event|5|||
127681398|NCT01391130|459458415|FG000|Overall Study|Withdrawal by Subject|3|||
127681399|NCT01391130|459458416|FG001|Overall Study|Withdrawal by Subject|2|||
127681400|NCT01391130|459458415|FG000|Overall Study|Physician Decision|2|||
127681401|NCT01391130|459458416|FG001|Overall Study|Physician Decision|3|||
127681402|NCT01391130|459458415|FG000|Overall Study|Did not Receive Drug|1|||
127681403|NCT01391130|459458416|FG001|Overall Study|Did not Receive Drug|1|||
127681404|NCT00880048|459458420|FG000|Overall Study|Adverse Event|2|||
127681405|NCT00880048|459458421|FG001|Overall Study|Adverse Event|3|||
127681406|NCT00880048|459458422|FG002|Overall Study|Adverse Event|5|||
127681407|NCT00880048|459458420|FG000|Overall Study|Lack of Efficacy|1|||
127681408|NCT00880048|459458421|FG001|Overall Study|Lack of Efficacy|2|||
127681409|NCT00880048|459458422|FG002|Overall Study|Lack of Efficacy|2|||
127681410|NCT00880048|459458420|FG000|Overall Study|Protocol Violation|4|||
127681411|NCT00880048|459458421|FG001|Overall Study|Protocol Violation|6|||
127681412|NCT00880048|459458422|FG002|Overall Study|Protocol Violation|5|||
127681413|NCT00880048|459458420|FG000|Overall Study|Lost to Follow-up|6|||
127681414|NCT00880048|459458421|FG001|Overall Study|Lost to Follow-up|6|||
127681415|NCT00880048|459458422|FG002|Overall Study|Lost to Follow-up|5|||
127681416|NCT00880048|459458420|FG000|Overall Study|Physician Decision|1|||
127681417|NCT00880048|459458421|FG001|Overall Study|Physician Decision|1|||
127681418|NCT00880048|459458422|FG002|Overall Study|Physician Decision|7|||
127681419|NCT00880048|459458420|FG000|Overall Study|Withdrawal by Subject|5|||
127681420|NCT00880048|459458421|FG001|Overall Study|Withdrawal by Subject|8|||
127681421|NCT00880048|459458422|FG002|Overall Study|Withdrawal by Subject|5|||
127681422|NCT00880048|459458420|FG000|Overall Study|Study closed/terminated|9|||
127681423|NCT00880048|459458421|FG001|Overall Study|Study closed/terminated|7|||
127681424|NCT00880048|459458422|FG002|Overall Study|Study closed/terminated|6|||
127681425|NCT01184508|459458427|FG000|Overall Study|Adverse Event|4|||
127681426|NCT01184508|459458428|FG001|Overall Study|Adverse Event|6|||
127681427|NCT01184508|459458427|FG000|Overall Study|Lack of Efficacy|1|||
127544863|NCT01748292|458962514|FG000|Overall Study|Withdrawal by Subject|0|||
127681428|NCT01184508|459458428|FG001|Overall Study|Lack of Efficacy|1|||
127681429|NCT01184508|459458427|FG000|Overall Study|Lost to Follow-up|1|||
127681430|NCT01184508|459458428|FG001|Overall Study|Lost to Follow-up|1|||
127681431|NCT01184508|459458427|FG000|Overall Study|Physician Decision|1|||
127681432|NCT01184508|459458428|FG001|Overall Study|Physician Decision|0|||
127681433|NCT01184508|459458427|FG000|Overall Study|Protocol Violation|3|||
127681434|NCT01184508|459458428|FG001|Overall Study|Protocol Violation|1|||
127681435|NCT01184508|459458427|FG000|Overall Study|Sponsor Decision|5|||
127681436|NCT01184508|459458428|FG001|Overall Study|Sponsor Decision|2|||
127681437|NCT01184508|459458427|FG000|Overall Study|Withdrawal by Subject|1|||
127681438|NCT01184508|459458428|FG001|Overall Study|Withdrawal by Subject|3|||
127681439|NCT01184508|459458427|FG000|Overall Study|Randomized, Not Treated|0|||
127681440|NCT01184508|459458428|FG001|Overall Study|Randomized, Not Treated|1|||
127681441|NCT00790790|459458436|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
127681442|NCT00790790|459458437|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
127681443|NCT00790790|459458438|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
127681444|NCT00790790|459458436|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
127544864|NCT01748292|458962515|FG001|Overall Study|Withdrawal by Subject|2|||
127544865|NCT01527370|458962518|FG000|Overall Study|Withdrawal by Subject|4|||
127544866|NCT01527370|458962518|FG000|Overall Study|Physician Decision|1|||
127544867|NCT01527370|458962518|FG000|Overall Study|Death|1|||
127544868|NCT02057250|458962519|FG000|AID Assessment Phase|Adverse Event|3|||
127544869|NCT02057250|458962520|FG001|AID Assessment Phase|Adverse Event|2|||
127544870|NCT02057250|458962521|FG002|AID Assessment Phase|Adverse Event|6|||
127544871|NCT02057250|458962522|FG003|AID Assessment Phase|Adverse Event|1|||
127544872|NCT02057250|458962523|FG004|AID Assessment Phase|Adverse Event|0|||
127544873|NCT02057250|458962519|FG000|AID Assessment Phase|Other than specified above|1|||
127544874|NCT02057250|458962520|FG001|AID Assessment Phase|Other than specified above|1|||
127544875|NCT02057250|458962521|FG002|AID Assessment Phase|Other than specified above|1|||
127544876|NCT02057250|458962522|FG003|AID Assessment Phase|Other than specified above|1|||
127544877|NCT02057250|458962523|FG004|AID Assessment Phase|Other than specified above|0|||
127544878|NCT02057250|458962519|FG000|Extension Phase|Adverse Event|0|||
128015760|NCT02612155|460682149|FG001|Overall Study|Death|1|||
128015761|NCT02612155|460682148|FG000|Overall Study|Lost to Follow-up|2|||
128015762|NCT02612155|460682149|FG001|Overall Study|Lost to Follow-up|2|||
128015763|NCT00005047|460682151|FG000|Overall Study|Withdrawal by Subject|12|||
128015764|NCT00005047|460682152|FG001|Overall Study|Withdrawal by Subject|0|||
128015765|NCT00005047|460682153|FG002|Overall Study|Withdrawal by Subject|0|||
128015766|NCT00005047|460682154|FG003|Overall Study|Withdrawal by Subject|0|||
128015767|NCT00005047|460682151|FG000|Overall Study|Adverse Event|5|||
128015768|NCT00005047|460682152|FG001|Overall Study|Adverse Event|0|||
128015769|NCT00005047|460682153|FG002|Overall Study|Adverse Event|0|||
128015770|NCT00005047|460682154|FG003|Overall Study|Adverse Event|0|||
128015771|NCT00005047|460682151|FG000|Overall Study|Lost to Follow-up|1|||
128015772|NCT00005047|460682152|FG001|Overall Study|Lost to Follow-up|0|||
128015773|NCT00005047|460682153|FG002|Overall Study|Lost to Follow-up|0|||
128015774|NCT00005047|460682154|FG003|Overall Study|Lost to Follow-up|0|||
128015775|NCT00005047|460682151|FG000|Overall Study|Lack of Efficacy|1|||
128015776|NCT00005047|460682152|FG001|Overall Study|Lack of Efficacy|0|||
128015777|NCT00005047|460682153|FG002|Overall Study|Lack of Efficacy|0|||
128015778|NCT00005047|460682154|FG003|Overall Study|Lack of Efficacy|0|||
128015779|NCT00098475|460682157|FG000|Step 1|Progressive disease|33|||
128015780|NCT00098475|460682158|FG001|Step 1|Progressive disease|35|||
128015781|NCT00098475|460682159|FG002|Step 1|Progressive disease|2|||
128015782|NCT00098475|460682160|FG003|Step 1|Progressive disease|1|||
127544879|NCT02057250|458962520|FG001|Extension Phase|Adverse Event|0|||
127544880|NCT02057250|458962521|FG002|Extension Phase|Adverse Event|0|||
127544881|NCT02057250|458962522|FG003|Extension Phase|Adverse Event|0|||
127544882|NCT02057250|458962523|FG004|Extension Phase|Adverse Event|15|||
127544883|NCT02057250|458962519|FG000|Extension Phase|Lack of Efficacy|0|||
127544884|NCT02057250|458962520|FG001|Extension Phase|Lack of Efficacy|0|||
127544885|NCT02057250|458962521|FG002|Extension Phase|Lack of Efficacy|0|||
127544886|NCT02057250|458962522|FG003|Extension Phase|Lack of Efficacy|0|||
127544887|NCT02057250|458962523|FG004|Extension Phase|Lack of Efficacy|10|||
127544888|NCT02057250|458962519|FG000|Extension Phase|Entered in this period but not treated|0|||
127544889|NCT02057250|458962520|FG001|Extension Phase|Entered in this period but not treated|0|||
127544890|NCT02057250|458962521|FG002|Extension Phase|Entered in this period but not treated|0|||
127544891|NCT02057250|458962522|FG003|Extension Phase|Entered in this period but not treated|0|||
127544892|NCT02057250|458962523|FG004|Extension Phase|Entered in this period but not treated|4|||
127544893|NCT02057250|458962519|FG000|Extension Phase|Other than specified above|0|||
127544894|NCT02057250|458962520|FG001|Extension Phase|Other than specified above|0|||
127544895|NCT02057250|458962521|FG002|Extension Phase|Other than specified above|0|||
127544896|NCT02057250|458962522|FG003|Extension Phase|Other than specified above|0|||
127544897|NCT02057250|458962523|FG004|Extension Phase|Other than specified above|7|||
127544898|NCT01435382|458962527|FG000|Overall Study|Lost to Follow-up|1|||
127544899|NCT01435382|458962528|FG001|Overall Study|Lost to Follow-up|0|||
127544900|NCT01435382|458962529|FG002|Overall Study|Lost to Follow-up|1|||
127681445|NCT00790790|459458437|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
127681446|NCT00790790|459458438|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
127681447|NCT00790790|459458436|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
127681448|NCT00790790|459458437|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
127681449|NCT00790790|459458438|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
127681450|NCT00790790|459458436|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
127681451|NCT00790790|459458437|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
127681452|NCT00790790|459458438|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
128015783|NCT00098475|460682157|FG000|Step 1|Adverse Event|56|||
127544901|NCT01435382|458962530|FG003|Overall Study|Lost to Follow-up|0|||
127544902|NCT01435382|458962527|FG000|Overall Study|Withdrawal by Subject|0|||
127544903|NCT01435382|458962528|FG001|Overall Study|Withdrawal by Subject|2|||
128015784|NCT00098475|460682158|FG001|Step 1|Adverse Event|37|||
128015785|NCT00098475|460682159|FG002|Step 1|Adverse Event|0|||
128015786|NCT00098475|460682160|FG003|Step 1|Adverse Event|1|||
128015787|NCT00098475|460682157|FG000|Step 1|Death|8|||
128015788|NCT00098475|460682158|FG001|Step 1|Death|5|||
128015789|NCT00098475|460682159|FG002|Step 1|Death|0|||
128015790|NCT00098475|460682160|FG003|Step 1|Death|1|||
128015791|NCT00098475|460682157|FG000|Step 1|Withdrawal by Subject|14|||
128015792|NCT00098475|460682158|FG001|Step 1|Withdrawal by Subject|11|||
128015793|NCT00098475|460682159|FG002|Step 1|Withdrawal by Subject|0|||
128015794|NCT00098475|460682160|FG003|Step 1|Withdrawal by Subject|0|||
128015795|NCT00098475|460682157|FG000|Step 1|Physician Decision|5|||
128015796|NCT00098475|460682158|FG001|Step 1|Physician Decision|2|||
128015797|NCT00098475|460682159|FG002|Step 1|Physician Decision|0|||
128015798|NCT00098475|460682160|FG003|Step 1|Physician Decision|0|||
128015799|NCT00098475|460682157|FG000|Step 1|Alternative therapy|31|||
128015800|NCT00098475|460682158|FG001|Step 1|Alternative therapy|43|||
128015801|NCT00098475|460682159|FG002|Step 1|Alternative therapy|1|||
128015802|NCT00098475|460682160|FG003|Step 1|Alternative therapy|0|||
128015803|NCT00098475|460682157|FG000|Step 1|Other disease|2|||
128015804|NCT00098475|460682158|FG001|Step 1|Other disease|1|||
128015805|NCT00098475|460682159|FG002|Step 1|Other disease|1|||
128015806|NCT00098475|460682160|FG003|Step 1|Other disease|0|||
128015807|NCT00098475|460682157|FG000|Step 1|Never started treatment|0|||
128015808|NCT00098475|460682158|FG001|Step 1|Never started treatment|2|||
128015809|NCT00098475|460682159|FG002|Step 1|Never started treatment|0|||
128015810|NCT00098475|460682160|FG003|Step 1|Never started treatment|0|||
128015811|NCT00098475|460682157|FG000|Step 1|Still on treatment as of this analysis|14|||
128015812|NCT00098475|460682158|FG001|Step 1|Still on treatment as of this analysis|27|||
128015813|NCT00098475|460682159|FG002|Step 1|Still on treatment as of this analysis|0|||
128015814|NCT00098475|460682160|FG003|Step 1|Still on treatment as of this analysis|0|||
128015815|NCT00098475|460682157|FG000|Step 1|Knee surgery|1|||
128015816|NCT00098475|460682158|FG001|Step 1|Knee surgery|0|||
128015817|NCT00098475|460682159|FG002|Step 1|Knee surgery|0|||
128015818|NCT00098475|460682160|FG003|Step 1|Knee surgery|0|||
128015819|NCT00098475|460682157|FG000|Step 1|Complications|1|||
128015820|NCT00098475|460682158|FG001|Step 1|Complications|0|||
128015821|NCT00098475|460682159|FG002|Step 1|Complications|0|||
128015822|NCT00098475|460682160|FG003|Step 1|Complications|0|||
128015823|NCT00098475|460682157|FG000|Step 1|Cannot comply due to other tx|0|||
128015824|NCT00098475|460682158|FG001|Step 1|Cannot comply due to other tx|1|||
128015825|NCT00098475|460682159|FG002|Step 1|Cannot comply due to other tx|0|||
128015826|NCT00098475|460682160|FG003|Step 1|Cannot comply due to other tx|0|||
128015827|NCT00098475|460682157|FG000|Step 1|Both patient and physician's decision|2|||
128015828|NCT00098475|460682158|FG001|Step 1|Both patient and physician's decision|1|||
128015829|NCT00098475|460682159|FG002|Step 1|Both patient and physician's decision|0|||
128015830|NCT00098475|460682160|FG003|Step 1|Both patient and physician's decision|0|||
128015831|NCT00098475|460682157|FG000|Step 1|Incorrect disease assessment|2|||
128015832|NCT00098475|460682158|FG001|Step 1|Incorrect disease assessment|0|||
128015833|NCT00098475|460682159|FG002|Step 1|Incorrect disease assessment|0|||
128015834|NCT00098475|460682160|FG003|Step 1|Incorrect disease assessment|0|||
128015835|NCT00098475|460682157|FG000|Step 1|Off treatment for > specified timeframe|1|||
128015836|NCT00098475|460682158|FG001|Step 1|Off treatment for > specified timeframe|1|||
128015837|NCT00098475|460682159|FG002|Step 1|Off treatment for > specified timeframe|0|||
128015838|NCT00098475|460682160|FG003|Step 1|Off treatment for > specified timeframe|0|||
128015839|NCT00098475|460682157|FG000|Step 1|Declining performance status|0|||
128015840|NCT00098475|460682158|FG001|Step 1|Declining performance status|1|||
128015841|NCT00098475|460682159|FG002|Step 1|Declining performance status|0|||
128015842|NCT00098475|460682160|FG003|Step 1|Declining performance status|0|||
128015843|NCT00098475|460682157|FG000|Step 1|Insurance issue|0|||
128015844|NCT00098475|460682158|FG001|Step 1|Insurance issue|1|||
128015845|NCT00098475|460682159|FG002|Step 1|Insurance issue|0|||
128015846|NCT00098475|460682160|FG003|Step 1|Insurance issue|0|||
127768154|NCT00600886|459776730|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
128015847|NCT00098475|460682157|FG000|Step 1|Rising paraprotein|0|||
128015848|NCT00098475|460682158|FG001|Step 1|Rising paraprotein|1|||
128015849|NCT00098475|460682159|FG002|Step 1|Rising paraprotein|0|||
128015850|NCT00098475|460682160|FG003|Step 1|Rising paraprotein|0|||
127768155|NCT00600886|459776731|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
128015851|NCT00098475|460682157|FG000|Step 1|Referred to other physicians|0|||
128015852|NCT00098475|460682158|FG001|Step 1|Referred to other physicians|1|||
128015853|NCT00098475|460682159|FG002|Step 1|Referred to other physicians|0|||
128015854|NCT00098475|460682160|FG003|Step 1|Referred to other physicians|0|||
128015855|NCT00098475|460682157|FG000|Step 1|Criteria to continue treatment not met|0|||
128015856|NCT00098475|460682158|FG001|Step 1|Criteria to continue treatment not met|1|||
127768156|NCT00600886|459776730|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
128015857|NCT00098475|460682159|FG002|Step 1|Criteria to continue treatment not met|0|||
128015858|NCT00098475|460682160|FG003|Step 1|Criteria to continue treatment not met|0|||
128015859|NCT00098475|460682157|FG000|Step 1|Misinterpretation of lab data|0|||
128015860|NCT00098475|460682158|FG001|Step 1|Misinterpretation of lab data|1|||
128015861|NCT00098475|460682159|FG002|Step 1|Misinterpretation of lab data|0|||
128015862|NCT00098475|460682160|FG003|Step 1|Misinterpretation of lab data|0|||
128015863|NCT00098475|460682157|FG000|Step 1|Patient fell with fracture|1|||
127768157|NCT00600886|459776731|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
127768158|NCT00600886|459776730|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
127768159|NCT00600886|459776731|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
127768160|NCT00600886|459776730|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
127768161|NCT00600886|459776731|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
128015864|NCT00098475|460682158|FG001|Step 1|Patient fell with fracture|0|||
127768162|NCT00600886|459776730|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
127768163|NCT00600886|459776731|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
127768164|NCT00600886|459776730|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
127768165|NCT00600886|459776731|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
127768166|NCT00600886|459776730|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
127768167|NCT00600886|459776731|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
127768168|NCT00600886|459776730|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
127768169|NCT00600886|459776731|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
127768170|NCT00600886|459776730|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
127768171|NCT00600886|459776731|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
127768172|NCT00600886|459776730|FG000|Extension - Same Treatment (FAS)|Death|1|||
127768173|NCT00600886|459776731|FG001|Extension - Same Treatment (FAS)|Death|1|||
127768174|NCT00600886|459776730|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
127768175|NCT00600886|459776731|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
128015865|NCT00098475|460682159|FG002|Step 1|Patient fell with fracture|0|||
128015866|NCT00098475|460682160|FG003|Step 1|Patient fell with fracture|0|||
128015867|NCT00098475|460682157|FG000|Step 1|Not documented|0|||
128015868|NCT00098475|460682158|FG001|Step 1|Not documented|1|||
128015869|NCT00098475|460682159|FG002|Step 1|Not documented|0|||
128015870|NCT00098475|460682160|FG003|Step 1|Not documented|0|||
128015871|NCT00098475|460682157|FG000|Step 2|Disease progression|1|||
128015872|NCT00098475|460682158|FG001|Step 2|Disease progression|4|||
128015873|NCT00098475|460682159|FG002|Step 2|Disease progression|0|||
128015874|NCT00098475|460682160|FG003|Step 2|Disease progression|0|||
128015875|NCT00098475|460682157|FG000|Step 2|Adverse Event|2|||
128015876|NCT00098475|460682158|FG001|Step 2|Adverse Event|0|||
128015877|NCT00098475|460682159|FG002|Step 2|Adverse Event|0|||
128015878|NCT00098475|460682160|FG003|Step 2|Adverse Event|0|||
128015879|NCT00098475|460682157|FG000|Step 2|Withdrawal by Subject|0|||
128015880|NCT00098475|460682158|FG001|Step 2|Withdrawal by Subject|2|||
128015881|NCT00098475|460682159|FG002|Step 2|Withdrawal by Subject|0|||
128015882|NCT00098475|460682160|FG003|Step 2|Withdrawal by Subject|0|||
128015883|NCT00098475|460682157|FG000|Step 2|Physician Decision|0|||
128015884|NCT00098475|460682158|FG001|Step 2|Physician Decision|1|||
128015885|NCT00098475|460682159|FG002|Step 2|Physician Decision|0|||
128015886|NCT00098475|460682160|FG003|Step 2|Physician Decision|0|||
128015887|NCT00098475|460682157|FG000|Step 2|Alternative therapy|1|||
128015888|NCT00098475|460682158|FG001|Step 2|Alternative therapy|2|||
128015889|NCT00098475|460682159|FG002|Step 2|Alternative therapy|0|||
128015890|NCT00098475|460682160|FG003|Step 2|Alternative therapy|0|||
128015891|NCT00098475|460682157|FG000|Step 2|Never started treatment|1|||
128015892|NCT00098475|460682158|FG001|Step 2|Never started treatment|1|||
128015893|NCT00098475|460682159|FG002|Step 2|Never started treatment|0|||
128015894|NCT00098475|460682160|FG003|Step 2|Never started treatment|0|||
128015895|NCT03168672|460682161|FG000|Overall Study|Withdrawal by Subject|13|||
128015896|NCT03168672|460682161|FG000|Overall Study|Death|3|||
128015897|NCT03168672|460682161|FG000|Overall Study|Investigator's Decision|137|||
128015898|NCT03168672|460682161|FG000|Overall Study|Adverse Event|1|||
128015899|NCT03168672|460682161|FG000|Overall Study|Other|2|||
128015900|NCT03168672|460682161|FG000|Overall Study|Started but not treated with GLOBAL ICON|15|||
128015901|NCT05436613|460682164|FG000|Overall Study|Lost to Follow-up|9|||
128015902|NCT05436613|460682164|FG000|Overall Study|Withdrawal by Subject|3|||
128015903|NCT05350202|460682167|FG000|Visit 1 - Baseline|Not-treated|18|||
128015904|NCT05350202|460682168|FG001|Visit 1 - Baseline|Not-treated|0|||
128015905|NCT05350202|460682167|FG000|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|25|||
128015906|NCT05350202|460682168|FG001|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|0|||
128015907|NCT05350202|460682167|FG000|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|36|||
128015908|NCT05350202|460682168|FG001|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|0|||
128015909|NCT05350202|460682167|FG000|Visit 1 to Visit 2 - 24 Weeks|Death|45|||
128015910|NCT05350202|460682168|FG001|Visit 1 to Visit 2 - 24 Weeks|Death|0|||
128015911|NCT05350202|460682167|FG000|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|7|||
128015912|NCT05350202|460682168|FG001|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|0|||
128015913|NCT05350202|460682167|FG000|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|6|||
128015914|NCT05350202|460682168|FG001|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|0|||
128015915|NCT05350202|460682167|FG000|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|38|||
128015916|NCT05350202|460682168|FG001|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|0|||
128015917|NCT04635423|460682169|FG000|Overall Study|Ongoing|493|||
128015918|NCT04635423|460682170|FG001|Overall Study|Ongoing|501|||
128015919|NCT04635423|460682169|FG000|Overall Study|Withdrawal by Subject|36|||
127544904|NCT01435382|458962529|FG002|Overall Study|Withdrawal by Subject|0|||
127544905|NCT01435382|458962530|FG003|Overall Study|Withdrawal by Subject|1|||
127544906|NCT00910650|458962531|FG000|Overall Study|Death|2|||
127544907|NCT03367793|458962532|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
127544908|NCT03367793|458962533|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
127544909|NCT03367793|458962534|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
127544910|NCT03367793|458962535|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
127544911|NCT03367793|458962536|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
127544912|NCT03367793|458962537|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
127544913|NCT02435992|458962538|FG000|Overall Study|non compliance with protocol|2|||
127544914|NCT02435992|458962539|FG001|Overall Study|non compliance with protocol|0|||
127544915|NCT02435992|458962540|FG002|Overall Study|non compliance with protocol|1|||
127544916|NCT02435992|458962541|FG003|Overall Study|non compliance with protocol|0|||
127544917|NCT02435992|458962542|FG004|Overall Study|non compliance with protocol|0|||
127544918|NCT02435992|458962538|FG000|Overall Study|Adverse Event|11|||
127544919|NCT02435992|458962539|FG001|Overall Study|Adverse Event|6|||
127544920|NCT02435992|458962540|FG002|Overall Study|Adverse Event|12|||
127544921|NCT02435992|458962541|FG003|Overall Study|Adverse Event|0|||
127544922|NCT02435992|458962542|FG004|Overall Study|Adverse Event|0|||
127544923|NCT02435992|458962538|FG000|Overall Study|Lack of Efficacy|4|||
127544924|NCT02435992|458962539|FG001|Overall Study|Lack of Efficacy|10|||
127544925|NCT02435992|458962540|FG002|Overall Study|Lack of Efficacy|9|||
127544926|NCT02435992|458962541|FG003|Overall Study|Lack of Efficacy|0|||
127544927|NCT02435992|458962542|FG004|Overall Study|Lack of Efficacy|0|||
127544928|NCT02435992|458962538|FG000|Overall Study|Withdrawal by Subject|10|||
127544929|NCT02435992|458962539|FG001|Overall Study|Withdrawal by Subject|8|||
127544930|NCT02435992|458962540|FG002|Overall Study|Withdrawal by Subject|20|||
127544931|NCT02435992|458962541|FG003|Overall Study|Withdrawal by Subject|0|||
127544932|NCT02435992|458962542|FG004|Overall Study|Withdrawal by Subject|0|||
127544933|NCT02435992|458962538|FG000|Overall Study|Other Reason|1|||
127544934|NCT02435992|458962539|FG001|Overall Study|Other Reason|0|||
127544935|NCT02435992|458962540|FG002|Overall Study|Other Reason|0|||
127544936|NCT02435992|458962541|FG003|Overall Study|Other Reason|0|||
127544937|NCT02435992|458962542|FG004|Overall Study|Other Reason|0|||
127544938|NCT02435992|458962538|FG000|Overall Study|Physician Decision|0|||
127544939|NCT02435992|458962539|FG001|Overall Study|Physician Decision|0|||
127544940|NCT02435992|458962540|FG002|Overall Study|Physician Decision|1|||
127544941|NCT02435992|458962541|FG003|Overall Study|Physician Decision|0|||
127544942|NCT02435992|458962542|FG004|Overall Study|Physician Decision|0|||
127544943|NCT00260533|458962543|FG000|Overall Study|Other|3|||
127544944|NCT00260533|458962544|FG001|Overall Study|Other|3|||
127544945|NCT01761877|458962545|FG000|Overall Study|Adverse Event|7|||
127544946|NCT01761877|458962546|FG001|Overall Study|Adverse Event|0|||
127544947|NCT01761877|458962545|FG000|Overall Study|Withdrawal by Subject|6|||
127544948|NCT01761877|458962546|FG001|Overall Study|Withdrawal by Subject|4|||
127544949|NCT01761877|458962545|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
127544950|NCT01761877|458962546|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
127544951|NCT01761877|458962545|FG000|Overall Study|Death|0|||
127544952|NCT01761877|458962546|FG001|Overall Study|Death|1|||
127544953|NCT01761877|458962545|FG000|Overall Study|MRI intolerant|1|||
127544954|NCT01761877|458962546|FG001|Overall Study|MRI intolerant|6|||
127544955|NCT01310777|458962548|FG000|Overall Study|Adverse Event|23|||
127544956|NCT01310777|458962549|FG001|Overall Study|Adverse Event|1|||
127544957|NCT01310777|458962550|FG002|Overall Study|Adverse Event|15|||
127544958|NCT01310777|458962548|FG000|Overall Study|Lost to Follow-up|0|||
127544959|NCT01310777|458962549|FG001|Overall Study|Lost to Follow-up|4|||
127544960|NCT01310777|458962550|FG002|Overall Study|Lost to Follow-up|1|||
127768176|NCT00600886|459776730|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
127768177|NCT00600886|459776731|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
127544961|NCT01310777|458962548|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
127544962|NCT01310777|458962549|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
127544963|NCT01310777|458962550|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
127768178|NCT00600886|459776730|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
127768179|NCT00600886|459776731|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
127544964|NCT01310777|458962548|FG000|Overall Study|Inadequate Control of IOP|5|||
127544965|NCT01310777|458962549|FG001|Overall Study|Inadequate Control of IOP|7|||
127544966|NCT01310777|458962550|FG002|Overall Study|Inadequate Control of IOP|10|||
127544967|NCT01310777|458962548|FG000|Overall Study|Other|4|||
127544968|NCT01310777|458962549|FG001|Overall Study|Other|1|||
127544969|NCT01310777|458962550|FG002|Overall Study|Other|2|||
127544970|NCT02224560|458962552|FG000|Overall Study|Protocol Deviation|1|||
127544971|NCT02224560|458962553|FG001|Overall Study|Protocol Deviation|0|||
127544972|NCT02224560|458962554|FG002|Overall Study|Protocol Deviation|0|||
127544973|NCT02224560|458962552|FG000|Overall Study|Withdrawal by Subject|2|||
127544974|NCT02224560|458962553|FG001|Overall Study|Withdrawal by Subject|0|||
127544975|NCT02224560|458962554|FG002|Overall Study|Withdrawal by Subject|1|||
127544976|NCT02224560|458962552|FG000|Overall Study|Met Withdrawal Criteria|1|||
127544977|NCT02224560|458962553|FG001|Overall Study|Met Withdrawal Criteria|0|||
127544978|NCT02224560|458962554|FG002|Overall Study|Met Withdrawal Criteria|0|||
127544979|NCT02224560|458962552|FG000|Overall Study|Adverse Event|4|||
127544980|NCT02224560|458962553|FG001|Overall Study|Adverse Event|1|||
127544981|NCT02224560|458962554|FG002|Overall Study|Adverse Event|1|||
127544982|NCT02224560|458962552|FG000|Overall Study|Withdrawn by Investigator|1|||
127544983|NCT02224560|458962553|FG001|Overall Study|Withdrawn by Investigator|1|||
127544984|NCT02224560|458962554|FG002|Overall Study|Withdrawn by Investigator|0|||
127544985|NCT02461758|458962555|FG000|Overall Study|Lost to Follow-up|0|||
127544986|NCT02461758|458962556|FG001|Overall Study|Lost to Follow-up|1|||
127544987|NCT02461758|458962557|FG002|Overall Study|Lost to Follow-up|1|||
127544988|NCT02461758|458962558|FG003|Overall Study|Lost to Follow-up|0|||
127544989|NCT02340026|458962561|FG000|Treatment Phase|Withdrawal by Subject|2|||
127544990|NCT02340026|458962562|FG001|Treatment Phase|Withdrawal by Subject|2|||
127544991|NCT02340026|458962561|FG000|Follow-up Phase|Lost to Follow-up|1|||
127544992|NCT02340026|458962562|FG001|Follow-up Phase|Lost to Follow-up|0|||
127544993|NCT02738801|458962574|FG000|Overall Study|Adverse Event|1|||
127544994|NCT02738801|458962575|FG001|Overall Study|Adverse Event|1|||
127544995|NCT02738801|458962574|FG000|Overall Study|Withdrawal by Subject|0|||
127544996|NCT02738801|458962575|FG001|Overall Study|Withdrawal by Subject|1|||
127544997|NCT01210313|458962576|FG000|Overall Study|Withdrawal by Subject|3|||
127544998|NCT01210313|458962576|FG000|Overall Study|Adverse Event|2|||
127544999|NCT01210313|458962576|FG000|Overall Study|Distant recurrence|4|||
127545000|NCT01210313|458962576|FG000|Overall Study|Non-compliance|7|||
127545001|NCT01710345|458962587|FG000|Overall Study|Adverse Event|0|||
127545002|NCT01710345|458962588|FG001|Overall Study|Adverse Event|2|||
127545003|NCT01710345|458962589|FG002|Overall Study|Adverse Event|0|||
127545004|NCT01710345|458962587|FG000|Overall Study|Lack of Efficacy|2|||
127545005|NCT01710345|458962588|FG001|Overall Study|Lack of Efficacy|3|||
127545006|NCT01710345|458962589|FG002|Overall Study|Lack of Efficacy|1|||
127545007|NCT01710345|458962587|FG000|Overall Study|Drug Dosing Error|1|||
127545008|NCT01710345|458962588|FG001|Overall Study|Drug Dosing Error|0|||
127545009|NCT01710345|458962589|FG002|Overall Study|Drug Dosing Error|0|||
127545010|NCT01502293|458962592|FG000|Overall Study|Progressive Disease|20|||
127545011|NCT01502293|458962593|FG001|Overall Study|Progressive Disease|12|||
127545012|NCT01502293|458962594|FG002|Overall Study|Progressive Disease|2|||
127545013|NCT01502293|458962592|FG000|Overall Study|Withdrawal by Subject|3|||
127545014|NCT01502293|458962593|FG001|Overall Study|Withdrawal by Subject|3|||
127545015|NCT01502293|458962594|FG002|Overall Study|Withdrawal by Subject|1|||
127545016|NCT01502293|458962592|FG000|Overall Study|Adverse Event|0|||
127545017|NCT01502293|458962593|FG001|Overall Study|Adverse Event|2|||
127545018|NCT01502293|458962594|FG002|Overall Study|Adverse Event|0|||
127545019|NCT01502293|458962592|FG000|Overall Study|Reason Not Specified|2|||
127545020|NCT01502293|458962593|FG001|Overall Study|Reason Not Specified|0|||
127545021|NCT01502293|458962594|FG002|Overall Study|Reason Not Specified|0|||
127545022|NCT01502293|458962592|FG000|Overall Study|Physician Decision|0|||
127545023|NCT01502293|458962593|FG001|Overall Study|Physician Decision|0|||
127545024|NCT01502293|458962594|FG002|Overall Study|Physician Decision|1|||
127545025|NCT03694353|458962595|FG000|Overall Study|Withdrawal by Subject|1|||
127545026|NCT03694353|458962595|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
127545027|NCT00124943|458964302|FG000|Phase II|Adverse Event|0|||
127545028|NCT00124943|458964303|FG001|Phase II|Adverse Event|2|||
127545029|NCT00124943|458964304|FG002|Phase II|Adverse Event|0|||
127545030|NCT00124943|458964305|FG003|Phase II|Adverse Event|1|||
127768180|NCT00600886|459776730|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
127768181|NCT00600886|459776731|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
127768182|NCT00600886|459776730|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
127768183|NCT00600886|459776731|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
127768184|NCT00600886|459776730|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
127768185|NCT00600886|459776731|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
127768186|NCT00600886|459776730|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
127545031|NCT00124943|458964302|FG000|Phase II|Protocol Violation|0|||
127545032|NCT00124943|458964303|FG001|Phase II|Protocol Violation|0|||
127545033|NCT00124943|458964304|FG002|Phase II|Protocol Violation|0|||
127545034|NCT00124943|458964305|FG003|Phase II|Protocol Violation|1|||
127545035|NCT00124943|458964302|FG000|Phase II|Lost to Follow-up|0|||
127545036|NCT00124943|458964303|FG001|Phase II|Lost to Follow-up|0|||
127545037|NCT00124943|458964304|FG002|Phase II|Lost to Follow-up|0|||
127545038|NCT00124943|458964305|FG003|Phase II|Lost to Follow-up|1|||
127545039|NCT00124943|458964302|FG000|Phase II|Withdrawal by Subject|0|||
127545040|NCT00124943|458964303|FG001|Phase II|Withdrawal by Subject|0|||
127545041|NCT00124943|458964304|FG002|Phase II|Withdrawal by Subject|0|||
127545042|NCT00124943|458964305|FG003|Phase II|Withdrawal by Subject|2|||
127545043|NCT00321620|458964306|FG000|Overall Study|Death|269|||
127545044|NCT00321620|458964307|FG001|Overall Study|Death|294|||
127545045|NCT00321620|458964306|FG000|Overall Study|Withdrawal by Subject|164|||
127545046|NCT00321620|458964307|FG001|Overall Study|Withdrawal by Subject|147|||
127545047|NCT00321620|458964306|FG000|Overall Study|Disease progression|113|||
127545048|NCT00321620|458964307|FG001|Overall Study|Disease progression|117|||
127545049|NCT00321620|458964306|FG000|Overall Study|Adverse Event|43|||
127545050|NCT00321620|458964307|FG001|Overall Study|Adverse Event|56|||
127545051|NCT00321620|458964306|FG000|Overall Study|Lost to Follow-up|13|||
127545052|NCT00321620|458964307|FG001|Overall Study|Lost to Follow-up|9|||
127545053|NCT00321620|458964306|FG000|Overall Study|Physician Decision|4|||
127545054|NCT00321620|458964307|FG001|Overall Study|Physician Decision|1|||
127545055|NCT00321620|458964306|FG000|Overall Study|Noncompliance|14|||
127545056|NCT00321620|458964307|FG001|Overall Study|Noncompliance|7|||
127545057|NCT00321620|458964306|FG000|Overall Study|Protocol deviation|4|||
127545058|NCT00321620|458964307|FG001|Overall Study|Protocol deviation|3|||
127545059|NCT00321620|458964306|FG000|Overall Study|Ineligibility determined|2|||
127545060|NCT00321620|458964307|FG001|Overall Study|Ineligibility determined|3|||
127545061|NCT00321620|458964306|FG000|Overall Study|Participant request|75|||
127545062|NCT00321620|458964307|FG001|Overall Study|Participant request|52|||
127545063|NCT00321620|458964306|FG000|Overall Study|Other|42|||
127545064|NCT00321620|458964307|FG001|Overall Study|Other|33|||
127545065|NCT03304626|458964310|FG000|Overall Study|Adverse Event|1|||
127545066|NCT03304626|458964311|FG001|Overall Study|Adverse Event|0|||
127545067|NCT03304626|458964310|FG000|Overall Study|Lack of Efficacy|1|||
127545068|NCT03304626|458964311|FG001|Overall Study|Lack of Efficacy|1|||
127545069|NCT04385277|458964312|FG000|Overall Study|Physician Decision|2|||
127545070|NCT04385277|458964312|FG000|Overall Study|Ineligible|1|||
127545071|NCT04385277|458964312|FG000|Overall Study|Patient/Parent Refusal|2|||
127545072|NCT02903771|458964317|FG000|Part A: Dose Escalation Cohort|Adverse Event|1|||
127545073|NCT02903771|458964318|FG001|Part A: Dose Escalation Cohort|Adverse Event|0|||
127545074|NCT02903771|458964319|FG002|Part A: Dose Escalation Cohort|Adverse Event|0|||
127545075|NCT02903771|458964320|FG003|Part A: Dose Escalation Cohort|Adverse Event|0|||
127545076|NCT02903771|458964321|FG004|Part A: Dose Escalation Cohort|Adverse Event|0|||
127545077|NCT02903771|458964322|FG005|Part A: Dose Escalation Cohort|Adverse Event|0|||
127545078|NCT02903771|458964323|FG006|Part A: Dose Escalation Cohort|Adverse Event|1|||
127545079|NCT02903771|458964317|FG000|Part A: Dose Escalation Cohort|Progressive disease|0|||
127545080|NCT02903771|458964318|FG001|Part A: Dose Escalation Cohort|Progressive disease|1|||
127545081|NCT02903771|458964319|FG002|Part A: Dose Escalation Cohort|Progressive disease|0|||
127545082|NCT02903771|458964320|FG003|Part A: Dose Escalation Cohort|Progressive disease|0|||
127545083|NCT02903771|458964321|FG004|Part A: Dose Escalation Cohort|Progressive disease|0|||
127545084|NCT02903771|458964322|FG005|Part A: Dose Escalation Cohort|Progressive disease|0|||
127545085|NCT02903771|458964323|FG006|Part A: Dose Escalation Cohort|Progressive disease|0|||
127545086|NCT02903771|458964317|FG000|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
127545087|NCT02903771|458964318|FG001|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
127545088|NCT02903771|458964319|FG002|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
127545089|NCT02903771|458964320|FG003|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
127545090|NCT02903771|458964321|FG004|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
127545091|NCT02903771|458964322|FG005|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
127545092|NCT02903771|458964323|FG006|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
127545093|NCT02903771|458964317|FG000|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
127545094|NCT02903771|458964318|FG001|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
127545095|NCT02903771|458964319|FG002|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
127545096|NCT02903771|458964320|FG003|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
127545097|NCT02903771|458964321|FG004|Part A: Dose Escalation Cohort|Lost to Follow-up|1|||
127545098|NCT02903771|458964322|FG005|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
127545099|NCT02903771|458964323|FG006|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
127545100|NCT02903771|458964317|FG000|Part A: Dose Escalation Cohort|Physician Decision|0|||
127768187|NCT00600886|459776731|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
127768188|NCT00600886|459776730|FG000|Extension - After Crossover (CAS)|Death|1|||
127768189|NCT00600886|459776731|FG001|Extension - After Crossover (CAS)|Death|0|||
127768190|NCT03075410|459776732|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
127768191|NCT03075410|459776733|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
127768192|NCT03075410|459776734|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
127768193|NCT03075410|459776735|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
127768194|NCT03075410|459776736|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
127545101|NCT02903771|458964318|FG001|Part A: Dose Escalation Cohort|Physician Decision|0|||
127545102|NCT02903771|458964319|FG002|Part A: Dose Escalation Cohort|Physician Decision|0|||
127545103|NCT02903771|458964320|FG003|Part A: Dose Escalation Cohort|Physician Decision|0|||
127545104|NCT02903771|458964321|FG004|Part A: Dose Escalation Cohort|Physician Decision|0|||
127545105|NCT02903771|458964322|FG005|Part A: Dose Escalation Cohort|Physician Decision|1|||
127545106|NCT02903771|458964323|FG006|Part A: Dose Escalation Cohort|Physician Decision|0|||
127545107|NCT02903771|458964317|FG000|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
127545108|NCT02903771|458964318|FG001|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
127545109|NCT02903771|458964319|FG002|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
127545110|NCT02903771|458964320|FG003|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
127545111|NCT02903771|458964321|FG004|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|2|||
127545112|NCT02903771|458964322|FG005|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
127545113|NCT02903771|458964323|FG006|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
127545114|NCT02903771|458964317|FG000|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
127545115|NCT02903771|458964318|FG001|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
127545116|NCT02903771|458964319|FG002|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
127545117|NCT02903771|458964320|FG003|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
127545118|NCT02903771|458964321|FG004|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|3|||
127545119|NCT02903771|458964322|FG005|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
127545120|NCT02903771|458964323|FG006|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
127545121|NCT02903771|458964317|FG000|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
127545122|NCT02903771|458964318|FG001|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
127545123|NCT02903771|458964319|FG002|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
127545124|NCT02903771|458964320|FG003|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
127545125|NCT02903771|458964321|FG004|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|2|||
127545126|NCT02903771|458964322|FG005|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
127545127|NCT02903771|458964323|FG006|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
127545128|NCT02903771|458964317|FG000|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
127545129|NCT02903771|458964318|FG001|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
127545130|NCT02903771|458964319|FG002|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
127545131|NCT02903771|458964320|FG003|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
127545132|NCT02903771|458964321|FG004|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|1|||
127545133|NCT02903771|458964322|FG005|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
127545134|NCT02903771|458964323|FG006|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
127545135|NCT02903771|458964317|FG000|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
127545136|NCT02903771|458964318|FG001|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
127545137|NCT02903771|458964319|FG002|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
127545138|NCT02903771|458964320|FG003|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
127545139|NCT02903771|458964321|FG004|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|2|||
127545140|NCT02903771|458964322|FG005|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
127545141|NCT02903771|458964323|FG006|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
127545142|NCT02903771|458964317|FG000|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
127545143|NCT02903771|458964318|FG001|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
127545144|NCT02903771|458964319|FG002|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
127545145|NCT02903771|458964320|FG003|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
127545146|NCT02903771|458964321|FG004|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|2|||
127545147|NCT02903771|458964322|FG005|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
127545148|NCT02903771|458964323|FG006|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
127545149|NCT00886379|458964324|FG000|Overall Study|Transferred Schools|0|||
127545150|NCT00886379|458964325|FG001|Overall Study|Transferred Schools|0|||
127545151|NCT00886379|458964326|FG002|Overall Study|Transferred Schools|2|||
127545152|NCT00886379|458964327|FG003|Overall Study|Transferred Schools|1|||
127545153|NCT00886379|458964328|FG004|Overall Study|Transferred Schools|1|||
127545154|NCT00886379|458964324|FG000|Overall Study|Final blood draw not obtained|3|||
127545155|NCT00886379|458964325|FG001|Overall Study|Final blood draw not obtained|3|||
127545156|NCT00886379|458964326|FG002|Overall Study|Final blood draw not obtained|4|||
127545157|NCT00886379|458964327|FG003|Overall Study|Final blood draw not obtained|2|||
127545158|NCT00886379|458964328|FG004|Overall Study|Final blood draw not obtained|2|||
127545159|NCT04558125|458964329|FG000|Overall Study|Death|1|||
127545160|NCT03137381|458964330|FG000|Overall Study|Adverse Event|3|||
127545161|NCT03137381|458964331|FG001|Overall Study|Adverse Event|0|||
127545162|NCT03137381|458964332|FG002|Overall Study|Adverse Event|2|||
127545163|NCT03137381|458964333|FG003|Overall Study|Adverse Event|0|||
127545164|NCT03137381|458964330|FG000|Overall Study|Lost to Follow-up|2|||
127545165|NCT03137381|458964331|FG001|Overall Study|Lost to Follow-up|1|||
127681453|NCT00790790|459458436|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
127681454|NCT00790790|459458437|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
127681455|NCT00790790|459458438|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
127681456|NCT02570711|459458439|FG000|Overall Study|Death|1|||
127681457|NCT02570711|459458440|FG001|Overall Study|Death|0|||
127681458|NCT02570711|459458439|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
127681459|NCT02570711|459458440|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
128015920|NCT04635423|460682170|FG001|Overall Study|Withdrawal by Subject|29|||
128015921|NCT03683030|460682179|FG000|Overall Study|Enrolled but screen failures|12|||
128015922|NCT03683030|460682180|FG001|Overall Study|Enrolled but screen failures|7|||
127545166|NCT03137381|458964332|FG002|Overall Study|Lost to Follow-up|1|||
127545167|NCT03137381|458964333|FG003|Overall Study|Lost to Follow-up|0|||
127681460|NCT02798835|459458441|FG000|Overall Study|Protocol Violation|0|||
127545168|NCT03137381|458964330|FG000|Overall Study|Protocol deviation|1|||
127545169|NCT03137381|458964331|FG001|Overall Study|Protocol deviation|1|||
127545170|NCT03137381|458964332|FG002|Overall Study|Protocol deviation|0|||
127545171|NCT03137381|458964333|FG003|Overall Study|Protocol deviation|1|||
127545172|NCT03137381|458964330|FG000|Overall Study|Withdrawal by Investigator|0|||
127545173|NCT03137381|458964331|FG001|Overall Study|Withdrawal by Investigator|1|||
127545174|NCT03137381|458964332|FG002|Overall Study|Withdrawal by Investigator|1|||
127545175|NCT03137381|458964333|FG003|Overall Study|Withdrawal by Investigator|0|||
127545176|NCT03137381|458964330|FG000|Overall Study|Withdrawal by Subject|3|||
127545177|NCT03137381|458964331|FG001|Overall Study|Withdrawal by Subject|4|||
127545178|NCT03137381|458964332|FG002|Overall Study|Withdrawal by Subject|3|||
127545179|NCT03137381|458964333|FG003|Overall Study|Withdrawal by Subject|0|||
127545180|NCT03137381|458964330|FG000|Overall Study|Pregnancy|0|||
127545181|NCT03137381|458964331|FG001|Overall Study|Pregnancy|0|||
127545182|NCT03137381|458964332|FG002|Overall Study|Pregnancy|1|||
127545183|NCT03137381|458964333|FG003|Overall Study|Pregnancy|0|||
127545184|NCT01980017|458964338|FG000|Overall Study|Lost to Follow-up|30|||
127545185|NCT01980017|458964339|FG001|Overall Study|Lost to Follow-up|21|||
127545186|NCT01980017|458964338|FG000|Overall Study|Death|0|||
127545187|NCT01980017|458964339|FG001|Overall Study|Death|1|||
127545188|NCT01353898|458964345|FG000|Overall Study|Study site terminated|0|||
127545189|NCT01353898|458964346|FG001|Overall Study|Study site terminated|0|||
127545190|NCT01353898|458964347|FG002|Overall Study|Study site terminated|0|||
127545191|NCT01353898|458964348|FG003|Overall Study|Study site terminated|0|||
127545192|NCT01353898|458964349|FG004|Overall Study|Study site terminated|0|||
127545193|NCT01353898|458964350|FG005|Overall Study|Study site terminated|1|||
127545194|NCT03558737|458964351|FG000|Overall Study|Death|1|||
127545195|NCT03558737|458964352|FG001|Overall Study|Death|1|||
127545196|NCT03041181|458964354|FG000|Overall Study|Disease Progression|1|||
127545197|NCT03041181|458964355|FG001|Overall Study|Disease Progression|2|||
127545198|NCT03224819|458964356|FG000|Overall Study|Withdrawal by Subject|0|||
127545199|NCT03224819|458964357|FG001|Overall Study|Withdrawal by Subject|0|||
127545200|NCT03224819|458964358|FG002|Overall Study|Withdrawal by Subject|0|||
127545201|NCT03224819|458964359|FG003|Overall Study|Withdrawal by Subject|0|||
127545202|NCT03224819|458964360|FG004|Overall Study|Withdrawal by Subject|0|||
127545203|NCT03224819|458964361|FG005|Overall Study|Withdrawal by Subject|0|||
127545204|NCT03224819|458964362|FG006|Overall Study|Withdrawal by Subject|0|||
127545205|NCT03224819|458964363|FG007|Overall Study|Withdrawal by Subject|0|||
127545206|NCT03224819|458964364|FG008|Overall Study|Withdrawal by Subject|0|||
127545207|NCT03224819|458964365|FG009|Overall Study|Withdrawal by Subject|0|||
127545208|NCT03224819|458964366|FG010|Overall Study|Withdrawal by Subject|0|||
127545209|NCT03224819|458964367|FG011|Overall Study|Withdrawal by Subject|0|||
127545210|NCT03224819|458964368|FG012|Overall Study|Withdrawal by Subject|1|||
127545211|NCT03224819|458964369|FG013|Overall Study|Withdrawal by Subject|0|||
127545212|NCT03224819|458964356|FG000|Overall Study|Sponsor Decision|0|||
127545213|NCT03224819|458964357|FG001|Overall Study|Sponsor Decision|0|||
127545214|NCT03224819|458964358|FG002|Overall Study|Sponsor Decision|0|||
127545215|NCT03224819|458964359|FG003|Overall Study|Sponsor Decision|1|||
127545216|NCT03224819|458964360|FG004|Overall Study|Sponsor Decision|1|||
127545217|NCT03224819|458964361|FG005|Overall Study|Sponsor Decision|2|||
127545218|NCT03224819|458964362|FG006|Overall Study|Sponsor Decision|1|||
127545219|NCT03224819|458964363|FG007|Overall Study|Sponsor Decision|1|||
127681461|NCT02798835|459458442|FG001|Overall Study|Protocol Violation|0|||
127681462|NCT02798835|459458443|FG002|Overall Study|Protocol Violation|3|||
127681463|NCT00841035|459458444|FG000|Phase 1 Overall Study|Physician Decision|13|||
127681464|NCT00094575|459458445|FG000|Overall Study|Death|146|||
127681465|NCT00094575|459458446|FG001|Overall Study|Death|146|||
127681466|NCT00961636|459458456|FG000|Overall Study|Adverse Event|35|||
127545220|NCT03224819|458964364|FG008|Overall Study|Sponsor Decision|1|||
127545221|NCT03224819|458964365|FG009|Overall Study|Sponsor Decision|2|||
127545222|NCT03224819|458964366|FG010|Overall Study|Sponsor Decision|1|||
127545223|NCT03224819|458964367|FG011|Overall Study|Sponsor Decision|1|||
127545224|NCT03224819|458964368|FG012|Overall Study|Sponsor Decision|1|||
127545225|NCT03224819|458964369|FG013|Overall Study|Sponsor Decision|0|||
127545226|NCT03224819|458964356|FG000|Overall Study|Lost to Follow-up|0|||
127545227|NCT03224819|458964357|FG001|Overall Study|Lost to Follow-up|0|||
127545228|NCT03224819|458964358|FG002|Overall Study|Lost to Follow-up|0|||
127545229|NCT03224819|458964359|FG003|Overall Study|Lost to Follow-up|0|||
127545230|NCT03224819|458964360|FG004|Overall Study|Lost to Follow-up|0|||
127545231|NCT03224819|458964361|FG005|Overall Study|Lost to Follow-up|0|||
127545232|NCT03224819|458964362|FG006|Overall Study|Lost to Follow-up|0|||
127545233|NCT03224819|458964363|FG007|Overall Study|Lost to Follow-up|0|||
127545234|NCT03224819|458964364|FG008|Overall Study|Lost to Follow-up|1|||
127545235|NCT03224819|458964365|FG009|Overall Study|Lost to Follow-up|0|||
127681467|NCT00961636|459458457|FG001|Overall Study|Adverse Event|54|||
127545236|NCT03224819|458964366|FG010|Overall Study|Lost to Follow-up|0|||
127545237|NCT03224819|458964367|FG011|Overall Study|Lost to Follow-up|0|||
127545238|NCT03224819|458964368|FG012|Overall Study|Lost to Follow-up|0|||
127681468|NCT00961636|459458458|FG002|Overall Study|Adverse Event|13|||
127681469|NCT00961636|459458456|FG000|Overall Study|Flushing Symptoms|29|||
127545239|NCT03224819|458964369|FG013|Overall Study|Lost to Follow-up|0|||
127545240|NCT03224819|458964356|FG000|Overall Study|Death|0|||
127545241|NCT03224819|458964357|FG001|Overall Study|Death|1|||
127545242|NCT03224819|458964358|FG002|Overall Study|Death|0|||
127545243|NCT03224819|458964359|FG003|Overall Study|Death|0|||
127545244|NCT03224819|458964360|FG004|Overall Study|Death|0|||
127545245|NCT03224819|458964361|FG005|Overall Study|Death|0|||
127545246|NCT03224819|458964362|FG006|Overall Study|Death|0|||
127545247|NCT03224819|458964363|FG007|Overall Study|Death|1|||
127545248|NCT03224819|458964364|FG008|Overall Study|Death|0|||
127545249|NCT03224819|458964365|FG009|Overall Study|Death|0|||
127545250|NCT03224819|458964366|FG010|Overall Study|Death|0|||
127545251|NCT03224819|458964367|FG011|Overall Study|Death|1|||
127545252|NCT03224819|458964368|FG012|Overall Study|Death|0|||
127545253|NCT03224819|458964369|FG013|Overall Study|Death|0|||
127545254|NCT04973449|458964374|FG000|Overall Study|Withdrawal by Subject|3|||
127545255|NCT04973449|458964375|FG001|Overall Study|Withdrawal by Subject|3|||
127545256|NCT04973449|458964376|FG002|Overall Study|Withdrawal by Subject|2|||
127545257|NCT04973449|458964377|FG003|Overall Study|Withdrawal by Subject|5|||
127545258|NCT04973449|458964378|FG004|Overall Study|Withdrawal by Subject|5|||
127545259|NCT04973449|458964379|FG005|Overall Study|Withdrawal by Subject|4|||
127545260|NCT04973449|458964380|FG006|Overall Study|Withdrawal by Subject|7|||
127545261|NCT04973449|458964381|FG007|Overall Study|Withdrawal by Subject|5|||
127545262|NCT04973449|458964374|FG000|Overall Study|Lost to Follow-up|15|||
127545263|NCT04973449|458964375|FG001|Overall Study|Lost to Follow-up|16|||
127545264|NCT04973449|458964376|FG002|Overall Study|Lost to Follow-up|16|||
127545265|NCT04973449|458964377|FG003|Overall Study|Lost to Follow-up|13|||
127545266|NCT04973449|458964378|FG004|Overall Study|Lost to Follow-up|5|||
127545267|NCT04973449|458964379|FG005|Overall Study|Lost to Follow-up|6|||
127545268|NCT04973449|458964380|FG006|Overall Study|Lost to Follow-up|10|||
127545269|NCT04973449|458964381|FG007|Overall Study|Lost to Follow-up|6|||
127545270|NCT04973449|458964374|FG000|Overall Study|Death|1|||
127545271|NCT04973449|458964375|FG001|Overall Study|Death|0|||
127545272|NCT04973449|458964376|FG002|Overall Study|Death|0|||
127545273|NCT04973449|458964377|FG003|Overall Study|Death|0|||
127545274|NCT04973449|458964378|FG004|Overall Study|Death|0|||
127545275|NCT04973449|458964379|FG005|Overall Study|Death|1|||
127545276|NCT04973449|458964380|FG006|Overall Study|Death|0|||
127545277|NCT04973449|458964381|FG007|Overall Study|Death|0|||
127545278|NCT04973449|458964374|FG000|Overall Study|Other|1|||
127545279|NCT04973449|458964375|FG001|Overall Study|Other|1|||
127545280|NCT04973449|458964376|FG002|Overall Study|Other|2|||
127545281|NCT04973449|458964377|FG003|Overall Study|Other|1|||
127545282|NCT04973449|458964378|FG004|Overall Study|Other|4|||
127545283|NCT04973449|458964379|FG005|Overall Study|Other|0|||
127545284|NCT04973449|458964380|FG006|Overall Study|Other|2|||
127545285|NCT04973449|458964381|FG007|Overall Study|Other|2|||
127545286|NCT00521079|458964382|FG000|Overall Study|Adverse Event|7|||
127545287|NCT00521079|458964383|FG001|Overall Study|Adverse Event|1|||
127545288|NCT00521079|458964382|FG000|Overall Study|Lost to Follow-up|2|||
127545289|NCT00521079|458964383|FG001|Overall Study|Lost to Follow-up|1|||
127545290|NCT00521079|458964382|FG000|Overall Study|Withdrawal by Subject|5|||
127545291|NCT00521079|458964383|FG001|Overall Study|Withdrawal by Subject|3|||
127545292|NCT01506596|458964384|FG000|Overall Study|ineligible pathology|1|||
127545293|NCT04408989|458964389|FG000|Overall Study|Lost to Follow-up|0|||
127545294|NCT04408989|458964390|FG001|Overall Study|Lost to Follow-up|0|||
127545295|NCT04408989|458964391|FG002|Overall Study|Lost to Follow-up|1|||
127545296|NCT04408989|458964389|FG000|Overall Study|Withdrawal by Subject|0|||
127545297|NCT04408989|458964390|FG001|Overall Study|Withdrawal by Subject|0|||
127545298|NCT04408989|458964391|FG002|Overall Study|Withdrawal by Subject|2|||
127545299|NCT01099267|458964398|FG000|MDS-003 Study|Adverse Event|37|||
127545300|NCT01099267|458964398|FG000|MDS-003 Study|Lack of Efficacy|52|||
127545301|NCT01099267|458964398|FG000|MDS-003 Study|Withdrawal by Subject|8|||
127545302|NCT01099267|458964398|FG000|MDS-003 Study|Lost to Follow-up|1|||
127545303|NCT01099267|458964398|FG000|MDS-003 Study|Death|11|||
127545304|NCT01099267|458964398|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
127545305|NCT01099267|458964398|FG000|MDS-003 Study|Disease Progression|7|||
127545306|NCT01099267|458964398|FG000|MDS-003 Study|Investigator Decision|2|||
127545307|NCT01099267|458964398|FG000|MDS-003 Study|Non-Compliance|2|||
127545308|NCT01099267|458964398|FG000|MDS-003 Study|Loss of Response|1|||
127545309|NCT01099267|458964398|FG000|MDS-003 Study|Secondary Malign Disease|1|||
127545310|NCT01838395|458964401|FG000|Overall Study|Withdrawal by Subject|0|||
127545311|NCT01838395|458964402|FG001|Overall Study|Withdrawal by Subject|0|||
127545312|NCT01838395|458964403|FG002|Overall Study|Withdrawal by Subject|0|||
127545313|NCT01838395|458964404|FG003|Overall Study|Withdrawal by Subject|0|||
127545314|NCT01838395|458964405|FG004|Overall Study|Withdrawal by Subject|1|||
127545315|NCT01838395|458964406|FG005|Overall Study|Withdrawal by Subject|0|||
127545316|NCT01838395|458964401|FG000|Overall Study|Death|0|||
127545317|NCT01838395|458964402|FG001|Overall Study|Death|0|||
127545318|NCT01838395|458964403|FG002|Overall Study|Death|1|||
127545319|NCT01838395|458964404|FG003|Overall Study|Death|0|||
127545320|NCT01838395|458964405|FG004|Overall Study|Death|0|||
127545321|NCT01838395|458964406|FG005|Overall Study|Death|0|||
127545322|NCT01838395|458964401|FG000|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
127545323|NCT01838395|458964402|FG001|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|1|||
127545324|NCT01838395|458964403|FG002|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
127545325|NCT01838395|458964404|FG003|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
127545326|NCT01838395|458964405|FG004|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
127545327|NCT01838395|458964406|FG005|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
127545328|NCT00651742|458964411|FG000|Overall Study|Objective Disease Progression|22|||
127545329|NCT00651742|458964411|FG000|Overall Study|Toxicity|3|||
127545330|NCT00651742|458964411|FG000|Overall Study|Investigator Judgment|1|||
127545331|NCT00651742|458964411|FG000|Overall Study|Withdrawal of Consent|1|||
127545332|NCT00651742|458964411|FG000|Overall Study|Enrolled but not treated|1|||
127545333|NCT04050553|458964412|FG000|Period 1|Physician Decision|2|||
127545334|NCT04050553|458964413|FG001|Period 1|Physician Decision|2|||
127545335|NCT04050553|458964412|FG000|Period 1|Adverse Event|1|||
127545336|NCT04050553|458964413|FG001|Period 1|Adverse Event|1|||
127545337|NCT04050553|458964412|FG000|Period 1|Withdrawal by Subject|0|||
127545338|NCT04050553|458964413|FG001|Period 1|Withdrawal by Subject|1|||
127545339|NCT04050553|458964412|FG000|Wash-out|Adverse Event|0|||
127545340|NCT04050553|458964413|FG001|Wash-out|Adverse Event|1|||
127545341|NCT04050553|458964412|FG000|Wash-out|Withdrawal by Subject|0|||
127545342|NCT04050553|458964413|FG001|Wash-out|Withdrawal by Subject|1|||
127545343|NCT01535040|458964414|FG000|Overall Study|Physician Decision|0|||
127545344|NCT01535040|458964415|FG001|Overall Study|Physician Decision|1|||
127545345|NCT01535040|458964414|FG000|Overall Study|Withdrawal by Subject|13|||
127545346|NCT01535040|458964415|FG001|Overall Study|Withdrawal by Subject|10|||
127545347|NCT01535040|458964414|FG000|Overall Study|Never Started|9|||
127545348|NCT01535040|458964415|FG001|Overall Study|Never Started|4|||
127545349|NCT01535040|458964414|FG000|Overall Study|Toxicity|7|||
127545350|NCT01535040|458964415|FG001|Overall Study|Toxicity|5|||
127545351|NCT01535040|458964414|FG000|Overall Study|Multiple Reasons|1|||
127545352|NCT01535040|458964415|FG001|Overall Study|Multiple Reasons|1|||
127545353|NCT05430854|458964416|FG000|Overall Study|Trial terminated by Sponsor|39|||
127545354|NCT05430854|458964417|FG001|Overall Study|Trial terminated by Sponsor|50|||
127545355|NCT05430854|458964418|FG002|Overall Study|Trial terminated by Sponsor|46|||
127545356|NCT05430854|458964416|FG000|Overall Study|Withdrawal by Subject|0|||
127545357|NCT05430854|458964417|FG001|Overall Study|Withdrawal by Subject|3|||
127545358|NCT05430854|458964418|FG002|Overall Study|Withdrawal by Subject|0|||
127545359|NCT04314284|458964419|FG000|Overall Study|Withdrawal by Subject|4|||
127545360|NCT04314284|458964420|FG001|Overall Study|Withdrawal by Subject|7|||
127545361|NCT04314284|458964419|FG000|Overall Study|Consented but did not complete survey|0|||
127545362|NCT04314284|458964420|FG001|Overall Study|Consented but did not complete survey|6|||
127545363|NCT01652235|458964423|FG000|Overall Study|Death|9|||
127545364|NCT01652235|458964423|FG000|Overall Study|Lost to Follow-up|5|||
127545365|NCT01652235|458964423|FG000|Overall Study|Withdrawal by Subject|2|||
127545366|NCT02023086|458964426|FG000|Overall Study|Withdrawal by Subject|2|||
127545367|NCT02023086|458964427|FG001|Overall Study|Withdrawal by Subject|0|||
127545368|NCT03472885|458964428|FG000|24-Week Treatment Period|Adverse Event|1|||
127545369|NCT02201953|458964429|FG000|Overall Study|Randomized but Never Treated|1|||
127545370|NCT02201953|458964430|FG001|Overall Study|Randomized but Never Treated|5|||
127545371|NCT02201953|458964429|FG000|Overall Study|Lack of Efficacy|9|||
127545372|NCT02201953|458964430|FG001|Overall Study|Lack of Efficacy|30|||
127545373|NCT02201953|458964429|FG000|Overall Study|Lost to Follow-up|8|||
127545374|NCT02201953|458964430|FG001|Overall Study|Lost to Follow-up|8|||
127681470|NCT00961636|459458457|FG001|Overall Study|Flushing Symptoms|46|||
127681471|NCT00961636|459458458|FG002|Overall Study|Flushing Symptoms|3|||
127681472|NCT00961636|459458456|FG000|Overall Study|Lost to Follow-up|2|||
127681473|NCT00961636|459458457|FG001|Overall Study|Lost to Follow-up|3|||
127681474|NCT00961636|459458458|FG002|Overall Study|Lost to Follow-up|1|||
127681475|NCT00961636|459458456|FG000|Overall Study|Physician Decision|3|||
127681476|NCT00961636|459458457|FG001|Overall Study|Physician Decision|1|||
127681477|NCT00961636|459458458|FG002|Overall Study|Physician Decision|1|||
128015923|NCT03683030|460682179|FG000|Overall Study|Enrolled but no catheter inserted|11|||
128015924|NCT03683030|460682180|FG001|Overall Study|Enrolled but no catheter inserted|13|||
127545375|NCT02201953|458964429|FG000|Overall Study|Withdrew Consent|2|||
127545376|NCT02201953|458964430|FG001|Overall Study|Withdrew Consent|5|||
127545377|NCT02201953|458964429|FG000|Overall Study|Adverse Event|0|||
127545378|NCT02201953|458964430|FG001|Overall Study|Adverse Event|5|||
127545379|NCT02201953|458964429|FG000|Overall Study|Death|0|||
127545380|NCT02201953|458964430|FG001|Overall Study|Death|3|||
127545381|NCT05523089|458964431|FG000|Overall Study|Withdrawal by Subject|1|||
127681478|NCT00961636|459458456|FG000|Overall Study|Protocol Violation|9|||
127681479|NCT00961636|459458457|FG001|Overall Study|Protocol Violation|5|||
127681480|NCT00961636|459458458|FG002|Overall Study|Protocol Violation|1|||
127545382|NCT05523089|458964432|FG001|Overall Study|Withdrawal by Subject|0|||
127681481|NCT00961636|459458456|FG000|Overall Study|Withdrawal by Subject|29|||
127545383|NCT05523089|458964433|FG002|Overall Study|Withdrawal by Subject|0|||
127545384|NCT05523089|458964431|FG000|Overall Study|Lost to Follow-up|1|||
127545385|NCT05523089|458964432|FG001|Overall Study|Lost to Follow-up|0|||
127545386|NCT05523089|458964433|FG002|Overall Study|Lost to Follow-up|0|||
127545387|NCT02638220|458964434|FG000|Overall Study|Lost to Follow-up|6|||
127545388|NCT02638220|458964434|FG000|Overall Study|Withdrawal by Subject|3|||
127545389|NCT02638220|458964434|FG000|Overall Study|Physician Decision|1|||
127545390|NCT02638220|458964434|FG000|Overall Study|Withdrawn, sample error, non-adherence, illness|6|||
127545391|NCT04323124|458964436|FG000|Overall Study|Adverse Event|0|||
127545392|NCT04323124|458964437|FG001|Overall Study|Adverse Event|0|||
127545393|NCT04323124|458964438|FG002|Overall Study|Adverse Event|0|||
127545394|NCT04323124|458964439|FG003|Overall Study|Adverse Event|0|||
127545395|NCT04323124|458964440|FG004|Overall Study|Adverse Event|0|||
127545396|NCT04323124|458964441|FG005|Overall Study|Adverse Event|1|||
127545397|NCT04323124|458964442|FG006|Overall Study|Adverse Event|0|||
127545398|NCT04323124|458964443|FG007|Overall Study|Adverse Event|1|||
127545399|NCT04323124|458964444|FG008|Overall Study|Adverse Event|1|||
127545400|NCT04323124|458964445|FG009|Overall Study|Adverse Event|0|||
127545401|NCT04323124|458964446|FG010|Overall Study|Adverse Event|0|||
127545402|NCT04323124|458964447|FG011|Overall Study|Adverse Event|0|||
127545403|NCT04323124|458964448|FG012|Overall Study|Adverse Event|0|||
127545404|NCT04323124|458964449|FG013|Overall Study|Adverse Event|0|||
127545405|NCT04323124|458964450|FG014|Overall Study|Adverse Event|0|||
127545406|NCT04323124|458964436|FG000|Overall Study|Other|0|||
127545407|NCT04323124|458964437|FG001|Overall Study|Other|0|||
127545408|NCT04323124|458964438|FG002|Overall Study|Other|0|||
127545409|NCT04323124|458964439|FG003|Overall Study|Other|0|||
127545410|NCT04323124|458964440|FG004|Overall Study|Other|1|||
127545411|NCT04323124|458964441|FG005|Overall Study|Other|0|||
127545412|NCT04323124|458964442|FG006|Overall Study|Other|0|||
127545413|NCT04323124|458964443|FG007|Overall Study|Other|0|||
127545414|NCT04323124|458964444|FG008|Overall Study|Other|1|||
127545415|NCT04323124|458964445|FG009|Overall Study|Other|0|||
127545416|NCT04323124|458964446|FG010|Overall Study|Other|0|||
127545417|NCT04323124|458964447|FG011|Overall Study|Other|0|||
127545418|NCT04323124|458964448|FG012|Overall Study|Other|0|||
127545419|NCT04323124|458964449|FG013|Overall Study|Other|0|||
127545420|NCT04323124|458964450|FG014|Overall Study|Other|0|||
127545421|NCT04323124|458964436|FG000|Overall Study|Coming from a red zone (COVID)|0|||
127545422|NCT04323124|458964437|FG001|Overall Study|Coming from a red zone (COVID)|0|||
127545423|NCT04323124|458964438|FG002|Overall Study|Coming from a red zone (COVID)|0|||
127545424|NCT04323124|458964439|FG003|Overall Study|Coming from a red zone (COVID)|0|||
127545425|NCT04323124|458964440|FG004|Overall Study|Coming from a red zone (COVID)|1|||
127545426|NCT04323124|458964441|FG005|Overall Study|Coming from a red zone (COVID)|1|||
127545427|NCT04323124|458964442|FG006|Overall Study|Coming from a red zone (COVID)|0|||
127545428|NCT04323124|458964443|FG007|Overall Study|Coming from a red zone (COVID)|0|||
127545429|NCT04323124|458964444|FG008|Overall Study|Coming from a red zone (COVID)|0|||
127545430|NCT04323124|458964445|FG009|Overall Study|Coming from a red zone (COVID)|0|||
127545431|NCT04323124|458964446|FG010|Overall Study|Coming from a red zone (COVID)|0|||
127681482|NCT00961636|459458457|FG001|Overall Study|Withdrawal by Subject|22|||
127681483|NCT00961636|459458458|FG002|Overall Study|Withdrawal by Subject|13|||
127681484|NCT01390402|459458459|FG000|Overall Study|Death|1|||
127681485|NCT01390402|459458459|FG000|Overall Study|Disease Progression|4|||
127681486|NCT02551055|459458462|FG000|Overall Study|Death|2|||
127681487|NCT02551055|459458463|FG001|Overall Study|Death|4|||
127681488|NCT02551055|459458464|FG002|Overall Study|Death|2|||
127681489|NCT02551055|459458465|FG003|Overall Study|Death|2|||
127681490|NCT02551055|459458466|FG004|Overall Study|Death|2|||
127681491|NCT02551055|459458467|FG005|Overall Study|Death|1|||
127681492|NCT02551055|459458468|FG006|Overall Study|Death|2|||
127681493|NCT02551055|459458469|FG007|Overall Study|Death|0|||
127681494|NCT02551055|459458462|FG000|Overall Study|Study Terminated by Sponsor|1|||
127681495|NCT02551055|459458463|FG001|Overall Study|Study Terminated by Sponsor|1|||
127545432|NCT04323124|458964447|FG011|Overall Study|Coming from a red zone (COVID)|0|||
127545433|NCT04323124|458964448|FG012|Overall Study|Coming from a red zone (COVID)|0|||
127545434|NCT04323124|458964449|FG013|Overall Study|Coming from a red zone (COVID)|0|||
127545435|NCT04323124|458964450|FG014|Overall Study|Coming from a red zone (COVID)|0|||
127545436|NCT04323124|458964436|FG000|Overall Study|No longer meets eligibility criteria|0|||
127545437|NCT04323124|458964437|FG001|Overall Study|No longer meets eligibility criteria|0|||
127545438|NCT04323124|458964438|FG002|Overall Study|No longer meets eligibility criteria|0|||
127681496|NCT02551055|459458464|FG002|Overall Study|Study Terminated by Sponsor|0|||
127681497|NCT02551055|459458465|FG003|Overall Study|Study Terminated by Sponsor|2|||
127681498|NCT02551055|459458466|FG004|Overall Study|Study Terminated by Sponsor|2|||
127681499|NCT02551055|459458467|FG005|Overall Study|Study Terminated by Sponsor|0|||
127545439|NCT04323124|458964439|FG003|Overall Study|No longer meets eligibility criteria|0|||
127545440|NCT04323124|458964440|FG004|Overall Study|No longer meets eligibility criteria|0|||
127681500|NCT02551055|459458468|FG006|Overall Study|Study Terminated by Sponsor|0|||
127681501|NCT02551055|459458469|FG007|Overall Study|Study Terminated by Sponsor|0|||
127545441|NCT04323124|458964441|FG005|Overall Study|No longer meets eligibility criteria|0|||
127545442|NCT04323124|458964442|FG006|Overall Study|No longer meets eligibility criteria|0|||
127545443|NCT04323124|458964443|FG007|Overall Study|No longer meets eligibility criteria|1|||
127545444|NCT04323124|458964444|FG008|Overall Study|No longer meets eligibility criteria|0|||
127545445|NCT04323124|458964445|FG009|Overall Study|No longer meets eligibility criteria|0|||
127545446|NCT04323124|458964446|FG010|Overall Study|No longer meets eligibility criteria|0|||
127545447|NCT04323124|458964447|FG011|Overall Study|No longer meets eligibility criteria|0|||
127545448|NCT04323124|458964448|FG012|Overall Study|No longer meets eligibility criteria|0|||
127545449|NCT04323124|458964449|FG013|Overall Study|No longer meets eligibility criteria|1|||
127545450|NCT04323124|458964450|FG014|Overall Study|No longer meets eligibility criteria|1|||
127545451|NCT04323124|458964436|FG000|Overall Study|Study terminated by sponsor|0|||
127545452|NCT04323124|458964437|FG001|Overall Study|Study terminated by sponsor|0|||
127545453|NCT04323124|458964438|FG002|Overall Study|Study terminated by sponsor|0|||
127545454|NCT04323124|458964439|FG003|Overall Study|Study terminated by sponsor|0|||
127545455|NCT04323124|458964440|FG004|Overall Study|Study terminated by sponsor|0|||
127545456|NCT04323124|458964441|FG005|Overall Study|Study terminated by sponsor|0|||
127545457|NCT04323124|458964442|FG006|Overall Study|Study terminated by sponsor|0|||
127545458|NCT04323124|458964443|FG007|Overall Study|Study terminated by sponsor|0|||
127545459|NCT04323124|458964444|FG008|Overall Study|Study terminated by sponsor|0|||
127545460|NCT04323124|458964445|FG009|Overall Study|Study terminated by sponsor|0|||
127545461|NCT04323124|458964446|FG010|Overall Study|Study terminated by sponsor|0|||
127545462|NCT04323124|458964447|FG011|Overall Study|Study terminated by sponsor|2|||
127545463|NCT04323124|458964448|FG012|Overall Study|Study terminated by sponsor|1|||
127545464|NCT04323124|458964449|FG013|Overall Study|Study terminated by sponsor|0|||
127545465|NCT04323124|458964450|FG014|Overall Study|Study terminated by sponsor|0|||
127545466|NCT00489307|458964451|FG000|Overall Study|Death|1|||
127545467|NCT00489307|458964452|FG001|Overall Study|Death|1|||
127545468|NCT00489307|458964451|FG000|Overall Study|Lost to Follow-up|2|||
127545469|NCT00489307|458964452|FG001|Overall Study|Lost to Follow-up|2|||
127545470|NCT00489307|458964451|FG000|Overall Study|Physician Decision|1|||
127545471|NCT00489307|458964452|FG001|Overall Study|Physician Decision|0|||
127545472|NCT00489307|458964451|FG000|Overall Study|Withdrawal by Subject|2|||
127545473|NCT00489307|458964452|FG001|Overall Study|Withdrawal by Subject|4|||
127545474|NCT00489307|458964451|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
127545475|NCT00489307|458964452|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
127545476|NCT00489307|458964451|FG000|Overall Study|Surgery after assignment|1|||
127545477|NCT00489307|458964452|FG001|Overall Study|Surgery after assignment|0|||
127545478|NCT00489307|458964451|FG000|Overall Study|Did not fill up the forms|2|||
127545479|NCT00489307|458964452|FG001|Overall Study|Did not fill up the forms|1|||
127545480|NCT00489307|458964451|FG000|Overall Study|Patient or family refusal|5|||
127545481|NCT00489307|458964452|FG001|Overall Study|Patient or family refusal|9|||
127545482|NCT03204188|458964455|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
127545483|NCT03204188|458964455|FG000|Immunotherapy Phase (1 Year)|Death|1|||
127545484|NCT03204188|458964455|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
127545485|NCT03204188|458964455|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
127545486|NCT01615939|458965740|FG000|Overall Study|Lost to Follow-up|5|||
127545487|NCT01615939|458965741|FG001|Overall Study|Lost to Follow-up|0|||
127545488|NCT02892344|458965745|FG000|Overall Study|Protocol deviation|3|||
127545489|NCT02892344|458965746|FG001|Overall Study|Protocol deviation|4|||
127545490|NCT02892344|458965745|FG000|Overall Study|Adverse Event|1|||
127545491|NCT02892344|458965746|FG001|Overall Study|Adverse Event|8|||
127545492|NCT02892344|458965745|FG000|Overall Study|Lost to Follow-up|0|||
127545493|NCT02892344|458965746|FG001|Overall Study|Lost to Follow-up|1|||
127545494|NCT02892344|458965745|FG000|Overall Study|Non-compliance with study treatment|0|||
127545495|NCT02892344|458965746|FG001|Overall Study|Non-compliance with study treatment|1|||
127545496|NCT02892344|458965745|FG000|Overall Study|Physician Decision|0|||
127545497|NCT02892344|458965746|FG001|Overall Study|Physician Decision|2|||
127545498|NCT02892344|458965745|FG000|Overall Study|Subject/guardian decision|0|||
127545499|NCT02892344|458965746|FG001|Overall Study|Subject/guardian decision|4|||
127545500|NCT02892344|458965745|FG000|Overall Study|Technical problems|0|||
127545501|NCT02892344|458965746|FG001|Overall Study|Technical problems|1|||
127545502|NCT01520506|458965747|FG000|Overall Study|Missed Visit|4|||
127545503|NCT01520506|458965747|FG000|Overall Study|Lost to Follow-up|1|||
127545504|NCT01520506|458965747|FG000|Overall Study|Withdrawal by Subject|1|||
127545505|NCT00425269|458965748|FG000|Overall Study|Pregnancy|5|||
127545506|NCT00425269|458965749|FG001|Overall Study|Pregnancy|7|||
127545507|NCT00425269|458965748|FG000|Overall Study|Lost to Follow-up|9|||
127545508|NCT00425269|458965749|FG001|Overall Study|Lost to Follow-up|9|||
127545509|NCT00425269|458965748|FG000|Overall Study|moved or medical reason|5|||
127545510|NCT00425269|458965749|FG001|Overall Study|moved or medical reason|4|||
127545511|NCT01084655|458965754|FG000|Overall Study|Radiographic disease progression|3|||
127545512|NCT01084655|458965755|FG001|Overall Study|Radiographic disease progression|2|||
127545513|NCT01084655|458965756|FG002|Overall Study|Radiographic disease progression|8|||
127545514|NCT01084655|458965754|FG000|Overall Study|Withdrawal by Subject|1|||
127545515|NCT01084655|458965755|FG001|Overall Study|Withdrawal by Subject|0|||
127545516|NCT01084655|458965756|FG002|Overall Study|Withdrawal by Subject|4|||
127545517|NCT01084655|458965754|FG000|Overall Study|Adverse Event|2|||
127545518|NCT01084655|458965755|FG001|Overall Study|Adverse Event|1|||
127545519|NCT01084655|458965756|FG002|Overall Study|Adverse Event|2|||
127545520|NCT01084655|458965754|FG000|Overall Study|Other|0|||
127545521|NCT01084655|458965755|FG001|Overall Study|Other|3|||
127545522|NCT01084655|458965756|FG002|Overall Study|Other|2|||
127545523|NCT01084655|458965754|FG000|Overall Study|Symptomatic deterioration|0|||
127545524|NCT01084655|458965755|FG001|Overall Study|Symptomatic deterioration|0|||
127681502|NCT02551055|459458462|FG000|Overall Study|Withdrawal by Subject|1|||
127681503|NCT02551055|459458463|FG001|Overall Study|Withdrawal by Subject|1|||
127681504|NCT02551055|459458464|FG002|Overall Study|Withdrawal by Subject|0|||
127681505|NCT02551055|459458465|FG003|Overall Study|Withdrawal by Subject|1|||
127681506|NCT02551055|459458466|FG004|Overall Study|Withdrawal by Subject|2|||
127681507|NCT02551055|459458467|FG005|Overall Study|Withdrawal by Subject|0|||
127681508|NCT02551055|459458468|FG006|Overall Study|Withdrawal by Subject|0|||
127681509|NCT02551055|459458469|FG007|Overall Study|Withdrawal by Subject|0|||
127681510|NCT02551055|459458462|FG000|Overall Study|Reason not specified|0|||
127681511|NCT02551055|459458463|FG001|Overall Study|Reason not specified|0|||
127681512|NCT02551055|459458464|FG002|Overall Study|Reason not specified|0|||
127681513|NCT02551055|459458465|FG003|Overall Study|Reason not specified|0|||
127681514|NCT02551055|459458466|FG004|Overall Study|Reason not specified|1|||
127681515|NCT02551055|459458467|FG005|Overall Study|Reason not specified|0|||
127681516|NCT02551055|459458468|FG006|Overall Study|Reason not specified|1|||
127681517|NCT02551055|459458469|FG007|Overall Study|Reason not specified|0|||
127681518|NCT00430300|459458473|FG000|Overall Study|Adverse Event|0|||
127681519|NCT00430300|459458474|FG001|Overall Study|Adverse Event|2|||
127681520|NCT00430300|459458475|FG002|Overall Study|Adverse Event|1|||
127681521|NCT00430300|459458476|FG003|Overall Study|Adverse Event|1|||
127681522|NCT00430300|459458473|FG000|Overall Study|Withdrawal by Subject|1|||
127681523|NCT00430300|459458474|FG001|Overall Study|Withdrawal by Subject|0|||
127681524|NCT00430300|459458475|FG002|Overall Study|Withdrawal by Subject|5|||
127681525|NCT00430300|459458476|FG003|Overall Study|Withdrawal by Subject|0|||
127681526|NCT00430300|459458473|FG000|Overall Study|Laboratory abnormality|1|||
127681527|NCT00430300|459458474|FG001|Overall Study|Laboratory abnormality|0|||
127681528|NCT00430300|459458475|FG002|Overall Study|Laboratory abnormality|0|||
127681529|NCT00430300|459458476|FG003|Overall Study|Laboratory abnormality|0|||
127681530|NCT00430300|459458473|FG000|Overall Study|Other|0|||
127681531|NCT00430300|459458474|FG001|Overall Study|Other|0|||
127681532|NCT00430300|459458475|FG002|Overall Study|Other|0|||
127681533|NCT00430300|459458476|FG003|Overall Study|Other|1|||
127681534|NCT02754479|459458477|FG000|Overall Study|Lost to Follow-up|1|||
127681535|NCT02041104|459458482|FG000|Overall Study|Lost to Follow-up|1|||
127681536|NCT02041104|459458483|FG001|Overall Study|Lost to Follow-up|4|||
127681537|NCT02041104|459458482|FG000|Overall Study|discomfort during OGTT|0|||
127681538|NCT02041104|459458483|FG001|Overall Study|discomfort during OGTT|3|||
127681539|NCT01063517|459458484|FG000|Overall Study|Consent withdrawal|1|||
127681540|NCT01063517|459458485|FG001|Overall Study|Consent withdrawal|0|||
127681541|NCT01063517|459458484|FG000|Overall Study|Study reached data cut-off|19|||
127681542|NCT01063517|459458485|FG001|Overall Study|Study reached data cut-off|7|||
127681543|NCT01063517|459458484|FG000|Overall Study|Lost to Follow-up|4|||
127681544|NCT01063517|459458485|FG001|Overall Study|Lost to Follow-up|3|||
127681545|NCT01063517|459458484|FG000|Overall Study|Withdrawal by Subject|1|||
127681546|NCT01063517|459458485|FG001|Overall Study|Withdrawal by Subject|2|||
127681547|NCT01063517|459458484|FG000|Overall Study|Death|33|||
127681548|NCT01063517|459458485|FG001|Overall Study|Death|48|||
127681549|NCT00617201|459458488|FG000|Overall Study|Lost to Follow-up|9|||
127681550|NCT00617201|459458489|FG001|Overall Study|Lost to Follow-up|13|||
127681551|NCT00546871|459458490|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
127681552|NCT00546871|459458491|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
127681553|NCT00546871|459458490|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
127545525|NCT01084655|458965756|FG002|Overall Study|Symptomatic deterioration|2|||
127681554|NCT00546871|459458491|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
127681555|NCT00546871|459458490|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
127681556|NCT00546871|459458491|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
127681557|NCT00546871|459458490|FG000|Study Extension Period|Protocol Violation|1|||
127681558|NCT00546871|459458491|FG001|Study Extension Period|Protocol Violation|0|||
127681559|NCT00546871|459458490|FG000|Study Extension Period|Withdrawal by Subject|0|||
127681560|NCT00546871|459458491|FG001|Study Extension Period|Withdrawal by Subject|1|||
127681561|NCT03762668|459460552|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
127681562|NCT03762668|459460553|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
127681563|NCT02027558|459460554|FG000|Overall Study|Death|0|||
127681564|NCT02027558|459460555|FG001|Overall Study|Death|1|||
127681565|NCT02027558|459460554|FG000|Overall Study|Withdrawal by Subject|2|||
127545526|NCT01084655|458965754|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
127545527|NCT01084655|458965755|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
128015925|NCT03683030|460682179|FG000|Overall Study|Withdrawal by Subject|0|||
128015926|NCT03683030|460682180|FG001|Overall Study|Withdrawal by Subject|2|||
128015927|NCT03683030|460682179|FG000|Overall Study|Early termination by subject|1|||
128015928|NCT03683030|460682180|FG001|Overall Study|Early termination by subject|0|||
127768195|NCT03075410|459776737|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
127768196|NCT03075410|459776738|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
127768197|NCT03075410|459776739|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
127768198|NCT03075410|459776740|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
127768199|NCT03075410|459776732|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
127768200|NCT03075410|459776733|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
127768201|NCT03075410|459776734|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
127768202|NCT03075410|459776735|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
127768203|NCT03075410|459776736|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
127768204|NCT03075410|459776737|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
127768205|NCT03075410|459776738|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
127768206|NCT03075410|459776739|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
127768207|NCT03075410|459776740|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
127768208|NCT01427751|459776741|FG000|Overall Study|Adverse Event|18|||
127768209|NCT01427751|459776742|FG001|Overall Study|Adverse Event|2|||
127768210|NCT01427751|459776741|FG000|Overall Study|No further treatment benefit expected|5|||
127768211|NCT01427751|459776742|FG001|Overall Study|No further treatment benefit expected|1|||
127768212|NCT01427751|459776741|FG000|Overall Study|Lost to Follow-up|3|||
127768213|NCT01427751|459776742|FG001|Overall Study|Lost to Follow-up|1|||
127768214|NCT01427751|459776741|FG000|Overall Study|Withdrawal of consent|2|||
127768215|NCT01427751|459776742|FG001|Overall Study|Withdrawal of consent|2|||
127768216|NCT01427751|459776741|FG000|Overall Study|Protocol Violation|6|||
127768217|NCT01427751|459776742|FG001|Overall Study|Protocol Violation|4|||
127768218|NCT01427751|459776741|FG000|Overall Study|Death|2|||
127768219|NCT01427751|459776742|FG001|Overall Study|Death|0|||
127768220|NCT01427751|459776741|FG000|Overall Study|Other miscellaneous reasons|6|||
127768221|NCT01427751|459776742|FG001|Overall Study|Other miscellaneous reasons|4|||
127768222|NCT02523599|459776743|FG000|Overall Study|Adverse Event|1|||
127768223|NCT02523599|459776744|FG001|Overall Study|Adverse Event|0|||
127768224|NCT02523599|459776743|FG000|Overall Study|Physician Decision|1|||
127768225|NCT02523599|459776744|FG001|Overall Study|Physician Decision|0|||
127768226|NCT02523599|459776743|FG000|Overall Study|Lost to Follow-up|4|||
127768227|NCT02523599|459776744|FG001|Overall Study|Lost to Follow-up|1|||
127768228|NCT02523599|459776743|FG000|Overall Study|Did not return for Day 30 visit|2|||
127768229|NCT02523599|459776744|FG001|Overall Study|Did not return for Day 30 visit|0|||
127768230|NCT03319849|459776748|FG000|Overall Study|Adverse Event|1|||
127768231|NCT03319849|459776749|FG001|Overall Study|Adverse Event|0|||
127768232|NCT03319849|459776748|FG000|Overall Study|Physician Decision|0|||
127768233|NCT03319849|459776749|FG001|Overall Study|Physician Decision|1|||
127768234|NCT03319849|459776748|FG000|Overall Study|Withdrawal by Subject|0|||
127768235|NCT03319849|459776749|FG001|Overall Study|Withdrawal by Subject|1|||
127768236|NCT03319849|459776748|FG000|Overall Study|COVID-19|0|||
127768237|NCT03319849|459776749|FG001|Overall Study|COVID-19|1|||
127768238|NCT03319849|459776748|FG000|Overall Study|Other|1|||
128015929|NCT03683030|460682179|FG000|Overall Study|Lost to Follow-up|0|||
128015930|NCT03683030|460682180|FG001|Overall Study|Lost to Follow-up|6|||
128015931|NCT03683030|460682179|FG000|Overall Study|Death|0|||
127681566|NCT02027558|459460555|FG001|Overall Study|Withdrawal by Subject|0|||
127681567|NCT02027558|459460554|FG000|Overall Study|Lost to Follow-up|4|||
127681568|NCT02027558|459460555|FG001|Overall Study|Lost to Follow-up|1|||
127681569|NCT02027558|459460554|FG000|Overall Study|Refused assessment|3|||
127681570|NCT02027558|459460555|FG001|Overall Study|Refused assessment|0|||
127681571|NCT02383472|459460556|FG000|Overall Study|Withdrawal by Subject|1|||
127681572|NCT02383472|459460557|FG001|Overall Study|Withdrawal by Subject|1|||
127681573|NCT02013830|459460558|FG000|Overall Study|Adverse Event|3|||
127681574|NCT02013830|459460558|FG000|Overall Study|Death|1|||
127681575|NCT02013830|459460558|FG000|Overall Study|Insufficient therapeutic response|25|||
127681576|NCT02013830|459460558|FG000|Overall Study|Refused treatment|1|||
127681577|NCT01111526|459460559|FG000|Overall Study|GVHD Disease Progression|0|||
127681578|NCT01111526|459460560|FG001|Overall Study|GVHD Disease Progression|1|||
127681579|NCT01111526|459460561|FG002|Overall Study|GVHD Disease Progression|2|||
127681580|NCT04424641|459460562|FG000|Overall Study|Death|1|||
127681581|NCT04424641|459460563|FG001|Overall Study|Death|2|||
127681582|NCT04424641|459460564|FG002|Overall Study|Death|3|||
127681583|NCT04424641|459460565|FG003|Overall Study|Death|0|||
127681584|NCT04424641|459460566|FG004|Overall Study|Death|3|||
127768239|NCT03319849|459776749|FG001|Overall Study|Other|2|||
128015932|NCT03683030|460682180|FG001|Overall Study|Death|2|||
127681585|NCT04424641|459460567|FG005|Overall Study|Death|0|||
127681586|NCT04424641|459460568|FG006|Overall Study|Death|1|||
128015933|NCT03683030|460682179|FG000|Overall Study|Catheter inserted but did not undergo ablation|0|||
128015934|NCT03683030|460682180|FG001|Overall Study|Catheter inserted but did not undergo ablation|1|||
127545528|NCT01084655|458965756|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
127545529|NCT00535496|458965757|FG000|Overall Study|Lost to Follow-up|0|||
127545530|NCT00535496|458965758|FG001|Overall Study|Lost to Follow-up|1|||
127545531|NCT00535496|458965759|FG002|Overall Study|Lost to Follow-up|0|||
127545532|NCT00535496|458965760|FG003|Overall Study|Lost to Follow-up|0|||
127545533|NCT00535496|458965757|FG000|Overall Study|Not treated with sugammadex|0|||
127545534|NCT00535496|458965758|FG001|Overall Study|Not treated with sugammadex|1|||
128015935|NCT02390284|460682181|FG000|Overall Study|Physician Decision|0|||
128015936|NCT02390284|460682182|FG001|Overall Study|Physician Decision|0|||
128015937|NCT02390284|460682183|FG002|Overall Study|Physician Decision|9|||
128015938|NCT03980223|460682184|FG000|Overall Study|Lost to Follow-up|3|||
128015939|NCT03980223|460682185|FG001|Overall Study|Lost to Follow-up|7|||
128015940|NCT03980223|460682186|FG002|Overall Study|Lost to Follow-up|10|||
128015941|NCT03980223|460682187|FG003|Overall Study|Lost to Follow-up|8|||
128015942|NCT03980223|460682184|FG000|Overall Study|Withdrawal by Subject|0|||
128015943|NCT03980223|460682185|FG001|Overall Study|Withdrawal by Subject|0|||
128015944|NCT03980223|460682186|FG002|Overall Study|Withdrawal by Subject|1|||
128015945|NCT03980223|460682187|FG003|Overall Study|Withdrawal by Subject|2|||
128015946|NCT03980223|460682184|FG000|Overall Study|Physician Decision|0|||
128015947|NCT03980223|460682185|FG001|Overall Study|Physician Decision|0|||
128015948|NCT03980223|460682186|FG002|Overall Study|Physician Decision|1|||
128015949|NCT03980223|460682187|FG003|Overall Study|Physician Decision|0|||
128015950|NCT03980223|460682184|FG000|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|72|||
128015951|NCT03980223|460682185|FG001|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|33|||
128015952|NCT03980223|460682186|FG002|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|20|||
128015953|NCT03980223|460682187|FG003|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|11|||
128015954|NCT06239610|460682188|FG000|Overall Study|no usable migration data for minimum of one day|11|||
128015955|NCT01922934|460682189|FG000|Eligible Patients|Death|0|||
128015956|NCT01922934|460682190|FG001|Eligible Patients|Death|7|||
128015957|NCT01922934|460682189|FG000|Eligible Patients|Physician Decision|17|||
128015958|NCT01922934|460682190|FG001|Eligible Patients|Physician Decision|0|||
128015959|NCT01922934|460682189|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
128015960|NCT01922934|460682190|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
128015961|NCT01922934|460682189|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
128015962|NCT01922934|460682190|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
128015963|NCT01922934|460682189|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
128015964|NCT01922934|460682190|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
128015965|NCT01922934|460682189|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
128015966|NCT01922934|460682190|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
128015967|NCT05166876|460682193|FG000|Overall Study|Withdrawal by Subject|1|||
128015968|NCT05166876|460682194|FG001|Overall Study|Withdrawal by Subject|0|||
127545535|NCT00535496|458965759|FG002|Overall Study|Not treated with sugammadex|0|||
127545536|NCT00535496|458965760|FG003|Overall Study|Not treated with sugammadex|0|||
127681587|NCT04424641|459460569|FG007|Overall Study|Death|2|||
127681588|NCT04424641|459460562|FG000|Overall Study|Sponsor decision|0|||
127681589|NCT04424641|459460563|FG001|Overall Study|Sponsor decision|2|||
127681590|NCT04424641|459460564|FG002|Overall Study|Sponsor decision|3|||
127681591|NCT04424641|459460565|FG003|Overall Study|Sponsor decision|7|||
127681592|NCT04424641|459460566|FG004|Overall Study|Sponsor decision|2|||
127681593|NCT04424641|459460567|FG005|Overall Study|Sponsor decision|2|||
127681594|NCT04424641|459460568|FG006|Overall Study|Sponsor decision|3|||
127681595|NCT04424641|459460569|FG007|Overall Study|Sponsor decision|4|||
127681596|NCT04424641|459460562|FG000|Overall Study|Withdrawal by Subject|0|||
127681597|NCT04424641|459460563|FG001|Overall Study|Withdrawal by Subject|0|||
127681598|NCT04424641|459460564|FG002|Overall Study|Withdrawal by Subject|0|||
127681599|NCT04424641|459460565|FG003|Overall Study|Withdrawal by Subject|0|||
127681600|NCT04424641|459460566|FG004|Overall Study|Withdrawal by Subject|1|||
127681601|NCT04424641|459460567|FG005|Overall Study|Withdrawal by Subject|0|||
127681602|NCT04424641|459460568|FG006|Overall Study|Withdrawal by Subject|0|||
127681603|NCT04424641|459460569|FG007|Overall Study|Withdrawal by Subject|0|||
127681604|NCT04424641|459460562|FG000|Overall Study|Other|0|||
127681605|NCT04424641|459460563|FG001|Overall Study|Other|0|||
127681606|NCT04424641|459460564|FG002|Overall Study|Other|1|||
128015969|NCT05166876|460682195|FG002|Overall Study|Withdrawal by Subject|0|||
128015970|NCT00658528|460682196|FG000|Overall Study|Adverse Event|5|||
128015971|NCT00658528|460682197|FG001|Overall Study|Adverse Event|7|||
127545537|NCT02326155|458965762|FG000|Overall Study|Adverse Event|21|||
127545538|NCT02326155|458965763|FG001|Overall Study|Adverse Event|5|||
127681607|NCT04424641|459460565|FG003|Overall Study|Other|0|||
127681608|NCT04424641|459460566|FG004|Overall Study|Other|0|||
127681609|NCT04424641|459460567|FG005|Overall Study|Other|0|||
127681610|NCT04424641|459460568|FG006|Overall Study|Other|0|||
127681611|NCT04424641|459460569|FG007|Overall Study|Other|0|||
127681612|NCT02296424|459460576|FG000|Part 1|New therapy for study indication|0|||
127545539|NCT02326155|458965762|FG000|Overall Study|Death|3|||
127545540|NCT02326155|458965763|FG001|Overall Study|Death|0|||
127545541|NCT02326155|458965762|FG000|Overall Study|Lack of Efficacy|49|||
127545542|NCT02326155|458965763|FG001|Overall Study|Lack of Efficacy|5|||
127545543|NCT02326155|458965762|FG000|Overall Study|Lost to Follow-up|14|||
127545544|NCT02326155|458965763|FG001|Overall Study|Lost to Follow-up|3|||
127545545|NCT02326155|458965762|FG000|Overall Study|Protocol Violation|2|||
127545546|NCT02326155|458965763|FG001|Overall Study|Protocol Violation|0|||
127545547|NCT02326155|458965762|FG000|Overall Study|Withdrawal by Subject|34|||
127545548|NCT02326155|458965763|FG001|Overall Study|Withdrawal by Subject|11|||
127545549|NCT02326155|458965762|FG000|Overall Study|Disease progression|37|||
127545550|NCT02326155|458965763|FG001|Overall Study|Disease progression|4|||
127768240|NCT03319849|459776748|FG000|Overall Study|Eligible and did not enroll in amendment|1|||
127768241|NCT03319849|459776749|FG001|Overall Study|Eligible and did not enroll in amendment|3|||
127768242|NCT03319849|459776748|FG000|Overall Study|Lost to Follow-up|0|||
127768243|NCT03319849|459776749|FG001|Overall Study|Lost to Follow-up|2|||
127768244|NCT01036763|459777983|FG000|Overall Study|Adverse Event|25|||
127768245|NCT01036763|459777983|FG000|Overall Study|Lost to Follow-up|28|||
127768246|NCT01036763|459777983|FG000|Overall Study|Other reason (not specified)|40|||
127768247|NCT01672723|459777984|FG000|First Intervention|Adverse Event|3|||
127768248|NCT01672723|459777985|FG001|First Intervention|Adverse Event|0|||
127768249|NCT00743275|459777986|FG000|Overall Study|Protocol Violation|0|||
127768250|NCT00743275|459777987|FG001|Overall Study|Protocol Violation|1|||
128015972|NCT00658528|460682196|FG000|Overall Study|Lost to Follow-up|14|||
128015973|NCT00658528|460682197|FG001|Overall Study|Lost to Follow-up|22|||
127545551|NCT02326155|458965762|FG000|Overall Study|Study close|188|||
127545552|NCT02326155|458965763|FG001|Overall Study|Study close|21|||
127545553|NCT02326155|458965762|FG000|Overall Study|except for study close|46|||
127545554|NCT02326155|458965763|FG001|Overall Study|except for study close|13|||
127545555|NCT05024032|458965764|FG000|Overall Study|Withdrawal by Subject|0|||
127681613|NCT02296424|459460577|FG001|Part 1|New therapy for study indication|1|||
127681614|NCT02296424|459460578|FG002|Part 1|New therapy for study indication|0|||
127681615|NCT02296424|459460579|FG003|Part 1|New therapy for study indication|0|||
127681616|NCT02296424|459460576|FG000|Part 1|Protocol Violation|0|||
127681617|NCT02296424|459460577|FG001|Part 1|Protocol Violation|1|||
127681618|NCT02296424|459460578|FG002|Part 1|Protocol Violation|0|||
127681619|NCT02296424|459460579|FG003|Part 1|Protocol Violation|0|||
127681620|NCT02296424|459460576|FG000|Part 1|Withdrawal by Subject|0|||
127681621|NCT02296424|459460577|FG001|Part 1|Withdrawal by Subject|2|||
127681622|NCT02296424|459460578|FG002|Part 1|Withdrawal by Subject|0|||
127681623|NCT02296424|459460579|FG003|Part 1|Withdrawal by Subject|0|||
127681624|NCT02296424|459460576|FG000|Part 1|Study terminated by sponsor|0|||
127681625|NCT02296424|459460577|FG001|Part 1|Study terminated by sponsor|1|||
127681626|NCT02296424|459460578|FG002|Part 1|Study terminated by sponsor|0|||
127681627|NCT02296424|459460579|FG003|Part 1|Study terminated by sponsor|0|||
127681628|NCT02296424|459460576|FG000|Part 1|Adverse Event|2|||
127681629|NCT02296424|459460577|FG001|Part 1|Adverse Event|11|||
127681630|NCT02296424|459460578|FG002|Part 1|Adverse Event|0|||
127681631|NCT02296424|459460579|FG003|Part 1|Adverse Event|0|||
127681632|NCT02296424|459460576|FG000|Part 1|Lack of Efficacy|5|||
127681633|NCT02296424|459460577|FG001|Part 1|Lack of Efficacy|17|||
127681634|NCT02296424|459460578|FG002|Part 1|Lack of Efficacy|0|||
127681635|NCT02296424|459460579|FG003|Part 1|Lack of Efficacy|0|||
127681636|NCT02296424|459460576|FG000|Part 1|16 directly started part II|16|||
127681637|NCT02296424|459460577|FG001|Part 1|16 directly started part II|0|||
127681638|NCT02296424|459460578|FG002|Part 1|16 directly started part II|0|||
127681639|NCT02296424|459460579|FG003|Part 1|16 directly started part II|0|||
127681640|NCT02296424|459460576|FG000|Part 2|Lack of Efficacy|0|||
127681641|NCT02296424|459460577|FG001|Part 2|Lack of Efficacy|0|||
127681642|NCT02296424|459460578|FG002|Part 2|Lack of Efficacy|1|||
127681643|NCT02296424|459460579|FG003|Part 2|Lack of Efficacy|0|||
127681644|NCT02296424|459460576|FG000|Part 2|Adverse Event|0|||
127681645|NCT02296424|459460577|FG001|Part 2|Adverse Event|0|||
127681646|NCT02296424|459460578|FG002|Part 2|Adverse Event|1|||
127681647|NCT02296424|459460579|FG003|Part 2|Adverse Event|0|||
127681648|NCT02296424|459460576|FG000|Part 2|Lost to Follow-up|0|||
127681649|NCT02296424|459460577|FG001|Part 2|Lost to Follow-up|0|||
127681650|NCT02296424|459460578|FG002|Part 2|Lost to Follow-up|1|||
127681651|NCT02296424|459460579|FG003|Part 2|Lost to Follow-up|0|||
127681652|NCT00743444|459460580|FG000|First Intervention|Catheter placement problems|0|||
127681653|NCT00743444|459460581|FG001|First Intervention|Catheter placement problems|1|||
127681654|NCT00743444|459460580|FG000|Washout Period|Adverse Event|0|||
127681655|NCT00743444|459460581|FG001|Washout Period|Adverse Event|1|||
127681656|NCT01337635|459460584|FG000|Overall Study|Lost to Follow-up|0|||
127681657|NCT01337635|459460585|FG001|Overall Study|Lost to Follow-up|1|||
127681658|NCT01307267|459460586|FG000|Overall Study|Death|4|||
127681659|NCT01307267|459460587|FG001|Overall Study|Death|3|||
127681660|NCT01307267|459460588|FG002|Overall Study|Death|5|||
127681661|NCT01307267|459460589|FG003|Overall Study|Death|3|||
127681662|NCT01307267|459460590|FG004|Overall Study|Death|1|||
127768251|NCT03938545|459777993|FG000|Overall Study|Lost to Follow-up|0|||
127768252|NCT03938545|459777994|FG001|Overall Study|Lost to Follow-up|0|||
127545556|NCT05024032|458965765|FG001|Overall Study|Withdrawal by Subject|3|||
127545557|NCT05024032|458965766|FG002|Overall Study|Withdrawal by Subject|4|||
127545558|NCT05024032|458965764|FG000|Overall Study|Adverse Event|0|||
127545559|NCT05024032|458965765|FG001|Overall Study|Adverse Event|1|||
127545560|NCT05024032|458965766|FG002|Overall Study|Adverse Event|0|||
127545561|NCT05024032|458965764|FG000|Overall Study|Protocol Deviation|1|||
127545562|NCT05024032|458965765|FG001|Overall Study|Protocol Deviation|0|||
127545563|NCT05024032|458965766|FG002|Overall Study|Protocol Deviation|0|||
127545564|NCT03591406|458965769|FG000|Overall Study|Adverse Event|5|||
127545565|NCT03591406|458965770|FG001|Overall Study|Adverse Event|3|||
127545566|NCT03591406|458965769|FG000|Overall Study|Protocol Violation|2|||
127545567|NCT03591406|458965770|FG001|Overall Study|Protocol Violation|1|||
127545568|NCT03591406|458965769|FG000|Overall Study|Withdrawal by Subject|0|||
127545569|NCT03591406|458965770|FG001|Overall Study|Withdrawal by Subject|5|||
127545570|NCT02066181|458965771|FG000|Overall Study|Withdrawal by Subject|1|||
127545571|NCT02066181|458965772|FG001|Overall Study|Withdrawal by Subject|1|||
127545572|NCT01083771|458965773|FG000|Overall Study|non-compliant|2|||
127545573|NCT01083771|458965773|FG000|Overall Study|Withdrawal by Subject|3|||
127545574|NCT00939393|458965776|FG000|Overall Study|Withdrawal by Subject|1|||
127545575|NCT00939393|458965777|FG001|Overall Study|Withdrawal by Subject|0|||
127545576|NCT00939393|458965776|FG000|Overall Study|Lost to Follow-up|3|||
127545577|NCT00939393|458965777|FG001|Overall Study|Lost to Follow-up|0|||
127545578|NCT02851615|458965778|FG000|Overall Study|Cognitive Issue|1|||
127545579|NCT02851615|458965779|FG001|Overall Study|Cognitive Issue|0|||
127545580|NCT02851615|458965778|FG000|Overall Study|Lost to Follow-up|0|||
127545581|NCT02851615|458965779|FG001|Overall Study|Lost to Follow-up|4|||
127545582|NCT00371150|458965788|FG000|Overall Study|Lost to Follow-up|3|||
127545583|NCT00371150|458965789|FG001|Overall Study|Lost to Follow-up|2|||
127545584|NCT03714672|458965790|FG000|Overall Study|Adverse Event|0|||
127545585|NCT03714672|458965791|FG001|Overall Study|Adverse Event|0|||
127545586|NCT03714672|458965792|FG002|Overall Study|Adverse Event|3|||
127545587|NCT03714672|458965793|FG003|Overall Study|Adverse Event|0|||
127545588|NCT03714672|458965790|FG000|Overall Study|Physician Decision|0|||
127681663|NCT01307267|459460591|FG005|Overall Study|Death|26|||
127681664|NCT01307267|459460592|FG006|Overall Study|Death|2|||
127681665|NCT01307267|459460593|FG007|Overall Study|Death|2|||
127681666|NCT01307267|459460594|FG008|Overall Study|Death|21|||
127681667|NCT01307267|459460595|FG009|Overall Study|Death|2|||
127681668|NCT01307267|459460596|FG010|Overall Study|Death|3|||
127681669|NCT01307267|459460597|FG011|Overall Study|Death|9|||
127681670|NCT01307267|459460598|FG012|Overall Study|Death|0|||
127681671|NCT01307267|459460599|FG013|Overall Study|Death|0|||
127681672|NCT01307267|459460600|FG014|Overall Study|Death|0|||
127681673|NCT01307267|459460601|FG015|Overall Study|Death|0|||
127681674|NCT01307267|459460602|FG016|Overall Study|Death|1|||
127681675|NCT01307267|459460603|FG017|Overall Study|Death|1|||
127681676|NCT01307267|459460604|FG018|Overall Study|Death|2|||
127681677|NCT01307267|459460605|FG019|Overall Study|Death|8|||
127681678|NCT01307267|459460606|FG020|Overall Study|Death|1|||
127681679|NCT01307267|459460607|FG021|Overall Study|Death|2|||
127681680|NCT01307267|459460608|FG022|Overall Study|Death|2|||
127681681|NCT01307267|459460586|FG000|Overall Study|Lost to Follow-up|0|||
127681682|NCT01307267|459460587|FG001|Overall Study|Lost to Follow-up|0|||
127681683|NCT01307267|459460588|FG002|Overall Study|Lost to Follow-up|0|||
127681684|NCT01307267|459460589|FG003|Overall Study|Lost to Follow-up|0|||
127681685|NCT01307267|459460590|FG004|Overall Study|Lost to Follow-up|0|||
127681686|NCT01307267|459460591|FG005|Overall Study|Lost to Follow-up|7|||
127681687|NCT01307267|459460592|FG006|Overall Study|Lost to Follow-up|0|||
127681688|NCT01307267|459460593|FG007|Overall Study|Lost to Follow-up|0|||
127681689|NCT01307267|459460594|FG008|Overall Study|Lost to Follow-up|1|||
127681690|NCT01307267|459460595|FG009|Overall Study|Lost to Follow-up|2|||
127768253|NCT03938545|459777995|FG002|Overall Study|Lost to Follow-up|0|||
127768254|NCT03938545|459777996|FG003|Overall Study|Lost to Follow-up|1|||
127545589|NCT03714672|458965791|FG001|Overall Study|Physician Decision|1|||
127681691|NCT01307267|459460596|FG010|Overall Study|Lost to Follow-up|1|||
127681692|NCT01307267|459460597|FG011|Overall Study|Lost to Follow-up|0|||
127545590|NCT03714672|458965792|FG002|Overall Study|Physician Decision|0|||
127545591|NCT03714672|458965793|FG003|Overall Study|Physician Decision|0|||
127545592|NCT03714672|458965790|FG000|Overall Study|Other Reason|1|||
127545593|NCT03714672|458965791|FG001|Overall Study|Other Reason|2|||
127545594|NCT03714672|458965792|FG002|Overall Study|Other Reason|1|||
127545595|NCT03714672|458965793|FG003|Overall Study|Other Reason|1|||
127545596|NCT03714672|458965790|FG000|Overall Study|Lost to Follow-up|1|||
127545597|NCT03714672|458965791|FG001|Overall Study|Lost to Follow-up|1|||
127681693|NCT01307267|459460598|FG012|Overall Study|Lost to Follow-up|0|||
127681694|NCT01307267|459460599|FG013|Overall Study|Lost to Follow-up|0|||
127681695|NCT01307267|459460600|FG014|Overall Study|Lost to Follow-up|0|||
127681696|NCT01307267|459460601|FG015|Overall Study|Lost to Follow-up|0|||
127681697|NCT01307267|459460602|FG016|Overall Study|Lost to Follow-up|0|||
127681698|NCT01307267|459460603|FG017|Overall Study|Lost to Follow-up|0|||
127681699|NCT01307267|459460604|FG018|Overall Study|Lost to Follow-up|0|||
127768255|NCT03938545|459777993|FG000|Overall Study|Non-compliance with study drug|0|||
127545598|NCT03714672|458965792|FG002|Overall Study|Lost to Follow-up|0|||
127545599|NCT03714672|458965793|FG003|Overall Study|Lost to Follow-up|0|||
127545600|NCT02345070|458965794|FG000|Overall Study|Adverse Event|12|||
127545601|NCT02345070|458965795|FG001|Overall Study|Adverse Event|8|||
127545602|NCT02345070|458965796|FG002|Overall Study|Adverse Event|16|||
127545603|NCT02345070|458965794|FG000|Overall Study|Poor compliance to protocol|2|||
127545604|NCT02345070|458965795|FG001|Overall Study|Poor compliance to protocol|0|||
127545605|NCT02345070|458965796|FG002|Overall Study|Poor compliance to protocol|0|||
127545606|NCT02345070|458965794|FG000|Overall Study|Other than specified above|6|||
127545607|NCT02345070|458965795|FG001|Overall Study|Other than specified above|3|||
127545608|NCT02345070|458965796|FG002|Overall Study|Other than specified above|7|||
127545609|NCT01709721|458965804|FG000|Open Label Phase|Withdrawal by Subject|0|||
127545610|NCT01709721|458965805|FG001|Open Label Phase|Withdrawal by Subject|0|||
127545611|NCT01709721|458965806|FG002|Open Label Phase|Withdrawal by Subject|5|||
127545612|NCT01709721|458965804|FG000|Open Label Phase|Adverse Event|0|||
127545613|NCT01709721|458965805|FG001|Open Label Phase|Adverse Event|0|||
127545614|NCT01709721|458965806|FG002|Open Label Phase|Adverse Event|8|||
127545615|NCT01709721|458965804|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
127545616|NCT01709721|458965805|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
127545617|NCT01709721|458965806|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
127545618|NCT01709721|458965804|FG000|Open Label Phase|Investigator Decision|0|||
127545619|NCT01709721|458965805|FG001|Open Label Phase|Investigator Decision|0|||
127545620|NCT01709721|458965806|FG002|Open Label Phase|Investigator Decision|1|||
127545621|NCT01709721|458965804|FG000|Open Label Phase|Sponsor Decision|0|||
127545622|NCT01709721|458965805|FG001|Open Label Phase|Sponsor Decision|0|||
127545623|NCT01709721|458965806|FG002|Open Label Phase|Sponsor Decision|2|||
127545624|NCT01709721|458965804|FG000|Open Label Phase|Protocol Violation|0|||
127545625|NCT01709721|458965805|FG001|Open Label Phase|Protocol Violation|0|||
127545626|NCT01709721|458965806|FG002|Open Label Phase|Protocol Violation|1|||
127545627|NCT01709721|458965804|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
127545628|NCT01709721|458965805|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
127545629|NCT01709721|458965806|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
127545630|NCT01709721|458965804|FG000|Open Label Phase|Inadequate Pain Control|0|||
127545631|NCT01709721|458965805|FG001|Open Label Phase|Inadequate Pain Control|0|||
127545632|NCT01709721|458965806|FG002|Open Label Phase|Inadequate Pain Control|37|||
127545633|NCT01709721|458965804|FG000|Open Label Phase|Other, Specify in text field in database|0|||
127545634|NCT01709721|458965805|FG001|Open Label Phase|Other, Specify in text field in database|0|||
127545635|NCT01709721|458965806|FG002|Open Label Phase|Other, Specify in text field in database|14|||
127545636|NCT01709721|458965804|FG000|Randomized Phase|Adverse Event|0|||
127545637|NCT01709721|458965805|FG001|Randomized Phase|Adverse Event|1|||
127545638|NCT01709721|458965806|FG002|Randomized Phase|Adverse Event|0|||
127545639|NCT01709721|458965804|FG000|Randomized Phase|Lost to Follow-up|1|||
127545640|NCT01709721|458965805|FG001|Randomized Phase|Lost to Follow-up|0|||
127545641|NCT01709721|458965806|FG002|Randomized Phase|Lost to Follow-up|0|||
127545642|NCT01709721|458965804|FG000|Randomized Phase|Inadequate Pain Control|1|||
127545643|NCT01709721|458965805|FG001|Randomized Phase|Inadequate Pain Control|2|||
127545644|NCT01709721|458965806|FG002|Randomized Phase|Inadequate Pain Control|0|||
127545645|NCT01709721|458965804|FG000|Randomized Phase|Other, Specify text field in database|1|||
127545646|NCT01709721|458965805|FG001|Randomized Phase|Other, Specify text field in database|3|||
127545647|NCT01709721|458965806|FG002|Randomized Phase|Other, Specify text field in database|0|||
127545648|NCT00423579|458965807|FG000|Overall Study|Lost to Follow-up|3|||
127545649|NCT00423579|458965808|FG001|Overall Study|Lost to Follow-up|0|||
127545650|NCT00423579|458965807|FG000|Overall Study|Protocol Violation|1|||
127545651|NCT00423579|458965808|FG001|Overall Study|Protocol Violation|3|||
127545652|NCT00423579|458965807|FG000|Overall Study|Diagnosis of diabetes|0|||
127545653|NCT00423579|458965808|FG001|Overall Study|Diagnosis of diabetes|1|||
127545654|NCT00106704|458965811|FG000|Overall Study|Adverse Event|10|||
127681700|NCT01307267|459460605|FG019|Overall Study|Lost to Follow-up|2|||
127681701|NCT01307267|459460606|FG020|Overall Study|Lost to Follow-up|0|||
127681702|NCT01307267|459460607|FG021|Overall Study|Lost to Follow-up|0|||
127681703|NCT01307267|459460608|FG022|Overall Study|Lost to Follow-up|0|||
127681704|NCT01307267|459460586|FG000|Overall Study|Withdrawal by Subject|0|||
127681705|NCT01307267|459460587|FG001|Overall Study|Withdrawal by Subject|0|||
127681706|NCT01307267|459460588|FG002|Overall Study|Withdrawal by Subject|0|||
127545655|NCT00106704|458965812|FG001|Overall Study|Adverse Event|7|||
127545656|NCT00106704|458965811|FG000|Overall Study|Death|2|||
127681707|NCT01307267|459460589|FG003|Overall Study|Withdrawal by Subject|0|||
127681708|NCT01307267|459460590|FG004|Overall Study|Withdrawal by Subject|0|||
127681709|NCT01307267|459460591|FG005|Overall Study|Withdrawal by Subject|1|||
127545657|NCT00106704|458965812|FG001|Overall Study|Death|1|||
127545658|NCT00106704|458965811|FG000|Overall Study|Lack of Efficacy|67|||
127545659|NCT00106704|458965812|FG001|Overall Study|Lack of Efficacy|69|||
127545660|NCT00106704|458965811|FG000|Overall Study|Lost to Follow-up|7|||
127545661|NCT00106704|458965812|FG001|Overall Study|Lost to Follow-up|3|||
127545662|NCT00106704|458965811|FG000|Overall Study|Pregnancy|1|||
127545663|NCT00106704|458965812|FG001|Overall Study|Pregnancy|0|||
127545664|NCT00106704|458965811|FG000|Overall Study|Protocol Violation|4|||
127545665|NCT00106704|458965812|FG001|Overall Study|Protocol Violation|7|||
127545666|NCT00106704|458965811|FG000|Overall Study|Withdrawal by Subject|14|||
127545667|NCT00106704|458965812|FG001|Overall Study|Withdrawal by Subject|21|||
127545668|NCT00106704|458965811|FG000|Overall Study|Patient moved|1|||
127545669|NCT00106704|458965812|FG001|Overall Study|Patient moved|0|||
127545670|NCT00106704|458965811|FG000|Overall Study|Site terminated|0|||
127545671|NCT00106704|458965812|FG001|Overall Study|Site terminated|1|||
127545672|NCT00106704|458965811|FG000|Overall Study|Planned major surgery|1|||
127545673|NCT00106704|458965812|FG001|Overall Study|Planned major surgery|0|||
127545674|NCT00106704|458965811|FG000|Overall Study|Patient Received Glycemic Medication|22|||
127545675|NCT00106704|458965812|FG001|Overall Study|Patient Received Glycemic Medication|41|||
127545676|NCT00106704|458965811|FG000|Overall Study|Unable to re-enter US|1|||
127545677|NCT00106704|458965812|FG001|Overall Study|Unable to re-enter US|0|||
127545678|NCT00106704|458965811|FG000|Overall Study|Laboratory test|1|||
127545679|NCT00106704|458965812|FG001|Overall Study|Laboratory test|1|||
127545680|NCT03773978|458965821|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
127545681|NCT03773978|458965822|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
127545682|NCT03773978|458965821|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
127545683|NCT03773978|458965822|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
127545684|NCT03773978|458965821|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
127545685|NCT03773978|458965822|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
127545686|NCT03773978|458965821|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
127545687|NCT03773978|458965822|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
127545688|NCT03773978|458965821|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
127545689|NCT03773978|458965822|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
127545690|NCT03773978|458965821|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
127545691|NCT03773978|458965822|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
127545692|NCT03773978|458965821|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
127545693|NCT03773978|458965822|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
127545694|NCT03773978|458965821|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
127545695|NCT03773978|458965822|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
127545696|NCT03773978|458965821|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
127545697|NCT03773978|458965822|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
127545698|NCT03773978|458965821|FG000|DBW Period|Adverse Event|2|||
127545699|NCT03773978|458965822|FG001|DBW Period|Adverse Event|2|||
127545700|NCT03773978|458965821|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
127545701|NCT03773978|458965822|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
127545702|NCT03773978|458965821|FG000|DBW Period|Withdrawal by Subject|2|||
127545703|NCT03773978|458965822|FG001|DBW Period|Withdrawal by Subject|1|||
127545704|NCT03773978|458965821|FG000|DBW Period|Due to epidemic or pandemic|5|||
127545705|NCT03773978|458965822|FG001|DBW Period|Due to epidemic or pandemic|6|||
127545706|NCT03773978|458965821|FG000|DBW Period|Study team decision|1|||
127545707|NCT03773978|458965822|FG001|DBW Period|Study team decision|0|||
127545708|NCT01033019|458965823|FG000|Overall Study|Withdrawal by Subject|1|||
127545709|NCT01033019|458965824|FG001|Overall Study|Withdrawal by Subject|0|||
127545710|NCT01498068|458965825|FG000|Overall Study|Withdrawal by Subject|1|||
127545711|NCT01498068|458965826|FG001|Overall Study|Withdrawal by Subject|1|||
127545712|NCT01318915|458965828|FG000|Overall Study|Lost to Follow-up|1|||
127545713|NCT00453206|458965830|FG000|Overall Study|Death|1|||
127545714|NCT03104868|458965831|FG000|6 Week Follow up|Lost to Follow-up|5|||
127545715|NCT03104868|458965832|FG001|6 Week Follow up|Lost to Follow-up|8|||
127545716|NCT03104868|458965831|FG000|6 Week Follow up|Death|1|||
127545717|NCT03104868|458965832|FG001|6 Week Follow up|Death|1|||
127545718|NCT03104868|458965831|FG000|6 Week Follow up|Withdrawal by Subject|7|||
127545719|NCT03104868|458965832|FG001|6 Week Follow up|Withdrawal by Subject|6|||
127545720|NCT03104868|458965831|FG000|6 Week Follow up|Completed Later Timepoint|24|||
127545721|NCT03104868|458965832|FG001|6 Week Follow up|Completed Later Timepoint|22|||
127545722|NCT03104868|458965831|FG000|6 Month Follow up|Lost to Follow-up|2|||
127545723|NCT03104868|458965832|FG001|6 Month Follow up|Lost to Follow-up|2|||
127545724|NCT03104868|458965831|FG000|6 Month Follow up|Death|0|||
127545725|NCT03104868|458965832|FG001|6 Month Follow up|Death|1|||
127545726|NCT03104868|458965831|FG000|6 Month Follow up|Completed Later Timepoint|22|||
127545727|NCT03104868|458965832|FG001|6 Month Follow up|Completed Later Timepoint|32|||
127545728|NCT03104868|458965831|FG000|12 Month Follow up|Lost to Follow-up|1|||
127545729|NCT03104868|458965832|FG001|12 Month Follow up|Lost to Follow-up|2|||
127545730|NCT03104868|458965831|FG000|12 Month Follow up|Death|0|||
127545731|NCT03104868|458965832|FG001|12 Month Follow up|Death|1|||
127545732|NCT03104868|458965831|FG000|12 Month Follow up|Withdrawal by Subject|0|||
127545733|NCT03104868|458965832|FG001|12 Month Follow up|Withdrawal by Subject|3|||
127545734|NCT03104868|458965831|FG000|12 Month Follow up|Completed Later Timepoint|32|||
128015974|NCT00658528|460682196|FG000|Overall Study|Withdrawal by Subject|8|||
127545735|NCT03104868|458965832|FG001|12 Month Follow up|Completed Later Timepoint|29|||
127545736|NCT03104868|458965831|FG000|18 Month Follow up|Lost to Follow-up|7|||
127545737|NCT03104868|458965832|FG001|18 Month Follow up|Lost to Follow-up|11|||
127545738|NCT03104868|458965831|FG000|18 Month Follow up|Death|2|||
127545739|NCT03104868|458965832|FG001|18 Month Follow up|Death|1|||
127545740|NCT03104868|458965831|FG000|18 Month Follow up|Withdrawal by Subject|1|||
127545741|NCT03104868|458965832|FG001|18 Month Follow up|Withdrawal by Subject|2|||
127545742|NCT03104868|458965831|FG000|18 Month Follow up|Graft Loss|1|||
127545743|NCT03104868|458965832|FG001|18 Month Follow up|Graft Loss|1|||
127545744|NCT03104868|458965831|FG000|18 Month Follow up|Completed Later Timepoint|19|||
127545745|NCT03104868|458965832|FG001|18 Month Follow up|Completed Later Timepoint|20|||
127545746|NCT03104868|458965831|FG000|24 Month Follow up|Lost to Follow-up|15|||
127545747|NCT03104868|458965832|FG001|24 Month Follow up|Lost to Follow-up|16|||
127545748|NCT03104868|458965831|FG000|24 Month Follow up|Death|3|||
127545749|NCT03104868|458965832|FG001|24 Month Follow up|Death|2|||
127545750|NCT03104868|458965831|FG000|24 Month Follow up|Withdrawal by Subject|1|||
127545751|NCT03104868|458965832|FG001|24 Month Follow up|Withdrawal by Subject|0|||
127545752|NCT03104868|458965831|FG000|24 Month Follow up|Graft Loss|2|||
127545753|NCT03104868|458965832|FG001|24 Month Follow up|Graft Loss|0|||
127545754|NCT03050801|458965835|FG000|Experiment 1|Lost to Follow-up|0|||
127545755|NCT03050801|458965836|FG001|Experiment 1|Lost to Follow-up|1|||
127545756|NCT03050801|458965837|FG002|Experiment 1|Lost to Follow-up|0|||
127545757|NCT03050801|458965838|FG003|Experiment 1|Lost to Follow-up|0|||
127545758|NCT03050801|458965839|FG004|Experiment 1|Lost to Follow-up|0|||
127545759|NCT03050801|458965840|FG005|Experiment 1|Lost to Follow-up|0|||
127545760|NCT03050801|458965835|FG000|Experiment 1|Physician Decision|0|||
127545761|NCT03050801|458965836|FG001|Experiment 1|Physician Decision|3|||
127545762|NCT03050801|458965837|FG002|Experiment 1|Physician Decision|0|||
127545763|NCT03050801|458965838|FG003|Experiment 1|Physician Decision|0|||
127681710|NCT01307267|459460592|FG006|Overall Study|Withdrawal by Subject|0|||
127681711|NCT01307267|459460593|FG007|Overall Study|Withdrawal by Subject|1|||
127681712|NCT01307267|459460594|FG008|Overall Study|Withdrawal by Subject|5|||
127681713|NCT01307267|459460595|FG009|Overall Study|Withdrawal by Subject|1|||
127681714|NCT01307267|459460596|FG010|Overall Study|Withdrawal by Subject|1|||
127681715|NCT01307267|459460597|FG011|Overall Study|Withdrawal by Subject|1|||
127681716|NCT01307267|459460598|FG012|Overall Study|Withdrawal by Subject|0|||
127681717|NCT01307267|459460599|FG013|Overall Study|Withdrawal by Subject|0|||
127681718|NCT01307267|459460600|FG014|Overall Study|Withdrawal by Subject|0|||
127681719|NCT01307267|459460601|FG015|Overall Study|Withdrawal by Subject|0|||
127681720|NCT01307267|459460602|FG016|Overall Study|Withdrawal by Subject|0|||
127681721|NCT01307267|459460603|FG017|Overall Study|Withdrawal by Subject|0|||
127681722|NCT01307267|459460604|FG018|Overall Study|Withdrawal by Subject|0|||
127681723|NCT01307267|459460605|FG019|Overall Study|Withdrawal by Subject|3|||
127681724|NCT01307267|459460606|FG020|Overall Study|Withdrawal by Subject|0|||
127681725|NCT01307267|459460607|FG021|Overall Study|Withdrawal by Subject|0|||
127681726|NCT01307267|459460608|FG022|Overall Study|Withdrawal by Subject|0|||
127681727|NCT01307267|459460586|FG000|Overall Study|Other|0|||
127681728|NCT01307267|459460587|FG001|Overall Study|Other|0|||
127681729|NCT01307267|459460588|FG002|Overall Study|Other|0|||
127681730|NCT01307267|459460589|FG003|Overall Study|Other|0|||
127681731|NCT01307267|459460590|FG004|Overall Study|Other|0|||
127681732|NCT01307267|459460591|FG005|Overall Study|Other|7|||
127681733|NCT01307267|459460592|FG006|Overall Study|Other|0|||
127681734|NCT01307267|459460593|FG007|Overall Study|Other|1|||
127681735|NCT01307267|459460594|FG008|Overall Study|Other|3|||
127681736|NCT01307267|459460595|FG009|Overall Study|Other|0|||
127681737|NCT01307267|459460596|FG010|Overall Study|Other|1|||
127545764|NCT03050801|458965839|FG004|Experiment 1|Physician Decision|0|||
127545765|NCT03050801|458965840|FG005|Experiment 1|Physician Decision|0|||
127545766|NCT03050801|458965835|FG000|Experiment 1|Change of experimental design|0|||
127681738|NCT01307267|459460597|FG011|Overall Study|Other|1|||
127681739|NCT01307267|459460598|FG012|Overall Study|Other|1|||
127681740|NCT01307267|459460599|FG013|Overall Study|Other|0|||
127681741|NCT01307267|459460600|FG014|Overall Study|Other|2|||
127681742|NCT01307267|459460601|FG015|Overall Study|Other|1|||
127681743|NCT01307267|459460602|FG016|Overall Study|Other|0|||
127681744|NCT01307267|459460603|FG017|Overall Study|Other|0|||
127681745|NCT01307267|459460604|FG018|Overall Study|Other|0|||
127681746|NCT01307267|459460605|FG019|Overall Study|Other|19|||
127681747|NCT01307267|459460606|FG020|Overall Study|Other|2|||
127681748|NCT01307267|459460607|FG021|Overall Study|Other|3|||
127768256|NCT03938545|459777994|FG001|Overall Study|Non-compliance with study drug|0|||
127681749|NCT01307267|459460608|FG022|Overall Study|Other|2|||
127681750|NCT04956575|459460609|FG000|Overall Study|Death|1|||
127681751|NCT04956575|459460610|FG001|Overall Study|Death|0|||
127681752|NCT04956575|459460611|FG002|Overall Study|Death|0|||
127545767|NCT03050801|458965836|FG001|Experiment 1|Change of experimental design|3|||
127545768|NCT03050801|458965837|FG002|Experiment 1|Change of experimental design|0|||
127545769|NCT03050801|458965838|FG003|Experiment 1|Change of experimental design|0|||
127545770|NCT03050801|458965839|FG004|Experiment 1|Change of experimental design|0|||
127545771|NCT03050801|458965840|FG005|Experiment 1|Change of experimental design|0|||
127545772|NCT03050801|458965835|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
127545773|NCT03050801|458965836|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
127545774|NCT03050801|458965837|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
127545775|NCT03050801|458965838|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
127545776|NCT03050801|458965839|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
127545777|NCT03050801|458965840|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
127545778|NCT03050801|458965835|FG000|Experiment 2|Lost to Follow-up|0|||
127545779|NCT03050801|458965836|FG001|Experiment 2|Lost to Follow-up|0|||
127545780|NCT03050801|458965837|FG002|Experiment 2|Lost to Follow-up|0|||
127545781|NCT03050801|458965838|FG003|Experiment 2|Lost to Follow-up|1|||
127545782|NCT03050801|458965839|FG004|Experiment 2|Lost to Follow-up|1|||
127545783|NCT03050801|458965840|FG005|Experiment 2|Lost to Follow-up|0|||
127545784|NCT03050801|458965835|FG000|Experiment 2|Physician Decision|0|||
127545785|NCT03050801|458965836|FG001|Experiment 2|Physician Decision|0|||
127545786|NCT03050801|458965837|FG002|Experiment 2|Physician Decision|0|||
127545787|NCT03050801|458965838|FG003|Experiment 2|Physician Decision|0|||
127545788|NCT03050801|458965839|FG004|Experiment 2|Physician Decision|1|||
127545789|NCT03050801|458965840|FG005|Experiment 2|Physician Decision|0|||
127545790|NCT03050801|458965835|FG000|Experiment 2|Pregnancy|0|||
127545791|NCT03050801|458965836|FG001|Experiment 2|Pregnancy|0|||
127545792|NCT03050801|458965837|FG002|Experiment 2|Pregnancy|0|||
127545793|NCT03050801|458965838|FG003|Experiment 2|Pregnancy|0|||
127545794|NCT03050801|458965839|FG004|Experiment 2|Pregnancy|1|||
127545795|NCT03050801|458965840|FG005|Experiment 2|Pregnancy|0|||
127545796|NCT03050801|458965835|FG000|Experiment 2|Withdrawal by Subject|0|||
127545797|NCT03050801|458965836|FG001|Experiment 2|Withdrawal by Subject|0|||
127545798|NCT03050801|458965837|FG002|Experiment 2|Withdrawal by Subject|0|||
127545799|NCT03050801|458965838|FG003|Experiment 2|Withdrawal by Subject|1|||
127545800|NCT03050801|458965839|FG004|Experiment 2|Withdrawal by Subject|0|||
127545801|NCT03050801|458965840|FG005|Experiment 2|Withdrawal by Subject|0|||
127545802|NCT03050801|458965835|FG000|Experiment 2|Poor data quality|0|||
127545803|NCT03050801|458965836|FG001|Experiment 2|Poor data quality|0|||
127545804|NCT03050801|458965837|FG002|Experiment 2|Poor data quality|0|||
127545805|NCT03050801|458965838|FG003|Experiment 2|Poor data quality|4|||
127545806|NCT03050801|458965839|FG004|Experiment 2|Poor data quality|1|||
127545807|NCT03050801|458965840|FG005|Experiment 2|Poor data quality|0|||
127545808|NCT03050801|458965835|FG000|Experiment 2|Discomfort during stimulation|0|||
127545809|NCT03050801|458965836|FG001|Experiment 2|Discomfort during stimulation|0|||
127545810|NCT03050801|458965837|FG002|Experiment 2|Discomfort during stimulation|0|||
127545811|NCT03050801|458965838|FG003|Experiment 2|Discomfort during stimulation|0|||
127545812|NCT03050801|458965839|FG004|Experiment 2|Discomfort during stimulation|0|||
127545813|NCT03050801|458965840|FG005|Experiment 2|Discomfort during stimulation|2|||
127545814|NCT00005780|458965841|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
127545815|NCT03600909|458965842|FG000|Overall Study|Not treated|0|||
127545816|NCT03600909|458965843|FG001|Overall Study|Not treated|3|||
127545817|NCT03600909|458965844|FG002|Overall Study|Not treated|0|||
127545818|NCT02651675|458965845|FG000|Overall Study|Death|0|||
127545819|NCT02651675|458965846|FG001|Overall Study|Death|0|||
127545820|NCT02651675|458965847|FG002|Overall Study|Death|1|||
127545821|NCT03674411|458965848|FG000|Overall Study|Non-treatment|4|||
127545822|NCT05082857|458965849|FG000|Overall Study|participants relocated and could not continue|2|||
127545823|NCT05082857|458965850|FG001|Overall Study|participants relocated and could not continue|1|||
127545824|NCT05082857|458965849|FG000|Overall Study|Lost to Follow-up|1|||
127545825|NCT05082857|458965850|FG001|Overall Study|Lost to Follow-up|3|||
127681753|NCT04956575|459460612|FG003|Overall Study|Death|0|||
127681754|NCT04956575|459460613|FG004|Overall Study|Death|0|||
127681755|NCT04956575|459460614|FG005|Overall Study|Death|0|||
127681756|NCT04956575|459460615|FG006|Overall Study|Death|0|||
127681757|NCT04956575|459460616|FG007|Overall Study|Death|1|||
127681758|NCT04956575|459460617|FG008|Overall Study|Death|0|||
127681759|NCT04956575|459460618|FG009|Overall Study|Death|1|||
127681760|NCT04956575|459460619|FG010|Overall Study|Death|0|||
127681761|NCT04956575|459460620|FG011|Overall Study|Death|0|||
127681762|NCT04956575|459460609|FG000|Overall Study|Lost to Follow-up|3|||
127681763|NCT04956575|459460610|FG001|Overall Study|Lost to Follow-up|4|||
127681764|NCT04956575|459460611|FG002|Overall Study|Lost to Follow-up|2|||
127681765|NCT04956575|459460612|FG003|Overall Study|Lost to Follow-up|3|||
127545826|NCT04672239|458965851|FG000|Week 2 Survey|Failed survey check items|1|||
127545827|NCT04672239|458965852|FG001|Week 2 Survey|Failed survey check items|2|||
127545828|NCT04672239|458965853|FG002|Week 2 Survey|Failed survey check items|3|||
127545829|NCT04672239|458965851|FG000|Week 2 Survey|Partially completed survey|7|||
127545830|NCT04672239|458965852|FG001|Week 2 Survey|Partially completed survey|1|||
127545831|NCT04672239|458965853|FG002|Week 2 Survey|Partially completed survey|4|||
127545832|NCT04672239|458965851|FG000|Week 2 Survey|Withdrawal by Subject|0|||
127545833|NCT04672239|458965852|FG001|Week 2 Survey|Withdrawal by Subject|1|||
127545834|NCT04672239|458965853|FG002|Week 2 Survey|Withdrawal by Subject|0|||
127545835|NCT04672239|458965851|FG000|Week 2 Survey|Lost to Follow-up|3|||
127681766|NCT04956575|459460613|FG004|Overall Study|Lost to Follow-up|1|||
127545836|NCT04672239|458965852|FG001|Week 2 Survey|Lost to Follow-up|2|||
127545837|NCT04672239|458965853|FG002|Week 2 Survey|Lost to Follow-up|5|||
127545838|NCT04672239|458965851|FG000|Week 6 Survey|Failed survey check items|2|||
127545839|NCT04672239|458965852|FG001|Week 6 Survey|Failed survey check items|2|||
127545840|NCT04672239|458965853|FG002|Week 6 Survey|Failed survey check items|2|||
127545841|NCT04672239|458965851|FG000|Week 6 Survey|Partially completed survey|3|||
127545842|NCT04672239|458965852|FG001|Week 6 Survey|Partially completed survey|3|||
127545843|NCT04672239|458965853|FG002|Week 6 Survey|Partially completed survey|2|||
127545844|NCT04672239|458965851|FG000|Week 6 Survey|Withdrawal by Subject|1|||
127545845|NCT04672239|458965852|FG001|Week 6 Survey|Withdrawal by Subject|1|||
127545846|NCT04672239|458965853|FG002|Week 6 Survey|Withdrawal by Subject|1|||
127545847|NCT04672239|458965851|FG000|Week 6 Survey|Withdrawn by PI|0|||
127545848|NCT04672239|458965852|FG001|Week 6 Survey|Withdrawn by PI|1|||
127545849|NCT04672239|458965853|FG002|Week 6 Survey|Withdrawn by PI|0|||
127545850|NCT04672239|458965851|FG000|Week 6 Survey|Lost to Follow-up|12|||
127545851|NCT04672239|458965852|FG001|Week 6 Survey|Lost to Follow-up|2|||
127545852|NCT04672239|458965853|FG002|Week 6 Survey|Lost to Follow-up|5|||
127545853|NCT04672239|458965851|FG000|3-Month Follow-up Survey|Failed survey check items|2|||
127545854|NCT04672239|458965852|FG001|3-Month Follow-up Survey|Failed survey check items|3|||
127545855|NCT04672239|458965853|FG002|3-Month Follow-up Survey|Failed survey check items|2|||
127545856|NCT04672239|458965851|FG000|3-Month Follow-up Survey|Partially completed survey|3|||
127545857|NCT04672239|458965852|FG001|3-Month Follow-up Survey|Partially completed survey|1|||
127545858|NCT04672239|458965853|FG002|3-Month Follow-up Survey|Partially completed survey|3|||
127545859|NCT04672239|458965851|FG000|3-Month Follow-up Survey|Withdrawal by Subject|0|||
127545860|NCT04672239|458965852|FG001|3-Month Follow-up Survey|Withdrawal by Subject|1|||
127545861|NCT04672239|458965853|FG002|3-Month Follow-up Survey|Withdrawal by Subject|1|||
127545862|NCT04672239|458965851|FG000|3-Month Follow-up Survey|Lost to Follow-up|17|||
127545863|NCT04672239|458965852|FG001|3-Month Follow-up Survey|Lost to Follow-up|5|||
127545864|NCT04672239|458965853|FG002|3-Month Follow-up Survey|Lost to Follow-up|11|||
127545865|NCT04672239|458965851|FG000|6-Month Follow-up Survey|Failed survey check items|2|||
127545866|NCT04672239|458965852|FG001|6-Month Follow-up Survey|Failed survey check items|0|||
127545867|NCT04672239|458965853|FG002|6-Month Follow-up Survey|Failed survey check items|0|||
127545868|NCT04672239|458965851|FG000|6-Month Follow-up Survey|Partially completed survey|7|||
127545869|NCT04672239|458965852|FG001|6-Month Follow-up Survey|Partially completed survey|0|||
127545870|NCT04672239|458965853|FG002|6-Month Follow-up Survey|Partially completed survey|2|||
127545871|NCT04672239|458965851|FG000|6-Month Follow-up Survey|Lost to Follow-up|13|||
127545872|NCT04672239|458965852|FG001|6-Month Follow-up Survey|Lost to Follow-up|12|||
127545873|NCT04672239|458965853|FG002|6-Month Follow-up Survey|Lost to Follow-up|9|||
127681767|NCT04956575|459460614|FG005|Overall Study|Lost to Follow-up|10|||
127545874|NCT04606134|458965854|FG000|Overall Study|Adverse Event|0|||
127681768|NCT04956575|459460615|FG006|Overall Study|Lost to Follow-up|11|||
127681769|NCT04956575|459460616|FG007|Overall Study|Lost to Follow-up|7|||
127681770|NCT04956575|459460617|FG008|Overall Study|Lost to Follow-up|4|||
127681771|NCT04956575|459460618|FG009|Overall Study|Lost to Follow-up|2|||
127681772|NCT04956575|459460619|FG010|Overall Study|Lost to Follow-up|3|||
127681773|NCT04956575|459460620|FG011|Overall Study|Lost to Follow-up|8|||
127681774|NCT04956575|459460609|FG000|Overall Study|Withdrawal by Subject|1|||
127681775|NCT04956575|459460610|FG001|Overall Study|Withdrawal by Subject|2|||
127681776|NCT04956575|459460611|FG002|Overall Study|Withdrawal by Subject|1|||
127681777|NCT04956575|459460612|FG003|Overall Study|Withdrawal by Subject|4|||
127681778|NCT04956575|459460613|FG004|Overall Study|Withdrawal by Subject|2|||
127681779|NCT04956575|459460614|FG005|Overall Study|Withdrawal by Subject|8|||
127681780|NCT04956575|459460615|FG006|Overall Study|Withdrawal by Subject|5|||
127681781|NCT04956575|459460616|FG007|Overall Study|Withdrawal by Subject|1|||
127681782|NCT04956575|459460617|FG008|Overall Study|Withdrawal by Subject|1|||
127681783|NCT04956575|459460618|FG009|Overall Study|Withdrawal by Subject|0|||
127681784|NCT04956575|459460619|FG010|Overall Study|Withdrawal by Subject|3|||
127681785|NCT04956575|459460620|FG011|Overall Study|Withdrawal by Subject|1|||
127681786|NCT03593876|459460621|FG000|Overall Study|Withdrawal by Subject|1|||
127681787|NCT03593876|459460621|FG000|Overall Study|Discharged home before intervention completion|2|||
127681788|NCT00814346|459460625|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
127545875|NCT04606134|458965855|FG001|Overall Study|Adverse Event|1|||
127545876|NCT05408429|458965861|FG000|Overall Study|Lost to Follow-up|1|||
127545877|NCT05408429|458965862|FG001|Overall Study|Lost to Follow-up|1|||
127545878|NCT05408429|458965863|FG002|Overall Study|Lost to Follow-up|0|||
127681789|NCT00814346|459460626|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
127681790|NCT00814346|459460625|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
127681791|NCT00814346|459460626|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
127681792|NCT00814346|459460625|FG000|Open Phase (17 Months)|Adverse Event|5|||
127681793|NCT00814346|459460626|FG001|Open Phase (17 Months)|Adverse Event|0|||
127681794|NCT00814346|459460625|FG000|Open Phase (17 Months)|Consent|2|||
127681795|NCT00814346|459460626|FG001|Open Phase (17 Months)|Consent|0|||
127545879|NCT05408429|458965861|FG000|Overall Study|Withdrawal by Subject|5|||
127768257|NCT03938545|459777995|FG002|Overall Study|Non-compliance with study drug|1|||
127768258|NCT03938545|459777996|FG003|Overall Study|Non-compliance with study drug|0|||
127768259|NCT03938545|459777993|FG000|Overall Study|Pregnancy|1|||
127768260|NCT03938545|459777994|FG001|Overall Study|Pregnancy|0|||
127768261|NCT03938545|459777995|FG002|Overall Study|Pregnancy|0|||
127768262|NCT03938545|459777996|FG003|Overall Study|Pregnancy|0|||
127768263|NCT03938545|459777993|FG000|Overall Study|Study terminated by sponsor|6|||
127768264|NCT03938545|459777994|FG001|Overall Study|Study terminated by sponsor|4|||
127768265|NCT03938545|459777995|FG002|Overall Study|Study terminated by sponsor|2|||
127768266|NCT03938545|459777996|FG003|Overall Study|Study terminated by sponsor|4|||
128015975|NCT00658528|460682197|FG001|Overall Study|Withdrawal by Subject|6|||
128015976|NCT00658528|460682196|FG000|Overall Study|Withdrawal of consent|5|||
128015977|NCT00658528|460682197|FG001|Overall Study|Withdrawal of consent|6|||
128015978|NCT00658528|460682196|FG000|Overall Study|Other|8|||
128015979|NCT00658528|460682197|FG001|Overall Study|Other|4|||
128015980|NCT04017962|460682199|FG000|Overall Study|Death|2|||
127768267|NCT03938545|459777993|FG000|Overall Study|Withdrawal by Subject|0|||
127768268|NCT03938545|459777994|FG001|Overall Study|Withdrawal by Subject|1|||
127768269|NCT03938545|459777995|FG002|Overall Study|Withdrawal by Subject|0|||
127768270|NCT03938545|459777996|FG003|Overall Study|Withdrawal by Subject|0|||
127768271|NCT03938545|459777993|FG000|Overall Study|Adverse Event|1|||
127768272|NCT03938545|459777994|FG001|Overall Study|Adverse Event|0|||
127768273|NCT03938545|459777995|FG002|Overall Study|Adverse Event|0|||
127768274|NCT03938545|459777996|FG003|Overall Study|Adverse Event|0|||
127768275|NCT01060540|459777997|FG000|Overall Study|Withdrawal by Subject|10|||
127768276|NCT01060540|459777998|FG001|Overall Study|Withdrawal by Subject|20|||
127768277|NCT01060540|459777997|FG000|Overall Study|Lost to Follow-up|52|||
127768278|NCT01060540|459777998|FG001|Overall Study|Lost to Follow-up|43|||
127768279|NCT01060540|459777997|FG000|Overall Study|Death|2|||
127768280|NCT01060540|459777998|FG001|Overall Study|Death|1|||
127768281|NCT01060540|459777997|FG000|Overall Study|Physician Decision|0|||
127768282|NCT01060540|459777998|FG001|Overall Study|Physician Decision|1|||
127768283|NCT03310268|459777999|FG000|Overall Study|(Not specified)|1|||
127768284|NCT03310268|459778000|FG001|Overall Study|(Not specified)|5|||
127768285|NCT03310268|459778001|FG002|Overall Study|(Not specified)|0|||
127768286|NCT01590017|459778002|FG000|Overall Study|Adverse Event|1|||
127768287|NCT01590017|459778002|FG000|Overall Study|Withdrawal by Subject|1|||
127768288|NCT01590017|459778002|FG000|Overall Study|Lack of Efficacy|1|||
127768289|NCT01590017|459778002|FG000|Overall Study|Physician Decision|1|||
127768290|NCT02527343|459778003|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
127768291|NCT02527343|459778004|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
127768292|NCT02527343|459778005|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
127768293|NCT02527343|459778006|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
127768294|NCT02527343|459778007|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
127768295|NCT02527343|459778008|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
127768296|NCT02527343|459778003|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
127768297|NCT02527343|459778004|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
127768298|NCT02527343|459778005|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
128015981|NCT04017962|460682200|FG001|Overall Study|Death|0|||
127768299|NCT02527343|459778006|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
127768300|NCT02527343|459778007|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
127768301|NCT02527343|459778008|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
127768302|NCT02527343|459778003|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
127768303|NCT02527343|459778004|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
127768304|NCT02527343|459778005|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
127768305|NCT02527343|459778006|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
127768306|NCT02527343|459778007|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
127768307|NCT02527343|459778008|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
127768308|NCT02527343|459778003|FG000|RT Period: Weeks 1 to 52|Other|4|||
127768309|NCT02527343|459778004|FG001|RT Period: Weeks 1 to 52|Other|3|||
127768310|NCT02527343|459778005|FG002|RT Period: Weeks 1 to 52|Other|0|||
127768311|NCT02527343|459778006|FG003|RT Period: Weeks 1 to 52|Other|0|||
127768312|NCT02527343|459778007|FG004|RT Period: Weeks 1 to 52|Other|0|||
127768313|NCT02527343|459778008|FG005|RT Period: Weeks 1 to 52|Other|0|||
127768314|NCT02527343|459778003|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
127768315|NCT02527343|459778004|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
127768316|NCT02527343|459778005|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
127768317|NCT02527343|459778006|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
128015982|NCT04017962|460682199|FG000|Overall Study|Lost to Follow-up|2|||
128015983|NCT04017962|460682200|FG001|Overall Study|Lost to Follow-up|0|||
127768318|NCT02527343|459778007|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
127768319|NCT02527343|459778008|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
127768320|NCT02527343|459778003|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
127545880|NCT05408429|458965862|FG001|Overall Study|Withdrawal by Subject|0|||
127545881|NCT05408429|458965863|FG002|Overall Study|Withdrawal by Subject|1|||
127545882|NCT04825678|458965867|FG000|Overall Study|Decision by Sponsor|2|||
127545883|NCT04825678|458965868|FG001|Overall Study|Decision by Sponsor|3|||
127545884|NCT04825678|458965867|FG000|Overall Study|Withdrawal of Consent From Study|7|||
127545885|NCT04825678|458965868|FG001|Overall Study|Withdrawal of Consent From Study|9|||
127545886|NCT04825678|458965867|FG000|Overall Study|Lost to Follow-up|3|||
127545887|NCT04825678|458965868|FG001|Overall Study|Lost to Follow-up|4|||
127545888|NCT04825678|458965867|FG000|Overall Study|Never Received Investigational Product|1|||
127545889|NCT04825678|458965868|FG001|Overall Study|Never Received Investigational Product|1|||
127545890|NCT01074970|458965870|FG000|Overall Study|Never Treated|0|||
127545891|NCT01074970|458965871|FG001|Overall Study|Never Treated|0|||
127545892|NCT01074970|458965872|FG002|Overall Study|Never Treated|8|||
127545893|NCT01074970|458965873|FG003|Overall Study|Never Treated|1|||
127545894|NCT01074970|458965870|FG000|Overall Study|Adverse Event|1|||
127545895|NCT01074970|458965871|FG001|Overall Study|Adverse Event|0|||
127545896|NCT01074970|458965872|FG002|Overall Study|Adverse Event|4|||
127545897|NCT01074970|458965873|FG003|Overall Study|Adverse Event|3|||
127545898|NCT01074970|458965870|FG000|Overall Study|Disease progression during treatment|3|||
127545899|NCT01074970|458965871|FG001|Overall Study|Disease progression during treatment|1|||
127545900|NCT01074970|458965872|FG002|Overall Study|Disease progression during treatment|2|||
127545901|NCT01074970|458965873|FG003|Overall Study|Disease progression during treatment|9|||
127545902|NCT01074970|458965870|FG000|Overall Study|Lost to Follow-up|0|||
127545903|NCT01074970|458965871|FG001|Overall Study|Lost to Follow-up|0|||
127545904|NCT01074970|458965872|FG002|Overall Study|Lost to Follow-up|1|||
127545905|NCT01074970|458965873|FG003|Overall Study|Lost to Follow-up|0|||
127545906|NCT01074970|458965870|FG000|Overall Study|Withdrawal by Subject|0|||
127545907|NCT01074970|458965871|FG001|Overall Study|Withdrawal by Subject|0|||
127545908|NCT01074970|458965872|FG002|Overall Study|Withdrawal by Subject|6|||
127545909|NCT01074970|458965873|FG003|Overall Study|Withdrawal by Subject|4|||
127545910|NCT00734149|458965875|FG000|Overall Study|Withdrawal by Subject|1|||
127545911|NCT02681523|458965876|FG000|Overall Study|Adverse Event|1|||
127545912|NCT02681523|458965876|FG000|Overall Study|Patient Non-compliance|1|||
127545913|NCT04328077|458967494|FG000|Overall Study|Lost to Follow-up|0|||
127545914|NCT04328077|458967495|FG001|Overall Study|Lost to Follow-up|1|||
127545915|NCT04328077|458967496|FG002|Overall Study|Lost to Follow-up|0|||
127545916|NCT04328077|458967497|FG003|Overall Study|Lost to Follow-up|0|||
127545917|NCT04328077|458967494|FG000|Overall Study|Withdrawal by Subject|0|||
127545918|NCT04328077|458967495|FG001|Overall Study|Withdrawal by Subject|1|||
127545919|NCT04328077|458967496|FG002|Overall Study|Withdrawal by Subject|1|||
127545920|NCT04328077|458967497|FG003|Overall Study|Withdrawal by Subject|3|||
127545921|NCT00744497|458967498|FG000|Overall Study|Withdrawal by Subject|21|||
127545922|NCT00744497|458967499|FG001|Overall Study|Withdrawal by Subject|18|||
127545923|NCT00744497|458967498|FG000|Overall Study|Death|11|||
127545924|NCT00744497|458967499|FG001|Overall Study|Death|9|||
127545925|NCT00744497|458967498|FG000|Overall Study|Lost to Follow-up|4|||
127545926|NCT00744497|458967499|FG001|Overall Study|Lost to Follow-up|2|||
127545927|NCT00744497|458967498|FG000|Overall Study|Poor compliance/noncompliance|9|||
127768321|NCT02527343|459778004|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
127768322|NCT02527343|459778005|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
127545928|NCT00744497|458967499|FG001|Overall Study|Poor compliance/noncompliance|5|||
127545929|NCT00744497|458967498|FG000|Overall Study|No longer meets study criteria|7|||
127545930|NCT00744497|458967499|FG001|Overall Study|No longer meets study criteria|3|||
127545931|NCT00744497|458967498|FG000|Overall Study|Administrative Reason By Sponsor|25|||
127545932|NCT00744497|458967499|FG001|Overall Study|Administrative Reason By Sponsor|8|||
127545933|NCT00744497|458967498|FG000|Overall Study|Disease progression|312|||
127545934|NCT00744497|458967499|FG001|Overall Study|Disease progression|219|||
127545935|NCT00744497|458967498|FG000|Overall Study|Study drug toxicity|68|||
127545936|NCT00744497|458967499|FG001|Overall Study|Study drug toxicity|141|||
127545937|NCT00744497|458967498|FG000|Overall Study|Adverse event unrelated to study drug|78|||
127545938|NCT00744497|458967499|FG001|Overall Study|Adverse event unrelated to study drug|122|||
127545939|NCT00744497|458967498|FG000|Overall Study|Patient requested to stop study drug|65|||
127545940|NCT00744497|458967499|FG001|Overall Study|Patient requested to stop study drug|80|||
127545941|NCT00744497|458967498|FG000|Overall Study|Maximum clinical benefit|141|||
127545942|NCT00744497|458967499|FG001|Overall Study|Maximum clinical benefit|142|||
127545943|NCT00744497|458967498|FG000|Overall Study|Not defined|19|||
127545944|NCT00744497|458967499|FG001|Overall Study|Not defined|13|||
127545945|NCT03819114|458967532|FG000|Overall Study|Protocol Violation|0|||
127545946|NCT03819114|458967533|FG001|Overall Study|Protocol Violation|1|||
127545947|NCT03819114|458967534|FG002|Overall Study|Protocol Violation|1|||
127545948|NCT03819114|458967535|FG003|Overall Study|Protocol Violation|0|||
127545949|NCT03819114|458967532|FG000|Overall Study|Lost to Follow-up|0|||
127545950|NCT03819114|458967533|FG001|Overall Study|Lost to Follow-up|0|||
127545951|NCT03819114|458967534|FG002|Overall Study|Lost to Follow-up|1|||
127545952|NCT03819114|458967535|FG003|Overall Study|Lost to Follow-up|0|||
127545953|NCT02492763|458967536|FG000|Overall Study|Withdrawal by Subject|0|||
127545954|NCT02492763|458967537|FG001|Overall Study|Withdrawal by Subject|2|||
128015984|NCT04017962|460682199|FG000|Overall Study|Physician Decision|1|||
127545955|NCT02492763|458967538|FG002|Overall Study|Withdrawal by Subject|1|||
127545956|NCT02492763|458967539|FG003|Overall Study|Withdrawal by Subject|0|||
127545957|NCT02492763|458967536|FG000|Overall Study|Adverse Event|3|||
127545958|NCT02492763|458967537|FG001|Overall Study|Adverse Event|1|||
127545959|NCT02492763|458967538|FG002|Overall Study|Adverse Event|1|||
127545960|NCT02492763|458967539|FG003|Overall Study|Adverse Event|2|||
127545961|NCT02492763|458967536|FG000|Overall Study|Death|0|||
127545962|NCT02492763|458967537|FG001|Overall Study|Death|0|||
127545963|NCT02492763|458967538|FG002|Overall Study|Death|1|||
127545964|NCT02492763|458967539|FG003|Overall Study|Death|0|||
127545965|NCT02492763|458967536|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
127545966|NCT02492763|458967537|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
127545967|NCT02492763|458967538|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
127545968|NCT02492763|458967539|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
127545969|NCT02492763|458967536|FG000|Overall Study|Lost to Follow-up|0|||
127545970|NCT02492763|458967537|FG001|Overall Study|Lost to Follow-up|0|||
127545971|NCT02492763|458967538|FG002|Overall Study|Lost to Follow-up|1|||
127545972|NCT02492763|458967539|FG003|Overall Study|Lost to Follow-up|0|||
127545973|NCT02492763|458967536|FG000|Overall Study|Non-Compliance With Study Drug|0|||
127545974|NCT02492763|458967537|FG001|Overall Study|Non-Compliance With Study Drug|1|||
127545975|NCT02492763|458967538|FG002|Overall Study|Non-Compliance With Study Drug|0|||
127545976|NCT02492763|458967539|FG003|Overall Study|Non-Compliance With Study Drug|0|||
127545977|NCT02492763|458967536|FG000|Overall Study|Screen Failure|0|||
127545978|NCT02492763|458967537|FG001|Overall Study|Screen Failure|0|||
127545979|NCT02492763|458967538|FG002|Overall Study|Screen Failure|0|||
127545980|NCT02492763|458967539|FG003|Overall Study|Screen Failure|1|||
127545981|NCT02492763|458967536|FG000|Overall Study|Study Terminated by Sponsor|13|||
127545982|NCT02492763|458967537|FG001|Overall Study|Study Terminated by Sponsor|10|||
127545983|NCT02492763|458967538|FG002|Overall Study|Study Terminated by Sponsor|6|||
127545984|NCT02492763|458967539|FG003|Overall Study|Study Terminated by Sponsor|10|||
127545985|NCT01747876|458967540|FG000|Overall Study|Adverse Event|1|||
127545986|NCT01747876|458967541|FG001|Overall Study|Adverse Event|0|||
128015985|NCT04017962|460682200|FG001|Overall Study|Physician Decision|0|||
128015986|NCT04017962|460682199|FG000|Overall Study|Discontinued LTV|5|||
127545987|NCT01747876|458967542|FG002|Overall Study|Adverse Event|2|||
127545988|NCT01747876|458967540|FG000|Overall Study|Withdrawal by Subject|0|||
127545989|NCT01747876|458967541|FG001|Overall Study|Withdrawal by Subject|1|||
127545990|NCT01747876|458967542|FG002|Overall Study|Withdrawal by Subject|1|||
127545991|NCT01747876|458967540|FG000|Overall Study|Disease progression|4|||
127545992|NCT01747876|458967541|FG001|Overall Study|Disease progression|13|||
127545993|NCT01747876|458967542|FG002|Overall Study|Disease progression|8|||
127545994|NCT01747876|458967540|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
127545995|NCT01747876|458967541|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
127545996|NCT01747876|458967542|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
127545997|NCT02379728|458967545|FG000|Overall Study|Lost to Follow-up|1|||
127545998|NCT02379728|458967546|FG001|Overall Study|Lost to Follow-up|0|||
127545999|NCT02379728|458967547|FG002|Overall Study|Lost to Follow-up|3|||
127546000|NCT02379728|458967548|FG003|Overall Study|Lost to Follow-up|0|||
127546001|NCT02379728|458967545|FG000|Overall Study|Withdrawal by Subject|5|||
127546002|NCT02379728|458967546|FG001|Overall Study|Withdrawal by Subject|0|||
127546003|NCT02379728|458967547|FG002|Overall Study|Withdrawal by Subject|5|||
127681796|NCT00814346|459460625|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
127681797|NCT00814346|459460626|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
127681798|NCT00814346|459460625|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
127681799|NCT00814346|459460626|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
127681800|NCT03622580|459460632|FG000|Overall Study|Death|16|||
127681801|NCT03622580|459460633|FG001|Overall Study|Death|21|||
127681802|NCT03622580|459460634|FG002|Overall Study|Death|13|||
127681803|NCT03622580|459460632|FG000|Overall Study|Adverse Event|6|||
127681804|NCT03622580|459460633|FG001|Overall Study|Adverse Event|6|||
127681805|NCT03622580|459460634|FG002|Overall Study|Adverse Event|5|||
127681806|NCT03622580|459460632|FG000|Overall Study|Withdrawal by Subject|12|||
127681807|NCT03622580|459460633|FG001|Overall Study|Withdrawal by Subject|7|||
127681808|NCT03622580|459460634|FG002|Overall Study|Withdrawal by Subject|19|||
127681809|NCT03622580|459460632|FG000|Overall Study|Lost to Follow-up|12|||
127681810|NCT03622580|459460633|FG001|Overall Study|Lost to Follow-up|9|||
127681811|NCT03622580|459460634|FG002|Overall Study|Lost to Follow-up|9|||
127681812|NCT03622580|459460632|FG000|Overall Study|Protocol Violation|1|||
127681813|NCT03622580|459460633|FG001|Overall Study|Protocol Violation|0|||
127681814|NCT03622580|459460634|FG002|Overall Study|Protocol Violation|1|||
127681815|NCT03622580|459460632|FG000|Overall Study|Physician Decision|3|||
127681816|NCT03622580|459460633|FG001|Overall Study|Physician Decision|0|||
127681817|NCT03622580|459460634|FG002|Overall Study|Physician Decision|1|||
127681818|NCT03622580|459460632|FG000|Overall Study|Pregnancy|0|||
127681819|NCT03622580|459460633|FG001|Overall Study|Pregnancy|1|||
127681820|NCT03622580|459460634|FG002|Overall Study|Pregnancy|0|||
127681821|NCT03622580|459460632|FG000|Overall Study|Lack of Efficacy|0|||
127681822|NCT03622580|459460633|FG001|Overall Study|Lack of Efficacy|0|||
127681823|NCT03622580|459460634|FG002|Overall Study|Lack of Efficacy|1|||
127681824|NCT03622580|459460632|FG000|Overall Study|Other|2|||
127681825|NCT03622580|459460633|FG001|Overall Study|Other|0|||
127681826|NCT03622580|459460634|FG002|Overall Study|Other|3|||
127681827|NCT05136443|459460635|FG000|Overall Study|Lost to Follow-up|2|||
127681828|NCT05136443|459460635|FG000|Overall Study|Adverse Event|2|||
127681829|NCT02613871|459460640|FG000|Overall Study|Death|2|||
127681830|NCT02613871|459460640|FG000|Overall Study|Withdrew Consent|1|||
127681831|NCT01930045|459460641|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
127681832|NCT01930045|459460642|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
127681833|NCT01930045|459460643|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
127681834|NCT01930045|459460644|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
127681835|NCT01930045|459460645|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
127681836|NCT01930045|459460646|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
127681837|NCT01930045|459460641|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
127681838|NCT01930045|459460642|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
127681839|NCT01930045|459460643|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
127681840|NCT01930045|459460644|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
127681841|NCT01930045|459460645|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
127681842|NCT01930045|459460646|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
127681843|NCT00494442|459460647|FG000|Overall Study|Death|1|||
127681844|NCT00494442|459460648|FG001|Overall Study|Death|1|||
127681845|NCT00494442|459460647|FG000|Overall Study|Lack of Efficacy|16|||
127681846|NCT00494442|459460648|FG001|Overall Study|Lack of Efficacy|10|||
127681847|NCT00494442|459460647|FG000|Overall Study|Adverse Event|0|||
127681848|NCT00494442|459460648|FG001|Overall Study|Adverse Event|2|||
127681849|NCT00494442|459460647|FG000|Overall Study|Physician Decision|0|||
127681850|NCT00494442|459460648|FG001|Overall Study|Physician Decision|1|||
127681851|NCT00494442|459460647|FG000|Overall Study|Non-compliance|0|||
127681852|NCT00494442|459460648|FG001|Overall Study|Non-compliance|1|||
127681853|NCT00494442|459460647|FG000|Overall Study|Intercurrent illness|0|||
127681854|NCT00494442|459460648|FG001|Overall Study|Intercurrent illness|1|||
127681855|NCT00831415|459460649|FG000|Overall Study|Adverse Event|14|||
127681856|NCT00831415|459460649|FG000|Overall Study|Failed to return|3|||
127681857|NCT00831415|459460649|FG000|Overall Study|Physician Decision|6|||
127681858|NCT00831415|459460649|FG000|Overall Study|Lost to Follow-up|9|||
127681859|NCT00831415|459460649|FG000|Overall Study|Protocol Violation|3|||
127681860|NCT00831415|459460649|FG000|Overall Study|Withdrawal by Subject|35|||
127681861|NCT00831415|459460649|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
127681862|NCT00831415|459460649|FG000|Overall Study|Death|1|||
127681863|NCT03034915|459460652|FG000|Overall Study|Adverse Event|29|||
127681864|NCT03034915|459460653|FG001|Overall Study|Adverse Event|32|||
127681865|NCT03034915|459460654|FG002|Overall Study|Adverse Event|22|||
127681866|NCT03034915|459460652|FG000|Overall Study|Lost to Follow-up|5|||
127681867|NCT03034915|459460653|FG001|Overall Study|Lost to Follow-up|13|||
127681868|NCT03034915|459460654|FG002|Overall Study|Lost to Follow-up|3|||
127681869|NCT03034915|459460652|FG000|Overall Study|Withdrawal by Subject|29|||
127681870|NCT03034915|459460653|FG001|Overall Study|Withdrawal by Subject|46|||
127681871|NCT03034915|459460654|FG002|Overall Study|Withdrawal by Subject|41|||
127681872|NCT03034915|459460652|FG000|Overall Study|Protocol Deviation|2|||
127681873|NCT03034915|459460653|FG001|Overall Study|Protocol Deviation|14|||
127681874|NCT03034915|459460654|FG002|Overall Study|Protocol Deviation|7|||
127681875|NCT03034915|459460652|FG000|Overall Study|Lack of Efficacy|8|||
127681876|NCT03034915|459460653|FG001|Overall Study|Lack of Efficacy|16|||
127681877|NCT03034915|459460654|FG002|Overall Study|Lack of Efficacy|18|||
127681878|NCT03034915|459460652|FG000|Overall Study|Site closed|2|||
127681879|NCT03034915|459460653|FG001|Overall Study|Site closed|2|||
127681880|NCT03034915|459460654|FG002|Overall Study|Site closed|4|||
127681881|NCT03034915|459460652|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
127681882|NCT03034915|459460653|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
127681883|NCT03034915|459460654|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
127681884|NCT03034915|459460652|FG000|Overall Study|Physician Decision|1|||
127681885|NCT03034915|459460653|FG001|Overall Study|Physician Decision|5|||
127681886|NCT03034915|459460654|FG002|Overall Study|Physician Decision|2|||
127681887|NCT03861767|459460657|FG000|Overall Study|Withdrawal by Subject|2|||
127681888|NCT03861767|459460658|FG001|Overall Study|Withdrawal by Subject|1|||
127681889|NCT03861767|459460659|FG002|Overall Study|Withdrawal by Subject|0|||
127681890|NCT03861767|459460660|FG003|Overall Study|Withdrawal by Subject|5|||
127681891|NCT03861767|459460661|FG004|Overall Study|Withdrawal by Subject|2|||
127681892|NCT03861767|459460662|FG005|Overall Study|Withdrawal by Subject|1|||
128015987|NCT04017962|460682200|FG001|Overall Study|Discontinued LTV|0|||
127681893|NCT03861767|459460663|FG006|Overall Study|Withdrawal by Subject|3|||
127681894|NCT03861767|459460664|FG007|Overall Study|Withdrawal by Subject|1|||
127681895|NCT03861767|459460665|FG008|Overall Study|Withdrawal by Subject|0|||
127681896|NCT03861767|459460666|FG009|Overall Study|Withdrawal by Subject|5|||
127546004|NCT02379728|458967548|FG003|Overall Study|Withdrawal by Subject|3|||
127546005|NCT02379728|458967545|FG000|Overall Study|Protocol Violation|0|||
127546006|NCT02379728|458967546|FG001|Overall Study|Protocol Violation|0|||
127546007|NCT02379728|458967547|FG002|Overall Study|Protocol Violation|2|||
127546008|NCT02379728|458967548|FG003|Overall Study|Protocol Violation|0|||
127546009|NCT05101122|458967549|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
127546010|NCT05101122|458967549|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
127546011|NCT05101122|458967549|FG000|AD313 80/5|Withdrawal by Subject|1|||
127681897|NCT01087762|459460667|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
127681898|NCT01087762|459460668|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
127681899|NCT01087762|459460669|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
127681900|NCT01087762|459460670|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
127681901|NCT01087762|459460671|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
127681902|NCT01087762|459460667|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
127681903|NCT01087762|459460668|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
127681904|NCT01087762|459460669|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
127681905|NCT01087762|459460670|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
127681906|NCT01087762|459460671|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
127681907|NCT01087762|459460667|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
127681908|NCT01087762|459460668|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
127681909|NCT01087762|459460669|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
127681910|NCT01087762|459460670|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
127681911|NCT01087762|459460671|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
127681912|NCT01087762|459460667|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
127681913|NCT01087762|459460668|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
127681914|NCT01087762|459460669|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
127681915|NCT01087762|459460670|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
127681916|NCT01087762|459460671|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
127681917|NCT01087762|459460667|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
127681918|NCT01087762|459460668|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
127681919|NCT01087762|459460669|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
127681920|NCT01087762|459460670|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
127681921|NCT01087762|459460671|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
127681922|NCT01087762|459460667|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
127681923|NCT01087762|459460668|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
127681924|NCT01087762|459460669|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
127681925|NCT01087762|459460670|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
127681926|NCT01087762|459460671|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
127681927|NCT01087762|459460667|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
127681928|NCT01087762|459460668|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
127681929|NCT01087762|459460669|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
127681930|NCT01087762|459460670|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
127681931|NCT01087762|459460671|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
127681932|NCT01087762|459460667|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
127681933|NCT01087762|459460668|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
127681934|NCT01087762|459460669|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
127681935|NCT01087762|459460670|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
127681936|NCT01087762|459460671|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
127681937|NCT01087762|459460667|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
127681938|NCT01087762|459460668|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
127681939|NCT01087762|459460669|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
127681940|NCT01087762|459460670|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
127681941|NCT01087762|459460671|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
127681942|NCT01087762|459460667|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
127681943|NCT01087762|459460668|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
127681944|NCT01087762|459460669|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
127681945|NCT01087762|459460670|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
127681946|NCT01087762|459460671|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
127681947|NCT01087762|459460667|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
127681948|NCT01087762|459460668|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
127681949|NCT01087762|459460669|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
127681950|NCT01087762|459460670|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
127681951|NCT01087762|459460671|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
127681952|NCT01087762|459460667|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
127681953|NCT01087762|459460668|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
127681954|NCT01087762|459460669|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
127546012|NCT05101122|458967549|FG000|AD313 80/10|Physician Decision|1|||
127546013|NCT03131219|458967551|FG000|Initial Evaluation Period|Adverse Event|2|||
127546014|NCT03131219|458967552|FG001|Initial Evaluation Period|Adverse Event|0|||
127546015|NCT03131219|458967551|FG000|Initial Evaluation Period|Protocol Violation|1|||
127546016|NCT03131219|458967552|FG001|Initial Evaluation Period|Protocol Violation|0|||
127546017|NCT03131219|458967551|FG000|Initial Evaluation Period|Deemed Ineligible Post Treatment|3|||
127546018|NCT03131219|458967552|FG001|Initial Evaluation Period|Deemed Ineligible Post Treatment|0|||
127546019|NCT03131219|458967551|FG000|Initial Evaluation Period|Physician Decision|1|||
127546020|NCT03131219|458967552|FG001|Initial Evaluation Period|Physician Decision|0|||
127546021|NCT03131219|458967551|FG000|Extension Period|Physician Decision|1|||
127546022|NCT03131219|458967552|FG001|Extension Period|Physician Decision|0|||
127546023|NCT01391546|458967556|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
127546024|NCT01391546|458967557|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
127546025|NCT04945733|458967558|FG000|Overall Study|Physician Decision|1|||
127546026|NCT04945733|458967559|FG001|Overall Study|Physician Decision|3|||
127546027|NCT04945733|458967560|FG002|Overall Study|Physician Decision|0|||
127546028|NCT04945733|458967558|FG000|Overall Study|Withdrawal by Subject|3|||
127546029|NCT04945733|458967559|FG001|Overall Study|Withdrawal by Subject|3|||
127546030|NCT04945733|458967560|FG002|Overall Study|Withdrawal by Subject|0|||
127546031|NCT05660577|458967563|FG000|Overall Study|Discontinued|9|||
127546032|NCT03363841|458967564|FG000|Overall Study|Adverse Event|1|||
127546033|NCT03363841|458967564|FG000|Overall Study|Withdrawal by Subject|1|||
127546034|NCT03363841|458967564|FG000|Overall Study|Death|7|||
127546035|NCT03363841|458967564|FG000|Overall Study|Physician Decision|1|||
127546036|NCT01744977|458967565|FG000|Overall Study|Withdrawal by Subject|1|||
127546037|NCT01744977|458967566|FG001|Overall Study|Withdrawal by Subject|2|||
127546038|NCT01744977|458967565|FG000|Overall Study|Death|2|||
127546039|NCT01744977|458967566|FG001|Overall Study|Death|3|||
127546040|NCT01744977|458967565|FG000|Overall Study|Lost to Follow-up|2|||
127546041|NCT01744977|458967566|FG001|Overall Study|Lost to Follow-up|0|||
127546042|NCT01744977|458967565|FG000|Overall Study|No longer meets inclusion|6|||
127546043|NCT01744977|458967566|FG001|Overall Study|No longer meets inclusion|0|||
127546044|NCT02156076|458967569|FG000|Treatment Period|no longer meets study criteria|0|||
127546045|NCT02156076|458967570|FG001|Treatment Period|no longer meets study criteria|0|||
127546046|NCT02156076|458967571|FG002|Treatment Period|no longer meets study criteria|1|||
127546047|NCT02156076|458967572|FG003|Treatment Period|no longer meets study criteria|0|||
127546048|NCT02156076|458967569|FG000|Treatment Period|Poor/non-compliance|0|||
127546049|NCT02156076|458967570|FG001|Treatment Period|Poor/non-compliance|1|||
127546050|NCT02156076|458967571|FG002|Treatment Period|Poor/non-compliance|0|||
127546051|NCT02156076|458967572|FG003|Treatment Period|Poor/non-compliance|0|||
127546052|NCT02156076|458967569|FG000|Treatment Period|Lost to Follow-up|0|||
127546053|NCT02156076|458967570|FG001|Treatment Period|Lost to Follow-up|0|||
127546054|NCT02156076|458967571|FG002|Treatment Period|Lost to Follow-up|0|||
127546055|NCT02156076|458967572|FG003|Treatment Period|Lost to Follow-up|1|||
127546056|NCT02156076|458967569|FG000|Treatment Period|Withdrawal by Subject|0|||
127546057|NCT02156076|458967570|FG001|Treatment Period|Withdrawal by Subject|0|||
127546058|NCT02156076|458967571|FG002|Treatment Period|Withdrawal by Subject|1|||
127546059|NCT02156076|458967572|FG003|Treatment Period|Withdrawal by Subject|0|||
127546060|NCT02156076|458967569|FG000|Treatment Period|Subject request to discontinue treatment|0|||
127546061|NCT02156076|458967570|FG001|Treatment Period|Subject request to discontinue treatment|1|||
127546062|NCT02156076|458967571|FG002|Treatment Period|Subject request to discontinue treatment|0|||
127546063|NCT02156076|458967572|FG003|Treatment Period|Subject request to discontinue treatment|0|||
127546064|NCT02156076|458967569|FG000|Treatment Period|Adverse Event|0|||
127546065|NCT02156076|458967570|FG001|Treatment Period|Adverse Event|0|||
127546066|NCT02156076|458967571|FG002|Treatment Period|Adverse Event|0|||
127546067|NCT02156076|458967572|FG003|Treatment Period|Adverse Event|1|||
127546068|NCT02156076|458967569|FG000|Follow-up Period|Withdrawal by Subject|1|||
127546069|NCT02156076|458967570|FG001|Follow-up Period|Withdrawal by Subject|0|||
127546070|NCT02156076|458967571|FG002|Follow-up Period|Withdrawal by Subject|0|||
127546071|NCT02156076|458967572|FG003|Follow-up Period|Withdrawal by Subject|0|||
127546072|NCT02085460|458967573|FG000|Overall Study|Adverse Event|2|||
127681955|NCT01087762|459460670|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
127681956|NCT01087762|459460671|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
127546073|NCT02085460|458967574|FG001|Overall Study|Adverse Event|2|||
127546074|NCT02085460|458967575|FG002|Overall Study|Adverse Event|1|||
127546075|NCT02085460|458967573|FG000|Overall Study|Physician Decision|1|||
127546076|NCT02085460|458967574|FG001|Overall Study|Physician Decision|1|||
127546077|NCT02085460|458967575|FG002|Overall Study|Physician Decision|2|||
127546078|NCT02085460|458967573|FG000|Overall Study|Withdrawal by Subject|11|||
127546079|NCT02085460|458967574|FG001|Overall Study|Withdrawal by Subject|5|||
127546080|NCT02085460|458967575|FG002|Overall Study|Withdrawal by Subject|7|||
127546081|NCT02703597|458967576|FG000|Assignment to Baseline|Lost to Follow-up|17|||
127546082|NCT02703597|458967577|FG001|Assignment to Baseline|Lost to Follow-up|16|||
127546083|NCT02703597|458967576|FG000|Baseline to First Post-test|Lost to Follow-up|61|||
127546084|NCT02703597|458967577|FG001|Baseline to First Post-test|Lost to Follow-up|92|||
127546085|NCT02703597|458967576|FG000|First Post-test to First Follow-up|Lost to Follow-up|5|||
127546086|NCT02703597|458967577|FG001|First Post-test to First Follow-up|Lost to Follow-up|3|||
127546087|NCT02703597|458967576|FG000|First Post-test to First Follow-up|Site drop out|0|||
127546088|NCT02703597|458967577|FG001|First Post-test to First Follow-up|Site drop out|58|||
127546089|NCT02703597|458967576|FG000|Recruitment Period for Assessment 5|Withdrawal by Site|16|||
127546090|NCT02703597|458967577|FG001|Recruitment Period for Assessment 5|Withdrawal by Site|0|||
127546091|NCT02703597|458967576|FG000|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|0|||
127546092|NCT02703597|458967577|FG001|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|71|||
127546093|NCT02703597|458967576|FG000|Assessment 5 to Second Post-test|Lost to Follow-up|27|||
127546094|NCT02703597|458967577|FG001|Assessment 5 to Second Post-test|Lost to Follow-up|0|||
127546095|NCT00763035|458967578|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
127546096|NCT00763035|458967579|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
127546097|NCT00763035|458967578|FG000|First Intervention|Adverse Event|0|||
127546098|NCT00763035|458967579|FG001|First Intervention|Adverse Event|1|||
127546099|NCT00763035|458967578|FG000|Second Intervention|Adverse Event|1|||
127546100|NCT00763035|458967579|FG001|Second Intervention|Adverse Event|0|||
127546101|NCT00763035|458967578|FG000|Second Intervention|Physician Decision|2|||
127546102|NCT00763035|458967579|FG001|Second Intervention|Physician Decision|0|||
127546103|NCT02131259|458967580|FG000|Overall Study|Progressive disease|751|||
127546104|NCT02131259|458967580|FG000|Overall Study|Adverse Event|341|||
127546105|NCT02131259|458967580|FG000|Overall Study|Lost to Follow-up|7|||
127546106|NCT02131259|458967580|FG000|Overall Study|Relocation|32|||
127546107|NCT02131259|458967580|FG000|Overall Study|Other|63|||
127546108|NCT02131259|458967580|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
127546109|NCT02131259|458967580|FG000|Overall Study|Progressive disease/relocation|1|||
127546110|NCT02131259|458967580|FG000|Overall Study|Progressive disease/other|2|||
127546111|NCT02131259|458967580|FG000|Overall Study|AE/lost to follow-up|1|||
127546112|NCT02131259|458967580|FG000|Overall Study|AE/other|1|||
127546113|NCT02131259|458967580|FG000|Overall Study|Progressive disease/AE/other|1|||
127768323|NCT02527343|459778006|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
127768324|NCT02527343|459778007|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
127768325|NCT02527343|459778008|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
127768326|NCT02527343|459778003|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
127768327|NCT02527343|459778004|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
127768328|NCT02527343|459778005|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
127768329|NCT02527343|459778006|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
127768330|NCT02527343|459778007|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
127768331|NCT02527343|459778008|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
127768332|NCT02527343|459778003|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
127768333|NCT02527343|459778004|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
127681957|NCT01087762|459460667|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
127681958|NCT01087762|459460668|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
127681959|NCT01087762|459460669|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
127681960|NCT01087762|459460670|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
127681961|NCT01087762|459460671|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
127681962|NCT00813904|459460672|FG000|Overall Study|Death|1|||
127681963|NCT00424762|459460678|FG000|Overall Study|Withdrawal by Subject|18|||
127681964|NCT00424762|459460679|FG001|Overall Study|Withdrawal by Subject|19|||
127681965|NCT00424762|459460678|FG000|Overall Study|Lost to Follow-up|2|||
127681966|NCT00424762|459460679|FG001|Overall Study|Lost to Follow-up|3|||
127681967|NCT01147341|459460687|FG000|Double Blind Period|Lack of Efficacy|1|||
127681968|NCT01147341|459460688|FG001|Double Blind Period|Lack of Efficacy|1|||
127681969|NCT01147341|459460687|FG000|Double Blind Period|Withdrawal by Subject|0|||
127681970|NCT01147341|459460688|FG001|Double Blind Period|Withdrawal by Subject|1|||
127681971|NCT01147341|459460687|FG000|Open Label Period|Lack of Efficacy|3|||
127681972|NCT01147341|459460688|FG001|Open Label Period|Lack of Efficacy|0|||
127681973|NCT01147341|459460687|FG000|Open Label Period|Subject moved|1|||
127681974|NCT01147341|459460688|FG001|Open Label Period|Subject moved|0|||
127681975|NCT03478696|459460689|FG000|Overall Study|Adverse Event|1|||
127681976|NCT03478696|459460690|FG001|Overall Study|Adverse Event|5|||
127681977|NCT03478696|459460689|FG000|Overall Study|Lost to Follow-up|1|||
127681978|NCT03478696|459460690|FG001|Overall Study|Lost to Follow-up|0|||
127681979|NCT03478696|459460689|FG000|Overall Study|Physician Decision|6|||
127681980|NCT03478696|459460690|FG001|Overall Study|Physician Decision|3|||
127681981|NCT03478696|459460689|FG000|Overall Study|Withdrawal by Subject|9|||
127681982|NCT03478696|459460690|FG001|Overall Study|Withdrawal by Subject|4|||
127768334|NCT02527343|459778005|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
127546114|NCT02131259|458967580|FG000|Overall Study|Missing|3|||
127546115|NCT02796170|458967581|FG000|Overall Study|Lost to Follow-up|3|||
127546116|NCT02796170|458967582|FG001|Overall Study|Lost to Follow-up|0|||
127546117|NCT02161016|458967589|FG000|Overall Study|withdrawn by IRB|1|||
127681983|NCT03615924|459460691|FG000|Overall Study|Withdrawal by Subject|2|||
127681984|NCT03615924|459460692|FG001|Overall Study|Withdrawal by Subject|5|||
127681985|NCT03615924|459460691|FG000|Overall Study|Death|3|||
127546118|NCT00003475|458967590|FG000|Overall Study|Not evaluable|13|||
127546119|NCT03818321|458967591|FG000|Overall Study|Withdrawal by Subject|1|||
127546120|NCT03818321|458967592|FG001|Overall Study|Withdrawal by Subject|2|||
127546121|NCT03216226|458967593|FG000|Overall Study|Adverse Event|3|||
127546122|NCT03216226|458967594|FG001|Overall Study|Adverse Event|0|||
127546123|NCT03216226|458967593|FG000|Overall Study|Protocol Violation|1|||
127546124|NCT03216226|458967594|FG001|Overall Study|Protocol Violation|3|||
127546125|NCT03216226|458967593|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
127546126|NCT03216226|458967594|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
127546127|NCT03216226|458967593|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
127546128|NCT03216226|458967594|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
127546129|NCT03216226|458967593|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
127546130|NCT03216226|458967594|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
127546131|NCT05249582|458967597|FG000|Overall Study|Technical Problems with virtual reality prevented completion|2|||
127546132|NCT05249582|458967598|FG001|Overall Study|Technical Problems with virtual reality prevented completion|0|||
127546133|NCT05249582|458967597|FG000|Overall Study|Internet connectivity prevented completion of the condition|0|||
127546134|NCT05249582|458967598|FG001|Overall Study|Internet connectivity prevented completion of the condition|1|||
127546135|NCT05249582|458967597|FG000|Overall Study|Declined to use virtual reality headset|1|||
127546136|NCT05249582|458967598|FG001|Overall Study|Declined to use virtual reality headset|0|||
127546137|NCT03675126|458967599|FG000|Overall Study|Study Terminated by Sponsor|9|||
127546138|NCT03675126|458967599|FG000|Overall Study|Death|2|||
127546139|NCT03675126|458967599|FG000|Overall Study|Withdrawal by Subject|4|||
127546140|NCT00001959|458967600|FG000|Overall Study|newly diagnosed colon cancer|1|||
127546141|NCT00001959|458967600|FG000|Overall Study|disabling sedation|1|||
127546142|NCT00001959|458967600|FG000|Overall Study|non-compliance|1|||
127546143|NCT04189952|458967602|FG000|Follow-up Period|Death|1|||
127546144|NCT04189952|458967602|FG000|Follow-up Period|Withdrawal by Subject|1|||
127546145|NCT01052493|458967603|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
127546146|NCT01052493|458967604|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
127546147|NCT01052493|458967605|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
127546148|NCT00283296|458967607|FG000|Overall Study|in-home trial not completed|5|||
127546149|NCT05386329|458967610|FG000|Overall Study|Lost to Follow-up|3|||
127546150|NCT00737672|458967617|FG000|Overall Study|Graft Abandonment|48|||
127546151|NCT00737672|458967618|FG001|Overall Study|Graft Abandonment|56|||
127546152|NCT00737672|458967617|FG000|Overall Study|Death|23|||
127546153|NCT00737672|458967618|FG001|Overall Study|Death|22|||
127546154|NCT00737672|458967617|FG000|Overall Study|Withdrawal by Subject|1|||
127546155|NCT00737672|458967618|FG001|Overall Study|Withdrawal by Subject|2|||
127546156|NCT00737672|458967617|FG000|Overall Study|Lost to Follow-up|1|||
127546157|NCT00737672|458967618|FG001|Overall Study|Lost to Follow-up|0|||
127546158|NCT00737672|458967617|FG000|Overall Study|Miscellaneous|7|||
127546159|NCT00737672|458967618|FG001|Overall Study|Miscellaneous|1|||
127546160|NCT00737672|458967617|FG000|Overall Study|Physician Decision|0|||
127546161|NCT00737672|458967618|FG001|Overall Study|Physician Decision|2|||
127546162|NCT02694185|458967619|FG000|Overall Study|Withdrawal by Subject|45|||
127546163|NCT02694185|458967620|FG001|Overall Study|Withdrawal by Subject|0|||
127546164|NCT05972993|458967627|FG000|Overall Study|Lost to Follow-up|2|||
127546165|NCT05972993|458967628|FG001|Overall Study|Lost to Follow-up|0|||
127546166|NCT05972993|458967629|FG002|Overall Study|Lost to Follow-up|1|||
127546167|NCT05972993|458967630|FG003|Overall Study|Lost to Follow-up|0|||
127546168|NCT05972993|458967631|FG004|Overall Study|Lost to Follow-up|0|||
127546169|NCT05972993|458967632|FG005|Overall Study|Lost to Follow-up|0|||
127546170|NCT05972993|458967633|FG006|Overall Study|Lost to Follow-up|0|||
127546171|NCT05972993|458967634|FG007|Overall Study|Lost to Follow-up|2|||
127546172|NCT05972993|458967635|FG008|Overall Study|Lost to Follow-up|0|||
127546173|NCT03866577|458967636|FG000|Overall Study|Protocol Violation|0|||
127546174|NCT03866577|458967637|FG001|Overall Study|Protocol Violation|0|||
127546175|NCT03866577|458967638|FG002|Overall Study|Protocol Violation|0|||
127546176|NCT03866577|458967639|FG003|Overall Study|Protocol Violation|0|||
127546177|NCT03866577|458967640|FG004|Overall Study|Protocol Violation|0|||
127546178|NCT03866577|458967641|FG005|Overall Study|Protocol Violation|0|||
127546179|NCT03866577|458967642|FG006|Overall Study|Protocol Violation|0|||
127546180|NCT03866577|458967643|FG007|Overall Study|Protocol Violation|0|||
127681986|NCT03615924|459460692|FG001|Overall Study|Death|1|||
127681987|NCT03615924|459460691|FG000|Overall Study|Lost to Follow-up|1|||
127681988|NCT03615924|459460692|FG001|Overall Study|Lost to Follow-up|0|||
128015988|NCT00462462|460682208|FG000|Overall Study|Physician Decision|0|||
128015989|NCT00462462|460682209|FG001|Overall Study|Physician Decision|1|||
127546181|NCT03866577|458967644|FG008|Overall Study|Protocol Violation|0|||
127681989|NCT03615924|459460691|FG000|Overall Study|Randomized in error|1|||
128015990|NCT01163617|460682210|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
127546182|NCT03866577|458967645|FG009|Overall Study|Protocol Violation|0|||
127546183|NCT03866577|458967646|FG010|Overall Study|Protocol Violation|0|||
127681990|NCT03615924|459460692|FG001|Overall Study|Randomized in error|0|||
127546184|NCT03866577|458967647|FG011|Overall Study|Protocol Violation|1|||
127546185|NCT03866577|458967648|FG012|Overall Study|Protocol Violation|0|||
127546186|NCT03866577|458967636|FG000|Overall Study|Withdrawal by Subject|0|||
127546187|NCT03866577|458967637|FG001|Overall Study|Withdrawal by Subject|0|||
127546188|NCT03866577|458967638|FG002|Overall Study|Withdrawal by Subject|0|||
127546189|NCT03866577|458967639|FG003|Overall Study|Withdrawal by Subject|0|||
127546190|NCT03866577|458967640|FG004|Overall Study|Withdrawal by Subject|0|||
127546191|NCT03866577|458967641|FG005|Overall Study|Withdrawal by Subject|0|||
127546192|NCT03866577|458967642|FG006|Overall Study|Withdrawal by Subject|0|||
127546193|NCT03866577|458967643|FG007|Overall Study|Withdrawal by Subject|0|||
127546194|NCT03866577|458967644|FG008|Overall Study|Withdrawal by Subject|1|||
127546195|NCT03866577|458967645|FG009|Overall Study|Withdrawal by Subject|1|||
127546196|NCT03866577|458967646|FG010|Overall Study|Withdrawal by Subject|0|||
127546197|NCT03866577|458967647|FG011|Overall Study|Withdrawal by Subject|0|||
127546198|NCT03866577|458967648|FG012|Overall Study|Withdrawal by Subject|0|||
127546199|NCT03866577|458967636|FG000|Overall Study|Not qualified for IVIg infusion|0|||
127546200|NCT03866577|458967637|FG001|Overall Study|Not qualified for IVIg infusion|0|||
127546201|NCT03866577|458967638|FG002|Overall Study|Not qualified for IVIg infusion|0|||
127546202|NCT03866577|458967639|FG003|Overall Study|Not qualified for IVIg infusion|0|||
127546203|NCT03866577|458967640|FG004|Overall Study|Not qualified for IVIg infusion|0|||
127546204|NCT03866577|458967641|FG005|Overall Study|Not qualified for IVIg infusion|0|||
127546205|NCT03866577|458967642|FG006|Overall Study|Not qualified for IVIg infusion|0|||
127546206|NCT03866577|458967643|FG007|Overall Study|Not qualified for IVIg infusion|0|||
127546207|NCT03866577|458967644|FG008|Overall Study|Not qualified for IVIg infusion|0|||
127546208|NCT03866577|458967645|FG009|Overall Study|Not qualified for IVIg infusion|1|||
127546209|NCT03866577|458967646|FG010|Overall Study|Not qualified for IVIg infusion|0|||
127546210|NCT03866577|458967647|FG011|Overall Study|Not qualified for IVIg infusion|0|||
127546211|NCT03866577|458967648|FG012|Overall Study|Not qualified for IVIg infusion|0|||
127546212|NCT03818256|458967649|FG000|Overall Study|Withdrawal by Subject|2|||
127546213|NCT03818256|458967650|FG001|Overall Study|Withdrawal by Subject|2|||
127546214|NCT03818256|458967649|FG000|Overall Study|Adverse Event|3|||
127546215|NCT03818256|458967650|FG001|Overall Study|Adverse Event|1|||
127546216|NCT03818256|458967649|FG000|Overall Study|Lost to Follow-up|0|||
127546217|NCT03818256|458967650|FG001|Overall Study|Lost to Follow-up|5|||
127546218|NCT03818256|458967649|FG000|Overall Study|Gaining weight without prohibited medication vyvanse|1|||
127546219|NCT03818256|458967650|FG001|Overall Study|Gaining weight without prohibited medication vyvanse|0|||
127546220|NCT03818256|458967649|FG000|Overall Study|Not reporting for scheduled visits|1|||
127546221|NCT03818256|458967650|FG001|Overall Study|Not reporting for scheduled visits|0|||
127546222|NCT03818256|458967649|FG000|Overall Study|Non-compliant with investigational product|1|||
127546223|NCT03818256|458967650|FG001|Overall Study|Non-compliant with investigational product|0|||
127546224|NCT03043794|458967656|FG000|Overall Study|Lost to Follow-up|1|||
127546225|NCT05565742|458967657|FG000|Overall Study|Withdrawal by Subject|0|||
127546226|NCT05565742|458967658|FG001|Overall Study|Withdrawal by Subject|0|||
127546227|NCT05565742|458967659|FG002|Overall Study|Withdrawal by Subject|2|||
127546228|NCT05565742|458967660|FG003|Overall Study|Withdrawal by Subject|2|||
127546229|NCT05565742|458967661|FG004|Overall Study|Withdrawal by Subject|2|||
127546230|NCT05565742|458967657|FG000|Overall Study|Death|1|||
127546231|NCT05565742|458967658|FG001|Overall Study|Death|0|||
127546232|NCT05565742|458967659|FG002|Overall Study|Death|0|||
127546233|NCT05565742|458967660|FG003|Overall Study|Death|0|||
127546234|NCT05565742|458967661|FG004|Overall Study|Death|0|||
127546235|NCT05565742|458967657|FG000|Overall Study|Participant Travelled Abroad|0|||
127546236|NCT05565742|458967658|FG001|Overall Study|Participant Travelled Abroad|0|||
127546237|NCT05565742|458967659|FG002|Overall Study|Participant Travelled Abroad|0|||
127546238|NCT05565742|458967660|FG003|Overall Study|Participant Travelled Abroad|0|||
127546239|NCT05565742|458967661|FG004|Overall Study|Participant Travelled Abroad|1|||
127546240|NCT02855125|458967662|FG000|Overall Study|Withdrawal by Subject|2|||
127546241|NCT02855125|458967663|FG001|Overall Study|Withdrawal by Subject|2|||
127546242|NCT02855125|458967662|FG000|Overall Study|Clinical Disease Progression|5|||
127546243|NCT02855125|458967663|FG001|Overall Study|Clinical Disease Progression|4|||
127546244|NCT02855125|458967662|FG000|Overall Study|Radiologic Disease Progression|36|||
127546245|NCT02855125|458967663|FG001|Overall Study|Radiologic Disease Progression|39|||
127546246|NCT02855125|458967662|FG000|Overall Study|Adverse Event|11|||
127546247|NCT02855125|458967663|FG001|Overall Study|Adverse Event|7|||
127546248|NCT02855125|458967662|FG000|Overall Study|Physician Decision|1|||
127546249|NCT02855125|458967663|FG001|Overall Study|Physician Decision|0|||
127681991|NCT03615924|459460691|FG000|Overall Study|Study termination by Sponsor|94|||
127546250|NCT02855125|458967662|FG000|Overall Study|On Treatment|9|||
127681992|NCT03615924|459460692|FG001|Overall Study|Study termination by Sponsor|86|||
127546251|NCT02855125|458967663|FG001|Overall Study|On Treatment|11|||
127546252|NCT02855125|458967662|FG000|Overall Study|Randomized but not treated|0|||
127546253|NCT02855125|458967663|FG001|Overall Study|Randomized but not treated|1|||
127546254|NCT04467905|458967664|FG000|Overall Study|Baseline heart rate <110 bpm|0|||
127546255|NCT04467905|458967665|FG001|Overall Study|Baseline heart rate <110 bpm|0|||
127546256|NCT04467905|458967666|FG002|Overall Study|Baseline heart rate <110 bpm|5|||
127546257|NCT04467905|458967664|FG000|Overall Study|Conversion to SR|0|||
127546258|NCT04467905|458967665|FG001|Overall Study|Conversion to SR|0|||
127546259|NCT04467905|458967666|FG002|Overall Study|Conversion to SR|3|||
127546260|NCT04467905|458967664|FG000|Overall Study|Technical issue with Holter ECG|0|||
127546261|NCT04467905|458967665|FG001|Overall Study|Technical issue with Holter ECG|0|||
127546262|NCT04467905|458967666|FG002|Overall Study|Technical issue with Holter ECG|3|||
127546263|NCT04467905|458967664|FG000|Overall Study|Hemodynamic instability|0|||
127546264|NCT04467905|458967665|FG001|Overall Study|Hemodynamic instability|0|||
127546265|NCT04467905|458967666|FG002|Overall Study|Hemodynamic instability|1|||
127546266|NCT04467905|458967664|FG000|Overall Study|Site misinterpretation of protocol|0|||
127546267|NCT04467905|458967665|FG001|Overall Study|Site misinterpretation of protocol|0|||
127546268|NCT04467905|458967666|FG002|Overall Study|Site misinterpretation of protocol|1|||
127546269|NCT04586205|458967670|FG000|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|1|||
127546270|NCT04586205|458967671|FG001|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|2|||
127546271|NCT01586364|458969882|FG000|Overall Study|Withdrawal by Subject|40|||
127546272|NCT01586364|458969882|FG000|Overall Study|Adverse Event|37|||
127546273|NCT01586364|458969882|FG000|Overall Study|Lost to Follow-up|17|||
127546274|NCT01586364|458969882|FG000|Overall Study|Protocol Violation|16|||
127546275|NCT01586364|458969882|FG000|Overall Study|Lack of Efficacy|1|||
127546276|NCT01586364|458969882|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
127546277|NCT01586364|458969882|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
127546278|NCT01586364|458969882|FG000|Overall Study|Other-Site closure due to PI illness|1|||
127546279|NCT01586364|458969882|FG000|Overall Study|Other-PI discretion, site closing|2|||
127546280|NCT01586364|458969882|FG000|Overall Study|Other-Not specified|1|||
127546281|NCT02121535|458969883|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
127546282|NCT02121535|458969884|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
127546283|NCT02121535|458969883|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
127546284|NCT02121535|458969884|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
127546285|NCT00091949|458969885|FG000|Overall Study|Withdrawal by Subject|117|||
127546286|NCT00091949|458969886|FG001|Overall Study|Withdrawal by Subject|110|||
127546287|NCT00091949|458969885|FG000|Overall Study|Lost to Follow-up|58|||
127546288|NCT00091949|458969886|FG001|Overall Study|Lost to Follow-up|41|||
127546289|NCT02083354|458969887|FG000|Overall Study|Withdrawal by Subject|9|||
127546290|NCT02083354|458969887|FG000|Overall Study|Lost to Follow-up|1|||
127546291|NCT02083354|458969887|FG000|Overall Study|Adverse Event|3|||
127546292|NCT02083354|458969887|FG000|Overall Study|Disease progression|46|||
127546293|NCT02083354|458969887|FG000|Overall Study|Study closed/terminated|5|||
127546294|NCT05291520|458969888|FG000|Overall Study|Lost to Follow-up|0|||
127546295|NCT05291520|458969889|FG001|Overall Study|Lost to Follow-up|0|||
127546296|NCT05291520|458969890|FG002|Overall Study|Lost to Follow-up|1|||
127546297|NCT01347112|458969891|FG000|Overall Study|Withdrawal by Subject|1|||
127546298|NCT01347112|458969892|FG001|Overall Study|Withdrawal by Subject|7|||
127546299|NCT01347112|458969891|FG000|Overall Study|Lost to Follow-up|3|||
127546300|NCT01347112|458969892|FG001|Overall Study|Lost to Follow-up|5|||
127546301|NCT00696072|458969897|FG000|Overall Study|continuing active treatment|10|||
127546302|NCT00696072|458969898|FG001|Overall Study|continuing active treatment|13|||
127546303|NCT00696072|458969897|FG000|Overall Study|Adverse Event|10|||
127546304|NCT00696072|458969898|FG001|Overall Study|Adverse Event|6|||
127546305|NCT00696072|458969897|FG000|Overall Study|Patient Request|3|||
127546306|NCT00696072|458969898|FG001|Overall Study|Patient Request|7|||
127546307|NCT00696072|458969897|FG000|Overall Study|Investigator Request|1|||
127546308|NCT00696072|458969898|FG001|Overall Study|Investigator Request|4|||
127546309|NCT00696072|458969897|FG000|Overall Study|Sponsor Request|0|||
127546310|NCT00696072|458969898|FG001|Overall Study|Sponsor Request|1|||
127546311|NCT00696072|458969897|FG000|Overall Study|Disease Progression|32|||
127546312|NCT00696072|458969898|FG001|Overall Study|Disease Progression|30|||
127546313|NCT00696072|458969897|FG000|Overall Study|Non-specified|1|||
127681993|NCT02808338|459460700|FG000|Screening|Screen Failure|10|||
127681994|NCT02808338|459460700|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
127681995|NCT02808338|459460700|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
127681996|NCT00057837|459460701|FG000|Overall Study|Progression/relapse|12|||
127681997|NCT00057837|459460702|FG001|Overall Study|Progression/relapse|14|||
128015991|NCT01163617|460682211|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
128015992|NCT01163617|460682212|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
127546314|NCT00696072|458969898|FG001|Overall Study|Non-specified|2|||
127546315|NCT02419001|458969907|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
127546316|NCT02419001|458969908|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
127546317|NCT00313014|458969909|FG000|Overall Study|Withdrawal by Subject|11|||
127546318|NCT00313014|458969910|FG001|Overall Study|Withdrawal by Subject|7|||
127546319|NCT00313014|458969911|FG002|Overall Study|Withdrawal by Subject|5|||
127546320|NCT00313014|458969909|FG000|Overall Study|Adverse Event|14|||
127681998|NCT00057837|459460701|FG000|Overall Study|Adverse Event|2|||
127546321|NCT00313014|458969910|FG001|Overall Study|Adverse Event|29|||
127546322|NCT00313014|458969911|FG002|Overall Study|Adverse Event|16|||
127546323|NCT00313014|458969909|FG000|Overall Study|Lost to Follow-up|7|||
127546324|NCT00313014|458969910|FG001|Overall Study|Lost to Follow-up|6|||
127546325|NCT00313014|458969911|FG002|Overall Study|Lost to Follow-up|10|||
127546326|NCT00313014|458969909|FG000|Overall Study|Administrative|9|||
127546327|NCT00313014|458969910|FG001|Overall Study|Administrative|6|||
127546328|NCT00313014|458969911|FG002|Overall Study|Administrative|14|||
127546329|NCT00313014|458969909|FG000|Overall Study|Lack of Efficacy|52|||
127546330|NCT00313014|458969910|FG001|Overall Study|Lack of Efficacy|25|||
127546331|NCT00313014|458969911|FG002|Overall Study|Lack of Efficacy|16|||
127546332|NCT01198795|458969914|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
127546333|NCT01198795|458969914|FG000|Overall Study|Withdrawal by Subject|17|||
127546334|NCT01198795|458969914|FG000|Overall Study|Lost to Follow-up|15|||
127546335|NCT01198795|458969914|FG000|Overall Study|Adverse Event|9|||
127546336|NCT01198795|458969914|FG000|Overall Study|Lack of Efficacy|5|||
127546337|NCT01198795|458969914|FG000|Overall Study|Protocol Violation|2|||
127546338|NCT01198795|458969914|FG000|Overall Study|Other Reason|4|||
127546339|NCT00936715|458969917|FG000|Overall Study|Investigators Discretion|1|||
127546340|NCT00936715|458969917|FG000|Overall Study|Protocol Violation|1|||
127546341|NCT00936715|458969917|FG000|Overall Study|Safety or Tolerability Reasons|4|||
127546342|NCT01337960|458969918|FG000|Overall Study|Lost to Follow-up|1|||
127546343|NCT01337960|458969919|FG001|Overall Study|Lost to Follow-up|0|||
127546344|NCT01337960|458969920|FG002|Overall Study|Lost to Follow-up|0|||
127546345|NCT01337960|458969918|FG000|Overall Study|Withdrawal by Subject|1|||
127546346|NCT01337960|458969919|FG001|Overall Study|Withdrawal by Subject|0|||
127546347|NCT01337960|458969920|FG002|Overall Study|Withdrawal by Subject|0|||
127546348|NCT01772316|458969921|FG000|Overall Study|Serious adverse event|1|||
127546349|NCT01772316|458969921|FG000|Overall Study|Inform consent withdrawn|1|||
127546350|NCT01772316|458969921|FG000|Overall Study|Withdrawn by sponsor decision|5|||
127546351|NCT00914316|458969925|FG000|Phase 1|Physician Decision|4|||
127546352|NCT00914316|458969926|FG001|Phase 1|Physician Decision|0|||
127546353|NCT00914316|458969927|FG002|Phase 1|Physician Decision|1|||
127546354|NCT00914316|458969928|FG003|Phase 1|Physician Decision|2|||
127546355|NCT00914316|458969925|FG000|Phase 1|Withdrawal by Subject|0|||
127546356|NCT00914316|458969926|FG001|Phase 1|Withdrawal by Subject|2|||
127546357|NCT00914316|458969927|FG002|Phase 1|Withdrawal by Subject|4|||
127546358|NCT00914316|458969928|FG003|Phase 1|Withdrawal by Subject|0|||
127546359|NCT00914316|458969925|FG000|Phase 1|Adverse Event|1|||
127546360|NCT00914316|458969926|FG001|Phase 1|Adverse Event|0|||
127546361|NCT00914316|458969927|FG002|Phase 1|Adverse Event|0|||
127546362|NCT00914316|458969928|FG003|Phase 1|Adverse Event|0|||
127546363|NCT00914316|458969925|FG000|Phase 2|Withdrawal by Subject|1|||
127546364|NCT00914316|458969926|FG001|Phase 2|Withdrawal by Subject|0|||
127546365|NCT00914316|458969927|FG002|Phase 2|Withdrawal by Subject|1|||
127546366|NCT00914316|458969928|FG003|Phase 2|Withdrawal by Subject|0|||
127546367|NCT01213472|458969939|FG000|Overall Study|Recurrence/Progressive disease|25|||
127546368|NCT01213472|458969939|FG000|Overall Study|Withdrawal by Subject|1|||
127546369|NCT01213472|458969939|FG000|Overall Study|Physician Decision|1|||
127546370|NCT04225897|458969945|FG000|Part A (Screening Visit to Day 7)|Adverse Event|0|||
127546371|NCT04225897|458969946|FG001|Part A (Screening Visit to Day 7)|Adverse Event|1|||
127546372|NCT04225897|458969947|FG002|Part A (Screening Visit to Day 7)|Adverse Event|0|||
127546373|NCT04225897|458969948|FG003|Part A (Screening Visit to Day 7)|Adverse Event|0|||
127546374|NCT04225897|458969949|FG004|Part A (Screening Visit to Day 7)|Adverse Event|0|||
127546375|NCT04225897|458969950|FG005|Part A (Screening Visit to Day 7)|Adverse Event|0|||
127546376|NCT04225897|458969951|FG006|Part A (Screening Visit to Day 7)|Adverse Event|0|||
127681999|NCT00057837|459460702|FG001|Overall Study|Adverse Event|12|||
127682000|NCT00057837|459460701|FG000|Overall Study|Death|5|||
127682001|NCT00057837|459460702|FG001|Overall Study|Death|4|||
127682002|NCT00057837|459460701|FG000|Overall Study|Withdrawal by Subject|5|||
127682003|NCT00057837|459460702|FG001|Overall Study|Withdrawal by Subject|3|||
127682004|NCT00057837|459460701|FG000|Overall Study|Alternative therapy|0|||
127682005|NCT00057837|459460702|FG001|Overall Study|Alternative therapy|1|||
127682006|NCT00057837|459460701|FG000|Overall Study|Other complicating disease|2|||
127682007|NCT00057837|459460702|FG001|Overall Study|Other complicating disease|1|||
127682008|NCT00057837|459460701|FG000|Overall Study|Physician Decision|1|||
127682009|NCT00057837|459460702|FG001|Overall Study|Physician Decision|0|||
127682010|NCT00057837|459460701|FG000|Overall Study|Ineligible|3|||
127546377|NCT04225897|458969952|FG007|Part A (Screening Visit to Day 7)|Adverse Event|0|||
127546378|NCT04225897|458969953|FG008|Part A (Screening Visit to Day 7)|Adverse Event|0|||
127546379|NCT04225897|458969954|FG009|Part A (Screening Visit to Day 7)|Adverse Event|0|||
127546380|NCT04225897|458969955|FG010|Part A (Screening Visit to Day 7)|Adverse Event|0|||
127546381|NCT04225897|458969956|FG011|Part A (Screening Visit to Day 7)|Adverse Event|0|||
127546382|NCT04225897|458969945|FG000|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
127682011|NCT00057837|459460702|FG001|Overall Study|Ineligible|3|||
127682012|NCT00057837|459460701|FG000|Overall Study|Never started treatment|1|||
127546383|NCT04225897|458969946|FG001|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
127546384|NCT04225897|458969947|FG002|Part A (Screening Visit to Day 7)|Lost to Follow-up|1|||
127546385|NCT04225897|458969948|FG003|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
127546386|NCT04225897|458969949|FG004|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
127546387|NCT04225897|458969950|FG005|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
127546388|NCT04225897|458969951|FG006|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
127546389|NCT04225897|458969952|FG007|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
127546390|NCT04225897|458969953|FG008|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
127546391|NCT04225897|458969954|FG009|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
127546392|NCT04225897|458969955|FG010|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
127546393|NCT04225897|458969956|FG011|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
127546394|NCT04225897|458969945|FG000|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
127546395|NCT04225897|458969946|FG001|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
127546396|NCT04225897|458969947|FG002|Part A (Screening Visit to Day 7)|Parent/legal guardian request|1|||
127546397|NCT04225897|458969948|FG003|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
127546398|NCT04225897|458969949|FG004|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
127546399|NCT04225897|458969950|FG005|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
127546400|NCT04225897|458969951|FG006|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
127546401|NCT04225897|458969952|FG007|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
127546402|NCT04225897|458969953|FG008|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
127546403|NCT04225897|458969954|FG009|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
127546404|NCT04225897|458969955|FG010|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
127546405|NCT04225897|458969956|FG011|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
127546406|NCT04225897|458969945|FG000|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
127546407|NCT04225897|458969946|FG001|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
127546408|NCT04225897|458969947|FG002|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
127546409|NCT04225897|458969948|FG003|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
127546410|NCT04225897|458969949|FG004|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
127546411|NCT04225897|458969950|FG005|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
127546412|NCT04225897|458969951|FG006|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
127546413|NCT04225897|458969952|FG007|Part B (Screening Visit to Day 12)|Parent/legal guardian request|1|||
127546414|NCT04225897|458969953|FG008|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
127546415|NCT04225897|458969954|FG009|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
127546416|NCT04225897|458969955|FG010|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
127546417|NCT04225897|458969956|FG011|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
127546418|NCT01285323|458969957|FG000|Overall Study|Adverse Event|9|||
127546419|NCT01285323|458969958|FG001|Overall Study|Adverse Event|8|||
127546420|NCT01285323|458969957|FG000|Overall Study|Lack of Efficacy|4|||
127546421|NCT01285323|458969958|FG001|Overall Study|Lack of Efficacy|2|||
127546422|NCT01285323|458969957|FG000|Overall Study|Withdrawal by Subject|15|||
127546423|NCT01285323|458969958|FG001|Overall Study|Withdrawal by Subject|11|||
127546424|NCT01285323|458969957|FG000|Overall Study|Protocol Violation|1|||
127546425|NCT01285323|458969958|FG001|Overall Study|Protocol Violation|2|||
127546426|NCT01285323|458969957|FG000|Overall Study|Non-compliance with study procedures|2|||
127546427|NCT01285323|458969958|FG001|Overall Study|Non-compliance with study procedures|3|||
127546428|NCT01285323|458969957|FG000|Overall Study|Lost to Follow-up|1|||
127546429|NCT01285323|458969958|FG001|Overall Study|Lost to Follow-up|1|||
127546430|NCT01285323|458969957|FG000|Overall Study|Other|1|||
127546431|NCT01285323|458969958|FG001|Overall Study|Other|3|||
127546432|NCT01472289|458969960|FG000|Overall Study|Death|2|||
127546433|NCT02668653|458969961|FG000|Overall Study|Refractory disease|41|||
127546434|NCT02668653|458969962|FG001|Overall Study|Refractory disease|70|||
127546435|NCT02668653|458969961|FG000|Overall Study|Relapse|44|||
127546436|NCT02668653|458969962|FG001|Overall Study|Relapse|65|||
127546437|NCT02668653|458969961|FG000|Overall Study|Adverse Event|58|||
127546438|NCT02668653|458969962|FG001|Overall Study|Adverse Event|23|||
127546439|NCT02668653|458969961|FG000|Overall Study|Subject decision to stop study drug|25|||
127546440|NCT02668653|458969962|FG001|Overall Study|Subject decision to stop study drug|23|||
127546441|NCT02668653|458969961|FG000|Overall Study|Other reasons not specified|16|||
127546442|NCT02668653|458969962|FG001|Overall Study|Other reasons not specified|11|||
127546443|NCT02668653|458969961|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
127546444|NCT02668653|458969962|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
127546445|NCT02668653|458969961|FG000|Overall Study|Investigator decision|10|||
127546446|NCT02668653|458969962|FG001|Overall Study|Investigator decision|7|||
127546447|NCT02668653|458969961|FG000|Overall Study|Failure to meet continuation criteria|5|||
127546448|NCT02668653|458969962|FG001|Overall Study|Failure to meet continuation criteria|12|||
127546449|NCT02668653|458969961|FG000|Overall Study|Lost to Follow-up|1|||
127546450|NCT02668653|458969962|FG001|Overall Study|Lost to Follow-up|0|||
127546451|NCT02668653|458969961|FG000|Overall Study|Pregnancy|0|||
127546452|NCT02668653|458969962|FG001|Overall Study|Pregnancy|1|||
127546453|NCT02668653|458969961|FG000|Overall Study|Death|0|||
127682013|NCT00057837|459460702|FG001|Overall Study|Never started treatment|1|||
127768335|NCT02527343|459778006|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
127682014|NCT02537522|459460703|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
127682015|NCT02537522|459460704|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
127768336|NCT02527343|459778007|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
127768337|NCT02527343|459778008|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
127768338|NCT02527343|459778003|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
127768339|NCT02527343|459778004|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
127768340|NCT02527343|459778005|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
127768341|NCT02527343|459778006|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
127768342|NCT02527343|459778007|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
127768343|NCT02527343|459778008|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
127768344|NCT02527343|459778003|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
127768345|NCT02527343|459778004|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
127768346|NCT02527343|459778005|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
127768347|NCT02527343|459778006|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
127768348|NCT02527343|459778007|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
127768349|NCT02527343|459778008|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
127768350|NCT02527343|459778003|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
127768351|NCT02527343|459778004|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
127768352|NCT02527343|459778005|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
127768353|NCT02527343|459778006|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
127768354|NCT02527343|459778007|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
127768355|NCT02527343|459778008|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
127768356|NCT02527343|459778003|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
127768357|NCT02527343|459778004|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
127768358|NCT02527343|459778005|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
127768359|NCT02527343|459778006|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
127768360|NCT02527343|459778007|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
127768361|NCT02527343|459778008|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
127768362|NCT02527343|459778003|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
127768363|NCT02527343|459778004|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
127768364|NCT02527343|459778005|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
127768365|NCT02527343|459778006|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
127768366|NCT02527343|459778007|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
127768367|NCT02527343|459778008|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
127768368|NCT04745026|459778013|FG000|Overall Study|Physician Decision|1|||
127768369|NCT04745026|459778014|FG001|Overall Study|Physician Decision|0|||
127768370|NCT04745026|459778013|FG000|Overall Study|Adverse Event|2|||
127768371|NCT04745026|459778014|FG001|Overall Study|Adverse Event|2|||
127768372|NCT04745026|459778013|FG000|Overall Study|Protocol Violation|1|||
127768373|NCT04745026|459778014|FG001|Overall Study|Protocol Violation|3|||
127768374|NCT04745026|459778013|FG000|Overall Study|Lost to Follow-up|4|||
127768375|NCT04745026|459778014|FG001|Overall Study|Lost to Follow-up|3|||
127768376|NCT04745026|459778013|FG000|Overall Study|Withdrawal by Subject|5|||
127682016|NCT02537522|459460705|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
127682017|NCT02537522|459460706|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
127682018|NCT02537522|459460703|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
127682019|NCT02537522|459460704|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
127682020|NCT02537522|459460705|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
127682021|NCT02537522|459460706|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
127682022|NCT02537522|459460703|FG000|Phase I - Contralateral|incorrect randomization|0|||
127682023|NCT02537522|459460704|FG001|Phase I - Contralateral|incorrect randomization|1|||
127682024|NCT02537522|459460705|FG002|Phase I - Contralateral|incorrect randomization|0|||
127682025|NCT02537522|459460706|FG003|Phase I - Contralateral|incorrect randomization|0|||
127682026|NCT02537522|459460703|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
127682027|NCT02537522|459460704|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
127682028|NCT02537522|459460705|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
127682029|NCT02537522|459460706|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
127682030|NCT02537522|459460703|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
127682031|NCT02537522|459460704|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
127682032|NCT02537522|459460705|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
127768377|NCT04745026|459778014|FG001|Overall Study|Withdrawal by Subject|5|||
127768378|NCT04426851|459778015|FG000|Part 2: Period 2+Washout|Withdrawal by Subject|0|||
127768379|NCT04426851|459778016|FG001|Part 2: Period 2+Washout|Withdrawal by Subject|1|||
127768380|NCT04426851|459778015|FG000|Part 2: Period 2+Washout|Adverse Event|1|||
127768381|NCT04426851|459778016|FG001|Part 2: Period 2+Washout|Adverse Event|0|||
127768382|NCT03256851|459778017|FG000|Overall Study|Withdrawal by Subject|1|||
127768383|NCT03256851|459778018|FG001|Overall Study|Withdrawal by Subject|0|||
127768384|NCT02208999|459778019|FG000|Overall Study|Lost to Follow-up|1|||
127768385|NCT00986674|459778020|FG000|Overall Study|Lack of Efficacy|28|||
127682033|NCT02537522|459460706|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
127768386|NCT00986674|459778021|FG001|Overall Study|Lack of Efficacy|25|||
127682034|NCT01350804|459460712|FG000|Core Study|Withdrawal by Subject|11|||
127682035|NCT01350804|459460713|FG001|Core Study|Withdrawal by Subject|17|||
127682036|NCT01350804|459460714|FG002|Core Study|Withdrawal by Subject|16|||
127682037|NCT01350804|459460715|FG003|Core Study|Withdrawal by Subject|7|||
127682038|NCT01350804|459460712|FG000|Core Study|Study terminated by Sponsor|0|||
127682039|NCT01350804|459460713|FG001|Core Study|Study terminated by Sponsor|0|||
127682040|NCT01350804|459460714|FG002|Core Study|Study terminated by Sponsor|0|||
127682041|NCT01350804|459460715|FG003|Core Study|Study terminated by Sponsor|2|||
127682042|NCT01350804|459460712|FG000|Core Study|Protocol deviation|1|||
127682043|NCT01350804|459460713|FG001|Core Study|Protocol deviation|0|||
127682044|NCT01350804|459460714|FG002|Core Study|Protocol deviation|1|||
127682045|NCT01350804|459460715|FG003|Core Study|Protocol deviation|0|||
127682046|NCT01350804|459460712|FG000|Core Study|Physician Decision|1|||
127682047|NCT01350804|459460713|FG001|Core Study|Physician Decision|0|||
127682048|NCT01350804|459460714|FG002|Core Study|Physician Decision|1|||
127682049|NCT01350804|459460715|FG003|Core Study|Physician Decision|3|||
127682050|NCT01350804|459460712|FG000|Core Study|Lost to Follow-up|3|||
127682051|NCT01350804|459460713|FG001|Core Study|Lost to Follow-up|0|||
127682052|NCT01350804|459460714|FG002|Core Study|Lost to Follow-up|2|||
127682053|NCT01350804|459460715|FG003|Core Study|Lost to Follow-up|1|||
127682054|NCT01350804|459460712|FG000|Core Study|Lack of Efficacy|16|||
127682055|NCT01350804|459460713|FG001|Core Study|Lack of Efficacy|19|||
127682056|NCT01350804|459460714|FG002|Core Study|Lack of Efficacy|18|||
127682057|NCT01350804|459460715|FG003|Core Study|Lack of Efficacy|5|||
127682058|NCT01350804|459460712|FG000|Core Study|Death|1|||
127682059|NCT01350804|459460713|FG001|Core Study|Death|1|||
127682060|NCT01350804|459460714|FG002|Core Study|Death|1|||
127682061|NCT01350804|459460715|FG003|Core Study|Death|0|||
127682062|NCT01350804|459460712|FG000|Core Study|Adverse Event|8|||
127682063|NCT01350804|459460713|FG001|Core Study|Adverse Event|10|||
127682064|NCT01350804|459460714|FG002|Core Study|Adverse Event|8|||
127682065|NCT01350804|459460715|FG003|Core Study|Adverse Event|8|||
127682066|NCT01350804|459460712|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
127682067|NCT01350804|459460713|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
127682068|NCT01350804|459460714|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
127682069|NCT01350804|459460715|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
127682070|NCT01350804|459460712|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
127682071|NCT01350804|459460713|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
127682072|NCT01350804|459460714|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
127682073|NCT01350804|459460715|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
127682074|NCT01350804|459460712|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
127682075|NCT01350804|459460713|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
127682076|NCT01350804|459460714|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
127682077|NCT01350804|459460715|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
127682078|NCT01350804|459460712|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
127682079|NCT01350804|459460713|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
127682080|NCT01350804|459460714|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
127682081|NCT01350804|459460715|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
127682082|NCT01350804|459460712|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
127682083|NCT01350804|459460713|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
127682084|NCT01350804|459460714|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
127682085|NCT01350804|459460715|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
127682086|NCT01350804|459460712|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
127682087|NCT01350804|459460713|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
127682088|NCT01350804|459460714|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
127682089|NCT01350804|459460715|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
127682090|NCT02299336|459460716|FG000|Overall Study|Withdrawal by Subject|11|||
127682091|NCT02299336|459460716|FG000|Overall Study|Adverse Event|1|||
127682092|NCT02299336|459460716|FG000|Overall Study|Death|1|||
127682093|NCT02299336|459460716|FG000|Overall Study|Lost to Follow-up|1|||
127682094|NCT02106442|459460718|FG000|Overall Study|Case Report Forms Uncollected|7|||
127682095|NCT02106442|459460718|FG000|Overall Study|Protocol Deviation|30|||
127682096|NCT05328297|459462246|FG000|Overall Study|Adverse Event|5|||
127682097|NCT05328297|459462247|FG001|Overall Study|Adverse Event|7|||
127682098|NCT05328297|459462246|FG000|Overall Study|Withdrawal by Subject|4|||
127682099|NCT05328297|459462247|FG001|Overall Study|Withdrawal by Subject|3|||
127682100|NCT05328297|459462246|FG000|Overall Study|Lack of Efficacy|1|||
127682101|NCT05328297|459462247|FG001|Overall Study|Lack of Efficacy|0|||
127682102|NCT05328297|459462246|FG000|Overall Study|Lost to Follow-up|1|||
127682103|NCT05328297|459462247|FG001|Overall Study|Lost to Follow-up|0|||
127682104|NCT05328297|459462246|FG000|Overall Study|Protocol Violation|1|||
127682105|NCT05328297|459462247|FG001|Overall Study|Protocol Violation|0|||
127682106|NCT05328297|459462246|FG000|Overall Study|Randomized but not treated|1|||
127682107|NCT05328297|459462247|FG001|Overall Study|Randomized but not treated|1|||
127682108|NCT01393119|459462251|FG000|Overall Study|Adverse Event|1|||
127682109|NCT01393119|459462252|FG001|Overall Study|Adverse Event|1|||
127546454|NCT02668653|458969962|FG001|Overall Study|Death|1|||
127546455|NCT02158442|458969965|FG000|Overall Study|Withdrawal by Subject|1|||
127546456|NCT02158442|458969966|FG001|Overall Study|Withdrawal by Subject|0|||
127546457|NCT02158442|458969965|FG000|Overall Study|Perfusion staff not available|1|||
127546458|NCT02158442|458969966|FG001|Overall Study|Perfusion staff not available|0|||
127546459|NCT01294553|458969967|FG000|Overall Study|Duplicated Participants|1|||
127546460|NCT01294553|458969967|FG000|Overall Study|Protocol Violation|268|||
127546461|NCT00926237|458969968|FG000|Overall Study|Withdrawal by Subject|2|||
127546462|NCT00926237|458969969|FG001|Overall Study|Withdrawal by Subject|1|||
127546463|NCT00632229|458969975|FG000|Overall Study|Adverse Event|6|||
127546464|NCT00632229|458969976|FG001|Overall Study|Adverse Event|0|||
127546465|NCT00632229|458969975|FG000|Overall Study|Lost to Follow-up|0|||
127546466|NCT00632229|458969976|FG001|Overall Study|Lost to Follow-up|3|||
127546467|NCT00632229|458969975|FG000|Overall Study|Lack of Efficacy|0|||
127546468|NCT00632229|458969976|FG001|Overall Study|Lack of Efficacy|2|||
127546469|NCT00632229|458969975|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
127546470|NCT00632229|458969976|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
127546471|NCT00577889|458969978|FG000|Overall Study|Withdrawal by Subject|1|||
127546472|NCT00577889|458969979|FG001|Overall Study|Withdrawal by Subject|0|||
127546473|NCT00577889|458969980|FG002|Overall Study|Withdrawal by Subject|0|||
127546474|NCT02667119|458969984|FG000|Overall Study|Lost to Follow-up|3|||
127546475|NCT02667119|458969985|FG001|Overall Study|Lost to Follow-up|0|||
127546476|NCT00474812|458969988|FG000|Overall Study|Withdrawal by Subject|5|||
127546477|NCT00474812|458969988|FG000|Overall Study|No Initiation of treatment|2|||
127546478|NCT02059278|458969989|FG000|Overall Study|Adverse Event|1|||
127546479|NCT02059278|458969990|FG001|Overall Study|Adverse Event|1|||
127546480|NCT02059278|458969989|FG000|Overall Study|Lost to Follow-up|1|||
127546481|NCT02059278|458969990|FG001|Overall Study|Lost to Follow-up|0|||
127546482|NCT02059278|458969989|FG000|Overall Study|Withdrawal by Subject|0|||
127546483|NCT02059278|458969990|FG001|Overall Study|Withdrawal by Subject|3|||
127546484|NCT02059278|458969989|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
127546485|NCT02059278|458969990|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
127546486|NCT04363320|458969992|FG000|Overall Study|Lost to Follow-up|43|||
127546487|NCT04363320|458969993|FG001|Overall Study|Lost to Follow-up|42|||
127546488|NCT04363320|458969994|FG002|Overall Study|Lost to Follow-up|24|||
127546489|NCT04363320|458969995|FG003|Overall Study|Lost to Follow-up|29|||
127546490|NCT04363320|458969992|FG000|Overall Study|Death|0|||
127546491|NCT04363320|458969993|FG001|Overall Study|Death|0|||
127546492|NCT04363320|458969994|FG002|Overall Study|Death|1|||
127546493|NCT04363320|458969995|FG003|Overall Study|Death|0|||
127546494|NCT05632211|458969996|FG000|Overall Study|Withdrawal by Subject|2|||
127546495|NCT05632211|458969997|FG001|Overall Study|Withdrawal by Subject|0|||
127546496|NCT05632211|458969998|FG002|Overall Study|Withdrawal by Subject|2|||
127546497|NCT05632211|458969996|FG000|Overall Study|Other reasons|1|||
127546498|NCT05632211|458969997|FG001|Overall Study|Other reasons|1|||
127546499|NCT05632211|458969998|FG002|Overall Study|Other reasons|1|||
127546500|NCT00541658|458969999|FG000|Overall Study|Adverse Event|28|||
127546501|NCT00541658|458970000|FG001|Overall Study|Adverse Event|37|||
127546502|NCT00541658|458970001|FG002|Overall Study|Adverse Event|25|||
127546503|NCT00541658|458969999|FG000|Overall Study|Physician Decision|0|||
127546504|NCT00541658|458970000|FG001|Overall Study|Physician Decision|0|||
127546505|NCT00541658|458970001|FG002|Overall Study|Physician Decision|4|||
127546506|NCT00541658|458969999|FG000|Overall Study|Lost to Follow-up|3|||
127546507|NCT00541658|458970000|FG001|Overall Study|Lost to Follow-up|3|||
127546508|NCT00541658|458970001|FG002|Overall Study|Lost to Follow-up|6|||
127546509|NCT00541658|458969999|FG000|Overall Study|Protocol Violation|0|||
127546510|NCT00541658|458970000|FG001|Overall Study|Protocol Violation|1|||
127546511|NCT00541658|458970001|FG002|Overall Study|Protocol Violation|1|||
127546512|NCT00541658|458969999|FG000|Overall Study|Withdrawal by Subject|28|||
127546513|NCT00541658|458970000|FG001|Overall Study|Withdrawal by Subject|32|||
127546514|NCT00541658|458970001|FG002|Overall Study|Withdrawal by Subject|32|||
127682110|NCT01393119|459462253|FG002|Overall Study|Adverse Event|0|||
127682111|NCT01393119|459462254|FG003|Overall Study|Adverse Event|1|||
127682112|NCT01393119|459462251|FG000|Overall Study|Withdrawal by Subject|0|||
127682113|NCT01393119|459462252|FG001|Overall Study|Withdrawal by Subject|1|||
127546515|NCT00541658|458969999|FG000|Overall Study|Took No Study Drug|1|||
127546516|NCT00541658|458970000|FG001|Overall Study|Took No Study Drug|0|||
127682114|NCT01393119|459462253|FG002|Overall Study|Withdrawal by Subject|1|||
127682115|NCT01393119|459462254|FG003|Overall Study|Withdrawal by Subject|0|||
127546517|NCT00541658|458970001|FG002|Overall Study|Took No Study Drug|0|||
127546518|NCT04123470|458970002|FG000|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|4|||
127546519|NCT04123470|458970003|FG001|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|0|||
127546520|NCT04123470|458970002|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|0|||
127546521|NCT04123470|458970003|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|1|||
127546522|NCT04123470|458970002|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|0|||
127546523|NCT04123470|458970003|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|7|||
127546524|NCT04123470|458970002|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|0|||
127546525|NCT04123470|458970003|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|1|||
127546526|NCT05530252|458970010|FG000|Overall Study|Lost to Follow-up|1|||
127546527|NCT05530252|458970011|FG001|Overall Study|Lost to Follow-up|1|||
127546528|NCT05530252|458970012|FG002|Overall Study|Lost to Follow-up|1|||
127546529|NCT04482647|458970018|FG000|Overall Study|Time constraints|2|||
127546530|NCT04482647|458970018|FG000|Overall Study|Health issues|1|||
127546531|NCT04482647|458970018|FG000|Overall Study|Death in the family|1|||
127546532|NCT04482647|458970018|FG000|Overall Study|Disliked the intervention|1|||
127546533|NCT04482647|458970018|FG000|Overall Study|No reasons specified|7|||
127546534|NCT04163341|458970019|FG000|Overall Study|Withdrawal by Subject|2|||
127546535|NCT04163341|458970020|FG001|Overall Study|Withdrawal by Subject|0|||
127546536|NCT04163341|458970019|FG000|Overall Study|Lost to Follow-up|3|||
127546537|NCT04163341|458970020|FG001|Overall Study|Lost to Follow-up|4|||
127546538|NCT02484391|458970021|FG000|Overall Study|Lack of Efficacy|15|||
127546539|NCT02484391|458970022|FG001|Overall Study|Lack of Efficacy|14|||
127546540|NCT02484391|458970023|FG002|Overall Study|Lack of Efficacy|3|||
127546541|NCT02484391|458970021|FG000|Overall Study|Lost to Follow-up|0|||
127546542|NCT02484391|458970022|FG001|Overall Study|Lost to Follow-up|0|||
127546543|NCT02484391|458970023|FG002|Overall Study|Lost to Follow-up|2|||
127546544|NCT02484391|458970021|FG000|Overall Study|Physician Decision|1|||
127546545|NCT02484391|458970022|FG001|Overall Study|Physician Decision|3|||
127546546|NCT02484391|458970023|FG002|Overall Study|Physician Decision|0|||
127546547|NCT02484391|458970021|FG000|Overall Study|Went to Transplant|5|||
127546548|NCT02484391|458970022|FG001|Overall Study|Went to Transplant|3|||
127546549|NCT02484391|458970023|FG002|Overall Study|Went to Transplant|2|||
127546550|NCT00911170|458970024|FG000|Treatment Period|Randomized in error|1|||
127546551|NCT00911170|458970025|FG001|Treatment Period|Randomized in error|1|||
127546552|NCT00911170|458970024|FG000|Treatment Period|Ineligibility determined|1|||
127546553|NCT00911170|458970025|FG001|Treatment Period|Ineligibility determined|3|||
127546554|NCT00911170|458970024|FG000|Treatment Period|Protocol deviation|1|||
127546555|NCT00911170|458970025|FG001|Treatment Period|Protocol deviation|2|||
127546556|NCT00911170|458970024|FG000|Treatment Period|Adverse Event|9|||
127546557|NCT00911170|458970025|FG001|Treatment Period|Adverse Event|10|||
127546558|NCT00911170|458970024|FG000|Treatment Period|Withdrawal by Subject|4|||
127546559|NCT00911170|458970025|FG001|Treatment Period|Withdrawal by Subject|4|||
127546560|NCT00911170|458970024|FG000|Treatment Period|Disease progression|0|||
127682116|NCT01393119|459462251|FG000|Overall Study|Lack of Efficacy|1|||
127682117|NCT01393119|459462252|FG001|Overall Study|Lack of Efficacy|0|||
127682118|NCT01393119|459462253|FG002|Overall Study|Lack of Efficacy|2|||
127682119|NCT01393119|459462254|FG003|Overall Study|Lack of Efficacy|1|||
127682120|NCT01393119|459462251|FG000|Overall Study|Protocol Violation|0|||
127682121|NCT01393119|459462252|FG001|Overall Study|Protocol Violation|0|||
127682122|NCT01393119|459462253|FG002|Overall Study|Protocol Violation|1|||
127682123|NCT01393119|459462254|FG003|Overall Study|Protocol Violation|0|||
127682124|NCT01393119|459462251|FG000|Overall Study|Death|0|||
127682125|NCT01393119|459462252|FG001|Overall Study|Death|0|||
127682126|NCT01393119|459462253|FG002|Overall Study|Death|0|||
127682127|NCT01393119|459462254|FG003|Overall Study|Death|1|||
127682128|NCT01393119|459462251|FG000|Overall Study|Randomized but Not treated|1|||
127682129|NCT01393119|459462252|FG001|Overall Study|Randomized but Not treated|0|||
127682130|NCT01393119|459462253|FG002|Overall Study|Randomized but Not treated|1|||
127682131|NCT01393119|459462254|FG003|Overall Study|Randomized but Not treated|1|||
127682132|NCT01393119|459462251|FG000|Overall Study|Sponsor Termination of Study|11|||
127682133|NCT01393119|459462252|FG001|Overall Study|Sponsor Termination of Study|12|||
127682134|NCT01393119|459462253|FG002|Overall Study|Sponsor Termination of Study|9|||
127682135|NCT01393119|459462254|FG003|Overall Study|Sponsor Termination of Study|12|||
127682136|NCT02544152|459462255|FG000|Overall Study|Adverse Event|0|||
127682137|NCT02544152|459462256|FG001|Overall Study|Adverse Event|4|||
127682138|NCT02544152|459462255|FG000|Overall Study|Withdrawal by Subject|0|||
127682139|NCT02544152|459462256|FG001|Overall Study|Withdrawal by Subject|3|||
127546561|NCT00911170|458970025|FG001|Treatment Period|Disease progression|2|||
127546562|NCT00911170|458970024|FG000|Treatment Period|Physician Decision|5|||
127546563|NCT00911170|458970025|FG001|Treatment Period|Physician Decision|5|||
127546564|NCT00911170|458970024|FG000|Treatment Period|Lost to Follow-up|0|||
127546565|NCT00911170|458970025|FG001|Treatment Period|Lost to Follow-up|1|||
127546566|NCT00911170|458970024|FG000|Treatment Period|Death|6|||
127546567|NCT00911170|458970025|FG001|Treatment Period|Death|9|||
127682140|NCT02544152|459462255|FG000|Overall Study|Other|1|||
127682141|NCT02544152|459462256|FG001|Overall Study|Other|0|||
127682142|NCT01759264|459462259|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
127682143|NCT01759264|459462259|FG000|Overall Study|Adverse Event|1|||
127546568|NCT00911170|458970024|FG000|Long Term Follow-Up|Continuing in study|274|||
127546569|NCT00911170|458970025|FG001|Long Term Follow-Up|Continuing in study|269|||
127546570|NCT00911170|458970024|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
127546571|NCT00911170|458970025|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
127682144|NCT01759264|459462259|FG000|Overall Study|Other|2|||
127682145|NCT01759264|459462259|FG000|Overall Study|Lost to Follow-up|2|||
127682146|NCT01759264|459462259|FG000|Overall Study|Withdrawal by Subject|3|||
127768387|NCT00986674|459778022|FG002|Overall Study|Lack of Efficacy|23|||
127546572|NCT00911170|458970024|FG000|Long Term Follow-Up|Physician Decision|5|||
127546573|NCT00911170|458970025|FG001|Long Term Follow-Up|Physician Decision|4|||
127546574|NCT00911170|458970024|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
127546575|NCT00911170|458970025|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
127546576|NCT00911170|458970024|FG000|Long Term Follow-Up|Death|116|||
127546577|NCT00911170|458970025|FG001|Long Term Follow-Up|Death|121|||
127546578|NCT02594124|458970026|FG000|Overall Study|Adverse Event|0|||
127546579|NCT02594124|458970027|FG001|Overall Study|Adverse Event|5|||
127546580|NCT02594124|458970028|FG002|Overall Study|Adverse Event|8|||
127546581|NCT02594124|458970029|FG003|Overall Study|Adverse Event|1|||
127546582|NCT02594124|458970030|FG004|Overall Study|Adverse Event|0|||
127546583|NCT02594124|458970031|FG005|Overall Study|Adverse Event|0|||
127546584|NCT02594124|458970032|FG006|Overall Study|Adverse Event|2|||
127546585|NCT02594124|458970033|FG007|Overall Study|Adverse Event|2|||
127546586|NCT02594124|458970034|FG008|Overall Study|Adverse Event|0|||
127546587|NCT02594124|458970026|FG000|Overall Study|Withdrawal by Subject|2|||
127546588|NCT02594124|458970027|FG001|Overall Study|Withdrawal by Subject|3|||
127546589|NCT02594124|458970028|FG002|Overall Study|Withdrawal by Subject|5|||
127546590|NCT02594124|458970029|FG003|Overall Study|Withdrawal by Subject|1|||
127546591|NCT02594124|458970030|FG004|Overall Study|Withdrawal by Subject|8|||
127546592|NCT02594124|458970031|FG005|Overall Study|Withdrawal by Subject|4|||
127546593|NCT02594124|458970032|FG006|Overall Study|Withdrawal by Subject|13|||
127546594|NCT02594124|458970033|FG007|Overall Study|Withdrawal by Subject|19|||
127546595|NCT02594124|458970034|FG008|Overall Study|Withdrawal by Subject|0|||
127546596|NCT02594124|458970026|FG000|Overall Study|Physician Decision|0|||
127546597|NCT02594124|458970027|FG001|Overall Study|Physician Decision|2|||
127546598|NCT02594124|458970028|FG002|Overall Study|Physician Decision|0|||
127546599|NCT02594124|458970029|FG003|Overall Study|Physician Decision|0|||
127546600|NCT02594124|458970030|FG004|Overall Study|Physician Decision|0|||
127546601|NCT02594124|458970031|FG005|Overall Study|Physician Decision|0|||
127546602|NCT02594124|458970032|FG006|Overall Study|Physician Decision|0|||
127546603|NCT02594124|458970033|FG007|Overall Study|Physician Decision|1|||
127546604|NCT02594124|458970034|FG008|Overall Study|Physician Decision|0|||
127546605|NCT02594124|458970026|FG000|Overall Study|Commercial drug|0|||
127546606|NCT02594124|458970027|FG001|Overall Study|Commercial drug|1|||
127546607|NCT02594124|458970028|FG002|Overall Study|Commercial drug|6|||
127546608|NCT02594124|458970029|FG003|Overall Study|Commercial drug|3|||
127546609|NCT02594124|458970030|FG004|Overall Study|Commercial drug|0|||
127546610|NCT02594124|458970031|FG005|Overall Study|Commercial drug|0|||
127546611|NCT02594124|458970032|FG006|Overall Study|Commercial drug|7|||
127546612|NCT02594124|458970033|FG007|Overall Study|Commercial drug|11|||
127546613|NCT02594124|458970034|FG008|Overall Study|Commercial drug|2|||
127546614|NCT02594124|458970026|FG000|Overall Study|Reason Not Specified|1|||
127546615|NCT02594124|458970027|FG001|Overall Study|Reason Not Specified|3|||
127546616|NCT02594124|458970028|FG002|Overall Study|Reason Not Specified|4|||
127546617|NCT02594124|458970029|FG003|Overall Study|Reason Not Specified|0|||
127546618|NCT02594124|458970030|FG004|Overall Study|Reason Not Specified|0|||
127546619|NCT02594124|458970031|FG005|Overall Study|Reason Not Specified|1|||
127546620|NCT02594124|458970032|FG006|Overall Study|Reason Not Specified|1|||
127546621|NCT02594124|458970033|FG007|Overall Study|Reason Not Specified|6|||
127546622|NCT02594124|458970034|FG008|Overall Study|Reason Not Specified|1|||
127546623|NCT02514083|458970040|FG000|Overall Study|Adverse Event|1|||
127546624|NCT01899040|458970041|FG000|Overall Study|Randomized in error|0|||
127546625|NCT01899040|458970042|FG001|Overall Study|Randomized in error|1|||
127546626|NCT01899040|458970043|FG002|Overall Study|Randomized in error|1|||
127546627|NCT01899040|458970041|FG000|Overall Study|Adverse Event|3|||
127546628|NCT01899040|458970042|FG001|Overall Study|Adverse Event|1|||
127546629|NCT01899040|458970043|FG002|Overall Study|Adverse Event|2|||
127546630|NCT01899040|458970041|FG000|Overall Study|Unspecified reasons|4|||
127546631|NCT01899040|458970042|FG001|Overall Study|Unspecified reasons|4|||
127546632|NCT01899040|458970043|FG002|Overall Study|Unspecified reasons|0|||
127546633|NCT01899040|458970041|FG000|Overall Study|Compliance issues|1|||
127682147|NCT01759264|459462259|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
127682148|NCT02015546|459462261|FG000|Overall Study|Withdrawal by Subject|1|||
127682149|NCT02015546|459462262|FG001|Overall Study|Withdrawal by Subject|1|||
127682150|NCT02015546|459462263|FG002|Overall Study|Withdrawal by Subject|1|||
127682151|NCT02015546|459462261|FG000|Overall Study|Screem Failure|2|||
127546634|NCT01899040|458970042|FG001|Overall Study|Compliance issues|2|||
127546635|NCT01899040|458970043|FG002|Overall Study|Compliance issues|0|||
127546636|NCT02141295|458971700|FG000|Overall Study|Adverse Event|1|||
127546637|NCT02141295|458971701|FG001|Overall Study|Adverse Event|18|||
127546638|NCT02141295|458971702|FG002|Overall Study|Adverse Event|11|||
127546639|NCT02141295|458971700|FG000|Overall Study|Physician Decision|2|||
127546640|NCT02141295|458971701|FG001|Overall Study|Physician Decision|19|||
127546641|NCT02141295|458971702|FG002|Overall Study|Physician Decision|14|||
127546642|NCT02141295|458971700|FG000|Overall Study|Study terminated by sponsor|0|||
127682152|NCT02015546|459462262|FG001|Overall Study|Screem Failure|1|||
127682153|NCT02015546|459462263|FG002|Overall Study|Screem Failure|3|||
127682154|NCT01426269|459462264|FG000|Period 1: 12 Weeks|Adverse Event|5|||
127546643|NCT02141295|458971701|FG001|Overall Study|Study terminated by sponsor|6|||
127546644|NCT02141295|458971702|FG002|Overall Study|Study terminated by sponsor|6|||
127546645|NCT02141295|458971700|FG000|Overall Study|Non-compliance|0|||
127546646|NCT02141295|458971701|FG001|Overall Study|Non-compliance|1|||
127546647|NCT02141295|458971702|FG002|Overall Study|Non-compliance|0|||
127546648|NCT02141295|458971700|FG000|Overall Study|Progressive disease|3|||
127546649|NCT02141295|458971701|FG001|Overall Study|Progressive disease|32|||
127546650|NCT02141295|458971702|FG002|Overall Study|Progressive disease|50|||
127546651|NCT02141295|458971700|FG000|Overall Study|Reason not specified|0|||
127546652|NCT02141295|458971701|FG001|Overall Study|Reason not specified|9|||
127546653|NCT02141295|458971702|FG002|Overall Study|Reason not specified|10|||
127546654|NCT02141295|458971700|FG000|Overall Study|Withdrawal by Subject|0|||
127546655|NCT02141295|458971701|FG001|Overall Study|Withdrawal by Subject|9|||
127546656|NCT02141295|458971702|FG002|Overall Study|Withdrawal by Subject|4|||
127546657|NCT01710501|458971703|FG000|Overall Study|Lost to Follow-up|2|||
127546658|NCT01710501|458971704|FG001|Overall Study|Lost to Follow-up|0|||
127546659|NCT01710501|458971705|FG002|Overall Study|Lost to Follow-up|0|||
127546660|NCT02536976|458971706|FG000|Overall Study|Physician Decision|0|||
127546661|NCT02536976|458971707|FG001|Overall Study|Physician Decision|1|||
127546662|NCT01671319|458971710|FG000|Overall Study|Withdrawal by Subject|1|||
127546663|NCT01709084|458971711|FG000|Overall Study|Lost to Follow-up|4|||
127546664|NCT01709084|458971712|FG001|Overall Study|Lost to Follow-up|7|||
127546665|NCT01709084|458971711|FG000|Overall Study|Withdrawal by Subject|2|||
127546666|NCT01709084|458971712|FG001|Overall Study|Withdrawal by Subject|2|||
127546667|NCT01709084|458971711|FG000|Overall Study|Adverse Event|5|||
127546668|NCT01709084|458971712|FG001|Overall Study|Adverse Event|0|||
127546669|NCT01709084|458971711|FG000|Overall Study|Other|5|||
127546670|NCT01709084|458971712|FG001|Overall Study|Other|3|||
127546671|NCT01709084|458971711|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
127546672|NCT01709084|458971712|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
127546673|NCT01709084|458971711|FG000|Overall Study|Not Treated|0|||
127546674|NCT01709084|458971712|FG001|Overall Study|Not Treated|2|||
127546675|NCT02144610|458971713|FG000|Overall Study|Physician Decision|1|||
127546676|NCT02144610|458971714|FG001|Overall Study|Physician Decision|0|||
127546677|NCT02144610|458971713|FG000|Overall Study|Withdrawal by Subject|1|||
127546678|NCT02144610|458971714|FG001|Overall Study|Withdrawal by Subject|5|||
127546679|NCT02144610|458971713|FG000|Overall Study|Death|2|||
127546680|NCT02144610|458971714|FG001|Overall Study|Death|2|||
127546681|NCT02144610|458971713|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
127546682|NCT02144610|458971714|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
127546683|NCT02144610|458971713|FG000|Overall Study|Other|0|||
127546684|NCT02144610|458971714|FG001|Overall Study|Other|1|||
127546685|NCT01054885|458971715|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
127546686|NCT01054885|458971716|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
127546687|NCT01054885|458971717|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
127546688|NCT01054885|458971718|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
127546689|NCT01054885|458971719|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
127546690|NCT01054885|458971720|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
127546691|NCT01054885|458971721|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
127546692|NCT01054885|458971715|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
127546693|NCT01054885|458971716|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
127546694|NCT01054885|458971717|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
127546695|NCT01054885|458971718|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
127546696|NCT01054885|458971719|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
127682155|NCT01426269|459462265|FG001|Period 1: 12 Weeks|Adverse Event|0|||
127682156|NCT01426269|459462266|FG002|Period 1: 12 Weeks|Adverse Event|0|||
127682157|NCT01426269|459462264|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
127682158|NCT01426269|459462265|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
127546697|NCT01054885|458971720|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
127546698|NCT01054885|458971721|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
127546699|NCT01054885|458971715|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
127546700|NCT01054885|458971716|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
127546701|NCT01054885|458971717|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
127546702|NCT01054885|458971718|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
127682159|NCT01426269|459462266|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
127682160|NCT01426269|459462264|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
127682161|NCT01426269|459462265|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
127546703|NCT01054885|458971719|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
127546704|NCT01054885|458971720|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
127546705|NCT01054885|458971721|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
127546706|NCT01054885|458971715|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
127682162|NCT01426269|459462266|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
127682163|NCT01426269|459462264|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
127546707|NCT01054885|458971716|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
127546708|NCT01054885|458971717|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
127546709|NCT01054885|458971718|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
127546710|NCT01054885|458971719|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
127546711|NCT01054885|458971720|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
127546712|NCT01054885|458971721|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
127546713|NCT01054885|458971715|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
127546714|NCT01054885|458971716|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
127546715|NCT01054885|458971717|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
127546716|NCT01054885|458971718|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
127546717|NCT01054885|458971719|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
127546718|NCT01054885|458971720|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
127546719|NCT01054885|458971721|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
127546720|NCT01054885|458971715|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
127546721|NCT01054885|458971716|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
127546722|NCT01054885|458971717|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
127546723|NCT01054885|458971718|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
127546724|NCT01054885|458971719|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
127546725|NCT01054885|458971720|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
127546726|NCT01054885|458971721|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
127546727|NCT01054885|458971715|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
127546728|NCT01054885|458971716|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
127546729|NCT01054885|458971717|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
127546730|NCT01054885|458971718|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
127546731|NCT01054885|458971719|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
127546732|NCT01054885|458971720|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
127546733|NCT01054885|458971721|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
127546734|NCT01054885|458971715|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
127546735|NCT01054885|458971716|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
127546736|NCT01054885|458971717|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
127546737|NCT01054885|458971718|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
127546738|NCT01054885|458971719|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
127546739|NCT01054885|458971720|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
127546740|NCT01054885|458971721|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
127546741|NCT01054885|458971715|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
127546742|NCT01054885|458971716|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
127546743|NCT01054885|458971717|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
127546744|NCT01054885|458971718|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
127546745|NCT01054885|458971719|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
127546746|NCT01054885|458971720|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
127546747|NCT01054885|458971721|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
127546748|NCT01054885|458971715|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
127546749|NCT01054885|458971716|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
127546750|NCT01054885|458971717|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
127546751|NCT01054885|458971718|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
127546752|NCT01054885|458971719|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
127546753|NCT01054885|458971720|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
127546754|NCT01054885|458971721|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
127546755|NCT01054885|458971715|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
127546756|NCT01054885|458971716|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
127682164|NCT01426269|459462265|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
127682165|NCT01426269|459462266|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
127682166|NCT01426269|459462264|FG000|Period 1: 12 Weeks|Pregnancy|1|||
127682167|NCT01426269|459462265|FG001|Period 1: 12 Weeks|Pregnancy|0|||
127682168|NCT01426269|459462266|FG002|Period 1: 12 Weeks|Pregnancy|0|||
127682169|NCT01426269|459462264|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
127682170|NCT01426269|459462265|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
127682171|NCT01426269|459462266|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
127682172|NCT01426269|459462264|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
127682173|NCT01426269|459462265|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
127682174|NCT01426269|459462266|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
127682175|NCT01426269|459462264|FG000|Period 2: 40 Weeks|Adverse Event|0|||
127768388|NCT00986674|459778020|FG000|Overall Study|Adverse Event|4|||
127768389|NCT00986674|459778021|FG001|Overall Study|Adverse Event|8|||
127546757|NCT01054885|458971717|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
127546758|NCT01054885|458971718|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
127546759|NCT01054885|458971719|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
127546760|NCT01054885|458971720|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
127546761|NCT01054885|458971721|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
127546762|NCT01054885|458971715|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
127546763|NCT01054885|458971716|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
127546764|NCT01054885|458971717|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
127546765|NCT01054885|458971718|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
127546766|NCT01054885|458971719|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
127546767|NCT01054885|458971720|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
127546768|NCT01054885|458971721|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
127546769|NCT01054885|458971715|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
127546770|NCT01054885|458971716|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
127546771|NCT01054885|458971717|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
127546772|NCT01054885|458971718|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
127546773|NCT01054885|458971719|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
127546774|NCT01054885|458971720|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
127546775|NCT01054885|458971721|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
127546776|NCT01054885|458971715|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
127546777|NCT01054885|458971716|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
127546778|NCT01054885|458971717|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
127546779|NCT01054885|458971718|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
127546780|NCT01054885|458971719|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
127546781|NCT01054885|458971720|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
127546782|NCT01054885|458971721|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
127546783|NCT01054885|458971715|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
127546784|NCT01054885|458971716|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
127546785|NCT01054885|458971717|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
127546786|NCT01054885|458971718|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
127546787|NCT01054885|458971719|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
127546788|NCT01054885|458971720|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
127546789|NCT01054885|458971721|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
127546790|NCT00214201|458971723|FG000|Overall Study|Withdrawal by Subject|2|||
127546791|NCT00214201|458971724|FG001|Overall Study|Withdrawal by Subject|0|||
127546792|NCT00214201|458971723|FG000|Overall Study|Death|0|||
127546793|NCT00214201|458971724|FG001|Overall Study|Death|2|||
127546794|NCT01399372|458971725|FG000|Overall Study|Protocol Violation|3|||
127546795|NCT01399372|458971726|FG001|Overall Study|Protocol Violation|1|||
127546796|NCT01432730|458971727|FG000|Period 1|Adverse Event|2|||
127546797|NCT01432730|458971728|FG001|Period 1|Adverse Event|0|||
127546798|NCT01432730|458971727|FG000|Period 2|Adverse Event|0|||
127546799|NCT01432730|458971728|FG001|Period 2|Adverse Event|4|||
127546800|NCT01421719|458971733|FG000|Overall Study|Withdrawal by Subject|4|||
127546801|NCT01712399|458971734|FG000|Overall Study|Lost to Follow-up|1|||
127546802|NCT01712399|458971734|FG000|Overall Study|Withdrawal by Subject|39|||
127546803|NCT01712399|458971734|FG000|Overall Study|Death|1|||
127546804|NCT01712399|458971734|FG000|Overall Study|Adverse Event|11|||
127546805|NCT01712399|458971734|FG000|Overall Study|Study closure|345|||
127546806|NCT01942837|458971735|FG000|Overall Study|Death|1|||
127546807|NCT01942837|458971735|FG000|Overall Study|Symptomatic or radiographic progression|49|||
127546808|NCT01942837|458971735|FG000|Overall Study|Adverse Event|6|||
127546809|NCT01942837|458971735|FG000|Overall Study|Physician Decision|3|||
127546810|NCT01942837|458971735|FG000|Overall Study|Withdrawal by Subject|2|||
127546811|NCT01942837|458971735|FG000|Overall Study|Intercurrent Illness|1|||
127546812|NCT01942837|458971735|FG000|Overall Study|On treatment|3|||
127546813|NCT01942837|458971735|FG000|Overall Study|Never initiate the treatment|2|||
127546814|NCT01298648|458971736|FG000|Overall Study|Withdrawal by Subject|2|||
127546815|NCT01298648|458971736|FG000|Overall Study|Lost to Follow-up|21|||
127546816|NCT02038933|458971752|FG000|Overall Study|Disease progression|104|||
127546817|NCT02038933|458971752|FG000|Overall Study|Study drug toxicity|6|||
127546818|NCT02038933|458971752|FG000|Overall Study|Adverse event unrelated to study drug|6|||
127546819|NCT02038933|458971752|FG000|Overall Study|Participant request to discontinue treatment|2|||
127546820|NCT02038933|458971752|FG000|Overall Study|Lost to Follow-up|1|||
127546821|NCT02038933|458971752|FG000|Overall Study|Other reasons|2|||
127546822|NCT03250273|458971753|FG000|Overall Study|Disease Progression|2|||
127546823|NCT03250273|458971754|FG001|Overall Study|Disease Progression|11|||
127546824|NCT03250273|458971753|FG000|Overall Study|Death|0|||
127546825|NCT03250273|458971754|FG001|Overall Study|Death|1|||
127682176|NCT01426269|459462265|FG001|Period 2: 40 Weeks|Adverse Event|1|||
127546826|NCT04154904|458971755|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
127546827|NCT04154904|458971756|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
127546828|NCT04154904|458971757|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
127546829|NCT04226742|458971758|FG000|Overall Study|Lost to Follow-up|16|||
127546830|NCT04226742|458971759|FG001|Overall Study|Lost to Follow-up|13|||
127546831|NCT04226742|458971758|FG000|Overall Study|Withdrawal by Subject|5|||
127546832|NCT04226742|458971759|FG001|Overall Study|Withdrawal by Subject|3|||
127546833|NCT01759446|458971761|FG000|Overall Study|Protocol Violation|1|||
127546834|NCT01759446|458971762|FG001|Overall Study|Protocol Violation|0|||
127546835|NCT01759446|458971763|FG002|Overall Study|Protocol Violation|1|||
127546836|NCT01759446|458971764|FG003|Overall Study|Protocol Violation|0|||
127546837|NCT01759446|458971765|FG004|Overall Study|Protocol Violation|0|||
127546838|NCT01759446|458971761|FG000|Overall Study|Withdrawal by Subject|0|||
127546839|NCT01759446|458971762|FG001|Overall Study|Withdrawal by Subject|1|||
127546840|NCT01759446|458971763|FG002|Overall Study|Withdrawal by Subject|0|||
127546841|NCT01759446|458971764|FG003|Overall Study|Withdrawal by Subject|1|||
127546842|NCT01759446|458971765|FG004|Overall Study|Withdrawal by Subject|0|||
127546843|NCT02606643|458971766|FG000|Overall Study|did not meet inclusion criteria|1|||
127546844|NCT02606643|458971767|FG001|Overall Study|did not meet inclusion criteria|3|||
127546845|NCT04313244|458971770|FG000|Overall Study|Withdrawal of Consent|3|||
127546846|NCT04313244|458971771|FG001|Overall Study|Withdrawal of Consent|3|||
127546847|NCT04313244|458971770|FG000|Overall Study|Met Exclusion Criteria|1|||
127546848|NCT04313244|458971771|FG001|Overall Study|Met Exclusion Criteria|0|||
127546849|NCT04313244|458971770|FG000|Overall Study|Invalid Informed Consent Form (ICF)|1|||
127546850|NCT04313244|458971771|FG001|Overall Study|Invalid Informed Consent Form (ICF)|0|||
127546851|NCT00907335|458971772|FG000|Overall Study|Withdrawal by Subject|2|||
127546852|NCT00907335|458971773|FG001|Overall Study|Withdrawal by Subject|0|||
127546853|NCT00907335|458971772|FG000|Overall Study|Adverse Event|4|||
127546854|NCT00907335|458971773|FG001|Overall Study|Adverse Event|1|||
127546855|NCT00907335|458971772|FG000|Overall Study|Lost to Follow-up|2|||
127546856|NCT00907335|458971773|FG001|Overall Study|Lost to Follow-up|0|||
127546857|NCT03879772|458971774|FG000|Overall Study|Adverse Event|2|||
127546858|NCT03879772|458971775|FG001|Overall Study|Adverse Event|2|||
127546859|NCT03879772|458971776|FG002|Overall Study|Adverse Event|3|||
127546860|NCT03879772|458971777|FG003|Overall Study|Adverse Event|4|||
127546861|NCT03879772|458971778|FG004|Overall Study|Adverse Event|3|||
127546862|NCT03879772|458971774|FG000|Overall Study|Treatment Failure|1|||
127546863|NCT03879772|458971775|FG001|Overall Study|Treatment Failure|0|||
127546864|NCT03879772|458971776|FG002|Overall Study|Treatment Failure|0|||
127682177|NCT01426269|459462266|FG002|Period 2: 40 Weeks|Adverse Event|2|||
127682178|NCT01426269|459462264|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
127682179|NCT01426269|459462265|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
127682180|NCT01426269|459462266|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
127682181|NCT01426269|459462264|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
127682182|NCT01426269|459462265|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
127682183|NCT01426269|459462266|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
127682184|NCT01426269|459462264|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
127682185|NCT01426269|459462265|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
127682186|NCT01426269|459462266|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
127682187|NCT01426269|459462264|FG000|Period 2: 40 Weeks|Site closed|0|||
127682188|NCT01426269|459462265|FG001|Period 2: 40 Weeks|Site closed|6|||
127682189|NCT01426269|459462266|FG002|Period 2: 40 Weeks|Site closed|5|||
127682190|NCT01426269|459462264|FG000|Period 2: 40 Weeks|Relapsed|0|||
127682191|NCT01426269|459462265|FG001|Period 2: 40 Weeks|Relapsed|9|||
127682192|NCT01426269|459462266|FG002|Period 2: 40 Weeks|Relapsed|18|||
127682193|NCT00186186|459462270|FG000|Overall Study|Lack of Efficacy|3|||
127682194|NCT00186186|459462270|FG000|Overall Study|Withdrawal by Subject|3|||
127682195|NCT00186186|459462270|FG000|Overall Study|Not reported as to reason|2|||
127682196|NCT01113931|459462273|FG000|Overall Study|Adverse Event|2|||
127682197|NCT01113931|459462274|FG001|Overall Study|Adverse Event|2|||
127682198|NCT01113931|459462273|FG000|Overall Study|Physician Decision|0|||
127682199|NCT01113931|459462274|FG001|Overall Study|Physician Decision|2|||
127682200|NCT01113931|459462273|FG000|Overall Study|Lost to Follow-up|12|||
127682201|NCT01113931|459462274|FG001|Overall Study|Lost to Follow-up|9|||
127682202|NCT01113931|459462273|FG000|Overall Study|Various|2|||
127682203|NCT01113931|459462274|FG001|Overall Study|Various|4|||
128015993|NCT01163617|460682213|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
128015994|NCT01163617|460682214|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
127546865|NCT03879772|458971777|FG003|Overall Study|Treatment Failure|2|||
127546866|NCT03879772|458971778|FG004|Overall Study|Treatment Failure|1|||
127546867|NCT03879772|458971774|FG000|Overall Study|Lost to Follow-up|0|||
127546868|NCT03879772|458971775|FG001|Overall Study|Lost to Follow-up|0|||
127546869|NCT03879772|458971776|FG002|Overall Study|Lost to Follow-up|0|||
127546870|NCT03879772|458971777|FG003|Overall Study|Lost to Follow-up|0|||
127546871|NCT03879772|458971778|FG004|Overall Study|Lost to Follow-up|1|||
127546872|NCT03879772|458971774|FG000|Overall Study|Withdrawal by Subject|0|||
127682204|NCT01113931|459462273|FG000|Overall Study|Withdrawal by Subject|3|||
127682205|NCT01113931|459462274|FG001|Overall Study|Withdrawal by Subject|0|||
127546873|NCT03879772|458971775|FG001|Overall Study|Withdrawal by Subject|1|||
127546874|NCT03879772|458971776|FG002|Overall Study|Withdrawal by Subject|3|||
127546875|NCT03879772|458971777|FG003|Overall Study|Withdrawal by Subject|1|||
127546876|NCT03879772|458971778|FG004|Overall Study|Withdrawal by Subject|1|||
127546877|NCT03879772|458971774|FG000|Overall Study|Protocol Violation|0|||
127546878|NCT03879772|458971775|FG001|Overall Study|Protocol Violation|0|||
127546879|NCT03879772|458971776|FG002|Overall Study|Protocol Violation|3|||
127546880|NCT03879772|458971777|FG003|Overall Study|Protocol Violation|1|||
127546881|NCT03879772|458971778|FG004|Overall Study|Protocol Violation|2|||
127546882|NCT03879772|458971774|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
127546883|NCT03879772|458971775|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
127546884|NCT03879772|458971776|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
127546885|NCT03879772|458971777|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
127546886|NCT03879772|458971778|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
127546887|NCT00728689|458971785|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
127546888|NCT00728689|458971786|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
127546889|NCT01867671|458971787|FG000|Overall Study|Adverse Event|5|||
127546890|NCT01867671|458971788|FG001|Overall Study|Adverse Event|3|||
127546891|NCT01867671|458971787|FG000|Overall Study|Anaphylaxis|0|||
127546892|NCT01867671|458971788|FG001|Overall Study|Anaphylaxis|1|||
127546893|NCT01867671|458971787|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
127546894|NCT01867671|458971788|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
127546895|NCT01867671|458971787|FG000|Overall Study|Lost to Follow-up|0|||
127546896|NCT01867671|458971788|FG001|Overall Study|Lost to Follow-up|1|||
127546897|NCT01867671|458971787|FG000|Overall Study|Non-compliance with Study Drug|1|||
127546898|NCT01867671|458971788|FG001|Overall Study|Non-compliance with Study Drug|2|||
127546899|NCT01867671|458971787|FG000|Overall Study|Withdrawal by Subject|21|||
127546900|NCT01867671|458971788|FG001|Overall Study|Withdrawal by Subject|21|||
127546901|NCT01523366|458971789|FG000|Treatment Period 1|Withdrawal by Subject|1|||
127546902|NCT01523366|458971790|FG001|Treatment Period 1|Withdrawal by Subject|0|||
127546903|NCT01523366|458971789|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
127546904|NCT01523366|458971790|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
127546905|NCT04543279|458971795|FG000|Overall Study|Withdrawal by Subject|1|||
127546906|NCT04543279|458971796|FG001|Overall Study|Withdrawal by Subject|0|||
127546907|NCT04543279|458971795|FG000|Overall Study|Adverse Event|1|||
127546908|NCT04543279|458971796|FG001|Overall Study|Adverse Event|0|||
127546909|NCT04543279|458971795|FG000|Overall Study|Physician Decision|1|||
127546910|NCT04543279|458971796|FG001|Overall Study|Physician Decision|0|||
127546911|NCT00929695|458971797|FG000|Overall Study|Death|2|||
127546912|NCT00929695|458971798|FG001|Overall Study|Death|1|||
127546913|NCT00929695|458971797|FG000|Overall Study|Withdrawal by Subject|0|||
127546914|NCT00929695|458971798|FG001|Overall Study|Withdrawal by Subject|2|||
127546915|NCT00929695|458971797|FG000|Overall Study|discharge home|4|||
127546916|NCT00929695|458971798|FG001|Overall Study|discharge home|3|||
127546917|NCT00929695|458971797|FG000|Overall Study|incorrect stratification|2|||
127546918|NCT00929695|458971798|FG001|Overall Study|incorrect stratification|0|||
127546919|NCT00887809|458971800|FG000|Overall Study|Patient Not Treated|3|||
127546920|NCT00887809|458971801|FG001|Overall Study|Patient Not Treated|0|||
127546921|NCT00887809|458971800|FG000|Overall Study|Death|1|||
127546922|NCT00887809|458971801|FG001|Overall Study|Death|0|||
127546923|NCT01352715|458971804|FG000|Overall Study|Death|3|||
127546924|NCT01352715|458971805|FG001|Overall Study|Death|3|||
127546925|NCT01352715|458971804|FG000|Overall Study|Lost to Follow-up|5|||
127546926|NCT01352715|458971805|FG001|Overall Study|Lost to Follow-up|7|||
127546927|NCT01352715|458971804|FG000|Overall Study|Withdrawal by Subject|4|||
127546928|NCT01352715|458971805|FG001|Overall Study|Withdrawal by Subject|8|||
127546929|NCT01352715|458971804|FG000|Overall Study|site closure|16|||
127546930|NCT01352715|458971805|FG001|Overall Study|site closure|15|||
127546931|NCT01352715|458971804|FG000|Overall Study|no final visit in closeout period|15|||
127546932|NCT01352715|458971805|FG001|Overall Study|no final visit in closeout period|12|||
127546933|NCT01352715|458971804|FG000|Overall Study|major ineligibility|2|||
127546934|NCT01352715|458971805|FG001|Overall Study|major ineligibility|1|||
127682206|NCT02567656|459462275|FG000|Overall Study|Premature discontinuation due to PD|1|||
127682207|NCT02567656|459462276|FG001|Overall Study|Premature discontinuation due to PD|1|||
127682208|NCT02567656|459462277|FG002|Overall Study|Premature discontinuation due to PD|2|||
127546935|NCT00871975|458971806|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
127546936|NCT00871975|458971806|FG000|Overall Study|Catheters could not be inserted|1|||
127546937|NCT00871975|458971806|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
127546938|NCT00871975|458971806|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
127546939|NCT00870740|458971807|FG000|Overall Study|Adverse Event|2|||
127546940|NCT00870740|458971808|FG001|Overall Study|Adverse Event|1|||
127546941|NCT00870740|458971809|FG002|Overall Study|Adverse Event|3|||
127546942|NCT00870740|458971810|FG003|Overall Study|Adverse Event|2|||
127546943|NCT00870740|458971811|FG004|Overall Study|Adverse Event|1|||
127546944|NCT00870740|458971812|FG005|Overall Study|Adverse Event|6|||
127546945|NCT00870740|458971807|FG000|Overall Study|Consent Withdrawn|6|||
127546946|NCT00870740|458971808|FG001|Overall Study|Consent Withdrawn|3|||
127546947|NCT00870740|458971809|FG002|Overall Study|Consent Withdrawn|4|||
127546948|NCT00870740|458971810|FG003|Overall Study|Consent Withdrawn|6|||
127546949|NCT00870740|458971811|FG004|Overall Study|Consent Withdrawn|6|||
127546950|NCT00870740|458971812|FG005|Overall Study|Consent Withdrawn|5|||
127546951|NCT00870740|458971807|FG000|Overall Study|Investigator Decision|2|||
127546952|NCT00870740|458971808|FG001|Overall Study|Investigator Decision|0|||
127546953|NCT00870740|458971809|FG002|Overall Study|Investigator Decision|1|||
127546954|NCT00870740|458971810|FG003|Overall Study|Investigator Decision|0|||
127546955|NCT00870740|458971811|FG004|Overall Study|Investigator Decision|0|||
127546956|NCT00870740|458971812|FG005|Overall Study|Investigator Decision|0|||
127546957|NCT00870740|458971807|FG000|Overall Study|Subject Non-compliance|0|||
127546958|NCT00870740|458971808|FG001|Overall Study|Subject Non-compliance|0|||
127546959|NCT00870740|458971809|FG002|Overall Study|Subject Non-compliance|0|||
127546960|NCT00870740|458971810|FG003|Overall Study|Subject Non-compliance|0|||
127546961|NCT00870740|458971811|FG004|Overall Study|Subject Non-compliance|0|||
127546962|NCT00870740|458971812|FG005|Overall Study|Subject Non-compliance|1|||
127682209|NCT02567656|459462278|FG003|Overall Study|Premature discontinuation due to PD|0|||
127682210|NCT02567656|459462279|FG004|Overall Study|Premature discontinuation due to PD|0|||
127682211|NCT02567656|459462280|FG005|Overall Study|Premature discontinuation due to PD|0|||
127682212|NCT03959241|459462286|FG000|Overall Study|Withdrawal by Subject|7|||
127682213|NCT03959241|459462287|FG001|Overall Study|Withdrawal by Subject|8|||
127682214|NCT03959241|459462286|FG000|Overall Study|Lost to Follow-up|1|||
127682215|NCT03959241|459462287|FG001|Overall Study|Lost to Follow-up|0|||
127682216|NCT03959241|459462286|FG000|Overall Study|Move to Hospice Care|1|||
127682217|NCT03959241|459462287|FG001|Overall Study|Move to Hospice Care|0|||
127682218|NCT03959241|459462286|FG000|Overall Study|Screen Failure|1|||
127682219|NCT03959241|459462287|FG001|Overall Study|Screen Failure|0|||
127682220|NCT03959241|459462286|FG000|Overall Study|Disease Relapse|0|||
127682221|NCT03959241|459462287|FG001|Overall Study|Disease Relapse|1|||
127682222|NCT03959241|459462286|FG000|Overall Study|Off Study|1|||
127682223|NCT03959241|459462287|FG001|Overall Study|Off Study|0|||
127682224|NCT00367991|459462288|FG000|Overall Study|Withdrawal by Subject|1|||
127682225|NCT00367991|459462289|FG001|Overall Study|Withdrawal by Subject|1|||
127682226|NCT00367991|459462288|FG000|Overall Study|Adverse Event|1|||
127682227|NCT00367991|459462289|FG001|Overall Study|Adverse Event|1|||
127682228|NCT00346151|459462290|FG000|Overall Study|Withdrawal by Subject|3|||
127682229|NCT00463788|459462293|FG000|Overall Study|Progressive Disease|86|||
127682230|NCT00463788|459462294|FG001|Overall Study|Progressive Disease|42|||
127682231|NCT00463788|459462293|FG000|Overall Study|Adverse Event|6|||
127682232|NCT00463788|459462294|FG001|Overall Study|Adverse Event|2|||
127682233|NCT00463788|459462293|FG000|Overall Study|Withdrawal by Subject|6|||
127682234|NCT00463788|459462294|FG001|Overall Study|Withdrawal by Subject|2|||
127682235|NCT00463788|459462293|FG000|Overall Study|Death|4|||
127682236|NCT00463788|459462294|FG001|Overall Study|Death|3|||
127682237|NCT00463788|459462293|FG000|Overall Study|Symptomatic Deterioration|2|||
127682238|NCT00463788|459462294|FG001|Overall Study|Symptomatic Deterioration|3|||
127682239|NCT00463788|459462293|FG000|Overall Study|Lost to Follow-up|1|||
127682240|NCT00463788|459462294|FG001|Overall Study|Lost to Follow-up|0|||
127682241|NCT00463788|459462293|FG000|Overall Study|Protocol Violation|0|||
127682242|NCT00463788|459462294|FG001|Overall Study|Protocol Violation|1|||
127682243|NCT00463788|459462293|FG000|Overall Study|Other|3|||
127682244|NCT00463788|459462294|FG001|Overall Study|Other|0|||
127682245|NCT00463788|459462293|FG000|Overall Study|Randomized but not treated|1|||
127682246|NCT00463788|459462294|FG001|Overall Study|Randomized but not treated|1|||
127682247|NCT00360698|459462295|FG000|Run-In|Physician Decision|0|||
127682248|NCT00360698|459462296|FG001|Run-In|Physician Decision|1|||
127682249|NCT00360698|459462295|FG000|Run-In|Withdrawal by Subject|0|||
127682250|NCT00360698|459462296|FG001|Run-In|Withdrawal by Subject|2|||
127682251|NCT00360698|459462295|FG000|Run-In|Non compliance with treatment procedure|0|||
127682252|NCT00360698|459462296|FG001|Run-In|Non compliance with treatment procedure|1|||
127682253|NCT00360698|459462295|FG000|Run-In|Sponsor request|0|||
127682254|NCT00360698|459462296|FG001|Run-In|Sponsor request|2|||
127682255|NCT00360698|459462295|FG000|Run-In|Patient did not meet inclusion criteria|0|||
127546963|NCT00870740|458971807|FG000|Overall Study|Death|0|||
127546964|NCT00870740|458971808|FG001|Overall Study|Death|0|||
127546965|NCT00870740|458971809|FG002|Overall Study|Death|0|||
127682256|NCT00360698|459462296|FG001|Run-In|Patient did not meet inclusion criteria|1|||
127682257|NCT00360698|459462295|FG000|Run-In|Patient personal reasons|0|||
127682258|NCT00360698|459462296|FG001|Run-In|Patient personal reasons|2|||
127682259|NCT00360698|459462295|FG000|Run-In|Need of insulin with meals|0|||
127682260|NCT00360698|459462296|FG001|Run-In|Need of insulin with meals|1|||
127768390|NCT00986674|459778022|FG002|Overall Study|Adverse Event|9|||
127768391|NCT00986674|459778020|FG000|Overall Study|Death|5|||
127546966|NCT00870740|458971810|FG003|Overall Study|Death|0|||
127546967|NCT00870740|458971811|FG004|Overall Study|Death|1|||
127546968|NCT00870740|458971812|FG005|Overall Study|Death|0|||
127546969|NCT00870740|458971807|FG000|Overall Study|Other|2|||
127546970|NCT00870740|458971808|FG001|Overall Study|Other|5|||
127546971|NCT00870740|458971809|FG002|Overall Study|Other|2|||
127546972|NCT00870740|458971810|FG003|Overall Study|Other|4|||
127546973|NCT00870740|458971811|FG004|Overall Study|Other|3|||
127546974|NCT00870740|458971812|FG005|Overall Study|Other|5|||
127546975|NCT03755934|458971813|FG000|Overall Study|Adverse Event|4|||
127546976|NCT03755934|458971814|FG001|Overall Study|Adverse Event|1|||
127546977|NCT03755934|458971815|FG002|Overall Study|Adverse Event|1|||
127546978|NCT03755934|458971816|FG003|Overall Study|Adverse Event|3|||
127546979|NCT03755934|458971813|FG000|Overall Study|Physician Decision|2|||
127546980|NCT03755934|458971814|FG001|Overall Study|Physician Decision|0|||
127546981|NCT03755934|458971815|FG002|Overall Study|Physician Decision|0|||
127546982|NCT03755934|458971816|FG003|Overall Study|Physician Decision|1|||
127546983|NCT03755934|458971813|FG000|Overall Study|Withdrawal by Subject|5|||
127546984|NCT03755934|458971814|FG001|Overall Study|Withdrawal by Subject|0|||
127546985|NCT03755934|458971815|FG002|Overall Study|Withdrawal by Subject|0|||
127546986|NCT03755934|458971816|FG003|Overall Study|Withdrawal by Subject|1|||
127546987|NCT03755934|458971813|FG000|Overall Study|Other|3|||
127546988|NCT03755934|458971814|FG001|Overall Study|Other|1|||
127546989|NCT03755934|458971815|FG002|Overall Study|Other|3|||
127546990|NCT03755934|458971816|FG003|Overall Study|Other|1|||
127546991|NCT00307801|458971819|FG000|Overall Study|Adverse Event|12|||
127546992|NCT00307801|458971820|FG001|Overall Study|Adverse Event|4|||
127546993|NCT00307801|458971819|FG000|Overall Study|Withdrawal by Subject|9|||
127546994|NCT00307801|458971820|FG001|Overall Study|Withdrawal by Subject|4|||
127546995|NCT00307801|458971819|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
127546996|NCT00307801|458971820|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
127546997|NCT00307801|458971819|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
127546998|NCT00307801|458971820|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
127546999|NCT00307801|458971819|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
127547000|NCT00307801|458971820|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
127547001|NCT00307801|458971819|FG000|Overall Study|Wrong Randomization|1|||
127547002|NCT00307801|458971820|FG001|Overall Study|Wrong Randomization|0|||
127547003|NCT00307801|458971819|FG000|Overall Study|Lack of Efficacy|0|||
127547004|NCT00307801|458971820|FG001|Overall Study|Lack of Efficacy|2|||
127547005|NCT00307801|458971819|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
127547006|NCT00307801|458971820|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
127547007|NCT00307801|458971819|FG000|Overall Study|Frustration with e-diary|1|||
127547008|NCT00307801|458971820|FG001|Overall Study|Frustration with e-diary|0|||
127547009|NCT00307801|458971819|FG000|Overall Study|Protocol Violation|3|||
127547010|NCT00307801|458971820|FG001|Overall Study|Protocol Violation|2|||
127547011|NCT00307801|458971819|FG000|Overall Study|No reason specified|2|||
127547012|NCT00307801|458971820|FG001|Overall Study|No reason specified|0|||
127547013|NCT00307801|458971819|FG000|Overall Study|Pregnancy|0|||
127682261|NCT00360698|459462295|FG000|Treatment Period|Non compliance with treatment procedure|1|||
127682262|NCT00360698|459462296|FG001|Treatment Period|Non compliance with treatment procedure|0|||
127682263|NCT00360698|459462295|FG000|Treatment Period|Early termination by error|0|||
127682264|NCT00360698|459462296|FG001|Treatment Period|Early termination by error|1|||
127682265|NCT03024606|459462299|FG000|Overall Study|Withdrawal by Subject|9|||
127682266|NCT03024606|459462300|FG001|Overall Study|Withdrawal by Subject|10|||
127682267|NCT01692938|459462301|FG000|Overall Study|Protocol Deviation|1|||
127682268|NCT01692938|459462302|FG001|Overall Study|Protocol Deviation|1|||
127682269|NCT01692938|459462301|FG000|Overall Study|Study completed prior to site completion|3|||
127682270|NCT01692938|459462302|FG001|Overall Study|Study completed prior to site completion|3|||
127682271|NCT02547922|459462304|FG000|Overall Study|Withdrawal by Subject|9|||
127682272|NCT02547922|459462305|FG001|Overall Study|Withdrawal by Subject|6|||
127682273|NCT02547922|459462306|FG002|Overall Study|Withdrawal by Subject|10|||
127682274|NCT02547922|459462304|FG000|Overall Study|Adverse Event|3|||
127682275|NCT02547922|459462305|FG001|Overall Study|Adverse Event|1|||
127682276|NCT02547922|459462306|FG002|Overall Study|Adverse Event|2|||
127682277|NCT02547922|459462304|FG000|Overall Study|Lost to Follow-up|1|||
127682278|NCT02547922|459462305|FG001|Overall Study|Lost to Follow-up|0|||
127682279|NCT02547922|459462306|FG002|Overall Study|Lost to Follow-up|0|||
127682280|NCT02547922|459462304|FG000|Overall Study|Lack of Efficacy|5|||
127768392|NCT00986674|459778021|FG001|Overall Study|Death|0|||
127768393|NCT00986674|459778022|FG002|Overall Study|Death|4|||
127682281|NCT02547922|459462305|FG001|Overall Study|Lack of Efficacy|7|||
127682282|NCT02547922|459462306|FG002|Overall Study|Lack of Efficacy|4|||
127682283|NCT02547922|459462304|FG000|Overall Study|Death|1|||
127682284|NCT02547922|459462305|FG001|Overall Study|Death|0|||
127547014|NCT00307801|458971820|FG001|Overall Study|Pregnancy|1|||
127547015|NCT00551642|458971823|FG000|Treatment Period|Protocol Deviation|6|||
127547016|NCT00551642|458971824|FG001|Treatment Period|Protocol Deviation|11|||
127547017|NCT00551642|458971823|FG000|Treatment Period|Delivery device failure|1|||
127547018|NCT00551642|458971824|FG001|Treatment Period|Delivery device failure|3|||
127547019|NCT00551642|458971823|FG000|Treatment Period|Physician Decision|0|||
127547020|NCT00551642|458971824|FG001|Treatment Period|Physician Decision|1|||
127547021|NCT00551642|458971823|FG000|Treatment Period|Death|33|||
127547022|NCT00551642|458971824|FG001|Treatment Period|Death|31|||
127682285|NCT02547922|459462306|FG002|Overall Study|Death|0|||
127547023|NCT00551642|458971823|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
127547024|NCT00551642|458971824|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
127547025|NCT00551642|458971823|FG000|Treatment Period|Adverse Event|15|||
127547026|NCT00551642|458971824|FG001|Treatment Period|Adverse Event|12|||
127547027|NCT00551642|458971823|FG000|Treatment Period|Withdrawal by Subject|2|||
127547028|NCT00551642|458971824|FG001|Treatment Period|Withdrawal by Subject|1|||
127547029|NCT03011099|458971825|FG000|Overall Study|Withdrawal by Subject|0|||
127547030|NCT03011099|458971826|FG001|Overall Study|Withdrawal by Subject|2|||
127547031|NCT01217229|458971829|FG000|Overall Study|Adverse Event|1|||
127547032|NCT01217229|458971829|FG000|Overall Study|Disease progression, deterioration|2|||
127547033|NCT01217229|458971829|FG000|Overall Study|Disease progression, Cheson criteria|14|||
127547034|NCT01217229|458971829|FG000|Overall Study|Protocol Violation|1|||
127547035|NCT01217229|458971829|FG000|Overall Study|Disease progression not confirmed|2|||
127547036|NCT03783078|458971832|FG000|Overall Study|Death|31|||
127547037|NCT03783078|458971832|FG000|Overall Study|Sponsor Decision|23|||
127547038|NCT03783078|458971832|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
127547039|NCT03955146|458971836|FG000|DB Period (48 Weeks)|Study terminated by sponsor|0|||
127547040|NCT03955146|458971837|FG001|DB Period (48 Weeks)|Study terminated by sponsor|0|||
127547041|NCT03955146|458971838|FG002|DB Period (48 Weeks)|Study terminated by sponsor|1|||
127547042|NCT03955146|458971839|FG003|DB Period (48 Weeks)|Study terminated by sponsor|4|||
127547043|NCT03955146|458971836|FG000|DB Period (48 Weeks)|Adverse Event|2|||
127547044|NCT03955146|458971837|FG001|DB Period (48 Weeks)|Adverse Event|5|||
127547045|NCT03955146|458971838|FG002|DB Period (48 Weeks)|Adverse Event|1|||
127547046|NCT03955146|458971839|FG003|DB Period (48 Weeks)|Adverse Event|2|||
127547047|NCT03955146|458971836|FG000|DB Period (48 Weeks)|Death|13|||
127547048|NCT03955146|458971837|FG001|DB Period (48 Weeks)|Death|17|||
127547049|NCT03955146|458971838|FG002|DB Period (48 Weeks)|Death|1|||
127547050|NCT03955146|458971839|FG003|DB Period (48 Weeks)|Death|0|||
127547051|NCT03955146|458971836|FG000|DB Period (48 Weeks)|Investigator Decision|2|||
127547052|NCT03955146|458971837|FG001|DB Period (48 Weeks)|Investigator Decision|2|||
127547053|NCT03955146|458971838|FG002|DB Period (48 Weeks)|Investigator Decision|0|||
127547054|NCT03955146|458971839|FG003|DB Period (48 Weeks)|Investigator Decision|0|||
127547055|NCT03955146|458971836|FG000|DB Period (48 Weeks)|Disease Progression|2|||
127547056|NCT03955146|458971837|FG001|DB Period (48 Weeks)|Disease Progression|0|||
127547057|NCT03955146|458971838|FG002|DB Period (48 Weeks)|Disease Progression|0|||
127547058|NCT03955146|458971839|FG003|DB Period (48 Weeks)|Disease Progression|0|||
127547059|NCT03955146|458971836|FG000|DB Period (48 Weeks)|Withdrawal by Subject|6|||
127547060|NCT03955146|458971837|FG001|DB Period (48 Weeks)|Withdrawal by Subject|3|||
127547061|NCT03955146|458971838|FG002|DB Period (48 Weeks)|Withdrawal by Subject|0|||
127547062|NCT03955146|458971839|FG003|DB Period (48 Weeks)|Withdrawal by Subject|1|||
127547063|NCT03955146|458971836|FG000|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
127547064|NCT03955146|458971837|FG001|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
127547065|NCT03955146|458971838|FG002|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
127768394|NCT00986674|459778020|FG000|Overall Study|Withdrawal by Subject|6|||
127768395|NCT00986674|459778021|FG001|Overall Study|Withdrawal by Subject|2|||
127768396|NCT00986674|459778022|FG002|Overall Study|Withdrawal by Subject|1|||
127768397|NCT00986674|459778020|FG000|Overall Study|alternative therapy|0|||
127768398|NCT00986674|459778021|FG001|Overall Study|alternative therapy|0|||
127768399|NCT00986674|459778022|FG002|Overall Study|alternative therapy|1|||
127768400|NCT00986674|459778020|FG000|Overall Study|not start protocol therapy|4|||
127768401|NCT00986674|459778021|FG001|Overall Study|not start protocol therapy|3|||
127768402|NCT00986674|459778022|FG002|Overall Study|not start protocol therapy|1|||
127768403|NCT00986674|459778020|FG000|Overall Study|unknown/not specify|0|||
127768404|NCT00986674|459778021|FG001|Overall Study|unknown/not specify|7|||
127768405|NCT00986674|459778022|FG002|Overall Study|unknown/not specify|9|||
127768406|NCT02128542|459778023|FG000|Overall Study|Lost to Follow-up|3|||
127768407|NCT02128542|459778024|FG001|Overall Study|Lost to Follow-up|0|||
127768408|NCT02128542|459778023|FG000|Overall Study|Withdrew Consent|1|||
127768409|NCT02128542|459778024|FG001|Overall Study|Withdrew Consent|0|||
127768410|NCT01853137|459778025|FG000|Overall Study|Lost to Follow-up|4|||
127768411|NCT01853137|459778026|FG001|Overall Study|Lost to Follow-up|1|||
127768412|NCT00825916|459778027|FG000|Overall Study|Lost to Follow-up|4|||
127768413|NCT00825916|459778028|FG001|Overall Study|Lost to Follow-up|2|||
127768414|NCT00825916|459778029|FG002|Overall Study|Lost to Follow-up|1|||
127768415|NCT01778023|459778030|FG000|Overall Study|Withdrawal by Subject|0|||
127768416|NCT01778023|459778031|FG001|Overall Study|Withdrawal by Subject|3|||
127768417|NCT01990560|459778032|FG000|Overall Study|Withdrawal by Subject|1|||
127547066|NCT03955146|458971839|FG003|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
127547067|NCT03955146|458971836|FG000|DB Period (48 Weeks)|Lung Transplant|0|||
127547068|NCT03955146|458971837|FG001|DB Period (48 Weeks)|Lung Transplant|1|||
127547069|NCT03955146|458971838|FG002|DB Period (48 Weeks)|Lung Transplant|0|||
127547070|NCT03955146|458971839|FG003|DB Period (48 Weeks)|Lung Transplant|0|||
127547071|NCT03955146|458971836|FG000|DB Period (48 Weeks)|Participant Decision|9|||
127547072|NCT03955146|458971837|FG001|DB Period (48 Weeks)|Participant Decision|12|||
127547073|NCT03955146|458971838|FG002|DB Period (48 Weeks)|Participant Decision|1|||
127682286|NCT02547922|459462304|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
127682287|NCT02547922|459462305|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
127682288|NCT02547922|459462306|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
127682289|NCT02547922|459462304|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
127682290|NCT02547922|459462305|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
127682291|NCT02547922|459462306|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
127682292|NCT02547922|459462304|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
127682293|NCT02547922|459462305|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
127682294|NCT02547922|459462306|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
127682295|NCT02547922|459462304|FG000|Overall Study|Physician Decision|2|||
127682296|NCT02547922|459462305|FG001|Overall Study|Physician Decision|1|||
127682297|NCT02547922|459462306|FG002|Overall Study|Physician Decision|2|||
127682298|NCT02547922|459462304|FG000|Overall Study|Patients did not receive IP|1|||
127682299|NCT02547922|459462305|FG001|Overall Study|Patients did not receive IP|1|||
127682300|NCT02547922|459462306|FG002|Overall Study|Patients did not receive IP|0|||
127682301|NCT01317420|459462311|FG000|Overall Study|Progressive disease according to RECIST|2|||
127682302|NCT01317420|459462312|FG001|Overall Study|Progressive disease according to RECIST|3|||
127682303|NCT01317420|459462313|FG002|Overall Study|Progressive disease according to RECIST|3|||
127682304|NCT01317420|459462314|FG003|Overall Study|Progressive disease according to RECIST|3|||
127682305|NCT01317420|459462315|FG004|Overall Study|Progressive disease according to RECIST|3|||
127682306|NCT01317420|459462316|FG005|Overall Study|Progressive disease according to RECIST|3|||
127682307|NCT01317420|459462317|FG006|Overall Study|Progressive disease according to RECIST|3|||
127682308|NCT01317420|459462318|FG007|Overall Study|Progressive disease according to RECIST|3|||
127682309|NCT01317420|459462319|FG008|Overall Study|Progressive disease according to RECIST|3|||
127682310|NCT01317420|459462320|FG009|Overall Study|Progressive disease according to RECIST|2|||
127682311|NCT01317420|459462321|FG010|Overall Study|Progressive disease according to RECIST|3|||
127682312|NCT01317420|459462322|FG011|Overall Study|Progressive disease according to RECIST|11|||
127682313|NCT01317420|459462323|FG012|Overall Study|Progressive disease according to RECIST|16|||
127682314|NCT01317420|459462311|FG000|Overall Study|Other adverse event|1|||
127682315|NCT01317420|459462312|FG001|Overall Study|Other adverse event|0|||
127682316|NCT01317420|459462313|FG002|Overall Study|Other adverse event|0|||
127682317|NCT01317420|459462314|FG003|Overall Study|Other adverse event|0|||
127682318|NCT01317420|459462315|FG004|Overall Study|Other adverse event|0|||
127682319|NCT01317420|459462316|FG005|Overall Study|Other adverse event|0|||
127682320|NCT01317420|459462317|FG006|Overall Study|Other adverse event|0|||
127682321|NCT01317420|459462318|FG007|Overall Study|Other adverse event|0|||
127682322|NCT01317420|459462319|FG008|Overall Study|Other adverse event|0|||
127682323|NCT01317420|459462320|FG009|Overall Study|Other adverse event|0|||
127682324|NCT01317420|459462321|FG010|Overall Study|Other adverse event|0|||
127682325|NCT01317420|459462322|FG011|Overall Study|Other adverse event|0|||
127682326|NCT01317420|459462323|FG012|Overall Study|Other adverse event|2|||
127682327|NCT01317420|459462311|FG000|Overall Study|Non-compliant with protocol|0|||
127682328|NCT01317420|459462312|FG001|Overall Study|Non-compliant with protocol|0|||
127682329|NCT01317420|459462313|FG002|Overall Study|Non-compliant with protocol|0|||
127682330|NCT01317420|459462314|FG003|Overall Study|Non-compliant with protocol|0|||
127682331|NCT01317420|459462315|FG004|Overall Study|Non-compliant with protocol|0|||
127682332|NCT01317420|459462316|FG005|Overall Study|Non-compliant with protocol|0|||
127682333|NCT01317420|459462317|FG006|Overall Study|Non-compliant with protocol|0|||
127682334|NCT01317420|459462318|FG007|Overall Study|Non-compliant with protocol|0|||
127682335|NCT01317420|459462319|FG008|Overall Study|Non-compliant with protocol|0|||
127682336|NCT01317420|459462320|FG009|Overall Study|Non-compliant with protocol|0|||
127682337|NCT01317420|459462321|FG010|Overall Study|Non-compliant with protocol|0|||
127682338|NCT01317420|459462322|FG011|Overall Study|Non-compliant with protocol|0|||
127682339|NCT01317420|459462323|FG012|Overall Study|Non-compliant with protocol|1|||
127682340|NCT01317420|459462311|FG000|Overall Study|Refused to cont. taking trial medication|0|||
127682341|NCT01317420|459462312|FG001|Overall Study|Refused to cont. taking trial medication|0|||
127682342|NCT01317420|459462313|FG002|Overall Study|Refused to cont. taking trial medication|0|||
127682343|NCT01317420|459462314|FG003|Overall Study|Refused to cont. taking trial medication|0|||
127682344|NCT01317420|459462315|FG004|Overall Study|Refused to cont. taking trial medication|0|||
127682345|NCT01317420|459462316|FG005|Overall Study|Refused to cont. taking trial medication|0|||
127682346|NCT01317420|459462317|FG006|Overall Study|Refused to cont. taking trial medication|0|||
127682347|NCT01317420|459462318|FG007|Overall Study|Refused to cont. taking trial medication|0|||
127682348|NCT01317420|459462319|FG008|Overall Study|Refused to cont. taking trial medication|0|||
127682349|NCT01317420|459462320|FG009|Overall Study|Refused to cont. taking trial medication|0|||
127682350|NCT01317420|459462321|FG010|Overall Study|Refused to cont. taking trial medication|0|||
127682351|NCT01317420|459462322|FG011|Overall Study|Refused to cont. taking trial medication|0|||
127682352|NCT01317420|459462323|FG012|Overall Study|Refused to cont. taking trial medication|1|||
127682353|NCT01317420|459462311|FG000|Overall Study|Reason other than those specified|0|||
127682354|NCT01317420|459462312|FG001|Overall Study|Reason other than those specified|0|||
127682355|NCT01317420|459462313|FG002|Overall Study|Reason other than those specified|0|||
127768418|NCT01098097|459778033|FG000|Overall Study|Adverse Event|17|||
127768419|NCT01098097|459778033|FG000|Overall Study|Lost to Follow-up|18|||
127768420|NCT01098097|459778033|FG000|Overall Study|Status unknown|16|||
127768421|NCT01098097|459778033|FG000|Overall Study|No reason reported|31|||
127768422|NCT01411215|459778034|FG000|Overall Study|Adverse Event|1|||
127768423|NCT01411215|459778035|FG001|Overall Study|Adverse Event|2|||
127768424|NCT01411215|459778034|FG000|Overall Study|Lack of Efficacy|2|||
127768425|NCT01411215|459778035|FG001|Overall Study|Lack of Efficacy|4|||
127768426|NCT01411215|459778034|FG000|Overall Study|Lost to Follow-up|12|||
127768427|NCT01411215|459778035|FG001|Overall Study|Lost to Follow-up|18|||
127768428|NCT01411215|459778034|FG000|Overall Study|Did not meet entrance criteria|0|||
127768429|NCT01411215|459778035|FG001|Overall Study|Did not meet entrance criteria|1|||
127768430|NCT01411215|459778034|FG000|Overall Study|Study terminated by sponsor|2|||
127768431|NCT01411215|459778035|FG001|Overall Study|Study terminated by sponsor|15|||
127768432|NCT01411215|459778034|FG000|Overall Study|Protocol Violation|3|||
127768433|NCT01411215|459778035|FG001|Overall Study|Protocol Violation|5|||
127768434|NCT01411215|459778034|FG000|Overall Study|Withdrawal by Subject|34|||
127768435|NCT01411215|459778035|FG001|Overall Study|Withdrawal by Subject|21|||
127768436|NCT01411215|459778034|FG000|Overall Study|Other|12|||
127768437|NCT01411215|459778035|FG001|Overall Study|Other|17|||
127768438|NCT01411215|459778034|FG000|Overall Study|Screen failure|0|||
127768439|NCT01411215|459778035|FG001|Overall Study|Screen failure|1|||
127768440|NCT00848926|459778036|FG000|Treatment Period|Progressive disease|45|||
127768441|NCT00848926|459778036|FG000|Treatment Period|Adverse Event|20|||
127768442|NCT00848926|459778036|FG000|Treatment Period|Physician Decision|12|||
127768443|NCT00848926|459778036|FG000|Treatment Period|Withdrawal by Subject|7|||
127768444|NCT00848926|459778036|FG000|Follow-up Period|Lost to Follow-up|7|||
127768445|NCT00848926|459778036|FG000|Follow-up Period|Withdrawal by Subject|3|||
127768446|NCT00848926|459778036|FG000|Follow-up Period|Other|2|||
127768447|NCT04025580|459778037|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
127768448|NCT04025580|459778038|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
127768449|NCT04025580|459778039|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
127768450|NCT04507126|459778042|FG000|Overall Study|Withdrawal by Subject|1|||
127768451|NCT04507126|459778042|FG000|Overall Study|Protocol Violation|2|||
127768452|NCT04507126|459778042|FG000|Overall Study|Physician Decision|1|||
127768453|NCT02924064|459778043|FG000|Overall Study|Adverse Event|2|||
127768454|NCT02924064|459778044|FG001|Overall Study|Adverse Event|2|||
127768455|NCT02924064|459778043|FG000|Overall Study|Lost to Follow-up|0|||
127768456|NCT02924064|459778044|FG001|Overall Study|Lost to Follow-up|2|||
127768457|NCT02924064|459778043|FG000|Overall Study|Physician Decision|0|||
127768458|NCT02924064|459778044|FG001|Overall Study|Physician Decision|2|||
127768459|NCT02924064|459778043|FG000|Overall Study|Protocol Violation|1|||
127768460|NCT02924064|459778044|FG001|Overall Study|Protocol Violation|3|||
127768461|NCT02924064|459778043|FG000|Overall Study|Withdrawal by Subject|4|||
127768462|NCT02924064|459778044|FG001|Overall Study|Withdrawal by Subject|5|||
127768463|NCT02924064|459778043|FG000|Overall Study|Other|17|||
127768464|NCT02924064|459778044|FG001|Overall Study|Other|29|||
127768465|NCT00966277|459778047|FG000|Overall Study|Withdrawal by Subject|3|||
127768466|NCT00966277|459778048|FG001|Overall Study|Withdrawal by Subject|0|||
127768467|NCT00966277|459778047|FG000|Overall Study|Ineligible|1|||
127768468|NCT00966277|459778048|FG001|Overall Study|Ineligible|3|||
127768469|NCT00966277|459778047|FG000|Overall Study|Treatment Plan Changed|0|||
127768470|NCT00966277|459778048|FG001|Overall Study|Treatment Plan Changed|1|||
127768471|NCT00138671|459778049|FG000|Overall Study|Death|0|||
127768472|NCT00138671|459778050|FG001|Overall Study|Death|3|||
127768473|NCT00138671|459778049|FG000|Overall Study|Adverse Event|6|||
127768474|NCT00138671|459778050|FG001|Overall Study|Adverse Event|3|||
127768475|NCT00138671|459778049|FG000|Overall Study|Lost to Follow-up|1|||
127768476|NCT00138671|459778050|FG001|Overall Study|Lost to Follow-up|2|||
127768477|NCT00138671|459778049|FG000|Overall Study|Withdrawal by Subject|3|||
127768478|NCT00138671|459778050|FG001|Overall Study|Withdrawal by Subject|5|||
127768479|NCT00138671|459778049|FG000|Overall Study|Other|3|||
127768480|NCT00138671|459778050|FG001|Overall Study|Other|3|||
127768481|NCT01488487|459778051|FG000|Overall Study|Adverse Event|6|||
127768482|NCT01488487|459778051|FG000|Overall Study|Death|1|||
128015995|NCT01163617|460682215|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
127768483|NCT01488487|459778051|FG000|Overall Study|Withdrawal by Subject|2|||
127768484|NCT01100034|459778052|FG000|Overall Study|Lost to Follow-up|11|||
127768485|NCT01100034|459778052|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
127768486|NCT01100034|459778052|FG000|Overall Study|Withdrawal by Subject|4|||
128015996|NCT01163617|460682216|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
127768487|NCT01100034|459778052|FG000|Overall Study|Sponsor decision|21|||
127768488|NCT01100034|459778052|FG000|Overall Study|Participated in another clinical trial|1|||
127768489|NCT01100034|459778052|FG000|Overall Study|Participants moved to another hospital|4|||
127768490|NCT01100034|459778052|FG000|Overall Study|Site closed due to non-responsiveness|1|||
127768491|NCT01831856|459778053|FG000|Overall Study|Adverse Event|5|||
127768492|NCT01831856|459778054|FG001|Overall Study|Adverse Event|8|||
127768493|NCT01831856|459778053|FG000|Overall Study|Lack of Efficacy|13|||
127682356|NCT01317420|459462314|FG003|Overall Study|Reason other than those specified|0|||
127682357|NCT01317420|459462315|FG004|Overall Study|Reason other than those specified|0|||
127682358|NCT01317420|459462316|FG005|Overall Study|Reason other than those specified|0|||
127682359|NCT01317420|459462317|FG006|Overall Study|Reason other than those specified|0|||
127682360|NCT01317420|459462318|FG007|Overall Study|Reason other than those specified|0|||
127682361|NCT01317420|459462319|FG008|Overall Study|Reason other than those specified|0|||
127682362|NCT01317420|459462320|FG009|Overall Study|Reason other than those specified|1|||
127682363|NCT01317420|459462321|FG010|Overall Study|Reason other than those specified|0|||
127682364|NCT01317420|459462322|FG011|Overall Study|Reason other than those specified|0|||
127682365|NCT01317420|459462323|FG012|Overall Study|Reason other than those specified|0|||
127682366|NCT03194958|459462324|FG000|Overall Study|Death|0|||
127682367|NCT03194958|459462325|FG001|Overall Study|Death|1|||
127682368|NCT03194958|459462326|FG002|Overall Study|Death|1|||
127682369|NCT03194958|459462327|FG003|Overall Study|Death|1|||
127682370|NCT03194958|459462324|FG000|Overall Study|Withdrawal by Subject|24|||
127682371|NCT03194958|459462325|FG001|Overall Study|Withdrawal by Subject|27|||
127682372|NCT03194958|459462326|FG002|Overall Study|Withdrawal by Subject|7|||
127682373|NCT03194958|459462327|FG003|Overall Study|Withdrawal by Subject|22|||
127682374|NCT03194958|459462324|FG000|Overall Study|Lost to Follow-up|168|||
127682375|NCT03194958|459462325|FG001|Overall Study|Lost to Follow-up|196|||
127682376|NCT03194958|459462326|FG002|Overall Study|Lost to Follow-up|174|||
127682377|NCT03194958|459462327|FG003|Overall Study|Lost to Follow-up|186|||
127682378|NCT01968226|459462329|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
127682379|NCT04975308|459462337|FG000|Overall Study|Withdrawal by Subject|6|||
127682380|NCT04975308|459462338|FG001|Overall Study|Withdrawal by Subject|16|||
127682381|NCT04975308|459462339|FG002|Overall Study|Withdrawal by Subject|6|||
127682382|NCT04975308|459462337|FG000|Overall Study|Physician Decision|0|||
127682383|NCT04975308|459462338|FG001|Overall Study|Physician Decision|3|||
127682384|NCT04975308|459462339|FG002|Overall Study|Physician Decision|1|||
127682385|NCT04975308|459462337|FG000|Overall Study|Adverse Event|10|||
127682386|NCT04975308|459462338|FG001|Overall Study|Adverse Event|1|||
127682387|NCT04975308|459462339|FG002|Overall Study|Adverse Event|12|||
127682388|NCT04975308|459462337|FG000|Overall Study|On study treatment (Ongoing)|65|||
127682389|NCT04975308|459462338|FG001|Overall Study|On study treatment (Ongoing)|43|||
127682390|NCT04975308|459462339|FG002|Overall Study|On study treatment (Ongoing)|75|||
127682391|NCT04975308|459462337|FG000|Overall Study|Protocol Deviation|4|||
127682392|NCT04975308|459462338|FG001|Overall Study|Protocol Deviation|3|||
127682393|NCT04975308|459462339|FG002|Overall Study|Protocol Deviation|2|||
127682394|NCT02709655|459462340|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
127682395|NCT02709655|459462341|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
127682396|NCT02709655|459462342|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
127682397|NCT02709655|459462343|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
127682398|NCT02709655|459462344|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
127682399|NCT02709655|459462340|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
127682400|NCT02709655|459462341|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
127682401|NCT02709655|459462342|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
127682402|NCT02709655|459462343|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
127682403|NCT02709655|459462344|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
127682404|NCT02709655|459462340|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
127682405|NCT02709655|459462341|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
127682406|NCT02709655|459462342|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
127682407|NCT02709655|459462343|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
127682408|NCT02709655|459462344|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
127682409|NCT02709655|459462340|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
127682410|NCT02709655|459462341|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
127682411|NCT02709655|459462342|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
127682412|NCT02709655|459462343|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
127682413|NCT02709655|459462344|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
127682414|NCT02709655|459462340|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
127682415|NCT02709655|459462341|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
127682416|NCT02709655|459462342|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
127682417|NCT02709655|459462343|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
127682418|NCT02709655|459462344|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
127682419|NCT02709655|459462340|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
127682420|NCT02709655|459462341|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
127682421|NCT02709655|459462342|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
127682422|NCT02709655|459462343|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
127682423|NCT02709655|459462344|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
127682424|NCT02709655|459462340|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
127682425|NCT02709655|459462341|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
127682426|NCT02709655|459462342|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
127768494|NCT01831856|459778054|FG001|Overall Study|Lack of Efficacy|11|||
127768495|NCT01831856|459778053|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
127768496|NCT01831856|459778054|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
127768497|NCT04620811|459778058|FG000|Overall Study|Withdrawal by Subject|18|||
127768498|NCT04620811|459778059|FG001|Overall Study|Withdrawal by Subject|15|||
127768499|NCT04620811|459778058|FG000|Overall Study|Adverse Event|6|||
127768500|NCT04620811|459778059|FG001|Overall Study|Adverse Event|11|||
127768501|NCT04620811|459778058|FG000|Overall Study|Lost to Follow-up|4|||
127768502|NCT04620811|459778059|FG001|Overall Study|Lost to Follow-up|8|||
127768503|NCT04620811|459778058|FG000|Overall Study|Physician Decision|1|||
127768504|NCT04620811|459778059|FG001|Overall Study|Physician Decision|4|||
127768505|NCT04620811|459778058|FG000|Overall Study|Sponsor Decision|0|||
127768506|NCT04620811|459778059|FG001|Overall Study|Sponsor Decision|1|||
127768507|NCT04620811|459778058|FG000|Overall Study|Elevation of ALT or AST|1|||
127768508|NCT04620811|459778059|FG001|Overall Study|Elevation of ALT or AST|0|||
127768509|NCT04620811|459778058|FG000|Overall Study|Other|3|||
127768510|NCT04620811|459778059|FG001|Overall Study|Other|5|||
127768511|NCT01078675|459778060|FG000|Overall Study|Withdrawal by Subject|7|||
127768512|NCT01078675|459778061|FG001|Overall Study|Withdrawal by Subject|3|||
127768513|NCT01078675|459778060|FG000|Overall Study|Protocol Violation|56|||
127768514|NCT01078675|459778061|FG001|Overall Study|Protocol Violation|0|||
127768515|NCT01078675|459778060|FG000|Overall Study|Provided in CRF for specific reasons|2|||
127768516|NCT01078675|459778061|FG001|Overall Study|Provided in CRF for specific reasons|3|||
127768517|NCT01078675|459778060|FG000|Overall Study|Adverse Event|3|||
127768518|NCT01078675|459778061|FG001|Overall Study|Adverse Event|0|||
127768519|NCT01759368|459778064|FG000|Overall Study|Lost to Follow-up|1|||
127768520|NCT01759368|459778065|FG001|Overall Study|Lost to Follow-up|0|||
127768521|NCT01191268|459778066|FG000|Overall Study|Withdrawal by Subject|19|||
127768522|NCT01191268|459778067|FG001|Overall Study|Withdrawal by Subject|25|||
127768523|NCT01191268|459778068|FG002|Overall Study|Withdrawal by Subject|21|||
127768524|NCT01191268|459778066|FG000|Overall Study|Adverse Event|21|||
127768525|NCT01191268|459778067|FG001|Overall Study|Adverse Event|13|||
127768526|NCT01191268|459778068|FG002|Overall Study|Adverse Event|8|||
127768527|NCT01191268|459778066|FG000|Overall Study|Physician Decision|6|||
127768528|NCT01191268|459778067|FG001|Overall Study|Physician Decision|8|||
127768529|NCT01191268|459778068|FG002|Overall Study|Physician Decision|9|||
127768530|NCT01191268|459778066|FG000|Overall Study|Lost to Follow-up|8|||
127768531|NCT01191268|459778067|FG001|Overall Study|Lost to Follow-up|5|||
127768532|NCT01191268|459778068|FG002|Overall Study|Lost to Follow-up|9|||
127768533|NCT01191268|459778066|FG000|Overall Study|Entry Criteria Not Met|3|||
127768534|NCT01191268|459778067|FG001|Overall Study|Entry Criteria Not Met|1|||
127768535|NCT01191268|459778068|FG002|Overall Study|Entry Criteria Not Met|1|||
127768536|NCT01191268|459778066|FG000|Overall Study|Death|0|||
127768537|NCT01191268|459778067|FG001|Overall Study|Death|1|||
127768538|NCT01191268|459778068|FG002|Overall Study|Death|3|||
127768539|NCT01191268|459778066|FG000|Overall Study|Protocol Violation|1|||
127768540|NCT01191268|459778067|FG001|Overall Study|Protocol Violation|0|||
127768541|NCT01191268|459778068|FG002|Overall Study|Protocol Violation|1|||
127768542|NCT01191268|459778066|FG000|Overall Study|Sponsor Decision|0|||
127768543|NCT01191268|459778067|FG001|Overall Study|Sponsor Decision|2|||
127768544|NCT01191268|459778068|FG002|Overall Study|Sponsor Decision|0|||
127768545|NCT02294227|459778071|FG000|Overall Study|Death|0|||
127768546|NCT02294227|459778072|FG001|Overall Study|Death|0|||
127768547|NCT02294227|459778073|FG002|Overall Study|Death|1|||
127768548|NCT02294227|459778071|FG000|Overall Study|Subject/Guardian Decision|6|||
127768549|NCT02294227|459778072|FG001|Overall Study|Subject/Guardian Decision|3|||
127768550|NCT02294227|459778073|FG002|Overall Study|Subject/Guardian Decision|7|||
127768551|NCT02294227|459778071|FG000|Overall Study|Physician Decision|1|||
127768552|NCT02294227|459778072|FG001|Overall Study|Physician Decision|2|||
127768553|NCT02294227|459778073|FG002|Overall Study|Physician Decision|1|||
127768554|NCT02294227|459778071|FG000|Overall Study|Lost to Follow-up|1|||
127768555|NCT02294227|459778072|FG001|Overall Study|Lost to Follow-up|0|||
127768556|NCT02294227|459778073|FG002|Overall Study|Lost to Follow-up|0|||
127768557|NCT02294227|459778071|FG000|Overall Study|Lack of Efficacy|11|||
127768558|NCT02294227|459778072|FG001|Overall Study|Lack of Efficacy|12|||
127768559|NCT02294227|459778073|FG002|Overall Study|Lack of Efficacy|8|||
127768560|NCT02294227|459778071|FG000|Overall Study|Adverse Event|6|||
127768561|NCT02294227|459778072|FG001|Overall Study|Adverse Event|8|||
127768562|NCT02294227|459778073|FG002|Overall Study|Adverse Event|2|||
127768563|NCT01636960|459778074|FG000|Induction Phase|Adverse Event|2|||
127768564|NCT01636960|459778074|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
127768565|NCT01636960|459778074|FG000|Maintenance Phase|Adverse Event|3|||
127768566|NCT01636960|459778074|FG000|Maintenance Phase|Progressive disease|1|||
127768567|NCT01209780|459778075|FG000|Overall Study|Adverse Event|0|||
127768568|NCT01209780|459778076|FG001|Overall Study|Adverse Event|1|||
127768569|NCT01209780|459778077|FG002|Overall Study|Adverse Event|0|||
127768570|NCT01209780|459778078|FG003|Overall Study|Adverse Event|0|||
127768571|NCT01209780|459778079|FG004|Overall Study|Adverse Event|0|||
127768572|NCT01209780|459778075|FG000|Overall Study|Withdrawal by Subject|9|||
127768573|NCT01209780|459778076|FG001|Overall Study|Withdrawal by Subject|2|||
127768574|NCT01209780|459778077|FG002|Overall Study|Withdrawal by Subject|1|||
127768575|NCT01209780|459778078|FG003|Overall Study|Withdrawal by Subject|1|||
127768576|NCT01209780|459778079|FG004|Overall Study|Withdrawal by Subject|0|||
127768577|NCT01209780|459778075|FG000|Overall Study|Lost to Follow-up|17|||
127768578|NCT01209780|459778076|FG001|Overall Study|Lost to Follow-up|12|||
127768579|NCT01209780|459778077|FG002|Overall Study|Lost to Follow-up|3|||
127768580|NCT01209780|459778078|FG003|Overall Study|Lost to Follow-up|9|||
127768581|NCT01209780|459778079|FG004|Overall Study|Lost to Follow-up|4|||
127768582|NCT01209780|459778075|FG000|Overall Study|Protocol Violation|0|||
127682427|NCT02709655|459462343|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
127682428|NCT02709655|459462344|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
127682429|NCT02709655|459462340|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
127682430|NCT02709655|459462341|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
127682431|NCT02709655|459462342|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
127682432|NCT02709655|459462343|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
127682433|NCT02709655|459462344|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
127682434|NCT02709655|459462340|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
127682435|NCT02709655|459462341|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
127682436|NCT02709655|459462342|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
127682437|NCT02709655|459462343|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
127682438|NCT02709655|459462344|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
127682439|NCT02709655|459462340|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
127682440|NCT02709655|459462341|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
127682441|NCT02709655|459462342|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
127682442|NCT02709655|459462343|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
127682443|NCT02709655|459462344|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
127682444|NCT02709655|459462340|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
127682445|NCT02709655|459462341|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
127682446|NCT02709655|459462342|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
127682447|NCT02709655|459462343|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
127682448|NCT02709655|459462344|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
127682449|NCT02709655|459462340|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
127682450|NCT02709655|459462341|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
127682451|NCT02709655|459462342|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
127682452|NCT02709655|459462343|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
127682453|NCT02709655|459462344|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
127682454|NCT02709655|459462340|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
127682455|NCT02709655|459462341|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
127682456|NCT02709655|459462342|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
127682457|NCT02709655|459462343|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
127682458|NCT02709655|459462344|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
127682459|NCT02709655|459462340|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
127682460|NCT02709655|459462341|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
127682461|NCT02709655|459462342|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
127682462|NCT02709655|459462343|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
127682463|NCT02709655|459462344|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
127682464|NCT02709655|459462340|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
127682465|NCT02709655|459462341|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
127682466|NCT02709655|459462342|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
127682467|NCT02709655|459462343|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
127682468|NCT02709655|459462344|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
127682469|NCT02709655|459462340|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
127682470|NCT02709655|459462341|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
127682471|NCT02709655|459462342|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
127682472|NCT02709655|459462343|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
127682473|NCT02709655|459462344|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
127682474|NCT00102063|459462345|FG000|Overall Study|Lack of Efficacy|5|||
127682475|NCT00102063|459462346|FG001|Overall Study|Lack of Efficacy|1|||
127682476|NCT00102063|459462347|FG002|Overall Study|Lack of Efficacy|1|||
127682477|NCT00102063|459462345|FG000|Overall Study|Adverse Event|7|||
127682478|NCT00102063|459462346|FG001|Overall Study|Adverse Event|4|||
127682479|NCT00102063|459462347|FG002|Overall Study|Adverse Event|2|||
127682480|NCT00102063|459462345|FG000|Overall Study|Withdrawal by Subject|4|||
127768583|NCT01209780|459778076|FG001|Overall Study|Protocol Violation|1|||
127768584|NCT01209780|459778077|FG002|Overall Study|Protocol Violation|0|||
127768585|NCT01209780|459778078|FG003|Overall Study|Protocol Violation|0|||
127768586|NCT01209780|459778079|FG004|Overall Study|Protocol Violation|0|||
127768587|NCT01209780|459778075|FG000|Overall Study|Inappropriate enrollment|0|||
127768588|NCT01209780|459778076|FG001|Overall Study|Inappropriate enrollment|2|||
127768589|NCT01209780|459778077|FG002|Overall Study|Inappropriate enrollment|0|||
127768590|NCT01209780|459778078|FG003|Overall Study|Inappropriate enrollment|0|||
127682481|NCT00102063|459462346|FG001|Overall Study|Withdrawal by Subject|12|||
127682482|NCT00102063|459462347|FG002|Overall Study|Withdrawal by Subject|5|||
127682483|NCT00102063|459462345|FG000|Overall Study|Lost to Follow-up|0|||
127682484|NCT00102063|459462346|FG001|Overall Study|Lost to Follow-up|0|||
127682485|NCT00102063|459462347|FG002|Overall Study|Lost to Follow-up|1|||
127682486|NCT00102063|459462345|FG000|Overall Study|Protocol Violation|0|||
127682487|NCT00102063|459462346|FG001|Overall Study|Protocol Violation|1|||
127682488|NCT00102063|459462347|FG002|Overall Study|Protocol Violation|1|||
127682489|NCT01493778|459462348|FG000|Overall Study|Withdrawal by Subject|8|||
127682490|NCT05082025|459462349|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 1 full cycle of treatment)|1|||
127682491|NCT04210180|459462350|FG000|Overall Study|Withdrawal by Subject|2|||
127682492|NCT01179334|459462351|FG000|Treatment Period|Adverse Event|1|||
127682493|NCT01179334|459462352|FG001|Treatment Period|Adverse Event|0|||
127682494|NCT01179334|459462351|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
127682495|NCT01179334|459462352|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
127682496|NCT01179334|459462351|FG000|Long-term Extension (LTE) Period|Death|3|||
127682497|NCT01179334|459462352|FG001|Long-term Extension (LTE) Period|Death|0|||
127682498|NCT01179334|459462351|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
127682499|NCT01179334|459462352|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
127682500|NCT00857649|459462353|FG000|Overall Study|Adverse Event|15|||
127682501|NCT00857649|459462354|FG001|Overall Study|Adverse Event|10|||
127682502|NCT00857649|459462353|FG000|Overall Study|Non-compliance|1|||
127682503|NCT00857649|459462354|FG001|Overall Study|Non-compliance|1|||
127682504|NCT00857649|459462353|FG000|Overall Study|Protocol Violation|2|||
127682505|NCT00857649|459462354|FG001|Overall Study|Protocol Violation|2|||
127682506|NCT00857649|459462353|FG000|Overall Study|Withdrawal of Consent|10|||
127682507|NCT00857649|459462354|FG001|Overall Study|Withdrawal of Consent|7|||
127682508|NCT00857649|459462353|FG000|Overall Study|Nursing Home Placement|2|||
127682509|NCT00857649|459462354|FG001|Overall Study|Nursing Home Placement|9|||
127682510|NCT00857649|459462353|FG000|Overall Study|Other Reasons|1|||
127682511|NCT00857649|459462354|FG001|Overall Study|Other Reasons|3|||
127682512|NCT05190419|459462355|FG000|Overall Study|Lack of Efficacy|8|||
127682513|NCT05190419|459462356|FG001|Overall Study|Lack of Efficacy|0|||
127682514|NCT05190419|459462357|FG002|Overall Study|Lack of Efficacy|1|||
127682515|NCT05190419|459462358|FG003|Overall Study|Lack of Efficacy|0|||
127682516|NCT05190419|459462355|FG000|Overall Study|Withdrawal by Subject|7|||
127682517|NCT05190419|459462356|FG001|Overall Study|Withdrawal by Subject|1|||
127682518|NCT05190419|459462357|FG002|Overall Study|Withdrawal by Subject|2|||
127682519|NCT05190419|459462358|FG003|Overall Study|Withdrawal by Subject|2|||
127682520|NCT05190419|459462355|FG000|Overall Study|Adverse Event|2|||
127682521|NCT05190419|459462356|FG001|Overall Study|Adverse Event|10|||
127682522|NCT05190419|459462357|FG002|Overall Study|Adverse Event|11|||
127682523|NCT05190419|459462358|FG003|Overall Study|Adverse Event|21|||
127682524|NCT05190419|459462355|FG000|Overall Study|Lost to Follow-up|1|||
127682525|NCT05190419|459462356|FG001|Overall Study|Lost to Follow-up|2|||
127682526|NCT05190419|459462357|FG002|Overall Study|Lost to Follow-up|3|||
127682527|NCT05190419|459462358|FG003|Overall Study|Lost to Follow-up|1|||
127682528|NCT05190419|459462355|FG000|Overall Study|Other|1|||
127682529|NCT05190419|459462356|FG001|Overall Study|Other|1|||
127682530|NCT05190419|459462357|FG002|Overall Study|Other|0|||
127682531|NCT05190419|459462358|FG003|Overall Study|Other|3|||
127682532|NCT00919763|459462359|FG000|Overall Study|Adverse Event|7|||
127682533|NCT00919763|459462360|FG001|Overall Study|Adverse Event|1|||
127682534|NCT00919763|459462359|FG000|Overall Study|Lost to Follow-up|1|||
127682535|NCT00919763|459462360|FG001|Overall Study|Lost to Follow-up|0|||
127682536|NCT00919763|459462359|FG000|Overall Study|Protocol Violation|1|||
127682537|NCT00919763|459462360|FG001|Overall Study|Protocol Violation|1|||
127682538|NCT00919763|459462359|FG000|Overall Study|Withdrawal by Subject|3|||
127682539|NCT00919763|459462360|FG001|Overall Study|Withdrawal by Subject|1|||
127682540|NCT00919763|459462359|FG000|Overall Study|Non-compliance|0|||
127682541|NCT00919763|459462360|FG001|Overall Study|Non-compliance|1|||
127682542|NCT05323734|459462369|FG000|Overall Study|Adverse Event|5|||
127682543|NCT05323734|459462370|FG001|Overall Study|Adverse Event|2|||
127682544|NCT05323734|459462369|FG000|Overall Study|Physician Decision|1|||
127682545|NCT05323734|459462370|FG001|Overall Study|Physician Decision|0|||
127682546|NCT05323734|459462369|FG000|Overall Study|Lack of Efficacy|1|||
127682547|NCT05323734|459462370|FG001|Overall Study|Lack of Efficacy|2|||
127682548|NCT05323734|459462369|FG000|Overall Study|Withdrawal by Subject|2|||
127682549|NCT05323734|459462370|FG001|Overall Study|Withdrawal by Subject|0|||
127682550|NCT05323734|459462369|FG000|Overall Study|Participant Withdrawn Due|0|||
127682551|NCT05323734|459462370|FG001|Overall Study|Participant Withdrawn Due|1|||
127682552|NCT02486718|459462371|FG000|Enrollment Phase|Death|19|||
127682553|NCT02486718|459462372|FG001|Enrollment Phase|Death|0|||
127682554|NCT02486718|459462373|FG002|Enrollment Phase|Death|0|||
127682555|NCT02486718|459462371|FG000|Enrollment Phase|Symptomatic deterioration|1|||
127682556|NCT02486718|459462372|FG001|Enrollment Phase|Symptomatic deterioration|0|||
127682557|NCT02486718|459462373|FG002|Enrollment Phase|Symptomatic deterioration|0|||
127682558|NCT02486718|459462371|FG000|Enrollment Phase|Withdrawal by Subject|86|||
127682559|NCT02486718|459462372|FG001|Enrollment Phase|Withdrawal by Subject|0|||
127682560|NCT02486718|459462373|FG002|Enrollment Phase|Withdrawal by Subject|0|||
127682561|NCT02486718|459462371|FG000|Enrollment Phase|Protocol Violation|18|||
127682562|NCT02486718|459462372|FG001|Enrollment Phase|Protocol Violation|0|||
127682563|NCT02486718|459462373|FG002|Enrollment Phase|Protocol Violation|0|||
127682564|NCT02486718|459462371|FG000|Enrollment Phase|Physician Decision|18|||
127682565|NCT02486718|459462372|FG001|Enrollment Phase|Physician Decision|0|||
127682566|NCT02486718|459462373|FG002|Enrollment Phase|Physician Decision|0|||
127682567|NCT02486718|459462371|FG000|Enrollment Phase|Reason not provided|41|||
127682568|NCT02486718|459462372|FG001|Enrollment Phase|Reason not provided|0|||
127682569|NCT02486718|459462373|FG002|Enrollment Phase|Reason not provided|0|||
127682570|NCT02486718|459462371|FG000|Enrollment Phase|Disease relapse|54|||
127682571|NCT02486718|459462372|FG001|Enrollment Phase|Disease relapse|0|||
127682572|NCT02486718|459462373|FG002|Enrollment Phase|Disease relapse|0|||
127682573|NCT02486718|459462371|FG000|Enrollment Phase|Lost to Follow-up|4|||
127682574|NCT02486718|459462372|FG001|Enrollment Phase|Lost to Follow-up|0|||
127682575|NCT02486718|459462373|FG002|Enrollment Phase|Lost to Follow-up|0|||
127682576|NCT02486718|459462371|FG000|Enrollment Phase|Adverse Event|34|||
127682577|NCT02486718|459462372|FG001|Enrollment Phase|Adverse Event|0|||
127682578|NCT02486718|459462373|FG002|Enrollment Phase|Adverse Event|0|||
127682579|NCT02486718|459462371|FG000|Randomized Phase|Withdrawal by Subject|0|||
127682580|NCT02486718|459462372|FG001|Randomized Phase|Withdrawal by Subject|44|||
127682581|NCT02486718|459462373|FG002|Randomized Phase|Withdrawal by Subject|47|||
127682582|NCT02486718|459462371|FG000|Randomized Phase|Protocol Violation|0|||
127682583|NCT02486718|459462372|FG001|Randomized Phase|Protocol Violation|2|||
127682584|NCT02486718|459462373|FG002|Randomized Phase|Protocol Violation|0|||
127682585|NCT02486718|459462371|FG000|Randomized Phase|Physician Decision|0|||
127682586|NCT02486718|459462372|FG001|Randomized Phase|Physician Decision|0|||
127682587|NCT02486718|459462373|FG002|Randomized Phase|Physician Decision|3|||
127682588|NCT02486718|459462371|FG000|Randomized Phase|Lost to Follow-up|0|||
127682589|NCT02486718|459462372|FG001|Randomized Phase|Lost to Follow-up|5|||
127682590|NCT02486718|459462373|FG002|Randomized Phase|Lost to Follow-up|11|||
127682591|NCT02486718|459462371|FG000|Randomized Phase|Disease Relapse|0|||
127682592|NCT02486718|459462372|FG001|Randomized Phase|Disease Relapse|1|||
127682593|NCT02486718|459462373|FG002|Randomized Phase|Disease Relapse|0|||
127682594|NCT02486718|459462371|FG000|Randomized Phase|Death|0|||
127682595|NCT02486718|459462372|FG001|Randomized Phase|Death|154|||
127682596|NCT02486718|459462373|FG002|Randomized Phase|Death|155|||
127682597|NCT02486718|459462371|FG000|Randomized Phase|Ongoing|0|||
127682598|NCT02486718|459462372|FG001|Randomized Phase|Ongoing|301|||
127682599|NCT02486718|459462373|FG002|Randomized Phase|Ongoing|282|||
127682600|NCT00256243|459462374|FG000|Overall Study|Lost to Follow-up|2|||
127682601|NCT00256243|459462374|FG000|Overall Study|Death|7|||
127682602|NCT00256243|459462374|FG000|Overall Study|Not treated|1|||
127682603|NCT05061693|459462375|FG000|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
127682604|NCT05061693|459462376|FG001|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
127682605|NCT05061693|459462377|FG002|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
127682606|NCT05061693|459462378|FG003|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
127682607|NCT05061693|459462379|FG004|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
127682608|NCT05061693|459462380|FG005|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
127682609|NCT05061693|459462381|FG006|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
127682610|NCT05061693|459462382|FG007|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
127682611|NCT05061693|459462383|FG008|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
127682612|NCT05061693|459462384|FG009|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
127682613|NCT05061693|459462385|FG010|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
127682614|NCT05061693|459462386|FG011|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
127682615|NCT05061693|459462375|FG000|16-week Placebo-controlled (PC) Period|Death|0|||
127682616|NCT05061693|459462376|FG001|16-week Placebo-controlled (PC) Period|Death|1|||
127682617|NCT05061693|459462377|FG002|16-week Placebo-controlled (PC) Period|Death|0|||
127682618|NCT05061693|459462378|FG003|16-week Placebo-controlled (PC) Period|Death|0|||
127682619|NCT05061693|459462379|FG004|16-week Placebo-controlled (PC) Period|Death|0|||
127682620|NCT05061693|459462380|FG005|16-week Placebo-controlled (PC) Period|Death|0|||
127682621|NCT05061693|459462381|FG006|16-week Placebo-controlled (PC) Period|Death|0|||
127682622|NCT05061693|459462382|FG007|16-week Placebo-controlled (PC) Period|Death|0|||
127682623|NCT05061693|459462383|FG008|16-week Placebo-controlled (PC) Period|Death|0|||
127682624|NCT05061693|459462384|FG009|16-week Placebo-controlled (PC) Period|Death|0|||
127682625|NCT05061693|459462385|FG010|16-week Placebo-controlled (PC) Period|Death|0|||
127682626|NCT05061693|459462386|FG011|16-week Placebo-controlled (PC) Period|Death|0|||
127682627|NCT05061693|459462375|FG000|16-week Placebo-controlled (PC) Period|Lack of Efficacy|1|||
127682628|NCT05061693|459462376|FG001|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
127682629|NCT05061693|459462377|FG002|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
127682630|NCT05061693|459462378|FG003|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
127682631|NCT05061693|459462379|FG004|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
127768591|NCT01209780|459778079|FG004|Overall Study|Inappropriate enrollment|1|||
127768592|NCT02709096|459778080|FG000|Overall Study|non-compliance|1|||
127768593|NCT02709096|459778081|FG001|Overall Study|non-compliance|1|||
127768594|NCT00511472|459778082|FG000|Overall Study|Clinical Adverse Event|1|||
127768595|NCT00511472|459778083|FG001|Overall Study|Clinical Adverse Event|2|||
127768596|NCT00511472|459778082|FG000|Overall Study|Laboratory Adverse Event|0|||
127768597|NCT00511472|459778083|FG001|Overall Study|Laboratory Adverse Event|2|||
127768598|NCT00511472|459778082|FG000|Overall Study|Not reported|2|||
127768599|NCT00511472|459778083|FG001|Overall Study|Not reported|2|||
127768600|NCT00505284|459778084|FG000|Overall Study|Adverse Event|3|||
127768601|NCT00505284|459778085|FG001|Overall Study|Adverse Event|7|||
127768602|NCT00505284|459778086|FG002|Overall Study|Adverse Event|9|||
127768603|NCT00505284|459778087|FG003|Overall Study|Adverse Event|14|||
127768604|NCT00505284|459778088|FG004|Overall Study|Adverse Event|22|||
127768605|NCT00505284|459778084|FG000|Overall Study|Protocol Violation|0|||
127768606|NCT00505284|459778085|FG001|Overall Study|Protocol Violation|1|||
127768607|NCT00505284|459778086|FG002|Overall Study|Protocol Violation|1|||
127768608|NCT00505284|459778087|FG003|Overall Study|Protocol Violation|0|||
127768609|NCT00505284|459778088|FG004|Overall Study|Protocol Violation|0|||
127768610|NCT00505284|459778084|FG000|Overall Study|Withdrawal by Subject|2|||
127768611|NCT00505284|459778085|FG001|Overall Study|Withdrawal by Subject|6|||
127768612|NCT00505284|459778086|FG002|Overall Study|Withdrawal by Subject|1|||
127768613|NCT00505284|459778087|FG003|Overall Study|Withdrawal by Subject|0|||
127768614|NCT00505284|459778088|FG004|Overall Study|Withdrawal by Subject|6|||
127768615|NCT00505284|459778084|FG000|Overall Study|Lack of Efficacy|0|||
127768616|NCT00505284|459778085|FG001|Overall Study|Lack of Efficacy|1|||
127768617|NCT00505284|459778086|FG002|Overall Study|Lack of Efficacy|1|||
127768618|NCT00505284|459778087|FG003|Overall Study|Lack of Efficacy|1|||
127768619|NCT00505284|459778088|FG004|Overall Study|Lack of Efficacy|1|||
127768620|NCT00505284|459778084|FG000|Overall Study|Physician Decision|0|||
127768621|NCT00505284|459778085|FG001|Overall Study|Physician Decision|1|||
127768622|NCT00505284|459778086|FG002|Overall Study|Physician Decision|0|||
127768623|NCT00505284|459778087|FG003|Overall Study|Physician Decision|0|||
127768624|NCT00505284|459778088|FG004|Overall Study|Physician Decision|0|||
127768625|NCT00505284|459778084|FG000|Overall Study|Other|5|||
127768626|NCT00505284|459778085|FG001|Overall Study|Other|0|||
127768627|NCT00505284|459778086|FG002|Overall Study|Other|0|||
127768628|NCT00505284|459778087|FG003|Overall Study|Other|4|||
127768629|NCT00505284|459778088|FG004|Overall Study|Other|4|||
127768630|NCT01588496|459778089|FG000|Overall Study|Withdrawal by Subject|0|||
127768631|NCT01588496|459778090|FG001|Overall Study|Withdrawal by Subject|1|||
127768632|NCT01588496|459778091|FG002|Overall Study|Withdrawal by Subject|0|||
127768633|NCT01551212|459778092|FG000|Overall Study|Graft loss/Retransplantation|0|||
127768634|NCT01551212|459778093|FG001|Overall Study|Graft loss/Retransplantation|1|||
127768635|NCT01551212|459778092|FG000|Overall Study|Administrative problems|1|||
127768636|NCT01551212|459778093|FG001|Overall Study|Administrative problems|2|||
127768637|NCT01551212|459778092|FG000|Overall Study|Lost to Follow-up|0|||
127768638|NCT01551212|459778093|FG001|Overall Study|Lost to Follow-up|1|||
127768639|NCT01551212|459778092|FG000|Overall Study|Protocol Violation|0|||
127768640|NCT01551212|459778093|FG001|Overall Study|Protocol Violation|1|||
127768641|NCT01551212|459778092|FG000|Overall Study|Withdrawal by Subject|0|||
127768642|NCT01551212|459778093|FG001|Overall Study|Withdrawal by Subject|7|||
127768643|NCT01551212|459778092|FG000|Overall Study|Death|2|||
127768644|NCT01551212|459778093|FG001|Overall Study|Death|4|||
127768645|NCT01551212|459778092|FG000|Overall Study|Never Received Study Treatment|2|||
127768646|NCT01551212|459778093|FG001|Overall Study|Never Received Study Treatment|4|||
127768647|NCT00705523|459778094|FG000|Overall Study|Lost to Follow-up|2|||
127768648|NCT00705523|459778095|FG001|Overall Study|Lost to Follow-up|3|||
127768649|NCT01013285|459778096|FG000|Overall Study|Death|48|||
127768650|NCT01013285|459778097|FG001|Overall Study|Death|89|||
127768651|NCT00953745|459778098|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
127768652|NCT00953745|459778099|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
127768653|NCT00953745|459778098|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
127768654|NCT00953745|459778099|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
127768655|NCT00953745|459778098|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
127768656|NCT00953745|459778099|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
127768657|NCT00953745|459778098|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
128015997|NCT01163617|460682217|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
127768658|NCT00953745|459778099|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
127768659|NCT00953745|459778098|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
127768660|NCT00953745|459778099|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
127768661|NCT00953745|459778098|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
127768662|NCT00953745|459778099|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
127768663|NCT03110185|459778102|FG000|Overall Study|Death|0|||
127768664|NCT03110185|459778103|FG001|Overall Study|Death|1|||
128015998|NCT01163617|460682210|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
127768665|NCT03110185|459778102|FG000|Overall Study|Withdrawal by Subject|2|||
127768666|NCT03110185|459778103|FG001|Overall Study|Withdrawal by Subject|7|||
127768667|NCT03110185|459778102|FG000|Overall Study|Time Constraints|0|||
127768668|NCT03110185|459778103|FG001|Overall Study|Time Constraints|6|||
127768669|NCT03110185|459778102|FG000|Overall Study|Conflict with care|5|||
127768670|NCT03110185|459778103|FG001|Overall Study|Conflict with care|12|||
127768671|NCT03110185|459778102|FG000|Overall Study|Protocol Violation|1|||
127768672|NCT03110185|459778103|FG001|Overall Study|Protocol Violation|4|||
127768673|NCT03110185|459778102|FG000|Overall Study|MRI Incompatible|2|||
127768674|NCT03110185|459778103|FG001|Overall Study|MRI Incompatible|0|||
127768675|NCT03110185|459778102|FG000|Overall Study|Patient Refusal|0|||
127768676|NCT03110185|459778103|FG001|Overall Study|Patient Refusal|1|||
127768677|NCT01575028|459778107|FG000|Overall Study|Physician Decision|0|||
127768678|NCT01575028|459778108|FG001|Overall Study|Physician Decision|1|||
127768679|NCT03534284|459778112|FG000|Overall Study|Death|2|||
127768680|NCT03534284|459778113|FG001|Overall Study|Death|3|||
127768681|NCT03534284|459778114|FG002|Overall Study|Death|3|||
127768682|NCT03534284|459778112|FG000|Overall Study|Withdrawal by Subject|5|||
127768683|NCT03534284|459778113|FG001|Overall Study|Withdrawal by Subject|0|||
127768684|NCT03534284|459778114|FG002|Overall Study|Withdrawal by Subject|0|||
127768685|NCT04737187|459778115|FG000|Overall Study|Switched to marketed drug|32|||
127768686|NCT04737187|459778116|FG001|Overall Study|Switched to marketed drug|4|||
127768687|NCT04737187|459778115|FG000|Overall Study|Radiological Progressive Disease|145|||
127768688|NCT04737187|459778116|FG001|Overall Study|Radiological Progressive Disease|146|||
127768689|NCT04737187|459778115|FG000|Overall Study|Clinical Progressive Disease|20|||
127768690|NCT04737187|459778116|FG001|Overall Study|Clinical Progressive Disease|20|||
127768691|NCT04737187|459778115|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
127768692|NCT04737187|459778116|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
127768693|NCT04737187|459778115|FG000|Overall Study|Adverse Event|16|||
127768694|NCT04737187|459778116|FG001|Overall Study|Adverse Event|16|||
127768695|NCT04737187|459778115|FG000|Overall Study|Physician Decision|2|||
127768696|NCT04737187|459778116|FG001|Overall Study|Physician Decision|0|||
127768697|NCT04737187|459778115|FG000|Overall Study|Withdrawal by Subject|5|||
127768698|NCT04737187|459778116|FG001|Overall Study|Withdrawal by Subject|8|||
127768699|NCT02401867|459779540|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
127768700|NCT02401867|459779540|FG000|Analysis|Cervical assay could not be conducted|9|||
127768701|NCT02795429|459779541|FG000|Overall Study|Adverse Event|1|||
127768702|NCT02795429|459779542|FG001|Overall Study|Adverse Event|2|||
127768703|NCT02795429|459779543|FG002|Overall Study|Adverse Event|1|||
127768704|NCT02795429|459779544|FG003|Overall Study|Adverse Event|2|||
127768705|NCT02795429|459779545|FG004|Overall Study|Adverse Event|1|||
127768706|NCT02795429|459779541|FG000|Overall Study|Death|1|||
127768707|NCT02795429|459779542|FG001|Overall Study|Death|0|||
127768708|NCT02795429|459779543|FG002|Overall Study|Death|1|||
127768709|NCT02795429|459779544|FG003|Overall Study|Death|2|||
127768710|NCT02795429|459779545|FG004|Overall Study|Death|1|||
127768711|NCT02795429|459779541|FG000|Overall Study|Physician Decision|0|||
127768712|NCT02795429|459779542|FG001|Overall Study|Physician Decision|0|||
127768713|NCT02795429|459779543|FG002|Overall Study|Physician Decision|2|||
127768714|NCT02795429|459779544|FG003|Overall Study|Physician Decision|1|||
127768715|NCT02795429|459779545|FG004|Overall Study|Physician Decision|5|||
127768716|NCT02795429|459779541|FG000|Overall Study|Progressive disease|3|||
127768717|NCT02795429|459779542|FG001|Overall Study|Progressive disease|7|||
127768718|NCT02795429|459779543|FG002|Overall Study|Progressive disease|6|||
127768719|NCT02795429|459779544|FG003|Overall Study|Progressive disease|26|||
127768720|NCT02795429|459779545|FG004|Overall Study|Progressive disease|20|||
127768721|NCT02795429|459779541|FG000|Overall Study|Subject/guardian decision|1|||
127768722|NCT02795429|459779542|FG001|Overall Study|Subject/guardian decision|1|||
127768723|NCT02795429|459779543|FG002|Overall Study|Subject/guardian decision|1|||
127768724|NCT02795429|459779544|FG003|Overall Study|Subject/guardian decision|1|||
127768725|NCT02795429|459779545|FG004|Overall Study|Subject/guardian decision|3|||
127768726|NCT01640054|459779548|FG000|Overall Study|Study-specific disc criteria|1|||
127768727|NCT01640054|459779548|FG000|Overall Study|Lack of Efficacy|3|||
127768728|NCT01640054|459779548|FG000|Overall Study|Adverse Event|2|||
127768729|NCT05220254|459779550|FG000|Overall Study|Withdrawal by Subject|4|||
127768730|NCT05220254|459779550|FG000|Overall Study|Removed due to ineligibility|1|||
127768731|NCT05220254|459779550|FG000|Overall Study|Lost to Follow-up|7|||
127768732|NCT01557283|459779551|FG000|Overall Study|Lost to Follow-up|7|||
127768733|NCT01557283|459779551|FG000|Overall Study|Non-responder|19|||
127768734|NCT01557283|459779551|FG000|Overall Study|Adverse Event|7|||
127768735|NCT01557283|459779551|FG000|Overall Study|Lack of Efficacy|1|||
127768736|NCT01557283|459779551|FG000|Overall Study|Non-compliance|1|||
127768737|NCT01557283|459779551|FG000|Overall Study|Withdrawal by Subject|1|||
127768738|NCT01557283|459779551|FG000|Overall Study|Participant's weight too high for dose|1|||
127768739|NCT01557283|459779551|FG000|Overall Study|Worsening of psoriasis|1|||
127768740|NCT01557283|459779551|FG000|Overall Study|Other|6|||
127768741|NCT02080221|459779552|FG000|Overall Study|Withdrawal by Subject|1|||
127768742|NCT02080221|459779552|FG000|Overall Study|Clinical Progression of Disease|1|||
127768743|NCT01386788|459779555|FG000|Overall Study|Lost to Follow-up|2|||
127547074|NCT03955146|458971839|FG003|DB Period (48 Weeks)|Participant Decision|1|||
127547075|NCT03955146|458971836|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|7|||
127547076|NCT03955146|458971837|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|1|||
127682632|NCT05061693|459462380|FG005|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
127682633|NCT05061693|459462381|FG006|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
127682634|NCT05061693|459462382|FG007|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
127682635|NCT05061693|459462383|FG008|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
127682636|NCT05061693|459462384|FG009|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
127682637|NCT05061693|459462385|FG010|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
127682638|NCT05061693|459462386|FG011|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
127682639|NCT05061693|459462375|FG000|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
127682640|NCT05061693|459462376|FG001|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
127682641|NCT05061693|459462377|FG002|16-week Placebo-controlled (PC) Period|Lost to Follow-up|1|||
127682642|NCT05061693|459462378|FG003|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
127682643|NCT05061693|459462379|FG004|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
127682644|NCT05061693|459462380|FG005|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
127682645|NCT05061693|459462381|FG006|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
127682646|NCT05061693|459462382|FG007|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
127682647|NCT05061693|459462383|FG008|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
127682648|NCT05061693|459462384|FG009|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
127682649|NCT05061693|459462385|FG010|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
127682650|NCT05061693|459462386|FG011|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
127682651|NCT05061693|459462375|FG000|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
127682652|NCT05061693|459462376|FG001|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
127682653|NCT05061693|459462377|FG002|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
127682654|NCT05061693|459462378|FG003|16-week Placebo-controlled (PC) Period|Protocol Violation|2|||
127682655|NCT05061693|459462379|FG004|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
127682656|NCT05061693|459462380|FG005|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
127682657|NCT05061693|459462381|FG006|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
127682658|NCT05061693|459462382|FG007|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
127682659|NCT05061693|459462383|FG008|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
127682660|NCT05061693|459462384|FG009|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
127682661|NCT05061693|459462385|FG010|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
127682662|NCT05061693|459462386|FG011|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
127682663|NCT05061693|459462375|FG000|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
127682664|NCT05061693|459462376|FG001|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|4|||
127682665|NCT05061693|459462377|FG002|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
127682666|NCT05061693|459462378|FG003|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
127682667|NCT05061693|459462379|FG004|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
127682668|NCT05061693|459462380|FG005|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
127682669|NCT05061693|459462381|FG006|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
127682670|NCT05061693|459462382|FG007|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
127682671|NCT05061693|459462383|FG008|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
127682672|NCT05061693|459462384|FG009|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
127682673|NCT05061693|459462385|FG010|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
127682674|NCT05061693|459462386|FG011|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
127682675|NCT05061693|459462375|FG000|24-week Extension Period|Adverse Event|0|||
127682676|NCT05061693|459462376|FG001|24-week Extension Period|Adverse Event|0|||
127682677|NCT05061693|459462377|FG002|24-week Extension Period|Adverse Event|0|||
127682678|NCT05061693|459462378|FG003|24-week Extension Period|Adverse Event|0|||
127682679|NCT05061693|459462379|FG004|24-week Extension Period|Adverse Event|0|||
127682680|NCT05061693|459462380|FG005|24-week Extension Period|Adverse Event|0|||
127682681|NCT05061693|459462381|FG006|24-week Extension Period|Adverse Event|0|||
127682682|NCT05061693|459462382|FG007|24-week Extension Period|Adverse Event|2|||
127682683|NCT05061693|459462383|FG008|24-week Extension Period|Adverse Event|2|||
127682684|NCT05061693|459462384|FG009|24-week Extension Period|Adverse Event|0|||
127682685|NCT05061693|459462385|FG010|24-week Extension Period|Adverse Event|1|||
127682686|NCT05061693|459462386|FG011|24-week Extension Period|Adverse Event|3|||
127682687|NCT05061693|459462375|FG000|24-week Extension Period|Lack of Efficacy|0|||
127682688|NCT05061693|459462376|FG001|24-week Extension Period|Lack of Efficacy|0|||
127682689|NCT05061693|459462377|FG002|24-week Extension Period|Lack of Efficacy|0|||
127682690|NCT05061693|459462378|FG003|24-week Extension Period|Lack of Efficacy|0|||
127682691|NCT05061693|459462379|FG004|24-week Extension Period|Lack of Efficacy|0|||
127682692|NCT05061693|459462380|FG005|24-week Extension Period|Lack of Efficacy|0|||
127682693|NCT05061693|459462381|FG006|24-week Extension Period|Lack of Efficacy|0|||
127682694|NCT05061693|459462382|FG007|24-week Extension Period|Lack of Efficacy|0|||
127682695|NCT05061693|459462383|FG008|24-week Extension Period|Lack of Efficacy|0|||
127682696|NCT05061693|459462384|FG009|24-week Extension Period|Lack of Efficacy|0|||
127768744|NCT00120406|459779558|FG000|Overall Study|Death|9|||
127768745|NCT00120406|459779559|FG001|Overall Study|Death|4|||
127768746|NCT00120406|459779558|FG000|Overall Study|Withdrawal by Subject|5|||
127768747|NCT00120406|459779559|FG001|Overall Study|Withdrawal by Subject|7|||
127768748|NCT00120406|459779558|FG000|Overall Study|Lost to Follow-up|5|||
127768749|NCT00120406|459779559|FG001|Overall Study|Lost to Follow-up|2|||
127768750|NCT00120406|459779558|FG000|Overall Study|received non-study stent|0|||
127768751|NCT00120406|459779559|FG001|Overall Study|received non-study stent|2|||
127768752|NCT00120406|459779558|FG000|Overall Study|patient moved but has not withdrawn|0|||
127768753|NCT00120406|459779559|FG001|Overall Study|patient moved but has not withdrawn|1|||
127768754|NCT02808143|459779560|FG000|Maintenance Phase|Disease recurrence|1|||
128015999|NCT01163617|460682211|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
128016000|NCT01163617|460682212|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
128016001|NCT01163617|460682213|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
128016002|NCT01163617|460682214|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
128016003|NCT01163617|460682215|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
127768755|NCT02808143|459779561|FG001|Maintenance Phase|Disease recurrence|3|||
127768756|NCT02808143|459779560|FG000|Maintenance Phase|Disease progression|1|||
127768757|NCT02808143|459779561|FG001|Maintenance Phase|Disease progression|2|||
127768758|NCT02808143|459779560|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
127768759|NCT02808143|459779561|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
127768760|NCT02808143|459779560|FG000|Survival Follow-Up|Disease recurrence|0|||
127768761|NCT02808143|459779561|FG001|Survival Follow-Up|Disease recurrence|2|||
127768762|NCT02808143|459779560|FG000|Survival Follow-Up|Adverse Event|0|||
127768763|NCT02808143|459779561|FG001|Survival Follow-Up|Adverse Event|1|||
127768764|NCT02808143|459779560|FG000|Survival Follow-Up|Death|1|||
127768765|NCT02808143|459779561|FG001|Survival Follow-Up|Death|0|||
127768766|NCT04964388|459779562|FG000|Overall Study|Lost to Follow-up|3|||
127768767|NCT04964388|459779563|FG001|Overall Study|Lost to Follow-up|2|||
127768768|NCT00250679|459779564|FG000|Overall Study|Adverse Event|12|||
127768769|NCT00250679|459779565|FG001|Overall Study|Adverse Event|15|||
127768770|NCT00250679|459779566|FG002|Overall Study|Adverse Event|16|||
127768771|NCT00250679|459779564|FG000|Overall Study|Protocol Violation|2|||
127768772|NCT00250679|459779565|FG001|Overall Study|Protocol Violation|4|||
127768773|NCT00250679|459779566|FG002|Overall Study|Protocol Violation|3|||
127768774|NCT00250679|459779564|FG000|Overall Study|Withdrawal by Subject|15|||
127768775|NCT00250679|459779565|FG001|Overall Study|Withdrawal by Subject|18|||
127768776|NCT00250679|459779566|FG002|Overall Study|Withdrawal by Subject|15|||
127768777|NCT00250679|459779564|FG000|Overall Study|Lost to Follow-up|3|||
127768778|NCT00250679|459779565|FG001|Overall Study|Lost to Follow-up|4|||
127768779|NCT00250679|459779566|FG002|Overall Study|Lost to Follow-up|2|||
127768780|NCT00250679|459779564|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
127768781|NCT00250679|459779565|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
127768782|NCT00250679|459779566|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
127768783|NCT00250679|459779564|FG000|Overall Study|Lack of Efficacy|0|||
127768784|NCT00250679|459779565|FG001|Overall Study|Lack of Efficacy|1|||
127768785|NCT00250679|459779566|FG002|Overall Study|Lack of Efficacy|3|||
127768786|NCT00250679|459779564|FG000|Overall Study|Technical Holter issues|1|||
127768787|NCT00250679|459779565|FG001|Overall Study|Technical Holter issues|0|||
127768788|NCT00250679|459779566|FG002|Overall Study|Technical Holter issues|2|||
127768789|NCT00250679|459779564|FG000|Overall Study|Moved|1|||
127768790|NCT00250679|459779565|FG001|Overall Study|Moved|1|||
127768791|NCT00250679|459779566|FG002|Overall Study|Moved|0|||
127768792|NCT00250679|459779564|FG000|Overall Study|Non-compliance|1|||
127768793|NCT00250679|459779565|FG001|Overall Study|Non-compliance|1|||
127768794|NCT00250679|459779566|FG002|Overall Study|Non-compliance|0|||
127768795|NCT00250679|459779564|FG000|Overall Study|various single events: hip surgery,diary|3|||
127768796|NCT00250679|459779565|FG001|Overall Study|various single events: hip surgery,diary|1|||
127768797|NCT00250679|459779566|FG002|Overall Study|various single events: hip surgery,diary|1|||
127768798|NCT00448279|459779568|FG000|Overall Study|Lost to Follow-up|2|||
127768799|NCT00448279|459779569|FG001|Overall Study|Lost to Follow-up|2|||
127768800|NCT00448279|459779568|FG000|Overall Study|Adverse Event|1|||
127768801|NCT00448279|459779569|FG001|Overall Study|Adverse Event|1|||
127768802|NCT00448279|459779568|FG000|Overall Study|Disease progression|16|||
127768803|NCT00448279|459779569|FG001|Overall Study|Disease progression|18|||
127768804|NCT00448279|459779568|FG000|Overall Study|Withdrawal by Subject|4|||
127768805|NCT00448279|459779569|FG001|Overall Study|Withdrawal by Subject|3|||
127768806|NCT00448279|459779568|FG000|Overall Study|Other|6|||
127768807|NCT00448279|459779569|FG001|Overall Study|Other|4|||
127768808|NCT00448279|459779568|FG000|Overall Study|Protocol Violation|0|||
127768809|NCT00448279|459779569|FG001|Overall Study|Protocol Violation|1|||
127768810|NCT03907410|459779570|FG000|Overall Study|Lost to Follow-up|4|||
127768811|NCT03907410|459779571|FG001|Overall Study|Lost to Follow-up|1|||
127768812|NCT03907410|459779572|FG002|Overall Study|Lost to Follow-up|1|||
127768813|NCT03907410|459779570|FG000|Overall Study|Lost to follow-up and research burden|0|||
127768814|NCT03907410|459779571|FG001|Overall Study|Lost to follow-up and research burden|0|||
127768815|NCT03907410|459779572|FG002|Overall Study|Lost to follow-up and research burden|1|||
127768816|NCT03718533|459779573|FG000|Overall Study|Myelodysplastic syndrome and study indication|1|||
127768817|NCT03718533|459779573|FG000|Overall Study|Protocol deviation|1|||
127768818|NCT03718533|459779573|FG000|Overall Study|Disease progression|1|||
127768819|NCT03718533|459779573|FG000|Overall Study|Relapse|1|||
127768820|NCT03718533|459779573|FG000|Overall Study|Physician Decision|2|||
127768821|NCT03718533|459779573|FG000|Overall Study|Physician Decision and Adverse Event|1|||
127768822|NCT01295034|459779574|FG000|Overall Study|Lost to Follow-up|5|||
127768823|NCT01295034|459779575|FG001|Overall Study|Lost to Follow-up|5|||
127768824|NCT01174160|459779578|FG000|Overall Study|Adverse Event|1|||
127768825|NCT01174160|459779579|FG001|Overall Study|Adverse Event|0|||
127768826|NCT01174160|459779578|FG000|Overall Study|Lost to Follow-up|1|||
127768827|NCT01174160|459779579|FG001|Overall Study|Lost to Follow-up|0|||
127768828|NCT01174160|459779578|FG000|Overall Study|Physician Decision|1|||
127768829|NCT01174160|459779579|FG001|Overall Study|Physician Decision|0|||
127768830|NCT01174160|459779578|FG000|Overall Study|Protocol Violation|4|||
127768831|NCT01174160|459779579|FG001|Overall Study|Protocol Violation|6|||
127768832|NCT01174160|459779578|FG000|Overall Study|Withdrawal by Subject|1|||
127768833|NCT01174160|459779579|FG001|Overall Study|Withdrawal by Subject|0|||
127768834|NCT04218084|459779580|FG000|Overall Study|Adverse Event|7|||
127768835|NCT04218084|459779581|FG001|Overall Study|Adverse Event|2|||
127768836|NCT04218084|459779580|FG000|Overall Study|Withdrawal of Consent|4|||
127768837|NCT04218084|459779581|FG001|Overall Study|Withdrawal of Consent|5|||
127768838|NCT04218084|459779580|FG000|Overall Study|Physician Decision|1|||
127768839|NCT04218084|459779581|FG001|Overall Study|Physician Decision|1|||
127768840|NCT04218084|459779580|FG000|Overall Study|Lost to Follow-up|1|||
127768841|NCT04218084|459779581|FG001|Overall Study|Lost to Follow-up|1|||
127768842|NCT04218084|459779580|FG000|Overall Study|Non-compliance with study drug|1|||
127768843|NCT04218084|459779581|FG001|Overall Study|Non-compliance with study drug|1|||
127768844|NCT04218084|459779580|FG000|Overall Study|Abnormal transcranial doppler (TCD)|19|||
127768845|NCT04218084|459779581|FG001|Overall Study|Abnormal transcranial doppler (TCD)|24|||
127768846|NCT04218084|459779580|FG000|Overall Study|Other|0|||
127768847|NCT04218084|459779581|FG001|Overall Study|Other|1|||
127768848|NCT04218084|459779580|FG000|Overall Study|Ongoing at data cut-off date|62|||
127768849|NCT04218084|459779581|FG001|Overall Study|Ongoing at data cut-off date|58|||
127768850|NCT05580588|459779582|FG000|Overall Study|Lack of Efficacy|12|||
127768851|NCT00211185|459779585|FG000|Overall Study|Death|2|||
127768852|NCT00211185|459779585|FG000|Overall Study|Disease progression|7|||
127768853|NCT00211185|459779585|FG000|Overall Study|Withdrawal by Subject|6|||
127768854|NCT00211185|459779585|FG000|Overall Study|Physician Decision|5|||
127768855|NCT00712673|459779586|FG000|Overall Study|Adverse Event|3|||
127768856|NCT00712673|459779587|FG001|Overall Study|Adverse Event|3|||
127768857|NCT00712673|459779588|FG002|Overall Study|Adverse Event|21|||
127768858|NCT00712673|459779589|FG003|Overall Study|Adverse Event|26|||
127768859|NCT00712673|459779586|FG000|Overall Study|Lack of Efficacy|2|||
127768860|NCT00712673|459779587|FG001|Overall Study|Lack of Efficacy|8|||
127768861|NCT00712673|459779588|FG002|Overall Study|Lack of Efficacy|8|||
127768862|NCT00712673|459779589|FG003|Overall Study|Lack of Efficacy|6|||
127768863|NCT00712673|459779586|FG000|Overall Study|Poor Compliance to Protocol|3|||
127768864|NCT00712673|459779587|FG001|Overall Study|Poor Compliance to Protocol|3|||
127768865|NCT00712673|459779588|FG002|Overall Study|Poor Compliance to Protocol|4|||
127768866|NCT00712673|459779589|FG003|Overall Study|Poor Compliance to Protocol|16|||
127768867|NCT00712673|459779586|FG000|Overall Study|Lost to Follow-up|1|||
127768868|NCT00712673|459779587|FG001|Overall Study|Lost to Follow-up|0|||
127768869|NCT00712673|459779588|FG002|Overall Study|Lost to Follow-up|2|||
127768870|NCT00712673|459779589|FG003|Overall Study|Lost to Follow-up|0|||
127768871|NCT00712673|459779586|FG000|Overall Study|Withdrawal by Subject|6|||
127768872|NCT00712673|459779587|FG001|Overall Study|Withdrawal by Subject|7|||
127768873|NCT00712673|459779588|FG002|Overall Study|Withdrawal by Subject|15|||
127768874|NCT00712673|459779589|FG003|Overall Study|Withdrawal by Subject|20|||
127768875|NCT00712673|459779586|FG000|Overall Study|Familial and Personal Reasons|5|||
127768876|NCT00712673|459779587|FG001|Overall Study|Familial and Personal Reasons|0|||
127768877|NCT00712673|459779588|FG002|Overall Study|Familial and Personal Reasons|5|||
127768878|NCT00712673|459779589|FG003|Overall Study|Familial and Personal Reasons|2|||
127768879|NCT00712673|459779586|FG000|Overall Study|Investigator's Decision|1|||
127768880|NCT00712673|459779587|FG001|Overall Study|Investigator's Decision|0|||
127768881|NCT00712673|459779588|FG002|Overall Study|Investigator's Decision|0|||
128016004|NCT01163617|460682216|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
127768882|NCT00712673|459779589|FG003|Overall Study|Investigator's Decision|0|||
127768883|NCT00712673|459779586|FG000|Overall Study|Protocol Violation|0|||
127768884|NCT00712673|459779587|FG001|Overall Study|Protocol Violation|0|||
127768885|NCT00712673|459779588|FG002|Overall Study|Protocol Violation|2|||
127768886|NCT00712673|459779589|FG003|Overall Study|Protocol Violation|0|||
127768887|NCT03603028|459779590|FG000|Overall Study|Withdrawal by Subject|1|||
127768888|NCT00842985|459779593|FG000|Screening|Did not meet entrance requirements|27|||
127768889|NCT00842985|459779593|FG000|First Intervention|Withdrawal by Subject|3|||
127768890|NCT00842985|459779593|FG000|First Intervention|Protocol Violation|3|||
127768891|NCT00842985|459779593|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
127768892|NCT00842985|459779593|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
127768893|NCT01952054|459779594|FG000|Overall Study|Physician Decision|1|||
127768894|NCT00836095|459779596|FG000|Overall Study|Physician Decision|0|||
127768895|NCT00836095|459779597|FG001|Overall Study|Physician Decision|3|||
127768896|NCT01768637|459779600|FG000|Overall Study|Lost to Follow-up|2|||
127768897|NCT01768637|459779601|FG001|Overall Study|Lost to Follow-up|7|||
127768898|NCT01768637|459779600|FG000|Overall Study|Difficult blood draw|1|||
127768899|NCT01768637|459779601|FG001|Overall Study|Difficult blood draw|0|||
127768900|NCT00887432|459779602|FG000|Overall Study|Start Excluded Therapy|3|||
127768901|NCT00887432|459779603|FG001|Overall Study|Start Excluded Therapy|0|||
127768902|NCT00887432|459779602|FG000|Overall Study|Did not complete treatment|6|||
127768903|NCT00887432|459779603|FG001|Overall Study|Did not complete treatment|8|||
127768904|NCT00887432|459779602|FG000|Overall Study|Protocol Violation|2|||
127768905|NCT00887432|459779603|FG001|Overall Study|Protocol Violation|3|||
127768906|NCT00887432|459779602|FG000|Overall Study|Withdrawal by Subject|3|||
127768907|NCT00887432|459779603|FG001|Overall Study|Withdrawal by Subject|2|||
127768908|NCT00887432|459779602|FG000|Overall Study|Lost to Follow-up|1|||
127768909|NCT00887432|459779603|FG001|Overall Study|Lost to Follow-up|0|||
127768910|NCT00887432|459779602|FG000|Overall Study|No reason provided|0|||
127768911|NCT00887432|459779603|FG001|Overall Study|No reason provided|1|||
127768912|NCT00899548|459779604|FG000|Overall Study|Physician Decision|3|||
127768913|NCT04781387|459779605|FG000|Overall Study|Withdrawal by Subject|1|||
127768914|NCT04781387|459779606|FG001|Overall Study|Withdrawal by Subject|0|||
127768915|NCT04781387|459779607|FG002|Overall Study|Withdrawal by Subject|1|||
127768916|NCT04781387|459779605|FG000|Overall Study|Lost to Follow-up|1|||
127768917|NCT04781387|459779606|FG001|Overall Study|Lost to Follow-up|0|||
127768918|NCT04781387|459779607|FG002|Overall Study|Lost to Follow-up|0|||
127768919|NCT01275131|459779615|FG000|Period 1|Withdrawal by Subject|1|||
127768920|NCT01275131|459779616|FG001|Period 1|Withdrawal by Subject|0|||
127768921|NCT01275131|459779617|FG002|Period 1|Withdrawal by Subject|3|||
127768922|NCT01275131|459779618|FG003|Period 1|Withdrawal by Subject|2|||
127768923|NCT01275131|459779615|FG000|Period 1|Physician Decision|1|||
127768924|NCT01275131|459779616|FG001|Period 1|Physician Decision|0|||
127768925|NCT01275131|459779617|FG002|Period 1|Physician Decision|0|||
127768926|NCT01275131|459779618|FG003|Period 1|Physician Decision|0|||
127768927|NCT01275131|459779615|FG000|Period 2 (Crossover)|Adverse Event|0|||
127768928|NCT01275131|459779616|FG001|Period 2 (Crossover)|Adverse Event|1|||
127768929|NCT01275131|459779617|FG002|Period 2 (Crossover)|Adverse Event|0|||
127768930|NCT01275131|459779618|FG003|Period 2 (Crossover)|Adverse Event|0|||
127768931|NCT01275131|459779615|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
127768932|NCT01275131|459779616|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
127768933|NCT01275131|459779617|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
127768934|NCT01275131|459779618|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
127768935|NCT00731120|459779619|FG000|Overall Study|Adverse Event|7|||
127768936|NCT00731120|459779620|FG001|Overall Study|Adverse Event|6|||
127768937|NCT00731120|459779621|FG002|Overall Study|Adverse Event|8|||
127768938|NCT00731120|459779619|FG000|Overall Study|Lack of Efficacy|4|||
127768939|NCT00731120|459779620|FG001|Overall Study|Lack of Efficacy|5|||
127768940|NCT00731120|459779621|FG002|Overall Study|Lack of Efficacy|4|||
127768941|NCT00731120|459779619|FG000|Overall Study|Noncompliance with Study Drug|3|||
127768942|NCT00731120|459779620|FG001|Overall Study|Noncompliance with Study Drug|3|||
127768943|NCT00731120|459779621|FG002|Overall Study|Noncompliance with Study Drug|1|||
127768944|NCT00731120|459779619|FG000|Overall Study|Protocol Deviations|1|||
127768945|NCT00731120|459779620|FG001|Overall Study|Protocol Deviations|6|||
127768946|NCT00731120|459779621|FG002|Overall Study|Protocol Deviations|1|||
127768947|NCT00731120|459779619|FG000|Overall Study|Withdrawal of Consent|13|||
127768948|NCT00731120|459779620|FG001|Overall Study|Withdrawal of Consent|8|||
127768949|NCT00731120|459779621|FG002|Overall Study|Withdrawal of Consent|4|||
127768950|NCT00731120|459779619|FG000|Overall Study|Lost to Follow-up|10|||
127768951|NCT00731120|459779620|FG001|Overall Study|Lost to Follow-up|15|||
127768952|NCT00731120|459779621|FG002|Overall Study|Lost to Follow-up|17|||
127768953|NCT00731120|459779619|FG000|Overall Study|Other|4|||
127768954|NCT00731120|459779620|FG001|Overall Study|Other|0|||
127768955|NCT00731120|459779621|FG002|Overall Study|Other|1|||
127768956|NCT00529958|459779626|FG000|2-Year Follow-up|Lost to Follow-up|1|||
127768957|NCT00529958|459779627|FG001|2-Year Follow-up|Lost to Follow-up|2|||
127768958|NCT00529958|459779628|FG002|2-Year Follow-up|Lost to Follow-up|2|||
127768959|NCT00529958|459779626|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
127768960|NCT00529958|459779627|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
127768961|NCT00529958|459779628|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
127768962|NCT00529958|459779626|FG000|5-Year Follow-up|Lost to Follow-up|2|||
127768963|NCT00529958|459779627|FG001|5-Year Follow-up|Lost to Follow-up|3|||
127768964|NCT00529958|459779628|FG002|5-Year Follow-up|Lost to Follow-up|1|||
128016005|NCT01163617|460682217|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
127547077|NCT03955146|458971838|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
127768965|NCT00529958|459779626|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
128016006|NCT01163617|460682210|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
128016007|NCT01163617|460682211|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
128016008|NCT01163617|460682212|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
128016009|NCT01163617|460682213|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
128016010|NCT01163617|460682214|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
128016011|NCT01163617|460682215|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
128016012|NCT01163617|460682216|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
128016013|NCT01163617|460682217|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
128016014|NCT02394756|460682218|FG000|Period 1|Lens Discomfort|0|||
128016015|NCT02394756|460682219|FG001|Period 1|Lens Discomfort|0|||
128016016|NCT02394756|460682220|FG002|Period 1|Lens Discomfort|0|||
128016017|NCT02394756|460682221|FG003|Period 1|Lens Discomfort|0|||
128016018|NCT02394756|460682222|FG004|Period 1|Lens Discomfort|0|||
128016019|NCT02394756|460682223|FG005|Period 1|Lens Discomfort|1|||
128016020|NCT02394756|460682218|FG000|Period 1|Withdrawal by Subject|0|||
128016021|NCT02394756|460682219|FG001|Period 1|Withdrawal by Subject|1|||
128016022|NCT02394756|460682220|FG002|Period 1|Withdrawal by Subject|1|||
128016023|NCT02394756|460682221|FG003|Period 1|Withdrawal by Subject|1|||
128016024|NCT02394756|460682222|FG004|Period 1|Withdrawal by Subject|0|||
128016025|NCT02394756|460682223|FG005|Period 1|Withdrawal by Subject|0|||
128016026|NCT02394756|460682218|FG000|Period 2|Unsatisfactory Visual Response|0|||
127547078|NCT03955146|458971839|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
127547079|NCT03955146|458971836|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
127547080|NCT03955146|458971837|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
127547081|NCT03955146|458971838|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
127547082|NCT03955146|458971839|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
127547083|NCT03955146|458971836|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
127547084|NCT03955146|458971837|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|1|||
127547085|NCT03955146|458971838|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
127547086|NCT03955146|458971839|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
127547087|NCT03955146|458971836|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
127547088|NCT03955146|458971837|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
127547089|NCT03955146|458971838|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
127547090|NCT03955146|458971839|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
127547091|NCT03955146|458971836|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|84|||
127547092|NCT03955146|458971837|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|88|||
127547093|NCT03955146|458971838|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
127547094|NCT03955146|458971839|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
127547095|NCT03955146|458971836|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|1|||
127547096|NCT03955146|458971837|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
127547097|NCT03955146|458971838|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
127547098|NCT03955146|458971839|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
127547099|NCT03955146|458971836|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|7|||
127547100|NCT03955146|458971837|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|5|||
127547101|NCT03955146|458971838|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
127547102|NCT03955146|458971839|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
127547103|NCT03955146|458971836|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|2|||
127547104|NCT03955146|458971837|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|1|||
127547105|NCT03955146|458971838|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
127547106|NCT03955146|458971839|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
127547107|NCT03955146|458971836|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|1|||
127547108|NCT03955146|458971837|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
127547109|NCT03955146|458971838|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
127547110|NCT03955146|458971839|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
127547111|NCT03955146|458971836|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|12|||
127547112|NCT03955146|458971837|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|13|||
127547113|NCT03955146|458971838|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
127547114|NCT03955146|458971839|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
127547115|NCT03955146|458971836|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|1|||
127547116|NCT03955146|458971837|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
127547117|NCT03955146|458971838|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
127547118|NCT03955146|458971839|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
127547119|NCT02002598|458971842|FG000|Dose Level 1|Withdrawal by Subject|1|||
127547120|NCT02002598|458971843|FG001|Dose Level 1|Withdrawal by Subject|0|||
127768966|NCT00529958|459779627|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
127768967|NCT00529958|459779628|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
127768968|NCT03316300|459779629|FG000|Overall Study|Withdrawal by Subject|3|||
127768969|NCT03316300|459779630|FG001|Overall Study|Withdrawal by Subject|2|||
127768970|NCT03316300|459779629|FG000|Overall Study|Eligible and did not enroll in amendment|4|||
127768971|NCT03316300|459779630|FG001|Overall Study|Eligible and did not enroll in amendment|4|||
127768972|NCT03316300|459779629|FG000|Overall Study|Adverse Event|1|||
127768973|NCT03316300|459779630|FG001|Overall Study|Adverse Event|0|||
127768974|NCT03316300|459779629|FG000|Overall Study|COVID-19|0|||
127768975|NCT03316300|459779630|FG001|Overall Study|COVID-19|1|||
127768976|NCT03756129|459779632|FG000|Overall Study|Adverse Event|1|||
127768977|NCT03756129|459779633|FG001|Overall Study|Adverse Event|1|||
127768978|NCT03756129|459779634|FG002|Overall Study|Adverse Event|0|||
127768979|NCT03756129|459779635|FG003|Overall Study|Adverse Event|2|||
127768980|NCT03756129|459779636|FG004|Overall Study|Adverse Event|0|||
127768981|NCT03756129|459779637|FG005|Overall Study|Adverse Event|0|||
127768982|NCT03756129|459779632|FG000|Overall Study|Withdrawal by Subject|2|||
127768983|NCT03756129|459779633|FG001|Overall Study|Withdrawal by Subject|1|||
127768984|NCT03756129|459779634|FG002|Overall Study|Withdrawal by Subject|3|||
127768985|NCT03756129|459779635|FG003|Overall Study|Withdrawal by Subject|1|||
127768986|NCT03756129|459779636|FG004|Overall Study|Withdrawal by Subject|1|||
127768987|NCT03756129|459779637|FG005|Overall Study|Withdrawal by Subject|3|||
127768988|NCT03756129|459779632|FG000|Overall Study|Lost to Follow-up|0|||
127768989|NCT03756129|459779633|FG001|Overall Study|Lost to Follow-up|0|||
127768990|NCT03756129|459779634|FG002|Overall Study|Lost to Follow-up|0|||
127768991|NCT03756129|459779635|FG003|Overall Study|Lost to Follow-up|0|||
127768992|NCT03756129|459779636|FG004|Overall Study|Lost to Follow-up|0|||
127768993|NCT03756129|459779637|FG005|Overall Study|Lost to Follow-up|1|||
127768994|NCT03756129|459779632|FG000|Overall Study|Physician Decision|0|||
127768995|NCT03756129|459779633|FG001|Overall Study|Physician Decision|0|||
127768996|NCT03756129|459779634|FG002|Overall Study|Physician Decision|0|||
127768997|NCT03756129|459779635|FG003|Overall Study|Physician Decision|0|||
127768998|NCT03756129|459779636|FG004|Overall Study|Physician Decision|0|||
127768999|NCT03756129|459779637|FG005|Overall Study|Physician Decision|1|||
127769000|NCT01315353|459779638|FG000|Overall Study|Death|2|||
127769001|NCT01315353|459779639|FG001|Overall Study|Death|1|||
127769002|NCT01315353|459779640|FG002|Overall Study|Death|0|||
127769003|NCT01315353|459779638|FG000|Overall Study|Withdrawal by Subject|2|||
127769004|NCT01315353|459779639|FG001|Overall Study|Withdrawal by Subject|6|||
127769005|NCT01315353|459779640|FG002|Overall Study|Withdrawal by Subject|1|||
127769006|NCT01315353|459779638|FG000|Overall Study|Lost to Follow-up|13|||
127769007|NCT01315353|459779639|FG001|Overall Study|Lost to Follow-up|6|||
127769008|NCT01315353|459779640|FG002|Overall Study|Lost to Follow-up|6|||
127769009|NCT01315353|459779638|FG000|Overall Study|Unwilling to adhere to requirements|5|||
127769010|NCT01315353|459779639|FG001|Overall Study|Unwilling to adhere to requirements|5|||
127547121|NCT02002598|458971844|FG002|Dose Level 1|Withdrawal by Subject|0|||
127769011|NCT01315353|459779640|FG002|Overall Study|Unwilling to adhere to requirements|4|||
127769012|NCT01315353|459779638|FG000|Overall Study|Site closing|7|||
127769013|NCT01315353|459779639|FG001|Overall Study|Site closing|4|||
127769014|NCT01315353|459779640|FG002|Overall Study|Site closing|0|||
127769015|NCT01315353|459779638|FG000|Overall Study|Taken off study by site in error|0|||
127769016|NCT01315353|459779639|FG001|Overall Study|Taken off study by site in error|1|||
127769017|NCT01315353|459779640|FG002|Overall Study|Taken off study by site in error|0|||
127769018|NCT01315353|459779638|FG000|Overall Study|Inadvertent randomization/assignment|0|||
127769019|NCT01315353|459779639|FG001|Overall Study|Inadvertent randomization/assignment|0|||
127769020|NCT01315353|459779640|FG002|Overall Study|Inadvertent randomization/assignment|2|||
127769021|NCT03567434|459779641|FG000|Overall Study|Lost to Follow-up|1|||
127769022|NCT03567434|459779642|FG001|Overall Study|Lost to Follow-up|3|||
127769023|NCT03035201|459779643|FG000|Overall Study|Death|9|||
127769024|NCT03035201|459779644|FG001|Overall Study|Death|12|||
127547122|NCT02002598|458971845|FG003|Dose Level 1|Withdrawal by Subject|0|||
127547123|NCT02002598|458971846|FG004|Dose Level 1|Withdrawal by Subject|0|||
127769025|NCT03035201|459779645|FG002|Overall Study|Death|9|||
127769026|NCT03035201|459779646|FG003|Overall Study|Death|10|||
127769027|NCT03035201|459779643|FG000|Overall Study|Withdrawal by Subject|51|||
128016027|NCT02394756|460682219|FG001|Period 2|Unsatisfactory Visual Response|0|||
127769028|NCT03035201|459779644|FG001|Overall Study|Withdrawal by Subject|49|||
127769029|NCT03035201|459779645|FG002|Overall Study|Withdrawal by Subject|37|||
127769030|NCT03035201|459779646|FG003|Overall Study|Withdrawal by Subject|46|||
127769031|NCT03035201|459779643|FG000|Overall Study|Lost to Follow-up|67|||
127769032|NCT03035201|459779644|FG001|Overall Study|Lost to Follow-up|51|||
127769033|NCT03035201|459779645|FG002|Overall Study|Lost to Follow-up|64|||
127769034|NCT03035201|459779646|FG003|Overall Study|Lost to Follow-up|69|||
127547124|NCT02628873|458971847|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
127547125|NCT02628873|458971848|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
127769035|NCT01050790|459779648|FG000|Overall Study|Adverse Event|1|||
127769036|NCT03705832|459779649|FG000|Overall Study|Physician Decision|0|||
127769037|NCT03705832|459779650|FG001|Overall Study|Physician Decision|1|||
127682697|NCT05061693|459462385|FG010|24-week Extension Period|Lack of Efficacy|2|||
127682698|NCT05061693|459462386|FG011|24-week Extension Period|Lack of Efficacy|0|||
127682699|NCT05061693|459462375|FG000|24-week Extension Period|Lost to Follow-up|0|||
127682700|NCT05061693|459462376|FG001|24-week Extension Period|Lost to Follow-up|0|||
127682701|NCT05061693|459462377|FG002|24-week Extension Period|Lost to Follow-up|0|||
127682702|NCT05061693|459462378|FG003|24-week Extension Period|Lost to Follow-up|0|||
127682703|NCT05061693|459462379|FG004|24-week Extension Period|Lost to Follow-up|0|||
127682704|NCT05061693|459462380|FG005|24-week Extension Period|Lost to Follow-up|0|||
127682705|NCT05061693|459462381|FG006|24-week Extension Period|Lost to Follow-up|1|||
127682706|NCT05061693|459462382|FG007|24-week Extension Period|Lost to Follow-up|0|||
127682707|NCT05061693|459462383|FG008|24-week Extension Period|Lost to Follow-up|1|||
127682708|NCT05061693|459462384|FG009|24-week Extension Period|Lost to Follow-up|1|||
127682709|NCT05061693|459462385|FG010|24-week Extension Period|Lost to Follow-up|0|||
127682710|NCT05061693|459462386|FG011|24-week Extension Period|Lost to Follow-up|0|||
127682711|NCT05061693|459462375|FG000|24-week Extension Period|Withdrawal by Subject|0|||
127682712|NCT05061693|459462376|FG001|24-week Extension Period|Withdrawal by Subject|0|||
127682713|NCT05061693|459462377|FG002|24-week Extension Period|Withdrawal by Subject|0|||
127682714|NCT05061693|459462378|FG003|24-week Extension Period|Withdrawal by Subject|0|||
127682715|NCT05061693|459462379|FG004|24-week Extension Period|Withdrawal by Subject|0|||
127682716|NCT05061693|459462380|FG005|24-week Extension Period|Withdrawal by Subject|0|||
127682717|NCT05061693|459462381|FG006|24-week Extension Period|Withdrawal by Subject|0|||
127682718|NCT05061693|459462382|FG007|24-week Extension Period|Withdrawal by Subject|0|||
127682719|NCT05061693|459462383|FG008|24-week Extension Period|Withdrawal by Subject|1|||
127682720|NCT05061693|459462384|FG009|24-week Extension Period|Withdrawal by Subject|2|||
127682721|NCT05061693|459462385|FG010|24-week Extension Period|Withdrawal by Subject|2|||
127682722|NCT05061693|459462386|FG011|24-week Extension Period|Withdrawal by Subject|1|||
127682723|NCT05061693|459462375|FG000|24-week Extension Period|Sponsor Decision|0|||
127682724|NCT05061693|459462376|FG001|24-week Extension Period|Sponsor Decision|0|||
127682725|NCT05061693|459462377|FG002|24-week Extension Period|Sponsor Decision|0|||
127682726|NCT05061693|459462378|FG003|24-week Extension Period|Sponsor Decision|0|||
127682727|NCT05061693|459462379|FG004|24-week Extension Period|Sponsor Decision|0|||
127682728|NCT05061693|459462380|FG005|24-week Extension Period|Sponsor Decision|0|||
127682729|NCT05061693|459462381|FG006|24-week Extension Period|Sponsor Decision|0|||
127682730|NCT05061693|459462382|FG007|24-week Extension Period|Sponsor Decision|1|||
127682731|NCT05061693|459462383|FG008|24-week Extension Period|Sponsor Decision|0|||
127682732|NCT05061693|459462384|FG009|24-week Extension Period|Sponsor Decision|0|||
127682733|NCT05061693|459462385|FG010|24-week Extension Period|Sponsor Decision|0|||
127682734|NCT05061693|459462386|FG011|24-week Extension Period|Sponsor Decision|0|||
127682735|NCT05061693|459462375|FG000|24-week Extension Period|Site Closure|0|||
127682736|NCT05061693|459462376|FG001|24-week Extension Period|Site Closure|0|||
127682737|NCT05061693|459462377|FG002|24-week Extension Period|Site Closure|0|||
127682738|NCT05061693|459462378|FG003|24-week Extension Period|Site Closure|0|||
127682739|NCT05061693|459462379|FG004|24-week Extension Period|Site Closure|0|||
127682740|NCT05061693|459462380|FG005|24-week Extension Period|Site Closure|0|||
127682741|NCT05061693|459462381|FG006|24-week Extension Period|Site Closure|0|||
127682742|NCT05061693|459462382|FG007|24-week Extension Period|Site Closure|0|||
127682743|NCT05061693|459462383|FG008|24-week Extension Period|Site Closure|1|||
127682744|NCT05061693|459462384|FG009|24-week Extension Period|Site Closure|0|||
127682745|NCT05061693|459462385|FG010|24-week Extension Period|Site Closure|0|||
127682746|NCT05061693|459462386|FG011|24-week Extension Period|Site Closure|1|||
127682747|NCT03823911|459462387|FG000|Overall Study|Lost to Follow-up|1|||
127682748|NCT03823911|459462388|FG001|Overall Study|Lost to Follow-up|5|||
127682749|NCT03823911|459462389|FG002|Overall Study|Lost to Follow-up|2|||
127682750|NCT03823911|459462387|FG000|Overall Study|Did not meet eligibility criteria|13|||
127682751|NCT03823911|459462388|FG001|Overall Study|Did not meet eligibility criteria|7|||
127682752|NCT03823911|459462389|FG002|Overall Study|Did not meet eligibility criteria|4|||
127682753|NCT03823911|459462387|FG000|Overall Study|Death|0|||
127682754|NCT03823911|459462388|FG001|Overall Study|Death|1|||
127682755|NCT03823911|459462389|FG002|Overall Study|Death|0|||
127682756|NCT01152190|459462390|FG000|Overall Study|Adverse Event|2|||
127682757|NCT01152190|459462391|FG001|Overall Study|Adverse Event|4|||
127682758|NCT01152190|459462390|FG000|Overall Study|Death|1|||
127682759|NCT01152190|459462391|FG001|Overall Study|Death|0|||
127682760|NCT01152190|459462390|FG000|Overall Study|Protocol Violation|1|||
127682761|NCT01152190|459462391|FG001|Overall Study|Protocol Violation|1|||
127682762|NCT01152190|459462390|FG000|Overall Study|Withdrawal by Subject|1|||
127682763|NCT01152190|459462391|FG001|Overall Study|Withdrawal by Subject|3|||
127682764|NCT00258895|459462392|FG000|Overall Study|Lost to Follow-up|3|||
127682765|NCT00258895|459462393|FG001|Overall Study|Lost to Follow-up|1|||
127682766|NCT00258895|459462392|FG000|Overall Study|Protocol Violation|6|||
127682767|NCT00258895|459462393|FG001|Overall Study|Protocol Violation|2|||
128016028|NCT02394756|460682220|FG002|Period 2|Unsatisfactory Visual Response|0|||
127682768|NCT00258895|459462392|FG000|Overall Study|Withdrawal by Subject|1|||
127682769|NCT00258895|459462393|FG001|Overall Study|Withdrawal by Subject|0|||
128016029|NCT02394756|460682221|FG003|Period 2|Unsatisfactory Visual Response|0|||
127682770|NCT00547118|459462394|FG000|Overall Study|Did not qualify prior to starting drug|1|||
127682771|NCT00547118|459462395|FG001|Overall Study|Did not qualify prior to starting drug|1|||
127682772|NCT00547118|459462394|FG000|Overall Study|Study suspended|7|||
127682773|NCT00547118|459462395|FG001|Overall Study|Study suspended|8|||
127682774|NCT04504916|459462399|FG000|Overall Study|Study terminated|7|||
127682775|NCT04504916|459462400|FG001|Overall Study|Study terminated|8|||
127682776|NCT04504916|459462399|FG000|Overall Study|Death|54|||
127682777|NCT04504916|459462400|FG001|Overall Study|Death|18|||
127682778|NCT04504916|459462399|FG000|Overall Study|Lost to Follow-up|1|||
127682779|NCT04504916|459462400|FG001|Overall Study|Lost to Follow-up|1|||
127682780|NCT04504916|459462399|FG000|Overall Study|Withdrawal by Subject|8|||
127682781|NCT04504916|459462400|FG001|Overall Study|Withdrawal by Subject|4|||
127682782|NCT04504916|459462399|FG000|Overall Study|Did not agree to follow-up|0|||
127682783|NCT04504916|459462400|FG001|Overall Study|Did not agree to follow-up|1|||
127682784|NCT00834834|459462401|FG000|Overall Study|Withdrawal by Subject|4|||
127682785|NCT00834834|459462402|FG001|Overall Study|Withdrawal by Subject|3|||
127682786|NCT00442117|459462403|FG000|Overall Study|Adverse Event|3|||
127682787|NCT00442117|459462404|FG001|Overall Study|Adverse Event|2|||
127682788|NCT00442117|459462403|FG000|Overall Study|Lack of Efficacy|2|||
127682789|NCT00442117|459462404|FG001|Overall Study|Lack of Efficacy|6|||
127682790|NCT00442117|459462403|FG000|Overall Study|Lost to Follow-up|1|||
127682791|NCT00442117|459462404|FG001|Overall Study|Lost to Follow-up|2|||
127682792|NCT00442117|459462403|FG000|Overall Study|Withdrawal by Subject|2|||
127682793|NCT00442117|459462404|FG001|Overall Study|Withdrawal by Subject|2|||
127682794|NCT00442117|459462403|FG000|Overall Study|Major Deviation|25|||
127682795|NCT00442117|459462404|FG001|Overall Study|Major Deviation|20|||
127682796|NCT00442117|459462403|FG000|Overall Study|Non compliance with protocol|3|||
127682797|NCT00442117|459462404|FG001|Overall Study|Non compliance with protocol|5|||
128016030|NCT02394756|460682222|FG004|Period 2|Unsatisfactory Visual Response|1|||
128016031|NCT02394756|460682223|FG005|Period 2|Unsatisfactory Visual Response|0|||
128016032|NCT02335944|460682224|FG000|Treatment Phase|Progressive Disease|2|||
128016033|NCT02335944|460682225|FG001|Treatment Phase|Progressive Disease|5|||
128016034|NCT02335944|460682226|FG002|Treatment Phase|Progressive Disease|2|||
128016035|NCT02335944|460682227|FG003|Treatment Phase|Progressive Disease|11|||
128016036|NCT02335944|460682228|FG004|Treatment Phase|Progressive Disease|4|||
128016037|NCT02335944|460682229|FG005|Treatment Phase|Progressive Disease|25|||
128016038|NCT02335944|460682230|FG006|Treatment Phase|Progressive Disease|2|||
128016039|NCT02335944|460682231|FG007|Treatment Phase|Progressive Disease|30|||
128016040|NCT02335944|460682232|FG008|Treatment Phase|Progressive Disease|27|||
128016041|NCT02335944|460682233|FG009|Treatment Phase|Progressive Disease|0|||
128016042|NCT02335944|460682224|FG000|Treatment Phase|Adverse Event|2|||
128016043|NCT02335944|460682225|FG001|Treatment Phase|Adverse Event|0|||
128016044|NCT02335944|460682226|FG002|Treatment Phase|Adverse Event|0|||
128016045|NCT02335944|460682227|FG003|Treatment Phase|Adverse Event|2|||
128016046|NCT02335944|460682228|FG004|Treatment Phase|Adverse Event|1|||
128016047|NCT02335944|460682229|FG005|Treatment Phase|Adverse Event|15|||
128016048|NCT02335944|460682230|FG006|Treatment Phase|Adverse Event|0|||
128016049|NCT02335944|460682231|FG007|Treatment Phase|Adverse Event|5|||
128016050|NCT02335944|460682232|FG008|Treatment Phase|Adverse Event|7|||
128016051|NCT02335944|460682233|FG009|Treatment Phase|Adverse Event|0|||
128016052|NCT02335944|460682224|FG000|Treatment Phase|Physician Decision|0|||
128016053|NCT02335944|460682225|FG001|Treatment Phase|Physician Decision|0|||
128016054|NCT02335944|460682226|FG002|Treatment Phase|Physician Decision|0|||
127682798|NCT00442117|459462403|FG000|Overall Study|Met Withdrawal Criteria|2|||
127682799|NCT00442117|459462404|FG001|Overall Study|Met Withdrawal Criteria|1|||
127682800|NCT01662336|459463413|FG000|Overall Study|Adverse Event|1|||
127682801|NCT01662336|459463413|FG000|Overall Study|No longer on LPV/r|30|||
127682802|NCT01662336|459463413|FG000|Overall Study|Other|29|||
127682803|NCT01662336|459463413|FG000|Overall Study|Withdrawal by Subject|6|||
127682804|NCT00178399|459463414|FG000|Overall Study|Physician Decision|4|||
127682805|NCT00178399|459463414|FG000|Overall Study|Withdrawal by Subject|8|||
127682806|NCT00178399|459463414|FG000|Overall Study|Lost to Follow-up|1|||
127682807|NCT00516321|459463415|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
127682808|NCT00516321|459463416|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
127682809|NCT00516321|459463417|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
127682810|NCT00516321|459463415|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
127682811|NCT00516321|459463416|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
127682812|NCT00516321|459463417|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
127682813|NCT00516321|459463415|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
127682814|NCT00516321|459463416|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
127682815|NCT00516321|459463417|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
128016055|NCT02335944|460682227|FG003|Treatment Phase|Physician Decision|1|||
128016056|NCT02335944|460682228|FG004|Treatment Phase|Physician Decision|0|||
128016057|NCT02335944|460682229|FG005|Treatment Phase|Physician Decision|6|||
128016058|NCT02335944|460682230|FG006|Treatment Phase|Physician Decision|1|||
128016059|NCT02335944|460682231|FG007|Treatment Phase|Physician Decision|2|||
127682816|NCT00516321|459463415|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
127682817|NCT00516321|459463416|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
127682818|NCT00516321|459463417|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
127682819|NCT00516321|459463415|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
127682820|NCT00516321|459463416|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
127682821|NCT00516321|459463417|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
127682822|NCT00516321|459463415|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
127682823|NCT00516321|459463416|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
127682824|NCT00516321|459463417|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
127682825|NCT00516321|459463415|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
127682826|NCT00516321|459463416|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
127682827|NCT00516321|459463417|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
127682828|NCT00516321|459463415|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
127682829|NCT00516321|459463416|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
127682830|NCT00516321|459463417|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
127682831|NCT00516321|459463415|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
127682832|NCT00516321|459463416|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
127682833|NCT00516321|459463417|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
127682834|NCT00516321|459463415|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
127682835|NCT00516321|459463416|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
127682836|NCT00516321|459463417|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
127682837|NCT00516321|459463415|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
127682838|NCT00516321|459463416|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
127682839|NCT00516321|459463417|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
127682840|NCT01765543|459463420|FG000|Overall Study|Death|1|||
127682841|NCT01765543|459463420|FG000|Overall Study|Withdrawal by Subject|2|||
127682842|NCT02423291|459463427|FG000|Overall Study|Lack of Efficacy|14|||
127682843|NCT02423291|459463427|FG000|Overall Study|Adverse Event|1|||
127682844|NCT05283395|459463429|FG000|Overall Study|Adverse Event|4|||
127682845|NCT05283395|459463430|FG001|Overall Study|Adverse Event|4|||
127682846|NCT05283395|459463431|FG002|Overall Study|Adverse Event|0|||
127682847|NCT05283395|459463429|FG000|Overall Study|Patient Lost to Follow-Up|0|||
127682848|NCT05283395|459463430|FG001|Overall Study|Patient Lost to Follow-Up|0|||
127682849|NCT05283395|459463431|FG002|Overall Study|Patient Lost to Follow-Up|1|||
127682850|NCT05283395|459463429|FG000|Overall Study|Patient Withdrawal|2|||
127682851|NCT05283395|459463430|FG001|Overall Study|Patient Withdrawal|4|||
127682852|NCT05283395|459463431|FG002|Overall Study|Patient Withdrawal|2|||
127682853|NCT05283395|459463429|FG000|Overall Study|Investigator Decision|1|||
127682854|NCT05283395|459463430|FG001|Overall Study|Investigator Decision|0|||
127682855|NCT05283395|459463431|FG002|Overall Study|Investigator Decision|1|||
127682856|NCT05283395|459463429|FG000|Overall Study|Enrolled in error|0|||
127682857|NCT05283395|459463430|FG001|Overall Study|Enrolled in error|0|||
127682858|NCT05283395|459463431|FG002|Overall Study|Enrolled in error|1|||
127682859|NCT00712335|459463436|FG000|Overall Study|Withdrawal by Subject|0|||
127682860|NCT00712335|459463437|FG001|Overall Study|Withdrawal by Subject|7|||
127682861|NCT00712335|459463438|FG002|Overall Study|Withdrawal by Subject|2|||
127682862|NCT00712335|459463439|FG003|Overall Study|Withdrawal by Subject|3|||
127682863|NCT00712335|459463440|FG004|Overall Study|Withdrawal by Subject|0|||
127682864|NCT00712335|459463436|FG000|Overall Study|Lost to Follow-up|2|||
127682865|NCT00712335|459463437|FG001|Overall Study|Lost to Follow-up|5|||
127682866|NCT00712335|459463438|FG002|Overall Study|Lost to Follow-up|0|||
127682867|NCT00712335|459463439|FG003|Overall Study|Lost to Follow-up|1|||
127682868|NCT00712335|459463440|FG004|Overall Study|Lost to Follow-up|0|||
127682869|NCT00712335|459463436|FG000|Overall Study|Protocol Violation|1|||
127682870|NCT00712335|459463437|FG001|Overall Study|Protocol Violation|2|||
127682871|NCT00712335|459463438|FG002|Overall Study|Protocol Violation|1|||
127682872|NCT00712335|459463439|FG003|Overall Study|Protocol Violation|0|||
127682873|NCT00712335|459463440|FG004|Overall Study|Protocol Violation|0|||
127682874|NCT00712335|459463436|FG000|Overall Study|Lack of Efficacy|0|||
127682875|NCT00712335|459463437|FG001|Overall Study|Lack of Efficacy|0|||
127682876|NCT00712335|459463438|FG002|Overall Study|Lack of Efficacy|1|||
127682877|NCT00712335|459463439|FG003|Overall Study|Lack of Efficacy|1|||
127682878|NCT00712335|459463440|FG004|Overall Study|Lack of Efficacy|0|||
127682879|NCT00712335|459463436|FG000|Overall Study|Other Reason|0|||
127682880|NCT00712335|459463437|FG001|Overall Study|Other Reason|3|||
127682881|NCT00712335|459463438|FG002|Overall Study|Other Reason|1|||
127682882|NCT00712335|459463439|FG003|Overall Study|Other Reason|0|||
127682883|NCT00712335|459463440|FG004|Overall Study|Other Reason|0|||
127682884|NCT03401112|459463441|FG000|Overall Study|Adverse Event|1|||
127682885|NCT03401112|459463442|FG001|Overall Study|Adverse Event|2|||
127682886|NCT03401112|459463443|FG002|Overall Study|Adverse Event|3|||
127682887|NCT03401112|459463444|FG003|Overall Study|Adverse Event|2|||
127682888|NCT03401112|459463445|FG004|Overall Study|Adverse Event|0|||
127682889|NCT03401112|459463441|FG000|Overall Study|Lost to Follow-up|1|||
127682890|NCT03401112|459463442|FG001|Overall Study|Lost to Follow-up|0|||
127682891|NCT03401112|459463443|FG002|Overall Study|Lost to Follow-up|0|||
127682892|NCT03401112|459463444|FG003|Overall Study|Lost to Follow-up|0|||
127682893|NCT03401112|459463445|FG004|Overall Study|Lost to Follow-up|0|||
127682894|NCT03401112|459463441|FG000|Overall Study|Noncompliance|1|||
127682895|NCT03401112|459463442|FG001|Overall Study|Noncompliance|2|||
127682896|NCT03401112|459463443|FG002|Overall Study|Noncompliance|3|||
127682897|NCT03401112|459463444|FG003|Overall Study|Noncompliance|0|||
127682898|NCT03401112|459463445|FG004|Overall Study|Noncompliance|0|||
127682899|NCT03401112|459463441|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
127682900|NCT03401112|459463442|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
127682901|NCT03401112|459463443|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
127682902|NCT03401112|459463444|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
127682903|NCT03401112|459463445|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
127682904|NCT03401112|459463441|FG000|Overall Study|Withdrawal by Subject|0|||
127682905|NCT03401112|459463442|FG001|Overall Study|Withdrawal by Subject|3|||
127682906|NCT03401112|459463443|FG002|Overall Study|Withdrawal by Subject|2|||
127682907|NCT03401112|459463444|FG003|Overall Study|Withdrawal by Subject|1|||
127682908|NCT03401112|459463445|FG004|Overall Study|Withdrawal by Subject|0|||
127682909|NCT03401112|459463441|FG000|Overall Study|Physician Decision|0|||
127682910|NCT03401112|459463442|FG001|Overall Study|Physician Decision|0|||
127682911|NCT03401112|459463443|FG002|Overall Study|Physician Decision|0|||
127682912|NCT03401112|459463444|FG003|Overall Study|Physician Decision|2|||
127682913|NCT03401112|459463445|FG004|Overall Study|Physician Decision|0|||
127682914|NCT03401112|459463441|FG000|Overall Study|Study was Terminated by Sponsor|0|||
127682915|NCT03401112|459463442|FG001|Overall Study|Study was Terminated by Sponsor|0|||
127682916|NCT03401112|459463443|FG002|Overall Study|Study was Terminated by Sponsor|0|||
127682917|NCT03401112|459463444|FG003|Overall Study|Study was Terminated by Sponsor|1|||
127682918|NCT03401112|459463445|FG004|Overall Study|Study was Terminated by Sponsor|0|||
127682919|NCT03401112|459463441|FG000|Overall Study|Day 1 Assessment not Done|1|||
127682920|NCT03401112|459463442|FG001|Overall Study|Day 1 Assessment not Done|0|||
127682921|NCT03401112|459463443|FG002|Overall Study|Day 1 Assessment not Done|0|||
127682922|NCT03401112|459463444|FG003|Overall Study|Day 1 Assessment not Done|0|||
127682923|NCT03401112|459463445|FG004|Overall Study|Day 1 Assessment not Done|0|||
127682924|NCT03401112|459463441|FG000|Overall Study|Not Dosed|0|||
127682925|NCT03401112|459463442|FG001|Overall Study|Not Dosed|0|||
127682926|NCT03401112|459463443|FG002|Overall Study|Not Dosed|1|||
127682927|NCT03401112|459463444|FG003|Overall Study|Not Dosed|0|||
127682928|NCT03401112|459463445|FG004|Overall Study|Not Dosed|0|||
127682929|NCT03401112|459463441|FG000|Overall Study|Missed Clinical Visit|0|||
127682930|NCT03401112|459463442|FG001|Overall Study|Missed Clinical Visit|0|||
127682931|NCT03401112|459463443|FG002|Overall Study|Missed Clinical Visit|1|||
127682932|NCT03401112|459463444|FG003|Overall Study|Missed Clinical Visit|0|||
127682933|NCT03401112|459463445|FG004|Overall Study|Missed Clinical Visit|0|||
127682934|NCT03401112|459463441|FG000|Overall Study|Missed Doses|0|||
127682935|NCT03401112|459463442|FG001|Overall Study|Missed Doses|0|||
127682936|NCT03401112|459463443|FG002|Overall Study|Missed Doses|1|||
127682937|NCT03401112|459463444|FG003|Overall Study|Missed Doses|0|||
127682938|NCT03401112|459463445|FG004|Overall Study|Missed Doses|0|||
127682939|NCT01202955|459463446|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
127682940|NCT01202955|459463447|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
127682941|NCT02115139|459463448|FG000|Overall Study|Protocol Violation|1|||
127682942|NCT02115139|459463448|FG000|Overall Study|treatment discontinuation|6|||
127682943|NCT01909778|459463449|FG000|Overall Study|failed screening|1|||
127682944|NCT02471755|459463451|FG000|Overall Study|Withdrawal by Subject|1|||
127682945|NCT02471755|459463452|FG001|Overall Study|Withdrawal by Subject|0|||
127682946|NCT02471755|459463451|FG000|Overall Study|Lost to Follow-up|0|||
127682947|NCT02471755|459463452|FG001|Overall Study|Lost to Follow-up|1|||
127682948|NCT04740164|459463453|FG000|Overall Study|Lack of Efficacy|4|||
127682949|NCT04740164|459463454|FG001|Overall Study|Lack of Efficacy|0|||
127682950|NCT04740164|459463453|FG000|Overall Study|Physician Decision|3|||
127682951|NCT04740164|459463454|FG001|Overall Study|Physician Decision|3|||
127682952|NCT04177394|459463455|FG000|Overall Study|Death|16|||
127682953|NCT04177394|459463455|FG000|Overall Study|Withdrawal by Subject|19|||
128016060|NCT02335944|460682232|FG008|Treatment Phase|Physician Decision|1|||
128016061|NCT02335944|460682233|FG009|Treatment Phase|Physician Decision|0|||
127682954|NCT04177394|459463455|FG000|Overall Study|Missed visits|61|||
127682955|NCT04177394|459463455|FG000|Overall Study|Expected Visits|15|||
127682956|NCT02248480|459463456|FG000|Overall Study|Lack of Efficacy|4|||
127682957|NCT02248480|459463457|FG001|Overall Study|Lack of Efficacy|6|||
127682958|NCT02248480|459463456|FG000|Overall Study|Adverse Event|11|||
127682959|NCT02248480|459463457|FG001|Overall Study|Adverse Event|2|||
127682960|NCT02248480|459463456|FG000|Overall Study|Withdrawal by Subject|2|||
127682961|NCT02248480|459463457|FG001|Overall Study|Withdrawal by Subject|4|||
127682962|NCT02248480|459463456|FG000|Overall Study|Entry Criteria Not Met|0|||
127682963|NCT02248480|459463457|FG001|Overall Study|Entry Criteria Not Met|1|||
127682964|NCT02248480|459463456|FG000|Overall Study|Other:Physician Decision|0|||
127682965|NCT02248480|459463457|FG001|Overall Study|Other:Physician Decision|1|||
127682966|NCT01595321|459463458|FG000|Overall Study|Adverse Event|1|||
127769038|NCT03705832|459779649|FG000|Overall Study|Withdrawal by Subject|1|||
127769039|NCT03705832|459779650|FG001|Overall Study|Withdrawal by Subject|0|||
127769040|NCT01880528|459779651|FG000|Overall Study|Other|1|||
127769041|NCT01880528|459779652|FG001|Overall Study|Other|1|||
127769042|NCT01439360|459779653|FG000|Overall Study|Adverse Event|4|||
127769043|NCT01439360|459779654|FG001|Overall Study|Adverse Event|16|||
127769044|NCT01439360|459779653|FG000|Overall Study|Lost to Follow-up|43|||
127769045|NCT01439360|459779654|FG001|Overall Study|Lost to Follow-up|58|||
127769046|NCT01439360|459779653|FG000|Overall Study|Others|10|||
127769047|NCT01439360|459779654|FG001|Overall Study|Others|5|||
127769048|NCT01439360|459779653|FG000|Overall Study|Protocol Violation|1|||
127769049|NCT01439360|459779654|FG001|Overall Study|Protocol Violation|0|||
127769050|NCT01439360|459779653|FG000|Overall Study|Withdrawal by Subject|140|||
127769051|NCT01439360|459779654|FG001|Overall Study|Withdrawal by Subject|129|||
127682967|NCT01595321|459463459|FG001|Overall Study|Adverse Event|1|||
127682968|NCT01595321|459463460|FG002|Overall Study|Adverse Event|1|||
127682969|NCT01595321|459463458|FG000|Overall Study|Lack of Efficacy|0|||
127682970|NCT01595321|459463459|FG001|Overall Study|Lack of Efficacy|0|||
127682971|NCT01595321|459463460|FG002|Overall Study|Lack of Efficacy|4|||
127682972|NCT00373529|459463461|FG000|Overall Study|Physician Decision|19|||
127682973|NCT00373529|459463461|FG000|Overall Study|Withdrawal by Subject|7|||
127682974|NCT00373529|459463461|FG000|Overall Study|Adverse Event|7|||
127682975|NCT00373529|459463461|FG000|Overall Study|Treatment failure|36|||
127682976|NCT00373529|459463461|FG000|Overall Study|Disease recurrence|10|||
127682977|NCT00373529|459463461|FG000|Overall Study|Death|16|||
127682978|NCT00373529|459463461|FG000|Overall Study|Need for treatment prohibited by study|1|||
127682979|NCT00373529|459463461|FG000|Overall Study|Other|8|||
127682980|NCT00373529|459463461|FG000|Overall Study|Failed independent confirmation of AML|3|||
127682981|NCT00373529|459463461|FG000|Overall Study|Consent violation|1|||
127682982|NCT00539292|459463467|FG000|Overall Study|Physician Decision|1|||
127682983|NCT00539292|459463468|FG001|Overall Study|Physician Decision|0|||
127682984|NCT00630786|459463469|FG000|Overall Study|Physician Decision|0|||
127682985|NCT00630786|459463470|FG001|Overall Study|Physician Decision|0|||
127682986|NCT00630786|459463471|FG002|Overall Study|Physician Decision|1|||
127682987|NCT00630786|459463469|FG000|Overall Study|Withdrawal by Subject|0|||
127682988|NCT00630786|459463470|FG001|Overall Study|Withdrawal by Subject|1|||
127682989|NCT00630786|459463471|FG002|Overall Study|Withdrawal by Subject|1|||
127682990|NCT00630786|459463469|FG000|Overall Study|Lost to Follow-up|0|||
127682991|NCT00630786|459463470|FG001|Overall Study|Lost to Follow-up|1|||
127682992|NCT00630786|459463471|FG002|Overall Study|Lost to Follow-up|0|||
127682993|NCT00630786|459463469|FG000|Overall Study|Other|1|||
127682994|NCT00630786|459463470|FG001|Overall Study|Other|0|||
127682995|NCT00630786|459463471|FG002|Overall Study|Other|0|||
127682996|NCT04009577|459463472|FG000|Core Study|Adverse Event|1|||
127682997|NCT04009577|459463473|FG001|Core Study|Adverse Event|0|||
127682998|NCT04009577|459463474|FG002|Core Study|Adverse Event|2|||
127682999|NCT04009577|459463475|FG003|Core Study|Adverse Event|4|||
127683000|NCT04009577|459463472|FG000|Core Study|Withdrawal by Subject|0|||
127683001|NCT04009577|459463473|FG001|Core Study|Withdrawal by Subject|0|||
127683002|NCT04009577|459463474|FG002|Core Study|Withdrawal by Subject|2|||
127683003|NCT04009577|459463475|FG003|Core Study|Withdrawal by Subject|0|||
127683004|NCT04009577|459463472|FG000|Core Study|Other|0|||
127683005|NCT04009577|459463473|FG001|Core Study|Other|0|||
127683006|NCT04009577|459463474|FG002|Core Study|Other|0|||
127683007|NCT04009577|459463475|FG003|Core Study|Other|1|||
127683008|NCT04009577|459463472|FG000|Extension Phase|Adverse Event|0|||
127683009|NCT04009577|459463473|FG001|Extension Phase|Adverse Event|0|||
127683010|NCT04009577|459463474|FG002|Extension Phase|Adverse Event|0|||
127683011|NCT04009577|459463475|FG003|Extension Phase|Adverse Event|1|||
127683012|NCT04009577|459463472|FG000|Extension Phase|Inadequate therapeutic effect|0|||
127683013|NCT04009577|459463473|FG001|Extension Phase|Inadequate therapeutic effect|0|||
127683014|NCT04009577|459463474|FG002|Extension Phase|Inadequate therapeutic effect|1|||
127683015|NCT04009577|459463475|FG003|Extension Phase|Inadequate therapeutic effect|0|||
127683016|NCT04009577|459463472|FG000|Extension Phase|Withdrawal by Subject|0|||
127683017|NCT04009577|459463473|FG001|Extension Phase|Withdrawal by Subject|0|||
127683018|NCT04009577|459463474|FG002|Extension Phase|Withdrawal by Subject|1|||
127683019|NCT04009577|459463475|FG003|Extension Phase|Withdrawal by Subject|0|||
127683020|NCT04009577|459463472|FG000|Extension Phase|Not Treated|0|||
127683021|NCT04009577|459463473|FG001|Extension Phase|Not Treated|0|||
127769052|NCT03727438|459779661|FG000|Intervention Period|Did not complete at least 3 calls but remained in study|7|||
127769053|NCT03727438|459779662|FG001|Intervention Period|Did not complete at least 3 calls but remained in study|1|||
127683022|NCT04009577|459463474|FG002|Extension Phase|Not Treated|2|||
127769054|NCT03727438|459779661|FG000|Intervention Period|Excluded (health)|1|||
127683023|NCT04009577|459463475|FG003|Extension Phase|Not Treated|0|||
127683024|NCT02020616|459463480|FG000|Overall Study|Adverse Event|0|||
127683025|NCT02020616|459463481|FG001|Overall Study|Adverse Event|0|||
127683026|NCT02020616|459463482|FG002|Overall Study|Adverse Event|0|||
127769055|NCT03727438|459779662|FG001|Intervention Period|Excluded (health)|0|||
127769056|NCT03727438|459779661|FG000|Intervention Period|Withdrawal by Subject|3|||
127769057|NCT03727438|459779662|FG001|Intervention Period|Withdrawal by Subject|1|||
127769058|NCT03727438|459779661|FG000|8 Week Assessment|Did not complete assessment but remained in study|6|||
127769059|NCT03727438|459779662|FG001|8 Week Assessment|Did not complete assessment but remained in study|5|||
127769060|NCT03727438|459779661|FG000|8 Week Assessment|Did not complete due to study error, remained in study|2|||
127769061|NCT03727438|459779662|FG001|8 Week Assessment|Did not complete due to study error, remained in study|0|||
127769062|NCT03727438|459779661|FG000|8 Week Assessment|Withdrawal by Subject|6|||
127769063|NCT03727438|459779662|FG001|8 Week Assessment|Withdrawal by Subject|1|||
127769064|NCT03727438|459779661|FG000|6 mo Assessment|did not complete assessment|10|||
127769065|NCT03727438|459779662|FG001|6 mo Assessment|did not complete assessment|11|||
127769066|NCT01912456|459781261|FG000|Period 1|Physician Decision|0|||
127769067|NCT01912456|459781262|FG001|Period 1|Physician Decision|0|||
127769068|NCT01912456|459781263|FG002|Period 1|Physician Decision|1|||
127769069|NCT01912456|459781264|FG003|Period 1|Physician Decision|0|||
127769070|NCT01912456|459781261|FG000|Period 1|non-compliance|1|||
127769071|NCT01912456|459781262|FG001|Period 1|non-compliance|0|||
127769072|NCT01912456|459781263|FG002|Period 1|non-compliance|0|||
127769073|NCT01912456|459781264|FG003|Period 1|non-compliance|1|||
127769074|NCT01912456|459781261|FG000|Period 1|Adverse Event|1|||
127769075|NCT01912456|459781262|FG001|Period 1|Adverse Event|0|||
127769076|NCT01912456|459781263|FG002|Period 1|Adverse Event|0|||
127769077|NCT01912456|459781264|FG003|Period 1|Adverse Event|1|||
127769078|NCT01912456|459781261|FG000|Period 1|Withdrawal by Subject|0|||
127769079|NCT01912456|459781262|FG001|Period 1|Withdrawal by Subject|1|||
127769080|NCT01912456|459781263|FG002|Period 1|Withdrawal by Subject|1|||
127769081|NCT01912456|459781264|FG003|Period 1|Withdrawal by Subject|1|||
127769082|NCT01912456|459781261|FG000|Period 2|Lack of Efficacy|0|||
127769083|NCT01912456|459781262|FG001|Period 2|Lack of Efficacy|2|||
127769084|NCT01912456|459781263|FG002|Period 2|Lack of Efficacy|0|||
127769085|NCT01912456|459781264|FG003|Period 2|Lack of Efficacy|0|||
127769086|NCT01912456|459781261|FG000|Period 2|Adverse Event|0|||
127769087|NCT01912456|459781262|FG001|Period 2|Adverse Event|0|||
127769088|NCT01912456|459781263|FG002|Period 2|Adverse Event|0|||
127769089|NCT01912456|459781264|FG003|Period 2|Adverse Event|1|||
127769090|NCT01201343|459781265|FG000|Overall Study|Adverse Event|6|||
127769091|NCT01201343|459781265|FG000|Overall Study|Withdrawal by Subject|5|||
127769092|NCT01201343|459781265|FG000|Overall Study|Lost to Follow-up|2|||
127769093|NCT01201343|459781265|FG000|Overall Study|Lack of Efficacy|2|||
127769094|NCT01201343|459781265|FG000|Overall Study|Participant wrongly included in trial|1|||
127769095|NCT01201343|459781265|FG000|Overall Study|Randomized, not treated|3|||
127769096|NCT01440374|459781268|FG000|Part 1: Open-label Phase|Adverse Event|5|||
127769097|NCT01440374|459781269|FG001|Part 1: Open-label Phase|Adverse Event|0|||
127769098|NCT01440374|459781270|FG002|Part 1: Open-label Phase|Adverse Event|0|||
127769099|NCT01440374|459781271|FG003|Part 1: Open-label Phase|Adverse Event|0|||
127769100|NCT01440374|459781268|FG000|Part 1: Open-label Phase|Physician Decision|1|||
127769101|NCT01440374|459781269|FG001|Part 1: Open-label Phase|Physician Decision|0|||
127769102|NCT01440374|459781270|FG002|Part 1: Open-label Phase|Physician Decision|0|||
127769103|NCT01440374|459781271|FG003|Part 1: Open-label Phase|Physician Decision|0|||
127769104|NCT01440374|459781268|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
127769105|NCT01440374|459781269|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
127769106|NCT01440374|459781270|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
127769107|NCT01440374|459781271|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
127769108|NCT01440374|459781268|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
127769109|NCT01440374|459781269|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
127769110|NCT01440374|459781270|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
127769111|NCT01440374|459781271|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
127769112|NCT01440374|459781268|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
127769113|NCT01440374|459781269|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
127769114|NCT01440374|459781270|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
127769115|NCT01440374|459781271|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
127769116|NCT01440374|459781268|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
127769117|NCT01440374|459781269|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
127547126|NCT02628873|458971847|FG000|Second Test (1 Hour)|Physician Decision|1|||
127547127|NCT02628873|458971848|FG001|Second Test (1 Hour)|Physician Decision|0|||
127769118|NCT01440374|459781270|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
127769119|NCT01440374|459781271|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
127769120|NCT01440374|459781268|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
127769121|NCT01440374|459781269|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
127769122|NCT01440374|459781270|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
127769123|NCT01440374|459781271|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
127769124|NCT01440374|459781268|FG000|Part 2; Double-blind Phase|Not treated|0|||
127769125|NCT01440374|459781269|FG001|Part 2; Double-blind Phase|Not treated|0|||
127769126|NCT01440374|459781270|FG002|Part 2; Double-blind Phase|Not treated|1|||
127769127|NCT01440374|459781271|FG003|Part 2; Double-blind Phase|Not treated|0|||
127769128|NCT01440374|459781268|FG000|Part 3: Extension|Withdrawal by Subject|0|||
127769129|NCT01440374|459781269|FG001|Part 3: Extension|Withdrawal by Subject|0|||
127769130|NCT01440374|459781270|FG002|Part 3: Extension|Withdrawal by Subject|0|||
127769131|NCT01440374|459781271|FG003|Part 3: Extension|Withdrawal by Subject|5|||
127769132|NCT01440374|459781268|FG000|Part 3: Extension|Adverse Event|0|||
127769133|NCT01440374|459781269|FG001|Part 3: Extension|Adverse Event|0|||
127769134|NCT01440374|459781270|FG002|Part 3: Extension|Adverse Event|0|||
127769135|NCT01440374|459781271|FG003|Part 3: Extension|Adverse Event|13|||
127769136|NCT01440374|459781268|FG000|Part 3: Extension|Physician Decision|0|||
127769137|NCT01440374|459781269|FG001|Part 3: Extension|Physician Decision|0|||
127769138|NCT01440374|459781270|FG002|Part 3: Extension|Physician Decision|0|||
127769139|NCT01440374|459781271|FG003|Part 3: Extension|Physician Decision|14|||
127769140|NCT01177722|459781277|FG000|Overall Study|Serious Adverse Event|0|||
127769141|NCT01177722|459781278|FG001|Overall Study|Serious Adverse Event|0|||
127769142|NCT01177722|459781279|FG002|Overall Study|Serious Adverse Event|1|||
127769143|NCT01177722|459781280|FG003|Overall Study|Serious Adverse Event|0|||
127769144|NCT01177722|459781277|FG000|Overall Study|Protocol Violation|0|||
127769145|NCT01177722|459781278|FG001|Overall Study|Protocol Violation|0|||
127769146|NCT01177722|459781279|FG002|Overall Study|Protocol Violation|1|||
127769147|NCT01177722|459781280|FG003|Overall Study|Protocol Violation|0|||
127769148|NCT01177722|459781277|FG000|Overall Study|Lost to Follow-up|3|||
127769149|NCT01177722|459781278|FG001|Overall Study|Lost to Follow-up|4|||
127769150|NCT01177722|459781279|FG002|Overall Study|Lost to Follow-up|3|||
127769151|NCT01177722|459781280|FG003|Overall Study|Lost to Follow-up|1|||
127769152|NCT01177722|459781277|FG000|Overall Study|Withdrawal by Subject|10|||
127769153|NCT01177722|459781278|FG001|Overall Study|Withdrawal by Subject|6|||
127769154|NCT01177722|459781279|FG002|Overall Study|Withdrawal by Subject|4|||
127769155|NCT01177722|459781280|FG003|Overall Study|Withdrawal by Subject|6|||
127769156|NCT01222507|459781281|FG000|Overall Study|Physician Decision|1|||
127769157|NCT01222507|459781281|FG000|Overall Study|Withdrawal by Subject|1|||
127769158|NCT02647320|459781282|FG000|Overall Study|Adverse Event|0|||
127769159|NCT02647320|459781283|FG001|Overall Study|Adverse Event|1|||
127769160|NCT02647320|459781284|FG002|Overall Study|Adverse Event|3|||
127769161|NCT02647320|459781285|FG003|Overall Study|Adverse Event|2|||
127769162|NCT02647320|459781286|FG004|Overall Study|Adverse Event|1|||
127769163|NCT02647320|459781282|FG000|Overall Study|Protocol Violation|0|||
127769164|NCT02647320|459781283|FG001|Overall Study|Protocol Violation|0|||
127769165|NCT02647320|459781284|FG002|Overall Study|Protocol Violation|3|||
127769166|NCT02647320|459781285|FG003|Overall Study|Protocol Violation|0|||
127769167|NCT02647320|459781286|FG004|Overall Study|Protocol Violation|0|||
127769168|NCT02647320|459781282|FG000|Overall Study|Withdrawal by Subject|7|||
127769169|NCT02647320|459781283|FG001|Overall Study|Withdrawal by Subject|4|||
127769170|NCT02647320|459781284|FG002|Overall Study|Withdrawal by Subject|2|||
127769171|NCT02647320|459781285|FG003|Overall Study|Withdrawal by Subject|2|||
127769172|NCT02647320|459781286|FG004|Overall Study|Withdrawal by Subject|7|||
127769173|NCT02647320|459781282|FG000|Overall Study|Persistent hyperglycemia|0|||
127769174|NCT02647320|459781283|FG001|Overall Study|Persistent hyperglycemia|1|||
127769175|NCT02647320|459781284|FG002|Overall Study|Persistent hyperglycemia|1|||
127769176|NCT02647320|459781285|FG003|Overall Study|Persistent hyperglycemia|1|||
127769177|NCT02647320|459781286|FG004|Overall Study|Persistent hyperglycemia|1|||
127769178|NCT02647320|459781282|FG000|Overall Study|Study terminated by sponsor|1|||
127769179|NCT02647320|459781283|FG001|Overall Study|Study terminated by sponsor|1|||
127769180|NCT02647320|459781284|FG002|Overall Study|Study terminated by sponsor|1|||
127769181|NCT02647320|459781285|FG003|Overall Study|Study terminated by sponsor|1|||
127769182|NCT02647320|459781286|FG004|Overall Study|Study terminated by sponsor|2|||
127769183|NCT02647320|459781282|FG000|Overall Study|Reason not provided|0|||
127769184|NCT02647320|459781283|FG001|Overall Study|Reason not provided|0|||
127769185|NCT02647320|459781284|FG002|Overall Study|Reason not provided|1|||
127769186|NCT02647320|459781285|FG003|Overall Study|Reason not provided|0|||
127769187|NCT02647320|459781286|FG004|Overall Study|Reason not provided|2|||
127769188|NCT02647320|459781282|FG000|Overall Study|Lost to Follow-up|1|||
127769189|NCT02647320|459781283|FG001|Overall Study|Lost to Follow-up|1|||
127769190|NCT02647320|459781284|FG002|Overall Study|Lost to Follow-up|0|||
127769191|NCT02647320|459781285|FG003|Overall Study|Lost to Follow-up|0|||
127769192|NCT02647320|459781286|FG004|Overall Study|Lost to Follow-up|0|||
127769193|NCT02647320|459781282|FG000|Overall Study|Develop anemia|1|||
127769194|NCT02647320|459781283|FG001|Overall Study|Develop anemia|0|||
127769195|NCT02647320|459781284|FG002|Overall Study|Develop anemia|0|||
127769196|NCT02647320|459781285|FG003|Overall Study|Develop anemia|0|||
127769197|NCT02647320|459781286|FG004|Overall Study|Develop anemia|0|||
127769198|NCT02647320|459781282|FG000|Overall Study|Lack of Efficacy|0|||
127769199|NCT02647320|459781283|FG001|Overall Study|Lack of Efficacy|0|||
127769200|NCT02647320|459781284|FG002|Overall Study|Lack of Efficacy|0|||
127769201|NCT02647320|459781285|FG003|Overall Study|Lack of Efficacy|1|||
127769202|NCT02647320|459781286|FG004|Overall Study|Lack of Efficacy|0|||
127769203|NCT02647320|459781282|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
127769204|NCT02647320|459781283|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
127769205|NCT02647320|459781284|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
127769206|NCT02647320|459781285|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
127769207|NCT02647320|459781286|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
127769208|NCT00596427|459781287|FG000|Overall Study|Withdrawal by Subject|2|||
127769209|NCT00596427|459781288|FG001|Overall Study|Withdrawal by Subject|2|||
127769210|NCT00596427|459781287|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
127769211|NCT00596427|459781288|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
127769212|NCT00596427|459781287|FG000|Overall Study|Protocol Violation|1|||
127769213|NCT00596427|459781288|FG001|Overall Study|Protocol Violation|0|||
127769214|NCT00320541|459781289|FG000|Overall Study|Adverse Event|21|||
127769215|NCT00320541|459781290|FG001|Overall Study|Adverse Event|19|||
127769216|NCT00320541|459781289|FG000|Overall Study|Protocol Violation|0|||
127769217|NCT00320541|459781290|FG001|Overall Study|Protocol Violation|1|||
127769218|NCT00320541|459781289|FG000|Overall Study|Withdrawal by Subject|12|||
127769219|NCT00320541|459781290|FG001|Overall Study|Withdrawal by Subject|16|||
127769220|NCT00320541|459781289|FG000|Overall Study|Physician Decision|9|||
127769221|NCT00320541|459781290|FG001|Overall Study|Physician Decision|13|||
127769222|NCT00320541|459781289|FG000|Overall Study|Other|3|||
127769223|NCT00320541|459781290|FG001|Overall Study|Other|4|||
127769224|NCT00320541|459781289|FG000|Overall Study|Sponsor Decision|2|||
127769225|NCT00320541|459781290|FG001|Overall Study|Sponsor Decision|1|||
127769226|NCT00320541|459781289|FG000|Overall Study|Death due to Study Disease|1|||
127769227|NCT00320541|459781290|FG001|Overall Study|Death due to Study Disease|3|||
127769228|NCT00320541|459781289|FG000|Overall Study|Death due to Adverse Event(s)|1|||
127769229|NCT00320541|459781290|FG001|Overall Study|Death due to Adverse Event(s)|0|||
127769230|NCT00320541|459781289|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
127769231|NCT00320541|459781290|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
127769232|NCT03057977|459781291|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
127769233|NCT03057977|459781292|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
127769234|NCT03057977|459781291|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
127769235|NCT03057977|459781292|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
127769236|NCT03057977|459781291|FG000|Discontinuation From Treatment|Protocol Violation|6|||
127769237|NCT03057977|459781292|FG001|Discontinuation From Treatment|Protocol Violation|5|||
127769238|NCT03057977|459781291|FG000|Discontinuation From Treatment|Not treated|4|||
127769239|NCT03057977|459781292|FG001|Discontinuation From Treatment|Not treated|0|||
127769240|NCT03057977|459781291|FG000|Discontinuation From Treatment|Adverse Event|343|||
127769241|NCT03057977|459781292|FG001|Discontinuation From Treatment|Adverse Event|337|||
127769242|NCT03057977|459781291|FG000|Discontinuation From Treatment|Reason Unknown|0|||
127769243|NCT03057977|459781292|FG001|Discontinuation From Treatment|Reason Unknown|1|||
127769244|NCT03057977|459781291|FG000|Discontinuation From Treatment|Personal Reasons|1|||
127769245|NCT03057977|459781292|FG001|Discontinuation From Treatment|Personal Reasons|1|||
127769246|NCT03057977|459781291|FG000|Discontinuation From Treatment|Unblinded medication|1|||
127769247|NCT03057977|459781292|FG001|Discontinuation From Treatment|Unblinded medication|0|||
127769248|NCT03057977|459781291|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
127769249|NCT03057977|459781292|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
127769250|NCT03057977|459781291|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
127769251|NCT03057977|459781292|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
127769252|NCT03057977|459781291|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
127769253|NCT03057977|459781292|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
127769254|NCT03057977|459781291|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
127769255|NCT03057977|459781292|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
127769256|NCT03057977|459781291|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
127769257|NCT03057977|459781292|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
127769258|NCT03057977|459781291|FG000|Discontinuation From Treatment|Not attending study visit|3|||
127769259|NCT03057977|459781292|FG001|Discontinuation From Treatment|Not attending study visit|10|||
127769260|NCT03057977|459781291|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
127769261|NCT03057977|459781292|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
127769262|NCT03057977|459781291|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
127769263|NCT03057977|459781292|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
127769264|NCT03057977|459781291|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
127769265|NCT03057977|459781292|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
127769266|NCT03057977|459781291|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
127769267|NCT03057977|459781292|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
127769268|NCT03057977|459781291|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
127769269|NCT03057977|459781292|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
127769270|NCT01650246|459781295|FG000|Overall Study|Adverse Event|23|||
127769271|NCT01650246|459781295|FG000|Overall Study|Protocol Violation|5|||
127547128|NCT02195518|458971849|FG000|Overall Study|Adverse Event|1|||
127769272|NCT01650246|459781295|FG000|Overall Study|Sponsor terminated study|53|||
127769273|NCT01650246|459781295|FG000|Overall Study|Lost to Follow-up|5|||
127769274|NCT01650246|459781295|FG000|Overall Study|Withdrawal by Subject|26|||
127769275|NCT01650246|459781295|FG000|Overall Study|Death|1|||
127769276|NCT01650246|459781295|FG000|Overall Study|Lack of Efficacy|30|||
127769277|NCT00953407|459781296|FG000|Overall Study|Failed inclusion criteria|1|||
127769278|NCT00953407|459781297|FG001|Overall Study|Failed inclusion criteria|1|||
127769279|NCT00953407|459781298|FG002|Overall Study|Failed inclusion criteria|1|||
127769280|NCT00953407|459781299|FG003|Overall Study|Failed inclusion criteria|1|||
127769281|NCT00953407|459781300|FG004|Overall Study|Failed inclusion criteria|1|||
127769282|NCT00953407|459781296|FG000|Overall Study|Lost to Follow-up|0|||
127769283|NCT00953407|459781297|FG001|Overall Study|Lost to Follow-up|0|||
127769284|NCT00953407|459781298|FG002|Overall Study|Lost to Follow-up|0|||
127769285|NCT00953407|459781299|FG003|Overall Study|Lost to Follow-up|1|||
127769286|NCT00953407|459781300|FG004|Overall Study|Lost to Follow-up|0|||
127769287|NCT03435497|459781302|FG000|Overall Study|Lost to Follow-up|1|||
127769288|NCT03435497|459781303|FG001|Overall Study|Lost to Follow-up|0|||
127769289|NCT03435497|459781302|FG000|Overall Study|Death|1|||
127769290|NCT03435497|459781303|FG001|Overall Study|Death|0|||
127769291|NCT03435497|459781302|FG000|Overall Study|Withdrawal by Subject|0|||
127769292|NCT03435497|459781303|FG001|Overall Study|Withdrawal by Subject|4|||
127769293|NCT03435497|459781302|FG000|Overall Study|Wrong survey administered|0|||
127769294|NCT03435497|459781303|FG001|Overall Study|Wrong survey administered|2|||
127769295|NCT00701779|459781304|FG000|Overall Study|Adverse Event|6|||
127769296|NCT00701779|459781304|FG000|Overall Study|Lost to Follow-up|1|||
127769297|NCT00701779|459781304|FG000|Overall Study|Withdrawal by Subject|2|||
127769298|NCT03645057|459781305|FG000|Randomization to Baseline|Lost to Follow-up|1|||
127769299|NCT03645057|459781306|FG001|Randomization to Baseline|Lost to Follow-up|0|||
127769300|NCT03645057|459781307|FG002|Randomization to Baseline|Lost to Follow-up|1|||
127769301|NCT03645057|459781308|FG003|Randomization to Baseline|Lost to Follow-up|0|||
127769302|NCT03645057|459781305|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
127769303|NCT03645057|459781306|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
127769304|NCT03645057|459781307|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
127769305|NCT03645057|459781308|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
127769306|NCT03645057|459781305|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
127769307|NCT03645057|459781306|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
127769308|NCT03645057|459781307|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
127769309|NCT03645057|459781308|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
127769310|NCT03645057|459781305|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
127769311|NCT03645057|459781306|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
127769312|NCT03645057|459781307|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
127769313|NCT03645057|459781308|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
127769314|NCT01873495|459781309|FG000|Overall Study|Withdrawal by Subject|1|||
127769315|NCT01873495|459781309|FG000|Overall Study|Physician Decision|3|||
127769316|NCT01873495|459781309|FG000|Overall Study|Adverse Event|1|||
127769317|NCT01873495|459781309|FG000|Overall Study|Removed for Transplantation|1|||
127769318|NCT01873495|459781309|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
127769319|NCT01206777|459781310|FG000|Overall Study|Death|1|||
127769320|NCT01206777|459781310|FG000|Overall Study|Adverse Event|1|||
127769321|NCT02986334|459781311|FG000|Overall Study|Withdrawal by Subject|0|||
127769322|NCT02986334|459781312|FG001|Overall Study|Withdrawal by Subject|1|||
127769323|NCT02986334|459781313|FG002|Overall Study|Withdrawal by Subject|2|||
127769324|NCT02986334|459781311|FG000|Overall Study|Lost to Follow-up|1|||
127769325|NCT02986334|459781312|FG001|Overall Study|Lost to Follow-up|2|||
127769326|NCT02986334|459781313|FG002|Overall Study|Lost to Follow-up|1|||
127769327|NCT02986334|459781311|FG000|Overall Study|Adverse Event|0|||
127769328|NCT02986334|459781312|FG001|Overall Study|Adverse Event|2|||
127769329|NCT02986334|459781313|FG002|Overall Study|Adverse Event|1|||
127769330|NCT02986334|459781311|FG000|Overall Study|non compliance in phone ratings|2|||
127769331|NCT02986334|459781312|FG001|Overall Study|non compliance in phone ratings|1|||
127769332|NCT02986334|459781313|FG002|Overall Study|non compliance in phone ratings|2|||
127769333|NCT02986334|459781311|FG000|Overall Study|undisclosed comorbidities|0|||
127769334|NCT02986334|459781312|FG001|Overall Study|undisclosed comorbidities|1|||
127769335|NCT02986334|459781313|FG002|Overall Study|undisclosed comorbidities|1|||
127769336|NCT03864146|459781314|FG000|Overall Study|Lost to Follow-up|14|||
127769337|NCT03864146|459781315|FG001|Overall Study|Lost to Follow-up|23|||
127769338|NCT03864146|459781314|FG000|Overall Study|Withdrawal by Subject|3|||
127769339|NCT03864146|459781315|FG001|Overall Study|Withdrawal by Subject|2|||
127769340|NCT01313637|459781319|FG000|Overall Study|Adverse Event|17|||
127769341|NCT01313637|459781320|FG001|Overall Study|Adverse Event|24|||
127769342|NCT01313637|459781321|FG002|Overall Study|Adverse Event|25|||
127769343|NCT01313637|459781322|FG003|Overall Study|Adverse Event|18|||
127769344|NCT01313637|459781319|FG000|Overall Study|Lack of Efficacy|44|||
127769345|NCT01313637|459781320|FG001|Overall Study|Lack of Efficacy|38|||
127769346|NCT01313637|459781321|FG002|Overall Study|Lack of Efficacy|37|||
127769347|NCT01313637|459781322|FG003|Overall Study|Lack of Efficacy|24|||
127769348|NCT01313637|459781319|FG000|Overall Study|Protocol Violation|4|||
127769349|NCT01313637|459781320|FG001|Overall Study|Protocol Violation|3|||
127769350|NCT01313637|459781321|FG002|Overall Study|Protocol Violation|11|||
127769351|NCT01313637|459781322|FG003|Overall Study|Protocol Violation|5|||
127769352|NCT01313637|459781319|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
127683027|NCT02020616|459463483|FG003|Overall Study|Adverse Event|0|||
127683028|NCT02020616|459463484|FG004|Overall Study|Adverse Event|0|||
127683029|NCT02020616|459463485|FG005|Overall Study|Adverse Event|1|||
127683030|NCT02020616|459463486|FG006|Overall Study|Adverse Event|1|||
127683031|NCT02020616|459463480|FG000|Overall Study|Physician Decision|0|||
127683032|NCT02020616|459463481|FG001|Overall Study|Physician Decision|0|||
127683033|NCT02020616|459463482|FG002|Overall Study|Physician Decision|0|||
127683034|NCT02020616|459463483|FG003|Overall Study|Physician Decision|0|||
127683035|NCT02020616|459463484|FG004|Overall Study|Physician Decision|0|||
127683036|NCT02020616|459463485|FG005|Overall Study|Physician Decision|1|||
127683037|NCT02020616|459463486|FG006|Overall Study|Physician Decision|2|||
127683038|NCT02020616|459463480|FG000|Overall Study|Withdrawal by Subject|0|||
127683039|NCT02020616|459463481|FG001|Overall Study|Withdrawal by Subject|0|||
127683040|NCT02020616|459463482|FG002|Overall Study|Withdrawal by Subject|1|||
127683041|NCT02020616|459463483|FG003|Overall Study|Withdrawal by Subject|0|||
127683042|NCT02020616|459463484|FG004|Overall Study|Withdrawal by Subject|0|||
127683043|NCT02020616|459463485|FG005|Overall Study|Withdrawal by Subject|1|||
127683044|NCT02020616|459463486|FG006|Overall Study|Withdrawal by Subject|1|||
127683045|NCT02020616|459463480|FG000|Overall Study|Lost to Follow-up|0|||
127683046|NCT02020616|459463481|FG001|Overall Study|Lost to Follow-up|1|||
127683047|NCT02020616|459463482|FG002|Overall Study|Lost to Follow-up|0|||
127683048|NCT02020616|459463483|FG003|Overall Study|Lost to Follow-up|1|||
127683049|NCT02020616|459463484|FG004|Overall Study|Lost to Follow-up|1|||
127683050|NCT02020616|459463485|FG005|Overall Study|Lost to Follow-up|1|||
127683051|NCT02020616|459463486|FG006|Overall Study|Lost to Follow-up|0|||
127683052|NCT02020616|459463480|FG000|Overall Study|Early Termination Criteria Met|0|||
127683053|NCT02020616|459463481|FG001|Overall Study|Early Termination Criteria Met|0|||
127683054|NCT02020616|459463482|FG002|Overall Study|Early Termination Criteria Met|1|||
127683055|NCT02020616|459463483|FG003|Overall Study|Early Termination Criteria Met|0|||
127683056|NCT02020616|459463484|FG004|Overall Study|Early Termination Criteria Met|0|||
127683057|NCT02020616|459463485|FG005|Overall Study|Early Termination Criteria Met|1|||
127683058|NCT02020616|459463486|FG006|Overall Study|Early Termination Criteria Met|0|||
127683059|NCT02020616|459463480|FG000|Overall Study|Randomized in Error|0|||
127683060|NCT02020616|459463481|FG001|Overall Study|Randomized in Error|0|||
127683061|NCT02020616|459463482|FG002|Overall Study|Randomized in Error|0|||
127683062|NCT02020616|459463483|FG003|Overall Study|Randomized in Error|1|||
127683063|NCT02020616|459463484|FG004|Overall Study|Randomized in Error|0|||
127683064|NCT02020616|459463485|FG005|Overall Study|Randomized in Error|0|||
127683065|NCT02020616|459463486|FG006|Overall Study|Randomized in Error|0|||
127683066|NCT02020616|459463480|FG000|Overall Study|Lack of Efficacy|0|||
127683067|NCT02020616|459463481|FG001|Overall Study|Lack of Efficacy|0|||
127683068|NCT02020616|459463482|FG002|Overall Study|Lack of Efficacy|0|||
127683069|NCT02020616|459463483|FG003|Overall Study|Lack of Efficacy|0|||
127683070|NCT02020616|459463484|FG004|Overall Study|Lack of Efficacy|1|||
127683071|NCT02020616|459463485|FG005|Overall Study|Lack of Efficacy|0|||
127683072|NCT02020616|459463486|FG006|Overall Study|Lack of Efficacy|0|||
127683073|NCT00305695|459463491|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
127683074|NCT00305695|459463492|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
127683075|NCT00305695|459463491|FG000|Overall Study|Did not have baseline scan|1|||
127683076|NCT00305695|459463492|FG001|Overall Study|Did not have baseline scan|1|||
127683077|NCT02031471|459463495|FG000|24 Week Treatment Period|Adverse Event|6|||
127683078|NCT02031471|459463495|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
127683079|NCT02031471|459463495|FG000|24 Week Treatment Period|Protocol Violation|1|||
127683080|NCT02031471|459463495|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
127683081|NCT02031471|459463495|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
127683082|NCT02031471|459463495|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
127683083|NCT02031471|459463495|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
127683084|NCT00997386|459463499|FG000|Overall Study|Death|7|||
127683085|NCT01579916|459463501|FG000|Overall Study|Lost to Follow-up|6|||
127683086|NCT01579916|459463502|FG001|Overall Study|Lost to Follow-up|1|||
127683087|NCT01579916|459463501|FG000|Overall Study|Withdrawal by Subject|1|||
127683088|NCT01579916|459463502|FG001|Overall Study|Withdrawal by Subject|1|||
127683089|NCT01579916|459463501|FG000|Overall Study|Death|1|||
127683090|NCT01579916|459463502|FG001|Overall Study|Death|0|||
127683091|NCT02994654|459463504|FG000|Overall Study|Lost to Follow-up|1|||
127683092|NCT03603717|459463513|FG000|Overall Study|Lost to Follow-up|20|||
127683093|NCT03603717|459463514|FG001|Overall Study|Lost to Follow-up|20|||
127683094|NCT03603717|459463513|FG000|Overall Study|Withdrawal by Subject|16|||
127683095|NCT03603717|459463514|FG001|Overall Study|Withdrawal by Subject|10|||
127683096|NCT00732381|459463515|FG000|Overall Study|Adverse Event|1|||
127683097|NCT00732381|459463516|FG001|Overall Study|Adverse Event|0|||
127683098|NCT00732381|459463515|FG000|Overall Study|Treatment Failure|1|||
127683099|NCT00732381|459463516|FG001|Overall Study|Treatment Failure|1|||
127769353|NCT01313637|459781320|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
127769354|NCT01313637|459781321|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
127769355|NCT01313637|459781322|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
127769356|NCT01313637|459781319|FG000|Overall Study|Lost to Follow-up|0|||
127769357|NCT01313637|459781320|FG001|Overall Study|Lost to Follow-up|2|||
127769358|NCT01313637|459781321|FG002|Overall Study|Lost to Follow-up|1|||
127769359|NCT01313637|459781322|FG003|Overall Study|Lost to Follow-up|3|||
127769360|NCT01313637|459781319|FG000|Overall Study|Withdrawal by Subject|11|||
127769361|NCT01313637|459781320|FG001|Overall Study|Withdrawal by Subject|13|||
127769362|NCT01313637|459781321|FG002|Overall Study|Withdrawal by Subject|18|||
127769363|NCT01313637|459781322|FG003|Overall Study|Withdrawal by Subject|15|||
127769364|NCT01037244|459781326|FG000|Overall Study|Adverse Event|3|||
127769365|NCT01037244|459781327|FG001|Overall Study|Adverse Event|2|||
127769366|NCT01037244|459781328|FG002|Overall Study|Adverse Event|6|||
127769367|NCT01037244|459781329|FG003|Overall Study|Adverse Event|3|||
127769368|NCT01037244|459781326|FG000|Overall Study|Lack of Efficacy|1|||
127769369|NCT01037244|459781327|FG001|Overall Study|Lack of Efficacy|1|||
127769370|NCT01037244|459781328|FG002|Overall Study|Lack of Efficacy|0|||
127769371|NCT01037244|459781329|FG003|Overall Study|Lack of Efficacy|1|||
127769372|NCT01037244|459781326|FG000|Overall Study|Lost to Follow-up|3|||
127769373|NCT01037244|459781327|FG001|Overall Study|Lost to Follow-up|3|||
127769374|NCT01037244|459781328|FG002|Overall Study|Lost to Follow-up|4|||
127769375|NCT01037244|459781329|FG003|Overall Study|Lost to Follow-up|4|||
127769376|NCT01037244|459781326|FG000|Overall Study|Withdrawal by Subject|1|||
127769377|NCT01037244|459781327|FG001|Overall Study|Withdrawal by Subject|5|||
127769378|NCT01037244|459781328|FG002|Overall Study|Withdrawal by Subject|3|||
127769379|NCT01037244|459781329|FG003|Overall Study|Withdrawal by Subject|5|||
127769380|NCT01037244|459781326|FG000|Overall Study|Partner Withdrew Consent|2|||
127769381|NCT01037244|459781327|FG001|Overall Study|Partner Withdrew Consent|1|||
127769382|NCT01037244|459781328|FG002|Overall Study|Partner Withdrew Consent|0|||
127769383|NCT01037244|459781329|FG003|Overall Study|Partner Withdrew Consent|0|||
127769384|NCT01037244|459781326|FG000|Overall Study|Various|3|||
127769385|NCT01037244|459781327|FG001|Overall Study|Various|2|||
127769386|NCT01037244|459781328|FG002|Overall Study|Various|1|||
127769387|NCT01037244|459781329|FG003|Overall Study|Various|1|||
127769388|NCT00690820|459781330|FG000|Period 1|Withdrawal by Subject|0|||
127769389|NCT00690820|459781331|FG001|Period 1|Withdrawal by Subject|1|||
127769390|NCT01768117|459781333|FG000|Overall Study|Lost to Follow-up|1|||
127769391|NCT01768117|459781333|FG000|Overall Study|Withdrawal by Subject|2|||
127769392|NCT01768117|459781333|FG000|Overall Study|Protocol Violation|3|||
127769393|NCT01249274|459781336|FG000|Overall Study|Lost to Follow-up|3|||
127769394|NCT01249274|459781337|FG001|Overall Study|Lost to Follow-up|4|||
127769395|NCT01249274|459781336|FG000|Overall Study|Received inpatient substance treatment|1|||
127769396|NCT01249274|459781337|FG001|Overall Study|Received inpatient substance treatment|2|||
127769397|NCT01000636|459781338|FG000|Overall Study|Withdrawal by Subject|1|||
127769398|NCT01000636|459781338|FG000|Overall Study|Adverse Event|1|||
127769399|NCT03451162|459781339|FG000|Overall Study|Lost to Follow-up|1|||
127769400|NCT03451162|459781340|FG001|Overall Study|Lost to Follow-up|0|||
127769401|NCT03451162|459781341|FG002|Overall Study|Lost to Follow-up|0|||
127769402|NCT03451162|459781342|FG003|Overall Study|Lost to Follow-up|0|||
127769403|NCT03451162|459781343|FG004|Overall Study|Lost to Follow-up|0|||
127769404|NCT03451162|459781339|FG000|Overall Study|Physician Decision|0|||
127769405|NCT03451162|459781340|FG001|Overall Study|Physician Decision|1|||
127769406|NCT03451162|459781341|FG002|Overall Study|Physician Decision|0|||
127769407|NCT03451162|459781342|FG003|Overall Study|Physician Decision|0|||
127769408|NCT03451162|459781343|FG004|Overall Study|Physician Decision|0|||
127769409|NCT03451162|459781339|FG000|Overall Study|Withdrawal by Subject|1|||
127769410|NCT03451162|459781340|FG001|Overall Study|Withdrawal by Subject|1|||
127769411|NCT03451162|459781341|FG002|Overall Study|Withdrawal by Subject|0|||
127769412|NCT03451162|459781342|FG003|Overall Study|Withdrawal by Subject|0|||
127769413|NCT03451162|459781343|FG004|Overall Study|Withdrawal by Subject|0|||
127769414|NCT03305731|459781344|FG000|Overall Study|Protocol Violation|1|||
127769415|NCT03658668|459781345|FG000|Overall Study|Time Commitment|1|||
127769416|NCT03658668|459781346|FG001|Overall Study|Time Commitment|1|||
127769417|NCT01127139|459781347|FG000|Overall Study|Adverse Event|40|||
127769418|NCT01127139|459781347|FG000|Overall Study|Incompliance|12|||
127769419|NCT01127139|459781347|FG000|Overall Study|Lack of Efficacy|4|||
127769420|NCT01127139|459781347|FG000|Overall Study|Reason not specified|1|||
127769421|NCT01498653|459781349|FG000|Overall Study|Adverse Event|2|||
127547129|NCT02195518|458971849|FG000|Overall Study|Protocol Violation|4|||
127769422|NCT01498653|459781350|FG001|Overall Study|Adverse Event|2|||
127769423|NCT01498653|459781349|FG000|Overall Study|Lack of Efficacy|12|||
127769424|NCT01498653|459781350|FG001|Overall Study|Lack of Efficacy|26|||
127769425|NCT01498653|459781349|FG000|Overall Study|Protocol Violation|0|||
127769426|NCT01498653|459781350|FG001|Overall Study|Protocol Violation|4|||
127769427|NCT01498653|459781349|FG000|Overall Study|Lost to Follow-up|1|||
127769428|NCT01498653|459781350|FG001|Overall Study|Lost to Follow-up|0|||
127547130|NCT02195518|458971849|FG000|Overall Study|Pregnancy|2|||
127769429|NCT01498653|459781349|FG000|Overall Study|Physician Decision|2|||
127769430|NCT01498653|459781350|FG001|Overall Study|Physician Decision|0|||
127769431|NCT01498653|459781349|FG000|Overall Study|Withdrawal by Subject|2|||
127769432|NCT01498653|459781350|FG001|Overall Study|Withdrawal by Subject|3|||
127769433|NCT05208866|459781351|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
127769434|NCT02070588|459781352|FG000|Overall Study|Withdrawal by Subject|29|||
127769435|NCT02070588|459781353|FG001|Overall Study|Withdrawal by Subject|1|||
127769436|NCT02070588|459781354|FG002|Overall Study|Withdrawal by Subject|0|||
127769437|NCT02070588|459781352|FG000|Overall Study|Writhdrawal due to early termination|9|||
127769438|NCT02070588|459781353|FG001|Overall Study|Writhdrawal due to early termination|0|||
127769439|NCT02070588|459781354|FG002|Overall Study|Writhdrawal due to early termination|0|||
127769440|NCT02070588|459781352|FG000|Overall Study|Adverse Event|1|||
127769441|NCT02070588|459781353|FG001|Overall Study|Adverse Event|0|||
127769442|NCT02070588|459781354|FG002|Overall Study|Adverse Event|0|||
127769443|NCT02216357|459781356|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
127769444|NCT02216357|459781357|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
127769445|NCT04964414|459781359|FG000|Overall Study|Lost to Follow-up|10|||
127769446|NCT04964414|459781360|FG001|Overall Study|Lost to Follow-up|8|||
127769447|NCT04964414|459781359|FG000|Overall Study|Withdrawal by Subject|1|||
127769448|NCT04964414|459781360|FG001|Overall Study|Withdrawal by Subject|1|||
127769449|NCT01718353|459781361|FG000|Overall Study|Lost to Follow-up|0|||
127769450|NCT01718353|459781362|FG001|Overall Study|Lost to Follow-up|1|||
127769451|NCT01718353|459781361|FG000|Overall Study|Principal Investigator's Decision|10|||
127769452|NCT01718353|459781362|FG001|Overall Study|Principal Investigator's Decision|4|||
127769453|NCT01718353|459781361|FG000|Overall Study|Randomized but not treated|2|||
127769454|NCT01718353|459781362|FG001|Overall Study|Randomized but not treated|0|||
127769455|NCT00455325|459781363|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
127769456|NCT00455325|459781364|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
127769457|NCT00455325|459781365|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
127769458|NCT00455325|459781366|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
127769459|NCT00455325|459781363|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
127769460|NCT00455325|459781364|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
127769461|NCT00455325|459781365|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
127769462|NCT00455325|459781366|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
127769463|NCT00455325|459781363|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
127769464|NCT00455325|459781364|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
127769465|NCT00455325|459781365|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
127769466|NCT00455325|459781366|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
127769467|NCT00455325|459781363|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
127769468|NCT00455325|459781364|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
127769469|NCT00455325|459781365|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
127769470|NCT00455325|459781366|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
127769471|NCT00455325|459781363|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
127769472|NCT00455325|459781364|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
127769473|NCT00455325|459781365|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
127769474|NCT00455325|459781366|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
127769475|NCT00455325|459781363|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
127769476|NCT00455325|459781364|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
127769477|NCT00455325|459781365|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
127769478|NCT00455325|459781366|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
127769479|NCT00455325|459781363|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
127769480|NCT00455325|459781364|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
127769481|NCT00455325|459781365|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
127769482|NCT00455325|459781366|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
127769483|NCT02745392|459781375|FG000|Overall Study|Lost to Follow-up|0|||
127769484|NCT02745392|459781376|FG001|Overall Study|Lost to Follow-up|1|||
127769485|NCT02745392|459781377|FG002|Overall Study|Lost to Follow-up|0|||
127769486|NCT02745392|459781378|FG003|Overall Study|Lost to Follow-up|0|||
127769487|NCT01691768|459781379|FG000|Overall Study|Death|0|||
127769488|NCT01691768|459781380|FG001|Overall Study|Death|2|||
127769489|NCT01691768|459781379|FG000|Overall Study|Lost to Follow-up|4|||
127769490|NCT01691768|459781380|FG001|Overall Study|Lost to Follow-up|3|||
127769491|NCT01691768|459781379|FG000|Overall Study|Withdrawal by Subject|10|||
127769492|NCT01691768|459781380|FG001|Overall Study|Withdrawal by Subject|9|||
127769493|NCT01691768|459781379|FG000|Overall Study|Relocated|0|||
127769494|NCT01691768|459781380|FG001|Overall Study|Relocated|1|||
127769495|NCT01691768|459781379|FG000|Overall Study|Investigator decision|1|||
127769496|NCT01691768|459781380|FG001|Overall Study|Investigator decision|1|||
127769497|NCT01959334|459781381|FG000|Second Dose|Adverse Event|1|||
127769498|NCT01959334|459781382|FG001|Second Dose|Adverse Event|0|||
127769499|NCT01959334|459781381|FG000|Third Dose|Adverse Event|0|||
127769500|NCT01959334|459781382|FG001|Third Dose|Adverse Event|1|||
127769501|NCT01580969|459781383|FG000|Overall Study|Physician Decision|3|||
127769502|NCT01580969|459781384|FG001|Overall Study|Physician Decision|0|||
127769503|NCT01580969|459781385|FG002|Overall Study|Physician Decision|0|||
127769504|NCT01079741|459781391|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
127769505|NCT01079741|459781392|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
127769506|NCT01079741|459781393|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
127769507|NCT01079741|459781394|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
127769508|NCT01079741|459781395|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
127769509|NCT01079741|459781391|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
127769510|NCT01079741|459781392|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
127769511|NCT01079741|459781393|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
127769512|NCT01079741|459781394|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
127769513|NCT01079741|459781395|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
127769514|NCT00446992|459781396|FG000|Overall Study|Adverse Event|11|||
127769515|NCT00446992|459781396|FG000|Overall Study|Lost to Follow-up|5|||
127769516|NCT02076178|459781397|FG000|Oral Phase|Adverse Event|0|||
127769517|NCT02076178|459781398|FG001|Oral Phase|Adverse Event|7|||
127769518|NCT02076178|459781397|FG000|Oral Phase|Withdrawal by Subject|0|||
127769519|NCT02076178|459781398|FG001|Oral Phase|Withdrawal by Subject|4|||
127769520|NCT02076178|459781397|FG000|Oral Phase|Physician Decision|0|||
127769521|NCT02076178|459781398|FG001|Oral Phase|Physician Decision|1|||
127769522|NCT02076178|459781397|FG000|Injection Phase|Protocol defined stopping criteria|1|||
127769523|NCT02076178|459781398|FG001|Injection Phase|Protocol defined stopping criteria|0|||
127769524|NCT02076178|459781397|FG000|Injection Phase|Withdrawal by Subject|0|||
127769525|NCT02076178|459781398|FG001|Injection Phase|Withdrawal by Subject|3|||
127769526|NCT02076178|459781397|FG000|Injection Phase|Physician Decision|0|||
127769527|NCT02076178|459781398|FG001|Injection Phase|Physician Decision|3|||
127769528|NCT02076178|459781397|FG000|Injection Phase|Lost to Follow-up|0|||
127769529|NCT02076178|459781398|FG001|Injection Phase|Lost to Follow-up|1|||
127769530|NCT02434939|459781406|FG000|Overall Study|Lack of Efficacy|34|||
127769531|NCT02434939|459781407|FG001|Overall Study|Lack of Efficacy|48|||
127769532|NCT02434939|459781406|FG000|Overall Study|Withdrawal by Subject|3|||
127769533|NCT02434939|459781407|FG001|Overall Study|Withdrawal by Subject|0|||
127769534|NCT02434939|459781406|FG000|Overall Study|Adverse Event|0|||
127769535|NCT02434939|459781407|FG001|Overall Study|Adverse Event|1|||
127769536|NCT00710021|459781412|FG000|Overall Study|Lost to Follow-up|1|||
127769537|NCT00710021|459781413|FG001|Overall Study|Lost to Follow-up|0|||
127769538|NCT00710021|459781414|FG002|Overall Study|Lost to Follow-up|0|||
127769539|NCT00710021|459781412|FG000|Overall Study|Subject's Decision|0|||
127769540|NCT00710021|459781413|FG001|Overall Study|Subject's Decision|1|||
127769541|NCT00710021|459781414|FG002|Overall Study|Subject's Decision|0|||
127769542|NCT00710021|459781412|FG000|Overall Study|Subject misrandomized|0|||
127769543|NCT00710021|459781413|FG001|Overall Study|Subject misrandomized|1|||
127769544|NCT00710021|459781414|FG002|Overall Study|Subject misrandomized|1|||
127769545|NCT00710021|459781412|FG000|Overall Study|Physician Decision|0|||
127769546|NCT00710021|459781413|FG001|Overall Study|Physician Decision|1|||
127769547|NCT00710021|459781414|FG002|Overall Study|Physician Decision|0|||
127769548|NCT01536015|459781415|FG000|Overall Study|Adverse Event|1|||
127769549|NCT01536015|459781416|FG001|Overall Study|Adverse Event|4|||
127769550|NCT01536015|459781415|FG000|Overall Study|Lost to Follow-up|0|||
127769551|NCT01536015|459781416|FG001|Overall Study|Lost to Follow-up|1|||
127769552|NCT01536015|459781415|FG000|Overall Study|Inclusion Criterion not met|2|||
127769553|NCT01536015|459781416|FG001|Overall Study|Inclusion Criterion not met|0|||
127769554|NCT01536015|459781415|FG000|Overall Study|Study closure|5|||
127769555|NCT01536015|459781416|FG001|Overall Study|Study closure|5|||
127769556|NCT00511901|459781418|FG000|Overall Study|Withdrawal by Subject|1|||
127769557|NCT00511901|459781419|FG001|Overall Study|Withdrawal by Subject|3|||
127769558|NCT02447172|459781420|FG000|Overall Study|Adverse Event|11|||
127769559|NCT02447172|459781421|FG001|Overall Study|Adverse Event|8|||
127769560|NCT02447172|459781422|FG002|Overall Study|Adverse Event|7|||
127769561|NCT02447172|459781420|FG000|Overall Study|Death|3|||
127769562|NCT02447172|459781421|FG001|Overall Study|Death|1|||
127769563|NCT02447172|459781422|FG002|Overall Study|Death|0|||
127769564|NCT02447172|459781420|FG000|Overall Study|Protocol Violation|2|||
127769565|NCT02447172|459781421|FG001|Overall Study|Protocol Violation|1|||
127769566|NCT02447172|459781422|FG002|Overall Study|Protocol Violation|2|||
127769567|NCT02447172|459781420|FG000|Overall Study|Lost to Follow-up|7|||
127769568|NCT02447172|459781421|FG001|Overall Study|Lost to Follow-up|4|||
127769569|NCT02447172|459781422|FG002|Overall Study|Lost to Follow-up|4|||
128016062|NCT02335944|460682224|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
127769570|NCT02447172|459781420|FG000|Overall Study|Withdrawal by Subject|5|||
127769571|NCT02447172|459781421|FG001|Overall Study|Withdrawal by Subject|1|||
127769572|NCT02447172|459781422|FG002|Overall Study|Withdrawal by Subject|3|||
127769573|NCT02447172|459781420|FG000|Overall Study|protocol specific treatment unrelated|3|||
127769574|NCT02447172|459781421|FG001|Overall Study|protocol specific treatment unrelated|0|||
127769575|NCT02447172|459781422|FG002|Overall Study|protocol specific treatment unrelated|2|||
127769576|NCT00001962|459782687|FG000|Overall Study|Lack of Efficacy|18|||
127769577|NCT00001962|459782687|FG000|Overall Study|Lack of Accrual|6|||
127769578|NCT00001962|459782687|FG000|Overall Study|Death|1|||
127769579|NCT00001962|459782687|FG000|Overall Study|Lost to Follow-up|2|||
127769580|NCT00001962|459782687|FG000|Overall Study|Adverse Event|1|||
127769581|NCT03442985|459782691|FG000|Overall Study|Sponsor Request|55|||
127769582|NCT03442985|459782692|FG001|Overall Study|Sponsor Request|60|||
127769583|NCT03442985|459782693|FG002|Overall Study|Sponsor Request|54|||
127769584|NCT03442985|459782691|FG000|Overall Study|Lost to Follow-up|5|||
127769585|NCT03442985|459782692|FG001|Overall Study|Lost to Follow-up|2|||
127769586|NCT03442985|459782693|FG002|Overall Study|Lost to Follow-up|7|||
127769587|NCT03442985|459782691|FG000|Overall Study|Withdrawal by Subject|2|||
127769588|NCT03442985|459782692|FG001|Overall Study|Withdrawal by Subject|3|||
127769589|NCT03442985|459782693|FG002|Overall Study|Withdrawal by Subject|4|||
127769590|NCT03442985|459782691|FG000|Overall Study|Adverse Event|0|||
127769591|NCT03442985|459782692|FG001|Overall Study|Adverse Event|1|||
127769592|NCT03442985|459782693|FG002|Overall Study|Adverse Event|0|||
127769593|NCT01217957|459782694|FG000|Phase 1|Withdrawal by Patient|1|||
127769594|NCT01217957|459782695|FG001|Phase 1|Withdrawal by Patient|0|||
127769595|NCT01217957|459782696|FG002|Phase 1|Withdrawal by Patient|1|||
127769596|NCT01217957|459782697|FG003|Phase 1|Withdrawal by Patient|1|||
127769597|NCT01217957|459782698|FG004|Phase 1|Withdrawal by Patient|0|||
127769598|NCT01217957|459782694|FG000|Phase 2|Withdrawal by Patient|0|||
127769599|NCT01217957|459782695|FG001|Phase 2|Withdrawal by Patient|0|||
127769600|NCT01217957|459782696|FG002|Phase 2|Withdrawal by Patient|0|||
127769601|NCT01217957|459782697|FG003|Phase 2|Withdrawal by Patient|0|||
127769602|NCT01217957|459782698|FG004|Phase 2|Withdrawal by Patient|1|||
127769603|NCT00846391|459782702|FG000|Overall Study|Physician Decision|0|||
127769604|NCT00846391|459782703|FG001|Overall Study|Physician Decision|0|||
127769605|NCT00846391|459782704|FG002|Overall Study|Physician Decision|1|||
127769606|NCT00846391|459782702|FG000|Overall Study|Study Terminated by Sponsor|1|||
127769607|NCT00846391|459782703|FG001|Overall Study|Study Terminated by Sponsor|2|||
127769608|NCT00846391|459782704|FG002|Overall Study|Study Terminated by Sponsor|2|||
127769609|NCT04634825|459782706|FG000|Overall Study|Death|10|||
127769610|NCT04634825|459782707|FG001|Overall Study|Death|3|||
127769611|NCT04634825|459782706|FG000|Overall Study|Lost to Follow-up|1|||
127769612|NCT04634825|459782707|FG001|Overall Study|Lost to Follow-up|0|||
127769613|NCT04634825|459782706|FG000|Overall Study|Study terminated by sponsor|35|||
127769614|NCT04634825|459782707|FG001|Overall Study|Study terminated by sponsor|11|||
127769615|NCT04634825|459782706|FG000|Overall Study|Withdrawal by Subject|2|||
127769616|NCT04634825|459782707|FG001|Overall Study|Withdrawal by Subject|0|||
127769617|NCT01745848|459782713|FG000|Overall Study|Adverse Event|6|||
127769618|NCT00679627|459782714|FG000|Overall Study|Death|41|||
127769619|NCT00679627|459782715|FG001|Overall Study|Death|29|||
127769620|NCT00679627|459782714|FG000|Overall Study|Adverse Event|43|||
127769621|NCT00679627|459782715|FG001|Overall Study|Adverse Event|53|||
127769622|NCT00679627|459782714|FG000|Overall Study|Withdrawal by Subject|168|||
127769623|NCT00679627|459782715|FG001|Overall Study|Withdrawal by Subject|172|||
127769624|NCT00679627|459782714|FG000|Overall Study|Lost to Follow-up|22|||
127769625|NCT00679627|459782715|FG001|Overall Study|Lost to Follow-up|26|||
127769626|NCT00679627|459782714|FG000|Overall Study|Early Study Closure|425|||
127769627|NCT00679627|459782715|FG001|Overall Study|Early Study Closure|405|||
127769628|NCT01886378|459782716|FG000|Overall Study|Adverse Event|1|||
127769629|NCT01886378|459782716|FG000|Overall Study|Withdrawal by Subject|4|||
127769630|NCT03021954|459782720|FG000|Overall Study|Lost to Follow-up|10|||
127769631|NCT03021954|459782721|FG001|Overall Study|Lost to Follow-up|43|||
127769632|NCT03021954|459782720|FG000|Overall Study|Subjects had avulsion trauma|4|||
127769633|NCT03021954|459782721|FG001|Overall Study|Subjects had avulsion trauma|1|||
127769634|NCT00069238|459782722|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
127769635|NCT00069238|459782723|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
127769636|NCT00069238|459782724|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
127769637|NCT00069238|459782722|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
127769638|NCT00069238|459782723|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
127769639|NCT00069238|459782724|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
127769640|NCT00069238|459782722|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
127769641|NCT00069238|459782723|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
127769642|NCT00069238|459782724|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
127769643|NCT01001832|459782725|FG000|Short-term Period|Adverse Event|2|||
127769644|NCT01001832|459782726|FG001|Short-term Period|Adverse Event|3|||
127769645|NCT01001832|459782725|FG000|Long-term Period|Adverse Event|2|||
127769646|NCT01001832|459782726|FG001|Long-term Period|Adverse Event|1|||
128016063|NCT02335944|460682225|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
127769647|NCT01001832|459782725|FG000|Long-term Period|Withdrawal by Subject|1|||
127769648|NCT01001832|459782726|FG001|Long-term Period|Withdrawal by Subject|0|||
127769649|NCT01001832|459782725|FG000|Long-term Period|Lack of Efficacy|0|||
127769650|NCT01001832|459782726|FG001|Long-term Period|Lack of Efficacy|2|||
127769651|NCT01001832|459782725|FG000|Long-term Period|Other|1|||
127769652|NCT01001832|459782726|FG001|Long-term Period|Other|2|||
127769653|NCT01001832|459782725|FG000|Follow-up Period|Withdrawal by Subject|1|||
127769654|NCT01001832|459782726|FG001|Follow-up Period|Withdrawal by Subject|0|||
127769655|NCT01001832|459782725|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
127769656|NCT01001832|459782726|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
127769657|NCT01001832|459782725|FG000|Follow-up Period|Other|2|||
127769658|NCT01001832|459782726|FG001|Follow-up Period|Other|1|||
127769659|NCT03581825|459782733|FG000|Period 1|Lens Discomfort|1|||
127769660|NCT03581825|459782734|FG001|Period 1|Lens Discomfort|0|||
127769661|NCT03581825|459782733|FG000|Period 2|Unsatisfactory Vision to Test|0|||
127769662|NCT03581825|459782734|FG001|Period 2|Unsatisfactory Vision to Test|1|||
127769663|NCT01668667|459782735|FG000|Overall Study|Adverse Event|3|||
127769664|NCT01668667|459782736|FG001|Overall Study|Adverse Event|6|||
127769665|NCT01668667|459782737|FG002|Overall Study|Adverse Event|4|||
127769666|NCT01668667|459782738|FG003|Overall Study|Adverse Event|4|||
127769667|NCT01668667|459782735|FG000|Overall Study|Lack of Efficacy|3|||
127769668|NCT01668667|459782736|FG001|Overall Study|Lack of Efficacy|2|||
127769669|NCT01668667|459782737|FG002|Overall Study|Lack of Efficacy|2|||
127769670|NCT01668667|459782738|FG003|Overall Study|Lack of Efficacy|3|||
127769671|NCT01668667|459782735|FG000|Overall Study|Protocol Violation|6|||
127769672|NCT01668667|459782736|FG001|Overall Study|Protocol Violation|10|||
127769673|NCT01668667|459782737|FG002|Overall Study|Protocol Violation|12|||
127769674|NCT01668667|459782738|FG003|Overall Study|Protocol Violation|5|||
127769675|NCT01668667|459782735|FG000|Overall Study|Lost to Follow-up|9|||
127769676|NCT01668667|459782736|FG001|Overall Study|Lost to Follow-up|4|||
127769677|NCT01668667|459782737|FG002|Overall Study|Lost to Follow-up|7|||
127769678|NCT01668667|459782738|FG003|Overall Study|Lost to Follow-up|6|||
127769679|NCT01668667|459782735|FG000|Overall Study|Physician Decision|3|||
127769680|NCT01668667|459782736|FG001|Overall Study|Physician Decision|0|||
127769681|NCT01668667|459782737|FG002|Overall Study|Physician Decision|1|||
127769682|NCT01668667|459782738|FG003|Overall Study|Physician Decision|0|||
127769683|NCT01668667|459782735|FG000|Overall Study|Withdrawal by Subject|7|||
127769684|NCT01668667|459782736|FG001|Overall Study|Withdrawal by Subject|4|||
127769685|NCT01668667|459782737|FG002|Overall Study|Withdrawal by Subject|5|||
127769686|NCT01668667|459782738|FG003|Overall Study|Withdrawal by Subject|5|||
127769687|NCT03343301|459782739|FG000|Overall Study|Withdrawal by Subject|1|||
127769688|NCT03343301|459782740|FG001|Overall Study|Withdrawal by Subject|1|||
127769689|NCT03343301|459782739|FG000|Overall Study|Death|0|||
127769690|NCT03343301|459782740|FG001|Overall Study|Death|2|||
127769691|NCT03343301|459782739|FG000|Overall Study|Other|0|||
127769692|NCT03343301|459782740|FG001|Overall Study|Other|6|||
127769693|NCT03343301|459782739|FG000|Overall Study|Missing|2|||
127769694|NCT03343301|459782740|FG001|Overall Study|Missing|0|||
127769695|NCT01013597|459782751|FG000|Overall Study|Withdrawal by Subject|1|||
127769696|NCT00427895|459782752|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
127769697|NCT00427895|459782753|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
127769698|NCT00427895|459782754|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
127769699|NCT00427895|459782755|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
127769700|NCT00427895|459782756|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
127769701|NCT00427895|459782757|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
127769702|NCT00427895|459782758|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
127769703|NCT00427895|459782759|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
127769704|NCT00427895|459782752|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
127769705|NCT00427895|459782753|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
127769706|NCT00427895|459782754|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
127769707|NCT00427895|459782755|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
127769708|NCT00427895|459782756|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
127769709|NCT00427895|459782757|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
127769710|NCT00427895|459782758|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
127769711|NCT00427895|459782759|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
127769712|NCT00427895|459782752|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
127769713|NCT00427895|459782753|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
127769714|NCT00427895|459782754|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
127769715|NCT00427895|459782755|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
127769716|NCT00427895|459782756|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
127769717|NCT00427895|459782757|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
127769718|NCT00427895|459782758|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
127769719|NCT00427895|459782759|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
127769720|NCT00427895|459782752|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
127769721|NCT00427895|459782753|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
127769722|NCT00427895|459782754|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
127769723|NCT00427895|459782755|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
127769724|NCT00427895|459782756|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
127769725|NCT00427895|459782757|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
127769726|NCT00427895|459782758|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
127769727|NCT00427895|459782759|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
127769728|NCT00427895|459782752|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
127769729|NCT00427895|459782753|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
127769730|NCT00427895|459782754|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
127769731|NCT00427895|459782755|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
127769732|NCT00427895|459782756|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
127769733|NCT00427895|459782757|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
127769734|NCT00427895|459782758|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
127769735|NCT00427895|459782759|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
127769736|NCT00427895|459782752|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
127769737|NCT00427895|459782753|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
127769738|NCT00427895|459782754|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
127769739|NCT00427895|459782755|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
127769740|NCT00427895|459782756|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
127769741|NCT00427895|459782757|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
127769742|NCT00427895|459782758|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
127769743|NCT00427895|459782759|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
127769744|NCT00427895|459782752|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
127769745|NCT00427895|459782753|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
127769746|NCT00427895|459782754|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
127769747|NCT00427895|459782755|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
127769748|NCT00427895|459782756|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
127769749|NCT00427895|459782757|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
127769750|NCT00427895|459782758|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
127769751|NCT00427895|459782759|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
127769752|NCT00427895|459782752|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
127769753|NCT00427895|459782753|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
127769754|NCT00427895|459782754|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
127769755|NCT00427895|459782755|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
127769756|NCT00427895|459782756|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
127769757|NCT00427895|459782757|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
127769758|NCT00427895|459782758|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
127769759|NCT00427895|459782759|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
127769760|NCT00427895|459782752|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
127769761|NCT00427895|459782753|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
127769762|NCT00427895|459782754|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
127769763|NCT00427895|459782755|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
127769764|NCT00427895|459782756|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
127769765|NCT00427895|459782757|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
127769766|NCT00427895|459782758|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
127769767|NCT00427895|459782759|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
127769768|NCT00427895|459782752|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
127769769|NCT00427895|459782753|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
127769770|NCT00427895|459782754|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
127769771|NCT00427895|459782755|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
127769772|NCT00427895|459782756|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
127769773|NCT00427895|459782757|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
127769774|NCT00427895|459782758|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
127769775|NCT00427895|459782759|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
127769776|NCT00427895|459782752|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
127769777|NCT00427895|459782753|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
127769778|NCT00427895|459782754|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
127769779|NCT00427895|459782755|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
127769780|NCT00427895|459782756|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
127769781|NCT00427895|459782757|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
127769782|NCT00427895|459782758|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
127769783|NCT00427895|459782759|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
127769784|NCT00427895|459782752|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
127769785|NCT00427895|459782753|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
127769786|NCT00427895|459782754|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
127769787|NCT00427895|459782755|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
127769788|NCT00427895|459782756|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
127769789|NCT00427895|459782757|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
127769790|NCT00427895|459782758|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
127769791|NCT00427895|459782759|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
127769792|NCT00427895|459782752|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
127769793|NCT00427895|459782753|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
127769794|NCT00427895|459782754|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
127769795|NCT00427895|459782755|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
127769796|NCT00427895|459782756|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
127769797|NCT00427895|459782757|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
127769798|NCT00427895|459782758|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
127683104|NCT00573833|459463522|FG000|Overall Study|Not Treated|2|||
127683105|NCT03544515|459465328|FG000|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|4|||
127683106|NCT03544515|459465329|FG001|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|2|||
127683107|NCT03544515|459465328|FG000|Overall Study|Lost to Follow-up|2|||
127683108|NCT03544515|459465329|FG001|Overall Study|Lost to Follow-up|0|||
127683109|NCT03175172|459465330|FG000|Overall Study|Death|3|||
127683110|NCT03175172|459465330|FG000|Overall Study|Withdrawal by Subject|3|||
127683111|NCT03175172|459465330|FG000|Overall Study|Lost to Follow-up|1|||
127683112|NCT03175172|459465330|FG000|Overall Study|Study Terminated by Sponsor|3|||
127683113|NCT03169244|459465331|FG000|Overall Study|Lost to Follow-up|1|||
127683114|NCT03169244|459465332|FG001|Overall Study|Lost to Follow-up|2|||
127683115|NCT03169244|459465331|FG000|Overall Study|Adverse Event|1|||
127683116|NCT03169244|459465332|FG001|Overall Study|Adverse Event|0|||
127683117|NCT03169244|459465331|FG000|Overall Study|Withdrawal by Subject|2|||
127683118|NCT03169244|459465332|FG001|Overall Study|Withdrawal by Subject|2|||
127683119|NCT03169244|459465331|FG000|Overall Study|Physician Decision|1|||
127683120|NCT03169244|459465332|FG001|Overall Study|Physician Decision|0|||
127683121|NCT04668339|459465333|FG000|Overall Study|Physician Decision|1|||
127683122|NCT04668339|459465334|FG001|Overall Study|Physician Decision|0|||
127683123|NCT04668339|459465335|FG002|Overall Study|Physician Decision|1|||
127683124|NCT04668339|459465336|FG003|Overall Study|Physician Decision|1|||
127683125|NCT04668339|459465333|FG000|Overall Study|Lost to Follow-up|14|||
127683126|NCT04668339|459465334|FG001|Overall Study|Lost to Follow-up|12|||
127683127|NCT04668339|459465335|FG002|Overall Study|Lost to Follow-up|8|||
127683128|NCT04668339|459465336|FG003|Overall Study|Lost to Follow-up|5|||
127683129|NCT04668339|459465333|FG000|Overall Study|Adverse Event|0|||
127683130|NCT04668339|459465334|FG001|Overall Study|Adverse Event|0|||
127683131|NCT04668339|459465335|FG002|Overall Study|Adverse Event|1|||
127683132|NCT04668339|459465336|FG003|Overall Study|Adverse Event|0|||
127683133|NCT04668339|459465333|FG000|Overall Study|Other than specified|3|||
127683134|NCT04668339|459465334|FG001|Overall Study|Other than specified|0|||
127683135|NCT04668339|459465335|FG002|Overall Study|Other than specified|1|||
127683136|NCT04668339|459465336|FG003|Overall Study|Other than specified|0|||
127683137|NCT04668339|459465333|FG000|Overall Study|Participant unblinded between Day 98 and 198|6|||
127683138|NCT04668339|459465334|FG001|Overall Study|Participant unblinded between Day 98 and 198|5|||
127683139|NCT04668339|459465335|FG002|Overall Study|Participant unblinded between Day 98 and 198|4|||
127683140|NCT04668339|459465336|FG003|Overall Study|Participant unblinded between Day 98 and 198|91|||
127683141|NCT04668339|459465333|FG000|Overall Study|Vaccine not Administered|0|||
127683142|NCT04668339|459465334|FG001|Overall Study|Vaccine not Administered|0|||
127683143|NCT04668339|459465335|FG002|Overall Study|Vaccine not Administered|1|||
127683144|NCT04668339|459465336|FG003|Overall Study|Vaccine not Administered|0|||
127683145|NCT04668339|459465333|FG000|Overall Study|Protocol Violation|18|||
127683146|NCT04668339|459465334|FG001|Overall Study|Protocol Violation|23|||
127683147|NCT04668339|459465335|FG002|Overall Study|Protocol Violation|12|||
127683148|NCT04668339|459465336|FG003|Overall Study|Protocol Violation|20|||
127683149|NCT04668339|459465333|FG000|Overall Study|Withdrawal by Subject|45|||
127683150|NCT04668339|459465334|FG001|Overall Study|Withdrawal by Subject|46|||
127683151|NCT04668339|459465335|FG002|Overall Study|Withdrawal by Subject|46|||
127683152|NCT04668339|459465336|FG003|Overall Study|Withdrawal by Subject|27|||
127683153|NCT04668339|459465333|FG000|Overall Study|Study Terminated by Sponsor|59|||
127683154|NCT04668339|459465334|FG001|Overall Study|Study Terminated by Sponsor|59|||
127683155|NCT04668339|459465335|FG002|Overall Study|Study Terminated by Sponsor|71|||
127683156|NCT04668339|459465336|FG003|Overall Study|Study Terminated by Sponsor|1|||
127683157|NCT03622593|459465337|FG000|Overall Study|Withdrawal by Subject|11|||
127683158|NCT03622593|459465338|FG001|Overall Study|Withdrawal by Subject|9|||
127683159|NCT03622593|459465339|FG002|Overall Study|Withdrawal by Subject|13|||
127683160|NCT03622593|459465337|FG000|Overall Study|Death|12|||
127683161|NCT03622593|459465338|FG001|Overall Study|Death|9|||
127683162|NCT03622593|459465339|FG002|Overall Study|Death|10|||
127683163|NCT03622593|459465337|FG000|Overall Study|Lost to Follow-up|11|||
127683164|NCT03622593|459465338|FG001|Overall Study|Lost to Follow-up|5|||
127683165|NCT03622593|459465339|FG002|Overall Study|Lost to Follow-up|8|||
127683166|NCT03622593|459465337|FG000|Overall Study|Adverse Event|4|||
127683167|NCT03622593|459465338|FG001|Overall Study|Adverse Event|5|||
127683168|NCT03622593|459465339|FG002|Overall Study|Adverse Event|6|||
127683169|NCT03622593|459465337|FG000|Overall Study|Physician Decision|2|||
127683170|NCT03622593|459465338|FG001|Overall Study|Physician Decision|1|||
127683171|NCT03622593|459465339|FG002|Overall Study|Physician Decision|6|||
127683172|NCT03622593|459465337|FG000|Overall Study|Other|2|||
127683173|NCT03622593|459465338|FG001|Overall Study|Other|2|||
127683174|NCT03622593|459465339|FG002|Overall Study|Other|3|||
127683175|NCT03622593|459465337|FG000|Overall Study|Protocol Violation|0|||
127683176|NCT03622593|459465338|FG001|Overall Study|Protocol Violation|0|||
127683177|NCT03622593|459465339|FG002|Overall Study|Protocol Violation|1|||
127683178|NCT03622593|459465337|FG000|Overall Study|Pregnancy|0|||
127683179|NCT03622593|459465338|FG001|Overall Study|Pregnancy|0|||
127683180|NCT03622593|459465339|FG002|Overall Study|Pregnancy|1|||
127683181|NCT02139046|459465340|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
127769799|NCT00427895|459782759|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
127769800|NCT00427895|459782752|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
127769801|NCT00427895|459782753|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
127769802|NCT00427895|459782754|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
127769803|NCT00427895|459782755|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
127769804|NCT00427895|459782756|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
127769805|NCT00427895|459782757|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
127769806|NCT00427895|459782758|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
127769807|NCT00427895|459782759|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
127769808|NCT00427895|459782752|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
127769809|NCT00427895|459782753|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
127769810|NCT00427895|459782754|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
127769811|NCT00427895|459782755|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
127769812|NCT00427895|459782756|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
127769813|NCT00427895|459782757|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
127769814|NCT00427895|459782758|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
127769815|NCT00427895|459782759|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
127769816|NCT00427895|459782752|FG000|Vax 1/Year 1 Follow-up|Death|1|||
127769817|NCT00427895|459782753|FG001|Vax 1/Year 1 Follow-up|Death|0|||
127769818|NCT00427895|459782754|FG002|Vax 1/Year 1 Follow-up|Death|0|||
127769819|NCT00427895|459782755|FG003|Vax 1/Year 1 Follow-up|Death|0|||
127769820|NCT00427895|459782756|FG004|Vax 1/Year 1 Follow-up|Death|0|||
127769821|NCT00427895|459782757|FG005|Vax 1/Year 1 Follow-up|Death|0|||
127769822|NCT00427895|459782758|FG006|Vax 1/Year 1 Follow-up|Death|0|||
127769823|NCT00427895|459782759|FG007|Vax 1/Year 1 Follow-up|Death|0|||
127769824|NCT00427895|459782752|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
127769825|NCT00427895|459782753|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
127769826|NCT00427895|459782754|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
127769827|NCT00427895|459782755|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
127769828|NCT00427895|459782756|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
127769829|NCT00427895|459782757|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
127769830|NCT00427895|459782758|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
127769831|NCT00427895|459782759|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
127769832|NCT00427895|459782752|FG000|Vax 1/Year 1 Follow-up|Other|0|||
127769833|NCT00427895|459782753|FG001|Vax 1/Year 1 Follow-up|Other|0|||
127769834|NCT00427895|459782754|FG002|Vax 1/Year 1 Follow-up|Other|0|||
127769835|NCT00427895|459782755|FG003|Vax 1/Year 1 Follow-up|Other|2|||
127769836|NCT00427895|459782756|FG004|Vax 1/Year 1 Follow-up|Other|0|||
127769837|NCT00427895|459782757|FG005|Vax 1/Year 1 Follow-up|Other|0|||
127769838|NCT00427895|459782758|FG006|Vax 1/Year 1 Follow-up|Other|0|||
127769839|NCT00427895|459782759|FG007|Vax 1/Year 1 Follow-up|Other|0|||
127769840|NCT00427895|459782752|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
127769841|NCT00427895|459782753|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
127769842|NCT00427895|459782754|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
127769843|NCT00427895|459782755|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
127769844|NCT00427895|459782756|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
127769845|NCT00427895|459782757|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
127769846|NCT00427895|459782758|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
127769847|NCT00427895|459782759|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
127769848|NCT00585195|459782762|FG000|Overall Study|Adverse Event|0|||
127769849|NCT00585195|459782763|FG001|Overall Study|Adverse Event|0|||
127769850|NCT00585195|459782764|FG002|Overall Study|Adverse Event|0|||
127769851|NCT00585195|459782765|FG003|Overall Study|Adverse Event|0|||
127769852|NCT00585195|459782766|FG004|Overall Study|Adverse Event|2|||
127769853|NCT00585195|459782767|FG005|Overall Study|Adverse Event|1|||
127769854|NCT00585195|459782768|FG006|Overall Study|Adverse Event|0|||
127769855|NCT00585195|459782769|FG007|Overall Study|Adverse Event|1|||
127769856|NCT00585195|459782770|FG008|Overall Study|Adverse Event|0|||
127769857|NCT00585195|459782771|FG009|Overall Study|Adverse Event|0|||
127769858|NCT00585195|459782772|FG010|Overall Study|Adverse Event|3|||
127769859|NCT00585195|459782773|FG011|Overall Study|Adverse Event|0|||
127769860|NCT00585195|459782774|FG012|Overall Study|Adverse Event|8|||
127769861|NCT00585195|459782775|FG013|Overall Study|Adverse Event|6|||
127769862|NCT00585195|459782776|FG014|Overall Study|Adverse Event|4|||
127769863|NCT00585195|459782777|FG015|Overall Study|Adverse Event|1|||
127769864|NCT00585195|459782778|FG016|Overall Study|Adverse Event|14|||
127769865|NCT00585195|459782779|FG017|Overall Study|Adverse Event|9|||
127769866|NCT00585195|459782780|FG018|Overall Study|Adverse Event|2|||
127769867|NCT00585195|459782781|FG019|Overall Study|Adverse Event|3|||
127547131|NCT02195518|458971849|FG000|Overall Study|Withdrawal by Subject|1|||
127769868|NCT00585195|459782782|FG020|Overall Study|Adverse Event|1|||
127769869|NCT00585195|459782762|FG000|Overall Study|Progressive Disease|2|||
127769870|NCT00585195|459782763|FG001|Overall Study|Progressive Disease|2|||
127769871|NCT00585195|459782764|FG002|Overall Study|Progressive Disease|5|||
127769872|NCT00585195|459782765|FG003|Overall Study|Progressive Disease|4|||
127683182|NCT02139046|459465341|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
127683183|NCT02139046|459465342|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
127683184|NCT02139046|459465343|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
127683185|NCT02139046|459465344|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
127683186|NCT02139046|459465340|FG000|Overall Study|Major Protocol Deviation|9|||
127683187|NCT02139046|459465341|FG001|Overall Study|Major Protocol Deviation|10|||
127683188|NCT02139046|459465342|FG002|Overall Study|Major Protocol Deviation|16|||
127683189|NCT02139046|459465343|FG003|Overall Study|Major Protocol Deviation|12|||
127683190|NCT02139046|459465344|FG004|Overall Study|Major Protocol Deviation|6|||
127683191|NCT02139046|459465340|FG000|Overall Study|Lost to Follow-up|13|||
127683192|NCT02139046|459465341|FG001|Overall Study|Lost to Follow-up|16|||
127683193|NCT02139046|459465342|FG002|Overall Study|Lost to Follow-up|16|||
127683194|NCT02139046|459465343|FG003|Overall Study|Lost to Follow-up|18|||
127683195|NCT02139046|459465344|FG004|Overall Study|Lost to Follow-up|13|||
127683196|NCT02139046|459465340|FG000|Overall Study|Voluntary Withdrawal|20|||
127683197|NCT02139046|459465341|FG001|Overall Study|Voluntary Withdrawal|8|||
127683198|NCT02139046|459465342|FG002|Overall Study|Voluntary Withdrawal|10|||
127683199|NCT02139046|459465343|FG003|Overall Study|Voluntary Withdrawal|15|||
127683200|NCT02139046|459465344|FG004|Overall Study|Voluntary Withdrawal|16|||
127683201|NCT02139046|459465340|FG000|Overall Study|Lack of Efficacy|0|||
127683202|NCT02139046|459465341|FG001|Overall Study|Lack of Efficacy|1|||
127683203|NCT02139046|459465342|FG002|Overall Study|Lack of Efficacy|2|||
127683204|NCT02139046|459465343|FG003|Overall Study|Lack of Efficacy|1|||
127683205|NCT02139046|459465344|FG004|Overall Study|Lack of Efficacy|2|||
127683206|NCT02139046|459465340|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
127683207|NCT02139046|459465341|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
127683208|NCT02139046|459465342|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
127683209|NCT02139046|459465343|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
127683210|NCT02139046|459465344|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
127683211|NCT02139046|459465340|FG000|Overall Study|Other Miscellaneous Reasons|10|||
127683212|NCT02139046|459465341|FG001|Overall Study|Other Miscellaneous Reasons|9|||
127683213|NCT02139046|459465342|FG002|Overall Study|Other Miscellaneous Reasons|4|||
127683214|NCT02139046|459465343|FG003|Overall Study|Other Miscellaneous Reasons|9|||
127683215|NCT02139046|459465344|FG004|Overall Study|Other Miscellaneous Reasons|12|||
127683216|NCT03557008|459465346|FG000|Overall Study|Withdrawal by Subject|2|||
127683217|NCT03557008|459465347|FG001|Overall Study|Withdrawal by Subject|2|||
127683218|NCT03557008|459465346|FG000|Overall Study|Early termination from study|3|||
127683219|NCT03557008|459465347|FG001|Overall Study|Early termination from study|1|||
127683220|NCT05876949|459465348|FG000|Overall Study|Withdrawal by Subject|1|||
127683221|NCT05876949|459465349|FG001|Overall Study|Withdrawal by Subject|3|||
127683222|NCT05876949|459465348|FG000|Overall Study|Physician Decision|0|||
127683223|NCT05876949|459465349|FG001|Overall Study|Physician Decision|2|||
127683224|NCT05876949|459465348|FG000|Overall Study|Death|0|||
127683225|NCT05876949|459465349|FG001|Overall Study|Death|1|||
127683226|NCT03644849|459465350|FG000|Overall Study|Lost to Follow-up|1|||
127683227|NCT03644849|459465351|FG001|Overall Study|Lost to Follow-up|3|||
127683228|NCT01177670|459465352|FG000|Overall Study|Study Terminated|115|||
127683229|NCT01177670|459465352|FG000|Overall Study|Physician Decision|50|||
127683230|NCT01177670|459465352|FG000|Overall Study|Withdrawal by Subject|4|||
127683231|NCT01145885|459465355|FG000|Overall Study|Progressive Disease|7|||
127683232|NCT03691428|459465356|FG000|Overall Study|Withdrawal by Subject|6|||
127683233|NCT03691428|459465357|FG001|Overall Study|Withdrawal by Subject|8|||
127683234|NCT02527148|459465358|FG000|Overall Study|Did not receive study intervention|1|||
127683235|NCT02527148|459465359|FG001|Overall Study|Did not receive study intervention|0|||
127683236|NCT01140048|459465360|FG000|Overall Study|Physician Decision|1|||
127683237|NCT01140048|459465360|FG000|Overall Study|Withdrawal by Subject|13|||
127683238|NCT01140048|459465360|FG000|Overall Study|Lost to Follow-up|31|||
127683239|NCT01831791|459465361|FG000|Overall Study|Withdrawal by Subject|10|||
127683240|NCT00494780|459465362|FG000|Overall Study|Adverse Event|1|||
127683241|NCT00494780|459465363|FG001|Overall Study|Adverse Event|0|||
127683242|NCT00494780|459465362|FG000|Overall Study|Withdrew before Dosed|0|||
127683243|NCT00494780|459465363|FG001|Overall Study|Withdrew before Dosed|1|||
127683244|NCT00494780|459465362|FG000|Overall Study|Progression of Study Disease|7|||
127683245|NCT00494780|459465363|FG001|Overall Study|Progression of Study Disease|8|||
127683246|NCT00494780|459465362|FG000|Overall Study|New Treatment|2|||
127683247|NCT00494780|459465363|FG001|Overall Study|New Treatment|2|||
127683248|NCT00494780|459465362|FG000|Overall Study|Non-compliance|1|||
127683249|NCT00494780|459465363|FG001|Overall Study|Non-compliance|0|||
127683250|NCT00494780|459465362|FG000|Overall Study|Residual Tumour Mass|0|||
127683251|NCT00494780|459465363|FG001|Overall Study|Residual Tumour Mass|1|||
127683252|NCT00494780|459465362|FG000|Overall Study|Insurance Issues|0|||
127683253|NCT00494780|459465363|FG001|Overall Study|Insurance Issues|1|||
127683254|NCT01254019|459465364|FG000|Overall Study|Adverse Event|0|||
127683255|NCT01254019|459465365|FG001|Overall Study|Adverse Event|2|||
127683256|NCT01254019|459465364|FG000|Overall Study|Protocol Violation|1|||
127683257|NCT01254019|459465365|FG001|Overall Study|Protocol Violation|0|||
127683258|NCT01254019|459465364|FG000|Overall Study|Withdrawal by Subject|0|||
127547132|NCT02195518|458971849|FG000|Overall Study|Lost to Follow-up|1|||
127547133|NCT00905164|458971852|FG000|Period 1|Protocol Violation|0|||
127547134|NCT00905164|458971853|FG001|Period 1|Protocol Violation|1|||
127547135|NCT01256788|458974352|FG000|Overall Study|Lost to Follow-up|5|||
127547136|NCT01256788|458974353|FG001|Overall Study|Lost to Follow-up|8|||
127547137|NCT01256788|458974354|FG002|Overall Study|Lost to Follow-up|3|||
127547138|NCT03312634|458974355|FG000|Overall Study|Adverse Event|11|||
127547139|NCT03312634|458974356|FG001|Overall Study|Adverse Event|0|||
127547140|NCT03312634|458974355|FG000|Overall Study|Sponsor request|2|||
127547141|NCT03312634|458974356|FG001|Overall Study|Sponsor request|0|||
127683259|NCT01254019|459465365|FG001|Overall Study|Withdrawal by Subject|2|||
127683260|NCT03061474|459465366|FG000|Overall Study|Adverse Event|2|||
127683261|NCT03061474|459465367|FG001|Overall Study|Adverse Event|0|||
127683262|NCT03061474|459465366|FG000|Overall Study|Safety Risk|0|||
127683263|NCT03061474|459465367|FG001|Overall Study|Safety Risk|1|||
127683264|NCT03061474|459465366|FG000|Overall Study|Participant unwilling or unable to participate|0|||
127683265|NCT03061474|459465367|FG001|Overall Study|Participant unwilling or unable to participate|2|||
127683266|NCT03061474|459465366|FG000|Overall Study|Lost to Follow-up|0|||
127683267|NCT03061474|459465367|FG001|Overall Study|Lost to Follow-up|1|||
127683268|NCT00980330|459465368|FG000|Overall Study|Adverse Event|0|||
127683269|NCT00980330|459465369|FG001|Overall Study|Adverse Event|0|||
127683270|NCT00980330|459465370|FG002|Overall Study|Adverse Event|0|||
127683271|NCT00980330|459465371|FG003|Overall Study|Adverse Event|1|||
127683272|NCT00980330|459465372|FG004|Overall Study|Adverse Event|0|||
127683273|NCT00980330|459465373|FG005|Overall Study|Adverse Event|0|||
127683274|NCT00980330|459465374|FG006|Overall Study|Adverse Event|0|||
127683275|NCT00980330|459465368|FG000|Overall Study|Lost to Follow-up|1|||
127683276|NCT00980330|459465369|FG001|Overall Study|Lost to Follow-up|1|||
127683277|NCT00980330|459465370|FG002|Overall Study|Lost to Follow-up|4|||
127683278|NCT00980330|459465371|FG003|Overall Study|Lost to Follow-up|2|||
127683279|NCT00980330|459465372|FG004|Overall Study|Lost to Follow-up|1|||
127683280|NCT00980330|459465373|FG005|Overall Study|Lost to Follow-up|1|||
127683281|NCT00980330|459465374|FG006|Overall Study|Lost to Follow-up|2|||
127683282|NCT00980330|459465368|FG000|Overall Study|Withdrawal by Subject|2|||
127683283|NCT00980330|459465369|FG001|Overall Study|Withdrawal by Subject|4|||
127683284|NCT00980330|459465370|FG002|Overall Study|Withdrawal by Subject|4|||
127683285|NCT00980330|459465371|FG003|Overall Study|Withdrawal by Subject|1|||
127683286|NCT00980330|459465372|FG004|Overall Study|Withdrawal by Subject|3|||
127683287|NCT00980330|459465373|FG005|Overall Study|Withdrawal by Subject|2|||
127683288|NCT00980330|459465374|FG006|Overall Study|Withdrawal by Subject|5|||
127683289|NCT00980330|459465368|FG000|Overall Study|(not specified)|2|||
127683290|NCT00980330|459465369|FG001|Overall Study|(not specified)|0|||
127683291|NCT00980330|459465370|FG002|Overall Study|(not specified)|0|||
127683292|NCT00980330|459465371|FG003|Overall Study|(not specified)|1|||
127683293|NCT00980330|459465372|FG004|Overall Study|(not specified)|1|||
127683294|NCT00980330|459465373|FG005|Overall Study|(not specified)|1|||
127683295|NCT00980330|459465374|FG006|Overall Study|(not specified)|0|||
127683296|NCT00666276|459465375|FG000|Overall Study|Protocol Violation|34|||
127683297|NCT00665444|459465378|FG000|Overall Study|Physician Decision|1|||
127683298|NCT00665444|459465378|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
127683299|NCT03299816|459465379|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
127683300|NCT03299816|459465380|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
127683301|NCT03299816|459465379|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
127683302|NCT03299816|459465380|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
127683303|NCT03299816|459465379|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
127683304|NCT03299816|459465380|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
127683305|NCT03520413|459465381|FG000|Overall Study|Lost to Follow-up|1|||
127683306|NCT03520413|459465382|FG001|Overall Study|Lost to Follow-up|1|||
127683307|NCT03520413|459465381|FG000|Overall Study|Withdrawal by Subject|1|||
127683308|NCT03520413|459465382|FG001|Overall Study|Withdrawal by Subject|2|||
127683309|NCT03520413|459465381|FG000|Overall Study|Death|0|||
127683310|NCT03520413|459465382|FG001|Overall Study|Death|1|||
127547142|NCT03312634|458974355|FG000|Overall Study|Withdrawal by Subject|31|||
127547143|NCT03312634|458974356|FG001|Overall Study|Withdrawal by Subject|9|||
127547144|NCT03312634|458974355|FG000|Overall Study|Enrolled in an interventional study|0|||
127547145|NCT03312634|458974356|FG001|Overall Study|Enrolled in an interventional study|52|||
127683311|NCT03520413|459465381|FG000|Overall Study|Physician Decision|3|||
127683312|NCT03520413|459465382|FG001|Overall Study|Physician Decision|3|||
127683313|NCT03520413|459465381|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
127683314|NCT03520413|459465382|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
127683315|NCT00869323|459465387|FG000|Maintenance Therapy|concurrent illness|1|||
127683316|NCT01135511|459465391|FG000|Overall Study|Adverse Event|0|||
127683317|NCT01135511|459465392|FG001|Overall Study|Adverse Event|1|||
127683318|NCT01135511|459465393|FG002|Overall Study|Adverse Event|2|||
127683319|NCT01135511|459465394|FG003|Overall Study|Adverse Event|0|||
127683320|NCT01135511|459465395|FG004|Overall Study|Adverse Event|0|||
127683321|NCT01135511|459465396|FG005|Overall Study|Adverse Event|1|||
127547146|NCT03312634|458974355|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
127547147|NCT03312634|458974356|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
127547148|NCT03312634|458974355|FG000|Overall Study|Death|0|||
127547149|NCT03312634|458974356|FG001|Overall Study|Death|1|||
127547150|NCT03312634|458974355|FG000|Overall Study|Non-compliance|0|||
127547151|NCT03312634|458974356|FG001|Overall Study|Non-compliance|2|||
127547152|NCT03312634|458974355|FG000|Overall Study|Lost to Follow-up|0|||
127547153|NCT03312634|458974356|FG001|Overall Study|Lost to Follow-up|1|||
127547154|NCT03312634|458974355|FG000|Overall Study|Enrolled into non-interventional study|0|||
127547155|NCT03312634|458974356|FG001|Overall Study|Enrolled into non-interventional study|5|||
127547156|NCT03312634|458974355|FG000|Overall Study|Worsening clinical condition|0|||
127547157|NCT03312634|458974356|FG001|Overall Study|Worsening clinical condition|1|||
127547158|NCT03312634|458974355|FG000|Overall Study|Participant did not want to travel|0|||
127547159|NCT03312634|458974356|FG001|Overall Study|Participant did not want to travel|1|||
127547160|NCT03312634|458974355|FG000|Overall Study|Physician Decision|1|||
127547161|NCT03312634|458974356|FG001|Overall Study|Physician Decision|0|||
127683322|NCT01135511|459465397|FG006|Overall Study|Adverse Event|0|||
127683323|NCT01135511|459465398|FG007|Overall Study|Adverse Event|1|||
127683324|NCT01135511|459465399|FG008|Overall Study|Adverse Event|0|||
127683325|NCT01135511|459465391|FG000|Overall Study|Lack of Efficacy|0|||
127683326|NCT01135511|459465392|FG001|Overall Study|Lack of Efficacy|1|||
127683327|NCT01135511|459465393|FG002|Overall Study|Lack of Efficacy|1|||
127683328|NCT01135511|459465394|FG003|Overall Study|Lack of Efficacy|2|||
127683329|NCT01135511|459465395|FG004|Overall Study|Lack of Efficacy|0|||
127683330|NCT01135511|459465396|FG005|Overall Study|Lack of Efficacy|0|||
127683331|NCT01135511|459465397|FG006|Overall Study|Lack of Efficacy|0|||
127683332|NCT01135511|459465398|FG007|Overall Study|Lack of Efficacy|0|||
127683333|NCT01135511|459465399|FG008|Overall Study|Lack of Efficacy|0|||
127683334|NCT01135511|459465391|FG000|Overall Study|Protocol Violation|0|||
127683335|NCT01135511|459465392|FG001|Overall Study|Protocol Violation|0|||
127683336|NCT01135511|459465393|FG002|Overall Study|Protocol Violation|3|||
127683337|NCT01135511|459465394|FG003|Overall Study|Protocol Violation|0|||
127683338|NCT01135511|459465395|FG004|Overall Study|Protocol Violation|0|||
127683339|NCT01135511|459465396|FG005|Overall Study|Protocol Violation|0|||
127683340|NCT01135511|459465397|FG006|Overall Study|Protocol Violation|0|||
127683341|NCT01135511|459465398|FG007|Overall Study|Protocol Violation|0|||
127683342|NCT01135511|459465399|FG008|Overall Study|Protocol Violation|0|||
127683343|NCT01135511|459465391|FG000|Overall Study|Pregnancy|0|||
127683344|NCT01135511|459465392|FG001|Overall Study|Pregnancy|0|||
127683345|NCT01135511|459465393|FG002|Overall Study|Pregnancy|0|||
127683346|NCT01135511|459465394|FG003|Overall Study|Pregnancy|1|||
127683347|NCT01135511|459465395|FG004|Overall Study|Pregnancy|0|||
127683348|NCT01135511|459465396|FG005|Overall Study|Pregnancy|0|||
127683349|NCT01135511|459465397|FG006|Overall Study|Pregnancy|0|||
127683350|NCT01135511|459465398|FG007|Overall Study|Pregnancy|0|||
127683351|NCT01135511|459465399|FG008|Overall Study|Pregnancy|0|||
127683352|NCT01135511|459465391|FG000|Overall Study|could not visit the clinic|0|||
127683353|NCT01135511|459465392|FG001|Overall Study|could not visit the clinic|1|||
127683354|NCT01135511|459465393|FG002|Overall Study|could not visit the clinic|2|||
127683355|NCT01135511|459465394|FG003|Overall Study|could not visit the clinic|0|||
127683356|NCT01135511|459465395|FG004|Overall Study|could not visit the clinic|0|||
127683357|NCT01135511|459465396|FG005|Overall Study|could not visit the clinic|0|||
127683358|NCT01135511|459465397|FG006|Overall Study|could not visit the clinic|0|||
127683359|NCT01135511|459465398|FG007|Overall Study|could not visit the clinic|0|||
127683360|NCT01135511|459465399|FG008|Overall Study|could not visit the clinic|0|||
127683361|NCT01135511|459465391|FG000|Overall Study|noncompliance with study drug taken|0|||
127683362|NCT01135511|459465392|FG001|Overall Study|noncompliance with study drug taken|0|||
127683363|NCT01135511|459465393|FG002|Overall Study|noncompliance with study drug taken|0|||
127547162|NCT03312634|458974355|FG000|Overall Study|Other|13|||
127547163|NCT03312634|458974356|FG001|Overall Study|Other|0|||
127547164|NCT05366738|458974357|FG000|Overall Study|Adverse Event|0|||
127683364|NCT01135511|459465394|FG003|Overall Study|noncompliance with study drug taken|0|||
127683365|NCT01135511|459465395|FG004|Overall Study|noncompliance with study drug taken|1|||
127683366|NCT01135511|459465396|FG005|Overall Study|noncompliance with study drug taken|0|||
127683367|NCT01135511|459465397|FG006|Overall Study|noncompliance with study drug taken|0|||
127683368|NCT01135511|459465398|FG007|Overall Study|noncompliance with study drug taken|0|||
127683369|NCT01135511|459465399|FG008|Overall Study|noncompliance with study drug taken|0|||
127683370|NCT01135511|459465391|FG000|Overall Study|Withdrawal by Subject|0|||
127683371|NCT01135511|459465392|FG001|Overall Study|Withdrawal by Subject|0|||
127683372|NCT01135511|459465393|FG002|Overall Study|Withdrawal by Subject|0|||
127683373|NCT01135511|459465394|FG003|Overall Study|Withdrawal by Subject|0|||
127683374|NCT01135511|459465395|FG004|Overall Study|Withdrawal by Subject|0|||
127683375|NCT01135511|459465396|FG005|Overall Study|Withdrawal by Subject|0|||
127547165|NCT05366738|458974358|FG001|Overall Study|Adverse Event|1|||
127547166|NCT05366738|458974359|FG002|Overall Study|Adverse Event|0|||
127683376|NCT01135511|459465397|FG006|Overall Study|Withdrawal by Subject|1|||
127683377|NCT01135511|459465398|FG007|Overall Study|Withdrawal by Subject|0|||
127769873|NCT00585195|459782766|FG004|Overall Study|Progressive Disease|6|||
127683378|NCT01135511|459465399|FG008|Overall Study|Withdrawal by Subject|1|||
127683379|NCT04054635|459465404|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
127683380|NCT04054635|459465405|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
127683381|NCT04054635|459465406|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
127683382|NCT04054635|459465404|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
127683383|NCT04054635|459465405|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
127683384|NCT04054635|459465406|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
127683385|NCT00891930|459465407|FG000|Part 1 Panitumumab + Irinotecan|Full Consent Withdrawn|2|||
127683386|NCT00891930|459465407|FG000|Part 1 Panitumumab + Irinotecan|Death|66|||
127683387|NCT00891930|459465407|FG000|Part 1 Panitumumab + Irinotecan|Lost to Follow-up|1|||
127683388|NCT00891930|459465407|FG000|Part 2 Panitumumab + AMG479|Full Consent Withdrawn|1|||
127769874|NCT00585195|459782767|FG005|Overall Study|Progressive Disease|4|||
127769875|NCT00585195|459782768|FG006|Overall Study|Progressive Disease|6|||
127769876|NCT00585195|459782769|FG007|Overall Study|Progressive Disease|3|||
127769877|NCT00585195|459782770|FG008|Overall Study|Progressive Disease|0|||
127769878|NCT00585195|459782771|FG009|Overall Study|Progressive Disease|5|||
127769879|NCT00585195|459782772|FG010|Overall Study|Progressive Disease|2|||
127769880|NCT00585195|459782773|FG011|Overall Study|Progressive Disease|25|||
127769881|NCT00585195|459782774|FG012|Overall Study|Progressive Disease|29|||
127769882|NCT00585195|459782775|FG013|Overall Study|Progressive Disease|26|||
127769883|NCT00585195|459782776|FG014|Overall Study|Progressive Disease|21|||
127769884|NCT00585195|459782777|FG015|Overall Study|Progressive Disease|12|||
127769885|NCT00585195|459782778|FG016|Overall Study|Progressive Disease|94|||
127769886|NCT00585195|459782779|FG017|Overall Study|Progressive Disease|42|||
127769887|NCT00585195|459782780|FG018|Overall Study|Progressive Disease|4|||
127769888|NCT00585195|459782781|FG019|Overall Study|Progressive Disease|9|||
127769889|NCT00585195|459782782|FG020|Overall Study|Progressive Disease|8|||
127769890|NCT00585195|459782762|FG000|Overall Study|Withdrawal by Subject|1|||
127769891|NCT00585195|459782763|FG001|Overall Study|Withdrawal by Subject|1|||
127769892|NCT00585195|459782764|FG002|Overall Study|Withdrawal by Subject|2|||
127769893|NCT00585195|459782765|FG003|Overall Study|Withdrawal by Subject|2|||
127769894|NCT00585195|459782766|FG004|Overall Study|Withdrawal by Subject|0|||
127769895|NCT00585195|459782767|FG005|Overall Study|Withdrawal by Subject|0|||
127769896|NCT00585195|459782768|FG006|Overall Study|Withdrawal by Subject|0|||
127769897|NCT00585195|459782769|FG007|Overall Study|Withdrawal by Subject|1|||
127769898|NCT00585195|459782770|FG008|Overall Study|Withdrawal by Subject|0|||
127769899|NCT00585195|459782771|FG009|Overall Study|Withdrawal by Subject|0|||
127769900|NCT00585195|459782772|FG010|Overall Study|Withdrawal by Subject|3|||
127769901|NCT00585195|459782773|FG011|Overall Study|Withdrawal by Subject|8|||
127769902|NCT00585195|459782774|FG012|Overall Study|Withdrawal by Subject|15|||
127769903|NCT00585195|459782775|FG013|Overall Study|Withdrawal by Subject|0|||
127769904|NCT00585195|459782776|FG014|Overall Study|Withdrawal by Subject|3|||
127769905|NCT00585195|459782777|FG015|Overall Study|Withdrawal by Subject|0|||
127769906|NCT00585195|459782778|FG016|Overall Study|Withdrawal by Subject|7|||
127769907|NCT00585195|459782779|FG017|Overall Study|Withdrawal by Subject|1|||
127769908|NCT00585195|459782780|FG018|Overall Study|Withdrawal by Subject|2|||
127769909|NCT00585195|459782781|FG019|Overall Study|Withdrawal by Subject|2|||
127769910|NCT00585195|459782782|FG020|Overall Study|Withdrawal by Subject|0|||
127769911|NCT00585195|459782762|FG000|Overall Study|Other|0|||
127769912|NCT00585195|459782763|FG001|Overall Study|Other|1|||
127769913|NCT00585195|459782764|FG002|Overall Study|Other|1|||
127769914|NCT00585195|459782765|FG003|Overall Study|Other|1|||
127769915|NCT00585195|459782766|FG004|Overall Study|Other|0|||
127769916|NCT00585195|459782767|FG005|Overall Study|Other|1|||
128016064|NCT02335944|460682226|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
128016065|NCT02335944|460682227|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
128016066|NCT02335944|460682228|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
127769917|NCT00585195|459782768|FG006|Overall Study|Other|0|||
127769918|NCT00585195|459782769|FG007|Overall Study|Other|0|||
127769919|NCT00585195|459782770|FG008|Overall Study|Other|2|||
127769920|NCT00585195|459782771|FG009|Overall Study|Other|1|||
127769921|NCT00585195|459782772|FG010|Overall Study|Other|0|||
127769922|NCT00585195|459782773|FG011|Overall Study|Other|19|||
127769923|NCT00585195|459782774|FG012|Overall Study|Other|24|||
127769924|NCT00585195|459782775|FG013|Overall Study|Other|7|||
127683389|NCT00891930|459465407|FG000|Part 2 Panitumumab + AMG479|Death|30|||
127769925|NCT00585195|459782776|FG014|Overall Study|Other|11|||
127769926|NCT00585195|459782777|FG015|Overall Study|Other|3|||
127769927|NCT00585195|459782778|FG016|Overall Study|Other|28|||
127769928|NCT00585195|459782779|FG017|Overall Study|Other|12|||
127769929|NCT00585195|459782780|FG018|Overall Study|Other|10|||
127769930|NCT00585195|459782781|FG019|Overall Study|Other|4|||
127769931|NCT00585195|459782782|FG020|Overall Study|Other|2|||
127769932|NCT00585195|459782762|FG000|Overall Study|Randomized not treated|0|||
127769933|NCT00585195|459782763|FG001|Overall Study|Randomized not treated|0|||
127769934|NCT00585195|459782764|FG002|Overall Study|Randomized not treated|1|||
127769935|NCT00585195|459782765|FG003|Overall Study|Randomized not treated|0|||
127769936|NCT00585195|459782766|FG004|Overall Study|Randomized not treated|1|||
127547167|NCT00906204|458974362|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
127547168|NCT00906204|458974363|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
127683390|NCT00638963|459465408|FG000|Overall Study|Withdrawal by Subject|1|||
127683391|NCT00638963|459465409|FG001|Overall Study|Withdrawal by Subject|0|||
127683392|NCT05001945|459465412|FG000|Overall Study|Adverse Event|0|||
127683393|NCT05001945|459465413|FG001|Overall Study|Adverse Event|0|||
127683394|NCT05001945|459465414|FG002|Overall Study|Adverse Event|0|||
127683395|NCT05001945|459465415|FG003|Overall Study|Adverse Event|1|||
127683396|NCT05001945|459465416|FG004|Overall Study|Adverse Event|0|||
127683397|NCT05001945|459465417|FG005|Overall Study|Adverse Event|0|||
127683398|NCT05001945|459465418|FG006|Overall Study|Adverse Event|0|||
127683399|NCT05001945|459465419|FG007|Overall Study|Adverse Event|0|||
127683400|NCT05001945|459465412|FG000|Overall Study|Lost to Follow-up|0|||
127683401|NCT05001945|459465413|FG001|Overall Study|Lost to Follow-up|1|||
127683402|NCT05001945|459465414|FG002|Overall Study|Lost to Follow-up|1|||
127683403|NCT05001945|459465415|FG003|Overall Study|Lost to Follow-up|2|||
127683404|NCT05001945|459465416|FG004|Overall Study|Lost to Follow-up|0|||
127683405|NCT05001945|459465417|FG005|Overall Study|Lost to Follow-up|1|||
127683406|NCT05001945|459465418|FG006|Overall Study|Lost to Follow-up|0|||
127683407|NCT05001945|459465419|FG007|Overall Study|Lost to Follow-up|0|||
127683408|NCT05001945|459465412|FG000|Overall Study|Protocol Violation|1|||
127683409|NCT05001945|459465413|FG001|Overall Study|Protocol Violation|0|||
127683410|NCT05001945|459465414|FG002|Overall Study|Protocol Violation|1|||
127683411|NCT05001945|459465415|FG003|Overall Study|Protocol Violation|1|||
127683412|NCT05001945|459465416|FG004|Overall Study|Protocol Violation|0|||
127683413|NCT05001945|459465417|FG005|Overall Study|Protocol Violation|1|||
127683414|NCT05001945|459465418|FG006|Overall Study|Protocol Violation|0|||
127683415|NCT05001945|459465419|FG007|Overall Study|Protocol Violation|0|||
127683416|NCT05001945|459465412|FG000|Overall Study|Withdrawal by Subject|0|||
127683417|NCT05001945|459465413|FG001|Overall Study|Withdrawal by Subject|0|||
127683418|NCT05001945|459465414|FG002|Overall Study|Withdrawal by Subject|0|||
127683419|NCT05001945|459465415|FG003|Overall Study|Withdrawal by Subject|1|||
127683420|NCT05001945|459465416|FG004|Overall Study|Withdrawal by Subject|1|||
127683421|NCT05001945|459465417|FG005|Overall Study|Withdrawal by Subject|1|||
127683422|NCT05001945|459465418|FG006|Overall Study|Withdrawal by Subject|0|||
127683423|NCT05001945|459465419|FG007|Overall Study|Withdrawal by Subject|1|||
127683424|NCT05001945|459465412|FG000|Overall Study|Not specified by Investigator|0|||
127683425|NCT05001945|459465413|FG001|Overall Study|Not specified by Investigator|3|||
127683426|NCT05001945|459465414|FG002|Overall Study|Not specified by Investigator|0|||
127683427|NCT05001945|459465415|FG003|Overall Study|Not specified by Investigator|0|||
127683428|NCT05001945|459465416|FG004|Overall Study|Not specified by Investigator|1|||
127683429|NCT05001945|459465417|FG005|Overall Study|Not specified by Investigator|0|||
127683430|NCT05001945|459465418|FG006|Overall Study|Not specified by Investigator|0|||
127683431|NCT05001945|459465419|FG007|Overall Study|Not specified by Investigator|0|||
127683432|NCT02448446|459465420|FG000|Overall Study|Withdrawal by Subject|1|||
127683433|NCT02448446|459465421|FG001|Overall Study|Withdrawal by Subject|0|||
127683434|NCT02425111|459465422|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
127683435|NCT02425111|459465422|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
127683436|NCT02425111|459465422|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
127683437|NCT02425111|459465422|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
127683438|NCT02425111|459465422|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
127683439|NCT02425111|459465422|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
127683440|NCT00545077|459465424|FG000|Overall Study|Treatment not received|5|||
127683441|NCT00545077|459465425|FG001|Overall Study|Treatment not received|1|||
127683442|NCT00545077|459465424|FG000|Overall Study|Disease Progression|131|||
127683443|NCT00545077|459465425|FG001|Overall Study|Disease Progression|98|||
127683444|NCT00545077|459465424|FG000|Overall Study|Withdrawal by Subject|3|||
127683445|NCT00545077|459465425|FG001|Overall Study|Withdrawal by Subject|14|||
127683446|NCT00545077|459465424|FG000|Overall Study|Physician Decision|6|||
127683447|NCT00545077|459465425|FG001|Overall Study|Physician Decision|3|||
127683448|NCT00545077|459465424|FG000|Overall Study|Lost to Follow-up|2|||
127683449|NCT00545077|459465425|FG001|Overall Study|Lost to Follow-up|0|||
127547169|NCT00906204|458974362|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
127683450|NCT00545077|459465424|FG000|Overall Study|Protocol Violation|1|||
127683451|NCT00545077|459465425|FG001|Overall Study|Protocol Violation|0|||
127683452|NCT00545077|459465424|FG000|Overall Study|Adverse Event|0|||
127683453|NCT00545077|459465425|FG001|Overall Study|Adverse Event|31|||
127683454|NCT00545077|459465424|FG000|Overall Study|Death|0|||
127683455|NCT00545077|459465425|FG001|Overall Study|Death|8|||
127683456|NCT02202499|459465426|FG000|Overall Study|Cancer diagnosis|0|||
127683457|NCT02202499|459465427|FG001|Overall Study|Cancer diagnosis|0|||
127683458|NCT02202499|459465428|FG002|Overall Study|Cancer diagnosis|1|||
127683459|NCT02202499|459465426|FG000|Overall Study|Moved from area|0|||
127683460|NCT02202499|459465427|FG001|Overall Study|Moved from area|0|||
127683461|NCT02202499|459465428|FG002|Overall Study|Moved from area|1|||
127683462|NCT02202499|459465426|FG000|Overall Study|Declined before randomization|1|||
127769937|NCT00585195|459782767|FG005|Overall Study|Randomized not treated|0|||
127769938|NCT00585195|459782768|FG006|Overall Study|Randomized not treated|1|||
127769939|NCT00585195|459782769|FG007|Overall Study|Randomized not treated|0|||
127769940|NCT00585195|459782770|FG008|Overall Study|Randomized not treated|0|||
127769941|NCT00585195|459782771|FG009|Overall Study|Randomized not treated|0|||
127769942|NCT00585195|459782772|FG010|Overall Study|Randomized not treated|2|||
127769943|NCT00585195|459782773|FG011|Overall Study|Randomized not treated|0|||
127769944|NCT00585195|459782774|FG012|Overall Study|Randomized not treated|0|||
127769945|NCT00585195|459782775|FG013|Overall Study|Randomized not treated|0|||
127769946|NCT00585195|459782776|FG014|Overall Study|Randomized not treated|0|||
127769947|NCT00585195|459782777|FG015|Overall Study|Randomized not treated|1|||
127769948|NCT00585195|459782778|FG016|Overall Study|Randomized not treated|0|||
127769949|NCT00585195|459782779|FG017|Overall Study|Randomized not treated|1|||
127769950|NCT00585195|459782780|FG018|Overall Study|Randomized not treated|3|||
127769951|NCT00585195|459782781|FG019|Overall Study|Randomized not treated|0|||
127769952|NCT00585195|459782782|FG020|Overall Study|Randomized not treated|2|||
127769953|NCT00585195|459782762|FG000|Overall Study|Death|0|||
127769954|NCT00585195|459782763|FG001|Overall Study|Death|0|||
127769955|NCT00585195|459782764|FG002|Overall Study|Death|0|||
127769956|NCT00585195|459782765|FG003|Overall Study|Death|0|||
127769957|NCT00585195|459782766|FG004|Overall Study|Death|0|||
127769958|NCT00585195|459782767|FG005|Overall Study|Death|0|||
127769959|NCT00585195|459782768|FG006|Overall Study|Death|0|||
127769960|NCT00585195|459782769|FG007|Overall Study|Death|0|||
127769961|NCT00585195|459782770|FG008|Overall Study|Death|1|||
127769962|NCT00585195|459782771|FG009|Overall Study|Death|0|||
127769963|NCT00585195|459782772|FG010|Overall Study|Death|1|||
127769964|NCT00585195|459782773|FG011|Overall Study|Death|1|||
127769965|NCT00585195|459782774|FG012|Overall Study|Death|7|||
127769966|NCT00585195|459782775|FG013|Overall Study|Death|2|||
127769967|NCT00585195|459782776|FG014|Overall Study|Death|8|||
127769968|NCT00585195|459782777|FG015|Overall Study|Death|2|||
127769969|NCT00585195|459782778|FG016|Overall Study|Death|11|||
127769970|NCT00585195|459782779|FG017|Overall Study|Death|0|||
127769971|NCT00585195|459782780|FG018|Overall Study|Death|0|||
127769972|NCT00585195|459782781|FG019|Overall Study|Death|0|||
127769973|NCT00585195|459782782|FG020|Overall Study|Death|1|||
127769974|NCT00585195|459782762|FG000|Overall Study|Lost to Follow-up|0|||
127769975|NCT00585195|459782763|FG001|Overall Study|Lost to Follow-up|0|||
127769976|NCT00585195|459782764|FG002|Overall Study|Lost to Follow-up|0|||
127769977|NCT00585195|459782765|FG003|Overall Study|Lost to Follow-up|0|||
127769978|NCT00585195|459782766|FG004|Overall Study|Lost to Follow-up|0|||
127769979|NCT00585195|459782767|FG005|Overall Study|Lost to Follow-up|0|||
127769980|NCT00585195|459782768|FG006|Overall Study|Lost to Follow-up|0|||
127769981|NCT00585195|459782769|FG007|Overall Study|Lost to Follow-up|0|||
127769982|NCT00585195|459782770|FG008|Overall Study|Lost to Follow-up|0|||
127769983|NCT00585195|459782771|FG009|Overall Study|Lost to Follow-up|0|||
127769984|NCT00585195|459782772|FG010|Overall Study|Lost to Follow-up|0|||
127769985|NCT00585195|459782773|FG011|Overall Study|Lost to Follow-up|0|||
127769986|NCT00585195|459782774|FG012|Overall Study|Lost to Follow-up|1|||
127769987|NCT00585195|459782775|FG013|Overall Study|Lost to Follow-up|0|||
127769988|NCT00585195|459782776|FG014|Overall Study|Lost to Follow-up|0|||
127769989|NCT00585195|459782777|FG015|Overall Study|Lost to Follow-up|0|||
127769990|NCT00585195|459782778|FG016|Overall Study|Lost to Follow-up|0|||
127769991|NCT00585195|459782779|FG017|Overall Study|Lost to Follow-up|2|||
127769992|NCT00585195|459782780|FG018|Overall Study|Lost to Follow-up|0|||
127769993|NCT00585195|459782781|FG019|Overall Study|Lost to Follow-up|0|||
127769994|NCT00585195|459782782|FG020|Overall Study|Lost to Follow-up|0|||
127769995|NCT00585195|459782762|FG000|Overall Study|Site Terminated by Sponsor|0|||
127769996|NCT00585195|459782763|FG001|Overall Study|Site Terminated by Sponsor|0|||
127769997|NCT00585195|459782764|FG002|Overall Study|Site Terminated by Sponsor|0|||
127769998|NCT00585195|459782765|FG003|Overall Study|Site Terminated by Sponsor|0|||
127769999|NCT00585195|459782766|FG004|Overall Study|Site Terminated by Sponsor|0|||
127770000|NCT00585195|459782767|FG005|Overall Study|Site Terminated by Sponsor|0|||
127770001|NCT00585195|459782768|FG006|Overall Study|Site Terminated by Sponsor|0|||
127770002|NCT00585195|459782769|FG007|Overall Study|Site Terminated by Sponsor|0|||
127770003|NCT00585195|459782770|FG008|Overall Study|Site Terminated by Sponsor|0|||
127770004|NCT00585195|459782771|FG009|Overall Study|Site Terminated by Sponsor|0|||
127770005|NCT00585195|459782772|FG010|Overall Study|Site Terminated by Sponsor|0|||
127770006|NCT00585195|459782773|FG011|Overall Study|Site Terminated by Sponsor|0|||
127770007|NCT00585195|459782774|FG012|Overall Study|Site Terminated by Sponsor|1|||
127770008|NCT00585195|459782775|FG013|Overall Study|Site Terminated by Sponsor|0|||
127770009|NCT00585195|459782776|FG014|Overall Study|Site Terminated by Sponsor|0|||
127770010|NCT00585195|459782777|FG015|Overall Study|Site Terminated by Sponsor|0|||
127770011|NCT00585195|459782778|FG016|Overall Study|Site Terminated by Sponsor|0|||
127770012|NCT00585195|459782779|FG017|Overall Study|Site Terminated by Sponsor|0|||
127770013|NCT00585195|459782780|FG018|Overall Study|Site Terminated by Sponsor|0|||
127770014|NCT00585195|459782781|FG019|Overall Study|Site Terminated by Sponsor|0|||
127770015|NCT00585195|459782782|FG020|Overall Study|Site Terminated by Sponsor|0|||
127770016|NCT00585195|459782762|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
127770017|NCT00585195|459782763|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
127770018|NCT00585195|459782764|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
127770019|NCT00585195|459782765|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
127770020|NCT00585195|459782766|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
127770021|NCT00585195|459782767|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
127770022|NCT00585195|459782768|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
127770023|NCT00585195|459782769|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
127770024|NCT00585195|459782770|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
127770025|NCT00585195|459782771|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
127770026|NCT00585195|459782772|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
127770027|NCT00585195|459782773|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
127770028|NCT00585195|459782774|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
127770029|NCT00585195|459782775|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
127770030|NCT00585195|459782776|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
127770031|NCT00585195|459782777|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
127770032|NCT00585195|459782778|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
127770033|NCT00585195|459782779|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
127770034|NCT00585195|459782780|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
127770035|NCT00585195|459782781|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
127770036|NCT00585195|459782782|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
127770037|NCT02796560|459782783|FG000|Overall Study|Adverse Event|2|||
127770038|NCT02796560|459782784|FG001|Overall Study|Adverse Event|0|||
127770039|NCT02796560|459782783|FG000|Overall Study|Withdrawal by Subject|2|||
127770040|NCT02796560|459782784|FG001|Overall Study|Withdrawal by Subject|2|||
127770041|NCT02533570|459782785|FG000|Overall Study|Adverse Event|0|||
127770042|NCT02533570|459782786|FG001|Overall Study|Adverse Event|1|||
127770043|NCT02533570|459782787|FG002|Overall Study|Adverse Event|1|||
127770044|NCT04002401|459782789|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|13|||
127770045|NCT04002401|459782789|FG000|Overall Study|Death|10|||
127770046|NCT04002401|459782789|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|2|||
127770047|NCT04002401|459782789|FG000|Overall Study|Enrolled but Never Treated|1|||
127770048|NCT04002401|459782789|FG000|Overall Study|Lost to Follow-up|1|||
127770049|NCT00423930|459782790|FG000|Overall Study|Withdrawal by Subject|2|||
127770050|NCT01009580|459782794|FG000|Overall Study|Adverse Event|4|||
127770051|NCT01009580|459782795|FG001|Overall Study|Adverse Event|4|||
127770052|NCT01009580|459782794|FG000|Overall Study|Lack of Efficacy|0|||
127770053|NCT01009580|459782795|FG001|Overall Study|Lack of Efficacy|1|||
127770054|NCT01009580|459782794|FG000|Overall Study|Protocol Violation|2|||
127770055|NCT01009580|459782795|FG001|Overall Study|Protocol Violation|3|||
127770056|NCT01009580|459782794|FG000|Overall Study|Withdrawal Criteria|4|||
127770057|NCT01009580|459782795|FG001|Overall Study|Withdrawal Criteria|6|||
127770058|NCT01009580|459782794|FG000|Overall Study|Unclassified|17|||
127770059|NCT01009580|459782795|FG001|Overall Study|Unclassified|21|||
127770060|NCT02881957|459782800|FG000|Overall Study|Comfort care|0|||
127770061|NCT02881957|459782801|FG001|Overall Study|Comfort care|1|||
127770062|NCT02881957|459782800|FG000|Overall Study|Concurrent trial enrollment|0|||
127770063|NCT02881957|459782801|FG001|Overall Study|Concurrent trial enrollment|1|||
127770064|NCT02881957|459782800|FG000|Overall Study|Discharged within 48 hours|0|||
127770065|NCT02881957|459782801|FG001|Overall Study|Discharged within 48 hours|1|||
127770066|NCT02881957|459782800|FG000|Overall Study|Withdrawal by Subject|2|||
127770067|NCT02881957|459782801|FG001|Overall Study|Withdrawal by Subject|1|||
127770068|NCT02881957|459782800|FG000|Overall Study|Protocol Violation|1|||
127770069|NCT02881957|459782801|FG001|Overall Study|Protocol Violation|0|||
127770070|NCT05269355|459782802|FG000|Overall Study|Progressive Disease|104|||
127770071|NCT05269355|459782803|FG001|Overall Study|Progressive Disease|68|||
127770072|NCT05269355|459782802|FG000|Overall Study|Study Terminated by Sponsor|87|||
127770073|NCT05269355|459782803|FG001|Overall Study|Study Terminated by Sponsor|29|||
127770074|NCT05269355|459782802|FG000|Overall Study|Adverse Event|15|||
127770075|NCT05269355|459782803|FG001|Overall Study|Adverse Event|8|||
127770076|NCT05269355|459782802|FG000|Overall Study|Withdrawal by Subject|18|||
127770077|NCT05269355|459782803|FG001|Overall Study|Withdrawal by Subject|5|||
127770078|NCT05269355|459782802|FG000|Overall Study|Physician Decision|6|||
127770079|NCT05269355|459782803|FG001|Overall Study|Physician Decision|4|||
127770080|NCT05269355|459782802|FG000|Overall Study|Death|3|||
127770081|NCT05269355|459782803|FG001|Overall Study|Death|5|||
127770082|NCT05269355|459782802|FG000|Overall Study|Other Than Specified|5|||
127770083|NCT05269355|459782803|FG001|Overall Study|Other Than Specified|1|||
127770084|NCT05269355|459782802|FG000|Overall Study|Randomized But Not Treated|1|||
127770085|NCT05269355|459782803|FG001|Overall Study|Randomized But Not Treated|0|||
127770086|NCT00081497|459782804|FG000|Overall Study|Adverse Event|2|||
127770087|NCT00081497|459782805|FG001|Overall Study|Adverse Event|0|||
127770088|NCT00081497|459782804|FG000|Overall Study|Death|0|||
127770089|NCT00081497|459782805|FG001|Overall Study|Death|1|||
127770090|NCT00081497|459782804|FG000|Overall Study|Withdrawal by Subject|1|||
127770091|NCT00081497|459782805|FG001|Overall Study|Withdrawal by Subject|0|||
127770092|NCT00081497|459782804|FG000|Overall Study|Non-compliance|0|||
127770093|NCT00081497|459782805|FG001|Overall Study|Non-compliance|1|||
127770094|NCT00345293|459782806|FG000|Overall Study|Unable to access line for sample|1|||
127770095|NCT00345293|459782807|FG001|Overall Study|Unable to access line for sample|0|||
127770096|NCT00345293|459782806|FG000|Overall Study|Withdrawal by Subject|1|||
127770097|NCT00345293|459782807|FG001|Overall Study|Withdrawal by Subject|0|||
127770098|NCT02390245|459782808|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
127770099|NCT02390245|459782809|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
127770100|NCT02390245|459782810|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
127770101|NCT02390245|459782808|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
127770102|NCT02390245|459782809|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
127770103|NCT02390245|459782810|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
127770104|NCT01328717|459784358|FG000|Overall Study|Adverse Event|1|||
127770105|NCT03440320|459784359|FG000|Overall Study|Withdrawal by Subject|0|||
127547170|NCT00906204|458974363|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
127547171|NCT00906204|458974362|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
127547172|NCT00906204|458974363|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
127683463|NCT02202499|459465427|FG001|Overall Study|Declined before randomization|0|||
127683464|NCT02202499|459465428|FG002|Overall Study|Declined before randomization|0|||
127683465|NCT02202499|459465426|FG000|Overall Study|Auto accident|1|||
127683466|NCT02202499|459465427|FG001|Overall Study|Auto accident|0|||
127683467|NCT02202499|459465428|FG002|Overall Study|Auto accident|0|||
127683468|NCT00535145|459465430|FG000|Phase I|Adverse Event|3|||
127683469|NCT00535145|459465430|FG000|Phase I|Lost to Follow-up|7|||
127683470|NCT00535145|459465430|FG000|Phase I|Withdrawal by Subject|6|||
127683471|NCT00535145|459465430|FG000|Phase I|(eligibility)|8|||
127683472|NCT00535145|459465430|FG000|Phase I|(protocol violation)|1|||
127683473|NCT00535145|459465430|FG000|Phase I|(PI decision)|1|||
127683474|NCT00535145|459465430|FG000|Phase I|(diagnosis)|3|||
127683475|NCT00535145|459465430|FG000|Phase II|Adverse Event|2|||
127683476|NCT00535145|459465430|FG000|Phase II|Lack of Efficacy|1|||
127683477|NCT00535145|459465430|FG000|Phase II|Lost to Follow-up|5|||
127683478|NCT00535145|459465430|FG000|Phase II|Withdrawal by Subject|5|||
127683479|NCT00535145|459465430|FG000|Phase II|Subject non-compliance|2|||
127683480|NCT03260140|459465431|FG000|Overall Study|Death|4|||
127683481|NCT03260140|459465432|FG001|Overall Study|Death|1|||
127683482|NCT03260140|459465431|FG000|Overall Study|Withdrawal by Subject|1|||
127683483|NCT03260140|459465432|FG001|Overall Study|Withdrawal by Subject|4|||
127683484|NCT00424645|459465434|FG000|Overall Study|Death|1|||
127683485|NCT00424645|459465435|FG001|Overall Study|Death|0|||
127683486|NCT00959946|459465438|FG000|Overall Study|Adverse Event|0|||
127683487|NCT00959946|459465439|FG001|Overall Study|Adverse Event|0|||
127683488|NCT00959946|459465440|FG002|Overall Study|Adverse Event|2|||
127683489|NCT00959946|459465441|FG003|Overall Study|Adverse Event|1|||
127683490|NCT00959946|459465442|FG004|Overall Study|Adverse Event|0|||
127683491|NCT00959946|459465443|FG005|Overall Study|Adverse Event|1|||
127683492|NCT00959946|459465444|FG006|Overall Study|Adverse Event|0|||
127683493|NCT00959946|459465445|FG007|Overall Study|Adverse Event|0|||
127683494|NCT00959946|459465438|FG000|Overall Study|Death|0|||
127683495|NCT00959946|459465439|FG001|Overall Study|Death|0|||
127683496|NCT00959946|459465440|FG002|Overall Study|Death|0|||
127683497|NCT00959946|459465441|FG003|Overall Study|Death|0|||
127683498|NCT00959946|459465442|FG004|Overall Study|Death|0|||
127683499|NCT00959946|459465443|FG005|Overall Study|Death|1|||
127683500|NCT00959946|459465444|FG006|Overall Study|Death|0|||
127683501|NCT00959946|459465445|FG007|Overall Study|Death|0|||
127683502|NCT00959946|459465438|FG000|Overall Study|Disease Progression|2|||
127683503|NCT00959946|459465439|FG001|Overall Study|Disease Progression|4|||
127683504|NCT00959946|459465440|FG002|Overall Study|Disease Progression|2|||
127683505|NCT00959946|459465441|FG003|Overall Study|Disease Progression|4|||
127683506|NCT00959946|459465442|FG004|Overall Study|Disease Progression|4|||
127683507|NCT00959946|459465443|FG005|Overall Study|Disease Progression|6|||
127683508|NCT00959946|459465444|FG006|Overall Study|Disease Progression|2|||
127683509|NCT00959946|459465445|FG007|Overall Study|Disease Progression|2|||
127683510|NCT00959946|459465438|FG000|Overall Study|Withdrawal by Subject|0|||
127683511|NCT00959946|459465439|FG001|Overall Study|Withdrawal by Subject|0|||
127683512|NCT00959946|459465440|FG002|Overall Study|Withdrawal by Subject|0|||
127683513|NCT00959946|459465441|FG003|Overall Study|Withdrawal by Subject|0|||
127683514|NCT00959946|459465442|FG004|Overall Study|Withdrawal by Subject|0|||
127770106|NCT03440320|459784360|FG001|Overall Study|Withdrawal by Subject|1|||
127770107|NCT04281004|459784371|FG000|Overall Study|Physician Decision|1|||
127770108|NCT04281004|459784372|FG001|Overall Study|Physician Decision|0|||
127683515|NCT00959946|459465443|FG005|Overall Study|Withdrawal by Subject|1|||
127683516|NCT00959946|459465444|FG006|Overall Study|Withdrawal by Subject|0|||
127683517|NCT00959946|459465445|FG007|Overall Study|Withdrawal by Subject|0|||
127683518|NCT00658996|459465448|FG000|First Intervention|Positive slit lamp finding|1|||
127683519|NCT00658996|459465449|FG001|First Intervention|Positive slit lamp finding|0|||
127683520|NCT00658996|459465448|FG000|First Intervention|Lack of lenses|0|||
127683521|NCT00658996|459465449|FG001|First Intervention|Lack of lenses|1|||
127770109|NCT03628898|459784373|FG000|Overall Study|Device deficiency|1|||
127770110|NCT01716117|459784376|FG000|Overall Study|Death|5|||
127770111|NCT01716117|459784377|FG001|Overall Study|Death|2|||
127770112|NCT01716117|459784376|FG000|Overall Study|Withdrawal by Subject|2|||
127770113|NCT01716117|459784377|FG001|Overall Study|Withdrawal by Subject|0|||
127770114|NCT00762970|459784381|FG000|Overall Study|Withdrawal by Subject|7|||
127770115|NCT00762970|459784382|FG001|Overall Study|Withdrawal by Subject|4|||
127770116|NCT00762970|459784383|FG002|Overall Study|Withdrawal by Subject|0|||
127770117|NCT00762970|459784381|FG000|Overall Study|Protocol Violation|3|||
127770118|NCT00762970|459784382|FG001|Overall Study|Protocol Violation|1|||
127770119|NCT00762970|459784383|FG002|Overall Study|Protocol Violation|1|||
127770120|NCT00762970|459784381|FG000|Overall Study|Lost to Follow-up|1|||
127770121|NCT00762970|459784382|FG001|Overall Study|Lost to Follow-up|2|||
127770122|NCT00762970|459784383|FG002|Overall Study|Lost to Follow-up|0|||
127770123|NCT00762970|459784381|FG000|Overall Study|Difficulty of handling lens|1|||
127770124|NCT00762970|459784382|FG001|Overall Study|Difficulty of handling lens|2|||
127770125|NCT00762970|459784383|FG002|Overall Study|Difficulty of handling lens|0|||
127770126|NCT01337115|459784387|FG000|Overall Study|Protocol Violation|2|||
127770127|NCT01337115|459784388|FG001|Overall Study|Protocol Violation|0|||
127770128|NCT00551460|459784394|FG000|Overall Study|Adverse Event|1|||
127770129|NCT00551460|459784394|FG000|Overall Study|Withdrawal by Subject|1|||
127770130|NCT00551460|459784394|FG000|Overall Study|Physician Decision|1|||
127770131|NCT00551460|459784394|FG000|Overall Study|Death|7|||
127770132|NCT00551460|459784394|FG000|Overall Study|Ineligible|4|||
127770133|NCT00551460|459784394|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
127770134|NCT00448123|459784395|FG000|Overall Study|Lost to Follow-up|9|||
127770135|NCT00448123|459784396|FG001|Overall Study|Lost to Follow-up|6|||
127770136|NCT00448123|459784395|FG000|Overall Study|Physician Decision|6|||
127770137|NCT00448123|459784396|FG001|Overall Study|Physician Decision|6|||
127770138|NCT02027623|459784398|FG000|Overall Study|Lost to Follow-up|3|||
127770139|NCT02027623|459784399|FG001|Overall Study|Lost to Follow-up|3|||
127770140|NCT02027623|459784398|FG000|Overall Study|Withdrawal by Subject|6|||
127770141|NCT02027623|459784399|FG001|Overall Study|Withdrawal by Subject|9|||
127770142|NCT00406653|459784403|FG000|Induction Period|Adverse Event|1|||
127770143|NCT00406653|459784404|FG001|Induction Period|Adverse Event|10|||
127770144|NCT00406653|459784405|FG002|Induction Period|Adverse Event|4|||
127770145|NCT00406653|459784406|FG003|Induction Period|Adverse Event|11|||
127770146|NCT00406653|459784407|FG004|Induction Period|Adverse Event|0|||
127770147|NCT00406653|459784408|FG005|Induction Period|Adverse Event|0|||
127770148|NCT00406653|459784409|FG006|Induction Period|Adverse Event|0|||
127770149|NCT00406653|459784403|FG000|Induction Period|Lack of Efficacy|11|||
127770150|NCT00406653|459784404|FG001|Induction Period|Lack of Efficacy|14|||
127770151|NCT00406653|459784405|FG002|Induction Period|Lack of Efficacy|8|||
127770152|NCT00406653|459784406|FG003|Induction Period|Lack of Efficacy|10|||
127770153|NCT00406653|459784407|FG004|Induction Period|Lack of Efficacy|0|||
127770154|NCT00406653|459784408|FG005|Induction Period|Lack of Efficacy|0|||
127770155|NCT00406653|459784409|FG006|Induction Period|Lack of Efficacy|0|||
127770156|NCT00406653|459784403|FG000|Induction Period|Lost to Follow-up|0|||
127770157|NCT00406653|459784404|FG001|Induction Period|Lost to Follow-up|2|||
127770158|NCT00406653|459784405|FG002|Induction Period|Lost to Follow-up|0|||
127770159|NCT00406653|459784406|FG003|Induction Period|Lost to Follow-up|0|||
127770160|NCT00406653|459784407|FG004|Induction Period|Lost to Follow-up|0|||
127770161|NCT00406653|459784408|FG005|Induction Period|Lost to Follow-up|0|||
127770162|NCT00406653|459784409|FG006|Induction Period|Lost to Follow-up|0|||
127880897|NCT00566631|460186057|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
127880898|NCT00566631|460186057|FG000|Part 2: Extension Phase|Death|1|||
127880899|NCT00566631|460186057|FG000|Part 2: Extension Phase|Other|5|||
127770163|NCT00406653|459784403|FG000|Induction Period|Withdrawal of Consent|2|||
127770164|NCT00406653|459784404|FG001|Induction Period|Withdrawal of Consent|5|||
127770165|NCT00406653|459784405|FG002|Induction Period|Withdrawal of Consent|1|||
127770166|NCT00406653|459784406|FG003|Induction Period|Withdrawal of Consent|2|||
127770167|NCT00406653|459784407|FG004|Induction Period|Withdrawal of Consent|0|||
127770168|NCT00406653|459784408|FG005|Induction Period|Withdrawal of Consent|0|||
127770169|NCT00406653|459784409|FG006|Induction Period|Withdrawal of Consent|0|||
127770170|NCT00406653|459784403|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
127770171|NCT00406653|459784404|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
127770172|NCT00406653|459784405|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
127770173|NCT00406653|459784406|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
127770174|NCT00406653|459784407|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
127770175|NCT00406653|459784408|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
127770176|NCT00406653|459784409|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
127770177|NCT00406653|459784403|FG000|Induction Period|Pregnancy|1|||
127770178|NCT00406653|459784404|FG001|Induction Period|Pregnancy|0|||
127770179|NCT00406653|459784405|FG002|Induction Period|Pregnancy|0|||
127770180|NCT00406653|459784406|FG003|Induction Period|Pregnancy|0|||
127770181|NCT00406653|459784407|FG004|Induction Period|Pregnancy|0|||
127770182|NCT00406653|459784408|FG005|Induction Period|Pregnancy|0|||
127770183|NCT00406653|459784409|FG006|Induction Period|Pregnancy|0|||
127770184|NCT00406653|459784403|FG000|Induction Period|Declined participation but followup done|0|||
127770185|NCT00406653|459784404|FG001|Induction Period|Declined participation but followup done|2|||
127770186|NCT00406653|459784405|FG002|Induction Period|Declined participation but followup done|1|||
127770187|NCT00406653|459784406|FG003|Induction Period|Declined participation but followup done|1|||
127770188|NCT00406653|459784407|FG004|Induction Period|Declined participation but followup done|0|||
127770189|NCT00406653|459784408|FG005|Induction Period|Declined participation but followup done|0|||
127770190|NCT00406653|459784409|FG006|Induction Period|Declined participation but followup done|0|||
127770191|NCT00406653|459784403|FG000|Induction Period|Given prohibited drug|0|||
127770192|NCT00406653|459784404|FG001|Induction Period|Given prohibited drug|1|||
127770193|NCT00406653|459784405|FG002|Induction Period|Given prohibited drug|2|||
127770194|NCT00406653|459784406|FG003|Induction Period|Given prohibited drug|0|||
127770195|NCT00406653|459784407|FG004|Induction Period|Given prohibited drug|0|||
127770196|NCT00406653|459784408|FG005|Induction Period|Given prohibited drug|0|||
127770197|NCT00406653|459784409|FG006|Induction Period|Given prohibited drug|0|||
127770198|NCT00406653|459784403|FG000|Induction Period|Incarcerated|0|||
127770199|NCT00406653|459784404|FG001|Induction Period|Incarcerated|0|||
127770200|NCT00406653|459784405|FG002|Induction Period|Incarcerated|1|||
127770201|NCT00406653|459784406|FG003|Induction Period|Incarcerated|0|||
127770202|NCT00406653|459784407|FG004|Induction Period|Incarcerated|0|||
127770203|NCT00406653|459784408|FG005|Induction Period|Incarcerated|0|||
127770204|NCT00406653|459784409|FG006|Induction Period|Incarcerated|0|||
127770205|NCT00406653|459784403|FG000|Induction Period|Patient relocated|0|||
127770206|NCT00406653|459784404|FG001|Induction Period|Patient relocated|0|||
127770207|NCT00406653|459784405|FG002|Induction Period|Patient relocated|1|||
127770208|NCT00406653|459784406|FG003|Induction Period|Patient relocated|0|||
127770209|NCT00406653|459784407|FG004|Induction Period|Patient relocated|0|||
127770210|NCT00406653|459784408|FG005|Induction Period|Patient relocated|0|||
127770211|NCT00406653|459784409|FG006|Induction Period|Patient relocated|0|||
127770212|NCT00406653|459784403|FG000|Maintenance Period|Adverse Event|0|||
127770213|NCT00406653|459784404|FG001|Maintenance Period|Adverse Event|0|||
127770214|NCT00406653|459784405|FG002|Maintenance Period|Adverse Event|0|||
127770215|NCT00406653|459784406|FG003|Maintenance Period|Adverse Event|0|||
127770216|NCT00406653|459784407|FG004|Maintenance Period|Adverse Event|1|||
127770217|NCT00406653|459784408|FG005|Maintenance Period|Adverse Event|1|||
127770218|NCT00406653|459784409|FG006|Maintenance Period|Adverse Event|0|||
127770219|NCT00406653|459784403|FG000|Maintenance Period|Lack of Efficacy|0|||
127770220|NCT00406653|459784404|FG001|Maintenance Period|Lack of Efficacy|0|||
127770221|NCT00406653|459784405|FG002|Maintenance Period|Lack of Efficacy|0|||
127770222|NCT00406653|459784406|FG003|Maintenance Period|Lack of Efficacy|0|||
127770223|NCT00406653|459784407|FG004|Maintenance Period|Lack of Efficacy|20|||
127770224|NCT00406653|459784408|FG005|Maintenance Period|Lack of Efficacy|26|||
127770225|NCT00406653|459784409|FG006|Maintenance Period|Lack of Efficacy|0|||
127770226|NCT00406653|459784403|FG000|Maintenance Period|Lost to Follow-up|0|||
127770227|NCT00406653|459784404|FG001|Maintenance Period|Lost to Follow-up|0|||
127770228|NCT00406653|459784405|FG002|Maintenance Period|Lost to Follow-up|0|||
127770229|NCT00406653|459784406|FG003|Maintenance Period|Lost to Follow-up|0|||
127770230|NCT00406653|459784407|FG004|Maintenance Period|Lost to Follow-up|2|||
127770231|NCT00406653|459784408|FG005|Maintenance Period|Lost to Follow-up|1|||
127770232|NCT00406653|459784409|FG006|Maintenance Period|Lost to Follow-up|0|||
127770233|NCT00406653|459784403|FG000|Maintenance Period|Withdrawal of Consent|0|||
127770234|NCT00406653|459784404|FG001|Maintenance Period|Withdrawal of Consent|0|||
127770235|NCT00406653|459784405|FG002|Maintenance Period|Withdrawal of Consent|0|||
127770236|NCT00406653|459784406|FG003|Maintenance Period|Withdrawal of Consent|0|||
127770237|NCT00406653|459784407|FG004|Maintenance Period|Withdrawal of Consent|2|||
127770238|NCT00406653|459784408|FG005|Maintenance Period|Withdrawal of Consent|0|||
127770239|NCT00406653|459784409|FG006|Maintenance Period|Withdrawal of Consent|0|||
127770240|NCT00406653|459784403|FG000|Maintenance Period|Pregnancy|0|||
127770241|NCT00406653|459784404|FG001|Maintenance Period|Pregnancy|0|||
127770242|NCT00406653|459784405|FG002|Maintenance Period|Pregnancy|0|||
127770243|NCT00406653|459784406|FG003|Maintenance Period|Pregnancy|0|||
127770244|NCT00406653|459784407|FG004|Maintenance Period|Pregnancy|0|||
127770245|NCT00406653|459784408|FG005|Maintenance Period|Pregnancy|1|||
127770246|NCT00406653|459784409|FG006|Maintenance Period|Pregnancy|0|||
127770247|NCT00406653|459784403|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
127770248|NCT00406653|459784404|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
127770249|NCT00406653|459784405|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
127770250|NCT00406653|459784406|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
127770251|NCT00406653|459784407|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
127770252|NCT00406653|459784408|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
127770253|NCT00406653|459784409|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
127770254|NCT00406653|459784403|FG000|Maintenance Period|Error in disease score evaluation|0|||
127770255|NCT00406653|459784404|FG001|Maintenance Period|Error in disease score evaluation|0|||
127770256|NCT00406653|459784405|FG002|Maintenance Period|Error in disease score evaluation|0|||
127770257|NCT00406653|459784406|FG003|Maintenance Period|Error in disease score evaluation|0|||
127770258|NCT00406653|459784407|FG004|Maintenance Period|Error in disease score evaluation|1|||
127770259|NCT00406653|459784408|FG005|Maintenance Period|Error in disease score evaluation|0|||
127770260|NCT00406653|459784409|FG006|Maintenance Period|Error in disease score evaluation|0|||
127770261|NCT00406653|459784403|FG000|Open-Label Period|Death|0|||
127770262|NCT00406653|459784404|FG001|Open-Label Period|Death|0|||
127770263|NCT00406653|459784405|FG002|Open-Label Period|Death|0|||
127770264|NCT00406653|459784406|FG003|Open-Label Period|Death|0|||
127770265|NCT00406653|459784407|FG004|Open-Label Period|Death|0|||
127770266|NCT00406653|459784408|FG005|Open-Label Period|Death|0|||
127770267|NCT00406653|459784409|FG006|Open-Label Period|Death|1|||
127770268|NCT00406653|459784403|FG000|Open-Label Period|Adverse Event|0|||
127770269|NCT00406653|459784404|FG001|Open-Label Period|Adverse Event|0|||
127770270|NCT00406653|459784405|FG002|Open-Label Period|Adverse Event|0|||
127770271|NCT00406653|459784406|FG003|Open-Label Period|Adverse Event|0|||
127770272|NCT00406653|459784407|FG004|Open-Label Period|Adverse Event|0|||
127770273|NCT00406653|459784408|FG005|Open-Label Period|Adverse Event|0|||
127770274|NCT00406653|459784409|FG006|Open-Label Period|Adverse Event|18|||
127770275|NCT00406653|459784403|FG000|Open-Label Period|Lack of Efficacy|0|||
127770276|NCT00406653|459784404|FG001|Open-Label Period|Lack of Efficacy|0|||
127770277|NCT00406653|459784405|FG002|Open-Label Period|Lack of Efficacy|0|||
127770278|NCT00406653|459784406|FG003|Open-Label Period|Lack of Efficacy|0|||
127770279|NCT00406653|459784407|FG004|Open-Label Period|Lack of Efficacy|0|||
127770280|NCT00406653|459784408|FG005|Open-Label Period|Lack of Efficacy|0|||
127770281|NCT00406653|459784409|FG006|Open-Label Period|Lack of Efficacy|160|||
127770282|NCT00406653|459784403|FG000|Open-Label Period|Lost to Follow-up|0|||
127770283|NCT00406653|459784404|FG001|Open-Label Period|Lost to Follow-up|0|||
127770284|NCT00406653|459784405|FG002|Open-Label Period|Lost to Follow-up|0|||
127770285|NCT00406653|459784406|FG003|Open-Label Period|Lost to Follow-up|0|||
127770286|NCT00406653|459784407|FG004|Open-Label Period|Lost to Follow-up|0|||
127770287|NCT00406653|459784408|FG005|Open-Label Period|Lost to Follow-up|0|||
127770288|NCT00406653|459784409|FG006|Open-Label Period|Lost to Follow-up|6|||
127770289|NCT00406653|459784403|FG000|Open-Label Period|Withdrawal of Consent|0|||
127770290|NCT00406653|459784404|FG001|Open-Label Period|Withdrawal of Consent|0|||
127770291|NCT00406653|459784405|FG002|Open-Label Period|Withdrawal of Consent|0|||
127770292|NCT00406653|459784406|FG003|Open-Label Period|Withdrawal of Consent|0|||
127770293|NCT00406653|459784407|FG004|Open-Label Period|Withdrawal of Consent|0|||
127770294|NCT00406653|459784408|FG005|Open-Label Period|Withdrawal of Consent|0|||
127770295|NCT00406653|459784409|FG006|Open-Label Period|Withdrawal of Consent|11|||
127770296|NCT00406653|459784403|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
127770297|NCT00406653|459784404|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
127770298|NCT00406653|459784405|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
127770299|NCT00406653|459784406|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
127770300|NCT00406653|459784407|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
127770301|NCT00406653|459784408|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
127770302|NCT00406653|459784409|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
127770303|NCT00406653|459784403|FG000|Open-Label Period|Pregnancy|0|||
127770304|NCT00406653|459784404|FG001|Open-Label Period|Pregnancy|0|||
127770305|NCT00406653|459784405|FG002|Open-Label Period|Pregnancy|0|||
127770306|NCT00406653|459784406|FG003|Open-Label Period|Pregnancy|0|||
127770307|NCT00406653|459784407|FG004|Open-Label Period|Pregnancy|0|||
127770308|NCT00406653|459784408|FG005|Open-Label Period|Pregnancy|0|||
127770309|NCT00406653|459784409|FG006|Open-Label Period|Pregnancy|2|||
127770310|NCT00406653|459784403|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
127770311|NCT00406653|459784404|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
127770312|NCT00406653|459784405|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
127770313|NCT00406653|459784406|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
127770314|NCT00406653|459784407|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
127770315|NCT00406653|459784408|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
127770316|NCT00406653|459784409|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
127770317|NCT00406653|459784403|FG000|Open-Label Period|Declined participation but followup done|0|||
127770318|NCT00406653|459784404|FG001|Open-Label Period|Declined participation but followup done|0|||
127770319|NCT00406653|459784405|FG002|Open-Label Period|Declined participation but followup done|0|||
127770320|NCT00406653|459784406|FG003|Open-Label Period|Declined participation but followup done|0|||
127770321|NCT00406653|459784407|FG004|Open-Label Period|Declined participation but followup done|0|||
127770322|NCT00406653|459784408|FG005|Open-Label Period|Declined participation but followup done|0|||
127770323|NCT00406653|459784409|FG006|Open-Label Period|Declined participation but followup done|8|||
127770324|NCT00406653|459784403|FG000|Open-Label Period|Discontinued by Sponsor|0|||
127770325|NCT00406653|459784404|FG001|Open-Label Period|Discontinued by Sponsor|0|||
127770326|NCT00406653|459784405|FG002|Open-Label Period|Discontinued by Sponsor|0|||
127770327|NCT00406653|459784406|FG003|Open-Label Period|Discontinued by Sponsor|0|||
127770328|NCT00406653|459784407|FG004|Open-Label Period|Discontinued by Sponsor|0|||
127770329|NCT00406653|459784408|FG005|Open-Label Period|Discontinued by Sponsor|0|||
127770330|NCT00406653|459784409|FG006|Open-Label Period|Discontinued by Sponsor|1|||
127770331|NCT00406653|459784403|FG000|Open-Label Period|Refused followup|0|||
127880900|NCT03387735|460186058|FG000|Overall Study|Lost to Follow-up|4|||
127880901|NCT03387735|460186059|FG001|Overall Study|Lost to Follow-up|8|||
127770332|NCT00406653|459784404|FG001|Open-Label Period|Refused followup|0|||
127770333|NCT00406653|459784405|FG002|Open-Label Period|Refused followup|0|||
127770334|NCT00406653|459784406|FG003|Open-Label Period|Refused followup|0|||
127770335|NCT00406653|459784407|FG004|Open-Label Period|Refused followup|0|||
127770336|NCT00406653|459784408|FG005|Open-Label Period|Refused followup|0|||
127770337|NCT00406653|459784409|FG006|Open-Label Period|Refused followup|1|||
127770338|NCT00818649|459784410|FG000|Overall Study|Declining performance status|2|||
127770339|NCT00818649|459784410|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
127770340|NCT00818649|459784410|FG000|Overall Study|Adverse Event|1|||
127770341|NCT03513588|459784411|FG000|Overall Study|Lost to Follow-up|0|||
127770342|NCT03513588|459784412|FG001|Overall Study|Lost to Follow-up|1|||
127770343|NCT03513588|459784413|FG002|Overall Study|Lost to Follow-up|1|||
127770344|NCT03513588|459784411|FG000|Overall Study|Study dosing paused by sponsor|1|||
127770345|NCT03513588|459784412|FG001|Overall Study|Study dosing paused by sponsor|1|||
127770346|NCT03513588|459784413|FG002|Overall Study|Study dosing paused by sponsor|0|||
127770347|NCT03513588|459784411|FG000|Overall Study|Death|0|||
127770348|NCT03513588|459784412|FG001|Overall Study|Death|0|||
127770349|NCT03513588|459784413|FG002|Overall Study|Death|1|||
127770350|NCT00940108|459784417|FG000|Overall Study|Adverse Event|2|||
127770351|NCT00940108|459784418|FG001|Overall Study|Adverse Event|4|||
127770352|NCT00940108|459784419|FG002|Overall Study|Adverse Event|0|||
127770353|NCT00940108|459784420|FG003|Overall Study|Adverse Event|2|||
127770354|NCT00940108|459784417|FG000|Overall Study|Withdrew Consent|2|||
127770355|NCT00940108|459784418|FG001|Overall Study|Withdrew Consent|1|||
127770356|NCT00940108|459784419|FG002|Overall Study|Withdrew Consent|0|||
127770357|NCT00940108|459784420|FG003|Overall Study|Withdrew Consent|1|||
127770358|NCT00940108|459784417|FG000|Overall Study|Dose 2 contraindicated|1|||
127770359|NCT00940108|459784418|FG001|Overall Study|Dose 2 contraindicated|1|||
127770360|NCT00940108|459784419|FG002|Overall Study|Dose 2 contraindicated|0|||
127770361|NCT00940108|459784420|FG003|Overall Study|Dose 2 contraindicated|1|||
127770362|NCT00940108|459784417|FG000|Overall Study|Declined further vaccination|0|||
127770363|NCT00940108|459784418|FG001|Overall Study|Declined further vaccination|1|||
127770364|NCT00940108|459784419|FG002|Overall Study|Declined further vaccination|3|||
127770365|NCT00940108|459784420|FG003|Overall Study|Declined further vaccination|0|||
127770366|NCT00940108|459784417|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
127770367|NCT00940108|459784418|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
127770368|NCT00940108|459784419|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
127770369|NCT00940108|459784420|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
127770370|NCT00940108|459784417|FG000|Overall Study|Viral illness after Dose 1|0|||
127770371|NCT00940108|459784418|FG001|Overall Study|Viral illness after Dose 1|1|||
127770372|NCT00940108|459784419|FG002|Overall Study|Viral illness after Dose 1|0|||
127770373|NCT00940108|459784420|FG003|Overall Study|Viral illness after Dose 1|0|||
127770374|NCT00940108|459784417|FG000|Overall Study|Diagnosed with H1N1|0|||
127770375|NCT00940108|459784418|FG001|Overall Study|Diagnosed with H1N1|0|||
127770376|NCT00940108|459784419|FG002|Overall Study|Diagnosed with H1N1|0|||
127770377|NCT00940108|459784420|FG003|Overall Study|Diagnosed with H1N1|1|||
127770378|NCT02075541|459784421|FG000|Overall Study|Serious Adverse Event|1|||
127770379|NCT02075541|459784422|FG001|Overall Study|Serious Adverse Event|4|||
127770380|NCT02075541|459784421|FG000|Overall Study|Protocol Violation|1|||
127770381|NCT02075541|459784422|FG001|Overall Study|Protocol Violation|0|||
127770382|NCT02075541|459784421|FG000|Overall Study|Withdrawal by Subject|1|||
127770383|NCT02075541|459784422|FG001|Overall Study|Withdrawal by Subject|3|||
127770384|NCT02075541|459784421|FG000|Overall Study|Sponsor study termination|0|||
127770385|NCT02075541|459784422|FG001|Overall Study|Sponsor study termination|1|||
127770386|NCT02075541|459784421|FG000|Overall Study|Other- unable to perform study procedure|1|||
127770387|NCT02075541|459784422|FG001|Overall Study|Other- unable to perform study procedure|0|||
127770388|NCT01142596|459784424|FG000|Overall Study|Withdrawal by Subject|9|||
127770389|NCT01142596|459784425|FG001|Overall Study|Withdrawal by Subject|35|||
127770390|NCT01142596|459784424|FG000|Overall Study|Adverse Event|8|||
127770391|NCT01142596|459784425|FG001|Overall Study|Adverse Event|35|||
127770392|NCT01142596|459784424|FG000|Overall Study|Lack of Efficacy|5|||
127770393|NCT01142596|459784425|FG001|Overall Study|Lack of Efficacy|9|||
127770394|NCT01142596|459784424|FG000|Overall Study|Lost to Follow-up|2|||
127770395|NCT01142596|459784425|FG001|Overall Study|Lost to Follow-up|3|||
127770396|NCT01142596|459784424|FG000|Overall Study|Other reason (not specified)|5|||
127770397|NCT01142596|459784425|FG001|Overall Study|Other reason (not specified)|4|||
127547173|NCT00906204|458974362|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
127770398|NCT01054846|459784426|FG000|Overall Study|Lost to Follow-up|76|||
127770399|NCT01054846|459784427|FG001|Overall Study|Lost to Follow-up|17|||
127770400|NCT02446886|459784428|FG000|Overall Study|Adverse Event|1|||
127770401|NCT02446886|459784429|FG001|Overall Study|Adverse Event|3|||
127770402|NCT02446886|459784428|FG000|Overall Study|Withdrawal by Subject|1|||
127770403|NCT02446886|459784429|FG001|Overall Study|Withdrawal by Subject|1|||
127770404|NCT00928447|459784430|FG000|Overall Study|Withdrawal by Subject|1|||
127770405|NCT00928447|459784430|FG000|Overall Study|Investigator's decision|1|||
127770406|NCT01259284|459784431|FG000|Overall Study|Study Termination|2|||
127770407|NCT01259284|459784432|FG001|Overall Study|Study Termination|0|||
127770408|NCT01259284|459784433|FG002|Overall Study|Study Termination|0|||
127770409|NCT01971203|459784434|FG000|Overall Study|Protocol Violation|3|||
127770410|NCT01971203|459784435|FG001|Overall Study|Protocol Violation|2|||
127770411|NCT01971203|459784434|FG000|Overall Study|Withdrawal by Subject|5|||
127770412|NCT01971203|459784435|FG001|Overall Study|Withdrawal by Subject|6|||
127770413|NCT01971203|459784434|FG000|Overall Study|Adverse Event|1|||
127770414|NCT01971203|459784435|FG001|Overall Study|Adverse Event|0|||
127770415|NCT00807235|459784436|FG000|Overall Study|Adverse Event|1|||
127770416|NCT00807235|459784437|FG001|Overall Study|Adverse Event|0|||
127770417|NCT01765179|459784438|FG000|Overall Study|Adverse Event|3|||
127770418|NCT01765179|459784438|FG000|Overall Study|Lost to Follow-up|5|||
127770419|NCT01765179|459784438|FG000|Overall Study|Non-compliance with study drug|2|||
127770420|NCT01765179|459784438|FG000|Overall Study|Protocol Violation|1|||
127547174|NCT00906204|458974363|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
127547175|NCT00906204|458974362|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
127547176|NCT00906204|458974363|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
127547177|NCT01597596|458974364|FG000|Overall Study|Study terminated by sponsor|1|||
127547178|NCT01597596|458974365|FG001|Overall Study|Study terminated by sponsor|0|||
127547179|NCT01597596|458974364|FG000|Overall Study|Physician Decision|0|||
127547180|NCT01597596|458974365|FG001|Overall Study|Physician Decision|1|||
127547181|NCT01389596|458974366|FG000|Overall Study|Protocol Violation|3|||
127547182|NCT01389596|458974367|FG001|Overall Study|Protocol Violation|4|||
127547183|NCT01389596|458974368|FG002|Overall Study|Protocol Violation|3|||
127547184|NCT01389596|458974366|FG000|Overall Study|Withdrawal by Subject|1|||
127547185|NCT01389596|458974367|FG001|Overall Study|Withdrawal by Subject|2|||
127547186|NCT01389596|458974368|FG002|Overall Study|Withdrawal by Subject|2|||
127547187|NCT01389596|458974366|FG000|Overall Study|Insufficient Clinical Response|3|||
127547188|NCT01389596|458974367|FG001|Overall Study|Insufficient Clinical Response|4|||
127547189|NCT01389596|458974368|FG002|Overall Study|Insufficient Clinical Response|5|||
127547190|NCT01389596|458974366|FG000|Overall Study|Adverse Event|1|||
127547191|NCT01389596|458974367|FG001|Overall Study|Adverse Event|4|||
127547192|NCT01389596|458974368|FG002|Overall Study|Adverse Event|0|||
127547193|NCT01389596|458974366|FG000|Overall Study|Death|0|||
127547194|NCT01389596|458974367|FG001|Overall Study|Death|1|||
127547195|NCT01389596|458974368|FG002|Overall Study|Death|0|||
127547196|NCT01389596|458974366|FG000|Overall Study|Other Unspecified|2|||
127547197|NCT01389596|458974367|FG001|Overall Study|Other Unspecified|1|||
127547198|NCT01389596|458974368|FG002|Overall Study|Other Unspecified|0|||
127547199|NCT01124006|458974372|FG000|Overall Study|Withdrawal by Subject|2|||
127547200|NCT01124006|458974373|FG001|Overall Study|Withdrawal by Subject|2|||
127547201|NCT01124006|458974374|FG002|Overall Study|Withdrawal by Subject|0|||
127547202|NCT01124006|458974372|FG000|Overall Study|Lost to Follow-up|1|||
127547203|NCT01124006|458974373|FG001|Overall Study|Lost to Follow-up|0|||
127547204|NCT01124006|458974374|FG002|Overall Study|Lost to Follow-up|1|||
127547205|NCT01124006|458974372|FG000|Overall Study|Other|0|||
127547206|NCT01124006|458974373|FG001|Overall Study|Other|0|||
127547207|NCT01124006|458974374|FG002|Overall Study|Other|1|||
127547208|NCT01803607|458974380|FG000|Overall Study|Adverse Event|5|||
127547209|NCT01803607|458974381|FG001|Overall Study|Adverse Event|3|||
127547210|NCT01803607|458974380|FG000|Overall Study|Lack of Efficacy|0|||
127547211|NCT01803607|458974381|FG001|Overall Study|Lack of Efficacy|1|||
127547212|NCT01803607|458974380|FG000|Overall Study|Protocol Violation|3|||
127547213|NCT01803607|458974381|FG001|Overall Study|Protocol Violation|2|||
127547214|NCT01803607|458974380|FG000|Overall Study|Study terminated by sponsor|54|||
127547215|NCT01803607|458974381|FG001|Overall Study|Study terminated by sponsor|56|||
127547216|NCT01803607|458974380|FG000|Overall Study|Withdrawal by Subject|6|||
127547217|NCT01803607|458974381|FG001|Overall Study|Withdrawal by Subject|5|||
127547218|NCT01281124|458974387|FG000|Overall Study|Death|1|||
127547219|NCT03038100|458974388|FG000|Overall Study|Death|289|||
127547220|NCT03038100|458974389|FG001|Overall Study|Death|272|||
127547221|NCT03038100|458974388|FG000|Overall Study|Lost to Follow-up|9|||
127770421|NCT01765179|459784438|FG000|Overall Study|Withdrawal by Subject|8|||
127770422|NCT01765179|459784438|FG000|Overall Study|Hematocrit >54%|3|||
127770423|NCT01765179|459784438|FG000|Overall Study|prohibited med|1|||
127547222|NCT03038100|458974389|FG001|Overall Study|Lost to Follow-up|10|||
127770424|NCT01765179|459784438|FG000|Overall Study|Out of country unable to finish study|1|||
127547223|NCT03038100|458974388|FG000|Overall Study|Protocol Deviation|1|||
127547224|NCT03038100|458974389|FG001|Overall Study|Protocol Deviation|4|||
127547225|NCT03038100|458974388|FG000|Overall Study|Withdrawal by Subject|45|||
127547226|NCT03038100|458974389|FG001|Overall Study|Withdrawal by Subject|51|||
127547227|NCT03038100|458974388|FG000|Overall Study|Study Terminated By Sponsor|305|||
127547228|NCT03038100|458974389|FG001|Overall Study|Study Terminated By Sponsor|311|||
127547229|NCT03038100|458974388|FG000|Overall Study|Physician Decision|1|||
127547230|NCT03038100|458974389|FG001|Overall Study|Physician Decision|3|||
127547231|NCT02392624|458974390|FG000|Overall Study|Withdrawal by Subject|15|||
127770425|NCT01765179|459784438|FG000|Overall Study|lack of venous access|1|||
127770426|NCT01765179|459784438|FG000|Overall Study|work conflict|1|||
127770427|NCT01765179|459784438|FG000|Overall Study|Ca elevated 10.6|1|||
127547232|NCT02392624|458974391|FG001|Overall Study|Withdrawal by Subject|12|||
127547233|NCT02392624|458974392|FG002|Overall Study|Withdrawal by Subject|9|||
127547234|NCT02392624|458974390|FG000|Overall Study|Adverse Event|4|||
127547235|NCT02392624|458974391|FG001|Overall Study|Adverse Event|1|||
127547236|NCT02392624|458974392|FG002|Overall Study|Adverse Event|2|||
127547237|NCT02392624|458974390|FG000|Overall Study|Pregnancy|1|||
127547238|NCT02392624|458974391|FG001|Overall Study|Pregnancy|0|||
127547239|NCT02392624|458974392|FG002|Overall Study|Pregnancy|0|||
127547240|NCT02392624|458974390|FG000|Overall Study|Protocol Violation|0|||
127547241|NCT02392624|458974391|FG001|Overall Study|Protocol Violation|0|||
127547242|NCT02392624|458974392|FG002|Overall Study|Protocol Violation|1|||
127547243|NCT02392624|458974390|FG000|Overall Study|Sponsor/Investigator Decision|2|||
127547244|NCT02392624|458974391|FG001|Overall Study|Sponsor/Investigator Decision|1|||
127547245|NCT02392624|458974392|FG002|Overall Study|Sponsor/Investigator Decision|0|||
127547246|NCT02392624|458974390|FG000|Overall Study|Other|49|||
127547247|NCT02392624|458974391|FG001|Overall Study|Other|1|||
127547248|NCT02392624|458974392|FG002|Overall Study|Other|1|||
127547249|NCT00706238|458974393|FG000|Overall Study|Disease progression|4|||
127547250|NCT00706238|458974393|FG000|Overall Study|Other|1|||
127547251|NCT03841604|458974398|FG000|Overall Study|Withdrawal by Subject|3|||
127547252|NCT03841604|458974399|FG001|Overall Study|Withdrawal by Subject|1|||
127547253|NCT03841604|458974398|FG000|Overall Study|Adverse Event|4|||
127547254|NCT03841604|458974399|FG001|Overall Study|Adverse Event|2|||
127547255|NCT03841604|458974398|FG000|Overall Study|Physician Decision|1|||
127547256|NCT03841604|458974399|FG001|Overall Study|Physician Decision|0|||
127547257|NCT03877510|458974402|FG000|Overall Study|Death|6|||
127547258|NCT03877510|458974402|FG000|Overall Study|Lost to Follow-up|2|||
127547259|NCT03877510|458974402|FG000|Overall Study|Non-compliance with study drug|2|||
127547260|NCT03877510|458974402|FG000|Overall Study|Lack of Efficacy|14|||
127547261|NCT03877510|458974402|FG000|Overall Study|Adverse Event|20|||
127547262|NCT03877510|458974402|FG000|Overall Study|Withdrawal by Subject|22|||
127547263|NCT03877510|458974402|FG000|Overall Study|Miscellaneous|1|||
127547264|NCT01417377|458974403|FG000|Overall Study|Lost to Follow-up|12|||
127547265|NCT01417377|458974403|FG000|Overall Study|Enrolled, but not treated|1|||
127547266|NCT02113982|458974404|FG000|Stage 1: Dose Escalation|Adverse Event|0|||
127547267|NCT02113982|458974405|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
127547268|NCT02113982|458974406|FG002|Stage 1: Dose Escalation|Adverse Event|2|||
127547269|NCT02113982|458974407|FG003|Stage 1: Dose Escalation|Adverse Event|4|||
127547270|NCT02113982|458974408|FG004|Stage 1: Dose Escalation|Adverse Event|1|||
127547271|NCT02113982|458974409|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
127547272|NCT02113982|458974410|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
127547273|NCT02113982|458974411|FG007|Stage 1: Dose Escalation|Adverse Event|0|||
127547274|NCT02113982|458974412|FG008|Stage 1: Dose Escalation|Adverse Event|0|||
127547275|NCT02113982|458974413|FG009|Stage 1: Dose Escalation|Adverse Event|0|||
127547276|NCT02113982|458974414|FG010|Stage 1: Dose Escalation|Adverse Event|0|||
127547277|NCT02113982|458974415|FG011|Stage 1: Dose Escalation|Adverse Event|0|||
127547278|NCT02113982|458974416|FG012|Stage 1: Dose Escalation|Adverse Event|0|||
127547279|NCT02113982|458974417|FG013|Stage 1: Dose Escalation|Adverse Event|0|||
127547280|NCT02113982|458974404|FG000|Stage 1: Dose Escalation|Progressive Disease|3|||
127547281|NCT02113982|458974405|FG001|Stage 1: Dose Escalation|Progressive Disease|1|||
127547282|NCT02113982|458974406|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
127547283|NCT02113982|458974407|FG003|Stage 1: Dose Escalation|Progressive Disease|2|||
127547284|NCT02113982|458974408|FG004|Stage 1: Dose Escalation|Progressive Disease|2|||
127547285|NCT02113982|458974409|FG005|Stage 1: Dose Escalation|Progressive Disease|1|||
127547286|NCT02113982|458974410|FG006|Stage 1: Dose Escalation|Progressive Disease|2|||
127547287|NCT02113982|458974411|FG007|Stage 1: Dose Escalation|Progressive Disease|0|||
127547288|NCT02113982|458974412|FG008|Stage 1: Dose Escalation|Progressive Disease|0|||
127547289|NCT02113982|458974413|FG009|Stage 1: Dose Escalation|Progressive Disease|0|||
127547290|NCT02113982|458974414|FG010|Stage 1: Dose Escalation|Progressive Disease|0|||
127547291|NCT02113982|458974415|FG011|Stage 1: Dose Escalation|Progressive Disease|0|||
127547292|NCT02113982|458974416|FG012|Stage 1: Dose Escalation|Progressive Disease|0|||
127547293|NCT02113982|458974417|FG013|Stage 1: Dose Escalation|Progressive Disease|0|||
127547294|NCT02113982|458974404|FG000|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
127547295|NCT02113982|458974405|FG001|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
127547296|NCT02113982|458974406|FG002|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
127547297|NCT02113982|458974407|FG003|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
127547298|NCT02113982|458974408|FG004|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
127547299|NCT02113982|458974409|FG005|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
127547300|NCT02113982|458974410|FG006|Stage 1: Dose Escalation|Withdrawal by Subject|1|||
127547301|NCT02113982|458974411|FG007|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
127547302|NCT02113982|458974412|FG008|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
127547303|NCT02113982|458974413|FG009|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
127770428|NCT02988622|459784439|FG000|Overall Study|Lost to Follow-up|17|||
127547304|NCT02113982|458974414|FG010|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
127547305|NCT02113982|458974415|FG011|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
127547306|NCT02113982|458974416|FG012|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
127547307|NCT02113982|458974417|FG013|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
127547308|NCT02113982|458974404|FG000|Stage 1: Dose Escalation|Transplant|0|||
127547309|NCT02113982|458974405|FG001|Stage 1: Dose Escalation|Transplant|1|||
127547310|NCT02113982|458974406|FG002|Stage 1: Dose Escalation|Transplant|0|||
127547311|NCT02113982|458974407|FG003|Stage 1: Dose Escalation|Transplant|0|||
127547312|NCT02113982|458974408|FG004|Stage 1: Dose Escalation|Transplant|0|||
127547313|NCT02113982|458974409|FG005|Stage 1: Dose Escalation|Transplant|1|||
127547314|NCT02113982|458974410|FG006|Stage 1: Dose Escalation|Transplant|0|||
127547315|NCT02113982|458974411|FG007|Stage 1: Dose Escalation|Transplant|0|||
127547316|NCT02113982|458974412|FG008|Stage 1: Dose Escalation|Transplant|0|||
127547317|NCT02113982|458974413|FG009|Stage 1: Dose Escalation|Transplant|0|||
127547318|NCT02113982|458974414|FG010|Stage 1: Dose Escalation|Transplant|0|||
127547319|NCT02113982|458974415|FG011|Stage 1: Dose Escalation|Transplant|0|||
127547320|NCT02113982|458974416|FG012|Stage 1: Dose Escalation|Transplant|0|||
127547321|NCT02113982|458974417|FG013|Stage 1: Dose Escalation|Transplant|0|||
127547322|NCT02113982|458974404|FG000|Stage 1: Dose Escalation|Other Therapy|0|||
127547323|NCT02113982|458974405|FG001|Stage 1: Dose Escalation|Other Therapy|0|||
127547324|NCT02113982|458974406|FG002|Stage 1: Dose Escalation|Other Therapy|0|||
127547325|NCT02113982|458974407|FG003|Stage 1: Dose Escalation|Other Therapy|0|||
127547326|NCT02113982|458974408|FG004|Stage 1: Dose Escalation|Other Therapy|0|||
127547327|NCT02113982|458974409|FG005|Stage 1: Dose Escalation|Other Therapy|1|||
127547328|NCT02113982|458974410|FG006|Stage 1: Dose Escalation|Other Therapy|0|||
127547329|NCT02113982|458974411|FG007|Stage 1: Dose Escalation|Other Therapy|0|||
127547330|NCT02113982|458974412|FG008|Stage 1: Dose Escalation|Other Therapy|0|||
127547331|NCT02113982|458974413|FG009|Stage 1: Dose Escalation|Other Therapy|0|||
127547332|NCT02113982|458974414|FG010|Stage 1: Dose Escalation|Other Therapy|0|||
127547333|NCT02113982|458974415|FG011|Stage 1: Dose Escalation|Other Therapy|0|||
127547334|NCT02113982|458974416|FG012|Stage 1: Dose Escalation|Other Therapy|0|||
127547335|NCT02113982|458974417|FG013|Stage 1: Dose Escalation|Other Therapy|0|||
127547336|NCT02113982|458974404|FG000|Stage 1: Dose Escalation|Complicating Disease|0|||
127547337|NCT02113982|458974405|FG001|Stage 1: Dose Escalation|Complicating Disease|1|||
127547338|NCT02113982|458974406|FG002|Stage 1: Dose Escalation|Complicating Disease|0|||
127547339|NCT02113982|458974407|FG003|Stage 1: Dose Escalation|Complicating Disease|0|||
127547340|NCT02113982|458974408|FG004|Stage 1: Dose Escalation|Complicating Disease|0|||
127547341|NCT02113982|458974409|FG005|Stage 1: Dose Escalation|Complicating Disease|0|||
127547342|NCT02113982|458974410|FG006|Stage 1: Dose Escalation|Complicating Disease|0|||
127547343|NCT02113982|458974411|FG007|Stage 1: Dose Escalation|Complicating Disease|0|||
127547344|NCT02113982|458974412|FG008|Stage 1: Dose Escalation|Complicating Disease|0|||
127547345|NCT02113982|458974413|FG009|Stage 1: Dose Escalation|Complicating Disease|0|||
127547346|NCT02113982|458974414|FG010|Stage 1: Dose Escalation|Complicating Disease|0|||
127547347|NCT02113982|458974415|FG011|Stage 1: Dose Escalation|Complicating Disease|0|||
127547348|NCT02113982|458974416|FG012|Stage 1: Dose Escalation|Complicating Disease|0|||
127547349|NCT02113982|458974417|FG013|Stage 1: Dose Escalation|Complicating Disease|0|||
127547350|NCT02113982|458974404|FG000|Stage 2: Cohort Expansion|Adverse Event|0|||
127547351|NCT02113982|458974405|FG001|Stage 2: Cohort Expansion|Adverse Event|0|||
127547352|NCT02113982|458974406|FG002|Stage 2: Cohort Expansion|Adverse Event|0|||
127547353|NCT02113982|458974407|FG003|Stage 2: Cohort Expansion|Adverse Event|0|||
127547354|NCT02113982|458974408|FG004|Stage 2: Cohort Expansion|Adverse Event|0|||
127547355|NCT02113982|458974409|FG005|Stage 2: Cohort Expansion|Adverse Event|0|||
127547356|NCT02113982|458974410|FG006|Stage 2: Cohort Expansion|Adverse Event|0|||
127547357|NCT02113982|458974411|FG007|Stage 2: Cohort Expansion|Adverse Event|1|||
127547358|NCT02113982|458974412|FG008|Stage 2: Cohort Expansion|Adverse Event|1|||
127547359|NCT02113982|458974413|FG009|Stage 2: Cohort Expansion|Adverse Event|1|||
127547360|NCT02113982|458974414|FG010|Stage 2: Cohort Expansion|Adverse Event|0|||
127547361|NCT02113982|458974415|FG011|Stage 2: Cohort Expansion|Adverse Event|0|||
127547362|NCT02113982|458974416|FG012|Stage 2: Cohort Expansion|Adverse Event|0|||
127547363|NCT02113982|458974417|FG013|Stage 2: Cohort Expansion|Adverse Event|0|||
127770429|NCT00178126|459784440|FG000|Overall Study|Lost to Follow-up|21|||
127770430|NCT00178126|459784441|FG001|Overall Study|Lost to Follow-up|21|||
127770431|NCT00178126|459784440|FG000|Overall Study|did not receive intervention|4|||
128016067|NCT02335944|460682229|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
127547364|NCT02113982|458974404|FG000|Stage 2: Cohort Expansion|Physician Decision|0|||
127547365|NCT02113982|458974405|FG001|Stage 2: Cohort Expansion|Physician Decision|0|||
127547366|NCT02113982|458974406|FG002|Stage 2: Cohort Expansion|Physician Decision|0|||
127547367|NCT02113982|458974407|FG003|Stage 2: Cohort Expansion|Physician Decision|0|||
127547368|NCT02113982|458974408|FG004|Stage 2: Cohort Expansion|Physician Decision|0|||
127547369|NCT02113982|458974409|FG005|Stage 2: Cohort Expansion|Physician Decision|0|||
127547370|NCT02113982|458974410|FG006|Stage 2: Cohort Expansion|Physician Decision|0|||
127547371|NCT02113982|458974411|FG007|Stage 2: Cohort Expansion|Physician Decision|7|||
127547372|NCT02113982|458974412|FG008|Stage 2: Cohort Expansion|Physician Decision|0|||
127770432|NCT00178126|459784441|FG001|Overall Study|did not receive intervention|6|||
128016068|NCT02335944|460682230|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
127547373|NCT02113982|458974413|FG009|Stage 2: Cohort Expansion|Physician Decision|1|||
127547374|NCT02113982|458974414|FG010|Stage 2: Cohort Expansion|Physician Decision|0|||
127547375|NCT02113982|458974415|FG011|Stage 2: Cohort Expansion|Physician Decision|0|||
127547376|NCT02113982|458974416|FG012|Stage 2: Cohort Expansion|Physician Decision|0|||
127547377|NCT02113982|458974417|FG013|Stage 2: Cohort Expansion|Physician Decision|0|||
127547378|NCT02113982|458974404|FG000|Stage 2: Cohort Expansion|Progressive Disease|0|||
127547379|NCT02113982|458974405|FG001|Stage 2: Cohort Expansion|Progressive Disease|0|||
127547380|NCT02113982|458974406|FG002|Stage 2: Cohort Expansion|Progressive Disease|0|||
127547381|NCT02113982|458974407|FG003|Stage 2: Cohort Expansion|Progressive Disease|0|||
127547382|NCT02113982|458974408|FG004|Stage 2: Cohort Expansion|Progressive Disease|0|||
127547383|NCT02113982|458974409|FG005|Stage 2: Cohort Expansion|Progressive Disease|0|||
127547384|NCT02113982|458974410|FG006|Stage 2: Cohort Expansion|Progressive Disease|0|||
127547385|NCT02113982|458974411|FG007|Stage 2: Cohort Expansion|Progressive Disease|19|||
127547386|NCT02113982|458974412|FG008|Stage 2: Cohort Expansion|Progressive Disease|0|||
127547387|NCT02113982|458974413|FG009|Stage 2: Cohort Expansion|Progressive Disease|5|||
127683522|NCT00658996|459465448|FG000|Crossover Period|Physician Decision|1|||
127683523|NCT00658996|459465449|FG001|Crossover Period|Physician Decision|0|||
127683524|NCT00658996|459465448|FG000|Crossover Period|Ineligible|1|||
127683525|NCT00658996|459465449|FG001|Crossover Period|Ineligible|1|||
127683526|NCT00658996|459465448|FG000|Second Intervention|Developed a stye on upper lid|1|||
127683527|NCT00658996|459465449|FG001|Second Intervention|Developed a stye on upper lid|0|||
127683528|NCT00658996|459465448|FG000|Second Intervention|Positive slit lamp finding|0|||
127683529|NCT00658996|459465449|FG001|Second Intervention|Positive slit lamp finding|1|||
127683530|NCT00206375|459465450|FG000|Overall Study|Lost to Follow-up|1|||
127683531|NCT00206375|459465451|FG001|Overall Study|Lost to Follow-up|0|||
127683532|NCT00206375|459465452|FG002|Overall Study|Lost to Follow-up|0|||
127683533|NCT00206375|459465450|FG000|Overall Study|Withdrawal by Subject|2|||
127683534|NCT00206375|459465451|FG001|Overall Study|Withdrawal by Subject|1|||
127683535|NCT00206375|459465452|FG002|Overall Study|Withdrawal by Subject|3|||
127683536|NCT00206375|459465450|FG000|Overall Study|Study terminated due to lack of funds|0|||
127683537|NCT00206375|459465451|FG001|Overall Study|Study terminated due to lack of funds|1|||
127683538|NCT00206375|459465452|FG002|Overall Study|Study terminated due to lack of funds|1|||
127683539|NCT01810263|459465459|FG000|Overall Study|Lost to Follow-up|8|||
127683540|NCT01810263|459465460|FG001|Overall Study|Lost to Follow-up|7|||
127683541|NCT00688519|459465461|FG000|Overall Study|Adverse Event|2|||
127683542|NCT00688519|459465462|FG001|Overall Study|Adverse Event|3|||
127683543|NCT00688519|459465461|FG000|Overall Study|Lost to Follow-up|3|||
127683544|NCT00688519|459465462|FG001|Overall Study|Lost to Follow-up|3|||
127683545|NCT00688519|459465461|FG000|Overall Study|Lack of Efficacy|3|||
127683546|NCT00688519|459465462|FG001|Overall Study|Lack of Efficacy|1|||
127683547|NCT00688519|459465461|FG000|Overall Study|Withdrawal by Subject|7|||
127683548|NCT00688519|459465462|FG001|Overall Study|Withdrawal by Subject|6|||
127683549|NCT00688519|459465461|FG000|Overall Study|Prohibited medication|1|||
127683550|NCT00688519|459465462|FG001|Overall Study|Prohibited medication|0|||
127683551|NCT00688519|459465461|FG000|Overall Study|Non-compliance|0|||
127683552|NCT00688519|459465462|FG001|Overall Study|Non-compliance|1|||
127683553|NCT00688519|459465461|FG000|Overall Study|Subject moved out of state|1|||
127683554|NCT00688519|459465462|FG001|Overall Study|Subject moved out of state|0|||
127683555|NCT00688519|459465461|FG000|Overall Study|Investigator decision|1|||
127683556|NCT00688519|459465462|FG001|Overall Study|Investigator decision|0|||
127683557|NCT00688519|459465461|FG000|Overall Study|Subject moved out of area|1|||
127683558|NCT00688519|459465462|FG001|Overall Study|Subject moved out of area|0|||
127683559|NCT00688519|459465461|FG000|Overall Study|Pregnancy|0|||
127683560|NCT00688519|459465462|FG001|Overall Study|Pregnancy|1|||
127683561|NCT01353963|459465463|FG000|Overall Study|Adverse Event|2|||
127683562|NCT03351075|459466571|FG000|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|6|||
127683563|NCT03351075|459466572|FG001|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|4|||
127683564|NCT03351075|459466571|FG000|Intensive Treatment Phase (4 mo FU)|Death|0|||
127683565|NCT03351075|459466572|FG001|Intensive Treatment Phase (4 mo FU)|Death|1|||
127683566|NCT03351075|459466571|FG000|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|1|||
127683567|NCT03351075|459466572|FG001|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|0|||
127683568|NCT03351075|459466571|FG000|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
127683569|NCT03351075|459466572|FG001|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
127683570|NCT00493649|459466573|FG000|Overall Study|Adverse Event|44|||
127683571|NCT00493649|459466573|FG000|Overall Study|Patient Request|21|||
127683572|NCT00493649|459466573|FG000|Overall Study|Investigator Request|2|||
127683573|NCT00493649|459466573|FG000|Overall Study|Disease Progression|1|||
127683574|NCT00493649|459466573|FG000|Overall Study|Lost to Follow-up|1|||
127683575|NCT00493649|459466573|FG000|Overall Study|Other|13|||
127683576|NCT05219253|459466574|FG000|Overall Study|Withdrawal by Subject|1|||
127683577|NCT05219253|459466575|FG001|Overall Study|Withdrawal by Subject|2|||
127683578|NCT03086369|459466576|FG000|Overall Study|Lost to Follow-up|1|||
127683579|NCT03086369|459466577|FG001|Overall Study|Lost to Follow-up|0|||
127683580|NCT03086369|459466578|FG002|Overall Study|Lost to Follow-up|0|||
127683581|NCT03086369|459466579|FG003|Overall Study|Lost to Follow-up|2|||
127683582|NCT03086369|459466580|FG004|Overall Study|Lost to Follow-up|1|||
127683583|NCT03086369|459466576|FG000|Overall Study|Physician Decision|0|||
127683584|NCT03086369|459466577|FG001|Overall Study|Physician Decision|0|||
127683585|NCT03086369|459466578|FG002|Overall Study|Physician Decision|0|||
127683586|NCT03086369|459466579|FG003|Overall Study|Physician Decision|1|||
127683587|NCT03086369|459466580|FG004|Overall Study|Physician Decision|2|||
127683588|NCT03086369|459466576|FG000|Overall Study|Withdrawal by Subject|0|||
127683589|NCT03086369|459466577|FG001|Overall Study|Withdrawal by Subject|0|||
127683590|NCT03086369|459466578|FG002|Overall Study|Withdrawal by Subject|0|||
127683591|NCT03086369|459466579|FG003|Overall Study|Withdrawal by Subject|5|||
127683592|NCT03086369|459466580|FG004|Overall Study|Withdrawal by Subject|3|||
127683593|NCT03086369|459466576|FG000|Overall Study|Progressive Disease|0|||
127683594|NCT03086369|459466577|FG001|Overall Study|Progressive Disease|0|||
127683595|NCT03086369|459466578|FG002|Overall Study|Progressive Disease|0|||
127683596|NCT03086369|459466579|FG003|Overall Study|Progressive Disease|1|||
127683597|NCT03086369|459466580|FG004|Overall Study|Progressive Disease|1|||
127683598|NCT04603924|459466583|FG000|Overall Study|Not Dosed|2|||
127683599|NCT04603924|459466584|FG001|Overall Study|Not Dosed|1|||
127683600|NCT04603924|459466583|FG000|Overall Study|Withdrawal by Subject|6|||
127683601|NCT04603924|459466584|FG001|Overall Study|Withdrawal by Subject|6|||
127683602|NCT04603924|459466583|FG000|Overall Study|Adverse Event|2|||
127683603|NCT04603924|459466584|FG001|Overall Study|Adverse Event|2|||
127683604|NCT01424397|459466592|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
127683605|NCT01424397|459466593|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
127683606|NCT01424397|459466594|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
127683607|NCT01424397|459466595|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
127683608|NCT01424397|459466596|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
127683609|NCT01424397|459466597|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
127683610|NCT01424397|459466598|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
127683611|NCT01424397|459466599|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
127683612|NCT01424397|459466600|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
127683613|NCT01424397|459466601|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
127683614|NCT01424397|459466602|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
127683615|NCT01424397|459466603|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
127683616|NCT01444417|459466604|FG000|Overall Study|Ineligibility Determined|0|||
127683617|NCT01444417|459466605|FG001|Overall Study|Ineligibility Determined|1|||
127683618|NCT01444417|459466604|FG000|Overall Study|Withdrawal by Subject|2|||
127683619|NCT01444417|459466605|FG001|Overall Study|Withdrawal by Subject|0|||
127683620|NCT03475316|459466608|FG000|6 Month Intervention|Adverse Event|2|||
127683621|NCT03475316|459466609|FG001|6 Month Intervention|Adverse Event|1|||
127683622|NCT03475316|459466608|FG000|6 Month Intervention|Withdrawal by Subject|2|||
127683623|NCT03475316|459466609|FG001|6 Month Intervention|Withdrawal by Subject|0|||
127683624|NCT03475316|459466608|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
127683625|NCT03475316|459466609|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
127683626|NCT03475316|459466608|FG000|9 Months|Study stopped due to COVID pandemic|3|||
127683627|NCT03475316|459466609|FG001|9 Months|Study stopped due to COVID pandemic|4|||
127683628|NCT02555215|459466610|FG000|Overall Study|Other|1|||
127683629|NCT02555215|459466610|FG000|Overall Study|Investigator Decision|2|||
127683630|NCT00468052|459466611|FG000|Overall Study|Protocol Violation|7|||
127683631|NCT00468052|459466612|FG001|Overall Study|Protocol Violation|8|||
127683632|NCT00457743|459466615|FG000|Overall Study|Adverse Event|0|||
127683633|NCT00457743|459466616|FG001|Overall Study|Adverse Event|4|||
127683634|NCT00457743|459466617|FG002|Overall Study|Adverse Event|0|||
127683635|NCT00457743|459466615|FG000|Overall Study|Lack of Efficacy|3|||
127683636|NCT00457743|459466616|FG001|Overall Study|Lack of Efficacy|23|||
127683637|NCT00457743|459466617|FG002|Overall Study|Lack of Efficacy|3|||
127683638|NCT00566527|459466618|FG000|Overall Study|Reason not provided|3|||
127683639|NCT00566527|459466619|FG001|Overall Study|Reason not provided|11|||
127683640|NCT00566527|459466620|FG002|Overall Study|Reason not provided|10|||
127683641|NCT00566527|459466618|FG000|Overall Study|Adverse Event|2|||
127683642|NCT00566527|459466619|FG001|Overall Study|Adverse Event|0|||
127683643|NCT00566527|459466620|FG002|Overall Study|Adverse Event|1|||
127683644|NCT00566527|459466618|FG000|Overall Study|Physician Decision|3|||
127683645|NCT00566527|459466619|FG001|Overall Study|Physician Decision|8|||
127683646|NCT00566527|459466620|FG002|Overall Study|Physician Decision|20|||
127683647|NCT00566527|459466618|FG000|Overall Study|Lost to Follow-up|3|||
127683648|NCT00566527|459466619|FG001|Overall Study|Lost to Follow-up|4|||
127683649|NCT00566527|459466620|FG002|Overall Study|Lost to Follow-up|4|||
127683650|NCT00566527|459466618|FG000|Overall Study|Withdrawal by Subject|6|||
127683651|NCT00566527|459466619|FG001|Overall Study|Withdrawal by Subject|43|||
127683652|NCT00566527|459466620|FG002|Overall Study|Withdrawal by Subject|43|||
127683653|NCT00356265|459466621|FG000|Overall Study|Withdrawal by Subject|0|||
127683654|NCT00356265|459466622|FG001|Overall Study|Withdrawal by Subject|0|||
127683655|NCT00356265|459466623|FG002|Overall Study|Withdrawal by Subject|1|||
127683656|NCT01837966|459466624|FG000|Overall Study|Withdrawal by Subject|2|||
127683657|NCT01837966|459466625|FG001|Overall Study|Withdrawal by Subject|1|||
127683658|NCT00159783|459466629|FG000|Overall Study|Adverse Event|5|||
127880902|NCT03387735|460186058|FG000|Overall Study|Death|4|||
127770433|NCT01204398|459784445|FG000|Overall Study|Adverse Event|1|||
127770434|NCT03562247|459784446|FG000|Overall Study|Lost to Follow-up|3|||
127770435|NCT03562247|459784447|FG001|Overall Study|Lost to Follow-up|1|||
127770436|NCT03562247|459784448|FG002|Overall Study|Lost to Follow-up|1|||
127770437|NCT00983931|459784449|FG000|14 Day Washout Period|Physician Decision|1|||
127770438|NCT01281969|459784452|FG000|Overall Study|not randomized didn't meet criteria|0|||
127770439|NCT01281969|459784453|FG001|Overall Study|not randomized didn't meet criteria|0|||
127770440|NCT01281969|459784454|FG002|Overall Study|not randomized didn't meet criteria|7|||
127770441|NCT01281969|459784452|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
127770442|NCT01281969|459784453|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
127770443|NCT01281969|459784454|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
127770444|NCT01281969|459784452|FG000|Overall Study|not randomized, child consent not given|0|||
127770445|NCT01281969|459784453|FG001|Overall Study|not randomized, child consent not given|0|||
127770446|NCT01281969|459784454|FG002|Overall Study|not randomized, child consent not given|2|||
127770447|NCT01201265|459784459|FG000|Overall Study|Death|14|||
127770448|NCT01201265|459784459|FG000|Overall Study|Insufficient Therapeutic Response|3|||
127770449|NCT01201265|459784459|FG000|Overall Study|Lost to Follow-up|10|||
127770450|NCT01201265|459784459|FG000|Overall Study|Withdrawal by Subject|7|||
127770451|NCT01201265|459784459|FG000|Overall Study|Disease Progression|4|||
127770452|NCT04640077|459784460|FG000|Period 1|Withdrawal by Subject|4|||
127770453|NCT04640077|459784461|FG001|Period 1|Withdrawal by Subject|5|||
127770454|NCT04640077|459784462|FG002|Period 1|Withdrawal by Subject|0|||
127770455|NCT04640077|459784460|FG000|Period 1|Adverse Event|1|||
127770456|NCT04640077|459784461|FG001|Period 1|Adverse Event|1|||
127770457|NCT04640077|459784462|FG002|Period 1|Adverse Event|0|||
127770458|NCT04640077|459784460|FG000|Period 1|Screen Failure|2|||
127770459|NCT04640077|459784461|FG001|Period 1|Screen Failure|0|||
127770460|NCT04640077|459784462|FG002|Period 1|Screen Failure|0|||
127770461|NCT04640077|459784460|FG000|Period 2|Withdrawal by Subject|0|||
127770462|NCT04640077|459784461|FG001|Period 2|Withdrawal by Subject|0|||
127770463|NCT04640077|459784462|FG002|Period 2|Withdrawal by Subject|18|||
127770464|NCT04640077|459784460|FG000|Period 2|Adverse Event|0|||
127770465|NCT04640077|459784461|FG001|Period 2|Adverse Event|0|||
127770466|NCT04640077|459784462|FG002|Period 2|Adverse Event|6|||
127770467|NCT04640077|459784460|FG000|Period 2|Lost to Follow-up|0|||
127770468|NCT04640077|459784461|FG001|Period 2|Lost to Follow-up|0|||
127770469|NCT04640077|459784462|FG002|Period 2|Lost to Follow-up|2|||
127770470|NCT04640077|459784460|FG000|Period 2|Death|0|||
127770471|NCT04640077|459784461|FG001|Period 2|Death|0|||
127770472|NCT04640077|459784462|FG002|Period 2|Death|2|||
127770473|NCT04640077|459784460|FG000|Period 2|Progressive Disease|0|||
127770474|NCT04640077|459784461|FG001|Period 2|Progressive Disease|0|||
127770475|NCT04640077|459784462|FG002|Period 2|Progressive Disease|1|||
127770476|NCT04640077|459784460|FG000|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
127770477|NCT04640077|459784461|FG001|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
127770478|NCT04640077|459784462|FG002|Period 2|Withdrawal Due To Caregiver Circumstances|1|||
127770479|NCT01257425|459784463|FG000|Overall Study|Lack of Efficacy|3|||
127770480|NCT01257425|459784464|FG001|Overall Study|Lack of Efficacy|3|||
127770481|NCT01257425|459784463|FG000|Overall Study|Adverse Event|1|||
127770482|NCT01257425|459784464|FG001|Overall Study|Adverse Event|1|||
127770483|NCT01257425|459784463|FG000|Overall Study|Protocol Violation|1|||
127770484|NCT01257425|459784464|FG001|Overall Study|Protocol Violation|1|||
127770485|NCT01257425|459784463|FG000|Overall Study|Withdrawal by Subject|0|||
127770486|NCT01257425|459784464|FG001|Overall Study|Withdrawal by Subject|1|||
127770487|NCT01257425|459784463|FG000|Overall Study|Death|1|||
127770488|NCT01257425|459784464|FG001|Overall Study|Death|0|||
127770489|NCT01182194|459784465|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
127770490|NCT01182194|459784466|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
127770491|NCT00368992|459784468|FG000|Overall Study|Ineligible|5|||
127770492|NCT00368992|459784468|FG000|Overall Study|Refused treatment|3|||
127770493|NCT00368992|459784468|FG000|Overall Study|Lack of Efficacy|63|||
127770494|NCT00368992|459784468|FG000|Overall Study|Adverse Event|26|||
127770495|NCT00368992|459784468|FG000|Overall Study|Death|4|||
127770496|NCT00368992|459784468|FG000|Overall Study|Other|9|||
127770497|NCT02668185|459784469|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
127880903|NCT03387735|460186059|FG001|Overall Study|Death|8|||
127770498|NCT02668185|459784470|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
127770499|NCT02668185|459784469|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
127770500|NCT02668185|459784470|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
127770501|NCT02668185|459784469|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
127770502|NCT02668185|459784470|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
127770503|NCT02668185|459784469|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
127770504|NCT02668185|459784470|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
127770505|NCT00723021|459784475|FG000|Intervention Period 4|Adverse Event|0|||
127770506|NCT00723021|459784476|FG001|Intervention Period 4|Adverse Event|0|||
127770507|NCT00723021|459784477|FG002|Intervention Period 4|Adverse Event|0|||
127770508|NCT00723021|459784478|FG003|Intervention Period 4|Adverse Event|0|||
127770509|NCT00723021|459784479|FG004|Intervention Period 4|Adverse Event|1|||
128016069|NCT02335944|460682231|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
128016070|NCT02335944|460682232|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
128016071|NCT02335944|460682233|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
128016072|NCT02335944|460682224|FG000|Treatment Phase|Subject/Guardian Decision|0|||
128016073|NCT02335944|460682225|FG001|Treatment Phase|Subject/Guardian Decision|0|||
128016074|NCT02335944|460682226|FG002|Treatment Phase|Subject/Guardian Decision|1|||
128016075|NCT02335944|460682227|FG003|Treatment Phase|Subject/Guardian Decision|0|||
128016076|NCT02335944|460682228|FG004|Treatment Phase|Subject/Guardian Decision|0|||
128016077|NCT02335944|460682229|FG005|Treatment Phase|Subject/Guardian Decision|1|||
128016078|NCT02335944|460682230|FG006|Treatment Phase|Subject/Guardian Decision|0|||
127683659|NCT00159783|459466630|FG001|Overall Study|Adverse Event|7|||
127683660|NCT00159783|459466631|FG002|Overall Study|Adverse Event|9|||
127683661|NCT00159783|459466629|FG000|Overall Study|Lack of Efficacy|1|||
127683662|NCT00159783|459466630|FG001|Overall Study|Lack of Efficacy|2|||
127683663|NCT00159783|459466631|FG002|Overall Study|Lack of Efficacy|3|||
127683664|NCT00159783|459466629|FG000|Overall Study|Withdrawal by Subject|7|||
127683665|NCT00159783|459466630|FG001|Overall Study|Withdrawal by Subject|11|||
127683666|NCT00159783|459466631|FG002|Overall Study|Withdrawal by Subject|12|||
127683667|NCT00159783|459466629|FG000|Overall Study|Lost to Follow-up|6|||
127683668|NCT00159783|459466630|FG001|Overall Study|Lost to Follow-up|5|||
127683669|NCT00159783|459466631|FG002|Overall Study|Lost to Follow-up|11|||
127683670|NCT00159783|459466629|FG000|Overall Study|Other|0|||
127683671|NCT00159783|459466630|FG001|Overall Study|Other|2|||
127683672|NCT00159783|459466631|FG002|Overall Study|Other|4|||
127683673|NCT02928224|459466632|FG000|Overall Study|Lost to Follow-up|1|||
127683674|NCT02928224|459466633|FG001|Overall Study|Lost to Follow-up|1|||
127683675|NCT02928224|459466634|FG002|Overall Study|Lost to Follow-up|3|||
127683676|NCT02928224|459466635|FG003|Overall Study|Lost to Follow-up|0|||
127683677|NCT02928224|459466632|FG000|Overall Study|Death|30|||
127683678|NCT02928224|459466633|FG001|Overall Study|Death|209|||
127683679|NCT02928224|459466634|FG002|Overall Study|Death|193|||
127683680|NCT02928224|459466635|FG003|Overall Study|Death|198|||
127683681|NCT02928224|459466632|FG000|Overall Study|Withdrawal by Subject|0|||
127683682|NCT02928224|459466633|FG001|Overall Study|Withdrawal by Subject|3|||
127683683|NCT02928224|459466634|FG002|Overall Study|Withdrawal by Subject|7|||
127683684|NCT02928224|459466635|FG003|Overall Study|Withdrawal by Subject|20|||
127683685|NCT02928224|459466632|FG000|Overall Study|Study participation terminated by sponsor|3|||
127683686|NCT02928224|459466633|FG001|Overall Study|Study participation terminated by sponsor|8|||
127683687|NCT02928224|459466634|FG002|Overall Study|Study participation terminated by sponsor|12|||
127683688|NCT02928224|459466635|FG003|Overall Study|Study participation terminated by sponsor|3|||
127683689|NCT02928224|459466632|FG000|Overall Study|Other|3|||
127683690|NCT02928224|459466633|FG001|Overall Study|Other|3|||
127683691|NCT02928224|459466634|FG002|Overall Study|Other|5|||
127683692|NCT02928224|459466635|FG003|Overall Study|Other|0|||
127683693|NCT01278394|459466638|FG000|Overall Study|Lost to Follow-up|1|||
127683694|NCT01236560|459466639|FG000|Overall Study|Adverse Event|0|||
127683695|NCT01236560|459466640|FG001|Overall Study|Adverse Event|2|||
127683696|NCT01236560|459466641|FG002|Overall Study|Adverse Event|1|||
127683697|NCT01236560|459466642|FG003|Overall Study|Adverse Event|3|||
127683698|NCT01236560|459466643|FG004|Overall Study|Adverse Event|0|||
127683699|NCT01236560|459466644|FG005|Overall Study|Adverse Event|0|||
127683700|NCT01236560|459466639|FG000|Overall Study|Death|0|||
127683701|NCT01236560|459466640|FG001|Overall Study|Death|1|||
127683702|NCT01236560|459466641|FG002|Overall Study|Death|0|||
127683703|NCT01236560|459466642|FG003|Overall Study|Death|1|||
127683704|NCT01236560|459466643|FG004|Overall Study|Death|0|||
127683705|NCT01236560|459466644|FG005|Overall Study|Death|0|||
127683706|NCT01236560|459466639|FG000|Overall Study|Lost to Follow-up|0|||
127683707|NCT01236560|459466640|FG001|Overall Study|Lost to Follow-up|1|||
127683708|NCT01236560|459466641|FG002|Overall Study|Lost to Follow-up|1|||
127683709|NCT01236560|459466642|FG003|Overall Study|Lost to Follow-up|0|||
127683710|NCT01236560|459466643|FG004|Overall Study|Lost to Follow-up|0|||
127683711|NCT01236560|459466644|FG005|Overall Study|Lost to Follow-up|0|||
127683712|NCT01236560|459466639|FG000|Overall Study|Physician Decision|0|||
127683713|NCT01236560|459466640|FG001|Overall Study|Physician Decision|1|||
127683714|NCT01236560|459466641|FG002|Overall Study|Physician Decision|8|||
127683715|NCT01236560|459466642|FG003|Overall Study|Physician Decision|0|||
127683716|NCT01236560|459466643|FG004|Overall Study|Physician Decision|0|||
127683717|NCT01236560|459466644|FG005|Overall Study|Physician Decision|0|||
127683718|NCT01236560|459466639|FG000|Overall Study|Withdrawal by Subject|0|||
127683719|NCT01236560|459466640|FG001|Overall Study|Withdrawal by Subject|0|||
127683720|NCT01236560|459466641|FG002|Overall Study|Withdrawal by Subject|1|||
127683721|NCT01236560|459466642|FG003|Overall Study|Withdrawal by Subject|2|||
127683722|NCT01236560|459466643|FG004|Overall Study|Withdrawal by Subject|0|||
127683723|NCT01236560|459466644|FG005|Overall Study|Withdrawal by Subject|0|||
127683724|NCT01236560|459466639|FG000|Overall Study|Progressive disease|5|||
127683725|NCT01236560|459466640|FG001|Overall Study|Progressive disease|19|||
127683726|NCT01236560|459466641|FG002|Overall Study|Progressive disease|9|||
127683727|NCT01236560|459466642|FG003|Overall Study|Progressive disease|16|||
127547388|NCT02113982|458974414|FG010|Stage 2: Cohort Expansion|Progressive Disease|7|||
127547389|NCT02113982|458974415|FG011|Stage 2: Cohort Expansion|Progressive Disease|0|||
127547390|NCT02113982|458974416|FG012|Stage 2: Cohort Expansion|Progressive Disease|0|||
127547391|NCT02113982|458974417|FG013|Stage 2: Cohort Expansion|Progressive Disease|0|||
127547392|NCT02113982|458974404|FG000|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
127547393|NCT02113982|458974405|FG001|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
127547394|NCT02113982|458974406|FG002|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
127547395|NCT02113982|458974407|FG003|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
127547396|NCT02113982|458974408|FG004|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
127547397|NCT02113982|458974409|FG005|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
127547398|NCT02113982|458974410|FG006|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
127547399|NCT02113982|458974411|FG007|Stage 2: Cohort Expansion|Withdrawal by Subject|4|||
127547400|NCT02113982|458974412|FG008|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
127547401|NCT02113982|458974413|FG009|Stage 2: Cohort Expansion|Withdrawal by Subject|1|||
127547402|NCT02113982|458974414|FG010|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
127547403|NCT02113982|458974415|FG011|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
127547404|NCT02113982|458974416|FG012|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
127547405|NCT02113982|458974417|FG013|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
127547406|NCT02113982|458974404|FG000|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
127547407|NCT02113982|458974405|FG001|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
127547408|NCT02113982|458974406|FG002|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
127547409|NCT02113982|458974407|FG003|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
127547410|NCT02113982|458974408|FG004|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
127547411|NCT02113982|458974409|FG005|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
127547412|NCT02113982|458974410|FG006|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
127547413|NCT02113982|458974411|FG007|Stage 2: Cohort Expansion|Lack of Efficacy|2|||
127547414|NCT02113982|458974412|FG008|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
127547415|NCT02113982|458974413|FG009|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
127547416|NCT02113982|458974414|FG010|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
127683728|NCT01236560|459466643|FG004|Overall Study|Progressive disease|0|||
127683729|NCT01236560|459466644|FG005|Overall Study|Progressive disease|0|||
127683730|NCT00468910|459466645|FG000|Overall Study|Lost to Follow-up|2|||
127683731|NCT00468910|459466646|FG001|Overall Study|Lost to Follow-up|1|||
127683732|NCT00468910|459466645|FG000|Overall Study|Withdrawal by Subject|2|||
127683733|NCT00468910|459466646|FG001|Overall Study|Withdrawal by Subject|1|||
127683734|NCT00468910|459466645|FG000|Overall Study|Medical Contraindication|0|||
127683735|NCT00468910|459466646|FG001|Overall Study|Medical Contraindication|1|||
127683736|NCT03144674|459466650|FG000|Overall Study|Participant Transferred to Rollover Study|1|||
127683737|NCT03144674|459466651|FG001|Overall Study|Participant Transferred to Rollover Study|1|||
127683738|NCT03144674|459466652|FG002|Overall Study|Participant Transferred to Rollover Study|5|||
127683739|NCT03144674|459466653|FG003|Overall Study|Participant Transferred to Rollover Study|6|||
127683740|NCT03144674|459466650|FG000|Overall Study|Death|3|||
127683741|NCT03144674|459466651|FG001|Overall Study|Death|2|||
127683742|NCT03144674|459466652|FG002|Overall Study|Death|6|||
127683743|NCT03144674|459466653|FG003|Overall Study|Death|24|||
127547417|NCT02113982|458974415|FG011|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
127547418|NCT02113982|458974416|FG012|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
127547419|NCT02113982|458974417|FG013|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
127547420|NCT02113982|458974404|FG000|Stage 2: Cohort Expansion|Transplant|0|||
127547421|NCT02113982|458974405|FG001|Stage 2: Cohort Expansion|Transplant|0|||
127547422|NCT02113982|458974406|FG002|Stage 2: Cohort Expansion|Transplant|0|||
127547423|NCT02113982|458974407|FG003|Stage 2: Cohort Expansion|Transplant|0|||
127547424|NCT02113982|458974408|FG004|Stage 2: Cohort Expansion|Transplant|0|||
127547425|NCT02113982|458974409|FG005|Stage 2: Cohort Expansion|Transplant|0|||
127547426|NCT02113982|458974410|FG006|Stage 2: Cohort Expansion|Transplant|0|||
127547427|NCT02113982|458974411|FG007|Stage 2: Cohort Expansion|Transplant|0|||
127547428|NCT02113982|458974412|FG008|Stage 2: Cohort Expansion|Transplant|0|||
127547429|NCT02113982|458974413|FG009|Stage 2: Cohort Expansion|Transplant|4|||
127547430|NCT02113982|458974414|FG010|Stage 2: Cohort Expansion|Transplant|2|||
127547431|NCT02113982|458974415|FG011|Stage 2: Cohort Expansion|Transplant|0|||
127547432|NCT02113982|458974416|FG012|Stage 2: Cohort Expansion|Transplant|0|||
127547433|NCT02113982|458974417|FG013|Stage 2: Cohort Expansion|Transplant|0|||
127547434|NCT02113982|458974404|FG000|Stage 2: Cohort Expansion|Patient Preference|0|||
127547435|NCT02113982|458974405|FG001|Stage 2: Cohort Expansion|Patient Preference|0|||
127547436|NCT02113982|458974406|FG002|Stage 2: Cohort Expansion|Patient Preference|0|||
127547437|NCT02113982|458974407|FG003|Stage 2: Cohort Expansion|Patient Preference|0|||
127547438|NCT02113982|458974408|FG004|Stage 2: Cohort Expansion|Patient Preference|0|||
127547439|NCT02113982|458974409|FG005|Stage 2: Cohort Expansion|Patient Preference|0|||
127547440|NCT02113982|458974410|FG006|Stage 2: Cohort Expansion|Patient Preference|0|||
127547441|NCT02113982|458974411|FG007|Stage 2: Cohort Expansion|Patient Preference|1|||
127547442|NCT02113982|458974412|FG008|Stage 2: Cohort Expansion|Patient Preference|0|||
127547443|NCT02113982|458974413|FG009|Stage 2: Cohort Expansion|Patient Preference|0|||
128016079|NCT02335944|460682231|FG007|Treatment Phase|Subject/Guardian Decision|4|||
128016080|NCT02335944|460682232|FG008|Treatment Phase|Subject/Guardian Decision|0|||
127547444|NCT02113982|458974414|FG010|Stage 2: Cohort Expansion|Patient Preference|1|||
127547445|NCT02113982|458974415|FG011|Stage 2: Cohort Expansion|Patient Preference|0|||
127547446|NCT02113982|458974416|FG012|Stage 2: Cohort Expansion|Patient Preference|0|||
127547447|NCT02113982|458974417|FG013|Stage 2: Cohort Expansion|Patient Preference|0|||
127547448|NCT02113982|458974404|FG000|Stage 2: Cohort Expansion|Other Therapy|0|||
127547449|NCT02113982|458974405|FG001|Stage 2: Cohort Expansion|Other Therapy|0|||
127547450|NCT02113982|458974406|FG002|Stage 2: Cohort Expansion|Other Therapy|0|||
127547451|NCT02113982|458974407|FG003|Stage 2: Cohort Expansion|Other Therapy|0|||
128016081|NCT02335944|460682233|FG009|Treatment Phase|Subject/Guardian Decision|0|||
128016082|NCT02335944|460682224|FG000|Post-treatment Follow-up|Progressive Disease|0|||
128016083|NCT02335944|460682225|FG001|Post-treatment Follow-up|Progressive Disease|0|||
128016084|NCT02335944|460682226|FG002|Post-treatment Follow-up|Progressive Disease|0|||
128016085|NCT02335944|460682227|FG003|Post-treatment Follow-up|Progressive Disease|1|||
128016086|NCT02335944|460682228|FG004|Post-treatment Follow-up|Progressive Disease|0|||
128016087|NCT02335944|460682229|FG005|Post-treatment Follow-up|Progressive Disease|9|||
128016088|NCT02335944|460682230|FG006|Post-treatment Follow-up|Progressive Disease|0|||
128016089|NCT02335944|460682231|FG007|Post-treatment Follow-up|Progressive Disease|2|||
128016090|NCT02335944|460682232|FG008|Post-treatment Follow-up|Progressive Disease|3|||
127547452|NCT02113982|458974408|FG004|Stage 2: Cohort Expansion|Other Therapy|0|||
127547453|NCT02113982|458974409|FG005|Stage 2: Cohort Expansion|Other Therapy|0|||
127547454|NCT02113982|458974410|FG006|Stage 2: Cohort Expansion|Other Therapy|0|||
127547455|NCT02113982|458974411|FG007|Stage 2: Cohort Expansion|Other Therapy|0|||
127547456|NCT02113982|458974412|FG008|Stage 2: Cohort Expansion|Other Therapy|0|||
127547457|NCT02113982|458974413|FG009|Stage 2: Cohort Expansion|Other Therapy|1|||
127547458|NCT02113982|458974414|FG010|Stage 2: Cohort Expansion|Other Therapy|0|||
127547459|NCT02113982|458974415|FG011|Stage 2: Cohort Expansion|Other Therapy|0|||
127547460|NCT02113982|458974416|FG012|Stage 2: Cohort Expansion|Other Therapy|0|||
127547461|NCT02113982|458974417|FG013|Stage 2: Cohort Expansion|Other Therapy|0|||
127547462|NCT02113982|458974404|FG000|Stage 3: Efficacy Cohort|Adverse Event|0|||
127547463|NCT02113982|458974405|FG001|Stage 3: Efficacy Cohort|Adverse Event|0|||
127547464|NCT02113982|458974406|FG002|Stage 3: Efficacy Cohort|Adverse Event|0|||
127683744|NCT03144674|459466650|FG000|Overall Study|Lost to Follow-up|0|||
127683745|NCT03144674|459466651|FG001|Overall Study|Lost to Follow-up|1|||
127683746|NCT03144674|459466652|FG002|Overall Study|Lost to Follow-up|0|||
127683747|NCT03144674|459466653|FG003|Overall Study|Lost to Follow-up|4|||
127683748|NCT03144674|459466650|FG000|Overall Study|Withdrawal by Participant|0|||
127683749|NCT03144674|459466651|FG001|Overall Study|Withdrawal by Participant|0|||
127683750|NCT03144674|459466652|FG002|Overall Study|Withdrawal by Participant|2|||
127683751|NCT03144674|459466653|FG003|Overall Study|Withdrawal by Participant|6|||
127683752|NCT03144674|459466650|FG000|Overall Study|Discharged from the Trust|0|||
127683753|NCT03144674|459466651|FG001|Overall Study|Discharged from the Trust|0|||
127683754|NCT03144674|459466652|FG002|Overall Study|Discharged from the Trust|1|||
127683755|NCT03144674|459466653|FG003|Overall Study|Discharged from the Trust|0|||
127683756|NCT03144674|459466650|FG000|Overall Study|Exclusion Criteria Met|0|||
127683757|NCT03144674|459466651|FG001|Overall Study|Exclusion Criteria Met|0|||
127683758|NCT03144674|459466652|FG002|Overall Study|Exclusion Criteria Met|1|||
127683759|NCT03144674|459466653|FG003|Overall Study|Exclusion Criteria Met|0|||
127683760|NCT03144674|459466650|FG000|Overall Study|Changed Physicians|0|||
127683761|NCT03144674|459466651|FG001|Overall Study|Changed Physicians|0|||
127683762|NCT03144674|459466652|FG002|Overall Study|Changed Physicians|0|||
127683763|NCT03144674|459466653|FG003|Overall Study|Changed Physicians|1|||
127683764|NCT03144674|459466650|FG000|Overall Study|Removed for Safety|0|||
127683765|NCT03144674|459466651|FG001|Overall Study|Removed for Safety|0|||
127683766|NCT03144674|459466652|FG002|Overall Study|Removed for Safety|0|||
127683767|NCT03144674|459466653|FG003|Overall Study|Removed for Safety|1|||
127683768|NCT03144674|459466650|FG000|Overall Study|Site Closed|0|||
127683769|NCT03144674|459466651|FG001|Overall Study|Site Closed|0|||
127683770|NCT03144674|459466652|FG002|Overall Study|Site Closed|0|||
127683771|NCT03144674|459466653|FG003|Overall Study|Site Closed|1|||
127683772|NCT03144674|459466650|FG000|Overall Study|Histological Criteria Not Met|0|||
127683773|NCT03144674|459466651|FG001|Overall Study|Histological Criteria Not Met|0|||
127683774|NCT03144674|459466652|FG002|Overall Study|Histological Criteria Not Met|0|||
127683775|NCT03144674|459466653|FG003|Overall Study|Histological Criteria Not Met|1|||
127683776|NCT03144674|459466650|FG000|Overall Study|Multifactorial Cognitive Decline|0|||
127683777|NCT03144674|459466651|FG001|Overall Study|Multifactorial Cognitive Decline|0|||
128016091|NCT02335944|460682233|FG009|Post-treatment Follow-up|Progressive Disease|0|||
127547465|NCT02113982|458974407|FG003|Stage 3: Efficacy Cohort|Adverse Event|0|||
127547466|NCT02113982|458974408|FG004|Stage 3: Efficacy Cohort|Adverse Event|0|||
127547467|NCT02113982|458974409|FG005|Stage 3: Efficacy Cohort|Adverse Event|0|||
127547468|NCT02113982|458974410|FG006|Stage 3: Efficacy Cohort|Adverse Event|0|||
127683778|NCT03144674|459466652|FG002|Overall Study|Multifactorial Cognitive Decline|0|||
127683779|NCT03144674|459466653|FG003|Overall Study|Multifactorial Cognitive Decline|1|||
127683780|NCT03144674|459466650|FG000|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
127683781|NCT03144674|459466651|FG001|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
127683782|NCT03144674|459466652|FG002|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
127683783|NCT03144674|459466653|FG003|Overall Study|Progression of Chronic Lymphocytic Leukemia|1|||
127683784|NCT03368664|459466654|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
127683785|NCT03368664|459466654|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
127683786|NCT03368664|459466654|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
127683787|NCT03368664|459466654|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
127683788|NCT00837616|459466655|FG000|Overall Study|Withdrawal by Subject|0|||
127683789|NCT00837616|459466656|FG001|Overall Study|Withdrawal by Subject|1|||
127683790|NCT00457691|459466658|FG000|Overall Study|Adverse Event|4|||
127683791|NCT00457691|459466659|FG001|Overall Study|Adverse Event|1|||
127683792|NCT00457691|459466658|FG000|Overall Study|Death|163|||
127683793|NCT00457691|459466659|FG001|Overall Study|Death|148|||
127683794|NCT00457691|459466658|FG000|Overall Study|Protocol Violation|1|||
127683795|NCT00457691|459466659|FG001|Overall Study|Protocol Violation|3|||
127683796|NCT00457691|459466658|FG000|Overall Study|Lost to Follow-up|23|||
127683797|NCT00457691|459466659|FG001|Overall Study|Lost to Follow-up|14|||
127683798|NCT00457691|459466658|FG000|Overall Study|Study terminated by Sponsor|1|||
127683799|NCT00457691|459466659|FG001|Overall Study|Study terminated by Sponsor|1|||
127683800|NCT00457691|459466658|FG000|Overall Study|Subject refused (reason other than AE)|14|||
127683801|NCT00457691|459466659|FG001|Overall Study|Subject refused (reason other than AE)|19|||
127683802|NCT00457691|459466658|FG000|Overall Study|Disease progression, study terminated|180|||
127683803|NCT00457691|459466659|FG001|Overall Study|Disease progression, study terminated|196|||
127683804|NCT01121549|459466662|FG000|Overall Study|Adverse Event|10|||
127683805|NCT01121549|459466662|FG000|Overall Study|Lack of Efficacy|11|||
127683806|NCT01121549|459466662|FG000|Overall Study|Lost to Follow-up|12|||
127683807|NCT01121549|459466662|FG000|Overall Study|Did not meet entrance criteria|9|||
127683808|NCT01121549|459466662|FG000|Overall Study|Study terminated by sponsor|197|||
127683809|NCT01121549|459466662|FG000|Overall Study|Pregnancy|1|||
127683810|NCT01121549|459466662|FG000|Overall Study|Protocol Violation|33|||
127683811|NCT01121549|459466662|FG000|Overall Study|Withdrawal by Subject|16|||
127683812|NCT01121549|459466662|FG000|Overall Study|Other|58|||
127683813|NCT04789408|459466663|FG000|Overall Study|Death|4|||
127683814|NCT04789408|459466664|FG001|Overall Study|Death|3|||
127683815|NCT04789408|459466665|FG002|Overall Study|Death|6|||
127683816|NCT04789408|459466663|FG000|Overall Study|Did not meet eligibility criteria|1|||
127683817|NCT04789408|459466664|FG001|Overall Study|Did not meet eligibility criteria|0|||
127683818|NCT04789408|459466665|FG002|Overall Study|Did not meet eligibility criteria|0|||
127683819|NCT04789408|459466663|FG000|Overall Study|Participant withdrawal of consent from further follow-up|0|||
127683820|NCT04789408|459466664|FG001|Overall Study|Participant withdrawal of consent from further follow-up|0|||
127683821|NCT04789408|459466665|FG002|Overall Study|Participant withdrawal of consent from further follow-up|1|||
127683822|NCT02079844|459466666|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
127683823|NCT02079844|459466667|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
127683824|NCT02079844|459466668|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
127683825|NCT02079844|459466666|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
127683826|NCT02079844|459466667|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
127683827|NCT02079844|459466668|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
127683828|NCT01420549|459466669|FG000|Overall Study|Adverse Event|1|||
127683829|NCT01420549|459466670|FG001|Overall Study|Adverse Event|1|||
127683830|NCT01420549|459466669|FG000|Overall Study|Lost to Follow-up|2|||
127683831|NCT01420549|459466670|FG001|Overall Study|Lost to Follow-up|2|||
127683832|NCT01420549|459466669|FG000|Overall Study|Protocol Violation|0|||
127683833|NCT01420549|459466670|FG001|Overall Study|Protocol Violation|1|||
127683834|NCT01420549|459466669|FG000|Overall Study|Non-adherence to medication|4|||
127683835|NCT01420549|459466670|FG001|Overall Study|Non-adherence to medication|1|||
127683836|NCT00002842|459468261|FG000|Overall Study|ineligible for surgical resection|27|||
127683837|NCT00508924|459468262|FG000|Overall Study|Protocol Violation|0|||
127683838|NCT00508924|459468263|FG001|Overall Study|Protocol Violation|0|||
127683839|NCT00508924|459468264|FG002|Overall Study|Protocol Violation|1|||
127683840|NCT00508924|459468265|FG003|Overall Study|Protocol Violation|1|||
127683841|NCT02755805|459468266|FG000|Overall Study|Lost to Follow-up|1|||
127683842|NCT02755805|459468267|FG001|Overall Study|Lost to Follow-up|2|||
127683843|NCT02755805|459468266|FG000|Overall Study|Refused assessments|1|||
127683844|NCT02755805|459468267|FG001|Overall Study|Refused assessments|0|||
127683845|NCT02755805|459468266|FG000|Overall Study|Withdrawal by Subject|0|||
127683846|NCT02755805|459468267|FG001|Overall Study|Withdrawal by Subject|2|||
127683847|NCT02252042|459468272|FG000|Overall Study|Adverse Event|9|||
127683848|NCT02252042|459468273|FG001|Overall Study|Adverse Event|6|||
127683849|NCT02252042|459468272|FG000|Overall Study|Death|209|||
127683850|NCT02252042|459468273|FG001|Overall Study|Death|217|||
127683851|NCT02252042|459468272|FG000|Overall Study|Physician Decision|0|||
127683852|NCT02252042|459468273|FG001|Overall Study|Physician Decision|2|||
128016092|NCT02335944|460682224|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
127683853|NCT02252042|459468272|FG000|Overall Study|Transferred to Extension Study|7|||
127683854|NCT02252042|459468273|FG001|Overall Study|Transferred to Extension Study|1|||
127547469|NCT02113982|458974411|FG007|Stage 3: Efficacy Cohort|Adverse Event|0|||
127547470|NCT02113982|458974412|FG008|Stage 3: Efficacy Cohort|Adverse Event|0|||
127547471|NCT02113982|458974413|FG009|Stage 3: Efficacy Cohort|Adverse Event|0|||
127547472|NCT02113982|458974414|FG010|Stage 3: Efficacy Cohort|Adverse Event|0|||
127547473|NCT02113982|458974415|FG011|Stage 3: Efficacy Cohort|Adverse Event|1|||
127547474|NCT02113982|458974416|FG012|Stage 3: Efficacy Cohort|Adverse Event|0|||
127547475|NCT02113982|458974417|FG013|Stage 3: Efficacy Cohort|Adverse Event|0|||
127547476|NCT02113982|458974404|FG000|Stage 3: Efficacy Cohort|Physician Decision|0|||
127547477|NCT02113982|458974405|FG001|Stage 3: Efficacy Cohort|Physician Decision|0|||
127547478|NCT02113982|458974406|FG002|Stage 3: Efficacy Cohort|Physician Decision|0|||
127547479|NCT02113982|458974407|FG003|Stage 3: Efficacy Cohort|Physician Decision|0|||
127547480|NCT02113982|458974408|FG004|Stage 3: Efficacy Cohort|Physician Decision|0|||
127547481|NCT02113982|458974409|FG005|Stage 3: Efficacy Cohort|Physician Decision|0|||
127547482|NCT02113982|458974410|FG006|Stage 3: Efficacy Cohort|Physician Decision|0|||
127547483|NCT02113982|458974411|FG007|Stage 3: Efficacy Cohort|Physician Decision|0|||
127547484|NCT02113982|458974412|FG008|Stage 3: Efficacy Cohort|Physician Decision|0|||
127547485|NCT02113982|458974413|FG009|Stage 3: Efficacy Cohort|Physician Decision|0|||
127547486|NCT02113982|458974414|FG010|Stage 3: Efficacy Cohort|Physician Decision|0|||
127547487|NCT02113982|458974415|FG011|Stage 3: Efficacy Cohort|Physician Decision|3|||
127547488|NCT02113982|458974416|FG012|Stage 3: Efficacy Cohort|Physician Decision|0|||
127547489|NCT02113982|458974417|FG013|Stage 3: Efficacy Cohort|Physician Decision|0|||
127547490|NCT02113982|458974404|FG000|Stage 3: Efficacy Cohort|Progressive Disease|0|||
127547491|NCT02113982|458974405|FG001|Stage 3: Efficacy Cohort|Progressive Disease|0|||
127547492|NCT02113982|458974406|FG002|Stage 3: Efficacy Cohort|Progressive Disease|0|||
127547493|NCT02113982|458974407|FG003|Stage 3: Efficacy Cohort|Progressive Disease|0|||
127547494|NCT02113982|458974408|FG004|Stage 3: Efficacy Cohort|Progressive Disease|0|||
127547495|NCT02113982|458974409|FG005|Stage 3: Efficacy Cohort|Progressive Disease|0|||
127547496|NCT02113982|458974410|FG006|Stage 3: Efficacy Cohort|Progressive Disease|0|||
127547497|NCT02113982|458974411|FG007|Stage 3: Efficacy Cohort|Progressive Disease|0|||
127547498|NCT02113982|458974412|FG008|Stage 3: Efficacy Cohort|Progressive Disease|0|||
127547499|NCT02113982|458974413|FG009|Stage 3: Efficacy Cohort|Progressive Disease|0|||
127547500|NCT02113982|458974414|FG010|Stage 3: Efficacy Cohort|Progressive Disease|0|||
127547501|NCT02113982|458974415|FG011|Stage 3: Efficacy Cohort|Progressive Disease|4|||
127547502|NCT02113982|458974416|FG012|Stage 3: Efficacy Cohort|Progressive Disease|0|||
127547503|NCT02113982|458974417|FG013|Stage 3: Efficacy Cohort|Progressive Disease|0|||
127547504|NCT02113982|458974404|FG000|Stage 3: Efficacy Cohort|Transplant|0|||
127547505|NCT02113982|458974405|FG001|Stage 3: Efficacy Cohort|Transplant|0|||
127547506|NCT02113982|458974406|FG002|Stage 3: Efficacy Cohort|Transplant|0|||
127547507|NCT02113982|458974407|FG003|Stage 3: Efficacy Cohort|Transplant|0|||
127547508|NCT02113982|458974408|FG004|Stage 3: Efficacy Cohort|Transplant|0|||
127547509|NCT02113982|458974409|FG005|Stage 3: Efficacy Cohort|Transplant|0|||
127547510|NCT02113982|458974410|FG006|Stage 3: Efficacy Cohort|Transplant|0|||
127547511|NCT02113982|458974411|FG007|Stage 3: Efficacy Cohort|Transplant|0|||
127547512|NCT02113982|458974412|FG008|Stage 3: Efficacy Cohort|Transplant|0|||
127547513|NCT02113982|458974413|FG009|Stage 3: Efficacy Cohort|Transplant|0|||
127547514|NCT02113982|458974414|FG010|Stage 3: Efficacy Cohort|Transplant|0|||
127547515|NCT02113982|458974415|FG011|Stage 3: Efficacy Cohort|Transplant|5|||
127547516|NCT02113982|458974416|FG012|Stage 3: Efficacy Cohort|Transplant|0|||
127547517|NCT02113982|458974417|FG013|Stage 3: Efficacy Cohort|Transplant|0|||
127547518|NCT02113982|458974404|FG000|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
127547519|NCT02113982|458974405|FG001|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
127547520|NCT02113982|458974406|FG002|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
127547521|NCT02113982|458974407|FG003|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
127547522|NCT02113982|458974408|FG004|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
127547523|NCT02113982|458974409|FG005|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
127547524|NCT02113982|458974410|FG006|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
127547525|NCT02113982|458974411|FG007|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
127547526|NCT02113982|458974412|FG008|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
127547527|NCT02113982|458974413|FG009|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
127547528|NCT02113982|458974414|FG010|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
127547529|NCT02113982|458974415|FG011|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
127547530|NCT02113982|458974416|FG012|Stage 4: First-line and R/R BPDCN|Adverse Event|4|||
127547531|NCT02113982|458974417|FG013|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
127547532|NCT02113982|458974404|FG000|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
127547533|NCT02113982|458974405|FG001|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
127547534|NCT02113982|458974406|FG002|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
127547535|NCT02113982|458974407|FG003|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
127547536|NCT02113982|458974408|FG004|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
127547537|NCT02113982|458974409|FG005|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
127547538|NCT02113982|458974410|FG006|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
127547539|NCT02113982|458974411|FG007|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
127683855|NCT02252042|459468272|FG000|Overall Study|Did Not Continue on Extension Study|7|||
127683856|NCT02252042|459468273|FG001|Overall Study|Did Not Continue on Extension Study|2|||
127683857|NCT02252042|459468272|FG000|Overall Study|Withdrawal by Subject|15|||
127683858|NCT02252042|459468273|FG001|Overall Study|Withdrawal by Subject|20|||
127683859|NCT02593149|459468274|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
127683860|NCT02593149|459468275|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
127683861|NCT02593149|459468274|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
127683862|NCT02593149|459468275|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
127683863|NCT00071799|459468276|FG000|Overall Study|Adverse Event|19|||
127683864|NCT00071799|459468277|FG001|Overall Study|Adverse Event|10|||
127683865|NCT00071799|459468276|FG000|Overall Study|Protocol Violation|1|||
127683866|NCT00071799|459468277|FG001|Overall Study|Protocol Violation|7|||
127683867|NCT00071799|459468276|FG000|Overall Study|Lost to Follow-up|1|||
127683868|NCT00071799|459468277|FG001|Overall Study|Lost to Follow-up|1|||
127683869|NCT00071799|459468276|FG000|Overall Study|Withdrawal by Subject|15|||
127683870|NCT00071799|459468277|FG001|Overall Study|Withdrawal by Subject|37|||
127683871|NCT00071799|459468276|FG000|Overall Study|Physician Decision|0|||
127683872|NCT00071799|459468277|FG001|Overall Study|Physician Decision|2|||
127683873|NCT00071799|459468276|FG000|Overall Study|Lack of Efficacy|11|||
127683874|NCT00071799|459468277|FG001|Overall Study|Lack of Efficacy|18|||
127683875|NCT00071799|459468276|FG000|Overall Study|Disease Progression|23|||
127683876|NCT00071799|459468277|FG001|Overall Study|Disease Progression|20|||
127683877|NCT00071799|459468276|FG000|Overall Study|Different Central+Local Pathology Review|0|||
127683878|NCT00071799|459468277|FG001|Overall Study|Different Central+Local Pathology Review|1|||
127683879|NCT00071799|459468276|FG000|Overall Study|Not Documented|0|||
127683880|NCT00071799|459468277|FG001|Overall Study|Not Documented|2|||
127683881|NCT00979992|459468279|FG000|Overall Study|Ineligible - inadequate pathology|1|||
127683882|NCT00979992|459468279|FG000|Overall Study|Ineligible - wrong cell type|2|||
127683883|NCT00979992|459468279|FG000|Overall Study|Refused - Never Treated|2|||
127683884|NCT04532528|459468283|FG000|Overall Study|Adverse Event|12|||
127683885|NCT04532528|459468284|FG001|Overall Study|Adverse Event|17|||
127683886|NCT04532528|459468283|FG000|Overall Study|Withdrawal of consent|16|||
127683887|NCT04532528|459468284|FG001|Overall Study|Withdrawal of consent|17|||
127683888|NCT04532528|459468283|FG000|Overall Study|Participant stop Dabigatran during the 12-month study period|22|||
127683889|NCT04532528|459468284|FG001|Overall Study|Participant stop Dabigatran during the 12-month study period|24|||
127683890|NCT04532528|459468283|FG000|Overall Study|Lost to Follow-up|69|||
127683891|NCT04532528|459468284|FG001|Overall Study|Lost to Follow-up|68|||
127683892|NCT04532528|459468283|FG000|Overall Study|Administrative problems|12|||
127683893|NCT04532528|459468284|FG001|Overall Study|Administrative problems|14|||
127683894|NCT04532528|459468283|FG000|Overall Study|Death|3|||
127683895|NCT04532528|459468284|FG001|Overall Study|Death|3|||
127683896|NCT04532528|459468283|FG000|Overall Study|Other|38|||
127683897|NCT04532528|459468284|FG001|Overall Study|Other|46|||
127683898|NCT01636687|459468285|FG000|Induction Period|Withdrawal by Subject|1|||
127683899|NCT01636687|459468286|FG001|Induction Period|Withdrawal by Subject|0|||
127683900|NCT01636687|459468287|FG002|Induction Period|Withdrawal by Subject|0|||
127683901|NCT01636687|459468288|FG003|Induction Period|Withdrawal by Subject|0|||
127683902|NCT01636687|459468289|FG004|Induction Period|Withdrawal by Subject|0|||
127683903|NCT01636687|459468285|FG000|Induction Period|Adverse Event|1|||
127683904|NCT01636687|459468286|FG001|Induction Period|Adverse Event|0|||
127683905|NCT01636687|459468287|FG002|Induction Period|Adverse Event|0|||
127683906|NCT01636687|459468288|FG003|Induction Period|Adverse Event|0|||
127683907|NCT01636687|459468289|FG004|Induction Period|Adverse Event|1|||
127683908|NCT01636687|459468285|FG000|Induction Period|Lack of Efficacy|0|||
127683909|NCT01636687|459468286|FG001|Induction Period|Lack of Efficacy|0|||
127683910|NCT01636687|459468287|FG002|Induction Period|Lack of Efficacy|0|||
127683911|NCT01636687|459468288|FG003|Induction Period|Lack of Efficacy|0|||
127683912|NCT01636687|459468289|FG004|Induction Period|Lack of Efficacy|1|||
127683913|NCT01636687|459468285|FG000|Induction Period|Physician Decision|1|||
127683914|NCT01636687|459468286|FG001|Induction Period|Physician Decision|0|||
127683915|NCT01636687|459468287|FG002|Induction Period|Physician Decision|0|||
127683916|NCT01636687|459468288|FG003|Induction Period|Physician Decision|0|||
127683917|NCT01636687|459468289|FG004|Induction Period|Physician Decision|0|||
127683918|NCT01636687|459468285|FG000|Maintenance Period|Withdrawal by Subject|2|||
127683919|NCT01636687|459468286|FG001|Maintenance Period|Withdrawal by Subject|0|||
127683920|NCT01636687|459468287|FG002|Maintenance Period|Withdrawal by Subject|2|||
127683921|NCT01636687|459468288|FG003|Maintenance Period|Withdrawal by Subject|0|||
127683922|NCT01636687|459468289|FG004|Maintenance Period|Withdrawal by Subject|0|||
127683923|NCT01636687|459468285|FG000|Maintenance Period|Adverse Event|1|||
127683924|NCT01636687|459468286|FG001|Maintenance Period|Adverse Event|0|||
127683925|NCT01636687|459468287|FG002|Maintenance Period|Adverse Event|0|||
127683926|NCT01636687|459468288|FG003|Maintenance Period|Adverse Event|0|||
127683927|NCT01636687|459468289|FG004|Maintenance Period|Adverse Event|0|||
127683928|NCT01636687|459468285|FG000|Maintenance Period|Lack of Efficacy|4|||
127683929|NCT01636687|459468286|FG001|Maintenance Period|Lack of Efficacy|1|||
127683930|NCT01636687|459468287|FG002|Maintenance Period|Lack of Efficacy|0|||
127683931|NCT01636687|459468288|FG003|Maintenance Period|Lack of Efficacy|0|||
127547540|NCT02113982|458974412|FG008|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
127547541|NCT02113982|458974413|FG009|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
127547542|NCT02113982|458974414|FG010|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
127547543|NCT02113982|458974415|FG011|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
127547544|NCT02113982|458974416|FG012|Stage 4: First-line and R/R BPDCN|Physician Decision|7|||
127547545|NCT02113982|458974417|FG013|Stage 4: First-line and R/R BPDCN|Physician Decision|2|||
127547546|NCT02113982|458974404|FG000|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
127547547|NCT02113982|458974405|FG001|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
127547548|NCT02113982|458974406|FG002|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
127547549|NCT02113982|458974407|FG003|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
127547550|NCT02113982|458974408|FG004|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
127547551|NCT02113982|458974409|FG005|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
127547552|NCT02113982|458974410|FG006|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
127547553|NCT02113982|458974411|FG007|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
127547554|NCT02113982|458974412|FG008|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
127547555|NCT02113982|458974413|FG009|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
127547556|NCT02113982|458974414|FG010|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
127547557|NCT02113982|458974415|FG011|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
127547558|NCT02113982|458974416|FG012|Stage 4: First-line and R/R BPDCN|Progressive Disease|14|||
127547559|NCT02113982|458974417|FG013|Stage 4: First-line and R/R BPDCN|Progressive Disease|3|||
127547560|NCT02113982|458974404|FG000|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
127547561|NCT02113982|458974405|FG001|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
127547562|NCT02113982|458974406|FG002|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
127547563|NCT02113982|458974407|FG003|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
127547564|NCT02113982|458974408|FG004|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
127547565|NCT02113982|458974409|FG005|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
127547566|NCT02113982|458974410|FG006|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
127547567|NCT02113982|458974411|FG007|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
127547568|NCT02113982|458974412|FG008|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
127547569|NCT02113982|458974413|FG009|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
127547570|NCT02113982|458974414|FG010|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
127547571|NCT02113982|458974415|FG011|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
127547572|NCT02113982|458974416|FG012|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|4|||
127547573|NCT02113982|458974417|FG013|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|2|||
127547574|NCT02113982|458974404|FG000|Stage 4: First-line and R/R BPDCN|Transplant|0|||
127547575|NCT02113982|458974405|FG001|Stage 4: First-line and R/R BPDCN|Transplant|0|||
127547576|NCT02113982|458974406|FG002|Stage 4: First-line and R/R BPDCN|Transplant|0|||
127547577|NCT02113982|458974407|FG003|Stage 4: First-line and R/R BPDCN|Transplant|0|||
127547578|NCT02113982|458974408|FG004|Stage 4: First-line and R/R BPDCN|Transplant|0|||
127547579|NCT02113982|458974409|FG005|Stage 4: First-line and R/R BPDCN|Transplant|0|||
127547580|NCT02113982|458974410|FG006|Stage 4: First-line and R/R BPDCN|Transplant|0|||
127547581|NCT02113982|458974411|FG007|Stage 4: First-line and R/R BPDCN|Transplant|0|||
127547582|NCT02113982|458974412|FG008|Stage 4: First-line and R/R BPDCN|Transplant|0|||
127547583|NCT02113982|458974413|FG009|Stage 4: First-line and R/R BPDCN|Transplant|0|||
127547584|NCT02113982|458974414|FG010|Stage 4: First-line and R/R BPDCN|Transplant|0|||
127547585|NCT02113982|458974415|FG011|Stage 4: First-line and R/R BPDCN|Transplant|0|||
127547586|NCT02113982|458974416|FG012|Stage 4: First-line and R/R BPDCN|Transplant|5|||
127547587|NCT02113982|458974417|FG013|Stage 4: First-line and R/R BPDCN|Transplant|0|||
127547588|NCT02113982|458974404|FG000|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
127547589|NCT02113982|458974405|FG001|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
127547590|NCT02113982|458974406|FG002|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
127547591|NCT02113982|458974407|FG003|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
127547592|NCT02113982|458974408|FG004|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
127547593|NCT02113982|458974409|FG005|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
127547594|NCT02113982|458974410|FG006|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
127547595|NCT02113982|458974411|FG007|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
127547596|NCT02113982|458974412|FG008|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
127547597|NCT02113982|458974413|FG009|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
127547598|NCT02113982|458974414|FG010|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
127547599|NCT02113982|458974415|FG011|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
127547600|NCT02113982|458974416|FG012|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|2|||
127547601|NCT02113982|458974417|FG013|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
127547602|NCT02113982|458974404|FG000|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
127547603|NCT02113982|458974405|FG001|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
127547604|NCT02113982|458974406|FG002|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
127547605|NCT02113982|458974407|FG003|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
127547606|NCT02113982|458974408|FG004|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
127547607|NCT02113982|458974409|FG005|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
127547608|NCT02113982|458974410|FG006|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
127547609|NCT02113982|458974411|FG007|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
127547610|NCT02113982|458974412|FG008|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
127547611|NCT02113982|458974413|FG009|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
127547612|NCT02113982|458974414|FG010|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
127547613|NCT02113982|458974415|FG011|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
127547614|NCT02113982|458974416|FG012|Stage 4: First-line and R/R BPDCN|Patient Preference|1|||
127547615|NCT02113982|458974417|FG013|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
127770510|NCT00770341|459784481|FG000|Overall Study|Did not meet eligibility criteria|1|||
127770511|NCT00770341|459784482|FG001|Overall Study|Did not meet eligibility criteria|0|||
127770512|NCT00770341|459784483|FG002|Overall Study|Did not meet eligibility criteria|0|||
127770513|NCT00770341|459784481|FG000|Overall Study|Withdrawal by Subject|0|||
127770514|NCT00770341|459784482|FG001|Overall Study|Withdrawal by Subject|1|||
127770515|NCT00770341|459784483|FG002|Overall Study|Withdrawal by Subject|0|||
127770516|NCT00770341|459784481|FG000|Overall Study|Clinical Adverse Event|3|||
127770517|NCT00770341|459784482|FG001|Overall Study|Clinical Adverse Event|1|||
127770518|NCT00770341|459784483|FG002|Overall Study|Clinical Adverse Event|2|||
127770519|NCT00770341|459784481|FG000|Overall Study|Laboratory adverse event|3|||
127770520|NCT00770341|459784482|FG001|Overall Study|Laboratory adverse event|3|||
127770521|NCT00770341|459784483|FG002|Overall Study|Laboratory adverse event|0|||
127770522|NCT00770341|459784481|FG000|Overall Study|Lack of Efficacy|3|||
127770523|NCT00770341|459784482|FG001|Overall Study|Lack of Efficacy|0|||
127770524|NCT00770341|459784483|FG002|Overall Study|Lack of Efficacy|1|||
127770525|NCT00770341|459784481|FG000|Overall Study|Other|1|||
127770526|NCT00770341|459784482|FG001|Overall Study|Other|0|||
127770527|NCT00770341|459784483|FG002|Overall Study|Other|0|||
127770528|NCT00770341|459784481|FG000|Overall Study|Not treated|1|||
127770529|NCT00770341|459784482|FG001|Overall Study|Not treated|0|||
127770530|NCT00770341|459784483|FG002|Overall Study|Not treated|0|||
127770531|NCT00960531|459784489|FG000|Overall Study|Lack of Efficacy|1|||
127770532|NCT00960531|459784490|FG001|Overall Study|Lack of Efficacy|0|||
127770533|NCT00960531|459784491|FG002|Overall Study|Lack of Efficacy|0|||
127770534|NCT00960531|459784492|FG003|Overall Study|Lack of Efficacy|0|||
127770535|NCT00960531|459784493|FG004|Overall Study|Lack of Efficacy|0|||
127770536|NCT00960531|459784494|FG005|Overall Study|Lack of Efficacy|0|||
127770537|NCT00960531|459784495|FG006|Overall Study|Lack of Efficacy|0|||
127770538|NCT00960531|459784496|FG007|Overall Study|Lack of Efficacy|0|||
127770539|NCT00960531|459784497|FG008|Overall Study|Lack of Efficacy|0|||
127770540|NCT00960531|459784498|FG009|Overall Study|Lack of Efficacy|0|||
127770541|NCT00960531|459784489|FG000|Overall Study|Withdrawal by Subject|1|||
127770542|NCT00960531|459784490|FG001|Overall Study|Withdrawal by Subject|0|||
127770543|NCT00960531|459784491|FG002|Overall Study|Withdrawal by Subject|5|||
127770544|NCT00960531|459784492|FG003|Overall Study|Withdrawal by Subject|2|||
127770545|NCT00960531|459784493|FG004|Overall Study|Withdrawal by Subject|0|||
127770546|NCT00960531|459784494|FG005|Overall Study|Withdrawal by Subject|0|||
127770547|NCT00960531|459784495|FG006|Overall Study|Withdrawal by Subject|2|||
127770548|NCT00960531|459784496|FG007|Overall Study|Withdrawal by Subject|0|||
127770549|NCT00960531|459784497|FG008|Overall Study|Withdrawal by Subject|1|||
127770550|NCT00960531|459784498|FG009|Overall Study|Withdrawal by Subject|0|||
127770551|NCT00960531|459784489|FG000|Overall Study|Caregiver Request|2|||
127770552|NCT00960531|459784490|FG001|Overall Study|Caregiver Request|0|||
127770553|NCT00960531|459784491|FG002|Overall Study|Caregiver Request|6|||
127770554|NCT00960531|459784492|FG003|Overall Study|Caregiver Request|5|||
127770555|NCT00960531|459784493|FG004|Overall Study|Caregiver Request|0|||
127770556|NCT00960531|459784494|FG005|Overall Study|Caregiver Request|2|||
127770557|NCT00960531|459784495|FG006|Overall Study|Caregiver Request|3|||
127770558|NCT00960531|459784496|FG007|Overall Study|Caregiver Request|1|||
127770559|NCT00960531|459784497|FG008|Overall Study|Caregiver Request|3|||
127770560|NCT00960531|459784498|FG009|Overall Study|Caregiver Request|0|||
127547616|NCT02085161|458974419|FG000|Overall Study|Not Treated|1|||
127547617|NCT02085161|458974420|FG001|Overall Study|Not Treated|0|||
127547618|NCT02085161|458974421|FG002|Overall Study|Not Treated|0|||
127770561|NCT00960531|459784489|FG000|Overall Study|Investigator Request|0|||
127770562|NCT00960531|459784490|FG001|Overall Study|Investigator Request|0|||
127770563|NCT00960531|459784491|FG002|Overall Study|Investigator Request|1|||
127770564|NCT00960531|459784492|FG003|Overall Study|Investigator Request|0|||
127770565|NCT00960531|459784493|FG004|Overall Study|Investigator Request|0|||
127770566|NCT00960531|459784494|FG005|Overall Study|Investigator Request|0|||
127770567|NCT00960531|459784495|FG006|Overall Study|Investigator Request|0|||
127770568|NCT00960531|459784496|FG007|Overall Study|Investigator Request|0|||
127770569|NCT00960531|459784497|FG008|Overall Study|Investigator Request|0|||
127770570|NCT00960531|459784498|FG009|Overall Study|Investigator Request|0|||
127770571|NCT00960531|459784489|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
127547619|NCT02085161|458974422|FG003|Overall Study|Not Treated|0|||
127547620|NCT02085161|458974419|FG000|Overall Study|Adverse Event|8|||
127547621|NCT02085161|458974420|FG001|Overall Study|Adverse Event|5|||
127547622|NCT02085161|458974421|FG002|Overall Study|Adverse Event|4|||
127547623|NCT02085161|458974422|FG003|Overall Study|Adverse Event|5|||
127547624|NCT02085161|458974419|FG000|Overall Study|Protocol Violation|0|||
127547625|NCT02085161|458974420|FG001|Overall Study|Protocol Violation|1|||
127547626|NCT02085161|458974421|FG002|Overall Study|Protocol Violation|0|||
127547627|NCT02085161|458974422|FG003|Overall Study|Protocol Violation|1|||
127547628|NCT02085161|458974419|FG000|Overall Study|Withdrawal by Subject|2|||
127547629|NCT02085161|458974420|FG001|Overall Study|Withdrawal by Subject|4|||
127547630|NCT02085161|458974421|FG002|Overall Study|Withdrawal by Subject|0|||
127547631|NCT02085161|458974422|FG003|Overall Study|Withdrawal by Subject|3|||
127547632|NCT02085161|458974419|FG000|Overall Study|Other Reason|1|||
127547633|NCT02085161|458974420|FG001|Overall Study|Other Reason|0|||
127547634|NCT02085161|458974421|FG002|Overall Study|Other Reason|1|||
127547635|NCT02085161|458974422|FG003|Overall Study|Other Reason|1|||
127547636|NCT01774721|458974427|FG000|Overall Study|Death|133|||
127547637|NCT01774721|458974428|FG001|Overall Study|Death|152|||
127547638|NCT01774721|458974427|FG000|Overall Study|Withdrawal by Subject|20|||
127547639|NCT01774721|458974428|FG001|Overall Study|Withdrawal by Subject|14|||
127547640|NCT01774721|458974427|FG000|Overall Study|Lost to Follow-up|6|||
127547641|NCT01774721|458974428|FG001|Overall Study|Lost to Follow-up|7|||
127547642|NCT01774721|458974427|FG000|Overall Study|Did not meet eligibility criteria|0|||
127547643|NCT01774721|458974428|FG001|Overall Study|Did not meet eligibility criteria|3|||
127547644|NCT01774721|458974427|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
127547645|NCT01774721|458974428|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
127547646|NCT01774721|458974427|FG000|Overall Study|Study terminated by sponsor|5|||
127547647|NCT01774721|458974428|FG001|Overall Study|Study terminated by sponsor|0|||
127547648|NCT01774721|458974427|FG000|Overall Study|Disease progression|5|||
127547649|NCT01774721|458974428|FG001|Overall Study|Disease progression|0|||
127547650|NCT01936870|458974429|FG000|Overall Study|No Visit After Treatment|176|||
127547651|NCT01936870|458974429|FG000|Overall Study|Protocol Violation|12|||
127547652|NCT01936870|458974429|FG000|Overall Study|No Drug Administration|1|||
127547653|NCT03848832|458974432|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
127547654|NCT03848832|458974433|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
127547655|NCT03848832|458974434|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
127547656|NCT03848832|458974432|FG000|Overall Study|Withdrawal by Subject|0|||
127547657|NCT03848832|458974433|FG001|Overall Study|Withdrawal by Subject|0|||
127547658|NCT03848832|458974434|FG002|Overall Study|Withdrawal by Subject|1|||
127547659|NCT03848832|458974432|FG000|Overall Study|Withdrawal (Covid-19)|0|||
127547660|NCT03848832|458974433|FG001|Overall Study|Withdrawal (Covid-19)|2|||
127547661|NCT03848832|458974434|FG002|Overall Study|Withdrawal (Covid-19)|0|||
127547662|NCT03848832|458974432|FG000|Overall Study|Physician Decision|2|||
127547663|NCT03848832|458974433|FG001|Overall Study|Physician Decision|1|||
127547664|NCT03848832|458974434|FG002|Overall Study|Physician Decision|3|||
127547665|NCT03848832|458974432|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
127547666|NCT03848832|458974433|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
127547667|NCT03848832|458974434|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
127547668|NCT03848832|458974432|FG000|Overall Study|Adverse Event|1|||
127547669|NCT03848832|458974433|FG001|Overall Study|Adverse Event|0|||
127547670|NCT03848832|458974434|FG002|Overall Study|Adverse Event|0|||
127547671|NCT02399163|458974436|FG000|Overall Study|Adverse Event|2|||
127547672|NCT02399163|458974436|FG000|Overall Study|Protocol Deviation|2|||
127547673|NCT02399163|458974436|FG000|Overall Study|Withdrawal by Participant|5|||
127547674|NCT04646044|458974438|FG000|Overall Study|Lost to Follow-up|0|||
127547675|NCT04646044|458974439|FG001|Overall Study|Lost to Follow-up|0|||
127547676|NCT04646044|458974440|FG002|Overall Study|Lost to Follow-up|1|||
127547677|NCT04646044|458974441|FG003|Overall Study|Lost to Follow-up|0|||
127547678|NCT04646044|458974438|FG000|Overall Study|Withdrawal by Subject|0|||
127547679|NCT04646044|458974439|FG001|Overall Study|Withdrawal by Subject|1|||
127547680|NCT04646044|458974440|FG002|Overall Study|Withdrawal by Subject|0|||
127547681|NCT04646044|458974441|FG003|Overall Study|Withdrawal by Subject|0|||
127547682|NCT03910244|458974442|FG000|Overall Study|Adverse Event|14|||
127547683|NCT03910244|458974443|FG001|Overall Study|Adverse Event|0|||
127547684|NCT03910244|458974442|FG000|Overall Study|Death|1|||
127547685|NCT03910244|458974443|FG001|Overall Study|Death|0|||
127547686|NCT03910244|458974442|FG000|Overall Study|Lost to Follow-up|0|||
127547687|NCT03910244|458974443|FG001|Overall Study|Lost to Follow-up|2|||
127547688|NCT03910244|458974442|FG000|Overall Study|Joint withdrawal decision|1|||
127547689|NCT03910244|458974443|FG001|Overall Study|Joint withdrawal decision|0|||
127547690|NCT03910244|458974442|FG000|Overall Study|Study Terminated by Sponsor|7|||
127547691|NCT03910244|458974443|FG001|Overall Study|Study Terminated by Sponsor|4|||
127547692|NCT03910244|458974442|FG000|Overall Study|Physician Decision|1|||
127547693|NCT03910244|458974443|FG001|Overall Study|Physician Decision|0|||
127547694|NCT03910244|458974442|FG000|Overall Study|Protocol Violation|1|||
127547695|NCT03910244|458974443|FG001|Overall Study|Protocol Violation|0|||
127547696|NCT03910244|458974442|FG000|Overall Study|Withdrawal by Subject|7|||
127547697|NCT03910244|458974443|FG001|Overall Study|Withdrawal by Subject|2|||
127547698|NCT03594110|458974444|FG000|Interventional Part|Participant concerned about study treatment|23|||
127547699|NCT03594110|458974445|FG001|Interventional Part|Participant concerned about study treatment|28|||
127547700|NCT03594110|458974444|FG000|Interventional Part|Doctor advice|38|||
127547701|NCT03594110|458974445|FG001|Interventional Part|Doctor advice|40|||
127547702|NCT03594110|458974444|FG000|Interventional Part|Participants' wish|89|||
127547703|NCT03594110|458974445|FG001|Interventional Part|Participants' wish|68|||
127547704|NCT03594110|458974444|FG000|Interventional Part|Adverse event-non-fatal events|119|||
127547705|NCT03594110|458974445|FG001|Interventional Part|Adverse event-non-fatal events|116|||
127547706|NCT03594110|458974444|FG000|Interventional Part|Study drug stopped, reason missing|336|||
127547707|NCT03594110|458974445|FG001|Interventional Part|Study drug stopped, reason missing|294|||
127547708|NCT03594110|458974444|FG000|Interventional Part|Cannot attend clinic because of personal problems|8|||
127547709|NCT03594110|458974445|FG001|Interventional Part|Cannot attend clinic because of personal problems|16|||
127547710|NCT03594110|458974444|FG000|Interventional Part|Cannot attend clinic because moving out of the area|15|||
127547711|NCT03594110|458974445|FG001|Interventional Part|Cannot attend clinic because moving out of the area|9|||
127547712|NCT03594110|458974444|FG000|Interventional Part|Contraindicated drug started|32|||
127547713|NCT03594110|458974445|FG001|Interventional Part|Contraindicated drug started|18|||
127547714|NCT03594110|458974444|FG000|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|58|||
127547715|NCT03594110|458974445|FG001|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|45|||
127547716|NCT03594110|458974444|FG000|Interventional Part|Adverse event-Serious fatal events|130|||
127547717|NCT03594110|458974445|FG001|Interventional Part|Adverse event-Serious fatal events|121|||
127547718|NCT03594110|458974444|FG000|Non-interventional Part|Withdrawal by Subject|3|||
127547719|NCT03594110|458974445|FG001|Non-interventional Part|Withdrawal by Subject|4|||
127547720|NCT03594110|458974444|FG000|Non-interventional Part|Lost to Follow-up|45|||
127547721|NCT03594110|458974445|FG001|Non-interventional Part|Lost to Follow-up|41|||
127547722|NCT00803569|458974448|FG000|Overall Study|Progressive Disease|3|||
127547723|NCT00803569|458974448|FG000|Overall Study|Noncompliance|1|||
127547724|NCT00684021|458974451|FG000|Overall Study|MRI Contraindicated|1|||
127547725|NCT00684021|458974452|FG001|Overall Study|MRI Contraindicated|1|||
127547726|NCT00684021|458974453|FG002|Overall Study|MRI Contraindicated|1|||
127547727|NCT00684021|458974454|FG003|Overall Study|MRI Contraindicated|0|||
127547728|NCT00684021|458974451|FG000|Overall Study|MRI not performed|0|||
127547729|NCT00684021|458974452|FG001|Overall Study|MRI not performed|1|||
127547730|NCT00684021|458974453|FG002|Overall Study|MRI not performed|1|||
127547731|NCT00684021|458974454|FG003|Overall Study|MRI not performed|2|||
127547732|NCT00684021|458974451|FG000|Overall Study|Death|1|||
127547733|NCT00684021|458974452|FG001|Overall Study|Death|0|||
127547734|NCT00684021|458974453|FG002|Overall Study|Death|0|||
127547735|NCT00684021|458974454|FG003|Overall Study|Death|0|||
127547736|NCT04041414|458974455|FG000|Overall Study|Lost to Follow-up|1|||
127547737|NCT04041414|458974456|FG001|Overall Study|Lost to Follow-up|2|||
127547738|NCT00930046|458974457|FG000|Overall Study|Wound catheter malfunctioned|1|||
127547739|NCT00930046|458974458|FG001|Overall Study|Wound catheter malfunctioned|2|||
127547740|NCT04004988|458974459|FG000|Period 1|Physician Decision|2|||
127547741|NCT04004988|458974460|FG001|Period 1|Physician Decision|0|||
127547742|NCT04004988|458974459|FG000|Period 1|Withdrawal by Subject|0|||
127547743|NCT04004988|458974460|FG001|Period 1|Withdrawal by Subject|1|||
127547744|NCT04004988|458974459|FG000|Period 1|Adverse Event|1|||
127547745|NCT04004988|458974460|FG001|Period 1|Adverse Event|2|||
127547746|NCT01598532|458974461|FG000|Overall Study|Lost to Follow-up|3|||
127547747|NCT01598532|458974461|FG000|Overall Study|Did not meet inclusion criteria|8|||
127547748|NCT03873116|458974462|FG000|Part 1|Study drug discontinuation due to rash|0|||
127547749|NCT03873116|458974463|FG001|Part 1|Study drug discontinuation due to rash|0|||
127547750|NCT03873116|458974464|FG002|Part 1|Study drug discontinuation due to rash|0|||
127547751|NCT03873116|458974465|FG003|Part 1|Study drug discontinuation due to rash|0|||
127547752|NCT03873116|458974466|FG004|Part 1|Study drug discontinuation due to rash|0|||
127547753|NCT03873116|458974467|FG005|Part 1|Study drug discontinuation due to rash|1|||
127770572|NCT00960531|459784490|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
127770573|NCT00960531|459784491|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
127770574|NCT00960531|459784492|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
127770575|NCT00960531|459784493|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
127770576|NCT00960531|459784494|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
127770577|NCT00960531|459784495|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
127770578|NCT00960531|459784496|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
127770579|NCT00960531|459784497|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
127547754|NCT03873116|458974462|FG000|Part 2|Withdrawal by Subject|0|||
127547755|NCT03873116|458974463|FG001|Part 2|Withdrawal by Subject|0|||
127547756|NCT03873116|458974464|FG002|Part 2|Withdrawal by Subject|1|||
127547757|NCT03873116|458974465|FG003|Part 2|Withdrawal by Subject|0|||
127547758|NCT03873116|458974466|FG004|Part 2|Withdrawal by Subject|0|||
127770580|NCT00960531|459784498|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
127547759|NCT03873116|458974467|FG005|Part 2|Withdrawal by Subject|0|||
127547760|NCT03873116|458974462|FG000|Part 2|Lab abnormality or AE|0|||
127547761|NCT03873116|458974463|FG001|Part 2|Lab abnormality or AE|0|||
127547762|NCT03873116|458974464|FG002|Part 2|Lab abnormality or AE|0|||
127547763|NCT03873116|458974465|FG003|Part 2|Lab abnormality or AE|0|||
127547764|NCT03873116|458974466|FG004|Part 2|Lab abnormality or AE|1|||
127547765|NCT03873116|458974467|FG005|Part 2|Lab abnormality or AE|0|||
127547766|NCT03873116|458974462|FG000|Part 3|Withdrawal by Subject|0|||
127547767|NCT03873116|458974463|FG001|Part 3|Withdrawal by Subject|0|||
127547768|NCT03873116|458974464|FG002|Part 3|Withdrawal by Subject|0|||
127547769|NCT03873116|458974465|FG003|Part 3|Withdrawal by Subject|0|||
127547770|NCT03873116|458974466|FG004|Part 3|Withdrawal by Subject|1|||
127547771|NCT03873116|458974467|FG005|Part 3|Withdrawal by Subject|0|||
127547772|NCT00912808|458974468|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
127770581|NCT00960531|459784489|FG000|Overall Study|Lost to Follow-up|0|||
127770582|NCT00960531|459784490|FG001|Overall Study|Lost to Follow-up|0|||
127770583|NCT00960531|459784491|FG002|Overall Study|Lost to Follow-up|1|||
127770584|NCT00960531|459784492|FG003|Overall Study|Lost to Follow-up|0|||
127770585|NCT00960531|459784493|FG004|Overall Study|Lost to Follow-up|0|||
127770586|NCT00960531|459784494|FG005|Overall Study|Lost to Follow-up|0|||
127770587|NCT00960531|459784495|FG006|Overall Study|Lost to Follow-up|1|||
127770588|NCT00960531|459784496|FG007|Overall Study|Lost to Follow-up|0|||
128016093|NCT02335944|460682225|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
128016094|NCT02335944|460682226|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
128016095|NCT02335944|460682227|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
128016096|NCT02335944|460682228|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
128016097|NCT02335944|460682229|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
128016098|NCT02335944|460682230|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
128016099|NCT02335944|460682231|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
128016100|NCT02335944|460682232|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
128016101|NCT02335944|460682233|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
128016102|NCT02335944|460682224|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
128016103|NCT02335944|460682225|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
127770589|NCT00960531|459784497|FG008|Overall Study|Lost to Follow-up|0|||
127770590|NCT00960531|459784498|FG009|Overall Study|Lost to Follow-up|0|||
127770591|NCT00960531|459784489|FG000|Overall Study|Failed to Return|2|||
127770592|NCT00960531|459784490|FG001|Overall Study|Failed to Return|0|||
127770593|NCT00960531|459784491|FG002|Overall Study|Failed to Return|0|||
127770594|NCT00960531|459784492|FG003|Overall Study|Failed to Return|0|||
127770595|NCT00960531|459784493|FG004|Overall Study|Failed to Return|0|||
127770596|NCT00960531|459784494|FG005|Overall Study|Failed to Return|0|||
127770597|NCT00960531|459784495|FG006|Overall Study|Failed to Return|0|||
127770598|NCT00960531|459784496|FG007|Overall Study|Failed to Return|2|||
127770599|NCT00960531|459784497|FG008|Overall Study|Failed to Return|0|||
127770600|NCT00960531|459784498|FG009|Overall Study|Failed to Return|0|||
127770601|NCT00960531|459784489|FG000|Overall Study|Adverse Event (AE)|2|||
128016104|NCT02335944|460682226|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
128016105|NCT02335944|460682227|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
128016106|NCT02335944|460682228|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
128016107|NCT02335944|460682229|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
128016108|NCT02335944|460682230|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
128016109|NCT02335944|460682231|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
128016110|NCT02335944|460682232|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
128016111|NCT02335944|460682233|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
128016112|NCT02335944|460682224|FG000|Post-treatment Follow-up|Adverse Event|0|||
128016113|NCT02335944|460682225|FG001|Post-treatment Follow-up|Adverse Event|0|||
128016114|NCT02335944|460682226|FG002|Post-treatment Follow-up|Adverse Event|0|||
128016115|NCT02335944|460682227|FG003|Post-treatment Follow-up|Adverse Event|0|||
128016116|NCT02335944|460682228|FG004|Post-treatment Follow-up|Adverse Event|0|||
128016117|NCT02335944|460682229|FG005|Post-treatment Follow-up|Adverse Event|1|||
128016118|NCT02335944|460682230|FG006|Post-treatment Follow-up|Adverse Event|0|||
128016119|NCT02335944|460682231|FG007|Post-treatment Follow-up|Adverse Event|0|||
128016120|NCT02335944|460682232|FG008|Post-treatment Follow-up|Adverse Event|0|||
127547773|NCT00912808|458974469|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
127547774|NCT00912808|458974468|FG000|Washout|Withdrawal by Subject|0|||
127547775|NCT00912808|458974469|FG001|Washout|Withdrawal by Subject|1|||
127547776|NCT00912808|458974468|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
128016121|NCT02335944|460682233|FG009|Post-treatment Follow-up|Adverse Event|0|||
128016122|NCT02335944|460682224|FG000|Post-treatment Follow-up|Death|0|||
128016123|NCT02335944|460682225|FG001|Post-treatment Follow-up|Death|0|||
127547777|NCT00912808|458974469|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
127547778|NCT00912808|458974468|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
127547779|NCT00912808|458974469|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
128016124|NCT02335944|460682226|FG002|Post-treatment Follow-up|Death|0|||
127770602|NCT00960531|459784490|FG001|Overall Study|Adverse Event (AE)|0|||
127770603|NCT00960531|459784491|FG002|Overall Study|Adverse Event (AE)|0|||
128016125|NCT02335944|460682227|FG003|Post-treatment Follow-up|Death|1|||
127547780|NCT04682366|458974470|FG000|Overall Study|Lost to Follow-up|1|||
127547781|NCT04682366|458974471|FG001|Overall Study|Lost to Follow-up|1|||
127547782|NCT00702221|458974472|FG000|Overall Study|Adverse Event|4|||
127547783|NCT00702221|458974473|FG001|Overall Study|Adverse Event|3|||
127547784|NCT02531802|458974476|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
127547785|NCT02531802|458974477|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
127547786|NCT02531802|458974478|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
127547787|NCT02531802|458974479|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
127547788|NCT02531802|458974480|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
127547789|NCT02531802|458974481|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
127547790|NCT02531802|458974482|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
127547791|NCT02531802|458974483|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
127547792|NCT02531802|458974484|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
127547793|NCT02531802|458974485|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
127547794|NCT02531802|458974486|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
127547795|NCT02531802|458974487|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
127547796|NCT02531802|458974488|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
127547797|NCT02531802|458974489|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
127547798|NCT02531802|458974490|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
127547799|NCT02531802|458974491|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
127547800|NCT02531802|458974492|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
127547801|NCT02531802|458974493|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
127547802|NCT02531802|458974494|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
127547803|NCT02531802|458974495|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
127547804|NCT02531802|458974496|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
127547805|NCT02531802|458974476|FG000|Received Vaccination 2|Physician Decision|0|||
127547806|NCT02531802|458974477|FG001|Received Vaccination 2|Physician Decision|0|||
127547807|NCT02531802|458974478|FG002|Received Vaccination 2|Physician Decision|0|||
127547808|NCT02531802|458974479|FG003|Received Vaccination 2|Physician Decision|0|||
127547809|NCT02531802|458974480|FG004|Received Vaccination 2|Physician Decision|0|||
127547810|NCT02531802|458974481|FG005|Received Vaccination 2|Physician Decision|1|||
127547811|NCT02531802|458974482|FG006|Received Vaccination 2|Physician Decision|0|||
127547812|NCT02531802|458974483|FG007|Received Vaccination 2|Physician Decision|0|||
127547813|NCT02531802|458974484|FG008|Received Vaccination 2|Physician Decision|0|||
127547814|NCT02531802|458974485|FG009|Received Vaccination 2|Physician Decision|2|||
127547815|NCT02531802|458974486|FG010|Received Vaccination 2|Physician Decision|0|||
127547816|NCT02531802|458974487|FG011|Received Vaccination 2|Physician Decision|0|||
127547817|NCT02531802|458974488|FG012|Received Vaccination 2|Physician Decision|0|||
127547818|NCT02531802|458974489|FG013|Received Vaccination 2|Physician Decision|1|||
127547819|NCT02531802|458974490|FG014|Received Vaccination 2|Physician Decision|0|||
127547820|NCT02531802|458974491|FG015|Received Vaccination 2|Physician Decision|0|||
127547821|NCT02531802|458974492|FG016|Received Vaccination 2|Physician Decision|0|||
127547822|NCT02531802|458974493|FG017|Received Vaccination 2|Physician Decision|1|||
127770604|NCT00960531|459784492|FG003|Overall Study|Adverse Event (AE)|0|||
127770605|NCT00960531|459784493|FG004|Overall Study|Adverse Event (AE)|0|||
127770606|NCT00960531|459784494|FG005|Overall Study|Adverse Event (AE)|1|||
127770607|NCT00960531|459784495|FG006|Overall Study|Adverse Event (AE)|2|||
127770608|NCT00960531|459784496|FG007|Overall Study|Adverse Event (AE)|0|||
127770609|NCT00960531|459784497|FG008|Overall Study|Adverse Event (AE)|2|||
127770610|NCT00960531|459784498|FG009|Overall Study|Adverse Event (AE)|0|||
127770611|NCT00960531|459784489|FG000|Overall Study|Reason not Specified|2|||
127770612|NCT00960531|459784490|FG001|Overall Study|Reason not Specified|1|||
127770613|NCT00960531|459784491|FG002|Overall Study|Reason not Specified|13|||
127770614|NCT00960531|459784492|FG003|Overall Study|Reason not Specified|1|||
127770615|NCT00960531|459784493|FG004|Overall Study|Reason not Specified|2|||
127770616|NCT00960531|459784494|FG005|Overall Study|Reason not Specified|0|||
127770617|NCT00960531|459784495|FG006|Overall Study|Reason not Specified|16|||
127770618|NCT00960531|459784496|FG007|Overall Study|Reason not Specified|0|||
127547823|NCT02531802|458974494|FG018|Received Vaccination 2|Physician Decision|0|||
127547824|NCT02531802|458974495|FG019|Received Vaccination 2|Physician Decision|0|||
127547825|NCT02531802|458974496|FG020|Received Vaccination 2|Physician Decision|0|||
127547826|NCT02531802|458974476|FG000|Received Vaccination 2|Adverse Event|0|||
127547827|NCT02531802|458974477|FG001|Received Vaccination 2|Adverse Event|0|||
127547828|NCT02531802|458974478|FG002|Received Vaccination 2|Adverse Event|0|||
127547829|NCT02531802|458974479|FG003|Received Vaccination 2|Adverse Event|0|||
127770619|NCT00960531|459784497|FG008|Overall Study|Reason not Specified|8|||
127770620|NCT00960531|459784498|FG009|Overall Study|Reason not Specified|1|||
127547830|NCT02531802|458974480|FG004|Received Vaccination 2|Adverse Event|0|||
127547831|NCT02531802|458974481|FG005|Received Vaccination 2|Adverse Event|2|||
127770621|NCT01163916|459784501|FG000|Overall Study|Withdrawal by Subject|2|||
127770622|NCT01163916|459784502|FG001|Overall Study|Withdrawal by Subject|0|||
127547832|NCT02531802|458974482|FG006|Received Vaccination 2|Adverse Event|0|||
127547833|NCT02531802|458974483|FG007|Received Vaccination 2|Adverse Event|0|||
127547834|NCT02531802|458974484|FG008|Received Vaccination 2|Adverse Event|0|||
127547835|NCT02531802|458974485|FG009|Received Vaccination 2|Adverse Event|0|||
127547836|NCT02531802|458974486|FG010|Received Vaccination 2|Adverse Event|0|||
127547837|NCT02531802|458974487|FG011|Received Vaccination 2|Adverse Event|0|||
127547838|NCT02531802|458974488|FG012|Received Vaccination 2|Adverse Event|0|||
127547839|NCT02531802|458974489|FG013|Received Vaccination 2|Adverse Event|0|||
127547840|NCT02531802|458974490|FG014|Received Vaccination 2|Adverse Event|0|||
127547841|NCT02531802|458974491|FG015|Received Vaccination 2|Adverse Event|0|||
127547842|NCT02531802|458974492|FG016|Received Vaccination 2|Adverse Event|0|||
127547843|NCT02531802|458974493|FG017|Received Vaccination 2|Adverse Event|2|||
127547844|NCT02531802|458974494|FG018|Received Vaccination 2|Adverse Event|1|||
127547845|NCT02531802|458974495|FG019|Received Vaccination 2|Adverse Event|0|||
127547846|NCT02531802|458974496|FG020|Received Vaccination 2|Adverse Event|1|||
127547847|NCT02531802|458974476|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
127547848|NCT02531802|458974477|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
127547849|NCT02531802|458974478|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
127547850|NCT02531802|458974479|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
127547851|NCT02531802|458974480|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
127547852|NCT02531802|458974481|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
127547853|NCT02531802|458974482|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
127547854|NCT02531802|458974483|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
127547855|NCT02531802|458974484|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
127547856|NCT02531802|458974485|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
127547857|NCT02531802|458974486|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
127547858|NCT02531802|458974487|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
127547859|NCT02531802|458974488|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
127547860|NCT02531802|458974489|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
127547861|NCT02531802|458974490|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
127547862|NCT02531802|458974491|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
127547863|NCT02531802|458974492|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
127547864|NCT02531802|458974493|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
127547865|NCT02531802|458974494|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
127547866|NCT02531802|458974495|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
127547867|NCT02531802|458974496|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
127547868|NCT03345784|458974497|FG000|Overall Study|Withdrawal by Subject|2|||
127547869|NCT03345784|458974498|FG001|Overall Study|Withdrawal by Subject|1|||
127547870|NCT04798196|458974499|FG000|Overall Study|Lost to Follow-up|3|||
127547871|NCT04798196|458974500|FG001|Overall Study|Lost to Follow-up|1|||
127547872|NCT04798196|458974501|FG002|Overall Study|Lost to Follow-up|3|||
127547873|NCT04596267|458974508|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
127547874|NCT04596267|458974509|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
127547875|NCT04596267|458974508|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
127547876|NCT04596267|458974509|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
127547877|NCT00071058|458974510|FG000|Overall Study|brain tumor-removed from study|1|||
127547878|NCT02000440|458974511|FG000|Overall Study|Adverse Event|3|||
127547879|NCT02000440|458974511|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
127547880|NCT04109547|458974512|FG000|Overall Study|Withdrawal by Subject|3|||
127547881|NCT04109547|458974513|FG001|Overall Study|Withdrawal by Subject|2|||
127547882|NCT04109547|458974514|FG002|Overall Study|Withdrawal by Subject|6|||
127547883|NCT04109547|458974515|FG003|Overall Study|Withdrawal by Subject|6|||
127547884|NCT04109547|458974512|FG000|Overall Study|Lost to Follow-up|0|||
127547885|NCT04109547|458974513|FG001|Overall Study|Lost to Follow-up|0|||
127547886|NCT04109547|458974514|FG002|Overall Study|Lost to Follow-up|0|||
127547887|NCT04109547|458974515|FG003|Overall Study|Lost to Follow-up|1|||
127547888|NCT04109547|458974512|FG000|Overall Study|Physician Decision|1|||
127547889|NCT04109547|458974513|FG001|Overall Study|Physician Decision|2|||
127547890|NCT04109547|458974514|FG002|Overall Study|Physician Decision|0|||
127547891|NCT04109547|458974515|FG003|Overall Study|Physician Decision|0|||
127547892|NCT01550003|458974516|FG000|Overall Study|Adverse Event|0|||
127547893|NCT01550003|458974517|FG001|Overall Study|Adverse Event|9|||
127547894|NCT01550003|458974518|FG002|Overall Study|Adverse Event|15|||
127547895|NCT01550003|458974516|FG000|Overall Study|Lack of Efficacy|4|||
127547896|NCT01550003|458974517|FG001|Overall Study|Lack of Efficacy|11|||
127547897|NCT01550003|458974518|FG002|Overall Study|Lack of Efficacy|15|||
127547898|NCT01550003|458974516|FG000|Overall Study|Protocol Violation|0|||
127547899|NCT01550003|458974517|FG001|Overall Study|Protocol Violation|3|||
127547900|NCT01550003|458974518|FG002|Overall Study|Protocol Violation|2|||
127547901|NCT01550003|458974516|FG000|Overall Study|Lost to Follow-up|1|||
127547902|NCT01550003|458974517|FG001|Overall Study|Lost to Follow-up|4|||
127547903|NCT01550003|458974518|FG002|Overall Study|Lost to Follow-up|8|||
128016126|NCT02335944|460682228|FG004|Post-treatment Follow-up|Death|0|||
127547904|NCT01550003|458974516|FG000|Overall Study|Consent withdrawn|2|||
127547905|NCT01550003|458974517|FG001|Overall Study|Consent withdrawn|11|||
127547906|NCT01550003|458974518|FG002|Overall Study|Consent withdrawn|23|||
127547907|NCT01550003|458974516|FG000|Overall Study|Missing|1|||
127547908|NCT01550003|458974517|FG001|Overall Study|Missing|0|||
127547909|NCT01550003|458974518|FG002|Overall Study|Missing|2|||
127547910|NCT01550003|458974516|FG000|Overall Study|Study closure as announced by sponsor|7|||
127547911|NCT01550003|458974517|FG001|Overall Study|Study closure as announced by sponsor|6|||
127547912|NCT01550003|458974518|FG002|Overall Study|Study closure as announced by sponsor|24|||
127547913|NCT01550003|458974516|FG000|Overall Study|Protocol Noncompliance|1|||
127547914|NCT01550003|458974517|FG001|Overall Study|Protocol Noncompliance|0|||
127547915|NCT01550003|458974518|FG002|Overall Study|Protocol Noncompliance|0|||
127547916|NCT01550003|458974516|FG000|Overall Study|Study closure|0|||
127547917|NCT01550003|458974517|FG001|Overall Study|Study closure|1|||
127547918|NCT01550003|458974518|FG002|Overall Study|Study closure|1|||
127547919|NCT01550003|458974516|FG000|Overall Study|Patient reached adulthood|0|||
127547920|NCT01550003|458974517|FG001|Overall Study|Patient reached adulthood|1|||
127547921|NCT01550003|458974518|FG002|Overall Study|Patient reached adulthood|0|||
127547922|NCT01550003|458974516|FG000|Overall Study|Early discontinuation at request of sponsor|0|||
127547923|NCT01550003|458974517|FG001|Overall Study|Early discontinuation at request of sponsor|2|||
127547924|NCT01550003|458974518|FG002|Overall Study|Early discontinuation at request of sponsor|4|||
127547925|NCT01550003|458974516|FG000|Overall Study|Sponsor's order|0|||
127547926|NCT01550003|458974517|FG001|Overall Study|Sponsor's order|3|||
127547927|NCT01550003|458974518|FG002|Overall Study|Sponsor's order|3|||
127547928|NCT01550003|458974516|FG000|Overall Study|Sponsor's decision|1|||
127547929|NCT01550003|458974517|FG001|Overall Study|Sponsor's decision|5|||
127547930|NCT01550003|458974518|FG002|Overall Study|Sponsor's decision|4|||
127547931|NCT01550003|458974516|FG000|Overall Study|Subject mother passed away|0|||
127547932|NCT01550003|458974517|FG001|Overall Study|Subject mother passed away|1|||
127547933|NCT01550003|458974518|FG002|Overall Study|Subject mother passed away|0|||
127547934|NCT01550003|458974516|FG000|Overall Study|Discontinuation|0|||
127547935|NCT01550003|458974517|FG001|Overall Study|Discontinuation|1|||
127547936|NCT01550003|458974518|FG002|Overall Study|Discontinuation|0|||
127547937|NCT01550003|458974516|FG000|Overall Study|Subject moved to rheumatology and out of study|0|||
127547938|NCT01550003|458974517|FG001|Overall Study|Subject moved to rheumatology and out of study|1|||
127547939|NCT01550003|458974518|FG002|Overall Study|Subject moved to rheumatology and out of study|1|||
127547940|NCT01550003|458974516|FG000|Overall Study|Site closure|0|||
127547941|NCT01550003|458974517|FG001|Overall Study|Site closure|2|||
127547942|NCT01550003|458974518|FG002|Overall Study|Site closure|0|||
127547943|NCT01550003|458974516|FG000|Overall Study|Pregnancy|0|||
127547944|NCT01550003|458974517|FG001|Overall Study|Pregnancy|1|||
127547945|NCT01550003|458974518|FG002|Overall Study|Pregnancy|0|||
127547946|NCT01550003|458974516|FG000|Overall Study|By medical decision and approved by the sponsor|0|||
127547947|NCT01550003|458974517|FG001|Overall Study|By medical decision and approved by the sponsor|0|||
127547948|NCT01550003|458974518|FG002|Overall Study|By medical decision and approved by the sponsor|1|||
127547949|NCT01550003|458974516|FG000|Overall Study|Subject is in college/unable to come to visits|0|||
127547950|NCT01550003|458974517|FG001|Overall Study|Subject is in college/unable to come to visits|0|||
127547951|NCT01550003|458974518|FG002|Overall Study|Subject is in college/unable to come to visits|1|||
127547952|NCT01550003|458974516|FG000|Overall Study|Switching to adult rheumatologist|0|||
127547953|NCT01550003|458974517|FG001|Overall Study|Switching to adult rheumatologist|0|||
127547954|NCT01550003|458974518|FG002|Overall Study|Switching to adult rheumatologist|1|||
127547955|NCT01550003|458974516|FG000|Overall Study|Patient transition to adult care|0|||
127770623|NCT01163916|459784503|FG002|Overall Study|Withdrawal by Subject|2|||
127547956|NCT01550003|458974517|FG001|Overall Study|Patient transition to adult care|0|||
127547957|NCT01550003|458974518|FG002|Overall Study|Patient transition to adult care|1|||
127547958|NCT01550003|458974516|FG000|Overall Study|Subject was able to obtain commercial cimzia|0|||
127547959|NCT01550003|458974517|FG001|Overall Study|Subject was able to obtain commercial cimzia|0|||
127547960|NCT01550003|458974518|FG002|Overall Study|Subject was able to obtain commercial cimzia|1|||
127547961|NCT01550003|458974516|FG000|Overall Study|Treatment or 12 week follow up visit completed|0|||
127547962|NCT01550003|458974517|FG001|Overall Study|Treatment or 12 week follow up visit completed|0|||
127547963|NCT01550003|458974518|FG002|Overall Study|Treatment or 12 week follow up visit completed|1|||
127547964|NCT01550003|458974516|FG000|Overall Study|Per Sponsor request|1|||
127547965|NCT01550003|458974517|FG001|Overall Study|Per Sponsor request|0|||
127547966|NCT01550003|458974518|FG002|Overall Study|Per Sponsor request|1|||
127683932|NCT01636687|459468289|FG004|Maintenance Period|Lack of Efficacy|0|||
127683933|NCT01636687|459468285|FG000|Maintenance Period|Lost to Follow-up|1|||
127683934|NCT01636687|459468286|FG001|Maintenance Period|Lost to Follow-up|1|||
127683935|NCT01636687|459468287|FG002|Maintenance Period|Lost to Follow-up|0|||
127683936|NCT01636687|459468288|FG003|Maintenance Period|Lost to Follow-up|0|||
127683937|NCT01636687|459468289|FG004|Maintenance Period|Lost to Follow-up|1|||
127683938|NCT01636687|459468285|FG000|Maintenance Period|Physician Decision|0|||
127683939|NCT01636687|459468286|FG001|Maintenance Period|Physician Decision|0|||
127683940|NCT01636687|459468287|FG002|Maintenance Period|Physician Decision|0|||
127683941|NCT01636687|459468288|FG003|Maintenance Period|Physician Decision|0|||
127683942|NCT01636687|459468289|FG004|Maintenance Period|Physician Decision|1|||
127770624|NCT01163916|459784501|FG000|Overall Study|Adverse Event|2|||
127770625|NCT01163916|459784502|FG001|Overall Study|Adverse Event|0|||
127770626|NCT01163916|459784503|FG002|Overall Study|Adverse Event|1|||
127770627|NCT01163916|459784501|FG000|Overall Study|Lack of Efficacy|2|||
127770628|NCT01163916|459784502|FG001|Overall Study|Lack of Efficacy|0|||
127770629|NCT01163916|459784503|FG002|Overall Study|Lack of Efficacy|1|||
127770630|NCT01163916|459784501|FG000|Overall Study|Other|24|||
127770631|NCT01163916|459784502|FG001|Overall Study|Other|4|||
127770632|NCT01163916|459784503|FG002|Overall Study|Other|16|||
127770633|NCT00883051|459784504|FG000|Overall Study|Lost to Follow-up|0|||
127770634|NCT00883051|459784505|FG001|Overall Study|Lost to Follow-up|0|||
127770635|NCT00883051|459784506|FG002|Overall Study|Lost to Follow-up|0|||
127770636|NCT00883051|459784507|FG003|Overall Study|Lost to Follow-up|0|||
127770637|NCT00883051|459784508|FG004|Overall Study|Lost to Follow-up|1|||
128016127|NCT02335944|460682229|FG005|Post-treatment Follow-up|Death|1|||
128016128|NCT02335944|460682230|FG006|Post-treatment Follow-up|Death|0|||
128016129|NCT02335944|460682231|FG007|Post-treatment Follow-up|Death|0|||
128016130|NCT02335944|460682232|FG008|Post-treatment Follow-up|Death|0|||
128016131|NCT02335944|460682233|FG009|Post-treatment Follow-up|Death|0|||
128016132|NCT02335944|460682224|FG000|Post-treatment Follow-up|Physician Decision|1|||
128016133|NCT02335944|460682225|FG001|Post-treatment Follow-up|Physician Decision|0|||
128016134|NCT02335944|460682226|FG002|Post-treatment Follow-up|Physician Decision|0|||
128016135|NCT02335944|460682227|FG003|Post-treatment Follow-up|Physician Decision|0|||
128016136|NCT02335944|460682228|FG004|Post-treatment Follow-up|Physician Decision|0|||
128016137|NCT02335944|460682229|FG005|Post-treatment Follow-up|Physician Decision|0|||
128016138|NCT02335944|460682230|FG006|Post-treatment Follow-up|Physician Decision|0|||
128016139|NCT02335944|460682231|FG007|Post-treatment Follow-up|Physician Decision|1|||
128016140|NCT02335944|460682232|FG008|Post-treatment Follow-up|Physician Decision|0|||
128016141|NCT02335944|460682233|FG009|Post-treatment Follow-up|Physician Decision|0|||
128016142|NCT00832975|460682234|FG000|Overall Study|Lost to Follow-up|7|||
128016143|NCT00832975|460682234|FG000|Overall Study|Protocol Violation|6|||
128016144|NCT00832975|460682234|FG000|Overall Study|Death|5|||
128016145|NCT00832975|460682234|FG000|Overall Study|Physician Decision|4|||
128016146|NCT00832975|460682234|FG000|Overall Study|Withdrawal by Subject|3|||
128016147|NCT00832975|460682234|FG000|Overall Study|Other reasons|14|||
128016148|NCT01706328|460682240|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
128016149|NCT01706328|460682241|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
128016150|NCT01706328|460682242|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
128016151|NCT01706328|460682240|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
128016152|NCT01706328|460682241|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
128016153|NCT01706328|460682242|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
128016154|NCT01706328|460682240|FG000|2-week Run-in Period|Physician Decision|4|||
128016155|NCT01706328|460682241|FG001|2-week Run-in Period|Physician Decision|0|||
128016156|NCT01706328|460682242|FG002|2-week Run-in Period|Physician Decision|0|||
128016157|NCT01706328|460682240|FG000|2-week Run-in Period|Adverse Event|4|||
128016158|NCT01706328|460682241|FG001|2-week Run-in Period|Adverse Event|0|||
128016159|NCT01706328|460682242|FG002|2-week Run-in Period|Adverse Event|0|||
128016160|NCT01706328|460682240|FG000|2-week Run-in Period|Lost to Follow-up|2|||
127547967|NCT01550003|458974516|FG000|Overall Study|Patient not compliance|0|||
127547968|NCT01550003|458974517|FG001|Overall Study|Patient not compliance|0|||
127770638|NCT00883051|459784504|FG000|Overall Study|Did not use study medication|24|||
127770639|NCT00883051|459784505|FG001|Overall Study|Did not use study medication|22|||
127770640|NCT00883051|459784506|FG002|Overall Study|Did not use study medication|29|||
127770641|NCT00883051|459784507|FG003|Overall Study|Did not use study medication|29|||
127770642|NCT00883051|459784508|FG004|Overall Study|Did not use study medication|17|||
127770643|NCT02337751|459784509|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
127770644|NCT02337751|459784510|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
127770645|NCT02337751|459784509|FG000|Overall Study|Voluntary Withdrawal|6|||
127770646|NCT02337751|459784510|FG001|Overall Study|Voluntary Withdrawal|8|||
128016161|NCT01706328|460682241|FG001|2-week Run-in Period|Lost to Follow-up|0|||
128016162|NCT01706328|460682242|FG002|2-week Run-in Period|Lost to Follow-up|0|||
128016163|NCT01706328|460682240|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
128016164|NCT01706328|460682241|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
128016165|NCT01706328|460682242|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
128016166|NCT01706328|460682240|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
128016167|NCT01706328|460682241|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
128016168|NCT01706328|460682242|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
128016169|NCT01706328|460682240|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
128016170|NCT01706328|460682241|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
128016171|NCT01706328|460682242|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
127770647|NCT02337751|459784509|FG000|Overall Study|Lack of Efficacy|2|||
127770648|NCT02337751|459784510|FG001|Overall Study|Lack of Efficacy|5|||
127770649|NCT02337751|459784509|FG000|Overall Study|Investigator's Judgement|1|||
127770650|NCT02337751|459784510|FG001|Overall Study|Investigator's Judgement|0|||
127547969|NCT01550003|458974518|FG002|Overall Study|Patient not compliance|1|||
127547970|NCT01550003|458974516|FG000|Overall Study|Non-compliance|0|||
127547971|NCT01550003|458974517|FG001|Overall Study|Non-compliance|0|||
127547972|NCT01550003|458974518|FG002|Overall Study|Non-compliance|1|||
127547973|NCT01550003|458974516|FG000|Overall Study|Study closed|0|||
127547974|NCT01550003|458974517|FG001|Overall Study|Study closed|1|||
127547975|NCT01550003|458974518|FG002|Overall Study|Study closed|0|||
127547976|NCT01550003|458974516|FG000|Overall Study|Transitioned to adult rheumatology|0|||
127547977|NCT01550003|458974517|FG001|Overall Study|Transitioned to adult rheumatology|0|||
127547978|NCT01550003|458974518|FG002|Overall Study|Transitioned to adult rheumatology|1|||
127547979|NCT01656408|458974519|FG000|Overall Study|Adverse Event|0|||
127547980|NCT01656408|458974520|FG001|Overall Study|Adverse Event|0|||
127547981|NCT01656408|458974521|FG002|Overall Study|Adverse Event|1|||
127547982|NCT01656408|458974522|FG003|Overall Study|Adverse Event|0|||
127547983|NCT01656408|458974523|FG004|Overall Study|Adverse Event|0|||
127547984|NCT01656408|458974524|FG005|Overall Study|Adverse Event|1|||
127547985|NCT01656408|458974525|FG006|Overall Study|Adverse Event|1|||
127547986|NCT01656408|458974526|FG007|Overall Study|Adverse Event|0|||
127683943|NCT01636687|459468285|FG000|Extension Period|technical problems|0|||
127683944|NCT01636687|459468286|FG001|Extension Period|technical problems|1|||
127547987|NCT01656408|458974527|FG008|Overall Study|Adverse Event|1|||
127770651|NCT02656823|459784517|FG000|Overall Study|Adverse Event|3|||
127770652|NCT02656823|459784517|FG000|Overall Study|Lost to Follow-up|2|||
127770653|NCT01910181|459784518|FG000|Overall Study|Death|37|||
127770654|NCT01910181|459784518|FG000|Overall Study|Lost to Follow-up|3|||
127770655|NCT01910181|459784518|FG000|Overall Study|Study Terminated by Sponsor|6|||
127770656|NCT00959647|459784522|FG000|Overall Study|Adverse Event|2|||
127770657|NCT00959647|459784522|FG000|Overall Study|Progressive disease|6|||
127770658|NCT00959647|459784522|FG000|Overall Study|Study terminated by sponsor|4|||
127770659|NCT00959647|459784522|FG000|Overall Study|Withdrawal by Subject|7|||
127770660|NCT01786174|459786890|FG000|Overall Study|Discontinued Study Drug|2|||
127770661|NCT01786174|459786891|FG001|Overall Study|Discontinued Study Drug|0|||
127770662|NCT01620255|459786892|FG000|Overall Study|Withdrawal by Subject|4|||
127770663|NCT01620255|459786893|FG001|Overall Study|Withdrawal by Subject|1|||
127770664|NCT01620255|459786894|FG002|Overall Study|Withdrawal by Subject|1|||
127770665|NCT01620255|459786895|FG003|Overall Study|Withdrawal by Subject|2|||
127770666|NCT01620255|459786896|FG004|Overall Study|Withdrawal by Subject|4|||
127770667|NCT01620255|459786892|FG000|Overall Study|Participant underwent fecal transplant|0|||
127770668|NCT01620255|459786893|FG001|Overall Study|Participant underwent fecal transplant|0|||
127770669|NCT01620255|459786894|FG002|Overall Study|Participant underwent fecal transplant|1|||
127770670|NCT01620255|459786895|FG003|Overall Study|Participant underwent fecal transplant|0|||
127770671|NCT01620255|459786896|FG004|Overall Study|Participant underwent fecal transplant|0|||
127770672|NCT01620255|459786892|FG000|Overall Study|Non-compliance|0|||
127770673|NCT01620255|459786893|FG001|Overall Study|Non-compliance|1|||
127770674|NCT01620255|459786894|FG002|Overall Study|Non-compliance|0|||
127770675|NCT01620255|459786895|FG003|Overall Study|Non-compliance|0|||
127770676|NCT01620255|459786896|FG004|Overall Study|Non-compliance|0|||
127770677|NCT01620255|459786892|FG000|Overall Study|Adverse Event|0|||
127770678|NCT01620255|459786893|FG001|Overall Study|Adverse Event|4|||
127770679|NCT01620255|459786894|FG002|Overall Study|Adverse Event|0|||
127770680|NCT01620255|459786895|FG003|Overall Study|Adverse Event|1|||
127547988|NCT01656408|458974528|FG009|Overall Study|Adverse Event|0|||
127547989|NCT01656408|458974519|FG000|Overall Study|Physician Decision|1|||
127547990|NCT01656408|458974520|FG001|Overall Study|Physician Decision|0|||
127547991|NCT01656408|458974521|FG002|Overall Study|Physician Decision|1|||
127683945|NCT01636687|459468287|FG002|Extension Period|technical problems|2|||
127683946|NCT01636687|459468288|FG003|Extension Period|technical problems|1|||
127683947|NCT01636687|459468289|FG004|Extension Period|technical problems|0|||
127683948|NCT01636687|459468285|FG000|Extension Period|Adverse Event|4|||
127683949|NCT01636687|459468286|FG001|Extension Period|Adverse Event|3|||
127683950|NCT01636687|459468287|FG002|Extension Period|Adverse Event|2|||
127683951|NCT01636687|459468288|FG003|Extension Period|Adverse Event|1|||
127683952|NCT01636687|459468289|FG004|Extension Period|Adverse Event|0|||
127547992|NCT01656408|458974522|FG003|Overall Study|Physician Decision|0|||
127547993|NCT01656408|458974523|FG004|Overall Study|Physician Decision|1|||
127683953|NCT01636687|459468285|FG000|Extension Period|Lack of Efficacy|7|||
127683954|NCT01636687|459468286|FG001|Extension Period|Lack of Efficacy|0|||
127770681|NCT01620255|459786896|FG004|Overall Study|Adverse Event|1|||
127770682|NCT01620255|459786892|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
127770683|NCT01620255|459786893|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
127770684|NCT01620255|459786894|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
127770685|NCT01620255|459786895|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
127770686|NCT01620255|459786896|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
127770687|NCT01155375|459786905|FG000|Overall Study|Adverse Event|1|||
127770688|NCT01155375|459786906|FG001|Overall Study|Adverse Event|0|||
127770689|NCT01480674|459786910|FG000|Overall Study|Death|23|||
127770690|NCT01480674|459786910|FG000|Overall Study|Lost to Follow-up|2|||
127547994|NCT01656408|458974524|FG005|Overall Study|Physician Decision|1|||
127547995|NCT01656408|458974525|FG006|Overall Study|Physician Decision|0|||
127547996|NCT01656408|458974526|FG007|Overall Study|Physician Decision|1|||
127547997|NCT01656408|458974527|FG008|Overall Study|Physician Decision|1|||
127547998|NCT01656408|458974528|FG009|Overall Study|Physician Decision|3|||
127547999|NCT01690143|458974531|FG000|Overall Study|Withdrawal by Subject|1|||
127548000|NCT03777982|458974532|FG000|Overall Study|Physician Decision|0|||
127548001|NCT03777982|458974533|FG001|Overall Study|Physician Decision|1|||
127548002|NCT03995368|458974534|FG000|Overall Study|Lost to Follow-up|1|||
127548003|NCT03995368|458974535|FG001|Overall Study|Lost to Follow-up|4|||
127548004|NCT03995368|458974536|FG002|Overall Study|Lost to Follow-up|1|||
127548005|NCT03995368|458974534|FG000|Overall Study|Did not meet inclusion criteria|1|||
127548006|NCT03995368|458974535|FG001|Overall Study|Did not meet inclusion criteria|6|||
127548007|NCT03995368|458974536|FG002|Overall Study|Did not meet inclusion criteria|3|||
127548008|NCT03995368|458974534|FG000|Overall Study|Withdrawal by Subject|0|||
127548009|NCT03995368|458974535|FG001|Overall Study|Withdrawal by Subject|1|||
127548010|NCT03995368|458974536|FG002|Overall Study|Withdrawal by Subject|1|||
127548011|NCT03592186|458974537|FG000|Overall Study|Withdrawal by Subject|1|||
127548012|NCT03592186|458974538|FG001|Overall Study|Withdrawal by Subject|0|||
127548013|NCT03592186|458974537|FG000|Overall Study|Lost to Follow-up|16|||
127548014|NCT03592186|458974538|FG001|Overall Study|Lost to Follow-up|11|||
127548015|NCT00361296|458974543|FG000|Overall Study|Physician Decision|1|||
127548016|NCT00361296|458974543|FG000|Overall Study|Lack of Efficacy|2|||
127548017|NCT00198822|458974544|FG000|Overall Study|Lost to Follow-up|14|||
127548018|NCT00198822|458974545|FG001|Overall Study|Lost to Follow-up|20|||
127548019|NCT00198822|458974546|FG002|Overall Study|Lost to Follow-up|21|||
127548020|NCT02072668|458974550|FG000|Second Intervention|Lost to Follow-up|1|||
127548021|NCT02072668|458974551|FG001|Second Intervention|Lost to Follow-up|0|||
127548022|NCT04730804|458974558|FG000|Overall Study|Physician Decision|0|||
127548023|NCT04730804|458974559|FG001|Overall Study|Physician Decision|0|||
127548024|NCT04730804|458974560|FG002|Overall Study|Physician Decision|0|||
127548025|NCT04730804|458974561|FG003|Overall Study|Physician Decision|0|||
127548026|NCT04730804|458974562|FG004|Overall Study|Physician Decision|0|||
127548027|NCT04730804|458974563|FG005|Overall Study|Physician Decision|1|||
127548028|NCT04730804|458974558|FG000|Overall Study|Withdrawal by Subject|0|||
127548029|NCT04730804|458974559|FG001|Overall Study|Withdrawal by Subject|0|||
127548030|NCT04730804|458974560|FG002|Overall Study|Withdrawal by Subject|0|||
127548031|NCT04730804|458974561|FG003|Overall Study|Withdrawal by Subject|0|||
127548032|NCT04730804|458974562|FG004|Overall Study|Withdrawal by Subject|1|||
127548033|NCT04730804|458974563|FG005|Overall Study|Withdrawal by Subject|2|||
127548034|NCT00554216|458976628|FG000|Overall Study|Lost to Follow-up|92|||
127548035|NCT00554216|458976629|FG001|Overall Study|Lost to Follow-up|31|||
127548036|NCT00554216|458976630|FG002|Overall Study|Lost to Follow-up|63|||
127548037|NCT00554216|458976628|FG000|Overall Study|Adverse Event|16|||
127548038|NCT00554216|458976629|FG001|Overall Study|Adverse Event|16|||
127548039|NCT00554216|458976630|FG002|Overall Study|Adverse Event|36|||
127548040|NCT00554216|458976628|FG000|Overall Study|Withdrawal by Subject|92|||
127548041|NCT00554216|458976629|FG001|Overall Study|Withdrawal by Subject|31|||
127548042|NCT00554216|458976630|FG002|Overall Study|Withdrawal by Subject|43|||
127548043|NCT00554216|458976628|FG000|Overall Study|Non compliance|10|||
127548044|NCT00554216|458976629|FG001|Overall Study|Non compliance|4|||
127548045|NCT00554216|458976630|FG002|Overall Study|Non compliance|5|||
127548046|NCT00554216|458976628|FG000|Overall Study|Pregnancy|2|||
127548047|NCT00554216|458976629|FG001|Overall Study|Pregnancy|1|||
127548048|NCT00554216|458976630|FG002|Overall Study|Pregnancy|14|||
127548049|NCT00554216|458976628|FG000|Overall Study|Restricted med|3|||
127548050|NCT00554216|458976629|FG001|Overall Study|Restricted med|1|||
127548051|NCT00554216|458976630|FG002|Overall Study|Restricted med|1|||
127548052|NCT00554216|458976628|FG000|Overall Study|Other|12|||
127683955|NCT01636687|459468287|FG002|Extension Period|Lack of Efficacy|2|||
127683956|NCT01636687|459468288|FG003|Extension Period|Lack of Efficacy|1|||
127683957|NCT01636687|459468289|FG004|Extension Period|Lack of Efficacy|0|||
127683958|NCT01636687|459468285|FG000|Extension Period|Lost to Follow-up|1|||
127683959|NCT01636687|459468286|FG001|Extension Period|Lost to Follow-up|0|||
127683960|NCT01636687|459468287|FG002|Extension Period|Lost to Follow-up|1|||
127548053|NCT00554216|458976629|FG001|Overall Study|Other|7|||
127548054|NCT00554216|458976630|FG002|Overall Study|Other|10|||
127548055|NCT00554216|458976628|FG000|Overall Study|Lack of Efficacy|15|||
127548056|NCT00554216|458976629|FG001|Overall Study|Lack of Efficacy|3|||
127548057|NCT00554216|458976630|FG002|Overall Study|Lack of Efficacy|0|||
127548058|NCT00628108|458976637|FG000|Overall Study|Adverse Event|0|||
127548059|NCT00628108|458976638|FG001|Overall Study|Adverse Event|3|||
127548060|NCT00628108|458976637|FG000|Overall Study|Withdrawal by Subject|1|||
127548061|NCT00628108|458976638|FG001|Overall Study|Withdrawal by Subject|0|||
127548062|NCT01760733|458976641|FG000|Waiting List|Death|18|||
127548063|NCT01760733|458976641|FG000|Waiting List|Removed from waiting list|41|||
127683961|NCT01636687|459468288|FG003|Extension Period|Lost to Follow-up|0|||
127683962|NCT01636687|459468289|FG004|Extension Period|Lost to Follow-up|0|||
127683963|NCT01636687|459468285|FG000|Extension Period|Physician Decision|1|||
127548064|NCT01760733|458976641|FG000|Waiting List|Not received a transplant yet|13|||
127548065|NCT01760733|458976641|FG000|Transplanted|Not reached 10 years post transplant|184|||
127548066|NCT01760733|458976641|FG000|Transplanted|Death|26|||
127548067|NCT01760733|458976641|FG000|Transplanted|Graft loss|7|||
127548068|NCT02404025|458976642|FG000|Overall Study|Adverse Event|1|||
127548069|NCT02404025|458976642|FG000|Overall Study|Lack of Efficacy|3|||
127548070|NCT01524796|458976643|FG000|Overall Study|Adverse Event|13|||
127548071|NCT01524796|458976643|FG000|Overall Study|Lack of Efficacy|3|||
127548072|NCT01524796|458976643|FG000|Overall Study|Lost to Follow-up|1|||
127548073|NCT01524796|458976643|FG000|Overall Study|The price|1|||
127548074|NCT01524796|458976643|FG000|Overall Study|Withdrawal by Subject|4|||
127548075|NCT01524796|458976643|FG000|Overall Study|Move|1|||
127548076|NCT01524796|458976643|FG000|Overall Study|Deterioration of pains|1|||
127548077|NCT01524796|458976643|FG000|Overall Study|Gall stone surgery|1|||
127548078|NCT01524796|458976643|FG000|Overall Study|Nervous about confidentiality|1|||
127548079|NCT01524796|458976643|FG000|Overall Study|Switch to carbamazapine|1|||
127548080|NCT01524796|458976643|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
127548081|NCT03938259|458976647|FG000|Overall Study|unable to establish baseline for ventilation|1|||
127548082|NCT03938259|458976648|FG001|Overall Study|unable to establish baseline for ventilation|1|||
127548083|NCT01907854|458976649|FG000|Overall Study|Protocol Violation|1|||
127548084|NCT01907854|458976650|FG001|Overall Study|Protocol Violation|1|||
127548085|NCT01907854|458976649|FG000|Overall Study|Withdrawal by Subject|9|||
127548086|NCT01907854|458976650|FG001|Overall Study|Withdrawal by Subject|7|||
127548087|NCT01907854|458976649|FG000|Overall Study|Lost to Follow-up|2|||
127548088|NCT01907854|458976650|FG001|Overall Study|Lost to Follow-up|2|||
127548089|NCT01907854|458976649|FG000|Overall Study|Unclassified|4|||
127548090|NCT01907854|458976650|FG001|Overall Study|Unclassified|3|||
127548091|NCT02215252|458976653|FG000|Overall Study|Adverse Event|1|||
127548092|NCT02215252|458976654|FG001|Overall Study|Adverse Event|5|||
127548093|NCT02215252|458976655|FG002|Overall Study|Adverse Event|2|||
127683964|NCT01636687|459468286|FG001|Extension Period|Physician Decision|0|||
127683965|NCT01636687|459468287|FG002|Extension Period|Physician Decision|0|||
127683966|NCT01636687|459468288|FG003|Extension Period|Physician Decision|1|||
127683967|NCT01636687|459468289|FG004|Extension Period|Physician Decision|0|||
127683968|NCT01636687|459468285|FG000|Extension Period|study terminated by sponsor|33|||
127683969|NCT01636687|459468286|FG001|Extension Period|study terminated by sponsor|50|||
127683970|NCT01636687|459468287|FG002|Extension Period|study terminated by sponsor|17|||
127683971|NCT01636687|459468288|FG003|Extension Period|study terminated by sponsor|23|||
127683972|NCT01636687|459468289|FG004|Extension Period|study terminated by sponsor|0|||
127683973|NCT01636687|459468285|FG000|Extension Period|Withdrawal by Subject|1|||
127683974|NCT01636687|459468286|FG001|Extension Period|Withdrawal by Subject|0|||
127683975|NCT01636687|459468287|FG002|Extension Period|Withdrawal by Subject|1|||
127683976|NCT01636687|459468288|FG003|Extension Period|Withdrawal by Subject|1|||
127683977|NCT01636687|459468289|FG004|Extension Period|Withdrawal by Subject|0|||
127683978|NCT01636687|459468285|FG000|Follow-up Period|Withdrawal by Subject|1|||
127683979|NCT01636687|459468286|FG001|Follow-up Period|Withdrawal by Subject|0|||
127683980|NCT01636687|459468287|FG002|Follow-up Period|Withdrawal by Subject|0|||
127683981|NCT01636687|459468288|FG003|Follow-up Period|Withdrawal by Subject|0|||
127683982|NCT01636687|459468289|FG004|Follow-up Period|Withdrawal by Subject|1|||
127683983|NCT03593213|459468295|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
127683984|NCT03593213|459468296|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
127683985|NCT03593213|459468297|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
127683986|NCT03593213|459468298|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
127683987|NCT03593213|459468295|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
127683988|NCT03593213|459468296|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
127683989|NCT03593213|459468297|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
127683990|NCT03593213|459468298|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
127683991|NCT03593213|459468295|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
127683992|NCT03593213|459468296|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
127683993|NCT03593213|459468297|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
127683994|NCT03593213|459468298|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
127683995|NCT03593213|459468295|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
127683996|NCT03593213|459468296|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
127683997|NCT03593213|459468297|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
127683998|NCT03593213|459468298|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
127683999|NCT03593213|459468295|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
127548094|NCT02215252|458976653|FG000|Overall Study|Lost to Follow-up|0|||
127548095|NCT02215252|458976654|FG001|Overall Study|Lost to Follow-up|0|||
127548096|NCT02215252|458976655|FG002|Overall Study|Lost to Follow-up|1|||
127548097|NCT02215252|458976653|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
127548098|NCT02215252|458976654|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
127684000|NCT03593213|459468296|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
127684001|NCT03593213|459468297|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
127548099|NCT02215252|458976655|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
127548100|NCT02215252|458976653|FG000|Overall Study|Protocol Violation|0|||
127548101|NCT02215252|458976654|FG001|Overall Study|Protocol Violation|1|||
127548102|NCT02215252|458976655|FG002|Overall Study|Protocol Violation|0|||
127548103|NCT02215252|458976653|FG000|Overall Study|Withdrawal by Subject|1|||
127548104|NCT02215252|458976654|FG001|Overall Study|Withdrawal by Subject|0|||
127548105|NCT02215252|458976655|FG002|Overall Study|Withdrawal by Subject|0|||
127548106|NCT02215252|458976653|FG000|Overall Study|Other|0|||
127548107|NCT02215252|458976654|FG001|Overall Study|Other|1|||
127548108|NCT02215252|458976655|FG002|Overall Study|Other|1|||
127548109|NCT02633306|458976656|FG000|Overall Study|Withdrawal by Subject|3|||
127548110|NCT00956007|458976657|FG000|Overall Study|Protocol Violation|27|||
127548111|NCT00956007|458976658|FG001|Overall Study|Protocol Violation|23|||
127548112|NCT03774576|458976659|FG000|Period 2|Adverse Event|1|||
127548113|NCT01746901|458976660|FG000|Naloxone Challenge Phase|Adverse Event|2|||
127548114|NCT01746901|458976661|FG001|Naloxone Challenge Phase|Adverse Event|0|||
127548115|NCT01746901|458976662|FG002|Naloxone Challenge Phase|Adverse Event|0|||
127548116|NCT01746901|458976663|FG003|Naloxone Challenge Phase|Adverse Event|0|||
127548117|NCT01746901|458976664|FG004|Naloxone Challenge Phase|Adverse Event|0|||
127548118|NCT01746901|458976665|FG005|Naloxone Challenge Phase|Adverse Event|0|||
127548119|NCT01746901|458976666|FG006|Naloxone Challenge Phase|Adverse Event|0|||
127548120|NCT01746901|458976667|FG007|Naloxone Challenge Phase|Adverse Event|0|||
127548121|NCT01746901|458976668|FG008|Naloxone Challenge Phase|Adverse Event|0|||
127548122|NCT01746901|458976660|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
127548123|NCT01746901|458976661|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
127548124|NCT01746901|458976662|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
127548125|NCT01746901|458976663|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
127548126|NCT01746901|458976664|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
127548127|NCT01746901|458976665|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
127548128|NCT01746901|458976666|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
127548129|NCT01746901|458976667|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
127548130|NCT01746901|458976668|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
127548131|NCT01746901|458976660|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
127548132|NCT01746901|458976661|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
127548133|NCT01746901|458976662|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
127548134|NCT01746901|458976663|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
127548135|NCT01746901|458976664|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
127548136|NCT01746901|458976665|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
127548137|NCT01746901|458976666|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
127548138|NCT01746901|458976667|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
127548139|NCT01746901|458976668|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
127548140|NCT01746901|458976660|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
127548141|NCT01746901|458976661|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
127548142|NCT01746901|458976662|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
127548143|NCT01746901|458976663|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
127548144|NCT01746901|458976664|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
127548145|NCT01746901|458976665|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
127548146|NCT01746901|458976666|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
127548147|NCT01746901|458976667|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
127548148|NCT01746901|458976668|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
127684002|NCT03593213|459468298|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
127684003|NCT03593213|459468295|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
127684004|NCT03593213|459468296|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
127684005|NCT03593213|459468297|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
127684006|NCT03593213|459468298|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
127684007|NCT03593213|459468295|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
127684008|NCT03593213|459468296|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
127684009|NCT03593213|459468297|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
127684010|NCT03593213|459468298|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
127684011|NCT03593213|459468295|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
127548149|NCT01746901|458976660|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
127548150|NCT01746901|458976661|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
127548151|NCT01746901|458976662|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
127548152|NCT01746901|458976663|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
127548153|NCT01746901|458976664|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
127548154|NCT01746901|458976665|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
127548155|NCT01746901|458976666|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
127548156|NCT01746901|458976667|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
127548157|NCT01746901|458976668|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
127548158|NCT01746901|458976660|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
127548159|NCT01746901|458976661|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
127548160|NCT01746901|458976662|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
127548161|NCT01746901|458976663|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
127548162|NCT01746901|458976664|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
127548163|NCT01746901|458976665|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
127548164|NCT01746901|458976666|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
127548165|NCT01746901|458976667|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
127548166|NCT01746901|458976668|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
127548167|NCT01746901|458976660|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
127548168|NCT01746901|458976661|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
127548169|NCT01746901|458976662|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
127548170|NCT01746901|458976663|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
127548171|NCT01746901|458976664|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
127548172|NCT01746901|458976665|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
127548173|NCT01746901|458976666|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
127548174|NCT01746901|458976667|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
127548175|NCT01746901|458976668|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
127548176|NCT01746901|458976660|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
127548177|NCT01746901|458976661|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
127548178|NCT01746901|458976662|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
127548179|NCT01746901|458976663|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
127548180|NCT01746901|458976664|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
127548181|NCT01746901|458976665|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
127548182|NCT01746901|458976666|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
127548183|NCT01746901|458976667|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
127548184|NCT01746901|458976668|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
127548185|NCT01746901|458976660|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
127548186|NCT01746901|458976661|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
127684012|NCT03593213|459468296|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
127684013|NCT03593213|459468297|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
127684014|NCT03593213|459468298|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
127684015|NCT03593213|459468295|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
127770691|NCT01480674|459786910|FG000|Overall Study|visit not done|10|||
127770692|NCT03818204|459786911|FG000|Overall Study|Could not close eye due to impaired facial nerve.|0|||
127548187|NCT01746901|458976662|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
127684016|NCT03593213|459468296|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
127684017|NCT03593213|459468297|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
127684018|NCT03593213|459468298|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
127684019|NCT03593213|459468295|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
127684020|NCT03593213|459468296|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
127684021|NCT03593213|459468297|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
127684022|NCT03593213|459468298|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
127684023|NCT03593213|459468295|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
127684024|NCT03593213|459468296|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
127684025|NCT03593213|459468297|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
127684026|NCT03593213|459468298|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
127684027|NCT03593213|459468295|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
127684028|NCT03593213|459468296|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
127684029|NCT03593213|459468297|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
127684030|NCT03593213|459468298|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
127684031|NCT03593213|459468295|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
127684032|NCT03593213|459468296|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
127684033|NCT03593213|459468297|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
127684034|NCT03593213|459468298|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
127684035|NCT03593213|459468295|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
127684036|NCT03593213|459468296|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
127684037|NCT03593213|459468297|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
127684038|NCT03593213|459468298|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
127684039|NCT03593213|459468295|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
127684040|NCT03593213|459468296|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
127770693|NCT03818204|459786912|FG001|Overall Study|Could not close eye due to impaired facial nerve.|0|||
127684041|NCT03593213|459468297|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
127684042|NCT03593213|459468298|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
127684043|NCT03593213|459468295|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
127684044|NCT03593213|459468296|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
127684045|NCT03593213|459468297|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
127684046|NCT03593213|459468298|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
127684047|NCT03593213|459468295|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
127684048|NCT03593213|459468296|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
127684049|NCT03593213|459468297|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
127684050|NCT03593213|459468298|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
127684051|NCT03593213|459468295|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
127684052|NCT03593213|459468296|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
127684053|NCT03593213|459468297|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
127684054|NCT03593213|459468298|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
127684055|NCT03593213|459468295|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
127684056|NCT03593213|459468296|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
127684057|NCT03593213|459468297|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
127684058|NCT03593213|459468298|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
127684059|NCT01460290|459468301|FG000|Overall Study|Adverse Event|3|||
127684060|NCT01460290|459468301|FG000|Overall Study|Elevated liver function|1|||
127684061|NCT02888080|459468310|FG000|Overall Study|Subject / Guardian decision|1|||
127684062|NCT02888080|459468311|FG001|Overall Study|Subject / Guardian decision|3|||
127684063|NCT02888080|459468310|FG000|Overall Study|New Therapy for study indication|1|||
127684064|NCT02888080|459468311|FG001|Overall Study|New Therapy for study indication|0|||
127684065|NCT02888080|459468310|FG000|Overall Study|Lack of Efficacy|0|||
127684066|NCT02888080|459468311|FG001|Overall Study|Lack of Efficacy|1|||
127684067|NCT02888080|459468310|FG000|Overall Study|Adverse Event|0|||
127684068|NCT02888080|459468311|FG001|Overall Study|Adverse Event|1|||
127684069|NCT00845832|459468312|FG000|Treatment Period|Adverse Event|0|||
127684070|NCT00845832|459468313|FG001|Treatment Period|Adverse Event|2|||
127684071|NCT00845832|459468314|FG002|Treatment Period|Adverse Event|0|||
127684072|NCT00845832|459468312|FG000|Treatment Period|Protocol Violation|1|||
127684073|NCT00845832|459468313|FG001|Treatment Period|Protocol Violation|1|||
127684074|NCT00845832|459468314|FG002|Treatment Period|Protocol Violation|0|||
127684075|NCT00845832|459468312|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
127684076|NCT00845832|459468313|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
127684077|NCT00845832|459468314|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
127684078|NCT00845832|459468312|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
127684079|NCT00845832|459468313|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
127684080|NCT00845832|459468314|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
127684081|NCT00189202|459468319|FG000|Overall Study|Physician Decision|5|||
127684082|NCT01039688|459468322|FG000|Overall Study|Adverse Event|38|||
127684083|NCT01039688|459468323|FG001|Overall Study|Adverse Event|39|||
127684084|NCT01039688|459468324|FG002|Overall Study|Adverse Event|24|||
127684085|NCT01039688|459468322|FG000|Overall Study|Lack of Efficacy|20|||
127684086|NCT01039688|459468323|FG001|Overall Study|Lack of Efficacy|11|||
127684087|NCT01039688|459468324|FG002|Overall Study|Lack of Efficacy|26|||
127684088|NCT01039688|459468322|FG000|Overall Study|Lost to Follow-up|11|||
127684089|NCT01039688|459468323|FG001|Overall Study|Lost to Follow-up|9|||
127684090|NCT01039688|459468324|FG002|Overall Study|Lost to Follow-up|5|||
127684091|NCT01039688|459468322|FG000|Overall Study|Other|13|||
127684092|NCT01039688|459468323|FG001|Overall Study|Other|25|||
127684093|NCT01039688|459468324|FG002|Overall Study|Other|12|||
127684094|NCT01039688|459468322|FG000|Overall Study|Withdrawal by Subject|23|||
127684095|NCT01039688|459468323|FG001|Overall Study|Withdrawal by Subject|27|||
127684096|NCT01039688|459468324|FG002|Overall Study|Withdrawal by Subject|13|||
127684097|NCT01039688|459468322|FG000|Overall Study|Death|2|||
127684098|NCT01039688|459468323|FG001|Overall Study|Death|0|||
127684099|NCT01039688|459468324|FG002|Overall Study|Death|0|||
127684100|NCT00668863|459468325|FG000|Overall Study|Objective Progression or Relapse|42|||
127684101|NCT00668863|459468325|FG000|Overall Study|Adverse Event|13|||
127684102|NCT00668863|459468325|FG000|Overall Study|Study Terminated by Sponsor|8|||
127684103|NCT00668863|459468325|FG000|Overall Study|Global Deterioration of Health Status|4|||
127684104|NCT00668863|459468325|FG000|Overall Study|Withdrawal by Subject|1|||
127684105|NCT00668863|459468325|FG000|Overall Study|Surgery|1|||
127684106|NCT00668863|459468325|FG000|Overall Study|Subject's work scheduling problem|1|||
127684107|NCT00668863|459468325|FG000|Overall Study|Physician Decision|1|||
127684108|NCT03844269|459468330|FG000|Overall Study|Withdrawal pre-intervention|1|||
127684109|NCT03844269|459468330|FG000|Overall Study|Did not complete the intervention|2|||
127684110|NCT00101010|459468332|FG000|Overall Study|Physician Decision|1|||
127684111|NCT05082935|459468347|FG000|Overall Study|Lost to Follow-up|549|||
127684112|NCT05082935|459468348|FG001|Overall Study|Lost to Follow-up|631|||
127770694|NCT03818204|459786913|FG002|Overall Study|Could not close eye due to impaired facial nerve.|0|||
127770695|NCT03818204|459786914|FG003|Overall Study|Could not close eye due to impaired facial nerve.|0|||
127770696|NCT03818204|459786915|FG004|Overall Study|Could not close eye due to impaired facial nerve.|1|||
127770697|NCT03818204|459786916|FG005|Overall Study|Could not close eye due to impaired facial nerve.|0|||
127770698|NCT03818204|459786917|FG006|Overall Study|Could not close eye due to impaired facial nerve.|0|||
127770699|NCT03818204|459786918|FG007|Overall Study|Could not close eye due to impaired facial nerve.|0|||
127770700|NCT03818204|459786919|FG008|Overall Study|Could not close eye due to impaired facial nerve.|0|||
127770701|NCT03818204|459786920|FG009|Overall Study|Could not close eye due to impaired facial nerve.|0|||
127770702|NCT03818204|459786921|FG010|Overall Study|Could not close eye due to impaired facial nerve.|0|||
127770703|NCT03818204|459786922|FG011|Overall Study|Could not close eye due to impaired facial nerve.|0|||
127770704|NCT03818204|459786923|FG012|Overall Study|Could not close eye due to impaired facial nerve.|0|||
128016172|NCT01706328|460682240|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
128016173|NCT01706328|460682241|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
128016174|NCT01706328|460682242|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
128016175|NCT01706328|460682240|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
127770705|NCT03818204|459786924|FG013|Overall Study|Could not close eye due to impaired facial nerve.|1|||
127770706|NCT03818204|459786925|FG014|Overall Study|Could not close eye due to impaired facial nerve.|0|||
127770707|NCT03818204|459786926|FG015|Overall Study|Could not close eye due to impaired facial nerve.|0|||
127770708|NCT03818204|459786927|FG016|Overall Study|Could not close eye due to impaired facial nerve.|0|||
127770709|NCT03818204|459786928|FG017|Overall Study|Could not close eye due to impaired facial nerve.|0|||
127770710|NCT03818204|459786929|FG018|Overall Study|Could not close eye due to impaired facial nerve.|0|||
127770711|NCT03818204|459786911|FG000|Overall Study|Physician Decision|0|||
127770712|NCT03818204|459786912|FG001|Overall Study|Physician Decision|0|||
127770713|NCT03818204|459786913|FG002|Overall Study|Physician Decision|0|||
127770714|NCT03818204|459786914|FG003|Overall Study|Physician Decision|0|||
127770715|NCT03818204|459786915|FG004|Overall Study|Physician Decision|0|||
127770716|NCT03818204|459786916|FG005|Overall Study|Physician Decision|0|||
127770717|NCT03818204|459786917|FG006|Overall Study|Physician Decision|0|||
127770718|NCT03818204|459786918|FG007|Overall Study|Physician Decision|0|||
127770719|NCT03818204|459786919|FG008|Overall Study|Physician Decision|0|||
127770720|NCT03818204|459786920|FG009|Overall Study|Physician Decision|0|||
127770721|NCT03818204|459786921|FG010|Overall Study|Physician Decision|0|||
127770722|NCT03818204|459786922|FG011|Overall Study|Physician Decision|0|||
128016176|NCT01706328|460682241|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
128016177|NCT01706328|460682242|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
128016178|NCT01706328|460682240|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
128016179|NCT01706328|460682241|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
128016180|NCT01706328|460682242|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
128016181|NCT01706328|460682240|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
128016182|NCT01706328|460682241|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
128016183|NCT01706328|460682242|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
128016184|NCT03018938|460682245|FG000|Overall Study|Death|0|||
128016185|NCT03018938|460682246|FG001|Overall Study|Death|1|||
128016186|NCT03018938|460682245|FG000|Overall Study|Lost to Follow-up|21|||
128016187|NCT03018938|460682246|FG001|Overall Study|Lost to Follow-up|32|||
128016188|NCT03018938|460682245|FG000|Overall Study|Withdrawal by Subject|38|||
128016189|NCT03018938|460682246|FG001|Overall Study|Withdrawal by Subject|45|||
128016190|NCT03018938|460682245|FG000|Overall Study|Physician Decision|3|||
128016191|NCT03018938|460682246|FG001|Overall Study|Physician Decision|2|||
128016192|NCT03018938|460682245|FG000|Overall Study|Sponsor Decision|0|||
128016193|NCT03018938|460682246|FG001|Overall Study|Sponsor Decision|1|||
128016194|NCT03018938|460682245|FG000|Overall Study|Screen failure-After randomization|4|||
128016195|NCT03018938|460682246|FG001|Overall Study|Screen failure-After randomization|2|||
128016196|NCT03018938|460682245|FG000|Overall Study|Not recorded|0|||
128016197|NCT03018938|460682246|FG001|Overall Study|Not recorded|2|||
128016198|NCT02811159|460682249|FG000|Treatment Course 1|Lost to Follow-up|1|||
128016199|NCT00191100|460682250|FG000|Overall Study|Adverse Event|18|||
127770723|NCT03818204|459786923|FG012|Overall Study|Physician Decision|0|||
127770724|NCT03818204|459786924|FG013|Overall Study|Physician Decision|0|||
127770725|NCT03818204|459786925|FG014|Overall Study|Physician Decision|1|||
127770726|NCT03818204|459786926|FG015|Overall Study|Physician Decision|0|||
127770727|NCT03818204|459786927|FG016|Overall Study|Physician Decision|0|||
127770728|NCT03818204|459786928|FG017|Overall Study|Physician Decision|0|||
127770729|NCT03818204|459786929|FG018|Overall Study|Physician Decision|0|||
127770730|NCT00887250|459786930|FG000|Overall Study|Adverse Event|3|||
127770731|NCT00887250|459786931|FG001|Overall Study|Adverse Event|0|||
127770732|NCT00887250|459786932|FG002|Overall Study|Adverse Event|7|||
128016200|NCT00191100|460682251|FG001|Overall Study|Adverse Event|1|||
128016201|NCT00191100|460682250|FG000|Overall Study|Lost to Follow-up|2|||
128016202|NCT00191100|460682251|FG001|Overall Study|Lost to Follow-up|0|||
127770733|NCT00887250|459786930|FG000|Overall Study|Lack of Efficacy|9|||
127548188|NCT01746901|458976663|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
127548189|NCT01746901|458976664|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
127548190|NCT01746901|458976665|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
127548191|NCT01746901|458976666|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
127548192|NCT01746901|458976667|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
127548193|NCT01746901|458976668|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
127548194|NCT01746901|458976660|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
127548195|NCT01746901|458976661|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
127548196|NCT01746901|458976662|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
127548197|NCT01746901|458976663|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
127548198|NCT01746901|458976664|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
127548199|NCT01746901|458976665|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
127548200|NCT01746901|458976666|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
127548201|NCT01746901|458976667|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
127548202|NCT01746901|458976668|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
127548203|NCT01746901|458976660|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
127548204|NCT01746901|458976661|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
127548205|NCT01746901|458976662|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
127548206|NCT01746901|458976663|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
127548207|NCT01746901|458976664|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
127548208|NCT01746901|458976665|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
127548209|NCT01746901|458976666|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
127548210|NCT01746901|458976667|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
127770734|NCT00887250|459786931|FG001|Overall Study|Lack of Efficacy|6|||
127770735|NCT00887250|459786932|FG002|Overall Study|Lack of Efficacy|1|||
127770736|NCT00887250|459786930|FG000|Overall Study|Lost to Follow-up|2|||
127548211|NCT01746901|458976668|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
127548212|NCT01746901|458976660|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
127548213|NCT01746901|458976661|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
127548214|NCT01746901|458976662|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
127548215|NCT01746901|458976663|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
127548216|NCT01746901|458976664|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
127548217|NCT01746901|458976665|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
127548218|NCT01746901|458976666|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
127548219|NCT01746901|458976667|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
127548220|NCT01746901|458976668|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
127548221|NCT05029362|458976672|FG000|Overall Study|Lost to Follow-up|9|||
127548222|NCT00927953|458976675|FG000|Overall Study|Death|2|||
127548223|NCT00927953|458976676|FG001|Overall Study|Death|1|||
127548224|NCT01409707|458976677|FG000|Overall Study|Withdrawal by Subject|5|||
127548225|NCT01409707|458976678|FG001|Overall Study|Withdrawal by Subject|17|||
127770737|NCT00887250|459786931|FG001|Overall Study|Lost to Follow-up|3|||
127770738|NCT00887250|459786932|FG002|Overall Study|Lost to Follow-up|1|||
127770739|NCT00887250|459786930|FG000|Overall Study|Protocol Violation|2|||
127770740|NCT00887250|459786931|FG001|Overall Study|Protocol Violation|2|||
127770741|NCT00887250|459786932|FG002|Overall Study|Protocol Violation|1|||
127770742|NCT00887250|459786930|FG000|Overall Study|Withdrawal by Subject|2|||
127770743|NCT00887250|459786931|FG001|Overall Study|Withdrawal by Subject|1|||
127770744|NCT00887250|459786932|FG002|Overall Study|Withdrawal by Subject|2|||
127770745|NCT00887250|459786930|FG000|Overall Study|Patient uncooperative|0|||
127770746|NCT00887250|459786931|FG001|Overall Study|Patient uncooperative|0|||
127770747|NCT00887250|459786932|FG002|Overall Study|Patient uncooperative|1|||
127770748|NCT01933113|459786933|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
127770749|NCT00879762|459786934|FG000|Overall Study|Lost to Follow-up|3|||
127770750|NCT00879762|459786935|FG001|Overall Study|Lost to Follow-up|1|||
127770751|NCT04981366|459786936|FG000|Overall Study|Withdrawal by Subject|5|||
127770752|NCT04981366|459786937|FG001|Overall Study|Withdrawal by Subject|4|||
127770753|NCT04981366|459786938|FG002|Overall Study|Withdrawal by Subject|8|||
127770754|NCT04981366|459786936|FG000|Overall Study|Health issues unrelated to the trial|1|||
127770755|NCT04981366|459786937|FG001|Overall Study|Health issues unrelated to the trial|2|||
127770756|NCT04981366|459786938|FG002|Overall Study|Health issues unrelated to the trial|0|||
127770757|NCT00881608|459786939|FG000|Overall Study|Study prematurely terminated|11|||
127770758|NCT03214094|459786940|FG000|Overall Study|Case Report Forms Uncollected|14|||
127770759|NCT03214094|459786940|FG000|Overall Study|Protocol Deviation|46|||
127770760|NCT00795951|459786946|FG000|Overall Study|Lost to Follow-up|1|||
127548226|NCT01409707|458976679|FG002|Overall Study|Withdrawal by Subject|16|||
127548227|NCT01658436|458976680|FG000|Overall Study|Adverse Event|6|||
127770761|NCT00795951|459786946|FG000|Overall Study|Withdrawal by Subject|1|||
127770762|NCT00655486|459786952|FG000|Overall Study|Adverse Event|10|||
127548228|NCT01658436|458976681|FG001|Overall Study|Adverse Event|5|||
127548229|NCT01658436|458976680|FG000|Overall Study|Physician Decision|1|||
127548230|NCT01658436|458976681|FG001|Overall Study|Physician Decision|0|||
127548231|NCT01658436|458976680|FG000|Overall Study|Progressive disease|12|||
127548232|NCT01658436|458976681|FG001|Overall Study|Progressive disease|4|||
127548233|NCT01658436|458976680|FG000|Overall Study|Study terminated by sponsor|0|||
127548234|NCT01658436|458976681|FG001|Overall Study|Study terminated by sponsor|1|||
127548235|NCT01658436|458976680|FG000|Overall Study|Subject/guardian decision|0|||
127548236|NCT01658436|458976681|FG001|Overall Study|Subject/guardian decision|1|||
127548237|NCT01658436|458976680|FG000|Overall Study|Death|1|||
127548238|NCT01658436|458976681|FG001|Overall Study|Death|0|||
127548239|NCT04322526|458976683|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
127548240|NCT04322526|458976684|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
127548241|NCT04322526|458976683|FG000|Washout (1 Week)|Lost to Follow-up|1|||
127548242|NCT04322526|458976684|FG001|Washout (1 Week)|Lost to Follow-up|2|||
127548243|NCT01523756|458976685|FG000|Baseline Period|Adverse Event|0|||
127548244|NCT01523756|458976686|FG001|Baseline Period|Adverse Event|1|||
127548245|NCT01523756|458976685|FG000|Test Period 1|Adverse Event|1|||
127548246|NCT01523756|458976686|FG001|Test Period 1|Adverse Event|0|||
127548247|NCT01523756|458976685|FG000|Test Period 2|Withdrawal by Subject|0|||
127548248|NCT01523756|458976686|FG001|Test Period 2|Withdrawal by Subject|1|||
127548249|NCT00993967|458976687|FG000|Overall Study|Adverse Event|8|||
127548250|NCT00993967|458976687|FG000|Overall Study|Death|1|||
127548251|NCT00993967|458976687|FG000|Overall Study|Lost to Follow-up|14|||
127548252|NCT00993967|458976687|FG000|Overall Study|Withdrawal by Subject|36|||
127548253|NCT00993967|458976687|FG000|Overall Study|Protocol Violation|2|||
127548254|NCT00515619|458976688|FG000|Overall Study|Adverse Event|34|||
127548255|NCT00515619|458976688|FG000|Overall Study|Lack of Efficacy|92|||
127548256|NCT00515619|458976688|FG000|Overall Study|Withdrawal by Subject|66|||
127548257|NCT00515619|458976688|FG000|Overall Study|Protocol Violation|3|||
127548258|NCT00515619|458976688|FG000|Overall Study|Lost to Follow-up|4|||
127548259|NCT00515619|458976688|FG000|Overall Study|Unsatisfactory compliance|6|||
127548260|NCT00515619|458976688|FG000|Overall Study|Other: Site discontinuing trials|2|||
127548261|NCT00515619|458976688|FG000|Overall Study|Other: Subject cannot attend visits|2|||
127548262|NCT00515619|458976688|FG000|Overall Study|Other: Subject required surgery|1|||
127548263|NCT00515619|458976688|FG000|Overall Study|Other: Subject moved to another country|1|||
127548264|NCT00515619|458976688|FG000|Overall Study|Other: Investigator decision|1|||
127548265|NCT00515619|458976688|FG000|Overall Study|Other: Subject became pregnant|1|||
127548266|NCT00515619|458976688|FG000|Overall Study|Other: Request from sponsor|1|||
127548267|NCT00515619|458976688|FG000|Overall Study|Other: Drug available on license|1|||
127548268|NCT00515619|458976688|FG000|Overall Study|Other: Subject interested in other AED|1|||
127548269|NCT02760498|458976689|FG000|Overall Study|Adverse Event|3|||
127548270|NCT02760498|458976690|FG001|Overall Study|Adverse Event|3|||
127548271|NCT02760498|458976691|FG002|Overall Study|Adverse Event|1|||
127548272|NCT02760498|458976692|FG003|Overall Study|Adverse Event|1|||
127548273|NCT02760498|458976693|FG004|Overall Study|Adverse Event|0|||
127548274|NCT02760498|458976694|FG005|Overall Study|Adverse Event|6|||
127548275|NCT02760498|458976689|FG000|Overall Study|Death|7|||
127548276|NCT02760498|458976690|FG001|Overall Study|Death|5|||
127548277|NCT02760498|458976691|FG002|Overall Study|Death|5|||
127548278|NCT02760498|458976692|FG003|Overall Study|Death|7|||
127548279|NCT02760498|458976693|FG004|Overall Study|Death|0|||
127548280|NCT02760498|458976694|FG005|Overall Study|Death|23|||
127548281|NCT02760498|458976689|FG000|Overall Study|Lost to Follow-up|0|||
127548282|NCT02760498|458976690|FG001|Overall Study|Lost to Follow-up|0|||
127548283|NCT02760498|458976691|FG002|Overall Study|Lost to Follow-up|0|||
127548284|NCT02760498|458976692|FG003|Overall Study|Lost to Follow-up|0|||
127548285|NCT02760498|458976693|FG004|Overall Study|Lost to Follow-up|0|||
127548286|NCT02760498|458976694|FG005|Overall Study|Lost to Follow-up|3|||
127548287|NCT02760498|458976689|FG000|Overall Study|Non-compliance with study drug|0|||
127548288|NCT02760498|458976690|FG001|Overall Study|Non-compliance with study drug|2|||
127548289|NCT02760498|458976691|FG002|Overall Study|Non-compliance with study drug|0|||
127548290|NCT02760498|458976692|FG003|Overall Study|Non-compliance with study drug|0|||
127548291|NCT02760498|458976693|FG004|Overall Study|Non-compliance with study drug|0|||
127548292|NCT02760498|458976694|FG005|Overall Study|Non-compliance with study drug|0|||
127548293|NCT02760498|458976689|FG000|Overall Study|Participant decision|1|||
127548294|NCT02760498|458976690|FG001|Overall Study|Participant decision|4|||
127548295|NCT02760498|458976691|FG002|Overall Study|Participant decision|2|||
127548296|NCT02760498|458976692|FG003|Overall Study|Participant decision|2|||
127548297|NCT02760498|458976693|FG004|Overall Study|Participant decision|1|||
127548298|NCT02760498|458976694|FG005|Overall Study|Participant decision|6|||
127548299|NCT02760498|458976689|FG000|Overall Study|Sponsor decision|0|||
127548300|NCT02760498|458976690|FG001|Overall Study|Sponsor decision|0|||
127548301|NCT02760498|458976691|FG002|Overall Study|Sponsor decision|0|||
127548302|NCT02760498|458976692|FG003|Overall Study|Sponsor decision|3|||
127548303|NCT02760498|458976693|FG004|Overall Study|Sponsor decision|0|||
127548304|NCT02760498|458976694|FG005|Overall Study|Sponsor decision|0|||
127548305|NCT02760498|458976689|FG000|Overall Study|Physician Decision|3|||
127548306|NCT02760498|458976690|FG001|Overall Study|Physician Decision|4|||
127548307|NCT02760498|458976691|FG002|Overall Study|Physician Decision|1|||
127548308|NCT02760498|458976692|FG003|Overall Study|Physician Decision|4|||
127548309|NCT02760498|458976693|FG004|Overall Study|Physician Decision|0|||
127548310|NCT02760498|458976694|FG005|Overall Study|Physician Decision|2|||
127548311|NCT02760498|458976689|FG000|Overall Study|Disease progression|21|||
127548312|NCT02760498|458976690|FG001|Overall Study|Disease progression|19|||
127548313|NCT02760498|458976691|FG002|Overall Study|Disease progression|20|||
127548314|NCT02760498|458976692|FG003|Overall Study|Disease progression|18|||
127684113|NCT05082935|459468347|FG000|Overall Study|Withdrawal by Subject|27|||
127684114|NCT05082935|459468348|FG001|Overall Study|Withdrawal by Subject|58|||
127684115|NCT02957136|459468350|FG000|Overall Study|Withdrawal by Subject|2|||
127684116|NCT02957136|459468351|FG001|Overall Study|Withdrawal by Subject|1|||
127684117|NCT00439569|459468352|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
127684118|NCT00439569|459468352|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
127684119|NCT00439569|459468352|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
127684120|NCT02755116|459468353|FG000|Overall Study|surgery converted to open, pt admitted|3|||
127684121|NCT02755116|459468354|FG001|Overall Study|surgery converted to open, pt admitted|1|||
127684122|NCT02200770|459468355|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
127684123|NCT02200770|459468356|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
127684124|NCT02200770|459468355|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
127684125|NCT02200770|459468356|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
127684126|NCT02200770|459468355|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
127684127|NCT02200770|459468356|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
127684128|NCT02200770|459468355|FG000|Randomized-controlled Period (RCP)|Other|1|||
127684129|NCT02200770|459468356|FG001|Randomized-controlled Period (RCP)|Other|2|||
127684130|NCT02200770|459468355|FG000|Open-label Period (OLP)|Adverse Event|1|||
127684131|NCT02200770|459468356|FG001|Open-label Period (OLP)|Adverse Event|2|||
127684132|NCT02200770|459468355|FG000|Open-label Period (OLP)|Death|1|||
127684133|NCT02200770|459468356|FG001|Open-label Period (OLP)|Death|2|||
127684134|NCT02200770|459468355|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
127684135|NCT02200770|459468356|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
127684136|NCT02200770|459468355|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
127684137|NCT02200770|459468356|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
127684138|NCT02200770|459468355|FG000|Open-label Period (OLP)|Other|6|||
127684139|NCT02200770|459468356|FG001|Open-label Period (OLP)|Other|15|||
127684140|NCT02214160|459468359|FG000|Overall Study|Withdrawal by Subject|1|||
127684141|NCT02214160|459468360|FG001|Overall Study|Withdrawal by Subject|0|||
127684142|NCT02214160|459468361|FG002|Overall Study|Withdrawal by Subject|6|||
127684143|NCT02214160|459468359|FG000|Overall Study|Death|2|||
127684144|NCT02214160|459468360|FG001|Overall Study|Death|2|||
127684145|NCT02214160|459468361|FG002|Overall Study|Death|1|||
127684146|NCT02214160|459468359|FG000|Overall Study|Subject Non-Compliance|0|||
127684147|NCT02214160|459468360|FG001|Overall Study|Subject Non-Compliance|3|||
127684148|NCT02214160|459468361|FG002|Overall Study|Subject Non-Compliance|1|||
127684149|NCT02214160|459468359|FG000|Overall Study|Adverse Event|0|||
127684150|NCT02214160|459468360|FG001|Overall Study|Adverse Event|1|||
127684151|NCT02214160|459468361|FG002|Overall Study|Adverse Event|1|||
127684152|NCT02214160|459468359|FG000|Overall Study|Sponsor Decision|0|||
127684153|NCT02214160|459468360|FG001|Overall Study|Sponsor Decision|2|||
127684154|NCT02214160|459468361|FG002|Overall Study|Sponsor Decision|0|||
127684155|NCT02214160|459468359|FG000|Overall Study|Protocol Violation|1|||
127684156|NCT02214160|459468360|FG001|Overall Study|Protocol Violation|0|||
127684157|NCT02214160|459468361|FG002|Overall Study|Protocol Violation|0|||
127684158|NCT02214160|459468359|FG000|Overall Study|Physician Decision|0|||
127684159|NCT02214160|459468360|FG001|Overall Study|Physician Decision|0|||
127684160|NCT02214160|459468361|FG002|Overall Study|Physician Decision|1|||
127684161|NCT02423798|459468362|FG000|Overall Study|Withdrawal by Subject|3|||
127684162|NCT01063972|459468363|FG000|Overall Study|Death|12|||
127684163|NCT01063972|459468364|FG001|Overall Study|Death|11|||
127684164|NCT01063972|459468363|FG000|Overall Study|Incarcerated|2|||
127684165|NCT01063972|459468364|FG001|Overall Study|Incarcerated|1|||
127684166|NCT01510717|459468366|FG000|Overall Study|Adverse Event|1|||
127684167|NCT01510717|459468367|FG001|Overall Study|Adverse Event|2|||
127684168|NCT01510717|459468366|FG000|Overall Study|Death|1|||
127684169|NCT01510717|459468367|FG001|Overall Study|Death|0|||
127684170|NCT01510717|459468366|FG000|Overall Study|Lost to Follow-up|0|||
127684171|NCT01510717|459468367|FG001|Overall Study|Lost to Follow-up|1|||
127684172|NCT01510717|459468366|FG000|Overall Study|Withdrawal by Subject|0|||
127684173|NCT01510717|459468367|FG001|Overall Study|Withdrawal by Subject|2|||
127548315|NCT02760498|458976693|FG004|Overall Study|Disease progression|4|||
127548316|NCT02760498|458976694|FG005|Overall Study|Disease progression|55|||
127684174|NCT01264679|459468368|FG000|Overall Study|Participation in Another Clinical Trial|1|||
127684175|NCT01264679|459468368|FG000|Overall Study|Physician Decision|1|||
127684176|NCT01264679|459468368|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
127684177|NCT01264679|459468368|FG000|Overall Study|Withdrawal by Subject|1|||
127684178|NCT01595061|459468374|FG000|Overall Study|Never Treated|3|||
127548317|NCT02760498|458976689|FG000|Overall Study|Withdrawal by Subject|4|||
127770763|NCT00655486|459786952|FG000|Overall Study|Lack of Efficacy|8|||
127770764|NCT00655486|459786952|FG000|Overall Study|Withdrawal by Subject|4|||
127770765|NCT00655486|459786952|FG000|Overall Study|Protocol Violation|1|||
127770766|NCT00655486|459786952|FG000|Overall Study|Unsatisfactory compliance|2|||
127770767|NCT00655486|459786952|FG000|Overall Study|Other: Pregnancy|1|||
127770768|NCT00655486|459786952|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
127770769|NCT00655486|459786952|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
127770770|NCT02768870|459786963|FG000|Overall Study|Death|1|||
127770771|NCT02768870|459786963|FG000|Overall Study|Reoperation|6|||
127770772|NCT02768870|459786963|FG000|Overall Study|Lost to Follow-up|1|||
127770773|NCT02768870|459786963|FG000|Overall Study|Exit|4|||
127770774|NCT03401229|459786964|FG000|Overall Study|Lost to Follow-up|2|||
127770775|NCT03401229|459786965|FG001|Overall Study|Lost to Follow-up|1|||
127770776|NCT03401229|459786964|FG000|Overall Study|Other|1|||
127770777|NCT03401229|459786965|FG001|Overall Study|Other|3|||
127770778|NCT03401229|459786964|FG000|Overall Study|Adverse Event|8|||
127770779|NCT03401229|459786965|FG001|Overall Study|Adverse Event|6|||
127770780|NCT03401229|459786964|FG000|Overall Study|Withdrawal by Subject|29|||
127770781|NCT03401229|459786965|FG001|Overall Study|Withdrawal by Subject|26|||
127770782|NCT03401229|459786964|FG000|Overall Study|COVID-19|0|||
127770783|NCT03401229|459786965|FG001|Overall Study|COVID-19|1|||
127770784|NCT01122862|459786966|FG000|Period 1|Protocol Violation|0|||
127770785|NCT01122862|459786967|FG001|Period 1|Protocol Violation|1|||
127770786|NCT01122862|459786968|FG002|Period 1|Protocol Violation|0|||
127770787|NCT01122862|459786966|FG000|Period 2|Adverse Event|0|||
127770788|NCT01122862|459786967|FG001|Period 2|Adverse Event|0|||
127770789|NCT01122862|459786968|FG002|Period 2|Adverse Event|1|||
127770790|NCT02699983|459786969|FG000|Overall Study|Withdrawal by Subject|1|||
127770791|NCT02699983|459786970|FG001|Overall Study|Withdrawal by Subject|0|||
127770792|NCT03575143|459786971|FG000|Overall Study|Lost to Follow-up|0|||
127770793|NCT03575143|459786972|FG001|Overall Study|Lost to Follow-up|0|||
127770794|NCT03575143|459786973|FG002|Overall Study|Lost to Follow-up|4|||
127770795|NCT03575143|459786971|FG000|Overall Study|Withdrawal by Subject|0|||
127770796|NCT03575143|459786972|FG001|Overall Study|Withdrawal by Subject|0|||
127770797|NCT03575143|459786973|FG002|Overall Study|Withdrawal by Subject|5|||
127770798|NCT03575143|459786971|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
127770799|NCT03575143|459786972|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
127770800|NCT03575143|459786973|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
127770801|NCT01287065|459786974|FG000|Treatment Period 1|Adverse Event|0|||
127770802|NCT01287065|459786975|FG001|Treatment Period 1|Adverse Event|0|||
127770803|NCT01287065|459786976|FG002|Treatment Period 1|Adverse Event|0|||
127770804|NCT01287065|459786977|FG003|Treatment Period 1|Adverse Event|0|||
127770805|NCT01287065|459786978|FG004|Treatment Period 1|Adverse Event|1|||
127770806|NCT01287065|459786979|FG005|Treatment Period 1|Adverse Event|0|||
127770807|NCT01287065|459786974|FG000|Treatment Period 1|Withdrawal by Subject|0|||
127770808|NCT01287065|459786975|FG001|Treatment Period 1|Withdrawal by Subject|0|||
127770809|NCT01287065|459786976|FG002|Treatment Period 1|Withdrawal by Subject|0|||
127770810|NCT01287065|459786977|FG003|Treatment Period 1|Withdrawal by Subject|0|||
127770811|NCT01287065|459786978|FG004|Treatment Period 1|Withdrawal by Subject|0|||
127770812|NCT01287065|459786979|FG005|Treatment Period 1|Withdrawal by Subject|1|||
127770813|NCT02875977|459786980|FG000|Overall Study|Lost to Follow-up|42|||
127770814|NCT02875977|459786981|FG001|Overall Study|Lost to Follow-up|29|||
127770815|NCT01259726|459786982|FG000|Overall Study|Death|1|||
127770816|NCT01259726|459786983|FG001|Overall Study|Death|0|||
127770817|NCT01259726|459786984|FG002|Overall Study|Death|0|||
127770818|NCT01259726|459786985|FG003|Overall Study|Death|0|||
127770819|NCT01259726|459786982|FG000|Overall Study|Physician Decision|2|||
127770820|NCT01259726|459786983|FG001|Overall Study|Physician Decision|0|||
127770821|NCT01259726|459786984|FG002|Overall Study|Physician Decision|1|||
127770822|NCT01259726|459786985|FG003|Overall Study|Physician Decision|1|||
127770823|NCT01259726|459786982|FG000|Overall Study|Withdrawal by Subject|1|||
127770824|NCT01259726|459786983|FG001|Overall Study|Withdrawal by Subject|3|||
127770825|NCT01259726|459786984|FG002|Overall Study|Withdrawal by Subject|2|||
127770826|NCT01259726|459786985|FG003|Overall Study|Withdrawal by Subject|1|||
127770827|NCT01259726|459786982|FG000|Overall Study|Lost to Follow-up|1|||
127770828|NCT01259726|459786983|FG001|Overall Study|Lost to Follow-up|1|||
127770829|NCT01259726|459786984|FG002|Overall Study|Lost to Follow-up|1|||
127770830|NCT01259726|459786985|FG003|Overall Study|Lost to Follow-up|3|||
127770831|NCT03421431|459786986|FG000|Overall Study|Adverse Event|2|||
127770832|NCT03421431|459786987|FG001|Overall Study|Adverse Event|1|||
127770833|NCT03421431|459786988|FG002|Overall Study|Adverse Event|12|||
127770834|NCT03421431|459786986|FG000|Overall Study|Lost to Follow-up|1|||
127770835|NCT03421431|459786987|FG001|Overall Study|Lost to Follow-up|1|||
127770836|NCT03421431|459786988|FG002|Overall Study|Lost to Follow-up|1|||
127770837|NCT03421431|459786986|FG000|Overall Study|Withdrawal by Subject|3|||
127770838|NCT03421431|459786987|FG001|Overall Study|Withdrawal by Subject|2|||
127770839|NCT03421431|459786988|FG002|Overall Study|Withdrawal by Subject|1|||
127770840|NCT03421431|459786986|FG000|Overall Study|Protocol Violation|0|||
127548318|NCT02760498|458976690|FG001|Overall Study|Withdrawal by Subject|7|||
127548319|NCT02760498|458976691|FG002|Overall Study|Withdrawal by Subject|5|||
127548320|NCT02760498|458976692|FG003|Overall Study|Withdrawal by Subject|1|||
127548321|NCT02760498|458976693|FG004|Overall Study|Withdrawal by Subject|0|||
127548322|NCT02760498|458976694|FG005|Overall Study|Withdrawal by Subject|6|||
127548323|NCT02760498|458976689|FG000|Overall Study|Other than specified|1|||
127548324|NCT02760498|458976690|FG001|Overall Study|Other than specified|6|||
127548325|NCT02760498|458976691|FG002|Overall Study|Other than specified|0|||
127548326|NCT02760498|458976692|FG003|Overall Study|Other than specified|3|||
127548327|NCT02760498|458976693|FG004|Overall Study|Other than specified|1|||
127548328|NCT02760498|458976694|FG005|Overall Study|Other than specified|0|||
127548329|NCT02760498|458976689|FG000|Overall Study|Not treated|0|||
127548330|NCT02760498|458976690|FG001|Overall Study|Not treated|0|||
127548331|NCT02760498|458976691|FG002|Overall Study|Not treated|0|||
127548332|NCT02760498|458976692|FG003|Overall Study|Not treated|0|||
127548333|NCT02760498|458976693|FG004|Overall Study|Not treated|0|||
127548334|NCT02760498|458976694|FG005|Overall Study|Not treated|2|||
127548335|NCT01467960|458976695|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
127548336|NCT01467960|458976696|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
127548337|NCT01467960|458976697|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
127548338|NCT01467960|458976698|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
127548339|NCT01467960|458976699|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
127548340|NCT01467960|458976700|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
127548341|NCT00771758|458976701|FG000|Overall Study|Adverse Event|2|||
127548342|NCT00771758|458976702|FG001|Overall Study|Adverse Event|8|||
127548343|NCT00771758|458976703|FG002|Overall Study|Adverse Event|1|||
127548344|NCT00771758|458976701|FG000|Overall Study|Lack of Efficacy|0|||
127548345|NCT00771758|458976702|FG001|Overall Study|Lack of Efficacy|2|||
127548346|NCT00771758|458976703|FG002|Overall Study|Lack of Efficacy|1|||
127548347|NCT00771758|458976701|FG000|Overall Study|Lost to Follow-up|1|||
127548348|NCT00771758|458976702|FG001|Overall Study|Lost to Follow-up|0|||
127548349|NCT00771758|458976703|FG002|Overall Study|Lost to Follow-up|0|||
127548350|NCT00771758|458976701|FG000|Overall Study|Protocol Violation|1|||
127548351|NCT00771758|458976702|FG001|Overall Study|Protocol Violation|0|||
127548352|NCT00771758|458976703|FG002|Overall Study|Protocol Violation|0|||
127548353|NCT00771758|458976701|FG000|Overall Study|Withdrawal by Subject|1|||
127548354|NCT00771758|458976702|FG001|Overall Study|Withdrawal by Subject|0|||
127548355|NCT00771758|458976703|FG002|Overall Study|Withdrawal by Subject|0|||
127548356|NCT00771758|458976701|FG000|Overall Study|Other|3|||
127548357|NCT00771758|458976702|FG001|Overall Study|Other|2|||
127548358|NCT00771758|458976703|FG002|Overall Study|Other|0|||
127548359|NCT03067077|458976704|FG000|Overall Study|Did not receive surgery|4|||
127548360|NCT03067077|458976705|FG001|Overall Study|Did not receive surgery|5|||
127548361|NCT03067077|458976704|FG000|Overall Study|Lost to Follow-up|3|||
127548362|NCT03067077|458976705|FG001|Overall Study|Lost to Follow-up|2|||
127548363|NCT00935584|458976708|FG000|Overall Study|Withdrawal by Subject|9|||
127548364|NCT00935584|458976709|FG001|Overall Study|Withdrawal by Subject|0|||
127548365|NCT00935584|458976708|FG000|Overall Study|Death|3|||
127684179|NCT01595061|459468374|FG000|Overall Study|Inadequate Pathology|1|||
127684180|NCT00529789|459468375|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
127684181|NCT00529789|459468375|FG000|Study Period II/III|Adverse Event|3|||
127684182|NCT00529789|459468375|FG000|Study Period II/III|Lack of Efficacy|2|||
127684183|NCT00529789|459468375|FG000|Study Period II/III|Withdrawal by Subject|1|||
127684184|NCT00529789|459468375|FG000|Study Period II/III|Protocol Violation|3|||
127684185|NCT00529789|459468375|FG000|Study Period II/III|Physician Decision|3|||
127684186|NCT00529789|459468375|FG000|Study Period II/III|Lost to Follow-up|3|||
127684187|NCT00529789|459468375|FG000|Study Period IV|Parent/Caregiver Decision|1|||
127684188|NCT00529789|459468375|FG000|Study Period IV|Adverse Event|1|||
127684189|NCT00529789|459468375|FG000|Study Period IV|Lack of Efficacy|1|||
127684190|NCT00529789|459468375|FG000|Study Period IV|Lost to Follow-up|3|||
127684191|NCT01430611|459468376|FG000|Overall Study|Adverse Event|0|||
127684192|NCT01430611|459468377|FG001|Overall Study|Adverse Event|1|||
127684193|NCT01430611|459468376|FG000|Overall Study|Protocol Violation|1|||
127684194|NCT01430611|459468377|FG001|Overall Study|Protocol Violation|0|||
127548366|NCT00935584|458976709|FG001|Overall Study|Death|0|||
127548367|NCT00935584|458976708|FG000|Overall Study|Lost to Follow-up|8|||
127548368|NCT00935584|458976709|FG001|Overall Study|Lost to Follow-up|0|||
127548369|NCT00935584|458976708|FG000|Overall Study|No show|9|||
127548370|NCT00935584|458976709|FG001|Overall Study|No show|0|||
127548371|NCT00935584|458976708|FG000|Overall Study|Relocated|3|||
127548372|NCT00935584|458976709|FG001|Overall Study|Relocated|0|||
127548373|NCT00935584|458976708|FG000|Overall Study|Patient changed provider|3|||
127548374|NCT00935584|458976709|FG001|Overall Study|Patient changed provider|0|||
127548375|NCT00935584|458976708|FG000|Overall Study|Provider dropped out of study|14|||
127548376|NCT00935584|458976709|FG001|Overall Study|Provider dropped out of study|4|||
127548377|NCT00687193|458976711|FG000|Overall Study|Adverse Event|0|||
127684195|NCT01430611|459468376|FG000|Overall Study|Lost to Follow-up|1|||
127684196|NCT01430611|459468377|FG001|Overall Study|Lost to Follow-up|0|||
127548378|NCT00687193|458976712|FG001|Overall Study|Adverse Event|1|||
127548379|NCT00687193|458976713|FG002|Overall Study|Adverse Event|2|||
127548380|NCT00687193|458976714|FG003|Overall Study|Adverse Event|3|||
127548381|NCT00687193|458976715|FG004|Overall Study|Adverse Event|0|||
127548382|NCT00687193|458976716|FG005|Overall Study|Adverse Event|2|||
127548383|NCT00687193|458976711|FG000|Overall Study|Lack of Efficacy|1|||
127548384|NCT00687193|458976712|FG001|Overall Study|Lack of Efficacy|1|||
127548385|NCT00687193|458976713|FG002|Overall Study|Lack of Efficacy|0|||
127548386|NCT00687193|458976714|FG003|Overall Study|Lack of Efficacy|0|||
127548387|NCT00687193|458976715|FG004|Overall Study|Lack of Efficacy|0|||
127548388|NCT00687193|458976716|FG005|Overall Study|Lack of Efficacy|2|||
127548389|NCT00687193|458976711|FG000|Overall Study|Protocol Violation|1|||
127548390|NCT00687193|458976712|FG001|Overall Study|Protocol Violation|2|||
127548391|NCT00687193|458976713|FG002|Overall Study|Protocol Violation|0|||
127548392|NCT00687193|458976714|FG003|Overall Study|Protocol Violation|1|||
127548393|NCT00687193|458976715|FG004|Overall Study|Protocol Violation|2|||
127548394|NCT00687193|458976716|FG005|Overall Study|Protocol Violation|0|||
127548395|NCT01394016|458976717|FG000|Overall Study|Progressive Disease|2|||
127548396|NCT01394016|458976718|FG001|Overall Study|Progressive Disease|0|||
127548397|NCT01394016|458976719|FG002|Overall Study|Progressive Disease|0|||
127548398|NCT01394016|458976720|FG003|Overall Study|Progressive Disease|0|||
127548399|NCT01394016|458976721|FG004|Overall Study|Progressive Disease|0|||
127548400|NCT01394016|458976722|FG005|Overall Study|Progressive Disease|0|||
127548401|NCT01394016|458976723|FG006|Overall Study|Progressive Disease|0|||
127548402|NCT01394016|458976724|FG007|Overall Study|Progressive Disease|0|||
127548403|NCT01394016|458976725|FG008|Overall Study|Progressive Disease|0|||
127548404|NCT01394016|458976726|FG009|Overall Study|Progressive Disease|0|||
127548405|NCT01394016|458976727|FG010|Overall Study|Progressive Disease|0|||
127548406|NCT01394016|458976728|FG011|Overall Study|Progressive Disease|0|||
127548407|NCT01394016|458976729|FG012|Overall Study|Progressive Disease|0|||
127548408|NCT01394016|458976730|FG013|Overall Study|Progressive Disease|0|||
127548409|NCT01394016|458976731|FG014|Overall Study|Progressive Disease|0|||
127548410|NCT01394016|458976732|FG015|Overall Study|Progressive Disease|0|||
127548411|NCT01394016|458976733|FG016|Overall Study|Progressive Disease|0|||
127548412|NCT01394016|458976734|FG017|Overall Study|Progressive Disease|0|||
127548413|NCT01394016|458976735|FG018|Overall Study|Progressive Disease|0|||
127548414|NCT01394016|458976717|FG000|Overall Study|Withdrawal by Subject|0|||
127548415|NCT01394016|458976718|FG001|Overall Study|Withdrawal by Subject|0|||
127548416|NCT01394016|458976719|FG002|Overall Study|Withdrawal by Subject|0|||
127548417|NCT01394016|458976720|FG003|Overall Study|Withdrawal by Subject|0|||
127548418|NCT01394016|458976721|FG004|Overall Study|Withdrawal by Subject|0|||
127548419|NCT01394016|458976722|FG005|Overall Study|Withdrawal by Subject|0|||
127684197|NCT01430611|459468376|FG000|Overall Study|Withdrawal by Subject|15|||
127770841|NCT03421431|459786987|FG001|Overall Study|Protocol Violation|1|||
127770842|NCT03421431|459786988|FG002|Overall Study|Protocol Violation|0|||
127770843|NCT03421431|459786986|FG000|Overall Study|Participant met Stopping Rules|0|||
127770844|NCT03421431|459786987|FG001|Overall Study|Participant met Stopping Rules|1|||
127684198|NCT01430611|459468377|FG001|Overall Study|Withdrawal by Subject|14|||
127684199|NCT02204982|459468378|FG000|Overall Study|Patient ineligible-medical monitor|1|||
127684200|NCT02204982|459468379|FG001|Overall Study|Patient ineligible-medical monitor|0|||
127684201|NCT02204982|459468378|FG000|Overall Study|Withdrawal by Subject|1|||
127684202|NCT02204982|459468379|FG001|Overall Study|Withdrawal by Subject|0|||
127684203|NCT02204982|459468378|FG000|Overall Study|Adverse Event|1|||
127684204|NCT02204982|459468379|FG001|Overall Study|Adverse Event|0|||
127684205|NCT02204982|459468378|FG000|Overall Study|Adverse Event and Investigator decision|1|||
127684206|NCT02204982|459468379|FG001|Overall Study|Adverse Event and Investigator decision|0|||
127684207|NCT02204982|459468378|FG000|Overall Study|Physician Decision|0|||
127684208|NCT02204982|459468379|FG001|Overall Study|Physician Decision|2|||
127684209|NCT02204982|459468378|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
127684210|NCT02204982|459468379|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
127684211|NCT02204982|459468378|FG000|Overall Study|Termination of Study bySponsor|0|||
127684212|NCT02204982|459468379|FG001|Overall Study|Termination of Study bySponsor|1|||
127684213|NCT00960141|459468380|FG000|Overall Study|Adverse Event|4|||
127684214|NCT00960141|459468381|FG001|Overall Study|Adverse Event|8|||
127684215|NCT00960141|459468382|FG002|Overall Study|Adverse Event|2|||
127684216|NCT00960141|459468380|FG000|Overall Study|Lack of Efficacy|3|||
127684217|NCT00960141|459468381|FG001|Overall Study|Lack of Efficacy|4|||
128016203|NCT00191100|460682250|FG000|Overall Study|Patient Moved|0|||
127548420|NCT01394016|458976723|FG006|Overall Study|Withdrawal by Subject|0|||
127548421|NCT01394016|458976724|FG007|Overall Study|Withdrawal by Subject|1|||
127548422|NCT01394016|458976725|FG008|Overall Study|Withdrawal by Subject|1|||
127548423|NCT01394016|458976726|FG009|Overall Study|Withdrawal by Subject|1|||
127548424|NCT01394016|458976727|FG010|Overall Study|Withdrawal by Subject|4|||
127548425|NCT01394016|458976728|FG011|Overall Study|Withdrawal by Subject|0|||
128016204|NCT00191100|460682251|FG001|Overall Study|Patient Moved|1|||
127548426|NCT01394016|458976729|FG012|Overall Study|Withdrawal by Subject|0|||
127548427|NCT01394016|458976730|FG013|Overall Study|Withdrawal by Subject|3|||
127548428|NCT01394016|458976731|FG014|Overall Study|Withdrawal by Subject|1|||
127548429|NCT01394016|458976732|FG015|Overall Study|Withdrawal by Subject|3|||
127548430|NCT01394016|458976733|FG016|Overall Study|Withdrawal by Subject|1|||
127548431|NCT01394016|458976734|FG017|Overall Study|Withdrawal by Subject|1|||
127548432|NCT01394016|458976735|FG018|Overall Study|Withdrawal by Subject|2|||
127548433|NCT01394016|458976717|FG000|Overall Study|Adverse Event|0|||
127548434|NCT01394016|458976718|FG001|Overall Study|Adverse Event|0|||
127548435|NCT01394016|458976719|FG002|Overall Study|Adverse Event|0|||
127548436|NCT01394016|458976720|FG003|Overall Study|Adverse Event|0|||
127548437|NCT01394016|458976721|FG004|Overall Study|Adverse Event|0|||
128016205|NCT00191100|460682250|FG000|Overall Study|Withdrawal by Subject|9|||
128016206|NCT00191100|460682251|FG001|Overall Study|Withdrawal by Subject|3|||
128016207|NCT00191100|460682250|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
128016208|NCT00191100|460682251|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
128016209|NCT00191100|460682250|FG000|Overall Study|Clinical Relapse|2|||
128016210|NCT00191100|460682251|FG001|Overall Study|Clinical Relapse|1|||
128016211|NCT00191100|460682250|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
128016212|NCT00191100|460682251|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
128016213|NCT00191100|460682250|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
128016214|NCT00191100|460682251|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
128016215|NCT00191100|460682250|FG000|Overall Study|Physician Decision|3|||
128016216|NCT00191100|460682251|FG001|Overall Study|Physician Decision|1|||
128016217|NCT00191100|460682250|FG000|Overall Study|Death from Study Drug Toxicity|2|||
128016218|NCT00191100|460682251|FG001|Overall Study|Death from Study Drug Toxicity|0|||
128016219|NCT00191100|460682250|FG000|Overall Study|Protocol Violation|1|||
128016220|NCT00191100|460682251|FG001|Overall Study|Protocol Violation|1|||
128016221|NCT00191100|460682250|FG000|Overall Study|Death from Other Cause|1|||
128016222|NCT00191100|460682251|FG001|Overall Study|Death from Other Cause|0|||
128016223|NCT00191100|460682250|FG000|Overall Study|Reason Not Specified|0|||
128016224|NCT00191100|460682251|FG001|Overall Study|Reason Not Specified|1|||
128016225|NCT02916771|460682256|FG000|Overall Study|Withdrawal by Subject|9|||
128016226|NCT02916771|460682256|FG000|Overall Study|Physician Decision|1|||
128016227|NCT02916771|460682256|FG000|Overall Study|Began treatment for another active malignancy|1|||
128016228|NCT01525589|460682257|FG000|Overall Study|Non-treatment-related AE|1|||
128016229|NCT01525589|460682258|FG001|Overall Study|Non-treatment-related AE|0|||
128016230|NCT01525589|460682259|FG002|Overall Study|Non-treatment-related AE|0|||
128016231|NCT01525589|460682257|FG000|Overall Study|Progressive disease|48|||
128016232|NCT01525589|460682258|FG001|Overall Study|Progressive disease|15|||
128016233|NCT01525589|460682259|FG002|Overall Study|Progressive disease|29|||
128016234|NCT01525589|460682257|FG000|Overall Study|Never treated|2|||
128016235|NCT01525589|460682258|FG001|Overall Study|Never treated|0|||
128016236|NCT01525589|460682259|FG002|Overall Study|Never treated|0|||
127684218|NCT00960141|459468382|FG002|Overall Study|Lack of Efficacy|2|||
127684219|NCT00960141|459468380|FG000|Overall Study|Lost to Follow-up|1|||
127684220|NCT00960141|459468381|FG001|Overall Study|Lost to Follow-up|0|||
127684221|NCT00960141|459468382|FG002|Overall Study|Lost to Follow-up|0|||
127684222|NCT00960141|459468380|FG000|Overall Study|Protocol Violation|1|||
127684223|NCT00960141|459468381|FG001|Overall Study|Protocol Violation|3|||
127684224|NCT00960141|459468382|FG002|Overall Study|Protocol Violation|2|||
127684225|NCT00960141|459468380|FG000|Overall Study|Withdrawal by Subject|1|||
127684226|NCT00960141|459468381|FG001|Overall Study|Withdrawal by Subject|2|||
127684227|NCT00960141|459468382|FG002|Overall Study|Withdrawal by Subject|1|||
127684228|NCT01792830|459468386|FG000|Overall Study|Withdrawal by Subject|22|||
127684229|NCT01792830|459468387|FG001|Overall Study|Withdrawal by Subject|0|||
127684230|NCT01792830|459468388|FG002|Overall Study|Withdrawal by Subject|0|||
127684231|NCT01792830|459468389|FG003|Overall Study|Withdrawal by Subject|2|||
127684232|NCT01792830|459468390|FG004|Overall Study|Withdrawal by Subject|1|||
127684233|NCT01792830|459468391|FG005|Overall Study|Withdrawal by Subject|1|||
127684234|NCT01792830|459468392|FG006|Overall Study|Withdrawal by Subject|1|||
127684235|NCT01792830|459468393|FG007|Overall Study|Withdrawal by Subject|1|||
127684236|NCT01792830|459468394|FG008|Overall Study|Withdrawal by Subject|7|||
127684237|NCT01792830|459468395|FG009|Overall Study|Withdrawal by Subject|0|||
127684238|NCT01792830|459468396|FG010|Overall Study|Withdrawal by Subject|2|||
127684239|NCT01792830|459468386|FG000|Overall Study|Death|3|||
127684240|NCT01792830|459468387|FG001|Overall Study|Death|0|||
127684241|NCT01792830|459468388|FG002|Overall Study|Death|0|||
127684242|NCT01792830|459468389|FG003|Overall Study|Death|1|||
127684243|NCT01792830|459468390|FG004|Overall Study|Death|0|||
127684244|NCT01792830|459468391|FG005|Overall Study|Death|0|||
127684245|NCT01792830|459468392|FG006|Overall Study|Death|1|||
127684246|NCT01792830|459468393|FG007|Overall Study|Death|0|||
127684247|NCT01792830|459468394|FG008|Overall Study|Death|1|||
128016237|NCT01525589|460682257|FG000|Overall Study|Physician Decision|4|||
128016238|NCT01525589|460682258|FG001|Overall Study|Physician Decision|2|||
128016239|NCT01525589|460682259|FG002|Overall Study|Physician Decision|2|||
128016240|NCT01525589|460682257|FG000|Overall Study|Death|0|||
128016241|NCT01525589|460682258|FG001|Overall Study|Death|0|||
128016242|NCT01525589|460682259|FG002|Overall Study|Death|2|||
128016243|NCT01525589|460682257|FG000|Overall Study|Treatment-related AE|1|||
127770845|NCT03421431|459786988|FG002|Overall Study|Participant met Stopping Rules|0|||
127770846|NCT00235326|459786996|FG000|Overall Study|Lost to Follow-up|746|||
127770847|NCT00235326|459786997|FG001|Overall Study|Lost to Follow-up|1400|||
127770848|NCT01128738|459786998|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
127770849|NCT01128738|459786999|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
127770850|NCT01128738|459786998|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
127770851|NCT01128738|459786999|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
127770852|NCT01128738|459786998|FG000|Second TP|Lost to Follow-up|0|||
127770853|NCT01128738|459786999|FG001|Second TP|Lost to Follow-up|1|||
127770854|NCT01128738|459786998|FG000|Second TP|Withdrawal by Subject|0|||
127770855|NCT01128738|459786999|FG001|Second TP|Withdrawal by Subject|2|||
127770856|NCT01178671|459787000|FG000|Overall Study|Adverse Event|4|||
127770857|NCT01178671|459787001|FG001|Overall Study|Adverse Event|6|||
127770858|NCT01178671|459787000|FG000|Overall Study|Protocol Violation|1|||
127770859|NCT01178671|459787001|FG001|Overall Study|Protocol Violation|1|||
127770860|NCT01178671|459787000|FG000|Overall Study|Lack of Efficacy|0|||
127770861|NCT01178671|459787001|FG001|Overall Study|Lack of Efficacy|1|||
127770862|NCT01178671|459787000|FG000|Overall Study|Lost to Follow-up|3|||
127770863|NCT01178671|459787001|FG001|Overall Study|Lost to Follow-up|1|||
127770864|NCT01178671|459787000|FG000|Overall Study|Physician Decision|4|||
127770865|NCT01178671|459787001|FG001|Overall Study|Physician Decision|6|||
127770866|NCT01211197|459787003|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
127770867|NCT01211197|459787004|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
127770868|NCT01211197|459787005|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
128016244|NCT01525589|460682258|FG001|Overall Study|Treatment-related AE|1|||
128016245|NCT01525589|460682259|FG002|Overall Study|Treatment-related AE|2|||
128016246|NCT01525589|460682257|FG000|Overall Study|Other reasons|0|||
128016247|NCT01525589|460682258|FG001|Overall Study|Other reasons|1|||
128016248|NCT01525589|460682259|FG002|Overall Study|Other reasons|0|||
128016249|NCT01525589|460682257|FG000|Overall Study|Withdrawal by Subject|0|||
128016250|NCT01525589|460682258|FG001|Overall Study|Withdrawal by Subject|1|||
128016251|NCT01525589|460682259|FG002|Overall Study|Withdrawal by Subject|0|||
128016252|NCT02924376|460682260|FG000|Overall Study|Progressive Disease|4|||
128016253|NCT02924376|460682261|FG001|Overall Study|Progressive Disease|0|||
128016254|NCT02924376|460682262|FG002|Overall Study|Progressive Disease|1|||
128016255|NCT02924376|460682263|FG003|Overall Study|Progressive Disease|0|||
128016256|NCT02924376|460682260|FG000|Overall Study|Death|73|||
128016257|NCT02924376|460682261|FG001|Overall Study|Death|18|||
128016258|NCT02924376|460682262|FG002|Overall Study|Death|15|||
128016259|NCT02924376|460682263|FG003|Overall Study|Death|2|||
128016260|NCT02924376|460682260|FG000|Overall Study|Lost to Follow-up|3|||
128016261|NCT02924376|460682261|FG001|Overall Study|Lost to Follow-up|0|||
128016262|NCT02924376|460682262|FG002|Overall Study|Lost to Follow-up|0|||
128016263|NCT02924376|460682263|FG003|Overall Study|Lost to Follow-up|0|||
128016264|NCT02924376|460682260|FG000|Overall Study|Study Terminated by Sponsor|19|||
128016265|NCT02924376|460682261|FG001|Overall Study|Study Terminated by Sponsor|0|||
128016266|NCT02924376|460682262|FG002|Overall Study|Study Terminated by Sponsor|0|||
128016267|NCT02924376|460682263|FG003|Overall Study|Study Terminated by Sponsor|0|||
128016268|NCT02924376|460682260|FG000|Overall Study|Physician Decision|1|||
128016269|NCT02924376|460682261|FG001|Overall Study|Physician Decision|0|||
128016270|NCT02924376|460682262|FG002|Overall Study|Physician Decision|0|||
128016271|NCT02924376|460682263|FG003|Overall Study|Physician Decision|0|||
128016272|NCT02924376|460682260|FG000|Overall Study|Withdrawal by Subject|7|||
128016273|NCT02924376|460682261|FG001|Overall Study|Withdrawal by Subject|2|||
128016274|NCT02924376|460682262|FG002|Overall Study|Withdrawal by Subject|1|||
128016275|NCT02924376|460682263|FG003|Overall Study|Withdrawal by Subject|0|||
128016276|NCT02924376|460682260|FG000|Overall Study|Rolled Over to Another Study|1|||
128016277|NCT02924376|460682261|FG001|Overall Study|Rolled Over to Another Study|0|||
128016278|NCT02924376|460682262|FG002|Overall Study|Rolled Over to Another Study|0|||
128016279|NCT02924376|460682263|FG003|Overall Study|Rolled Over to Another Study|0|||
128016280|NCT06481579|460682265|FG000|Overall Study|Death|1|||
127548438|NCT01394016|458976722|FG005|Overall Study|Adverse Event|0|||
127548439|NCT01394016|458976723|FG006|Overall Study|Adverse Event|0|||
127548440|NCT01394016|458976724|FG007|Overall Study|Adverse Event|0|||
128016281|NCT06481579|460682266|FG001|Overall Study|Death|0|||
128016282|NCT06481579|460682265|FG000|Overall Study|Withdrawal by Subject|3|||
128016283|NCT06481579|460682266|FG001|Overall Study|Withdrawal by Subject|0|||
128016284|NCT06481579|460682265|FG000|Overall Study|Other|1|||
128016285|NCT06481579|460682266|FG001|Overall Study|Other|1|||
128016286|NCT06455111|460682267|FG000|Overall Study|Withdrawal by Subject|11|||
127548441|NCT01394016|458976725|FG008|Overall Study|Adverse Event|0|||
127770869|NCT01211197|459787006|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
127770870|NCT01211197|459787007|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
127880904|NCT00537056|460186060|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
128016287|NCT06455111|460682268|FG001|Overall Study|Withdrawal by Subject|4|||
128016288|NCT00975923|460683189|FG000|Overall Study|Withdrawal by Subject|0|||
128016289|NCT00975923|460683190|FG001|Overall Study|Withdrawal by Subject|1|||
128016290|NCT02572167|460683193|FG000|Overall Study|Withdrawal by Subject|0|||
127548442|NCT01394016|458976726|FG009|Overall Study|Adverse Event|1|||
127548443|NCT01394016|458976727|FG010|Overall Study|Adverse Event|0|||
127548444|NCT01394016|458976728|FG011|Overall Study|Adverse Event|0|||
127548445|NCT01394016|458976729|FG012|Overall Study|Adverse Event|0|||
127548446|NCT01394016|458976730|FG013|Overall Study|Adverse Event|0|||
127548447|NCT01394016|458976731|FG014|Overall Study|Adverse Event|0|||
127548448|NCT01394016|458976732|FG015|Overall Study|Adverse Event|0|||
127548449|NCT01394016|458976733|FG016|Overall Study|Adverse Event|1|||
127548450|NCT01394016|458976734|FG017|Overall Study|Adverse Event|1|||
127548451|NCT01394016|458976735|FG018|Overall Study|Adverse Event|0|||
127548452|NCT01394016|458976717|FG000|Overall Study|Sponsor Decision|0|||
127548453|NCT01394016|458976718|FG001|Overall Study|Sponsor Decision|0|||
127548454|NCT01394016|458976719|FG002|Overall Study|Sponsor Decision|0|||
127548455|NCT01394016|458976720|FG003|Overall Study|Sponsor Decision|0|||
127548456|NCT01394016|458976721|FG004|Overall Study|Sponsor Decision|0|||
127548457|NCT01394016|458976722|FG005|Overall Study|Sponsor Decision|0|||
127548458|NCT01394016|458976723|FG006|Overall Study|Sponsor Decision|0|||
127548459|NCT01394016|458976724|FG007|Overall Study|Sponsor Decision|0|||
127548460|NCT01394016|458976725|FG008|Overall Study|Sponsor Decision|0|||
127548461|NCT01394016|458976726|FG009|Overall Study|Sponsor Decision|0|||
127770871|NCT01211197|459787008|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
127770872|NCT01211197|459787003|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
127770873|NCT01211197|459787004|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
128016291|NCT02572167|460683194|FG001|Overall Study|Withdrawal by Subject|3|||
128016292|NCT02572167|460683195|FG002|Overall Study|Withdrawal by Subject|0|||
128016293|NCT02572167|460683193|FG000|Overall Study|Lost to Follow-up|2|||
128016294|NCT02572167|460683194|FG001|Overall Study|Lost to Follow-up|5|||
128016295|NCT02572167|460683195|FG002|Overall Study|Lost to Follow-up|3|||
128016296|NCT02572167|460683193|FG000|Overall Study|Death|0|||
128016297|NCT02572167|460683194|FG001|Overall Study|Death|8|||
128016298|NCT02572167|460683195|FG002|Overall Study|Death|3|||
128016299|NCT02572167|460683193|FG000|Overall Study|Did not meet inclusion criteria|0|||
128016300|NCT02572167|460683194|FG001|Overall Study|Did not meet inclusion criteria|0|||
128016301|NCT02572167|460683195|FG002|Overall Study|Did not meet inclusion criteria|1|||
128016302|NCT02572167|460683193|FG000|Overall Study|Study closure by Sponsor|4|||
128016303|NCT02572167|460683194|FG001|Overall Study|Study closure by Sponsor|40|||
128016304|NCT02572167|460683195|FG002|Overall Study|Study closure by Sponsor|24|||
128016305|NCT06354257|460683201|FG000|Treatment Period 1|Withdrawal by Subject|1|||
128016306|NCT06354257|460683201|FG000|Treatment Period 2|Adverse Event|1|||
128016307|NCT04132050|460683202|FG000|Period I (Double-blind Period)|Adverse Event|3|||
128016308|NCT04132050|460683203|FG001|Period I (Double-blind Period)|Adverse Event|0|||
128016309|NCT04132050|460683202|FG000|Period I (Double-blind Period)|Lack of Efficacy|9|||
128016310|NCT04132050|460683203|FG001|Period I (Double-blind Period)|Lack of Efficacy|8|||
128016311|NCT04132050|460683202|FG000|R788 Treatment Period|Adverse Event|5|||
128016312|NCT04132050|460683203|FG001|R788 Treatment Period|Adverse Event|0|||
128016313|NCT04132050|460683202|FG000|R788 Treatment Period|Lack of Efficacy|5|||
127770874|NCT01211197|459787005|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
127770875|NCT01211197|459787006|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
127770876|NCT01211197|459787007|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
127770877|NCT01211197|459787008|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
127770878|NCT05116046|459787011|FG000|Overall Study|Withdrawal by parent/guardian|2|||
127770879|NCT05116046|459787012|FG001|Overall Study|Withdrawal by parent/guardian|1|||
127770880|NCT05116046|459787013|FG002|Overall Study|Withdrawal by parent/guardian|1|||
127770881|NCT05116046|459787011|FG000|Overall Study|Study terminated by sponsor|14|||
127770882|NCT05116046|459787012|FG001|Overall Study|Study terminated by sponsor|16|||
127770883|NCT05116046|459787013|FG002|Overall Study|Study terminated by sponsor|1|||
127770884|NCT02683941|459787014|FG000|Double-blind Phase|Adverse Event|0|||
127770885|NCT02683941|459787015|FG001|Double-blind Phase|Adverse Event|1|||
127770886|NCT02683941|459787014|FG000|Double-blind Phase|Withdrawal by Subject|4|||
127770887|NCT02683941|459787015|FG001|Double-blind Phase|Withdrawal by Subject|2|||
127770888|NCT02683941|459787014|FG000|Double-blind Phase|Lost to Follow-up|1|||
127770889|NCT02683941|459787015|FG001|Double-blind Phase|Lost to Follow-up|0|||
127770890|NCT02683941|459787014|FG000|Double-blind Phase|Disease Progression|5|||
127770891|NCT02683941|459787015|FG001|Double-blind Phase|Disease Progression|2|||
128016314|NCT04132050|460683203|FG001|R788 Treatment Period|Lack of Efficacy|0|||
128016315|NCT04132050|460683202|FG000|R788 Treatment Period|Withdrawal by Subject|1|||
128016316|NCT04132050|460683203|FG001|R788 Treatment Period|Withdrawal by Subject|0|||
128016317|NCT00433537|460683204|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
127548462|NCT01394016|458976727|FG010|Overall Study|Sponsor Decision|0|||
127548463|NCT01394016|458976728|FG011|Overall Study|Sponsor Decision|0|||
127548464|NCT01394016|458976729|FG012|Overall Study|Sponsor Decision|1|||
127548465|NCT01394016|458976730|FG013|Overall Study|Sponsor Decision|0|||
127770892|NCT02683941|459787014|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
127770893|NCT02683941|459787015|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
127770894|NCT02683941|459787014|FG000|Open-label Treatment Phase|Disease Progression|1|||
127770895|NCT02683941|459787015|FG001|Open-label Treatment Phase|Disease Progression|2|||
127770896|NCT02683941|459787014|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
127770897|NCT02683941|459787015|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
127770898|NCT02683941|459787014|FG000|Open-label Treatment Phase|Other|1|||
127770899|NCT02683941|459787015|FG001|Open-label Treatment Phase|Other|0|||
127770900|NCT02683941|459787014|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
127770901|NCT02683941|459787015|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
127770902|NCT02683941|459787014|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
127770903|NCT02683941|459787015|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
127770904|NCT02683941|459787014|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
127770905|NCT02683941|459787015|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
127770906|NCT02683941|459787014|FG000|Open-label Follow-up Phase|Other|8|||
127770907|NCT02683941|459787015|FG001|Open-label Follow-up Phase|Other|1|||
127770908|NCT00261846|459787016|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
127770909|NCT00261846|459787017|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
127770910|NCT00261846|459787018|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
127770911|NCT00261846|459787019|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
127770912|NCT00261846|459787020|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
127770913|NCT00261846|459787021|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
127770914|NCT00261846|459787022|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
128016318|NCT00433537|460683205|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
128016319|NCT00433537|460683206|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
128016320|NCT00433537|460683204|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
128016321|NCT00433537|460683205|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
128016322|NCT00433537|460683206|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
128016323|NCT00433537|460683204|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
128016324|NCT00433537|460683205|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
128016325|NCT00433537|460683206|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
128016326|NCT00433537|460683204|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
128016327|NCT00433537|460683205|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
128016328|NCT00433537|460683206|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
128016329|NCT00433537|460683204|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
128016330|NCT00433537|460683205|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
128016331|NCT00433537|460683206|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
128016332|NCT00433537|460683204|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
128016333|NCT00433537|460683205|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
128016334|NCT00433537|460683206|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
128016335|NCT00433537|460683204|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
128016336|NCT00433537|460683205|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
128016337|NCT00433537|460683206|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
128016338|NCT00433537|460683204|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
128016339|NCT00433537|460683205|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
128016340|NCT00433537|460683206|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
128016341|NCT00433537|460683204|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
128016342|NCT00433537|460683205|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
128016343|NCT00433537|460683206|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
128016344|NCT01757847|460683207|FG000|Overall Study|Withdrawal by Subject|3|||
128016345|NCT01757847|460683208|FG001|Overall Study|Withdrawal by Subject|4|||
128016346|NCT03370276|460683209|FG000|Overall Study|Death|0|||
128016347|NCT03370276|460683210|FG001|Overall Study|Death|2|||
128016348|NCT03370276|460683211|FG002|Overall Study|Death|5|||
128016349|NCT00831844|460683212|FG000|Overall Study|Adverse Event|2|||
128016350|NCT00831844|460683213|FG001|Overall Study|Adverse Event|0|||
128016351|NCT00831844|460683214|FG002|Overall Study|Adverse Event|0|||
128016352|NCT00831844|460683215|FG003|Overall Study|Adverse Event|0|||
128016353|NCT00831844|460683216|FG004|Overall Study|Adverse Event|1|||
128016354|NCT00831844|460683217|FG005|Overall Study|Adverse Event|1|||
128016355|NCT00831844|460683218|FG006|Overall Study|Adverse Event|2|||
128016356|NCT00831844|460683219|FG007|Overall Study|Adverse Event|0|||
128016357|NCT00831844|460683220|FG008|Overall Study|Adverse Event|0|||
128016358|NCT00831844|460683221|FG009|Overall Study|Adverse Event|0|||
128016359|NCT00831844|460683212|FG000|Overall Study|Death|0|||
128016360|NCT00831844|460683213|FG001|Overall Study|Death|0|||
128016361|NCT00831844|460683214|FG002|Overall Study|Death|0|||
128016362|NCT00831844|460683215|FG003|Overall Study|Death|1|||
128016363|NCT00831844|460683216|FG004|Overall Study|Death|0|||
128016364|NCT00831844|460683217|FG005|Overall Study|Death|0|||
128016365|NCT00831844|460683218|FG006|Overall Study|Death|0|||
128016366|NCT00831844|460683219|FG007|Overall Study|Death|0|||
128016367|NCT00831844|460683220|FG008|Overall Study|Death|0|||
128016368|NCT00831844|460683221|FG009|Overall Study|Death|0|||
128016369|NCT00831844|460683212|FG000|Overall Study|Lack of Efficacy|8|||
128016370|NCT00831844|460683213|FG001|Overall Study|Lack of Efficacy|10|||
128016371|NCT00831844|460683214|FG002|Overall Study|Lack of Efficacy|15|||
127548466|NCT01394016|458976731|FG014|Overall Study|Sponsor Decision|0|||
127548467|NCT01394016|458976732|FG015|Overall Study|Sponsor Decision|0|||
127548468|NCT01394016|458976733|FG016|Overall Study|Sponsor Decision|0|||
127548469|NCT01394016|458976734|FG017|Overall Study|Sponsor Decision|0|||
127548470|NCT01394016|458976735|FG018|Overall Study|Sponsor Decision|0|||
127548471|NCT01394016|458976717|FG000|Overall Study|Lost to Follow-up|0|||
127548472|NCT01394016|458976718|FG001|Overall Study|Lost to Follow-up|0|||
127548473|NCT01394016|458976719|FG002|Overall Study|Lost to Follow-up|0|||
127548474|NCT01394016|458976720|FG003|Overall Study|Lost to Follow-up|0|||
127548475|NCT01394016|458976721|FG004|Overall Study|Lost to Follow-up|0|||
127548476|NCT01394016|458976722|FG005|Overall Study|Lost to Follow-up|0|||
127548477|NCT01394016|458976723|FG006|Overall Study|Lost to Follow-up|0|||
127548478|NCT01394016|458976724|FG007|Overall Study|Lost to Follow-up|0|||
127548479|NCT01394016|458976725|FG008|Overall Study|Lost to Follow-up|0|||
127548480|NCT01394016|458976726|FG009|Overall Study|Lost to Follow-up|0|||
127548481|NCT01394016|458976727|FG010|Overall Study|Lost to Follow-up|0|||
127548482|NCT01394016|458976728|FG011|Overall Study|Lost to Follow-up|0|||
127548483|NCT01394016|458976729|FG012|Overall Study|Lost to Follow-up|0|||
127548484|NCT01394016|458976730|FG013|Overall Study|Lost to Follow-up|0|||
127548485|NCT01394016|458976731|FG014|Overall Study|Lost to Follow-up|0|||
127548486|NCT01394016|458976732|FG015|Overall Study|Lost to Follow-up|0|||
127548487|NCT01394016|458976733|FG016|Overall Study|Lost to Follow-up|0|||
127548488|NCT01394016|458976734|FG017|Overall Study|Lost to Follow-up|0|||
127548489|NCT01394016|458976735|FG018|Overall Study|Lost to Follow-up|1|||
127548490|NCT03534804|458976736|FG000|Overall Study|Withdrawal by Subject|1|||
127548491|NCT04986904|458976737|FG000|Overall Study|Lost to Follow-up|11|||
127548492|NCT04986904|458976737|FG000|Overall Study|Withdrawal by Subject|1|||
127548493|NCT00174187|458976738|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
127548494|NCT00174187|458976739|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
127548495|NCT00174187|458976740|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
127548496|NCT00174187|458976738|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
127548497|NCT00174187|458976739|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
127548498|NCT00174187|458976740|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
127548499|NCT00174187|458976738|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
128016372|NCT00831844|460683215|FG003|Overall Study|Lack of Efficacy|8|||
128016373|NCT00831844|460683216|FG004|Overall Study|Lack of Efficacy|11|||
128016374|NCT00831844|460683217|FG005|Overall Study|Lack of Efficacy|17|||
128016375|NCT00831844|460683218|FG006|Overall Study|Lack of Efficacy|8|||
128016376|NCT00831844|460683219|FG007|Overall Study|Lack of Efficacy|9|||
128016377|NCT00831844|460683220|FG008|Overall Study|Lack of Efficacy|7|||
128016378|NCT00831844|460683221|FG009|Overall Study|Lack of Efficacy|0|||
128016379|NCT00831844|460683212|FG000|Overall Study|Physician Decision|0|||
128016380|NCT00831844|460683213|FG001|Overall Study|Physician Decision|1|||
128016381|NCT00831844|460683214|FG002|Overall Study|Physician Decision|3|||
128016382|NCT00831844|460683215|FG003|Overall Study|Physician Decision|1|||
128016383|NCT00831844|460683216|FG004|Overall Study|Physician Decision|1|||
128016384|NCT00831844|460683217|FG005|Overall Study|Physician Decision|1|||
128016385|NCT00831844|460683218|FG006|Overall Study|Physician Decision|0|||
128016386|NCT00831844|460683219|FG007|Overall Study|Physician Decision|0|||
128016387|NCT00831844|460683220|FG008|Overall Study|Physician Decision|1|||
128016388|NCT00831844|460683221|FG009|Overall Study|Physician Decision|0|||
128016389|NCT00831844|460683212|FG000|Overall Study|Withdrawal by Subject|0|||
128016390|NCT00831844|460683213|FG001|Overall Study|Withdrawal by Subject|0|||
128016391|NCT00831844|460683214|FG002|Overall Study|Withdrawal by Subject|1|||
128016392|NCT00831844|460683215|FG003|Overall Study|Withdrawal by Subject|0|||
128016393|NCT00831844|460683216|FG004|Overall Study|Withdrawal by Subject|0|||
127548500|NCT00174187|458976739|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
127548501|NCT00174187|458976740|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
127684248|NCT01792830|459468395|FG009|Overall Study|Death|0|||
127684249|NCT01792830|459468396|FG010|Overall Study|Death|1|||
127684250|NCT01792830|459468386|FG000|Overall Study|Adverse Event|0|||
127684251|NCT01792830|459468387|FG001|Overall Study|Adverse Event|0|||
128016394|NCT00831844|460683217|FG005|Overall Study|Withdrawal by Subject|0|||
128016395|NCT00831844|460683218|FG006|Overall Study|Withdrawal by Subject|0|||
127548502|NCT00174187|458976738|FG000|Period 1 (up to 3 Years)|Other|0|||
127684252|NCT01792830|459468388|FG002|Overall Study|Adverse Event|0|||
128016396|NCT00831844|460683219|FG007|Overall Study|Withdrawal by Subject|1|||
127548503|NCT00174187|458976739|FG001|Period 1 (up to 3 Years)|Other|1|||
127548504|NCT00174187|458976740|FG002|Period 1 (up to 3 Years)|Other|0|||
127548505|NCT00174187|458976738|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
127548506|NCT00174187|458976739|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
127548507|NCT00174187|458976740|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
127548508|NCT00174187|458976738|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
127684253|NCT01792830|459468389|FG003|Overall Study|Adverse Event|0|||
127684254|NCT01792830|459468390|FG004|Overall Study|Adverse Event|0|||
127684255|NCT01792830|459468391|FG005|Overall Study|Adverse Event|0|||
128016397|NCT00831844|460683220|FG008|Overall Study|Withdrawal by Subject|1|||
128016398|NCT00831844|460683221|FG009|Overall Study|Withdrawal by Subject|0|||
127548509|NCT00174187|458976739|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
127548510|NCT00174187|458976740|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
127548511|NCT00174187|458976738|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
127548512|NCT00174187|458976739|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
127548513|NCT00174187|458976740|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
127548514|NCT00174187|458976738|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
127548515|NCT00174187|458976739|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
127548516|NCT00174187|458976740|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
127548517|NCT00174187|458976738|FG000|Period 2 (After 3 Years)|Other|0|||
127548518|NCT00174187|458976739|FG001|Period 2 (After 3 Years)|Other|0|||
127548519|NCT00174187|458976740|FG002|Period 2 (After 3 Years)|Other|5|||
127548520|NCT03435211|458976741|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
127548521|NCT00759941|458976742|FG000|Overall Study|Use of medication|1|||
127548522|NCT00759941|458976743|FG001|Overall Study|Use of medication|0|||
127548523|NCT00759941|458976742|FG000|Overall Study|Adverse Event|1|||
127548524|NCT00759941|458976743|FG001|Overall Study|Adverse Event|0|||
127548525|NCT00759941|458976742|FG000|Overall Study|Exited in error by site|1|||
127548526|NCT00759941|458976743|FG001|Overall Study|Exited in error by site|1|||
127548527|NCT03863080|458976744|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
127548528|NCT03863080|458976745|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
127548529|NCT03863080|458976746|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
127548530|NCT03863080|458976747|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
127548531|NCT03863080|458976744|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
127548532|NCT03863080|458976745|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
127548533|NCT03863080|458976746|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
127548534|NCT03863080|458976747|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
127548535|NCT03863080|458976744|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
127548536|NCT03863080|458976745|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
127548537|NCT03863080|458976746|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
127548538|NCT03863080|458976747|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
127548539|NCT01342211|458976748|FG000|Overall Study|Lost to Follow-up|0|||
127548540|NCT01342211|458976749|FG001|Overall Study|Lost to Follow-up|0|||
127548541|NCT01342211|458976750|FG002|Overall Study|Lost to Follow-up|0|||
127548542|NCT01342211|458976751|FG003|Overall Study|Lost to Follow-up|1|||
127548543|NCT01342211|458976752|FG004|Overall Study|Lost to Follow-up|0|||
127548544|NCT01342211|458976748|FG000|Overall Study|Adverse Event|0|||
127548545|NCT01342211|458976749|FG001|Overall Study|Adverse Event|0|||
127548546|NCT01342211|458976750|FG002|Overall Study|Adverse Event|0|||
127548547|NCT01342211|458976751|FG003|Overall Study|Adverse Event|0|||
127548548|NCT01342211|458976752|FG004|Overall Study|Adverse Event|1|||
127548549|NCT01342211|458976748|FG000|Overall Study|Withdrawal by Subject|0|||
127548550|NCT01342211|458976749|FG001|Overall Study|Withdrawal by Subject|0|||
127548551|NCT01342211|458976750|FG002|Overall Study|Withdrawal by Subject|0|||
127548552|NCT01342211|458976751|FG003|Overall Study|Withdrawal by Subject|1|||
127548553|NCT01342211|458976752|FG004|Overall Study|Withdrawal by Subject|0|||
127548554|NCT01342211|458976748|FG000|Overall Study|Randomized, but not Treated|0|||
127548555|NCT01342211|458976749|FG001|Overall Study|Randomized, but not Treated|2|||
127548556|NCT01342211|458976750|FG002|Overall Study|Randomized, but not Treated|0|||
127548557|NCT01342211|458976751|FG003|Overall Study|Randomized, but not Treated|0|||
127548558|NCT01342211|458976752|FG004|Overall Study|Randomized, but not Treated|1|||
127548559|NCT01588522|458976768|FG000|Overall Study|Withdrawal by Subject|1|||
127548560|NCT01588522|458976769|FG001|Overall Study|Withdrawal by Subject|5|||
127548561|NCT01588522|458976770|FG002|Overall Study|Withdrawal by Subject|3|||
127548562|NCT01588522|458976771|FG003|Overall Study|Withdrawal by Subject|1|||
127548563|NCT01588522|458976772|FG004|Overall Study|Withdrawal by Subject|2|||
127548564|NCT01588522|458976773|FG005|Overall Study|Withdrawal by Subject|0|||
127770915|NCT00261846|459787023|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
127770916|NCT00261846|459787024|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
127770917|NCT00261846|459787025|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
127770918|NCT00261846|459787026|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
127770919|NCT00261846|459787027|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
127770920|NCT00261846|459787016|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
127770921|NCT00261846|459787017|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
127548565|NCT01588522|458976768|FG000|Overall Study|Lack of Efficacy|0|||
127548566|NCT01588522|458976769|FG001|Overall Study|Lack of Efficacy|0|||
127548567|NCT01588522|458976770|FG002|Overall Study|Lack of Efficacy|0|||
127548568|NCT01588522|458976771|FG003|Overall Study|Lack of Efficacy|0|||
127548569|NCT01588522|458976772|FG004|Overall Study|Lack of Efficacy|1|||
127770922|NCT00261846|459787018|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
127548570|NCT01588522|458976773|FG005|Overall Study|Lack of Efficacy|0|||
127548571|NCT01588522|458976768|FG000|Overall Study|Adverse Event|0|||
127548572|NCT01588522|458976769|FG001|Overall Study|Adverse Event|0|||
127548573|NCT01588522|458976770|FG002|Overall Study|Adverse Event|0|||
127548574|NCT01588522|458976771|FG003|Overall Study|Adverse Event|1|||
127548575|NCT01588522|458976772|FG004|Overall Study|Adverse Event|0|||
127548576|NCT01588522|458976773|FG005|Overall Study|Adverse Event|0|||
127548577|NCT01588522|458976768|FG000|Overall Study|Grade 2 alopecia|1|||
127548578|NCT01588522|458976769|FG001|Overall Study|Grade 2 alopecia|0|||
127548579|NCT01588522|458976770|FG002|Overall Study|Grade 2 alopecia|0|||
127548580|NCT01588522|458976771|FG003|Overall Study|Grade 2 alopecia|0|||
127548581|NCT01588522|458976772|FG004|Overall Study|Grade 2 alopecia|0|||
127548582|NCT01588522|458976773|FG005|Overall Study|Grade 2 alopecia|0|||
127548583|NCT01588522|458976768|FG000|Overall Study|Severe toxicity of chemotherapy|0|||
127548584|NCT01588522|458976769|FG001|Overall Study|Severe toxicity of chemotherapy|0|||
127548585|NCT01588522|458976770|FG002|Overall Study|Severe toxicity of chemotherapy|1|||
127548586|NCT01588522|458976771|FG003|Overall Study|Severe toxicity of chemotherapy|0|||
127548587|NCT01588522|458976772|FG004|Overall Study|Severe toxicity of chemotherapy|0|||
127548588|NCT01588522|458976773|FG005|Overall Study|Severe toxicity of chemotherapy|0|||
127548589|NCT01588522|458976768|FG000|Overall Study|Taken off taxane-based regimen|0|||
127548590|NCT01588522|458976769|FG001|Overall Study|Taken off taxane-based regimen|0|||
127548591|NCT01588522|458976770|FG002|Overall Study|Taken off taxane-based regimen|0|||
127548592|NCT01588522|458976771|FG003|Overall Study|Taken off taxane-based regimen|1|||
127548593|NCT01588522|458976772|FG004|Overall Study|Taken off taxane-based regimen|0|||
127548594|NCT01588522|458976773|FG005|Overall Study|Taken off taxane-based regimen|0|||
127548595|NCT01588522|458976768|FG000|Overall Study|Did not initiate chemotherapy|0|||
127548596|NCT01588522|458976769|FG001|Overall Study|Did not initiate chemotherapy|0|||
127548597|NCT01588522|458976770|FG002|Overall Study|Did not initiate chemotherapy|0|||
127548598|NCT01588522|458976771|FG003|Overall Study|Did not initiate chemotherapy|0|||
127548599|NCT01588522|458976772|FG004|Overall Study|Did not initiate chemotherapy|1|||
127548600|NCT01588522|458976773|FG005|Overall Study|Did not initiate chemotherapy|0|||
127548601|NCT03205423|458976776|FG000|Overall Study|Personal|1|||
127548602|NCT03205423|458976777|FG001|Overall Study|Personal|1|||
127548603|NCT03205423|458976776|FG000|Overall Study|Physician Decision|0|||
127548604|NCT03205423|458976777|FG001|Overall Study|Physician Decision|2|||
127548605|NCT05786651|458976780|FG000|Overall Study|fire alarm during testing session, incomplete testing|1|||
127548606|NCT04390763|458976781|FG000|Safety run-in Part|Adverse Event|4|||
127548607|NCT04390763|458976782|FG001|Safety run-in Part|Adverse Event|0|||
127548608|NCT04390763|458976783|FG002|Safety run-in Part|Adverse Event|0|||
127548609|NCT04390763|458976784|FG003|Safety run-in Part|Adverse Event|0|||
127548610|NCT04390763|458976781|FG000|Safety run-in Part|Physician Decision|1|||
127548611|NCT04390763|458976782|FG001|Safety run-in Part|Physician Decision|0|||
127548612|NCT04390763|458976783|FG002|Safety run-in Part|Physician Decision|0|||
127548613|NCT04390763|458976784|FG003|Safety run-in Part|Physician Decision|0|||
127548614|NCT04390763|458976781|FG000|Safety run-in Part|Progressive Disease|6|||
127548615|NCT04390763|458976782|FG001|Safety run-in Part|Progressive Disease|0|||
127548616|NCT04390763|458976783|FG002|Safety run-in Part|Progressive Disease|0|||
127548617|NCT04390763|458976784|FG003|Safety run-in Part|Progressive Disease|0|||
127548618|NCT04390763|458976781|FG000|Randomized Part|Adverse Event|0|||
127548619|NCT04390763|458976782|FG001|Randomized Part|Adverse Event|11|||
127548620|NCT04390763|458976783|FG002|Randomized Part|Adverse Event|5|||
127548621|NCT04390763|458976784|FG003|Randomized Part|Adverse Event|5|||
127548622|NCT04390763|458976781|FG000|Randomized Part|Death|0|||
127548623|NCT04390763|458976782|FG001|Randomized Part|Death|3|||
127548624|NCT04390763|458976783|FG002|Randomized Part|Death|4|||
127548625|NCT04390763|458976784|FG003|Randomized Part|Death|2|||
127770923|NCT00261846|459787019|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
127548626|NCT04390763|458976781|FG000|Randomized Part|Physician Decision|0|||
127548627|NCT04390763|458976782|FG001|Randomized Part|Physician Decision|2|||
127548628|NCT04390763|458976783|FG002|Randomized Part|Physician Decision|2|||
127548629|NCT04390763|458976784|FG003|Randomized Part|Physician Decision|9|||
128016399|NCT00831844|460683212|FG000|Overall Study|Ineligible|0|||
128016400|NCT00831844|460683213|FG001|Overall Study|Ineligible|1|||
127548630|NCT04390763|458976781|FG000|Randomized Part|Progressive Disease|0|||
127548631|NCT04390763|458976782|FG001|Randomized Part|Progressive Disease|24|||
127548632|NCT04390763|458976783|FG002|Randomized Part|Progressive Disease|31|||
127548633|NCT04390763|458976784|FG003|Randomized Part|Progressive Disease|23|||
127548634|NCT04390763|458976781|FG000|Randomized Part|Study terminated by sponsor|0|||
127548635|NCT04390763|458976782|FG001|Randomized Part|Study terminated by sponsor|1|||
127548636|NCT04390763|458976783|FG002|Randomized Part|Study terminated by sponsor|0|||
127548637|NCT04390763|458976784|FG003|Randomized Part|Study terminated by sponsor|0|||
127548638|NCT04390763|458976781|FG000|Randomized Part|Participant Decision|0|||
127770924|NCT00261846|459787020|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
127770925|NCT00261846|459787021|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
127770926|NCT00261846|459787022|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
127548639|NCT04390763|458976782|FG001|Randomized Part|Participant Decision|5|||
127548640|NCT04390763|458976783|FG002|Randomized Part|Participant Decision|7|||
127548641|NCT04390763|458976784|FG003|Randomized Part|Participant Decision|6|||
127880905|NCT03020966|460186064|FG000|Overall Study|Withdrawal by Subject|2|||
127880906|NCT03020966|460186065|FG001|Overall Study|Withdrawal by Subject|0|||
127880907|NCT02628418|460186069|FG000|Overall Study|Lost to Follow-up|1|||
127880908|NCT02628418|460186070|FG001|Overall Study|Lost to Follow-up|2|||
127880909|NCT01215955|460186071|FG000|Overall Study|Adverse Event|1|||
128016401|NCT00831844|460683214|FG002|Overall Study|Ineligible|1|||
128016402|NCT00831844|460683215|FG003|Overall Study|Ineligible|0|||
128016403|NCT00831844|460683216|FG004|Overall Study|Ineligible|1|||
128016404|NCT00831844|460683217|FG005|Overall Study|Ineligible|0|||
128016405|NCT00831844|460683218|FG006|Overall Study|Ineligible|0|||
128016406|NCT00831844|460683219|FG007|Overall Study|Ineligible|0|||
128016407|NCT00831844|460683220|FG008|Overall Study|Ineligible|0|||
128016408|NCT00831844|460683221|FG009|Overall Study|Ineligible|0|||
128016409|NCT00843882|460683222|FG000|Step 1|Lack of Efficacy|14|||
128016410|NCT00843882|460683223|FG001|Step 1|Lack of Efficacy|10|||
128016411|NCT00843882|460683224|FG002|Step 1|Lack of Efficacy|21|||
128016412|NCT00843882|460683222|FG000|Step 1|Adverse Event|8|||
128016413|NCT00843882|460683223|FG001|Step 1|Adverse Event|17|||
128016414|NCT00843882|460683224|FG002|Step 1|Adverse Event|20|||
128016415|NCT00843882|460683222|FG000|Step 1|Death|1|||
128016416|NCT00843882|460683223|FG001|Step 1|Death|2|||
128016417|NCT00843882|460683224|FG002|Step 1|Death|4|||
128016418|NCT00843882|460683222|FG000|Step 1|Withdrawal by Subject|6|||
128016419|NCT00843882|460683223|FG001|Step 1|Withdrawal by Subject|12|||
128016420|NCT00843882|460683224|FG002|Step 1|Withdrawal by Subject|9|||
128016421|NCT00843882|460683222|FG000|Step 1|Physician Decision|0|||
128016422|NCT00843882|460683223|FG001|Step 1|Physician Decision|5|||
128016423|NCT00843882|460683224|FG002|Step 1|Physician Decision|1|||
128016424|NCT00843882|460683222|FG000|Step 1|Patient and physician's decision|0|||
128016425|NCT00843882|460683223|FG001|Step 1|Patient and physician's decision|0|||
128016426|NCT00843882|460683224|FG002|Step 1|Patient and physician's decision|1|||
128016427|NCT00843882|460683222|FG000|Step 1|Other complicating disease|1|||
128016428|NCT00843882|460683223|FG001|Step 1|Other complicating disease|3|||
128016429|NCT00843882|460683224|FG002|Step 1|Other complicating disease|4|||
128016430|NCT00843882|460683222|FG000|Step 1|Alternative therapy|0|||
128016431|NCT00843882|460683223|FG001|Step 1|Alternative therapy|1|||
128016432|NCT00843882|460683224|FG002|Step 1|Alternative therapy|1|||
128016433|NCT00843882|460683222|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
128016434|NCT00843882|460683223|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
128016435|NCT00843882|460683224|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
128016436|NCT00843882|460683222|FG000|Step 1|Off treatment reason unknown|0|||
128016437|NCT00843882|460683223|FG001|Step 1|Off treatment reason unknown|1|||
128016438|NCT00843882|460683224|FG002|Step 1|Off treatment reason unknown|4|||
128016439|NCT00843882|460683222|FG000|Step 1|Never started treatment|2|||
128016440|NCT00843882|460683223|FG001|Step 1|Never started treatment|0|||
128016441|NCT00843882|460683224|FG002|Step 1|Never started treatment|0|||
128016442|NCT00843882|460683222|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
128016443|NCT00843882|460683223|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
128016444|NCT00843882|460683224|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
128016445|NCT00843882|460683222|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
128016446|NCT00843882|460683223|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
128016447|NCT00843882|460683224|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
128016448|NCT00843882|460683222|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
128016449|NCT00843882|460683223|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
128016450|NCT00843882|460683224|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
128016451|NCT00843882|460683222|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
128016452|NCT00843882|460683223|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
128016453|NCT00843882|460683224|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
128016454|NCT00843882|460683222|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
128016455|NCT00843882|460683223|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
128016456|NCT00843882|460683224|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
127880910|NCT01215955|460186072|FG001|Overall Study|Adverse Event|4|||
127880911|NCT01215955|460186073|FG002|Overall Study|Adverse Event|2|||
128016457|NCT00843882|460683222|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
128016458|NCT00843882|460683223|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
128016459|NCT00843882|460683224|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
128016460|NCT00843882|460683222|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
127880912|NCT01215955|460186074|FG003|Overall Study|Adverse Event|3|||
127880913|NCT01215955|460186071|FG000|Overall Study|Death|2|||
128016461|NCT00843882|460683223|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
128016462|NCT00843882|460683224|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
127548642|NCT04390763|458976781|FG000|Randomized Part|Not treated|0|||
127880914|NCT01215955|460186072|FG001|Overall Study|Death|0|||
127880915|NCT01215955|460186073|FG002|Overall Study|Death|1|||
128016463|NCT05317546|460683225|FG000|First Wash-Out Period|Withdrawal by Subject|1|||
128016464|NCT05317546|460683226|FG001|First Wash-Out Period|Withdrawal by Subject|2|||
127880916|NCT01215955|460186074|FG003|Overall Study|Death|3|||
128016465|NCT03331250|460683227|FG000|Overall Study|Withdrawal by Subject|1|||
128016466|NCT04590963|460683228|FG000|Overall Study|Death|118|||
128016467|NCT04590963|460683229|FG001|Overall Study|Death|59|||
128016468|NCT04590963|460683228|FG000|Overall Study|Lost to Follow-up|1|||
128016469|NCT04590963|460683229|FG001|Overall Study|Lost to Follow-up|1|||
128016470|NCT04590963|460683228|FG000|Overall Study|Progressive disease|0|||
128016471|NCT04590963|460683229|FG001|Overall Study|Progressive disease|1|||
128016472|NCT04590963|460683228|FG000|Overall Study|Study terminated by sponsor|103|||
128016473|NCT04590963|460683229|FG001|Overall Study|Study terminated by sponsor|50|||
128016474|NCT04590963|460683228|FG000|Overall Study|Withdrawal by Subject|15|||
128016475|NCT04590963|460683229|FG001|Overall Study|Withdrawal by Subject|8|||
128016476|NCT04590963|460683228|FG000|Overall Study|Ongoing at data cut-off|9|||
128016477|NCT04590963|460683229|FG001|Overall Study|Ongoing at data cut-off|4|||
128016478|NCT04590963|460683228|FG000|Overall Study|Screen failure|1|||
128016479|NCT04590963|460683229|FG001|Overall Study|Screen failure|0|||
127548643|NCT04390763|458976782|FG001|Randomized Part|Not treated|4|||
127548644|NCT04390763|458976783|FG002|Randomized Part|Not treated|2|||
127548645|NCT04390763|458976784|FG003|Randomized Part|Not treated|7|||
127548646|NCT04949490|458976786|FG000|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
127548647|NCT04949490|458976787|FG001|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
127548648|NCT04949490|458976788|FG002|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
127548649|NCT04949490|458976789|FG003|Group A and Group B|Non-study SARS-COV-2 vaccination|2|||
127548650|NCT04949490|458976790|FG004|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
127548651|NCT04949490|458976791|FG005|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
127548652|NCT04949490|458976786|FG000|Group A and Group B|Withdrawal by Subject|0|||
127548653|NCT04949490|458976787|FG001|Group A and Group B|Withdrawal by Subject|0|||
127548654|NCT04949490|458976788|FG002|Group A and Group B|Withdrawal by Subject|1|||
127548655|NCT04949490|458976789|FG003|Group A and Group B|Withdrawal by Subject|0|||
127548656|NCT04949490|458976790|FG004|Group A and Group B|Withdrawal by Subject|0|||
127548657|NCT04949490|458976791|FG005|Group A and Group B|Withdrawal by Subject|0|||
127548658|NCT04949490|458976786|FG000|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
127548659|NCT04949490|458976787|FG001|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
127548660|NCT04949490|458976788|FG002|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
127548661|NCT04949490|458976789|FG003|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
127548662|NCT04949490|458976790|FG004|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
127548663|NCT04949490|458976791|FG005|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|2|||
127548664|NCT04949490|458976786|FG000|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
127548665|NCT04949490|458976787|FG001|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
127548666|NCT04949490|458976788|FG002|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
127548667|NCT04949490|458976789|FG003|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
127548668|NCT04949490|458976790|FG004|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|1|||
127548669|NCT04949490|458976791|FG005|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
127548670|NCT02017405|458976792|FG000|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
127548671|NCT02017405|458976793|FG001|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
127548672|NCT02017405|458976794|FG002|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
127548673|NCT02017405|458976795|FG003|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
127548674|NCT02017405|458976796|FG004|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
127548675|NCT02017405|458976797|FG005|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|1|||
127548676|NCT02017405|458976792|FG000|Open-label Phase|Adverse Event|1|||
127548677|NCT02017405|458976793|FG001|Open-label Phase|Adverse Event|1|||
127548678|NCT02017405|458976794|FG002|Open-label Phase|Adverse Event|0|||
127548679|NCT02017405|458976795|FG003|Open-label Phase|Adverse Event|0|||
127548680|NCT02017405|458976796|FG004|Open-label Phase|Adverse Event|0|||
127548681|NCT02017405|458976797|FG005|Open-label Phase|Adverse Event|0|||
127548682|NCT00463567|458978481|FG000|Overall Study|Adverse Event|29|||
127548683|NCT00463567|458978482|FG001|Overall Study|Adverse Event|26|||
127548684|NCT00463567|458978483|FG002|Overall Study|Adverse Event|17|||
127548685|NCT00463567|458978484|FG003|Overall Study|Adverse Event|46|||
127548686|NCT00463567|458978485|FG004|Overall Study|Adverse Event|10|||
127548687|NCT00463567|458978486|FG005|Overall Study|Adverse Event|10|||
128016480|NCT04057365|460683230|FG000|Overall Study|Withdrawal by Subject|2|||
128016481|NCT04057365|460683231|FG001|Overall Study|Withdrawal by Subject|0|||
127548688|NCT00463567|458978487|FG006|Overall Study|Adverse Event|4|||
127548689|NCT00463567|458978481|FG000|Overall Study|Withdrawal by Subject|29|||
127548690|NCT00463567|458978482|FG001|Overall Study|Withdrawal by Subject|22|||
127548691|NCT00463567|458978483|FG002|Overall Study|Withdrawal by Subject|20|||
127548692|NCT00463567|458978484|FG003|Overall Study|Withdrawal by Subject|37|||
127548693|NCT00463567|458978485|FG004|Overall Study|Withdrawal by Subject|6|||
127548694|NCT00463567|458978486|FG005|Overall Study|Withdrawal by Subject|5|||
127548695|NCT00463567|458978487|FG006|Overall Study|Withdrawal by Subject|1|||
128016482|NCT04738487|460683232|FG000|Overall Study|Participant Ongoing in Study|298|||
128016483|NCT04738487|460683233|FG001|Overall Study|Participant Ongoing in Study|297|||
128016484|NCT04738487|460683232|FG000|Overall Study|Withdrawal by Subject|7|||
127880917|NCT01215955|460186071|FG000|Overall Study|Entry Criteria Not Met|1|||
127880918|NCT01215955|460186072|FG001|Overall Study|Entry Criteria Not Met|3|||
127880919|NCT01215955|460186073|FG002|Overall Study|Entry Criteria Not Met|4|||
127880920|NCT01215955|460186074|FG003|Overall Study|Entry Criteria Not Met|7|||
127880921|NCT01215955|460186071|FG000|Overall Study|Lack of Efficacy|1|||
127880922|NCT01215955|460186072|FG001|Overall Study|Lack of Efficacy|2|||
127880923|NCT01215955|460186073|FG002|Overall Study|Lack of Efficacy|1|||
127880924|NCT01215955|460186074|FG003|Overall Study|Lack of Efficacy|0|||
127880925|NCT01215955|460186071|FG000|Overall Study|Lost to Follow-up|4|||
127770927|NCT00261846|459787023|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
127770928|NCT00261846|459787024|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
127770929|NCT00261846|459787025|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
127770930|NCT00261846|459787026|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
127770931|NCT00261846|459787027|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
127770932|NCT00261846|459787016|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
127770933|NCT00261846|459787017|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
127770934|NCT00261846|459787018|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
127770935|NCT00261846|459787019|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
127770936|NCT00261846|459787020|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
127770937|NCT00261846|459787021|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
127770938|NCT00261846|459787022|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
127770939|NCT00261846|459787023|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
127880926|NCT01215955|460186072|FG001|Overall Study|Lost to Follow-up|4|||
128016485|NCT04738487|460683233|FG001|Overall Study|Withdrawal by Subject|9|||
128016486|NCT04738487|460683232|FG000|Overall Study|Lost to Follow-up|2|||
128016487|NCT04738487|460683233|FG001|Overall Study|Lost to Follow-up|0|||
128016488|NCT04738487|460683232|FG000|Overall Study|Death|287|||
128016489|NCT04738487|460683233|FG001|Overall Study|Death|306|||
128016490|NCT03976375|460683234|FG000|Overall Study|Death|158|||
128016491|NCT03976375|460683235|FG001|Overall Study|Death|160|||
128016492|NCT03976375|460683236|FG002|Overall Study|Death|42|||
128016493|NCT03976375|460683234|FG000|Overall Study|Lost to Follow-up|2|||
128016494|NCT03976375|460683235|FG001|Overall Study|Lost to Follow-up|1|||
128016495|NCT03976375|460683236|FG002|Overall Study|Lost to Follow-up|1|||
128016496|NCT03976375|460683234|FG000|Overall Study|Withdrawal by Subject|5|||
128016497|NCT03976375|460683235|FG001|Overall Study|Withdrawal by Subject|9|||
128016498|NCT03976375|460683236|FG002|Overall Study|Withdrawal by Subject|4|||
128016499|NCT03976375|460683234|FG000|Overall Study|Sponsor decision|20|||
128016500|NCT03976375|460683235|FG001|Overall Study|Sponsor decision|19|||
128016501|NCT03976375|460683236|FG002|Overall Study|Sponsor decision|1|||
128016502|NCT01063114|460683237|FG000|Overall Study|Lost to Follow-up|1|||
128016503|NCT05556057|460683238|FG000|Overall Study|Lost to Follow-up|5|||
128016504|NCT05556057|460683239|FG001|Overall Study|Lost to Follow-up|4|||
128016505|NCT05556057|460683238|FG000|Overall Study|Withdrawal by Subject|0|||
128016506|NCT05556057|460683239|FG001|Overall Study|Withdrawal by Subject|2|||
127684256|NCT01792830|459468392|FG006|Overall Study|Adverse Event|0|||
127684257|NCT01792830|459468393|FG007|Overall Study|Adverse Event|0|||
127684258|NCT01792830|459468394|FG008|Overall Study|Adverse Event|1|||
127684259|NCT01792830|459468395|FG009|Overall Study|Adverse Event|0|||
127684260|NCT01792830|459468396|FG010|Overall Study|Adverse Event|0|||
127684261|NCT00925899|459469775|FG000|Part 1|Death|1|||
127684262|NCT00925899|459469776|FG001|Part 1|Death|2|||
127684263|NCT00925899|459469775|FG000|Part 1|Withdrawal by Subject|10|||
127684264|NCT00925899|459469776|FG001|Part 1|Withdrawal by Subject|9|||
127684265|NCT00683696|459469777|FG000|Overall Study|Withdrawn due to study closure|337|||
127684266|NCT00683696|459469778|FG001|Overall Study|Withdrawn due to study closure|338|||
127684267|NCT00683696|459469777|FG000|Overall Study|Withdrawn prior to study closure|13|||
127684268|NCT00683696|459469778|FG001|Overall Study|Withdrawn prior to study closure|28|||
127684269|NCT00683696|459469777|FG000|Overall Study|Lost to Follow-up|5|||
127684270|NCT00683696|459469778|FG001|Overall Study|Lost to Follow-up|6|||
127684271|NCT00683696|459469777|FG000|Overall Study|Vital status follow-up only|3|||
127684272|NCT00683696|459469778|FG001|Overall Study|Vital status follow-up only|3|||
127684273|NCT00683696|459469777|FG000|Overall Study|Death|46|||
127684274|NCT00683696|459469778|FG001|Overall Study|Death|30|||
127684275|NCT02396316|459469779|FG000|Overall Study|Physician Decision|1|||
127684276|NCT02396316|459469780|FG001|Overall Study|Physician Decision|0|||
127684277|NCT02396316|459469779|FG000|Overall Study|Progressive disease|6|||
127880927|NCT01215955|460186073|FG002|Overall Study|Lost to Follow-up|8|||
127880928|NCT01215955|460186074|FG003|Overall Study|Lost to Follow-up|9|||
128016507|NCT02466971|460683243|FG000|Overall Study|eligible and never treated|14|||
128016508|NCT02466971|460683244|FG001|Overall Study|eligible and never treated|20|||
128016509|NCT02466971|460683243|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
128016510|NCT02466971|460683244|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
127684278|NCT02396316|459469780|FG001|Overall Study|Progressive disease|3|||
127684279|NCT02396316|459469779|FG000|Overall Study|Protocol Violation|0|||
127684280|NCT02396316|459469780|FG001|Overall Study|Protocol Violation|1|||
127684281|NCT02396316|459469779|FG000|Overall Study|Treatment unblinded|0|||
127548696|NCT00463567|458978481|FG000|Overall Study|Protocol Deviation|13|||
127548697|NCT00463567|458978482|FG001|Overall Study|Protocol Deviation|9|||
127548698|NCT00463567|458978483|FG002|Overall Study|Protocol Deviation|14|||
127548699|NCT00463567|458978484|FG003|Overall Study|Protocol Deviation|11|||
127548700|NCT00463567|458978485|FG004|Overall Study|Protocol Deviation|1|||
127548701|NCT00463567|458978486|FG005|Overall Study|Protocol Deviation|1|||
127548702|NCT00463567|458978487|FG006|Overall Study|Protocol Deviation|2|||
127548703|NCT00463567|458978481|FG000|Overall Study|Lost to Follow-up|12|||
127548704|NCT00463567|458978482|FG001|Overall Study|Lost to Follow-up|6|||
127548705|NCT00463567|458978483|FG002|Overall Study|Lost to Follow-up|13|||
127548706|NCT00463567|458978484|FG003|Overall Study|Lost to Follow-up|8|||
127548707|NCT00463567|458978485|FG004|Overall Study|Lost to Follow-up|1|||
127548708|NCT00463567|458978486|FG005|Overall Study|Lost to Follow-up|1|||
127548709|NCT00463567|458978487|FG006|Overall Study|Lost to Follow-up|1|||
127548710|NCT00463567|458978481|FG000|Overall Study|Administrative problems|5|||
127548711|NCT00463567|458978482|FG001|Overall Study|Administrative problems|3|||
127548712|NCT00463567|458978483|FG002|Overall Study|Administrative problems|6|||
127548713|NCT00463567|458978484|FG003|Overall Study|Administrative problems|9|||
127548714|NCT00463567|458978485|FG004|Overall Study|Administrative problems|3|||
127548715|NCT00463567|458978486|FG005|Overall Study|Administrative problems|2|||
127548716|NCT00463567|458978487|FG006|Overall Study|Administrative problems|2|||
127548717|NCT00463567|458978481|FG000|Overall Study|Lack of Efficacy|4|||
127548718|NCT00463567|458978482|FG001|Overall Study|Lack of Efficacy|9|||
127548719|NCT00463567|458978483|FG002|Overall Study|Lack of Efficacy|9|||
127548720|NCT00463567|458978484|FG003|Overall Study|Lack of Efficacy|17|||
127548721|NCT00463567|458978485|FG004|Overall Study|Lack of Efficacy|1|||
127548722|NCT00463567|458978486|FG005|Overall Study|Lack of Efficacy|0|||
127548723|NCT00463567|458978487|FG006|Overall Study|Lack of Efficacy|1|||
127548724|NCT00463567|458978481|FG000|Overall Study|Abnormal lab value(s)|1|||
127548725|NCT00463567|458978482|FG001|Overall Study|Abnormal lab value(s)|1|||
127548726|NCT00463567|458978483|FG002|Overall Study|Abnormal lab value(s)|2|||
127548727|NCT00463567|458978484|FG003|Overall Study|Abnormal lab value(s)|1|||
127548728|NCT00463567|458978485|FG004|Overall Study|Abnormal lab value(s)|1|||
127548729|NCT00463567|458978486|FG005|Overall Study|Abnormal lab value(s)|0|||
127548730|NCT00463567|458978487|FG006|Overall Study|Abnormal lab value(s)|0|||
127548731|NCT00463567|458978481|FG000|Overall Study|Abnormal test procedure result(s)|1|||
127548732|NCT00463567|458978482|FG001|Overall Study|Abnormal test procedure result(s)|1|||
127548733|NCT00463567|458978483|FG002|Overall Study|Abnormal test procedure result(s)|6|||
127548734|NCT00463567|458978484|FG003|Overall Study|Abnormal test procedure result(s)|2|||
127548735|NCT00463567|458978485|FG004|Overall Study|Abnormal test procedure result(s)|0|||
127548736|NCT00463567|458978486|FG005|Overall Study|Abnormal test procedure result(s)|2|||
127548737|NCT00463567|458978487|FG006|Overall Study|Abnormal test procedure result(s)|0|||
127548738|NCT00463567|458978481|FG000|Overall Study|Death|1|||
127548739|NCT00463567|458978482|FG001|Overall Study|Death|0|||
127548740|NCT00463567|458978483|FG002|Overall Study|Death|2|||
127684282|NCT02396316|459469780|FG001|Overall Study|Treatment unblinded|1|||
127684283|NCT02189252|459469781|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
127684284|NCT02189252|459469782|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
127684285|NCT02189252|459469783|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
127684286|NCT02189252|459469784|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
127684287|NCT02189252|459469781|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
127684288|NCT02189252|459469782|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
127684289|NCT02189252|459469783|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
127684290|NCT02189252|459469784|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
127684291|NCT00840177|459469785|FG000|Overall Study|Adverse Event|5|||
127684292|NCT00840177|459469786|FG001|Overall Study|Adverse Event|1|||
127684293|NCT00840177|459469787|FG002|Overall Study|Adverse Event|1|||
127684294|NCT00840177|459469785|FG000|Overall Study|Refusal unrelated to adverse events|1|||
127684295|NCT00840177|459469786|FG001|Overall Study|Refusal unrelated to adverse events|0|||
127684296|NCT00840177|459469787|FG002|Overall Study|Refusal unrelated to adverse events|1|||
127684297|NCT00840177|459469785|FG000|Overall Study|Progression/relapse|2|||
127684298|NCT00840177|459469786|FG001|Overall Study|Progression/relapse|0|||
127684299|NCT00840177|459469787|FG002|Overall Study|Progression/relapse|0|||
127684300|NCT00840177|459469785|FG000|Overall Study|Death|4|||
127684301|NCT00840177|459469786|FG001|Overall Study|Death|5|||
127770940|NCT00261846|459787024|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
127548741|NCT00463567|458978484|FG003|Overall Study|Death|0|||
127548742|NCT00463567|458978485|FG004|Overall Study|Death|0|||
127548743|NCT00463567|458978486|FG005|Overall Study|Death|0|||
127548744|NCT00463567|458978487|FG006|Overall Study|Death|0|||
127548745|NCT03077412|458978488|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
127548746|NCT03077412|458978489|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
127548747|NCT03077412|458978490|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
127548748|NCT03077412|458978488|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
127548749|NCT03077412|458978489|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
127548750|NCT03077412|458978490|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
127548751|NCT03077412|458978488|FG000|Overall Study|Adverse Event|1|||
127548752|NCT03077412|458978489|FG001|Overall Study|Adverse Event|2|||
127548753|NCT03077412|458978490|FG002|Overall Study|Adverse Event|2|||
127548754|NCT03077412|458978488|FG000|Overall Study|Investigator's Discretion|0|||
127548755|NCT03077412|458978489|FG001|Overall Study|Investigator's Discretion|1|||
127548756|NCT03077412|458978490|FG002|Overall Study|Investigator's Discretion|1|||
127548757|NCT03077412|458978488|FG000|Overall Study|Withdrew Consent|0|||
127548758|NCT03077412|458978489|FG001|Overall Study|Withdrew Consent|2|||
127548759|NCT03077412|458978490|FG002|Overall Study|Withdrew Consent|0|||
127548760|NCT02266888|458978491|FG000|Overall Study|Death|2|||
127548761|NCT02266888|458978492|FG001|Overall Study|Death|2|||
127548762|NCT02266888|458978493|FG002|Overall Study|Death|4|||
127548763|NCT02266888|458978494|FG003|Overall Study|Death|2|||
127548764|NCT02266888|458978491|FG000|Overall Study|Physician Decision|0|||
127548765|NCT02266888|458978492|FG001|Overall Study|Physician Decision|1|||
127548766|NCT02266888|458978493|FG002|Overall Study|Physician Decision|2|||
127548767|NCT02266888|458978494|FG003|Overall Study|Physician Decision|2|||
127548768|NCT02266888|458978491|FG000|Overall Study|Study Terminated|5|||
127548769|NCT02266888|458978492|FG001|Overall Study|Study Terminated|1|||
127548770|NCT02266888|458978493|FG002|Overall Study|Study Terminated|0|||
127548771|NCT02266888|458978494|FG003|Overall Study|Study Terminated|0|||
127548772|NCT02266888|458978491|FG000|Overall Study|No Longer Eligible|0|||
127548773|NCT02266888|458978492|FG001|Overall Study|No Longer Eligible|0|||
127548774|NCT02266888|458978493|FG002|Overall Study|No Longer Eligible|0|||
127548775|NCT02266888|458978494|FG003|Overall Study|No Longer Eligible|2|||
127548776|NCT02266888|458978491|FG000|Overall Study|Randomization Closed|0|||
127548777|NCT02266888|458978492|FG001|Overall Study|Randomization Closed|0|||
127548778|NCT02266888|458978493|FG002|Overall Study|Randomization Closed|4|||
127548779|NCT02266888|458978494|FG003|Overall Study|Randomization Closed|0|||
127548780|NCT02266888|458978491|FG000|Overall Study|Personnel unavailable at transplant|0|||
127548781|NCT02266888|458978492|FG001|Overall Study|Personnel unavailable at transplant|0|||
127548782|NCT02266888|458978493|FG002|Overall Study|Personnel unavailable at transplant|0|||
127548783|NCT02266888|458978494|FG003|Overall Study|Personnel unavailable at transplant|1|||
127548784|NCT02266888|458978491|FG000|Overall Study|Transfer of care|0|||
127548785|NCT02266888|458978492|FG001|Overall Study|Transfer of care|0|||
127548786|NCT02266888|458978493|FG002|Overall Study|Transfer of care|1|||
127548787|NCT02266888|458978494|FG003|Overall Study|Transfer of care|0|||
127548788|NCT02351856|458978495|FG000|Overall Study|Adverse Event|2|||
127548789|NCT02351856|458978495|FG000|Overall Study|Physician Decision|5|||
127548790|NCT02351856|458978495|FG000|Overall Study|Study terminated by sponsor|1|||
127548791|NCT01458392|458978496|FG000|Overall Study|Death|2|||
127548792|NCT01458392|458978497|FG001|Overall Study|Death|11|||
127548793|NCT01458392|458978498|FG002|Overall Study|Death|22|||
127548794|NCT01458392|458978496|FG000|Overall Study|At the discretion of the sponsor|0|||
127548795|NCT01458392|458978497|FG001|Overall Study|At the discretion of the sponsor|2|||
127548796|NCT01458392|458978498|FG002|Overall Study|At the discretion of the sponsor|7|||
127548797|NCT01458392|458978496|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
127548798|NCT01458392|458978497|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
127548799|NCT01458392|458978498|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
127548800|NCT01193244|458978501|FG000|Overall Study|Withdrawal by Subject|79|||
127548801|NCT01193244|458978502|FG001|Overall Study|Withdrawal by Subject|97|||
127548802|NCT01193244|458978501|FG000|Overall Study|Other|303|||
127548803|NCT01193244|458978502|FG001|Overall Study|Other|278|||
127548804|NCT01193244|458978501|FG000|Overall Study|Lost to Follow-up|6|||
127548805|NCT01193244|458978502|FG001|Overall Study|Lost to Follow-up|15|||
127548806|NCT03763877|458978512|FG000|Overall Study|Withdrawal by Subject|3|||
127548807|NCT03763877|458978513|FG001|Overall Study|Withdrawal by Subject|1|||
127548808|NCT03763877|458978514|FG002|Overall Study|Withdrawal by Subject|3|||
127548809|NCT03763877|458978515|FG003|Overall Study|Withdrawal by Subject|4|||
127548810|NCT03763877|458978512|FG000|Overall Study|Adverse Event|1|||
127548811|NCT03763877|458978513|FG001|Overall Study|Adverse Event|1|||
127548812|NCT03763877|458978514|FG002|Overall Study|Adverse Event|3|||
127548813|NCT03763877|458978515|FG003|Overall Study|Adverse Event|1|||
127548814|NCT03763877|458978512|FG000|Overall Study|Protocol Violation|1|||
127548815|NCT03763877|458978513|FG001|Overall Study|Protocol Violation|1|||
127548816|NCT03763877|458978514|FG002|Overall Study|Protocol Violation|0|||
127548817|NCT03763877|458978515|FG003|Overall Study|Protocol Violation|0|||
127548818|NCT03763877|458978512|FG000|Overall Study|Lost to Follow-up|0|||
127548819|NCT03763877|458978513|FG001|Overall Study|Lost to Follow-up|1|||
127548820|NCT03763877|458978514|FG002|Overall Study|Lost to Follow-up|1|||
127548821|NCT03763877|458978515|FG003|Overall Study|Lost to Follow-up|0|||
127548822|NCT03040336|458978516|FG000|Overall Study|Death|1|||
127548823|NCT03040336|458978517|FG001|Overall Study|Death|0|||
127548824|NCT03040336|458978516|FG000|Overall Study|Withdrawal by Subject|2|||
127684302|NCT00840177|459469787|FG002|Overall Study|Death|5|||
127684303|NCT00840177|459469785|FG000|Overall Study|not protocol specified|6|||
127548825|NCT03040336|458978517|FG001|Overall Study|Withdrawal by Subject|3|||
127548826|NCT00068692|458978522|FG000|Step 1: Registration|Disese progression/relapse|5|||
127548827|NCT00068692|458978523|FG001|Step 1: Registration|Disese progression/relapse|0|||
127548828|NCT00068692|458978524|FG002|Step 1: Registration|Disese progression/relapse|0|||
127548829|NCT00068692|458978525|FG003|Step 1: Registration|Disese progression/relapse|0|||
127548830|NCT00068692|458978526|FG004|Step 1: Registration|Disese progression/relapse|0|||
127548831|NCT00068692|458978527|FG005|Step 1: Registration|Disese progression/relapse|0|||
127548832|NCT00068692|458978528|FG006|Step 1: Registration|Disese progression/relapse|0|||
127548833|NCT00068692|458978529|FG007|Step 1: Registration|Disese progression/relapse|0|||
127770941|NCT00261846|459787025|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
127770942|NCT00261846|459787026|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
127770943|NCT00261846|459787027|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
127770944|NCT00261846|459787016|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
127770945|NCT00261846|459787017|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
127770946|NCT00261846|459787018|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
127770947|NCT00261846|459787019|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
127770948|NCT00261846|459787020|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
127770949|NCT00261846|459787021|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
127770950|NCT00261846|459787022|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
127770951|NCT00261846|459787023|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
127770952|NCT00261846|459787024|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
127770953|NCT00261846|459787025|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
127548834|NCT00068692|458978522|FG000|Step 1: Registration|Adverse Event|7|||
127548835|NCT00068692|458978523|FG001|Step 1: Registration|Adverse Event|0|||
128016511|NCT02466971|460683243|FG000|Overall Study|ineligible and treated|1|||
128016512|NCT02466971|460683244|FG001|Overall Study|ineligible and treated|0|||
128016513|NCT02466971|460683243|FG000|Overall Study|ineligible and never treated|0|||
128016514|NCT02466971|460683244|FG001|Overall Study|ineligible and never treated|1|||
128016515|NCT04818112|460683249|FG000|Overall Study|Withdrawal by Subject|54|||
128016516|NCT04818112|460683250|FG001|Overall Study|Withdrawal by Subject|12|||
128016517|NCT04818112|460683249|FG000|Overall Study|Lost to Follow-up|38|||
128016518|NCT04818112|460683250|FG001|Overall Study|Lost to Follow-up|10|||
128016519|NCT06187909|460683251|FG000|Overall Study|Withdrawal by Subject|2|||
128016520|NCT06187909|460683252|FG001|Overall Study|Withdrawal by Subject|2|||
128016521|NCT05020743|460683257|FG000|Overall Study|Enrollment in Interventional Study|2|||
128016522|NCT05020743|460683258|FG001|Overall Study|Enrollment in Interventional Study|9|||
128016523|NCT05020743|460683259|FG002|Overall Study|Enrollment in Interventional Study|0|||
128016524|NCT05020743|460683257|FG000|Overall Study|Withdrawal by Subject|0|||
128016525|NCT05020743|460683258|FG001|Overall Study|Withdrawal by Subject|3|||
128016526|NCT05020743|460683259|FG002|Overall Study|Withdrawal by Subject|1|||
127770954|NCT00261846|459787026|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
127770955|NCT00261846|459787027|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
127770956|NCT00261846|459787016|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
127770957|NCT00261846|459787017|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
127770958|NCT00261846|459787018|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
127770959|NCT00261846|459787019|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
127770960|NCT00261846|459787020|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
127770961|NCT00261846|459787021|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
127770962|NCT00261846|459787022|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
127770963|NCT00261846|459787023|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
127770964|NCT00261846|459787024|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
127770965|NCT00261846|459787025|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
127770966|NCT00261846|459787026|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
127770967|NCT00261846|459787027|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
127770968|NCT00261846|459787016|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
127770969|NCT00261846|459787017|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
127770970|NCT00261846|459787018|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
127770971|NCT00261846|459787019|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
127770972|NCT00261846|459787020|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
127770973|NCT00261846|459787021|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
128016527|NCT05020743|460683257|FG000|Overall Study|Lost to Follow-up|1|||
128016528|NCT05020743|460683258|FG001|Overall Study|Lost to Follow-up|0|||
128016529|NCT05020743|460683259|FG002|Overall Study|Lost to Follow-up|0|||
128016530|NCT05020743|460683257|FG000|Overall Study|Study Termination by Sponsor|10|||
127548836|NCT00068692|458978524|FG002|Step 1: Registration|Adverse Event|0|||
127770974|NCT00261846|459787022|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
127770975|NCT00261846|459787023|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
127770976|NCT00261846|459787024|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
127770977|NCT00261846|459787025|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
127770978|NCT00261846|459787026|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
127770979|NCT00261846|459787027|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
127770980|NCT00261846|459787016|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
127770981|NCT00261846|459787017|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
127880929|NCT01215955|460186071|FG000|Overall Study|Physician Decision|4|||
128016531|NCT05020743|460683258|FG001|Overall Study|Study Termination by Sponsor|11|||
128016532|NCT05020743|460683259|FG002|Overall Study|Study Termination by Sponsor|10|||
128016533|NCT03488524|460683260|FG000|Overall Study|Withdrawal by Subject|51|||
128016534|NCT03488524|460683260|FG000|Overall Study|Death|19|||
127770982|NCT00261846|459787018|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
127770983|NCT00261846|459787019|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
127770984|NCT00261846|459787020|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
127770985|NCT00261846|459787021|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
127770986|NCT00261846|459787022|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
127770987|NCT00261846|459787023|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
127770988|NCT00261846|459787024|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
127770989|NCT00261846|459787025|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
127770990|NCT00261846|459787026|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
127770991|NCT00261846|459787027|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
127770992|NCT01009203|459787028|FG000|Overall Study|Withdrawal by Subject|1|||
127770993|NCT01009203|459787028|FG000|Overall Study|Adverse Event|5|||
127770994|NCT01009203|459787028|FG000|Overall Study|Treatment-unrelated death|1|||
127770995|NCT00892723|459787029|FG000|Overall Study|Lost to Follow-up|1|||
127770996|NCT00892723|459787030|FG001|Overall Study|Lost to Follow-up|3|||
127770997|NCT00892723|459787031|FG002|Overall Study|Lost to Follow-up|1|||
127770998|NCT00892723|459787029|FG000|Overall Study|Withdrawal by Subject|1|||
127770999|NCT00892723|459787030|FG001|Overall Study|Withdrawal by Subject|1|||
127771000|NCT00892723|459787031|FG002|Overall Study|Withdrawal by Subject|1|||
127771001|NCT00150969|459787032|FG000|24 Month Main Study|Adverse Event|3|||
128016535|NCT03488524|460683260|FG000|Overall Study|Study Sponsor|11|||
128016536|NCT03488524|460683260|FG000|Overall Study|Physician Decision|4|||
128016537|NCT03488524|460683260|FG000|Overall Study|Lost to Follow-up|3|||
128016538|NCT01937299|460683263|FG000|Overall Study|Adverse Event|13|||
128016539|NCT01937299|460683264|FG001|Overall Study|Adverse Event|0|||
128016540|NCT01937299|460683263|FG000|Overall Study|Lack of Efficacy|0|||
128016541|NCT01937299|460683264|FG001|Overall Study|Lack of Efficacy|4|||
128016542|NCT01937299|460683263|FG000|Overall Study|Withdrawal by Subject|1|||
128016543|NCT01937299|460683264|FG001|Overall Study|Withdrawal by Subject|0|||
128016544|NCT01913353|460683265|FG000|Overall Study|Adverse Event|2|||
128016545|NCT01913353|460683266|FG001|Overall Study|Adverse Event|0|||
128016546|NCT01913353|460683265|FG000|Overall Study|Physician Decision|0|||
128016547|NCT01913353|460683266|FG001|Overall Study|Physician Decision|2|||
128016548|NCT01913353|460683265|FG000|Overall Study|Withdrawal by Subject|20|||
128016549|NCT01913353|460683266|FG001|Overall Study|Withdrawal by Subject|6|||
128016550|NCT01913353|460683265|FG000|Overall Study|multiple reasons|10|||
128016551|NCT01913353|460683266|FG001|Overall Study|multiple reasons|7|||
128016552|NCT01260948|460683267|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
128016553|NCT01260948|460683268|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
128016554|NCT01260948|460683267|FG000|Second Intervention|Emesis|0|||
128016555|NCT01260948|460683268|FG001|Second Intervention|Emesis|1|||
128016556|NCT02406612|460683269|FG000|Overall Study|Screening Failure|3|||
128016557|NCT02406612|460683270|FG001|Overall Study|Screening Failure|0|||
128016558|NCT02406612|460683269|FG000|Overall Study|Intra-procedural Exclusion|1|||
128016559|NCT02406612|460683270|FG001|Overall Study|Intra-procedural Exclusion|3|||
128016560|NCT02406612|460683269|FG000|Overall Study|Guidewire Failure|0|||
128016561|NCT02406612|460683270|FG001|Overall Study|Guidewire Failure|1|||
128016562|NCT05759338|460683271|FG000|Overall Study|Withdrawal by Subject|3|||
128016563|NCT04611126|460683272|FG000|Overall Study|TIL expansion unsuccessful|1|||
128016564|NCT04611126|460683273|FG001|Overall Study|TIL expansion unsuccessful|0|||
128016565|NCT03459846|460683278|FG000|Overall Study|Death|52|||
128016566|NCT03459846|460683279|FG001|Overall Study|Death|46|||
128016567|NCT03459846|460683278|FG000|Overall Study|Study terminated by sponsor|24|||
128016568|NCT03459846|460683279|FG001|Overall Study|Study terminated by sponsor|28|||
128016569|NCT03459846|460683278|FG000|Overall Study|Withdrawal by Subject|2|||
128016570|NCT03459846|460683279|FG001|Overall Study|Withdrawal by Subject|2|||
128016571|NCT05763875|460683288|FG000|Overall Study|Subject decision|5|||
128016572|NCT05763875|460683289|FG001|Overall Study|Subject decision|2|||
128016573|NCT05763875|460683290|FG002|Overall Study|Subject decision|1|||
128016574|NCT05763875|460683288|FG000|Overall Study|Lost to Follow-up|4|||
128016575|NCT05763875|460683289|FG001|Overall Study|Lost to Follow-up|1|||
127771002|NCT00150969|459787033|FG001|24 Month Main Study|Adverse Event|4|||
127771003|NCT00150969|459787032|FG000|24 Month Main Study|Death|1|||
127771004|NCT00150969|459787033|FG001|24 Month Main Study|Death|1|||
127880930|NCT01215955|460186072|FG001|Overall Study|Physician Decision|10|||
128016576|NCT05763875|460683290|FG002|Overall Study|Lost to Follow-up|2|||
128016577|NCT05763875|460683288|FG000|Overall Study|Adverse Event|1|||
128016578|NCT05763875|460683289|FG001|Overall Study|Adverse Event|0|||
128016579|NCT05763875|460683290|FG002|Overall Study|Adverse Event|0|||
128016580|NCT00217737|460683291|FG000|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
128016581|NCT00217737|460683292|FG001|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
128016582|NCT00217737|460683293|FG002|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
128016583|NCT00217737|460683294|FG003|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|252|||
128016584|NCT00217737|460683291|FG000|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
128016585|NCT00217737|460683292|FG001|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
128016586|NCT00217737|460683293|FG002|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
128016587|NCT00217737|460683294|FG003|Step 1 Registration (Risk Assessment)|No tumor block assessments|83|||
128016588|NCT00217737|460683291|FG000|Step 1 Registration (Risk Assessment)|Ineligible|0|||
128016589|NCT00217737|460683292|FG001|Step 1 Registration (Risk Assessment)|Ineligible|0|||
128016590|NCT00217737|460683293|FG002|Step 1 Registration (Risk Assessment)|Ineligible|0|||
128016591|NCT00217737|460683294|FG003|Step 1 Registration (Risk Assessment)|Ineligible|68|||
128016592|NCT00217737|460683291|FG000|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
128016593|NCT00217737|460683292|FG001|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
127548837|NCT00068692|458978525|FG003|Step 1: Registration|Adverse Event|0|||
127548838|NCT00068692|458978526|FG004|Step 1: Registration|Adverse Event|0|||
127548839|NCT00068692|458978527|FG005|Step 1: Registration|Adverse Event|0|||
127548840|NCT00068692|458978528|FG006|Step 1: Registration|Adverse Event|0|||
127548841|NCT00068692|458978529|FG007|Step 1: Registration|Adverse Event|0|||
127548842|NCT00068692|458978522|FG000|Step 1: Registration|Death|1|||
127548843|NCT00068692|458978523|FG001|Step 1: Registration|Death|0|||
127548844|NCT00068692|458978524|FG002|Step 1: Registration|Death|0|||
127548845|NCT00068692|458978525|FG003|Step 1: Registration|Death|0|||
127548846|NCT00068692|458978526|FG004|Step 1: Registration|Death|0|||
127548847|NCT00068692|458978527|FG005|Step 1: Registration|Death|0|||
127548848|NCT00068692|458978528|FG006|Step 1: Registration|Death|0|||
127548849|NCT00068692|458978529|FG007|Step 1: Registration|Death|0|||
127548850|NCT00068692|458978522|FG000|Step 1: Registration|Withdrawal by Subject|11|||
127548851|NCT00068692|458978523|FG001|Step 1: Registration|Withdrawal by Subject|0|||
127548852|NCT00068692|458978524|FG002|Step 1: Registration|Withdrawal by Subject|0|||
127548853|NCT00068692|458978525|FG003|Step 1: Registration|Withdrawal by Subject|0|||
127548854|NCT00068692|458978526|FG004|Step 1: Registration|Withdrawal by Subject|0|||
127548855|NCT00068692|458978527|FG005|Step 1: Registration|Withdrawal by Subject|0|||
127548856|NCT00068692|458978528|FG006|Step 1: Registration|Withdrawal by Subject|0|||
127548857|NCT00068692|458978529|FG007|Step 1: Registration|Withdrawal by Subject|0|||
127548858|NCT00068692|458978522|FG000|Step 1: Registration|Alternative therapy|2|||
127548859|NCT00068692|458978523|FG001|Step 1: Registration|Alternative therapy|0|||
127548860|NCT00068692|458978524|FG002|Step 1: Registration|Alternative therapy|0|||
127548861|NCT00068692|458978525|FG003|Step 1: Registration|Alternative therapy|0|||
127548862|NCT00068692|458978526|FG004|Step 1: Registration|Alternative therapy|0|||
127548863|NCT00068692|458978527|FG005|Step 1: Registration|Alternative therapy|0|||
127548864|NCT00068692|458978528|FG006|Step 1: Registration|Alternative therapy|0|||
127548865|NCT00068692|458978529|FG007|Step 1: Registration|Alternative therapy|0|||
127548866|NCT00068692|458978522|FG000|Step 1: Registration|Complicating disease|2|||
127548867|NCT00068692|458978523|FG001|Step 1: Registration|Complicating disease|0|||
127548868|NCT00068692|458978524|FG002|Step 1: Registration|Complicating disease|0|||
127548869|NCT00068692|458978525|FG003|Step 1: Registration|Complicating disease|0|||
127548870|NCT00068692|458978526|FG004|Step 1: Registration|Complicating disease|0|||
127548871|NCT00068692|458978527|FG005|Step 1: Registration|Complicating disease|0|||
127548872|NCT00068692|458978528|FG006|Step 1: Registration|Complicating disease|0|||
127548873|NCT00068692|458978529|FG007|Step 1: Registration|Complicating disease|0|||
127548874|NCT00068692|458978522|FG000|Step 1: Registration|Protocol Violation|1|||
127548875|NCT00068692|458978523|FG001|Step 1: Registration|Protocol Violation|0|||
127548876|NCT00068692|458978524|FG002|Step 1: Registration|Protocol Violation|0|||
127548877|NCT00068692|458978525|FG003|Step 1: Registration|Protocol Violation|0|||
127548878|NCT00068692|458978526|FG004|Step 1: Registration|Protocol Violation|0|||
127548879|NCT00068692|458978527|FG005|Step 1: Registration|Protocol Violation|0|||
127548880|NCT00068692|458978528|FG006|Step 1: Registration|Protocol Violation|0|||
127548881|NCT00068692|458978529|FG007|Step 1: Registration|Protocol Violation|0|||
127548882|NCT00068692|458978522|FG000|Step 1: Registration|Not eligible|6|||
127548883|NCT00068692|458978523|FG001|Step 1: Registration|Not eligible|0|||
127548884|NCT00068692|458978524|FG002|Step 1: Registration|Not eligible|0|||
127548885|NCT00068692|458978525|FG003|Step 1: Registration|Not eligible|0|||
127548886|NCT00068692|458978526|FG004|Step 1: Registration|Not eligible|0|||
127771005|NCT00150969|459787032|FG000|24 Month Main Study|Lack of Efficacy|1|||
127771006|NCT00150969|459787033|FG001|24 Month Main Study|Lack of Efficacy|8|||
127771007|NCT00150969|459787032|FG000|24 Month Main Study|Lost to Follow-up|3|||
128016594|NCT00217737|460683293|FG002|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
127548887|NCT00068692|458978527|FG005|Step 1: Registration|Not eligible|0|||
127548888|NCT00068692|458978528|FG006|Step 1: Registration|Not eligible|0|||
127548889|NCT00068692|458978529|FG007|Step 1: Registration|Not eligible|0|||
127771008|NCT00150969|459787033|FG001|24 Month Main Study|Lost to Follow-up|2|||
127771009|NCT00150969|459787032|FG000|24 Month Main Study|Protocol Violation|4|||
127771010|NCT00150969|459787033|FG001|24 Month Main Study|Protocol Violation|2|||
127548890|NCT00068692|458978522|FG000|Step 1: Registration|Other|2|||
127548891|NCT00068692|458978523|FG001|Step 1: Registration|Other|0|||
127548892|NCT00068692|458978524|FG002|Step 1: Registration|Other|0|||
127548893|NCT00068692|458978525|FG003|Step 1: Registration|Other|0|||
127548894|NCT00068692|458978526|FG004|Step 1: Registration|Other|0|||
127548895|NCT00068692|458978527|FG005|Step 1: Registration|Other|0|||
127548896|NCT00068692|458978528|FG006|Step 1: Registration|Other|0|||
127548897|NCT00068692|458978529|FG007|Step 1: Registration|Other|0|||
127548898|NCT00068692|458978522|FG000|Step 1: Registration|Not start protocol therapy|3|||
127548899|NCT00068692|458978523|FG001|Step 1: Registration|Not start protocol therapy|0|||
127548900|NCT00068692|458978524|FG002|Step 1: Registration|Not start protocol therapy|0|||
127548901|NCT00068692|458978525|FG003|Step 1: Registration|Not start protocol therapy|0|||
127548902|NCT00068692|458978526|FG004|Step 1: Registration|Not start protocol therapy|0|||
127548903|NCT00068692|458978527|FG005|Step 1: Registration|Not start protocol therapy|0|||
127548904|NCT00068692|458978528|FG006|Step 1: Registration|Not start protocol therapy|0|||
127548905|NCT00068692|458978529|FG007|Step 1: Registration|Not start protocol therapy|0|||
127548906|NCT00068692|458978522|FG000|Step 1: Registration|Registered but not randomized|0|||
127548907|NCT00068692|458978523|FG001|Step 1: Registration|Registered but not randomized|1|||
127548908|NCT00068692|458978524|FG002|Step 1: Registration|Registered but not randomized|0|||
127548909|NCT00068692|458978525|FG003|Step 1: Registration|Registered but not randomized|0|||
127548910|NCT00068692|458978526|FG004|Step 1: Registration|Registered but not randomized|0|||
127548911|NCT00068692|458978527|FG005|Step 1: Registration|Registered but not randomized|0|||
127548912|NCT00068692|458978528|FG006|Step 1: Registration|Registered but not randomized|0|||
127548913|NCT00068692|458978529|FG007|Step 1: Registration|Registered but not randomized|0|||
127548914|NCT00068692|458978522|FG000|Step 2: Randomization|Disesae progression/replase|0|||
127548915|NCT00068692|458978523|FG001|Step 2: Randomization|Disesae progression/replase|0|||
127548916|NCT00068692|458978524|FG002|Step 2: Randomization|Disesae progression/replase|1|||
127548917|NCT00068692|458978525|FG003|Step 2: Randomization|Disesae progression/replase|1|||
127548918|NCT00068692|458978526|FG004|Step 2: Randomization|Disesae progression/replase|0|||
127548919|NCT00068692|458978527|FG005|Step 2: Randomization|Disesae progression/replase|0|||
127548920|NCT00068692|458978528|FG006|Step 2: Randomization|Disesae progression/replase|0|||
127548921|NCT00068692|458978529|FG007|Step 2: Randomization|Disesae progression/replase|0|||
127548922|NCT00068692|458978522|FG000|Step 2: Randomization|Adverse Event|0|||
127548923|NCT00068692|458978523|FG001|Step 2: Randomization|Adverse Event|0|||
127548924|NCT00068692|458978524|FG002|Step 2: Randomization|Adverse Event|4|||
127548925|NCT00068692|458978525|FG003|Step 2: Randomization|Adverse Event|2|||
127548926|NCT00068692|458978526|FG004|Step 2: Randomization|Adverse Event|2|||
127548927|NCT00068692|458978527|FG005|Step 2: Randomization|Adverse Event|3|||
127548928|NCT00068692|458978528|FG006|Step 2: Randomization|Adverse Event|4|||
127548929|NCT00068692|458978529|FG007|Step 2: Randomization|Adverse Event|4|||
127548930|NCT00068692|458978522|FG000|Step 2: Randomization|Death|0|||
127548931|NCT00068692|458978523|FG001|Step 2: Randomization|Death|0|||
127548932|NCT00068692|458978524|FG002|Step 2: Randomization|Death|0|||
127548933|NCT00068692|458978525|FG003|Step 2: Randomization|Death|0|||
127548934|NCT00068692|458978526|FG004|Step 2: Randomization|Death|1|||
127548935|NCT00068692|458978527|FG005|Step 2: Randomization|Death|0|||
127548936|NCT00068692|458978528|FG006|Step 2: Randomization|Death|0|||
127548937|NCT00068692|458978529|FG007|Step 2: Randomization|Death|1|||
127548938|NCT00068692|458978522|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
127548939|NCT00068692|458978523|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
127548940|NCT00068692|458978524|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
127548941|NCT00068692|458978525|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
127548942|NCT00068692|458978526|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
127548943|NCT00068692|458978527|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
127548944|NCT00068692|458978528|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
127548945|NCT00068692|458978529|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
127548946|NCT00068692|458978522|FG000|Step 2: Randomization|alternative therapy|0|||
127548947|NCT00068692|458978523|FG001|Step 2: Randomization|alternative therapy|0|||
127548948|NCT00068692|458978524|FG002|Step 2: Randomization|alternative therapy|0|||
127548949|NCT00068692|458978525|FG003|Step 2: Randomization|alternative therapy|1|||
127548950|NCT00068692|458978526|FG004|Step 2: Randomization|alternative therapy|1|||
127548951|NCT00068692|458978527|FG005|Step 2: Randomization|alternative therapy|0|||
127548952|NCT00068692|458978528|FG006|Step 2: Randomization|alternative therapy|0|||
127548953|NCT00068692|458978529|FG007|Step 2: Randomization|alternative therapy|0|||
127684304|NCT00840177|459469786|FG001|Overall Study|not protocol specified|3|||
127684305|NCT00840177|459469787|FG002|Overall Study|not protocol specified|0|||
127684306|NCT00840177|459469785|FG000|Overall Study|Ineligible|0|||
127684307|NCT00840177|459469786|FG001|Overall Study|Ineligible|0|||
127684308|NCT00840177|459469787|FG002|Overall Study|Ineligible|3|||
127684309|NCT00840177|459469785|FG000|Overall Study|Did not start treatment|0|||
127684310|NCT00840177|459469786|FG001|Overall Study|Did not start treatment|0|||
127684311|NCT00840177|459469787|FG002|Overall Study|Did not start treatment|1|||
127684312|NCT01391832|459469788|FG000|Overall Study|Withdrawal by Subject|21|||
127684313|NCT01391832|459469789|FG001|Overall Study|Withdrawal by Subject|22|||
127548954|NCT00068692|458978522|FG000|Step 2: Randomization|Physician Decision|0|||
127548955|NCT00068692|458978523|FG001|Step 2: Randomization|Physician Decision|0|||
127548956|NCT00068692|458978524|FG002|Step 2: Randomization|Physician Decision|0|||
127548957|NCT00068692|458978525|FG003|Step 2: Randomization|Physician Decision|1|||
127548958|NCT00068692|458978526|FG004|Step 2: Randomization|Physician Decision|1|||
127548959|NCT00068692|458978527|FG005|Step 2: Randomization|Physician Decision|0|||
127548960|NCT00068692|458978528|FG006|Step 2: Randomization|Physician Decision|0|||
127548961|NCT00068692|458978529|FG007|Step 2: Randomization|Physician Decision|0|||
127548962|NCT00068692|458978522|FG000|Step 2: Randomization|Other|0|||
127548963|NCT00068692|458978523|FG001|Step 2: Randomization|Other|0|||
127548964|NCT00068692|458978524|FG002|Step 2: Randomization|Other|0|||
127548965|NCT00068692|458978525|FG003|Step 2: Randomization|Other|1|||
127548966|NCT00068692|458978526|FG004|Step 2: Randomization|Other|0|||
127548967|NCT00068692|458978527|FG005|Step 2: Randomization|Other|1|||
127548968|NCT00068692|458978528|FG006|Step 2: Randomization|Other|0|||
127548969|NCT00068692|458978529|FG007|Step 2: Randomization|Other|0|||
127548970|NCT00068692|458978522|FG000|Step 2: Randomization|never start protocol therapy|0|||
127548971|NCT00068692|458978523|FG001|Step 2: Randomization|never start protocol therapy|0|||
127548972|NCT00068692|458978524|FG002|Step 2: Randomization|never start protocol therapy|1|||
127548973|NCT00068692|458978525|FG003|Step 2: Randomization|never start protocol therapy|0|||
127548974|NCT00068692|458978526|FG004|Step 2: Randomization|never start protocol therapy|1|||
127548975|NCT00068692|458978527|FG005|Step 2: Randomization|never start protocol therapy|0|||
127548976|NCT00068692|458978528|FG006|Step 2: Randomization|never start protocol therapy|0|||
127548977|NCT00068692|458978529|FG007|Step 2: Randomization|never start protocol therapy|0|||
127548978|NCT00248040|458978534|FG000|Overall Study|transplantectomy|2|||
127548979|NCT00248040|458978535|FG001|Overall Study|transplantectomy|1|||
127548980|NCT00248040|458978536|FG002|Overall Study|transplantectomy|3|||
127548981|NCT00248040|458978534|FG000|Overall Study|transplant cancelled post treat start|1|||
127548982|NCT00248040|458978535|FG001|Overall Study|transplant cancelled post treat start|0|||
127548983|NCT00248040|458978536|FG002|Overall Study|transplant cancelled post treat start|0|||
127548984|NCT00248040|458978534|FG000|Overall Study|Death|0|||
127548985|NCT00248040|458978535|FG001|Overall Study|Death|0|||
127548986|NCT00248040|458978536|FG002|Overall Study|Death|1|||
127548987|NCT01002339|458978539|FG000|Overall Study|Withdrawal by Subject|0|||
127548988|NCT01002339|458978540|FG001|Overall Study|Withdrawal by Subject|1|||
127548989|NCT01002339|458978541|FG002|Overall Study|Withdrawal by Subject|0|||
127548990|NCT01002339|458978539|FG000|Overall Study|Incorrect treatment assignment|0|||
127548991|NCT01002339|458978540|FG001|Overall Study|Incorrect treatment assignment|0|||
127548992|NCT01002339|458978541|FG002|Overall Study|Incorrect treatment assignment|1|||
127548993|NCT01002339|458978539|FG000|Overall Study|Protocol Violation|0|||
127548994|NCT01002339|458978540|FG001|Overall Study|Protocol Violation|0|||
127548995|NCT01002339|458978541|FG002|Overall Study|Protocol Violation|2|||
127548996|NCT01002339|458978539|FG000|Overall Study|Lung cancer detected before transplant|0|||
127548997|NCT01002339|458978540|FG001|Overall Study|Lung cancer detected before transplant|0|||
127548998|NCT01002339|458978541|FG002|Overall Study|Lung cancer detected before transplant|1|||
127548999|NCT01002339|458978539|FG000|Overall Study|Randomized. Not transplanted|0|||
127549000|NCT01002339|458978540|FG001|Overall Study|Randomized. Not transplanted|0|||
127549001|NCT01002339|458978541|FG002|Overall Study|Randomized. Not transplanted|1|||
127549002|NCT00790842|458978542|FG000|Dose Level 1|Adverse Event|1|||
127549003|NCT00790842|458978543|FG001|Dose Level 1|Adverse Event|0|||
127549004|NCT00790842|458978544|FG002|Dose Level 1|Adverse Event|0|||
127549005|NCT00790842|458978545|FG003|Dose Level 1|Adverse Event|2|||
127549006|NCT00790842|458978546|FG004|Dose Level 1|Adverse Event|0|||
127549007|NCT00790842|458978547|FG005|Dose Level 1|Adverse Event|0|||
127549008|NCT00790842|458978548|FG006|Dose Level 1|Adverse Event|0|||
127549009|NCT00790842|458978549|FG007|Dose Level 1|Adverse Event|1|||
127549010|NCT00790842|458978550|FG008|Dose Level 1|Adverse Event|0|||
127549011|NCT00790842|458978551|FG009|Dose Level 1|Adverse Event|0|||
127549012|NCT00790842|458978552|FG010|Dose Level 1|Adverse Event|0|||
127549013|NCT00790842|458978542|FG000|Dose Level 1|Physician Decision|1|||
127549014|NCT00790842|458978543|FG001|Dose Level 1|Physician Decision|0|||
127549015|NCT00790842|458978544|FG002|Dose Level 1|Physician Decision|0|||
127549016|NCT00790842|458978545|FG003|Dose Level 1|Physician Decision|0|||
127549017|NCT00790842|458978546|FG004|Dose Level 1|Physician Decision|0|||
127549018|NCT00790842|458978547|FG005|Dose Level 1|Physician Decision|0|||
127549019|NCT00790842|458978548|FG006|Dose Level 1|Physician Decision|0|||
127549020|NCT00790842|458978549|FG007|Dose Level 1|Physician Decision|1|||
127549021|NCT00790842|458978550|FG008|Dose Level 1|Physician Decision|0|||
127549022|NCT00790842|458978551|FG009|Dose Level 1|Physician Decision|0|||
127549023|NCT00790842|458978552|FG010|Dose Level 1|Physician Decision|0|||
127771011|NCT00150969|459787032|FG000|24 Month Main Study|Withdrawal by Subject|7|||
127771012|NCT00150969|459787033|FG001|24 Month Main Study|Withdrawal by Subject|4|||
127549024|NCT00790842|458978542|FG000|Dose Level 1|Withdrawal by Subject|1|||
127549025|NCT00790842|458978543|FG001|Dose Level 1|Withdrawal by Subject|0|||
127549026|NCT00790842|458978544|FG002|Dose Level 1|Withdrawal by Subject|0|||
127549027|NCT00790842|458978545|FG003|Dose Level 1|Withdrawal by Subject|0|||
127549028|NCT00790842|458978546|FG004|Dose Level 1|Withdrawal by Subject|0|||
127549029|NCT00790842|458978547|FG005|Dose Level 1|Withdrawal by Subject|0|||
127549030|NCT00790842|458978548|FG006|Dose Level 1|Withdrawal by Subject|0|||
127549031|NCT00790842|458978549|FG007|Dose Level 1|Withdrawal by Subject|0|||
127549032|NCT00790842|458978550|FG008|Dose Level 1|Withdrawal by Subject|0|||
127549033|NCT00790842|458978551|FG009|Dose Level 1|Withdrawal by Subject|0|||
127549034|NCT00790842|458978552|FG010|Dose Level 1|Withdrawal by Subject|0|||
127549035|NCT00790842|458978542|FG000|Dose Level 2|Death|0|||
127549036|NCT00790842|458978543|FG001|Dose Level 2|Death|1|||
127549037|NCT00790842|458978544|FG002|Dose Level 2|Death|0|||
127549038|NCT00790842|458978545|FG003|Dose Level 2|Death|0|||
127549039|NCT00790842|458978546|FG004|Dose Level 2|Death|1|||
127549040|NCT00790842|458978547|FG005|Dose Level 2|Death|0|||
127549041|NCT00790842|458978548|FG006|Dose Level 2|Death|0|||
127549042|NCT00790842|458978549|FG007|Dose Level 2|Death|0|||
127549043|NCT00790842|458978550|FG008|Dose Level 2|Death|0|||
127549044|NCT00790842|458978551|FG009|Dose Level 2|Death|0|||
127549045|NCT00790842|458978552|FG010|Dose Level 2|Death|0|||
127549046|NCT00790842|458978542|FG000|Dose Level 2|Physician Decision|0|||
127549047|NCT00790842|458978543|FG001|Dose Level 2|Physician Decision|1|||
127549048|NCT00790842|458978544|FG002|Dose Level 2|Physician Decision|0|||
127549049|NCT00790842|458978545|FG003|Dose Level 2|Physician Decision|0|||
127549050|NCT00790842|458978546|FG004|Dose Level 2|Physician Decision|0|||
127549051|NCT00790842|458978547|FG005|Dose Level 2|Physician Decision|0|||
127549052|NCT00790842|458978548|FG006|Dose Level 2|Physician Decision|0|||
127549053|NCT00790842|458978549|FG007|Dose Level 2|Physician Decision|0|||
127549054|NCT00790842|458978550|FG008|Dose Level 2|Physician Decision|0|||
127549055|NCT00790842|458978551|FG009|Dose Level 2|Physician Decision|0|||
127549056|NCT00790842|458978552|FG010|Dose Level 2|Physician Decision|0|||
127549057|NCT00790842|458978542|FG000|Dose Level 2|Withdrawal by Subject|0|||
127549058|NCT00790842|458978543|FG001|Dose Level 2|Withdrawal by Subject|1|||
127549059|NCT00790842|458978544|FG002|Dose Level 2|Withdrawal by Subject|0|||
127549060|NCT00790842|458978545|FG003|Dose Level 2|Withdrawal by Subject|0|||
127549061|NCT00790842|458978546|FG004|Dose Level 2|Withdrawal by Subject|0|||
127549062|NCT00790842|458978547|FG005|Dose Level 2|Withdrawal by Subject|0|||
127549063|NCT00790842|458978548|FG006|Dose Level 2|Withdrawal by Subject|0|||
127549064|NCT00790842|458978549|FG007|Dose Level 2|Withdrawal by Subject|0|||
127549065|NCT00790842|458978550|FG008|Dose Level 2|Withdrawal by Subject|0|||
127684314|NCT01391832|459469788|FG000|Overall Study|Lost to Follow-up|0|||
127684315|NCT01391832|459469789|FG001|Overall Study|Lost to Follow-up|1|||
127684316|NCT00566735|459469793|FG000|Overall Study|Withdrawal by Subject|0|||
127684317|NCT00566735|459469794|FG001|Overall Study|Withdrawal by Subject|1|||
127684318|NCT00566735|459469793|FG000|Overall Study|Refused neuropsychological testing|2|||
127684319|NCT00566735|459469794|FG001|Overall Study|Refused neuropsychological testing|5|||
127684320|NCT00566735|459469793|FG000|Overall Study|Switched into a manic episode|0|||
127684321|NCT00566735|459469794|FG001|Overall Study|Switched into a manic episode|1|||
127684322|NCT00925587|459469796|FG000|Overall Study|Protocol Specified Criteria|6|||
127684323|NCT00925587|459469797|FG001|Overall Study|Protocol Specified Criteria|6|||
127684324|NCT00925587|459469796|FG000|Overall Study|Physician Decision|4|||
127684325|NCT00925587|459469797|FG001|Overall Study|Physician Decision|1|||
127684326|NCT00925587|459469796|FG000|Overall Study|Protocol Violation|6|||
127684327|NCT00925587|459469797|FG001|Overall Study|Protocol Violation|4|||
127684328|NCT00925587|459469796|FG000|Overall Study|Withdrawal by Subject|9|||
127684329|NCT00925587|459469797|FG001|Overall Study|Withdrawal by Subject|6|||
127684330|NCT00925587|459469796|FG000|Overall Study|Death|5|||
127684331|NCT00925587|459469797|FG001|Overall Study|Death|5|||
127684332|NCT00925587|459469796|FG000|Overall Study|Adverse Event|6|||
127684333|NCT00925587|459469797|FG001|Overall Study|Adverse Event|2|||
127684334|NCT00925587|459469796|FG000|Overall Study|Lost to Follow-up|0|||
127684335|NCT00925587|459469797|FG001|Overall Study|Lost to Follow-up|1|||
127684336|NCT00686855|459469805|FG000|Overall Study|Lost to Follow-up|1|||
127684337|NCT00686855|459469806|FG001|Overall Study|Lost to Follow-up|0|||
127684338|NCT00686855|459469805|FG000|Overall Study|Progressive GVHD|0|||
127684339|NCT00686855|459469806|FG001|Overall Study|Progressive GVHD|1|||
127684340|NCT01460446|459469812|FG000|Overall Study|Non-compliance|2|||
127684341|NCT01460446|459469813|FG001|Overall Study|Non-compliance|9|||
127684342|NCT01460446|459469812|FG000|Overall Study|Consent Withdrawn|0|||
127684343|NCT01460446|459469813|FG001|Overall Study|Consent Withdrawn|4|||
127684344|NCT01460446|459469812|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
127684345|NCT01460446|459469813|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
127684346|NCT01460446|459469812|FG000|Overall Study|Surgery/Illness|1|||
127549066|NCT00790842|458978551|FG009|Dose Level 2|Withdrawal by Subject|0|||
127549067|NCT00790842|458978552|FG010|Dose Level 2|Withdrawal by Subject|0|||
127549068|NCT00790842|458978542|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
127684347|NCT01460446|459469813|FG001|Overall Study|Surgery/Illness|1|||
127684348|NCT01460446|459469812|FG000|Overall Study|Pregnancy|1|||
127684349|NCT01460446|459469813|FG001|Overall Study|Pregnancy|0|||
127549069|NCT00790842|458978543|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
127549070|NCT00790842|458978544|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
127549071|NCT00790842|458978545|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
127684350|NCT01460446|459469812|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
127684351|NCT01460446|459469813|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
127549072|NCT00790842|458978546|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
127549073|NCT00790842|458978547|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
127549074|NCT00790842|458978548|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
127549075|NCT00790842|458978549|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
127549076|NCT00790842|458978550|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
127549077|NCT00790842|458978551|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
127549078|NCT00790842|458978552|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
127549079|NCT00790842|458978542|FG000|Dose Level 3|Adverse Event|0|||
127549080|NCT00790842|458978543|FG001|Dose Level 3|Adverse Event|0|||
127549081|NCT00790842|458978544|FG002|Dose Level 3|Adverse Event|1|||
127549082|NCT00790842|458978545|FG003|Dose Level 3|Adverse Event|0|||
127549083|NCT00790842|458978546|FG004|Dose Level 3|Adverse Event|0|||
127549084|NCT00790842|458978547|FG005|Dose Level 3|Adverse Event|0|||
127549085|NCT00790842|458978548|FG006|Dose Level 3|Adverse Event|0|||
127549086|NCT00790842|458978549|FG007|Dose Level 3|Adverse Event|0|||
127549087|NCT00790842|458978550|FG008|Dose Level 3|Adverse Event|0|||
127549088|NCT00790842|458978551|FG009|Dose Level 3|Adverse Event|0|||
127549089|NCT00790842|458978552|FG010|Dose Level 3|Adverse Event|0|||
127549090|NCT00790842|458978542|FG000|Dose Level 3|Withdrawal by Subject|0|||
127549091|NCT00790842|458978543|FG001|Dose Level 3|Withdrawal by Subject|0|||
127549092|NCT00790842|458978544|FG002|Dose Level 3|Withdrawal by Subject|3|||
127549093|NCT00790842|458978545|FG003|Dose Level 3|Withdrawal by Subject|0|||
127549094|NCT00790842|458978546|FG004|Dose Level 3|Withdrawal by Subject|0|||
127549095|NCT00790842|458978547|FG005|Dose Level 3|Withdrawal by Subject|0|||
127549096|NCT00790842|458978548|FG006|Dose Level 3|Withdrawal by Subject|0|||
127549097|NCT00790842|458978549|FG007|Dose Level 3|Withdrawal by Subject|0|||
127549098|NCT00790842|458978550|FG008|Dose Level 3|Withdrawal by Subject|0|||
127549099|NCT00790842|458978551|FG009|Dose Level 3|Withdrawal by Subject|2|||
127549100|NCT00790842|458978552|FG010|Dose Level 3|Withdrawal by Subject|0|||
127549101|NCT00790842|458978542|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
127549102|NCT00790842|458978543|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
127549103|NCT00790842|458978544|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
127549104|NCT00790842|458978545|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
127549105|NCT00790842|458978546|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
127549106|NCT00790842|458978547|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
127549107|NCT00790842|458978548|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
127549108|NCT00790842|458978549|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
127549109|NCT00790842|458978550|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
127549110|NCT00790842|458978551|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
127549111|NCT00790842|458978552|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
127549112|NCT00790842|458978542|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
127549113|NCT00790842|458978543|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
127549114|NCT00790842|458978544|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
127549115|NCT00790842|458978545|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
127549116|NCT00790842|458978546|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
127549117|NCT00790842|458978547|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
127549118|NCT00790842|458978548|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
127549119|NCT00790842|458978549|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
127549120|NCT00790842|458978550|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
127549121|NCT00790842|458978551|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
127549122|NCT00790842|458978552|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
127549123|NCT00790842|458978542|FG000|Dose Level 4|Adverse Event|0|||
127549124|NCT00790842|458978543|FG001|Dose Level 4|Adverse Event|0|||
128016595|NCT00217737|460683294|FG003|Step 1 Registration (Risk Assessment)|Uninformative tumor block|18|||
128016596|NCT00217737|460683291|FG000|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
128016597|NCT00217737|460683292|FG001|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
128016598|NCT00217737|460683293|FG002|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
128016599|NCT00217737|460683294|FG003|Step 1 Registration (Risk Assessment)|Physician Decision|16|||
128016600|NCT00217737|460683291|FG000|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
128016601|NCT00217737|460683292|FG001|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
127549125|NCT00790842|458978544|FG002|Dose Level 4|Adverse Event|0|||
127549126|NCT00790842|458978545|FG003|Dose Level 4|Adverse Event|0|||
127549127|NCT00790842|458978546|FG004|Dose Level 4|Adverse Event|0|||
127549128|NCT00790842|458978547|FG005|Dose Level 4|Adverse Event|0|||
127549129|NCT00790842|458978548|FG006|Dose Level 4|Adverse Event|1|||
127549130|NCT00790842|458978549|FG007|Dose Level 4|Adverse Event|0|||
127549131|NCT00790842|458978550|FG008|Dose Level 4|Adverse Event|0|||
127549132|NCT00790842|458978551|FG009|Dose Level 4|Adverse Event|0|||
127549133|NCT00790842|458978552|FG010|Dose Level 4|Adverse Event|0|||
127549134|NCT00790842|458978542|FG000|Dose Level 4|Physician Decision|0|||
127549135|NCT00790842|458978543|FG001|Dose Level 4|Physician Decision|0|||
127549136|NCT00790842|458978544|FG002|Dose Level 4|Physician Decision|0|||
127549137|NCT00790842|458978545|FG003|Dose Level 4|Physician Decision|0|||
128016602|NCT00217737|460683293|FG002|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
128016603|NCT00217737|460683294|FG003|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|16|||
128016604|NCT00217737|460683291|FG000|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
128016605|NCT00217737|460683292|FG001|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
128016606|NCT00217737|460683293|FG002|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
128016607|NCT00217737|460683294|FG003|Step 1 Registration (Risk Assessment)|Staff/site error|9|||
128016608|NCT00217737|460683291|FG000|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
127771013|NCT00150969|459787032|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
127771014|NCT00150969|459787033|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
127771015|NCT00150969|459787032|FG000|24-48 Month Extension|Lack of Efficacy|0|||
127771016|NCT00150969|459787033|FG001|24-48 Month Extension|Lack of Efficacy|1|||
127771017|NCT00150969|459787032|FG000|24-48 Month Extension|Adverse Event|1|||
127771018|NCT00150969|459787033|FG001|24-48 Month Extension|Adverse Event|3|||
127771019|NCT00150969|459787032|FG000|24-48 Month Extension|Other Reason|81|||
127771020|NCT00150969|459787033|FG001|24-48 Month Extension|Other Reason|91|||
127771021|NCT00615836|459787034|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
127771022|NCT00615836|459787035|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
127771023|NCT00615836|459787036|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
127771024|NCT00615836|459787037|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
127771025|NCT00615836|459787038|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
127771026|NCT00615836|459787034|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
127771027|NCT00615836|459787035|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
127771028|NCT00615836|459787036|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
127771029|NCT00615836|459787037|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
127771030|NCT00615836|459787038|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
127771031|NCT00615836|459787034|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
127771032|NCT00615836|459787035|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
127771033|NCT00615836|459787036|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
127771034|NCT00615836|459787037|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
127771035|NCT00615836|459787038|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
127771036|NCT00615836|459787034|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
127771037|NCT00615836|459787035|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
127771038|NCT00615836|459787036|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
127771039|NCT00615836|459787037|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
127771040|NCT00615836|459787038|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
127771041|NCT00615836|459787034|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
127771042|NCT00615836|459787035|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
127771043|NCT00615836|459787036|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
127771044|NCT00615836|459787037|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
127771045|NCT00615836|459787038|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
127771046|NCT00615836|459787034|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
127771047|NCT00615836|459787035|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
127771048|NCT00615836|459787036|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
127771049|NCT00615836|459787037|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
127771050|NCT00615836|459787038|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
127771051|NCT00615836|459787034|FG000|Extension Study (FE992026 CS31)|Other|10|||
127771052|NCT00615836|459787035|FG001|Extension Study (FE992026 CS31)|Other|7|||
127771053|NCT00615836|459787036|FG002|Extension Study (FE992026 CS31)|Other|8|||
127771054|NCT00615836|459787037|FG003|Extension Study (FE992026 CS31)|Other|8|||
127771055|NCT00615836|459787038|FG004|Extension Study (FE992026 CS31)|Other|0|||
127771056|NCT00615836|459787034|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
127771057|NCT00615836|459787035|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
127771058|NCT00615836|459787036|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
128016609|NCT00217737|460683292|FG001|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
128016610|NCT00217737|460683293|FG002|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
128016611|NCT00217737|460683294|FG003|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|9|||
128016612|NCT00217737|460683291|FG000|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
128016613|NCT00217737|460683292|FG001|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
128016614|NCT00217737|460683293|FG002|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
128016615|NCT00217737|460683294|FG003|Step 1 Registration (Risk Assessment)|Adverse Event|6|||
127771059|NCT00615836|459787037|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
127771060|NCT00615836|459787038|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
127771061|NCT00615836|459787034|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
127771062|NCT00615836|459787035|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
127771063|NCT00615836|459787036|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
127771064|NCT00615836|459787037|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
127549138|NCT00790842|458978546|FG004|Dose Level 4|Physician Decision|0|||
127549139|NCT00790842|458978547|FG005|Dose Level 4|Physician Decision|0|||
127549140|NCT00790842|458978548|FG006|Dose Level 4|Physician Decision|1|||
127549141|NCT00790842|458978549|FG007|Dose Level 4|Physician Decision|0|||
127549142|NCT00790842|458978550|FG008|Dose Level 4|Physician Decision|0|||
127549143|NCT00790842|458978551|FG009|Dose Level 4|Physician Decision|0|||
127549144|NCT00790842|458978552|FG010|Dose Level 4|Physician Decision|1|||
127549145|NCT00790842|458978542|FG000|Dose Level 4|Withdrawal by Subject|0|||
127549146|NCT00790842|458978543|FG001|Dose Level 4|Withdrawal by Subject|0|||
127549147|NCT00790842|458978544|FG002|Dose Level 4|Withdrawal by Subject|0|||
127549148|NCT00790842|458978545|FG003|Dose Level 4|Withdrawal by Subject|0|||
127549149|NCT00790842|458978546|FG004|Dose Level 4|Withdrawal by Subject|0|||
127549150|NCT00790842|458978547|FG005|Dose Level 4|Withdrawal by Subject|0|||
127549151|NCT00790842|458978548|FG006|Dose Level 4|Withdrawal by Subject|0|||
127549152|NCT00790842|458978549|FG007|Dose Level 4|Withdrawal by Subject|0|||
127549153|NCT00790842|458978550|FG008|Dose Level 4|Withdrawal by Subject|0|||
127549154|NCT00790842|458978551|FG009|Dose Level 4|Withdrawal by Subject|0|||
127549155|NCT00790842|458978552|FG010|Dose Level 4|Withdrawal by Subject|1|||
127549156|NCT00790842|458978542|FG000|Expansion Cohort|Adverse Event|0|||
127549157|NCT00790842|458978543|FG001|Expansion Cohort|Adverse Event|0|||
127549158|NCT00790842|458978544|FG002|Expansion Cohort|Adverse Event|0|||
127549159|NCT00790842|458978545|FG003|Expansion Cohort|Adverse Event|0|||
127549160|NCT00790842|458978546|FG004|Expansion Cohort|Adverse Event|0|||
127549161|NCT00790842|458978547|FG005|Expansion Cohort|Adverse Event|0|||
127549162|NCT00790842|458978548|FG006|Expansion Cohort|Adverse Event|1|||
127549163|NCT00790842|458978549|FG007|Expansion Cohort|Adverse Event|0|||
127549164|NCT00790842|458978550|FG008|Expansion Cohort|Adverse Event|0|||
127549165|NCT00790842|458978551|FG009|Expansion Cohort|Adverse Event|0|||
127549166|NCT00790842|458978552|FG010|Expansion Cohort|Adverse Event|0|||
127549167|NCT00790842|458978542|FG000|Expansion Cohort|Death|0|||
127549168|NCT00790842|458978543|FG001|Expansion Cohort|Death|0|||
127549169|NCT00790842|458978544|FG002|Expansion Cohort|Death|2|||
127549170|NCT00790842|458978545|FG003|Expansion Cohort|Death|0|||
127549171|NCT00790842|458978546|FG004|Expansion Cohort|Death|0|||
127549172|NCT00790842|458978547|FG005|Expansion Cohort|Death|0|||
127549173|NCT00790842|458978548|FG006|Expansion Cohort|Death|0|||
127549174|NCT00790842|458978549|FG007|Expansion Cohort|Death|0|||
127549175|NCT00790842|458978550|FG008|Expansion Cohort|Death|0|||
127549176|NCT00790842|458978551|FG009|Expansion Cohort|Death|0|||
127549177|NCT00790842|458978552|FG010|Expansion Cohort|Death|0|||
127549178|NCT00790842|458978542|FG000|Expansion Cohort|Physician Decision|0|||
127549179|NCT00790842|458978543|FG001|Expansion Cohort|Physician Decision|0|||
127549180|NCT00790842|458978544|FG002|Expansion Cohort|Physician Decision|1|||
127549181|NCT00790842|458978545|FG003|Expansion Cohort|Physician Decision|0|||
127549182|NCT00790842|458978546|FG004|Expansion Cohort|Physician Decision|0|||
127549183|NCT00790842|458978547|FG005|Expansion Cohort|Physician Decision|0|||
127549184|NCT00790842|458978548|FG006|Expansion Cohort|Physician Decision|0|||
127549185|NCT00790842|458978549|FG007|Expansion Cohort|Physician Decision|0|||
127549186|NCT00790842|458978550|FG008|Expansion Cohort|Physician Decision|0|||
127549187|NCT00790842|458978551|FG009|Expansion Cohort|Physician Decision|0|||
127549188|NCT00790842|458978552|FG010|Expansion Cohort|Physician Decision|0|||
127549189|NCT00790842|458978542|FG000|Expansion Cohort|Withdrawal by Subject|0|||
127771065|NCT00615836|459787038|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
127771066|NCT01313689|459787039|FG000|24-Week Randomization 1|Adverse Event|10|||
127771067|NCT01313689|459787040|FG001|24-Week Randomization 1|Adverse Event|5|||
127549190|NCT00790842|458978543|FG001|Expansion Cohort|Withdrawal by Subject|0|||
127549191|NCT00790842|458978544|FG002|Expansion Cohort|Withdrawal by Subject|3|||
127549192|NCT00790842|458978545|FG003|Expansion Cohort|Withdrawal by Subject|0|||
127549193|NCT00790842|458978546|FG004|Expansion Cohort|Withdrawal by Subject|0|||
127549194|NCT00790842|458978547|FG005|Expansion Cohort|Withdrawal by Subject|0|||
127549195|NCT00790842|458978548|FG006|Expansion Cohort|Withdrawal by Subject|0|||
127549196|NCT00790842|458978549|FG007|Expansion Cohort|Withdrawal by Subject|0|||
127549197|NCT00790842|458978550|FG008|Expansion Cohort|Withdrawal by Subject|0|||
127549198|NCT00790842|458978551|FG009|Expansion Cohort|Withdrawal by Subject|0|||
127549199|NCT00790842|458978552|FG010|Expansion Cohort|Withdrawal by Subject|0|||
127549200|NCT00790842|458978542|FG000|Expansion Cohort|Study Closure|0|||
127549201|NCT00790842|458978543|FG001|Expansion Cohort|Study Closure|0|||
127549202|NCT00790842|458978544|FG002|Expansion Cohort|Study Closure|1|||
127549203|NCT00790842|458978545|FG003|Expansion Cohort|Study Closure|0|||
127549204|NCT00790842|458978546|FG004|Expansion Cohort|Study Closure|0|||
127549205|NCT00790842|458978547|FG005|Expansion Cohort|Study Closure|0|||
127549206|NCT00790842|458978548|FG006|Expansion Cohort|Study Closure|0|||
127771068|NCT01313689|459787041|FG002|24-Week Randomization 1|Adverse Event|0|||
127771069|NCT01313689|459787042|FG003|24-Week Randomization 1|Adverse Event|0|||
127549207|NCT00790842|458978549|FG007|Expansion Cohort|Study Closure|0|||
127549208|NCT00790842|458978550|FG008|Expansion Cohort|Study Closure|0|||
127549209|NCT00790842|458978551|FG009|Expansion Cohort|Study Closure|0|||
127549210|NCT00790842|458978552|FG010|Expansion Cohort|Study Closure|0|||
127549211|NCT00419952|458978553|FG000|Overall Study|Adverse Event|8|||
127549212|NCT00419952|458978554|FG001|Overall Study|Adverse Event|10|||
127549213|NCT00419952|458978553|FG000|Overall Study|Withdrawal by Subject|44|||
127549214|NCT00419952|458978554|FG001|Overall Study|Withdrawal by Subject|43|||
127549215|NCT00419952|458978553|FG000|Overall Study|Lost to Follow-up|43|||
127549216|NCT00419952|458978554|FG001|Overall Study|Lost to Follow-up|34|||
127549217|NCT00419952|458978553|FG000|Overall Study|Protocol Violation|32|||
127549218|NCT00419952|458978554|FG001|Overall Study|Protocol Violation|24|||
127549219|NCT00419952|458978553|FG000|Overall Study|Pregnancy|4|||
127549220|NCT00419952|458978554|FG001|Overall Study|Pregnancy|2|||
127549221|NCT00419952|458978553|FG000|Overall Study|Physician Decision|1|||
127549222|NCT00419952|458978554|FG001|Overall Study|Physician Decision|3|||
127549223|NCT00419952|458978553|FG000|Overall Study|Incorrectly enrolled|10|||
127549224|NCT00419952|458978554|FG001|Overall Study|Incorrectly enrolled|3|||
127549225|NCT00419952|458978553|FG000|Overall Study|Intake of prohibited medication|2|||
127549226|NCT00419952|458978554|FG001|Overall Study|Intake of prohibited medication|2|||
127549227|NCT00419952|458978553|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
127549228|NCT00419952|458978554|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
127549229|NCT00419952|458978553|FG000|Overall Study|Diary or medication non-compliance|2|||
127549230|NCT00419952|458978554|FG001|Overall Study|Diary or medication non-compliance|4|||
127549231|NCT00419952|458978553|FG000|Overall Study|Abnormal ECG|1|||
127549232|NCT00419952|458978554|FG001|Overall Study|Abnormal ECG|0|||
127549233|NCT03126591|458978555|FG000|Overall Study|Death|6|||
127549234|NCT03126591|458978556|FG001|Overall Study|Death|3|||
127549235|NCT03126591|458978557|FG002|Overall Study|Death|17|||
127549236|NCT03126591|458978555|FG000|Overall Study|Progressive Disease|0|||
127771070|NCT01313689|459787043|FG004|24-Week Randomization 1|Adverse Event|0|||
127771071|NCT01313689|459787039|FG000|24-Week Randomization 1|Physician Decision|4|||
127549237|NCT03126591|458978556|FG001|Overall Study|Progressive Disease|1|||
127771072|NCT01313689|459787040|FG001|24-Week Randomization 1|Physician Decision|5|||
127771073|NCT01313689|459787041|FG002|24-Week Randomization 1|Physician Decision|0|||
127771074|NCT01313689|459787042|FG003|24-Week Randomization 1|Physician Decision|0|||
127771075|NCT01313689|459787043|FG004|24-Week Randomization 1|Physician Decision|0|||
127771076|NCT01313689|459787039|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
127771077|NCT01313689|459787040|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
127771078|NCT01313689|459787041|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
127771079|NCT01313689|459787042|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
127771080|NCT01313689|459787043|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
127771081|NCT01313689|459787039|FG000|24-Week Randomization 2|Adverse Event|0|||
127771082|NCT01313689|459787040|FG001|24-Week Randomization 2|Adverse Event|0|||
127771083|NCT01313689|459787041|FG002|24-Week Randomization 2|Adverse Event|2|||
127771084|NCT01313689|459787042|FG003|24-Week Randomization 2|Adverse Event|0|||
127771085|NCT01313689|459787043|FG004|24-Week Randomization 2|Adverse Event|8|||
127771086|NCT01313689|459787039|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
127771087|NCT01313689|459787040|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
127771088|NCT01313689|459787041|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
127771089|NCT01313689|459787042|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
127771090|NCT01313689|459787043|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
127771091|NCT01313689|459787039|FG000|24-Week Randomization 2|Physician Decision|0|||
127771092|NCT01313689|459787040|FG001|24-Week Randomization 2|Physician Decision|0|||
127771093|NCT01313689|459787041|FG002|24-Week Randomization 2|Physician Decision|0|||
127771094|NCT01313689|459787042|FG003|24-Week Randomization 2|Physician Decision|0|||
127771095|NCT01313689|459787043|FG004|24-Week Randomization 2|Physician Decision|4|||
127771096|NCT01007448|459787044|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
127771097|NCT01007448|459787045|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
127771098|NCT01007448|459787044|FG000|Overall Study|Staph Skin Infection Flare|1|||
127771099|NCT01007448|459787045|FG001|Overall Study|Staph Skin Infection Flare|0|||
127771100|NCT01007448|459787044|FG000|Overall Study|Participant Leaving the Country|1|||
127771101|NCT01007448|459787045|FG001|Overall Study|Participant Leaving the Country|0|||
127771102|NCT01007448|459787044|FG000|Overall Study|Participant Given Prohibited Medication|1|||
127771103|NCT01007448|459787045|FG001|Overall Study|Participant Given Prohibited Medication|0|||
127771104|NCT01007448|459787044|FG000|Overall Study|Progressive Disease|1|||
127549238|NCT03126591|458978557|FG002|Overall Study|Progressive Disease|2|||
127771105|NCT01007448|459787045|FG001|Overall Study|Progressive Disease|2|||
127771106|NCT01007448|459787044|FG000|Overall Study|Lack of Efficacy|2|||
127771107|NCT01007448|459787045|FG001|Overall Study|Lack of Efficacy|0|||
127549239|NCT03126591|458978555|FG000|Overall Study|Terminated by Sponsor|0|||
127549240|NCT03126591|458978556|FG001|Overall Study|Terminated by Sponsor|1|||
127549241|NCT03126591|458978557|FG002|Overall Study|Terminated by Sponsor|4|||
127549242|NCT03126591|458978555|FG000|Overall Study|Withdrawal by Subject|1|||
127549243|NCT03126591|458978556|FG001|Overall Study|Withdrawal by Subject|1|||
127549244|NCT03126591|458978557|FG002|Overall Study|Withdrawal by Subject|4|||
127549245|NCT02158546|458978558|FG000|Overall Study|Physician Decision|0|||
127771108|NCT01007448|459787044|FG000|Overall Study|Withdrawal by Subject|2|||
127771109|NCT01007448|459787045|FG001|Overall Study|Withdrawal by Subject|3|||
128016616|NCT00217737|460683291|FG000|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
128016617|NCT00217737|460683292|FG001|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
128016618|NCT00217737|460683293|FG002|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
128016619|NCT00217737|460683294|FG003|Step 1 Registration (Risk Assessment)|Insurance issues|4|||
128016620|NCT00217737|460683291|FG000|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
128016621|NCT00217737|460683292|FG001|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
128016622|NCT00217737|460683293|FG002|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
127684352|NCT01867216|459469814|FG000|Overall Study|Withdrawal by Subject|2|||
127684353|NCT01867216|459469815|FG001|Overall Study|Withdrawal by Subject|0|||
127684354|NCT01867216|459469816|FG002|Overall Study|Withdrawal by Subject|0|||
127684355|NCT01867216|459469817|FG003|Overall Study|Withdrawal by Subject|0|||
127684356|NCT01867216|459469818|FG004|Overall Study|Withdrawal by Subject|1|||
127684357|NCT01867216|459469819|FG005|Overall Study|Withdrawal by Subject|0|||
127684358|NCT01867216|459469820|FG006|Overall Study|Withdrawal by Subject|1|||
127684359|NCT01867216|459469814|FG000|Overall Study|Physician Decision|1|||
127684360|NCT01867216|459469815|FG001|Overall Study|Physician Decision|0|||
127684361|NCT01867216|459469816|FG002|Overall Study|Physician Decision|0|||
127684362|NCT01867216|459469817|FG003|Overall Study|Physician Decision|0|||
127684363|NCT01867216|459469818|FG004|Overall Study|Physician Decision|0|||
127684364|NCT01867216|459469819|FG005|Overall Study|Physician Decision|0|||
127684365|NCT01867216|459469820|FG006|Overall Study|Physician Decision|0|||
127684366|NCT01867216|459469814|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
127684367|NCT01867216|459469815|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
127684368|NCT01867216|459469816|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
127684369|NCT01867216|459469817|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
127684370|NCT01867216|459469818|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
127684371|NCT01867216|459469819|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
127684372|NCT01867216|459469820|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
127684373|NCT01318382|459469823|FG000|Overall Study|Physician Decision|2|||
127684374|NCT01318382|459469823|FG000|Overall Study|Device Malfunction|10|||
127684375|NCT01318382|459469823|FG000|Overall Study|Protocol Violation|1|||
127684376|NCT01599104|459469824|FG000|Overall Study|Withdrawal by Subject|1|||
127684377|NCT01599104|459469825|FG001|Overall Study|Withdrawal by Subject|1|||
127684378|NCT01599104|459469826|FG002|Overall Study|Withdrawal by Subject|2|||
127684379|NCT01599104|459469824|FG000|Overall Study|Technical Problems|1|||
127684380|NCT01599104|459469825|FG001|Overall Study|Technical Problems|0|||
127684381|NCT01599104|459469826|FG002|Overall Study|Technical Problems|0|||
127684382|NCT01599104|459469824|FG000|Overall Study|Physician Decision|3|||
127684383|NCT01599104|459469825|FG001|Overall Study|Physician Decision|2|||
127684384|NCT01599104|459469826|FG002|Overall Study|Physician Decision|2|||
127684385|NCT01599104|459469824|FG000|Overall Study|Non-compliance with study treatment|0|||
127684386|NCT01599104|459469825|FG001|Overall Study|Non-compliance with study treatment|1|||
127684387|NCT01599104|459469826|FG002|Overall Study|Non-compliance with study treatment|0|||
127684388|NCT01599104|459469824|FG000|Overall Study|Lack of Efficacy|4|||
127684389|NCT01599104|459469825|FG001|Overall Study|Lack of Efficacy|4|||
127684390|NCT01599104|459469826|FG002|Overall Study|Lack of Efficacy|10|||
127684391|NCT01599104|459469824|FG000|Overall Study|Adverse Event|7|||
127684392|NCT01599104|459469825|FG001|Overall Study|Adverse Event|6|||
127684393|NCT01599104|459469826|FG002|Overall Study|Adverse Event|12|||
127684394|NCT00714714|459469827|FG000|Overall Study|Adverse Event|1|||
127684395|NCT01308567|459469838|FG000|Overall Study|Lost to Follow-up|2|||
127684396|NCT01308567|459469839|FG001|Overall Study|Lost to Follow-up|4|||
127684397|NCT01308567|459469840|FG002|Overall Study|Lost to Follow-up|4|||
127684398|NCT00542789|459469841|FG000|Overall Study|Adverse Event|18|||
127684399|NCT00542789|459469842|FG001|Overall Study|Adverse Event|17|||
127684400|NCT00542789|459469841|FG000|Overall Study|Withdrawal by Subject|7|||
127684401|NCT00542789|459469842|FG001|Overall Study|Withdrawal by Subject|3|||
127684402|NCT00542789|459469841|FG000|Overall Study|Protocol Violation|8|||
127684403|NCT00542789|459469842|FG001|Overall Study|Protocol Violation|1|||
127684404|NCT00542789|459469841|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
127684405|NCT00542789|459469842|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
127684406|NCT03454529|459469852|FG000|Overall Study|Did not receive treatment|6|||
127684407|NCT03454529|459469852|FG000|Overall Study|Received < 80% doses|1|||
127684408|NCT01582100|459469856|FG000|Overall Study|Adverse Event|1|||
127684409|NCT01582100|459469856|FG000|Overall Study|Withdrawal by Subject|1|||
127684410|NCT01040689|459469861|FG000|Overall Study|Adverse Event|0|||
127684411|NCT01040689|459469862|FG001|Overall Study|Adverse Event|0|||
127684412|NCT01040689|459469863|FG002|Overall Study|Adverse Event|2|||
127684413|NCT01040689|459469864|FG003|Overall Study|Adverse Event|4|||
127684414|NCT01040689|459469861|FG000|Overall Study|Lack of Efficacy|0|||
127684415|NCT01040689|459469862|FG001|Overall Study|Lack of Efficacy|0|||
127684416|NCT01040689|459469863|FG002|Overall Study|Lack of Efficacy|1|||
127684417|NCT01040689|459469864|FG003|Overall Study|Lack of Efficacy|0|||
127684418|NCT01040689|459469861|FG000|Overall Study|Lost to Follow-up|1|||
127684419|NCT01040689|459469862|FG001|Overall Study|Lost to Follow-up|0|||
127684420|NCT01040689|459469863|FG002|Overall Study|Lost to Follow-up|0|||
127684421|NCT01040689|459469864|FG003|Overall Study|Lost to Follow-up|0|||
127684422|NCT01040689|459469861|FG000|Overall Study|Withdrawal by Subject|2|||
127684423|NCT01040689|459469862|FG001|Overall Study|Withdrawal by Subject|1|||
127684424|NCT01040689|459469863|FG002|Overall Study|Withdrawal by Subject|1|||
127684425|NCT01040689|459469864|FG003|Overall Study|Withdrawal by Subject|0|||
127684426|NCT01040689|459469861|FG000|Overall Study|Other reasons not listed above|0|||
127684427|NCT01040689|459469862|FG001|Overall Study|Other reasons not listed above|1|||
127684428|NCT01040689|459469863|FG002|Overall Study|Other reasons not listed above|0|||
127684429|NCT01040689|459469864|FG003|Overall Study|Other reasons not listed above|0|||
127684430|NCT01185561|459469865|FG000|Overall Study|Lost to Follow-up|0|||
127684431|NCT01185561|459469866|FG001|Overall Study|Lost to Follow-up|4|||
127684432|NCT01185561|459469865|FG000|Overall Study|Withdrawal by Subject|2|||
127684433|NCT01185561|459469866|FG001|Overall Study|Withdrawal by Subject|8|||
127684434|NCT01078116|459469867|FG000|Overall Study|Lost to Follow-up|17|||
127684435|NCT01078116|459469867|FG000|Overall Study|Adverse Event|5|||
127684436|NCT01078116|459469867|FG000|Overall Study|Withdrawal by Subject|8|||
127684437|NCT01078116|459469867|FG000|Overall Study|Lack of effectiveness|15|||
127684438|NCT01078116|459469867|FG000|Overall Study|Case report form not completed|3|||
127684439|NCT02616900|459469868|FG000|Overall Study|Lack of Efficacy|7|||
127684440|NCT02616900|459469868|FG000|Overall Study|Lost to Follow-up|2|||
127684441|NCT02616900|459469868|FG000|Overall Study|Protocol Violation|5|||
127684442|NCT02616900|459469868|FG000|Overall Study|Withdrawal by Subject|3|||
127684443|NCT02616900|459469868|FG000|Overall Study|Incomplete data|6|||
127684444|NCT02499159|459469869|FG000|Randomization|Protocol Violation|1|||
127684445|NCT02499159|459469870|FG001|Randomization|Protocol Violation|1|||
127684446|NCT02499159|459469869|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
127684447|NCT02499159|459469870|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
127684448|NCT02499159|459469869|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
127684449|NCT02499159|459469870|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
127684450|NCT02499159|459469869|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
127684451|NCT02499159|459469870|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
127684452|NCT02499159|459469869|FG000|30-Day Follow-Up Phone Call|Other|1|||
127684453|NCT02499159|459469870|FG001|30-Day Follow-Up Phone Call|Other|0|||
127684454|NCT02564744|459469871|FG000|Overall Study|Investigator decision|0|||
127684455|NCT02564744|459469872|FG001|Overall Study|Investigator decision|0|||
127684456|NCT02564744|459469873|FG002|Overall Study|Investigator decision|0|||
127684457|NCT02564744|459469874|FG003|Overall Study|Investigator decision|0|||
127684458|NCT02564744|459469875|FG004|Overall Study|Investigator decision|1|||
127684459|NCT02564744|459469871|FG000|Overall Study|Death|10|||
127684460|NCT02564744|459469872|FG001|Overall Study|Death|5|||
127684461|NCT02564744|459469873|FG002|Overall Study|Death|4|||
127684462|NCT02564744|459469874|FG003|Overall Study|Death|16|||
127684463|NCT02564744|459469875|FG004|Overall Study|Death|16|||
127684464|NCT02564744|459469871|FG000|Overall Study|End of study Page Missing|0|||
127684465|NCT02564744|459469872|FG001|Overall Study|End of study Page Missing|0|||
127684466|NCT02564744|459469873|FG002|Overall Study|End of study Page Missing|3|||
127684467|NCT02564744|459469874|FG003|Overall Study|End of study Page Missing|3|||
127684468|NCT02564744|459469875|FG004|Overall Study|End of study Page Missing|0|||
127684469|NCT02564744|459469871|FG000|Overall Study|Subject Withdrew Consent|1|||
127684470|NCT02564744|459469872|FG001|Overall Study|Subject Withdrew Consent|1|||
127684471|NCT02564744|459469873|FG002|Overall Study|Subject Withdrew Consent|1|||
127684472|NCT02564744|459469874|FG003|Overall Study|Subject Withdrew Consent|0|||
127684473|NCT02564744|459469875|FG004|Overall Study|Subject Withdrew Consent|2|||
127684474|NCT02564744|459469871|FG000|Overall Study|Lost to Follow-up|0|||
127684475|NCT02564744|459469872|FG001|Overall Study|Lost to Follow-up|1|||
127684476|NCT02564744|459469873|FG002|Overall Study|Lost to Follow-up|0|||
127684477|NCT02564744|459469874|FG003|Overall Study|Lost to Follow-up|0|||
127684478|NCT02564744|459469875|FG004|Overall Study|Lost to Follow-up|1|||
127684479|NCT02564744|459469871|FG000|Overall Study|Reason not specified|1|||
127684480|NCT02564744|459469872|FG001|Overall Study|Reason not specified|0|||
127684481|NCT02564744|459469873|FG002|Overall Study|Reason not specified|0|||
127684482|NCT02564744|459469874|FG003|Overall Study|Reason not specified|0|||
127684483|NCT02564744|459469875|FG004|Overall Study|Reason not specified|0|||
127684484|NCT01190007|459469876|FG000|Overall Study|Withdrawal by Subject|4|||
127684485|NCT01190007|459469876|FG000|Overall Study|Adverse Event|8|||
127684486|NCT01190007|459469876|FG000|Overall Study|Difficulty of visit for complications|1|||
127684487|NCT01190007|459469876|FG000|Overall Study|Participant was arrested|1|||
127684488|NCT02594735|459469879|FG000|Overall Study|Adverse Event|1|||
127684489|NCT01075217|459469886|FG000|Overall Study|Adverse Event|1|||
127684490|NCT01075217|459469887|FG001|Overall Study|Adverse Event|1|||
127684491|NCT01075217|459469886|FG000|Overall Study|Physician Decision|1|||
127684492|NCT01075217|459469887|FG001|Overall Study|Physician Decision|0|||
127684493|NCT02969863|459469888|FG000|Overall Study|Physician Decision|1|||
127684494|NCT02969863|459469889|FG001|Overall Study|Physician Decision|0|||
127684495|NCT02969863|459469890|FG002|Overall Study|Physician Decision|0|||
127684496|NCT02969863|459469891|FG003|Overall Study|Physician Decision|0|||
127549246|NCT02158546|458978559|FG001|Overall Study|Physician Decision|1|||
127549247|NCT02158546|458978560|FG002|Overall Study|Physician Decision|0|||
127549248|NCT02158546|458978561|FG003|Overall Study|Physician Decision|0|||
127549249|NCT02158546|458978558|FG000|Overall Study|Non-compliance|0|||
127549250|NCT02158546|458978559|FG001|Overall Study|Non-compliance|1|||
127549251|NCT02158546|458978560|FG002|Overall Study|Non-compliance|0|||
127549252|NCT02158546|458978561|FG003|Overall Study|Non-compliance|1|||
127549253|NCT02158546|458978558|FG000|Overall Study|Failure to meet eligibility criteria|0|||
127549254|NCT02158546|458978559|FG001|Overall Study|Failure to meet eligibility criteria|1|||
127549255|NCT02158546|458978560|FG002|Overall Study|Failure to meet eligibility criteria|0|||
127549256|NCT02158546|458978561|FG003|Overall Study|Failure to meet eligibility criteria|0|||
127549257|NCT02158546|458978558|FG000|Overall Study|Lack of Efficacy|1|||
127549258|NCT02158546|458978559|FG001|Overall Study|Lack of Efficacy|1|||
127549259|NCT02158546|458978560|FG002|Overall Study|Lack of Efficacy|0|||
127549260|NCT02158546|458978561|FG003|Overall Study|Lack of Efficacy|0|||
127549261|NCT02158546|458978558|FG000|Overall Study|Adverse Event|2|||
127549262|NCT02158546|458978559|FG001|Overall Study|Adverse Event|2|||
127549263|NCT02158546|458978560|FG002|Overall Study|Adverse Event|0|||
127549264|NCT02158546|458978561|FG003|Overall Study|Adverse Event|0|||
127549265|NCT02158546|458978558|FG000|Overall Study|Withdrawal by Subject|6|||
127549266|NCT02158546|458978559|FG001|Overall Study|Withdrawal by Subject|2|||
127549267|NCT02158546|458978560|FG002|Overall Study|Withdrawal by Subject|1|||
127549268|NCT02158546|458978561|FG003|Overall Study|Withdrawal by Subject|0|||
127549269|NCT02158546|458978558|FG000|Overall Study|Lost to Follow-up|5|||
127549270|NCT02158546|458978559|FG001|Overall Study|Lost to Follow-up|4|||
127549271|NCT02158546|458978560|FG002|Overall Study|Lost to Follow-up|0|||
127549272|NCT02158546|458978561|FG003|Overall Study|Lost to Follow-up|1|||
127549273|NCT02158546|458978558|FG000|Overall Study|Site Excluded|5|||
127549274|NCT02158546|458978559|FG001|Overall Study|Site Excluded|5|||
127549275|NCT02158546|458978560|FG002|Overall Study|Site Excluded|3|||
127549276|NCT02158546|458978561|FG003|Overall Study|Site Excluded|4|||
127549277|NCT02351817|458978562|FG000|Period 1|Adverse Event|1|||
127549278|NCT02351817|458978563|FG001|Period 1|Adverse Event|2|||
127549279|NCT02351817|458978562|FG000|Period 1|Lack of Efficacy|0|||
127549280|NCT02351817|458978563|FG001|Period 1|Lack of Efficacy|1|||
127549281|NCT02351817|458978562|FG000|Period 2|Adverse Event|0|||
127549282|NCT02351817|458978563|FG001|Period 2|Adverse Event|2|||
127549283|NCT02351817|458978562|FG000|Period 2|Protocol Violation|1|||
127549284|NCT02351817|458978563|FG001|Period 2|Protocol Violation|0|||
127549285|NCT02488915|458978566|FG000|Overall Study|Death|21|||
127549286|NCT02488915|458978566|FG000|Overall Study|Lost to Follow-up|4|||
127549287|NCT02488915|458978566|FG000|Overall Study|Withdrawal by Subject|1|||
127549288|NCT02976038|458978567|FG000|Overall Study|Physician Decision|22|||
127549289|NCT02976038|458978567|FG000|Overall Study|Withdrawal by Subject|3|||
127549290|NCT02976038|458978567|FG000|Overall Study|Lost to Follow-up|2|||
127549291|NCT02976038|458978567|FG000|Overall Study|Adverse Event|1|||
127549292|NCT01046396|458978568|FG000|Overall Study|Withdrawal by Subject|5|||
127549293|NCT01208207|458978569|FG000|Part I|Adverse Event|19|||
127549294|NCT01208207|458978570|FG001|Part I|Adverse Event|2|||
127549295|NCT01208207|458978571|FG002|Part I|Adverse Event|6|||
127549296|NCT01208207|458978572|FG003|Part I|Adverse Event|0|||
127549297|NCT01208207|458978573|FG004|Part I|Adverse Event|0|||
127549298|NCT01208207|458978574|FG005|Part I|Adverse Event|0|||
127771110|NCT01007448|459787044|FG000|Overall Study|Adverse Event|1|||
127771111|NCT01007448|459787045|FG001|Overall Study|Adverse Event|4|||
127771112|NCT02121834|459787047|FG000|Overall Study|Protocol Violation|0|||
127771113|NCT02121834|459787048|FG001|Overall Study|Protocol Violation|1|||
127771114|NCT02121834|459787049|FG002|Overall Study|Protocol Violation|0|||
128016623|NCT00217737|460683294|FG003|Step 1 Registration (Risk Assessment)|Non-compliance|2|||
128016624|NCT00217737|460683291|FG000|Step 1 Registration (Risk Assessment)|Death|0|||
127549299|NCT01208207|458978575|FG006|Part I|Adverse Event|0|||
127549300|NCT01208207|458978569|FG000|Part I|Lack of Efficacy|21|||
127549301|NCT01208207|458978570|FG001|Part I|Lack of Efficacy|3|||
127549302|NCT01208207|458978571|FG002|Part I|Lack of Efficacy|2|||
127549303|NCT01208207|458978572|FG003|Part I|Lack of Efficacy|0|||
127549304|NCT01208207|458978573|FG004|Part I|Lack of Efficacy|0|||
127549305|NCT01208207|458978574|FG005|Part I|Lack of Efficacy|0|||
127549306|NCT01208207|458978575|FG006|Part I|Lack of Efficacy|0|||
127549307|NCT01208207|458978569|FG000|Part I|Lost to Follow-up|6|||
127549308|NCT01208207|458978570|FG001|Part I|Lost to Follow-up|1|||
127771115|NCT02121834|459787050|FG003|Overall Study|Protocol Violation|0|||
127771116|NCT02121834|459787051|FG004|Overall Study|Protocol Violation|0|||
127771117|NCT02121834|459787052|FG005|Overall Study|Protocol Violation|0|||
127549309|NCT01208207|458978571|FG002|Part I|Lost to Follow-up|0|||
127549310|NCT01208207|458978572|FG003|Part I|Lost to Follow-up|0|||
127549311|NCT01208207|458978573|FG004|Part I|Lost to Follow-up|0|||
127549312|NCT01208207|458978574|FG005|Part I|Lost to Follow-up|0|||
127549313|NCT01208207|458978575|FG006|Part I|Lost to Follow-up|0|||
127549314|NCT01208207|458978569|FG000|Part I|Non-Compliance With Study Drug|1|||
127549315|NCT01208207|458978570|FG001|Part I|Non-Compliance With Study Drug|0|||
127771118|NCT02121834|459787053|FG006|Overall Study|Protocol Violation|0|||
127549316|NCT01208207|458978571|FG002|Part I|Non-Compliance With Study Drug|1|||
127549317|NCT01208207|458978572|FG003|Part I|Non-Compliance With Study Drug|0|||
127549318|NCT01208207|458978573|FG004|Part I|Non-Compliance With Study Drug|0|||
127549319|NCT01208207|458978574|FG005|Part I|Non-Compliance With Study Drug|0|||
127549320|NCT01208207|458978575|FG006|Part I|Non-Compliance With Study Drug|0|||
127549321|NCT01208207|458978569|FG000|Part I|Physician Decision|0|||
127549322|NCT01208207|458978570|FG001|Part I|Physician Decision|1|||
127549323|NCT01208207|458978571|FG002|Part I|Physician Decision|0|||
127549324|NCT01208207|458978572|FG003|Part I|Physician Decision|0|||
127549325|NCT01208207|458978573|FG004|Part I|Physician Decision|0|||
127549326|NCT01208207|458978574|FG005|Part I|Physician Decision|0|||
127549327|NCT01208207|458978575|FG006|Part I|Physician Decision|0|||
127549328|NCT01208207|458978569|FG000|Part I|Progressive Disease|1|||
127549329|NCT01208207|458978570|FG001|Part I|Progressive Disease|0|||
127549330|NCT01208207|458978571|FG002|Part I|Progressive Disease|0|||
127549331|NCT01208207|458978572|FG003|Part I|Progressive Disease|0|||
127549332|NCT01208207|458978573|FG004|Part I|Progressive Disease|0|||
127549333|NCT01208207|458978574|FG005|Part I|Progressive Disease|0|||
127549334|NCT01208207|458978575|FG006|Part I|Progressive Disease|0|||
127549335|NCT01208207|458978569|FG000|Part I|Protocol Violation|8|||
127549336|NCT01208207|458978570|FG001|Part I|Protocol Violation|0|||
127549337|NCT01208207|458978571|FG002|Part I|Protocol Violation|2|||
127549338|NCT01208207|458978572|FG003|Part I|Protocol Violation|0|||
127549339|NCT01208207|458978573|FG004|Part I|Protocol Violation|0|||
127549340|NCT01208207|458978574|FG005|Part I|Protocol Violation|0|||
127549341|NCT01208207|458978575|FG006|Part I|Protocol Violation|0|||
127549342|NCT01208207|458978569|FG000|Part I|Withdrawal by Subject|14|||
127549343|NCT01208207|458978570|FG001|Part I|Withdrawal by Subject|4|||
127549344|NCT01208207|458978571|FG002|Part I|Withdrawal by Subject|4|||
127549345|NCT01208207|458978572|FG003|Part I|Withdrawal by Subject|0|||
127549346|NCT01208207|458978573|FG004|Part I|Withdrawal by Subject|0|||
127549347|NCT01208207|458978574|FG005|Part I|Withdrawal by Subject|0|||
127549348|NCT01208207|458978575|FG006|Part I|Withdrawal by Subject|0|||
127684497|NCT02969863|459469892|FG004|Overall Study|Physician Decision|0|||
127684498|NCT02969863|459469893|FG005|Overall Study|Physician Decision|0|||
127684499|NCT03737240|459469894|FG000|Overall Study|Lost to Follow-up|16|||
127684500|NCT03737240|459469895|FG001|Overall Study|Lost to Follow-up|15|||
127684501|NCT00364013|459469896|FG000|Overall Study|Ineligibility determined|4|||
127684502|NCT00364013|459469897|FG001|Overall Study|Ineligibility determined|2|||
127684503|NCT00364013|459469896|FG000|Overall Study|Adverse Event|4|||
127684504|NCT00364013|459469897|FG001|Overall Study|Adverse Event|3|||
127684505|NCT00364013|459469896|FG000|Overall Study|Withdrawal by Subject|13|||
127684506|NCT00364013|459469897|FG001|Overall Study|Withdrawal by Subject|18|||
127684507|NCT00364013|459469896|FG000|Overall Study|Physician Decision|3|||
127684508|NCT00364013|459469897|FG001|Overall Study|Physician Decision|3|||
127684509|NCT00364013|459469896|FG000|Overall Study|Lost to Follow-up|10|||
127684510|NCT00364013|459469897|FG001|Overall Study|Lost to Follow-up|3|||
127684511|NCT00364013|459469896|FG000|Overall Study|Protocol-specified criteria|6|||
127684512|NCT00364013|459469897|FG001|Overall Study|Protocol-specified criteria|6|||
127684513|NCT00364013|459469896|FG000|Overall Study|Other|41|||
127684514|NCT00364013|459469897|FG001|Overall Study|Other|47|||
127684515|NCT00364013|459469896|FG000|Overall Study|Ongoing|20|||
127684516|NCT00364013|459469897|FG001|Overall Study|Ongoing|13|||
127684517|NCT00585533|459469898|FG000|Overall Study|objective or symptomatic progression|9|||
127684518|NCT01254188|459469899|FG000|Overall Study|Disease Progression|6|||
127684519|NCT01254188|459469899|FG000|Overall Study|Protocol Violation|6|||
127684520|NCT01254188|459469899|FG000|Overall Study|Pregnancy|2|||
127684521|NCT01254188|459469899|FG000|Overall Study|Death|4|||
127684522|NCT01254188|459469899|FG000|Overall Study|Lost to Follow-up|5|||
127684523|NCT01254188|459469899|FG000|Overall Study|Withdrawal by Subject|7|||
127684524|NCT01254188|459469899|FG000|Overall Study|Adverse Event|43|||
127684525|NCT01254188|459469899|FG000|Overall Study|per investigator discretion|20|||
127684526|NCT01369498|459469900|FG000|Overall Study|Lack of Efficacy|9|||
127684527|NCT01369498|459469901|FG001|Overall Study|Lack of Efficacy|9|||
127684528|NCT01369498|459469902|FG002|Overall Study|Lack of Efficacy|1|||
127549349|NCT01208207|458978569|FG000|Part II|Withdrawal by Subject|0|||
127549350|NCT01208207|458978570|FG001|Part II|Withdrawal by Subject|0|||
127549351|NCT01208207|458978571|FG002|Part II|Withdrawal by Subject|0|||
127549352|NCT01208207|458978572|FG003|Part II|Withdrawal by Subject|10|||
127684529|NCT01369498|459469903|FG003|Overall Study|Lack of Efficacy|3|||
127549353|NCT01208207|458978573|FG004|Part II|Withdrawal by Subject|9|||
127549354|NCT01208207|458978574|FG005|Part II|Withdrawal by Subject|3|||
127549355|NCT01208207|458978575|FG006|Part II|Withdrawal by Subject|5|||
127549356|NCT01208207|458978569|FG000|Part II|Adverse Event|0|||
127549357|NCT01208207|458978570|FG001|Part II|Adverse Event|0|||
127549358|NCT01208207|458978571|FG002|Part II|Adverse Event|0|||
127549359|NCT01208207|458978572|FG003|Part II|Adverse Event|5|||
127549360|NCT01208207|458978573|FG004|Part II|Adverse Event|9|||
127684530|NCT01369498|459469900|FG000|Overall Study|Adverse Event|1|||
127684531|NCT01369498|459469901|FG001|Overall Study|Adverse Event|2|||
127684532|NCT01369498|459469902|FG002|Overall Study|Adverse Event|0|||
127684533|NCT01369498|459469903|FG003|Overall Study|Adverse Event|1|||
127771119|NCT02121834|459787047|FG000|Overall Study|Withdrawal by Subject|0|||
127771120|NCT02121834|459787048|FG001|Overall Study|Withdrawal by Subject|1|||
127771121|NCT02121834|459787049|FG002|Overall Study|Withdrawal by Subject|1|||
127771122|NCT02121834|459787050|FG003|Overall Study|Withdrawal by Subject|0|||
127771123|NCT02121834|459787051|FG004|Overall Study|Withdrawal by Subject|0|||
127771124|NCT02121834|459787052|FG005|Overall Study|Withdrawal by Subject|0|||
127771125|NCT02121834|459787053|FG006|Overall Study|Withdrawal by Subject|0|||
127771126|NCT02121834|459787047|FG000|Overall Study|Lost to Follow-up|0|||
127771127|NCT02121834|459787048|FG001|Overall Study|Lost to Follow-up|0|||
127771128|NCT02121834|459787049|FG002|Overall Study|Lost to Follow-up|1|||
127771129|NCT02121834|459787050|FG003|Overall Study|Lost to Follow-up|0|||
127771130|NCT02121834|459787051|FG004|Overall Study|Lost to Follow-up|0|||
127771131|NCT02121834|459787052|FG005|Overall Study|Lost to Follow-up|0|||
127771132|NCT02121834|459787053|FG006|Overall Study|Lost to Follow-up|0|||
127771133|NCT03353350|459787054|FG000|30-week Core Treatment Period|Protocol Violation|1|||
127771134|NCT03353350|459787055|FG001|30-week Core Treatment Period|Protocol Violation|1|||
127771135|NCT03353350|459787056|FG002|30-week Core Treatment Period|Protocol Violation|1|||
127771136|NCT03353350|459787057|FG003|30-week Core Treatment Period|Protocol Violation|0|||
127771137|NCT03353350|459787054|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
128016625|NCT00217737|460683292|FG001|Step 1 Registration (Risk Assessment)|Death|0|||
128016626|NCT00217737|460683293|FG002|Step 1 Registration (Risk Assessment)|Death|0|||
128016627|NCT00217737|460683294|FG003|Step 1 Registration (Risk Assessment)|Death|1|||
128016628|NCT00217737|460683291|FG000|Step 1 Registration (Risk Assessment)|Disease progression|0|||
128016629|NCT00217737|460683292|FG001|Step 1 Registration (Risk Assessment)|Disease progression|0|||
128016630|NCT00217737|460683293|FG002|Step 1 Registration (Risk Assessment)|Disease progression|0|||
128016631|NCT00217737|460683294|FG003|Step 1 Registration (Risk Assessment)|Disease progression|1|||
128016632|NCT00217737|460683291|FG000|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
128016633|NCT00217737|460683292|FG001|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
128016634|NCT00217737|460683293|FG002|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
128016635|NCT00217737|460683294|FG003|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|1|||
128016636|NCT00217737|460683291|FG000|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
128016637|NCT00217737|460683292|FG001|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
128016638|NCT00217737|460683293|FG002|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
128016639|NCT00217737|460683294|FG003|Step 1 Registration (Risk Assessment)|Lost to Follow-up|1|||
128016640|NCT00217737|460683291|FG000|Step 1 Registration (Risk Assessment)|Other|0|||
128016641|NCT00217737|460683292|FG001|Step 1 Registration (Risk Assessment)|Other|0|||
128016642|NCT00217737|460683293|FG002|Step 1 Registration (Risk Assessment)|Other|0|||
128016643|NCT00217737|460683294|FG003|Step 1 Registration (Risk Assessment)|Other|12|||
128016644|NCT00217737|460683291|FG000|Step 1 Registration (Risk Assessment)|Registration error|0|||
128016645|NCT00217737|460683292|FG001|Step 1 Registration (Risk Assessment)|Registration error|0|||
128016646|NCT00217737|460683293|FG002|Step 1 Registration (Risk Assessment)|Registration error|0|||
128016647|NCT00217737|460683294|FG003|Step 1 Registration (Risk Assessment)|Registration error|1|||
128016648|NCT00217737|460683291|FG000|Step 2 Randomization/Registration|Adverse Event|59|||
128016649|NCT00217737|460683292|FG001|Step 2 Randomization/Registration|Adverse Event|98|||
128016650|NCT00217737|460683293|FG002|Step 2 Randomization/Registration|Adverse Event|0|||
128016651|NCT00217737|460683294|FG003|Step 2 Randomization/Registration|Adverse Event|0|||
128016652|NCT00217737|460683291|FG000|Step 2 Randomization/Registration|Withdrawal by Subject|53|||
128016653|NCT00217737|460683292|FG001|Step 2 Randomization/Registration|Withdrawal by Subject|105|||
128016654|NCT00217737|460683293|FG002|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
128016655|NCT00217737|460683294|FG003|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
128016656|NCT00217737|460683291|FG000|Step 2 Randomization/Registration|Study suspension|0|||
128016657|NCT00217737|460683292|FG001|Step 2 Randomization/Registration|Study suspension|45|||
128016658|NCT00217737|460683293|FG002|Step 2 Randomization/Registration|Study suspension|0|||
128016659|NCT00217737|460683294|FG003|Step 2 Randomization/Registration|Study suspension|0|||
128016660|NCT00217737|460683291|FG000|Step 2 Randomization/Registration|Complicating disease|5|||
128016661|NCT00217737|460683292|FG001|Step 2 Randomization/Registration|Complicating disease|5|||
128016662|NCT00217737|460683293|FG002|Step 2 Randomization/Registration|Complicating disease|0|||
128016663|NCT00217737|460683294|FG003|Step 2 Randomization/Registration|Complicating disease|0|||
128016664|NCT00217737|460683291|FG000|Step 2 Randomization/Registration|Death|2|||
128016665|NCT00217737|460683292|FG001|Step 2 Randomization/Registration|Death|3|||
127549361|NCT01208207|458978574|FG005|Part II|Adverse Event|4|||
127549362|NCT01208207|458978575|FG006|Part II|Adverse Event|2|||
127549363|NCT01208207|458978569|FG000|Part II|Lack of Efficacy|0|||
127549364|NCT01208207|458978570|FG001|Part II|Lack of Efficacy|0|||
127549365|NCT01208207|458978571|FG002|Part II|Lack of Efficacy|0|||
127771138|NCT03353350|459787055|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
127771139|NCT03353350|459787056|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
127771140|NCT03353350|459787057|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
127549366|NCT01208207|458978572|FG003|Part II|Lack of Efficacy|6|||
127549367|NCT01208207|458978573|FG004|Part II|Lack of Efficacy|4|||
127549368|NCT01208207|458978574|FG005|Part II|Lack of Efficacy|3|||
127549369|NCT01208207|458978575|FG006|Part II|Lack of Efficacy|3|||
127549370|NCT01208207|458978569|FG000|Part II|Lost to Follow-up|0|||
127549371|NCT01208207|458978570|FG001|Part II|Lost to Follow-up|0|||
127549372|NCT01208207|458978571|FG002|Part II|Lost to Follow-up|0|||
127549373|NCT01208207|458978572|FG003|Part II|Lost to Follow-up|4|||
127549374|NCT01208207|458978573|FG004|Part II|Lost to Follow-up|0|||
127549375|NCT01208207|458978574|FG005|Part II|Lost to Follow-up|2|||
127549376|NCT01208207|458978575|FG006|Part II|Lost to Follow-up|1|||
127549377|NCT01208207|458978569|FG000|Part II|Non-Compliance With Study Drug|0|||
127549378|NCT01208207|458978570|FG001|Part II|Non-Compliance With Study Drug|0|||
127549379|NCT01208207|458978571|FG002|Part II|Non-Compliance With Study Drug|0|||
127549380|NCT01208207|458978572|FG003|Part II|Non-Compliance With Study Drug|4|||
127549381|NCT01208207|458978573|FG004|Part II|Non-Compliance With Study Drug|1|||
127549382|NCT01208207|458978574|FG005|Part II|Non-Compliance With Study Drug|1|||
127549383|NCT01208207|458978575|FG006|Part II|Non-Compliance With Study Drug|0|||
127549384|NCT01208207|458978569|FG000|Part II|Physician Decision|0|||
127549385|NCT01208207|458978570|FG001|Part II|Physician Decision|0|||
127549386|NCT01208207|458978571|FG002|Part II|Physician Decision|0|||
127549387|NCT01208207|458978572|FG003|Part II|Physician Decision|1|||
127549388|NCT01208207|458978573|FG004|Part II|Physician Decision|0|||
127549389|NCT01208207|458978574|FG005|Part II|Physician Decision|2|||
127549390|NCT01208207|458978575|FG006|Part II|Physician Decision|0|||
127549391|NCT01208207|458978569|FG000|Part II|Protocol Violation|0|||
127549392|NCT01208207|458978570|FG001|Part II|Protocol Violation|0|||
127549393|NCT01208207|458978571|FG002|Part II|Protocol Violation|0|||
127549394|NCT01208207|458978572|FG003|Part II|Protocol Violation|1|||
127549395|NCT01208207|458978573|FG004|Part II|Protocol Violation|0|||
127549396|NCT01208207|458978574|FG005|Part II|Protocol Violation|0|||
127549397|NCT01208207|458978575|FG006|Part II|Protocol Violation|0|||
127549398|NCT01208207|458978569|FG000|Part II|Technical Problems|0|||
127549399|NCT01208207|458978570|FG001|Part II|Technical Problems|0|||
127549400|NCT01208207|458978571|FG002|Part II|Technical Problems|0|||
127549401|NCT01208207|458978572|FG003|Part II|Technical Problems|1|||
127684534|NCT01369498|459469900|FG000|Overall Study|Withdrawal of Consent|0|||
127684535|NCT01369498|459469901|FG001|Overall Study|Withdrawal of Consent|1|||
127684536|NCT01369498|459469902|FG002|Overall Study|Withdrawal of Consent|1|||
127684537|NCT01369498|459469903|FG003|Overall Study|Withdrawal of Consent|1|||
127684538|NCT01369498|459469900|FG000|Overall Study|Death|0|||
127684539|NCT01369498|459469901|FG001|Overall Study|Death|0|||
127684540|NCT01369498|459469902|FG002|Overall Study|Death|1|||
127684541|NCT01369498|459469903|FG003|Overall Study|Death|0|||
127684542|NCT01369498|459469900|FG000|Overall Study|Investigator's Discretion|1|||
127684543|NCT01369498|459469901|FG001|Overall Study|Investigator's Discretion|0|||
127684544|NCT01369498|459469902|FG002|Overall Study|Investigator's Discretion|1|||
127684545|NCT01369498|459469903|FG003|Overall Study|Investigator's Discretion|3|||
127684546|NCT01369498|459469900|FG000|Overall Study|Unknown Reason|1|||
127684547|NCT01369498|459469901|FG001|Overall Study|Unknown Reason|0|||
127684548|NCT01369498|459469902|FG002|Overall Study|Unknown Reason|11|||
127684549|NCT01369498|459469903|FG003|Overall Study|Unknown Reason|6|||
127684550|NCT01369498|459469900|FG000|Overall Study|Disease Progression|0|||
127684551|NCT01369498|459469901|FG001|Overall Study|Disease Progression|0|||
127684552|NCT01369498|459469902|FG002|Overall Study|Disease Progression|0|||
127684553|NCT01369498|459469903|FG003|Overall Study|Disease Progression|1|||
127684554|NCT01124734|459469907|FG000|Overall Study|Disease progression|13|||
127684555|NCT01124734|459469907|FG000|Overall Study|Adverse Event|1|||
127684556|NCT01124734|459469907|FG000|Overall Study|Withdrawal by Subject|1|||
127684557|NCT01124734|459469907|FG000|Overall Study|Elected for alternative treatment|2|||
127684558|NCT03482011|459469908|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
127684559|NCT03482011|459469909|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
127684560|NCT03482011|459469910|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
127684561|NCT03482011|459469911|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
127684562|NCT03482011|459469912|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
127684563|NCT03482011|459469913|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
127684564|NCT03482011|459469914|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
127684565|NCT03482011|459469915|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
127549402|NCT01208207|458978573|FG004|Part II|Technical Problems|0|||
127549403|NCT01208207|458978574|FG005|Part II|Technical Problems|1|||
127549404|NCT01208207|458978575|FG006|Part II|Technical Problems|0|||
127549405|NCT00724698|458978576|FG000|Overall Study|Adverse Event|9|||
127549406|NCT00724698|458978576|FG000|Overall Study|Failure of Therapy|4|||
127549407|NCT00724698|458978576|FG000|Overall Study|Poor Compliance|16|||
127684566|NCT03482011|459469908|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
127684567|NCT03482011|459469909|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
127684568|NCT03482011|459469910|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
127549408|NCT00724698|458978576|FG000|Overall Study|Lost to Follow-up|36|||
127549409|NCT00724698|458978576|FG000|Overall Study|No Info|25|||
127684569|NCT03482011|459469911|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
127880931|NCT01215955|460186073|FG002|Overall Study|Physician Decision|8|||
127549410|NCT00665652|458978577|FG000|Overall Study|Adverse Event|4|||
127549411|NCT00665652|458978577|FG000|Overall Study|Death|1|||
127549412|NCT00665652|458978577|FG000|Overall Study|No longer met inclusion criteria.|1|||
127549413|NCT02556177|458978580|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
127549414|NCT02556177|458978581|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
127549415|NCT02900378|458978587|FG000|Randomization (Visit 2)|Adverse Event|14|||
127549416|NCT02900378|458978588|FG001|Randomization (Visit 2)|Adverse Event|11|||
127549417|NCT02900378|458978587|FG000|Randomization (Visit 2)|Death|1|||
127549418|NCT02900378|458978588|FG001|Randomization (Visit 2)|Death|4|||
127549419|NCT02900378|458978587|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
127549420|NCT02900378|458978588|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
127549421|NCT02900378|458978587|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
127549422|NCT02900378|458978588|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
127549423|NCT02900378|458978587|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
127549424|NCT02900378|458978588|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
127549425|NCT02900378|458978587|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
127549426|NCT02900378|458978588|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
127549427|NCT02900378|458978587|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
127549428|NCT02900378|458978588|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
127549429|NCT01249261|458978602|FG000|Overall Study|Withdrawal by Subject|1|||
127549430|NCT01249261|458978603|FG001|Overall Study|Withdrawal by Subject|0|||
127549431|NCT00482053|458978607|FG000|Inter-treatment Period|Disease progression|1|||
127549432|NCT01967940|458978609|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
127549433|NCT01967940|458978610|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
127771141|NCT03353350|459787054|FG000|30-week Core Treatment Period|Adverse Event|0|||
127771142|NCT03353350|459787055|FG001|30-week Core Treatment Period|Adverse Event|4|||
128016666|NCT00217737|460683293|FG002|Step 2 Randomization/Registration|Death|0|||
128016667|NCT00217737|460683294|FG003|Step 2 Randomization/Registration|Death|0|||
127549434|NCT01967940|458978611|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
127771143|NCT03353350|459787056|FG002|30-week Core Treatment Period|Adverse Event|2|||
127771144|NCT03353350|459787057|FG003|30-week Core Treatment Period|Adverse Event|3|||
127771145|NCT03353350|459787054|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
127771146|NCT03353350|459787055|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
127771147|NCT03353350|459787056|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
127771148|NCT03353350|459787057|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
127771149|NCT03353350|459787054|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
127771150|NCT03353350|459787055|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
127771151|NCT03353350|459787056|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
127771152|NCT03353350|459787057|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
127771153|NCT03353350|459787054|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
127771154|NCT03353350|459787055|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
127771155|NCT03353350|459787056|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
127771156|NCT03353350|459787057|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
127771157|NCT03353350|459787054|FG000|26-week Treatment Extension Period|Adverse Event|1|||
127771158|NCT03353350|459787055|FG001|26-week Treatment Extension Period|Adverse Event|0|||
127771159|NCT03353350|459787056|FG002|26-week Treatment Extension Period|Adverse Event|0|||
127771160|NCT03353350|459787057|FG003|26-week Treatment Extension Period|Adverse Event|1|||
127771161|NCT03353350|459787054|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
127771162|NCT03353350|459787055|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
127771163|NCT03353350|459787056|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
127771164|NCT03353350|459787057|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
127771165|NCT00147823|459787063|FG000|Overall Study|Lost to Follow-up|6|||
127771166|NCT00147823|459787064|FG001|Overall Study|Lost to Follow-up|12|||
127771167|NCT00147823|459787063|FG000|Overall Study|Physician Decision|1|||
127771168|NCT00147823|459787064|FG001|Overall Study|Physician Decision|0|||
127771169|NCT00147823|459787063|FG000|Overall Study|Withdrawal by Subject|0|||
127771170|NCT00147823|459787064|FG001|Overall Study|Withdrawal by Subject|1|||
127771171|NCT00147823|459787063|FG000|Overall Study|Did not receive vitoss due to infection|6|||
127771172|NCT00147823|459787064|FG001|Overall Study|Did not receive vitoss due to infection|2|||
127771173|NCT01012713|459787065|FG000|Overall Study|Lack of Efficacy|3|||
127771174|NCT02571049|459787066|FG000|Screening|Did not meet entry criteria|2|||
127771175|NCT02571049|459787067|FG001|Screening|Did not meet entry criteria|2|||
127771176|NCT02571049|459787066|FG000|Randomization|No migraine attack|0|||
127549435|NCT01967940|458978612|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
127549436|NCT01967940|458978609|FG000|Part 2|Adverse Event|0|||
127549437|NCT01967940|458978610|FG001|Part 2|Adverse Event|0|||
127771177|NCT02571049|459787067|FG001|Randomization|No migraine attack|1|||
127771178|NCT02571049|459787066|FG000|Randomization|Adverse Event|0|||
127771179|NCT02571049|459787067|FG001|Randomization|Adverse Event|1|||
127771180|NCT01055262|459787068|FG000|Overall Study|Adverse Event|5|||
128016668|NCT00217737|460683291|FG000|Step 2 Randomization/Registration|Non-compliant|2|||
127549438|NCT01967940|458978611|FG002|Part 2|Adverse Event|0|||
127549439|NCT01967940|458978612|FG003|Part 2|Adverse Event|1|||
127549440|NCT01967940|458978609|FG000|Part 2|Unknown Reason|0|||
127549441|NCT01967940|458978610|FG001|Part 2|Unknown Reason|0|||
127549442|NCT01967940|458978611|FG002|Part 2|Unknown Reason|0|||
127549443|NCT01967940|458978612|FG003|Part 2|Unknown Reason|1|||
127549444|NCT01663103|458978613|FG000|Overall Study|Withdrawal by Subject|1|||
127549445|NCT01663103|458978614|FG001|Overall Study|Withdrawal by Subject|2|||
127549446|NCT01663103|458978613|FG000|Overall Study|Adverse Event|1|||
127549447|NCT01663103|458978614|FG001|Overall Study|Adverse Event|0|||
127549448|NCT01663103|458978613|FG000|Overall Study|dog bite|1|||
127549449|NCT01663103|458978614|FG001|Overall Study|dog bite|0|||
127549450|NCT03113487|458978619|FG000|Overall Study|After cycle 1 sepsis was deemed present at baseline, so the patient was ineligible|1|||
127549451|NCT00391586|458978624|FG000|Overall Study|Progressive disease|13|||
127549452|NCT00391586|458978624|FG000|Overall Study|Adverse Event|5|||
127549453|NCT00391586|458978624|FG000|Overall Study|Physician Decision|2|||
127549454|NCT00391586|458978624|FG000|Overall Study|Death|4|||
127549455|NCT00904982|458978625|FG000|Overall Study|Withdrawal by Subject|2|||
127549456|NCT00904982|458978626|FG001|Overall Study|Withdrawal by Subject|0|||
127549457|NCT00904982|458978627|FG002|Overall Study|Withdrawal by Subject|0|||
127549458|NCT00904982|458978628|FG003|Overall Study|Withdrawal by Subject|0|||
127549459|NCT02420821|458978636|FG000|Overall Study|Lost to Follow-up|6|||
127549460|NCT02420821|458978637|FG001|Overall Study|Lost to Follow-up|6|||
127549461|NCT02420821|458978636|FG000|Overall Study|Non-compliance|0|||
127549462|NCT02420821|458978637|FG001|Overall Study|Non-compliance|2|||
127549463|NCT02420821|458978636|FG000|Overall Study|Physician Decision|6|||
127549464|NCT02420821|458978637|FG001|Overall Study|Physician Decision|2|||
127549465|NCT02420821|458978636|FG000|Overall Study|Withdrawal by Subject|32|||
127549466|NCT02420821|458978637|FG001|Overall Study|Withdrawal by Subject|25|||
128016669|NCT00217737|460683292|FG001|Step 2 Randomization/Registration|Non-compliant|4|||
128016670|NCT00217737|460683293|FG002|Step 2 Randomization/Registration|Non-compliant|0|||
128016671|NCT00217737|460683294|FG003|Step 2 Randomization/Registration|Non-compliant|0|||
128016672|NCT00217737|460683291|FG000|Step 2 Randomization/Registration|Physician Decision|2|||
128016673|NCT00217737|460683292|FG001|Step 2 Randomization/Registration|Physician Decision|2|||
128016674|NCT00217737|460683293|FG002|Step 2 Randomization/Registration|Physician Decision|0|||
128016675|NCT00217737|460683294|FG003|Step 2 Randomization/Registration|Physician Decision|0|||
128016676|NCT00217737|460683291|FG000|Step 2 Randomization/Registration|Alternative therapy|0|||
128016677|NCT00217737|460683292|FG001|Step 2 Randomization/Registration|Alternative therapy|1|||
128016678|NCT00217737|460683293|FG002|Step 2 Randomization/Registration|Alternative therapy|0|||
128016679|NCT00217737|460683294|FG003|Step 2 Randomization/Registration|Alternative therapy|0|||
128016680|NCT00217737|460683291|FG000|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
128016681|NCT00217737|460683292|FG001|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|1|||
128016682|NCT00217737|460683293|FG002|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
128016683|NCT00217737|460683294|FG003|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
128016684|NCT00217737|460683291|FG000|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
128016685|NCT00217737|460683292|FG001|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|1|||
128016686|NCT00217737|460683293|FG002|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
128016687|NCT00217737|460683294|FG003|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
128016688|NCT00217737|460683291|FG000|Step 2 Randomization/Registration|Incorrect Cancer Stage|1|||
128016689|NCT00217737|460683292|FG001|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
127771181|NCT01055262|459787068|FG000|Overall Study|Protocol Violation|3|||
127771182|NCT01055262|459787068|FG000|Overall Study|Uncooperativeness|1|||
127771183|NCT03370471|459787069|FG000|Overall Study|Withdrawal by Subject|6|||
127771184|NCT03370471|459787070|FG001|Overall Study|Withdrawal by Subject|1|||
127771185|NCT03370471|459787069|FG000|Overall Study|Unable to access veins for blood draw|0|||
127771186|NCT03370471|459787070|FG001|Overall Study|Unable to access veins for blood draw|1|||
128016690|NCT00217737|460683293|FG002|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
128016691|NCT00217737|460683294|FG003|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
128016692|NCT00217737|460683291|FG000|Step 2 Randomization/Registration|Never started protocol therapy|31|||
128016693|NCT00217737|460683292|FG001|Step 2 Randomization/Registration|Never started protocol therapy|48|||
128016694|NCT00217737|460683293|FG002|Step 2 Randomization/Registration|Never started protocol therapy|0|||
128016695|NCT00217737|460683294|FG003|Step 2 Randomization/Registration|Never started protocol therapy|0|||
128016696|NCT00217737|460683291|FG000|Step 2 Randomization/Registration|Other|1|||
128016697|NCT00217737|460683292|FG001|Step 2 Randomization/Registration|Other|2|||
128016698|NCT00217737|460683293|FG002|Step 2 Randomization/Registration|Other|0|||
128016699|NCT00217737|460683294|FG003|Step 2 Randomization/Registration|Other|0|||
127549467|NCT02420821|458978636|FG000|Overall Study|Death|270|||
127549468|NCT02420821|458978637|FG001|Overall Study|Death|263|||
127549469|NCT02420821|458978636|FG000|Overall Study|Study Terminated By Sponsor|145|||
127549470|NCT02420821|458978637|FG001|Overall Study|Study Terminated By Sponsor|149|||
127549471|NCT02420821|458978636|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
127771187|NCT03370471|459787069|FG000|Overall Study|Screen fail|1|||
127549472|NCT02420821|458978637|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
127549473|NCT02420821|458978636|FG000|Overall Study|Adverse Event|0|||
127549474|NCT02420821|458978637|FG001|Overall Study|Adverse Event|1|||
127549475|NCT02420821|458978636|FG000|Overall Study|Protinuria|0|||
127549476|NCT02420821|458978637|FG001|Overall Study|Protinuria|1|||
127549477|NCT02420821|458978636|FG000|Overall Study|Progressive Disease|1|||
127549478|NCT02420821|458978637|FG001|Overall Study|Progressive Disease|1|||
127549479|NCT02420821|458978636|FG000|Overall Study|Disease Progression|0|||
127549480|NCT02420821|458978637|FG001|Overall Study|Disease Progression|1|||
127549481|NCT02420821|458978636|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
127549482|NCT02420821|458978637|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
127549483|NCT00686712|458978638|FG000|Overall Study|Protocol Violation|8|||
127549484|NCT00686712|458978639|FG001|Overall Study|Protocol Violation|8|||
127549485|NCT00686712|458978640|FG002|Overall Study|Protocol Violation|10|||
127549486|NCT00686712|458978638|FG000|Overall Study|Lost to Follow-up|1|||
127549487|NCT00686712|458978639|FG001|Overall Study|Lost to Follow-up|2|||
127549488|NCT00686712|458978640|FG002|Overall Study|Lost to Follow-up|3|||
127549489|NCT00686712|458978638|FG000|Overall Study|Adverse Event|1|||
127549490|NCT00686712|458978639|FG001|Overall Study|Adverse Event|1|||
127549491|NCT00686712|458978640|FG002|Overall Study|Adverse Event|0|||
127549492|NCT03987503|458978641|FG000|Overall Study|Lost to Follow-up|20|||
127549493|NCT03987503|458978641|FG000|Overall Study|Withdrawal by Subject|2|||
127549494|NCT01929317|458978650|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
127549495|NCT01929317|458978651|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
127549496|NCT01929317|458978650|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
127549497|NCT01929317|458978651|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
127549498|NCT01929317|458978650|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
127549499|NCT01929317|458978651|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
127549500|NCT01929317|458978650|FG000|Long-term Phase|Adverse Event|5|||
127549501|NCT01929317|458978651|FG001|Long-term Phase|Adverse Event|1|||
127549502|NCT01929317|458978650|FG000|Long-term Phase|Physician Decision|3|||
127549503|NCT01929317|458978651|FG001|Long-term Phase|Physician Decision|0|||
127549504|NCT01929317|458978650|FG000|Long-term Phase|Withdrawal by Subject|4|||
127549505|NCT01929317|458978651|FG001|Long-term Phase|Withdrawal by Subject|0|||
127549506|NCT01929317|458978650|FG000|Long-term Phase|Protocol Violation|1|||
127549507|NCT01929317|458978651|FG001|Long-term Phase|Protocol Violation|0|||
127549508|NCT01929317|458978650|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
127549509|NCT01929317|458978651|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
127549510|NCT01929317|458978650|FG000|Long-term Phase|Study Closed/Terminated|5|||
127549511|NCT01929317|458978651|FG001|Long-term Phase|Study Closed/Terminated|3|||
127549512|NCT01716234|458978652|FG000|Overall Study|Protocol Violation|0|||
127549513|NCT01716234|458978653|FG001|Overall Study|Protocol Violation|0|||
127549514|NCT01716234|458978654|FG002|Overall Study|Protocol Violation|0|||
127549515|NCT01716234|458978655|FG003|Overall Study|Protocol Violation|1|||
127549516|NCT01716234|458978656|FG004|Overall Study|Protocol Violation|1|||
127549517|NCT01716234|458978657|FG005|Overall Study|Protocol Violation|1|||
127549518|NCT01716234|458978658|FG006|Overall Study|Protocol Violation|0|||
127549519|NCT01716234|458978652|FG000|Overall Study|Lack of Efficacy|0|||
127549520|NCT01716234|458978653|FG001|Overall Study|Lack of Efficacy|0|||
127549521|NCT01716234|458978654|FG002|Overall Study|Lack of Efficacy|0|||
127549522|NCT01716234|458978655|FG003|Overall Study|Lack of Efficacy|1|||
127549523|NCT01716234|458978656|FG004|Overall Study|Lack of Efficacy|0|||
127549524|NCT01716234|458978657|FG005|Overall Study|Lack of Efficacy|0|||
127549525|NCT01716234|458978658|FG006|Overall Study|Lack of Efficacy|0|||
127684570|NCT03482011|459469912|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
127684571|NCT03482011|459469913|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
127684572|NCT03482011|459469914|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
127684573|NCT03482011|459469915|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
127684574|NCT03482011|459469908|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
127684575|NCT03482011|459469909|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
127684576|NCT03482011|459469910|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
127549526|NCT01716234|458978652|FG000|Overall Study|Did not meet protocol eligibility|0|||
127549527|NCT01716234|458978653|FG001|Overall Study|Did not meet protocol eligibility|0|||
127549528|NCT01716234|458978654|FG002|Overall Study|Did not meet protocol eligibility|1|||
127549529|NCT01716234|458978655|FG003|Overall Study|Did not meet protocol eligibility|0|||
127549530|NCT01716234|458978656|FG004|Overall Study|Did not meet protocol eligibility|0|||
127549531|NCT01716234|458978657|FG005|Overall Study|Did not meet protocol eligibility|4|||
127549532|NCT01716234|458978658|FG006|Overall Study|Did not meet protocol eligibility|0|||
127549533|NCT01716234|458978652|FG000|Overall Study|Adverse Event|7|||
127549534|NCT01716234|458978653|FG001|Overall Study|Adverse Event|10|||
127684577|NCT03482011|459469911|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
127684578|NCT03482011|459469912|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
127771188|NCT03370471|459787070|FG001|Overall Study|Screen fail|0|||
127549535|NCT01716234|458978654|FG002|Overall Study|Adverse Event|2|||
127549536|NCT01716234|458978655|FG003|Overall Study|Adverse Event|8|||
127549537|NCT01716234|458978656|FG004|Overall Study|Adverse Event|3|||
127549538|NCT01716234|458978657|FG005|Overall Study|Adverse Event|6|||
127549539|NCT01716234|458978658|FG006|Overall Study|Adverse Event|0|||
127549540|NCT01716234|458978652|FG000|Overall Study|Withdrawal by Subject|3|||
128016700|NCT05578872|460683295|FG000|Overall Study|Withdrawal by Subject|2|||
127549541|NCT01716234|458978653|FG001|Overall Study|Withdrawal by Subject|0|||
127549542|NCT01716234|458978654|FG002|Overall Study|Withdrawal by Subject|2|||
127549543|NCT01716234|458978655|FG003|Overall Study|Withdrawal by Subject|2|||
127549544|NCT01716234|458978656|FG004|Overall Study|Withdrawal by Subject|1|||
127549545|NCT01716234|458978657|FG005|Overall Study|Withdrawal by Subject|3|||
127549546|NCT01716234|458978658|FG006|Overall Study|Withdrawal by Subject|0|||
127549547|NCT03815929|458978660|FG000|Overall Study|Lost to Follow-up|2|||
128016701|NCT05578872|460683296|FG001|Overall Study|Withdrawal by Subject|1|||
128016702|NCT05578872|460683295|FG000|Overall Study|Adverse Event|1|||
128016703|NCT05578872|460683296|FG001|Overall Study|Adverse Event|1|||
128016704|NCT05578872|460683295|FG000|Overall Study|Physician Decision|1|||
128016705|NCT05578872|460683296|FG001|Overall Study|Physician Decision|2|||
128016706|NCT05578872|460683295|FG000|Overall Study|Progressive disease|10|||
128016707|NCT05578872|460683296|FG001|Overall Study|Progressive disease|9|||
128016708|NCT05578872|460683295|FG000|Overall Study|Sponsor decision|0|||
128016709|NCT05578872|460683296|FG001|Overall Study|Sponsor decision|1|||
128016710|NCT05578872|460683295|FG000|Overall Study|Toxicity and Patient's decision|0|||
128016711|NCT05578872|460683296|FG001|Overall Study|Toxicity and Patient's decision|1|||
128016712|NCT03506477|460684053|FG000|Overall Study|Withdrawal by Subject|1|||
128016713|NCT03506477|460684054|FG001|Overall Study|Withdrawal by Subject|0|||
128016714|NCT02717611|460684055|FG000|Overall Study|Death|13|||
128016715|NCT02717611|460684055|FG000|Overall Study|Withdrawal by Subject|6|||
128016716|NCT02717611|460684055|FG000|Overall Study|Active, not recruiting|40|||
128016717|NCT02717611|460684055|FG000|Overall Study|Complicating disease|1|||
128016718|NCT00325416|460684056|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
128016719|NCT00325416|460684057|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
128016720|NCT00325416|460684056|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
128016721|NCT00325416|460684057|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
128016722|NCT00325416|460684056|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
128016723|NCT00325416|460684057|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
128016724|NCT00325416|460684056|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
128016725|NCT00325416|460684057|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
128016726|NCT00325416|460684056|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
128016727|NCT00325416|460684057|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
128016728|NCT00325416|460684056|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
128016729|NCT00325416|460684057|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
128016730|NCT04589650|460684058|FG000|Overall Study|Subject decision|6|||
128016731|NCT04589650|460684059|FG001|Overall Study|Subject decision|2|||
128016732|NCT04589650|460684060|FG002|Overall Study|Subject decision|2|||
128016733|NCT04589650|460684061|FG003|Overall Study|Subject decision|0|||
128016734|NCT04589650|460684062|FG004|Overall Study|Subject decision|0|||
128016735|NCT04589650|460684063|FG005|Overall Study|Subject decision|0|||
128016736|NCT04589650|460684058|FG000|Overall Study|Adverse Event|3|||
128016737|NCT04589650|460684059|FG001|Overall Study|Adverse Event|1|||
128016738|NCT04589650|460684060|FG002|Overall Study|Adverse Event|1|||
128016739|NCT04589650|460684061|FG003|Overall Study|Adverse Event|1|||
128016740|NCT04589650|460684062|FG004|Overall Study|Adverse Event|0|||
128016741|NCT04589650|460684063|FG005|Overall Study|Adverse Event|1|||
128016742|NCT04589650|460684058|FG000|Overall Study|Physician Decision|1|||
128016743|NCT04589650|460684059|FG001|Overall Study|Physician Decision|1|||
128016744|NCT04589650|460684060|FG002|Overall Study|Physician Decision|0|||
128016745|NCT04589650|460684061|FG003|Overall Study|Physician Decision|0|||
128016746|NCT04589650|460684062|FG004|Overall Study|Physician Decision|0|||
128016747|NCT04589650|460684063|FG005|Overall Study|Physician Decision|0|||
128016748|NCT04589650|460684058|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
128016749|NCT04589650|460684059|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
128016750|NCT04589650|460684060|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
128016751|NCT04589650|460684061|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
127549548|NCT03815929|458978661|FG001|Overall Study|Lost to Follow-up|1|||
127549549|NCT03815929|458978662|FG002|Overall Study|Lost to Follow-up|0|||
127549550|NCT03815929|458978660|FG000|Overall Study|Physician Decision|2|||
127549551|NCT03815929|458978661|FG001|Overall Study|Physician Decision|2|||
128016752|NCT04589650|460684062|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
128016753|NCT04589650|460684063|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
128016754|NCT04589650|460684058|FG000|Overall Study|Death|0|||
128016755|NCT04589650|460684059|FG001|Overall Study|Death|0|||
128016756|NCT04589650|460684060|FG002|Overall Study|Death|0|||
128016757|NCT04589650|460684061|FG003|Overall Study|Death|1|||
128016758|NCT04589650|460684062|FG004|Overall Study|Death|0|||
128016759|NCT04589650|460684063|FG005|Overall Study|Death|0|||
128016760|NCT04589650|460684058|FG000|Overall Study|Guardian Decision|0|||
128016761|NCT04589650|460684059|FG001|Overall Study|Guardian Decision|0|||
127549552|NCT03815929|458978662|FG002|Overall Study|Physician Decision|0|||
127549553|NCT03815929|458978660|FG000|Overall Study|Withdrawal by Subject|0|||
127549554|NCT03815929|458978661|FG001|Overall Study|Withdrawal by Subject|0|||
127549555|NCT03815929|458978662|FG002|Overall Study|Withdrawal by Subject|1|||
127549556|NCT03326713|458978663|FG000|Overall Study|Death|2|||
127549557|NCT03326713|458978664|FG001|Overall Study|Death|1|||
127549558|NCT03326713|458978665|FG002|Overall Study|Death|0|||
127549559|NCT03326713|458978663|FG000|Overall Study|Lost to Follow-up|20|||
127549560|NCT03326713|458978664|FG001|Overall Study|Lost to Follow-up|21|||
127549561|NCT03326713|458978665|FG002|Overall Study|Lost to Follow-up|33|||
127549562|NCT03326713|458978663|FG000|Overall Study|Withdrawal by Subject|1|||
127549563|NCT03326713|458978664|FG001|Overall Study|Withdrawal by Subject|2|||
127549564|NCT03326713|458978665|FG002|Overall Study|Withdrawal by Subject|11|||
127549565|NCT03326713|458978663|FG000|Overall Study|Found Ineligible|11|||
127549566|NCT03326713|458978664|FG001|Overall Study|Found Ineligible|11|||
127549567|NCT03326713|458978665|FG002|Overall Study|Found Ineligible|8|||
127549568|NCT06078124|458978667|FG000|Overall Study|Lost to Follow-up|14|||
127549569|NCT06078124|458978668|FG001|Overall Study|Lost to Follow-up|14|||
127549570|NCT01198977|458978669|FG000|Overall Study|Lost to Follow-up|1|||
127549571|NCT01198977|458978670|FG001|Overall Study|Lost to Follow-up|0|||
127549572|NCT04721977|458978676|FG000|Overall Study|Death|15|||
127549573|NCT04721977|458978676|FG000|Overall Study|Ongoing|51|||
127549574|NCT02864394|458978677|FG000|Overall Study|Death|184|||
127549575|NCT02864394|458978678|FG001|Overall Study|Death|189|||
127549576|NCT02864394|458978677|FG000|Overall Study|Lost to Follow-up|0|||
127549577|NCT02864394|458978678|FG001|Overall Study|Lost to Follow-up|2|||
127549578|NCT02864394|458978677|FG000|Overall Study|Sponsor Decision|26|||
127549579|NCT02864394|458978678|FG001|Overall Study|Sponsor Decision|11|||
127549580|NCT02864394|458978677|FG000|Overall Study|Withdrawal by Subject|3|||
127549581|NCT02864394|458978678|FG001|Overall Study|Withdrawal by Subject|10|||
127549582|NCT00777153|458980229|FG000|Overall Study|Lost to Follow-up|1|||
127549583|NCT00777153|458980230|FG001|Overall Study|Lost to Follow-up|1|||
127549584|NCT00777153|458980231|FG002|Overall Study|Lost to Follow-up|0|||
127549585|NCT00777153|458980229|FG000|Overall Study|Death|85|||
127549586|NCT00777153|458980230|FG001|Overall Study|Death|73|||
127549587|NCT00777153|458980231|FG002|Overall Study|Death|33|||
127549588|NCT00777153|458980229|FG000|Overall Study|Withdrawal by Subject|3|||
127549589|NCT00777153|458980230|FG001|Overall Study|Withdrawal by Subject|4|||
127549590|NCT00777153|458980231|FG002|Overall Study|Withdrawal by Subject|3|||
127549591|NCT00777153|458980229|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
127549592|NCT00777153|458980230|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
127549593|NCT00777153|458980231|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
127549594|NCT02079246|458980233|FG000|OLEX|Withdrawal before treatment|1|||
127549595|NCT02079246|458980234|FG001|OLEX|Withdrawal before treatment|0|||
127549596|NCT02079246|458980233|FG000|OLEX|Death|11|||
127549597|NCT02079246|458980234|FG001|OLEX|Death|0|||
127549598|NCT02079246|458980233|FG000|OLEX|Adverse Event|66|||
127549599|NCT02079246|458980234|FG001|OLEX|Adverse Event|0|||
127549600|NCT02079246|458980233|FG000|OLEX|Withdrawal by Subject|60|||
127549601|NCT02079246|458980234|FG001|OLEX|Withdrawal by Subject|0|||
127549602|NCT02079246|458980233|FG000|OLEX|Lost to Follow-up|6|||
127549603|NCT02079246|458980234|FG001|OLEX|Lost to Follow-up|0|||
127549604|NCT02079246|458980233|FG000|OLEX|Protocol Violation|6|||
127549605|NCT02079246|458980234|FG001|OLEX|Protocol Violation|0|||
127549606|NCT02079246|458980233|FG000|OLEX|Lack of Efficacy|3|||
127549607|NCT02079246|458980234|FG001|OLEX|Lack of Efficacy|0|||
127549608|NCT02079246|458980233|FG000|OLEX|Results of the lead-in studies|58|||
127549609|NCT02079246|458980234|FG001|OLEX|Results of the lead-in studies|0|||
127549610|NCT02079246|458980233|FG000|OLEX|Other: Disallowed medication|8|||
127549611|NCT02079246|458980234|FG001|OLEX|Other: Disallowed medication|0|||
127549612|NCT02079246|458980233|FG000|OLEX|Other: Insufficient compliance|2|||
127549613|NCT02079246|458980234|FG001|OLEX|Other: Insufficient compliance|0|||
127549614|NCT02079246|458980233|FG000|OLEX|Other: Caregiver unavailable|3|||
127549615|NCT02079246|458980234|FG001|OLEX|Other: Caregiver unavailable|0|||
127549616|NCT02079246|458980233|FG000|OLEX|Other: Coordinator decision|1|||
127549617|NCT02079246|458980234|FG001|OLEX|Other: Coordinator decision|0|||
127549618|NCT02079246|458980233|FG000|OLEX|Other: Worsening of condition|1|||
127549619|NCT02079246|458980234|FG001|OLEX|Other: Worsening of condition|0|||
127549620|NCT02079246|458980233|FG000|OLEX|Other: Moved to nursing home|1|||
127549621|NCT02079246|458980234|FG001|OLEX|Other: Moved to nursing home|0|||
127549622|NCT02079246|458980233|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
127549623|NCT02079246|458980234|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
127549624|NCT02079246|458980233|FG000|OLEX-MEM|Adverse Event|0|||
127549625|NCT02079246|458980234|FG001|OLEX-MEM|Adverse Event|6|||
127549626|NCT02079246|458980233|FG000|OLEX-MEM|Withdrawal by Subject|0|||
127549627|NCT02079246|458980234|FG001|OLEX-MEM|Withdrawal by Subject|7|||
127549628|NCT02079246|458980233|FG000|OLEX-MEM|Protocol Violation|0|||
127549629|NCT02079246|458980234|FG001|OLEX-MEM|Protocol Violation|2|||
127549630|NCT02079246|458980233|FG000|OLEX-MEM|Lost to Follow-up|0|||
127549631|NCT02079246|458980234|FG001|OLEX-MEM|Lost to Follow-up|1|||
127549632|NCT02079246|458980233|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
127549633|NCT02079246|458980234|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
127549634|NCT00918255|458980240|FG000|Overall Study|Adverse Event|1|||
127549635|NCT00918255|458980241|FG001|Overall Study|Adverse Event|0|||
127549636|NCT00918255|458980242|FG002|Overall Study|Adverse Event|0|||
127549637|NCT00918255|458980240|FG000|Overall Study|Withdrawal by Subject|1|||
127549638|NCT00918255|458980241|FG001|Overall Study|Withdrawal by Subject|0|||
127549639|NCT00918255|458980242|FG002|Overall Study|Withdrawal by Subject|2|||
127549640|NCT00918255|458980240|FG000|Overall Study|Lack of Efficacy|1|||
127549641|NCT00918255|458980241|FG001|Overall Study|Lack of Efficacy|0|||
127549642|NCT00918255|458980242|FG002|Overall Study|Lack of Efficacy|0|||
127549643|NCT00918255|458980240|FG000|Overall Study|Lost to Follow-up|1|||
127549644|NCT00918255|458980241|FG001|Overall Study|Lost to Follow-up|0|||
127549645|NCT00918255|458980242|FG002|Overall Study|Lost to Follow-up|2|||
127549646|NCT00918255|458980240|FG000|Overall Study|Exceeded allowed number of interventions|0|||
127549647|NCT00918255|458980241|FG001|Overall Study|Exceeded allowed number of interventions|0|||
127549648|NCT00918255|458980242|FG002|Overall Study|Exceeded allowed number of interventions|1|||
127549649|NCT00918255|458980240|FG000|Overall Study|Non-compliance|1|||
127549650|NCT00918255|458980241|FG001|Overall Study|Non-compliance|0|||
127549651|NCT00918255|458980242|FG002|Overall Study|Non-compliance|0|||
127549652|NCT00918255|458980240|FG000|Overall Study|Investigator discretion|1|||
127549653|NCT00918255|458980241|FG001|Overall Study|Investigator discretion|0|||
127549654|NCT00918255|458980242|FG002|Overall Study|Investigator discretion|0|||
127549655|NCT03557034|458980243|FG000|Overall Study|Withdrawal by Subject|1|||
127549656|NCT03557034|458980244|FG001|Overall Study|Withdrawal by Subject|0|||
127549657|NCT00719472|458980248|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
127549658|NCT00719472|458980248|FG000|Enrolled in Study|Subject decision to withdraw|8|||
127549659|NCT00719472|458980248|FG000|Enrolled in Study|Various Reasons|17|||
127549660|NCT00719472|458980248|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
127549661|NCT00719472|458980248|FG000|Received Cycle 1 Treatment|Death|5|||
127549662|NCT00719472|458980248|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
127549663|NCT00719472|458980248|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
127549664|NCT00719472|458980248|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
127549665|NCT00719472|458980248|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
127549666|NCT00719472|458980248|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
127549667|NCT00719472|458980248|FG000|Received Cycle 2 Treatment|Death|6|||
127549668|NCT00719472|458980248|FG000|Received Cycle 2 Treatment|Disease progression|3|||
127549669|NCT00719472|458980248|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
127549670|NCT00719472|458980248|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
127549671|NCT00719472|458980248|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
127549672|NCT00719472|458980248|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
127549673|NCT01244893|458980249|FG000|Baseline|Protocol Violation|0|||
127549674|NCT01244893|458980250|FG001|Baseline|Protocol Violation|1|||
127549675|NCT01244893|458980249|FG000|1-Week Follow Up|Lost to Follow-up|1|||
127549676|NCT01244893|458980250|FG001|1-Week Follow Up|Lost to Follow-up|0|||
127549677|NCT00711191|458980252|FG000|Overall Study|Adverse Event|1|||
127549678|NCT00711191|458980253|FG001|Overall Study|Adverse Event|1|||
127549679|NCT00711191|458980254|FG002|Overall Study|Adverse Event|2|||
127549680|NCT00711191|458980252|FG000|Overall Study|Objective progression or relapse|2|||
127549681|NCT00711191|458980253|FG001|Overall Study|Objective progression or relapse|3|||
127549682|NCT00711191|458980254|FG002|Overall Study|Objective progression or relapse|7|||
127549683|NCT00711191|458980252|FG000|Overall Study|Withdrawal by Subject|0|||
127549684|NCT00711191|458980253|FG001|Overall Study|Withdrawal by Subject|1|||
127549685|NCT00711191|458980254|FG002|Overall Study|Withdrawal by Subject|3|||
127549686|NCT02118961|458980255|FG000|Overall Study|Withdrawal by Subject|1|||
127549687|NCT02118961|458980256|FG001|Overall Study|Withdrawal by Subject|0|||
127549688|NCT03809104|458980257|FG000|Overall Study|Withdrawal by Subject|3|||
127549689|NCT02968004|458980258|FG000|Main Study Phase|Adverse Event|1|||
127549690|NCT02968004|458980259|FG001|Main Study Phase|Adverse Event|0|||
127549691|NCT02968004|458980258|FG000|Main Study Phase|Withdrawal by Subject|0|||
127549692|NCT02968004|458980259|FG001|Main Study Phase|Withdrawal by Subject|1|||
127549693|NCT02968004|458980258|FG000|Open Label Extension (OLE) Year 1|Adverse Event|0|||
127549694|NCT02968004|458980259|FG001|Open Label Extension (OLE) Year 1|Adverse Event|6|||
127549695|NCT02968004|458980258|FG000|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
127549696|NCT02968004|458980259|FG001|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
127549697|NCT02968004|458980258|FG000|Open Label Extension (OLE) Year 1|Miscellaneous|0|||
127549698|NCT02968004|458980259|FG001|Open Label Extension (OLE) Year 1|Miscellaneous|1|||
127549699|NCT02968004|458980258|FG000|Open Label Extension (OLE) Year 2|Adverse Event|1|||
127549700|NCT02968004|458980259|FG001|Open Label Extension (OLE) Year 2|Adverse Event|1|||
127549701|NCT02968004|458980258|FG000|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
127549702|NCT02968004|458980259|FG001|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
127549703|NCT02968004|458980258|FG000|Open Label Extension (OLE) Year 2|Miscellaneous|0|||
127771189|NCT00561951|459787071|FG000|Overall Study|Adverse Event|11|||
127771190|NCT00561951|459787072|FG001|Overall Study|Adverse Event|14|||
127771191|NCT00561951|459787073|FG002|Overall Study|Adverse Event|14|||
127771192|NCT00561951|459787071|FG000|Overall Study|Lack of Efficacy|5|||
127771193|NCT00561951|459787072|FG001|Overall Study|Lack of Efficacy|3|||
127771194|NCT00561951|459787073|FG002|Overall Study|Lack of Efficacy|2|||
127771195|NCT00561951|459787071|FG000|Overall Study|Lost to Follow-up|1|||
127771196|NCT00561951|459787072|FG001|Overall Study|Lost to Follow-up|1|||
127771197|NCT00561951|459787073|FG002|Overall Study|Lost to Follow-up|0|||
127771198|NCT00561951|459787071|FG000|Overall Study|Withdrawal by Subject|10|||
127771199|NCT00561951|459787072|FG001|Overall Study|Withdrawal by Subject|9|||
127771200|NCT00561951|459787073|FG002|Overall Study|Withdrawal by Subject|10|||
127771201|NCT00561951|459787071|FG000|Overall Study|Protocol Violation|4|||
127771202|NCT00561951|459787072|FG001|Overall Study|Protocol Violation|3|||
127771203|NCT00561951|459787073|FG002|Overall Study|Protocol Violation|4|||
127771204|NCT00561951|459787071|FG000|Overall Study|Physician Decision|1|||
127771205|NCT00561951|459787072|FG001|Overall Study|Physician Decision|0|||
127771206|NCT00561951|459787073|FG002|Overall Study|Physician Decision|0|||
127771207|NCT00561951|459787071|FG000|Overall Study|Pregnancy|0|||
127771208|NCT00561951|459787072|FG001|Overall Study|Pregnancy|1|||
127771209|NCT00561951|459787073|FG002|Overall Study|Pregnancy|0|||
127771210|NCT00561951|459787071|FG000|Overall Study|Meet Withdrawal Criterion|0|||
127771211|NCT00561951|459787072|FG001|Overall Study|Meet Withdrawal Criterion|1|||
127771212|NCT00561951|459787073|FG002|Overall Study|Meet Withdrawal Criterion|1|||
127771213|NCT00561951|459787071|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
127771214|NCT00561951|459787072|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
127771215|NCT00561951|459787073|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
127771216|NCT00392327|459787085|FG000|Overall Study|Death|1|||
127771217|NCT00392327|459787086|FG001|Overall Study|Death|0|||
127771218|NCT00392327|459787087|FG002|Overall Study|Death|1|||
127771219|NCT00392327|459787088|FG003|Overall Study|Death|0|||
127771220|NCT00392327|459787089|FG004|Overall Study|Death|0|||
127771221|NCT00392327|459787090|FG005|Overall Study|Death|0|||
127771222|NCT00392327|459787091|FG006|Overall Study|Death|0|||
127771223|NCT00392327|459787092|FG007|Overall Study|Death|0|||
127771224|NCT00392327|459787085|FG000|Overall Study|Lack of Efficacy|8|||
127771225|NCT00392327|459787086|FG001|Overall Study|Lack of Efficacy|8|||
127771226|NCT00392327|459787087|FG002|Overall Study|Lack of Efficacy|9|||
127771227|NCT00392327|459787088|FG003|Overall Study|Lack of Efficacy|6|||
127771228|NCT00392327|459787089|FG004|Overall Study|Lack of Efficacy|3|||
127771229|NCT00392327|459787090|FG005|Overall Study|Lack of Efficacy|3|||
127771230|NCT00392327|459787091|FG006|Overall Study|Lack of Efficacy|3|||
127771231|NCT00392327|459787092|FG007|Overall Study|Lack of Efficacy|3|||
127771232|NCT00392327|459787085|FG000|Overall Study|Physician Decision|3|||
127771233|NCT00392327|459787086|FG001|Overall Study|Physician Decision|5|||
127771234|NCT00392327|459787087|FG002|Overall Study|Physician Decision|2|||
127771235|NCT00392327|459787088|FG003|Overall Study|Physician Decision|2|||
127771236|NCT00392327|459787089|FG004|Overall Study|Physician Decision|0|||
127771237|NCT00392327|459787090|FG005|Overall Study|Physician Decision|1|||
127771238|NCT00392327|459787091|FG006|Overall Study|Physician Decision|5|||
127771239|NCT00392327|459787092|FG007|Overall Study|Physician Decision|3|||
127771240|NCT00392327|459787085|FG000|Overall Study|Protocol Violation|0|||
127771241|NCT00392327|459787086|FG001|Overall Study|Protocol Violation|0|||
127771242|NCT00392327|459787087|FG002|Overall Study|Protocol Violation|1|||
127771243|NCT00392327|459787088|FG003|Overall Study|Protocol Violation|0|||
127771244|NCT00392327|459787089|FG004|Overall Study|Protocol Violation|0|||
127771245|NCT00392327|459787090|FG005|Overall Study|Protocol Violation|0|||
127771246|NCT00392327|459787091|FG006|Overall Study|Protocol Violation|0|||
127771247|NCT00392327|459787092|FG007|Overall Study|Protocol Violation|0|||
127771248|NCT00392327|459787085|FG000|Overall Study|Withdrawal by Subject|3|||
127771249|NCT00392327|459787086|FG001|Overall Study|Withdrawal by Subject|2|||
127771250|NCT00392327|459787087|FG002|Overall Study|Withdrawal by Subject|4|||
127771251|NCT00392327|459787088|FG003|Overall Study|Withdrawal by Subject|6|||
127771252|NCT00392327|459787089|FG004|Overall Study|Withdrawal by Subject|0|||
127771253|NCT00392327|459787090|FG005|Overall Study|Withdrawal by Subject|1|||
127771254|NCT00392327|459787091|FG006|Overall Study|Withdrawal by Subject|1|||
127771255|NCT00392327|459787092|FG007|Overall Study|Withdrawal by Subject|5|||
127771256|NCT00392327|459787085|FG000|Overall Study|Ineligible|0|||
127771257|NCT00392327|459787086|FG001|Overall Study|Ineligible|4|||
127771258|NCT00392327|459787087|FG002|Overall Study|Ineligible|3|||
127771259|NCT00392327|459787088|FG003|Overall Study|Ineligible|2|||
127771260|NCT00392327|459787089|FG004|Overall Study|Ineligible|0|||
127771261|NCT00392327|459787090|FG005|Overall Study|Ineligible|0|||
127771262|NCT00392327|459787091|FG006|Overall Study|Ineligible|0|||
127771263|NCT00392327|459787092|FG007|Overall Study|Ineligible|0|||
127771264|NCT04508023|459787093|FG000|Overall Study|Withdrawal by Subject|1|||
127771265|NCT04508023|459787094|FG001|Overall Study|Withdrawal by Subject|2|||
127771266|NCT03261700|459787099|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
127771267|NCT03261700|459787100|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
127771268|NCT01340196|459788958|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
128016762|NCT04589650|460684060|FG002|Overall Study|Guardian Decision|0|||
128016763|NCT04589650|460684061|FG003|Overall Study|Guardian Decision|1|||
128016764|NCT04589650|460684062|FG004|Overall Study|Guardian Decision|0|||
127771269|NCT00171704|459788961|FG000|Overall Study|Adverse Event|24|||
127771270|NCT00171704|459788962|FG001|Overall Study|Adverse Event|33|||
127771271|NCT00171704|459788961|FG000|Overall Study|Disease Progression|14|||
127771272|NCT00171704|459788962|FG001|Overall Study|Disease Progression|9|||
127771273|NCT00171704|459788961|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
127771274|NCT00171704|459788962|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
127771275|NCT00171704|459788961|FG000|Overall Study|Administrative Problems|2|||
127771276|NCT00171704|459788962|FG001|Overall Study|Administrative Problems|1|||
127771277|NCT00171704|459788961|FG000|Overall Study|Death|2|||
127771278|NCT00171704|459788962|FG001|Overall Study|Death|2|||
127771279|NCT00171704|459788961|FG000|Overall Study|Withdrawal by Subject|1|||
127771280|NCT00171704|459788962|FG001|Overall Study|Withdrawal by Subject|3|||
127771281|NCT00171704|459788961|FG000|Overall Study|Protocol Violation|0|||
127771282|NCT00171704|459788962|FG001|Overall Study|Protocol Violation|1|||
127771283|NCT02141984|459788963|FG000|Overall Study|Lack of Efficacy|2|||
127771284|NCT00816400|459788967|FG000|Overall Study|Death|2|||
127771285|NCT00816400|459788968|FG001|Overall Study|Death|3|||
127771286|NCT00816400|459788969|FG002|Overall Study|Death|3|||
127771287|NCT00816400|459788970|FG003|Overall Study|Death|3|||
127771288|NCT00816400|459788971|FG004|Overall Study|Death|2|||
127771289|NCT00816400|459788972|FG005|Overall Study|Death|3|||
127771290|NCT00816400|459788973|FG006|Overall Study|Death|2|||
127771291|NCT00816400|459788974|FG007|Overall Study|Death|5|||
127771292|NCT00816400|459788975|FG008|Overall Study|Death|6|||
127771293|NCT00816400|459788967|FG000|Overall Study|In hospice care at the end of the study|0|||
127771294|NCT00816400|459788968|FG001|Overall Study|In hospice care at the end of the study|0|||
127771295|NCT00816400|459788969|FG002|Overall Study|In hospice care at the end of the study|2|||
127771296|NCT00816400|459788970|FG003|Overall Study|In hospice care at the end of the study|0|||
127771297|NCT00816400|459788971|FG004|Overall Study|In hospice care at the end of the study|0|||
127771298|NCT00816400|459788972|FG005|Overall Study|In hospice care at the end of the study|0|||
127771299|NCT00816400|459788973|FG006|Overall Study|In hospice care at the end of the study|0|||
127771300|NCT00816400|459788974|FG007|Overall Study|In hospice care at the end of the study|0|||
127771301|NCT00816400|459788975|FG008|Overall Study|In hospice care at the end of the study|0|||
127771302|NCT00081770|459788976|FG000|Overall Study|Adverse Event|130|||
127771303|NCT00081770|459788977|FG001|Overall Study|Adverse Event|98|||
127771304|NCT00081770|459788978|FG002|Overall Study|Adverse Event|136|||
127771305|NCT00081770|459788976|FG000|Overall Study|Lack of Efficacy|262|||
127771306|NCT00081770|459788977|FG001|Overall Study|Lack of Efficacy|357|||
127771307|NCT00081770|459788978|FG002|Overall Study|Lack of Efficacy|211|||
127771308|NCT00081770|459788976|FG000|Overall Study|Lost to Follow-up|45|||
127771309|NCT00081770|459788977|FG001|Overall Study|Lost to Follow-up|34|||
127771310|NCT00081770|459788978|FG002|Overall Study|Lost to Follow-up|45|||
127771311|NCT00081770|459788976|FG000|Overall Study|Protocol Violation|15|||
127771312|NCT00081770|459788977|FG001|Overall Study|Protocol Violation|10|||
127771313|NCT00081770|459788978|FG002|Overall Study|Protocol Violation|10|||
127771314|NCT00081770|459788976|FG000|Overall Study|Withdrawal by Subject|45|||
127771315|NCT00081770|459788977|FG001|Overall Study|Withdrawal by Subject|40|||
127771316|NCT00081770|459788978|FG002|Overall Study|Withdrawal by Subject|42|||
127771317|NCT00081770|459788976|FG000|Overall Study|Did not meet protocol eligibility|2|||
127771318|NCT00081770|459788977|FG001|Overall Study|Did not meet protocol eligibility|0|||
127771319|NCT00081770|459788978|FG002|Overall Study|Did not meet protocol eligibility|3|||
127771320|NCT00081770|459788976|FG000|Overall Study|Administrative|1|||
127771321|NCT00081770|459788977|FG001|Overall Study|Administrative|0|||
127771322|NCT00081770|459788978|FG002|Overall Study|Administrative|1|||
127771323|NCT00081770|459788976|FG000|Overall Study|Other|2|||
127771324|NCT00081770|459788977|FG001|Overall Study|Other|7|||
127771325|NCT00081770|459788978|FG002|Overall Study|Other|8|||
127771326|NCT00601419|459788979|FG000|Overall Study|Lost to Follow-up|3|||
127771327|NCT00601419|459788979|FG000|Overall Study|Missed Visits|1|||
127880932|NCT01215955|460186074|FG003|Overall Study|Physician Decision|11|||
127771328|NCT01614197|459788980|FG000|Overall Study|Withdrawal by Subject|0|||
127771329|NCT01614197|459788981|FG001|Overall Study|Withdrawal by Subject|1|||
127771330|NCT01614197|459788982|FG002|Overall Study|Withdrawal by Subject|0|||
127771331|NCT01614197|459788983|FG003|Overall Study|Withdrawal by Subject|0|||
127771332|NCT00288509|459788984|FG000|Treatment Cycle 1|Adverse Event|1|||
127771333|NCT00288509|459788984|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
127771334|NCT00288509|459788984|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
127771335|NCT00288509|459788984|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
127771336|NCT00288509|459788984|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
127771337|NCT00288509|459788984|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
127771338|NCT00288509|459788984|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
127880933|NCT01215955|460186071|FG000|Overall Study|Protocol Violation|17|||
127880934|NCT01215955|460186072|FG001|Overall Study|Protocol Violation|13|||
128016765|NCT04589650|460684063|FG005|Overall Study|Guardian Decision|0|||
128016766|NCT02324153|460684064|FG000|Overall Study|Withdrawal by Subject|4|||
127549704|NCT02968004|458980259|FG001|Open Label Extension (OLE) Year 2|Miscellaneous|1|||
127549705|NCT02968004|458980258|FG000|Open Label Extension (OLE) Year 3|Adverse Event|1|||
127549706|NCT02968004|458980259|FG001|Open Label Extension (OLE) Year 3|Adverse Event|0|||
127549707|NCT02968004|458980258|FG000|Open Label Extension (OLE) Year 3|Withdrawal by Subject|2|||
127549708|NCT02968004|458980259|FG001|Open Label Extension (OLE) Year 3|Withdrawal by Subject|1|||
127549709|NCT02968004|458980258|FG000|Open Label Extension (OLE) Year 3|Prohibited Treatments|0|||
127549710|NCT02968004|458980259|FG001|Open Label Extension (OLE) Year 3|Prohibited Treatments|1|||
127549711|NCT02968004|458980258|FG000|Open Label Extension (OLE) Year 3|Local Crisis|1|||
127549712|NCT02968004|458980259|FG001|Open Label Extension (OLE) Year 3|Local Crisis|0|||
127549713|NCT02968004|458980258|FG000|Open Label Extension (OLE) Year 4|Withdrawal by Subject|3|||
127549714|NCT02968004|458980259|FG001|Open Label Extension (OLE) Year 4|Withdrawal by Subject|4|||
127549715|NCT02968004|458980258|FG000|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|0|||
127549716|NCT02968004|458980259|FG001|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|1|||
127549717|NCT02968004|458980258|FG000|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|27|||
127549718|NCT02968004|458980259|FG001|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|21|||
127549719|NCT02968004|458980258|FG000|Open Label Extension (OLE) Year 4|Bone Age Reached|3|||
127549720|NCT02968004|458980259|FG001|Open Label Extension (OLE) Year 4|Bone Age Reached|1|||
127549721|NCT02968004|458980258|FG000|Open Label Extension (OLE) Year 4|Local Crisis|10|||
127549722|NCT02968004|458980259|FG001|Open Label Extension (OLE) Year 4|Local Crisis|9|||
127549723|NCT02968004|458980258|FG000|Open Label Extension (OLE) Year 4|Miscellaneous|2|||
127549724|NCT02968004|458980259|FG001|Open Label Extension (OLE) Year 4|Miscellaneous|0|||
127549725|NCT02968004|458980258|FG000|Open Label Extension (OLE) Year 5|Withdrawal by Subject|1|||
127549726|NCT02968004|458980259|FG001|Open Label Extension (OLE) Year 5|Withdrawal by Subject|0|||
127549727|NCT02968004|458980258|FG000|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|2|||
127549728|NCT02968004|458980259|FG001|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|6|||
127549729|NCT02968004|458980258|FG000|Open Label Extension (OLE) Year 5|Bone Age Reached,|1|||
127549730|NCT02968004|458980259|FG001|Open Label Extension (OLE) Year 5|Bone Age Reached,|0|||
127549731|NCT02968004|458980258|FG000|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|1|||
127549732|NCT02968004|458980259|FG001|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|0|||
127549733|NCT02968004|458980258|FG000|Open Label Extension (OLE) Year 5|Local Crisis|1|||
127549734|NCT02968004|458980259|FG001|Open Label Extension (OLE) Year 5|Local Crisis|0|||
127549735|NCT03722238|458980262|FG000|Overall Study|Protocol Violation|1|||
127549736|NCT03722238|458980263|FG001|Overall Study|Protocol Violation|0|||
127549737|NCT03722238|458980262|FG000|Overall Study|Physician Decision|1|||
127549738|NCT03722238|458980263|FG001|Overall Study|Physician Decision|0|||
127549739|NCT03722238|458980262|FG000|Overall Study|Death|1|||
127549740|NCT03722238|458980263|FG001|Overall Study|Death|0|||
127549741|NCT03722238|458980262|FG000|Overall Study|Lost to Follow-up|6|||
127549742|NCT03722238|458980263|FG001|Overall Study|Lost to Follow-up|0|||
127549743|NCT03722238|458980262|FG000|Overall Study|Partial missing data|44|||
127549744|NCT03722238|458980263|FG001|Overall Study|Partial missing data|1|||
127549745|NCT03722238|458980262|FG000|Overall Study|Withdrawal by Subject|2|||
127549746|NCT03722238|458980263|FG001|Overall Study|Withdrawal by Subject|0|||
127549747|NCT03722238|458980262|FG000|Overall Study|Other|4|||
127549748|NCT03722238|458980263|FG001|Overall Study|Other|0|||
127549749|NCT03722238|458980262|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
127549750|NCT03722238|458980263|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
127549751|NCT03722238|458980262|FG000|Overall Study|Did not meet risk classification group criteria|90|||
127549752|NCT03722238|458980263|FG001|Overall Study|Did not meet risk classification group criteria|0|||
127549753|NCT03722238|458980262|FG000|Overall Study|Did not sign consent|17|||
127549754|NCT03722238|458980263|FG001|Overall Study|Did not sign consent|0|||
127549755|NCT03722238|458980262|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
128016767|NCT02324153|460684065|FG001|Overall Study|Withdrawal by Subject|1|||
127549756|NCT03722238|458980263|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
127549757|NCT03722238|458980262|FG000|Overall Study|Not willing to purchase study medication|142|||
127549758|NCT03722238|458980263|FG001|Overall Study|Not willing to purchase study medication|0|||
127549759|NCT03722238|458980262|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
127684579|NCT03482011|459469913|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
127684580|NCT03482011|459469914|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
127684581|NCT03482011|459469915|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
127684582|NCT03482011|459469908|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
127684583|NCT03482011|459469909|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
127684584|NCT03482011|459469910|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
127684585|NCT03482011|459469911|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
127684586|NCT03482011|459469912|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
127684587|NCT03482011|459469913|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
127684588|NCT03482011|459469914|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
127880935|NCT01215955|460186073|FG002|Overall Study|Protocol Violation|8|||
127549760|NCT03722238|458980263|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
127549761|NCT00885170|458980272|FG000|Overall Study|Adverse Event|12|||
127549762|NCT00885170|458980273|FG001|Overall Study|Adverse Event|4|||
127549763|NCT00885170|458980272|FG000|Overall Study|Excessive bone loss|6|||
127549764|NCT00885170|458980273|FG001|Overall Study|Excessive bone loss|3|||
127549765|NCT00885170|458980272|FG000|Overall Study|Lost to Follow-up|2|||
127549766|NCT00885170|458980273|FG001|Overall Study|Lost to Follow-up|1|||
127549767|NCT00885170|458980272|FG000|Overall Study|Physician Decision|2|||
127549768|NCT00885170|458980273|FG001|Overall Study|Physician Decision|1|||
127549769|NCT00885170|458980272|FG000|Overall Study|Protocol Violation|3|||
127549770|NCT00885170|458980273|FG001|Overall Study|Protocol Violation|1|||
127549771|NCT00885170|458980272|FG000|Overall Study|Withdrawal by Subject|13|||
127549772|NCT00885170|458980273|FG001|Overall Study|Withdrawal by Subject|13|||
127549773|NCT03771664|458980274|FG000|Overall Study|Adverse Event|1|||
127549774|NCT03771664|458980275|FG001|Overall Study|Adverse Event|0|||
127549775|NCT03771664|458980274|FG000|Overall Study|Lost to Follow-up|1|||
127549776|NCT03771664|458980275|FG001|Overall Study|Lost to Follow-up|0|||
127549777|NCT03771664|458980274|FG000|Overall Study|Withdrawal by Participant|1|||
127549778|NCT03771664|458980275|FG001|Overall Study|Withdrawal by Participant|4|||
127549779|NCT03771664|458980274|FG000|Overall Study|Randomized but not Treated|0|||
127549780|NCT03771664|458980275|FG001|Overall Study|Randomized but not Treated|1|||
127549781|NCT00561925|458980276|FG000|14 Day Lead-In Period|Adverse Event|38|||
127549782|NCT00561925|458980277|FG001|14 Day Lead-In Period|Adverse Event|0|||
127549783|NCT00561925|458980278|FG002|14 Day Lead-In Period|Adverse Event|0|||
127549784|NCT00561925|458980279|FG003|14 Day Lead-In Period|Adverse Event|0|||
127549785|NCT00561925|458980280|FG004|14 Day Lead-In Period|Adverse Event|0|||
127549786|NCT00561925|458980276|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
127549787|NCT00561925|458980277|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
127549788|NCT00561925|458980278|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
127549789|NCT00561925|458980279|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
127549790|NCT00561925|458980280|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
127549791|NCT00561925|458980276|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
127549792|NCT00561925|458980277|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
127549793|NCT00561925|458980278|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
127549794|NCT00561925|458980279|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
127549795|NCT00561925|458980280|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
127684589|NCT03482011|459469915|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
127771339|NCT00288509|459788984|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
127771340|NCT00288509|459788984|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
127549796|NCT00561925|458980276|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
127684590|NCT03482011|459469908|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
127684591|NCT03482011|459469909|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
127684592|NCT03482011|459469910|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
127684593|NCT03482011|459469911|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
127684594|NCT03482011|459469912|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
127684595|NCT03482011|459469913|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
127684596|NCT03482011|459469914|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
127684597|NCT03482011|459469915|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
127684598|NCT03482011|459469908|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
127684599|NCT03482011|459469909|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
127684600|NCT03482011|459469910|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
127684601|NCT03482011|459469911|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
127684602|NCT03482011|459469912|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
127684603|NCT03482011|459469913|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
127684604|NCT03482011|459469914|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
127684605|NCT03482011|459469915|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
127684606|NCT03482011|459469908|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
127684607|NCT03482011|459469909|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
127684608|NCT03482011|459469910|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
127684609|NCT03482011|459469911|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
127684610|NCT03482011|459469912|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
127684611|NCT03482011|459469913|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
127684612|NCT03482011|459469914|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
127684613|NCT03482011|459469915|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
127684614|NCT03482011|459469908|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
127771341|NCT00288509|459788984|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
127771342|NCT00288509|459788984|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
127549797|NCT00561925|458980277|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
127549798|NCT00561925|458980278|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
127549799|NCT00561925|458980279|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
127549800|NCT00561925|458980280|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
127549801|NCT00561925|458980276|FG000|14 Day Lead-In Period|Other|5|||
127549802|NCT00561925|458980277|FG001|14 Day Lead-In Period|Other|0|||
127549803|NCT00561925|458980278|FG002|14 Day Lead-In Period|Other|0|||
127549804|NCT00561925|458980279|FG003|14 Day Lead-In Period|Other|0|||
127549805|NCT00561925|458980280|FG004|14 Day Lead-In Period|Other|0|||
127549806|NCT00561925|458980276|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
127549807|NCT00561925|458980277|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
127549808|NCT00561925|458980278|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
127549809|NCT00561925|458980279|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
127549810|NCT00561925|458980280|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
127549811|NCT00561925|458980276|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
127549812|NCT00561925|458980277|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
127549813|NCT00561925|458980278|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
127549814|NCT00561925|458980279|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
127549815|NCT00561925|458980280|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
127549816|NCT00561925|458980276|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
127549817|NCT00561925|458980277|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
127549818|NCT00561925|458980278|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
127549819|NCT00561925|458980279|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
127549820|NCT00561925|458980280|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
127549821|NCT00561925|458980276|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
127549822|NCT00561925|458980277|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
127549823|NCT00561925|458980278|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
127549824|NCT00561925|458980279|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
127549825|NCT00561925|458980280|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
127549826|NCT00561925|458980276|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
127549827|NCT00561925|458980277|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
127549828|NCT00561925|458980278|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
127549829|NCT00561925|458980279|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
127549830|NCT00561925|458980280|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
127549831|NCT00561925|458980276|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
127549832|NCT00561925|458980277|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
127549833|NCT00561925|458980278|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
127549834|NCT00561925|458980279|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
127549835|NCT00561925|458980280|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
127549836|NCT00561925|458980276|FG000|144-week Double-blind, Double-dummy|Death|0|||
127549837|NCT00561925|458980277|FG001|144-week Double-blind, Double-dummy|Death|6|||
127549838|NCT00561925|458980278|FG002|144-week Double-blind, Double-dummy|Death|3|||
127549839|NCT00561925|458980279|FG003|144-week Double-blind, Double-dummy|Death|0|||
127549840|NCT00561925|458980280|FG004|144-week Double-blind, Double-dummy|Death|0|||
127549841|NCT00561925|458980276|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
127549842|NCT00561925|458980277|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
127549843|NCT00561925|458980278|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
127549844|NCT00561925|458980279|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
127549845|NCT00561925|458980280|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
127549846|NCT00561925|458980276|FG000|144-week Double-blind, Double-dummy|Other|0|||
127549847|NCT00561925|458980277|FG001|144-week Double-blind, Double-dummy|Other|8|||
127549848|NCT00561925|458980278|FG002|144-week Double-blind, Double-dummy|Other|11|||
127549849|NCT00561925|458980279|FG003|144-week Double-blind, Double-dummy|Other|0|||
127549850|NCT00561925|458980280|FG004|144-week Double-blind, Double-dummy|Other|0|||
127549851|NCT00561925|458980276|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
127549852|NCT00561925|458980277|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
127549853|NCT00561925|458980278|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
127549854|NCT00561925|458980279|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
127549855|NCT00561925|458980280|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
127549856|NCT00891904|458980281|FG000|Overall Study|Death|1|||
127549857|NCT00891904|458980281|FG000|Overall Study|Adverse Event|1|||
127549858|NCT05021978|458980282|FG000|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|1|||
128016768|NCT02324153|460684064|FG000|Overall Study|Surgery postponed after randomization|3|||
128016769|NCT02324153|460684065|FG001|Overall Study|Surgery postponed after randomization|0|||
127549859|NCT05021978|458980283|FG001|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
127684615|NCT03482011|459469909|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
127684616|NCT03482011|459469910|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
127684617|NCT03482011|459469911|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
127684618|NCT03482011|459469912|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
127684619|NCT03482011|459469913|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
127684620|NCT03482011|459469914|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
127684621|NCT03482011|459469915|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
127684622|NCT03482011|459469908|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
127684623|NCT03482011|459469909|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
127549860|NCT05021978|458980284|FG002|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
127549861|NCT05021978|458980285|FG003|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
127549862|NCT05021978|458980282|FG000|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
127549863|NCT05021978|458980283|FG001|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|6|||
127549864|NCT05021978|458980284|FG002|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
127549865|NCT05021978|458980285|FG003|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
127549866|NCT02177032|458980288|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
127549867|NCT02177032|458980289|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
127549868|NCT02177032|458980290|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
127549869|NCT02177032|458980291|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
127549870|NCT02177032|458980288|FG000|Overall Study|Lost to Follow-up|0|||
127549871|NCT02177032|458980289|FG001|Overall Study|Lost to Follow-up|2|||
127549872|NCT02177032|458980290|FG002|Overall Study|Lost to Follow-up|0|||
127549873|NCT02177032|458980291|FG003|Overall Study|Lost to Follow-up|0|||
127549874|NCT02177032|458980288|FG000|Overall Study|OTHER|2|||
127549875|NCT02177032|458980289|FG001|Overall Study|OTHER|0|||
127549876|NCT02177032|458980290|FG002|Overall Study|OTHER|1|||
127549877|NCT02177032|458980291|FG003|Overall Study|OTHER|0|||
127549878|NCT02177032|458980288|FG000|Overall Study|Withdrawal by Subject|1|||
127549879|NCT02177032|458980289|FG001|Overall Study|Withdrawal by Subject|0|||
127549880|NCT02177032|458980290|FG002|Overall Study|Withdrawal by Subject|1|||
127549881|NCT02177032|458980291|FG003|Overall Study|Withdrawal by Subject|0|||
127549882|NCT03096288|458980293|FG000|Overall Study|Withdrawal by Subject|0|||
127549883|NCT03096288|458980294|FG001|Overall Study|Withdrawal by Subject|1|||
127549884|NCT03096288|458980295|FG002|Overall Study|Withdrawal by Subject|0|||
127549885|NCT03096288|458980296|FG003|Overall Study|Withdrawal by Subject|1|||
127549886|NCT02558296|458980300|FG000|Completed the Study Through Week 24|Adverse Event|9|||
127549887|NCT02558296|458980301|FG001|Completed the Study Through Week 24|Adverse Event|3|||
127549888|NCT02558296|458980300|FG000|Completed the Study Through Week 24|Death|7|||
127549889|NCT02558296|458980301|FG001|Completed the Study Through Week 24|Death|7|||
127549890|NCT02558296|458980300|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
127549891|NCT02558296|458980301|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
127549892|NCT02558296|458980300|FG000|Completed the Study Through Week 24|Physician Decision|1|||
127549893|NCT02558296|458980301|FG001|Completed the Study Through Week 24|Physician Decision|0|||
127549894|NCT02558296|458980300|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
127549895|NCT02558296|458980301|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
127549896|NCT02558296|458980300|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
128016770|NCT02324153|460684064|FG000|Overall Study|Developed delirium preoperatively|1|||
128016771|NCT02324153|460684065|FG001|Overall Study|Developed delirium preoperatively|0|||
128016772|NCT03122106|460684068|FG000|Overall Study|Not enough tissue|1|||
128016773|NCT03122106|460684068|FG000|Overall Study|Disease progression during screening|2|||
128016774|NCT03122106|460684068|FG000|Overall Study|Poor RNA quality for vaccine|1|||
127549897|NCT02558296|458980301|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
127549898|NCT02558296|458980300|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
127549899|NCT02558296|458980301|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
127549900|NCT02558296|458980300|FG000|Completed the Study|Adverse Event|14|||
127549901|NCT02558296|458980301|FG001|Completed the Study|Adverse Event|5|||
127549902|NCT02558296|458980300|FG000|Completed the Study|Death|39|||
127549903|NCT02558296|458980301|FG001|Completed the Study|Death|25|||
127684624|NCT03482011|459469910|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
127880936|NCT01215955|460186074|FG003|Overall Study|Protocol Violation|8|||
127549904|NCT02558296|458980300|FG000|Completed the Study|Lost to Follow-up|31|||
127549905|NCT02558296|458980301|FG001|Completed the Study|Lost to Follow-up|23|||
127549906|NCT02558296|458980300|FG000|Completed the Study|Physician Decision|6|||
127549907|NCT02558296|458980301|FG001|Completed the Study|Physician Decision|0|||
127549908|NCT02558296|458980300|FG000|Completed the Study|Protocol Violation|2|||
127549909|NCT02558296|458980301|FG001|Completed the Study|Protocol Violation|1|||
127549910|NCT02558296|458980300|FG000|Completed the Study|Withdrawal by Subject|53|||
127549911|NCT02558296|458980301|FG001|Completed the Study|Withdrawal by Subject|31|||
127549912|NCT02558296|458980300|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
127549913|NCT02558296|458980301|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
127549914|NCT02819804|458980302|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
127549915|NCT00346697|458980305|FG000|Overall Study|Lost to Follow-up|0|||
127549916|NCT00346697|458980306|FG001|Overall Study|Lost to Follow-up|1|||
127549917|NCT01055197|458980312|FG000|Overall Study|Protocol Violation|7|||
127549918|NCT01055197|458980313|FG001|Overall Study|Protocol Violation|2|||
127549919|NCT01055197|458980312|FG000|Overall Study|Withdrawal by Subject|2|||
127549920|NCT01055197|458980313|FG001|Overall Study|Withdrawal by Subject|0|||
127549921|NCT00389610|458980314|FG000|Overall Study|Disease Progression|0|||
127549922|NCT00389610|458980315|FG001|Overall Study|Disease Progression|19|||
127549923|NCT00389610|458980314|FG000|Overall Study|Death|0|||
128016775|NCT01147458|460684071|FG000|First Intervention|Study terminated by sponsor|8|||
127771343|NCT00288509|459788984|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
128016776|NCT01147458|460684072|FG001|First Intervention|Study terminated by sponsor|8|||
128016777|NCT01147458|460684073|FG002|First Intervention|Study terminated by sponsor|7|||
128016778|NCT01147458|460684074|FG003|First Intervention|Study terminated by sponsor|8|||
128016779|NCT01147458|460684071|FG000|First Intervention|Protocol Violation|2|||
128016780|NCT01147458|460684072|FG001|First Intervention|Protocol Violation|3|||
128016781|NCT01147458|460684073|FG002|First Intervention|Protocol Violation|2|||
128016782|NCT01147458|460684074|FG003|First Intervention|Protocol Violation|3|||
128016783|NCT01147458|460684071|FG000|First Intervention|Withdrawal by Subject|3|||
128016784|NCT01147458|460684072|FG001|First Intervention|Withdrawal by Subject|0|||
128016785|NCT01147458|460684073|FG002|First Intervention|Withdrawal by Subject|1|||
128016786|NCT01147458|460684074|FG003|First Intervention|Withdrawal by Subject|0|||
128016787|NCT01147458|460684071|FG000|First Intervention|Adverse Event|0|||
128016788|NCT01147458|460684072|FG001|First Intervention|Adverse Event|3|||
128016789|NCT01147458|460684073|FG002|First Intervention|Adverse Event|2|||
128016790|NCT01147458|460684074|FG003|First Intervention|Adverse Event|3|||
128016791|NCT01147458|460684071|FG000|First Intervention|Other|1|||
128016792|NCT01147458|460684072|FG001|First Intervention|Other|2|||
128016793|NCT01147458|460684073|FG002|First Intervention|Other|0|||
128016794|NCT01147458|460684074|FG003|First Intervention|Other|0|||
128016795|NCT01147458|460684071|FG000|Second Intervention|Study terminated by sponsor|7|||
128016796|NCT01147458|460684072|FG001|Second Intervention|Study terminated by sponsor|5|||
128016797|NCT01147458|460684073|FG002|Second Intervention|Study terminated by sponsor|5|||
128016798|NCT01147458|460684074|FG003|Second Intervention|Study terminated by sponsor|3|||
128016799|NCT01147458|460684071|FG000|Second Intervention|Protocol Violation|0|||
128016800|NCT01147458|460684072|FG001|Second Intervention|Protocol Violation|1|||
128016801|NCT01147458|460684073|FG002|Second Intervention|Protocol Violation|1|||
128016802|NCT01147458|460684074|FG003|Second Intervention|Protocol Violation|0|||
128016803|NCT01147458|460684071|FG000|Second Intervention|Withdrawal by Subject|0|||
128016804|NCT01147458|460684072|FG001|Second Intervention|Withdrawal by Subject|1|||
128016805|NCT01147458|460684073|FG002|Second Intervention|Withdrawal by Subject|0|||
128016806|NCT01147458|460684074|FG003|Second Intervention|Withdrawal by Subject|0|||
128016807|NCT01147458|460684071|FG000|Second Intervention|Adverse Event|2|||
128016808|NCT01147458|460684072|FG001|Second Intervention|Adverse Event|0|||
128016809|NCT01147458|460684073|FG002|Second Intervention|Adverse Event|1|||
128016810|NCT01147458|460684074|FG003|Second Intervention|Adverse Event|1|||
128016811|NCT01147458|460684071|FG000|Second Intervention|Other|0|||
128016812|NCT01147458|460684072|FG001|Second Intervention|Other|0|||
128016813|NCT01147458|460684073|FG002|Second Intervention|Other|1|||
128016814|NCT01147458|460684074|FG003|Second Intervention|Other|0|||
128016815|NCT03550209|460684075|FG000|Overall Study|Lost to Follow-up|1|||
128016816|NCT03550209|460684076|FG001|Overall Study|Lost to Follow-up|0|||
128016817|NCT03550209|460684077|FG002|Overall Study|Lost to Follow-up|1|||
128016818|NCT03550209|460684078|FG003|Overall Study|Lost to Follow-up|0|||
128016819|NCT03550209|460684075|FG000|Overall Study|Withdrawal by Subject|0|||
128016820|NCT03550209|460684076|FG001|Overall Study|Withdrawal by Subject|3|||
128016821|NCT03550209|460684077|FG002|Overall Study|Withdrawal by Subject|1|||
128016822|NCT03550209|460684078|FG003|Overall Study|Withdrawal by Subject|2|||
128016823|NCT03550209|460684075|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
128016824|NCT03550209|460684076|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
128016825|NCT03550209|460684077|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
128016826|NCT03550209|460684078|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
128016827|NCT02555878|460684079|FG000|Overall Study|Lost to Follow-up|2|||
127771344|NCT00288509|459788984|FG000|Treatment Cycle 4|Physician Decision|4|||
127771345|NCT00288509|459788984|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
127771346|NCT03840486|459788985|FG000|Overall Study|Withdrawal by Subject|0|||
127771347|NCT03840486|459788986|FG001|Overall Study|Withdrawal by Subject|1|||
127771348|NCT03840486|459788987|FG002|Overall Study|Withdrawal by Subject|0|||
127771349|NCT03840486|459788988|FG003|Overall Study|Withdrawal by Subject|0|||
127771350|NCT03840486|459788989|FG004|Overall Study|Withdrawal by Subject|0|||
127771351|NCT03840486|459788990|FG005|Overall Study|Withdrawal by Subject|0|||
127771352|NCT03840486|459788991|FG006|Overall Study|Withdrawal by Subject|0|||
127771353|NCT03840486|459788992|FG007|Overall Study|Withdrawal by Subject|0|||
127771354|NCT03840486|459788993|FG008|Overall Study|Withdrawal by Subject|0|||
127771355|NCT03840486|459788994|FG009|Overall Study|Withdrawal by Subject|0|||
127771356|NCT03840486|459788995|FG010|Overall Study|Withdrawal by Subject|0|||
127771357|NCT03840486|459788996|FG011|Overall Study|Withdrawal by Subject|0|||
127771358|NCT02963610|459788997|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
127771359|NCT01774110|459788998|FG000|Overall Study|Lost to Follow-up|7|||
128016828|NCT02555878|460684080|FG001|Overall Study|Lost to Follow-up|3|||
128016829|NCT02555878|460684079|FG000|Overall Study|Withdrawal by Subject|48|||
128016830|NCT02555878|460684080|FG001|Overall Study|Withdrawal by Subject|48|||
128016831|NCT02555878|460684079|FG000|Overall Study|Adverse Event|12|||
128016832|NCT02555878|460684080|FG001|Overall Study|Adverse Event|8|||
128016833|NCT02555878|460684079|FG000|Overall Study|Death|74|||
128016834|NCT02555878|460684080|FG001|Overall Study|Death|59|||
127549924|NCT00389610|458980315|FG001|Overall Study|Death|1|||
127549925|NCT00389610|458980314|FG000|Overall Study|Physician Decision|0|||
127549926|NCT00389610|458980315|FG001|Overall Study|Physician Decision|1|||
127549927|NCT00389610|458980314|FG000|Overall Study|Withdrawal by Subject|0|||
127549928|NCT00389610|458980315|FG001|Overall Study|Withdrawal by Subject|1|||
127549929|NCT00538902|458980316|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
127549930|NCT00538902|458980317|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
127549931|NCT00538902|458980318|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
127549932|NCT00538902|458980316|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
127549933|NCT00538902|458980317|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
127549934|NCT00538902|458980318|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
127549935|NCT00538902|458980316|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
127549936|NCT00538902|458980317|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
127549937|NCT00538902|458980318|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
127549938|NCT00538902|458980316|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
127549939|NCT00538902|458980317|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
127549940|NCT00538902|458980318|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
127549941|NCT00538902|458980316|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
127549942|NCT00538902|458980317|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
127549943|NCT00538902|458980318|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
127549944|NCT00538902|458980316|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
127549945|NCT00538902|458980317|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
127549946|NCT00538902|458980318|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
127549947|NCT00538902|458980316|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
127549948|NCT00538902|458980317|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
127549949|NCT00538902|458980318|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
127549950|NCT00538902|458980316|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
127549951|NCT00538902|458980317|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
127549952|NCT00538902|458980318|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
127549953|NCT03739203|458980319|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
127549954|NCT03739203|458980320|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
127549955|NCT03739203|458980321|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
127549956|NCT03739203|458980319|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
127549957|NCT03739203|458980320|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
127549958|NCT03739203|458980321|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
127549959|NCT03739203|458980319|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
127549960|NCT03739203|458980320|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
127549961|NCT03739203|458980321|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
127549962|NCT03739203|458980319|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
127549963|NCT03739203|458980320|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
127549964|NCT03739203|458980321|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
127549965|NCT03739203|458980319|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
127549966|NCT03739203|458980320|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
127549967|NCT03739203|458980321|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
127549968|NCT03739203|458980319|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
127549969|NCT03739203|458980320|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
127549970|NCT03739203|458980321|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
127549971|NCT03739203|458980319|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
127549972|NCT03739203|458980320|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
127549973|NCT03739203|458980321|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
127549974|NCT03739203|458980319|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
127549975|NCT03739203|458980320|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
127549976|NCT03739203|458980321|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
127684625|NCT03482011|459469911|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
127684626|NCT03482011|459469912|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
127684627|NCT03482011|459469913|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
127684628|NCT03482011|459469914|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
127684629|NCT03482011|459469915|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
127684630|NCT03482011|459469908|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
127684631|NCT03482011|459469909|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
127684632|NCT03482011|459469910|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
127684633|NCT03482011|459469911|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
127684634|NCT03482011|459469912|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
127684635|NCT03482011|459469913|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
127684636|NCT03482011|459469914|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
127880937|NCT01215955|460186071|FG000|Overall Study|Sponsor Decision|1|||
128016835|NCT02555878|460684079|FG000|Overall Study|Protocol Violation|1|||
128016836|NCT02555878|460684080|FG001|Overall Study|Protocol Violation|2|||
128016837|NCT02555878|460684079|FG000|Overall Study|Physician Decision|12|||
128016838|NCT02555878|460684080|FG001|Overall Study|Physician Decision|13|||
128016839|NCT02555878|460684079|FG000|Overall Study|Other|17|||
128016840|NCT02555878|460684080|FG001|Overall Study|Other|17|||
128016841|NCT00765076|460684081|FG000|Overall Study|Adverse Event|1|||
128016842|NCT00765076|460684082|FG001|Overall Study|Adverse Event|0|||
128016843|NCT00765076|460684083|FG002|Overall Study|Adverse Event|0|||
128016844|NCT00765076|460684081|FG000|Overall Study|Withdrawal by Subject|0|||
128016845|NCT00765076|460684082|FG001|Overall Study|Withdrawal by Subject|0|||
128016846|NCT00765076|460684083|FG002|Overall Study|Withdrawal by Subject|1|||
128016847|NCT02875080|460684084|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
128016848|NCT02875080|460684085|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
128016849|NCT02875080|460684086|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
128016850|NCT00768053|460684087|FG000|Overall Study|Adverse Event|10|||
128016851|NCT00768053|460684087|FG000|Overall Study|Lost to Follow-up|1|||
128016852|NCT01164475|460684088|FG000|Overall Study|Lack of Efficacy|1|||
128016853|NCT01164475|460684089|FG001|Overall Study|Lack of Efficacy|0|||
128016854|NCT01164475|460684088|FG000|Overall Study|Other|0|||
128016855|NCT01164475|460684089|FG001|Overall Study|Other|1|||
128016856|NCT01164475|460684088|FG000|Overall Study|Progressive disease|0|||
128016857|NCT01164475|460684089|FG001|Overall Study|Progressive disease|1|||
128016858|NCT01164475|460684088|FG000|Overall Study|Protocol Violation|1|||
128016859|NCT01164475|460684089|FG001|Overall Study|Protocol Violation|0|||
128016860|NCT04603066|460684091|FG000|Wash-out (3 Weeks)|Protocol Violation|1|||
128016861|NCT04603066|460684092|FG001|Wash-out (3 Weeks)|Protocol Violation|0|||
128016864|NCT01371981|460684095|FG000|Overall Study|Adverse Event|12|||
128016865|NCT01371981|460684096|FG001|Overall Study|Adverse Event|17|||
128016866|NCT01371981|460684097|FG002|Overall Study|Adverse Event|0|||
128016867|NCT01371981|460684098|FG003|Overall Study|Adverse Event|4|||
128016868|NCT01371981|460684099|FG004|Overall Study|Adverse Event|1|||
128016869|NCT01371981|460684100|FG005|Overall Study|Adverse Event|0|||
128016870|NCT01371981|460684095|FG000|Overall Study|Death|22|||
128016871|NCT01371981|460684096|FG001|Overall Study|Death|16|||
128016872|NCT01371981|460684097|FG002|Overall Study|Death|0|||
128016873|NCT01371981|460684098|FG003|Overall Study|Death|0|||
128016874|NCT01371981|460684099|FG004|Overall Study|Death|2|||
128016875|NCT01371981|460684100|FG005|Overall Study|Death|2|||
128016876|NCT01371981|460684095|FG000|Overall Study|Lack of Efficacy|69|||
128016877|NCT01371981|460684096|FG001|Overall Study|Lack of Efficacy|61|||
128016878|NCT01371981|460684097|FG002|Overall Study|Lack of Efficacy|4|||
128016879|NCT01371981|460684098|FG003|Overall Study|Lack of Efficacy|8|||
128016880|NCT01371981|460684099|FG004|Overall Study|Lack of Efficacy|5|||
128016881|NCT01371981|460684100|FG005|Overall Study|Lack of Efficacy|0|||
128016882|NCT01371981|460684095|FG000|Overall Study|Physician Decision|48|||
128016883|NCT01371981|460684096|FG001|Overall Study|Physician Decision|63|||
128016884|NCT01371981|460684097|FG002|Overall Study|Physician Decision|1|||
128016885|NCT01371981|460684098|FG003|Overall Study|Physician Decision|7|||
128016886|NCT01371981|460684099|FG004|Overall Study|Physician Decision|14|||
128016887|NCT01371981|460684100|FG005|Overall Study|Physician Decision|3|||
128016888|NCT01371981|460684095|FG000|Overall Study|Withdrawal by Subject|12|||
128016889|NCT01371981|460684096|FG001|Overall Study|Withdrawal by Subject|19|||
128016890|NCT01371981|460684097|FG002|Overall Study|Withdrawal by Subject|1|||
128016891|NCT01371981|460684098|FG003|Overall Study|Withdrawal by Subject|2|||
127684637|NCT03482011|459469915|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
127684638|NCT03482011|459469908|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
127684639|NCT03482011|459469909|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
127684640|NCT03482011|459469910|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
127684641|NCT03482011|459469911|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
127684642|NCT03482011|459469912|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
128016892|NCT01371981|460684099|FG004|Overall Study|Withdrawal by Subject|10|||
128016893|NCT01371981|460684100|FG005|Overall Study|Withdrawal by Subject|3|||
128016894|NCT01371981|460684095|FG000|Overall Study|Ineligible|19|||
128016895|NCT01371981|460684096|FG001|Overall Study|Ineligible|13|||
128016896|NCT01371981|460684097|FG002|Overall Study|Ineligible|0|||
128016897|NCT01371981|460684098|FG003|Overall Study|Ineligible|0|||
128016898|NCT01371981|460684099|FG004|Overall Study|Ineligible|0|||
128016899|NCT01371981|460684100|FG005|Overall Study|Ineligible|4|||
128016900|NCT01371981|460684095|FG000|Overall Study|Did not start treatment|2|||
128016901|NCT01371981|460684096|FG001|Overall Study|Did not start treatment|3|||
128016902|NCT01371981|460684097|FG002|Overall Study|Did not start treatment|0|||
128016903|NCT01371981|460684098|FG003|Overall Study|Did not start treatment|0|||
128016904|NCT01371981|460684099|FG004|Overall Study|Did not start treatment|0|||
128016905|NCT01371981|460684100|FG005|Overall Study|Did not start treatment|2|||
128016906|NCT03244189|460684101|FG000|Overall Study|Death|0|||
128016907|NCT03244189|460684102|FG001|Overall Study|Death|2|||
127549977|NCT03739203|458980319|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
127549978|NCT03739203|458980320|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
127549979|NCT03739203|458980321|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
127549980|NCT03739203|458980319|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
127549981|NCT03739203|458980320|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
127549982|NCT03739203|458980321|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
127549983|NCT03739203|458980319|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
127549984|NCT03739203|458980320|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
127549985|NCT03739203|458980321|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
127549986|NCT03131570|458980322|FG000|Overall Study|Adverse Event|1|||
127549987|NCT03131570|458980323|FG001|Overall Study|Adverse Event|0|||
127549988|NCT01782378|458980324|FG000|First Series|Lost to Follow-up|7|||
127549989|NCT01782378|458980325|FG001|First Series|Lost to Follow-up|8|||
127549990|NCT01782378|458980324|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
127549991|NCT01782378|458980325|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
127549992|NCT01782378|458980324|FG000|Second Series|Lost to Follow-up|8|||
127771360|NCT00640016|459788999|FG000|Overall Study|Withdrawal by Subject|0|||
127771361|NCT00640016|459789000|FG001|Overall Study|Withdrawal by Subject|1|||
127771362|NCT00640016|459789001|FG002|Overall Study|Withdrawal by Subject|0|||
127771363|NCT00640016|459789002|FG003|Overall Study|Withdrawal by Subject|0|||
127771364|NCT00640016|459788999|FG000|Overall Study|Study termination|2|||
127771365|NCT00640016|459789000|FG001|Overall Study|Study termination|1|||
127771366|NCT00640016|459789001|FG002|Overall Study|Study termination|3|||
127771367|NCT00640016|459789002|FG003|Overall Study|Study termination|2|||
127771368|NCT00640016|459788999|FG000|Overall Study|Adverse Event|0|||
127771369|NCT00640016|459789000|FG001|Overall Study|Adverse Event|0|||
127771370|NCT00640016|459789001|FG002|Overall Study|Adverse Event|0|||
127771371|NCT00640016|459789002|FG003|Overall Study|Adverse Event|1|||
127771372|NCT01978262|459789007|FG000|Overall Study|Withdrawal by Subject|9|||
127771373|NCT01978262|459789007|FG000|Overall Study|Lost to Follow-up|2|||
127771374|NCT00141726|459789015|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
127771375|NCT01790126|459789016|FG000|Overall Study|PSA Progression|12|||
127771376|NCT01790126|459789017|FG001|Overall Study|PSA Progression|16|||
127771377|NCT01790126|459789018|FG002|Overall Study|PSA Progression|16|||
127771378|NCT01790126|459789016|FG000|Overall Study|Other|5|||
127771379|NCT01790126|459789017|FG001|Overall Study|Other|4|||
127771380|NCT01790126|459789018|FG002|Overall Study|Other|8|||
127771381|NCT01790126|459789016|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
127771382|NCT01790126|459789017|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
127771383|NCT01790126|459789018|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
127771384|NCT01790126|459789016|FG000|Overall Study|Withdrawal by Physician|1|||
127771385|NCT01790126|459789017|FG001|Overall Study|Withdrawal by Physician|1|||
127771386|NCT01790126|459789018|FG002|Overall Study|Withdrawal by Physician|2|||
127771387|NCT01790126|459789016|FG000|Overall Study|Withdrawal by Subject|3|||
127771388|NCT01790126|459789017|FG001|Overall Study|Withdrawal by Subject|1|||
127771389|NCT01790126|459789018|FG002|Overall Study|Withdrawal by Subject|2|||
127771390|NCT01790126|459789016|FG000|Overall Study|Lost to Follow-up|1|||
127771391|NCT01790126|459789017|FG001|Overall Study|Lost to Follow-up|0|||
127771392|NCT01790126|459789018|FG002|Overall Study|Lost to Follow-up|1|||
127771393|NCT01790126|459789016|FG000|Overall Study|Adverse Event|0|||
127771394|NCT01790126|459789017|FG001|Overall Study|Adverse Event|2|||
127771395|NCT01790126|459789018|FG002|Overall Study|Adverse Event|0|||
127771396|NCT01790126|459789016|FG000|Overall Study|Death|2|||
127771397|NCT01790126|459789017|FG001|Overall Study|Death|0|||
127771398|NCT01790126|459789018|FG002|Overall Study|Death|0|||
127771399|NCT01790126|459789016|FG000|Overall Study|Radiographic Progression|3|||
127771400|NCT01790126|459789017|FG001|Overall Study|Radiographic Progression|1|||
127771401|NCT01790126|459789018|FG002|Overall Study|Radiographic Progression|0|||
127549993|NCT01782378|458980325|FG001|Second Series|Lost to Follow-up|7|||
127549994|NCT01782378|458980324|FG000|Second Series|Did not choose to complete S2 Optional|18|||
127549995|NCT01782378|458980325|FG001|Second Series|Did not choose to complete S2 Optional|0|||
127549996|NCT00830440|458980326|FG000|Overall Study|Protocol Violation|1|||
127549997|NCT00830440|458980327|FG001|Overall Study|Protocol Violation|0|||
127771402|NCT02435966|459789019|FG000|Overall Study|Withdrawal by Subject|0|||
127771403|NCT02435966|459789020|FG001|Overall Study|Withdrawal by Subject|1|||
127771404|NCT02435966|459789021|FG002|Overall Study|Withdrawal by Subject|0|||
127771405|NCT02349451|459789024|FG000|Overall Study|Withdrawal by Subject|0|||
127771406|NCT02349451|459789025|FG001|Overall Study|Withdrawal by Subject|1|||
127771407|NCT02349451|459789026|FG002|Overall Study|Withdrawal by Subject|2|||
127771408|NCT02349451|459789027|FG003|Overall Study|Withdrawal by Subject|1|||
127549998|NCT00830440|458980326|FG000|Overall Study|Withdrawal by Subject|1|||
127549999|NCT00830440|458980327|FG001|Overall Study|Withdrawal by Subject|0|||
127550000|NCT00830440|458980326|FG000|Overall Study|unsuccessful procedure|4|||
127771409|NCT02168842|459789029|FG000|Overall Study|Withdrawal by Subject|5|||
127771410|NCT02168842|459789030|FG001|Overall Study|Withdrawal by Subject|3|||
127771411|NCT02168842|459789029|FG000|Overall Study|Lost to Follow-up|0|||
127550001|NCT00830440|458980327|FG001|Overall Study|unsuccessful procedure|0|||
127550002|NCT00830440|458980326|FG000|Overall Study|Adverse Event|2|||
127550003|NCT00830440|458980327|FG001|Overall Study|Adverse Event|0|||
127550004|NCT00942604|458980333|FG000|Overall Study|Protocol Violation|1|||
127550005|NCT00942604|458980334|FG001|Overall Study|Protocol Violation|1|||
127550006|NCT00942604|458980333|FG000|Overall Study|Adverse Event|0|||
127550007|NCT00942604|458980334|FG001|Overall Study|Adverse Event|1|||
127550008|NCT00942604|458980333|FG000|Overall Study|Withdrawal by Subject|0|||
127550009|NCT00942604|458980334|FG001|Overall Study|Withdrawal by Subject|1|||
127550010|NCT00942604|458980333|FG000|Overall Study|Patient relocation|1|||
127550011|NCT00942604|458980334|FG001|Overall Study|Patient relocation|1|||
127550012|NCT01188343|458980335|FG000|Overall Study|Not vaccinated|0|||
127550013|NCT01188343|458980336|FG001|Overall Study|Not vaccinated|2|||
127550014|NCT01188343|458980337|FG002|Overall Study|Not vaccinated|1|||
127550015|NCT01188343|458980335|FG000|Overall Study|Withdrawal by Subject|1|||
127550016|NCT01188343|458980336|FG001|Overall Study|Withdrawal by Subject|24|||
127550017|NCT01188343|458980337|FG002|Overall Study|Withdrawal by Subject|0|||
127550018|NCT01143246|458980338|FG000|Overall Study|Adverse Event|24|||
127550019|NCT01143246|458980339|FG001|Overall Study|Adverse Event|28|||
127550020|NCT01143246|458980338|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
127550021|NCT01143246|458980339|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
127550022|NCT01143246|458980338|FG000|Overall Study|Lost to Follow-up|0|||
127550023|NCT01143246|458980339|FG001|Overall Study|Lost to Follow-up|1|||
127550024|NCT01143246|458980338|FG000|Overall Study|Death|16|||
127550025|NCT01143246|458980339|FG001|Overall Study|Death|15|||
127550026|NCT01143246|458980338|FG000|Overall Study|Reason not Specified|3|||
127550027|NCT01143246|458980339|FG001|Overall Study|Reason not Specified|5|||
127550028|NCT04119414|458980340|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
127550029|NCT03058146|458980341|FG000|Overall Study|Withdrawal by Subject|4|||
127550030|NCT03058146|458980342|FG001|Overall Study|Withdrawal by Subject|1|||
127550031|NCT03058146|458980341|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
127550032|NCT03058146|458980342|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
127550033|NCT01352793|458980345|FG000|Overall Study|Lost to Follow-up|289|||
127550034|NCT01352793|458980346|FG001|Overall Study|Lost to Follow-up|125|||
127550035|NCT01352793|458980345|FG000|Overall Study|Withdrawal by Subject|120|||
127550036|NCT01352793|458980346|FG001|Overall Study|Withdrawal by Subject|55|||
127550037|NCT01352793|458980345|FG000|Overall Study|Protocol Violation|44|||
127550038|NCT01352793|458980346|FG001|Overall Study|Protocol Violation|23|||
127771412|NCT02168842|459789030|FG001|Overall Study|Lost to Follow-up|2|||
127550039|NCT01352793|458980345|FG000|Overall Study|Adverse Event|44|||
127550040|NCT01352793|458980346|FG001|Overall Study|Adverse Event|10|||
127550041|NCT01352793|458980345|FG000|Overall Study|Physician Decision|1|||
127550042|NCT01352793|458980346|FG001|Overall Study|Physician Decision|0|||
127550043|NCT01352793|458980345|FG000|Overall Study|Pregnancy|26|||
127550044|NCT01352793|458980346|FG001|Overall Study|Pregnancy|8|||
127550045|NCT01352793|458980345|FG000|Overall Study|Other|25|||
127550046|NCT01352793|458980346|FG001|Overall Study|Other|7|||
127771413|NCT02168842|459789029|FG000|Overall Study|Death|2|||
127771414|NCT02168842|459789030|FG001|Overall Study|Death|1|||
127771415|NCT02168842|459789029|FG000|Overall Study|Physician Decision|1|||
127771416|NCT02168842|459789030|FG001|Overall Study|Physician Decision|2|||
127550047|NCT01352793|458980345|FG000|Overall Study|Medication error|2|||
127550048|NCT01352793|458980346|FG001|Overall Study|Medication error|2|||
127550049|NCT01352793|458980345|FG000|Overall Study|Death|1|||
127550050|NCT01352793|458980346|FG001|Overall Study|Death|0|||
127550051|NCT01352793|458980345|FG000|Overall Study|Randomized but not vaccinated|8|||
127550052|NCT01352793|458980346|FG001|Overall Study|Randomized but not vaccinated|0|||
127550053|NCT01352793|458980345|FG000|Overall Study|No longer meets eligibility criteria|25|||
127550054|NCT01352793|458980346|FG001|Overall Study|No longer meets eligibility criteria|15|||
127550055|NCT02839200|458980349|FG000|Overall Study|Withdrawal by Subject|2|||
127771417|NCT00325039|459789031|FG000|Overall Study|Lost to Follow-up|18|||
127771418|NCT00325039|459789032|FG001|Overall Study|Lost to Follow-up|14|||
127550056|NCT02839200|458980350|FG001|Overall Study|Withdrawal by Subject|0|||
127771419|NCT02974088|459789033|FG000|Overall Study|Lost to Follow-up|0|||
127550057|NCT02839200|458980351|FG002|Overall Study|Withdrawal by Subject|1|||
127550058|NCT02839200|458980352|FG003|Overall Study|Withdrawal by Subject|0|||
127550059|NCT02839200|458980353|FG004|Overall Study|Withdrawal by Subject|0|||
127880938|NCT01215955|460186072|FG001|Overall Study|Sponsor Decision|2|||
127550060|NCT02839200|458980354|FG005|Overall Study|Withdrawal by Subject|1|||
127550061|NCT02839200|458980349|FG000|Overall Study|Lost to Follow-up|2|||
127550062|NCT02839200|458980350|FG001|Overall Study|Lost to Follow-up|0|||
127550063|NCT02839200|458980351|FG002|Overall Study|Lost to Follow-up|0|||
127550064|NCT02839200|458980352|FG003|Overall Study|Lost to Follow-up|0|||
127550065|NCT02839200|458980353|FG004|Overall Study|Lost to Follow-up|1|||
127550066|NCT02839200|458980354|FG005|Overall Study|Lost to Follow-up|0|||
127550067|NCT02839200|458980349|FG000|Overall Study|Adverse Event|0|||
127550068|NCT02839200|458980350|FG001|Overall Study|Adverse Event|0|||
127771420|NCT02974088|459789034|FG001|Overall Study|Lost to Follow-up|2|||
127550069|NCT02839200|458980351|FG002|Overall Study|Adverse Event|0|||
127550070|NCT02839200|458980352|FG003|Overall Study|Adverse Event|0|||
127550071|NCT02839200|458980353|FG004|Overall Study|Adverse Event|1|||
127550072|NCT02839200|458980354|FG005|Overall Study|Adverse Event|0|||
127550073|NCT02839200|458980349|FG000|Overall Study|Randomized in error|0|||
127550074|NCT02839200|458980350|FG001|Overall Study|Randomized in error|1|||
127550075|NCT02839200|458980351|FG002|Overall Study|Randomized in error|0|||
127550076|NCT02839200|458980352|FG003|Overall Study|Randomized in error|0|||
127550077|NCT02839200|458980353|FG004|Overall Study|Randomized in error|0|||
127550078|NCT02839200|458980354|FG005|Overall Study|Randomized in error|0|||
127550079|NCT01094119|458980357|FG000|Overall Study|Lack of Efficacy|2|||
127550080|NCT01094119|458980358|FG001|Overall Study|Lack of Efficacy|4|||
127550081|NCT02205736|458980361|FG000|Overall Study|Lost to Follow-up|106|||
127550082|NCT01648751|458980369|FG000|Overall Study|Withdrawal by Subject|2|||
127550083|NCT01648751|458980370|FG001|Overall Study|Withdrawal by Subject|3|||
127550084|NCT03467750|458980373|FG000|Overall Study|Surgery canceled|1|||
127550085|NCT03467750|458980374|FG001|Overall Study|Surgery canceled|0|||
127550086|NCT03467750|458980373|FG000|Overall Study|Protocol Violation|1|||
127550087|NCT03467750|458980374|FG001|Overall Study|Protocol Violation|1|||
127550088|NCT03467750|458980373|FG000|Overall Study|Withdrawal by Subject|0|||
127550089|NCT03467750|458980374|FG001|Overall Study|Withdrawal by Subject|1|||
127550090|NCT05673876|458980375|FG000|Overall Study|Death|3|||
127550091|NCT05673876|458980376|FG001|Overall Study|Death|1|||
127550092|NCT05673876|458980375|FG000|Overall Study|Study Terminated by Sponsor|0|||
127550093|NCT05673876|458980376|FG001|Overall Study|Study Terminated by Sponsor|1|||
127550094|NCT05673876|458980375|FG000|Overall Study|Physician Decision|0|||
127550095|NCT05673876|458980376|FG001|Overall Study|Physician Decision|1|||
127550096|NCT02749422|458980379|FG000|Overall Study|Lost to Follow-up|0|||
127550097|NCT02749422|458980380|FG001|Overall Study|Lost to Follow-up|2|||
127550098|NCT02749422|458980379|FG000|Overall Study|Ineligible|0|||
127550099|NCT02749422|458980380|FG001|Overall Study|Ineligible|1|||
127550100|NCT02807402|458980383|FG000|Overall Study|Failure to Return|1|||
127550101|NCT02807402|458980383|FG000|Overall Study|Death|3|||
127550102|NCT02807402|458980383|FG000|Overall Study|Other|2|||
127550103|NCT04610281|458982304|FG000|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|1|||
127550104|NCT04610281|458982305|FG001|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|4|||
127550105|NCT00753506|458982308|FG000|Overall Study|Withdrawal by Subject|4|||
127550106|NCT00753506|458982309|FG001|Overall Study|Withdrawal by Subject|1|||
127550107|NCT00753506|458982308|FG000|Overall Study|Lost to Follow-up|2|||
127550108|NCT00753506|458982309|FG001|Overall Study|Lost to Follow-up|0|||
127550109|NCT00753506|458982308|FG000|Overall Study|Other reason|1|||
127550110|NCT00753506|458982309|FG001|Overall Study|Other reason|1|||
127550111|NCT00357552|458982310|FG000|Screening|Did not meet eligibility criteria|84|||
127550112|NCT00357552|458982310|FG000|Weeks 0 to 24|Death|1|||
127550113|NCT00357552|458982310|FG000|Weeks 24 to 104|Death|3|||
127550114|NCT00357552|458982310|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
127550115|NCT00521404|458982313|FG000|Overall Study|Adverse Event|13|||
127550116|NCT00521404|458982313|FG000|Overall Study|Disease Progression|33|||
127550117|NCT00521404|458982313|FG000|Overall Study|Investigator decision|5|||
127550118|NCT00521404|458982313|FG000|Overall Study|Withdrawal of consent|3|||
127550119|NCT00521404|458982313|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
127550120|NCT00521404|458982313|FG000|Overall Study|Other|7|||
127771421|NCT02974088|459789033|FG000|Overall Study|Adverse Event|0|||
127771422|NCT02974088|459789034|FG001|Overall Study|Adverse Event|1|||
128016908|NCT03244189|460684101|FG000|Overall Study|Lost to Follow-up|92|||
128016909|NCT03244189|460684102|FG001|Overall Study|Lost to Follow-up|107|||
128016910|NCT03244189|460684101|FG000|Overall Study|Physician Decision|4|||
128016911|NCT03244189|460684102|FG001|Overall Study|Physician Decision|2|||
127550121|NCT00882557|458982314|FG000|Overall Study|Withdrawal by Subject|1|||
127771423|NCT00687973|459789040|FG000|Overall Study|Adverse Event|18|||
127771424|NCT00687973|459789041|FG001|Overall Study|Adverse Event|28|||
127771425|NCT00687973|459789040|FG000|Overall Study|Lack of Efficacy|2|||
127771426|NCT00687973|459789041|FG001|Overall Study|Lack of Efficacy|3|||
127771427|NCT00687973|459789040|FG000|Overall Study|Protocol Violation|1|||
127771428|NCT00687973|459789041|FG001|Overall Study|Protocol Violation|2|||
127771429|NCT00687973|459789040|FG000|Overall Study|Administrative Reasons|0|||
127771430|NCT00687973|459789041|FG001|Overall Study|Administrative Reasons|2|||
127550122|NCT00882557|458982315|FG001|Overall Study|Withdrawal by Subject|0|||
127550123|NCT00882557|458982314|FG000|Overall Study|Trouble with Vein Access|1|||
128016912|NCT03244189|460684101|FG000|Overall Study|Pregnancy|7|||
127550124|NCT00882557|458982315|FG001|Overall Study|Trouble with Vein Access|0|||
127550125|NCT00882557|458982314|FG000|Overall Study|Randomized Not Treated|0|||
127550126|NCT00882557|458982315|FG001|Overall Study|Randomized Not Treated|1|||
127550127|NCT02282605|458982316|FG000|Overall Study|negative SA result on Day -1|3|||
127550128|NCT02282605|458982317|FG001|Overall Study|negative SA result on Day -1|0|||
127771431|NCT00687973|459789040|FG000|Overall Study|Withdrawal by Subject|3|||
127550129|NCT02282605|458982318|FG002|Overall Study|negative SA result on Day -1|0|||
127771432|NCT00687973|459789041|FG001|Overall Study|Withdrawal by Subject|3|||
127550130|NCT03584789|458982325|FG000|Overall Study|refused EHR permission|19|||
127550131|NCT03584789|458982326|FG001|Overall Study|refused EHR permission|28|||
127550132|NCT03584789|458982327|FG002|Overall Study|refused EHR permission|23|||
127550133|NCT03584789|458982325|FG000|Overall Study|patients tied to a provider who retired|0|||
127550134|NCT03584789|458982326|FG001|Overall Study|patients tied to a provider who retired|0|||
127550135|NCT03584789|458982327|FG002|Overall Study|patients tied to a provider who retired|3|||
127550136|NCT02035267|458982328|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
127550137|NCT02035267|458982329|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
127550138|NCT02035267|458982330|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
127550139|NCT02035267|458982331|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
127550140|NCT02035267|458982328|FG000|Overall Study|Adverse Event|0|||
127550141|NCT02035267|458982329|FG001|Overall Study|Adverse Event|0|||
127550142|NCT02035267|458982330|FG002|Overall Study|Adverse Event|1|||
127550143|NCT02035267|458982331|FG003|Overall Study|Adverse Event|0|||
127550144|NCT02035267|458982328|FG000|Overall Study|Lost to Follow-up|0|||
127550145|NCT02035267|458982329|FG001|Overall Study|Lost to Follow-up|0|||
127550146|NCT02035267|458982330|FG002|Overall Study|Lost to Follow-up|0|||
127550147|NCT02035267|458982331|FG003|Overall Study|Lost to Follow-up|1|||
127550148|NCT02035267|458982328|FG000|Overall Study|Other unspecified|0|||
127550149|NCT02035267|458982329|FG001|Overall Study|Other unspecified|1|||
127550150|NCT02035267|458982330|FG002|Overall Study|Other unspecified|0|||
127550151|NCT02035267|458982331|FG003|Overall Study|Other unspecified|0|||
127550152|NCT00602472|458982338|FG000|Overall Study|Adverse Event|5|||
127550153|NCT00602472|458982339|FG001|Overall Study|Adverse Event|23|||
127550154|NCT00602472|458982338|FG000|Overall Study|Protocol Violation|4|||
127550155|NCT00602472|458982339|FG001|Overall Study|Protocol Violation|19|||
127550156|NCT00602472|458982338|FG000|Overall Study|Withdrawal by Subject|8|||
127550157|NCT00602472|458982339|FG001|Overall Study|Withdrawal by Subject|14|||
127550158|NCT00602472|458982338|FG000|Overall Study|Other incl. lack of efficacy|4|||
127550159|NCT00602472|458982339|FG001|Overall Study|Other incl. lack of efficacy|2|||
127550160|NCT03038880|458982340|FG000|Overall Study|Death|1|||
127550161|NCT03038880|458982341|FG001|Overall Study|Death|2|||
127550162|NCT03038880|458982342|FG002|Overall Study|Death|0|||
127550163|NCT03038880|458982340|FG000|Overall Study|Physician Decision|2|||
127550164|NCT03038880|458982341|FG001|Overall Study|Physician Decision|1|||
127550165|NCT03038880|458982342|FG002|Overall Study|Physician Decision|0|||
127550166|NCT02803580|458982343|FG000|Overall Study|Death|13|||
127550167|NCT02803580|458982343|FG000|Overall Study|Lost to Follow-up|19|||
127550168|NCT02803580|458982343|FG000|Overall Study|Withdrawal by Subject|3|||
127550169|NCT02803580|458982343|FG000|Overall Study|Inclusion in clinical trial|1|||
127550170|NCT02054104|458982350|FG000|Overall Study|Did not want to continue due to college classes|1|||
127684643|NCT03482011|459469913|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
127684644|NCT03482011|459469914|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
127684645|NCT03482011|459469915|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
127684646|NCT03482011|459469908|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
127684647|NCT03482011|459469909|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
127684648|NCT03482011|459469910|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
127684649|NCT03482011|459469911|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
127684650|NCT03482011|459469912|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
127684651|NCT03482011|459469913|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
127684652|NCT03482011|459469914|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
127684653|NCT03482011|459469915|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
127684654|NCT03482011|459469908|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
127684655|NCT03482011|459469909|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
127684656|NCT03482011|459469910|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
127684657|NCT03482011|459469911|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
127684658|NCT03482011|459469912|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
127684659|NCT03482011|459469913|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
127684660|NCT03482011|459469914|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
127684661|NCT03482011|459469915|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
127684662|NCT03482011|459469908|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
127684663|NCT03482011|459469909|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
127684664|NCT03482011|459469910|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
127684665|NCT03482011|459469911|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
127684666|NCT03482011|459469912|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
127771433|NCT00343252|459789044|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
127771434|NCT00343252|459789045|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
127550171|NCT02054104|458982351|FG001|Overall Study|Did not want to continue due to college classes|0|||
127550172|NCT02054104|458982350|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
127550173|NCT02054104|458982351|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
127550174|NCT02054104|458982350|FG000|Overall Study|No evidence of immunologic response|2|||
127550175|NCT02054104|458982351|FG001|Overall Study|No evidence of immunologic response|2|||
127550176|NCT02054104|458982350|FG000|Overall Study|Disease Progression On Study|4|||
128016913|NCT03244189|460684102|FG001|Overall Study|Pregnancy|5|||
128016914|NCT03244189|460684101|FG000|Overall Study|Protocol Violation|0|||
128016915|NCT03244189|460684102|FG001|Overall Study|Protocol Violation|2|||
128016916|NCT03244189|460684101|FG000|Overall Study|Withdrawal by Subject|45|||
128016917|NCT03244189|460684102|FG001|Overall Study|Withdrawal by Subject|23|||
128016918|NCT03244189|460684101|FG000|Overall Study|Technical Problems|2|||
128016919|NCT03244189|460684102|FG001|Overall Study|Technical Problems|0|||
128016920|NCT06170827|460684103|FG000|Overall Study|Withdrawal by Subject|1|||
128016921|NCT06170827|460684104|FG001|Overall Study|Withdrawal by Subject|1|||
128016922|NCT05253807|460684105|FG000|Overall Study|Death|1|||
128016923|NCT05253807|460684106|FG001|Overall Study|Death|4|||
128016924|NCT05253807|460684105|FG000|Overall Study|Withdrawal by Subject|1|||
128016925|NCT05253807|460684106|FG001|Overall Study|Withdrawal by Subject|0|||
128016926|NCT05253807|460684105|FG000|Overall Study|Study Terminated by Sponsor|1|||
128016927|NCT05253807|460684106|FG001|Overall Study|Study Terminated by Sponsor|1|||
128016928|NCT00632359|460684113|FG000|Overall Study|Withdrawal by Subject|2|||
128016929|NCT06717399|460684114|FG000|Overall Study|Death|1|||
128016930|NCT02145390|460684115|FG000|Overall Study|Withdrawal by Subject|1|||
128016931|NCT01732783|460684834|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
128016932|NCT01732783|460684835|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
128016933|NCT01732783|460684836|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
127550177|NCT02054104|458982351|FG001|Overall Study|Disease Progression On Study|5|||
127550178|NCT02054104|458982350|FG000|Overall Study|Diagnosis of lymphoma|0|||
127684667|NCT03482011|459469913|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
127684668|NCT03482011|459469914|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
127684669|NCT03482011|459469915|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
127684670|NCT03482011|459469908|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
127684671|NCT03482011|459469909|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
127684672|NCT03482011|459469910|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
127684673|NCT03482011|459469911|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
127684674|NCT03482011|459469912|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
127684675|NCT03482011|459469913|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
127684676|NCT03482011|459469914|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
127684677|NCT03482011|459469915|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
127684678|NCT02538107|459469916|FG000|Overall Study|Did not receive any Mircera dose|11|||
127684679|NCT02538107|459469916|FG000|Overall Study|Missing|5|||
127684680|NCT02538107|459469916|FG000|Overall Study|Necessity of dialysis|20|||
127684681|NCT02538107|459469916|FG000|Overall Study|Administration of other ESA|11|||
127684682|NCT02538107|459469916|FG000|Overall Study|No further treatment necessary|18|||
127684683|NCT02538107|459469916|FG000|Overall Study|Withdrawal by Subject|17|||
127684684|NCT02538107|459469916|FG000|Overall Study|Death|4|||
127684685|NCT02538107|459469916|FG000|Overall Study|Administrative reason|5|||
127684686|NCT02538107|459469916|FG000|Overall Study|Adverse Event|4|||
127684687|NCT02538107|459469916|FG000|Overall Study|Surgery|1|||
127684688|NCT02538107|459469916|FG000|Overall Study|Other|7|||
127684689|NCT02538107|459469916|FG000|Overall Study|Not recorded|7|||
127684690|NCT01198028|459469919|FG000|Overall Study|Adverse Event|5|||
127684691|NCT01198028|459469919|FG000|Overall Study|Death|3|||
127684692|NCT01198028|459469919|FG000|Overall Study|Physician Decision|2|||
127684693|NCT01597258|459469926|FG000|Overall Study|No Drug Administration|1|||
127684694|NCT03215927|459471850|FG000|Randomized, Placebo-controlled|Lack of Efficacy|0|||
127684695|NCT03215927|459471851|FG001|Randomized, Placebo-controlled|Lack of Efficacy|1|||
127684696|NCT03215927|459471850|FG000|Open Label Extension|Adverse Event|1|||
127684697|NCT03215927|459471851|FG001|Open Label Extension|Adverse Event|0|||
127684698|NCT03215927|459471850|FG000|Open Label Extension|Lack of Efficacy|1|||
127684699|NCT03215927|459471851|FG001|Open Label Extension|Lack of Efficacy|0|||
127684700|NCT03215927|459471850|FG000|Open Label Extension|Death|0|||
127684701|NCT03215927|459471851|FG001|Open Label Extension|Death|1|||
127684702|NCT03889925|459471854|FG000|Overall Study|Lost to Follow-up|11|||
127684703|NCT03889925|459471855|FG001|Overall Study|Lost to Follow-up|10|||
127684704|NCT03073941|459471856|FG000|Overall Study|Received non-study device intraoperatively|0|||
127684705|NCT03073941|459471857|FG001|Overall Study|Received non-study device intraoperatively|2|||
127684706|NCT03073941|459471856|FG000|Overall Study|Death|1|||
127684707|NCT03073941|459471857|FG001|Overall Study|Death|0|||
127684708|NCT03073941|459471856|FG000|Overall Study|Withdrawal by Subject|1|||
127684709|NCT03073941|459471857|FG001|Overall Study|Withdrawal by Subject|3|||
127684710|NCT03073941|459471856|FG000|Overall Study|Lost to Follow-up|5|||
127684711|NCT03073941|459471857|FG001|Overall Study|Lost to Follow-up|4|||
127684712|NCT03073941|459471856|FG000|Overall Study|Adverse Event|4|||
127684713|NCT03073941|459471857|FG001|Overall Study|Adverse Event|2|||
127684714|NCT03073941|459471856|FG000|Overall Study|Met an exclusion criterion|0|||
128016934|NCT01732783|460684834|FG000|Overall Study|Death|13|||
128016935|NCT01732783|460684835|FG001|Overall Study|Death|4|||
128016936|NCT01732783|460684836|FG002|Overall Study|Death|1|||
127684715|NCT03073941|459471857|FG001|Overall Study|Met an exclusion criterion|1|||
127880939|NCT01215955|460186073|FG002|Overall Study|Sponsor Decision|0|||
128016937|NCT01732783|460684834|FG000|Overall Study|Lost to Follow-up|7|||
127550179|NCT02054104|458982351|FG001|Overall Study|Diagnosis of lymphoma|1|||
127550180|NCT02054104|458982350|FG000|Overall Study|Inconclusive response|0|||
127550181|NCT02054104|458982351|FG001|Overall Study|Inconclusive response|1|||
127550182|NCT00823615|458982352|FG000|Period 2|Lost to Follow-up|2|||
127550183|NCT00823615|458982353|FG001|Period 2|Lost to Follow-up|0|||
127550184|NCT00823615|458982352|FG000|Period 2|Time/Job Conflict|1|||
127550185|NCT00823615|458982353|FG001|Period 2|Time/Job Conflict|2|||
127550186|NCT03926611|458982355|FG000|Overall Study|Adverse Event|0|||
127550187|NCT03926611|458982356|FG001|Overall Study|Adverse Event|0|||
127550188|NCT03926611|458982357|FG002|Overall Study|Adverse Event|0|||
127550189|NCT03926611|458982358|FG003|Overall Study|Adverse Event|3|||
128016938|NCT01732783|460684835|FG001|Overall Study|Lost to Follow-up|1|||
128016939|NCT01732783|460684836|FG002|Overall Study|Lost to Follow-up|1|||
128016940|NCT01732783|460684834|FG000|Overall Study|Administrative Decision|8|||
128016941|NCT01732783|460684835|FG001|Overall Study|Administrative Decision|2|||
128016942|NCT01732783|460684836|FG002|Overall Study|Administrative Decision|1|||
128016943|NCT01732783|460684834|FG000|Overall Study|Withdrawal by Subject|1|||
128016944|NCT01732783|460684835|FG001|Overall Study|Withdrawal by Subject|0|||
128016945|NCT01732783|460684836|FG002|Overall Study|Withdrawal by Subject|0|||
128016946|NCT03421808|460684853|FG000|Overall Study|COVID related problems|2|||
127684716|NCT00304031|459471859|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
127684717|NCT00304031|459471860|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
127684718|NCT00304031|459471861|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
127684719|NCT00304031|459471859|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
127684720|NCT00304031|459471860|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
127684721|NCT00304031|459471861|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
127684722|NCT00304031|459471859|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
127684723|NCT00304031|459471860|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
127684724|NCT00304031|459471861|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
127684725|NCT00304031|459471859|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
127684726|NCT00304031|459471860|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
127684727|NCT00304031|459471861|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
127684728|NCT00304031|459471859|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
127684729|NCT00304031|459471860|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
127684730|NCT00304031|459471861|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
127684731|NCT00304031|459471859|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
127684732|NCT00304031|459471860|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
127684733|NCT00304031|459471861|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
127684734|NCT00304031|459471859|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
127684735|NCT00304031|459471860|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
127684736|NCT00304031|459471861|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
127684737|NCT00304031|459471859|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
127684738|NCT00304031|459471860|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
127684739|NCT00304031|459471861|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
127684740|NCT00304031|459471859|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
127684741|NCT00304031|459471860|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
127684742|NCT00304031|459471861|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
127684743|NCT04250883|459471862|FG000|Overall Study|Lost to Follow-up|1|||
127684744|NCT04250883|459471863|FG001|Overall Study|Lost to Follow-up|0|||
127684745|NCT01188655|459471865|FG000|Overall Study|Lack of Efficacy|1|||
127684746|NCT01188655|459471865|FG000|Overall Study|Lost to Follow-up|1|||
127684747|NCT01188655|459471865|FG000|Overall Study|Other|11|||
127684748|NCT01823536|459471866|FG000|Overall Study|Lost to Follow-up|1|||
127684749|NCT01823536|459471867|FG001|Overall Study|Lost to Follow-up|0|||
127684750|NCT01823536|459471868|FG002|Overall Study|Lost to Follow-up|0|||
127684751|NCT01823536|459471869|FG003|Overall Study|Lost to Follow-up|1|||
127684752|NCT01823536|459471870|FG004|Overall Study|Lost to Follow-up|1|||
127684753|NCT01823536|459471871|FG005|Overall Study|Lost to Follow-up|0|||
127684754|NCT01823536|459471866|FG000|Overall Study|Protocol Violation|0|||
127684755|NCT01823536|459471867|FG001|Overall Study|Protocol Violation|1|||
127684756|NCT01823536|459471868|FG002|Overall Study|Protocol Violation|0|||
127684757|NCT01823536|459471869|FG003|Overall Study|Protocol Violation|0|||
127684758|NCT01823536|459471870|FG004|Overall Study|Protocol Violation|0|||
127684759|NCT01823536|459471871|FG005|Overall Study|Protocol Violation|0|||
127684760|NCT01823536|459471866|FG000|Overall Study|Withdrawal by Subject|1|||
127684761|NCT01823536|459471867|FG001|Overall Study|Withdrawal by Subject|1|||
127684762|NCT01823536|459471868|FG002|Overall Study|Withdrawal by Subject|0|||
127880940|NCT01215955|460186074|FG003|Overall Study|Sponsor Decision|1|||
128016947|NCT03421808|460684854|FG001|Overall Study|COVID related problems|0|||
128016948|NCT03421808|460684853|FG000|Overall Study|Withdrawal by Subject|1|||
128016949|NCT03421808|460684854|FG001|Overall Study|Withdrawal by Subject|0|||
127550190|NCT03926611|458982359|FG004|Overall Study|Adverse Event|1|||
127550191|NCT03926611|458982360|FG005|Overall Study|Adverse Event|3|||
127550192|NCT03926611|458982361|FG006|Overall Study|Adverse Event|0|||
127550193|NCT03926611|458982355|FG000|Overall Study|Lack of Efficacy|1|||
127550194|NCT03926611|458982356|FG001|Overall Study|Lack of Efficacy|2|||
127550195|NCT03926611|458982357|FG002|Overall Study|Lack of Efficacy|0|||
127550196|NCT03926611|458982358|FG003|Overall Study|Lack of Efficacy|0|||
127550197|NCT03926611|458982359|FG004|Overall Study|Lack of Efficacy|1|||
127550198|NCT03926611|458982360|FG005|Overall Study|Lack of Efficacy|0|||
127550199|NCT03926611|458982361|FG006|Overall Study|Lack of Efficacy|1|||
127550200|NCT03926611|458982355|FG000|Overall Study|Physician Decision|0|||
127550201|NCT03926611|458982356|FG001|Overall Study|Physician Decision|0|||
127550202|NCT03926611|458982357|FG002|Overall Study|Physician Decision|0|||
127550203|NCT03926611|458982358|FG003|Overall Study|Physician Decision|0|||
127550204|NCT03926611|458982359|FG004|Overall Study|Physician Decision|0|||
127550205|NCT03926611|458982360|FG005|Overall Study|Physician Decision|1|||
127550206|NCT03926611|458982361|FG006|Overall Study|Physician Decision|0|||
127550207|NCT03926611|458982355|FG000|Overall Study|Protocol Violation|1|||
127550208|NCT03926611|458982356|FG001|Overall Study|Protocol Violation|0|||
127550209|NCT03926611|458982357|FG002|Overall Study|Protocol Violation|0|||
127550210|NCT03926611|458982358|FG003|Overall Study|Protocol Violation|1|||
127550211|NCT03926611|458982359|FG004|Overall Study|Protocol Violation|1|||
127550212|NCT03926611|458982360|FG005|Overall Study|Protocol Violation|1|||
127550213|NCT03926611|458982361|FG006|Overall Study|Protocol Violation|1|||
127550214|NCT03926611|458982355|FG000|Overall Study|Technical problems|0|||
127550215|NCT03926611|458982356|FG001|Overall Study|Technical problems|0|||
127550216|NCT03926611|458982357|FG002|Overall Study|Technical problems|0|||
127550217|NCT03926611|458982358|FG003|Overall Study|Technical problems|0|||
127550218|NCT03926611|458982359|FG004|Overall Study|Technical problems|0|||
127550219|NCT03926611|458982360|FG005|Overall Study|Technical problems|1|||
127550220|NCT03926611|458982361|FG006|Overall Study|Technical problems|0|||
127550221|NCT03926611|458982355|FG000|Overall Study|Withdrawal by Subject|1|||
127550222|NCT03926611|458982356|FG001|Overall Study|Withdrawal by Subject|1|||
127550223|NCT03926611|458982357|FG002|Overall Study|Withdrawal by Subject|1|||
127550224|NCT03926611|458982358|FG003|Overall Study|Withdrawal by Subject|0|||
127550225|NCT03926611|458982359|FG004|Overall Study|Withdrawal by Subject|0|||
127550226|NCT03926611|458982360|FG005|Overall Study|Withdrawal by Subject|1|||
127550227|NCT03926611|458982361|FG006|Overall Study|Withdrawal by Subject|3|||
127550228|NCT03926611|458982355|FG000|Overall Study|Covid-19 pandemic|0|||
127550229|NCT03926611|458982356|FG001|Overall Study|Covid-19 pandemic|0|||
127550230|NCT03926611|458982357|FG002|Overall Study|Covid-19 pandemic|1|||
127550231|NCT03926611|458982358|FG003|Overall Study|Covid-19 pandemic|0|||
127550232|NCT03926611|458982359|FG004|Overall Study|Covid-19 pandemic|1|||
127550233|NCT03926611|458982360|FG005|Overall Study|Covid-19 pandemic|2|||
127550234|NCT03926611|458982361|FG006|Overall Study|Covid-19 pandemic|0|||
127550235|NCT00084136|458982364|FG000|PI Comparison|Death|10|||
127550236|NCT00084136|458982365|FG001|PI Comparison|Death|9|||
127550237|NCT00084136|458982366|FG002|PI Comparison|Death|0|||
127550238|NCT00084136|458982364|FG000|PI Comparison|Lost to Follow-up|11|||
127550239|NCT00084136|458982365|FG001|PI Comparison|Lost to Follow-up|8|||
127550240|NCT00084136|458982366|FG002|PI Comparison|Lost to Follow-up|0|||
127550241|NCT00084136|458982364|FG000|PI Comparison|Withdrawal by Subject|33|||
127550242|NCT00084136|458982365|FG001|PI Comparison|Withdrawal by Subject|30|||
127550243|NCT00084136|458982366|FG002|PI Comparison|Withdrawal by Subject|0|||
127550244|NCT00084136|458982364|FG000|PI Comparison|Clinic site closed|1|||
127550245|NCT00084136|458982365|FG001|PI Comparison|Clinic site closed|0|||
127550246|NCT00084136|458982366|FG002|PI Comparison|Clinic site closed|0|||
127550247|NCT00084136|458982364|FG000|NRTI Comparison|Death|20|||
127550248|NCT00084136|458982365|FG001|NRTI Comparison|Death|0|||
127550249|NCT00084136|458982366|FG002|NRTI Comparison|Death|18|||
127550250|NCT00084136|458982364|FG000|NRTI Comparison|Lost to Follow-up|14|||
127550251|NCT00084136|458982365|FG001|NRTI Comparison|Lost to Follow-up|0|||
127550252|NCT00084136|458982366|FG002|NRTI Comparison|Lost to Follow-up|12|||
127550253|NCT00084136|458982364|FG000|NRTI Comparison|Withdrawal by Subject|54|||
127550254|NCT00084136|458982365|FG001|NRTI Comparison|Withdrawal by Subject|0|||
127550255|NCT00084136|458982366|FG002|NRTI Comparison|Withdrawal by Subject|38|||
127550256|NCT00084136|458982364|FG000|NRTI Comparison|Clinic site closed|12|||
127550257|NCT00084136|458982365|FG001|NRTI Comparison|Clinic site closed|0|||
127550258|NCT00084136|458982366|FG002|NRTI Comparison|Clinic site closed|14|||
127550259|NCT00084136|458982364|FG000|NRTI Comparison|Not reason above|1|||
127550260|NCT00084136|458982365|FG001|NRTI Comparison|Not reason above|0|||
127684763|NCT01823536|459471869|FG003|Overall Study|Withdrawal by Subject|0|||
127684764|NCT01823536|459471870|FG004|Overall Study|Withdrawal by Subject|0|||
127684765|NCT01823536|459471871|FG005|Overall Study|Withdrawal by Subject|0|||
127684766|NCT01823536|459471866|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
127684767|NCT01823536|459471867|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
127684768|NCT01823536|459471868|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
127684769|NCT01823536|459471869|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
127684770|NCT01823536|459471870|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
127684771|NCT01823536|459471871|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
127550261|NCT00084136|458982366|FG002|NRTI Comparison|Not reason above|0|||
127550262|NCT02230670|458982367|FG000|Overall Study|Adverse Event|1|||
127550263|NCT02230670|458982368|FG001|Overall Study|Adverse Event|2|||
127550264|NCT02230670|458982367|FG000|Overall Study|Withdrawal by Subject|2|||
127550265|NCT02230670|458982368|FG001|Overall Study|Withdrawal by Subject|2|||
127550266|NCT02230670|458982367|FG000|Overall Study|Physician Decision|0|||
127550267|NCT02230670|458982368|FG001|Overall Study|Physician Decision|1|||
127550268|NCT02230670|458982367|FG000|Overall Study|Protocol Violation|0|||
127550269|NCT02230670|458982368|FG001|Overall Study|Protocol Violation|1|||
127550270|NCT02230670|458982367|FG000|Overall Study|Progression to Child-Pugh C|1|||
127550271|NCT02230670|458982368|FG001|Overall Study|Progression to Child-Pugh C|2|||
127550272|NCT00836693|458982371|FG000|Overall Study|Adverse Event|4|||
127550273|NCT00836693|458982372|FG001|Overall Study|Adverse Event|1|||
127550274|NCT00836693|458982371|FG000|Overall Study|Sponsor Decision|0|||
127550275|NCT00836693|458982372|FG001|Overall Study|Sponsor Decision|1|||
127550276|NCT00836693|458982371|FG000|Overall Study|Physician Decision|2|||
127550277|NCT00836693|458982372|FG001|Overall Study|Physician Decision|0|||
127550278|NCT00836693|458982371|FG000|Overall Study|Withdrawal by Subject|9|||
127550279|NCT00836693|458982372|FG001|Overall Study|Withdrawal by Subject|4|||
127550280|NCT00836693|458982371|FG000|Overall Study|Protocol Violation|1|||
127550281|NCT00836693|458982372|FG001|Overall Study|Protocol Violation|0|||
127550282|NCT00836693|458982371|FG000|Overall Study|Lost to Follow-up|1|||
127550283|NCT00836693|458982372|FG001|Overall Study|Lost to Follow-up|0|||
127550284|NCT02612779|458982373|FG000|Overall Study|Administrative reason by sponsor|4|||
127550285|NCT02612779|458982374|FG001|Overall Study|Administrative reason by sponsor|1|||
127550286|NCT02612779|458982373|FG000|Overall Study|No longer meet study criteria|0|||
127550287|NCT02612779|458982374|FG001|Overall Study|No longer meet study criteria|1|||
127550288|NCT02612779|458982373|FG000|Overall Study|Disease progression|29|||
127550289|NCT02612779|458982374|FG001|Overall Study|Disease progression|2|||
127550290|NCT02612779|458982373|FG000|Overall Study|Study drug toxicity|10|||
127550291|NCT02612779|458982374|FG001|Overall Study|Study drug toxicity|1|||
127550292|NCT02612779|458982373|FG000|Overall Study|Death|1|||
127550293|NCT02612779|458982374|FG001|Overall Study|Death|0|||
127550294|NCT02612779|458982373|FG000|Overall Study|Adverse event unrelated to study drug|5|||
127550295|NCT02612779|458982374|FG001|Overall Study|Adverse event unrelated to study drug|0|||
127550296|NCT02612779|458982373|FG000|Overall Study|Participant withdrew consent|4|||
127550297|NCT02612779|458982374|FG001|Overall Study|Participant withdrew consent|0|||
127550298|NCT02612779|458982373|FG000|Overall Study|Lost to Follow-up|1|||
127550299|NCT02612779|458982374|FG001|Overall Study|Lost to Follow-up|0|||
127550300|NCT02612779|458982373|FG000|Overall Study|Maximum clinical benefit|10|||
127550301|NCT02612779|458982374|FG001|Overall Study|Maximum clinical benefit|1|||
127550302|NCT02612779|458982373|FG000|Overall Study|Other reasons|4|||
127550303|NCT02612779|458982374|FG001|Overall Study|Other reasons|0|||
127550304|NCT01750229|458982375|FG000|Randomized Crossover Phase|Adverse Event|1|||
127550305|NCT01750229|458982375|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
127550306|NCT01750229|458982375|FG000|Long-term Follow-up Phase|Adverse Event|2|||
127550307|NCT01750229|458982375|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
127550308|NCT01411891|458982378|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
127550309|NCT01411891|458982379|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
127550310|NCT02004093|458982380|FG000|Overall Study|Death|2|||
127550311|NCT02004093|458982381|FG001|Overall Study|Death|1|||
127550312|NCT02004093|458982380|FG000|Overall Study|Lack of Efficacy|66|||
127550313|NCT02004093|458982381|FG001|Overall Study|Lack of Efficacy|62|||
127550314|NCT02004093|458982380|FG000|Overall Study|Protocol Violation|0|||
127550315|NCT02004093|458982381|FG001|Overall Study|Protocol Violation|1|||
127550316|NCT02004093|458982380|FG000|Overall Study|Lost to Follow-up|0|||
127550317|NCT02004093|458982381|FG001|Overall Study|Lost to Follow-up|1|||
127550318|NCT02004093|458982380|FG000|Overall Study|Withdrawal by Subject|3|||
127550319|NCT02004093|458982381|FG001|Overall Study|Withdrawal by Subject|7|||
127550320|NCT02004093|458982380|FG000|Overall Study|Other|3|||
127550321|NCT02004093|458982381|FG001|Overall Study|Other|1|||
127550322|NCT00414596|458982382|FG000|Overall Study|Protocol Violation|2|||
128016950|NCT03421808|460684853|FG000|Overall Study|Protocol Violation|0|||
127550323|NCT04639258|458982384|FG000|Overall Study|Screen failure|5|||
127550324|NCT04639258|458982384|FG000|Overall Study|Physician Decision|2|||
128016951|NCT03421808|460684854|FG001|Overall Study|Protocol Violation|1|||
127550325|NCT04639258|458982384|FG000|Overall Study|Early study termination|3|||
127550326|NCT04639258|458982384|FG000|Overall Study|Withdrawal by Subject|1|||
127550327|NCT00297258|458982386|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
127550328|NCT00297258|458982386|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
127550329|NCT00297258|458982386|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
127550330|NCT00297258|458982386|FG000|Overall Study|Intercurrent Illness|3|||
127550331|NCT00297258|458982386|FG000|Overall Study|Intercurrent Death|2|||
127550332|NCT00297258|458982386|FG000|Overall Study|Deteriorization of General Condition|1|||
127550333|NCT00297258|458982386|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
128016952|NCT02872714|460684857|FG000|Overall Study|Progressive Disease|1|||
127550334|NCT00297258|458982386|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
127771435|NCT00343252|459789044|FG000|6 Months (All Treated Participants)|Death|0|||
127771436|NCT00343252|459789045|FG001|6 Months (All Treated Participants)|Death|2|||
127771437|NCT00343252|459789044|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
127771438|NCT00343252|459789045|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
127771439|NCT00343252|459789044|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
127771440|NCT00343252|459789045|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
127771441|NCT00343252|459789044|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
127771442|NCT00343252|459789045|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
127771443|NCT00343252|459789044|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
127771444|NCT00343252|459789045|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
127771445|NCT00343252|459789044|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
127771446|NCT00343252|459789045|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
127771447|NCT00343252|459789044|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
127771448|NCT00343252|459789045|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
127771449|NCT00343252|459789044|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
127771450|NCT00343252|459789045|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
127771451|NCT00343252|459789044|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
127771452|NCT00343252|459789045|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
127771453|NCT00343252|459789044|FG000|12 Months (All Treated Participants)|Death|3|||
127771454|NCT00343252|459789045|FG001|12 Months (All Treated Participants)|Death|3|||
127771455|NCT00343252|459789044|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
127771456|NCT00343252|459789045|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
127771457|NCT00343252|459789044|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
127771458|NCT00343252|459789045|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
127771459|NCT00343252|459789044|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
127771460|NCT00343252|459789045|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
127771461|NCT00343252|459789044|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
127771462|NCT00343252|459789045|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
127771463|NCT00343252|459789044|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
127771464|NCT00343252|459789045|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
127771465|NCT00343252|459789044|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
127771466|NCT00343252|459789045|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
127771467|NCT00343252|459789044|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
127771468|NCT00343252|459789045|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
127771469|NCT00343252|459789044|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
127771470|NCT00343252|459789045|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
127771471|NCT00343252|459789044|FG000|18 Months (All Treated Participants)|Death|4|||
127771472|NCT00343252|459789045|FG001|18 Months (All Treated Participants)|Death|5|||
127771473|NCT00343252|459789044|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
127771474|NCT00343252|459789045|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
127771475|NCT00343252|459789044|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
127771476|NCT00343252|459789045|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
127771477|NCT00343252|459789044|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
127771478|NCT00343252|459789045|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
127771479|NCT00343252|459789044|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
127771480|NCT00343252|459789045|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
127771481|NCT00343252|459789044|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
127771482|NCT00343252|459789045|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
127771483|NCT00343252|459789044|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
127771484|NCT00343252|459789045|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
127771485|NCT00343252|459789044|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
127771486|NCT00343252|459789045|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
127771487|NCT01740323|459789046|FG000|Overall Study|Adverse Event|1|||
127771488|NCT01740323|459789047|FG001|Overall Study|Adverse Event|0|||
127771489|NCT01740323|459789046|FG000|Overall Study|Randomized but did not take study drug|1|||
127771490|NCT01740323|459789047|FG001|Overall Study|Randomized but did not take study drug|0|||
127771491|NCT02019927|459789050|FG000|Overall Study|Lost to Follow-up|2|||
127771492|NCT02019927|459789051|FG001|Overall Study|Lost to Follow-up|4|||
127771493|NCT02019927|459789052|FG002|Overall Study|Lost to Follow-up|1|||
127771494|NCT02019927|459789053|FG003|Overall Study|Lost to Follow-up|2|||
127771495|NCT02019927|459789054|FG004|Overall Study|Lost to Follow-up|3|||
127771496|NCT02019927|459789055|FG005|Overall Study|Lost to Follow-up|1|||
127771497|NCT03945825|459789058|FG000|Overall Study|Enrolled but treatment not administered|0|||
127771498|NCT03945825|459789059|FG001|Overall Study|Enrolled but treatment not administered|0|||
127771499|NCT03945825|459789060|FG002|Overall Study|Enrolled but treatment not administered|0|||
127771500|NCT03945825|459789061|FG003|Overall Study|Enrolled but treatment not administered|0|||
127771501|NCT03945825|459789062|FG004|Overall Study|Enrolled but treatment not administered|1|||
128016953|NCT02872714|460684858|FG001|Overall Study|Progressive Disease|2|||
127684772|NCT01823536|459471866|FG000|Overall Study|Met exclusion criterion No 6|0|||
127684773|NCT01823536|459471867|FG001|Overall Study|Met exclusion criterion No 6|0|||
127684774|NCT01823536|459471868|FG002|Overall Study|Met exclusion criterion No 6|0|||
127684775|NCT01823536|459471869|FG003|Overall Study|Met exclusion criterion No 6|1|||
127684776|NCT01823536|459471870|FG004|Overall Study|Met exclusion criterion No 6|0|||
127684777|NCT01823536|459471871|FG005|Overall Study|Met exclusion criterion No 6|0|||
127684778|NCT01823536|459471866|FG000|Overall Study|Subject moved out of the state|0|||
127684779|NCT01823536|459471867|FG001|Overall Study|Subject moved out of the state|0|||
127684780|NCT01823536|459471868|FG002|Overall Study|Subject moved out of the state|0|||
127684781|NCT01823536|459471869|FG003|Overall Study|Subject moved out of the state|0|||
127684782|NCT01823536|459471870|FG004|Overall Study|Subject moved out of the state|1|||
127684783|NCT01823536|459471871|FG005|Overall Study|Subject moved out of the state|0|||
127684784|NCT03648762|459471875|FG000|Overall Study|Lost to Follow-up|1|||
127684785|NCT03648762|459471876|FG001|Overall Study|Lost to Follow-up|2|||
127684786|NCT03648762|459471877|FG002|Overall Study|Lost to Follow-up|0|||
127684787|NCT03648762|459471875|FG000|Overall Study|Withdrawal by Subject|5|||
127684788|NCT03648762|459471876|FG001|Overall Study|Withdrawal by Subject|2|||
127684789|NCT03648762|459471877|FG002|Overall Study|Withdrawal by Subject|1|||
127684790|NCT01875848|459471887|FG000|Overall Study|Withdrawal by Subject|2|||
127684791|NCT01875848|459471888|FG001|Overall Study|Withdrawal by Subject|0|||
127684792|NCT02407249|459471889|FG000|Overall Study|Did not complete 12-month follow-up|13|||
127684793|NCT02407249|459471889|FG000|Overall Study|Not treated|13|||
127684794|NCT03345901|459471892|FG000|Overall Study|The study was terminated|18|||
127684795|NCT00722046|459471893|FG000|Overall Study|Adverse Event|0|||
127684796|NCT00722046|459471894|FG001|Overall Study|Adverse Event|1|||
127684797|NCT00722046|459471895|FG002|Overall Study|Adverse Event|2|||
127684798|NCT00722046|459471896|FG003|Overall Study|Adverse Event|1|||
127684799|NCT00722046|459471897|FG004|Overall Study|Adverse Event|2|||
127684800|NCT00722046|459471898|FG005|Overall Study|Adverse Event|1|||
127684801|NCT00722046|459471899|FG006|Overall Study|Adverse Event|0|||
127684802|NCT00722046|459471893|FG000|Overall Study|Death|0|||
127684803|NCT00722046|459471894|FG001|Overall Study|Death|1|||
127684804|NCT00722046|459471895|FG002|Overall Study|Death|0|||
127684805|NCT00722046|459471896|FG003|Overall Study|Death|0|||
127684806|NCT00722046|459471897|FG004|Overall Study|Death|0|||
127684807|NCT00722046|459471898|FG005|Overall Study|Death|0|||
127684808|NCT00722046|459471899|FG006|Overall Study|Death|2|||
127684809|NCT00722046|459471893|FG000|Overall Study|Protocol Violation|1|||
127684810|NCT00722046|459471894|FG001|Overall Study|Protocol Violation|0|||
127684811|NCT00722046|459471895|FG002|Overall Study|Protocol Violation|0|||
127684812|NCT00722046|459471896|FG003|Overall Study|Protocol Violation|0|||
127684813|NCT00722046|459471897|FG004|Overall Study|Protocol Violation|0|||
127684814|NCT00722046|459471898|FG005|Overall Study|Protocol Violation|1|||
127684815|NCT00722046|459471899|FG006|Overall Study|Protocol Violation|0|||
127684816|NCT00722046|459471893|FG000|Overall Study|Withdrawal by Subject|3|||
127684817|NCT00722046|459471894|FG001|Overall Study|Withdrawal by Subject|3|||
127684818|NCT00722046|459471895|FG002|Overall Study|Withdrawal by Subject|4|||
127684819|NCT00722046|459471896|FG003|Overall Study|Withdrawal by Subject|4|||
127684820|NCT00722046|459471897|FG004|Overall Study|Withdrawal by Subject|4|||
127684821|NCT00722046|459471898|FG005|Overall Study|Withdrawal by Subject|7|||
127684822|NCT00722046|459471899|FG006|Overall Study|Withdrawal by Subject|3|||
127684823|NCT00722046|459471893|FG000|Overall Study|Randomized, but not treated|1|||
127684824|NCT00722046|459471894|FG001|Overall Study|Randomized, but not treated|1|||
127684825|NCT00722046|459471895|FG002|Overall Study|Randomized, but not treated|0|||
127684826|NCT00722046|459471896|FG003|Overall Study|Randomized, but not treated|2|||
127684827|NCT00722046|459471897|FG004|Overall Study|Randomized, but not treated|0|||
127684828|NCT00722046|459471898|FG005|Overall Study|Randomized, but not treated|0|||
127684829|NCT00722046|459471899|FG006|Overall Study|Randomized, but not treated|0|||
127684830|NCT00722046|459471893|FG000|Overall Study|Other|0|||
127684831|NCT00722046|459471894|FG001|Overall Study|Other|0|||
127684832|NCT00722046|459471895|FG002|Overall Study|Other|1|||
127684833|NCT00722046|459471896|FG003|Overall Study|Other|1|||
127684834|NCT00722046|459471897|FG004|Overall Study|Other|3|||
127684835|NCT00722046|459471898|FG005|Overall Study|Other|2|||
127684836|NCT00722046|459471899|FG006|Overall Study|Other|1|||
127684837|NCT02731755|459471900|FG000|First Intervention|Withdrawal by Subject|0|||
127684838|NCT02731755|459471901|FG001|First Intervention|Withdrawal by Subject|2|||
127684839|NCT04218110|459471902|FG000|Overall Study|Withdrawal by Subject|0|||
127684840|NCT04218110|459471903|FG001|Overall Study|Withdrawal by Subject|0|||
127684841|NCT04218110|459471904|FG002|Overall Study|Withdrawal by Subject|0|||
127684842|NCT04218110|459471905|FG003|Overall Study|Withdrawal by Subject|1|||
127684843|NCT00799396|459471906|FG000|Clopidogrel Treatment|Adverse Event|6|||
127684844|NCT00799396|459471906|FG000|Clopidogrel Treatment|Physician Decision|5|||
127684845|NCT00799396|459471906|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
127684846|NCT00799396|459471906|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
127684847|NCT00799396|459471906|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
127684848|NCT01149369|459471907|FG000|Overall Study|Adverse Event|6|||
127550335|NCT00297258|458982386|FG000|Overall Study|Switch to Commercial Treatment|1|||
127550336|NCT00297258|458982386|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
127550337|NCT00734539|458982387|FG000|Main Study|Death|33|||
127550338|NCT00734539|458982388|FG001|Main Study|Death|32|||
127550339|NCT00734539|458982387|FG000|Main Study|Physician Decision|2|||
127550340|NCT00734539|458982388|FG001|Main Study|Physician Decision|0|||
127550341|NCT00734539|458982387|FG000|Main Study|Withdrawal by Subject|1|||
127550342|NCT00734539|458982388|FG001|Main Study|Withdrawal by Subject|3|||
127550343|NCT00734539|458982387|FG000|Main Study|Enrolled in error; ineligible|1|||
127550344|NCT00734539|458982388|FG001|Main Study|Enrolled in error; ineligible|0|||
127550345|NCT02504151|458982391|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
127550346|NCT02504151|458982392|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
127550347|NCT02504151|458982391|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
127550348|NCT02504151|458982392|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
127550349|NCT02504151|458982391|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
127550350|NCT02504151|458982392|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
127550351|NCT02504151|458982391|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
127550352|NCT02504151|458982392|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
127550353|NCT05038982|458982393|FG000|Overall Study|Withdrawal by Subject|0|||
127550354|NCT05038982|458982394|FG001|Overall Study|Withdrawal by Subject|2|||
127550355|NCT02557139|458982400|FG000|Overall Study|Significant liver elevation|1|||
127550356|NCT02557139|458982401|FG001|Overall Study|Significant liver elevation|0|||
127550357|NCT02557139|458982402|FG002|Overall Study|Significant liver elevation|1|||
127550358|NCT02557139|458982400|FG000|Overall Study|Withdrawal by Subject|1|||
127550359|NCT02557139|458982401|FG001|Overall Study|Withdrawal by Subject|0|||
127550360|NCT02557139|458982402|FG002|Overall Study|Withdrawal by Subject|0|||
127550361|NCT02557139|458982400|FG000|Overall Study|Illness of prohibited medication|0|||
127550362|NCT02557139|458982401|FG001|Overall Study|Illness of prohibited medication|0|||
127550363|NCT02557139|458982402|FG002|Overall Study|Illness of prohibited medication|1|||
127550364|NCT01454102|458982404|FG000|Overall Study|Continuing in the treatment period|0|||
127771502|NCT03945825|459789063|FG005|Overall Study|Enrolled but treatment not administered|0|||
127771503|NCT03945825|459789058|FG000|Overall Study|Lost to Follow-up|1|||
127771504|NCT03945825|459789059|FG001|Overall Study|Lost to Follow-up|5|||
127771505|NCT03945825|459789060|FG002|Overall Study|Lost to Follow-up|0|||
127771506|NCT03945825|459789061|FG003|Overall Study|Lost to Follow-up|1|||
127771507|NCT03945825|459789062|FG004|Overall Study|Lost to Follow-up|2|||
127771508|NCT03945825|459789063|FG005|Overall Study|Lost to Follow-up|2|||
127771509|NCT03945825|459789058|FG000|Overall Study|Withdrawal by Subject|1|||
127771510|NCT03945825|459789059|FG001|Overall Study|Withdrawal by Subject|0|||
127771511|NCT03945825|459789060|FG002|Overall Study|Withdrawal by Subject|1|||
127771512|NCT03945825|459789061|FG003|Overall Study|Withdrawal by Subject|1|||
127771513|NCT03945825|459789062|FG004|Overall Study|Withdrawal by Subject|0|||
127771514|NCT03945825|459789063|FG005|Overall Study|Withdrawal by Subject|1|||
127771515|NCT01423253|459789071|FG000|Overall Study|Adverse Event|2|||
127771516|NCT01423253|459789071|FG000|Overall Study|Lack of Efficacy|2|||
127771517|NCT01423253|459789071|FG000|Overall Study|Lost to Follow-up|1|||
127771518|NCT01423253|459789071|FG000|Overall Study|Protocol Violation|2|||
127771519|NCT01423253|459789071|FG000|Overall Study|Withdrawal by Subject|2|||
127771520|NCT00307125|459789072|FG000|Screening Phase|Adverse Event|1|||
127771521|NCT00307125|459789073|FG001|Screening Phase|Adverse Event|0|||
127771522|NCT00307125|459789074|FG002|Screening Phase|Adverse Event|0|||
127771523|NCT00307125|459789072|FG000|Screening Phase|Protocol Violation|27|||
127771524|NCT00307125|459789073|FG001|Screening Phase|Protocol Violation|0|||
127771525|NCT00307125|459789074|FG002|Screening Phase|Protocol Violation|0|||
127771526|NCT00307125|459789072|FG000|Screening Phase|Lost to Follow-up|87|||
127771527|NCT00307125|459789073|FG001|Screening Phase|Lost to Follow-up|0|||
127771528|NCT00307125|459789074|FG002|Screening Phase|Lost to Follow-up|0|||
127771529|NCT00307125|459789072|FG000|Screening Phase|Death|10|||
127771530|NCT00307125|459789073|FG001|Screening Phase|Death|0|||
127550365|NCT01454102|458982405|FG001|Overall Study|Continuing in the treatment period|0|||
127550366|NCT01454102|458982406|FG002|Overall Study|Continuing in the treatment period|0|||
127550367|NCT01454102|458982407|FG003|Overall Study|Continuing in the treatment period|0|||
127550368|NCT01454102|458982408|FG004|Overall Study|Continuing in the treatment period|3|||
127880941|NCT01215955|460186071|FG000|Overall Study|Withdrawal by Subject|14|||
127880942|NCT01215955|460186072|FG001|Overall Study|Withdrawal by Subject|15|||
127880943|NCT01215955|460186073|FG002|Overall Study|Withdrawal by Subject|13|||
127880944|NCT01215955|460186074|FG003|Overall Study|Withdrawal by Subject|9|||
127880945|NCT01215955|460186071|FG000|Overall Study|Quality Issues|0|||
127880946|NCT01215955|460186072|FG001|Overall Study|Quality Issues|0|||
127880947|NCT01215955|460186073|FG002|Overall Study|Quality Issues|3|||
127550369|NCT01454102|458982409|FG005|Overall Study|Continuing in the treatment period|3|||
127550370|NCT01454102|458982410|FG006|Overall Study|Continuing in the treatment period|2|||
127550371|NCT01454102|458982411|FG007|Overall Study|Continuing in the treatment period|0|||
127550372|NCT01454102|458982412|FG008|Overall Study|Continuing in the treatment period|1|||
127771531|NCT00307125|459789074|FG002|Screening Phase|Death|0|||
127771532|NCT00307125|459789072|FG000|Screening Phase|Withdrawal by Subject|77|||
127880948|NCT01215955|460186074|FG003|Overall Study|Quality Issues|2|||
127880949|NCT01523301|460186075|FG000|Overall Study|Adverse Event|25|||
127880950|NCT01523301|460186076|FG001|Overall Study|Adverse Event|16|||
127880951|NCT01523301|460186075|FG000|Overall Study|Lack of Efficacy|0|||
127880952|NCT01523301|460186076|FG001|Overall Study|Lack of Efficacy|2|||
127880953|NCT01523301|460186075|FG000|Overall Study|Protocol Violation|3|||
127880954|NCT01523301|460186076|FG001|Overall Study|Protocol Violation|4|||
127880955|NCT01523301|460186075|FG000|Overall Study|Lost to Follow-up|1|||
127880956|NCT01523301|460186076|FG001|Overall Study|Lost to Follow-up|0|||
127880957|NCT01523301|460186075|FG000|Overall Study|Withdrawal by Subject|6|||
127880958|NCT01523301|460186076|FG001|Overall Study|Withdrawal by Subject|8|||
127880959|NCT01523301|460186075|FG000|Overall Study|Other Reason|0|||
127880960|NCT01523301|460186076|FG001|Overall Study|Other Reason|2|||
127880961|NCT01447628|460186077|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
127880962|NCT01447628|460186078|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
128016954|NCT02872714|460684859|FG002|Overall Study|Progressive Disease|0|||
128016955|NCT02872714|460684860|FG003|Overall Study|Progressive Disease|0|||
128016956|NCT02872714|460684861|FG004|Overall Study|Progressive Disease|0|||
128016957|NCT02872714|460684857|FG000|Overall Study|Death|87|||
128016958|NCT02872714|460684858|FG001|Overall Study|Death|36|||
128016959|NCT02872714|460684859|FG002|Overall Study|Death|8|||
128016960|NCT02872714|460684860|FG003|Overall Study|Death|81|||
128016961|NCT02872714|460684861|FG004|Overall Study|Death|2|||
128016962|NCT02872714|460684857|FG000|Overall Study|Lost to Follow-up|2|||
128016963|NCT02872714|460684858|FG001|Overall Study|Lost to Follow-up|1|||
128016964|NCT02872714|460684859|FG002|Overall Study|Lost to Follow-up|0|||
128016965|NCT02872714|460684860|FG003|Overall Study|Lost to Follow-up|3|||
128016966|NCT02872714|460684861|FG004|Overall Study|Lost to Follow-up|0|||
128016967|NCT02872714|460684857|FG000|Overall Study|Physician Decision|0|||
128016968|NCT02872714|460684858|FG001|Overall Study|Physician Decision|0|||
128016969|NCT02872714|460684859|FG002|Overall Study|Physician Decision|0|||
128016970|NCT02872714|460684860|FG003|Overall Study|Physician Decision|1|||
128016971|NCT02872714|460684861|FG004|Overall Study|Physician Decision|0|||
128016972|NCT02872714|460684857|FG000|Overall Study|Withdrawal by Subject|1|||
128016973|NCT02872714|460684858|FG001|Overall Study|Withdrawal by Subject|3|||
128016974|NCT02872714|460684859|FG002|Overall Study|Withdrawal by Subject|0|||
128016975|NCT02872714|460684860|FG003|Overall Study|Withdrawal by Subject|2|||
128016976|NCT02872714|460684861|FG004|Overall Study|Withdrawal by Subject|0|||
128016977|NCT02872714|460684857|FG000|Overall Study|Captured as Other|2|||
128016978|NCT02872714|460684858|FG001|Overall Study|Captured as Other|0|||
128016979|NCT02872714|460684859|FG002|Overall Study|Captured as Other|0|||
128016980|NCT02872714|460684860|FG003|Overall Study|Captured as Other|1|||
128016981|NCT02872714|460684861|FG004|Overall Study|Captured as Other|0|||
128016982|NCT02180867|460684864|FG000|Overall Study|Adverse Event|3|||
128016983|NCT02180867|460684865|FG001|Overall Study|Adverse Event|4|||
128016984|NCT02180867|460684866|FG002|Overall Study|Adverse Event|1|||
128016985|NCT02180867|460684867|FG003|Overall Study|Adverse Event|5|||
128016986|NCT02180867|460684868|FG004|Overall Study|Adverse Event|0|||
128016987|NCT02180867|460684869|FG005|Overall Study|Adverse Event|0|||
128016988|NCT02180867|460684870|FG006|Overall Study|Adverse Event|0|||
128016989|NCT02180867|460684864|FG000|Overall Study|Death|0|||
128016990|NCT02180867|460684865|FG001|Overall Study|Death|0|||
128016991|NCT02180867|460684866|FG002|Overall Study|Death|0|||
127880963|NCT01447628|460186079|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
127880964|NCT01447628|460186080|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
128016992|NCT02180867|460684867|FG003|Overall Study|Death|0|||
128016993|NCT02180867|460684868|FG004|Overall Study|Death|1|||
128016994|NCT02180867|460684869|FG005|Overall Study|Death|0|||
128016995|NCT02180867|460684870|FG006|Overall Study|Death|0|||
128016996|NCT02180867|460684864|FG000|Overall Study|Lack of Efficacy|0|||
128016997|NCT02180867|460684865|FG001|Overall Study|Lack of Efficacy|2|||
128016998|NCT02180867|460684866|FG002|Overall Study|Lack of Efficacy|0|||
128016999|NCT02180867|460684867|FG003|Overall Study|Lack of Efficacy|1|||
128017000|NCT02180867|460684868|FG004|Overall Study|Lack of Efficacy|6|||
128017001|NCT02180867|460684869|FG005|Overall Study|Lack of Efficacy|0|||
128017002|NCT02180867|460684870|FG006|Overall Study|Lack of Efficacy|1|||
128017003|NCT02180867|460684864|FG000|Overall Study|Physician Decision|1|||
128017004|NCT02180867|460684865|FG001|Overall Study|Physician Decision|3|||
128017005|NCT02180867|460684866|FG002|Overall Study|Physician Decision|1|||
128017006|NCT02180867|460684867|FG003|Overall Study|Physician Decision|10|||
128017007|NCT02180867|460684868|FG004|Overall Study|Physician Decision|9|||
128017008|NCT02180867|460684869|FG005|Overall Study|Physician Decision|3|||
128017009|NCT02180867|460684870|FG006|Overall Study|Physician Decision|4|||
128017010|NCT02180867|460684864|FG000|Overall Study|Withdrawal by Subject|0|||
128017011|NCT02180867|460684865|FG001|Overall Study|Withdrawal by Subject|0|||
128017012|NCT02180867|460684866|FG002|Overall Study|Withdrawal by Subject|0|||
128017013|NCT02180867|460684867|FG003|Overall Study|Withdrawal by Subject|1|||
128017014|NCT02180867|460684868|FG004|Overall Study|Withdrawal by Subject|1|||
128017015|NCT02180867|460684869|FG005|Overall Study|Withdrawal by Subject|0|||
128017016|NCT02180867|460684870|FG006|Overall Study|Withdrawal by Subject|0|||
127550373|NCT01454102|458982413|FG009|Overall Study|Continuing in the treatment period|0|||
127550374|NCT01454102|458982414|FG010|Overall Study|Continuing in the treatment period|0|||
127550375|NCT01454102|458982415|FG011|Overall Study|Continuing in the treatment period|4|||
127550376|NCT01454102|458982416|FG012|Overall Study|Continuing in the treatment period|7|||
127550377|NCT01454102|458982417|FG013|Overall Study|Continuing in the treatment period|4|||
127550378|NCT01454102|458982418|FG014|Overall Study|Continuing in the treatment period|3|||
127550379|NCT01454102|458982419|FG015|Overall Study|Continuing in the treatment period|1|||
127550380|NCT02592798|458982424|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
127550381|NCT02592798|458982425|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
127550382|NCT02592798|458982424|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
127550383|NCT02592798|458982425|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
127550384|NCT02592798|458982424|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
127550385|NCT02592798|458982425|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
127550386|NCT02592798|458982424|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
127550387|NCT02592798|458982425|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
127550388|NCT02592798|458982424|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
127550389|NCT02592798|458982425|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
127550390|NCT02592798|458982424|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
127550391|NCT02592798|458982425|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
127550392|NCT02592798|458982424|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
127550393|NCT02592798|458982425|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
127550394|NCT02592798|458982424|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
127550395|NCT02592798|458982425|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
127550396|NCT02592798|458982424|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
127550397|NCT02592798|458982425|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
127550398|NCT02592798|458982424|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
127550399|NCT02592798|458982425|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
127550400|NCT02592798|458982424|FG000|Transition From DB2 to OLE|Other reasons|1|||
127550401|NCT02592798|458982425|FG001|Transition From DB2 to OLE|Other reasons|0|||
127550402|NCT02592798|458982424|FG000|Open Label Period (OLE)|Other reasons|0|||
127550403|NCT02592798|458982425|FG001|Open Label Period (OLE)|Other reasons|2|||
127550404|NCT02592798|458982424|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
127550405|NCT02592798|458982425|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
127550406|NCT02592798|458982424|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
127550407|NCT02592798|458982425|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
127550408|NCT02592798|458982424|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
127550409|NCT02592798|458982425|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
127550410|NCT02592798|458982424|FG000|Open Label Period (OLE)|Adverse Event|0|||
127550411|NCT02592798|458982425|FG001|Open Label Period (OLE)|Adverse Event|1|||
127550412|NCT00705016|458982426|FG000|Overall Study|Adverse Event|6|||
127550413|NCT00705016|458982427|FG001|Overall Study|Adverse Event|11|||
127550414|NCT00705016|458982428|FG002|Overall Study|Adverse Event|10|||
127550415|NCT00705016|458982426|FG000|Overall Study|Death|5|||
127550416|NCT00705016|458982427|FG001|Overall Study|Death|7|||
127550417|NCT00705016|458982428|FG002|Overall Study|Death|5|||
127550418|NCT00705016|458982426|FG000|Overall Study|Protocol Violation|0|||
127550419|NCT00705016|458982427|FG001|Overall Study|Protocol Violation|1|||
127550420|NCT00705016|458982428|FG002|Overall Study|Protocol Violation|1|||
127550421|NCT00705016|458982426|FG000|Overall Study|Withdrawal by Subject|4|||
127550422|NCT00705016|458982427|FG001|Overall Study|Withdrawal by Subject|3|||
127550423|NCT00705016|458982428|FG002|Overall Study|Withdrawal by Subject|2|||
127550424|NCT00705016|458982426|FG000|Overall Study|Progressive Disease|33|||
127550425|NCT00705016|458982427|FG001|Overall Study|Progressive Disease|29|||
127550426|NCT00705016|458982428|FG002|Overall Study|Progressive Disease|33|||
127550427|NCT00705016|458982426|FG000|Overall Study|Symptomatic Deterioration|3|||
127550428|NCT00705016|458982427|FG001|Overall Study|Symptomatic Deterioration|1|||
127550429|NCT00705016|458982428|FG002|Overall Study|Symptomatic Deterioration|1|||
127550430|NCT00705016|458982426|FG000|Overall Study|Other|9|||
127550431|NCT00705016|458982427|FG001|Overall Study|Other|6|||
127550432|NCT00705016|458982428|FG002|Overall Study|Other|6|||
127550433|NCT05567783|458982431|FG000|Overall Study|Death|2|||
127550434|NCT05567783|458982432|FG001|Overall Study|Death|3|||
127550435|NCT05567783|458982433|FG002|Overall Study|Death|0|||
127550436|NCT05567783|458982431|FG000|Overall Study|Lost to Follow-up|25|||
127550437|NCT05567783|458982432|FG001|Overall Study|Lost to Follow-up|19|||
127550438|NCT05567783|458982433|FG002|Overall Study|Lost to Follow-up|17|||
127684849|NCT01149369|459471908|FG001|Overall Study|Adverse Event|3|||
127684850|NCT02601820|459471911|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
127684851|NCT02601820|459471911|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
127684852|NCT02601820|459471911|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
127684853|NCT02601820|459471911|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
127684854|NCT02242487|459471912|FG000|Overall Study|Adverse Event|13|||
127684855|NCT02242487|459471913|FG001|Overall Study|Adverse Event|15|||
127684856|NCT02242487|459471912|FG000|Overall Study|Lack of Efficacy|4|||
128017017|NCT02180867|460684864|FG000|Overall Study|Ineligible|1|||
128017018|NCT02180867|460684865|FG001|Overall Study|Ineligible|2|||
128017019|NCT02180867|460684866|FG002|Overall Study|Ineligible|0|||
128017020|NCT02180867|460684867|FG003|Overall Study|Ineligible|3|||
128017021|NCT02180867|460684868|FG004|Overall Study|Ineligible|5|||
128017022|NCT02180867|460684869|FG005|Overall Study|Ineligible|0|||
127550439|NCT05567783|458982431|FG000|Overall Study|Physician Decision|10|||
127550440|NCT05567783|458982432|FG001|Overall Study|Physician Decision|7|||
127550441|NCT05567783|458982433|FG002|Overall Study|Physician Decision|9|||
127550442|NCT05567783|458982431|FG000|Overall Study|Study Terminated by Sponsor|924|||
127550443|NCT05567783|458982432|FG001|Overall Study|Study Terminated by Sponsor|937|||
127550444|NCT05567783|458982433|FG002|Overall Study|Study Terminated by Sponsor|941|||
127550445|NCT05567783|458982431|FG000|Overall Study|Withdrawal by Subject|23|||
127550446|NCT05567783|458982432|FG001|Overall Study|Withdrawal by Subject|27|||
127550447|NCT05567783|458982433|FG002|Overall Study|Withdrawal by Subject|24|||
127550448|NCT05567783|458982431|FG000|Overall Study|Incarcerated|1|||
127550449|NCT05567783|458982432|FG001|Overall Study|Incarcerated|0|||
127550450|NCT05567783|458982433|FG002|Overall Study|Incarcerated|0|||
127550451|NCT05567783|458982431|FG000|Overall Study|Participant randomized in error|4|||
127550452|NCT05567783|458982432|FG001|Overall Study|Participant randomized in error|2|||
127550453|NCT05567783|458982433|FG002|Overall Study|Participant randomized in error|2|||
127550454|NCT03944577|458982439|FG000|Overall Study|Adverse Event|3|||
127550455|NCT03133793|458982445|FG000|Overall Study|Withdrawal by Subject|0|||
127550456|NCT03133793|458982446|FG001|Overall Study|Withdrawal by Subject|4|||
127550457|NCT03133793|458982447|FG002|Overall Study|Withdrawal by Subject|2|||
127550458|NCT03133793|458982448|FG003|Overall Study|Withdrawal by Subject|4|||
127550459|NCT03133793|458982445|FG000|Overall Study|Lost to Follow-up|1|||
127550460|NCT03133793|458982446|FG001|Overall Study|Lost to Follow-up|0|||
127550461|NCT03133793|458982447|FG002|Overall Study|Lost to Follow-up|2|||
127684857|NCT02242487|459471913|FG001|Overall Study|Lack of Efficacy|6|||
127684858|NCT02242487|459471912|FG000|Overall Study|Protocol Violation|2|||
127684859|NCT02242487|459471913|FG001|Overall Study|Protocol Violation|0|||
127684860|NCT02242487|459471912|FG000|Overall Study|Lost to Follow-up|2|||
127684861|NCT02242487|459471913|FG001|Overall Study|Lost to Follow-up|1|||
127684862|NCT02242487|459471912|FG000|Overall Study|Other - Miscellaneous|4|||
127684863|NCT02242487|459471913|FG001|Overall Study|Other - Miscellaneous|6|||
127684864|NCT02242487|459471912|FG000|Overall Study|Withdrawal by Subject|37|||
127684865|NCT02242487|459471913|FG001|Overall Study|Withdrawal by Subject|19|||
127684866|NCT01599793|459471914|FG000|Overall Study|Adverse Event|2|||
127684867|NCT00636207|459471921|FG000|Overall Study|Adverse Event|1|||
127684868|NCT00636207|459471922|FG001|Overall Study|Adverse Event|0|||
127684869|NCT00636207|459471923|FG002|Overall Study|Adverse Event|0|||
127684870|NCT00636207|459471924|FG003|Overall Study|Adverse Event|0|||
127684871|NCT00636207|459471925|FG004|Overall Study|Adverse Event|0|||
127684872|NCT00636207|459471926|FG005|Overall Study|Adverse Event|0|||
127684873|NCT00636207|459471927|FG006|Overall Study|Adverse Event|0|||
127684874|NCT00636207|459471921|FG000|Overall Study|Withdrawal by Subject|0|||
127684875|NCT00636207|459471922|FG001|Overall Study|Withdrawal by Subject|1|||
127684876|NCT00636207|459471923|FG002|Overall Study|Withdrawal by Subject|0|||
127684877|NCT00636207|459471924|FG003|Overall Study|Withdrawal by Subject|0|||
127684878|NCT00636207|459471925|FG004|Overall Study|Withdrawal by Subject|1|||
127684879|NCT00636207|459471926|FG005|Overall Study|Withdrawal by Subject|0|||
127684880|NCT00636207|459471927|FG006|Overall Study|Withdrawal by Subject|0|||
127684881|NCT01576484|459471928|FG000|Overall Study|Adverse Event|1|||
127684882|NCT01576484|459471929|FG001|Overall Study|Adverse Event|1|||
127684883|NCT01576484|459471928|FG000|Overall Study|Protocol Violation|0|||
127684884|NCT01576484|459471929|FG001|Overall Study|Protocol Violation|2|||
127684885|NCT01576484|459471928|FG000|Overall Study|Sponsor Decision|2|||
127684886|NCT01576484|459471929|FG001|Overall Study|Sponsor Decision|8|||
127684887|NCT01576484|459471928|FG000|Overall Study|Withdrawal by Subject|0|||
127684888|NCT01576484|459471929|FG001|Overall Study|Withdrawal by Subject|3|||
127684889|NCT01576484|459471928|FG000|Overall Study|Other|2|||
127684890|NCT01576484|459471929|FG001|Overall Study|Other|5|||
127684891|NCT01943799|459471930|FG000|Overall Study|Lost to Follow-up|0|||
127684892|NCT01943799|459471931|FG001|Overall Study|Lost to Follow-up|1|||
127684893|NCT01943799|459471932|FG002|Overall Study|Lost to Follow-up|1|||
127684894|NCT01943799|459471933|FG003|Overall Study|Lost to Follow-up|0|||
127550462|NCT03133793|458982448|FG003|Overall Study|Lost to Follow-up|0|||
127550463|NCT03133793|458982445|FG000|Overall Study|Death|0|||
127550464|NCT03133793|458982446|FG001|Overall Study|Death|0|||
127550465|NCT03133793|458982447|FG002|Overall Study|Death|0|||
127684895|NCT01943799|459471930|FG000|Overall Study|Protocol Violation|1|||
127684896|NCT01943799|459471931|FG001|Overall Study|Protocol Violation|0|||
127684897|NCT01943799|459471932|FG002|Overall Study|Protocol Violation|0|||
127684898|NCT01943799|459471933|FG003|Overall Study|Protocol Violation|0|||
127684899|NCT01943799|459471930|FG000|Overall Study|Withdrawal by Subject|4|||
127684900|NCT01943799|459471931|FG001|Overall Study|Withdrawal by Subject|2|||
128017023|NCT02180867|460684870|FG006|Overall Study|Ineligible|0|||
127550466|NCT03133793|458982448|FG003|Overall Study|Death|1|||
128017024|NCT02180867|460684864|FG000|Overall Study|Repeat Eligibility Studies|0|||
127880965|NCT00185731|460186081|FG000|Overall Study|Withdrawal by Subject|1|||
127880966|NCT00185731|460186081|FG000|Overall Study|Not Eligible|1|||
127880967|NCT03087773|460186082|FG000|Overall Study|Withdrawal by Subject|8|||
127880968|NCT03087773|460186083|FG001|Overall Study|Withdrawal by Subject|4|||
127880969|NCT03087773|460186082|FG000|Overall Study|Lost to Follow-up|12|||
127880970|NCT03087773|460186083|FG001|Overall Study|Lost to Follow-up|8|||
127880971|NCT01787188|460186090|FG000|Overall Study|Adverse Event|2|||
127880972|NCT01787188|460186091|FG001|Overall Study|Adverse Event|4|||
127880973|NCT01787188|460186092|FG002|Overall Study|Adverse Event|6|||
127880974|NCT01787188|460186090|FG000|Overall Study|Lack of Efficacy|7|||
127880975|NCT01787188|460186091|FG001|Overall Study|Lack of Efficacy|3|||
127880976|NCT01787188|460186092|FG002|Overall Study|Lack of Efficacy|5|||
127880977|NCT01787188|460186090|FG000|Overall Study|Non-compliance with Study Drug|0|||
127880978|NCT01787188|460186091|FG001|Overall Study|Non-compliance with Study Drug|1|||
127880979|NCT01787188|460186092|FG002|Overall Study|Non-compliance with Study Drug|0|||
127880980|NCT01787188|460186090|FG000|Overall Study|Withdrawal by Subject|4|||
127880981|NCT01787188|460186091|FG001|Overall Study|Withdrawal by Subject|3|||
127880982|NCT01787188|460186092|FG002|Overall Study|Withdrawal by Subject|2|||
127880983|NCT01787188|460186090|FG000|Overall Study|Protocol Violation|3|||
127880984|NCT01787188|460186091|FG001|Overall Study|Protocol Violation|2|||
127771533|NCT00307125|459789073|FG001|Screening Phase|Withdrawal by Subject|0|||
127771534|NCT00307125|459789074|FG002|Screening Phase|Withdrawal by Subject|0|||
127771535|NCT00307125|459789072|FG000|Screening Phase|Physician Decision|26|||
127771536|NCT00307125|459789073|FG001|Screening Phase|Physician Decision|0|||
127771537|NCT00307125|459789074|FG002|Screening Phase|Physician Decision|0|||
127771538|NCT00307125|459789072|FG000|Screening Phase|Sponsor Decision|4|||
127771539|NCT00307125|459789073|FG001|Screening Phase|Sponsor Decision|0|||
127771540|NCT00307125|459789074|FG002|Screening Phase|Sponsor Decision|0|||
127771541|NCT00307125|459789072|FG000|Screening Phase|Study Terminated|17|||
127771542|NCT00307125|459789073|FG001|Screening Phase|Study Terminated|0|||
127771543|NCT00307125|459789074|FG002|Screening Phase|Study Terminated|0|||
127771544|NCT00307125|459789072|FG000|Screening Phase|Graft Loss|3|||
127771545|NCT00307125|459789073|FG001|Screening Phase|Graft Loss|0|||
127771546|NCT00307125|459789074|FG002|Screening Phase|Graft Loss|0|||
127771547|NCT00307125|459789072|FG000|Screening Phase|Graft Failure|8|||
127771548|NCT00307125|459789073|FG001|Screening Phase|Graft Failure|0|||
127771549|NCT00307125|459789074|FG002|Screening Phase|Graft Failure|0|||
127771550|NCT00307125|459789072|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
127771551|NCT00307125|459789073|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
127771552|NCT00307125|459789074|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
127771553|NCT00307125|459789072|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
127771554|NCT00307125|459789073|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
127771555|NCT00307125|459789074|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
127771556|NCT00307125|459789072|FG000|Screening Phase|Moved or transferred facilities|34|||
127771557|NCT00307125|459789073|FG001|Screening Phase|Moved or transferred facilities|0|||
127771558|NCT00307125|459789074|FG002|Screening Phase|Moved or transferred facilities|0|||
127771559|NCT00307125|459789072|FG000|Screening Phase|Received Pancreas Transplant|8|||
127771560|NCT00307125|459789073|FG001|Screening Phase|Received Pancreas Transplant|0|||
127771561|NCT00307125|459789074|FG002|Screening Phase|Received Pancreas Transplant|0|||
127771562|NCT00307125|459789072|FG000|Screening Phase|Ineligible for pilot|4|||
127771563|NCT00307125|459789073|FG001|Screening Phase|Ineligible for pilot|0|||
127771564|NCT00307125|459789074|FG002|Screening Phase|Ineligible for pilot|0|||
127771565|NCT00307125|459789072|FG000|Screening Phase|Try to get pregnant|1|||
127771566|NCT00307125|459789073|FG001|Screening Phase|Try to get pregnant|0|||
127771567|NCT00307125|459789074|FG002|Screening Phase|Try to get pregnant|0|||
127771568|NCT00307125|459789072|FG000|Screening Phase|Developed acute leukemia|1|||
127771569|NCT00307125|459789073|FG001|Screening Phase|Developed acute leukemia|0|||
127771570|NCT00307125|459789074|FG002|Screening Phase|Developed acute leukemia|0|||
127771571|NCT00307125|459789072|FG000|Screening Phase|Metastatic colon cancer|1|||
127771572|NCT00307125|459789073|FG001|Screening Phase|Metastatic colon cancer|0|||
127771573|NCT00307125|459789074|FG002|Screening Phase|Metastatic colon cancer|0|||
127771574|NCT00307125|459789072|FG000|Screening Phase|Malignancy|1|||
127771575|NCT00307125|459789073|FG001|Screening Phase|Malignancy|0|||
127771576|NCT00307125|459789074|FG002|Screening Phase|Malignancy|0|||
127771577|NCT00307125|459789072|FG000|Screening Phase|PAK|1|||
127771578|NCT00307125|459789073|FG001|Screening Phase|PAK|0|||
127771579|NCT00307125|459789074|FG002|Screening Phase|PAK|0|||
127771580|NCT00307125|459789072|FG000|Screening Phase|Ineligible|1|||
127771581|NCT00307125|459789073|FG001|Screening Phase|Ineligible|0|||
127880985|NCT01787188|460186092|FG002|Overall Study|Protocol Violation|3|||
127880986|NCT01787188|460186090|FG000|Overall Study|Lost to Follow-up|1|||
127880987|NCT01787188|460186091|FG001|Overall Study|Lost to Follow-up|2|||
127771582|NCT00307125|459789074|FG002|Screening Phase|Ineligible|0|||
127880988|NCT01787188|460186092|FG002|Overall Study|Lost to Follow-up|2|||
127880989|NCT01787188|460186090|FG000|Overall Study|Other, including patient moved|0|||
127880990|NCT01787188|460186091|FG001|Overall Study|Other, including patient moved|3|||
127771583|NCT00307125|459789072|FG000|Screening Phase|Screen Error|1|||
127550467|NCT03070964|458982449|FG000|Overall Study|Progressive disease|8|||
127550468|NCT03070964|458982449|FG000|Overall Study|Treatment-unrelated adverse event|2|||
127550469|NCT03070964|458982449|FG000|Overall Study|Never treated|1|||
127550470|NCT03070964|458982449|FG000|Overall Study|Physician Decision|1|||
127771584|NCT00307125|459789073|FG001|Screening Phase|Screen Error|0|||
127771585|NCT00307125|459789074|FG002|Screening Phase|Screen Error|0|||
127771586|NCT00307125|459789072|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
127771587|NCT00307125|459789073|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
127771588|NCT00307125|459789074|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
127771589|NCT00307125|459789072|FG000|Screening Phase|AMR and treated with rituximab|1|||
127771590|NCT00307125|459789073|FG001|Screening Phase|AMR and treated with rituximab|0|||
127771591|NCT00307125|459789074|FG002|Screening Phase|AMR and treated with rituximab|0|||
127771592|NCT00307125|459789072|FG000|Screening Phase|Coronary artery bypass|1|||
127771593|NCT00307125|459789073|FG001|Screening Phase|Coronary artery bypass|0|||
127771594|NCT00307125|459789074|FG002|Screening Phase|Coronary artery bypass|0|||
127771595|NCT00307125|459789072|FG000|Pilot Phase|Lost to Follow-up|0|||
127771596|NCT00307125|459789073|FG001|Pilot Phase|Lost to Follow-up|1|||
127771597|NCT00307125|459789074|FG002|Pilot Phase|Lost to Follow-up|0|||
127771598|NCT00307125|459789072|FG000|Pilot Phase|Withdrawal by Subject|0|||
127771599|NCT00307125|459789073|FG001|Pilot Phase|Withdrawal by Subject|1|||
127771600|NCT00307125|459789074|FG002|Pilot Phase|Withdrawal by Subject|1|||
127771601|NCT00051363|459789075|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
127771602|NCT00051363|459789076|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
128017025|NCT02180867|460684865|FG001|Overall Study|Repeat Eligibility Studies|0|||
128017026|NCT02180867|460684866|FG002|Overall Study|Repeat Eligibility Studies|0|||
128017027|NCT02180867|460684867|FG003|Overall Study|Repeat Eligibility Studies|0|||
128017028|NCT02180867|460684868|FG004|Overall Study|Repeat Eligibility Studies|1|||
128017029|NCT02180867|460684869|FG005|Overall Study|Repeat Eligibility Studies|0|||
127771603|NCT00051363|459789075|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
127771604|NCT00051363|459789076|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
127771605|NCT00051363|459789075|FG000|Overall Study|Death|2|||
127771606|NCT00051363|459789076|FG001|Overall Study|Death|2|||
127771607|NCT00051363|459789075|FG000|Overall Study|Excluded Pre-Randomization|2|||
127771608|NCT00051363|459789076|FG001|Overall Study|Excluded Pre-Randomization|5|||
127771609|NCT00985153|459789077|FG000|Overall Study|Lost to Follow-up|16|||
127771610|NCT00985153|459789078|FG001|Overall Study|Lost to Follow-up|19|||
127771611|NCT00985153|459789079|FG002|Overall Study|Lost to Follow-up|17|||
127771612|NCT00985153|459789080|FG003|Overall Study|Lost to Follow-up|20|||
127771613|NCT00985153|459789077|FG000|Overall Study|Protocol Violation|3|||
127771614|NCT00985153|459789078|FG001|Overall Study|Protocol Violation|2|||
127771615|NCT00985153|459789079|FG002|Overall Study|Protocol Violation|4|||
127771616|NCT00985153|459789080|FG003|Overall Study|Protocol Violation|3|||
127771617|NCT00985153|459789077|FG000|Overall Study|Withdrawal by Subject|6|||
127771618|NCT00985153|459789078|FG001|Overall Study|Withdrawal by Subject|11|||
127771619|NCT00985153|459789079|FG002|Overall Study|Withdrawal by Subject|11|||
127771620|NCT00985153|459789080|FG003|Overall Study|Withdrawal by Subject|10|||
127771621|NCT00985153|459789077|FG000|Overall Study|Missed One or More Bleeds|7|||
127771622|NCT00985153|459789078|FG001|Overall Study|Missed One or More Bleeds|7|||
127771623|NCT00985153|459789079|FG002|Overall Study|Missed One or More Bleeds|8|||
127771624|NCT00985153|459789080|FG003|Overall Study|Missed One or More Bleeds|10|||
127771625|NCT00985153|459789077|FG000|Overall Study|Incomplete Safety Follow-up|3|||
127771626|NCT00985153|459789078|FG001|Overall Study|Incomplete Safety Follow-up|5|||
127771627|NCT00985153|459789079|FG002|Overall Study|Incomplete Safety Follow-up|4|||
127771628|NCT00985153|459789080|FG003|Overall Study|Incomplete Safety Follow-up|4|||
127771629|NCT01596621|459789082|FG000|Overall Study|Death|4|||
127771630|NCT01596621|459789082|FG000|Overall Study|Withdrawal by Subject|9|||
127771631|NCT01596621|459789082|FG000|Overall Study|Disease Progression|49|||
127771632|NCT01596621|459789082|FG000|Overall Study|Lost to Follow-up|3|||
127771633|NCT01596621|459789082|FG000|Overall Study|Other than specified|13|||
127771634|NCT00421707|459789087|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
127771635|NCT00421707|459789088|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
127771636|NCT00421707|459789087|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
127771637|NCT00421707|459789088|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
127771638|NCT00421707|459789087|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
127771639|NCT00421707|459789088|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
127771640|NCT00421707|459789087|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
127771641|NCT00421707|459789088|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
128017030|NCT02180867|460684870|FG006|Overall Study|Repeat Eligibility Studies|0|||
127771642|NCT00421707|459789087|FG000|Period 2: Washout|Adverse Event|1|||
127771643|NCT00421707|459789088|FG001|Period 2: Washout|Adverse Event|1|||
127771644|NCT00421707|459789087|FG000|Period 2: Washout|Withdrawal by Subject|0|||
128017031|NCT02180867|460684864|FG000|Overall Study|Refusal of further protocol therapy|1|||
128017032|NCT02180867|460684865|FG001|Overall Study|Refusal of further protocol therapy|0|||
127550471|NCT03070964|458982449|FG000|Overall Study|Withdrawal by Subject|1|||
127771645|NCT00421707|459789088|FG001|Period 2: Washout|Withdrawal by Subject|1|||
127771646|NCT00421707|459789087|FG000|Period 2: Washout|Lost to Follow-up|0|||
127771647|NCT00421707|459789088|FG001|Period 2: Washout|Lost to Follow-up|1|||
127771648|NCT00421707|459789087|FG000|Period 2: Washout|Other: Pregnancy|0|||
127771649|NCT00421707|459789088|FG001|Period 2: Washout|Other: Pregnancy|1|||
127771650|NCT00421707|459789087|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
127771651|NCT00421707|459789088|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
127771652|NCT00421707|459789087|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
127771653|NCT00421707|459789088|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
127771654|NCT00421707|459789087|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
127771655|NCT00421707|459789088|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
127771656|NCT01723254|459789089|FG000|Overall Study|Conflict with work schedule|0|||
127771657|NCT01723254|459789090|FG001|Overall Study|Conflict with work schedule|0|||
127771658|NCT01723254|459789091|FG002|Overall Study|Conflict with work schedule|0|||
127771659|NCT01723254|459789092|FG003|Overall Study|Conflict with work schedule|0|||
127771660|NCT01723254|459789093|FG004|Overall Study|Conflict with work schedule|0|||
127771661|NCT01723254|459789094|FG005|Overall Study|Conflict with work schedule|0|||
127771662|NCT01723254|459789095|FG006|Overall Study|Conflict with work schedule|0|||
127771663|NCT01723254|459789096|FG007|Overall Study|Conflict with work schedule|1|||
127771664|NCT01723254|459789089|FG000|Overall Study|Personal issues|0|||
127771665|NCT01723254|459789090|FG001|Overall Study|Personal issues|0|||
127771666|NCT01723254|459789091|FG002|Overall Study|Personal issues|0|||
127771667|NCT01723254|459789092|FG003|Overall Study|Personal issues|0|||
127771668|NCT01723254|459789093|FG004|Overall Study|Personal issues|0|||
127771669|NCT01723254|459789094|FG005|Overall Study|Personal issues|1|||
127771670|NCT01723254|459789095|FG006|Overall Study|Personal issues|0|||
127771671|NCT01723254|459789096|FG007|Overall Study|Personal issues|0|||
127771672|NCT01723254|459789089|FG000|Overall Study|No longer have time to participate|0|||
127771673|NCT01723254|459789090|FG001|Overall Study|No longer have time to participate|0|||
127771674|NCT01723254|459789091|FG002|Overall Study|No longer have time to participate|0|||
127771675|NCT01723254|459789092|FG003|Overall Study|No longer have time to participate|1|||
127771676|NCT01723254|459789093|FG004|Overall Study|No longer have time to participate|0|||
127771677|NCT01723254|459789094|FG005|Overall Study|No longer have time to participate|0|||
127771678|NCT01723254|459789095|FG006|Overall Study|No longer have time to participate|0|||
127771679|NCT01723254|459789096|FG007|Overall Study|No longer have time to participate|0|||
127771680|NCT01723254|459789089|FG000|Overall Study|Move/Left to another country/city|0|||
127771681|NCT01723254|459789090|FG001|Overall Study|Move/Left to another country/city|0|||
127771682|NCT01723254|459789091|FG002|Overall Study|Move/Left to another country/city|2|||
127771683|NCT01723254|459789092|FG003|Overall Study|Move/Left to another country/city|1|||
127771684|NCT01723254|459789093|FG004|Overall Study|Move/Left to another country/city|1|||
127771685|NCT01723254|459789094|FG005|Overall Study|Move/Left to another country/city|0|||
127771686|NCT01723254|459789095|FG006|Overall Study|Move/Left to another country/city|0|||
127771687|NCT01723254|459789096|FG007|Overall Study|Move/Left to another country/city|0|||
127771688|NCT01723254|459789089|FG000|Overall Study|Protocol Violation|0|||
127771689|NCT01723254|459789090|FG001|Overall Study|Protocol Violation|1|||
127771690|NCT01723254|459789091|FG002|Overall Study|Protocol Violation|0|||
127771691|NCT01723254|459789092|FG003|Overall Study|Protocol Violation|0|||
127771692|NCT01723254|459789093|FG004|Overall Study|Protocol Violation|0|||
127771693|NCT01723254|459789094|FG005|Overall Study|Protocol Violation|0|||
127771694|NCT01723254|459789095|FG006|Overall Study|Protocol Violation|0|||
127771695|NCT01723254|459789096|FG007|Overall Study|Protocol Violation|0|||
127771696|NCT01723254|459789089|FG000|Overall Study|Withdrawal by Subject|1|||
127771697|NCT01723254|459789090|FG001|Overall Study|Withdrawal by Subject|2|||
127771698|NCT01723254|459789091|FG002|Overall Study|Withdrawal by Subject|1|||
127771699|NCT01723254|459789092|FG003|Overall Study|Withdrawal by Subject|0|||
127771700|NCT01723254|459789093|FG004|Overall Study|Withdrawal by Subject|1|||
127771701|NCT01723254|459789094|FG005|Overall Study|Withdrawal by Subject|1|||
127771702|NCT01723254|459789095|FG006|Overall Study|Withdrawal by Subject|1|||
127771703|NCT01723254|459789096|FG007|Overall Study|Withdrawal by Subject|2|||
127771704|NCT01074216|459789097|FG000|Overall Study|Physician Decision|1|||
127771705|NCT01074216|459789097|FG000|Overall Study|Not Treated|12|||
127771706|NCT01323634|459789098|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
127771707|NCT01323634|459789099|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
127771708|NCT01323634|459789100|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
127771709|NCT01323634|459789098|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
127771710|NCT01323634|459789099|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
127771711|NCT01323634|459789100|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
127771712|NCT01323634|459789098|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
127771713|NCT01323634|459789099|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
127771714|NCT01323634|459789100|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
127771715|NCT01323634|459789098|FG000|2-week Run-in Period|Physician Decision|5|||
127771716|NCT01323634|459789099|FG001|2-week Run-in Period|Physician Decision|0|||
127771717|NCT01323634|459789100|FG002|2-week Run-in Period|Physician Decision|0|||
127771718|NCT01323634|459789098|FG000|2-week Run-in Period|Protocol Violation|1|||
127550472|NCT03070964|458982449|FG000|Overall Study|Adverse Event|1|||
127550473|NCT01285557|458982450|FG000|Overall Study|Death|173|||
127550474|NCT01285557|458982451|FG001|Overall Study|Death|90|||
127550475|NCT01285557|458982450|FG000|Overall Study|Lost to Follow-up|6|||
127550476|NCT01285557|458982451|FG001|Overall Study|Lost to Follow-up|2|||
127550477|NCT01285557|458982450|FG000|Overall Study|Withdrew Consent|6|||
127550478|NCT01285557|458982451|FG001|Overall Study|Withdrew Consent|1|||
127550479|NCT01285557|458982450|FG000|Overall Study|Sponsor Study Termination|23|||
127550480|NCT01285557|458982451|FG001|Overall Study|Sponsor Study Termination|13|||
127550481|NCT01285557|458982450|FG000|Overall Study|Randomized but not treated|1|||
127550482|NCT01285557|458982451|FG001|Overall Study|Randomized but not treated|1|||
127550483|NCT01285557|458982450|FG000|Overall Study|Study follow-up ongoing|28|||
127550484|NCT01285557|458982451|FG001|Overall Study|Study follow-up ongoing|14|||
127550485|NCT01285557|458982450|FG000|Overall Study|Sponsor Decision|2|||
127550486|NCT01285557|458982451|FG001|Overall Study|Sponsor Decision|1|||
127550487|NCT05615922|458982453|FG000|Overall Study|Lost to Follow-up|1|||
127550488|NCT03173248|458982456|FG000|Overall Study|Death|28|||
127550489|NCT03173248|458982457|FG001|Overall Study|Death|46|||
127550490|NCT03173248|458982456|FG000|Overall Study|Lost to Follow-up|0|||
127550491|NCT03173248|458982457|FG001|Overall Study|Lost to Follow-up|1|||
127550492|NCT03173248|458982456|FG000|Overall Study|Withdrawal by Subject|6|||
127550493|NCT03173248|458982457|FG001|Overall Study|Withdrawal by Subject|4|||
127550494|NCT03173248|458982456|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
127550495|NCT03173248|458982457|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
127550496|NCT02991768|458982459|FG000|Overall Study|Physician Decision|4|||
127550497|NCT04500158|458982462|FG000|Overall Study|Physician Decision|17|||
127550498|NCT04500158|458982463|FG001|Overall Study|Physician Decision|11|||
127550499|NCT04922216|458982466|FG000|Overall Study|Withdrawal by Subject|0|||
127550500|NCT04922216|458982467|FG001|Overall Study|Withdrawal by Subject|1|||
127550501|NCT04922216|458982468|FG002|Overall Study|Withdrawal by Subject|0|||
127550502|NCT04922216|458982469|FG003|Overall Study|Withdrawal by Subject|0|||
127550503|NCT04922216|458982470|FG004|Overall Study|Withdrawal by Subject|0|||
127550504|NCT04922216|458982471|FG005|Overall Study|Withdrawal by Subject|0|||
127550505|NCT04922216|458982472|FG006|Overall Study|Withdrawal by Subject|0|||
127550506|NCT04922216|458982473|FG007|Overall Study|Withdrawal by Subject|2|||
127550507|NCT04922216|458982474|FG008|Overall Study|Withdrawal by Subject|0|||
127550508|NCT04922216|458982475|FG009|Overall Study|Withdrawal by Subject|0|||
127550509|NCT04922216|458982476|FG010|Overall Study|Withdrawal by Subject|0|||
127550510|NCT04922216|458982477|FG011|Overall Study|Withdrawal by Subject|0|||
127550511|NCT04922216|458982478|FG012|Overall Study|Withdrawal by Subject|1|||
127550512|NCT04922216|458982479|FG013|Overall Study|Withdrawal by Subject|1|||
127550513|NCT04922216|458982480|FG014|Overall Study|Withdrawal by Subject|1|||
127550514|NCT04922216|458982481|FG015|Overall Study|Withdrawal by Subject|0|||
127550515|NCT04922216|458982482|FG016|Overall Study|Withdrawal by Subject|0|||
127550516|NCT04922216|458982483|FG017|Overall Study|Withdrawal by Subject|1|||
127550517|NCT04922216|458982484|FG018|Overall Study|Withdrawal by Subject|1|||
127550518|NCT04922216|458982485|FG019|Overall Study|Withdrawal by Subject|1|||
127550519|NCT04922216|458982486|FG020|Overall Study|Withdrawal by Subject|1|||
127550520|NCT04922216|458982487|FG021|Overall Study|Withdrawal by Subject|0|||
127550521|NCT04922216|458982488|FG022|Overall Study|Withdrawal by Subject|0|||
127550522|NCT04922216|458982489|FG023|Overall Study|Withdrawal by Subject|2|||
127550523|NCT04922216|458982490|FG024|Overall Study|Withdrawal by Subject|0|||
127550524|NCT04922216|458982491|FG025|Overall Study|Withdrawal by Subject|0|||
127550525|NCT04922216|458982492|FG026|Overall Study|Withdrawal by Subject|1|||
127550526|NCT04922216|458982493|FG027|Overall Study|Withdrawal by Subject|0|||
127550527|NCT04922216|458982494|FG028|Overall Study|Withdrawal by Subject|0|||
127550528|NCT04922216|458982495|FG029|Overall Study|Withdrawal by Subject|0|||
127684901|NCT01943799|459471932|FG002|Overall Study|Withdrawal by Subject|1|||
127684902|NCT01943799|459471933|FG003|Overall Study|Withdrawal by Subject|0|||
127684903|NCT04594759|459471934|FG000|Overall Study|Lost to Follow-up|3|||
127684904|NCT03811574|459471937|FG000|Overall Study|Withdrawal by Subject|2|||
127684905|NCT03811574|459471938|FG001|Overall Study|Withdrawal by Subject|4|||
127684906|NCT03811574|459471939|FG002|Overall Study|Withdrawal by Subject|0|||
127684907|NCT01832480|459471940|FG000|Overall Study|Lost to Follow-up|33|||
127684908|NCT01832480|459471941|FG001|Overall Study|Lost to Follow-up|30|||
127684909|NCT01832480|459471940|FG000|Overall Study|Withdrawal by Subject|0|||
127684910|NCT01832480|459471941|FG001|Overall Study|Withdrawal by Subject|2|||
127684911|NCT01832480|459471940|FG000|Overall Study|post randomization ineligible|8|||
127684912|NCT01832480|459471941|FG001|Overall Study|post randomization ineligible|10|||
127684913|NCT05609032|459471942|FG000|Overall Study|Lost to Follow-up|3|||
127684914|NCT05609032|459471943|FG001|Overall Study|Lost to Follow-up|1|||
127684915|NCT05609032|459471942|FG000|Overall Study|Withdrawal by Subject|1|||
127550529|NCT04922216|458982496|FG030|Overall Study|Withdrawal by Subject|1|||
127550530|NCT04922216|458982497|FG031|Overall Study|Withdrawal by Subject|0|||
127550531|NCT04922216|458982466|FG000|Overall Study|Lost to Follow-up|1|||
127550532|NCT04922216|458982467|FG001|Overall Study|Lost to Follow-up|0|||
127550533|NCT04922216|458982468|FG002|Overall Study|Lost to Follow-up|2|||
128017033|NCT02180867|460684866|FG002|Overall Study|Refusal of further protocol therapy|2|||
128017034|NCT02180867|460684867|FG003|Overall Study|Refusal of further protocol therapy|6|||
128017035|NCT02180867|460684868|FG004|Overall Study|Refusal of further protocol therapy|4|||
128017036|NCT02180867|460684869|FG005|Overall Study|Refusal of further protocol therapy|0|||
128017037|NCT02180867|460684870|FG006|Overall Study|Refusal of further protocol therapy|0|||
128017038|NCT02337686|460684871|FG000|Overall Study|Adverse Event|1|||
128017039|NCT00177671|460685530|FG000|Overall Study|Withdrawal by Subject|5|||
128017040|NCT00177671|460685531|FG001|Overall Study|Withdrawal by Subject|6|||
128017041|NCT00177671|460685530|FG000|Overall Study|medical complications|2|||
128017042|NCT00177671|460685531|FG001|Overall Study|medical complications|0|||
128017043|NCT00177671|460685530|FG000|Overall Study|Adverse Event|6|||
127771719|NCT01323634|459789099|FG001|2-week Run-in Period|Protocol Violation|0|||
127771720|NCT01323634|459789100|FG002|2-week Run-in Period|Protocol Violation|0|||
127771721|NCT01323634|459789098|FG000|2-week Run-in Period|Adverse Event|1|||
127771722|NCT01323634|459789099|FG001|2-week Run-in Period|Adverse Event|0|||
127771723|NCT01323634|459789100|FG002|2-week Run-in Period|Adverse Event|0|||
127771724|NCT01323634|459789098|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
127771725|NCT01323634|459789099|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
127771726|NCT01323634|459789100|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
127771727|NCT01323634|459789098|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
127771728|NCT01323634|459789099|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
127771729|NCT01323634|459789100|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
127771730|NCT01323634|459789098|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
127771731|NCT01323634|459789099|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
127771732|NCT01323634|459789100|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
127771733|NCT01323634|459789098|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
127771734|NCT01323634|459789099|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
127771735|NCT01323634|459789100|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
127771736|NCT01323634|459789098|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
127771737|NCT01323634|459789099|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
127771738|NCT01323634|459789100|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
127771739|NCT01323634|459789098|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
127771740|NCT01323634|459789099|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
127771741|NCT01323634|459789100|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
127771742|NCT01323634|459789098|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
127771743|NCT01323634|459789099|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
127771744|NCT01323634|459789100|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
127771745|NCT05056987|459789101|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
127771746|NCT05056987|459789102|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
127771747|NCT05056987|459789101|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
127771748|NCT05056987|459789102|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
127771749|NCT02678247|459789105|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
127771750|NCT02678247|459789106|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
127771751|NCT02678247|459789105|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
127771752|NCT02678247|459789106|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
127771753|NCT02678247|459789105|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
127771754|NCT02678247|459789106|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
127771755|NCT02678247|459789105|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
127771756|NCT02678247|459789106|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
127771757|NCT02678247|459789105|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
127771758|NCT02678247|459789106|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
127771759|NCT02678247|459789105|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
127771760|NCT02678247|459789106|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
127771761|NCT04223856|459789107|FG000|Overall Study|Progressive disease|153|||
127771762|NCT04223856|459789108|FG001|Overall Study|Progressive disease|73|||
128017044|NCT00177671|460685531|FG001|Overall Study|Adverse Event|0|||
128017045|NCT00177671|460685530|FG000|Overall Study|Physician Decision|12|||
128017046|NCT00177671|460685531|FG001|Overall Study|Physician Decision|8|||
127684916|NCT05609032|459471943|FG001|Overall Study|Withdrawal by Subject|0|||
127684917|NCT00958633|459471944|FG000|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
127684918|NCT00958633|459471945|FG001|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
127684919|NCT00958633|459471946|FG002|Open-Label (up to 16 Weeks)|Lost to Follow-up|14|||
127684920|NCT00958633|459471944|FG000|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
127684921|NCT00958633|459471945|FG001|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
127684922|NCT00958633|459471946|FG002|Open-Label (up to 16 Weeks)|Withdrawal by Subject|18|||
127684923|NCT00958633|459471944|FG000|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
127684924|NCT00958633|459471945|FG001|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
127684925|NCT00958633|459471946|FG002|Open-Label (up to 16 Weeks)|Worsening of symptoms|13|||
127684926|NCT00958633|459471944|FG000|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
127550534|NCT04922216|458982469|FG003|Overall Study|Lost to Follow-up|0|||
127550535|NCT04922216|458982470|FG004|Overall Study|Lost to Follow-up|0|||
127550536|NCT04922216|458982471|FG005|Overall Study|Lost to Follow-up|2|||
127550537|NCT04922216|458982472|FG006|Overall Study|Lost to Follow-up|0|||
127550538|NCT04922216|458982473|FG007|Overall Study|Lost to Follow-up|1|||
127550539|NCT04922216|458982474|FG008|Overall Study|Lost to Follow-up|1|||
127550540|NCT04922216|458982475|FG009|Overall Study|Lost to Follow-up|2|||
127550541|NCT04922216|458982476|FG010|Overall Study|Lost to Follow-up|2|||
127550542|NCT04922216|458982477|FG011|Overall Study|Lost to Follow-up|1|||
127550543|NCT04922216|458982478|FG012|Overall Study|Lost to Follow-up|1|||
127550544|NCT04922216|458982479|FG013|Overall Study|Lost to Follow-up|0|||
127550545|NCT04922216|458982480|FG014|Overall Study|Lost to Follow-up|1|||
127550546|NCT04922216|458982481|FG015|Overall Study|Lost to Follow-up|0|||
127550547|NCT04922216|458982482|FG016|Overall Study|Lost to Follow-up|0|||
127550548|NCT04922216|458982483|FG017|Overall Study|Lost to Follow-up|2|||
127550549|NCT04922216|458982484|FG018|Overall Study|Lost to Follow-up|1|||
127550550|NCT04922216|458982485|FG019|Overall Study|Lost to Follow-up|0|||
127550551|NCT04922216|458982486|FG020|Overall Study|Lost to Follow-up|1|||
127550552|NCT04922216|458982487|FG021|Overall Study|Lost to Follow-up|0|||
127550553|NCT04922216|458982488|FG022|Overall Study|Lost to Follow-up|2|||
127550554|NCT04922216|458982489|FG023|Overall Study|Lost to Follow-up|1|||
127550555|NCT04922216|458982490|FG024|Overall Study|Lost to Follow-up|0|||
127550556|NCT04922216|458982491|FG025|Overall Study|Lost to Follow-up|2|||
127550557|NCT04922216|458982492|FG026|Overall Study|Lost to Follow-up|0|||
127550558|NCT04922216|458982493|FG027|Overall Study|Lost to Follow-up|0|||
127550559|NCT04922216|458982494|FG028|Overall Study|Lost to Follow-up|1|||
127550560|NCT04922216|458982495|FG029|Overall Study|Lost to Follow-up|0|||
127550561|NCT04922216|458982496|FG030|Overall Study|Lost to Follow-up|2|||
127550562|NCT04922216|458982497|FG031|Overall Study|Lost to Follow-up|1|||
127550563|NCT03278249|458982498|FG000|Overall Study|Withdrawal by Subject|2|||
127550564|NCT03278249|458982498|FG000|Overall Study|Lost to Follow-up|1|||
127550565|NCT04801420|458982499|FG000|Overall Study|Other|1|||
127550566|NCT04801420|458982500|FG001|Overall Study|Other|2|||
127550567|NCT04801420|458982501|FG002|Overall Study|Other|1|||
127550568|NCT04801420|458982499|FG000|Overall Study|Lost to Follow-up|7|||
127550569|NCT04801420|458982500|FG001|Overall Study|Lost to Follow-up|9|||
127550570|NCT04801420|458982501|FG002|Overall Study|Lost to Follow-up|10|||
127550571|NCT04801420|458982499|FG000|Overall Study|Moved from study area|0|||
127550572|NCT04801420|458982500|FG001|Overall Study|Moved from study area|1|||
127550573|NCT04801420|458982501|FG002|Overall Study|Moved from study area|1|||
127550574|NCT04801420|458982499|FG000|Overall Study|Withdrawal by Subject|5|||
127550575|NCT04801420|458982500|FG001|Overall Study|Withdrawal by Subject|1|||
127550576|NCT04801420|458982501|FG002|Overall Study|Withdrawal by Subject|4|||
127550577|NCT04801420|458982499|FG000|Overall Study|Individual stopping criteria reached|0|||
127550578|NCT04801420|458982500|FG001|Overall Study|Individual stopping criteria reached|1|||
127550579|NCT04801420|458982501|FG002|Overall Study|Individual stopping criteria reached|0|||
127550580|NCT04801420|458982499|FG000|Overall Study|Ongoing in the study|195|||
127550581|NCT04801420|458982500|FG001|Overall Study|Ongoing in the study|195|||
127550582|NCT04801420|458982501|FG002|Overall Study|Ongoing in the study|192|||
127550583|NCT04774094|458982502|FG000|Overall Study|Other|2|||
127550584|NCT04774094|458982502|FG000|Overall Study|Withdrawal by Subject|9|||
127550585|NCT04774094|458982502|FG000|Overall Study|Lost to Follow-up|7|||
127550586|NCT04774094|458982502|FG000|Overall Study|Lack of Efficacy|5|||
127550587|NCT04774094|458982502|FG000|Overall Study|Death|17|||
127771763|NCT04223856|459789107|FG000|Overall Study|Adverse Event|97|||
127771764|NCT04223856|459789108|FG001|Overall Study|Adverse Event|62|||
127771765|NCT04223856|459789107|FG000|Overall Study|Physician Decision|9|||
127771766|NCT04223856|459789108|FG001|Overall Study|Physician Decision|28|||
127550588|NCT04774094|458982502|FG000|Overall Study|Adverse Event|4|||
127550589|NCT04988477|458982504|FG000|Overall Study|Death|1|||
127550590|NCT04988477|458982505|FG001|Overall Study|Death|0|||
127550591|NCT04988477|458982506|FG002|Overall Study|Death|0|||
127550592|NCT04988477|458982504|FG000|Overall Study|Lost to Follow-up|5|||
127550593|NCT04988477|458982505|FG001|Overall Study|Lost to Follow-up|2|||
127550594|NCT04988477|458982506|FG002|Overall Study|Lost to Follow-up|0|||
127550595|NCT04988477|458982504|FG000|Overall Study|Withdrawal by Subject|2|||
127550596|NCT04988477|458982505|FG001|Overall Study|Withdrawal by Subject|0|||
127550597|NCT04988477|458982506|FG002|Overall Study|Withdrawal by Subject|0|||
127550598|NCT04145349|458983982|FG000|Overall Study|Withdrawal by Subject|3|||
127550599|NCT04145349|458983983|FG001|Overall Study|Withdrawal by Subject|0|||
127550600|NCT04145349|458983982|FG000|Overall Study|Lost to Follow-up|0|||
127550601|NCT04145349|458983983|FG001|Overall Study|Lost to Follow-up|1|||
127550602|NCT04145349|458983982|FG000|Overall Study|On study treatment (Ongoing)|0|||
127550603|NCT04145349|458983983|FG001|Overall Study|On study treatment (Ongoing)|1|||
127550604|NCT01148979|458983984|FG000|Overall Study|Lost to Follow-up|0|||
127771767|NCT04223856|459789107|FG000|Overall Study|Withdrawal by Subject|22|||
127550605|NCT01148979|458983985|FG001|Overall Study|Lost to Follow-up|1|||
127550606|NCT00775190|458983986|FG000|Overall Study|Lost to Follow-up|2|||
127550607|NCT00775190|458983987|FG001|Overall Study|Lost to Follow-up|3|||
128017047|NCT02293499|460685532|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
128017048|NCT02293499|460685533|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
128017049|NCT02293499|460685534|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
128017050|NCT02293499|460685532|FG000|Intervention - Camp|Withdrawal by Subject|3|||
128017051|NCT02293499|460685533|FG001|Intervention - Camp|Withdrawal by Subject|6|||
128017052|NCT02293499|460685534|FG002|Intervention - Camp|Withdrawal by Subject|2|||
128017053|NCT02293499|460685532|FG000|Intervention - Camp|these are those not showing up at camp|24|||
128017054|NCT02293499|460685533|FG001|Intervention - Camp|these are those not showing up at camp|28|||
128017055|NCT02293499|460685534|FG002|Intervention - Camp|these are those not showing up at camp|4|||
128017056|NCT02293499|460685532|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
128017057|NCT02293499|460685533|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
128017058|NCT02293499|460685534|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
128017059|NCT02293499|460685532|FG000|3 Month Follow Up|Lost to Follow-up|14|||
128017060|NCT02293499|460685533|FG001|3 Month Follow Up|Lost to Follow-up|15|||
128017061|NCT02293499|460685534|FG002|3 Month Follow Up|Lost to Follow-up|6|||
128017062|NCT02293499|460685532|FG000|6 Month Follow Up|Lost to Follow-up|17|||
128017063|NCT02293499|460685533|FG001|6 Month Follow Up|Lost to Follow-up|27|||
128017064|NCT02293499|460685534|FG002|6 Month Follow Up|Lost to Follow-up|6|||
128017065|NCT02293499|460685532|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
128017066|NCT02293499|460685533|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
128017067|NCT02293499|460685534|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
128017068|NCT02293499|460685532|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
128017069|NCT02293499|460685533|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
128017070|NCT02293499|460685534|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
128017071|NCT02293499|460685532|FG000|9 Month Follow Up|Lost to Follow-up|24|||
128017072|NCT02293499|460685533|FG001|9 Month Follow Up|Lost to Follow-up|28|||
128017073|NCT02293499|460685534|FG002|9 Month Follow Up|Lost to Follow-up|4|||
128017074|NCT02293499|460685532|FG000|12 Month Follow Up|Lost to Follow-up|26|||
128017075|NCT02293499|460685533|FG001|12 Month Follow Up|Lost to Follow-up|25|||
128017076|NCT02293499|460685534|FG002|12 Month Follow Up|Lost to Follow-up|6|||
128017077|NCT02293499|460685532|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
128017078|NCT02293499|460685533|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
128017079|NCT02293499|460685534|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
128017080|NCT02293499|460685532|FG000|15 Month Follow Up|Lost to Follow-up|22|||
128017081|NCT02293499|460685533|FG001|15 Month Follow Up|Lost to Follow-up|22|||
128017082|NCT02293499|460685534|FG002|15 Month Follow Up|Lost to Follow-up|7|||
128017083|NCT01847209|460685537|FG000|Overall Study|Withdrawal by Subject|1|||
128017084|NCT01847209|460685537|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
128017085|NCT02737618|460685556|FG000|Overall Study|Withdrawal by Subject|9|||
128017086|NCT01879852|460685560|FG000|Overall Study|Withdrawal by Subject|2|||
128017087|NCT01879852|460685561|FG001|Overall Study|Withdrawal by Subject|0|||
128017088|NCT02696616|460685562|FG000|Overall Study|Adverse Event|0|||
128017089|NCT02696616|460685563|FG001|Overall Study|Adverse Event|1|||
128017090|NCT02696616|460685564|FG002|Overall Study|Adverse Event|0|||
128017091|NCT02696616|460685565|FG003|Overall Study|Adverse Event|0|||
128017092|NCT02696616|460685566|FG004|Overall Study|Adverse Event|0|||
128017093|NCT02696616|460685567|FG005|Overall Study|Adverse Event|0|||
128017094|NCT02696616|460685568|FG006|Overall Study|Adverse Event|0|||
128017095|NCT01500083|460685571|FG000|Overall Study|Adverse Event|4|||
127684927|NCT00958633|459471945|FG001|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
127684928|NCT00958633|459471946|FG002|Open-Label (up to 16 Weeks)|Lack of Efficacy|8|||
127684929|NCT00958633|459471944|FG000|Open-Label (up to 16 Weeks)|Non-adherence|0|||
127684930|NCT00958633|459471945|FG001|Open-Label (up to 16 Weeks)|Non-adherence|0|||
127684931|NCT00958633|459471946|FG002|Open-Label (up to 16 Weeks)|Non-adherence|2|||
127684932|NCT00958633|459471944|FG000|Open-Label (up to 16 Weeks)|Physician Decision|0|||
127684933|NCT00958633|459471945|FG001|Open-Label (up to 16 Weeks)|Physician Decision|0|||
127684934|NCT00958633|459471946|FG002|Open-Label (up to 16 Weeks)|Physician Decision|4|||
127684935|NCT00958633|459471944|FG000|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|1|||
127684936|NCT00958633|459471945|FG001|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
127684937|NCT00958633|459471946|FG002|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
127684938|NCT01373346|459471957|FG000|Overall Study|Death|1|||
127684939|NCT01395758|459471959|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
127684940|NCT01395758|459471960|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
127684941|NCT01395758|459471961|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
127684942|NCT00433199|459471962|FG000|Double-Blind Period|Adverse Event|0|||
127684943|NCT00433199|459471963|FG001|Double-Blind Period|Adverse Event|25|||
128017096|NCT01500083|460685572|FG001|Overall Study|Adverse Event|17|||
128017097|NCT01500083|460685571|FG000|Overall Study|Death|0|||
128017098|NCT01500083|460685572|FG001|Overall Study|Death|2|||
128017099|NCT01500083|460685571|FG000|Overall Study|Lost to Follow-up|1|||
128017100|NCT01500083|460685572|FG001|Overall Study|Lost to Follow-up|0|||
127684944|NCT00433199|459471962|FG000|Double-Blind Period|Lack of Efficacy|0|||
127550608|NCT00775190|458983986|FG000|Overall Study|Withdrawal by Subject|1|||
127550609|NCT00775190|458983987|FG001|Overall Study|Withdrawal by Subject|2|||
127550610|NCT00775190|458983986|FG000|Overall Study|Protocol Violation|1|||
127550611|NCT00775190|458983987|FG001|Overall Study|Protocol Violation|0|||
127550612|NCT01600716|458983988|FG000|Overall Study|Other Reasons|3|||
127550613|NCT01600716|458983989|FG001|Overall Study|Other Reasons|1|||
127550614|NCT01600716|458983988|FG000|Overall Study|Personal Reasons|0|||
127550615|NCT01600716|458983989|FG001|Overall Study|Personal Reasons|2|||
127550616|NCT01600716|458983988|FG000|Overall Study|Lost to Follow-up|0|||
127550617|NCT01600716|458983989|FG001|Overall Study|Lost to Follow-up|2|||
127550618|NCT01600716|458983988|FG000|Overall Study|Pregnancy|1|||
127550619|NCT01600716|458983989|FG001|Overall Study|Pregnancy|0|||
127550620|NCT01600716|458983988|FG000|Overall Study|Lack of Efficacy|2|||
127550621|NCT01600716|458983989|FG001|Overall Study|Lack of Efficacy|1|||
127550622|NCT01600716|458983988|FG000|Overall Study|Adverse Event|1|||
127550623|NCT01600716|458983989|FG001|Overall Study|Adverse Event|1|||
127550624|NCT03349034|458983992|FG000|Overall Study|catheters dislodged during transport|2|||
127550625|NCT03349034|458983993|FG001|Overall Study|catheters dislodged during transport|0|||
127550626|NCT03349034|458983992|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
127550627|NCT03349034|458983993|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
127550628|NCT03349034|458983992|FG000|Overall Study|soft tissue flap used|1|||
127550629|NCT03349034|458983993|FG001|Overall Study|soft tissue flap used|0|||
127550630|NCT03349034|458983992|FG000|Overall Study|Other|0|||
127550631|NCT03349034|458983993|FG001|Overall Study|Other|1|||
127550632|NCT00865566|458983994|FG000|Overall Study|Death|1|||
127550633|NCT00865566|458983995|FG001|Overall Study|Death|11|||
127550634|NCT00865566|458983994|FG000|Overall Study|Lost to Follow-up|314|||
127550635|NCT00865566|458983995|FG001|Overall Study|Lost to Follow-up|315|||
127550636|NCT00865566|458983994|FG000|Overall Study|Withdrawal by Subject|45|||
127550637|NCT00865566|458983995|FG001|Overall Study|Withdrawal by Subject|65|||
127550638|NCT00865566|458983994|FG000|Overall Study|Physician Decision|0|||
127550639|NCT00865566|458983995|FG001|Overall Study|Physician Decision|1|||
127550640|NCT00865566|458983994|FG000|Overall Study|Participant relocated|78|||
127550641|NCT00865566|458983995|FG001|Overall Study|Participant relocated|107|||
127550642|NCT00865566|458983994|FG000|Overall Study|Participant unable to adhere|27|||
127550643|NCT00865566|458983995|FG001|Overall Study|Participant unable to adhere|42|||
127550644|NCT00865566|458983994|FG000|Overall Study|Other; N=245 due to early study closure|154|||
127550645|NCT00865566|458983995|FG001|Overall Study|Other; N=245 due to early study closure|139|||
127550646|NCT00865566|458983994|FG000|Overall Study|HIV infection|5|||
127550647|NCT00865566|458983995|FG001|Overall Study|HIV infection|7|||
127550648|NCT00815659|458983996|FG000|Overall Study|Adverse Event|9|||
127550649|NCT00815659|458983996|FG000|Overall Study|Withdrawal by Subject|9|||
127550650|NCT00815659|458983996|FG000|Overall Study|Lost to Follow-up|4|||
127550651|NCT00815659|458983996|FG000|Overall Study|Protocol Violation|1|||
127550652|NCT03847896|458983997|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
127550653|NCT03847896|458983998|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
127550654|NCT03847896|458983999|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
127550655|NCT03847896|458984000|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
127550656|NCT03847896|458984001|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
127550657|NCT03847896|458983997|FG000|Overall Study|Withdrawal by Subject|2|||
127684945|NCT00433199|459471963|FG001|Double-Blind Period|Lack of Efficacy|2|||
127684946|NCT00433199|459471962|FG000|Double-Blind Period|Lost to Follow-up|2|||
127684947|NCT00433199|459471963|FG001|Double-Blind Period|Lost to Follow-up|5|||
127684948|NCT00433199|459471962|FG000|Double-Blind Period|Withdrawal by Subject|8|||
127684949|NCT00433199|459471963|FG001|Double-Blind Period|Withdrawal by Subject|19|||
127684950|NCT00433199|459471962|FG000|Double-Blind Period|Protocol Violation|1|||
127684951|NCT00433199|459471963|FG001|Double-Blind Period|Protocol Violation|10|||
127684952|NCT00433199|459471962|FG000|Double-Blind Period|Administrative|1|||
127684953|NCT00433199|459471963|FG001|Double-Blind Period|Administrative|5|||
127684954|NCT00433199|459471962|FG000|Open-Label Period|Adverse Event|0|||
127684955|NCT00433199|459471963|FG001|Open-Label Period|Adverse Event|19|||
127684956|NCT00433199|459471962|FG000|Open-Label Period|Lack of Efficacy|0|||
127684957|NCT00433199|459471963|FG001|Open-Label Period|Lack of Efficacy|2|||
127684958|NCT00433199|459471962|FG000|Open-Label Period|Lost to Follow-up|0|||
127550658|NCT03847896|458983998|FG001|Overall Study|Withdrawal by Subject|10|||
127550659|NCT03847896|458983999|FG002|Overall Study|Withdrawal by Subject|5|||
127550660|NCT03847896|458984000|FG003|Overall Study|Withdrawal by Subject|9|||
127550661|NCT03847896|458984001|FG004|Overall Study|Withdrawal by Subject|8|||
127550662|NCT03847896|458983997|FG000|Overall Study|Withdrawal by parent/guardian|0|||
127550663|NCT03847896|458983998|FG001|Overall Study|Withdrawal by parent/guardian|0|||
127550664|NCT03847896|458983999|FG002|Overall Study|Withdrawal by parent/guardian|1|||
127550665|NCT03847896|458984000|FG003|Overall Study|Withdrawal by parent/guardian|0|||
127550666|NCT03847896|458984001|FG004|Overall Study|Withdrawal by parent/guardian|0|||
127684959|NCT00433199|459471963|FG001|Open-Label Period|Lost to Follow-up|3|||
127550667|NCT03847896|458983997|FG000|Overall Study|Adverse Event|2|||
127550668|NCT03847896|458983998|FG001|Overall Study|Adverse Event|1|||
127550669|NCT03847896|458983999|FG002|Overall Study|Adverse Event|3|||
127550670|NCT03847896|458984000|FG003|Overall Study|Adverse Event|2|||
127550671|NCT03847896|458984001|FG004|Overall Study|Adverse Event|4|||
127550672|NCT03847896|458983997|FG000|Overall Study|A severe exacerbation event|0|||
127550673|NCT03847896|458983998|FG001|Overall Study|A severe exacerbation event|0|||
127550674|NCT03847896|458983999|FG002|Overall Study|A severe exacerbation event|0|||
127550675|NCT03847896|458984000|FG003|Overall Study|A severe exacerbation event|0|||
127550676|NCT03847896|458984001|FG004|Overall Study|A severe exacerbation event|3|||
127550677|NCT03847896|458983997|FG000|Overall Study|Protocol Violation|0|||
127550678|NCT03847896|458983998|FG001|Overall Study|Protocol Violation|2|||
127550679|NCT03847896|458983999|FG002|Overall Study|Protocol Violation|1|||
127550680|NCT03847896|458984000|FG003|Overall Study|Protocol Violation|0|||
127550681|NCT03847896|458984001|FG004|Overall Study|Protocol Violation|2|||
127550682|NCT03847896|458983997|FG000|Overall Study|Lost to Follow-up|0|||
127550683|NCT03847896|458983998|FG001|Overall Study|Lost to Follow-up|0|||
127550684|NCT03847896|458983999|FG002|Overall Study|Lost to Follow-up|0|||
127550685|NCT03847896|458984000|FG003|Overall Study|Lost to Follow-up|1|||
127550686|NCT03847896|458984001|FG004|Overall Study|Lost to Follow-up|0|||
127550687|NCT03847896|458983997|FG000|Overall Study|Condition under investigation worsened|0|||
127550688|NCT03847896|458983998|FG001|Overall Study|Condition under investigation worsened|0|||
127550689|NCT03847896|458983999|FG002|Overall Study|Condition under investigation worsened|0|||
127550690|NCT03847896|458984000|FG003|Overall Study|Condition under investigation worsened|1|||
127550691|NCT03847896|458984001|FG004|Overall Study|Condition under investigation worsened|1|||
127550692|NCT03847896|458983997|FG000|Overall Study|Lack of Efficacy|0|||
127550693|NCT03847896|458983998|FG001|Overall Study|Lack of Efficacy|0|||
127550694|NCT03847896|458983999|FG002|Overall Study|Lack of Efficacy|0|||
127550695|NCT03847896|458984000|FG003|Overall Study|Lack of Efficacy|2|||
127550696|NCT03847896|458984001|FG004|Overall Study|Lack of Efficacy|2|||
127550697|NCT03847896|458983997|FG000|Overall Study|Other reasons|3|||
127550698|NCT03847896|458983998|FG001|Overall Study|Other reasons|3|||
127550699|NCT03847896|458983999|FG002|Overall Study|Other reasons|1|||
127550700|NCT03847896|458984000|FG003|Overall Study|Other reasons|2|||
127550701|NCT03847896|458984001|FG004|Overall Study|Other reasons|1|||
127550702|NCT02978781|458984002|FG000|Part A|Adverse Event|1|||
127550703|NCT02978781|458984003|FG001|Part A|Adverse Event|1|||
127550704|NCT02978781|458984004|FG002|Part A|Adverse Event|0|||
127550705|NCT02978781|458984005|FG003|Part A|Adverse Event|0|||
127550706|NCT02978781|458984006|FG004|Part A|Adverse Event|0|||
127550707|NCT02978781|458984002|FG000|Part A|Withdrawal by Subject|0|||
127550708|NCT02978781|458984003|FG001|Part A|Withdrawal by Subject|1|||
127550709|NCT02978781|458984004|FG002|Part A|Withdrawal by Subject|0|||
127550710|NCT02978781|458984005|FG003|Part A|Withdrawal by Subject|0|||
127550711|NCT02978781|458984006|FG004|Part A|Withdrawal by Subject|0|||
127550712|NCT02978781|458984002|FG000|Part B|Withdrawal by Subject|0|||
127550713|NCT02978781|458984003|FG001|Part B|Withdrawal by Subject|0|||
127550714|NCT02978781|458984004|FG002|Part B|Withdrawal by Subject|0|||
127550715|NCT02978781|458984005|FG003|Part B|Withdrawal by Subject|1|||
127550716|NCT02978781|458984006|FG004|Part B|Withdrawal by Subject|0|||
127550717|NCT02978781|458984002|FG000|Part C|Adverse Event|0|||
127550718|NCT02978781|458984003|FG001|Part C|Adverse Event|0|||
127550719|NCT02978781|458984004|FG002|Part C|Adverse Event|0|||
127684960|NCT00433199|459471962|FG000|Open-Label Period|Withdrawal by Subject|0|||
127684961|NCT00433199|459471963|FG001|Open-Label Period|Withdrawal by Subject|7|||
127684962|NCT00433199|459471962|FG000|Open-Label Period|Protocol Violation|0|||
127684963|NCT00433199|459471963|FG001|Open-Label Period|Protocol Violation|2|||
127684964|NCT00433199|459471962|FG000|Open-Label Period|Administrative|0|||
127684965|NCT00433199|459471963|FG001|Open-Label Period|Administrative|1|||
127684966|NCT00357097|459471964|FG000|Overall Study|Did not meet inclusion criteria|5|||
127684967|NCT00357097|459471965|FG001|Overall Study|Did not meet inclusion criteria|3|||
127684968|NCT00357097|459471964|FG000|Overall Study|Adverse Event|34|||
127684969|NCT00357097|459471965|FG001|Overall Study|Adverse Event|6|||
127684970|NCT00357097|459471964|FG000|Overall Study|Withdrawal by Subject|8|||
127684971|NCT00357097|459471965|FG001|Overall Study|Withdrawal by Subject|7|||
127684972|NCT00357097|459471964|FG000|Overall Study|Non-compliance|1|||
127550720|NCT02978781|458984005|FG003|Part C|Adverse Event|0|||
127550721|NCT02978781|458984006|FG004|Part C|Adverse Event|2|||
127550722|NCT02978781|458984002|FG000|Part C|Withdrawal by Subject|0|||
127550723|NCT02978781|458984003|FG001|Part C|Withdrawal by Subject|0|||
127550724|NCT02978781|458984004|FG002|Part C|Withdrawal by Subject|0|||
127550725|NCT02978781|458984005|FG003|Part C|Withdrawal by Subject|0|||
127550726|NCT02978781|458984006|FG004|Part C|Withdrawal by Subject|1|||
127550727|NCT02978781|458984002|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
127550728|NCT02978781|458984003|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
127550729|NCT02978781|458984004|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
127684973|NCT00357097|459471965|FG001|Overall Study|Non-compliance|2|||
127684974|NCT00357097|459471964|FG000|Overall Study|Lack of Efficacy|2|||
127684975|NCT00357097|459471965|FG001|Overall Study|Lack of Efficacy|8|||
127684976|NCT00357097|459471964|FG000|Overall Study|Met Exclusion Criteria|3|||
127684977|NCT00357097|459471965|FG001|Overall Study|Met Exclusion Criteria|1|||
127550730|NCT02978781|458984005|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
127550731|NCT02978781|458984006|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
127550732|NCT02453321|458984007|FG000|Overall Study|Weakness|1|||
127550733|NCT02453321|458984008|FG001|Overall Study|Weakness|1|||
127550734|NCT02453321|458984009|FG002|Overall Study|Weakness|2|||
127550735|NCT02453321|458984007|FG000|Overall Study|Deep Venous Thrombosis|0|||
127550736|NCT02453321|458984008|FG001|Overall Study|Deep Venous Thrombosis|1|||
127550737|NCT02453321|458984009|FG002|Overall Study|Deep Venous Thrombosis|0|||
127550738|NCT00892099|458984011|FG000|Overall Study|Death|1|||
127550739|NCT00892099|458984012|FG001|Overall Study|Death|0|||
127550740|NCT00892099|458984013|FG002|Overall Study|Death|1|||
127550741|NCT00892099|458984011|FG000|Overall Study|Adverse Event|1|||
127550742|NCT00892099|458984012|FG001|Overall Study|Adverse Event|0|||
127550743|NCT00892099|458984013|FG002|Overall Study|Adverse Event|0|||
127550744|NCT00892099|458984011|FG000|Overall Study|replocated|1|||
127550745|NCT00892099|458984012|FG001|Overall Study|replocated|0|||
127550746|NCT00892099|458984013|FG002|Overall Study|replocated|2|||
127550747|NCT00892099|458984011|FG000|Overall Study|Prolonged hospitalization|1|||
127550748|NCT00892099|458984012|FG001|Overall Study|Prolonged hospitalization|0|||
127550749|NCT00892099|458984013|FG002|Overall Study|Prolonged hospitalization|1|||
127550750|NCT00892099|458984011|FG000|Overall Study|no further details|1|||
127550751|NCT00892099|458984012|FG001|Overall Study|no further details|0|||
127550752|NCT00892099|458984013|FG002|Overall Study|no further details|1|||
127550753|NCT00892099|458984011|FG000|Overall Study|kidney function recovered|0|||
127550754|NCT00892099|458984012|FG001|Overall Study|kidney function recovered|1|||
127550755|NCT00892099|458984013|FG002|Overall Study|kidney function recovered|0|||
127550756|NCT00892099|458984011|FG000|Overall Study|investigator decision|0|||
127550757|NCT00892099|458984012|FG001|Overall Study|investigator decision|0|||
127550758|NCT00892099|458984013|FG002|Overall Study|investigator decision|1|||
127550759|NCT00892099|458984011|FG000|Overall Study|Lost to Follow-up|0|||
127550760|NCT00892099|458984012|FG001|Overall Study|Lost to Follow-up|0|||
127550761|NCT00892099|458984013|FG002|Overall Study|Lost to Follow-up|1|||
127550762|NCT01657019|458984014|FG000|Overall Study|Withdrawal by Subject|65|||
127550763|NCT01657019|458984014|FG000|Overall Study|Adverse Event|55|||
127550764|NCT01657019|458984014|FG000|Overall Study|Lost to Follow-up|48|||
127550765|NCT01657019|458984014|FG000|Overall Study|Protocol Violation|6|||
127550766|NCT01657019|458984014|FG000|Overall Study|Lack of Efficacy|3|||
127550767|NCT01657019|458984014|FG000|Overall Study|Other|58|||
127550768|NCT00998296|458984017|FG000|Overall Study|Progressive disease|0|||
127550769|NCT00998296|458984018|FG001|Overall Study|Progressive disease|1|||
127550770|NCT00998296|458984019|FG002|Overall Study|Progressive disease|0|||
127550771|NCT00998296|458984020|FG003|Overall Study|Progressive disease|0|||
127550772|NCT00998296|458984021|FG004|Overall Study|Progressive disease|0|||
127550773|NCT00998296|458984022|FG005|Overall Study|Progressive disease|0|||
127550774|NCT00998296|458984023|FG006|Overall Study|Progressive disease|1|||
127684978|NCT00357097|459471964|FG000|Overall Study|Other|1|||
127684979|NCT00357097|459471965|FG001|Overall Study|Other|1|||
127684980|NCT00357097|459471964|FG000|Overall Study|Increase of RLS Symptoms|0|||
128017101|NCT01500083|460685571|FG000|Overall Study|Withdrawal of Consent|0|||
127684981|NCT00357097|459471965|FG001|Overall Study|Increase of RLS Symptoms|1|||
127684982|NCT00794118|459471966|FG000|Overall Study|Lost to Follow-up|16|||
127684983|NCT00794118|459471966|FG000|Overall Study|Withdrawal by Subject|9|||
127684984|NCT00794118|459471966|FG000|Overall Study|Changed hospital center|2|||
127684985|NCT04305405|459471967|FG000|Overall Study|Withdrawal by parent/guardian|0|||
127684986|NCT04305405|459471968|FG001|Overall Study|Withdrawal by parent/guardian|1|||
127684987|NCT00529659|459471969|FG000|Overall Study|Adverse Event|8|||
127684988|NCT00529659|459471970|FG001|Overall Study|Adverse Event|7|||
127684989|NCT00529659|459471969|FG000|Overall Study|Lost to Follow-up|0|||
127684990|NCT00529659|459471970|FG001|Overall Study|Lost to Follow-up|2|||
127771768|NCT04223856|459789108|FG001|Overall Study|Withdrawal by Subject|24|||
127771769|NCT04223856|459789107|FG000|Overall Study|Other|7|||
127550775|NCT00998296|458984024|FG007|Overall Study|Progressive disease|0|||
127550776|NCT00998296|458984025|FG008|Overall Study|Progressive disease|0|||
127550777|NCT00998296|458984026|FG009|Overall Study|Progressive disease|14|||
127550778|NCT00998296|458984027|FG010|Overall Study|Progressive disease|5|||
127550779|NCT00998296|458984017|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
127550780|NCT00998296|458984018|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
127550781|NCT00998296|458984019|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
127550782|NCT00998296|458984020|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
127550783|NCT00998296|458984021|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
127550784|NCT00998296|458984022|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
127550785|NCT00998296|458984023|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
127684991|NCT00529659|459471969|FG000|Overall Study|Physician Decision|0|||
127684992|NCT00529659|459471970|FG001|Overall Study|Physician Decision|2|||
127684993|NCT00529659|459471969|FG000|Overall Study|Protocol Violation|2|||
127771770|NCT04223856|459789108|FG001|Overall Study|Other|2|||
127550786|NCT00998296|458984024|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
127550787|NCT00998296|458984025|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
127550788|NCT00998296|458984026|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
127550789|NCT00998296|458984027|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
127550790|NCT00998296|458984017|FG000|Overall Study|Other adverse event|0|||
127550791|NCT00998296|458984018|FG001|Overall Study|Other adverse event|0|||
127550792|NCT00998296|458984019|FG002|Overall Study|Other adverse event|0|||
127550793|NCT00998296|458984020|FG003|Overall Study|Other adverse event|0|||
127550794|NCT00998296|458984021|FG004|Overall Study|Other adverse event|1|||
127550795|NCT00998296|458984022|FG005|Overall Study|Other adverse event|0|||
127550796|NCT00998296|458984023|FG006|Overall Study|Other adverse event|0|||
127550797|NCT00998296|458984024|FG007|Overall Study|Other adverse event|0|||
127550798|NCT00998296|458984025|FG008|Overall Study|Other adverse event|0|||
127550799|NCT00998296|458984026|FG009|Overall Study|Other adverse event|1|||
127550800|NCT00998296|458984027|FG010|Overall Study|Other adverse event|2|||
127550801|NCT00998296|458984017|FG000|Overall Study|Refused to continue taking trial med.|0|||
127550802|NCT00998296|458984018|FG001|Overall Study|Refused to continue taking trial med.|0|||
127550803|NCT00998296|458984019|FG002|Overall Study|Refused to continue taking trial med.|0|||
127550804|NCT00998296|458984020|FG003|Overall Study|Refused to continue taking trial med.|0|||
127550805|NCT00998296|458984021|FG004|Overall Study|Refused to continue taking trial med.|0|||
127550806|NCT00998296|458984022|FG005|Overall Study|Refused to continue taking trial med.|0|||
127550807|NCT00998296|458984023|FG006|Overall Study|Refused to continue taking trial med.|0|||
127550808|NCT00998296|458984024|FG007|Overall Study|Refused to continue taking trial med.|0|||
127550809|NCT00998296|458984025|FG008|Overall Study|Refused to continue taking trial med.|0|||
127550810|NCT00998296|458984026|FG009|Overall Study|Refused to continue taking trial med.|2|||
127550811|NCT00998296|458984027|FG010|Overall Study|Refused to continue taking trial med.|0|||
127550812|NCT00998296|458984017|FG000|Overall Study|Reason other than those specified above|0|||
127550813|NCT00998296|458984018|FG001|Overall Study|Reason other than those specified above|0|||
127550814|NCT00998296|458984019|FG002|Overall Study|Reason other than those specified above|0|||
127550815|NCT00998296|458984020|FG003|Overall Study|Reason other than those specified above|0|||
127550816|NCT00998296|458984021|FG004|Overall Study|Reason other than those specified above|0|||
127550817|NCT00998296|458984022|FG005|Overall Study|Reason other than those specified above|0|||
127550818|NCT00998296|458984023|FG006|Overall Study|Reason other than those specified above|0|||
127771771|NCT04223856|459789107|FG000|Overall Study|Randomized but not treated|2|||
127771772|NCT04223856|459789108|FG001|Overall Study|Randomized but not treated|11|||
127771773|NCT04223856|459789107|FG000|Overall Study|On-treatment|144|||
127771774|NCT04223856|459789108|FG001|Overall Study|On-treatment|0|||
127771775|NCT03226275|459789109|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
127771776|NCT03226275|459789110|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
127771777|NCT03226275|459789111|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
127771778|NCT03226275|459789112|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
127771779|NCT03226275|459789109|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
127771780|NCT03226275|459789110|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
127771781|NCT03226275|459789111|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
127771782|NCT03226275|459789112|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
127771783|NCT03442114|459789113|FG000|Overall Study|Lost to Follow-up|13|||
127771784|NCT03442114|459789114|FG001|Overall Study|Lost to Follow-up|13|||
127771785|NCT03442114|459789113|FG000|Overall Study|Physician Decision|2|||
127771786|NCT03442114|459789114|FG001|Overall Study|Physician Decision|2|||
127771787|NCT03442114|459789113|FG000|Overall Study|Protocol Violation|0|||
127771788|NCT03442114|459789114|FG001|Overall Study|Protocol Violation|2|||
127771789|NCT03442114|459789113|FG000|Overall Study|Withdrawal by Subject|1|||
127771790|NCT03442114|459789114|FG001|Overall Study|Withdrawal by Subject|3|||
127771791|NCT03442114|459789113|FG000|Overall Study|Guardianship Change|0|||
127771792|NCT03442114|459789114|FG001|Overall Study|Guardianship Change|1|||
127771793|NCT02903368|459789115|FG000|Part 1|Adverse Event|3|||
127771794|NCT02903368|459789116|FG001|Part 1|Adverse Event|0|||
127880991|NCT01787188|460186092|FG002|Overall Study|Other, including patient moved|0|||
127550819|NCT00998296|458984024|FG007|Overall Study|Reason other than those specified above|0|||
127550820|NCT00998296|458984025|FG008|Overall Study|Reason other than those specified above|0|||
127550821|NCT00998296|458984026|FG009|Overall Study|Reason other than those specified above|1|||
127550822|NCT00998296|458984027|FG010|Overall Study|Reason other than those specified above|0|||
127550823|NCT02346721|458984028|FG000|Overall Study|Withdrew Consent|3|||
127550824|NCT02346721|458984028|FG000|Overall Study|Lack of Efficacy|1|||
127550825|NCT04396639|458984031|FG000|Overall Study|Withdrawal by Subject|1|||
127550826|NCT04396639|458984031|FG000|Overall Study|Other|1|||
127550827|NCT01544335|458984032|FG000|Overall Study|Lost to Follow-up|27|||
127550828|NCT01544335|458984032|FG000|Overall Study|Death|4|||
127771795|NCT02903368|459789117|FG002|Part 1|Adverse Event|0|||
127771796|NCT02903368|459789118|FG003|Part 1|Adverse Event|0|||
127771797|NCT02903368|459789115|FG000|Part 1|Withdrawal by Subject|1|||
127771798|NCT02903368|459789116|FG001|Part 1|Withdrawal by Subject|0|||
127550829|NCT01544335|458984032|FG000|Overall Study|Disease progression|3|||
127550830|NCT01544335|458984032|FG000|Overall Study|Baseline Measurements not Available|19|||
127550831|NCT05375760|458984035|FG000|Overall Study|Adverse Event|1|||
127550832|NCT05375760|458984036|FG001|Overall Study|Adverse Event|0|||
127550833|NCT05375760|458984035|FG000|Overall Study|Death|0|||
127550834|NCT05375760|458984036|FG001|Overall Study|Death|1|||
127550835|NCT05375760|458984035|FG000|Overall Study|Lost to Follow-up|6|||
127550836|NCT05375760|458984036|FG001|Overall Study|Lost to Follow-up|6|||
127550837|NCT05375760|458984035|FG000|Overall Study|Withdrawal by Subject|17|||
127550838|NCT05375760|458984036|FG001|Overall Study|Withdrawal by Subject|19|||
127550839|NCT05375760|458984035|FG000|Overall Study|Dosing halted by FDA|96|||
127550840|NCT05375760|458984036|FG001|Overall Study|Dosing halted by FDA|100|||
127550841|NCT05375760|458984035|FG000|Overall Study|Not compliant with study visit|2|||
127550842|NCT05375760|458984036|FG001|Overall Study|Not compliant with study visit|0|||
127550843|NCT05375760|458984035|FG000|Overall Study|Physician Decision|1|||
127550844|NCT05375760|458984036|FG001|Overall Study|Physician Decision|0|||
127550845|NCT05375760|458984035|FG000|Overall Study|Signed ICF addendum, however refused procedures|1|||
127550846|NCT05375760|458984036|FG001|Overall Study|Signed ICF addendum, however refused procedures|0|||
127550847|NCT05375760|458984035|FG000|Overall Study|Participant moved|1|||
127550848|NCT05375760|458984036|FG001|Overall Study|Participant moved|0|||
127550849|NCT00363480|458984037|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
127550850|NCT00363480|458984037|FG000|Overall Study|Adverse Event|4|||
127550851|NCT00363480|458984037|FG000|Overall Study|Lost to Follow-up|5|||
127550852|NCT00363480|458984037|FG000|Overall Study|Withdrawal by Subject|5|||
127550853|NCT00363480|458984037|FG000|Overall Study|Non-compliance of subject|1|||
127550854|NCT00363480|458984037|FG000|Overall Study|Participant discontinued on its own|1|||
127550855|NCT01721044|458984040|FG000|Treatment Period|Adverse Event|7|||
127550856|NCT01721044|458984041|FG001|Treatment Period|Adverse Event|7|||
127550857|NCT01721044|458984042|FG002|Treatment Period|Adverse Event|10|||
127550858|NCT01721044|458984040|FG000|Treatment Period|Death|0|||
127550859|NCT01721044|458984041|FG001|Treatment Period|Death|0|||
127550860|NCT01721044|458984042|FG002|Treatment Period|Death|1|||
127550861|NCT01721044|458984040|FG000|Treatment Period|Lack of Efficacy|16|||
127550862|NCT01721044|458984041|FG001|Treatment Period|Lack of Efficacy|4|||
127550863|NCT01721044|458984042|FG002|Treatment Period|Lack of Efficacy|4|||
127550864|NCT01721044|458984040|FG000|Treatment Period|Lost to Follow-up|0|||
127550865|NCT01721044|458984041|FG001|Treatment Period|Lost to Follow-up|0|||
127550866|NCT01721044|458984042|FG002|Treatment Period|Lost to Follow-up|1|||
127550867|NCT01721044|458984040|FG000|Treatment Period|Physician Decision|1|||
127550868|NCT01721044|458984041|FG001|Treatment Period|Physician Decision|0|||
127550869|NCT01721044|458984042|FG002|Treatment Period|Physician Decision|2|||
127550870|NCT01721044|458984040|FG000|Treatment Period|Protocol Violation|1|||
127550871|NCT01721044|458984041|FG001|Treatment Period|Protocol Violation|0|||
127550872|NCT01721044|458984042|FG002|Treatment Period|Protocol Violation|0|||
127550873|NCT01721044|458984040|FG000|Treatment Period|Withdrawal by Subject|7|||
127550874|NCT01721044|458984041|FG001|Treatment Period|Withdrawal by Subject|6|||
127550875|NCT01721044|458984042|FG002|Treatment Period|Withdrawal by Subject|1|||
127550876|NCT04032093|458984043|FG000|Overall Study|Lost to Follow-up|7|||
127550877|NCT04032093|458984044|FG001|Overall Study|Lost to Follow-up|7|||
127550878|NCT04032093|458984045|FG002|Overall Study|Lost to Follow-up|6|||
127684994|NCT00529659|459471970|FG001|Overall Study|Protocol Violation|6|||
127684995|NCT00529659|459471969|FG000|Overall Study|Withdrawal by Subject|1|||
127684996|NCT00529659|459471970|FG001|Overall Study|Withdrawal by Subject|6|||
128017102|NCT01500083|460685572|FG001|Overall Study|Withdrawal of Consent|1|||
127684997|NCT03887650|459471972|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
127684998|NCT03887650|459471973|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
127684999|NCT03887650|459471972|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
128017103|NCT01500083|460685571|FG000|Overall Study|Disease Progression|2|||
127550879|NCT04032093|458984046|FG003|Overall Study|Lost to Follow-up|10|||
127550880|NCT04032093|458984047|FG004|Overall Study|Lost to Follow-up|13|||
127685000|NCT03887650|459471973|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
128017104|NCT01500083|460685572|FG001|Overall Study|Disease Progression|10|||
128017105|NCT01500083|460685571|FG000|Overall Study|Investigator Discretion|3|||
127550881|NCT04032093|458984048|FG005|Overall Study|Lost to Follow-up|7|||
127550882|NCT04032093|458984049|FG006|Overall Study|Lost to Follow-up|7|||
127550883|NCT04032093|458984050|FG007|Overall Study|Lost to Follow-up|5|||
127550884|NCT04032093|458984051|FG008|Overall Study|Lost to Follow-up|9|||
127550885|NCT04032093|458984052|FG009|Overall Study|Lost to Follow-up|12|||
127550886|NCT04032093|458984043|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
127550887|NCT04032093|458984044|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
127550888|NCT04032093|458984045|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
127550889|NCT04032093|458984046|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
127550890|NCT04032093|458984047|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
127550891|NCT04032093|458984048|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
127550892|NCT04032093|458984049|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
127685001|NCT03887650|459471972|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
127550893|NCT04032093|458984050|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
127550894|NCT04032093|458984051|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
127550895|NCT04032093|458984052|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
127550896|NCT04032093|458984043|FG000|Overall Study|Other|1|||
127550897|NCT04032093|458984044|FG001|Overall Study|Other|0|||
127550898|NCT04032093|458984045|FG002|Overall Study|Other|0|||
127550899|NCT04032093|458984046|FG003|Overall Study|Other|1|||
127550900|NCT04032093|458984047|FG004|Overall Study|Other|1|||
127550901|NCT04032093|458984048|FG005|Overall Study|Other|0|||
127550902|NCT04032093|458984049|FG006|Overall Study|Other|0|||
127550903|NCT04032093|458984050|FG007|Overall Study|Other|0|||
127550904|NCT04032093|458984051|FG008|Overall Study|Other|0|||
127550905|NCT04032093|458984052|FG009|Overall Study|Other|1|||
127550906|NCT04032093|458984043|FG000|Overall Study|Withdrawal by Subject|1|||
127550907|NCT04032093|458984044|FG001|Overall Study|Withdrawal by Subject|3|||
127550908|NCT04032093|458984045|FG002|Overall Study|Withdrawal by Subject|2|||
127550909|NCT04032093|458984046|FG003|Overall Study|Withdrawal by Subject|2|||
127550910|NCT04032093|458984047|FG004|Overall Study|Withdrawal by Subject|3|||
127550911|NCT04032093|458984048|FG005|Overall Study|Withdrawal by Subject|0|||
127550912|NCT04032093|458984049|FG006|Overall Study|Withdrawal by Subject|0|||
127550913|NCT04032093|458984050|FG007|Overall Study|Withdrawal by Subject|0|||
127550914|NCT04032093|458984051|FG008|Overall Study|Withdrawal by Subject|0|||
127550915|NCT04032093|458984052|FG009|Overall Study|Withdrawal by Subject|0|||
127550916|NCT04032093|458984043|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
127550917|NCT04032093|458984044|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
127550918|NCT04032093|458984045|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
127550919|NCT04032093|458984046|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
127771799|NCT02903368|459789117|FG002|Part 1|Withdrawal by Subject|0|||
127771800|NCT02903368|459789118|FG003|Part 1|Withdrawal by Subject|0|||
127771801|NCT02903368|459789115|FG000|Part 2|Adverse Event|0|||
127771802|NCT02903368|459789116|FG001|Part 2|Adverse Event|0|||
127771803|NCT02903368|459789117|FG002|Part 2|Adverse Event|5|||
127771804|NCT02903368|459789118|FG003|Part 2|Adverse Event|0|||
127771805|NCT02903368|459789115|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
127771806|NCT02903368|459789116|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
127771807|NCT02903368|459789117|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
127771808|NCT02903368|459789118|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
127771809|NCT02903368|459789115|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
127771810|NCT02903368|459789116|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
127771811|NCT02903368|459789117|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
127771812|NCT02903368|459789118|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
127771813|NCT02903368|459789115|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
127550920|NCT04032093|458984047|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
127550921|NCT04032093|458984048|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
127550922|NCT04032093|458984049|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
127550923|NCT04032093|458984050|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
127550924|NCT04032093|458984051|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
127550925|NCT04032093|458984052|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
127550926|NCT04032093|458984043|FG000|Overall Study|Adverse Event|0|||
127550927|NCT04032093|458984044|FG001|Overall Study|Adverse Event|0|||
127550928|NCT04032093|458984045|FG002|Overall Study|Adverse Event|0|||
127550929|NCT04032093|458984046|FG003|Overall Study|Adverse Event|0|||
127550930|NCT04032093|458984047|FG004|Overall Study|Adverse Event|0|||
127550931|NCT04032093|458984048|FG005|Overall Study|Adverse Event|0|||
127550932|NCT04032093|458984049|FG006|Overall Study|Adverse Event|0|||
127550933|NCT04032093|458984050|FG007|Overall Study|Adverse Event|0|||
127550934|NCT04032093|458984051|FG008|Overall Study|Adverse Event|0|||
127550935|NCT04032093|458984052|FG009|Overall Study|Adverse Event|1|||
127550936|NCT04032093|458984043|FG000|Overall Study|Physician Decision|0|||
127550937|NCT04032093|458984044|FG001|Overall Study|Physician Decision|0|||
127550938|NCT04032093|458984045|FG002|Overall Study|Physician Decision|0|||
127550939|NCT04032093|458984046|FG003|Overall Study|Physician Decision|0|||
127550940|NCT04032093|458984047|FG004|Overall Study|Physician Decision|0|||
127771814|NCT02903368|459789116|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
127771815|NCT02903368|459789117|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
127771816|NCT02903368|459789118|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
127550941|NCT04032093|458984048|FG005|Overall Study|Physician Decision|1|||
127550942|NCT04032093|458984049|FG006|Overall Study|Physician Decision|0|||
127550943|NCT04032093|458984050|FG007|Overall Study|Physician Decision|0|||
127550944|NCT04032093|458984051|FG008|Overall Study|Physician Decision|0|||
127550945|NCT04032093|458984052|FG009|Overall Study|Physician Decision|0|||
127550946|NCT01457703|458984058|FG000|Overall Study|Screen Failure|5|||
127550947|NCT01457703|458984059|FG001|Overall Study|Screen Failure|7|||
127550948|NCT01457703|458984058|FG000|Overall Study|Withdrawal by Subject|1|||
128017106|NCT01500083|460685572|FG001|Overall Study|Investigator Discretion|8|||
128017107|NCT01500083|460685571|FG000|Overall Study|Other Reasons|2|||
128017108|NCT01500083|460685572|FG001|Overall Study|Other Reasons|5|||
128017109|NCT01555931|460685573|FG000|Overall Study|Lost to Follow-up|2|||
128017110|NCT01555931|460685574|FG001|Overall Study|Lost to Follow-up|5|||
128017111|NCT02299167|460685577|FG000|Overall Study|patients were excluded from the study|11|||
128017112|NCT04598828|460685578|FG000|Overall Study|Physician Decision|1|||
128017113|NCT04598828|460685579|FG001|Overall Study|Physician Decision|0|||
128017114|NCT04598828|460685578|FG000|Overall Study|Withdrawal by Subject|0|||
128017115|NCT04598828|460685579|FG001|Overall Study|Withdrawal by Subject|1|||
128017116|NCT04598828|460685578|FG000|Overall Study|Withdrawal by Subject|0|||
128017117|NCT04598828|460685579|FG001|Overall Study|Withdrawal by Subject|1|||
128017118|NCT02676973|460685580|FG000|Overall Study|Withdrawal by Subject|9|||
128017119|NCT02676973|460685581|FG001|Overall Study|Withdrawal by Subject|8|||
128017120|NCT02676973|460685582|FG002|Overall Study|Withdrawal by Subject|11|||
128017121|NCT02676973|460685580|FG000|Overall Study|Lost to Follow-up|8|||
128017122|NCT02676973|460685581|FG001|Overall Study|Lost to Follow-up|12|||
128017123|NCT02676973|460685582|FG002|Overall Study|Lost to Follow-up|8|||
128017124|NCT02676973|460685580|FG000|Overall Study|Death|2|||
128017125|NCT02676973|460685581|FG001|Overall Study|Death|1|||
128017126|NCT02676973|460685582|FG002|Overall Study|Death|5|||
128017127|NCT01078662|460685584|FG000|Overall Study|Death|41|||
128017128|NCT01078662|460685585|FG001|Overall Study|Death|103|||
128017129|NCT01078662|460685586|FG002|Overall Study|Death|18|||
128017130|NCT01078662|460685587|FG003|Overall Study|Death|5|||
128017131|NCT01078662|460685588|FG004|Overall Study|Death|8|||
128017132|NCT01078662|460685584|FG000|Overall Study|Patients reached data cut-off|12|||
128017133|NCT01078662|460685585|FG001|Overall Study|Patients reached data cut-off|53|||
127550949|NCT01457703|458984059|FG001|Overall Study|Withdrawal by Subject|4|||
127550950|NCT00949702|458984060|FG000|Overall Study|Death|40|||
127685002|NCT03887650|459471973|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
127685003|NCT01170962|459471974|FG000|Treatment Period|Lack of Efficacy|96|||
127685004|NCT01170962|459471975|FG001|Treatment Period|Lack of Efficacy|91|||
127685005|NCT01170962|459471976|FG002|Treatment Period|Lack of Efficacy|7|||
127685006|NCT01170962|459471974|FG000|Treatment Period|Adverse Event|11|||
127685007|NCT01170962|459471975|FG001|Treatment Period|Adverse Event|12|||
127685008|NCT01170962|459471976|FG002|Treatment Period|Adverse Event|3|||
127685009|NCT01170962|459471974|FG000|Treatment Period|Withdrawal by Subject|2|||
127685010|NCT01170962|459471975|FG001|Treatment Period|Withdrawal by Subject|1|||
127685011|NCT01170962|459471976|FG002|Treatment Period|Withdrawal by Subject|0|||
127685012|NCT01170962|459471974|FG000|Treatment Period|Lost to Follow-up|1|||
127685013|NCT01170962|459471975|FG001|Treatment Period|Lost to Follow-up|1|||
127685014|NCT01170962|459471976|FG002|Treatment Period|Lost to Follow-up|1|||
127685015|NCT01170962|459471974|FG000|Treatment Period|Participant no longer meets criteria|0|||
127685016|NCT01170962|459471975|FG001|Treatment Period|Participant no longer meets criteria|1|||
127685017|NCT01170962|459471976|FG002|Treatment Period|Participant no longer meets criteria|0|||
127685018|NCT01170962|459471974|FG000|Treatment Period|Request to discontinue treatment|7|||
127685019|NCT01170962|459471975|FG001|Treatment Period|Request to discontinue treatment|3|||
127685020|NCT01170962|459471976|FG002|Treatment Period|Request to discontinue treatment|1|||
127685021|NCT01170962|459471974|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
127685022|NCT01170962|459471975|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
127685023|NCT01170962|459471976|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
127685024|NCT01170962|459471974|FG000|Follow up Period|Withdrawal by Subject|14|||
127685025|NCT01170962|459471975|FG001|Follow up Period|Withdrawal by Subject|10|||
127685026|NCT01170962|459471976|FG002|Follow up Period|Withdrawal by Subject|2|||
127685027|NCT01170962|459471974|FG000|Follow up Period|Lost to Follow-up|13|||
127685028|NCT01170962|459471975|FG001|Follow up Period|Lost to Follow-up|8|||
127685029|NCT01170962|459471976|FG002|Follow up Period|Lost to Follow-up|1|||
127685030|NCT01170962|459471974|FG000|Follow up Period|Death|2|||
127685031|NCT01170962|459471975|FG001|Follow up Period|Death|2|||
127550951|NCT00949702|458984060|FG000|Overall Study|Disease progression|7|||
127550952|NCT00949702|458984060|FG000|Overall Study|Withdrawal of consent|1|||
127685032|NCT01170962|459471976|FG002|Follow up Period|Death|0|||
127685033|NCT01170962|459471974|FG000|Follow up Period|Others|10|||
128017134|NCT01078662|460685586|FG002|Overall Study|Patients reached data cut-off|2|||
128017135|NCT01078662|460685587|FG003|Overall Study|Patients reached data cut-off|2|||
128017136|NCT01078662|460685588|FG004|Overall Study|Patients reached data cut-off|3|||
127685034|NCT01170962|459471975|FG001|Follow up Period|Others|7|||
127685035|NCT01170962|459471976|FG002|Follow up Period|Others|3|||
127685036|NCT02674750|459471985|FG000|Overall Study|Death|4|||
127685037|NCT02674750|459471986|FG001|Overall Study|Death|5|||
127685038|NCT02674750|459471987|FG002|Overall Study|Death|8|||
127685039|NCT02674750|459471985|FG000|Overall Study|Lost to Follow-up|0|||
127685040|NCT02674750|459471986|FG001|Overall Study|Lost to Follow-up|8|||
127685041|NCT02674750|459471987|FG002|Overall Study|Lost to Follow-up|0|||
128017137|NCT01078662|460685584|FG000|Overall Study|Withdrawal by Subject|4|||
128017138|NCT01078662|460685585|FG001|Overall Study|Withdrawal by Subject|11|||
128017139|NCT01078662|460685586|FG002|Overall Study|Withdrawal by Subject|1|||
127550953|NCT01654302|458984061|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
127550954|NCT01654302|458984062|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
127550955|NCT02952820|458984063|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
127550956|NCT02952820|458984064|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
127550957|NCT02952820|458984065|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
127550958|NCT02952820|458984063|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
127550959|NCT02952820|458984064|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
127550960|NCT02952820|458984065|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
127550961|NCT02952820|458984063|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
127550962|NCT02952820|458984064|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
127550963|NCT02952820|458984065|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
127550964|NCT02952820|458984063|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
127550965|NCT02952820|458984064|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
127550966|NCT02952820|458984065|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
127550967|NCT02952820|458984063|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
127550968|NCT02952820|458984064|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
127550969|NCT02952820|458984065|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
127550970|NCT02952820|458984063|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
127550971|NCT02952820|458984064|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
127550972|NCT02952820|458984065|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
127550973|NCT02952820|458984063|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
127550974|NCT02952820|458984064|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
127550975|NCT02952820|458984065|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
127550976|NCT02952820|458984063|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
127550977|NCT02952820|458984064|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
127550978|NCT02952820|458984065|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
127550979|NCT02952820|458984063|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
127550980|NCT02952820|458984064|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
127550981|NCT02952820|458984065|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
127550982|NCT02952820|458984063|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
127550983|NCT02952820|458984064|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
127550984|NCT02952820|458984065|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
127550985|NCT02952820|458984063|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
127550986|NCT02952820|458984064|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
127550987|NCT02952820|458984065|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
127550988|NCT02952820|458984063|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
127550989|NCT02952820|458984064|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
127550990|NCT02952820|458984065|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
127550991|NCT02952820|458984063|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
127550992|NCT02952820|458984064|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
127550993|NCT02952820|458984065|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
127550994|NCT02952820|458984063|FG000|Active Treatment Period (6 Months)|Not treated|0|||
127550995|NCT02952820|458984064|FG001|Active Treatment Period (6 Months)|Not treated|0|||
127550996|NCT02952820|458984065|FG002|Active Treatment Period (6 Months)|Not treated|1|||
127550997|NCT04139018|458984066|FG000|Overall Study|Screen fail|1|||
127550998|NCT04139018|458984067|FG001|Overall Study|Screen fail|0|||
127550999|NCT04139018|458984066|FG000|Overall Study|Withdrawal by Subject|2|||
127551000|NCT04139018|458984067|FG001|Overall Study|Withdrawal by Subject|0|||
127771817|NCT02245672|459790327|FG000|Overall Study|Adverse Event|4|||
127771818|NCT02245672|459790328|FG001|Overall Study|Adverse Event|4|||
127771819|NCT02245672|459790329|FG002|Overall Study|Adverse Event|4|||
127771820|NCT02245672|459790327|FG000|Overall Study|Lost to Follow-up|3|||
127771821|NCT02245672|459790328|FG001|Overall Study|Lost to Follow-up|5|||
127771822|NCT02245672|459790329|FG002|Overall Study|Lost to Follow-up|1|||
127771823|NCT02245672|459790327|FG000|Overall Study|Withdrawal by Subject|6|||
127771824|NCT02245672|459790328|FG001|Overall Study|Withdrawal by Subject|3|||
127771825|NCT02245672|459790329|FG002|Overall Study|Withdrawal by Subject|0|||
127771826|NCT02245672|459790327|FG000|Overall Study|Randomized in error (not treated)|0|||
127551001|NCT04139018|458984066|FG000|Overall Study|Lost to Follow-up|0|||
127551002|NCT04139018|458984067|FG001|Overall Study|Lost to Follow-up|1|||
127551003|NCT03486834|458984068|FG000|Overall Study|Withdrawal by Subject|46|||
127551004|NCT03486834|458984069|FG001|Overall Study|Withdrawal by Subject|46|||
127551005|NCT03486834|458984070|FG002|Overall Study|Withdrawal by Subject|52|||
127551006|NCT03486834|458984068|FG000|Overall Study|Adverse Event|8|||
127551007|NCT03486834|458984069|FG001|Overall Study|Adverse Event|7|||
127551008|NCT03486834|458984070|FG002|Overall Study|Adverse Event|0|||
127551009|NCT03486834|458984068|FG000|Overall Study|Lost to Follow-up|41|||
127771827|NCT02245672|459790328|FG001|Overall Study|Randomized in error (not treated)|1|||
127771828|NCT02245672|459790329|FG002|Overall Study|Randomized in error (not treated)|0|||
127551010|NCT03486834|458984069|FG001|Overall Study|Lost to Follow-up|24|||
127551011|NCT03486834|458984070|FG002|Overall Study|Lost to Follow-up|39|||
127551012|NCT03486834|458984068|FG000|Overall Study|Non-compliance with Study Drug|2|||
127551013|NCT03486834|458984069|FG001|Overall Study|Non-compliance with Study Drug|2|||
127551014|NCT03486834|458984070|FG002|Overall Study|Non-compliance with Study Drug|0|||
127551015|NCT03486834|458984068|FG000|Overall Study|Physician Decision|5|||
127551016|NCT03486834|458984069|FG001|Overall Study|Physician Decision|2|||
127551017|NCT03486834|458984070|FG002|Overall Study|Physician Decision|3|||
127551018|NCT03486834|458984068|FG000|Overall Study|Pregnancy|10|||
127551019|NCT03486834|458984069|FG001|Overall Study|Pregnancy|12|||
127551020|NCT03486834|458984070|FG002|Overall Study|Pregnancy|12|||
127551021|NCT03486834|458984068|FG000|Overall Study|Protocol Deviation|2|||
127551022|NCT03486834|458984069|FG001|Overall Study|Protocol Deviation|3|||
127551023|NCT03486834|458984070|FG002|Overall Study|Protocol Deviation|3|||
127551024|NCT03486834|458984068|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
127551025|NCT03486834|458984069|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
127551026|NCT03486834|458984070|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
127551027|NCT03486834|458984068|FG000|Overall Study|Randomized but not treated|4|||
127551028|NCT03486834|458984069|FG001|Overall Study|Randomized but not treated|4|||
127551029|NCT03486834|458984070|FG002|Overall Study|Randomized but not treated|1|||
127551030|NCT04476797|458984071|FG000|Overall Study|Withdrawal by Subject|1|||
127551031|NCT04476797|458984072|FG001|Overall Study|Withdrawal by Subject|0|||
127551032|NCT04476797|458984073|FG002|Overall Study|Withdrawal by Subject|0|||
127551033|NCT04476797|458984071|FG000|Overall Study|Death|0|||
127551034|NCT04476797|458984072|FG001|Overall Study|Death|1|||
127551035|NCT04476797|458984073|FG002|Overall Study|Death|2|||
127551036|NCT04476797|458984071|FG000|Overall Study|Sponsor Terminated Study|0|||
127551037|NCT04476797|458984072|FG001|Overall Study|Sponsor Terminated Study|18|||
127551038|NCT04476797|458984073|FG002|Overall Study|Sponsor Terminated Study|17|||
127685042|NCT02674750|459471985|FG000|Overall Study|Lack of Efficacy|1|||
127685043|NCT02674750|459471986|FG001|Overall Study|Lack of Efficacy|17|||
127685044|NCT02674750|459471987|FG002|Overall Study|Lack of Efficacy|3|||
127685045|NCT02674750|459471985|FG000|Overall Study|Withdrawal by Subject|0|||
127685046|NCT02674750|459471986|FG001|Overall Study|Withdrawal by Subject|7|||
127685047|NCT02674750|459471987|FG002|Overall Study|Withdrawal by Subject|1|||
127685048|NCT02674750|459471985|FG000|Overall Study|Other|0|||
127685049|NCT02674750|459471986|FG001|Overall Study|Other|8|||
127685050|NCT02674750|459471987|FG002|Overall Study|Other|0|||
127685051|NCT01685606|459471990|FG000|Overall Study|Withdrawal by Subject|1|||
127685052|NCT01199705|459471991|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
127685053|NCT01415349|459471992|FG000|Treatment Period 1|Adverse Event|0|||
127685054|NCT01415349|459471993|FG001|Treatment Period 1|Adverse Event|1|||
127685055|NCT01415349|459471992|FG000|Treatment Period 1|Withdrawal by Subject|0|||
127685056|NCT01415349|459471993|FG001|Treatment Period 1|Withdrawal by Subject|1|||
127685057|NCT01616459|459471996|FG000|Overall Study|Adverse Event|1|||
127685058|NCT01616459|459471997|FG001|Overall Study|Adverse Event|1|||
127685059|NCT01616459|459471998|FG002|Overall Study|Adverse Event|2|||
127685060|NCT01616459|459471999|FG003|Overall Study|Adverse Event|0|||
127685061|NCT01616459|459471996|FG000|Overall Study|Lost to Follow-up|1|||
127685062|NCT01616459|459471997|FG001|Overall Study|Lost to Follow-up|11|||
127685063|NCT01616459|459471998|FG002|Overall Study|Lost to Follow-up|3|||
127685064|NCT01616459|459471999|FG003|Overall Study|Lost to Follow-up|2|||
127685065|NCT01616459|459471996|FG000|Overall Study|Protocol Violation|0|||
127685066|NCT01616459|459471997|FG001|Overall Study|Protocol Violation|0|||
127685067|NCT01616459|459471998|FG002|Overall Study|Protocol Violation|0|||
127685068|NCT01616459|459471999|FG003|Overall Study|Protocol Violation|2|||
127685069|NCT01616459|459471996|FG000|Overall Study|Withdrawal by Subject|2|||
127685070|NCT01616459|459471997|FG001|Overall Study|Withdrawal by Subject|4|||
128017140|NCT01078662|460685587|FG003|Overall Study|Withdrawal by Subject|0|||
127551039|NCT03614156|458984090|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
127551040|NCT03614156|458984091|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
127685071|NCT01616459|459471998|FG002|Overall Study|Withdrawal by Subject|4|||
127685072|NCT01616459|459471999|FG003|Overall Study|Withdrawal by Subject|4|||
127685073|NCT01616459|459471996|FG000|Overall Study|Other reason|0|||
127685074|NCT01616459|459471997|FG001|Overall Study|Other reason|1|||
127685075|NCT01616459|459471998|FG002|Overall Study|Other reason|1|||
127880992|NCT05349188|460186095|FG000|Overall Study|Withdrawal by Subject|1|||
127685076|NCT01616459|459471999|FG003|Overall Study|Other reason|0|||
127685077|NCT04980755|459472000|FG000|Body Reprogramming Courses|Too unwell to attend|6|||
128017141|NCT01078662|460685588|FG004|Overall Study|Withdrawal by Subject|0|||
127551041|NCT03614156|458984092|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
127551042|NCT03614156|458984093|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
127551043|NCT03614156|458984090|FG000|Open-Label Treatment Period|Adverse Event|7|||
127551044|NCT03614156|458984091|FG001|Open-Label Treatment Period|Adverse Event|0|||
127685078|NCT04980755|459472000|FG000|Body Reprogramming Courses|Work commitment|2|||
127685079|NCT04980755|459472000|FG000|Body Reprogramming Courses|Unsure when the course started|1|||
127685080|NCT04980755|459472000|FG000|Body Reprogramming Courses|Could not be contacted to provide a reason|6|||
127551045|NCT03614156|458984092|FG002|Open-Label Treatment Period|Adverse Event|0|||
127551046|NCT03614156|458984093|FG003|Open-Label Treatment Period|Adverse Event|0|||
127551047|NCT03614156|458984090|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
127551048|NCT03614156|458984091|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
127551049|NCT03614156|458984092|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
127551050|NCT03614156|458984093|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
127551051|NCT03614156|458984090|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
127551052|NCT03614156|458984091|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
127551053|NCT03614156|458984092|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
127551054|NCT03614156|458984093|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
127551055|NCT03614156|458984090|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
127551056|NCT03614156|458984091|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
127551057|NCT03614156|458984092|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
127551058|NCT03614156|458984093|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
128017142|NCT01078662|460685584|FG000|Overall Study|Protocol Violation|0|||
128017143|NCT01078662|460685585|FG001|Overall Study|Protocol Violation|1|||
127551059|NCT03614156|458984090|FG000|Open-Label Treatment Period|Protocol Violation|2|||
127685081|NCT00089544|459473254|FG000|Overall Study|Ineligible|1|||
127685082|NCT00089544|459473255|FG001|Overall Study|Ineligible|0|||
127685083|NCT01622868|459473261|FG000|Overall Study|Protocol Violation|7|||
127685084|NCT01622868|459473262|FG001|Overall Study|Protocol Violation|0|||
127685085|NCT04425629|459473263|FG000|Overall Study|Adverse Event|0|||
127685086|NCT04425629|459473264|FG001|Overall Study|Adverse Event|0|||
127685087|NCT04425629|459473265|FG002|Overall Study|Adverse Event|0|||
127685088|NCT04425629|459473266|FG003|Overall Study|Adverse Event|0|||
127685089|NCT04425629|459473267|FG004|Overall Study|Adverse Event|1|||
127685090|NCT04425629|459473268|FG005|Overall Study|Adverse Event|0|||
127685091|NCT04425629|459473269|FG006|Overall Study|Adverse Event|0|||
127685092|NCT04425629|459473270|FG007|Overall Study|Adverse Event|0|||
127685093|NCT04425629|459473271|FG008|Overall Study|Adverse Event|0|||
127685094|NCT04425629|459473272|FG009|Overall Study|Adverse Event|3|||
127685095|NCT04425629|459473273|FG010|Overall Study|Adverse Event|2|||
127685096|NCT04425629|459473274|FG011|Overall Study|Adverse Event|1|||
127685097|NCT04425629|459473275|FG012|Overall Study|Adverse Event|1|||
127685098|NCT04425629|459473276|FG013|Overall Study|Adverse Event|0|||
127685099|NCT04425629|459473277|FG014|Overall Study|Adverse Event|0|||
127685100|NCT04425629|459473278|FG015|Overall Study|Adverse Event|0|||
127685101|NCT04425629|459473279|FG016|Overall Study|Adverse Event|0|||
127685102|NCT04425629|459473280|FG017|Overall Study|Adverse Event|0|||
127685103|NCT04425629|459473281|FG018|Overall Study|Adverse Event|0|||
127685104|NCT04425629|459473263|FG000|Overall Study|Lost to Follow-up|1|||
127685105|NCT04425629|459473264|FG001|Overall Study|Lost to Follow-up|3|||
127685106|NCT04425629|459473265|FG002|Overall Study|Lost to Follow-up|1|||
127685107|NCT04425629|459473266|FG003|Overall Study|Lost to Follow-up|7|||
127685108|NCT04425629|459473267|FG004|Overall Study|Lost to Follow-up|1|||
127685109|NCT04425629|459473268|FG005|Overall Study|Lost to Follow-up|2|||
127685110|NCT04425629|459473269|FG006|Overall Study|Lost to Follow-up|1|||
127685111|NCT04425629|459473270|FG007|Overall Study|Lost to Follow-up|0|||
127685112|NCT04425629|459473271|FG008|Overall Study|Lost to Follow-up|1|||
127685113|NCT04425629|459473272|FG009|Overall Study|Lost to Follow-up|64|||
127685114|NCT04425629|459473273|FG010|Overall Study|Lost to Follow-up|70|||
127685115|NCT04425629|459473274|FG011|Overall Study|Lost to Follow-up|98|||
127685116|NCT04425629|459473275|FG012|Overall Study|Lost to Follow-up|30|||
127685117|NCT04425629|459473276|FG013|Overall Study|Lost to Follow-up|0|||
127685118|NCT04425629|459473277|FG014|Overall Study|Lost to Follow-up|5|||
127685119|NCT04425629|459473278|FG015|Overall Study|Lost to Follow-up|4|||
127685120|NCT04425629|459473279|FG016|Overall Study|Lost to Follow-up|0|||
127685121|NCT04425629|459473280|FG017|Overall Study|Lost to Follow-up|3|||
127685122|NCT04425629|459473281|FG018|Overall Study|Lost to Follow-up|1|||
127685123|NCT04425629|459473263|FG000|Overall Study|Subject Decision|0|||
127685124|NCT04425629|459473264|FG001|Overall Study|Subject Decision|2|||
127685125|NCT04425629|459473265|FG002|Overall Study|Subject Decision|1|||
127685126|NCT04425629|459473266|FG003|Overall Study|Subject Decision|3|||
127685127|NCT04425629|459473267|FG004|Overall Study|Subject Decision|6|||
127685128|NCT04425629|459473268|FG005|Overall Study|Subject Decision|6|||
127685129|NCT04425629|459473269|FG006|Overall Study|Subject Decision|3|||
127685130|NCT04425629|459473270|FG007|Overall Study|Subject Decision|3|||
127685131|NCT04425629|459473271|FG008|Overall Study|Subject Decision|1|||
127685132|NCT04425629|459473272|FG009|Overall Study|Subject Decision|70|||
127771829|NCT00971932|459790330|FG000|Overall Study|Withdrawal by Subject|1|||
127551060|NCT03614156|458984091|FG001|Open-Label Treatment Period|Protocol Violation|0|||
127685133|NCT04425629|459473273|FG010|Overall Study|Subject Decision|95|||
127685134|NCT04425629|459473274|FG011|Overall Study|Subject Decision|124|||
127685135|NCT04425629|459473275|FG012|Overall Study|Subject Decision|25|||
127685136|NCT04425629|459473276|FG013|Overall Study|Subject Decision|0|||
127551061|NCT03614156|458984092|FG002|Open-Label Treatment Period|Protocol Violation|0|||
127685137|NCT04425629|459473277|FG014|Overall Study|Subject Decision|1|||
127685138|NCT04425629|459473278|FG015|Overall Study|Subject Decision|4|||
128017144|NCT01078662|460685586|FG002|Overall Study|Protocol Violation|0|||
127771830|NCT00971932|459790330|FG000|Overall Study|Investigator's decision|2|||
127771831|NCT00971932|459790330|FG000|Overall Study|Ongoing|4|||
127771832|NCT01765192|459790333|FG000|Treatment Period 1|Adverse Event|0|||
127771833|NCT01765192|459790334|FG001|Treatment Period 1|Adverse Event|1|||
127771834|NCT01765192|459790333|FG000|Washout Period|Voluntary Withdrawal|1|||
127771835|NCT01765192|459790334|FG001|Washout Period|Voluntary Withdrawal|1|||
127771836|NCT01765192|459790333|FG000|Washout Period|Reason not specified|1|||
127771837|NCT01765192|459790334|FG001|Washout Period|Reason not specified|0|||
127771838|NCT01765192|459790333|FG000|Treatment Period 2|Reason not specified|0|||
127771839|NCT01765192|459790334|FG001|Treatment Period 2|Reason not specified|2|||
127771840|NCT01765192|459790333|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
127771841|NCT01765192|459790334|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
127771842|NCT00876694|459790339|FG000|Overall Study|Adverse Event|10|||
127771843|NCT00876694|459790340|FG001|Overall Study|Adverse Event|7|||
127771844|NCT00876694|459790339|FG000|Overall Study|Subject withdrew consent|6|||
127771845|NCT00876694|459790340|FG001|Overall Study|Subject withdrew consent|4|||
127771846|NCT00876694|459790339|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
127771847|NCT00876694|459790340|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
127771848|NCT00876694|459790339|FG000|Overall Study|Abnormal test procedure result(s)|1|||
127771849|NCT00876694|459790340|FG001|Overall Study|Abnormal test procedure result(s)|0|||
127771850|NCT00876694|459790339|FG000|Overall Study|Administrative problems|1|||
127771851|NCT00876694|459790340|FG001|Overall Study|Administrative problems|1|||
127771852|NCT00876694|459790339|FG000|Overall Study|Death|1|||
127771853|NCT00876694|459790340|FG001|Overall Study|Death|0|||
127771854|NCT01215422|459790345|FG000|Overall Study|Relocation|1|||
127771855|NCT01215422|459790346|FG001|Overall Study|Relocation|0|||
127771856|NCT01215422|459790347|FG002|Overall Study|Relocation|0|||
127771857|NCT01215422|459790348|FG003|Overall Study|Relocation|0|||
127771858|NCT01215422|459790345|FG000|Overall Study|Failed intubations|0|||
127771859|NCT01215422|459790346|FG001|Overall Study|Failed intubations|0|||
127771860|NCT01215422|459790347|FG002|Overall Study|Failed intubations|3|||
127771861|NCT01215422|459790348|FG003|Overall Study|Failed intubations|8|||
127771862|NCT01215422|459790345|FG000|Overall Study|Did not complete all intubations|7|||
127771863|NCT01215422|459790346|FG001|Overall Study|Did not complete all intubations|0|||
127771864|NCT01215422|459790347|FG002|Overall Study|Did not complete all intubations|0|||
127771865|NCT01215422|459790348|FG003|Overall Study|Did not complete all intubations|0|||
127771866|NCT00294554|459790351|FG000|Overall Study|Lack of Efficacy|0|||
127771867|NCT00294554|459790352|FG001|Overall Study|Lack of Efficacy|1|||
127771868|NCT00294554|459790351|FG000|Overall Study|Physician Decision|0|||
127771869|NCT00294554|459790352|FG001|Overall Study|Physician Decision|1|||
127771870|NCT00462865|459790353|FG000|Overall Study|Adverse Event|1|||
127771871|NCT02864381|459790354|FG000|Overall Study|Death|58|||
127771872|NCT02864381|459790355|FG001|Overall Study|Death|61|||
127771873|NCT02864381|459790354|FG000|Overall Study|Withdrew Consent|5|||
127771874|NCT02864381|459790355|FG001|Overall Study|Withdrew Consent|6|||
127771875|NCT02864381|459790354|FG000|Overall Study|Reason Unknown|7|||
127771876|NCT02864381|459790355|FG001|Overall Study|Reason Unknown|3|||
127771877|NCT02864381|459790354|FG000|Overall Study|Lost to Follow-up|1|||
127771878|NCT02864381|459790355|FG001|Overall Study|Lost to Follow-up|1|||
127771879|NCT02864381|459790354|FG000|Overall Study|Investigator's Discretion|1|||
127771880|NCT02864381|459790355|FG001|Overall Study|Investigator's Discretion|0|||
127771881|NCT02864381|459790354|FG000|Overall Study|Protocol Violation|0|||
127771882|NCT02864381|459790355|FG001|Overall Study|Protocol Violation|1|||
127771883|NCT04142450|459790356|FG000|Overall Study|Screen Failure|1|||
127771884|NCT04142450|459790356|FG000|Overall Study|Lost to Follow-up|1|||
127771885|NCT01146054|459790357|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
127771886|NCT01146054|459790357|FG000|Overall Study|Rapid tumor progression|2|||
127771887|NCT01146054|459790357|FG000|Overall Study|Other illness precluded treatment|2|||
127771888|NCT01146054|459790357|FG000|Overall Study|Lost to Follow-up|1|||
127771889|NCT04335812|459790358|FG000|Overall Study|Withdrawal by Subject|1|||
127771890|NCT04335812|459790359|FG001|Overall Study|Withdrawal by Subject|3|||
127771891|NCT04335812|459790358|FG000|Overall Study|Lost to Follow-up|12|||
127771892|NCT04335812|459790359|FG001|Overall Study|Lost to Follow-up|12|||
127771893|NCT04335812|459790358|FG000|Overall Study|Did not engage in the intervention|22|||
127771894|NCT04335812|459790359|FG001|Overall Study|Did not engage in the intervention|18|||
127771895|NCT03249714|459790370|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
127771896|NCT03249714|459790371|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
127771897|NCT03249714|459790370|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
127771898|NCT03249714|459790371|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
127771899|NCT03249714|459790370|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
127771900|NCT03249714|459790371|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
127771901|NCT03249714|459790370|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
127771902|NCT03249714|459790371|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
127771903|NCT01607554|459790379|FG000|Overall Study|Disease progression|2|||
127771904|NCT01139021|459790380|FG000|Overall Study|Adverse Event|0|||
127771905|NCT01139021|459790381|FG001|Overall Study|Adverse Event|0|||
127551062|NCT03614156|458984093|FG003|Open-Label Treatment Period|Protocol Violation|0|||
127551063|NCT03614156|458984090|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
127551064|NCT03614156|458984091|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
127551065|NCT03614156|458984092|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
127551066|NCT03614156|458984093|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
127551067|NCT03614156|458984090|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
127551068|NCT03614156|458984091|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
127551069|NCT03614156|458984092|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
127551070|NCT03614156|458984093|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
127551071|NCT03614156|458984090|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
127551072|NCT03614156|458984091|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
127551073|NCT03614156|458984092|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
127551074|NCT03614156|458984093|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
127551075|NCT03614156|458984090|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
127551076|NCT03614156|458984091|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
127551077|NCT03614156|458984092|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
127551078|NCT03614156|458984093|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
127551079|NCT03614156|458984090|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
127551080|NCT03614156|458984091|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
127551081|NCT03614156|458984092|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
127551082|NCT03614156|458984093|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
127551083|NCT03614156|458984090|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
127551084|NCT03614156|458984091|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
127551085|NCT03614156|458984092|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
127551086|NCT03614156|458984093|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
127551087|NCT03614156|458984090|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
127551088|NCT03614156|458984091|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
127551089|NCT03614156|458984092|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
127551090|NCT03614156|458984093|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
127551091|NCT03614156|458984090|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
127551092|NCT03614156|458984091|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
127551093|NCT03614156|458984092|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
127551094|NCT03614156|458984093|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
127551095|NCT03614156|458984090|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
127551096|NCT03614156|458984091|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
127551097|NCT03614156|458984092|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
127551098|NCT03614156|458984093|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
127551099|NCT03614156|458984090|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
127551100|NCT03614156|458984091|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
127551101|NCT03614156|458984092|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
127551102|NCT03614156|458984093|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
127551103|NCT03614156|458984090|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
127551104|NCT03614156|458984091|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
127551105|NCT03614156|458984092|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
127551106|NCT03614156|458984093|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
127551107|NCT04287517|458984097|FG000|Overall Study|Withdrawal by Subject|1|||
127551108|NCT04287517|458984098|FG001|Overall Study|Withdrawal by Subject|1|||
127551109|NCT00834093|458984101|FG000|Overall Study|Progressive Disease|3|||
127551110|NCT00834093|458984101|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
127551111|NCT01587924|458984102|FG000|Overall Study|Adverse Event|0|||
127551112|NCT01587924|458984103|FG001|Overall Study|Adverse Event|2|||
127551113|NCT01587924|458984104|FG002|Overall Study|Adverse Event|0|||
127685139|NCT04425629|459473279|FG016|Overall Study|Subject Decision|1|||
127685140|NCT04425629|459473280|FG017|Overall Study|Subject Decision|0|||
127685141|NCT04425629|459473281|FG018|Overall Study|Subject Decision|2|||
127685142|NCT04425629|459473263|FG000|Overall Study|Death|0|||
127685143|NCT04425629|459473264|FG001|Overall Study|Death|0|||
127685144|NCT04425629|459473265|FG002|Overall Study|Death|0|||
127685145|NCT04425629|459473266|FG003|Overall Study|Death|0|||
127685146|NCT04425629|459473267|FG004|Overall Study|Death|0|||
127685147|NCT04425629|459473268|FG005|Overall Study|Death|0|||
127685148|NCT04425629|459473269|FG006|Overall Study|Death|0|||
127685149|NCT04425629|459473270|FG007|Overall Study|Death|0|||
127685150|NCT04425629|459473271|FG008|Overall Study|Death|0|||
127685151|NCT04425629|459473272|FG009|Overall Study|Death|11|||
127685152|NCT04425629|459473273|FG010|Overall Study|Death|2|||
127685153|NCT04425629|459473274|FG011|Overall Study|Death|4|||
127685154|NCT04425629|459473275|FG012|Overall Study|Death|0|||
127685155|NCT04425629|459473276|FG013|Overall Study|Death|0|||
127551114|NCT01587924|458984105|FG003|Overall Study|Adverse Event|0|||
127685156|NCT04425629|459473277|FG014|Overall Study|Death|0|||
127551115|NCT01587924|458984102|FG000|Overall Study|Protocol Violation|2|||
127551116|NCT01587924|458984103|FG001|Overall Study|Protocol Violation|1|||
127551117|NCT01587924|458984104|FG002|Overall Study|Protocol Violation|2|||
127551118|NCT01587924|458984105|FG003|Overall Study|Protocol Violation|1|||
127551119|NCT01587924|458984102|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
127551120|NCT01587924|458984103|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
127551121|NCT01587924|458984104|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
127771906|NCT01139021|459790382|FG002|Overall Study|Adverse Event|0|||
127771907|NCT01139021|459790383|FG003|Overall Study|Adverse Event|0|||
127771908|NCT01139021|459790384|FG004|Overall Study|Adverse Event|1|||
127771909|NCT01139021|459790385|FG005|Overall Study|Adverse Event|0|||
127551122|NCT01587924|458984105|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
127551123|NCT01587924|458984102|FG000|Overall Study|Withdrawal by Subject|0|||
127551124|NCT01587924|458984103|FG001|Overall Study|Withdrawal by Subject|1|||
127551125|NCT01587924|458984104|FG002|Overall Study|Withdrawal by Subject|1|||
127551126|NCT01587924|458984105|FG003|Overall Study|Withdrawal by Subject|0|||
127551127|NCT03313037|458984112|FG000|Overall Study|Protocol Violation|4|||
127551128|NCT03313037|458984113|FG001|Overall Study|Protocol Violation|1|||
127551129|NCT03313037|458984112|FG000|Overall Study|Other|1|||
127551130|NCT03313037|458984113|FG001|Overall Study|Other|1|||
127551131|NCT03313037|458984112|FG000|Overall Study|Withdrawal by Subject|4|||
127551132|NCT03313037|458984113|FG001|Overall Study|Withdrawal by Subject|3|||
127551133|NCT03313037|458984112|FG000|Overall Study|No longer meets eligibility criteria|1|||
127551134|NCT03313037|458984113|FG001|Overall Study|No longer meets eligibility criteria|7|||
127551135|NCT03313037|458984112|FG000|Overall Study|Lost to Follow-up|9|||
127551136|NCT03313037|458984113|FG001|Overall Study|Lost to Follow-up|8|||
127771910|NCT01139021|459790380|FG000|Overall Study|Lost to Follow-up|0|||
127551137|NCT03313037|458984112|FG000|Overall Study|Randomized but not treated|1|||
127551138|NCT03313037|458984113|FG001|Overall Study|Randomized but not treated|0|||
127551139|NCT02379091|458984114|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
127551140|NCT02379091|458984115|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
127551141|NCT02379091|458984116|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
127551142|NCT02379091|458984117|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
127551143|NCT02379091|458984114|FG000|Overall Study|Principal Investigator Discretion|0|||
127551144|NCT02379091|458984115|FG001|Overall Study|Principal Investigator Discretion|1|||
127551145|NCT02379091|458984116|FG002|Overall Study|Principal Investigator Discretion|0|||
127551146|NCT02379091|458984117|FG003|Overall Study|Principal Investigator Discretion|0|||
127551147|NCT02379091|458984114|FG000|Overall Study|Lost to Follow-up|0|||
127551148|NCT02379091|458984115|FG001|Overall Study|Lost to Follow-up|0|||
127551149|NCT02379091|458984116|FG002|Overall Study|Lost to Follow-up|0|||
127551150|NCT02379091|458984117|FG003|Overall Study|Lost to Follow-up|1|||
127551151|NCT02379091|458984114|FG000|Overall Study|Voluntary Withdrawal|2|||
127771911|NCT01139021|459790381|FG001|Overall Study|Lost to Follow-up|0|||
127771912|NCT01139021|459790382|FG002|Overall Study|Lost to Follow-up|0|||
127771913|NCT01139021|459790383|FG003|Overall Study|Lost to Follow-up|0|||
127771914|NCT01139021|459790384|FG004|Overall Study|Lost to Follow-up|2|||
127771915|NCT01139021|459790385|FG005|Overall Study|Lost to Follow-up|0|||
127771916|NCT01139021|459790380|FG000|Overall Study|Protocol Violation|1|||
127771917|NCT01139021|459790381|FG001|Overall Study|Protocol Violation|0|||
127771918|NCT01139021|459790382|FG002|Overall Study|Protocol Violation|0|||
127771919|NCT01139021|459790383|FG003|Overall Study|Protocol Violation|0|||
127771920|NCT01139021|459790384|FG004|Overall Study|Protocol Violation|2|||
127771921|NCT01139021|459790385|FG005|Overall Study|Protocol Violation|0|||
127771922|NCT01139021|459790380|FG000|Overall Study|Withdrawal by Subject|0|||
127771923|NCT01139021|459790381|FG001|Overall Study|Withdrawal by Subject|0|||
127771924|NCT01139021|459790382|FG002|Overall Study|Withdrawal by Subject|0|||
127771925|NCT01139021|459790383|FG003|Overall Study|Withdrawal by Subject|1|||
127771926|NCT01139021|459790384|FG004|Overall Study|Withdrawal by Subject|4|||
127771927|NCT01139021|459790385|FG005|Overall Study|Withdrawal by Subject|0|||
127771928|NCT01026454|459790386|FG000|Second Intervention|Pregnancy|1|||
127771929|NCT01026454|459790387|FG001|Second Intervention|Pregnancy|1|||
127771930|NCT00394953|459790388|FG000|First Treatment Period|Adverse Event|1|||
127771931|NCT00394953|459790389|FG001|First Treatment Period|Adverse Event|2|||
128017145|NCT01078662|460685587|FG003|Overall Study|Protocol Violation|0|||
127551152|NCT02379091|458984115|FG001|Overall Study|Voluntary Withdrawal|5|||
127551153|NCT02379091|458984116|FG002|Overall Study|Voluntary Withdrawal|2|||
127551154|NCT02379091|458984117|FG003|Overall Study|Voluntary Withdrawal|4|||
128017146|NCT01078662|460685588|FG004|Overall Study|Protocol Violation|0|||
127771932|NCT00394953|459790388|FG000|First Treatment Period|Death|6|||
127771933|NCT00394953|459790389|FG001|First Treatment Period|Death|7|||
127771934|NCT00394953|459790388|FG000|First Treatment Period|Lack of Efficacy|1|||
128017147|NCT01078662|460685584|FG000|Overall Study|Lost to Follow-up|1|||
127551155|NCT02379091|458984114|FG000|Overall Study|Study Termination|7|||
127551156|NCT02379091|458984115|FG001|Overall Study|Study Termination|2|||
127551157|NCT02379091|458984116|FG002|Overall Study|Study Termination|5|||
127551158|NCT02379091|458984117|FG003|Overall Study|Study Termination|8|||
127771935|NCT00394953|459790389|FG001|First Treatment Period|Lack of Efficacy|1|||
127551159|NCT02379091|458984114|FG000|Overall Study|Lack of Efficacy|3|||
127551160|NCT02379091|458984115|FG001|Overall Study|Lack of Efficacy|0|||
127551161|NCT02379091|458984116|FG002|Overall Study|Lack of Efficacy|0|||
127551162|NCT02379091|458984117|FG003|Overall Study|Lack of Efficacy|0|||
127551163|NCT02129699|458984120|FG000|Overall Study|Did not start treatment|3|||
127551164|NCT02129699|458984121|FG001|Overall Study|Did not start treatment|2|||
127551165|NCT01076361|458984125|FG000|Overall Study|22 leads were excluded from analysis|21|||
127551166|NCT00630838|458984128|FG000|Overall Study|Death|0|||
127551167|NCT00630838|458984129|FG001|Overall Study|Death|1|||
127551168|NCT00630838|458984128|FG000|Overall Study|Lost to Follow-up|0|||
127551169|NCT00630838|458984129|FG001|Overall Study|Lost to Follow-up|1|||
127551170|NCT00670748|458984133|FG000|Overall Study|Death during treatment|1|||
127551171|NCT00670748|458984134|FG001|Overall Study|Death during treatment|1|||
127551172|NCT00670748|458984135|FG002|Overall Study|Death during treatment|1|||
127551173|NCT00670748|458984136|FG003|Overall Study|Death during treatment|0|||
127551174|NCT00670748|458984133|FG000|Overall Study|Not off study|2|||
127551175|NCT00670748|458984134|FG001|Overall Study|Not off study|1|||
127551176|NCT00670748|458984135|FG002|Overall Study|Not off study|1|||
127771936|NCT00394953|459790388|FG000|First Treatment Period|Withdrawal by Subject|6|||
127771937|NCT00394953|459790389|FG001|First Treatment Period|Withdrawal by Subject|3|||
127771938|NCT00394953|459790388|FG000|First Treatment Period|Lost to Follow-up|0|||
127771939|NCT00394953|459790389|FG001|First Treatment Period|Lost to Follow-up|1|||
127771940|NCT00394953|459790388|FG000|First Treatment Period|Renal transplant|11|||
127771941|NCT00394953|459790389|FG001|First Treatment Period|Renal transplant|7|||
127771942|NCT00394953|459790388|FG000|First Treatment Period|Not defined|4|||
127771943|NCT00394953|459790389|FG001|First Treatment Period|Not defined|1|||
127771944|NCT00394953|459790388|FG000|Second Treatment Period|Adverse Event|2|||
127771945|NCT00394953|459790389|FG001|Second Treatment Period|Adverse Event|5|||
127771946|NCT00394953|459790388|FG000|Second Treatment Period|Death|8|||
127771947|NCT00394953|459790389|FG001|Second Treatment Period|Death|4|||
127551177|NCT00670748|458984136|FG003|Overall Study|Not off study|1|||
127551178|NCT01646125|458985735|FG000|Overall Study|Untreated|2|||
127551179|NCT01646125|458985736|FG001|Overall Study|Untreated|5|||
127551180|NCT01646125|458985735|FG000|Overall Study|Adverse Event|2|||
127551181|NCT01646125|458985736|FG001|Overall Study|Adverse Event|1|||
127551182|NCT01646125|458985735|FG000|Overall Study|Death|1|||
127551183|NCT01646125|458985736|FG001|Overall Study|Death|1|||
127771948|NCT00394953|459790388|FG000|Second Treatment Period|Lack of Efficacy|9|||
127771949|NCT00394953|459790389|FG001|Second Treatment Period|Lack of Efficacy|47|||
127771950|NCT00394953|459790388|FG000|Second Treatment Period|Withdrawal by Subject|3|||
127771951|NCT00394953|459790389|FG001|Second Treatment Period|Withdrawal by Subject|3|||
127771952|NCT00394953|459790388|FG000|Second Treatment Period|Lost to Follow-up|0|||
127771953|NCT00394953|459790389|FG001|Second Treatment Period|Lost to Follow-up|1|||
127551184|NCT01646125|458985735|FG000|Overall Study|Physician Decision|1|||
127551185|NCT01646125|458985736|FG001|Overall Study|Physician Decision|3|||
127551186|NCT01646125|458985735|FG000|Overall Study|Progressive disease|22|||
127551187|NCT01646125|458985736|FG001|Overall Study|Progressive disease|16|||
127551188|NCT01646125|458985735|FG000|Overall Study|Study terminated by sponsor|2|||
127551189|NCT01646125|458985736|FG001|Overall Study|Study terminated by sponsor|1|||
127551190|NCT01646125|458985735|FG000|Overall Study|Subject/Guardian decision|1|||
127551191|NCT01646125|458985736|FG001|Overall Study|Subject/Guardian decision|1|||
127551192|NCT01376804|458985737|FG000|Treatment Period|Withdrawal by Subject|1|||
127551193|NCT01376804|458985737|FG000|Treatment Period|Adverse Event|6|||
127551194|NCT01376804|458985737|FG000|Treatment Period|Patient did not receive study drug|1|||
127551195|NCT00904033|458985742|FG000|Overall Study|Withdrawal by Subject|1|||
127551196|NCT00904033|458985743|FG001|Overall Study|Withdrawal by Subject|1|||
127551197|NCT00904033|458985744|FG002|Overall Study|Withdrawal by Subject|0|||
127551198|NCT00904033|458985745|FG003|Overall Study|Withdrawal by Subject|0|||
127551199|NCT00904033|458985742|FG000|Overall Study|Physician Decision|0|||
127551200|NCT00904033|458985743|FG001|Overall Study|Physician Decision|0|||
127551201|NCT00904033|458985744|FG002|Overall Study|Physician Decision|1|||
127771954|NCT00394953|459790388|FG000|Second Treatment Period|Renal transplant|4|||
127771955|NCT00394953|459790389|FG001|Second Treatment Period|Renal transplant|6|||
127771956|NCT00394953|459790388|FG000|Second Treatment Period|Not defined|3|||
127880993|NCT05349188|460186096|FG001|Overall Study|Withdrawal by Subject|0|||
128017148|NCT01078662|460685585|FG001|Overall Study|Lost to Follow-up|0|||
127551202|NCT00904033|458985745|FG003|Overall Study|Physician Decision|0|||
127551203|NCT00904033|458985742|FG000|Overall Study|Unable to obtain final blood draw|0|||
127551204|NCT00904033|458985743|FG001|Overall Study|Unable to obtain final blood draw|0|||
127551205|NCT00904033|458985744|FG002|Overall Study|Unable to obtain final blood draw|0|||
127551206|NCT00904033|458985745|FG003|Overall Study|Unable to obtain final blood draw|2|||
127551207|NCT01357850|458985746|FG000|Overall Study|Lost to Follow-up|1|||
127771957|NCT00394953|459790389|FG001|Second Treatment Period|Not defined|8|||
127771958|NCT02196714|459790395|FG000|Overall Study|Protocol Violation|0|||
128017149|NCT01078662|460685586|FG002|Overall Study|Lost to Follow-up|0|||
127551208|NCT01357850|458985747|FG001|Overall Study|Lost to Follow-up|0|||
127551209|NCT01357850|458985748|FG002|Overall Study|Lost to Follow-up|0|||
127771959|NCT02196714|459790396|FG001|Overall Study|Protocol Violation|0|||
127771960|NCT02196714|459790397|FG002|Overall Study|Protocol Violation|1|||
127771961|NCT02196714|459790398|FG003|Overall Study|Protocol Violation|0|||
127771962|NCT01592864|459790400|FG000|Overall Study|Withdrawal by Subject|0|||
127771963|NCT01592864|459790401|FG001|Overall Study|Withdrawal by Subject|1|||
127771964|NCT01294683|459790408|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
127771965|NCT01294683|459790409|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
127771966|NCT01294683|459790408|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
127771967|NCT01294683|459790409|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
127771968|NCT01294683|459790408|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
127771969|NCT01294683|459790409|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
127771970|NCT01294683|459790408|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
127771971|NCT01294683|459790409|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
127771972|NCT01294683|459790408|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
127771973|NCT01294683|459790409|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
127771974|NCT01294683|459790408|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
127771975|NCT01294683|459790409|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
127771976|NCT01294683|459790408|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
127771977|NCT01294683|459790409|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
127771978|NCT01294683|459790408|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
127551210|NCT01357850|458985749|FG003|Overall Study|Lost to Follow-up|0|||
127551211|NCT01177397|458985750|FG000|Overall Study|Protocol Violation|0|||
127551212|NCT01177397|458985751|FG001|Overall Study|Protocol Violation|0|||
127551213|NCT01177397|458985752|FG002|Overall Study|Protocol Violation|0|||
127551214|NCT01177397|458985753|FG003|Overall Study|Protocol Violation|0|||
127551215|NCT01177397|458985754|FG004|Overall Study|Protocol Violation|0|||
127551216|NCT01177397|458985755|FG005|Overall Study|Protocol Violation|1|||
127551217|NCT01177397|458985756|FG006|Overall Study|Protocol Violation|0|||
127551218|NCT01177397|458985757|FG007|Overall Study|Protocol Violation|0|||
127551219|NCT01177397|458985758|FG008|Overall Study|Protocol Violation|0|||
127551220|NCT01177397|458985759|FG009|Overall Study|Protocol Violation|0|||
127771979|NCT01294683|459790409|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
127771980|NCT01294683|459790408|FG000|Post Crossover (Period III)|Adverse Event|6|||
127771981|NCT01294683|459790409|FG001|Post Crossover (Period III)|Adverse Event|6|||
127771982|NCT01294683|459790408|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
127771983|NCT01294683|459790409|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
127771984|NCT01294683|459790408|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
127771985|NCT01294683|459790409|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
127771986|NCT01294683|459790408|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
127771987|NCT01294683|459790409|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
127771988|NCT01032382|459790410|FG000|Overall Study|Disease dissemination|1|||
127771989|NCT01032382|459790411|FG001|Overall Study|Disease dissemination|1|||
127771990|NCT01032382|459790410|FG000|Overall Study|Treatment failure|3|||
127771991|NCT01032382|459790411|FG001|Overall Study|Treatment failure|1|||
127771992|NCT01032382|459790410|FG000|Overall Study|Index lesion relapse|1|||
127771993|NCT01032382|459790411|FG001|Overall Study|Index lesion relapse|3|||
127771994|NCT00412971|459790412|FG000|Overall Study|Lost to Follow-up|17|||
127771995|NCT00412971|459790413|FG001|Overall Study|Lost to Follow-up|9|||
127771996|NCT00412971|459790412|FG000|Overall Study|Protocol Violation|13|||
127771997|NCT00412971|459790413|FG001|Overall Study|Protocol Violation|1|||
127771998|NCT02409368|459790414|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
127771999|NCT02409368|459790415|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
127772000|NCT02409368|459790416|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
127772001|NCT02409368|459790417|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
127772002|NCT02409368|459790414|FG000|ECOG Reclassification|Death|1|||
128017150|NCT01078662|460685587|FG003|Overall Study|Lost to Follow-up|0|||
127772003|NCT02409368|459790415|FG001|ECOG Reclassification|Death|5|||
127772004|NCT02409368|459790416|FG002|ECOG Reclassification|Death|0|||
127772005|NCT02409368|459790417|FG003|ECOG Reclassification|Death|0|||
127772006|NCT02409368|459790414|FG000|ECOG Reclassification|Disease Progression|113|||
127772007|NCT02409368|459790415|FG001|ECOG Reclassification|Disease Progression|382|||
127772008|NCT02409368|459790416|FG002|ECOG Reclassification|Disease Progression|70|||
127772009|NCT02409368|459790417|FG003|ECOG Reclassification|Disease Progression|1|||
127772010|NCT02409368|459790414|FG000|ECOG Reclassification|Lost to Follow-up|1|||
127772011|NCT02409368|459790415|FG001|ECOG Reclassification|Lost to Follow-up|5|||
128017151|NCT01078662|460685588|FG004|Overall Study|Lost to Follow-up|0|||
127772012|NCT02409368|459790416|FG002|ECOG Reclassification|Lost to Follow-up|0|||
127772013|NCT02409368|459790417|FG003|ECOG Reclassification|Lost to Follow-up|0|||
127772014|NCT02409368|459790414|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
127551221|NCT01177397|458985760|FG010|Overall Study|Protocol Violation|0|||
127551222|NCT01177397|458985761|FG011|Overall Study|Protocol Violation|0|||
127551223|NCT01177397|458985750|FG000|Overall Study|Lost to Follow-up|0|||
127551224|NCT01177397|458985751|FG001|Overall Study|Lost to Follow-up|0|||
127551225|NCT01177397|458985752|FG002|Overall Study|Lost to Follow-up|0|||
127772015|NCT02409368|459790415|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
127772016|NCT02409368|459790416|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
127772017|NCT02409368|459790417|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
127772018|NCT02409368|459790414|FG000|ECOG Reclassification|Poor/non-compliance|0|||
127772019|NCT02409368|459790415|FG001|ECOG Reclassification|Poor/non-compliance|3|||
127772020|NCT02409368|459790416|FG002|ECOG Reclassification|Poor/non-compliance|2|||
127772021|NCT02409368|459790417|FG003|ECOG Reclassification|Poor/non-compliance|0|||
127772022|NCT02409368|459790414|FG000|ECOG Reclassification|Study drug toxicity|17|||
127772023|NCT02409368|459790415|FG001|ECOG Reclassification|Study drug toxicity|42|||
127772024|NCT02409368|459790416|FG002|ECOG Reclassification|Study drug toxicity|7|||
127772025|NCT02409368|459790417|FG003|ECOG Reclassification|Study drug toxicity|0|||
127772026|NCT02409368|459790414|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
127551226|NCT01177397|458985753|FG003|Overall Study|Lost to Follow-up|0|||
127551227|NCT01177397|458985754|FG004|Overall Study|Lost to Follow-up|1|||
127551228|NCT01177397|458985755|FG005|Overall Study|Lost to Follow-up|0|||
127551229|NCT01177397|458985756|FG006|Overall Study|Lost to Follow-up|0|||
127551230|NCT01177397|458985757|FG007|Overall Study|Lost to Follow-up|2|||
127551231|NCT01177397|458985758|FG008|Overall Study|Lost to Follow-up|0|||
127551232|NCT01177397|458985759|FG009|Overall Study|Lost to Follow-up|0|||
127551233|NCT01177397|458985760|FG010|Overall Study|Lost to Follow-up|0|||
127551234|NCT01177397|458985761|FG011|Overall Study|Lost to Follow-up|0|||
127551235|NCT01177397|458985750|FG000|Overall Study|Death|0|||
127772027|NCT02409368|459790415|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
127772028|NCT02409368|459790416|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
127772029|NCT02409368|459790417|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
127772030|NCT02409368|459790414|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
127772031|NCT02409368|459790415|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
127772032|NCT02409368|459790416|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
127772033|NCT02409368|459790417|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
127772034|NCT02409368|459790414|FG000|ECOG Reclassification|Participant withdrew consent|2|||
127772035|NCT02409368|459790415|FG001|ECOG Reclassification|Participant withdrew consent|3|||
127772036|NCT02409368|459790416|FG002|ECOG Reclassification|Participant withdrew consent|4|||
127772037|NCT02409368|459790417|FG003|ECOG Reclassification|Participant withdrew consent|0|||
127772038|NCT02409368|459790414|FG000|ECOG Reclassification|Other Reasons|5|||
127772039|NCT02409368|459790415|FG001|ECOG Reclassification|Other Reasons|26|||
127772040|NCT02409368|459790416|FG002|ECOG Reclassification|Other Reasons|2|||
127772041|NCT02409368|459790417|FG003|ECOG Reclassification|Other Reasons|0|||
127772042|NCT02409368|459790414|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
127772043|NCT02409368|459790415|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
127772044|NCT02409368|459790416|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
127772045|NCT02409368|459790417|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
127772046|NCT02041520|459790418|FG000|Overall Study|Adverse Event|2|||
127772047|NCT02041520|459790419|FG001|Overall Study|Adverse Event|1|||
127772048|NCT02041520|459790418|FG000|Overall Study|Withdrawal by Subject|3|||
127772049|NCT02041520|459790419|FG001|Overall Study|Withdrawal by Subject|4|||
127772050|NCT02041520|459790418|FG000|Overall Study|Protocol Violation|1|||
127772051|NCT02041520|459790419|FG001|Overall Study|Protocol Violation|0|||
127772052|NCT02041520|459790418|FG000|Overall Study|Lost to Follow-up|0|||
127772053|NCT02041520|459790419|FG001|Overall Study|Lost to Follow-up|1|||
127772054|NCT02041520|459790418|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
127772055|NCT02041520|459790419|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
127772056|NCT01759407|459790420|FG000|Overall Study|Protocol Violation|0|||
127772057|NCT01759407|459790421|FG001|Overall Study|Protocol Violation|2|||
127772058|NCT03737474|459790422|FG000|Overall Study|Adverse Event|18|||
127772059|NCT03737474|459790423|FG001|Overall Study|Adverse Event|48|||
127772060|NCT03737474|459790422|FG000|Overall Study|Lack of Efficacy|1|||
127772061|NCT03737474|459790423|FG001|Overall Study|Lack of Efficacy|3|||
127772062|NCT03737474|459790422|FG000|Overall Study|Protocol Violation|0|||
127772063|NCT03737474|459790423|FG001|Overall Study|Protocol Violation|8|||
127772064|NCT03737474|459790422|FG000|Overall Study|Withdrawal by Subject|5|||
127772065|NCT03737474|459790423|FG001|Overall Study|Withdrawal by Subject|20|||
127772066|NCT03737474|459790422|FG000|Overall Study|Non-compliance With Study Drug|0|||
127772067|NCT03737474|459790423|FG001|Overall Study|Non-compliance With Study Drug|1|||
127772068|NCT03737474|459790422|FG000|Overall Study|Physician Decision|1|||
127772069|NCT03737474|459790423|FG001|Overall Study|Physician Decision|4|||
127772070|NCT02513745|459790424|FG000|Overall Study|Criteria at time of surgery not met.|3|||
127772071|NCT02513745|459790425|FG001|Overall Study|Criteria at time of surgery not met.|3|||
127772072|NCT01209143|459790426|FG000|Overall Study|Adverse Event|2|||
127772073|NCT01209143|459790427|FG001|Overall Study|Adverse Event|1|||
127772074|NCT01209143|459790426|FG000|Overall Study|Death|0|||
127772075|NCT01209143|459790427|FG001|Overall Study|Death|1|||
127551236|NCT01177397|458985751|FG001|Overall Study|Death|0|||
127551237|NCT01177397|458985752|FG002|Overall Study|Death|1|||
127551238|NCT01177397|458985753|FG003|Overall Study|Death|1|||
127772076|NCT01209143|459790426|FG000|Overall Study|Physician Decision|3|||
127772077|NCT01209143|459790427|FG001|Overall Study|Physician Decision|1|||
127772078|NCT01209143|459790426|FG000|Overall Study|Lost to Follow-up|1|||
127772079|NCT01209143|459790427|FG001|Overall Study|Lost to Follow-up|0|||
127772080|NCT01209143|459790426|FG000|Overall Study|Withdrawal by Subject|2|||
127772081|NCT01209143|459790427|FG001|Overall Study|Withdrawal by Subject|1|||
127772082|NCT01209143|459790426|FG000|Overall Study|Disease progression|11|||
127772083|NCT01209143|459790427|FG001|Overall Study|Disease progression|16|||
127772084|NCT00753272|459790431|FG000|Overall Study|Adverse Event|878|||
127772085|NCT00753272|459790432|FG001|Overall Study|Adverse Event|869|||
127772086|NCT00753272|459790431|FG000|Overall Study|Protocol Violation|28|||
127772087|NCT00753272|459790432|FG001|Overall Study|Protocol Violation|46|||
127772088|NCT00753272|459790431|FG000|Overall Study|Withdrawal by Subject|2481|||
127772089|NCT00753272|459790432|FG001|Overall Study|Withdrawal by Subject|2407|||
127772090|NCT00753272|459790431|FG000|Overall Study|Lost to Follow-up|491|||
127772091|NCT00753272|459790432|FG001|Overall Study|Lost to Follow-up|497|||
127772092|NCT00753272|459790431|FG000|Overall Study|Other|1104|||
127772093|NCT00753272|459790432|FG001|Overall Study|Other|1088|||
127772094|NCT00971243|459790433|FG000|Double Blind Period|Adverse Event|2|||
127772095|NCT00971243|459790434|FG001|Double Blind Period|Adverse Event|3|||
127772096|NCT00971243|459790435|FG002|Double Blind Period|Adverse Event|2|||
127772097|NCT00971243|459790436|FG003|Double Blind Period|Adverse Event|2|||
127772098|NCT00971243|459790437|FG004|Double Blind Period|Adverse Event|3|||
127772099|NCT00971243|459790433|FG000|Double Blind Period|Lost to Follow-up|0|||
127772100|NCT00971243|459790434|FG001|Double Blind Period|Lost to Follow-up|1|||
127772101|NCT00971243|459790435|FG002|Double Blind Period|Lost to Follow-up|1|||
127772102|NCT00971243|459790436|FG003|Double Blind Period|Lost to Follow-up|0|||
127772103|NCT00971243|459790437|FG004|Double Blind Period|Lost to Follow-up|1|||
127772104|NCT00971243|459790433|FG000|Double Blind Period|Physician Decision|10|||
127772105|NCT00971243|459790434|FG001|Double Blind Period|Physician Decision|6|||
127772106|NCT00971243|459790435|FG002|Double Blind Period|Physician Decision|7|||
127772107|NCT00971243|459790436|FG003|Double Blind Period|Physician Decision|6|||
127772108|NCT00971243|459790437|FG004|Double Blind Period|Physician Decision|7|||
127772109|NCT00971243|459790433|FG000|Double Blind Period|Protocol Violation|2|||
127772110|NCT00971243|459790434|FG001|Double Blind Period|Protocol Violation|0|||
127772111|NCT00971243|459790435|FG002|Double Blind Period|Protocol Violation|3|||
127772112|NCT00971243|459790436|FG003|Double Blind Period|Protocol Violation|2|||
127772113|NCT00971243|459790437|FG004|Double Blind Period|Protocol Violation|2|||
127772114|NCT00971243|459790433|FG000|Double Blind Period|Withdrawal by Subject|4|||
127772115|NCT00971243|459790434|FG001|Double Blind Period|Withdrawal by Subject|1|||
127772116|NCT00971243|459790435|FG002|Double Blind Period|Withdrawal by Subject|4|||
127772117|NCT00971243|459790436|FG003|Double Blind Period|Withdrawal by Subject|4|||
127772118|NCT00971243|459790437|FG004|Double Blind Period|Withdrawal by Subject|4|||
127772119|NCT00971243|459790433|FG000|Double Blind Period|Other reasons|1|||
127772120|NCT00971243|459790434|FG001|Double Blind Period|Other reasons|0|||
127772121|NCT00971243|459790435|FG002|Double Blind Period|Other reasons|2|||
127772122|NCT00971243|459790436|FG003|Double Blind Period|Other reasons|0|||
127772123|NCT00971243|459790437|FG004|Double Blind Period|Other reasons|1|||
127551239|NCT01177397|458985754|FG004|Overall Study|Death|0|||
127551240|NCT01177397|458985755|FG005|Overall Study|Death|0|||
127551241|NCT01177397|458985756|FG006|Overall Study|Death|0|||
127772124|NCT00971243|459790433|FG000|Open-label Period|Adverse Event|1|||
127772125|NCT00971243|459790434|FG001|Open-label Period|Adverse Event|0|||
127772126|NCT00971243|459790435|FG002|Open-label Period|Adverse Event|1|||
127772127|NCT00971243|459790436|FG003|Open-label Period|Adverse Event|1|||
127772128|NCT00971243|459790437|FG004|Open-label Period|Adverse Event|0|||
127772129|NCT00971243|459790433|FG000|Open-label Period|Physician Decision|5|||
127772130|NCT00971243|459790434|FG001|Open-label Period|Physician Decision|9|||
127772131|NCT00971243|459790435|FG002|Open-label Period|Physician Decision|3|||
128017152|NCT00700635|460685589|FG000|Overall Study|Adverse Event|1|||
128017153|NCT00700635|460685590|FG001|Overall Study|Adverse Event|0|||
128017154|NCT00700635|460685591|FG002|Overall Study|Adverse Event|0|||
127551242|NCT01177397|458985757|FG007|Overall Study|Death|5|||
127551243|NCT01177397|458985758|FG008|Overall Study|Death|2|||
127551244|NCT01177397|458985759|FG009|Overall Study|Death|1|||
127551245|NCT01177397|458985760|FG010|Overall Study|Death|0|||
127772132|NCT00971243|459790436|FG003|Open-label Period|Physician Decision|7|||
127772133|NCT00971243|459790437|FG004|Open-label Period|Physician Decision|2|||
127772134|NCT00971243|459790433|FG000|Open-label Period|Protocol Violation|1|||
127772135|NCT00971243|459790434|FG001|Open-label Period|Protocol Violation|1|||
127772136|NCT00971243|459790435|FG002|Open-label Period|Protocol Violation|1|||
127772137|NCT00971243|459790436|FG003|Open-label Period|Protocol Violation|0|||
127772138|NCT00971243|459790437|FG004|Open-label Period|Protocol Violation|1|||
127772139|NCT00971243|459790433|FG000|Open-label Period|Withdrawal by Subject|1|||
127772140|NCT00971243|459790434|FG001|Open-label Period|Withdrawal by Subject|0|||
127772141|NCT00971243|459790435|FG002|Open-label Period|Withdrawal by Subject|0|||
127772142|NCT00971243|459790436|FG003|Open-label Period|Withdrawal by Subject|2|||
127772143|NCT00971243|459790437|FG004|Open-label Period|Withdrawal by Subject|1|||
127551246|NCT01177397|458985761|FG011|Overall Study|Death|0|||
128017155|NCT00700635|460685589|FG000|Overall Study|Lost to Follow-up|1|||
128017156|NCT00700635|460685590|FG001|Overall Study|Lost to Follow-up|3|||
128017157|NCT00700635|460685591|FG002|Overall Study|Lost to Follow-up|0|||
128017158|NCT00700635|460685589|FG000|Overall Study|Protocol Violation|2|||
128017159|NCT00700635|460685590|FG001|Overall Study|Protocol Violation|2|||
128017160|NCT00700635|460685591|FG002|Overall Study|Protocol Violation|0|||
128017161|NCT00700635|460685589|FG000|Overall Study|Withdrawal by Subject|7|||
128017162|NCT00700635|460685590|FG001|Overall Study|Withdrawal by Subject|3|||
128017163|NCT00700635|460685591|FG002|Overall Study|Withdrawal by Subject|1|||
128017164|NCT04937387|460685594|FG000|Overall Study|Adverse Event|1|||
128017165|NCT04937387|460685595|FG001|Overall Study|Adverse Event|0|||
128017166|NCT04937387|460685596|FG002|Overall Study|Adverse Event|2|||
128017167|NCT04937387|460685597|FG003|Overall Study|Adverse Event|0|||
128017168|NCT04937387|460685594|FG000|Overall Study|Lack of Efficacy|1|||
128017169|NCT04937387|460685595|FG001|Overall Study|Lack of Efficacy|0|||
128017170|NCT04937387|460685596|FG002|Overall Study|Lack of Efficacy|0|||
128017171|NCT04937387|460685597|FG003|Overall Study|Lack of Efficacy|1|||
128017172|NCT04937387|460685594|FG000|Overall Study|Withdrawal by Subject|1|||
128017173|NCT04937387|460685595|FG001|Overall Study|Withdrawal by Subject|0|||
128017174|NCT04937387|460685596|FG002|Overall Study|Withdrawal by Subject|1|||
128017175|NCT04937387|460685597|FG003|Overall Study|Withdrawal by Subject|1|||
128017176|NCT04937387|460685594|FG000|Overall Study|Randomized in error|0|||
128017177|NCT04937387|460685595|FG001|Overall Study|Randomized in error|0|||
128017178|NCT04937387|460685596|FG002|Overall Study|Randomized in error|0|||
128017179|NCT04937387|460685597|FG003|Overall Study|Randomized in error|1|||
128017180|NCT00980460|460685601|FG000|Overall Study|Death|0|||
128017181|NCT00980460|460685602|FG001|Overall Study|Death|0|||
128017182|NCT00980460|460685603|FG002|Overall Study|Death|1|||
128017183|NCT00980460|460685604|FG003|Overall Study|Death|2|||
128017184|NCT00980460|460685605|FG004|Overall Study|Death|1|||
128017185|NCT00980460|460685601|FG000|Overall Study|Lack of Efficacy|0|||
128017186|NCT00980460|460685602|FG001|Overall Study|Lack of Efficacy|0|||
128017187|NCT00980460|460685603|FG002|Overall Study|Lack of Efficacy|10|||
128017188|NCT00980460|460685604|FG003|Overall Study|Lack of Efficacy|6|||
128017189|NCT00980460|460685605|FG004|Overall Study|Lack of Efficacy|8|||
128017190|NCT00980460|460685601|FG000|Overall Study|Lost to Follow-up|0|||
128017191|NCT00980460|460685602|FG001|Overall Study|Lost to Follow-up|0|||
127685157|NCT04425629|459473278|FG015|Overall Study|Death|0|||
127685158|NCT04425629|459473279|FG016|Overall Study|Death|0|||
127685159|NCT04425629|459473280|FG017|Overall Study|Death|0|||
127685160|NCT04425629|459473281|FG018|Overall Study|Death|0|||
127685161|NCT04425629|459473263|FG000|Overall Study|Sponsor Request|0|||
127685162|NCT04425629|459473264|FG001|Overall Study|Sponsor Request|0|||
127685163|NCT04425629|459473265|FG002|Overall Study|Sponsor Request|0|||
127685164|NCT04425629|459473266|FG003|Overall Study|Sponsor Request|2|||
127685165|NCT04425629|459473267|FG004|Overall Study|Sponsor Request|2|||
127685166|NCT04425629|459473268|FG005|Overall Study|Sponsor Request|2|||
127685167|NCT04425629|459473269|FG006|Overall Study|Sponsor Request|1|||
127685168|NCT04425629|459473270|FG007|Overall Study|Sponsor Request|0|||
127685169|NCT04425629|459473271|FG008|Overall Study|Sponsor Request|0|||
127685170|NCT04425629|459473272|FG009|Overall Study|Sponsor Request|9|||
127685171|NCT04425629|459473273|FG010|Overall Study|Sponsor Request|9|||
127685172|NCT04425629|459473274|FG011|Overall Study|Sponsor Request|10|||
127685173|NCT04425629|459473275|FG012|Overall Study|Sponsor Request|8|||
127685174|NCT04425629|459473276|FG013|Overall Study|Sponsor Request|0|||
127685175|NCT04425629|459473277|FG014|Overall Study|Sponsor Request|0|||
127685176|NCT04425629|459473278|FG015|Overall Study|Sponsor Request|1|||
127685177|NCT04425629|459473279|FG016|Overall Study|Sponsor Request|0|||
127685178|NCT04425629|459473280|FG017|Overall Study|Sponsor Request|0|||
127685179|NCT04425629|459473281|FG018|Overall Study|Sponsor Request|0|||
127685180|NCT04425629|459473263|FG000|Overall Study|Physician Decision|0|||
127685181|NCT04425629|459473264|FG001|Overall Study|Physician Decision|0|||
127685182|NCT04425629|459473265|FG002|Overall Study|Physician Decision|0|||
127685183|NCT04425629|459473266|FG003|Overall Study|Physician Decision|0|||
127685184|NCT04425629|459473267|FG004|Overall Study|Physician Decision|0|||
128017192|NCT00980460|460685603|FG002|Overall Study|Lost to Follow-up|0|||
128017193|NCT00980460|460685604|FG003|Overall Study|Lost to Follow-up|1|||
128017194|NCT00980460|460685605|FG004|Overall Study|Lost to Follow-up|0|||
128017195|NCT00980460|460685601|FG000|Overall Study|Physician Decision|0|||
127685185|NCT04425629|459473268|FG005|Overall Study|Physician Decision|0|||
127685186|NCT04425629|459473269|FG006|Overall Study|Physician Decision|0|||
127685187|NCT04425629|459473270|FG007|Overall Study|Physician Decision|0|||
127685188|NCT04425629|459473271|FG008|Overall Study|Physician Decision|0|||
127685189|NCT04425629|459473272|FG009|Overall Study|Physician Decision|4|||
127685190|NCT04425629|459473273|FG010|Overall Study|Physician Decision|3|||
127685191|NCT04425629|459473274|FG011|Overall Study|Physician Decision|5|||
128017196|NCT00980460|460685602|FG001|Overall Study|Physician Decision|0|||
128017197|NCT00980460|460685603|FG002|Overall Study|Physician Decision|11|||
128017198|NCT00980460|460685604|FG003|Overall Study|Physician Decision|5|||
128017199|NCT00980460|460685605|FG004|Overall Study|Physician Decision|3|||
128017200|NCT00980460|460685601|FG000|Overall Study|Withdrawal by Subject|0|||
127551247|NCT01177397|458985750|FG000|Overall Study|Withdrawal by Subject|0|||
127551248|NCT01177397|458985751|FG001|Overall Study|Withdrawal by Subject|0|||
127551249|NCT01177397|458985752|FG002|Overall Study|Withdrawal by Subject|1|||
127551250|NCT01177397|458985753|FG003|Overall Study|Withdrawal by Subject|1|||
127551251|NCT01177397|458985754|FG004|Overall Study|Withdrawal by Subject|1|||
127551252|NCT01177397|458985755|FG005|Overall Study|Withdrawal by Subject|2|||
127551253|NCT01177397|458985756|FG006|Overall Study|Withdrawal by Subject|0|||
127551254|NCT01177397|458985757|FG007|Overall Study|Withdrawal by Subject|5|||
127551255|NCT01177397|458985758|FG008|Overall Study|Withdrawal by Subject|9|||
127551256|NCT01177397|458985759|FG009|Overall Study|Withdrawal by Subject|1|||
127551257|NCT01177397|458985760|FG010|Overall Study|Withdrawal by Subject|1|||
127551258|NCT01177397|458985761|FG011|Overall Study|Withdrawal by Subject|0|||
127551259|NCT01177397|458985750|FG000|Overall Study|Adverse Event|0|||
127551260|NCT01177397|458985751|FG001|Overall Study|Adverse Event|0|||
127551261|NCT01177397|458985752|FG002|Overall Study|Adverse Event|1|||
127551262|NCT01177397|458985753|FG003|Overall Study|Adverse Event|2|||
127685192|NCT04425629|459473275|FG012|Overall Study|Physician Decision|1|||
127685193|NCT04425629|459473276|FG013|Overall Study|Physician Decision|0|||
127685194|NCT04425629|459473277|FG014|Overall Study|Physician Decision|0|||
127685195|NCT04425629|459473278|FG015|Overall Study|Physician Decision|1|||
127685196|NCT04425629|459473279|FG016|Overall Study|Physician Decision|0|||
127685197|NCT04425629|459473280|FG017|Overall Study|Physician Decision|0|||
127685198|NCT04425629|459473281|FG018|Overall Study|Physician Decision|0|||
127685199|NCT04425629|459473263|FG000|Overall Study|Lack of Efficacy|0|||
127685200|NCT04425629|459473264|FG001|Overall Study|Lack of Efficacy|0|||
127685201|NCT04425629|459473265|FG002|Overall Study|Lack of Efficacy|0|||
127685202|NCT04425629|459473266|FG003|Overall Study|Lack of Efficacy|0|||
127685203|NCT04425629|459473267|FG004|Overall Study|Lack of Efficacy|0|||
127685204|NCT04425629|459473268|FG005|Overall Study|Lack of Efficacy|0|||
127685205|NCT04425629|459473269|FG006|Overall Study|Lack of Efficacy|0|||
127685206|NCT04425629|459473270|FG007|Overall Study|Lack of Efficacy|0|||
127685207|NCT04425629|459473271|FG008|Overall Study|Lack of Efficacy|0|||
127685208|NCT04425629|459473272|FG009|Overall Study|Lack of Efficacy|0|||
127685209|NCT04425629|459473273|FG010|Overall Study|Lack of Efficacy|1|||
127685210|NCT04425629|459473274|FG011|Overall Study|Lack of Efficacy|0|||
127685211|NCT04425629|459473275|FG012|Overall Study|Lack of Efficacy|0|||
127685212|NCT04425629|459473276|FG013|Overall Study|Lack of Efficacy|0|||
127685213|NCT04425629|459473277|FG014|Overall Study|Lack of Efficacy|0|||
127685214|NCT04425629|459473278|FG015|Overall Study|Lack of Efficacy|0|||
127685215|NCT04425629|459473279|FG016|Overall Study|Lack of Efficacy|0|||
127685216|NCT04425629|459473280|FG017|Overall Study|Lack of Efficacy|0|||
127685217|NCT04425629|459473281|FG018|Overall Study|Lack of Efficacy|0|||
127685218|NCT00610649|459473283|FG000|Overall Study|Adverse Event|1|||
127685219|NCT00610649|459473284|FG001|Overall Study|Adverse Event|0|||
127685220|NCT00610649|459473285|FG002|Overall Study|Adverse Event|0|||
127685221|NCT00610649|459473286|FG003|Overall Study|Adverse Event|0|||
127685222|NCT00610649|459473287|FG004|Overall Study|Adverse Event|0|||
127685223|NCT00610649|459473288|FG005|Overall Study|Adverse Event|0|||
127685224|NCT00610649|459473289|FG006|Overall Study|Adverse Event|0|||
127685225|NCT00610649|459473290|FG007|Overall Study|Adverse Event|0|||
127685226|NCT00610649|459473291|FG008|Overall Study|Adverse Event|0|||
127685227|NCT00610649|459473292|FG009|Overall Study|Adverse Event|0|||
127685228|NCT00610649|459473293|FG010|Overall Study|Adverse Event|1|||
127685229|NCT00610649|459473283|FG000|Overall Study|Family Emergency|0|||
127685230|NCT00610649|459473284|FG001|Overall Study|Family Emergency|1|||
127685231|NCT00610649|459473285|FG002|Overall Study|Family Emergency|0|||
127685232|NCT00610649|459473286|FG003|Overall Study|Family Emergency|0|||
127685233|NCT00610649|459473287|FG004|Overall Study|Family Emergency|0|||
127685234|NCT00610649|459473288|FG005|Overall Study|Family Emergency|0|||
127685235|NCT00610649|459473289|FG006|Overall Study|Family Emergency|0|||
127685236|NCT00610649|459473290|FG007|Overall Study|Family Emergency|0|||
127685237|NCT00610649|459473291|FG008|Overall Study|Family Emergency|0|||
127685238|NCT00610649|459473292|FG009|Overall Study|Family Emergency|0|||
127685239|NCT00610649|459473293|FG010|Overall Study|Family Emergency|0|||
127551263|NCT01177397|458985754|FG004|Overall Study|Adverse Event|0|||
127551264|NCT01177397|458985755|FG005|Overall Study|Adverse Event|12|||
127551265|NCT01177397|458985756|FG006|Overall Study|Adverse Event|1|||
127551266|NCT01177397|458985757|FG007|Overall Study|Adverse Event|14|||
127685240|NCT00610649|459473283|FG000|Overall Study|Withdrawal by Subject|0|||
127685241|NCT00610649|459473284|FG001|Overall Study|Withdrawal by Subject|0|||
127685242|NCT00610649|459473285|FG002|Overall Study|Withdrawal by Subject|0|||
127685243|NCT00610649|459473286|FG003|Overall Study|Withdrawal by Subject|0|||
127685244|NCT00610649|459473287|FG004|Overall Study|Withdrawal by Subject|0|||
127685245|NCT00610649|459473288|FG005|Overall Study|Withdrawal by Subject|0|||
127685246|NCT00610649|459473289|FG006|Overall Study|Withdrawal by Subject|0|||
127551267|NCT01177397|458985758|FG008|Overall Study|Adverse Event|8|||
127551268|NCT01177397|458985759|FG009|Overall Study|Adverse Event|6|||
127551269|NCT01177397|458985760|FG010|Overall Study|Adverse Event|3|||
127685247|NCT00610649|459473290|FG007|Overall Study|Withdrawal by Subject|0|||
127685248|NCT00610649|459473291|FG008|Overall Study|Withdrawal by Subject|0|||
127772144|NCT00971243|459790433|FG000|Open-label Period|Other reason|0|||
127772145|NCT00971243|459790434|FG001|Open-label Period|Other reason|0|||
127772146|NCT00971243|459790435|FG002|Open-label Period|Other reason|0|||
127772147|NCT00971243|459790436|FG003|Open-label Period|Other reason|0|||
127772148|NCT00971243|459790437|FG004|Open-label Period|Other reason|2|||
127772149|NCT00026208|459790440|FG000|Overall Study|Complications of auto accident|1|||
127772150|NCT00026208|459790441|FG001|Overall Study|Complications of auto accident|0|||
127772151|NCT05266586|459790442|FG000|Overall Study|Adverse Event|2|||
127772152|NCT05266586|459790443|FG001|Overall Study|Adverse Event|2|||
127772153|NCT05266586|459790444|FG002|Overall Study|Adverse Event|1|||
127772154|NCT05266586|459790442|FG000|Overall Study|Withdrawal by Subject|1|||
127772155|NCT05266586|459790443|FG001|Overall Study|Withdrawal by Subject|0|||
127772156|NCT05266586|459790444|FG002|Overall Study|Withdrawal by Subject|1|||
127772157|NCT05266586|459790442|FG000|Overall Study|Non-compliance with study drug|0|||
127772158|NCT05266586|459790443|FG001|Overall Study|Non-compliance with study drug|1|||
127772159|NCT05266586|459790444|FG002|Overall Study|Non-compliance with study drug|0|||
127772160|NCT05266586|459790442|FG000|Overall Study|Subject unable to adhere to all protocol requirements|1|||
127772161|NCT05266586|459790443|FG001|Overall Study|Subject unable to adhere to all protocol requirements|0|||
127772162|NCT05266586|459790444|FG002|Overall Study|Subject unable to adhere to all protocol requirements|0|||
127772163|NCT02225353|459790445|FG000|Overall Study|Lost to Follow-up|0|||
127772164|NCT02225353|459790446|FG001|Overall Study|Lost to Follow-up|1|||
127772165|NCT02225353|459790447|FG002|Overall Study|Lost to Follow-up|3|||
127772166|NCT02225353|459790445|FG000|Overall Study|Protocol Violation|4|||
127772167|NCT02225353|459790446|FG001|Overall Study|Protocol Violation|5|||
127772168|NCT02225353|459790447|FG002|Overall Study|Protocol Violation|12|||
127772169|NCT03604523|459790448|FG000|Overall Study|Physician Decision|1|||
127772170|NCT03604523|459790449|FG001|Overall Study|Physician Decision|0|||
127772171|NCT02730598|459790455|FG000|Overall Study|Withdrawal by Subject|3|||
127772172|NCT02730598|459790456|FG001|Overall Study|Withdrawal by Subject|3|||
127772173|NCT02730598|459790455|FG000|Overall Study|Protocol Violation|0|||
127772174|NCT02730598|459790456|FG001|Overall Study|Protocol Violation|1|||
127772175|NCT02730598|459790455|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
127772176|NCT02730598|459790456|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
127772177|NCT01675479|459790457|FG000|Overall Study|Lost to Follow-up|11|||
127772178|NCT01340651|459790459|FG000|Overall Study|Adverse Event|3|||
127772179|NCT01340651|459790459|FG000|Overall Study|Consent Withdrawn|2|||
127772180|NCT01340651|459790459|FG000|Overall Study|Commercial Supply per Sponsor|12|||
127772181|NCT01696942|459790464|FG000|Overall Study|Withdrawal by Subject|1|||
127772182|NCT01696942|459790465|FG001|Overall Study|Withdrawal by Subject|0|||
127772183|NCT01696942|459790464|FG000|Overall Study|Protocol Violation|1|||
127772184|NCT01696942|459790465|FG001|Overall Study|Protocol Violation|2|||
127772185|NCT01696942|459790464|FG000|Overall Study|screen failure|0|||
127772186|NCT01696942|459790465|FG001|Overall Study|screen failure|1|||
127772187|NCT00688103|459790466|FG000|Overall Study|Adverse Event|4|||
127772188|NCT00688103|459790467|FG001|Overall Study|Adverse Event|1|||
128017201|NCT00980460|460685602|FG001|Overall Study|Withdrawal by Subject|0|||
128017202|NCT00980460|460685603|FG002|Overall Study|Withdrawal by Subject|1|||
128017203|NCT00980460|460685604|FG003|Overall Study|Withdrawal by Subject|0|||
128017204|NCT00980460|460685605|FG004|Overall Study|Withdrawal by Subject|0|||
128017205|NCT00980460|460685601|FG000|Overall Study|Ineligible|0|||
128017206|NCT00980460|460685602|FG001|Overall Study|Ineligible|2|||
128017207|NCT00980460|460685603|FG002|Overall Study|Ineligible|3|||
128017208|NCT00980460|460685604|FG003|Overall Study|Ineligible|1|||
128017209|NCT00980460|460685605|FG004|Overall Study|Ineligible|4|||
128017210|NCT00980460|460685601|FG000|Overall Study|Refusal of further therapy|0|||
127772189|NCT00688103|459790466|FG000|Overall Study|Lack of Efficacy|11|||
127772190|NCT00688103|459790467|FG001|Overall Study|Lack of Efficacy|1|||
128017211|NCT00980460|460685602|FG001|Overall Study|Refusal of further therapy|2|||
128017212|NCT00980460|460685603|FG002|Overall Study|Refusal of further therapy|3|||
128017213|NCT00980460|460685604|FG003|Overall Study|Refusal of further therapy|2|||
128017214|NCT00980460|460685605|FG004|Overall Study|Refusal of further therapy|0|||
128017215|NCT00980460|460685601|FG000|Overall Study|No therapy within 42 days of resection|0|||
128017216|NCT00980460|460685602|FG001|Overall Study|No therapy within 42 days of resection|0|||
128017217|NCT00980460|460685603|FG002|Overall Study|No therapy within 42 days of resection|3|||
128017218|NCT00980460|460685604|FG003|Overall Study|No therapy within 42 days of resection|1|||
128017219|NCT00980460|460685605|FG004|Overall Study|No therapy within 42 days of resection|0|||
128017220|NCT00980460|460685601|FG000|Overall Study|No transplant by protocol timepoints|0|||
127772191|NCT00688103|459790466|FG000|Overall Study|Withdrawal by Subject|4|||
127772192|NCT00688103|459790467|FG001|Overall Study|Withdrawal by Subject|2|||
127772193|NCT00688103|459790466|FG000|Overall Study|complex reasons|11|||
127772194|NCT00688103|459790467|FG001|Overall Study|complex reasons|9|||
127772195|NCT01313117|459790468|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
127772196|NCT01313117|459790468|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
127772197|NCT01101477|459793553|FG000|Overall Study|Protocol Violation|5|||
127772198|NCT01101477|459793554|FG001|Overall Study|Protocol Violation|3|||
127551270|NCT01177397|458985761|FG011|Overall Study|Adverse Event|7|||
127551271|NCT01177397|458985750|FG000|Overall Study|Disease progression|1|||
127551272|NCT01177397|458985751|FG001|Overall Study|Disease progression|2|||
127685249|NCT00610649|459473292|FG009|Overall Study|Withdrawal by Subject|1|||
127685250|NCT00610649|459473293|FG010|Overall Study|Withdrawal by Subject|0|||
127685251|NCT00414544|459473296|FG000|Overall Study|Lost to Follow-up|14|||
127685252|NCT02271854|459473298|FG000|Overall Study|Withdrawal by Subject|2|||
127685253|NCT02271854|459473298|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
127685254|NCT02271854|459473298|FG000|Overall Study|Lost to Follow-up|1|||
127685255|NCT02529995|459473299|FG000|Part A|Ongoing Study at Data Cut-off|14|||
127685256|NCT02529995|459473300|FG001|Part A|Ongoing Study at Data Cut-off|16|||
127685257|NCT02529995|459473299|FG000|Part A|Discontinued Study|1|||
127685258|NCT02529995|459473300|FG001|Part A|Discontinued Study|0|||
127685259|NCT02529995|459473299|FG000|Part B|Ongoing Study at Data Cut-off|0|||
127685260|NCT02529995|459473300|FG001|Part B|Ongoing Study at Data Cut-off|7|||
127685261|NCT02529995|459473299|FG000|Part B|Discontinued Study|6|||
127685262|NCT02529995|459473300|FG001|Part B|Discontinued Study|5|||
127685263|NCT01236001|459473302|FG000|Overall Study|Adverse Event|5|||
127685264|NCT01236001|459473303|FG001|Overall Study|Adverse Event|14|||
127685265|NCT01236001|459473302|FG000|Overall Study|Lack of Efficacy|6|||
127685266|NCT01236001|459473303|FG001|Overall Study|Lack of Efficacy|6|||
127685267|NCT01236001|459473302|FG000|Overall Study|Lost to Follow-up|6|||
127685268|NCT01236001|459473303|FG001|Overall Study|Lost to Follow-up|1|||
127685269|NCT01236001|459473302|FG000|Overall Study|Incompliance|1|||
127685270|NCT01236001|459473303|FG001|Overall Study|Incompliance|0|||
127685271|NCT01236001|459473302|FG000|Overall Study|Planned Visit After End of Study|0|||
127685272|NCT01236001|459473303|FG001|Overall Study|Planned Visit After End of Study|1|||
127685273|NCT01943916|459473305|FG000|Overall Study|Technically invalid images|10|||
127685274|NCT01943916|459473305|FG000|Overall Study|Enrollment Failure|23|||
127685275|NCT01943916|459473305|FG000|Overall Study|Pilot Phase exclusion|100|||
127685276|NCT01943916|459473305|FG000|Overall Study|Quality Assurance Reader Fail|130|||
127685277|NCT01943916|459473305|FG000|Overall Study|Technical Failure|39|||
127685278|NCT01943916|459473305|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
127685279|NCT01943916|459473305|FG000|Overall Study|No Truth Panel Review|38|||
127685280|NCT01943916|459473305|FG000|Overall Study|Protocol Deviation|1|||
127685281|NCT05274217|459473306|FG000|Overall Study|Study terminated.|11|||
127685282|NCT05274217|459473307|FG001|Overall Study|Study terminated.|0|||
127685283|NCT02261467|459473308|FG000|Overall Study|Enrolled in Error|1|||
127685284|NCT02261467|459473309|FG001|Overall Study|Enrolled in Error|0|||
127685285|NCT02261467|459473308|FG000|Overall Study|Protocol Violation|0|||
127685286|NCT02261467|459473309|FG001|Overall Study|Protocol Violation|1|||
127685287|NCT02261467|459473308|FG000|Overall Study|Personal Reasons|17|||
127685288|NCT02261467|459473309|FG001|Overall Study|Personal Reasons|22|||
127685289|NCT02261467|459473308|FG000|Overall Study|Lost to Follow-up|2|||
127685290|NCT02261467|459473309|FG001|Overall Study|Lost to Follow-up|13|||
127685291|NCT02261467|459473308|FG000|Overall Study|Adverse Event|1|||
127685292|NCT02261467|459473309|FG001|Overall Study|Adverse Event|1|||
127685293|NCT01787760|459473311|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
127685294|NCT01787760|459473312|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
127685295|NCT01787760|459473313|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
127685296|NCT01787760|459473311|FG000|Overall Study|Decompensated on left exotropia|0|||
127685297|NCT01787760|459473312|FG001|Overall Study|Decompensated on left exotropia|0|||
127685298|NCT01787760|459473313|FG002|Overall Study|Decompensated on left exotropia|1|||
127685299|NCT01787760|459473311|FG000|Overall Study|Dryness|0|||
127685300|NCT01787760|459473312|FG001|Overall Study|Dryness|1|||
127685301|NCT01787760|459473313|FG002|Overall Study|Dryness|0|||
127685302|NCT01787760|459473311|FG000|Overall Study|Relocation|1|||
127685303|NCT01787760|459473312|FG001|Overall Study|Relocation|1|||
127685304|NCT01787760|459473313|FG002|Overall Study|Relocation|0|||
127685305|NCT01787760|459473311|FG000|Overall Study|Lens discomfort|3|||
127685306|NCT01787760|459473312|FG001|Overall Study|Lens discomfort|0|||
127685307|NCT01787760|459473313|FG002|Overall Study|Lens discomfort|0|||
127685308|NCT01787760|459473311|FG000|Overall Study|Lens handling difficulty|1|||
127685309|NCT01787760|459473312|FG001|Overall Study|Lens handling difficulty|2|||
127685310|NCT01787760|459473313|FG002|Overall Study|Lens handling difficulty|0|||
127685311|NCT01787760|459473311|FG000|Overall Study|Protocol Violation|6|||
127685312|NCT01787760|459473312|FG001|Overall Study|Protocol Violation|0|||
127685313|NCT01787760|459473313|FG002|Overall Study|Protocol Violation|1|||
127685314|NCT01787760|459473311|FG000|Overall Study|Withdrawal by Subject|5|||
127685315|NCT01787760|459473312|FG001|Overall Study|Withdrawal by Subject|1|||
127685316|NCT01787760|459473313|FG002|Overall Study|Withdrawal by Subject|2|||
127685317|NCT01787760|459473311|FG000|Overall Study|Lost to Follow-up|1|||
127685318|NCT01787760|459473312|FG001|Overall Study|Lost to Follow-up|0|||
127685319|NCT01787760|459473313|FG002|Overall Study|Lost to Follow-up|1|||
127685320|NCT01787760|459473311|FG000|Overall Study|Stroke|1|||
127685321|NCT01787760|459473312|FG001|Overall Study|Stroke|0|||
127685322|NCT01787760|459473313|FG002|Overall Study|Stroke|0|||
127685323|NCT01787760|459473311|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
127772199|NCT01101477|459793555|FG002|Overall Study|Protocol Violation|1|||
127551273|NCT01177397|458985752|FG002|Overall Study|Disease progression|5|||
127551274|NCT01177397|458985753|FG003|Overall Study|Disease progression|5|||
127551275|NCT01177397|458985754|FG004|Overall Study|Disease progression|4|||
127551276|NCT01177397|458985755|FG005|Overall Study|Disease progression|10|||
127551277|NCT01177397|458985756|FG006|Overall Study|Disease progression|10|||
127551278|NCT01177397|458985757|FG007|Overall Study|Disease progression|21|||
127551279|NCT01177397|458985758|FG008|Overall Study|Disease progression|18|||
127551280|NCT01177397|458985759|FG009|Overall Study|Disease progression|12|||
127551281|NCT01177397|458985760|FG010|Overall Study|Disease progression|10|||
127551282|NCT01177397|458985761|FG011|Overall Study|Disease progression|8|||
127551283|NCT01177397|458985750|FG000|Overall Study|Other reasons|0|||
127551284|NCT01177397|458985751|FG001|Overall Study|Other reasons|0|||
127551285|NCT01177397|458985752|FG002|Overall Study|Other reasons|1|||
127551286|NCT01177397|458985753|FG003|Overall Study|Other reasons|0|||
127551287|NCT01177397|458985754|FG004|Overall Study|Other reasons|1|||
127551288|NCT01177397|458985755|FG005|Overall Study|Other reasons|1|||
127551289|NCT01177397|458985756|FG006|Overall Study|Other reasons|2|||
127551290|NCT01177397|458985757|FG007|Overall Study|Other reasons|6|||
127551291|NCT01177397|458985758|FG008|Overall Study|Other reasons|10|||
127551292|NCT01177397|458985759|FG009|Overall Study|Other reasons|8|||
127551293|NCT01177397|458985760|FG010|Overall Study|Other reasons|0|||
127551294|NCT01177397|458985761|FG011|Overall Study|Other reasons|2|||
127551295|NCT02395471|458985762|FG000|Overall Study|Lost to Follow-up|2|||
127551296|NCT02395471|458985763|FG001|Overall Study|Lost to Follow-up|0|||
127551297|NCT02395471|458985762|FG000|Overall Study|Withdrawal by Subject|2|||
127551298|NCT02395471|458985763|FG001|Overall Study|Withdrawal by Subject|1|||
127772200|NCT02382016|459793556|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
127772201|NCT02382016|459793557|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
127772202|NCT02382016|459793556|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
127772203|NCT02382016|459793557|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
127772204|NCT02382016|459793556|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
127772205|NCT02382016|459793557|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
127772206|NCT02382016|459793556|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
127772207|NCT02382016|459793557|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
127772208|NCT02382016|459793556|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
127772209|NCT02382016|459793557|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
127772210|NCT02382016|459793556|FG000|Open-label (OL) Treatment Period|Death|4|||
127772211|NCT02382016|459793557|FG001|Open-label (OL) Treatment Period|Death|0|||
127772212|NCT02382016|459793556|FG000|OL Extension Period|Physician Decision|3|||
127772213|NCT02382016|459793557|FG001|OL Extension Period|Physician Decision|0|||
127772214|NCT02382016|459793556|FG000|OL Extension Period|Death|2|||
127772215|NCT02382016|459793557|FG001|OL Extension Period|Death|0|||
127772216|NCT02382016|459793556|FG000|OL Extension Period|Withdrawal by Subject|1|||
127772217|NCT02382016|459793557|FG001|OL Extension Period|Withdrawal by Subject|0|||
127772218|NCT00084266|459793558|FG000|Overall Study|Death|42|||
127772219|NCT00084266|459793559|FG001|Overall Study|Death|39|||
127772220|NCT00084266|459793558|FG000|Overall Study|Adverse Event|8|||
127772221|NCT00084266|459793559|FG001|Overall Study|Adverse Event|5|||
127772222|NCT00084266|459793558|FG000|Overall Study|Lack of Efficacy|2|||
127772223|NCT00084266|459793559|FG001|Overall Study|Lack of Efficacy|4|||
127772224|NCT00084266|459793558|FG000|Overall Study|Lost to Follow-up|5|||
127772225|NCT00084266|459793559|FG001|Overall Study|Lost to Follow-up|3|||
127772226|NCT00084266|459793558|FG000|Overall Study|Participant not willing to participate|3|||
127772227|NCT00084266|459793559|FG001|Overall Study|Participant not willing to participate|8|||
127772228|NCT00084266|459793558|FG000|Overall Study|Other|360|||
127772229|NCT00084266|459793559|FG001|Overall Study|Other|344|||
127772230|NCT00084266|459793558|FG000|Overall Study|Randomized not treated|21|||
127772231|NCT00084266|459793559|FG001|Overall Study|Randomized not treated|20|||
127772232|NCT00730171|459793560|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
128017221|NCT00980460|460685602|FG001|Overall Study|No transplant by protocol timepoints|0|||
127551299|NCT02395471|458985762|FG000|Overall Study|Physician Decision|1|||
127551300|NCT02395471|458985763|FG001|Overall Study|Physician Decision|0|||
127551301|NCT02395471|458985762|FG000|Overall Study|Protocol Violation|0|||
127551302|NCT02395471|458985763|FG001|Overall Study|Protocol Violation|1|||
127551303|NCT02395471|458985762|FG000|Overall Study|Failure to swollow sponge twice|1|||
127551304|NCT02395471|458985763|FG001|Overall Study|Failure to swollow sponge twice|0|||
127551305|NCT02395471|458985762|FG000|Overall Study|Patient did not return for procedure|0|||
127551306|NCT02395471|458985763|FG001|Overall Study|Patient did not return for procedure|1|||
127772233|NCT00730171|459793560|FG000|Overall Study|Adverse Event|193|||
127772234|NCT00730171|459793560|FG000|Overall Study|Protocol Violation|48|||
127772235|NCT00730171|459793560|FG000|Overall Study|Withdrawal by Subject|202|||
127772236|NCT00730171|459793560|FG000|Overall Study|Lost to Follow-up|121|||
127772237|NCT00730171|459793560|FG000|Overall Study|Insufficient Therapeutic Response|141|||
127772238|NCT00730171|459793560|FG000|Overall Study|Other|61|||
127772239|NCT01729156|459793561|FG000|Overall Study|Withdrawal by Subject|1|||
127772240|NCT01729156|459793562|FG001|Overall Study|Withdrawal by Subject|0|||
128017222|NCT00980460|460685603|FG002|Overall Study|No transplant by protocol timepoints|3|||
128017223|NCT00980460|460685604|FG003|Overall Study|No transplant by protocol timepoints|0|||
128017224|NCT00980460|460685605|FG004|Overall Study|No transplant by protocol timepoints|0|||
128017225|NCT00690898|460686540|FG000|SCREENING|Screen failure|18|||
128017226|NCT00690898|460686540|FG000|TREATMENT|Adverse Event|3|||
128017227|NCT00690898|460686540|FG000|TREATMENT|Lack of Efficacy|18|||
128017228|NCT00690898|460686540|FG000|TREATMENT|Withdrawal by Subject|4|||
128017229|NCT00690898|460686540|FG000|TREATMENT|Other (not otherwise specified)|1|||
127551307|NCT02395471|458985762|FG000|Overall Study|Subject not eligible|1|||
127551308|NCT02395471|458985763|FG001|Overall Study|Subject not eligible|0|||
127685324|NCT01787760|459473312|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
127685325|NCT01787760|459473313|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
127685326|NCT01787760|459473311|FG000|Overall Study|Unsatisfactory physiological response|2|||
127685327|NCT01787760|459473312|FG001|Overall Study|Unsatisfactory physiological response|4|||
127685328|NCT01787760|459473313|FG002|Overall Study|Unsatisfactory physiological response|0|||
127685329|NCT01787760|459473311|FG000|Overall Study|Unsatisfactory visual response|1|||
127685330|NCT01787760|459473312|FG001|Overall Study|Unsatisfactory visual response|1|||
127685331|NCT01787760|459473313|FG002|Overall Study|Unsatisfactory visual response|0|||
127685332|NCT01787760|459473311|FG000|Overall Study|Near vision blur|1|||
127685333|NCT01787760|459473312|FG001|Overall Study|Near vision blur|0|||
127685334|NCT01787760|459473313|FG002|Overall Study|Near vision blur|0|||
127685335|NCT03512756|459473314|FG000|Part 1|Death|23|||
127685336|NCT03512756|459473315|FG001|Part 1|Death|18|||
127685337|NCT03512756|459473316|FG002|Part 1|Death|0|||
127685338|NCT03512756|459473317|FG003|Part 1|Death|0|||
127685339|NCT03512756|459473314|FG000|Part 1|Lost to Follow-up|0|||
127685340|NCT03512756|459473315|FG001|Part 1|Lost to Follow-up|3|||
127685341|NCT03512756|459473316|FG002|Part 1|Lost to Follow-up|0|||
127685342|NCT03512756|459473317|FG003|Part 1|Lost to Follow-up|0|||
127685343|NCT03512756|459473314|FG000|Part 1|Physician Decision|0|||
127685344|NCT03512756|459473315|FG001|Part 1|Physician Decision|1|||
127685345|NCT03512756|459473316|FG002|Part 1|Physician Decision|0|||
127685346|NCT03512756|459473317|FG003|Part 1|Physician Decision|0|||
127685347|NCT03512756|459473314|FG000|Part 1|Withdrawal by Subject|2|||
127685348|NCT03512756|459473315|FG001|Part 1|Withdrawal by Subject|2|||
127685349|NCT03512756|459473316|FG002|Part 1|Withdrawal by Subject|0|||
127685350|NCT03512756|459473317|FG003|Part 1|Withdrawal by Subject|0|||
127685351|NCT03512756|459473314|FG000|Part 2|Death|0|||
127685352|NCT03512756|459473315|FG001|Part 2|Death|0|||
127685353|NCT03512756|459473316|FG002|Part 2|Death|32|||
127685354|NCT03512756|459473317|FG003|Part 2|Death|21|||
127685355|NCT03512756|459473314|FG000|Part 2|Lost to Follow-up|0|||
127685356|NCT03512756|459473315|FG001|Part 2|Lost to Follow-up|0|||
127685357|NCT03512756|459473316|FG002|Part 2|Lost to Follow-up|1|||
127685358|NCT03512756|459473317|FG003|Part 2|Lost to Follow-up|0|||
127685359|NCT03512756|459473314|FG000|Part 2|Physician Decision|0|||
127685360|NCT03512756|459473315|FG001|Part 2|Physician Decision|0|||
127685361|NCT03512756|459473316|FG002|Part 2|Physician Decision|2|||
127685362|NCT03512756|459473317|FG003|Part 2|Physician Decision|4|||
127685363|NCT03512756|459473314|FG000|Part 2|Study Terminated by Sponsor|0|||
127685364|NCT03512756|459473315|FG001|Part 2|Study Terminated by Sponsor|0|||
127685365|NCT03512756|459473316|FG002|Part 2|Study Terminated by Sponsor|2|||
127685366|NCT03512756|459473317|FG003|Part 2|Study Terminated by Sponsor|6|||
127685367|NCT03512756|459473314|FG000|Part 2|Protocol Violation|0|||
127685368|NCT03512756|459473315|FG001|Part 2|Protocol Violation|0|||
127685369|NCT03512756|459473316|FG002|Part 2|Protocol Violation|1|||
127685370|NCT03512756|459473317|FG003|Part 2|Protocol Violation|0|||
127685371|NCT03512756|459473314|FG000|Part 2|Withdrawal by Subject|0|||
127685372|NCT03512756|459473315|FG001|Part 2|Withdrawal by Subject|0|||
127685373|NCT03512756|459473316|FG002|Part 2|Withdrawal by Subject|3|||
127685374|NCT03512756|459473317|FG003|Part 2|Withdrawal by Subject|9|||
127685375|NCT00736853|459473318|FG000|Open-Label Period|Physician Decision|2|||
127685376|NCT00736853|459473319|FG001|Open-Label Period|Physician Decision|0|||
127685377|NCT00736853|459473320|FG002|Open-Label Period|Physician Decision|0|||
127685378|NCT00736853|459473318|FG000|Open-Label Period|Adverse Event|31|||
127685379|NCT00736853|459473319|FG001|Open-Label Period|Adverse Event|0|||
127685380|NCT00736853|459473320|FG002|Open-Label Period|Adverse Event|0|||
127685381|NCT00736853|459473318|FG000|Open-Label Period|Withdrawal by Subject|16|||
127685382|NCT00736853|459473319|FG001|Open-Label Period|Withdrawal by Subject|0|||
127685383|NCT00736853|459473320|FG002|Open-Label Period|Withdrawal by Subject|0|||
127685384|NCT00736853|459473318|FG000|Open-Label Period|Started but not treated|42|||
127685385|NCT00736853|459473319|FG001|Open-Label Period|Started but not treated|0|||
127685386|NCT00736853|459473320|FG002|Open-Label Period|Started but not treated|0|||
127685387|NCT00736853|459473318|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
127551309|NCT00118417|458985764|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
127685388|NCT00736853|459473319|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
127685389|NCT00736853|459473320|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
127685390|NCT00736853|459473318|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
127685391|NCT00736853|459473319|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
127772241|NCT01729156|459793563|FG002|Overall Study|Withdrawal by Subject|0|||
127772242|NCT02544217|459793564|FG000|Overall Study|Withdrawal by Subject|1|||
127772243|NCT02544217|459793565|FG001|Overall Study|Withdrawal by Subject|1|||
127772244|NCT02544217|459793566|FG002|Overall Study|Withdrawal by Subject|0|||
127772245|NCT02544217|459793567|FG003|Overall Study|Withdrawal by Subject|0|||
127772246|NCT02544217|459793568|FG004|Overall Study|Withdrawal by Subject|0|||
127772247|NCT02544217|459793569|FG005|Overall Study|Withdrawal by Subject|0|||
127772248|NCT02901041|459793572|FG000|Overall Study|Withdrawal by PI|4|||
127772249|NCT02901041|459793573|FG001|Overall Study|Withdrawal by PI|8|||
127772250|NCT02901041|459793572|FG000|Overall Study|Withdrawal by Subject|7|||
127772251|NCT02901041|459793573|FG001|Overall Study|Withdrawal by Subject|3|||
127772252|NCT00975507|459793577|FG000|Overall Study|Adverse Event|1|||
127772253|NCT00975507|459793578|FG001|Overall Study|Adverse Event|0|||
127772254|NCT00975507|459793577|FG000|Overall Study|Lost to Follow-up|7|||
127772255|NCT00975507|459793578|FG001|Overall Study|Lost to Follow-up|1|||
127772256|NCT00975507|459793577|FG000|Overall Study|Protocol Violation|2|||
127772257|NCT00975507|459793578|FG001|Overall Study|Protocol Violation|0|||
127772258|NCT00975507|459793577|FG000|Overall Study|Withdrawal by Subject|10|||
127772259|NCT00975507|459793578|FG001|Overall Study|Withdrawal by Subject|3|||
127772260|NCT01112306|459793581|FG000|Overall Study|Death|175|||
127772261|NCT01112306|459793581|FG000|Overall Study|Lost to Follow-up|9|||
127772262|NCT01112306|459793581|FG000|Overall Study|Withdrawal by Subject|31|||
127772263|NCT01112306|459793581|FG000|Overall Study|Other|70|||
127772264|NCT03952806|459793583|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
127772265|NCT03952806|459793584|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
127772266|NCT03952806|459793583|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
127772267|NCT03952806|459793584|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
127772268|NCT03952806|459793583|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
127772269|NCT03952806|459793584|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
127772270|NCT03952806|459793583|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
127772271|NCT03952806|459793584|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
127772272|NCT03952806|459793583|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
127772273|NCT03952806|459793584|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
127772274|NCT03952806|459793583|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
127772275|NCT03952806|459793584|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
127772276|NCT03952806|459793583|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
127772277|NCT03952806|459793584|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
127772278|NCT03952806|459793583|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
127772279|NCT03952806|459793584|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
127772280|NCT03952806|459793583|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
127772281|NCT03952806|459793584|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
127772282|NCT03952806|459793583|FG000|OLE Phase (48 Weeks)|Other|16|||
127772283|NCT03952806|459793584|FG001|OLE Phase (48 Weeks)|Other|13|||
127772284|NCT00655863|459793585|FG000|Overall Study|Lost to Follow-up|0|||
127772285|NCT00655863|459793586|FG001|Overall Study|Lost to Follow-up|0|||
127551310|NCT00118417|458985765|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
127551311|NCT00118417|458985764|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
127551312|NCT00118417|458985765|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
127551313|NCT00118417|458985764|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
127551314|NCT00118417|458985765|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
127551315|NCT00118417|458985764|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
127551316|NCT00118417|458985765|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
127772286|NCT00655863|459793587|FG002|Overall Study|Lost to Follow-up|1|||
127772287|NCT01138007|459793588|FG000|Overall Study|Adverse Event|4|||
127772288|NCT01138007|459793589|FG001|Overall Study|Adverse Event|12|||
127772289|NCT01138007|459793590|FG002|Overall Study|Adverse Event|9|||
127772290|NCT01138007|459793588|FG000|Overall Study|Lack of Efficacy|2|||
127772291|NCT01138007|459793589|FG001|Overall Study|Lack of Efficacy|0|||
127772292|NCT01138007|459793590|FG002|Overall Study|Lack of Efficacy|6|||
127772293|NCT01138007|459793588|FG000|Overall Study|Protocol Violation|2|||
127772294|NCT01138007|459793589|FG001|Overall Study|Protocol Violation|3|||
127772295|NCT01138007|459793590|FG002|Overall Study|Protocol Violation|2|||
127772296|NCT01138007|459793588|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
127772297|NCT01138007|459793589|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
127772298|NCT01138007|459793590|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
127772299|NCT01138007|459793588|FG000|Overall Study|Lost to Follow-up|3|||
127772300|NCT01138007|459793589|FG001|Overall Study|Lost to Follow-up|3|||
127551317|NCT00118417|458985764|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
127551318|NCT00118417|458985765|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
127772301|NCT01138007|459793590|FG002|Overall Study|Lost to Follow-up|5|||
127551319|NCT00785785|458985766|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
127772302|NCT01138007|459793588|FG000|Overall Study|Physician Decision|0|||
127772303|NCT01138007|459793589|FG001|Overall Study|Physician Decision|5|||
127772304|NCT01138007|459793590|FG002|Overall Study|Physician Decision|3|||
128017230|NCT02008370|460686543|FG000|Overall Study|Lost to Follow-up|7|||
127551320|NCT00785785|458985767|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
127551321|NCT00785785|458985766|FG000|Core Phase up to 36 Months|Adverse Event|31|||
127551322|NCT00785785|458985767|FG001|Core Phase up to 36 Months|Adverse Event|21|||
127551323|NCT00785785|458985766|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
127551324|NCT00785785|458985767|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
127551325|NCT00785785|458985766|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
127551326|NCT00785785|458985767|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
127551327|NCT00785785|458985766|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
127551328|NCT00785785|458985767|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
127551329|NCT00785785|458985766|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
127551330|NCT00785785|458985767|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
127551331|NCT00785785|458985766|FG000|Core Phase up to 36 Months|Administrative problems|3|||
127551332|NCT00785785|458985767|FG001|Core Phase up to 36 Months|Administrative problems|3|||
127551333|NCT00785785|458985766|FG000|Core Phase up to 36 Months|Death|5|||
127551334|NCT00785785|458985767|FG001|Core Phase up to 36 Months|Death|8|||
127551335|NCT00785785|458985766|FG000|Core Phase up to 36 Months|Disease progression|139|||
127551336|NCT00785785|458985767|FG001|Core Phase up to 36 Months|Disease progression|119|||
127551337|NCT00785785|458985766|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
127685392|NCT00736853|459473320|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
127685393|NCT00736853|459473318|FG000|Double-Blind Period|Lack of Efficacy|0|||
127772305|NCT01138007|459793588|FG000|Overall Study|Withdrawal by Subject|5|||
127772306|NCT01138007|459793589|FG001|Overall Study|Withdrawal by Subject|6|||
127772307|NCT01138007|459793590|FG002|Overall Study|Withdrawal by Subject|15|||
127772308|NCT04661878|459793591|FG000|Overall Study|Lost to Follow-up|6|||
127772309|NCT04661878|459793592|FG001|Overall Study|Lost to Follow-up|5|||
127685394|NCT00736853|459473319|FG001|Double-Blind Period|Lack of Efficacy|19|||
127685395|NCT00736853|459473320|FG002|Double-Blind Period|Lack of Efficacy|42|||
127685396|NCT00736853|459473318|FG000|Double-Blind Period|Adverse Event|0|||
127685397|NCT00736853|459473319|FG001|Double-Blind Period|Adverse Event|3|||
127685398|NCT00736853|459473320|FG002|Double-Blind Period|Adverse Event|2|||
127685399|NCT00736853|459473318|FG000|Double-Blind Period|Withdrawal by Subject|0|||
127685400|NCT00736853|459473319|FG001|Double-Blind Period|Withdrawal by Subject|1|||
127685401|NCT00736853|459473320|FG002|Double-Blind Period|Withdrawal by Subject|4|||
127685402|NCT00736853|459473318|FG000|Double-Blind Period|Ineligible to participate the study|0|||
127685403|NCT00736853|459473319|FG001|Double-Blind Period|Ineligible to participate the study|1|||
127685404|NCT00736853|459473320|FG002|Double-Blind Period|Ineligible to participate the study|0|||
127685405|NCT01041417|459473323|FG000|Overall Study|Adverse Event|5|||
127685406|NCT01041417|459473324|FG001|Overall Study|Adverse Event|2|||
127685407|NCT01041417|459473323|FG000|Overall Study|Lost to Follow-up|1|||
127685408|NCT01041417|459473324|FG001|Overall Study|Lost to Follow-up|1|||
127685409|NCT01041417|459473323|FG000|Overall Study|Death|1|||
127685410|NCT01041417|459473324|FG001|Overall Study|Death|0|||
127685411|NCT02299375|459473327|FG000|Overall Study|Adverse Event, serious fatal|1|||
127685412|NCT02299375|459473328|FG001|Overall Study|Adverse Event, serious fatal|3|||
127685413|NCT02299375|459473327|FG000|Overall Study|Adverse Event, non-fatal|8|||
127685414|NCT02299375|459473328|FG001|Overall Study|Adverse Event, non-fatal|9|||
127685415|NCT02299375|459473327|FG000|Overall Study|Lack of Efficacy|1|||
127685416|NCT02299375|459473328|FG001|Overall Study|Lack of Efficacy|3|||
127685417|NCT02299375|459473327|FG000|Overall Study|Protocol Violation|1|||
127685418|NCT02299375|459473328|FG001|Overall Study|Protocol Violation|3|||
127685419|NCT02299375|459473327|FG000|Overall Study|Other: Met stopping criteria|1|||
127685420|NCT02299375|459473328|FG001|Overall Study|Other: Met stopping criteria|0|||
127685421|NCT02299375|459473327|FG000|Overall Study|Other: Study closed/terminated|66|||
127685422|NCT02299375|459473328|FG001|Overall Study|Other: Study closed/terminated|55|||
127685423|NCT02299375|459473327|FG000|Overall Study|Lost to Follow-up|0|||
127685424|NCT02299375|459473328|FG001|Overall Study|Lost to Follow-up|2|||
127685425|NCT02299375|459473327|FG000|Overall Study|Physician Decision|1|||
127685426|NCT02299375|459473328|FG001|Overall Study|Physician Decision|1|||
127685427|NCT02299375|459473327|FG000|Overall Study|Withdrawal by Subject|1|||
127685428|NCT02299375|459473328|FG001|Overall Study|Withdrawal by Subject|4|||
127685429|NCT00704184|459473329|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
127685430|NCT00704184|459473330|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
127685431|NCT00704184|459473331|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
127685432|NCT00704184|459473332|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
127685433|NCT00704184|459473333|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
127551338|NCT00785785|458985767|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
127551339|NCT00785785|458985766|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
127551340|NCT00785785|458985767|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
127685434|NCT00704184|459473329|FG000|Open-Label Treatment|Adverse Event|0|||
127685435|NCT00704184|459473330|FG001|Open-Label Treatment|Adverse Event|0|||
127685436|NCT00704184|459473331|FG002|Open-Label Treatment|Adverse Event|2|||
127685437|NCT00704184|459473332|FG003|Open-Label Treatment|Adverse Event|0|||
127685438|NCT00704184|459473333|FG004|Open-Label Treatment|Adverse Event|1|||
127772310|NCT04442737|459793597|FG000|Overall Study|Lost to Follow-up|1|||
127772311|NCT04442737|459793598|FG001|Overall Study|Lost to Follow-up|3|||
127772312|NCT04442737|459793597|FG000|Overall Study|Withdrawal by Subject|3|||
127772313|NCT04442737|459793598|FG001|Overall Study|Withdrawal by Subject|2|||
127772314|NCT04442737|459793597|FG000|Overall Study|Adverse Event|3|||
127772315|NCT04442737|459793598|FG001|Overall Study|Adverse Event|2|||
127772316|NCT04442737|459793597|FG000|Overall Study|Death|0|||
127772317|NCT04442737|459793598|FG001|Overall Study|Death|1|||
127772318|NCT04442737|459793597|FG000|Overall Study|Protocol Violation|0|||
127772319|NCT04442737|459793598|FG001|Overall Study|Protocol Violation|2|||
127772320|NCT04442737|459793597|FG000|Overall Study|Other|1|||
127772321|NCT04442737|459793598|FG001|Overall Study|Other|1|||
127772322|NCT00744523|459793599|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
127772323|NCT00744523|459793600|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
127772324|NCT05333224|459793604|FG000|Overall Study - Infants|Lost to Follow-up|1|||
127772325|NCT05333224|459793605|FG001|Overall Study - Infants|Lost to Follow-up|1|||
127772326|NCT00063154|459793606|FG000|Overall Study|Disease progression|27|||
127772327|NCT00063154|459793606|FG000|Overall Study|Adverse Event|2|||
127772328|NCT00063154|459793606|FG000|Overall Study|Physician Decision|10|||
127772329|NCT00063154|459793606|FG000|Overall Study|Death|3|||
127772330|NCT00063154|459793606|FG000|Overall Study|Reason unspecified|1|||
127772331|NCT00063154|459793606|FG000|Overall Study|Did not receive treatment|8|||
127772332|NCT03588728|459793607|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
127772333|NCT03588728|459793608|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
127772334|NCT03588728|459793609|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
127772335|NCT03588728|459793610|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
127772336|NCT03588728|459793607|FG000|Overall Study|Lab shut down due to COVID-19|0|||
127772337|NCT03588728|459793608|FG001|Overall Study|Lab shut down due to COVID-19|0|||
127772338|NCT03588728|459793609|FG002|Overall Study|Lab shut down due to COVID-19|0|||
127772339|NCT03588728|459793610|FG003|Overall Study|Lab shut down due to COVID-19|1|||
127772340|NCT03588728|459793607|FG000|Overall Study|multiple technical issues|1|||
127772341|NCT03588728|459793608|FG001|Overall Study|multiple technical issues|0|||
127772342|NCT03588728|459793609|FG002|Overall Study|multiple technical issues|0|||
127772343|NCT03588728|459793610|FG003|Overall Study|multiple technical issues|0|||
127772344|NCT03588728|459793607|FG000|Overall Study|Hospitalized for COVID|1|||
127772345|NCT03588728|459793608|FG001|Overall Study|Hospitalized for COVID|0|||
127772346|NCT03588728|459793609|FG002|Overall Study|Hospitalized for COVID|0|||
127772347|NCT03588728|459793610|FG003|Overall Study|Hospitalized for COVID|0|||
127772348|NCT03588728|459793607|FG000|Overall Study|Schedule change unable to attend sessions|1|||
127772349|NCT03588728|459793608|FG001|Overall Study|Schedule change unable to attend sessions|0|||
127772350|NCT03588728|459793609|FG002|Overall Study|Schedule change unable to attend sessions|0|||
127772351|NCT03588728|459793610|FG003|Overall Study|Schedule change unable to attend sessions|0|||
127772352|NCT02027701|459793611|FG000|Overall Study|Adverse Event|3|||
127772353|NCT02027701|459793611|FG000|Overall Study|Lack of Efficacy|8|||
127772354|NCT02027701|459793611|FG000|Overall Study|Physician Decision|2|||
127772355|NCT02027701|459793611|FG000|Overall Study|Withdrawal by Subject|3|||
127772356|NCT03285178|459793612|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
127772357|NCT03285178|459793613|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
127772358|NCT03285178|459793614|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
127772359|NCT03285178|459793615|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
127772360|NCT03285178|459793616|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
127772361|NCT03285178|459793617|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
127772362|NCT03285178|459793618|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
127772363|NCT03285178|459793612|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
127772364|NCT03285178|459793613|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
127772365|NCT03285178|459793614|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
127772366|NCT03285178|459793615|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
127772367|NCT03285178|459793616|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
127772368|NCT03285178|459793617|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
127772369|NCT03285178|459793618|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
127772370|NCT03285178|459793612|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
127772371|NCT03285178|459793613|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
127772372|NCT03285178|459793614|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
127772373|NCT03285178|459793615|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
127772374|NCT03285178|459793616|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
127772375|NCT03285178|459793617|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
127772376|NCT03285178|459793618|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
127772377|NCT03285178|459793612|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
127772378|NCT03285178|459793613|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
127772379|NCT03285178|459793614|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
127772380|NCT03285178|459793615|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
127772381|NCT03285178|459793616|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
127772382|NCT03285178|459793617|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
127772383|NCT03285178|459793618|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
127772384|NCT03285178|459793612|FG000|Single-Blind Run-In Period|Physician Decision|2|||
127772385|NCT03285178|459793613|FG001|Single-Blind Run-In Period|Physician Decision|0|||
127772386|NCT03285178|459793614|FG002|Single-Blind Run-In Period|Physician Decision|0|||
127772387|NCT03285178|459793615|FG003|Single-Blind Run-In Period|Physician Decision|0|||
127772388|NCT03285178|459793616|FG004|Single-Blind Run-In Period|Physician Decision|0|||
127772389|NCT03285178|459793617|FG005|Single-Blind Run-In Period|Physician Decision|0|||
127772390|NCT03285178|459793618|FG006|Single-Blind Run-In Period|Physician Decision|0|||
127772391|NCT03285178|459793612|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
127772392|NCT03285178|459793613|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
127772393|NCT03285178|459793614|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
127772394|NCT03285178|459793615|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
127772395|NCT03285178|459793616|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
127772396|NCT03285178|459793617|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
127772397|NCT03285178|459793618|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
127772398|NCT03285178|459793612|FG000|Double-Blind Treatment Period|Adverse Event|0|||
127772399|NCT03285178|459793613|FG001|Double-Blind Treatment Period|Adverse Event|0|||
127772400|NCT03285178|459793614|FG002|Double-Blind Treatment Period|Adverse Event|0|||
127772401|NCT03285178|459793615|FG003|Double-Blind Treatment Period|Adverse Event|0|||
127772402|NCT03285178|459793616|FG004|Double-Blind Treatment Period|Adverse Event|0|||
127772403|NCT03285178|459793617|FG005|Double-Blind Treatment Period|Adverse Event|0|||
127772404|NCT03285178|459793618|FG006|Double-Blind Treatment Period|Adverse Event|2|||
127772405|NCT03285178|459793612|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
127772406|NCT03285178|459793613|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
127551341|NCT00785785|458985766|FG000|Optional Extension Phase|Adverse Event|4|||
127551342|NCT00785785|458985767|FG001|Optional Extension Phase|Adverse Event|5|||
127551343|NCT00785785|458985766|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
127551344|NCT00785785|458985767|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
127772407|NCT03285178|459793614|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
127772408|NCT03285178|459793615|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
127772409|NCT03285178|459793616|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
127772410|NCT03285178|459793617|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
127772411|NCT03285178|459793618|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
128017231|NCT03317496|460686544|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
128017232|NCT03317496|460686545|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
128017233|NCT03317496|460686546|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
128017234|NCT03317496|460686547|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
128017235|NCT03317496|460686548|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
128017236|NCT03317496|460686544|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
128017237|NCT03317496|460686545|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
128017238|NCT03317496|460686546|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
128017239|NCT03317496|460686547|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
128017240|NCT03317496|460686548|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
128017241|NCT03317496|460686544|FG000|Phase 1b Lead-in: Treatment|Death|0|||
128017242|NCT03317496|460686545|FG001|Phase 1b Lead-in: Treatment|Death|0|||
128017243|NCT03317496|460686546|FG002|Phase 1b Lead-in: Treatment|Death|1|||
128017244|NCT03317496|460686547|FG003|Phase 1b Lead-in: Treatment|Death|0|||
128017245|NCT03317496|460686548|FG004|Phase 1b Lead-in: Treatment|Death|0|||
128017246|NCT03317496|460686544|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
128017247|NCT03317496|460686545|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
128017248|NCT03317496|460686546|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
128017249|NCT03317496|460686547|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
128017250|NCT03317496|460686548|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
128017251|NCT03317496|460686544|FG000|Phase 1b Lead-in: Treatment|Other|2|||
127551345|NCT00785785|458985766|FG000|Optional Extension Phase|Lost to Follow-up|1|||
127551346|NCT00785785|458985767|FG001|Optional Extension Phase|Lost to Follow-up|0|||
127551347|NCT00785785|458985766|FG000|Optional Extension Phase|Administrative problems|2|||
127551348|NCT00785785|458985767|FG001|Optional Extension Phase|Administrative problems|0|||
128017252|NCT03317496|460686545|FG001|Phase 1b Lead-in: Treatment|Other|1|||
127551349|NCT00785785|458985766|FG000|Optional Extension Phase|Death|1|||
127551350|NCT00785785|458985767|FG001|Optional Extension Phase|Death|5|||
127772412|NCT03285178|459793612|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
127551351|NCT00785785|458985766|FG000|Optional Extension Phase|Disease progression|22|||
127772413|NCT03285178|459793613|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
127772414|NCT03285178|459793614|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
127772415|NCT03285178|459793615|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
127772416|NCT03285178|459793616|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
127772417|NCT03285178|459793617|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
127772418|NCT03285178|459793618|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
127772419|NCT03285178|459793612|FG000|Double-Blind Treatment Period|COVID-19|0|||
127772420|NCT03285178|459793613|FG001|Double-Blind Treatment Period|COVID-19|0|||
127772421|NCT03285178|459793614|FG002|Double-Blind Treatment Period|COVID-19|1|||
127772422|NCT03285178|459793615|FG003|Double-Blind Treatment Period|COVID-19|0|||
127772423|NCT03285178|459793616|FG004|Double-Blind Treatment Period|COVID-19|0|||
127772424|NCT03285178|459793617|FG005|Double-Blind Treatment Period|COVID-19|0|||
127772425|NCT03285178|459793618|FG006|Double-Blind Treatment Period|COVID-19|0|||
127772426|NCT01388790|459793619|FG000|Overall Study|Ongoing at data cut-off date|8|||
127772427|NCT01128894|459793620|FG000|Overall Study|Adverse Event|31|||
127772428|NCT01128894|459793621|FG001|Overall Study|Adverse Event|41|||
127772429|NCT01128894|459793620|FG000|Overall Study|Protocol Violation|2|||
127772430|NCT01128894|459793621|FG001|Overall Study|Protocol Violation|1|||
127772431|NCT01128894|459793620|FG000|Overall Study|Noncompliance|4|||
127772432|NCT01128894|459793621|FG001|Overall Study|Noncompliance|5|||
127772433|NCT01128894|459793620|FG000|Overall Study|Lost to Follow-up|8|||
127772434|NCT01128894|459793621|FG001|Overall Study|Lost to Follow-up|8|||
127772435|NCT01128894|459793620|FG000|Overall Study|Withdrawal by Subject|10|||
127772436|NCT01128894|459793621|FG001|Overall Study|Withdrawal by Subject|12|||
127772437|NCT01128894|459793620|FG000|Overall Study|Physician Decision|2|||
127772438|NCT01128894|459793621|FG001|Overall Study|Physician Decision|1|||
127772439|NCT01128894|459793620|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
127772440|NCT01128894|459793621|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
127772441|NCT00195507|459793622|FG000|Overall Study|Adverse Event|24|||
127772442|NCT00195507|459793623|FG001|Overall Study|Adverse Event|13|||
127772443|NCT00195507|459793622|FG000|Overall Study|Death|0|||
127772444|NCT00195507|459793623|FG001|Overall Study|Death|1|||
127772445|NCT00195507|459793622|FG000|Overall Study|Failed to Return|4|||
127772446|NCT00195507|459793623|FG001|Overall Study|Failed to Return|3|||
127772447|NCT00195507|459793622|FG000|Overall Study|Physician Decision|1|||
127772448|NCT00195507|459793623|FG001|Overall Study|Physician Decision|2|||
127772449|NCT00195507|459793622|FG000|Overall Study|Lost to Follow-up|3|||
127772450|NCT00195507|459793623|FG001|Overall Study|Lost to Follow-up|2|||
127772451|NCT00195507|459793622|FG000|Overall Study|Protocol Violation|5|||
127772452|NCT00195507|459793623|FG001|Overall Study|Protocol Violation|4|||
127772453|NCT00195507|459793622|FG000|Overall Study|Lack of Efficacy|40|||
127772454|NCT00195507|459793623|FG001|Overall Study|Lack of Efficacy|67|||
127772455|NCT00195507|459793622|FG000|Overall Study|Withdrawal by Subject|16|||
127772456|NCT00195507|459793623|FG001|Overall Study|Withdrawal by Subject|23|||
127772457|NCT00195507|459793622|FG000|Overall Study|Protocol Deviation|6|||
127772458|NCT00195507|459793623|FG001|Overall Study|Protocol Deviation|3|||
127772459|NCT00973362|459793624|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
127772460|NCT00973362|459793625|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
127772461|NCT00973362|459793624|FG000|Baseline Evaluation|No colposcopy visit|62|||
127772462|NCT00973362|459793625|FG001|Baseline Evaluation|No colposcopy visit|0|||
127772463|NCT00973362|459793624|FG000|Baseline Evaluation|Inevaluable|686|||
127772464|NCT00973362|459793625|FG001|Baseline Evaluation|Inevaluable|223|||
127772465|NCT00973362|459793624|FG000|3-Year Follow-up|Lost to Follow-up|17|||
127772466|NCT00973362|459793625|FG001|3-Year Follow-up|Lost to Follow-up|0|||
127772467|NCT00887679|459793626|FG000|Overall Study|Withdrawal by Subject|1|||
127772468|NCT00887679|459793626|FG000|Overall Study|Lost to Follow-up|4|||
127772469|NCT00887679|459793626|FG000|Overall Study|Physician Decision|5|||
127772470|NCT02578862|459793633|FG000|Overall Study|Withdrawal by Subject|0|||
128017253|NCT03317496|460686546|FG002|Phase 1b Lead-in: Treatment|Other|0|||
128017254|NCT03317496|460686547|FG003|Phase 1b Lead-in: Treatment|Other|0|||
128017255|NCT03317496|460686548|FG004|Phase 1b Lead-in: Treatment|Other|0|||
128017256|NCT03317496|460686544|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
128017257|NCT03317496|460686545|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
128017258|NCT03317496|460686546|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
128017259|NCT03317496|460686547|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
127772471|NCT02578862|459793634|FG001|Overall Study|Withdrawal by Subject|1|||
127772472|NCT02578862|459793633|FG000|Overall Study|Unplanned unilateral procedure|0|||
127772473|NCT02578862|459793634|FG001|Overall Study|Unplanned unilateral procedure|1|||
127772474|NCT04079803|459793635|FG000|Overall Study|Withdrawal by Subject|0|||
127772475|NCT04079803|459793636|FG001|Overall Study|Withdrawal by Subject|0|||
127772476|NCT04079803|459793637|FG002|Overall Study|Withdrawal by Subject|1|||
127772477|NCT01881750|459793638|FG000|Overall Study|Changes in concomitant therapies|2|||
127772478|NCT01881750|459793639|FG001|Overall Study|Changes in concomitant therapies|3|||
127772479|NCT01881750|459793638|FG000|Overall Study|Lost to Follow-up|0|||
127772480|NCT01881750|459793639|FG001|Overall Study|Lost to Follow-up|1|||
128017260|NCT03317496|460686548|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
128017261|NCT03317496|460686544|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
128017262|NCT03317496|460686545|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
128017263|NCT03317496|460686546|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
128017264|NCT03317496|460686547|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
128017265|NCT03317496|460686548|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
128017266|NCT03317496|460686544|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
128017267|NCT03317496|460686545|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
128017268|NCT03317496|460686546|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
128017269|NCT03317496|460686547|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
128017270|NCT03317496|460686548|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
128017271|NCT03317496|460686544|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
128017272|NCT03317496|460686545|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
128017273|NCT03317496|460686546|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
128017274|NCT03317496|460686547|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
128017275|NCT03317496|460686548|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
128017276|NCT03317496|460686544|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
128017277|NCT03317496|460686545|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
128017278|NCT03317496|460686546|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
128017279|NCT03317496|460686547|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
128017280|NCT03317496|460686548|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
128017281|NCT03317496|460686544|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
128017282|NCT03317496|460686545|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
128017283|NCT03317496|460686546|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
128017284|NCT03317496|460686547|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
128017285|NCT03317496|460686548|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
128017286|NCT03317496|460686544|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
128017287|NCT03317496|460686545|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
128017288|NCT03317496|460686546|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
128017289|NCT03317496|460686547|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
128017290|NCT03317496|460686548|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
128017291|NCT03317496|460686544|FG000|Phase 2: Treatment|Adverse Event|0|||
128017292|NCT03317496|460686545|FG001|Phase 2: Treatment|Adverse Event|0|||
128017293|NCT03317496|460686546|FG002|Phase 2: Treatment|Adverse Event|0|||
128017294|NCT03317496|460686547|FG003|Phase 2: Treatment|Adverse Event|0|||
128017295|NCT03317496|460686548|FG004|Phase 2: Treatment|Adverse Event|6|||
127551352|NCT00785785|458985767|FG001|Optional Extension Phase|Disease progression|70|||
127551353|NCT00785785|458985766|FG000|Optional Extension Phase|Protocol deviation|0|||
127685439|NCT00704184|459473329|FG000|Open-Label Treatment|Lack of Efficacy|0|||
127685440|NCT00704184|459473330|FG001|Open-Label Treatment|Lack of Efficacy|2|||
127685441|NCT00704184|459473331|FG002|Open-Label Treatment|Lack of Efficacy|2|||
127685442|NCT00704184|459473332|FG003|Open-Label Treatment|Lack of Efficacy|2|||
127685443|NCT00704184|459473333|FG004|Open-Label Treatment|Lack of Efficacy|1|||
127685444|NCT00704184|459473329|FG000|Open-Label Treatment|Physician Decision|0|||
127685445|NCT00704184|459473330|FG001|Open-Label Treatment|Physician Decision|0|||
127685446|NCT00704184|459473331|FG002|Open-Label Treatment|Physician Decision|0|||
127685447|NCT00704184|459473332|FG003|Open-Label Treatment|Physician Decision|0|||
127685448|NCT00704184|459473333|FG004|Open-Label Treatment|Physician Decision|1|||
127685449|NCT00704184|459473329|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
127685450|NCT00704184|459473330|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
127685451|NCT00704184|459473331|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
127685452|NCT00704184|459473332|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
127685453|NCT00704184|459473333|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
127685454|NCT01764464|459473334|FG000|First Intervention|Withdrawal by Subject|1|||
127685455|NCT01764464|459473335|FG001|First Intervention|Withdrawal by Subject|0|||
127685456|NCT01764464|459473334|FG000|First Intervention|Lost to Follow-up|1|||
127685457|NCT01764464|459473335|FG001|First Intervention|Lost to Follow-up|0|||
127685458|NCT01764464|459473334|FG000|First Intervention|Adverse Event|0|||
127685459|NCT01764464|459473335|FG001|First Intervention|Adverse Event|2|||
127685460|NCT01764464|459473334|FG000|First Intervention|did not receive study drug|0|||
127685461|NCT01764464|459473335|FG001|First Intervention|did not receive study drug|1|||
127685462|NCT01764464|459473334|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
127685463|NCT01764464|459473335|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
127685464|NCT03473340|459473342|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
128017296|NCT03317496|460686544|FG000|Phase 2: Treatment|Progressive disease|0|||
127685465|NCT03473340|459473343|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
127685466|NCT03473340|459473342|FG000|Overall Study|Withdrawal by Subject|1|||
127685467|NCT03473340|459473343|FG001|Overall Study|Withdrawal by Subject|0|||
128017297|NCT03317496|460686545|FG001|Phase 2: Treatment|Progressive disease|0|||
128017298|NCT03317496|460686546|FG002|Phase 2: Treatment|Progressive disease|0|||
128017299|NCT03317496|460686547|FG003|Phase 2: Treatment|Progressive disease|0|||
128017300|NCT03317496|460686548|FG004|Phase 2: Treatment|Progressive disease|22|||
128017301|NCT03317496|460686544|FG000|Phase 2: Treatment|Other|0|||
127551354|NCT00785785|458985767|FG001|Optional Extension Phase|Protocol deviation|2|||
127551355|NCT00785785|458985766|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
127551356|NCT00785785|458985767|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
127551357|NCT01383356|458985768|FG000|Period 1|Adverse Event|5|||
127551358|NCT01383356|458985769|FG001|Period 1|Adverse Event|3|||
127551359|NCT01383356|458985768|FG000|Period 1|Non-compliance|3|||
127551360|NCT01383356|458985769|FG001|Period 1|Non-compliance|0|||
127551361|NCT01383356|458985768|FG000|Period 1|Out of Range Mid-study-Test|0|||
127551362|NCT01383356|458985769|FG001|Period 1|Out of Range Mid-study-Test|1|||
127551363|NCT01383356|458985768|FG000|Period 1|Personal|0|||
127551364|NCT01383356|458985769|FG001|Period 1|Personal|2|||
127551365|NCT03219528|458985770|FG000|Overall Study|Lost to Follow-up|5|||
127551366|NCT03219528|458985771|FG001|Overall Study|Lost to Follow-up|4|||
127551367|NCT03219528|458985770|FG000|Overall Study|Withdrawal by Subject|4|||
127551368|NCT03219528|458985771|FG001|Overall Study|Withdrawal by Subject|4|||
127551369|NCT01532986|458985772|FG000|Overall Study|Death|9|||
127551370|NCT01532986|458985773|FG001|Overall Study|Death|9|||
127551371|NCT01532986|458985772|FG000|Overall Study|Withdrawal by Subject|7|||
127551372|NCT01532986|458985773|FG001|Overall Study|Withdrawal by Subject|10|||
127551373|NCT01532986|458985772|FG000|Overall Study|Physician Decision|7|||
127551374|NCT01532986|458985773|FG001|Overall Study|Physician Decision|5|||
127551375|NCT02120898|458985774|FG000|Overall Study|Withdrawal by Subject|4|||
127551376|NCT02120898|458985775|FG001|Overall Study|Withdrawal by Subject|2|||
127551377|NCT02120898|458985776|FG002|Overall Study|Withdrawal by Subject|2|||
127551378|NCT02120898|458985774|FG000|Overall Study|Non-compliance with study drug|3|||
127685468|NCT03473340|459473342|FG000|Overall Study|Lost to Follow-up|1|||
127685469|NCT03473340|459473343|FG001|Overall Study|Lost to Follow-up|2|||
127685470|NCT03394885|459473345|FG000|Overall Study|Adverse Event|4|||
127685471|NCT03394885|459473345|FG000|Overall Study|Lack of Efficacy|1|||
127685472|NCT03394885|459473345|FG000|Overall Study|Physician Decision|1|||
127685473|NCT03394885|459473345|FG000|Overall Study|Withdrawal by Subject|8|||
127685474|NCT03394885|459473345|FG000|Overall Study|Alternative Therapy|1|||
127685475|NCT01212991|459473353|FG000|Double-blind|Lost to Follow-up|8|||
127685476|NCT01212991|459473354|FG001|Double-blind|Lost to Follow-up|4|||
127685477|NCT01212991|459473355|FG002|Double-blind|Lost to Follow-up|0|||
127685478|NCT01212991|459473353|FG000|Double-blind|Death|699|||
127685479|NCT01212991|459473354|FG001|Double-blind|Death|550|||
127685480|NCT01212991|459473355|FG002|Double-blind|Death|0|||
127685481|NCT01212991|459473353|FG000|Double-blind|Withdrawal by Subject|16|||
127685482|NCT01212991|459473354|FG001|Double-blind|Withdrawal by Subject|19|||
127685483|NCT01212991|459473355|FG002|Double-blind|Withdrawal by Subject|0|||
127685484|NCT01212991|459473353|FG000|Double-blind|Other|7|||
127685485|NCT01212991|459473354|FG001|Double-blind|Other|0|||
127685486|NCT01212991|459473355|FG002|Double-blind|Other|0|||
127685487|NCT01212991|459473353|FG000|Double-blind|Sponsor decision|142|||
127685488|NCT01212991|459473354|FG001|Double-blind|Sponsor decision|38|||
127685489|NCT01212991|459473355|FG002|Double-blind|Sponsor decision|0|||
127685490|NCT01212991|459473353|FG000|Open-label|Death|0|||
127685491|NCT01212991|459473354|FG001|Open-label|Death|0|||
127685492|NCT01212991|459473355|FG002|Open-label|Death|166|||
127685493|NCT01212991|459473353|FG000|Open-label|Lost to Follow-up|0|||
127685494|NCT01212991|459473354|FG001|Open-label|Lost to Follow-up|0|||
127685495|NCT01212991|459473355|FG002|Open-label|Lost to Follow-up|5|||
127685496|NCT01212991|459473353|FG000|Open-label|Withdrawal by Subject|0|||
127685497|NCT01212991|459473354|FG001|Open-label|Withdrawal by Subject|0|||
127685498|NCT01212991|459473355|FG002|Open-label|Withdrawal by Subject|7|||
127685499|NCT01212991|459473353|FG000|Open-label|Sponsor decision|0|||
127685500|NCT01212991|459473354|FG001|Open-label|Sponsor decision|0|||
127685501|NCT01212991|459473355|FG002|Open-label|Sponsor decision|53|||
127685502|NCT01212991|459473353|FG000|Open-label|Other|0|||
127685503|NCT01212991|459473354|FG001|Open-label|Other|0|||
127685504|NCT01212991|459473355|FG002|Open-label|Other|3|||
127685505|NCT00801983|459473358|FG000|Period 1|Lost to Follow-up|2|||
127685506|NCT00801983|459473359|FG001|Period 1|Lost to Follow-up|0|||
127685507|NCT00801983|459473358|FG000|Period 1|Withdrawal by Subject|2|||
127551379|NCT02120898|458985775|FG001|Overall Study|Non-compliance with study drug|0|||
127551380|NCT02120898|458985776|FG002|Overall Study|Non-compliance with study drug|0|||
127685508|NCT00801983|459473359|FG001|Period 1|Withdrawal by Subject|8|||
127685509|NCT00801983|459473358|FG000|Period 2|Withdrawal by Subject|2|||
127685510|NCT00801983|459473359|FG001|Period 2|Withdrawal by Subject|1|||
127880994|NCT02756078|460186097|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
127551381|NCT02120898|458985774|FG000|Overall Study|Adverse Event|1|||
127551382|NCT02120898|458985775|FG001|Overall Study|Adverse Event|2|||
127551383|NCT02120898|458985776|FG002|Overall Study|Adverse Event|1|||
127551384|NCT02120898|458985774|FG000|Overall Study|Protocol Violation|1|||
127685511|NCT05135000|459473360|FG000|Overall Study|Adverse Event|2|||
127685512|NCT05135000|459473361|FG001|Overall Study|Adverse Event|0|||
127685513|NCT05135000|459473360|FG000|Overall Study|Lost to Follow-up|1|||
127685514|NCT05135000|459473361|FG001|Overall Study|Lost to Follow-up|0|||
127685515|NCT05135000|459473360|FG000|Overall Study|Study Terminated by Sponsor|6|||
127685516|NCT05135000|459473361|FG001|Overall Study|Study Terminated by Sponsor|3|||
127551385|NCT02120898|458985775|FG001|Overall Study|Protocol Violation|2|||
127551386|NCT02120898|458985776|FG002|Overall Study|Protocol Violation|0|||
127551387|NCT02120898|458985774|FG000|Overall Study|Lost to Follow-up|0|||
127551388|NCT02120898|458985775|FG001|Overall Study|Lost to Follow-up|0|||
127551389|NCT02120898|458985776|FG002|Overall Study|Lost to Follow-up|1|||
127551390|NCT00043979|458985777|FG000|Period 1|recipient with progressive disease|7|||
127551391|NCT00043979|458985778|FG001|Period 1|recipient with progressive disease|4|||
127551392|NCT00043979|458985779|FG002|Period 1|recipient with progressive disease|3|||
127551393|NCT04614974|458985781|FG000|Overall Study|Lost to Follow-up|14|||
127551394|NCT04614974|458985782|FG001|Overall Study|Lost to Follow-up|11|||
127551395|NCT01635153|458985783|FG000|Overall Study|Lost to Follow-up|40|||
127551396|NCT01635153|458985784|FG001|Overall Study|Lost to Follow-up|43|||
127551397|NCT00658359|458985785|FG000|Overall Study|Death|3|||
127551398|NCT00658359|458985786|FG001|Overall Study|Death|1|||
127551399|NCT00658359|458985787|FG002|Overall Study|Death|2|||
127551400|NCT00658359|458985785|FG000|Overall Study|Adverse Event|13|||
127551401|NCT00658359|458985786|FG001|Overall Study|Adverse Event|6|||
127551402|NCT00658359|458985787|FG002|Overall Study|Adverse Event|9|||
127551403|NCT00658359|458985785|FG000|Overall Study|Protocol Violation|1|||
128017302|NCT03317496|460686545|FG001|Phase 2: Treatment|Other|0|||
128017303|NCT03317496|460686546|FG002|Phase 2: Treatment|Other|0|||
128017304|NCT03317496|460686547|FG003|Phase 2: Treatment|Other|0|||
128017305|NCT03317496|460686548|FG004|Phase 2: Treatment|Other|4|||
128017306|NCT03317496|460686544|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
128017307|NCT03317496|460686545|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
128017308|NCT03317496|460686546|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
128017309|NCT03317496|460686547|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
128017310|NCT03317496|460686548|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
128017311|NCT03317496|460686544|FG000|Phase 2: Treatment|Physician Decision|0|||
128017312|NCT03317496|460686545|FG001|Phase 2: Treatment|Physician Decision|0|||
128017313|NCT03317496|460686546|FG002|Phase 2: Treatment|Physician Decision|0|||
127551404|NCT00658359|458985786|FG001|Overall Study|Protocol Violation|0|||
127551405|NCT00658359|458985787|FG002|Overall Study|Protocol Violation|0|||
127551406|NCT00658359|458985785|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
127551407|NCT00658359|458985786|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
127551408|NCT00658359|458985787|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
127551409|NCT00658359|458985785|FG000|Overall Study|Withdrawal by Subject|7|||
127551410|NCT00658359|458985786|FG001|Overall Study|Withdrawal by Subject|4|||
127551411|NCT00658359|458985787|FG002|Overall Study|Withdrawal by Subject|2|||
127551412|NCT00658359|458985785|FG000|Overall Study|Lost to Follow-up|2|||
128017314|NCT03317496|460686547|FG003|Phase 2: Treatment|Physician Decision|0|||
128017315|NCT03317496|460686548|FG004|Phase 2: Treatment|Physician Decision|1|||
128017316|NCT03317496|460686544|FG000|Phase 2: Treatment|Death|0|||
128017317|NCT03317496|460686545|FG001|Phase 2: Treatment|Death|0|||
128017318|NCT03317496|460686546|FG002|Phase 2: Treatment|Death|0|||
128017319|NCT03317496|460686547|FG003|Phase 2: Treatment|Death|0|||
128017320|NCT03317496|460686548|FG004|Phase 2: Treatment|Death|1|||
128017321|NCT03317496|460686544|FG000|Phase 2: Follow-up|Death|0|||
128017322|NCT03317496|460686545|FG001|Phase 2: Follow-up|Death|0|||
128017323|NCT03317496|460686546|FG002|Phase 2: Follow-up|Death|0|||
128017324|NCT03317496|460686547|FG003|Phase 2: Follow-up|Death|0|||
128017325|NCT03317496|460686548|FG004|Phase 2: Follow-up|Death|24|||
128017326|NCT03317496|460686544|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
128017327|NCT03317496|460686545|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
128017328|NCT03317496|460686546|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
128017329|NCT03317496|460686547|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
128017330|NCT03317496|460686548|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
127551413|NCT00658359|458985786|FG001|Overall Study|Lost to Follow-up|2|||
127551414|NCT00658359|458985787|FG002|Overall Study|Lost to Follow-up|4|||
127551415|NCT00658359|458985785|FG000|Overall Study|Lack of Efficacy|0|||
127551416|NCT00658359|458985786|FG001|Overall Study|Lack of Efficacy|1|||
127772481|NCT02804178|459793641|FG000|Overall Study|Adverse Event|1|||
127551417|NCT00658359|458985787|FG002|Overall Study|Lack of Efficacy|0|||
127551418|NCT02754440|458985788|FG000|Overall Study|Protocol Violation|3|||
128017331|NCT03317496|460686544|FG000|Phase 2: Follow-up|Other|0|||
128017332|NCT03317496|460686545|FG001|Phase 2: Follow-up|Other|0|||
128017333|NCT03317496|460686546|FG002|Phase 2: Follow-up|Other|0|||
127551419|NCT02754440|458985789|FG001|Overall Study|Protocol Violation|2|||
127551420|NCT02754440|458985790|FG002|Overall Study|Protocol Violation|2|||
127551421|NCT02754440|458985791|FG003|Overall Study|Protocol Violation|6|||
127551422|NCT02754440|458985788|FG000|Overall Study|Adverse Event|3|||
128017334|NCT03317496|460686547|FG003|Phase 2: Follow-up|Other|0|||
128017335|NCT03317496|460686548|FG004|Phase 2: Follow-up|Other|1|||
128017336|NCT03317496|460686544|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
128017337|NCT03317496|460686545|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
128017338|NCT03317496|460686546|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
128017339|NCT03317496|460686547|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
128017340|NCT03317496|460686548|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
128017341|NCT01001104|460686553|FG000|Overall Study|Adverse Event|2|||
128017342|NCT01001104|460686554|FG001|Overall Study|Adverse Event|1|||
128017343|NCT01001104|460686555|FG002|Overall Study|Adverse Event|0|||
128017344|NCT01001104|460686556|FG003|Overall Study|Adverse Event|0|||
128017345|NCT01001104|460686553|FG000|Overall Study|Lost to Follow-up|0|||
128017346|NCT01001104|460686554|FG001|Overall Study|Lost to Follow-up|0|||
128017347|NCT01001104|460686555|FG002|Overall Study|Lost to Follow-up|1|||
128017348|NCT01001104|460686556|FG003|Overall Study|Lost to Follow-up|0|||
128017349|NCT01001104|460686553|FG000|Overall Study|Entry Criteria Not Met|0|||
128017350|NCT01001104|460686554|FG001|Overall Study|Entry Criteria Not Met|0|||
128017351|NCT01001104|460686555|FG002|Overall Study|Entry Criteria Not Met|0|||
128017352|NCT01001104|460686556|FG003|Overall Study|Entry Criteria Not Met|1|||
128017353|NCT01001104|460686553|FG000|Overall Study|Withdrawal by Subject|0|||
128017354|NCT01001104|460686554|FG001|Overall Study|Withdrawal by Subject|0|||
128017355|NCT01001104|460686555|FG002|Overall Study|Withdrawal by Subject|0|||
128017356|NCT01001104|460686556|FG003|Overall Study|Withdrawal by Subject|2|||
128017357|NCT02397837|460686557|FG000|Overall Study|Withdrawal by Subject|6|||
128017358|NCT02397837|460686558|FG001|Overall Study|Withdrawal by Subject|5|||
128017359|NCT02397837|460686557|FG000|Overall Study|Physician Decision|1|||
128017360|NCT02397837|460686558|FG001|Overall Study|Physician Decision|1|||
128017361|NCT00599313|460686560|FG000|Overall Study|Adverse Event|19|||
128017362|NCT00599313|460686560|FG000|Overall Study|Disease Progression|12|||
128017363|NCT00599313|460686560|FG000|Overall Study|Patient Request|4|||
128017364|NCT00599313|460686560|FG000|Overall Study|Ineligible|1|||
127685517|NCT02763319|459474775|FG000|Overall Study|Adverse Event|12|||
127685518|NCT02763319|459474776|FG001|Overall Study|Adverse Event|3|||
127685519|NCT02763319|459474775|FG000|Overall Study|Death|123|||
127685520|NCT02763319|459474776|FG001|Overall Study|Death|123|||
127685521|NCT02763319|459474775|FG000|Overall Study|Lost to Follow-up|6|||
127685522|NCT02763319|459474776|FG001|Overall Study|Lost to Follow-up|7|||
127685523|NCT02763319|459474775|FG000|Overall Study|Noncompliance with Study Drug|2|||
127685524|NCT02763319|459474776|FG001|Overall Study|Noncompliance with Study Drug|0|||
127685525|NCT02763319|459474775|FG000|Overall Study|"Captured as Other in Database"|29|||
127685526|NCT02763319|459474776|FG001|Overall Study|"Captured as Other in Database"|34|||
127685527|NCT02763319|459474775|FG000|Overall Study|Physician Decision|1|||
127685528|NCT02763319|459474776|FG001|Overall Study|Physician Decision|7|||
127685529|NCT02763319|459474775|FG000|Overall Study|Progressive Disease|24|||
127685530|NCT02763319|459474776|FG001|Overall Study|Progressive Disease|27|||
127685531|NCT02763319|459474775|FG000|Overall Study|Completed the Maximum per Protocol Treatment Period|1|||
127685532|NCT02763319|459474776|FG001|Overall Study|Completed the Maximum per Protocol Treatment Period|0|||
127685533|NCT02763319|459474775|FG000|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|2|||
127685534|NCT02763319|459474776|FG001|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|1|||
127685535|NCT02763319|459474775|FG000|Overall Study|Withdrawal by Subject|26|||
127685536|NCT02763319|459474776|FG001|Overall Study|Withdrawal by Subject|25|||
127685537|NCT04252586|459474777|FG000|Overall Study|Withdrawal by parent/guardian|3|||
127685538|NCT04252586|459474777|FG000|Overall Study|Adverse Event|1|||
127685539|NCT04252586|459474777|FG000|Overall Study|Death|2|||
127685540|NCT04252586|459474777|FG000|Overall Study|Study terminated by sponsor|4|||
127685541|NCT04252586|459474777|FG000|Overall Study|Sponsor request|10|||
127685542|NCT04252586|459474777|FG000|Overall Study|Did not complete treatment period|1|||
127685543|NCT02767765|459474779|FG000|Overall Study|Adverse Event|4|||
127685544|NCT02767765|459474779|FG000|Overall Study|Death|1|||
127685545|NCT02767765|459474779|FG000|Overall Study|Insufficient response|1|||
127685546|NCT02767765|459474779|FG000|Overall Study|Lost to Follow-up|2|||
127685547|NCT02767765|459474779|FG000|Overall Study|Investigator decision|1|||
127685548|NCT02767765|459474779|FG000|Overall Study|Non-Compliance|1|||
127685549|NCT02767765|459474779|FG000|Overall Study|Withdrawal by Subject|1|||
127685550|NCT01951170|459474781|FG000|Overall Study|Investigator decision|1|||
127685551|NCT04512482|459474786|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
127685552|NCT04512482|459474787|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
127685553|NCT00446459|459474790|FG000|8 Months|Protocol Violation|12|||
127685554|NCT00446459|459474790|FG000|12 Months|Protocol Violation|4|||
127685555|NCT00446459|459474790|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
127685556|NCT00391898|459474805|FG000|Overall Study|Adverse Event|3|||
127685557|NCT00391898|459474806|FG001|Overall Study|Adverse Event|0|||
127685558|NCT00391898|459474805|FG000|Overall Study|Other|8|||
127685559|NCT00391898|459474806|FG001|Overall Study|Other|10|||
127685560|NCT02918279|459474809|FG000|Overall Study|Lost to Follow-up|3|||
127685561|NCT02918279|459474810|FG001|Overall Study|Lost to Follow-up|6|||
127685562|NCT02918279|459474809|FG000|Overall Study|Withdrawal by Subject|5|||
127685563|NCT02918279|459474810|FG001|Overall Study|Withdrawal by Subject|15|||
127685564|NCT02918279|459474809|FG000|Overall Study|Withdrawal by parent/guardian|2|||
128017365|NCT02536794|460686561|FG000|Reached 1st Response Assessment|Adverse Event|2|||
128017366|NCT02536794|460686561|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
128017367|NCT02536794|460686561|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
128017368|NCT02536794|460686561|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
128017369|NCT02536794|460686561|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
128017370|NCT02536794|460686561|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
128017371|NCT00817063|460686568|FG000|Overall Study|Adverse Event|32|||
128017372|NCT00817063|460686569|FG001|Overall Study|Adverse Event|13|||
128017373|NCT00817063|460686568|FG000|Overall Study|Death|1|||
128017374|NCT00817063|460686569|FG001|Overall Study|Death|1|||
128017375|NCT00817063|460686568|FG000|Overall Study|Lack of Efficacy|33|||
128017376|NCT00817063|460686569|FG001|Overall Study|Lack of Efficacy|86|||
128017377|NCT00817063|460686568|FG000|Overall Study|Failure to Return|13|||
127551423|NCT02754440|458985789|FG001|Overall Study|Adverse Event|1|||
127551424|NCT02754440|458985790|FG002|Overall Study|Adverse Event|0|||
127551425|NCT02754440|458985791|FG003|Overall Study|Adverse Event|9|||
127551426|NCT02754440|458985788|FG000|Overall Study|Withdrawal by Subject|0|||
127551427|NCT02754440|458985789|FG001|Overall Study|Withdrawal by Subject|0|||
127551428|NCT02754440|458985790|FG002|Overall Study|Withdrawal by Subject|0|||
127551429|NCT02754440|458985791|FG003|Overall Study|Withdrawal by Subject|1|||
127551430|NCT02754440|458985788|FG000|Overall Study|Equipment failure|0|||
127551431|NCT02754440|458985789|FG001|Overall Study|Equipment failure|5|||
127551432|NCT02754440|458985790|FG002|Overall Study|Equipment failure|5|||
127551433|NCT02754440|458985791|FG003|Overall Study|Equipment failure|7|||
127551434|NCT02754440|458985788|FG000|Overall Study|Subject issues not resulting in AE|0|||
127551435|NCT02754440|458985789|FG001|Overall Study|Subject issues not resulting in AE|0|||
127551436|NCT02754440|458985790|FG002|Overall Study|Subject issues not resulting in AE|0|||
127551437|NCT02754440|458985791|FG003|Overall Study|Subject issues not resulting in AE|12|||
127551438|NCT02560558|458985795|FG000|Overall Study|Adverse Event|1|||
127551439|NCT02560558|458985796|FG001|Overall Study|Adverse Event|0|||
127551440|NCT02560558|458985795|FG000|Overall Study|Death|0|||
127551441|NCT02560558|458985796|FG001|Overall Study|Death|2|||
127551442|NCT02560558|458985795|FG000|Overall Study|Lost to Follow-up|0|||
127551443|NCT02560558|458985796|FG001|Overall Study|Lost to Follow-up|4|||
127551444|NCT02560558|458985795|FG000|Overall Study|Protocol Violation|3|||
127551445|NCT02560558|458985796|FG001|Overall Study|Protocol Violation|0|||
127551446|NCT02560558|458985795|FG000|Overall Study|Withdrawal by Subject|3|||
127551447|NCT02560558|458985796|FG001|Overall Study|Withdrawal by Subject|0|||
127551448|NCT01263197|458985803|FG000|First Intervention (Period 1)|Adverse Event|0|||
127551449|NCT01263197|458985804|FG001|First Intervention (Period 1)|Adverse Event|0|||
127551450|NCT01263197|458985805|FG002|First Intervention (Period 1)|Adverse Event|0|||
127551451|NCT01263197|458985806|FG003|First Intervention (Period 1)|Adverse Event|0|||
127551452|NCT01263197|458985807|FG004|First Intervention (Period 1)|Adverse Event|0|||
127551453|NCT01263197|458985808|FG005|First Intervention (Period 1)|Adverse Event|1|||
127551454|NCT01263197|458985803|FG000|Washout Period 1|Protocol Violation|0|||
127551455|NCT01263197|458985804|FG001|Washout Period 1|Protocol Violation|0|||
127551456|NCT01263197|458985805|FG002|Washout Period 1|Protocol Violation|0|||
127551457|NCT01263197|458985806|FG003|Washout Period 1|Protocol Violation|0|||
127551458|NCT01263197|458985807|FG004|Washout Period 1|Protocol Violation|1|||
127551459|NCT01263197|458985808|FG005|Washout Period 1|Protocol Violation|0|||
127551460|NCT01263197|458985803|FG000|Washout Period 2|Physician Decision|0|||
127551461|NCT01263197|458985804|FG001|Washout Period 2|Physician Decision|0|||
127551462|NCT01263197|458985805|FG002|Washout Period 2|Physician Decision|0|||
127551463|NCT01263197|458985806|FG003|Washout Period 2|Physician Decision|0|||
127551464|NCT01263197|458985807|FG004|Washout Period 2|Physician Decision|0|||
127551465|NCT01263197|458985808|FG005|Washout Period 2|Physician Decision|1|||
127551466|NCT01263197|458985803|FG000|Washout Period 2|Protocol Violation|0|||
127551467|NCT01263197|458985804|FG001|Washout Period 2|Protocol Violation|0|||
127551468|NCT01263197|458985805|FG002|Washout Period 2|Protocol Violation|0|||
127551469|NCT01263197|458985806|FG003|Washout Period 2|Protocol Violation|1|||
127551470|NCT01263197|458985807|FG004|Washout Period 2|Protocol Violation|0|||
127551471|NCT01263197|458985808|FG005|Washout Period 2|Protocol Violation|0|||
127551472|NCT01263197|458985803|FG000|Third Intervention (Period 3)|Adverse Event|0|||
127551473|NCT01263197|458985804|FG001|Third Intervention (Period 3)|Adverse Event|1|||
127551474|NCT01263197|458985805|FG002|Third Intervention (Period 3)|Adverse Event|0|||
127551475|NCT01263197|458985806|FG003|Third Intervention (Period 3)|Adverse Event|0|||
127551476|NCT01263197|458985807|FG004|Third Intervention (Period 3)|Adverse Event|0|||
127551477|NCT01263197|458985808|FG005|Third Intervention (Period 3)|Adverse Event|0|||
127551478|NCT02454517|458985809|FG000|Overall Study|Withdrawal by Subject|3|||
127551479|NCT02454517|458985810|FG001|Overall Study|Withdrawal by Subject|0|||
127551480|NCT02454517|458985809|FG000|Overall Study|Lost to Follow-up|4|||
128017378|NCT00817063|460686569|FG001|Overall Study|Failure to Return|12|||
127551481|NCT02454517|458985810|FG001|Overall Study|Lost to Follow-up|7|||
127551482|NCT02454517|458985809|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
128017379|NCT00817063|460686568|FG000|Overall Study|Violation of Selection at Entry|7|||
128017380|NCT00817063|460686569|FG001|Overall Study|Violation of Selection at Entry|4|||
127551483|NCT02454517|458985810|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
127551484|NCT01189032|458985811|FG000|Overall Study|Adverse Event|1|||
127551485|NCT01189032|458985812|FG001|Overall Study|Adverse Event|3|||
127551486|NCT01189032|458985813|FG002|Overall Study|Adverse Event|4|||
127551487|NCT01189032|458985811|FG000|Overall Study|Lack of Efficacy|2|||
127551488|NCT01189032|458985812|FG001|Overall Study|Lack of Efficacy|3|||
127551489|NCT01189032|458985813|FG002|Overall Study|Lack of Efficacy|0|||
127551490|NCT01189032|458985811|FG000|Overall Study|Withdrawal by Subject|1|||
127551491|NCT01189032|458985812|FG001|Overall Study|Withdrawal by Subject|0|||
127551492|NCT01189032|458985813|FG002|Overall Study|Withdrawal by Subject|1|||
127551493|NCT01189032|458985811|FG000|Overall Study|Protocol Violation|1|||
127551494|NCT01189032|458985812|FG001|Overall Study|Protocol Violation|1|||
127551495|NCT01189032|458985813|FG002|Overall Study|Protocol Violation|1|||
127551496|NCT00473382|458985814|FG000|Core Study|Adverse Event|3|||
127551497|NCT00473382|458985815|FG001|Core Study|Adverse Event|1|||
127551498|NCT00473382|458985816|FG002|Core Study|Adverse Event|1|||
127551499|NCT00473382|458985814|FG000|Core Study|Death|3|||
127551500|NCT00473382|458985815|FG001|Core Study|Death|5|||
127551501|NCT00473382|458985816|FG002|Core Study|Death|10|||
127551502|NCT00473382|458985814|FG000|Core Study|Lost to Follow-up|3|||
127551503|NCT00473382|458985815|FG001|Core Study|Lost to Follow-up|3|||
127551504|NCT00473382|458985816|FG002|Core Study|Lost to Follow-up|3|||
127551505|NCT00473382|458985814|FG000|Core Study|Physician Decision|1|||
127551506|NCT00473382|458985815|FG001|Core Study|Physician Decision|2|||
127551507|NCT00473382|458985816|FG002|Core Study|Physician Decision|2|||
127551508|NCT00473382|458985814|FG000|Core Study|Subject non-compliance|5|||
127551509|NCT00473382|458985815|FG001|Core Study|Subject non-compliance|2|||
127551510|NCT00473382|458985816|FG002|Core Study|Subject non-compliance|1|||
127551511|NCT00473382|458985814|FG000|Core Study|Subject needed other treatment|1|||
127551512|NCT00473382|458985815|FG001|Core Study|Subject needed other treatment|3|||
127551513|NCT00473382|458985816|FG002|Core Study|Subject needed other treatment|2|||
127551514|NCT00473382|458985814|FG000|Core Study|Subject's decision|12|||
127551515|NCT00473382|458985815|FG001|Core Study|Subject's decision|11|||
127551516|NCT00473382|458985816|FG002|Core Study|Subject's decision|10|||
127551517|NCT00473382|458985814|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
127551518|NCT00473382|458985815|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
127551519|NCT00473382|458985816|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
127551520|NCT00473382|458985814|FG000|Open-label Extension Through Month 48|Death|1|||
127551521|NCT00473382|458985815|FG001|Open-label Extension Through Month 48|Death|3|||
127551522|NCT00473382|458985816|FG002|Open-label Extension Through Month 48|Death|3|||
127551523|NCT00473382|458985814|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
127551524|NCT00473382|458985815|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
127551525|NCT00473382|458985816|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
127551526|NCT00473382|458985814|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
127551527|NCT00473382|458985815|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
127551528|NCT00473382|458985816|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
127551529|NCT00473382|458985814|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
127551530|NCT00473382|458985815|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
127551531|NCT00473382|458985816|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
127551532|NCT00473382|458985814|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
127551533|NCT00473382|458985815|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
127551534|NCT00473382|458985816|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
127551535|NCT00473382|458985814|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
127551536|NCT00473382|458985815|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
127551537|NCT00473382|458985816|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
127551538|NCT00473382|458985814|FG000|Open-label Extension Through Month 60|Death|1|||
127551539|NCT00473382|458985815|FG001|Open-label Extension Through Month 60|Death|7|||
127551540|NCT00473382|458985816|FG002|Open-label Extension Through Month 60|Death|4|||
127551541|NCT00473382|458985814|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
127551542|NCT00473382|458985815|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
127551543|NCT00473382|458985816|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
127551544|NCT00473382|458985814|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
127551545|NCT00473382|458985815|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
127772482|NCT01106404|459793642|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
128017381|NCT00817063|460686568|FG000|Overall Study|Protocol Violation|3|||
128017382|NCT00817063|460686569|FG001|Overall Study|Protocol Violation|8|||
128017383|NCT00817063|460686568|FG000|Overall Study|Withdrawal by Subject|17|||
127551546|NCT00473382|458985816|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
128017384|NCT00817063|460686569|FG001|Overall Study|Withdrawal by Subject|37|||
128017385|NCT00817063|460686568|FG000|Overall Study|Early Improvement|19|||
128017386|NCT00817063|460686569|FG001|Overall Study|Early Improvement|4|||
128017387|NCT00817063|460686568|FG000|Overall Study|Administrative|10|||
127551547|NCT00473382|458985814|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
127642869|NCT00113568|459313202|FG000|Overall Study|Withdrawal by Subject|117|||
128017388|NCT00817063|460686569|FG001|Overall Study|Administrative|4|||
128017389|NCT00817063|460686568|FG000|Overall Study|Abnormality of Laboratory Test|2|||
127551548|NCT00473382|458985815|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
127551549|NCT00473382|458985816|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
127551550|NCT00473382|458985814|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
127551551|NCT00473382|458985815|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
127551552|NCT00473382|458985816|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
127551553|NCT01134055|458985817|FG000|Overall Study|Adverse Event|5|||
127551554|NCT01134055|458985818|FG001|Overall Study|Adverse Event|2|||
127551555|NCT01134055|458985819|FG002|Overall Study|Adverse Event|2|||
127551556|NCT01134055|458985820|FG003|Overall Study|Adverse Event|2|||
127551557|NCT01134055|458985821|FG004|Overall Study|Adverse Event|5|||
127551558|NCT01134055|458985822|FG005|Overall Study|Adverse Event|7|||
127551559|NCT01134055|458985823|FG006|Overall Study|Adverse Event|2|||
127551560|NCT01134055|458985817|FG000|Overall Study|Lost to Follow-up|0|||
127551561|NCT01134055|458985818|FG001|Overall Study|Lost to Follow-up|1|||
127551562|NCT01134055|458985819|FG002|Overall Study|Lost to Follow-up|0|||
127551563|NCT01134055|458985820|FG003|Overall Study|Lost to Follow-up|1|||
127551564|NCT01134055|458985821|FG004|Overall Study|Lost to Follow-up|0|||
127551565|NCT01134055|458985822|FG005|Overall Study|Lost to Follow-up|0|||
127551566|NCT01134055|458985823|FG006|Overall Study|Lost to Follow-up|0|||
127551567|NCT01134055|458985817|FG000|Overall Study|Withdrawal by Subject|3|||
127551568|NCT01134055|458985818|FG001|Overall Study|Withdrawal by Subject|3|||
127551569|NCT01134055|458985819|FG002|Overall Study|Withdrawal by Subject|1|||
127551570|NCT01134055|458985820|FG003|Overall Study|Withdrawal by Subject|2|||
127551571|NCT01134055|458985821|FG004|Overall Study|Withdrawal by Subject|0|||
127551572|NCT01134055|458985822|FG005|Overall Study|Withdrawal by Subject|0|||
127551573|NCT01134055|458985823|FG006|Overall Study|Withdrawal by Subject|8|||
127551574|NCT01134055|458985817|FG000|Overall Study|Protocol Violation|0|||
127551575|NCT01134055|458985818|FG001|Overall Study|Protocol Violation|0|||
127551576|NCT01134055|458985819|FG002|Overall Study|Protocol Violation|0|||
127551577|NCT01134055|458985820|FG003|Overall Study|Protocol Violation|1|||
127551578|NCT01134055|458985821|FG004|Overall Study|Protocol Violation|1|||
127551579|NCT01134055|458985822|FG005|Overall Study|Protocol Violation|0|||
127551580|NCT01134055|458985823|FG006|Overall Study|Protocol Violation|0|||
127551581|NCT01134055|458985817|FG000|Overall Study|Physician Decision|0|||
127551582|NCT01134055|458985818|FG001|Overall Study|Physician Decision|0|||
127551583|NCT01134055|458985819|FG002|Overall Study|Physician Decision|0|||
127551584|NCT01134055|458985820|FG003|Overall Study|Physician Decision|0|||
127551585|NCT01134055|458985821|FG004|Overall Study|Physician Decision|0|||
127551586|NCT01134055|458985822|FG005|Overall Study|Physician Decision|0|||
127551587|NCT01134055|458985823|FG006|Overall Study|Physician Decision|1|||
127551588|NCT00275509|458985824|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
127551589|NCT00275509|458985825|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
127551590|NCT03388164|458985830|FG000|Overall Study|Withdrawal by Subject|3|||
127551591|NCT03388164|458985831|FG001|Overall Study|Withdrawal by Subject|1|||
127551592|NCT03023397|458985836|FG000|Run-In|Failed screening allergen challenge|1|||
127551593|NCT03023397|458985837|FG001|Run-In|Failed screening allergen challenge|0|||
127551594|NCT03023397|458985838|FG002|Run-In|Failed screening allergen challenge|0|||
127551595|NCT03023397|458985836|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
127551596|NCT03023397|458985837|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
127551597|NCT03023397|458985838|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
127551598|NCT01146795|458985842|FG000|Overall Study|Withdrawal by Subject|4|||
127551599|NCT01146795|458985842|FG000|Overall Study|Adverse Event|6|||
127551600|NCT01146795|458985842|FG000|Overall Study|Still in treatment at study closure|10|||
127551601|NCT03853109|458985843|FG000|Overall Study|Withdrawal by Subject|0|||
127551602|NCT03853109|458985844|FG001|Overall Study|Withdrawal by Subject|0|||
127551603|NCT03853109|458985845|FG002|Overall Study|Withdrawal by Subject|1|||
127551604|NCT03853109|458985846|FG003|Overall Study|Withdrawal by Subject|2|||
127551605|NCT03853109|458985847|FG004|Overall Study|Withdrawal by Subject|1|||
127551606|NCT03853109|458985848|FG005|Overall Study|Withdrawal by Subject|4|||
127551607|NCT03853109|458985849|FG006|Overall Study|Withdrawal by Subject|5|||
127551608|NCT03853109|458985850|FG007|Overall Study|Withdrawal by Subject|3|||
127685565|NCT02918279|459474810|FG001|Overall Study|Withdrawal by parent/guardian|1|||
127685566|NCT02918279|459474809|FG000|Overall Study|Other|3|||
127685567|NCT02918279|459474810|FG001|Overall Study|Other|1|||
127551609|NCT03853109|458985843|FG000|Overall Study|Decision by Sponsor|0|||
127551610|NCT03853109|458985844|FG001|Overall Study|Decision by Sponsor|0|||
127551611|NCT03853109|458985845|FG002|Overall Study|Decision by Sponsor|1|||
127551612|NCT03853109|458985846|FG003|Overall Study|Decision by Sponsor|0|||
127551613|NCT03853109|458985847|FG004|Overall Study|Decision by Sponsor|1|||
127551614|NCT03853109|458985848|FG005|Overall Study|Decision by Sponsor|1|||
127551615|NCT03853109|458985849|FG006|Overall Study|Decision by Sponsor|10|||
127551616|NCT03853109|458985850|FG007|Overall Study|Decision by Sponsor|2|||
127551617|NCT03853109|458985843|FG000|Overall Study|Lost to Follow-up|0|||
127685568|NCT00309907|459474811|FG000|Overall Study|Death|4|||
127685569|NCT00309907|459474811|FG000|Overall Study|Physician Decision|1|||
127551618|NCT03853109|458985844|FG001|Overall Study|Lost to Follow-up|0|||
127551619|NCT03853109|458985845|FG002|Overall Study|Lost to Follow-up|0|||
127551620|NCT03853109|458985846|FG003|Overall Study|Lost to Follow-up|0|||
127551621|NCT03853109|458985847|FG004|Overall Study|Lost to Follow-up|1|||
127551622|NCT03853109|458985848|FG005|Overall Study|Lost to Follow-up|3|||
127551623|NCT03853109|458985849|FG006|Overall Study|Lost to Follow-up|0|||
127551624|NCT03853109|458985850|FG007|Overall Study|Lost to Follow-up|0|||
127551625|NCT03853109|458985843|FG000|Overall Study|Death|2|||
127551626|NCT03853109|458985844|FG001|Overall Study|Death|5|||
127551627|NCT03853109|458985845|FG002|Overall Study|Death|8|||
127551628|NCT03853109|458985846|FG003|Overall Study|Death|10|||
127551629|NCT03853109|458985847|FG004|Overall Study|Death|3|||
127551630|NCT03853109|458985848|FG005|Overall Study|Death|20|||
127551631|NCT03853109|458985849|FG006|Overall Study|Death|10|||
127551632|NCT03853109|458985850|FG007|Overall Study|Death|5|||
127551633|NCT02745119|458985853|FG000|Overall Study|Adverse Event|1|||
127551634|NCT02745119|458985854|FG001|Overall Study|Adverse Event|0|||
127551635|NCT02745119|458985855|FG002|Overall Study|Adverse Event|1|||
127551636|NCT02745119|458985856|FG003|Overall Study|Adverse Event|3|||
127551637|NCT02745119|458985853|FG000|Overall Study|Death|3|||
127551638|NCT02745119|458985854|FG001|Overall Study|Death|3|||
127551639|NCT02745119|458985855|FG002|Overall Study|Death|0|||
127551640|NCT02745119|458985856|FG003|Overall Study|Death|4|||
127551641|NCT02745119|458985853|FG000|Overall Study|Lost to Follow-up|0|||
127551642|NCT02745119|458985854|FG001|Overall Study|Lost to Follow-up|0|||
127551643|NCT02745119|458985855|FG002|Overall Study|Lost to Follow-up|0|||
127551644|NCT02745119|458985856|FG003|Overall Study|Lost to Follow-up|1|||
127551645|NCT02745119|458985853|FG000|Overall Study|Protocol Deviation|0|||
127551646|NCT02745119|458985854|FG001|Overall Study|Protocol Deviation|0|||
127551647|NCT02745119|458985855|FG002|Overall Study|Protocol Deviation|0|||
127551648|NCT02745119|458985856|FG003|Overall Study|Protocol Deviation|1|||
127551649|NCT02745119|458985853|FG000|Overall Study|Withdrawal by Subject|7|||
127551650|NCT02745119|458985854|FG001|Overall Study|Withdrawal by Subject|15|||
127551651|NCT02745119|458985855|FG002|Overall Study|Withdrawal by Subject|8|||
127551652|NCT02745119|458985856|FG003|Overall Study|Withdrawal by Subject|14|||
127551653|NCT02745119|458985853|FG000|Overall Study|Study Terminated by Sponsor|134|||
127551654|NCT02745119|458985854|FG001|Overall Study|Study Terminated by Sponsor|252|||
127551655|NCT02745119|458985855|FG002|Overall Study|Study Terminated by Sponsor|135|||
127551656|NCT02745119|458985856|FG003|Overall Study|Study Terminated by Sponsor|251|||
127551657|NCT02745119|458985853|FG000|Overall Study|Physician Decision|0|||
127551658|NCT02745119|458985854|FG001|Overall Study|Physician Decision|2|||
127551659|NCT02745119|458985855|FG002|Overall Study|Physician Decision|2|||
127551660|NCT02745119|458985856|FG003|Overall Study|Physician Decision|2|||
127551661|NCT02745119|458985853|FG000|Overall Study|Reason Not Specified|0|||
127551662|NCT02745119|458985854|FG001|Overall Study|Reason Not Specified|2|||
127551663|NCT02745119|458985855|FG002|Overall Study|Reason Not Specified|0|||
127551664|NCT02745119|458985856|FG003|Overall Study|Reason Not Specified|1|||
127551665|NCT00432172|458985857|FG000|Overall Study|Physician Decision|0|||
127551666|NCT00432172|458985858|FG001|Overall Study|Physician Decision|0|||
127551667|NCT00432172|458985859|FG002|Overall Study|Physician Decision|2|||
127551668|NCT00432172|458985860|FG003|Overall Study|Physician Decision|0|||
127551669|NCT00432172|458985857|FG000|Overall Study|Adverse Event|4|||
127551670|NCT00432172|458985858|FG001|Overall Study|Adverse Event|2|||
127551671|NCT00432172|458985859|FG002|Overall Study|Adverse Event|4|||
127551672|NCT00432172|458985860|FG003|Overall Study|Adverse Event|3|||
127551673|NCT00432172|458985857|FG000|Overall Study|Disease progression|0|||
127551674|NCT00432172|458985858|FG001|Overall Study|Disease progression|2|||
127551675|NCT00432172|458985859|FG002|Overall Study|Disease progression|5|||
127551676|NCT00432172|458985860|FG003|Overall Study|Disease progression|1|||
127551677|NCT00432172|458985857|FG000|Overall Study|Withdrawal by Subject|0|||
127551678|NCT00432172|458985858|FG001|Overall Study|Withdrawal by Subject|1|||
127551679|NCT00432172|458985859|FG002|Overall Study|Withdrawal by Subject|0|||
127551680|NCT00432172|458985860|FG003|Overall Study|Withdrawal by Subject|2|||
127551681|NCT00432172|458985857|FG000|Overall Study|No treatment received|2|||
127551682|NCT00432172|458985858|FG001|Overall Study|No treatment received|2|||
127551683|NCT00432172|458985859|FG002|Overall Study|No treatment received|0|||
127551684|NCT00432172|458985860|FG003|Overall Study|No treatment received|1|||
127551685|NCT02425943|458985861|FG000|Overall Study|Adverse Event|3|||
127551686|NCT02425943|458985862|FG001|Overall Study|Adverse Event|1|||
127551687|NCT02425943|458985861|FG000|Overall Study|Lost to Follow-up|59|||
127551688|NCT02425943|458985862|FG001|Overall Study|Lost to Follow-up|37|||
127551689|NCT02425943|458985861|FG000|Overall Study|Protocol Violation|4|||
127551690|NCT02425943|458985862|FG001|Overall Study|Protocol Violation|1|||
127551691|NCT02425943|458985861|FG000|Overall Study|Withdrawal by Subject|64|||
127551692|NCT02425943|458985862|FG001|Overall Study|Withdrawal by Subject|31|||
127551693|NCT02425943|458985861|FG000|Overall Study|Other|6|||
127551694|NCT02425943|458985862|FG001|Overall Study|Other|0|||
127551695|NCT01106248|458985864|FG000|Overall Study|Adverse Event|1|||
127551696|NCT01106248|458985864|FG000|Overall Study|Administrative|2|||
127551697|NCT00357903|458985865|FG000|Overall Study|Adverse Event|87|||
127551698|NCT00357903|458985866|FG001|Overall Study|Adverse Event|4|||
127551699|NCT00357903|458985865|FG000|Overall Study|Death|33|||
127551700|NCT00357903|458985866|FG001|Overall Study|Death|0|||
127551701|NCT00357903|458985865|FG000|Overall Study|Lost to Follow-up|23|||
127551702|NCT00357903|458985866|FG001|Overall Study|Lost to Follow-up|4|||
127551703|NCT00357903|458985865|FG000|Overall Study|Physician Decision|39|||
127551704|NCT00357903|458985866|FG001|Overall Study|Physician Decision|5|||
127551705|NCT00357903|458985865|FG000|Overall Study|Withdrawal by Subject|57|||
127551706|NCT00357903|458985866|FG001|Overall Study|Withdrawal by Subject|7|||
127551707|NCT00357903|458985865|FG000|Overall Study|Completed month 12 only|0|||
127551708|NCT00357903|458985866|FG001|Overall Study|Completed month 12 only|1|||
127551709|NCT00357903|458985865|FG000|Overall Study|Protocol issues|14|||
127551710|NCT00357903|458985866|FG001|Overall Study|Protocol issues|3|||
127551711|NCT00357903|458985865|FG000|Overall Study|Response status|61|||
127551712|NCT00357903|458985866|FG001|Overall Study|Response status|9|||
127551713|NCT00357903|458985865|FG000|Overall Study|Other|49|||
127551714|NCT00357903|458985866|FG001|Overall Study|Other|10|||
127551715|NCT00606593|458985867|FG000|Overall Study|Adverse Event|0|||
127551716|NCT00606593|458985868|FG001|Overall Study|Adverse Event|0|||
127551717|NCT00606593|458985869|FG002|Overall Study|Adverse Event|0|||
127551718|NCT00606593|458985870|FG003|Overall Study|Adverse Event|1|||
127551719|NCT00606593|458985871|FG004|Overall Study|Adverse Event|1|||
127551720|NCT00606593|458985872|FG005|Overall Study|Adverse Event|0|||
127551721|NCT00606593|458985873|FG006|Overall Study|Adverse Event|1|||
127551722|NCT00606593|458985874|FG007|Overall Study|Adverse Event|2|||
127551723|NCT00606593|458985875|FG008|Overall Study|Adverse Event|1|||
127551724|NCT00606593|458985876|FG009|Overall Study|Adverse Event|0|||
127551725|NCT00606593|458985867|FG000|Overall Study|Withdrawal of consent|1|||
127551726|NCT00606593|458985868|FG001|Overall Study|Withdrawal of consent|0|||
127551727|NCT00606593|458985869|FG002|Overall Study|Withdrawal of consent|1|||
127551728|NCT00606593|458985870|FG003|Overall Study|Withdrawal of consent|0|||
127551729|NCT00606593|458985871|FG004|Overall Study|Withdrawal of consent|0|||
127551730|NCT00606593|458985872|FG005|Overall Study|Withdrawal of consent|0|||
127551731|NCT00606593|458985873|FG006|Overall Study|Withdrawal of consent|0|||
127551732|NCT00606593|458985874|FG007|Overall Study|Withdrawal of consent|0|||
127551733|NCT00606593|458985875|FG008|Overall Study|Withdrawal of consent|0|||
127551734|NCT00606593|458985876|FG009|Overall Study|Withdrawal of consent|0|||
127551735|NCT00606593|458985867|FG000|Overall Study|Administrative/Other|0|||
127551736|NCT00606593|458985868|FG001|Overall Study|Administrative/Other|0|||
127551737|NCT00606593|458985869|FG002|Overall Study|Administrative/Other|1|||
127551738|NCT00606593|458985870|FG003|Overall Study|Administrative/Other|0|||
127551739|NCT00606593|458985871|FG004|Overall Study|Administrative/Other|0|||
127551740|NCT00606593|458985872|FG005|Overall Study|Administrative/Other|0|||
127551741|NCT00606593|458985873|FG006|Overall Study|Administrative/Other|0|||
127551742|NCT00606593|458985874|FG007|Overall Study|Administrative/Other|0|||
127551743|NCT00606593|458985875|FG008|Overall Study|Administrative/Other|0|||
127772483|NCT01106404|459793643|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
127772484|NCT01106404|459793642|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
127772485|NCT01106404|459793643|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
127772486|NCT01106404|459793642|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
127551744|NCT00606593|458985876|FG009|Overall Study|Administrative/Other|0|||
127551745|NCT03181529|458985877|FG000|Overall Study|Withdrawal by Subject|1|||
127551746|NCT03181529|458985878|FG001|Overall Study|Withdrawal by Subject|1|||
127551747|NCT03181529|458985877|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
127551748|NCT03181529|458985878|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
127551749|NCT06042855|458985881|FG000|Overall Study|No Receipt of Study Drug|48|||
127551750|NCT06042855|458985882|FG001|Overall Study|No Receipt of Study Drug|57|||
127551751|NCT06042855|458985881|FG000|Overall Study|Administratively Withdrawn|59|||
127551752|NCT06042855|458985882|FG001|Overall Study|Administratively Withdrawn|59|||
127551753|NCT00525161|458985889|FG000|Overall Study|Adverse Event|1|||
127551754|NCT02447003|458985890|FG000|Overall Study|Other|0|||
127551755|NCT02447003|458985891|FG001|Overall Study|Other|4|||
127551756|NCT02447003|458985890|FG000|Overall Study|Site discontinued|0|||
127772487|NCT01106404|459793643|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
127772488|NCT01106404|459793642|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
127772489|NCT01106404|459793643|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
127551757|NCT02447003|458985891|FG001|Overall Study|Site discontinued|2|||
127551758|NCT02447003|458985890|FG000|Overall Study|Physician Decision|0|||
127551759|NCT02447003|458985891|FG001|Overall Study|Physician Decision|1|||
127551760|NCT02447003|458985890|FG000|Overall Study|Withdrawal by Subject|4|||
127551761|NCT02447003|458985891|FG001|Overall Study|Withdrawal by Subject|3|||
127551762|NCT02447003|458985890|FG000|Overall Study|Sponsor Decision|6|||
127551763|NCT02447003|458985891|FG001|Overall Study|Sponsor Decision|11|||
127551764|NCT02447003|458985890|FG000|Overall Study|Progressive Disease|1|||
127551765|NCT02447003|458985891|FG001|Overall Study|Progressive Disease|0|||
127551766|NCT02447003|458985890|FG000|Overall Study|Lost to Follow-up|5|||
127551767|NCT02447003|458985891|FG001|Overall Study|Lost to Follow-up|0|||
127551768|NCT02447003|458985890|FG000|Overall Study|Death|154|||
127551769|NCT02447003|458985891|FG001|Overall Study|Death|63|||
127551770|NCT03848728|458985892|FG000|Overall Study|Death|16|||
127551771|NCT03848728|458985893|FG001|Overall Study|Death|13|||
127551772|NCT03848728|458985892|FG000|Overall Study|Outmigrated to non-study community|98|||
127551773|NCT03848728|458985893|FG001|Overall Study|Outmigrated to non-study community|106|||
127551774|NCT03848728|458985892|FG000|Overall Study|Transfered to non-study clinic|32|||
127551775|NCT03848728|458985893|FG001|Overall Study|Transfered to non-study clinic|48|||
127551776|NCT03848728|458985892|FG000|Overall Study|Withdrawal by Subject|1|||
127551777|NCT03848728|458985893|FG001|Overall Study|Withdrawal by Subject|0|||
127551778|NCT04161157|458985894|FG000|Overall Study|Lost to Follow-up|4|||
127551779|NCT04161157|458985894|FG000|Overall Study|Death|3|||
127551780|NCT04161157|458985894|FG000|Overall Study|Ineligible|2|||
127551781|NCT04161157|458985894|FG000|Overall Study|Withdrawal by Subject|4|||
127551782|NCT01108185|458985895|FG000|Overall Study|Non-compliance|15|||
127551783|NCT01108185|458985895|FG000|Overall Study|Lost to Follow-up|12|||
127551784|NCT02581410|458985896|FG000|Vaccination Phase|Adverse Event|2|||
127551785|NCT02581410|458985897|FG001|Vaccination Phase|Adverse Event|1|||
127551786|NCT02581410|458985896|FG000|Vaccination Phase|Withdrawal by Subject|0|||
127551787|NCT02581410|458985897|FG001|Vaccination Phase|Withdrawal by Subject|1|||
127551788|NCT02581410|458985896|FG000|Vaccination Phase|Migrated/moved from study area|0|||
127551789|NCT02581410|458985897|FG001|Vaccination Phase|Migrated/moved from study area|1|||
127551790|NCT02581410|458985896|FG000|End of Study Phase|Adverse Event|4|||
127551791|NCT02581410|458985897|FG001|End of Study Phase|Adverse Event|3|||
127551792|NCT02581410|458985896|FG000|End of Study Phase|Withdrawal by Subject|1|||
127551793|NCT02581410|458985897|FG001|End of Study Phase|Withdrawal by Subject|2|||
127551794|NCT02581410|458985896|FG000|End of Study Phase|Migrated/moved from study area|0|||
127551795|NCT02581410|458985897|FG001|End of Study Phase|Migrated/moved from study area|3|||
127551796|NCT02581410|458985896|FG000|End of Study Phase|Lost to Follow-up|0|||
127551797|NCT02581410|458985897|FG001|End of Study Phase|Lost to Follow-up|2|||
127551798|NCT02581410|458985896|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
127551799|NCT02581410|458985897|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
127551800|NCT06083506|458985903|FG000|Overall Study|Physician Decision|2|||
127551801|NCT06083506|458985903|FG000|Overall Study|Lack of Efficacy|1|||
127551802|NCT03529422|458985904|FG000|Overall Study|Withdrawal by Subject|1|||
127551803|NCT03529422|458985904|FG000|Overall Study|Protocol Violation|1|||
127551804|NCT03529422|458985904|FG000|Overall Study|Disease progression|2|||
127551805|NCT02000115|458985905|FG000|Overall Study|Death|56|||
127551806|NCT02000115|458985906|FG001|Overall Study|Death|45|||
127551807|NCT02000115|458985907|FG002|Overall Study|Death|0|||
127551808|NCT02000115|458985908|FG003|Overall Study|Death|0|||
127551809|NCT02000115|458985905|FG000|Overall Study|Missed Visit|6|||
127551810|NCT02000115|458985906|FG001|Overall Study|Missed Visit|8|||
127551811|NCT02000115|458985907|FG002|Overall Study|Missed Visit|1|||
127551812|NCT02000115|458985908|FG003|Overall Study|Missed Visit|0|||
127551813|NCT02000115|458985905|FG000|Overall Study|Protocol Violation|2|||
127551814|NCT02000115|458985906|FG001|Overall Study|Protocol Violation|1|||
127551815|NCT02000115|458985907|FG002|Overall Study|Protocol Violation|0|||
127551816|NCT02000115|458985908|FG003|Overall Study|Protocol Violation|0|||
127551817|NCT02000115|458985905|FG000|Overall Study|Physician Decision|2|||
127551818|NCT02000115|458985906|FG001|Overall Study|Physician Decision|0|||
127551819|NCT02000115|458985907|FG002|Overall Study|Physician Decision|0|||
127551820|NCT02000115|458985908|FG003|Overall Study|Physician Decision|0|||
127551821|NCT02000115|458985905|FG000|Overall Study|Withdrawal by Subject|11|||
127551822|NCT02000115|458985906|FG001|Overall Study|Withdrawal by Subject|11|||
127551823|NCT02000115|458985907|FG002|Overall Study|Withdrawal by Subject|0|||
127551824|NCT02000115|458985908|FG003|Overall Study|Withdrawal by Subject|0|||
127772490|NCT01290601|459793644|FG000|Overall Study|Adverse Event|0|||
127772491|NCT01290601|459793645|FG001|Overall Study|Adverse Event|2|||
127772492|NCT01290601|459793646|FG002|Overall Study|Adverse Event|0|||
127772493|NCT01290601|459793647|FG003|Overall Study|Adverse Event|0|||
127772494|NCT01290601|459793644|FG000|Overall Study|Lack of Efficacy|2|||
127772495|NCT01290601|459793645|FG001|Overall Study|Lack of Efficacy|1|||
127772496|NCT01290601|459793646|FG002|Overall Study|Lack of Efficacy|0|||
127772497|NCT01290601|459793647|FG003|Overall Study|Lack of Efficacy|0|||
127772498|NCT01290601|459793644|FG000|Overall Study|Lost to Follow-up|7|||
127551825|NCT02000115|458985905|FG000|Overall Study|Lost to Follow-up|0|||
127551826|NCT02000115|458985906|FG001|Overall Study|Lost to Follow-up|1|||
127551827|NCT02000115|458985907|FG002|Overall Study|Lost to Follow-up|0|||
127551828|NCT02000115|458985908|FG003|Overall Study|Lost to Follow-up|0|||
127551829|NCT02000115|458985905|FG000|Overall Study|Non-compliance|2|||
127551830|NCT02000115|458985906|FG001|Overall Study|Non-compliance|1|||
127551831|NCT02000115|458985907|FG002|Overall Study|Non-compliance|0|||
127551832|NCT02000115|458985908|FG003|Overall Study|Non-compliance|0|||
127551833|NCT02000115|458985905|FG000|Overall Study|Withdrawn on day of randomization|0|||
127551834|NCT02000115|458985906|FG001|Overall Study|Withdrawn on day of randomization|1|||
127551835|NCT02000115|458985907|FG002|Overall Study|Withdrawn on day of randomization|0|||
128017390|NCT00817063|460686569|FG001|Overall Study|Abnormality of Laboratory Test|1|||
128017391|NCT01496456|460686570|FG000|Overall Study|Protocol Violation|1|||
128017392|NCT01496456|460686570|FG000|Overall Study|Lost to Follow-up|7|||
128017393|NCT04919161|460686571|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
128017394|NCT04919161|460686572|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
128017395|NCT04919161|460686571|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
128017396|NCT04919161|460686572|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
128017397|NCT04919161|460686571|FG000|Overall Study|Acute ankle sprain after session 1|0|||
128017398|NCT04919161|460686572|FG001|Overall Study|Acute ankle sprain after session 1|1|||
128017399|NCT02489773|460686573|FG000|Overall Study|Lost to Follow-up|4|||
128017400|NCT02489773|460686574|FG001|Overall Study|Lost to Follow-up|1|||
128017401|NCT02489773|460686573|FG000|Overall Study|Physician Decision|1|||
128017402|NCT02489773|460686574|FG001|Overall Study|Physician Decision|0|||
128017403|NCT02489773|460686573|FG000|Overall Study|Withdrawal by Subject|1|||
128017404|NCT02489773|460686574|FG001|Overall Study|Withdrawal by Subject|0|||
128017405|NCT02489773|460686573|FG000|Overall Study|Leave the country or the state|1|||
128017406|NCT02489773|460686574|FG001|Overall Study|Leave the country or the state|1|||
128017407|NCT00712920|460686575|FG000|Overall Study|Adverse Event|3|||
128017408|NCT00712920|460686576|FG001|Overall Study|Adverse Event|4|||
128017409|NCT00712920|460686577|FG002|Overall Study|Adverse Event|7|||
128017410|NCT00712920|460686575|FG000|Overall Study|Withdrawal by Subject|4|||
128017411|NCT00712920|460686576|FG001|Overall Study|Withdrawal by Subject|2|||
128017412|NCT00712920|460686577|FG002|Overall Study|Withdrawal by Subject|1|||
128017413|NCT00712920|460686575|FG000|Overall Study|Lost to Follow-up|1|||
128017414|NCT00712920|460686576|FG001|Overall Study|Lost to Follow-up|4|||
128017415|NCT00712920|460686577|FG002|Overall Study|Lost to Follow-up|0|||
128017416|NCT00712920|460686575|FG000|Overall Study|Lack of Efficacy|1|||
128017417|NCT00712920|460686576|FG001|Overall Study|Lack of Efficacy|0|||
128017418|NCT00712920|460686577|FG002|Overall Study|Lack of Efficacy|1|||
128017419|NCT00712920|460686575|FG000|Overall Study|Other|5|||
128017420|NCT00712920|460686576|FG001|Overall Study|Other|7|||
128017421|NCT00712920|460686577|FG002|Overall Study|Other|3|||
128017422|NCT00712920|460686575|FG000|Overall Study|Non-compliance|3|||
128017423|NCT00712920|460686576|FG001|Overall Study|Non-compliance|0|||
128017424|NCT00712920|460686577|FG002|Overall Study|Non-compliance|0|||
128017425|NCT02362451|460686580|FG000|Overall Study|Withdrawal by Subject|0|||
128017426|NCT02362451|460686581|FG001|Overall Study|Withdrawal by Subject|1|||
128017427|NCT02362451|460686580|FG000|Overall Study|Lack of Efficacy|2|||
128017428|NCT02362451|460686581|FG001|Overall Study|Lack of Efficacy|0|||
128017429|NCT02362451|460686580|FG000|Overall Study|Progression|1|||
128017430|NCT02362451|460686581|FG001|Overall Study|Progression|0|||
128017431|NCT02362451|460686580|FG000|Overall Study|Participant chose other therapy.|1|||
128017432|NCT02362451|460686581|FG001|Overall Study|Participant chose other therapy.|0|||
128017433|NCT01922011|460686585|FG000|Overall Study|Protocol Violation|0|||
128017434|NCT01922011|460686586|FG001|Overall Study|Protocol Violation|1|||
128017435|NCT01922011|460686585|FG000|Overall Study|Physician Decision|0|||
128017436|NCT01922011|460686586|FG001|Overall Study|Physician Decision|1|||
128017437|NCT01922011|460686585|FG000|Overall Study|Parent/Guardian Decision|3|||
128017438|NCT01922011|460686586|FG001|Overall Study|Parent/Guardian Decision|0|||
128017439|NCT01922011|460686585|FG000|Overall Study|Lost to Follow-up|0|||
128017440|NCT01922011|460686586|FG001|Overall Study|Lost to Follow-up|1|||
128017441|NCT01922011|460686585|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
128017442|NCT01922011|460686586|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
128017443|NCT01922011|460686585|FG000|Overall Study|Not Treated|1|||
128017444|NCT01922011|460686586|FG001|Overall Study|Not Treated|0|||
128017445|NCT01922011|460686585|FG000|Overall Study|Lack of willing home health agency|1|||
128017446|NCT01922011|460686586|FG001|Overall Study|Lack of willing home health agency|0|||
128017447|NCT01922011|460686585|FG000|Overall Study|Randomized in error|1|||
128017448|NCT01922011|460686586|FG001|Overall Study|Randomized in error|0|||
128017449|NCT00153920|460686588|FG000|Overall Study|Adverse Event|9|||
128017450|NCT00153920|460686588|FG000|Overall Study|Progressive Disease|9|||
128017451|NCT00153920|460686588|FG000|Overall Study|Physician Decision|3|||
128017452|NCT00153920|460686588|FG000|Overall Study|Lack of Response|3|||
127685570|NCT00309907|459474811|FG000|Overall Study|Ineligible|11|||
127685571|NCT00309907|459474811|FG000|Overall Study|Major infectious event|4|||
128017453|NCT00153920|460686588|FG000|Overall Study|Death|2|||
128017454|NCT00153920|460686588|FG000|Overall Study|Withdrawal by Subject|1|||
128017455|NCT00153920|460686588|FG000|Overall Study|Non-Protocol Therapy|1|||
128017456|NCT00153920|460686588|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
128017457|NCT00153920|460686588|FG000|Overall Study|Progressive Disease before Trt|1|||
128017458|NCT01695746|460686592|FG000|Overall Study|Adverse Event|1|||
128017459|NCT01695746|460686592|FG000|Overall Study|Non-compliance by the participant|3|||
128017460|NCT01695746|460686592|FG000|Overall Study|Protocol Violation|5|||
128017461|NCT01695746|460686592|FG000|Overall Study|Participant not willing to participate|3|||
128017462|NCT04615507|460686593|FG000|Period 1|Covid-19 exposure|2|||
128017463|NCT04615507|460686594|FG001|Period 1|Covid-19 exposure|1|||
128017464|NCT04615507|460686593|FG000|Period 2|Covid-19 exposure|0|||
127551836|NCT02000115|458985908|FG003|Overall Study|Withdrawn on day of randomization|0|||
127551837|NCT02000115|458985905|FG000|Overall Study|Still on Study|0|||
127551838|NCT02000115|458985906|FG001|Overall Study|Still on Study|0|||
127551839|NCT02000115|458985907|FG002|Overall Study|Still on Study|0|||
127551840|NCT02000115|458985908|FG003|Overall Study|Still on Study|53|||
127551841|NCT05006573|458985911|FG000|Double-blind Treatment Period|Physician Decision|2|||
127551842|NCT05006573|458985912|FG001|Double-blind Treatment Period|Physician Decision|0|||
127551843|NCT05006573|458985911|FG000|Double-blind Treatment Period|Study terminated by sponsor|1|||
127551844|NCT05006573|458985912|FG001|Double-blind Treatment Period|Study terminated by sponsor|0|||
127551845|NCT05006573|458985911|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
127551846|NCT05006573|458985912|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
127551847|NCT05006573|458985911|FG000|Double-blind Treatment Period|Protocol Violation|2|||
127551848|NCT05006573|458985912|FG001|Double-blind Treatment Period|Protocol Violation|0|||
127551849|NCT05006573|458985911|FG000|Double-blind Treatment Period|Subject decision without consent withdrawn|0|||
127551850|NCT05006573|458985912|FG001|Double-blind Treatment Period|Subject decision without consent withdrawn|1|||
127551851|NCT05006573|458985911|FG000|Open-label Extension Period|Subject decision without consent withdrawn|0|||
127551852|NCT05006573|458985912|FG001|Open-label Extension Period|Subject decision without consent withdrawn|1|||
127551853|NCT03493464|458985915|FG000|Overall Study|Surgery not performed|1|||
127551854|NCT02374450|458985916|FG000|Overall Study|Protocol Violation|0|||
127551855|NCT02374450|458985917|FG001|Overall Study|Protocol Violation|1|||
127551856|NCT02374450|458985918|FG002|Overall Study|Protocol Violation|0|||
127551857|NCT02374450|458985916|FG000|Overall Study|Withdrawal by Subject|91|||
127551858|NCT02374450|458985917|FG001|Overall Study|Withdrawal by Subject|110|||
127551859|NCT02374450|458985918|FG002|Overall Study|Withdrawal by Subject|4|||
127551860|NCT02374450|458985916|FG000|Overall Study|Lost to Follow-up|168|||
127551861|NCT02374450|458985917|FG001|Overall Study|Lost to Follow-up|194|||
127551862|NCT02374450|458985918|FG002|Overall Study|Lost to Follow-up|138|||
127551863|NCT02374450|458985916|FG000|Overall Study|Death|173|||
127551864|NCT02374450|458985917|FG001|Overall Study|Death|185|||
127551865|NCT02374450|458985918|FG002|Overall Study|Death|81|||
127551866|NCT02374450|458985916|FG000|Overall Study|Migrated from the study area|538|||
127551867|NCT02374450|458985917|FG001|Overall Study|Migrated from the study area|648|||
127551868|NCT02374450|458985918|FG002|Overall Study|Migrated from the study area|181|||
127551869|NCT02374450|458985916|FG000|Overall Study|Enrollment in NCT03855995 study|0|||
127551870|NCT02374450|458985917|FG001|Overall Study|Enrollment in NCT03855995 study|1|||
127551871|NCT02374450|458985918|FG002|Overall Study|Enrollment in NCT03855995 study|0|||
127551872|NCT02374450|458985916|FG000|Overall Study|Vaccination with RTS,S/AS01E vaccine|2|||
127551873|NCT02374450|458985917|FG001|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
127551874|NCT02374450|458985918|FG002|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
127551875|NCT02374450|458985916|FG000|Overall Study|Other|0|||
127551876|NCT02374450|458985917|FG001|Overall Study|Other|21|||
127551877|NCT02374450|458985918|FG002|Overall Study|Other|79|||
127551878|NCT01106690|458987306|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
127551879|NCT01106690|458987307|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
127551880|NCT01106690|458987308|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
127551881|NCT01106690|458987306|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
127551882|NCT01106690|458987307|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
127551883|NCT01106690|458987308|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
127551884|NCT01106690|458987306|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
127551885|NCT01106690|458987307|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
127551886|NCT01106690|458987308|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
127551887|NCT01106690|458987306|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
127551888|NCT01106690|458987307|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
127551889|NCT01106690|458987308|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
127551890|NCT01106690|458987306|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
127551891|NCT01106690|458987307|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
127551892|NCT01106690|458987308|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
127551893|NCT01106690|458987306|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
127551894|NCT01106690|458987307|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
127551895|NCT01106690|458987308|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
127685572|NCT00244855|459474812|FG000|Overall Study|Withdrawal by Subject|0|||
127551896|NCT01106690|458987306|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
127685573|NCT00244855|459474813|FG001|Overall Study|Withdrawal by Subject|1|||
127551897|NCT01106690|458987307|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
127551898|NCT01106690|458987308|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
127551899|NCT01106690|458987306|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
127685574|NCT00869258|459474814|FG000|Overall Study|Physician Decision|1|||
127685575|NCT01641198|459474815|FG000|After 12 Months of Function|Lost to Follow-up|3|||
127685576|NCT01641198|459474816|FG001|After 12 Months of Function|Lost to Follow-up|2|||
127772499|NCT01290601|459793645|FG001|Overall Study|Lost to Follow-up|2|||
127551900|NCT01106690|458987307|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
127551901|NCT01106690|458987308|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
127551902|NCT01106690|458987306|FG000|Core Period: Baseline to Week 26|Other|10|||
127551903|NCT01106690|458987307|FG001|Core Period: Baseline to Week 26|Other|2|||
127551904|NCT01106690|458987308|FG002|Core Period: Baseline to Week 26|Other|6|||
127551905|NCT01106690|458987306|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
127551906|NCT01106690|458987307|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
127551907|NCT01106690|458987308|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
127551908|NCT01106690|458987306|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
127551909|NCT01106690|458987307|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
127551910|NCT01106690|458987308|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
127551911|NCT01106690|458987306|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
127551912|NCT01106690|458987307|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
127551913|NCT01106690|458987308|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
127551914|NCT01106690|458987306|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
127551915|NCT01106690|458987307|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
127551916|NCT01106690|458987308|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
127551917|NCT01106690|458987306|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
127551918|NCT01106690|458987307|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
127551919|NCT01106690|458987308|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
127551920|NCT01106690|458987306|FG000|Extension Period: Week 26 to Week 52|Other|8|||
127551921|NCT01106690|458987307|FG001|Extension Period: Week 26 to Week 52|Other|3|||
127551922|NCT01106690|458987308|FG002|Extension Period: Week 26 to Week 52|Other|4|||
127551923|NCT01106690|458987306|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
127551924|NCT01106690|458987307|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
127551925|NCT01106690|458987308|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
127551926|NCT00831181|458987309|FG000|Overall Study|Adverse Event|12|||
127551927|NCT04085289|458987310|FG000|Overall Study|Withdrawal by Subject|0|||
127551928|NCT04085289|458987311|FG001|Overall Study|Withdrawal by Subject|0|||
127551929|NCT04085289|458987312|FG002|Overall Study|Withdrawal by Subject|1|||
127551930|NCT02919995|458987315|FG000|Overall Study|Adverse Event|0|||
127551931|NCT02919995|458987316|FG001|Overall Study|Adverse Event|0|||
127551932|NCT02919995|458987317|FG002|Overall Study|Adverse Event|0|||
127551933|NCT02919995|458987318|FG003|Overall Study|Adverse Event|0|||
127551934|NCT02919995|458987319|FG004|Overall Study|Adverse Event|0|||
127551935|NCT02919995|458987320|FG005|Overall Study|Adverse Event|1|||
127551936|NCT03196349|458987331|FG000|Overall Study|Did not receive study drug|0|||
127551937|NCT03196349|458987332|FG001|Overall Study|Did not receive study drug|1|||
127551938|NCT03196349|458987333|FG002|Overall Study|Did not receive study drug|2|||
127551939|NCT03196349|458987331|FG000|Overall Study|No data entered|2|||
127551940|NCT03196349|458987332|FG001|Overall Study|No data entered|4|||
127551941|NCT03196349|458987333|FG002|Overall Study|No data entered|0|||
127551942|NCT03196349|458987331|FG000|Overall Study|Study Terminated early|15|||
127551943|NCT03196349|458987332|FG001|Overall Study|Study Terminated early|9|||
127551944|NCT03196349|458987333|FG002|Overall Study|Study Terminated early|11|||
127551945|NCT03967444|458987334|FG000|Overall Study|Lost to Follow-up|1|||
127551946|NCT03967444|458987335|FG001|Overall Study|Lost to Follow-up|2|||
127551947|NCT01821118|458987342|FG000|Overall Study|Death|0|||
127551948|NCT01821118|458987343|FG001|Overall Study|Death|1|||
127551949|NCT01605799|458987344|FG000|Overall Study|Withdrawal by Subject|2|||
127551950|NCT01605799|458987345|FG001|Overall Study|Withdrawal by Subject|1|||
127551951|NCT00345358|458987346|FG000|Primary Vaccination Phase|Other|0|||
127551952|NCT00345358|458987347|FG001|Primary Vaccination Phase|Other|1|||
127551953|NCT00345358|458987348|FG002|Primary Vaccination Phase|Other|1|||
127551954|NCT00345358|458987349|FG003|Primary Vaccination Phase|Other|0|||
127551955|NCT00345358|458987346|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
127551956|NCT00345358|458987347|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
127551957|NCT00345358|458987348|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
127551958|NCT00345358|458987349|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
128017465|NCT04615507|460686594|FG001|Period 2|Covid-19 exposure|1|||
128017466|NCT04615507|460686593|FG000|Period 2|Protocol Violation|1|||
128017467|NCT04615507|460686594|FG001|Period 2|Protocol Violation|0|||
127551959|NCT00345358|458987346|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
127551960|NCT00345358|458987347|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
127551961|NCT00345358|458987348|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
127551962|NCT00345358|458987349|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
127551963|NCT00345358|458987346|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
127551964|NCT00345358|458987347|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
127551965|NCT00345358|458987348|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
127551966|NCT00345358|458987349|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
128017468|NCT04615507|460686593|FG000|Period 2|Withdrawal by Subject|1|||
127551967|NCT00345358|458987346|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
127551968|NCT00345358|458987347|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
127551969|NCT00345358|458987348|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
127551970|NCT00345358|458987349|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
127551971|NCT00345358|458987346|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
127551972|NCT00345358|458987347|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
127551973|NCT00345358|458987348|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
127551974|NCT00345358|458987349|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
127551975|NCT02892448|458987350|FG000|Overall Study|Screening failure|2|||
127551976|NCT02892448|458987351|FG001|Overall Study|Screening failure|2|||
127551977|NCT02892448|458987352|FG002|Overall Study|Screening failure|1|||
127551978|NCT00499083|458987353|FG000|Overall Study|Not evaluable|3|||
127551979|NCT00686686|458987354|FG000|Overall Study|Non-compliance|1|||
127551980|NCT00686686|458987354|FG000|Overall Study|Adverse Event|2|||
127551981|NCT00686686|458987354|FG000|Overall Study|Lost to Follow-up|3|||
127551982|NCT01012440|458987355|FG000|Overall Study|Withdrawal by Subject|2|||
127551983|NCT00594815|458987356|FG000|Overall Study|Never Treated|3|||
127551984|NCT00594815|458987356|FG000|Overall Study|Withdrawal by Subject|2|||
127551985|NCT00594815|458987356|FG000|Overall Study|Toxicity|4|||
127551986|NCT00131248|458987360|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
127551987|NCT00131248|458987361|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
127551988|NCT00477386|458987362|FG000|Overall Study|Adverse Event|4|||
127551989|NCT00477386|458987363|FG001|Overall Study|Adverse Event|8|||
127551990|NCT00477386|458987362|FG000|Overall Study|Disease progression, relapse|3|||
127551991|NCT00477386|458987363|FG001|Overall Study|Disease progression, relapse|4|||
127551992|NCT00477386|458987362|FG000|Overall Study|Disease progression, refractory|1|||
127551993|NCT00477386|458987363|FG001|Overall Study|Disease progression, refractory|3|||
127551994|NCT00477386|458987362|FG000|Overall Study|Other|1|||
127551995|NCT00477386|458987363|FG001|Overall Study|Other|2|||
127551996|NCT00477386|458987362|FG000|Overall Study|Physician Decision|1|||
127551997|NCT00477386|458987363|FG001|Overall Study|Physician Decision|0|||
127551998|NCT00477386|458987362|FG000|Overall Study|Withdrawal by Subject|1|||
127551999|NCT00477386|458987363|FG001|Overall Study|Withdrawal by Subject|0|||
127552000|NCT01254422|458987364|FG000|Overall Study|Protocol Violation|1|||
127552001|NCT01254422|458987365|FG001|Overall Study|Protocol Violation|0|||
127552002|NCT01254422|458987364|FG000|Overall Study|Adverse Event|1|||
127552003|NCT01254422|458987365|FG001|Overall Study|Adverse Event|0|||
127552004|NCT01254422|458987364|FG000|Overall Study|Serious adverse event|0|||
127552005|NCT01254422|458987365|FG001|Overall Study|Serious adverse event|1|||
127552006|NCT01254422|458987364|FG000|Overall Study|Lost to Follow-up|1|||
127552007|NCT01254422|458987365|FG001|Overall Study|Lost to Follow-up|0|||
127552008|NCT02207088|458987366|FG000|Overall Study|Adverse Event|2|||
127552009|NCT00643162|458987367|FG000|Overall Study|Withdrawal by Subject|1|||
127552010|NCT00643162|458987368|FG001|Overall Study|Withdrawal by Subject|1|||
127552011|NCT02691507|458987369|FG000|Overall Study|Missed Visit 3|0|||
127552012|NCT02691507|458987370|FG001|Overall Study|Missed Visit 3|1|||
127552013|NCT01812252|458987371|FG000|Overall Study|Persistent Disease|1|||
127552014|NCT01812252|458987372|FG001|Overall Study|Persistent Disease|0|||
127552015|NCT01812252|458987371|FG000|Overall Study|Not transplanted|11|||
127552016|NCT01812252|458987372|FG001|Overall Study|Not transplanted|11|||
127552017|NCT01812252|458987371|FG000|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|5|||
127552018|NCT01812252|458987372|FG001|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|3|||
127552019|NCT01812252|458987371|FG000|Overall Study|Withdrawal by Subject|1|||
127552020|NCT01812252|458987372|FG001|Overall Study|Withdrawal by Subject|1|||
127552021|NCT01812252|458987371|FG000|Overall Study|Screen Failure|1|||
127552022|NCT01812252|458987372|FG001|Overall Study|Screen Failure|0|||
127552023|NCT04634253|458987374|FG000|Overall Study|Adverse Event|1|||
127552024|NCT04634253|458987375|FG001|Overall Study|Adverse Event|1|||
127552025|NCT04634253|458987376|FG002|Overall Study|Adverse Event|0|||
127552026|NCT04634253|458987374|FG000|Overall Study|Physician Decision|0|||
127552027|NCT04634253|458987375|FG001|Overall Study|Physician Decision|1|||
127552028|NCT04634253|458987376|FG002|Overall Study|Physician Decision|0|||
127552029|NCT04634253|458987374|FG000|Overall Study|Withdrawal by Subject|1|||
127552030|NCT04634253|458987375|FG001|Overall Study|Withdrawal by Subject|0|||
127552031|NCT04634253|458987376|FG002|Overall Study|Withdrawal by Subject|3|||
127552032|NCT03155841|458987377|FG000|Overall Study|Protocol Violation|3|||
127552033|NCT03155841|458987378|FG001|Overall Study|Protocol Violation|4|||
127552034|NCT02721966|458987384|FG000|Overall Study|Protocol Violation|1|||
127552035|NCT02721966|458987385|FG001|Overall Study|Protocol Violation|0|||
127552036|NCT02721966|458987386|FG002|Overall Study|Protocol Violation|0|||
127685577|NCT01641198|459474817|FG002|After 12 Months of Function|Lost to Follow-up|2|||
127685578|NCT01641198|459474815|FG000|After 12 Months of Function|Protocol Violation|1|||
127685579|NCT01641198|459474816|FG001|After 12 Months of Function|Protocol Violation|0|||
127685580|NCT01641198|459474817|FG002|After 12 Months of Function|Protocol Violation|0|||
127552037|NCT02721966|458987387|FG003|Overall Study|Protocol Violation|0|||
127552038|NCT02721966|458987388|FG004|Overall Study|Protocol Violation|0|||
128017469|NCT04615507|460686594|FG001|Period 2|Withdrawal by Subject|0|||
128017470|NCT04615507|460686593|FG000|Period 2|Adverse Event|0|||
128017471|NCT04615507|460686594|FG001|Period 2|Adverse Event|1|||
128017472|NCT04615507|460686593|FG000|Period 3|Covid-19 exposure|0|||
128017473|NCT04615507|460686594|FG001|Period 3|Covid-19 exposure|1|||
128017474|NCT05172570|460686596|FG000|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
128017475|NCT05172570|460686597|FG001|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|1|||
128017476|NCT05172570|460686598|FG002|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
128017477|NCT05172570|460686596|FG000|Overall Study|PI Decision due to equipment shortages|0|||
128017478|NCT05172570|460686597|FG001|Overall Study|PI Decision due to equipment shortages|0|||
128017479|NCT05172570|460686598|FG002|Overall Study|PI Decision due to equipment shortages|1|||
128017480|NCT01202591|460686599|FG000|Overall Study|Adverse Event|2|||
128017481|NCT01202591|460686600|FG001|Overall Study|Adverse Event|1|||
128017482|NCT01202591|460686601|FG002|Overall Study|Adverse Event|4|||
128017483|NCT01202591|460686602|FG003|Overall Study|Adverse Event|4|||
127552039|NCT02721966|458987384|FG000|Overall Study|Withdrawal by Subject|9|||
127552040|NCT02721966|458987385|FG001|Overall Study|Withdrawal by Subject|2|||
127685581|NCT01641198|459474815|FG000|After 12 Months of Function|Adverse Event|0|||
128017484|NCT01202591|460686603|FG004|Overall Study|Adverse Event|0|||
128017485|NCT01202591|460686604|FG005|Overall Study|Adverse Event|0|||
128017486|NCT01202591|460686599|FG000|Overall Study|Other reason as per investigator|3|||
128017487|NCT01202591|460686600|FG001|Overall Study|Other reason as per investigator|4|||
128017488|NCT01202591|460686601|FG002|Overall Study|Other reason as per investigator|7|||
128017489|NCT01202591|460686602|FG003|Overall Study|Other reason as per investigator|3|||
128017490|NCT01202591|460686603|FG004|Overall Study|Other reason as per investigator|1|||
128017491|NCT01202591|460686604|FG005|Overall Study|Other reason as per investigator|3|||
128017492|NCT01202591|460686599|FG000|Overall Study|Withdrawal by Subject|0|||
128017493|NCT01202591|460686600|FG001|Overall Study|Withdrawal by Subject|0|||
128017494|NCT01202591|460686601|FG002|Overall Study|Withdrawal by Subject|0|||
128017495|NCT01202591|460686602|FG003|Overall Study|Withdrawal by Subject|0|||
128017496|NCT01202591|460686603|FG004|Overall Study|Withdrawal by Subject|2|||
128017497|NCT01202591|460686604|FG005|Overall Study|Withdrawal by Subject|1|||
128017498|NCT01202591|460686599|FG000|Overall Study|Objective Disease Progression|0|||
128017499|NCT01202591|460686600|FG001|Overall Study|Objective Disease Progression|0|||
128017500|NCT01202591|460686601|FG002|Overall Study|Objective Disease Progression|0|||
128017501|NCT01202591|460686602|FG003|Overall Study|Objective Disease Progression|0|||
128017502|NCT01202591|460686603|FG004|Overall Study|Objective Disease Progression|2|||
128017503|NCT01202591|460686604|FG005|Overall Study|Objective Disease Progression|0|||
128017504|NCT02830087|460686607|FG000|Overall Study|No study staff to follow-up patients|4|||
128017505|NCT02830087|460686608|FG001|Overall Study|No study staff to follow-up patients|4|||
128017506|NCT02830087|460686609|FG002|Overall Study|No study staff to follow-up patients|4|||
128017507|NCT02830087|460686610|FG003|Overall Study|No study staff to follow-up patients|3|||
128017508|NCT02830087|460686611|FG004|Overall Study|No study staff to follow-up patients|3|||
128017509|NCT02830087|460686612|FG005|Overall Study|No study staff to follow-up patients|3|||
128017510|NCT02583269|460686613|FG000|Overall Study|Patient hospitalized prior to start|1|||
128017511|NCT02583269|460686614|FG001|Overall Study|Patient hospitalized prior to start|0|||
128017512|NCT02583269|460686615|FG002|Overall Study|Patient hospitalized prior to start|0|||
128017513|NCT02583269|460686616|FG003|Overall Study|Patient hospitalized prior to start|0|||
128017514|NCT02583269|460686617|FG004|Overall Study|Patient hospitalized prior to start|0|||
128017515|NCT03611946|460686621|FG000|Overall Study|Withdrawal by Subject|0|||
128017516|NCT03611946|460686622|FG001|Overall Study|Withdrawal by Subject|0|||
128017517|NCT03611946|460686623|FG002|Overall Study|Withdrawal by Subject|1|||
128017518|NCT03611946|460686624|FG003|Overall Study|Withdrawal by Subject|0|||
127685582|NCT01641198|459474816|FG001|After 12 Months of Function|Adverse Event|1|||
127685583|NCT01641198|459474817|FG002|After 12 Months of Function|Adverse Event|0|||
127685584|NCT01641198|459474815|FG000|After 24 Months of Function|Lost to Follow-up|4|||
127685585|NCT01641198|459474816|FG001|After 24 Months of Function|Lost to Follow-up|9|||
127685586|NCT01641198|459474817|FG002|After 24 Months of Function|Lost to Follow-up|6|||
128017519|NCT02207608|460686625|FG000|Overall Study|Adverse Event|1|||
127685587|NCT01641198|459474815|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
128017520|NCT02207608|460686626|FG001|Overall Study|Adverse Event|0|||
128017521|NCT02850406|460686627|FG000|Part B (Up to 28 Weeks)|Adverse Event|0|||
128017522|NCT02850406|460686628|FG001|Part B (Up to 28 Weeks)|Adverse Event|0|||
128017523|NCT02850406|460686629|FG002|Part B (Up to 28 Weeks)|Adverse Event|0|||
128017524|NCT02850406|460686630|FG003|Part B (Up to 28 Weeks)|Adverse Event|1|||
128017525|NCT02850406|460686631|FG004|Part B (Up to 28 Weeks)|Adverse Event|0|||
128017526|NCT02850406|460686632|FG005|Part B (Up to 28 Weeks)|Adverse Event|0|||
128017527|NCT02850406|460686633|FG006|Part B (Up to 28 Weeks)|Adverse Event|0|||
128017528|NCT02850406|460686634|FG007|Part B (Up to 28 Weeks)|Adverse Event|0|||
128017529|NCT02850406|460686627|FG000|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
128017530|NCT02850406|460686628|FG001|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
128017531|NCT02850406|460686629|FG002|Part B (Up to 28 Weeks)|Withdrawal by Subject|1|||
128017532|NCT02850406|460686630|FG003|Part B (Up to 28 Weeks)|Withdrawal by Subject|2|||
128017533|NCT02850406|460686631|FG004|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
128017534|NCT02850406|460686632|FG005|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
128017535|NCT02850406|460686633|FG006|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
128017536|NCT02850406|460686634|FG007|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
128017537|NCT02850406|460686627|FG000|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
128017538|NCT02850406|460686628|FG001|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
128017539|NCT02850406|460686629|FG002|Part B (Up to 28 Weeks)|Lost to Follow-up|1|||
128017540|NCT02850406|460686630|FG003|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
128017541|NCT02850406|460686631|FG004|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
128017542|NCT02850406|460686632|FG005|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
128017543|NCT02850406|460686633|FG006|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
128017544|NCT02850406|460686634|FG007|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
128017545|NCT02850406|460686627|FG000|Part B (Up to 28 Weeks)|Non compliance|0|||
128017546|NCT02850406|460686628|FG001|Part B (Up to 28 Weeks)|Non compliance|0|||
128017547|NCT02850406|460686629|FG002|Part B (Up to 28 Weeks)|Non compliance|1|||
128017548|NCT02850406|460686630|FG003|Part B (Up to 28 Weeks)|Non compliance|0|||
128017549|NCT02850406|460686631|FG004|Part B (Up to 28 Weeks)|Non compliance|0|||
128017550|NCT02850406|460686632|FG005|Part B (Up to 28 Weeks)|Non compliance|0|||
128017551|NCT02850406|460686633|FG006|Part B (Up to 28 Weeks)|Non compliance|0|||
128017552|NCT02850406|460686634|FG007|Part B (Up to 28 Weeks)|Non compliance|0|||
128017553|NCT02850406|460686627|FG000|Part C (Up to 52 Weeks)|Adverse Event|0|||
128017554|NCT02850406|460686628|FG001|Part C (Up to 52 Weeks)|Adverse Event|0|||
128017555|NCT02850406|460686629|FG002|Part C (Up to 52 Weeks)|Adverse Event|0|||
128017556|NCT02850406|460686630|FG003|Part C (Up to 52 Weeks)|Adverse Event|0|||
128017557|NCT02850406|460686631|FG004|Part C (Up to 52 Weeks)|Adverse Event|4|||
128017558|NCT02850406|460686632|FG005|Part C (Up to 52 Weeks)|Adverse Event|2|||
128017559|NCT02850406|460686633|FG006|Part C (Up to 52 Weeks)|Adverse Event|0|||
128017560|NCT02850406|460686634|FG007|Part C (Up to 52 Weeks)|Adverse Event|0|||
128017561|NCT02850406|460686627|FG000|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
128017562|NCT02850406|460686628|FG001|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
128017563|NCT02850406|460686629|FG002|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
128017564|NCT02850406|460686630|FG003|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
128017565|NCT02850406|460686631|FG004|Part C (Up to 52 Weeks)|Withdrawal by Subject|6|||
128017566|NCT02850406|460686632|FG005|Part C (Up to 52 Weeks)|Withdrawal by Subject|3|||
128017567|NCT02850406|460686633|FG006|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
128017568|NCT02850406|460686634|FG007|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
128017569|NCT02850406|460686627|FG000|Part C (Up to 52 Weeks)|Physician Decision|0|||
128017570|NCT02850406|460686628|FG001|Part C (Up to 52 Weeks)|Physician Decision|0|||
128017571|NCT02850406|460686629|FG002|Part C (Up to 52 Weeks)|Physician Decision|0|||
128017572|NCT02850406|460686630|FG003|Part C (Up to 52 Weeks)|Physician Decision|0|||
128017573|NCT02850406|460686631|FG004|Part C (Up to 52 Weeks)|Physician Decision|1|||
128017574|NCT02850406|460686632|FG005|Part C (Up to 52 Weeks)|Physician Decision|0|||
128017575|NCT02850406|460686633|FG006|Part C (Up to 52 Weeks)|Physician Decision|0|||
128017576|NCT02850406|460686634|FG007|Part C (Up to 52 Weeks)|Physician Decision|0|||
128017577|NCT02850406|460686627|FG000|Part C (Up to 52 Weeks)|Other|0|||
128017578|NCT02850406|460686628|FG001|Part C (Up to 52 Weeks)|Other|0|||
128017579|NCT02850406|460686629|FG002|Part C (Up to 52 Weeks)|Other|0|||
128017580|NCT02850406|460686630|FG003|Part C (Up to 52 Weeks)|Other|0|||
128017581|NCT02850406|460686631|FG004|Part C (Up to 52 Weeks)|Other|1|||
128017582|NCT02850406|460686632|FG005|Part C (Up to 52 Weeks)|Other|3|||
128017583|NCT02850406|460686633|FG006|Part C (Up to 52 Weeks)|Other|0|||
128017584|NCT02850406|460686634|FG007|Part C (Up to 52 Weeks)|Other|0|||
128017585|NCT02850406|460686627|FG000|Part D (Up to 52 Weeks)|Adverse Event|0|||
127772500|NCT01290601|459793646|FG002|Overall Study|Lost to Follow-up|0|||
127772501|NCT01290601|459793647|FG003|Overall Study|Lost to Follow-up|0|||
127772502|NCT01290601|459793644|FG000|Overall Study|Other|1|||
127772503|NCT01290601|459793645|FG001|Overall Study|Other|0|||
127772504|NCT01290601|459793646|FG002|Overall Study|Other|0|||
128017586|NCT02850406|460686628|FG001|Part D (Up to 52 Weeks)|Adverse Event|0|||
128017587|NCT02850406|460686629|FG002|Part D (Up to 52 Weeks)|Adverse Event|0|||
128017588|NCT02850406|460686630|FG003|Part D (Up to 52 Weeks)|Adverse Event|0|||
128017589|NCT02850406|460686631|FG004|Part D (Up to 52 Weeks)|Adverse Event|0|||
128017590|NCT02850406|460686632|FG005|Part D (Up to 52 Weeks)|Adverse Event|0|||
127772505|NCT01290601|459793647|FG003|Overall Study|Other|0|||
127772506|NCT01290601|459793644|FG000|Overall Study|Protocol Violation|1|||
127772507|NCT01290601|459793645|FG001|Overall Study|Protocol Violation|0|||
128017591|NCT02850406|460686633|FG006|Part D (Up to 52 Weeks)|Adverse Event|1|||
128017592|NCT02850406|460686634|FG007|Part D (Up to 52 Weeks)|Adverse Event|0|||
128017593|NCT02850406|460686627|FG000|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
128017594|NCT02850406|460686628|FG001|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
128017595|NCT02850406|460686629|FG002|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
128017596|NCT02850406|460686630|FG003|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
128017597|NCT02850406|460686631|FG004|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
128017598|NCT02850406|460686632|FG005|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
128017599|NCT02850406|460686633|FG006|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
128017600|NCT02850406|460686634|FG007|Part D (Up to 52 Weeks)|Withdrawal by Subject|1|||
128017601|NCT02850406|460686627|FG000|Part D (Up to 52 Weeks)|Physician Decision|0|||
128017602|NCT02850406|460686628|FG001|Part D (Up to 52 Weeks)|Physician Decision|0|||
128017603|NCT02850406|460686629|FG002|Part D (Up to 52 Weeks)|Physician Decision|0|||
128017604|NCT02850406|460686630|FG003|Part D (Up to 52 Weeks)|Physician Decision|0|||
128017605|NCT02850406|460686631|FG004|Part D (Up to 52 Weeks)|Physician Decision|0|||
128017606|NCT02850406|460686632|FG005|Part D (Up to 52 Weeks)|Physician Decision|0|||
128017607|NCT02850406|460686633|FG006|Part D (Up to 52 Weeks)|Physician Decision|1|||
128017608|NCT02850406|460686634|FG007|Part D (Up to 52 Weeks)|Physician Decision|1|||
128017609|NCT02850406|460686627|FG000|Part D (Up to 52 Weeks)|Other|0|||
128017610|NCT02850406|460686628|FG001|Part D (Up to 52 Weeks)|Other|0|||
128017611|NCT02850406|460686629|FG002|Part D (Up to 52 Weeks)|Other|0|||
128017612|NCT02850406|460686630|FG003|Part D (Up to 52 Weeks)|Other|0|||
128017613|NCT02850406|460686631|FG004|Part D (Up to 52 Weeks)|Other|0|||
128017614|NCT02850406|460686632|FG005|Part D (Up to 52 Weeks)|Other|0|||
128017615|NCT02850406|460686633|FG006|Part D (Up to 52 Weeks)|Other|0|||
128017616|NCT02850406|460686634|FG007|Part D (Up to 52 Weeks)|Other|1|||
128017617|NCT00876395|460687628|FG000|Overall Study|Untreated|8|||
128017618|NCT00876395|460687629|FG001|Overall Study|Untreated|1|||
128017619|NCT00876395|460687628|FG000|Overall Study|Adverse Event|63|||
128017620|NCT00876395|460687629|FG001|Overall Study|Adverse Event|11|||
128017621|NCT00876395|460687628|FG000|Overall Study|Abnormal test procedure result(s)|1|||
128017622|NCT00876395|460687629|FG001|Overall Study|Abnormal test procedure result(s)|0|||
128017623|NCT00876395|460687628|FG000|Overall Study|Disease progression|259|||
128017624|NCT00876395|460687629|FG001|Overall Study|Disease progression|162|||
128017625|NCT00876395|460687628|FG000|Overall Study|New cancer therapy|25|||
128017626|NCT00876395|460687629|FG001|Overall Study|New cancer therapy|7|||
128017627|NCT00876395|460687628|FG000|Overall Study|Protocol Violation|5|||
128017628|NCT00876395|460687629|FG001|Overall Study|Protocol Violation|2|||
128017629|NCT00876395|460687628|FG000|Overall Study|Withdrawal by Subject|66|||
128017630|NCT00876395|460687629|FG001|Overall Study|Withdrawal by Subject|33|||
128017631|NCT00876395|460687628|FG000|Overall Study|Lost to Follow-up|2|||
128017632|NCT00876395|460687629|FG001|Overall Study|Lost to Follow-up|0|||
128017633|NCT00876395|460687628|FG000|Overall Study|Administrative problems|39|||
128017634|NCT00876395|460687629|FG001|Overall Study|Administrative problems|23|||
128017635|NCT00876395|460687628|FG000|Overall Study|Death|12|||
128017636|NCT00876395|460687629|FG001|Overall Study|Death|0|||
128017637|NCT03807843|460687630|FG000|Overall Study|Lost to Follow-up|1|||
128017638|NCT03807843|460687631|FG001|Overall Study|Lost to Follow-up|0|||
128017639|NCT01312129|460687632|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
128017640|NCT01312129|460687633|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
128017641|NCT00924651|460687636|FG000|Overall Study|Chemo started too soon|2|||
128017642|NCT00924651|460687637|FG001|Overall Study|Chemo started too soon|3|||
128017643|NCT00924651|460687636|FG000|Overall Study|No Reason|3|||
128017644|NCT00924651|460687637|FG001|Overall Study|No Reason|7|||
128017645|NCT00924651|460687636|FG000|Overall Study|Overwhelmed|6|||
128017646|NCT00924651|460687637|FG001|Overall Study|Overwhelmed|6|||
128017647|NCT00924651|460687636|FG000|Overall Study|Noncompliant|1|||
127772508|NCT01290601|459793646|FG002|Overall Study|Protocol Violation|0|||
127772509|NCT01290601|459793647|FG003|Overall Study|Protocol Violation|0|||
127772510|NCT01749540|459793648|FG000|Overall Study|Protocol Violation|0|||
127772511|NCT01749540|459793649|FG001|Overall Study|Protocol Violation|0|||
127772512|NCT01749540|459793650|FG002|Overall Study|Protocol Violation|0|||
127772513|NCT01749540|459793651|FG003|Overall Study|Protocol Violation|0|||
127772514|NCT01749540|459793652|FG004|Overall Study|Protocol Violation|0|||
127772515|NCT01749540|459793653|FG005|Overall Study|Protocol Violation|1|||
128017648|NCT00924651|460687637|FG001|Overall Study|Noncompliant|4|||
128017649|NCT00924651|460687636|FG000|Overall Study|Medical|1|||
128017650|NCT00924651|460687637|FG001|Overall Study|Medical|3|||
127772516|NCT01749540|459793654|FG006|Overall Study|Protocol Violation|1|||
127772517|NCT01749540|459793648|FG000|Overall Study|Withdrawal by Subject|0|||
127772518|NCT01749540|459793649|FG001|Overall Study|Withdrawal by Subject|0|||
127772519|NCT01749540|459793650|FG002|Overall Study|Withdrawal by Subject|0|||
128017651|NCT00924651|460687636|FG000|Overall Study|Changed Mind|10|||
128017652|NCT00924651|460687637|FG001|Overall Study|Changed Mind|1|||
128017653|NCT00924651|460687636|FG000|Overall Study|Incomplete Form|2|||
128017654|NCT00924651|460687637|FG001|Overall Study|Incomplete Form|1|||
127552041|NCT02721966|458987386|FG002|Overall Study|Withdrawal by Subject|3|||
127552042|NCT02721966|458987387|FG003|Overall Study|Withdrawal by Subject|7|||
127552043|NCT02721966|458987388|FG004|Overall Study|Withdrawal by Subject|0|||
128017655|NCT00662259|460687638|FG000|Overall Study|Adverse Event|2|||
128017656|NCT00662259|460687639|FG001|Overall Study|Adverse Event|0|||
128017657|NCT01750346|460687640|FG000|Overall Study|Adverse Event|1|||
128017658|NCT01750346|460687641|FG001|Overall Study|Adverse Event|0|||
128017659|NCT01750346|460687642|FG002|Overall Study|Adverse Event|0|||
128017660|NCT02034591|460687643|FG000|Overall Study|Withdrawal by Subject|0|||
128017661|NCT02034591|460687644|FG001|Overall Study|Withdrawal by Subject|0|||
128017662|NCT02034591|460687645|FG002|Overall Study|Withdrawal by Subject|0|||
128017663|NCT02034591|460687646|FG003|Overall Study|Withdrawal by Subject|0|||
128017664|NCT02034591|460687647|FG004|Overall Study|Withdrawal by Subject|1|||
128017665|NCT02034591|460687648|FG005|Overall Study|Withdrawal by Subject|0|||
128017666|NCT01121926|460687651|FG000|First Intervention Period|Adverse Event|1|||
128017667|NCT01121926|460687652|FG001|First Intervention Period|Adverse Event|0|||
128017668|NCT01121926|460687651|FG000|Washout Period|Adverse Event|0|||
128017669|NCT01121926|460687652|FG001|Washout Period|Adverse Event|1|||
128017670|NCT01121926|460687651|FG000|Washout Period|Positive pregnancy test|0|||
128017671|NCT01121926|460687652|FG001|Washout Period|Positive pregnancy test|1|||
128017672|NCT00416949|460687653|FG000|Overall Study|Patients refused to participate|5|||
128017673|NCT02782468|460687654|FG000|Overall Study|Progressive Disease|2|||
128017674|NCT02782468|460687655|FG001|Overall Study|Progressive Disease|5|||
128017675|NCT02782468|460687656|FG002|Overall Study|Progressive Disease|0|||
128017676|NCT02782468|460687657|FG003|Overall Study|Progressive Disease|4|||
128017677|NCT02782468|460687654|FG000|Overall Study|Adverse Event|0|||
128017678|NCT02782468|460687655|FG001|Overall Study|Adverse Event|2|||
128017679|NCT02782468|460687656|FG002|Overall Study|Adverse Event|2|||
128017680|NCT02782468|460687657|FG003|Overall Study|Adverse Event|3|||
128017681|NCT02782468|460687654|FG000|Overall Study|Other|0|||
128017682|NCT02782468|460687655|FG001|Overall Study|Other|0|||
128017683|NCT02782468|460687656|FG002|Overall Study|Other|1|||
128017684|NCT02782468|460687657|FG003|Overall Study|Other|1|||
128017685|NCT02782468|460687654|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
128017686|NCT02782468|460687655|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
128017687|NCT02782468|460687656|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
128017688|NCT02782468|460687657|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
128017689|NCT02782468|460687654|FG000|Overall Study|Symptomatic Deterioration|0|||
128017690|NCT02782468|460687655|FG001|Overall Study|Symptomatic Deterioration|0|||
128017691|NCT02782468|460687656|FG002|Overall Study|Symptomatic Deterioration|0|||
128017692|NCT02782468|460687657|FG003|Overall Study|Symptomatic Deterioration|1|||
128017693|NCT02782468|460687654|FG000|Overall Study|Withdrawal by Subject|1|||
128017694|NCT02782468|460687655|FG001|Overall Study|Withdrawal by Subject|0|||
128017695|NCT02782468|460687656|FG002|Overall Study|Withdrawal by Subject|0|||
128017696|NCT02782468|460687657|FG003|Overall Study|Withdrawal by Subject|0|||
128017697|NCT01410604|460687659|FG000|Overall Study|Adverse Event|2|||
128017698|NCT01410604|460687660|FG001|Overall Study|Adverse Event|1|||
128017699|NCT01410604|460687659|FG000|Overall Study|Lost to Follow-up|1|||
128017700|NCT01410604|460687660|FG001|Overall Study|Lost to Follow-up|0|||
128017701|NCT01410604|460687659|FG000|Overall Study|Physician Decision|0|||
128017702|NCT01410604|460687660|FG001|Overall Study|Physician Decision|1|||
128017703|NCT00356590|460687661|FG000|Overall Study|Adverse Event|54|||
128017704|NCT00356590|460687661|FG000|Overall Study|Death|10|||
128017705|NCT00356590|460687661|FG000|Overall Study|Lost to Follow-up|35|||
128017706|NCT00356590|460687661|FG000|Overall Study|Physician Decision|46|||
128017707|NCT00356590|460687661|FG000|Overall Study|Withdrawal by Subject|41|||
128017708|NCT00356590|460687661|FG000|Overall Study|Completed month 12 only|2|||
128017709|NCT00356590|460687661|FG000|Overall Study|Protocol issues|6|||
128017710|NCT00356590|460687661|FG000|Overall Study|Response status|28|||
128017711|NCT00356590|460687661|FG000|Overall Study|Other|52|||
128017712|NCT00898807|460687669|FG000|Overall Study|Withdrawal by Subject|5|||
128017713|NCT00898807|460687670|FG001|Overall Study|Withdrawal by Subject|3|||
128017714|NCT00898807|460687669|FG000|Overall Study|Family pressure to discontinue|2|||
128017715|NCT00898807|460687670|FG001|Overall Study|Family pressure to discontinue|2|||
128017716|NCT00898807|460687669|FG000|Overall Study|Lost to Follow-up|1|||
128017717|NCT00898807|460687670|FG001|Overall Study|Lost to Follow-up|3|||
128017718|NCT00898807|460687669|FG000|Overall Study|Death|0|||
128017719|NCT00898807|460687670|FG001|Overall Study|Death|1|||
128017720|NCT02115386|460687671|FG000|Overall Study|Protocol Violation|1|||
128017721|NCT02115386|460687671|FG000|Overall Study|Administrative - trial was terminated|6|||
127552044|NCT02721966|458987384|FG000|Overall Study|Adverse Event|4|||
128017722|NCT02493855|460687672|FG000|Overall Study|Non-compliance|1|||
128017723|NCT02493855|460687673|FG001|Overall Study|Non-compliance|0|||
128017724|NCT02493855|460687674|FG002|Overall Study|Non-compliance|0|||
128017725|NCT02493855|460687672|FG000|Overall Study|Adverse Event|0|||
128017726|NCT02493855|460687673|FG001|Overall Study|Adverse Event|1|||
128017727|NCT02493855|460687674|FG002|Overall Study|Adverse Event|0|||
128017728|NCT02493855|460687672|FG000|Overall Study|Withdrawal by Subject|1|||
127552045|NCT02721966|458987385|FG001|Overall Study|Adverse Event|4|||
128017729|NCT02493855|460687673|FG001|Overall Study|Withdrawal by Subject|0|||
128017730|NCT02493855|460687674|FG002|Overall Study|Withdrawal by Subject|0|||
128017731|NCT02453048|460687675|FG000|Overall Study|Only part of initial 6 mo. study|0|||
128017732|NCT02453048|460687676|FG001|Overall Study|Only part of initial 6 mo. study|0|||
128017733|NCT02453048|460687677|FG002|Overall Study|Only part of initial 6 mo. study|0|||
128017734|NCT02453048|460687678|FG003|Overall Study|Only part of initial 6 mo. study|0|||
128017735|NCT02453048|460687679|FG004|Overall Study|Only part of initial 6 mo. study|6|||
128017736|NCT02453048|460687675|FG000|Overall Study|Lost to Follow-up|0|||
128017737|NCT02453048|460687676|FG001|Overall Study|Lost to Follow-up|1|||
128017738|NCT02453048|460687677|FG002|Overall Study|Lost to Follow-up|2|||
128017739|NCT02453048|460687678|FG003|Overall Study|Lost to Follow-up|0|||
128017740|NCT02453048|460687679|FG004|Overall Study|Lost to Follow-up|0|||
128017741|NCT01482221|460687680|FG000|Overall Study|Lack of Efficacy|1|||
128017742|NCT01482221|460687681|FG001|Overall Study|Lack of Efficacy|0|||
128017743|NCT01482221|460687682|FG002|Overall Study|Lack of Efficacy|1|||
128017744|NCT01482221|460687680|FG000|Overall Study|Lost to Follow-up|3|||
128017745|NCT01482221|460687681|FG001|Overall Study|Lost to Follow-up|2|||
128017746|NCT01482221|460687682|FG002|Overall Study|Lost to Follow-up|1|||
128017747|NCT01482221|460687680|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
128017748|NCT01482221|460687681|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
128017749|NCT01482221|460687682|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
128017750|NCT01482221|460687680|FG000|Overall Study|Condition under Investigation Worsened|3|||
128017751|NCT01482221|460687681|FG001|Overall Study|Condition under Investigation Worsened|2|||
128017752|NCT01482221|460687682|FG002|Overall Study|Condition under Investigation Worsened|4|||
128017753|NCT01482221|460687680|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
128017754|NCT01482221|460687681|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
128017755|NCT01482221|460687682|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
128017756|NCT01482221|460687680|FG000|Overall Study|Adverse Event|1|||
128017757|NCT01482221|460687681|FG001|Overall Study|Adverse Event|7|||
128017758|NCT01482221|460687682|FG002|Overall Study|Adverse Event|3|||
128017759|NCT01482221|460687680|FG000|Overall Study|Withdrawal by Subject|10|||
128017760|NCT01482221|460687681|FG001|Overall Study|Withdrawal by Subject|7|||
128017761|NCT01482221|460687682|FG002|Overall Study|Withdrawal by Subject|12|||
128017762|NCT01482221|460687680|FG000|Overall Study|Incorrect randomization|0|||
128017763|NCT01482221|460687681|FG001|Overall Study|Incorrect randomization|1|||
128017764|NCT01482221|460687682|FG002|Overall Study|Incorrect randomization|0|||
128017765|NCT01482221|460687680|FG000|Overall Study|Physician Decision|0|||
128017766|NCT01482221|460687681|FG001|Overall Study|Physician Decision|1|||
128017767|NCT01482221|460687682|FG002|Overall Study|Physician Decision|0|||
128017768|NCT03086343|460687683|FG000|Period 1|Adverse Event|7|||
128017769|NCT03086343|460687684|FG001|Period 1|Adverse Event|7|||
128017770|NCT03086343|460687685|FG002|Period 1|Adverse Event|0|||
128017771|NCT03086343|460687686|FG003|Period 1|Adverse Event|1|||
128017772|NCT03086343|460687683|FG000|Period 1|Withdrawal by Subject|6|||
128017773|NCT03086343|460687684|FG001|Period 1|Withdrawal by Subject|10|||
128017774|NCT03086343|460687685|FG002|Period 1|Withdrawal by Subject|0|||
128017775|NCT03086343|460687686|FG003|Period 1|Withdrawal by Subject|0|||
128017776|NCT03086343|460687683|FG000|Period 1|Lost to Follow-up|1|||
128017777|NCT03086343|460687684|FG001|Period 1|Lost to Follow-up|3|||
128017778|NCT03086343|460687685|FG002|Period 1|Lost to Follow-up|1|||
128017779|NCT03086343|460687686|FG003|Period 1|Lost to Follow-up|0|||
128017780|NCT03086343|460687683|FG000|Period 1|Other, Not Specified|10|||
128017781|NCT03086343|460687684|FG001|Period 1|Other, Not Specified|12|||
128017782|NCT03086343|460687685|FG002|Period 1|Other, Not Specified|2|||
128017783|NCT03086343|460687686|FG003|Period 1|Other, Not Specified|1|||
128017784|NCT03086343|460687683|FG000|Period 1|Missing|1|||
128017785|NCT03086343|460687684|FG001|Period 1|Missing|0|||
128017786|NCT03086343|460687685|FG002|Period 1|Missing|0|||
128017787|NCT03086343|460687686|FG003|Period 1|Missing|0|||
128017788|NCT03086343|460687683|FG000|Period 2|Adverse Event|20|||
128017789|NCT03086343|460687684|FG001|Period 2|Adverse Event|11|||
128017790|NCT03086343|460687685|FG002|Period 2|Adverse Event|1|||
128017791|NCT03086343|460687686|FG003|Period 2|Adverse Event|2|||
127552046|NCT02721966|458987386|FG002|Overall Study|Adverse Event|3|||
127685588|NCT01641198|459474816|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
128017792|NCT03086343|460687683|FG000|Period 2|Withdrawal by Subject|15|||
128017793|NCT03086343|460687684|FG001|Period 2|Withdrawal by Subject|25|||
128017794|NCT03086343|460687685|FG002|Period 2|Withdrawal by Subject|2|||
128017795|NCT03086343|460687686|FG003|Period 2|Withdrawal by Subject|2|||
128017796|NCT03086343|460687683|FG000|Period 2|Lost to Follow-up|6|||
128017797|NCT03086343|460687684|FG001|Period 2|Lost to Follow-up|11|||
128017798|NCT03086343|460687685|FG002|Period 2|Lost to Follow-up|1|||
128017799|NCT03086343|460687686|FG003|Period 2|Lost to Follow-up|0|||
128017800|NCT03086343|460687683|FG000|Period 2|COVID-19 Infection|5|||
128017801|NCT03086343|460687684|FG001|Period 2|COVID-19 Infection|0|||
128017802|NCT03086343|460687685|FG002|Period 2|COVID-19 Infection|0|||
128017803|NCT03086343|460687686|FG003|Period 2|COVID-19 Infection|0|||
128017804|NCT03086343|460687683|FG000|Period 2|COVID-19 Logistical Restrictions|1|||
127772520|NCT01749540|459793651|FG003|Overall Study|Withdrawal by Subject|1|||
127772521|NCT01749540|459793652|FG004|Overall Study|Withdrawal by Subject|0|||
127772522|NCT01749540|459793653|FG005|Overall Study|Withdrawal by Subject|0|||
127772523|NCT01749540|459793654|FG006|Overall Study|Withdrawal by Subject|0|||
127772524|NCT01749540|459793648|FG000|Overall Study|Initiated into extension study A536-06|0|||
127772525|NCT01749540|459793649|FG001|Overall Study|Initiated into extension study A536-06|0|||
127772526|NCT01749540|459793650|FG002|Overall Study|Initiated into extension study A536-06|0|||
127772527|NCT01749540|459793651|FG003|Overall Study|Initiated into extension study A536-06|0|||
127772528|NCT01749540|459793652|FG004|Overall Study|Initiated into extension study A536-06|0|||
127772529|NCT01749540|459793653|FG005|Overall Study|Initiated into extension study A536-06|2|||
127772530|NCT01749540|459793654|FG006|Overall Study|Initiated into extension study A536-06|24|||
127772531|NCT01296347|459793655|FG000|Allocation|Withdrawal by Subject|1|||
127772532|NCT01296347|459793656|FG001|Allocation|Withdrawal by Subject|2|||
127772533|NCT01296347|459793655|FG000|Allocation|Lack of Efficacy|1|||
127772534|NCT01296347|459793656|FG001|Allocation|Lack of Efficacy|2|||
127772535|NCT01296347|459793655|FG000|Allocation|not received infusion|1|||
127772536|NCT01296347|459793656|FG001|Allocation|not received infusion|0|||
127772537|NCT01296347|459793655|FG000|6 Week Follow up|Death|0|||
127772538|NCT01296347|459793656|FG001|6 Week Follow up|Death|1|||
127772539|NCT01296347|459793655|FG000|3 Month Follow up|Death|1|||
127772540|NCT01296347|459793656|FG001|3 Month Follow up|Death|0|||
127772541|NCT01296347|459793655|FG000|3 Month Follow up|Lost to Follow-up|0|||
127772542|NCT01296347|459793656|FG001|3 Month Follow up|Lost to Follow-up|1|||
128017805|NCT03086343|460687684|FG001|Period 2|COVID-19 Logistical Restrictions|0|||
128017806|NCT03086343|460687685|FG002|Period 2|COVID-19 Logistical Restrictions|0|||
128017807|NCT03086343|460687686|FG003|Period 2|COVID-19 Logistical Restrictions|0|||
128017808|NCT03086343|460687683|FG000|Period 2|Other, Not Specified|23|||
128017809|NCT03086343|460687684|FG001|Period 2|Other, Not Specified|22|||
128017810|NCT03086343|460687685|FG002|Period 2|Other, Not Specified|2|||
128017811|NCT03086343|460687686|FG003|Period 2|Other, Not Specified|4|||
128017812|NCT01047501|460687687|FG000|Overall Study|Adverse Event|7|||
128017813|NCT01047501|460687688|FG001|Overall Study|Adverse Event|8|||
128017814|NCT01047501|460687689|FG002|Overall Study|Adverse Event|5|||
128017815|NCT01047501|460687687|FG000|Overall Study|Withdrew Consent|6|||
128017816|NCT01047501|460687688|FG001|Overall Study|Withdrew Consent|2|||
128017817|NCT01047501|460687689|FG002|Overall Study|Withdrew Consent|4|||
128017818|NCT01047501|460687687|FG000|Overall Study|Lost to Follow-up|0|||
128017819|NCT01047501|460687688|FG001|Overall Study|Lost to Follow-up|1|||
128017820|NCT01047501|460687689|FG002|Overall Study|Lost to Follow-up|1|||
128017821|NCT01047501|460687687|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
128017822|NCT01047501|460687688|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
127772543|NCT01296347|459793655|FG000|6 Month Follow up|Death|2|||
127772544|NCT01296347|459793656|FG001|6 Month Follow up|Death|1|||
127772545|NCT01296347|459793655|FG000|6 Month Follow up|Lost to Follow-up|0|||
127772546|NCT01296347|459793656|FG001|6 Month Follow up|Lost to Follow-up|1|||
127772547|NCT01296347|459793655|FG000|12 Month Follow up|Lost to Follow-up|3|||
127772548|NCT01296347|459793656|FG001|12 Month Follow up|Lost to Follow-up|1|||
127772549|NCT01296347|459793655|FG000|12 Month Follow up|Death|1|||
127772550|NCT01296347|459793656|FG001|12 Month Follow up|Death|1|||
127772551|NCT01296347|459793655|FG000|12 Month Follow up|Withdrawal by Subject|0|||
127772552|NCT01296347|459793656|FG001|12 Month Follow up|Withdrawal by Subject|1|||
127772553|NCT02240693|459793657|FG000|Overall Study|Adverse Event|0|||
127772554|NCT02240693|459793658|FG001|Overall Study|Adverse Event|0|||
127772555|NCT02240693|459793659|FG002|Overall Study|Adverse Event|0|||
128017823|NCT01047501|460687689|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
128017824|NCT01047501|460687687|FG000|Overall Study|Death|1|||
128017825|NCT01047501|460687688|FG001|Overall Study|Death|0|||
128017826|NCT01047501|460687689|FG002|Overall Study|Death|0|||
128017827|NCT01047501|460687687|FG000|Overall Study|Other discontinuation|1|||
128017828|NCT01047501|460687688|FG001|Overall Study|Other discontinuation|0|||
128017829|NCT01047501|460687689|FG002|Overall Study|Other discontinuation|1|||
128017830|NCT01047501|460687687|FG000|Overall Study|Investigator judgement|0|||
128017831|NCT01047501|460687688|FG001|Overall Study|Investigator judgement|0|||
127772556|NCT02240693|459793660|FG003|Overall Study|Adverse Event|0|||
127772557|NCT02240693|459793661|FG004|Overall Study|Adverse Event|1|||
127772558|NCT02240693|459793657|FG000|Overall Study|Withdrawal by Subject|0|||
127772559|NCT02240693|459793658|FG001|Overall Study|Withdrawal by Subject|0|||
127772560|NCT02240693|459793659|FG002|Overall Study|Withdrawal by Subject|2|||
127772561|NCT02240693|459793660|FG003|Overall Study|Withdrawal by Subject|1|||
127772562|NCT02240693|459793661|FG004|Overall Study|Withdrawal by Subject|0|||
128017832|NCT01047501|460687689|FG002|Overall Study|Investigator judgement|1|||
128017833|NCT00741611|460687690|FG000|Overall Study|Death|0|||
128017834|NCT00741611|460687691|FG001|Overall Study|Death|0|||
128017835|NCT00741611|460687692|FG002|Overall Study|Death|1|||
128017836|NCT00741611|460687690|FG000|Overall Study|Withdrawal by Subject|0|||
128017837|NCT00741611|460687691|FG001|Overall Study|Withdrawal by Subject|2|||
128017838|NCT00741611|460687692|FG002|Overall Study|Withdrawal by Subject|2|||
128017839|NCT01510756|460687699|FG000|Overall Study|Death|1|||
128017840|NCT01510756|460687699|FG000|Overall Study|Lack of Efficacy|2|||
128017841|NCT01510756|460687699|FG000|Overall Study|Physician Decision|1|||
128017842|NCT03600428|460687703|FG000|Overall Study|Not eligible|0|||
128017843|NCT03600428|460687704|FG001|Overall Study|Not eligible|1|||
128017844|NCT03600428|460687703|FG000|Overall Study|Lost to Follow-up|5|||
128017845|NCT03600428|460687704|FG001|Overall Study|Lost to Follow-up|4|||
128017846|NCT04398134|460687705|FG000|Overall Study|Adverse Event|0|||
128017847|NCT04398134|460687706|FG001|Overall Study|Adverse Event|0|||
128017848|NCT04398134|460687707|FG002|Overall Study|Adverse Event|1|||
128017849|NCT04398134|460687708|FG003|Overall Study|Adverse Event|0|||
128017850|NCT04398134|460687705|FG000|Overall Study|Withdrawal by Subject|2|||
128017851|NCT04398134|460687706|FG001|Overall Study|Withdrawal by Subject|0|||
128017852|NCT04398134|460687707|FG002|Overall Study|Withdrawal by Subject|0|||
128017853|NCT04398134|460687708|FG003|Overall Study|Withdrawal by Subject|1|||
128017854|NCT04398134|460687705|FG000|Overall Study|Study Terminated by Sponsor|30|||
128017855|NCT04398134|460687706|FG001|Overall Study|Study Terminated by Sponsor|11|||
128017856|NCT04398134|460687707|FG002|Overall Study|Study Terminated by Sponsor|32|||
128017857|NCT04398134|460687708|FG003|Overall Study|Study Terminated by Sponsor|11|||
128017858|NCT01666652|460687711|FG000|Overall Study|Serious Adverse Event|0|||
128017859|NCT01666652|460687712|FG001|Overall Study|Serious Adverse Event|0|||
128017860|NCT01666652|460687713|FG002|Overall Study|Serious Adverse Event|0|||
128017861|NCT01666652|460687714|FG003|Overall Study|Serious Adverse Event|1|||
128017862|NCT01666652|460687715|FG004|Overall Study|Serious Adverse Event|0|||
128017863|NCT01666652|460687711|FG000|Overall Study|Withdrawal by Subject|0|||
128017864|NCT01666652|460687712|FG001|Overall Study|Withdrawal by Subject|0|||
128017865|NCT01666652|460687713|FG002|Overall Study|Withdrawal by Subject|0|||
128017866|NCT01666652|460687714|FG003|Overall Study|Withdrawal by Subject|0|||
128017867|NCT01666652|460687715|FG004|Overall Study|Withdrawal by Subject|1|||
128017868|NCT01666652|460687711|FG000|Overall Study|Moved from study area|1|||
128017869|NCT01666652|460687712|FG001|Overall Study|Moved from study area|0|||
128017870|NCT01666652|460687713|FG002|Overall Study|Moved from study area|0|||
128017871|NCT01666652|460687714|FG003|Overall Study|Moved from study area|2|||
128017872|NCT01666652|460687715|FG004|Overall Study|Moved from study area|0|||
128017873|NCT01666652|460687711|FG000|Overall Study|Lost to Follow-up|1|||
128017874|NCT01666652|460687712|FG001|Overall Study|Lost to Follow-up|1|||
128017875|NCT01666652|460687713|FG002|Overall Study|Lost to Follow-up|1|||
128017876|NCT01666652|460687714|FG003|Overall Study|Lost to Follow-up|1|||
128017877|NCT01666652|460687715|FG004|Overall Study|Lost to Follow-up|0|||
128017878|NCT01018979|460687716|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
128017879|NCT01018979|460687717|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
128017880|NCT01018979|460687716|FG000|Overall Study|Not received at least one dose|0|||
128017881|NCT01018979|460687717|FG001|Overall Study|Not received at least one dose|1|||
128017882|NCT03010501|460687720|FG000|Study Week 1|Withdrawal by Subject|2|||
128017883|NCT03010501|460687721|FG001|Study Week 1|Withdrawal by Subject|1|||
128017884|NCT03010501|460687722|FG002|Study Week 1|Withdrawal by Subject|0|||
128017885|NCT03010501|460687723|FG003|Study Week 1|Withdrawal by Subject|2|||
128017886|NCT03010501|460687724|FG004|Study Week 1|Withdrawal by Subject|0|||
128017887|NCT03010501|460687725|FG005|Study Week 1|Withdrawal by Subject|0|||
128017888|NCT03010501|460687720|FG000|Study Week 3|Withdrawal by Subject|0|||
128017889|NCT03010501|460687721|FG001|Study Week 3|Withdrawal by Subject|0|||
128017890|NCT03010501|460687722|FG002|Study Week 3|Withdrawal by Subject|0|||
128017891|NCT03010501|460687723|FG003|Study Week 3|Withdrawal by Subject|1|||
128017892|NCT03010501|460687724|FG004|Study Week 3|Withdrawal by Subject|0|||
128017893|NCT03010501|460687725|FG005|Study Week 3|Withdrawal by Subject|0|||
128017894|NCT00640289|460687726|FG000|Overall Study|Death|3|||
128017895|NCT00640289|460687726|FG000|Overall Study|Withdrawal by Subject|1|||
128017896|NCT00640289|460687726|FG000|Overall Study|Lost to Follow-up|1|||
128017897|NCT00640289|460687726|FG000|Overall Study|Data collected under different amendment|2|||
128017898|NCT00640289|460687726|FG000|Overall Study|Transferred to another center|1|||
128017899|NCT00640289|460687726|FG000|Overall Study|Missing status|5|||
127552047|NCT02721966|458987387|FG003|Overall Study|Adverse Event|0|||
127552048|NCT02721966|458987388|FG004|Overall Study|Adverse Event|0|||
127552049|NCT02721966|458987384|FG000|Overall Study|Death|1|||
127685589|NCT01641198|459474817|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
128017900|NCT00544882|460687729|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
128017901|NCT00544882|460687730|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
128017902|NCT00544882|460687731|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
128017903|NCT00544882|460687729|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
128017904|NCT00544882|460687730|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
128017905|NCT00544882|460687731|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
128017906|NCT00544882|460687729|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
128017907|NCT00544882|460687730|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
128017908|NCT00544882|460687731|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
127685590|NCT01641198|459474815|FG000|At 15-20 Years of Function|Death|1|||
127685591|NCT01641198|459474816|FG001|At 15-20 Years of Function|Death|0|||
127685592|NCT01641198|459474817|FG002|At 15-20 Years of Function|Death|1|||
128017909|NCT00544882|460687729|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
128017910|NCT00544882|460687730|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
128017911|NCT00544882|460687731|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
128017912|NCT00544882|460687729|FG000|Cycle 3: Follow-up|Noncompliance|0|||
128017913|NCT00544882|460687730|FG001|Cycle 3: Follow-up|Noncompliance|1|||
128017914|NCT00544882|460687731|FG002|Cycle 3: Follow-up|Noncompliance|0|||
128017915|NCT00544882|460687729|FG000|Cycle 3: Follow-up|Pregnancy|0|||
128017916|NCT00544882|460687730|FG001|Cycle 3: Follow-up|Pregnancy|1|||
128017917|NCT00544882|460687731|FG002|Cycle 3: Follow-up|Pregnancy|0|||
128017918|NCT03043573|460687732|FG000|Overall Study|Lost to Follow-up|3|||
128017919|NCT03043573|460687733|FG001|Overall Study|Lost to Follow-up|3|||
128017920|NCT03043573|460687732|FG000|Overall Study|Physician Decision|0|||
128017921|NCT03043573|460687733|FG001|Overall Study|Physician Decision|5|||
128017922|NCT03043573|460687732|FG000|Overall Study|Withdrawal by Subject|0|||
128017923|NCT03043573|460687733|FG001|Overall Study|Withdrawal by Subject|4|||
128017924|NCT03580928|460687741|FG000|Overall Study|Death|0|||
128017925|NCT03580928|460687742|FG001|Overall Study|Death|3|||
128017926|NCT03580928|460687741|FG000|Overall Study|Withdrawal by Subject|2|||
128017927|NCT03580928|460687742|FG001|Overall Study|Withdrawal by Subject|1|||
128017928|NCT03580928|460687741|FG000|Overall Study|Lost to Follow-up|2|||
128017929|NCT03580928|460687742|FG001|Overall Study|Lost to Follow-up|0|||
128017930|NCT03580928|460687741|FG000|Overall Study|Progressive Disease|0|||
128017931|NCT03580928|460687742|FG001|Overall Study|Progressive Disease|1|||
128017932|NCT05800145|460687743|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|7|||
128017933|NCT05800145|460687744|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
128017934|NCT05800145|460687745|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
128017935|NCT05800145|460687746|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|3|||
128017936|NCT05800145|460687747|FG004|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
128017937|NCT05800145|460687748|FG005|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
128017938|NCT05800145|460687743|FG000|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|1|||
128017939|NCT05800145|460687744|FG001|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
128017940|NCT05800145|460687745|FG002|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
128017941|NCT05800145|460687746|FG003|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|3|||
128017942|NCT05800145|460687747|FG004|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
128017943|NCT05800145|460687748|FG005|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
128017944|NCT05800145|460687743|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
128017945|NCT05800145|460687744|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|5|||
128017946|NCT05800145|460687745|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|0|||
128017947|NCT05800145|460687746|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|3|||
128017948|NCT05800145|460687747|FG004|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
128017949|NCT05800145|460687748|FG005|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
128017950|NCT01373229|460689198|FG000|Overall Study|Death|3|||
128017951|NCT01373229|460689198|FG000|Overall Study|Physician Decision|3|||
128017952|NCT00143507|460689200|FG000|Overall Study|Death|572|||
128017953|NCT00143507|460689201|FG001|Overall Study|Death|547|||
128017954|NCT00143507|460689200|FG000|Overall Study|Withdrawal by Subject|114|||
128017955|NCT00143507|460689201|FG001|Overall Study|Withdrawal by Subject|102|||
128017956|NCT00143507|460689200|FG000|Overall Study|Lost to Follow-up|1|||
128017957|NCT00143507|460689201|FG001|Overall Study|Lost to Follow-up|0|||
128017958|NCT00143507|460689200|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
128017959|NCT00143507|460689201|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
128017960|NCT00587457|460689202|FG000|Overall Study|Adverse Event|1|||
128017961|NCT00587457|460689203|FG001|Overall Study|Adverse Event|2|||
128017962|NCT00587457|460689204|FG002|Overall Study|Adverse Event|1|||
128017963|NCT00587457|460689202|FG000|Overall Study|Disease progression|2|||
128017964|NCT00587457|460689203|FG001|Overall Study|Disease progression|0|||
128017965|NCT00587457|460689204|FG002|Overall Study|Disease progression|2|||
128017966|NCT00587457|460689202|FG000|Overall Study|Initiation of alternative therapy|0|||
128017967|NCT00587457|460689203|FG001|Overall Study|Initiation of alternative therapy|1|||
128017968|NCT00587457|460689204|FG002|Overall Study|Initiation of alternative therapy|0|||
128017969|NCT00587457|460689202|FG000|Overall Study|Undefined|0|||
128017970|NCT00587457|460689203|FG001|Overall Study|Undefined|0|||
128017971|NCT00587457|460689204|FG002|Overall Study|Undefined|1|||
128017972|NCT00587457|460689202|FG000|Overall Study|Development of neutralizing Abs|0|||
128017973|NCT00587457|460689203|FG001|Overall Study|Development of neutralizing Abs|0|||
128017974|NCT00587457|460689204|FG002|Overall Study|Development of neutralizing Abs|1|||
127552050|NCT02721966|458987385|FG001|Overall Study|Death|0|||
127552051|NCT02721966|458987386|FG002|Overall Study|Death|0|||
127552052|NCT02721966|458987387|FG003|Overall Study|Death|0|||
127552053|NCT02721966|458987388|FG004|Overall Study|Death|0|||
127552054|NCT02721966|458987384|FG000|Overall Study|Lack of Efficacy|7|||
127552055|NCT02721966|458987385|FG001|Overall Study|Lack of Efficacy|4|||
127552056|NCT02721966|458987386|FG002|Overall Study|Lack of Efficacy|0|||
127552057|NCT02721966|458987387|FG003|Overall Study|Lack of Efficacy|0|||
128017975|NCT03234881|460689205|FG000|Overall Study|Lost to Follow-up|9|||
128017976|NCT03234881|460689206|FG001|Overall Study|Lost to Follow-up|3|||
127552058|NCT02721966|458987388|FG004|Overall Study|Lack of Efficacy|0|||
127552059|NCT02721966|458987384|FG000|Overall Study|Lost to Follow-up|0|||
127772563|NCT02240693|459793657|FG000|Overall Study|Other than specified|0|||
127552060|NCT02721966|458987385|FG001|Overall Study|Lost to Follow-up|0|||
127552061|NCT02721966|458987386|FG002|Overall Study|Lost to Follow-up|3|||
127772564|NCT02240693|459793658|FG001|Overall Study|Other than specified|0|||
127772565|NCT02240693|459793659|FG002|Overall Study|Other than specified|2|||
127772566|NCT02240693|459793660|FG003|Overall Study|Other than specified|0|||
127772567|NCT02240693|459793661|FG004|Overall Study|Other than specified|0|||
127772568|NCT01585987|459793662|FG000|Randomized|Withdrawal by Subject|0|||
127772569|NCT01585987|459793663|FG001|Randomized|Withdrawal by Subject|4|||
127772570|NCT01585987|459793662|FG000|Randomized|No longer met criteria|0|||
127772571|NCT01585987|459793663|FG001|Randomized|No longer met criteria|2|||
127772572|NCT01585987|459793662|FG000|Treated|Disease Progression|39|||
127772573|NCT01585987|459793663|FG001|Treated|Disease Progression|36|||
127772574|NCT01585987|459793662|FG000|Treated|Study Drug Toxicity|9|||
127772575|NCT01585987|459793663|FG001|Treated|Study Drug Toxicity|5|||
127772576|NCT01585987|459793662|FG000|Treated|Adverse Event|3|||
127772577|NCT01585987|459793663|FG001|Treated|Adverse Event|0|||
127772578|NCT01585987|459793662|FG000|Treated|Withdrawal by Subject|1|||
127772579|NCT01585987|459793663|FG001|Treated|Withdrawal by Subject|2|||
127772580|NCT01585987|459793662|FG000|Treated|Death|1|||
127772581|NCT01585987|459793663|FG001|Treated|Death|0|||
127772582|NCT01585987|459793662|FG000|Treated|Lost to Follow-up|0|||
127772583|NCT01585987|459793663|FG001|Treated|Lost to Follow-up|1|||
127772584|NCT01585987|459793662|FG000|Treated|Maximum Clinical Benefit|0|||
127772585|NCT01585987|459793663|FG001|Treated|Maximum Clinical Benefit|1|||
127772586|NCT01585987|459793662|FG000|Treated|Non-Specified|1|||
127772587|NCT01585987|459793663|FG001|Treated|Non-Specified|2|||
127772588|NCT01585987|459793662|FG000|Treated|Subject Request|0|||
127772589|NCT01585987|459793663|FG001|Treated|Subject Request|1|||
127772590|NCT01585987|459793662|FG000|Treated|Poor/Non-Compliance|0|||
127772591|NCT01585987|459793663|FG001|Treated|Poor/Non-Compliance|1|||
127772592|NCT00413972|459793667|FG000|Overall Study|Adverse Event|2|||
127772593|NCT00413972|459793668|FG001|Overall Study|Adverse Event|1|||
127772594|NCT00413972|459793669|FG002|Overall Study|Adverse Event|0|||
127772595|NCT00413972|459793670|FG003|Overall Study|Adverse Event|0|||
127772596|NCT00413972|459793667|FG000|Overall Study|Lost to Follow-up|1|||
127772597|NCT00413972|459793668|FG001|Overall Study|Lost to Follow-up|2|||
127772598|NCT00413972|459793669|FG002|Overall Study|Lost to Follow-up|1|||
127772599|NCT00413972|459793670|FG003|Overall Study|Lost to Follow-up|0|||
127772600|NCT00413972|459793667|FG000|Overall Study|Withdrawal by Subject|4|||
127772601|NCT00413972|459793668|FG001|Overall Study|Withdrawal by Subject|5|||
127772602|NCT00413972|459793669|FG002|Overall Study|Withdrawal by Subject|7|||
127772603|NCT00413972|459793670|FG003|Overall Study|Withdrawal by Subject|2|||
127772604|NCT00413972|459793667|FG000|Overall Study|Protocol Violation|0|||
127772605|NCT00413972|459793668|FG001|Overall Study|Protocol Violation|0|||
127772606|NCT00413972|459793669|FG002|Overall Study|Protocol Violation|2|||
127772607|NCT00413972|459793670|FG003|Overall Study|Protocol Violation|0|||
127772608|NCT00413972|459793667|FG000|Overall Study|Other|0|||
127772609|NCT00413972|459793668|FG001|Overall Study|Other|0|||
127772610|NCT00413972|459793669|FG002|Overall Study|Other|0|||
127772611|NCT00413972|459793670|FG003|Overall Study|Other|1|||
127772612|NCT01145755|459793671|FG000|Overall Study|Adverse Event|2|||
127772613|NCT01145755|459793672|FG001|Overall Study|Adverse Event|4|||
127772614|NCT01145755|459793673|FG002|Overall Study|Adverse Event|2|||
127772615|NCT01145755|459793671|FG000|Overall Study|Withdrawal by Subject|2|||
127772616|NCT01145755|459793672|FG001|Overall Study|Withdrawal by Subject|2|||
127772617|NCT01145755|459793673|FG002|Overall Study|Withdrawal by Subject|2|||
127772618|NCT01145755|459793671|FG000|Overall Study|Lost to Follow-up|2|||
128017977|NCT00729586|460689207|FG000|Overall Study|Ineligible|0|||
128017978|NCT00729586|460689208|FG001|Overall Study|Ineligible|1|||
128017979|NCT00729586|460689207|FG000|Overall Study|never treated|1|||
128017980|NCT00729586|460689208|FG001|Overall Study|never treated|0|||
128017981|NCT01991314|460689209|FG000|Overall Study|Adverse Event|5|||
128017982|NCT01991314|460689210|FG001|Overall Study|Adverse Event|1|||
128017983|NCT01991314|460689209|FG000|Overall Study|Lost to Follow-up|6|||
128017984|NCT01991314|460689210|FG001|Overall Study|Lost to Follow-up|10|||
128017985|NCT00970944|460689212|FG000|Overall Study|Death|1|||
128017986|NCT00970944|460689213|FG001|Overall Study|Death|0|||
128017987|NCT00970944|460689212|FG000|Overall Study|Physician Decision|0|||
128017988|NCT00970944|460689213|FG001|Overall Study|Physician Decision|2|||
128017989|NCT00972738|460689214|FG000|Overall Study|Adverse Event|7|||
128017990|NCT00972738|460689215|FG001|Overall Study|Adverse Event|1|||
128017991|NCT00972738|460689216|FG002|Overall Study|Adverse Event|8|||
128017992|NCT00972738|460689214|FG000|Overall Study|Protocol Violation|2|||
128017993|NCT00972738|460689215|FG001|Overall Study|Protocol Violation|1|||
128017994|NCT00972738|460689216|FG002|Overall Study|Protocol Violation|3|||
128017995|NCT00972738|460689214|FG000|Overall Study|Lost to Follow-up|1|||
128017996|NCT00972738|460689215|FG001|Overall Study|Lost to Follow-up|0|||
128017997|NCT00972738|460689216|FG002|Overall Study|Lost to Follow-up|1|||
128017998|NCT00972738|460689214|FG000|Overall Study|Lack of Efficacy|5|||
128017999|NCT00972738|460689215|FG001|Overall Study|Lack of Efficacy|1|||
128018000|NCT00972738|460689216|FG002|Overall Study|Lack of Efficacy|11|||
128018001|NCT00972738|460689214|FG000|Overall Study|Withdrawal by Subject|5|||
128018002|NCT00972738|460689215|FG001|Overall Study|Withdrawal by Subject|1|||
128018003|NCT00972738|460689216|FG002|Overall Study|Withdrawal by Subject|4|||
128018004|NCT00972738|460689214|FG000|Overall Study|Moved|0|||
128018005|NCT00972738|460689215|FG001|Overall Study|Moved|0|||
128018006|NCT00972738|460689216|FG002|Overall Study|Moved|1|||
128018007|NCT00972738|460689214|FG000|Overall Study|Other|1|||
128018008|NCT00972738|460689215|FG001|Overall Study|Other|2|||
128018009|NCT00972738|460689216|FG002|Overall Study|Other|1|||
128018010|NCT03915067|460689217|FG000|Overall Study|Adverse Event|0|||
128018011|NCT03915067|460689218|FG001|Overall Study|Adverse Event|0|||
128018012|NCT03915067|460689219|FG002|Overall Study|Adverse Event|1|||
128018013|NCT03915067|460689217|FG000|Overall Study|Withdrawal by Subject|4|||
128018014|NCT03915067|460689218|FG001|Overall Study|Withdrawal by Subject|3|||
128018015|NCT03915067|460689219|FG002|Overall Study|Withdrawal by Subject|0|||
128018016|NCT03915067|460689217|FG000|Overall Study|Lost to Follow-up|3|||
128018017|NCT03915067|460689218|FG001|Overall Study|Lost to Follow-up|2|||
128018018|NCT03915067|460689219|FG002|Overall Study|Lost to Follow-up|0|||
128018019|NCT03915067|460689217|FG000|Overall Study|Protocol Deviation|0|||
128018020|NCT03915067|460689218|FG001|Overall Study|Protocol Deviation|0|||
128018021|NCT03915067|460689219|FG002|Overall Study|Protocol Deviation|1|||
128018022|NCT03915067|460689217|FG000|Overall Study|Covid-19 Related Issues|2|||
128018023|NCT03915067|460689218|FG001|Overall Study|Covid-19 Related Issues|4|||
128018024|NCT03915067|460689219|FG002|Overall Study|Covid-19 Related Issues|4|||
128018025|NCT03915067|460689217|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
128018026|NCT03915067|460689218|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
128018027|NCT03915067|460689219|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
128018028|NCT01033942|460689220|FG000|Overall Study|Withdrawal by Subject|1|||
128018029|NCT01033942|460689221|FG001|Overall Study|Withdrawal by Subject|1|||
128018030|NCT01033942|460689222|FG002|Overall Study|Withdrawal by Subject|1|||
128018031|NCT01033942|460689220|FG000|Overall Study|Lost to Follow-up|1|||
127772619|NCT01145755|459793672|FG001|Overall Study|Lost to Follow-up|3|||
127772620|NCT01145755|459793673|FG002|Overall Study|Lost to Follow-up|1|||
127772621|NCT01145755|459793671|FG000|Overall Study|Protocol Violation|0|||
127772622|NCT01145755|459793672|FG001|Overall Study|Protocol Violation|3|||
127772623|NCT01145755|459793673|FG002|Overall Study|Protocol Violation|1|||
127772624|NCT01145755|459793671|FG000|Overall Study|Study Closure|14|||
127772625|NCT01145755|459793672|FG001|Overall Study|Study Closure|14|||
127772626|NCT01145755|459793673|FG002|Overall Study|Study Closure|17|||
127772627|NCT01145755|459793671|FG000|Overall Study|Lack of Efficacy|0|||
127772628|NCT01145755|459793672|FG001|Overall Study|Lack of Efficacy|1|||
128018032|NCT01033942|460689221|FG001|Overall Study|Lost to Follow-up|0|||
128018033|NCT01033942|460689222|FG002|Overall Study|Lost to Follow-up|0|||
127772629|NCT01145755|459793673|FG002|Overall Study|Lack of Efficacy|0|||
127772630|NCT01145755|459793671|FG000|Overall Study|Patient could not swollow medication|0|||
128018034|NCT01033942|460689220|FG000|Overall Study|Enrolled in Extension Study|0|||
127772631|NCT01145755|459793672|FG001|Overall Study|Patient could not swollow medication|0|||
127772632|NCT01145755|459793673|FG002|Overall Study|Patient could not swollow medication|1|||
127772633|NCT01145755|459793671|FG000|Overall Study|Withdrawal by Subject|0|||
128018035|NCT01033942|460689221|FG001|Overall Study|Enrolled in Extension Study|3|||
128018036|NCT01033942|460689222|FG002|Overall Study|Enrolled in Extension Study|0|||
128018037|NCT02693418|460689223|FG000|Overall Study|Lost to Follow-up|1|||
128018038|NCT02693418|460689224|FG001|Overall Study|Lost to Follow-up|2|||
128018039|NCT02693418|460689225|FG002|Overall Study|Lost to Follow-up|0|||
128018040|NCT02693418|460689226|FG003|Overall Study|Lost to Follow-up|0|||
128018041|NCT02693418|460689227|FG004|Overall Study|Lost to Follow-up|0|||
128018042|NCT02693418|460689223|FG000|Overall Study|Menses during study period|0|||
128018043|NCT02693418|460689224|FG001|Overall Study|Menses during study period|0|||
128018044|NCT02693418|460689225|FG002|Overall Study|Menses during study period|2|||
128018045|NCT02693418|460689226|FG003|Overall Study|Menses during study period|0|||
128018046|NCT02693418|460689227|FG004|Overall Study|Menses during study period|0|||
128018047|NCT02260986|460689233|FG000|Overall Study|Adverse Event|24|||
128018048|NCT02260986|460689234|FG001|Overall Study|Adverse Event|0|||
128018049|NCT02260986|460689235|FG002|Overall Study|Adverse Event|11|||
128018050|NCT02260986|460689233|FG000|Overall Study|Lack of Efficacy|27|||
128018051|NCT02260986|460689234|FG001|Overall Study|Lack of Efficacy|3|||
128018052|NCT02260986|460689235|FG002|Overall Study|Lack of Efficacy|0|||
128018053|NCT02260986|460689233|FG000|Overall Study|Protocol Violation|14|||
128018054|NCT02260986|460689234|FG001|Overall Study|Protocol Violation|5|||
128018055|NCT02260986|460689235|FG002|Overall Study|Protocol Violation|16|||
128018056|NCT02260986|460689233|FG000|Overall Study|Car accident|0|||
128018057|NCT02260986|460689234|FG001|Overall Study|Car accident|0|||
128018058|NCT02260986|460689235|FG002|Overall Study|Car accident|1|||
128018059|NCT02260986|460689233|FG000|Overall Study|Withdrawal by Subject|17|||
128018060|NCT02260986|460689234|FG001|Overall Study|Withdrawal by Subject|4|||
128018061|NCT02260986|460689235|FG002|Overall Study|Withdrawal by Subject|9|||
128018062|NCT02260986|460689233|FG000|Overall Study|Incorrect randomization|0|||
128018063|NCT02260986|460689234|FG001|Overall Study|Incorrect randomization|1|||
128018064|NCT02260986|460689235|FG002|Overall Study|Incorrect randomization|0|||
128018065|NCT02260986|460689233|FG000|Overall Study|Lack of investigation product supply|2|||
128018066|NCT02260986|460689234|FG001|Overall Study|Lack of investigation product supply|0|||
127552062|NCT02721966|458987387|FG003|Overall Study|Lost to Follow-up|0|||
127552063|NCT02721966|458987388|FG004|Overall Study|Lost to Follow-up|0|||
127552064|NCT02721966|458987384|FG000|Overall Study|Physician Decision|1|||
127552065|NCT02721966|458987385|FG001|Overall Study|Physician Decision|1|||
127552066|NCT02721966|458987386|FG002|Overall Study|Physician Decision|0|||
127552067|NCT02721966|458987387|FG003|Overall Study|Physician Decision|0|||
127685593|NCT01068743|459474819|FG000|Period 3|Adverse Event|0|||
127685594|NCT01068743|459474820|FG001|Period 3|Adverse Event|1|||
127685595|NCT01068743|459474821|FG002|Period 3|Adverse Event|0|||
127685596|NCT01068743|459474822|FG003|Period 3|Adverse Event|0|||
127685597|NCT02507752|459474823|FG000|Overall Study|Adverse Event|1|||
127685598|NCT02507752|459474823|FG000|Overall Study|Protocol Violation|6|||
127685599|NCT02507752|459474823|FG000|Overall Study|Lost to Follow-up|7|||
127685600|NCT02507752|459474823|FG000|Overall Study|Infusion reaction at first infusion|1|||
127685601|NCT02507752|459474823|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
127685602|NCT02507752|459474823|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
127685603|NCT00939510|459474833|FG000|Overall Study|Withdrawal by Subject|1|||
127685604|NCT05782231|459474847|FG000|Overall Study|Withdrawal by Subject|1|||
127685605|NCT02528188|459474851|FG000|Overall Study|Adverse Event|23|||
127685606|NCT02528188|459474852|FG001|Overall Study|Adverse Event|22|||
127685607|NCT02528188|459474853|FG002|Overall Study|Adverse Event|8|||
127685608|NCT02528188|459474851|FG000|Overall Study|Protocol Violation|4|||
127685609|NCT02528188|459474852|FG001|Overall Study|Protocol Violation|6|||
127685610|NCT02528188|459474853|FG002|Overall Study|Protocol Violation|4|||
127685611|NCT02528188|459474851|FG000|Overall Study|Lack of Efficacy|19|||
127685612|NCT02528188|459474852|FG001|Overall Study|Lack of Efficacy|21|||
127685613|NCT02528188|459474853|FG002|Overall Study|Lack of Efficacy|22|||
127685614|NCT02528188|459474851|FG000|Overall Study|Withdrawal by Subject|97|||
127685615|NCT02528188|459474852|FG001|Overall Study|Withdrawal by Subject|104|||
127685616|NCT02528188|459474853|FG002|Overall Study|Withdrawal by Subject|100|||
127685617|NCT02528188|459474851|FG000|Overall Study|Lost to Follow-up|25|||
127685618|NCT02528188|459474852|FG001|Overall Study|Lost to Follow-up|21|||
127685619|NCT02528188|459474853|FG002|Overall Study|Lost to Follow-up|31|||
127685620|NCT02528188|459474851|FG000|Overall Study|Death|4|||
127685621|NCT02528188|459474852|FG001|Overall Study|Death|4|||
127685622|NCT02528188|459474853|FG002|Overall Study|Death|0|||
127685623|NCT02528188|459474851|FG000|Overall Study|Other|89|||
127685624|NCT02528188|459474852|FG001|Overall Study|Other|91|||
127685625|NCT02528188|459474853|FG002|Overall Study|Other|74|||
127685626|NCT02528188|459474851|FG000|Overall Study|Randomized but not treated|6|||
127685627|NCT02528188|459474852|FG001|Overall Study|Randomized but not treated|7|||
127685628|NCT02528188|459474853|FG002|Overall Study|Randomized but not treated|12|||
127685629|NCT01692730|459474859|FG000|Overall Study|Lost to Follow-up|225|||
128018067|NCT02260986|460689235|FG002|Overall Study|Lack of investigation product supply|1|||
128018068|NCT02260986|460689233|FG000|Overall Study|Lost to Follow-up|4|||
128018069|NCT02260986|460689234|FG001|Overall Study|Lost to Follow-up|0|||
128018070|NCT02260986|460689235|FG002|Overall Study|Lost to Follow-up|3|||
127552068|NCT02721966|458987388|FG004|Overall Study|Physician Decision|0|||
127552069|NCT02721966|458987384|FG000|Overall Study|Pregnancy|1|||
127685630|NCT01692730|459474860|FG001|Overall Study|Lost to Follow-up|227|||
127685631|NCT00933400|459474861|FG000|Overall Study|Withdrawal by Subject|21|||
127685632|NCT00933400|459474862|FG001|Overall Study|Withdrawal by Subject|1|||
127685633|NCT00716859|459474863|FG000|Overall Study|Adverse Event|4|||
127685634|NCT00716859|459474864|FG001|Overall Study|Adverse Event|1|||
128018071|NCT02260986|460689233|FG000|Overall Study|Pregnancy|2|||
128018072|NCT02260986|460689234|FG001|Overall Study|Pregnancy|0|||
128018073|NCT02260986|460689235|FG002|Overall Study|Pregnancy|0|||
128018074|NCT01793935|460689238|FG000|Overall Study|Pregnancy|1|||
128018075|NCT01793935|460689239|FG001|Overall Study|Pregnancy|0|||
128018076|NCT01793935|460689238|FG000|Overall Study|Protocol Violation|2|||
128018077|NCT01793935|460689239|FG001|Overall Study|Protocol Violation|1|||
128018078|NCT01793935|460689238|FG000|Overall Study|Adverse Event|2|||
128018079|NCT01793935|460689239|FG001|Overall Study|Adverse Event|0|||
128018080|NCT01793935|460689238|FG000|Overall Study|Patient did not take study medication|1|||
128018081|NCT01793935|460689239|FG001|Overall Study|Patient did not take study medication|1|||
128018082|NCT01793935|460689238|FG000|Overall Study|Lost to Follow-up|0|||
128018083|NCT01793935|460689239|FG001|Overall Study|Lost to Follow-up|1|||
128018084|NCT00313170|460689241|FG000|Overall Study|Death|2|||
128018085|NCT00313170|460689242|FG001|Overall Study|Death|4|||
128018086|NCT00313170|460689243|FG002|Overall Study|Death|2|||
128018087|NCT00313170|460689241|FG000|Overall Study|Adverse Event|1|||
128018088|NCT00313170|460689242|FG001|Overall Study|Adverse Event|2|||
128018089|NCT00313170|460689243|FG002|Overall Study|Adverse Event|0|||
128018090|NCT00313170|460689241|FG000|Overall Study|Disease progression|31|||
128018091|NCT00313170|460689242|FG001|Overall Study|Disease progression|26|||
128018092|NCT00313170|460689243|FG002|Overall Study|Disease progression|27|||
128018093|NCT00313170|460689241|FG000|Overall Study|Withdrawal by Subject|1|||
128018094|NCT00313170|460689242|FG001|Overall Study|Withdrawal by Subject|0|||
128018095|NCT00313170|460689243|FG002|Overall Study|Withdrawal by Subject|1|||
128018096|NCT00313170|460689241|FG000|Overall Study|Incorrect enrollment|0|||
128018097|NCT00313170|460689242|FG001|Overall Study|Incorrect enrollment|2|||
128018098|NCT00313170|460689243|FG002|Overall Study|Incorrect enrollment|1|||
128018099|NCT00313170|460689241|FG000|Overall Study|Lost to Follow-up|0|||
128018100|NCT00313170|460689242|FG001|Overall Study|Lost to Follow-up|0|||
128018101|NCT00313170|460689243|FG002|Overall Study|Lost to Follow-up|1|||
128018102|NCT00313170|460689241|FG000|Overall Study|Progression (investigators opinion)|1|||
128018103|NCT00313170|460689242|FG001|Overall Study|Progression (investigators opinion)|0|||
128018104|NCT00313170|460689243|FG002|Overall Study|Progression (investigators opinion)|0|||
128018105|NCT00529035|460689244|FG000|Overall Study|Withdrawal by Subject|1|||
128018106|NCT02175758|460689245|FG000|Treatment Phase|Lost to Follow-up|0|||
128018107|NCT02175758|460689246|FG001|Treatment Phase|Lost to Follow-up|1|||
128018108|NCT02175758|460689247|FG002|Treatment Phase|Lost to Follow-up|0|||
128018109|NCT02175758|460689248|FG003|Treatment Phase|Lost to Follow-up|0|||
128018110|NCT02175758|460689249|FG004|Treatment Phase|Lost to Follow-up|0|||
127772634|NCT01145755|459793672|FG001|Overall Study|Withdrawal by Subject|0|||
127772635|NCT01145755|459793673|FG002|Overall Study|Withdrawal by Subject|1|||
127772636|NCT01145755|459793671|FG000|Overall Study|Positive urine ethanol|0|||
127772637|NCT01145755|459793672|FG001|Overall Study|Positive urine ethanol|1|||
128018111|NCT02175758|460689250|FG005|Treatment Phase|Lost to Follow-up|0|||
128018112|NCT02175758|460689245|FG000|Treatment Phase|Adverse Event|0|||
128018113|NCT02175758|460689246|FG001|Treatment Phase|Adverse Event|0|||
128018114|NCT02175758|460689247|FG002|Treatment Phase|Adverse Event|0|||
127772638|NCT01145755|459793673|FG002|Overall Study|Positive urine ethanol|0|||
127772639|NCT02092220|459793679|FG000|Period 1|Unrelated Illness|0|||
127772640|NCT02092220|459793680|FG001|Period 1|Unrelated Illness|2|||
127772641|NCT02092220|459793679|FG000|Period 2|Severe Hypoglycaemia|1|||
127772642|NCT02092220|459793680|FG001|Period 2|Severe Hypoglycaemia|0|||
127772643|NCT02092220|459793679|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
127772644|NCT02092220|459793680|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
127772645|NCT02739360|459793681|FG000|Overall Study|Adverse Event|1|||
127772646|NCT02739360|459793681|FG000|Overall Study|Study terminated by Sponsor|2|||
127772647|NCT01193920|459793682|FG000|Overall Study|Withdrawal by Subject|1|||
127772648|NCT01193920|459793683|FG001|Overall Study|Withdrawal by Subject|0|||
127772649|NCT01193920|459793684|FG002|Overall Study|Withdrawal by Subject|5|||
127772650|NCT01193920|459793685|FG003|Overall Study|Withdrawal by Subject|1|||
128018115|NCT02175758|460689248|FG003|Treatment Phase|Adverse Event|0|||
128018116|NCT02175758|460689249|FG004|Treatment Phase|Adverse Event|1|||
128018117|NCT02175758|460689250|FG005|Treatment Phase|Adverse Event|0|||
128018118|NCT05607043|460689254|FG000|Overall Study|Lost to Follow-up|2|||
127772651|NCT01193920|459793686|FG004|Overall Study|Withdrawal by Subject|3|||
127772652|NCT01193920|459793687|FG005|Overall Study|Withdrawal by Subject|1|||
128018119|NCT00429299|460689258|FG000|Overall Study|Disease Progression|1|||
128018120|NCT00429299|460689259|FG001|Overall Study|Disease Progression|1|||
128018121|NCT00429299|460689260|FG002|Overall Study|Disease Progression|0|||
128018122|NCT00429299|460689258|FG000|Overall Study|Adverse Event|2|||
128018123|NCT00429299|460689259|FG001|Overall Study|Adverse Event|5|||
128018124|NCT00429299|460689260|FG002|Overall Study|Adverse Event|1|||
127772653|NCT01193920|459793688|FG006|Overall Study|Withdrawal by Subject|3|||
128018125|NCT00429299|460689258|FG000|Overall Study|Protocol Violation|1|||
128018126|NCT00429299|460689259|FG001|Overall Study|Protocol Violation|0|||
128018127|NCT00429299|460689260|FG002|Overall Study|Protocol Violation|0|||
128018128|NCT00429299|460689258|FG000|Overall Study|Withdrawal by Subject|0|||
128018129|NCT00429299|460689259|FG001|Overall Study|Withdrawal by Subject|1|||
128018130|NCT00429299|460689260|FG002|Overall Study|Withdrawal by Subject|3|||
128018131|NCT04871113|460689261|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
128018132|NCT04871113|460689262|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
128018133|NCT04871113|460689263|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
128018134|NCT04871113|460689264|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
128018135|NCT04871113|460689265|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
128018136|NCT04871113|460689266|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|1|||
128018137|NCT04871113|460689267|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
128018138|NCT04871113|460689268|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
128018139|NCT04871113|460689269|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
128018140|NCT04871113|460689270|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
128018141|NCT04871113|460689261|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
128018142|NCT04871113|460689262|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
128018143|NCT04871113|460689263|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
128018144|NCT04871113|460689264|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
128018145|NCT04871113|460689265|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
128018146|NCT04871113|460689266|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
128018147|NCT04871113|460689267|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|1|||
128018148|NCT04871113|460689268|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|2|||
128018149|NCT04871113|460689269|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
128018150|NCT04871113|460689270|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
128018151|NCT01257542|460689271|FG000|Overall Study|Protocol Violation|3|||
128018152|NCT01257542|460689272|FG001|Overall Study|Protocol Violation|5|||
128018153|NCT01257542|460689271|FG000|Overall Study|Withdrawal by Subject|0|||
128018154|NCT01257542|460689272|FG001|Overall Study|Withdrawal by Subject|2|||
128018155|NCT02202616|460689275|FG000|Overall Study|Screen failed|24|||
128018156|NCT02202616|460689275|FG000|Overall Study|Adverse Event|32|||
128018157|NCT02202616|460689275|FG000|Overall Study|Protocol deviation|18|||
128018158|NCT02202616|460689275|FG000|Overall Study|Patient withdrew consent|12|||
128018159|NCT02202616|460689275|FG000|Overall Study|Lost to Follow-up|6|||
128018160|NCT02202616|460689275|FG000|Overall Study|Administrative problems|6|||
128018161|NCT02202616|460689275|FG000|Overall Study|Abnormal test procedure result|1|||
128018162|NCT02202616|460689275|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
128018163|NCT01334515|460689276|FG000|Overall Study|Adverse Event|1|||
128018164|NCT01334515|460689277|FG001|Overall Study|Adverse Event|6|||
128018165|NCT01334515|460689276|FG000|Overall Study|Death|1|||
128018166|NCT01334515|460689277|FG001|Overall Study|Death|0|||
128018167|NCT01334515|460689276|FG000|Overall Study|Lack of Efficacy|8|||
128018168|NCT01334515|460689277|FG001|Overall Study|Lack of Efficacy|21|||
128018169|NCT01334515|460689276|FG000|Overall Study|Physician Decision|1|||
128018170|NCT01334515|460689277|FG001|Overall Study|Physician Decision|1|||
128018171|NCT01334515|460689276|FG000|Overall Study|Withdrawal by Subject|1|||
128018172|NCT01334515|460689277|FG001|Overall Study|Withdrawal by Subject|1|||
128018173|NCT04327271|460689278|FG000|Overall Study|Death|1|||
127772654|NCT01193920|459793689|FG007|Overall Study|Withdrawal by Subject|0|||
127772655|NCT01193920|459793690|FG008|Overall Study|Withdrawal by Subject|1|||
127772656|NCT01193920|459793691|FG009|Overall Study|Withdrawal by Subject|0|||
127772657|NCT01193920|459793682|FG000|Overall Study|Lost to Follow-up|1|||
127772658|NCT01193920|459793683|FG001|Overall Study|Lost to Follow-up|0|||
127772659|NCT01193920|459793684|FG002|Overall Study|Lost to Follow-up|1|||
127772660|NCT01193920|459793685|FG003|Overall Study|Lost to Follow-up|1|||
127772661|NCT01193920|459793686|FG004|Overall Study|Lost to Follow-up|3|||
127772662|NCT01193920|459793687|FG005|Overall Study|Lost to Follow-up|3|||
127772663|NCT01193920|459793688|FG006|Overall Study|Lost to Follow-up|1|||
127772664|NCT01193920|459793689|FG007|Overall Study|Lost to Follow-up|0|||
127772665|NCT01193920|459793690|FG008|Overall Study|Lost to Follow-up|2|||
127772666|NCT01193920|459793691|FG009|Overall Study|Lost to Follow-up|3|||
127772667|NCT01193920|459793682|FG000|Overall Study|Protocol Violation|1|||
127772668|NCT01193920|459793683|FG001|Overall Study|Protocol Violation|0|||
127772669|NCT01193920|459793684|FG002|Overall Study|Protocol Violation|0|||
127772670|NCT01193920|459793685|FG003|Overall Study|Protocol Violation|0|||
127772671|NCT01193920|459793686|FG004|Overall Study|Protocol Violation|0|||
127772672|NCT01193920|459793687|FG005|Overall Study|Protocol Violation|0|||
128018174|NCT04327271|460689279|FG001|Overall Study|Death|0|||
128018175|NCT04327271|460689278|FG000|Overall Study|Withdrawal by Subject|1|||
127772673|NCT01193920|459793688|FG006|Overall Study|Protocol Violation|0|||
128018176|NCT04327271|460689279|FG001|Overall Study|Withdrawal by Subject|0|||
128018177|NCT04327271|460689278|FG000|Overall Study|randomization error (data capture)|4|||
128018178|NCT04327271|460689279|FG001|Overall Study|randomization error (data capture)|3|||
128018179|NCT01479530|460689281|FG000|Overall Study|Adverse Event|5|||
128018180|NCT01479530|460689282|FG001|Overall Study|Adverse Event|6|||
128018181|NCT01479530|460689281|FG000|Overall Study|Lack of Efficacy|0|||
128018182|NCT01479530|460689282|FG001|Overall Study|Lack of Efficacy|1|||
127772674|NCT01193920|459793689|FG007|Overall Study|Protocol Violation|0|||
127772675|NCT01193920|459793690|FG008|Overall Study|Protocol Violation|0|||
127772676|NCT01193920|459793691|FG009|Overall Study|Protocol Violation|0|||
127772677|NCT01193920|459793682|FG000|Overall Study|Death|0|||
127772678|NCT01193920|459793683|FG001|Overall Study|Death|0|||
127772679|NCT01193920|459793684|FG002|Overall Study|Death|0|||
127772680|NCT01193920|459793685|FG003|Overall Study|Death|1|||
127772681|NCT01193920|459793686|FG004|Overall Study|Death|0|||
127772682|NCT01193920|459793687|FG005|Overall Study|Death|0|||
127772683|NCT01193920|459793688|FG006|Overall Study|Death|2|||
127772684|NCT01193920|459793689|FG007|Overall Study|Death|3|||
127772685|NCT01193920|459793690|FG008|Overall Study|Death|2|||
127772686|NCT01193920|459793691|FG009|Overall Study|Death|4|||
127772687|NCT01193920|459793682|FG000|Overall Study|Unable to classify|0|||
127772688|NCT01193920|459793683|FG001|Overall Study|Unable to classify|0|||
127772689|NCT01193920|459793684|FG002|Overall Study|Unable to classify|0|||
127772690|NCT01193920|459793685|FG003|Overall Study|Unable to classify|1|||
127772691|NCT01193920|459793686|FG004|Overall Study|Unable to classify|0|||
127772692|NCT01193920|459793687|FG005|Overall Study|Unable to classify|0|||
127772693|NCT01193920|459793688|FG006|Overall Study|Unable to classify|0|||
127772694|NCT01193920|459793689|FG007|Overall Study|Unable to classify|1|||
127772695|NCT01193920|459793690|FG008|Overall Study|Unable to classify|0|||
127772696|NCT01193920|459793691|FG009|Overall Study|Unable to classify|0|||
127772697|NCT01231516|459793694|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
127772698|NCT01231516|459793695|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
127772699|NCT01231516|459793694|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
127772700|NCT01231516|459793695|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
127772701|NCT01231516|459793694|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
127772702|NCT01231516|459793695|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
128018183|NCT01479530|460689281|FG000|Overall Study|Protocol Violation|2|||
128018184|NCT01479530|460689282|FG001|Overall Study|Protocol Violation|3|||
127772703|NCT01231516|459793694|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
127772704|NCT01231516|459793695|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
127772705|NCT01231516|459793694|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
127772706|NCT01231516|459793695|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
127772707|NCT01231516|459793694|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
127772708|NCT01231516|459793695|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
127772709|NCT01231516|459793694|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
127772710|NCT01231516|459793695|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
127772711|NCT01231516|459793694|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
127772712|NCT01231516|459793695|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
127772713|NCT01231516|459793694|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
127772714|NCT01231516|459793695|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
127772715|NCT01231516|459793694|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
127772716|NCT01231516|459793695|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
128018185|NCT01479530|460689281|FG000|Overall Study|Withdrawal of Consent|3|||
128018186|NCT01479530|460689282|FG001|Overall Study|Withdrawal of Consent|2|||
128018187|NCT00303628|460689283|FG000|Overall Study|Disease progression|0|||
128018188|NCT00303628|460689284|FG001|Overall Study|Disease progression|1|||
128018189|NCT00303628|460689283|FG000|Overall Study|Adverse Event|26|||
128018190|NCT00303628|460689284|FG001|Overall Study|Adverse Event|36|||
128018191|NCT00303628|460689283|FG000|Overall Study|Death|0|||
128018192|NCT00303628|460689284|FG001|Overall Study|Death|1|||
128018193|NCT00303628|460689283|FG000|Overall Study|Withdrawal by Subject|11|||
128018194|NCT00303628|460689284|FG001|Overall Study|Withdrawal by Subject|20|||
128018195|NCT00303628|460689283|FG000|Overall Study|Alternative therapy|2|||
128018196|NCT00303628|460689284|FG001|Overall Study|Alternative therapy|0|||
128018197|NCT00303628|460689283|FG000|Overall Study|Other complicating disease|0|||
128018198|NCT00303628|460689284|FG001|Overall Study|Other complicating disease|1|||
128018199|NCT00303628|460689283|FG000|Overall Study|Not start protocol therapy|3|||
128018200|NCT00303628|460689284|FG001|Overall Study|Not start protocol therapy|5|||
127772717|NCT01231516|459793694|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
127772718|NCT01231516|459793695|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
127772719|NCT01231516|459793694|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
127772720|NCT01231516|459793695|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
127772721|NCT01231516|459793694|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
127772722|NCT01231516|459793695|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
127772723|NCT01231516|459793694|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
127772724|NCT01231516|459793695|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
128018201|NCT00303628|460689283|FG000|Overall Study|Other|8|||
128018202|NCT00303628|460689284|FG001|Overall Study|Other|9|||
128018203|NCT00776997|460689285|FG000|Overall Study|Adverse Event|2|||
128018204|NCT03487445|460689286|FG000|Randomization|Not treated for administrative reasons|1|||
128018205|NCT03487445|460689287|FG001|Randomization|Not treated for administrative reasons|0|||
128018206|NCT03301714|460689288|FG000|Overall Study|Lost to Follow-up|10|||
128018207|NCT03301714|460689289|FG001|Overall Study|Lost to Follow-up|4|||
128018208|NCT03301714|460689290|FG002|Overall Study|Lost to Follow-up|4|||
128018209|NCT03301714|460689288|FG000|Overall Study|Did not receive allocated intervention|0|||
128018210|NCT03301714|460689289|FG001|Overall Study|Did not receive allocated intervention|2|||
128018211|NCT03301714|460689290|FG002|Overall Study|Did not receive allocated intervention|3|||
128018212|NCT03412890|460689299|FG000|Overall Study|Adverse Event|5|||
128018213|NCT03412890|460689300|FG001|Overall Study|Adverse Event|5|||
128018214|NCT03412890|460689301|FG002|Overall Study|Adverse Event|9|||
128018215|NCT03412890|460689299|FG000|Overall Study|Protocol deviation|2|||
128018216|NCT03412890|460689300|FG001|Overall Study|Protocol deviation|1|||
128018217|NCT03412890|460689301|FG002|Overall Study|Protocol deviation|2|||
128018218|NCT03412890|460689299|FG000|Overall Study|Lost to Follow-up|7|||
128018219|NCT03412890|460689300|FG001|Overall Study|Lost to Follow-up|10|||
128018220|NCT03412890|460689301|FG002|Overall Study|Lost to Follow-up|10|||
128018221|NCT03412890|460689299|FG000|Overall Study|Withdrawal by Subject|9|||
128018222|NCT03412890|460689300|FG001|Overall Study|Withdrawal by Subject|12|||
128018223|NCT03412890|460689301|FG002|Overall Study|Withdrawal by Subject|11|||
128018224|NCT03412890|460689299|FG000|Overall Study|Lack of Efficacy|2|||
128018225|NCT03412890|460689300|FG001|Overall Study|Lack of Efficacy|7|||
128018226|NCT03412890|460689301|FG002|Overall Study|Lack of Efficacy|5|||
128018227|NCT03412890|460689299|FG000|Overall Study|Other|5|||
128018228|NCT03412890|460689300|FG001|Overall Study|Other|6|||
128018229|NCT03412890|460689301|FG002|Overall Study|Other|5|||
128018230|NCT03412890|460689299|FG000|Overall Study|Participants who did not receive any study drug|0|||
128018231|NCT03412890|460689300|FG001|Overall Study|Participants who did not receive any study drug|1|||
128018232|NCT03412890|460689301|FG002|Overall Study|Participants who did not receive any study drug|0|||
128018233|NCT02949934|460689302|FG000|Natural Drinking Period|Adverse Event|1|||
128018234|NCT02949934|460689303|FG001|Natural Drinking Period|Adverse Event|0|||
128018235|NCT02949934|460689304|FG002|Natural Drinking Period|Adverse Event|0|||
128018236|NCT02949934|460689305|FG003|Natural Drinking Period|Adverse Event|1|||
128018237|NCT02949934|460689306|FG004|Natural Drinking Period|Adverse Event|0|||
128018238|NCT02949934|460689307|FG005|Natural Drinking Period|Adverse Event|0|||
128018239|NCT02949934|460689302|FG000|Natural Drinking Period|Lost to Follow-up|0|||
128018240|NCT02949934|460689303|FG001|Natural Drinking Period|Lost to Follow-up|0|||
128018241|NCT02949934|460689304|FG002|Natural Drinking Period|Lost to Follow-up|0|||
128018242|NCT02949934|460689305|FG003|Natural Drinking Period|Lost to Follow-up|0|||
128018243|NCT02949934|460689306|FG004|Natural Drinking Period|Lost to Follow-up|1|||
128018244|NCT02949934|460689307|FG005|Natural Drinking Period|Lost to Follow-up|0|||
128018245|NCT02949934|460689302|FG000|Neuroimaging|Protocol Violation|2|||
128018246|NCT02949934|460689303|FG001|Neuroimaging|Protocol Violation|0|||
128018247|NCT02949934|460689304|FG002|Neuroimaging|Protocol Violation|0|||
128018248|NCT02949934|460689305|FG003|Neuroimaging|Protocol Violation|0|||
128018249|NCT02949934|460689306|FG004|Neuroimaging|Protocol Violation|1|||
128018250|NCT02949934|460689307|FG005|Neuroimaging|Protocol Violation|0|||
128018251|NCT02949934|460689302|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
127772725|NCT01231516|459793694|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
128018252|NCT02949934|460689303|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
128018253|NCT02949934|460689304|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
128018254|NCT02949934|460689305|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
128018255|NCT02949934|460689306|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
128018256|NCT02949934|460689307|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
127772726|NCT01231516|459793695|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
127772727|NCT01231516|459793694|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
128018257|NCT02949934|460689302|FG000|Neuroimaging|Not scanned|0|||
128018258|NCT02949934|460689303|FG001|Neuroimaging|Not scanned|0|||
128018259|NCT02949934|460689304|FG002|Neuroimaging|Not scanned|1|||
128018260|NCT02949934|460689305|FG003|Neuroimaging|Not scanned|0|||
128018261|NCT02949934|460689306|FG004|Neuroimaging|Not scanned|0|||
128018262|NCT02949934|460689307|FG005|Neuroimaging|Not scanned|2|||
128018263|NCT02949934|460689302|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
128018264|NCT02949934|460689303|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
128018265|NCT02949934|460689304|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
128018266|NCT02949934|460689305|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
128018267|NCT02949934|460689306|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
128018268|NCT02949934|460689307|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
128018269|NCT02949934|460689302|FG000|Bar Laboratory|Adverse Event|1|||
128018270|NCT02949934|460689303|FG001|Bar Laboratory|Adverse Event|0|||
128018271|NCT02949934|460689304|FG002|Bar Laboratory|Adverse Event|2|||
128018272|NCT02949934|460689305|FG003|Bar Laboratory|Adverse Event|0|||
128018273|NCT02949934|460689306|FG004|Bar Laboratory|Adverse Event|1|||
128018274|NCT02949934|460689307|FG005|Bar Laboratory|Adverse Event|0|||
128018275|NCT02949934|460689302|FG000|Bar Laboratory|Protocol Violation|0|||
128018276|NCT02949934|460689303|FG001|Bar Laboratory|Protocol Violation|0|||
128018277|NCT02949934|460689304|FG002|Bar Laboratory|Protocol Violation|0|||
128018278|NCT02949934|460689305|FG003|Bar Laboratory|Protocol Violation|1|||
128018279|NCT02949934|460689306|FG004|Bar Laboratory|Protocol Violation|0|||
128018280|NCT02949934|460689307|FG005|Bar Laboratory|Protocol Violation|0|||
128018281|NCT03599713|460689311|FG000|Overall Study|Death|38|||
128018282|NCT03599713|460689312|FG001|Overall Study|Death|3|||
128018283|NCT03599713|460689311|FG000|Overall Study|Withdrawal by Subject|17|||
128018284|NCT03599713|460689312|FG001|Overall Study|Withdrawal by Subject|0|||
128018285|NCT03599713|460689311|FG000|Overall Study|Lost to Follow-up|4|||
128018286|NCT03599713|460689312|FG001|Overall Study|Lost to Follow-up|0|||
128018287|NCT03599713|460689311|FG000|Overall Study|Discontinued Due to End of Study|42|||
128018288|NCT03599713|460689312|FG001|Overall Study|Discontinued Due to End of Study|3|||
128018289|NCT04167670|460690301|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
128018290|NCT04167670|460690302|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
128018291|NCT04167670|460690303|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
128018292|NCT04167670|460690301|FG000|Overall Study|Significant protocol deviation|3|||
128018293|NCT04167670|460690302|FG001|Overall Study|Significant protocol deviation|1|||
128018294|NCT04167670|460690303|FG002|Overall Study|Significant protocol deviation|0|||
128018295|NCT04167670|460690301|FG000|Overall Study|Lost to Follow-up|0|||
128018296|NCT04167670|460690302|FG001|Overall Study|Lost to Follow-up|3|||
128018297|NCT04167670|460690303|FG002|Overall Study|Lost to Follow-up|3|||
128018298|NCT04167670|460690301|FG000|Overall Study|Voluntary Withdrawal|0|||
128018299|NCT04167670|460690302|FG001|Overall Study|Voluntary Withdrawal|1|||
128018300|NCT04167670|460690303|FG002|Overall Study|Voluntary Withdrawal|1|||
128018301|NCT04167670|460690301|FG000|Overall Study|Withdrawal of Consent|4|||
128018302|NCT04167670|460690302|FG001|Overall Study|Withdrawal of Consent|1|||
128018303|NCT04167670|460690303|FG002|Overall Study|Withdrawal of Consent|3|||
128018304|NCT04167670|460690301|FG000|Overall Study|Miscellaneous|7|||
128018305|NCT04167670|460690302|FG001|Overall Study|Miscellaneous|5|||
128018306|NCT04167670|460690303|FG002|Overall Study|Miscellaneous|3|||
128018307|NCT01127061|460690304|FG000|Overall Study|Lost to Follow-up|7|||
128018308|NCT01127061|460690305|FG001|Overall Study|Lost to Follow-up|10|||
128018309|NCT01127061|460690304|FG000|Overall Study|Physician Decision|3|||
128018310|NCT01127061|460690305|FG001|Overall Study|Physician Decision|3|||
128018311|NCT04827446|460690306|FG000|Overall Study|Lost to Follow-up|1|||
128018312|NCT04827446|460690307|FG001|Overall Study|Lost to Follow-up|1|||
128018313|NCT04827446|460690306|FG000|Overall Study|Death|2|||
128018314|NCT04827446|460690307|FG001|Overall Study|Death|0|||
128018315|NCT04827446|460690306|FG000|Overall Study|Withdrawal by Subject|2|||
128018316|NCT04827446|460690307|FG001|Overall Study|Withdrawal by Subject|2|||
128018317|NCT00003456|460690312|FG000|Overall Study|Not evaluable|8|||
128018318|NCT00479232|460690313|FG000|Overall Study|Adverse Event|0|||
128018319|NCT00479232|460690314|FG001|Overall Study|Adverse Event|0|||
128018320|NCT00479232|460690315|FG002|Overall Study|Adverse Event|5|||
128018321|NCT00479232|460690316|FG003|Overall Study|Adverse Event|0|||
128018322|NCT00479232|460690317|FG004|Overall Study|Adverse Event|0|||
127772728|NCT01231516|459793695|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
127772729|NCT03170154|459793696|FG000|Overall Study|Lost to Follow-up|4|||
128018323|NCT00479232|460690318|FG005|Overall Study|Adverse Event|10|||
127772730|NCT03170154|459793696|FG000|Overall Study|Death|2|||
128018324|NCT00479232|460690313|FG000|Overall Study|Deviation from Protocol|0|||
128018325|NCT00479232|460690314|FG001|Overall Study|Deviation from Protocol|0|||
128018326|NCT00479232|460690315|FG002|Overall Study|Deviation from Protocol|1|||
128018327|NCT00479232|460690316|FG003|Overall Study|Deviation from Protocol|0|||
128018328|NCT00479232|460690317|FG004|Overall Study|Deviation from Protocol|0|||
128018329|NCT00479232|460690318|FG005|Overall Study|Deviation from Protocol|0|||
128018330|NCT00479232|460690313|FG000|Overall Study|Lack of Efficacy|0|||
128018331|NCT00479232|460690314|FG001|Overall Study|Lack of Efficacy|0|||
128018332|NCT00479232|460690315|FG002|Overall Study|Lack of Efficacy|2|||
128018333|NCT00479232|460690316|FG003|Overall Study|Lack of Efficacy|0|||
128018334|NCT00479232|460690317|FG004|Overall Study|Lack of Efficacy|0|||
128018335|NCT00479232|460690318|FG005|Overall Study|Lack of Efficacy|4|||
128018336|NCT00479232|460690313|FG000|Overall Study|Physician Decision|0|||
128018337|NCT00479232|460690314|FG001|Overall Study|Physician Decision|0|||
128018338|NCT00479232|460690315|FG002|Overall Study|Physician Decision|2|||
128018339|NCT00479232|460690316|FG003|Overall Study|Physician Decision|0|||
128018340|NCT00479232|460690317|FG004|Overall Study|Physician Decision|0|||
128018341|NCT00479232|460690318|FG005|Overall Study|Physician Decision|1|||
127772731|NCT03170154|459793696|FG000|Overall Study|Withdrawal by Subject|2|||
127772732|NCT01117857|459793697|FG000|Overall Study|Lost to Follow-up|4|||
127772733|NCT01117857|459793697|FG000|Overall Study|Withdrawal by Subject|4|||
127772734|NCT01117857|459793697|FG000|Overall Study|Physician Decision|1|||
127772735|NCT00633061|459793698|FG000|Overall Study|Study closed|86|||
127772736|NCT00633061|459793699|FG001|Overall Study|Study closed|0|||
127772737|NCT05245097|459793700|FG000|Overall Study|Adverse Event|13|||
127772738|NCT05245097|459793701|FG001|Overall Study|Adverse Event|2|||
127772739|NCT05245097|459793700|FG000|Overall Study|Protocol Violation|8|||
127772740|NCT05245097|459793701|FG001|Overall Study|Protocol Violation|6|||
127772741|NCT05245097|459793700|FG000|Overall Study|Withdrawal by Subject|18|||
127772742|NCT05245097|459793701|FG001|Overall Study|Withdrawal by Subject|0|||
127772743|NCT05245097|459793700|FG000|Overall Study|Death|6|||
127772744|NCT05245097|459793701|FG001|Overall Study|Death|7|||
127772745|NCT05245097|459793700|FG000|Overall Study|Physician Decision|6|||
127772746|NCT05245097|459793701|FG001|Overall Study|Physician Decision|0|||
127772747|NCT05245097|459793700|FG000|Overall Study|Relocation|4|||
127772748|NCT05245097|459793701|FG001|Overall Study|Relocation|3|||
127772749|NCT00607022|459793709|FG000|Overall Study|Withdrawal by Subject|1|||
127772750|NCT00607022|459793710|FG001|Overall Study|Withdrawal by Subject|0|||
127772751|NCT00607022|459793711|FG002|Overall Study|Withdrawal by Subject|0|||
127772752|NCT00810394|459793712|FG000|Overall Study|Withdrawal by Subject|3|||
127772753|NCT03282240|459793713|FG000|Overall Study|Adverse Event|2|||
127772754|NCT03282240|459793714|FG001|Overall Study|Adverse Event|2|||
127772755|NCT03282240|459793715|FG002|Overall Study|Adverse Event|0|||
127772756|NCT03282240|459793713|FG000|Overall Study|Lost to Follow-up|3|||
127772757|NCT03282240|459793714|FG001|Overall Study|Lost to Follow-up|0|||
127772758|NCT03282240|459793715|FG002|Overall Study|Lost to Follow-up|0|||
127772759|NCT03282240|459793713|FG000|Overall Study|Protocol Deviation|4|||
127772760|NCT03282240|459793714|FG001|Overall Study|Protocol Deviation|1|||
127772761|NCT03282240|459793715|FG002|Overall Study|Protocol Deviation|2|||
127772762|NCT03282240|459793713|FG000|Overall Study|Withdrawal by Subject|1|||
127772763|NCT03282240|459793714|FG001|Overall Study|Withdrawal by Subject|0|||
127772764|NCT03282240|459793715|FG002|Overall Study|Withdrawal by Subject|1|||
127772765|NCT03254485|459793716|FG000|Overall Study|Adverse Event|3|||
127772766|NCT03254485|459793717|FG001|Overall Study|Adverse Event|0|||
127772767|NCT03254485|459793718|FG002|Overall Study|Adverse Event|0|||
127772768|NCT03254485|459793719|FG003|Overall Study|Adverse Event|6|||
127772769|NCT03254485|459793716|FG000|Overall Study|Protocol Violation|6|||
127772770|NCT03254485|459793717|FG001|Overall Study|Protocol Violation|0|||
127772771|NCT03254485|459793718|FG002|Overall Study|Protocol Violation|0|||
127772772|NCT03254485|459793719|FG003|Overall Study|Protocol Violation|2|||
127772773|NCT03254485|459793716|FG000|Overall Study|Withdrawal by Subject|1|||
127772774|NCT03254485|459793717|FG001|Overall Study|Withdrawal by Subject|0|||
127772775|NCT03254485|459793718|FG002|Overall Study|Withdrawal by Subject|0|||
127772776|NCT03254485|459793719|FG003|Overall Study|Withdrawal by Subject|4|||
127772777|NCT03254485|459793716|FG000|Overall Study|Death|0|||
127772778|NCT03254485|459793717|FG001|Overall Study|Death|0|||
127772779|NCT03254485|459793718|FG002|Overall Study|Death|0|||
127772780|NCT03254485|459793719|FG003|Overall Study|Death|1|||
127772781|NCT03254485|459793716|FG000|Overall Study|Lost to Follow-up|1|||
127772782|NCT03254485|459793717|FG001|Overall Study|Lost to Follow-up|0|||
127772783|NCT03254485|459793718|FG002|Overall Study|Lost to Follow-up|0|||
127772784|NCT03254485|459793719|FG003|Overall Study|Lost to Follow-up|0|||
127772785|NCT03254485|459793716|FG000|Overall Study|Other|1|||
127772786|NCT03254485|459793717|FG001|Overall Study|Other|0|||
127772787|NCT03254485|459793718|FG002|Overall Study|Other|0|||
127772788|NCT03254485|459793719|FG003|Overall Study|Other|2|||
128018342|NCT00479232|460690313|FG000|Overall Study|Progressive Disease|3|||
127772789|NCT02146326|459793720|FG000|Overall Study|Lost to Follow-up|3|||
127772790|NCT02146326|459793721|FG001|Overall Study|Lost to Follow-up|3|||
127772791|NCT02146326|459793722|FG002|Overall Study|Lost to Follow-up|11|||
127772792|NCT02146326|459793723|FG003|Overall Study|Lost to Follow-up|19|||
127772793|NCT02146326|459793720|FG000|Overall Study|Withdrawal by Subject|2|||
127772794|NCT02146326|459793721|FG001|Overall Study|Withdrawal by Subject|1|||
127772795|NCT02146326|459793722|FG002|Overall Study|Withdrawal by Subject|15|||
127772796|NCT02146326|459793723|FG003|Overall Study|Withdrawal by Subject|11|||
127772797|NCT02146326|459793720|FG000|Overall Study|Separated from mental health center|23|||
127772798|NCT02146326|459793721|FG001|Overall Study|Separated from mental health center|33|||
127772799|NCT02146326|459793722|FG002|Overall Study|Separated from mental health center|0|||
127772800|NCT02146326|459793723|FG003|Overall Study|Separated from mental health center|0|||
127772801|NCT02146326|459793720|FG000|Overall Study|Incarcerated|0|||
127772802|NCT02146326|459793721|FG001|Overall Study|Incarcerated|0|||
128018343|NCT00479232|460690314|FG001|Overall Study|Progressive Disease|1|||
127772803|NCT02146326|459793722|FG002|Overall Study|Incarcerated|3|||
127772804|NCT02146326|459793723|FG003|Overall Study|Incarcerated|8|||
127772805|NCT02146326|459793720|FG000|Overall Study|Death|0|||
127772806|NCT02146326|459793721|FG001|Overall Study|Death|0|||
127772807|NCT02146326|459793722|FG002|Overall Study|Death|4|||
127772808|NCT02146326|459793723|FG003|Overall Study|Death|4|||
127772809|NCT02146326|459793720|FG000|Overall Study|Unable to complete interview|0|||
127772810|NCT02146326|459793721|FG001|Overall Study|Unable to complete interview|0|||
127772811|NCT02146326|459793722|FG002|Overall Study|Unable to complete interview|10|||
127772812|NCT02146326|459793723|FG003|Overall Study|Unable to complete interview|6|||
127772813|NCT02910739|459793724|FG000|Overall Study|Adverse Event|1|||
127772814|NCT02910739|459793725|FG001|Overall Study|Adverse Event|0|||
127772815|NCT02910739|459793726|FG002|Overall Study|Adverse Event|0|||
127772816|NCT02910739|459793727|FG003|Overall Study|Adverse Event|0|||
127772817|NCT01598311|459793733|FG000|Overall Study|Physician Decision|4|||
127772818|NCT01598311|459793734|FG001|Overall Study|Physician Decision|5|||
127772819|NCT01598311|459793733|FG000|Overall Study|Adverse Event|9|||
127772820|NCT01598311|459793734|FG001|Overall Study|Adverse Event|13|||
127772821|NCT01598311|459793733|FG000|Overall Study|Lost to Follow-up|7|||
127772822|NCT01598311|459793734|FG001|Overall Study|Lost to Follow-up|12|||
127772823|NCT01598311|459793733|FG000|Overall Study|Withdrawal by Subject|9|||
127772824|NCT01598311|459793734|FG001|Overall Study|Withdrawal by Subject|13|||
127772825|NCT01598311|459793733|FG000|Overall Study|No reason provided.|0|||
127772826|NCT01598311|459793734|FG001|Overall Study|No reason provided.|5|||
127772827|NCT01598311|459793733|FG000|Overall Study|Randomized but never treated|8|||
127772828|NCT01598311|459793734|FG001|Overall Study|Randomized but never treated|5|||
127772829|NCT01598311|459793733|FG000|Overall Study|Treated but no confirmed CDAD|9|||
127772830|NCT01598311|459793734|FG001|Overall Study|Treated but no confirmed CDAD|8|||
127772831|NCT01598311|459793733|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
127772832|NCT01598311|459793734|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
127772833|NCT03602261|459793735|FG000|Overall Study|Adverse Event|5|||
127772834|NCT03602261|459793736|FG001|Overall Study|Adverse Event|1|||
127772835|NCT03602261|459793735|FG000|Overall Study|Physician Decision|1|||
127772836|NCT03602261|459793736|FG001|Overall Study|Physician Decision|0|||
127772837|NCT03602261|459793735|FG000|Overall Study|Withdrawal by Subject|1|||
127772838|NCT03602261|459793736|FG001|Overall Study|Withdrawal by Subject|1|||
127772839|NCT03602261|459793735|FG000|Overall Study|Lack of Efficacy|0|||
127772840|NCT03602261|459793736|FG001|Overall Study|Lack of Efficacy|1|||
127772841|NCT03602261|459793735|FG000|Overall Study|Subject moving out of state|1|||
127772842|NCT03602261|459793736|FG001|Overall Study|Subject moving out of state|0|||
127772843|NCT05677893|459795343|FG000|Overall Study|Withdrawal by Subject|0|||
127772844|NCT05677893|459795344|FG001|Overall Study|Withdrawal by Subject|0|||
127772845|NCT05677893|459795345|FG002|Overall Study|Withdrawal by Subject|0|||
127772846|NCT05677893|459795346|FG003|Overall Study|Withdrawal by Subject|0|||
127772847|NCT05677893|459795347|FG004|Overall Study|Withdrawal by Subject|1|||
127772848|NCT05677893|459795348|FG005|Overall Study|Withdrawal by Subject|1|||
127772849|NCT05677893|459795349|FG006|Overall Study|Withdrawal by Subject|0|||
127772850|NCT05677893|459795343|FG000|Overall Study|Others|1|||
127772851|NCT05677893|459795344|FG001|Overall Study|Others|0|||
127772852|NCT05677893|459795345|FG002|Overall Study|Others|0|||
127772853|NCT05677893|459795346|FG003|Overall Study|Others|0|||
127772854|NCT05677893|459795347|FG004|Overall Study|Others|0|||
127772855|NCT05677893|459795348|FG005|Overall Study|Others|0|||
127772856|NCT05677893|459795349|FG006|Overall Study|Others|0|||
127772857|NCT01485354|459795350|FG000|Overall Study|Withdrawal by Subject|5|||
127772858|NCT02101034|459795351|FG000|Overall Study|Enrolled but did not start treatment|0|||
127772859|NCT02101034|459795352|FG001|Overall Study|Enrolled but did not start treatment|0|||
127772860|NCT02101034|459795353|FG002|Overall Study|Enrolled but did not start treatment|1|||
127772861|NCT02101034|459795354|FG003|Overall Study|Enrolled but did not start treatment|0|||
127772862|NCT02101034|459795355|FG004|Overall Study|Enrolled but did not start treatment|0|||
127772863|NCT01103245|459795360|FG000|Overall Study|Withdrawal by Subject|1|||
127772864|NCT01103245|459795361|FG001|Overall Study|Withdrawal by Subject|0|||
127772865|NCT01103245|459795362|FG002|Overall Study|Withdrawal by Subject|3|||
127772866|NCT01103245|459795363|FG003|Overall Study|Withdrawal by Subject|0|||
127772867|NCT01103245|459795360|FG000|Overall Study|Inadequate IV access|1|||
127772868|NCT01103245|459795361|FG001|Overall Study|Inadequate IV access|0|||
127772869|NCT01103245|459795362|FG002|Overall Study|Inadequate IV access|0|||
127772870|NCT01103245|459795363|FG003|Overall Study|Inadequate IV access|0|||
127772871|NCT01103245|459795360|FG000|Overall Study|Adverse Event|0|||
127772872|NCT01103245|459795361|FG001|Overall Study|Adverse Event|2|||
127772873|NCT01103245|459795362|FG002|Overall Study|Adverse Event|1|||
127772874|NCT01103245|459795363|FG003|Overall Study|Adverse Event|0|||
127772875|NCT01103245|459795360|FG000|Overall Study|Physician Decision|1|||
127772876|NCT01103245|459795361|FG001|Overall Study|Physician Decision|0|||
127772877|NCT01103245|459795362|FG002|Overall Study|Physician Decision|0|||
127772878|NCT01103245|459795363|FG003|Overall Study|Physician Decision|0|||
127772879|NCT00720941|459795365|FG000|Overall Study|Protocol Violation|1|||
128018344|NCT00479232|460690315|FG002|Overall Study|Progressive Disease|12|||
128018345|NCT00479232|460690316|FG003|Overall Study|Progressive Disease|3|||
128018346|NCT00479232|460690317|FG004|Overall Study|Progressive Disease|3|||
128018347|NCT00479232|460690318|FG005|Overall Study|Progressive Disease|12|||
128018348|NCT00479232|460690313|FG000|Overall Study|Withdrew Consent|0|||
128018349|NCT00479232|460690314|FG001|Overall Study|Withdrew Consent|2|||
128018350|NCT00479232|460690315|FG002|Overall Study|Withdrew Consent|6|||
128018351|NCT00479232|460690316|FG003|Overall Study|Withdrew Consent|0|||
128018352|NCT00479232|460690317|FG004|Overall Study|Withdrew Consent|1|||
128018353|NCT00479232|460690318|FG005|Overall Study|Withdrew Consent|3|||
128018354|NCT05399771|460690319|FG000|Overall Study|Physician Decision|3|||
128018355|NCT05399771|460690319|FG000|Overall Study|Adverse Event|1|||
128018356|NCT00484159|460690321|FG000|Overall Study|Lost to Follow-up|1|||
128018357|NCT00484159|460690322|FG001|Overall Study|Lost to Follow-up|1|||
128018358|NCT00484159|460690323|FG002|Overall Study|Lost to Follow-up|0|||
128018359|NCT02513199|460690326|FG000|Treatment|Death|1|||
128018360|NCT02513199|460690326|FG000|Treatment|Lost to Follow-up|1|||
128018361|NCT02513199|460690326|FG000|Follow-Up|Death|11|||
128018362|NCT01771913|460690332|FG000|Overall Study|Withdrawal by Subject|1|||
128018363|NCT01771913|460690333|FG001|Overall Study|Withdrawal by Subject|0|||
128018364|NCT04307394|460690334|FG000|Overall Study|Lost to Follow-up|3|||
128018365|NCT04307394|460690334|FG000|Overall Study|Withdrawal by Subject|2|||
128018366|NCT00407511|460690342|FG000|Overall Study|Adverse Event|9|||
128018367|NCT00407511|460690342|FG000|Overall Study|Lost to Follow-up|4|||
128018368|NCT00407511|460690342|FG000|Overall Study|Other|5|||
128018369|NCT00407511|460690342|FG000|Overall Study|Withdrawal by Subject|4|||
128018370|NCT03439514|460690343|FG000|Double-Blind Treatment Period|Other|4|||
128018371|NCT03439514|460690344|FG001|Double-Blind Treatment Period|Other|1|||
128018372|NCT03439514|460690343|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
128018373|NCT03439514|460690344|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
128018374|NCT03439514|460690343|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
128018375|NCT03439514|460690344|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
128018376|NCT03439514|460690343|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
128018377|NCT03439514|460690344|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
128018378|NCT03439514|460690343|FG000|Double-Blind Treatment Period|Death|1|||
128018379|NCT03439514|460690344|FG001|Double-Blind Treatment Period|Death|2|||
128018380|NCT04900272|460690345|FG000|Overall Study|Lost to Follow-up|2|||
128018381|NCT04900272|460690345|FG000|Overall Study|Withdrawal due to technical difficulties (see above)|3|||
128018382|NCT04900272|460690345|FG000|Overall Study|Withdrawal by Subject|1|||
128018383|NCT05059080|460690346|FG000|Overall Study|Withdrawal by Subject|3|||
128018384|NCT05059080|460690346|FG000|Overall Study|Study Terminated by Sponsor|64|||
128018385|NCT00800540|460690347|FG000|Period One: 6 Weeks|Noncompliance|1|||
128018386|NCT00800540|460690348|FG001|Period One: 6 Weeks|Noncompliance|0|||
127772880|NCT00720941|459795366|FG001|Overall Study|Protocol Violation|2|||
127772881|NCT00720941|459795365|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|8|||
127772882|NCT00720941|459795366|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|7|||
127772883|NCT00720941|459795365|FG000|Overall Study|Lost to Follow-up|20|||
127772884|NCT00720941|459795366|FG001|Overall Study|Lost to Follow-up|15|||
127772885|NCT00720941|459795365|FG000|Overall Study|Physician Decision|14|||
127772886|NCT00720941|459795366|FG001|Overall Study|Physician Decision|12|||
127772887|NCT00720941|459795365|FG000|Overall Study|Withdrawal by Subject|29|||
127772888|NCT00720941|459795366|FG001|Overall Study|Withdrawal by Subject|36|||
127772889|NCT00604279|459795367|FG000|Overall Study|Lack of Efficacy|22|||
127772890|NCT00604279|459795368|FG001|Overall Study|Lack of Efficacy|9|||
127772891|NCT00604279|459795367|FG000|Overall Study|Lost to Follow-up|9|||
127772892|NCT00604279|459795368|FG001|Overall Study|Lost to Follow-up|14|||
127772893|NCT00604279|459795367|FG000|Overall Study|Pregnancy|2|||
127772894|NCT00604279|459795368|FG001|Overall Study|Pregnancy|0|||
127772895|NCT00604279|459795367|FG000|Overall Study|Protocol Violation|3|||
127772896|NCT00604279|459795368|FG001|Overall Study|Protocol Violation|1|||
127772897|NCT00604279|459795367|FG000|Overall Study|Withdrawal by Subject|16|||
127772898|NCT00604279|459795368|FG001|Overall Study|Withdrawal by Subject|5|||
127772899|NCT00604279|459795367|FG000|Overall Study|Adverse Event|4|||
127772900|NCT00604279|459795368|FG001|Overall Study|Adverse Event|5|||
127772901|NCT00604279|459795367|FG000|Overall Study|Other|8|||
127772902|NCT00604279|459795368|FG001|Overall Study|Other|4|||
127772903|NCT00355056|459795369|FG000|Randomization Period|Early Termination|4|||
127772904|NCT00355056|459795370|FG001|Randomization Period|Early Termination|6|||
127772905|NCT01072877|459795376|FG000|Overall Study|Lost to Follow-up|1|||
127772906|NCT01072877|459795377|FG001|Overall Study|Lost to Follow-up|1|||
127772907|NCT01072877|459795378|FG002|Overall Study|Lost to Follow-up|0|||
128018387|NCT00800540|460690347|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
127772908|NCT01072877|459795379|FG003|Overall Study|Lost to Follow-up|2|||
128018388|NCT00800540|460690348|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
128018389|NCT00800540|460690347|FG000|Period 2: 6 Weeks|Adverse Event|0|||
128018390|NCT00800540|460690348|FG001|Period 2: 6 Weeks|Adverse Event|1|||
128018391|NCT03927157|460690349|FG000|Overall Study|Adverse Event|1|||
128018392|NCT03927157|460690350|FG001|Overall Study|Adverse Event|3|||
128018393|NCT03927157|460690349|FG000|Overall Study|Protocol Violation|1|||
128018394|NCT03927157|460690350|FG001|Overall Study|Protocol Violation|2|||
128018395|NCT03927157|460690349|FG000|Overall Study|Withdrawal by Subject|8|||
128018396|NCT03927157|460690350|FG001|Overall Study|Withdrawal by Subject|21|||
128018397|NCT03927157|460690349|FG000|Overall Study|Due to COVID-19 pandemic|5|||
128018398|NCT03927157|460690350|FG001|Overall Study|Due to COVID-19 pandemic|2|||
128018399|NCT03927157|460690349|FG000|Overall Study|Protocol-specified withdrawal criterion met|0|||
128018400|NCT03927157|460690350|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
128018401|NCT03927157|460690349|FG000|Overall Study|Other than above|0|||
128018402|NCT03927157|460690350|FG001|Overall Study|Other than above|1|||
128018403|NCT02447029|460690351|FG000|Overall Study|Withdrawal by Subject|3|||
128018404|NCT02447029|460690352|FG001|Overall Study|Withdrawal by Subject|2|||
128018405|NCT01239745|460690353|FG000|Overall Study|Study terminated by sponsor|45|||
128018406|NCT01239745|460690353|FG000|Overall Study|Adverse Event|1|||
128018407|NCT00726557|460690354|FG000|Overall Study|Screening failure|4|||
128018408|NCT00726557|460690354|FG000|Overall Study|No end of treatment documentation|37|||
128018409|NCT00726557|460690354|FG000|Overall Study|No follow-up documentation available|55|||
128018410|NCT00726557|460690354|FG000|Overall Study|Treatment less than 3 months|17|||
128018411|NCT00726557|460690354|FG000|Overall Study|Inclusion criteria not met|15|||
128018412|NCT00081458|460690357|FG000|Overall Study|Adverse Event|1|||
128018413|NCT00081458|460690358|FG001|Overall Study|Adverse Event|5|||
128018414|NCT00081458|460690359|FG002|Overall Study|Adverse Event|2|||
128018415|NCT00081458|460690357|FG000|Overall Study|Withdrawal by Subject|0|||
128018416|NCT00081458|460690358|FG001|Overall Study|Withdrawal by Subject|3|||
128018417|NCT00081458|460690359|FG002|Overall Study|Withdrawal by Subject|1|||
128018418|NCT00081458|460690357|FG000|Overall Study|Randomized but not dosed|0|||
128018419|NCT00081458|460690358|FG001|Overall Study|Randomized but not dosed|0|||
128018420|NCT00081458|460690359|FG002|Overall Study|Randomized but not dosed|1|||
128018421|NCT00549328|460690360|FG000|Overall Study|Adverse Event|2|||
128018422|NCT00549328|460690360|FG000|Overall Study|Disease Progression|10|||
128018423|NCT00549328|460690360|FG000|Overall Study|Death|1|||
128018424|NCT00549328|460690360|FG000|Overall Study|Use of Prohibited Medication|1|||
128018425|NCT00770484|460690361|FG000|Overall Study|Withdrawal by Subject|1|||
128018426|NCT00770484|460690362|FG001|Overall Study|Withdrawal by Subject|0|||
128018427|NCT01946802|460690367|FG000|Overall Study|Death|1|||
128018428|NCT01946802|460690367|FG000|Overall Study|Withdrawal by Subject|2|||
128018429|NCT01946802|460690367|FG000|Overall Study|Combined septic shock|1|||
128018430|NCT01946802|460690367|FG000|Overall Study|Protocol Violation|1|||
128018431|NCT03097315|460690368|FG000|Overall Study|Withdrawal by Subject|1|||
128018432|NCT03384966|460690369|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
128018433|NCT03384966|460690370|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
128018434|NCT03384966|460690371|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
127552070|NCT02721966|458987385|FG001|Overall Study|Pregnancy|0|||
127552071|NCT02721966|458987386|FG002|Overall Study|Pregnancy|0|||
128018435|NCT03384966|460690369|FG000|Follow-up Period|Adverse Event|1|||
128018436|NCT03384966|460690370|FG001|Follow-up Period|Adverse Event|0|||
128018437|NCT03384966|460690371|FG002|Follow-up Period|Adverse Event|0|||
128018438|NCT02836769|460690373|FG000|Overall Study|Lost to Follow-up|10|||
128018439|NCT02836769|460690373|FG000|Overall Study|Medical withdrawal|2|||
127552072|NCT02721966|458987387|FG003|Overall Study|Pregnancy|0|||
128018440|NCT02836769|460690373|FG000|Overall Study|Withdrawal by Subject|3|||
128018441|NCT00376506|460690378|FG000|Overall Study|Death|0|||
128018442|NCT00376506|460690379|FG001|Overall Study|Death|2|||
128018443|NCT02948400|460690382|FG000|Overall Study|Withdrawal by Subject|17|||
128018444|NCT02948400|460690383|FG001|Overall Study|Withdrawal by Subject|10|||
128018445|NCT02948400|460690382|FG000|Overall Study|failed to attend appointments|47|||
128018446|NCT02948400|460690383|FG001|Overall Study|failed to attend appointments|34|||
128018447|NCT02948400|460690382|FG000|Overall Study|COVID-related closure|6|||
128018448|NCT02948400|460690383|FG001|Overall Study|COVID-related closure|2|||
128018449|NCT02948400|460690382|FG000|Overall Study|sibling discovered to be in study so participant ineligible|1|||
128018450|NCT02948400|460690383|FG001|Overall Study|sibling discovered to be in study so participant ineligible|0|||
128018451|NCT02948400|460690382|FG000|Overall Study|motion sickness in virtual reality|2|||
128018452|NCT02948400|460690383|FG001|Overall Study|motion sickness in virtual reality|0|||
128018453|NCT02403271|460690384|FG000|Period 1|Other varied reasons|1|||
128018454|NCT02403271|460690385|FG001|Period 1|Other varied reasons|0|||
128018455|NCT02403271|460690384|FG000|Period 2|Withdrawal by Subject|0|||
128018456|NCT02403271|460690385|FG001|Period 2|Withdrawal by Subject|14|||
128018457|NCT02403271|460690384|FG000|Period 2|Death|0|||
128018458|NCT02403271|460690385|FG001|Period 2|Death|84|||
128018459|NCT02403271|460690384|FG000|Period 2|Lost to Follow-up|0|||
128018460|NCT02403271|460690385|FG001|Period 2|Lost to Follow-up|2|||
128018461|NCT02403271|460690384|FG000|Period 2|Study Terminated by Sponsor|0|||
128018462|NCT02403271|460690385|FG001|Period 2|Study Terminated by Sponsor|14|||
128018463|NCT02403271|460690384|FG000|Period 2|Other varied reasons|0|||
128018464|NCT02403271|460690385|FG001|Period 2|Other varied reasons|10|||
128018465|NCT00221104|460690390|FG000|Overall Study|Adverse Event|1|||
128018466|NCT00221104|460690391|FG001|Overall Study|Adverse Event|0|||
128018467|NCT00221104|460690390|FG000|Overall Study|Physician Decision|1|||
128018468|NCT00221104|460690391|FG001|Overall Study|Physician Decision|0|||
128018469|NCT00221104|460690390|FG000|Overall Study|Protocol Violation|2|||
128018470|NCT00221104|460690391|FG001|Overall Study|Protocol Violation|0|||
128018471|NCT00221104|460690390|FG000|Overall Study|Withdrawal by Subject|42|||
128018472|NCT00221104|460690391|FG001|Overall Study|Withdrawal by Subject|29|||
128018473|NCT00221104|460690390|FG000|Overall Study|Others|37|||
128018474|NCT00221104|460690391|FG001|Overall Study|Others|47|||
128018475|NCT02989389|460690392|FG000|Period 1|Lost to Follow-up|0|||
128018476|NCT02989389|460690393|FG001|Period 1|Lost to Follow-up|1|||
128018477|NCT02989389|460690394|FG002|Period 1|Lost to Follow-up|0|||
128018478|NCT02989389|460690395|FG003|Period 1|Lost to Follow-up|0|||
128018479|NCT02989389|460690396|FG004|Period 1|Lost to Follow-up|0|||
128018480|NCT02989389|460690397|FG005|Period 1|Lost to Follow-up|0|||
128018481|NCT02989389|460690398|FG006|Period 1|Lost to Follow-up|0|||
128018482|NCT02989389|460690399|FG007|Period 1|Lost to Follow-up|0|||
128018483|NCT02989389|460690400|FG008|Period 1|Lost to Follow-up|0|||
128018484|NCT02989389|460690401|FG009|Period 1|Lost to Follow-up|0|||
128018485|NCT02989389|460690392|FG000|Period 1|Physician Decision|0|||
128018486|NCT02989389|460690393|FG001|Period 1|Physician Decision|0|||
128018487|NCT02989389|460690394|FG002|Period 1|Physician Decision|0|||
128018488|NCT02989389|460690395|FG003|Period 1|Physician Decision|0|||
128018489|NCT02989389|460690396|FG004|Period 1|Physician Decision|0|||
128018490|NCT02989389|460690397|FG005|Period 1|Physician Decision|0|||
128018491|NCT02989389|460690398|FG006|Period 1|Physician Decision|0|||
128018492|NCT02989389|460690399|FG007|Period 1|Physician Decision|0|||
128018493|NCT02989389|460690400|FG008|Period 1|Physician Decision|1|||
128018494|NCT02989389|460690401|FG009|Period 1|Physician Decision|0|||
128018495|NCT04470427|460690402|FG000|Part A: Blinded|Discontinued from Study in Part A|831|||
128018496|NCT04470427|460690403|FG001|Part A: Blinded|Discontinued from Study in Part A|548|||
128018497|NCT04470427|460690404|FG002|Part A: Blinded|Discontinued from Study in Part A|0|||
128018498|NCT04470427|460690405|FG003|Part A: Blinded|Discontinued from Study in Part A|0|||
128018499|NCT04470427|460690406|FG004|Part A: Blinded|Discontinued from Study in Part A|0|||
128018500|NCT04470427|460690407|FG005|Part A: Blinded|Discontinued from Study in Part A|0|||
128018501|NCT04470427|460690402|FG000|Part B :Open-label|Other than specified|0|||
128018502|NCT04470427|460690403|FG001|Part B :Open-label|Other than specified|0|||
128018503|NCT04470427|460690404|FG002|Part B :Open-label|Other than specified|788|||
127685635|NCT00716859|459474863|FG000|Overall Study|Lack of Efficacy|3|||
128018504|NCT04470427|460690405|FG003|Part B :Open-label|Other than specified|0|||
128018505|NCT04470427|460690406|FG004|Part B :Open-label|Other than specified|523|||
128018506|NCT04470427|460690407|FG005|Part B :Open-label|Other than specified|0|||
128018507|NCT04470427|460690402|FG000|Part B :Open-label|Discontinued from Study in Part B|0|||
128018508|NCT04470427|460690403|FG001|Part B :Open-label|Discontinued from Study in Part B|0|||
128018509|NCT04470427|460690404|FG002|Part B :Open-label|Discontinued from Study in Part B|1576|||
128018510|NCT04470427|460690405|FG003|Part B :Open-label|Discontinued from Study in Part B|2185|||
128018511|NCT04470427|460690406|FG004|Part B :Open-label|Discontinued from Study in Part B|4490|||
128018512|NCT04470427|460690407|FG005|Part B :Open-label|Discontinued from Study in Part B|0|||
128018513|NCT04470427|460690402|FG000|Part C: Booster|Discontinued from Study in Part C|0|||
128018514|NCT04470427|460690403|FG001|Part C: Booster|Discontinued from Study in Part C|0|||
128018515|NCT04470427|460690404|FG002|Part C: Booster|Discontinued from Study in Part C|0|||
128018516|NCT04470427|460690405|FG003|Part C: Booster|Discontinued from Study in Part C|0|||
128018517|NCT04470427|460690406|FG004|Part C: Booster|Discontinued from Study in Part C|0|||
128018518|NCT04470427|460690407|FG005|Part C: Booster|Discontinued from Study in Part C|2918|||
128018519|NCT00021255|460690408|FG000|Overall Study|Death|1|||
128018520|NCT00021255|460690409|FG001|Overall Study|Death|0|||
128018521|NCT00021255|460690410|FG002|Overall Study|Death|2|||
128018522|NCT00021255|460690408|FG000|Overall Study|Breast cancer relapse|5|||
128018523|NCT00021255|460690409|FG001|Overall Study|Breast cancer relapse|18|||
128018524|NCT00021255|460690410|FG002|Overall Study|Breast cancer relapse|11|||
128018525|NCT00021255|460690408|FG000|Overall Study|Second primary malignancy|0|||
128018526|NCT00021255|460690409|FG001|Overall Study|Second primary malignancy|4|||
128018527|NCT00021255|460690410|FG002|Overall Study|Second primary malignancy|1|||
128018528|NCT00021255|460690408|FG000|Overall Study|Withdrawal by Subject|41|||
128018529|NCT00021255|460690409|FG001|Overall Study|Withdrawal by Subject|64|||
128018530|NCT00021255|460690410|FG002|Overall Study|Withdrawal by Subject|26|||
128018531|NCT00021255|460690408|FG000|Overall Study|Lost to Follow-up|0|||
128018532|NCT00021255|460690409|FG001|Overall Study|Lost to Follow-up|2|||
128018533|NCT00021255|460690410|FG002|Overall Study|Lost to Follow-up|3|||
128018534|NCT00021255|460690408|FG000|Overall Study|Cardiac toxicity|0|||
128018535|NCT00021255|460690409|FG001|Overall Study|Cardiac toxicity|61|||
128018536|NCT00021255|460690410|FG002|Overall Study|Cardiac toxicity|32|||
128018537|NCT00021255|460690408|FG000|Overall Study|Herceptin toxicity|0|||
128018538|NCT00021255|460690409|FG001|Overall Study|Herceptin toxicity|22|||
128018539|NCT00021255|460690410|FG002|Overall Study|Herceptin toxicity|6|||
128018540|NCT00021255|460690408|FG000|Overall Study|Adverse Event|46|||
128018541|NCT00021255|460690409|FG001|Overall Study|Adverse Event|30|||
128018542|NCT00021255|460690410|FG002|Overall Study|Adverse Event|18|||
128018543|NCT00021255|460690408|FG000|Overall Study|Protocol Violation|0|||
128018544|NCT00021255|460690409|FG001|Overall Study|Protocol Violation|2|||
128018545|NCT00021255|460690410|FG002|Overall Study|Protocol Violation|0|||
128018546|NCT00021255|460690408|FG000|Overall Study|Other than specified above|0|||
128018547|NCT00021255|460690409|FG001|Overall Study|Other than specified above|38|||
128018548|NCT00021255|460690410|FG002|Overall Study|Other than specified above|19|||
128018549|NCT00021255|460690408|FG000|Overall Study|Missing|0|||
128018550|NCT00021255|460690409|FG001|Overall Study|Missing|27|||
128018551|NCT00021255|460690410|FG002|Overall Study|Missing|13|||
128018552|NCT00021255|460690408|FG000|Overall Study|Randomized but not treated|28|||
128018553|NCT00021255|460690409|FG001|Overall Study|Randomized but not treated|2|||
128018554|NCT00021255|460690410|FG002|Overall Study|Randomized but not treated|18|||
128018555|NCT01132755|460690413|FG000|Overall Study|Procedure not done due to medical reason|23|||
128018556|NCT01132755|460690413|FG000|Overall Study|Protocol Violation|15|||
128018557|NCT01132755|460690413|FG000|Overall Study|Withdrawal by Subject|4|||
128018558|NCT02232698|460690414|FG000|Overall Study|Pregnancy|1|||
128018559|NCT02232698|460690415|FG001|Overall Study|Pregnancy|1|||
128018560|NCT02232698|460690414|FG000|Overall Study|Met exclusion criteria|1|||
128018561|NCT02232698|460690415|FG001|Overall Study|Met exclusion criteria|1|||
128018562|NCT02232698|460690414|FG000|Overall Study|Had device-associated symptoms|7|||
128018563|NCT02232698|460690415|FG001|Overall Study|Had device-associated symptoms|0|||
128018564|NCT02232698|460690414|FG000|Overall Study|Non-compliance with study device|1|||
128018565|NCT02232698|460690415|FG001|Overall Study|Non-compliance with study device|4|||
128018566|NCT02232698|460690414|FG000|Overall Study|Allocated to control group|0|||
128018567|NCT02232698|460690415|FG001|Overall Study|Allocated to control group|3|||
128018568|NCT02232698|460690414|FG000|Overall Study|Withdrawal by Subject|0|||
128018569|NCT02232698|460690415|FG001|Overall Study|Withdrawal by Subject|11|||
128018570|NCT02393755|460690416|FG000|Overall Study|Withdrawal by Subject|0|||
128018571|NCT02393755|460690417|FG001|Overall Study|Withdrawal by Subject|3|||
128018572|NCT02393755|460690416|FG000|Overall Study|Adverse Event|0|||
127552073|NCT02721966|458987388|FG004|Overall Study|Pregnancy|0|||
127552074|NCT02721966|458987384|FG000|Overall Study|Did not continue to period 2|5|||
128018573|NCT02393755|460690417|FG001|Overall Study|Adverse Event|2|||
128018574|NCT02393755|460690416|FG000|Overall Study|Physician Decision|0|||
128018575|NCT02393755|460690417|FG001|Overall Study|Physician Decision|2|||
128018576|NCT02337946|460690418|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
128018577|NCT02337946|460690419|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
128018578|NCT02337946|460690420|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
128018579|NCT02337946|460690418|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
128018580|NCT02337946|460690419|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
127642870|NCT00113568|459313202|FG000|Overall Study|Other|112|||
128018581|NCT02337946|460690420|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
128018582|NCT02337946|460690418|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
128018583|NCT02337946|460690419|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
128018584|NCT02337946|460690420|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
128018585|NCT02337946|460690418|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
128018586|NCT02337946|460690419|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
127772909|NCT01072877|459795380|FG004|Overall Study|Lost to Follow-up|0|||
127772910|NCT00995020|459795381|FG000|Overall Study|margin analysis not performed|2|||
127772911|NCT00995020|459795382|FG001|Overall Study|margin analysis not performed|5|||
127772912|NCT00995020|459795381|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
127772913|NCT00995020|459795382|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
127772914|NCT02720536|459795383|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
128018587|NCT02337946|460690420|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
128018588|NCT02337946|460690418|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
128018589|NCT02337946|460690419|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
128018590|NCT02337946|460690420|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
128018591|NCT02337946|460690418|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
128018592|NCT02337946|460690419|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
128018593|NCT02337946|460690420|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
128018594|NCT02337946|460690418|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
128018595|NCT02337946|460690419|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
128018596|NCT02337946|460690420|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
128018597|NCT02337946|460690418|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
128018598|NCT02337946|460690419|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
128018599|NCT02337946|460690420|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
128018600|NCT02337946|460690418|FG000|In-between Period|Without Informed Consent|1|||
128018601|NCT02337946|460690419|FG001|In-between Period|Without Informed Consent|0|||
128018602|NCT02337946|460690420|FG002|In-between Period|Without Informed Consent|0|||
128018603|NCT02337946|460690418|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
128018604|NCT02337946|460690419|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
128018605|NCT02337946|460690420|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
128018606|NCT02337946|460690418|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
128018607|NCT02337946|460690419|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
128018608|NCT02337946|460690420|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
128018609|NCT02337946|460690418|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
128018610|NCT02337946|460690419|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
127772915|NCT02720536|459795383|FG000|Overall Study|PR - pregnancy|2|||
127772916|NCT02720536|459795383|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
127772917|NCT02720536|459795383|FG000|Overall Study|PR - death|1|||
127772918|NCT02720536|459795383|FG000|Overall Study|PR - adverse event|1|||
127772919|NCT02720536|459795383|FG000|Overall Study|PR - abnormal lab value(s)|1|||
127772920|NCT02720536|459795383|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
127772921|NCT00719563|459795391|FG000|Overall Study|Adverse Event|16|||
127772922|NCT00719563|459795392|FG001|Overall Study|Adverse Event|13|||
127772923|NCT00719563|459795391|FG000|Overall Study|Medical condition changed|3|||
127772924|NCT00719563|459795392|FG001|Overall Study|Medical condition changed|5|||
127772925|NCT00719563|459795391|FG000|Overall Study|Lack of Efficacy|3|||
127772926|NCT00719563|459795392|FG001|Overall Study|Lack of Efficacy|7|||
127772927|NCT00719563|459795391|FG000|Overall Study|Personal reasons|6|||
127772928|NCT00719563|459795392|FG001|Overall Study|Personal reasons|7|||
127772929|NCT00719563|459795391|FG000|Overall Study|Unknown reasons|4|||
127772930|NCT00719563|459795392|FG001|Overall Study|Unknown reasons|6|||
127772931|NCT00719563|459795391|FG000|Overall Study|Noncompliant|1|||
127772932|NCT00719563|459795392|FG001|Overall Study|Noncompliant|1|||
127772933|NCT00719563|459795391|FG000|Overall Study|Lost to Follow-up|5|||
127772934|NCT00719563|459795392|FG001|Overall Study|Lost to Follow-up|3|||
127772935|NCT00792805|459795395|FG000|Overall Study|Adverse Event|12|||
128018611|NCT02337946|460690420|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
128018612|NCT02337946|460690418|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
128018613|NCT02337946|460690419|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
128018614|NCT02337946|460690420|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
128018615|NCT02337946|460690418|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
127772936|NCT00792805|459795396|FG001|Overall Study|Adverse Event|10|||
127772937|NCT00792805|459795397|FG002|Overall Study|Adverse Event|10|||
127880995|NCT02756078|460186098|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
127772938|NCT00792805|459795395|FG000|Overall Study|Subject withdrew consent|5|||
127772939|NCT00792805|459795396|FG001|Overall Study|Subject withdrew consent|6|||
127772940|NCT00792805|459795397|FG002|Overall Study|Subject withdrew consent|5|||
127772941|NCT00792805|459795395|FG000|Overall Study|Administrative problems|2|||
127772942|NCT00792805|459795396|FG001|Overall Study|Administrative problems|0|||
127772943|NCT00792805|459795397|FG002|Overall Study|Administrative problems|4|||
127552075|NCT02721966|458987385|FG001|Overall Study|Did not continue to period 2|12|||
127772944|NCT00792805|459795395|FG000|Overall Study|Abnormal test procedure result(s)|1|||
127772945|NCT00792805|459795396|FG001|Overall Study|Abnormal test procedure result(s)|2|||
127772946|NCT00792805|459795397|FG002|Overall Study|Abnormal test procedure result(s)|0|||
127772947|NCT00792805|459795395|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
127772948|NCT00792805|459795396|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
127772949|NCT00792805|459795397|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
127772950|NCT00792805|459795395|FG000|Overall Study|Lost to Follow-up|1|||
127772951|NCT00792805|459795396|FG001|Overall Study|Lost to Follow-up|1|||
127772952|NCT00792805|459795397|FG002|Overall Study|Lost to Follow-up|6|||
127772953|NCT00792805|459795395|FG000|Overall Study|Abnormal laboratory value(s)|0|||
127772954|NCT00792805|459795396|FG001|Overall Study|Abnormal laboratory value(s)|0|||
127772955|NCT00792805|459795397|FG002|Overall Study|Abnormal laboratory value(s)|1|||
127772956|NCT00792805|459795395|FG000|Overall Study|Protocol deviation|0|||
127772957|NCT00792805|459795396|FG001|Overall Study|Protocol deviation|1|||
127772958|NCT00792805|459795397|FG002|Overall Study|Protocol deviation|1|||
127772959|NCT02120625|459795398|FG000|Overall Study|Physician Decision|2|||
127772960|NCT03278106|459795399|FG000|Overall Study|No protocol treatment|1|||
127772961|NCT00820027|459795400|FG000|Overall Study|Adverse Event|15|||
127772962|NCT00820027|459795401|FG001|Overall Study|Adverse Event|8|||
127772963|NCT00820027|459795402|FG002|Overall Study|Adverse Event|10|||
127772964|NCT00820027|459795403|FG003|Overall Study|Adverse Event|5|||
127772965|NCT00820027|459795400|FG000|Overall Study|Lack of Efficacy|2|||
127772966|NCT00820027|459795401|FG001|Overall Study|Lack of Efficacy|1|||
127772967|NCT00820027|459795402|FG002|Overall Study|Lack of Efficacy|2|||
127772968|NCT00820027|459795403|FG003|Overall Study|Lack of Efficacy|2|||
127772969|NCT00820027|459795400|FG000|Overall Study|Physician Decision|0|||
127772970|NCT00820027|459795401|FG001|Overall Study|Physician Decision|1|||
127772971|NCT00820027|459795402|FG002|Overall Study|Physician Decision|1|||
127772972|NCT00820027|459795403|FG003|Overall Study|Physician Decision|0|||
127772973|NCT00820027|459795400|FG000|Overall Study|Protocol Violation|3|||
127772974|NCT00820027|459795401|FG001|Overall Study|Protocol Violation|0|||
127772975|NCT00820027|459795402|FG002|Overall Study|Protocol Violation|4|||
127772976|NCT00820027|459795403|FG003|Overall Study|Protocol Violation|0|||
127772977|NCT00820027|459795400|FG000|Overall Study|Withdrawal by Subject|6|||
127772978|NCT00820027|459795401|FG001|Overall Study|Withdrawal by Subject|4|||
127772979|NCT00820027|459795402|FG002|Overall Study|Withdrawal by Subject|4|||
127772980|NCT00820027|459795403|FG003|Overall Study|Withdrawal by Subject|6|||
127772981|NCT02982187|459795404|FG000|Overall Study|Withdrawal by Subject|0|||
128018616|NCT02337946|460690419|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
128018617|NCT02337946|460690420|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
128018618|NCT02337946|460690418|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
128018619|NCT02337946|460690419|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
128018620|NCT02337946|460690420|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
128018621|NCT05324371|460690422|FG000|Overall Study|Withdrawal by Subject|1|||
127552076|NCT02721966|458987386|FG002|Overall Study|Did not continue to period 2|0|||
127552077|NCT02721966|458987387|FG003|Overall Study|Did not continue to period 2|0|||
127772982|NCT02982187|459795405|FG001|Overall Study|Withdrawal by Subject|0|||
127772983|NCT02982187|459795406|FG002|Overall Study|Withdrawal by Subject|0|||
127772984|NCT02982187|459795407|FG003|Overall Study|Withdrawal by Subject|0|||
127772985|NCT02982187|459795408|FG004|Overall Study|Withdrawal by Subject|0|||
127772986|NCT02982187|459795409|FG005|Overall Study|Withdrawal by Subject|0|||
127772987|NCT02982187|459795410|FG006|Overall Study|Withdrawal by Subject|1|||
127772988|NCT02982187|459795411|FG007|Overall Study|Withdrawal by Subject|0|||
127772989|NCT03437278|459795412|FG000|Overall Study|Adverse Event|0|||
127772990|NCT03437278|459795413|FG001|Overall Study|Adverse Event|0|||
127772991|NCT03437278|459795414|FG002|Overall Study|Adverse Event|1|||
127772992|NCT03437278|459795412|FG000|Overall Study|Progressive disease|1|||
128018622|NCT05324371|460690422|FG000|Overall Study|Death|1|||
128018623|NCT01251861|460690424|FG000|Overall Study|Disease progression|6|||
128018624|NCT01251861|460690425|FG001|Overall Study|Disease progression|6|||
127552078|NCT02721966|458987388|FG004|Overall Study|Did not continue to period 2|5|||
127552079|NCT03857867|458987389|FG000|Overall Study|Physician Decision|1|||
127772993|NCT03437278|459795413|FG001|Overall Study|Progressive disease|0|||
127772994|NCT03437278|459795414|FG002|Overall Study|Progressive disease|0|||
127772995|NCT03437278|459795412|FG000|Overall Study|Physician Decision|1|||
127772996|NCT03437278|459795413|FG001|Overall Study|Physician Decision|0|||
128018625|NCT01251861|460690424|FG000|Overall Study|Adverse Event|2|||
127772997|NCT03437278|459795414|FG002|Overall Study|Physician Decision|1|||
127772998|NCT01630434|459795415|FG000|Overall Study|Donor lungs turned down|1|||
127772999|NCT01630434|459795416|FG001|Overall Study|Donor lungs turned down|0|||
127773000|NCT01630434|459795415|FG000|Overall Study|Protocol Violation|9|||
127773001|NCT01630434|459795416|FG001|Overall Study|Protocol Violation|4|||
127773002|NCT01630434|459795415|FG000|Overall Study|Death|20|||
127773003|NCT01630434|459795416|FG001|Overall Study|Death|26|||
128018626|NCT01251861|460690425|FG001|Overall Study|Adverse Event|17|||
127773004|NCT02893930|459795417|FG000|Overall Study|Adverse Event|3|||
128018627|NCT01251861|460690424|FG000|Overall Study|Withdrawal by Subject|2|||
128018628|NCT01251861|460690425|FG001|Overall Study|Withdrawal by Subject|2|||
128018629|NCT01251861|460690424|FG000|Overall Study|Alternative therapy|1|||
128018630|NCT01251861|460690425|FG001|Overall Study|Alternative therapy|0|||
128018631|NCT01251861|460690424|FG000|Overall Study|Other complicating disease|0|||
128018632|NCT01251861|460690425|FG001|Overall Study|Other complicating disease|1|||
128018633|NCT01251861|460690424|FG000|Overall Study|Physician Decision|1|||
128018634|NCT01251861|460690425|FG001|Overall Study|Physician Decision|0|||
128018635|NCT01251861|460690424|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
128018636|NCT01251861|460690425|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
128018637|NCT01251861|460690424|FG000|Overall Study|Other|1|||
128018638|NCT01251861|460690425|FG001|Overall Study|Other|0|||
128018639|NCT01251861|460690424|FG000|Overall Study|Never started therapy|4|||
128018640|NCT01251861|460690425|FG001|Overall Study|Never started therapy|1|||
127552080|NCT00607373|458987390|FG000|Treatment Period|Adverse Event|0|||
127552081|NCT00607373|458987391|FG001|Treatment Period|Adverse Event|4|||
127552082|NCT00607373|458987390|FG000|Treatment Period|Physician Decision|0|||
127552083|NCT00607373|458987391|FG001|Treatment Period|Physician Decision|1|||
127552084|NCT00607373|458987390|FG000|Treatment Period|Withdrawal by Subject|0|||
128018641|NCT01251861|460690424|FG000|Overall Study|Potential interaction of drugs|0|||
128018642|NCT01251861|460690425|FG001|Overall Study|Potential interaction of drugs|1|||
128018643|NCT03720847|460691263|FG000|Washout|Physician Decision|1|||
128018644|NCT03720847|460691264|FG001|Washout|Physician Decision|2|||
128018645|NCT01239680|460691265|FG000|Overall Study|Withdrawal by Subject|2|||
128018646|NCT01239680|460691266|FG001|Overall Study|Withdrawal by Subject|0|||
128018647|NCT03033901|460691267|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
128018648|NCT03033901|460691267|FG000|Overall Study|Refused PSG|23|||
128018649|NCT03033901|460691267|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
128018650|NCT03033901|460691267|FG000|Overall Study|Missing Oximetry Data|3|||
128018651|NCT01521364|460691275|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
128018652|NCT01521364|460691275|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
128018653|NCT02636283|460691276|FG000|Overall Study|Adverse Event|2|||
128018654|NCT02636283|460691277|FG001|Overall Study|Adverse Event|0|||
128018655|NCT02636283|460691276|FG000|Overall Study|Trial Terminated Prematurely|0|||
128018656|NCT02636283|460691277|FG001|Overall Study|Trial Terminated Prematurely|3|||
128018657|NCT00195429|460691280|FG000|Overall Study|Adverse Event|2|||
128018658|NCT00195429|460691281|FG001|Overall Study|Adverse Event|4|||
128018659|NCT00195429|460691280|FG000|Overall Study|Lack of Efficacy|2|||
128018660|NCT00195429|460691281|FG001|Overall Study|Lack of Efficacy|1|||
128018661|NCT00195429|460691280|FG000|Overall Study|Lost to Follow-up|1|||
128018662|NCT00195429|460691281|FG001|Overall Study|Lost to Follow-up|0|||
128018663|NCT02541903|460691282|FG000|Overall Study|Death|1|||
128018664|NCT03637374|460691283|FG000|Overall Study|Death|2|||
128018665|NCT03637374|460691284|FG001|Overall Study|Death|0|||
128018666|NCT04795323|460691287|FG000|Overall Study|Did not interact with TARA|1|||
128018667|NCT04795323|460691288|FG001|Overall Study|Did not interact with TARA|0|||
128018668|NCT03142750|460691294|FG000|Overall Study|Lost to Follow-up|4|||
128018669|NCT03142750|460691295|FG001|Overall Study|Lost to Follow-up|1|||
128018670|NCT04925934|460691296|FG000|Overall Study|Adverse Event|1|||
128018671|NCT04925934|460691297|FG001|Overall Study|Adverse Event|0|||
128018672|NCT04925934|460691298|FG002|Overall Study|Adverse Event|0|||
128018673|NCT04925934|460691296|FG000|Overall Study|Lost to Follow-up|2|||
128018674|NCT04925934|460691297|FG001|Overall Study|Lost to Follow-up|0|||
128018675|NCT04925934|460691298|FG002|Overall Study|Lost to Follow-up|1|||
128018676|NCT04925934|460691296|FG000|Overall Study|Death|0|||
128018677|NCT04925934|460691297|FG001|Overall Study|Death|1|||
128018678|NCT04925934|460691298|FG002|Overall Study|Death|0|||
128018679|NCT04925934|460691296|FG000|Overall Study|Withdrawal by Subject|8|||
128018680|NCT04925934|460691297|FG001|Overall Study|Withdrawal by Subject|5|||
128018681|NCT04925934|460691298|FG002|Overall Study|Withdrawal by Subject|9|||
128018682|NCT04925934|460691296|FG000|Overall Study|Other|2|||
128018683|NCT04925934|460691297|FG001|Overall Study|Other|2|||
128018684|NCT04925934|460691298|FG002|Overall Study|Other|2|||
128018685|NCT04925934|460691296|FG000|Overall Study|Eastern European Conflict|7|||
128018686|NCT04925934|460691297|FG001|Overall Study|Eastern European Conflict|3|||
128018687|NCT04925934|460691298|FG002|Overall Study|Eastern European Conflict|2|||
128018688|NCT03158688|460691299|FG000|Overall Study|Withdrawal by Subject|14|||
128018689|NCT03158688|460691300|FG001|Overall Study|Withdrawal by Subject|28|||
128018690|NCT03158688|460691299|FG000|Overall Study|Decision by sponsor|13|||
128018691|NCT03158688|460691300|FG001|Overall Study|Decision by sponsor|37|||
128018692|NCT03158688|460691299|FG000|Overall Study|Lost to Follow-up|4|||
128018693|NCT03158688|460691300|FG001|Overall Study|Lost to Follow-up|3|||
128018694|NCT03158688|460691299|FG000|Overall Study|Death|74|||
128018695|NCT03158688|460691300|FG001|Overall Study|Death|142|||
128018696|NCT00374868|460691304|FG000|Overall Study|Adverse Event|12|||
128018697|NCT00374868|460691304|FG000|Overall Study|Progressive Disease|7|||
128018698|NCT00374868|460691304|FG000|Overall Study|Physician Decision|13|||
127552085|NCT00607373|458987391|FG001|Treatment Period|Withdrawal by Subject|1|||
128018699|NCT00374868|460691304|FG000|Overall Study|Lost to Follow-up|1|||
128018700|NCT00374868|460691304|FG000|Overall Study|Death|2|||
128018701|NCT00374868|460691304|FG000|Overall Study|Other - Not Specified|1|||
128018702|NCT03188185|460691305|FG000|Stage 1|Adverse Event|4|||
128018703|NCT03188185|460691306|FG001|Stage 1|Adverse Event|12|||
128018704|NCT03188185|460691307|FG002|Stage 1|Adverse Event|0|||
128018705|NCT03188185|460691308|FG003|Stage 1|Adverse Event|0|||
128018706|NCT03188185|460691305|FG000|Stage 1|Lack of Efficacy|0|||
128018707|NCT03188185|460691306|FG001|Stage 1|Lack of Efficacy|2|||
128018708|NCT03188185|460691307|FG002|Stage 1|Lack of Efficacy|0|||
128018709|NCT03188185|460691308|FG003|Stage 1|Lack of Efficacy|0|||
128018710|NCT03188185|460691305|FG000|Stage 1|Lost to Follow-up|6|||
128018711|NCT03188185|460691306|FG001|Stage 1|Lost to Follow-up|1|||
128018712|NCT03188185|460691307|FG002|Stage 1|Lost to Follow-up|0|||
128018713|NCT03188185|460691308|FG003|Stage 1|Lost to Follow-up|0|||
128018714|NCT03188185|460691305|FG000|Stage 1|Withdrawal by Subject|9|||
128018715|NCT03188185|460691306|FG001|Stage 1|Withdrawal by Subject|0|||
128018716|NCT03188185|460691307|FG002|Stage 1|Withdrawal by Subject|0|||
128018717|NCT03188185|460691308|FG003|Stage 1|Withdrawal by Subject|0|||
128018718|NCT03188185|460691305|FG000|Stage 1|Identified as a professional patient|0|||
128018719|NCT03188185|460691306|FG001|Stage 1|Identified as a professional patient|1|||
128018720|NCT03188185|460691307|FG002|Stage 1|Identified as a professional patient|0|||
128018721|NCT03188185|460691308|FG003|Stage 1|Identified as a professional patient|0|||
128018722|NCT03188185|460691305|FG000|Stage 2|Adverse Event|0|||
128018723|NCT03188185|460691306|FG001|Stage 2|Adverse Event|0|||
128018724|NCT03188185|460691307|FG002|Stage 2|Adverse Event|2|||
128018725|NCT03188185|460691308|FG003|Stage 2|Adverse Event|4|||
128018726|NCT03188185|460691305|FG000|Stage 2|Lack of Efficacy|0|||
128018727|NCT03188185|460691306|FG001|Stage 2|Lack of Efficacy|0|||
128018728|NCT03188185|460691307|FG002|Stage 2|Lack of Efficacy|3|||
128018729|NCT03188185|460691308|FG003|Stage 2|Lack of Efficacy|0|||
128018730|NCT03188185|460691305|FG000|Stage 2|Lost to Follow-up|0|||
128018731|NCT03188185|460691306|FG001|Stage 2|Lost to Follow-up|0|||
128018732|NCT03188185|460691307|FG002|Stage 2|Lost to Follow-up|1|||
128018733|NCT03188185|460691308|FG003|Stage 2|Lost to Follow-up|0|||
128018734|NCT03188185|460691305|FG000|Stage 2|Physician Decision|0|||
128018735|NCT03188185|460691306|FG001|Stage 2|Physician Decision|0|||
128018736|NCT03188185|460691307|FG002|Stage 2|Physician Decision|0|||
128018737|NCT03188185|460691308|FG003|Stage 2|Physician Decision|1|||
128018738|NCT03188185|460691305|FG000|Stage 2|Withdrawal by Subject|0|||
128018739|NCT03188185|460691306|FG001|Stage 2|Withdrawal by Subject|0|||
128018740|NCT03188185|460691307|FG002|Stage 2|Withdrawal by Subject|3|||
128018741|NCT03188185|460691308|FG003|Stage 2|Withdrawal by Subject|1|||
128018742|NCT02315625|460691312|FG000|First Intervention|Disease Progression|1|||
128018743|NCT02315625|460691313|FG001|First Intervention|Disease Progression|0|||
128018744|NCT02315625|460691312|FG000|Second Intervention|Physician Decision|2|||
128018745|NCT02315625|460691313|FG001|Second Intervention|Physician Decision|1|||
128018746|NCT02315625|460691312|FG000|Second Intervention|Study closure|1|||
128018747|NCT02315625|460691313|FG001|Second Intervention|Study closure|0|||
128018748|NCT02315625|460691312|FG000|Second Intervention|Disease Progression|1|||
128018749|NCT02315625|460691313|FG001|Second Intervention|Disease Progression|0|||
128018750|NCT04822194|460691316|FG000|Overall Study|Withdrawal by Subject|5|||
128018751|NCT04822194|460691317|FG001|Overall Study|Withdrawal by Subject|4|||
128018752|NCT04822194|460691316|FG000|Overall Study|Technical issues with MR scanner|1|||
128018753|NCT04822194|460691317|FG001|Overall Study|Technical issues with MR scanner|0|||
128018754|NCT04822194|460691316|FG000|Overall Study|Lost to Follow-up|5|||
128018755|NCT04822194|460691317|FG001|Overall Study|Lost to Follow-up|7|||
128018756|NCT01947933|460691319|FG000|Overall Study|Withdrawal by Subject|0|||
128018757|NCT01947933|460691320|FG001|Overall Study|Withdrawal by Subject|0|||
128018758|NCT01947933|460691321|FG002|Overall Study|Withdrawal by Subject|1|||
128018759|NCT01947933|460691322|FG003|Overall Study|Withdrawal by Subject|0|||
128018760|NCT01947933|460691323|FG004|Overall Study|Withdrawal by Subject|0|||
128018761|NCT01947933|460691324|FG005|Overall Study|Withdrawal by Subject|0|||
128018762|NCT01947933|460691325|FG006|Overall Study|Withdrawal by Subject|0|||
128018763|NCT01947933|460691326|FG007|Overall Study|Withdrawal by Subject|0|||
128018764|NCT01947933|460691327|FG008|Overall Study|Withdrawal by Subject|0|||
128018765|NCT01947933|460691319|FG000|Overall Study|Lost to Follow-up|0|||
128018766|NCT01947933|460691320|FG001|Overall Study|Lost to Follow-up|0|||
128018767|NCT01947933|460691321|FG002|Overall Study|Lost to Follow-up|0|||
128018768|NCT01947933|460691322|FG003|Overall Study|Lost to Follow-up|0|||
128018769|NCT01947933|460691323|FG004|Overall Study|Lost to Follow-up|0|||
128018770|NCT01947933|460691324|FG005|Overall Study|Lost to Follow-up|0|||
128018771|NCT01947933|460691325|FG006|Overall Study|Lost to Follow-up|0|||
128018772|NCT01947933|460691326|FG007|Overall Study|Lost to Follow-up|0|||
128018773|NCT01947933|460691327|FG008|Overall Study|Lost to Follow-up|1|||
128018774|NCT00294398|460691328|FG000|Overall Study|Lost to Follow-up|21|||
128018775|NCT00294398|460691329|FG001|Overall Study|Lost to Follow-up|26|||
128018776|NCT02965833|460691332|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
128018777|NCT02965833|460691333|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
128018778|NCT02965833|460691332|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
128018779|NCT02965833|460691333|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
128018780|NCT02965833|460691332|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
128018781|NCT02965833|460691333|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
128018782|NCT02965833|460691332|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
128018783|NCT02965833|460691333|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
128018784|NCT02965833|460691332|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
128018785|NCT02965833|460691333|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
128018786|NCT03407482|460691337|FG000|Overall Study|Adverse Event|12|||
128018787|NCT03407482|460691337|FG000|Overall Study|Disease Relapse|1|||
128018788|NCT03407482|460691337|FG000|Overall Study|Lost to Follow-up|1|||
128018789|NCT03407482|460691337|FG000|Overall Study|Non-Compliance With Study Drug|1|||
128018790|NCT03407482|460691337|FG000|Overall Study|Pregnancy|2|||
128018791|NCT03407482|460691337|FG000|Overall Study|Protocol Violation|1|||
128018792|NCT03407482|460691337|FG000|Overall Study|Study Terminated By Sponsor|106|||
128018793|NCT03407482|460691337|FG000|Overall Study|Withdrawal by Subject|6|||
128018794|NCT03407482|460691337|FG000|Overall Study|Data Entry Error|1|||
128018795|NCT03442569|460691340|FG000|Overall Study|Subject was ineligible after enrollment|1|||
128018796|NCT05089357|460691341|FG000|Overall Study|Withdrawal by Subject|23|||
128018797|NCT05089357|460691341|FG000|Overall Study|Lost to Follow-up|6|||
128018798|NCT05089357|460691341|FG000|Overall Study|Medical reason|1|||
128018799|NCT05089357|460691341|FG000|Overall Study|Due to completion of project, participants did not enter the follow-up window period and withdrew|2|||
128018800|NCT05089357|460691341|FG000|Overall Study|Pregnancy|2|||
128018801|NCT05752487|460691346|FG000|Overall Study|Enrolled, not treated|9|||
128018802|NCT05752487|460691346|FG000|Overall Study|Study catheter inserted but did not undergo ablation|1|||
128018803|NCT05752487|460691346|FG000|Overall Study|Withdrawal by Subject|2|||
128018804|NCT03091439|460691347|FG000|Overall Study|Study Terminated by the Sponsor|1|||
128018805|NCT03091439|460691348|FG001|Overall Study|Study Terminated by the Sponsor|0|||
128018806|NCT01214720|460691353|FG000|Overall Study|Alive and still on treatment|34|||
128018807|NCT01214720|460691354|FG001|Overall Study|Alive and still on treatment|18|||
128018808|NCT01214720|460691353|FG000|Overall Study|Alive and in follow-up|45|||
128018809|NCT01214720|460691354|FG001|Overall Study|Alive and in follow-up|48|||
128018810|NCT01214720|460691353|FG000|Overall Study|Lost to Follow-up|6|||
128018811|NCT01214720|460691354|FG001|Overall Study|Lost to Follow-up|2|||
128018812|NCT02347787|460691355|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
127773005|NCT02893930|459795417|FG000|Overall Study|Death|1|||
127773006|NCT02893930|459795417|FG000|Overall Study|Disease progression|5|||
127773007|NCT02893930|459795417|FG000|Overall Study|Withdrawal by Subject|2|||
127773008|NCT02893930|459795417|FG000|Overall Study|Physician Decision|1|||
127773009|NCT02893930|459795417|FG000|Overall Study|Ineligible|1|||
127773010|NCT02349360|459795418|FG000|Overall Study|Withdrawal by Subject|0|||
127773011|NCT02349360|459795419|FG001|Overall Study|Withdrawal by Subject|1|||
127773012|NCT01176773|459795420|FG000|Overall Study|Screen Failure|2|||
127773013|NCT01176773|459795420|FG000|Overall Study|Withdrew consent|1|||
127773014|NCT03181451|459795426|FG000|Overall Study|Adverse Event|0|||
127773015|NCT03181451|459795427|FG001|Overall Study|Adverse Event|1|||
127773016|NCT03181451|459795428|FG002|Overall Study|Adverse Event|0|||
127773017|NCT03181451|459795426|FG000|Overall Study|Withdrawal by Subject|0|||
127773018|NCT03181451|459795427|FG001|Overall Study|Withdrawal by Subject|1|||
127773019|NCT03181451|459795428|FG002|Overall Study|Withdrawal by Subject|0|||
127773020|NCT01326533|459795432|FG000|Overall Study|Lost to Follow-up|2|||
127773021|NCT01326533|459795433|FG001|Overall Study|Lost to Follow-up|0|||
127773022|NCT01326533|459795432|FG000|Overall Study|Withdrawal by Subject|1|||
127773023|NCT01326533|459795433|FG001|Overall Study|Withdrawal by Subject|0|||
127773024|NCT01326533|459795432|FG000|Overall Study|Adverse Event|1|||
127773025|NCT01326533|459795433|FG001|Overall Study|Adverse Event|0|||
127773026|NCT00926211|459795436|FG000|Overall Study|Lost to Follow-up|1|||
127773027|NCT00775450|459795439|FG000|Overall Study|Serious Adverse Event|2|||
127773028|NCT00775450|459795440|FG001|Overall Study|Serious Adverse Event|0|||
127773029|NCT00775450|459795441|FG002|Overall Study|Serious Adverse Event|0|||
128018813|NCT02347787|460691356|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
128018814|NCT02347787|460691355|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
128018815|NCT02347787|460691356|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
128018816|NCT02347787|460691355|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
128018817|NCT02347787|460691356|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
127552086|NCT00607373|458987390|FG000|Follow-up Period|Other|0|||
127773030|NCT00775450|459795442|FG003|Overall Study|Serious Adverse Event|0|||
128018818|NCT02347787|460691355|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
127552087|NCT00607373|458987391|FG001|Follow-up Period|Other|1|||
127773031|NCT00775450|459795443|FG004|Overall Study|Serious Adverse Event|0|||
127773032|NCT00775450|459795439|FG000|Overall Study|Protocol Violation|0|||
127773033|NCT00775450|459795440|FG001|Overall Study|Protocol Violation|0|||
127773034|NCT00775450|459795441|FG002|Overall Study|Protocol Violation|0|||
127773035|NCT00775450|459795442|FG003|Overall Study|Protocol Violation|0|||
127773036|NCT00775450|459795443|FG004|Overall Study|Protocol Violation|1|||
128018819|NCT02347787|460691356|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
127552088|NCT00607373|458987390|FG000|Follow-up Period|Protocol Violation|0|||
127552089|NCT00607373|458987391|FG001|Follow-up Period|Protocol Violation|1|||
127642871|NCT01292239|459313203|FG000|Overall Study|Other|1|||
127773037|NCT00775450|459795439|FG000|Overall Study|Withdrawal by Subject|1|||
127773038|NCT00775450|459795440|FG001|Overall Study|Withdrawal by Subject|0|||
127773039|NCT00775450|459795441|FG002|Overall Study|Withdrawal by Subject|0|||
127773040|NCT00775450|459795442|FG003|Overall Study|Withdrawal by Subject|0|||
127773041|NCT00775450|459795443|FG004|Overall Study|Withdrawal by Subject|1|||
127773042|NCT00894686|459795446|FG000|Overall Study|Withdrawal by Subject|50|||
127773043|NCT00894686|459795446|FG000|Overall Study|Physician Decision|1|||
127773044|NCT00894686|459795446|FG000|Overall Study|Other|5|||
127773045|NCT00564018|459795449|FG000|Overall Study|Withdrawal by Subject|2|||
127773046|NCT00564018|459795450|FG001|Overall Study|Withdrawal by Subject|3|||
127773047|NCT00564018|459795451|FG002|Overall Study|Withdrawal by Subject|1|||
127773048|NCT03267940|459795452|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
127773049|NCT03267940|459795453|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
127773050|NCT03267940|459795454|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
127773051|NCT03267940|459795455|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
127773052|NCT03267940|459795456|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
127773053|NCT03267940|459795457|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
127773054|NCT03267940|459795452|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
127773055|NCT03267940|459795453|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
127773056|NCT03267940|459795454|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
127773057|NCT03267940|459795455|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
127773058|NCT03267940|459795456|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
127773059|NCT03267940|459795457|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
127773060|NCT03267940|459795452|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
127773061|NCT03267940|459795453|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
127773062|NCT03267940|459795454|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
127773063|NCT03267940|459795455|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
127773064|NCT03267940|459795456|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
127773065|NCT03267940|459795457|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
127773066|NCT03267940|459795452|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
127773067|NCT03267940|459795453|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
127773068|NCT03267940|459795454|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
127773069|NCT03267940|459795455|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
127773070|NCT03267940|459795456|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
127773071|NCT03267940|459795457|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
127773072|NCT03267940|459795452|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
127773073|NCT03267940|459795453|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
127773074|NCT03267940|459795454|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
127773075|NCT03267940|459795455|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
127773076|NCT03267940|459795456|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
127773077|NCT03267940|459795457|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
127773078|NCT03267940|459795452|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
127773079|NCT03267940|459795453|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
127773080|NCT03267940|459795454|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
127773081|NCT03267940|459795455|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
127773082|NCT03267940|459795456|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
127773083|NCT03267940|459795457|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
127773084|NCT03267940|459795452|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
127773085|NCT03267940|459795453|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
127773086|NCT03267940|459795454|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
127773087|NCT03267940|459795455|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
127773088|NCT03267940|459795456|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
127773089|NCT03267940|459795457|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
127773090|NCT03267940|459795452|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
127773091|NCT03267940|459795453|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
127773092|NCT03267940|459795454|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
127773093|NCT03267940|459795455|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
127773094|NCT03267940|459795456|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
127773095|NCT03267940|459795457|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
127773096|NCT03267940|459795452|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
128018820|NCT05643794|460692763|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
127773097|NCT03267940|459795453|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
127773098|NCT03267940|459795454|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
127773099|NCT03267940|459795455|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
127773100|NCT03267940|459795456|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
127773101|NCT03267940|459795457|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
127773102|NCT00388154|459795464|FG000|Overall Study|Withdrawal by Subject|1|||
127773103|NCT01948908|459795467|FG000|Overall Study|Protocol Violation|1|||
127773104|NCT01948908|459795468|FG001|Overall Study|Protocol Violation|0|||
127773105|NCT01948908|459795469|FG002|Overall Study|Protocol Violation|2|||
127773106|NCT03291587|459795470|FG000|Overall Study|Lost to Follow-up|62|||
127773107|NCT03291587|459795471|FG001|Overall Study|Lost to Follow-up|43|||
127773108|NCT03291587|459795470|FG000|Overall Study|Refused to Answer|5|||
127773109|NCT03291587|459795471|FG001|Overall Study|Refused to Answer|2|||
127773110|NCT03291587|459795470|FG000|Overall Study|Death|2|||
127773111|NCT03291587|459795471|FG001|Overall Study|Death|4|||
128018821|NCT05643794|460692764|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|0|||
128018822|NCT05643794|460692765|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
128018823|NCT05643794|460692763|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
128018824|NCT05643794|460692764|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
128018825|NCT05643794|460692765|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
128018826|NCT05643794|460692763|FG000|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
128018827|NCT05643794|460692764|FG001|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
128018828|NCT05643794|460692765|FG002|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
128018829|NCT05643794|460692763|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
128018830|NCT05643794|460692764|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
128018831|NCT05643794|460692765|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
128018832|NCT05643794|460692763|FG000|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
128018833|NCT05643794|460692764|FG001|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
128018834|NCT05643794|460692765|FG002|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
128018835|NCT05643794|460692763|FG000|Treatment Period 2 (12 Weeks)|New Work Commitments|1|||
128018836|NCT05643794|460692764|FG001|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
128018837|NCT05643794|460692765|FG002|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
128018838|NCT01363076|460692770|FG000|Overall Study|Withdrawal by Subject|0|||
128018839|NCT01363076|460692771|FG001|Overall Study|Withdrawal by Subject|1|||
128018840|NCT04706403|460692772|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
128018841|NCT04706403|460692773|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
128018842|NCT04706403|460692774|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
128018843|NCT04706403|460692775|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
128018844|NCT04706403|460692776|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
128018845|NCT00182637|460692777|FG000|Overall Study|Adverse Event|2|||
128018846|NCT00182637|460692777|FG000|Overall Study|Disease Progression|1|||
128018847|NCT04766333|460692779|FG000|Overall Study|Lost to Follow-up|40|||
128018848|NCT04766333|460692780|FG001|Overall Study|Lost to Follow-up|826|||
128018849|NCT00639379|460692781|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
128018850|NCT00639379|460692782|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
128018851|NCT00639379|460692781|FG000|Period 1 - 2 Weeks|lens issue|3|||
128018852|NCT00639379|460692782|FG001|Period 1 - 2 Weeks|lens issue|0|||
128018853|NCT02582632|460692786|FG000|Overall Study|Other|1|||
128018854|NCT03298061|460692787|FG000|Overall Study|Adverse Event|3|||
128018855|NCT03298061|460692787|FG000|Overall Study|Lack of Efficacy|6|||
128018856|NCT03298061|460692787|FG000|Overall Study|Protocol Violation|1|||
128018857|NCT03298061|460692787|FG000|Overall Study|Physician Decision|7|||
128018858|NCT03298061|460692787|FG000|Overall Study|Withdrawal by Subject|10|||
128018859|NCT02383173|460692788|FG000|Overall Study|Palliative Care Team withdrew|0|||
128018860|NCT02383173|460692789|FG001|Overall Study|Palliative Care Team withdrew|2|||
128018861|NCT01297244|460692790|FG000|Overall Study|Progressive disease|22|||
128018862|NCT01297244|460692791|FG001|Overall Study|Progressive disease|3|||
128018863|NCT01297244|460692790|FG000|Overall Study|Adverse Event|9|||
128018864|NCT01297244|460692791|FG001|Overall Study|Adverse Event|1|||
128018865|NCT01297244|460692790|FG000|Overall Study|Death|1|||
127552090|NCT00607373|458987390|FG000|Follow-up Period|Withdrawal by Subject|1|||
127552091|NCT00607373|458987391|FG001|Follow-up Period|Withdrawal by Subject|3|||
127552092|NCT02170077|458987392|FG000|Overall Study|Withdrawal by Subject|3|||
127552093|NCT02170077|458987393|FG001|Overall Study|Withdrawal by Subject|4|||
127552094|NCT02170077|458987394|FG002|Overall Study|Withdrawal by Subject|2|||
127773112|NCT03291587|459795470|FG000|Overall Study|Not interested in participating|8|||
127773113|NCT03291587|459795471|FG001|Overall Study|Not interested in participating|6|||
127773114|NCT03291587|459795470|FG000|Overall Study|Too busy to participate|4|||
128018866|NCT01297244|460692791|FG001|Overall Study|Death|1|||
127773115|NCT03291587|459795471|FG001|Overall Study|Too busy to participate|2|||
127773116|NCT00796120|459795472|FG000|Overall Study|Death|3|||
127773117|NCT00796120|459795473|FG001|Overall Study|Death|0|||
127552095|NCT02170077|458987392|FG000|Overall Study|Adverse Event|4|||
128018867|NCT01297244|460692790|FG000|Overall Study|Clinical progression|1|||
128018868|NCT01297244|460692791|FG001|Overall Study|Clinical progression|1|||
128018869|NCT01297244|460692790|FG000|Overall Study|Withdrawal by Subject|2|||
128018870|NCT01297244|460692791|FG001|Overall Study|Withdrawal by Subject|0|||
128018871|NCT03677401|460692792|FG000|Overall Study|Adverse Event|4|||
128018872|NCT03677401|460692793|FG001|Overall Study|Adverse Event|14|||
128018873|NCT03677401|460692792|FG000|Overall Study|Lack of Efficacy|3|||
128018874|NCT03677401|460692793|FG001|Overall Study|Lack of Efficacy|1|||
128018875|NCT03677401|460692792|FG000|Overall Study|Withdrawal by Subject|2|||
127552096|NCT02170077|458987393|FG001|Overall Study|Adverse Event|4|||
127552097|NCT02170077|458987394|FG002|Overall Study|Adverse Event|4|||
127552098|NCT02170077|458987392|FG000|Overall Study|Lost to Follow-up|0|||
127552099|NCT02170077|458987393|FG001|Overall Study|Lost to Follow-up|1|||
127552100|NCT02170077|458987394|FG002|Overall Study|Lost to Follow-up|0|||
127552101|NCT02170077|458987392|FG000|Overall Study|Exclusion criteria|2|||
127552102|NCT02170077|458987393|FG001|Overall Study|Exclusion criteria|2|||
127552103|NCT02170077|458987394|FG002|Overall Study|Exclusion criteria|5|||
127552104|NCT02170077|458987392|FG000|Overall Study|Exacerbation of seizures|0|||
127552105|NCT02170077|458987393|FG001|Overall Study|Exacerbation of seizures|2|||
127880996|NCT02756078|460186097|FG000|Period 1|Lost to Follow-up|0|||
128018876|NCT03677401|460692793|FG001|Overall Study|Withdrawal by Subject|2|||
127552106|NCT02170077|458987394|FG002|Overall Study|Exacerbation of seizures|1|||
127552107|NCT01780974|458987395|FG000|Overall Study|Death|1|||
128018877|NCT03677401|460692792|FG000|Overall Study|Sponsor decision|0|||
127773118|NCT00796120|459795472|FG000|Overall Study|Adverse Event|11|||
127773119|NCT00796120|459795473|FG001|Overall Study|Adverse Event|6|||
127773120|NCT00796120|459795472|FG000|Overall Study|Progressive disease|22|||
127773121|NCT00796120|459795473|FG001|Overall Study|Progressive disease|13|||
127773122|NCT00796120|459795472|FG000|Overall Study|Participant refusal|3|||
127773123|NCT00796120|459795473|FG001|Overall Study|Participant refusal|4|||
127773124|NCT00796120|459795472|FG000|Overall Study|Other|6|||
127773125|NCT00796120|459795473|FG001|Overall Study|Other|17|||
127773126|NCT00796120|459795472|FG000|Overall Study|Physician Decision|16|||
127773127|NCT00796120|459795473|FG001|Overall Study|Physician Decision|17|||
127773128|NCT00796120|459795472|FG000|Overall Study|Randomized but not treated|0|||
127773129|NCT00796120|459795473|FG001|Overall Study|Randomized but not treated|3|||
127773130|NCT01898923|459795475|FG000|Overall Study|Lack of Efficacy|5|||
128018878|NCT03677401|460692793|FG001|Overall Study|Sponsor decision|1|||
128018879|NCT03677401|460692792|FG000|Overall Study|Reason Unspecified|1|||
128018880|NCT03677401|460692793|FG001|Overall Study|Reason Unspecified|0|||
128018881|NCT01177410|460692794|FG000|Overall Study|Adverse Event|0|||
128018882|NCT01177410|460692795|FG001|Overall Study|Adverse Event|2|||
128018883|NCT01177410|460692796|FG002|Overall Study|Adverse Event|2|||
127552108|NCT01780974|458987396|FG001|Overall Study|Death|0|||
127773131|NCT01898923|459795476|FG001|Overall Study|Lack of Efficacy|6|||
127773132|NCT01898923|459795475|FG000|Overall Study|Adverse Event|3|||
127773133|NCT01898923|459795476|FG001|Overall Study|Adverse Event|1|||
127773134|NCT01898923|459795475|FG000|Overall Study|Lost to Follow-up|0|||
127773135|NCT01898923|459795476|FG001|Overall Study|Lost to Follow-up|1|||
127773136|NCT01898923|459795475|FG000|Overall Study|Withdrawal by Subject|4|||
127773137|NCT01898923|459795476|FG001|Overall Study|Withdrawal by Subject|7|||
127773138|NCT01898923|459795475|FG000|Overall Study|Physician Decision|3|||
127773139|NCT01898923|459795476|FG001|Overall Study|Physician Decision|4|||
127773140|NCT01898923|459795475|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
127773141|NCT01898923|459795476|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
127773142|NCT00381303|459795479|FG000|Overall Study|Lost to Follow-up|25|||
127773143|NCT00381303|459795480|FG001|Overall Study|Lost to Follow-up|9|||
127773144|NCT00381303|459795479|FG000|Overall Study|AE/HIV-related event|22|||
127773145|NCT00381303|459795480|FG001|Overall Study|AE/HIV-related event|6|||
127773146|NCT00381303|459795479|FG000|Overall Study|Non-Adherence|13|||
127773147|NCT00381303|459795480|FG001|Overall Study|Non-Adherence|6|||
127773148|NCT00381303|459795479|FG000|Overall Study|Withdrawal by Subject|13|||
127773149|NCT00381303|459795480|FG001|Overall Study|Withdrawal by Subject|6|||
127773150|NCT00381303|459795479|FG000|Overall Study|Virologic failure|6|||
127773151|NCT00381303|459795480|FG001|Overall Study|Virologic failure|4|||
127773152|NCT00381303|459795479|FG000|Overall Study|Ineligible to continue the trial|2|||
127773153|NCT00381303|459795480|FG001|Overall Study|Ineligible to continue the trial|1|||
127773154|NCT00381303|459795479|FG000|Overall Study|Pregnancy|2|||
127773155|NCT00381303|459795480|FG001|Overall Study|Pregnancy|0|||
127773156|NCT00381303|459795479|FG000|Overall Study|Physician Decision|1|||
127773157|NCT00381303|459795480|FG001|Overall Study|Physician Decision|0|||
127773158|NCT00381303|459795479|FG000|Overall Study|Physician's decision to close the site|3|||
127773159|NCT00381303|459795480|FG001|Overall Study|Physician's decision to close the site|1|||
127773160|NCT00381303|459795479|FG000|Overall Study|Subject moved out of state|2|||
127773161|NCT00381303|459795480|FG001|Overall Study|Subject moved out of state|0|||
127773162|NCT00381303|459795479|FG000|Overall Study|Subject taking too many different meds|1|||
127773163|NCT00381303|459795480|FG001|Overall Study|Subject taking too many different meds|0|||
127773164|NCT00381303|459795479|FG000|Overall Study|No virologic response by week 12|1|||
127773165|NCT00381303|459795480|FG001|Overall Study|No virologic response by week 12|0|||
127773166|NCT00381303|459795479|FG000|Overall Study|Subject was too busy for appointments|1|||
127773167|NCT00381303|459795480|FG001|Overall Study|Subject was too busy for appointments|0|||
127773168|NCT00381303|459795479|FG000|Overall Study|Subject did not continue visits|1|||
127773169|NCT00381303|459795480|FG001|Overall Study|Subject did not continue visits|0|||
127773170|NCT00381303|459795479|FG000|Overall Study|Subject primary physician's decision|1|||
127773171|NCT00381303|459795480|FG001|Overall Study|Subject primary physician's decision|0|||
127773172|NCT01966471|459795483|FG000|Overall Study|Death|44|||
127773173|NCT01966471|459795484|FG001|Overall Study|Death|56|||
127773174|NCT01966471|459795483|FG000|Overall Study|Lost to Follow-up|46|||
127773175|NCT01966471|459795484|FG001|Overall Study|Lost to Follow-up|39|||
127773176|NCT01966471|459795483|FG000|Overall Study|Various reasons|4|||
127773177|NCT01966471|459795484|FG001|Overall Study|Various reasons|4|||
127773178|NCT01966471|459795483|FG000|Overall Study|Physician Decision|7|||
127773179|NCT01966471|459795484|FG001|Overall Study|Physician Decision|5|||
127773180|NCT01966471|459795483|FG000|Overall Study|Study Terminated By Sponsor|758|||
127773181|NCT01966471|459795484|FG001|Overall Study|Study Terminated By Sponsor|773|||
127773182|NCT01966471|459795483|FG000|Overall Study|Withdrawal by Subject|59|||
127773183|NCT01966471|459795484|FG001|Overall Study|Withdrawal by Subject|51|||
127773184|NCT01030198|459795485|FG000|Overall Study|Could not measure efficacy accurately|0|||
128018884|NCT01177410|460692794|FG000|Overall Study|Withdrawal by Subject|1|||
127552109|NCT01780974|458987395|FG000|Overall Study|Adverse Event|1|||
127552110|NCT01780974|458987396|FG001|Overall Study|Adverse Event|3|||
127773185|NCT01030198|459795486|FG001|Overall Study|Could not measure efficacy accurately|7|||
127773186|NCT02370043|459795487|FG000|Overall Study|Withdrawal by Subject|0|||
127773187|NCT02370043|459795488|FG001|Overall Study|Withdrawal by Subject|0|||
127773188|NCT02370043|459795489|FG002|Overall Study|Withdrawal by Subject|0|||
128018885|NCT01177410|460692795|FG001|Overall Study|Withdrawal by Subject|4|||
128018886|NCT01177410|460692796|FG002|Overall Study|Withdrawal by Subject|3|||
128018887|NCT01177410|460692794|FG000|Overall Study|Lost to Follow-up|0|||
128018888|NCT01177410|460692795|FG001|Overall Study|Lost to Follow-up|1|||
128018889|NCT01177410|460692796|FG002|Overall Study|Lost to Follow-up|0|||
128018890|NCT00875667|460692801|FG000|Overall Study|Adverse Event|29|||
128018891|NCT00875667|460692802|FG001|Overall Study|Adverse Event|10|||
128018892|NCT00875667|460692801|FG000|Overall Study|Withdrawal by Subject|17|||
128018893|NCT00875667|460692802|FG001|Overall Study|Withdrawal by Subject|5|||
128018894|NCT00875667|460692801|FG000|Overall Study|Death|7|||
128018895|NCT00875667|460692802|FG001|Overall Study|Death|2|||
128018896|NCT00875667|460692801|FG000|Overall Study|Protocol Violation|2|||
128018897|NCT00875667|460692802|FG001|Overall Study|Protocol Violation|0|||
128018898|NCT00875667|460692801|FG000|Overall Study|Disease Progression|100|||
128018899|NCT00875667|460692802|FG001|Overall Study|Disease Progression|49|||
128018900|NCT00875667|460692801|FG000|Overall Study|Miscellaneous|12|||
128018901|NCT00875667|460692802|FG001|Overall Study|Miscellaneous|6|||
128018902|NCT00875667|460692801|FG000|Overall Study|Randomized but no Study Drug Given|3|||
128018903|NCT00875667|460692802|FG001|Overall Study|Randomized but no Study Drug Given|1|||
128018904|NCT00894647|460692803|FG000|Overall Study|Adverse Event|5|||
128018905|NCT00894647|460692804|FG001|Overall Study|Adverse Event|4|||
128018906|NCT00894647|460692803|FG000|Overall Study|Withdrawal by Subject|4|||
128018907|NCT00894647|460692804|FG001|Overall Study|Withdrawal by Subject|4|||
128018908|NCT00894647|460692803|FG000|Overall Study|Lost to Follow-up|0|||
128018909|NCT00894647|460692804|FG001|Overall Study|Lost to Follow-up|2|||
128018910|NCT00894647|460692803|FG000|Overall Study|Non-compliance with study procedures|0|||
128018911|NCT00894647|460692804|FG001|Overall Study|Non-compliance with study procedures|2|||
128018912|NCT00894647|460692803|FG000|Overall Study|Other, not due to AE|1|||
127773189|NCT02370043|459795490|FG003|Overall Study|Withdrawal by Subject|0|||
127773190|NCT02370043|459795491|FG004|Overall Study|Withdrawal by Subject|1|||
127773191|NCT02370043|459795492|FG005|Overall Study|Withdrawal by Subject|1|||
127773192|NCT00688181|459795493|FG000|Overall Study|Lost to Follow-up|17|||
127773193|NCT00688181|459795493|FG000|Overall Study|Unknown Reason|4|||
127773194|NCT00688181|459795493|FG000|Overall Study|Non-clinical Reason|2|||
127773195|NCT01050205|459795494|FG000|Overall Study|Lost to Follow-up|7|||
127773196|NCT01050205|459795495|FG001|Overall Study|Lost to Follow-up|1|||
127773197|NCT01050205|459795494|FG000|Overall Study|Withdrawal by Subject|1|||
127773198|NCT01050205|459795495|FG001|Overall Study|Withdrawal by Subject|1|||
127773199|NCT01050205|459795494|FG000|Overall Study|Relocated from area|1|||
127773200|NCT01050205|459795495|FG001|Overall Study|Relocated from area|2|||
127773201|NCT01050205|459795494|FG000|Overall Study|Discontinued Intervention|2|||
127773202|NCT01050205|459795495|FG001|Overall Study|Discontinued Intervention|0|||
127773203|NCT01119001|459795496|FG000|Overall Study|Withdrawal by Subject|2|||
127773204|NCT00954421|459795497|FG000|Screening|screen failures|3|||
127773205|NCT00954421|459795497|FG000|6 Months of DBS|Withdrawal by Subject|1|||
127773206|NCT00954421|459795497|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
127773207|NCT00777946|459795498|FG000|Overall Study|Adverse Event|11|||
127773208|NCT00777946|459795499|FG001|Overall Study|Adverse Event|1|||
127773209|NCT00777946|459795500|FG002|Overall Study|Adverse Event|3|||
127773210|NCT00777946|459795498|FG000|Overall Study|Lack of Efficacy|0|||
127773211|NCT00777946|459795499|FG001|Overall Study|Lack of Efficacy|0|||
127773212|NCT00777946|459795500|FG002|Overall Study|Lack of Efficacy|9|||
128018913|NCT00894647|460692804|FG001|Overall Study|Other, not due to AE|2|||
127773213|NCT00777946|459795498|FG000|Overall Study|Condition no longer required study drug|1|||
128018914|NCT01913470|460692805|FG000|Overall Study|Lost to Follow-up|0|||
128018915|NCT01913470|460692806|FG001|Overall Study|Lost to Follow-up|1|||
128018916|NCT01913470|460692805|FG000|Overall Study|Physician Decision|0|||
128018917|NCT01913470|460692806|FG001|Overall Study|Physician Decision|1|||
128018918|NCT01913470|460692805|FG000|Overall Study|Withdrawal by Subject|0|||
127773214|NCT00777946|459795499|FG001|Overall Study|Condition no longer required study drug|0|||
127773215|NCT00777946|459795500|FG002|Overall Study|Condition no longer required study drug|0|||
127773216|NCT00777946|459795498|FG000|Overall Study|Patient withdrew consent|3|||
127773217|NCT00777946|459795499|FG001|Overall Study|Patient withdrew consent|2|||
128018919|NCT01913470|460692806|FG001|Overall Study|Withdrawal by Subject|1|||
128018920|NCT00923702|460692812|FG000|Overall Study|Ongoing enrollment|0|||
128018921|NCT00923702|460692813|FG001|Overall Study|Ongoing enrollment|0|||
128018922|NCT00923702|460692814|FG002|Overall Study|Ongoing enrollment|0|||
128018923|NCT00923702|460692815|FG003|Overall Study|Ongoing enrollment|0|||
127552111|NCT01724346|458987397|FG000|Overall Study|Death|42|||
127773218|NCT00777946|459795500|FG002|Overall Study|Patient withdrew consent|3|||
128018924|NCT00923702|460692816|FG004|Overall Study|Ongoing enrollment|354|||
128018925|NCT02143778|460692817|FG000|Overall Study|Withdrawal by Subject|2|||
128018926|NCT02143778|460692817|FG000|Overall Study|Device malfunction|1|||
127773219|NCT00777946|459795498|FG000|Overall Study|Lost to Follow-up|3|||
127773220|NCT00777946|459795499|FG001|Overall Study|Lost to Follow-up|1|||
127773221|NCT00777946|459795500|FG002|Overall Study|Lost to Follow-up|0|||
127773222|NCT00777946|459795498|FG000|Overall Study|Protocol deviation|2|||
127773223|NCT00777946|459795499|FG001|Overall Study|Protocol deviation|1|||
127773224|NCT00777946|459795500|FG002|Overall Study|Protocol deviation|1|||
127773225|NCT00777946|459795498|FG000|Overall Study|Randomized in error|1|||
127773226|NCT00777946|459795499|FG001|Overall Study|Randomized in error|1|||
128018927|NCT00625378|460692819|FG000|Overall Study|Adverse Event|22|||
128018928|NCT00625378|460692820|FG001|Overall Study|Adverse Event|0|||
128018929|NCT00625378|460692819|FG000|Overall Study|Withdrawal by Subject|16|||
128018930|NCT00625378|460692820|FG001|Overall Study|Withdrawal by Subject|0|||
128018931|NCT00625378|460692819|FG000|Overall Study|Death|38|||
128018932|NCT00625378|460692820|FG001|Overall Study|Death|0|||
128018933|NCT00625378|460692819|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
128018934|NCT00625378|460692820|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
128018935|NCT00625378|460692819|FG000|Overall Study|Lost to Follow-up|17|||
127552112|NCT01724346|458987398|FG001|Overall Study|Death|42|||
127773227|NCT00777946|459795500|FG002|Overall Study|Randomized in error|0|||
127773228|NCT04675151|459795501|FG000|Overall Study|Protocol Violation|1|||
128018936|NCT00625378|460692820|FG001|Overall Study|Lost to Follow-up|0|||
128018937|NCT00625378|460692819|FG000|Overall Study|Non-compliant with study medication|3|||
128018938|NCT00625378|460692820|FG001|Overall Study|Non-compliant with study medication|0|||
128018939|NCT00625378|460692819|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
128018940|NCT00625378|460692820|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
128018941|NCT00625378|460692819|FG000|Overall Study|Medical decision|1|||
128018942|NCT00625378|460692820|FG001|Overall Study|Medical decision|0|||
127773229|NCT04675151|459795502|FG001|Overall Study|Protocol Violation|0|||
127773230|NCT04675151|459795503|FG002|Overall Study|Protocol Violation|0|||
127773231|NCT04675151|459795504|FG003|Overall Study|Protocol Violation|1|||
127773232|NCT00567268|459797115|FG000|Overall Study|Protocol Violation|7|||
127773233|NCT00567268|459797115|FG000|Overall Study|Lost to Follow-up|36|||
127773234|NCT00567268|459797115|FG000|Overall Study|No Visit After First Day of Treatment|2|||
127773235|NCT00567268|459797115|FG000|Overall Study|No Drug Administration|4|||
127773236|NCT00567268|459797115|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
127773237|NCT01717989|459797116|FG000|Overall Study|Ineligibility determined|6|||
127773238|NCT01717989|459797116|FG000|Overall Study|Protocol deviation|6|||
127773239|NCT01717989|459797116|FG000|Overall Study|Withdrawal by Subject|11|||
127773240|NCT01717989|459797116|FG000|Overall Study|Physician Decision|2|||
127773241|NCT01717989|459797116|FG000|Overall Study|Lost to Follow-up|11|||
127773242|NCT01717989|459797116|FG000|Overall Study|Death|439|||
127773243|NCT01717989|459797116|FG000|Overall Study|Protocol-specified criteria|551|||
127773244|NCT01717989|459797116|FG000|Overall Study|Other|40|||
127773245|NCT03224325|459797117|FG000|Overall Study|Adverse Event|1|||
127773246|NCT03224325|459797118|FG001|Overall Study|Adverse Event|0|||
128018943|NCT00625378|460692819|FG000|Overall Study|Multiple toxicities|1|||
128018944|NCT00625378|460692820|FG001|Overall Study|Multiple toxicities|0|||
128018945|NCT00625378|460692819|FG000|Overall Study|New cancer|1|||
128018946|NCT00625378|460692820|FG001|Overall Study|New cancer|0|||
128018947|NCT00625378|460692819|FG000|Overall Study|PTA program|2|||
128018948|NCT00625378|460692820|FG001|Overall Study|PTA program|0|||
128018949|NCT00625378|460692819|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
128018950|NCT00625378|460692820|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
128018951|NCT00625378|460692819|FG000|Overall Study|Sponsor decision|1|||
128018952|NCT00625378|460692820|FG001|Overall Study|Sponsor decision|0|||
128018953|NCT00625378|460692819|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
128018954|NCT00625378|460692820|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
128018955|NCT00625378|460692819|FG000|Overall Study|Switch to commercial drug|6|||
128018956|NCT00625378|460692820|FG001|Overall Study|Switch to commercial drug|1|||
128018957|NCT00625378|460692819|FG000|Overall Study|Missing|2|||
128018958|NCT00625378|460692820|FG001|Overall Study|Missing|0|||
127773247|NCT03224325|459797119|FG002|Overall Study|Adverse Event|0|||
127773248|NCT03224325|459797120|FG003|Overall Study|Adverse Event|0|||
127773249|NCT03224325|459797121|FG004|Overall Study|Adverse Event|0|||
127773250|NCT03224325|459797122|FG005|Overall Study|Adverse Event|0|||
127773251|NCT03224325|459797123|FG006|Overall Study|Adverse Event|1|||
127773252|NCT03224325|459797117|FG000|Overall Study|Withdrawal by Subject|0|||
127773253|NCT03224325|459797118|FG001|Overall Study|Withdrawal by Subject|0|||
128018959|NCT00625378|460692819|FG000|Overall Study|End of treatment not available|2|||
128018960|NCT00625378|460692820|FG001|Overall Study|End of treatment not available|0|||
128018961|NCT00625378|460692819|FG000|Overall Study|Never treated|2|||
128018962|NCT00625378|460692820|FG001|Overall Study|Never treated|0|||
128018963|NCT02639559|460692822|FG000|Overall Study|Mobilization failure|0|||
128018964|NCT02639559|460692823|FG001|Overall Study|Mobilization failure|3|||
127773254|NCT03224325|459797119|FG002|Overall Study|Withdrawal by Subject|0|||
127773255|NCT03224325|459797120|FG003|Overall Study|Withdrawal by Subject|1|||
127552113|NCT01724346|458987397|FG000|Overall Study|Lost to Follow-up|5|||
127552114|NCT01724346|458987398|FG001|Overall Study|Lost to Follow-up|1|||
127552115|NCT01724346|458987397|FG000|Overall Study|Withdrawal by Subject|27|||
128018965|NCT02639559|460692822|FG000|Overall Study|Issues with vascular acess|1|||
128018966|NCT02639559|460692823|FG001|Overall Study|Issues with vascular acess|0|||
128018967|NCT03880565|460692828|FG000|Overall Study|Withdrawal by Subject|1|||
128018968|NCT03880565|460692829|FG001|Overall Study|Withdrawal by Subject|0|||
128018969|NCT02969018|460692830|FG000|Overall Study|Adverse Event|2|||
128018970|NCT02969018|460692831|FG001|Overall Study|Adverse Event|4|||
128018971|NCT02969018|460692832|FG002|Overall Study|Adverse Event|1|||
128018972|NCT02969018|460692833|FG003|Overall Study|Adverse Event|2|||
128018973|NCT02969018|460692834|FG004|Overall Study|Adverse Event|0|||
128018974|NCT02969018|460692835|FG005|Overall Study|Adverse Event|1|||
128018975|NCT02969018|460692836|FG006|Overall Study|Adverse Event|2|||
128018976|NCT02969018|460692837|FG007|Overall Study|Adverse Event|0|||
128018977|NCT02969018|460692830|FG000|Overall Study|Lack of Efficacy|0|||
128018978|NCT02969018|460692831|FG001|Overall Study|Lack of Efficacy|1|||
128018979|NCT02969018|460692832|FG002|Overall Study|Lack of Efficacy|0|||
128018980|NCT02969018|460692833|FG003|Overall Study|Lack of Efficacy|0|||
128018981|NCT02969018|460692834|FG004|Overall Study|Lack of Efficacy|1|||
128018982|NCT02969018|460692835|FG005|Overall Study|Lack of Efficacy|1|||
128018983|NCT02969018|460692836|FG006|Overall Study|Lack of Efficacy|1|||
128018984|NCT02969018|460692837|FG007|Overall Study|Lack of Efficacy|1|||
128018985|NCT02969018|460692830|FG000|Overall Study|Lost to Follow-up|1|||
128018986|NCT02969018|460692831|FG001|Overall Study|Lost to Follow-up|2|||
128018987|NCT02969018|460692832|FG002|Overall Study|Lost to Follow-up|2|||
128018988|NCT02969018|460692833|FG003|Overall Study|Lost to Follow-up|0|||
128018989|NCT02969018|460692834|FG004|Overall Study|Lost to Follow-up|1|||
128018990|NCT02969018|460692835|FG005|Overall Study|Lost to Follow-up|1|||
128018991|NCT02969018|460692836|FG006|Overall Study|Lost to Follow-up|0|||
128018992|NCT02969018|460692837|FG007|Overall Study|Lost to Follow-up|1|||
128018993|NCT02969018|460692830|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
128018994|NCT02969018|460692831|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
128018995|NCT02969018|460692832|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
128018996|NCT02969018|460692833|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
128018997|NCT02969018|460692834|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
128018998|NCT02969018|460692835|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
128018999|NCT02969018|460692836|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
128019000|NCT02969018|460692837|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
128019001|NCT02969018|460692830|FG000|Overall Study|Non-Compliance With Study Drug|1|||
128019002|NCT02969018|460692831|FG001|Overall Study|Non-Compliance With Study Drug|0|||
128019003|NCT02969018|460692832|FG002|Overall Study|Non-Compliance With Study Drug|0|||
128019004|NCT02969018|460692833|FG003|Overall Study|Non-Compliance With Study Drug|0|||
128019005|NCT02969018|460692834|FG004|Overall Study|Non-Compliance With Study Drug|0|||
128019006|NCT02969018|460692835|FG005|Overall Study|Non-Compliance With Study Drug|0|||
128019007|NCT02969018|460692836|FG006|Overall Study|Non-Compliance With Study Drug|0|||
128019008|NCT02969018|460692837|FG007|Overall Study|Non-Compliance With Study Drug|0|||
128019009|NCT02969018|460692830|FG000|Overall Study|Other|0|||
128019010|NCT02969018|460692831|FG001|Overall Study|Other|0|||
128019011|NCT02969018|460692832|FG002|Overall Study|Other|0|||
128019012|NCT02969018|460692833|FG003|Overall Study|Other|1|||
128019013|NCT02969018|460692834|FG004|Overall Study|Other|0|||
128019014|NCT02969018|460692835|FG005|Overall Study|Other|0|||
128019015|NCT02969018|460692836|FG006|Overall Study|Other|0|||
128019016|NCT02969018|460692837|FG007|Overall Study|Other|2|||
128019017|NCT02969018|460692830|FG000|Overall Study|Pregnancy|0|||
128019018|NCT02969018|460692831|FG001|Overall Study|Pregnancy|0|||
128019019|NCT02969018|460692832|FG002|Overall Study|Pregnancy|0|||
128019020|NCT02969018|460692833|FG003|Overall Study|Pregnancy|0|||
128019021|NCT02969018|460692834|FG004|Overall Study|Pregnancy|0|||
128019022|NCT02969018|460692835|FG005|Overall Study|Pregnancy|1|||
128019023|NCT02969018|460692836|FG006|Overall Study|Pregnancy|0|||
128019024|NCT02969018|460692837|FG007|Overall Study|Pregnancy|0|||
128019025|NCT02969018|460692830|FG000|Overall Study|Protocol Violation|0|||
128019026|NCT02969018|460692831|FG001|Overall Study|Protocol Violation|0|||
128019027|NCT02969018|460692832|FG002|Overall Study|Protocol Violation|1|||
128019028|NCT02969018|460692833|FG003|Overall Study|Protocol Violation|1|||
128019029|NCT02969018|460692834|FG004|Overall Study|Protocol Violation|0|||
128019030|NCT02969018|460692835|FG005|Overall Study|Protocol Violation|0|||
128019031|NCT02969018|460692836|FG006|Overall Study|Protocol Violation|0|||
128019032|NCT02969018|460692837|FG007|Overall Study|Protocol Violation|0|||
128019033|NCT02969018|460692830|FG000|Overall Study|Withdrawal by Subject|0|||
128019034|NCT02969018|460692831|FG001|Overall Study|Withdrawal by Subject|1|||
128019035|NCT02969018|460692832|FG002|Overall Study|Withdrawal by Subject|2|||
128019036|NCT02969018|460692833|FG003|Overall Study|Withdrawal by Subject|1|||
128019037|NCT02969018|460692834|FG004|Overall Study|Withdrawal by Subject|0|||
128019038|NCT02969018|460692835|FG005|Overall Study|Withdrawal by Subject|4|||
128019039|NCT02969018|460692836|FG006|Overall Study|Withdrawal by Subject|4|||
128019040|NCT02969018|460692837|FG007|Overall Study|Withdrawal by Subject|3|||
127773256|NCT03224325|459797121|FG004|Overall Study|Withdrawal by Subject|0|||
127773257|NCT03224325|459797122|FG005|Overall Study|Withdrawal by Subject|0|||
127773258|NCT03224325|459797123|FG006|Overall Study|Withdrawal by Subject|0|||
127773259|NCT02952001|459797125|FG000|Overall Study|Adverse Event|3|||
127773260|NCT02952001|459797126|FG001|Overall Study|Adverse Event|0|||
127773261|NCT02952001|459797125|FG000|Overall Study|Prohibited therapy|10|||
127773262|NCT02952001|459797126|FG001|Overall Study|Prohibited therapy|3|||
127773263|NCT02952001|459797125|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
127773264|NCT02952001|459797126|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
127773265|NCT00937833|459797131|FG000|Overall Study|Protocol Violation|1|||
127773266|NCT00937833|459797132|FG001|Overall Study|Protocol Violation|2|||
127773267|NCT00937833|459797131|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
128019041|NCT00367458|460692838|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
128019042|NCT00367458|460692839|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
128019043|NCT04790201|460692845|FG000|Overall Study|Lost to Follow-up|0|||
128019044|NCT04790201|460692846|FG001|Overall Study|Lost to Follow-up|0|||
128019045|NCT04790201|460692847|FG002|Overall Study|Lost to Follow-up|2|||
128019046|NCT04790201|460692845|FG000|Overall Study|Death|0|||
128019047|NCT04790201|460692846|FG001|Overall Study|Death|1|||
128019048|NCT04790201|460692847|FG002|Overall Study|Death|0|||
128019049|NCT04790201|460692845|FG000|Overall Study|Protocol Violation|1|||
128019050|NCT04790201|460692846|FG001|Overall Study|Protocol Violation|0|||
128019051|NCT04790201|460692847|FG002|Overall Study|Protocol Violation|1|||
128019052|NCT03670628|460692848|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
128019053|NCT03670628|460692849|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
128019054|NCT03670628|460692848|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
128019055|NCT03670628|460692849|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
128019056|NCT02691663|460692853|FG000|Overall Study|Screen failure after baseline|2|||
128019057|NCT02691663|460692854|FG001|Overall Study|Screen failure after baseline|2|||
128019058|NCT02691663|460692853|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
128019059|NCT02691663|460692854|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
128019060|NCT02691663|460692853|FG000|Overall Study|Withdrawn after Follow up 2|1|||
128019061|NCT02691663|460692854|FG001|Overall Study|Withdrawn after Follow up 2|1|||
128019062|NCT02691663|460692853|FG000|Overall Study|Lost to Follow-up|3|||
128019063|NCT02691663|460692854|FG001|Overall Study|Lost to Follow-up|2|||
128019064|NCT01716156|460692857|FG000|Overall Study|Protocol Violation|1|||
128019065|NCT01716156|460692858|FG001|Overall Study|Protocol Violation|0|||
128019066|NCT01716156|460692859|FG002|Overall Study|Protocol Violation|0|||
128019067|NCT01716156|460692857|FG000|Overall Study|Withdrawal by Subject|0|||
128019068|NCT01716156|460692858|FG001|Overall Study|Withdrawal by Subject|1|||
128019069|NCT01716156|460692859|FG002|Overall Study|Withdrawal by Subject|2|||
128019070|NCT01716156|460692857|FG000|Overall Study|Lost to Follow-up|1|||
128019071|NCT01716156|460692858|FG001|Overall Study|Lost to Follow-up|0|||
128019072|NCT01716156|460692859|FG002|Overall Study|Lost to Follow-up|0|||
128019073|NCT03925220|460692860|FG000|Overall Study|Withdrawal by Subject|4|||
128019074|NCT03925220|460692861|FG001|Overall Study|Withdrawal by Subject|4|||
128019075|NCT03925220|460692862|FG002|Overall Study|Withdrawal by Subject|4|||
128019076|NCT03925220|460692863|FG003|Overall Study|Withdrawal by Subject|4|||
128019077|NCT03925220|460692860|FG000|Overall Study|Lost to Follow-up|40|||
128019078|NCT03925220|460692861|FG001|Overall Study|Lost to Follow-up|46|||
128019079|NCT03925220|460692862|FG002|Overall Study|Lost to Follow-up|37|||
128019080|NCT03925220|460692863|FG003|Overall Study|Lost to Follow-up|38|||
128019081|NCT05221866|460692864|FG000|Overall Study|Withdrawal by Subject|5|||
128019082|NCT05221866|460692865|FG001|Overall Study|Withdrawal by Subject|7|||
128019083|NCT05221866|460692866|FG002|Overall Study|Withdrawal by Subject|6|||
128019084|NCT05221866|460692867|FG003|Overall Study|Withdrawal by Subject|4|||
128019085|NCT05221866|460692864|FG000|Overall Study|Physician Decision|3|||
128019086|NCT05221866|460692865|FG001|Overall Study|Physician Decision|2|||
128019087|NCT05221866|460692866|FG002|Overall Study|Physician Decision|1|||
128019088|NCT05221866|460692867|FG003|Overall Study|Physician Decision|4|||
128019089|NCT05221866|460692864|FG000|Overall Study|Lost to Follow-up|12|||
128019090|NCT05221866|460692865|FG001|Overall Study|Lost to Follow-up|17|||
128019091|NCT05221866|460692866|FG002|Overall Study|Lost to Follow-up|14|||
128019092|NCT05221866|460692867|FG003|Overall Study|Lost to Follow-up|14|||
128019093|NCT05221866|460692864|FG000|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|7|||
128019094|NCT05221866|460692865|FG001|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|5|||
127773268|NCT00937833|459797132|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
127773269|NCT00937833|459797131|FG000|Overall Study|Lost to Follow-up|10|||
128019095|NCT05221866|460692866|FG002|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|0|||
128019096|NCT05221866|460692867|FG003|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|4|||
127552116|NCT01724346|458987398|FG001|Overall Study|Withdrawal by Subject|19|||
128019097|NCT05561140|460692868|FG000|Randomized Treatment Period|Adverse Event|1|||
128019098|NCT05561140|460692869|FG001|Randomized Treatment Period|Adverse Event|0|||
128019099|NCT05561140|460692868|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
128019100|NCT05561140|460692869|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
128019101|NCT05561140|460692868|FG000|Open Label Treatment Period|Adverse Event|6|||
128019102|NCT05561140|460692869|FG001|Open Label Treatment Period|Adverse Event|4|||
128019103|NCT05561140|460692868|FG000|Open Label Treatment Period|Lost to Follow-up|1|||
128019104|NCT05561140|460692869|FG001|Open Label Treatment Period|Lost to Follow-up|1|||
128019105|NCT05561140|460692868|FG000|Open Label Treatment Period|Physician Decision|0|||
128019106|NCT05561140|460692869|FG001|Open Label Treatment Period|Physician Decision|1|||
128019107|NCT05561140|460692868|FG000|Open Label Treatment Period|Pregnancy|1|||
128019108|NCT05561140|460692869|FG001|Open Label Treatment Period|Pregnancy|0|||
128019109|NCT05561140|460692868|FG000|Open Label Treatment Period|Study terminated by sponsor|29|||
128019110|NCT05561140|460692869|FG001|Open Label Treatment Period|Study terminated by sponsor|30|||
128019111|NCT05561140|460692868|FG000|Open Label Treatment Period|Withdrawal by Subject|0|||
128019112|NCT05561140|460692869|FG001|Open Label Treatment Period|Withdrawal by Subject|1|||
128019113|NCT05561140|460692868|FG000|Open Label Treatment Period|Other|1|||
128019114|NCT05561140|460692869|FG001|Open Label Treatment Period|Other|0|||
128019115|NCT01944774|460692870|FG000|Overall Study|Withdrawal by Subject|2|||
128019116|NCT01944774|460692871|FG001|Overall Study|Withdrawal by Subject|3|||
128019117|NCT01944774|460692872|FG002|Overall Study|Withdrawal by Subject|3|||
128019118|NCT01944774|460692870|FG000|Overall Study|Adverse Event|3|||
128019119|NCT01944774|460692871|FG001|Overall Study|Adverse Event|2|||
128019120|NCT01944774|460692872|FG002|Overall Study|Adverse Event|3|||
128019121|NCT01944774|460692870|FG000|Overall Study|Lack of Efficacy|1|||
128019122|NCT01944774|460692871|FG001|Overall Study|Lack of Efficacy|2|||
128019123|NCT01944774|460692872|FG002|Overall Study|Lack of Efficacy|2|||
128019124|NCT01944774|460692870|FG000|Overall Study|Lost to Follow-up|0|||
128019125|NCT01944774|460692871|FG001|Overall Study|Lost to Follow-up|1|||
128019126|NCT01944774|460692872|FG002|Overall Study|Lost to Follow-up|0|||
128019127|NCT03325439|460692874|FG000|Overall Study|Ineligibility|3|||
128019128|NCT01179516|460692875|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
128019129|NCT01179516|460692876|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
128019130|NCT01179516|460692877|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
128019131|NCT01179516|460692875|FG000|Overall Study|Lack of Efficacy|4|||
128019132|NCT01179516|460692876|FG001|Overall Study|Lack of Efficacy|2|||
128019133|NCT01179516|460692877|FG002|Overall Study|Lack of Efficacy|0|||
128019134|NCT01179516|460692875|FG000|Overall Study|Noncompliance with Study Drug|2|||
128019135|NCT01179516|460692876|FG001|Overall Study|Noncompliance with Study Drug|0|||
128019136|NCT01179516|460692877|FG002|Overall Study|Noncompliance with Study Drug|1|||
128019137|NCT01179516|460692875|FG000|Overall Study|Protocol Deviations|4|||
128019138|NCT01179516|460692876|FG001|Overall Study|Protocol Deviations|3|||
128019139|NCT01179516|460692877|FG002|Overall Study|Protocol Deviations|3|||
128019140|NCT01179516|460692875|FG000|Overall Study|Withdrawal of Consent|2|||
128019141|NCT01179516|460692876|FG001|Overall Study|Withdrawal of Consent|6|||
128019142|NCT01179516|460692877|FG002|Overall Study|Withdrawal of Consent|10|||
128019143|NCT01179516|460692875|FG000|Overall Study|Lost to Follow-up|7|||
128019144|NCT01179516|460692876|FG001|Overall Study|Lost to Follow-up|7|||
128019145|NCT01179516|460692877|FG002|Overall Study|Lost to Follow-up|3|||
128019146|NCT01179516|460692875|FG000|Overall Study|Other|2|||
128019147|NCT01179516|460692876|FG001|Overall Study|Other|0|||
128019148|NCT01179516|460692877|FG002|Overall Study|Other|2|||
128019149|NCT03349515|460692878|FG000|Overall Study|Lack of Efficacy|2|||
128019150|NCT03349515|460692879|FG001|Overall Study|Lack of Efficacy|0|||
128019151|NCT03349515|460692878|FG000|Overall Study|Physician Decision|3|||
128019152|NCT03349515|460692879|FG001|Overall Study|Physician Decision|1|||
128019153|NCT02503865|460692880|FG000|Overall Study|Moved out of area|1|||
128019154|NCT02503865|460692881|FG001|Overall Study|Moved out of area|8|||
128019155|NCT02503865|460692882|FG002|Overall Study|Moved out of area|0|||
128019156|NCT02503865|460692880|FG000|Overall Study|Refused treatment|4|||
128019157|NCT02503865|460692881|FG001|Overall Study|Refused treatment|39|||
128019158|NCT02503865|460692882|FG002|Overall Study|Refused treatment|2|||
128019159|NCT05073315|460692883|FG000|Period 1 (Lead-in Period)|Adverse Event|6|||
128019160|NCT05073315|460692884|FG001|Period 1 (Lead-in Period)|Adverse Event|0|||
128019161|NCT05073315|460692885|FG002|Period 1 (Lead-in Period)|Adverse Event|0|||
128019162|NCT05073315|460692883|FG000|Period 1 (Lead-in Period)|Death|1|||
128019163|NCT05073315|460692884|FG001|Period 1 (Lead-in Period)|Death|0|||
128019164|NCT05073315|460692885|FG002|Period 1 (Lead-in Period)|Death|0|||
128019165|NCT05073315|460692883|FG000|Period 1 (Lead-in Period)|Withdrawal by Subject|6|||
128019166|NCT05073315|460692884|FG001|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
128019167|NCT05073315|460692885|FG002|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
128019168|NCT05073315|460692883|FG000|Period 1 (Lead-in Period)|Lost to Follow-up|3|||
128019169|NCT05073315|460692884|FG001|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
128019170|NCT05073315|460692885|FG002|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
128019171|NCT05073315|460692883|FG000|Period 1 (Lead-in Period)|Protocol Violation|5|||
128019172|NCT05073315|460692884|FG001|Period 1 (Lead-in Period)|Protocol Violation|0|||
128019173|NCT05073315|460692885|FG002|Period 1 (Lead-in Period)|Protocol Violation|0|||
128019174|NCT05073315|460692883|FG000|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|23|||
128019175|NCT05073315|460692884|FG001|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
128019176|NCT05073315|460692885|FG002|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
128019177|NCT05073315|460692883|FG000|Period 1 (Lead-in Period)|Lack of Efficacy|1|||
128019178|NCT05073315|460692884|FG001|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
128019179|NCT05073315|460692885|FG002|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
128019180|NCT05073315|460692883|FG000|Period 2|Adverse Event|0|||
128019181|NCT05073315|460692884|FG001|Period 2|Adverse Event|3|||
128019182|NCT05073315|460692885|FG002|Period 2|Adverse Event|6|||
128019183|NCT05073315|460692883|FG000|Period 2|Lost to Follow-up|0|||
128019184|NCT05073315|460692884|FG001|Period 2|Lost to Follow-up|5|||
128019185|NCT05073315|460692885|FG002|Period 2|Lost to Follow-up|5|||
128019186|NCT05073315|460692883|FG000|Period 2|Withdrawal by Subject|0|||
128019187|NCT05073315|460692884|FG001|Period 2|Withdrawal by Subject|4|||
128019188|NCT05073315|460692885|FG002|Period 2|Withdrawal by Subject|9|||
128019189|NCT05073315|460692883|FG000|Period 2|Protocol Violation|0|||
128019190|NCT05073315|460692884|FG001|Period 2|Protocol Violation|0|||
128019191|NCT05073315|460692885|FG002|Period 2|Protocol Violation|1|||
128019192|NCT01529268|460692886|FG000|Overall Study|Lost to Follow-up|9|||
128019193|NCT01529268|460692887|FG001|Overall Study|Lost to Follow-up|3|||
128019194|NCT01529268|460692886|FG000|Overall Study|Moved|3|||
128019195|NCT01529268|460692887|FG001|Overall Study|Moved|0|||
128019196|NCT04069520|460692897|FG000|Overall Study|Lost to Follow-up|0|||
128019197|NCT04069520|460692898|FG001|Overall Study|Lost to Follow-up|2|||
128019198|NCT04069520|460692897|FG000|Overall Study|Withdrawal by Subject|0|||
128019199|NCT04069520|460692898|FG001|Overall Study|Withdrawal by Subject|1|||
128019200|NCT04069520|460692897|FG000|Overall Study|Prior Injury|1|||
128019201|NCT04069520|460692898|FG001|Overall Study|Prior Injury|0|||
128019202|NCT04069520|460692897|FG000|Overall Study|Orthodontia|1|||
128019203|NCT04069520|460692898|FG001|Overall Study|Orthodontia|0|||
128019204|NCT04069520|460692897|FG000|Overall Study|Cut from team|0|||
128019205|NCT04069520|460692898|FG001|Overall Study|Cut from team|2|||
128019206|NCT01068912|460692899|FG000|Overall Study|Adverse Event|2|||
128019207|NCT01068912|460692900|FG001|Overall Study|Adverse Event|3|||
128019208|NCT01068912|460692901|FG002|Overall Study|Adverse Event|2|||
128019209|NCT01068912|460692899|FG000|Overall Study|Withdrawal by Subject|5|||
128019210|NCT01068912|460692900|FG001|Overall Study|Withdrawal by Subject|6|||
128019211|NCT01068912|460692901|FG002|Overall Study|Withdrawal by Subject|6|||
128019212|NCT01068912|460692899|FG000|Overall Study|Lost to Follow-up|3|||
128019213|NCT01068912|460692900|FG001|Overall Study|Lost to Follow-up|7|||
128019214|NCT01068912|460692901|FG002|Overall Study|Lost to Follow-up|3|||
128019215|NCT01068912|460692899|FG000|Overall Study|Protocol Violation|0|||
128019216|NCT01068912|460692900|FG001|Overall Study|Protocol Violation|2|||
128019217|NCT01068912|460692901|FG002|Overall Study|Protocol Violation|0|||
128019218|NCT01068912|460692899|FG000|Overall Study|aggravation influenza|1|||
128019219|NCT01068912|460692900|FG001|Overall Study|aggravation influenza|1|||
128019220|NCT01068912|460692901|FG002|Overall Study|aggravation influenza|1|||
128019221|NCT01068912|460692899|FG000|Overall Study|other underlying illness|0|||
128019222|NCT01068912|460692900|FG001|Overall Study|other underlying illness|3|||
128019223|NCT01068912|460692901|FG002|Overall Study|other underlying illness|3|||
128019224|NCT00118287|460692902|FG000|Overall Study|Intracranial haemorrhage|1|||
128019225|NCT00118287|460692902|FG000|Overall Study|Muscle pain|1|||
128019226|NCT05537571|460692903|FG000|Overall Study|Withdrawal by Subject|1|||
128019227|NCT05537571|460692904|FG001|Overall Study|Withdrawal by Subject|1|||
128019228|NCT05537571|460692905|FG002|Overall Study|Withdrawal by Subject|0|||
128019229|NCT05537571|460692906|FG003|Overall Study|Withdrawal by Subject|0|||
128019230|NCT05537571|460692907|FG004|Overall Study|Withdrawal by Subject|0|||
128019231|NCT05537571|460692903|FG000|Overall Study|Adverse Event|2|||
128019232|NCT05537571|460692904|FG001|Overall Study|Adverse Event|0|||
128019233|NCT05537571|460692905|FG002|Overall Study|Adverse Event|0|||
128019234|NCT05537571|460692906|FG003|Overall Study|Adverse Event|0|||
128019235|NCT05537571|460692907|FG004|Overall Study|Adverse Event|0|||
128019236|NCT05537571|460692903|FG000|Overall Study|Hepatitis A screening result|2|||
128019237|NCT05537571|460692904|FG001|Overall Study|Hepatitis A screening result|0|||
128019238|NCT05537571|460692905|FG002|Overall Study|Hepatitis A screening result|0|||
128019239|NCT05537571|460692906|FG003|Overall Study|Hepatitis A screening result|0|||
128019240|NCT05537571|460692907|FG004|Overall Study|Hepatitis A screening result|0|||
128019241|NCT05537571|460692903|FG000|Overall Study|Lost to Follow-up|0|||
128019242|NCT05537571|460692904|FG001|Overall Study|Lost to Follow-up|0|||
128019243|NCT05537571|460692905|FG002|Overall Study|Lost to Follow-up|1|||
128019244|NCT05537571|460692906|FG003|Overall Study|Lost to Follow-up|0|||
128019245|NCT05537571|460692907|FG004|Overall Study|Lost to Follow-up|1|||
128019246|NCT01860989|460692908|FG000|Overall Study|Unsatisfactory therapeutic|5|||
128019247|NCT01685437|460692909|FG000|Overall Study|Withdrawal by Subject|22|||
128019248|NCT01685437|460692909|FG000|Overall Study|Lost to Follow-up|3|||
128019249|NCT01685437|460692909|FG000|Overall Study|Adverse Event|1|||
128019250|NCT01685437|460692909|FG000|Overall Study|Protocol Violation|4|||
128019251|NCT01685437|460692909|FG000|Overall Study|Unable to make visits due to work|1|||
128019252|NCT03770455|460692910|FG000|Overall Study|Screen failures|3|||
128019253|NCT01039675|460692913|FG000|Overall Study|Adverse Event|0|||
128019254|NCT01039675|460692914|FG001|Overall Study|Adverse Event|2|||
128019255|NCT01039675|460692913|FG000|Overall Study|Lack of Efficacy|0|||
128019256|NCT01039675|460692914|FG001|Overall Study|Lack of Efficacy|2|||
128019257|NCT01039675|460692913|FG000|Overall Study|Withdrawal by Subject|0|||
128019258|NCT01039675|460692914|FG001|Overall Study|Withdrawal by Subject|1|||
128019259|NCT01039675|460692913|FG000|Overall Study|Lost to Follow-up|0|||
128019260|NCT01039675|460692914|FG001|Overall Study|Lost to Follow-up|1|||
128019261|NCT01039675|460692913|FG000|Overall Study|Physician Decision|0|||
128019262|NCT01039675|460692914|FG001|Overall Study|Physician Decision|1|||
128019263|NCT00134719|460694525|FG000|Primary Vaccination Phase|Adverse Event|4|||
128019264|NCT00134719|460694526|FG001|Primary Vaccination Phase|Adverse Event|0|||
128019265|NCT00134719|460694527|FG002|Primary Vaccination Phase|Adverse Event|0|||
128019266|NCT00134719|460694525|FG000|Primary Vaccination Phase|Protocol Violation|1|||
128019267|NCT00134719|460694526|FG001|Primary Vaccination Phase|Protocol Violation|0|||
128019268|NCT00134719|460694527|FG002|Primary Vaccination Phase|Protocol Violation|0|||
128019269|NCT00134719|460694525|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
128019270|NCT00134719|460694526|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
128019271|NCT00134719|460694527|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
128019272|NCT00134719|460694525|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
128019273|NCT00134719|460694526|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
128019274|NCT00134719|460694527|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
128019275|NCT00134719|460694525|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
128019276|NCT00134719|460694526|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
128019277|NCT00134719|460694527|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
128019278|NCT00134719|460694525|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
128019279|NCT00134719|460694526|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
128019280|NCT00134719|460694527|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
128019281|NCT03439839|460694528|FG000|Overall Study|Death|3|||
128019282|NCT03439839|460694529|FG001|Overall Study|Death|0|||
128019283|NCT00723944|460694535|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
128019284|NCT00723944|460694536|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
128019285|NCT00723944|460694535|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
128019286|NCT00723944|460694536|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
128019287|NCT00723944|460694535|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
128019288|NCT00723944|460694536|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
128019289|NCT05177094|460694537|FG000|Overall Study|Adverse Event|5|||
128019290|NCT05177094|460694538|FG001|Overall Study|Adverse Event|5|||
128019291|NCT05177094|460694537|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
128019292|NCT05177094|460694538|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
128019293|NCT05177094|460694537|FG000|Overall Study|Protocol Deviation|3|||
128019294|NCT05177094|460694538|FG001|Overall Study|Protocol Deviation|0|||
128019295|NCT05177094|460694537|FG000|Overall Study|Withdrawal by Subject|6|||
128019296|NCT05177094|460694538|FG001|Overall Study|Withdrawal by Subject|3|||
128019297|NCT05177094|460694537|FG000|Overall Study|Participant could not tolerate long study visits|1|||
128019298|NCT05177094|460694538|FG001|Overall Study|Participant could not tolerate long study visits|0|||
128019299|NCT02400736|460694539|FG000|Overall Study|Lost to Follow-up|6|||
128019300|NCT02400736|460694540|FG001|Overall Study|Lost to Follow-up|6|||
128019301|NCT02400736|460694539|FG000|Overall Study|Withdrawal by Subject|2|||
128019302|NCT02400736|460694540|FG001|Overall Study|Withdrawal by Subject|1|||
128019303|NCT02400736|460694539|FG000|Overall Study|Moved from the area|3|||
128019304|NCT02400736|460694540|FG001|Overall Study|Moved from the area|1|||
128019305|NCT00992836|460694546|FG000|Overall Study|Lost to Follow-up|1|||
128019306|NCT00992836|460694546|FG000|Overall Study|Withdrawal by Subject|2|||
128019307|NCT00992836|460694546|FG000|Overall Study|Protocol Violation|2|||
128019308|NCT01617967|460694547|FG000|Overall Study|Protocol Violation|0|||
128019309|NCT01617967|460694548|FG001|Overall Study|Protocol Violation|0|||
128019310|NCT01617967|460694549|FG002|Overall Study|Protocol Violation|0|||
128019311|NCT01617967|460694550|FG003|Overall Study|Protocol Violation|1|||
128019312|NCT01617967|460694551|FG004|Overall Study|Protocol Violation|0|||
128019313|NCT01617967|460694552|FG005|Overall Study|Protocol Violation|0|||
128019314|NCT01617967|460694547|FG000|Overall Study|Withdrawal by Subject|0|||
128019315|NCT01617967|460694548|FG001|Overall Study|Withdrawal by Subject|0|||
128019316|NCT01617967|460694549|FG002|Overall Study|Withdrawal by Subject|0|||
128019317|NCT01617967|460694550|FG003|Overall Study|Withdrawal by Subject|0|||
128019318|NCT01617967|460694551|FG004|Overall Study|Withdrawal by Subject|0|||
128019319|NCT01617967|460694552|FG005|Overall Study|Withdrawal by Subject|1|||
128019320|NCT01617967|460694547|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
127552117|NCT01724346|458987397|FG000|Overall Study|Did Not Rollover From Parent Study|5|||
128019321|NCT01617967|460694548|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
128019322|NCT01617967|460694549|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
127552118|NCT01724346|458987398|FG001|Overall Study|Did Not Rollover From Parent Study|8|||
127773270|NCT00937833|459797132|FG001|Overall Study|Lost to Follow-up|8|||
127773271|NCT00937833|459797131|FG000|Overall Study|Withdrawal by Subject|4|||
127773272|NCT00937833|459797132|FG001|Overall Study|Withdrawal by Subject|6|||
127773273|NCT00818389|459797134|FG000|Overall Study|Death|1|||
127773274|NCT00818389|459797135|FG001|Overall Study|Death|3|||
127773275|NCT00818389|459797134|FG000|Overall Study|ALS Disease Progression|1|||
127773276|NCT00818389|459797135|FG001|Overall Study|ALS Disease Progression|0|||
127773277|NCT00818389|459797134|FG000|Overall Study|Withdrawal by Subject|2|||
127773278|NCT00818389|459797135|FG001|Overall Study|Withdrawal by Subject|2|||
127773279|NCT00818389|459797134|FG000|Overall Study|Adverse Event|0|||
127773280|NCT00818389|459797135|FG001|Overall Study|Adverse Event|1|||
127773281|NCT03548987|459797136|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
127773282|NCT03548987|459797137|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
128019323|NCT01617967|460694550|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
128019324|NCT01617967|460694551|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
128019325|NCT01617967|460694552|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
128019326|NCT05276804|460694559|FG000|Overall Study|screen failure|23|||
128019327|NCT05276804|460694560|FG001|Overall Study|screen failure|0|||
128019328|NCT02827708|460694561|FG000|Overall Study|Lost to Follow-up|3|||
128019329|NCT02827708|460694562|FG001|Overall Study|Lost to Follow-up|1|||
128019330|NCT02827708|460694561|FG000|Overall Study|Withdrawal by Subject|1|||
128019331|NCT02827708|460694562|FG001|Overall Study|Withdrawal by Subject|2|||
128019332|NCT02827708|460694561|FG000|Overall Study|Death|1|||
128019333|NCT02827708|460694562|FG001|Overall Study|Death|2|||
128019334|NCT01137812|460694563|FG000|Overall Study|Adverse Event|21|||
128019335|NCT01137812|460694564|FG001|Overall Study|Adverse Event|14|||
128019336|NCT01137812|460694563|FG000|Overall Study|Lost to Follow-up|6|||
128019337|NCT01137812|460694564|FG001|Overall Study|Lost to Follow-up|8|||
128019338|NCT01137812|460694563|FG000|Overall Study|Physician Decision|25|||
128019339|NCT01137812|460694564|FG001|Overall Study|Physician Decision|17|||
128019340|NCT01137812|460694563|FG000|Overall Study|Protocol Violation|5|||
128019341|NCT01137812|460694564|FG001|Overall Study|Protocol Violation|4|||
128019342|NCT01137812|460694563|FG000|Overall Study|Withdrawal by Subject|5|||
128019343|NCT01137812|460694564|FG001|Overall Study|Withdrawal by Subject|13|||
128019344|NCT01137812|460694563|FG000|Overall Study|Death|2|||
128019345|NCT01137812|460694564|FG001|Overall Study|Death|0|||
128019346|NCT01137812|460694563|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
128019347|NCT01137812|460694564|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
128019348|NCT01137812|460694563|FG000|Overall Study|Other|19|||
128019349|NCT01137812|460694564|FG001|Overall Study|Other|27|||
128019350|NCT04621760|460694568|FG000|Overall Study|Lost to Follow-up|2|||
128019351|NCT04621760|460694569|FG001|Overall Study|Lost to Follow-up|4|||
128019352|NCT04621760|460694568|FG000|Overall Study|Withdrawal by Subject|1|||
128019353|NCT04621760|460694569|FG001|Overall Study|Withdrawal by Subject|0|||
128019354|NCT04602000|460694572|FG000|Overall Study|Withdrawal by Subject|3|||
128019355|NCT04602000|460694573|FG001|Overall Study|Withdrawal by Subject|6|||
128019356|NCT04602000|460694574|FG002|Overall Study|Withdrawal by Subject|3|||
128019357|NCT04602000|460694575|FG003|Overall Study|Withdrawal by Subject|27|||
128019358|NCT04602000|460694576|FG004|Overall Study|Withdrawal by Subject|39|||
128019359|NCT04602000|460694572|FG000|Overall Study|Physician Decision|1|||
128019360|NCT04602000|460694573|FG001|Overall Study|Physician Decision|0|||
128019361|NCT04602000|460694574|FG002|Overall Study|Physician Decision|0|||
128019362|NCT04602000|460694575|FG003|Overall Study|Physician Decision|2|||
128019363|NCT04602000|460694576|FG004|Overall Study|Physician Decision|2|||
128019364|NCT04602000|460694572|FG000|Overall Study|Death|0|||
128019365|NCT04602000|460694573|FG001|Overall Study|Death|1|||
128019366|NCT04602000|460694574|FG002|Overall Study|Death|0|||
128019367|NCT04602000|460694575|FG003|Overall Study|Death|1|||
128019368|NCT04602000|460694576|FG004|Overall Study|Death|2|||
128019369|NCT04602000|460694572|FG000|Overall Study|Lost to Follow-up|0|||
128019370|NCT04602000|460694573|FG001|Overall Study|Lost to Follow-up|0|||
128019371|NCT04602000|460694574|FG002|Overall Study|Lost to Follow-up|0|||
128019372|NCT04602000|460694575|FG003|Overall Study|Lost to Follow-up|3|||
128019373|NCT04602000|460694576|FG004|Overall Study|Lost to Follow-up|4|||
127773283|NCT03548987|459797136|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
127773284|NCT03548987|459797137|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
127880997|NCT02756078|460186098|FG001|Period 1|Lost to Follow-up|2|||
127880998|NCT02756078|460186097|FG000|Period 1|Protocol Violation|0|||
128019374|NCT04602000|460694572|FG000|Overall Study|Other|4|||
128019375|NCT04602000|460694573|FG001|Overall Study|Other|1|||
128019376|NCT04602000|460694574|FG002|Overall Study|Other|2|||
128019377|NCT04602000|460694575|FG003|Overall Study|Other|5|||
128019378|NCT04602000|460694576|FG004|Overall Study|Other|4|||
128019379|NCT04602000|460694572|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
128019380|NCT04602000|460694573|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
128019381|NCT04602000|460694574|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
128019382|NCT04602000|460694575|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
128019383|NCT04602000|460694576|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
128019384|NCT00471354|460694577|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
128019385|NCT00471354|460694577|FG000|Overall Study|Adverse Event|13|||
128019386|NCT00471354|460694577|FG000|Overall Study|Protocol Violation|12|||
128019387|NCT00471354|460694577|FG000|Overall Study|Withdrawal by Subject|1|||
128019388|NCT00471354|460694577|FG000|Overall Study|Physician Decision|4|||
128019389|NCT00471354|460694577|FG000|Overall Study|Sponsor Decision|1|||
128019390|NCT00471354|460694577|FG000|Overall Study|Lost to Follow-up|3|||
128019391|NCT00471354|460694577|FG000|Overall Study|Lack of Efficacy|5|||
128019392|NCT00471354|460694577|FG000|Overall Study|Patient/Caregiver Decision|12|||
128019393|NCT02573467|460694581|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
128019394|NCT02573467|460694582|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
128019395|NCT02573467|460694583|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
128019396|NCT02573467|460694584|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
128019397|NCT02573467|460694581|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
128019398|NCT02573467|460694582|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
128019399|NCT02573467|460694583|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
128019400|NCT02573467|460694584|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
128019401|NCT02573467|460694581|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
128019402|NCT02573467|460694582|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
128019403|NCT02573467|460694583|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
128019404|NCT02573467|460694584|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
128019405|NCT02573467|460694581|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
128019406|NCT02573467|460694582|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
128019407|NCT02573467|460694583|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
128019408|NCT02573467|460694584|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
128019409|NCT02573467|460694581|FG000|Post-treatment Follow up Epoch|Death|1|||
128019410|NCT02573467|460694582|FG001|Post-treatment Follow up Epoch|Death|1|||
128019411|NCT02573467|460694583|FG002|Post-treatment Follow up Epoch|Death|0|||
128019412|NCT02573467|460694584|FG003|Post-treatment Follow up Epoch|Death|1|||
128019413|NCT02573467|460694581|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
128019414|NCT02573467|460694582|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
128019415|NCT02573467|460694583|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
128019416|NCT02573467|460694584|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
128019417|NCT02573467|460694581|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
128019418|NCT02573467|460694582|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
128019419|NCT02573467|460694583|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
128019420|NCT02573467|460694584|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
128019421|NCT02153827|460694585|FG000|Overall Study|Lost to Follow-up|3|||
128019422|NCT02153827|460694586|FG001|Overall Study|Lost to Follow-up|9|||
128019423|NCT05762679|460694587|FG000|Overall Study|Withdrawal by Subject|1|||
128019424|NCT05762679|460694587|FG000|Overall Study|No analyzable imaging data|1|||
128019425|NCT04339972|460694588|FG000|Overall Study|Scheduling Issues|3|||
128019426|NCT04339972|460694589|FG001|Overall Study|Scheduling Issues|3|||
128019427|NCT04339972|460694588|FG000|Overall Study|dropout|1|||
128019428|NCT04339972|460694589|FG001|Overall Study|dropout|1|||
128019429|NCT04339972|460694588|FG000|Overall Study|Technical issues|1|||
128019430|NCT04339972|460694589|FG001|Overall Study|Technical issues|0|||
128019431|NCT04339972|460694588|FG000|Overall Study|Claustraphobia|0|||
128019432|NCT04339972|460694589|FG001|Overall Study|Claustraphobia|1|||
128019433|NCT02942407|460694590|FG000|Overall Study|Lost to Follow-up|3|||
128019434|NCT02942407|460694591|FG001|Overall Study|Lost to Follow-up|2|||
128019435|NCT02942407|460694590|FG000|Overall Study|Withdrawal by Subject|7|||
128019436|NCT02942407|460694591|FG001|Overall Study|Withdrawal by Subject|9|||
128019437|NCT02942407|460694590|FG000|Overall Study|Death|16|||
127773285|NCT03548987|459797136|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
128019438|NCT02942407|460694591|FG001|Overall Study|Death|13|||
128019439|NCT06377488|460694592|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|2|||
128019440|NCT06377488|460694592|FG000|Overall Study|Unsatisfactory Lens Fitting due to Test Article|2|||
128019441|NCT06377488|460694592|FG000|Overall Study|Protocol Violation|1|||
128019442|NCT06377488|460694592|FG000|Overall Study|Lost to Follow-up|1|||
128019443|NCT06377488|460694592|FG000|Overall Study|Incorrect Lens Dispensed|2|||
128019444|NCT00774748|460694595|FG000|Overall Study|Lost to Follow-up|3|||
128019445|NCT00866320|460694596|FG000|Overall Study|Withdrawal by Subject|4|||
128019446|NCT00866320|460694596|FG000|Overall Study|Death|2|||
128019447|NCT00303953|460694597|FG000|Overall Study|Ineligible|1|||
128019448|NCT00303953|460694597|FG000|Overall Study|Death|1|||
128019449|NCT00303953|460694597|FG000|Overall Study|Adverse Event|4|||
128019450|NCT00303953|460694597|FG000|Overall Study|Lack of Efficacy|12|||
128019451|NCT00303953|460694597|FG000|Overall Study|Physician Decision|1|||
128019452|NCT00387127|460694598|FG000|Overall Study|Lost to Follow-up|0|||
128019453|NCT00387127|460694599|FG001|Overall Study|Lost to Follow-up|4|||
128019454|NCT00387127|460694598|FG000|Overall Study|Death|16|||
128019455|NCT00387127|460694599|FG001|Overall Study|Death|16|||
128019456|NCT00387127|460694598|FG000|Overall Study|Physician Decision|0|||
128019457|NCT00387127|460694599|FG001|Overall Study|Physician Decision|1|||
128019458|NCT00387127|460694598|FG000|Overall Study|Withdrawal by Subject|3|||
128019459|NCT00387127|460694599|FG001|Overall Study|Withdrawal by Subject|2|||
128019460|NCT00387127|460694598|FG000|Overall Study|Required by Protocol Amendment #4|12|||
128019461|NCT00387127|460694599|FG001|Overall Study|Required by Protocol Amendment #4|10|||
128019462|NCT00387127|460694598|FG000|Overall Study|Serious Adverse Event|1|||
128019463|NCT00387127|460694599|FG001|Overall Study|Serious Adverse Event|1|||
128019464|NCT00387127|460694598|FG000|Overall Study|Sponsor Unblinded|1|||
128019465|NCT00387127|460694599|FG001|Overall Study|Sponsor Unblinded|0|||
128019466|NCT01786109|460694600|FG000|Overall Study|fail manometry barostat tube placement|1|||
128019467|NCT01786109|460694601|FG001|Overall Study|fail manometry barostat tube placement|0|||
128019468|NCT01786109|460694602|FG002|Overall Study|fail manometry barostat tube placement|0|||
128019469|NCT01786109|460694600|FG000|Overall Study|unrelated illness|0|||
128019470|NCT01786109|460694601|FG001|Overall Study|unrelated illness|0|||
128019471|NCT01786109|460694602|FG002|Overall Study|unrelated illness|1|||
128019472|NCT01786109|460694600|FG000|Overall Study|adverse effects colon preparation|0|||
128019473|NCT01786109|460694601|FG001|Overall Study|adverse effects colon preparation|0|||
128019474|NCT01786109|460694602|FG002|Overall Study|adverse effects colon preparation|1|||
128019475|NCT00699751|460694607|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
128019476|NCT00699751|460694608|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
128019477|NCT00699751|460694607|FG000|Period 1: Without/Before Drug Switch|Death|28|||
128019478|NCT00699751|460694608|FG001|Period 1: Without/Before Drug Switch|Death|29|||
128019479|NCT00699751|460694607|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
128019480|NCT00699751|460694608|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
128019481|NCT00699751|460694607|FG000|Period 1: Without/Before Drug Switch|Other|30|||
128019482|NCT00699751|460694608|FG001|Period 1: Without/Before Drug Switch|Other|20|||
128019483|NCT00699751|460694607|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
128019484|NCT00699751|460694608|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
128019485|NCT00699751|460694607|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
128019486|NCT00699751|460694608|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
128019487|NCT00699751|460694607|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
128019488|NCT00699751|460694608|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
128019489|NCT00699751|460694607|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
128019490|NCT00699751|460694608|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
128019491|NCT00985790|460694611|FG000|Overall Study|Withdrawal by Subject|1|||
128019492|NCT00985790|460694612|FG001|Overall Study|Withdrawal by Subject|1|||
128019493|NCT00985790|460694611|FG000|Overall Study|Lost to Follow-up|6|||
128019494|NCT00985790|460694612|FG001|Overall Study|Lost to Follow-up|7|||
128019495|NCT04124965|460694613|FG000|Overall Study|Adverse event, non-fatal|3|||
128019496|NCT04124965|460694614|FG001|Overall Study|Adverse event, non-fatal|1|||
128019497|NCT04124965|460694613|FG000|Overall Study|Withdrawal by Subject|1|||
128019498|NCT04124965|460694614|FG001|Overall Study|Withdrawal by Subject|1|||
128019499|NCT04124965|460694613|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
128019500|NCT04124965|460694614|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
128019501|NCT04124965|460694613|FG000|Overall Study|Pregnancy|1|||
128019502|NCT04124965|460694614|FG001|Overall Study|Pregnancy|0|||
128019503|NCT04124965|460694613|FG000|Overall Study|Sponsor and participant decision|0|||
128019504|NCT04124965|460694614|FG001|Overall Study|Sponsor and participant decision|1|||
128019505|NCT04124965|460694613|FG000|Overall Study|Personal surgery|0|||
128019506|NCT04124965|460694614|FG001|Overall Study|Personal surgery|1|||
128019507|NCT04124965|460694613|FG000|Overall Study|Physician Decision|0|||
128019508|NCT04124965|460694614|FG001|Overall Study|Physician Decision|1|||
128019509|NCT02184156|460694615|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
128019510|NCT02184156|460694616|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
128019511|NCT02184156|460694615|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
128019512|NCT02184156|460694616|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
128019513|NCT00002874|460694617|FG000|Overall Study|Withdrawal by Subject|1|||
128019514|NCT00002874|460694618|FG001|Overall Study|Withdrawal by Subject|1|||
128019515|NCT00002874|460694617|FG000|Overall Study|Protocol Violation|44|||
128019516|NCT00002874|460694618|FG001|Overall Study|Protocol Violation|34|||
128019517|NCT01397747|460694619|FG000|Overall Study|Multitarget DNA test excluded|689|||
128019518|NCT01397747|460694619|FG000|Overall Study|Colonoscopy excluded|304|||
128019519|NCT01397747|460694619|FG000|Overall Study|FIT excluded|34|||
128019520|NCT03828383|460694620|FG000|Overall Study|Lost to Follow-up|3|||
128019521|NCT03828383|460694621|FG001|Overall Study|Lost to Follow-up|2|||
128019522|NCT03828383|460694620|FG000|Overall Study|Withdrawal by Subject|4|||
128019523|NCT03828383|460694621|FG001|Overall Study|Withdrawal by Subject|5|||
128019524|NCT00308685|460694623|FG000|Overall Study|Lost to Follow-up|1|||
128019525|NCT00308685|460694624|FG001|Overall Study|Lost to Follow-up|0|||
128019526|NCT00308685|460694623|FG000|Overall Study|Need to administer prohibited medication|1|||
128019527|NCT00308685|460694624|FG001|Overall Study|Need to administer prohibited medication|2|||
128019528|NCT00308685|460694623|FG000|Overall Study|Other than specified|1|||
128019529|NCT00308685|460694624|FG001|Overall Study|Other than specified|3|||
127642872|NCT01292239|459313204|FG001|Overall Study|Other|1|||
128019530|NCT03158311|460694627|FG000|Overall Study|Subject/Guardian Decision|10|||
128019531|NCT03158311|460694628|FG001|Overall Study|Subject/Guardian Decision|6|||
128019532|NCT03158311|460694629|FG002|Overall Study|Subject/Guardian Decision|11|||
128019533|NCT03158311|460694627|FG000|Overall Study|Adverse Event|5|||
128019534|NCT03158311|460694628|FG001|Overall Study|Adverse Event|3|||
127552119|NCT02876601|458987399|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
127552120|NCT02876601|458987400|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
128019535|NCT03158311|460694629|FG002|Overall Study|Adverse Event|3|||
128019536|NCT03158311|460694627|FG000|Overall Study|Techinical Problems|3|||
128019537|NCT03158311|460694628|FG001|Overall Study|Techinical Problems|1|||
128019538|NCT03158311|460694629|FG002|Overall Study|Techinical Problems|5|||
128019539|NCT03158311|460694627|FG000|Overall Study|Physician Decision|2|||
128019540|NCT03158311|460694628|FG001|Overall Study|Physician Decision|3|||
128019541|NCT03158311|460694629|FG002|Overall Study|Physician Decision|7|||
128019542|NCT03158311|460694627|FG000|Overall Study|Lost to Follow-up|1|||
128019543|NCT03158311|460694628|FG001|Overall Study|Lost to Follow-up|1|||
128019544|NCT03158311|460694629|FG002|Overall Study|Lost to Follow-up|1|||
128019545|NCT03158311|460694627|FG000|Overall Study|Sponsor decision|1|||
128019546|NCT03158311|460694628|FG001|Overall Study|Sponsor decision|0|||
128019547|NCT03158311|460694629|FG002|Overall Study|Sponsor decision|0|||
128019548|NCT03158311|460694627|FG000|Overall Study|Pregnancy|0|||
128019549|NCT03158311|460694628|FG001|Overall Study|Pregnancy|2|||
128019550|NCT03158311|460694629|FG002|Overall Study|Pregnancy|0|||
128019551|NCT03158311|460694627|FG000|Overall Study|Randomized in error|0|||
128019552|NCT03158311|460694628|FG001|Overall Study|Randomized in error|0|||
128019553|NCT03158311|460694629|FG002|Overall Study|Randomized in error|1|||
128019554|NCT01018953|460694630|FG000|Overall Study|Adverse Event|2|||
128019555|NCT01018953|460694630|FG000|Overall Study|Withdrawal by Subject|1|||
128019556|NCT01018953|460694630|FG000|Overall Study|Study termination by sponsor|5|||
128019557|NCT02665455|460694631|FG000|Overall Study|Withdrawal by Subject|6|||
128019558|NCT02665455|460694631|FG000|Overall Study|Lost to Follow-up|1|||
128019559|NCT02665455|460694631|FG000|Overall Study|Adverse Event|1|||
128019560|NCT02665455|460694631|FG000|Overall Study|Protocol Violation|1|||
128019561|NCT01928771|460694633|FG000|Overall Study|Adverse Event|6|||
128019562|NCT01928771|460694634|FG001|Overall Study|Adverse Event|5|||
128019563|NCT01928771|460694635|FG002|Overall Study|Adverse Event|1|||
128019564|NCT01928771|460694633|FG000|Overall Study|Death|2|||
128019565|NCT01928771|460694634|FG001|Overall Study|Death|2|||
127552121|NCT02876601|458987401|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
127773286|NCT03548987|459797137|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
127773287|NCT03548987|459797136|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
127773288|NCT03548987|459797137|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
127773289|NCT03548987|459797136|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
127773290|NCT03548987|459797137|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
127773291|NCT03548987|459797136|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
127773292|NCT03548987|459797137|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
127773293|NCT03548987|459797136|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
127773294|NCT03548987|459797137|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
127773295|NCT03548987|459797136|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
127773296|NCT03548987|459797137|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
127773297|NCT03548987|459797136|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
127773298|NCT03548987|459797137|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
127773299|NCT03548987|459797136|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
127773300|NCT03548987|459797137|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
127773301|NCT03548987|459797136|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
127773302|NCT03548987|459797137|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
127773303|NCT03548987|459797136|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
127773304|NCT03548987|459797137|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
127773305|NCT03548987|459797136|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
127773306|NCT03548987|459797137|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
127773307|NCT03548987|459797136|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
127773308|NCT03548987|459797137|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
127773309|NCT00756470|459797142|FG000|Overall Study|Withdrawal by Subject|1|||
127773310|NCT00756470|459797142|FG000|Overall Study|Adverse Event|4|||
127773311|NCT02604433|459797143|FG000|Overall Study|Withdrawal by Subject|37|||
127773312|NCT02604433|459797144|FG001|Overall Study|Withdrawal by Subject|16|||
127773313|NCT02604433|459797143|FG000|Overall Study|Adverse Event|4|||
127773314|NCT02604433|459797144|FG001|Overall Study|Adverse Event|0|||
127773315|NCT02604433|459797143|FG000|Overall Study|Other reasons|3|||
127773316|NCT02604433|459797144|FG001|Overall Study|Other reasons|5|||
127773317|NCT02604433|459797143|FG000|Overall Study|Death|4|||
127773318|NCT02604433|459797144|FG001|Overall Study|Death|1|||
127773319|NCT02604433|459797143|FG000|Overall Study|Transition to Rollover Protocol|169|||
127773320|NCT02604433|459797144|FG001|Overall Study|Transition to Rollover Protocol|82|||
127773321|NCT02604433|459797143|FG000|Overall Study|Physician Decision|1|||
127773322|NCT02604433|459797144|FG001|Overall Study|Physician Decision|1|||
127773323|NCT02604433|459797143|FG000|Overall Study|Lack of Efficacy|0|||
127773324|NCT02604433|459797144|FG001|Overall Study|Lack of Efficacy|1|||
127773325|NCT02202551|459797145|FG000|Overall Study|Adverse Event|8|||
127773326|NCT02202551|459797146|FG001|Overall Study|Adverse Event|19|||
127773327|NCT02202551|459797147|FG002|Overall Study|Adverse Event|5|||
127773328|NCT02202551|459797148|FG003|Overall Study|Adverse Event|9|||
127773329|NCT02202551|459797145|FG000|Overall Study|Death|3|||
127773330|NCT02202551|459797146|FG001|Overall Study|Death|2|||
127773331|NCT02202551|459797147|FG002|Overall Study|Death|1|||
127773332|NCT02202551|459797148|FG003|Overall Study|Death|1|||
127773333|NCT02202551|459797145|FG000|Overall Study|Lost to Follow-up|0|||
128019566|NCT01928771|460694635|FG002|Overall Study|Death|2|||
128019567|NCT01928771|460694633|FG000|Overall Study|Lost to Follow-up|5|||
128019568|NCT01928771|460694634|FG001|Overall Study|Lost to Follow-up|6|||
128019569|NCT01928771|460694635|FG002|Overall Study|Lost to Follow-up|3|||
128019570|NCT01928771|460694633|FG000|Overall Study|Withdrawal by Subject|20|||
128019571|NCT01928771|460694634|FG001|Overall Study|Withdrawal by Subject|15|||
128019572|NCT01928771|460694635|FG002|Overall Study|Withdrawal by Subject|17|||
128019573|NCT01928771|460694633|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
128019574|NCT01928771|460694634|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
128019575|NCT01928771|460694635|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
128019576|NCT01928771|460694633|FG000|Overall Study|Other Reasons|9|||
128019577|NCT01928771|460694634|FG001|Overall Study|Other Reasons|9|||
128019578|NCT01928771|460694635|FG002|Overall Study|Other Reasons|14|||
127552122|NCT02876601|458987402|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
127552123|NCT00256997|458987403|FG000|Overall Study|Protocol Violation|1|||
127773334|NCT02202551|459797146|FG001|Overall Study|Lost to Follow-up|1|||
127773335|NCT02202551|459797147|FG002|Overall Study|Lost to Follow-up|0|||
127773336|NCT02202551|459797148|FG003|Overall Study|Lost to Follow-up|1|||
127773337|NCT02202551|459797145|FG000|Overall Study|Needed to take excluded medication|0|||
127773338|NCT02202551|459797146|FG001|Overall Study|Needed to take excluded medication|2|||
127773339|NCT02202551|459797147|FG002|Overall Study|Needed to take excluded medication|0|||
127773340|NCT02202551|459797148|FG003|Overall Study|Needed to take excluded medication|1|||
127773341|NCT02202551|459797145|FG000|Overall Study|Subject moved away|0|||
128019579|NCT01928771|460694633|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
128019580|NCT01928771|460694634|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
128019581|NCT01928771|460694635|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
128019582|NCT03932331|460694636|FG000|Overall Study|Death|0|||
128019583|NCT03932331|460694637|FG001|Overall Study|Death|7|||
128019584|NCT03932331|460694638|FG002|Overall Study|Death|2|||
128019585|NCT03932331|460694636|FG000|Overall Study|Withdrawal by Subject|0|||
128019586|NCT03932331|460694637|FG001|Overall Study|Withdrawal by Subject|3|||
128019587|NCT03932331|460694638|FG002|Overall Study|Withdrawal by Subject|0|||
128019588|NCT03932331|460694636|FG000|Overall Study|Meet the point of final analysis for this cohort|8|||
128019589|NCT03932331|460694637|FG001|Overall Study|Meet the point of final analysis for this cohort|23|||
128019590|NCT03932331|460694638|FG002|Overall Study|Meet the point of final analysis for this cohort|0|||
128019591|NCT03932331|460694636|FG000|Overall Study|Progressive disease|3|||
128019592|NCT03932331|460694637|FG001|Overall Study|Progressive disease|0|||
128019593|NCT03932331|460694638|FG002|Overall Study|Progressive disease|0|||
128019594|NCT03932331|460694636|FG000|Overall Study|Lung infection|1|||
128019595|NCT03932331|460694637|FG001|Overall Study|Lung infection|0|||
128019596|NCT03932331|460694638|FG002|Overall Study|Lung infection|0|||
128019597|NCT03932331|460694636|FG000|Overall Study|Other|0|||
128019598|NCT03932331|460694637|FG001|Overall Study|Other|0|||
128019599|NCT03932331|460694638|FG002|Overall Study|Other|58|||
128019600|NCT01937117|460694639|FG000|Overall Study|Disease Progression|7|||
128019601|NCT01937117|460694639|FG000|Overall Study|Physician Decision|4|||
128019602|NCT01937117|460694639|FG000|Overall Study|Adverse Event|2|||
128019603|NCT01407367|460694644|FG000|Overall Study|Death|24|||
128019604|NCT01407367|460694645|FG001|Overall Study|Death|32|||
128019605|NCT01407367|460694644|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
128019606|NCT01407367|460694645|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
128019607|NCT01407367|460694644|FG000|Overall Study|Withdrawal by Subject|4|||
128019608|NCT01407367|460694645|FG001|Overall Study|Withdrawal by Subject|15|||
128019609|NCT01407367|460694644|FG000|Overall Study|Lost to Follow-up|0|||
128019610|NCT01407367|460694645|FG001|Overall Study|Lost to Follow-up|2|||
128019611|NCT01452347|460694646|FG000|Overall Study|Adverse Event|2|||
128019612|NCT01452347|460694647|FG001|Overall Study|Adverse Event|1|||
128019613|NCT01452347|460694646|FG000|Overall Study|Non compliance protocol|2|||
128019614|NCT01452347|460694647|FG001|Overall Study|Non compliance protocol|0|||
128019615|NCT01452347|460694646|FG000|Overall Study|Lost to Follow-up|2|||
128019616|NCT01452347|460694647|FG001|Overall Study|Lost to Follow-up|0|||
128019617|NCT01452347|460694646|FG000|Overall Study|Withdrawal by Subject|3|||
128019618|NCT01452347|460694647|FG001|Overall Study|Withdrawal by Subject|3|||
128019619|NCT01452347|460694646|FG000|Overall Study|Not treated|6|||
128019620|NCT01452347|460694647|FG001|Overall Study|Not treated|3|||
128019621|NCT01452347|460694646|FG000|Overall Study|Other reason not defined above|2|||
128019622|NCT01452347|460694647|FG001|Overall Study|Other reason not defined above|0|||
128019623|NCT02642679|460696379|FG000|Overall Study|Withdrawal by Subject|1|||
128019624|NCT02642679|460696379|FG000|Overall Study|Physician Decision|1|||
128019625|NCT02642679|460696379|FG000|Overall Study|Physician Decision|1|||
128019626|NCT01112267|460696381|FG000|Overall Study|Adverse Event|24|||
128019627|NCT01112267|460696382|FG001|Overall Study|Adverse Event|6|||
128019628|NCT01112267|460696381|FG000|Overall Study|Withdrawal by Subject|3|||
128019629|NCT01112267|460696382|FG001|Overall Study|Withdrawal by Subject|5|||
128019630|NCT01112267|460696381|FG000|Overall Study|Protocol Violation|5|||
128019631|NCT01112267|460696382|FG001|Overall Study|Protocol Violation|3|||
128019632|NCT01112267|460696381|FG000|Overall Study|Participants not compliant|1|||
128019633|NCT01112267|460696382|FG001|Overall Study|Participants not compliant|2|||
128019634|NCT01112267|460696381|FG000|Overall Study|Participants not receive any study drug|1|||
128019635|NCT01112267|460696382|FG001|Overall Study|Participants not receive any study drug|2|||
128019636|NCT05638737|460696385|FG000|Overall Study|Withdrawal by Subject|4|||
128019637|NCT05638737|460696386|FG001|Overall Study|Withdrawal by Subject|7|||
128019638|NCT03641924|460696389|FG000|Overall Study|Withdrawal by Subject|26|||
128019639|NCT03641924|460696389|FG000|Overall Study|Lost to Follow-up|16|||
128019640|NCT03641924|460696389|FG000|Overall Study|Protocol Violation|10|||
128019641|NCT04333498|460696390|FG000|Overall Study|Lost to Follow-up|1|||
128019642|NCT04333498|460696391|FG001|Overall Study|Lost to Follow-up|0|||
128019643|NCT04333498|460696390|FG000|Overall Study|Lost to Follow-up|0|||
128019644|NCT04333498|460696391|FG001|Overall Study|Lost to Follow-up|1|||
128019645|NCT01565694|460696392|FG000|Dose-Titration Period|Adverse Event|4|||
128019646|NCT01565694|460696392|FG000|Dose-Titration Period|Protocol Violation|10|||
128019647|NCT01565694|460696392|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
128019648|NCT00541229|460696396|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
128019649|NCT00541229|460696397|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
128019650|NCT00541229|460696398|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
128019651|NCT00541229|460696399|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
128019652|NCT00541229|460696400|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
128019653|NCT00541229|460696401|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
128019654|NCT00541229|460696396|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
128019655|NCT00541229|460696397|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
128019656|NCT00541229|460696398|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
128019657|NCT00541229|460696399|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
128019658|NCT00541229|460696400|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
128019659|NCT00541229|460696401|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
128019660|NCT00541229|460696396|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
128019661|NCT00541229|460696397|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
128019662|NCT00541229|460696398|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
128019663|NCT00541229|460696399|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
128019664|NCT00541229|460696400|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
128019665|NCT00541229|460696401|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
128019666|NCT00541229|460696396|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
128019667|NCT00541229|460696397|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
128019668|NCT00541229|460696398|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
128019669|NCT00541229|460696399|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
128019670|NCT00541229|460696400|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
128019671|NCT00541229|460696401|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
128019672|NCT00541229|460696396|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
128019673|NCT00541229|460696397|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
128019674|NCT00541229|460696398|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
128019675|NCT00541229|460696399|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
128019676|NCT00541229|460696400|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
128019677|NCT00541229|460696401|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
128019678|NCT00541229|460696396|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
128019679|NCT00541229|460696397|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
128019680|NCT00541229|460696398|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
128019681|NCT00541229|460696399|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
128019682|NCT00541229|460696400|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
128019683|NCT00541229|460696401|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
128019684|NCT00541229|460696396|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
128019685|NCT00541229|460696397|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
128019686|NCT00541229|460696398|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
128019687|NCT00541229|460696399|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
128019688|NCT00541229|460696400|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
128019689|NCT00541229|460696401|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
128019690|NCT00541229|460696396|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
128019691|NCT00541229|460696397|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
128019692|NCT00541229|460696398|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
128019693|NCT00541229|460696399|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
128019694|NCT00541229|460696400|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
128019695|NCT00541229|460696401|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
128019696|NCT00541229|460696396|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
128019697|NCT00541229|460696397|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
128019698|NCT00541229|460696398|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
128019699|NCT00541229|460696399|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
128019700|NCT00541229|460696400|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
128019701|NCT00541229|460696401|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
128019702|NCT00541229|460696396|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
128019703|NCT00541229|460696397|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
128019704|NCT00541229|460696398|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
128019705|NCT00541229|460696399|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
128019706|NCT00541229|460696400|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
128019707|NCT00541229|460696401|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
128019708|NCT00541229|460696396|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
128019709|NCT00541229|460696397|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
128019710|NCT00541229|460696398|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
128019711|NCT00541229|460696399|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
128019712|NCT00541229|460696400|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
128019713|NCT00541229|460696401|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
128019714|NCT00541229|460696396|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
128019715|NCT00541229|460696397|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
128019716|NCT00541229|460696398|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
128019717|NCT00541229|460696399|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
128019718|NCT00541229|460696400|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
127685636|NCT00716859|459474864|FG001|Overall Study|Lack of Efficacy|0|||
128019719|NCT00541229|460696401|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
128019720|NCT00541229|460696396|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
128019721|NCT00541229|460696397|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
128019722|NCT00541229|460696398|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
128019723|NCT00541229|460696399|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
128019724|NCT00541229|460696400|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
128019725|NCT00541229|460696401|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
128019726|NCT00541229|460696396|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
128019727|NCT00541229|460696397|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
128019728|NCT00541229|460696398|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
128019729|NCT00541229|460696399|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
128019730|NCT00541229|460696400|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
128019731|NCT00541229|460696401|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
128019732|NCT00541229|460696396|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
128019733|NCT00541229|460696397|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
128019734|NCT00541229|460696398|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
128019735|NCT00541229|460696399|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
128019736|NCT00541229|460696400|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
128019737|NCT00541229|460696401|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
128019738|NCT00541229|460696396|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
128019739|NCT00541229|460696397|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
128019740|NCT00541229|460696398|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
128019741|NCT00541229|460696399|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
128019742|NCT00541229|460696400|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
128019743|NCT00541229|460696401|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
128019744|NCT01807520|460696402|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
128019745|NCT01807520|460696403|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
128019746|NCT01807520|460696404|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
128019747|NCT01807520|460696405|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
128019748|NCT01807520|460696406|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
128019749|NCT01807520|460696407|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
128019750|NCT01807520|460696408|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
128019751|NCT01807520|460696402|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
128019752|NCT01807520|460696403|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
128019753|NCT01807520|460696404|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
128019754|NCT01807520|460696405|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
128019755|NCT01807520|460696406|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
128019756|NCT01807520|460696407|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
128019757|NCT01807520|460696408|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
128019758|NCT01807520|460696402|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
128019759|NCT01807520|460696403|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
128019760|NCT01807520|460696404|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
128019761|NCT01807520|460696405|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
128019762|NCT01807520|460696406|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
128019763|NCT01807520|460696407|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
128019764|NCT01807520|460696408|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
128019765|NCT01807520|460696402|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
128019766|NCT01807520|460696403|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
128019767|NCT01807520|460696404|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
128019768|NCT01807520|460696405|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
128019769|NCT01807520|460696406|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
127685637|NCT00716859|459474863|FG000|Overall Study|Withdrawal by Subject|1|||
127685638|NCT00716859|459474864|FG001|Overall Study|Withdrawal by Subject|3|||
127685639|NCT00716859|459474863|FG000|Overall Study|Not treated|1|||
127685640|NCT00716859|459474864|FG001|Overall Study|Not treated|1|||
127685641|NCT03750968|459474865|FG000|Overall Study|Adverse Event|2|||
127685642|NCT03750968|459474866|FG001|Overall Study|Adverse Event|0|||
127685643|NCT03750968|459474865|FG000|Overall Study|Lost to Follow-up|1|||
127685644|NCT03750968|459474866|FG001|Overall Study|Lost to Follow-up|3|||
127685645|NCT00411216|459474872|FG000|Overall Study|Ten participants were entered into the c|0|||
127685646|NCT00411216|459474873|FG001|Overall Study|Ten participants were entered into the c|2|||
127685647|NCT02918071|459474874|FG000|Overall Study|Withdrawal by Subject|2|||
127685648|NCT02918071|459474874|FG000|Overall Study|Lost to Follow-up|1|||
127685649|NCT00203411|459474877|FG000|Follow-up|Progressive Disease|4|||
127685650|NCT01251354|459474878|FG000|Overall Study|Adverse Event|1|||
127685651|NCT01251354|459474878|FG000|Overall Study|Investigator's Decision|1|||
127685652|NCT01251354|459474878|FG000|Overall Study|Disease Progression|4|||
127685653|NCT05094141|459474888|FG000|Overall Study|Death|0|||
127685654|NCT05094141|459474889|FG001|Overall Study|Death|0|||
127685655|NCT05094141|459474890|FG002|Overall Study|Death|1|||
127685656|NCT05094141|459474888|FG000|Overall Study|Withdrawal by Subject|0|||
127685657|NCT05094141|459474889|FG001|Overall Study|Withdrawal by Subject|0|||
127685658|NCT05094141|459474890|FG002|Overall Study|Withdrawal by Subject|1|||
127685659|NCT05094141|459474888|FG000|Overall Study|Subject did not want to wear the VR Helmet|0|||
128019770|NCT01807520|460696407|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
128019771|NCT01807520|460696408|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
128019772|NCT01807520|460696402|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
128019773|NCT01807520|460696403|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
128019774|NCT01807520|460696404|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
128019775|NCT01807520|460696405|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
128019776|NCT01807520|460696406|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
128019777|NCT01807520|460696407|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
128019778|NCT01807520|460696408|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
128019779|NCT01807520|460696402|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
128019780|NCT01807520|460696403|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
128019781|NCT01807520|460696404|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
128019782|NCT01807520|460696405|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
128019783|NCT01807520|460696406|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
128019784|NCT01807520|460696407|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
128019785|NCT01807520|460696408|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
128019786|NCT01807520|460696402|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
128019787|NCT01807520|460696403|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
128019788|NCT01807520|460696404|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
128019789|NCT01807520|460696405|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
128019790|NCT01807520|460696406|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
128019791|NCT01807520|460696407|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
127773342|NCT02202551|459797146|FG001|Overall Study|Subject moved away|1|||
128019792|NCT01807520|460696408|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
128019793|NCT01807520|460696402|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
128019794|NCT01807520|460696403|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
128019795|NCT01807520|460696404|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
128019796|NCT01807520|460696405|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
128019797|NCT01807520|460696406|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
128019798|NCT01807520|460696407|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
128019799|NCT01807520|460696408|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
128019800|NCT01807520|460696402|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
128019801|NCT01807520|460696403|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
128019802|NCT01807520|460696404|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
128019803|NCT01807520|460696405|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
128019804|NCT01807520|460696406|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
128019805|NCT01807520|460696407|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
128019806|NCT01807520|460696408|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
128019807|NCT01807520|460696402|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
128019808|NCT01807520|460696403|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
128019809|NCT01807520|460696404|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
128019810|NCT01807520|460696405|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
128019811|NCT01807520|460696406|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
128019812|NCT01807520|460696407|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
128019813|NCT01807520|460696408|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
128019814|NCT01807520|460696402|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
128019815|NCT01807520|460696403|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
128019816|NCT01807520|460696404|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
128019817|NCT01807520|460696405|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
128019818|NCT01807520|460696406|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
128019819|NCT01807520|460696407|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
128019820|NCT01807520|460696408|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
128019821|NCT01807520|460696402|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
128019822|NCT01807520|460696403|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
128019823|NCT01807520|460696404|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
128019824|NCT01807520|460696405|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
128019825|NCT01807520|460696406|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
128019826|NCT01807520|460696407|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
128019827|NCT01807520|460696408|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
128019828|NCT01807520|460696402|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
128019829|NCT01807520|460696403|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
128019830|NCT01807520|460696404|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
128019831|NCT01807520|460696405|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
128019832|NCT01807520|460696406|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
128019833|NCT01807520|460696407|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
128019834|NCT01807520|460696408|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
128019835|NCT01807520|460696402|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
128019836|NCT01807520|460696403|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
128019837|NCT01807520|460696404|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
128019838|NCT01807520|460696405|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
128019839|NCT01807520|460696406|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
128019840|NCT01807520|460696407|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
128019841|NCT01807520|460696408|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
128019842|NCT01807520|460696402|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
128019843|NCT01807520|460696403|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
128019844|NCT01807520|460696404|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
128019845|NCT01807520|460696405|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
128019846|NCT01807520|460696406|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
128019847|NCT01807520|460696407|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
128019848|NCT01807520|460696408|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
128019849|NCT01807520|460696402|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
128019850|NCT01807520|460696403|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
128019851|NCT01807520|460696404|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
128019852|NCT01807520|460696405|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
128019853|NCT01807520|460696406|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
128019854|NCT01807520|460696407|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
128019855|NCT01807520|460696408|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
128019856|NCT01807520|460696402|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
128019857|NCT01807520|460696403|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
128019858|NCT01807520|460696404|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
128019859|NCT01807520|460696405|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
128019860|NCT01807520|460696406|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
128019861|NCT01807520|460696407|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
128019862|NCT01807520|460696408|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
128019863|NCT01797185|460696409|FG000|Overall Study|Adverse Event|5|||
128019864|NCT01797185|460696410|FG001|Overall Study|Adverse Event|15|||
128019865|NCT01797185|460696411|FG002|Overall Study|Adverse Event|6|||
128019866|NCT01797185|460696409|FG000|Overall Study|Withdrawal by Subject|6|||
128019867|NCT01797185|460696410|FG001|Overall Study|Withdrawal by Subject|9|||
128019868|NCT01797185|460696411|FG002|Overall Study|Withdrawal by Subject|5|||
128019869|NCT01797185|460696409|FG000|Overall Study|Site terminated|8|||
128019870|NCT01797185|460696410|FG001|Overall Study|Site terminated|4|||
128019871|NCT01797185|460696411|FG002|Overall Study|Site terminated|0|||
128019872|NCT01797185|460696409|FG000|Overall Study|Lost to Follow-up|2|||
128019873|NCT01797185|460696410|FG001|Overall Study|Lost to Follow-up|6|||
128019874|NCT01797185|460696411|FG002|Overall Study|Lost to Follow-up|1|||
128019875|NCT01797185|460696409|FG000|Overall Study|Withdrawn per sponsor|5|||
128019876|NCT01797185|460696410|FG001|Overall Study|Withdrawn per sponsor|0|||
128019877|NCT01797185|460696411|FG002|Overall Study|Withdrawn per sponsor|0|||
128019878|NCT01797185|460696409|FG000|Overall Study|Physician Decision|1|||
128019879|NCT01797185|460696410|FG001|Overall Study|Physician Decision|3|||
128019880|NCT01797185|460696411|FG002|Overall Study|Physician Decision|0|||
128019881|NCT01797185|460696409|FG000|Overall Study|Protocol Violation|1|||
128019882|NCT01797185|460696410|FG001|Overall Study|Protocol Violation|1|||
128019883|NCT01797185|460696411|FG002|Overall Study|Protocol Violation|0|||
128019884|NCT01875237|460696412|FG000|Overall Study|GVDH before DLI|1|||
128019885|NCT01875237|460696413|FG001|Overall Study|GVDH before DLI|0|||
128019886|NCT01875237|460696412|FG000|Overall Study|DLI cells could not be produced|1|||
128019887|NCT01875237|460696413|FG001|Overall Study|DLI cells could not be produced|0|||
128019888|NCT03558672|460696414|FG000|Overall Study|Study Early Termination|10|||
128019889|NCT00421733|460696416|FG000|Overall Study|Adverse Event|4|||
128019890|NCT00421733|460696417|FG001|Overall Study|Adverse Event|9|||
128019891|NCT00421733|460696418|FG002|Overall Study|Adverse Event|2|||
128019892|NCT00421733|460696416|FG000|Overall Study|Lost to Follow-up|1|||
128019893|NCT00421733|460696417|FG001|Overall Study|Lost to Follow-up|2|||
128019894|NCT00421733|460696418|FG002|Overall Study|Lost to Follow-up|4|||
128019895|NCT00421733|460696416|FG000|Overall Study|Withdrawal by Subject|1|||
128019896|NCT00421733|460696417|FG001|Overall Study|Withdrawal by Subject|2|||
128019897|NCT00421733|460696418|FG002|Overall Study|Withdrawal by Subject|7|||
128019898|NCT00421733|460696416|FG000|Overall Study|Death|0|||
128019899|NCT00421733|460696417|FG001|Overall Study|Death|3|||
128019900|NCT00421733|460696418|FG002|Overall Study|Death|0|||
128019901|NCT00421733|460696416|FG000|Overall Study|Required dialysis|1|||
128019902|NCT00421733|460696417|FG001|Overall Study|Required dialysis|0|||
128019903|NCT00421733|460696418|FG002|Overall Study|Required dialysis|0|||
128019904|NCT00421733|460696416|FG000|Overall Study|Administrative|2|||
128019905|NCT00421733|460696417|FG001|Overall Study|Administrative|0|||
128019906|NCT00421733|460696418|FG002|Overall Study|Administrative|0|||
128019907|NCT00421733|460696416|FG000|Overall Study|Did not satisfy entry criteria|1|||
128019908|NCT00421733|460696417|FG001|Overall Study|Did not satisfy entry criteria|3|||
128019909|NCT00421733|460696418|FG002|Overall Study|Did not satisfy entry criteria|2|||
128019910|NCT00421733|460696416|FG000|Overall Study|Sponsor request|1|||
127773343|NCT02202551|459797147|FG002|Overall Study|Subject moved away|0|||
127773344|NCT02202551|459797148|FG003|Overall Study|Subject moved away|0|||
127773345|NCT02202551|459797145|FG000|Overall Study|DBS surgery|3|||
127773346|NCT02202551|459797146|FG001|Overall Study|DBS surgery|0|||
127773347|NCT02202551|459797147|FG002|Overall Study|DBS surgery|0|||
127773348|NCT02202551|459797148|FG003|Overall Study|DBS surgery|0|||
127773349|NCT02202551|459797145|FG000|Overall Study|Dyskinesia upon taper|1|||
127773350|NCT02202551|459797146|FG001|Overall Study|Dyskinesia upon taper|0|||
127773351|NCT02202551|459797147|FG002|Overall Study|Dyskinesia upon taper|0|||
127773352|NCT02202551|459797148|FG003|Overall Study|Dyskinesia upon taper|0|||
127773353|NCT02202551|459797145|FG000|Overall Study|Lack of Efficacy|0|||
127773354|NCT02202551|459797146|FG001|Overall Study|Lack of Efficacy|1|||
127773355|NCT02202551|459797147|FG002|Overall Study|Lack of Efficacy|0|||
127773356|NCT02202551|459797148|FG003|Overall Study|Lack of Efficacy|0|||
127773357|NCT02202551|459797145|FG000|Overall Study|Physician Decision|1|||
127773358|NCT02202551|459797146|FG001|Overall Study|Physician Decision|0|||
127773359|NCT02202551|459797147|FG002|Overall Study|Physician Decision|0|||
127773360|NCT02202551|459797148|FG003|Overall Study|Physician Decision|0|||
127773361|NCT02202551|459797145|FG000|Overall Study|Site closure|3|||
127773362|NCT02202551|459797146|FG001|Overall Study|Site closure|0|||
127773363|NCT02202551|459797147|FG002|Overall Study|Site closure|0|||
128019911|NCT00421733|460696417|FG001|Overall Study|Sponsor request|0|||
128019912|NCT00421733|460696418|FG002|Overall Study|Sponsor request|3|||
128019913|NCT00421733|460696416|FG000|Overall Study|Protocol deviation|4|||
128019914|NCT00421733|460696417|FG001|Overall Study|Protocol deviation|7|||
128019915|NCT00421733|460696418|FG002|Overall Study|Protocol deviation|2|||
128019916|NCT02265744|460696423|FG000|Overall Study|Poor/Non-compliance|1|||
128019917|NCT02265744|460696424|FG001|Overall Study|Poor/Non-compliance|1|||
128019918|NCT02265744|460696425|FG002|Overall Study|Poor/Non-compliance|0|||
128019919|NCT02265744|460696426|FG003|Overall Study|Poor/Non-compliance|0|||
128019920|NCT02265744|460696427|FG004|Overall Study|Poor/Non-compliance|2|||
128019921|NCT02265744|460696423|FG000|Overall Study|Lost to Follow-up|0|||
128019922|NCT02265744|460696424|FG001|Overall Study|Lost to Follow-up|0|||
128019923|NCT02265744|460696425|FG002|Overall Study|Lost to Follow-up|0|||
128019924|NCT02265744|460696426|FG003|Overall Study|Lost to Follow-up|1|||
128019925|NCT02265744|460696427|FG004|Overall Study|Lost to Follow-up|0|||
128019926|NCT02265744|460696423|FG000|Overall Study|Death|0|||
128019927|NCT02265744|460696424|FG001|Overall Study|Death|0|||
128019928|NCT02265744|460696425|FG002|Overall Study|Death|0|||
128019929|NCT02265744|460696426|FG003|Overall Study|Death|2|||
128019930|NCT02265744|460696427|FG004|Overall Study|Death|0|||
128019931|NCT02265744|460696423|FG000|Overall Study|Withdrawal by Subject|2|||
128019932|NCT02265744|460696424|FG001|Overall Study|Withdrawal by Subject|0|||
128019933|NCT02265744|460696425|FG002|Overall Study|Withdrawal by Subject|0|||
128019934|NCT02265744|460696426|FG003|Overall Study|Withdrawal by Subject|2|||
128019935|NCT02265744|460696427|FG004|Overall Study|Withdrawal by Subject|0|||
128019936|NCT02265744|460696423|FG000|Overall Study|Participant request to discontinue|2|||
128019937|NCT02265744|460696424|FG001|Overall Study|Participant request to discontinue|2|||
128019938|NCT02265744|460696425|FG002|Overall Study|Participant request to discontinue|2|||
128019939|NCT02265744|460696426|FG003|Overall Study|Participant request to discontinue|0|||
128019940|NCT02265744|460696427|FG004|Overall Study|Participant request to discontinue|0|||
128019941|NCT02265744|460696423|FG000|Overall Study|Adverse Event|8|||
128019942|NCT02265744|460696424|FG001|Overall Study|Adverse Event|4|||
128019943|NCT02265744|460696425|FG002|Overall Study|Adverse Event|9|||
128019944|NCT02265744|460696426|FG003|Overall Study|Adverse Event|8|||
128019945|NCT02265744|460696427|FG004|Overall Study|Adverse Event|2|||
128019946|NCT02265744|460696423|FG000|Overall Study|Lack of Efficacy|2|||
128019947|NCT02265744|460696424|FG001|Overall Study|Lack of Efficacy|4|||
128019948|NCT02265744|460696425|FG002|Overall Study|Lack of Efficacy|3|||
128019949|NCT02265744|460696426|FG003|Overall Study|Lack of Efficacy|4|||
128019950|NCT02265744|460696427|FG004|Overall Study|Lack of Efficacy|5|||
128019951|NCT02265744|460696423|FG000|Overall Study|Reason not provided by Investigator|1|||
128019952|NCT02265744|460696424|FG001|Overall Study|Reason not provided by Investigator|0|||
128019953|NCT02265744|460696425|FG002|Overall Study|Reason not provided by Investigator|0|||
127773364|NCT02202551|459797148|FG003|Overall Study|Site closure|1|||
127773365|NCT02202551|459797145|FG000|Overall Study|Unable to complete visits per protocol|1|||
127773366|NCT02202551|459797146|FG001|Overall Study|Unable to complete visits per protocol|0|||
127773367|NCT02202551|459797147|FG002|Overall Study|Unable to complete visits per protocol|0|||
127773368|NCT02202551|459797148|FG003|Overall Study|Unable to complete visits per protocol|0|||
127773369|NCT02202551|459797145|FG000|Overall Study|Worsening Dyskinesia|0|||
128019954|NCT02265744|460696426|FG003|Overall Study|Reason not provided by Investigator|2|||
128019955|NCT02265744|460696427|FG004|Overall Study|Reason not provided by Investigator|0|||
128019956|NCT02265744|460696423|FG000|Overall Study|Administrative reason by sponsor|3|||
128019957|NCT02265744|460696424|FG001|Overall Study|Administrative reason by sponsor|2|||
128019958|NCT02265744|460696425|FG002|Overall Study|Administrative reason by sponsor|2|||
128019959|NCT02265744|460696426|FG003|Overall Study|Administrative reason by sponsor|3|||
128019960|NCT02265744|460696427|FG004|Overall Study|Administrative reason by sponsor|3|||
128019961|NCT02265744|460696423|FG000|Overall Study|Subject no longer meets study criteria|0|||
128019962|NCT02265744|460696424|FG001|Overall Study|Subject no longer meets study criteria|0|||
128019963|NCT02265744|460696425|FG002|Overall Study|Subject no longer meets study criteria|0|||
128019964|NCT02265744|460696426|FG003|Overall Study|Subject no longer meets study criteria|0|||
128019965|NCT02265744|460696427|FG004|Overall Study|Subject no longer meets study criteria|1|||
128019966|NCT02265744|460696423|FG000|Overall Study|Pregnancy|1|||
128019967|NCT02265744|460696424|FG001|Overall Study|Pregnancy|2|||
128019968|NCT02265744|460696425|FG002|Overall Study|Pregnancy|1|||
128019969|NCT02265744|460696426|FG003|Overall Study|Pregnancy|1|||
128019970|NCT02265744|460696427|FG004|Overall Study|Pregnancy|0|||
128019971|NCT05161936|460696430|FG000|Overall Study|Study terminated by Sponsor|1|||
128019972|NCT05161936|460696431|FG001|Overall Study|Study terminated by Sponsor|0|||
128019973|NCT05161936|460696432|FG002|Overall Study|Study terminated by Sponsor|0|||
128019974|NCT05161936|460696430|FG000|Overall Study|Withdrawal by Subject|0|||
128019975|NCT05161936|460696431|FG001|Overall Study|Withdrawal by Subject|0|||
128019976|NCT05161936|460696432|FG002|Overall Study|Withdrawal by Subject|1|||
128019977|NCT01158404|460696435|FG000|Overall Study|Withdrawal by Subject|0|||
128019978|NCT01158404|460696436|FG001|Overall Study|Withdrawal by Subject|1|||
128019979|NCT01158404|460696437|FG002|Overall Study|Withdrawal by Subject|0|||
128019980|NCT01158404|460696438|FG003|Overall Study|Withdrawal by Subject|0|||
128019981|NCT01158404|460696439|FG004|Overall Study|Withdrawal by Subject|3|||
128019982|NCT01158404|460696440|FG005|Overall Study|Withdrawal by Subject|1|||
128019983|NCT01158404|460696441|FG006|Overall Study|Withdrawal by Subject|0|||
128019984|NCT01158404|460696442|FG007|Overall Study|Withdrawal by Subject|1|||
128019985|NCT01158404|460696435|FG000|Overall Study|Physician Decision|0|||
128019986|NCT01158404|460696436|FG001|Overall Study|Physician Decision|0|||
128019987|NCT01158404|460696437|FG002|Overall Study|Physician Decision|0|||
128019988|NCT01158404|460696438|FG003|Overall Study|Physician Decision|0|||
128019989|NCT01158404|460696439|FG004|Overall Study|Physician Decision|0|||
128019990|NCT01158404|460696440|FG005|Overall Study|Physician Decision|0|||
128019991|NCT01158404|460696441|FG006|Overall Study|Physician Decision|0|||
128019992|NCT01158404|460696442|FG007|Overall Study|Physician Decision|1|||
128019993|NCT01158404|460696435|FG000|Overall Study|Progressive Disease|0|||
128019994|NCT01158404|460696436|FG001|Overall Study|Progressive Disease|0|||
128019995|NCT01158404|460696437|FG002|Overall Study|Progressive Disease|0|||
128019996|NCT01158404|460696438|FG003|Overall Study|Progressive Disease|0|||
128019997|NCT01158404|460696439|FG004|Overall Study|Progressive Disease|0|||
128019998|NCT01158404|460696440|FG005|Overall Study|Progressive Disease|0|||
128019999|NCT01158404|460696441|FG006|Overall Study|Progressive Disease|1|||
128020000|NCT01158404|460696442|FG007|Overall Study|Progressive Disease|0|||
128020001|NCT02384460|460696446|FG000|Overall Study|Protocol Violation|0|||
128020002|NCT02384460|460696447|FG001|Overall Study|Protocol Violation|1|||
128020003|NCT02384460|460696446|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
128020004|NCT02384460|460696447|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
128020005|NCT02384460|460696446|FG000|Overall Study|Adverse Event|5|||
128020006|NCT02384460|460696447|FG001|Overall Study|Adverse Event|2|||
128020007|NCT02384460|460696446|FG000|Overall Study|Withdrawal by Subject|0|||
128020008|NCT02384460|460696447|FG001|Overall Study|Withdrawal by Subject|3|||
128020009|NCT02384460|460696446|FG000|Overall Study|Elective medical treatment|1|||
128020010|NCT02384460|460696447|FG001|Overall Study|Elective medical treatment|0|||
128020011|NCT02384460|460696446|FG000|Overall Study|Non-compliance|1|||
128020012|NCT02384460|460696447|FG001|Overall Study|Non-compliance|0|||
128020013|NCT01060111|460696448|FG000|Overall Study|Adverse Event|9|||
128020014|NCT01060111|460696449|FG001|Overall Study|Adverse Event|5|||
128020015|NCT01060111|460696450|FG002|Overall Study|Adverse Event|18|||
128020016|NCT01060111|460696448|FG000|Overall Study|Lack of Efficacy|2|||
128020017|NCT01060111|460696449|FG001|Overall Study|Lack of Efficacy|1|||
128020018|NCT01060111|460696450|FG002|Overall Study|Lack of Efficacy|0|||
128020019|NCT01060111|460696448|FG000|Overall Study|Inappropriate participant|5|||
128020020|NCT01060111|460696449|FG001|Overall Study|Inappropriate participant|4|||
128020021|NCT01060111|460696450|FG002|Overall Study|Inappropriate participant|5|||
128020022|NCT01060111|460696448|FG000|Overall Study|Participants' evasion for hospital visit|0|||
128020023|NCT01060111|460696449|FG001|Overall Study|Participants' evasion for hospital visit|3|||
128020024|NCT01060111|460696450|FG002|Overall Study|Participants' evasion for hospital visit|2|||
128020025|NCT01060111|460696448|FG000|Overall Study|Participants' non-cooperation|8|||
128020026|NCT01060111|460696449|FG001|Overall Study|Participants' non-cooperation|6|||
128020027|NCT01060111|460696450|FG002|Overall Study|Participants' non-cooperation|6|||
128020028|NCT01060111|460696448|FG000|Overall Study|Adverse event and insufficient effect|0|||
128020029|NCT01060111|460696449|FG001|Overall Study|Adverse event and insufficient effect|1|||
128020030|NCT01060111|460696450|FG002|Overall Study|Adverse event and insufficient effect|0|||
127773370|NCT02202551|459797146|FG001|Overall Study|Worsening Dyskinesia|0|||
127773371|NCT02202551|459797147|FG002|Overall Study|Worsening Dyskinesia|0|||
127773372|NCT02202551|459797148|FG003|Overall Study|Worsening Dyskinesia|1|||
127773373|NCT02202551|459797145|FG000|Overall Study|Protocol Violation|0|||
127773374|NCT02202551|459797146|FG001|Overall Study|Protocol Violation|1|||
127773375|NCT02202551|459797147|FG002|Overall Study|Protocol Violation|0|||
127773376|NCT02202551|459797148|FG003|Overall Study|Protocol Violation|0|||
127773377|NCT02202551|459797145|FG000|Overall Study|Sponsor's decision|2|||
127773378|NCT02202551|459797146|FG001|Overall Study|Sponsor's decision|0|||
127773379|NCT02202551|459797147|FG002|Overall Study|Sponsor's decision|0|||
127773380|NCT02202551|459797148|FG003|Overall Study|Sponsor's decision|0|||
127773381|NCT02202551|459797145|FG000|Overall Study|Subject unwilling to proceed|1|||
127773382|NCT02202551|459797146|FG001|Overall Study|Subject unwilling to proceed|5|||
127773383|NCT02202551|459797147|FG002|Overall Study|Subject unwilling to proceed|3|||
127773384|NCT02202551|459797148|FG003|Overall Study|Subject unwilling to proceed|5|||
127773385|NCT02202551|459797145|FG000|Overall Study|Subject consent withdrawn|0|||
127773386|NCT02202551|459797146|FG001|Overall Study|Subject consent withdrawn|3|||
127773387|NCT02202551|459797147|FG002|Overall Study|Subject consent withdrawn|1|||
127773388|NCT02202551|459797148|FG003|Overall Study|Subject consent withdrawn|2|||
127773389|NCT02202551|459797145|FG000|Overall Study|eGFR<50mL/min/m2|2|||
127773390|NCT02202551|459797146|FG001|Overall Study|eGFR<50mL/min/m2|2|||
127773391|NCT02202551|459797147|FG002|Overall Study|eGFR<50mL/min/m2|0|||
127773392|NCT02202551|459797148|FG003|Overall Study|eGFR<50mL/min/m2|1|||
127773393|NCT02147353|459797149|FG000|Overall Study|Lost to Follow-up|2|||
127773394|NCT02147353|459797150|FG001|Overall Study|Lost to Follow-up|0|||
127773395|NCT02147353|459797149|FG000|Overall Study|unable to make visits|4|||
127773396|NCT02147353|459797150|FG001|Overall Study|unable to make visits|0|||
127773397|NCT02147353|459797149|FG000|Overall Study|medication noncompliance|3|||
127773398|NCT02147353|459797150|FG001|Overall Study|medication noncompliance|0|||
127773399|NCT00752622|459797178|FG000|Induction Phase|Adverse Event|3|||
127773400|NCT00752622|459797178|FG000|Induction Phase|Other|3|||
127773401|NCT00752622|459797178|FG000|Induction Phase|Non-responder|14|||
127773402|NCT00752622|459797178|FG000|Induction Phase|Withdrawal by Subject|1|||
127773403|NCT00752622|459797178|FG000|Induction Phase|Premature study termination|14|||
127773404|NCT00752622|459797178|FG000|Observational Phase|Premature Study Termination|36|||
127773405|NCT00752622|459797178|FG000|Observational Phase|Non-responder|2|||
127773406|NCT00752622|459797178|FG000|Observational Phase|Withdrawal by Subject|2|||
127773407|NCT00752622|459797178|FG000|Observational Phase|Adverse Event|1|||
127773408|NCT00752622|459797178|FG000|Observational Phase|Other|2|||
127773409|NCT00752622|459797178|FG000|Interventional Phase|Non-responder|2|||
127773410|NCT00752622|459797178|FG000|Interventional Phase|Physician Decision|1|||
127773411|NCT00752622|459797178|FG000|Interventional Phase|Premature Study Termination|5|||
127773412|NCT00576836|459797179|FG000|Overall Study|Death|0|||
127773413|NCT00576836|459797180|FG001|Overall Study|Death|1|||
127773414|NCT00576836|459797179|FG000|Overall Study|Physician Decision|0|||
127773415|NCT00576836|459797180|FG001|Overall Study|Physician Decision|1|||
127773416|NCT02520284|459797181|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
127773417|NCT02520284|459797182|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
127773418|NCT02520284|459797183|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
127773419|NCT02520284|459797181|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
127773420|NCT02520284|459797182|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
127773421|NCT02520284|459797183|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
127773422|NCT02520284|459797181|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
127773423|NCT02520284|459797182|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
127773424|NCT02520284|459797183|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
127773425|NCT02520284|459797181|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
128020031|NCT01060111|460696448|FG000|Overall Study|Participants' non-cooperation|1|||
128020032|NCT01060111|460696449|FG001|Overall Study|Participants' non-cooperation|0|||
128020033|NCT01060111|460696450|FG002|Overall Study|Participants' non-cooperation|0|||
128020034|NCT01060111|460696448|FG000|Overall Study|Other|2|||
128020035|NCT01060111|460696449|FG001|Overall Study|Other|3|||
128020036|NCT01060111|460696450|FG002|Overall Study|Other|4|||
128020037|NCT04999020|460696453|FG000|Randomized Controlled Period (RCP)|Withdrawal by Subject|1|||
127773426|NCT02520284|459797182|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
127773427|NCT02520284|459797183|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
127773428|NCT02520284|459797181|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
127773429|NCT02520284|459797182|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
127773430|NCT02520284|459797183|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
127773431|NCT02520284|459797181|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
127773432|NCT02520284|459797182|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
127773433|NCT02520284|459797183|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
127880999|NCT02756078|460186098|FG001|Period 1|Protocol Violation|1|||
128020038|NCT04999020|460696454|FG001|Randomized Controlled Period (RCP)|Withdrawal by Subject|2|||
128020039|NCT04999020|460696455|FG002|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
128020040|NCT04999020|460696456|FG003|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
128020041|NCT04999020|460696453|FG000|Randomized Controlled Period (RCP)|Physician Decision|1|||
128020042|NCT04999020|460696454|FG001|Randomized Controlled Period (RCP)|Physician Decision|1|||
128020043|NCT04999020|460696455|FG002|Randomized Controlled Period (RCP)|Physician Decision|0|||
128020044|NCT04999020|460696456|FG003|Randomized Controlled Period (RCP)|Physician Decision|0|||
128020045|NCT04999020|460696453|FG000|Randomized Controlled Period (RCP)|Adverse Event|2|||
128020046|NCT04999020|460696454|FG001|Randomized Controlled Period (RCP)|Adverse Event|0|||
128020047|NCT04999020|460696455|FG002|Randomized Controlled Period (RCP)|Adverse Event|0|||
128020048|NCT04999020|460696456|FG003|Randomized Controlled Period (RCP)|Adverse Event|0|||
128020049|NCT04999020|460696453|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
128020050|NCT04999020|460696454|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
128020051|NCT04999020|460696455|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
128020052|NCT04999020|460696456|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
128020053|NCT04999020|460696453|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
128020054|NCT04999020|460696454|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
128020055|NCT04999020|460696455|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|17|||
128020056|NCT04999020|460696456|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
128020057|NCT04999020|460696453|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
128020058|NCT04999020|460696454|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
128020059|NCT04999020|460696455|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
128020060|NCT04999020|460696456|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
128020061|NCT04999020|460696453|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
128020062|NCT04999020|460696454|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
128020063|NCT04999020|460696455|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
128020064|NCT04999020|460696456|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
128020065|NCT04999020|460696453|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
128020066|NCT04999020|460696454|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
128020067|NCT04999020|460696455|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
128020068|NCT04999020|460696456|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
128020069|NCT02448043|460696457|FG000|Overall Study|Withdrawal by Subject|2|||
128020070|NCT02448043|460696458|FG001|Overall Study|Withdrawal by Subject|2|||
128020071|NCT02448043|460696457|FG000|Overall Study|Protocol Violation|1|||
128020072|NCT02448043|460696458|FG001|Overall Study|Protocol Violation|2|||
128020073|NCT00997126|460696461|FG000|Overall Study|Physician Decision|7|||
128020074|NCT00997126|460696462|FG001|Overall Study|Physician Decision|11|||
128020075|NCT02112552|460696473|FG000|Overall Study|Withdrawal by Subject|1|||
128020076|NCT02112552|460696473|FG000|Overall Study|Adverse Event|1|||
128020077|NCT02965456|460696474|FG000|Overall Study|Lost to Follow-up|40|||
128020078|NCT02965456|460696475|FG001|Overall Study|Lost to Follow-up|18|||
128020079|NCT02965456|460696474|FG000|Overall Study|Subject Request|22|||
128020080|NCT02965456|460696475|FG001|Overall Study|Subject Request|13|||
128020081|NCT02965456|460696474|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
128020082|NCT02965456|460696475|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
128020083|NCT02965456|460696474|FG000|Overall Study|Adverse Event|3|||
128020084|NCT02965456|460696475|FG001|Overall Study|Adverse Event|0|||
128020085|NCT02965456|460696474|FG000|Overall Study|Noncompliance with Study Drug|1|||
128020086|NCT02965456|460696475|FG001|Overall Study|Noncompliance with Study Drug|1|||
128020087|NCT02965456|460696474|FG000|Overall Study|Worsening Condition|0|||
128020088|NCT02965456|460696475|FG001|Overall Study|Worsening Condition|2|||
128020089|NCT02965456|460696474|FG000|Overall Study|Lack of Efficacy|1|||
128020090|NCT02965456|460696475|FG001|Overall Study|Lack of Efficacy|0|||
128020091|NCT02965456|460696474|FG000|Overall Study|Physician Decision|0|||
128020092|NCT02965456|460696475|FG001|Overall Study|Physician Decision|1|||
128020093|NCT02965456|460696474|FG000|Overall Study|Pregnancy|1|||
128020094|NCT02965456|460696475|FG001|Overall Study|Pregnancy|0|||
128020095|NCT02965456|460696474|FG000|Overall Study|Protocol Violation|0|||
128020096|NCT02965456|460696475|FG001|Overall Study|Protocol Violation|1|||
128020097|NCT02965456|460696474|FG000|Overall Study|Participant ran out of study drug|0|||
128020098|NCT02965456|460696475|FG001|Overall Study|Participant ran out of study drug|1|||
128020099|NCT02583477|460696476|FG000|Overall Study|Adverse Event|0|||
128020100|NCT02583477|460696477|FG001|Overall Study|Adverse Event|2|||
128020101|NCT02583477|460696476|FG000|Overall Study|Death|1|||
128020102|NCT02583477|460696477|FG001|Overall Study|Death|16|||
128020103|NCT02583477|460696476|FG000|Overall Study|Study terminated|2|||
128020104|NCT02583477|460696477|FG001|Overall Study|Study terminated|2|||
128020105|NCT04465955|460696478|FG000|Overall Study|Withdrew consent|6|||
128020106|NCT04465955|460696479|FG001|Overall Study|Withdrew consent|10|||
128020107|NCT04465955|460696480|FG002|Overall Study|Withdrew consent|7|||
128020108|NCT04465955|460696478|FG000|Overall Study|Adverse Event|6|||
128020109|NCT04465955|460696479|FG001|Overall Study|Adverse Event|5|||
128020110|NCT04465955|460696480|FG002|Overall Study|Adverse Event|1|||
127552124|NCT00256997|458987404|FG001|Overall Study|Protocol Violation|4|||
127552125|NCT00256997|458987403|FG000|Overall Study|Lack of Efficacy|1|||
128020111|NCT04465955|460696478|FG000|Overall Study|Lost to Follow-up|2|||
128020112|NCT04465955|460696479|FG001|Overall Study|Lost to Follow-up|0|||
128020113|NCT04465955|460696480|FG002|Overall Study|Lost to Follow-up|3|||
128020114|NCT04465955|460696478|FG000|Overall Study|Other|1|||
128020115|NCT04465955|460696479|FG001|Overall Study|Other|1|||
128020116|NCT04465955|460696480|FG002|Overall Study|Other|3|||
128020117|NCT01327703|460696481|FG000|Second Treatment Period|Adverse Event|1|||
128020118|NCT01327703|460696482|FG001|Second Treatment Period|Adverse Event|1|||
128020119|NCT01327703|460696481|FG000|Second Treatment Period|Protocol Violation|0|||
128020120|NCT01327703|460696482|FG001|Second Treatment Period|Protocol Violation|1|||
128020121|NCT01131585|460696483|FG000|Overall Study|Adverse Event|0|||
128020122|NCT01131585|460696484|FG001|Overall Study|Adverse Event|2|||
128020123|NCT01131585|460696483|FG000|Overall Study|Abnormal laboratory value|1|||
128020124|NCT01131585|460696484|FG001|Overall Study|Abnormal laboratory value|0|||
128020125|NCT01131585|460696483|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
128020126|NCT01131585|460696484|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
128020127|NCT01131585|460696483|FG000|Overall Study|Protocol Violation|2|||
128020128|NCT01131585|460696484|FG001|Overall Study|Protocol Violation|1|||
128020129|NCT01131585|460696483|FG000|Overall Study|Withdrawal by Subject|3|||
128020130|NCT01131585|460696484|FG001|Overall Study|Withdrawal by Subject|3|||
128020131|NCT01131585|460696483|FG000|Overall Study|Lost to Follow-up|0|||
128020132|NCT01131585|460696484|FG001|Overall Study|Lost to Follow-up|1|||
128020133|NCT01131585|460696483|FG000|Overall Study|Administrative problems|1|||
128020134|NCT01131585|460696484|FG001|Overall Study|Administrative problems|1|||
128020135|NCT01131585|460696483|FG000|Overall Study|Study termination|78|||
128020136|NCT01131585|460696484|FG001|Overall Study|Study termination|32|||
128020137|NCT00927082|460696485|FG000|Overall Study|Lost to Follow-up|9|||
128020138|NCT00927082|460696486|FG001|Overall Study|Lost to Follow-up|8|||
128020139|NCT00927082|460696487|FG002|Overall Study|Lost to Follow-up|12|||
128020140|NCT00927082|460696488|FG003|Overall Study|Lost to Follow-up|16|||
128020141|NCT00927082|460696485|FG000|Overall Study|Withdrawal by Subject|3|||
128020142|NCT00927082|460696486|FG001|Overall Study|Withdrawal by Subject|2|||
128020143|NCT00927082|460696487|FG002|Overall Study|Withdrawal by Subject|7|||
128020144|NCT00927082|460696488|FG003|Overall Study|Withdrawal by Subject|2|||
128020145|NCT00927082|460696485|FG000|Overall Study|Death|0|||
128020146|NCT00927082|460696486|FG001|Overall Study|Death|0|||
128020147|NCT00927082|460696487|FG002|Overall Study|Death|1|||
128020148|NCT00927082|460696488|FG003|Overall Study|Death|0|||
128020149|NCT00927082|460696485|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
128020150|NCT00927082|460696486|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
128020151|NCT00927082|460696487|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
128020152|NCT00927082|460696488|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
128020153|NCT00812097|460696489|FG000|Overall Study|Death|3|||
128020154|NCT00812097|460696490|FG001|Overall Study|Death|10|||
128020155|NCT00812097|460696491|FG002|Overall Study|Death|3|||
128020156|NCT00812097|460696492|FG003|Overall Study|Death|3|||
128020157|NCT00812097|460696489|FG000|Overall Study|Withdrawal by Subject|14|||
128020158|NCT00812097|460696490|FG001|Overall Study|Withdrawal by Subject|12|||
128020159|NCT00812097|460696491|FG002|Overall Study|Withdrawal by Subject|8|||
128020160|NCT00812097|460696492|FG003|Overall Study|Withdrawal by Subject|2|||
128020161|NCT00812097|460696489|FG000|Overall Study|Lost to Follow-up|90|||
128020162|NCT00812097|460696490|FG001|Overall Study|Lost to Follow-up|14|||
128020163|NCT00812097|460696491|FG002|Overall Study|Lost to Follow-up|17|||
128020164|NCT00812097|460696492|FG003|Overall Study|Lost to Follow-up|5|||
128020165|NCT00812097|460696489|FG000|Overall Study|Explantation of study device(s)|27|||
128020166|NCT00812097|460696490|FG001|Overall Study|Explantation of study device(s)|29|||
128020167|NCT00812097|460696491|FG002|Overall Study|Explantation of study device(s)|14|||
128020168|NCT00812097|460696492|FG003|Overall Study|Explantation of study device(s)|20|||
128020169|NCT00812097|460696489|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
128020170|NCT00812097|460696490|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
128020171|NCT00812097|460696491|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
128020172|NCT00812097|460696492|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
127552126|NCT00256997|458987404|FG001|Overall Study|Lack of Efficacy|4|||
127552127|NCT00256997|458987403|FG000|Overall Study|Death|2|||
127552128|NCT00256997|458987404|FG001|Overall Study|Death|0|||
127552129|NCT00256997|458987403|FG000|Overall Study|Adverse Event|4|||
127552130|NCT00256997|458987404|FG001|Overall Study|Adverse Event|0|||
127552131|NCT00256997|458987403|FG000|Overall Study|Lost to Follow-up|3|||
127552132|NCT00256997|458987404|FG001|Overall Study|Lost to Follow-up|5|||
127552133|NCT00256997|458987403|FG000|Overall Study|Withdrawal by Subject|13|||
127552134|NCT00256997|458987404|FG001|Overall Study|Withdrawal by Subject|3|||
127552135|NCT00256997|458987403|FG000|Overall Study|Started but not treated|2|||
127552136|NCT00256997|458987404|FG001|Overall Study|Started but not treated|0|||
127552137|NCT00256997|458987403|FG000|Overall Study|Other|5|||
127552138|NCT00256997|458987404|FG001|Overall Study|Other|8|||
127552139|NCT00256997|458987403|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
127552140|NCT00256997|458987404|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
127552141|NCT00256997|458987403|FG000|Overall Study|Participant Non-compliant|3|||
127552142|NCT00256997|458987404|FG001|Overall Study|Participant Non-compliant|6|||
127552143|NCT00256997|458987403|FG000|Overall Study|Investigator Withdrew Participant|2|||
127552144|NCT00256997|458987404|FG001|Overall Study|Investigator Withdrew Participant|1|||
127552145|NCT01967238|458987405|FG000|Overall Study|Adverse Event|1|||
127552146|NCT01967238|458987406|FG001|Overall Study|Adverse Event|1|||
127552147|NCT01967238|458987407|FG002|Overall Study|Adverse Event|0|||
127552148|NCT01967238|458987405|FG000|Overall Study|Lost to Follow-up|1|||
127552149|NCT01967238|458987406|FG001|Overall Study|Lost to Follow-up|0|||
127552150|NCT01967238|458987407|FG002|Overall Study|Lost to Follow-up|1|||
127552151|NCT01967238|458987405|FG000|Overall Study|Withdrawal by Subject|0|||
128020173|NCT00317369|460696493|FG000|Overall Study|Adverse Event|2|||
128020174|NCT00317369|460696494|FG001|Overall Study|Adverse Event|1|||
128020175|NCT00317369|460696495|FG002|Overall Study|Adverse Event|0|||
128020176|NCT00317369|460696493|FG000|Overall Study|Lack of Efficacy|0|||
128020177|NCT00317369|460696494|FG001|Overall Study|Lack of Efficacy|1|||
127552152|NCT01967238|458987406|FG001|Overall Study|Withdrawal by Subject|0|||
127552153|NCT01967238|458987407|FG002|Overall Study|Withdrawal by Subject|1|||
127552154|NCT05232682|458987408|FG000|Overall Study|Lost to Follow-up|2|||
127552155|NCT03387085|458987409|FG000|Overall Study|Reason for Treatment Discontinuation|7|||
127552156|NCT01442103|458988331|FG000|Overall Study|Lost to Follow-up|2|||
127552157|NCT02202759|458988332|FG000|Overall Study|Study Terminated by Sponsor|3|||
127552158|NCT02202759|458988333|FG001|Overall Study|Study Terminated by Sponsor|3|||
127552159|NCT02202759|458988334|FG002|Overall Study|Study Terminated by Sponsor|3|||
127552160|NCT02202759|458988332|FG000|Overall Study|Withdrawal by Subject|2|||
127552161|NCT02202759|458988333|FG001|Overall Study|Withdrawal by Subject|1|||
127552162|NCT02202759|458988334|FG002|Overall Study|Withdrawal by Subject|1|||
127552163|NCT02202759|458988332|FG000|Overall Study|Reason not Specified|4|||
127552164|NCT02202759|458988333|FG001|Overall Study|Reason not Specified|11|||
127552165|NCT02202759|458988334|FG002|Overall Study|Reason not Specified|10|||
127552166|NCT01987453|458988335|FG000|Overall Study|Death|0|||
128020178|NCT00317369|460696495|FG002|Overall Study|Lack of Efficacy|1|||
128020179|NCT00317369|460696493|FG000|Overall Study|Withdrawal by Subject|0|||
128020180|NCT00317369|460696494|FG001|Overall Study|Withdrawal by Subject|0|||
128020181|NCT00317369|460696495|FG002|Overall Study|Withdrawal by Subject|1|||
128020182|NCT00849472|460696496|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
128020183|NCT00849472|460696496|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
128020184|NCT00849472|460696496|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
128020185|NCT00849472|460696496|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
128020186|NCT00849472|460696496|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
128020187|NCT00849472|460696496|FG000|Weekly Paclitaxel|Disease Progression|1|||
128020188|NCT00849472|460696496|FG000|Weekly Paclitaxel|Adverse Event|11|||
128020189|NCT00849472|460696496|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
128020190|NCT00849472|460696496|FG000|Weekly Paclitaxel|Physician Decision|3|||
128020191|NCT00849472|460696496|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
128020192|NCT00849472|460696496|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
128020193|NCT00849472|460696496|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
128020194|NCT00849472|460696496|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
128020195|NCT00849472|460696496|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
128020196|NCT00849472|460696496|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
128020197|NCT00849472|460696496|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
127552167|NCT01987453|458988336|FG001|Overall Study|Death|0|||
127552168|NCT01987453|458988337|FG002|Overall Study|Death|1|||
127552169|NCT01987453|458988335|FG000|Overall Study|Lack of Efficacy|1|||
127552170|NCT01987453|458988336|FG001|Overall Study|Lack of Efficacy|12|||
127552171|NCT01987453|458988337|FG002|Overall Study|Lack of Efficacy|0|||
127552172|NCT04953728|458988339|FG000|Overall Study|Withdrawal by Subject|3|||
127552173|NCT04953728|458988339|FG000|Overall Study|Physician Decision|1|||
128020198|NCT00849472|460696496|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
128020199|NCT00825175|460696497|FG000|Overall Study|Withdrawal by Subject|0|||
127552174|NCT02105662|458988340|FG000|Overall Study|Lost to Follow-up|5|||
127552175|NCT02105662|458988340|FG000|Overall Study|Withdrawal by Subject|1|||
127552176|NCT02331277|458988343|FG000|Overall Study|Withdrawal by Subject|1|||
127552177|NCT02331277|458988344|FG001|Overall Study|Withdrawal by Subject|0|||
127552178|NCT03978117|458988345|FG000|Overall Study|Non-Compliance|26|||
127552179|NCT03978117|458988346|FG001|Overall Study|Non-Compliance|26|||
127552180|NCT03978117|458988345|FG000|Overall Study|Lost to Follow-up|4|||
127552181|NCT03978117|458988346|FG001|Overall Study|Lost to Follow-up|4|||
127552182|NCT05462756|458988347|FG000|Treatment Period|Adverse Event|3|||
127552183|NCT05462756|458988348|FG001|Treatment Period|Adverse Event|0|||
127552184|NCT05462756|458988347|FG000|Treatment Period|Assigned Treatment by Mistake|4|||
127552185|NCT05462756|458988348|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
127552186|NCT05462756|458988347|FG000|Treatment Period|Death|0|||
127552187|NCT05462756|458988348|FG001|Treatment Period|Death|1|||
127552188|NCT05462756|458988347|FG000|Treatment Period|Lost to Follow-up|2|||
127552189|NCT05462756|458988348|FG001|Treatment Period|Lost to Follow-up|1|||
127552190|NCT05462756|458988347|FG000|Treatment Period|Non-Compliance with Study Drug|1|||
127552191|NCT05462756|458988348|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
127552192|NCT05462756|458988347|FG000|Treatment Period|Physician Decision|2|||
127552193|NCT05462756|458988348|FG001|Treatment Period|Physician Decision|0|||
127552194|NCT05462756|458988347|FG000|Treatment Period|Protocol Violation|0|||
127552195|NCT05462756|458988348|FG001|Treatment Period|Protocol Violation|1|||
127552196|NCT05462756|458988347|FG000|Treatment Period|Withdrawal by Subject|5|||
127552197|NCT05462756|458988348|FG001|Treatment Period|Withdrawal by Subject|12|||
127552198|NCT05462756|458988347|FG000|Follow-Up Period|Adverse Event|1|||
127552199|NCT05462756|458988348|FG001|Follow-Up Period|Adverse Event|0|||
127552200|NCT05462756|458988347|FG000|Follow-Up Period|Death|1|||
127552201|NCT05462756|458988348|FG001|Follow-Up Period|Death|0|||
127552202|NCT05462756|458988347|FG000|Follow-Up Period|Lost to Follow-up|3|||
127552203|NCT05462756|458988348|FG001|Follow-Up Period|Lost to Follow-up|1|||
127552204|NCT05462756|458988347|FG000|Follow-Up Period|Withdrawal by Subject|0|||
127552205|NCT05462756|458988348|FG001|Follow-Up Period|Withdrawal by Subject|4|||
127552206|NCT00990704|458988350|FG000|Overall Study|Adverse Event|1|||
127552207|NCT00990704|458988351|FG001|Overall Study|Adverse Event|1|||
127552208|NCT00990704|458988350|FG000|Overall Study|Physician Decision|0|||
127685660|NCT05094141|459474889|FG001|Overall Study|Subject did not want to wear the VR Helmet|0|||
127685661|NCT05094141|459474890|FG002|Overall Study|Subject did not want to wear the VR Helmet|2|||
127881000|NCT02756078|460186097|FG000|Period 1|Adverse Event|1|||
127552209|NCT00990704|458988351|FG001|Overall Study|Physician Decision|1|||
127552210|NCT04040933|458988352|FG000|Overall Study|Protocol Violation|1|||
127552211|NCT04040933|458988352|FG000|Overall Study|Withdrawal by Subject|2|||
127552212|NCT01354899|458988356|FG000|Overall Study|discharge from the hospital|2|||
127552213|NCT01354899|458988356|FG000|Overall Study|Protocol Violation|1|||
127552214|NCT01071798|458988357|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
127552215|NCT01071798|458988357|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
127552216|NCT01071798|458988357|FG000|Participants Who Received One Cycle|Patient requirement|20|||
127552217|NCT01071798|458988357|FG000|Participants Who Received One Cycle|Death|5|||
127552218|NCT01071798|458988357|FG000|Participants Who Received One Cycle|Change of therapy|6|||
127552219|NCT01071798|458988357|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
127552220|NCT01071798|458988357|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
127552221|NCT01071798|458988357|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
127552222|NCT01071798|458988357|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
127552223|NCT01071798|458988357|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
127552224|NCT00641667|458988358|FG000|Overall Study|Withdrawal by Subject|1|||
127552225|NCT00641667|458988358|FG000|Overall Study|Adverse Event|1|||
127552226|NCT00641667|458988358|FG000|Overall Study|Physician Decision|1|||
127552227|NCT00641667|458988358|FG000|Overall Study|Worsening of underlying disease|3|||
127552228|NCT01235741|458988359|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
127552229|NCT01235741|458988360|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
127552230|NCT01235741|458988361|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
127552231|NCT01235741|458988359|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
127552232|NCT01235741|458988360|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
127552233|NCT01235741|458988361|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
127552234|NCT01235741|458988359|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
127552235|NCT01235741|458988360|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
127552236|NCT01235741|458988361|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
127552237|NCT01235741|458988359|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
127552238|NCT01235741|458988360|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
127552239|NCT01235741|458988361|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
127552240|NCT01235741|458988359|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
127552241|NCT01235741|458988360|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
127552242|NCT01235741|458988361|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
127552243|NCT01235741|458988359|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
127552244|NCT01235741|458988360|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
127552245|NCT01235741|458988361|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
127552246|NCT01235741|458988359|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
127552247|NCT01235741|458988360|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
127552248|NCT01235741|458988361|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
128020200|NCT00825175|460696498|FG001|Overall Study|Withdrawal by Subject|5|||
128020201|NCT02691572|460696500|FG000|Overall Study|Withdrawal by Subject|1|||
128020202|NCT02691572|460696501|FG001|Overall Study|Withdrawal by Subject|0|||
128020203|NCT02691572|460696500|FG000|Overall Study|Protocol Violation|0|||
128020204|NCT02691572|460696501|FG001|Overall Study|Protocol Violation|1|||
128020205|NCT03370302|460696505|FG000|Dose Escalation Phase|Other|0|||
127552249|NCT01235741|458988359|FG000|Randomized to Treatment|Adverse Event|0|||
127552250|NCT01235741|458988360|FG001|Randomized to Treatment|Adverse Event|1|||
127552251|NCT01235741|458988361|FG002|Randomized to Treatment|Adverse Event|1|||
127773434|NCT02520284|459797181|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
127773435|NCT02520284|459797182|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
127773436|NCT02520284|459797183|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
127773437|NCT02520284|459797181|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
127773438|NCT02520284|459797182|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
127773439|NCT02520284|459797183|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
127773440|NCT02520284|459797181|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
127773441|NCT02520284|459797182|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
127773442|NCT02520284|459797183|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
127773443|NCT02520284|459797181|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
127773444|NCT02520284|459797182|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
127773445|NCT02520284|459797183|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
127773446|NCT02520284|459797181|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
127773447|NCT02520284|459797182|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
127773448|NCT02520284|459797183|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
127773449|NCT01211522|459797187|FG000|Overall Study|Withdrawal by Subject|3|||
127773450|NCT01211522|459797188|FG001|Overall Study|Withdrawal by Subject|7|||
127773451|NCT01211522|459797189|FG002|Overall Study|Withdrawal by Subject|5|||
127773452|NCT01116882|459797195|FG000|30-day|Lost to Follow-up|50|||
128020206|NCT03370302|460696506|FG001|Dose Escalation Phase|Other|1|||
128020207|NCT03370302|460696507|FG002|Dose Escalation Phase|Other|1|||
128020208|NCT03370302|460696508|FG003|Dose Escalation Phase|Other|0|||
128020209|NCT03370302|460696509|FG004|Dose Escalation Phase|Other|0|||
128020210|NCT03370302|460696510|FG005|Dose Escalation Phase|Other|0|||
127552252|NCT01235741|458988359|FG000|Randomized to Treatment|Sponsor terminated study|0|||
128020211|NCT03370302|460696505|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
128020212|NCT03370302|460696506|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
128020213|NCT03370302|460696507|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
127552253|NCT01235741|458988360|FG001|Randomized to Treatment|Sponsor terminated study|35|||
127552254|NCT01235741|458988361|FG002|Randomized to Treatment|Sponsor terminated study|34|||
127552255|NCT01235741|458988359|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
127552256|NCT01235741|458988360|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
127552257|NCT01235741|458988361|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
127552258|NCT01235741|458988359|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
127552259|NCT01235741|458988360|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
127552260|NCT01235741|458988361|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
127552261|NCT01235741|458988359|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
127552262|NCT01235741|458988360|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
127552263|NCT01235741|458988361|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
127552264|NCT01528969|458988362|FG000|Overall Study|absent from the school at baseline|2|||
127552265|NCT01528969|458988363|FG001|Overall Study|absent from the school at baseline|0|||
127552266|NCT00098813|458988364|FG000|Overall Study|Death|8|||
127552267|NCT00098813|458988364|FG000|Overall Study|Protocol Violation|1|||
127552268|NCT00098813|458988364|FG000|Overall Study|Withdrawal by Subject|7|||
127552269|NCT00098813|458988364|FG000|Overall Study|Progression of Disease|1|||
127552270|NCT00098813|458988364|FG000|Overall Study|Other complicating disease|1|||
127552271|NCT00098813|458988364|FG000|Overall Study|Reversal of RAI resistance|1|||
127552272|NCT00220636|458988365|FG000|Overall Study|Withdrawal by Subject|4|||
127552273|NCT01662102|458988371|FG000|Overall Study|Sponsor's decision|1|||
127552274|NCT01662102|458988372|FG001|Overall Study|Sponsor's decision|0|||
127552275|NCT00196313|458988375|FG000|Overall Study|Protocol Violation|2|||
127552276|NCT00196313|458988376|FG001|Overall Study|Protocol Violation|3|||
127552277|NCT00196313|458988375|FG000|Overall Study|Withdrawal by Subject|3|||
127552278|NCT00196313|458988376|FG001|Overall Study|Withdrawal by Subject|1|||
127552279|NCT00196313|458988375|FG000|Overall Study|Adverse Event|3|||
127552280|NCT00196313|458988376|FG001|Overall Study|Adverse Event|1|||
127552281|NCT00196313|458988375|FG000|Overall Study|Subject Pregnant|1|||
127552282|NCT00196313|458988376|FG001|Overall Study|Subject Pregnant|1|||
127552283|NCT00196313|458988375|FG000|Overall Study|Lost to Follow-up|2|||
127552284|NCT00196313|458988376|FG001|Overall Study|Lost to Follow-up|2|||
127552285|NCT02577718|458988379|FG000|Overall Study|Death|6|||
127552286|NCT02577718|458988379|FG000|Overall Study|Withdrawal by Subject|2|||
127552287|NCT01995838|458988380|FG000|Overall Study|Lost to Follow-up|0|||
127552288|NCT01995838|458988381|FG001|Overall Study|Lost to Follow-up|1|||
127552289|NCT01995838|458988382|FG002|Overall Study|Lost to Follow-up|0|||
127552290|NCT01995838|458988383|FG003|Overall Study|Lost to Follow-up|0|||
128020214|NCT03370302|460696508|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
128020215|NCT03370302|460696509|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
128020216|NCT03370302|460696510|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
128020217|NCT03370302|460696505|FG000|Dose Escalation Phase|Adverse Event|1|||
128020218|NCT03370302|460696506|FG001|Dose Escalation Phase|Adverse Event|0|||
128020219|NCT03370302|460696507|FG002|Dose Escalation Phase|Adverse Event|2|||
128020220|NCT03370302|460696508|FG003|Dose Escalation Phase|Adverse Event|0|||
128020221|NCT03370302|460696509|FG004|Dose Escalation Phase|Adverse Event|0|||
128020222|NCT03370302|460696510|FG005|Dose Escalation Phase|Adverse Event|0|||
127552291|NCT01995838|458988384|FG004|Overall Study|Lost to Follow-up|0|||
127552292|NCT01995838|458988385|FG005|Overall Study|Lost to Follow-up|0|||
127552293|NCT01995838|458988386|FG006|Overall Study|Lost to Follow-up|1|||
127552294|NCT01995838|458988380|FG000|Overall Study|Participant choice|2|||
127552295|NCT01995838|458988381|FG001|Overall Study|Participant choice|0|||
127552296|NCT01995838|458988382|FG002|Overall Study|Participant choice|0|||
127552297|NCT01995838|458988383|FG003|Overall Study|Participant choice|0|||
127552298|NCT01995838|458988384|FG004|Overall Study|Participant choice|0|||
128020223|NCT03370302|460696505|FG000|Dose Escalation Phase|Progressive Disease|2|||
127773453|NCT01116882|459797196|FG001|30-day|Lost to Follow-up|21|||
127773454|NCT01116882|459797195|FG000|30-day|Withdrawal by Subject|2|||
127773455|NCT01116882|459797196|FG001|30-day|Withdrawal by Subject|4|||
128020224|NCT03370302|460696506|FG001|Dose Escalation Phase|Progressive Disease|4|||
128020225|NCT03370302|460696507|FG002|Dose Escalation Phase|Progressive Disease|2|||
128020226|NCT03370302|460696508|FG003|Dose Escalation Phase|Progressive Disease|0|||
128020227|NCT03370302|460696509|FG004|Dose Escalation Phase|Progressive Disease|3|||
128020228|NCT03370302|460696510|FG005|Dose Escalation Phase|Progressive Disease|1|||
128020229|NCT03370302|460696505|FG000|Dose Expansion Phase|Progressive Disease|0|||
128020230|NCT03370302|460696506|FG001|Dose Expansion Phase|Progressive Disease|0|||
128020231|NCT03370302|460696507|FG002|Dose Expansion Phase|Progressive Disease|0|||
128020232|NCT03370302|460696508|FG003|Dose Expansion Phase|Progressive Disease|6|||
128020233|NCT03370302|460696509|FG004|Dose Expansion Phase|Progressive Disease|0|||
128020234|NCT03370302|460696510|FG005|Dose Expansion Phase|Progressive Disease|0|||
128020235|NCT01428128|460696511|FG000|Overall Study|Withdrawal by Subject|4|||
128020236|NCT01428128|460696511|FG000|Overall Study|Screen failure by p53|10|||
128020237|NCT01428128|460696511|FG000|Overall Study|Received Neulasta in one cycle|2|||
128020238|NCT01428128|460696511|FG000|Overall Study|Adverse Event|1|||
128020239|NCT04180696|460696513|FG000|Overall Study|Death|5|||
128020240|NCT04180696|460696514|FG001|Overall Study|Death|6|||
128020241|NCT04180696|460696513|FG000|Overall Study|Lost to Follow-up|1|||
128020242|NCT04180696|460696514|FG001|Overall Study|Lost to Follow-up|0|||
128020243|NCT04180696|460696513|FG000|Overall Study|Withdrawal by Subject|0|||
128020244|NCT04180696|460696514|FG001|Overall Study|Withdrawal by Subject|1|||
128020245|NCT00424008|460696515|FG000|Overall Study|Adverse Event|8|||
128020246|NCT00424008|460696516|FG001|Overall Study|Adverse Event|6|||
128020247|NCT00424008|460696515|FG000|Overall Study|Lack of Efficacy|40|||
128020248|NCT00424008|460696516|FG001|Overall Study|Lack of Efficacy|34|||
128020249|NCT00424008|460696515|FG000|Overall Study|Lost to Follow-up|1|||
128020250|NCT00424008|460696516|FG001|Overall Study|Lost to Follow-up|2|||
128020251|NCT00424008|460696515|FG000|Overall Study|Withdrawal by Subject|5|||
128020252|NCT00424008|460696516|FG001|Overall Study|Withdrawal by Subject|8|||
128020253|NCT00424008|460696515|FG000|Overall Study|Noncompliance with protocol|13|||
128020254|NCT00424008|460696516|FG001|Overall Study|Noncompliance with protocol|7|||
128020255|NCT00424008|460696515|FG000|Overall Study|Did not meet protocol eligibility|16|||
128020256|NCT00424008|460696516|FG001|Overall Study|Did not meet protocol eligibility|21|||
128020257|NCT00424008|460696515|FG000|Overall Study|Administrative|266|||
128020258|NCT00424008|460696516|FG001|Overall Study|Administrative|257|||
128020259|NCT02593864|460696521|FG000|Overall Study|Withdrawal by Subject|3|||
128020260|NCT02593864|460696521|FG000|Overall Study|Lost to Follow-up|3|||
128020261|NCT04739709|460696522|FG000|Overall Study|Physician Decision|1|||
128020262|NCT04739709|460696523|FG001|Overall Study|Physician Decision|0|||
128020263|NCT02530242|460696538|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
128020264|NCT02530242|460696539|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
128020265|NCT00283959|460696540|FG000|Extension Period|Low Compliance|1|||
128020266|NCT05591755|460696541|FG000|Overall Study|Screen Failure|1|||
128020267|NCT05591755|460696542|FG001|Overall Study|Screen Failure|0|||
128020268|NCT05591755|460696543|FG002|Overall Study|Screen Failure|0|||
128020269|NCT05591755|460696544|FG003|Overall Study|Screen Failure|0|||
128020270|NCT05591755|460696541|FG000|Overall Study|Protocol Violation|0|||
128020271|NCT05591755|460696542|FG001|Overall Study|Protocol Violation|0|||
128020272|NCT05591755|460696543|FG002|Overall Study|Protocol Violation|2|||
128020273|NCT05591755|460696544|FG003|Overall Study|Protocol Violation|0|||
128020274|NCT05591755|460696541|FG000|Overall Study|Withdrawal by Subject|0|||
128020275|NCT05591755|460696542|FG001|Overall Study|Withdrawal by Subject|1|||
128020276|NCT05591755|460696543|FG002|Overall Study|Withdrawal by Subject|0|||
128020277|NCT05591755|460696544|FG003|Overall Study|Withdrawal by Subject|0|||
128020278|NCT00433290|460696545|FG000|Overall Study|Adverse Event|24|||
128020279|NCT00433290|460696546|FG001|Overall Study|Adverse Event|7|||
128020280|NCT00433290|460696545|FG000|Overall Study|Lack of Efficacy|1|||
128020281|NCT00433290|460696546|FG001|Overall Study|Lack of Efficacy|5|||
127773456|NCT01116882|459797195|FG000|30-day|Other Reasons|16|||
127773457|NCT01116882|459797196|FG001|30-day|Other Reasons|6|||
127773458|NCT01116882|459797195|FG000|12-month|Lost to Follow-up|111|||
127881001|NCT02756078|460186098|FG001|Period 1|Adverse Event|10|||
128020282|NCT00433290|460696545|FG000|Overall Study|Withdrawal by Subject|4|||
128020283|NCT00433290|460696546|FG001|Overall Study|Withdrawal by Subject|2|||
128020284|NCT00433290|460696545|FG000|Overall Study|Protocol Violation|3|||
128020285|NCT00433290|460696546|FG001|Overall Study|Protocol Violation|2|||
128020286|NCT00433290|460696545|FG000|Overall Study|Physician Decision|2|||
128020287|NCT00433290|460696546|FG001|Overall Study|Physician Decision|0|||
128020288|NCT00433290|460696545|FG000|Overall Study|Entry Criteria Not Met|0|||
128020289|NCT00433290|460696546|FG001|Overall Study|Entry Criteria Not Met|1|||
128020290|NCT00433290|460696545|FG000|Overall Study|Lost to Follow-up|1|||
128020291|NCT00433290|460696546|FG001|Overall Study|Lost to Follow-up|0|||
128020292|NCT01483651|460696547|FG000|Overall Study|Withdrawal by Subject|0|||
128020293|NCT01483651|460696548|FG001|Overall Study|Withdrawal by Subject|1|||
127552299|NCT01995838|458988385|FG005|Overall Study|Participant choice|1|||
127552300|NCT01995838|458988386|FG006|Overall Study|Participant choice|1|||
127552301|NCT01995838|458988380|FG000|Overall Study|Adverse Event|0|||
127552302|NCT01995838|458988381|FG001|Overall Study|Adverse Event|0|||
127552303|NCT01995838|458988382|FG002|Overall Study|Adverse Event|0|||
127552304|NCT01995838|458988383|FG003|Overall Study|Adverse Event|0|||
127552305|NCT01995838|458988384|FG004|Overall Study|Adverse Event|0|||
127552306|NCT01995838|458988385|FG005|Overall Study|Adverse Event|0|||
127552307|NCT01995838|458988386|FG006|Overall Study|Adverse Event|1|||
127552308|NCT01995838|458988380|FG000|Overall Study|Withdrawal by Subject|0|||
127552309|NCT01995838|458988381|FG001|Overall Study|Withdrawal by Subject|0|||
127552310|NCT01995838|458988382|FG002|Overall Study|Withdrawal by Subject|0|||
127552311|NCT01995838|458988383|FG003|Overall Study|Withdrawal by Subject|0|||
127552312|NCT01995838|458988384|FG004|Overall Study|Withdrawal by Subject|1|||
127881002|NCT02756078|460186097|FG000|Period 1|Withdrawal by Subject|6|||
127552313|NCT01995838|458988385|FG005|Overall Study|Withdrawal by Subject|0|||
127552314|NCT01995838|458988386|FG006|Overall Study|Withdrawal by Subject|0|||
127552315|NCT01995838|458988380|FG000|Overall Study|Other|3|||
127552316|NCT01995838|458988381|FG001|Overall Study|Other|1|||
127552317|NCT01995838|458988382|FG002|Overall Study|Other|0|||
127552318|NCT01995838|458988383|FG003|Overall Study|Other|2|||
127552319|NCT01995838|458988384|FG004|Overall Study|Other|1|||
127552320|NCT01995838|458988385|FG005|Overall Study|Other|1|||
127552321|NCT01995838|458988386|FG006|Overall Study|Other|2|||
127552322|NCT01967576|458988387|FG000|Overall Study|Withdrawal by Subject|3|||
127552323|NCT01967576|458988387|FG000|Overall Study|Progressed/Removed from treatment|1|||
127552324|NCT01967576|458988387|FG000|Overall Study|Study closing at site|1|||
127552325|NCT01967576|458988387|FG000|Overall Study|Adverse Event|1|||
127552326|NCT01967576|458988387|FG000|Overall Study|Refused further treatment|1|||
127552327|NCT02157883|458988388|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
127552328|NCT02157883|458988388|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
127552329|NCT02157883|458988388|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
127552330|NCT02157883|458988388|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
127552331|NCT02157883|458988388|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
127552332|NCT00888940|458988389|FG000|Overall Study|Adverse Event|12|||
127552333|NCT00888940|458988390|FG001|Overall Study|Adverse Event|3|||
127552334|NCT00888940|458988389|FG000|Overall Study|Lost to Follow-up|5|||
127552335|NCT00888940|458988390|FG001|Overall Study|Lost to Follow-up|5|||
127552336|NCT00888940|458988389|FG000|Overall Study|Randomized Not Treated|11|||
127552337|NCT00888940|458988390|FG001|Overall Study|Randomized Not Treated|13|||
127552338|NCT01578486|458988391|FG000|Overall Study|Physician Decision|3|||
127552339|NCT01578486|458988391|FG000|Overall Study|Withdrawal by Subject|2|||
127552340|NCT02536963|458988392|FG000|Overall Study|Withdrawal by Subject|18|||
127552341|NCT02668393|458988394|FG000|Overall Study|Progressive disease|6|||
127552342|NCT02668393|458988395|FG001|Overall Study|Progressive disease|3|||
127552343|NCT02668393|458988394|FG000|Overall Study|Adverse Event|0|||
127552344|NCT02668393|458988395|FG001|Overall Study|Adverse Event|2|||
127552345|NCT02668393|458988394|FG000|Overall Study|Withdrawal from the trial|0|||
127552346|NCT02668393|458988395|FG001|Overall Study|Withdrawal from the trial|1|||
127552347|NCT02668393|458988394|FG000|Overall Study|Lack of benefit and side effects|1|||
127552348|NCT02668393|458988395|FG001|Overall Study|Lack of benefit and side effects|0|||
127552349|NCT02141204|458988396|FG000|Overall Study|Lost to Follow-up|2|||
127773459|NCT01116882|459797196|FG001|12-month|Lost to Follow-up|42|||
127773460|NCT01116882|459797195|FG000|12-month|Other Reasons|151|||
127773461|NCT01116882|459797196|FG001|12-month|Other Reasons|49|||
127773462|NCT01116882|459797195|FG000|12-month|Withdrawal by Subject|5|||
127773463|NCT01116882|459797196|FG001|12-month|Withdrawal by Subject|8|||
127773464|NCT00547365|459797197|FG000|Overall Study|Physician Decision|1|||
127773465|NCT00547365|459797197|FG000|Overall Study|Lost to Follow-up|1|||
127773466|NCT00547365|459797197|FG000|Overall Study|Protocol Violation|2|||
127773467|NCT00547365|459797197|FG000|Overall Study|death (not related to study)|4|||
127773468|NCT01139658|459797198|FG000|Overall Study|Adverse Event|10|||
127773469|NCT01139658|459797199|FG001|Overall Study|Adverse Event|27|||
127773470|NCT01139658|459797198|FG000|Overall Study|Lack of Efficacy|15|||
127773471|NCT01139658|459797199|FG001|Overall Study|Lack of Efficacy|7|||
127773472|NCT01139658|459797198|FG000|Overall Study|Withdrawal by Subject|2|||
127773473|NCT01139658|459797199|FG001|Overall Study|Withdrawal by Subject|4|||
127773474|NCT01139658|459797198|FG000|Overall Study|No documentation of treatment|1|||
127773475|NCT01139658|459797199|FG001|Overall Study|No documentation of treatment|0|||
127773476|NCT01139658|459797198|FG000|Overall Study|Other|28|||
127773477|NCT01139658|459797199|FG001|Overall Study|Other|75|||
127773478|NCT01777269|459797200|FG000|Overall Study|Adverse Event|24|||
127773479|NCT01777269|459797201|FG001|Overall Study|Adverse Event|33|||
127773480|NCT01777269|459797200|FG000|Overall Study|Lack of Efficacy|8|||
127773481|NCT01777269|459797201|FG001|Overall Study|Lack of Efficacy|10|||
127773482|NCT01777269|459797200|FG000|Overall Study|Protocol Violation|4|||
127773483|NCT01777269|459797201|FG001|Overall Study|Protocol Violation|4|||
127773484|NCT01777269|459797200|FG000|Overall Study|Participants reached stopping criteria|1|||
127773485|NCT01777269|459797201|FG001|Overall Study|Participants reached stopping criteria|1|||
127773486|NCT01777269|459797200|FG000|Overall Study|Lost to Follow-up|4|||
127552350|NCT02141204|458988397|FG001|Overall Study|Lost to Follow-up|1|||
127773487|NCT01777269|459797201|FG001|Overall Study|Lost to Follow-up|0|||
127773488|NCT01777269|459797200|FG000|Overall Study|Physician Decision|5|||
127773489|NCT01777269|459797201|FG001|Overall Study|Physician Decision|2|||
127773490|NCT01777269|459797200|FG000|Overall Study|Withdrawal by Subject|9|||
127773491|NCT01777269|459797201|FG001|Overall Study|Withdrawal by Subject|9|||
127773492|NCT00504881|459797202|FG000|Overall Study|Lack of Efficacy|1|||
127773493|NCT00504881|459797203|FG001|Overall Study|Lack of Efficacy|5|||
127773494|NCT00504881|459797202|FG000|Overall Study|Lost to Follow-up|0|||
127552351|NCT02141204|458988396|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
127552352|NCT02141204|458988397|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
127552353|NCT02141204|458988396|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
127552354|NCT02141204|458988397|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
127552355|NCT02141204|458988396|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
127773495|NCT00504881|459797203|FG001|Overall Study|Lost to Follow-up|2|||
127773496|NCT00504881|459797202|FG000|Overall Study|Withdrawal by Subject|1|||
127552356|NCT02141204|458988397|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
127552357|NCT01918306|458988398|FG000|Overall Study|progresive disease|4|||
127552358|NCT01918306|458988399|FG001|Overall Study|progresive disease|0|||
127552359|NCT01918306|458988400|FG002|Overall Study|progresive disease|1|||
128020294|NCT01483651|460696549|FG002|Overall Study|Withdrawal by Subject|1|||
127552360|NCT01918306|458988401|FG003|Overall Study|progresive disease|1|||
127552361|NCT01918306|458988398|FG000|Overall Study|Withdrawal by Subject|0|||
127552362|NCT01918306|458988399|FG001|Overall Study|Withdrawal by Subject|0|||
127552363|NCT01918306|458988400|FG002|Overall Study|Withdrawal by Subject|0|||
127552364|NCT01918306|458988401|FG003|Overall Study|Withdrawal by Subject|2|||
127552365|NCT01918306|458988398|FG000|Overall Study|neutropenia|1|||
127552366|NCT01918306|458988399|FG001|Overall Study|neutropenia|0|||
127552367|NCT01918306|458988400|FG002|Overall Study|neutropenia|0|||
127552368|NCT01918306|458988401|FG003|Overall Study|neutropenia|0|||
127552369|NCT01918306|458988398|FG000|Overall Study|Lack of Efficacy|1|||
127552370|NCT01918306|458988399|FG001|Overall Study|Lack of Efficacy|0|||
127552371|NCT01918306|458988400|FG002|Overall Study|Lack of Efficacy|0|||
127552372|NCT01918306|458988401|FG003|Overall Study|Lack of Efficacy|0|||
127552373|NCT01918306|458988398|FG000|Overall Study|progress disease, crossover|0|||
127552374|NCT01918306|458988399|FG001|Overall Study|progress disease, crossover|0|||
127552375|NCT01918306|458988400|FG002|Overall Study|progress disease, crossover|1|||
127552376|NCT01918306|458988401|FG003|Overall Study|progress disease, crossover|0|||
127552377|NCT01958164|458988403|FG000|Overall Study|Adverse Event|0|||
127552378|NCT01958164|458988404|FG001|Overall Study|Adverse Event|2|||
127552379|NCT01958164|458988403|FG000|Overall Study|Lost to Follow-up|2|||
127552380|NCT01958164|458988404|FG001|Overall Study|Lost to Follow-up|3|||
127552381|NCT02963506|458988405|FG000|Double-Blind Period|Adverse Event|0|||
127552382|NCT02963506|458988406|FG001|Double-Blind Period|Adverse Event|0|||
127552383|NCT02963506|458988407|FG002|Double-Blind Period|Adverse Event|1|||
127552384|NCT02963506|458988408|FG003|Double-Blind Period|Adverse Event|0|||
127552385|NCT02963506|458988409|FG004|Double-Blind Period|Adverse Event|0|||
127552386|NCT02963506|458988410|FG005|Double-Blind Period|Adverse Event|0|||
127552387|NCT02963506|458988411|FG006|Double-Blind Period|Adverse Event|0|||
127552388|NCT02963506|458988412|FG007|Double-Blind Period|Adverse Event|0|||
127552389|NCT02963506|458988413|FG008|Double-Blind Period|Adverse Event|0|||
128020295|NCT01483651|460696550|FG003|Overall Study|Withdrawal by Subject|0|||
128020296|NCT01483651|460696551|FG004|Overall Study|Withdrawal by Subject|0|||
128020297|NCT01483651|460696552|FG005|Overall Study|Withdrawal by Subject|1|||
127552390|NCT02963506|458988414|FG009|Double-Blind Period|Adverse Event|0|||
127552391|NCT02963506|458988415|FG010|Double-Blind Period|Adverse Event|0|||
128020298|NCT00504309|460696562|FG000|Overall Study|Death|0|||
128020299|NCT00504309|460696563|FG001|Overall Study|Death|0|||
128020300|NCT00504309|460696564|FG002|Overall Study|Death|0|||
128020301|NCT00504309|460696565|FG003|Overall Study|Death|0|||
128020302|NCT00504309|460696566|FG004|Overall Study|Death|1|||
128020303|NCT00504309|460696567|FG005|Overall Study|Death|0|||
128020304|NCT00504309|460696562|FG000|Overall Study|Withdrawal by Subject|0|||
128020305|NCT00504309|460696563|FG001|Overall Study|Withdrawal by Subject|0|||
128020306|NCT00504309|460696564|FG002|Overall Study|Withdrawal by Subject|1|||
128020307|NCT00504309|460696565|FG003|Overall Study|Withdrawal by Subject|0|||
128020308|NCT00504309|460696566|FG004|Overall Study|Withdrawal by Subject|0|||
128020309|NCT00504309|460696567|FG005|Overall Study|Withdrawal by Subject|0|||
128020310|NCT03345095|460696568|FG000|Overall Study|Lack of Efficacy|184|||
128020311|NCT03345095|460696569|FG001|Overall Study|Lack of Efficacy|156|||
128020312|NCT03345095|460696568|FG000|Overall Study|Adverse Event|36|||
128020313|NCT03345095|460696569|FG001|Overall Study|Adverse Event|118|||
128020314|NCT03345095|460696568|FG000|Overall Study|Withdrawal by Subject|22|||
128020315|NCT03345095|460696569|FG001|Overall Study|Withdrawal by Subject|59|||
128020316|NCT03345095|460696568|FG000|Overall Study|Physician Decision|3|||
128020317|NCT03345095|460696569|FG001|Overall Study|Physician Decision|18|||
128020318|NCT03345095|460696568|FG000|Overall Study|Death|2|||
128020319|NCT03345095|460696569|FG001|Overall Study|Death|4|||
128020320|NCT03345095|460696568|FG000|Overall Study|Other reasons|2|||
128020321|NCT03345095|460696569|FG001|Overall Study|Other reasons|11|||
128020322|NCT03345095|460696568|FG000|Overall Study|Protocol Violation|0|||
128020323|NCT03345095|460696569|FG001|Overall Study|Protocol Violation|1|||
128020324|NCT01121575|460696570|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
128020325|NCT01121575|460696571|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
127552392|NCT02963506|458988416|FG011|Double-Blind Period|Adverse Event|0|||
127552393|NCT02963506|458988417|FG012|Double-Blind Period|Adverse Event|0|||
127552394|NCT02963506|458988405|FG000|Double-Blind Period|Death|0|||
128020326|NCT01121575|460696572|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
128020327|NCT01121575|460696573|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
128020328|NCT01121575|460696574|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
128020329|NCT01121575|460696575|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
128020330|NCT01121575|460696570|FG000|Overall Study|Unspecified Reasons|8|||
128020331|NCT01121575|460696571|FG001|Overall Study|Unspecified Reasons|6|||
128020332|NCT01121575|460696572|FG002|Overall Study|Unspecified Reasons|7|||
127773497|NCT00504881|459797203|FG001|Overall Study|Withdrawal by Subject|4|||
127773498|NCT00504881|459797202|FG000|Overall Study|Non-Compliance|1|||
127773499|NCT00504881|459797203|FG001|Overall Study|Non-Compliance|0|||
127773500|NCT00504881|459797202|FG000|Overall Study|No Birth Control|0|||
127773501|NCT00504881|459797203|FG001|Overall Study|No Birth Control|1|||
127773502|NCT00504881|459797202|FG000|Overall Study|Safety Visit not performed|0|||
127773503|NCT00504881|459797203|FG001|Overall Study|Safety Visit not performed|1|||
127773504|NCT00504881|459797202|FG000|Overall Study|AE, serious fatal|0|||
127773505|NCT00504881|459797203|FG001|Overall Study|AE, serious fatal|1|||
127773506|NCT00504881|459797202|FG000|Overall Study|SAE, non-fatal|2|||
127773507|NCT00504881|459797203|FG001|Overall Study|SAE, non-fatal|6|||
127773508|NCT00504881|459797202|FG000|Overall Study|AE, non-serious non-fatal|4|||
127773509|NCT00504881|459797203|FG001|Overall Study|AE, non-serious non-fatal|14|||
127773510|NCT00504881|459797202|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
127773511|NCT00504881|459797203|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
127773512|NCT00504881|459797202|FG000|Overall Study|AE of unknown type|1|||
127881003|NCT02756078|460186098|FG001|Period 1|Withdrawal by Subject|6|||
128020333|NCT01121575|460696573|FG003|Overall Study|Unspecified Reasons|5|||
128020334|NCT01121575|460696574|FG004|Overall Study|Unspecified Reasons|13|||
128020335|NCT01121575|460696575|FG005|Overall Study|Unspecified Reasons|10|||
128020336|NCT01121575|460696570|FG000|Overall Study|Death|6|||
128020337|NCT01121575|460696571|FG001|Overall Study|Death|0|||
128020338|NCT01121575|460696572|FG002|Overall Study|Death|0|||
128020339|NCT01121575|460696573|FG003|Overall Study|Death|1|||
128020340|NCT01121575|460696574|FG004|Overall Study|Death|7|||
128020341|NCT01121575|460696575|FG005|Overall Study|Death|1|||
128020342|NCT00724503|460696577|FG000|Overall Study|Lost to Follow-up|4|||
128020343|NCT00724503|460696578|FG001|Overall Study|Lost to Follow-up|8|||
128020344|NCT00724503|460696577|FG000|Overall Study|Withdrawal by Subject|11|||
128020345|NCT00724503|460696578|FG001|Overall Study|Withdrawal by Subject|23|||
128020346|NCT00724503|460696577|FG000|Overall Study|Death|190|||
128020347|NCT00724503|460696578|FG001|Overall Study|Death|182|||
128020348|NCT00724503|460696577|FG000|Overall Study|Adverse Event|1|||
128020349|NCT00724503|460696578|FG001|Overall Study|Adverse Event|0|||
128020350|NCT00724503|460696577|FG000|Overall Study|Not otherwise specified|4|||
128020351|NCT00724503|460696578|FG001|Overall Study|Not otherwise specified|7|||
128020352|NCT01186419|460696581|FG000|Overall Study|Withdrawal by Subject|5|||
128020353|NCT01186419|460696582|FG001|Overall Study|Withdrawal by Subject|3|||
128020354|NCT01186419|460696581|FG000|Overall Study|Adverse Event|1|||
128020355|NCT01186419|460696582|FG001|Overall Study|Adverse Event|2|||
128020356|NCT01186419|460696581|FG000|Overall Study|Physician Decision|0|||
128020357|NCT01186419|460696582|FG001|Overall Study|Physician Decision|3|||
128020358|NCT01186419|460696581|FG000|Overall Study|Other|1|||
128020359|NCT01186419|460696582|FG001|Overall Study|Other|1|||
128020360|NCT05417113|460698075|FG000|Overall Study|Lost to Follow-up|2|||
128020361|NCT05417113|460698076|FG001|Overall Study|Lost to Follow-up|2|||
128020362|NCT01022580|460698077|FG000|Overall Study|Death|18|||
128020363|NCT01022580|460698078|FG001|Overall Study|Death|22|||
128020364|NCT01500096|460698081|FG000|Overall Study|Lost to Follow-up|1|||
128020365|NCT01500096|460698082|FG001|Overall Study|Lost to Follow-up|0|||
128020366|NCT01500096|460698083|FG002|Overall Study|Lost to Follow-up|0|||
128020367|NCT01500096|460698084|FG003|Overall Study|Lost to Follow-up|2|||
128020368|NCT01734928|460698085|FG000|Randomization|Physician Decision|0|||
128020369|NCT01734928|460698086|FG001|Randomization|Physician Decision|1|||
128020370|NCT01734928|460698085|FG000|Randomization|clinical progression|0|||
128020371|NCT01734928|460698086|FG001|Randomization|clinical progression|1|||
128020372|NCT01734928|460698085|FG000|Randomization|progressive disease|0|||
128020373|NCT01734928|460698086|FG001|Randomization|progressive disease|2|||
128020374|NCT01734928|460698085|FG000|Randomization|Withdrew informed consent|0|||
128020375|NCT01734928|460698086|FG001|Randomization|Withdrew informed consent|4|||
128020376|NCT01734928|460698085|FG000|Randomization|Death|1|||
128020377|NCT01734928|460698086|FG001|Randomization|Death|0|||
128020378|NCT01734928|460698085|FG000|Randomization|Randomization error|1|||
128020379|NCT01734928|460698086|FG001|Randomization|Randomization error|0|||
128020380|NCT01734928|460698085|FG000|Randomization|Lost to Follow-up|1|||
127773513|NCT00504881|459797203|FG001|Overall Study|AE of unknown type|0|||
127773514|NCT00803270|459797205|FG000|Overall Study|Lost to Follow-up|1|||
127773515|NCT00803270|459797206|FG001|Overall Study|Lost to Follow-up|2|||
127773516|NCT00593957|459797210|FG000|Overall Study|Physician Decision|0|||
128020381|NCT01734928|460698086|FG001|Randomization|Lost to Follow-up|0|||
128020382|NCT01734928|460698085|FG000|Treatment Period|Lost to Follow-up|0|||
128020383|NCT01734928|460698086|FG001|Treatment Period|Lost to Follow-up|2|||
128020384|NCT01734928|460698085|FG000|Treatment Period|Progressive Disease|167|||
128020385|NCT01734928|460698086|FG001|Treatment Period|Progressive Disease|165|||
128020386|NCT01734928|460698085|FG000|Treatment Period|Adverse Event|39|||
128020387|NCT01734928|460698086|FG001|Treatment Period|Adverse Event|52|||
128020388|NCT01734928|460698085|FG000|Treatment Period|Withdrawal of Consent|25|||
128020389|NCT01734928|460698086|FG001|Treatment Period|Withdrawal of Consent|22|||
128020390|NCT01734928|460698085|FG000|Treatment Period|Death|20|||
128020391|NCT01734928|460698086|FG001|Treatment Period|Death|9|||
127552395|NCT02963506|458988406|FG001|Double-Blind Period|Death|0|||
127552396|NCT02963506|458988407|FG002|Double-Blind Period|Death|0|||
127552397|NCT02963506|458988408|FG003|Double-Blind Period|Death|1|||
127552398|NCT02963506|458988409|FG004|Double-Blind Period|Death|0|||
127552399|NCT02963506|458988410|FG005|Double-Blind Period|Death|0|||
127552400|NCT02963506|458988411|FG006|Double-Blind Period|Death|0|||
127552401|NCT02963506|458988412|FG007|Double-Blind Period|Death|0|||
127552402|NCT02963506|458988413|FG008|Double-Blind Period|Death|0|||
127552403|NCT02963506|458988414|FG009|Double-Blind Period|Death|0|||
127552404|NCT02963506|458988415|FG010|Double-Blind Period|Death|0|||
127552405|NCT02963506|458988416|FG011|Double-Blind Period|Death|0|||
127552406|NCT02963506|458988417|FG012|Double-Blind Period|Death|0|||
127552407|NCT02963506|458988405|FG000|Double-Blind Period|Lost to Follow-up|0|||
127552408|NCT02963506|458988406|FG001|Double-Blind Period|Lost to Follow-up|1|||
127552409|NCT02963506|458988407|FG002|Double-Blind Period|Lost to Follow-up|0|||
127552410|NCT02963506|458988408|FG003|Double-Blind Period|Lost to Follow-up|0|||
127552411|NCT02963506|458988409|FG004|Double-Blind Period|Lost to Follow-up|0|||
127552412|NCT02963506|458988410|FG005|Double-Blind Period|Lost to Follow-up|0|||
127773517|NCT00593957|459797211|FG001|Overall Study|Physician Decision|1|||
127773518|NCT00593957|459797212|FG002|Overall Study|Physician Decision|2|||
127773519|NCT00494481|459797215|FG000|Overall Study|Condition under investigation worsened|11|||
127773520|NCT00494481|459797216|FG001|Overall Study|Condition under investigation worsened|13|||
127773521|NCT00494481|459797215|FG000|Overall Study|Adverse Event|15|||
127773522|NCT00494481|459797216|FG001|Overall Study|Adverse Event|11|||
127773523|NCT00494481|459797215|FG000|Overall Study|Other|1|||
127773524|NCT00494481|459797216|FG001|Overall Study|Other|0|||
127773525|NCT00494481|459797215|FG000|Overall Study|Never received IP|2|||
127773526|NCT00494481|459797216|FG001|Overall Study|Never received IP|0|||
127773527|NCT02973048|459797217|FG000|Overall Study|Epidural catheter insertion failure|1|||
127773528|NCT02973048|459797218|FG001|Overall Study|Epidural catheter insertion failure|0|||
127773529|NCT02973048|459797217|FG000|Overall Study|Withdrawal by Subject|0|||
127773530|NCT02973048|459797218|FG001|Overall Study|Withdrawal by Subject|3|||
127773531|NCT00332189|459797219|FG000|Overall Study|Adverse Event|3|||
127773532|NCT00332189|459797219|FG000|Overall Study|Uncooperative/Noncompliant|3|||
127773533|NCT00332189|459797219|FG000|Overall Study|Withdrawal by Subject|9|||
127773534|NCT00332189|459797219|FG000|Overall Study|Lack of Efficacy|4|||
127773535|NCT00332189|459797219|FG000|Overall Study|Moved out of country|2|||
127773536|NCT02279862|459797220|FG000|Overall Study|Study drug toxicity|3|||
127773537|NCT02279862|459797221|FG001|Overall Study|Study drug toxicity|6|||
127773538|NCT02279862|459797220|FG000|Overall Study|No longer meets criteria|0|||
127773539|NCT02279862|459797221|FG001|Overall Study|No longer meets criteria|1|||
127773540|NCT02279862|459797220|FG000|Overall Study|Administrative reason by sponsor|0|||
127552413|NCT02963506|458988411|FG006|Double-Blind Period|Lost to Follow-up|0|||
127552414|NCT02963506|458988412|FG007|Double-Blind Period|Lost to Follow-up|0|||
127552415|NCT02963506|458988413|FG008|Double-Blind Period|Lost to Follow-up|0|||
127552416|NCT02963506|458988414|FG009|Double-Blind Period|Lost to Follow-up|0|||
127552417|NCT02963506|458988415|FG010|Double-Blind Period|Lost to Follow-up|0|||
127773541|NCT02279862|459797221|FG001|Overall Study|Administrative reason by sponsor|1|||
127552418|NCT02963506|458988416|FG011|Double-Blind Period|Lost to Follow-up|0|||
127552419|NCT02963506|458988417|FG012|Double-Blind Period|Lost to Follow-up|0|||
127773542|NCT02279862|459797220|FG000|Overall Study|Disease progression|5|||
127773543|NCT02279862|459797221|FG001|Overall Study|Disease progression|2|||
127552420|NCT02963506|458988405|FG000|Double-Blind Period|Withdrawal by Subject|0|||
127552421|NCT02963506|458988406|FG001|Double-Blind Period|Withdrawal by Subject|0|||
127552422|NCT02963506|458988407|FG002|Double-Blind Period|Withdrawal by Subject|1|||
127552423|NCT02963506|458988408|FG003|Double-Blind Period|Withdrawal by Subject|1|||
127552424|NCT02963506|458988409|FG004|Double-Blind Period|Withdrawal by Subject|0|||
127552425|NCT02963506|458988410|FG005|Double-Blind Period|Withdrawal by Subject|0|||
127552426|NCT02963506|458988411|FG006|Double-Blind Period|Withdrawal by Subject|0|||
127552427|NCT02963506|458988412|FG007|Double-Blind Period|Withdrawal by Subject|0|||
127552428|NCT02963506|458988413|FG008|Double-Blind Period|Withdrawal by Subject|0|||
127552429|NCT02963506|458988414|FG009|Double-Blind Period|Withdrawal by Subject|0|||
127552430|NCT02963506|458988415|FG010|Double-Blind Period|Withdrawal by Subject|0|||
127552431|NCT02963506|458988416|FG011|Double-Blind Period|Withdrawal by Subject|0|||
127552432|NCT02963506|458988417|FG012|Double-Blind Period|Withdrawal by Subject|0|||
127552433|NCT02963506|458988405|FG000|Double-Blind Period|No compliance|0|||
127552434|NCT02963506|458988406|FG001|Double-Blind Period|No compliance|1|||
127552435|NCT02963506|458988407|FG002|Double-Blind Period|No compliance|0|||
127552436|NCT02963506|458988408|FG003|Double-Blind Period|No compliance|0|||
127552437|NCT02963506|458988409|FG004|Double-Blind Period|No compliance|0|||
127552438|NCT02963506|458988410|FG005|Double-Blind Period|No compliance|0|||
127552439|NCT02963506|458988411|FG006|Double-Blind Period|No compliance|0|||
127552440|NCT02963506|458988412|FG007|Double-Blind Period|No compliance|0|||
127552441|NCT02963506|458988413|FG008|Double-Blind Period|No compliance|0|||
127552442|NCT02963506|458988414|FG009|Double-Blind Period|No compliance|0|||
127552443|NCT02963506|458988415|FG010|Double-Blind Period|No compliance|0|||
127552444|NCT02963506|458988416|FG011|Double-Blind Period|No compliance|0|||
127552445|NCT02963506|458988417|FG012|Double-Blind Period|No compliance|0|||
127552446|NCT02963506|458988405|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
127552447|NCT02963506|458988406|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
127552448|NCT02963506|458988407|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
127552449|NCT02963506|458988408|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
127552450|NCT02963506|458988409|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
127552451|NCT02963506|458988410|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
127552452|NCT02963506|458988411|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
127552453|NCT02963506|458988412|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
127552454|NCT02963506|458988413|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
127552455|NCT02963506|458988414|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
127552456|NCT02963506|458988415|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
127552457|NCT02963506|458988416|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
127552458|NCT02963506|458988417|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
127552459|NCT02963506|458988405|FG000|Dose-Blind Period|Adverse Event|0|||
127552460|NCT02963506|458988406|FG001|Dose-Blind Period|Adverse Event|0|||
127552461|NCT02963506|458988407|FG002|Dose-Blind Period|Adverse Event|0|||
127552462|NCT02963506|458988408|FG003|Dose-Blind Period|Adverse Event|0|||
127552463|NCT02963506|458988409|FG004|Dose-Blind Period|Adverse Event|0|||
127552464|NCT02963506|458988410|FG005|Dose-Blind Period|Adverse Event|1|||
127552465|NCT02963506|458988411|FG006|Dose-Blind Period|Adverse Event|3|||
127552466|NCT02963506|458988412|FG007|Dose-Blind Period|Adverse Event|2|||
127552467|NCT02963506|458988413|FG008|Dose-Blind Period|Adverse Event|2|||
127552468|NCT02963506|458988414|FG009|Dose-Blind Period|Adverse Event|2|||
127552469|NCT02963506|458988415|FG010|Dose-Blind Period|Adverse Event|1|||
127552470|NCT02963506|458988416|FG011|Dose-Blind Period|Adverse Event|1|||
127773544|NCT02279862|459797220|FG000|Overall Study|Study closed by sponsor|16|||
127773545|NCT02279862|459797221|FG001|Overall Study|Study closed by sponsor|13|||
127773546|NCT02279862|459797220|FG000|Overall Study|Other|1|||
127773547|NCT02279862|459797221|FG001|Overall Study|Other|2|||
127773548|NCT02279862|459797220|FG000|Overall Study|Withdrawal by Subject|1|||
127773549|NCT02279862|459797221|FG001|Overall Study|Withdrawal by Subject|0|||
127773550|NCT03431857|459797224|FG000|Overall Study|Death|6|||
127773551|NCT03431857|459797224|FG000|Overall Study|Lost to Follow-up|41|||
128020392|NCT01734928|460698085|FG000|Treatment Period|Other Reasons|27|||
128020393|NCT01734928|460698086|FG001|Treatment Period|Other Reasons|19|||
128020394|NCT01734928|460698085|FG000|Treatment Period|Pregnancy|0|||
128020395|NCT01734928|460698086|FG001|Treatment Period|Pregnancy|1|||
128020396|NCT03600350|460698087|FG000|Overall Study|Death|1|||
128020397|NCT03600350|460698087|FG000|Overall Study|On Follow Up|18|||
128020398|NCT02323334|460698088|FG000|Period 3|Lost to Follow-up|0|||
127552471|NCT02963506|458988417|FG012|Dose-Blind Period|Adverse Event|6|||
127552472|NCT02963506|458988405|FG000|Dose-Blind Period|Lack of Efficacy|0|||
128020399|NCT02323334|460698089|FG001|Period 3|Lost to Follow-up|0|||
128020400|NCT02323334|460698090|FG002|Period 3|Lost to Follow-up|1|||
127552473|NCT02963506|458988406|FG001|Dose-Blind Period|Lack of Efficacy|0|||
127552474|NCT02963506|458988407|FG002|Dose-Blind Period|Lack of Efficacy|0|||
127552475|NCT02963506|458988408|FG003|Dose-Blind Period|Lack of Efficacy|0|||
127552476|NCT02963506|458988409|FG004|Dose-Blind Period|Lack of Efficacy|0|||
127552477|NCT02963506|458988410|FG005|Dose-Blind Period|Lack of Efficacy|0|||
127552478|NCT02963506|458988411|FG006|Dose-Blind Period|Lack of Efficacy|0|||
127773552|NCT03431857|459797224|FG000|Overall Study|Adverse Event|6|||
128020401|NCT02323334|460698091|FG003|Period 3|Lost to Follow-up|0|||
128020402|NCT02323334|460698092|FG004|Period 3|Lost to Follow-up|0|||
128020403|NCT02323334|460698093|FG005|Period 3|Lost to Follow-up|0|||
127773553|NCT03431857|459797224|FG000|Overall Study|Withdrawal by Subject|1|||
127773554|NCT01163721|459797226|FG000|Overall Study|Adverse Event|5|||
127773555|NCT01163721|459797227|FG001|Overall Study|Adverse Event|6|||
127773556|NCT01163721|459797226|FG000|Overall Study|Withdrawal by Subject|3|||
127773557|NCT01163721|459797227|FG001|Overall Study|Withdrawal by Subject|4|||
127773558|NCT01163721|459797226|FG000|Overall Study|Lost to Follow-up|0|||
127773559|NCT01163721|459797227|FG001|Overall Study|Lost to Follow-up|1|||
127773560|NCT01163721|459797226|FG000|Overall Study|Physician Decision|0|||
127773561|NCT01163721|459797227|FG001|Overall Study|Physician Decision|1|||
127773562|NCT02511678|459797230|FG000|Overall Study|Withdrawal by Subject|2|||
128020404|NCT02323334|460698094|FG006|Period 3|Lost to Follow-up|0|||
128020405|NCT02323334|460698095|FG007|Period 3|Lost to Follow-up|0|||
128020406|NCT02323334|460698096|FG008|Period 3|Lost to Follow-up|0|||
128020407|NCT02323334|460698097|FG009|Period 3|Lost to Follow-up|0|||
128020408|NCT02323334|460698098|FG010|Period 3|Lost to Follow-up|0|||
128020409|NCT02323334|460698099|FG011|Period 3|Lost to Follow-up|0|||
128020410|NCT02323334|460698100|FG012|Period 3|Lost to Follow-up|0|||
128020411|NCT02323334|460698101|FG013|Period 3|Lost to Follow-up|0|||
128020412|NCT02323334|460698102|FG014|Period 3|Lost to Follow-up|0|||
128020413|NCT02323334|460698103|FG015|Period 3|Lost to Follow-up|0|||
128020414|NCT02323334|460698104|FG016|Period 3|Lost to Follow-up|0|||
128020415|NCT02323334|460698088|FG000|Period 3|Withdrawal by Subject|1|||
128020416|NCT02323334|460698089|FG001|Period 3|Withdrawal by Subject|0|||
128020417|NCT02323334|460698090|FG002|Period 3|Withdrawal by Subject|0|||
128020418|NCT02323334|460698091|FG003|Period 3|Withdrawal by Subject|0|||
128020419|NCT02323334|460698092|FG004|Period 3|Withdrawal by Subject|0|||
128020420|NCT02323334|460698093|FG005|Period 3|Withdrawal by Subject|0|||
128020421|NCT02323334|460698094|FG006|Period 3|Withdrawal by Subject|0|||
128020422|NCT02323334|460698095|FG007|Period 3|Withdrawal by Subject|0|||
128020423|NCT02323334|460698096|FG008|Period 3|Withdrawal by Subject|0|||
128020424|NCT02323334|460698097|FG009|Period 3|Withdrawal by Subject|0|||
128020425|NCT02323334|460698098|FG010|Period 3|Withdrawal by Subject|0|||
128020426|NCT02323334|460698099|FG011|Period 3|Withdrawal by Subject|0|||
128020427|NCT02323334|460698100|FG012|Period 3|Withdrawal by Subject|0|||
128020428|NCT02323334|460698101|FG013|Period 3|Withdrawal by Subject|0|||
128020429|NCT02323334|460698102|FG014|Period 3|Withdrawal by Subject|0|||
128020430|NCT02323334|460698103|FG015|Period 3|Withdrawal by Subject|0|||
128020431|NCT02323334|460698104|FG016|Period 3|Withdrawal by Subject|0|||
128020432|NCT00552058|460698105|FG000|Overall Study|Adverse Event|8|||
128020433|NCT00552058|460698106|FG001|Overall Study|Adverse Event|7|||
128020434|NCT00552058|460698105|FG000|Overall Study|Lack of Efficacy|1|||
128020435|NCT00552058|460698106|FG001|Overall Study|Lack of Efficacy|5|||
128020436|NCT00552058|460698105|FG000|Overall Study|Lost to Follow-up|1|||
128020437|NCT00552058|460698106|FG001|Overall Study|Lost to Follow-up|0|||
128020438|NCT00552058|460698105|FG000|Overall Study|Withdrawal by Subject|4|||
128020439|NCT00552058|460698106|FG001|Overall Study|Withdrawal by Subject|4|||
128020440|NCT00552058|460698105|FG000|Overall Study|Other: Protocol Violation|0|||
128020441|NCT00552058|460698106|FG001|Overall Study|Other: Protocol Violation|1|||
128020442|NCT00552058|460698105|FG000|Overall Study|Other: Non Compliance|1|||
128020443|NCT00552058|460698106|FG001|Overall Study|Other: Non Compliance|2|||
128020444|NCT00552058|460698105|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
128020445|NCT00552058|460698106|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
128020446|NCT00552058|460698105|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
128020447|NCT00552058|460698106|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
128020448|NCT00552058|460698105|FG000|Overall Study|Other: Positive Stool Result|0|||
128020449|NCT00552058|460698106|FG001|Overall Study|Other: Positive Stool Result|1|||
128020450|NCT00552058|460698105|FG000|Overall Study|Other: Randomized in error|0|||
128020451|NCT00552058|460698106|FG001|Overall Study|Other: Randomized in error|1|||
128020452|NCT00552058|460698105|FG000|Overall Study|Other: Sponsors Decision|0|||
128020453|NCT00552058|460698106|FG001|Overall Study|Other: Sponsors Decision|1|||
128020454|NCT00552058|460698105|FG000|Overall Study|Other: Early Roll Over|1|||
128020455|NCT00552058|460698106|FG001|Overall Study|Other: Early Roll Over|0|||
128020456|NCT03520569|460698107|FG000|Overall Study|Withdrawal by Subject|1|||
128020457|NCT03418675|460698110|FG000|Overall Study|Lost to Follow-up|13|||
127773563|NCT02511678|459797230|FG000|Overall Study|Lost to Follow-up|4|||
127773564|NCT02511678|459797230|FG000|Overall Study|Death|19|||
127773565|NCT02511678|459797230|FG000|Overall Study|Adverse Event|1|||
128020458|NCT03418675|460698111|FG001|Overall Study|Lost to Follow-up|10|||
128020459|NCT03418675|460698110|FG000|Overall Study|Adverse Event|2|||
128020460|NCT03418675|460698111|FG001|Overall Study|Adverse Event|0|||
128020461|NCT03422718|460698112|FG000|12 Month Interventional Trial Period|Lost to Follow-up|26|||
128020462|NCT03422718|460698113|FG001|12 Month Interventional Trial Period|Lost to Follow-up|16|||
128020463|NCT03422718|460698114|FG002|12 Month Interventional Trial Period|Lost to Follow-up|23|||
128020464|NCT03422718|460698115|FG003|12 Month Interventional Trial Period|Lost to Follow-up|27|||
128020465|NCT03422718|460698116|FG004|12 Month Interventional Trial Period|Lost to Follow-up|21|||
128020466|NCT03422718|460698117|FG005|12 Month Interventional Trial Period|Lost to Follow-up|22|||
128020467|NCT03422718|460698118|FG006|12 Month Interventional Trial Period|Lost to Follow-up|36|||
127552479|NCT02963506|458988412|FG007|Dose-Blind Period|Lack of Efficacy|1|||
127552480|NCT02963506|458988413|FG008|Dose-Blind Period|Lack of Efficacy|0|||
127552481|NCT02963506|458988414|FG009|Dose-Blind Period|Lack of Efficacy|1|||
127552482|NCT02963506|458988415|FG010|Dose-Blind Period|Lack of Efficacy|0|||
127552483|NCT02963506|458988416|FG011|Dose-Blind Period|Lack of Efficacy|0|||
127552484|NCT02963506|458988417|FG012|Dose-Blind Period|Lack of Efficacy|0|||
127552485|NCT02963506|458988405|FG000|Dose-Blind Period|Lost to Follow-up|0|||
127552486|NCT02963506|458988406|FG001|Dose-Blind Period|Lost to Follow-up|0|||
127552487|NCT02963506|458988407|FG002|Dose-Blind Period|Lost to Follow-up|0|||
127552488|NCT02963506|458988408|FG003|Dose-Blind Period|Lost to Follow-up|0|||
127552489|NCT02963506|458988409|FG004|Dose-Blind Period|Lost to Follow-up|0|||
127552490|NCT02963506|458988410|FG005|Dose-Blind Period|Lost to Follow-up|1|||
127552491|NCT02963506|458988411|FG006|Dose-Blind Period|Lost to Follow-up|0|||
127552492|NCT02963506|458988412|FG007|Dose-Blind Period|Lost to Follow-up|0|||
127552493|NCT02963506|458988413|FG008|Dose-Blind Period|Lost to Follow-up|1|||
127552494|NCT02963506|458988414|FG009|Dose-Blind Period|Lost to Follow-up|0|||
127552495|NCT02963506|458988415|FG010|Dose-Blind Period|Lost to Follow-up|0|||
127552496|NCT02963506|458988416|FG011|Dose-Blind Period|Lost to Follow-up|1|||
127552497|NCT02963506|458988417|FG012|Dose-Blind Period|Lost to Follow-up|0|||
127552498|NCT02963506|458988405|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
127552499|NCT02963506|458988406|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
127552500|NCT02963506|458988407|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
127552501|NCT02963506|458988408|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
127552502|NCT02963506|458988409|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
127552503|NCT02963506|458988410|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
127552504|NCT02963506|458988411|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
127552505|NCT02963506|458988412|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
127552506|NCT02963506|458988413|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
127552507|NCT02963506|458988414|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
127552508|NCT02963506|458988415|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
127552509|NCT02963506|458988416|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
127552510|NCT02963506|458988417|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
127552511|NCT02963506|458988405|FG000|Dose-Blind Period|Sponsor decision|0|||
127552512|NCT02963506|458988406|FG001|Dose-Blind Period|Sponsor decision|0|||
127552513|NCT02963506|458988407|FG002|Dose-Blind Period|Sponsor decision|0|||
127552514|NCT02963506|458988408|FG003|Dose-Blind Period|Sponsor decision|0|||
127552515|NCT02963506|458988409|FG004|Dose-Blind Period|Sponsor decision|0|||
127552516|NCT02963506|458988410|FG005|Dose-Blind Period|Sponsor decision|1|||
127552517|NCT02963506|458988411|FG006|Dose-Blind Period|Sponsor decision|0|||
127552518|NCT02963506|458988412|FG007|Dose-Blind Period|Sponsor decision|0|||
127552519|NCT02963506|458988413|FG008|Dose-Blind Period|Sponsor decision|0|||
127552520|NCT02963506|458988414|FG009|Dose-Blind Period|Sponsor decision|0|||
127552521|NCT02963506|458988415|FG010|Dose-Blind Period|Sponsor decision|0|||
127552522|NCT02963506|458988416|FG011|Dose-Blind Period|Sponsor decision|0|||
127552523|NCT02963506|458988417|FG012|Dose-Blind Period|Sponsor decision|0|||
127552524|NCT02963506|458988405|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
127552525|NCT02963506|458988406|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
127552526|NCT02963506|458988407|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
127552527|NCT02963506|458988408|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
127552528|NCT02963506|458988409|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
127552529|NCT02963506|458988410|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
127552530|NCT02963506|458988411|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
127552531|NCT02963506|458988412|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
127552532|NCT02963506|458988413|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
127552533|NCT02963506|458988414|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
127552534|NCT02963506|458988415|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
127552535|NCT02963506|458988416|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
127552536|NCT02963506|458988417|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
127552537|NCT00828204|458988420|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
127552538|NCT00828204|458988421|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
127552539|NCT00828204|458988420|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
127552540|NCT00828204|458988421|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
127552541|NCT00828204|458988420|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
127552542|NCT00828204|458988421|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
127552543|NCT00828204|458988420|FG000|Main Study: After Study Restart|Adverse Event|0|||
127552544|NCT00828204|458988421|FG001|Main Study: After Study Restart|Adverse Event|2|||
127552545|NCT00828204|458988420|FG000|Main Study: After Study Restart|Noncompliance|0|||
127552546|NCT00828204|458988421|FG001|Main Study: After Study Restart|Noncompliance|1|||
127552547|NCT00828204|458988420|FG000|Extension Study|Lost to Follow-up|0|||
127552548|NCT00828204|458988421|FG001|Extension Study|Lost to Follow-up|1|||
127552549|NCT00828204|458988420|FG000|Extension Study|Physician Decision|0|||
127552550|NCT00828204|458988421|FG001|Extension Study|Physician Decision|2|||
127685662|NCT05094141|459474888|FG000|Overall Study|Did not participate in randomization|0|||
128020468|NCT03422718|460698119|FG007|12 Month Interventional Trial Period|Lost to Follow-up|25|||
128020469|NCT03422718|460698112|FG000|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
128020470|NCT03422718|460698113|FG001|12 Month Interventional Trial Period|Withdrawal by Subject|13|||
128020471|NCT03422718|460698114|FG002|12 Month Interventional Trial Period|Withdrawal by Subject|15|||
128020472|NCT03422718|460698115|FG003|12 Month Interventional Trial Period|Withdrawal by Subject|12|||
128020473|NCT03422718|460698116|FG004|12 Month Interventional Trial Period|Withdrawal by Subject|7|||
128020474|NCT03422718|460698117|FG005|12 Month Interventional Trial Period|Withdrawal by Subject|8|||
128020475|NCT03422718|460698118|FG006|12 Month Interventional Trial Period|Withdrawal by Subject|4|||
128020476|NCT03422718|460698119|FG007|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
128020477|NCT03422718|460698112|FG000|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|8|||
128020478|NCT03422718|460698113|FG001|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|11|||
128020479|NCT03422718|460698114|FG002|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|16|||
128020480|NCT03422718|460698115|FG003|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
128020481|NCT03422718|460698116|FG004|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|17|||
128020482|NCT03422718|460698117|FG005|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
128020483|NCT03422718|460698118|FG006|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
128020484|NCT03422718|460698119|FG007|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|10|||
128020485|NCT03422718|460698112|FG000|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
128020486|NCT03422718|460698113|FG001|Optional Six Month Follow-Up Period|Withdrawal by Subject|3|||
128020487|NCT03422718|460698114|FG002|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
128020488|NCT03422718|460698115|FG003|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
128020489|NCT03422718|460698116|FG004|Optional Six Month Follow-Up Period|Withdrawal by Subject|1|||
128020490|NCT03422718|460698117|FG005|Optional Six Month Follow-Up Period|Withdrawal by Subject|2|||
128020491|NCT03422718|460698118|FG006|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
128020492|NCT03422718|460698119|FG007|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
128020493|NCT03422718|460698112|FG000|Optional Six Month Follow-Up Period|ineligible|8|||
128020494|NCT03422718|460698113|FG001|Optional Six Month Follow-Up Period|ineligible|5|||
128020495|NCT03422718|460698114|FG002|Optional Six Month Follow-Up Period|ineligible|2|||
128020496|NCT03422718|460698115|FG003|Optional Six Month Follow-Up Period|ineligible|2|||
128020497|NCT03422718|460698116|FG004|Optional Six Month Follow-Up Period|ineligible|1|||
128020498|NCT03422718|460698117|FG005|Optional Six Month Follow-Up Period|ineligible|5|||
128020499|NCT03422718|460698118|FG006|Optional Six Month Follow-Up Period|ineligible|2|||
128020500|NCT03422718|460698119|FG007|Optional Six Month Follow-Up Period|ineligible|4|||
128020501|NCT03422718|460698112|FG000|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
128020502|NCT03422718|460698113|FG001|Optional Six Month Follow-Up Period|Lost to Follow-up|11|||
128020503|NCT03422718|460698114|FG002|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
128020504|NCT03422718|460698115|FG003|Optional Six Month Follow-Up Period|Lost to Follow-up|4|||
128020505|NCT03422718|460698116|FG004|Optional Six Month Follow-Up Period|Lost to Follow-up|9|||
128020506|NCT03422718|460698117|FG005|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
128020507|NCT03422718|460698118|FG006|Optional Six Month Follow-Up Period|Lost to Follow-up|3|||
128020508|NCT03422718|460698119|FG007|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
128020509|NCT01178411|460698120|FG000|Overall Study|Adverse Event|5|||
128020510|NCT01178411|460698120|FG000|Overall Study|Withdrawal by Subject|4|||
128020511|NCT01178411|460698120|FG000|Overall Study|Protocol Violation|1|||
128020512|NCT01178411|460698120|FG000|Overall Study|Progressive disease per RECIST|32|||
128020513|NCT01178411|460698120|FG000|Overall Study|Progressive disease per clinician|9|||
128020514|NCT01178411|460698120|FG000|Overall Study|Physician Decision|6|||
128020515|NCT01178411|460698120|FG000|Overall Study|Death|1|||
128020516|NCT01178411|460698120|FG000|Overall Study|No reason provided|1|||
128020517|NCT01178411|460698120|FG000|Overall Study|Drug manufacturing ended|1|||
128020518|NCT01129284|460698121|FG000|Overall Study|Adverse Event|2|||
128020519|NCT01129284|460698122|FG001|Overall Study|Adverse Event|0|||
128020520|NCT01129284|460698123|FG002|Overall Study|Adverse Event|1|||
128020521|NCT00845182|460698131|FG000|Overall Study|Lost to Follow-up|3|||
127685663|NCT05094141|459474889|FG001|Overall Study|Did not participate in randomization|0|||
127881004|NCT02756078|460186097|FG000|Period 1|Lens Discomfort|2|||
128020522|NCT00845182|460698132|FG001|Overall Study|Lost to Follow-up|3|||
128020523|NCT00845182|460698133|FG002|Overall Study|Lost to Follow-up|4|||
128020524|NCT00845182|460698131|FG000|Overall Study|Adverse Event|0|||
128020525|NCT00845182|460698132|FG001|Overall Study|Adverse Event|1|||
127552551|NCT00750438|458988424|FG000|Overall Study|Protocol Violation|4|||
127552552|NCT00750438|458988425|FG001|Overall Study|Protocol Violation|1|||
127552553|NCT00750438|458988424|FG000|Overall Study|Physician Decision|2|||
127552554|NCT00750438|458988425|FG001|Overall Study|Physician Decision|2|||
127552555|NCT00750438|458988424|FG000|Overall Study|Withdrawal by Subject|1|||
127552556|NCT00750438|458988425|FG001|Overall Study|Withdrawal by Subject|1|||
127552557|NCT00354432|458988428|FG000|Overall Study|Adverse Event|3|||
127552558|NCT00354432|458988429|FG001|Overall Study|Adverse Event|1|||
127552559|NCT00354432|458988430|FG002|Overall Study|Adverse Event|5|||
127552560|NCT00354432|458988431|FG003|Overall Study|Adverse Event|5|||
127552561|NCT00354432|458988428|FG000|Overall Study|Off/Toxicity|3|||
127552562|NCT00354432|458988429|FG001|Overall Study|Off/Toxicity|7|||
127552563|NCT00354432|458988430|FG002|Overall Study|Off/Toxicity|5|||
127552564|NCT00354432|458988431|FG003|Overall Study|Off/Toxicity|5|||
127552565|NCT02736578|458988432|FG000|Overall Study|Adverse Event|1|||
127552566|NCT02736578|458988433|FG001|Overall Study|Adverse Event|0|||
127552567|NCT02827877|458988434|FG000|Overall Study|Withdrawal by Subject|1|||
127552568|NCT04163016|458988435|FG000|Enrollment|Adverse Event|1|||
127552569|NCT04163016|458988436|FG001|Enrollment|Adverse Event|0|||
127552570|NCT04163016|458988437|FG002|Enrollment|Adverse Event|0|||
127552571|NCT04163016|458988438|FG003|Enrollment|Adverse Event|0|||
127552572|NCT04163016|458988435|FG000|Treatment|Adverse Event|0|||
127552573|NCT04163016|458988436|FG001|Treatment|Adverse Event|1|||
127552574|NCT04163016|458988437|FG002|Treatment|Adverse Event|0|||
127552575|NCT04163016|458988438|FG003|Treatment|Adverse Event|0|||
127552576|NCT04163016|458988435|FG000|Treatment|Withdrawal by Subject|0|||
127552577|NCT04163016|458988436|FG001|Treatment|Withdrawal by Subject|2|||
127552578|NCT04163016|458988437|FG002|Treatment|Withdrawal by Subject|0|||
127552579|NCT04163016|458988438|FG003|Treatment|Withdrawal by Subject|0|||
127552580|NCT04163016|458988435|FG000|Treatment|Indeterminate TB-test|0|||
127552581|NCT04163016|458988436|FG001|Treatment|Indeterminate TB-test|0|||
127552582|NCT04163016|458988437|FG002|Treatment|Indeterminate TB-test|0|||
127552583|NCT04163016|458988438|FG003|Treatment|Indeterminate TB-test|1|||
127552584|NCT04163016|458988435|FG000|Treatment|Participant did not want to continue in study|0|||
127552585|NCT04163016|458988436|FG001|Treatment|Participant did not want to continue in study|0|||
127552586|NCT04163016|458988437|FG002|Treatment|Participant did not want to continue in study|0|||
127552587|NCT04163016|458988438|FG003|Treatment|Participant did not want to continue in study|1|||
127552588|NCT01590888|458990029|FG000|Overall Study|Adverse Event|3|||
127552589|NCT01590888|458990030|FG001|Overall Study|Adverse Event|0|||
127552590|NCT01590888|458990031|FG002|Overall Study|Adverse Event|1|||
127552591|NCT01590888|458990029|FG000|Overall Study|Lost to Follow-up|1|||
127552592|NCT01590888|458990030|FG001|Overall Study|Lost to Follow-up|0|||
127552593|NCT01590888|458990031|FG002|Overall Study|Lost to Follow-up|0|||
127552594|NCT00145158|458990037|FG000|Overall Study|premature withdrawal|2|||
127552595|NCT00145158|458990038|FG001|Overall Study|premature withdrawal|3|||
127552596|NCT01705509|458990042|FG000|Inclusion CPET|Screen Failure|5|||
127552597|NCT01705509|458990042|FG000|Inclusion CPET|Withdrawal by Subject|2|||
127552598|NCT01705509|458990042|FG000|CPET w/ Ranexa|Screen Failure|2|||
127552599|NCT01227018|458990043|FG000|Overall Study|Disease progression|9|||
127552600|NCT01227018|458990043|FG000|Overall Study|Toxicity|2|||
127552601|NCT01227018|458990043|FG000|Overall Study|Withdrew after beginning treatment|4|||
127552602|NCT00753649|458990044|FG000|Overall Study|Migrated/moved from study area|1|||
127552603|NCT00753649|458990045|FG001|Overall Study|Migrated/moved from study area|0|||
127552604|NCT00753649|458990044|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
127552605|NCT00753649|458990045|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
127552606|NCT00753649|458990044|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
127552607|NCT00753649|458990045|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
127552608|NCT00753649|458990044|FG000|Overall Study|Protocol Violation|2|||
127552609|NCT00753649|458990045|FG001|Overall Study|Protocol Violation|0|||
127552610|NCT00499616|458990046|FG000|Overall Study|Death|1|||
127552611|NCT00499616|458990047|FG001|Overall Study|Death|5|||
127552612|NCT00499616|458990048|FG002|Overall Study|Death|3|||
127552613|NCT00499616|458990049|FG003|Overall Study|Death|1|||
128020526|NCT00845182|460698133|FG002|Overall Study|Adverse Event|1|||
128020527|NCT00845182|460698131|FG000|Overall Study|Physician Decision|0|||
128020528|NCT00845182|460698132|FG001|Overall Study|Physician Decision|0|||
127552614|NCT00499616|458990046|FG000|Overall Study|Lack of Efficacy|5|||
127552615|NCT00499616|458990047|FG001|Overall Study|Lack of Efficacy|0|||
128020529|NCT00845182|460698133|FG002|Overall Study|Physician Decision|1|||
127552616|NCT00499616|458990048|FG002|Overall Study|Lack of Efficacy|19|||
127552617|NCT00499616|458990049|FG003|Overall Study|Lack of Efficacy|0|||
127552618|NCT00499616|458990046|FG000|Overall Study|Lost to Follow-up|0|||
127552619|NCT00499616|458990047|FG001|Overall Study|Lost to Follow-up|0|||
127552620|NCT00499616|458990048|FG002|Overall Study|Lost to Follow-up|1|||
127552621|NCT00499616|458990049|FG003|Overall Study|Lost to Follow-up|0|||
127552622|NCT00499616|458990046|FG000|Overall Study|Physician Decision|6|||
127552623|NCT00499616|458990047|FG001|Overall Study|Physician Decision|16|||
127552624|NCT00499616|458990048|FG002|Overall Study|Physician Decision|9|||
128020530|NCT01625182|460698134|FG000|Overall Study|Administrative problems|1|||
127552625|NCT00499616|458990049|FG003|Overall Study|Physician Decision|0|||
127552626|NCT00499616|458990046|FG000|Overall Study|Withdrawal by Subject|1|||
127552627|NCT00499616|458990047|FG001|Overall Study|Withdrawal by Subject|0|||
127552628|NCT00499616|458990048|FG002|Overall Study|Withdrawal by Subject|1|||
127552629|NCT00499616|458990049|FG003|Overall Study|Withdrawal by Subject|0|||
127552630|NCT00499616|458990046|FG000|Overall Study|Ineligible|1|||
127552631|NCT00499616|458990047|FG001|Overall Study|Ineligible|2|||
127552632|NCT00499616|458990048|FG002|Overall Study|Ineligible|0|||
127552633|NCT00499616|458990049|FG003|Overall Study|Ineligible|15|||
127552634|NCT00499616|458990046|FG000|Overall Study|Not evaluable|0|||
127552635|NCT00499616|458990047|FG001|Overall Study|Not evaluable|0|||
127552636|NCT00499616|458990048|FG002|Overall Study|Not evaluable|0|||
127552637|NCT00499616|458990049|FG003|Overall Study|Not evaluable|41|||
127552638|NCT00499616|458990046|FG000|Overall Study|Patient/Parent Refusal|1|||
127552639|NCT00499616|458990047|FG001|Overall Study|Patient/Parent Refusal|5|||
127552640|NCT00499616|458990048|FG002|Overall Study|Patient/Parent Refusal|3|||
127552641|NCT00499616|458990049|FG003|Overall Study|Patient/Parent Refusal|0|||
127552642|NCT01938716|458990054|FG000|Overall Study|Physician Decision|2|||
127552643|NCT01938716|458990054|FG000|Overall Study|Withdrawal by Subject|2|||
127552644|NCT00372593|458990055|FG000|Overall Study|Adverse Event|43|||
127552645|NCT00372593|458990056|FG001|Overall Study|Adverse Event|45|||
127552646|NCT00372593|458990057|FG002|Overall Study|Adverse Event|0|||
127552647|NCT00372593|458990055|FG000|Overall Study|Death|16|||
127552648|NCT00372593|458990056|FG001|Overall Study|Death|20|||
127552649|NCT00372593|458990057|FG002|Overall Study|Death|1|||
127552650|NCT00372593|458990055|FG000|Overall Study|Lack of Efficacy|82|||
127552651|NCT00372593|458990056|FG001|Overall Study|Lack of Efficacy|71|||
128020531|NCT01625182|460698135|FG001|Overall Study|Administrative problems|0|||
128020532|NCT01625182|460698134|FG000|Overall Study|Protocol deviation|0|||
128020533|NCT01625182|460698135|FG001|Overall Study|Protocol deviation|2|||
128020534|NCT01625182|460698134|FG000|Overall Study|Adverse Event|2|||
128020535|NCT01625182|460698135|FG001|Overall Study|Adverse Event|0|||
128020536|NCT01625182|460698134|FG000|Overall Study|Withdrawal by Subject|5|||
128020537|NCT01625182|460698135|FG001|Overall Study|Withdrawal by Subject|1|||
128020538|NCT01625182|460698134|FG000|Overall Study|Lack of Efficacy|12|||
128020539|NCT01625182|460698135|FG001|Overall Study|Lack of Efficacy|8|||
128020540|NCT00447278|460698138|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
128020541|NCT00447278|460698139|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
128020542|NCT00447278|460698138|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
128020543|NCT00447278|460698139|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
128020544|NCT00447278|460698138|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
128020545|NCT00447278|460698139|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
128020546|NCT00447278|460698138|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
128020547|NCT00447278|460698139|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
128020548|NCT00447278|460698138|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
128020549|NCT00447278|460698139|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
128020550|NCT00447278|460698138|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
128020551|NCT00447278|460698139|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
128020552|NCT00447278|460698138|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
128020553|NCT00447278|460698139|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
128020554|NCT00447278|460698138|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
128020555|NCT00447278|460698139|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
128020556|NCT00447278|460698138|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
128020557|NCT00447278|460698139|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
128020558|NCT00447278|460698138|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
128020559|NCT00447278|460698139|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
128020560|NCT00447278|460698138|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
128020561|NCT00447278|460698139|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
128020562|NCT00447278|460698138|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
127552652|NCT00372593|458990057|FG002|Overall Study|Lack of Efficacy|2|||
127552653|NCT00372593|458990055|FG000|Overall Study|Lost to Follow-up|1|||
127552654|NCT00372593|458990056|FG001|Overall Study|Lost to Follow-up|0|||
127552655|NCT00372593|458990057|FG002|Overall Study|Lost to Follow-up|0|||
127552656|NCT00372593|458990055|FG000|Overall Study|Physician Decision|42|||
127552657|NCT00372593|458990056|FG001|Overall Study|Physician Decision|41|||
127773566|NCT02511678|459797230|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
127773567|NCT02511678|459797230|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
127552658|NCT00372593|458990057|FG002|Overall Study|Physician Decision|0|||
127552659|NCT00372593|458990055|FG000|Overall Study|Ineligible|20|||
127552660|NCT00372593|458990056|FG001|Overall Study|Ineligible|21|||
127773568|NCT02511678|459797230|FG000|Overall Study|Required Radiofrequency Ablation|1|||
127773569|NCT02511678|459797230|FG000|Overall Study|Biopsy was Negative|1|||
128020563|NCT00447278|460698139|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
128020564|NCT00447278|460698138|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
127552661|NCT00372593|458990057|FG002|Overall Study|Ineligible|1|||
127552662|NCT00433004|458990058|FG000|Overall Study|Lost to Follow-up|5|||
127552663|NCT00433004|458990059|FG001|Overall Study|Lost to Follow-up|7|||
127552664|NCT03534180|458990060|FG000|Overall Study|Withdrawal by Subject|1|||
127552665|NCT00330967|458990061|FG000|Overall Study|Withdrawal by Subject|0|||
127552666|NCT00330967|458990062|FG001|Overall Study|Withdrawal by Subject|5|||
127552667|NCT00330967|458990061|FG000|Overall Study|Physician Decision|0|||
127552668|NCT00330967|458990062|FG001|Overall Study|Physician Decision|9|||
127552669|NCT02578706|458990068|FG000|Overall Study|Withdrawal by Subject|1|||
127552670|NCT02578706|458990069|FG001|Overall Study|Withdrawal by Subject|0|||
127552671|NCT02578706|458990070|FG002|Overall Study|Withdrawal by Subject|0|||
127552672|NCT02578706|458990068|FG000|Overall Study|Lost to Follow-up|0|||
127552673|NCT02578706|458990069|FG001|Overall Study|Lost to Follow-up|4|||
127552674|NCT02578706|458990070|FG002|Overall Study|Lost to Follow-up|0|||
127552675|NCT02578706|458990068|FG000|Overall Study|Physician Decision|0|||
127552676|NCT02578706|458990069|FG001|Overall Study|Physician Decision|1|||
127773570|NCT02511678|459797230|FG000|Overall Study|Protocol Violation|1|||
127552677|NCT02578706|458990070|FG002|Overall Study|Physician Decision|0|||
127552678|NCT02015637|458990074|FG000|Overall Study|Lost to Follow-up|3|||
127552679|NCT02015637|458990075|FG001|Overall Study|Lost to Follow-up|5|||
127552680|NCT02015637|458990074|FG000|Overall Study|Adverse Event|3|||
127552681|NCT02015637|458990075|FG001|Overall Study|Adverse Event|0|||
127552682|NCT02015637|458990074|FG000|Overall Study|Did not take study drug|2|||
127552683|NCT02015637|458990075|FG001|Overall Study|Did not take study drug|0|||
127552684|NCT02223858|458990078|FG000|Overall Study|Death|1|||
127552685|NCT02223858|458990079|FG001|Overall Study|Death|1|||
127552686|NCT02223858|458990078|FG000|Overall Study|Lost to Follow-up|6|||
127552687|NCT02223858|458990079|FG001|Overall Study|Lost to Follow-up|11|||
127552688|NCT02223858|458990078|FG000|Overall Study|Withdrawal by Subject|8|||
127552689|NCT02223858|458990079|FG001|Overall Study|Withdrawal by Subject|5|||
127552690|NCT02223858|458990078|FG000|Overall Study|Refused|9|||
127552691|NCT02223858|458990079|FG001|Overall Study|Refused|9|||
127552692|NCT04455815|458990082|FG000|Randomisation Phase|Adverse Event|1|||
127552693|NCT04455815|458990083|FG001|Randomisation Phase|Adverse Event|0|||
127552694|NCT04455815|458990082|FG000|Treatment Phase|Adverse Event|0|||
127552695|NCT04455815|458990083|FG001|Treatment Phase|Adverse Event|1|||
127552696|NCT04455815|458990082|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
127552697|NCT04455815|458990083|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
127552698|NCT04455815|458990082|FG000|Treatment Phase|Withdrawal by Subject|1|||
127552699|NCT04455815|458990083|FG001|Treatment Phase|Withdrawal by Subject|1|||
127552700|NCT02106390|458990084|FG000|Overall Study|Withdrawal by Subject|15|||
127552701|NCT02106390|458990085|FG001|Overall Study|Withdrawal by Subject|16|||
127552702|NCT02106390|458990086|FG002|Overall Study|Withdrawal by Subject|15|||
127552703|NCT02106390|458990084|FG000|Overall Study|Lost to Follow-up|25|||
127552704|NCT02106390|458990085|FG001|Overall Study|Lost to Follow-up|20|||
127552705|NCT02106390|458990086|FG002|Overall Study|Lost to Follow-up|13|||
127552706|NCT02106390|458990084|FG000|Overall Study|Other: Administrative Reason|8|||
127552707|NCT02106390|458990085|FG001|Overall Study|Other: Administrative Reason|5|||
127552708|NCT02106390|458990086|FG002|Overall Study|Other: Administrative Reason|12|||
127552709|NCT02106390|458990084|FG000|Overall Study|Other: Unspecified|1|||
127552710|NCT02106390|458990085|FG001|Overall Study|Other: Unspecified|4|||
127552711|NCT02106390|458990086|FG002|Overall Study|Other: Unspecified|2|||
127552712|NCT02106390|458990084|FG000|Overall Study|Adverse Event|0|||
127552713|NCT02106390|458990085|FG001|Overall Study|Adverse Event|2|||
127552714|NCT02106390|458990086|FG002|Overall Study|Adverse Event|1|||
127552715|NCT02106390|458990084|FG000|Overall Study|Protocol Violation|0|||
127552716|NCT02106390|458990085|FG001|Overall Study|Protocol Violation|1|||
127552717|NCT02106390|458990086|FG002|Overall Study|Protocol Violation|0|||
127552718|NCT03198507|458990087|FG000|Overall Study|Withdrawal by Subject|1|||
127552719|NCT03198507|458990088|FG001|Overall Study|Withdrawal by Subject|0|||
127552720|NCT00241839|458990091|FG000|Overall Study|Withdrawal by Subject|18|||
127552721|NCT00241839|458990092|FG001|Overall Study|Withdrawal by Subject|17|||
127773571|NCT02511678|459797230|FG000|Overall Study|Received Radiation Treatment|1|||
127773572|NCT01295281|459797231|FG000|First Intervention (7 Days)|Death|0|||
127773573|NCT01295281|459797232|FG001|First Intervention (7 Days)|Death|1|||
127773574|NCT01411839|459797234|FG000|Overall Study|Lost to Follow-up|4|||
127773575|NCT01411839|459797235|FG001|Overall Study|Lost to Follow-up|3|||
127773576|NCT05461794|459797238|FG000|Overall Study|Withdrawal by Subject|1|||
127773577|NCT05461794|459797239|FG001|Overall Study|Withdrawal by Subject|1|||
127773578|NCT05461794|459797240|FG002|Overall Study|Withdrawal by Subject|3|||
127773579|NCT05461794|459797238|FG000|Overall Study|Study Terminated By Sponsor|18|||
127773580|NCT05461794|459797239|FG001|Overall Study|Study Terminated By Sponsor|13|||
127773581|NCT05461794|459797240|FG002|Overall Study|Study Terminated By Sponsor|16|||
127773582|NCT05461794|459797238|FG000|Overall Study|Death|20|||
128020565|NCT00447278|460698139|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
128020566|NCT00447278|460698138|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
128020567|NCT00447278|460698139|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
128020568|NCT01348698|460698140|FG000|Overall Study|Does not meet lesion size criteria|1|||
127552722|NCT00241839|458990091|FG000|Overall Study|Adverse Event|1|||
127552723|NCT00241839|458990092|FG001|Overall Study|Adverse Event|1|||
127552724|NCT02863419|458990095|FG000|Overall Study|Lost to Follow-up|0|||
127552725|NCT02863419|458990096|FG001|Overall Study|Lost to Follow-up|1|||
127552726|NCT02863419|458990097|FG002|Overall Study|Lost to Follow-up|4|||
127552727|NCT02863419|458990095|FG000|Overall Study|Withdrawal by Subject|5|||
127773583|NCT05461794|459797239|FG001|Overall Study|Death|5|||
128020569|NCT01348698|460698140|FG000|Overall Study|Death|3|||
127552728|NCT02863419|458990096|FG001|Overall Study|Withdrawal by Subject|5|||
127773584|NCT05461794|459797240|FG002|Overall Study|Death|19|||
128020570|NCT01348698|460698140|FG000|Overall Study|PI decision to close study|68|||
127552729|NCT02863419|458990097|FG002|Overall Study|Withdrawal by Subject|3|||
127552730|NCT02863419|458990095|FG000|Overall Study|Died|3|||
127773585|NCT00467285|459797241|FG000|Overall Study|Lost to Follow-up|4|||
127881005|NCT02756078|460186098|FG001|Period 1|Lens Discomfort|2|||
127552731|NCT02863419|458990096|FG001|Overall Study|Died|4|||
128020571|NCT02595749|460698141|FG000|Overall Study|Withdrawal by Subject|12|||
128020572|NCT02595749|460698142|FG001|Overall Study|Withdrawal by Subject|7|||
128020573|NCT00263562|460698143|FG000|Overall Study|Protocol Violation|3|||
128020574|NCT00263562|460698144|FG001|Overall Study|Protocol Violation|0|||
128020575|NCT05427916|460698150|FG000|Overall Study|Adverse Event|3|||
128020576|NCT05427916|460698151|FG001|Overall Study|Adverse Event|0|||
128020577|NCT05427916|460698150|FG000|Overall Study|Lack of Efficacy|6|||
128020578|NCT05427916|460698151|FG001|Overall Study|Lack of Efficacy|0|||
128020579|NCT05427916|460698150|FG000|Overall Study|Active arm terminated; trial was ended.|3|||
128020580|NCT05427916|460698151|FG001|Overall Study|Active arm terminated; trial was ended.|8|||
128020581|NCT05558410|460698152|FG000|Overall Study|Adverse Event|1|||
128020582|NCT05558410|460698153|FG001|Overall Study|Adverse Event|2|||
128020583|NCT05558410|460698154|FG002|Overall Study|Adverse Event|0|||
128020584|NCT05558410|460698152|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
128020585|NCT05558410|460698153|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
128020586|NCT05558410|460698154|FG002|Overall Study|Withdrawal of consent (not due to AE)|2|||
128020587|NCT05558410|460698152|FG000|Overall Study|Lost to Follow-up|10|||
127773586|NCT00467285|459797242|FG001|Overall Study|Lost to Follow-up|4|||
127773587|NCT01853982|459797243|FG000|Overall Study|Withdrawal by Subject|1|||
127773588|NCT01853982|459797244|FG001|Overall Study|Withdrawal by Subject|0|||
127773589|NCT01853982|459797243|FG000|Overall Study|Death|1|||
127552732|NCT02863419|458990097|FG002|Overall Study|Died|1|||
127552733|NCT00060840|458990102|FG000|Overall Study|Change in surgical plan|2|||
127552734|NCT00060840|458990103|FG001|Overall Study|Change in surgical plan|6|||
127552735|NCT00060840|458990102|FG000|Overall Study|Death|0|||
127552736|NCT00060840|458990103|FG001|Overall Study|Death|1|||
127552737|NCT00060840|458990102|FG000|Overall Study|Withdrawal by Subject|0|||
127552738|NCT00060840|458990103|FG001|Overall Study|Withdrawal by Subject|1|||
127552739|NCT00060840|458990102|FG000|Overall Study|Subinvestigator unavailable|0|||
127552740|NCT00060840|458990103|FG001|Overall Study|Subinvestigator unavailable|1|||
127552741|NCT00060840|458990102|FG000|Overall Study|Physician Decision|1|||
127552742|NCT00060840|458990103|FG001|Overall Study|Physician Decision|0|||
127552743|NCT00060840|458990102|FG000|Overall Study|Other|1|||
127552744|NCT00060840|458990103|FG001|Overall Study|Other|0|||
127552745|NCT02284243|458990104|FG000|Overall Study|Lack of Efficacy|3|||
127552746|NCT02284243|458990105|FG001|Overall Study|Lack of Efficacy|3|||
127552747|NCT02284243|458990104|FG000|Overall Study|Adverse Event|1|||
127552748|NCT02284243|458990105|FG001|Overall Study|Adverse Event|0|||
127552749|NCT00541385|458990108|FG000|Overall Study|Adverse Event|6|||
127552750|NCT00541385|458990109|FG001|Overall Study|Adverse Event|3|||
127552751|NCT00541385|458990108|FG000|Overall Study|Withdrawal by Subject|2|||
127552752|NCT00541385|458990109|FG001|Overall Study|Withdrawal by Subject|2|||
127552753|NCT00541385|458990108|FG000|Overall Study|Lost to Follow-up|6|||
127552754|NCT00541385|458990109|FG001|Overall Study|Lost to Follow-up|1|||
127552755|NCT00541385|458990108|FG000|Overall Study|Parasite reappearance/malaria|67|||
127552756|NCT00541385|458990109|FG001|Overall Study|Parasite reappearance/malaria|32|||
127552757|NCT04139798|458990110|FG000|Overall Study|Withdrawal by Subject|6|||
127552758|NCT04139798|458990111|FG001|Overall Study|Withdrawal by Subject|5|||
127552759|NCT04139798|458990110|FG000|Overall Study|Lost to Follow-up|2|||
127552760|NCT04139798|458990111|FG001|Overall Study|Lost to Follow-up|5|||
127552761|NCT04139798|458990110|FG000|Overall Study|Discontinued|4|||
127552762|NCT04139798|458990111|FG001|Overall Study|Discontinued|2|||
127552763|NCT04139798|458990110|FG000|Overall Study|Adverse Event|1|||
127552764|NCT04139798|458990111|FG001|Overall Study|Adverse Event|3|||
127552765|NCT04139798|458990110|FG000|Overall Study|Protocol Violation|1|||
127552766|NCT04139798|458990111|FG001|Overall Study|Protocol Violation|0|||
127552767|NCT04269889|458990112|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|14|||
127552768|NCT04308291|458990117|FG000|Run-In Phase|Withdrawal by Subject|4|||
127552769|NCT04308291|458990117|FG000|Study Phase 6-M|Withdrawal by Subject|13|||
127552770|NCT04308291|458990117|FG000|Study Phase 6-M|Physician Decision|2|||
127552771|NCT04308291|458990117|FG000|Study Phase 6-M|Carelink uploading issues (Linux user)|1|||
127552772|NCT04308291|458990117|FG000|Study Phase 12-M|Withdrawal by Subject|11|||
127552773|NCT04308291|458990117|FG000|Study Phase 12-M|Physician Decision|2|||
127552774|NCT04308291|458990117|FG000|Study Phase 12-M|Hospitalization for cause not related to the study (Pancytopenia)|1|||
127552775|NCT01499355|458990118|FG000|Run-In Period|Study Termination|15|||
127552776|NCT01499355|458990119|FG001|Run-In Period|Study Termination|0|||
127552777|NCT01499355|458990120|FG002|Run-In Period|Study Termination|0|||
127552778|NCT01499355|458990121|FG003|Run-In Period|Study Termination|0|||
127552779|NCT01499355|458990118|FG000|Run-In Period|Other|3|||
127552780|NCT01499355|458990119|FG001|Run-In Period|Other|0|||
127552781|NCT01499355|458990120|FG002|Run-In Period|Other|0|||
127552782|NCT01499355|458990121|FG003|Run-In Period|Other|0|||
127552783|NCT01499355|458990118|FG000|Run-In Period|Death|2|||
127552784|NCT01499355|458990119|FG001|Run-In Period|Death|0|||
127552785|NCT01499355|458990120|FG002|Run-In Period|Death|0|||
127552786|NCT01499355|458990121|FG003|Run-In Period|Death|0|||
127773590|NCT01853982|459797244|FG001|Overall Study|Death|0|||
127773591|NCT01853982|459797243|FG000|Overall Study|Lost to Follow-up|0|||
128020588|NCT05558410|460698153|FG001|Overall Study|Lost to Follow-up|17|||
128020589|NCT05558410|460698154|FG002|Overall Study|Lost to Follow-up|19|||
127552787|NCT01499355|458990118|FG000|Run-In Period|Investigator Decision|2|||
127552788|NCT01499355|458990119|FG001|Run-In Period|Investigator Decision|0|||
127552789|NCT01499355|458990120|FG002|Run-In Period|Investigator Decision|0|||
127552790|NCT01499355|458990121|FG003|Run-In Period|Investigator Decision|0|||
127552791|NCT01499355|458990118|FG000|Run-In Period|Consent Withdrawn|1|||
127552792|NCT01499355|458990119|FG001|Run-In Period|Consent Withdrawn|0|||
127552793|NCT01499355|458990120|FG002|Run-In Period|Consent Withdrawn|0|||
127552794|NCT01499355|458990121|FG003|Run-In Period|Consent Withdrawn|0|||
127552795|NCT01499355|458990118|FG000|Run-In Period|Adverse Event|8|||
127552796|NCT01499355|458990119|FG001|Run-In Period|Adverse Event|0|||
127552797|NCT01499355|458990120|FG002|Run-In Period|Adverse Event|0|||
127552798|NCT01499355|458990121|FG003|Run-In Period|Adverse Event|0|||
127773592|NCT01853982|459797244|FG001|Overall Study|Lost to Follow-up|1|||
127552799|NCT01499355|458990118|FG000|Double-Blind Period|Adverse Event|0|||
127773593|NCT05066724|459797250|FG000|Overall Study|Adverse Event|1|||
127773594|NCT05066724|459797250|FG000|Overall Study|Non-Compliance With Study Drug|5|||
127552800|NCT01499355|458990119|FG001|Double-Blind Period|Adverse Event|2|||
127552801|NCT01499355|458990120|FG002|Double-Blind Period|Adverse Event|3|||
127552802|NCT01499355|458990121|FG003|Double-Blind Period|Adverse Event|2|||
127552803|NCT01499355|458990118|FG000|Double-Blind Period|Study Termination|0|||
127552804|NCT01499355|458990119|FG001|Double-Blind Period|Study Termination|18|||
127552805|NCT01499355|458990120|FG002|Double-Blind Period|Study Termination|16|||
127552806|NCT01499355|458990121|FG003|Double-Blind Period|Study Termination|14|||
127552807|NCT01499355|458990118|FG000|Double-Blind Period|Other|0|||
127552808|NCT01499355|458990119|FG001|Double-Blind Period|Other|1|||
127552809|NCT01499355|458990120|FG002|Double-Blind Period|Other|2|||
127552810|NCT01499355|458990121|FG003|Double-Blind Period|Other|2|||
127552811|NCT01499355|458990118|FG000|Double-Blind Period|Death|0|||
127552812|NCT01499355|458990119|FG001|Double-Blind Period|Death|1|||
127552813|NCT01499355|458990120|FG002|Double-Blind Period|Death|0|||
127552814|NCT01499355|458990121|FG003|Double-Blind Period|Death|0|||
127552815|NCT01499355|458990118|FG000|Double-Blind Period|Investigator Decision|0|||
127552816|NCT01499355|458990119|FG001|Double-Blind Period|Investigator Decision|0|||
127552817|NCT01499355|458990120|FG002|Double-Blind Period|Investigator Decision|3|||
127552818|NCT01499355|458990121|FG003|Double-Blind Period|Investigator Decision|3|||
127552819|NCT01499355|458990118|FG000|Double-Blind Period|Consent Withdrawn|0|||
127552820|NCT01499355|458990119|FG001|Double-Blind Period|Consent Withdrawn|0|||
127552821|NCT01499355|458990120|FG002|Double-Blind Period|Consent Withdrawn|1|||
127552822|NCT01499355|458990121|FG003|Double-Blind Period|Consent Withdrawn|2|||
127552823|NCT01499355|458990118|FG000|Double-Blind Period|Lost to Follow-up|0|||
127552824|NCT01499355|458990119|FG001|Double-Blind Period|Lost to Follow-up|1|||
127552825|NCT01499355|458990120|FG002|Double-Blind Period|Lost to Follow-up|0|||
127552826|NCT01499355|458990121|FG003|Double-Blind Period|Lost to Follow-up|0|||
127552827|NCT01526733|458990122|FG000|Phase 1|Protocol Violation|1|||
127552828|NCT01526733|458990123|FG001|Phase 1|Protocol Violation|0|||
127552829|NCT01526733|458990122|FG000|Phase 1|Withdrawal by Subject|1|||
127552830|NCT01526733|458990123|FG001|Phase 1|Withdrawal by Subject|1|||
127552831|NCT02699749|458990129|FG000|Overall Study|Other|0|||
127552832|NCT02699749|458990130|FG001|Overall Study|Other|0|||
127552833|NCT02699749|458990131|FG002|Overall Study|Other|2|||
127552834|NCT02699749|458990132|FG003|Overall Study|Other|0|||
127552835|NCT02699749|458990133|FG004|Overall Study|Other|0|||
127552836|NCT02699749|458990134|FG005|Overall Study|Other|1|||
127552837|NCT02699749|458990135|FG006|Overall Study|Other|1|||
127552838|NCT02699749|458990136|FG007|Overall Study|Other|0|||
127552839|NCT02699749|458990137|FG008|Overall Study|Other|0|||
127552840|NCT02699749|458990138|FG009|Overall Study|Other|0|||
127552841|NCT02699749|458990139|FG010|Overall Study|Other|1|||
127552842|NCT02699749|458990140|FG011|Overall Study|Other|0|||
127552843|NCT02699749|458990141|FG012|Overall Study|Other|0|||
127552844|NCT02699749|458990142|FG013|Overall Study|Other|0|||
127552845|NCT02699749|458990129|FG000|Overall Study|Progressive Disease|3|||
127552846|NCT02699749|458990130|FG001|Overall Study|Progressive Disease|3|||
127552847|NCT02699749|458990131|FG002|Overall Study|Progressive Disease|14|||
127552848|NCT02699749|458990132|FG003|Overall Study|Progressive Disease|3|||
127552849|NCT02699749|458990133|FG004|Overall Study|Progressive Disease|3|||
127552850|NCT02699749|458990134|FG005|Overall Study|Progressive Disease|7|||
127552851|NCT02699749|458990135|FG006|Overall Study|Progressive Disease|5|||
127552852|NCT02699749|458990136|FG007|Overall Study|Progressive Disease|5|||
127552853|NCT02699749|458990137|FG008|Overall Study|Progressive Disease|6|||
127552854|NCT02699749|458990138|FG009|Overall Study|Progressive Disease|6|||
127552855|NCT02699749|458990139|FG010|Overall Study|Progressive Disease|5|||
127552856|NCT02699749|458990140|FG011|Overall Study|Progressive Disease|4|||
127552857|NCT02699749|458990141|FG012|Overall Study|Progressive Disease|3|||
127552858|NCT02699749|458990142|FG013|Overall Study|Progressive Disease|5|||
127552859|NCT02699749|458990129|FG000|Overall Study|Death|0|||
127552860|NCT02699749|458990130|FG001|Overall Study|Death|0|||
127552861|NCT02699749|458990131|FG002|Overall Study|Death|0|||
127552862|NCT02699749|458990132|FG003|Overall Study|Death|0|||
127552863|NCT02699749|458990133|FG004|Overall Study|Death|0|||
127552864|NCT02699749|458990134|FG005|Overall Study|Death|0|||
127552865|NCT02699749|458990135|FG006|Overall Study|Death|0|||
127552866|NCT02699749|458990136|FG007|Overall Study|Death|0|||
127552867|NCT02699749|458990137|FG008|Overall Study|Death|0|||
127552868|NCT02699749|458990138|FG009|Overall Study|Death|0|||
127552869|NCT02699749|458990139|FG010|Overall Study|Death|0|||
127552870|NCT02699749|458990140|FG011|Overall Study|Death|0|||
127552871|NCT02699749|458990141|FG012|Overall Study|Death|0|||
127552872|NCT02699749|458990142|FG013|Overall Study|Death|1|||
127552873|NCT02699749|458990129|FG000|Overall Study|Lost to Follow-up|0|||
127552874|NCT02699749|458990130|FG001|Overall Study|Lost to Follow-up|0|||
127552875|NCT02699749|458990131|FG002|Overall Study|Lost to Follow-up|0|||
127552876|NCT02699749|458990132|FG003|Overall Study|Lost to Follow-up|0|||
127552877|NCT02699749|458990133|FG004|Overall Study|Lost to Follow-up|0|||
127552878|NCT02699749|458990134|FG005|Overall Study|Lost to Follow-up|1|||
127552879|NCT02699749|458990135|FG006|Overall Study|Lost to Follow-up|0|||
127552880|NCT02699749|458990136|FG007|Overall Study|Lost to Follow-up|1|||
127552881|NCT02699749|458990137|FG008|Overall Study|Lost to Follow-up|0|||
127552882|NCT02699749|458990138|FG009|Overall Study|Lost to Follow-up|0|||
127552883|NCT02699749|458990139|FG010|Overall Study|Lost to Follow-up|0|||
127552884|NCT02699749|458990140|FG011|Overall Study|Lost to Follow-up|0|||
127552885|NCT02699749|458990141|FG012|Overall Study|Lost to Follow-up|0|||
127552886|NCT02699749|458990142|FG013|Overall Study|Lost to Follow-up|0|||
127552887|NCT01599637|458990143|FG000|Overall Study|administrative problems|0|||
127552888|NCT01599637|458990144|FG001|Overall Study|administrative problems|2|||
127552889|NCT01599637|458990145|FG002|Overall Study|administrative problems|0|||
127552890|NCT01599637|458990143|FG000|Overall Study|Adverse Event|1|||
127552891|NCT01599637|458990144|FG001|Overall Study|Adverse Event|0|||
127552892|NCT01599637|458990145|FG002|Overall Study|Adverse Event|0|||
127552893|NCT02565108|458990146|FG000|Overall Study|Adverse Event|1|||
127552894|NCT02565108|458990147|FG001|Overall Study|Adverse Event|0|||
127552895|NCT02565108|458990146|FG000|Overall Study|Withdrew Consent|1|||
127552896|NCT02565108|458990147|FG001|Overall Study|Withdrew Consent|0|||
127552897|NCT01310075|458990148|FG000|Overall Study|Lost to Follow-up|1|||
127552898|NCT01310075|458990149|FG001|Overall Study|Lost to Follow-up|0|||
127552899|NCT01310075|458990148|FG000|Overall Study|Physician Decision|10|||
127552900|NCT01310075|458990149|FG001|Overall Study|Physician Decision|7|||
127552901|NCT01310075|458990148|FG000|Overall Study|Protocol Violation|2|||
127552902|NCT01310075|458990149|FG001|Overall Study|Protocol Violation|2|||
127552903|NCT01310075|458990148|FG000|Overall Study|Withdrawal by Subject|1|||
128020590|NCT05558410|460698152|FG000|Overall Study|Death|1|||
128020591|NCT05558410|460698153|FG001|Overall Study|Death|0|||
128020592|NCT05558410|460698154|FG002|Overall Study|Death|0|||
128020593|NCT05558410|460698152|FG000|Overall Study|Other non-compliance|0|||
128020594|NCT05558410|460698153|FG001|Overall Study|Other non-compliance|1|||
128020595|NCT05558410|460698154|FG002|Overall Study|Other non-compliance|2|||
128020596|NCT05558410|460698152|FG000|Overall Study|Sponsor Decision|1|||
128020597|NCT05558410|460698153|FG001|Overall Study|Sponsor Decision|0|||
128020598|NCT05558410|460698154|FG002|Overall Study|Sponsor Decision|0|||
128020599|NCT05558410|460698152|FG000|Overall Study|Other|1|||
128020600|NCT05558410|460698153|FG001|Overall Study|Other|0|||
128020601|NCT05558410|460698154|FG002|Overall Study|Other|1|||
128020602|NCT00933166|460698159|FG000|Overall Study|Lost to Follow-up|4|||
128020603|NCT00933166|460698159|FG000|Overall Study|Lack of Efficacy|9|||
128020604|NCT00933166|460698159|FG000|Overall Study|Unavailable|4|||
128020605|NCT00933166|460698159|FG000|Overall Study|Withdrawal by Subject|1|||
128020606|NCT03501277|460698165|FG000|Intervention Period 1 (4 Days)|Other|0|||
128020607|NCT03501277|460698166|FG001|Intervention Period 1 (4 Days)|Other|0|||
128020608|NCT03501277|460698167|FG002|Intervention Period 1 (4 Days)|Other|1|||
128020609|NCT03501277|460698168|FG003|Intervention Period 1 (4 Days)|Other|0|||
128020610|NCT03501277|460698165|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
127552904|NCT01310075|458990149|FG001|Overall Study|Withdrawal by Subject|1|||
127552905|NCT02395081|458990150|FG000|Overall Study|Withdrawal by Subject|1|||
127552906|NCT02395081|458990151|FG001|Overall Study|Withdrawal by Subject|1|||
127552907|NCT02395081|458990152|FG002|Overall Study|Withdrawal by Subject|0|||
128020611|NCT03501277|460698166|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
128020612|NCT03501277|460698167|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
128020613|NCT03501277|460698168|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
128020614|NCT03501277|460698165|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
128020615|NCT03501277|460698166|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
127552908|NCT02395081|458990150|FG000|Overall Study|Moved where blood couldn't be collected|4|||
127552909|NCT02395081|458990151|FG001|Overall Study|Moved where blood couldn't be collected|1|||
127552910|NCT02395081|458990152|FG002|Overall Study|Moved where blood couldn't be collected|3|||
127552911|NCT02395081|458990150|FG000|Overall Study|Fetal Loss|2|||
127552912|NCT02395081|458990151|FG001|Overall Study|Fetal Loss|3|||
127552913|NCT02395081|458990152|FG002|Overall Study|Fetal Loss|1|||
127552914|NCT02991040|458990153|FG000|Overall Study|Withdrawal by Subject|2|||
127552915|NCT02991040|458990153|FG000|Overall Study|Lost to Follow-up|2|||
127552916|NCT01869764|458990154|FG000|Overall Study|Withdrawal by Subject|0|||
127552917|NCT01869764|458990155|FG001|Overall Study|Withdrawal by Subject|2|||
127552918|NCT01286480|458990156|FG000|Overall Study|Withdrawal by Subject|5|||
127552919|NCT01286480|458990157|FG001|Overall Study|Withdrawal by Subject|3|||
127552920|NCT01626872|458990158|FG000|Overall Study|Physician Decision|13|||
127552921|NCT01626872|458990159|FG001|Overall Study|Physician Decision|9|||
127552922|NCT01626872|458990160|FG002|Overall Study|Physician Decision|6|||
127552923|NCT01626872|458990158|FG000|Overall Study|Withdrawal by Subject|19|||
127552924|NCT01626872|458990159|FG001|Overall Study|Withdrawal by Subject|27|||
127552925|NCT01626872|458990160|FG002|Overall Study|Withdrawal by Subject|8|||
127552926|NCT01626872|458990158|FG000|Overall Study|Adverse Event (including Death)|20|||
127552927|NCT01626872|458990159|FG001|Overall Study|Adverse Event (including Death)|28|||
127552928|NCT01626872|458990160|FG002|Overall Study|Adverse Event (including Death)|8|||
127552929|NCT01626872|458990158|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
127552930|NCT01626872|458990159|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
127552931|NCT01626872|458990160|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
127552932|NCT00960999|458990161|FG000|Overall Study|Withdrawal by Subject|1|||
127552933|NCT00960999|458990162|FG001|Overall Study|Withdrawal by Subject|0|||
127552934|NCT00960999|458990161|FG000|Overall Study|Protocol Violation|5|||
127552935|NCT00960999|458990162|FG001|Overall Study|Protocol Violation|2|||
127552936|NCT00960999|458990161|FG000|Overall Study|RT dose constraints not met|2|||
127552937|NCT00960999|458990162|FG001|Overall Study|RT dose constraints not met|0|||
127552938|NCT01696188|458990163|FG000|Overall Study|Protocol Violation|1|||
127552939|NCT01696188|458990164|FG001|Overall Study|Protocol Violation|1|||
127552940|NCT00928408|458990167|FG000|Overall Study|Other|2|||
127552941|NCT00928408|458990167|FG000|Overall Study|Withdrawal by Subject|4|||
127552942|NCT00928408|458990167|FG000|Overall Study|Death|5|||
127552943|NCT00928408|458990167|FG000|Overall Study|Lost to Follow-up|12|||
127552944|NCT00787644|458990168|FG000|Overall Study|Lost to Follow-up|1|||
127552945|NCT00787644|458990169|FG001|Overall Study|Lost to Follow-up|1|||
127552946|NCT00787644|458990168|FG000|Overall Study|Withdrawal by Subject|1|||
127552947|NCT00787644|458990169|FG001|Overall Study|Withdrawal by Subject|1|||
127552948|NCT00536744|458990170|FG000|Overall Study|Adverse Event|13|||
127552949|NCT00536744|458990171|FG001|Overall Study|Adverse Event|10|||
127552950|NCT00536744|458990170|FG000|Overall Study|Death|2|||
127552951|NCT00536744|458990171|FG001|Overall Study|Death|1|||
127552952|NCT00536744|458990170|FG000|Overall Study|Physician Decision|3|||
127552953|NCT00536744|458990171|FG001|Overall Study|Physician Decision|1|||
127552954|NCT00536744|458990170|FG000|Overall Study|Lost to Follow-up|3|||
127552955|NCT00536744|458990171|FG001|Overall Study|Lost to Follow-up|5|||
127552956|NCT00536744|458990170|FG000|Overall Study|Withdrawal by Subject|7|||
127552957|NCT00536744|458990171|FG001|Overall Study|Withdrawal by Subject|8|||
127552958|NCT00536744|458990170|FG000|Overall Study|PI tried alternative treatment|1|||
127552959|NCT00536744|458990171|FG001|Overall Study|PI tried alternative treatment|3|||
127552960|NCT01642589|458990175|FG000|Overall Study|Withdrawal by Subject|1|||
127552961|NCT01642589|458990176|FG001|Overall Study|Withdrawal by Subject|1|||
127552962|NCT02908672|458990181|FG000|Run-in Period|Death|12|||
127552963|NCT02908672|458990182|FG001|Run-in Period|Death|10|||
127552964|NCT02908672|458990183|FG002|Run-in Period|Death|0|||
127552965|NCT02908672|458990184|FG003|Run-in Period|Death|0|||
127552966|NCT02908672|458990181|FG000|Run-in Period|Lost to Follow-up|1|||
127552967|NCT02908672|458990182|FG001|Run-in Period|Lost to Follow-up|1|||
127773595|NCT05066724|459797250|FG000|Overall Study|Withdrawal by Subject|6|||
127773596|NCT05066724|459797250|FG000|Overall Study|Physician Decision|2|||
127773597|NCT00475033|459797253|FG000|Infant Series|Failed to return|3|||
128020616|NCT03501277|460698167|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
127552968|NCT02908672|458990183|FG002|Run-in Period|Lost to Follow-up|0|||
127773598|NCT00475033|459797254|FG001|Infant Series|Failed to return|4|||
127552969|NCT02908672|458990184|FG003|Run-in Period|Lost to Follow-up|0|||
127552970|NCT02908672|458990181|FG000|Run-in Period|Reason Not Specified|2|||
127552971|NCT02908672|458990182|FG001|Run-in Period|Reason Not Specified|0|||
127552972|NCT02908672|458990183|FG002|Run-in Period|Reason Not Specified|0|||
128020617|NCT03501277|460698168|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
127552973|NCT02908672|458990184|FG003|Run-in Period|Reason Not Specified|0|||
127552974|NCT02908672|458990181|FG000|Run-in Period|Protocol Violation|1|||
127552975|NCT02908672|458990182|FG001|Run-in Period|Protocol Violation|1|||
127552976|NCT02908672|458990183|FG002|Run-in Period|Protocol Violation|0|||
127552977|NCT02908672|458990184|FG003|Run-in Period|Protocol Violation|0|||
127773599|NCT00475033|459797253|FG000|Infant Series|Parent or legal guardian request|1|||
127552978|NCT02908672|458990181|FG000|Run-in Period|Study Ended by Sponsor|5|||
127552979|NCT02908672|458990182|FG001|Run-in Period|Study Ended by Sponsor|1|||
127552980|NCT02908672|458990183|FG002|Run-in Period|Study Ended by Sponsor|0|||
127552981|NCT02908672|458990184|FG003|Run-in Period|Study Ended by Sponsor|0|||
127552982|NCT02908672|458990181|FG000|Run-in Period|Withdrawal by Subject|3|||
127552983|NCT02908672|458990182|FG001|Run-in Period|Withdrawal by Subject|9|||
127552984|NCT02908672|458990183|FG002|Run-in Period|Withdrawal by Subject|0|||
127552985|NCT02908672|458990184|FG003|Run-in Period|Withdrawal by Subject|0|||
127552986|NCT02908672|458990181|FG000|Triple Combination Period|Death|0|||
127552987|NCT02908672|458990182|FG001|Triple Combination Period|Death|0|||
127552988|NCT02908672|458990183|FG002|Triple Combination Period|Death|150|||
127552989|NCT02908672|458990184|FG003|Triple Combination Period|Death|127|||
127552990|NCT02908672|458990181|FG000|Triple Combination Period|Lost to Follow-up|0|||
127552991|NCT02908672|458990182|FG001|Triple Combination Period|Lost to Follow-up|0|||
127552992|NCT02908672|458990183|FG002|Triple Combination Period|Lost to Follow-up|6|||
127552993|NCT02908672|458990184|FG003|Triple Combination Period|Lost to Follow-up|8|||
127552994|NCT02908672|458990181|FG000|Triple Combination Period|Reason Not Specified|0|||
127552995|NCT02908672|458990182|FG001|Triple Combination Period|Reason Not Specified|0|||
127552996|NCT02908672|458990183|FG002|Triple Combination Period|Reason Not Specified|0|||
127552997|NCT02908672|458990184|FG003|Triple Combination Period|Reason Not Specified|1|||
127552998|NCT02908672|458990181|FG000|Triple Combination Period|Physician Decision|0|||
127552999|NCT02908672|458990182|FG001|Triple Combination Period|Physician Decision|0|||
127553000|NCT02908672|458990183|FG002|Triple Combination Period|Physician Decision|1|||
127553001|NCT02908672|458990184|FG003|Triple Combination Period|Physician Decision|1|||
127553002|NCT02908672|458990181|FG000|Triple Combination Period|Study Ended by Sponsor|0|||
127553003|NCT02908672|458990182|FG001|Triple Combination Period|Study Ended by Sponsor|0|||
127553004|NCT02908672|458990183|FG002|Triple Combination Period|Study Ended by Sponsor|61|||
127553005|NCT02908672|458990184|FG003|Triple Combination Period|Study Ended by Sponsor|77|||
127553006|NCT02908672|458990181|FG000|Triple Combination Period|Withdrawal by Subject|0|||
127553007|NCT02908672|458990182|FG001|Triple Combination Period|Withdrawal by Subject|0|||
127553008|NCT02908672|458990183|FG002|Triple Combination Period|Withdrawal by Subject|13|||
127553009|NCT02908672|458990184|FG003|Triple Combination Period|Withdrawal by Subject|16|||
127553010|NCT00123422|458991648|FG000|Overall Study|Physician Decision|2|||
127553011|NCT00123422|458991649|FG001|Overall Study|Physician Decision|2|||
127553012|NCT00123422|458991650|FG002|Overall Study|Physician Decision|6|||
127553013|NCT00123422|458991648|FG000|Overall Study|Withdrawal by Subject|1|||
127553014|NCT00123422|458991649|FG001|Overall Study|Withdrawal by Subject|2|||
127553015|NCT00123422|458991650|FG002|Overall Study|Withdrawal by Subject|2|||
127553016|NCT00123422|458991648|FG000|Overall Study|Lost to Follow-up|1|||
127553017|NCT00123422|458991649|FG001|Overall Study|Lost to Follow-up|2|||
127553018|NCT00123422|458991650|FG002|Overall Study|Lost to Follow-up|2|||
127553019|NCT01255436|458991653|FG000|Overall Study|Lost to Follow-up|178|||
127553020|NCT01255436|458991654|FG001|Overall Study|Lost to Follow-up|191|||
127553021|NCT01255436|458991653|FG000|Overall Study|Death, stroke, or MI|4|||
127553022|NCT01255436|458991654|FG001|Overall Study|Death, stroke, or MI|3|||
127553023|NCT01358721|458991658|FG000|Overall Study|Withdrawal by Subject|0|||
127553024|NCT01358721|458991659|FG001|Overall Study|Withdrawal by Subject|0|||
127553025|NCT01358721|458991660|FG002|Overall Study|Withdrawal by Subject|0|||
127553026|NCT01358721|458991661|FG003|Overall Study|Withdrawal by Subject|1|||
127553027|NCT01358721|458991658|FG000|Overall Study|Death|0|||
127553028|NCT01358721|458991659|FG001|Overall Study|Death|2|||
127553029|NCT01358721|458991660|FG002|Overall Study|Death|0|||
127553030|NCT01358721|458991661|FG003|Overall Study|Death|0|||
127553031|NCT01358721|458991658|FG000|Overall Study|Study Drug Toxicity|1|||
127553032|NCT01358721|458991659|FG001|Overall Study|Study Drug Toxicity|3|||
127553033|NCT01358721|458991660|FG002|Overall Study|Study Drug Toxicity|4|||
127553034|NCT01358721|458991661|FG003|Overall Study|Study Drug Toxicity|5|||
127553035|NCT01358721|458991658|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
127553036|NCT01358721|458991659|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
127553037|NCT01358721|458991660|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
127553038|NCT01358721|458991661|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
127553039|NCT01358721|458991658|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
127553040|NCT01358721|458991659|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
127553041|NCT01358721|458991660|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
127553042|NCT01358721|458991661|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
127553043|NCT01358721|458991658|FG000|Overall Study|Adverse Event related to study drug|1|||
127553044|NCT01358721|458991659|FG001|Overall Study|Adverse Event related to study drug|0|||
127553045|NCT01358721|458991660|FG002|Overall Study|Adverse Event related to study drug|0|||
127553046|NCT01358721|458991661|FG003|Overall Study|Adverse Event related to study drug|1|||
127553047|NCT01358721|458991658|FG000|Overall Study|Disease Progression|19|||
127553048|NCT01358721|458991659|FG001|Overall Study|Disease Progression|15|||
127553049|NCT01358721|458991660|FG002|Overall Study|Disease Progression|17|||
127553050|NCT01358721|458991661|FG003|Overall Study|Disease Progression|15|||
127553051|NCT01358721|458991658|FG000|Overall Study|Out of State/Unmet Criteria|0|||
127553052|NCT01358721|458991659|FG001|Overall Study|Out of State/Unmet Criteria|0|||
127553053|NCT01358721|458991660|FG002|Overall Study|Out of State/Unmet Criteria|1|||
127553054|NCT01358721|458991661|FG003|Overall Study|Out of State/Unmet Criteria|0|||
127553055|NCT01908803|458991662|FG000|Overall Study|Adverse Event|1|||
127553056|NCT01908803|458991663|FG001|Overall Study|Adverse Event|0|||
127553057|NCT01908803|458991662|FG000|Overall Study|Physician Decision|0|||
127553058|NCT01908803|458991663|FG001|Overall Study|Physician Decision|1|||
127553059|NCT01908803|458991662|FG000|Overall Study|Withdrawal by Subject|1|||
127553060|NCT01908803|458991663|FG001|Overall Study|Withdrawal by Subject|0|||
127553061|NCT01908803|458991662|FG000|Overall Study|Randomization Error|1|||
127553062|NCT01908803|458991663|FG001|Overall Study|Randomization Error|0|||
127553063|NCT01908803|458991662|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
127553064|NCT01908803|458991663|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
127553065|NCT00867815|458991664|FG000|Overall Study|Lost to Follow-up|1|||
127553066|NCT01864603|458991665|FG000|Stage 2|DSMB design modification|86056|||
127553067|NCT01864603|458991666|FG001|Stage 2|DSMB design modification|92558|||
127553068|NCT00001213|458991667|FG000|Overall Study|Death|18|||
127553069|NCT01554241|458991669|FG000|Overall Study|Death|3|||
127553070|NCT01554241|458991670|FG001|Overall Study|Death|1|||
127553071|NCT01554241|458991671|FG002|Overall Study|Death|1|||
127553072|NCT01554241|458991672|FG003|Overall Study|Death|0|||
127553073|NCT01554241|458991669|FG000|Overall Study|protocol specified renal stone|0|||
127553074|NCT01554241|458991670|FG001|Overall Study|protocol specified renal stone|0|||
127553075|NCT01554241|458991671|FG002|Overall Study|protocol specified renal stone|0|||
127553076|NCT01554241|458991672|FG003|Overall Study|protocol specified renal stone|1|||
127553077|NCT01554241|458991669|FG000|Overall Study|protocol specified change in eGFR|0|||
127553078|NCT01554241|458991670|FG001|Overall Study|protocol specified change in eGFR|0|||
127553079|NCT01554241|458991671|FG002|Overall Study|protocol specified change in eGFR|1|||
127553080|NCT01554241|458991672|FG003|Overall Study|protocol specified change in eGFR|0|||
127553081|NCT01554241|458991669|FG000|Overall Study|Withdrawal by Subject|0|||
127553082|NCT01554241|458991670|FG001|Overall Study|Withdrawal by Subject|0|||
127553083|NCT01554241|458991671|FG002|Overall Study|Withdrawal by Subject|2|||
127553084|NCT01554241|458991672|FG003|Overall Study|Withdrawal by Subject|0|||
127553085|NCT00790088|458991679|FG000|Overall Study|Protocol Violation|11|||
127553086|NCT00790088|458991679|FG000|Overall Study|Withdrawal by Subject|17|||
127553087|NCT00790088|458991679|FG000|Overall Study|Lost to Follow-up|7|||
127553088|NCT00790088|458991679|FG000|Overall Study|Physician Decision|4|||
127553089|NCT05661409|458991680|FG000|Overall Study|Drug administered, but monitor disconnected|1|||
127553090|NCT05661409|458991681|FG001|Overall Study|Drug administered, but monitor disconnected|0|||
127553091|NCT05661409|458991682|FG002|Overall Study|Drug administered, but monitor disconnected|0|||
127553092|NCT05661409|458991683|FG003|Overall Study|Drug administered, but monitor disconnected|0|||
127553093|NCT05661409|458991684|FG004|Overall Study|Drug administered, but monitor disconnected|0|||
127553094|NCT05661409|458991685|FG005|Overall Study|Drug administered, but monitor disconnected|0|||
127553095|NCT05661409|458991680|FG000|Overall Study|No TOFR data; problem with the monitor|0|||
127553096|NCT05661409|458991681|FG001|Overall Study|No TOFR data; problem with the monitor|1|||
127553097|NCT05661409|458991682|FG002|Overall Study|No TOFR data; problem with the monitor|0|||
127553098|NCT05661409|458991683|FG003|Overall Study|No TOFR data; problem with the monitor|0|||
127553099|NCT05661409|458991684|FG004|Overall Study|No TOFR data; problem with the monitor|0|||
127553100|NCT05661409|458991685|FG005|Overall Study|No TOFR data; problem with the monitor|0|||
127553101|NCT05661409|458991680|FG000|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
127553102|NCT05661409|458991681|FG001|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
127553103|NCT05661409|458991682|FG002|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
127553104|NCT05661409|458991683|FG003|Overall Study|TOFR≥0.9 at time of drug admin.|1|||
127553105|NCT05661409|458991684|FG004|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
127553106|NCT05661409|458991685|FG005|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
127553107|NCT05661409|458991680|FG000|Overall Study|Lost TOFR data prior to time study drug given|0|||
127773600|NCT00475033|459797254|FG001|Infant Series|Parent or legal guardian request|5|||
127773601|NCT00475033|459797253|FG000|Infant Series|Protocol Violation|1|||
127773602|NCT00475033|459797254|FG001|Infant Series|Protocol Violation|2|||
127773603|NCT00475033|459797253|FG000|Infant Series|Lost to Follow-up|2|||
127773604|NCT00475033|459797254|FG001|Infant Series|Lost to Follow-up|0|||
127773605|NCT00475033|459797253|FG000|Infant Series|Adverse Event|0|||
127773606|NCT00475033|459797254|FG001|Infant Series|Adverse Event|2|||
127773607|NCT00475033|459797253|FG000|After the Infant Series|Adverse Event|0|||
127773608|NCT00475033|459797254|FG001|After the Infant Series|Adverse Event|4|||
127773609|NCT00475033|459797253|FG000|After the Infant Series|Parent or legal guardian request|2|||
127773610|NCT00475033|459797254|FG001|After the Infant Series|Parent or legal guardian request|2|||
127773611|NCT00475033|459797253|FG000|After the Infant Series|Failed to return|2|||
127553108|NCT05661409|458991681|FG001|Overall Study|Lost TOFR data prior to time study drug given|0|||
127553109|NCT05661409|458991682|FG002|Overall Study|Lost TOFR data prior to time study drug given|0|||
127553110|NCT05661409|458991683|FG003|Overall Study|Lost TOFR data prior to time study drug given|0|||
127553111|NCT05661409|458991684|FG004|Overall Study|Lost TOFR data prior to time study drug given|0|||
127553112|NCT05661409|458991685|FG005|Overall Study|Lost TOFR data prior to time study drug given|1|||
127553113|NCT05661409|458991680|FG000|Overall Study|Miscommu-nication about administration|0|||
127553114|NCT05661409|458991681|FG001|Overall Study|Miscommu-nication about administration|0|||
127553115|NCT05661409|458991682|FG002|Overall Study|Miscommu-nication about administration|0|||
127553116|NCT05661409|458991683|FG003|Overall Study|Miscommu-nication about administration|0|||
127553117|NCT05661409|458991684|FG004|Overall Study|Miscommu-nication about administration|0|||
127553118|NCT05661409|458991685|FG005|Overall Study|Miscommu-nication about administration|1|||
127553119|NCT04439136|458991686|FG000|Overall Study|Ineligible|1|||
127553120|NCT04439136|458991686|FG000|Overall Study|Never Started Treatment|2|||
127553121|NCT04439136|458991686|FG000|Overall Study|Adverse Event|4|||
127553122|NCT04439136|458991686|FG000|Overall Study|Death|3|||
127553123|NCT04439136|458991686|FG000|Overall Study|Disease Progression|27|||
127553124|NCT04439136|458991686|FG000|Overall Study|Alternative Therapy|1|||
127553125|NCT04439136|458991686|FG000|Overall Study|Increased Tumor Burden|1|||
127553126|NCT04439136|458991686|FG000|Overall Study|Symptomatic Detrioration|1|||
127553127|NCT04329806|458991687|FG000|Overall Study|Physician Decision|3|||
127553128|NCT04329806|458991688|FG001|Overall Study|Physician Decision|4|||
127553129|NCT02636595|458991691|FG000|Overall Study|Lost to Follow-up|1|||
127553130|NCT02636595|458991691|FG000|Overall Study|Other|1|||
127553131|NCT03682770|458991694|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
127553132|NCT03682770|458991695|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|1|||
127553133|NCT03682770|458991696|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
127553134|NCT03682770|458991697|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
127553135|NCT03682770|458991698|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
127553136|NCT03682770|458991699|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
127553137|NCT03682770|458991700|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
127553138|NCT03682770|458991694|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
127553139|NCT03682770|458991695|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
127553140|NCT03682770|458991696|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
127553141|NCT03682770|458991697|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
127553142|NCT03682770|458991698|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
127553143|NCT03682770|458991699|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
127553144|NCT03682770|458991700|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
127553145|NCT03682770|458991694|FG000|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
127553146|NCT03682770|458991695|FG001|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
127553147|NCT03682770|458991696|FG002|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|7|||
127553148|NCT03682770|458991697|FG003|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|3|||
127553149|NCT03682770|458991698|FG004|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
127553150|NCT03682770|458991699|FG005|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
127553151|NCT03682770|458991700|FG006|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
127553152|NCT03682770|458991694|FG000|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
127553153|NCT03682770|458991695|FG001|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
127553154|NCT03682770|458991696|FG002|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
127553155|NCT03682770|458991697|FG003|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|1|||
127553156|NCT03682770|458991698|FG004|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
127553157|NCT03682770|458991699|FG005|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
127553158|NCT03682770|458991700|FG006|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
127553159|NCT03682770|458991694|FG000|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
127553160|NCT03682770|458991695|FG001|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
127553161|NCT03682770|458991696|FG002|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|1|||
127553162|NCT03682770|458991697|FG003|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|2|||
127553163|NCT03682770|458991698|FG004|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
127553164|NCT03682770|458991699|FG005|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
127553165|NCT03682770|458991700|FG006|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
127553166|NCT03682770|458991694|FG000|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
127553167|NCT03682770|458991695|FG001|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
127553168|NCT03682770|458991696|FG002|AR101 Up-dosing Period (Week 28-40)|Adverse Event|1|||
127553169|NCT03682770|458991697|FG003|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
127553170|NCT03682770|458991698|FG004|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
127553171|NCT03682770|458991699|FG005|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
127553172|NCT03682770|458991700|FG006|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
127553173|NCT03682770|458991694|FG000|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
127553174|NCT03682770|458991695|FG001|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
127553175|NCT03682770|458991696|FG002|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|1|||
127553176|NCT03682770|458991697|FG003|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
127553177|NCT03682770|458991698|FG004|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
127553178|NCT03682770|458991699|FG005|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
127553179|NCT03682770|458991700|FG006|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
127553180|NCT03682770|458991694|FG000|AR101 Up-dosing Period (Week 28-40)|Other|0|||
127553181|NCT03682770|458991695|FG001|AR101 Up-dosing Period (Week 28-40)|Other|0|||
127553182|NCT03682770|458991696|FG002|AR101 Up-dosing Period (Week 28-40)|Other|0|||
127553183|NCT03682770|458991697|FG003|AR101 Up-dosing Period (Week 28-40)|Other|2|||
127553184|NCT03682770|458991698|FG004|AR101 Up-dosing Period (Week 28-40)|Other|0|||
127553185|NCT03682770|458991699|FG005|AR101 Up-dosing Period (Week 28-40)|Other|0|||
127553186|NCT03682770|458991700|FG006|AR101 Up-dosing Period (Week 28-40)|Other|0|||
127553187|NCT03682770|458991694|FG000|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
127553188|NCT03682770|458991695|FG001|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
127553189|NCT03682770|458991696|FG002|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
127553190|NCT03682770|458991697|FG003|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
127553191|NCT03682770|458991698|FG004|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|3|||
127553192|NCT03682770|458991699|FG005|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
127553193|NCT03682770|458991700|FG006|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
127553194|NCT03682770|458991694|FG000|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
127553195|NCT03682770|458991695|FG001|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
127553196|NCT03682770|458991696|FG002|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
127553197|NCT03682770|458991697|FG003|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
127553198|NCT03682770|458991698|FG004|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|1|||
127553199|NCT03682770|458991699|FG005|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
127553200|NCT03682770|458991700|FG006|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
127553201|NCT03682770|458991694|FG000|AR101 Maintenance Period: (Week 52-64)|Other|0|||
127553202|NCT03682770|458991695|FG001|AR101 Maintenance Period: (Week 52-64)|Other|0|||
127553203|NCT03682770|458991696|FG002|AR101 Maintenance Period: (Week 52-64)|Other|0|||
127553204|NCT03682770|458991697|FG003|AR101 Maintenance Period: (Week 52-64)|Other|0|||
127553205|NCT03682770|458991698|FG004|AR101 Maintenance Period: (Week 52-64)|Other|0|||
127553206|NCT03682770|458991699|FG005|AR101 Maintenance Period: (Week 52-64)|Other|1|||
127553207|NCT03682770|458991700|FG006|AR101 Maintenance Period: (Week 52-64)|Other|0|||
127553208|NCT03682770|458991694|FG000|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
127553209|NCT03682770|458991695|FG001|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
127553210|NCT03682770|458991696|FG002|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
127553211|NCT03682770|458991697|FG003|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
127553212|NCT03682770|458991698|FG004|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
127553213|NCT03682770|458991699|FG005|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|1|||
127553214|NCT03682770|458991700|FG006|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|2|||
127553215|NCT02362282|458991701|FG000|Overall Study|Withdrawal by Subject|1|||
127553216|NCT02362282|458991702|FG001|Overall Study|Withdrawal by Subject|0|||
127553217|NCT01470326|458991703|FG000|Overall Study|Protocol Violation|32|||
127553218|NCT01470326|458991703|FG000|Overall Study|No Drug Administration Information|2|||
127553219|NCT01470326|458991703|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
127553220|NCT01166282|458991704|FG000|Open-label Period|Adverse Event|0|||
127553221|NCT01166282|458991705|FG001|Open-label Period|Adverse Event|0|||
127553222|NCT01166282|458991706|FG002|Open-label Period|Adverse Event|6|||
127553223|NCT01166282|458991704|FG000|Open-label Period|Withdrawal by Subject|0|||
127553224|NCT01166282|458991705|FG001|Open-label Period|Withdrawal by Subject|0|||
127553225|NCT01166282|458991706|FG002|Open-label Period|Withdrawal by Subject|4|||
127553226|NCT01166282|458991704|FG000|Open-label Period|Lack of Efficacy|0|||
127553227|NCT01166282|458991705|FG001|Open-label Period|Lack of Efficacy|0|||
128020618|NCT03501277|460698165|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
128020619|NCT03501277|460698166|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
128020620|NCT03501277|460698167|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
128020621|NCT03501277|460698168|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
128020622|NCT01860404|460698173|FG000|Overall Study|Lost to Follow-up|3|||
128020623|NCT01860404|460698174|FG001|Overall Study|Lost to Follow-up|4|||
128020624|NCT01860404|460698175|FG002|Overall Study|Lost to Follow-up|1|||
127553228|NCT01166282|458991706|FG002|Open-label Period|Lack of Efficacy|2|||
127553229|NCT01166282|458991704|FG000|Open-label Period|Remission|0|||
127553230|NCT01166282|458991705|FG001|Open-label Period|Remission|0|||
127553231|NCT01166282|458991706|FG002|Open-label Period|Remission|4|||
127553232|NCT01166282|458991704|FG000|Open-label Period|Irregular Compliance|0|||
127553233|NCT01166282|458991705|FG001|Open-label Period|Irregular Compliance|0|||
128020625|NCT01860404|460698176|FG003|Overall Study|Lost to Follow-up|6|||
128020626|NCT01860404|460698177|FG004|Overall Study|Lost to Follow-up|4|||
127553234|NCT01166282|458991706|FG002|Open-label Period|Irregular Compliance|1|||
127553235|NCT00380367|458991711|FG000|Overall Study|Lost to Follow-up|1|||
127553236|NCT00380367|458991711|FG000|Overall Study|Withdrawal by Subject|1|||
127553237|NCT00392769|458991715|FG000|Overall Study|Clinical Deterioration|9|||
127553238|NCT00392769|458991715|FG000|Overall Study|Adverse Event|1|||
127553239|NCT00439517|458991722|FG000|Overall Study|Subject on treatment|1|||
127553240|NCT00439517|458991723|FG001|Overall Study|Subject on treatment|0|||
127553241|NCT00439517|458991722|FG000|Overall Study|Subject in survival follow-up|1|||
127553242|NCT00439517|458991723|FG001|Overall Study|Subject in survival follow-up|0|||
127553243|NCT02304367|458991726|FG000|Overall Study|Lack of Response to Bruosumab|1|||
127553244|NCT02304367|458991726|FG000|Overall Study|Sponsor Decision|3|||
127553245|NCT02304367|458991726|FG000|Overall Study|Death|2|||
127553246|NCT02304367|458991726|FG000|Overall Study|Physician Decision|1|||
127553247|NCT02304367|458991726|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
127553248|NCT00526071|458991727|FG000|Overall Study|Adverse Event|1|||
127553249|NCT00526071|458991727|FG000|Overall Study|Withdrawal by Subject|1|||
127553250|NCT00526071|458991727|FG000|Overall Study|Lack of Response to Study Drug|4|||
127553251|NCT00318643|458991733|FG000|Overall Study|Adverse Event|0|||
127553252|NCT00318643|458991734|FG001|Overall Study|Adverse Event|0|||
127553253|NCT00318643|458991735|FG002|Overall Study|Adverse Event|0|||
127553254|NCT00318643|458991736|FG003|Overall Study|Adverse Event|0|||
127553255|NCT00318643|458991737|FG004|Overall Study|Adverse Event|1|||
127553256|NCT00318643|458991733|FG000|Overall Study|Participant's Decision|0|||
127553257|NCT00318643|458991734|FG001|Overall Study|Participant's Decision|0|||
127553258|NCT00318643|458991735|FG002|Overall Study|Participant's Decision|0|||
127553259|NCT00318643|458991736|FG003|Overall Study|Participant's Decision|0|||
127553260|NCT00318643|458991737|FG004|Overall Study|Participant's Decision|1|||
127553261|NCT00318643|458991733|FG000|Overall Study|Investigator's Decision|0|||
127553262|NCT00318643|458991734|FG001|Overall Study|Investigator's Decision|0|||
127553263|NCT00318643|458991735|FG002|Overall Study|Investigator's Decision|0|||
127553264|NCT00318643|458991736|FG003|Overall Study|Investigator's Decision|0|||
127553265|NCT00318643|458991737|FG004|Overall Study|Investigator's Decision|1|||
127553266|NCT02500797|458991740|FG000|Overall Study|Cancel (rapid disease progression)|0|||
127553267|NCT02500797|458991741|FG001|Overall Study|Cancel (rapid disease progression)|0|||
127553268|NCT02500797|458991742|FG002|Overall Study|Cancel (rapid disease progression)|0|||
127553269|NCT02500797|458991743|FG003|Overall Study|Cancel (rapid disease progression)|0|||
127553270|NCT02500797|458991744|FG004|Overall Study|Cancel (rapid disease progression)|1|||
127553271|NCT02500797|458991745|FG005|Overall Study|Cancel (rapid disease progression)|1|||
127553272|NCT02500797|458991746|FG006|Overall Study|Cancel (rapid disease progression)|0|||
127553273|NCT02500797|458991747|FG007|Overall Study|Cancel (rapid disease progression)|0|||
127553274|NCT02500797|458991740|FG000|Overall Study|Withdrawal by Subject|1|||
127553275|NCT02500797|458991741|FG001|Overall Study|Withdrawal by Subject|0|||
127553276|NCT02500797|458991742|FG002|Overall Study|Withdrawal by Subject|0|||
127553277|NCT02500797|458991743|FG003|Overall Study|Withdrawal by Subject|0|||
127553278|NCT02500797|458991744|FG004|Overall Study|Withdrawal by Subject|0|||
127553279|NCT02500797|458991745|FG005|Overall Study|Withdrawal by Subject|0|||
127553280|NCT02500797|458991746|FG006|Overall Study|Withdrawal by Subject|0|||
127553281|NCT02500797|458991747|FG007|Overall Study|Withdrawal by Subject|0|||
127553282|NCT00357006|458991754|FG000|Overall Study|Lost to Follow-up|1|||
127553283|NCT00357006|458991755|FG001|Overall Study|Lost to Follow-up|2|||
127553284|NCT00357006|458991756|FG002|Overall Study|Lost to Follow-up|1|||
127553285|NCT00357006|458991754|FG000|Overall Study|Withdrawal by Subject|1|||
127553286|NCT00357006|458991755|FG001|Overall Study|Withdrawal by Subject|3|||
127553287|NCT00357006|458991756|FG002|Overall Study|Withdrawal by Subject|2|||
127553288|NCT00976560|458991757|FG000|Overall Study|Adverse Event|5|||
127553289|NCT00976560|458991758|FG001|Overall Study|Adverse Event|5|||
127553290|NCT00976560|458991757|FG000|Overall Study|Lack of Efficacy|3|||
127553291|NCT00976560|458991758|FG001|Overall Study|Lack of Efficacy|5|||
127553292|NCT00976560|458991757|FG000|Overall Study|Protocol Violation|1|||
127553293|NCT00976560|458991758|FG001|Overall Study|Protocol Violation|0|||
127553294|NCT00976560|458991757|FG000|Overall Study|Lost to Follow-up|1|||
127553295|NCT00976560|458991758|FG001|Overall Study|Lost to Follow-up|0|||
127553296|NCT00976560|458991757|FG000|Overall Study|Physician Decision|2|||
127553297|NCT00976560|458991758|FG001|Overall Study|Physician Decision|0|||
127553298|NCT00976560|458991757|FG000|Overall Study|Withdrawal by Subject|2|||
127553299|NCT00976560|458991758|FG001|Overall Study|Withdrawal by Subject|3|||
127773612|NCT00475033|459797254|FG001|After the Infant Series|Failed to return|1|||
127553300|NCT03710161|458991759|FG000|Overall Study|Study halted due to COVID pandemic|3|||
127553301|NCT03710161|458991760|FG001|Overall Study|Study halted due to COVID pandemic|2|||
127553302|NCT01216189|458991761|FG000|Overall Study|Lost to Follow-up|21|||
127553303|NCT01216189|458991762|FG001|Overall Study|Lost to Follow-up|3|||
127553304|NCT01216189|458991761|FG000|Overall Study|Death|4|||
127553305|NCT01216189|458991762|FG001|Overall Study|Death|2|||
127553306|NCT00125164|458991765|FG000|Overall Study|Adverse Event|0|||
128020627|NCT01860404|460698173|FG000|Overall Study|Withdrawal by Subject|0|||
128020628|NCT01860404|460698174|FG001|Overall Study|Withdrawal by Subject|0|||
128020629|NCT01860404|460698175|FG002|Overall Study|Withdrawal by Subject|4|||
128020630|NCT01860404|460698176|FG003|Overall Study|Withdrawal by Subject|0|||
128020631|NCT01860404|460698177|FG004|Overall Study|Withdrawal by Subject|0|||
128020632|NCT02762604|460698178|FG000|Overall Study|Lost to Follow-up|2|||
128020633|NCT02762604|460698179|FG001|Overall Study|Lost to Follow-up|7|||
128020634|NCT02762604|460698178|FG000|Overall Study|Study Suspension due to COVID pandemic|1|||
128020635|NCT02762604|460698179|FG001|Overall Study|Study Suspension due to COVID pandemic|3|||
128020636|NCT06038643|460698180|FG000|Overall Study|Withdrawal by Subject|9|||
128020637|NCT06038643|460698181|FG001|Overall Study|Withdrawal by Subject|4|||
127553307|NCT00125164|458991766|FG001|Overall Study|Adverse Event|0|||
127553308|NCT00125164|458991767|FG002|Overall Study|Adverse Event|2|||
127553309|NCT00125164|458991768|FG003|Overall Study|Adverse Event|4|||
127553310|NCT00125164|458991765|FG000|Overall Study|Lost to Follow-up|0|||
127553311|NCT00125164|458991766|FG001|Overall Study|Lost to Follow-up|0|||
127553312|NCT00125164|458991767|FG002|Overall Study|Lost to Follow-up|1|||
127553313|NCT00125164|458991768|FG003|Overall Study|Lost to Follow-up|1|||
127553314|NCT00125164|458991765|FG000|Overall Study|Withdrawal by Subject|2|||
127553315|NCT00125164|458991766|FG001|Overall Study|Withdrawal by Subject|0|||
127553316|NCT00125164|458991767|FG002|Overall Study|Withdrawal by Subject|1|||
127553317|NCT00125164|458991768|FG003|Overall Study|Withdrawal by Subject|1|||
127553318|NCT01339052|458991769|FG000|Overall Study|Disease progression|13|||
127553319|NCT01339052|458991770|FG001|Overall Study|Disease progression|46|||
127553320|NCT01339052|458991769|FG000|Overall Study|Adverse Event|1|||
127553321|NCT01339052|458991770|FG001|Overall Study|Adverse Event|1|||
127553322|NCT01339052|458991769|FG000|Overall Study|Withdrawal by Subject|0|||
127553323|NCT01339052|458991770|FG001|Overall Study|Withdrawal by Subject|3|||
127553324|NCT01339052|458991769|FG000|Overall Study|Physician Decision|1|||
127553325|NCT01339052|458991770|FG001|Overall Study|Physician Decision|0|||
127553326|NCT02637037|458991771|FG000|Overall Study|Positive drug screen at admission|1|||
127553327|NCT02637037|458991772|FG001|Overall Study|Positive drug screen at admission|0|||
127553328|NCT02637037|458991771|FG000|Overall Study|Withdrawal by Subject|2|||
127553329|NCT02637037|458991772|FG001|Overall Study|Withdrawal by Subject|1|||
127553330|NCT02637037|458991771|FG000|Overall Study|Adverse Event|1|||
127553331|NCT02637037|458991772|FG001|Overall Study|Adverse Event|0|||
127553332|NCT03339219|458991773|FG000|Overall Study|Death|12|||
127553333|NCT03339219|458991773|FG000|Overall Study|Site Terminated by Sponsor|22|||
127553334|NCT03339219|458991773|FG000|Overall Study|Withdrawal by Subject|1|||
127553335|NCT01469377|458991775|FG000|Overall Study|Protocol Deviation|7|||
127553336|NCT01469377|458991776|FG001|Overall Study|Protocol Deviation|10|||
127553337|NCT01469377|458991777|FG002|Overall Study|Protocol Deviation|10|||
127553338|NCT01469377|458991775|FG000|Overall Study|Lost to Follow-up|3|||
127553339|NCT01469377|458991776|FG001|Overall Study|Lost to Follow-up|2|||
127553340|NCT01469377|458991777|FG002|Overall Study|Lost to Follow-up|5|||
127553341|NCT01469377|458991775|FG000|Overall Study|Withdrawal of Consent|12|||
127553342|NCT01469377|458991776|FG001|Overall Study|Withdrawal of Consent|14|||
127553343|NCT01469377|458991777|FG002|Overall Study|Withdrawal of Consent|15|||
127553344|NCT01469377|458991775|FG000|Overall Study|Adverse Event|8|||
127553345|NCT01469377|458991776|FG001|Overall Study|Adverse Event|18|||
127553346|NCT01469377|458991777|FG002|Overall Study|Adverse Event|36|||
127553347|NCT01469377|458991775|FG000|Overall Study|Insufficient Therapeutic Response|3|||
127553348|NCT01469377|458991776|FG001|Overall Study|Insufficient Therapeutic Response|4|||
127553349|NCT01469377|458991777|FG002|Overall Study|Insufficient Therapeutic Response|0|||
127553350|NCT01469377|458991775|FG000|Overall Study|Other Miscellaneous Reasons|2|||
127553351|NCT01469377|458991776|FG001|Overall Study|Other Miscellaneous Reasons|0|||
127553352|NCT01469377|458991777|FG002|Overall Study|Other Miscellaneous Reasons|0|||
127553353|NCT01733680|458991778|FG000|Overall Study|Withdrawal by Subject|0|||
127553354|NCT01733680|458991779|FG001|Overall Study|Withdrawal by Subject|1|||
127553355|NCT02302339|458991782|FG000|Overall Study|Lost to Follow-up|1|||
127553356|NCT02302339|458991783|FG001|Overall Study|Lost to Follow-up|0|||
128020638|NCT06038643|460698180|FG000|Overall Study|Excluded (not longer fulfilled enrollment criteria)|1|||
128020639|NCT06038643|460698181|FG001|Overall Study|Excluded (not longer fulfilled enrollment criteria)|0|||
127553357|NCT02302339|458991784|FG002|Overall Study|Lost to Follow-up|0|||
127553358|NCT02302339|458991785|FG003|Overall Study|Lost to Follow-up|0|||
127553359|NCT02302339|458991782|FG000|Overall Study|Withdrawal by Subject|0|||
127553360|NCT02302339|458991783|FG001|Overall Study|Withdrawal by Subject|2|||
127553361|NCT02302339|458991784|FG002|Overall Study|Withdrawal by Subject|1|||
127553362|NCT02302339|458991785|FG003|Overall Study|Withdrawal by Subject|0|||
127553363|NCT01185080|458991786|FG000|Overall Study|Adverse Event|1|||
128020640|NCT05259033|460698191|FG000|Overall Study|Withdrawal by Subject|10|||
128020641|NCT05259033|460698192|FG001|Overall Study|Withdrawal by Subject|5|||
127553364|NCT01185080|458991787|FG001|Overall Study|Adverse Event|1|||
127553365|NCT01185080|458991788|FG002|Overall Study|Adverse Event|0|||
127553366|NCT01185080|458991786|FG000|Overall Study|Personal reasons|0|||
127553367|NCT01185080|458991787|FG001|Overall Study|Personal reasons|0|||
127553368|NCT01185080|458991788|FG002|Overall Study|Personal reasons|1|||
127553369|NCT01104311|458991793|FG000|Overall Study|Withdrawal by Subject|6|||
127553370|NCT01104311|458991794|FG001|Overall Study|Withdrawal by Subject|6|||
127553371|NCT01104311|458991793|FG000|Overall Study|Protocol Violation|0|||
127553372|NCT01104311|458991794|FG001|Overall Study|Protocol Violation|1|||
127553373|NCT01104311|458991793|FG000|Overall Study|Physician Decision|2|||
127553374|NCT01104311|458991794|FG001|Overall Study|Physician Decision|2|||
127553375|NCT01104311|458991793|FG000|Overall Study|low compliance|1|||
127553376|NCT01104311|458991794|FG001|Overall Study|low compliance|1|||
127553377|NCT01104311|458991793|FG000|Overall Study|Adverse Event|1|||
127553378|NCT01104311|458991794|FG001|Overall Study|Adverse Event|2|||
127553379|NCT03207763|458993779|FG000|Overall Study|Lost to Follow-up|1|||
127553380|NCT03207763|458993780|FG001|Overall Study|Lost to Follow-up|0|||
127553381|NCT02605122|458993781|FG000|Overall Study|Withdrawal by Subject|4|||
127553382|NCT02605122|458993782|FG001|Overall Study|Withdrawal by Subject|1|||
127553383|NCT02605122|458993781|FG000|Overall Study|Lost to Follow-up|1|||
127553384|NCT02605122|458993782|FG001|Overall Study|Lost to Follow-up|1|||
127553385|NCT00807001|458993790|FG000|Overall Study|Non-compliance|0|||
127553386|NCT00807001|458993791|FG001|Overall Study|Non-compliance|1|||
127553387|NCT00807001|458993792|FG002|Overall Study|Non-compliance|0|||
127553388|NCT00807001|458993793|FG003|Overall Study|Non-compliance|0|||
127553389|NCT00807001|458993794|FG004|Overall Study|Non-compliance|0|||
127553390|NCT00854113|458993795|FG000|Overall Study|Adverse Event|0|||
127553391|NCT00854113|458993796|FG001|Overall Study|Adverse Event|0|||
127553392|NCT00854113|458993797|FG002|Overall Study|Adverse Event|0|||
127553393|NCT00854113|458993798|FG003|Overall Study|Adverse Event|0|||
127553394|NCT00854113|458993799|FG004|Overall Study|Adverse Event|0|||
127553395|NCT00854113|458993800|FG005|Overall Study|Adverse Event|0|||
127553396|NCT00854113|458993801|FG006|Overall Study|Adverse Event|0|||
127553397|NCT00854113|458993802|FG007|Overall Study|Adverse Event|2|||
127553398|NCT00854113|458993803|FG008|Overall Study|Adverse Event|0|||
127553399|NCT00854113|458993804|FG009|Overall Study|Adverse Event|0|||
127553400|NCT00854113|458993805|FG010|Overall Study|Adverse Event|0|||
127553401|NCT00854113|458993795|FG000|Overall Study|Withdrawal by Subject|0|||
127553402|NCT00854113|458993796|FG001|Overall Study|Withdrawal by Subject|0|||
127553403|NCT00854113|458993797|FG002|Overall Study|Withdrawal by Subject|0|||
127553404|NCT00854113|458993798|FG003|Overall Study|Withdrawal by Subject|0|||
127553405|NCT00854113|458993799|FG004|Overall Study|Withdrawal by Subject|0|||
127553406|NCT00854113|458993800|FG005|Overall Study|Withdrawal by Subject|0|||
127553407|NCT00854113|458993801|FG006|Overall Study|Withdrawal by Subject|0|||
127553408|NCT00854113|458993802|FG007|Overall Study|Withdrawal by Subject|1|||
127553409|NCT00854113|458993803|FG008|Overall Study|Withdrawal by Subject|1|||
127553410|NCT00854113|458993804|FG009|Overall Study|Withdrawal by Subject|0|||
127553411|NCT00854113|458993805|FG010|Overall Study|Withdrawal by Subject|0|||
127553412|NCT02273596|458993809|FG000|24-Week Treatment Period|Adverse Event|3|||
127553413|NCT02273596|458993809|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
127553414|NCT02273596|458993809|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
127553415|NCT02273596|458993809|FG000|24-Week Treatment Period|Physician Decision|1|||
127553416|NCT02273596|458993809|FG000|24-Week Treatment Period|Protocol Deviation|1|||
127553417|NCT02273596|458993809|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
127553418|NCT02273596|458993809|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
127553419|NCT02273596|458993809|FG000|Extension Period|Lost to Follow-up|1|||
127553420|NCT02273596|458993809|FG000|Extension Period|Protocol Deviation|1|||
127553421|NCT02604160|458993810|FG000|Overall Study|Protocol Violation|0|||
127553422|NCT02604160|458993811|FG001|Overall Study|Protocol Violation|1|||
127553423|NCT02604160|458993810|FG000|Overall Study|Physician Decision|0|||
127553424|NCT02604160|458993811|FG001|Overall Study|Physician Decision|1|||
127553425|NCT01596062|458993812|FG000|Overall Study|Adverse Event|1|||
128020642|NCT05259033|460698191|FG000|Overall Study|Lost to Follow-up|1|||
127553426|NCT01596062|458993813|FG001|Overall Study|Adverse Event|0|||
127553427|NCT01596062|458993814|FG002|Overall Study|Adverse Event|2|||
127553428|NCT01596062|458993812|FG000|Overall Study|Lack of Efficacy|0|||
127553429|NCT01596062|458993813|FG001|Overall Study|Lack of Efficacy|0|||
128020643|NCT05259033|460698192|FG001|Overall Study|Lost to Follow-up|0|||
128020644|NCT05259033|460698191|FG000|Overall Study|Death|2|||
128020645|NCT05259033|460698192|FG001|Overall Study|Death|0|||
128020646|NCT04210375|460698193|FG000|Overall Study|Death|0|||
128020647|NCT04210375|460698194|FG001|Overall Study|Death|1|||
128020648|NCT04210375|460698195|FG002|Overall Study|Death|0|||
128020649|NCT04210375|460698196|FG003|Overall Study|Death|0|||
128020650|NCT01405911|460698197|FG000|Overall Study|Pre-treatment lab AE|0|||
128020651|NCT01405911|460698198|FG001|Overall Study|Pre-treatment lab AE|1|||
128020652|NCT01405911|460698199|FG002|Overall Study|Pre-treatment lab AE|0|||
128020653|NCT01405911|460698197|FG000|Overall Study|Lost to Follow-up|0|||
127553430|NCT01596062|458993814|FG002|Overall Study|Lack of Efficacy|1|||
127553431|NCT02139592|458993815|FG000|Overall Study|Case Report Forms Uncollected|8|||
127553432|NCT03180840|458993816|FG000|Overall Study|Withdrawal by Subject|1|||
127553433|NCT01413204|458993824|FG000|Overall Study|Adverse Event|1|||
127553434|NCT01413204|458993825|FG001|Overall Study|Adverse Event|2|||
127553435|NCT01413204|458993826|FG002|Overall Study|Adverse Event|2|||
127553436|NCT01413204|458993824|FG000|Overall Study|Physician Decision|3|||
127553437|NCT01413204|458993825|FG001|Overall Study|Physician Decision|0|||
127553438|NCT01413204|458993826|FG002|Overall Study|Physician Decision|2|||
127553439|NCT01413204|458993824|FG000|Overall Study|Withdrawal by Subject|1|||
127553440|NCT01413204|458993825|FG001|Overall Study|Withdrawal by Subject|4|||
127553441|NCT01413204|458993826|FG002|Overall Study|Withdrawal by Subject|4|||
127553442|NCT01413204|458993824|FG000|Overall Study|Clearly not eligible for the study|0|||
127553443|NCT01413204|458993825|FG001|Overall Study|Clearly not eligible for the study|0|||
127553444|NCT01413204|458993826|FG002|Overall Study|Clearly not eligible for the study|1|||
127553445|NCT01413204|458993824|FG000|Overall Study|Fasting plasma glucose level increased|1|||
127553446|NCT01413204|458993825|FG001|Overall Study|Fasting plasma glucose level increased|0|||
127553447|NCT01413204|458993826|FG002|Overall Study|Fasting plasma glucose level increased|10|||
127553448|NCT02974543|458993829|FG000|Overall Study|Withdrawal by Subject|1|||
127553449|NCT02974543|458993830|FG001|Overall Study|Withdrawal by Subject|0|||
127553450|NCT00742235|458993831|FG000|Overall Study|Lost to Follow-up|0|||
127553451|NCT00742235|458993832|FG001|Overall Study|Lost to Follow-up|31|||
127553452|NCT01237899|458993833|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
127553453|NCT01237899|458993834|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
127553454|NCT01237899|458993835|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
127553455|NCT01237899|458993836|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
127553456|NCT01237899|458993837|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
127553457|NCT01237899|458993838|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
127553458|NCT01237899|458993839|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
127553459|NCT01237899|458993840|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
127553460|NCT01237899|458993841|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
127553461|NCT01237899|458993842|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
127553462|NCT01237899|458993843|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
127553463|NCT04730271|458993844|FG000|Overall Study|Adverse Event|0|||
127553464|NCT04730271|458993845|FG001|Overall Study|Adverse Event|2|||
127553465|NCT04730271|458993844|FG000|Overall Study|Withdrawal by Subject|1|||
127553466|NCT04730271|458993845|FG001|Overall Study|Withdrawal by Subject|1|||
127553467|NCT04730271|458993844|FG000|Overall Study|Protocol Violation|7|||
127553468|NCT04730271|458993845|FG001|Overall Study|Protocol Violation|13|||
127553469|NCT04730271|458993844|FG000|Overall Study|Lost to Follow-up|3|||
127553470|NCT04730271|458993845|FG001|Overall Study|Lost to Follow-up|3|||
127553471|NCT04730271|458993844|FG000|Overall Study|Death|1|||
127553472|NCT04730271|458993845|FG001|Overall Study|Death|0|||
127553473|NCT05782179|458993846|FG000|Overall Study|Adverse Event|0|||
127553474|NCT05782179|458993847|FG001|Overall Study|Adverse Event|0|||
127553475|NCT05782179|458993848|FG002|Overall Study|Adverse Event|2|||
127553476|NCT05782179|458993849|FG003|Overall Study|Adverse Event|0|||
127553477|NCT05782179|458993850|FG004|Overall Study|Adverse Event|0|||
127553478|NCT05782179|458993851|FG005|Overall Study|Adverse Event|0|||
127553479|NCT03599089|458993852|FG000|Overall Study|Lost to Follow-up|1|||
127553480|NCT03599089|458993853|FG001|Overall Study|Lost to Follow-up|0|||
127553481|NCT03599089|458993854|FG002|Overall Study|Lost to Follow-up|0|||
127553482|NCT03599089|458993855|FG003|Overall Study|Lost to Follow-up|0|||
127553483|NCT03599089|458993852|FG000|Overall Study|Withdrawal by Subject|2|||
127553484|NCT03599089|458993853|FG001|Overall Study|Withdrawal by Subject|1|||
127553485|NCT03599089|458993854|FG002|Overall Study|Withdrawal by Subject|0|||
127553486|NCT03599089|458993855|FG003|Overall Study|Withdrawal by Subject|0|||
127553487|NCT03599089|458993852|FG000|Overall Study|Lack of Efficacy|0|||
127553488|NCT03599089|458993853|FG001|Overall Study|Lack of Efficacy|0|||
127553489|NCT03599089|458993854|FG002|Overall Study|Lack of Efficacy|1|||
127553490|NCT03599089|458993855|FG003|Overall Study|Lack of Efficacy|2|||
127773613|NCT00475033|459797253|FG000|After the Infant Series|Protocol Violation|1|||
127773614|NCT00475033|459797254|FG001|After the Infant Series|Protocol Violation|0|||
127553491|NCT03214666|458993856|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
127553492|NCT03214666|458993857|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
127553493|NCT03214666|458993858|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
127553494|NCT03214666|458993859|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
127553495|NCT03214666|458993860|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
127773615|NCT00475033|459797253|FG000|After the Infant Series|Lost to Follow-up|1|||
127773616|NCT00475033|459797254|FG001|After the Infant Series|Lost to Follow-up|0|||
127553496|NCT03214666|458993861|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
127553497|NCT00470275|458993862|FG000|Overall Study|Death|1|||
127553498|NCT00470275|458993862|FG000|Overall Study|Lack of Efficacy|7|||
127553499|NCT00470275|458993862|FG000|Overall Study|Withdrawal by Subject|2|||
128020654|NCT01405911|460698198|FG001|Overall Study|Lost to Follow-up|1|||
127553500|NCT01519921|458993863|FG000|Overall Study|Adverse Event|10|||
127553501|NCT01519921|458993864|FG001|Overall Study|Adverse Event|9|||
127553502|NCT01519921|458993863|FG000|Overall Study|Lack of Efficacy|4|||
127553503|NCT01519921|458993864|FG001|Overall Study|Lack of Efficacy|3|||
127553504|NCT01519921|458993863|FG000|Overall Study|Withdrawal by Subject|3|||
127553505|NCT01519921|458993864|FG001|Overall Study|Withdrawal by Subject|0|||
127553506|NCT01519921|458993863|FG000|Overall Study|Lost to Follow-up|2|||
127553507|NCT01519921|458993864|FG001|Overall Study|Lost to Follow-up|1|||
127553508|NCT01519921|458993863|FG000|Overall Study|Treatment refusal|2|||
127553509|NCT01519921|458993864|FG001|Overall Study|Treatment refusal|1|||
127553510|NCT01519921|458993863|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
127553511|NCT01519921|458993864|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
127553512|NCT01415882|458993865|FG000|Overall Study|Ineligible|1|||
127553513|NCT01415882|458993866|FG001|Overall Study|Ineligible|0|||
127553514|NCT01415882|458993867|FG002|Overall Study|Ineligible|0|||
127553515|NCT01415882|458993868|FG003|Overall Study|Ineligible|3|||
127553516|NCT01415882|458993869|FG004|Overall Study|Ineligible|0|||
127553517|NCT01415882|458993865|FG000|Overall Study|Withdrawal by Subject|0|||
127553518|NCT01415882|458993866|FG001|Overall Study|Withdrawal by Subject|1|||
127553519|NCT01415882|458993867|FG002|Overall Study|Withdrawal by Subject|0|||
127553520|NCT01415882|458993868|FG003|Overall Study|Withdrawal by Subject|1|||
127553521|NCT01415882|458993869|FG004|Overall Study|Withdrawal by Subject|0|||
127553522|NCT01932437|458993870|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
127553523|NCT01932437|458993871|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
127553524|NCT01932437|458993872|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
127553525|NCT01932437|458993873|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
127553526|NCT01932437|458993874|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
127553527|NCT01932437|458993875|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
127553528|NCT00074490|458993876|FG000|Overall Study|Progressive malignancy|0|||
127553529|NCT00074490|458993877|FG001|Overall Study|Progressive malignancy|7|||
127553530|NCT00074490|458993878|FG002|Overall Study|Progressive malignancy|0|||
127553531|NCT00074490|458993879|FG003|Overall Study|Progressive malignancy|0|||
127553532|NCT00074490|458993880|FG004|Overall Study|Progressive malignancy|3|||
127553533|NCT00074490|458993881|FG005|Overall Study|Progressive malignancy|0|||
127553534|NCT02722499|458993882|FG000|Overall Study|Lost to Follow-up|2|||
127553535|NCT02722499|458993883|FG001|Overall Study|Lost to Follow-up|0|||
127553536|NCT02722499|458993884|FG002|Overall Study|Lost to Follow-up|1|||
127553537|NCT04638660|458993895|FG000|Overall Study|Withdrawal by Subject|2|||
127553538|NCT04638660|458993896|FG001|Overall Study|Withdrawal by Subject|0|||
127553539|NCT04638660|458993895|FG000|Overall Study|Lost to Follow-up|1|||
127553540|NCT04638660|458993896|FG001|Overall Study|Lost to Follow-up|0|||
127553541|NCT03610269|458993898|FG000|Overall Study|Physician Decision|10|||
127553542|NCT03610269|458993898|FG000|Overall Study|Protocol Violation|1|||
127553543|NCT03610269|458993898|FG000|Overall Study|Unable to draw blood|1|||
127553544|NCT03610269|458993898|FG000|Overall Study|Screen fail|4|||
127553545|NCT04411667|458993901|FG000|Overall Study|Physician Decision|1|||
127553546|NCT04411667|458993902|FG001|Overall Study|Physician Decision|0|||
127553547|NCT00067002|458993903|FG000|Overall Study|Early Death|1|||
127553548|NCT00067002|458993904|FG001|Overall Study|Early Death|2|||
127553549|NCT00067002|458993903|FG000|Overall Study|Delayed|1|||
127553550|NCT00067002|458993904|FG001|Overall Study|Delayed|1|||
127553551|NCT00067002|458993903|FG000|Overall Study|Graft Failure|5|||
127553552|NCT00067002|458993904|FG001|Overall Study|Graft Failure|6|||
127553553|NCT01354314|458993909|FG000|Overall Study|Lost to Follow-up|1|||
127553554|NCT01354314|458993910|FG001|Overall Study|Lost to Follow-up|0|||
127553555|NCT01354314|458993911|FG002|Overall Study|Lost to Follow-up|1|||
127553556|NCT01354314|458993912|FG003|Overall Study|Lost to Follow-up|1|||
127773617|NCT00475033|459797253|FG000|After the Infant Series|Other|0|||
128020655|NCT01405911|460698199|FG002|Overall Study|Lost to Follow-up|0|||
128020656|NCT01405911|460698197|FG000|Overall Study|Protocol Violation|1|||
128020657|NCT01405911|460698198|FG001|Overall Study|Protocol Violation|0|||
128020658|NCT01405911|460698199|FG002|Overall Study|Protocol Violation|0|||
128020659|NCT01405911|460698197|FG000|Overall Study|Withdrawal by Subject|3|||
128020660|NCT01405911|460698198|FG001|Overall Study|Withdrawal by Subject|1|||
128020661|NCT01405911|460698199|FG002|Overall Study|Withdrawal by Subject|1|||
128020662|NCT05762744|460698201|FG000|1st iv Glucose Tolerance Test|Withdrawal by Subject|0|||
128020663|NCT05762744|460698202|FG001|1st iv Glucose Tolerance Test|Withdrawal by Subject|1|||
128020664|NCT05762744|460698201|FG000|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
128020665|NCT05762744|460698202|FG001|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
128020666|NCT01671059|460698203|FG000|Overall Study|Adverse Event|4|||
128020667|NCT01671059|460698203|FG000|Overall Study|Lack of Efficacy|1|||
128020668|NCT01560416|460698204|FG000|Randomized Phase|Crossover Participants|7|||
128020669|NCT01560416|460698205|FG001|Randomized Phase|Crossover Participants|0|||
128020670|NCT01179399|460698206|FG000|Overall Study|Adverse Event|1|||
127553557|NCT01354314|458993909|FG000|Overall Study|Withdrawal by Subject|0|||
128020671|NCT01179399|460698206|FG000|Overall Study|Lack of Efficacy|30|||
128020672|NCT01179399|460698206|FG000|Overall Study|Withdrawal by Subject|1|||
127553558|NCT01354314|458993910|FG001|Overall Study|Withdrawal by Subject|0|||
127553559|NCT01354314|458993911|FG002|Overall Study|Withdrawal by Subject|1|||
127553560|NCT01354314|458993912|FG003|Overall Study|Withdrawal by Subject|0|||
127553561|NCT01354314|458993909|FG000|Overall Study|Adverse Event|0|||
127553562|NCT01354314|458993910|FG001|Overall Study|Adverse Event|0|||
127553563|NCT01354314|458993911|FG002|Overall Study|Adverse Event|0|||
127553564|NCT01354314|458993912|FG003|Overall Study|Adverse Event|1|||
127553565|NCT01354314|458993909|FG000|Overall Study|Protocol Violation|1|||
127553566|NCT01354314|458993910|FG001|Overall Study|Protocol Violation|1|||
127553567|NCT01354314|458993911|FG002|Overall Study|Protocol Violation|0|||
127553568|NCT01354314|458993912|FG003|Overall Study|Protocol Violation|0|||
127553569|NCT01354314|458993909|FG000|Overall Study|Less than 90% Adherence|4|||
127553570|NCT01354314|458993910|FG001|Overall Study|Less than 90% Adherence|2|||
127553571|NCT01354314|458993911|FG002|Overall Study|Less than 90% Adherence|6|||
127553572|NCT01354314|458993912|FG003|Overall Study|Less than 90% Adherence|4|||
127553573|NCT00714870|458993915|FG000|Overall Study|Lost to Follow-up|22|||
127553574|NCT00714870|458993916|FG001|Overall Study|Lost to Follow-up|5|||
127553575|NCT00714870|458993915|FG000|Overall Study|patient unable to come b/c back pain|1|||
127553576|NCT00714870|458993916|FG001|Overall Study|patient unable to come b/c back pain|0|||
127553577|NCT00714870|458993915|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
127553578|NCT00714870|458993916|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
127553579|NCT03399552|458993917|FG000|Overall Study|No evidence of disease|1|||
127553580|NCT03399552|458993917|FG000|Overall Study|Unevaluable|1|||
127553581|NCT02357368|458993918|FG000|Overall Study|Lost to Follow-up|0|||
127553582|NCT02357368|458993919|FG001|Overall Study|Lost to Follow-up|0|||
127773618|NCT00475033|459797254|FG001|After the Infant Series|Other|1|||
127773619|NCT00475033|459797253|FG000|Toddler Dose|Parent or legal guardian request|2|||
127773620|NCT00475033|459797254|FG001|Toddler Dose|Parent or legal guardian request|0|||
127773621|NCT00475033|459797253|FG000|Toddler Dose|Failed to return|1|||
127773622|NCT00475033|459797254|FG001|Toddler Dose|Failed to return|0|||
127773623|NCT00475033|459797253|FG000|Toddler Dose|Lost to Follow-up|1|||
127773624|NCT00475033|459797254|FG001|Toddler Dose|Lost to Follow-up|0|||
127773625|NCT03444324|459797257|FG000|Overall Study|Withdrawal by Subject|0|||
127773626|NCT03444324|459797258|FG001|Overall Study|Withdrawal by Subject|1|||
127773627|NCT03444324|459797257|FG000|Overall Study|Lost to Follow-up|4|||
127773628|NCT03444324|459797258|FG001|Overall Study|Lost to Follow-up|2|||
127773629|NCT03444324|459797257|FG000|Overall Study|Protocol Violation|0|||
127773630|NCT03444324|459797258|FG001|Overall Study|Protocol Violation|1|||
127773631|NCT03444324|459797257|FG000|Overall Study|Lack of Trial Compliance|1|||
127773632|NCT03444324|459797258|FG001|Overall Study|Lack of Trial Compliance|1|||
127773633|NCT03444324|459797257|FG000|Overall Study|Physical disability to come to the site for the closing visit|0|||
127773634|NCT03444324|459797258|FG001|Overall Study|Physical disability to come to the site for the closing visit|1|||
127773635|NCT00658684|459797259|FG000|Overall Study|Adverse Event|10|||
127773636|NCT00658684|459797260|FG001|Overall Study|Adverse Event|8|||
127773637|NCT00658684|459797261|FG002|Overall Study|Adverse Event|2|||
127773638|NCT00658684|459797262|FG003|Overall Study|Adverse Event|0|||
127773639|NCT00658684|459797259|FG000|Overall Study|Withdrawal by Subject|6|||
127773640|NCT00658684|459797260|FG001|Overall Study|Withdrawal by Subject|4|||
127773641|NCT00658684|459797261|FG002|Overall Study|Withdrawal by Subject|1|||
127773642|NCT00658684|459797262|FG003|Overall Study|Withdrawal by Subject|1|||
127773643|NCT00658684|459797259|FG000|Overall Study|Lack of Efficacy|1|||
127773644|NCT00658684|459797260|FG001|Overall Study|Lack of Efficacy|1|||
127773645|NCT00658684|459797261|FG002|Overall Study|Lack of Efficacy|0|||
127773646|NCT00658684|459797262|FG003|Overall Study|Lack of Efficacy|0|||
127773647|NCT00658684|459797259|FG000|Overall Study|Protocol Violation|1|||
127773648|NCT00658684|459797260|FG001|Overall Study|Protocol Violation|1|||
127773649|NCT00658684|459797261|FG002|Overall Study|Protocol Violation|0|||
127773650|NCT00658684|459797262|FG003|Overall Study|Protocol Violation|0|||
127773651|NCT00658684|459797259|FG000|Overall Study|Pregnancy|1|||
127773652|NCT00658684|459797260|FG001|Overall Study|Pregnancy|1|||
127773653|NCT00658684|459797261|FG002|Overall Study|Pregnancy|0|||
127773654|NCT00658684|459797262|FG003|Overall Study|Pregnancy|0|||
127773655|NCT06515483|459797265|FG000|Overall Study|Subject withdraw due to family issues|1|||
128020673|NCT03334175|460698207|FG000|Overall Study|Lost to Follow-up|0|||
127553583|NCT02357368|458993920|FG002|Overall Study|Lost to Follow-up|0|||
127553584|NCT02357368|458993921|FG003|Overall Study|Lost to Follow-up|1|||
127553585|NCT02357368|458993918|FG000|Overall Study|Pregnancy|3|||
127553586|NCT02357368|458993919|FG001|Overall Study|Pregnancy|2|||
127553587|NCT02357368|458993920|FG002|Overall Study|Pregnancy|0|||
127553588|NCT02357368|458993921|FG003|Overall Study|Pregnancy|0|||
127553589|NCT02357368|458993918|FG000|Overall Study|Withdrawal by Subject|3|||
127773656|NCT06515483|459797266|FG001|Overall Study|Subject withdraw due to family issues|0|||
127773657|NCT01390181|459798541|FG000|Overall Study|Lost to Follow-up|1|||
127773658|NCT01390181|459798541|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
127773659|NCT02805725|459798542|FG000|Phase I (Dose Escalation Part)|Clinical progression|0|||
127773660|NCT02805725|459798543|FG001|Phase I (Dose Escalation Part)|Clinical progression|0|||
127773661|NCT02805725|459798544|FG002|Phase I (Dose Escalation Part)|Clinical progression|1|||
127553590|NCT02357368|458993919|FG001|Overall Study|Withdrawal by Subject|1|||
127553591|NCT02357368|458993920|FG002|Overall Study|Withdrawal by Subject|1|||
127553592|NCT02357368|458993921|FG003|Overall Study|Withdrawal by Subject|2|||
127553593|NCT02377817|458993922|FG000|Overall Study|Transportation/childcare barriers.|2|||
127553594|NCT02377817|458993923|FG001|Overall Study|Transportation/childcare barriers.|0|||
127553595|NCT02377817|458993922|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
127553596|NCT02377817|458993923|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
127553597|NCT03895840|458993924|FG000|Overall Study|Withdrawal by Subject|21|||
127553598|NCT01931566|458993925|FG000|Overall Study|Randomized But Not Treated|6|||
127553599|NCT01931566|458993926|FG001|Overall Study|Randomized But Not Treated|9|||
127553600|NCT01931566|458993927|FG002|Overall Study|Randomized But Not Treated|14|||
127553601|NCT01931566|458993925|FG000|Overall Study|Adverse Event|37|||
127553602|NCT01931566|458993926|FG001|Overall Study|Adverse Event|167|||
127553603|NCT01931566|458993927|FG002|Overall Study|Adverse Event|132|||
127553604|NCT01931566|458993925|FG000|Overall Study|Major Protocol Deviation|5|||
127553605|NCT01931566|458993926|FG001|Overall Study|Major Protocol Deviation|14|||
127553606|NCT01931566|458993927|FG002|Overall Study|Major Protocol Deviation|21|||
127553607|NCT01931566|458993925|FG000|Overall Study|Lost to Follow-up|3|||
127553608|NCT01931566|458993926|FG001|Overall Study|Lost to Follow-up|26|||
127553609|NCT01931566|458993927|FG002|Overall Study|Lost to Follow-up|23|||
127553610|NCT01931566|458993925|FG000|Overall Study|Voluntary Withdrawal|78|||
127553611|NCT01931566|458993926|FG001|Overall Study|Voluntary Withdrawal|245|||
127553612|NCT01931566|458993927|FG002|Overall Study|Voluntary Withdrawal|225|||
127553613|NCT01931566|458993925|FG000|Overall Study|Study Termination|289|||
127553614|NCT01931566|458993926|FG001|Overall Study|Study Termination|968|||
127553615|NCT01931566|458993927|FG002|Overall Study|Study Termination|1037|||
127553616|NCT01931566|458993925|FG000|Overall Study|Reason Not Specified|11|||
127553617|NCT01931566|458993926|FG001|Overall Study|Reason Not Specified|47|||
127553618|NCT01931566|458993927|FG002|Overall Study|Reason Not Specified|53|||
127553619|NCT01931566|458993925|FG000|Overall Study|Missing|0|||
127553620|NCT01931566|458993926|FG001|Overall Study|Missing|0|||
127553621|NCT01931566|458993927|FG002|Overall Study|Missing|1|||
127553622|NCT00760617|458993933|FG000|Overall Study|Adverse Event|5|||
127553623|NCT00760617|458993934|FG001|Overall Study|Adverse Event|2|||
127553624|NCT00760617|458993935|FG002|Overall Study|Adverse Event|0|||
127553625|NCT00760617|458993933|FG000|Overall Study|Lost to Follow-up|0|||
127553626|NCT00760617|458993934|FG001|Overall Study|Lost to Follow-up|0|||
127553627|NCT00760617|458993935|FG002|Overall Study|Lost to Follow-up|5|||
127553628|NCT01147874|458993936|FG000|Overall Study|Adverse Event|5|||
127553629|NCT01147874|458993936|FG000|Overall Study|Investigator's Request|1|||
127553630|NCT01147874|458993936|FG000|Overall Study|Lost to Follow-up|25|||
127553631|NCT01147874|458993936|FG000|Overall Study|Other|5|||
127553632|NCT01147874|458993936|FG000|Overall Study|Protocol Violation|5|||
127553633|NCT01147874|458993936|FG000|Overall Study|Sponsor's Decision|2|||
127553634|NCT01147874|458993936|FG000|Overall Study|Withdrawal by Subject|24|||
127553635|NCT04625101|458993938|FG000|Overall Study|Withdrawal by Subject|0|||
127553636|NCT04625101|458993939|FG001|Overall Study|Withdrawal by Subject|1|||
127553637|NCT04625101|458993938|FG000|Overall Study|Protocol Deviation|1|||
127553638|NCT04625101|458993939|FG001|Overall Study|Protocol Deviation|0|||
127553639|NCT00467753|458993944|FG000|Overall Study|Lost to Follow-up|1|||
127553640|NCT00467753|458993945|FG001|Overall Study|Lost to Follow-up|2|||
127553641|NCT00467753|458993944|FG000|Overall Study|Adverse Event|2|||
127553642|NCT00467753|458993945|FG001|Overall Study|Adverse Event|0|||
127553643|NCT02175030|458993946|FG000|Overall Study|Failed screen after consent|7|||
127553644|NCT02175030|458993947|FG001|Overall Study|Failed screen after consent|6|||
127553645|NCT02175030|458993946|FG000|Overall Study|Failed IUD Insertion|20|||
127553646|NCT02175030|458993947|FG001|Overall Study|Failed IUD Insertion|21|||
127553647|NCT02175030|458993946|FG000|Overall Study|Physician Decision|1|||
127553648|NCT02175030|458993947|FG001|Overall Study|Physician Decision|1|||
127553649|NCT02175030|458993946|FG000|Overall Study|Lost to Follow-up|6|||
127553650|NCT02175030|458993947|FG001|Overall Study|Lost to Follow-up|6|||
127553651|NCT02175030|458993946|FG000|Overall Study|Withdrawal by Subject|1|||
127553652|NCT02175030|458993947|FG001|Overall Study|Withdrawal by Subject|4|||
127553653|NCT02817464|458993949|FG000|Overall Study|Lost to Follow-up|1|||
127553654|NCT02817464|458993950|FG001|Overall Study|Lost to Follow-up|0|||
127553655|NCT02817464|458993949|FG000|Overall Study|Discontinued early due to personal decision|1|||
127553656|NCT02817464|458993950|FG001|Overall Study|Discontinued early due to personal decision|1|||
127553657|NCT00885534|458993951|FG000|Overall Study|Patient deemed ineligible|1|||
127553658|NCT02453711|458993952|FG000|Overall Study|Withdrawal by Subject|5|||
127553659|NCT02453711|458993953|FG001|Overall Study|Withdrawal by Subject|4|||
127553660|NCT02453711|458993954|FG002|Overall Study|Withdrawal by Subject|6|||
127553661|NCT02453711|458993955|FG003|Overall Study|Withdrawal by Subject|4|||
127553662|NCT02453711|458993956|FG004|Overall Study|Withdrawal by Subject|1|||
127553663|NCT02453711|458993957|FG005|Overall Study|Withdrawal by Subject|1|||
127553664|NCT02453711|458993958|FG006|Overall Study|Withdrawal by Subject|0|||
127553665|NCT02453711|458993959|FG007|Overall Study|Withdrawal by Subject|1|||
127553666|NCT02453711|458993960|FG008|Overall Study|Withdrawal by Subject|7|||
128020674|NCT03334175|460698208|FG001|Overall Study|Lost to Follow-up|1|||
128020675|NCT03738215|460698209|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
128020676|NCT03738215|460698210|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
128020677|NCT03738215|460698211|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
128020678|NCT03738215|460698209|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
128020679|NCT03738215|460698210|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
128020680|NCT03738215|460698211|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
128020681|NCT03738215|460698209|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
128020682|NCT03738215|460698210|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
128020683|NCT03738215|460698211|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
128020684|NCT03738215|460698209|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
128020685|NCT03738215|460698210|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
128020686|NCT03738215|460698211|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
128020687|NCT03738215|460698209|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
128020688|NCT03738215|460698210|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
128020689|NCT03738215|460698211|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
128020690|NCT03738215|460698209|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
128020691|NCT03738215|460698210|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
128020692|NCT03738215|460698211|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
128020693|NCT03738215|460698209|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
128020694|NCT03738215|460698210|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
128020695|NCT03738215|460698211|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
128020696|NCT03738215|460698209|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
128020697|NCT03738215|460698210|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
128020698|NCT03738215|460698211|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
128020699|NCT03738215|460698209|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
128020700|NCT03738215|460698210|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
128020701|NCT03738215|460698211|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
128020702|NCT03738215|460698209|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
128020703|NCT03738215|460698210|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
128020704|NCT03738215|460698211|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
128020705|NCT01695772|460698213|FG000|Overall Study|Withdrawal by Subject|18|||
128020706|NCT01695772|460698213|FG000|Overall Study|Progressive Disease|8|||
128020707|NCT01695772|460698213|FG000|Overall Study|Investigator Decision|5|||
128020708|NCT01695772|460698213|FG000|Overall Study|Lost to Follow-up|4|||
128020709|NCT01695772|460698213|FG000|Overall Study|Protocol Violation|2|||
128020710|NCT01695772|460698213|FG000|Overall Study|Unspecified Reason|1|||
128020711|NCT03921541|460700169|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
128020712|NCT03921541|460700170|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
128020713|NCT01653262|460700171|FG000|Overall Study|Lack of Efficacy|1|||
128020714|NCT01653262|460700171|FG000|Overall Study|SAE, non-fatal|1|||
128020715|NCT01653262|460700171|FG000|Overall Study|AE, non-serious non-fatal|1|||
128020716|NCT00420407|460700173|FG000|Overall Study|Lost to Follow-up|0|||
128020717|NCT00420407|460700174|FG001|Overall Study|Lost to Follow-up|3|||
128020718|NCT00420407|460700173|FG000|Overall Study|Physician Decision|2|||
128020719|NCT00420407|460700174|FG001|Overall Study|Physician Decision|1|||
128020720|NCT00420407|460700173|FG000|Overall Study|subject identified as detainee|1|||
128020721|NCT00420407|460700174|FG001|Overall Study|subject identified as detainee|0|||
128020722|NCT00420407|460700173|FG000|Overall Study|subject identified as Jehovah's witness|1|||
128020723|NCT00420407|460700174|FG001|Overall Study|subject identified as Jehovah's witness|0|||
128020724|NCT00420407|460700173|FG000|Overall Study|Withdrawal by Subject|0|||
128020725|NCT00420407|460700174|FG001|Overall Study|Withdrawal by Subject|2|||
128020726|NCT04633447|460700175|FG000|Main Study (From Week 0 up to Week 60)|Adverse Event|8|||
128020727|NCT04633447|460700176|FG001|Main Study (From Week 0 up to Week 60)|Adverse Event|2|||
128020728|NCT04633447|460700175|FG000|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
128020729|NCT04633447|460700176|FG001|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
128020730|NCT04633447|460700175|FG000|Main Study (From Week 0 up to Week 60)|Physician Decision|0|||
128020731|NCT04633447|460700176|FG001|Main Study (From Week 0 up to Week 60)|Physician Decision|1|||
127881006|NCT02756078|460186097|FG000|Period 2|Adverse Event|3|||
128020732|NCT04633447|460700175|FG000|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|2|||
128020733|NCT04633447|460700176|FG001|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|0|||
128020734|NCT04633447|460700175|FG000|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|3|||
128020735|NCT04633447|460700176|FG001|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|2|||
128020736|NCT04633447|460700175|FG000|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
128020737|NCT04633447|460700176|FG001|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
128020738|NCT01778985|460700178|FG000|Overall Study|Lost to Follow-up|1|||
128020739|NCT01778985|460700179|FG001|Overall Study|Lost to Follow-up|0|||
128020740|NCT01778985|460700178|FG000|Overall Study|Physician Decision|2|||
128020741|NCT01778985|460700179|FG001|Overall Study|Physician Decision|2|||
128020742|NCT01778985|460700178|FG000|Overall Study|Protocol Violation|4|||
128020743|NCT01778985|460700179|FG001|Overall Study|Protocol Violation|1|||
128020744|NCT00088881|460700180|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
128020745|NCT00088881|460700180|FG000|Step 1 - R-CHOP|Adverse Event|1|||
128020746|NCT00088881|460700180|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
128020747|NCT00088881|460700180|FG000|Step 1 - R-CHOP|Physician Decision|1|||
128020748|NCT00088881|460700180|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
128020749|NCT00088881|460700180|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
128020750|NCT00088881|460700180|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
128020751|NCT01631188|460700186|FG000|Overall Study|Physician Decision|75|||
128020752|NCT00835978|460700187|FG000|Overall Study|Death|33|||
128020753|NCT00835978|460700188|FG001|Overall Study|Death|40|||
128020754|NCT00835978|460700189|FG002|Overall Study|Death|49|||
128020755|NCT00835978|460700190|FG003|Overall Study|Death|4|||
128020756|NCT00835978|460700187|FG000|Overall Study|Lost to Follow-up|3|||
128020757|NCT00835978|460700188|FG001|Overall Study|Lost to Follow-up|4|||
128020758|NCT00835978|460700189|FG002|Overall Study|Lost to Follow-up|2|||
128020759|NCT00835978|460700190|FG003|Overall Study|Lost to Follow-up|1|||
128020760|NCT00835978|460700187|FG000|Overall Study|Other|5|||
128020761|NCT00835978|460700188|FG001|Overall Study|Other|1|||
128020762|NCT00835978|460700189|FG002|Overall Study|Other|8|||
128020763|NCT00835978|460700190|FG003|Overall Study|Other|0|||
128020764|NCT00835978|460700187|FG000|Overall Study|Objective progression or relapse|2|||
128020765|NCT00835978|460700188|FG001|Overall Study|Objective progression or relapse|0|||
128020766|NCT00835978|460700189|FG002|Overall Study|Objective progression or relapse|1|||
128020767|NCT00835978|460700190|FG003|Overall Study|Objective progression or relapse|0|||
128020768|NCT00835978|460700187|FG000|Overall Study|Adverse Event|1|||
128020769|NCT00835978|460700188|FG001|Overall Study|Adverse Event|0|||
128020770|NCT00835978|460700189|FG002|Overall Study|Adverse Event|1|||
128020771|NCT00835978|460700190|FG003|Overall Study|Adverse Event|0|||
128020772|NCT00835978|460700187|FG000|Overall Study|Withdrawal by Subject|0|||
128020773|NCT00835978|460700188|FG001|Overall Study|Withdrawal by Subject|3|||
128020774|NCT00835978|460700189|FG002|Overall Study|Withdrawal by Subject|0|||
128020775|NCT00835978|460700190|FG003|Overall Study|Withdrawal by Subject|5|||
128020776|NCT00835978|460700187|FG000|Overall Study|Study terminated by sponsor|12|||
128020777|NCT00835978|460700188|FG001|Overall Study|Study terminated by sponsor|8|||
128020778|NCT00835978|460700189|FG002|Overall Study|Study terminated by sponsor|30|||
128020779|NCT00835978|460700190|FG003|Overall Study|Study terminated by sponsor|0|||
128020780|NCT03684057|460700191|FG000|Overall Study|Withdrawal by Subject|4|||
128020781|NCT03684057|460700192|FG001|Overall Study|Withdrawal by Subject|5|||
128020782|NCT01105130|460700193|FG000|Overall Study|Withdrawal by Subject|4|||
128020783|NCT01105130|460700194|FG001|Overall Study|Withdrawal by Subject|6|||
128020784|NCT01105130|460700195|FG002|Overall Study|Withdrawal by Subject|2|||
128020785|NCT01105130|460700193|FG000|Overall Study|Never Started|2|||
128020786|NCT01105130|460700194|FG001|Overall Study|Never Started|2|||
128020787|NCT01105130|460700195|FG002|Overall Study|Never Started|4|||
128020788|NCT01105130|460700193|FG000|Overall Study|Toxicity|1|||
128020789|NCT01105130|460700194|FG001|Overall Study|Toxicity|3|||
128020790|NCT01105130|460700195|FG002|Overall Study|Toxicity|2|||
127553667|NCT02453711|458993952|FG000|Overall Study|Lost to Follow-up|5|||
127553668|NCT02453711|458993953|FG001|Overall Study|Lost to Follow-up|3|||
127553669|NCT02453711|458993954|FG002|Overall Study|Lost to Follow-up|2|||
127553670|NCT02453711|458993955|FG003|Overall Study|Lost to Follow-up|3|||
128020791|NCT01105130|460700193|FG000|Overall Study|Multiple Reasons|3|||
128020792|NCT01105130|460700194|FG001|Overall Study|Multiple Reasons|0|||
128020793|NCT01105130|460700195|FG002|Overall Study|Multiple Reasons|2|||
128020794|NCT02927145|460700198|FG000|Initial Recruitment|Withdrawal by Subject|0|||
127553671|NCT02453711|458993956|FG004|Overall Study|Lost to Follow-up|1|||
128020795|NCT02927145|460700199|FG001|Initial Recruitment|Withdrawal by Subject|1|||
128020796|NCT02927145|460700200|FG002|Initial Recruitment|Withdrawal by Subject|1|||
128020797|NCT02927145|460700201|FG003|Initial Recruitment|Withdrawal by Subject|4|||
128020798|NCT02927145|460700202|FG004|Initial Recruitment|Withdrawal by Subject|1|||
128020799|NCT02927145|460700203|FG005|Initial Recruitment|Withdrawal by Subject|1|||
128020800|NCT02927145|460700204|FG006|Initial Recruitment|Withdrawal by Subject|0|||
128020801|NCT02927145|460700205|FG007|Initial Recruitment|Withdrawal by Subject|0|||
128020802|NCT02927145|460700206|FG008|Initial Recruitment|Withdrawal by Subject|2|||
128020803|NCT02927145|460700198|FG000|Initial Recruitment|Adverse Event|0|||
128020804|NCT02927145|460700199|FG001|Initial Recruitment|Adverse Event|0|||
128020805|NCT02927145|460700200|FG002|Initial Recruitment|Adverse Event|0|||
128020806|NCT02927145|460700201|FG003|Initial Recruitment|Adverse Event|0|||
128020807|NCT02927145|460700202|FG004|Initial Recruitment|Adverse Event|2|||
128020808|NCT02927145|460700203|FG005|Initial Recruitment|Adverse Event|0|||
128020809|NCT02927145|460700204|FG006|Initial Recruitment|Adverse Event|0|||
127553672|NCT02453711|458993957|FG005|Overall Study|Lost to Follow-up|5|||
127553673|NCT02453711|458993958|FG006|Overall Study|Lost to Follow-up|2|||
127553674|NCT02453711|458993959|FG007|Overall Study|Lost to Follow-up|6|||
127553675|NCT02453711|458993960|FG008|Overall Study|Lost to Follow-up|6|||
127553676|NCT02453711|458993952|FG000|Overall Study|Death|0|||
127553677|NCT02453711|458993953|FG001|Overall Study|Death|0|||
127553678|NCT02453711|458993954|FG002|Overall Study|Death|0|||
127553679|NCT02453711|458993955|FG003|Overall Study|Death|0|||
127553680|NCT02453711|458993956|FG004|Overall Study|Death|0|||
127553681|NCT02453711|458993957|FG005|Overall Study|Death|0|||
127553682|NCT02453711|458993958|FG006|Overall Study|Death|1|||
127553683|NCT02453711|458993959|FG007|Overall Study|Death|0|||
127553684|NCT02453711|458993960|FG008|Overall Study|Death|0|||
127553685|NCT02453711|458993952|FG000|Overall Study|Unclassified|1|||
127553686|NCT02453711|458993953|FG001|Overall Study|Unclassified|0|||
127553687|NCT02453711|458993954|FG002|Overall Study|Unclassified|1|||
127553688|NCT02453711|458993955|FG003|Overall Study|Unclassified|0|||
127553689|NCT02453711|458993956|FG004|Overall Study|Unclassified|0|||
127553690|NCT02453711|458993957|FG005|Overall Study|Unclassified|0|||
127553691|NCT02453711|458993958|FG006|Overall Study|Unclassified|0|||
127553692|NCT02453711|458993959|FG007|Overall Study|Unclassified|0|||
127553693|NCT02453711|458993960|FG008|Overall Study|Unclassified|0|||
127553694|NCT01273519|458993963|FG000|Overall Study|Adverse Event|3|||
127553695|NCT01273519|458993964|FG001|Overall Study|Adverse Event|0|||
127553696|NCT01273519|458993965|FG002|Overall Study|Adverse Event|0|||
127553697|NCT01273519|458993963|FG000|Overall Study|Lost to Follow-up|2|||
127553698|NCT01273519|458993964|FG001|Overall Study|Lost to Follow-up|1|||
127553699|NCT01273519|458993965|FG002|Overall Study|Lost to Follow-up|3|||
127553700|NCT01273519|458993963|FG000|Overall Study|Lack of Efficacy|8|||
127553701|NCT01273519|458993964|FG001|Overall Study|Lack of Efficacy|3|||
127553702|NCT01273519|458993965|FG002|Overall Study|Lack of Efficacy|4|||
127553703|NCT01273519|458993963|FG000|Overall Study|Other|6|||
127553704|NCT01273519|458993964|FG001|Overall Study|Other|1|||
127553705|NCT01273519|458993965|FG002|Overall Study|Other|1|||
127553706|NCT04292899|458993966|FG000|Overall Study|Death|21|||
127553707|NCT04292899|458993967|FG001|Overall Study|Death|28|||
127553708|NCT04292899|458993968|FG002|Overall Study|Death|188|||
127553709|NCT04292899|458993969|FG003|Overall Study|Death|371|||
127553710|NCT04292899|458993966|FG000|Overall Study|Lost to Follow-up|8|||
127553711|NCT04292899|458993967|FG001|Overall Study|Lost to Follow-up|4|||
127553712|NCT04292899|458993968|FG002|Overall Study|Lost to Follow-up|22|||
127553713|NCT04292899|458993969|FG003|Overall Study|Lost to Follow-up|235|||
127553714|NCT04292899|458993966|FG000|Overall Study|Withdrew consent|1|||
127553715|NCT04292899|458993967|FG001|Overall Study|Withdrew consent|0|||
127553716|NCT04292899|458993968|FG002|Overall Study|Withdrew consent|11|||
127553717|NCT04292899|458993969|FG003|Overall Study|Withdrew consent|32|||
127553718|NCT04292899|458993966|FG000|Overall Study|Adverse Event|2|||
127553719|NCT04292899|458993967|FG001|Overall Study|Adverse Event|1|||
127553720|NCT04292899|458993968|FG002|Overall Study|Adverse Event|2|||
127553721|NCT04292899|458993969|FG003|Overall Study|Adverse Event|2|||
127553722|NCT04292899|458993966|FG000|Overall Study|Investigator's Discretion|0|||
127553723|NCT04292899|458993967|FG001|Overall Study|Investigator's Discretion|0|||
127553724|NCT04292899|458993968|FG002|Overall Study|Investigator's Discretion|0|||
127553725|NCT04292899|458993969|FG003|Overall Study|Investigator's Discretion|3|||
127553726|NCT04292899|458993966|FG000|Overall Study|Non-compliance With Study Drug|0|||
127553727|NCT04292899|458993967|FG001|Overall Study|Non-compliance With Study Drug|0|||
127553728|NCT04292899|458993968|FG002|Overall Study|Non-compliance With Study Drug|0|||
127553729|NCT04292899|458993969|FG003|Overall Study|Non-compliance With Study Drug|1|||
127553730|NCT04292899|458993966|FG000|Overall Study|Protocol Violation|0|||
127553731|NCT04292899|458993967|FG001|Overall Study|Protocol Violation|0|||
127553732|NCT04292899|458993968|FG002|Overall Study|Protocol Violation|0|||
127553733|NCT04292899|458993969|FG003|Overall Study|Protocol Violation|1|||
127553734|NCT03695367|458993970|FG000|Overall Study|Missed the Day 28 visit.|1|||
128020810|NCT02927145|460700205|FG007|Initial Recruitment|Adverse Event|0|||
128020811|NCT02927145|460700206|FG008|Initial Recruitment|Adverse Event|0|||
127553735|NCT03695367|458993971|FG001|Overall Study|Missed the Day 28 visit.|0|||
127553736|NCT03695367|458993970|FG000|Overall Study|Lost to Follow-up|0|||
127553737|NCT03695367|458993971|FG001|Overall Study|Lost to Follow-up|1|||
127553738|NCT03695367|458993970|FG000|Overall Study|Withdrawal by Subject|0|||
127553739|NCT03695367|458993971|FG001|Overall Study|Withdrawal by Subject|1|||
127553740|NCT03695367|458993970|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
127553741|NCT03695367|458993971|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
127553742|NCT02687191|458995545|FG000|Overall Study|Death|0|||
127553743|NCT02687191|458995546|FG001|Overall Study|Death|1|||
127553744|NCT02687191|458995547|FG002|Overall Study|Death|1|||
127553745|NCT02687191|458995548|FG003|Overall Study|Death|0|||
127553746|NCT02687191|458995549|FG004|Overall Study|Death|1|||
127553747|NCT02687191|458995550|FG005|Overall Study|Death|1|||
127553748|NCT02687191|458995545|FG000|Overall Study|Withdrawal by Subject|0|||
127553749|NCT02687191|458995546|FG001|Overall Study|Withdrawal by Subject|0|||
127553750|NCT02687191|458995547|FG002|Overall Study|Withdrawal by Subject|0|||
127553751|NCT02687191|458995548|FG003|Overall Study|Withdrawal by Subject|1|||
127553752|NCT02687191|458995549|FG004|Overall Study|Withdrawal by Subject|0|||
127553753|NCT02687191|458995550|FG005|Overall Study|Withdrawal by Subject|0|||
127553754|NCT01788358|458995551|FG000|Overall Study|Other|11|||
127553755|NCT01788358|458995551|FG000|Overall Study|Logistical difficulties|1|||
127553756|NCT01788358|458995551|FG000|Overall Study|Lost to Follow-up|5|||
127553757|NCT01788358|458995551|FG000|Overall Study|Protocol Violation|3|||
127553758|NCT01788358|458995551|FG000|Overall Study|Withdrawal by Subject|26|||
127553759|NCT01788358|458995551|FG000|Overall Study|Lack of Efficacy|1|||
127553760|NCT01788358|458995551|FG000|Overall Study|Adverse Event|51|||
127553761|NCT02873702|458995554|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
127553762|NCT02873702|458995555|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
127553763|NCT02873702|458995556|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
127553764|NCT02873702|458995557|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
127553765|NCT02873702|458995554|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
127553766|NCT02873702|458995555|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
127553767|NCT02873702|458995556|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
127553768|NCT02873702|458995557|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
127553769|NCT02873702|458995554|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
127553770|NCT02873702|458995555|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
127553771|NCT02873702|458995556|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
127553772|NCT02873702|458995557|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
127553773|NCT02873702|458995554|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
127553774|NCT02873702|458995555|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
127553775|NCT02873702|458995556|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
127553776|NCT02873702|458995557|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
127553777|NCT02873702|458995554|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
127553778|NCT02873702|458995555|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
127553779|NCT02873702|458995556|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
127553780|NCT02873702|458995557|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
127553781|NCT01039376|458995560|FG000|Overall Study|Lost to Follow-up|5|||
127553782|NCT01039376|458995561|FG001|Overall Study|Lost to Follow-up|12|||
127553783|NCT01039376|458995560|FG000|Overall Study|Physician Decision|15|||
127553784|NCT01039376|458995561|FG001|Overall Study|Physician Decision|10|||
127553785|NCT01039376|458995560|FG000|Overall Study|Withdrawal by Subject|20|||
127553786|NCT01039376|458995561|FG001|Overall Study|Withdrawal by Subject|32|||
127553787|NCT01039376|458995560|FG000|Overall Study|Study terminated by Sponsor|90|||
127553788|NCT01039376|458995561|FG001|Overall Study|Study terminated by Sponsor|72|||
127553789|NCT03252925|458995562|FG000|Overall Study|Withdrawal by Subject|1|||
127553790|NCT03252925|458995563|FG001|Overall Study|Withdrawal by Subject|0|||
127553791|NCT03252925|458995562|FG000|Overall Study|Protocol Violation|6|||
127553792|NCT03252925|458995563|FG001|Overall Study|Protocol Violation|0|||
127553793|NCT03252925|458995562|FG000|Overall Study|Adverse Event|1|||
127553794|NCT03252925|458995563|FG001|Overall Study|Adverse Event|0|||
127553795|NCT03252925|458995562|FG000|Overall Study|Lost to Follow-up|6|||
127553796|NCT03252925|458995563|FG001|Overall Study|Lost to Follow-up|6|||
127553797|NCT04555616|458995564|FG000|Overall Study|Death|1|||
127553798|NCT04555616|458995565|FG001|Overall Study|Death|0|||
127553799|NCT04555616|458995566|FG002|Overall Study|Death|1|||
127553800|NCT04555616|458995564|FG000|Overall Study|Withdrawal by Subject|2|||
127553801|NCT04555616|458995565|FG001|Overall Study|Withdrawal by Subject|1|||
127553802|NCT04555616|458995566|FG002|Overall Study|Withdrawal by Subject|0|||
127553803|NCT04816669|458995567|FG000|Part 1|Adverse Event|1|||
127553804|NCT04816669|458995568|FG001|Part 1|Adverse Event|1|||
127553805|NCT04816669|458995569|FG002|Part 1|Adverse Event|0|||
127553806|NCT04816669|458995570|FG003|Part 1|Adverse Event|0|||
127553807|NCT04816669|458995567|FG000|Part 1|Lost to Follow-up|2|||
127553808|NCT04816669|458995568|FG001|Part 1|Lost to Follow-up|2|||
127553809|NCT04816669|458995569|FG002|Part 1|Lost to Follow-up|0|||
127553810|NCT04816669|458995570|FG003|Part 1|Lost to Follow-up|0|||
127553811|NCT04816669|458995567|FG000|Part 1|Protocol Violation|0|||
127553812|NCT04816669|458995568|FG001|Part 1|Protocol Violation|1|||
127553813|NCT04816669|458995569|FG002|Part 1|Protocol Violation|0|||
127553814|NCT04816669|458995570|FG003|Part 1|Protocol Violation|0|||
127553815|NCT04816669|458995567|FG000|Part 1|Withdrawal by Subject|1|||
127553816|NCT04816669|458995568|FG001|Part 1|Withdrawal by Subject|2|||
127553817|NCT04816669|458995569|FG002|Part 1|Withdrawal by Subject|0|||
127553818|NCT04816669|458995570|FG003|Part 1|Withdrawal by Subject|0|||
127553819|NCT04816669|458995567|FG000|Part 2|Other|0|||
127553820|NCT04816669|458995568|FG001|Part 2|Other|0|||
127553821|NCT04816669|458995569|FG002|Part 2|Other|1|||
127553822|NCT04816669|458995570|FG003|Part 2|Other|0|||
127553823|NCT04816669|458995567|FG000|Part 2|Withdrawal by Subject|0|||
127553824|NCT04816669|458995568|FG001|Part 2|Withdrawal by Subject|0|||
127553825|NCT04816669|458995569|FG002|Part 2|Withdrawal by Subject|0|||
127553826|NCT04816669|458995570|FG003|Part 2|Withdrawal by Subject|1|||
127553827|NCT04816669|458995567|FG000|Part 2|Lost to Follow-up|0|||
127553828|NCT04816669|458995568|FG001|Part 2|Lost to Follow-up|0|||
127553829|NCT04816669|458995569|FG002|Part 2|Lost to Follow-up|1|||
127773662|NCT02805725|459798545|FG003|Phase I (Dose Escalation Part)|Clinical progression|0|||
127773663|NCT02805725|459798546|FG004|Phase I (Dose Escalation Part)|Clinical progression|0|||
127773664|NCT02805725|459798542|FG000|Phase I (Dose Escalation Part)|Adverse Event|0|||
127773665|NCT02805725|459798543|FG001|Phase I (Dose Escalation Part)|Adverse Event|0|||
127773666|NCT02805725|459798544|FG002|Phase I (Dose Escalation Part)|Adverse Event|1|||
127773667|NCT02805725|459798545|FG003|Phase I (Dose Escalation Part)|Adverse Event|2|||
127773668|NCT02805725|459798546|FG004|Phase I (Dose Escalation Part)|Adverse Event|0|||
127773669|NCT02805725|459798542|FG000|Phase II|Protocol Violation|0|||
127773670|NCT02805725|459798543|FG001|Phase II|Protocol Violation|0|||
127773671|NCT02805725|459798544|FG002|Phase II|Protocol Violation|0|||
128020812|NCT02927145|460700198|FG000|Invitation for Additional Challenge|Pregnancy|0|||
128020813|NCT02927145|460700199|FG001|Invitation for Additional Challenge|Pregnancy|0|||
127553830|NCT04816669|458995570|FG003|Part 2|Lost to Follow-up|0|||
127553831|NCT01229267|458995571|FG000|Overall Study|Adverse Event|4|||
127553832|NCT01229267|458995572|FG001|Overall Study|Adverse Event|6|||
127553833|NCT01229267|458995573|FG002|Overall Study|Adverse Event|3|||
127553834|NCT01229267|458995574|FG003|Overall Study|Adverse Event|2|||
127553835|NCT01229267|458995575|FG004|Overall Study|Adverse Event|10|||
127553836|NCT01229267|458995571|FG000|Overall Study|Death|40|||
127553837|NCT01229267|458995572|FG001|Overall Study|Death|37|||
127553838|NCT01229267|458995573|FG002|Overall Study|Death|35|||
127553839|NCT01229267|458995574|FG003|Overall Study|Death|13|||
127553840|NCT01229267|458995575|FG004|Overall Study|Death|103|||
127553841|NCT01229267|458995571|FG000|Overall Study|Withdrawal by Subject|23|||
127553842|NCT01229267|458995572|FG001|Overall Study|Withdrawal by Subject|22|||
127553843|NCT01229267|458995573|FG002|Overall Study|Withdrawal by Subject|32|||
127553844|NCT01229267|458995574|FG003|Overall Study|Withdrawal by Subject|14|||
127553845|NCT01229267|458995575|FG004|Overall Study|Withdrawal by Subject|59|||
127553846|NCT01229267|458995571|FG000|Overall Study|Protocol Violation|0|||
127553847|NCT01229267|458995572|FG001|Overall Study|Protocol Violation|1|||
127553848|NCT01229267|458995573|FG002|Overall Study|Protocol Violation|0|||
127553849|NCT01229267|458995574|FG003|Overall Study|Protocol Violation|0|||
127553850|NCT01229267|458995575|FG004|Overall Study|Protocol Violation|0|||
127553851|NCT01229267|458995571|FG000|Overall Study|Progressive disease|0|||
127553852|NCT01229267|458995572|FG001|Overall Study|Progressive disease|0|||
127553853|NCT01229267|458995573|FG002|Overall Study|Progressive disease|0|||
127553854|NCT01229267|458995574|FG003|Overall Study|Progressive disease|0|||
127553855|NCT01229267|458995575|FG004|Overall Study|Progressive disease|1|||
127553856|NCT01229267|458995571|FG000|Overall Study|Physician Decision|8|||
127553857|NCT01229267|458995572|FG001|Overall Study|Physician Decision|11|||
127553858|NCT01229267|458995573|FG002|Overall Study|Physician Decision|8|||
127553859|NCT01229267|458995574|FG003|Overall Study|Physician Decision|3|||
127553860|NCT01229267|458995575|FG004|Overall Study|Physician Decision|25|||
127553861|NCT01229267|458995571|FG000|Overall Study|Lost to Follow-up|6|||
127553862|NCT01229267|458995572|FG001|Overall Study|Lost to Follow-up|5|||
127553863|NCT01229267|458995573|FG002|Overall Study|Lost to Follow-up|8|||
127553864|NCT01229267|458995574|FG003|Overall Study|Lost to Follow-up|3|||
127553865|NCT01229267|458995575|FG004|Overall Study|Lost to Follow-up|22|||
127553866|NCT02446899|458995580|FG000|Overall Study|Adverse Event|4|||
127553867|NCT02446899|458995581|FG001|Overall Study|Adverse Event|7|||
127553868|NCT02446899|458995580|FG000|Overall Study|Condition Under Investigation Worsened|1|||
127553869|NCT02446899|458995581|FG001|Overall Study|Condition Under Investigation Worsened|4|||
127553870|NCT02446899|458995580|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
127553871|NCT02446899|458995581|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
127553872|NCT02446899|458995580|FG000|Overall Study|Lack of Efficacy|2|||
127553873|NCT02446899|458995581|FG001|Overall Study|Lack of Efficacy|8|||
127553874|NCT02446899|458995580|FG000|Overall Study|Lost to Follow-up|1|||
127553875|NCT02446899|458995581|FG001|Overall Study|Lost to Follow-up|3|||
128020814|NCT02927145|460700200|FG002|Invitation for Additional Challenge|Pregnancy|0|||
128020815|NCT02927145|460700201|FG003|Invitation for Additional Challenge|Pregnancy|0|||
127553876|NCT02446899|458995580|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
127553877|NCT02446899|458995581|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
127553878|NCT02446899|458995580|FG000|Overall Study|Withdrawal by Subject|11|||
127553879|NCT02446899|458995581|FG001|Overall Study|Withdrawal by Subject|19|||
127553880|NCT02446899|458995580|FG000|Overall Study|Miscellaneous|5|||
127553881|NCT02446899|458995581|FG001|Overall Study|Miscellaneous|4|||
127773672|NCT02805725|459798545|FG003|Phase II|Protocol Violation|0|||
127773673|NCT02805725|459798546|FG004|Phase II|Protocol Violation|6|||
127773674|NCT01195545|459798547|FG000|Overall Study|Protocol Violation|4|||
127881007|NCT02756078|460186098|FG001|Period 2|Adverse Event|5|||
127553882|NCT02446899|458995580|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
127553883|NCT02446899|458995581|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
127553884|NCT04050202|458995582|FG000|Overall Study|Lost to Follow-up|2|||
127553885|NCT01499277|458995586|FG000|Overall Study|Adverse Event|3|||
127553886|NCT01499277|458995587|FG001|Overall Study|Adverse Event|6|||
127553887|NCT01499277|458995586|FG000|Overall Study|Death|3|||
128020816|NCT02927145|460700202|FG004|Invitation for Additional Challenge|Pregnancy|0|||
128020817|NCT02927145|460700203|FG005|Invitation for Additional Challenge|Pregnancy|0|||
128020818|NCT02927145|460700204|FG006|Invitation for Additional Challenge|Pregnancy|1|||
128020819|NCT02927145|460700205|FG007|Invitation for Additional Challenge|Pregnancy|0|||
128020820|NCT02927145|460700206|FG008|Invitation for Additional Challenge|Pregnancy|0|||
128020821|NCT00327171|460700207|FG000|Overall Study|Did not receive study medication|3|||
128020822|NCT00327171|460700208|FG001|Overall Study|Did not receive study medication|0|||
128020823|NCT00327171|460700207|FG000|Overall Study|Adverse Event|23|||
128020824|NCT00327171|460700208|FG001|Overall Study|Adverse Event|23|||
128020825|NCT00327171|460700207|FG000|Overall Study|Disease progression/lack of efficacy|68|||
128020826|NCT00327171|460700208|FG001|Overall Study|Disease progression/lack of efficacy|69|||
128020827|NCT00327171|460700207|FG000|Overall Study|Investigator/participant request|1|||
128020828|NCT00327171|460700208|FG001|Overall Study|Investigator/participant request|8|||
128020829|NCT00327171|460700207|FG000|Overall Study|Clinical progression|12|||
128020830|NCT00327171|460700208|FG001|Overall Study|Clinical progression|8|||
128020831|NCT00327171|460700207|FG000|Overall Study|Undisclosed history of ischemia|0|||
128020832|NCT00327171|460700208|FG001|Overall Study|Undisclosed history of ischemia|1|||
128020833|NCT00327171|460700207|FG000|Overall Study|Other|1|||
128020834|NCT00327171|460700208|FG001|Overall Study|Other|0|||
128020835|NCT01363440|460700209|FG000|Overall Study|Adverse Event|5|||
128020836|NCT01363440|460700210|FG001|Overall Study|Adverse Event|4|||
128020837|NCT01363440|460700211|FG002|Overall Study|Adverse Event|4|||
128020838|NCT01363440|460700209|FG000|Overall Study|Death|3|||
128020839|NCT01363440|460700210|FG001|Overall Study|Death|7|||
128020840|NCT01363440|460700211|FG002|Overall Study|Death|5|||
128020841|NCT01363440|460700209|FG000|Overall Study|Withdrawal by Subject|9|||
128020842|NCT01363440|460700210|FG001|Overall Study|Withdrawal by Subject|11|||
128020843|NCT01363440|460700211|FG002|Overall Study|Withdrawal by Subject|11|||
128020844|NCT01363440|460700209|FG000|Overall Study|Lost to Follow-up|2|||
128020845|NCT01363440|460700210|FG001|Overall Study|Lost to Follow-up|4|||
128020846|NCT01363440|460700211|FG002|Overall Study|Lost to Follow-up|5|||
128020847|NCT01363440|460700209|FG000|Overall Study|Other|4|||
128020848|NCT01363440|460700210|FG001|Overall Study|Other|5|||
128020849|NCT01363440|460700211|FG002|Overall Study|Other|2|||
128020850|NCT02506036|460700214|FG000|First Intervention (4-6 Weeks)|Death|1|||
128020851|NCT02506036|460700215|FG001|First Intervention (4-6 Weeks)|Death|0|||
128020852|NCT02506036|460700214|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
128020853|NCT02506036|460700215|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
128020854|NCT02506036|460700214|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
128020855|NCT02506036|460700215|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
128020856|NCT00530075|460700216|FG000|Overall Study|Adverse Event|1|||
128020857|NCT00530075|460700216|FG000|Overall Study|Death|1|||
128020858|NCT00530075|460700216|FG000|Overall Study|Lack of Efficacy|3|||
128020859|NCT00530075|460700216|FG000|Overall Study|Protocol Violation|1|||
128020860|NCT00530075|460700216|FG000|Overall Study|Withdrawal by Subject|1|||
128020861|NCT00758043|460700220|FG000|Overall Study|Adverse Event|1|||
128020862|NCT00758043|460700221|FG001|Overall Study|Adverse Event|20|||
128020863|NCT00758043|460700222|FG002|Overall Study|Adverse Event|12|||
128020864|NCT00758043|460700223|FG003|Overall Study|Adverse Event|62|||
128020865|NCT00758043|460700220|FG000|Overall Study|Lack of Efficacy|0|||
128020866|NCT00758043|460700221|FG001|Overall Study|Lack of Efficacy|6|||
128020867|NCT00758043|460700222|FG002|Overall Study|Lack of Efficacy|18|||
128020868|NCT00758043|460700223|FG003|Overall Study|Lack of Efficacy|12|||
128020869|NCT00758043|460700220|FG000|Overall Study|Refused Further Treatment|0|||
128020870|NCT00758043|460700221|FG001|Overall Study|Refused Further Treatment|11|||
128020871|NCT00758043|460700222|FG002|Overall Study|Refused Further Treatment|5|||
128020872|NCT00758043|460700223|FG003|Overall Study|Refused Further Treatment|8|||
128020873|NCT00758043|460700220|FG000|Overall Study|Lost to Follow-up|0|||
128020874|NCT00758043|460700221|FG001|Overall Study|Lost to Follow-up|2|||
128020875|NCT00758043|460700222|FG002|Overall Study|Lost to Follow-up|2|||
128020876|NCT00758043|460700223|FG003|Overall Study|Lost to Follow-up|5|||
128020877|NCT00758043|460700220|FG000|Overall Study|Withdrawal by Subject|0|||
128020878|NCT00758043|460700221|FG001|Overall Study|Withdrawal by Subject|1|||
128020879|NCT00758043|460700222|FG002|Overall Study|Withdrawal by Subject|1|||
128020880|NCT00758043|460700223|FG003|Overall Study|Withdrawal by Subject|4|||
128020881|NCT00758043|460700220|FG000|Overall Study|Required Prohibited Medication|0|||
127553888|NCT01499277|458995587|FG001|Overall Study|Death|2|||
128020882|NCT00758043|460700221|FG001|Overall Study|Required Prohibited Medication|0|||
128020883|NCT00758043|460700222|FG002|Overall Study|Required Prohibited Medication|1|||
128020884|NCT00758043|460700223|FG003|Overall Study|Required Prohibited Medication|3|||
128020885|NCT00758043|460700220|FG000|Overall Study|Non-Compliant With study Drug|0|||
128020886|NCT00758043|460700221|FG001|Overall Study|Non-Compliant With study Drug|0|||
128020887|NCT00758043|460700222|FG002|Overall Study|Non-Compliant With study Drug|0|||
128020888|NCT00758043|460700223|FG003|Overall Study|Non-Compliant With study Drug|1|||
128020889|NCT00758043|460700220|FG000|Overall Study|Other Reasons|0|||
128020890|NCT00758043|460700221|FG001|Overall Study|Other Reasons|1|||
127553889|NCT01499277|458995586|FG000|Overall Study|Lost to Follow-up|15|||
127553890|NCT01499277|458995587|FG001|Overall Study|Lost to Follow-up|8|||
127553891|NCT01499277|458995586|FG000|Overall Study|Protocol Violation|2|||
127553892|NCT01499277|458995587|FG001|Overall Study|Protocol Violation|3|||
127553893|NCT01499277|458995586|FG000|Overall Study|Withdrawal by Subject|16|||
127553894|NCT01499277|458995587|FG001|Overall Study|Withdrawal by Subject|6|||
127553895|NCT01499277|458995586|FG000|Overall Study|Lack of therapeutic response and other|8|||
127553896|NCT01499277|458995587|FG001|Overall Study|Lack of therapeutic response and other|7|||
127553897|NCT02141438|458995589|FG000|Overall Study|Death|1308|||
127553898|NCT02141438|458995589|FG000|Overall Study|Lost to Follow-up|84|||
127553899|NCT02141438|458995589|FG000|Overall Study|Withdrawal by Subject|52|||
127553900|NCT02141438|458995589|FG000|Overall Study|Physician Decision|1|||
127553901|NCT02141438|458995589|FG000|Overall Study|Patients without documented end of observation due to premature site closure|5|||
127553902|NCT03675321|458995592|FG000|Overall Study|Lack of Efficacy|2|||
127553903|NCT03675321|458995593|FG001|Overall Study|Lack of Efficacy|2|||
127553904|NCT03675321|458995592|FG000|Overall Study|Withdrawal by Subject|1|||
127553905|NCT03675321|458995593|FG001|Overall Study|Withdrawal by Subject|3|||
127553906|NCT02999672|458995603|FG000|Overall Study|Death|0|||
127553907|NCT02999672|458995604|FG001|Overall Study|Death|1|||
127553908|NCT02999672|458995603|FG000|Overall Study|Study Terminated by Sponsor|0|||
127553909|NCT02999672|458995604|FG001|Overall Study|Study Terminated by Sponsor|1|||
127553910|NCT02999672|458995603|FG000|Overall Study|Progressive Disease|9|||
127553911|NCT02999672|458995604|FG001|Overall Study|Progressive Disease|5|||
127553912|NCT02999672|458995603|FG000|Overall Study|Adverse Event|4|||
127553913|NCT02999672|458995604|FG001|Overall Study|Adverse Event|0|||
127553914|NCT03565497|458995605|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
127553915|NCT03565497|458995606|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
127553916|NCT03565497|458995607|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
127553917|NCT03565497|458995605|FG000|Overall Study|Lost to Follow-up|1|||
127553918|NCT03565497|458995606|FG001|Overall Study|Lost to Follow-up|1|||
127553919|NCT03565497|458995607|FG002|Overall Study|Lost to Follow-up|2|||
127553920|NCT03565497|458995605|FG000|Overall Study|Withdrawal by Subject|1|||
127553921|NCT03565497|458995606|FG001|Overall Study|Withdrawal by Subject|1|||
127553922|NCT03565497|458995607|FG002|Overall Study|Withdrawal by Subject|1|||
127553923|NCT01075685|458995608|FG000|Overall Study|Protocol Violation|9|||
127553924|NCT01075685|458995609|FG001|Overall Study|Protocol Violation|1|||
127553925|NCT01075685|458995608|FG000|Overall Study|Withdrawal by Subject|20|||
127553926|NCT01075685|458995609|FG001|Overall Study|Withdrawal by Subject|5|||
127553927|NCT01075685|458995608|FG000|Overall Study|Lost to Follow-up|563|||
127553928|NCT01075685|458995609|FG001|Overall Study|Lost to Follow-up|220|||
127773675|NCT02425644|459798548|FG000|Overall Study|Lost to Follow-up|2|||
127553929|NCT02858362|458995612|FG000|Overall Study|Protocol Violation|0|||
127553930|NCT02858362|458995613|FG001|Overall Study|Protocol Violation|1|||
127553931|NCT02858362|458995614|FG002|Overall Study|Protocol Violation|0|||
127553932|NCT02858362|458995612|FG000|Overall Study|Withdrawal by Subject|1|||
127553933|NCT02858362|458995613|FG001|Overall Study|Withdrawal by Subject|0|||
127553934|NCT02858362|458995614|FG002|Overall Study|Withdrawal by Subject|0|||
127553935|NCT02858362|458995612|FG000|Overall Study|Early Study Termination|0|||
127553936|NCT02858362|458995613|FG001|Overall Study|Early Study Termination|0|||
127553937|NCT02858362|458995614|FG002|Overall Study|Early Study Termination|3|||
127553938|NCT02858362|458995612|FG000|Overall Study|Lost to Follow-up|1|||
127553939|NCT02858362|458995613|FG001|Overall Study|Lost to Follow-up|0|||
127553940|NCT02858362|458995614|FG002|Overall Study|Lost to Follow-up|0|||
127553941|NCT02194985|458995615|FG000|Overall Study|Adverse Event|1|||
127773676|NCT02425644|459798549|FG001|Overall Study|Lost to Follow-up|3|||
127773677|NCT02425644|459798548|FG000|Overall Study|Withdrawal by Subject|41|||
127773678|NCT02425644|459798549|FG001|Overall Study|Withdrawal by Subject|36|||
127773679|NCT02425644|459798548|FG000|Overall Study|Lack of Efficacy|3|||
127773680|NCT02425644|459798549|FG001|Overall Study|Lack of Efficacy|10|||
128020891|NCT00758043|460700222|FG002|Overall Study|Other Reasons|0|||
128020892|NCT00758043|460700223|FG003|Overall Study|Other Reasons|5|||
127553942|NCT02194985|458995615|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
127553943|NCT02194985|458995615|FG000|Overall Study|Physician Decision|4|||
127553944|NCT02194985|458995615|FG000|Overall Study|Lost to Follow-up|1|||
127553945|NCT02194985|458995615|FG000|Overall Study|Withdrawal by Subject|2|||
127553946|NCT02561832|458995616|FG000|Overall Study|Withdrawal by Subject|1|||
127553947|NCT02561832|458995617|FG001|Overall Study|Withdrawal by Subject|1|||
127553948|NCT02561832|458995616|FG000|Overall Study|Adverse Event|3|||
127553949|NCT02561832|458995617|FG001|Overall Study|Adverse Event|0|||
127553950|NCT02561832|458995616|FG000|Overall Study|Disease progression|3|||
127773681|NCT02425644|459798548|FG000|Overall Study|Adverse Event|13|||
127553951|NCT02561832|458995617|FG001|Overall Study|Disease progression|3|||
127773682|NCT02425644|459798549|FG001|Overall Study|Adverse Event|3|||
127553952|NCT01262989|458995619|FG000|Period 1|Lost to Follow-up|1|||
127553953|NCT01262989|458995620|FG001|Period 1|Lost to Follow-up|1|||
127553954|NCT01262989|458995619|FG000|Period 1|Intercurrent disease|0|||
127553955|NCT01262989|458995620|FG001|Period 1|Intercurrent disease|1|||
127553956|NCT01262989|458995619|FG000|Period 1|Positive answer for exclusion criteria|0|||
127553957|NCT01262989|458995620|FG001|Period 1|Positive answer for exclusion criteria|1|||
127553958|NCT01262989|458995619|FG000|Period 2|Intercurrent disease|0|||
127553959|NCT01262989|458995620|FG001|Period 2|Intercurrent disease|1|||
127553960|NCT03048578|458995621|FG000|Overall Study|Withdrawal by Subject|5|||
127553961|NCT03048578|458995622|FG001|Overall Study|Withdrawal by Subject|6|||
127553962|NCT03048578|458995621|FG000|Overall Study|Lost to Follow-up|22|||
127553963|NCT03048578|458995622|FG001|Overall Study|Lost to Follow-up|10|||
127773683|NCT02425644|459798548|FG000|Overall Study|Death|0|||
127773684|NCT02425644|459798549|FG001|Overall Study|Death|2|||
127773685|NCT02425644|459798548|FG000|Overall Study|Other|18|||
127773686|NCT02425644|459798549|FG001|Overall Study|Other|17|||
127773687|NCT00909792|459798550|FG000|Period 1|Did not meet inclusion criteria|0|||
127773688|NCT00909792|459798551|FG001|Period 1|Did not meet inclusion criteria|1|||
127773689|NCT00909792|459798550|FG000|Period 2|Biomicroscopy|1|||
127773690|NCT00909792|459798551|FG001|Period 2|Biomicroscopy|0|||
127773691|NCT00909792|459798550|FG000|Period 2|Lost to Follow-up|0|||
127773692|NCT00909792|459798551|FG001|Period 2|Lost to Follow-up|1|||
127773693|NCT00293722|459798554|FG000|Overall Study|Other|427|||
127773694|NCT02824263|459798556|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
127773695|NCT02824263|459798557|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
127773696|NCT02824263|459798556|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
127773697|NCT02824263|459798557|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
127773698|NCT00568321|459798558|FG000|Overall Study|Adverse Event|1|||
127773699|NCT00568321|459798559|FG001|Overall Study|Adverse Event|0|||
127773700|NCT00568321|459798560|FG002|Overall Study|Adverse Event|0|||
127773701|NCT00568321|459798558|FG000|Overall Study|Lack of Efficacy|8|||
127773702|NCT00568321|459798559|FG001|Overall Study|Lack of Efficacy|5|||
127773703|NCT00568321|459798560|FG002|Overall Study|Lack of Efficacy|6|||
127773704|NCT00568321|459798558|FG000|Overall Study|Lost to Follow-up|0|||
127773705|NCT00568321|459798559|FG001|Overall Study|Lost to Follow-up|0|||
127773706|NCT00568321|459798560|FG002|Overall Study|Lost to Follow-up|1|||
127773707|NCT00568321|459798558|FG000|Overall Study|Withdrawal by Subject|2|||
127773708|NCT00568321|459798559|FG001|Overall Study|Withdrawal by Subject|0|||
127773709|NCT00568321|459798560|FG002|Overall Study|Withdrawal by Subject|0|||
127773710|NCT00568321|459798558|FG000|Overall Study|Protocol Violation|0|||
127773711|NCT00568321|459798559|FG001|Overall Study|Protocol Violation|0|||
127773712|NCT00568321|459798560|FG002|Overall Study|Protocol Violation|1|||
127773713|NCT00568321|459798558|FG000|Overall Study|Randomized, not treated|2|||
127773714|NCT00568321|459798559|FG001|Overall Study|Randomized, not treated|0|||
127773715|NCT00568321|459798560|FG002|Overall Study|Randomized, not treated|1|||
127773716|NCT00221195|459798561|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
127773717|NCT00221195|459798562|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
127773718|NCT00221195|459798561|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
127773719|NCT00221195|459798562|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
127773720|NCT00221195|459798561|FG000|Washout Period (Months 7-9)|Death|0|||
127773721|NCT00221195|459798562|FG001|Washout Period (Months 7-9)|Death|1|||
127773722|NCT00221195|459798561|FG000|Therapy 2 (Months 10-15)|Death|1|||
127773723|NCT00221195|459798562|FG001|Therapy 2 (Months 10-15)|Death|0|||
127773724|NCT00221195|459798561|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
127773725|NCT00221195|459798562|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
127773726|NCT01369511|459798563|FG000|Overall Study|Adverse Event|1|||
127773727|NCT01369511|459798564|FG001|Overall Study|Adverse Event|1|||
127773728|NCT01369511|459798565|FG002|Overall Study|Adverse Event|5|||
127773729|NCT01369511|459798566|FG003|Overall Study|Adverse Event|0|||
127773730|NCT01369511|459798563|FG000|Overall Study|Entry criteria not met|2|||
127773731|NCT01369511|459798564|FG001|Overall Study|Entry criteria not met|0|||
127773732|NCT01369511|459798565|FG002|Overall Study|Entry criteria not met|0|||
127773733|NCT01369511|459798566|FG003|Overall Study|Entry criteria not met|1|||
127773734|NCT01369511|459798563|FG000|Overall Study|Lost to Follow-up|0|||
127773735|NCT01369511|459798564|FG001|Overall Study|Lost to Follow-up|1|||
127773736|NCT01369511|459798565|FG002|Overall Study|Lost to Follow-up|1|||
127773737|NCT01369511|459798566|FG003|Overall Study|Lost to Follow-up|2|||
127553964|NCT03048578|458995621|FG000|Overall Study|Adverse Event|1|||
127773738|NCT01369511|459798563|FG000|Overall Study|Protocol Violation|0|||
127773739|NCT01369511|459798564|FG001|Overall Study|Protocol Violation|1|||
127773740|NCT01369511|459798565|FG002|Overall Study|Protocol Violation|0|||
127773741|NCT01369511|459798566|FG003|Overall Study|Protocol Violation|2|||
127773742|NCT01369511|459798563|FG000|Overall Study|Physician Decision|3|||
127773743|NCT01369511|459798564|FG001|Overall Study|Physician Decision|4|||
127553965|NCT03048578|458995622|FG001|Overall Study|Adverse Event|2|||
127773744|NCT01369511|459798565|FG002|Overall Study|Physician Decision|0|||
127773745|NCT01369511|459798566|FG003|Overall Study|Physician Decision|0|||
127773746|NCT01369511|459798563|FG000|Overall Study|Sponsor decision|2|||
127773747|NCT01369511|459798564|FG001|Overall Study|Sponsor decision|0|||
127553966|NCT03048578|458995621|FG000|Overall Study|Terminated|3|||
127553967|NCT03048578|458995622|FG001|Overall Study|Terminated|2|||
127773748|NCT01369511|459798565|FG002|Overall Study|Sponsor decision|1|||
127773749|NCT01369511|459798566|FG003|Overall Study|Sponsor decision|0|||
127553968|NCT00996333|458995625|FG000|Overall Study|Screen failure|1|||
127553969|NCT00996333|458995625|FG000|Overall Study|Withdrawal by Subject|1|||
127553970|NCT00996333|458995625|FG000|Overall Study|Death|4|||
127553971|NCT00996333|458995625|FG000|Overall Study|Adverse Event|1|||
127553972|NCT00996333|458995625|FG000|Overall Study|Physician Decision|1|||
127553973|NCT00996333|458995625|FG000|Overall Study|Other|5|||
127553974|NCT03566485|458995626|FG000|Overall Study|Disease progression|5|||
127553975|NCT03566485|458995627|FG001|Overall Study|Disease progression|4|||
127553976|NCT03566485|458995626|FG000|Overall Study|Clinical progression|0|||
127553977|NCT03566485|458995627|FG001|Overall Study|Clinical progression|1|||
127553978|NCT03566485|458995626|FG000|Overall Study|Toxicity|0|||
127553979|NCT03566485|458995627|FG001|Overall Study|Toxicity|2|||
127553980|NCT04999852|458995628|FG000|Overall Study|Withdrawal by Subject|11|||
127553981|NCT04999852|458995629|FG001|Overall Study|Withdrawal by Subject|1|||
127553982|NCT04999852|458995628|FG000|Overall Study|Switched to different psychotherapy that was ineligible for study|2|||
127553983|NCT04999852|458995629|FG001|Overall Study|Switched to different psychotherapy that was ineligible for study|0|||
127553984|NCT04939415|458995630|FG000|Overall Study|Withdrawal by Subject|1|||
127553985|NCT04939415|458995631|FG001|Overall Study|Withdrawal by Subject|3|||
127553986|NCT04939415|458995630|FG000|Overall Study|Lost to Follow-up|0|||
127553987|NCT04939415|458995631|FG001|Overall Study|Lost to Follow-up|2|||
127553988|NCT00478023|458995632|FG000|Overall Study|Adverse Event|11|||
127553989|NCT00478023|458995633|FG001|Overall Study|Adverse Event|7|||
127553990|NCT00478023|458995634|FG002|Overall Study|Adverse Event|8|||
127553991|NCT00478023|458995635|FG003|Overall Study|Adverse Event|14|||
127553992|NCT00478023|458995636|FG004|Overall Study|Adverse Event|6|||
127553993|NCT00478023|458995632|FG000|Overall Study|Death|1|||
127553994|NCT00478023|458995633|FG001|Overall Study|Death|0|||
127553995|NCT00478023|458995634|FG002|Overall Study|Death|0|||
127553996|NCT00478023|458995635|FG003|Overall Study|Death|0|||
127553997|NCT00478023|458995636|FG004|Overall Study|Death|0|||
127553998|NCT00478023|458995632|FG000|Overall Study|Lack of Efficacy|11|||
127553999|NCT00478023|458995633|FG001|Overall Study|Lack of Efficacy|10|||
127554000|NCT00478023|458995634|FG002|Overall Study|Lack of Efficacy|4|||
127554001|NCT00478023|458995635|FG003|Overall Study|Lack of Efficacy|5|||
127554002|NCT00478023|458995636|FG004|Overall Study|Lack of Efficacy|41|||
127554003|NCT00478023|458995632|FG000|Overall Study|Lost to Follow-up|3|||
127554004|NCT00478023|458995633|FG001|Overall Study|Lost to Follow-up|1|||
127554005|NCT00478023|458995634|FG002|Overall Study|Lost to Follow-up|1|||
127554006|NCT00478023|458995635|FG003|Overall Study|Lost to Follow-up|1|||
127554007|NCT00478023|458995636|FG004|Overall Study|Lost to Follow-up|0|||
127554008|NCT00478023|458995632|FG000|Overall Study|Withdrawal by Subject|2|||
127554009|NCT00478023|458995633|FG001|Overall Study|Withdrawal by Subject|3|||
127554010|NCT00478023|458995634|FG002|Overall Study|Withdrawal by Subject|2|||
127554011|NCT00478023|458995635|FG003|Overall Study|Withdrawal by Subject|4|||
127554012|NCT00478023|458995636|FG004|Overall Study|Withdrawal by Subject|5|||
127554013|NCT00478023|458995632|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
127554014|NCT00478023|458995633|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
127554015|NCT00478023|458995634|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
127554016|NCT00478023|458995635|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
127554017|NCT00478023|458995636|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
127554018|NCT01209325|458995637|FG000|Overall Study|Lost to Follow-up|24|||
127554019|NCT01209325|458995637|FG000|Overall Study|Adverse Event|1|||
127554020|NCT01209325|458995637|FG000|Overall Study|Relocated|3|||
127554021|NCT01209325|458995637|FG000|Overall Study|Refusal after starting therapy|8|||
127554022|NCT01209325|458995637|FG000|Overall Study|Protocol Violation|4|||
127554023|NCT01209325|458995637|FG000|Overall Study|Refusal prior to therapy|1|||
127554024|NCT01209325|458995637|FG000|Overall Study|Incarceration|2|||
127554025|NCT00396253|458995638|FG000|Overall Study|Protocol Violation|1|||
127554026|NCT00396253|458995638|FG000|Overall Study|Withdrawal by Subject|7|||
127554027|NCT00396253|458995638|FG000|Overall Study|Death|3|||
127554028|NCT00396253|458995638|FG000|Overall Study|Physician Decision|1|||
127554029|NCT00396253|458995638|FG000|Overall Study|Change in eligibility status|1|||
127554030|NCT05340478|458995640|FG000|Overall Study|Scheduling Issues|10|||
127554031|NCT05340478|458995641|FG001|Overall Study|Scheduling Issues|4|||
127554032|NCT05340478|458995640|FG000|Overall Study|Neither member of dyad started treatment|2|||
127554033|NCT05340478|458995641|FG001|Overall Study|Neither member of dyad started treatment|2|||
127554034|NCT05340478|458995640|FG000|Overall Study|Withdrawn from study|2|||
127554035|NCT05340478|458995641|FG001|Overall Study|Withdrawn from study|2|||
127554036|NCT05340478|458995640|FG000|Overall Study|Lost to Follow-up|1|||
127554037|NCT05340478|458995641|FG001|Overall Study|Lost to Follow-up|4|||
127554038|NCT02506244|458995644|FG000|Overall Study|Did not undergo active monitoring|458|||
127554039|NCT02506244|458995645|FG001|Overall Study|Did not undergo active monitoring|459|||
127554040|NCT02506244|458995646|FG002|Overall Study|Did not undergo active monitoring|0|||
127554041|NCT00092443|458995647|FG000|Overall Study|Adverse Event|9|||
127554042|NCT00092443|458995648|FG001|Overall Study|Adverse Event|13|||
127554043|NCT00092443|458995647|FG000|Overall Study|Lost to Follow-up|7|||
127554044|NCT00092443|458995648|FG001|Overall Study|Lost to Follow-up|3|||
127554045|NCT00092443|458995647|FG000|Overall Study|Protocol Violation|11|||
127554046|NCT00092443|458995648|FG001|Overall Study|Protocol Violation|9|||
127554047|NCT00092443|458995647|FG000|Overall Study|Withdrawal by Subject|9|||
127554048|NCT00092443|458995648|FG001|Overall Study|Withdrawal by Subject|11|||
127554049|NCT00092443|458995647|FG000|Overall Study|Moved|5|||
127554050|NCT00092443|458995648|FG001|Overall Study|Moved|5|||
127554051|NCT00092443|458995647|FG000|Overall Study|Other|17|||
127554052|NCT00092443|458995648|FG001|Overall Study|Other|13|||
127554053|NCT01160822|458995649|FG000|Overall Study|Adverse Event|0|||
127554054|NCT01160822|458995650|FG001|Overall Study|Adverse Event|0|||
127554055|NCT01160822|458995651|FG002|Overall Study|Adverse Event|0|||
127554056|NCT01160822|458995652|FG003|Overall Study|Adverse Event|0|||
127554057|NCT01160822|458995653|FG004|Overall Study|Adverse Event|1|||
127554058|NCT01160822|458995654|FG005|Overall Study|Adverse Event|2|||
127554059|NCT01160822|458995655|FG006|Overall Study|Adverse Event|5|||
127554060|NCT01160822|458995649|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
127554061|NCT01160822|458995650|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
127554062|NCT01160822|458995651|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
127554063|NCT01160822|458995652|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
127554064|NCT01160822|458995653|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
127554065|NCT01160822|458995654|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
127554066|NCT01160822|458995655|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
127554067|NCT01160822|458995649|FG000|Overall Study|Withdrawal by Subject|0|||
127554068|NCT01160822|458995650|FG001|Overall Study|Withdrawal by Subject|0|||
127554069|NCT01160822|458995651|FG002|Overall Study|Withdrawal by Subject|0|||
127554070|NCT01160822|458995652|FG003|Overall Study|Withdrawal by Subject|0|||
127554071|NCT01160822|458995653|FG004|Overall Study|Withdrawal by Subject|0|||
127554072|NCT01160822|458995654|FG005|Overall Study|Withdrawal by Subject|0|||
127554073|NCT01160822|458995655|FG006|Overall Study|Withdrawal by Subject|1|||
127554074|NCT01160822|458995649|FG000|Overall Study|Lost to Follow-up|0|||
127554075|NCT01160822|458995650|FG001|Overall Study|Lost to Follow-up|0|||
127554076|NCT01160822|458995651|FG002|Overall Study|Lost to Follow-up|0|||
127554077|NCT01160822|458995652|FG003|Overall Study|Lost to Follow-up|0|||
127554078|NCT01160822|458995653|FG004|Overall Study|Lost to Follow-up|1|||
127554079|NCT01160822|458995654|FG005|Overall Study|Lost to Follow-up|0|||
127554080|NCT01160822|458995655|FG006|Overall Study|Lost to Follow-up|0|||
127554081|NCT01160822|458995649|FG000|Overall Study|Administrative problems|0|||
127554082|NCT01160822|458995650|FG001|Overall Study|Administrative problems|0|||
127554083|NCT01160822|458995651|FG002|Overall Study|Administrative problems|0|||
127554084|NCT01160822|458995652|FG003|Overall Study|Administrative problems|0|||
127554085|NCT01160822|458995653|FG004|Overall Study|Administrative problems|1|||
128020893|NCT02400580|460700227|FG000|Overall Study|Withdrawal by Subject|1|||
127554086|NCT01160822|458995654|FG005|Overall Study|Administrative problems|0|||
127554087|NCT01160822|458995655|FG006|Overall Study|Administrative problems|0|||
127554088|NCT01160822|458995649|FG000|Overall Study|Protocol deviation|0|||
127554089|NCT01160822|458995650|FG001|Overall Study|Protocol deviation|0|||
127554090|NCT01160822|458995651|FG002|Overall Study|Protocol deviation|0|||
127554091|NCT01160822|458995652|FG003|Overall Study|Protocol deviation|0|||
127554092|NCT01160822|458995653|FG004|Overall Study|Protocol deviation|2|||
127554093|NCT01160822|458995654|FG005|Overall Study|Protocol deviation|0|||
127554094|NCT01160822|458995655|FG006|Overall Study|Protocol deviation|0|||
127554095|NCT04717336|458995660|FG000|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
127554096|NCT04717336|458995661|FG001|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
127773750|NCT01369511|459798563|FG000|Overall Study|Withdrawal by Subject|5|||
127773751|NCT01369511|459798564|FG001|Overall Study|Withdrawal by Subject|6|||
127773752|NCT01369511|459798565|FG002|Overall Study|Withdrawal by Subject|4|||
127773753|NCT01369511|459798566|FG003|Overall Study|Withdrawal by Subject|6|||
128020894|NCT02400580|460700228|FG001|Overall Study|Withdrawal by Subject|1|||
128020895|NCT02400580|460700227|FG000|Overall Study|Adverse Event|1|||
128020896|NCT02400580|460700228|FG001|Overall Study|Adverse Event|0|||
128020897|NCT00965094|460700229|FG000|Overall Study|Adverse Event|5|||
128020898|NCT00965094|460700230|FG001|Overall Study|Adverse Event|0|||
128020899|NCT00965094|460700229|FG000|Overall Study|Lost to Follow-up|0|||
128020900|NCT00965094|460700230|FG001|Overall Study|Lost to Follow-up|1|||
128020901|NCT01336972|460700234|FG000|Overall Study|Adverse Event|1|||
128020902|NCT01336972|460700235|FG001|Overall Study|Adverse Event|1|||
128020903|NCT01336972|460700236|FG002|Overall Study|Adverse Event|0|||
128020904|NCT04433975|460700239|FG000|1-month Follow Up|Withdrawal by Subject|1|||
128020905|NCT04433975|460700240|FG001|1-month Follow Up|Withdrawal by Subject|1|||
128020906|NCT04433975|460700239|FG000|1-month Follow Up|Lost to Follow-up|21|||
128020907|NCT04433975|460700240|FG001|1-month Follow Up|Lost to Follow-up|25|||
128020908|NCT04433975|460700239|FG000|3-month Follow Up|Lost to Follow-up|20|||
128020909|NCT04433975|460700240|FG001|3-month Follow Up|Lost to Follow-up|24|||
127554097|NCT04717336|458995660|FG000|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
127554098|NCT04717336|458995661|FG001|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
127554099|NCT02116205|458995671|FG000|Overall Study|Withdrawal by Subject|2|||
127554100|NCT02116205|458995672|FG001|Overall Study|Withdrawal by Subject|4|||
127554101|NCT02116205|458995673|FG002|Overall Study|Withdrawal by Subject|1|||
127554102|NCT02116205|458995674|FG003|Overall Study|Withdrawal by Subject|3|||
127554103|NCT02116205|458995671|FG000|Overall Study|Lost to Follow-up|0|||
127554104|NCT02116205|458995672|FG001|Overall Study|Lost to Follow-up|2|||
127554105|NCT02116205|458995673|FG002|Overall Study|Lost to Follow-up|1|||
127554106|NCT02116205|458995674|FG003|Overall Study|Lost to Follow-up|2|||
127554107|NCT02116205|458995671|FG000|Overall Study|Physician Decision|0|||
127554108|NCT02116205|458995672|FG001|Overall Study|Physician Decision|1|||
127554109|NCT02116205|458995673|FG002|Overall Study|Physician Decision|1|||
127554110|NCT02116205|458995674|FG003|Overall Study|Physician Decision|1|||
127554111|NCT02116205|458995671|FG000|Overall Study|Exclusion criteria|0|||
127554112|NCT02116205|458995672|FG001|Overall Study|Exclusion criteria|0|||
127554113|NCT02116205|458995673|FG002|Overall Study|Exclusion criteria|1|||
127554114|NCT02116205|458995674|FG003|Overall Study|Exclusion criteria|0|||
127554115|NCT02541604|458995675|FG000|Overall Study|Death|6|||
127554116|NCT02541604|458995676|FG001|Overall Study|Death|5|||
127554117|NCT02541604|458995677|FG002|Overall Study|Death|7|||
127554118|NCT02541604|458995678|FG003|Overall Study|Death|2|||
127554119|NCT02541604|458995679|FG004|Overall Study|Death|9|||
127554120|NCT02541604|458995680|FG005|Overall Study|Death|8|||
127554121|NCT02541604|458995681|FG006|Overall Study|Death|9|||
127554122|NCT02541604|458995682|FG007|Overall Study|Death|9|||
127554123|NCT02541604|458995683|FG008|Overall Study|Death|3|||
127554124|NCT02541604|458995684|FG009|Overall Study|Death|4|||
127554125|NCT02541604|458995685|FG010|Overall Study|Death|2|||
127554126|NCT02541604|458995686|FG011|Overall Study|Death|3|||
127554127|NCT02541604|458995675|FG000|Overall Study|Lost to Follow-up|2|||
127554128|NCT02541604|458995676|FG001|Overall Study|Lost to Follow-up|0|||
127554129|NCT02541604|458995677|FG002|Overall Study|Lost to Follow-up|1|||
127554130|NCT02541604|458995678|FG003|Overall Study|Lost to Follow-up|0|||
127554131|NCT02541604|458995679|FG004|Overall Study|Lost to Follow-up|0|||
127554132|NCT02541604|458995680|FG005|Overall Study|Lost to Follow-up|1|||
127554133|NCT02541604|458995681|FG006|Overall Study|Lost to Follow-up|1|||
127554134|NCT02541604|458995682|FG007|Overall Study|Lost to Follow-up|0|||
127554135|NCT02541604|458995683|FG008|Overall Study|Lost to Follow-up|0|||
127554136|NCT02541604|458995684|FG009|Overall Study|Lost to Follow-up|0|||
127554137|NCT02541604|458995685|FG010|Overall Study|Lost to Follow-up|0|||
127554138|NCT02541604|458995686|FG011|Overall Study|Lost to Follow-up|0|||
127554139|NCT02541604|458995675|FG000|Overall Study|Withdrawal by Subject|2|||
127554140|NCT02541604|458995676|FG001|Overall Study|Withdrawal by Subject|0|||
127554141|NCT02541604|458995677|FG002|Overall Study|Withdrawal by Subject|1|||
127554142|NCT02541604|458995678|FG003|Overall Study|Withdrawal by Subject|0|||
127554143|NCT02541604|458995679|FG004|Overall Study|Withdrawal by Subject|1|||
127554144|NCT02541604|458995680|FG005|Overall Study|Withdrawal by Subject|1|||
127554145|NCT02541604|458995681|FG006|Overall Study|Withdrawal by Subject|0|||
127554146|NCT02541604|458995682|FG007|Overall Study|Withdrawal by Subject|0|||
127554147|NCT02541604|458995683|FG008|Overall Study|Withdrawal by Subject|1|||
127554148|NCT02541604|458995684|FG009|Overall Study|Withdrawal by Subject|0|||
127554149|NCT02541604|458995685|FG010|Overall Study|Withdrawal by Subject|0|||
127554150|NCT02541604|458995686|FG011|Overall Study|Withdrawal by Subject|0|||
127554151|NCT02541604|458995675|FG000|Overall Study|Study Terminated by Sponsor|1|||
127554152|NCT02541604|458995676|FG001|Overall Study|Study Terminated by Sponsor|4|||
127554153|NCT02541604|458995677|FG002|Overall Study|Study Terminated by Sponsor|2|||
127554154|NCT02541604|458995678|FG003|Overall Study|Study Terminated by Sponsor|1|||
127554155|NCT02541604|458995679|FG004|Overall Study|Study Terminated by Sponsor|0|||
127554156|NCT02541604|458995680|FG005|Overall Study|Study Terminated by Sponsor|0|||
127554157|NCT02541604|458995681|FG006|Overall Study|Study Terminated by Sponsor|0|||
127554158|NCT02541604|458995682|FG007|Overall Study|Study Terminated by Sponsor|0|||
127554159|NCT02541604|458995683|FG008|Overall Study|Study Terminated by Sponsor|0|||
127554160|NCT02541604|458995684|FG009|Overall Study|Study Terminated by Sponsor|0|||
127554161|NCT02541604|458995685|FG010|Overall Study|Study Terminated by Sponsor|0|||
127554162|NCT02541604|458995686|FG011|Overall Study|Study Terminated by Sponsor|0|||
127554163|NCT02541604|458995675|FG000|Overall Study|Medical condition may jeopardize safety|0|||
127554164|NCT02541604|458995676|FG001|Overall Study|Medical condition may jeopardize safety|0|||
127554165|NCT02541604|458995677|FG002|Overall Study|Medical condition may jeopardize safety|0|||
127554166|NCT02541604|458995678|FG003|Overall Study|Medical condition may jeopardize safety|0|||
127554167|NCT02541604|458995679|FG004|Overall Study|Medical condition may jeopardize safety|0|||
128020910|NCT04433975|460700239|FG000|3-month Follow Up|Death|1|||
128020911|NCT04433975|460700240|FG001|3-month Follow Up|Death|0|||
127554168|NCT02541604|458995680|FG005|Overall Study|Medical condition may jeopardize safety|0|||
128020912|NCT04433975|460700239|FG000|3-month Follow Up|Withdrawal by Subject|2|||
127554169|NCT02541604|458995681|FG006|Overall Study|Medical condition may jeopardize safety|0|||
127554170|NCT02541604|458995682|FG007|Overall Study|Medical condition may jeopardize safety|1|||
127554171|NCT02541604|458995683|FG008|Overall Study|Medical condition may jeopardize safety|0|||
127554172|NCT02541604|458995684|FG009|Overall Study|Medical condition may jeopardize safety|0|||
127554173|NCT02541604|458995685|FG010|Overall Study|Medical condition may jeopardize safety|0|||
127554174|NCT02541604|458995686|FG011|Overall Study|Medical condition may jeopardize safety|0|||
127554175|NCT02752165|458995693|FG000|Overall Study|Withdrawal by Subject|6|||
127554176|NCT02752165|458995694|FG001|Overall Study|Withdrawal by Subject|6|||
128020913|NCT04433975|460700240|FG001|3-month Follow Up|Withdrawal by Subject|0|||
128020914|NCT04433975|460700239|FG000|6-month Follow Up|Lost to Follow-up|23|||
128020915|NCT04433975|460700240|FG001|6-month Follow Up|Lost to Follow-up|28|||
128020916|NCT04433975|460700239|FG000|6-month Follow Up|Withdrawal by Subject|1|||
128020917|NCT04433975|460700240|FG001|6-month Follow Up|Withdrawal by Subject|1|||
128020918|NCT04433975|460700239|FG000|9-month Follow Up|Lost to Follow-up|27|||
128020919|NCT04433975|460700240|FG001|9-month Follow Up|Lost to Follow-up|36|||
128020920|NCT04433975|460700239|FG000|9-month Follow Up|Death|0|||
128020921|NCT04433975|460700240|FG001|9-month Follow Up|Death|1|||
128020922|NCT04433975|460700239|FG000|12-month Follow Up|Lost to Follow-up|27|||
127554177|NCT02752165|458995693|FG000|Overall Study|Protocol Violation|6|||
127554178|NCT02752165|458995694|FG001|Overall Study|Protocol Violation|5|||
127554179|NCT02752165|458995693|FG000|Overall Study|Lost to Follow-up|33|||
127554180|NCT02752165|458995694|FG001|Overall Study|Lost to Follow-up|38|||
127554181|NCT01704599|458995696|FG000|Overall Study|Adverse Event|1|||
127554182|NCT02840461|458995697|FG000|Overall Study|Adverse Event|1|||
127554183|NCT02840461|458995698|FG001|Overall Study|Adverse Event|5|||
127554184|NCT02840461|458995699|FG002|Overall Study|Adverse Event|3|||
127554185|NCT02840461|458995697|FG000|Overall Study|Lost to Follow-up|10|||
127554186|NCT02840461|458995698|FG001|Overall Study|Lost to Follow-up|7|||
127554187|NCT02840461|458995699|FG002|Overall Study|Lost to Follow-up|6|||
127554188|NCT02840461|458995697|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
127554189|NCT02840461|458995698|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
127554190|NCT02840461|458995699|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
128020923|NCT04433975|460700240|FG001|12-month Follow Up|Lost to Follow-up|31|||
128020924|NCT04606771|460700241|FG000|Overall Study|Patients ongoing study at data cut-off|9|||
128020925|NCT04606771|460700242|FG001|Overall Study|Patients ongoing study at data cut-off|9|||
127554191|NCT02840461|458995697|FG000|Overall Study|Protocol Violation|2|||
127554192|NCT02840461|458995698|FG001|Overall Study|Protocol Violation|3|||
127554193|NCT02840461|458995699|FG002|Overall Study|Protocol Violation|1|||
127554194|NCT02840461|458995697|FG000|Overall Study|Withdrawal by Subject|10|||
127554195|NCT02840461|458995698|FG001|Overall Study|Withdrawal by Subject|6|||
127773754|NCT01180998|459798568|FG000|Overall Study|Poor Vision|0|||
127773755|NCT01180998|459798569|FG001|Overall Study|Poor Vision|2|||
128020926|NCT04606771|460700241|FG000|Overall Study|Death|5|||
128020927|NCT04606771|460700242|FG001|Overall Study|Death|6|||
128020928|NCT04606771|460700241|FG000|Overall Study|Wrong randomisation|0|||
128020929|NCT04606771|460700242|FG001|Overall Study|Wrong randomisation|1|||
127554196|NCT02840461|458995699|FG002|Overall Study|Withdrawal by Subject|2|||
127554197|NCT02840461|458995697|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
127554198|NCT02840461|458995698|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
127554199|NCT02840461|458995699|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
127554200|NCT01737502|458995702|FG000|Phase I|Disease progression|2|||
127554201|NCT01737502|458995703|FG001|Phase I|Disease progression|3|||
127554202|NCT01737502|458995702|FG000|Phase I|Complicating disease|1|||
127554203|NCT01737502|458995703|FG001|Phase I|Complicating disease|0|||
127554204|NCT01737502|458995702|FG000|Phase II|Adverse Event|0|||
127554205|NCT01737502|458995703|FG001|Phase II|Adverse Event|3|||
127554206|NCT01737502|458995702|FG000|Phase II|Disease progression|0|||
127554207|NCT01737502|458995703|FG001|Phase II|Disease progression|18|||
127554208|NCT01737502|458995702|FG000|Phase II|Death|0|||
127554209|NCT01737502|458995703|FG001|Phase II|Death|1|||
127554210|NCT01737502|458995702|FG000|Phase II|Transition to hospice care|0|||
127554211|NCT01737502|458995703|FG001|Phase II|Transition to hospice care|1|||
127554212|NCT04672655|458995707|FG000|Overall Study|Lost to Follow-up|12|||
127554213|NCT04672655|458995708|FG001|Overall Study|Lost to Follow-up|17|||
128020930|NCT04392635|460700243|FG000|Overall Study|Lost to Follow-up|0|||
128020931|NCT04392635|460700244|FG001|Overall Study|Lost to Follow-up|1|||
127554214|NCT04672655|458995707|FG000|Overall Study|Withdrawal by Subject|1|||
127554215|NCT04672655|458995708|FG001|Overall Study|Withdrawal by Subject|0|||
127554216|NCT04672655|458995707|FG000|Overall Study|Withdrawal by Study|1|||
127554217|NCT04672655|458995708|FG001|Overall Study|Withdrawal by Study|0|||
127554218|NCT00494676|458995709|FG000|Allocation|Withdrawal by Subject|2|||
127554219|NCT00494676|458995710|FG001|Allocation|Withdrawal by Subject|4|||
127554220|NCT00494676|458995709|FG000|First Intervention|Withdrawal by Subject|1|||
127554221|NCT00494676|458995710|FG001|First Intervention|Withdrawal by Subject|3|||
127554222|NCT00494676|458995709|FG000|Second Intervention|Withdrawal by Subject|1|||
127554223|NCT00494676|458995710|FG001|Second Intervention|Withdrawal by Subject|1|||
127554224|NCT02736890|458997007|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
127554225|NCT02736890|458997008|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
127554226|NCT02736890|458997007|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
127554227|NCT02736890|458997008|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
127554228|NCT02904954|458997009|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
127554229|NCT02904954|458997010|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
127554230|NCT02904954|458997009|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
127554231|NCT02904954|458997010|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
127554232|NCT02904954|458997009|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
127554233|NCT02904954|458997010|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
127554234|NCT02904954|458997009|FG000|Adjuvant Durvalumab|Recurrence|2|||
127554235|NCT02904954|458997010|FG001|Adjuvant Durvalumab|Recurrence|0|||
127554236|NCT02904954|458997009|FG000|Adjuvant Durvalumab|Adverse Event|2|||
127554237|NCT02904954|458997010|FG001|Adjuvant Durvalumab|Adverse Event|6|||
127554238|NCT02904954|458997009|FG000|Adjuvant Durvalumab|Participant wishes|12|||
127554239|NCT02904954|458997010|FG001|Adjuvant Durvalumab|Participant wishes|7|||
127554240|NCT02904954|458997009|FG000|Adjuvant Durvalumab|Physician Decision|2|||
127554241|NCT02904954|458997010|FG001|Adjuvant Durvalumab|Physician Decision|1|||
127554242|NCT02904954|458997009|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
127554243|NCT02904954|458997010|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
127554244|NCT02904954|458997009|FG000|Adjuvant Durvalumab|Death|0|||
127554245|NCT02904954|458997010|FG001|Adjuvant Durvalumab|Death|1|||
127554246|NCT02904954|458997009|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
127554247|NCT02904954|458997010|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
128020932|NCT02030418|460700245|FG000|Overall Study|Death|78|||
128020933|NCT02030418|460700245|FG000|Overall Study|Missed 12-Month Visit|9|||
128020934|NCT02030418|460700245|FG000|Overall Study|Withdrawn|57|||
128020935|NCT00896233|460700256|FG000|Overall Study|Claustrophobia during MRI|1|||
128020936|NCT04280562|460700257|FG000|Study|Adverse Event|2|||
128020937|NCT04280562|460700258|FG001|Study|Adverse Event|0|||
128020938|NCT04280562|460700257|FG000|Study|Lost to Follow-up|3|||
128020939|NCT04280562|460700258|FG001|Study|Lost to Follow-up|3|||
128020940|NCT05507450|460700259|FG000|Overall Study|Death|0|||
128020941|NCT05507450|460700260|FG001|Overall Study|Death|0|||
128020942|NCT05507450|460700261|FG002|Overall Study|Death|1|||
128020943|NCT05507450|460700262|FG003|Overall Study|Death|0|||
128020944|NCT05507450|460700259|FG000|Overall Study|Lost to Follow-up|22|||
128020945|NCT05507450|460700260|FG001|Overall Study|Lost to Follow-up|20|||
128020946|NCT05507450|460700261|FG002|Overall Study|Lost to Follow-up|20|||
128020947|NCT05507450|460700262|FG003|Overall Study|Lost to Follow-up|7|||
128020948|NCT05507450|460700259|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
128020949|NCT05507450|460700260|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
128020950|NCT05507450|460700261|FG002|Overall Study|Randomized By Mistake Without Study Treatment|1|||
128020951|NCT05507450|460700262|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
128020952|NCT05507450|460700259|FG000|Overall Study|Withdrawal by Subject|4|||
128020953|NCT05507450|460700260|FG001|Overall Study|Withdrawal by Subject|11|||
128020954|NCT05507450|460700261|FG002|Overall Study|Withdrawal by Subject|7|||
127554248|NCT01491607|458997011|FG000|Overall Study|Lost to Follow-up|7|||
127554249|NCT01491607|458997011|FG000|Overall Study|Withdrawal by Subject|3|||
127554250|NCT01317277|458997012|FG000|Overall Study|Lost to Follow-up|3|||
127554251|NCT01317277|458997013|FG001|Overall Study|Lost to Follow-up|1|||
127554252|NCT01317277|458997012|FG000|Overall Study|Lost MEMS|1|||
127554253|NCT01317277|458997013|FG001|Overall Study|Lost MEMS|1|||
127554254|NCT01317277|458997012|FG000|Overall Study|Unable to comply with intervention|1|||
127554255|NCT01317277|458997013|FG001|Overall Study|Unable to comply with intervention|0|||
127554256|NCT01317277|458997012|FG000|Overall Study|Withdrawal by Subject|1|||
127554257|NCT01317277|458997013|FG001|Overall Study|Withdrawal by Subject|0|||
127554258|NCT01317277|458997012|FG000|Overall Study|Adverse Event|1|||
127554259|NCT01317277|458997013|FG001|Overall Study|Adverse Event|0|||
127554260|NCT00774566|458997014|FG000|Overall Study|Protocol Violation|18|||
127554261|NCT00774566|458997015|FG001|Overall Study|Protocol Violation|15|||
127554262|NCT02813577|458997020|FG000|Overall Study|Study terminated|4|||
127554263|NCT01301027|458997027|FG000|Overall Study|Physician Decision|2|||
127554264|NCT01301027|458997028|FG001|Overall Study|Physician Decision|0|||
127554265|NCT01301027|458997027|FG000|Overall Study|Withdrawal by Subject|2|||
127554266|NCT01301027|458997028|FG001|Overall Study|Withdrawal by Subject|3|||
127554267|NCT01301027|458997027|FG000|Overall Study|Adverse Event|0|||
127554268|NCT01301027|458997028|FG001|Overall Study|Adverse Event|2|||
127554269|NCT01301027|458997027|FG000|Overall Study|Fracture|1|||
127554270|NCT01301027|458997028|FG001|Overall Study|Fracture|3|||
127554271|NCT01301027|458997027|FG000|Overall Study|Transplant|0|||
127554272|NCT01301027|458997028|FG001|Overall Study|Transplant|2|||
127554273|NCT01301027|458997027|FG000|Overall Study|Volume Overload|3|||
127554274|NCT01301027|458997028|FG001|Overall Study|Volume Overload|0|||
127554275|NCT02023697|458997029|FG000|Treatment Period|Radiological progression|13|||
127554276|NCT02023697|458997030|FG001|Treatment Period|Radiological progression|17|||
127554277|NCT02023697|458997031|FG002|Treatment Period|Radiological progression|26|||
127554278|NCT02023697|458997029|FG000|Treatment Period|Never Treated|5|||
127554279|NCT02023697|458997030|FG001|Treatment Period|Never Treated|6|||
127554280|NCT02023697|458997031|FG002|Treatment Period|Never Treated|10|||
127554281|NCT02023697|458997029|FG000|Treatment Period|Adverse Event|13|||
127554282|NCT02023697|458997030|FG001|Treatment Period|Adverse Event|25|||
127554283|NCT02023697|458997031|FG002|Treatment Period|Adverse Event|23|||
127554284|NCT02023697|458997029|FG000|Treatment Period|Logistical difficulties|1|||
127554285|NCT02023697|458997030|FG001|Treatment Period|Logistical difficulties|1|||
127554286|NCT02023697|458997031|FG002|Treatment Period|Logistical difficulties|1|||
127554287|NCT02023697|458997029|FG000|Treatment Period|Clinical progression|10|||
127554288|NCT02023697|458997030|FG001|Treatment Period|Clinical progression|8|||
127554289|NCT02023697|458997031|FG002|Treatment Period|Clinical progression|28|||
127554290|NCT02023697|458997029|FG000|Treatment Period|Withdrawal by Subject|4|||
127554291|NCT02023697|458997030|FG001|Treatment Period|Withdrawal by Subject|5|||
127554292|NCT02023697|458997031|FG002|Treatment Period|Withdrawal by Subject|13|||
127554293|NCT02023697|458997029|FG000|Treatment Period|Safety outcome reached|0|||
127554294|NCT02023697|458997030|FG001|Treatment Period|Safety outcome reached|1|||
127554295|NCT02023697|458997031|FG002|Treatment Period|Safety outcome reached|0|||
127554296|NCT02023697|458997029|FG000|Treatment Period|Physician Decision|0|||
127554297|NCT02023697|458997030|FG001|Treatment Period|Physician Decision|0|||
127554298|NCT02023697|458997031|FG002|Treatment Period|Physician Decision|1|||
127554299|NCT02023697|458997029|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
127554300|NCT02023697|458997030|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
127554301|NCT02023697|458997031|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
127554302|NCT02023697|458997029|FG000|Active Follow-up Period|Lost to Follow-up|1|||
127554303|NCT02023697|458997030|FG001|Active Follow-up Period|Lost to Follow-up|1|||
127554304|NCT02023697|458997031|FG002|Active Follow-up Period|Lost to Follow-up|1|||
127554305|NCT02023697|458997029|FG000|Active Follow-up Period|Deterioration of general condition|1|||
127554306|NCT02023697|458997030|FG001|Active Follow-up Period|Deterioration of general condition|1|||
127554307|NCT02023697|458997031|FG002|Active Follow-up Period|Deterioration of general condition|1|||
127554308|NCT02023697|458997029|FG000|Active Follow-up Period|Other unspecified|2|||
127554309|NCT02023697|458997030|FG001|Active Follow-up Period|Other unspecified|0|||
127554310|NCT02023697|458997031|FG002|Active Follow-up Period|Other unspecified|1|||
127554311|NCT02023697|458997029|FG000|Active Follow-up Period|Clinical progression|0|||
127554312|NCT02023697|458997030|FG001|Active Follow-up Period|Clinical progression|2|||
127554313|NCT02023697|458997031|FG002|Active Follow-up Period|Clinical progression|1|||
127554314|NCT02023697|458997029|FG000|Active Follow-up Period|Radiological progression|0|||
127554315|NCT02023697|458997030|FG001|Active Follow-up Period|Radiological progression|0|||
127554316|NCT02023697|458997031|FG002|Active Follow-up Period|Radiological progression|1|||
127554317|NCT02023697|458997029|FG000|Active Follow-up Period|Death|83|||
127554318|NCT02023697|458997030|FG001|Active Follow-up Period|Death|82|||
127554319|NCT02023697|458997031|FG002|Active Follow-up Period|Death|87|||
127554320|NCT02023697|458997029|FG000|Long-term Follow-up Period|Death|9|||
127554321|NCT02023697|458997030|FG001|Long-term Follow-up Period|Death|6|||
127554322|NCT02023697|458997031|FG002|Long-term Follow-up Period|Death|4|||
127554323|NCT02023697|458997029|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
127554324|NCT02023697|458997030|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
127554325|NCT02023697|458997031|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
127554326|NCT02023697|458997029|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
127554327|NCT02023697|458997030|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
127554328|NCT02023697|458997031|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
127554329|NCT02023697|458997029|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
127554330|NCT02023697|458997030|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
127554331|NCT02023697|458997031|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
127554332|NCT02023697|458997029|FG000|Long-term Follow-up Period|Technical problems|0|||
127554333|NCT02023697|458997030|FG001|Long-term Follow-up Period|Technical problems|0|||
127554334|NCT02023697|458997031|FG002|Long-term Follow-up Period|Technical problems|1|||
127554335|NCT02023697|458997029|FG000|Long-term Follow-up Period|Other unspecified|6|||
127554336|NCT02023697|458997030|FG001|Long-term Follow-up Period|Other unspecified|3|||
127554337|NCT02023697|458997031|FG002|Long-term Follow-up Period|Other unspecified|5|||
127554338|NCT00845897|458997032|FG000|Overall Study|Lost to Follow-up|1|||
127554339|NCT00845897|458997033|FG001|Overall Study|Lost to Follow-up|1|||
127554340|NCT00845897|458997034|FG002|Overall Study|Lost to Follow-up|0|||
127554341|NCT00845897|458997032|FG000|Overall Study|Withdrawal by Subject|0|||
127554342|NCT00845897|458997033|FG001|Overall Study|Withdrawal by Subject|3|||
127554343|NCT00845897|458997034|FG002|Overall Study|Withdrawal by Subject|2|||
127554344|NCT00845897|458997032|FG000|Overall Study|Ulcer did not heal|1|||
127554345|NCT00845897|458997033|FG001|Overall Study|Ulcer did not heal|0|||
127554346|NCT00845897|458997034|FG002|Overall Study|Ulcer did not heal|1|||
127554347|NCT00845897|458997032|FG000|Overall Study|Too ill to participate|0|||
127554348|NCT00845897|458997033|FG001|Overall Study|Too ill to participate|1|||
127554349|NCT00845897|458997034|FG002|Overall Study|Too ill to participate|0|||
127554350|NCT00611026|458997037|FG000|Randomized to Double-blind Treatment|Not treated|2|||
127554351|NCT00611026|458997038|FG001|Randomized to Double-blind Treatment|Not treated|1|||
127554352|NCT00611026|458997039|FG002|Randomized to Double-blind Treatment|Not treated|3|||
127554353|NCT00611026|458997037|FG000|Double-blind Treatment Period|Death|1|||
127554354|NCT00611026|458997038|FG001|Double-blind Treatment Period|Death|0|||
127554355|NCT00611026|458997039|FG002|Double-blind Treatment Period|Death|0|||
127554356|NCT00611026|458997037|FG000|Double-blind Treatment Period|Adverse Event|9|||
127554357|NCT00611026|458997038|FG001|Double-blind Treatment Period|Adverse Event|28|||
127554358|NCT00611026|458997039|FG002|Double-blind Treatment Period|Adverse Event|46|||
127554359|NCT00611026|458997037|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
127554360|NCT00611026|458997038|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
127554361|NCT00611026|458997039|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
127554362|NCT00611026|458997037|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
127554363|NCT00611026|458997038|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
127554364|NCT00611026|458997039|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
127554365|NCT00611026|458997037|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
127554366|NCT00611026|458997038|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
127554367|NCT00611026|458997039|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
127554368|NCT00611026|458997037|FG000|Double-blind Treatment Period|Other|13|||
127554369|NCT00611026|458997038|FG001|Double-blind Treatment Period|Other|20|||
127554370|NCT00611026|458997039|FG002|Double-blind Treatment Period|Other|18|||
127554371|NCT05019521|458997040|FG000|Primary Evaluation Period (52 Weeks)|Adverse Event|7|||
127554372|NCT05019521|458997041|FG001|Primary Evaluation Period (52 Weeks)|Adverse Event|9|||
127554373|NCT05019521|458997042|FG002|Primary Evaluation Period (52 Weeks)|Adverse Event|8|||
127554374|NCT05019521|458997043|FG003|Primary Evaluation Period (52 Weeks)|Adverse Event|4|||
127554375|NCT05019521|458997044|FG004|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
127554376|NCT05019521|458997045|FG005|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
127554377|NCT05019521|458997046|FG006|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
127554378|NCT05019521|458997040|FG000|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
127554379|NCT05019521|458997041|FG001|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
127554380|NCT05019521|458997042|FG002|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
127554381|NCT05019521|458997043|FG003|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
127554382|NCT05019521|458997044|FG004|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
127554383|NCT05019521|458997045|FG005|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
127554384|NCT05019521|458997046|FG006|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
127554385|NCT05019521|458997040|FG000|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|7|||
127554386|NCT05019521|458997041|FG001|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|13|||
127554387|NCT05019521|458997042|FG002|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|6|||
128020955|NCT05507450|460700262|FG003|Overall Study|Withdrawal by Subject|3|||
128020956|NCT05507450|460700259|FG000|Overall Study|Participant left the country|0|||
127773756|NCT01180998|459798570|FG002|Overall Study|Poor Vision|2|||
127773757|NCT01180998|459798568|FG000|Overall Study|Lost to Follow-up|0|||
127773758|NCT01180998|459798569|FG001|Overall Study|Lost to Follow-up|0|||
127773759|NCT01180998|459798570|FG002|Overall Study|Lost to Follow-up|1|||
127773760|NCT01180998|459798568|FG000|Overall Study|Protocol Violation|1|||
127773761|NCT01180998|459798569|FG001|Overall Study|Protocol Violation|2|||
128020957|NCT05507450|460700260|FG001|Overall Study|Participant left the country|0|||
128020958|NCT05507450|460700261|FG002|Overall Study|Participant left the country|1|||
128020959|NCT05507450|460700262|FG003|Overall Study|Participant left the country|0|||
128020960|NCT00514917|460700263|FG000|Overall Study|Death|4|||
128020961|NCT00514917|460700264|FG001|Overall Study|Death|10|||
128020962|NCT00514917|460700263|FG000|Overall Study|Protocol Violation|1|||
128020963|NCT00514917|460700264|FG001|Overall Study|Protocol Violation|0|||
128020964|NCT00514917|460700263|FG000|Overall Study|Lost to Follow-up|4|||
128020965|NCT00514917|460700264|FG001|Overall Study|Lost to Follow-up|3|||
128020966|NCT00514917|460700263|FG000|Overall Study|Withdrawal by Subject|18|||
128020967|NCT00514917|460700264|FG001|Overall Study|Withdrawal by Subject|16|||
128020968|NCT00514917|460700263|FG000|Overall Study|Discontinued due to study closure|88|||
128020969|NCT00514917|460700264|FG001|Overall Study|Discontinued due to study closure|81|||
128020970|NCT00514917|460700263|FG000|Overall Study|Undefined|11|||
128020971|NCT00514917|460700264|FG001|Overall Study|Undefined|5|||
128020972|NCT04149353|460700268|FG000|Overall Study|Study terminated|1|||
128020973|NCT00309244|460700271|FG000|Overall Study|Adverse Event|29|||
128020974|NCT00309244|460700272|FG001|Overall Study|Adverse Event|12|||
128020975|NCT00309244|460700271|FG000|Overall Study|Lost to Follow-up|6|||
128020976|NCT00309244|460700272|FG001|Overall Study|Lost to Follow-up|22|||
128020977|NCT00309244|460700271|FG000|Overall Study|Physician Decision|5|||
128020978|NCT00309244|460700272|FG001|Overall Study|Physician Decision|8|||
128020979|NCT00309244|460700271|FG000|Overall Study|Protocol Violation|6|||
128020980|NCT00309244|460700272|FG001|Overall Study|Protocol Violation|3|||
128020981|NCT00309244|460700271|FG000|Overall Study|Withdrawal by Subject|50|||
128020982|NCT00309244|460700272|FG001|Overall Study|Withdrawal by Subject|32|||
128020983|NCT00309244|460700271|FG000|Overall Study|Various|7|||
128020984|NCT00309244|460700272|FG001|Overall Study|Various|7|||
128020985|NCT00309244|460700271|FG000|Overall Study|Randomized but not dosed|11|||
128020986|NCT00309244|460700272|FG001|Overall Study|Randomized but not dosed|12|||
128020987|NCT00309244|460700271|FG000|Overall Study|Death|4|||
128020988|NCT00309244|460700272|FG001|Overall Study|Death|1|||
128020989|NCT01263028|460700273|FG000|Overall Study|Withdrawal by Subject|1|||
128020990|NCT01263028|460700273|FG000|Overall Study|Adverse Event|1|||
128020991|NCT01263028|460700273|FG000|Overall Study|Study terminated due to low enrollment.|4|||
128020992|NCT03019588|460700274|FG000|Overall Study|Death|44|||
128020993|NCT03019588|460700275|FG001|Overall Study|Death|46|||
128020994|NCT03019588|460700274|FG000|Overall Study|Study terminated by Sponsor|3|||
128020995|NCT03019588|460700275|FG001|Overall Study|Study terminated by Sponsor|1|||
128020996|NCT00887588|460700276|FG000|Core Period|Death|1|||
128020997|NCT00887588|460700277|FG001|Core Period|Death|1|||
128020998|NCT00887588|460700276|FG000|Core Period|Lost to Follow-up|3|||
128020999|NCT00887588|460700277|FG001|Core Period|Lost to Follow-up|1|||
128021000|NCT00887588|460700276|FG000|Core Period|Withdrawal by Subject|6|||
128021001|NCT00887588|460700277|FG001|Core Period|Withdrawal by Subject|8|||
128021002|NCT00887588|460700276|FG000|Core Period|Adverse Event|9|||
128021003|NCT00887588|460700277|FG001|Core Period|Adverse Event|11|||
128021004|NCT00887588|460700276|FG000|Extension Period|Adverse Event|4|||
128021005|NCT00887588|460700277|FG001|Extension Period|Adverse Event|4|||
128021006|NCT00887588|460700276|FG000|Extension Period|Death|0|||
128021007|NCT00887588|460700277|FG001|Extension Period|Death|1|||
128021008|NCT00887588|460700276|FG000|Extension Period|Protocol deviation|1|||
128021009|NCT00887588|460700277|FG001|Extension Period|Protocol deviation|0|||
128021010|NCT00887588|460700276|FG000|Extension Period|Lost to Follow-up|1|||
128021011|NCT00887588|460700277|FG001|Extension Period|Lost to Follow-up|0|||
128021012|NCT00366535|460700278|FG000|First Phase: 12 Weeks|Adverse Event|1|||
128021013|NCT00366535|460700279|FG001|First Phase: 12 Weeks|Adverse Event|3|||
128021014|NCT00366535|460700278|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
127773762|NCT01180998|459798570|FG002|Overall Study|Protocol Violation|0|||
128021015|NCT00366535|460700279|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
128021016|NCT00366535|460700278|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
128021017|NCT00366535|460700279|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
128021018|NCT00366535|460700278|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
128021019|NCT00366535|460700279|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
128021020|NCT03753542|460700285|FG000|Overall Study|Lost to Follow-up|9|||
128021021|NCT03753542|460700286|FG001|Overall Study|Lost to Follow-up|14|||
128021022|NCT06100250|460700287|FG000|Overall Study|Lost to Follow-up|5|||
128021023|NCT02021318|460700288|FG000|Overall Study|Adverse Event|2|||
128021024|NCT02021318|460700289|FG001|Overall Study|Adverse Event|1|||
127773763|NCT01180998|459798568|FG000|Overall Study|Withdrawal by Subject|0|||
127773764|NCT01180998|459798569|FG001|Overall Study|Withdrawal by Subject|0|||
128021025|NCT02021318|460700288|FG000|Overall Study|Death|33|||
128021026|NCT02021318|460700289|FG001|Overall Study|Death|34|||
128021027|NCT02021318|460700288|FG000|Overall Study|Lost to Follow-up|3|||
127554388|NCT05019521|458997043|FG003|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|9|||
127554389|NCT05019521|458997044|FG004|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
127554390|NCT05019521|458997045|FG005|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
127554391|NCT05019521|458997046|FG006|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
127554392|NCT05019521|458997040|FG000|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
127554393|NCT05019521|458997041|FG001|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
127554394|NCT05019521|458997042|FG002|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
127554395|NCT05019521|458997043|FG003|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
127554396|NCT05019521|458997044|FG004|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
127554397|NCT05019521|458997045|FG005|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
127554398|NCT05019521|458997046|FG006|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
127554399|NCT05019521|458997040|FG000|Primary Evaluation Period (52 Weeks)|Death|0|||
127554400|NCT05019521|458997041|FG001|Primary Evaluation Period (52 Weeks)|Death|1|||
127554401|NCT05019521|458997042|FG002|Primary Evaluation Period (52 Weeks)|Death|0|||
127554402|NCT05019521|458997043|FG003|Primary Evaluation Period (52 Weeks)|Death|3|||
127554403|NCT05019521|458997044|FG004|Primary Evaluation Period (52 Weeks)|Death|0|||
127554404|NCT05019521|458997045|FG005|Primary Evaluation Period (52 Weeks)|Death|0|||
127554405|NCT05019521|458997046|FG006|Primary Evaluation Period (52 Weeks)|Death|0|||
127554406|NCT05019521|458997040|FG000|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
127554407|NCT05019521|458997041|FG001|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
127554408|NCT05019521|458997042|FG002|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
127554409|NCT05019521|458997043|FG003|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
127554410|NCT05019521|458997044|FG004|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
127554411|NCT05019521|458997045|FG005|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
127554412|NCT05019521|458997046|FG006|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
127554413|NCT05019521|458997040|FG000|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
127554414|NCT05019521|458997041|FG001|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
127554415|NCT05019521|458997042|FG002|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
127554416|NCT05019521|458997043|FG003|Primary Evaluation Period (52 Weeks)|Other Than Specified|2|||
127554417|NCT05019521|458997044|FG004|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
127554418|NCT05019521|458997045|FG005|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
127554419|NCT05019521|458997046|FG006|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
127554420|NCT05019521|458997040|FG000|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
127554421|NCT05019521|458997041|FG001|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
127554422|NCT05019521|458997042|FG002|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
127554423|NCT05019521|458997043|FG003|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
127554424|NCT05019521|458997044|FG004|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
127554425|NCT05019521|458997045|FG005|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
127554426|NCT05019521|458997046|FG006|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
127554427|NCT05019521|458997040|FG000|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
127554428|NCT05019521|458997041|FG001|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
127554429|NCT05019521|458997042|FG002|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
127554430|NCT05019521|458997043|FG003|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
127554431|NCT05019521|458997044|FG004|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
127554432|NCT05019521|458997045|FG005|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
127554433|NCT05019521|458997046|FG006|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
127554434|NCT05019521|458997040|FG000|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|3|||
127554435|NCT05019521|458997041|FG001|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
127554436|NCT05019521|458997042|FG002|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
127554437|NCT05019521|458997043|FG003|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
127554438|NCT05019521|458997044|FG004|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|5|||
127554439|NCT05019521|458997045|FG005|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
127554440|NCT05019521|458997046|FG006|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
127554441|NCT05019521|458997040|FG000|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
127554442|NCT05019521|458997041|FG001|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|1|||
127554443|NCT05019521|458997042|FG002|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|2|||
127773765|NCT01180998|459798570|FG002|Overall Study|Withdrawal by Subject|1|||
127773766|NCT01180998|459798568|FG000|Overall Study|Poor comfort|3|||
127773767|NCT01180998|459798569|FG001|Overall Study|Poor comfort|0|||
127773768|NCT01180998|459798570|FG002|Overall Study|Poor comfort|4|||
127773769|NCT01180998|459798568|FG000|Overall Study|Poor lens handling|0|||
127773770|NCT01180998|459798569|FG001|Overall Study|Poor lens handling|0|||
127773771|NCT01180998|459798570|FG002|Overall Study|Poor lens handling|2|||
127773772|NCT01176968|459798571|FG000|Overall Study|Adverse Event|10|||
127773773|NCT01176968|459798572|FG001|Overall Study|Adverse Event|11|||
127554444|NCT05019521|458997043|FG003|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
127554445|NCT05019521|458997044|FG004|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
127554446|NCT05019521|458997045|FG005|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
127554447|NCT05019521|458997046|FG006|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
127554448|NCT05019521|458997040|FG000|Secondary Evaluation Period (52 Weeks)|Death|0|||
127554449|NCT05019521|458997041|FG001|Secondary Evaluation Period (52 Weeks)|Death|1|||
127554450|NCT05019521|458997042|FG002|Secondary Evaluation Period (52 Weeks)|Death|1|||
127554451|NCT05019521|458997043|FG003|Secondary Evaluation Period (52 Weeks)|Death|0|||
127554452|NCT05019521|458997044|FG004|Secondary Evaluation Period (52 Weeks)|Death|1|||
127554453|NCT05019521|458997045|FG005|Secondary Evaluation Period (52 Weeks)|Death|0|||
127554454|NCT05019521|458997046|FG006|Secondary Evaluation Period (52 Weeks)|Death|0|||
127554455|NCT05019521|458997040|FG000|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
127554456|NCT05019521|458997041|FG001|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
127554457|NCT05019521|458997042|FG002|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
127554458|NCT05019521|458997043|FG003|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
127554459|NCT05019521|458997044|FG004|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
127554460|NCT05019521|458997045|FG005|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
127554461|NCT05019521|458997046|FG006|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
127554462|NCT05019521|458997040|FG000|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
127554463|NCT05019521|458997041|FG001|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
127554464|NCT05019521|458997042|FG002|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
127554465|NCT05019521|458997043|FG003|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
127554466|NCT05019521|458997044|FG004|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
127554467|NCT05019521|458997045|FG005|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
127554468|NCT05019521|458997046|FG006|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
127554469|NCT05019521|458997040|FG000|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|49|||
127554470|NCT05019521|458997041|FG001|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|45|||
127773774|NCT01176968|459798571|FG000|Overall Study|Death|2|||
127773775|NCT01176968|459798572|FG001|Overall Study|Death|3|||
127773776|NCT01176968|459798571|FG000|Overall Study|Lack of Efficacy|0|||
127773777|NCT01176968|459798572|FG001|Overall Study|Lack of Efficacy|1|||
127773778|NCT01176968|459798571|FG000|Overall Study|Lost to Follow-up|16|||
127773779|NCT01176968|459798572|FG001|Overall Study|Lost to Follow-up|14|||
127773780|NCT01176968|459798571|FG000|Overall Study|Withdrawal by Subject|48|||
127773781|NCT01176968|459798572|FG001|Overall Study|Withdrawal by Subject|48|||
127773782|NCT01176968|459798571|FG000|Overall Study|Protocol Violation|2|||
127773783|NCT01176968|459798572|FG001|Overall Study|Protocol Violation|1|||
127773784|NCT01176968|459798571|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
127773785|NCT01176968|459798572|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
127773786|NCT01176968|459798571|FG000|Overall Study|Study terminated by sponsor|0|||
127773787|NCT01176968|459798572|FG001|Overall Study|Study terminated by sponsor|1|||
127773788|NCT01176968|459798571|FG000|Overall Study|Reason not defined|5|||
127773789|NCT01176968|459798572|FG001|Overall Study|Reason not defined|3|||
127773790|NCT00718640|459798573|FG000|Overall Study|Adverse Event|4|||
127773791|NCT00718640|459798573|FG000|Overall Study|Death|1|||
127773792|NCT00718640|459798573|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
127773793|NCT01207596|459798576|FG000|Overall Study|Physician Decision|4|||
127773794|NCT01207596|459798576|FG000|Overall Study|Lack of Efficacy|1|||
127773795|NCT01207596|459798576|FG000|Overall Study|Adverse Event|3|||
127773796|NCT01207596|459798576|FG000|Overall Study|Withdrawal by Subject|1|||
127773797|NCT00068588|459798577|FG000|Overall Study|Adverse Event|0|||
127773798|NCT00068588|459798578|FG001|Overall Study|Adverse Event|0|||
127773799|NCT00068588|459798579|FG002|Overall Study|Adverse Event|2|||
127773800|NCT00068588|459798577|FG000|Overall Study|Withdrawal by Subject|0|||
127773801|NCT00068588|459798578|FG001|Overall Study|Withdrawal by Subject|0|||
127773802|NCT00068588|459798579|FG002|Overall Study|Withdrawal by Subject|1|||
127773803|NCT00068588|459798577|FG000|Overall Study|Poor KPS|0|||
127773804|NCT00068588|459798578|FG001|Overall Study|Poor KPS|0|||
127773805|NCT00068588|459798579|FG002|Overall Study|Poor KPS|1|||
127773806|NCT05193500|459798580|FG000|Overall Study|Withdrawal by Subject|7|||
127773807|NCT05193500|459798581|FG001|Overall Study|Withdrawal by Subject|4|||
127773808|NCT05193500|459798582|FG002|Overall Study|Withdrawal by Subject|3|||
127773809|NCT05193500|459798583|FG003|Overall Study|Withdrawal by Subject|5|||
127773810|NCT04098068|459798584|FG000|Overall Study|Disease Progression|7|||
127773811|NCT04098068|459798584|FG000|Overall Study|Withdrawal by Subject|2|||
127773812|NCT04098068|459798584|FG000|Overall Study|New Cancer Diagnosis|1|||
127773813|NCT03871829|459798585|FG000|Overall Study|Lost to Follow-up|0|||
127773814|NCT03871829|459798586|FG001|Overall Study|Lost to Follow-up|1|||
127773815|NCT03871829|459798585|FG000|Overall Study|Withdrawal by Subject|1|||
127881008|NCT02756078|460186097|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
127881009|NCT02756078|460186098|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
127554471|NCT05019521|458997042|FG002|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|53|||
127554472|NCT05019521|458997043|FG003|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|0|||
127554473|NCT05019521|458997044|FG004|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|13|||
127554474|NCT05019521|458997045|FG005|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|17|||
127554475|NCT05019521|458997046|FG006|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|14|||
127554476|NCT02533453|458997050|FG000|Overall Study|Adverse Event|6|||
127554477|NCT02533453|458997050|FG000|Overall Study|Protocol Violation|1|||
127554478|NCT02533453|458997050|FG000|Overall Study|Withdrawal by Subject|2|||
127554479|NCT00068419|458997051|FG000|Overall Study|Adverse Event|3|||
127554480|NCT00068419|458997051|FG000|Overall Study|Lack of Efficacy|24|||
127554481|NCT00068419|458997051|FG000|Overall Study|Lost to Follow-up|1|||
127554482|NCT00068419|458997051|FG000|Overall Study|Physician Decision|7|||
127554483|NCT00068419|458997051|FG000|Overall Study|Withdrawal by Subject|14|||
127554484|NCT00068419|458997051|FG000|Overall Study|Ineligible|11|||
127554485|NCT00314795|458997056|FG000|Overall Study|Adverse Event|8|||
127554486|NCT00314795|458997056|FG000|Overall Study|Death|4|||
127554487|NCT00314795|458997056|FG000|Overall Study|Reason not Specified|3|||
127554488|NCT00314795|458997056|FG000|Overall Study|Renal Transplant|3|||
127554489|NCT00314795|458997056|FG000|Overall Study|Participants Withdrew Consent|2|||
127554490|NCT01500720|458997057|FG000|Overall Study|Randomized But Not Treated|1|||
127554491|NCT01500720|458997058|FG001|Overall Study|Randomized But Not Treated|1|||
127554492|NCT01500720|458997057|FG000|Overall Study|Other|4|||
127554493|NCT01500720|458997058|FG001|Overall Study|Other|8|||
127554494|NCT02527421|458997059|FG000|Overall Study|Withdrawal by Subject|1|||
127554495|NCT02527421|458997060|FG001|Overall Study|Withdrawal by Subject|0|||
127554496|NCT00806819|458997061|FG000|Overall Study|progressive disease (modified RECIST )|217|||
127554497|NCT00806819|458997062|FG001|Overall Study|progressive disease (modified RECIST )|216|||
127554498|NCT00806819|458997061|FG000|Overall Study|Worsening or AE of underlying disease|18|||
127554499|NCT00806819|458997062|FG001|Overall Study|Worsening or AE of underlying disease|25|||
127554500|NCT00806819|458997061|FG000|Overall Study|Other AE|38|||
127554501|NCT00806819|458997062|FG001|Overall Study|Other AE|40|||
127554502|NCT00806819|458997061|FG000|Overall Study|Protocol Violation|9|||
127554503|NCT00806819|458997062|FG001|Overall Study|Protocol Violation|4|||
127554504|NCT00806819|458997061|FG000|Overall Study|Lost to Follow-up|1|||
127554505|NCT00806819|458997062|FG001|Overall Study|Lost to Follow-up|0|||
127554506|NCT00806819|458997061|FG000|Overall Study|Withdrawal by Subject|32|||
127554507|NCT00806819|458997062|FG001|Overall Study|Withdrawal by Subject|29|||
127554508|NCT00806819|458997061|FG000|Overall Study|Not treated|6|||
127554509|NCT00806819|458997062|FG001|Overall Study|Not treated|3|||
127554510|NCT00806819|458997061|FG000|Overall Study|Reasons other than stated above|25|||
127554511|NCT00806819|458997062|FG001|Overall Study|Reasons other than stated above|41|||
127554512|NCT00802945|458997071|FG000|Overall Study|Death|27|||
127554513|NCT00802945|458997072|FG001|Overall Study|Death|23|||
127554514|NCT00802945|458997071|FG000|Overall Study|Terminated by sponsor|8|||
127554515|NCT00802945|458997072|FG001|Overall Study|Terminated by sponsor|12|||
127554516|NCT03843541|458997073|FG000|Overall Study|Adverse Event|4|||
127554517|NCT03843541|458997074|FG001|Overall Study|Adverse Event|2|||
127554518|NCT03843541|458997075|FG002|Overall Study|Adverse Event|3|||
127554519|NCT03843541|458997073|FG000|Overall Study|Death|1|||
127554520|NCT03843541|458997074|FG001|Overall Study|Death|0|||
127554521|NCT03843541|458997075|FG002|Overall Study|Death|0|||
127554522|NCT03843541|458997073|FG000|Overall Study|Lack of adherence to study medication|0|||
127554523|NCT03843541|458997074|FG001|Overall Study|Lack of adherence to study medication|0|||
127554524|NCT03843541|458997075|FG002|Overall Study|Lack of adherence to study medication|1|||
127554525|NCT03843541|458997073|FG000|Overall Study|Physician Decision|1|||
127554526|NCT03843541|458997074|FG001|Overall Study|Physician Decision|2|||
127554527|NCT03843541|458997075|FG002|Overall Study|Physician Decision|2|||
127554528|NCT03843541|458997073|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
127554529|NCT03843541|458997074|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
127554530|NCT03843541|458997075|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
127554531|NCT03843541|458997073|FG000|Overall Study|Withdrawal by Subject|6|||
127554532|NCT03843541|458997074|FG001|Overall Study|Withdrawal by Subject|9|||
127554533|NCT03843541|458997075|FG002|Overall Study|Withdrawal by Subject|7|||
127554534|NCT03843541|458997073|FG000|Overall Study|Administration of rescue mucolytic|0|||
127554535|NCT03843541|458997074|FG001|Overall Study|Administration of rescue mucolytic|0|||
127554536|NCT03843541|458997075|FG002|Overall Study|Administration of rescue mucolytic|1|||
127554537|NCT03843541|458997073|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
127554538|NCT03843541|458997074|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
127554539|NCT03843541|458997075|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
127554540|NCT05307692|458997079|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
127554541|NCT05307692|458997080|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|1|||
127554542|NCT05307692|458997081|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
127554543|NCT05307692|458997082|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
127554544|NCT05307692|458997079|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
127554545|NCT05307692|458997080|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|2|||
127554546|NCT05307692|458997081|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
127554547|NCT05307692|458997082|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
127554548|NCT05307692|458997079|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
127554549|NCT05307692|458997080|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
127554550|NCT05307692|458997081|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
127554551|NCT05307692|458997082|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
127554552|NCT05307692|458997079|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|2|||
127554553|NCT05307692|458997080|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|3|||
127554554|NCT05307692|458997081|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
127554555|NCT05307692|458997082|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
127554556|NCT05307692|458997079|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
127554557|NCT05307692|458997080|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Other|1|||
127554558|NCT05307692|458997081|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
127554559|NCT05307692|458997082|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
127554560|NCT05307692|458997079|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|2|||
127554561|NCT05307692|458997080|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|1|||
127554562|NCT05307692|458997081|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
127554563|NCT05307692|458997082|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
127554564|NCT05307692|458997079|FG000|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
127554565|NCT05307692|458997080|FG001|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
127554566|NCT05307692|458997081|FG002|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
127554567|NCT05307692|458997082|FG003|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|1|||
127554568|NCT05307692|458997079|FG000|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
127554569|NCT05307692|458997080|FG001|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
127554570|NCT05307692|458997081|FG002|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
127554571|NCT05307692|458997082|FG003|FU Phase (Day 43 to Day 57):|Protocol Violation|3|||
127554572|NCT02003924|458997084|FG000|Double-blind Phase|Lost to Follow-up|2|||
127554573|NCT02003924|458997085|FG001|Double-blind Phase|Lost to Follow-up|1|||
127554574|NCT02003924|458997086|FG002|Double-blind Phase|Lost to Follow-up|0|||
127554575|NCT02003924|458997084|FG000|Double-blind Phase|Protocol Violation|1|||
127554576|NCT02003924|458997085|FG001|Double-blind Phase|Protocol Violation|2|||
127554577|NCT02003924|458997086|FG002|Double-blind Phase|Protocol Violation|0|||
127554578|NCT02003924|458997084|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
127554579|NCT02003924|458997085|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
127554580|NCT02003924|458997086|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
127554581|NCT02003924|458997084|FG000|Double-blind Phase|Disease Progression|229|||
127554582|NCT02003924|458997085|FG001|Double-blind Phase|Disease Progression|247|||
127554583|NCT02003924|458997086|FG002|Double-blind Phase|Disease Progression|0|||
127554584|NCT02003924|458997084|FG000|Double-blind Phase|Adverse Event|120|||
127554585|NCT02003924|458997085|FG001|Double-blind Phase|Adverse Event|31|||
127554586|NCT02003924|458997086|FG002|Double-blind Phase|Adverse Event|0|||
127554587|NCT02003924|458997084|FG000|Double-blind Phase|Randomized But not Treated|3|||
127554588|NCT02003924|458997085|FG001|Double-blind Phase|Randomized But not Treated|3|||
127554589|NCT02003924|458997086|FG002|Double-blind Phase|Randomized But not Treated|0|||
127554590|NCT02003924|458997084|FG000|Double-blind Phase|Other|29|||
127554591|NCT02003924|458997085|FG001|Double-blind Phase|Other|50|||
127554592|NCT02003924|458997086|FG002|Double-blind Phase|Other|0|||
127554593|NCT02003924|458997084|FG000|Open-label Phase|Lost to Follow-up|0|||
127554594|NCT02003924|458997085|FG001|Open-label Phase|Lost to Follow-up|0|||
127554595|NCT02003924|458997086|FG002|Open-label Phase|Lost to Follow-up|1|||
127554596|NCT02003924|458997084|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
127554597|NCT02003924|458997085|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
127554598|NCT02003924|458997086|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
127554599|NCT02003924|458997084|FG000|Open-label Phase|Disease Progression|59|||
127554600|NCT02003924|458997085|FG001|Open-label Phase|Disease Progression|0|||
127554601|NCT02003924|458997086|FG002|Open-label Phase|Disease Progression|5|||
127554602|NCT02003924|458997084|FG000|Open-label Phase|Adverse Event|25|||
127554603|NCT02003924|458997085|FG001|Open-label Phase|Adverse Event|0|||
127554604|NCT02003924|458997086|FG002|Open-label Phase|Adverse Event|10|||
127554605|NCT02003924|458997084|FG000|Open-label Phase|Other|7|||
127554606|NCT02003924|458997085|FG001|Open-label Phase|Other|0|||
127554607|NCT02003924|458997086|FG002|Open-label Phase|Other|0|||
127554608|NCT02003924|458997084|FG000|Long-term Follow-up Phase|Death|288|||
127554609|NCT02003924|458997085|FG001|Long-term Follow-up Phase|Death|174|||
127554610|NCT02003924|458997086|FG002|Long-term Follow-up Phase|Death|4|||
127554611|NCT02003924|458997084|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
127554612|NCT02003924|458997085|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
127554613|NCT02003924|458997086|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
127554614|NCT02003924|458997084|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
127554615|NCT02003924|458997085|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
127554616|NCT02003924|458997086|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
127554617|NCT02003924|458997084|FG000|Long-term Follow-up Phase|Other|5|||
127554618|NCT02003924|458997085|FG001|Long-term Follow-up Phase|Other|2|||
127554619|NCT02003924|458997086|FG002|Long-term Follow-up Phase|Other|1|||
127554620|NCT00560352|458997090|FG000|Overall Study|Adverse event unrelated to study drug|2|||
127554621|NCT00560352|458997091|FG001|Overall Study|Adverse event unrelated to study drug|1|||
127554622|NCT00560352|458997092|FG002|Overall Study|Adverse event unrelated to study drug|1|||
127554623|NCT00560352|458997090|FG000|Overall Study|Study drug toxicity|3|||
127554624|NCT00560352|458997091|FG001|Overall Study|Study drug toxicity|0|||
127554625|NCT00560352|458997092|FG002|Overall Study|Study drug toxicity|1|||
127554626|NCT00560352|458997090|FG000|Overall Study|Disease progression|0|||
127554627|NCT00560352|458997091|FG001|Overall Study|Disease progression|1|||
127554628|NCT00560352|458997092|FG002|Overall Study|Disease progression|1|||
127554629|NCT00560352|458997090|FG000|Overall Study|Withdrawal by Subject|1|||
127554630|NCT00560352|458997091|FG001|Overall Study|Withdrawal by Subject|1|||
127554631|NCT00560352|458997092|FG002|Overall Study|Withdrawal by Subject|1|||
127554632|NCT00560352|458997090|FG000|Overall Study|Maximum clinical benefit|1|||
127554633|NCT00560352|458997091|FG001|Overall Study|Maximum clinical benefit|0|||
127554634|NCT00560352|458997092|FG002|Overall Study|Maximum clinical benefit|0|||
127554635|NCT05767749|458997096|FG000|Overall Study|Withdrawal by Subject|0|||
127554636|NCT05767749|458997097|FG001|Overall Study|Withdrawal by Subject|0|||
127554637|NCT05767749|458997098|FG002|Overall Study|Withdrawal by Subject|2|||
127554638|NCT05767749|458997099|FG003|Overall Study|Withdrawal by Subject|2|||
127554639|NCT05767749|458997100|FG004|Overall Study|Withdrawal by Subject|2|||
127554640|NCT05767749|458997101|FG005|Overall Study|Withdrawal by Subject|2|||
127554641|NCT01077050|458998686|FG000|Overall Study|Subjects signed ICF could not be located|1|||
127554642|NCT01077050|458998686|FG000|Overall Study|Screen failure|8|||
127554643|NCT00684060|458998687|FG000|Overall Study|Lost to Follow-up|1|||
127554644|NCT00684060|458998688|FG001|Overall Study|Lost to Follow-up|0|||
127554645|NCT00684060|458998687|FG000|Overall Study|New stenosis identified|1|||
127554646|NCT00684060|458998688|FG001|Overall Study|New stenosis identified|0|||
127554647|NCT00684060|458998687|FG000|Overall Study|Unable to collect MRI|1|||
127554648|NCT00684060|458998688|FG001|Overall Study|Unable to collect MRI|2|||
127554649|NCT00684060|458998687|FG000|Overall Study|Death|0|||
127554650|NCT00684060|458998688|FG001|Overall Study|Death|1|||
127554651|NCT00702715|458998689|FG000|Overall Study|Lost to Follow-up|1|||
127554652|NCT00702715|458998690|FG001|Overall Study|Lost to Follow-up|0|||
127554653|NCT03751657|458998695|FG000|Overall Study|Physician Decision|0|||
127554654|NCT03751657|458998696|FG001|Overall Study|Physician Decision|1|||
128021028|NCT02021318|460700289|FG001|Overall Study|Lost to Follow-up|3|||
128021029|NCT02021318|460700288|FG000|Overall Study|Progressive Disease|0|||
128021030|NCT02021318|460700289|FG001|Overall Study|Progressive Disease|1|||
128021031|NCT02021318|460700288|FG000|Overall Study|Withdrawal by Subject|30|||
127554655|NCT03751657|458998695|FG000|Overall Study|Withdrawal by Subject|1|||
127554656|NCT03751657|458998696|FG001|Overall Study|Withdrawal by Subject|1|||
127554657|NCT03751657|458998695|FG000|Overall Study|Lost to Follow-up|2|||
128021032|NCT02021318|460700289|FG001|Overall Study|Withdrawal by Subject|18|||
127554658|NCT03751657|458998696|FG001|Overall Study|Lost to Follow-up|1|||
127554659|NCT03894813|458998697|FG000|Overall Study|Adverse Event|1|||
127554660|NCT03894813|458998698|FG001|Overall Study|Adverse Event|1|||
127554661|NCT03894813|458998697|FG000|Overall Study|Lack of Efficacy|3|||
127554662|NCT03894813|458998698|FG001|Overall Study|Lack of Efficacy|3|||
127554663|NCT03894813|458998697|FG000|Overall Study|Lost to Follow-up|1|||
127554664|NCT03894813|458998698|FG001|Overall Study|Lost to Follow-up|0|||
127554665|NCT03894813|458998697|FG000|Overall Study|Pregnancy|2|||
127554666|NCT03894813|458998698|FG001|Overall Study|Pregnancy|1|||
127554667|NCT03894813|458998697|FG000|Overall Study|Protocol Violation|3|||
127554668|NCT03894813|458998698|FG001|Overall Study|Protocol Violation|7|||
127554669|NCT03894813|458998697|FG000|Overall Study|Withdrawal by Subject|1|||
127554670|NCT03894813|458998698|FG001|Overall Study|Withdrawal by Subject|3|||
127554671|NCT03894813|458998697|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
127554672|NCT03894813|458998698|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
127554673|NCT03083873|458998700|FG000|Overall Study|Death|6|||
127554674|NCT03083873|458998701|FG001|Overall Study|Death|15|||
127554675|NCT03083873|458998702|FG002|Overall Study|Death|13|||
127554676|NCT03083873|458998703|FG003|Overall Study|Death|9|||
127554677|NCT03083873|458998704|FG004|Overall Study|Death|0|||
127554678|NCT03083873|458998700|FG000|Overall Study|Sponsor Terminated Study|0|||
127554679|NCT03083873|458998701|FG001|Overall Study|Sponsor Terminated Study|1|||
127554680|NCT03083873|458998702|FG002|Overall Study|Sponsor Terminated Study|2|||
127554681|NCT03083873|458998703|FG003|Overall Study|Sponsor Terminated Study|3|||
127554682|NCT03083873|458998704|FG004|Overall Study|Sponsor Terminated Study|0|||
127554683|NCT03083873|458998700|FG000|Overall Study|Lost to Follow-up|0|||
127554684|NCT03083873|458998701|FG001|Overall Study|Lost to Follow-up|1|||
127554685|NCT03083873|458998702|FG002|Overall Study|Lost to Follow-up|1|||
127554686|NCT03083873|458998703|FG003|Overall Study|Lost to Follow-up|0|||
127554687|NCT03083873|458998704|FG004|Overall Study|Lost to Follow-up|0|||
127554688|NCT03083873|458998700|FG000|Overall Study|Withdrawal by Subject|2|||
127554689|NCT03083873|458998701|FG001|Overall Study|Withdrawal by Subject|0|||
127773816|NCT03871829|459798586|FG001|Overall Study|Withdrawal by Subject|1|||
127773817|NCT03871829|459798585|FG000|Overall Study|Death|12|||
127773818|NCT03871829|459798586|FG001|Overall Study|Death|8|||
127773819|NCT03871829|459798585|FG000|Overall Study|Study terminated by sponsor|31|||
127773820|NCT03871829|459798586|FG001|Overall Study|Study terminated by sponsor|34|||
127773821|NCT01106014|459798587|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
127773822|NCT01106014|459798588|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
127773823|NCT01106014|459798587|FG000|Overall Study|Adverse Event|78|||
127773824|NCT01106014|459798588|FG001|Overall Study|Adverse Event|42|||
127773825|NCT01106014|459798587|FG000|Overall Study|Withdrawal by Subject|43|||
127773826|NCT01106014|459798588|FG001|Overall Study|Withdrawal by Subject|37|||
127773827|NCT01106014|459798587|FG000|Overall Study|Administrative reason|7|||
127773828|NCT01106014|459798588|FG001|Overall Study|Administrative reason|6|||
127773829|NCT01106014|459798587|FG000|Overall Study|Lost to Follow-up|2|||
127773830|NCT01106014|459798588|FG001|Overall Study|Lost to Follow-up|3|||
127773831|NCT00784693|459798594|FG000|Overall Study|Lost to Follow-up|0|||
127773832|NCT00784693|459798595|FG001|Overall Study|Lost to Follow-up|1|||
127773833|NCT00784693|459798594|FG000|Overall Study|Lack of Efficacy|1|||
127773834|NCT00784693|459798595|FG001|Overall Study|Lack of Efficacy|1|||
127773835|NCT00784693|459798594|FG000|Overall Study|Withdrawal by Subject|0|||
127773836|NCT00784693|459798595|FG001|Overall Study|Withdrawal by Subject|4|||
127773837|NCT00784693|459798594|FG000|Overall Study|Randomized but not Treated|1|||
127773838|NCT00784693|459798595|FG001|Overall Study|Randomized but not Treated|0|||
127773839|NCT00784693|459798594|FG000|Overall Study|Other|1|||
127773840|NCT00784693|459798595|FG001|Overall Study|Other|0|||
127773841|NCT05458479|459798596|FG000|Overall Study|Lost to Follow-up|1|||
127773842|NCT00908232|459798597|FG000|Cycle 1 to 4|Death|5|||
127773843|NCT00908232|459798598|FG001|Cycle 1 to 4|Death|0|||
127773844|NCT00908232|459798599|FG002|Cycle 1 to 4|Death|0|||
127773845|NCT00908232|459798600|FG003|Cycle 1 to 4|Death|0|||
128021033|NCT02021318|460700288|FG000|Overall Study|Physician Decision|3|||
127554690|NCT03083873|458998702|FG002|Overall Study|Withdrawal by Subject|0|||
127554691|NCT03083873|458998703|FG003|Overall Study|Withdrawal by Subject|0|||
127554692|NCT03083873|458998704|FG004|Overall Study|Withdrawal by Subject|0|||
127554693|NCT03083873|458998700|FG000|Overall Study|Did Not Receive TIL|2|||
127554694|NCT03083873|458998701|FG001|Overall Study|Did Not Receive TIL|5|||
127554695|NCT03083873|458998702|FG002|Overall Study|Did Not Receive TIL|3|||
127554696|NCT03083873|458998703|FG003|Overall Study|Did Not Receive TIL|1|||
127554697|NCT03083873|458998704|FG004|Overall Study|Did Not Receive TIL|0|||
127773846|NCT00908232|459798597|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
127773847|NCT00908232|459798598|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
127773848|NCT00908232|459798599|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
127773849|NCT00908232|459798600|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
127773850|NCT00908232|459798597|FG000|Cycle 1 to 4|Progressive Disease|6|||
127773851|NCT00908232|459798598|FG001|Cycle 1 to 4|Progressive Disease|0|||
128021034|NCT02021318|460700289|FG001|Overall Study|Physician Decision|3|||
127773852|NCT00908232|459798599|FG002|Cycle 1 to 4|Progressive Disease|0|||
127773853|NCT00908232|459798600|FG003|Cycle 1 to 4|Progressive Disease|0|||
127773854|NCT00908232|459798597|FG000|Cycle 1 to 4|Adverse Event|12|||
127773855|NCT00908232|459798598|FG001|Cycle 1 to 4|Adverse Event|0|||
127773856|NCT00908232|459798599|FG002|Cycle 1 to 4|Adverse Event|0|||
127773857|NCT00908232|459798600|FG003|Cycle 1 to 4|Adverse Event|0|||
127773858|NCT00908232|459798597|FG000|Cycle 1 to 4|Other|1|||
127773859|NCT00908232|459798598|FG001|Cycle 1 to 4|Other|0|||
127773860|NCT00908232|459798599|FG002|Cycle 1 to 4|Other|0|||
127773861|NCT00908232|459798600|FG003|Cycle 1 to 4|Other|0|||
127773862|NCT00908232|459798597|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
127773863|NCT00908232|459798598|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
127773864|NCT00908232|459798599|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
127773865|NCT00908232|459798600|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
127773866|NCT00908232|459798597|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
127773867|NCT00908232|459798598|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
127773868|NCT00908232|459798599|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
127773869|NCT00908232|459798600|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
127773870|NCT00908232|459798597|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
127773871|NCT00908232|459798598|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
127773872|NCT00908232|459798599|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
127773873|NCT00908232|459798600|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
127773874|NCT00908232|459798597|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
127773875|NCT00908232|459798598|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
127773876|NCT00908232|459798599|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
127773877|NCT00908232|459798600|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
127773878|NCT00908232|459798597|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
127773879|NCT00908232|459798598|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
127773880|NCT00908232|459798599|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
127773881|NCT00908232|459798600|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
127773882|NCT00908232|459798597|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
127773883|NCT00908232|459798598|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
127773884|NCT00908232|459798599|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
127773885|NCT00908232|459798600|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
127773886|NCT00908232|459798597|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
127773887|NCT00908232|459798598|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
127773888|NCT00908232|459798599|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
127773889|NCT00908232|459798600|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
127773890|NCT00908232|459798597|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
127773891|NCT00908232|459798598|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
127773892|NCT00908232|459798599|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
127773893|NCT00908232|459798600|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
127773894|NCT02260882|459798601|FG000|Overall Study|Protocol Violation|0|||
127773895|NCT02260882|459798602|FG001|Overall Study|Protocol Violation|1|||
127773896|NCT02119325|459798603|FG000|Washout Period 1|Adverse Event|0|||
127773897|NCT02119325|459798604|FG001|Washout Period 1|Adverse Event|1|||
127773898|NCT01386658|459798605|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
127773899|NCT01386658|459798606|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
127773900|NCT01386658|459798605|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
127773901|NCT01386658|459798606|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
127773902|NCT00954174|459798607|FG000|Overall Study|Adverse Event|28|||
127773903|NCT00954174|459798608|FG001|Overall Study|Adverse Event|23|||
127773904|NCT00954174|459798609|FG002|Overall Study|Adverse Event|4|||
127773905|NCT00954174|459798610|FG003|Overall Study|Adverse Event|9|||
127773906|NCT00954174|459798607|FG000|Overall Study|Death|4|||
127773907|NCT00954174|459798608|FG001|Overall Study|Death|2|||
127773908|NCT00954174|459798609|FG002|Overall Study|Death|0|||
127773909|NCT00954174|459798610|FG003|Overall Study|Death|0|||
127773910|NCT00954174|459798607|FG000|Overall Study|Lack of Efficacy|32|||
127773911|NCT00954174|459798608|FG001|Overall Study|Lack of Efficacy|22|||
127773912|NCT00954174|459798609|FG002|Overall Study|Lack of Efficacy|8|||
127773913|NCT00954174|459798610|FG003|Overall Study|Lack of Efficacy|6|||
127773914|NCT00954174|459798607|FG000|Overall Study|Withdrawal by Subject|14|||
127773915|NCT00954174|459798608|FG001|Overall Study|Withdrawal by Subject|10|||
127773916|NCT00954174|459798609|FG002|Overall Study|Withdrawal by Subject|4|||
127773917|NCT00954174|459798610|FG003|Overall Study|Withdrawal by Subject|3|||
127773918|NCT00954174|459798607|FG000|Overall Study|Medical Reason|4|||
127773919|NCT00954174|459798608|FG001|Overall Study|Medical Reason|2|||
127773920|NCT00954174|459798609|FG002|Overall Study|Medical Reason|1|||
127773921|NCT00954174|459798610|FG003|Overall Study|Medical Reason|0|||
127773922|NCT00954174|459798607|FG000|Overall Study|Ineligible|40|||
127773923|NCT00954174|459798608|FG001|Overall Study|Ineligible|47|||
127773924|NCT00954174|459798609|FG002|Overall Study|Ineligible|7|||
127773925|NCT00954174|459798610|FG003|Overall Study|Ineligible|4|||
127773926|NCT00954174|459798607|FG000|Overall Study|Never Treated|4|||
127773927|NCT00954174|459798608|FG001|Overall Study|Never Treated|17|||
127773928|NCT00954174|459798609|FG002|Overall Study|Never Treated|0|||
128021035|NCT02021318|460700288|FG000|Overall Study|Miscellaneous|2|||
127773929|NCT00954174|459798610|FG003|Overall Study|Never Treated|3|||
127773930|NCT01776424|459798615|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
128021036|NCT02021318|460700289|FG001|Overall Study|Miscellaneous|3|||
128021037|NCT00421993|460700293|FG000|Overall Study|Withdrawal by Subject|22|||
128021038|NCT00421993|460700294|FG001|Overall Study|Withdrawal by Subject|23|||
128021039|NCT00421993|460700295|FG002|Overall Study|Withdrawal by Subject|23|||
128021040|NCT00421993|460700296|FG003|Overall Study|Withdrawal by Subject|24|||
128021041|NCT00421993|460700293|FG000|Overall Study|Lost to Follow-up|18|||
128021042|NCT00421993|460700294|FG001|Overall Study|Lost to Follow-up|19|||
128021043|NCT00421993|460700295|FG002|Overall Study|Lost to Follow-up|22|||
128021044|NCT00421993|460700296|FG003|Overall Study|Lost to Follow-up|20|||
128021045|NCT00421993|460700293|FG000|Overall Study|Adverse Event|11|||
128021046|NCT00421993|460700294|FG001|Overall Study|Adverse Event|1|||
128021047|NCT00421993|460700295|FG002|Overall Study|Adverse Event|6|||
128021048|NCT00421993|460700296|FG003|Overall Study|Adverse Event|4|||
128021049|NCT00421993|460700293|FG000|Overall Study|Protocol Violation|2|||
128021050|NCT00421993|460700294|FG001|Overall Study|Protocol Violation|2|||
128021051|NCT00421993|460700295|FG002|Overall Study|Protocol Violation|0|||
128021052|NCT00421993|460700296|FG003|Overall Study|Protocol Violation|1|||
128021053|NCT00421993|460700293|FG000|Overall Study|Lack of Efficacy|0|||
128021054|NCT00421993|460700294|FG001|Overall Study|Lack of Efficacy|3|||
128021055|NCT00421993|460700295|FG002|Overall Study|Lack of Efficacy|0|||
128021056|NCT00421993|460700296|FG003|Overall Study|Lack of Efficacy|5|||
128021057|NCT00421993|460700293|FG000|Overall Study|Pregnancy|0|||
128021058|NCT00421993|460700294|FG001|Overall Study|Pregnancy|1|||
128021059|NCT00421993|460700295|FG002|Overall Study|Pregnancy|1|||
128021060|NCT00421993|460700296|FG003|Overall Study|Pregnancy|2|||
128021061|NCT00421993|460700293|FG000|Overall Study|Subject transportation issues|0|||
128021062|NCT00421993|460700294|FG001|Overall Study|Subject transportation issues|0|||
128021063|NCT00421993|460700295|FG002|Overall Study|Subject transportation issues|0|||
128021064|NCT00421993|460700296|FG003|Overall Study|Subject transportation issues|1|||
128021065|NCT01980888|460700297|FG000|Overall Study|Study Terminated by Sponsor|116|||
128021066|NCT01980888|460700298|FG001|Overall Study|Study Terminated by Sponsor|122|||
128021067|NCT01980888|460700297|FG000|Overall Study|Withdrew Consent|17|||
128021068|NCT01980888|460700298|FG001|Overall Study|Withdrew Consent|6|||
128021069|NCT01980888|460700297|FG000|Overall Study|Investigator's Discretion|8|||
128021070|NCT01980888|460700298|FG001|Overall Study|Investigator's Discretion|3|||
128021071|NCT01980888|460700297|FG000|Overall Study|Non-Compliance with Study Drug|3|||
128021072|NCT01980888|460700298|FG001|Overall Study|Non-Compliance with Study Drug|2|||
128021073|NCT01030900|460700309|FG000|Overall Study|Not treated due to congestive heart failure|1|||
128021074|NCT01030900|460700309|FG000|Overall Study|Not treated due to rapid disease|1|||
128021075|NCT00441896|460700310|FG000|Overall Study|Withdrawal by Subject|0|||
128021076|NCT00441896|460700311|FG001|Overall Study|Withdrawal by Subject|0|||
128021077|NCT00441896|460700312|FG002|Overall Study|Withdrawal by Subject|0|||
128021078|NCT00441896|460700313|FG003|Overall Study|Withdrawal by Subject|1|||
128021079|NCT00441896|460700314|FG004|Overall Study|Withdrawal by Subject|0|||
128021080|NCT00441896|460700315|FG005|Overall Study|Withdrawal by Subject|0|||
128021081|NCT00441896|460700316|FG006|Overall Study|Withdrawal by Subject|0|||
128021082|NCT00441896|460700317|FG007|Overall Study|Withdrawal by Subject|0|||
128021083|NCT00441896|460700318|FG008|Overall Study|Withdrawal by Subject|0|||
128021084|NCT00441896|460700319|FG009|Overall Study|Withdrawal by Subject|0|||
128021085|NCT00441896|460700310|FG000|Overall Study|Other|0|||
128021086|NCT00441896|460700311|FG001|Overall Study|Other|0|||
128021087|NCT00441896|460700312|FG002|Overall Study|Other|0|||
128021088|NCT00441896|460700313|FG003|Overall Study|Other|0|||
128021089|NCT00441896|460700314|FG004|Overall Study|Other|1|||
128021090|NCT00441896|460700315|FG005|Overall Study|Other|0|||
128021091|NCT00441896|460700316|FG006|Overall Study|Other|0|||
128021092|NCT00441896|460700317|FG007|Overall Study|Other|0|||
128021093|NCT00441896|460700318|FG008|Overall Study|Other|0|||
128021094|NCT00441896|460700319|FG009|Overall Study|Other|0|||
128021095|NCT01350973|460700320|FG000|Overall Study|Adverse Event|4|||
127881010|NCT02756078|460186097|FG000|Period 2|Withdrawal by Subject|3|||
128021096|NCT01350973|460700321|FG001|Overall Study|Adverse Event|7|||
127554698|NCT01677377|458998705|FG000|Overall Study|Protocol Violation|1|||
128021097|NCT01350973|460700322|FG002|Overall Study|Adverse Event|7|||
128021098|NCT01350973|460700320|FG000|Overall Study|Voluntary Withdrawal|2|||
128021099|NCT01350973|460700321|FG001|Overall Study|Voluntary Withdrawal|1|||
128021100|NCT01350973|460700322|FG002|Overall Study|Voluntary Withdrawal|1|||
127554699|NCT01677377|458998706|FG001|Overall Study|Protocol Violation|0|||
127554700|NCT01677377|458998707|FG002|Overall Study|Protocol Violation|0|||
127554701|NCT01677377|458998705|FG000|Overall Study|Lost to Follow-up|0|||
127554702|NCT01677377|458998706|FG001|Overall Study|Lost to Follow-up|1|||
127554703|NCT01677377|458998707|FG002|Overall Study|Lost to Follow-up|1|||
127554704|NCT01677377|458998705|FG000|Overall Study|Withdrawal by Subject|0|||
127554705|NCT01677377|458998706|FG001|Overall Study|Withdrawal by Subject|0|||
127554706|NCT01677377|458998707|FG002|Overall Study|Withdrawal by Subject|3|||
127554707|NCT01677377|458998705|FG000|Overall Study|Lack of Efficacy|0|||
127554708|NCT01677377|458998706|FG001|Overall Study|Lack of Efficacy|0|||
127554709|NCT01677377|458998707|FG002|Overall Study|Lack of Efficacy|1|||
127554710|NCT01677377|458998705|FG000|Overall Study|Pregnancy|0|||
127554711|NCT01677377|458998706|FG001|Overall Study|Pregnancy|0|||
127554712|NCT01677377|458998707|FG002|Overall Study|Pregnancy|1|||
127554713|NCT02656693|458998721|FG000|Overall Study|Pregnancy|1|||
127554714|NCT02656693|458998722|FG001|Overall Study|Pregnancy|1|||
127554715|NCT02656693|458998723|FG002|Overall Study|Pregnancy|1|||
127554716|NCT02656693|458998721|FG000|Overall Study|Bariatric surgery|0|||
127554717|NCT02656693|458998722|FG001|Overall Study|Bariatric surgery|1|||
127554718|NCT02656693|458998723|FG002|Overall Study|Bariatric surgery|2|||
127554719|NCT02269267|458998725|FG000|Overall Study|Death|5|||
127554720|NCT03773796|458998726|FG000|Overall Study|Adverse Event|1|||
127554721|NCT03773796|458998726|FG000|Overall Study|Withdrawal by Subject|1|||
127554722|NCT03773796|458998726|FG000|Overall Study|Lack of Efficacy|1|||
127554723|NCT03805659|458998728|FG000|Overall Study|Withdrawal by Subject|0|||
127554724|NCT03805659|458998729|FG001|Overall Study|Withdrawal by Subject|1|||
127554725|NCT00796419|458998732|FG000|Overall Study|Death|0|||
127554726|NCT00796419|458998733|FG001|Overall Study|Death|1|||
127554727|NCT01250145|458998734|FG000|Overall Study|Adverse Event|2|||
127554728|NCT01250145|458998735|FG001|Overall Study|Adverse Event|1|||
127554729|NCT01250145|458998734|FG000|Overall Study|Withdrawal by Subject|0|||
127554730|NCT01250145|458998735|FG001|Overall Study|Withdrawal by Subject|4|||
127554731|NCT01069900|458998738|FG000|Overall Study|Technical problems|0|||
127554732|NCT01069900|458998739|FG001|Overall Study|Technical problems|1|||
127554733|NCT01069900|458998738|FG000|Overall Study|Lost to Follow-up|7|||
127554734|NCT01069900|458998739|FG001|Overall Study|Lost to Follow-up|1|||
127554735|NCT01069900|458998738|FG000|Overall Study|Withdrawal by Subject|6|||
127554736|NCT01069900|458998739|FG001|Overall Study|Withdrawal by Subject|1|||
127554737|NCT01069900|458998738|FG000|Overall Study|Protocol Violation|4|||
127554738|NCT01069900|458998739|FG001|Overall Study|Protocol Violation|1|||
127554739|NCT01069900|458998738|FG000|Overall Study|Insufficient Therapeutic effect|1|||
127554740|NCT01069900|458998739|FG001|Overall Study|Insufficient Therapeutic effect|0|||
127554741|NCT01675544|458998748|FG000|Overall Study|Withdrawal by Subject|2|||
127554742|NCT01168219|458998755|FG000|Overall Study|off study before starting treatment|2|||
127554743|NCT01168219|458998755|FG000|Overall Study|withdrew before transplant|1|||
127554744|NCT01168219|458998755|FG000|Overall Study|ineligible due to CML|2|||
127554745|NCT02600819|458998756|FG000|GEN Phase|Adverse Event|2|||
127554746|NCT02600819|458998757|FG001|GEN Phase|Adverse Event|0|||
127554747|NCT02600819|458998756|FG000|GEN Phase|Death|2|||
127554748|NCT02600819|458998757|FG001|GEN Phase|Death|0|||
127554749|NCT02600819|458998756|FG000|GEN Phase|Investigator's Discretion|4|||
127554750|NCT02600819|458998757|FG001|GEN Phase|Investigator's Discretion|0|||
127554751|NCT02600819|458998756|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
127554752|NCT02600819|458998757|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
127554753|NCT02600819|458998756|FG000|GEN Phase|Withdrew Consent|5|||
127554754|NCT02600819|458998757|FG001|GEN Phase|Withdrew Consent|0|||
127554755|NCT02600819|458998756|FG000|GEN Phase|Lost to Follow-up|2|||
127554756|NCT02600819|458998757|FG001|GEN Phase|Lost to Follow-up|0|||
127554757|NCT01027273|458998758|FG000|Overall Study|Lost to Follow-up|57|||
127554758|NCT01027273|458998759|FG001|Overall Study|Lost to Follow-up|31|||
127554759|NCT01027273|458998758|FG000|Overall Study|Death|2|||
127554760|NCT01027273|458998759|FG001|Overall Study|Death|2|||
127554761|NCT05097963|458998762|FG000|Overall Study|Protocol Violation|13|||
127554762|NCT05097963|458998762|FG000|Overall Study|Withdrawal by Subject|21|||
127554763|NCT02948634|458998763|FG000|Overall Study|Lack of efficacy and study suspended|10|||
127554764|NCT02948634|458998764|FG001|Overall Study|Lack of efficacy and study suspended|2|||
127554765|NCT03830892|458998765|FG000|Overall Study|Physician Decision|2|||
127554766|NCT03830892|458998766|FG001|Overall Study|Physician Decision|3|||
127554767|NCT03830892|458998765|FG000|Overall Study|Study terminated due to COVID|4|||
127554768|NCT03830892|458998766|FG001|Overall Study|Study terminated due to COVID|0|||
127554769|NCT03830892|458998765|FG000|Overall Study|Protocol Violation|0|||
127554770|NCT03830892|458998766|FG001|Overall Study|Protocol Violation|1|||
127554771|NCT03830892|458998765|FG000|Overall Study|Withdrawal by Subject|0|||
127554772|NCT03830892|458998766|FG001|Overall Study|Withdrawal by Subject|2|||
127554773|NCT04661579|458998767|FG000|Overall Study|Lost to Follow-up|19|||
127554774|NCT04661579|458998768|FG001|Overall Study|Lost to Follow-up|10|||
127554775|NCT04661579|458998769|FG002|Overall Study|Lost to Follow-up|2|||
127554776|NCT04661579|458998770|FG003|Overall Study|Lost to Follow-up|7|||
127554777|NCT04661579|458998771|FG004|Overall Study|Lost to Follow-up|11|||
127554778|NCT04661579|458998767|FG000|Overall Study|Physician Decision|2|||
127554779|NCT04661579|458998768|FG001|Overall Study|Physician Decision|0|||
127554780|NCT04661579|458998769|FG002|Overall Study|Physician Decision|0|||
127554781|NCT04661579|458998770|FG003|Overall Study|Physician Decision|1|||
127554782|NCT04661579|458998771|FG004|Overall Study|Physician Decision|0|||
127554783|NCT04661579|458998767|FG000|Overall Study|Withdrawal by Subject|1|||
127554784|NCT04661579|458998768|FG001|Overall Study|Withdrawal by Subject|4|||
127554785|NCT04661579|458998769|FG002|Overall Study|Withdrawal by Subject|0|||
127554786|NCT04661579|458998770|FG003|Overall Study|Withdrawal by Subject|2|||
127554787|NCT04661579|458998771|FG004|Overall Study|Withdrawal by Subject|0|||
127554788|NCT04661579|458998767|FG000|Overall Study|Death|1|||
127554789|NCT04661579|458998768|FG001|Overall Study|Death|0|||
127554790|NCT04661579|458998769|FG002|Overall Study|Death|0|||
127554791|NCT04661579|458998770|FG003|Overall Study|Death|0|||
127554792|NCT04661579|458998771|FG004|Overall Study|Death|0|||
127554793|NCT04661579|458998767|FG000|Overall Study|Other|1|||
127554794|NCT04661579|458998768|FG001|Overall Study|Other|2|||
127554795|NCT04661579|458998769|FG002|Overall Study|Other|1|||
127554796|NCT04661579|458998770|FG003|Overall Study|Other|1|||
127554797|NCT04661579|458998771|FG004|Overall Study|Other|1|||
127554798|NCT04661579|458998767|FG000|Overall Study|Randomized but Did Not Receive Study Product|4|||
127554799|NCT04661579|458998768|FG001|Overall Study|Randomized but Did Not Receive Study Product|4|||
127554800|NCT04661579|458998769|FG002|Overall Study|Randomized but Did Not Receive Study Product|1|||
127554801|NCT04661579|458998770|FG003|Overall Study|Randomized but Did Not Receive Study Product|5|||
127554802|NCT04661579|458998771|FG004|Overall Study|Randomized but Did Not Receive Study Product|1|||
127554803|NCT00337675|458998773|FG000|Overall Study|Adverse Event|10|||
127554804|NCT00337675|458998774|FG001|Overall Study|Adverse Event|9|||
127554805|NCT00337675|458998775|FG002|Overall Study|Adverse Event|19|||
127554806|NCT00337675|458998773|FG000|Overall Study|Lack of Efficacy|10|||
127554807|NCT00337675|458998774|FG001|Overall Study|Lack of Efficacy|7|||
127554808|NCT00337675|458998775|FG002|Overall Study|Lack of Efficacy|9|||
127554809|NCT00337675|458998773|FG000|Overall Study|Lost to Follow-up|22|||
127554810|NCT00337675|458998774|FG001|Overall Study|Lost to Follow-up|19|||
127554811|NCT00337675|458998775|FG002|Overall Study|Lost to Follow-up|17|||
127554812|NCT00337675|458998773|FG000|Overall Study|Physician Decision|9|||
127554813|NCT00337675|458998774|FG001|Overall Study|Physician Decision|17|||
127554814|NCT00337675|458998775|FG002|Overall Study|Physician Decision|14|||
127554815|NCT00337675|458998773|FG000|Overall Study|Protocol Violation|21|||
127554816|NCT00337675|458998774|FG001|Overall Study|Protocol Violation|24|||
127554817|NCT00337675|458998775|FG002|Overall Study|Protocol Violation|19|||
127554818|NCT00337675|458998773|FG000|Overall Study|Withdrawal by Subject|25|||
127554819|NCT00337675|458998774|FG001|Overall Study|Withdrawal by Subject|25|||
127554820|NCT00337675|458998775|FG002|Overall Study|Withdrawal by Subject|19|||
127554821|NCT00337675|458998773|FG000|Overall Study|Progressive Disease|0|||
127554822|NCT00337675|458998774|FG001|Overall Study|Progressive Disease|2|||
127554823|NCT00337675|458998775|FG002|Overall Study|Progressive Disease|0|||
127554824|NCT00337675|458998773|FG000|Overall Study|Trial Terminated|0|||
127554825|NCT00337675|458998774|FG001|Overall Study|Trial Terminated|0|||
127554826|NCT00337675|458998775|FG002|Overall Study|Trial Terminated|2|||
127773931|NCT01776424|459798616|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
127773932|NCT01776424|459798617|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
127773933|NCT01776424|459798615|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
127773934|NCT01776424|459798616|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
127773935|NCT01776424|459798617|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
128021101|NCT02638493|460700326|FG000|Overall Study|Inability to provide semen samples|2|||
128021102|NCT02638493|460700327|FG001|Overall Study|Inability to provide semen samples|0|||
128021103|NCT02638493|460700328|FG002|Overall Study|Inability to provide semen samples|0|||
127554827|NCT00859456|458998776|FG000|Overall Study|Adverse Event|3|||
127554828|NCT00859456|458998776|FG000|Overall Study|Progressive disease|2|||
127554829|NCT00859456|458998776|FG000|Overall Study|Non-compliance|3|||
127554830|NCT00775593|458998781|FG000|Overall Study|Unmet eligibility criteria|6|||
127554831|NCT00775593|458998781|FG000|Overall Study|Death|1|||
127554832|NCT02067676|458998782|FG000|Overall Study|Withdrawal by Subject|1|||
127554833|NCT02067676|458998783|FG001|Overall Study|Withdrawal by Subject|0|||
127554834|NCT02067676|458998784|FG002|Overall Study|Withdrawal by Subject|0|||
127554835|NCT02067676|458998785|FG003|Overall Study|Withdrawal by Subject|0|||
127554836|NCT02067676|458998786|FG004|Overall Study|Withdrawal by Subject|0|||
127554837|NCT02067676|458998787|FG005|Overall Study|Withdrawal by Subject|0|||
127554838|NCT03904693|458998795|FG000|Overall Study|Death|0|||
127554839|NCT03904693|458998796|FG001|Overall Study|Death|0|||
127554840|NCT03904693|458998797|FG002|Overall Study|Death|3|||
127554841|NCT03904693|458998795|FG000|Overall Study|Physician Decision|0|||
127554842|NCT03904693|458998796|FG001|Overall Study|Physician Decision|0|||
127554843|NCT03904693|458998797|FG002|Overall Study|Physician Decision|2|||
127554844|NCT03904693|458998795|FG000|Overall Study|Withdrawal by Subject|0|||
127554845|NCT03904693|458998796|FG001|Overall Study|Withdrawal by Subject|1|||
127554846|NCT03904693|458998797|FG002|Overall Study|Withdrawal by Subject|4|||
127554847|NCT00369265|458998798|FG000|Overall Study|Study terminated|4|||
127554848|NCT00369265|458998799|FG001|Overall Study|Study terminated|7|||
127554849|NCT00048074|458998802|FG000|Overall Study|Adverse Event|46|||
127554850|NCT00048074|458998803|FG001|Overall Study|Adverse Event|41|||
127554851|NCT00048074|458998804|FG002|Overall Study|Adverse Event|53|||
127554852|NCT00048074|458998802|FG000|Overall Study|Death|3|||
127554853|NCT00048074|458998803|FG001|Overall Study|Death|3|||
127554854|NCT00048074|458998804|FG002|Overall Study|Death|2|||
127554855|NCT00048074|458998802|FG000|Overall Study|Lost to Follow-up|2|||
127554856|NCT00048074|458998803|FG001|Overall Study|Lost to Follow-up|6|||
127554857|NCT00048074|458998804|FG002|Overall Study|Lost to Follow-up|6|||
127554858|NCT00048074|458998802|FG000|Overall Study|Withdrawal by Subject|28|||
127554859|NCT00048074|458998803|FG001|Overall Study|Withdrawal by Subject|30|||
127554860|NCT00048074|458998804|FG002|Overall Study|Withdrawal by Subject|35|||
127554861|NCT00048074|458998802|FG000|Overall Study|Protocol Violation|1|||
127554862|NCT00048074|458998803|FG001|Overall Study|Protocol Violation|3|||
127554863|NCT00048074|458998804|FG002|Overall Study|Protocol Violation|0|||
127554864|NCT00048074|458998802|FG000|Overall Study|Study participation was terminated|0|||
127554865|NCT00048074|458998803|FG001|Overall Study|Study participation was terminated|1|||
127554866|NCT00048074|458998804|FG002|Overall Study|Study participation was terminated|0|||
127554867|NCT00048074|458998802|FG000|Overall Study|Husband ill|0|||
127554868|NCT00048074|458998803|FG001|Overall Study|Husband ill|1|||
127554869|NCT00048074|458998804|FG002|Overall Study|Husband ill|0|||
127554870|NCT00048074|458998802|FG000|Overall Study|Poor compliance|0|||
127554871|NCT00048074|458998803|FG001|Overall Study|Poor compliance|1|||
127554872|NCT00048074|458998804|FG002|Overall Study|Poor compliance|0|||
127554873|NCT00048074|458998802|FG000|Overall Study|Out of station|0|||
127554874|NCT00048074|458998803|FG001|Overall Study|Out of station|1|||
127554875|NCT00048074|458998804|FG002|Overall Study|Out of station|1|||
127554876|NCT00048074|458998802|FG000|Overall Study|Social reasons|1|||
127554877|NCT00048074|458998803|FG001|Overall Study|Social reasons|0|||
127554878|NCT00048074|458998804|FG002|Overall Study|Social reasons|0|||
127554879|NCT02873377|458998805|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
127554880|NCT02873377|458998806|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
127554881|NCT02873377|458998805|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
127554882|NCT02873377|458998806|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
127554883|NCT01032889|458998820|FG000|Overall Study|Adverse Event|2|||
127554884|NCT01032889|458998821|FG001|Overall Study|Adverse Event|2|||
127554885|NCT01032889|458998822|FG002|Overall Study|Adverse Event|0|||
127554886|NCT01032889|458998820|FG000|Overall Study|Withdrawal of Consent|1|||
127554887|NCT01032889|458998821|FG001|Overall Study|Withdrawal of Consent|2|||
127554888|NCT01032889|458998822|FG002|Overall Study|Withdrawal of Consent|1|||
127554889|NCT01032889|458998820|FG000|Overall Study|Patient Request|0|||
127554890|NCT01032889|458998821|FG001|Overall Study|Patient Request|1|||
127554891|NCT01032889|458998822|FG002|Overall Study|Patient Request|0|||
127554892|NCT01032889|458998820|FG000|Overall Study|Lost to Follow-up|1|||
127773936|NCT01776424|459798615|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
127554893|NCT01032889|458998821|FG001|Overall Study|Lost to Follow-up|1|||
127554894|NCT01032889|458998822|FG002|Overall Study|Lost to Follow-up|0|||
127554895|NCT01032889|458998820|FG000|Overall Study|Lack of Submental Fat|2|||
127554896|NCT01032889|458998821|FG001|Overall Study|Lack of Submental Fat|8|||
127554897|NCT01032889|458998822|FG002|Overall Study|Lack of Submental Fat|1|||
127554898|NCT01032889|458998820|FG000|Overall Study|Miscellaneous Reasons|2|||
127554899|NCT01032889|458998821|FG001|Overall Study|Miscellaneous Reasons|1|||
127554900|NCT01032889|458998822|FG002|Overall Study|Miscellaneous Reasons|1|||
127881011|NCT02756078|460186098|FG001|Period 2|Withdrawal by Subject|1|||
127554901|NCT02039843|458998823|FG000|Randomization and Observation Period|Adverse Event|2|||
127554902|NCT02039843|458998824|FG001|Randomization and Observation Period|Adverse Event|0|||
127554903|NCT02039843|458998823|FG000|Randomization and Observation Period|Death|1|||
127554904|NCT02039843|458998824|FG001|Randomization and Observation Period|Death|0|||
127554905|NCT02039843|458998823|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
127554906|NCT02039843|458998824|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
127554907|NCT02039843|458998823|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
127554908|NCT02039843|458998824|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
127554909|NCT02039843|458998823|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
127554910|NCT02039843|458998824|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
127554911|NCT02039843|458998823|FG000|Pairing With a Study Dog|Death|1|||
127554912|NCT02039843|458998824|FG001|Pairing With a Study Dog|Death|0|||
127554913|NCT02039843|458998823|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
127554914|NCT02039843|458998824|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
127554915|NCT02039843|458998823|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
127554916|NCT02039843|458998824|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
127554917|NCT02039843|458998823|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
127554918|NCT02039843|458998824|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
127554919|NCT02624986|458998829|FG000|Overall Study|Death|0|||
127554920|NCT02624986|458998830|FG001|Overall Study|Death|1|||
127554921|NCT02624986|458998831|FG002|Overall Study|Death|2|||
127554922|NCT02624986|458998832|FG003|Overall Study|Death|2|||
127554923|NCT02624986|458998833|FG004|Overall Study|Death|2|||
127554924|NCT02624986|458998834|FG005|Overall Study|Death|0|||
127554925|NCT02624986|458998835|FG006|Overall Study|Death|0|||
127554926|NCT02624986|458998836|FG007|Overall Study|Death|1|||
127554927|NCT02624986|458998829|FG000|Overall Study|Study Terminated by Sponsor|1|||
127554928|NCT02624986|458998830|FG001|Overall Study|Study Terminated by Sponsor|1|||
127554929|NCT02624986|458998831|FG002|Overall Study|Study Terminated by Sponsor|0|||
127554930|NCT02624986|458998832|FG003|Overall Study|Study Terminated by Sponsor|1|||
127554931|NCT02624986|458998833|FG004|Overall Study|Study Terminated by Sponsor|2|||
127554932|NCT02624986|458998834|FG005|Overall Study|Study Terminated by Sponsor|2|||
127554933|NCT02624986|458998835|FG006|Overall Study|Study Terminated by Sponsor|4|||
127554934|NCT02624986|458998836|FG007|Overall Study|Study Terminated by Sponsor|3|||
127554935|NCT02624986|458998829|FG000|Overall Study|Progressive Disease|0|||
127554936|NCT02624986|458998830|FG001|Overall Study|Progressive Disease|1|||
127554937|NCT02624986|458998831|FG002|Overall Study|Progressive Disease|0|||
127554938|NCT02624986|458998832|FG003|Overall Study|Progressive Disease|0|||
127554939|NCT02624986|458998833|FG004|Overall Study|Progressive Disease|0|||
127554940|NCT02624986|458998834|FG005|Overall Study|Progressive Disease|0|||
127554941|NCT02624986|458998835|FG006|Overall Study|Progressive Disease|0|||
127554942|NCT02624986|458998836|FG007|Overall Study|Progressive Disease|0|||
127554943|NCT02624986|458998829|FG000|Overall Study|Protocol Violation|1|||
127554944|NCT02624986|458998830|FG001|Overall Study|Protocol Violation|0|||
127554945|NCT02624986|458998831|FG002|Overall Study|Protocol Violation|0|||
127554946|NCT02624986|458998832|FG003|Overall Study|Protocol Violation|0|||
127554947|NCT02624986|458998833|FG004|Overall Study|Protocol Violation|0|||
127554948|NCT02624986|458998834|FG005|Overall Study|Protocol Violation|0|||
127554949|NCT02624986|458998835|FG006|Overall Study|Protocol Violation|0|||
127554950|NCT02624986|458998836|FG007|Overall Study|Protocol Violation|0|||
127554951|NCT02624986|458998829|FG000|Overall Study|Withdrawal by Subject|0|||
127881012|NCT00943384|460186099|FG000|Overall Study|Dispositioned prior to treatment|23|||
127554952|NCT02624986|458998830|FG001|Overall Study|Withdrawal by Subject|0|||
127554953|NCT02624986|458998831|FG002|Overall Study|Withdrawal by Subject|0|||
127554954|NCT02624986|458998832|FG003|Overall Study|Withdrawal by Subject|0|||
127554955|NCT02624986|458998833|FG004|Overall Study|Withdrawal by Subject|0|||
127554956|NCT02624986|458998834|FG005|Overall Study|Withdrawal by Subject|0|||
127554957|NCT02624986|458998835|FG006|Overall Study|Withdrawal by Subject|0|||
127554958|NCT02624986|458998836|FG007|Overall Study|Withdrawal by Subject|1|||
127554959|NCT00740857|458998837|FG000|Overall Study|Withdrawal by Subject|1|||
127554960|NCT00740857|458998838|FG001|Overall Study|Withdrawal by Subject|0|||
127554961|NCT00740857|458998839|FG002|Overall Study|Withdrawal by Subject|0|||
127881013|NCT00943384|460186099|FG000|Overall Study|Treated off protocol-protocol violation|5|||
127554962|NCT03532451|458998843|FG000|Overall Study|Withdrawal by Subject|0|||
127554963|NCT03532451|458998844|FG001|Overall Study|Withdrawal by Subject|1|||
127554964|NCT03532451|458998843|FG000|Overall Study|Did not undergo surgery|1|||
127554965|NCT03532451|458998844|FG001|Overall Study|Did not undergo surgery|1|||
127554966|NCT00943072|459000436|FG000|Overall Study|Adverse Event|0|||
127554967|NCT00943072|459000437|FG001|Overall Study|Adverse Event|3|||
127554968|NCT00943072|459000436|FG000|Overall Study|Death|0|||
127554969|NCT00943072|459000437|FG001|Overall Study|Death|2|||
127554970|NCT00943072|459000436|FG000|Overall Study|Withdrawal by Subject|3|||
127554971|NCT00943072|459000437|FG001|Overall Study|Withdrawal by Subject|1|||
127554972|NCT00943072|459000436|FG000|Overall Study|Protocol Violation|0|||
127554973|NCT00943072|459000437|FG001|Overall Study|Protocol Violation|1|||
127554974|NCT00943072|459000436|FG000|Overall Study|Lost to Follow-up|1|||
127554975|NCT00943072|459000437|FG001|Overall Study|Lost to Follow-up|2|||
127554976|NCT00943072|459000436|FG000|Overall Study|Lack of Efficacy|0|||
127554977|NCT00943072|459000437|FG001|Overall Study|Lack of Efficacy|4|||
127554978|NCT00943072|459000436|FG000|Overall Study|Other|1|||
127554979|NCT00943072|459000437|FG001|Overall Study|Other|1|||
127554980|NCT00552188|459000438|FG000|Overall Study|Adverse Event|0|||
127554981|NCT00552188|459000439|FG001|Overall Study|Adverse Event|2|||
127554982|NCT00552188|459000438|FG000|Overall Study|Lost to Follow-up|2|||
127554983|NCT00552188|459000439|FG001|Overall Study|Lost to Follow-up|1|||
127554984|NCT00552188|459000438|FG000|Overall Study|Withdrawal of consent|0|||
127554985|NCT00552188|459000439|FG001|Overall Study|Withdrawal of consent|1|||
127554986|NCT00552188|459000438|FG000|Overall Study|Subject returned to home country|0|||
127554987|NCT00552188|459000439|FG001|Overall Study|Subject returned to home country|1|||
127554988|NCT03887702|459000440|FG000|Overall Study|Study terminated|0|||
127554989|NCT03887702|459000441|FG001|Overall Study|Study terminated|0|||
127554990|NCT03887702|459000442|FG002|Overall Study|Study terminated|2|||
127554991|NCT03887702|459000443|FG003|Overall Study|Study terminated|2|||
127554992|NCT01193257|459000444|FG000|Overall Study|Death|202|||
127554993|NCT01193257|459000445|FG001|Overall Study|Death|391|||
127554994|NCT01193257|459000444|FG000|Overall Study|Study termination by sponsor|0|||
127554995|NCT01193257|459000445|FG001|Overall Study|Study termination by sponsor|3|||
127554996|NCT01193257|459000444|FG000|Overall Study|Withdrawal by Subject|26|||
127554997|NCT01193257|459000445|FG001|Overall Study|Withdrawal by Subject|86|||
127554998|NCT01193257|459000444|FG000|Overall Study|Lost to Follow-up|2|||
127554999|NCT01193257|459000445|FG001|Overall Study|Lost to Follow-up|3|||
127555000|NCT01193257|459000444|FG000|Overall Study|Unblinded due to futility|135|||
127555001|NCT01193257|459000445|FG001|Overall Study|Unblinded due to futility|251|||
128021104|NCT01033071|460700329|FG000|Overall Study|Adverse Event|28|||
128021105|NCT01033071|460700330|FG001|Overall Study|Adverse Event|51|||
128021106|NCT01033071|460700331|FG002|Overall Study|Adverse Event|26|||
128021107|NCT01033071|460700329|FG000|Overall Study|Protocol Violation|0|||
128021108|NCT01033071|460700330|FG001|Overall Study|Protocol Violation|2|||
128021109|NCT01033071|460700331|FG002|Overall Study|Protocol Violation|1|||
128021110|NCT01033071|460700329|FG000|Overall Study|Lost to Follow-up|4|||
128021111|NCT01033071|460700330|FG001|Overall Study|Lost to Follow-up|5|||
128021112|NCT01033071|460700331|FG002|Overall Study|Lost to Follow-up|5|||
128021113|NCT01033071|460700329|FG000|Overall Study|Withdrawal by Subject|17|||
127555002|NCT00441064|459000450|FG000|Overall Study|Adverse Event|1|||
127555003|NCT00441064|459000451|FG001|Overall Study|Adverse Event|0|||
127555004|NCT00441064|459000450|FG000|Overall Study|Abnormal laboratory values|0|||
127555005|NCT00441064|459000451|FG001|Overall Study|Abnormal laboratory values|2|||
127555006|NCT00441064|459000450|FG000|Overall Study|Abnormal test procedure results|0|||
127555007|NCT00441064|459000451|FG001|Overall Study|Abnormal test procedure results|1|||
127555008|NCT00441064|459000450|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
127555009|NCT00441064|459000451|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
127555010|NCT00441064|459000450|FG000|Overall Study|Protocol Deviation|3|||
127555011|NCT00441064|459000451|FG001|Overall Study|Protocol Deviation|2|||
128021114|NCT01033071|460700330|FG001|Overall Study|Withdrawal by Subject|14|||
128021115|NCT01033071|460700331|FG002|Overall Study|Withdrawal by Subject|11|||
127555012|NCT00441064|459000450|FG000|Overall Study|Patient withdrew consent|5|||
127555013|NCT00441064|459000451|FG001|Overall Study|Patient withdrew consent|2|||
127555014|NCT00953056|459000452|FG000|Overall Study|Withdrew Consent|0|||
127555015|NCT00953056|459000453|FG001|Overall Study|Withdrew Consent|0|||
127555016|NCT00953056|459000454|FG002|Overall Study|Withdrew Consent|0|||
127555017|NCT00953056|459000455|FG003|Overall Study|Withdrew Consent|0|||
127555018|NCT00953056|459000456|FG004|Overall Study|Withdrew Consent|2|||
127555019|NCT00953056|459000457|FG005|Overall Study|Withdrew Consent|3|||
127555020|NCT00953056|459000452|FG000|Overall Study|Serious Adverse Event|0|||
127555021|NCT00953056|459000453|FG001|Overall Study|Serious Adverse Event|0|||
127555022|NCT00953056|459000454|FG002|Overall Study|Serious Adverse Event|0|||
127555023|NCT00953056|459000455|FG003|Overall Study|Serious Adverse Event|0|||
127555024|NCT00953056|459000456|FG004|Overall Study|Serious Adverse Event|0|||
127555025|NCT00953056|459000457|FG005|Overall Study|Serious Adverse Event|1|||
127555026|NCT03962504|459000458|FG000|Overall Study|Other|11|||
127555027|NCT03962504|459000459|FG001|Overall Study|Other|32|||
127555028|NCT00889720|459000460|FG000|Overall Study|Withdrawal by Subject|4|||
127555029|NCT00889720|459000460|FG000|Overall Study|Other|4|||
127555030|NCT01327482|459000461|FG000|Overall Study|Adverse Event|1|||
127555031|NCT00476229|459000462|FG000|Overall Study|Progressive shortness of breath|1|||
127555032|NCT02164461|459000463|FG000|Overall Study|Adverse Event|0|||
127555033|NCT02164461|459000464|FG001|Overall Study|Adverse Event|0|||
127555034|NCT02164461|459000465|FG002|Overall Study|Adverse Event|1|||
127555035|NCT02164461|459000463|FG000|Overall Study|Disease Progression|1|||
127555036|NCT02164461|459000464|FG001|Overall Study|Disease Progression|3|||
127555037|NCT02164461|459000465|FG002|Overall Study|Disease Progression|4|||
127555038|NCT02164461|459000463|FG000|Overall Study|Withdrawal by Subject|0|||
127555039|NCT02164461|459000464|FG001|Overall Study|Withdrawal by Subject|3|||
127555040|NCT02164461|459000465|FG002|Overall Study|Withdrawal by Subject|0|||
127555041|NCT03865381|459000468|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
127555042|NCT03865381|459000468|FG000|Overall Study|Withdrawal by Subject|2|||
127555043|NCT05626322|459000469|FG000|Overall Study|Death|2|||
127555044|NCT05626322|459000470|FG001|Overall Study|Death|0|||
127555045|NCT05626322|459000471|FG002|Overall Study|Death|0|||
127555046|NCT05626322|459000469|FG000|Overall Study|Physician Decision|1|||
127555047|NCT05626322|459000470|FG001|Overall Study|Physician Decision|0|||
127555048|NCT05626322|459000471|FG002|Overall Study|Physician Decision|0|||
127555049|NCT05626322|459000469|FG000|Overall Study|Progressive Disease|0|||
127555050|NCT05626322|459000470|FG001|Overall Study|Progressive Disease|1|||
127555051|NCT05626322|459000471|FG002|Overall Study|Progressive Disease|1|||
127555052|NCT05626322|459000469|FG000|Overall Study|Study terminated by sponsor|0|||
127555053|NCT05626322|459000470|FG001|Overall Study|Study terminated by sponsor|1|||
127555054|NCT05626322|459000471|FG002|Overall Study|Study terminated by sponsor|0|||
127555055|NCT01519167|459000472|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
127555056|NCT01519167|459000473|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
127555057|NCT01519167|459000472|FG000|Overall Study|Adverse Event|0|||
127555058|NCT01519167|459000473|FG001|Overall Study|Adverse Event|1|||
127555059|NCT01519167|459000472|FG000|Overall Study|Lack of Efficacy|0|||
127555060|NCT01519167|459000473|FG001|Overall Study|Lack of Efficacy|1|||
127555061|NCT01519167|459000472|FG000|Overall Study|Medical condition changes&deep sedation|0|||
127555062|NCT01519167|459000473|FG001|Overall Study|Medical condition changes&deep sedation|2|||
127555063|NCT01519167|459000472|FG000|Overall Study|Physician Decision|0|||
128021116|NCT01033071|460700329|FG000|Overall Study|Lack of Efficacy|0|||
128021117|NCT01033071|460700330|FG001|Overall Study|Lack of Efficacy|1|||
128021118|NCT01033071|460700331|FG002|Overall Study|Lack of Efficacy|1|||
128021119|NCT01033071|460700329|FG000|Overall Study|Other|6|||
128021120|NCT01033071|460700330|FG001|Overall Study|Other|4|||
128021121|NCT01033071|460700331|FG002|Overall Study|Other|3|||
127555064|NCT01519167|459000473|FG001|Overall Study|Physician Decision|1|||
127555065|NCT04200352|459000484|FG000|Overall Study|Death|1|||
127555066|NCT04200352|459000484|FG000|Overall Study|Adverse Event|6|||
127555067|NCT04200352|459000484|FG000|Overall Study|Withdrawal by parent/guardian|6|||
127773937|NCT01776424|459798616|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
127555068|NCT04200352|459000484|FG000|Overall Study|Lack of Efficacy|1|||
127773938|NCT01776424|459798617|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
127773939|NCT01776424|459798615|FG000|LTOLE Part (Open Label)|Refused|5|||
127555069|NCT04200352|459000484|FG000|Overall Study|Other than specified|6|||
127773940|NCT01776424|459798616|FG001|LTOLE Part (Open Label)|Refused|2|||
127555070|NCT00993148|459000485|FG000|Overall Study|Lost to Follow-up|2|||
127555071|NCT00993148|459000485|FG000|Overall Study|never initiated treatment|1|||
127555072|NCT00233064|459000486|FG000|Overall Study|Lost to Follow-up|7|||
127555073|NCT00233064|459000487|FG001|Overall Study|Lost to Follow-up|7|||
127555074|NCT00233064|459000486|FG000|Overall Study|Withdrawal by Subject|5|||
127555075|NCT00233064|459000487|FG001|Overall Study|Withdrawal by Subject|3|||
127555076|NCT00233064|459000486|FG000|Overall Study|Death|0|||
127555077|NCT00233064|459000487|FG001|Overall Study|Death|1|||
127555078|NCT00233064|459000486|FG000|Overall Study|Relocation|0|||
127555079|NCT00233064|459000487|FG001|Overall Study|Relocation|1|||
128021122|NCT00004859|460700334|FG000|Overall Study|Lack of Efficacy|43|||
127555080|NCT00233064|459000486|FG000|Overall Study|Protocol Violation|1|||
127555081|NCT00233064|459000487|FG001|Overall Study|Protocol Violation|0|||
127555082|NCT00233064|459000486|FG000|Overall Study|Moved to Dom. Republic|1|||
127555083|NCT00233064|459000487|FG001|Overall Study|Moved to Dom. Republic|0|||
127555084|NCT01120964|459000494|FG000|Overall Study|Did not receive full treatment|1|||
127555085|NCT01120964|459000495|FG001|Overall Study|Did not receive full treatment|0|||
127555086|NCT04237116|459000499|FG000|Overall Study|Adverse Event|0|||
127555087|NCT04237116|459000500|FG001|Overall Study|Adverse Event|1|||
127555088|NCT04237116|459000499|FG000|Overall Study|Study terminated by Sponsor|4|||
127555089|NCT04237116|459000500|FG001|Overall Study|Study terminated by Sponsor|1|||
127555090|NCT00472030|459000501|FG000|Overall Study|Physician Decision|1|||
127555091|NCT00472030|459000502|FG001|Overall Study|Physician Decision|0|||
127555092|NCT00829504|459000503|FG000|First Intervention|Adverse Event|1|||
127555093|NCT00829504|459000504|FG001|First Intervention|Adverse Event|0|||
127555094|NCT00829504|459000503|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
127555095|NCT00829504|459000504|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
127555096|NCT00829504|459000503|FG000|Second Intervention|Physician Decision|1|||
127555097|NCT00829504|459000504|FG001|Second Intervention|Physician Decision|0|||
127555098|NCT03212144|459000505|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
127555099|NCT03212144|459000506|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
127555100|NCT03212144|459000505|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
127555101|NCT03212144|459000506|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
127555102|NCT00599339|459000507|FG000|Overall Study|Adverse Event|79|||
127555103|NCT00599339|459000507|FG000|Overall Study|Withdrawal by Subject|137|||
127555104|NCT00599339|459000507|FG000|Overall Study|Other Reason|179|||
127555105|NCT00599339|459000507|FG000|Overall Study|Lost to Follow-up|221|||
127555106|NCT00599339|459000507|FG000|Overall Study|No valid data consent|36|||
127555107|NCT00599339|459000507|FG000|Overall Study|Study Termination Status Unknown|12|||
127555108|NCT00912197|459000510|FG000|Overall Study|Withdrawal by Subject|3|||
127555109|NCT00912197|459000511|FG001|Overall Study|Withdrawal by Subject|3|||
127555110|NCT01615029|459000517|FG000|Overall Study|Adverse Event|0|||
127555111|NCT01615029|459000518|FG001|Overall Study|Adverse Event|0|||
127555112|NCT01615029|459000519|FG002|Overall Study|Adverse Event|0|||
127555113|NCT01615029|459000520|FG003|Overall Study|Adverse Event|0|||
127555114|NCT01615029|459000521|FG004|Overall Study|Adverse Event|1|||
127555115|NCT01615029|459000517|FG000|Overall Study|Death|0|||
127555116|NCT01615029|459000518|FG001|Overall Study|Death|0|||
128021123|NCT00004859|460700335|FG001|Overall Study|Lack of Efficacy|113|||
128021124|NCT00004859|460700334|FG000|Overall Study|Adverse Event|31|||
128021125|NCT00004859|460700335|FG001|Overall Study|Adverse Event|93|||
128021126|NCT00004859|460700334|FG000|Overall Study|Death|5|||
128021127|NCT00004859|460700335|FG001|Overall Study|Death|5|||
128021128|NCT00004859|460700334|FG000|Overall Study|Withdrawal by Subject|7|||
128021129|NCT00004859|460700335|FG001|Overall Study|Withdrawal by Subject|33|||
128021130|NCT00004859|460700334|FG000|Overall Study|Protocol Violation|2|||
128021131|NCT00004859|460700335|FG001|Overall Study|Protocol Violation|2|||
128021132|NCT00004859|460700334|FG000|Overall Study|other disease|0|||
128021133|NCT00004859|460700335|FG001|Overall Study|other disease|3|||
127555117|NCT01615029|459000519|FG002|Overall Study|Death|0|||
128021134|NCT00004859|460700334|FG000|Overall Study|error|3|||
128021135|NCT00004859|460700335|FG001|Overall Study|error|1|||
128021136|NCT00004859|460700334|FG000|Overall Study|missing data|14|||
127555118|NCT01615029|459000520|FG003|Overall Study|Death|0|||
127555119|NCT01615029|459000521|FG004|Overall Study|Death|1|||
127555120|NCT01615029|459000517|FG000|Overall Study|Lost to Follow-up|0|||
127555121|NCT01615029|459000518|FG001|Overall Study|Lost to Follow-up|0|||
127555122|NCT01615029|459000519|FG002|Overall Study|Lost to Follow-up|0|||
127555123|NCT01615029|459000520|FG003|Overall Study|Lost to Follow-up|0|||
127555124|NCT01615029|459000521|FG004|Overall Study|Lost to Follow-up|1|||
127555125|NCT01615029|459000517|FG000|Overall Study|Progressive disease|2|||
127555126|NCT01615029|459000518|FG001|Overall Study|Progressive disease|1|||
127555127|NCT01615029|459000519|FG002|Overall Study|Progressive disease|1|||
127773941|NCT01776424|459798617|FG002|LTOLE Part (Open Label)|Refused|11|||
128021137|NCT00004859|460700335|FG001|Overall Study|missing data|11|||
128021138|NCT00004859|460700334|FG000|Overall Study|Other|13|||
128021139|NCT00004859|460700335|FG001|Overall Study|Other|21|||
127555128|NCT01615029|459000520|FG003|Overall Study|Progressive disease|1|||
127555129|NCT01615029|459000521|FG004|Overall Study|Progressive disease|5|||
127555130|NCT01615029|459000517|FG000|Overall Study|Physician Decision|0|||
127555131|NCT01615029|459000518|FG001|Overall Study|Physician Decision|0|||
127555132|NCT01615029|459000519|FG002|Overall Study|Physician Decision|0|||
127555133|NCT01615029|459000520|FG003|Overall Study|Physician Decision|0|||
127555134|NCT01615029|459000521|FG004|Overall Study|Physician Decision|1|||
127555135|NCT01615029|459000517|FG000|Overall Study|Ongoing|1|||
127555136|NCT01615029|459000518|FG001|Overall Study|Ongoing|2|||
127555137|NCT01615029|459000519|FG002|Overall Study|Ongoing|3|||
127555138|NCT01615029|459000520|FG003|Overall Study|Ongoing|2|||
127555139|NCT01615029|459000521|FG004|Overall Study|Ongoing|23|||
127555140|NCT01326104|459000522|FG000|Overall Study|progressed prior to vaccine|0|||
127555141|NCT01326104|459000523|FG001|Overall Study|progressed prior to vaccine|2|||
127555142|NCT01326104|459000522|FG000|Overall Study|unable to make vaccine|0|||
127555143|NCT01326104|459000523|FG001|Overall Study|unable to make vaccine|2|||
127555144|NCT01287741|459000524|FG000|Overall Study|Withdrawal by Subject|35|||
127555145|NCT01287741|459000525|FG001|Overall Study|Withdrawal by Subject|38|||
127555146|NCT01287741|459000524|FG000|Overall Study|Protocol Violation|2|||
127555147|NCT01287741|459000525|FG001|Overall Study|Protocol Violation|0|||
127555148|NCT01287741|459000524|FG000|Overall Study|Physician Decision|15|||
127555149|NCT01287741|459000525|FG001|Overall Study|Physician Decision|23|||
127555150|NCT01287741|459000524|FG000|Overall Study|Non-compliance|8|||
127555151|NCT01287741|459000525|FG001|Overall Study|Non-compliance|6|||
127555152|NCT01287741|459000524|FG000|Overall Study|Lost to Follow-up|10|||
127555153|NCT01287741|459000525|FG001|Overall Study|Lost to Follow-up|8|||
127555154|NCT01287741|459000524|FG000|Overall Study|Death|32|||
127555155|NCT01287741|459000525|FG001|Overall Study|Death|44|||
127555156|NCT01287741|459000524|FG000|Overall Study|Adverse Event|4|||
127555157|NCT01287741|459000525|FG001|Overall Study|Adverse Event|6|||
127555158|NCT01287741|459000524|FG000|Overall Study|Study terminated by Sponsor|307|||
127555159|NCT01287741|459000525|FG001|Overall Study|Study terminated by Sponsor|315|||
127555160|NCT01287741|459000524|FG000|Overall Study|Progressive disease|190|||
127555161|NCT01287741|459000525|FG001|Overall Study|Progressive disease|166|||
127555162|NCT01287741|459000524|FG000|Overall Study|Reason not specified|23|||
127555163|NCT01287741|459000525|FG001|Overall Study|Reason not specified|9|||
127555164|NCT04421027|459000526|FG000|Treatment Period|Adverse Event|5|||
127555165|NCT04421027|459000527|FG001|Treatment Period|Adverse Event|3|||
127555166|NCT04421027|459000528|FG002|Treatment Period|Adverse Event|0|||
127555167|NCT04421027|459000529|FG003|Treatment Period|Adverse Event|0|||
127555168|NCT04421027|459000526|FG000|Treatment Period|Death|98|||
127555169|NCT04421027|459000527|FG001|Treatment Period|Death|61|||
127555170|NCT04421027|459000528|FG002|Treatment Period|Death|0|||
127555171|NCT04421027|459000529|FG003|Treatment Period|Death|0|||
127555172|NCT04421027|459000526|FG000|Treatment Period|Lost to Follow-up|22|||
127555173|NCT04421027|459000527|FG001|Treatment Period|Lost to Follow-up|20|||
127555174|NCT04421027|459000528|FG002|Treatment Period|Lost to Follow-up|0|||
127555175|NCT04421027|459000529|FG003|Treatment Period|Lost to Follow-up|0|||
127555176|NCT04421027|459000526|FG000|Treatment Period|Other-Unknown|15|||
127555177|NCT04421027|459000527|FG001|Treatment Period|Other-Unknown|9|||
127555178|NCT04421027|459000528|FG002|Treatment Period|Other-Unknown|0|||
127555179|NCT04421027|459000529|FG003|Treatment Period|Other-Unknown|0|||
127555180|NCT04421027|459000526|FG000|Treatment Period|Physician Decision|1|||
127555181|NCT04421027|459000527|FG001|Treatment Period|Physician Decision|1|||
127555182|NCT04421027|459000528|FG002|Treatment Period|Physician Decision|0|||
127555183|NCT04421027|459000529|FG003|Treatment Period|Physician Decision|0|||
127555184|NCT04421027|459000526|FG000|Treatment Period|Withdrawal by Subject|7|||
127555185|NCT04421027|459000527|FG001|Treatment Period|Withdrawal by Subject|12|||
127555186|NCT04421027|459000528|FG002|Treatment Period|Withdrawal by Subject|0|||
127555187|NCT04421027|459000529|FG003|Treatment Period|Withdrawal by Subject|0|||
127555188|NCT04421027|459000526|FG000|Treatment Period|Randomized Not Dosed|9|||
127555189|NCT04421027|459000527|FG001|Treatment Period|Randomized Not Dosed|14|||
127555190|NCT04421027|459000528|FG002|Treatment Period|Randomized Not Dosed|0|||
127555191|NCT04421027|459000529|FG003|Treatment Period|Randomized Not Dosed|0|||
127555192|NCT04421027|459000526|FG000|Follow-Up Period|Adverse Event|0|||
127555193|NCT04421027|459000527|FG001|Follow-Up Period|Adverse Event|0|||
127555194|NCT04421027|459000528|FG002|Follow-Up Period|Adverse Event|0|||
127555195|NCT04421027|459000529|FG003|Follow-Up Period|Adverse Event|3|||
127555196|NCT04421027|459000526|FG000|Follow-Up Period|Death|0|||
127555197|NCT04421027|459000527|FG001|Follow-Up Period|Death|0|||
127555198|NCT04421027|459000528|FG002|Follow-Up Period|Death|16|||
127555199|NCT04421027|459000529|FG003|Follow-Up Period|Death|17|||
127555200|NCT04421027|459000526|FG000|Follow-Up Period|Lost to Follow-up|0|||
127555201|NCT04421027|459000527|FG001|Follow-Up Period|Lost to Follow-up|0|||
127555202|NCT04421027|459000528|FG002|Follow-Up Period|Lost to Follow-up|7|||
127555203|NCT04421027|459000529|FG003|Follow-Up Period|Lost to Follow-up|7|||
127555204|NCT04421027|459000526|FG000|Follow-Up Period|Protocol Deviation|0|||
127555205|NCT04421027|459000527|FG001|Follow-Up Period|Protocol Deviation|0|||
127555206|NCT04421027|459000528|FG002|Follow-Up Period|Protocol Deviation|1|||
127555207|NCT04421027|459000529|FG003|Follow-Up Period|Protocol Deviation|0|||
127555208|NCT04421027|459000526|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
127555209|NCT04421027|459000527|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
127555210|NCT04421027|459000528|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
127555211|NCT04421027|459000529|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
127555212|NCT04421027|459000526|FG000|Follow-Up Period|Left message, participant did not call back|0|||
127555213|NCT04421027|459000527|FG001|Follow-Up Period|Left message, participant did not call back|0|||
127555214|NCT04421027|459000528|FG002|Follow-Up Period|Left message, participant did not call back|0|||
127555215|NCT04421027|459000529|FG003|Follow-Up Period|Left message, participant did not call back|1|||
127555216|NCT04421027|459000526|FG000|Follow-Up Period|Participant died|0|||
127555217|NCT04421027|459000527|FG001|Follow-Up Period|Participant died|0|||
127555218|NCT04421027|459000528|FG002|Follow-Up Period|Participant died|0|||
127555219|NCT04421027|459000529|FG003|Follow-Up Period|Participant died|1|||
127555220|NCT04421027|459000526|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
127555221|NCT04421027|459000527|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
127555222|NCT04421027|459000528|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
127555223|NCT04421027|459000529|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
127555224|NCT02930018|459000537|FG000|Overall Study|Lost to Follow-up|1|||
127555225|NCT02930018|459000538|FG001|Overall Study|Lost to Follow-up|1|||
127555226|NCT02930018|459000537|FG000|Overall Study|Withdrawal by Subject|5|||
127555227|NCT02930018|459000538|FG001|Overall Study|Withdrawal by Subject|2|||
127555228|NCT04434937|459000542|FG000|Overall Study|Death|4|||
127555229|NCT04434937|459000542|FG000|Overall Study|Withdrawal by Subject|1|||
127555230|NCT04434937|459000542|FG000|Overall Study|Transitioned to Rollover Study|19|||
127555231|NCT04434937|459000542|FG000|Overall Study|Progressive Disease|18|||
127555232|NCT00114517|459000543|FG000|Overall Study|Adverse Event|6|||
127555233|NCT00114517|459000544|FG001|Overall Study|Adverse Event|1|||
127555234|NCT00114517|459000545|FG002|Overall Study|Adverse Event|6|||
127555235|NCT00114517|459000546|FG003|Overall Study|Adverse Event|3|||
127555236|NCT00114517|459000543|FG000|Overall Study|Lost to Follow-up|2|||
127555237|NCT00114517|459000544|FG001|Overall Study|Lost to Follow-up|2|||
127555238|NCT00114517|459000545|FG002|Overall Study|Lost to Follow-up|2|||
127555239|NCT00114517|459000546|FG003|Overall Study|Lost to Follow-up|1|||
127773942|NCT01776424|459798615|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
127773943|NCT01776424|459798616|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
127773944|NCT01776424|459798617|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
127773945|NCT00146757|459798618|FG000|Overall Study|Death|1|||
127773946|NCT00146757|459798619|FG001|Overall Study|Death|0|||
127773947|NCT00146757|459798618|FG000|Overall Study|Adverse Event|1|||
127773948|NCT00146757|459798619|FG001|Overall Study|Adverse Event|0|||
127773949|NCT03037619|459798631|FG000|Overall Study|Lost to Follow-up|0|||
127773950|NCT03037619|459798632|FG001|Overall Study|Lost to Follow-up|1|||
127773951|NCT01498289|459798633|FG000|Overall Study|Adverse Event|16|||
127773952|NCT01498289|459798634|FG001|Overall Study|Adverse Event|18|||
127773953|NCT01498289|459798633|FG000|Overall Study|Death|6|||
127773954|NCT01498289|459798634|FG001|Overall Study|Death|8|||
127773955|NCT01498289|459798633|FG000|Overall Study|Withdrawal unrelated to AE|16|||
127773956|NCT01498289|459798634|FG001|Overall Study|Withdrawal unrelated to AE|16|||
127773957|NCT01498289|459798633|FG000|Overall Study|Progression/relapse|53|||
127773958|NCT01498289|459798634|FG001|Overall Study|Progression/relapse|59|||
127773959|NCT01498289|459798633|FG000|Overall Study|Not protocol specified|7|||
127773960|NCT01498289|459798634|FG001|Overall Study|Not protocol specified|2|||
127773961|NCT01498289|459798633|FG000|Overall Study|Reason under review|0|||
127773962|NCT01498289|459798634|FG001|Overall Study|Reason under review|1|||
127773963|NCT01794923|459798635|FG000|Overall Study|Adverse Event|0|||
127773964|NCT01794923|459798636|FG001|Overall Study|Adverse Event|0|||
127773965|NCT01794923|459798637|FG002|Overall Study|Adverse Event|1|||
127773966|NCT02030405|459798644|FG000|Overall Study|Withdrawal by Subject|1|||
127555240|NCT00114517|459000543|FG000|Overall Study|Too busy|3|||
127555241|NCT00114517|459000544|FG001|Overall Study|Too busy|1|||
127555242|NCT00114517|459000545|FG002|Overall Study|Too busy|1|||
127555243|NCT00114517|459000546|FG003|Overall Study|Too busy|2|||
127555244|NCT00114517|459000543|FG000|Overall Study|Moved from area|0|||
127555245|NCT00114517|459000544|FG001|Overall Study|Moved from area|3|||
127555246|NCT00114517|459000545|FG002|Overall Study|Moved from area|2|||
127773967|NCT02030405|459798644|FG000|Overall Study|Lost to Follow-up|1|||
127773968|NCT03707925|459798646|FG000|Overall Study|Inevaluable|1|||
127773969|NCT01472380|459798648|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
127773970|NCT01472380|459798648|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
127773971|NCT00292461|459798649|FG000|Overall Study|Adverse Event|4|||
127773972|NCT00292461|459798650|FG001|Overall Study|Adverse Event|2|||
127555247|NCT00114517|459000546|FG003|Overall Study|Moved from area|1|||
127555248|NCT00114517|459000543|FG000|Overall Study|Did not want estradiol|1|||
127555249|NCT00114517|459000544|FG001|Overall Study|Did not want estradiol|1|||
127555250|NCT00114517|459000545|FG002|Overall Study|Did not want estradiol|0|||
127555251|NCT00114517|459000546|FG003|Overall Study|Did not want estradiol|0|||
127555252|NCT00114517|459000543|FG000|Overall Study|Armed-services duty|0|||
127555253|NCT00114517|459000544|FG001|Overall Study|Armed-services duty|1|||
127555254|NCT00114517|459000545|FG002|Overall Study|Armed-services duty|0|||
127555255|NCT00114517|459000546|FG003|Overall Study|Armed-services duty|1|||
127555256|NCT00114517|459000543|FG000|Overall Study|Competing family issue|0|||
127555257|NCT00114517|459000544|FG001|Overall Study|Competing family issue|1|||
127555258|NCT00114517|459000545|FG002|Overall Study|Competing family issue|0|||
127555259|NCT00114517|459000546|FG003|Overall Study|Competing family issue|1|||
127555260|NCT00114517|459000543|FG000|Overall Study|Physician Decision|0|||
127555261|NCT00114517|459000544|FG001|Overall Study|Physician Decision|1|||
127555262|NCT00114517|459000545|FG002|Overall Study|Physician Decision|0|||
127555263|NCT00114517|459000546|FG003|Overall Study|Physician Decision|0|||
127555264|NCT00114517|459000543|FG000|Overall Study|Lost interest|0|||
127555265|NCT00114517|459000544|FG001|Overall Study|Lost interest|0|||
127555266|NCT00114517|459000545|FG002|Overall Study|Lost interest|1|||
127555267|NCT00114517|459000546|FG003|Overall Study|Lost interest|0|||
127555268|NCT00114517|459000543|FG000|Overall Study|Weight increase|0|||
127555269|NCT00114517|459000544|FG001|Overall Study|Weight increase|0|||
127555270|NCT00114517|459000545|FG002|Overall Study|Weight increase|1|||
127555271|NCT00114517|459000546|FG003|Overall Study|Weight increase|0|||
127555272|NCT00114517|459000543|FG000|Overall Study|Concern about blood clots|0|||
127555273|NCT00114517|459000544|FG001|Overall Study|Concern about blood clots|0|||
127555274|NCT00114517|459000545|FG002|Overall Study|Concern about blood clots|1|||
127555275|NCT00114517|459000546|FG003|Overall Study|Concern about blood clots|0|||
127555276|NCT00114517|459000543|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
127555277|NCT00114517|459000544|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
127555278|NCT00114517|459000545|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
127555279|NCT00114517|459000546|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
127555280|NCT00924027|459000548|FG000|Overall Study|Lost to Further Follow-Up|4|||
127555281|NCT00924027|459000549|FG001|Overall Study|Lost to Further Follow-Up|0|||
127555282|NCT00924027|459000550|FG002|Overall Study|Lost to Further Follow-Up|0|||
127555283|NCT00924027|459000551|FG003|Overall Study|Lost to Further Follow-Up|0|||
127555284|NCT00924027|459000548|FG000|Overall Study|Physician Decision|1|||
127555285|NCT00924027|459000549|FG001|Overall Study|Physician Decision|0|||
127555286|NCT00924027|459000550|FG002|Overall Study|Physician Decision|0|||
127555287|NCT00924027|459000551|FG003|Overall Study|Physician Decision|1|||
127555288|NCT00924027|459000548|FG000|Overall Study|Withdrawal: Refused further treatment|1|||
127555289|NCT00924027|459000549|FG001|Overall Study|Withdrawal: Refused further treatment|0|||
127555290|NCT00924027|459000550|FG002|Overall Study|Withdrawal: Refused further treatment|0|||
127555291|NCT00924027|459000551|FG003|Overall Study|Withdrawal: Refused further treatment|0|||
127555292|NCT00924027|459000548|FG000|Overall Study|Withdrawal: Refused to start treatment|1|||
127555293|NCT00924027|459000549|FG001|Overall Study|Withdrawal: Refused to start treatment|0|||
127555294|NCT00924027|459000550|FG002|Overall Study|Withdrawal: Refused to start treatment|0|||
127555295|NCT00924027|459000551|FG003|Overall Study|Withdrawal: Refused to start treatment|0|||
127555296|NCT00924027|459000548|FG000|Overall Study|Withdrawal: Refused further follow-up|1|||
127555297|NCT00924027|459000549|FG001|Overall Study|Withdrawal: Refused further follow-up|0|||
127555298|NCT00924027|459000550|FG002|Overall Study|Withdrawal: Refused further follow-up|0|||
127555299|NCT00924027|459000551|FG003|Overall Study|Withdrawal: Refused further follow-up|0|||
127555300|NCT04695977|459000553|FG000|Overall Study|Sponsor Decision|9|||
127555301|NCT04695977|459000554|FG001|Overall Study|Sponsor Decision|4|||
127555302|NCT04695977|459000553|FG000|Overall Study|Death|2|||
127555303|NCT04695977|459000554|FG001|Overall Study|Death|5|||
127555304|NCT04193189|459000555|FG000|Overall Study|Lost to Follow-up|9|||
127555305|NCT04193189|459000556|FG001|Overall Study|Lost to Follow-up|7|||
127555306|NCT04193189|459000557|FG002|Overall Study|Lost to Follow-up|9|||
127555307|NCT04193189|459000558|FG003|Overall Study|Lost to Follow-up|0|||
127555308|NCT04193189|459000555|FG000|Overall Study|Withdrawal by Subject|1|||
128021140|NCT04073407|460700336|FG000|Part 1|Withdrawal by Subject|1|||
128021141|NCT04073407|460700337|FG001|Part 1|Withdrawal by Subject|0|||
128021142|NCT04073407|460700336|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
127555309|NCT04193189|459000556|FG001|Overall Study|Withdrawal by Subject|2|||
127555310|NCT04193189|459000557|FG002|Overall Study|Withdrawal by Subject|2|||
127555311|NCT04193189|459000558|FG003|Overall Study|Withdrawal by Subject|0|||
127555312|NCT04193189|459000555|FG000|Overall Study|Death|1|||
127555313|NCT04193189|459000556|FG001|Overall Study|Death|1|||
127555314|NCT04193189|459000557|FG002|Overall Study|Death|0|||
127555315|NCT04193189|459000558|FG003|Overall Study|Death|0|||
127555316|NCT04193189|459000555|FG000|Overall Study|Protocol Violation|0|||
127555317|NCT04193189|459000556|FG001|Overall Study|Protocol Violation|0|||
128021143|NCT04073407|460700337|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
128021144|NCT04073407|460700336|FG000|Part 2|Withdrawal by Subject|0|||
128021145|NCT04073407|460700337|FG001|Part 2|Withdrawal by Subject|1|||
128021146|NCT04941898|460702796|FG000|Overall Study|Protocol Violation|1|||
128021147|NCT02724644|460702797|FG000|Overall Study|Adverse Event|7|||
128021148|NCT02724644|460702798|FG001|Overall Study|Adverse Event|1|||
128021149|NCT02724644|460702797|FG000|Overall Study|Lost to Follow-up|6|||
128021150|NCT02724644|460702798|FG001|Overall Study|Lost to Follow-up|2|||
128021151|NCT02724644|460702797|FG000|Overall Study|Withdrawal by Subject|7|||
128021152|NCT02724644|460702798|FG001|Overall Study|Withdrawal by Subject|1|||
128021153|NCT02724644|460702797|FG000|Overall Study|Administrative|1|||
128021154|NCT02724644|460702798|FG001|Overall Study|Administrative|0|||
128021155|NCT00884949|460702799|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
128021156|NCT00884949|460702799|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
128021157|NCT01567085|460702802|FG000|Overall Study|Death|6|||
128021158|NCT01567085|460702802|FG000|Overall Study|Adverse Event|6|||
128021159|NCT01567085|460702802|FG000|Overall Study|Lost to Follow-up|3|||
128021160|NCT01567085|460702802|FG000|Overall Study|Graft loss|2|||
128021161|NCT01567085|460702802|FG000|Overall Study|Renal transplantectomy|1|||
128021162|NCT01567085|460702802|FG000|Overall Study|Returned to chronic dialysis|1|||
128021163|NCT01567085|460702802|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
128021164|NCT00504231|460702806|FG000|Overall Study|Discrepant chart documentation re route|0|||
128021165|NCT00504231|460702807|FG001|Overall Study|Discrepant chart documentation re route|0|||
128021166|NCT00504231|460702808|FG002|Overall Study|Discrepant chart documentation re route|1|||
128021167|NCT00504231|460702809|FG003|Overall Study|Discrepant chart documentation re route|0|||
128021168|NCT03928704|460702811|FG000|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
128021169|NCT03928704|460702812|FG001|Double-Blind Treatment Period:Week 1-16|Patient Compliance|1|||
128021170|NCT03928704|460702813|FG002|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
128021171|NCT03928704|460702814|FG003|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
128021172|NCT03928704|460702815|FG004|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
128021173|NCT03928704|460702816|FG005|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
128021174|NCT03928704|460702811|FG000|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|4|||
128021175|NCT03928704|460702812|FG001|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
128021176|NCT03928704|460702813|FG002|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
128021177|NCT03928704|460702814|FG003|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
128021178|NCT03928704|460702815|FG004|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
127773973|NCT00292461|459798649|FG000|Overall Study|Lack of Efficacy|1|||
127773974|NCT00292461|459798650|FG001|Overall Study|Lack of Efficacy|0|||
128021179|NCT03928704|460702816|FG005|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
127773975|NCT00292461|459798649|FG000|Overall Study|Withdrawal by Subject|0|||
127555318|NCT04193189|459000557|FG002|Overall Study|Protocol Violation|0|||
127555319|NCT04193189|459000558|FG003|Overall Study|Protocol Violation|1|||
127555320|NCT03474965|459000559|FG000|Overall Study|Pregnancy|1|||
127555321|NCT03474965|459000560|FG001|Overall Study|Pregnancy|0|||
127555322|NCT03474965|459000561|FG002|Overall Study|Pregnancy|0|||
127555323|NCT03474965|459000562|FG003|Overall Study|Pregnancy|0|||
127555324|NCT03474965|459000559|FG000|Overall Study|Lost to Follow-up|0|||
127555325|NCT03474965|459000560|FG001|Overall Study|Lost to Follow-up|0|||
127555326|NCT03474965|459000561|FG002|Overall Study|Lost to Follow-up|1|||
127555327|NCT03474965|459000562|FG003|Overall Study|Lost to Follow-up|0|||
127555328|NCT03474965|459000559|FG000|Overall Study|Death|1|||
127555329|NCT03474965|459000560|FG001|Overall Study|Death|0|||
127555330|NCT03474965|459000561|FG002|Overall Study|Death|0|||
127555331|NCT03474965|459000562|FG003|Overall Study|Death|0|||
127555332|NCT03474965|459000559|FG000|Overall Study|Adverse Event|1|||
127555333|NCT03474965|459000560|FG001|Overall Study|Adverse Event|0|||
127555334|NCT03474965|459000561|FG002|Overall Study|Adverse Event|0|||
127555335|NCT03474965|459000562|FG003|Overall Study|Adverse Event|1|||
127555336|NCT03474965|459000559|FG000|Overall Study|Physician Decision|3|||
127555337|NCT03474965|459000560|FG001|Overall Study|Physician Decision|1|||
127555338|NCT03474965|459000561|FG002|Overall Study|Physician Decision|2|||
127555339|NCT03474965|459000562|FG003|Overall Study|Physician Decision|0|||
127555340|NCT03474965|459000559|FG000|Overall Study|Participant Decision|7|||
127555341|NCT03474965|459000560|FG001|Overall Study|Participant Decision|0|||
127555342|NCT03474965|459000561|FG002|Overall Study|Participant Decision|1|||
127555343|NCT03474965|459000562|FG003|Overall Study|Participant Decision|0|||
127555344|NCT03474965|459000559|FG000|Overall Study|Guardian Decision|4|||
127555345|NCT03474965|459000560|FG001|Overall Study|Guardian Decision|2|||
127555346|NCT03474965|459000561|FG002|Overall Study|Guardian Decision|7|||
127555347|NCT03474965|459000562|FG003|Overall Study|Guardian Decision|2|||
127555348|NCT00539864|459002406|FG000|Overall Study|Lost to Follow-up|0|||
127555349|NCT00539864|459002407|FG001|Overall Study|Lost to Follow-up|1|||
127555350|NCT00539864|459002406|FG000|Overall Study|Withdrawal by Subject|1|||
127555351|NCT00539864|459002407|FG001|Overall Study|Withdrawal by Subject|1|||
127555352|NCT02840799|459002408|FG000|Phase 1|Physician Decision|1|||
127555353|NCT02840799|459002409|FG001|Phase 1|Physician Decision|3|||
127555354|NCT02840799|459002408|FG000|Phase 1|Withdrawal by Subject|4|||
127555355|NCT02840799|459002409|FG001|Phase 1|Withdrawal by Subject|0|||
127555356|NCT02840799|459002408|FG000|Phase 2 (Crossover)|Adverse Event|0|||
127555357|NCT02840799|459002409|FG001|Phase 2 (Crossover)|Adverse Event|1|||
127555358|NCT02840799|459002408|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
127555359|NCT02840799|459002409|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
127555360|NCT02565784|459002410|FG000|First Treatment|Adverse Event|1|||
127555361|NCT02565784|459002410|FG000|First Treatment|Withdrawal by Subject|1|||
127555362|NCT02565784|459002410|FG000|Second Treatment|Withdrawal by Subject|2|||
127555363|NCT00476008|459002427|FG000|Overall Study|Adverse Event|4|||
127555364|NCT00476008|459002428|FG001|Overall Study|Adverse Event|4|||
127555365|NCT00476008|459002427|FG000|Overall Study|Placebo concerns|2|||
127555366|NCT00476008|459002428|FG001|Overall Study|Placebo concerns|2|||
127555367|NCT00476008|459002427|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
127555368|NCT00476008|459002428|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
127555369|NCT00476008|459002427|FG000|Overall Study|Withdrawal by Subject|0|||
127555370|NCT00476008|459002428|FG001|Overall Study|Withdrawal by Subject|1|||
127555371|NCT00476008|459002427|FG000|Overall Study|Death|1|||
127555372|NCT00476008|459002428|FG001|Overall Study|Death|0|||
127555373|NCT00792571|459002431|FG000|Overall Study|Death|1|||
127555374|NCT00792571|459002431|FG000|Overall Study|Adverse Event|4|||
127555375|NCT00792571|459002431|FG000|Overall Study|Withdrawal by Subject|1|||
127555376|NCT00792571|459002431|FG000|Overall Study|Other|4|||
127555377|NCT01088048|459002432|FG000|Overall Study|Adverse Event|7|||
127555378|NCT01088048|459002433|FG001|Overall Study|Adverse Event|9|||
127555379|NCT01088048|459002434|FG002|Overall Study|Adverse Event|7|||
127555380|NCT01088048|459002435|FG003|Overall Study|Adverse Event|5|||
127555381|NCT01088048|459002436|FG004|Overall Study|Adverse Event|6|||
127555382|NCT01088048|459002437|FG005|Overall Study|Adverse Event|3|||
127555383|NCT01088048|459002438|FG006|Overall Study|Adverse Event|3|||
127555384|NCT01088048|459002439|FG007|Overall Study|Adverse Event|0|||
127555385|NCT01088048|459002440|FG008|Overall Study|Adverse Event|2|||
127555386|NCT01088048|459002441|FG009|Overall Study|Adverse Event|2|||
127555387|NCT01088048|459002432|FG000|Overall Study|Withdrew Consent|1|||
127555388|NCT01088048|459002433|FG001|Overall Study|Withdrew Consent|1|||
127555389|NCT01088048|459002434|FG002|Overall Study|Withdrew Consent|1|||
127555390|NCT01088048|459002435|FG003|Overall Study|Withdrew Consent|1|||
127555391|NCT01088048|459002436|FG004|Overall Study|Withdrew Consent|2|||
127555392|NCT01088048|459002437|FG005|Overall Study|Withdrew Consent|1|||
127555393|NCT01088048|459002438|FG006|Overall Study|Withdrew Consent|0|||
127555394|NCT01088048|459002439|FG007|Overall Study|Withdrew Consent|2|||
127555395|NCT01088048|459002440|FG008|Overall Study|Withdrew Consent|2|||
127555396|NCT01088048|459002441|FG009|Overall Study|Withdrew Consent|1|||
127881014|NCT00943384|460186099|FG000|Overall Study|Lost to Follow-up|16|||
127555397|NCT01088048|459002432|FG000|Overall Study|Concomitant Medication Prohibited|1|||
127555398|NCT01088048|459002433|FG001|Overall Study|Concomitant Medication Prohibited|0|||
127555399|NCT01088048|459002434|FG002|Overall Study|Concomitant Medication Prohibited|0|||
127555400|NCT01088048|459002435|FG003|Overall Study|Concomitant Medication Prohibited|0|||
127555401|NCT01088048|459002436|FG004|Overall Study|Concomitant Medication Prohibited|0|||
127555402|NCT01088048|459002437|FG005|Overall Study|Concomitant Medication Prohibited|0|||
127555403|NCT01088048|459002438|FG006|Overall Study|Concomitant Medication Prohibited|0|||
127555404|NCT01088048|459002439|FG007|Overall Study|Concomitant Medication Prohibited|0|||
127555405|NCT01088048|459002440|FG008|Overall Study|Concomitant Medication Prohibited|0|||
127555406|NCT01088048|459002441|FG009|Overall Study|Concomitant Medication Prohibited|0|||
127555407|NCT01088048|459002432|FG000|Overall Study|Investigator Request|2|||
127555408|NCT01088048|459002433|FG001|Overall Study|Investigator Request|2|||
127555409|NCT01088048|459002434|FG002|Overall Study|Investigator Request|0|||
127555410|NCT01088048|459002435|FG003|Overall Study|Investigator Request|0|||
127555411|NCT01088048|459002436|FG004|Overall Study|Investigator Request|3|||
127555412|NCT01088048|459002437|FG005|Overall Study|Investigator Request|1|||
127555413|NCT01088048|459002438|FG006|Overall Study|Investigator Request|1|||
127555414|NCT01088048|459002439|FG007|Overall Study|Investigator Request|0|||
127555415|NCT01088048|459002440|FG008|Overall Study|Investigator Request|0|||
127555416|NCT01088048|459002441|FG009|Overall Study|Investigator Request|0|||
127555417|NCT01088048|459002432|FG000|Overall Study|Patient Non-compliance|0|||
127555418|NCT01088048|459002433|FG001|Overall Study|Patient Non-compliance|1|||
127555419|NCT01088048|459002434|FG002|Overall Study|Patient Non-compliance|0|||
127555420|NCT01088048|459002435|FG003|Overall Study|Patient Non-compliance|0|||
127555421|NCT01088048|459002436|FG004|Overall Study|Patient Non-compliance|0|||
128021180|NCT03928704|460702811|FG000|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|1|||
128021181|NCT03928704|460702812|FG001|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
127555422|NCT01088048|459002437|FG005|Overall Study|Patient Non-compliance|0|||
127555423|NCT01088048|459002438|FG006|Overall Study|Patient Non-compliance|0|||
127555424|NCT01088048|459002439|FG007|Overall Study|Patient Non-compliance|0|||
127555425|NCT01088048|459002440|FG008|Overall Study|Patient Non-compliance|0|||
127555426|NCT01088048|459002441|FG009|Overall Study|Patient Non-compliance|0|||
127555427|NCT01088048|459002432|FG000|Overall Study|Disease Progression|7|||
127555428|NCT01088048|459002433|FG001|Overall Study|Disease Progression|4|||
127555429|NCT01088048|459002434|FG002|Overall Study|Disease Progression|3|||
127555430|NCT01088048|459002435|FG003|Overall Study|Disease Progression|5|||
127555431|NCT01088048|459002436|FG004|Overall Study|Disease Progression|3|||
127555432|NCT01088048|459002437|FG005|Overall Study|Disease Progression|3|||
127555433|NCT01088048|459002438|FG006|Overall Study|Disease Progression|2|||
127555434|NCT01088048|459002439|FG007|Overall Study|Disease Progression|1|||
127555435|NCT01088048|459002440|FG008|Overall Study|Disease Progression|0|||
127555436|NCT01088048|459002441|FG009|Overall Study|Disease Progression|0|||
127555437|NCT01088048|459002432|FG000|Overall Study|Death|1|||
127555438|NCT01088048|459002433|FG001|Overall Study|Death|5|||
127555439|NCT01088048|459002434|FG002|Overall Study|Death|3|||
127555440|NCT01088048|459002435|FG003|Overall Study|Death|3|||
127555441|NCT01088048|459002436|FG004|Overall Study|Death|1|||
127555442|NCT01088048|459002437|FG005|Overall Study|Death|3|||
127555443|NCT01088048|459002438|FG006|Overall Study|Death|0|||
127555444|NCT01088048|459002439|FG007|Overall Study|Death|0|||
127555445|NCT01088048|459002440|FG008|Overall Study|Death|3|||
127555446|NCT01088048|459002441|FG009|Overall Study|Death|1|||
127555447|NCT01088048|459002432|FG000|Overall Study|Other|3|||
127555448|NCT01088048|459002433|FG001|Overall Study|Other|5|||
127555449|NCT01088048|459002434|FG002|Overall Study|Other|0|||
127555450|NCT01088048|459002435|FG003|Overall Study|Other|0|||
127555451|NCT01088048|459002436|FG004|Overall Study|Other|2|||
127555452|NCT01088048|459002437|FG005|Overall Study|Other|0|||
127555453|NCT01088048|459002438|FG006|Overall Study|Other|0|||
127555454|NCT01088048|459002439|FG007|Overall Study|Other|2|||
127555455|NCT01088048|459002440|FG008|Overall Study|Other|0|||
127555456|NCT01088048|459002441|FG009|Overall Study|Other|0|||
128021182|NCT03928704|460702813|FG002|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
127555457|NCT01621802|459002442|FG000|Overall Study|Protocol Violation|0|||
127555458|NCT01621802|459002443|FG001|Overall Study|Protocol Violation|0|||
127555459|NCT01621802|459002444|FG002|Overall Study|Protocol Violation|0|||
127555460|NCT01621802|459002445|FG003|Overall Study|Protocol Violation|0|||
127555461|NCT01621802|459002446|FG004|Overall Study|Protocol Violation|0|||
127555462|NCT01621802|459002447|FG005|Overall Study|Protocol Violation|1|||
127773976|NCT00292461|459798650|FG001|Overall Study|Withdrawal by Subject|1|||
127773977|NCT00292461|459798649|FG000|Overall Study|Protocol Violation|4|||
127555463|NCT01621802|459002442|FG000|Overall Study|Withdrawal by Subject|8|||
127555464|NCT01621802|459002443|FG001|Overall Study|Withdrawal by Subject|4|||
127555465|NCT01621802|459002444|FG002|Overall Study|Withdrawal by Subject|4|||
127555466|NCT01621802|459002445|FG003|Overall Study|Withdrawal by Subject|2|||
127555467|NCT01621802|459002446|FG004|Overall Study|Withdrawal by Subject|2|||
127555468|NCT01621802|459002447|FG005|Overall Study|Withdrawal by Subject|0|||
127555469|NCT01621802|459002442|FG000|Overall Study|Migrated/moved from study area|0|||
127555470|NCT01621802|459002443|FG001|Overall Study|Migrated/moved from study area|0|||
127555471|NCT01621802|459002444|FG002|Overall Study|Migrated/moved from study area|2|||
127555472|NCT01621802|459002445|FG003|Overall Study|Migrated/moved from study area|0|||
127555473|NCT01621802|459002446|FG004|Overall Study|Migrated/moved from study area|1|||
127555474|NCT01621802|459002447|FG005|Overall Study|Migrated/moved from study area|0|||
127555475|NCT01621802|459002442|FG000|Overall Study|Others|3|||
127555476|NCT01621802|459002443|FG001|Overall Study|Others|3|||
127555477|NCT01621802|459002444|FG002|Overall Study|Others|3|||
127555478|NCT01621802|459002445|FG003|Overall Study|Others|2|||
127555479|NCT01621802|459002446|FG004|Overall Study|Others|1|||
127555480|NCT01621802|459002447|FG005|Overall Study|Others|0|||
127555481|NCT01621802|459002442|FG000|Overall Study|Lost to Follow-up|36|||
127555482|NCT01621802|459002443|FG001|Overall Study|Lost to Follow-up|16|||
127555483|NCT01621802|459002444|FG002|Overall Study|Lost to Follow-up|24|||
127555484|NCT01621802|459002445|FG003|Overall Study|Lost to Follow-up|7|||
127555485|NCT01621802|459002446|FG004|Overall Study|Lost to Follow-up|31|||
127555486|NCT01621802|459002447|FG005|Overall Study|Lost to Follow-up|11|||
127555487|NCT03790696|459002449|FG000|Overall Study|Cognitive training task was too difficult for child to complete.|0|||
127555488|NCT03790696|459002450|FG001|Overall Study|Cognitive training task was too difficult for child to complete.|1|||
127555489|NCT01149148|459002451|FG000|Overall Study|Lost to Follow-up|1|||
127555490|NCT01149148|459002452|FG001|Overall Study|Lost to Follow-up|2|||
127555491|NCT01149148|459002451|FG000|Overall Study|Death|1|||
127555492|NCT01149148|459002452|FG001|Overall Study|Death|0|||
127555493|NCT03436082|459002453|FG000|Overall Study|Did not undergo procedure|1|||
127555494|NCT03436082|459002454|FG001|Overall Study|Did not undergo procedure|0|||
127555495|NCT00950859|459002457|FG000|Overall Study|Adverse Event|3|||
127555496|NCT00950859|459002458|FG001|Overall Study|Adverse Event|3|||
127555497|NCT00950859|459002457|FG000|Overall Study|Insufficient Viral Load Response|12|||
127555498|NCT00950859|459002458|FG001|Overall Study|Insufficient Viral Load Response|3|||
127555499|NCT00950859|459002457|FG000|Overall Study|Protocol Violation|1|||
127555500|NCT00950859|459002458|FG001|Overall Study|Protocol Violation|1|||
127555501|NCT00950859|459002457|FG000|Overall Study|Lost to Follow-up|0|||
127555502|NCT00950859|459002458|FG001|Overall Study|Lost to Follow-up|3|||
127555503|NCT04896086|459002459|FG000|Overall Study|Lost to Follow-up|0|||
127555504|NCT04896086|459002460|FG001|Overall Study|Lost to Follow-up|2|||
127555505|NCT04896086|459002461|FG002|Overall Study|Lost to Follow-up|1|||
127555506|NCT04896086|459002462|FG003|Overall Study|Lost to Follow-up|0|||
127555507|NCT04896086|459002463|FG004|Overall Study|Lost to Follow-up|0|||
127555508|NCT04896086|459002459|FG000|Overall Study|Physician Decision|0|||
127555509|NCT04896086|459002460|FG001|Overall Study|Physician Decision|1|||
127555510|NCT04896086|459002461|FG002|Overall Study|Physician Decision|0|||
127555511|NCT04896086|459002462|FG003|Overall Study|Physician Decision|0|||
127555512|NCT04896086|459002463|FG004|Overall Study|Physician Decision|0|||
127555513|NCT04896086|459002459|FG000|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
127555514|NCT04896086|459002460|FG001|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
127555515|NCT04896086|459002461|FG002|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
127555516|NCT04896086|459002462|FG003|Overall Study|Difficulties were experienced with vein access for blood sample collection|1|||
127555517|NCT04896086|459002463|FG004|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
127555518|NCT04896086|459002459|FG000|Overall Study|Participant had a syncopal event during a blood draw|0|||
127555519|NCT04896086|459002460|FG001|Overall Study|Participant had a syncopal event during a blood draw|0|||
127555520|NCT04896086|459002461|FG002|Overall Study|Participant had a syncopal event during a blood draw|0|||
127555521|NCT04896086|459002462|FG003|Overall Study|Participant had a syncopal event during a blood draw|1|||
127555522|NCT04896086|459002463|FG004|Overall Study|Participant had a syncopal event during a blood draw|0|||
127555523|NCT02249832|459002466|FG000|Overall Study|Withdrawal by Subject|3|||
127555524|NCT02249832|459002466|FG000|Overall Study|Lost to Follow-up|10|||
127773978|NCT00292461|459798650|FG001|Overall Study|Protocol Violation|3|||
128021183|NCT03928704|460702814|FG003|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
128021184|NCT03928704|460702815|FG004|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
128021185|NCT03928704|460702816|FG005|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
128021186|NCT03928704|460702811|FG000|Double-Blind Treatment Period:Week 1-16|Adverse Event|3|||
128021187|NCT03928704|460702812|FG001|Double-Blind Treatment Period:Week 1-16|Adverse Event|1|||
128021188|NCT03928704|460702813|FG002|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
127555525|NCT02563067|459002475|FG000|Overall Study|Subject/guardian decision|14|||
127555526|NCT02563067|459002476|FG001|Overall Study|Subject/guardian decision|20|||
127555527|NCT02563067|459002477|FG002|Overall Study|Subject/guardian decision|16|||
127555528|NCT02563067|459002475|FG000|Overall Study|Physician Decision|0|||
127555529|NCT02563067|459002476|FG001|Overall Study|Physician Decision|1|||
127555530|NCT02563067|459002477|FG002|Overall Study|Physician Decision|3|||
127555531|NCT02563067|459002475|FG000|Overall Study|Lost to Follow-up|1|||
127555532|NCT02563067|459002476|FG001|Overall Study|Lost to Follow-up|2|||
127555533|NCT02563067|459002477|FG002|Overall Study|Lost to Follow-up|0|||
127555534|NCT02563067|459002475|FG000|Overall Study|Technical problems|0|||
128021189|NCT03928704|460702814|FG003|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
127773979|NCT00292461|459798649|FG000|Overall Study|Lost to Follow-up|1|||
127773980|NCT00292461|459798650|FG001|Overall Study|Lost to Follow-up|0|||
127773981|NCT04484259|459798666|FG000|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
127773982|NCT04484259|459798667|FG001|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
127773983|NCT04484259|459798668|FG002|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
127773984|NCT04484259|459798669|FG003|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|9|||
127773985|NCT04484259|459798670|FG004|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
127773986|NCT04484259|459798666|FG000|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
127773987|NCT04484259|459798667|FG001|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
127773988|NCT04484259|459798668|FG002|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
127773989|NCT04484259|459798669|FG003|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|4|||
127773990|NCT04484259|459798670|FG004|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
127773991|NCT04484259|459798666|FG000|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
127773992|NCT04484259|459798667|FG001|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
127773993|NCT04484259|459798668|FG002|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
127773994|NCT04484259|459798669|FG003|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|2|||
127773995|NCT04484259|459798670|FG004|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
127773996|NCT04484259|459798666|FG000|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
127773997|NCT04484259|459798667|FG001|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
127773998|NCT04484259|459798668|FG002|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
127773999|NCT04484259|459798669|FG003|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|4|||
127774000|NCT04484259|459798670|FG004|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
127774001|NCT04484259|459798666|FG000|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
127774002|NCT04484259|459798667|FG001|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
127774003|NCT04484259|459798668|FG002|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
127774004|NCT04484259|459798669|FG003|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
127774005|NCT04484259|459798670|FG004|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|1|||
127774006|NCT04484259|459798666|FG000|Randomized Treatment|Withdrawal by Subject|1|||
127774007|NCT04484259|459798667|FG001|Randomized Treatment|Withdrawal by Subject|0|||
127774008|NCT04484259|459798668|FG002|Randomized Treatment|Withdrawal by Subject|0|||
127774009|NCT04484259|459798669|FG003|Randomized Treatment|Withdrawal by Subject|0|||
127774010|NCT04484259|459798670|FG004|Randomized Treatment|Withdrawal by Subject|0|||
127774011|NCT04908189|459798671|FG000|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|1|||
127774012|NCT04908189|459798672|FG001|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|3|||
127774013|NCT04908189|459798673|FG002|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|0|||
127774014|NCT04908189|459798671|FG000|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|6|||
127774015|NCT04908189|459798672|FG001|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|4|||
127774016|NCT04908189|459798673|FG002|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|10|||
127774017|NCT04908189|459798671|FG000|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
127774018|NCT04908189|459798672|FG001|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|4|||
127774019|NCT04908189|459798673|FG002|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
127774020|NCT04908189|459798671|FG000|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|6|||
127774021|NCT04908189|459798672|FG001|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|8|||
127774022|NCT04908189|459798673|FG002|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|3|||
127774023|NCT04908189|459798671|FG000|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|3|||
127774024|NCT04908189|459798672|FG001|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
127774025|NCT04908189|459798673|FG002|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
127774026|NCT04908189|459798671|FG000|Placebo-Controlled (Week 0 - Week 16)|Other reasons|2|||
127774027|NCT04908189|459798672|FG001|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
127774028|NCT04908189|459798673|FG002|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
127774029|NCT04908189|459798671|FG000|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
127774030|NCT04908189|459798672|FG001|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
127774031|NCT04908189|459798673|FG002|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|1|||
127774032|NCT04908189|459798671|FG000|Active Treatment (Week 16 - Week 52)|Adverse Event|9|||
127774033|NCT04908189|459798672|FG001|Active Treatment (Week 16 - Week 52)|Adverse Event|7|||
127774034|NCT04908189|459798673|FG002|Active Treatment (Week 16 - Week 52)|Adverse Event|3|||
127774035|NCT04908189|459798671|FG000|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
127774036|NCT04908189|459798672|FG001|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
127774037|NCT04908189|459798673|FG002|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|4|||
127774038|NCT04908189|459798671|FG000|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
127774039|NCT04908189|459798672|FG001|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
127774040|NCT04908189|459798673|FG002|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|2|||
127881015|NCT00943384|460186099|FG000|Overall Study|Withdrawal by Subject|5|||
127555535|NCT02563067|459002476|FG001|Overall Study|Technical problems|1|||
127555536|NCT02563067|459002477|FG002|Overall Study|Technical problems|0|||
127555537|NCT02563067|459002475|FG000|Overall Study|Lack of Efficacy|1|||
127555538|NCT02563067|459002476|FG001|Overall Study|Lack of Efficacy|0|||
127555539|NCT02563067|459002477|FG002|Overall Study|Lack of Efficacy|0|||
127555540|NCT02563067|459002475|FG000|Overall Study|Death|0|||
127555541|NCT02563067|459002476|FG001|Overall Study|Death|1|||
127555542|NCT02563067|459002477|FG002|Overall Study|Death|1|||
127555543|NCT02563067|459002475|FG000|Overall Study|Adverse Event|2|||
127555544|NCT02563067|459002476|FG001|Overall Study|Adverse Event|1|||
127555545|NCT02563067|459002477|FG002|Overall Study|Adverse Event|0|||
127555546|NCT02563067|459002475|FG000|Overall Study|Death post Treatment/safety period|1|||
127555547|NCT02563067|459002476|FG001|Overall Study|Death post Treatment/safety period|0|||
127555548|NCT02563067|459002477|FG002|Overall Study|Death post Treatment/safety period|0|||
127555549|NCT03544333|459002483|FG000|Overall Study|Withdrawal by Subject|1|||
127555550|NCT03544333|459002484|FG001|Overall Study|Withdrawal by Subject|0|||
127555551|NCT01039519|459002489|FG000|Treatment|Progressive disease|20|||
127555552|NCT01039519|459002489|FG000|Treatment|Treatment failure|2|||
127555553|NCT01039519|459002489|FG000|Treatment|Adverse Event|3|||
127555554|NCT01039519|459002489|FG000|Treatment|Physician Decision|2|||
127555555|NCT01039519|459002489|FG000|Survival Follow-up|Death|23|||
127555556|NCT01039519|459002489|FG000|Survival Follow-up|Sponsor decision|4|||
127555557|NCT00808080|459002495|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
127555558|NCT01330108|459002496|FG000|Overall Study|Withdrawal by Subject|4|||
127555559|NCT00243269|459002497|FG000|Overall Study|Protocol Violation|2|||
127555560|NCT00243269|459002498|FG001|Overall Study|Protocol Violation|1|||
127555561|NCT00243269|459002499|FG002|Overall Study|Protocol Violation|0|||
127555562|NCT00243269|459002500|FG003|Overall Study|Protocol Violation|1|||
127555563|NCT00243269|459002497|FG000|Overall Study|Lost to Follow-up|1|||
127555564|NCT00243269|459002498|FG001|Overall Study|Lost to Follow-up|0|||
127555565|NCT00243269|459002499|FG002|Overall Study|Lost to Follow-up|1|||
127555566|NCT00243269|459002500|FG003|Overall Study|Lost to Follow-up|3|||
127555567|NCT03052400|459002501|FG000|Overall Study|Lost to Follow-up|1|||
127555568|NCT03052400|459002502|FG001|Overall Study|Lost to Follow-up|0|||
127555569|NCT03052400|459002501|FG000|Overall Study|Withdrawal by Subject|0|||
127555570|NCT03052400|459002502|FG001|Overall Study|Withdrawal by Subject|1|||
127555571|NCT00555061|459002503|FG000|Overall Study|Adverse Event|3|||
127555572|NCT00555061|459002503|FG000|Overall Study|Protocol Violation|1|||
127555573|NCT00555061|459002503|FG000|Overall Study|Lost to Follow-up|2|||
127555574|NCT00555061|459002503|FG000|Overall Study|Withdrawal by Subject|2|||
127555575|NCT00555061|459002503|FG000|Overall Study|Participant enrolled, but never treated|1|||
127555576|NCT00485134|459002505|FG000|Overall Study|Lost to Follow-up|1|||
127555577|NCT00485134|459002506|FG001|Overall Study|Lost to Follow-up|0|||
127555578|NCT00485134|459002507|FG002|Overall Study|Lost to Follow-up|0|||
127555579|NCT00485134|459002508|FG003|Overall Study|Lost to Follow-up|0|||
127555580|NCT00485134|459002509|FG004|Overall Study|Lost to Follow-up|0|||
127555581|NCT00485134|459002510|FG005|Overall Study|Lost to Follow-up|0|||
127555582|NCT00485134|459002511|FG006|Overall Study|Lost to Follow-up|0|||
127555583|NCT00485134|459002512|FG007|Overall Study|Lost to Follow-up|0|||
127555584|NCT00485134|459002505|FG000|Overall Study|Withdrawal by Subject|0|||
127555585|NCT00485134|459002506|FG001|Overall Study|Withdrawal by Subject|1|||
127555586|NCT00485134|459002507|FG002|Overall Study|Withdrawal by Subject|0|||
127555587|NCT00485134|459002508|FG003|Overall Study|Withdrawal by Subject|0|||
127555588|NCT00485134|459002509|FG004|Overall Study|Withdrawal by Subject|0|||
127555589|NCT00485134|459002510|FG005|Overall Study|Withdrawal by Subject|0|||
127555590|NCT00485134|459002511|FG006|Overall Study|Withdrawal by Subject|0|||
127555591|NCT00485134|459002512|FG007|Overall Study|Withdrawal by Subject|0|||
127555592|NCT00485134|459002505|FG000|Overall Study|Change in health status|0|||
127555593|NCT00485134|459002506|FG001|Overall Study|Change in health status|1|||
127774041|NCT04908189|459798671|FG000|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|2|||
127774042|NCT04908189|459798672|FG001|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|1|||
127774043|NCT04908189|459798673|FG002|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|0|||
127555594|NCT00485134|459002507|FG002|Overall Study|Change in health status|2|||
127555595|NCT00485134|459002508|FG003|Overall Study|Change in health status|1|||
127774044|NCT04908189|459798671|FG000|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
127555596|NCT00485134|459002509|FG004|Overall Study|Change in health status|0|||
127555597|NCT00485134|459002510|FG005|Overall Study|Change in health status|1|||
127555598|NCT00485134|459002511|FG006|Overall Study|Change in health status|0|||
127555599|NCT00485134|459002512|FG007|Overall Study|Change in health status|0|||
127555600|NCT00485134|459002505|FG000|Overall Study|Withdrew for adverse event|0|||
127555601|NCT00485134|459002506|FG001|Overall Study|Withdrew for adverse event|0|||
127555602|NCT00485134|459002507|FG002|Overall Study|Withdrew for adverse event|1|||
127555603|NCT00485134|459002508|FG003|Overall Study|Withdrew for adverse event|0|||
127555604|NCT00485134|459002509|FG004|Overall Study|Withdrew for adverse event|0|||
127555605|NCT00485134|459002510|FG005|Overall Study|Withdrew for adverse event|0|||
127555606|NCT00485134|459002511|FG006|Overall Study|Withdrew for adverse event|0|||
127555607|NCT00485134|459002512|FG007|Overall Study|Withdrew for adverse event|0|||
127555608|NCT00485134|459002505|FG000|Overall Study|Positive drug test|0|||
128021190|NCT03928704|460702815|FG004|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
128021191|NCT03928704|460702816|FG005|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
128021192|NCT03928704|460702811|FG000|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
127555609|NCT00485134|459002506|FG001|Overall Study|Positive drug test|0|||
127555610|NCT00485134|459002507|FG002|Overall Study|Positive drug test|0|||
127555611|NCT00485134|459002508|FG003|Overall Study|Positive drug test|0|||
128021193|NCT03928704|460702812|FG001|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
128021194|NCT03928704|460702813|FG002|Maintenance Period: Week 16-52|Withdrawal By Study Participant|12|||
128021195|NCT03928704|460702814|FG003|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
128021196|NCT03928704|460702815|FG004|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
128021197|NCT03928704|460702816|FG005|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
128021198|NCT03928704|460702811|FG000|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
128021199|NCT03928704|460702812|FG001|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
128021200|NCT03928704|460702813|FG002|Maintenance Period: Week 16-52|Lack of Efficacy|4|||
128021201|NCT03928704|460702814|FG003|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
128021202|NCT03928704|460702815|FG004|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
128021203|NCT03928704|460702816|FG005|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
128021204|NCT03928704|460702811|FG000|Maintenance Period: Week 16-52|Adverse Event|0|||
128021205|NCT03928704|460702812|FG001|Maintenance Period: Week 16-52|Adverse Event|0|||
128021206|NCT03928704|460702813|FG002|Maintenance Period: Week 16-52|Adverse Event|5|||
128021207|NCT03928704|460702814|FG003|Maintenance Period: Week 16-52|Adverse Event|0|||
128021208|NCT03928704|460702815|FG004|Maintenance Period: Week 16-52|Adverse Event|0|||
128021209|NCT03928704|460702816|FG005|Maintenance Period: Week 16-52|Adverse Event|0|||
128021210|NCT03928704|460702811|FG000|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
128021211|NCT03928704|460702812|FG001|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
128021212|NCT03928704|460702813|FG002|Maintenance Period: Week 16-52|Lost to Follow-up|1|||
128021213|NCT03928704|460702814|FG003|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
128021214|NCT03928704|460702815|FG004|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
128021215|NCT03928704|460702816|FG005|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
128021216|NCT03928704|460702811|FG000|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
128021217|NCT03928704|460702812|FG001|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
128021218|NCT03928704|460702813|FG002|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
128021219|NCT03928704|460702814|FG003|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
128021220|NCT03928704|460702815|FG004|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
128021221|NCT03928704|460702816|FG005|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|2|||
128021222|NCT03928704|460702811|FG000|Maintenance Period: Week 16-52|Non- Compliance|0|||
128021223|NCT03928704|460702812|FG001|Maintenance Period: Week 16-52|Non- Compliance|0|||
128021224|NCT03928704|460702813|FG002|Maintenance Period: Week 16-52|Non- Compliance|0|||
128021225|NCT03928704|460702814|FG003|Maintenance Period: Week 16-52|Non- Compliance|0|||
128021226|NCT03928704|460702815|FG004|Maintenance Period: Week 16-52|Non- Compliance|0|||
128021227|NCT03928704|460702816|FG005|Maintenance Period: Week 16-52|Non- Compliance|1|||
128021228|NCT04575324|460702821|FG000|Overall Study|Lost to Follow-up|29|||
128021229|NCT04575324|460702822|FG001|Overall Study|Lost to Follow-up|25|||
128021230|NCT04575324|460702821|FG000|Overall Study|Death|1|||
128021231|NCT04575324|460702822|FG001|Overall Study|Death|2|||
128021232|NCT04575324|460702821|FG000|Overall Study|Withdrawn: Did not meet eligibility criteria|0|||
128021233|NCT04575324|460702822|FG001|Overall Study|Withdrawn: Did not meet eligibility criteria|1|||
128021234|NCT01002105|460702823|FG000|Overall Study|Lost to Follow-up|10|||
128021235|NCT01002105|460702824|FG001|Overall Study|Lost to Follow-up|16|||
128021236|NCT01002105|460702823|FG000|Overall Study|non compliance|5|||
128021237|NCT01002105|460702824|FG001|Overall Study|non compliance|3|||
128021238|NCT01002105|460702823|FG000|Overall Study|condition worsened|4|||
128021239|NCT01002105|460702824|FG001|Overall Study|condition worsened|2|||
128021240|NCT00456612|460702828|FG000|Overall Study|Withdrawal by Subject|3|||
128021241|NCT00266812|460702829|FG000|Overall Study|Disease Progression|9|||
128021242|NCT00266812|460702830|FG001|Overall Study|Disease Progression|3|||
128021243|NCT00266812|460702829|FG000|Overall Study|Death|5|||
128021244|NCT00266812|460702830|FG001|Overall Study|Death|4|||
128021245|NCT00266812|460702829|FG000|Overall Study|Adverse Event|3|||
128021246|NCT00266812|460702830|FG001|Overall Study|Adverse Event|1|||
128021247|NCT00266812|460702829|FG000|Overall Study|Protocol Violation|0|||
128021248|NCT00266812|460702830|FG001|Overall Study|Protocol Violation|1|||
128021249|NCT00266812|460702829|FG000|Overall Study|Withdrawal by Subject|0|||
128021250|NCT00266812|460702830|FG001|Overall Study|Withdrawal by Subject|2|||
128021251|NCT00266812|460702829|FG000|Overall Study|Discontinued before starting study drug|4|||
128021252|NCT00266812|460702830|FG001|Overall Study|Discontinued before starting study drug|0|||
128021253|NCT03695094|460702831|FG000|Overall Study|Adverse Event|1|||
128021254|NCT03695094|460702832|FG001|Overall Study|Adverse Event|1|||
128021255|NCT03695094|460702831|FG000|Overall Study|Withdrawal by Subject|1|||
128021256|NCT03695094|460702832|FG001|Overall Study|Withdrawal by Subject|0|||
127555612|NCT00485134|459002509|FG004|Overall Study|Positive drug test|2|||
127555613|NCT00485134|459002510|FG005|Overall Study|Positive drug test|1|||
127555614|NCT00485134|459002511|FG006|Overall Study|Positive drug test|0|||
127555615|NCT00485134|459002512|FG007|Overall Study|Positive drug test|0|||
127555616|NCT00485134|459002505|FG000|Overall Study|Non-compliance|0|||
127555617|NCT00485134|459002506|FG001|Overall Study|Non-compliance|0|||
127555618|NCT00485134|459002507|FG002|Overall Study|Non-compliance|0|||
127555619|NCT00485134|459002508|FG003|Overall Study|Non-compliance|0|||
127555620|NCT00485134|459002509|FG004|Overall Study|Non-compliance|1|||
127555621|NCT00485134|459002510|FG005|Overall Study|Non-compliance|2|||
127555622|NCT00485134|459002511|FG006|Overall Study|Non-compliance|2|||
127555623|NCT00485134|459002512|FG007|Overall Study|Non-compliance|0|||
127555624|NCT00485134|459002505|FG000|Overall Study|Unable to comply with study schedule|0|||
127555625|NCT00485134|459002506|FG001|Overall Study|Unable to comply with study schedule|0|||
127555626|NCT00485134|459002507|FG002|Overall Study|Unable to comply with study schedule|0|||
127555627|NCT00485134|459002508|FG003|Overall Study|Unable to comply with study schedule|0|||
127555628|NCT00485134|459002509|FG004|Overall Study|Unable to comply with study schedule|0|||
127555629|NCT00485134|459002510|FG005|Overall Study|Unable to comply with study schedule|0|||
127555630|NCT00485134|459002511|FG006|Overall Study|Unable to comply with study schedule|0|||
127555631|NCT00485134|459002512|FG007|Overall Study|Unable to comply with study schedule|1|||
127555632|NCT00485134|459002505|FG000|Overall Study|Pregnancy|0|||
127555633|NCT00485134|459002506|FG001|Overall Study|Pregnancy|0|||
127555634|NCT00485134|459002507|FG002|Overall Study|Pregnancy|0|||
127555635|NCT00485134|459002508|FG003|Overall Study|Pregnancy|0|||
127555636|NCT00485134|459002509|FG004|Overall Study|Pregnancy|0|||
127555637|NCT00485134|459002510|FG005|Overall Study|Pregnancy|0|||
127555638|NCT00485134|459002511|FG006|Overall Study|Pregnancy|1|||
127555639|NCT00485134|459002512|FG007|Overall Study|Pregnancy|0|||
127555640|NCT00970684|459002513|FG000|Overall Study|Lack of Efficacy|5|||
127555641|NCT00970684|459002513|FG000|Overall Study|Adverse Event|4|||
127555642|NCT00970684|459002513|FG000|Overall Study|Withdrawal by Subject|1|||
127555643|NCT00481091|459002514|FG000|Overall Study|Withdrawal by Subject|0|||
127555644|NCT00481091|459002515|FG001|Overall Study|Withdrawal by Subject|1|||
127555645|NCT00481091|459002516|FG002|Overall Study|Withdrawal by Subject|1|||
127555646|NCT00481091|459002517|FG003|Overall Study|Withdrawal by Subject|0|||
127555647|NCT00481091|459002518|FG004|Overall Study|Withdrawal by Subject|0|||
127555648|NCT00481091|459002519|FG005|Overall Study|Withdrawal by Subject|0|||
127555649|NCT00481091|459002520|FG006|Overall Study|Withdrawal by Subject|0|||
127555650|NCT00481091|459002521|FG007|Overall Study|Withdrawal by Subject|0|||
127555651|NCT00481091|459002522|FG008|Overall Study|Withdrawal by Subject|1|||
127555652|NCT00481091|459002523|FG009|Overall Study|Withdrawal by Subject|6|||
127555653|NCT00481091|459002514|FG000|Overall Study|Other, Not Specified|0|||
127555654|NCT00481091|459002515|FG001|Overall Study|Other, Not Specified|1|||
127555655|NCT00481091|459002516|FG002|Overall Study|Other, Not Specified|1|||
127555656|NCT00481091|459002517|FG003|Overall Study|Other, Not Specified|0|||
127555657|NCT00481091|459002518|FG004|Overall Study|Other, Not Specified|0|||
127555658|NCT00481091|459002519|FG005|Overall Study|Other, Not Specified|1|||
127555659|NCT00481091|459002520|FG006|Overall Study|Other, Not Specified|0|||
127555660|NCT00481091|459002521|FG007|Overall Study|Other, Not Specified|0|||
127555661|NCT00481091|459002522|FG008|Overall Study|Other, Not Specified|0|||
127555662|NCT00481091|459002523|FG009|Overall Study|Other, Not Specified|4|||
127555663|NCT00481091|459002514|FG000|Overall Study|Adverse Event|1|||
127555664|NCT00481091|459002515|FG001|Overall Study|Adverse Event|2|||
127555665|NCT00481091|459002516|FG002|Overall Study|Adverse Event|0|||
127555666|NCT00481091|459002517|FG003|Overall Study|Adverse Event|1|||
127555667|NCT00481091|459002518|FG004|Overall Study|Adverse Event|1|||
127555668|NCT00481091|459002519|FG005|Overall Study|Adverse Event|1|||
127555669|NCT00481091|459002520|FG006|Overall Study|Adverse Event|2|||
127555670|NCT00481091|459002521|FG007|Overall Study|Adverse Event|1|||
127555671|NCT00481091|459002522|FG008|Overall Study|Adverse Event|1|||
127555672|NCT00481091|459002523|FG009|Overall Study|Adverse Event|6|||
127555673|NCT00481091|459002514|FG000|Overall Study|Progressive disease clinical|0|||
127555674|NCT00481091|459002515|FG001|Overall Study|Progressive disease clinical|0|||
127555675|NCT00481091|459002516|FG002|Overall Study|Progressive disease clinical|0|||
127555676|NCT00481091|459002517|FG003|Overall Study|Progressive disease clinical|0|||
127555677|NCT00481091|459002518|FG004|Overall Study|Progressive disease clinical|0|||
127555678|NCT00481091|459002519|FG005|Overall Study|Progressive disease clinical|0|||
127555679|NCT00481091|459002520|FG006|Overall Study|Progressive disease clinical|0|||
127555680|NCT00481091|459002521|FG007|Overall Study|Progressive disease clinical|0|||
127555681|NCT00481091|459002522|FG008|Overall Study|Progressive disease clinical|1|||
127555682|NCT00481091|459002523|FG009|Overall Study|Progressive disease clinical|7|||
127881016|NCT00835068|460186102|FG000|Overall Study|Death|1|||
127774045|NCT04908189|459798672|FG001|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
127774046|NCT04908189|459798673|FG002|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
127774047|NCT02684357|459798676|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
127774048|NCT02684357|459798677|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
127774049|NCT02684357|459798678|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
127774050|NCT02684357|459798679|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
127774051|NCT02684357|459798680|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
127774052|NCT02684357|459798681|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
127774053|NCT02684357|459798676|FG000|Part A|Lost to Follow-up|0|||
127774054|NCT02684357|459798677|FG001|Part A|Lost to Follow-up|2|||
127774055|NCT02684357|459798678|FG002|Part A|Lost to Follow-up|2|||
127774056|NCT02684357|459798679|FG003|Part A|Lost to Follow-up|0|||
127774057|NCT02684357|459798680|FG004|Part A|Lost to Follow-up|0|||
127774058|NCT02684357|459798681|FG005|Part A|Lost to Follow-up|0|||
127774059|NCT02684357|459798676|FG000|Part A|Withdrawal by Subject|3|||
127774060|NCT02684357|459798677|FG001|Part A|Withdrawal by Subject|0|||
127774061|NCT02684357|459798678|FG002|Part A|Withdrawal by Subject|0|||
127774062|NCT02684357|459798679|FG003|Part A|Withdrawal by Subject|0|||
127774063|NCT02684357|459798680|FG004|Part A|Withdrawal by Subject|0|||
127774064|NCT02684357|459798681|FG005|Part A|Withdrawal by Subject|0|||
127774065|NCT02684357|459798676|FG000|Part A|Other|0|||
127774066|NCT02684357|459798677|FG001|Part A|Other|1|||
127774067|NCT02684357|459798678|FG002|Part A|Other|0|||
127774068|NCT02684357|459798679|FG003|Part A|Other|0|||
127774069|NCT02684357|459798680|FG004|Part A|Other|0|||
127774070|NCT02684357|459798681|FG005|Part A|Other|0|||
127774071|NCT02684357|459798676|FG000|Part B|Adverse Event (Other)|0|||
127774072|NCT02684357|459798677|FG001|Part B|Adverse Event (Other)|0|||
127774073|NCT02684357|459798678|FG002|Part B|Adverse Event (Other)|0|||
127774074|NCT02684357|459798679|FG003|Part B|Adverse Event (Other)|1|||
127774075|NCT02684357|459798680|FG004|Part B|Adverse Event (Other)|1|||
127774076|NCT02684357|459798681|FG005|Part B|Adverse Event (Other)|1|||
127774077|NCT02684357|459798676|FG000|Part B|Lost to Follow-up|0|||
127774078|NCT02684357|459798677|FG001|Part B|Lost to Follow-up|0|||
127774079|NCT02684357|459798678|FG002|Part B|Lost to Follow-up|0|||
127774080|NCT02684357|459798679|FG003|Part B|Lost to Follow-up|1|||
127774081|NCT02684357|459798680|FG004|Part B|Lost to Follow-up|1|||
127774082|NCT02684357|459798681|FG005|Part B|Lost to Follow-up|7|||
127774083|NCT02684357|459798676|FG000|Part B|Withdrawal by Subject|0|||
127774084|NCT02684357|459798677|FG001|Part B|Withdrawal by Subject|0|||
127774085|NCT02684357|459798678|FG002|Part B|Withdrawal by Subject|0|||
127774086|NCT02684357|459798679|FG003|Part B|Withdrawal by Subject|0|||
127774087|NCT02684357|459798680|FG004|Part B|Withdrawal by Subject|2|||
127774088|NCT02684357|459798681|FG005|Part B|Withdrawal by Subject|4|||
127774089|NCT02684357|459798676|FG000|Part B|Other|0|||
127774090|NCT02684357|459798677|FG001|Part B|Other|0|||
127774091|NCT02684357|459798678|FG002|Part B|Other|0|||
127774092|NCT02684357|459798679|FG003|Part B|Other|1|||
127774093|NCT02684357|459798680|FG004|Part B|Other|0|||
127774094|NCT02684357|459798681|FG005|Part B|Other|1|||
127774095|NCT01079130|459798682|FG000|Overall Study|Adverse Event|1|||
127774096|NCT01079130|459798683|FG001|Overall Study|Adverse Event|1|||
127774097|NCT01079130|459798684|FG002|Overall Study|Adverse Event|0|||
127774098|NCT01079130|459798685|FG003|Overall Study|Adverse Event|1|||
128021257|NCT02316613|460702835|FG000|Overall Study|Death|63|||
128021258|NCT02316613|460702835|FG000|Overall Study|Lost to Follow-up|9|||
128021259|NCT02316613|460702835|FG000|Overall Study|Lymphoma transformation|2|||
128021260|NCT02316613|460702835|FG000|Overall Study|Participant moved/changed medical team|11|||
128021261|NCT02316613|460702835|FG000|Overall Study|No data and duplicate cases|5|||
128021262|NCT02316613|460702835|FG000|Overall Study|Did not met selection criteria|14|||
128021263|NCT01166945|460702836|FG000|Randomized|diagnosed with Group A strep|4|||
128021264|NCT01166945|460702837|FG001|Randomized|diagnosed with Group A strep|4|||
128021265|NCT01166945|460702836|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
128021266|NCT01166945|460702837|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
128021267|NCT01166945|460702836|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
127774099|NCT01079130|459798686|FG004|Overall Study|Adverse Event|5|||
127774100|NCT01079130|459798687|FG005|Overall Study|Adverse Event|1|||
127774101|NCT01079130|459798682|FG000|Overall Study|Administrative problems|1|||
127774102|NCT01079130|459798683|FG001|Overall Study|Administrative problems|3|||
127774103|NCT01079130|459798684|FG002|Overall Study|Administrative problems|0|||
127774104|NCT01079130|459798685|FG003|Overall Study|Administrative problems|0|||
127774105|NCT01079130|459798686|FG004|Overall Study|Administrative problems|0|||
127774106|NCT01079130|459798687|FG005|Overall Study|Administrative problems|1|||
127774107|NCT01079130|459798682|FG000|Overall Study|Withdrawal by Subject|0|||
127774108|NCT01079130|459798683|FG001|Overall Study|Withdrawal by Subject|1|||
127774109|NCT01079130|459798684|FG002|Overall Study|Withdrawal by Subject|0|||
127774110|NCT01079130|459798685|FG003|Overall Study|Withdrawal by Subject|0|||
127774111|NCT01079130|459798686|FG004|Overall Study|Withdrawal by Subject|1|||
127774112|NCT01079130|459798687|FG005|Overall Study|Withdrawal by Subject|3|||
128021268|NCT01166945|460702837|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
128021269|NCT01166945|460702836|FG000|Day 30|Lost to Follow-up|4|||
128021270|NCT01166945|460702837|FG001|Day 30|Lost to Follow-up|3|||
128021271|NCT00784927|460702838|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
128021272|NCT00784927|460702838|FG000|Overall Study|Protocol Violation|1|||
128021273|NCT00784927|460702838|FG000|Overall Study|Ineligible|1|||
128021274|NCT00422461|460702845|FG000|Overall Study|Adverse Event|1|||
128021275|NCT00422461|460702846|FG001|Overall Study|Adverse Event|2|||
128021276|NCT00422461|460702847|FG002|Overall Study|Adverse Event|1|||
128021277|NCT00422461|460702848|FG003|Overall Study|Adverse Event|1|||
128021278|NCT00422461|460702845|FG000|Overall Study|Other|0|||
128021279|NCT00422461|460702846|FG001|Overall Study|Other|0|||
128021280|NCT00422461|460702847|FG002|Overall Study|Other|0|||
128021281|NCT00422461|460702848|FG003|Overall Study|Other|2|||
128021282|NCT00422461|460702845|FG000|Overall Study|Participants no longer willing to participate in study|1|||
128021283|NCT00422461|460702846|FG001|Overall Study|Participants no longer willing to participate in study|0|||
128021284|NCT00422461|460702847|FG002|Overall Study|Participants no longer willing to participate in study|0|||
128021285|NCT00422461|460702848|FG003|Overall Study|Participants no longer willing to participate in study|0|||
128021286|NCT00422461|460702845|FG000|Overall Study|Randomized but not treated|1|||
128021287|NCT00422461|460702846|FG001|Overall Study|Randomized but not treated|1|||
128021288|NCT00422461|460702847|FG002|Overall Study|Randomized but not treated|0|||
128021289|NCT00422461|460702848|FG003|Overall Study|Randomized but not treated|0|||
128021290|NCT01471574|460702849|FG000|Treatment Period|Lack of Efficacy|12|||
128021291|NCT01471574|460702850|FG001|Treatment Period|Lack of Efficacy|4|||
128021292|NCT01471574|460702851|FG002|Treatment Period|Lack of Efficacy|14|||
128021293|NCT01471574|460702852|FG003|Treatment Period|Lack of Efficacy|1|||
128021294|NCT01471574|460702849|FG000|Treatment Period|Adverse Event|7|||
128021295|NCT01471574|460702850|FG001|Treatment Period|Adverse Event|3|||
128021296|NCT01471574|460702851|FG002|Treatment Period|Adverse Event|6|||
128021297|NCT01471574|460702852|FG003|Treatment Period|Adverse Event|1|||
128021298|NCT01471574|460702849|FG000|Treatment Period|Withdrawal by Subject|5|||
128021299|NCT01471574|460702850|FG001|Treatment Period|Withdrawal by Subject|1|||
128021300|NCT01471574|460702851|FG002|Treatment Period|Withdrawal by Subject|1|||
128021301|NCT01471574|460702852|FG003|Treatment Period|Withdrawal by Subject|0|||
128021302|NCT01471574|460702849|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
128021303|NCT01471574|460702850|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
128021304|NCT01471574|460702851|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
128021305|NCT01471574|460702852|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
128021306|NCT01471574|460702849|FG000|Treatment Period|Lost to Follow-up|1|||
128021307|NCT01471574|460702850|FG001|Treatment Period|Lost to Follow-up|2|||
128021308|NCT01471574|460702851|FG002|Treatment Period|Lost to Follow-up|2|||
128021309|NCT01471574|460702852|FG003|Treatment Period|Lost to Follow-up|0|||
128021310|NCT01471574|460702849|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
128021311|NCT01471574|460702850|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
128021312|NCT01471574|460702851|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
128021313|NCT01471574|460702852|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
128021314|NCT01471574|460702849|FG000|Treatment Period|Other|1|||
128021315|NCT01471574|460702850|FG001|Treatment Period|Other|0|||
128021316|NCT01471574|460702851|FG002|Treatment Period|Other|0|||
128021317|NCT01471574|460702852|FG003|Treatment Period|Other|0|||
128021318|NCT01471574|460702849|FG000|Follow-up Period|Withdrawal by Subject|3|||
128021319|NCT01471574|460702850|FG001|Follow-up Period|Withdrawal by Subject|0|||
128021320|NCT01471574|460702851|FG002|Follow-up Period|Withdrawal by Subject|3|||
127881017|NCT00835068|460186103|FG001|Overall Study|Death|0|||
128021321|NCT01471574|460702852|FG003|Follow-up Period|Withdrawal by Subject|1|||
128021322|NCT01471574|460702849|FG000|Follow-up Period|Lost to Follow-up|4|||
128021323|NCT01471574|460702850|FG001|Follow-up Period|Lost to Follow-up|1|||
128021324|NCT01471574|460702851|FG002|Follow-up Period|Lost to Follow-up|3|||
127555683|NCT00481091|459002514|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
127555684|NCT00481091|459002515|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
127555685|NCT00481091|459002516|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
127555686|NCT00481091|459002517|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
127555687|NCT00481091|459002518|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
127555688|NCT00481091|459002519|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
127555689|NCT00481091|459002520|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
127555690|NCT00481091|459002521|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
127555691|NCT00481091|459002522|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
127555692|NCT00481091|459002523|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
127555693|NCT00481091|459002514|FG000|Overall Study|Progressive disease other|1|||
127555694|NCT00481091|459002515|FG001|Overall Study|Progressive disease other|1|||
127555695|NCT00481091|459002516|FG002|Overall Study|Progressive disease other|0|||
127555696|NCT00481091|459002517|FG003|Overall Study|Progressive disease other|1|||
127555697|NCT00481091|459002518|FG004|Overall Study|Progressive disease other|1|||
127555698|NCT00481091|459002519|FG005|Overall Study|Progressive disease other|1|||
127555699|NCT00481091|459002520|FG006|Overall Study|Progressive disease other|0|||
127555700|NCT00481091|459002521|FG007|Overall Study|Progressive disease other|2|||
127555701|NCT00481091|459002522|FG008|Overall Study|Progressive disease other|0|||
127555702|NCT00481091|459002523|FG009|Overall Study|Progressive disease other|0|||
127555703|NCT00481091|459002514|FG000|Overall Study|No reason given|0|||
127555704|NCT00481091|459002515|FG001|Overall Study|No reason given|0|||
127555705|NCT00481091|459002516|FG002|Overall Study|No reason given|1|||
127555706|NCT00481091|459002517|FG003|Overall Study|No reason given|1|||
127555707|NCT00481091|459002518|FG004|Overall Study|No reason given|1|||
127555708|NCT00481091|459002519|FG005|Overall Study|No reason given|0|||
127555709|NCT00481091|459002520|FG006|Overall Study|No reason given|1|||
127555710|NCT00481091|459002521|FG007|Overall Study|No reason given|1|||
128021325|NCT01471574|460702852|FG003|Follow-up Period|Lost to Follow-up|2|||
128021326|NCT01471574|460702849|FG000|Follow-up Period|Death|0|||
128021327|NCT01471574|460702850|FG001|Follow-up Period|Death|0|||
128021328|NCT01471574|460702851|FG002|Follow-up Period|Death|1|||
128021329|NCT01471574|460702852|FG003|Follow-up Period|Death|0|||
128021330|NCT01471574|460702849|FG000|Follow-up Period|Follow-up no longer required|0|||
128021331|NCT01471574|460702850|FG001|Follow-up Period|Follow-up no longer required|1|||
128021332|NCT01471574|460702851|FG002|Follow-up Period|Follow-up no longer required|0|||
128021333|NCT01471574|460702852|FG003|Follow-up Period|Follow-up no longer required|0|||
128021334|NCT01795937|460702853|FG000|Overall Study|Withdrawal by Subject|1|||
128021335|NCT01795937|460702854|FG001|Overall Study|Withdrawal by Subject|0|||
128021336|NCT01795937|460702855|FG002|Overall Study|Withdrawal by Subject|0|||
128021337|NCT01795937|460702853|FG000|Overall Study|Physician Decision|0|||
128021338|NCT01795937|460702854|FG001|Overall Study|Physician Decision|1|||
128021339|NCT01795937|460702855|FG002|Overall Study|Physician Decision|0|||
128021340|NCT01028053|460702856|FG000|Overall Study|Screen Failure|113|||
128021341|NCT01028053|460702856|FG000|Overall Study|Patient Request|11|||
128021342|NCT01028053|460702856|FG000|Overall Study|Protocol Violation|1|||
128021343|NCT01028053|460702856|FG000|Overall Study|Physician Decision|2|||
128021344|NCT01028053|460702856|FG000|Overall Study|Technical Problem|1|||
128021345|NCT01028053|460702856|FG000|Overall Study|Terminated by Sponsor|1|||
128021346|NCT01028053|460702856|FG000|Overall Study|Various reasons|4|||
128021347|NCT04027946|460702861|FG000|Overall Study|Screen failures|3|||
128021348|NCT00983957|460702863|FG000|Overall Study|Adverse Event|1|||
128021349|NCT00983957|460702863|FG000|Overall Study|Personal Reasons|1|||
128021350|NCT00986232|460702864|FG000|Overall Study|Adverse Event|1|||
128021351|NCT00986232|460702865|FG001|Overall Study|Adverse Event|2|||
128021352|NCT00986232|460702866|FG002|Overall Study|Adverse Event|3|||
128021353|NCT00986232|460702867|FG003|Overall Study|Adverse Event|0|||
128021354|NCT00986232|460702864|FG000|Overall Study|Lost to Follow-up|19|||
128021355|NCT00986232|460702865|FG001|Overall Study|Lost to Follow-up|12|||
128021356|NCT00986232|460702866|FG002|Overall Study|Lost to Follow-up|12|||
128021357|NCT00986232|460702867|FG003|Overall Study|Lost to Follow-up|7|||
128021358|NCT00986232|460702864|FG000|Overall Study|Protocol Violation|2|||
128021359|NCT00986232|460702865|FG001|Overall Study|Protocol Violation|3|||
128021360|NCT00986232|460702866|FG002|Overall Study|Protocol Violation|0|||
128021361|NCT00986232|460702867|FG003|Overall Study|Protocol Violation|1|||
128021362|NCT00986232|460702864|FG000|Overall Study|Withdrawal by Subject|13|||
128021363|NCT00986232|460702865|FG001|Overall Study|Withdrawal by Subject|16|||
128021364|NCT00986232|460702866|FG002|Overall Study|Withdrawal by Subject|12|||
127555711|NCT00481091|459002522|FG008|Overall Study|No reason given|1|||
127555712|NCT00481091|459002523|FG009|Overall Study|No reason given|4|||
127555713|NCT04294680|459002524|FG000|Overall Study|Withdrawal by Subject|2|||
127555714|NCT04294680|459002525|FG001|Overall Study|Withdrawal by Subject|1|||
127555715|NCT04294680|459002524|FG000|Overall Study|Follow-up visits completed outside of window|1|||
128021365|NCT00986232|460702867|FG003|Overall Study|Withdrawal by Subject|3|||
128021366|NCT00986232|460702864|FG000|Overall Study|Missed one or more bleeds|13|||
127774113|NCT01079130|459798682|FG000|Overall Study|Protocol deviation|0|||
127774114|NCT01079130|459798683|FG001|Overall Study|Protocol deviation|2|||
127774115|NCT01079130|459798684|FG002|Overall Study|Protocol deviation|1|||
127774116|NCT01079130|459798685|FG003|Overall Study|Protocol deviation|2|||
127774117|NCT01079130|459798686|FG004|Overall Study|Protocol deviation|0|||
127774118|NCT01079130|459798687|FG005|Overall Study|Protocol deviation|0|||
127774119|NCT01079130|459798682|FG000|Overall Study|Abnormal test procedure result(s)|0|||
127774120|NCT01079130|459798683|FG001|Overall Study|Abnormal test procedure result(s)|0|||
127774121|NCT01079130|459798684|FG002|Overall Study|Abnormal test procedure result(s)|0|||
127774122|NCT01079130|459798685|FG003|Overall Study|Abnormal test procedure result(s)|0|||
127774123|NCT01079130|459798686|FG004|Overall Study|Abnormal test procedure result(s)|1|||
127774124|NCT01079130|459798687|FG005|Overall Study|Abnormal test procedure result(s)|0|||
127774125|NCT01079130|459798682|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
127774126|NCT01079130|459798683|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
127774127|NCT01079130|459798684|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
127774128|NCT01079130|459798685|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
127774129|NCT01079130|459798686|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
127774130|NCT01079130|459798687|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
127774131|NCT01079130|459798682|FG000|Overall Study|Lost to Follow-up|0|||
127774132|NCT01079130|459798683|FG001|Overall Study|Lost to Follow-up|0|||
127774133|NCT01079130|459798684|FG002|Overall Study|Lost to Follow-up|0|||
127774134|NCT01079130|459798685|FG003|Overall Study|Lost to Follow-up|0|||
127774135|NCT01079130|459798686|FG004|Overall Study|Lost to Follow-up|1|||
127774136|NCT01079130|459798687|FG005|Overall Study|Lost to Follow-up|0|||
127774137|NCT01839487|459798688|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
127774138|NCT01839487|459798689|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
127774139|NCT01839487|459798690|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
127774140|NCT01839487|459798691|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
127774141|NCT01839487|459798692|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
127774142|NCT01839487|459798693|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
127774143|NCT01839487|459798688|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
127774144|NCT01839487|459798689|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
127774145|NCT01839487|459798690|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
127774146|NCT01839487|459798691|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
127774147|NCT01839487|459798692|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
127774148|NCT01839487|459798693|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
127774149|NCT01839487|459798688|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
127774150|NCT01839487|459798689|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
127774151|NCT01839487|459798690|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
127774152|NCT01839487|459798691|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
127774153|NCT01839487|459798692|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
127774154|NCT01839487|459798693|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
127774155|NCT01839487|459798688|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
127774156|NCT01839487|459798689|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
127774157|NCT01839487|459798690|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
127774158|NCT01839487|459798691|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
127774159|NCT01839487|459798692|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
127774160|NCT01839487|459798693|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
127774161|NCT01839487|459798688|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
127774162|NCT01839487|459798689|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
127774163|NCT01839487|459798690|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
127774164|NCT01839487|459798691|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
128021367|NCT00986232|460702865|FG001|Overall Study|Missed one or more bleeds|10|||
128021368|NCT00986232|460702866|FG002|Overall Study|Missed one or more bleeds|6|||
128021369|NCT00986232|460702867|FG003|Overall Study|Missed one or more bleeds|7|||
128021370|NCT00986232|460702864|FG000|Overall Study|Incomplete safety follow-up|3|||
128021371|NCT00986232|460702865|FG001|Overall Study|Incomplete safety follow-up|7|||
128021372|NCT00986232|460702866|FG002|Overall Study|Incomplete safety follow-up|2|||
128021373|NCT00986232|460702867|FG003|Overall Study|Incomplete safety follow-up|2|||
128021374|NCT00790933|460702868|FG000|Overall Study|Adverse Event|94|||
127774165|NCT01839487|459798692|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
127774166|NCT01839487|459798693|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
127774167|NCT01839487|459798688|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
127774168|NCT01839487|459798689|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
127774169|NCT01839487|459798690|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
127774170|NCT01839487|459798691|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
127774171|NCT01839487|459798692|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
127774172|NCT01839487|459798693|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
127774173|NCT01839487|459798688|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
127774174|NCT01839487|459798689|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
127774175|NCT01839487|459798690|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
127774176|NCT01839487|459798691|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
127774177|NCT01839487|459798692|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
127774178|NCT01839487|459798693|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
127774179|NCT01839487|459798688|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
127774180|NCT01839487|459798689|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
127774181|NCT01839487|459798690|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
127774182|NCT01839487|459798691|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
127774183|NCT01839487|459798692|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
127774184|NCT01839487|459798693|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
127774185|NCT01839487|459798688|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
127774186|NCT01839487|459798689|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
127774187|NCT01839487|459798690|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
127774188|NCT01839487|459798691|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
127774189|NCT01839487|459798692|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
127774190|NCT01839487|459798693|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
127774191|NCT01658826|459798704|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
127774192|NCT01658826|459798705|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
127774193|NCT01658826|459798704|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
127774194|NCT01658826|459798705|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
127774195|NCT01658826|459798704|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
127774196|NCT01658826|459798705|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
127774197|NCT01658826|459798704|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
127774198|NCT01658826|459798705|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
127774199|NCT01658826|459798704|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
127774200|NCT01658826|459798705|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
127774201|NCT01658826|459798704|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
127774202|NCT01658826|459798705|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
127555716|NCT04294680|459002525|FG001|Overall Study|Follow-up visits completed outside of window|0|||
127774203|NCT01658826|459798704|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
127774204|NCT01658826|459798705|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
127774205|NCT01658826|459798704|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
127774206|NCT01658826|459798705|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
127774207|NCT01658826|459798704|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
127774208|NCT01658826|459798705|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
127774209|NCT04821869|459798706|FG000|Overall Study|Adverse Event|4|||
127774210|NCT04821869|459798706|FG000|Overall Study|Withdrawal by Subject|2|||
127774211|NCT04821869|459798706|FG000|Overall Study|Did not meet FEV1 criteria|1|||
127774212|NCT01256658|459800281|FG000|Period 1|Lost to Follow-up|837|||
128021375|NCT00790933|460702869|FG001|Overall Study|Adverse Event|119|||
128021376|NCT00790933|460702870|FG002|Overall Study|Adverse Event|65|||
127555717|NCT01296672|459002526|FG000|Overall Study|Lost to Follow-up|73|||
127555718|NCT01296672|459002527|FG001|Overall Study|Lost to Follow-up|18|||
127555719|NCT04027608|459002528|FG000|Overall Study|Withdrawal by Subject|13|||
127555720|NCT04027608|459002529|FG001|Overall Study|Withdrawal by Subject|2|||
127555721|NCT04027608|459002528|FG000|Overall Study|Protocol Violation|2|||
128021377|NCT00790933|460702871|FG003|Overall Study|Adverse Event|5|||
128021378|NCT00790933|460702872|FG004|Overall Study|Adverse Event|69|||
127555722|NCT04027608|459002529|FG001|Overall Study|Protocol Violation|1|||
127555723|NCT04027608|459002528|FG000|Overall Study|Physician Decision|1|||
127555724|NCT04027608|459002529|FG001|Overall Study|Physician Decision|0|||
127555725|NCT04027608|459002528|FG000|Overall Study|Lost to Follow-up|20|||
127555726|NCT04027608|459002529|FG001|Overall Study|Lost to Follow-up|4|||
127555727|NCT01396447|459002532|FG000|Overall Study|Did Not Receive Treatment|3|||
127555728|NCT01396447|459002533|FG001|Overall Study|Did Not Receive Treatment|2|||
127774213|NCT01256658|459800282|FG001|Period 1|Lost to Follow-up|661|||
127774214|NCT01256658|459800281|FG000|Period 1|Withdrawal by Subject|35|||
128021379|NCT00790933|460702868|FG000|Overall Study|Protocol Violation(s)|8|||
128021380|NCT00790933|460702869|FG001|Overall Study|Protocol Violation(s)|18|||
128021381|NCT00790933|460702870|FG002|Overall Study|Protocol Violation(s)|7|||
128021382|NCT00790933|460702871|FG003|Overall Study|Protocol Violation(s)|0|||
128021383|NCT00790933|460702872|FG004|Overall Study|Protocol Violation(s)|12|||
128021384|NCT00790933|460702868|FG000|Overall Study|Lack of Efficacy|192|||
127555729|NCT01396447|459002534|FG002|Overall Study|Did Not Receive Treatment|1|||
127555730|NCT01396447|459002535|FG003|Overall Study|Did Not Receive Treatment|0|||
127555731|NCT01396447|459002532|FG000|Overall Study|Adverse Event|15|||
127881018|NCT00835068|460186102|FG000|Overall Study|Adverse Event|0|||
128021385|NCT00790933|460702869|FG001|Overall Study|Lack of Efficacy|176|||
128021386|NCT00790933|460702870|FG002|Overall Study|Lack of Efficacy|130|||
128021387|NCT00790933|460702871|FG003|Overall Study|Lack of Efficacy|1|||
128021388|NCT00790933|460702872|FG004|Overall Study|Lack of Efficacy|121|||
128021389|NCT00790933|460702868|FG000|Overall Study|Study Terminated by Sponsor|0|||
128021390|NCT00790933|460702869|FG001|Overall Study|Study Terminated by Sponsor|0|||
128021391|NCT00790933|460702870|FG002|Overall Study|Study Terminated by Sponsor|1|||
128021392|NCT00790933|460702871|FG003|Overall Study|Study Terminated by Sponsor|0|||
128021393|NCT00790933|460702872|FG004|Overall Study|Study Terminated by Sponsor|0|||
128021394|NCT00790933|460702868|FG000|Overall Study|Withdrawal by Subject|123|||
128021395|NCT00790933|460702869|FG001|Overall Study|Withdrawal by Subject|120|||
128021396|NCT00790933|460702870|FG002|Overall Study|Withdrawal by Subject|52|||
128021397|NCT00790933|460702871|FG003|Overall Study|Withdrawal by Subject|6|||
128021398|NCT00790933|460702872|FG004|Overall Study|Withdrawal by Subject|50|||
128021399|NCT00790933|460702868|FG000|Overall Study|Lost to Follow-up|13|||
128021400|NCT00790933|460702869|FG001|Overall Study|Lost to Follow-up|31|||
128021401|NCT00790933|460702870|FG002|Overall Study|Lost to Follow-up|10|||
128021402|NCT00790933|460702871|FG003|Overall Study|Lost to Follow-up|1|||
128021403|NCT00790933|460702872|FG004|Overall Study|Lost to Follow-up|15|||
128021404|NCT00790933|460702868|FG000|Overall Study|Reason Not Specified|8|||
128021405|NCT00790933|460702869|FG001|Overall Study|Reason Not Specified|16|||
128021406|NCT00790933|460702870|FG002|Overall Study|Reason Not Specified|4|||
128021407|NCT00790933|460702871|FG003|Overall Study|Reason Not Specified|1|||
128021408|NCT00790933|460702872|FG004|Overall Study|Reason Not Specified|9|||
128021409|NCT00245570|460702875|FG000|Washout Between Periods III and IV|Adverse Event|0|||
128021410|NCT00245570|460702876|FG001|Washout Between Periods III and IV|Adverse Event|1|||
128021411|NCT00245570|460702877|FG002|Washout Between Periods III and IV|Adverse Event|0|||
128021412|NCT00245570|460702878|FG003|Washout Between Periods III and IV|Adverse Event|0|||
128021413|NCT00245570|460702879|FG004|Washout Between Periods III and IV|Adverse Event|0|||
128021414|NCT00245570|460702880|FG005|Washout Between Periods III and IV|Adverse Event|0|||
128021415|NCT01829165|460702881|FG000|Overall Study|Did not complete intervention|2|||
128021416|NCT01829165|460702882|FG001|Overall Study|Did not complete intervention|0|||
128021417|NCT04233580|460702905|FG000|Overall Study|Adverse Event|3|||
128021418|NCT04233580|460702906|FG001|Overall Study|Adverse Event|3|||
128021419|NCT04233580|460702905|FG000|Overall Study|Withdrawal by Subject|2|||
128021420|NCT04233580|460702906|FG001|Overall Study|Withdrawal by Subject|1|||
128021421|NCT02441114|460702907|FG000|Washout2|Withdrawal by Subject|4|||
128021422|NCT03446573|460702909|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
128021423|NCT03446573|460702910|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
128021424|NCT03446573|460702909|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
128021425|NCT03446573|460702910|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
128021426|NCT03446573|460702909|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
127555732|NCT01396447|459002533|FG001|Overall Study|Adverse Event|12|||
128021427|NCT03446573|460702910|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
128021428|NCT03446573|460702909|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
128021429|NCT03446573|460702910|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
128021430|NCT03446573|460702909|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
128021431|NCT03446573|460702910|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
128021432|NCT03446573|460702909|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
128021433|NCT03446573|460702910|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
128021434|NCT03446573|460702909|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
128021435|NCT03446573|460702910|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
128021436|NCT03446573|460702909|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
128021437|NCT03446573|460702910|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
128021438|NCT03446573|460702909|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
128021439|NCT03446573|460702910|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
128021440|NCT03446573|460702909|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
128021441|NCT03446573|460702910|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
128021442|NCT03446573|460702909|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
128021443|NCT03446573|460702910|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
128021444|NCT03446573|460702909|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
128021445|NCT03446573|460702910|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
128021446|NCT03446573|460702909|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
128021447|NCT03446573|460702910|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
128021448|NCT03954938|460702911|FG000|Overall Study|Withdrawal by Subject|2|||
128021449|NCT03954938|460702911|FG000|Overall Study|Adverse Event|1|||
128021450|NCT01371565|460702912|FG000|Overall Study|Withdrawal by Subject|1|||
128021451|NCT01371565|460702912|FG000|Overall Study|Death|1|||
128021452|NCT01371565|460702912|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
128021453|NCT04270760|460702913|FG000|Overall Study|Withdrawal by Subject|0|||
128021454|NCT04270760|460702914|FG001|Overall Study|Withdrawal by Subject|1|||
128021455|NCT04270760|460702915|FG002|Overall Study|Withdrawal by Subject|3|||
128021456|NCT04270760|460702916|FG003|Overall Study|Withdrawal by Subject|0|||
128021457|NCT04270760|460702917|FG004|Overall Study|Withdrawal by Subject|0|||
128021458|NCT04270760|460702913|FG000|Overall Study|Lost to Follow-up|1|||
128021459|NCT04270760|460702914|FG001|Overall Study|Lost to Follow-up|2|||
128021460|NCT04270760|460702915|FG002|Overall Study|Lost to Follow-up|1|||
128021461|NCT04270760|460702916|FG003|Overall Study|Lost to Follow-up|0|||
128021462|NCT04270760|460702917|FG004|Overall Study|Lost to Follow-up|0|||
128021463|NCT04270760|460702913|FG000|Overall Study|Death|0|||
128021464|NCT04270760|460702914|FG001|Overall Study|Death|0|||
128021465|NCT04270760|460702915|FG002|Overall Study|Death|0|||
128021466|NCT04270760|460702916|FG003|Overall Study|Death|0|||
127685664|NCT05094141|459474890|FG002|Overall Study|Did not participate in randomization|33|||
127685665|NCT01170026|459476309|FG000|Overall Study|Lost to Follow-up|4|||
127555733|NCT01396447|459002534|FG002|Overall Study|Adverse Event|12|||
127555734|NCT01396447|459002535|FG003|Overall Study|Adverse Event|17|||
127555735|NCT01396447|459002532|FG000|Overall Study|Insufficient Therapeutic Response|5|||
127555736|NCT01396447|459002533|FG001|Overall Study|Insufficient Therapeutic Response|5|||
127555737|NCT01396447|459002534|FG002|Overall Study|Insufficient Therapeutic Response|2|||
127555738|NCT01396447|459002535|FG003|Overall Study|Insufficient Therapeutic Response|4|||
127555739|NCT01396447|459002532|FG000|Overall Study|Protocol Violation|5|||
127555740|NCT01396447|459002533|FG001|Overall Study|Protocol Violation|2|||
127555741|NCT01396447|459002534|FG002|Overall Study|Protocol Violation|3|||
127555742|NCT01396447|459002535|FG003|Overall Study|Protocol Violation|7|||
127555743|NCT01396447|459002532|FG000|Overall Study|Withdrawal of Consent|11|||
127555744|NCT01396447|459002533|FG001|Overall Study|Withdrawal of Consent|9|||
127555745|NCT01396447|459002534|FG002|Overall Study|Withdrawal of Consent|4|||
127555746|NCT01396447|459002535|FG003|Overall Study|Withdrawal of Consent|15|||
127555747|NCT01396447|459002532|FG000|Overall Study|Lost to Follow-up|4|||
127555748|NCT01396447|459002533|FG001|Overall Study|Lost to Follow-up|8|||
127555749|NCT01396447|459002534|FG002|Overall Study|Lost to Follow-up|7|||
127555750|NCT01396447|459002535|FG003|Overall Study|Lost to Follow-up|9|||
127555751|NCT01396447|459002532|FG000|Overall Study|Other Miscellaneous Reasons|0|||
127555752|NCT01396447|459002533|FG001|Overall Study|Other Miscellaneous Reasons|2|||
127555753|NCT01396447|459002534|FG002|Overall Study|Other Miscellaneous Reasons|1|||
127555754|NCT01396447|459002535|FG003|Overall Study|Other Miscellaneous Reasons|0|||
127555755|NCT01386970|459002537|FG000|Overall Study|Withdrawal by Subject|0|||
127555756|NCT01386970|459002538|FG001|Overall Study|Withdrawal by Subject|1|||
127555757|NCT01386970|459002537|FG000|Overall Study|Adverse Event|4|||
127555758|NCT01386970|459002538|FG001|Overall Study|Adverse Event|1|||
127555759|NCT04881942|459002539|FG000|Overall Study|Adverse Event|0|||
127555760|NCT04881942|459002540|FG001|Overall Study|Adverse Event|0|||
127555761|NCT04881942|459002541|FG002|Overall Study|Adverse Event|0|||
127555762|NCT04881942|459002542|FG003|Overall Study|Adverse Event|0|||
127555763|NCT04881942|459002543|FG004|Overall Study|Adverse Event|1|||
127555764|NCT04881942|459002539|FG000|Overall Study|Alternates|0|||
127555765|NCT04881942|459002540|FG001|Overall Study|Alternates|0|||
127555766|NCT04881942|459002541|FG002|Overall Study|Alternates|0|||
127555767|NCT04881942|459002542|FG003|Overall Study|Alternates|0|||
127555768|NCT04881942|459002543|FG004|Overall Study|Alternates|2|||
127555769|NCT01349959|459002544|FG000|Overall Study|Adverse Event|7|||
127555770|NCT02675634|459002545|FG000|Test Period 1|Adverse Event|0|||
127555771|NCT02675634|459002546|FG001|Test Period 1|Adverse Event|1|||
127555772|NCT02675634|459002547|FG002|Test Period 1|Adverse Event|0|||
127555773|NCT02675634|459002548|FG003|Test Period 1|Adverse Event|1|||
127555774|NCT02675634|459002549|FG004|Test Period 1|Adverse Event|0|||
127555775|NCT02675634|459002550|FG005|Test Period 1|Adverse Event|0|||
127555776|NCT02675634|459002545|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
127555777|NCT02675634|459002546|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
127555778|NCT02675634|459002547|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
127555779|NCT02675634|459002548|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
127555780|NCT02675634|459002549|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
127555781|NCT02675634|459002550|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
127555782|NCT02675634|459002545|FG000|Test Period 2|Lack of Efficacy|1|||
127555783|NCT02675634|459002546|FG001|Test Period 2|Lack of Efficacy|0|||
127555784|NCT02675634|459002547|FG002|Test Period 2|Lack of Efficacy|0|||
127555785|NCT02675634|459002548|FG003|Test Period 2|Lack of Efficacy|0|||
127555786|NCT02675634|459002549|FG004|Test Period 2|Lack of Efficacy|0|||
127555787|NCT02675634|459002550|FG005|Test Period 2|Lack of Efficacy|0|||
127555788|NCT02675634|459002545|FG000|Test Period 2|Adverse Event|0|||
127555789|NCT02675634|459002546|FG001|Test Period 2|Adverse Event|0|||
127555790|NCT02675634|459002547|FG002|Test Period 2|Adverse Event|0|||
127555791|NCT02675634|459002548|FG003|Test Period 2|Adverse Event|0|||
127555792|NCT02675634|459002549|FG004|Test Period 2|Adverse Event|0|||
127555793|NCT02675634|459002550|FG005|Test Period 2|Adverse Event|1|||
127555794|NCT01652534|459002551|FG000|Overall Study|Lack of Efficacy|1|||
127555795|NCT01652534|459002552|FG001|Overall Study|Lack of Efficacy|0|||
127555796|NCT03860259|459002553|FG000|Overall Study|Lost to Follow-up|5|||
127555797|NCT03860259|459002554|FG001|Overall Study|Lost to Follow-up|5|||
127685666|NCT01170026|459476310|FG001|Overall Study|Lost to Follow-up|2|||
127685667|NCT04623008|459476311|FG000|Baseline to T2|Withdrawal by Subject|4|||
127685668|NCT04623008|459476312|FG001|Baseline to T2|Withdrawal by Subject|2|||
127555798|NCT03860259|459002553|FG000|Overall Study|Protocol Violation|1|||
127555799|NCT03860259|459002554|FG001|Overall Study|Protocol Violation|0|||
127555800|NCT00811018|459002555|FG000|Overall Study|Additional Chronic Treatment|31|||
127555801|NCT00811018|459002555|FG000|Overall Study|Adverse Event|79|||
127555802|NCT00811018|459002555|FG000|Overall Study|Death|147|||
127555803|NCT00811018|459002555|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
127555804|NCT00811018|459002555|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
127555805|NCT00811018|459002555|FG000|Overall Study|Investigator Decision|57|||
127555806|NCT00811018|459002555|FG000|Overall Study|Lost to Follow-up|19|||
127555807|NCT00811018|459002555|FG000|Overall Study|Pregnancy|6|||
127555808|NCT00811018|459002555|FG000|Overall Study|Sponsor Decision|450|||
127555809|NCT00811018|459002555|FG000|Overall Study|Withdrawal by Subject|70|||
127555810|NCT00811018|459002555|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
127555811|NCT00811018|459002555|FG000|Overall Study|Other|26|||
127555812|NCT00934362|459002559|FG000|Overall Study|Adverse Event|1|||
127555813|NCT00934362|459002560|FG001|Overall Study|Adverse Event|0|||
127555814|NCT03527732|459002561|FG000|Overall Study|Lost to Follow-up|21|||
127555815|NCT03527732|459002562|FG001|Overall Study|Lost to Follow-up|23|||
127555816|NCT03527732|459002563|FG002|Overall Study|Lost to Follow-up|80|||
127555817|NCT03527732|459002564|FG003|Overall Study|Lost to Follow-up|62|||
127555818|NCT03527732|459002565|FG004|Overall Study|Lost to Follow-up|12|||
127555819|NCT03527732|459002566|FG005|Overall Study|Lost to Follow-up|20|||
127555820|NCT02280408|459002567|FG000|Overall Study|Lost to Follow-up|0|||
127555821|NCT02280408|459002568|FG001|Overall Study|Lost to Follow-up|2|||
127555822|NCT02280408|459002569|FG002|Overall Study|Lost to Follow-up|0|||
127555823|NCT02280408|459002570|FG003|Overall Study|Lost to Follow-up|0|||
127555824|NCT01092117|459002571|FG000|Index Procedure to 1 Month|Death|1|||
127555825|NCT01092117|459002571|FG000|1 Month|Death|1|||
127555826|NCT01092117|459002571|FG000|1 Month|Withdrawal by Subject|1|||
127555827|NCT01092117|459002571|FG000|1 Month|Lost to Follow-up|1|||
127555828|NCT01092117|459002571|FG000|6 Months|Death|2|||
127555829|NCT01092117|459002571|FG000|6 Months|Withdrawal by Subject|3|||
127555830|NCT01092117|459002571|FG000|12 Month|Death|11|||
127555831|NCT01092117|459002571|FG000|12 Month|Withdrawal by Subject|2|||
127555832|NCT01092117|459002571|FG000|12 Month|Lost to Follow-up|1|||
127555833|NCT01092117|459002571|FG000|Year 2|Death|5|||
127555834|NCT01092117|459002571|FG000|Year 2|Withdrawal by Subject|4|||
127555835|NCT01092117|459002571|FG000|Year 2|Lost to Follow-up|1|||
127555836|NCT01092117|459002571|FG000|Year 3|Death|7|||
127555837|NCT01092117|459002571|FG000|Year 3|Withdrawal by Subject|9|||
127555838|NCT01092117|459002571|FG000|Year 3|Lost to Follow-up|3|||
127555839|NCT01092117|459002571|FG000|Year 4|Death|8|||
127555840|NCT01092117|459002571|FG000|Year 4|Withdrawal by Subject|4|||
127555841|NCT01092117|459002571|FG000|Year 4|Lost to Follow-up|4|||
127555842|NCT03710083|459002572|FG000|Overall Study|Withdrawal by Subject|2|||
127555843|NCT03710083|459002572|FG000|Overall Study|Unsuccessful Procedure|1|||
127555844|NCT05300763|459002573|FG000|Overall Study|Adverse Event|0|||
127555845|NCT05300763|459002574|FG001|Overall Study|Adverse Event|1|||
127555846|NCT05300763|459002573|FG000|Overall Study|Major Protocol Deviation|1|||
127555847|NCT05300763|459002574|FG001|Overall Study|Major Protocol Deviation|0|||
127555848|NCT05300763|459002573|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
127555849|NCT05300763|459002574|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
127555850|NCT03801031|459002576|FG000|Overall Study|Lost to Follow-up|1|||
127555851|NCT03801031|459002577|FG001|Overall Study|Lost to Follow-up|0|||
127555852|NCT03801031|459002576|FG000|Overall Study|Unable to comply|1|||
127555853|NCT03801031|459002577|FG001|Overall Study|Unable to comply|0|||
127555854|NCT03801031|459002576|FG000|Overall Study|Withdrawal by Subject|0|||
127555855|NCT03801031|459002577|FG001|Overall Study|Withdrawal by Subject|1|||
127555856|NCT02948088|459002578|FG000|Overall Study|Lost to Follow-up|8|||
127555857|NCT02948088|459002578|FG000|Overall Study|Death|1|||
127555858|NCT02948088|459002578|FG000|Overall Study|Withdrawal by Subject|4|||
127555859|NCT02948088|459002578|FG000|Overall Study|Other|2|||
127555860|NCT01409811|459002579|FG000|Overall Study|Insurance denial|1|||
127555861|NCT01942733|459002580|FG000|Overall Study|Lost to Follow-up|1|||
127555862|NCT01942733|459002580|FG000|Overall Study|Non-compliance with IMP|1|||
127555863|NCT01942733|459002580|FG000|Overall Study|Administrative|1|||
127555864|NCT00634101|459002581|FG000|Overall Study|Study Terminated|3|||
127555865|NCT00634101|459002582|FG001|Overall Study|Study Terminated|3|||
127555866|NCT00634101|459002581|FG000|Overall Study|Lost to Follow-up|2|||
127555867|NCT00634101|459002582|FG001|Overall Study|Lost to Follow-up|0|||
127555868|NCT01077076|459002586|FG000|First Intervention|Withdrawal by Subject|1|||
127555869|NCT01077076|459002587|FG001|First Intervention|Withdrawal by Subject|0|||
127774215|NCT01256658|459800282|FG001|Period 1|Withdrawal by Subject|43|||
127774216|NCT01256658|459800281|FG000|Period 1|Death|48|||
127555870|NCT01077076|459002588|FG002|First Intervention|Withdrawal by Subject|0|||
127555871|NCT01077076|459002589|FG003|First Intervention|Withdrawal by Subject|0|||
127774217|NCT01256658|459800282|FG001|Period 1|Death|44|||
127555872|NCT01077076|459002590|FG004|First Intervention|Withdrawal by Subject|0|||
127555873|NCT01077076|459002591|FG005|First Intervention|Withdrawal by Subject|0|||
127555874|NCT01077076|459002586|FG000|Third Intervention|Death in the participant's family|0|||
127555875|NCT01077076|459002587|FG001|Third Intervention|Death in the participant's family|0|||
127555876|NCT01077076|459002588|FG002|Third Intervention|Death in the participant's family|0|||
127555877|NCT01077076|459002589|FG003|Third Intervention|Death in the participant's family|0|||
127555878|NCT01077076|459002590|FG004|Third Intervention|Death in the participant's family|0|||
127555879|NCT01077076|459002591|FG005|Third Intervention|Death in the participant's family|1|||
127555880|NCT02100696|459002593|FG000|Induction Phase|Adverse Event|0|||
127555881|NCT02100696|459002594|FG001|Induction Phase|Adverse Event|0|||
127555882|NCT02100696|459002595|FG002|Induction Phase|Adverse Event|1|||
127555883|NCT02100696|459002596|FG003|Induction Phase|Adverse Event|0|||
127774218|NCT02525861|459800288|FG000|Overall Study|Adverse Event|1|||
127555884|NCT02100696|459002597|FG004|Induction Phase|Adverse Event|0|||
127555885|NCT02100696|459002598|FG005|Induction Phase|Adverse Event|0|||
127555886|NCT02100696|459002593|FG000|Induction Phase|Lost to Follow-up|1|||
127555887|NCT02100696|459002594|FG001|Induction Phase|Lost to Follow-up|0|||
127555888|NCT02100696|459002595|FG002|Induction Phase|Lost to Follow-up|1|||
127555889|NCT02100696|459002596|FG003|Induction Phase|Lost to Follow-up|0|||
127555890|NCT02100696|459002597|FG004|Induction Phase|Lost to Follow-up|0|||
127555891|NCT02100696|459002598|FG005|Induction Phase|Lost to Follow-up|0|||
127555892|NCT02100696|459002593|FG000|Induction Phase|Protocol Violation|0|||
127555893|NCT02100696|459002594|FG001|Induction Phase|Protocol Violation|1|||
127555894|NCT02100696|459002595|FG002|Induction Phase|Protocol Violation|1|||
127555895|NCT02100696|459002596|FG003|Induction Phase|Protocol Violation|0|||
127555896|NCT02100696|459002597|FG004|Induction Phase|Protocol Violation|0|||
127555897|NCT02100696|459002598|FG005|Induction Phase|Protocol Violation|0|||
127555898|NCT02100696|459002593|FG000|Induction Phase|Withdrawal by Subject|8|||
127555899|NCT02100696|459002594|FG001|Induction Phase|Withdrawal by Subject|2|||
127555900|NCT02100696|459002595|FG002|Induction Phase|Withdrawal by Subject|13|||
127555901|NCT02100696|459002596|FG003|Induction Phase|Withdrawal by Subject|0|||
127555902|NCT02100696|459002597|FG004|Induction Phase|Withdrawal by Subject|0|||
127555903|NCT02100696|459002598|FG005|Induction Phase|Withdrawal by Subject|0|||
127555904|NCT02100696|459002593|FG000|Induction Phase|Physician Decision|1|||
127555905|NCT02100696|459002594|FG001|Induction Phase|Physician Decision|0|||
127555906|NCT02100696|459002595|FG002|Induction Phase|Physician Decision|2|||
127555907|NCT02100696|459002596|FG003|Induction Phase|Physician Decision|0|||
127555908|NCT02100696|459002597|FG004|Induction Phase|Physician Decision|0|||
127555909|NCT02100696|459002598|FG005|Induction Phase|Physician Decision|0|||
127555910|NCT02100696|459002593|FG000|Induction Phase|Multiple Reasons|5|||
127555911|NCT02100696|459002594|FG001|Induction Phase|Multiple Reasons|2|||
127555912|NCT02100696|459002595|FG002|Induction Phase|Multiple Reasons|8|||
127555913|NCT02100696|459002596|FG003|Induction Phase|Multiple Reasons|0|||
127555914|NCT02100696|459002597|FG004|Induction Phase|Multiple Reasons|0|||
127555915|NCT02100696|459002598|FG005|Induction Phase|Multiple Reasons|0|||
127555916|NCT02100696|459002593|FG000|Maintenance Phase|Adverse Event|0|||
127555917|NCT02100696|459002594|FG001|Maintenance Phase|Adverse Event|0|||
127555918|NCT02100696|459002595|FG002|Maintenance Phase|Adverse Event|0|||
127555919|NCT02100696|459002596|FG003|Maintenance Phase|Adverse Event|0|||
127555920|NCT02100696|459002597|FG004|Maintenance Phase|Adverse Event|0|||
127555921|NCT02100696|459002598|FG005|Maintenance Phase|Adverse Event|2|||
127555922|NCT02100696|459002593|FG000|Maintenance Phase|Lost to Follow-up|0|||
127555923|NCT02100696|459002594|FG001|Maintenance Phase|Lost to Follow-up|0|||
127555924|NCT02100696|459002595|FG002|Maintenance Phase|Lost to Follow-up|0|||
127555925|NCT02100696|459002596|FG003|Maintenance Phase|Lost to Follow-up|0|||
127555926|NCT02100696|459002597|FG004|Maintenance Phase|Lost to Follow-up|1|||
127555927|NCT02100696|459002598|FG005|Maintenance Phase|Lost to Follow-up|0|||
127555928|NCT02100696|459002593|FG000|Maintenance Phase|Protocol Violation|0|||
127555929|NCT02100696|459002594|FG001|Maintenance Phase|Protocol Violation|0|||
127685669|NCT04623008|459476311|FG000|Baseline to T3|Withdrawal by Subject|4|||
127685670|NCT04623008|459476312|FG001|Baseline to T3|Withdrawal by Subject|2|||
128021467|NCT04270760|460702917|FG004|Overall Study|Death|1|||
128021468|NCT02070991|460702918|FG000|Overall Study|Death|2|||
128021469|NCT02070991|460702919|FG001|Overall Study|Death|0|||
128021470|NCT02070991|460702918|FG000|Overall Study|Withdrawal by Subject|1|||
128021471|NCT02070991|460702919|FG001|Overall Study|Withdrawal by Subject|0|||
128021472|NCT02421510|460702920|FG000|Overall Study|Other|4|||
128021473|NCT02421510|460702921|FG001|Overall Study|Other|2|||
128021474|NCT02421510|460702922|FG002|Overall Study|Other|3|||
127555930|NCT02100696|459002595|FG002|Maintenance Phase|Protocol Violation|0|||
127555931|NCT02100696|459002596|FG003|Maintenance Phase|Protocol Violation|0|||
127555932|NCT02100696|459002597|FG004|Maintenance Phase|Protocol Violation|1|||
127685671|NCT03785782|459476322|FG000|Overall Study|their lesions' were not suitable for the study criteria|2|||
127685672|NCT03785782|459476323|FG001|Overall Study|their lesions' were not suitable for the study criteria|0|||
127685673|NCT03785782|459476322|FG000|Overall Study|Withdrawal by Subject|1|||
127685674|NCT03785782|459476323|FG001|Overall Study|Withdrawal by Subject|1|||
127685675|NCT03785782|459476322|FG000|Overall Study|insufficient image quality.|3|||
127685676|NCT03785782|459476323|FG001|Overall Study|insufficient image quality.|0|||
127685677|NCT03779048|459476324|FG000|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|8|||
127685678|NCT03779048|459476325|FG001|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
127685679|NCT03779048|459476326|FG002|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
127685680|NCT03779048|459476324|FG000|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|5|||
127705200|NCT01928394|459551580|FG013|Treatment Period|Lost to Follow-up|0|||
128021475|NCT02421510|460702920|FG000|Overall Study|Protocol Violation|1|||
128021476|NCT02421510|460702921|FG001|Overall Study|Protocol Violation|2|||
127555933|NCT02100696|459002598|FG005|Maintenance Phase|Protocol Violation|0|||
127555934|NCT02100696|459002593|FG000|Maintenance Phase|Withdrawal by Subject|0|||
127555935|NCT02100696|459002594|FG001|Maintenance Phase|Withdrawal by Subject|0|||
127555936|NCT02100696|459002595|FG002|Maintenance Phase|Withdrawal by Subject|0|||
127555937|NCT02100696|459002596|FG003|Maintenance Phase|Withdrawal by Subject|1|||
127555938|NCT02100696|459002597|FG004|Maintenance Phase|Withdrawal by Subject|4|||
127555939|NCT02100696|459002598|FG005|Maintenance Phase|Withdrawal by Subject|2|||
127555940|NCT02100696|459002593|FG000|Maintenance Phase|Physician Decision|0|||
127555941|NCT02100696|459002594|FG001|Maintenance Phase|Physician Decision|0|||
127555942|NCT02100696|459002595|FG002|Maintenance Phase|Physician Decision|0|||
127555943|NCT02100696|459002596|FG003|Maintenance Phase|Physician Decision|0|||
127555944|NCT02100696|459002597|FG004|Maintenance Phase|Physician Decision|1|||
127555945|NCT02100696|459002598|FG005|Maintenance Phase|Physician Decision|0|||
127555946|NCT02100696|459002593|FG000|Maintenance Phase|Multiple Reasons|0|||
127555947|NCT02100696|459002594|FG001|Maintenance Phase|Multiple Reasons|0|||
127555948|NCT02100696|459002595|FG002|Maintenance Phase|Multiple Reasons|0|||
127555949|NCT02100696|459002596|FG003|Maintenance Phase|Multiple Reasons|0|||
127555950|NCT02100696|459002597|FG004|Maintenance Phase|Multiple Reasons|2|||
127555951|NCT02100696|459002598|FG005|Maintenance Phase|Multiple Reasons|1|||
127555952|NCT02260180|459004063|FG000|Overall Study|Adverse Event|2|||
127555953|NCT02260180|459004064|FG001|Overall Study|Adverse Event|0|||
127555954|NCT02260180|459004065|FG002|Overall Study|Adverse Event|1|||
127555955|NCT03860818|459004069|FG000|Overall Study|Death|144|||
127555956|NCT03860818|459004070|FG001|Overall Study|Death|195|||
127555957|NCT03860818|459004069|FG000|Overall Study|Graft Loss|32|||
127555958|NCT03860818|459004070|FG001|Overall Study|Graft Loss|45|||
127555959|NCT03126344|459004071|FG000|Overall Study|Lost to Follow-up|0|||
127555960|NCT03126344|459004072|FG001|Overall Study|Lost to Follow-up|0|||
127555961|NCT03126344|459004073|FG002|Overall Study|Lost to Follow-up|5|||
127555962|NCT01139008|459004074|FG000|Overall Study|Withdrawal by Subject|5|||
127555963|NCT01139008|459004074|FG000|Overall Study|Non-compliant, lost product|1|||
127555964|NCT01715857|459004075|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
127555965|NCT00505778|459004079|FG000|Overall Study|Adverse Event|2|||
127555966|NCT00505778|459004080|FG001|Overall Study|Adverse Event|7|||
127555967|NCT00505778|459004079|FG000|Overall Study|Physician Decision|8|||
127555968|NCT00505778|459004080|FG001|Overall Study|Physician Decision|14|||
127555969|NCT00505778|459004079|FG000|Overall Study|Lost to Follow-up|17|||
127555970|NCT00505778|459004080|FG001|Overall Study|Lost to Follow-up|23|||
127555971|NCT00505778|459004079|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
127555972|NCT00505778|459004080|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
127555973|NCT00505778|459004079|FG000|Overall Study|Protocol Violation|7|||
127555974|NCT00505778|459004080|FG001|Overall Study|Protocol Violation|9|||
127555975|NCT00505778|459004079|FG000|Overall Study|Withdrawal by Subject|29|||
127555976|NCT00505778|459004080|FG001|Overall Study|Withdrawal by Subject|14|||
127555977|NCT00505778|459004079|FG000|Overall Study|Relapse|65|||
127555978|NCT00505778|459004080|FG001|Overall Study|Relapse|65|||
127555979|NCT00505778|459004079|FG000|Overall Study|Took No Study Drug|2|||
127555980|NCT00505778|459004080|FG001|Overall Study|Took No Study Drug|2|||
127555981|NCT05367492|459004082|FG000|Study Intervention (Week 12)|Withdrawal by Subject|0|||
127555982|NCT05367492|459004083|FG001|Study Intervention (Week 12)|Withdrawal by Subject|2|||
127555983|NCT05367492|459004084|FG002|Study Intervention (Week 12)|Withdrawal by Subject|0|||
127555984|NCT05367492|459004082|FG000|Study Intervention (Week 12)|Lost to Follow-up|0|||
127555985|NCT05367492|459004083|FG001|Study Intervention (Week 12)|Lost to Follow-up|2|||
127555986|NCT05367492|459004084|FG002|Study Intervention (Week 12)|Lost to Follow-up|1|||
127555987|NCT05367492|459004082|FG000|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
127555988|NCT05367492|459004083|FG001|Study Follow Up (Week 24)|Withdrawal by Subject|1|||
127555989|NCT05367492|459004084|FG002|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
127555990|NCT05367492|459004082|FG000|Study Follow Up (Week 24)|Lost to Follow-up|0|||
127555991|NCT05367492|459004083|FG001|Study Follow Up (Week 24)|Lost to Follow-up|1|||
127555992|NCT05367492|459004084|FG002|Study Follow Up (Week 24)|Lost to Follow-up|0|||
127555993|NCT00423917|459004088|FG000|Overall Study|Cancel|2|||
127555994|NCT00423917|459004088|FG000|Overall Study|Ineligible|1|||
127555995|NCT01175083|459004091|FG000|Primary Epoch|Withdrawal by Subject|0|||
127555996|NCT01175083|459004092|FG001|Primary Epoch|Withdrawal by Subject|0|||
127555997|NCT01175083|459004093|FG002|Primary Epoch|Withdrawal by Subject|0|||
127555998|NCT01175083|459004094|FG003|Primary Epoch|Withdrawal by Subject|0|||
127555999|NCT01175083|459004095|FG004|Primary Epoch|Withdrawal by Subject|0|||
127556000|NCT01175083|459004096|FG005|Primary Epoch|Withdrawal by Subject|2|||
127556001|NCT01175083|459004091|FG000|Primary Epoch|Lost to Follow-up|0|||
127556002|NCT01175083|459004092|FG001|Primary Epoch|Lost to Follow-up|0|||
127556003|NCT01175083|459004093|FG002|Primary Epoch|Lost to Follow-up|0|||
127556004|NCT01175083|459004094|FG003|Primary Epoch|Lost to Follow-up|0|||
127556005|NCT01175083|459004095|FG004|Primary Epoch|Lost to Follow-up|0|||
127556006|NCT01175083|459004096|FG005|Primary Epoch|Lost to Follow-up|1|||
127556007|NCT01175083|459004091|FG000|Booster Epoch|Death|0|||
127556008|NCT01175083|459004092|FG001|Booster Epoch|Death|0|||
127556009|NCT01175083|459004093|FG002|Booster Epoch|Death|1|||
127556010|NCT01175083|459004094|FG003|Booster Epoch|Death|0|||
127556011|NCT01175083|459004095|FG004|Booster Epoch|Death|0|||
127556012|NCT01175083|459004096|FG005|Booster Epoch|Death|0|||
127556013|NCT01175083|459004091|FG000|Booster Epoch|Withdrawal by Subject|0|||
127556014|NCT01175083|459004092|FG001|Booster Epoch|Withdrawal by Subject|0|||
127556015|NCT01175083|459004093|FG002|Booster Epoch|Withdrawal by Subject|0|||
127556016|NCT01175083|459004094|FG003|Booster Epoch|Withdrawal by Subject|1|||
127556017|NCT01175083|459004095|FG004|Booster Epoch|Withdrawal by Subject|0|||
127556018|NCT01175083|459004096|FG005|Booster Epoch|Withdrawal by Subject|0|||
127556019|NCT00475306|459004097|FG000|Overall Study|Protocol Violation|1|||
127556020|NCT00475306|459004098|FG001|Overall Study|Protocol Violation|1|||
127556021|NCT00475306|459004099|FG002|Overall Study|Protocol Violation|0|||
127556022|NCT00475306|459004100|FG003|Overall Study|Protocol Violation|1|||
127556023|NCT01716052|459004101|FG000|Overall Study|Withdrawal of funding|1|||
127556024|NCT01716052|459004102|FG001|Overall Study|Withdrawal of funding|1|||
127556025|NCT02405442|459004103|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
127556026|NCT02405442|459004104|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
127556027|NCT02405442|459004105|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
127556028|NCT02405442|459004106|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
127556029|NCT02405442|459004103|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
127556030|NCT02405442|459004104|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
127556031|NCT02405442|459004105|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
127556032|NCT02405442|459004106|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
127556033|NCT02405442|459004103|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
127556034|NCT02405442|459004104|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
127556035|NCT02405442|459004105|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
127556036|NCT02405442|459004106|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
127556037|NCT02405442|459004103|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
127556038|NCT02405442|459004104|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
127556039|NCT02405442|459004105|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
127556040|NCT02405442|459004106|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
127556041|NCT02405442|459004103|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
127556042|NCT02405442|459004104|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
127556043|NCT02405442|459004105|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
127556044|NCT02405442|459004106|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
127556045|NCT02405442|459004103|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
127556046|NCT02405442|459004104|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
127556047|NCT02405442|459004105|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
127556048|NCT02405442|459004106|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
127556049|NCT02405442|459004103|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
127556050|NCT02405442|459004104|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
127556051|NCT02405442|459004105|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
127556052|NCT02405442|459004106|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
127556053|NCT02405442|459004103|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
127556054|NCT02405442|459004104|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
127556055|NCT02405442|459004105|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
127556056|NCT02405442|459004106|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
127556057|NCT02405442|459004103|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
127556058|NCT02405442|459004104|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
127556059|NCT02405442|459004105|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
127556060|NCT02405442|459004106|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
128021477|NCT02421510|460702922|FG002|Overall Study|Protocol Violation|0|||
127556061|NCT02405442|459004103|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
127556062|NCT02405442|459004104|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
127556063|NCT02405442|459004105|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
127556064|NCT02405442|459004106|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
127556065|NCT02405442|459004103|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
127556066|NCT02405442|459004104|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
127556067|NCT02405442|459004105|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
128021478|NCT02421510|460702920|FG000|Overall Study|Death|1|||
127556068|NCT02405442|459004106|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
127556069|NCT02405442|459004103|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
127556070|NCT02405442|459004104|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
127556071|NCT02405442|459004105|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
127556072|NCT02405442|459004106|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
127556073|NCT02405442|459004103|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
127556074|NCT02405442|459004104|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
127556075|NCT02405442|459004105|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
127556076|NCT02405442|459004106|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
127556077|NCT02405442|459004103|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
127556078|NCT02405442|459004104|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
127556079|NCT02405442|459004105|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
127556080|NCT02405442|459004106|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
127556081|NCT03275350|459004108|FG000|Overall Study|Lost to Follow-up|4|||
127556082|NCT03275350|459004109|FG001|Overall Study|Lost to Follow-up|6|||
127556083|NCT03275350|459004108|FG000|Overall Study|Death|2|||
127556084|NCT03275350|459004109|FG001|Overall Study|Death|1|||
127556085|NCT03275350|459004108|FG000|Overall Study|Physician Decision|1|||
127556086|NCT03275350|459004109|FG001|Overall Study|Physician Decision|0|||
127556087|NCT03275350|459004108|FG000|Overall Study|Incarcerated|1|||
127556088|NCT03275350|459004109|FG001|Overall Study|Incarcerated|1|||
127556089|NCT00578292|459004110|FG000|Overall Study|Death|1|||
127556090|NCT00578292|459004110|FG000|Overall Study|Graft failure|2|||
127556091|NCT00856518|459004114|FG000|Overall Study|Lost to Follow-up|4|||
127556092|NCT00856518|459004115|FG001|Overall Study|Lost to Follow-up|2|||
127556093|NCT04849559|459004116|FG000|Overall Study|Withdrawal by Subject|2|||
127556094|NCT04849559|459004117|FG001|Overall Study|Withdrawal by Subject|1|||
127556095|NCT00947193|459004118|FG000|Overall Study|Lost to Follow-up|1|||
127556096|NCT00947193|459004119|FG001|Overall Study|Lost to Follow-up|0|||
127556097|NCT00947193|459004118|FG000|Overall Study|Withdrawal by Subject|1|||
127556098|NCT00947193|459004119|FG001|Overall Study|Withdrawal by Subject|0|||
127556099|NCT00947193|459004118|FG000|Overall Study|Factor VIII >1%|1|||
127556100|NCT00947193|459004119|FG001|Overall Study|Factor VIII >1%|0|||
127556101|NCT00926029|459004120|FG000|Overall Study|Lost to Follow-up|2|||
127556102|NCT00926029|459004121|FG001|Overall Study|Lost to Follow-up|1|||
127556103|NCT00926029|459004122|FG002|Overall Study|Lost to Follow-up|1|||
127556104|NCT02105961|459004123|FG000|Overall Study|Adverse Event|18|||
127556105|NCT02105961|459004124|FG001|Overall Study|Adverse Event|7|||
127556106|NCT02105961|459004125|FG002|Overall Study|Adverse Event|13|||
127556107|NCT02105961|459004123|FG000|Overall Study|Lack of Efficacy|3|||
127556108|NCT02105961|459004124|FG001|Overall Study|Lack of Efficacy|0|||
127556109|NCT02105961|459004125|FG002|Overall Study|Lack of Efficacy|3|||
127556110|NCT02105961|459004123|FG000|Overall Study|Lost to Follow-up|2|||
127556111|NCT02105961|459004124|FG001|Overall Study|Lost to Follow-up|0|||
127556112|NCT02105961|459004125|FG002|Overall Study|Lost to Follow-up|1|||
127556113|NCT02105961|459004123|FG000|Overall Study|Physician Decision|3|||
127556114|NCT02105961|459004124|FG001|Overall Study|Physician Decision|3|||
127556115|NCT02105961|459004125|FG002|Overall Study|Physician Decision|2|||
127556116|NCT02105961|459004123|FG000|Overall Study|Withdrawal by Subject|15|||
127556117|NCT02105961|459004124|FG001|Overall Study|Withdrawal by Subject|7|||
127556118|NCT02105961|459004125|FG002|Overall Study|Withdrawal by Subject|11|||
127556119|NCT04154189|459004128|FG000|Overall Study|Withdrawal by Subject|4|||
127556120|NCT04154189|459004129|FG001|Overall Study|Withdrawal by Subject|6|||
127556121|NCT04154189|459004128|FG000|Overall Study|Survival follow-up discontinued by sponsor|8|||
127556122|NCT04154189|459004129|FG001|Overall Study|Survival follow-up discontinued by sponsor|10|||
127556123|NCT04154189|459004128|FG000|Overall Study|Participants transitioned to patient access program (PAP)|1|||
127556124|NCT04154189|459004129|FG001|Overall Study|Participants transitioned to patient access program (PAP)|0|||
127556125|NCT04154189|459004128|FG000|Overall Study|Participants transitioned to managed access program (MAP)|2|||
127556126|NCT04154189|459004129|FG001|Overall Study|Participants transitioned to managed access program (MAP)|0|||
127556127|NCT04154189|459004128|FG000|Overall Study|Death|25|||
127556128|NCT04154189|459004129|FG001|Overall Study|Death|25|||
127556129|NCT02474069|459004130|FG000|Selection Phase (SP)|Adverse Event|8|||
127556130|NCT02474069|459004131|FG001|Selection Phase (SP)|Adverse Event|0|||
127556131|NCT02474069|459004132|FG002|Selection Phase (SP)|Adverse Event|0|||
127556132|NCT02474069|459004130|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
127556133|NCT02474069|459004131|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
127556134|NCT02474069|459004132|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
127556135|NCT02474069|459004130|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
127556136|NCT02474069|459004131|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
127556137|NCT02474069|459004132|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
127556138|NCT02474069|459004130|FG000|Selection Phase (SP)|Physician Decision|1|||
127556139|NCT02474069|459004131|FG001|Selection Phase (SP)|Physician Decision|0|||
127556140|NCT02474069|459004132|FG002|Selection Phase (SP)|Physician Decision|0|||
127556141|NCT02474069|459004130|FG000|Selection Phase (SP)|Protocol Violation|1|||
127556142|NCT02474069|459004131|FG001|Selection Phase (SP)|Protocol Violation|0|||
127556143|NCT02474069|459004132|FG002|Selection Phase (SP)|Protocol Violation|0|||
127556144|NCT02474069|459004130|FG000|Selection Phase (SP)|No longer requires treatment|1|||
127556145|NCT02474069|459004131|FG001|Selection Phase (SP)|No longer requires treatment|0|||
127556146|NCT02474069|459004132|FG002|Selection Phase (SP)|No longer requires treatment|0|||
127556147|NCT02474069|459004130|FG000|Selection Phase (SP)|Technical Problem|1|||
127556148|NCT02474069|459004131|FG001|Selection Phase (SP)|Technical Problem|0|||
127556149|NCT02474069|459004132|FG002|Selection Phase (SP)|Technical Problem|0|||
127556150|NCT02474069|459004130|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
127556151|NCT02474069|459004131|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
127556152|NCT02474069|459004132|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
127556153|NCT02474069|459004130|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
127774219|NCT02525861|459800289|FG001|Overall Study|Adverse Event|0|||
127774220|NCT02525861|459800288|FG000|Overall Study|Withdrawal by Subject|0|||
127774221|NCT02525861|459800289|FG001|Overall Study|Withdrawal by Subject|1|||
127774222|NCT02525861|459800288|FG000|Overall Study|Physician Decision|0|||
127774223|NCT02525861|459800289|FG001|Overall Study|Physician Decision|1|||
127774224|NCT01794520|459800290|FG000|Overall Study|Adverse events- related to progression|0|||
127774225|NCT01794520|459800291|FG001|Overall Study|Adverse events- related to progression|0|||
127774226|NCT01794520|459800292|FG002|Overall Study|Adverse events- related to progression|1|||
127774227|NCT01794520|459800293|FG003|Overall Study|Adverse events- related to progression|2|||
127774228|NCT01794520|459800294|FG004|Overall Study|Adverse events- related to progression|0|||
127774229|NCT01794520|459800295|FG005|Overall Study|Adverse events- related to progression|1|||
127774230|NCT01794520|459800296|FG006|Overall Study|Adverse events- related to progression|0|||
127774231|NCT01794520|459800290|FG000|Overall Study|Adverse event- not related to progression|1|||
127774232|NCT01794520|459800291|FG001|Overall Study|Adverse event- not related to progression|1|||
127774233|NCT01794520|459800292|FG002|Overall Study|Adverse event- not related to progression|0|||
127774234|NCT01794520|459800293|FG003|Overall Study|Adverse event- not related to progression|0|||
127774235|NCT01794520|459800294|FG004|Overall Study|Adverse event- not related to progression|2|||
127774236|NCT01794520|459800295|FG005|Overall Study|Adverse event- not related to progression|0|||
127774237|NCT01794520|459800296|FG006|Overall Study|Adverse event- not related to progression|0|||
127774238|NCT01794520|459800290|FG000|Overall Study|Progressive disease|5|||
127774239|NCT01794520|459800291|FG001|Overall Study|Progressive disease|6|||
128021479|NCT02421510|460702921|FG001|Overall Study|Death|0|||
128021480|NCT02421510|460702922|FG002|Overall Study|Death|0|||
128021481|NCT02421510|460702920|FG000|Overall Study|Noncompliance with study drug|1|||
128021482|NCT02421510|460702921|FG001|Overall Study|Noncompliance with study drug|0|||
128021483|NCT02421510|460702922|FG002|Overall Study|Noncompliance with study drug|0|||
128021484|NCT02421510|460702920|FG000|Overall Study|Physician Decision|1|||
128021485|NCT02421510|460702921|FG001|Overall Study|Physician Decision|1|||
128021486|NCT02421510|460702922|FG002|Overall Study|Physician Decision|3|||
128021487|NCT02421510|460702920|FG000|Overall Study|Adverse Event|9|||
128021488|NCT02421510|460702921|FG001|Overall Study|Adverse Event|10|||
128021489|NCT02421510|460702922|FG002|Overall Study|Adverse Event|18|||
128021490|NCT02421510|460702920|FG000|Overall Study|Pregnancy|1|||
128021491|NCT02421510|460702921|FG001|Overall Study|Pregnancy|1|||
128021492|NCT02421510|460702922|FG002|Overall Study|Pregnancy|0|||
128021493|NCT02421510|460702920|FG000|Overall Study|Withdrawal by Subject|14|||
128021494|NCT02421510|460702921|FG001|Overall Study|Withdrawal by Subject|18|||
128021495|NCT02421510|460702922|FG002|Overall Study|Withdrawal by Subject|12|||
128021496|NCT02421510|460702920|FG000|Overall Study|Lost to Follow-up|1|||
128021497|NCT02421510|460702921|FG001|Overall Study|Lost to Follow-up|1|||
128021498|NCT02421510|460702922|FG002|Overall Study|Lost to Follow-up|0|||
128021499|NCT00827242|460702923|FG000|Overall Study|Withdrawal by Subject|2|||
128021500|NCT00827242|460702924|FG001|Overall Study|Withdrawal by Subject|4|||
128021501|NCT00827242|460702923|FG000|Overall Study|Protocol Violation|1|||
128021502|NCT00827242|460702924|FG001|Overall Study|Protocol Violation|3|||
128021503|NCT00827242|460702923|FG000|Overall Study|Lost to Follow-up|0|||
128021504|NCT00827242|460702924|FG001|Overall Study|Lost to Follow-up|3|||
128021505|NCT00827242|460702923|FG000|Overall Study|Adverse Event Excluding Death|2|||
128021506|NCT00827242|460702924|FG001|Overall Study|Adverse Event Excluding Death|1|||
128021507|NCT00827242|460702923|FG000|Overall Study|Entry Criteria Not Met|4|||
128021508|NCT00827242|460702924|FG001|Overall Study|Entry Criteria Not Met|1|||
127556154|NCT02474069|459004131|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
128021509|NCT00827242|460702923|FG000|Overall Study|Physician Decision|2|||
128021510|NCT00827242|460702924|FG001|Overall Study|Physician Decision|0|||
128021511|NCT00827242|460702923|FG000|Overall Study|Death|1|||
127556155|NCT02474069|459004132|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
128021512|NCT00827242|460702924|FG001|Overall Study|Death|0|||
128021513|NCT00827242|460702923|FG000|Overall Study|Lack of Efficacy|1|||
128021514|NCT00827242|460702924|FG001|Overall Study|Lack of Efficacy|0|||
128021515|NCT02609633|460702929|FG000|Overall Study|Consent Withdrawn|0|||
128021516|NCT02609633|460702930|FG001|Overall Study|Consent Withdrawn|1|||
127556156|NCT02474069|459004130|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
127556157|NCT02474069|459004131|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
127556158|NCT02474069|459004132|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
127556159|NCT02474069|459004130|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
127556160|NCT02474069|459004131|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
127556161|NCT02474069|459004132|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
127556162|NCT02474069|459004130|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
127556163|NCT02474069|459004131|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
127556164|NCT02474069|459004132|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
127556165|NCT02474069|459004130|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
127556166|NCT02474069|459004131|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
127556167|NCT02474069|459004132|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
127556168|NCT04173494|459004133|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
127556169|NCT04173494|459004134|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
127556170|NCT04173494|459004133|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
127556171|NCT04173494|459004134|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
127556172|NCT04173494|459004133|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
127556173|NCT04173494|459004134|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
127556174|NCT04173494|459004133|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
127556175|NCT04173494|459004134|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
127556176|NCT04173494|459004133|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
127556177|NCT04173494|459004134|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
127556178|NCT04173494|459004133|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
127556179|NCT04173494|459004134|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
127556180|NCT04173494|459004133|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
127556181|NCT04173494|459004134|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
127556182|NCT04173494|459004133|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
127556183|NCT04173494|459004134|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
127556184|NCT04173494|459004133|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
127556185|NCT04173494|459004134|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
127556186|NCT04173494|459004133|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
127556187|NCT04173494|459004134|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
127685681|NCT03779048|459476325|FG001|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
127685682|NCT03779048|459476326|FG002|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
127685683|NCT03779048|459476324|FG000|Phase 2: Randomized Trial|Lost to Follow-up|0|||
127685684|NCT03779048|459476325|FG001|Phase 2: Randomized Trial|Lost to Follow-up|2|||
127685685|NCT03779048|459476326|FG002|Phase 2: Randomized Trial|Lost to Follow-up|2|||
127685686|NCT05777785|459476327|FG000|Overall Study|Withdrawal by Subject|5|||
127685687|NCT05777785|459476327|FG000|Overall Study|Lost to Follow-up|1|||
127685688|NCT04588259|459476329|FG000|Run-in Period|Run-in failure|0|||
127685689|NCT04588259|459476330|FG001|Run-in Period|Run-in failure|23|||
127685690|NCT04588259|459476329|FG000|Run-in Period|Withdrawn before randomisation|0|||
127685691|NCT04588259|459476330|FG001|Run-in Period|Withdrawn before randomisation|8|||
127685692|NCT04588259|459476329|FG000|Treatment Period|Withdrawal by Subject|6|||
127685693|NCT04588259|459476330|FG001|Treatment Period|Withdrawal by Subject|6|||
127685694|NCT00232180|459476336|FG000|Double-blind (DB) Phase|Death|186|||
127685695|NCT00232180|459476337|FG001|Double-blind (DB) Phase|Death|222|||
127685696|NCT00232180|459476338|FG002|Double-blind (DB) Phase|Death|0|||
127685697|NCT00232180|459476336|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
127685698|NCT00232180|459476337|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
127685699|NCT00232180|459476338|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
127685700|NCT00232180|459476336|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
127685701|NCT00232180|459476337|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
127685702|NCT00232180|459476338|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
127685703|NCT00232180|459476336|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
127685704|NCT00232180|459476337|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
127685705|NCT00232180|459476338|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
127685706|NCT00232180|459476336|FG000|Double-blind (DB) Phase|Adverse Event|83|||
127685707|NCT00232180|459476337|FG001|Double-blind (DB) Phase|Adverse Event|100|||
127685708|NCT00232180|459476338|FG002|Double-blind (DB) Phase|Adverse Event|0|||
127685709|NCT00232180|459476336|FG000|Double-blind (DB) Phase|Other|70|||
127685710|NCT00232180|459476337|FG001|Double-blind (DB) Phase|Other|75|||
127685711|NCT00232180|459476338|FG002|Double-blind (DB) Phase|Other|0|||
127685712|NCT00232180|459476336|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
127685713|NCT00232180|459476337|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
127685714|NCT00232180|459476338|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
127685715|NCT00232180|459476336|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
127685716|NCT00232180|459476337|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
127685717|NCT00232180|459476338|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
127685718|NCT00232180|459476336|FG000|Open Label Phase|Death|0|||
127556188|NCT04173494|459004133|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
127556189|NCT04173494|459004134|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
127556190|NCT04173494|459004133|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
127556191|NCT04173494|459004134|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
127556192|NCT04173494|459004133|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
127556193|NCT04173494|459004134|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
127556194|NCT04173494|459004133|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
127556195|NCT04173494|459004134|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
127556196|NCT04173494|459004133|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
127556197|NCT04173494|459004134|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
127556198|NCT04173494|459004133|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
127556199|NCT04173494|459004134|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
127556200|NCT01623050|459004137|FG000|Overall Study|Lost to Follow-up|9|||
127556201|NCT02147561|459004140|FG000|Overall Study|Lost to Follow-up|3|||
127556202|NCT02147561|459004140|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
127556203|NCT01191762|459004141|FG000|Overall Study|Adverse Event|1|||
127556204|NCT01191762|459004142|FG001|Overall Study|Adverse Event|0|||
127556205|NCT00393861|459004145|FG000|Overall Study|Adverse Event|2|||
127556206|NCT00393861|459004145|FG000|Overall Study|Disease Progression|24|||
127556207|NCT00459186|459004146|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
127556208|NCT00459186|459004146|FG000|PET Imaging and Assessment|Adverse Event|3|||
127556209|NCT01485172|459004147|FG000|Overall Study|Adverse Event|2|||
127556210|NCT01485172|459004148|FG001|Overall Study|Adverse Event|1|||
127556211|NCT01485172|459004149|FG002|Overall Study|Adverse Event|2|||
127556212|NCT01485172|459004150|FG003|Overall Study|Adverse Event|2|||
127556213|NCT01485172|459004151|FG004|Overall Study|Adverse Event|1|||
127556214|NCT01485172|459004152|FG005|Overall Study|Adverse Event|2|||
127556215|NCT01485172|459004147|FG000|Overall Study|Lack of Efficacy|2|||
127556216|NCT01485172|459004148|FG001|Overall Study|Lack of Efficacy|0|||
127556217|NCT01485172|459004149|FG002|Overall Study|Lack of Efficacy|0|||
127556218|NCT01485172|459004150|FG003|Overall Study|Lack of Efficacy|0|||
127556219|NCT01485172|459004151|FG004|Overall Study|Lack of Efficacy|0|||
127556220|NCT01485172|459004152|FG005|Overall Study|Lack of Efficacy|0|||
127556221|NCT01485172|459004147|FG000|Overall Study|Protocol Violation|0|||
127556222|NCT01485172|459004148|FG001|Overall Study|Protocol Violation|0|||
127556223|NCT01485172|459004149|FG002|Overall Study|Protocol Violation|4|||
127556224|NCT01485172|459004150|FG003|Overall Study|Protocol Violation|5|||
127556225|NCT01485172|459004151|FG004|Overall Study|Protocol Violation|1|||
127556226|NCT01485172|459004152|FG005|Overall Study|Protocol Violation|0|||
127556227|NCT01485172|459004147|FG000|Overall Study|Protocol defined stopping criteria|1|||
127556228|NCT01485172|459004148|FG001|Overall Study|Protocol defined stopping criteria|0|||
127556229|NCT01485172|459004149|FG002|Overall Study|Protocol defined stopping criteria|0|||
127556230|NCT01485172|459004150|FG003|Overall Study|Protocol defined stopping criteria|0|||
127556231|NCT01485172|459004151|FG004|Overall Study|Protocol defined stopping criteria|1|||
127556232|NCT01485172|459004152|FG005|Overall Study|Protocol defined stopping criteria|0|||
127556233|NCT01485172|459004147|FG000|Overall Study|Lost to Follow-up|0|||
127556234|NCT01485172|459004148|FG001|Overall Study|Lost to Follow-up|0|||
127556235|NCT01485172|459004149|FG002|Overall Study|Lost to Follow-up|1|||
127556236|NCT01485172|459004150|FG003|Overall Study|Lost to Follow-up|0|||
127556237|NCT01485172|459004151|FG004|Overall Study|Lost to Follow-up|0|||
127556238|NCT01485172|459004152|FG005|Overall Study|Lost to Follow-up|1|||
127556239|NCT01485172|459004147|FG000|Overall Study|Physician Decision|0|||
127556240|NCT01485172|459004148|FG001|Overall Study|Physician Decision|0|||
127556241|NCT01485172|459004149|FG002|Overall Study|Physician Decision|0|||
127556242|NCT01485172|459004150|FG003|Overall Study|Physician Decision|0|||
127556243|NCT01485172|459004151|FG004|Overall Study|Physician Decision|1|||
127556244|NCT01485172|459004152|FG005|Overall Study|Physician Decision|0|||
127556245|NCT01485172|459004147|FG000|Overall Study|Withdrawal by Subject|2|||
127556246|NCT01485172|459004148|FG001|Overall Study|Withdrawal by Subject|0|||
127556247|NCT01485172|459004149|FG002|Overall Study|Withdrawal by Subject|0|||
127556248|NCT01485172|459004150|FG003|Overall Study|Withdrawal by Subject|1|||
127556249|NCT01485172|459004151|FG004|Overall Study|Withdrawal by Subject|1|||
127556250|NCT01485172|459004152|FG005|Overall Study|Withdrawal by Subject|1|||
127556251|NCT02283762|459004156|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
127556252|NCT02283762|459004157|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
127556253|NCT02283762|459004156|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
127556254|NCT02283762|459004157|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
127556255|NCT02283762|459004156|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
127556256|NCT02283762|459004157|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
127556257|NCT02283762|459004156|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
127556258|NCT02283762|459004157|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
127556259|NCT02283762|459004156|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
127556260|NCT02283762|459004157|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
127881019|NCT00835068|460186103|FG001|Overall Study|Adverse Event|1|||
127556261|NCT02283762|459004156|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
127556262|NCT02283762|459004157|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
127556263|NCT02283762|459004156|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
127556264|NCT02283762|459004157|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
127556265|NCT02283762|459004156|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
127556266|NCT02283762|459004157|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
127556267|NCT02283762|459004156|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
127556268|NCT02283762|459004157|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
127556269|NCT02283762|459004156|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
127556270|NCT02283762|459004157|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
127556271|NCT02283762|459004156|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
127556272|NCT02283762|459004157|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
127556273|NCT02283762|459004156|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
127556274|NCT02283762|459004157|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
127556275|NCT02920242|459004158|FG000|Overall Study|Withdrawal by Subject|1|||
127556276|NCT02920242|459004159|FG001|Overall Study|Withdrawal by Subject|0|||
127556277|NCT02920242|459004160|FG002|Overall Study|Withdrawal by Subject|1|||
127556278|NCT02920242|459004158|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
127556279|NCT02920242|459004159|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
127556280|NCT02920242|459004160|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
127556281|NCT00202878|459004161|FG000|Overall Study|Death|964|||
127556282|NCT00202878|459004162|FG001|Overall Study|Death|968|||
127556283|NCT00202878|459004161|FG000|Overall Study|Only Vital Status Known|357|||
127556284|NCT00202878|459004162|FG001|Overall Study|Only Vital Status Known|356|||
127556285|NCT00202878|459004161|FG000|Overall Study|Lost to Follow-up|44|||
127556286|NCT00202878|459004162|FG001|Overall Study|Lost to Follow-up|49|||
127556287|NCT00202878|459004161|FG000|Overall Study|Site Closure|39|||
127556288|NCT00202878|459004162|FG001|Overall Study|Site Closure|36|||
127556289|NCT00202878|459004161|FG000|Overall Study|Withdrawal by Subject|795|||
127556290|NCT00202878|459004162|FG001|Overall Study|Withdrawal by Subject|808|||
127556291|NCT01587014|459004163|FG000|Overall Study|Death|2|||
127556292|NCT00838513|459004168|FG000|Screening Period|Screen Failure|3|||
127556293|NCT00838513|459004168|FG000|Extension Treatment Period|Death|1|||
127556294|NCT00838513|459004168|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
127556295|NCT00139477|459004172|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
127556296|NCT00139477|459004173|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
127556297|NCT00139477|459004172|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
127556298|NCT00139477|459004173|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
127556299|NCT00139477|459004172|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
127556300|NCT00139477|459004173|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
127556301|NCT00139477|459004172|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
127556302|NCT00139477|459004173|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
127556303|NCT00139477|459004172|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
127556304|NCT00139477|459004173|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
127556305|NCT00139477|459004172|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
127556306|NCT00139477|459004173|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
127556307|NCT00139477|459004172|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
127556308|NCT00139477|459004173|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
127556309|NCT00573144|459004181|FG000|Overall Study|Withdrawal by Subject|2|||
127556310|NCT00573144|459004182|FG001|Overall Study|Withdrawal by Subject|3|||
127556311|NCT02625909|459004183|FG000|Overall Study|Death|2|||
127556312|NCT02625909|459004184|FG001|Overall Study|Death|0|||
127556313|NCT02625909|459004183|FG000|Overall Study|Lost to Follow-up|3|||
127556314|NCT02625909|459004184|FG001|Overall Study|Lost to Follow-up|5|||
127556315|NCT02625909|459004183|FG000|Overall Study|Lack of Efficacy|9|||
127556316|NCT02625909|459004184|FG001|Overall Study|Lack of Efficacy|2|||
127556317|NCT02625909|459004183|FG000|Overall Study|Reinfection|3|||
127556318|NCT02625909|459004184|FG001|Overall Study|Reinfection|2|||
127556319|NCT02367833|459004185|FG000|Overall Study|Withdrawal by Subject|1|||
127685719|NCT00232180|459476337|FG001|Open Label Phase|Death|0|||
127685720|NCT00232180|459476338|FG002|Open Label Phase|Death|48|||
127685721|NCT00232180|459476336|FG000|Open Label Phase|Lost to Follow-up|0|||
127685722|NCT00232180|459476337|FG001|Open Label Phase|Lost to Follow-up|0|||
127685723|NCT00232180|459476338|FG002|Open Label Phase|Lost to Follow-up|5|||
127685724|NCT00232180|459476336|FG000|Open Label Phase|Protocol Violation|0|||
128021517|NCT02609633|460702929|FG000|Overall Study|Protocol Deviation|1|||
128021518|NCT02609633|460702930|FG001|Overall Study|Protocol Deviation|0|||
128021519|NCT02609633|460702929|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
127556320|NCT02367833|459004186|FG001|Overall Study|Withdrawal by Subject|1|||
127556321|NCT02367833|459004187|FG002|Overall Study|Withdrawal by Subject|0|||
127556322|NCT01976741|459004188|FG000|Overall Study|Withdrawal by Subject|1|||
128021520|NCT02609633|460702930|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
127556323|NCT01976741|459004189|FG001|Overall Study|Withdrawal by Subject|0|||
127556324|NCT01976741|459004190|FG002|Overall Study|Withdrawal by Subject|1|||
127556325|NCT01976741|459004191|FG003|Overall Study|Withdrawal by Subject|1|||
127556326|NCT01976741|459004192|FG004|Overall Study|Withdrawal by Subject|0|||
127556327|NCT01976741|459004193|FG005|Overall Study|Withdrawal by Subject|0|||
127556328|NCT01976741|459004194|FG006|Overall Study|Withdrawal by Subject|1|||
127556329|NCT01976741|459004195|FG007|Overall Study|Withdrawal by Subject|4|||
127556330|NCT01976741|459004196|FG008|Overall Study|Withdrawal by Subject|0|||
127556331|NCT01976741|459004197|FG009|Overall Study|Withdrawal by Subject|0|||
127556332|NCT01976741|459004188|FG000|Overall Study|Adverse Event|0|||
127556333|NCT01976741|459004189|FG001|Overall Study|Adverse Event|0|||
127556334|NCT01976741|459004190|FG002|Overall Study|Adverse Event|2|||
127556335|NCT01976741|459004191|FG003|Overall Study|Adverse Event|0|||
127556336|NCT01976741|459004192|FG004|Overall Study|Adverse Event|0|||
127556337|NCT01976741|459004193|FG005|Overall Study|Adverse Event|0|||
127556338|NCT01976741|459004194|FG006|Overall Study|Adverse Event|3|||
127556339|NCT01976741|459004195|FG007|Overall Study|Adverse Event|8|||
127556340|NCT01976741|459004196|FG008|Overall Study|Adverse Event|1|||
127556341|NCT01976741|459004197|FG009|Overall Study|Adverse Event|4|||
127556342|NCT00670306|459004198|FG000|Overall Study|Adverse Event|8|||
127556343|NCT00670306|459004198|FG000|Overall Study|Lack of Efficacy|10|||
127556344|NCT00670306|459004198|FG000|Overall Study|Withdrawal by Subject|9|||
127556345|NCT00670306|459004198|FG000|Overall Study|Physician Decision|1|||
127556346|NCT00670306|459004198|FG000|Overall Study|Lost to Follow-up|8|||
127556347|NCT00670306|459004198|FG000|Overall Study|incl/excl criterias did not meet|19|||
127556348|NCT05334212|459004199|FG000|Overall Study|Study terminated prematurely|7|||
127556349|NCT01668589|459004200|FG000|Overall Study|Lost to Follow-up|29|||
127556350|NCT01668589|459004201|FG001|Overall Study|Lost to Follow-up|37|||
127556351|NCT01668589|459004202|FG002|Overall Study|Lost to Follow-up|15|||
127556352|NCT01668589|459004203|FG003|Overall Study|Lost to Follow-up|5|||
127556353|NCT01668589|459004200|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
127556354|NCT01668589|459004201|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
127556355|NCT01668589|459004202|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
127556356|NCT01668589|459004203|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
127556357|NCT01668589|459004200|FG000|Overall Study|Death|12|||
127556358|NCT01668589|459004201|FG001|Overall Study|Death|3|||
127556359|NCT01668589|459004202|FG002|Overall Study|Death|2|||
127556360|NCT01668589|459004203|FG003|Overall Study|Death|11|||
127556361|NCT01668589|459004200|FG000|Overall Study|Other|44|||
127556362|NCT01668589|459004201|FG001|Overall Study|Other|10|||
128021521|NCT02609633|460702929|FG000|Overall Study|Reason not Specified|2|||
127556363|NCT01668589|459004202|FG002|Overall Study|Other|7|||
127556364|NCT01668589|459004203|FG003|Overall Study|Other|15|||
127556365|NCT04393454|459004204|FG000|Overall Study|Death|1|||
127556366|NCT04393454|459004204|FG000|Overall Study|Lost to Follow-up|1|||
127556367|NCT03304249|459004206|FG000|Overall Study|Lost to Follow-up|8|||
127685725|NCT00232180|459476337|FG001|Open Label Phase|Protocol Violation|0|||
127685726|NCT00232180|459476338|FG002|Open Label Phase|Protocol Violation|3|||
127685727|NCT00232180|459476336|FG000|Open Label Phase|Study terminated by sponsor|0|||
127685728|NCT00232180|459476337|FG001|Open Label Phase|Study terminated by sponsor|0|||
127685729|NCT00232180|459476338|FG002|Open Label Phase|Study terminated by sponsor|3|||
127685730|NCT00232180|459476336|FG000|Open Label Phase|Withdrawal by Subject|0|||
127685731|NCT00232180|459476337|FG001|Open Label Phase|Withdrawal by Subject|0|||
127685732|NCT00232180|459476338|FG002|Open Label Phase|Withdrawal by Subject|37|||
127685733|NCT00232180|459476336|FG000|Open Label Phase|Other|0|||
127685734|NCT00232180|459476337|FG001|Open Label Phase|Other|0|||
127685735|NCT00232180|459476338|FG002|Open Label Phase|Other|16|||
127685736|NCT00232180|459476336|FG000|Open Label Phase|Adverse Event|0|||
127685737|NCT00232180|459476337|FG001|Open Label Phase|Adverse Event|0|||
127685738|NCT00232180|459476338|FG002|Open Label Phase|Adverse Event|25|||
127685739|NCT00232180|459476336|FG000|Open Label Phase|Laboratory abnormality|0|||
127685740|NCT00232180|459476337|FG001|Open Label Phase|Laboratory abnormality|0|||
127685741|NCT00232180|459476338|FG002|Open Label Phase|Laboratory abnormality|10|||
127685742|NCT00232180|459476336|FG000|Open Label Phase|Randomized but not treated|0|||
127685743|NCT00232180|459476337|FG001|Open Label Phase|Randomized but not treated|0|||
127685744|NCT00232180|459476338|FG002|Open Label Phase|Randomized but not treated|1|||
127685745|NCT03452189|459476339|FG000|First Intervention (3 Months)|Adverse Event|1|||
127685746|NCT03452189|459476340|FG001|First Intervention (3 Months)|Adverse Event|0|||
127685747|NCT03452189|459476339|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
128021522|NCT02609633|460702930|FG001|Overall Study|Reason not Specified|1|||
127685748|NCT03452189|459476340|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
127685749|NCT01571596|459476349|FG000|Overall Study|Adverse Event|2|||
127685750|NCT01571596|459476350|FG001|Overall Study|Adverse Event|0|||
128021523|NCT00899847|460702931|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
128021524|NCT05987540|460702932|FG000|Overall Study|Withdrawal by Subject|2|||
127556368|NCT03304249|459004207|FG001|Overall Study|Lost to Follow-up|10|||
127556369|NCT03304249|459004206|FG000|Overall Study|Withdrawal by Subject|12|||
128021525|NCT05987540|460702932|FG000|Overall Study|Death|1|||
128021526|NCT05987540|460702932|FG000|Overall Study|Study Termination|1|||
128021527|NCT05987540|460702932|FG000|Overall Study|Adverse Event|2|||
128021528|NCT00471107|460702933|FG000|Overall Study|Technical problems/data loss|3|||
128021529|NCT00471107|460702934|FG001|Overall Study|Technical problems/data loss|1|||
128021530|NCT00471107|460702935|FG002|Overall Study|Technical problems/data loss|3|||
128021531|NCT01769443|460702936|FG000|Overall Study|Study closure|1|||
128021532|NCT01769443|460702937|FG001|Overall Study|Study closure|0|||
128021533|NCT04996264|460702938|FG000|Overall Study|Lost to Follow-up|0|||
128021534|NCT04996264|460702939|FG001|Overall Study|Lost to Follow-up|1|||
128021535|NCT04996264|460702938|FG000|Overall Study|Withdrawal by Subject|4|||
128021536|NCT04996264|460702939|FG001|Overall Study|Withdrawal by Subject|3|||
128021537|NCT04996264|460702938|FG000|Overall Study|1 left AMA|0|||
128021538|NCT04996264|460702939|FG001|Overall Study|1 left AMA|1|||
128021539|NCT04996264|460702938|FG000|Overall Study|Subject changed hospitals|0|||
128021540|NCT04996264|460702939|FG001|Overall Study|Subject changed hospitals|1|||
128021541|NCT04996264|460702938|FG000|Overall Study|unable to complete due to work|0|||
128021542|NCT04996264|460702939|FG001|Overall Study|unable to complete due to work|1|||
128021543|NCT01279200|460702942|FG000|Overall Study|Withdrawal by Subject|1|||
128021544|NCT01279200|460702943|FG001|Overall Study|Withdrawal by Subject|3|||
128021545|NCT01279200|460702942|FG000|Overall Study|Patient withdrawal due to high cost|0|||
128021546|NCT01279200|460702943|FG001|Overall Study|Patient withdrawal due to high cost|1|||
128021547|NCT01279200|460702942|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
128021548|NCT01279200|460702943|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
128021549|NCT01279200|460702942|FG000|Overall Study|ultrasound screening failure|0|||
128021550|NCT01279200|460702943|FG001|Overall Study|ultrasound screening failure|1|||
128021551|NCT01279200|460702942|FG000|Overall Study|Lost to Follow-up|0|||
128021552|NCT01279200|460702943|FG001|Overall Study|Lost to Follow-up|1|||
128021553|NCT01279200|460702942|FG000|Overall Study|Adverse Event|1|||
128021554|NCT01279200|460702943|FG001|Overall Study|Adverse Event|0|||
128021555|NCT01149538|460702944|FG000|Overall Study|Lost to Follow-up|0|||
128021556|NCT01149538|460702945|FG001|Overall Study|Lost to Follow-up|1|||
128021557|NCT01149538|460702944|FG000|Overall Study|Withdrawal by Subject|5|||
128021558|NCT01149538|460702945|FG001|Overall Study|Withdrawal by Subject|3|||
128021559|NCT00888849|460702946|FG000|Overall Study|Death|4|||
128021560|NCT00888849|460702947|FG001|Overall Study|Death|7|||
128021561|NCT00888849|460702946|FG000|Overall Study|Lost to Follow-up|1|||
128021562|NCT00888849|460702947|FG001|Overall Study|Lost to Follow-up|2|||
128021563|NCT02697422|460702954|FG000|Overall Study|Declined exit survey|9|||
128021564|NCT02697422|460702955|FG001|Overall Study|Declined exit survey|2|||
128021565|NCT02697422|460702954|FG000|Overall Study|Lost to Follow-up|13|||
128021566|NCT02697422|460702955|FG001|Overall Study|Lost to Follow-up|8|||
128021567|NCT02697422|460702954|FG000|Overall Study|Death|2|||
128021568|NCT02697422|460702955|FG001|Overall Study|Death|1|||
128021569|NCT02697422|460702954|FG000|Overall Study|Withdrawal by Subject|0|||
128021570|NCT02697422|460702955|FG001|Overall Study|Withdrawal by Subject|1|||
128021571|NCT02697422|460702954|FG000|Overall Study|Physician Decision|1|||
128021572|NCT02697422|460702955|FG001|Overall Study|Physician Decision|1|||
128021573|NCT02697422|460702954|FG000|Overall Study|Exit survey data lost|1|||
128021574|NCT02697422|460702955|FG001|Overall Study|Exit survey data lost|0|||
128021575|NCT01873833|460702957|FG000|Overall Study|Withdrawal by Subject|1|||
128021576|NCT03983109|460702960|FG000|Overall Study|Operational Hurdles Linked to Usage Methodologies|12|||
128021577|NCT03983109|460702961|FG001|Overall Study|Operational Hurdles Linked to Usage Methodologies|0|||
128021578|NCT02068599|460702963|FG000|Overall Study|Adverse Event|4|||
128021579|NCT02068599|460702964|FG001|Overall Study|Adverse Event|1|||
128021580|NCT02068599|460702965|FG002|Overall Study|Adverse Event|1|||
128021581|NCT02068599|460702963|FG000|Overall Study|Withdrawal by Subject|2|||
128021582|NCT02068599|460702964|FG001|Overall Study|Withdrawal by Subject|7|||
128021583|NCT02068599|460702965|FG002|Overall Study|Withdrawal by Subject|5|||
128021584|NCT02068599|460702963|FG000|Overall Study|Protocol Violation|4|||
127556370|NCT03304249|459004207|FG001|Overall Study|Withdrawal by Subject|2|||
127556371|NCT03304249|459004206|FG000|Overall Study|Moved Out of District|4|||
127556372|NCT03304249|459004207|FG001|Overall Study|Moved Out of District|2|||
128021585|NCT02068599|460702964|FG001|Overall Study|Protocol Violation|2|||
127556373|NCT02102204|459006715|FG000|Overall Study|Withdrawal by Subject|137|||
128021586|NCT02068599|460702965|FG002|Overall Study|Protocol Violation|3|||
128021587|NCT02068599|460702963|FG000|Overall Study|Lost to Follow-up|1|||
128021588|NCT02068599|460702964|FG001|Overall Study|Lost to Follow-up|0|||
127774240|NCT01794520|459800292|FG002|Overall Study|Progressive disease|2|||
128021589|NCT02068599|460702965|FG002|Overall Study|Lost to Follow-up|0|||
128021590|NCT02068599|460702963|FG000|Overall Study|Lack of Efficacy|0|||
128021591|NCT02068599|460702964|FG001|Overall Study|Lack of Efficacy|0|||
128021592|NCT02068599|460702965|FG002|Overall Study|Lack of Efficacy|3|||
127685751|NCT01571596|459476351|FG002|Overall Study|Adverse Event|0|||
127685752|NCT01571596|459476349|FG000|Overall Study|Study Terminated by the Sponsor|0|||
128021593|NCT02068599|460702963|FG000|Overall Study|Noncompliance|0|||
128021594|NCT02068599|460702964|FG001|Overall Study|Noncompliance|0|||
128021595|NCT02068599|460702965|FG002|Overall Study|Noncompliance|1|||
128021596|NCT01871727|460702966|FG000|Lead-In Part (1 Year 2 Months)|Disease Progression|1|||
128021597|NCT01871727|460702967|FG001|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
128021598|NCT01871727|460702968|FG002|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
128021599|NCT01871727|460702969|FG003|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
128021600|NCT01871727|460702970|FG004|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
128021601|NCT01871727|460702966|FG000|Main Study Part (2 Years 4 Months)|Other|0|||
128021602|NCT01871727|460702967|FG001|Main Study Part (2 Years 4 Months)|Other|0|||
128021603|NCT01871727|460702968|FG002|Main Study Part (2 Years 4 Months)|Other|0|||
128021604|NCT01871727|460702969|FG003|Main Study Part (2 Years 4 Months)|Other|0|||
128021605|NCT01871727|460702970|FG004|Main Study Part (2 Years 4 Months)|Other|2|||
128021606|NCT01871727|460702966|FG000|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
128021607|NCT01871727|460702967|FG001|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
128021608|NCT01871727|460702968|FG002|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
128021609|NCT01871727|460702969|FG003|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
128021610|NCT01871727|460702970|FG004|Main Study Part (2 Years 4 Months)|Sponsor Decision|11|||
128021611|NCT01871727|460702966|FG000|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
128021612|NCT01871727|460702967|FG001|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
128021613|NCT01871727|460702968|FG002|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
128021614|NCT01871727|460702969|FG003|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
128021615|NCT01871727|460702970|FG004|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|9|||
128021616|NCT01871727|460702966|FG000|Main Study Part (2 Years 4 Months)|Disease progression|0|||
128021617|NCT01871727|460702967|FG001|Main Study Part (2 Years 4 Months)|Disease progression|0|||
128021618|NCT01871727|460702968|FG002|Main Study Part (2 Years 4 Months)|Disease progression|0|||
128021619|NCT01871727|460702969|FG003|Main Study Part (2 Years 4 Months)|Disease progression|0|||
128021620|NCT01871727|460702970|FG004|Main Study Part (2 Years 4 Months)|Disease progression|20|||
128021621|NCT01871727|460702966|FG000|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
128021622|NCT01871727|460702967|FG001|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
128021623|NCT01871727|460702968|FG002|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
128021624|NCT01871727|460702969|FG003|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
128021625|NCT01871727|460702970|FG004|Main Study Part (2 Years 4 Months)|Lost to Follow-up|2|||
128021626|NCT01871727|460702966|FG000|Main Study Part (2 Years 4 Months)|Not treated|0|||
128021627|NCT01871727|460702967|FG001|Main Study Part (2 Years 4 Months)|Not treated|0|||
128021628|NCT01871727|460702968|FG002|Main Study Part (2 Years 4 Months)|Not treated|0|||
128021629|NCT01871727|460702969|FG003|Main Study Part (2 Years 4 Months)|Not treated|0|||
128021630|NCT01871727|460702970|FG004|Main Study Part (2 Years 4 Months)|Not treated|1|||
128021631|NCT00356421|460702972|FG000|Overall Study|Lack of Efficacy|3|||
128021632|NCT00356421|460702973|FG001|Overall Study|Lack of Efficacy|0|||
128021633|NCT00356421|460702972|FG000|Overall Study|Withdrawal by Subject|9|||
128021634|NCT00356421|460702973|FG001|Overall Study|Withdrawal by Subject|2|||
128021635|NCT00356421|460702972|FG000|Overall Study|Related to study drug|15|||
128021636|NCT00356421|460702973|FG001|Overall Study|Related to study drug|12|||
128021637|NCT00356421|460702972|FG000|Overall Study|Not related to study drug|5|||
128021638|NCT00356421|460702973|FG001|Overall Study|Not related to study drug|3|||
128021639|NCT00501085|460702974|FG000|Overall Study|Lost to Follow-up|195|||
128021640|NCT00501085|460702974|FG000|Overall Study|Withdrawal by Subject|34|||
128021641|NCT00501085|460702974|FG000|Overall Study|Subject Decision|1|||
128021642|NCT00501085|460702974|FG000|Overall Study|Revision Surgery|7|||
128021643|NCT00501085|460702974|FG000|Overall Study|Explantation Surgery|26|||
128021644|NCT00501085|460702974|FG000|Overall Study|Adverse Event|4|||
128021645|NCT00501085|460702974|FG000|Overall Study|Non-Compliance|24|||
128021646|NCT00501085|460702974|FG000|Overall Study|Study closed by sponsor|109|||
127685753|NCT01571596|459476350|FG001|Overall Study|Study Terminated by the Sponsor|1|||
127685754|NCT01571596|459476351|FG002|Overall Study|Study Terminated by the Sponsor|1|||
127685755|NCT02706717|459476352|FG000|Overall Study|Withdrawal by Subject|1|||
127685756|NCT02706717|459476353|FG001|Overall Study|Withdrawal by Subject|8|||
128021647|NCT00501085|460702974|FG000|Overall Study|Other loss to follow-up|32|||
128021648|NCT02958527|460702975|FG000|Overall Study|Not collected CRFs|12|||
128021649|NCT00250718|460702979|FG000|Overall Study|Death|1|||
128021650|NCT00250718|460702979|FG000|Overall Study|Adverse Event|1|||
128021651|NCT00250718|460702979|FG000|Overall Study|Withdrawal by Subject|1|||
128021652|NCT01666314|460702980|FG000|Overall Study|Adverse Event|3|||
128021653|NCT01666314|460702981|FG001|Overall Study|Adverse Event|13|||
128021654|NCT01666314|460702982|FG002|Overall Study|Adverse Event|7|||
128021655|NCT01666314|460702983|FG003|Overall Study|Adverse Event|7|||
127685757|NCT02706717|459476352|FG000|Overall Study|Lost to Follow-up|0|||
127685758|NCT02706717|459476353|FG001|Overall Study|Lost to Follow-up|1|||
128021656|NCT01666314|460702980|FG000|Overall Study|Progressive Disease|11|||
128021657|NCT01666314|460702981|FG001|Overall Study|Progressive Disease|9|||
127556374|NCT02102204|459006715|FG000|Overall Study|Death|92|||
127556375|NCT02102204|459006715|FG000|Overall Study|Lost to Follow-up|65|||
127556376|NCT02102204|459006715|FG000|Overall Study|Sponsor Decision|5|||
127556377|NCT02102204|459006715|FG000|Overall Study|Ongoing|5|||
127556378|NCT01865552|459006716|FG000|Period 1|Adverse Event|1|||
127556379|NCT01865552|459006717|FG001|Period 1|Adverse Event|0|||
127556380|NCT01865552|459006718|FG002|Period 1|Adverse Event|0|||
127556381|NCT01865552|459006719|FG003|Period 1|Adverse Event|1|||
127556382|NCT01865552|459006720|FG004|Period 1|Adverse Event|1|||
127556383|NCT01865552|459006721|FG005|Period 1|Adverse Event|1|||
127556384|NCT01865552|459006716|FG000|Period 1|Pathological lab|0|||
127556385|NCT01865552|459006717|FG001|Period 1|Pathological lab|0|||
127556386|NCT01865552|459006718|FG002|Period 1|Pathological lab|0|||
127556387|NCT01865552|459006719|FG003|Period 1|Pathological lab|0|||
127556388|NCT01865552|459006720|FG004|Period 1|Pathological lab|1|||
127556389|NCT01865552|459006721|FG005|Period 1|Pathological lab|0|||
127556390|NCT01865552|459006716|FG000|Period 1|Other|0|||
127556391|NCT01865552|459006717|FG001|Period 1|Other|0|||
127556392|NCT01865552|459006718|FG002|Period 1|Other|0|||
127556393|NCT01865552|459006719|FG003|Period 1|Other|0|||
127556394|NCT01865552|459006720|FG004|Period 1|Other|1|||
127556395|NCT01865552|459006721|FG005|Period 1|Other|0|||
127556396|NCT03085797|459006723|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
127556397|NCT03085797|459006724|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
127556398|NCT03085797|459006723|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
127881020|NCT00835068|460186102|FG000|Overall Study|Other|8|||
127881021|NCT00835068|460186103|FG001|Overall Study|Other|0|||
127556399|NCT03085797|459006724|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
127556400|NCT03085797|459006723|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
127556401|NCT03085797|459006724|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
127556402|NCT01837823|459006725|FG000|Overall Study|Lost to Follow-up|6|||
127556403|NCT00436345|459006728|FG000|Overall Study|ICU resident beyond follow-up period|3|||
127556404|NCT00436345|459006729|FG001|Overall Study|ICU resident beyond follow-up period|0|||
127556405|NCT02078960|459006730|FG000|Treatment Period|Other|0|||
127556406|NCT02078960|459006731|FG001|Treatment Period|Other|0|||
127556407|NCT02078960|459006732|FG002|Treatment Period|Other|1|||
127556408|NCT02078960|459006730|FG000|Treatment Period|Lack of Efficacy|0|||
127556409|NCT02078960|459006731|FG001|Treatment Period|Lack of Efficacy|1|||
127556410|NCT02078960|459006732|FG002|Treatment Period|Lack of Efficacy|0|||
127556411|NCT02078960|459006730|FG000|Treatment Period|Disease progression - accelerated phase|0|||
127556412|NCT02078960|459006731|FG001|Treatment Period|Disease progression - accelerated phase|1|||
127556413|NCT02078960|459006732|FG002|Treatment Period|Disease progression - accelerated phase|0|||
127556414|NCT02078960|459006730|FG000|Treatment Period|Disease progression - blast phase|1|||
127556415|NCT02078960|459006731|FG001|Treatment Period|Disease progression - blast phase|0|||
127556416|NCT02078960|459006732|FG002|Treatment Period|Disease progression - blast phase|0|||
127556417|NCT02078960|459006730|FG000|Treatment Period|Withdrawal by Subject|0|||
127556418|NCT02078960|459006731|FG001|Treatment Period|Withdrawal by Subject|1|||
127556419|NCT02078960|459006732|FG002|Treatment Period|Withdrawal by Subject|1|||
127556420|NCT02078960|459006730|FG000|Treatment Period|Adverse Event|1|||
127556421|NCT02078960|459006731|FG001|Treatment Period|Adverse Event|0|||
127556422|NCT02078960|459006732|FG002|Treatment Period|Adverse Event|0|||
127556423|NCT02078960|459006730|FG000|Treatment Period|Death|0|||
127556424|NCT02078960|459006731|FG001|Treatment Period|Death|0|||
127556425|NCT02078960|459006732|FG002|Treatment Period|Death|1|||
127556426|NCT02078960|459006730|FG000|Follow-up Period|Death|2|||
127556427|NCT02078960|459006731|FG001|Follow-up Period|Death|0|||
127556428|NCT02078960|459006732|FG002|Follow-up Period|Death|0|||
127556429|NCT02078960|459006730|FG000|Follow-up Period|Lost to Follow-up|0|||
127556430|NCT02078960|459006731|FG001|Follow-up Period|Lost to Follow-up|1|||
127556431|NCT02078960|459006732|FG002|Follow-up Period|Lost to Follow-up|0|||
127556432|NCT04248491|459006733|FG000|Overall Study|Lost to Follow-up|1|||
127556433|NCT04248491|459006734|FG001|Overall Study|Lost to Follow-up|0|||
127556434|NCT02597478|459006741|FG000|Overall Study|Withdrawal by Subject|2|||
127556435|NCT02597478|459006742|FG001|Overall Study|Withdrawal by Subject|0|||
127556436|NCT02597478|459006741|FG000|Overall Study|Change of opioid dose|1|||
127556437|NCT02597478|459006742|FG001|Overall Study|Change of opioid dose|0|||
127556438|NCT02597478|459006741|FG000|Overall Study|Insufficient exertional dyspnea|0|||
127556439|NCT02597478|459006742|FG001|Overall Study|Insufficient exertional dyspnea|1|||
127556440|NCT01652469|459006743|FG000|Overall Study|Withdrawal by Subject|1|||
127556441|NCT01652469|459006744|FG001|Overall Study|Withdrawal by Subject|4|||
128021658|NCT01666314|460702982|FG002|Overall Study|Progressive Disease|19|||
127556442|NCT01652469|459006743|FG000|Overall Study|Lost to Follow-up|0|||
128021659|NCT01666314|460702983|FG003|Overall Study|Progressive Disease|20|||
128021660|NCT01666314|460702980|FG000|Overall Study|Symptomatic Deterioration|1|||
127556443|NCT01652469|459006744|FG001|Overall Study|Lost to Follow-up|2|||
127556444|NCT00796978|459006745|FG000|Overall Study|Cardiac adverse event|5|||
127556445|NCT00796978|459006745|FG000|Overall Study|Adverse Event|4|||
127556446|NCT00796978|459006745|FG000|Overall Study|Withdrawal by Subject|3|||
127556447|NCT00771953|459006747|FG000|Overall Study|Adverse Event|5|||
127685759|NCT02706717|459476352|FG000|Overall Study|Physician Decision|0|||
127685760|NCT02706717|459476353|FG001|Overall Study|Physician Decision|1|||
127685761|NCT02706717|459476352|FG000|Overall Study|Death|0|||
127685762|NCT02706717|459476353|FG001|Overall Study|Death|1|||
127685763|NCT02512965|459476358|FG000|Overall Study|Withdrawal by Subject|0|||
127685764|NCT02512965|459476359|FG001|Overall Study|Withdrawal by Subject|4|||
128021661|NCT01666314|460702981|FG001|Overall Study|Symptomatic Deterioration|0|||
128021662|NCT01666314|460702982|FG002|Overall Study|Symptomatic Deterioration|2|||
128021663|NCT01666314|460702983|FG003|Overall Study|Symptomatic Deterioration|0|||
128021664|NCT01666314|460702980|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
128021665|NCT01666314|460702981|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
128021666|NCT01666314|460702982|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
128021667|NCT01666314|460702983|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
128021668|NCT01666314|460702980|FG000|Overall Study|Withdrawal by Subject|1|||
128021669|NCT01666314|460702981|FG001|Overall Study|Withdrawal by Subject|1|||
128021670|NCT01666314|460702982|FG002|Overall Study|Withdrawal by Subject|2|||
128021671|NCT01666314|460702983|FG003|Overall Study|Withdrawal by Subject|3|||
128021672|NCT01666314|460702980|FG000|Overall Study|Reason not Specified|10|||
128021673|NCT01666314|460702981|FG001|Overall Study|Reason not Specified|7|||
128021674|NCT01666314|460702982|FG002|Overall Study|Reason not Specified|5|||
128021675|NCT01666314|460702983|FG003|Overall Study|Reason not Specified|5|||
128021676|NCT02015104|460702984|FG000|Overall Study|Withdrew consent after first dose drug|1|||
128021677|NCT02015104|460702985|FG001|Overall Study|Withdrew consent after first dose drug|0|||
128021678|NCT02015104|460702984|FG000|Overall Study|Withdrew consent prior to treatment|0|||
128021679|NCT02015104|460702985|FG001|Overall Study|Withdrew consent prior to treatment|1|||
128021680|NCT03022630|460704548|FG000|Overall Study|Death|9|||
128021681|NCT03022630|460704549|FG001|Overall Study|Death|7|||
128021682|NCT03022630|460704548|FG000|Overall Study|Withdrawal by Subject|0|||
128021683|NCT03022630|460704549|FG001|Overall Study|Withdrawal by Subject|5|||
128021684|NCT03197935|460704550|FG000|Overall Study|Death due to any cause|26|||
128021685|NCT03197935|460704551|FG001|Overall Study|Death due to any cause|15|||
128021686|NCT03197935|460704550|FG000|Overall Study|Lost to Follow-up|3|||
128021687|NCT03197935|460704551|FG001|Overall Study|Lost to Follow-up|5|||
128021688|NCT03197935|460704550|FG000|Overall Study|Physician Decision|2|||
128021689|NCT03197935|460704551|FG001|Overall Study|Physician Decision|1|||
128021690|NCT03197935|460704550|FG000|Overall Study|Withdrawal by Subject|16|||
128021691|NCT03197935|460704551|FG001|Overall Study|Withdrawal by Subject|8|||
128021692|NCT00574951|460704562|FG000|Overall Study|Ineligible - improper prior treatment|1|||
128021693|NCT01160744|460704569|FG000|Overall Study|Withdrawal by Subject|11|||
128021694|NCT01160744|460704570|FG001|Overall Study|Withdrawal by Subject|5|||
128021695|NCT01160744|460704571|FG002|Overall Study|Withdrawal by Subject|6|||
128021696|NCT01160744|460704572|FG003|Overall Study|Withdrawal by Subject|4|||
128021697|NCT01160744|460704569|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
128021698|NCT01160744|460704570|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
128021699|NCT01160744|460704571|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
128021700|NCT01160744|460704572|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
128021701|NCT02056288|460704573|FG000|In-Hospital Data|Surgery cancelled|1|||
128021702|NCT02056288|460704574|FG001|In-Hospital Data|Surgery cancelled|0|||
128021703|NCT02056288|460704573|FG000|In-Hospital Data|Protocol Violation|3|||
128021704|NCT02056288|460704574|FG001|In-Hospital Data|Protocol Violation|0|||
128021705|NCT02056288|460704573|FG000|In-Hospital Data|Physician Decision|1|||
128021706|NCT02056288|460704574|FG001|In-Hospital Data|Physician Decision|0|||
128021707|NCT02056288|460704573|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
128021708|NCT02056288|460704574|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
128021709|NCT02301429|460704575|FG000|Overall Study|not acceptable vascular anatomy|3|||
128021710|NCT01502072|460704576|FG000|Overall Study|Withdrawal by Subject|1|||
128021711|NCT01502072|460704577|FG001|Overall Study|Withdrawal by Subject|0|||
128021712|NCT01502072|460704578|FG002|Overall Study|Withdrawal by Subject|0|||
128021713|NCT01502072|460704576|FG000|Overall Study|Death|0|||
128021714|NCT01502072|460704577|FG001|Overall Study|Death|1|||
128021715|NCT01502072|460704578|FG002|Overall Study|Death|0|||
128021716|NCT00500110|460704579|FG000|Overall Study|Withdrawal by Subject|3|||
128021717|NCT04676646|460704580|FG000|Open-label Run-in Phase|Adverse Event|3|||
127685765|NCT00835770|459476363|FG000|Overall Study|MS Relapse|17|||
127685766|NCT00835770|459476364|FG001|Overall Study|MS Relapse|23|||
127685767|NCT00835770|459476363|FG000|Overall Study|MS Progression|14|||
127685768|NCT00835770|459476364|FG001|Overall Study|MS Progression|9|||
128021718|NCT04676646|460704581|FG001|Open-label Run-in Phase|Adverse Event|0|||
128021719|NCT04676646|460704582|FG002|Open-label Run-in Phase|Adverse Event|0|||
128021720|NCT04676646|460704580|FG000|Open-label Run-in Phase|Death|3|||
128021721|NCT04676646|460704581|FG001|Open-label Run-in Phase|Death|0|||
128021722|NCT04676646|460704582|FG002|Open-label Run-in Phase|Death|0|||
128021723|NCT04676646|460704580|FG000|Open-label Run-in Phase|Study-specific Withdrawal Criteria|2|||
127685769|NCT00835770|459476363|FG000|Overall Study|Adverse Event|113|||
127685770|NCT00835770|459476364|FG001|Overall Study|Adverse Event|124|||
127556448|NCT00771953|459006748|FG001|Overall Study|Adverse Event|3|||
127556449|NCT00771953|459006747|FG000|Overall Study|Death|2|||
127556450|NCT00771953|459006748|FG001|Overall Study|Death|2|||
127556451|NCT00771953|459006747|FG000|Overall Study|Progression before active Tx|1|||
127556452|NCT00771953|459006748|FG001|Overall Study|Progression before active Tx|2|||
127556453|NCT00771953|459006747|FG000|Overall Study|Sponsor decision|1|||
127556454|NCT00771953|459006748|FG001|Overall Study|Sponsor decision|0|||
127556455|NCT00771953|459006747|FG000|Overall Study|Other complicating disease|1|||
127556456|NCT00771953|459006748|FG001|Overall Study|Other complicating disease|0|||
127556457|NCT00771953|459006747|FG000|Overall Study|Withdrawal by Subject|0|||
127556458|NCT00771953|459006748|FG001|Overall Study|Withdrawal by Subject|3|||
127556459|NCT05246514|459006750|FG000|Overall Study|Ongoing in the study at data cut-off date|58|||
127556460|NCT05246514|459006750|FG000|Overall Study|Withdrawal by Subject|1|||
127556461|NCT05246514|459006750|FG000|Overall Study|Death|13|||
127556462|NCT02910986|459006751|FG000|Overall Study|non-Latina|14|||
127556463|NCT02910986|459006752|FG001|Overall Study|non-Latina|13|||
127556464|NCT02910986|459006753|FG002|Overall Study|non-Latina|12|||
127556465|NCT02910986|459006751|FG000|Overall Study|Failure to return T! survey|72|||
127556466|NCT02910986|459006752|FG001|Overall Study|Failure to return T! survey|84|||
127556467|NCT02910986|459006753|FG002|Overall Study|Failure to return T! survey|72|||
127556468|NCT02910986|459006751|FG000|Overall Study|T1 Survey not 14-180 post education|25|||
127556469|NCT02910986|459006752|FG001|Overall Study|T1 Survey not 14-180 post education|25|||
127556470|NCT02910986|459006753|FG002|Overall Study|T1 Survey not 14-180 post education|115|||
127556471|NCT02910986|459006751|FG000|Overall Study|Withdrew after randomization prior to start of intervention|0|||
127556472|NCT02910986|459006752|FG001|Overall Study|Withdrew after randomization prior to start of intervention|0|||
127556473|NCT02910986|459006753|FG002|Overall Study|Withdrew after randomization prior to start of intervention|2|||
127556474|NCT04380519|459006754|FG000|Overall Study|Withdrawal by Subject|4|||
127556475|NCT04380519|459006755|FG001|Overall Study|Withdrawal by Subject|0|||
127556476|NCT04380519|459006756|FG002|Overall Study|Withdrawal by Subject|1|||
127556477|NCT04380519|459006754|FG000|Overall Study|Death|14|||
127556478|NCT04380519|459006755|FG001|Overall Study|Death|9|||
127556479|NCT04380519|459006756|FG002|Overall Study|Death|6|||
127556480|NCT04380519|459006754|FG000|Overall Study|Adverse Event|0|||
127556481|NCT04380519|459006755|FG001|Overall Study|Adverse Event|1|||
127556482|NCT04380519|459006756|FG002|Overall Study|Adverse Event|0|||
127556483|NCT04380519|459006754|FG000|Overall Study|relatives' decision|0|||
127556484|NCT04380519|459006755|FG001|Overall Study|relatives' decision|1|||
127556485|NCT04380519|459006756|FG002|Overall Study|relatives' decision|0|||
127556486|NCT01727024|459006757|FG000|Period 1|Lost to Follow-up|1|||
127556487|NCT01727024|459006758|FG001|Period 1|Lost to Follow-up|1|||
127556488|NCT01727024|459006757|FG000|Period 1|Withdrawal by Subject|2|||
127556489|NCT01727024|459006758|FG001|Period 1|Withdrawal by Subject|3|||
127556490|NCT00486291|459006759|FG000|Overall Study|Adverse Event|3|||
127556491|NCT00486291|459006760|FG001|Overall Study|Adverse Event|4|||
127556492|NCT00486291|459006759|FG000|Overall Study|Lost to Follow-up|3|||
127556493|NCT00486291|459006760|FG001|Overall Study|Lost to Follow-up|7|||
127556494|NCT00486291|459006759|FG000|Overall Study|protocol non-compliance|10|||
127556495|NCT00486291|459006760|FG001|Overall Study|protocol non-compliance|15|||
127556496|NCT00486291|459006759|FG000|Overall Study|requirement for restricted medication|0|||
127556497|NCT00486291|459006760|FG001|Overall Study|requirement for restricted medication|3|||
127556498|NCT00126490|459006761|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
127556499|NCT00975780|459006762|FG000|Follow Up|Death|88|||
127685771|NCT00835770|459476363|FG000|Overall Study|Lost to Follow-up|22|||
127685772|NCT00835770|459476364|FG001|Overall Study|Lost to Follow-up|19|||
127685773|NCT00835770|459476363|FG000|Overall Study|Consent Withdrawn|144|||
127685774|NCT00835770|459476364|FG001|Overall Study|Consent Withdrawn|156|||
127685775|NCT00835770|459476363|FG000|Overall Study|Investigator Decision|42|||
127685776|NCT00835770|459476364|FG001|Overall Study|Investigator Decision|42|||
127685777|NCT00835770|459476363|FG000|Overall Study|Participant Non-Compliance|11|||
127685778|NCT00835770|459476364|FG001|Overall Study|Participant Non-Compliance|9|||
127685779|NCT00835770|459476363|FG000|Overall Study|Death|4|||
127685780|NCT00835770|459476364|FG001|Overall Study|Death|6|||
127685781|NCT00835770|459476363|FG000|Overall Study|Other|115|||
127685782|NCT00835770|459476364|FG001|Overall Study|Other|104|||
127685783|NCT00835770|459476363|FG000|Overall Study|Other|2|||
127685784|NCT00835770|459476364|FG001|Overall Study|Other|1|||
127685785|NCT01185782|459476365|FG000|Overall Study|Adverse Event|0|||
127556500|NCT00975780|459006763|FG001|Follow Up|Death|122|||
127685786|NCT01185782|459476366|FG001|Overall Study|Adverse Event|1|||
127685787|NCT01185782|459476365|FG000|Overall Study|Protocol Violation|1|||
127685788|NCT01185782|459476366|FG001|Overall Study|Protocol Violation|0|||
127556501|NCT00975780|459006762|FG000|Follow Up|Facility Withdrawal|7|||
127556502|NCT00975780|459006763|FG001|Follow Up|Facility Withdrawal|23|||
127556503|NCT00975780|459006762|FG000|Follow Up|Discharged from Facility|7|||
127556504|NCT00975780|459006763|FG001|Follow Up|Discharged from Facility|12|||
127556505|NCT03051178|459006766|FG000|Overall Study|Withdrawal by Subject|5|||
127685789|NCT01185782|459476365|FG000|Overall Study|Poor Response to Treatment|3|||
127685790|NCT01185782|459476366|FG001|Overall Study|Poor Response to Treatment|1|||
127556506|NCT01598506|459006767|FG000|Overall Study|Withdrawal by Subject|2|||
127556507|NCT00035932|459006774|FG000|Overall Study|Adverse Event|10|||
127556508|NCT00035932|459006775|FG001|Overall Study|Adverse Event|9|||
127556509|NCT00035932|459006776|FG002|Overall Study|Adverse Event|9|||
127556510|NCT00035932|459006774|FG000|Overall Study|Death|0|||
127556511|NCT00035932|459006775|FG001|Overall Study|Death|0|||
127556512|NCT00035932|459006776|FG002|Overall Study|Death|1|||
127556513|NCT00035932|459006774|FG000|Overall Study|Disease Progression / Relapse|1|||
127556514|NCT00035932|459006775|FG001|Overall Study|Disease Progression / Relapse|1|||
127556515|NCT00035932|459006776|FG002|Overall Study|Disease Progression / Relapse|0|||
127556516|NCT00035932|459006774|FG000|Overall Study|Lost to Follow-up|4|||
127556517|NCT00035932|459006775|FG001|Overall Study|Lost to Follow-up|4|||
127556518|NCT00035932|459006776|FG002|Overall Study|Lost to Follow-up|3|||
127556519|NCT00035932|459006774|FG000|Overall Study|Noncompliance|6|||
127556520|NCT00035932|459006775|FG001|Overall Study|Noncompliance|7|||
127556521|NCT00035932|459006776|FG002|Overall Study|Noncompliance|6|||
127556522|NCT00035932|459006774|FG000|Overall Study|Protocol Violation While on Study|0|||
127556523|NCT00035932|459006775|FG001|Overall Study|Protocol Violation While on Study|1|||
127556524|NCT00035932|459006776|FG002|Overall Study|Protocol Violation While on Study|2|||
127556525|NCT00035932|459006774|FG000|Overall Study|Withdrawal by Subject|1|||
127556526|NCT00035932|459006775|FG001|Overall Study|Withdrawal by Subject|5|||
127556527|NCT00035932|459006776|FG002|Overall Study|Withdrawal by Subject|0|||
127556528|NCT00035932|459006774|FG000|Overall Study|Study Termination by Sponsor|1|||
127556529|NCT00035932|459006775|FG001|Overall Study|Study Termination by Sponsor|0|||
127556530|NCT00035932|459006776|FG002|Overall Study|Study Termination by Sponsor|0|||
127556531|NCT00035932|459006774|FG000|Overall Study|Lack of Efficacy|33|||
127556532|NCT00035932|459006775|FG001|Overall Study|Lack of Efficacy|33|||
127556533|NCT00035932|459006776|FG002|Overall Study|Lack of Efficacy|28|||
127556534|NCT01388335|459006777|FG000|Period 1|Progressive Disease|1|||
127556535|NCT01388335|459006777|FG000|Period 2|Progressive Disease|2|||
127556536|NCT01388335|459006777|FG000|Period 2|Sponsor Decision|1|||
127556537|NCT01388335|459006777|FG000|Safety Extension|Progressive Disease|7|||
127556538|NCT04080167|459006780|FG000|Overall Study|Lost to Follow-up-Patients|7|||
127556539|NCT04080167|459006781|FG001|Overall Study|Lost to Follow-up-Patients|14|||
127556540|NCT04080167|459006782|FG002|Overall Study|Lost to Follow-up-Patients|0|||
127556541|NCT04080167|459006780|FG000|Overall Study|Lost to Follow-up-Providers|2|||
127556542|NCT04080167|459006781|FG001|Overall Study|Lost to Follow-up-Providers|2|||
127556543|NCT04080167|459006782|FG002|Overall Study|Lost to Follow-up-Providers|0|||
127556544|NCT04080167|459006780|FG000|Overall Study|Withdrawal by Subject|1|||
127556545|NCT04080167|459006781|FG001|Overall Study|Withdrawal by Subject|2|||
127556546|NCT04080167|459006782|FG002|Overall Study|Withdrawal by Subject|0|||
127556547|NCT04080167|459006780|FG000|Overall Study|Withdrawal by Provider|0|||
127556548|NCT04080167|459006781|FG001|Overall Study|Withdrawal by Provider|0|||
127556549|NCT04080167|459006782|FG002|Overall Study|Withdrawal by Provider|4|||
127556550|NCT04080167|459006780|FG000|Overall Study|Death-Patient|2|||
127556551|NCT04080167|459006781|FG001|Overall Study|Death-Patient|1|||
127556552|NCT04080167|459006782|FG002|Overall Study|Death-Patient|0|||
127556553|NCT04080167|459006780|FG000|Overall Study|Hydroxyurea New Starts|0|||
127556554|NCT04080167|459006781|FG001|Overall Study|Hydroxyurea New Starts|0|||
127556555|NCT04080167|459006782|FG002|Overall Study|Hydroxyurea New Starts|1|||
127556556|NCT04080167|459006780|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
127556557|NCT04080167|459006781|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
127685791|NCT01185782|459476365|FG000|Overall Study|Other|2|||
127685792|NCT01185782|459476366|FG001|Overall Study|Other|5|||
127685793|NCT01185782|459476365|FG000|Overall Study|Randomized but not treated|0|||
127685794|NCT01185782|459476366|FG001|Overall Study|Randomized but not treated|4|||
127685795|NCT03740009|459476371|FG000|Overall Study|Physician Decision|9|||
127685796|NCT03740009|459476371|FG000|Overall Study|Lost to Follow-up|1|||
127685797|NCT01061151|459476372|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
127685798|NCT01061151|459476373|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
127685799|NCT01061151|459476374|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
127685800|NCT01061151|459476375|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
127685801|NCT01061151|459476372|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
127685802|NCT01061151|459476373|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
127685803|NCT01061151|459476374|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
127685804|NCT01061151|459476375|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
127685805|NCT01061151|459476372|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
127774241|NCT01794520|459800293|FG003|Overall Study|Progressive disease|5|||
127556558|NCT04080167|459006782|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
127556559|NCT02167139|459006783|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
127556560|NCT02167139|459006784|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
127556561|NCT02167139|459006785|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
127556562|NCT02167139|459006786|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
127556563|NCT02167139|459006783|FG000|Randomised, Double-blind|Adverse Event|2|||
127556564|NCT02167139|459006784|FG001|Randomised, Double-blind|Adverse Event|9|||
127556565|NCT02167139|459006785|FG002|Randomised, Double-blind|Adverse Event|0|||
127556566|NCT02167139|459006786|FG003|Randomised, Double-blind|Adverse Event|0|||
127556567|NCT02167139|459006783|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
127556568|NCT02167139|459006784|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
127556569|NCT02167139|459006785|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
127556570|NCT02167139|459006786|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
127556571|NCT02167139|459006783|FG000|Randomised, Double-blind|Other|3|||
127556572|NCT02167139|459006784|FG001|Randomised, Double-blind|Other|0|||
127556573|NCT02167139|459006785|FG002|Randomised, Double-blind|Other|0|||
127556574|NCT02167139|459006786|FG003|Randomised, Double-blind|Other|0|||
127556575|NCT02167139|459006783|FG000|Transition-extension|Adverse Event|2|||
127556576|NCT02167139|459006784|FG001|Transition-extension|Adverse Event|0|||
127556577|NCT02167139|459006785|FG002|Transition-extension|Adverse Event|2|||
127556578|NCT02167139|459006786|FG003|Transition-extension|Adverse Event|3|||
127556579|NCT02167139|459006783|FG000|Transition-extension|Withdrawal by Subject|2|||
127556580|NCT02167139|459006784|FG001|Transition-extension|Withdrawal by Subject|0|||
127556581|NCT02167139|459006785|FG002|Transition-extension|Withdrawal by Subject|4|||
127556582|NCT02167139|459006786|FG003|Transition-extension|Withdrawal by Subject|1|||
127556583|NCT02167139|459006783|FG000|Transition-extension|Lack of Efficacy|0|||
127556584|NCT02167139|459006784|FG001|Transition-extension|Lack of Efficacy|0|||
127556585|NCT02167139|459006785|FG002|Transition-extension|Lack of Efficacy|1|||
127556586|NCT02167139|459006786|FG003|Transition-extension|Lack of Efficacy|1|||
127556587|NCT02167139|459006783|FG000|Transition-extension|Other|1|||
127556588|NCT02167139|459006784|FG001|Transition-extension|Other|0|||
127556589|NCT02167139|459006785|FG002|Transition-extension|Other|1|||
127556590|NCT02167139|459006786|FG003|Transition-extension|Other|0|||
127556591|NCT02167139|459006783|FG000|Transition-extension|Lost to Follow-up|1|||
127556592|NCT02167139|459006784|FG001|Transition-extension|Lost to Follow-up|0|||
127556593|NCT02167139|459006785|FG002|Transition-extension|Lost to Follow-up|0|||
127556594|NCT02167139|459006786|FG003|Transition-extension|Lost to Follow-up|0|||
127556595|NCT04413617|459006787|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
127556596|NCT04413617|459006788|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
127556597|NCT04413617|459006789|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
127556598|NCT04413617|459006790|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
127556599|NCT04413617|459006791|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
127556600|NCT04413617|459006787|FG000|Overall Study|Protocol Violation|0|||
127556601|NCT04413617|459006788|FG001|Overall Study|Protocol Violation|1|||
127556602|NCT04413617|459006789|FG002|Overall Study|Protocol Violation|0|||
127556603|NCT04413617|459006790|FG003|Overall Study|Protocol Violation|0|||
127556604|NCT04413617|459006791|FG004|Overall Study|Protocol Violation|1|||
127556605|NCT04413617|459006787|FG000|Overall Study|Lack of Efficacy|2|||
127556606|NCT04413617|459006788|FG001|Overall Study|Lack of Efficacy|0|||
127556607|NCT04413617|459006789|FG002|Overall Study|Lack of Efficacy|2|||
127556608|NCT04413617|459006790|FG003|Overall Study|Lack of Efficacy|1|||
127556609|NCT04413617|459006791|FG004|Overall Study|Lack of Efficacy|0|||
127556610|NCT04413617|459006787|FG000|Overall Study|Withdrawal by Subject|3|||
127556611|NCT04413617|459006788|FG001|Overall Study|Withdrawal by Subject|4|||
127556612|NCT04413617|459006789|FG002|Overall Study|Withdrawal by Subject|2|||
127556613|NCT04413617|459006790|FG003|Overall Study|Withdrawal by Subject|5|||
127556614|NCT04413617|459006791|FG004|Overall Study|Withdrawal by Subject|3|||
127556615|NCT04413617|459006787|FG000|Overall Study|Death|1|||
127556616|NCT04413617|459006788|FG001|Overall Study|Death|0|||
127556617|NCT04413617|459006789|FG002|Overall Study|Death|0|||
127556618|NCT04413617|459006790|FG003|Overall Study|Death|0|||
127556619|NCT04413617|459006791|FG004|Overall Study|Death|0|||
127556620|NCT04413617|459006787|FG000|Overall Study|Adverse Event|1|||
127556621|NCT04413617|459006788|FG001|Overall Study|Adverse Event|0|||
127556622|NCT04413617|459006789|FG002|Overall Study|Adverse Event|0|||
127556623|NCT04413617|459006790|FG003|Overall Study|Adverse Event|1|||
127556624|NCT04413617|459006791|FG004|Overall Study|Adverse Event|1|||
127556625|NCT04413617|459006787|FG000|Overall Study|COVID-19|0|||
127556626|NCT04413617|459006788|FG001|Overall Study|COVID-19|1|||
127556627|NCT04413617|459006789|FG002|Overall Study|COVID-19|0|||
127556628|NCT04413617|459006790|FG003|Overall Study|COVID-19|0|||
127556629|NCT04413617|459006791|FG004|Overall Study|COVID-19|0|||
127556630|NCT02657408|459006792|FG000|Overall Study|Adverse Event|3|||
127556631|NCT02657408|459006793|FG001|Overall Study|Adverse Event|7|||
127556632|NCT00324961|459006795|FG000|Overall Study|Adverse Event|5|||
127556633|NCT00324961|459006795|FG000|Overall Study|Consent Withdrawn|11|||
127556634|NCT00324961|459006795|FG000|Overall Study|Lost to Follow-up|22|||
127556635|NCT00324961|459006795|FG000|Overall Study|Protocol Violation|3|||
127556636|NCT00324961|459006795|FG000|Overall Study|Other|2|||
127556637|NCT03350672|459006798|FG000|Overall Study|Withdrawal by Subject|7|||
127556638|NCT03350672|459006799|FG001|Overall Study|Withdrawal by Subject|0|||
127556639|NCT03350672|459006800|FG002|Overall Study|Withdrawal by Subject|0|||
127556640|NCT01459497|459006801|FG000|Overall Study|Inability to meet trial constraints.|1|||
127556641|NCT01459497|459006802|FG001|Overall Study|Inability to meet trial constraints.|0|||
127556642|NCT01459497|459006801|FG000|Overall Study|Physician Decision|1|||
127556643|NCT01459497|459006802|FG001|Overall Study|Physician Decision|1|||
127556644|NCT01459497|459006801|FG000|Overall Study|Hospitalization.|0|||
127556645|NCT01459497|459006802|FG001|Overall Study|Hospitalization.|3|||
127556646|NCT01459497|459006801|FG000|Overall Study|Disease progression.|0|||
127556647|NCT01459497|459006802|FG001|Overall Study|Disease progression.|1|||
127556648|NCT01192191|459006803|FG000|Overall Study|Adverse Event|7|||
127556649|NCT01192191|459006804|FG001|Overall Study|Adverse Event|12|||
127556650|NCT01192191|459006803|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
127556651|NCT01192191|459006804|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
127556652|NCT01192191|459006803|FG000|Overall Study|Lost to Follow-up|0|||
127556653|NCT01192191|459006804|FG001|Overall Study|Lost to Follow-up|1|||
127556654|NCT01192191|459006803|FG000|Overall Study|Withdrawal by Subject|1|||
127556655|NCT01192191|459006804|FG001|Overall Study|Withdrawal by Subject|6|||
127556656|NCT03530124|459006807|FG000|Overall Study|Withdrawal by Subject|0|||
127556657|NCT03530124|459006808|FG001|Overall Study|Withdrawal by Subject|1|||
127556658|NCT03530124|459006807|FG000|Overall Study|Protocol Violation|1|||
127556659|NCT03530124|459006808|FG001|Overall Study|Protocol Violation|0|||
127556660|NCT03530124|459006807|FG000|Overall Study|Discharged prior to study completion|1|||
127556661|NCT03530124|459006808|FG001|Overall Study|Discharged prior to study completion|0|||
127556662|NCT01047553|459006809|FG000|Overall Study|Adverse Event|10|||
127556663|NCT01047553|459006810|FG001|Overall Study|Adverse Event|5|||
127556664|NCT01047553|459006809|FG000|Overall Study|Withdrawal by Subject|4|||
127556665|NCT01047553|459006810|FG001|Overall Study|Withdrawal by Subject|2|||
127556666|NCT01047553|459006809|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
127556667|NCT01047553|459006810|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
127556668|NCT01047553|459006809|FG000|Overall Study|Lost to Follow-up|1|||
127556669|NCT01047553|459006810|FG001|Overall Study|Lost to Follow-up|0|||
127556670|NCT01047553|459006809|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
127556671|NCT01047553|459006810|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
127556672|NCT01047553|459006809|FG000|Overall Study|PI's decision|0|||
127556673|NCT01047553|459006810|FG001|Overall Study|PI's decision|1|||
127556674|NCT01583296|459006811|FG000|Overall Study|Withdrawal by Subject|11|||
127556675|NCT01583296|459006812|FG001|Overall Study|Withdrawal by Subject|10|||
127556676|NCT01063283|459006813|FG000|Cycle 1|Adverse Event|2|||
127556677|NCT01063283|459006814|FG001|Cycle 1|Adverse Event|0|||
127556678|NCT01063283|459006815|FG002|Cycle 1|Adverse Event|0|||
127556679|NCT01063283|459006813|FG000|Cycle 1|Technical failure in data collection|1|||
127556680|NCT01063283|459006814|FG001|Cycle 1|Technical failure in data collection|0|||
127556681|NCT01063283|459006815|FG002|Cycle 1|Technical failure in data collection|0|||
127556682|NCT03179319|459006816|FG000|Overall Study|Lost to Follow-up|6|||
127556683|NCT03179319|459006817|FG001|Overall Study|Lost to Follow-up|0|||
127556684|NCT01120717|459006818|FG000|Overall Study|Withdrawal by Subject|11|||
127556685|NCT01120717|459006819|FG001|Overall Study|Withdrawal by Subject|6|||
127556686|NCT01120717|459006818|FG000|Overall Study|Adverse Event|10|||
127556687|NCT01120717|459006819|FG001|Overall Study|Adverse Event|6|||
127556688|NCT01120717|459006818|FG000|Overall Study|Protocol Deviation|2|||
127556689|NCT01120717|459006819|FG001|Overall Study|Protocol Deviation|5|||
127556690|NCT01120717|459006818|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
127556691|NCT01120717|459006819|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
127685806|NCT01061151|459476373|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
127685807|NCT01061151|459476374|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
127685808|NCT01061151|459476375|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
127685809|NCT01061151|459476372|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
127556692|NCT01120717|459006818|FG000|Overall Study|Lost to Follow-up|2|||
127556693|NCT01120717|459006819|FG001|Overall Study|Lost to Follow-up|3|||
127685810|NCT01061151|459476373|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
127685811|NCT01061151|459476374|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
127685812|NCT01061151|459476375|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
127685813|NCT01061151|459476372|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
127685814|NCT01061151|459476373|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
127685815|NCT01061151|459476374|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
127685816|NCT01061151|459476375|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
127685817|NCT01061151|459476372|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
127685818|NCT01061151|459476373|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
127685819|NCT01061151|459476374|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
127556694|NCT01120717|459006818|FG000|Overall Study|Death|3|||
127556695|NCT01120717|459006819|FG001|Overall Study|Death|1|||
127556696|NCT01120717|459006818|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
127556697|NCT01120717|459006819|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
127556698|NCT05343624|459006820|FG000|Overall Study|Chart review not completed|1|||
127556699|NCT02504216|459006827|FG000|Overall Study|Lost to Follow-up|3|||
127556700|NCT02504216|459006828|FG001|Overall Study|Lost to Follow-up|3|||
127556701|NCT02504216|459006827|FG000|Overall Study|Withdrawal by Subject|8|||
127556702|NCT02504216|459006828|FG001|Overall Study|Withdrawal by Subject|12|||
127556703|NCT00862082|459006829|FG000|Overall Study|Sponsor decision to terminate the study|5|||
127556704|NCT00862082|459006830|FG001|Overall Study|Sponsor decision to terminate the study|0|||
127556705|NCT00862082|459006829|FG000|Overall Study|Withdrawal by Subject|0|||
127556706|NCT00862082|459006830|FG001|Overall Study|Withdrawal by Subject|1|||
127556707|NCT00223080|459006831|FG000|Overall Study|Withdrawal by Subject|253|||
127556708|NCT00223080|459006832|FG001|Overall Study|Withdrawal by Subject|232|||
127556709|NCT00223080|459006831|FG000|Overall Study|Required contraindicated med|0|||
127556710|NCT00223080|459006832|FG001|Overall Study|Required contraindicated med|1|||
127556711|NCT00223080|459006831|FG000|Overall Study|Non-compliant|7|||
127556712|NCT00223080|459006832|FG001|Overall Study|Non-compliant|7|||
127556713|NCT00223080|459006831|FG000|Overall Study|Moved from study area|37|||
127556714|NCT00223080|459006832|FG001|Overall Study|Moved from study area|47|||
127556715|NCT00223080|459006831|FG000|Overall Study|Lost to Follow-up|259|||
127556716|NCT00223080|459006832|FG001|Overall Study|Lost to Follow-up|284|||
127556717|NCT00223080|459006831|FG000|Overall Study|Death|85|||
127556718|NCT00223080|459006832|FG001|Overall Study|Death|74|||
127556719|NCT00223080|459006831|FG000|Overall Study|Other|14|||
127556720|NCT00223080|459006832|FG001|Overall Study|Other|11|||
127556721|NCT00223080|459006831|FG000|Overall Study|Reason not provided|141|||
127556722|NCT00223080|459006832|FG001|Overall Study|Reason not provided|140|||
127556723|NCT00223080|459006831|FG000|Overall Study|Adverse Event|0|||
127556724|NCT00223080|459006832|FG001|Overall Study|Adverse Event|1|||
127556725|NCT02598583|459006833|FG000|Extension Period|Withdrawal by Subject|1|||
127556726|NCT02598583|459006834|FG001|Extension Period|Withdrawal by Subject|0|||
127556727|NCT03237286|459006835|FG000|Overall Study|Withdrawal by Subject|1|||
127556728|NCT03237286|459006836|FG001|Overall Study|Withdrawal by Subject|0|||
127556729|NCT03237286|459006837|FG002|Overall Study|Withdrawal by Subject|2|||
127556730|NCT03237286|459006835|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
127556731|NCT03237286|459006836|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
127556732|NCT03237286|459006837|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
127556733|NCT00948441|459006838|FG000|Overall Study|no longer meet inclusion criteria|1|||
127556734|NCT00948441|459006839|FG001|Overall Study|no longer meet inclusion criteria|4|||
127556735|NCT03500224|459006848|FG000|Overall Study|Withdrawal by Subject|2|||
127556736|NCT01324401|459006851|FG000|Overall Study|Withdrawn before any treatment|0|||
127556737|NCT01324401|459006852|FG001|Overall Study|Withdrawn before any treatment|3|||
127556738|NCT01324401|459006851|FG000|Overall Study|Adverse Event|1|||
127556739|NCT01324401|459006852|FG001|Overall Study|Adverse Event|3|||
127556740|NCT01708902|459006854|FG000|Overall Study|Adverse Event|3|||
127556741|NCT01708902|459006855|FG001|Overall Study|Adverse Event|4|||
127556742|NCT01708902|459006856|FG002|Overall Study|Adverse Event|9|||
127556743|NCT01708902|459006857|FG003|Overall Study|Adverse Event|2|||
127556744|NCT01708902|459006858|FG004|Overall Study|Adverse Event|7|||
127556745|NCT01708902|459006859|FG005|Overall Study|Adverse Event|3|||
127556746|NCT01708902|459006860|FG006|Overall Study|Adverse Event|5|||
127556747|NCT01708902|459006854|FG000|Overall Study|Lack of Efficacy|3|||
127556748|NCT01708902|459006855|FG001|Overall Study|Lack of Efficacy|1|||
127556749|NCT01708902|459006856|FG002|Overall Study|Lack of Efficacy|0|||
127556750|NCT01708902|459006857|FG003|Overall Study|Lack of Efficacy|0|||
127556751|NCT01708902|459006858|FG004|Overall Study|Lack of Efficacy|0|||
127556752|NCT01708902|459006859|FG005|Overall Study|Lack of Efficacy|1|||
127556753|NCT01708902|459006860|FG006|Overall Study|Lack of Efficacy|0|||
127685820|NCT01061151|459476375|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
127685821|NCT01061151|459476372|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
127685822|NCT01061151|459476373|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
127685823|NCT01061151|459476374|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
127685824|NCT01061151|459476375|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
127685825|NCT01061151|459476372|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
127685826|NCT01061151|459476373|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
127685827|NCT01061151|459476374|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
127685828|NCT01061151|459476375|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
127685829|NCT01061151|459476372|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
127556754|NCT01708902|459006854|FG000|Overall Study|Non compliance with protocol|0|||
127556755|NCT01708902|459006855|FG001|Overall Study|Non compliance with protocol|2|||
127556756|NCT01708902|459006856|FG002|Overall Study|Non compliance with protocol|1|||
127556757|NCT01708902|459006857|FG003|Overall Study|Non compliance with protocol|3|||
127556758|NCT01708902|459006858|FG004|Overall Study|Non compliance with protocol|0|||
127556759|NCT01708902|459006859|FG005|Overall Study|Non compliance with protocol|0|||
127556760|NCT01708902|459006860|FG006|Overall Study|Non compliance with protocol|0|||
127556761|NCT01708902|459006854|FG000|Overall Study|Lost to Follow-up|2|||
127556762|NCT01708902|459006855|FG001|Overall Study|Lost to Follow-up|1|||
127556763|NCT01708902|459006856|FG002|Overall Study|Lost to Follow-up|2|||
127556764|NCT01708902|459006857|FG003|Overall Study|Lost to Follow-up|2|||
127556765|NCT01708902|459006858|FG004|Overall Study|Lost to Follow-up|0|||
127556766|NCT01708902|459006859|FG005|Overall Study|Lost to Follow-up|0|||
127556767|NCT01708902|459006860|FG006|Overall Study|Lost to Follow-up|1|||
127556768|NCT01708902|459006854|FG000|Overall Study|Refused to continue trial medication|8|||
127556769|NCT01708902|459006855|FG001|Overall Study|Refused to continue trial medication|0|||
127556770|NCT01708902|459006856|FG002|Overall Study|Refused to continue trial medication|4|||
127556771|NCT01708902|459006857|FG003|Overall Study|Refused to continue trial medication|2|||
127556772|NCT01708902|459006858|FG004|Overall Study|Refused to continue trial medication|8|||
127556773|NCT01708902|459006859|FG005|Overall Study|Refused to continue trial medication|1|||
127556774|NCT01708902|459006860|FG006|Overall Study|Refused to continue trial medication|1|||
127556775|NCT01708902|459006854|FG000|Overall Study|Other Reason|1|||
127556776|NCT01708902|459006855|FG001|Overall Study|Other Reason|0|||
127556777|NCT01708902|459006856|FG002|Overall Study|Other Reason|1|||
127556778|NCT01708902|459006857|FG003|Overall Study|Other Reason|1|||
127556779|NCT01708902|459006858|FG004|Overall Study|Other Reason|1|||
127556780|NCT01708902|459006859|FG005|Overall Study|Other Reason|2|||
127556781|NCT01708902|459006860|FG006|Overall Study|Other Reason|0|||
127556782|NCT02152956|459006861|FG000|Overall Study|Adverse Event|0|||
127556783|NCT02152956|459006862|FG001|Overall Study|Adverse Event|0|||
127556784|NCT02152956|459006863|FG002|Overall Study|Adverse Event|0|||
127556785|NCT02152956|459006864|FG003|Overall Study|Adverse Event|0|||
127556786|NCT02152956|459006865|FG004|Overall Study|Adverse Event|0|||
127556787|NCT02152956|459006866|FG005|Overall Study|Adverse Event|0|||
127556788|NCT02152956|459006867|FG006|Overall Study|Adverse Event|0|||
127556789|NCT02152956|459006868|FG007|Overall Study|Adverse Event|0|||
127556790|NCT02152956|459006869|FG008|Overall Study|Adverse Event|0|||
127556791|NCT02152956|459006870|FG009|Overall Study|Adverse Event|0|||
127556792|NCT02152956|459006871|FG010|Overall Study|Adverse Event|0|||
127556793|NCT02152956|459006872|FG011|Overall Study|Adverse Event|4|||
127556794|NCT02152956|459006873|FG012|Overall Study|Adverse Event|0|||
127556795|NCT02152956|459006861|FG000|Overall Study|Death|0|||
127556796|NCT02152956|459006862|FG001|Overall Study|Death|3|||
127556797|NCT02152956|459006863|FG002|Overall Study|Death|3|||
127556798|NCT02152956|459006864|FG003|Overall Study|Death|4|||
127556799|NCT02152956|459006865|FG004|Overall Study|Death|1|||
127556800|NCT02152956|459006866|FG005|Overall Study|Death|2|||
127556801|NCT02152956|459006867|FG006|Overall Study|Death|6|||
127556802|NCT02152956|459006868|FG007|Overall Study|Death|6|||
127556803|NCT02152956|459006869|FG008|Overall Study|Death|4|||
127556804|NCT02152956|459006870|FG009|Overall Study|Death|5|||
127556805|NCT02152956|459006871|FG010|Overall Study|Death|3|||
127774242|NCT01794520|459800294|FG004|Overall Study|Progressive disease|27|||
127774243|NCT01794520|459800295|FG005|Overall Study|Progressive disease|18|||
127774244|NCT01794520|459800296|FG006|Overall Study|Progressive disease|0|||
127774245|NCT01794520|459800290|FG000|Overall Study|Withdrew consent|0|||
127774246|NCT01794520|459800291|FG001|Overall Study|Withdrew consent|0|||
127774247|NCT01794520|459800292|FG002|Overall Study|Withdrew consent|1|||
127774248|NCT01794520|459800293|FG003|Overall Study|Withdrew consent|1|||
127774249|NCT01794520|459800294|FG004|Overall Study|Withdrew consent|0|||
127774250|NCT01794520|459800295|FG005|Overall Study|Withdrew consent|0|||
127774251|NCT01794520|459800296|FG006|Overall Study|Withdrew consent|0|||
127774252|NCT01794520|459800290|FG000|Overall Study|Lost to Follow-up|0|||
127774253|NCT01794520|459800291|FG001|Overall Study|Lost to Follow-up|0|||
127774254|NCT01794520|459800292|FG002|Overall Study|Lost to Follow-up|0|||
127774255|NCT01794520|459800293|FG003|Overall Study|Lost to Follow-up|0|||
127774256|NCT01794520|459800294|FG004|Overall Study|Lost to Follow-up|1|||
127774257|NCT01794520|459800295|FG005|Overall Study|Lost to Follow-up|0|||
127774258|NCT01794520|459800296|FG006|Overall Study|Lost to Follow-up|0|||
127774259|NCT01794520|459800290|FG000|Overall Study|Toxicity|0|||
127774260|NCT01794520|459800291|FG001|Overall Study|Toxicity|2|||
127774261|NCT01794520|459800292|FG002|Overall Study|Toxicity|0|||
127774262|NCT01794520|459800293|FG003|Overall Study|Toxicity|0|||
127774263|NCT01794520|459800294|FG004|Overall Study|Toxicity|0|||
127774264|NCT01794520|459800295|FG005|Overall Study|Toxicity|0|||
127774265|NCT01794520|459800296|FG006|Overall Study|Toxicity|0|||
127774266|NCT01794520|459800290|FG000|Overall Study|Study terminated by sponsor|0|||
127881022|NCT00835068|460186102|FG000|Overall Study|Withdrawal by Subject|1|||
127556806|NCT02152956|459006872|FG011|Overall Study|Death|143|||
127556807|NCT02152956|459006873|FG012|Overall Study|Death|12|||
127556808|NCT02152956|459006861|FG000|Overall Study|Lost to Follow-up|0|||
127556809|NCT02152956|459006862|FG001|Overall Study|Lost to Follow-up|1|||
127556810|NCT02152956|459006863|FG002|Overall Study|Lost to Follow-up|0|||
127556811|NCT02152956|459006864|FG003|Overall Study|Lost to Follow-up|0|||
127556812|NCT02152956|459006865|FG004|Overall Study|Lost to Follow-up|0|||
127556813|NCT02152956|459006866|FG005|Overall Study|Lost to Follow-up|0|||
127556814|NCT02152956|459006867|FG006|Overall Study|Lost to Follow-up|0|||
127556815|NCT02152956|459006868|FG007|Overall Study|Lost to Follow-up|0|||
127556816|NCT02152956|459006869|FG008|Overall Study|Lost to Follow-up|0|||
127556817|NCT02152956|459006870|FG009|Overall Study|Lost to Follow-up|0|||
127556818|NCT02152956|459006871|FG010|Overall Study|Lost to Follow-up|0|||
127556819|NCT02152956|459006872|FG011|Overall Study|Lost to Follow-up|3|||
127556820|NCT02152956|459006873|FG012|Overall Study|Lost to Follow-up|0|||
127556821|NCT02152956|459006861|FG000|Overall Study|Withdrawal by Subject|1|||
127556822|NCT02152956|459006862|FG001|Overall Study|Withdrawal by Subject|0|||
127556823|NCT02152956|459006863|FG002|Overall Study|Withdrawal by Subject|1|||
127556824|NCT02152956|459006864|FG003|Overall Study|Withdrawal by Subject|0|||
127556825|NCT02152956|459006865|FG004|Overall Study|Withdrawal by Subject|2|||
127556826|NCT02152956|459006866|FG005|Overall Study|Withdrawal by Subject|2|||
127556827|NCT02152956|459006867|FG006|Overall Study|Withdrawal by Subject|0|||
127556828|NCT02152956|459006868|FG007|Overall Study|Withdrawal by Subject|0|||
127556829|NCT02152956|459006869|FG008|Overall Study|Withdrawal by Subject|1|||
127556830|NCT02152956|459006870|FG009|Overall Study|Withdrawal by Subject|0|||
127556831|NCT02152956|459006871|FG010|Overall Study|Withdrawal by Subject|0|||
127556832|NCT02152956|459006872|FG011|Overall Study|Withdrawal by Subject|4|||
127556833|NCT02152956|459006873|FG012|Overall Study|Withdrawal by Subject|0|||
127556834|NCT02152956|459006861|FG000|Overall Study|Physician Decision|0|||
127556835|NCT02152956|459006862|FG001|Overall Study|Physician Decision|0|||
127556836|NCT02152956|459006863|FG002|Overall Study|Physician Decision|0|||
127556837|NCT02152956|459006864|FG003|Overall Study|Physician Decision|0|||
127556838|NCT02152956|459006865|FG004|Overall Study|Physician Decision|0|||
127556839|NCT02152956|459006866|FG005|Overall Study|Physician Decision|0|||
127556840|NCT02152956|459006867|FG006|Overall Study|Physician Decision|0|||
127556841|NCT02152956|459006868|FG007|Overall Study|Physician Decision|0|||
127556842|NCT02152956|459006869|FG008|Overall Study|Physician Decision|0|||
127556843|NCT02152956|459006870|FG009|Overall Study|Physician Decision|0|||
127556844|NCT02152956|459006871|FG010|Overall Study|Physician Decision|0|||
127556845|NCT02152956|459006872|FG011|Overall Study|Physician Decision|1|||
127556846|NCT02152956|459006873|FG012|Overall Study|Physician Decision|0|||
127556847|NCT02152956|459006861|FG000|Overall Study|Study terminated by sponsor|0|||
127556848|NCT02152956|459006862|FG001|Overall Study|Study terminated by sponsor|0|||
127556849|NCT02152956|459006863|FG002|Overall Study|Study terminated by sponsor|0|||
127556850|NCT02152956|459006864|FG003|Overall Study|Study terminated by sponsor|0|||
127556851|NCT02152956|459006865|FG004|Overall Study|Study terminated by sponsor|0|||
127556852|NCT02152956|459006866|FG005|Overall Study|Study terminated by sponsor|0|||
127556853|NCT02152956|459006867|FG006|Overall Study|Study terminated by sponsor|0|||
127556854|NCT02152956|459006868|FG007|Overall Study|Study terminated by sponsor|0|||
127556855|NCT02152956|459006869|FG008|Overall Study|Study terminated by sponsor|0|||
127556856|NCT02152956|459006870|FG009|Overall Study|Study terminated by sponsor|0|||
127556857|NCT02152956|459006871|FG010|Overall Study|Study terminated by sponsor|0|||
127556858|NCT02152956|459006872|FG011|Overall Study|Study terminated by sponsor|29|||
127556859|NCT02152956|459006873|FG012|Overall Study|Study terminated by sponsor|0|||
127556860|NCT02152956|459006861|FG000|Overall Study|progressive disease|0|||
127556861|NCT02152956|459006862|FG001|Overall Study|progressive disease|0|||
127556862|NCT02152956|459006863|FG002|Overall Study|progressive disease|0|||
127556863|NCT02152956|459006864|FG003|Overall Study|progressive disease|0|||
127556864|NCT02152956|459006865|FG004|Overall Study|progressive disease|0|||
127556865|NCT02152956|459006866|FG005|Overall Study|progressive disease|0|||
127556866|NCT02152956|459006867|FG006|Overall Study|progressive disease|0|||
127556867|NCT02152956|459006868|FG007|Overall Study|progressive disease|0|||
127556868|NCT02152956|459006869|FG008|Overall Study|progressive disease|1|||
127556869|NCT02152956|459006870|FG009|Overall Study|progressive disease|0|||
127556870|NCT02152956|459006871|FG010|Overall Study|progressive disease|0|||
127556871|NCT02152956|459006872|FG011|Overall Study|progressive disease|1|||
127556872|NCT02152956|459006873|FG012|Overall Study|progressive disease|0|||
127556873|NCT02445794|459006874|FG000|Overall Study|Adverse Event|0|||
127556874|NCT02445794|459006875|FG001|Overall Study|Adverse Event|0|||
127556875|NCT02445794|459006876|FG002|Overall Study|Adverse Event|2|||
127556876|NCT02445794|459006877|FG003|Overall Study|Adverse Event|0|||
127556877|NCT04189224|459006878|FG000|Period 2|Adverse Event|0|||
127556878|NCT04189224|459006879|FG001|Period 2|Adverse Event|1|||
127685830|NCT01061151|459476373|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
127685831|NCT01061151|459476374|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
127685832|NCT01061151|459476375|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
127685833|NCT01061151|459476372|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
127556879|NCT04198714|459006880|FG000|Overall Study|Physician Decision|0|||
127556880|NCT04198714|459006881|FG001|Overall Study|Physician Decision|1|||
127556881|NCT01064947|459006882|FG000|Overall Study|negative culture|41|||
127556882|NCT02970942|459006883|FG000|Overall Study|Death|0|||
127556883|NCT02970942|459006884|FG001|Overall Study|Death|1|||
127556884|NCT02970942|459006885|FG002|Overall Study|Death|0|||
127556885|NCT02970942|459006886|FG003|Overall Study|Death|0|||
127556886|NCT02970942|459006883|FG000|Overall Study|Lost to Follow-up|1|||
127556887|NCT02970942|459006884|FG001|Overall Study|Lost to Follow-up|0|||
127556888|NCT02970942|459006885|FG002|Overall Study|Lost to Follow-up|2|||
127556889|NCT02970942|459006886|FG003|Overall Study|Lost to Follow-up|1|||
127556890|NCT02970942|459006883|FG000|Overall Study|Withdrawal by Subject|3|||
127556891|NCT02970942|459006884|FG001|Overall Study|Withdrawal by Subject|5|||
127556892|NCT02970942|459006885|FG002|Overall Study|Withdrawal by Subject|3|||
127556893|NCT02970942|459006886|FG003|Overall Study|Withdrawal by Subject|2|||
127556894|NCT02529553|459006889|FG000|Overall Study|Progressive Disease|1|||
127556895|NCT02529553|459006890|FG001|Overall Study|Progressive Disease|0|||
127556896|NCT02529553|459006891|FG002|Overall Study|Progressive Disease|1|||
127556897|NCT02529553|459006892|FG003|Overall Study|Progressive Disease|3|||
127556898|NCT02529553|459006893|FG004|Overall Study|Progressive Disease|2|||
127556899|NCT02529553|459006894|FG005|Overall Study|Progressive Disease|3|||
127556900|NCT02529553|459006895|FG006|Overall Study|Progressive Disease|3|||
127556901|NCT02529553|459006896|FG007|Overall Study|Progressive Disease|5|||
127556902|NCT02529553|459006897|FG008|Overall Study|Progressive Disease|3|||
127556903|NCT02529553|459006889|FG000|Overall Study|Physician Decision|0|||
127556904|NCT02529553|459006890|FG001|Overall Study|Physician Decision|1|||
127556905|NCT02529553|459006891|FG002|Overall Study|Physician Decision|0|||
127556906|NCT02529553|459006892|FG003|Overall Study|Physician Decision|0|||
127556907|NCT02529553|459006893|FG004|Overall Study|Physician Decision|1|||
127556908|NCT02529553|459006894|FG005|Overall Study|Physician Decision|0|||
127556909|NCT02529553|459006895|FG006|Overall Study|Physician Decision|0|||
127556910|NCT02529553|459006896|FG007|Overall Study|Physician Decision|0|||
127556911|NCT02529553|459006897|FG008|Overall Study|Physician Decision|0|||
127556912|NCT02529553|459006889|FG000|Overall Study|Withdrawal by Subject|0|||
127556913|NCT02529553|459006890|FG001|Overall Study|Withdrawal by Subject|0|||
127556914|NCT02529553|459006891|FG002|Overall Study|Withdrawal by Subject|0|||
127556915|NCT02529553|459006892|FG003|Overall Study|Withdrawal by Subject|0|||
127556916|NCT02529553|459006893|FG004|Overall Study|Withdrawal by Subject|0|||
127556917|NCT02529553|459006894|FG005|Overall Study|Withdrawal by Subject|1|||
127556918|NCT02529553|459006895|FG006|Overall Study|Withdrawal by Subject|0|||
127556919|NCT02529553|459006896|FG007|Overall Study|Withdrawal by Subject|1|||
127556920|NCT02529553|459006897|FG008|Overall Study|Withdrawal by Subject|0|||
127556921|NCT00488683|459006898|FG000|Overall Study|Withdrawal by Subject|1|||
127556922|NCT00488683|459006899|FG001|Overall Study|Withdrawal by Subject|2|||
127556923|NCT00488683|459006900|FG002|Overall Study|Withdrawal by Subject|2|||
127556924|NCT00488683|459006898|FG000|Overall Study|Lost to Follow-up|5|||
127556925|NCT00488683|459006899|FG001|Overall Study|Lost to Follow-up|3|||
127556926|NCT00488683|459006900|FG002|Overall Study|Lost to Follow-up|0|||
127556927|NCT00488683|459006898|FG000|Overall Study|Protocol Violation|5|||
127556928|NCT00488683|459006899|FG001|Overall Study|Protocol Violation|1|||
127556929|NCT00488683|459006900|FG002|Overall Study|Protocol Violation|0|||
127556930|NCT00488683|459006898|FG000|Overall Study|Unable to Classify|1|||
127556931|NCT00488683|459006899|FG001|Overall Study|Unable to Classify|0|||
127556932|NCT00488683|459006900|FG002|Overall Study|Unable to Classify|0|||
127556933|NCT04549545|459008401|FG000|Initial Period|Withdrawal by Subject|4|||
127556934|NCT04549545|459008402|FG001|Initial Period|Withdrawal by Subject|0|||
127556935|NCT04549545|459008401|FG000|Initial Period|Additional ENT Procedure|3|||
127556936|NCT04549545|459008402|FG001|Initial Period|Additional ENT Procedure|0|||
127556937|NCT04549545|459008401|FG000|Initial Period|Lost to Follow-up|3|||
127556938|NCT04549545|459008402|FG001|Initial Period|Lost to Follow-up|1|||
127556939|NCT04549545|459008401|FG000|Initial Period|Ineligible for Crossover and Exited as study complete|0|||
127556940|NCT04549545|459008402|FG001|Initial Period|Ineligible for Crossover and Exited as study complete|9|||
127556941|NCT04549545|459008401|FG000|Crossover Period|Additional ENT Procedure|0|||
127556942|NCT04549545|459008402|FG001|Crossover Period|Additional ENT Procedure|6|||
127556943|NCT04549545|459008401|FG000|Crossover Period|Lost to Follow-up|0|||
127556944|NCT04549545|459008402|FG001|Crossover Period|Lost to Follow-up|1|||
127556945|NCT04549545|459008401|FG000|Crossover Period|Withdrawal by Subject|0|||
127556946|NCT04549545|459008402|FG001|Crossover Period|Withdrawal by Subject|4|||
127556947|NCT01006291|459008406|FG000|Overall Study|Adverse Event|2|||
127556948|NCT01006291|459008407|FG001|Overall Study|Adverse Event|1|||
127556949|NCT01006291|459008408|FG002|Overall Study|Adverse Event|2|||
127556950|NCT01006291|459008406|FG000|Overall Study|Lack of Efficacy|2|||
127774267|NCT01794520|459800291|FG001|Overall Study|Study terminated by sponsor|0|||
128021724|NCT04676646|460704581|FG001|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
128021725|NCT04676646|460704582|FG002|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
128021726|NCT04676646|460704580|FG000|Open-label Run-in Phase|Failure to Meet Randomization Criteria|144|||
128021727|NCT04676646|460704581|FG001|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
127556951|NCT01006291|459008407|FG001|Overall Study|Lack of Efficacy|2|||
127556952|NCT01006291|459008408|FG002|Overall Study|Lack of Efficacy|1|||
127556953|NCT01006291|459008406|FG000|Overall Study|Protocol Violation|3|||
127556954|NCT01006291|459008407|FG001|Overall Study|Protocol Violation|3|||
127556955|NCT01006291|459008408|FG002|Overall Study|Protocol Violation|3|||
127556956|NCT01006291|459008406|FG000|Overall Study|Withdrawal criteria|5|||
127556957|NCT01006291|459008407|FG001|Overall Study|Withdrawal criteria|4|||
127556958|NCT01006291|459008408|FG002|Overall Study|Withdrawal criteria|4|||
127556959|NCT01006291|459008406|FG000|Overall Study|Other|14|||
127556960|NCT01006291|459008407|FG001|Overall Study|Other|14|||
127556961|NCT01006291|459008408|FG002|Overall Study|Other|17|||
127556962|NCT03079102|459008409|FG000|Overall Study|Physician Decision|0|||
127556963|NCT03079102|459008410|FG001|Overall Study|Physician Decision|1|||
127556964|NCT02923921|459008411|FG000|Overall Study|Sponsor Decision|39|||
127556965|NCT02923921|459008412|FG001|Overall Study|Sponsor Decision|38|||
127556966|NCT02923921|459008411|FG000|Overall Study|Lost to Follow-up|1|||
127556967|NCT02923921|459008412|FG001|Overall Study|Lost to Follow-up|0|||
127556968|NCT02923921|459008411|FG000|Overall Study|Withdrawal by Subject|6|||
127556969|NCT02923921|459008412|FG001|Overall Study|Withdrawal by Subject|13|||
127556970|NCT02923921|459008411|FG000|Overall Study|Unknown, Not Collected|7|||
127556971|NCT02923921|459008412|FG001|Overall Study|Unknown, Not Collected|6|||
127556972|NCT00479687|459008413|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
127556973|NCT00479687|459008414|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
127556974|NCT00479687|459008415|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
127556975|NCT00479687|459008413|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
127556976|NCT00479687|459008414|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
127556977|NCT00479687|459008415|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
127556978|NCT00479687|459008413|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
127556979|NCT00479687|459008414|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
127556980|NCT00479687|459008415|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
127556981|NCT00479687|459008413|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
127556982|NCT00479687|459008414|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
127556983|NCT00479687|459008415|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
127556984|NCT00479687|459008413|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
127556985|NCT00479687|459008414|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
127556986|NCT00479687|459008415|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
127556987|NCT00479687|459008413|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
127556988|NCT00479687|459008414|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
127556989|NCT00479687|459008415|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
127556990|NCT00479687|459008413|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
127556991|NCT00479687|459008414|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
127556992|NCT00479687|459008415|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
127556993|NCT00479687|459008413|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
127556994|NCT00479687|459008414|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
127556995|NCT00479687|459008415|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
127556996|NCT00479687|459008413|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
127556997|NCT00479687|459008414|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
127556998|NCT00479687|459008415|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
127556999|NCT00295880|459008416|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
127557000|NCT00295880|459008416|FG000|Overall Study|Unit randomization did not occur|1|||
127557001|NCT01474239|459008417|FG000|Overall Study|Disease Progression|37|||
127557002|NCT01474239|459008418|FG001|Overall Study|Disease Progression|25|||
127557003|NCT01474239|459008417|FG000|Overall Study|Adverse Event|12|||
127557004|NCT01474239|459008418|FG001|Overall Study|Adverse Event|3|||
127557005|NCT01474239|459008417|FG000|Overall Study|Withdrawal by Subject|1|||
127557006|NCT01474239|459008418|FG001|Overall Study|Withdrawal by Subject|2|||
127557007|NCT01474239|459008417|FG000|Overall Study|Death|1|||
127557008|NCT01474239|459008418|FG001|Overall Study|Death|1|||
127557009|NCT01474239|459008417|FG000|Overall Study|Clinical Disease Progression|7|||
127557010|NCT01474239|459008418|FG001|Overall Study|Clinical Disease Progression|1|||
127557011|NCT01474239|459008417|FG000|Overall Study|Withdrawal for Economic Reason|1|||
127557012|NCT01474239|459008418|FG001|Overall Study|Withdrawal for Economic Reason|0|||
127557013|NCT02175199|459008421|FG000|Overall Study|Withdrawal by Subject|1|||
127557014|NCT02175199|459008422|FG001|Overall Study|Withdrawal by Subject|5|||
127557015|NCT02175199|459008421|FG000|Overall Study|Randomized in Error|1|||
127557016|NCT02175199|459008422|FG001|Overall Study|Randomized in Error|0|||
127557017|NCT02175199|459008421|FG000|Overall Study|Sponsor Decision|1|||
127557018|NCT02175199|459008422|FG001|Overall Study|Sponsor Decision|0|||
127557019|NCT03983317|459008429|FG000|Overall Study|Physician Decision|5|||
127557020|NCT01761162|459008430|FG000|Overall Study|Withdrawal by Subject|3|||
127557021|NCT02741518|459008431|FG000|Overall Study|Withdrawal by Subject|1|||
127557022|NCT02741518|459008432|FG001|Overall Study|Withdrawal by Subject|1|||
127685834|NCT01061151|459476373|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
127685835|NCT01061151|459476374|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
127685836|NCT01061151|459476375|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
127685837|NCT01061151|459476372|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
127685838|NCT01061151|459476373|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
127685839|NCT01061151|459476374|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
127557023|NCT01349049|459008433|FG000|Overall Study|Disease progression|3|||
127685840|NCT01061151|459476375|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
127557024|NCT01349049|459008434|FG001|Overall Study|Disease progression|5|||
127557025|NCT01349049|459008435|FG002|Overall Study|Disease progression|3|||
127557026|NCT01349049|459008436|FG003|Overall Study|Disease progression|2|||
127557027|NCT01349049|459008437|FG004|Overall Study|Disease progression|2|||
127557028|NCT01349049|459008438|FG005|Overall Study|Disease progression|2|||
127557029|NCT01349049|459008439|FG006|Overall Study|Disease progression|3|||
127557030|NCT01349049|459008440|FG007|Overall Study|Disease progression|2|||
127557031|NCT01349049|459008441|FG008|Overall Study|Disease progression|33|||
127557032|NCT01349049|459008433|FG000|Overall Study|Adverse Event|0|||
127557033|NCT01349049|459008434|FG001|Overall Study|Adverse Event|1|||
127557034|NCT01349049|459008435|FG002|Overall Study|Adverse Event|0|||
127557035|NCT01349049|459008436|FG003|Overall Study|Adverse Event|0|||
127557036|NCT01349049|459008437|FG004|Overall Study|Adverse Event|0|||
127557037|NCT01349049|459008438|FG005|Overall Study|Adverse Event|3|||
127557038|NCT01349049|459008439|FG006|Overall Study|Adverse Event|1|||
127557039|NCT01349049|459008440|FG007|Overall Study|Adverse Event|0|||
127557040|NCT01349049|459008441|FG008|Overall Study|Adverse Event|4|||
127557041|NCT01349049|459008433|FG000|Overall Study|Physician Decision|0|||
127557042|NCT01349049|459008434|FG001|Overall Study|Physician Decision|1|||
127557043|NCT01349049|459008435|FG002|Overall Study|Physician Decision|0|||
127557044|NCT01349049|459008436|FG003|Overall Study|Physician Decision|0|||
127557045|NCT01349049|459008437|FG004|Overall Study|Physician Decision|0|||
127557046|NCT01349049|459008438|FG005|Overall Study|Physician Decision|0|||
127557047|NCT01349049|459008439|FG006|Overall Study|Physician Decision|0|||
127557048|NCT01349049|459008440|FG007|Overall Study|Physician Decision|0|||
127557049|NCT01349049|459008441|FG008|Overall Study|Physician Decision|2|||
127557050|NCT01349049|459008433|FG000|Overall Study|Protocol Violation|0|||
127557051|NCT01349049|459008434|FG001|Overall Study|Protocol Violation|0|||
127557052|NCT01349049|459008435|FG002|Overall Study|Protocol Violation|0|||
127557053|NCT01349049|459008436|FG003|Overall Study|Protocol Violation|0|||
127557054|NCT01349049|459008437|FG004|Overall Study|Protocol Violation|0|||
127557055|NCT01349049|459008438|FG005|Overall Study|Protocol Violation|0|||
127557056|NCT01349049|459008439|FG006|Overall Study|Protocol Violation|0|||
127557057|NCT01349049|459008440|FG007|Overall Study|Protocol Violation|0|||
127557058|NCT01349049|459008441|FG008|Overall Study|Protocol Violation|1|||
127557059|NCT01349049|459008433|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
127557060|NCT01349049|459008434|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
127557061|NCT01349049|459008435|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
127557062|NCT01349049|459008436|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
127557063|NCT01349049|459008437|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
127557064|NCT01349049|459008438|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
127557065|NCT01349049|459008439|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
127557066|NCT01349049|459008440|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
127557067|NCT01349049|459008441|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
127557068|NCT01349049|459008433|FG000|Overall Study|Other|0|||
127557069|NCT01349049|459008434|FG001|Overall Study|Other|0|||
127557070|NCT01349049|459008435|FG002|Overall Study|Other|0|||
127557071|NCT01349049|459008436|FG003|Overall Study|Other|0|||
127557072|NCT01349049|459008437|FG004|Overall Study|Other|0|||
127557073|NCT01349049|459008438|FG005|Overall Study|Other|1|||
127557074|NCT01349049|459008439|FG006|Overall Study|Other|0|||
127557075|NCT01349049|459008440|FG007|Overall Study|Other|0|||
127557076|NCT01349049|459008441|FG008|Overall Study|Other|4|||
127557077|NCT01349049|459008433|FG000|Overall Study|Death|0|||
127557078|NCT01349049|459008434|FG001|Overall Study|Death|0|||
127557079|NCT01349049|459008435|FG002|Overall Study|Death|0|||
127557080|NCT01349049|459008436|FG003|Overall Study|Death|0|||
127557081|NCT01349049|459008437|FG004|Overall Study|Death|0|||
127557082|NCT01349049|459008438|FG005|Overall Study|Death|0|||
127557083|NCT01349049|459008439|FG006|Overall Study|Death|0|||
127557084|NCT01349049|459008440|FG007|Overall Study|Death|1|||
127557085|NCT01349049|459008441|FG008|Overall Study|Death|5|||
127557086|NCT01349049|459008433|FG000|Overall Study|Non-compliance|0|||
127557087|NCT01349049|459008434|FG001|Overall Study|Non-compliance|0|||
127557088|NCT01349049|459008435|FG002|Overall Study|Non-compliance|0|||
127557089|NCT01349049|459008436|FG003|Overall Study|Non-compliance|1|||
127557090|NCT01349049|459008437|FG004|Overall Study|Non-compliance|0|||
127557091|NCT01349049|459008438|FG005|Overall Study|Non-compliance|0|||
127685841|NCT01061151|459476372|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
127557092|NCT01349049|459008439|FG006|Overall Study|Non-compliance|0|||
127557093|NCT01349049|459008440|FG007|Overall Study|Non-compliance|0|||
127557094|NCT01349049|459008441|FG008|Overall Study|Non-compliance|0|||
127557095|NCT01349049|459008433|FG000|Overall Study|Withdrawal by Subject|0|||
127557096|NCT01349049|459008434|FG001|Overall Study|Withdrawal by Subject|0|||
127557097|NCT01349049|459008435|FG002|Overall Study|Withdrawal by Subject|0|||
127557098|NCT01349049|459008436|FG003|Overall Study|Withdrawal by Subject|0|||
127557099|NCT01349049|459008437|FG004|Overall Study|Withdrawal by Subject|0|||
127557100|NCT01349049|459008438|FG005|Overall Study|Withdrawal by Subject|0|||
127557101|NCT01349049|459008439|FG006|Overall Study|Withdrawal by Subject|0|||
127557102|NCT01349049|459008440|FG007|Overall Study|Withdrawal by Subject|0|||
127557103|NCT01349049|459008441|FG008|Overall Study|Withdrawal by Subject|6|||
127557104|NCT04681352|459008447|FG000|Overall Study|Lost to Follow-up|2|||
127557105|NCT04681352|459008447|FG000|Overall Study|Withdrawal by Subject|22|||
127557106|NCT01643772|459008448|FG000|Overall Study|Protocol Violation|0|||
127557107|NCT01643772|459008449|FG001|Overall Study|Protocol Violation|0|||
127557108|NCT01643772|459008450|FG002|Overall Study|Protocol Violation|0|||
127557109|NCT01643772|459008451|FG003|Overall Study|Protocol Violation|1|||
127557110|NCT01643772|459008448|FG000|Overall Study|Adverse Event|0|||
127557111|NCT01643772|459008449|FG001|Overall Study|Adverse Event|0|||
127557112|NCT01643772|459008450|FG002|Overall Study|Adverse Event|0|||
127557113|NCT01643772|459008451|FG003|Overall Study|Adverse Event|1|||
127557114|NCT02810444|459008452|FG000|Overall Study|Screen Failures|14|||
127557115|NCT02810444|459008452|FG000|Overall Study|Withdrawal by Subject|4|||
127557116|NCT02810444|459008452|FG000|Overall Study|Adverse Event|3|||
127557117|NCT02785770|459008453|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
127557118|NCT02785770|459008454|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
127557119|NCT02785770|459008455|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
127557120|NCT02785770|459008456|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
127557121|NCT02785770|459008453|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
127557122|NCT02785770|459008454|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
127557123|NCT02785770|459008455|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
127557124|NCT02785770|459008456|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
127557125|NCT02785770|459008453|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
127557126|NCT02785770|459008454|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
127557127|NCT02785770|459008455|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
127557128|NCT02785770|459008456|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
127557129|NCT04518995|459008457|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
127557130|NCT04518995|459008458|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
127557131|NCT04518995|459008459|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
127557132|NCT04518995|459008457|FG000|Overall Study|Lack of Efficacy|2|||
127557133|NCT04518995|459008458|FG001|Overall Study|Lack of Efficacy|1|||
127557134|NCT04518995|459008459|FG002|Overall Study|Lack of Efficacy|0|||
127557135|NCT04518995|459008457|FG000|Overall Study|Non-compliance With Study Drug|0|||
127557136|NCT04518995|459008458|FG001|Overall Study|Non-compliance With Study Drug|3|||
127557137|NCT04518995|459008459|FG002|Overall Study|Non-compliance With Study Drug|2|||
127557138|NCT04518995|459008457|FG000|Overall Study|Pregnancy|0|||
127557139|NCT04518995|459008458|FG001|Overall Study|Pregnancy|0|||
127557140|NCT04518995|459008459|FG002|Overall Study|Pregnancy|1|||
127557141|NCT04518995|459008457|FG000|Overall Study|Protocol Violation|2|||
127557142|NCT04518995|459008458|FG001|Overall Study|Protocol Violation|0|||
127557143|NCT04518995|459008459|FG002|Overall Study|Protocol Violation|1|||
127557144|NCT04518995|459008457|FG000|Overall Study|Reason not Specified|4|||
127557145|NCT04518995|459008458|FG001|Overall Study|Reason not Specified|11|||
127557146|NCT04518995|459008459|FG002|Overall Study|Reason not Specified|2|||
127557147|NCT04518995|459008457|FG000|Overall Study|Lost to Follow-up|1|||
127557148|NCT04518995|459008458|FG001|Overall Study|Lost to Follow-up|10|||
127557149|NCT04518995|459008459|FG002|Overall Study|Lost to Follow-up|6|||
127557150|NCT00545272|459008462|FG000|Overall Study|Protocol deviation|0|||
127557151|NCT00545272|459008463|FG001|Overall Study|Protocol deviation|1|||
127557152|NCT00545272|459008464|FG002|Overall Study|Protocol deviation|0|||
127557153|NCT00545272|459008465|FG003|Overall Study|Protocol deviation|1|||
127557154|NCT00545272|459008466|FG004|Overall Study|Protocol deviation|0|||
127557155|NCT00545272|459008467|FG005|Overall Study|Protocol deviation|1|||
127557156|NCT00545272|459008462|FG000|Overall Study|Adverse Event|0|||
127557157|NCT00545272|459008463|FG001|Overall Study|Adverse Event|0|||
127557158|NCT00545272|459008464|FG002|Overall Study|Adverse Event|1|||
127685842|NCT01061151|459476373|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
127685843|NCT01061151|459476374|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
127685844|NCT01061151|459476375|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
127685845|NCT01061151|459476372|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
127685846|NCT01061151|459476373|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
127685847|NCT01061151|459476374|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
127685848|NCT01061151|459476375|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
127685849|NCT01061151|459476372|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
127685850|NCT01061151|459476373|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
127685851|NCT01061151|459476374|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
127685852|NCT01061151|459476375|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
128021728|NCT04676646|460704582|FG002|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
127557159|NCT00545272|459008465|FG003|Overall Study|Adverse Event|0|||
127557160|NCT00545272|459008466|FG004|Overall Study|Adverse Event|0|||
127557161|NCT00545272|459008467|FG005|Overall Study|Adverse Event|1|||
127557162|NCT00545272|459008462|FG000|Overall Study|Abnormal laboratory value(s)|0|||
127557163|NCT00545272|459008463|FG001|Overall Study|Abnormal laboratory value(s)|0|||
127557164|NCT00545272|459008464|FG002|Overall Study|Abnormal laboratory value(s)|0|||
127557165|NCT00545272|459008465|FG003|Overall Study|Abnormal laboratory value(s)|0|||
127557166|NCT00545272|459008466|FG004|Overall Study|Abnormal laboratory value(s)|0|||
127557167|NCT00545272|459008467|FG005|Overall Study|Abnormal laboratory value(s)|1|||
127557168|NCT00545272|459008462|FG000|Overall Study|Abnormal test procedure result(s)|0|||
127557169|NCT00545272|459008463|FG001|Overall Study|Abnormal test procedure result(s)|0|||
127557170|NCT00545272|459008464|FG002|Overall Study|Abnormal test procedure result(s)|0|||
127557171|NCT00545272|459008465|FG003|Overall Study|Abnormal test procedure result(s)|0|||
127557172|NCT00545272|459008466|FG004|Overall Study|Abnormal test procedure result(s)|1|||
127557173|NCT00545272|459008467|FG005|Overall Study|Abnormal test procedure result(s)|0|||
127557174|NCT00545272|459008462|FG000|Overall Study|Lost to Follow-up|0|||
128021729|NCT04676646|460704580|FG000|Open-label Run-in Phase|Lost to Follow-up|1|||
128021730|NCT04676646|460704581|FG001|Open-label Run-in Phase|Lost to Follow-up|0|||
128021731|NCT04676646|460704582|FG002|Open-label Run-in Phase|Lost to Follow-up|0|||
128021732|NCT04676646|460704580|FG000|Open-label Run-in Phase|Withdrawal by Subject|8|||
128021733|NCT04676646|460704581|FG001|Open-label Run-in Phase|Withdrawal by Subject|0|||
128021734|NCT04676646|460704582|FG002|Open-label Run-in Phase|Withdrawal by Subject|0|||
128021735|NCT04676646|460704580|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|1|||
128021736|NCT04676646|460704581|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
128021737|NCT04676646|460704582|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
128021738|NCT04676646|460704580|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|1|||
128021739|NCT04676646|460704581|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
128021740|NCT04676646|460704582|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
128021741|NCT04676646|460704580|FG000|Randomised-withdrawal Phase|Adverse Event|0|||
128021742|NCT04676646|460704581|FG001|Randomised-withdrawal Phase|Adverse Event|5|||
128021743|NCT04676646|460704582|FG002|Randomised-withdrawal Phase|Adverse Event|5|||
128021744|NCT04676646|460704580|FG000|Randomised-withdrawal Phase|Death|0|||
127557175|NCT00545272|459008463|FG001|Overall Study|Lost to Follow-up|0|||
127557176|NCT00545272|459008464|FG002|Overall Study|Lost to Follow-up|0|||
128021745|NCT04676646|460704581|FG001|Randomised-withdrawal Phase|Death|1|||
128021746|NCT04676646|460704582|FG002|Randomised-withdrawal Phase|Death|2|||
128021747|NCT04676646|460704580|FG000|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|0|||
128021748|NCT04676646|460704581|FG001|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|2|||
128021749|NCT04676646|460704582|FG002|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|4|||
128021750|NCT04676646|460704580|FG000|Randomised-withdrawal Phase|Lost to Follow-up|0|||
128021751|NCT04676646|460704581|FG001|Randomised-withdrawal Phase|Lost to Follow-up|1|||
128021752|NCT04676646|460704582|FG002|Randomised-withdrawal Phase|Lost to Follow-up|0|||
128021753|NCT04676646|460704580|FG000|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
128021754|NCT04676646|460704581|FG001|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|1|||
127557177|NCT00545272|459008465|FG003|Overall Study|Lost to Follow-up|0|||
127557178|NCT00545272|459008466|FG004|Overall Study|Lost to Follow-up|1|||
127557179|NCT00545272|459008467|FG005|Overall Study|Lost to Follow-up|0|||
127557180|NCT04491604|459008468|FG000|Overall Study|Withdrawal by Subject|3|||
127557181|NCT00373113|459008469|FG000|Overall Study|Death|1|||
127557182|NCT00373113|459008470|FG001|Overall Study|Death|7|||
128021755|NCT04676646|460704582|FG002|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
128021756|NCT04676646|460704580|FG000|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
127557183|NCT00373113|459008469|FG000|Overall Study|Adverse Event|38|||
127557184|NCT00373113|459008470|FG001|Overall Study|Adverse Event|24|||
127557185|NCT00373113|459008469|FG000|Overall Study|Study terminated by sponsor|9|||
127557186|NCT00373113|459008470|FG001|Overall Study|Study terminated by sponsor|1|||
127557187|NCT00373113|459008469|FG000|Overall Study|Global deterioration of health status|10|||
127557188|NCT00373113|459008470|FG001|Overall Study|Global deterioration of health status|7|||
128021757|NCT04676646|460704581|FG001|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|1|||
127557189|NCT00373113|459008469|FG000|Overall Study|Lost to Follow-up|1|||
127557190|NCT00373113|459008470|FG001|Overall Study|Lost to Follow-up|3|||
128021758|NCT04676646|460704582|FG002|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
128021759|NCT04676646|460704580|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
128021760|NCT04676646|460704581|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
127557191|NCT00373113|459008469|FG000|Overall Study|Objective progression or relapse|150|||
127557192|NCT00373113|459008470|FG001|Overall Study|Objective progression or relapse|169|||
127557193|NCT00373113|459008469|FG000|Overall Study|Other|14|||
127557194|NCT00373113|459008470|FG001|Overall Study|Other|17|||
127557195|NCT00373113|459008469|FG000|Overall Study|Protocol Violation|5|||
127557196|NCT00373113|459008470|FG001|Overall Study|Protocol Violation|1|||
127557197|NCT00373113|459008469|FG000|Overall Study|Withdrawal by Subject|10|||
127557198|NCT00373113|459008470|FG001|Overall Study|Withdrawal by Subject|15|||
127557199|NCT00975689|459008473|FG000|Overall Study|Adverse Event|0|||
127557200|NCT00975689|459008474|FG001|Overall Study|Adverse Event|3|||
127557201|NCT00975689|459008473|FG000|Overall Study|Withdrawal by Subject|1|||
127557202|NCT00975689|459008474|FG001|Overall Study|Withdrawal by Subject|0|||
127557203|NCT00975689|459008473|FG000|Overall Study|Physician Decision|1|||
127557204|NCT00975689|459008474|FG001|Overall Study|Physician Decision|0|||
127557205|NCT01402102|459008475|FG000|Overall Study|Protocol Violation|1|||
127557206|NCT01402102|459008476|FG001|Overall Study|Protocol Violation|0|||
127557207|NCT01402102|459008475|FG000|Overall Study|Insufficiency of compliance|1|||
127557208|NCT01402102|459008476|FG001|Overall Study|Insufficiency of compliance|1|||
127557209|NCT01402102|459008475|FG000|Overall Study|Withdrawal by Subject|0|||
127557210|NCT01402102|459008476|FG001|Overall Study|Withdrawal by Subject|2|||
127557211|NCT01305577|459008478|FG000|Overall Study|Adverse Event|2|||
127557212|NCT01305577|459008479|FG001|Overall Study|Adverse Event|2|||
127557213|NCT01305577|459008480|FG002|Overall Study|Adverse Event|1|||
127557214|NCT01305577|459008478|FG000|Overall Study|Withdrawal by Subject|7|||
127557215|NCT01305577|459008479|FG001|Overall Study|Withdrawal by Subject|5|||
127557216|NCT01305577|459008480|FG002|Overall Study|Withdrawal by Subject|6|||
127557217|NCT01305577|459008478|FG000|Overall Study|Lost to Follow-up|4|||
127557218|NCT01305577|459008479|FG001|Overall Study|Lost to Follow-up|3|||
127557219|NCT01305577|459008480|FG002|Overall Study|Lost to Follow-up|2|||
127557220|NCT01305577|459008478|FG000|Overall Study|Protocol Deviation|0|||
127557221|NCT01305577|459008479|FG001|Overall Study|Protocol Deviation|1|||
127557222|NCT01305577|459008480|FG002|Overall Study|Protocol Deviation|1|||
127557223|NCT00905645|459008481|FG000|Overall Study|Death (not device related)|10|||
127557224|NCT00905645|459008482|FG001|Overall Study|Death (not device related)|4|||
127557225|NCT00905645|459008483|FG002|Overall Study|Death (not device related)|15|||
127557226|NCT00905645|459008484|FG003|Overall Study|Death (not device related)|8|||
127557227|NCT00905645|459008481|FG000|Overall Study|Explantation of study device(s)|78|||
127557228|NCT00905645|459008482|FG001|Overall Study|Explantation of study device(s)|47|||
127557229|NCT00905645|459008483|FG002|Overall Study|Explantation of study device(s)|28|||
127557230|NCT00905645|459008484|FG003|Overall Study|Explantation of study device(s)|21|||
127557231|NCT00905645|459008481|FG000|Overall Study|Subject Request|41|||
127557232|NCT00905645|459008482|FG001|Overall Study|Subject Request|17|||
127557233|NCT00905645|459008483|FG002|Overall Study|Subject Request|13|||
127557234|NCT00905645|459008484|FG003|Overall Study|Subject Request|11|||
127557235|NCT00905645|459008481|FG000|Overall Study|Lost to Follow-up|299|||
127557236|NCT00905645|459008482|FG001|Overall Study|Lost to Follow-up|103|||
127557237|NCT00905645|459008483|FG002|Overall Study|Lost to Follow-up|51|||
127557238|NCT00905645|459008484|FG003|Overall Study|Lost to Follow-up|12|||
127557239|NCT02364336|459008485|FG000|Overall Study|Adverse Event|0|||
127557240|NCT02364336|459008486|FG001|Overall Study|Adverse Event|1|||
127557241|NCT01731938|459008487|FG000|Preliminary Part I|Withdrawal by Subject|2|||
127557242|NCT01731938|459008488|FG001|Preliminary Part I|Withdrawal by Subject|2|||
127557243|NCT01731938|459008487|FG000|Preliminary Part I|Physician Decision|1|||
127557244|NCT01731938|459008488|FG001|Preliminary Part I|Physician Decision|0|||
127557245|NCT01731938|459008487|FG000|Preliminary Part I|Lost to Follow-up|0|||
127557246|NCT01731938|459008488|FG001|Preliminary Part I|Lost to Follow-up|3|||
127557247|NCT01731938|459008487|FG000|Preliminary Part I|Missed Week 6 visit|0|||
127557248|NCT01731938|459008488|FG001|Preliminary Part I|Missed Week 6 visit|3|||
127557249|NCT01731938|459008487|FG000|Primary Part II|Withdrawal by Subject|5|||
127557250|NCT01731938|459008488|FG001|Primary Part II|Withdrawal by Subject|4|||
127557251|NCT01731938|459008487|FG000|Primary Part II|Lost to Follow-up|4|||
127557252|NCT01731938|459008488|FG001|Primary Part II|Lost to Follow-up|5|||
127557253|NCT01731938|459008487|FG000|Primary Part II|Death|2|||
127557254|NCT01731938|459008488|FG001|Primary Part II|Death|1|||
127557255|NCT01731938|459008487|FG000|Primary Part II|Missed Week 6 visit|2|||
127557256|NCT01731938|459008488|FG001|Primary Part II|Missed Week 6 visit|3|||
127557257|NCT04931888|459008489|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
127685853|NCT01061151|459476372|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
127685854|NCT01061151|459476373|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
127685855|NCT01061151|459476374|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
127685856|NCT01061151|459476375|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
127685857|NCT04530747|459476378|FG000|Overall Study|Withdrawal by Subject|1|||
127685858|NCT04530747|459476379|FG001|Overall Study|Withdrawal by Subject|0|||
127685859|NCT03292913|459476380|FG000|Overall Study|Death|9|||
127685860|NCT03292913|459476381|FG001|Overall Study|Death|3|||
127685861|NCT03292913|459476380|FG000|Overall Study|Lost to Follow-up|49|||
127685862|NCT03292913|459476381|FG001|Overall Study|Lost to Follow-up|49|||
127685863|NCT03292913|459476380|FG000|Overall Study|Withdrawal by Subject|2|||
127557258|NCT04931888|459008490|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
127557259|NCT04931888|459008491|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
127557260|NCT04931888|459008492|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
127557261|NCT02136069|459008493|FG000|Overall Study|UC flare-up|1|||
127557262|NCT02136069|459008494|FG001|Overall Study|UC flare-up|0|||
127557263|NCT02136069|459008493|FG000|Overall Study|Adverse Event|6|||
127557264|NCT02136069|459008494|FG001|Overall Study|Adverse Event|8|||
127557265|NCT02136069|459008493|FG000|Overall Study|Death|0|||
127685864|NCT03292913|459476381|FG001|Overall Study|Withdrawal by Subject|0|||
127685865|NCT03292913|459476380|FG000|Overall Study|Clinic closed due to COVID|22|||
127557266|NCT02136069|459008494|FG001|Overall Study|Death|1|||
127557267|NCT02136069|459008493|FG000|Overall Study|Lack of Efficacy|10|||
127557268|NCT02136069|459008494|FG001|Overall Study|Lack of Efficacy|4|||
127557269|NCT02136069|459008493|FG000|Overall Study|Lost to Follow-up|1|||
127557270|NCT02136069|459008494|FG001|Overall Study|Lost to Follow-up|0|||
127557271|NCT02136069|459008493|FG000|Overall Study|Non-Compliance|1|||
127557272|NCT02136069|459008494|FG001|Overall Study|Non-Compliance|0|||
127557273|NCT02136069|459008493|FG000|Overall Study|Physician Decision|5|||
127557274|NCT02136069|459008494|FG001|Overall Study|Physician Decision|4|||
127557275|NCT02136069|459008493|FG000|Overall Study|Withdrawal by Subject|10|||
127557276|NCT02136069|459008494|FG001|Overall Study|Withdrawal by Subject|11|||
127557277|NCT04538144|459008495|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
127557278|NCT04538144|459008496|FG001|Washout (1 Week)|Withdrawal by Subject|0|||
127557279|NCT04538144|459008497|FG002|Washout (1 Week)|Withdrawal by Subject|0|||
127557280|NCT04538144|459008498|FG003|Washout (1 Week)|Withdrawal by Subject|1|||
127557281|NCT01092546|459008499|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
127557282|NCT00947882|459008517|FG000|Overall Study|Adverse Event|0|||
127557283|NCT00947882|459008518|FG001|Overall Study|Adverse Event|1|||
127557284|NCT00947882|459008519|FG002|Overall Study|Adverse Event|4|||
127557285|NCT00947882|459008520|FG003|Overall Study|Adverse Event|4|||
127557286|NCT00947882|459008517|FG000|Overall Study|Withdrawal by Subject|2|||
127557287|NCT00947882|459008518|FG001|Overall Study|Withdrawal by Subject|0|||
127557288|NCT00947882|459008519|FG002|Overall Study|Withdrawal by Subject|8|||
127557289|NCT00947882|459008520|FG003|Overall Study|Withdrawal by Subject|2|||
127557290|NCT00947882|459008517|FG000|Overall Study|Protocol Violation|0|||
127557291|NCT00947882|459008518|FG001|Overall Study|Protocol Violation|0|||
127557292|NCT00947882|459008519|FG002|Overall Study|Protocol Violation|1|||
127557293|NCT00947882|459008520|FG003|Overall Study|Protocol Violation|0|||
127557294|NCT00947882|459008517|FG000|Overall Study|Lost to Follow-up|0|||
127557295|NCT00947882|459008518|FG001|Overall Study|Lost to Follow-up|2|||
127557296|NCT00947882|459008519|FG002|Overall Study|Lost to Follow-up|1|||
127557297|NCT00947882|459008520|FG003|Overall Study|Lost to Follow-up|0|||
127557298|NCT00947882|459008517|FG000|Overall Study|Other/Unknown|10|||
127557299|NCT00947882|459008518|FG001|Overall Study|Other/Unknown|13|||
127557300|NCT00947882|459008519|FG002|Overall Study|Other/Unknown|3|||
127557301|NCT00947882|459008520|FG003|Overall Study|Other/Unknown|6|||
127557302|NCT00947882|459008517|FG000|Overall Study|Trial Terminated by Sponsor|62|||
127557303|NCT00947882|459008518|FG001|Overall Study|Trial Terminated by Sponsor|61|||
127557304|NCT00947882|459008519|FG002|Overall Study|Trial Terminated by Sponsor|62|||
127557305|NCT00947882|459008520|FG003|Overall Study|Trial Terminated by Sponsor|70|||
127557306|NCT00329797|459008521|FG000|Overall Study|Protocol Violation|1|||
127557307|NCT00329797|459008522|FG001|Overall Study|Protocol Violation|0|||
127557308|NCT00329797|459008521|FG000|Overall Study|Withdrawal by Subject|6|||
127557309|NCT00329797|459008522|FG001|Overall Study|Withdrawal by Subject|6|||
127557310|NCT03037580|459008525|FG000|Overall Study|Withdrawal by Subject|3|||
127557311|NCT03037580|459008526|FG001|Overall Study|Withdrawal by Subject|0|||
127557312|NCT03037580|459008525|FG000|Overall Study|Adverse Event|1|||
127557313|NCT03037580|459008526|FG001|Overall Study|Adverse Event|0|||
127557314|NCT03037580|459008525|FG000|Overall Study|Study Terminated by Sponsor|12|||
127557315|NCT03037580|459008526|FG001|Overall Study|Study Terminated by Sponsor|15|||
127557316|NCT03037580|459008525|FG000|Overall Study|Death|0|||
127557317|NCT03037580|459008526|FG001|Overall Study|Death|1|||
127557318|NCT02087423|459008527|FG000|Overall Study|Withdrawal by Subject|20|||
127557319|NCT02087423|459008528|FG001|Overall Study|Withdrawal by Subject|20|||
127557320|NCT02087423|459008529|FG002|Overall Study|Withdrawal by Subject|3|||
127557321|NCT02087423|459008527|FG000|Overall Study|Death|68|||
127557322|NCT02087423|459008528|FG001|Overall Study|Death|207|||
127557323|NCT02087423|459008529|FG002|Overall Study|Death|40|||
127557324|NCT02087423|459008527|FG000|Overall Study|Lost to Follow-up|0|||
127557325|NCT02087423|459008528|FG001|Overall Study|Lost to Follow-up|2|||
127685866|NCT03292913|459476381|FG001|Overall Study|Clinic closed due to COVID|36|||
127685867|NCT03950622|459476382|FG000|Overall Study|Withdrawal by Subject|1|||
127685868|NCT03950622|459476383|FG001|Overall Study|Withdrawal by Subject|0|||
127685869|NCT03950622|459476382|FG000|Overall Study|Protocol Deviation|0|||
127685870|NCT03950622|459476383|FG001|Overall Study|Protocol Deviation|1|||
127685871|NCT03950622|459476382|FG000|Overall Study|Physician Decision|1|||
127685872|NCT03950622|459476383|FG001|Overall Study|Physician Decision|0|||
127685873|NCT03950622|459476382|FG000|Overall Study|Lost to Follow-up|5|||
127685874|NCT03950622|459476383|FG001|Overall Study|Lost to Follow-up|5|||
127685875|NCT03950622|459476382|FG000|Overall Study|Death|1|||
127557326|NCT02087423|459008529|FG002|Overall Study|Lost to Follow-up|0|||
127685876|NCT03950622|459476383|FG001|Overall Study|Death|1|||
127685877|NCT03752151|459476384|FG000|Overall Study|Withdrawal by Subject|1|||
127685878|NCT03752151|459476384|FG000|Overall Study|Protocol Violation|1|||
127685879|NCT00529516|459476385|FG000|Overall Study|Adverse Event|2|||
127557327|NCT02087423|459008527|FG000|Overall Study|Terminated from study at final DCO|23|||
127557328|NCT02087423|459008528|FG001|Overall Study|Terminated from study at final DCO|36|||
127557329|NCT02087423|459008529|FG002|Overall Study|Terminated from study at final DCO|25|||
127557330|NCT00530816|459008531|FG000|Overall Study|Progressive Disease|16|||
127557331|NCT00530816|459008532|FG001|Overall Study|Progressive Disease|24|||
127774268|NCT01794520|459800292|FG002|Overall Study|Study terminated by sponsor|1|||
127774269|NCT01794520|459800293|FG003|Overall Study|Study terminated by sponsor|0|||
127774270|NCT01794520|459800294|FG004|Overall Study|Study terminated by sponsor|1|||
127774271|NCT01794520|459800295|FG005|Overall Study|Study terminated by sponsor|0|||
127774272|NCT01794520|459800296|FG006|Overall Study|Study terminated by sponsor|7|||
127774273|NCT01794520|459800290|FG000|Overall Study|Death|0|||
127774274|NCT01794520|459800291|FG001|Overall Study|Death|0|||
127557332|NCT00530816|459008533|FG002|Overall Study|Progressive Disease|24|||
127557333|NCT00530816|459008531|FG000|Overall Study|Adverse Event|6|||
127557334|NCT00530816|459008532|FG001|Overall Study|Adverse Event|13|||
127557335|NCT00530816|459008533|FG002|Overall Study|Adverse Event|7|||
127557336|NCT00530816|459008531|FG000|Overall Study|Other|3|||
127557337|NCT00530816|459008532|FG001|Overall Study|Other|3|||
127557338|NCT00530816|459008533|FG002|Overall Study|Other|4|||
127557339|NCT00530816|459008531|FG000|Overall Study|Withdrawal by Subject|1|||
127557340|NCT00530816|459008532|FG001|Overall Study|Withdrawal by Subject|2|||
127557341|NCT00530816|459008533|FG002|Overall Study|Withdrawal by Subject|6|||
127557342|NCT00899431|459008540|FG000|Overall Study|Physician Decision|1|||
127557343|NCT00899431|459008541|FG001|Overall Study|Physician Decision|0|||
127557344|NCT00899431|459008542|FG002|Overall Study|Physician Decision|0|||
127557345|NCT00661427|459008543|FG000|Overall Study|Adverse Event|5|||
127557346|NCT00661427|459008544|FG001|Overall Study|Adverse Event|5|||
127557347|NCT00661427|459008543|FG000|Overall Study|Patient not treated|0|||
127557348|NCT00661427|459008544|FG001|Overall Study|Patient not treated|2|||
127557349|NCT01253577|459008548|FG000|Overall Study|Lost to Follow-up|3|||
127557350|NCT02509026|459008549|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
127557351|NCT02509026|459008549|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
127557352|NCT02509026|459008549|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
127557353|NCT02509026|459008549|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
127557354|NCT02509026|459008549|FG000|Induction Period (24 Weeks)|Other|2|||
127557355|NCT02509026|459008549|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
127557356|NCT02509026|459008549|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
127557357|NCT02509026|459008549|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
127557358|NCT02509026|459008549|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
127557359|NCT02509026|459008549|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
127557360|NCT02509026|459008549|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
127557361|NCT02509026|459008549|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
127557362|NCT02509026|459008549|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
127557363|NCT02834793|459010337|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
127557364|NCT02834793|459010338|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
127557365|NCT02834793|459010339|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
127557366|NCT02834793|459010340|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
127557367|NCT02834793|459010337|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
127557368|NCT02834793|459010338|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
127557369|NCT02834793|459010339|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
127557370|NCT02834793|459010340|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
127557371|NCT02834793|459010337|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
127557372|NCT02834793|459010338|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
127557373|NCT02834793|459010339|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
127557374|NCT02834793|459010340|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
127557375|NCT02834793|459010337|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
127685880|NCT00529516|459476386|FG001|Overall Study|Adverse Event|1|||
127685881|NCT00529516|459476387|FG002|Overall Study|Adverse Event|0|||
127685882|NCT00529516|459476385|FG000|Overall Study|Withdrawal by Subject|1|||
127685883|NCT00529516|459476386|FG001|Overall Study|Withdrawal by Subject|1|||
127685884|NCT00529516|459476387|FG002|Overall Study|Withdrawal by Subject|0|||
127685885|NCT00529516|459476385|FG000|Overall Study|Lost to Follow-up|0|||
127685886|NCT00529516|459476386|FG001|Overall Study|Lost to Follow-up|0|||
127685887|NCT00529516|459476387|FG002|Overall Study|Lost to Follow-up|1|||
127685888|NCT03051165|459476389|FG000|Overall Study|Withdrawal by Subject|1|||
127685889|NCT03051165|459476389|FG000|Overall Study|Early termination of study|12|||
127685890|NCT02092116|459476393|FG000|Overall Study|Withdrawal by Subject|0|||
127774275|NCT01794520|459800292|FG002|Overall Study|Death|0|||
127774276|NCT01794520|459800293|FG003|Overall Study|Death|0|||
127557376|NCT02834793|459010338|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
127557377|NCT02834793|459010339|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
127685891|NCT02092116|459476394|FG001|Overall Study|Withdrawal by Subject|3|||
127685892|NCT02092116|459476393|FG000|Overall Study|Adverse Event|0|||
127685893|NCT02092116|459476394|FG001|Overall Study|Adverse Event|1|||
127774277|NCT01794520|459800294|FG004|Overall Study|Death|1|||
127774278|NCT01794520|459800295|FG005|Overall Study|Death|0|||
127557378|NCT02834793|459010340|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
127557379|NCT02834793|459010337|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
127557380|NCT02834793|459010338|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
127557381|NCT02834793|459010339|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
127774279|NCT01794520|459800296|FG006|Overall Study|Death|22|||
127557382|NCT02834793|459010340|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
127557383|NCT02834793|459010337|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
127557384|NCT02834793|459010338|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
127557385|NCT02834793|459010339|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
127557386|NCT02834793|459010340|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
127557387|NCT02834793|459010337|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
127557388|NCT02834793|459010338|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
127557389|NCT02834793|459010339|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
127557390|NCT02834793|459010340|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
127557391|NCT02834793|459010337|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
127557392|NCT02834793|459010338|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
127557393|NCT02834793|459010339|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
127557394|NCT02834793|459010340|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
127557395|NCT02834793|459010337|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
127557396|NCT02834793|459010338|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
127557397|NCT02834793|459010339|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
127557398|NCT02834793|459010340|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
127557399|NCT02834793|459010337|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
127557400|NCT02834793|459010338|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
127557401|NCT02834793|459010339|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
127557402|NCT02834793|459010340|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
127557403|NCT02834793|459010337|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
127557404|NCT02834793|459010338|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
127557405|NCT02834793|459010339|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
127557406|NCT02834793|459010340|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
127557407|NCT02834793|459010337|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
127557408|NCT02834793|459010338|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
127557409|NCT02834793|459010339|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
127557410|NCT02834793|459010340|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
127557411|NCT02834793|459010337|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
127557412|NCT02834793|459010338|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
127557413|NCT02834793|459010339|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
127557414|NCT02834793|459010340|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
127557415|NCT02834793|459010337|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
127557416|NCT02834793|459010338|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
127557417|NCT02834793|459010339|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
127557418|NCT02834793|459010340|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
127557419|NCT02834793|459010337|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
127557420|NCT02834793|459010338|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
127557421|NCT02834793|459010339|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
127557422|NCT02834793|459010340|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
127557423|NCT01049009|459010341|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
127557424|NCT01049009|459010342|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
127557425|NCT01049009|459010341|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
127557426|NCT01049009|459010342|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
127557427|NCT01049009|459010341|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
127557428|NCT01049009|459010342|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
127557429|NCT01049009|459010341|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
127557430|NCT01049009|459010342|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
127557431|NCT02350478|459010343|FG000|Overall Study|Lost to Follow-up|5|||
127557432|NCT02350478|459010344|FG001|Overall Study|Lost to Follow-up|1|||
127557433|NCT00622440|459010345|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
127557434|NCT00622440|459010346|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
127557435|NCT00622440|459010345|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
127557436|NCT00622440|459010346|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
127557437|NCT00622440|459010345|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
127557438|NCT00622440|459010346|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
127557439|NCT00622440|459010345|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
127557440|NCT00622440|459010346|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
127557441|NCT01667419|459010349|FG000|Overall Study|Reason Not Specified|1|||
127557442|NCT01667419|459010350|FG001|Overall Study|Reason Not Specified|0|||
127557443|NCT01667419|459010351|FG002|Overall Study|Reason Not Specified|0|||
127557444|NCT01667419|459010352|FG003|Overall Study|Reason Not Specified|0|||
127557445|NCT01667419|459010349|FG000|Overall Study|Withdrawal by Subject|16|||
127557446|NCT01667419|459010350|FG001|Overall Study|Withdrawal by Subject|8|||
127557447|NCT01667419|459010351|FG002|Overall Study|Withdrawal by Subject|9|||
127557448|NCT01667419|459010352|FG003|Overall Study|Withdrawal by Subject|8|||
127557449|NCT01667419|459010349|FG000|Overall Study|Non-compliance|0|||
127557450|NCT01667419|459010350|FG001|Overall Study|Non-compliance|0|||
127557451|NCT01667419|459010351|FG002|Overall Study|Non-compliance|0|||
127557452|NCT01667419|459010352|FG003|Overall Study|Non-compliance|1|||
127557453|NCT01667419|459010349|FG000|Overall Study|Protocol Violation|1|||
127557454|NCT01667419|459010350|FG001|Overall Study|Protocol Violation|0|||
127557455|NCT01667419|459010351|FG002|Overall Study|Protocol Violation|0|||
127557456|NCT01667419|459010352|FG003|Overall Study|Protocol Violation|0|||
127557457|NCT01667419|459010349|FG000|Overall Study|Lost to Follow-up|7|||
127557458|NCT01667419|459010350|FG001|Overall Study|Lost to Follow-up|6|||
127557459|NCT01667419|459010351|FG002|Overall Study|Lost to Follow-up|2|||
127557460|NCT01667419|459010352|FG003|Overall Study|Lost to Follow-up|4|||
127557461|NCT01667419|459010349|FG000|Overall Study|Death|18|||
127557462|NCT01667419|459010350|FG001|Overall Study|Death|33|||
127557463|NCT01667419|459010351|FG002|Overall Study|Death|25|||
127557464|NCT01667419|459010352|FG003|Overall Study|Death|26|||
127557465|NCT04364984|459010353|FG000|Overall Study|Death|2|||
127557466|NCT04364984|459010354|FG001|Overall Study|Death|2|||
127557467|NCT04364984|459010355|FG002|Overall Study|Death|0|||
127557468|NCT01941186|459010356|FG000|Follow-up|Lost to Follow-up|1|||
127557469|NCT01941186|459010357|FG001|Follow-up|Lost to Follow-up|0|||
127557470|NCT02722304|459010358|FG000|Overall Study|Study Terminated by Sponsor|1|||
127557471|NCT02722304|459010359|FG001|Overall Study|Study Terminated by Sponsor|0|||
127557472|NCT02722304|459010360|FG002|Overall Study|Study Terminated by Sponsor|2|||
127557473|NCT02722304|459010361|FG003|Overall Study|Study Terminated by Sponsor|1|||
127557474|NCT02722304|459010362|FG004|Overall Study|Study Terminated by Sponsor|1|||
127557475|NCT02722304|459010358|FG000|Overall Study|Other|0|||
127557476|NCT02722304|459010359|FG001|Overall Study|Other|0|||
127557477|NCT02722304|459010360|FG002|Overall Study|Other|0|||
127557478|NCT02722304|459010361|FG003|Overall Study|Other|1|||
127557479|NCT02722304|459010362|FG004|Overall Study|Other|1|||
127557480|NCT01068600|459010363|FG000|Overall Study|Withdrawal by Subject|5|||
127557481|NCT01068600|459010364|FG001|Overall Study|Withdrawal by Subject|6|||
127557482|NCT01068600|459010363|FG000|Overall Study|Adverse Event|3|||
127557483|NCT01068600|459010364|FG001|Overall Study|Adverse Event|3|||
127557484|NCT01068600|459010363|FG000|Overall Study|Abnormal laboratory value(s)|1|||
127557485|NCT01068600|459010364|FG001|Overall Study|Abnormal laboratory value(s)|0|||
127557486|NCT01068600|459010363|FG000|Overall Study|Lost to Follow-up|1|||
127557487|NCT01068600|459010364|FG001|Overall Study|Lost to Follow-up|2|||
127557488|NCT01068600|459010363|FG000|Overall Study|Protocol deviation|1|||
127557489|NCT01068600|459010364|FG001|Overall Study|Protocol deviation|1|||
127557490|NCT01068600|459010363|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
127557491|NCT01068600|459010364|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
127557492|NCT01068600|459010363|FG000|Overall Study|Administrative problems|0|||
127557493|NCT01068600|459010364|FG001|Overall Study|Administrative problems|1|||
127557494|NCT02644109|459010365|FG000|Overall Study|Adverse Event|0|||
127557495|NCT02644109|459010366|FG001|Overall Study|Adverse Event|4|||
127557496|NCT01519869|459010369|FG000|Overall Study|Lost to Follow-up|1|||
127685894|NCT03074331|459476395|FG000|Overall Study|Enrolled but Not Treated|1|||
127685895|NCT03074331|459476395|FG000|Overall Study|Lost to Follow-up|5|||
127685896|NCT03074331|459476395|FG000|Overall Study|Withdrew Consent|1|||
127685897|NCT01546753|459476400|FG000|Overall Study|anxiety|1|||
127685898|NCT01546753|459476401|FG001|Overall Study|anxiety|1|||
127685899|NCT01546753|459476400|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
127685900|NCT01546753|459476401|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
127685901|NCT00546754|459476405|FG000|Overall Study|Serious Adverse Event|1|||
127685902|NCT00546754|459476406|FG001|Overall Study|Serious Adverse Event|1|||
127685903|NCT00546754|459476405|FG000|Overall Study|Adverse Event|11|||
127685904|NCT00546754|459476406|FG001|Overall Study|Adverse Event|16|||
127685905|NCT00546754|459476405|FG000|Overall Study|Lack of Efficacy|1|||
127557497|NCT03023813|459010370|FG000|Overall Study|Lost to Follow-up|1|||
127557498|NCT03023813|459010371|FG001|Overall Study|Lost to Follow-up|2|||
127557499|NCT03023813|459010372|FG002|Overall Study|Lost to Follow-up|0|||
127557500|NCT00312195|459010376|FG000|Overall Study|Adverse Event|4|||
127557501|NCT00312195|459010377|FG001|Overall Study|Adverse Event|6|||
127557502|NCT00312195|459010376|FG000|Overall Study|Lost to Follow-up|1|||
127557503|NCT00312195|459010377|FG001|Overall Study|Lost to Follow-up|0|||
127557504|NCT00312195|459010376|FG000|Overall Study|Protocol Violation|1|||
127557505|NCT00312195|459010377|FG001|Overall Study|Protocol Violation|0|||
127557506|NCT02511106|459010378|FG000|Overall Study|Lost to Follow-up|6|||
127557507|NCT02511106|459010379|FG001|Overall Study|Lost to Follow-up|4|||
127557508|NCT02511106|459010378|FG000|Overall Study|Withdrawal by Subject|24|||
127557509|NCT02511106|459010379|FG001|Overall Study|Withdrawal by Subject|21|||
127685906|NCT00546754|459476406|FG001|Overall Study|Lack of Efficacy|1|||
127685907|NCT00546754|459476405|FG000|Overall Study|Lost to Follow-up|9|||
127685908|NCT00546754|459476406|FG001|Overall Study|Lost to Follow-up|15|||
127557510|NCT02511106|459010378|FG000|Overall Study|Death|42|||
127557511|NCT02511106|459010379|FG001|Overall Study|Death|82|||
127557512|NCT02511106|459010378|FG000|Overall Study|Ongoing study at data cut-off|3|||
127557513|NCT02511106|459010379|FG001|Overall Study|Ongoing study at data cut-off|2|||
127557514|NCT02511106|459010378|FG000|Overall Study|Without specified reason|3|||
127557515|NCT02511106|459010379|FG001|Overall Study|Without specified reason|0|||
127557516|NCT00344487|459010381|FG000|Overall Study|immunologic failure|1|||
127557517|NCT01262820|459010384|FG000|Overall Study|Adverse Event|5|||
127557518|NCT01262820|459010384|FG000|Overall Study|Lack of Efficacy|9|||
127557519|NCT01262820|459010384|FG000|Overall Study|Drug held for 21+ days|1|||
127557520|NCT00104520|459010385|FG000|Overall Study|Unrelated adverse event|34|||
127557521|NCT00104520|459010386|FG001|Overall Study|Unrelated adverse event|47|||
127557522|NCT00104520|459010385|FG000|Overall Study|Study drug intolerance|0|||
127557523|NCT00104520|459010386|FG001|Overall Study|Study drug intolerance|1|||
127557524|NCT00104520|459010385|FG000|Overall Study|Related adverse event|13|||
127557525|NCT00104520|459010386|FG001|Overall Study|Related adverse event|15|||
127557526|NCT00104520|459010385|FG000|Overall Study|Lost to Follow-up|1|||
127557527|NCT00104520|459010386|FG001|Overall Study|Lost to Follow-up|0|||
127557528|NCT00104520|459010385|FG000|Overall Study|Noncompliance|0|||
127557529|NCT00104520|459010386|FG001|Overall Study|Noncompliance|2|||
127557530|NCT00104520|459010385|FG000|Overall Study|Personal/administrative|1|||
127557531|NCT00104520|459010386|FG001|Overall Study|Personal/administrative|1|||
127557532|NCT00104520|459010385|FG000|Overall Study|Other|1|||
127557533|NCT00104520|459010386|FG001|Overall Study|Other|5|||
127557534|NCT01026324|459010388|FG000|Follow up/Survival|Withdrawal by Subject|1|||
127557535|NCT01026324|459010389|FG001|Follow up/Survival|Withdrawal by Subject|0|||
127557536|NCT01026324|459010390|FG002|Follow up/Survival|Withdrawal by Subject|0|||
127557537|NCT05188053|459010391|FG000|Overall Study|Lost to Follow-up|23|||
127557538|NCT05188053|459010392|FG001|Overall Study|Lost to Follow-up|30|||
127685909|NCT00546754|459476405|FG000|Overall Study|Protocol Violation|3|||
127685910|NCT00546754|459476406|FG001|Overall Study|Protocol Violation|0|||
127685911|NCT00546754|459476405|FG000|Overall Study|Withdrawal by Subject|6|||
127685912|NCT00546754|459476406|FG001|Overall Study|Withdrawal by Subject|7|||
127685913|NCT00546754|459476405|FG000|Overall Study|Dyspnea|1|||
127685914|NCT00546754|459476406|FG001|Overall Study|Dyspnea|0|||
127685915|NCT00546754|459476405|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
127685916|NCT00546754|459476406|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
127685917|NCT00546754|459476405|FG000|Overall Study|Hip Replacement|1|||
127685918|NCT00546754|459476406|FG001|Overall Study|Hip Replacement|0|||
127685919|NCT00546754|459476405|FG000|Overall Study|Suicide|1|||
127685920|NCT00546754|459476406|FG001|Overall Study|Suicide|0|||
127685921|NCT00546754|459476405|FG000|Overall Study|Missing Cooperation|1|||
127685922|NCT00546754|459476406|FG001|Overall Study|Missing Cooperation|0|||
127685923|NCT00546754|459476405|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
127685924|NCT00546754|459476406|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
127685925|NCT00546754|459476405|FG000|Overall Study|Patient's Decision|0|||
127685926|NCT00546754|459476406|FG001|Overall Study|Patient's Decision|1|||
127685927|NCT00546754|459476405|FG000|Overall Study|Missing|14|||
127685928|NCT00546754|459476406|FG001|Overall Study|Missing|7|||
127685929|NCT00311363|459476409|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
127685930|NCT00311363|459476410|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
127685931|NCT00311363|459476411|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
127685932|NCT00311363|459476409|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
127685933|NCT00311363|459476410|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
127685934|NCT00311363|459476411|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
127685935|NCT00311363|459476409|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
127685936|NCT00311363|459476410|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
127685937|NCT00311363|459476411|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
127685938|NCT00311363|459476409|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
127685939|NCT00311363|459476410|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
127685940|NCT00311363|459476411|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
127685941|NCT00311363|459476409|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
127685942|NCT00311363|459476410|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
127685943|NCT00311363|459476411|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
127685944|NCT00311363|459476409|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
127685945|NCT00311363|459476410|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
127685946|NCT00311363|459476411|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
127685947|NCT00311363|459476409|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
127685948|NCT00311363|459476410|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
127685949|NCT00311363|459476411|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
127557539|NCT05188053|459010391|FG000|Overall Study|Protocol Violation|16|||
127557540|NCT05188053|459010392|FG001|Overall Study|Protocol Violation|16|||
127557541|NCT05188053|459010391|FG000|Overall Study|Physician Decision|3|||
127557542|NCT05188053|459010392|FG001|Overall Study|Physician Decision|0|||
127557543|NCT05188053|459010391|FG000|Overall Study|Withdrawal by Subject|0|||
127557544|NCT05188053|459010392|FG001|Overall Study|Withdrawal by Subject|1|||
127685950|NCT00311363|459476409|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
127685951|NCT00311363|459476410|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
127557545|NCT02447302|459010396|FG000|Overall Study|Physician Decision|1|||
127557546|NCT02447302|459010397|FG001|Overall Study|Physician Decision|0|||
127557547|NCT02447302|459010398|FG002|Overall Study|Physician Decision|0|||
127557548|NCT02447302|459010396|FG000|Overall Study|Adverse Event|4|||
127557549|NCT02447302|459010397|FG001|Overall Study|Adverse Event|3|||
127557550|NCT02447302|459010398|FG002|Overall Study|Adverse Event|0|||
127557551|NCT02447302|459010396|FG000|Overall Study|Withdrawal by Subject|0|||
127557552|NCT02447302|459010397|FG001|Overall Study|Withdrawal by Subject|1|||
127557553|NCT02447302|459010398|FG002|Overall Study|Withdrawal by Subject|5|||
127557554|NCT02447302|459010396|FG000|Overall Study|Sponsor Decision|0|||
127557555|NCT02447302|459010397|FG001|Overall Study|Sponsor Decision|0|||
127557556|NCT02447302|459010398|FG002|Overall Study|Sponsor Decision|1|||
127557557|NCT01456897|459010403|FG000|Overall Study|Adverse Event|19|||
127557558|NCT01456897|459010404|FG001|Overall Study|Adverse Event|22|||
127557559|NCT01456897|459010403|FG000|Overall Study|Protocol Violation|3|||
127557560|NCT01456897|459010404|FG001|Overall Study|Protocol Violation|4|||
127557561|NCT01456897|459010403|FG000|Overall Study|Physician Decision|5|||
127557562|NCT01456897|459010404|FG001|Overall Study|Physician Decision|3|||
127557563|NCT01456897|459010403|FG000|Overall Study|Withdrawal by Subject|44|||
127557564|NCT01456897|459010404|FG001|Overall Study|Withdrawal by Subject|17|||
127557565|NCT01456897|459010403|FG000|Overall Study|Lack of Efficacy|4|||
127557566|NCT01456897|459010404|FG001|Overall Study|Lack of Efficacy|11|||
127557567|NCT01396070|459010410|FG000|Overall Study|Withdrawal by Subject|2|||
127557568|NCT01396070|459010410|FG000|Overall Study|Death|2|||
127557569|NCT01396070|459010410|FG000|Overall Study|Adverse Event|8|||
127557570|NCT01396070|459010410|FG000|Overall Study|Physician Decision|3|||
127557571|NCT01396070|459010410|FG000|Overall Study|Lack of Efficacy|4|||
127557572|NCT01561313|459010412|FG000|Overall Study|Withdrawal by Subject|1|||
127557573|NCT01561313|459010413|FG001|Overall Study|Withdrawal by Subject|0|||
127557574|NCT01561313|459010412|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
127557575|NCT01561313|459010413|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
127557576|NCT04254913|459010414|FG000|Overall Study|Adverse Event|1|||
127557577|NCT01396057|459010415|FG000|Overall Study|Adverse Event|2|||
127557578|NCT01396057|459010416|FG001|Overall Study|Adverse Event|6|||
127557579|NCT01396057|459010415|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
127557580|NCT01396057|459010416|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
127557581|NCT01396057|459010415|FG000|Overall Study|Protocol deviation|4|||
127557582|NCT01396057|459010416|FG001|Overall Study|Protocol deviation|4|||
127557583|NCT01396057|459010415|FG000|Overall Study|Consent withdrawn|3|||
127557584|NCT01396057|459010416|FG001|Overall Study|Consent withdrawn|2|||
127557585|NCT02695420|459010417|FG000|Overall Study|Death|0|||
127557586|NCT02695420|459010418|FG001|Overall Study|Death|1|||
127557587|NCT02695420|459010419|FG002|Overall Study|Death|0|||
127557588|NCT02695420|459010420|FG003|Overall Study|Death|0|||
127557589|NCT04535453|459010421|FG000|Overall Study|Death|0|||
127557590|NCT04535453|459010422|FG001|Overall Study|Death|1|||
127557591|NCT04535453|459010423|FG002|Overall Study|Death|0|||
127557592|NCT04535453|459010424|FG003|Overall Study|Death|0|||
127557593|NCT04535453|459010425|FG004|Overall Study|Death|0|||
127557594|NCT04535453|459010426|FG005|Overall Study|Death|0|||
127557595|NCT04535453|459010427|FG006|Overall Study|Death|0|||
127557596|NCT04535453|459010428|FG007|Overall Study|Death|0|||
127557597|NCT04535453|459010429|FG008|Overall Study|Death|0|||
127557598|NCT04535453|459010430|FG009|Overall Study|Death|0|||
127557599|NCT04535453|459010431|FG010|Overall Study|Death|0|||
127557600|NCT04535453|459010432|FG011|Overall Study|Death|0|||
127557601|NCT04535453|459010421|FG000|Overall Study|Lost to Follow-up|1|||
127557602|NCT04535453|459010422|FG001|Overall Study|Lost to Follow-up|1|||
127557603|NCT04535453|459010423|FG002|Overall Study|Lost to Follow-up|1|||
127557604|NCT04535453|459010424|FG003|Overall Study|Lost to Follow-up|0|||
127557605|NCT04535453|459010425|FG004|Overall Study|Lost to Follow-up|3|||
127557606|NCT04535453|459010426|FG005|Overall Study|Lost to Follow-up|1|||
127557607|NCT04535453|459010427|FG006|Overall Study|Lost to Follow-up|0|||
127557608|NCT04535453|459010428|FG007|Overall Study|Lost to Follow-up|0|||
127557609|NCT04535453|459010429|FG008|Overall Study|Lost to Follow-up|1|||
127685952|NCT00311363|459476411|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
127685953|NCT00311363|459476409|FG000|24-Week Single-Blind Treatment Period|Death|1|||
127557610|NCT04535453|459010430|FG009|Overall Study|Lost to Follow-up|1|||
127557611|NCT04535453|459010431|FG010|Overall Study|Lost to Follow-up|0|||
127557612|NCT04535453|459010432|FG011|Overall Study|Lost to Follow-up|0|||
127557613|NCT04535453|459010421|FG000|Overall Study|Physician Decision|0|||
127557614|NCT04535453|459010422|FG001|Overall Study|Physician Decision|0|||
127557615|NCT04535453|459010423|FG002|Overall Study|Physician Decision|0|||
127685954|NCT00311363|459476410|FG001|24-Week Single-Blind Treatment Period|Death|0|||
127557616|NCT04535453|459010424|FG003|Overall Study|Physician Decision|1|||
127557617|NCT04535453|459010425|FG004|Overall Study|Physician Decision|0|||
127557618|NCT04535453|459010426|FG005|Overall Study|Physician Decision|0|||
127557619|NCT04535453|459010427|FG006|Overall Study|Physician Decision|0|||
127557620|NCT04535453|459010428|FG007|Overall Study|Physician Decision|0|||
127557621|NCT04535453|459010429|FG008|Overall Study|Physician Decision|0|||
127557622|NCT04535453|459010430|FG009|Overall Study|Physician Decision|0|||
128021761|NCT04676646|460704582|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|1|||
128021762|NCT04676646|460704580|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
128021763|NCT04676646|460704581|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|1|||
128021764|NCT04676646|460704582|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
128021765|NCT04676646|460704580|FG000|Randomised-withdrawal Phase|Withdrawal by Subject|0|||
128021766|NCT04676646|460704581|FG001|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
128021767|NCT04676646|460704582|FG002|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
128021768|NCT02217982|460704583|FG000|Overall Study|Trial discontinued|1|||
128021769|NCT02217982|460704584|FG001|Overall Study|Trial discontinued|0|||
128021770|NCT02217982|460704583|FG000|Overall Study|Adverse Event|0|||
128021771|NCT02217982|460704584|FG001|Overall Study|Adverse Event|1|||
128021772|NCT03123588|460704587|FG000|Overall Study|Study Terminated by Sponsor|2|||
128021773|NCT03123588|460704588|FG001|Overall Study|Study Terminated by Sponsor|5|||
128021774|NCT03123588|460704587|FG000|Overall Study|Withdrawal by Subject|1|||
128021775|NCT03123588|460704588|FG001|Overall Study|Withdrawal by Subject|0|||
128021776|NCT03123588|460704587|FG000|Overall Study|Adverse Event|1|||
128021777|NCT03123588|460704588|FG001|Overall Study|Adverse Event|0|||
128021778|NCT03123588|460704587|FG000|Overall Study|Physician Decision|2|||
128021779|NCT03123588|460704588|FG001|Overall Study|Physician Decision|1|||
128021780|NCT01755637|460704593|FG000|Period 1|Adverse Event|0|||
128021781|NCT01755637|460704594|FG001|Period 1|Adverse Event|1|||
128021782|NCT01814332|460704595|FG000|Overall Study|Adverse Event|8|||
128021783|NCT01814332|460704596|FG001|Overall Study|Adverse Event|3|||
128021784|NCT01814332|460704595|FG000|Overall Study|Withdrawal by Subject|3|||
128021785|NCT01814332|460704596|FG001|Overall Study|Withdrawal by Subject|8|||
128021786|NCT01814332|460704595|FG000|Overall Study|Protocol Violation|0|||
128021787|NCT01814332|460704596|FG001|Overall Study|Protocol Violation|4|||
128021788|NCT01814332|460704595|FG000|Overall Study|Lost to Follow-up|5|||
128021789|NCT01814332|460704596|FG001|Overall Study|Lost to Follow-up|1|||
128021790|NCT01096186|460704598|FG000|Overall Study|Adverse Event|16|||
128021791|NCT01096186|460704598|FG000|Overall Study|Death|4|||
128021792|NCT01096186|460704598|FG000|Overall Study|Lack of Efficacy|4|||
128021793|NCT01096186|460704598|FG000|Overall Study|Lost to Follow-up|2|||
128021794|NCT01096186|460704598|FG000|Overall Study|Withdrawal by Subject|22|||
128021795|NCT01096186|460704598|FG000|Overall Study|Physician Decision|1|||
128021796|NCT01096186|460704598|FG000|Overall Study|Noncompliance with study drug|1|||
128021797|NCT00122187|460704603|FG000|Overall Study|Withdrew because of resource limitations|2|||
128021798|NCT00122187|460704604|FG001|Overall Study|Withdrew because of resource limitations|2|||
128021799|NCT02061592|460704605|FG000|Period 1|Withdrawal by Subject|1|||
128021800|NCT02061592|460704606|FG001|Period 1|Withdrawal by Subject|0|||
128021801|NCT02061592|460704605|FG000|Period 1|Protocol Violation|1|||
128021802|NCT02061592|460704606|FG001|Period 1|Protocol Violation|0|||
128021803|NCT02061592|460704605|FG000|Period 2|Lost to Follow-up|0|||
128021804|NCT02061592|460704606|FG001|Period 2|Lost to Follow-up|1|||
128021805|NCT03338023|460704607|FG000|Overall Study|Withdrawal by Subject|3|||
128021806|NCT03338023|460704608|FG001|Overall Study|Withdrawal by Subject|4|||
128021807|NCT03338023|460704607|FG000|Overall Study|Protocol Violation|3|||
128021808|NCT03338023|460704608|FG001|Overall Study|Protocol Violation|3|||
128021809|NCT03338023|460704607|FG000|Overall Study|Lost to Follow-up|2|||
128021810|NCT03338023|460704608|FG001|Overall Study|Lost to Follow-up|1|||
128021811|NCT03338023|460704607|FG000|Overall Study|Physician Decision|1|||
128021812|NCT03338023|460704608|FG001|Overall Study|Physician Decision|2|||
128021813|NCT00685698|460704609|FG000|Overall Study|Withdrawal by Subject|1|||
128021814|NCT00685698|460704609|FG000|Overall Study|Protocol Violation|6|||
128021815|NCT00685698|460704609|FG000|Overall Study|Adverse Event|3|||
128021816|NCT00685698|460704609|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
128021817|NCT00685698|460704609|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
128021818|NCT00685698|460704609|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
128021819|NCT05061706|460704611|FG000|Overall Study|Adverse Event|29|||
128021820|NCT05061706|460704612|FG001|Overall Study|Adverse Event|1|||
128021821|NCT05061706|460704611|FG000|Overall Study|Lack of Efficacy|0|||
128021822|NCT05061706|460704612|FG001|Overall Study|Lack of Efficacy|1|||
128021823|NCT05061706|460704611|FG000|Overall Study|Lost to Follow-up|2|||
128021824|NCT05061706|460704612|FG001|Overall Study|Lost to Follow-up|2|||
128021825|NCT05061706|460704611|FG000|Overall Study|Protocol Violation|3|||
128021826|NCT05061706|460704612|FG001|Overall Study|Protocol Violation|1|||
128021827|NCT05061706|460704611|FG000|Overall Study|Withdrawal by Subject|3|||
128021828|NCT05061706|460704612|FG001|Overall Study|Withdrawal by Subject|9|||
128021829|NCT00724893|460704613|FG000|Overall Study|Adverse Event|76|||
128021830|NCT00724893|460704614|FG001|Overall Study|Adverse Event|142|||
128021831|NCT00724893|460704613|FG000|Overall Study|Withdrawal by Subject|0|||
128021832|NCT00724893|460704614|FG001|Overall Study|Withdrawal by Subject|1|||
128021833|NCT00724893|460704613|FG000|Overall Study|Lack of virologic response|94|||
128021834|NCT00724893|460704614|FG001|Overall Study|Lack of virologic response|202|||
128021835|NCT00724893|460704613|FG000|Overall Study|Reason not specified|193|||
127557623|NCT04535453|459010431|FG010|Overall Study|Physician Decision|0|||
127557624|NCT04535453|459010432|FG011|Overall Study|Physician Decision|0|||
127557625|NCT04535453|459010421|FG000|Overall Study|Withdrawal by Subject|3|||
127557626|NCT04535453|459010422|FG001|Overall Study|Withdrawal by Subject|6|||
127557627|NCT04535453|459010423|FG002|Overall Study|Withdrawal by Subject|3|||
127557628|NCT04535453|459010424|FG003|Overall Study|Withdrawal by Subject|3|||
127557629|NCT04535453|459010425|FG004|Overall Study|Withdrawal by Subject|2|||
127557630|NCT04535453|459010426|FG005|Overall Study|Withdrawal by Subject|1|||
127557631|NCT04535453|459010427|FG006|Overall Study|Withdrawal by Subject|1|||
127557632|NCT04535453|459010428|FG007|Overall Study|Withdrawal by Subject|1|||
127557633|NCT04535453|459010429|FG008|Overall Study|Withdrawal by Subject|1|||
127557634|NCT04535453|459010430|FG009|Overall Study|Withdrawal by Subject|1|||
127557635|NCT04535453|459010431|FG010|Overall Study|Withdrawal by Subject|0|||
127557636|NCT04535453|459010432|FG011|Overall Study|Withdrawal by Subject|1|||
127557637|NCT04535453|459010421|FG000|Overall Study|Other|0|||
127557638|NCT04535453|459010422|FG001|Overall Study|Other|0|||
127557639|NCT04535453|459010423|FG002|Overall Study|Other|1|||
127557640|NCT04535453|459010424|FG003|Overall Study|Other|0|||
127557641|NCT04535453|459010425|FG004|Overall Study|Other|1|||
127557642|NCT04535453|459010426|FG005|Overall Study|Other|0|||
127557643|NCT04535453|459010427|FG006|Overall Study|Other|1|||
127557644|NCT04535453|459010428|FG007|Overall Study|Other|1|||
127557645|NCT04535453|459010429|FG008|Overall Study|Other|1|||
127557646|NCT04535453|459010430|FG009|Overall Study|Other|0|||
127557647|NCT04535453|459010431|FG010|Overall Study|Other|0|||
127557648|NCT04535453|459010432|FG011|Overall Study|Other|0|||
127557649|NCT02929407|459010433|FG000|Overall Study|Adverse Event|1|||
127557650|NCT00916929|459010434|FG000|Overall Study|Lost to Follow-up|1|||
127557651|NCT00916929|459010435|FG001|Overall Study|Lost to Follow-up|3|||
127557652|NCT00916929|459010434|FG000|Overall Study|Death|5|||
127557653|NCT00916929|459010435|FG001|Overall Study|Death|10|||
127557654|NCT00916929|459010434|FG000|Overall Study|Withdrawal by Subject|1|||
127557655|NCT00916929|459010435|FG001|Overall Study|Withdrawal by Subject|5|||
127557656|NCT00916929|459010434|FG000|Overall Study|Left ventricular epicardial lead|1|||
127557657|NCT00916929|459010435|FG001|Overall Study|Left ventricular epicardial lead|2|||
127557658|NCT00916929|459010434|FG000|Overall Study|Transferred to hospice care|1|||
127557659|NCT00916929|459010435|FG001|Overall Study|Transferred to hospice care|1|||
127557660|NCT00916929|459010434|FG000|Overall Study|System explant|1|||
127557661|NCT00916929|459010435|FG001|Overall Study|System explant|0|||
127557662|NCT00916929|459010434|FG000|Overall Study|Moved to another state|0|||
127557663|NCT00916929|459010435|FG001|Overall Study|Moved to another state|1|||
127557664|NCT00916929|459010434|FG000|Overall Study|Device unable to process impedance data|0|||
127557665|NCT00916929|459010435|FG001|Overall Study|Device unable to process impedance data|7|||
127557666|NCT02442804|459010440|FG000|Overall Study|Withdrawal by Subject|0|||
127557667|NCT02442804|459010441|FG001|Overall Study|Withdrawal by Subject|1|||
127557668|NCT02442804|459010440|FG000|Overall Study|Adverse Event|1|||
127557669|NCT02442804|459010441|FG001|Overall Study|Adverse Event|0|||
127557670|NCT02036853|459010442|FG000|Overall Study|Adverse Event|0|||
127557671|NCT02036853|459010443|FG001|Overall Study|Adverse Event|2|||
127557672|NCT02036853|459010442|FG000|Overall Study|Lack of Efficacy|0|||
127557673|NCT02036853|459010443|FG001|Overall Study|Lack of Efficacy|2|||
127557674|NCT02036853|459010442|FG000|Overall Study|Physician Decision|0|||
127557675|NCT02036853|459010443|FG001|Overall Study|Physician Decision|1|||
127557676|NCT02036853|459010442|FG000|Overall Study|Withdrawal by Subject|0|||
127557677|NCT02036853|459010443|FG001|Overall Study|Withdrawal by Subject|1|||
127557678|NCT01742286|459010447|FG000|Escalation Phase|Administrative problems|1|||
127557679|NCT01742286|459010448|FG001|Escalation Phase|Administrative problems|1|||
127557680|NCT01742286|459010449|FG002|Escalation Phase|Administrative problems|0|||
127685955|NCT00311363|459476411|FG002|24-Week Single-Blind Treatment Period|Death|0|||
127685956|NCT00311363|459476409|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
128021836|NCT00724893|460704614|FG001|Overall Study|Reason not specified|7|||
128021837|NCT00724893|460704613|FG000|Overall Study|Patient choice|0|||
128021838|NCT00724893|460704614|FG001|Overall Study|Patient choice|26|||
128021839|NCT00724893|460704613|FG000|Overall Study|Geographic reasons|0|||
128021840|NCT00724893|460704614|FG001|Overall Study|Geographic reasons|11|||
127557681|NCT01742286|459010450|FG003|Escalation Phase|Administrative problems|0|||
127557682|NCT01742286|459010451|FG004|Escalation Phase|Administrative problems|0|||
127557683|NCT01742286|459010452|FG005|Escalation Phase|Administrative problems|0|||
127557684|NCT01742286|459010453|FG006|Escalation Phase|Administrative problems|2|||
127557685|NCT01742286|459010447|FG000|Escalation Phase|Adverse Event|0|||
127557686|NCT01742286|459010448|FG001|Escalation Phase|Adverse Event|1|||
127557687|NCT01742286|459010449|FG002|Escalation Phase|Adverse Event|2|||
127557688|NCT01742286|459010450|FG003|Escalation Phase|Adverse Event|0|||
127557689|NCT01742286|459010451|FG004|Escalation Phase|Adverse Event|0|||
127557690|NCT01742286|459010452|FG005|Escalation Phase|Adverse Event|1|||
127557691|NCT01742286|459010453|FG006|Escalation Phase|Adverse Event|0|||
127685957|NCT00311363|459476410|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
127557692|NCT01742286|459010447|FG000|Escalation Phase|Disease progression|3|||
127557693|NCT01742286|459010448|FG001|Escalation Phase|Disease progression|7|||
127557694|NCT01742286|459010449|FG002|Escalation Phase|Disease progression|4|||
127557695|NCT01742286|459010450|FG003|Escalation Phase|Disease progression|1|||
127557696|NCT01742286|459010451|FG004|Escalation Phase|Disease progression|4|||
127557697|NCT01742286|459010452|FG005|Escalation Phase|Disease progression|3|||
127557698|NCT01742286|459010453|FG006|Escalation Phase|Disease progression|2|||
127557699|NCT01742286|459010447|FG000|Escalation Phase|Death|0|||
127557700|NCT01742286|459010448|FG001|Escalation Phase|Death|0|||
127557701|NCT01742286|459010449|FG002|Escalation Phase|Death|0|||
127557702|NCT01742286|459010450|FG003|Escalation Phase|Death|0|||
127557703|NCT01742286|459010451|FG004|Escalation Phase|Death|0|||
127557704|NCT01742286|459010452|FG005|Escalation Phase|Death|1|||
127557705|NCT01742286|459010453|FG006|Escalation Phase|Death|0|||
127557706|NCT01742286|459010447|FG000|Escalation Phase|Physician Decision|0|||
127557707|NCT01742286|459010448|FG001|Escalation Phase|Physician Decision|3|||
127557708|NCT01742286|459010449|FG002|Escalation Phase|Physician Decision|0|||
127557709|NCT01742286|459010450|FG003|Escalation Phase|Physician Decision|1|||
127557710|NCT01742286|459010451|FG004|Escalation Phase|Physician Decision|0|||
127557711|NCT01742286|459010452|FG005|Escalation Phase|Physician Decision|0|||
127557712|NCT01742286|459010453|FG006|Escalation Phase|Physician Decision|2|||
127557713|NCT01742286|459010447|FG000|Escalation Phase|Subject/guardian decision|1|||
127557714|NCT01742286|459010448|FG001|Escalation Phase|Subject/guardian decision|0|||
127557715|NCT01742286|459010449|FG002|Escalation Phase|Subject/guardian decision|0|||
127557716|NCT01742286|459010450|FG003|Escalation Phase|Subject/guardian decision|0|||
127557717|NCT01742286|459010451|FG004|Escalation Phase|Subject/guardian decision|0|||
127557718|NCT01742286|459010452|FG005|Escalation Phase|Subject/guardian decision|0|||
127557719|NCT01742286|459010453|FG006|Escalation Phase|Subject/guardian decision|0|||
127557720|NCT01742286|459010447|FG000|Expansion Phase|Administrative problems|0|||
127557721|NCT01742286|459010448|FG001|Expansion Phase|Administrative problems|0|||
127557722|NCT01742286|459010449|FG002|Expansion Phase|Administrative problems|0|||
127557723|NCT01742286|459010450|FG003|Expansion Phase|Administrative problems|0|||
127557724|NCT01742286|459010451|FG004|Expansion Phase|Administrative problems|0|||
127557725|NCT01742286|459010452|FG005|Expansion Phase|Administrative problems|0|||
127557726|NCT01742286|459010453|FG006|Expansion Phase|Administrative problems|5|||
127557727|NCT01742286|459010447|FG000|Expansion Phase|Physician Decision|0|||
127557728|NCT01742286|459010448|FG001|Expansion Phase|Physician Decision|0|||
127557729|NCT01742286|459010449|FG002|Expansion Phase|Physician Decision|4|||
127557730|NCT01742286|459010450|FG003|Expansion Phase|Physician Decision|0|||
127557731|NCT01742286|459010451|FG004|Expansion Phase|Physician Decision|0|||
127557732|NCT01742286|459010452|FG005|Expansion Phase|Physician Decision|0|||
127557733|NCT01742286|459010453|FG006|Expansion Phase|Physician Decision|9|||
127557734|NCT01742286|459010447|FG000|Expansion Phase|Adverse Event|0|||
127557735|NCT01742286|459010448|FG001|Expansion Phase|Adverse Event|0|||
127557736|NCT01742286|459010449|FG002|Expansion Phase|Adverse Event|0|||
127557737|NCT01742286|459010450|FG003|Expansion Phase|Adverse Event|0|||
127557738|NCT01742286|459010451|FG004|Expansion Phase|Adverse Event|0|||
127557739|NCT01742286|459010452|FG005|Expansion Phase|Adverse Event|0|||
127557740|NCT01742286|459010453|FG006|Expansion Phase|Adverse Event|6|||
127557741|NCT01742286|459010447|FG000|Expansion Phase|Disease progression|0|||
127557742|NCT01742286|459010448|FG001|Expansion Phase|Disease progression|0|||
127557743|NCT01742286|459010449|FG002|Expansion Phase|Disease progression|3|||
127557744|NCT01742286|459010450|FG003|Expansion Phase|Disease progression|0|||
127557745|NCT01742286|459010451|FG004|Expansion Phase|Disease progression|0|||
127557746|NCT01742286|459010452|FG005|Expansion Phase|Disease progression|0|||
127557747|NCT01742286|459010453|FG006|Expansion Phase|Disease progression|15|||
127557748|NCT01742286|459010447|FG000|Expansion Phase|Withdrawal by Subject|0|||
127557749|NCT01742286|459010448|FG001|Expansion Phase|Withdrawal by Subject|0|||
127557750|NCT01742286|459010449|FG002|Expansion Phase|Withdrawal by Subject|0|||
127685958|NCT00311363|459476411|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
128021841|NCT00724893|460704613|FG000|Overall Study|Incarceration|0|||
127685959|NCT00311363|459476409|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
127685960|NCT00311363|459476410|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
127685961|NCT00311363|459476411|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
127685962|NCT00311363|459476409|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
127557751|NCT01742286|459010450|FG003|Expansion Phase|Withdrawal by Subject|0|||
127557752|NCT01742286|459010451|FG004|Expansion Phase|Withdrawal by Subject|0|||
127557753|NCT01742286|459010452|FG005|Expansion Phase|Withdrawal by Subject|0|||
127557754|NCT01742286|459010453|FG006|Expansion Phase|Withdrawal by Subject|1|||
127557755|NCT04530136|459010454|FG000|Overall Study|Lost to Follow-up|2|||
127557756|NCT04530136|459010455|FG001|Overall Study|Lost to Follow-up|3|||
127557757|NCT04530136|459010454|FG000|Overall Study|Withdrawal by Subject|1|||
127557758|NCT04530136|459010455|FG001|Overall Study|Withdrawal by Subject|0|||
127557759|NCT04530136|459010454|FG000|Overall Study|Death|0|||
127557760|NCT04530136|459010455|FG001|Overall Study|Death|1|||
127557761|NCT01309282|459010456|FG000|Overall Study|Lost to Follow-up|1|||
127557762|NCT01387542|459010457|FG000|Overall Study|Adverse Event|3|||
127774280|NCT01794520|459800290|FG000|Overall Study|Other, not specified|0|||
127774281|NCT01794520|459800291|FG001|Overall Study|Other, not specified|0|||
127774282|NCT01794520|459800292|FG002|Overall Study|Other, not specified|1|||
127774283|NCT01794520|459800293|FG003|Overall Study|Other, not specified|1|||
127774284|NCT01794520|459800294|FG004|Overall Study|Other, not specified|4|||
127774285|NCT01794520|459800295|FG005|Overall Study|Other, not specified|1|||
127774286|NCT01794520|459800296|FG006|Overall Study|Other, not specified|2|||
127774287|NCT04796896|459800298|FG000|Overall Study|Adverse Event|1|||
127774288|NCT04796896|459800299|FG001|Overall Study|Adverse Event|0|||
127774289|NCT04796896|459800300|FG002|Overall Study|Adverse Event|0|||
127774290|NCT04796896|459800301|FG003|Overall Study|Adverse Event|0|||
127774291|NCT04796896|459800302|FG004|Overall Study|Adverse Event|0|||
127774292|NCT04796896|459800303|FG005|Overall Study|Adverse Event|1|||
127774293|NCT04796896|459800304|FG006|Overall Study|Adverse Event|1|||
127774294|NCT04796896|459800305|FG007|Overall Study|Adverse Event|0|||
127774295|NCT04796896|459800306|FG008|Overall Study|Adverse Event|1|||
127774296|NCT04796896|459800307|FG009|Overall Study|Adverse Event|1|||
127774297|NCT04796896|459800308|FG010|Overall Study|Adverse Event|1|||
128021842|NCT00724893|460704614|FG001|Overall Study|Incarceration|9|||
128021843|NCT00724893|460704613|FG000|Overall Study|Substance abuse|0|||
128021844|NCT00724893|460704614|FG001|Overall Study|Substance abuse|3|||
128021845|NCT00724893|460704613|FG000|Overall Study|Financial reasons|0|||
128021846|NCT00724893|460704614|FG001|Overall Study|Financial reasons|2|||
128021847|NCT00724893|460704613|FG000|Overall Study|Assigned shorter treatment|0|||
128021848|NCT00724893|460704614|FG001|Overall Study|Assigned shorter treatment|2|||
128021849|NCT00724893|460704613|FG000|Overall Study|Lost to Follow-up|0|||
128021850|NCT00724893|460704614|FG001|Overall Study|Lost to Follow-up|52|||
128021851|NCT00724893|460704613|FG000|Overall Study|Unknown, missing data|1|||
128021852|NCT00724893|460704614|FG001|Overall Study|Unknown, missing data|1|||
128021853|NCT02945046|460704618|FG000|Overall Study|Adverse Event|1|||
128021854|NCT02945046|460704619|FG001|Overall Study|Adverse Event|0|||
128021855|NCT02945046|460704620|FG002|Overall Study|Adverse Event|2|||
128021856|NCT02945046|460704618|FG000|Overall Study|Withdrawal by Subject|3|||
128021857|NCT02945046|460704619|FG001|Overall Study|Withdrawal by Subject|3|||
128021858|NCT02945046|460704620|FG002|Overall Study|Withdrawal by Subject|3|||
128021859|NCT02945046|460704618|FG000|Overall Study|Protocol Violation|2|||
128021860|NCT02945046|460704619|FG001|Overall Study|Protocol Violation|3|||
128021861|NCT02945046|460704620|FG002|Overall Study|Protocol Violation|2|||
128021862|NCT02945046|460704618|FG000|Overall Study|Lost to Follow-up|1|||
128021863|NCT02945046|460704619|FG001|Overall Study|Lost to Follow-up|1|||
128021864|NCT02945046|460704620|FG002|Overall Study|Lost to Follow-up|0|||
128021865|NCT02945046|460704618|FG000|Overall Study|Lack of Efficacy|1|||
128021866|NCT02945046|460704619|FG001|Overall Study|Lack of Efficacy|2|||
128021867|NCT02945046|460704620|FG002|Overall Study|Lack of Efficacy|1|||
128021868|NCT02945046|460704618|FG000|Overall Study|Other than specified|5|||
128021869|NCT02945046|460704619|FG001|Overall Study|Other than specified|4|||
128021870|NCT02945046|460704620|FG002|Overall Study|Other than specified|7|||
128021871|NCT03113136|460704621|FG000|Overall Study|Lost to Follow-up|22|||
128021872|NCT03113136|460704622|FG001|Overall Study|Lost to Follow-up|47|||
128021873|NCT03113136|460704623|FG002|Overall Study|Lost to Follow-up|54|||
128021874|NCT03113136|460704621|FG000|Overall Study|Withdrawal by Subject|4|||
128021875|NCT03113136|460704622|FG001|Overall Study|Withdrawal by Subject|13|||
128021876|NCT03113136|460704623|FG002|Overall Study|Withdrawal by Subject|14|||
127774298|NCT04796896|459800309|FG011|Overall Study|Adverse Event|0|||
128021877|NCT03113136|460704621|FG000|Overall Study|Ineligible|0|||
128021878|NCT03113136|460704622|FG001|Overall Study|Ineligible|2|||
128021879|NCT03113136|460704623|FG002|Overall Study|Ineligible|1|||
128021880|NCT03113136|460704621|FG000|Overall Study|Study Team Decision|1|||
128021881|NCT03113136|460704622|FG001|Overall Study|Study Team Decision|4|||
128021882|NCT03113136|460704623|FG002|Overall Study|Study Team Decision|0|||
128021883|NCT02675452|460704624|FG000|Overall Study|Sponsor decision|0|||
128021884|NCT02675452|460704625|FG001|Overall Study|Sponsor decision|0|||
128021885|NCT02675452|460704626|FG002|Overall Study|Sponsor decision|0|||
128021886|NCT02675452|460704627|FG003|Overall Study|Sponsor decision|0|||
128021887|NCT02675452|460704628|FG004|Overall Study|Sponsor decision|0|||
128021888|NCT02675452|460704629|FG005|Overall Study|Sponsor decision|0|||
128021889|NCT02675452|460704630|FG006|Overall Study|Sponsor decision|0|||
128021890|NCT02675452|460704631|FG007|Overall Study|Sponsor decision|0|||
128021891|NCT02675452|460704632|FG008|Overall Study|Sponsor decision|0|||
128021892|NCT02675452|460704633|FG009|Overall Study|Sponsor decision|1|||
128021893|NCT02675452|460704634|FG010|Overall Study|Sponsor decision|0|||
128021894|NCT02675452|460704635|FG011|Overall Study|Sponsor decision|0|||
128021895|NCT02675452|460704636|FG012|Overall Study|Sponsor decision|0|||
128021896|NCT02675452|460704637|FG013|Overall Study|Sponsor decision|2|||
127774299|NCT04796896|459800298|FG000|Overall Study|Lost to Follow-up|24|||
128021897|NCT02675452|460704638|FG014|Overall Study|Sponsor decision|1|||
128021898|NCT02675452|460704639|FG015|Overall Study|Sponsor decision|0|||
128021899|NCT02675452|460704640|FG016|Overall Study|Sponsor decision|1|||
127774300|NCT04796896|459800299|FG001|Overall Study|Lost to Follow-up|15|||
128021900|NCT02675452|460704641|FG017|Overall Study|Sponsor decision|0|||
127557763|NCT01387542|459010457|FG000|Overall Study|Withdrawal by Subject|1|||
127557764|NCT01387542|459010457|FG000|Overall Study|Changed diagnosis|1|||
127557765|NCT01387542|459010457|FG000|Overall Study|Insufficient response|1|||
127557766|NCT01387542|459010457|FG000|Overall Study|Non-compliant|1|||
127557767|NCT01387542|459010457|FG000|Overall Study|Lost to Follow-up|1|||
127557768|NCT01010867|459010460|FG000|Overall Study|< 50% adherence to probiotic|1|||
127557769|NCT01233232|459010461|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
127557770|NCT01233232|459010462|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
127557771|NCT01233232|459010463|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
127557772|NCT02762370|459010464|FG000|Overall Study|Protocol Violation|1|||
127557773|NCT02762370|459010465|FG001|Overall Study|Protocol Violation|0|||
127557774|NCT02633020|459010466|FG000|Overall Study|Adverse Event|1|||
127557775|NCT02633020|459010467|FG001|Overall Study|Adverse Event|0|||
127557776|NCT01136785|459010468|FG000|Overall Study|Protocol Violation|2|||
127557777|NCT01136785|459010469|FG001|Overall Study|Protocol Violation|1|||
127557778|NCT01388985|459010470|FG000|Overall Study|Death|0|||
127557779|NCT01388985|459010471|FG001|Overall Study|Death|1|||
127557780|NCT01388985|459010470|FG000|Overall Study|Lost to Follow-up|30|||
127557781|NCT01388985|459010471|FG001|Overall Study|Lost to Follow-up|30|||
127557782|NCT01388985|459010470|FG000|Overall Study|Withdrawal by Subject|13|||
127557783|NCT01388985|459010471|FG001|Overall Study|Withdrawal by Subject|4|||
127557784|NCT01388985|459010470|FG000|Overall Study|Subject unavailable|1|||
127557785|NCT01388985|459010471|FG001|Overall Study|Subject unavailable|1|||
127557786|NCT01388985|459010470|FG000|Overall Study|Other (no reason)|0|||
127557787|NCT01388985|459010471|FG001|Overall Study|Other (no reason)|1|||
127557788|NCT01388985|459010470|FG000|Overall Study|Error of nurse|5|||
127557789|NCT01388985|459010471|FG001|Overall Study|Error of nurse|1|||
127557790|NCT01057589|459010472|FG000|Overall Study|Disease Progression|35|||
127557791|NCT01057589|459010472|FG000|Overall Study|Adverse Event|10|||
127557792|NCT01057589|459010472|FG000|Overall Study|Physician Decision|8|||
127557793|NCT01057589|459010472|FG000|Overall Study|Withdrawal by Subject|3|||
127557794|NCT01057589|459010472|FG000|Overall Study|Sponsor Decision|1|||
127557795|NCT01057589|459010472|FG000|Overall Study|Death|8|||
127557796|NCT01057589|459010472|FG000|Overall Study|Lost to Follow-up|1|||
127557797|NCT02954172|459010473|FG000|Overall Study|Protocol Violation|3|||
127557798|NCT02954172|459010474|FG001|Overall Study|Protocol Violation|0|||
127557799|NCT02954172|459010473|FG000|Overall Study|allergic reaction|2|||
127557800|NCT02954172|459010474|FG001|Overall Study|allergic reaction|1|||
127557801|NCT02954172|459010473|FG000|Overall Study|non-measurable lesions at baseline|1|||
127557802|NCT02954172|459010474|FG001|Overall Study|non-measurable lesions at baseline|2|||
127557803|NCT00853567|459010477|FG000|Overall Study|Study prematurely terminated|71|||
127557804|NCT01497366|459010481|FG000|Overall Study|Virologic failure|2|||
127557805|NCT01497366|459010482|FG001|Overall Study|Virologic failure|50|||
127685963|NCT00311363|459476410|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
127685964|NCT00311363|459476411|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
127685965|NCT00311363|459476409|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
127685966|NCT00311363|459476410|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
127685967|NCT00311363|459476411|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
127685968|NCT00311363|459476409|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
127685969|NCT00311363|459476410|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
127685970|NCT00311363|459476411|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
127685971|NCT00311363|459476409|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
127685972|NCT00311363|459476410|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
127685973|NCT00311363|459476411|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
127685974|NCT03830866|459476412|FG000|Overall Study|Death|90|||
127685975|NCT03830866|459476413|FG001|Overall Study|Death|111|||
127685976|NCT03830866|459476412|FG000|Overall Study|Lost to Follow-up|7|||
127685977|NCT03830866|459476413|FG001|Overall Study|Lost to Follow-up|7|||
127685978|NCT03830866|459476412|FG000|Overall Study|Withdrawal by Subject|19|||
127685979|NCT03830866|459476413|FG001|Overall Study|Withdrawal by Subject|16|||
127685980|NCT03830866|459476412|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
127685981|NCT03830866|459476413|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
128021901|NCT02675452|460704642|FG018|Overall Study|Sponsor decision|0|||
127557806|NCT01497366|459010481|FG000|Overall Study|Lost to Follow-up|11|||
127557807|NCT01497366|459010482|FG001|Overall Study|Lost to Follow-up|10|||
127557808|NCT01497366|459010481|FG000|Overall Study|Withdrawal by Subject|6|||
127557809|NCT01497366|459010482|FG001|Overall Study|Withdrawal by Subject|6|||
127557810|NCT01497366|459010481|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
127557811|NCT01497366|459010482|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
127557812|NCT01497366|459010481|FG000|Overall Study|Other|5|||
127557813|NCT01497366|459010482|FG001|Overall Study|Other|0|||
127557814|NCT01497366|459010481|FG000|Overall Study|Death|1|||
127685982|NCT03830866|459476412|FG000|Overall Study|Other|1|||
127685983|NCT03830866|459476413|FG001|Overall Study|Other|1|||
127685984|NCT00988858|459476415|FG000|Overall Study|Adverse Event|7|||
128021902|NCT02675452|460704643|FG019|Overall Study|Sponsor decision|0|||
127557815|NCT01497366|459010482|FG001|Overall Study|Death|1|||
127557816|NCT01497366|459010481|FG000|Overall Study|Randomized but not treated|7|||
127557817|NCT01497366|459010482|FG001|Overall Study|Randomized but not treated|21|||
127557818|NCT02745080|459010496|FG000|Overall Study|Adverse Event|13|||
127557819|NCT02745080|459010497|FG001|Overall Study|Adverse Event|21|||
127557820|NCT02745080|459010496|FG000|Overall Study|Lack of Efficacy|11|||
127557821|NCT02745080|459010497|FG001|Overall Study|Lack of Efficacy|23|||
127557822|NCT02745080|459010496|FG000|Overall Study|Lost to Follow-up|3|||
127557823|NCT02745080|459010497|FG001|Overall Study|Lost to Follow-up|3|||
127557824|NCT02745080|459010496|FG000|Overall Study|Physician Decision|3|||
127557825|NCT02745080|459010497|FG001|Overall Study|Physician Decision|0|||
127557826|NCT02745080|459010496|FG000|Overall Study|Protocol Violation|3|||
127557827|NCT02745080|459010497|FG001|Overall Study|Protocol Violation|1|||
127557828|NCT02745080|459010496|FG000|Overall Study|Withdrawal by Subject|22|||
127557829|NCT02745080|459010497|FG001|Overall Study|Withdrawal by Subject|41|||
127557830|NCT01338298|459010500|FG000|Overall Study|Withdrawal by Subject|1|||
127557831|NCT01338298|459010501|FG001|Overall Study|Withdrawal by Subject|1|||
127557832|NCT01338298|459010500|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
127557833|NCT01338298|459010501|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
127557834|NCT01338298|459010500|FG000|Overall Study|Administrative error|0|||
127557835|NCT01338298|459010501|FG001|Overall Study|Administrative error|1|||
127557836|NCT01338298|459010500|FG000|Overall Study|Positive symptom worsening|1|||
127557837|NCT01338298|459010501|FG001|Overall Study|Positive symptom worsening|0|||
127557838|NCT01338298|459010500|FG000|Overall Study|Depressive symptoms and nausea|1|||
127557839|NCT01338298|459010501|FG001|Overall Study|Depressive symptoms and nausea|0|||
127557840|NCT01338298|459010500|FG000|Overall Study|Non-adherence|1|||
127557841|NCT01338298|459010501|FG001|Overall Study|Non-adherence|0|||
127557842|NCT00334113|459010502|FG000|Overall Study|Lost to Follow-up|2|||
127557843|NCT00334113|459010503|FG001|Overall Study|Lost to Follow-up|2|||
127557844|NCT00334113|459010502|FG000|Overall Study|Withdrawal by Subject|0|||
127557845|NCT00334113|459010503|FG001|Overall Study|Withdrawal by Subject|1|||
127557846|NCT00721968|459010504|FG000|Overall Study|Lost to Follow-up|2|||
127557847|NCT00721968|459010505|FG001|Overall Study|Lost to Follow-up|0|||
127557848|NCT05601544|459010506|FG000|Phase 2 Period 1|Adverse Event|0|||
127557849|NCT05601544|459010507|FG001|Phase 2 Period 1|Adverse Event|1|||
127557850|NCT05601544|459010508|FG002|Phase 2 Period 1|Adverse Event|0|||
127557851|NCT05601544|459010509|FG003|Phase 2 Period 1|Adverse Event|0|||
127557852|NCT05601544|459010510|FG004|Phase 2 Period 1|Adverse Event|0|||
127557853|NCT05601544|459010511|FG005|Phase 2 Period 1|Adverse Event|0|||
127557854|NCT03818035|459010516|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
127557855|NCT03818035|459010517|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
127557856|NCT03818035|459010518|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
127557857|NCT03818035|459010519|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
127557858|NCT03818035|459010516|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
127557859|NCT03818035|459010517|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
127557860|NCT03818035|459010518|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
127557861|NCT03818035|459010519|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
127557862|NCT03818035|459010516|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
127557863|NCT03818035|459010517|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
127557864|NCT03818035|459010518|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
127557865|NCT03818035|459010519|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
127557866|NCT03818035|459010516|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
127557867|NCT03818035|459010517|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
127557868|NCT03818035|459010518|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
127557869|NCT03818035|459010519|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
127557870|NCT03818035|459010516|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
127557871|NCT03818035|459010517|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
127557872|NCT03818035|459010518|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
127557873|NCT03818035|459010519|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
127557874|NCT03818035|459010516|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
127557875|NCT03818035|459010517|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
127557876|NCT03818035|459010518|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
127557877|NCT03818035|459010519|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
127557878|NCT03818035|459010516|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
127557879|NCT03818035|459010517|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
127557880|NCT03818035|459010518|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
127557881|NCT03818035|459010519|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
127557882|NCT03818035|459010516|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
127557883|NCT03818035|459010517|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
127557884|NCT03818035|459010518|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
127557885|NCT03818035|459010519|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
127557886|NCT03818035|459010516|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
127557887|NCT03818035|459010517|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
127557888|NCT03818035|459010518|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
127557889|NCT03818035|459010519|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
127557890|NCT03818035|459010516|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
127557891|NCT03818035|459010517|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
127557892|NCT03818035|459010518|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
127557893|NCT03818035|459010519|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
127557894|NCT03818035|459010516|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
127557895|NCT03818035|459010517|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
127557896|NCT03818035|459010518|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
127557897|NCT03818035|459010519|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
127557898|NCT03818035|459010516|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
127557899|NCT03818035|459010517|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
127557900|NCT03818035|459010518|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
127557901|NCT03818035|459010519|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
127557902|NCT03818035|459010516|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
127557903|NCT03818035|459010517|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
127557904|NCT03818035|459010518|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
127557905|NCT03818035|459010519|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
127557906|NCT03818035|459010516|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
127557907|NCT03818035|459010517|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
127557908|NCT03818035|459010518|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
127557909|NCT03818035|459010519|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
127557910|NCT03818035|459010516|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
127557911|NCT03818035|459010517|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
127557912|NCT03818035|459010518|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
127557913|NCT03818035|459010519|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
127557914|NCT03374202|459010522|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
127557915|NCT03374202|459010523|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
127557916|NCT03374202|459010524|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
127557917|NCT03374202|459010522|FG000|Five Year Long Term Follow Up|Death|0|||
127557918|NCT03374202|459010523|FG001|Five Year Long Term Follow Up|Death|1|||
127557919|NCT03374202|459010524|FG002|Five Year Long Term Follow Up|Death|0|||
127557920|NCT00843284|459012169|FG000|Overall Study|Adverse Event|39|||
127557921|NCT00843284|459012169|FG000|Overall Study|Lack of Efficacy|5|||
127557922|NCT00843284|459012169|FG000|Overall Study|Lost to Follow-up|11|||
127557923|NCT00843284|459012169|FG000|Overall Study|Other|10|||
127557924|NCT00843284|459012169|FG000|Overall Study|Withdrawal by Subject|4|||
127557925|NCT00843284|459012169|FG000|Overall Study|Death|3|||
127557926|NCT00122980|459012174|FG000|Overall Study|Death|0|||
127557927|NCT00122980|459012175|FG001|Overall Study|Death|1|||
127557928|NCT00122980|459012174|FG000|Overall Study|Physician Decision|2|||
127557929|NCT00122980|459012175|FG001|Overall Study|Physician Decision|0|||
127557930|NCT00122980|459012174|FG000|Overall Study|Protocol Violation|5|||
128021903|NCT02675452|460704644|FG020|Overall Study|Sponsor decision|0|||
128021904|NCT02675452|460704645|FG021|Overall Study|Sponsor decision|0|||
128021905|NCT02675452|460704646|FG022|Overall Study|Sponsor decision|0|||
128021906|NCT02675452|460704647|FG023|Overall Study|Sponsor decision|0|||
128021907|NCT02675452|460704648|FG024|Overall Study|Sponsor decision|0|||
128021908|NCT02675452|460704649|FG025|Overall Study|Sponsor decision|0|||
128021909|NCT02675452|460704650|FG026|Overall Study|Sponsor decision|2|||
128021910|NCT02675452|460704651|FG027|Overall Study|Sponsor decision|0|||
128021911|NCT02675452|460704652|FG028|Overall Study|Sponsor decision|0|||
128021912|NCT02675452|460704624|FG000|Overall Study|Withdrawal by Subject|0|||
128021913|NCT02675452|460704625|FG001|Overall Study|Withdrawal by Subject|0|||
128021914|NCT02675452|460704626|FG002|Overall Study|Withdrawal by Subject|0|||
127557931|NCT00122980|459012175|FG001|Overall Study|Protocol Violation|1|||
127557932|NCT00122980|459012174|FG000|Overall Study|Withdrawal by Subject|2|||
127557933|NCT00122980|459012175|FG001|Overall Study|Withdrawal by Subject|3|||
127557934|NCT00122980|459012174|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
127557935|NCT00122980|459012175|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
127557936|NCT00122980|459012174|FG000|Overall Study|Study termination|27|||
127557937|NCT00122980|459012175|FG001|Overall Study|Study termination|35|||
127557938|NCT01124864|459012176|FG000|Overall Study|Follow up phase competed as per protocol|18|||
127557939|NCT01124864|459012177|FG001|Overall Study|Follow up phase competed as per protocol|22|||
127557940|NCT01124864|459012178|FG002|Overall Study|Follow up phase competed as per protocol|24|||
127557941|NCT01124864|459012179|FG003|Overall Study|Follow up phase competed as per protocol|18|||
127557942|NCT01124864|459012180|FG004|Overall Study|Follow up phase competed as per protocol|26|||
127557943|NCT01124864|459012181|FG005|Overall Study|Follow up phase competed as per protocol|2|||
127557944|NCT01124864|459012176|FG000|Overall Study|Death|6|||
127557945|NCT01124864|459012177|FG001|Overall Study|Death|9|||
128021915|NCT02675452|460704627|FG003|Overall Study|Withdrawal by Subject|0|||
128021916|NCT02675452|460704628|FG004|Overall Study|Withdrawal by Subject|0|||
127557946|NCT01124864|459012178|FG002|Overall Study|Death|6|||
127557947|NCT01124864|459012179|FG003|Overall Study|Death|2|||
127557948|NCT01124864|459012180|FG004|Overall Study|Death|1|||
128021917|NCT02675452|460704629|FG005|Overall Study|Withdrawal by Subject|0|||
127557949|NCT01124864|459012181|FG005|Overall Study|Death|0|||
127557950|NCT01124864|459012176|FG000|Overall Study|Withdrawal by Subject|2|||
127557951|NCT01124864|459012177|FG001|Overall Study|Withdrawal by Subject|3|||
127557952|NCT01124864|459012178|FG002|Overall Study|Withdrawal by Subject|4|||
127557953|NCT01124864|459012179|FG003|Overall Study|Withdrawal by Subject|0|||
127557954|NCT01124864|459012180|FG004|Overall Study|Withdrawal by Subject|2|||
127557955|NCT01124864|459012181|FG005|Overall Study|Withdrawal by Subject|1|||
127557956|NCT01124864|459012176|FG000|Overall Study|Lost to Follow-up|1|||
127557957|NCT01124864|459012177|FG001|Overall Study|Lost to Follow-up|1|||
127557958|NCT01124864|459012178|FG002|Overall Study|Lost to Follow-up|0|||
127557959|NCT01124864|459012179|FG003|Overall Study|Lost to Follow-up|1|||
127557960|NCT01124864|459012180|FG004|Overall Study|Lost to Follow-up|0|||
127557961|NCT01124864|459012181|FG005|Overall Study|Lost to Follow-up|0|||
127557962|NCT01124864|459012176|FG000|Overall Study|Protocol Violation|1|||
127557963|NCT01124864|459012177|FG001|Overall Study|Protocol Violation|0|||
127557964|NCT01124864|459012178|FG002|Overall Study|Protocol Violation|0|||
127557965|NCT01124864|459012179|FG003|Overall Study|Protocol Violation|0|||
127557966|NCT01124864|459012180|FG004|Overall Study|Protocol Violation|1|||
127557967|NCT01124864|459012181|FG005|Overall Study|Protocol Violation|0|||
127557968|NCT01243242|459012182|FG000|Overall Study|Adverse Event|1|||
127557969|NCT01243242|459012183|FG001|Overall Study|Adverse Event|1|||
127557970|NCT01243242|459012182|FG000|Overall Study|Withdrawal by Subject|1|||
127557971|NCT01243242|459012183|FG001|Overall Study|Withdrawal by Subject|1|||
127557972|NCT01243242|459012182|FG000|Overall Study|Physician Decision|0|||
127557973|NCT01243242|459012183|FG001|Overall Study|Physician Decision|1|||
127557974|NCT01243242|459012182|FG000|Overall Study|sponsor decision|0|||
127557975|NCT01243242|459012183|FG001|Overall Study|sponsor decision|1|||
127557976|NCT01243242|459012182|FG000|Overall Study|non compliance|1|||
127557977|NCT01243242|459012183|FG001|Overall Study|non compliance|0|||
127557978|NCT01256294|459012193|FG000|Overall Study|Adverse Event|1|||
127557979|NCT01256294|459012194|FG001|Overall Study|Adverse Event|0|||
127557980|NCT01256294|459012193|FG000|Overall Study|Withdrawal by Subject|1|||
127557981|NCT01256294|459012194|FG001|Overall Study|Withdrawal by Subject|1|||
127557982|NCT01256294|459012193|FG000|Overall Study|Protocol deviation|2|||
127557983|NCT01256294|459012194|FG001|Overall Study|Protocol deviation|1|||
127557984|NCT02160899|459012195|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
127557985|NCT02160899|459012196|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
127557986|NCT02160899|459012197|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
127557987|NCT02160899|459012198|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
127557988|NCT02160899|459012199|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
127557989|NCT02160899|459012200|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
127557990|NCT00798759|459012202|FG000|Overall Study|Adverse Event|3|||
127557991|NCT00798759|459012203|FG001|Overall Study|Adverse Event|3|||
127557992|NCT00798759|459012202|FG000|Overall Study|Lost to Follow-up|1|||
127557993|NCT00798759|459012203|FG001|Overall Study|Lost to Follow-up|1|||
127557994|NCT00798759|459012202|FG000|Overall Study|Protocol Violation|4|||
127557995|NCT00798759|459012203|FG001|Overall Study|Protocol Violation|8|||
127557996|NCT00798759|459012202|FG000|Overall Study|Other|0|||
127557997|NCT00798759|459012203|FG001|Overall Study|Other|1|||
127557998|NCT00724711|459012204|FG000|Overall Study|Adverse Event|7|||
127557999|NCT00724711|459012205|FG001|Overall Study|Adverse Event|3|||
127558000|NCT00724711|459012204|FG000|Overall Study|Pregnancy|0|||
127558001|NCT00724711|459012205|FG001|Overall Study|Pregnancy|1|||
127558002|NCT00724711|459012204|FG000|Overall Study|Lack of Efficacy|0|||
127774301|NCT04796896|459800300|FG002|Overall Study|Lost to Follow-up|6|||
127774302|NCT04796896|459800301|FG003|Overall Study|Lost to Follow-up|4|||
127774303|NCT04796896|459800302|FG004|Overall Study|Lost to Follow-up|21|||
127774304|NCT04796896|459800303|FG005|Overall Study|Lost to Follow-up|55|||
127774305|NCT04796896|459800304|FG006|Overall Study|Lost to Follow-up|237|||
127774306|NCT04796896|459800305|FG007|Overall Study|Lost to Follow-up|52|||
127774307|NCT04796896|459800306|FG008|Overall Study|Lost to Follow-up|221|||
127774308|NCT04796896|459800307|FG009|Overall Study|Lost to Follow-up|43|||
127558003|NCT00724711|459012205|FG001|Overall Study|Lack of Efficacy|1|||
127558004|NCT00724711|459012204|FG000|Overall Study|Physician Decision|0|||
127558005|NCT00724711|459012205|FG001|Overall Study|Physician Decision|3|||
127558006|NCT00724711|459012204|FG000|Overall Study|Withdrawal by Subject|5|||
127558007|NCT00724711|459012205|FG001|Overall Study|Withdrawal by Subject|4|||
127558008|NCT00724711|459012204|FG000|Overall Study|Lost to Follow-up|4|||
127774309|NCT04796896|459800308|FG010|Overall Study|Lost to Follow-up|142|||
127774310|NCT04796896|459800309|FG011|Overall Study|Lost to Follow-up|18|||
127558009|NCT00724711|459012205|FG001|Overall Study|Lost to Follow-up|5|||
127558010|NCT00724711|459012204|FG000|Overall Study|Protocol Violation|1|||
127558011|NCT00724711|459012205|FG001|Overall Study|Protocol Violation|0|||
127558012|NCT01945710|459012206|FG000|Overall Study|Progressive Disease|5|||
127558013|NCT01945710|459012207|FG001|Overall Study|Progressive Disease|4|||
127558014|NCT01945710|459012208|FG002|Overall Study|Progressive Disease|3|||
127558015|NCT01945710|459012209|FG003|Overall Study|Progressive Disease|2|||
127774311|NCT04796896|459800298|FG000|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|5|||
127558016|NCT01945710|459012210|FG004|Overall Study|Progressive Disease|7|||
127558017|NCT01945710|459012211|FG005|Overall Study|Progressive Disease|3|||
127558018|NCT01945710|459012212|FG006|Overall Study|Progressive Disease|19|||
127558019|NCT01945710|459012206|FG000|Overall Study|Adverse Event|0|||
127558020|NCT01945710|459012207|FG001|Overall Study|Adverse Event|1|||
127558021|NCT01945710|459012208|FG002|Overall Study|Adverse Event|0|||
127558022|NCT01945710|459012209|FG003|Overall Study|Adverse Event|0|||
127558023|NCT01945710|459012210|FG004|Overall Study|Adverse Event|0|||
127558024|NCT01945710|459012211|FG005|Overall Study|Adverse Event|0|||
127558025|NCT01945710|459012212|FG006|Overall Study|Adverse Event|0|||
127558026|NCT01945710|459012206|FG000|Overall Study|Other|2|||
127558027|NCT01945710|459012207|FG001|Overall Study|Other|0|||
127558028|NCT01945710|459012208|FG002|Overall Study|Other|3|||
127558029|NCT01945710|459012209|FG003|Overall Study|Other|1|||
127558030|NCT01945710|459012210|FG004|Overall Study|Other|1|||
127558031|NCT01945710|459012211|FG005|Overall Study|Other|0|||
127558032|NCT01945710|459012212|FG006|Overall Study|Other|4|||
127558033|NCT01945710|459012206|FG000|Overall Study|Withdrawal by Subject|0|||
127558034|NCT01945710|459012207|FG001|Overall Study|Withdrawal by Subject|1|||
127558035|NCT01945710|459012208|FG002|Overall Study|Withdrawal by Subject|1|||
127558036|NCT01945710|459012209|FG003|Overall Study|Withdrawal by Subject|0|||
127558037|NCT01945710|459012210|FG004|Overall Study|Withdrawal by Subject|1|||
127558038|NCT01945710|459012211|FG005|Overall Study|Withdrawal by Subject|0|||
127558039|NCT01945710|459012212|FG006|Overall Study|Withdrawal by Subject|0|||
127558040|NCT00375609|459012213|FG000|Overall Study|Did not receive treatment|1|||
127558041|NCT00375609|459012214|FG001|Overall Study|Did not receive treatment|0|||
127558042|NCT00375609|459012215|FG002|Overall Study|Did not receive treatment|0|||
127558043|NCT00375609|459012213|FG000|Overall Study|Adverse Event|0|||
127558044|NCT00375609|459012214|FG001|Overall Study|Adverse Event|3|||
127558045|NCT00375609|459012215|FG002|Overall Study|Adverse Event|0|||
127558046|NCT00375609|459012213|FG000|Overall Study|Lost to Follow-up|1|||
127558047|NCT00375609|459012214|FG001|Overall Study|Lost to Follow-up|0|||
127558048|NCT00375609|459012215|FG002|Overall Study|Lost to Follow-up|0|||
127558049|NCT00375609|459012213|FG000|Overall Study|Physician Decision|0|||
127558050|NCT00375609|459012214|FG001|Overall Study|Physician Decision|0|||
127558051|NCT00375609|459012215|FG002|Overall Study|Physician Decision|1|||
127558052|NCT00375609|459012213|FG000|Overall Study|Withdrawal by Subject|1|||
127558053|NCT00375609|459012214|FG001|Overall Study|Withdrawal by Subject|4|||
127558054|NCT00375609|459012215|FG002|Overall Study|Withdrawal by Subject|0|||
127558055|NCT00375609|459012213|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
127558056|NCT00375609|459012214|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
127558057|NCT00375609|459012215|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
127558058|NCT01368562|459012216|FG000|Overall Study|Adverse Event|1|||
127774312|NCT04796896|459800299|FG001|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|4|||
127774313|NCT04796896|459800300|FG002|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|0|||
128021918|NCT02675452|460704630|FG006|Overall Study|Withdrawal by Subject|0|||
128021919|NCT02675452|460704631|FG007|Overall Study|Withdrawal by Subject|0|||
128021920|NCT02675452|460704632|FG008|Overall Study|Withdrawal by Subject|0|||
128021921|NCT02675452|460704633|FG009|Overall Study|Withdrawal by Subject|1|||
128021922|NCT02675452|460704634|FG010|Overall Study|Withdrawal by Subject|0|||
128021923|NCT02675452|460704635|FG011|Overall Study|Withdrawal by Subject|1|||
128021924|NCT02675452|460704636|FG012|Overall Study|Withdrawal by Subject|0|||
128021925|NCT02675452|460704637|FG013|Overall Study|Withdrawal by Subject|1|||
128021926|NCT02675452|460704638|FG014|Overall Study|Withdrawal by Subject|1|||
127558059|NCT01368562|459012216|FG000|Overall Study|Disease progression|1|||
127774314|NCT04796896|459800301|FG003|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|3|||
127774315|NCT04796896|459800302|FG004|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
128021927|NCT02675452|460704639|FG015|Overall Study|Withdrawal by Subject|0|||
128021928|NCT02675452|460704640|FG016|Overall Study|Withdrawal by Subject|2|||
128021929|NCT02675452|460704641|FG017|Overall Study|Withdrawal by Subject|0|||
127558060|NCT01368562|459012216|FG000|Overall Study|Lost to Follow-up|1|||
127558061|NCT01368562|459012216|FG000|Overall Study|Death|6|||
127558062|NCT01368562|459012216|FG000|Overall Study|Unresponsive to treatment|5|||
127558063|NCT01368562|459012216|FG000|Overall Study|Other|3|||
128021930|NCT02675452|460704642|FG018|Overall Study|Withdrawal by Subject|0|||
128021931|NCT02675452|460704643|FG019|Overall Study|Withdrawal by Subject|0|||
128021932|NCT02675452|460704644|FG020|Overall Study|Withdrawal by Subject|0|||
128021933|NCT02675452|460704645|FG021|Overall Study|Withdrawal by Subject|0|||
127558064|NCT01368562|459012216|FG000|Overall Study|Other than specified|2|||
127558065|NCT01754727|459012219|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
127558066|NCT02338882|459012222|FG000|Overall Study|Death|1|||
127558067|NCT02338882|459012223|FG001|Overall Study|Death|0|||
127558068|NCT02338882|459012222|FG000|Overall Study|Lost to Follow-up|6|||
127558069|NCT02338882|459012223|FG001|Overall Study|Lost to Follow-up|3|||
127558070|NCT04838977|459012228|FG000|Overall Study|Lost to Follow-up|2|||
127558071|NCT04838977|459012229|FG001|Overall Study|Lost to Follow-up|3|||
127558072|NCT04838977|459012228|FG000|Overall Study|Withdrawal by Subject|1|||
128021934|NCT02675452|460704646|FG022|Overall Study|Withdrawal by Subject|3|||
128021935|NCT02675452|460704647|FG023|Overall Study|Withdrawal by Subject|0|||
128021936|NCT02675452|460704648|FG024|Overall Study|Withdrawal by Subject|1|||
128021937|NCT02675452|460704649|FG025|Overall Study|Withdrawal by Subject|0|||
128021938|NCT02675452|460704650|FG026|Overall Study|Withdrawal by Subject|1|||
128021939|NCT02675452|460704651|FG027|Overall Study|Withdrawal by Subject|3|||
128021940|NCT02675452|460704652|FG028|Overall Study|Withdrawal by Subject|4|||
128021941|NCT02675452|460704624|FG000|Overall Study|Death|0|||
128021942|NCT02675452|460704625|FG001|Overall Study|Death|0|||
128021943|NCT02675452|460704626|FG002|Overall Study|Death|1|||
128021944|NCT02675452|460704627|FG003|Overall Study|Death|0|||
128021945|NCT02675452|460704628|FG004|Overall Study|Death|0|||
128021946|NCT02675452|460704629|FG005|Overall Study|Death|1|||
128021947|NCT02675452|460704630|FG006|Overall Study|Death|0|||
128021948|NCT02675452|460704631|FG007|Overall Study|Death|0|||
127558073|NCT04838977|459012229|FG001|Overall Study|Withdrawal by Subject|1|||
127558074|NCT02891070|459012234|FG000|Overall Study|Adverse Event|1|||
127558075|NCT02891070|459012235|FG001|Overall Study|Adverse Event|0|||
127558076|NCT02891070|459012234|FG000|Overall Study|Physician Decision|0|||
127558077|NCT02891070|459012235|FG001|Overall Study|Physician Decision|1|||
127558078|NCT02891070|459012234|FG000|Overall Study|Lost to Follow-up|4|||
128021949|NCT02675452|460704632|FG008|Overall Study|Death|1|||
128021950|NCT02675452|460704633|FG009|Overall Study|Death|0|||
128021951|NCT02675452|460704634|FG010|Overall Study|Death|0|||
128021952|NCT02675452|460704635|FG011|Overall Study|Death|0|||
128021953|NCT02675452|460704636|FG012|Overall Study|Death|1|||
128021954|NCT02675452|460704637|FG013|Overall Study|Death|0|||
128021955|NCT02675452|460704638|FG014|Overall Study|Death|0|||
128021956|NCT02675452|460704639|FG015|Overall Study|Death|2|||
128021957|NCT02675452|460704640|FG016|Overall Study|Death|0|||
127558079|NCT02891070|459012235|FG001|Overall Study|Lost to Follow-up|4|||
127558080|NCT02891070|459012234|FG000|Overall Study|Other|1|||
127685985|NCT00988858|459476415|FG000|Overall Study|Death|1|||
127685986|NCT00988858|459476415|FG000|Overall Study|Physician Decision|1|||
128021958|NCT02675452|460704641|FG017|Overall Study|Death|0|||
128021959|NCT02675452|460704642|FG018|Overall Study|Death|4|||
128021960|NCT02675452|460704643|FG019|Overall Study|Death|3|||
128021961|NCT02675452|460704644|FG020|Overall Study|Death|3|||
128021962|NCT02675452|460704645|FG021|Overall Study|Death|3|||
128021963|NCT02675452|460704646|FG022|Overall Study|Death|7|||
128021964|NCT02675452|460704647|FG023|Overall Study|Death|5|||
128021965|NCT02675452|460704648|FG024|Overall Study|Death|3|||
128021966|NCT02675452|460704649|FG025|Overall Study|Death|4|||
128021967|NCT02675452|460704650|FG026|Overall Study|Death|7|||
128021968|NCT02675452|460704651|FG027|Overall Study|Death|6|||
128021969|NCT02675452|460704652|FG028|Overall Study|Death|9|||
128021970|NCT02675452|460704624|FG000|Overall Study|Lost to Follow-up|0|||
128021971|NCT02675452|460704625|FG001|Overall Study|Lost to Follow-up|1|||
128021972|NCT02675452|460704626|FG002|Overall Study|Lost to Follow-up|0|||
128021973|NCT02675452|460704627|FG003|Overall Study|Lost to Follow-up|0|||
128021974|NCT02675452|460704628|FG004|Overall Study|Lost to Follow-up|0|||
128021975|NCT02675452|460704629|FG005|Overall Study|Lost to Follow-up|0|||
128021976|NCT02675452|460704630|FG006|Overall Study|Lost to Follow-up|0|||
128021977|NCT02675452|460704631|FG007|Overall Study|Lost to Follow-up|0|||
128021978|NCT02675452|460704632|FG008|Overall Study|Lost to Follow-up|0|||
128021979|NCT02675452|460704633|FG009|Overall Study|Lost to Follow-up|0|||
128021980|NCT02675452|460704634|FG010|Overall Study|Lost to Follow-up|0|||
127685987|NCT00988858|459476415|FG000|Overall Study|Sponsor Decision|1|||
127685988|NCT03764475|459476416|FG000|Overall Study|Adverse Event|11|||
127685989|NCT03764475|459476417|FG001|Overall Study|Adverse Event|2|||
127685990|NCT03764475|459476416|FG000|Overall Study|Lost to Follow-up|24|||
128021981|NCT02675452|460704635|FG011|Overall Study|Lost to Follow-up|0|||
128021982|NCT02675452|460704636|FG012|Overall Study|Lost to Follow-up|1|||
128021983|NCT02675452|460704637|FG013|Overall Study|Lost to Follow-up|0|||
128021984|NCT02675452|460704638|FG014|Overall Study|Lost to Follow-up|0|||
128021985|NCT02675452|460704639|FG015|Overall Study|Lost to Follow-up|0|||
127558081|NCT02891070|459012235|FG001|Overall Study|Other|0|||
127558082|NCT02891070|459012234|FG000|Overall Study|Protocol Violation|0|||
127558083|NCT02891070|459012235|FG001|Overall Study|Protocol Violation|1|||
127685991|NCT03764475|459476417|FG001|Overall Study|Lost to Follow-up|10|||
127685992|NCT03764475|459476416|FG000|Overall Study|Withdrawal by Subject|26|||
127685993|NCT03764475|459476417|FG001|Overall Study|Withdrawal by Subject|10|||
127685994|NCT03764475|459476416|FG000|Overall Study|Lack of Efficacy|3|||
128021986|NCT02675452|460704640|FG016|Overall Study|Lost to Follow-up|0|||
128021987|NCT02675452|460704641|FG017|Overall Study|Lost to Follow-up|0|||
127685995|NCT03764475|459476417|FG001|Overall Study|Lack of Efficacy|0|||
128021988|NCT02675452|460704642|FG018|Overall Study|Lost to Follow-up|0|||
128021989|NCT02675452|460704643|FG019|Overall Study|Lost to Follow-up|0|||
128021990|NCT02675452|460704644|FG020|Overall Study|Lost to Follow-up|0|||
128021991|NCT02675452|460704645|FG021|Overall Study|Lost to Follow-up|0|||
128021992|NCT02675452|460704646|FG022|Overall Study|Lost to Follow-up|0|||
128021993|NCT02675452|460704647|FG023|Overall Study|Lost to Follow-up|0|||
128021994|NCT02675452|460704648|FG024|Overall Study|Lost to Follow-up|0|||
128021995|NCT02675452|460704649|FG025|Overall Study|Lost to Follow-up|0|||
128021996|NCT02675452|460704650|FG026|Overall Study|Lost to Follow-up|1|||
128021997|NCT02675452|460704651|FG027|Overall Study|Lost to Follow-up|0|||
128021998|NCT02675452|460704652|FG028|Overall Study|Lost to Follow-up|0|||
128021999|NCT02675452|460704624|FG000|Overall Study|Other|0|||
128022000|NCT02675452|460704625|FG001|Overall Study|Other|0|||
128022001|NCT02675452|460704626|FG002|Overall Study|Other|0|||
128022002|NCT02675452|460704627|FG003|Overall Study|Other|0|||
128022003|NCT02675452|460704628|FG004|Overall Study|Other|0|||
128022004|NCT02675452|460704629|FG005|Overall Study|Other|0|||
128022005|NCT02675452|460704630|FG006|Overall Study|Other|0|||
128022006|NCT02675452|460704631|FG007|Overall Study|Other|0|||
128022007|NCT02675452|460704632|FG008|Overall Study|Other|0|||
128022008|NCT02675452|460704633|FG009|Overall Study|Other|0|||
128022009|NCT02675452|460704634|FG010|Overall Study|Other|0|||
128022010|NCT02675452|460704635|FG011|Overall Study|Other|0|||
128022011|NCT02675452|460704636|FG012|Overall Study|Other|0|||
128022012|NCT02675452|460704637|FG013|Overall Study|Other|0|||
128022013|NCT02675452|460704638|FG014|Overall Study|Other|0|||
128022014|NCT02675452|460704639|FG015|Overall Study|Other|0|||
128022015|NCT02675452|460704640|FG016|Overall Study|Other|0|||
128022016|NCT02675452|460704641|FG017|Overall Study|Other|0|||
128022017|NCT02675452|460704642|FG018|Overall Study|Other|0|||
128022018|NCT02675452|460704643|FG019|Overall Study|Other|0|||
128022019|NCT02675452|460704644|FG020|Overall Study|Other|0|||
127558084|NCT02891070|459012234|FG000|Overall Study|Withdrawal by Subject|1|||
127558085|NCT02891070|459012235|FG001|Overall Study|Withdrawal by Subject|2|||
127558086|NCT02891070|459012234|FG000|Overall Study|Death|3|||
127558087|NCT02891070|459012235|FG001|Overall Study|Death|0|||
127558088|NCT02934503|459012236|FG000|Overall Study|progression of disease|3|||
127558089|NCT02934503|459012236|FG000|Overall Study|Withdrawal by Subject|1|||
127558090|NCT00724867|459012237|FG000|Overall Study|Adverse Event|25|||
127558091|NCT00724867|459012237|FG000|Overall Study|Lack of Efficacy|14|||
127558092|NCT00724867|459012237|FG000|Overall Study|Lost to Follow-up|12|||
127558093|NCT00724867|459012237|FG000|Overall Study|Non-compliance with study drug|6|||
127558094|NCT00724867|459012237|FG000|Overall Study|Physician Decision|17|||
127558095|NCT00724867|459012237|FG000|Overall Study|Protocol Violation|1|||
127558096|NCT00724867|459012237|FG000|Overall Study|Withdrawal by Subject|31|||
127558097|NCT00724867|459012237|FG000|Overall Study|Sponsor decision to end study|14|||
127558098|NCT00724867|459012237|FG000|Overall Study|Subject incarcerated|1|||
127558099|NCT00724867|459012237|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
127558100|NCT00724867|459012237|FG000|Overall Study|Subject moved out of state|1|||
127685996|NCT03764475|459476416|FG000|Overall Study|COVID-19 Disruption|2|||
127685997|NCT03764475|459476417|FG001|Overall Study|COVID-19 Disruption|0|||
127685998|NCT05510245|459476421|FG000|Overall Study|Withdrawal by Subject|1|||
127685999|NCT05510245|459476422|FG001|Overall Study|Withdrawal by Subject|0|||
127686000|NCT05510245|459476423|FG002|Overall Study|Withdrawal by Subject|0|||
127686001|NCT01759771|459476427|FG000|Overall Study|Withdrawal by Subject|1|||
127686002|NCT01759771|459476428|FG001|Overall Study|Withdrawal by Subject|1|||
127686003|NCT03942042|459476429|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
127686004|NCT03942042|459476430|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
127686005|NCT03942042|459476429|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
127686006|NCT03942042|459476430|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
127686007|NCT01849055|459476433|FG000|Overall Study|Withdrawal by Subject|0|||
127686008|NCT01849055|459476434|FG001|Overall Study|Withdrawal by Subject|0|||
127686009|NCT01849055|459476435|FG002|Overall Study|Withdrawal by Subject|1|||
127686010|NCT01849055|459476436|FG003|Overall Study|Withdrawal by Subject|0|||
127686011|NCT01849055|459476437|FG004|Overall Study|Withdrawal by Subject|0|||
127686012|NCT01849055|459476438|FG005|Overall Study|Withdrawal by Subject|0|||
127686013|NCT01239316|459476439|FG000|Overall Study|Progression/Relapse|11|||
128022020|NCT02675452|460704645|FG021|Overall Study|Other|0|||
128022021|NCT02675452|460704646|FG022|Overall Study|Other|0|||
128022022|NCT02675452|460704647|FG023|Overall Study|Other|0|||
128022023|NCT02675452|460704648|FG024|Overall Study|Other|0|||
127558101|NCT00724867|459012237|FG000|Overall Study|Elected to exit due to site closure|2|||
127558102|NCT02881567|459012240|FG000|Overall Study|Adverse Event|1|||
127558103|NCT02881567|459012240|FG000|Overall Study|Lost to Follow-up|3|||
127558104|NCT02881567|459012240|FG000|Overall Study|Consent withdrawn|1|||
127558105|NCT02881567|459012240|FG000|Overall Study|Investigator decision|1|||
127686014|NCT01239316|459476439|FG000|Overall Study|Adverse Event|1|||
127686015|NCT02139943|459476440|FG000|Overall Study|Adverse Event|0|||
127686016|NCT02139943|459476441|FG001|Overall Study|Adverse Event|1|||
127686017|NCT02139943|459476442|FG002|Overall Study|Adverse Event|2|||
127686018|NCT02139943|459476440|FG000|Overall Study|Lost to Follow-up|3|||
128022024|NCT02675452|460704649|FG025|Overall Study|Other|0|||
128022025|NCT02675452|460704650|FG026|Overall Study|Other|1|||
128022026|NCT02675452|460704651|FG027|Overall Study|Other|0|||
128022027|NCT02675452|460704652|FG028|Overall Study|Other|0|||
128022028|NCT02939781|460704653|FG000|Overall Study|Protocol Violation|8|||
128022029|NCT02939781|460704653|FG000|Overall Study|Withdrawal by Subject|1|||
127558106|NCT02881567|459012240|FG000|Overall Study|Study terminated by sponsor|9|||
127558107|NCT02881567|459012240|FG000|Overall Study|Reason not Specified|3|||
127558108|NCT04335136|459012242|FG000|Overall Study|Death|8|||
127558109|NCT04335136|459012243|FG001|Overall Study|Death|4|||
127558110|NCT04335136|459012242|FG000|Overall Study|Lost to Follow-up|2|||
127558111|NCT04335136|459012243|FG001|Overall Study|Lost to Follow-up|0|||
127558112|NCT04335136|459012242|FG000|Overall Study|Protocol Violation|1|||
127558113|NCT04335136|459012243|FG001|Overall Study|Protocol Violation|0|||
127558114|NCT04335136|459012242|FG000|Overall Study|Withdrawal by Subject|1|||
127558115|NCT04335136|459012243|FG001|Overall Study|Withdrawal by Subject|1|||
127558116|NCT04335136|459012242|FG000|Overall Study|Health-threatening condition|0|||
127558117|NCT04335136|459012243|FG001|Overall Study|Health-threatening condition|1|||
127558118|NCT04335136|459012242|FG000|Overall Study|Adverse Event|0|||
127558119|NCT04335136|459012243|FG001|Overall Study|Adverse Event|1|||
127558120|NCT04335136|459012242|FG000|Overall Study|Erroneously randomized|2|||
127558121|NCT04335136|459012243|FG001|Overall Study|Erroneously randomized|0|||
127558122|NCT01536067|459012244|FG000|Overall Study|Disease Progression|1|||
127558123|NCT03120351|459012245|FG000|Overall Study|Physician Decision|1|||
127558124|NCT03120351|459012246|FG001|Overall Study|Physician Decision|1|||
127558125|NCT01256190|459012247|FG000|Overall Study|Lost to Follow-up|2|||
127558126|NCT01256190|459012248|FG001|Overall Study|Lost to Follow-up|0|||
127558127|NCT02423902|459012249|FG000|Overall Study|Disease progression|1|||
127558128|NCT02423902|459012250|FG001|Overall Study|Disease progression|4|||
127558129|NCT04693234|459012251|FG000|Overall Study|Death|79|||
127558130|NCT04693234|459012252|FG001|Overall Study|Death|19|||
127686019|NCT02139943|459476441|FG001|Overall Study|Lost to Follow-up|2|||
127686020|NCT02139943|459476442|FG002|Overall Study|Lost to Follow-up|2|||
127686021|NCT02139943|459476440|FG000|Overall Study|Withdrawal by Subject|4|||
127686022|NCT02139943|459476441|FG001|Overall Study|Withdrawal by Subject|3|||
127686023|NCT02139943|459476442|FG002|Overall Study|Withdrawal by Subject|0|||
127686024|NCT02139943|459476440|FG000|Overall Study|Other|0|||
127686025|NCT02139943|459476441|FG001|Overall Study|Other|0|||
127686026|NCT02139943|459476442|FG002|Overall Study|Other|1|||
127686027|NCT02139943|459476440|FG000|Overall Study|Participant wishes to discontinue|2|||
127686028|NCT02139943|459476441|FG001|Overall Study|Participant wishes to discontinue|0|||
127686029|NCT02139943|459476442|FG002|Overall Study|Participant wishes to discontinue|0|||
127686030|NCT02139943|459476440|FG000|Overall Study|Participant in Poor Compliance|1|||
127686031|NCT02139943|459476441|FG001|Overall Study|Participant in Poor Compliance|0|||
127686032|NCT02139943|459476442|FG002|Overall Study|Participant in Poor Compliance|1|||
127686033|NCT02139943|459476440|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
127686034|NCT02139943|459476441|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
127686035|NCT02139943|459476442|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
127686036|NCT04411056|459478140|FG000|Overall Study|surgery cancelled|1|||
127686037|NCT04411056|459478141|FG001|Overall Study|surgery cancelled|0|||
127686038|NCT04411056|459478140|FG000|Overall Study|Equipment problem during intubation|0|||
127686039|NCT04411056|459478141|FG001|Overall Study|Equipment problem during intubation|1|||
127686040|NCT03122886|459478144|FG000|Overall Study|Withdrawal by Subject|1|||
127686041|NCT03122886|459478145|FG001|Overall Study|Withdrawal by Subject|2|||
127686042|NCT03422276|459478146|FG000|Overall Study|Withdrawal by Subject|21|||
127686043|NCT03422276|459478147|FG001|Overall Study|Withdrawal by Subject|25|||
127686044|NCT03422276|459478148|FG002|Overall Study|Withdrawal by Subject|14|||
127686045|NCT03422276|459478149|FG003|Overall Study|Withdrawal by Subject|16|||
127686046|NCT03422276|459478146|FG000|Overall Study|Death|14|||
127686047|NCT03422276|459478147|FG001|Overall Study|Death|21|||
127686048|NCT03422276|459478148|FG002|Overall Study|Death|3|||
127686049|NCT03422276|459478149|FG003|Overall Study|Death|1|||
127686050|NCT03422276|459478146|FG000|Overall Study|Discontinued, ineligible|4|||
127686051|NCT03422276|459478147|FG001|Overall Study|Discontinued, ineligible|3|||
127686052|NCT03422276|459478148|FG002|Overall Study|Discontinued, ineligible|0|||
127686053|NCT03422276|459478149|FG003|Overall Study|Discontinued, ineligible|0|||
127686054|NCT03422276|459478146|FG000|Overall Study|Lost to Follow-up|15|||
127686055|NCT03422276|459478147|FG001|Overall Study|Lost to Follow-up|8|||
127686056|NCT03422276|459478148|FG002|Overall Study|Lost to Follow-up|13|||
127686057|NCT03422276|459478149|FG003|Overall Study|Lost to Follow-up|4|||
127686058|NCT03422276|459478146|FG000|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
127686059|NCT03422276|459478147|FG001|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
127686060|NCT03422276|459478148|FG002|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
128022030|NCT03003468|460704657|FG000|Overall Study|Withdrawal by Subject|0|||
127558131|NCT04693234|459012251|FG000|Overall Study|Sponsor Ended Study|47|||
127558132|NCT04693234|459012252|FG001|Overall Study|Sponsor Ended Study|18|||
127558133|NCT04693234|459012251|FG000|Overall Study|Withdrawal by Subject|10|||
127558134|NCT04693234|459012252|FG001|Overall Study|Withdrawal by Subject|2|||
127558135|NCT04693234|459012251|FG000|Overall Study|Lost to Follow-up|2|||
127558136|NCT04693234|459012252|FG001|Overall Study|Lost to Follow-up|1|||
127558137|NCT04643158|459012253|FG000|Overall Study|Study terminated by sponsor|0|||
127686061|NCT03422276|459478149|FG003|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
128022031|NCT03003468|460704658|FG001|Overall Study|Withdrawal by Subject|0|||
128022032|NCT03003468|460704659|FG002|Overall Study|Withdrawal by Subject|1|||
128022033|NCT03003468|460704657|FG000|Overall Study|No measurable lesions|0|||
128022034|NCT03003468|460704658|FG001|Overall Study|No measurable lesions|0|||
128022035|NCT03003468|460704659|FG002|Overall Study|No measurable lesions|1|||
128022036|NCT02114684|460704660|FG000|Overall Study|Death|6|||
128022037|NCT02114684|460704661|FG001|Overall Study|Death|4|||
128022038|NCT02114684|460704660|FG000|Overall Study|Lost to Follow-up|1|||
127774316|NCT04796896|459800303|FG005|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|194|||
127774317|NCT04796896|459800304|FG006|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|37|||
128022039|NCT02114684|460704661|FG001|Overall Study|Lost to Follow-up|2|||
128022040|NCT02114684|460704660|FG000|Overall Study|Withdrawal by Subject|1|||
128022041|NCT02114684|460704661|FG001|Overall Study|Withdrawal by Subject|2|||
128022042|NCT02114684|460704660|FG000|Overall Study|Relocation|3|||
128022043|NCT02114684|460704661|FG001|Overall Study|Relocation|1|||
128022044|NCT02114684|460704660|FG000|Overall Study|Rifampicin resistant on culture|0|||
128022045|NCT02114684|460704661|FG001|Overall Study|Rifampicin resistant on culture|1|||
128022046|NCT02114684|460704660|FG000|Overall Study|Patient Incarcerated|1|||
128022047|NCT02114684|460704661|FG001|Overall Study|Patient Incarcerated|0|||
128022048|NCT04625972|460704664|FG000|Overall Study|Death|3|||
127558138|NCT04643158|459012254|FG001|Overall Study|Study terminated by sponsor|0|||
127558139|NCT04643158|459012255|FG002|Overall Study|Study terminated by sponsor|1|||
127558140|NCT04643158|459012256|FG003|Overall Study|Study terminated by sponsor|0|||
127558141|NCT04643158|459012257|FG004|Overall Study|Study terminated by sponsor|0|||
127558142|NCT04643158|459012258|FG005|Overall Study|Study terminated by sponsor|1|||
127558143|NCT04643158|459012259|FG006|Overall Study|Study terminated by sponsor|0|||
127558144|NCT04643158|459012253|FG000|Overall Study|Global/country situation|0|||
127558145|NCT04643158|459012254|FG001|Overall Study|Global/country situation|0|||
127558146|NCT04643158|459012255|FG002|Overall Study|Global/country situation|1|||
127558147|NCT04643158|459012256|FG003|Overall Study|Global/country situation|0|||
127774318|NCT04796896|459800305|FG007|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|222|||
127774319|NCT04796896|459800306|FG008|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|29|||
127774320|NCT04796896|459800307|FG009|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|115|||
127774321|NCT04796896|459800308|FG010|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|9|||
127774322|NCT04796896|459800309|FG011|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
127774323|NCT04796896|459800298|FG000|Overall Study|Physician Decision|1|||
128022049|NCT04625972|460704665|FG001|Overall Study|Death|2|||
128022050|NCT04625972|460704664|FG000|Overall Study|Lost to Follow-up|82|||
128022051|NCT04625972|460704665|FG001|Overall Study|Lost to Follow-up|38|||
128022052|NCT04625972|460704664|FG000|Overall Study|Physician Decision|2|||
128022053|NCT04625972|460704665|FG001|Overall Study|Physician Decision|0|||
128022054|NCT04625972|460704664|FG000|Overall Study|Protocol Violation|0|||
128022055|NCT04625972|460704665|FG001|Overall Study|Protocol Violation|1|||
128022056|NCT04625972|460704664|FG000|Overall Study|Withdrawal by Subject|37|||
128022057|NCT04625972|460704665|FG001|Overall Study|Withdrawal by Subject|24|||
128022058|NCT04625972|460704664|FG000|Overall Study|Not specified elsewhere|8|||
128022059|NCT04625972|460704665|FG001|Overall Study|Not specified elsewhere|6|||
128022060|NCT03259308|460704672|FG000|Overall Study|Adverse Event|5|||
128022061|NCT03259308|460704673|FG001|Overall Study|Adverse Event|4|||
128022062|NCT03259308|460704674|FG002|Overall Study|Adverse Event|1|||
128022063|NCT03259308|460704672|FG000|Overall Study|Withdrawal by Subject|2|||
128022064|NCT03259308|460704673|FG001|Overall Study|Withdrawal by Subject|1|||
128022065|NCT03259308|460704674|FG002|Overall Study|Withdrawal by Subject|3|||
128022066|NCT03259308|460704672|FG000|Overall Study|Lost to Follow-up|0|||
128022067|NCT03259308|460704673|FG001|Overall Study|Lost to Follow-up|0|||
127558148|NCT04643158|459012257|FG004|Overall Study|Global/country situation|0|||
127558149|NCT04643158|459012258|FG005|Overall Study|Global/country situation|0|||
127774324|NCT04796896|459800299|FG001|Overall Study|Physician Decision|0|||
127774325|NCT04796896|459800300|FG002|Overall Study|Physician Decision|0|||
127774326|NCT04796896|459800301|FG003|Overall Study|Physician Decision|0|||
127774327|NCT04796896|459800302|FG004|Overall Study|Physician Decision|0|||
127774328|NCT04796896|459800303|FG005|Overall Study|Physician Decision|3|||
127774329|NCT04796896|459800304|FG006|Overall Study|Physician Decision|18|||
128022068|NCT03259308|460704674|FG002|Overall Study|Lost to Follow-up|1|||
128022069|NCT03259308|460704672|FG000|Overall Study|Pregnancy|0|||
128022070|NCT03259308|460704673|FG001|Overall Study|Pregnancy|0|||
128022071|NCT03259308|460704674|FG002|Overall Study|Pregnancy|1|||
128022072|NCT03259308|460704672|FG000|Overall Study|Protocol Deviation|0|||
128022073|NCT03259308|460704673|FG001|Overall Study|Protocol Deviation|3|||
128022074|NCT03259308|460704674|FG002|Overall Study|Protocol Deviation|0|||
128022075|NCT03259308|460704672|FG000|Overall Study|Lack of Efficacy|0|||
128022076|NCT03259308|460704673|FG001|Overall Study|Lack of Efficacy|0|||
128022077|NCT03259308|460704674|FG002|Overall Study|Lack of Efficacy|1|||
128022078|NCT00694122|460704675|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
127558150|NCT04643158|459012259|FG006|Overall Study|Global/country situation|0|||
128022079|NCT00694122|460704676|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
127558151|NCT04643158|459012253|FG000|Overall Study|Withdrawal by Subject|0|||
127558152|NCT04643158|459012254|FG001|Overall Study|Withdrawal by Subject|0|||
127558153|NCT04643158|459012255|FG002|Overall Study|Withdrawal by Subject|0|||
127558154|NCT04643158|459012256|FG003|Overall Study|Withdrawal by Subject|0|||
127558155|NCT04643158|459012257|FG004|Overall Study|Withdrawal by Subject|0|||
127558156|NCT04643158|459012258|FG005|Overall Study|Withdrawal by Subject|1|||
127558157|NCT04643158|459012259|FG006|Overall Study|Withdrawal by Subject|0|||
127558158|NCT04540198|459012260|FG000|Overall Study|Lost to Follow-up|25|||
127558159|NCT04540198|459012261|FG001|Overall Study|Lost to Follow-up|23|||
127558160|NCT04540198|459012260|FG000|Overall Study|Withdrawal by Subject|15|||
127558161|NCT04540198|459012261|FG001|Overall Study|Withdrawal by Subject|9|||
127558162|NCT04540198|459012260|FG000|Overall Study|Discontinued|1|||
127558163|NCT04540198|459012261|FG001|Overall Study|Discontinued|0|||
127558164|NCT02888119|459012274|FG000|Overall Study|Lost to Follow-up|5|||
127558165|NCT02888119|459012275|FG001|Overall Study|Lost to Follow-up|4|||
127558166|NCT02888119|459012276|FG002|Overall Study|Lost to Follow-up|0|||
127558167|NCT03679754|459012277|FG000|Overall Study|Investigator request|1|||
127558168|NCT00964171|459012278|FG000|Overall Study|Death|5|||
127558169|NCT00910299|459012282|FG000|Overall Study|Withdrawal by Subject|16|||
127774330|NCT04796896|459800305|FG007|Overall Study|Physician Decision|1|||
127774331|NCT04796896|459800306|FG008|Overall Study|Physician Decision|7|||
127774332|NCT04796896|459800307|FG009|Overall Study|Physician Decision|0|||
127774333|NCT04796896|459800308|FG010|Overall Study|Physician Decision|5|||
127774334|NCT04796896|459800309|FG011|Overall Study|Physician Decision|0|||
127774335|NCT04796896|459800298|FG000|Overall Study|Withdrawal by Subject|36|||
127774336|NCT04796896|459800299|FG001|Overall Study|Withdrawal by Subject|31|||
127774337|NCT04796896|459800300|FG002|Overall Study|Withdrawal by Subject|11|||
127774338|NCT04796896|459800301|FG003|Overall Study|Withdrawal by Subject|8|||
127774339|NCT04796896|459800302|FG004|Overall Study|Withdrawal by Subject|16|||
128022080|NCT00694122|460704675|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
127774340|NCT04796896|459800303|FG005|Overall Study|Withdrawal by Subject|162|||
127774341|NCT04796896|459800304|FG006|Overall Study|Withdrawal by Subject|299|||
127774342|NCT04796896|459800305|FG007|Overall Study|Withdrawal by Subject|149|||
127774343|NCT04796896|459800306|FG008|Overall Study|Withdrawal by Subject|303|||
127774344|NCT04796896|459800307|FG009|Overall Study|Withdrawal by Subject|94|||
127774345|NCT04796896|459800308|FG010|Overall Study|Withdrawal by Subject|192|||
127774346|NCT04796896|459800309|FG011|Overall Study|Withdrawal by Subject|16|||
127774347|NCT04796896|459800298|FG000|Overall Study|Other Than Specified|6|||
127774348|NCT04796896|459800299|FG001|Overall Study|Other Than Specified|5|||
127774349|NCT04796896|459800300|FG002|Overall Study|Other Than Specified|3|||
127774350|NCT04796896|459800301|FG003|Overall Study|Other Than Specified|2|||
127774351|NCT04796896|459800302|FG004|Overall Study|Other Than Specified|6|||
127774352|NCT04796896|459800303|FG005|Overall Study|Other Than Specified|31|||
127774353|NCT04796896|459800304|FG006|Overall Study|Other Than Specified|86|||
127774354|NCT04796896|459800305|FG007|Overall Study|Other Than Specified|66|||
127774355|NCT04796896|459800306|FG008|Overall Study|Other Than Specified|388|||
127774356|NCT04796896|459800307|FG009|Overall Study|Other Than Specified|48|||
127774357|NCT04796896|459800308|FG010|Overall Study|Other Than Specified|258|||
127774358|NCT04796896|459800309|FG011|Overall Study|Other Than Specified|4|||
127774359|NCT04796896|459800298|FG000|Overall Study|Protocol Deviation|0|||
127774360|NCT04796896|459800299|FG001|Overall Study|Protocol Deviation|0|||
127774361|NCT04796896|459800300|FG002|Overall Study|Protocol Deviation|0|||
127774362|NCT04796896|459800301|FG003|Overall Study|Protocol Deviation|1|||
127774363|NCT04796896|459800302|FG004|Overall Study|Protocol Deviation|1|||
127774364|NCT04796896|459800303|FG005|Overall Study|Protocol Deviation|2|||
128022081|NCT00694122|460704676|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
128022082|NCT00694122|460704675|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
128022083|NCT00694122|460704676|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
128022084|NCT03020888|460704681|FG000|Overall Study|Physician Decision|4|||
127558170|NCT00910299|459012283|FG001|Overall Study|Withdrawal by Subject|13|||
127558171|NCT00910299|459012282|FG000|Overall Study|Sponsor Decision|58|||
127558172|NCT00910299|459012283|FG001|Overall Study|Sponsor Decision|60|||
127558173|NCT00910299|459012282|FG000|Overall Study|Didn't receive any study drug|2|||
127558174|NCT00910299|459012283|FG001|Overall Study|Didn't receive any study drug|1|||
127558175|NCT00884741|459012285|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
127558176|NCT00884741|459012286|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
127774365|NCT04796896|459800304|FG006|Overall Study|Protocol Deviation|2|||
127774366|NCT04796896|459800305|FG007|Overall Study|Protocol Deviation|2|||
128022085|NCT03020888|460704681|FG000|Overall Study|Withdrawal by Subject|6|||
127558177|NCT00884741|459012287|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
127774367|NCT04796896|459800306|FG008|Overall Study|Protocol Deviation|2|||
127774368|NCT04796896|459800307|FG009|Overall Study|Protocol Deviation|1|||
127558178|NCT00884741|459012288|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
127774369|NCT04796896|459800308|FG010|Overall Study|Protocol Deviation|0|||
127774370|NCT04796896|459800309|FG011|Overall Study|Protocol Deviation|0|||
127774371|NCT04796896|459800298|FG000|Overall Study|Missing|0|||
127558179|NCT00884741|459012285|FG000|Step 1 Registration: Tissue Screening|Death|3|||
127558180|NCT00884741|459012286|FG001|Step 1 Registration: Tissue Screening|Death|0|||
127558181|NCT00884741|459012287|FG002|Step 1 Registration: Tissue Screening|Death|0|||
127558182|NCT00884741|459012288|FG003|Step 1 Registration: Tissue Screening|Death|0|||
127558183|NCT00884741|459012285|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
127558184|NCT00884741|459012286|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
128022086|NCT03020888|460704681|FG000|Overall Study|Insurance coverage|2|||
128022087|NCT03020888|460704681|FG000|Overall Study|Lost to Follow-up|1|||
128022088|NCT01198548|460704688|FG000|Overall Study|Disease Progression|9|||
128022089|NCT01198548|460704688|FG000|Overall Study|Administrative Decision|1|||
128022090|NCT01245062|460704690|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
128022091|NCT01245062|460704691|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
128022092|NCT01245062|460704692|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
128022093|NCT01245062|460704690|FG000|Randomization and Crossover Phase|Physician Decision|2|||
128022094|NCT01245062|460704691|FG001|Randomization and Crossover Phase|Physician Decision|4|||
127558185|NCT00884741|459012287|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
127558186|NCT00884741|459012288|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
127558187|NCT00884741|459012285|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
127558188|NCT00884741|459012286|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
127774372|NCT04796896|459800299|FG001|Overall Study|Missing|0|||
127774373|NCT04796896|459800300|FG002|Overall Study|Missing|0|||
127774374|NCT04796896|459800301|FG003|Overall Study|Missing|0|||
127774375|NCT04796896|459800302|FG004|Overall Study|Missing|0|||
127774376|NCT04796896|459800303|FG005|Overall Study|Missing|0|||
127774377|NCT04796896|459800304|FG006|Overall Study|Missing|2|||
127774378|NCT04796896|459800305|FG007|Overall Study|Missing|1|||
127774379|NCT04796896|459800306|FG008|Overall Study|Missing|2|||
127774380|NCT04796896|459800307|FG009|Overall Study|Missing|1|||
127774381|NCT04796896|459800308|FG010|Overall Study|Missing|1|||
127774382|NCT04796896|459800309|FG011|Overall Study|Missing|0|||
127774383|NCT04796896|459800298|FG000|Overall Study|Death|0|||
127774384|NCT04796896|459800299|FG001|Overall Study|Death|0|||
127774385|NCT04796896|459800300|FG002|Overall Study|Death|0|||
127774386|NCT04796896|459800301|FG003|Overall Study|Death|0|||
127774387|NCT04796896|459800302|FG004|Overall Study|Death|0|||
127774388|NCT04796896|459800303|FG005|Overall Study|Death|0|||
127774389|NCT04796896|459800304|FG006|Overall Study|Death|0|||
127774390|NCT04796896|459800305|FG007|Overall Study|Death|0|||
127774391|NCT04796896|459800306|FG008|Overall Study|Death|1|||
127774392|NCT04796896|459800307|FG009|Overall Study|Death|0|||
127774393|NCT04796896|459800308|FG010|Overall Study|Death|0|||
127774394|NCT04796896|459800309|FG011|Overall Study|Death|0|||
127774395|NCT04356183|459800310|FG000|Overall Study|Lost to Follow-up|1|||
127774396|NCT04356183|459800311|FG001|Overall Study|Lost to Follow-up|0|||
127774397|NCT04356183|459800310|FG000|Overall Study|Withdrawal by Subject|1|||
127774398|NCT04356183|459800311|FG001|Overall Study|Withdrawal by Subject|1|||
127774399|NCT01177787|459800312|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
127774400|NCT01177787|459800312|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
127774401|NCT01177787|459800312|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
127774402|NCT00402363|459800313|FG000|Overall Study|Adverse Event|9|||
127774403|NCT00402363|459800314|FG001|Overall Study|Adverse Event|14|||
127774404|NCT00402363|459800315|FG002|Overall Study|Adverse Event|2|||
127774405|NCT00402363|459800316|FG003|Overall Study|Adverse Event|2|||
127774406|NCT00402363|459800313|FG000|Overall Study|Withdrew Consent|10|||
127774407|NCT00402363|459800314|FG001|Overall Study|Withdrew Consent|5|||
127774408|NCT00402363|459800315|FG002|Overall Study|Withdrew Consent|2|||
127774409|NCT00402363|459800316|FG003|Overall Study|Withdrew Consent|1|||
127774410|NCT00402363|459800313|FG000|Overall Study|Protocol Violation|3|||
127774411|NCT00402363|459800314|FG001|Overall Study|Protocol Violation|5|||
127774412|NCT00402363|459800315|FG002|Overall Study|Protocol Violation|0|||
127774413|NCT00402363|459800316|FG003|Overall Study|Protocol Violation|3|||
127774414|NCT00402363|459800313|FG000|Overall Study|Lost to Follow-up|5|||
128022095|NCT01245062|460704692|FG002|Randomization and Crossover Phase|Physician Decision|0|||
128022096|NCT01245062|460704690|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
127558189|NCT00884741|459012287|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
127558190|NCT00884741|459012288|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
127558191|NCT00884741|459012285|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
128022097|NCT01245062|460704691|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
127774415|NCT00402363|459800314|FG001|Overall Study|Lost to Follow-up|4|||
127774416|NCT00402363|459800315|FG002|Overall Study|Lost to Follow-up|0|||
127774417|NCT00402363|459800316|FG003|Overall Study|Lost to Follow-up|2|||
127774418|NCT00402363|459800313|FG000|Overall Study|"Captured as Other"|6|||
127774419|NCT00402363|459800314|FG001|Overall Study|"Captured as Other"|2|||
127774420|NCT00402363|459800315|FG002|Overall Study|"Captured as Other"|2|||
127774421|NCT00402363|459800316|FG003|Overall Study|"Captured as Other"|2|||
127774422|NCT02634346|459800317|FG000|Overall Study|Withdrawal by Subject|8|||
127774423|NCT02634346|459800318|FG001|Overall Study|Withdrawal by Subject|9|||
127774424|NCT02634346|459800319|FG002|Overall Study|Withdrawal by Subject|8|||
127558192|NCT00884741|459012286|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
127558193|NCT00884741|459012287|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
127558194|NCT00884741|459012288|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
127558195|NCT00884741|459012285|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
127558196|NCT00884741|459012286|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
127558197|NCT00884741|459012287|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
127558198|NCT00884741|459012288|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
127558199|NCT00884741|459012285|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
127558200|NCT00884741|459012286|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
127558201|NCT00884741|459012287|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
127558202|NCT00884741|459012288|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
127558203|NCT00884741|459012285|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
127558204|NCT00884741|459012286|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
127558205|NCT00884741|459012287|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
127686062|NCT03422276|459478146|FG000|Overall Study|Incarcerated prior to first follow-up|0|||
127686063|NCT03422276|459478147|FG001|Overall Study|Incarcerated prior to first follow-up|1|||
127686064|NCT03422276|459478148|FG002|Overall Study|Incarcerated prior to first follow-up|0|||
127558206|NCT00884741|459012288|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
127558207|NCT00884741|459012285|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
128022098|NCT01245062|460704692|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
128022099|NCT01245062|460704690|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
128022100|NCT01245062|460704691|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
128022101|NCT01245062|460704692|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
128022102|NCT01245062|460704690|FG000|Cross-over Phase|Lost to Follow-up|0|||
128022103|NCT01245062|460704691|FG001|Cross-over Phase|Lost to Follow-up|0|||
128022104|NCT01245062|460704692|FG002|Cross-over Phase|Lost to Follow-up|1|||
128022105|NCT01245062|460704690|FG000|Cross-over Phase|Physician Decision|0|||
128022106|NCT01245062|460704691|FG001|Cross-over Phase|Physician Decision|0|||
128022107|NCT01245062|460704692|FG002|Cross-over Phase|Physician Decision|1|||
128022108|NCT01245062|460704690|FG000|Cross-over Phase|Withdrew Consent|0|||
128022109|NCT01245062|460704691|FG001|Cross-over Phase|Withdrew Consent|0|||
128022110|NCT01245062|460704692|FG002|Cross-over Phase|Withdrew Consent|4|||
128022111|NCT01245062|460704690|FG000|Cross-over Phase|Study closed/ terminated|0|||
128022112|NCT01245062|460704691|FG001|Cross-over Phase|Study closed/ terminated|0|||
128022113|NCT01245062|460704692|FG002|Cross-over Phase|Study closed/ terminated|11|||
128022114|NCT06025695|460704693|FG000|Overall Study|Adverse Event|5|||
128022115|NCT06025695|460704694|FG001|Overall Study|Adverse Event|6|||
128022116|NCT06025695|460704693|FG000|Overall Study|Migrated / Moved from the Study Area|13|||
128022117|NCT06025695|460704694|FG001|Overall Study|Migrated / Moved from the Study Area|10|||
128022118|NCT06025695|460704693|FG000|Overall Study|Other|23|||
128022119|NCT06025695|460704694|FG001|Overall Study|Other|19|||
128022120|NCT06025695|460704693|FG000|Overall Study|Adverse Event Requiring Expedited Report|1|||
128022121|NCT06025695|460704694|FG001|Overall Study|Adverse Event Requiring Expedited Report|0|||
127558208|NCT00884741|459012286|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
127558209|NCT00884741|459012287|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
127558210|NCT00884741|459012288|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
127558211|NCT00884741|459012285|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
127558212|NCT00884741|459012286|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
127558213|NCT00884741|459012287|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
127558214|NCT00884741|459012288|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
127558215|NCT00884741|459012285|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
127558216|NCT00884741|459012286|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
127558217|NCT00884741|459012287|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
128022122|NCT03834883|460704695|FG000|Second Treatment|Withdrawal by Subject|1|||
128022123|NCT03834883|460704696|FG001|Second Treatment|Withdrawal by Subject|0|||
128022124|NCT03834883|460704697|FG002|Second Treatment|Withdrawal by Subject|0|||
128022125|NCT03834883|460704698|FG003|Second Treatment|Withdrawal by Subject|0|||
128022126|NCT03834883|460704695|FG000|Second Treatment|COVID-19 pandemic|1|||
127558218|NCT00884741|459012288|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
127558219|NCT00884741|459012285|FG000|Randomization|Protocol Violation|0|||
127558220|NCT00884741|459012286|FG001|Randomization|Protocol Violation|0|||
127558221|NCT00884741|459012287|FG002|Randomization|Protocol Violation|8|||
127558222|NCT00884741|459012288|FG003|Randomization|Protocol Violation|8|||
127558223|NCT00499590|459012291|FG000|Overall Study|Study Terminated|112|||
127558224|NCT00499590|459012292|FG001|Overall Study|Study Terminated|112|||
127558225|NCT00499590|459012293|FG002|Overall Study|Study Terminated|112|||
127558226|NCT00499590|459012291|FG000|Overall Study|Not treated|1|||
127558227|NCT00499590|459012292|FG001|Overall Study|Not treated|0|||
127558228|NCT00499590|459012293|FG002|Overall Study|Not treated|1|||
127558229|NCT05661851|459012294|FG000|Overall Study|Protocol Violation|1|||
127558230|NCT05661851|459012295|FG001|Overall Study|Protocol Violation|1|||
127774425|NCT02634346|459800317|FG000|Overall Study|Adverse Event|2|||
127774426|NCT02634346|459800318|FG001|Overall Study|Adverse Event|2|||
128022127|NCT03834883|460704696|FG001|Second Treatment|COVID-19 pandemic|0|||
127774427|NCT02634346|459800319|FG002|Overall Study|Adverse Event|7|||
128022128|NCT03834883|460704697|FG002|Second Treatment|COVID-19 pandemic|1|||
128022129|NCT03834883|460704698|FG003|Second Treatment|COVID-19 pandemic|1|||
128022130|NCT01301092|460704701|FG000|Overall Study|Lost to Follow-up|0|||
128022131|NCT01301092|460704702|FG001|Overall Study|Lost to Follow-up|0|||
127558231|NCT05661851|459012294|FG000|Overall Study|Covid-19 Related|3|||
128022132|NCT01301092|460704703|FG002|Overall Study|Lost to Follow-up|1|||
128022133|NCT00853047|460704704|FG000|Core Phase|Participant Request|0|||
127774428|NCT02634346|459800317|FG000|Overall Study|Lack of Efficacy|1|||
128022134|NCT00853047|460704705|FG001|Core Phase|Participant Request|0|||
128022135|NCT00853047|460704706|FG002|Core Phase|Participant Request|0|||
128022136|NCT00853047|460704707|FG003|Core Phase|Participant Request|1|||
128022137|NCT00853047|460704708|FG004|Core Phase|Participant Request|0|||
128022138|NCT00853047|460704709|FG005|Core Phase|Participant Request|0|||
128022139|NCT00853047|460704704|FG000|Open-Label Extension Phase|Participant Request|0|||
128022140|NCT00853047|460704705|FG001|Open-Label Extension Phase|Participant Request|0|||
128022141|NCT00853047|460704706|FG002|Open-Label Extension Phase|Participant Request|0|||
128022142|NCT00853047|460704707|FG003|Open-Label Extension Phase|Participant Request|0|||
128022143|NCT00853047|460704708|FG004|Open-Label Extension Phase|Participant Request|0|||
128022144|NCT00853047|460704709|FG005|Open-Label Extension Phase|Participant Request|7|||
128022145|NCT00853047|460704704|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
128022146|NCT00853047|460704705|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
128022147|NCT00853047|460704706|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
128022148|NCT00853047|460704707|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
128022149|NCT00853047|460704708|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
128022150|NCT00853047|460704709|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
128022151|NCT00853047|460704704|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
128022152|NCT00853047|460704705|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
128022153|NCT00853047|460704706|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
128022154|NCT00853047|460704707|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
128022155|NCT00853047|460704708|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
128022156|NCT00853047|460704709|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
128022157|NCT00853047|460704704|FG000|Open-Label Extension Phase|Investigator Decision|0|||
128022158|NCT00853047|460704705|FG001|Open-Label Extension Phase|Investigator Decision|0|||
128022159|NCT00853047|460704706|FG002|Open-Label Extension Phase|Investigator Decision|0|||
128022160|NCT00853047|460704707|FG003|Open-Label Extension Phase|Investigator Decision|0|||
128022161|NCT00853047|460704708|FG004|Open-Label Extension Phase|Investigator Decision|0|||
128022162|NCT00853047|460704709|FG005|Open-Label Extension Phase|Investigator Decision|1|||
128022163|NCT00853047|460704704|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
128022164|NCT00853047|460704705|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
128022165|NCT00853047|460704706|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
128022166|NCT00853047|460704707|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
128022167|NCT00853047|460704708|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
128022168|NCT00853047|460704709|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
128022169|NCT00160615|460706582|FG000|Overall Study|Adverse Event|5|||
128022170|NCT00160615|460706583|FG001|Overall Study|Adverse Event|12|||
128022171|NCT00160615|460706582|FG000|Overall Study|Withdrawal by Subject|0|||
128022172|NCT00160615|460706583|FG001|Overall Study|Withdrawal by Subject|2|||
128022173|NCT00160615|460706582|FG000|Overall Study|Lack of Efficacy|11|||
128022174|NCT00160615|460706583|FG001|Overall Study|Lack of Efficacy|23|||
128022175|NCT00160615|460706582|FG000|Overall Study|Patient decision|1|||
128022176|NCT00160615|460706583|FG001|Overall Study|Patient decision|2|||
128022177|NCT00160615|460706582|FG000|Overall Study|Investigator decision|1|||
128022178|NCT00160615|460706583|FG001|Overall Study|Investigator decision|1|||
128022179|NCT00160615|460706582|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
128022180|NCT00160615|460706583|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
128022181|NCT00160615|460706582|FG000|Overall Study|Switch to surgical treatment|0|||
128022182|NCT00160615|460706583|FG001|Overall Study|Switch to surgical treatment|2|||
128022183|NCT00160615|460706582|FG000|Overall Study|Non-compliance was suspected|0|||
128022184|NCT00160615|460706583|FG001|Overall Study|Non-compliance was suspected|1|||
128022185|NCT00160615|460706582|FG000|Overall Study|Poor compliance|0|||
128022186|NCT00160615|460706583|FG001|Overall Study|Poor compliance|1|||
128022187|NCT03166631|460706584|FG000|Overall Study|Progressive disease|2|||
128022188|NCT03166631|460706585|FG001|Overall Study|Progressive disease|1|||
128022189|NCT03166631|460706586|FG002|Overall Study|Progressive disease|3|||
128022190|NCT03166631|460706587|FG003|Overall Study|Progressive disease|4|||
128022191|NCT03166631|460706588|FG004|Overall Study|Progressive disease|2|||
128022192|NCT03166631|460706589|FG005|Overall Study|Progressive disease|2|||
128022193|NCT03166631|460706590|FG006|Overall Study|Progressive disease|5|||
128022194|NCT03166631|460706591|FG007|Overall Study|Progressive disease|6|||
128022195|NCT03166631|460706592|FG008|Overall Study|Progressive disease|11|||
128022196|NCT03166631|460706593|FG009|Overall Study|Progressive disease|5|||
128022197|NCT03166631|460706594|FG010|Overall Study|Progressive disease|7|||
128022198|NCT03166631|460706584|FG000|Overall Study|Physician Decision|0|||
128022199|NCT03166631|460706585|FG001|Overall Study|Physician Decision|0|||
128022200|NCT03166631|460706586|FG002|Overall Study|Physician Decision|0|||
128022201|NCT03166631|460706587|FG003|Overall Study|Physician Decision|0|||
128022202|NCT03166631|460706588|FG004|Overall Study|Physician Decision|0|||
128022203|NCT03166631|460706589|FG005|Overall Study|Physician Decision|0|||
128022204|NCT03166631|460706590|FG006|Overall Study|Physician Decision|1|||
128022205|NCT03166631|460706591|FG007|Overall Study|Physician Decision|0|||
128022206|NCT03166631|460706592|FG008|Overall Study|Physician Decision|1|||
128022207|NCT03166631|460706593|FG009|Overall Study|Physician Decision|0|||
128022208|NCT03166631|460706594|FG010|Overall Study|Physician Decision|1|||
128022209|NCT03166631|460706584|FG000|Overall Study|Death|0|||
128022210|NCT03166631|460706585|FG001|Overall Study|Death|0|||
128022211|NCT03166631|460706586|FG002|Overall Study|Death|0|||
128022212|NCT03166631|460706587|FG003|Overall Study|Death|0|||
128022213|NCT03166631|460706588|FG004|Overall Study|Death|1|||
128022214|NCT03166631|460706589|FG005|Overall Study|Death|0|||
128022215|NCT03166631|460706590|FG006|Overall Study|Death|1|||
128022216|NCT03166631|460706591|FG007|Overall Study|Death|0|||
128022217|NCT03166631|460706592|FG008|Overall Study|Death|0|||
128022218|NCT03166631|460706593|FG009|Overall Study|Death|0|||
128022219|NCT03166631|460706594|FG010|Overall Study|Death|0|||
128022220|NCT03166631|460706584|FG000|Overall Study|Adverse Event|1|||
128022221|NCT03166631|460706585|FG001|Overall Study|Adverse Event|0|||
128022222|NCT03166631|460706586|FG002|Overall Study|Adverse Event|0|||
128022223|NCT03166631|460706587|FG003|Overall Study|Adverse Event|0|||
128022224|NCT03166631|460706588|FG004|Overall Study|Adverse Event|0|||
128022225|NCT03166631|460706589|FG005|Overall Study|Adverse Event|1|||
128022226|NCT03166631|460706590|FG006|Overall Study|Adverse Event|1|||
128022227|NCT03166631|460706591|FG007|Overall Study|Adverse Event|0|||
128022228|NCT03166631|460706592|FG008|Overall Study|Adverse Event|1|||
128022229|NCT03166631|460706593|FG009|Overall Study|Adverse Event|2|||
128022230|NCT03166631|460706594|FG010|Overall Study|Adverse Event|1|||
128022231|NCT03166631|460706584|FG000|Overall Study|Withdrawal by Subject|0|||
128022232|NCT03166631|460706585|FG001|Overall Study|Withdrawal by Subject|0|||
128022233|NCT03166631|460706586|FG002|Overall Study|Withdrawal by Subject|0|||
128022234|NCT03166631|460706587|FG003|Overall Study|Withdrawal by Subject|0|||
128022235|NCT03166631|460706588|FG004|Overall Study|Withdrawal by Subject|0|||
128022236|NCT03166631|460706589|FG005|Overall Study|Withdrawal by Subject|0|||
128022237|NCT03166631|460706590|FG006|Overall Study|Withdrawal by Subject|0|||
128022238|NCT03166631|460706591|FG007|Overall Study|Withdrawal by Subject|0|||
128022239|NCT03166631|460706592|FG008|Overall Study|Withdrawal by Subject|1|||
128022240|NCT03166631|460706593|FG009|Overall Study|Withdrawal by Subject|1|||
128022241|NCT03166631|460706594|FG010|Overall Study|Withdrawal by Subject|0|||
128022242|NCT00284934|460706595|FG000|Overall Study|Adverse Event|1|||
128022243|NCT00284934|460706596|FG001|Overall Study|Adverse Event|2|||
128022244|NCT00284934|460706595|FG000|Overall Study|Other reasons|3|||
128022245|NCT00284934|460706596|FG001|Overall Study|Other reasons|1|||
128022246|NCT03309605|460706601|FG000|Overall Study|Adverse Event|0|||
128022247|NCT03309605|460706602|FG001|Overall Study|Adverse Event|0|||
128022248|NCT03309605|460706603|FG002|Overall Study|Adverse Event|0|||
128022249|NCT03309605|460706604|FG003|Overall Study|Adverse Event|1|||
128022250|NCT03309605|460706605|FG004|Overall Study|Adverse Event|0|||
128022251|NCT03309605|460706606|FG005|Overall Study|Adverse Event|0|||
128022252|NCT03309605|460706607|FG006|Overall Study|Adverse Event|2|||
128022253|NCT03309605|460706608|FG007|Overall Study|Adverse Event|1|||
128022254|NCT03309605|460706601|FG000|Overall Study|Withdrawal by Subject|0|||
128022255|NCT03309605|460706602|FG001|Overall Study|Withdrawal by Subject|0|||
128022256|NCT03309605|460706603|FG002|Overall Study|Withdrawal by Subject|0|||
128022257|NCT03309605|460706604|FG003|Overall Study|Withdrawal by Subject|0|||
128022258|NCT03309605|460706605|FG004|Overall Study|Withdrawal by Subject|1|||
128022259|NCT03309605|460706606|FG005|Overall Study|Withdrawal by Subject|0|||
128022260|NCT03309605|460706607|FG006|Overall Study|Withdrawal by Subject|1|||
128022261|NCT03309605|460706608|FG007|Overall Study|Withdrawal by Subject|1|||
128022262|NCT00864513|460706609|FG000|Overall Study|Withdrawal by Subject|3|||
128022263|NCT05938010|460706610|FG000|Overall Study|Lost to Follow-up|2|||
128022264|NCT03073109|460706611|FG000|Overall Study|Adverse Event|0|||
128022265|NCT03073109|460706612|FG001|Overall Study|Adverse Event|1|||
128022266|NCT03073109|460706611|FG000|Overall Study|Other|2|||
128022267|NCT03073109|460706612|FG001|Overall Study|Other|0|||
128022268|NCT03073109|460706611|FG000|Overall Study|Lost to Follow-up|8|||
128022269|NCT03073109|460706612|FG001|Overall Study|Lost to Follow-up|1|||
128022270|NCT01562444|460706616|FG000|Overall Study|Did not meet entry criteria|2|||
128022271|NCT01562444|460706617|FG001|Overall Study|Did not meet entry criteria|0|||
128022272|NCT01562444|460706618|FG002|Overall Study|Did not meet entry criteria|3|||
127686065|NCT03422276|459478149|FG003|Overall Study|Incarcerated prior to first follow-up|0|||
128022273|NCT01562444|460706616|FG000|Overall Study|Did not comply with blood draw schedule|1|||
128022274|NCT01562444|460706617|FG001|Overall Study|Did not comply with blood draw schedule|0|||
128022275|NCT01562444|460706618|FG002|Overall Study|Did not comply with blood draw schedule|1|||
128022276|NCT01562444|460706616|FG000|Overall Study|Unavailable serological results|0|||
128022277|NCT01562444|460706617|FG001|Overall Study|Unavailable serological results|2|||
128022278|NCT01562444|460706618|FG002|Overall Study|Unavailable serological results|2|||
128022279|NCT01562444|460706616|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
128022280|NCT01562444|460706617|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
128022281|NCT01562444|460706618|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
128022282|NCT01562444|460706616|FG000|Overall Study|Protocol forbidden medication|1|||
128022283|NCT01562444|460706617|FG001|Overall Study|Protocol forbidden medication|0|||
128022284|NCT01562444|460706618|FG002|Overall Study|Protocol forbidden medication|0|||
128022285|NCT03055195|460706621|FG000|Overall Study|Lack of Efficacy|1|||
128022286|NCT03055195|460706622|FG001|Overall Study|Lack of Efficacy|0|||
127558232|NCT05661851|459012295|FG001|Overall Study|Covid-19 Related|4|||
127558233|NCT05661851|459012294|FG000|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|1|||
127558234|NCT05661851|459012295|FG001|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|0|||
128022287|NCT03055195|460706621|FG000|Overall Study|Withdrawal by Subject|6|||
128022288|NCT03055195|460706622|FG001|Overall Study|Withdrawal by Subject|7|||
128022289|NCT03055195|460706621|FG000|Overall Study|Study Terminated by Sponsor|2|||
128022290|NCT03055195|460706622|FG001|Overall Study|Study Terminated by Sponsor|6|||
128022291|NCT03055195|460706621|FG000|Overall Study|Protocol Violation|2|||
128022292|NCT03055195|460706622|FG001|Overall Study|Protocol Violation|1|||
128022293|NCT03055195|460706621|FG000|Overall Study|Physician Decision|1|||
128022294|NCT03055195|460706622|FG001|Overall Study|Physician Decision|0|||
128022295|NCT02568423|460706623|FG000|Overall Study|Lost to Follow-up|0|||
128022296|NCT02568423|460706624|FG001|Overall Study|Lost to Follow-up|2|||
128022297|NCT02568423|460706625|FG002|Overall Study|Lost to Follow-up|0|||
128022298|NCT02568423|460706626|FG003|Overall Study|Lost to Follow-up|0|||
128022299|NCT02568423|460706627|FG004|Overall Study|Lost to Follow-up|0|||
128022300|NCT02568423|460706628|FG005|Overall Study|Lost to Follow-up|0|||
128022301|NCT02568423|460706629|FG006|Overall Study|Lost to Follow-up|0|||
128022302|NCT02568423|460706630|FG007|Overall Study|Lost to Follow-up|0|||
128022303|NCT02568423|460706623|FG000|Overall Study|Physician Decision|0|||
128022304|NCT02568423|460706624|FG001|Overall Study|Physician Decision|0|||
128022305|NCT02568423|460706625|FG002|Overall Study|Physician Decision|0|||
127558235|NCT05661851|459012294|FG000|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|0|||
127558236|NCT05661851|459012295|FG001|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|1|||
127558237|NCT00612807|459012296|FG000|Overall Study|Withdrawal by Subject|2|||
127558238|NCT00612807|459012297|FG001|Overall Study|Withdrawal by Subject|0|||
127686066|NCT03422276|459478146|FG000|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
127686067|NCT03422276|459478147|FG001|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
128022306|NCT02568423|460706626|FG003|Overall Study|Physician Decision|0|||
128022307|NCT02568423|460706627|FG004|Overall Study|Physician Decision|0|||
128022308|NCT02568423|460706628|FG005|Overall Study|Physician Decision|1|||
128022309|NCT02568423|460706629|FG006|Overall Study|Physician Decision|0|||
128022310|NCT02568423|460706630|FG007|Overall Study|Physician Decision|0|||
128022311|NCT01027416|460706634|FG000|Overall Study|Withdrawal by Subject|0|||
128022312|NCT01027416|460706635|FG001|Overall Study|Withdrawal by Subject|1|||
128022313|NCT01027416|460706634|FG000|Overall Study|Physician Decision|1|||
128022314|NCT01027416|460706635|FG001|Overall Study|Physician Decision|4|||
128022315|NCT02930941|460706637|FG000|Overall Study|Lost to Follow-up|1|||
128022316|NCT02930941|460706638|FG001|Overall Study|Lost to Follow-up|2|||
128022317|NCT00289978|460706641|FG000|Overall Study|Withdrawal by Subject|31|||
128022318|NCT00289978|460706642|FG001|Overall Study|Withdrawal by Subject|17|||
128022319|NCT00289978|460706643|FG002|Overall Study|Withdrawal by Subject|28|||
128022320|NCT00289978|460706641|FG000|Overall Study|Adverse Event|22|||
128022321|NCT00289978|460706642|FG001|Overall Study|Adverse Event|13|||
128022322|NCT00289978|460706643|FG002|Overall Study|Adverse Event|18|||
128022323|NCT00289978|460706641|FG000|Overall Study|Lack of Efficacy|13|||
128022324|NCT00289978|460706642|FG001|Overall Study|Lack of Efficacy|6|||
128022325|NCT00289978|460706643|FG002|Overall Study|Lack of Efficacy|25|||
128022326|NCT00289978|460706641|FG000|Overall Study|Abnormal laboratory value(s)|20|||
128022327|NCT00289978|460706642|FG001|Overall Study|Abnormal laboratory value(s)|9|||
128022328|NCT00289978|460706643|FG002|Overall Study|Abnormal laboratory value(s)|1|||
128022329|NCT00289978|460706641|FG000|Overall Study|Lost to Follow-up|3|||
128022330|NCT00289978|460706642|FG001|Overall Study|Lost to Follow-up|5|||
128022331|NCT00289978|460706643|FG002|Overall Study|Lost to Follow-up|7|||
128022332|NCT00289978|460706641|FG000|Overall Study|Protocol Violation|5|||
128022333|NCT00289978|460706642|FG001|Overall Study|Protocol Violation|5|||
128022334|NCT00289978|460706643|FG002|Overall Study|Protocol Violation|4|||
128022335|NCT00289978|460706641|FG000|Overall Study|Abnormal test procedure result(s)|2|||
128022336|NCT00289978|460706642|FG001|Overall Study|Abnormal test procedure result(s)|1|||
128022337|NCT00289978|460706643|FG002|Overall Study|Abnormal test procedure result(s)|1|||
128022338|NCT00289978|460706641|FG000|Overall Study|Death|1|||
128022339|NCT00289978|460706642|FG001|Overall Study|Death|0|||
128022340|NCT00289978|460706643|FG002|Overall Study|Death|2|||
128022341|NCT00720083|460706644|FG000|Overall Study|Ineligible|1|||
128022342|NCT00720083|460706645|FG001|Overall Study|Ineligible|2|||
128022343|NCT01967277|460706646|FG000|Overall Study|Lost to Follow-up|1|||
128022344|NCT01967277|460706647|FG001|Overall Study|Lost to Follow-up|2|||
128022345|NCT01967277|460706646|FG000|Overall Study|Unrelated illness|0|||
128022346|NCT01967277|460706647|FG001|Overall Study|Unrelated illness|1|||
128022347|NCT00585585|460706651|FG000|Overall Study|Adverse Event|1|||
128022348|NCT00103506|460706652|FG000|Overall Study|Study closed by sponsor|34|||
128022349|NCT00103506|460706653|FG001|Overall Study|Study closed by sponsor|37|||
128022350|NCT00103506|460706652|FG000|Overall Study|Death|257|||
128022351|NCT00103506|460706653|FG001|Overall Study|Death|253|||
128022352|NCT00103506|460706652|FG000|Overall Study|Lost to Follow-up|13|||
128022353|NCT00103506|460706653|FG001|Overall Study|Lost to Follow-up|13|||
128022354|NCT00103506|460706652|FG000|Overall Study|Withdrawal by Subject|18|||
128022355|NCT00103506|460706653|FG001|Overall Study|Withdrawal by Subject|21|||
128022356|NCT00585169|460706654|FG000|Overall Study|Withdrawal by Subject|1|||
128022357|NCT00710970|460706655|FG000|Overall Study|Never took drug|3|||
128022358|NCT01028560|460706656|FG000|Overall Study|Lack of Efficacy|3|||
128022359|NCT01028560|460706657|FG001|Overall Study|Lack of Efficacy|6|||
128022360|NCT01028560|460706656|FG000|Overall Study|Withdrawal by Subject|7|||
128022361|NCT01028560|460706657|FG001|Overall Study|Withdrawal by Subject|12|||
128022362|NCT03055221|460706658|FG000|Overall Study|Adverse Event|2|||
128022363|NCT03055221|460706658|FG000|Overall Study|Withdrawal by Subject|4|||
128022364|NCT03055221|460706658|FG000|Overall Study|Death|6|||
128022365|NCT03055221|460706658|FG000|Overall Study|Physician Decision|1|||
128022366|NCT03055221|460706658|FG000|Overall Study|Study terminated by Sponsor|3|||
128022367|NCT03055221|460706658|FG000|Overall Study|Lost to Follow-up|4|||
128022368|NCT01243424|460706659|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
127558239|NCT01215097|459012304|FG000|Overall Study|Adverse Event|1|||
127558240|NCT01215097|459012305|FG001|Overall Study|Adverse Event|3|||
127558241|NCT01215097|459012304|FG000|Overall Study|Protocol Violation|0|||
127558242|NCT01215097|459012305|FG001|Overall Study|Protocol Violation|2|||
127686068|NCT03422276|459478148|FG002|Overall Study|Discontinued, no longer caregiver for patient participant|10|||
128022369|NCT01243424|460706660|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
128022370|NCT01243424|460706659|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
128022371|NCT01243424|460706660|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
128022372|NCT01243424|460706659|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
128022373|NCT01243424|460706660|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
127774429|NCT02634346|459800318|FG001|Overall Study|Lack of Efficacy|2|||
128022374|NCT01243424|460706659|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
128022375|NCT01243424|460706660|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
128022376|NCT01243424|460706659|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
128022377|NCT01243424|460706660|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
128022378|NCT01243424|460706659|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
128022379|NCT01243424|460706660|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
128022380|NCT01243424|460706659|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
128022381|NCT01243424|460706660|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
128022382|NCT01243424|460706659|FG000|Discontinuation From Treatment|Not treated|5|||
128022383|NCT01243424|460706660|FG001|Discontinuation From Treatment|Not treated|4|||
128022384|NCT01243424|460706659|FG000|Discontinuation From Treatment|Adverse Event|457|||
128022385|NCT01243424|460706660|FG001|Discontinuation From Treatment|Adverse Event|523|||
128022386|NCT01243424|460706659|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
128022387|NCT01243424|460706660|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
128022388|NCT01243424|460706659|FG000|Discontinuation From Treatment|Protocol Violation|46|||
128022389|NCT01243424|460706660|FG001|Discontinuation From Treatment|Protocol Violation|47|||
127881023|NCT00835068|460186103|FG001|Overall Study|Withdrawal by Subject|0|||
127881024|NCT02575807|460186104|FG000|Overall Study|Death|8|||
128022390|NCT01243424|460706659|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
128022391|NCT01243424|460706660|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
127558243|NCT01215097|459012304|FG000|Overall Study|Lost to Follow-up|2|||
127558244|NCT01215097|459012305|FG001|Overall Study|Lost to Follow-up|0|||
128022392|NCT01243424|460706659|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
128022393|NCT01243424|460706660|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
128022394|NCT01243424|460706659|FG000|Discontinuation From Treatment|Other than listed above|230|||
128022395|NCT01243424|460706660|FG001|Discontinuation From Treatment|Other than listed above|211|||
128022396|NCT00397930|460706663|FG000|Overall Study|Personal reasons|14|||
128022397|NCT00397930|460706664|FG001|Overall Study|Personal reasons|8|||
128022398|NCT00397930|460706663|FG000|Overall Study|Other medical|9|||
128022399|NCT00397930|460706664|FG001|Overall Study|Other medical|4|||
128022400|NCT00397930|460706663|FG000|Overall Study|Unknown reasons|9|||
128022401|NCT00397930|460706664|FG001|Overall Study|Unknown reasons|14|||
128022402|NCT00397930|460706663|FG000|Overall Study|Noncompliant|3|||
128022403|NCT00397930|460706664|FG001|Overall Study|Noncompliant|2|||
128022404|NCT00397930|460706663|FG000|Overall Study|Too time-consuming|2|||
128022405|NCT00397930|460706664|FG001|Overall Study|Too time-consuming|9|||
128022406|NCT00397930|460706663|FG000|Overall Study|Started own yoga program|1|||
128022407|NCT00397930|460706664|FG001|Overall Study|Started own yoga program|1|||
128022408|NCT00397930|460706663|FG000|Overall Study|Did not want to be in control group|0|||
128022409|NCT00397930|460706664|FG001|Overall Study|Did not want to be in control group|1|||
128022410|NCT00397930|460706663|FG000|Overall Study|Withdrawal by Subject|0|||
128022411|NCT00397930|460706664|FG001|Overall Study|Withdrawal by Subject|8|||
128022412|NCT00397930|460706663|FG000|Overall Study|Missing data|0|||
128022413|NCT00397930|460706664|FG001|Overall Study|Missing data|4|||
128022414|NCT01441414|460706671|FG000|Overall Study|Participant died|9|||
128022415|NCT01441414|460706671|FG000|Overall Study|Other reasons|3|||
128022416|NCT01441414|460706671|FG000|Overall Study|Study terminated by sponsor|2|||
128022417|NCT01441414|460706671|FG000|Overall Study|Subject refused further follow-up|1|||
128022418|NCT01773889|460706678|FG000|Overall Study|lack of funding|2|||
128022419|NCT00617903|460706684|FG000|Overall Study|Withdrawal by Subject|2|||
128022420|NCT00617903|460706685|FG001|Overall Study|Withdrawal by Subject|3|||
128022421|NCT00617903|460706684|FG000|Overall Study|Lost to Follow-up|1|||
128022422|NCT00617903|460706685|FG001|Overall Study|Lost to Follow-up|1|||
128022423|NCT00617903|460706684|FG000|Overall Study|Lack of Efficacy|0|||
128022424|NCT00617903|460706685|FG001|Overall Study|Lack of Efficacy|1|||
128022425|NCT00617903|460706684|FG000|Overall Study|Adverse Event|0|||
128022426|NCT00617903|460706685|FG001|Overall Study|Adverse Event|1|||
128022427|NCT00617903|460706684|FG000|Overall Study|noncompliance|0|||
128022428|NCT00617903|460706685|FG001|Overall Study|noncompliance|1|||
128022429|NCT05156125|460706686|FG000|Overall Study|Lack of Efficacy|1|||
128022430|NCT05156125|460706687|FG001|Overall Study|Lack of Efficacy|1|||
128022431|NCT05156125|460706688|FG002|Overall Study|Lack of Efficacy|1|||
128022432|NCT05156125|460706686|FG000|Overall Study|Physician Decision|0|||
128022433|NCT05156125|460706687|FG001|Overall Study|Physician Decision|0|||
128022434|NCT05156125|460706688|FG002|Overall Study|Physician Decision|1|||
128022435|NCT05156125|460706686|FG000|Overall Study|Non-compliance|0|||
128022436|NCT05156125|460706687|FG001|Overall Study|Non-compliance|1|||
128022437|NCT05156125|460706688|FG002|Overall Study|Non-compliance|1|||
128022438|NCT05156125|460706686|FG000|Overall Study|Withdrawal by Subject|0|||
128022439|NCT05156125|460706687|FG001|Overall Study|Withdrawal by Subject|0|||
128022440|NCT05156125|460706688|FG002|Overall Study|Withdrawal by Subject|1|||
128022441|NCT05156125|460706686|FG000|Overall Study|Adverse Event|2|||
128022442|NCT05156125|460706687|FG001|Overall Study|Adverse Event|1|||
128022443|NCT05156125|460706688|FG002|Overall Study|Adverse Event|0|||
128022444|NCT01058005|460706694|FG000|Overall Study|Adverse Event|0|||
128022445|NCT01058005|460706695|FG001|Overall Study|Adverse Event|2|||
128022446|NCT01058005|460706696|FG002|Overall Study|Adverse Event|1|||
128022447|NCT01058005|460706694|FG000|Overall Study|Physician Decision|2|||
128022448|NCT01058005|460706695|FG001|Overall Study|Physician Decision|2|||
128022449|NCT01058005|460706696|FG002|Overall Study|Physician Decision|0|||
128022450|NCT01058005|460706694|FG000|Overall Study|Withdrawal by Subject|4|||
127686069|NCT03422276|459478149|FG003|Overall Study|Discontinued, no longer caregiver for patient participant|3|||
127686070|NCT03422276|459478146|FG000|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
127686071|NCT03422276|459478147|FG001|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
127686072|NCT03422276|459478148|FG002|Overall Study|Discontinued, for caregiver, death of patient participant|8|||
127686073|NCT03422276|459478149|FG003|Overall Study|Discontinued, for caregiver, death of patient participant|17|||
128022451|NCT01058005|460706695|FG001|Overall Study|Withdrawal by Subject|5|||
128022452|NCT01058005|460706696|FG002|Overall Study|Withdrawal by Subject|11|||
128022453|NCT01058005|460706694|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
128022454|NCT01058005|460706695|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
128022455|NCT01058005|460706696|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
128022456|NCT01058005|460706694|FG000|Overall Study|Reason Missing|5|||
128022457|NCT01058005|460706695|FG001|Overall Study|Reason Missing|3|||
128022458|NCT01058005|460706696|FG002|Overall Study|Reason Missing|1|||
128022459|NCT00927186|460706697|FG000|12 Months Primary Study|Adverse Event|5|||
128022460|NCT00927186|460706698|FG001|12 Months Primary Study|Adverse Event|2|||
128022461|NCT00927186|460706697|FG000|12 Months Primary Study|Lost to Follow-up|1|||
128022462|NCT00927186|460706698|FG001|12 Months Primary Study|Lost to Follow-up|0|||
128022463|NCT00927186|460706697|FG000|12 Months Primary Study|Protocol Violation|0|||
127686074|NCT03422276|459478146|FG000|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
127686075|NCT03422276|459478147|FG001|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
127686076|NCT03422276|459478148|FG002|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|1|||
127686077|NCT03422276|459478149|FG003|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
127686078|NCT05985044|459478150|FG000|Overall Study|Death|6|||
127686079|NCT05985044|459478150|FG000|Overall Study|Lost to Follow-up|4|||
127686080|NCT05985044|459478150|FG000|Overall Study|Incapacitation|3|||
127686081|NCT05985044|459478150|FG000|Overall Study|Withdrawal by Subject|2|||
128022464|NCT00927186|460706698|FG001|12 Months Primary Study|Protocol Violation|1|||
128022465|NCT00927186|460706697|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
128022466|NCT00927186|460706698|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
128022467|NCT01698008|460706699|FG000|Overall Study|Withdrawal by Subject|1|||
128022468|NCT01698008|460706700|FG001|Overall Study|Withdrawal by Subject|2|||
128022469|NCT02287025|460706701|FG000|Overall Study|Not treated|2|||
128022470|NCT02287025|460706702|FG001|Overall Study|Not treated|0|||
128022471|NCT02287025|460706701|FG000|Overall Study|Progression of disease|3|||
128022472|NCT02287025|460706702|FG001|Overall Study|Progression of disease|2|||
128022473|NCT02287025|460706701|FG000|Overall Study|Adverse Event|2|||
128022474|NCT02287025|460706702|FG001|Overall Study|Adverse Event|4|||
128022475|NCT02287025|460706701|FG000|Overall Study|Withdrawal by Subject|2|||
128022476|NCT02287025|460706702|FG001|Overall Study|Withdrawal by Subject|2|||
128022477|NCT02287025|460706701|FG000|Overall Study|Screening failed|1|||
128022478|NCT02287025|460706702|FG001|Overall Study|Screening failed|1|||
128022479|NCT00799864|460706705|FG000|Overall Study|Participant reached a virologic endpoint|9|||
128022480|NCT00799864|460706706|FG001|Overall Study|Participant reached a virologic endpoint|2|||
128022481|NCT00799864|460706707|FG002|Overall Study|Participant reached a virologic endpoint|2|||
127558245|NCT01215097|459012304|FG000|Overall Study|Withdrawal by Subject|6|||
127558246|NCT01215097|459012305|FG001|Overall Study|Withdrawal by Subject|3|||
127558247|NCT01215097|459012304|FG000|Overall Study|Lack of Efficacy|0|||
127558248|NCT01215097|459012305|FG001|Overall Study|Lack of Efficacy|3|||
127558249|NCT01215097|459012304|FG000|Overall Study|patient's refusal to come|2|||
127558250|NCT01215097|459012305|FG001|Overall Study|patient's refusal to come|2|||
127558251|NCT01215097|459012304|FG000|Overall Study|patient's private reason|1|||
127558252|NCT01215097|459012305|FG001|Overall Study|patient's private reason|1|||
127558253|NCT02252939|459012306|FG000|Overall Study|Lost to Follow-up|3|||
127558254|NCT00870584|459012307|FG000|Overall Study|Adverse Event|3|||
127558255|NCT00870584|459012308|FG001|Overall Study|Adverse Event|3|||
127558256|NCT00870584|459012307|FG000|Overall Study|Withdrawal by Subject|6|||
127558257|NCT00870584|459012308|FG001|Overall Study|Withdrawal by Subject|7|||
127558258|NCT00870584|459012307|FG000|Overall Study|Lost to Follow-up|5|||
127558259|NCT00870584|459012308|FG001|Overall Study|Lost to Follow-up|1|||
127558260|NCT00870584|459012307|FG000|Overall Study|Protocol Deviation|2|||
127558261|NCT00870584|459012308|FG001|Overall Study|Protocol Deviation|2|||
128022482|NCT00799864|460706708|FG003|Overall Study|Participant reached a virologic endpoint|0|||
128022483|NCT00799864|460706709|FG004|Overall Study|Participant reached a virologic endpoint|0|||
128022484|NCT00799864|460706705|FG000|Overall Study|Other|2|||
128022485|NCT00799864|460706706|FG001|Overall Study|Other|1|||
128022486|NCT00799864|460706707|FG002|Overall Study|Other|0|||
128022487|NCT00799864|460706708|FG003|Overall Study|Other|0|||
128022488|NCT00799864|460706709|FG004|Overall Study|Other|0|||
128022489|NCT02346370|460706710|FG000|Overall Study|Not treated|1|||
128022490|NCT02346370|460706711|FG001|Overall Study|Not treated|0|||
128022491|NCT02346370|460706712|FG002|Overall Study|Not treated|0|||
128022492|NCT02346370|460706710|FG000|Overall Study|Withdrawal of consent|1|||
128022493|NCT02346370|460706711|FG001|Overall Study|Withdrawal of consent|0|||
128022494|NCT02346370|460706712|FG002|Overall Study|Withdrawal of consent|0|||
128022495|NCT02346370|460706710|FG000|Overall Study|Death|1|||
128022496|NCT02346370|460706711|FG001|Overall Study|Death|3|||
128022497|NCT02346370|460706712|FG002|Overall Study|Death|1|||
128022498|NCT02346370|460706710|FG000|Overall Study|Sponsor discontinued study|5|||
127686082|NCT02279095|459478153|FG000|Overall Study|Non-Compliance|1|||
127686083|NCT02279095|459478153|FG000|Overall Study|Withdrawal by Subject|8|||
127686084|NCT02279095|459478153|FG000|Overall Study|Adverse Event|2|||
128022499|NCT02346370|460706711|FG001|Overall Study|Sponsor discontinued study|0|||
128022500|NCT02346370|460706712|FG002|Overall Study|Sponsor discontinued study|2|||
128022501|NCT02346370|460706710|FG000|Overall Study|Radiologic progression|0|||
128022502|NCT02346370|460706711|FG001|Overall Study|Radiologic progression|0|||
128022503|NCT02346370|460706712|FG002|Overall Study|Radiologic progression|1|||
128022504|NCT02346370|460706710|FG000|Overall Study|Physician Decision|0|||
128022505|NCT02346370|460706711|FG001|Overall Study|Physician Decision|1|||
128022506|NCT02346370|460706712|FG002|Overall Study|Physician Decision|0|||
128022507|NCT03528577|460706715|FG000|Sequence 1|Failed Spirometry|1|||
128022508|NCT03528577|460706715|FG000|Sequence 1|Restricted medication|1|||
128022509|NCT03528577|460706715|FG000|Sequence 2|Adverse Event|1|||
128022510|NCT03528577|460706715|FG000|Sequence 2|Withdrawal by Subject|1|||
128022511|NCT03528577|460706715|FG000|Sequence 2|Failed Spirometry|1|||
127558262|NCT01001325|459012309|FG000|Overall Study|Lost to Follow-up|16|||
127686085|NCT02279095|459478153|FG000|Overall Study|Other|7|||
128022512|NCT03528577|460706715|FG000|Sequence 3|Failed Spirometry|1|||
127558263|NCT01001325|459012310|FG001|Overall Study|Lost to Follow-up|10|||
127558264|NCT01001325|459012309|FG000|Overall Study|Protocol Violation|2|||
127558265|NCT01001325|459012310|FG001|Overall Study|Protocol Violation|0|||
128022513|NCT03528577|460706715|FG000|Sequence 4|Failed Spirometry|2|||
128022514|NCT03528577|460706715|FG000|Sequence 4|Adverse Event|1|||
128022515|NCT04882215|460706716|FG000|Overall Study|Withdrawal by Subject|5|||
128022516|NCT04882215|460706717|FG001|Overall Study|Withdrawal by Subject|0|||
128022517|NCT04263532|460706718|FG000|Overall Study|Withdrawal by Subject|2|||
128022518|NCT04263532|460706719|FG001|Overall Study|Withdrawal by Subject|0|||
128022519|NCT04098302|460706722|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|3|||
128022520|NCT04098302|460706723|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|11|||
128022521|NCT04098302|460706724|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
128022522|NCT04098302|460706725|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
128022523|NCT04098302|460706722|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|5|||
128022524|NCT04098302|460706723|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
128022525|NCT04098302|460706724|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
128022526|NCT04098302|460706725|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
128022527|NCT04098302|460706722|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|2|||
128022528|NCT04098302|460706723|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|3|||
128022529|NCT04098302|460706724|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
128022530|NCT04098302|460706725|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
128022531|NCT04098302|460706722|FG000|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
128022532|NCT04098302|460706723|FG001|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
128022533|NCT04098302|460706724|FG002|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
128022534|NCT04098302|460706725|FG003|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
128022535|NCT04098302|460706722|FG000|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
128022536|NCT04098302|460706723|FG001|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
128022537|NCT04098302|460706724|FG002|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
128022538|NCT04098302|460706725|FG003|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
128022539|NCT04098302|460706722|FG000|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
128022540|NCT04098302|460706723|FG001|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
128022541|NCT04098302|460706724|FG002|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
128022542|NCT04098302|460706725|FG003|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|1|||
128022543|NCT04098302|460706722|FG000|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
128022544|NCT04098302|460706723|FG001|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
128022545|NCT04098302|460706724|FG002|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|1|||
128022546|NCT04098302|460706725|FG003|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
128022547|NCT04098302|460706722|FG000|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
128022548|NCT04098302|460706723|FG001|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
128022549|NCT04098302|460706724|FG002|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
128022550|NCT04098302|460706725|FG003|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|1|||
128022551|NCT01290731|460706728|FG000|Overall Study|Withdrawal by Subject|1|||
128022552|NCT01399099|460706729|FG000|Overall Study|Lost to Follow-up|14|||
128022553|NCT01399099|460706729|FG000|Overall Study|Physician Decision|1|||
128022554|NCT01399099|460706729|FG000|Overall Study|Protocol Violation|1|||
128022555|NCT01399099|460706729|FG000|Overall Study|Skin Irritation|13|||
128022556|NCT01399099|460706729|FG000|Overall Study|Infection|1|||
128022557|NCT01399099|460706729|FG000|Overall Study|Miscellaneous|4|||
128022558|NCT01668537|460706730|FG000|Overall Study|Request to Discontinue Prematurely|1|||
128022559|NCT01668537|460706731|FG001|Overall Study|Request to Discontinue Prematurely|1|||
128022560|NCT01668537|460706730|FG000|Overall Study|Subject unwilling/unable to comply|5|||
128022561|NCT01668537|460706731|FG001|Overall Study|Subject unwilling/unable to comply|0|||
128022562|NCT01668537|460706730|FG000|Overall Study|Reason Precludes Participation|1|||
128022563|NCT01668537|460706731|FG001|Overall Study|Reason Precludes Participation|0|||
128022564|NCT01668537|460706730|FG000|Overall Study|Lost to Follow-up|13|||
128022565|NCT01668537|460706731|FG001|Overall Study|Lost to Follow-up|6|||
128022566|NCT01668537|460706730|FG000|Overall Study|Other|2|||
128022567|NCT01668537|460706731|FG001|Overall Study|Other|3|||
128022568|NCT05064800|460706732|FG000|Period 3|Withdrawal by Subject|0|||
128022569|NCT05064800|460706733|FG001|Period 3|Withdrawal by Subject|0|||
128022570|NCT05064800|460706734|FG002|Period 3|Withdrawal by Subject|0|||
128022571|NCT05064800|460706735|FG003|Period 3|Withdrawal by Subject|0|||
128022572|NCT05064800|460706736|FG004|Period 3|Withdrawal by Subject|1|||
128022573|NCT05064800|460706737|FG005|Period 3|Withdrawal by Subject|0|||
128022574|NCT04477486|460706738|FG000|Overall Study|Death|2|||
128022575|NCT04477486|460706738|FG000|Overall Study|Ongoing at Time of Analysis|11|||
128022576|NCT01078545|460706741|FG000|Overall Study|Lost to Follow-up|13|||
128022577|NCT01078545|460706741|FG000|Overall Study|Physician Decision|6|||
128022578|NCT01078545|460706741|FG000|Overall Study|Withdrawal by Subject|3|||
128022579|NCT01078545|460706741|FG000|Overall Study|Death|3|||
128022580|NCT01078545|460706741|FG000|Overall Study|Participant moved to another physician|1|||
128022581|NCT02497755|460706742|FG000|Overall Study|Protocol Violation|1|||
128022582|NCT02497755|460706743|FG001|Overall Study|Protocol Violation|0|||
128022583|NCT01774370|460706746|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
128022584|NCT01774370|460706746|FG000|Overall Study|Administered prior to the contract date|4|||
128022585|NCT01774370|460706746|FG000|Overall Study|Subjects of contraindications|34|||
128022586|NCT01774370|460706746|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
128022587|NCT01774370|460706746|FG000|Overall Study|Follow-up failure|34|||
128022588|NCT05436288|460706747|FG000|Overall Study|Lost to Follow-up|1|||
128022589|NCT05436288|460706747|FG000|Overall Study|Adverse Event|1|||
128022590|NCT01436500|460706751|FG000|Overall Study|Death|1|||
128022591|NCT01436500|460706752|FG001|Overall Study|Death|0|||
128022592|NCT01436500|460706753|FG002|Overall Study|Death|0|||
128022593|NCT01436500|460706754|FG003|Overall Study|Death|0|||
128022594|NCT01436500|460706755|FG004|Overall Study|Death|0|||
128022595|NCT01436500|460706751|FG000|Overall Study|Adverse Event|0|||
128022596|NCT01436500|460706752|FG001|Overall Study|Adverse Event|2|||
128022597|NCT01436500|460706753|FG002|Overall Study|Adverse Event|2|||
128022598|NCT01436500|460706754|FG003|Overall Study|Adverse Event|0|||
128022599|NCT01436500|460706755|FG004|Overall Study|Adverse Event|1|||
128022600|NCT01436500|460706751|FG000|Overall Study|Withdrawal by Subject|0|||
128022601|NCT01436500|460706752|FG001|Overall Study|Withdrawal by Subject|0|||
128022602|NCT01436500|460706753|FG002|Overall Study|Withdrawal by Subject|2|||
128022603|NCT01436500|460706754|FG003|Overall Study|Withdrawal by Subject|0|||
128022604|NCT01436500|460706755|FG004|Overall Study|Withdrawal by Subject|2|||
128022605|NCT01436500|460706751|FG000|Overall Study|Physician Decision|0|||
128022606|NCT01436500|460706752|FG001|Overall Study|Physician Decision|0|||
128022607|NCT01436500|460706753|FG002|Overall Study|Physician Decision|1|||
128022608|NCT01436500|460706754|FG003|Overall Study|Physician Decision|0|||
127558266|NCT01584440|459012311|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
127558267|NCT01584440|459012312|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
127558268|NCT01584440|459012313|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
127558269|NCT01584440|459012314|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
127558270|NCT01584440|459012315|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
127558271|NCT01584440|459012311|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
127558272|NCT01584440|459012312|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
127558273|NCT01584440|459012313|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
127558274|NCT01584440|459012314|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
127558275|NCT01584440|459012315|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
127558276|NCT01584440|459012311|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
127558277|NCT01584440|459012312|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
127558278|NCT01584440|459012313|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
127558279|NCT01584440|459012314|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
127558280|NCT01584440|459012315|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
127558281|NCT01584440|459012311|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
127558282|NCT01584440|459012312|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
127558283|NCT01584440|459012313|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
127558284|NCT01584440|459012314|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
127558285|NCT01584440|459012315|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
127558286|NCT01584440|459012311|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
127558287|NCT01584440|459012312|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
127558288|NCT01584440|459012313|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
127558289|NCT01584440|459012314|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
127558290|NCT01584440|459012315|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
127558291|NCT01584440|459012311|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
127558292|NCT01584440|459012312|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
127558293|NCT01584440|459012313|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
127558294|NCT01584440|459012314|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
127558295|NCT01584440|459012315|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
127558296|NCT01584440|459012311|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
127558297|NCT01584440|459012312|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
127558298|NCT01584440|459012313|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
127558299|NCT01584440|459012314|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
127558300|NCT01584440|459012315|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
127558301|NCT01584440|459012311|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
127558302|NCT01584440|459012312|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
128022609|NCT01436500|460706755|FG004|Overall Study|Physician Decision|0|||
128022610|NCT01436500|460706751|FG000|Overall Study|liver transplant|1|||
128022611|NCT01436500|460706752|FG001|Overall Study|liver transplant|0|||
128022612|NCT01436500|460706753|FG002|Overall Study|liver transplant|0|||
128022613|NCT01436500|460706754|FG003|Overall Study|liver transplant|0|||
128022614|NCT01436500|460706755|FG004|Overall Study|liver transplant|0|||
128022615|NCT01436500|460706751|FG000|Overall Study|initiation of dialysis|0|||
128022616|NCT01436500|460706752|FG001|Overall Study|initiation of dialysis|0|||
127558303|NCT01584440|459012313|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
127558304|NCT01584440|459012314|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
128022617|NCT01436500|460706753|FG002|Overall Study|initiation of dialysis|0|||
128022618|NCT01436500|460706754|FG003|Overall Study|initiation of dialysis|0|||
128022619|NCT01436500|460706755|FG004|Overall Study|initiation of dialysis|1|||
128022620|NCT01436500|460706751|FG000|Overall Study|discontinued study drug|1|||
128022621|NCT01436500|460706752|FG001|Overall Study|discontinued study drug|0|||
128022622|NCT01436500|460706753|FG002|Overall Study|discontinued study drug|0|||
128022623|NCT01436500|460706754|FG003|Overall Study|discontinued study drug|0|||
128022624|NCT01436500|460706755|FG004|Overall Study|discontinued study drug|0|||
128022625|NCT01436500|460706751|FG000|Overall Study|Other|0|||
128022626|NCT01436500|460706752|FG001|Overall Study|Other|1|||
128022627|NCT01436500|460706753|FG002|Overall Study|Other|0|||
128022628|NCT01436500|460706754|FG003|Overall Study|Other|1|||
128022629|NCT01436500|460706755|FG004|Overall Study|Other|0|||
128022630|NCT01487161|460706757|FG000|Overall Study|Adverse Event|1|||
128022631|NCT01487161|460706758|FG001|Overall Study|Adverse Event|0|||
128022632|NCT01487161|460706759|FG002|Overall Study|Adverse Event|0|||
128022633|NCT01487161|460706760|FG003|Overall Study|Adverse Event|0|||
128022634|NCT01487161|460706757|FG000|Overall Study|Withdrawal by Subject|1|||
128022635|NCT01487161|460706758|FG001|Overall Study|Withdrawal by Subject|1|||
128022636|NCT01487161|460706759|FG002|Overall Study|Withdrawal by Subject|1|||
128022637|NCT01487161|460706760|FG003|Overall Study|Withdrawal by Subject|2|||
128022638|NCT01487161|460706757|FG000|Overall Study|missing data|0|||
128022639|NCT01487161|460706758|FG001|Overall Study|missing data|1|||
128022640|NCT01487161|460706759|FG002|Overall Study|missing data|0|||
128022641|NCT01487161|460706760|FG003|Overall Study|missing data|0|||
128022642|NCT02569242|460706761|FG000|Overall Study|Death|1|||
128022643|NCT02569242|460706762|FG001|Overall Study|Death|0|||
128022644|NCT02569242|460706761|FG000|Overall Study|Withdrawal by Subject|0|||
128022645|NCT02569242|460706762|FG001|Overall Study|Withdrawal by Subject|1|||
128022646|NCT00689052|460706763|FG000|Overall Study|Adverse Event|4|||
128022647|NCT00689052|460706764|FG001|Overall Study|Adverse Event|6|||
128022648|NCT00689052|460706763|FG000|Overall Study|Protocol Violation|1|||
128022649|NCT00689052|460706764|FG001|Overall Study|Protocol Violation|0|||
128022650|NCT00689052|460706763|FG000|Overall Study|Lost to Follow-up|2|||
128022651|NCT00689052|460706764|FG001|Overall Study|Lost to Follow-up|0|||
128022652|NCT00689052|460706763|FG000|Overall Study|Withdrawal by Subject|2|||
128022653|NCT00689052|460706764|FG001|Overall Study|Withdrawal by Subject|0|||
128022654|NCT00689052|460706763|FG000|Overall Study|Early termination of the trial|22|||
128022655|NCT00689052|460706764|FG001|Overall Study|Early termination of the trial|24|||
128022656|NCT01727154|460706766|FG000|Overall Study|Death|17|||
128022657|NCT01727154|460706766|FG000|Overall Study|Withdrawal by Subject|14|||
128022658|NCT01727154|460706766|FG000|Overall Study|Subject Withdrew Consent|18|||
128022659|NCT01727154|460706766|FG000|Overall Study|Study Terminated|6|||
128022660|NCT01727154|460706766|FG000|Overall Study|No Discontinuation Documentation|4|||
128022661|NCT00003474|460706767|FG000|Overall Study|Not Evaluable|14|||
128022662|NCT03554473|460708209|FG000|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|2|||
128022663|NCT03554473|460708210|FG001|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
128022664|NCT03554473|460708211|FG002|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
128022665|NCT03554473|460708209|FG000|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|1|||
128022666|NCT03554473|460708210|FG001|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
128022667|NCT03554473|460708211|FG002|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
128022668|NCT03554473|460708209|FG000|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
128022669|NCT03554473|460708210|FG001|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
128022670|NCT03554473|460708211|FG002|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|4|||
128022671|NCT04971837|460708215|FG000|Overall Study|Long Term Illness|1|||
128022672|NCT04971837|460708215|FG000|Overall Study|BMI too low|9|||
128022673|NCT04971837|460708215|FG000|Overall Study|geographic location|1|||
128022674|NCT04971837|460708215|FG000|Overall Study|Discontinued scheduling conflict|1|||
128022675|NCT00567580|460708216|FG000|Overall Study|Protocol Violation|28|||
128022676|NCT00567580|460708217|FG001|Overall Study|Protocol Violation|24|||
128022677|NCT00567580|460708218|FG002|Overall Study|Protocol Violation|24|||
128022678|NCT00382070|460708219|FG000|Overall Study|No follow up data mapped to Other|17|||
128022679|NCT00382070|460708220|FG001|Overall Study|No follow up data mapped to Other|19|||
128022680|NCT00382070|460708219|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
128022681|NCT00382070|460708220|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
128022682|NCT00382070|460708219|FG000|Overall Study|No clinical assessment|9|||
128022683|NCT00382070|460708220|FG001|Overall Study|No clinical assessment|11|||
128022684|NCT02082483|460708226|FG000|Overall Study|Lost to Follow-up|1|||
128022685|NCT02082483|460708227|FG001|Overall Study|Lost to Follow-up|1|||
128022686|NCT02082483|460708226|FG000|Overall Study|Withdrawal by Subject|2|||
128022687|NCT02082483|460708227|FG001|Overall Study|Withdrawal by Subject|1|||
128022688|NCT02082483|460708226|FG000|Overall Study|Physician Decision|1|||
128022689|NCT02082483|460708227|FG001|Overall Study|Physician Decision|1|||
128022690|NCT02082483|460708226|FG000|Overall Study|Death|2|||
128022691|NCT02082483|460708227|FG001|Overall Study|Death|3|||
127558305|NCT01584440|459012315|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
127558306|NCT01584440|459012311|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
128022692|NCT00145327|460708229|FG000|Overall Study|Withdrawal by Subject|77|||
128022693|NCT00145327|460708230|FG001|Overall Study|Withdrawal by Subject|72|||
127558307|NCT01584440|459012312|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
127558308|NCT01584440|459012313|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
127558309|NCT01584440|459012314|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
128022694|NCT00145327|460708231|FG002|Overall Study|Withdrawal by Subject|164|||
128022695|NCT00145327|460708229|FG000|Overall Study|Death|26|||
128022696|NCT00145327|460708230|FG001|Overall Study|Death|18|||
128022697|NCT00145327|460708231|FG002|Overall Study|Death|30|||
128022698|NCT00145327|460708229|FG000|Overall Study|Adverse Event|14|||
128022699|NCT00145327|460708230|FG001|Overall Study|Adverse Event|11|||
128022700|NCT00145327|460708231|FG002|Overall Study|Adverse Event|22|||
128022701|NCT00145327|460708229|FG000|Overall Study|Lost to Follow-up|9|||
128022702|NCT00145327|460708230|FG001|Overall Study|Lost to Follow-up|14|||
128022703|NCT00145327|460708231|FG002|Overall Study|Lost to Follow-up|14|||
128022704|NCT00145327|460708229|FG000|Overall Study|Administrative problems|12|||
128022705|NCT00145327|460708230|FG001|Overall Study|Administrative problems|9|||
128022706|NCT00145327|460708231|FG002|Overall Study|Administrative problems|13|||
128022707|NCT00145327|460708229|FG000|Overall Study|Protocol Violation|2|||
128022708|NCT00145327|460708230|FG001|Overall Study|Protocol Violation|0|||
128022709|NCT00145327|460708231|FG002|Overall Study|Protocol Violation|2|||
128022710|NCT00145327|460708229|FG000|Overall Study|Abnormal laboratory value(s)|1|||
128022711|NCT00145327|460708230|FG001|Overall Study|Abnormal laboratory value(s)|0|||
128022712|NCT00145327|460708231|FG002|Overall Study|Abnormal laboratory value(s)|2|||
128022713|NCT00145327|460708229|FG000|Overall Study|Missing - not stated|1|||
128022714|NCT00145327|460708230|FG001|Overall Study|Missing - not stated|0|||
128022715|NCT00145327|460708231|FG002|Overall Study|Missing - not stated|1|||
128022716|NCT02802865|460708232|FG000|Overall Study|Pregnancy|1|||
128022717|NCT02802865|460708233|FG001|Overall Study|Pregnancy|1|||
128022718|NCT02802865|460708232|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
128022719|NCT02802865|460708233|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
128022720|NCT00762788|460708234|FG000|Overall Study|Lost to Follow-up|26|||
128022721|NCT00762788|460708235|FG001|Overall Study|Lost to Follow-up|37|||
128022722|NCT00762788|460708236|FG002|Overall Study|Lost to Follow-up|21|||
128022723|NCT00762788|460708237|FG003|Overall Study|Lost to Follow-up|26|||
128022724|NCT00762788|460708238|FG004|Overall Study|Lost to Follow-up|13|||
128022725|NCT00762788|460708239|FG005|Overall Study|Lost to Follow-up|21|||
128022726|NCT01454063|460708240|FG000|Randomized|Adverse Event|1|||
128022727|NCT01454063|460708241|FG001|Randomized|Adverse Event|1|||
128022728|NCT01454063|460708240|FG000|Randomized|Protocol Violation|0|||
128022729|NCT01454063|460708241|FG001|Randomized|Protocol Violation|1|||
128022730|NCT02391584|460708242|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
128022731|NCT02391584|460708243|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
127558310|NCT01584440|459012315|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
127558311|NCT01821560|459012316|FG000|Overall Study|Lost to Follow-up|5|||
127558312|NCT01821560|459012317|FG001|Overall Study|Lost to Follow-up|5|||
127558313|NCT01821560|459012316|FG000|Overall Study|Withdrawal by Subject|1|||
127558314|NCT01821560|459012317|FG001|Overall Study|Withdrawal by Subject|1|||
127558315|NCT01821560|459012316|FG000|Overall Study|Protocol Violation|0|||
127558316|NCT01821560|459012317|FG001|Overall Study|Protocol Violation|1|||
127558317|NCT00531427|459012320|FG000|Overall Study|Withdrawal by Subject|7|||
127558318|NCT00531427|459012321|FG001|Overall Study|Withdrawal by Subject|13|||
127558319|NCT00531427|459012320|FG000|Overall Study|Adverse Event|44|||
127558320|NCT00531427|459012321|FG001|Overall Study|Adverse Event|30|||
127558321|NCT00531427|459012320|FG000|Overall Study|Lost to Follow-up|4|||
127558322|NCT00531427|459012321|FG001|Overall Study|Lost to Follow-up|3|||
127558323|NCT00531427|459012320|FG000|Overall Study|Lack of Efficacy|14|||
127558324|NCT00531427|459012321|FG001|Overall Study|Lack of Efficacy|39|||
128022732|NCT02391584|460708242|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
128022733|NCT02391584|460708243|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
127558325|NCT00531427|459012320|FG000|Overall Study|Administrative|4|||
128022734|NCT02391584|460708242|FG000|3 Month|Lost to Follow-up|1|||
128022735|NCT02391584|460708243|FG001|3 Month|Lost to Follow-up|0|||
127558326|NCT00531427|459012321|FG001|Overall Study|Administrative|9|||
127558327|NCT02626624|459012336|FG000|Overall Study|Adverse Event|1|||
127558328|NCT02626624|459012336|FG000|Overall Study|Lost to Follow-up|3|||
127558329|NCT02626624|459012336|FG000|Overall Study|Protocol Violation|4|||
127558330|NCT02626624|459012336|FG000|Overall Study|Death|2|||
127774430|NCT02634346|459800319|FG002|Overall Study|Lack of Efficacy|8|||
128022736|NCT02391584|460708242|FG000|6 Month|Withdrawal by Subject|1|||
128022737|NCT02391584|460708243|FG001|6 Month|Withdrawal by Subject|0|||
128022738|NCT02391584|460708242|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
128022739|NCT02391584|460708243|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
128022740|NCT00710554|460708249|FG000|Overall Study|Adverse Event|24|||
128022741|NCT00710554|460708250|FG001|Overall Study|Adverse Event|7|||
128022742|NCT00710554|460708249|FG000|Overall Study|Withdrawal by Subject|7|||
128022743|NCT00710554|460708250|FG001|Overall Study|Withdrawal by Subject|3|||
128022744|NCT00710554|460708249|FG000|Overall Study|Lost to Follow-up|7|||
128022745|NCT00710554|460708250|FG001|Overall Study|Lost to Follow-up|1|||
128022746|NCT00710554|460708249|FG000|Overall Study|Lack of Efficacy|11|||
128022747|NCT00710554|460708250|FG001|Overall Study|Lack of Efficacy|12|||
128022748|NCT00710554|460708249|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
128022749|NCT00710554|460708250|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
128022750|NCT01433978|460708253|FG000|Core Study|Adverse Event, Non-Fatal|0|||
128022751|NCT01433978|460708254|FG001|Core Study|Adverse Event, Non-Fatal|1|||
128022752|NCT01433978|460708255|FG002|Core Study|Adverse Event, Non-Fatal|0|||
128022753|NCT01433978|460708253|FG000|Core Study|Lack of Efficacy|5|||
128022754|NCT01433978|460708254|FG001|Core Study|Lack of Efficacy|1|||
128022755|NCT01433978|460708255|FG002|Core Study|Lack of Efficacy|0|||
128022756|NCT01433978|460708253|FG000|Core Study|Study Terminated by Sponsor|6|||
128022757|NCT01433978|460708254|FG001|Core Study|Study Terminated by Sponsor|9|||
128022758|NCT01433978|460708255|FG002|Core Study|Study Terminated by Sponsor|0|||
128022759|NCT01433978|460708253|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
128022760|NCT01433978|460708254|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
128022761|NCT01433978|460708255|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
128022762|NCT01433978|460708253|FG000|Extension Phase|Lack of Efficacy|0|||
128022763|NCT01433978|460708254|FG001|Extension Phase|Lack of Efficacy|0|||
128022764|NCT01433978|460708255|FG002|Extension Phase|Lack of Efficacy|1|||
128022765|NCT01433978|460708253|FG000|Extension Phase|Study Terminated by Sponsor|0|||
128022766|NCT01433978|460708254|FG001|Extension Phase|Study Terminated by Sponsor|0|||
128022767|NCT01433978|460708255|FG002|Extension Phase|Study Terminated by Sponsor|4|||
128022768|NCT02018887|460708256|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
128022769|NCT02018887|460708257|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
128022770|NCT02018887|460708258|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
128022771|NCT02018887|460708259|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
128022772|NCT02018887|460708260|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
127558331|NCT01395524|459014068|FG000|Overall Study|Non-compliance with study schedule|1|||
127558332|NCT01395524|459014069|FG001|Overall Study|Non-compliance with study schedule|0|||
127558333|NCT01395524|459014070|FG002|Overall Study|Non-compliance with study schedule|1|||
127558334|NCT01395524|459014068|FG000|Overall Study|Lost to Follow-up|3|||
127558335|NCT01395524|459014069|FG001|Overall Study|Lost to Follow-up|1|||
127558336|NCT01395524|459014070|FG002|Overall Study|Lost to Follow-up|1|||
127558337|NCT01395524|459014068|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
127558338|NCT01395524|459014069|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
127558339|NCT01395524|459014070|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
127558340|NCT01395524|459014068|FG000|Overall Study|Severe noncompliance with protocol|1|||
127558341|NCT01395524|459014069|FG001|Overall Study|Severe noncompliance with protocol|0|||
127558342|NCT01395524|459014070|FG002|Overall Study|Severe noncompliance with protocol|0|||
127558343|NCT01395524|459014068|FG000|Overall Study|Adverse Event|4|||
127558344|NCT01395524|459014069|FG001|Overall Study|Adverse Event|4|||
127558345|NCT01395524|459014070|FG002|Overall Study|Adverse Event|3|||
127558346|NCT01395524|459014068|FG000|Overall Study|Death|1|||
127558347|NCT01395524|459014069|FG001|Overall Study|Death|0|||
127558348|NCT01395524|459014070|FG002|Overall Study|Death|0|||
127558349|NCT01395524|459014068|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
127558350|NCT01395524|459014069|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
127558351|NCT01395524|459014070|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
127558352|NCT01395524|459014068|FG000|Overall Study|Withdrawal by Subject|4|||
127558353|NCT01395524|459014069|FG001|Overall Study|Withdrawal by Subject|8|||
127558354|NCT01395524|459014070|FG002|Overall Study|Withdrawal by Subject|8|||
127558355|NCT01395524|459014068|FG000|Overall Study|Did not receive treatment|1|||
127558356|NCT01395524|459014069|FG001|Overall Study|Did not receive treatment|1|||
127558357|NCT01395524|459014070|FG002|Overall Study|Did not receive treatment|3|||
127558358|NCT01395524|459014068|FG000|Overall Study|Subject had spinal surgery|0|||
127558359|NCT01395524|459014069|FG001|Overall Study|Subject had spinal surgery|0|||
128022773|NCT02018887|460708261|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
127558360|NCT01395524|459014070|FG002|Overall Study|Subject had spinal surgery|1|||
127558361|NCT01657461|459014071|FG000|Overall Study|Death|9|||
128022774|NCT02018887|460708262|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
128022775|NCT02018887|460708263|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
127558362|NCT01657461|459014072|FG001|Overall Study|Death|12|||
127558363|NCT01657461|459014071|FG000|Overall Study|Lost to Follow-up|0|||
127558364|NCT01657461|459014072|FG001|Overall Study|Lost to Follow-up|3|||
127558365|NCT01657461|459014071|FG000|Overall Study|Physician Decision|0|||
128022776|NCT02018887|460708264|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
128022777|NCT02018887|460708265|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
128022778|NCT02018887|460708266|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
128022779|NCT02018887|460708256|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
128022780|NCT02018887|460708257|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
128022781|NCT02018887|460708258|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
127558366|NCT01657461|459014072|FG001|Overall Study|Physician Decision|2|||
127558367|NCT01657461|459014071|FG000|Overall Study|Withdrawal by Subject|1|||
127558368|NCT01657461|459014072|FG001|Overall Study|Withdrawal by Subject|3|||
127558369|NCT01868542|459014073|FG000|Overall Study|Protocol Violation|0|||
127558370|NCT01868542|459014074|FG001|Overall Study|Protocol Violation|1|||
127558371|NCT01868542|459014073|FG000|Overall Study|Unclassified|0|||
127558372|NCT01868542|459014074|FG001|Overall Study|Unclassified|1|||
127558373|NCT00669409|459014079|FG000|Part 2|Withdrawal by Subject|0|||
127558374|NCT00669409|459014080|FG001|Part 2|Withdrawal by Subject|0|||
127558375|NCT00669409|459014081|FG002|Part 2|Withdrawal by Subject|0|||
127558376|NCT00669409|459014082|FG003|Part 2|Withdrawal by Subject|0|||
127774431|NCT02634346|459800317|FG000|Overall Study|Lost to Follow-up|1|||
127774432|NCT02634346|459800318|FG001|Overall Study|Lost to Follow-up|0|||
127774433|NCT02634346|459800319|FG002|Overall Study|Lost to Follow-up|0|||
127774434|NCT02634346|459800317|FG000|Overall Study|Protocol Violation|0|||
128022782|NCT02018887|460708259|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
128022783|NCT02018887|460708260|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
128022784|NCT02018887|460708261|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
128022785|NCT02018887|460708262|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
128022786|NCT02018887|460708263|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
128022787|NCT02018887|460708264|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
128022788|NCT02018887|460708265|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
128022789|NCT02018887|460708266|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
128022790|NCT02018887|460708256|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
128022791|NCT02018887|460708257|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
128022792|NCT02018887|460708258|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
128022793|NCT02018887|460708259|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
128022794|NCT02018887|460708260|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
127774435|NCT02634346|459800318|FG001|Overall Study|Protocol Violation|1|||
127774436|NCT02634346|459800319|FG002|Overall Study|Protocol Violation|0|||
127774437|NCT00667355|459800320|FG000|Overall Study|Adverse Event|5|||
127774438|NCT00667355|459800320|FG000|Overall Study|Lost to Follow-up|1|||
127774439|NCT00667355|459800320|FG000|Overall Study|Other reason was not specified|5|||
127774440|NCT01676909|459800322|FG000|Overall Study|Withdrawal by Subject|3|||
127774441|NCT01676909|459800323|FG001|Overall Study|Withdrawal by Subject|5|||
128022795|NCT02018887|460708261|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
128022796|NCT02018887|460708262|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
128022797|NCT02018887|460708263|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
128022798|NCT02018887|460708264|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
128022799|NCT02018887|460708265|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
128022800|NCT02018887|460708266|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
128022801|NCT02018887|460708256|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
128022802|NCT02018887|460708257|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
128022803|NCT02018887|460708258|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
128022804|NCT02018887|460708259|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
128022805|NCT02018887|460708260|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
127774442|NCT01676909|459800322|FG000|Overall Study|Lost to Follow-up|15|||
127774443|NCT01676909|459800323|FG001|Overall Study|Lost to Follow-up|9|||
127774444|NCT02175004|459800327|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
127774445|NCT02175004|459800328|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
127774446|NCT02175004|459800327|FG000|Overall Study|Investigator Judgment|1|||
128022806|NCT02018887|460708261|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
128022807|NCT02018887|460708262|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
128022808|NCT02018887|460708263|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
128022809|NCT02018887|460708264|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
128022810|NCT02018887|460708265|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
128022811|NCT02018887|460708266|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
128022812|NCT04053452|460708267|FG000|Overall Study|Withdrawal by Subject|1|||
127558377|NCT00669409|459014083|FG004|Part 2|Withdrawal by Subject|0|||
127558378|NCT00669409|459014084|FG005|Part 2|Withdrawal by Subject|0|||
127774447|NCT02175004|459800328|FG001|Overall Study|Investigator Judgment|4|||
127774448|NCT02175004|459800327|FG000|Overall Study|Voluntary Withdrawal|6|||
127774449|NCT02175004|459800328|FG001|Overall Study|Voluntary Withdrawal|19|||
127774450|NCT02175004|459800327|FG000|Overall Study|Liver Transplant|1|||
127774451|NCT02175004|459800328|FG001|Overall Study|Liver Transplant|0|||
128022813|NCT04053452|460708268|FG001|Overall Study|Withdrawal by Subject|0|||
128022814|NCT04053452|460708267|FG000|Overall Study|Time restraint due to inpatient needs|1|||
128022815|NCT04053452|460708268|FG001|Overall Study|Time restraint due to inpatient needs|2|||
127558379|NCT00669409|459014085|FG006|Part 2|Withdrawal by Subject|0|||
127558380|NCT00669409|459014086|FG007|Part 2|Withdrawal by Subject|0|||
127774452|NCT02175004|459800327|FG000|Overall Study|Disease Progression|1|||
127774453|NCT02175004|459800328|FG001|Overall Study|Disease Progression|0|||
127558381|NCT00669409|459014087|FG008|Part 2|Withdrawal by Subject|0|||
127798470|NCT01789970|459885615|FG002|Open-label Titration Period|Protocol Violation|0|||
127798471|NCT01789970|459885613|FG000|Open-label Titration Period|Lost to Follow-up|5|||
128022816|NCT01421134|460708269|FG000|Overall Study|Adverse Event|3|||
128022817|NCT01421134|460708270|FG001|Overall Study|Adverse Event|5|||
128022818|NCT01421134|460708269|FG000|Overall Study|Lack of Efficacy|2|||
128022819|NCT01421134|460708270|FG001|Overall Study|Lack of Efficacy|4|||
128022820|NCT01421134|460708269|FG000|Overall Study|Protocol Violation|0|||
128022821|NCT01421134|460708270|FG001|Overall Study|Protocol Violation|3|||
128022822|NCT01421134|460708269|FG000|Overall Study|Withdrawal by Subject|1|||
128022823|NCT01421134|460708270|FG001|Overall Study|Withdrawal by Subject|1|||
128022824|NCT01421134|460708269|FG000|Overall Study|Administrative|0|||
128022825|NCT01421134|460708270|FG001|Overall Study|Administrative|1|||
128022826|NCT01421134|460708269|FG000|Overall Study|Lost to Follow-up|1|||
128022827|NCT01421134|460708270|FG001|Overall Study|Lost to Follow-up|1|||
128022828|NCT02959892|460708271|FG000|Overall Study|PET tracer synthesis failure|1|||
128022829|NCT02959892|460708272|FG001|Overall Study|PET tracer synthesis failure|0|||
128022830|NCT02959892|460708271|FG000|Overall Study|Study termination|0|||
128022831|NCT02959892|460708272|FG001|Overall Study|Study termination|1|||
128022832|NCT03364686|460708274|FG000|Overall Study|Physician Decision|2|||
128022833|NCT01936974|460708277|FG000|Overall Study|Physician Decision|2|||
128022834|NCT01936974|460708278|FG001|Overall Study|Physician Decision|5|||
128022835|NCT04584554|460708281|FG000|Overall Study|Withdrawal by Subject|2|||
128022836|NCT04584554|460708282|FG001|Overall Study|Withdrawal by Subject|2|||
128022837|NCT02807181|460708283|FG000|Overall Study|Death|28|||
128022838|NCT02807181|460708284|FG001|Overall Study|Death|24|||
128022839|NCT02807181|460708283|FG000|Overall Study|Withdrawal by Subject|1|||
128022840|NCT02807181|460708284|FG001|Overall Study|Withdrawal by Subject|1|||
128022841|NCT02807181|460708283|FG000|Overall Study|Lost to Follow-up|0|||
128022842|NCT02807181|460708284|FG001|Overall Study|Lost to Follow-up|2|||
128022843|NCT02807181|460708283|FG000|Overall Study|Subject decision|1|||
128022844|NCT02807181|460708284|FG001|Overall Study|Subject decision|0|||
128022845|NCT02807181|460708283|FG000|Overall Study|Biopsy of tumor removed from resection|1|||
128022846|NCT02807181|460708284|FG001|Overall Study|Biopsy of tumor removed from resection|0|||
128022847|NCT02807181|460708283|FG000|Overall Study|In Study|3|||
128022848|NCT02807181|460708284|FG001|Overall Study|In Study|3|||
128022849|NCT02807181|460708283|FG000|Overall Study|Post Progression|3|||
128022850|NCT02807181|460708284|FG001|Overall Study|Post Progression|2|||
128022851|NCT00063999|460708285|FG000|Overall Study|Withdrawal by Subject|1|||
128022852|NCT00063999|460708286|FG001|Overall Study|Withdrawal by Subject|0|||
128022853|NCT00063999|460708285|FG000|Overall Study|Ineligible|44|||
128022854|NCT00063999|460708286|FG001|Overall Study|Ineligible|24|||
128022855|NCT03767894|460708290|FG000|Overall Study|Withdrawal by Subject|1|||
128022856|NCT04243837|460708291|FG000|Overall Study|Adverse Event|2|||
128022857|NCT04243837|460708292|FG001|Overall Study|Adverse Event|1|||
128022858|NCT04243837|460708291|FG000|Overall Study|Withdrawal by Subject|4|||
128022859|NCT04243837|460708292|FG001|Overall Study|Withdrawal by Subject|2|||
128022860|NCT04243837|460708291|FG000|Overall Study|Covid-19 lock down|1|||
128022861|NCT04243837|460708292|FG001|Overall Study|Covid-19 lock down|0|||
128022862|NCT04243837|460708291|FG000|Overall Study|Study Terminated by Sponsor|11|||
128022863|NCT04243837|460708292|FG001|Overall Study|Study Terminated by Sponsor|12|||
128022864|NCT02280499|460708296|FG000|Overall Study|Death|14|||
128022865|NCT02280499|460708296|FG000|Overall Study|Lost to Follow-up|42|||
128022866|NCT02280499|460708296|FG000|Overall Study|Adverse Event|5|||
128022867|NCT00977561|460708297|FG000|Overall Study|Death|3|||
128022868|NCT00977561|460708298|FG001|Overall Study|Death|2|||
128022869|NCT00977561|460708297|FG000|Overall Study|Study terminated|0|||
128022870|NCT00977561|460708298|FG001|Overall Study|Study terminated|2|||
128022871|NCT00977561|460708297|FG000|Overall Study|Other|2|||
128022872|NCT00977561|460708298|FG001|Overall Study|Other|0|||
128022873|NCT01968785|460708308|FG000|Overall Study|Withdrawal by Subject|1|||
128022874|NCT01968785|460708309|FG001|Overall Study|Withdrawal by Subject|0|||
128022875|NCT04000724|460708318|FG000|Overall Study|Withdrawal by Subject|5|||
128022876|NCT04000724|460708319|FG001|Overall Study|Withdrawal by Subject|3|||
128022877|NCT04000724|460708320|FG002|Overall Study|Withdrawal by Subject|4|||
128022878|NCT04000724|460708318|FG000|Overall Study|Lost to Follow-up|11|||
128022879|NCT04000724|460708319|FG001|Overall Study|Lost to Follow-up|7|||
128022880|NCT04000724|460708320|FG002|Overall Study|Lost to Follow-up|13|||
128022881|NCT00455455|460708321|FG000|Washout|Withdrawal by Subject|0|||
128022882|NCT00455455|460708322|FG001|Washout|Withdrawal by Subject|1|||
128022883|NCT00455455|460708321|FG000|Washout|Withdrawal by Subject|1|||
128022884|NCT00455455|460708322|FG001|Washout|Withdrawal by Subject|0|||
128022885|NCT01827943|460708323|FG000|Overall Study|Protocol Violation|8|||
128022886|NCT01827943|460708323|FG000|Overall Study|Never treated because of an rapid progression|1|||
128022887|NCT04689009|460708328|FG000|Overall Study|Adverse Event|1|||
128022888|NCT04689009|460708329|FG001|Overall Study|Adverse Event|0|||
128022889|NCT04689009|460708328|FG000|Overall Study|Lost to Follow-up|1|||
128022890|NCT04689009|460708329|FG001|Overall Study|Lost to Follow-up|2|||
128022891|NCT04689009|460708328|FG000|Overall Study|Withdrawal by Subject|4|||
128022892|NCT04689009|460708329|FG001|Overall Study|Withdrawal by Subject|3|||
128022893|NCT04689009|460708328|FG000|Overall Study|Protocol Violation|1|||
128022894|NCT04689009|460708329|FG001|Overall Study|Protocol Violation|0|||
128022895|NCT02187055|460708331|FG000|Overall Study|Lack of Efficacy|10|||
128022896|NCT02187055|460708332|FG001|Overall Study|Lack of Efficacy|3|||
128022897|NCT02187055|460708333|FG002|Overall Study|Lack of Efficacy|7|||
128022898|NCT02187055|460708331|FG000|Overall Study|Lost to Follow-up|2|||
128022899|NCT02187055|460708332|FG001|Overall Study|Lost to Follow-up|7|||
128022900|NCT02187055|460708333|FG002|Overall Study|Lost to Follow-up|3|||
128022901|NCT02187055|460708331|FG000|Overall Study|No longer meets eligibility criteria|0|||
128022902|NCT02187055|460708332|FG001|Overall Study|No longer meets eligibility criteria|2|||
128022903|NCT02187055|460708333|FG002|Overall Study|No longer meets eligibility criteria|0|||
128022904|NCT02187055|460708331|FG000|Overall Study|No longer willing to participate|6|||
128022905|NCT02187055|460708332|FG001|Overall Study|No longer willing to participate|8|||
128022906|NCT02187055|460708333|FG002|Overall Study|No longer willing to participate|10|||
128022907|NCT02187055|460708331|FG000|Overall Study|Other|5|||
128022908|NCT02187055|460708332|FG001|Overall Study|Other|6|||
128022909|NCT02187055|460708333|FG002|Overall Study|Other|3|||
128022910|NCT02187055|460708331|FG000|Overall Study|Protocol Violation|9|||
128022911|NCT02187055|460708332|FG001|Overall Study|Protocol Violation|9|||
128022912|NCT02187055|460708333|FG002|Overall Study|Protocol Violation|4|||
128022913|NCT02187055|460708331|FG000|Overall Study|Pregnancy|3|||
128022914|NCT02187055|460708332|FG001|Overall Study|Pregnancy|1|||
128022915|NCT02187055|460708333|FG002|Overall Study|Pregnancy|0|||
128022916|NCT02187055|460708331|FG000|Overall Study|Withdrawal by Subject|11|||
128022917|NCT02187055|460708332|FG001|Overall Study|Withdrawal by Subject|11|||
128022918|NCT02187055|460708333|FG002|Overall Study|Withdrawal by Subject|11|||
128022919|NCT02187055|460708331|FG000|Overall Study|Adverse Event|21|||
128022920|NCT02187055|460708332|FG001|Overall Study|Adverse Event|26|||
128022921|NCT02187055|460708333|FG002|Overall Study|Adverse Event|36|||
128022922|NCT02187055|460708331|FG000|Overall Study|Death|2|||
128022923|NCT02187055|460708332|FG001|Overall Study|Death|0|||
128022924|NCT02187055|460708333|FG002|Overall Study|Death|0|||
128022925|NCT03520387|460708336|FG000|Pre-Randomization|Withdrawal by Subject|1|||
128022926|NCT03520387|460708337|FG001|Pre-Randomization|Withdrawal by Subject|0|||
128022927|NCT03520387|460708338|FG002|Pre-Randomization|Withdrawal by Subject|0|||
128022928|NCT03520387|460708339|FG003|Pre-Randomization|Withdrawal by Subject|0|||
128022929|NCT03520387|460708340|FG004|Pre-Randomization|Withdrawal by Subject|0|||
128022930|NCT03520387|460708336|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
128022931|NCT03520387|460708337|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
128022932|NCT03520387|460708338|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
128022933|NCT03520387|460708339|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
128022934|NCT03520387|460708340|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
128022935|NCT03336866|460708341|FG000|Overall Study|Lost to Follow-up|2|||
128022936|NCT03336866|460708342|FG001|Overall Study|Lost to Follow-up|0|||
128022937|NCT03336866|460708343|FG002|Overall Study|Lost to Follow-up|3|||
128022938|NCT03336866|460708341|FG000|Overall Study|Withdrawal by Subject|1|||
128022939|NCT03336866|460708342|FG001|Overall Study|Withdrawal by Subject|1|||
128022940|NCT03336866|460708343|FG002|Overall Study|Withdrawal by Subject|0|||
128022941|NCT03336866|460708341|FG000|Overall Study|Noncompliance with clinic house rules|0|||
128022942|NCT03336866|460708342|FG001|Overall Study|Noncompliance with clinic house rules|0|||
128022943|NCT03336866|460708343|FG002|Overall Study|Noncompliance with clinic house rules|1|||
128022944|NCT00541775|460708344|FG000|Overall Study|Adverse Event|3|||
128022945|NCT00541775|460708345|FG001|Overall Study|Adverse Event|2|||
128022946|NCT00541775|460708346|FG002|Overall Study|Adverse Event|1|||
128022947|NCT00541775|460708344|FG000|Overall Study|Lack of Efficacy|0|||
128022948|NCT00541775|460708345|FG001|Overall Study|Lack of Efficacy|0|||
128022949|NCT00541775|460708346|FG002|Overall Study|Lack of Efficacy|3|||
128022950|NCT00541775|460708344|FG000|Overall Study|Lost to Follow-up|0|||
128022951|NCT00541775|460708345|FG001|Overall Study|Lost to Follow-up|0|||
128022952|NCT00541775|460708346|FG002|Overall Study|Lost to Follow-up|2|||
128022953|NCT00541775|460708344|FG000|Overall Study|Protocol Violation|1|||
128022954|NCT00541775|460708345|FG001|Overall Study|Protocol Violation|0|||
128022955|NCT00541775|460708346|FG002|Overall Study|Protocol Violation|0|||
127686086|NCT02279095|459478153|FG000|Overall Study|Lost to Follow-up|1|||
128022956|NCT00541775|460708344|FG000|Overall Study|Withdrawal by Subject and Other|5|||
128022957|NCT00541775|460708345|FG001|Overall Study|Withdrawal by Subject and Other|0|||
128022958|NCT00541775|460708346|FG002|Overall Study|Withdrawal by Subject and Other|2|||
128022959|NCT00032487|460708347|FG000|Overall Study|Withdrawal by Subject|67|||
128022960|NCT00032487|460708348|FG001|Overall Study|Withdrawal by Subject|43|||
128022961|NCT00032487|460708347|FG000|Overall Study|Adverse Event|3|||
128022962|NCT00032487|460708348|FG001|Overall Study|Adverse Event|7|||
128022963|NCT00032487|460708347|FG000|Overall Study|Lost to Follow-up|57|||
128022964|NCT00032487|460708348|FG001|Overall Study|Lost to Follow-up|58|||
128022965|NCT00032487|460708347|FG000|Overall Study|Had other reason|12|||
128022966|NCT00032487|460708348|FG001|Overall Study|Had other reason|12|||
128022967|NCT05737745|460708349|FG000|Overall Study|Withdrawal by Subject|0|||
128022968|NCT05737745|460708350|FG001|Overall Study|Withdrawal by Subject|6|||
128022969|NCT05737745|460708351|FG002|Overall Study|Withdrawal by Subject|1|||
128022970|NCT02547935|460708352|FG000|Overall Study|Other|0|||
128022971|NCT02547935|460708353|FG001|Overall Study|Other|1|||
128022972|NCT02547935|460708354|FG002|Overall Study|Other|0|||
128022973|NCT02547935|460708352|FG000|Overall Study|Withdrawal by Subject|2|||
128022974|NCT02547935|460708353|FG001|Overall Study|Withdrawal by Subject|3|||
128022975|NCT02547935|460708354|FG002|Overall Study|Withdrawal by Subject|4|||
128022976|NCT02547935|460708352|FG000|Overall Study|Screen Failure|2|||
128022977|NCT02547935|460708353|FG001|Overall Study|Screen Failure|0|||
128022978|NCT02547935|460708354|FG002|Overall Study|Screen Failure|0|||
128022979|NCT02547935|460708352|FG000|Overall Study|Physician Decision|0|||
128022980|NCT02547935|460708353|FG001|Overall Study|Physician Decision|1|||
128022981|NCT02547935|460708354|FG002|Overall Study|Physician Decision|0|||
128022982|NCT02547935|460708352|FG000|Overall Study|Lost to Follow-up|0|||
128022983|NCT02547935|460708353|FG001|Overall Study|Lost to Follow-up|2|||
128022984|NCT02547935|460708354|FG002|Overall Study|Lost to Follow-up|1|||
128022985|NCT02547935|460708352|FG000|Overall Study|Death|1|||
128022986|NCT02547935|460708353|FG001|Overall Study|Death|1|||
128022987|NCT02547935|460708354|FG002|Overall Study|Death|0|||
128022988|NCT02487199|460708357|FG000|Overall Study|Withdrew Consent|0|||
128022989|NCT02487199|460708358|FG001|Overall Study|Withdrew Consent|1|||
128022990|NCT03735498|460710655|FG000|Overall Study|Withdrawal by Subject|3|||
128022991|NCT03735498|460710655|FG000|Overall Study|Two participants did not complete all 6 sessions|2|||
128022992|NCT02014103|460710657|FG000|Overall Study|Protocol Violation|7|||
128022993|NCT02014103|460710658|FG001|Overall Study|Protocol Violation|7|||
128022994|NCT02014103|460710657|FG000|Overall Study|Adverse Event|1|||
128022995|NCT02014103|460710658|FG001|Overall Study|Adverse Event|0|||
128022996|NCT02014103|460710657|FG000|Overall Study|Lost venous access|1|||
128022997|NCT02014103|460710658|FG001|Overall Study|Lost venous access|0|||
128022998|NCT02014103|460710657|FG000|Overall Study|Withdrawal by Subject|0|||
128022999|NCT02014103|460710658|FG001|Overall Study|Withdrawal by Subject|2|||
128023000|NCT04289298|460710660|FG000|Overall Study|Lost to Follow-up|5|||
128023001|NCT04289298|460710661|FG001|Overall Study|Lost to Follow-up|0|||
128023002|NCT04289298|460710660|FG000|Overall Study|Withdrawal by Subject|2|||
128023003|NCT04289298|460710661|FG001|Overall Study|Withdrawal by Subject|0|||
128023004|NCT00620035|460710662|FG000|Overall Study|Adverse Event|106|||
128023005|NCT00620035|460710662|FG000|Overall Study|Withdrawal of Informed Consent|1|||
128023006|NCT00620035|460710662|FG000|Overall Study|Other Reason|38|||
128023007|NCT01629563|460710664|FG000|Overall Study|Adverse Event|16|||
128023008|NCT01629563|460710665|FG001|Overall Study|Adverse Event|16|||
128023009|NCT01629563|460710664|FG000|Overall Study|Death|2|||
128023010|NCT01629563|460710665|FG001|Overall Study|Death|0|||
128023011|NCT01629563|460710664|FG000|Overall Study|Lack of Efficacy|2|||
128023012|NCT01629563|460710665|FG001|Overall Study|Lack of Efficacy|3|||
128023013|NCT01629563|460710664|FG000|Overall Study|Lost to Follow-up|1|||
128023014|NCT01629563|460710665|FG001|Overall Study|Lost to Follow-up|0|||
128023015|NCT01629563|460710664|FG000|Overall Study|Pregnancy|1|||
128023016|NCT01629563|460710665|FG001|Overall Study|Pregnancy|2|||
128023017|NCT01629563|460710664|FG000|Overall Study|Protocol Violation|0|||
128023018|NCT01629563|460710665|FG001|Overall Study|Protocol Violation|1|||
128023019|NCT01629563|460710664|FG000|Overall Study|Withdrawal by Subject|27|||
128023020|NCT01629563|460710665|FG001|Overall Study|Withdrawal by Subject|20|||
128023021|NCT01629563|460710664|FG000|Overall Study|surgery|0|||
128023022|NCT01629563|460710665|FG001|Overall Study|surgery|3|||
128023023|NCT01629563|460710664|FG000|Overall Study|Lack of return of menses|12|||
127558382|NCT00669409|459014088|FG009|Part 2|Withdrawal by Subject|1|||
127686087|NCT05938413|459478154|FG000|Overall Study|Lost to Follow-up|1|||
127686088|NCT05938413|459478155|FG001|Overall Study|Lost to Follow-up|7|||
127686089|NCT05938413|459478154|FG000|Overall Study|Withdrawal by Subject|1|||
128023024|NCT01629563|460710665|FG001|Overall Study|Lack of return of menses|7|||
128023025|NCT01629563|460710664|FG000|Overall Study|Protocol Violation|0|||
128023026|NCT01629563|460710665|FG001|Overall Study|Protocol Violation|1|||
128023027|NCT01108796|460710666|FG000|Overall Study|Adverse Event|0|||
128023028|NCT01108796|460710667|FG001|Overall Study|Adverse Event|1|||
128023029|NCT01108796|460710666|FG000|Overall Study|Lost to Follow-up|7|||
128023030|NCT01108796|460710667|FG001|Overall Study|Lost to Follow-up|6|||
128023031|NCT00454142|460710668|FG000|Overall Study|Withdrawal by Subject|1|||
128023032|NCT02545127|460710675|FG000|Overall Study|Lost to Follow-up|1|||
128023033|NCT02545127|460710676|FG001|Overall Study|Lost to Follow-up|0|||
127558383|NCT00669409|459014089|FG010|Part 2|Withdrawal by Subject|0|||
127686090|NCT05938413|459478155|FG001|Overall Study|Withdrawal by Subject|1|||
127686091|NCT05644444|459478160|FG000|Tolerance Phase|Adverse Event|0|||
127686092|NCT05644444|459478161|FG001|Tolerance Phase|Adverse Event|2|||
128023034|NCT01245751|460710677|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
128023035|NCT01245751|460710678|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
128023036|NCT01245751|460710679|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
128023037|NCT01245751|460710680|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
128023038|NCT01245751|460710677|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
128023039|NCT01245751|460710678|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
128023040|NCT01245751|460710679|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
128023041|NCT01245751|460710680|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
128023042|NCT01245751|460710677|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
128023043|NCT01245751|460710678|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
128023044|NCT01245751|460710679|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
128023045|NCT01245751|460710680|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
128023046|NCT05788328|460710681|FG000|Treatment Period 4 (5 Days)|Other|1|||
128023047|NCT05788328|460710681|FG000|Treatment Period 8 (4 Days)|Adverse Event|1|||
128023048|NCT03315689|460710682|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
128023049|NCT03315689|460710683|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
128023050|NCT03315689|460710682|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
128023051|NCT03315689|460710683|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
128023052|NCT03315689|460710682|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
128023053|NCT03315689|460710683|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
128023054|NCT01783015|460710685|FG000|Blinded Treatment|Adverse Event|0|||
128023055|NCT01783015|460710686|FG001|Blinded Treatment|Adverse Event|1|||
128023056|NCT01783015|460710687|FG002|Blinded Treatment|Adverse Event|0|||
128023057|NCT01783015|460710685|FG000|Blinded Treatment|Protocol Violation|0|||
128023058|NCT01783015|460710686|FG001|Blinded Treatment|Protocol Violation|1|||
128023059|NCT01783015|460710687|FG002|Blinded Treatment|Protocol Violation|0|||
128023060|NCT01783015|460710685|FG000|Blinded Treatment|Withdrawal by Subject|0|||
128023061|NCT01783015|460710686|FG001|Blinded Treatment|Withdrawal by Subject|1|||
128023062|NCT01783015|460710687|FG002|Blinded Treatment|Withdrawal by Subject|0|||
128023063|NCT01783015|460710685|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
128023064|NCT01783015|460710686|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
128023065|NCT01783015|460710687|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
128023066|NCT01783015|460710685|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
128023067|NCT01783015|460710686|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
128023068|NCT01783015|460710687|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
128023069|NCT00985192|460710688|FG000|Overall Study|Withdrawal by Subject|1|||
128023070|NCT00985192|460710688|FG000|Overall Study|Disease Progression|1|||
128023071|NCT00985192|460710688|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
128023072|NCT00669331|460710689|FG000|Randomisation to First Dose|Adverse Event|1|||
128023073|NCT00669331|460710690|FG001|Randomisation to First Dose|Adverse Event|0|||
128023074|NCT00669331|460710689|FG000|Randomisation to First Dose|Protocol Violation|1|||
128023075|NCT00669331|460710690|FG001|Randomisation to First Dose|Protocol Violation|0|||
128023076|NCT00669331|460710689|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
128023077|NCT00669331|460710690|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
128023078|NCT00669331|460710689|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
128023079|NCT00669331|460710690|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
128023080|NCT00669331|460710689|FG000|Randomisation to First Dose|Death|1|||
128023081|NCT00669331|460710690|FG001|Randomisation to First Dose|Death|0|||
128023082|NCT00669331|460710689|FG000|Randomisation to First Dose|Sponsor decision|0|||
128023083|NCT00669331|460710690|FG001|Randomisation to First Dose|Sponsor decision|1|||
128023084|NCT00669331|460710689|FG000|Randomisation to First Dose|Randomised in error|3|||
128023085|NCT00669331|460710690|FG001|Randomisation to First Dose|Randomised in error|10|||
128023086|NCT00669331|460710689|FG000|Blinded Treatment Period|Adverse Event|16|||
128023087|NCT00669331|460710690|FG001|Blinded Treatment Period|Adverse Event|10|||
128023088|NCT00669331|460710689|FG000|Blinded Treatment Period|Protocol Violation|1|||
128023089|NCT00669331|460710690|FG001|Blinded Treatment Period|Protocol Violation|1|||
128023090|NCT00669331|460710689|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
128023091|NCT00669331|460710690|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
128023092|NCT00669331|460710689|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
128023093|NCT00669331|460710690|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
128023094|NCT00669331|460710689|FG000|Blinded Treatment Period|Death|0|||
128023095|NCT00669331|460710690|FG001|Blinded Treatment Period|Death|2|||
127558384|NCT03583385|459014091|FG000|Treatment Period 1|Withdrawal by Subject|1|||
127686093|NCT05644444|459478160|FG000|Treatment Phase|Adverse Event|0|||
127686094|NCT05644444|459478161|FG001|Treatment Phase|Adverse Event|2|||
127686095|NCT04817670|459478162|FG000|Overall Study|Withdrawal by Subject|1|||
127686096|NCT04817670|459478163|FG001|Overall Study|Withdrawal by Subject|0|||
127686097|NCT04817670|459478164|FG002|Overall Study|Withdrawal by Subject|0|||
127686098|NCT04817670|459478165|FG003|Overall Study|Withdrawal by Subject|0|||
127686099|NCT04817670|459478166|FG004|Overall Study|Withdrawal by Subject|0|||
127774454|NCT02175004|459800327|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
127686100|NCT04817670|459478162|FG000|Overall Study|Lost to Follow-up|0|||
127686101|NCT04817670|459478163|FG001|Overall Study|Lost to Follow-up|0|||
127686102|NCT04817670|459478164|FG002|Overall Study|Lost to Follow-up|1|||
128023096|NCT00669331|460710689|FG000|Blinded Treatment Period|Physician Decision|3|||
128023097|NCT00669331|460710690|FG001|Blinded Treatment Period|Physician Decision|3|||
128023098|NCT00669331|460710689|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
128023099|NCT00669331|460710690|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
128023100|NCT00509600|460710693|FG000|Overall Study|Adverse Event|1|||
128023101|NCT03794544|460710695|FG000|Overall Study|Withdrawal by Subject|1|||
128023102|NCT03794544|460710696|FG001|Overall Study|Withdrawal by Subject|1|||
128023103|NCT03794544|460710697|FG002|Overall Study|Withdrawal by Subject|0|||
128023104|NCT03794544|460710698|FG003|Overall Study|Withdrawal by Subject|0|||
128023105|NCT03794544|460710695|FG000|Overall Study|Death|0|||
128023106|NCT03794544|460710696|FG001|Overall Study|Death|0|||
128023107|NCT03794544|460710697|FG002|Overall Study|Death|0|||
128023108|NCT03794544|460710698|FG003|Overall Study|Death|1|||
128023109|NCT03794544|460710695|FG000|Overall Study|Lost to Follow-up|0|||
128023110|NCT03794544|460710696|FG001|Overall Study|Lost to Follow-up|1|||
128023111|NCT03794544|460710697|FG002|Overall Study|Lost to Follow-up|1|||
128023112|NCT03794544|460710698|FG003|Overall Study|Lost to Follow-up|0|||
128023113|NCT03794544|460710695|FG000|Overall Study|Other|0|||
128023114|NCT03794544|460710696|FG001|Overall Study|Other|1|||
128023115|NCT03794544|460710697|FG002|Overall Study|Other|0|||
128023116|NCT03794544|460710698|FG003|Overall Study|Other|0|||
128023117|NCT00676052|460710700|FG000|Overall Study|Adverse Event|0|||
128023118|NCT00676052|460710701|FG001|Overall Study|Adverse Event|1|||
128023119|NCT00676052|460710702|FG002|Overall Study|Adverse Event|1|||
128023120|NCT00676052|460710703|FG003|Overall Study|Adverse Event|2|||
128023121|NCT00676052|460710704|FG004|Overall Study|Adverse Event|2|||
128023122|NCT00676052|460710705|FG005|Overall Study|Adverse Event|2|||
128023123|NCT00676052|460710700|FG000|Overall Study|Lack of Efficacy|2|||
128023124|NCT00676052|460710701|FG001|Overall Study|Lack of Efficacy|2|||
128023125|NCT00676052|460710702|FG002|Overall Study|Lack of Efficacy|1|||
128023126|NCT00676052|460710703|FG003|Overall Study|Lack of Efficacy|1|||
128023127|NCT00676052|460710704|FG004|Overall Study|Lack of Efficacy|2|||
128023128|NCT00676052|460710705|FG005|Overall Study|Lack of Efficacy|1|||
128023129|NCT00676052|460710700|FG000|Overall Study|Protocol Violation|5|||
128023130|NCT00676052|460710701|FG001|Overall Study|Protocol Violation|3|||
128023131|NCT00676052|460710702|FG002|Overall Study|Protocol Violation|2|||
128023132|NCT00676052|460710703|FG003|Overall Study|Protocol Violation|2|||
128023133|NCT00676052|460710704|FG004|Overall Study|Protocol Violation|1|||
128023134|NCT00676052|460710705|FG005|Overall Study|Protocol Violation|2|||
128023135|NCT00676052|460710700|FG000|Overall Study|Lost to Follow-up|0|||
128023136|NCT00676052|460710701|FG001|Overall Study|Lost to Follow-up|0|||
128023137|NCT00676052|460710702|FG002|Overall Study|Lost to Follow-up|0|||
128023138|NCT00676052|460710703|FG003|Overall Study|Lost to Follow-up|0|||
128023139|NCT00676052|460710704|FG004|Overall Study|Lost to Follow-up|1|||
128023140|NCT00676052|460710705|FG005|Overall Study|Lost to Follow-up|0|||
128023141|NCT00676052|460710700|FG000|Overall Study|Physician Decision|1|||
128023142|NCT00676052|460710701|FG001|Overall Study|Physician Decision|1|||
128023143|NCT00676052|460710702|FG002|Overall Study|Physician Decision|1|||
128023144|NCT00676052|460710703|FG003|Overall Study|Physician Decision|0|||
128023145|NCT00676052|460710704|FG004|Overall Study|Physician Decision|0|||
128023146|NCT00676052|460710705|FG005|Overall Study|Physician Decision|1|||
128023147|NCT00676052|460710700|FG000|Overall Study|Withdrawal by Subject|1|||
128023148|NCT00676052|460710701|FG001|Overall Study|Withdrawal by Subject|0|||
128023149|NCT00676052|460710702|FG002|Overall Study|Withdrawal by Subject|1|||
128023150|NCT00676052|460710703|FG003|Overall Study|Withdrawal by Subject|0|||
128023151|NCT00676052|460710704|FG004|Overall Study|Withdrawal by Subject|0|||
128023152|NCT00676052|460710705|FG005|Overall Study|Withdrawal by Subject|0|||
128023153|NCT01960842|460710710|FG000|Overall Study|Adverse Event|1|||
128023154|NCT01960842|460710710|FG000|Overall Study|Withdrawal by Subject|2|||
128023155|NCT01301001|460710711|FG000|First Intervention|Lost to Follow-up|4|||
128023156|NCT01301001|460710712|FG001|First Intervention|Lost to Follow-up|4|||
128023157|NCT01301001|460710711|FG000|First Intervention|Withdrawal by Subject|1|||
128023158|NCT01301001|460710712|FG001|First Intervention|Withdrawal by Subject|4|||
128023159|NCT01301001|460710711|FG000|First Intervention|Adverse Event|5|||
128023160|NCT01301001|460710712|FG001|First Intervention|Adverse Event|0|||
128023161|NCT01301001|460710711|FG000|First Intervention|Protocol Violation|0|||
128023162|NCT01301001|460710712|FG001|First Intervention|Protocol Violation|1|||
128023163|NCT01301001|460710711|FG000|Second Intervention|Adverse Event|2|||
128023164|NCT01301001|460710712|FG001|Second Intervention|Adverse Event|0|||
128023165|NCT01301001|460710711|FG000|Second Intervention|Withdrawal by Subject|2|||
128023166|NCT01301001|460710712|FG001|Second Intervention|Withdrawal by Subject|0|||
128023167|NCT00378560|460710713|FG000|Overall Study|Adverse Event|1|||
128023168|NCT00378560|460710714|FG001|Overall Study|Adverse Event|0|||
127798472|NCT01789970|459885614|FG001|Open-label Titration Period|Lost to Follow-up|0|||
128023169|NCT00378560|460710713|FG000|Overall Study|Lost to Follow-up|24|||
128023170|NCT00378560|460710714|FG001|Overall Study|Lost to Follow-up|29|||
128023171|NCT00378560|460710713|FG000|Overall Study|Protocol Violation|2|||
128023172|NCT00378560|460710714|FG001|Overall Study|Protocol Violation|0|||
128023173|NCT00378560|460710713|FG000|Overall Study|Withdrawal by Subject|17|||
128023174|NCT00378560|460710714|FG001|Overall Study|Withdrawal by Subject|21|||
128023175|NCT00378560|460710713|FG000|Overall Study|Moved|4|||
128023176|NCT00378560|460710714|FG001|Overall Study|Moved|3|||
128023177|NCT00378560|460710713|FG000|Overall Study|Pregnancy|7|||
128023178|NCT00378560|460710714|FG001|Overall Study|Pregnancy|5|||
128023179|NCT00378560|460710713|FG000|Overall Study|Laboratory test values abnormal|1|||
128023180|NCT00378560|460710714|FG001|Overall Study|Laboratory test values abnormal|0|||
128023181|NCT00976391|460710715|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
128023182|NCT00976391|460710716|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
128023183|NCT00976391|460710715|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
128023184|NCT00976391|460710716|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
128023185|NCT00976391|460710715|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
128023186|NCT00976391|460710716|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
128023187|NCT00976391|460710715|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
128023188|NCT00976391|460710716|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
128023189|NCT00976391|460710715|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
128023190|NCT00976391|460710716|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
128023191|NCT00976391|460710715|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
128023192|NCT00976391|460710716|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
128023193|NCT00976391|460710715|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
128023194|NCT00976391|460710716|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
128023195|NCT00976391|460710715|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
128023196|NCT00976391|460710716|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
128023197|NCT00976391|460710715|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
128023198|NCT00976391|460710716|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
128023199|NCT00976391|460710715|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
128023200|NCT00976391|460710716|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
128023201|NCT00976391|460710715|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
128023202|NCT00976391|460710716|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
128023203|NCT00976391|460710715|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
128023204|NCT00976391|460710716|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
128023205|NCT00976391|460710715|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
128023206|NCT00976391|460710716|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
128023207|NCT00976391|460710715|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
128023208|NCT00976391|460710716|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
128023209|NCT02852434|460710717|FG000|Overall Study|Withdrawal by Subject|0|||
128023210|NCT02852434|460710718|FG001|Overall Study|Withdrawal by Subject|1|||
128023211|NCT02852434|460710717|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
128023212|NCT02852434|460710718|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
128023213|NCT01145222|460710721|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
128023214|NCT01145222|460710722|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
128023215|NCT01145222|460710723|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
128023216|NCT01145222|460710724|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
127558385|NCT03583385|459014092|FG001|Treatment Period 1|Withdrawal by Subject|1|||
128023217|NCT01145222|460710721|FG000|Overall Study|Poor bowel preparation|0|||
128023218|NCT01145222|460710722|FG001|Overall Study|Poor bowel preparation|0|||
128023219|NCT01145222|460710723|FG002|Overall Study|Poor bowel preparation|0|||
128023220|NCT01145222|460710724|FG003|Overall Study|Poor bowel preparation|1|||
128023221|NCT01011283|460710726|FG000|Overall Study|Adverse Event|4|||
128023222|NCT01011283|460710727|FG001|Overall Study|Adverse Event|2|||
128023223|NCT01011283|460710726|FG000|Overall Study|Progressive Disease|0|||
128023224|NCT01011283|460710727|FG001|Overall Study|Progressive Disease|2|||
128023225|NCT01011283|460710726|FG000|Overall Study|Terminated by Sponsor|5|||
128023226|NCT01011283|460710727|FG001|Overall Study|Terminated by Sponsor|5|||
128023227|NCT01011283|460710726|FG000|Overall Study|Other|2|||
128023228|NCT01011283|460710727|FG001|Overall Study|Other|2|||
128023229|NCT04865978|460710731|FG000|Overall Study|One patient did not complete the study due to infection and device explant|1|||
127558386|NCT03583385|459014091|FG000|Treatment Period 2|Adverse Event|1|||
127558387|NCT03583385|459014092|FG001|Treatment Period 2|Adverse Event|0|||
127558388|NCT00095940|459014095|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
127558389|NCT00095940|459014096|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
127558390|NCT00095940|459014097|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
127686103|NCT04817670|459478165|FG003|Overall Study|Lost to Follow-up|0|||
127686104|NCT04817670|459478166|FG004|Overall Study|Lost to Follow-up|0|||
128023230|NCT04865978|460710732|FG001|Overall Study|One patient did not complete the study due to infection and device explant|0|||
128023231|NCT03835117|460710733|FG000|Phase II - Week 13- Week 24|Lost to Follow-up|2|||
128023232|NCT03835117|460710734|FG001|Phase II - Week 13- Week 24|Lost to Follow-up|3|||
128023233|NCT00609973|460710739|FG000|Overall Study|Adverse Event|2|||
128023234|NCT00609973|460710740|FG001|Overall Study|Adverse Event|1|||
128023235|NCT00609973|460710739|FG000|Overall Study|Protocol Violation|4|||
127686105|NCT03312907|459478167|FG000|Overall Study|Adverse Event|1|||
127686106|NCT03312907|459478168|FG001|Overall Study|Adverse Event|6|||
127558391|NCT00095940|459014098|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
128023236|NCT00609973|460710740|FG001|Overall Study|Protocol Violation|3|||
128023237|NCT00609973|460710739|FG000|Overall Study|Lost to Follow-up|2|||
128023238|NCT00609973|460710740|FG001|Overall Study|Lost to Follow-up|1|||
128023239|NCT00609973|460710739|FG000|Overall Study|Withdrawal by Subject|0|||
128023240|NCT00609973|460710740|FG001|Overall Study|Withdrawal by Subject|1|||
128023241|NCT00191152|460710742|FG000|Initial Treatment|Adverse Event|43|||
128023242|NCT00191152|460710743|FG001|Initial Treatment|Adverse Event|67|||
128023243|NCT00191152|460710742|FG000|Initial Treatment|Physician Decision|40|||
128023244|NCT00191152|460710743|FG001|Initial Treatment|Physician Decision|31|||
128023245|NCT00191152|460710742|FG000|Initial Treatment|Withdrawal by Subject|40|||
128023246|NCT00191152|460710743|FG001|Initial Treatment|Withdrawal by Subject|28|||
128023247|NCT00191152|460710742|FG000|Initial Treatment|Lost to Follow-up|0|||
128023248|NCT00191152|460710743|FG001|Initial Treatment|Lost to Follow-up|6|||
128023249|NCT00191152|460710742|FG000|Initial Treatment|Other|18|||
128023250|NCT00191152|460710743|FG001|Initial Treatment|Other|21|||
128023251|NCT00191152|460710742|FG000|Crossover Treatment|Adverse Event|8|||
128023252|NCT00191152|460710743|FG001|Crossover Treatment|Adverse Event|8|||
128023253|NCT00191152|460710742|FG000|Crossover Treatment|Physician Decision|7|||
128023254|NCT00191152|460710743|FG001|Crossover Treatment|Physician Decision|7|||
128023255|NCT00191152|460710742|FG000|Crossover Treatment|Withdrawal by Subject|6|||
128023256|NCT00191152|460710743|FG001|Crossover Treatment|Withdrawal by Subject|9|||
128023257|NCT00191152|460710742|FG000|Crossover Treatment|Lost to Follow-up|2|||
128023258|NCT00191152|460710743|FG001|Crossover Treatment|Lost to Follow-up|1|||
128023259|NCT00191152|460710742|FG000|Crossover Treatment|Other|4|||
128023260|NCT00191152|460710743|FG001|Crossover Treatment|Other|3|||
128023261|NCT00114777|460710744|FG000|Randomization to Month 36|Death|10|||
128023262|NCT00114777|460710745|FG001|Randomization to Month 36|Death|4|||
128023263|NCT00114777|460710746|FG002|Randomization to Month 36|Death|3|||
128023264|NCT00114777|460710744|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
128023265|NCT00114777|460710745|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
128023266|NCT00114777|460710746|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
128023267|NCT00114777|460710744|FG000|Randomization to Month 36|Lack of Efficacy|19|||
128023268|NCT00114777|460710745|FG001|Randomization to Month 36|Lack of Efficacy|15|||
128023269|NCT00114777|460710746|FG002|Randomization to Month 36|Lack of Efficacy|17|||
128023270|NCT00114777|460710744|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
128023271|NCT00114777|460710745|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
128023272|NCT00114777|460710746|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
128023273|NCT00114777|460710744|FG000|Randomization to Month 36|Adverse Event|34|||
128023274|NCT00114777|460710745|FG001|Randomization to Month 36|Adverse Event|35|||
128023275|NCT00114777|460710746|FG002|Randomization to Month 36|Adverse Event|44|||
128023276|NCT00114777|460710744|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
128023277|NCT00114777|460710745|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
128023278|NCT00114777|460710746|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
128023279|NCT00114777|460710744|FG000|Randomization to Month 36|Other|9|||
128023280|NCT00114777|460710745|FG001|Randomization to Month 36|Other|3|||
128023281|NCT00114777|460710746|FG002|Randomization to Month 36|Other|12|||
128023282|NCT00114777|460710744|FG000|Long-Term Extension to Month 84|Death|8|||
128023283|NCT00114777|460710745|FG001|Long-Term Extension to Month 84|Death|13|||
128023284|NCT00114777|460710746|FG002|Long-Term Extension to Month 84|Death|7|||
128023285|NCT00114777|460710744|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
127686107|NCT03312907|459478169|FG002|Overall Study|Adverse Event|1|||
127686108|NCT03312907|459478167|FG000|Overall Study|Protocol Violation|2|||
127686109|NCT03312907|459478168|FG001|Overall Study|Protocol Violation|3|||
127686110|NCT03312907|459478169|FG002|Overall Study|Protocol Violation|4|||
127686111|NCT03312907|459478167|FG000|Overall Study|Lost to Follow-up|2|||
127686112|NCT03312907|459478168|FG001|Overall Study|Lost to Follow-up|3|||
128023286|NCT00114777|460710745|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
128023287|NCT00114777|460710746|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
128023288|NCT00114777|460710744|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
128023289|NCT00114777|460710745|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
128023290|NCT00114777|460710746|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
128023291|NCT00114777|460710744|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
128023292|NCT00114777|460710745|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
128023293|NCT00114777|460710746|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
128023294|NCT00114777|460710744|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
128023295|NCT00114777|460710745|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
128023296|NCT00114777|460710746|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
128023297|NCT00114777|460710744|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
128023298|NCT00114777|460710745|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
128023299|NCT00114777|460710746|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
128023300|NCT00114777|460710744|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
128023301|NCT00114777|460710745|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
128023302|NCT00114777|460710746|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
127686113|NCT03312907|459478169|FG002|Overall Study|Lost to Follow-up|2|||
127686114|NCT03312907|459478167|FG000|Overall Study|Physician Decision|3|||
127686115|NCT03312907|459478168|FG001|Overall Study|Physician Decision|4|||
128023303|NCT00114777|460710744|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
128023304|NCT00114777|460710745|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
128023305|NCT00114777|460710746|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
128023306|NCT00114777|460710744|FG000|Long-Term Extension to Month 84|Other|2|||
128023307|NCT00114777|460710745|FG001|Long-Term Extension to Month 84|Other|0|||
128023308|NCT00114777|460710746|FG002|Long-Term Extension to Month 84|Other|2|||
128023309|NCT00629239|460710750|FG000|Overall Study|Adverse Event|7|||
128023310|NCT00629239|460710751|FG001|Overall Study|Adverse Event|4|||
128023311|NCT00629239|460710750|FG000|Overall Study|Physician Decision|1|||
128023312|NCT00629239|460710751|FG001|Overall Study|Physician Decision|0|||
128023313|NCT01851369|460710752|FG000|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
127558392|NCT00095940|459014099|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
127558393|NCT00095940|459014100|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
127558394|NCT00095940|459014101|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
127558395|NCT00095940|459014102|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
127558396|NCT00095940|459014103|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
127558397|NCT00095940|459014095|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
127558398|NCT00095940|459014096|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
127558399|NCT00095940|459014097|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
127558400|NCT00095940|459014098|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
127558401|NCT00095940|459014099|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
127558402|NCT00095940|459014100|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
127558403|NCT00095940|459014101|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
127558404|NCT00095940|459014102|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
127558405|NCT00095940|459014103|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
127558406|NCT00095940|459014095|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
127558407|NCT00095940|459014096|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
127558408|NCT00095940|459014097|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
127558409|NCT00095940|459014098|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
127558410|NCT00095940|459014099|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
127558411|NCT00095940|459014100|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
127558412|NCT00095940|459014101|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
127558413|NCT00095940|459014102|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
127558414|NCT00095940|459014103|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
127558415|NCT02314637|459014104|FG000|Overall Study|Adverse Event|4|||
128023314|NCT01851369|460710753|FG001|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
128023315|NCT01851369|460710754|FG002|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
128023316|NCT01851369|460710755|FG003|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
128023317|NCT01851369|460710756|FG004|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
128023318|NCT01851369|460710757|FG005|Phase I Dose Escalation|Declined to participate (before treatment started)|1|||
128023319|NCT01851369|460710758|FG006|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
128023320|NCT01851369|460710759|FG007|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
128023321|NCT01851369|460710760|FG008|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
128023322|NCT01851369|460710761|FG009|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
128023323|NCT01851369|460710762|FG010|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
128023324|NCT01851369|460710763|FG011|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
128023325|NCT01851369|460710764|FG012|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
128023326|NCT02453191|460710765|FG000|Overall Study|Withdrawal by Subject|1|||
128023327|NCT02336503|460710768|FG000|Overall Study|Lost to Follow-up|0|||
128023328|NCT02336503|460710769|FG001|Overall Study|Lost to Follow-up|3|||
128023329|NCT02336503|460710770|FG002|Overall Study|Lost to Follow-up|0|||
128023330|NCT02336503|460710771|FG003|Overall Study|Lost to Follow-up|2|||
128023331|NCT02336503|460710768|FG000|Overall Study|Withdrawal by Subject|2|||
128023332|NCT02336503|460710769|FG001|Overall Study|Withdrawal by Subject|0|||
128023333|NCT02336503|460710770|FG002|Overall Study|Withdrawal by Subject|0|||
128023334|NCT02336503|460710771|FG003|Overall Study|Withdrawal by Subject|4|||
128023335|NCT02336503|460710768|FG000|Overall Study|Adverse Event|0|||
128023336|NCT02336503|460710769|FG001|Overall Study|Adverse Event|0|||
128023337|NCT02336503|460710770|FG002|Overall Study|Adverse Event|1|||
128023338|NCT02336503|460710771|FG003|Overall Study|Adverse Event|0|||
128023339|NCT01543503|460710772|FG000|Overall Study|Lost to Follow-up|32|||
128023340|NCT01543503|460710773|FG001|Overall Study|Lost to Follow-up|36|||
128023341|NCT01543503|460710772|FG000|Overall Study|Adverse Event|9|||
127558416|NCT02314637|459014105|FG001|Overall Study|Adverse Event|8|||
127558417|NCT02314637|459014104|FG000|Overall Study|Lack of Efficacy|1|||
127558418|NCT02314637|459014105|FG001|Overall Study|Lack of Efficacy|0|||
127558419|NCT02314637|459014104|FG000|Overall Study|Physician Decision|5|||
127558420|NCT02314637|459014105|FG001|Overall Study|Physician Decision|2|||
127558421|NCT02314637|459014104|FG000|Overall Study|Withdrawal by Subject|5|||
127558422|NCT02314637|459014105|FG001|Overall Study|Withdrawal by Subject|4|||
127558423|NCT02314637|459014104|FG000|Overall Study|Other Reason|1|||
127558424|NCT02314637|459014105|FG001|Overall Study|Other Reason|0|||
127558425|NCT03539549|459014109|FG000|Overall Study|Adverse Event|12|||
127558426|NCT03539549|459014109|FG000|Overall Study|Lost to Follow-up|1|||
127558427|NCT03539549|459014109|FG000|Overall Study|Death|2|||
127558428|NCT03539549|459014109|FG000|Overall Study|Progressive Disease|1|||
127558429|NCT03539549|459014109|FG000|Overall Study|Reason not Specified|1|||
127558430|NCT02864862|459014115|FG000|Overall Study|Lost to Follow-up|1|||
127558431|NCT02864862|459014116|FG001|Overall Study|Lost to Follow-up|0|||
127558432|NCT02864862|459014117|FG002|Overall Study|Lost to Follow-up|1|||
127558433|NCT02864862|459014115|FG000|Overall Study|Protocol Violation|0|||
127558434|NCT02864862|459014116|FG001|Overall Study|Protocol Violation|0|||
127558435|NCT02864862|459014117|FG002|Overall Study|Protocol Violation|1|||
127558436|NCT05573386|459014124|FG000|Overall Study|Withdrawal by Subject|3|||
127558437|NCT05573386|459014125|FG001|Overall Study|Withdrawal by Subject|2|||
127558438|NCT03646123|459014126|FG000|Overall Study|Withdrawal by Subject|2|||
127558439|NCT03646123|459014127|FG001|Overall Study|Withdrawal by Subject|2|||
127558440|NCT03646123|459014128|FG002|Overall Study|Withdrawal by Subject|3|||
127558441|NCT03646123|459014126|FG000|Overall Study|Study termination by sponsor|0|||
127558442|NCT03646123|459014127|FG001|Overall Study|Study termination by sponsor|45|||
127558443|NCT03646123|459014128|FG002|Overall Study|Study termination by sponsor|139|||
127558444|NCT03646123|459014126|FG000|Overall Study|Lost to Follow-up|4|||
127558445|NCT03646123|459014127|FG001|Overall Study|Lost to Follow-up|10|||
127558446|NCT03646123|459014128|FG002|Overall Study|Lost to Follow-up|10|||
127558447|NCT03646123|459014126|FG000|Overall Study|Death|2|||
127558448|NCT03646123|459014127|FG001|Overall Study|Death|1|||
127558449|NCT03646123|459014128|FG002|Overall Study|Death|1|||
127558450|NCT03646123|459014126|FG000|Overall Study|Other|2|||
127558451|NCT03646123|459014127|FG001|Overall Study|Other|0|||
127558452|NCT03646123|459014128|FG002|Overall Study|Other|2|||
127558453|NCT04195893|459014135|FG000|Second Intervention|Withdrawal by Subject|1|||
127558454|NCT04195893|459014136|FG001|Second Intervention|Withdrawal by Subject|0|||
127558455|NCT01802073|459014139|FG000|Overall Study|Lost to Follow-up|0|||
127558456|NCT01802073|459014140|FG001|Overall Study|Lost to Follow-up|1|||
127558457|NCT01802073|459014139|FG000|Overall Study|Non-compliant|4|||
127558458|NCT01802073|459014140|FG001|Overall Study|Non-compliant|2|||
127558459|NCT01802073|459014139|FG000|Overall Study|Withdrawal by Subject|1|||
127558460|NCT01802073|459014140|FG001|Overall Study|Withdrawal by Subject|1|||
127558461|NCT01802073|459014139|FG000|Overall Study|Physician Decision|0|||
127558462|NCT01802073|459014140|FG001|Overall Study|Physician Decision|7|||
127558463|NCT02123472|459014144|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
127558464|NCT02123472|459014145|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
127558465|NCT00918736|459014146|FG000|Overall Study|Withdrawal by Subject|4|||
127774455|NCT02175004|459800328|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
127774456|NCT00823901|459800329|FG000|Overall Study|Adverse Event|1|||
127774457|NCT00823901|459800330|FG001|Overall Study|Adverse Event|1|||
127774458|NCT00823901|459800329|FG000|Overall Study|Lack of Efficacy|1|||
127774459|NCT00823901|459800330|FG001|Overall Study|Lack of Efficacy|0|||
127774460|NCT00823901|459800329|FG000|Overall Study|Lost to Follow-up|2|||
127774461|NCT00823901|459800330|FG001|Overall Study|Lost to Follow-up|1|||
127774462|NCT01376349|459800332|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
127774463|NCT01376349|459800333|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
127774464|NCT01376349|459800334|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
127774465|NCT01376349|459800332|FG000|Raondomized Treatment|Adverse Event|13|||
127774466|NCT01376349|459800333|FG001|Raondomized Treatment|Adverse Event|17|||
127774467|NCT01376349|459800334|FG002|Raondomized Treatment|Adverse Event|14|||
127774468|NCT01376349|459800332|FG000|Raondomized Treatment|Unkown|1|||
128023342|NCT01543503|460710773|FG001|Overall Study|Adverse Event|13|||
127774469|NCT01376349|459800333|FG001|Raondomized Treatment|Unkown|2|||
127774470|NCT01376349|459800334|FG002|Raondomized Treatment|Unkown|1|||
127774471|NCT01376349|459800332|FG000|Raondomized Treatment|Alternative Treatment|0|||
127774472|NCT01376349|459800333|FG001|Raondomized Treatment|Alternative Treatment|0|||
128023343|NCT01543503|460710772|FG000|Overall Study|Lack of Efficacy|4|||
128023344|NCT01543503|460710773|FG001|Overall Study|Lack of Efficacy|16|||
127558466|NCT01474018|459014147|FG000|Overall Study|Lost to Follow-up|0|||
127558467|NCT01474018|459014148|FG001|Overall Study|Lost to Follow-up|1|||
127558468|NCT01474018|459014147|FG000|Overall Study|Withdrawal by Subject|0|||
127558469|NCT01474018|459014148|FG001|Overall Study|Withdrawal by Subject|2|||
127558470|NCT02433080|459014149|FG000|Overall Study|Lost to Follow-up|1|||
127558471|NCT02433080|459014150|FG001|Overall Study|Lost to Follow-up|2|||
127558472|NCT02433080|459014149|FG000|Overall Study|Withdrawal by Subject|0|||
128023345|NCT01543503|460710772|FG000|Overall Study|Participant withdrew informed consent|8|||
127558473|NCT02433080|459014150|FG001|Overall Study|Withdrawal by Subject|2|||
127558474|NCT01137604|459014151|FG000|Overall Study|Adverse Event|3|||
127558475|NCT01137604|459014152|FG001|Overall Study|Adverse Event|6|||
127774473|NCT01376349|459800334|FG002|Raondomized Treatment|Alternative Treatment|1|||
127558476|NCT01137604|459014153|FG002|Overall Study|Adverse Event|9|||
127558477|NCT01137604|459014154|FG003|Overall Study|Adverse Event|9|||
127558478|NCT01137604|459014151|FG000|Overall Study|Participant Choice|0|||
127558479|NCT01137604|459014152|FG001|Overall Study|Participant Choice|2|||
127558480|NCT01137604|459014153|FG002|Overall Study|Participant Choice|2|||
127558481|NCT01137604|459014154|FG003|Overall Study|Participant Choice|0|||
127558482|NCT01137604|459014151|FG000|Overall Study|Withdrawal of consent|0|||
127558483|NCT01137604|459014152|FG001|Overall Study|Withdrawal of consent|0|||
127558484|NCT01137604|459014153|FG002|Overall Study|Withdrawal of consent|0|||
127558485|NCT01137604|459014154|FG003|Overall Study|Withdrawal of consent|2|||
127558486|NCT01137604|459014151|FG000|Overall Study|Clinical progression/deterioration|1|||
127558487|NCT01137604|459014152|FG001|Overall Study|Clinical progression/deterioration|2|||
127558488|NCT01137604|459014153|FG002|Overall Study|Clinical progression/deterioration|2|||
127558489|NCT01137604|459014154|FG003|Overall Study|Clinical progression/deterioration|0|||
127558490|NCT03462511|459014158|FG000|Overall Study|Withdrawal by Subject|2|||
127558491|NCT03462511|459014159|FG001|Overall Study|Withdrawal by Subject|3|||
127558492|NCT02925416|459014160|FG000|Overall Study|Adverse Event|2|||
127558493|NCT02925416|459014161|FG001|Overall Study|Adverse Event|0|||
127558494|NCT03595228|459014162|FG000|Overall Study|Death|2|||
127558495|NCT03595228|459014162|FG000|Overall Study|Lack of Efficacy|13|||
127558496|NCT03595228|459014162|FG000|Overall Study|Withdrawal by Subject|3|||
127558497|NCT03595228|459014162|FG000|Overall Study|Withdrawal by Sponsor|1|||
127558498|NCT00200356|459014163|FG000|Overall Study|Lack of Efficacy|3|||
127558499|NCT00200356|459014164|FG001|Overall Study|Lack of Efficacy|3|||
127558500|NCT00200356|459014163|FG000|Overall Study|Protocol Violation|4|||
127558501|NCT00200356|459014164|FG001|Overall Study|Protocol Violation|4|||
127558502|NCT00200356|459014163|FG000|Overall Study|Nontreatment|1|||
127558503|NCT00200356|459014164|FG001|Overall Study|Nontreatment|0|||
127558504|NCT00435045|459014166|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
127558505|NCT00435045|459014167|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
127558506|NCT00435045|459014166|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
128023346|NCT01543503|460710773|FG001|Overall Study|Participant withdrew informed consent|10|||
128023347|NCT01543503|460710772|FG000|Overall Study|Change of jobs|0|||
128023348|NCT01543503|460710773|FG001|Overall Study|Change of jobs|1|||
128023349|NCT01543503|460710772|FG000|Overall Study|Intolerance to the biologic treatment|0|||
128023350|NCT01543503|460710773|FG001|Overall Study|Intolerance to the biologic treatment|1|||
128023351|NCT01543503|460710772|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
128023352|NCT01543503|460710773|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
128023353|NCT01543503|460710772|FG000|Overall Study|Participant did not complete last visit|0|||
128023354|NCT01543503|460710773|FG001|Overall Study|Participant did not complete last visit|2|||
128023355|NCT01543503|460710772|FG000|Overall Study|Refused to continue treatment|7|||
128023356|NCT01543503|460710773|FG001|Overall Study|Refused to continue treatment|0|||
128023357|NCT01543503|460710772|FG000|Overall Study|Incorrect medication received|1|||
128023358|NCT01543503|460710773|FG001|Overall Study|Incorrect medication received|0|||
128023359|NCT01543503|460710772|FG000|Overall Study|Participant moved to another city|2|||
128023360|NCT01543503|460710773|FG001|Overall Study|Participant moved to another city|0|||
128023361|NCT01543503|460710772|FG000|Overall Study|Participant will not return for visits|0|||
128023362|NCT01543503|460710773|FG001|Overall Study|Participant will not return for visits|2|||
128023363|NCT01543503|460710772|FG000|Overall Study|Participant transferred to another city|1|||
128023364|NCT01543503|460710773|FG001|Overall Study|Participant transferred to another city|0|||
128023365|NCT01543503|460710772|FG000|Overall Study|Participant moved to Scotland|1|||
128023366|NCT01543503|460710773|FG001|Overall Study|Participant moved to Scotland|0|||
128023367|NCT01543503|460710772|FG000|Overall Study|Participant decision to stop treatment|1|||
128023368|NCT01543503|460710773|FG001|Overall Study|Participant decision to stop treatment|0|||
128023369|NCT01543503|460710772|FG000|Overall Study|Investigator did not wish to participate|1|||
128023370|NCT01543503|460710773|FG001|Overall Study|Investigator did not wish to participate|1|||
128023371|NCT01543503|460710772|FG000|Overall Study|Participant recruited after closing date|0|||
128023372|NCT01543503|460710773|FG001|Overall Study|Participant recruited after closing date|1|||
128023373|NCT01543503|460710772|FG000|Overall Study|Site stopped participation|5|||
128023374|NCT01543503|460710773|FG001|Overall Study|Site stopped participation|1|||
127558507|NCT00435045|459014167|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
127686116|NCT03312907|459478169|FG002|Overall Study|Physician Decision|2|||
127686117|NCT03312907|459478167|FG000|Overall Study|Withdrawal by Subject|9|||
127686118|NCT03312907|459478168|FG001|Overall Study|Withdrawal by Subject|14|||
127686119|NCT03312907|459478169|FG002|Overall Study|Withdrawal by Subject|10|||
127686120|NCT04723394|459478178|FG000|Overall Study|Adverse Event|0|||
127686121|NCT04723394|459478179|FG001|Overall Study|Adverse Event|3|||
127558508|NCT00435045|459014166|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
127558509|NCT00435045|459014167|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
127558510|NCT00435045|459014166|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
127558511|NCT00435045|459014167|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
127558512|NCT00435045|459014166|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
127558513|NCT00435045|459014167|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
127558514|NCT00435045|459014166|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
127558515|NCT00435045|459014167|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
127558516|NCT00435045|459014166|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
127558517|NCT00435045|459014167|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
127558518|NCT00435045|459014166|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
127558519|NCT00435045|459014167|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
127558520|NCT00435045|459014166|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
127558521|NCT00435045|459014167|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
127558522|NCT00435045|459014166|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
127558523|NCT00435045|459014167|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
127558524|NCT00435045|459014166|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
127558525|NCT00435045|459014167|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
127558526|NCT01297491|459014168|FG000|Overall Study|Adverse Event|11|||
127558527|NCT01297491|459014169|FG001|Overall Study|Adverse Event|6|||
127558528|NCT01297491|459014168|FG000|Overall Study|Physician Decision|3|||
127558529|NCT01297491|459014169|FG001|Overall Study|Physician Decision|2|||
127558530|NCT01297491|459014168|FG000|Overall Study|Progressive disease|11|||
127558531|NCT01297491|459014169|FG001|Overall Study|Progressive disease|20|||
127558532|NCT01297491|459014168|FG000|Overall Study|Patient/Guardian decision|3|||
127558533|NCT01297491|459014169|FG001|Overall Study|Patient/Guardian decision|4|||
127558534|NCT01297491|459014168|FG000|Overall Study|Death|2|||
127558535|NCT01297491|459014169|FG001|Overall Study|Death|1|||
127558536|NCT01015638|459014172|FG000|Overall Study|Withdrawal by Subject|1|||
127558537|NCT01015638|459014173|FG001|Overall Study|Withdrawal by Subject|0|||
127558538|NCT01703754|459014180|FG000|Overall Study|Clinically significant disease progression|2|||
127558539|NCT01703754|459014181|FG001|Overall Study|Clinically significant disease progression|2|||
127558540|NCT01703754|459014182|FG002|Overall Study|Clinically significant disease progression|1|||
127558541|NCT01703754|459014180|FG000|Overall Study|Adverse Event|1|||
127558542|NCT01703754|459014181|FG001|Overall Study|Adverse Event|1|||
127558543|NCT01703754|459014182|FG002|Overall Study|Adverse Event|0|||
127558544|NCT01703754|459014180|FG000|Overall Study|Withdrawal by Subject|2|||
127558545|NCT01703754|459014181|FG001|Overall Study|Withdrawal by Subject|0|||
127558546|NCT01703754|459014182|FG002|Overall Study|Withdrawal by Subject|0|||
127558547|NCT00776919|459014183|FG000|Overall Study|Withdrawal by Subject|16|||
127558548|NCT00776919|459014184|FG001|Overall Study|Withdrawal by Subject|14|||
127558549|NCT00776919|459014185|FG002|Overall Study|Withdrawal by Subject|15|||
127558550|NCT00776919|459014186|FG003|Overall Study|Withdrawal by Subject|26|||
127558551|NCT00776919|459014183|FG000|Overall Study|Lost to Follow-up|8|||
127558552|NCT00776919|459014184|FG001|Overall Study|Lost to Follow-up|12|||
127558553|NCT00776919|459014185|FG002|Overall Study|Lost to Follow-up|11|||
127558554|NCT00776919|459014186|FG003|Overall Study|Lost to Follow-up|8|||
127558555|NCT00776919|459014183|FG000|Overall Study|Adverse Event|1|||
127558556|NCT00776919|459014184|FG001|Overall Study|Adverse Event|0|||
127558557|NCT00776919|459014185|FG002|Overall Study|Adverse Event|2|||
127558558|NCT00776919|459014186|FG003|Overall Study|Adverse Event|2|||
127558559|NCT00776919|459014183|FG000|Overall Study|Protocol Violation|1|||
127558560|NCT00776919|459014184|FG001|Overall Study|Protocol Violation|2|||
127558561|NCT00776919|459014185|FG002|Overall Study|Protocol Violation|0|||
127558562|NCT00776919|459014186|FG003|Overall Study|Protocol Violation|1|||
127558563|NCT00776919|459014183|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
127558564|NCT00776919|459014184|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
127558565|NCT00776919|459014185|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
127558566|NCT00776919|459014186|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
127558567|NCT03179605|459014187|FG000|Overall Study|Withdrawal by Subject|1|||
127558568|NCT00711477|459014188|FG000|Overall Study|Adverse Event|3|||
127558569|NCT00711477|459014189|FG001|Overall Study|Adverse Event|1|||
127558570|NCT00711477|459014188|FG000|Overall Study|Lost to Follow-up|0|||
127558571|NCT00711477|459014189|FG001|Overall Study|Lost to Follow-up|1|||
127558572|NCT00711477|459014188|FG000|Overall Study|Noncompliance|0|||
127558573|NCT00711477|459014189|FG001|Overall Study|Noncompliance|1|||
127558574|NCT02878798|459014190|FG000|Overall Study|Withdrawal by Subject|5|||
127558575|NCT02878798|459014191|FG001|Overall Study|Withdrawal by Subject|4|||
127558576|NCT02878798|459014190|FG000|Overall Study|Lost to Follow-up|2|||
127558577|NCT02878798|459014191|FG001|Overall Study|Lost to Follow-up|2|||
127558578|NCT02878798|459014190|FG000|Overall Study|Protocol Violation|0|||
127558579|NCT02878798|459014191|FG001|Overall Study|Protocol Violation|1|||
127558580|NCT00101452|459014194|FG000|Overall Study|Adverse Event|2|||
127558581|NCT00101452|459014195|FG001|Overall Study|Adverse Event|0|||
127558582|NCT00101452|459014196|FG002|Overall Study|Adverse Event|1|||
127558583|NCT00101452|459014194|FG000|Overall Study|Lost to Follow-up|13|||
127558584|NCT00101452|459014195|FG001|Overall Study|Lost to Follow-up|8|||
127558585|NCT00101452|459014196|FG002|Overall Study|Lost to Follow-up|14|||
127558586|NCT00101452|459014194|FG000|Overall Study|Withdrawal by Subject|10|||
127558587|NCT00101452|459014195|FG001|Overall Study|Withdrawal by Subject|14|||
127558588|NCT00101452|459014196|FG002|Overall Study|Withdrawal by Subject|9|||
127558589|NCT00101452|459014194|FG000|Overall Study|Baseline Fail|2|||
127558590|NCT00101452|459014195|FG001|Overall Study|Baseline Fail|1|||
127558591|NCT00101452|459014196|FG002|Overall Study|Baseline Fail|2|||
127558592|NCT00101452|459014194|FG000|Overall Study|Physician Decision|0|||
127558593|NCT00101452|459014195|FG001|Overall Study|Physician Decision|3|||
127558594|NCT00101452|459014196|FG002|Overall Study|Physician Decision|2|||
127558595|NCT00101452|459014194|FG000|Overall Study|Protocol Violation|2|||
127558596|NCT00101452|459014195|FG001|Overall Study|Protocol Violation|1|||
127558597|NCT00101452|459014196|FG002|Overall Study|Protocol Violation|3|||
127558598|NCT00101452|459014194|FG000|Overall Study|Other|15|||
127558599|NCT00101452|459014195|FG001|Overall Study|Other|16|||
127558600|NCT00101452|459014196|FG002|Overall Study|Other|12|||
127558601|NCT01014910|459014198|FG000|Overall Study|Withdrawal by Subject|0|||
127558602|NCT01014910|459014199|FG001|Overall Study|Withdrawal by Subject|2|||
127558603|NCT00145977|459014200|FG000|Overall Study|Lack of Efficacy|0|||
127558604|NCT00145977|459014201|FG001|Overall Study|Lack of Efficacy|4|||
127558605|NCT00145977|459014200|FG000|Overall Study|Lost to Follow-up|1|||
127558606|NCT00145977|459014201|FG001|Overall Study|Lost to Follow-up|0|||
127558607|NCT00145977|459014200|FG000|Overall Study|Withdrawal by Subject|1|||
127558608|NCT00145977|459014201|FG001|Overall Study|Withdrawal by Subject|0|||
127558609|NCT00782834|459014202|FG000|Treatment Phase|fibrous tumor not GIST|1|||
127558610|NCT02055118|459014203|FG000|Overall Study|Withdrawal by Subject|0|||
127558611|NCT02055118|459014204|FG001|Overall Study|Withdrawal by Subject|2|||
127558612|NCT02055118|459014205|FG002|Overall Study|Withdrawal by Subject|0|||
127558613|NCT02281383|459014206|FG000|Overall Study|Progressive Disease|1|||
127558614|NCT02281383|459014206|FG000|Overall Study|Withdrawal by Subject|6|||
127558615|NCT02281383|459014206|FG000|Overall Study|Protocol Violation|2|||
127558616|NCT02281383|459014206|FG000|Overall Study|Death|1|||
127558617|NCT02281383|459014206|FG000|Overall Study|Adverse Event|2|||
127558618|NCT02259088|459014207|FG000|Overall Study|Adverse Event|6|||
127558619|NCT02259088|459014208|FG001|Overall Study|Adverse Event|4|||
127558620|NCT02259088|459014207|FG000|Overall Study|Lost to Follow-up|2|||
127558621|NCT02259088|459014208|FG001|Overall Study|Lost to Follow-up|0|||
127558622|NCT02259088|459014207|FG000|Overall Study|Death|2|||
127558623|NCT02259088|459014208|FG001|Overall Study|Death|0|||
127558624|NCT02259088|459014207|FG000|Overall Study|Physician Decision|5|||
127558625|NCT02259088|459014208|FG001|Overall Study|Physician Decision|2|||
127558626|NCT02259088|459014207|FG000|Overall Study|Protocol deviation|5|||
127558627|NCT02259088|459014208|FG001|Overall Study|Protocol deviation|0|||
127558628|NCT02259088|459014207|FG000|Overall Study|Subject/guardian decision|8|||
127558629|NCT02259088|459014208|FG001|Overall Study|Subject/guardian decision|8|||
127558630|NCT02560025|459014211|FG000|Overall Study|Ineligible after consent/ registration|3|||
127558631|NCT02703337|459014212|FG000|Period One (Part A)|Withdrawal by Subject|0|||
127558632|NCT02703337|459014213|FG001|Period One (Part A)|Withdrawal by Subject|0|||
127558633|NCT02703337|459014214|FG002|Period One (Part A)|Withdrawal by Subject|0|||
127558634|NCT02703337|459014215|FG003|Period One (Part A)|Withdrawal by Subject|0|||
127558635|NCT02703337|459014216|FG004|Period One (Part A)|Withdrawal by Subject|1|||
127558636|NCT02703337|459014217|FG005|Period One (Part A)|Withdrawal by Subject|0|||
127558637|NCT02703337|459014218|FG006|Period One (Part A)|Withdrawal by Subject|0|||
127558638|NCT02703337|459014219|FG007|Period One (Part A)|Withdrawal by Subject|0|||
127558639|NCT00282308|459014220|FG000|Treatment Period|Lost to Follow-up|1|||
127558640|NCT00282308|459014221|FG001|Treatment Period|Lost to Follow-up|0|||
127558641|NCT00282308|459014222|FG002|Treatment Period|Lost to Follow-up|0|||
127558642|NCT00282308|459014220|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
127558643|NCT00282308|459014221|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
127558644|NCT00282308|459014222|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
127558645|NCT00282308|459014220|FG000|Treatment Period|Adverse Event|0|||
127558646|NCT00282308|459014221|FG001|Treatment Period|Adverse Event|2|||
127558647|NCT00282308|459014222|FG002|Treatment Period|Adverse Event|0|||
127558648|NCT00282308|459014220|FG000|Treatment Period|Not Treated with Study Drug|1|||
128023375|NCT01543503|460710772|FG000|Overall Study|Participant did not attend a visit|1|||
128023376|NCT01543503|460710773|FG001|Overall Study|Participant did not attend a visit|0|||
127558649|NCT00282308|459014221|FG001|Treatment Period|Not Treated with Study Drug|0|||
127558650|NCT00282308|459014222|FG002|Treatment Period|Not Treated with Study Drug|0|||
127558651|NCT00282308|459014220|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
127686122|NCT04723394|459478178|FG000|Overall Study|Death|8|||
127686123|NCT04723394|459478179|FG001|Overall Study|Death|8|||
127686124|NCT04723394|459478178|FG000|Overall Study|Lost to Follow-up|20|||
127686125|NCT04723394|459478179|FG001|Overall Study|Lost to Follow-up|17|||
128023377|NCT01543503|460710772|FG000|Overall Study|Moved to other rheumatologic site|0|||
128023378|NCT01543503|460710773|FG001|Overall Study|Moved to other rheumatologic site|1|||
128023379|NCT01543503|460710772|FG000|Overall Study|Participant consented to another study|0|||
128023380|NCT01543503|460710773|FG001|Overall Study|Participant consented to another study|2|||
127558652|NCT00282308|459014221|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
127558653|NCT00282308|459014222|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
127558654|NCT00282308|459014220|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
127558655|NCT00282308|459014221|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
127558656|NCT00282308|459014222|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
127558657|NCT00282308|459014220|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
127558658|NCT00282308|459014221|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
127558659|NCT00282308|459014222|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
127558660|NCT00282308|459014220|FG000|Safety Follow-up Period|Adverse Event|0|||
127558661|NCT00282308|459014221|FG001|Safety Follow-up Period|Adverse Event|0|||
127558662|NCT00282308|459014222|FG002|Safety Follow-up Period|Adverse Event|1|||
127558663|NCT00282308|459014220|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
127558664|NCT00282308|459014221|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
127558665|NCT00282308|459014222|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
127558666|NCT00282308|459014220|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
127558667|NCT00282308|459014221|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
127558668|NCT00282308|459014222|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
127558669|NCT00282308|459014220|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
127558670|NCT00282308|459014221|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
127558671|NCT00282308|459014222|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
127558672|NCT02872285|459014223|FG000|Overall Study|Withdrawal by Subject|2|||
127558673|NCT02872285|459014224|FG001|Overall Study|Withdrawal by Subject|0|||
127558674|NCT02872285|459014223|FG000|Overall Study|Lost to Follow-up|2|||
127558675|NCT02872285|459014224|FG001|Overall Study|Lost to Follow-up|2|||
127558676|NCT02872285|459014223|FG000|Overall Study|Discontinued due to back surgery|1|||
127558677|NCT02872285|459014224|FG001|Overall Study|Discontinued due to back surgery|0|||
127558678|NCT03425253|459014225|FG000|Overall Study|Adverse Event|2|||
127558679|NCT03425253|459014225|FG000|Overall Study|Lost to Follow-up|3|||
127558680|NCT03425253|459014225|FG000|Overall Study|Withdrew Consent|6|||
127558681|NCT03425253|459014225|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
127558682|NCT04129151|459015681|FG000|Overall Study|Adverse Event|1|||
127558683|NCT04129151|459015681|FG000|Overall Study|Disease Progression|7|||
127558684|NCT04129151|459015681|FG000|Overall Study|Study closure|1|||
127558685|NCT01311024|459015683|FG000|Overall Study|Protocol Violation|35|||
127558686|NCT01311024|459015684|FG001|Overall Study|Protocol Violation|22|||
127558687|NCT01523275|459015685|FG000|Overall Study|Lost to Follow-up|1|||
127558688|NCT01523275|459015686|FG001|Overall Study|Lost to Follow-up|2|||
127558689|NCT01523275|459015685|FG000|Overall Study|Withdrawal by Subject|1|||
127558690|NCT01523275|459015686|FG001|Overall Study|Withdrawal by Subject|0|||
127558691|NCT00689117|459015687|FG000|Overall Study|Adverse Event|6|||
127558692|NCT00689117|459015688|FG001|Overall Study|Adverse Event|0|||
127558693|NCT00689117|459015689|FG002|Overall Study|Adverse Event|5|||
127558694|NCT00689117|459015690|FG003|Overall Study|Adverse Event|0|||
127558695|NCT00689117|459015687|FG000|Overall Study|Lost to Follow-up|26|||
127558696|NCT00689117|459015688|FG001|Overall Study|Lost to Follow-up|19|||
127558697|NCT00689117|459015689|FG002|Overall Study|Lost to Follow-up|17|||
127558698|NCT00689117|459015690|FG003|Overall Study|Lost to Follow-up|11|||
127558699|NCT00689117|459015687|FG000|Overall Study|Lack of Efficacy|1|||
127558700|NCT00689117|459015688|FG001|Overall Study|Lack of Efficacy|2|||
127558701|NCT00689117|459015689|FG002|Overall Study|Lack of Efficacy|2|||
127558702|NCT00689117|459015690|FG003|Overall Study|Lack of Efficacy|2|||
127774474|NCT00162032|459800335|FG000|Overall Study|Lost to Follow-up|4|||
127774475|NCT00162032|459800336|FG001|Overall Study|Lost to Follow-up|2|||
127774476|NCT00162032|459800335|FG000|Overall Study|Reason not specified|1|||
127774477|NCT00162032|459800336|FG001|Overall Study|Reason not specified|0|||
127558703|NCT00689117|459015687|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
127774478|NCT00833911|459800337|FG000|Titration|Adverse Event|18|||
127774479|NCT00833911|459800337|FG000|Titration|Withdrawal by Subject|3|||
127774480|NCT00833911|459800337|FG000|Maintenance Phase I|Adverse Event|73|||
127774481|NCT00833911|459800337|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
127774482|NCT00833911|459800337|FG000|Maintenance Phase I|Physician Decision|10|||
127774483|NCT00833911|459800337|FG000|Maintenance Phase I|Lack of Efficacy|4|||
127774484|NCT00833911|459800337|FG000|Maintenance Phase II|Adverse Event|6|||
127774485|NCT00833911|459800337|FG000|Maintenance Phase II|Physician Decision|2|||
127774486|NCT00833911|459800337|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
127774487|NCT00833911|459800337|FG000|Maintenance Phase II|Lack of Efficacy|1|||
127558704|NCT00689117|459015688|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
127774488|NCT01137955|459800338|FG000|Overall Study|Withdrawal by Subject|5|||
127774489|NCT01137955|459800339|FG001|Overall Study|Withdrawal by Subject|4|||
127774490|NCT00216203|459800342|FG000|Overall Study|Withdrawal by Subject|2|||
127558705|NCT00689117|459015689|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
127558706|NCT00689117|459015690|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
127558707|NCT00689117|459015687|FG000|Overall Study|Withdrawal by Subject|19|||
127558708|NCT00689117|459015688|FG001|Overall Study|Withdrawal by Subject|18|||
127558709|NCT00689117|459015689|FG002|Overall Study|Withdrawal by Subject|26|||
127558710|NCT00689117|459015690|FG003|Overall Study|Withdrawal by Subject|13|||
127774491|NCT01324323|459800343|FG000|Overall Study|Withdrawal by Subject|1|||
127558711|NCT00689117|459015687|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
127558712|NCT00689117|459015688|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
127558713|NCT00689117|459015689|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
127558714|NCT00689117|459015690|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
127558715|NCT00689117|459015687|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
127558716|NCT00689117|459015688|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
127558717|NCT00689117|459015689|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
127558718|NCT00689117|459015690|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
127558719|NCT00689117|459015687|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
127558720|NCT00689117|459015688|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
127558721|NCT00689117|459015689|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
127558722|NCT00689117|459015690|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
127558723|NCT00689117|459015687|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
127558724|NCT00689117|459015688|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
127558725|NCT00689117|459015689|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
127558726|NCT00689117|459015690|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
127558727|NCT00689117|459015687|FG000|Overall Study|Use of Prohibitive Medication|2|||
127558728|NCT00689117|459015688|FG001|Overall Study|Use of Prohibitive Medication|1|||
127558729|NCT00689117|459015689|FG002|Overall Study|Use of Prohibitive Medication|3|||
127558730|NCT00689117|459015690|FG003|Overall Study|Use of Prohibitive Medication|0|||
127558731|NCT00689117|459015687|FG000|Overall Study|Pregnancy|0|||
127558732|NCT00689117|459015688|FG001|Overall Study|Pregnancy|2|||
127558733|NCT00689117|459015689|FG002|Overall Study|Pregnancy|0|||
127558734|NCT00689117|459015690|FG003|Overall Study|Pregnancy|2|||
127558735|NCT00689117|459015687|FG000|Overall Study|Incarceration|2|||
127558736|NCT00689117|459015688|FG001|Overall Study|Incarceration|0|||
127558737|NCT00689117|459015689|FG002|Overall Study|Incarceration|0|||
127558738|NCT00689117|459015690|FG003|Overall Study|Incarceration|0|||
127558739|NCT00689117|459015687|FG000|Overall Study|Fear of Birth Defects|0|||
127558740|NCT00689117|459015688|FG001|Overall Study|Fear of Birth Defects|0|||
127558741|NCT00689117|459015689|FG002|Overall Study|Fear of Birth Defects|1|||
127558742|NCT00689117|459015690|FG003|Overall Study|Fear of Birth Defects|0|||
127558743|NCT00689117|459015687|FG000|Overall Study|Transportation|1|||
127558744|NCT00689117|459015688|FG001|Overall Study|Transportation|0|||
127558745|NCT00689117|459015689|FG002|Overall Study|Transportation|0|||
127558746|NCT00689117|459015690|FG003|Overall Study|Transportation|0|||
127558747|NCT00689117|459015687|FG000|Overall Study|Patient Withdrew from Study|0|||
127558748|NCT00689117|459015688|FG001|Overall Study|Patient Withdrew from Study|0|||
127558749|NCT00689117|459015689|FG002|Overall Study|Patient Withdrew from Study|0|||
127558750|NCT00689117|459015690|FG003|Overall Study|Patient Withdrew from Study|1|||
127558751|NCT00689117|459015687|FG000|Overall Study|Personal Reason|0|||
127558752|NCT00689117|459015688|FG001|Overall Study|Personal Reason|1|||
127558753|NCT00689117|459015689|FG002|Overall Study|Personal Reason|0|||
127558754|NCT00689117|459015690|FG003|Overall Study|Personal Reason|0|||
127558755|NCT00689117|459015687|FG000|Overall Study|Dispensing Error|0|||
127558756|NCT00689117|459015688|FG001|Overall Study|Dispensing Error|1|||
127558757|NCT00689117|459015689|FG002|Overall Study|Dispensing Error|0|||
127558758|NCT00689117|459015690|FG003|Overall Study|Dispensing Error|0|||
127558759|NCT01206322|459015691|FG000|Overall Study|Adverse Event|0|||
127558760|NCT01206322|459015692|FG001|Overall Study|Adverse Event|0|||
127558761|NCT01206322|459015693|FG002|Overall Study|Adverse Event|0|||
127558762|NCT01206322|459015694|FG003|Overall Study|Adverse Event|1|||
127558763|NCT01989208|459015705|FG000|200 mg (7 Days)|Protocol Violation|0|||
127558764|NCT01989208|459015706|FG001|200 mg (7 Days)|Protocol Violation|1|||
127558765|NCT04973436|459015707|FG000|Overall Study|Lost to Follow-up|3|||
127558766|NCT04973436|459015707|FG000|Overall Study|Withdrawal by Subject|1|||
127774492|NCT03153137|459800344|FG000|Overall Study|Lost to Follow-up|1|||
127774493|NCT03153137|459800345|FG001|Overall Study|Lost to Follow-up|0|||
127774494|NCT03153137|459800344|FG000|Overall Study|Withdrawal by Subject|2|||
127774495|NCT03153137|459800345|FG001|Overall Study|Withdrawal by Subject|1|||
127774496|NCT03153137|459800344|FG000|Overall Study|Physician Decision|0|||
127774497|NCT03153137|459800345|FG001|Overall Study|Physician Decision|3|||
127558767|NCT04973436|459015707|FG000|Overall Study|Death|2|||
127558768|NCT00566696|459015708|FG000|Overall Study|Met Exclusion Criteria|2|||
127558769|NCT00566696|459015708|FG000|Overall Study|Muromonab not available|1|||
127558770|NCT00566696|459015708|FG000|Overall Study|Health Status Change|1|||
127558771|NCT00566696|459015708|FG000|Overall Study|Physician Decision|1|||
127774498|NCT00993915|459800352|FG000|Overall Study|Insufficient clinical response|3|||
127558772|NCT00566696|459015708|FG000|Overall Study|Non-Patient Donors|37|||
127558773|NCT06338462|459015709|FG000|Overall Study|No intervention received due to inaccurate contact info, no WhatsApp, no internet, or no smartphone|52|||
127558774|NCT02872935|459015713|FG000|Overall Study|Other|0|||
127558775|NCT02872935|459015714|FG001|Overall Study|Other|1|||
127558776|NCT01276054|459015718|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
127774499|NCT00993915|459800352|FG000|Overall Study|Withdrawal by Subject|2|||
127774500|NCT00993915|459800352|FG000|Overall Study|Other|1|||
127774501|NCT00993915|459800352|FG000|Overall Study|Ongoing|3|||
127774502|NCT04209621|459800360|FG000|Overall Study|Death|1|||
127774503|NCT04209621|459800360|FG000|Overall Study|Study Terminated Early|2|||
127774504|NCT02249767|459800361|FG000|Overall Study|Did not use medication|8|||
127774505|NCT02249767|459800362|FG001|Overall Study|Did not use medication|9|||
127774506|NCT02249767|459800363|FG002|Overall Study|Did not use medication|8|||
127774507|NCT01372410|459800364|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
127774508|NCT01372410|459800365|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
127774509|NCT01372410|459800366|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
127774510|NCT01372410|459800367|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
127774511|NCT01372410|459800368|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
127774512|NCT01372410|459800369|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
127774513|NCT01372410|459800370|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
127774514|NCT01372410|459800371|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
127774515|NCT01372410|459800364|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
127774516|NCT01372410|459800365|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
127558777|NCT01276054|459015719|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
127774517|NCT01372410|459800366|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
127774518|NCT01372410|459800367|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
127774519|NCT01372410|459800368|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
127774520|NCT01372410|459800369|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
127774521|NCT01372410|459800370|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
127774522|NCT01372410|459800371|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
127774523|NCT01372410|459800364|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
127774524|NCT01372410|459800365|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
127774525|NCT01372410|459800366|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
127774526|NCT01372410|459800367|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
127774527|NCT01372410|459800368|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
127774528|NCT01372410|459800369|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
127774529|NCT01372410|459800370|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
127774530|NCT01372410|459800371|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
127774531|NCT01372410|459800364|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
127774532|NCT01372410|459800365|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
127774533|NCT01372410|459800366|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
127774534|NCT01372410|459800367|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
127774535|NCT01372410|459800368|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
127774536|NCT01372410|459800369|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
127774537|NCT01372410|459800370|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
127774538|NCT01372410|459800371|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
127774539|NCT01372410|459800364|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
128023381|NCT01543503|460710772|FG000|Overall Study|Participant went to United States|1|||
127558778|NCT02792829|459015720|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
127558779|NCT02792829|459015721|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
127558780|NCT02792829|459015722|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
127558781|NCT02792829|459015723|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
127558782|NCT02792829|459015724|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
127558783|NCT02792829|459015725|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
127558784|NCT02792829|459015726|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
127558785|NCT02792829|459015727|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
127558786|NCT02792829|459015720|FG000|Treatment Period 2|Adverse Event|0|||
127558787|NCT02792829|459015721|FG001|Treatment Period 2|Adverse Event|0|||
127558788|NCT02792829|459015722|FG002|Treatment Period 2|Adverse Event|0|||
127558789|NCT02792829|459015723|FG003|Treatment Period 2|Adverse Event|0|||
127558790|NCT02792829|459015724|FG004|Treatment Period 2|Adverse Event|1|||
127558791|NCT02792829|459015725|FG005|Treatment Period 2|Adverse Event|0|||
127558792|NCT02792829|459015726|FG006|Treatment Period 2|Adverse Event|1|||
127558793|NCT02792829|459015727|FG007|Treatment Period 2|Adverse Event|1|||
127558794|NCT02792829|459015720|FG000|Treatment Period 2|Use of proscribed medications|0|||
127558795|NCT02792829|459015721|FG001|Treatment Period 2|Use of proscribed medications|0|||
127558796|NCT02792829|459015722|FG002|Treatment Period 2|Use of proscribed medications|0|||
127558797|NCT02792829|459015723|FG003|Treatment Period 2|Use of proscribed medications|0|||
127558798|NCT02792829|459015724|FG004|Treatment Period 2|Use of proscribed medications|0|||
127558799|NCT02792829|459015725|FG005|Treatment Period 2|Use of proscribed medications|0|||
127558800|NCT02792829|459015726|FG006|Treatment Period 2|Use of proscribed medications|0|||
127558801|NCT02792829|459015727|FG007|Treatment Period 2|Use of proscribed medications|1|||
127558802|NCT00452361|459015728|FG000|Overall Study|Adverse Event|8|||
127558803|NCT00452361|459015729|FG001|Overall Study|Adverse Event|0|||
127774540|NCT01372410|459800365|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
127774541|NCT01372410|459800366|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
127774542|NCT01372410|459800367|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
127558804|NCT00452361|459015728|FG000|Overall Study|Withdrawal by Subject|0|||
127558805|NCT00452361|459015729|FG001|Overall Study|Withdrawal by Subject|1|||
127558806|NCT00452361|459015728|FG000|Overall Study|Premature termination|13|||
127558807|NCT00452361|459015729|FG001|Overall Study|Premature termination|9|||
127558808|NCT03116152|459015732|FG000|Overall Study|Disease Progression|49|||
127558809|NCT03116152|459015733|FG001|Overall Study|Disease Progression|47|||
127558810|NCT03116152|459015732|FG000|Overall Study|Death|5|||
127558811|NCT03116152|459015733|FG001|Overall Study|Death|2|||
127558812|NCT03116152|459015732|FG000|Overall Study|Adverse Event|21|||
127558813|NCT03116152|459015733|FG001|Overall Study|Adverse Event|7|||
127558814|NCT03116152|459015732|FG000|Overall Study|Protocol Violation|2|||
127558815|NCT03116152|459015733|FG001|Overall Study|Protocol Violation|2|||
127558816|NCT03116152|459015732|FG000|Overall Study|Withdrawal by Subject|0|||
127558817|NCT03116152|459015733|FG001|Overall Study|Withdrawal by Subject|1|||
127558818|NCT03116152|459015732|FG000|Overall Study|Physician Decision|3|||
127558819|NCT03116152|459015733|FG001|Overall Study|Physician Decision|2|||
127558820|NCT03116152|459015732|FG000|Overall Study|other|11|||
127558821|NCT03116152|459015733|FG001|Overall Study|other|34|||
127558822|NCT02379637|459015734|FG000|Overall Study|Protocol Violation|0|||
127558823|NCT02379637|459015735|FG001|Overall Study|Protocol Violation|1|||
127558824|NCT02379637|459015734|FG000|Overall Study|Adverse Event|1|||
127558825|NCT02379637|459015735|FG001|Overall Study|Adverse Event|0|||
127558826|NCT02379637|459015734|FG000|Overall Study|Withdrawal by Subject|1|||
127558827|NCT02379637|459015735|FG001|Overall Study|Withdrawal by Subject|0|||
127558828|NCT00862641|459015736|FG000|Overall Study|Randomized, but drug not received|1|||
127558829|NCT00862641|459015737|FG001|Overall Study|Randomized, but drug not received|4|||
127558830|NCT00862641|459015738|FG002|Overall Study|Randomized, but drug not received|1|||
127558831|NCT00862641|459015739|FG003|Overall Study|Randomized, but drug not received|4|||
127558832|NCT00228553|459015743|FG000|Overall Study|Adverse Event|112|||
127558833|NCT00228553|459015743|FG000|Overall Study|Lack of Efficacy|34|||
127558834|NCT00228553|459015743|FG000|Overall Study|Lost to Follow-up|67|||
127558835|NCT00228553|459015743|FG000|Overall Study|Physician Decision|48|||
127558836|NCT00228553|459015743|FG000|Overall Study|Protocol Violation|6|||
127558837|NCT00228553|459015743|FG000|Overall Study|Withdrawal by Subject|115|||
127558838|NCT00228553|459015743|FG000|Overall Study|Pregnancy|2|||
127558839|NCT00228553|459015743|FG000|Overall Study|Miscellaneous|46|||
127686126|NCT04723394|459478178|FG000|Overall Study|Physician Decision|1|||
127686127|NCT04723394|459478179|FG001|Overall Study|Physician Decision|0|||
127686128|NCT04723394|459478178|FG000|Overall Study|Withdrawal by Subject|20|||
127558840|NCT02873429|459015744|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
127558841|NCT02873429|459015745|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
127558842|NCT02873429|459015744|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
127558843|NCT02873429|459015745|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
127558844|NCT02873429|459015744|FG000|16 Weeks|Lost to Follow-up|3|||
127558845|NCT02873429|459015745|FG001|16 Weeks|Lost to Follow-up|0|||
127558846|NCT05477108|459015746|FG000|Overall Study|Participants randomized, not treated|1|||
127686129|NCT04723394|459478179|FG001|Overall Study|Withdrawal by Subject|34|||
127686130|NCT04723394|459478178|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
127686131|NCT04723394|459478179|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
127686132|NCT00774397|459478180|FG000|Overall Study|Adverse Event|1|||
127686133|NCT00774397|459478181|FG001|Overall Study|Adverse Event|3|||
127686134|NCT00774397|459478182|FG002|Overall Study|Adverse Event|16|||
127686135|NCT00774397|459478183|FG003|Overall Study|Adverse Event|8|||
127686136|NCT00774397|459478184|FG004|Overall Study|Adverse Event|8|||
127686137|NCT00774397|459478185|FG005|Overall Study|Adverse Event|3|||
127686138|NCT00774397|459478186|FG006|Overall Study|Adverse Event|16|||
127686139|NCT00774397|459478180|FG000|Overall Study|Lack of Efficacy|11|||
127686140|NCT00774397|459478181|FG001|Overall Study|Lack of Efficacy|4|||
127686141|NCT00774397|459478182|FG002|Overall Study|Lack of Efficacy|5|||
127686142|NCT00774397|459478183|FG003|Overall Study|Lack of Efficacy|3|||
127686143|NCT00774397|459478184|FG004|Overall Study|Lack of Efficacy|27|||
127686144|NCT00774397|459478185|FG005|Overall Study|Lack of Efficacy|15|||
127686145|NCT00774397|459478186|FG006|Overall Study|Lack of Efficacy|9|||
127686146|NCT00774397|459478180|FG000|Overall Study|Protocol Violation|0|||
127686147|NCT00774397|459478181|FG001|Overall Study|Protocol Violation|1|||
127686148|NCT00774397|459478182|FG002|Overall Study|Protocol Violation|3|||
127686149|NCT00774397|459478183|FG003|Overall Study|Protocol Violation|1|||
127686150|NCT00774397|459478184|FG004|Overall Study|Protocol Violation|2|||
127686151|NCT00774397|459478185|FG005|Overall Study|Protocol Violation|1|||
127774543|NCT01372410|459800368|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
127558847|NCT05477108|459015747|FG001|Overall Study|Participants randomized, not treated|1|||
127558848|NCT05477108|459015748|FG002|Overall Study|Participants randomized, not treated|1|||
127558849|NCT05477108|459015746|FG000|Overall Study|Physician Decision|0|||
127686152|NCT00774397|459478186|FG006|Overall Study|Protocol Violation|0|||
127558850|NCT05477108|459015747|FG001|Overall Study|Physician Decision|0|||
128023382|NCT01543503|460710773|FG001|Overall Study|Participant went to United States|0|||
128023383|NCT01543503|460710772|FG000|Overall Study|Screen failure|1|||
128023384|NCT01543503|460710773|FG001|Overall Study|Screen failure|0|||
128023385|NCT01210443|460710780|FG000|Overall Study|Study terminated by sponsor|2|||
128023386|NCT01309100|460710781|FG000|Overall Study|Protocol Violation|1|||
128023387|NCT01309100|460710781|FG000|Overall Study|Positive Slit lamp finding|1|||
128023388|NCT03808909|460710783|FG000|Overall Study|Lost to Follow-up|3|||
128023389|NCT03808909|460710784|FG001|Overall Study|Lost to Follow-up|0|||
128023390|NCT01084135|460710785|FG000|20 Week|Physician Decision|0|||
128023391|NCT01084135|460710786|FG001|20 Week|Physician Decision|1|||
128023392|NCT03335566|460710787|FG000|Overall Study|Adverse Event|0|||
128023393|NCT03335566|460710788|FG001|Overall Study|Adverse Event|1|||
128023394|NCT03335566|460710787|FG000|Overall Study|Lost to Follow-up|1|||
128023395|NCT03335566|460710788|FG001|Overall Study|Lost to Follow-up|0|||
128023396|NCT03335566|460710787|FG000|Overall Study|Technical Problems|1|||
128023397|NCT03335566|460710788|FG001|Overall Study|Technical Problems|0|||
128023398|NCT03335566|460710787|FG000|Overall Study|Protocol Violation|1|||
128023399|NCT03335566|460710788|FG001|Overall Study|Protocol Violation|0|||
128023400|NCT03335566|460710787|FG000|Overall Study|Other than specified above|1|||
128023401|NCT03335566|460710788|FG001|Overall Study|Other than specified above|2|||
128023402|NCT00663351|460710789|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
128023403|NCT00663351|460710790|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
128023404|NCT00663351|460710789|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
128023405|NCT00663351|460710790|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
128023406|NCT00663351|460710789|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
128023407|NCT00663351|460710790|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
128023408|NCT00663351|460710789|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
128023409|NCT00663351|460710790|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
128023410|NCT00663351|460710789|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
128023411|NCT00663351|460710790|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
128023412|NCT00663351|460710789|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
128023413|NCT00663351|460710790|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
128023414|NCT00545948|460710791|FG000|Overall Study|Not Treated|1|||
128023415|NCT00545948|460710792|FG001|Overall Study|Not Treated|1|||
128023416|NCT00545948|460710793|FG002|Overall Study|Not Treated|7|||
128023417|NCT03467945|460710794|FG000|Treatment Period 2|Withdrawal by Subject|0|||
128023418|NCT03467945|460710795|FG001|Treatment Period 2|Withdrawal by Subject|1|||
128023419|NCT03467945|460710796|FG002|Treatment Period 2|Withdrawal by Subject|0|||
128023420|NCT03467945|460710797|FG003|Treatment Period 2|Withdrawal by Subject|0|||
128023421|NCT03467945|460710794|FG000|Treatment Period 3|Withdrawal by Subject|1|||
128023422|NCT03467945|460710795|FG001|Treatment Period 3|Withdrawal by Subject|0|||
128023423|NCT03467945|460710796|FG002|Treatment Period 3|Withdrawal by Subject|2|||
128023424|NCT03467945|460710797|FG003|Treatment Period 3|Withdrawal by Subject|1|||
128023425|NCT02975700|460710800|FG000|Overall Study|Adverse Event|1|||
128023426|NCT02975700|460710800|FG000|Overall Study|Progressive disease|3|||
128023427|NCT02975700|460710800|FG000|Overall Study|Failed screening criteria|2|||
128023428|NCT05660538|460710802|FG000|Overall Study|Adverse Event|0|||
128023429|NCT05660538|460710803|FG001|Overall Study|Adverse Event|0|||
128023430|NCT05660538|460710804|FG002|Overall Study|Adverse Event|1|||
128023431|NCT05660538|460710805|FG003|Overall Study|Adverse Event|0|||
128023432|NCT05660538|460710802|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
128023433|NCT05660538|460710803|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
128023434|NCT05660538|460710804|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
128023435|NCT05660538|460710805|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
128023436|NCT05660538|460710802|FG000|Overall Study|Lost to Follow-up|0|||
128023437|NCT05660538|460710803|FG001|Overall Study|Lost to Follow-up|0|||
128023438|NCT05660538|460710804|FG002|Overall Study|Lost to Follow-up|1|||
128023439|NCT05660538|460710805|FG003|Overall Study|Lost to Follow-up|1|||
128023440|NCT05660538|460710802|FG000|Overall Study|Death|0|||
128023441|NCT05660538|460710803|FG001|Overall Study|Death|0|||
128023442|NCT05660538|460710804|FG002|Overall Study|Death|1|||
128023443|NCT05660538|460710805|FG003|Overall Study|Death|0|||
128023444|NCT05660538|460710802|FG000|Overall Study|Physician Decision|0|||
127686153|NCT00774397|459478180|FG000|Overall Study|Lost to Follow-up|0|||
127686154|NCT00774397|459478181|FG001|Overall Study|Lost to Follow-up|1|||
127686155|NCT00774397|459478182|FG002|Overall Study|Lost to Follow-up|1|||
127686156|NCT00774397|459478183|FG003|Overall Study|Lost to Follow-up|1|||
127686157|NCT00774397|459478184|FG004|Overall Study|Lost to Follow-up|0|||
128023445|NCT05660538|460710803|FG001|Overall Study|Physician Decision|0|||
128023446|NCT05660538|460710804|FG002|Overall Study|Physician Decision|0|||
128023447|NCT05660538|460710805|FG003|Overall Study|Physician Decision|1|||
128023448|NCT05660538|460710802|FG000|Overall Study|Sponsor Decision|1|||
127686158|NCT00774397|459478185|FG005|Overall Study|Lost to Follow-up|1|||
128023449|NCT05660538|460710803|FG001|Overall Study|Sponsor Decision|0|||
128023450|NCT05660538|460710804|FG002|Overall Study|Sponsor Decision|0|||
128023451|NCT05660538|460710805|FG003|Overall Study|Sponsor Decision|0|||
127558851|NCT05477108|459015748|FG002|Overall Study|Physician Decision|1|||
127558852|NCT05477108|459015746|FG000|Overall Study|withdrawn from study|0|||
127558853|NCT05477108|459015747|FG001|Overall Study|withdrawn from study|0|||
127558854|NCT05477108|459015748|FG002|Overall Study|withdrawn from study|1|||
127558855|NCT02660983|459015749|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
127558856|NCT02660983|459015750|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
127558857|NCT02660983|459015749|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
127558858|NCT02660983|459015750|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
127558859|NCT02660983|459015749|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
127558860|NCT02660983|459015750|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
127558861|NCT02660983|459015749|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
127558862|NCT02660983|459015750|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
127558863|NCT02660983|459015749|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
127558864|NCT02660983|459015750|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
127558865|NCT02660983|459015749|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
127558866|NCT02660983|459015750|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
127558867|NCT02660983|459015749|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
127558868|NCT02660983|459015750|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
127558869|NCT01165216|459015758|FG000|Overall Study|Adverse Event|6|||
127558870|NCT01165216|459015759|FG001|Overall Study|Adverse Event|3|||
127558871|NCT01165216|459015758|FG000|Overall Study|Withdrawal by Subject|1|||
127558872|NCT01165216|459015759|FG001|Overall Study|Withdrawal by Subject|1|||
127558873|NCT01165216|459015758|FG000|Overall Study|Disease progression|1|||
127558874|NCT01165216|459015759|FG001|Overall Study|Disease progression|3|||
127558875|NCT04303195|459015761|FG000|Overall Study|Adverse Event|1|||
127558876|NCT04303195|459015762|FG001|Overall Study|Adverse Event|3|||
127558877|NCT04303195|459015763|FG002|Overall Study|Adverse Event|7|||
127558878|NCT04303195|459015764|FG003|Overall Study|Adverse Event|0|||
127558879|NCT04303195|459015761|FG000|Overall Study|Lost to Follow-up|1|||
127558880|NCT04303195|459015762|FG001|Overall Study|Lost to Follow-up|0|||
127558881|NCT04303195|459015763|FG002|Overall Study|Lost to Follow-up|1|||
127558882|NCT04303195|459015764|FG003|Overall Study|Lost to Follow-up|4|||
127558883|NCT04303195|459015761|FG000|Overall Study|Withdrawal by Subject|3|||
127558884|NCT04303195|459015762|FG001|Overall Study|Withdrawal by Subject|1|||
127558885|NCT04303195|459015763|FG002|Overall Study|Withdrawal by Subject|1|||
127558886|NCT04303195|459015764|FG003|Overall Study|Withdrawal by Subject|1|||
127558887|NCT04303195|459015761|FG000|Overall Study|No study drug administered or protocol deviation|0|||
127558888|NCT04303195|459015762|FG001|Overall Study|No study drug administered or protocol deviation|2|||
127558889|NCT04303195|459015763|FG002|Overall Study|No study drug administered or protocol deviation|0|||
127558890|NCT04303195|459015764|FG003|Overall Study|No study drug administered or protocol deviation|2|||
127558891|NCT06457204|459015765|FG000|Washout|Adverse Event|0|||
127558892|NCT06457204|459015766|FG001|Washout|Adverse Event|2|||
127558893|NCT01065454|459015767|FG000|Treatment|Adverse Event|7|||
127558894|NCT01065454|459015768|FG001|Treatment|Adverse Event|4|||
127558895|NCT01065454|459015769|FG002|Treatment|Adverse Event|3|||
127558896|NCT01065454|459015770|FG003|Treatment|Adverse Event|6|||
127558897|NCT01065454|459015767|FG000|Treatment|Death|1|||
127558898|NCT01065454|459015768|FG001|Treatment|Death|0|||
127558899|NCT01065454|459015769|FG002|Treatment|Death|0|||
127558900|NCT01065454|459015770|FG003|Treatment|Death|0|||
127558901|NCT01065454|459015767|FG000|Treatment|Non-compliance|1|||
127558902|NCT01065454|459015768|FG001|Treatment|Non-compliance|0|||
127558903|NCT01065454|459015769|FG002|Treatment|Non-compliance|0|||
127558904|NCT01065454|459015770|FG003|Treatment|Non-compliance|1|||
127558905|NCT01065454|459015767|FG000|Treatment|Protocol Decision|0|||
127558906|NCT01065454|459015768|FG001|Treatment|Protocol Decision|0|||
127558907|NCT01065454|459015769|FG002|Treatment|Protocol Decision|3|||
127558908|NCT01065454|459015770|FG003|Treatment|Protocol Decision|2|||
127558909|NCT01065454|459015767|FG000|Treatment|Protocol Violation|1|||
127558910|NCT01065454|459015768|FG001|Treatment|Protocol Violation|0|||
127558911|NCT01065454|459015769|FG002|Treatment|Protocol Violation|1|||
127558912|NCT01065454|459015770|FG003|Treatment|Protocol Violation|0|||
127558913|NCT01065454|459015767|FG000|Treatment|Withdrawal by Subject|3|||
127558914|NCT01065454|459015768|FG001|Treatment|Withdrawal by Subject|1|||
127686159|NCT00774397|459478186|FG006|Overall Study|Lost to Follow-up|0|||
127686160|NCT00774397|459478180|FG000|Overall Study|Refused to continue trial medication|1|||
127558915|NCT01065454|459015769|FG002|Treatment|Withdrawal by Subject|2|||
127558916|NCT01065454|459015770|FG003|Treatment|Withdrawal by Subject|3|||
127558917|NCT01065454|459015767|FG000|Follow up|Adverse Event|1|||
127558918|NCT01065454|459015768|FG001|Follow up|Adverse Event|0|||
127558919|NCT01065454|459015769|FG002|Follow up|Adverse Event|0|||
127558920|NCT01065454|459015770|FG003|Follow up|Adverse Event|1|||
127558921|NCT01065454|459015767|FG000|Follow up|Death|0|||
127558922|NCT01065454|459015768|FG001|Follow up|Death|1|||
127558923|NCT01065454|459015769|FG002|Follow up|Death|1|||
127686161|NCT00774397|459478181|FG001|Overall Study|Refused to continue trial medication|3|||
127558924|NCT01065454|459015770|FG003|Follow up|Death|0|||
127558925|NCT01065454|459015767|FG000|Follow up|Lost to Follow-up|0|||
127558926|NCT01065454|459015768|FG001|Follow up|Lost to Follow-up|0|||
127558927|NCT01065454|459015769|FG002|Follow up|Lost to Follow-up|0|||
127558928|NCT01065454|459015770|FG003|Follow up|Lost to Follow-up|1|||
127774544|NCT01372410|459800369|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
128023452|NCT05660538|460710802|FG000|Overall Study|Other|1|||
128023453|NCT05660538|460710803|FG001|Overall Study|Other|0|||
128023454|NCT05660538|460710804|FG002|Overall Study|Other|0|||
128023455|NCT05660538|460710805|FG003|Overall Study|Other|1|||
128023456|NCT05660538|460710802|FG000|Overall Study|Randomized but did not receive study drug|1|||
128023457|NCT05660538|460710803|FG001|Overall Study|Randomized but did not receive study drug|0|||
128023458|NCT05660538|460710804|FG002|Overall Study|Randomized but did not receive study drug|0|||
128023459|NCT05660538|460710805|FG003|Overall Study|Randomized but did not receive study drug|1|||
128023460|NCT05660538|460710802|FG000|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
128023461|NCT05660538|460710803|FG001|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|4|||
128023462|NCT05660538|460710804|FG002|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
128023463|NCT05660538|460710805|FG003|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
128023464|NCT04518410|460710807|FG000|Overall Study|Lost to Follow-up|1|||
128023465|NCT04518410|460710808|FG001|Overall Study|Lost to Follow-up|1|||
128023466|NCT04518410|460710809|FG002|Overall Study|Lost to Follow-up|8|||
128023467|NCT04518410|460710810|FG003|Overall Study|Lost to Follow-up|5|||
128023468|NCT04518410|460710811|FG004|Overall Study|Lost to Follow-up|92|||
128023469|NCT04518410|460710812|FG005|Overall Study|Lost to Follow-up|25|||
128023470|NCT04518410|460710813|FG006|Overall Study|Lost to Follow-up|25|||
128023471|NCT04518410|460710814|FG007|Overall Study|Lost to Follow-up|3|||
128023472|NCT04518410|460710815|FG008|Overall Study|Lost to Follow-up|2|||
128023473|NCT04518410|460710816|FG009|Overall Study|Lost to Follow-up|13|||
128023474|NCT04518410|460710817|FG010|Overall Study|Lost to Follow-up|9|||
128023475|NCT04518410|460710818|FG011|Overall Study|Lost to Follow-up|13|||
128023476|NCT04518410|460710819|FG012|Overall Study|Lost to Follow-up|9|||
128023477|NCT04518410|460710820|FG013|Overall Study|Lost to Follow-up|13|||
128023478|NCT04518410|460710821|FG014|Overall Study|Lost to Follow-up|8|||
128023479|NCT04518410|460710822|FG015|Overall Study|Lost to Follow-up|10|||
128023480|NCT04518410|460710823|FG016|Overall Study|Lost to Follow-up|6|||
128023481|NCT04518410|460710824|FG017|Overall Study|Lost to Follow-up|13|||
128023482|NCT04518410|460710825|FG018|Overall Study|Lost to Follow-up|21|||
128023483|NCT04518410|460710826|FG019|Overall Study|Lost to Follow-up|6|||
128023484|NCT04518410|460710827|FG020|Overall Study|Lost to Follow-up|7|||
128023485|NCT04518410|460710828|FG021|Overall Study|Lost to Follow-up|21|||
128023486|NCT04518410|460710829|FG022|Overall Study|Lost to Follow-up|1|||
128023487|NCT04518410|460710830|FG023|Overall Study|Lost to Follow-up|7|||
128023488|NCT04518410|460710831|FG024|Overall Study|Lost to Follow-up|6|||
128023489|NCT04518410|460710807|FG000|Overall Study|Withdrawal by Subject|1|||
128023490|NCT04518410|460710808|FG001|Overall Study|Withdrawal by Subject|2|||
128023491|NCT04518410|460710809|FG002|Overall Study|Withdrawal by Subject|2|||
128023492|NCT04518410|460710810|FG003|Overall Study|Withdrawal by Subject|3|||
128023493|NCT04518410|460710811|FG004|Overall Study|Withdrawal by Subject|20|||
128023494|NCT04518410|460710812|FG005|Overall Study|Withdrawal by Subject|20|||
128023495|NCT04518410|460710813|FG006|Overall Study|Withdrawal by Subject|25|||
128023496|NCT04518410|460710814|FG007|Overall Study|Withdrawal by Subject|6|||
128023497|NCT04518410|460710815|FG008|Overall Study|Withdrawal by Subject|1|||
128023498|NCT04518410|460710816|FG009|Overall Study|Withdrawal by Subject|12|||
128023499|NCT04518410|460710817|FG010|Overall Study|Withdrawal by Subject|5|||
128023500|NCT04518410|460710818|FG011|Overall Study|Withdrawal by Subject|7|||
128023501|NCT04518410|460710819|FG012|Overall Study|Withdrawal by Subject|2|||
128023502|NCT04518410|460710820|FG013|Overall Study|Withdrawal by Subject|13|||
128023503|NCT04518410|460710821|FG014|Overall Study|Withdrawal by Subject|4|||
128023504|NCT04518410|460710822|FG015|Overall Study|Withdrawal by Subject|9|||
128023505|NCT04518410|460710823|FG016|Overall Study|Withdrawal by Subject|0|||
128023506|NCT04518410|460710824|FG017|Overall Study|Withdrawal by Subject|15|||
128023507|NCT04518410|460710825|FG018|Overall Study|Withdrawal by Subject|12|||
127558929|NCT01065454|459015767|FG000|Follow up|Progressive disease|0|||
127558930|NCT01065454|459015768|FG001|Follow up|Progressive disease|0|||
127774545|NCT01372410|459800370|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
128023508|NCT04518410|460710826|FG019|Overall Study|Withdrawal by Subject|9|||
128023509|NCT04518410|460710827|FG020|Overall Study|Withdrawal by Subject|14|||
127774546|NCT01372410|459800371|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
128023510|NCT04518410|460710828|FG021|Overall Study|Withdrawal by Subject|3|||
128023511|NCT04518410|460710829|FG022|Overall Study|Withdrawal by Subject|2|||
128023512|NCT04518410|460710830|FG023|Overall Study|Withdrawal by Subject|9|||
128023513|NCT04518410|460710831|FG024|Overall Study|Withdrawal by Subject|8|||
128023514|NCT04518410|460710807|FG000|Overall Study|Other|1|||
128023515|NCT04518410|460710808|FG001|Overall Study|Other|0|||
127558931|NCT01065454|459015769|FG002|Follow up|Progressive disease|0|||
127558932|NCT01065454|459015770|FG003|Follow up|Progressive disease|1|||
127558933|NCT01065454|459015767|FG000|Follow up|Withdrawal by Subject|1|||
127558934|NCT01065454|459015768|FG001|Follow up|Withdrawal by Subject|1|||
127558935|NCT01065454|459015769|FG002|Follow up|Withdrawal by Subject|1|||
127558936|NCT01065454|459015770|FG003|Follow up|Withdrawal by Subject|0|||
127558937|NCT01065454|459015767|FG000|Follow up|study ongoing|37|||
127558938|NCT01065454|459015768|FG001|Follow up|study ongoing|22|||
127558939|NCT01065454|459015769|FG002|Follow up|study ongoing|15|||
127558940|NCT01065454|459015770|FG003|Follow up|study ongoing|41|||
127558941|NCT01601652|459015771|FG000|Overall Study|Death|1|||
127558942|NCT05688670|459015772|FG000|Overall Study|Change in surgery plan|1|||
127558943|NCT05688670|459015773|FG001|Overall Study|Change in surgery plan|4|||
127558944|NCT05688670|459015772|FG000|Overall Study|Inability to extubate|1|||
127558945|NCT05688670|459015773|FG001|Overall Study|Inability to extubate|2|||
127558946|NCT05688670|459015772|FG000|Overall Study|Day of surgery cancellation|0|||
127558947|NCT05688670|459015773|FG001|Overall Study|Day of surgery cancellation|1|||
127558948|NCT05688670|459015772|FG000|Overall Study|Reintubated on PCICU arrival|0|||
127558949|NCT05688670|459015773|FG001|Overall Study|Reintubated on PCICU arrival|1|||
127558950|NCT01097005|459015779|FG000|Overall Study|Case Report Form not collected|18|||
127558951|NCT01097005|459015779|FG000|Overall Study|Subjects cannot visit the hospital|1|||
127558952|NCT01097005|459015779|FG000|Overall Study|Poor medication compliance|1|||
127558953|NCT01097005|459015779|FG000|Overall Study|No examination data available|244|||
127558954|NCT01097005|459015779|FG000|Overall Study|Deviation from exclusion criteria|37|||
127558955|NCT01097005|459015779|FG000|Overall Study|Adverse Event|14|||
127558956|NCT01097005|459015779|FG000|Overall Study|Discontinuance by complication|50|||
127558957|NCT04614324|459015784|FG000|Overall Study|Lost to Follow-up|3|||
127558958|NCT04614324|459015784|FG000|Overall Study|Physician Decision|1|||
127558959|NCT04614324|459015784|FG000|Overall Study|Withdrawal by Subject|2|||
127558960|NCT04614324|459015784|FG000|Overall Study|Remaining in Follow up|123|||
127558961|NCT05289037|459015785|FG000|Overall Study|Withdrawal by Subject|7|||
127558962|NCT05289037|459015786|FG001|Overall Study|Withdrawal by Subject|0|||
127558963|NCT05289037|459015787|FG002|Overall Study|Withdrawal by Subject|3|||
127558964|NCT05289037|459015788|FG003|Overall Study|Withdrawal by Subject|3|||
127558965|NCT05289037|459015789|FG004|Overall Study|Withdrawal by Subject|1|||
127558966|NCT05289037|459015790|FG005|Overall Study|Withdrawal by Subject|5|||
127558967|NCT05289037|459015791|FG006|Overall Study|Withdrawal by Subject|2|||
127558968|NCT05289037|459015792|FG007|Overall Study|Withdrawal by Subject|1|||
127558969|NCT05289037|459015793|FG008|Overall Study|Withdrawal by Subject|2|||
127558970|NCT05289037|459015794|FG009|Overall Study|Withdrawal by Subject|2|||
127558971|NCT05289037|459015795|FG010|Overall Study|Withdrawal by Subject|1|||
127558972|NCT05289037|459015796|FG011|Overall Study|Withdrawal by Subject|0|||
127558973|NCT05289037|459015797|FG012|Overall Study|Withdrawal by Subject|1|||
127558974|NCT05289037|459015798|FG013|Overall Study|Withdrawal by Subject|2|||
127558975|NCT05289037|459015799|FG014|Overall Study|Withdrawal by Subject|0|||
127558976|NCT05289037|459015800|FG015|Overall Study|Withdrawal by Subject|3|||
127558977|NCT05289037|459015801|FG016|Overall Study|Withdrawal by Subject|3|||
127558978|NCT05289037|459015785|FG000|Overall Study|Lost to Follow-up|1|||
127558979|NCT05289037|459015786|FG001|Overall Study|Lost to Follow-up|4|||
127558980|NCT05289037|459015787|FG002|Overall Study|Lost to Follow-up|3|||
127558981|NCT05289037|459015788|FG003|Overall Study|Lost to Follow-up|3|||
127558982|NCT05289037|459015789|FG004|Overall Study|Lost to Follow-up|3|||
127558983|NCT05289037|459015790|FG005|Overall Study|Lost to Follow-up|2|||
127558984|NCT05289037|459015791|FG006|Overall Study|Lost to Follow-up|3|||
127558985|NCT05289037|459015792|FG007|Overall Study|Lost to Follow-up|2|||
127558986|NCT05289037|459015793|FG008|Overall Study|Lost to Follow-up|2|||
127558987|NCT05289037|459015794|FG009|Overall Study|Lost to Follow-up|1|||
127558988|NCT05289037|459015795|FG010|Overall Study|Lost to Follow-up|3|||
127558989|NCT05289037|459015796|FG011|Overall Study|Lost to Follow-up|4|||
127558990|NCT05289037|459015797|FG012|Overall Study|Lost to Follow-up|2|||
127558991|NCT05289037|459015798|FG013|Overall Study|Lost to Follow-up|7|||
127558992|NCT05289037|459015799|FG014|Overall Study|Lost to Follow-up|4|||
127558993|NCT05289037|459015800|FG015|Overall Study|Lost to Follow-up|6|||
127558994|NCT05289037|459015801|FG016|Overall Study|Lost to Follow-up|4|||
127558995|NCT05289037|459015785|FG000|Overall Study|Death|0|||
127558996|NCT05289037|459015786|FG001|Overall Study|Death|0|||
127558997|NCT05289037|459015787|FG002|Overall Study|Death|0|||
127558998|NCT05289037|459015788|FG003|Overall Study|Death|0|||
127558999|NCT05289037|459015789|FG004|Overall Study|Death|0|||
127559000|NCT05289037|459015790|FG005|Overall Study|Death|1|||
127559001|NCT05289037|459015791|FG006|Overall Study|Death|0|||
127559002|NCT05289037|459015792|FG007|Overall Study|Death|0|||
127559003|NCT05289037|459015793|FG008|Overall Study|Death|0|||
127559004|NCT05289037|459015794|FG009|Overall Study|Death|0|||
127559005|NCT05289037|459015795|FG010|Overall Study|Death|0|||
127559006|NCT05289037|459015796|FG011|Overall Study|Death|0|||
127559007|NCT05289037|459015797|FG012|Overall Study|Death|0|||
127559008|NCT05289037|459015798|FG013|Overall Study|Death|0|||
127559009|NCT05289037|459015799|FG014|Overall Study|Death|1|||
127559010|NCT05289037|459015800|FG015|Overall Study|Death|0|||
127559011|NCT05289037|459015801|FG016|Overall Study|Death|0|||
128023516|NCT04518410|460710809|FG002|Overall Study|Other|0|||
127559012|NCT05289037|459015785|FG000|Overall Study|Did not receive vaccine|0|||
127559013|NCT05289037|459015786|FG001|Overall Study|Did not receive vaccine|3|||
127559014|NCT05289037|459015787|FG002|Overall Study|Did not receive vaccine|0|||
127559015|NCT05289037|459015788|FG003|Overall Study|Did not receive vaccine|0|||
127559016|NCT05289037|459015789|FG004|Overall Study|Did not receive vaccine|1|||
127559017|NCT05289037|459015790|FG005|Overall Study|Did not receive vaccine|1|||
127559018|NCT05289037|459015791|FG006|Overall Study|Did not receive vaccine|1|||
127559019|NCT05289037|459015792|FG007|Overall Study|Did not receive vaccine|0|||
127559020|NCT05289037|459015793|FG008|Overall Study|Did not receive vaccine|0|||
127559021|NCT05289037|459015794|FG009|Overall Study|Did not receive vaccine|0|||
127559022|NCT05289037|459015795|FG010|Overall Study|Did not receive vaccine|0|||
127559023|NCT05289037|459015796|FG011|Overall Study|Did not receive vaccine|0|||
127559024|NCT05289037|459015797|FG012|Overall Study|Did not receive vaccine|0|||
127559025|NCT05289037|459015798|FG013|Overall Study|Did not receive vaccine|0|||
127559026|NCT05289037|459015799|FG014|Overall Study|Did not receive vaccine|1|||
127559027|NCT05289037|459015800|FG015|Overall Study|Did not receive vaccine|0|||
127559028|NCT05289037|459015801|FG016|Overall Study|Did not receive vaccine|0|||
127559029|NCT05289037|459015785|FG000|Overall Study|Unable to make last visit|0|||
127559030|NCT05289037|459015786|FG001|Overall Study|Unable to make last visit|0|||
127559031|NCT05289037|459015787|FG002|Overall Study|Unable to make last visit|1|||
127559032|NCT05289037|459015788|FG003|Overall Study|Unable to make last visit|0|||
127559033|NCT05289037|459015789|FG004|Overall Study|Unable to make last visit|0|||
127559034|NCT05289037|459015790|FG005|Overall Study|Unable to make last visit|0|||
127559035|NCT05289037|459015791|FG006|Overall Study|Unable to make last visit|0|||
127559036|NCT05289037|459015792|FG007|Overall Study|Unable to make last visit|0|||
127559037|NCT05289037|459015793|FG008|Overall Study|Unable to make last visit|0|||
127559038|NCT05289037|459015794|FG009|Overall Study|Unable to make last visit|0|||
127559039|NCT05289037|459015795|FG010|Overall Study|Unable to make last visit|0|||
127559040|NCT05289037|459015796|FG011|Overall Study|Unable to make last visit|0|||
127559041|NCT05289037|459015797|FG012|Overall Study|Unable to make last visit|0|||
127559042|NCT05289037|459015798|FG013|Overall Study|Unable to make last visit|0|||
127559043|NCT05289037|459015799|FG014|Overall Study|Unable to make last visit|0|||
127559044|NCT05289037|459015800|FG015|Overall Study|Unable to make last visit|0|||
127559045|NCT05289037|459015801|FG016|Overall Study|Unable to make last visit|0|||
127559046|NCT05289037|459015785|FG000|Overall Study|Protocol deviation|0|||
127686162|NCT00774397|459478182|FG002|Overall Study|Refused to continue trial medication|2|||
127686163|NCT00774397|459478183|FG003|Overall Study|Refused to continue trial medication|2|||
127686164|NCT00774397|459478184|FG004|Overall Study|Refused to continue trial medication|6|||
127686165|NCT00774397|459478185|FG005|Overall Study|Refused to continue trial medication|2|||
128023517|NCT04518410|460710810|FG003|Overall Study|Other|1|||
128023518|NCT04518410|460710811|FG004|Overall Study|Other|6|||
128023519|NCT04518410|460710812|FG005|Overall Study|Other|6|||
128023520|NCT04518410|460710813|FG006|Overall Study|Other|5|||
128023521|NCT04518410|460710814|FG007|Overall Study|Other|2|||
128023522|NCT04518410|460710815|FG008|Overall Study|Other|0|||
128023523|NCT04518410|460710816|FG009|Overall Study|Other|1|||
128023524|NCT04518410|460710817|FG010|Overall Study|Other|0|||
128023525|NCT04518410|460710818|FG011|Overall Study|Other|2|||
128023526|NCT04518410|460710819|FG012|Overall Study|Other|0|||
128023527|NCT04518410|460710820|FG013|Overall Study|Other|0|||
128023528|NCT04518410|460710821|FG014|Overall Study|Other|0|||
127559047|NCT05289037|459015786|FG001|Overall Study|Protocol deviation|0|||
127559048|NCT05289037|459015787|FG002|Overall Study|Protocol deviation|0|||
127559049|NCT05289037|459015788|FG003|Overall Study|Protocol deviation|0|||
127686166|NCT00774397|459478186|FG006|Overall Study|Refused to continue trial medication|3|||
127686167|NCT00774397|459478180|FG000|Overall Study|Not treated|0|||
127686168|NCT00774397|459478181|FG001|Overall Study|Not treated|0|||
127686169|NCT00774397|459478182|FG002|Overall Study|Not treated|0|||
127774547|NCT01372410|459800364|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
127774548|NCT01372410|459800365|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
128023529|NCT04518410|460710822|FG015|Overall Study|Other|3|||
128023530|NCT04518410|460710823|FG016|Overall Study|Other|1|||
127559050|NCT05289037|459015789|FG004|Overall Study|Protocol deviation|0|||
127559051|NCT05289037|459015790|FG005|Overall Study|Protocol deviation|0|||
127559052|NCT05289037|459015791|FG006|Overall Study|Protocol deviation|0|||
127559053|NCT05289037|459015792|FG007|Overall Study|Protocol deviation|0|||
127559054|NCT05289037|459015793|FG008|Overall Study|Protocol deviation|0|||
127559055|NCT05289037|459015794|FG009|Overall Study|Protocol deviation|0|||
127559056|NCT05289037|459015795|FG010|Overall Study|Protocol deviation|0|||
127686170|NCT00774397|459478183|FG003|Overall Study|Not treated|0|||
127686171|NCT00774397|459478184|FG004|Overall Study|Not treated|1|||
127686172|NCT00774397|459478185|FG005|Overall Study|Not treated|0|||
128023531|NCT04518410|460710824|FG017|Overall Study|Other|1|||
128023532|NCT04518410|460710825|FG018|Overall Study|Other|1|||
128023533|NCT04518410|460710826|FG019|Overall Study|Other|0|||
128023534|NCT04518410|460710827|FG020|Overall Study|Other|1|||
128023535|NCT04518410|460710828|FG021|Overall Study|Other|0|||
127559057|NCT05289037|459015796|FG011|Overall Study|Protocol deviation|0|||
127559058|NCT05289037|459015797|FG012|Overall Study|Protocol deviation|0|||
127559059|NCT05289037|459015798|FG013|Overall Study|Protocol deviation|0|||
127559060|NCT05289037|459015799|FG014|Overall Study|Protocol deviation|0|||
127559061|NCT05289037|459015800|FG015|Overall Study|Protocol deviation|1|||
127559062|NCT05289037|459015801|FG016|Overall Study|Protocol deviation|0|||
127559063|NCT05141448|459015802|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
127559064|NCT05141448|459015803|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
127559065|NCT05141448|459015804|FG002|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
127559066|NCT05141448|459015805|FG003|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
127559067|NCT05141448|459015806|FG004|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
127559068|NCT05141448|459015807|FG005|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
127559069|NCT05141448|459015802|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
127559070|NCT05141448|459015803|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
127559071|NCT05141448|459015804|FG002|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
127559072|NCT05141448|459015805|FG003|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
127559073|NCT05141448|459015806|FG004|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
127559074|NCT05141448|459015807|FG005|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
127559075|NCT05141448|459015802|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
127559076|NCT05141448|459015803|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
127559077|NCT05141448|459015804|FG002|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
127559078|NCT05141448|459015805|FG003|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
127559079|NCT05141448|459015806|FG004|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
127559080|NCT05141448|459015807|FG005|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
127559081|NCT05141448|459015802|FG000|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
127559082|NCT05141448|459015803|FG001|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
127559083|NCT05141448|459015804|FG002|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
127559084|NCT05141448|459015805|FG003|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
127559085|NCT05141448|459015806|FG004|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
127559086|NCT05141448|459015807|FG005|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
127559087|NCT05141448|459015802|FG000|Period 2|COVID-19 Related|0|||
127559088|NCT05141448|459015803|FG001|Period 2|COVID-19 Related|0|||
127774549|NCT01372410|459800366|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
127774550|NCT01372410|459800367|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
127774551|NCT01372410|459800368|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
127774552|NCT01372410|459800369|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
127774553|NCT01372410|459800370|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
127774554|NCT01372410|459800371|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
127774555|NCT01372410|459800364|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
127774556|NCT01372410|459800365|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
127774557|NCT01372410|459800366|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
127774558|NCT01372410|459800367|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
127774559|NCT01372410|459800368|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
127774560|NCT01372410|459800369|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
127774561|NCT01372410|459800370|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
127774562|NCT01372410|459800371|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
127774563|NCT01372410|459800364|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
127774564|NCT01372410|459800365|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
127774565|NCT01372410|459800366|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
127774566|NCT01372410|459800367|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
127774567|NCT01372410|459800368|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
127774568|NCT01372410|459800369|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
127774569|NCT01372410|459800370|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
127774570|NCT01372410|459800371|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
127774571|NCT01372410|459800364|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
127774572|NCT01372410|459800365|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
127774573|NCT01372410|459800366|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
127774574|NCT01372410|459800367|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
127774575|NCT01372410|459800368|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
127774576|NCT01372410|459800369|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
127774577|NCT01372410|459800370|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
127774578|NCT01372410|459800371|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
127774579|NCT01372410|459800364|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
128023536|NCT04518410|460710829|FG022|Overall Study|Other|1|||
128023537|NCT04518410|460710830|FG023|Overall Study|Other|2|||
127774580|NCT01372410|459800365|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
127559089|NCT05141448|459015804|FG002|Period 2|COVID-19 Related|0|||
128023538|NCT04518410|460710831|FG024|Overall Study|Other|2|||
127559090|NCT05141448|459015805|FG003|Period 2|COVID-19 Related|1|||
127559091|NCT05141448|459015806|FG004|Period 2|COVID-19 Related|0|||
127559092|NCT05141448|459015807|FG005|Period 2|COVID-19 Related|1|||
127559093|NCT05141448|459015802|FG000|3|Covid-19 related|2|||
127559094|NCT05141448|459015803|FG001|3|Covid-19 related|0|||
127559095|NCT05141448|459015804|FG002|3|Covid-19 related|0|||
127559096|NCT05141448|459015805|FG003|3|Covid-19 related|0|||
127559097|NCT05141448|459015806|FG004|3|Covid-19 related|0|||
127559098|NCT05141448|459015807|FG005|3|Covid-19 related|1|||
127559099|NCT05141448|459015802|FG000|4|Unsatisfactory Visual Response due to Test Article|1|||
127559100|NCT05141448|459015803|FG001|4|Unsatisfactory Visual Response due to Test Article|0|||
127559101|NCT05141448|459015804|FG002|4|Unsatisfactory Visual Response due to Test Article|0|||
127559102|NCT05141448|459015805|FG003|4|Unsatisfactory Visual Response due to Test Article|0|||
127559103|NCT05141448|459015806|FG004|4|Unsatisfactory Visual Response due to Test Article|0|||
127559104|NCT05141448|459015807|FG005|4|Unsatisfactory Visual Response due to Test Article|0|||
127559105|NCT04627285|459015808|FG000|Overall Study|Adverse Event|0|||
127559106|NCT04627285|459015809|FG001|Overall Study|Adverse Event|2|||
127559107|NCT04627285|459015808|FG000|Overall Study|Lost to Follow-up|1|||
127559108|NCT04627285|459015809|FG001|Overall Study|Lost to Follow-up|0|||
127559109|NCT04627285|459015808|FG000|Overall Study|Withdrawal by Subject|1|||
127559110|NCT04627285|459015809|FG001|Overall Study|Withdrawal by Subject|1|||
127559111|NCT04627285|459015808|FG000|Overall Study|Sponsor decision|5|||
127559112|NCT04627285|459015809|FG001|Overall Study|Sponsor decision|0|||
127559113|NCT04627285|459015808|FG000|Overall Study|Participant left country; aunt informed the site|0|||
127559114|NCT04627285|459015809|FG001|Overall Study|Participant left country; aunt informed the site|1|||
127559115|NCT01217307|459017732|FG000|Overall Study|Withdrawal by Subject|0|||
127559116|NCT01217307|459017733|FG001|Overall Study|Withdrawal by Subject|1|||
127559117|NCT00942994|459017740|FG000|Overall Study|Adverse Event|7|||
127559118|NCT00942994|459017741|FG001|Overall Study|Adverse Event|4|||
127559119|NCT00942994|459017740|FG000|Overall Study|Abnormal laboratory value(s)|1|||
127559120|NCT00942994|459017741|FG001|Overall Study|Abnormal laboratory value(s)|0|||
127559121|NCT00942994|459017740|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
127559122|NCT00942994|459017741|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
127559123|NCT00942994|459017740|FG000|Overall Study|Patient withdrew consent|5|||
127559124|NCT00942994|459017741|FG001|Overall Study|Patient withdrew consent|8|||
127559125|NCT00942994|459017740|FG000|Overall Study|Lost to Follow-up|1|||
127559126|NCT00942994|459017741|FG001|Overall Study|Lost to Follow-up|4|||
127559127|NCT00942994|459017740|FG000|Overall Study|Protocol deviation|1|||
127559128|NCT00942994|459017741|FG001|Overall Study|Protocol deviation|2|||
127559129|NCT01874340|459017744|FG000|Overall Study|Study terminated by Sponsor|6|||
127559130|NCT01874340|459017745|FG001|Overall Study|Study terminated by Sponsor|8|||
127559131|NCT01874340|459017746|FG002|Overall Study|Study terminated by Sponsor|8|||
127559132|NCT01874340|459017747|FG003|Overall Study|Study terminated by Sponsor|4|||
127559133|NCT01874340|459017744|FG000|Overall Study|Withdrawal by Subject|0|||
127559134|NCT01874340|459017745|FG001|Overall Study|Withdrawal by Subject|0|||
127559135|NCT01874340|459017746|FG002|Overall Study|Withdrawal by Subject|0|||
127559136|NCT01874340|459017747|FG003|Overall Study|Withdrawal by Subject|1|||
127559137|NCT01086358|459017756|FG000|First Intervention|Lost to Follow-up|9|||
127559138|NCT01086358|459017757|FG001|First Intervention|Lost to Follow-up|4|||
127559139|NCT01086358|459017756|FG000|First Intervention|Withdrawal by Subject|0|||
127559140|NCT01086358|459017757|FG001|First Intervention|Withdrawal by Subject|1|||
127559141|NCT01086358|459017756|FG000|Second Intervention|Lost to Follow-up|4|||
127559142|NCT01086358|459017757|FG001|Second Intervention|Lost to Follow-up|4|||
127559143|NCT02471612|459017760|FG000|Overall Study|Lost to Follow-up|2|||
127559144|NCT03206788|459017761|FG000|Overall Study|Withdrawal by Subject|0|||
127559145|NCT03206788|459017762|FG001|Overall Study|Withdrawal by Subject|1|||
127559146|NCT03206788|459017761|FG000|Overall Study|Adverse Event|0|||
127559147|NCT03206788|459017762|FG001|Overall Study|Adverse Event|1|||
127559148|NCT03206788|459017761|FG000|Overall Study|Physician Decision|0|||
127559149|NCT03206788|459017762|FG001|Overall Study|Physician Decision|1|||
127686173|NCT00774397|459478186|FG006|Overall Study|Not treated|1|||
127686174|NCT00774397|459478180|FG000|Overall Study|Other than those stated above|1|||
127686175|NCT00774397|459478181|FG001|Overall Study|Other than those stated above|1|||
127686176|NCT00774397|459478182|FG002|Overall Study|Other than those stated above|3|||
127686177|NCT00774397|459478183|FG003|Overall Study|Other than those stated above|2|||
127686178|NCT00774397|459478184|FG004|Overall Study|Other than those stated above|2|||
127559150|NCT03899805|459017763|FG000|Overall Study|Physician Decision|3|||
127559151|NCT03899805|459017764|FG001|Overall Study|Physician Decision|0|||
127559152|NCT03899805|459017765|FG002|Overall Study|Physician Decision|2|||
127559153|NCT03899805|459017763|FG000|Overall Study|Withdrawal by Subject|1|||
127559154|NCT03899805|459017764|FG001|Overall Study|Withdrawal by Subject|0|||
127559155|NCT03899805|459017765|FG002|Overall Study|Withdrawal by Subject|2|||
127559156|NCT03899805|459017763|FG000|Overall Study|Progressive Disease|10|||
127559157|NCT03899805|459017764|FG001|Overall Study|Progressive Disease|18|||
127559158|NCT03899805|459017765|FG002|Overall Study|Progressive Disease|12|||
127559159|NCT03899805|459017763|FG000|Overall Study|Adverse Event|3|||
127559160|NCT03899805|459017764|FG001|Overall Study|Adverse Event|1|||
127559161|NCT03899805|459017765|FG002|Overall Study|Adverse Event|0|||
127559162|NCT03899805|459017763|FG000|Overall Study|Death|2|||
127559163|NCT03899805|459017764|FG001|Overall Study|Death|0|||
127559164|NCT03899805|459017765|FG002|Overall Study|Death|0|||
127559165|NCT03899805|459017763|FG000|Overall Study|Came off for surgery|0|||
127559166|NCT03899805|459017764|FG001|Overall Study|Came off for surgery|0|||
127559167|NCT03899805|459017765|FG002|Overall Study|Came off for surgery|1|||
127559168|NCT03317405|459017766|FG000|Overall Study|Withdrawal by Subject|1|||
127559169|NCT03317405|459017767|FG001|Overall Study|Withdrawal by Subject|0|||
127559170|NCT03317405|459017768|FG002|Overall Study|Withdrawal by Subject|0|||
127559171|NCT03317405|459017766|FG000|Overall Study|Physician Decision|0|||
127559172|NCT03317405|459017767|FG001|Overall Study|Physician Decision|0|||
127559173|NCT03317405|459017768|FG002|Overall Study|Physician Decision|1|||
127559174|NCT03317405|459017766|FG000|Overall Study|Surgery Rescheduled|0|||
127559175|NCT03317405|459017767|FG001|Overall Study|Surgery Rescheduled|1|||
127559176|NCT03317405|459017768|FG002|Overall Study|Surgery Rescheduled|0|||
127559177|NCT00984620|459017771|FG000|Overall Study|Adverse Event|5|||
127559178|NCT00984620|459017772|FG001|Overall Study|Adverse Event|5|||
127559179|NCT00984620|459017771|FG000|Overall Study|Lost to Follow-up|1|||
127559180|NCT00984620|459017772|FG001|Overall Study|Lost to Follow-up|1|||
127559181|NCT00984620|459017771|FG000|Overall Study|Withdrawal by Subject|0|||
127559182|NCT00984620|459017772|FG001|Overall Study|Withdrawal by Subject|2|||
127559183|NCT00984620|459017771|FG000|Overall Study|reason other than listed above|0|||
127559184|NCT00984620|459017772|FG001|Overall Study|reason other than listed above|4|||
127559185|NCT01018810|459017773|FG000|Overall Study|Withdrawal by Subject|0|||
127559186|NCT01018810|459017774|FG001|Overall Study|Withdrawal by Subject|1|||
127559187|NCT01018810|459017775|FG002|Overall Study|Withdrawal by Subject|0|||
127559188|NCT01018810|459017776|FG003|Overall Study|Withdrawal by Subject|0|||
127559189|NCT01018810|459017777|FG004|Overall Study|Withdrawal by Subject|0|||
127559190|NCT01018810|459017773|FG000|Overall Study|Sponsor Decision|2|||
127559191|NCT01018810|459017774|FG001|Overall Study|Sponsor Decision|0|||
127559192|NCT01018810|459017775|FG002|Overall Study|Sponsor Decision|1|||
127559193|NCT01018810|459017776|FG003|Overall Study|Sponsor Decision|1|||
127559194|NCT01018810|459017777|FG004|Overall Study|Sponsor Decision|1|||
127559195|NCT01640314|459017778|FG000|Overall Study|Protocol Violation|0|||
127559196|NCT01640314|459017779|FG001|Overall Study|Protocol Violation|1|||
127559197|NCT04450381|459017781|FG000|Overall Study|Protocol Violation|4|||
127559198|NCT04450381|459017781|FG000|Overall Study|Wrong device setting|2|||
127559199|NCT02424578|459017782|FG000|Overall Study|Withdrawal by Subject|0|||
127559200|NCT02424578|459017783|FG001|Overall Study|Withdrawal by Subject|1|||
127559201|NCT00470834|459017786|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
127559202|NCT00470834|459017787|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
127559203|NCT00470834|459017786|FG000|Treatment Period (18 Months)|Adverse Event|7|||
127559204|NCT00470834|459017787|FG001|Treatment Period (18 Months)|Adverse Event|6|||
127559205|NCT00470834|459017786|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
127559206|NCT00470834|459017787|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
127559207|NCT00470834|459017786|FG000|Treatment Period (18 Months)|Physician Decision|4|||
127559208|NCT00470834|459017787|FG001|Treatment Period (18 Months)|Physician Decision|4|||
127559209|NCT00470834|459017786|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
127559210|NCT00470834|459017787|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
127559211|NCT00470834|459017786|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
127559212|NCT00470834|459017787|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
127559213|NCT00470834|459017786|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
127686179|NCT00774397|459478185|FG005|Overall Study|Other than those stated above|0|||
127559214|NCT00470834|459017787|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
127559215|NCT00470834|459017786|FG000|Treatment Period (18 Months)|Non-compliance|1|||
127559216|NCT00470834|459017787|FG001|Treatment Period (18 Months)|Non-compliance|0|||
127559217|NCT00470834|459017786|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
127559218|NCT00470834|459017787|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
127559219|NCT00470834|459017786|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
127559220|NCT00470834|459017787|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
127559221|NCT00470834|459017786|FG000|Extension Period (24 Months)|Adverse Event|3|||
127559222|NCT00470834|459017787|FG001|Extension Period (24 Months)|Adverse Event|4|||
127559223|NCT00470834|459017786|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
127559224|NCT00470834|459017787|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
127559225|NCT00470834|459017786|FG000|Extension Period (24 Months)|Physician Decision|4|||
127559226|NCT00470834|459017787|FG001|Extension Period (24 Months)|Physician Decision|3|||
127559227|NCT00470834|459017786|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
127559228|NCT00470834|459017787|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
127559229|NCT00470834|459017786|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
127559230|NCT00470834|459017787|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
127559231|NCT00470834|459017786|FG000|Extension Period (24 Months)|Non-compliance|0|||
127559232|NCT00470834|459017787|FG001|Extension Period (24 Months)|Non-compliance|1|||
127559233|NCT00470834|459017786|FG000|Extension Period (24 Months)|Disease Progression|0|||
127559234|NCT00470834|459017787|FG001|Extension Period (24 Months)|Disease Progression|1|||
127559235|NCT02640508|459017790|FG000|Overall Study|Death|19|||
127559236|NCT02640508|459017790|FG000|Overall Study|Withdrawal by Subject|8|||
128023539|NCT04518410|460710807|FG000|Overall Study|Protocol Violation|0|||
128023540|NCT04518410|460710808|FG001|Overall Study|Protocol Violation|0|||
128023541|NCT04518410|460710809|FG002|Overall Study|Protocol Violation|0|||
128023542|NCT04518410|460710810|FG003|Overall Study|Protocol Violation|2|||
128023543|NCT04518410|460710811|FG004|Overall Study|Protocol Violation|17|||
128023544|NCT04518410|460710812|FG005|Overall Study|Protocol Violation|1|||
128023545|NCT04518410|460710813|FG006|Overall Study|Protocol Violation|2|||
128023546|NCT04518410|460710814|FG007|Overall Study|Protocol Violation|1|||
128023547|NCT04518410|460710815|FG008|Overall Study|Protocol Violation|0|||
128023548|NCT04518410|460710816|FG009|Overall Study|Protocol Violation|0|||
128023549|NCT04518410|460710817|FG010|Overall Study|Protocol Violation|0|||
128023550|NCT04518410|460710818|FG011|Overall Study|Protocol Violation|0|||
128023551|NCT04518410|460710819|FG012|Overall Study|Protocol Violation|0|||
128023552|NCT04518410|460710820|FG013|Overall Study|Protocol Violation|0|||
128023553|NCT04518410|460710821|FG014|Overall Study|Protocol Violation|0|||
128023554|NCT04518410|460710822|FG015|Overall Study|Protocol Violation|0|||
128023555|NCT04518410|460710823|FG016|Overall Study|Protocol Violation|1|||
128023556|NCT04518410|460710824|FG017|Overall Study|Protocol Violation|1|||
128023557|NCT04518410|460710825|FG018|Overall Study|Protocol Violation|0|||
128023558|NCT04518410|460710826|FG019|Overall Study|Protocol Violation|0|||
128023559|NCT04518410|460710827|FG020|Overall Study|Protocol Violation|1|||
128023560|NCT04518410|460710828|FG021|Overall Study|Protocol Violation|2|||
128023561|NCT04518410|460710829|FG022|Overall Study|Protocol Violation|0|||
128023562|NCT04518410|460710830|FG023|Overall Study|Protocol Violation|3|||
128023563|NCT04518410|460710831|FG024|Overall Study|Protocol Violation|0|||
128023564|NCT04518410|460710807|FG000|Overall Study|Death|0|||
128023565|NCT04518410|460710808|FG001|Overall Study|Death|0|||
128023566|NCT04518410|460710809|FG002|Overall Study|Death|0|||
128023567|NCT04518410|460710810|FG003|Overall Study|Death|0|||
128023568|NCT04518410|460710811|FG004|Overall Study|Death|12|||
128023569|NCT04518410|460710812|FG005|Overall Study|Death|2|||
128023570|NCT04518410|460710813|FG006|Overall Study|Death|11|||
128023571|NCT04518410|460710814|FG007|Overall Study|Death|0|||
128023572|NCT04518410|460710815|FG008|Overall Study|Death|1|||
128023573|NCT04518410|460710816|FG009|Overall Study|Death|0|||
128023574|NCT04518410|460710817|FG010|Overall Study|Death|0|||
128023575|NCT04518410|460710818|FG011|Overall Study|Death|0|||
128023576|NCT04518410|460710819|FG012|Overall Study|Death|0|||
128023577|NCT04518410|460710820|FG013|Overall Study|Death|1|||
128023578|NCT04518410|460710821|FG014|Overall Study|Death|1|||
128023579|NCT04518410|460710822|FG015|Overall Study|Death|0|||
128023580|NCT04518410|460710823|FG016|Overall Study|Death|0|||
128023581|NCT04518410|460710824|FG017|Overall Study|Death|1|||
128023582|NCT04518410|460710825|FG018|Overall Study|Death|4|||
128023583|NCT04518410|460710826|FG019|Overall Study|Death|4|||
128023584|NCT04518410|460710827|FG020|Overall Study|Death|1|||
128023585|NCT04518410|460710828|FG021|Overall Study|Death|0|||
128023586|NCT04518410|460710829|FG022|Overall Study|Death|0|||
128023587|NCT04518410|460710830|FG023|Overall Study|Death|0|||
128023588|NCT04518410|460710831|FG024|Overall Study|Death|0|||
128023589|NCT04518410|460710807|FG000|Overall Study|Requirement to start alternative therapy|0|||
128023590|NCT04518410|460710808|FG001|Overall Study|Requirement to start alternative therapy|0|||
128023591|NCT04518410|460710809|FG002|Overall Study|Requirement to start alternative therapy|1|||
128023592|NCT04518410|460710810|FG003|Overall Study|Requirement to start alternative therapy|0|||
128023593|NCT04518410|460710811|FG004|Overall Study|Requirement to start alternative therapy|0|||
128023594|NCT04518410|460710812|FG005|Overall Study|Requirement to start alternative therapy|0|||
128023595|NCT04518410|460710813|FG006|Overall Study|Requirement to start alternative therapy|0|||
128023596|NCT04518410|460710814|FG007|Overall Study|Requirement to start alternative therapy|0|||
128023597|NCT04518410|460710815|FG008|Overall Study|Requirement to start alternative therapy|0|||
128023598|NCT04518410|460710816|FG009|Overall Study|Requirement to start alternative therapy|0|||
128023599|NCT04518410|460710817|FG010|Overall Study|Requirement to start alternative therapy|0|||
128023600|NCT04518410|460710818|FG011|Overall Study|Requirement to start alternative therapy|0|||
128023601|NCT04518410|460710819|FG012|Overall Study|Requirement to start alternative therapy|0|||
128023602|NCT04518410|460710820|FG013|Overall Study|Requirement to start alternative therapy|0|||
128023603|NCT04518410|460710821|FG014|Overall Study|Requirement to start alternative therapy|0|||
128023604|NCT04518410|460710822|FG015|Overall Study|Requirement to start alternative therapy|0|||
128023605|NCT04518410|460710823|FG016|Overall Study|Requirement to start alternative therapy|0|||
128023606|NCT04518410|460710824|FG017|Overall Study|Requirement to start alternative therapy|0|||
128023607|NCT04518410|460710825|FG018|Overall Study|Requirement to start alternative therapy|0|||
128023608|NCT04518410|460710826|FG019|Overall Study|Requirement to start alternative therapy|0|||
128023609|NCT04518410|460710827|FG020|Overall Study|Requirement to start alternative therapy|0|||
128023610|NCT04518410|460710828|FG021|Overall Study|Requirement to start alternative therapy|0|||
128023611|NCT04518410|460710829|FG022|Overall Study|Requirement to start alternative therapy|0|||
128023612|NCT04518410|460710830|FG023|Overall Study|Requirement to start alternative therapy|0|||
128023613|NCT04518410|460710831|FG024|Overall Study|Requirement to start alternative therapy|0|||
128023614|NCT04518410|460710807|FG000|Overall Study|Randomized but not treated|0|||
127559237|NCT02640508|459017790|FG000|Overall Study|Physician Decision|1|||
127559238|NCT02640508|459017790|FG000|Overall Study|Lost to Follow-up|1|||
127559239|NCT05405257|459017791|FG000|Overall Study|Withdrawal by Subject|1|||
127559240|NCT02365480|459017795|FG000|Overall Study|Withdrawal by Subject|2|||
127559241|NCT02365480|459017796|FG001|Overall Study|Withdrawal by Subject|0|||
127559242|NCT02791763|459017797|FG000|Overall Study|Protocol Violation|0|||
127559243|NCT02791763|459017798|FG001|Overall Study|Protocol Violation|0|||
127559244|NCT02791763|459017799|FG002|Overall Study|Protocol Violation|1|||
127559245|NCT02791763|459017797|FG000|Overall Study|Withdrawal by Subject|5|||
127559246|NCT02791763|459017798|FG001|Overall Study|Withdrawal by Subject|1|||
127559247|NCT02791763|459017799|FG002|Overall Study|Withdrawal by Subject|0|||
127559248|NCT02791763|459017797|FG000|Overall Study|Physician Decision|0|||
127559249|NCT02791763|459017798|FG001|Overall Study|Physician Decision|1|||
127559250|NCT02791763|459017799|FG002|Overall Study|Physician Decision|0|||
127559251|NCT02791763|459017797|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
127559252|NCT02791763|459017798|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
127559253|NCT02791763|459017799|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
127559254|NCT02791763|459017797|FG000|Overall Study|Cancer event|1|||
127559255|NCT02791763|459017798|FG001|Overall Study|Cancer event|3|||
127559256|NCT02791763|459017799|FG002|Overall Study|Cancer event|0|||
127559257|NCT02791763|459017797|FG000|Overall Study|Participant had renal transplant|3|||
127559258|NCT02791763|459017798|FG001|Overall Study|Participant had renal transplant|0|||
127559259|NCT02791763|459017799|FG002|Overall Study|Participant had renal transplant|0|||
127559260|NCT02791763|459017797|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
127559261|NCT02791763|459017798|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
127559262|NCT02791763|459017799|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
127559263|NCT02791763|459017797|FG000|Overall Study|Adverse Event|12|||
127559264|NCT02791763|459017798|FG001|Overall Study|Adverse Event|13|||
127559265|NCT02791763|459017799|FG002|Overall Study|Adverse Event|7|||
127559266|NCT04534686|459017800|FG000|Baseline Measurement|Lost to Follow-up|4|||
127559267|NCT04534686|459017801|FG001|Baseline Measurement|Lost to Follow-up|6|||
127559268|NCT04534686|459017800|FG000|Baseline Measurement|Withdrawal by Subject|3|||
127559269|NCT04534686|459017801|FG001|Baseline Measurement|Withdrawal by Subject|1|||
127559270|NCT04534686|459017800|FG000|Intervention|Withdrawal by Subject|2|||
127559271|NCT04534686|459017801|FG001|Intervention|Withdrawal by Subject|2|||
127559272|NCT00635999|459017802|FG000|Overall Study|Withdrawal by Subject|4|||
127559273|NCT00635999|459017803|FG001|Overall Study|Withdrawal by Subject|2|||
127559274|NCT00635999|459017804|FG002|Overall Study|Withdrawal by Subject|1|||
127559275|NCT01781299|459017805|FG000|Overall Study|Withdrawal by Subject|0|||
127559276|NCT01781299|459017806|FG001|Overall Study|Withdrawal by Subject|1|||
127559277|NCT02636361|459017807|FG000|Period 4|Physician Decision|0|||
127559278|NCT02636361|459017808|FG001|Period 4|Physician Decision|0|||
127559279|NCT02636361|459017809|FG002|Period 4|Physician Decision|0|||
127559280|NCT02636361|459017810|FG003|Period 4|Physician Decision|1|||
127559281|NCT02636361|459017811|FG004|Period 4|Physician Decision|0|||
127559282|NCT02032238|459017812|FG000|Overall Study|Lost to Follow-up|2|||
127559283|NCT02032238|459017813|FG001|Overall Study|Lost to Follow-up|0|||
127559284|NCT02410343|459017814|FG000|Core Period (24 Weeks)|Adverse Event|1|||
127559285|NCT02410343|459017815|FG001|Core Period (24 Weeks)|Adverse Event|0|||
127559286|NCT02410343|459017814|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
127559287|NCT02410343|459017815|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
127559288|NCT02410343|459017814|FG000|Extension Period (12 Months)|Adverse Event|1|||
127559289|NCT02410343|459017815|FG001|Extension Period (12 Months)|Adverse Event|0|||
127559290|NCT02410343|459017814|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
127559291|NCT02410343|459017815|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
127686180|NCT00774397|459478186|FG006|Overall Study|Other than those stated above|1|||
127686181|NCT00077675|459478192|FG000|Overall Study|Adverse Event|1|||
127686182|NCT00077675|459478193|FG001|Overall Study|Adverse Event|2|||
128023615|NCT04518410|460710808|FG001|Overall Study|Randomized but not treated|0|||
128023616|NCT04518410|460710809|FG002|Overall Study|Randomized but not treated|0|||
127559292|NCT02720042|459017820|FG000|Overall Study|Death|3|||
127559293|NCT02720042|459017820|FG000|Overall Study|Lost to Follow-up|4|||
127559294|NCT02720042|459017820|FG000|Overall Study|Withdrawal by Subject|1|||
127559295|NCT02720042|459017820|FG000|Overall Study|Physician Decision|3|||
127559296|NCT02720042|459017820|FG000|Overall Study|Phasix Mesh explanted|1|||
127686183|NCT00077675|459478192|FG000|Overall Study|Lost to Follow-up|6|||
127686184|NCT00077675|459478193|FG001|Overall Study|Lost to Follow-up|3|||
127559297|NCT02720042|459017820|FG000|Overall Study|unable due to non-study-related illness|3|||
127559298|NCT00246740|459017823|FG000|Initial Enrollment|Death|1|||
127559299|NCT00246740|459017824|FG001|Initial Enrollment|Death|0|||
127559300|NCT00246740|459017823|FG000|Initial Enrollment|Additional surgery scheduled|0|||
127559301|NCT00246740|459017824|FG001|Initial Enrollment|Additional surgery scheduled|2|||
127559302|NCT00246740|459017823|FG000|Initial Enrollment|Surgery schedule change|4|||
127559303|NCT00246740|459017824|FG001|Initial Enrollment|Surgery schedule change|4|||
128023617|NCT04518410|460710810|FG003|Overall Study|Randomized but not treated|2|||
127559304|NCT00246740|459017823|FG000|Initial Enrollment|Other|1|||
127559305|NCT00246740|459017824|FG001|Initial Enrollment|Other|2|||
127559306|NCT01510769|459017825|FG000|Overall Study|Adverse Event|7|||
127559307|NCT01510769|459017826|FG001|Overall Study|Adverse Event|6|||
127559308|NCT01510769|459017827|FG002|Overall Study|Adverse Event|4|||
127559309|NCT01510769|459017825|FG000|Overall Study|Gout Flare|0|||
127559310|NCT01510769|459017826|FG001|Overall Study|Gout Flare|3|||
127559311|NCT01510769|459017827|FG002|Overall Study|Gout Flare|1|||
127559312|NCT01510769|459017825|FG000|Overall Study|Protocol Violation|11|||
127559313|NCT01510769|459017826|FG001|Overall Study|Protocol Violation|10|||
127559314|NCT01510769|459017827|FG002|Overall Study|Protocol Violation|9|||
127559315|NCT01510769|459017825|FG000|Overall Study|Lost to Follow-up|5|||
127559316|NCT01510769|459017826|FG001|Overall Study|Lost to Follow-up|1|||
127559317|NCT01510769|459017827|FG002|Overall Study|Lost to Follow-up|5|||
127559318|NCT01510769|459017825|FG000|Overall Study|Withdrawal by Subject|3|||
127559319|NCT01510769|459017826|FG001|Overall Study|Withdrawal by Subject|4|||
127559320|NCT01510769|459017827|FG002|Overall Study|Withdrawal by Subject|3|||
127559321|NCT01510769|459017825|FG000|Overall Study|Death|1|||
127559322|NCT01510769|459017826|FG001|Overall Study|Death|1|||
127559323|NCT01510769|459017827|FG002|Overall Study|Death|0|||
127559324|NCT01536392|459017830|FG000|Overall Study|Adverse Event|2|||
127559325|NCT01536392|459017831|FG001|Overall Study|Adverse Event|2|||
127559326|NCT01536392|459017830|FG000|Overall Study|Physician Decision|2|||
127559327|NCT01536392|459017831|FG001|Overall Study|Physician Decision|3|||
127559328|NCT01536392|459017830|FG000|Overall Study|Withdrawal by Subject|3|||
127559329|NCT01536392|459017831|FG001|Overall Study|Withdrawal by Subject|6|||
127559330|NCT01536392|459017830|FG000|Overall Study|Non Compliance|3|||
127559331|NCT01536392|459017831|FG001|Overall Study|Non Compliance|4|||
127559332|NCT01536392|459017830|FG000|Overall Study|Completed therapy early|3|||
127559333|NCT01536392|459017831|FG001|Overall Study|Completed therapy early|0|||
127559334|NCT00934440|459017832|FG000|Overall Study|Lost to Follow-up|1|||
127559335|NCT00744042|459017834|FG000|Overall Study|Withdrawal by Subject|1|||
127559336|NCT03158285|459017839|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
127559337|NCT03158285|459017840|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
127559338|NCT03158285|459017841|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
127559339|NCT03158285|459017839|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
127559340|NCT03158285|459017840|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
127559341|NCT03158285|459017841|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
127559342|NCT03158285|459017839|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
127559343|NCT03158285|459017840|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
127559344|NCT03158285|459017841|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
127559345|NCT03158285|459017839|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
127559346|NCT03158285|459017840|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
127559347|NCT03158285|459017841|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
127559348|NCT03158285|459017839|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
127559349|NCT03158285|459017840|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
127559350|NCT03158285|459017841|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
127559351|NCT03158285|459017839|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
127559352|NCT03158285|459017840|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
127559353|NCT03158285|459017841|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
127559354|NCT03158285|459017839|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
127559355|NCT03158285|459017840|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
127559356|NCT03158285|459017841|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
127559357|NCT03158285|459017839|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
127559358|NCT03158285|459017840|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
127559359|NCT03158285|459017841|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
127559360|NCT03158285|459017839|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
127559361|NCT03158285|459017840|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
127559362|NCT03158285|459017841|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
127559363|NCT03158285|459017839|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
127559364|NCT03158285|459017840|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
127559365|NCT03158285|459017841|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
127559366|NCT03158285|459017839|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
127559367|NCT03158285|459017840|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
127559368|NCT03158285|459017841|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
127559369|NCT03158285|459017839|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
127559370|NCT03158285|459017840|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
127559371|NCT03158285|459017841|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
127559372|NCT03158285|459017839|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
127559373|NCT03158285|459017840|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
127559374|NCT03158285|459017841|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
127686185|NCT00077675|459478192|FG000|Overall Study|Withdrawal by Subject|1|||
127559375|NCT03158285|459017839|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
127559376|NCT03158285|459017840|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
127559377|NCT03158285|459017841|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
127559378|NCT03158285|459017839|FG000|Active Treatment Period: Week 52-100|Death|1|||
127559379|NCT03158285|459017840|FG001|Active Treatment Period: Week 52-100|Death|0|||
127559380|NCT03158285|459017841|FG002|Active Treatment Period: Week 52-100|Death|0|||
127559381|NCT03158285|459017839|FG000|Active Treatment Period: Week 52-100|Other|4|||
127559382|NCT03158285|459017840|FG001|Active Treatment Period: Week 52-100|Other|1|||
127559383|NCT03158285|459017841|FG002|Active Treatment Period: Week 52-100|Other|0|||
127559384|NCT01516034|459017845|FG000|Overall Study|Physician Decision|1|||
127559385|NCT01516034|459017845|FG000|Overall Study|Lack of Efficacy|7|||
127559386|NCT01818752|459017846|FG000|Overall Study|Adverse Event|64|||
127559387|NCT01818752|459017847|FG001|Overall Study|Adverse Event|74|||
127559388|NCT01818752|459017846|FG000|Overall Study|Death|14|||
127559389|NCT01818752|459017847|FG001|Overall Study|Death|18|||
127559390|NCT01818752|459017846|FG000|Overall Study|Non-compliance|16|||
127559391|NCT01818752|459017847|FG001|Overall Study|Non-compliance|20|||
127559392|NCT01818752|459017846|FG000|Overall Study|Withdrawal by Subject|15|||
127559393|NCT01818752|459017847|FG001|Overall Study|Withdrawal by Subject|14|||
127559394|NCT01818752|459017846|FG000|Overall Study|Physician Decision|9|||
127559395|NCT01818752|459017847|FG001|Overall Study|Physician Decision|8|||
127559396|NCT01818752|459017846|FG000|Overall Study|Disease Progression|54|||
127559397|NCT01818752|459017847|FG001|Overall Study|Disease Progression|48|||
127559398|NCT01818752|459017846|FG000|Overall Study|Other|7|||
127559399|NCT01818752|459017847|FG001|Overall Study|Other|8|||
127559400|NCT01818752|459017846|FG000|Overall Study|Continuing Treatment|1|||
127559401|NCT01818752|459017847|FG001|Overall Study|Continuing Treatment|4|||
127559402|NCT01818752|459017846|FG000|Overall Study|Randomized but not Dosed|7|||
127559403|NCT01818752|459017847|FG001|Overall Study|Randomized but not Dosed|4|||
127559404|NCT01033448|459017848|FG000|Overall Study|Withdrawal by Subject|4|||
127559405|NCT01033448|459017848|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
127559406|NCT01033448|459017848|FG000|Overall Study|Lost to Follow-up|3|||
127559407|NCT01033448|459017848|FG000|Overall Study|Withdrew due to other reasons|3|||
127559408|NCT01033448|459017848|FG000|Overall Study|Unknown disposition|1|||
127559409|NCT02228980|459017849|FG000|Overall Study|Adverse Event|14|||
127559410|NCT02228980|459017850|FG001|Overall Study|Adverse Event|0|||
127559411|NCT02228980|459017851|FG002|Overall Study|Adverse Event|0|||
127559412|NCT02228980|459017852|FG003|Overall Study|Adverse Event|0|||
127559413|NCT02228980|459017849|FG000|Overall Study|Protocol Violation|7|||
127559414|NCT02228980|459017850|FG001|Overall Study|Protocol Violation|0|||
127559415|NCT02228980|459017851|FG002|Overall Study|Protocol Violation|0|||
127559416|NCT02228980|459017852|FG003|Overall Study|Protocol Violation|0|||
127559417|NCT02228980|459017849|FG000|Overall Study|Withdrawal by Subject|3|||
127559418|NCT02228980|459017850|FG001|Overall Study|Withdrawal by Subject|3|||
127559419|NCT02228980|459017851|FG002|Overall Study|Withdrawal by Subject|2|||
127559420|NCT02228980|459017852|FG003|Overall Study|Withdrawal by Subject|3|||
127559421|NCT04270370|459017853|FG000|Overall Study|Lost to Follow-up|1|||
127559422|NCT04270370|459017854|FG001|Overall Study|Lost to Follow-up|0|||
127559423|NCT04270370|459017855|FG002|Overall Study|Lost to Follow-up|0|||
127559424|NCT04270370|459017856|FG003|Overall Study|Lost to Follow-up|0|||
127559425|NCT04270370|459017857|FG004|Overall Study|Lost to Follow-up|0|||
127559426|NCT04270370|459017858|FG005|Overall Study|Lost to Follow-up|0|||
127559427|NCT04270370|459017859|FG006|Overall Study|Lost to Follow-up|0|||
127559428|NCT04270370|459017860|FG007|Overall Study|Lost to Follow-up|0|||
127559429|NCT04270370|459017861|FG008|Overall Study|Lost to Follow-up|1|||
127559430|NCT04270370|459017862|FG009|Overall Study|Lost to Follow-up|0|||
127559431|NCT04270370|459017863|FG010|Overall Study|Lost to Follow-up|0|||
127559432|NCT04270370|459017864|FG011|Overall Study|Lost to Follow-up|0|||
127559433|NCT03060551|459017865|FG000|Overall Study|Withdrawal by Subject|1|||
127559434|NCT03060551|459017865|FG000|Overall Study|Adverse Event|1|||
127559435|NCT01324141|459017866|FG000|Overall Study|Declined to participate before treatment started|1|||
127774581|NCT01372410|459800366|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
128023618|NCT04518410|460710811|FG004|Overall Study|Randomized but not treated|6|||
128023619|NCT04518410|460710812|FG005|Overall Study|Randomized but not treated|4|||
128023620|NCT04518410|460710813|FG006|Overall Study|Randomized but not treated|3|||
127559436|NCT01324141|459017866|FG000|Overall Study|Disease progression on study|1|||
127559437|NCT04629066|459017869|FG000|Overall Study|Lost to Follow-up|3|||
127559438|NCT04629066|459017870|FG001|Overall Study|Lost to Follow-up|2|||
127559439|NCT00530504|459017873|FG000|Overall Study|Death|54|||
127559440|NCT00530504|459017873|FG000|Overall Study|Lost to Follow-up|26|||
127559441|NCT00530504|459017873|FG000|Overall Study|Withdrawal by Subject|39|||
127559442|NCT00530504|459017873|FG000|Overall Study|Exited study due to other reasons|33|||
127559443|NCT01808092|459017878|FG000|Overall Study|Death|39|||
127559444|NCT01808092|459017879|FG001|Overall Study|Death|29|||
127559445|NCT01808092|459017878|FG000|Overall Study|Lost to Follow-up|3|||
127559446|NCT01808092|459017879|FG001|Overall Study|Lost to Follow-up|7|||
127774582|NCT01372410|459800367|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
128023621|NCT04518410|460710814|FG007|Overall Study|Randomized but not treated|3|||
127559447|NCT01808092|459017878|FG000|Overall Study|Withdrawal by Subject|9|||
127559448|NCT01808092|459017879|FG001|Overall Study|Withdrawal by Subject|4|||
127559449|NCT01808092|459017878|FG000|Overall Study|Other Eligibility criteria|3|||
127559450|NCT01808092|459017879|FG001|Overall Study|Other Eligibility criteria|5|||
127559451|NCT03952039|459017880|FG000|Overall Study|Adverse Event|22|||
127559452|NCT03952039|459017881|FG001|Overall Study|Adverse Event|8|||
127559453|NCT03952039|459017880|FG000|Overall Study|Withdrawal by Participant|17|||
127559454|NCT03952039|459017881|FG001|Overall Study|Withdrawal by Participant|12|||
127559455|NCT03952039|459017880|FG000|Overall Study|Death|13|||
127559456|NCT03952039|459017881|FG001|Overall Study|Death|6|||
127559457|NCT03952039|459017880|FG000|Overall Study|Lack of Efficacy|12|||
127559458|NCT03952039|459017881|FG001|Overall Study|Lack of Efficacy|2|||
127559459|NCT03952039|459017880|FG000|Overall Study|Physician Decision|9|||
127559460|NCT03952039|459017881|FG001|Overall Study|Physician Decision|3|||
127559461|NCT03952039|459017880|FG000|Overall Study|Progressive Disease|6|||
127559462|NCT03952039|459017881|FG001|Overall Study|Progressive Disease|4|||
127559463|NCT03952039|459017880|FG000|Overall Study|Other Reasons|12|||
127559464|NCT03952039|459017881|FG001|Overall Study|Other Reasons|4|||
127559465|NCT05009979|459017882|FG000|Overall Study|Withdrawal by Subject|1|||
127559466|NCT03703297|459017883|FG000|Overall Study|Death|115|||
127559467|NCT03703297|459017884|FG001|Overall Study|Death|0|||
127559468|NCT03703297|459017885|FG002|Overall Study|Death|144|||
127559469|NCT03703297|459017883|FG000|Overall Study|Withdrawal by Subject|9|||
127559470|NCT03703297|459017884|FG001|Overall Study|Withdrawal by Subject|0|||
127559471|NCT03703297|459017885|FG002|Overall Study|Withdrawal by Subject|11|||
127559472|NCT03703297|459017883|FG000|Overall Study|Ongoing at the time of DCO|140|||
127559473|NCT03703297|459017884|FG001|Overall Study|Ongoing at the time of DCO|200|||
127559474|NCT03703297|459017885|FG002|Overall Study|Ongoing at the time of DCO|111|||
127559475|NCT03844945|459019391|FG000|Overall Study|Adverse Event|1|||
127559476|NCT03844945|459019392|FG001|Overall Study|Adverse Event|1|||
127559477|NCT03844945|459019393|FG002|Overall Study|Adverse Event|4|||
127559478|NCT03844945|459019394|FG003|Overall Study|Adverse Event|0|||
127559479|NCT03844945|459019391|FG000|Overall Study|Withdrawal by Subject|0|||
127559480|NCT03844945|459019392|FG001|Overall Study|Withdrawal by Subject|0|||
127559481|NCT03844945|459019393|FG002|Overall Study|Withdrawal by Subject|1|||
127559482|NCT03844945|459019394|FG003|Overall Study|Withdrawal by Subject|0|||
127559483|NCT03844945|459019391|FG000|Overall Study|Lack of Efficacy|0|||
127559484|NCT03844945|459019392|FG001|Overall Study|Lack of Efficacy|0|||
127559485|NCT03844945|459019393|FG002|Overall Study|Lack of Efficacy|0|||
127559486|NCT03844945|459019394|FG003|Overall Study|Lack of Efficacy|1|||
127559487|NCT04473235|459019397|FG000|Overall Study|Lost to Follow-up|6|||
127559488|NCT04473235|459019398|FG001|Overall Study|Lost to Follow-up|5|||
127559489|NCT04473235|459019397|FG000|Overall Study|Declined continuation|2|||
127559490|NCT04473235|459019398|FG001|Overall Study|Declined continuation|0|||
127559491|NCT04473235|459019397|FG000|Overall Study|Physician Decision|1|||
127559492|NCT04473235|459019398|FG001|Overall Study|Physician Decision|1|||
127559493|NCT04473235|459019397|FG000|Overall Study|Protocol Violation|10|||
127559494|NCT04473235|459019398|FG001|Overall Study|Protocol Violation|6|||
127559495|NCT01754402|459019399|FG000|Overall Study|Death|0|||
127559496|NCT01754402|459019400|FG001|Overall Study|Death|0|||
127559497|NCT01754402|459019401|FG002|Overall Study|Death|1|||
127559498|NCT01754402|459019399|FG000|Overall Study|Adverse Event|2|||
127559499|NCT01754402|459019400|FG001|Overall Study|Adverse Event|2|||
127559500|NCT01754402|459019401|FG002|Overall Study|Adverse Event|1|||
127559501|NCT01754402|459019399|FG000|Overall Study|Withdrawal by Subject|0|||
127559502|NCT01754402|459019400|FG001|Overall Study|Withdrawal by Subject|0|||
127559503|NCT01754402|459019401|FG002|Overall Study|Withdrawal by Subject|1|||
127559504|NCT01754402|459019399|FG000|Overall Study|Lack of Efficacy|0|||
127559505|NCT01754402|459019400|FG001|Overall Study|Lack of Efficacy|0|||
127559506|NCT01754402|459019401|FG002|Overall Study|Lack of Efficacy|1|||
127559507|NCT01282463|459019402|FG000|Overall Study|Lost to Follow-up|1|||
127559508|NCT01282463|459019403|FG001|Overall Study|Lost to Follow-up|0|||
127559509|NCT01282463|459019404|FG002|Overall Study|Lost to Follow-up|0|||
127559510|NCT01282463|459019402|FG000|Overall Study|Withdrawal by Subject|6|||
127559511|NCT01282463|459019403|FG001|Overall Study|Withdrawal by Subject|2|||
127559512|NCT01282463|459019404|FG002|Overall Study|Withdrawal by Subject|3|||
127559513|NCT01282463|459019402|FG000|Overall Study|"Never Treated Death"|0|||
127559514|NCT01282463|459019403|FG001|Overall Study|"Never Treated Death"|1|||
127559515|NCT01282463|459019404|FG002|Overall Study|"Never Treated Death"|0|||
127559516|NCT01282463|459019402|FG000|Overall Study|"Never Treated PD"|0|||
127774583|NCT01372410|459800368|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
128023622|NCT04518410|460710815|FG008|Overall Study|Randomized but not treated|0|||
127559517|NCT01282463|459019403|FG001|Overall Study|"Never Treated PD"|1|||
127559518|NCT01282463|459019404|FG002|Overall Study|"Never Treated PD"|0|||
127559519|NCT01282463|459019402|FG000|Overall Study|Protocol Violation|0|||
127559520|NCT01282463|459019403|FG001|Overall Study|Protocol Violation|0|||
127774584|NCT01372410|459800369|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
127559521|NCT01282463|459019404|FG002|Overall Study|Protocol Violation|1|||
127559522|NCT01282463|459019402|FG000|Overall Study|Physician Decision|1|||
127559523|NCT01282463|459019403|FG001|Overall Study|Physician Decision|0|||
127559524|NCT01282463|459019404|FG002|Overall Study|Physician Decision|0|||
127559525|NCT02051933|459019407|FG000|Overall Study|Physician Decision|0|||
128023623|NCT04518410|460710816|FG009|Overall Study|Randomized but not treated|4|||
128023624|NCT04518410|460710817|FG010|Overall Study|Randomized but not treated|0|||
127559526|NCT02051933|459019408|FG001|Overall Study|Physician Decision|1|||
127559527|NCT01221285|459019409|FG000|Overall Study|Withdrawal by Subject|1|||
128023625|NCT04518410|460710818|FG011|Overall Study|Randomized but not treated|0|||
128023626|NCT04518410|460710819|FG012|Overall Study|Randomized but not treated|1|||
128023627|NCT04518410|460710820|FG013|Overall Study|Randomized but not treated|3|||
128023628|NCT04518410|460710821|FG014|Overall Study|Randomized but not treated|3|||
128023629|NCT04518410|460710822|FG015|Overall Study|Randomized but not treated|3|||
128023630|NCT04518410|460710823|FG016|Overall Study|Randomized but not treated|4|||
128023631|NCT04518410|460710824|FG017|Overall Study|Randomized but not treated|5|||
128023632|NCT04518410|460710825|FG018|Overall Study|Randomized but not treated|4|||
128023633|NCT04518410|460710826|FG019|Overall Study|Randomized but not treated|0|||
128023634|NCT04518410|460710827|FG020|Overall Study|Randomized but not treated|0|||
128023635|NCT04518410|460710828|FG021|Overall Study|Randomized but not treated|5|||
128023636|NCT04518410|460710829|FG022|Overall Study|Randomized but not treated|0|||
128023637|NCT04518410|460710830|FG023|Overall Study|Randomized but not treated|3|||
128023638|NCT04518410|460710831|FG024|Overall Study|Randomized but not treated|1|||
128023639|NCT04518410|460710807|FG000|Overall Study|Screen Fail but Randomized|0|||
128023640|NCT04518410|460710808|FG001|Overall Study|Screen Fail but Randomized|0|||
128023641|NCT04518410|460710809|FG002|Overall Study|Screen Fail but Randomized|0|||
128023642|NCT04518410|460710810|FG003|Overall Study|Screen Fail but Randomized|0|||
128023643|NCT04518410|460710811|FG004|Overall Study|Screen Fail but Randomized|2|||
128023644|NCT04518410|460710812|FG005|Overall Study|Screen Fail but Randomized|0|||
128023645|NCT04518410|460710813|FG006|Overall Study|Screen Fail but Randomized|0|||
128023646|NCT04518410|460710814|FG007|Overall Study|Screen Fail but Randomized|0|||
127559528|NCT00588861|459019413|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
127559529|NCT00588861|459019414|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
127559530|NCT00588861|459019413|FG000|6 Months|Patients did not return for follow-up|98|||
127559531|NCT00588861|459019414|FG001|6 Months|Patients did not return for follow-up|73|||
127559532|NCT00588861|459019413|FG000|1 Year|Patients did not return for follow-up|89|||
128023647|NCT04518410|460710815|FG008|Overall Study|Screen Fail but Randomized|0|||
128023648|NCT04518410|460710816|FG009|Overall Study|Screen Fail but Randomized|0|||
127559533|NCT00588861|459019414|FG001|1 Year|Patients did not return for follow-up|82|||
127559534|NCT00588861|459019413|FG000|2 Years|Patients did not return for follow-up|92|||
128023649|NCT04518410|460710817|FG010|Overall Study|Screen Fail but Randomized|0|||
128023650|NCT04518410|460710818|FG011|Overall Study|Screen Fail but Randomized|0|||
128023651|NCT04518410|460710819|FG012|Overall Study|Screen Fail but Randomized|0|||
128023652|NCT04518410|460710820|FG013|Overall Study|Screen Fail but Randomized|0|||
128023653|NCT04518410|460710821|FG014|Overall Study|Screen Fail but Randomized|0|||
128023654|NCT04518410|460710822|FG015|Overall Study|Screen Fail but Randomized|0|||
127559535|NCT00588861|459019414|FG001|2 Years|Patients did not return for follow-up|87|||
127559536|NCT00588861|459019413|FG000|4 Years|Patients did not return for follow-up|91|||
127559537|NCT00588861|459019414|FG001|4 Years|Patients did not return for follow-up|103|||
127559538|NCT00588861|459019413|FG000|6 Years|Patients did not return for follow-up|104|||
127559539|NCT00588861|459019414|FG001|6 Years|Patients did not return for follow-up|109|||
127559540|NCT00588861|459019413|FG000|8 Years|Patients did not return for follow-up|105|||
127559541|NCT00588861|459019414|FG001|8 Years|Patients did not return for follow-up|114|||
127559542|NCT00588861|459019413|FG000|10 Years|Incomplete due to study termination|107|||
127559543|NCT00588861|459019414|FG001|10 Years|Incomplete due to study termination|114|||
127559544|NCT02730195|459019415|FG000|Overall Study|Withdrawal by Subject|1|||
127559545|NCT01239992|459019417|FG000|Overall Study|Withdrawal by Subject|2|||
127559546|NCT02848729|459019420|FG000|Overall Study|Withdrawal by Subject|1|||
127559547|NCT02848729|459019421|FG001|Overall Study|Withdrawal by Subject|0|||
127559548|NCT02848729|459019420|FG000|Overall Study|Emesis|15|||
127559549|NCT02848729|459019421|FG001|Overall Study|Emesis|11|||
127686186|NCT00077675|459478193|FG001|Overall Study|Withdrawal by Subject|0|||
127559550|NCT01904773|459019422|FG000|Screen|Screen failure|3|||
127559551|NCT01904773|459019423|FG001|Screen|Screen failure|0|||
127559552|NCT01904773|459019424|FG002|Screen|Screen failure|0|||
127559553|NCT01904773|459019425|FG003|Screen|Screen failure|0|||
128023655|NCT04518410|460710823|FG016|Overall Study|Screen Fail but Randomized|0|||
128023656|NCT04518410|460710824|FG017|Overall Study|Screen Fail but Randomized|0|||
128023657|NCT04518410|460710825|FG018|Overall Study|Screen Fail but Randomized|0|||
128023658|NCT04518410|460710826|FG019|Overall Study|Screen Fail but Randomized|0|||
128023659|NCT04518410|460710827|FG020|Overall Study|Screen Fail but Randomized|0|||
128023660|NCT04518410|460710828|FG021|Overall Study|Screen Fail but Randomized|0|||
128023661|NCT04518410|460710829|FG022|Overall Study|Screen Fail but Randomized|0|||
127559554|NCT01904773|459019426|FG004|Screen|Screen failure|0|||
127559555|NCT01904773|459019427|FG005|Screen|Screen failure|0|||
127559556|NCT01904773|459019428|FG006|Screen|Screen failure|0|||
127559557|NCT01904773|459019429|FG007|Screen|Screen failure|0|||
127559558|NCT01904773|459019430|FG008|Screen|Screen failure|0|||
127559559|NCT01904773|459019422|FG000|Screen|Withdrawal by Subject|1|||
127559560|NCT01904773|459019423|FG001|Screen|Withdrawal by Subject|0|||
127559561|NCT01904773|459019424|FG002|Screen|Withdrawal by Subject|0|||
127559562|NCT01904773|459019425|FG003|Screen|Withdrawal by Subject|0|||
128023662|NCT04518410|460710830|FG023|Overall Study|Screen Fail but Randomized|0|||
128023663|NCT04518410|460710831|FG024|Overall Study|Screen Fail but Randomized|0|||
128023664|NCT04518410|460710807|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
128023665|NCT04518410|460710808|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
128023666|NCT04518410|460710809|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
128023667|NCT04518410|460710810|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
128023668|NCT04518410|460710811|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
127559563|NCT01904773|459019426|FG004|Screen|Withdrawal by Subject|0|||
127559564|NCT01904773|459019427|FG005|Screen|Withdrawal by Subject|0|||
127559565|NCT01904773|459019428|FG006|Screen|Withdrawal by Subject|0|||
127559566|NCT01904773|459019429|FG007|Screen|Withdrawal by Subject|0|||
127559567|NCT01904773|459019430|FG008|Screen|Withdrawal by Subject|0|||
127559568|NCT01904773|459019422|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
127559569|NCT01904773|459019423|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
127559570|NCT01904773|459019424|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
127559571|NCT01904773|459019425|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
127559572|NCT01904773|459019426|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
127559573|NCT01904773|459019427|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
127559574|NCT01904773|459019428|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
127559575|NCT01904773|459019429|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
127559576|NCT01904773|459019430|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
127559577|NCT01904773|459019422|FG000|First Intervention|Adverse Event|0|||
127559578|NCT01904773|459019423|FG001|First Intervention|Adverse Event|0|||
127559579|NCT01904773|459019424|FG002|First Intervention|Adverse Event|0|||
128023669|NCT04518410|460710812|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|37|||
128023670|NCT04518410|460710813|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|23|||
128023671|NCT04518410|460710814|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
128023672|NCT04518410|460710815|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|6|||
128023673|NCT04518410|460710816|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
128023674|NCT04518410|460710817|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
127559580|NCT01904773|459019425|FG003|First Intervention|Adverse Event|0|||
127559581|NCT01904773|459019426|FG004|First Intervention|Adverse Event|0|||
127559582|NCT01904773|459019427|FG005|First Intervention|Adverse Event|0|||
127559583|NCT01904773|459019428|FG006|First Intervention|Adverse Event|1|||
127559584|NCT01904773|459019429|FG007|First Intervention|Adverse Event|0|||
127559585|NCT01904773|459019430|FG008|First Intervention|Adverse Event|0|||
127559586|NCT01904773|459019422|FG000|Placebo Washout First Intervention|Condition worsened|0|||
127686187|NCT00077675|459478192|FG000|Overall Study|Other|0|||
127686188|NCT00077675|459478193|FG001|Overall Study|Other|1|||
127686189|NCT00077675|459478192|FG000|Overall Study|Never received study treatment|3|||
127686190|NCT00077675|459478193|FG001|Overall Study|Never received study treatment|3|||
127686191|NCT02765100|459478196|FG000|Overall Study|subject found ineligible after baseline|1|||
127686192|NCT02765100|459478197|FG001|Overall Study|subject found ineligible after baseline|1|||
127686193|NCT02765100|459478196|FG000|Overall Study|Lost to Follow-up|0|||
127686194|NCT02765100|459478197|FG001|Overall Study|Lost to Follow-up|1|||
127686195|NCT02675244|459478198|FG000|Overall Study|Death|9|||
127686196|NCT02675244|459478199|FG001|Overall Study|Death|6|||
127686197|NCT02675244|459478198|FG000|Overall Study|Withdrawal by Subject|3|||
127686198|NCT02675244|459478199|FG001|Overall Study|Withdrawal by Subject|6|||
127686199|NCT02675244|459478198|FG000|Overall Study|Lost to Follow-up|1|||
127686200|NCT02675244|459478199|FG001|Overall Study|Lost to Follow-up|1|||
127686201|NCT02675244|459478198|FG000|Overall Study|Ongoing at 2 Years|190|||
127686202|NCT02675244|459478199|FG001|Overall Study|Ongoing at 2 Years|185|||
127686203|NCT02652442|459478200|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
127559587|NCT01904773|459019423|FG001|Placebo Washout First Intervention|Condition worsened|1|||
127559588|NCT01904773|459019424|FG002|Placebo Washout First Intervention|Condition worsened|0|||
127559589|NCT01904773|459019425|FG003|Placebo Washout First Intervention|Condition worsened|0|||
127559590|NCT01904773|459019426|FG004|Placebo Washout First Intervention|Condition worsened|0|||
127559591|NCT01904773|459019427|FG005|Placebo Washout First Intervention|Condition worsened|0|||
127559592|NCT01904773|459019428|FG006|Placebo Washout First Intervention|Condition worsened|0|||
127559593|NCT01904773|459019429|FG007|Placebo Washout First Intervention|Condition worsened|0|||
127559594|NCT01904773|459019430|FG008|Placebo Washout First Intervention|Condition worsened|0|||
127559595|NCT01904773|459019422|FG000|Fifth Intervention|Adverse Event|0|||
127559596|NCT01904773|459019423|FG001|Fifth Intervention|Adverse Event|0|||
127559597|NCT01904773|459019424|FG002|Fifth Intervention|Adverse Event|0|||
127559598|NCT01904773|459019425|FG003|Fifth Intervention|Adverse Event|0|||
127559599|NCT01904773|459019426|FG004|Fifth Intervention|Adverse Event|0|||
127559600|NCT01904773|459019427|FG005|Fifth Intervention|Adverse Event|0|||
127559601|NCT01904773|459019428|FG006|Fifth Intervention|Adverse Event|0|||
127559602|NCT01904773|459019429|FG007|Fifth Intervention|Adverse Event|1|||
127559603|NCT01904773|459019430|FG008|Fifth Intervention|Adverse Event|0|||
127559604|NCT01904773|459019422|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
127559605|NCT01904773|459019423|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
127559606|NCT01904773|459019424|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
127559607|NCT01904773|459019425|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
127559608|NCT01904773|459019426|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
127559609|NCT01904773|459019427|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
127559610|NCT01904773|459019428|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
127559611|NCT01904773|459019429|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
127559612|NCT01904773|459019430|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
127559613|NCT00220779|459019434|FG000|Overall Study|Adverse Event|1|||
127559614|NCT00220779|459019435|FG001|Overall Study|Adverse Event|0|||
127559615|NCT00220779|459019436|FG002|Overall Study|Adverse Event|0|||
127559616|NCT00220779|459019434|FG000|Overall Study|Withdrawal by Subject|1|||
127559617|NCT00220779|459019435|FG001|Overall Study|Withdrawal by Subject|4|||
127559618|NCT00220779|459019436|FG002|Overall Study|Withdrawal by Subject|1|||
127559619|NCT00220779|459019434|FG000|Overall Study|Non-compliance|1|||
127559620|NCT00220779|459019435|FG001|Overall Study|Non-compliance|0|||
127559621|NCT00220779|459019436|FG002|Overall Study|Non-compliance|0|||
127559622|NCT00220779|459019434|FG000|Overall Study|Too time consuming|1|||
127559623|NCT00220779|459019435|FG001|Overall Study|Too time consuming|0|||
127559624|NCT00220779|459019436|FG002|Overall Study|Too time consuming|0|||
127559625|NCT00220779|459019434|FG000|Overall Study|Pregnancy|0|||
127559626|NCT00220779|459019435|FG001|Overall Study|Pregnancy|0|||
127559627|NCT00220779|459019436|FG002|Overall Study|Pregnancy|2|||
127559628|NCT00220779|459019434|FG000|Overall Study|Lack of Efficacy|3|||
127559629|NCT00220779|459019435|FG001|Overall Study|Lack of Efficacy|0|||
127559630|NCT00220779|459019436|FG002|Overall Study|Lack of Efficacy|1|||
127559631|NCT00791076|459019437|FG000|Overall Study|Study was terminated,PI left institution|8|||
127559632|NCT02248675|459019438|FG000|Overall Study|Lost to Follow-up|3|||
127686204|NCT00293293|459478203|FG000|Overall Study|Withdrawal by Subject|1|||
127686205|NCT00293293|459478204|FG001|Overall Study|Withdrawal by Subject|1|||
127686206|NCT00293293|459478203|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
127686207|NCT00293293|459478204|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
127686208|NCT00293293|459478203|FG000|Overall Study|Patient discontinued chemotherapy|0|||
127686209|NCT00293293|459478204|FG001|Overall Study|Patient discontinued chemotherapy|1|||
127686210|NCT02988817|459478205|FG000|Overall Study|Withdrawal by Subject|1|||
127686211|NCT02988817|459478206|FG001|Overall Study|Withdrawal by Subject|0|||
128023675|NCT04518410|460710818|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
128023676|NCT04518410|460710819|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
128023677|NCT04518410|460710820|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
128023678|NCT04518410|460710821|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
128023679|NCT04518410|460710822|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
128023680|NCT04518410|460710823|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
128023681|NCT04518410|460710824|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
127559633|NCT02248675|459019439|FG001|Overall Study|Lost to Follow-up|1|||
127559634|NCT03390101|459019442|FG000|Weeks 0-12|Withdrawal by Subject|0|||
127559635|NCT03390101|459019443|FG001|Weeks 0-12|Withdrawal by Subject|1|||
127559636|NCT03390101|459019444|FG002|Weeks 0-12|Withdrawal by Subject|1|||
127559637|NCT03390101|459019442|FG000|Weeks 0-12|Lost to Follow-up|0|||
127559638|NCT03390101|459019443|FG001|Weeks 0-12|Lost to Follow-up|1|||
127559639|NCT03390101|459019444|FG002|Weeks 0-12|Lost to Follow-up|0|||
127559640|NCT03390101|459019442|FG000|Weeks 12-54|Withdrawal by Subject|0|||
127559641|NCT03390101|459019443|FG001|Weeks 12-54|Withdrawal by Subject|3|||
127559642|NCT03390101|459019444|FG002|Weeks 12-54|Withdrawal by Subject|1|||
127559643|NCT03390101|459019442|FG000|Weeks 12-54|Pregnancy|1|||
127686212|NCT02988817|459478207|FG002|Overall Study|Withdrawal by Subject|0|||
127559644|NCT03390101|459019443|FG001|Weeks 12-54|Pregnancy|0|||
127559645|NCT03390101|459019444|FG002|Weeks 12-54|Pregnancy|0|||
127559646|NCT03390101|459019442|FG000|Weeks 12-54|Adverse Event|2|||
127559647|NCT03390101|459019443|FG001|Weeks 12-54|Adverse Event|1|||
127559648|NCT03390101|459019444|FG002|Weeks 12-54|Adverse Event|1|||
127559649|NCT00281658|459019449|FG000|Randomized Phase|Adverse Event|0|||
127559650|NCT00281658|459019450|FG001|Randomized Phase|Adverse Event|2|||
127559651|NCT00281658|459019451|FG002|Randomized Phase|Adverse Event|0|||
127559652|NCT00281658|459019452|FG003|Randomized Phase|Adverse Event|0|||
127559653|NCT00281658|459019449|FG000|Randomized Phase|Lost to Follow-up|34|||
127559654|NCT00281658|459019450|FG001|Randomized Phase|Lost to Follow-up|27|||
127559655|NCT00281658|459019451|FG002|Randomized Phase|Lost to Follow-up|0|||
127559656|NCT00281658|459019452|FG003|Randomized Phase|Lost to Follow-up|0|||
127559657|NCT00281658|459019449|FG000|Randomized Phase|Withdrawal by Subject|8|||
127559658|NCT00281658|459019450|FG001|Randomized Phase|Withdrawal by Subject|7|||
127559659|NCT00281658|459019451|FG002|Randomized Phase|Withdrawal by Subject|0|||
127559660|NCT00281658|459019452|FG003|Randomized Phase|Withdrawal by Subject|0|||
127559661|NCT00281658|459019449|FG000|Randomized Phase|Study closed/terminated|1|||
127559662|NCT00281658|459019450|FG001|Randomized Phase|Study closed/terminated|1|||
127559663|NCT00281658|459019451|FG002|Randomized Phase|Study closed/terminated|0|||
127559664|NCT00281658|459019452|FG003|Randomized Phase|Study closed/terminated|0|||
127559665|NCT00281658|459019449|FG000|Randomized Phase|Disease progression|36|||
127559666|NCT00281658|459019450|FG001|Randomized Phase|Disease progression|27|||
127559667|NCT00281658|459019451|FG002|Randomized Phase|Disease progression|0|||
127559668|NCT00281658|459019452|FG003|Randomized Phase|Disease progression|0|||
127559669|NCT00281658|459019449|FG000|Randomized Phase|Physician Decision|1|||
127559670|NCT00281658|459019450|FG001|Randomized Phase|Physician Decision|1|||
127559671|NCT00281658|459019451|FG002|Randomized Phase|Physician Decision|0|||
127559672|NCT00281658|459019452|FG003|Randomized Phase|Physician Decision|0|||
127559673|NCT00281658|459019449|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
127559674|NCT00281658|459019450|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
127559675|NCT00281658|459019451|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
127559676|NCT00281658|459019452|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
127559677|NCT00281658|459019449|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
127559678|NCT00281658|459019450|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
127559679|NCT00281658|459019451|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
127559680|NCT00281658|459019452|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
127559681|NCT00281658|459019449|FG000|Randomized Phase|Treatment ongoing|1|||
127559682|NCT00281658|459019450|FG001|Randomized Phase|Treatment ongoing|0|||
127559683|NCT00281658|459019451|FG002|Randomized Phase|Treatment ongoing|0|||
127559684|NCT00281658|459019452|FG003|Randomized Phase|Treatment ongoing|0|||
127559685|NCT00281658|459019449|FG000|Open Label Phase|Adverse Event|0|||
127559686|NCT00281658|459019450|FG001|Open Label Phase|Adverse Event|0|||
127559687|NCT00281658|459019451|FG002|Open Label Phase|Adverse Event|1|||
127559688|NCT00281658|459019452|FG003|Open Label Phase|Adverse Event|0|||
127559689|NCT00281658|459019449|FG000|Open Label Phase|Lost to Follow-up|0|||
127559690|NCT00281658|459019450|FG001|Open Label Phase|Lost to Follow-up|0|||
127559691|NCT00281658|459019451|FG002|Open Label Phase|Lost to Follow-up|16|||
127559692|NCT00281658|459019452|FG003|Open Label Phase|Lost to Follow-up|2|||
127559693|NCT00281658|459019449|FG000|Open Label Phase|Withdrawal by Subject|0|||
127686213|NCT02988817|459478208|FG003|Overall Study|Withdrawal by Subject|1|||
127686214|NCT02988817|459478209|FG004|Overall Study|Withdrawal by Subject|3|||
127686215|NCT02988817|459478210|FG005|Overall Study|Withdrawal by Subject|1|||
127686216|NCT02988817|459478211|FG006|Overall Study|Withdrawal by Subject|2|||
127686217|NCT02988817|459478212|FG007|Overall Study|Withdrawal by Subject|1|||
127559694|NCT00281658|459019450|FG001|Open Label Phase|Withdrawal by Subject|0|||
127559695|NCT00281658|459019451|FG002|Open Label Phase|Withdrawal by Subject|3|||
127559696|NCT00281658|459019452|FG003|Open Label Phase|Withdrawal by Subject|2|||
127686218|NCT02988817|459478213|FG008|Overall Study|Withdrawal by Subject|1|||
127774585|NCT01372410|459800370|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
127686219|NCT02988817|459478214|FG009|Overall Study|Withdrawal by Subject|1|||
127686220|NCT02988817|459478215|FG010|Overall Study|Withdrawal by Subject|1|||
127559697|NCT00281658|459019449|FG000|Open Label Phase|Disease progression|0|||
127559698|NCT00281658|459019450|FG001|Open Label Phase|Disease progression|0|||
127559699|NCT00281658|459019451|FG002|Open Label Phase|Disease progression|18|||
127559700|NCT00281658|459019452|FG003|Open Label Phase|Disease progression|0|||
127559701|NCT00281658|459019449|FG000|Open Label Phase|Physician Decision|0|||
127559702|NCT00281658|459019450|FG001|Open Label Phase|Physician Decision|0|||
127559703|NCT00281658|459019451|FG002|Open Label Phase|Physician Decision|1|||
127559704|NCT00281658|459019452|FG003|Open Label Phase|Physician Decision|0|||
127559705|NCT00281658|459019449|FG000|Open Label Phase|Relocation of patient|0|||
127559706|NCT00281658|459019450|FG001|Open Label Phase|Relocation of patient|0|||
127559707|NCT00281658|459019451|FG002|Open Label Phase|Relocation of patient|1|||
127559708|NCT00281658|459019452|FG003|Open Label Phase|Relocation of patient|0|||
127559709|NCT00281658|459019449|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
127559710|NCT00281658|459019450|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
127559711|NCT00281658|459019451|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
127559712|NCT00281658|459019452|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
127559713|NCT00813943|459019456|FG000|Overall Study|Ongoing at cut-off date|5|||
127559714|NCT00813943|459019457|FG001|Overall Study|Ongoing at cut-off date|5|||
127559715|NCT00813943|459019458|FG002|Overall Study|Ongoing at cut-off date|3|||
127559716|NCT01343693|459019459|FG000|Overall Study|Lost to Follow-up|9|||
127559717|NCT02551991|459019460|FG000|Overall Study|Death|5|||
127559718|NCT02551991|459019461|FG001|Overall Study|Death|7|||
127559719|NCT02551991|459019462|FG002|Overall Study|Death|8|||
127559720|NCT02551991|459019463|FG003|Overall Study|Death|7|||
127559721|NCT02551991|459019464|FG004|Overall Study|Death|17|||
127559722|NCT02551991|459019460|FG000|Overall Study|Withdrawal by Subject|1|||
127559723|NCT02551991|459019461|FG001|Overall Study|Withdrawal by Subject|0|||
127559724|NCT02551991|459019462|FG002|Overall Study|Withdrawal by Subject|0|||
127559725|NCT02551991|459019463|FG003|Overall Study|Withdrawal by Subject|0|||
127559726|NCT02551991|459019464|FG004|Overall Study|Withdrawal by Subject|2|||
127559727|NCT02551991|459019460|FG000|Overall Study|Lost to Follow-up|0|||
127559728|NCT02551991|459019461|FG001|Overall Study|Lost to Follow-up|0|||
127559729|NCT02551991|459019462|FG002|Overall Study|Lost to Follow-up|1|||
127559730|NCT02551991|459019463|FG003|Overall Study|Lost to Follow-up|0|||
127559731|NCT02551991|459019464|FG004|Overall Study|Lost to Follow-up|0|||
127559732|NCT02551991|459019460|FG000|Overall Study|Sponsor Decision|1|||
127559733|NCT02551991|459019461|FG001|Overall Study|Sponsor Decision|0|||
127559734|NCT02551991|459019462|FG002|Overall Study|Sponsor Decision|1|||
127559735|NCT02551991|459019463|FG003|Overall Study|Sponsor Decision|0|||
127559736|NCT02551991|459019464|FG004|Overall Study|Sponsor Decision|5|||
127559737|NCT02551991|459019460|FG000|Overall Study|Other|0|||
127559738|NCT02551991|459019461|FG001|Overall Study|Other|0|||
127559739|NCT02551991|459019462|FG002|Overall Study|Other|0|||
127559740|NCT02551991|459019463|FG003|Overall Study|Other|0|||
127559741|NCT02551991|459019464|FG004|Overall Study|Other|1|||
127559742|NCT00265148|459019465|FG000|Overall Study|Adverse Event|2|||
127559743|NCT00265148|459019466|FG001|Overall Study|Adverse Event|2|||
127559744|NCT00265148|459019465|FG000|Overall Study|Lack of Efficacy|0|||
127559745|NCT00265148|459019466|FG001|Overall Study|Lack of Efficacy|2|||
127559746|NCT00265148|459019465|FG000|Overall Study|Protocol Violation|3|||
127559747|NCT00265148|459019466|FG001|Overall Study|Protocol Violation|2|||
127559748|NCT00265148|459019465|FG000|Overall Study|Lost to Follow-up|0|||
127559749|NCT00265148|459019466|FG001|Overall Study|Lost to Follow-up|1|||
127559750|NCT00265148|459019465|FG000|Overall Study|Withdrawal by Subject|2|||
127559751|NCT00265148|459019466|FG001|Overall Study|Withdrawal by Subject|1|||
127559752|NCT00265148|459019465|FG000|Overall Study|Physician Decision|1|||
127559753|NCT00265148|459019466|FG001|Overall Study|Physician Decision|0|||
127559754|NCT00265148|459019465|FG000|Overall Study|Increasing frailty|0|||
127559755|NCT00265148|459019466|FG001|Overall Study|Increasing frailty|1|||
127559756|NCT00265148|459019465|FG000|Overall Study|Subject chose to change of the dose|1|||
127559757|NCT00265148|459019466|FG001|Overall Study|Subject chose to change of the dose|0|||
127559758|NCT01463007|459019467|FG000|Overall Study|Physician Decision|1|||
127559759|NCT00444678|459019468|FG000|Overall Study|Toxicity|11|||
127559760|NCT00444678|459019468|FG000|Overall Study|Disease Progression|12|||
127559761|NCT00444678|459019468|FG000|Overall Study|Death|3|||
127559762|NCT00444678|459019468|FG000|Overall Study|Physician Decision|3|||
127559763|NCT00444678|459019468|FG000|Overall Study|Withdrawal by Subject|2|||
127559764|NCT00606905|459019469|FG000|Overall Study|No Pregnancy|9|||
127559765|NCT00606905|459019470|FG001|Overall Study|No Pregnancy|6|||
128023682|NCT04518410|460710825|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|16|||
127559766|NCT00606905|459019469|FG000|Overall Study|Non-Index Pregnancy|1|||
127559767|NCT00606905|459019470|FG001|Overall Study|Non-Index Pregnancy|4|||
127559768|NCT00606905|459019469|FG000|Overall Study|Withdrew|5|||
127559769|NCT00606905|459019470|FG001|Overall Study|Withdrew|5|||
127559770|NCT00859638|459019471|FG000|Overall Study|Lost to Follow-up|6|||
127559771|NCT00859638|459019472|FG001|Overall Study|Lost to Follow-up|1|||
127559772|NCT00859638|459019471|FG000|Overall Study|Withdrawal by Subject|3|||
127559773|NCT00859638|459019472|FG001|Overall Study|Withdrawal by Subject|2|||
127559774|NCT00859638|459019471|FG000|Overall Study|Ill health|1|||
127559775|NCT00859638|459019472|FG001|Overall Study|Ill health|1|||
127559776|NCT02969408|459019474|FG000|Overall Study|Adverse Event|2|||
127559777|NCT02969408|459019474|FG000|Overall Study|Withdrawal by Subject|8|||
127559778|NCT02969408|459019474|FG000|Overall Study|Lost to Follow-up|4|||
127559779|NCT02969408|459019474|FG000|Overall Study|Protocol Violation|1|||
127559780|NCT02969408|459019474|FG000|Overall Study|Other than specified|1|||
127559781|NCT02779556|459019478|FG000|Baseline|Partial baseline interview completed|1|||
127559782|NCT02779556|459019479|FG001|Baseline|Partial baseline interview completed|0|||
127559783|NCT02779556|459019478|FG000|3 Months|Lost to Follow-up|40|||
127559784|NCT02779556|459019479|FG001|3 Months|Lost to Follow-up|29|||
127559785|NCT02779556|459019478|FG000|3 Months|Missed 3 month clinic visit|27|||
127559786|NCT02779556|459019479|FG001|3 Months|Missed 3 month clinic visit|19|||
127559787|NCT02779556|459019478|FG000|6 Month|Lost to Follow-up|33|||
127559788|NCT02779556|459019479|FG001|6 Month|Lost to Follow-up|39|||
127559789|NCT02779556|459019478|FG000|6 Month HbA1c|No value collected during window|69|||
127559790|NCT02779556|459019479|FG001|6 Month HbA1c|No value collected during window|50|||
127559791|NCT02779556|459019478|FG000|12 Month HbA1c|No value collected during window|138|||
127559792|NCT02779556|459019479|FG001|12 Month HbA1c|No value collected during window|102|||
127559793|NCT03110770|459019483|FG000|Overall Study|Death|1|||
127559794|NCT03110770|459019484|FG001|Overall Study|Death|0|||
127559795|NCT03110770|459019485|FG002|Overall Study|Death|0|||
127559796|NCT03110770|459019486|FG003|Overall Study|Death|1|||
127559797|NCT03110770|459019487|FG004|Overall Study|Death|0|||
127559798|NCT03110770|459019483|FG000|Overall Study|Enrolled but did not receive product|0|||
127559799|NCT03110770|459019484|FG001|Overall Study|Enrolled but did not receive product|0|||
127559800|NCT03110770|459019485|FG002|Overall Study|Enrolled but did not receive product|0|||
127559801|NCT03110770|459019486|FG003|Overall Study|Enrolled but did not receive product|8|||
127559802|NCT03110770|459019487|FG004|Overall Study|Enrolled but did not receive product|7|||
127559803|NCT03110770|459019483|FG000|Overall Study|Lost to Follow-up|0|||
127559804|NCT03110770|459019484|FG001|Overall Study|Lost to Follow-up|0|||
127559805|NCT03110770|459019485|FG002|Overall Study|Lost to Follow-up|0|||
127559806|NCT03110770|459019486|FG003|Overall Study|Lost to Follow-up|53|||
127559807|NCT03110770|459019487|FG004|Overall Study|Lost to Follow-up|45|||
127559808|NCT03110770|459019483|FG000|Overall Study|Investigator Decision|0|||
127559809|NCT03110770|459019484|FG001|Overall Study|Investigator Decision|0|||
127559810|NCT03110770|459019485|FG002|Overall Study|Investigator Decision|0|||
127559811|NCT03110770|459019486|FG003|Overall Study|Investigator Decision|5|||
127559812|NCT03110770|459019487|FG004|Overall Study|Investigator Decision|3|||
127559813|NCT03110770|459019483|FG000|Overall Study|Withdrawal by Subject|0|||
127559814|NCT03110770|459019484|FG001|Overall Study|Withdrawal by Subject|0|||
127559815|NCT03110770|459019485|FG002|Overall Study|Withdrawal by Subject|0|||
127559816|NCT03110770|459019486|FG003|Overall Study|Withdrawal by Subject|24|||
127559817|NCT03110770|459019487|FG004|Overall Study|Withdrawal by Subject|24|||
127559818|NCT03110770|459019483|FG000|Overall Study|Moved from area|5|||
127559819|NCT03110770|459019484|FG001|Overall Study|Moved from area|0|||
127559820|NCT03110770|459019485|FG002|Overall Study|Moved from area|2|||
127559821|NCT03110770|459019486|FG003|Overall Study|Moved from area|42|||
127559822|NCT03110770|459019487|FG004|Overall Study|Moved from area|43|||
127559823|NCT03110770|459019483|FG000|Overall Study|Illness/Injury unrelated to product|0|||
127559824|NCT03110770|459019484|FG001|Overall Study|Illness/Injury unrelated to product|0|||
127559825|NCT03110770|459019485|FG002|Overall Study|Illness/Injury unrelated to product|0|||
127559826|NCT03110770|459019486|FG003|Overall Study|Illness/Injury unrelated to product|0|||
127559827|NCT03110770|459019487|FG004|Overall Study|Illness/Injury unrelated to product|1|||
127559828|NCT01767142|459019490|FG000|Overall Study|Lost to Follow-up|3|||
127559829|NCT02082340|459019494|FG000|Overall Study|Lost to Follow-up|1|||
127559830|NCT02082340|459019495|FG001|Overall Study|Lost to Follow-up|1|||
127559831|NCT01625260|459019496|FG000|Overall Study|Adverse Event|3|||
127559832|NCT01625260|459019497|FG001|Overall Study|Adverse Event|0|||
127559833|NCT01625260|459019496|FG000|Overall Study|Study Terminated by Investigator|2|||
127559834|NCT01625260|459019497|FG001|Overall Study|Study Terminated by Investigator|0|||
127559835|NCT01625260|459019496|FG000|Overall Study|Disease Progression|2|||
127559836|NCT01625260|459019497|FG001|Overall Study|Disease Progression|0|||
127559837|NCT01625260|459019496|FG000|Overall Study|PI and subject decided to terminate treatment|0|||
127559838|NCT01625260|459019497|FG001|Overall Study|PI and subject decided to terminate treatment|1|||
127559839|NCT01024309|459019498|FG000|Overall Study|Physician Decision|4|||
127559840|NCT01024309|459019499|FG001|Overall Study|Physician Decision|0|||
127559841|NCT01024309|459019498|FG000|Overall Study|Withdrawal by Subject|4|||
127559842|NCT01024309|459019499|FG001|Overall Study|Withdrawal by Subject|4|||
127559843|NCT05194579|459019502|FG000|Overall Study|Lost to Follow-up|2|||
127559844|NCT05194579|459019503|FG001|Overall Study|Lost to Follow-up|3|||
127559845|NCT05194579|459019502|FG000|Overall Study|Withdrawal by Subject|3|||
127686221|NCT02988817|459478216|FG011|Overall Study|Withdrawal by Subject|12|||
127686222|NCT02988817|459478217|FG012|Overall Study|Withdrawal by Subject|6|||
127686223|NCT02988817|459478218|FG013|Overall Study|Withdrawal by Subject|6|||
127686224|NCT02988817|459478219|FG014|Overall Study|Withdrawal by Subject|4|||
127686225|NCT02988817|459478220|FG015|Overall Study|Withdrawal by Subject|5|||
127686226|NCT02988817|459478221|FG016|Overall Study|Withdrawal by Subject|4|||
127686227|NCT02988817|459478222|FG017|Overall Study|Withdrawal by Subject|11|||
127686228|NCT02988817|459478223|FG018|Overall Study|Withdrawal by Subject|4|||
127686229|NCT02988817|459478224|FG019|Overall Study|Withdrawal by Subject|2|||
127686230|NCT02988817|459478205|FG000|Overall Study|Death|0|||
128023683|NCT04518410|460710826|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
128023684|NCT04518410|460710827|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|19|||
127559846|NCT05194579|459019503|FG001|Overall Study|Withdrawal by Subject|4|||
127559847|NCT05194579|459019502|FG000|Overall Study|Refused further study procedures|0|||
127559848|NCT05194579|459019503|FG001|Overall Study|Refused further study procedures|1|||
127559849|NCT05194579|459019502|FG000|Overall Study|Protocol deviation|1|||
127559850|NCT05194579|459019503|FG001|Overall Study|Protocol deviation|0|||
127559851|NCT03890666|459019504|FG000|Overall Study|Withdrawal by Subject|0|||
127559852|NCT03890666|459019505|FG001|Overall Study|Withdrawal by Subject|1|||
127559853|NCT03890666|459019504|FG000|Overall Study|Protocol deviation|1|||
127559854|NCT03890666|459019505|FG001|Overall Study|Protocol deviation|4|||
127559855|NCT03890666|459019504|FG000|Overall Study|Lost to Follow-up|2|||
127559856|NCT03890666|459019505|FG001|Overall Study|Lost to Follow-up|5|||
127559857|NCT03890666|459019504|FG000|Overall Study|Other than specified|1|||
127559858|NCT03890666|459019505|FG001|Overall Study|Other than specified|8|||
127559859|NCT01639729|459019506|FG000|Overall Study|Withdrawal by Subject|1|||
127559860|NCT01639729|459019507|FG001|Overall Study|Withdrawal by Subject|0|||
127559861|NCT01639729|459019508|FG002|Overall Study|Withdrawal by Subject|1|||
127559862|NCT01639729|459019509|FG003|Overall Study|Withdrawal by Subject|1|||
127559863|NCT01639729|459019510|FG004|Overall Study|Withdrawal by Subject|0|||
127559864|NCT01639729|459019511|FG005|Overall Study|Withdrawal by Subject|0|||
127559865|NCT00567255|459019512|FG000|Overall Study|Adverse Event|241|||
127559866|NCT00567255|459019513|FG001|Overall Study|Adverse Event|68|||
127559867|NCT00567255|459019512|FG000|Overall Study|Lost to Follow-up|77|||
127559868|NCT00567255|459019513|FG001|Overall Study|Lost to Follow-up|48|||
127559869|NCT00567255|459019512|FG000|Overall Study|Withdrawal by Subject|75|||
127559870|NCT00567255|459019513|FG001|Overall Study|Withdrawal by Subject|56|||
127559871|NCT00567255|459019512|FG000|Overall Study|Lack of Efficacy|19|||
127774586|NCT01372410|459800371|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
127774587|NCT04585646|459800372|FG000|First Intervention|Physician Decision|1|||
127774588|NCT04585646|459800373|FG001|First Intervention|Physician Decision|0|||
127686231|NCT02988817|459478206|FG001|Overall Study|Death|1|||
127686232|NCT02988817|459478207|FG002|Overall Study|Death|3|||
127686233|NCT02988817|459478208|FG003|Overall Study|Death|1|||
127686234|NCT02988817|459478209|FG004|Overall Study|Death|6|||
127686235|NCT02988817|459478210|FG005|Overall Study|Death|10|||
127686236|NCT02988817|459478211|FG006|Overall Study|Death|1|||
127686237|NCT02988817|459478212|FG007|Overall Study|Death|2|||
127686238|NCT02988817|459478213|FG008|Overall Study|Death|1|||
127686239|NCT02988817|459478214|FG009|Overall Study|Death|5|||
127686240|NCT02988817|459478215|FG010|Overall Study|Death|1|||
127686241|NCT02988817|459478216|FG011|Overall Study|Death|8|||
127686242|NCT02988817|459478217|FG012|Overall Study|Death|9|||
127686243|NCT02988817|459478218|FG013|Overall Study|Death|17|||
127686244|NCT02988817|459478219|FG014|Overall Study|Death|18|||
127686245|NCT02988817|459478220|FG015|Overall Study|Death|30|||
127686246|NCT02988817|459478221|FG016|Overall Study|Death|17|||
127686247|NCT02988817|459478222|FG017|Overall Study|Death|38|||
127686248|NCT02988817|459478223|FG018|Overall Study|Death|14|||
127686249|NCT02988817|459478224|FG019|Overall Study|Death|16|||
127686250|NCT02988817|459478205|FG000|Overall Study|Other|0|||
127686251|NCT02988817|459478206|FG001|Overall Study|Other|0|||
127686252|NCT02988817|459478207|FG002|Overall Study|Other|0|||
127686253|NCT02988817|459478208|FG003|Overall Study|Other|1|||
127686254|NCT02988817|459478209|FG004|Overall Study|Other|1|||
127686255|NCT02988817|459478210|FG005|Overall Study|Other|0|||
127686256|NCT02988817|459478211|FG006|Overall Study|Other|0|||
127686257|NCT02988817|459478212|FG007|Overall Study|Other|0|||
127686258|NCT02988817|459478213|FG008|Overall Study|Other|0|||
127686259|NCT02988817|459478214|FG009|Overall Study|Other|0|||
127686260|NCT02988817|459478215|FG010|Overall Study|Other|0|||
127774589|NCT04585646|459800372|FG000|First Intervention|Lost to Follow-up|0|||
127686261|NCT02988817|459478216|FG011|Overall Study|Other|0|||
127559872|NCT00567255|459019513|FG001|Overall Study|Lack of Efficacy|33|||
127559873|NCT00567255|459019512|FG000|Overall Study|Protocol Violation|20|||
127559874|NCT00567255|459019513|FG001|Overall Study|Protocol Violation|8|||
127559875|NCT00567255|459019512|FG000|Overall Study|Pregnancy|6|||
127559876|NCT00567255|459019513|FG001|Overall Study|Pregnancy|0|||
127686262|NCT02988817|459478217|FG012|Overall Study|Other|0|||
127686263|NCT02988817|459478218|FG013|Overall Study|Other|0|||
127686264|NCT02988817|459478219|FG014|Overall Study|Other|0|||
127686265|NCT02988817|459478220|FG015|Overall Study|Other|1|||
127686266|NCT02988817|459478221|FG016|Overall Study|Other|0|||
127686267|NCT02988817|459478222|FG017|Overall Study|Other|0|||
127686268|NCT02988817|459478223|FG018|Overall Study|Other|0|||
127686269|NCT02988817|459478224|FG019|Overall Study|Other|0|||
127686270|NCT02988817|459478205|FG000|Overall Study|Lost to Follow-up|0|||
127686271|NCT02988817|459478206|FG001|Overall Study|Lost to Follow-up|0|||
127686272|NCT02988817|459478207|FG002|Overall Study|Lost to Follow-up|0|||
127686273|NCT02988817|459478208|FG003|Overall Study|Lost to Follow-up|0|||
127559877|NCT00567255|459019512|FG000|Overall Study|Drug noncompliance,moved,other|25|||
127559878|NCT00567255|459019513|FG001|Overall Study|Drug noncompliance,moved,other|15|||
127559879|NCT03052426|459019514|FG000|Overall Study|Withdrawal by Subject|0|||
127559880|NCT03052426|459019515|FG001|Overall Study|Withdrawal by Subject|1|||
127559881|NCT03052426|459019516|FG002|Overall Study|Withdrawal by Subject|0|||
127559882|NCT03052426|459019514|FG000|Overall Study|Lost to Follow-up|2|||
127559883|NCT03052426|459019515|FG001|Overall Study|Lost to Follow-up|0|||
127559884|NCT03052426|459019516|FG002|Overall Study|Lost to Follow-up|1|||
127559885|NCT03083990|459019519|FG000|Overall Study|Adverse Event|1|||
127559886|NCT03083990|459019520|FG001|Overall Study|Adverse Event|0|||
127559887|NCT04145219|459019521|FG000|Overall Study|Adverse Event|18|||
127559888|NCT04145219|459019522|FG001|Overall Study|Adverse Event|6|||
127559889|NCT04145219|459019521|FG000|Overall Study|Lost to Follow-up|2|||
127559890|NCT04145219|459019522|FG001|Overall Study|Lost to Follow-up|3|||
127559891|NCT04145219|459019521|FG000|Overall Study|Physician Decision|0|||
127559892|NCT04145219|459019522|FG001|Overall Study|Physician Decision|2|||
127559893|NCT04145219|459019521|FG000|Overall Study|Withdrawal by Subject|12|||
127559894|NCT04145219|459019522|FG001|Overall Study|Withdrawal by Subject|8|||
127559895|NCT04145219|459019521|FG000|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
127559896|NCT04145219|459019522|FG001|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
127559897|NCT03672097|459019523|FG000|Period 1|Withdrawal by Subject|2|||
127559898|NCT03672097|459019523|FG000|Period 1|Adverse Event|1|||
127559899|NCT03672097|459019523|FG000|Period 1|Did not receive treatment|1|||
127559900|NCT03672097|459019523|FG000|Period 2|Withdrawal by Subject|3|||
127559901|NCT03672097|459019523|FG000|Period 2|Other|1|||
127559902|NCT01290796|459019524|FG000|Overall Study|Lost to Follow-up|21|||
127559903|NCT01290796|459019524|FG000|Overall Study|Withdrawal by Subject|4|||
127559904|NCT01290796|459019524|FG000|Overall Study|Physician Decision|2|||
127559905|NCT01290796|459019524|FG000|Overall Study|Secondary Surgical Intervention|2|||
127559906|NCT01290796|459019524|FG000|Overall Study|Withdrawal by Sponsor|1|||
127559907|NCT04975438|459019525|FG000|Overall Study|Lost to Follow-up|1|||
127559908|NCT04975438|459019526|FG001|Overall Study|Lost to Follow-up|0|||
127559909|NCT04975438|459019527|FG002|Overall Study|Lost to Follow-up|1|||
127559910|NCT04975438|459019528|FG003|Overall Study|Lost to Follow-up|0|||
127559911|NCT04975438|459019525|FG000|Overall Study|Withdrawal by Subject|1|||
127559912|NCT04975438|459019526|FG001|Overall Study|Withdrawal by Subject|0|||
127559913|NCT04975438|459019527|FG002|Overall Study|Withdrawal by Subject|0|||
127559914|NCT04975438|459019528|FG003|Overall Study|Withdrawal by Subject|0|||
127559915|NCT01950013|459019535|FG000|Overall Study|Withdrawal by Subject|0|||
127559916|NCT01950013|459019536|FG001|Overall Study|Withdrawal by Subject|2|||
127559917|NCT01950013|459019537|FG002|Overall Study|Withdrawal by Subject|0|||
127559918|NCT00275340|459019538|FG000|Overall Study|Lost to Follow-up|2|||
127559919|NCT00275340|459019539|FG001|Overall Study|Lost to Follow-up|4|||
127559920|NCT01798849|459019542|FG000|Overall Study|Physician Decision|0|||
127774590|NCT04585646|459800373|FG001|First Intervention|Lost to Follow-up|3|||
127774591|NCT04585646|459800372|FG000|First Intervention|Withdrawal by Subject|0|||
127559921|NCT01798849|459019543|FG001|Overall Study|Physician Decision|0|||
127559922|NCT01798849|459019544|FG002|Overall Study|Physician Decision|1|||
127559923|NCT00335764|459019545|FG000|Overall Study|wrong histology|1|||
127559924|NCT00335764|459019546|FG001|Overall Study|wrong histology|0|||
127559925|NCT00335764|459019547|FG002|Overall Study|wrong histology|0|||
127559926|NCT00335764|459019548|FG003|Overall Study|wrong histology|0|||
127559927|NCT00335764|459019549|FG004|Overall Study|wrong histology|1|||
127559928|NCT02466659|459019552|FG000|Overall Study|Lost to Follow-up|5|||
127559929|NCT02466659|459019553|FG001|Overall Study|Lost to Follow-up|2|||
127559930|NCT00929643|459019554|FG000|Overall Study|Protocol Violation|2|||
127559931|NCT00750152|459019555|FG000|Overall Study|Adverse Event|2|||
127559932|NCT00750152|459019556|FG001|Overall Study|Adverse Event|1|||
127559933|NCT00750152|459019555|FG000|Overall Study|Lost to Follow-up|8|||
127559934|NCT00750152|459019556|FG001|Overall Study|Lost to Follow-up|13|||
128023685|NCT04518410|460710828|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
128023686|NCT04518410|460710829|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
128023687|NCT04518410|460710830|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
128023688|NCT04518410|460710831|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
127559935|NCT00750152|459019555|FG000|Overall Study|Withdrawal by Subject|3|||
127559936|NCT00750152|459019556|FG001|Overall Study|Withdrawal by Subject|3|||
127559937|NCT00750152|459019555|FG000|Overall Study|Physician Decision|1|||
127559938|NCT00750152|459019556|FG001|Overall Study|Physician Decision|1|||
127559939|NCT00750152|459019555|FG000|Overall Study|Non-compliance|0|||
127559940|NCT00750152|459019556|FG001|Overall Study|Non-compliance|1|||
127559941|NCT00750152|459019555|FG000|Overall Study|Termination by sponsor|1|||
127559942|NCT00750152|459019556|FG001|Overall Study|Termination by sponsor|0|||
127559943|NCT00750152|459019555|FG000|Overall Study|Other|7|||
127774592|NCT04585646|459800373|FG001|First Intervention|Withdrawal by Subject|1|||
127559944|NCT00750152|459019556|FG001|Overall Study|Other|8|||
128023689|NCT04518410|460710807|FG000|Overall Study|Dual Enrolled Subject|0|||
128023690|NCT04518410|460710808|FG001|Overall Study|Dual Enrolled Subject|0|||
128023691|NCT04518410|460710809|FG002|Overall Study|Dual Enrolled Subject|0|||
128023692|NCT04518410|460710810|FG003|Overall Study|Dual Enrolled Subject|0|||
128023693|NCT04518410|460710811|FG004|Overall Study|Dual Enrolled Subject|0|||
128023694|NCT04518410|460710812|FG005|Overall Study|Dual Enrolled Subject|0|||
128023695|NCT04518410|460710813|FG006|Overall Study|Dual Enrolled Subject|0|||
128023696|NCT04518410|460710814|FG007|Overall Study|Dual Enrolled Subject|0|||
127559945|NCT02034409|459019561|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
127559946|NCT02034409|459019562|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
127559947|NCT02034409|459019561|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
127559948|NCT02034409|459019562|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
127559949|NCT02034409|459019561|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
127559950|NCT02034409|459019562|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
127559951|NCT02034409|459019561|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
127559952|NCT02034409|459019562|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
127559953|NCT02034409|459019561|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
127559954|NCT02034409|459019562|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
127559955|NCT02034409|459019561|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
127559956|NCT02034409|459019562|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
127559957|NCT01699867|459019563|FG000|Overall Study|Screening Failure|3|||
127559958|NCT01888432|459021515|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
127559959|NCT01888432|459021516|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
127559960|NCT01888432|459021515|FG000|12-month Analysis (FAS)|Physician Decision|1|||
127559961|NCT01888432|459021516|FG001|12-month Analysis (FAS)|Physician Decision|1|||
127559962|NCT01888432|459021515|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
127559963|NCT01888432|459021516|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
127559964|NCT01888432|459021515|FG000|12-month Analysis (FAS)|Death|4|||
127559965|NCT01888432|459021516|FG001|12-month Analysis (FAS)|Death|3|||
127559966|NCT01888432|459021515|FG000|24-month Analysis (FAS)|Graft loss|0|||
127559967|NCT01888432|459021516|FG001|24-month Analysis (FAS)|Graft loss|1|||
127559968|NCT01888432|459021515|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
127559969|NCT01888432|459021516|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
127559970|NCT01888432|459021515|FG000|24-month Analysis (FAS)|Physician Decision|2|||
127559971|NCT01888432|459021516|FG001|24-month Analysis (FAS)|Physician Decision|4|||
127559972|NCT01888432|459021515|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
127559973|NCT01888432|459021516|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
127559974|NCT01888432|459021515|FG000|24-month Analysis (FAS)|Death|8|||
127559975|NCT01888432|459021516|FG001|24-month Analysis (FAS)|Death|4|||
127559976|NCT01888432|459021515|FG000|36-month Analysis (Extension)|Death|1|||
127559977|NCT01888432|459021516|FG001|36-month Analysis (Extension)|Death|0|||
127559978|NCT00130247|459021519|FG000|Overall Study|Pregnancy|1|||
127559979|NCT00130247|459021520|FG001|Overall Study|Pregnancy|0|||
127559980|NCT00130247|459021519|FG000|Overall Study|Post-randomization exclusion|1|||
127559981|NCT00130247|459021520|FG001|Overall Study|Post-randomization exclusion|2|||
127559982|NCT00130247|459021519|FG000|Overall Study|Not compliant with DOT|0|||
127559983|NCT00130247|459021520|FG001|Overall Study|Not compliant with DOT|2|||
127559984|NCT02123251|459021521|FG000|Overall Study|Death|1|||
127559985|NCT02123251|459021522|FG001|Overall Study|Death|1|||
127559986|NCT02123251|459021521|FG000|Overall Study|Withdrawal by Subject|0|||
127559987|NCT02123251|459021522|FG001|Overall Study|Withdrawal by Subject|3|||
127559988|NCT02123251|459021521|FG000|Overall Study|Lost Medicaid eligibility|29|||
127559989|NCT02123251|459021522|FG001|Overall Study|Lost Medicaid eligibility|22|||
127559990|NCT02123251|459021521|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
127559991|NCT02123251|459021522|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
127559992|NCT02704143|459021523|FG000|Overall Study|disease progression|10|||
127559993|NCT01235598|459021524|FG000|Overall Study|Adverse Event|0|||
127559994|NCT01235598|459021525|FG001|Overall Study|Adverse Event|3|||
127774593|NCT02465463|459800375|FG000|Overall Study|Lost to Follow-up|2|||
127774594|NCT02465463|459800376|FG001|Overall Study|Lost to Follow-up|1|||
127559995|NCT01235598|459021524|FG000|Overall Study|Lack of Efficacy|0|||
127559996|NCT01235598|459021525|FG001|Overall Study|Lack of Efficacy|1|||
127559997|NCT01235598|459021524|FG000|Overall Study|Withdrawal by Subject|1|||
127559998|NCT01235598|459021525|FG001|Overall Study|Withdrawal by Subject|0|||
127774595|NCT02465463|459800375|FG000|Overall Study|Death|1|||
127559999|NCT02151773|459021526|FG000|Overall Study|Protocol Deviation|64|||
127560000|NCT00395343|459021527|FG000|Overall Study|Adverse Event|13|||
127560001|NCT00395343|459021528|FG001|Overall Study|Adverse Event|5|||
127560002|NCT00395343|459021527|FG000|Overall Study|Lack of Efficacy|0|||
127560003|NCT00395343|459021528|FG001|Overall Study|Lack of Efficacy|1|||
127560004|NCT00395343|459021527|FG000|Overall Study|Lost to Follow-up|4|||
128023697|NCT04518410|460710815|FG008|Overall Study|Dual Enrolled Subject|0|||
128023698|NCT04518410|460710816|FG009|Overall Study|Dual Enrolled Subject|0|||
128023699|NCT04518410|460710817|FG010|Overall Study|Dual Enrolled Subject|0|||
128023700|NCT04518410|460710818|FG011|Overall Study|Dual Enrolled Subject|0|||
128023701|NCT04518410|460710819|FG012|Overall Study|Dual Enrolled Subject|0|||
128023702|NCT04518410|460710820|FG013|Overall Study|Dual Enrolled Subject|0|||
127560005|NCT00395343|459021528|FG001|Overall Study|Lost to Follow-up|4|||
127560006|NCT00395343|459021527|FG000|Overall Study|Physician Decision|2|||
127560007|NCT00395343|459021528|FG001|Overall Study|Physician Decision|4|||
127560008|NCT00395343|459021527|FG000|Overall Study|Protocol Violation|6|||
127560009|NCT00395343|459021528|FG001|Overall Study|Protocol Violation|8|||
127560010|NCT00395343|459021527|FG000|Overall Study|Withdrawal by Subject|11|||
127560011|NCT00395343|459021528|FG001|Overall Study|Withdrawal by Subject|12|||
127560012|NCT00395343|459021527|FG000|Overall Study|Other|5|||
127560013|NCT00395343|459021528|FG001|Overall Study|Other|2|||
127560014|NCT00387790|459021531|FG000|Overall Study|Adverse Event|5|||
127560015|NCT00387790|459021531|FG000|Overall Study|Lack of Efficacy|2|||
127560016|NCT00387790|459021531|FG000|Overall Study|Physician Decision|2|||
127560017|NCT00387790|459021531|FG000|Overall Study|Withdrawal by Subject|3|||
127560018|NCT00387790|459021531|FG000|Overall Study|Ineligible for study|2|||
127560019|NCT03319745|459021541|FG000|Overall Study|Death|1|||
127560020|NCT03319745|459021541|FG000|Overall Study|Toxicity Precluding Surgery|1|||
127560021|NCT00870103|459021542|FG000|Overall Study|Physician Decision|2|||
127560022|NCT00870103|459021542|FG000|Overall Study|Lost to Follow-up|2|||
127560023|NCT01317550|459021543|FG000|Overall Study|Withdrawal by Subject|1|||
128023703|NCT04518410|460710821|FG014|Overall Study|Dual Enrolled Subject|0|||
128023704|NCT04518410|460710822|FG015|Overall Study|Dual Enrolled Subject|0|||
128023705|NCT04518410|460710823|FG016|Overall Study|Dual Enrolled Subject|0|||
128023706|NCT04518410|460710824|FG017|Overall Study|Dual Enrolled Subject|1|||
128023707|NCT04518410|460710825|FG018|Overall Study|Dual Enrolled Subject|0|||
128023708|NCT04518410|460710826|FG019|Overall Study|Dual Enrolled Subject|0|||
128023709|NCT04518410|460710827|FG020|Overall Study|Dual Enrolled Subject|0|||
128023710|NCT04518410|460710828|FG021|Overall Study|Dual Enrolled Subject|0|||
128023711|NCT04518410|460710829|FG022|Overall Study|Dual Enrolled Subject|0|||
128023712|NCT04518410|460710830|FG023|Overall Study|Dual Enrolled Subject|0|||
127560024|NCT01317550|459021544|FG001|Overall Study|Withdrawal by Subject|0|||
128023713|NCT04518410|460710831|FG024|Overall Study|Dual Enrolled Subject|0|||
127560025|NCT01317550|459021545|FG002|Overall Study|Withdrawal by Subject|0|||
127560026|NCT01317550|459021546|FG003|Overall Study|Withdrawal by Subject|0|||
127560027|NCT01317550|459021543|FG000|Overall Study|Lack of compliance study med|1|||
127560028|NCT01317550|459021544|FG001|Overall Study|Lack of compliance study med|0|||
127560029|NCT01317550|459021545|FG002|Overall Study|Lack of compliance study med|0|||
127686274|NCT02988817|459478209|FG004|Overall Study|Lost to Follow-up|0|||
127686275|NCT02988817|459478210|FG005|Overall Study|Lost to Follow-up|0|||
127686276|NCT02988817|459478211|FG006|Overall Study|Lost to Follow-up|0|||
127686277|NCT02988817|459478212|FG007|Overall Study|Lost to Follow-up|0|||
127686278|NCT02988817|459478213|FG008|Overall Study|Lost to Follow-up|1|||
128023714|NCT03462563|460710832|FG000|Overall Study|Death|1|||
128023715|NCT03462563|460710833|FG001|Overall Study|Death|1|||
128023716|NCT03462563|460710832|FG000|Overall Study|Termination of study|2|||
128023717|NCT03462563|460710833|FG001|Overall Study|Termination of study|1|||
128023718|NCT03462563|460710832|FG000|Overall Study|Adverse Event|1|||
128023719|NCT03462563|460710833|FG001|Overall Study|Adverse Event|3|||
128023720|NCT03462563|460710832|FG000|Overall Study|Unspecified reason|10|||
128023721|NCT03462563|460710833|FG001|Overall Study|Unspecified reason|12|||
128023722|NCT03462563|460710832|FG000|Overall Study|Physician Decision|1|||
128023723|NCT03462563|460710833|FG001|Overall Study|Physician Decision|0|||
128023724|NCT01740427|460710834|FG000|Overall Study|Objective Progression or Relapse|286|||
128023725|NCT01740427|460710835|FG001|Overall Study|Objective Progression or Relapse|172|||
128023726|NCT01740427|460710834|FG000|Overall Study|Adverse Event|32|||
128023727|NCT01740427|460710835|FG001|Overall Study|Adverse Event|9|||
128023728|NCT01740427|460710834|FG000|Overall Study|Global Deterioration of Health Status|28|||
128023729|NCT01740427|460710835|FG001|Overall Study|Global Deterioration of Health Status|12|||
128023730|NCT01740427|460710834|FG000|Overall Study|Participant Refused Continued Treatment|27|||
127560030|NCT01317550|459021546|FG003|Overall Study|Lack of compliance study med|0|||
127560031|NCT03179202|459021547|FG000|Overall Study|Screen Failure|67|||
127686279|NCT02988817|459478214|FG009|Overall Study|Lost to Follow-up|0|||
127686280|NCT02988817|459478215|FG010|Overall Study|Lost to Follow-up|1|||
127686281|NCT02988817|459478216|FG011|Overall Study|Lost to Follow-up|1|||
127686282|NCT02988817|459478217|FG012|Overall Study|Lost to Follow-up|0|||
127560032|NCT03179202|459021547|FG000|Overall Study|Subject Lost to Follow Up|12|||
127560033|NCT03179202|459021547|FG000|Overall Study|Withdrawal by Subject|7|||
127560034|NCT03179202|459021547|FG000|Overall Study|Adverse Event|3|||
127560035|NCT03179202|459021547|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
127560036|NCT03179202|459021547|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
127560037|NCT03255629|459021548|FG000|Overall Study|Adverse Event|1|||
127560038|NCT03255629|459021549|FG001|Overall Study|Adverse Event|0|||
127560039|NCT03255629|459021548|FG000|Overall Study|did not experience hypoglycemia|2|||
127560040|NCT03255629|459021549|FG001|Overall Study|did not experience hypoglycemia|1|||
127560041|NCT01120782|459021550|FG000|Overall Study|Test article shipping error|11|||
127560042|NCT01776307|459021561|FG000|Overall Study|Not dosed|0|||
127560043|NCT01776307|459021562|FG001|Overall Study|Not dosed|0|||
127560044|NCT01776307|459021563|FG002|Overall Study|Not dosed|1|||
127560045|NCT03615040|459021564|FG000|Overall Study|Withdrawal by Subject|2|||
127560046|NCT03615040|459021565|FG001|Overall Study|Withdrawal by Subject|1|||
127560047|NCT03615040|459021564|FG000|Overall Study|Physician Decision|2|||
127560048|NCT03615040|459021565|FG001|Overall Study|Physician Decision|2|||
127560049|NCT03615040|459021564|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
127560050|NCT03615040|459021565|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
128023731|NCT01740427|460710835|FG001|Overall Study|Participant Refused Continued Treatment|15|||
128023732|NCT01740427|460710834|FG000|Overall Study|Unspecified reasons|52|||
127560051|NCT03615040|459021564|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
127560052|NCT03615040|459021565|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
127560053|NCT03615040|459021564|FG000|Overall Study|Death|0|||
127560054|NCT03615040|459021565|FG001|Overall Study|Death|2|||
127560055|NCT04224688|459021573|FG000|Overall Study|Withdrawal by Subject|1|||
127686283|NCT02988817|459478218|FG013|Overall Study|Lost to Follow-up|0|||
127686284|NCT02988817|459478219|FG014|Overall Study|Lost to Follow-up|1|||
127686285|NCT02988817|459478220|FG015|Overall Study|Lost to Follow-up|1|||
127686286|NCT02988817|459478221|FG016|Overall Study|Lost to Follow-up|2|||
127686287|NCT02988817|459478222|FG017|Overall Study|Lost to Follow-up|3|||
127686288|NCT02988817|459478223|FG018|Overall Study|Lost to Follow-up|0|||
127686289|NCT02988817|459478224|FG019|Overall Study|Lost to Follow-up|0|||
127686290|NCT02988817|459478205|FG000|Overall Study|Sponsor decision|0|||
127686291|NCT02988817|459478206|FG001|Overall Study|Sponsor decision|0|||
127686292|NCT02988817|459478207|FG002|Overall Study|Sponsor decision|0|||
127686293|NCT02988817|459478208|FG003|Overall Study|Sponsor decision|0|||
127686294|NCT02988817|459478209|FG004|Overall Study|Sponsor decision|0|||
127686295|NCT02988817|459478210|FG005|Overall Study|Sponsor decision|0|||
127686296|NCT02988817|459478211|FG006|Overall Study|Sponsor decision|0|||
127686297|NCT02988817|459478212|FG007|Overall Study|Sponsor decision|0|||
127686298|NCT02988817|459478213|FG008|Overall Study|Sponsor decision|0|||
127686299|NCT02988817|459478214|FG009|Overall Study|Sponsor decision|0|||
127686300|NCT02988817|459478215|FG010|Overall Study|Sponsor decision|0|||
127686301|NCT02988817|459478216|FG011|Overall Study|Sponsor decision|1|||
127686302|NCT02988817|459478217|FG012|Overall Study|Sponsor decision|1|||
127686303|NCT02988817|459478218|FG013|Overall Study|Sponsor decision|2|||
127686304|NCT02988817|459478219|FG014|Overall Study|Sponsor decision|2|||
127686305|NCT02988817|459478220|FG015|Overall Study|Sponsor decision|6|||
127686306|NCT02988817|459478221|FG016|Overall Study|Sponsor decision|2|||
127686307|NCT02988817|459478222|FG017|Overall Study|Sponsor decision|3|||
127686308|NCT02988817|459478223|FG018|Overall Study|Sponsor decision|2|||
127686309|NCT02988817|459478224|FG019|Overall Study|Sponsor decision|7|||
127686310|NCT02988817|459478205|FG000|Overall Study|Physician Decision|0|||
127686311|NCT02988817|459478206|FG001|Overall Study|Physician Decision|0|||
127686312|NCT02988817|459478207|FG002|Overall Study|Physician Decision|0|||
127686313|NCT02988817|459478208|FG003|Overall Study|Physician Decision|0|||
127686314|NCT02988817|459478209|FG004|Overall Study|Physician Decision|0|||
127686315|NCT02988817|459478210|FG005|Overall Study|Physician Decision|0|||
127686316|NCT02988817|459478211|FG006|Overall Study|Physician Decision|0|||
127686317|NCT02988817|459478212|FG007|Overall Study|Physician Decision|0|||
127686318|NCT02988817|459478213|FG008|Overall Study|Physician Decision|0|||
127686319|NCT02988817|459478214|FG009|Overall Study|Physician Decision|0|||
127686320|NCT02988817|459478215|FG010|Overall Study|Physician Decision|0|||
127686321|NCT02988817|459478216|FG011|Overall Study|Physician Decision|0|||
127686322|NCT02988817|459478217|FG012|Overall Study|Physician Decision|0|||
127686323|NCT02988817|459478218|FG013|Overall Study|Physician Decision|0|||
127686324|NCT02988817|459478219|FG014|Overall Study|Physician Decision|0|||
127686325|NCT02988817|459478220|FG015|Overall Study|Physician Decision|1|||
127686326|NCT02988817|459478221|FG016|Overall Study|Physician Decision|0|||
127686327|NCT02988817|459478222|FG017|Overall Study|Physician Decision|0|||
127686328|NCT02988817|459478223|FG018|Overall Study|Physician Decision|1|||
127686329|NCT02988817|459478224|FG019|Overall Study|Physician Decision|1|||
127686330|NCT03733119|459478225|FG000|Overall Study|Physician Decision|2|||
127686331|NCT03733119|459478226|FG001|Overall Study|Physician Decision|1|||
127686332|NCT03733119|459478225|FG000|Overall Study|ineligible to treat per protocol|0|||
127686333|NCT03733119|459478226|FG001|Overall Study|ineligible to treat per protocol|1|||
127686334|NCT00807937|459478233|FG000|Overall Study|Adverse Event|12|||
127686335|NCT00807937|459478234|FG001|Overall Study|Adverse Event|12|||
127686336|NCT00807937|459478235|FG002|Overall Study|Adverse Event|5|||
127560056|NCT04224688|459021574|FG001|Overall Study|Withdrawal by Subject|3|||
127560057|NCT04224688|459021573|FG000|Overall Study|Lack of Efficacy|1|||
127560058|NCT04224688|459021574|FG001|Overall Study|Lack of Efficacy|1|||
127686337|NCT00807937|459478236|FG003|Overall Study|Adverse Event|4|||
127560059|NCT04224688|459021573|FG000|Overall Study|Adverse event, not fatal|0|||
127560060|NCT04224688|459021574|FG001|Overall Study|Adverse event, not fatal|2|||
127560061|NCT04224688|459021573|FG000|Overall Study|COVID-19|0|||
127560062|NCT04224688|459021574|FG001|Overall Study|COVID-19|1|||
127560063|NCT04074161|459021575|FG000|Overall Study|Withdrawal by Subject|2|||
127560064|NCT04074161|459021576|FG001|Overall Study|Withdrawal by Subject|4|||
127560065|NCT04074161|459021577|FG002|Overall Study|Withdrawal by Subject|1|||
127560066|NCT04074161|459021575|FG000|Overall Study|Lost to Follow-up|4|||
127560067|NCT04074161|459021576|FG001|Overall Study|Lost to Follow-up|5|||
127560068|NCT04074161|459021577|FG002|Overall Study|Lost to Follow-up|3|||
127560069|NCT03232333|459021591|FG000|Overall Study|Infection or Osteomyelitis|9|||
127560070|NCT03232333|459021591|FG000|Overall Study|Lost to Follow-up|4|||
127560071|NCT03232333|459021591|FG000|Overall Study|Withdrawal by Subject|2|||
128023733|NCT01740427|460710835|FG001|Overall Study|Unspecified reasons|8|||
128023734|NCT01740427|460710834|FG000|Overall Study|Death|10|||
128023735|NCT01740427|460710835|FG001|Overall Study|Death|3|||
128023736|NCT01740427|460710834|FG000|Overall Study|Protocol Violation|5|||
128023737|NCT01740427|460710835|FG001|Overall Study|Protocol Violation|3|||
128023738|NCT01740427|460710834|FG000|Overall Study|Lost to Follow-up|3|||
128023739|NCT01740427|460710835|FG001|Overall Study|Lost to Follow-up|0|||
128023740|NCT01740427|460710834|FG000|Overall Study|Site Terminated by Sponsor|1|||
128023741|NCT01740427|460710835|FG001|Overall Study|Site Terminated by Sponsor|0|||
128023742|NCT04796207|460710836|FG000|Overall Study|Lost to Follow-up|7|||
128023743|NCT04796207|460710837|FG001|Overall Study|Lost to Follow-up|2|||
128023744|NCT00165698|460710840|FG000|Overall Study|Adverse Event|2|||
128023745|NCT00165698|460710841|FG001|Overall Study|Adverse Event|10|||
128023746|NCT00165698|460710840|FG000|Overall Study|Lost to Follow-up|2|||
128023747|NCT00165698|460710841|FG001|Overall Study|Lost to Follow-up|2|||
128023748|NCT00165698|460710840|FG000|Overall Study|Withdrawal by Subject|2|||
128023749|NCT00165698|460710841|FG001|Overall Study|Withdrawal by Subject|1|||
128023750|NCT00165698|460710840|FG000|Overall Study|Protocol Violation|1|||
128023751|NCT00165698|460710841|FG001|Overall Study|Protocol Violation|0|||
128023752|NCT00165698|460710840|FG000|Overall Study|Not Taken/Lost the medicine|1|||
128023753|NCT00165698|460710841|FG001|Overall Study|Not Taken/Lost the medicine|2|||
128023754|NCT01107457|460710842|FG000|Part A|Adverse Event|1|||
128023755|NCT01107457|460710843|FG001|Part A|Adverse Event|2|||
128023756|NCT01107457|460710844|FG002|Part A|Adverse Event|1|||
128023757|NCT01107457|460710845|FG003|Part A|Adverse Event|0|||
128023758|NCT01107457|460710846|FG004|Part A|Adverse Event|0|||
128023759|NCT01107457|460710847|FG005|Part A|Adverse Event|0|||
128023760|NCT01107457|460710842|FG000|Part A|Withdrawal by Subject|3|||
128023761|NCT01107457|460710843|FG001|Part A|Withdrawal by Subject|3|||
128023762|NCT01107457|460710844|FG002|Part A|Withdrawal by Subject|0|||
128023763|NCT01107457|460710845|FG003|Part A|Withdrawal by Subject|3|||
128023764|NCT01107457|460710846|FG004|Part A|Withdrawal by Subject|1|||
128023765|NCT01107457|460710847|FG005|Part A|Withdrawal by Subject|0|||
128023766|NCT01107457|460710842|FG000|Part A|Lost to Follow-up|0|||
128023767|NCT01107457|460710843|FG001|Part A|Lost to Follow-up|1|||
128023768|NCT01107457|460710844|FG002|Part A|Lost to Follow-up|0|||
128023769|NCT01107457|460710845|FG003|Part A|Lost to Follow-up|0|||
128023770|NCT01107457|460710846|FG004|Part A|Lost to Follow-up|0|||
128023771|NCT01107457|460710847|FG005|Part A|Lost to Follow-up|0|||
128023772|NCT01107457|460710842|FG000|Part A|Lack of Efficacy|1|||
128023773|NCT01107457|460710843|FG001|Part A|Lack of Efficacy|0|||
128023774|NCT01107457|460710844|FG002|Part A|Lack of Efficacy|0|||
128023775|NCT01107457|460710845|FG003|Part A|Lack of Efficacy|0|||
128023776|NCT01107457|460710846|FG004|Part A|Lack of Efficacy|0|||
128023777|NCT01107457|460710847|FG005|Part A|Lack of Efficacy|0|||
128023778|NCT01107457|460710842|FG000|Part A|Protocol Violation|0|||
127560072|NCT03087617|459021597|FG000|Overall Study|Lost to Follow-up|32|||
127686338|NCT00807937|459478233|FG000|Overall Study|Protocol Violation|4|||
127686339|NCT00807937|459478234|FG001|Overall Study|Protocol Violation|5|||
127686340|NCT00807937|459478235|FG002|Overall Study|Protocol Violation|3|||
127686341|NCT00807937|459478236|FG003|Overall Study|Protocol Violation|3|||
127686342|NCT00807937|459478233|FG000|Overall Study|Withdrawal by Subject|5|||
127686343|NCT00807937|459478234|FG001|Overall Study|Withdrawal by Subject|4|||
127686344|NCT00807937|459478235|FG002|Overall Study|Withdrawal by Subject|1|||
127686345|NCT00807937|459478236|FG003|Overall Study|Withdrawal by Subject|4|||
127686346|NCT00807937|459478233|FG000|Overall Study|Lost to Follow-up|4|||
127686347|NCT00807937|459478234|FG001|Overall Study|Lost to Follow-up|0|||
127686348|NCT00807937|459478235|FG002|Overall Study|Lost to Follow-up|2|||
127686349|NCT00807937|459478236|FG003|Overall Study|Lost to Follow-up|1|||
127686350|NCT00807937|459478233|FG000|Overall Study|Lack of Efficacy|0|||
127686351|NCT00807937|459478234|FG001|Overall Study|Lack of Efficacy|0|||
127686352|NCT00807937|459478235|FG002|Overall Study|Lack of Efficacy|1|||
127686353|NCT00807937|459478236|FG003|Overall Study|Lack of Efficacy|2|||
127560073|NCT03087617|459021598|FG001|Overall Study|Lost to Follow-up|30|||
127560074|NCT03087617|459021599|FG002|Overall Study|Lost to Follow-up|30|||
128023779|NCT01107457|460710843|FG001|Part A|Protocol Violation|1|||
128023780|NCT01107457|460710844|FG002|Part A|Protocol Violation|0|||
128023781|NCT01107457|460710845|FG003|Part A|Protocol Violation|0|||
128023782|NCT01107457|460710846|FG004|Part A|Protocol Violation|0|||
127560075|NCT03087617|459021600|FG003|Overall Study|Lost to Follow-up|39|||
127560076|NCT03091348|459021602|FG000|Overall Study|Lost to Follow-up|2|||
127560077|NCT03091348|459021603|FG001|Overall Study|Lost to Follow-up|1|||
127560078|NCT00706342|459021604|FG000|Overall Study|Adverse Event|3|||
127560079|NCT00706342|459021604|FG000|Overall Study|Not responding to treatment|2|||
127560080|NCT00706342|459021604|FG000|Overall Study|Withdrawn due to failure to respond|1|||
127560081|NCT00706342|459021604|FG000|Overall Study|Death|1|||
127560082|NCT00706342|459021604|FG000|Overall Study|Withdrew from the study on his own.|1|||
127560083|NCT00706342|459021604|FG000|Overall Study|Investigator discretion|2|||
127560084|NCT00706342|459021604|FG000|Overall Study|Non-responder Week 12|1|||
128023783|NCT01107457|460710847|FG005|Part A|Protocol Violation|0|||
128023784|NCT01107457|460710842|FG000|Part B and C|Adverse Event|0|||
128023785|NCT01107457|460710843|FG001|Part B and C|Adverse Event|0|||
128023786|NCT01107457|460710844|FG002|Part B and C|Adverse Event|0|||
128023787|NCT01107457|460710845|FG003|Part B and C|Adverse Event|0|||
128023788|NCT01107457|460710846|FG004|Part B and C|Adverse Event|0|||
128023789|NCT01107457|460710847|FG005|Part B and C|Adverse Event|12|||
128023790|NCT01107457|460710842|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
128023791|NCT01107457|460710843|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
128023792|NCT01107457|460710844|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
128023793|NCT01107457|460710845|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
128023794|NCT01107457|460710846|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
128023795|NCT01107457|460710847|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
128023796|NCT01107457|460710842|FG000|Part B and C|Physician Decision|0|||
127560085|NCT00706342|459021604|FG000|Overall Study|Ongoing|6|||
127560086|NCT00706342|459021604|FG000|Overall Study|WIthdrawal of consent|1|||
127560087|NCT01419197|459021609|FG000|Overall Study|Death|247|||
127560088|NCT01419197|459021610|FG001|Overall Study|Death|122|||
127560089|NCT01419197|459021609|FG000|Overall Study|Physician Decision|4|||
127560090|NCT01419197|459021610|FG001|Overall Study|Physician Decision|4|||
127686354|NCT00807937|459478233|FG000|Overall Study|Intake of prohibited medicine|0|||
127686355|NCT00807937|459478234|FG001|Overall Study|Intake of prohibited medicine|0|||
127686356|NCT00807937|459478235|FG002|Overall Study|Intake of prohibited medicine|2|||
127686357|NCT00807937|459478236|FG003|Overall Study|Intake of prohibited medicine|0|||
127686358|NCT00807937|459478233|FG000|Overall Study|All other reasons (not provided)|2|||
127686359|NCT00807937|459478234|FG001|Overall Study|All other reasons (not provided)|4|||
127686360|NCT00807937|459478235|FG002|Overall Study|All other reasons (not provided)|0|||
127686361|NCT00807937|459478236|FG003|Overall Study|All other reasons (not provided)|1|||
127686362|NCT00510887|459478239|FG000|Overall Study|Lost to Follow-up|1|||
127686363|NCT03485950|459478251|FG000|Overall Study|Adverse Event|1|||
127686364|NCT03485950|459478252|FG001|Overall Study|Adverse Event|0|||
127686365|NCT03485950|459478251|FG000|Overall Study|Death|3|||
127686366|NCT03485950|459478252|FG001|Overall Study|Death|2|||
127686367|NCT03485950|459478251|FG000|Overall Study|Withdrawal by Subject|3|||
127686368|NCT03485950|459478252|FG001|Overall Study|Withdrawal by Subject|0|||
127686369|NCT00390299|459478256|FG000|Overall Study|Cancellation|1|||
127686370|NCT00390299|459478257|FG001|Overall Study|Cancellation|0|||
127686371|NCT00390299|459478258|FG002|Overall Study|Cancellation|0|||
127686372|NCT00390299|459478259|FG003|Overall Study|Cancellation|0|||
127686373|NCT00390299|459478260|FG004|Overall Study|Cancellation|0|||
127686374|NCT00970359|459478265|FG000|Overall Study|Not Treated|4|||
127686375|NCT00088413|459478269|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
127686376|NCT00088413|459478270|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
127686377|NCT00088413|459478271|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
127686378|NCT00088413|459478272|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
127686379|NCT00088413|459478269|FG000|Overall Study|Adverse Events/Side Effects|0|||
127686380|NCT00088413|459478270|FG001|Overall Study|Adverse Events/Side Effects|1|||
127686381|NCT00088413|459478271|FG002|Overall Study|Adverse Events/Side Effects|1|||
127686382|NCT00088413|459478272|FG003|Overall Study|Adverse Events/Side Effects|0|||
127686383|NCT00088413|459478269|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
127686384|NCT00088413|459478270|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
127686385|NCT00088413|459478271|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
127686386|NCT00088413|459478272|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
127686387|NCT00088413|459478269|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
127686388|NCT00088413|459478270|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
127560091|NCT01419197|459021609|FG000|Overall Study|Non-compliance|3|||
127560092|NCT01419197|459021610|FG001|Overall Study|Non-compliance|1|||
127686389|NCT00088413|459478271|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
127686390|NCT00088413|459478272|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
127686391|NCT00088413|459478269|FG000|Overall Study|Death|0|||
127686392|NCT00088413|459478270|FG001|Overall Study|Death|1|||
127686393|NCT00088413|459478271|FG002|Overall Study|Death|0|||
128023797|NCT01107457|460710843|FG001|Part B and C|Physician Decision|0|||
127560093|NCT01419197|459021609|FG000|Overall Study|Withdrawal by Subject|33|||
127560094|NCT01419197|459021610|FG001|Overall Study|Withdrawal by Subject|32|||
128023798|NCT01107457|460710844|FG002|Part B and C|Physician Decision|0|||
128023799|NCT01107457|460710845|FG003|Part B and C|Physician Decision|0|||
128023800|NCT01107457|460710846|FG004|Part B and C|Physician Decision|0|||
128023801|NCT01107457|460710847|FG005|Part B and C|Physician Decision|3|||
128023802|NCT01107457|460710842|FG000|Part B and C|Lack of Efficacy|0|||
128023803|NCT01107457|460710843|FG001|Part B and C|Lack of Efficacy|0|||
128023804|NCT01107457|460710844|FG002|Part B and C|Lack of Efficacy|0|||
128023805|NCT01107457|460710845|FG003|Part B and C|Lack of Efficacy|0|||
128023806|NCT01107457|460710846|FG004|Part B and C|Lack of Efficacy|0|||
128023807|NCT01107457|460710847|FG005|Part B and C|Lack of Efficacy|7|||
128023808|NCT01107457|460710842|FG000|Part B and C|Lost to Follow-up|0|||
128023809|NCT01107457|460710843|FG001|Part B and C|Lost to Follow-up|0|||
128023810|NCT01107457|460710844|FG002|Part B and C|Lost to Follow-up|0|||
128023811|NCT01107457|460710845|FG003|Part B and C|Lost to Follow-up|0|||
128023812|NCT01107457|460710846|FG004|Part B and C|Lost to Follow-up|0|||
128023813|NCT01107457|460710847|FG005|Part B and C|Lost to Follow-up|10|||
128023814|NCT01107457|460710842|FG000|Part B and C|Protocol Violation|0|||
128023815|NCT01107457|460710843|FG001|Part B and C|Protocol Violation|0|||
128023816|NCT01107457|460710844|FG002|Part B and C|Protocol Violation|0|||
128023817|NCT01107457|460710845|FG003|Part B and C|Protocol Violation|0|||
128023818|NCT01107457|460710846|FG004|Part B and C|Protocol Violation|0|||
128023819|NCT01107457|460710847|FG005|Part B and C|Protocol Violation|1|||
128023820|NCT01107457|460710842|FG000|Part B and C|Sponsor Decision|0|||
128023821|NCT01107457|460710843|FG001|Part B and C|Sponsor Decision|0|||
128023822|NCT01107457|460710844|FG002|Part B and C|Sponsor Decision|0|||
128023823|NCT01107457|460710845|FG003|Part B and C|Sponsor Decision|0|||
128023824|NCT01107457|460710846|FG004|Part B and C|Sponsor Decision|0|||
128023825|NCT01107457|460710847|FG005|Part B and C|Sponsor Decision|66|||
128023826|NCT01107457|460710842|FG000|Part B and C|Withdrawal by Subject|0|||
128023827|NCT01107457|460710843|FG001|Part B and C|Withdrawal by Subject|0|||
128023828|NCT01107457|460710844|FG002|Part B and C|Withdrawal by Subject|0|||
128023829|NCT01107457|460710845|FG003|Part B and C|Withdrawal by Subject|0|||
128023830|NCT01107457|460710846|FG004|Part B and C|Withdrawal by Subject|0|||
128023831|NCT01107457|460710847|FG005|Part B and C|Withdrawal by Subject|16|||
128023832|NCT01107457|460710842|FG000|Part B and C|Clinical Relapse|0|||
128023833|NCT01107457|460710843|FG001|Part B and C|Clinical Relapse|0|||
128023834|NCT01107457|460710844|FG002|Part B and C|Clinical Relapse|0|||
128023835|NCT01107457|460710845|FG003|Part B and C|Clinical Relapse|0|||
128023836|NCT01107457|460710846|FG004|Part B and C|Clinical Relapse|0|||
128023837|NCT01107457|460710847|FG005|Part B and C|Clinical Relapse|4|||
128023838|NCT03679884|460710848|FG000|Overall Study|Other|12|||
128023839|NCT03679884|460710849|FG001|Overall Study|Other|12|||
128023840|NCT03679884|460710850|FG002|Overall Study|Other|12|||
128023841|NCT03679884|460710851|FG003|Overall Study|Other|7|||
128023842|NCT03679884|460710852|FG004|Overall Study|Other|8|||
128023843|NCT03679884|460710848|FG000|Overall Study|Lack of Efficacy|15|||
128023844|NCT03679884|460710849|FG001|Overall Study|Lack of Efficacy|29|||
128023845|NCT03679884|460710850|FG002|Overall Study|Lack of Efficacy|13|||
128023846|NCT03679884|460710851|FG003|Overall Study|Lack of Efficacy|29|||
128023847|NCT03679884|460710852|FG004|Overall Study|Lack of Efficacy|10|||
128023848|NCT03679884|460710848|FG000|Overall Study|Death|1|||
128023849|NCT03679884|460710849|FG001|Overall Study|Death|0|||
128023850|NCT03679884|460710850|FG002|Overall Study|Death|0|||
128023851|NCT03679884|460710851|FG003|Overall Study|Death|0|||
128023852|NCT03679884|460710852|FG004|Overall Study|Death|0|||
128023853|NCT03679884|460710848|FG000|Overall Study|Adverse Event|2|||
128023854|NCT03679884|460710849|FG001|Overall Study|Adverse Event|10|||
128023855|NCT03679884|460710850|FG002|Overall Study|Adverse Event|9|||
127560095|NCT01419197|459021609|FG000|Overall Study|Study Completed by Sponsor|103|||
127560096|NCT01419197|459021610|FG001|Overall Study|Study Completed by Sponsor|34|||
127560097|NCT01419197|459021609|FG000|Overall Study|Reason Not Specified|0|||
127560098|NCT01419197|459021610|FG001|Overall Study|Reason Not Specified|1|||
127560099|NCT01419197|459021609|FG000|Overall Study|Lost to Follow-up|14|||
127560100|NCT01419197|459021610|FG001|Overall Study|Lost to Follow-up|4|||
127560101|NCT00146848|459021615|FG000|Pre-randomization|Death|19|||
127560102|NCT00146848|459021616|FG001|Pre-randomization|Death|0|||
127560103|NCT00146848|459021617|FG002|Pre-randomization|Death|0|||
127560104|NCT00146848|459021615|FG000|Pre-randomization|Lost to Follow-up|70|||
128023856|NCT03679884|460710851|FG003|Overall Study|Adverse Event|6|||
128023857|NCT03679884|460710852|FG004|Overall Study|Adverse Event|6|||
127560105|NCT00146848|459021616|FG001|Pre-randomization|Lost to Follow-up|0|||
127560106|NCT00146848|459021617|FG002|Pre-randomization|Lost to Follow-up|0|||
127560107|NCT00146848|459021615|FG000|Pre-randomization|Physician Decision|8|||
127686394|NCT00088413|459478272|FG003|Overall Study|Death|0|||
128023858|NCT03679884|460710848|FG000|Overall Study|Withdrawal by Subject|12|||
128023859|NCT03679884|460710849|FG001|Overall Study|Withdrawal by Subject|23|||
128023860|NCT03679884|460710850|FG002|Overall Study|Withdrawal by Subject|8|||
128023861|NCT03679884|460710851|FG003|Overall Study|Withdrawal by Subject|8|||
128023862|NCT03679884|460710852|FG004|Overall Study|Withdrawal by Subject|9|||
128023863|NCT03679884|460710848|FG000|Overall Study|Lost to Follow-up|1|||
128023864|NCT03679884|460710849|FG001|Overall Study|Lost to Follow-up|4|||
128023865|NCT03679884|460710850|FG002|Overall Study|Lost to Follow-up|2|||
127560108|NCT00146848|459021616|FG001|Pre-randomization|Physician Decision|0|||
127560109|NCT00146848|459021617|FG002|Pre-randomization|Physician Decision|0|||
127560110|NCT00146848|459021615|FG000|Pre-randomization|Protocol Violation|172|||
127560111|NCT00146848|459021616|FG001|Pre-randomization|Protocol Violation|0|||
127560112|NCT00146848|459021617|FG002|Pre-randomization|Protocol Violation|0|||
127560113|NCT00146848|459021615|FG000|Pre-randomization|Withdrawal by Subject|40|||
127560114|NCT00146848|459021616|FG001|Pre-randomization|Withdrawal by Subject|0|||
127560115|NCT00146848|459021617|FG002|Pre-randomization|Withdrawal by Subject|0|||
127560116|NCT00146848|459021615|FG000|Post-randomization|Lost to Follow-up|12|||
127560117|NCT00146848|459021616|FG001|Post-randomization|Lost to Follow-up|15|||
127560118|NCT00146848|459021617|FG002|Post-randomization|Lost to Follow-up|12|||
127560119|NCT00146848|459021615|FG000|Post-randomization|Withdrawn|26|||
127560120|NCT00146848|459021616|FG001|Post-randomization|Withdrawn|32|||
127686395|NCT00088413|459478269|FG000|Overall Study|Progressive disease|9|||
127686396|NCT00088413|459478270|FG001|Overall Study|Progressive disease|11|||
127686397|NCT00088413|459478271|FG002|Overall Study|Progressive disease|8|||
127686398|NCT00088413|459478272|FG003|Overall Study|Progressive disease|14|||
127686399|NCT00088413|459478269|FG000|Overall Study|Other|0|||
127686400|NCT00088413|459478270|FG001|Overall Study|Other|1|||
127686401|NCT00088413|459478271|FG002|Overall Study|Other|0|||
127686402|NCT00088413|459478272|FG003|Overall Study|Other|0|||
127686403|NCT00088413|459478269|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
127686404|NCT00088413|459478270|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
127686405|NCT00088413|459478271|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
127686406|NCT00088413|459478272|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
127686407|NCT00632424|459478275|FG000|Overall Study|Disease Progression|17|||
127686408|NCT00632424|459478275|FG000|Overall Study|Study Drug Toxicity|1|||
127686409|NCT02531113|459478276|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
127686410|NCT02531113|459478276|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
127686411|NCT02531113|459478276|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
127686412|NCT02531113|459478276|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
127686413|NCT02531113|459478276|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
127686414|NCT02531113|459478276|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
127686415|NCT02531113|459478276|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
127686416|NCT02531113|459478276|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
127686417|NCT03807778|459478277|FG000|Overall Study|Adverse Event|0|||
127686418|NCT03807778|459478278|FG001|Overall Study|Adverse Event|0|||
127686419|NCT03807778|459478279|FG002|Overall Study|Adverse Event|3|||
127686420|NCT03807778|459478280|FG003|Overall Study|Adverse Event|5|||
127686421|NCT03807778|459478277|FG000|Overall Study|Progressive Disease|4|||
127686422|NCT03807778|459478278|FG001|Overall Study|Progressive Disease|2|||
127686423|NCT03807778|459478279|FG002|Overall Study|Progressive Disease|8|||
127686424|NCT03807778|459478280|FG003|Overall Study|Progressive Disease|15|||
127686425|NCT03807778|459478277|FG000|Overall Study|Symptomatic Deterioration|0|||
127686426|NCT03807778|459478278|FG001|Overall Study|Symptomatic Deterioration|1|||
127686427|NCT03807778|459478279|FG002|Overall Study|Symptomatic Deterioration|0|||
127686428|NCT03807778|459478280|FG003|Overall Study|Symptomatic Deterioration|1|||
127686429|NCT03807778|459478277|FG000|Overall Study|Withdrawal by Subject|0|||
127686430|NCT03807778|459478278|FG001|Overall Study|Withdrawal by Subject|1|||
127686431|NCT03807778|459478279|FG002|Overall Study|Withdrawal by Subject|0|||
127686432|NCT03807778|459478280|FG003|Overall Study|Withdrawal by Subject|1|||
127686433|NCT03807778|459478277|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
127686434|NCT03807778|459478278|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
127686435|NCT03807778|459478279|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
127686436|NCT03807778|459478280|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
127686437|NCT01780298|459479619|FG000|Overall Study|Physician Decision|1|||
127686438|NCT01780298|459479620|FG001|Overall Study|Physician Decision|5|||
127686439|NCT01780298|459479621|FG002|Overall Study|Physician Decision|1|||
127686440|NCT01780298|459479622|FG003|Overall Study|Physician Decision|1|||
127686441|NCT01780298|459479619|FG000|Overall Study|Subject not matched|1|||
127686442|NCT01780298|459479620|FG001|Overall Study|Subject not matched|0|||
127686443|NCT01780298|459479621|FG002|Overall Study|Subject not matched|1|||
127686444|NCT01780298|459479622|FG003|Overall Study|Subject not matched|0|||
127881025|NCT02575807|460186105|FG001|Overall Study|Death|3|||
127686445|NCT01780298|459479619|FG000|Overall Study|Adverse Event|0|||
127686446|NCT01780298|459479620|FG001|Overall Study|Adverse Event|0|||
127686447|NCT01780298|459479621|FG002|Overall Study|Adverse Event|2|||
127686448|NCT01780298|459479622|FG003|Overall Study|Adverse Event|0|||
127686449|NCT03936660|459479623|FG000|Overall Study|Missing medication data at 6 and 12 months.|2|||
127560121|NCT00146848|459021617|FG002|Post-randomization|Withdrawn|27|||
127560122|NCT00271505|459021619|FG000|Overall Study|Screen Failure|3|||
127686450|NCT03936660|459479624|FG001|Overall Study|Missing medication data at 6 and 12 months.|2|||
128023866|NCT03679884|460710851|FG003|Overall Study|Lost to Follow-up|0|||
128023867|NCT03679884|460710852|FG004|Overall Study|Lost to Follow-up|3|||
128023868|NCT00362609|460710853|FG000|Overall Study|Withdrawal by Subject|0|||
128023869|NCT00362609|460710854|FG001|Overall Study|Withdrawal by Subject|1|||
128023870|NCT00362609|460710853|FG000|Overall Study|Protocol Violation|0|||
128023871|NCT00362609|460710854|FG001|Overall Study|Protocol Violation|1|||
128023872|NCT01800058|460710863|FG000|Overall Study|Lost to Follow-up|1|||
128023873|NCT05206604|460712582|FG000|Overall Study|Non-compliance with study drug|0|||
128023874|NCT05206604|460712583|FG001|Overall Study|Non-compliance with study drug|0|||
128023875|NCT05206604|460712584|FG002|Overall Study|Non-compliance with study drug|0|||
128023876|NCT05206604|460712585|FG003|Overall Study|Non-compliance with study drug|0|||
128023877|NCT05206604|460712586|FG004|Overall Study|Non-compliance with study drug|0|||
128023878|NCT05206604|460712587|FG005|Overall Study|Non-compliance with study drug|1|||
128023879|NCT05206604|460712588|FG006|Overall Study|Non-compliance with study drug|0|||
128023880|NCT05206604|460712589|FG007|Overall Study|Non-compliance with study drug|0|||
128023881|NCT03787212|460712590|FG000|Period 1|Study Termination|2|||
127560123|NCT00271505|459021619|FG000|Overall Study|Adverse Event|1|||
127560124|NCT00271505|459021619|FG000|Overall Study|Death|1|||
127560125|NCT04556383|459021620|FG000|PCP|Lack of Efficacy|28|||
127560126|NCT04556383|459021621|FG001|PCP|Lack of Efficacy|23|||
128023882|NCT03787212|460712591|FG001|Period 1|Study Termination|2|||
128023883|NCT04193176|460712592|FG000|Overall Study|Withdrawal by Subject|6|||
128023884|NCT04193176|460712593|FG001|Overall Study|Withdrawal by Subject|10|||
128023885|NCT02370394|460712595|FG000|Overall Study|Lost to Follow-up|2|||
128023886|NCT02370394|460712596|FG001|Overall Study|Lost to Follow-up|1|||
128023887|NCT02370394|460712595|FG000|Overall Study|Withdrawal by Subject|0|||
128023888|NCT02370394|460712596|FG001|Overall Study|Withdrawal by Subject|1|||
128023889|NCT00520572|460712598|FG000|Overall Study|Adverse Event|9|||
128023890|NCT00520572|460712599|FG001|Overall Study|Adverse Event|3|||
128023891|NCT00520572|460712600|FG002|Overall Study|Adverse Event|6|||
128023892|NCT00520572|460712601|FG003|Overall Study|Adverse Event|9|||
128023893|NCT00520572|460712602|FG004|Overall Study|Adverse Event|7|||
128023894|NCT00520572|460712603|FG005|Overall Study|Adverse Event|2|||
128023895|NCT00520572|460712598|FG000|Overall Study|Withdrawal by Subject|0|||
128023896|NCT00520572|460712599|FG001|Overall Study|Withdrawal by Subject|9|||
128023897|NCT00520572|460712600|FG002|Overall Study|Withdrawal by Subject|5|||
128023898|NCT00520572|460712601|FG003|Overall Study|Withdrawal by Subject|2|||
128023899|NCT00520572|460712602|FG004|Overall Study|Withdrawal by Subject|2|||
128023900|NCT00520572|460712603|FG005|Overall Study|Withdrawal by Subject|0|||
128023901|NCT00520572|460712598|FG000|Overall Study|Protocol Violation|0|||
128023902|NCT00520572|460712599|FG001|Overall Study|Protocol Violation|0|||
128023903|NCT00520572|460712600|FG002|Overall Study|Protocol Violation|1|||
128023904|NCT00520572|460712601|FG003|Overall Study|Protocol Violation|0|||
128023905|NCT00520572|460712602|FG004|Overall Study|Protocol Violation|0|||
128023906|NCT00520572|460712603|FG005|Overall Study|Protocol Violation|0|||
128023907|NCT00520572|460712598|FG000|Overall Study|Lack of Efficacy|1|||
128023908|NCT00520572|460712599|FG001|Overall Study|Lack of Efficacy|1|||
128023909|NCT00520572|460712600|FG002|Overall Study|Lack of Efficacy|1|||
128023910|NCT00520572|460712601|FG003|Overall Study|Lack of Efficacy|2|||
128023911|NCT00520572|460712602|FG004|Overall Study|Lack of Efficacy|1|||
128023912|NCT00520572|460712603|FG005|Overall Study|Lack of Efficacy|0|||
128023913|NCT00520572|460712598|FG000|Overall Study|Lost to Follow-up|0|||
128023914|NCT00520572|460712599|FG001|Overall Study|Lost to Follow-up|0|||
128023915|NCT00520572|460712600|FG002|Overall Study|Lost to Follow-up|0|||
128023916|NCT00520572|460712601|FG003|Overall Study|Lost to Follow-up|0|||
128023917|NCT00520572|460712602|FG004|Overall Study|Lost to Follow-up|1|||
128023918|NCT00520572|460712603|FG005|Overall Study|Lost to Follow-up|0|||
128023919|NCT00520572|460712598|FG000|Overall Study|Incorrect enrollment|1|||
128023920|NCT00520572|460712599|FG001|Overall Study|Incorrect enrollment|0|||
128023921|NCT00520572|460712600|FG002|Overall Study|Incorrect enrollment|1|||
127560127|NCT04556383|459021622|FG002|PCP|Lack of Efficacy|23|||
127560128|NCT04556383|459021623|FG003|PCP|Lack of Efficacy|0|||
128023922|NCT00520572|460712601|FG003|Overall Study|Incorrect enrollment|0|||
128023923|NCT00520572|460712602|FG004|Overall Study|Incorrect enrollment|1|||
128023924|NCT00520572|460712603|FG005|Overall Study|Incorrect enrollment|0|||
128023925|NCT00520572|460712598|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
127560129|NCT04556383|459021620|FG000|PCP|Study terminated by sponsor|15|||
128023926|NCT00520572|460712599|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
128023927|NCT00520572|460712600|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
128023928|NCT00520572|460712601|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
128023929|NCT00520572|460712602|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
128023930|NCT00520572|460712603|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
128023931|NCT00520572|460712598|FG000|Overall Study|Long break in taking Medication|0|||
128023932|NCT00520572|460712599|FG001|Overall Study|Long break in taking Medication|0|||
127560130|NCT04556383|459021621|FG001|PCP|Study terminated by sponsor|13|||
128023933|NCT00520572|460712600|FG002|Overall Study|Long break in taking Medication|0|||
128023934|NCT00520572|460712601|FG003|Overall Study|Long break in taking Medication|1|||
127560131|NCT04556383|459021622|FG002|PCP|Study terminated by sponsor|16|||
127560132|NCT04556383|459021623|FG003|PCP|Study terminated by sponsor|0|||
127560133|NCT04556383|459021620|FG000|PCP|Withdrawal by Subject|8|||
127560134|NCT04556383|459021621|FG001|PCP|Withdrawal by Subject|6|||
127560135|NCT04556383|459021622|FG002|PCP|Withdrawal by Subject|6|||
127560136|NCT04556383|459021623|FG003|PCP|Withdrawal by Subject|0|||
127686451|NCT02724592|459479626|FG000|Overall Study|Lost to Follow-up|4|||
127686452|NCT02724592|459479627|FG001|Overall Study|Lost to Follow-up|1|||
128023935|NCT00520572|460712602|FG004|Overall Study|Long break in taking Medication|0|||
128023936|NCT00520572|460712603|FG005|Overall Study|Long break in taking Medication|0|||
128023937|NCT00520572|460712598|FG000|Overall Study|Did not receive Treatment|1|||
128023938|NCT00520572|460712599|FG001|Overall Study|Did not receive Treatment|0|||
128023939|NCT00520572|460712600|FG002|Overall Study|Did not receive Treatment|1|||
128023940|NCT00520572|460712601|FG003|Overall Study|Did not receive Treatment|0|||
128023941|NCT00520572|460712602|FG004|Overall Study|Did not receive Treatment|0|||
128023942|NCT00520572|460712603|FG005|Overall Study|Did not receive Treatment|0|||
128023943|NCT02181621|460712604|FG000|Overall Study|Adverse Event|1|||
128023944|NCT02181621|460712605|FG001|Overall Study|Adverse Event|0|||
128023945|NCT02181621|460712604|FG000|Overall Study|Previously Enrolled|0|||
128023946|NCT02181621|460712605|FG001|Overall Study|Previously Enrolled|1|||
128023947|NCT02181621|460712604|FG000|Overall Study|Enrollment Hold|1|||
128023948|NCT02181621|460712605|FG001|Overall Study|Enrollment Hold|1|||
128023949|NCT00960856|460712607|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
128023950|NCT00960856|460712608|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
128023951|NCT00960856|460712609|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
128023952|NCT00960856|460712610|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
128023953|NCT00960856|460712607|FG000|Washout Period of 7 Days|Adverse Event|0|||
128023954|NCT00960856|460712608|FG001|Washout Period of 7 Days|Adverse Event|0|||
128023955|NCT00960856|460712609|FG002|Washout Period of 7 Days|Adverse Event|1|||
128023956|NCT00960856|460712610|FG003|Washout Period of 7 Days|Adverse Event|0|||
128023957|NCT03387046|460712611|FG000|Overall Study|Adverse Event|1|||
128023958|NCT03387046|460712612|FG001|Overall Study|Adverse Event|1|||
128023959|NCT00120250|460712615|FG000|Overall Study|Lost to Follow-up|1|||
127686453|NCT02584829|459479628|FG000|Overall Study|Physician Decision|1|||
127686454|NCT02584829|459479629|FG001|Overall Study|Physician Decision|0|||
127686455|NCT02584829|459479628|FG000|Overall Study|Withdrawal by Subject|0|||
127686456|NCT02584829|459479629|FG001|Overall Study|Withdrawal by Subject|1|||
127686457|NCT02584829|459479628|FG000|Overall Study|Progressive Disease|0|||
127686458|NCT02584829|459479629|FG001|Overall Study|Progressive Disease|3|||
127686459|NCT01939899|459479631|FG000|Lead-in Dose Finding Phase|Death|0|||
127686460|NCT01939899|459479632|FG001|Lead-in Dose Finding Phase|Death|3|||
127686461|NCT01939899|459479633|FG002|Lead-in Dose Finding Phase|Death|1|||
127686462|NCT01939899|459479634|FG003|Lead-in Dose Finding Phase|Death|0|||
127686463|NCT01939899|459479635|FG004|Lead-in Dose Finding Phase|Death|0|||
127686464|NCT01939899|459479631|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
127686465|NCT01939899|459479632|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
127686466|NCT01939899|459479633|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
127686467|NCT01939899|459479634|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
127686468|NCT01939899|459479635|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
127686469|NCT01939899|459479631|FG000|Lead-in Dose Finding Phase|Other|0|||
127686470|NCT01939899|459479632|FG001|Lead-in Dose Finding Phase|Other|0|||
127686471|NCT01939899|459479633|FG002|Lead-in Dose Finding Phase|Other|1|||
127686472|NCT01939899|459479634|FG003|Lead-in Dose Finding Phase|Other|0|||
127686473|NCT01939899|459479635|FG004|Lead-in Dose Finding Phase|Other|0|||
127686474|NCT01939899|459479631|FG000|Phase 2|Withdrawal by Subject|0|||
127686475|NCT01939899|459479632|FG001|Phase 2|Withdrawal by Subject|0|||
127686476|NCT01939899|459479633|FG002|Phase 2|Withdrawal by Subject|0|||
127686477|NCT01939899|459479634|FG003|Phase 2|Withdrawal by Subject|2|||
127686478|NCT01939899|459479635|FG004|Phase 2|Withdrawal by Subject|0|||
127686479|NCT01939899|459479631|FG000|Phase 2|Disease Progression|0|||
127686480|NCT01939899|459479632|FG001|Phase 2|Disease Progression|0|||
127686481|NCT01939899|459479633|FG002|Phase 2|Disease Progression|0|||
127774596|NCT02465463|459800376|FG001|Overall Study|Death|0|||
127774597|NCT02465463|459800375|FG000|Overall Study|Protocol Violation|1|||
128023960|NCT00120250|460712616|FG001|Overall Study|Lost to Follow-up|1|||
128023961|NCT00120250|460712615|FG000|Overall Study|Protocol Violation|0|||
128023962|NCT00120250|460712616|FG001|Overall Study|Protocol Violation|1|||
128023963|NCT01964560|460712630|FG000|Overall Study|Adverse Event|23|||
128023964|NCT01964560|460712630|FG000|Overall Study|Lack of Efficacy|46|||
128023965|NCT01964560|460712630|FG000|Overall Study|Protocol deviation|2|||
127686482|NCT01939899|459479634|FG003|Phase 2|Disease Progression|9|||
127686483|NCT01939899|459479635|FG004|Phase 2|Disease Progression|1|||
127686484|NCT00585052|459479636|FG000|Overall Study|Withdrawal by Subject|1|||
128023966|NCT01964560|460712630|FG000|Overall Study|Lost to Follow-up|4|||
128023967|NCT01964560|460712630|FG000|Overall Study|Withdrawal by Subject|64|||
128023968|NCT01964560|460712630|FG000|Overall Study|Surgery-hemispherotomy|1|||
127560137|NCT04556383|459021620|FG000|PCP|Adverse Event|1|||
127560138|NCT04556383|459021621|FG001|PCP|Adverse Event|7|||
127560139|NCT04556383|459021622|FG002|PCP|Adverse Event|7|||
127774598|NCT02465463|459800376|FG001|Overall Study|Protocol Violation|0|||
127774599|NCT03294109|459800380|FG000|Overall Study|Withdrawal by Subject|6|||
127774600|NCT03294109|459800381|FG001|Overall Study|Withdrawal by Subject|5|||
127774601|NCT04744285|459800382|FG000|Overall Study|Withdrawal by Subject|1|||
127774602|NCT04744285|459800383|FG001|Overall Study|Withdrawal by Subject|1|||
127774603|NCT04744285|459800384|FG002|Overall Study|Withdrawal by Subject|2|||
127774604|NCT04744285|459800385|FG003|Overall Study|Withdrawal by Subject|1|||
127774605|NCT01774084|459800386|FG000|Overall Study|Personal reasons|1|||
127774606|NCT01774084|459800387|FG001|Overall Study|Personal reasons|0|||
127774607|NCT00821431|459800388|FG000|Overall Study|Adverse Event|6|||
127774608|NCT00821431|459800389|FG001|Overall Study|Adverse Event|3|||
127774609|NCT00821431|459800388|FG000|Overall Study|Withdrawal by Subject|5|||
127774610|NCT00821431|459800389|FG001|Overall Study|Withdrawal by Subject|0|||
127774611|NCT00821431|459800388|FG000|Overall Study|Lost to Follow-up|1|||
127774612|NCT00821431|459800389|FG001|Overall Study|Lost to Follow-up|0|||
127774613|NCT00821431|459800388|FG000|Overall Study|Protocol Violation|3|||
127774614|NCT00821431|459800389|FG001|Overall Study|Protocol Violation|1|||
127774615|NCT00821431|459800388|FG000|Overall Study|Physician Decision|0|||
127774616|NCT00821431|459800389|FG001|Overall Study|Physician Decision|1|||
127774617|NCT04526197|459800394|FG000|Period 1|Adverse Event|0|||
127774618|NCT04526197|459800395|FG001|Period 1|Adverse Event|1|||
127774619|NCT04526197|459800394|FG000|Period 1|Withdrawal by Subject|1|||
127774620|NCT04526197|459800395|FG001|Period 1|Withdrawal by Subject|0|||
127774621|NCT04526197|459800394|FG000|Period 2|Adverse Event|0|||
127774622|NCT04526197|459800395|FG001|Period 2|Adverse Event|1|||
127774623|NCT04526197|459800394|FG000|Period 2|Withdrawal by Subject|0|||
127774624|NCT04526197|459800395|FG001|Period 2|Withdrawal by Subject|1|||
127774625|NCT02411578|459800397|FG000|Crossover Trial Phase|Pregnancy|0|||
127774626|NCT02411578|459800398|FG001|Crossover Trial Phase|Pregnancy|1|||
127774627|NCT00651157|459800399|FG000|Overall Study|Death|1|||
127774628|NCT00651157|459800399|FG000|Overall Study|Protocol Violation|1|||
127774629|NCT00364156|459800400|FG000|Overall Study|Withdrawal by Subject|73|||
127774630|NCT00364156|459800401|FG001|Overall Study|Withdrawal by Subject|80|||
127774631|NCT00364156|459800400|FG000|Overall Study|Protocol Violation|6|||
127774632|NCT00364156|459800401|FG001|Overall Study|Protocol Violation|1|||
127774633|NCT05125679|459800408|FG000|Overall Study|Study Terminated by Sponsor|2|||
127774634|NCT05125679|459800409|FG001|Overall Study|Study Terminated by Sponsor|5|||
127774635|NCT04683731|459800414|FG000|Overall Study|Withdrawal by Subject|1|||
127774636|NCT04683731|459800415|FG001|Overall Study|Withdrawal by Subject|0|||
127774637|NCT04683731|459800416|FG002|Overall Study|Withdrawal by Subject|3|||
127774638|NCT04683731|459800417|FG003|Overall Study|Withdrawal by Subject|2|||
127774639|NCT04683731|459800414|FG000|Overall Study|Determined patient was not eligible|3|||
127774640|NCT04683731|459800415|FG001|Overall Study|Determined patient was not eligible|3|||
127774641|NCT04683731|459800416|FG002|Overall Study|Determined patient was not eligible|12|||
127774642|NCT04683731|459800417|FG003|Overall Study|Determined patient was not eligible|3|||
127774643|NCT02958267|459800420|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
127774644|NCT02958267|459800421|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
127774645|NCT02958267|459800420|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
127774646|NCT02958267|459800421|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
127774647|NCT02958267|459800420|FG000|Follow-up Visits|Additional treatment pursued|2|||
127774648|NCT02958267|459800421|FG001|Follow-up Visits|Additional treatment pursued|1|||
127774649|NCT01210118|459800424|FG000|Overall Study|Lost to Follow-up|1|||
127774650|NCT01210118|459800425|FG001|Overall Study|Lost to Follow-up|1|||
127774651|NCT01210118|459800424|FG000|Overall Study|Protocol Violation|1|||
127774652|NCT01210118|459800425|FG001|Overall Study|Protocol Violation|1|||
127686485|NCT05489484|459479640|FG000|Overall Study|withdrawn|1|||
127686486|NCT00444600|459479643|FG000|Overall Study|Death|7|||
127686487|NCT00444600|459479644|FG001|Overall Study|Death|5|||
127686488|NCT00444600|459479645|FG002|Overall Study|Death|3|||
127686489|NCT00444600|459479646|FG003|Overall Study|Death|2|||
127686490|NCT00444600|459479643|FG000|Overall Study|Dropped|11|||
127686491|NCT00444600|459479644|FG001|Overall Study|Dropped|11|||
127686492|NCT00444600|459479645|FG002|Overall Study|Dropped|7|||
127686493|NCT00444600|459479646|FG003|Overall Study|Dropped|7|||
127686494|NCT00444600|459479643|FG000|Overall Study|Missed visit|1|||
127686495|NCT00444600|459479644|FG001|Overall Study|Missed visit|0|||
127686496|NCT00444600|459479645|FG002|Overall Study|Missed visit|0|||
127686497|NCT00444600|459479646|FG003|Overall Study|Missed visit|1|||
127686498|NCT05132478|459479647|FG000|Overall Study|did not complete survey after consent|1|||
127686499|NCT05132478|459479648|FG001|Overall Study|did not complete survey after consent|1|||
127686500|NCT05132478|459479647|FG000|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
127686501|NCT05132478|459479648|FG001|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
127686502|NCT00106080|459479649|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
127686503|NCT00106080|459479650|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
127686504|NCT01414738|459479653|FG000|Overall Study|Death|26|||
127686505|NCT01414738|459479653|FG000|Overall Study|Refused testing|5|||
127774653|NCT01210118|459800424|FG000|Overall Study|Spontaneous abortion|1|||
127560140|NCT04556383|459021623|FG003|PCP|Adverse Event|0|||
127560141|NCT04556383|459021620|FG000|PCP|Other, Not Specified|1|||
127560142|NCT04556383|459021621|FG001|PCP|Other, Not Specified|2|||
127560143|NCT04556383|459021622|FG002|PCP|Other, Not Specified|1|||
127774654|NCT01210118|459800425|FG001|Overall Study|Spontaneous abortion|3|||
127774655|NCT01422850|459800428|FG000|Overall Study|Physician Decision|3|||
127774656|NCT04484831|459800429|FG000|Overall Study|Withdrawal by Subject|1|||
127774657|NCT04484831|459800430|FG001|Overall Study|Withdrawal by Subject|0|||
127774658|NCT02244996|459800431|FG000|Overall Study|Lack of Efficacy|2|||
127774659|NCT02244996|459800432|FG001|Overall Study|Lack of Efficacy|6|||
127774660|NCT01335009|459800433|FG000|Overall Study|Too ill to travel to study sites|1|||
127774661|NCT01335009|459800434|FG001|Overall Study|Too ill to travel to study sites|0|||
127774662|NCT01335009|459800433|FG000|Overall Study|Death|28|||
127774663|NCT01335009|459800434|FG001|Overall Study|Death|32|||
127774664|NCT01335009|459800433|FG000|Overall Study|Withdrawal by Subject|1|||
127774665|NCT01335009|459800434|FG001|Overall Study|Withdrawal by Subject|1|||
127774666|NCT01335009|459800433|FG000|Overall Study|Lost to Follow-up|1|||
127774667|NCT01335009|459800434|FG001|Overall Study|Lost to Follow-up|0|||
127774668|NCT03971422|459801666|FG000|Overall Study|Lost to Follow-up|0|||
127774669|NCT03971422|459801667|FG001|Overall Study|Lost to Follow-up|1|||
127774670|NCT03971422|459801668|FG002|Overall Study|Lost to Follow-up|0|||
127774671|NCT03971422|459801666|FG000|Overall Study|Lack of Efficacy|5|||
127774672|NCT03971422|459801667|FG001|Overall Study|Lack of Efficacy|1|||
127774673|NCT03971422|459801668|FG002|Overall Study|Lack of Efficacy|1|||
127774674|NCT03971422|459801666|FG000|Overall Study|Adverse event, not fatal|2|||
127774675|NCT03971422|459801667|FG001|Overall Study|Adverse event, not fatal|2|||
127774676|NCT03971422|459801668|FG002|Overall Study|Adverse event, not fatal|5|||
127774677|NCT03971422|459801666|FG000|Overall Study|Worsening of MG Symptoms|1|||
127774678|NCT03971422|459801667|FG001|Overall Study|Worsening of MG Symptoms|4|||
127774679|NCT03971422|459801668|FG002|Overall Study|Worsening of MG Symptoms|2|||
127774680|NCT03971422|459801666|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
127774681|NCT03971422|459801667|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
127774682|NCT03971422|459801668|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
127774683|NCT03971422|459801666|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
127774684|NCT03971422|459801667|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
127774685|NCT03971422|459801668|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
127774686|NCT03971422|459801666|FG000|Overall Study|Due to COVID-19 pandemic|0|||
127774687|NCT03971422|459801667|FG001|Overall Study|Due to COVID-19 pandemic|1|||
127774688|NCT03971422|459801668|FG002|Overall Study|Due to COVID-19 pandemic|1|||
127774689|NCT04751656|459801671|FG000|Overall Study|Lost to Follow-up|1|||
127774690|NCT03566810|459801672|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
127774691|NCT03566810|459801673|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
127774692|NCT03566810|459801674|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
127774693|NCT03566810|459801675|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
127774694|NCT03217266|459801676|FG000|Step 1: Dose Level 1|Did not start protocol treatment|1|||
127774695|NCT03217266|459801677|FG001|Step 1: Dose Level 1|Did not start protocol treatment|0|||
127774696|NCT03217266|459801678|FG002|Step 1: Dose Level 1|Did not start protocol treatment|0|||
127774697|NCT03217266|459801679|FG003|Step 1: Dose Level 1|Did not start protocol treatment|0|||
127774698|NCT03217266|459801676|FG000|Step 1: Dose Level 2|Did not start protocol treatment|1|||
127774699|NCT03217266|459801677|FG001|Step 1: Dose Level 2|Did not start protocol treatment|2|||
127774700|NCT03217266|459801678|FG002|Step 1: Dose Level 2|Did not start protocol treatment|0|||
127774701|NCT03217266|459801679|FG003|Step 1: Dose Level 2|Did not start protocol treatment|0|||
127774702|NCT03217266|459801676|FG000|Step 1: Dose Level 3|Did not start treatment|1|||
127774703|NCT03217266|459801677|FG001|Step 1: Dose Level 3|Did not start treatment|0|||
127774704|NCT03217266|459801678|FG002|Step 1: Dose Level 3|Did not start treatment|0|||
127774705|NCT03217266|459801679|FG003|Step 1: Dose Level 3|Did not start treatment|0|||
127774706|NCT01955122|459801687|FG000|Overall Study|Physician Decision|5|||
127774707|NCT01955122|459801688|FG001|Overall Study|Physician Decision|5|||
127774708|NCT00826111|459801689|FG000|Overall Study|Lost to Follow-up|0|||
127774709|NCT00826111|459801690|FG001|Overall Study|Lost to Follow-up|1|||
127774710|NCT00826111|459801689|FG000|Overall Study|Protocol Violation|1|||
127774711|NCT00826111|459801690|FG001|Overall Study|Protocol Violation|0|||
127774712|NCT00826111|459801689|FG000|Overall Study|Withdrawal by Subject|5|||
127774713|NCT00826111|459801690|FG001|Overall Study|Withdrawal by Subject|0|||
127774714|NCT00826111|459801689|FG000|Overall Study|Physician Decision|1|||
127774715|NCT00826111|459801690|FG001|Overall Study|Physician Decision|1|||
127774716|NCT01672788|459801691|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
127774717|NCT01672788|459801692|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
127560144|NCT04556383|459021623|FG003|PCP|Other, Not Specified|0|||
127774718|NCT01672788|459801693|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
127560145|NCT04556383|459021620|FG000|PCP|Protocol Violation|1|||
127774719|NCT01672788|459801694|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
127774720|NCT03511053|459801702|FG000|Overall Study|Withdrawal by Subject|1|||
127774721|NCT01128361|459801703|FG000|Overall Study|Lost to Follow-up|0|||
127560146|NCT04556383|459021621|FG001|PCP|Protocol Violation|0|||
127560147|NCT04556383|459021622|FG002|PCP|Protocol Violation|1|||
127686506|NCT01414738|459479653|FG000|Overall Study|Lost to Follow-up|2|||
128023969|NCT01964560|460712630|FG000|Overall Study|Surgery|1|||
128023970|NCT01964560|460712630|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
128023971|NCT01964560|460712630|FG000|Overall Study|Patient and Investigator choice|1|||
128023972|NCT01964560|460712630|FG000|Overall Study|Patient was prescribed CBD|1|||
128023973|NCT01964560|460712630|FG000|Overall Study|Participant moved to another country|1|||
127686507|NCT01414738|459479653|FG000|Overall Study|Refused, disease progression|8|||
127686508|NCT01414738|459479653|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
127686509|NCT01839331|459479654|FG000|Overall Study|Early Termination|3|||
127686510|NCT01839331|459479655|FG001|Overall Study|Early Termination|0|||
127686511|NCT01839331|459479656|FG002|Overall Study|Early Termination|1|||
127686512|NCT01839331|459479657|FG003|Overall Study|Early Termination|2|||
127686513|NCT01839331|459479654|FG000|Overall Study|Protocol Violation|1|||
127686514|NCT01839331|459479655|FG001|Overall Study|Protocol Violation|6|||
127560148|NCT04556383|459021623|FG003|PCP|Protocol Violation|0|||
127560149|NCT04556383|459021620|FG000|PCP|Lost to Follow-up|1|||
127560150|NCT04556383|459021621|FG001|PCP|Lost to Follow-up|0|||
127560151|NCT04556383|459021622|FG002|PCP|Lost to Follow-up|0|||
127560152|NCT04556383|459021623|FG003|PCP|Lost to Follow-up|0|||
127560153|NCT04556383|459021620|FG000|PCP|Physician Decision|0|||
127560154|NCT04556383|459021621|FG001|PCP|Physician Decision|1|||
127560155|NCT04556383|459021622|FG002|PCP|Physician Decision|0|||
127560156|NCT04556383|459021623|FG003|PCP|Physician Decision|0|||
127560157|NCT04556383|459021620|FG000|PCP|Site terminated by sponsor|0|||
127560158|NCT04556383|459021621|FG001|PCP|Site terminated by sponsor|1|||
127686515|NCT01839331|459479656|FG002|Overall Study|Protocol Violation|4|||
127686516|NCT01839331|459479657|FG003|Overall Study|Protocol Violation|3|||
127686517|NCT04056624|459479658|FG000|Overall Study|Withdrawal by Subject|0|||
127686518|NCT04056624|459479659|FG001|Overall Study|Withdrawal by Subject|0|||
127686519|NCT04056624|459479660|FG002|Overall Study|Withdrawal by Subject|1|||
127686520|NCT04056624|459479658|FG000|Overall Study|Protocol Violation|1|||
127686521|NCT04056624|459479659|FG001|Overall Study|Protocol Violation|2|||
127686522|NCT04056624|459479660|FG002|Overall Study|Protocol Violation|0|||
127686523|NCT00703820|459479661|FG000|Overall Study|Adverse Event|12|||
127686524|NCT00703820|459479662|FG001|Overall Study|Adverse Event|17|||
127686525|NCT00703820|459479661|FG000|Overall Study|Death|5|||
127686526|NCT00703820|459479662|FG001|Overall Study|Death|0|||
127686527|NCT00703820|459479661|FG000|Overall Study|Lack of Efficacy|11|||
127686528|NCT00703820|459479662|FG001|Overall Study|Lack of Efficacy|11|||
127686529|NCT00703820|459479661|FG000|Overall Study|Received non-protocol therapy|1|||
127686530|NCT00703820|459479662|FG001|Overall Study|Received non-protocol therapy|0|||
127686531|NCT00703820|459479661|FG000|Overall Study|Physician Decision|4|||
127686532|NCT00703820|459479662|FG001|Overall Study|Physician Decision|5|||
127686533|NCT00703820|459479661|FG000|Overall Study|Withdrawal by Subject|2|||
127686534|NCT00703820|459479662|FG001|Overall Study|Withdrawal by Subject|1|||
127686535|NCT03531840|459479667|FG000|Overall Study|Death on study|3|||
127686536|NCT03531840|459479668|FG001|Overall Study|Death on study|2|||
127686537|NCT03531840|459479669|FG002|Overall Study|Death on study|1|||
127686538|NCT03531840|459479670|FG003|Overall Study|Death on study|2|||
127686539|NCT03531840|459479667|FG000|Overall Study|Death during follow up|2|||
127686540|NCT03531840|459479668|FG001|Overall Study|Death during follow up|3|||
127686541|NCT03531840|459479669|FG002|Overall Study|Death during follow up|4|||
127686542|NCT03531840|459479670|FG003|Overall Study|Death during follow up|1|||
127686543|NCT00761605|459479672|FG000|Overall Study|Adverse Event|26|||
127686544|NCT00761605|459479672|FG000|Overall Study|Death|2|||
127686545|NCT00761605|459479672|FG000|Overall Study|Lack of Efficacy|26|||
127686546|NCT00761605|459479672|FG000|Overall Study|Lost to Follow-up|29|||
127686547|NCT00761605|459479672|FG000|Overall Study|Withdrawal by Subject|37|||
127686548|NCT00761605|459479672|FG000|Overall Study|Other|21|||
127686549|NCT02267824|459479673|FG000|Overall Study|Pregnancy|1|||
127686550|NCT02267824|459479674|FG001|Overall Study|Pregnancy|1|||
127686551|NCT02267824|459479673|FG000|Overall Study|Lost to Follow-up|4|||
127686552|NCT02267824|459479674|FG001|Overall Study|Lost to Follow-up|0|||
127686553|NCT02267824|459479673|FG000|Overall Study|Protocol Violation|3|||
127686554|NCT02267824|459479674|FG001|Overall Study|Protocol Violation|0|||
127686555|NCT02267824|459479673|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
127686556|NCT02267824|459479674|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
128023974|NCT02565186|460712631|FG000|Overall Study|Adverse Event|113|||
128023975|NCT02565186|460712632|FG001|Overall Study|Adverse Event|148|||
128023976|NCT02565186|460712631|FG000|Overall Study|Lost to Follow-up|102|||
128023977|NCT02565186|460712632|FG001|Overall Study|Lost to Follow-up|93|||
128023978|NCT02565186|460712631|FG000|Overall Study|Non-Compliance|57|||
127686557|NCT03451721|459479675|FG000|Overall Study|Death|1|||
127686558|NCT01985334|459479676|FG000|Overall Study|Administrative problems|1|||
127686559|NCT01985334|459479677|FG001|Overall Study|Administrative problems|1|||
127560159|NCT04556383|459021622|FG002|PCP|Site terminated by sponsor|0|||
127560160|NCT04556383|459021623|FG003|PCP|Site terminated by sponsor|0|||
127560161|NCT04556383|459021620|FG000|OLE|Study terminated by sponsor|0|||
127560162|NCT04556383|459021621|FG001|OLE|Study terminated by sponsor|0|||
128023979|NCT02565186|460712632|FG001|Overall Study|Non-Compliance|55|||
128023980|NCT02565186|460712631|FG000|Overall Study|Withdrawal by Subject|229|||
128023981|NCT02565186|460712632|FG001|Overall Study|Withdrawal by Subject|214|||
128023982|NCT02565186|460712631|FG000|Overall Study|Physician Decision|18|||
128023983|NCT02565186|460712632|FG001|Overall Study|Physician Decision|16|||
128023984|NCT02565186|460712631|FG000|Overall Study|Sponsor Request|5|||
128023985|NCT02565186|460712632|FG001|Overall Study|Sponsor Request|9|||
128023986|NCT02565186|460712631|FG000|Overall Study|Missing|1|||
128023987|NCT02565186|460712632|FG001|Overall Study|Missing|0|||
128023988|NCT02565186|460712631|FG000|Overall Study|Did Not Receive Study Drug|55|||
127560163|NCT04556383|459021622|FG002|OLE|Study terminated by sponsor|0|||
127560164|NCT04556383|459021623|FG003|OLE|Study terminated by sponsor|68|||
127560165|NCT04556383|459021620|FG000|OLE|Withdrawal by Subject|0|||
127560166|NCT04556383|459021621|FG001|OLE|Withdrawal by Subject|0|||
127560167|NCT04556383|459021622|FG002|OLE|Withdrawal by Subject|0|||
127560168|NCT04556383|459021623|FG003|OLE|Withdrawal by Subject|10|||
127560169|NCT04556383|459021620|FG000|OLE|Lack of Efficacy|0|||
127686560|NCT01985334|459479678|FG002|Overall Study|Administrative problems|0|||
127686561|NCT01985334|459479679|FG003|Overall Study|Administrative problems|2|||
127686562|NCT01985334|459479680|FG004|Overall Study|Administrative problems|0|||
127686563|NCT01985334|459479681|FG005|Overall Study|Administrative problems|1|||
127686564|NCT01985334|459479682|FG006|Overall Study|Administrative problems|1|||
127686565|NCT01985334|459479683|FG007|Overall Study|Administrative problems|3|||
127686566|NCT01985334|459479676|FG000|Overall Study|Death|1|||
127686567|NCT01985334|459479677|FG001|Overall Study|Death|0|||
127686568|NCT01985334|459479678|FG002|Overall Study|Death|0|||
127686569|NCT01985334|459479679|FG003|Overall Study|Death|3|||
127686570|NCT01985334|459479680|FG004|Overall Study|Death|0|||
127686571|NCT01985334|459479681|FG005|Overall Study|Death|0|||
127686572|NCT01985334|459479682|FG006|Overall Study|Death|1|||
127686573|NCT01985334|459479683|FG007|Overall Study|Death|2|||
127686574|NCT01985334|459479676|FG000|Overall Study|Worsening of disease|0|||
127686575|NCT01985334|459479677|FG001|Overall Study|Worsening of disease|0|||
127686576|NCT01985334|459479678|FG002|Overall Study|Worsening of disease|0|||
127686577|NCT01985334|459479679|FG003|Overall Study|Worsening of disease|1|||
127686578|NCT01985334|459479680|FG004|Overall Study|Worsening of disease|0|||
127686579|NCT01985334|459479681|FG005|Overall Study|Worsening of disease|3|||
127686580|NCT01985334|459479682|FG006|Overall Study|Worsening of disease|0|||
127686581|NCT01985334|459479683|FG007|Overall Study|Worsening of disease|1|||
127686582|NCT01985334|459479676|FG000|Overall Study|Other|2|||
127686583|NCT01985334|459479677|FG001|Overall Study|Other|9|||
127686584|NCT01985334|459479678|FG002|Overall Study|Other|7|||
127686585|NCT01985334|459479679|FG003|Overall Study|Other|17|||
127686586|NCT01985334|459479680|FG004|Overall Study|Other|4|||
127686587|NCT01985334|459479681|FG005|Overall Study|Other|8|||
127686588|NCT01985334|459479682|FG006|Overall Study|Other|4|||
127686589|NCT01985334|459479683|FG007|Overall Study|Other|7|||
127686590|NCT01985334|459479676|FG000|Overall Study|Protocol deviation|6|||
127686591|NCT01985334|459479677|FG001|Overall Study|Protocol deviation|31|||
127686592|NCT01985334|459479678|FG002|Overall Study|Protocol deviation|25|||
127686593|NCT01985334|459479679|FG003|Overall Study|Protocol deviation|84|||
127686594|NCT01985334|459479680|FG004|Overall Study|Protocol deviation|17|||
127686595|NCT01985334|459479681|FG005|Overall Study|Protocol deviation|47|||
127686596|NCT01985334|459479682|FG006|Overall Study|Protocol deviation|15|||
127686597|NCT01985334|459479683|FG007|Overall Study|Protocol deviation|42|||
127686598|NCT01985334|459479676|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
127686599|NCT01985334|459479677|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
127686600|NCT01985334|459479678|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
127686601|NCT01985334|459479679|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
127686602|NCT01985334|459479680|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
127686603|NCT01985334|459479681|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
128023989|NCT02565186|460712632|FG001|Overall Study|Did Not Receive Study Drug|86|||
127560170|NCT04556383|459021621|FG001|OLE|Lack of Efficacy|0|||
127686604|NCT01985334|459479682|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
127686605|NCT01985334|459479683|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
127686606|NCT01985334|459479676|FG000|Overall Study|Subject withdrawal of consent|3|||
127774722|NCT01128361|459801704|FG001|Overall Study|Lost to Follow-up|1|||
128023990|NCT03994120|460712633|FG000|Overall Study|Lost to Follow-up|3|||
128023991|NCT03994120|460712634|FG001|Overall Study|Lost to Follow-up|1|||
128023992|NCT00183391|460712635|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
128023993|NCT00183391|460712636|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
127560171|NCT04556383|459021622|FG002|OLE|Lack of Efficacy|0|||
127686607|NCT01985334|459479677|FG001|Overall Study|Subject withdrawal of consent|6|||
127686608|NCT01985334|459479678|FG002|Overall Study|Subject withdrawal of consent|2|||
127686609|NCT01985334|459479679|FG003|Overall Study|Subject withdrawal of consent|28|||
127560172|NCT04556383|459021623|FG003|OLE|Lack of Efficacy|7|||
128023994|NCT00183391|460712635|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
128023995|NCT00183391|460712636|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
127560173|NCT04556383|459021620|FG000|OLE|Adverse Event|0|||
127560174|NCT04556383|459021621|FG001|OLE|Adverse Event|0|||
127560175|NCT04556383|459021622|FG002|OLE|Adverse Event|0|||
127560176|NCT04556383|459021623|FG003|OLE|Adverse Event|2|||
127560177|NCT04556383|459021620|FG000|OLE|Other, Not Specified|0|||
127560178|NCT04556383|459021621|FG001|OLE|Other, Not Specified|0|||
127560179|NCT04556383|459021622|FG002|OLE|Other, Not Specified|0|||
127560180|NCT04556383|459021623|FG003|OLE|Other, Not Specified|2|||
127560181|NCT04556383|459021620|FG000|OLE|Death|0|||
127560182|NCT04556383|459021621|FG001|OLE|Death|0|||
127560183|NCT04556383|459021622|FG002|OLE|Death|0|||
127560184|NCT04556383|459021623|FG003|OLE|Death|1|||
127560185|NCT04556383|459021620|FG000|OLE|Lost to Follow-up|0|||
127560186|NCT04556383|459021621|FG001|OLE|Lost to Follow-up|0|||
127560187|NCT04556383|459021622|FG002|OLE|Lost to Follow-up|0|||
127560188|NCT04556383|459021623|FG003|OLE|Lost to Follow-up|1|||
127560189|NCT00119678|459021629|FG000|Double-blind Treatment Period|Death|1|||
127560190|NCT00119678|459021630|FG001|Double-blind Treatment Period|Death|0|||
127560191|NCT00119678|459021629|FG000|Double-blind Treatment Period|Adverse Event|7|||
127560192|NCT00119678|459021630|FG001|Double-blind Treatment Period|Adverse Event|1|||
127560193|NCT00119678|459021629|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
127560194|NCT00119678|459021630|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
127560195|NCT00119678|459021629|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
127560196|NCT00119678|459021630|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
127560197|NCT00119678|459021629|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
127560198|NCT00119678|459021630|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
127560199|NCT00119678|459021629|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
127560200|NCT00119678|459021630|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
127560201|NCT00119678|459021629|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
127560202|NCT00119678|459021630|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
127560203|NCT00119678|459021629|FG000|Double-blind Treatment Period|Pregnancy|0|||
127560204|NCT00119678|459021630|FG001|Double-blind Treatment Period|Pregnancy|2|||
127686610|NCT01985334|459479680|FG004|Overall Study|Subject withdrawal of consent|4|||
127686611|NCT01985334|459479681|FG005|Overall Study|Subject withdrawal of consent|19|||
127686612|NCT01985334|459479682|FG006|Overall Study|Subject withdrawal of consent|0|||
127560205|NCT00119678|459021629|FG000|Double-blind Treatment Period|Not treated|1|||
127560206|NCT00119678|459021630|FG001|Double-blind Treatment Period|Not treated|2|||
127686613|NCT01985334|459479683|FG007|Overall Study|Subject withdrawal of consent|20|||
127686614|NCT01985334|459479676|FG000|Overall Study|Adverse Event|0|||
127686615|NCT01985334|459479677|FG001|Overall Study|Adverse Event|8|||
127686616|NCT01985334|459479678|FG002|Overall Study|Adverse Event|2|||
127686617|NCT01985334|459479679|FG003|Overall Study|Adverse Event|26|||
127686618|NCT01985334|459479680|FG004|Overall Study|Adverse Event|3|||
127686619|NCT01985334|459479681|FG005|Overall Study|Adverse Event|18|||
127686620|NCT01985334|459479682|FG006|Overall Study|Adverse Event|3|||
127686621|NCT01985334|459479683|FG007|Overall Study|Adverse Event|15|||
127686622|NCT01985334|459479676|FG000|Overall Study|Other|4|||
127686623|NCT01985334|459479677|FG001|Overall Study|Other|2|||
127686624|NCT01985334|459479678|FG002|Overall Study|Other|3|||
127686625|NCT01985334|459479679|FG003|Overall Study|Other|10|||
127686626|NCT01985334|459479680|FG004|Overall Study|Other|1|||
127686627|NCT01985334|459479681|FG005|Overall Study|Other|6|||
127686628|NCT01985334|459479682|FG006|Overall Study|Other|2|||
127686629|NCT01985334|459479683|FG007|Overall Study|Other|2|||
127560207|NCT00119678|459021629|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
127560208|NCT00119678|459021630|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
127560209|NCT00119678|459021629|FG000|Open-label Treatment Period|Death|1|||
127560210|NCT00119678|459021630|FG001|Open-label Treatment Period|Death|0|||
127560211|NCT00119678|459021629|FG000|Open-label Treatment Period|Adverse Event|3|||
127560212|NCT00119678|459021630|FG001|Open-label Treatment Period|Adverse Event|0|||
127686630|NCT01985334|459479676|FG000|Overall Study|Medication non-compliance|0|||
127560213|NCT00119678|459021629|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
127560214|NCT00119678|459021630|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
127560215|NCT00119678|459021629|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
127686631|NCT01985334|459479677|FG001|Overall Study|Medication non-compliance|4|||
127686632|NCT01985334|459479678|FG002|Overall Study|Medication non-compliance|1|||
127881026|NCT02575807|460186106|FG002|Overall Study|Death|7|||
127560216|NCT00119678|459021630|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
127560217|NCT00119678|459021629|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
127560218|NCT00119678|459021630|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
127560219|NCT00119678|459021629|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
127560220|NCT00119678|459021630|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
127774723|NCT01128361|459801703|FG000|Overall Study|Withdrawal by Subject|5|||
127774724|NCT01128361|459801704|FG001|Overall Study|Withdrawal by Subject|2|||
127774725|NCT01929980|459801705|FG000|Overall Study|Physician Decision|1|||
127774726|NCT00985166|459801706|FG000|Overall Study|Lost to Follow-up|3|||
127774727|NCT00985166|459801707|FG001|Overall Study|Lost to Follow-up|2|||
127774728|NCT00985166|459801708|FG002|Overall Study|Lost to Follow-up|2|||
127774729|NCT00985166|459801706|FG000|Overall Study|Withdrawal by Subject|3|||
127774730|NCT00985166|459801707|FG001|Overall Study|Withdrawal by Subject|2|||
127774731|NCT00985166|459801708|FG002|Overall Study|Withdrawal by Subject|0|||
127774732|NCT00985166|459801706|FG000|Overall Study|Test not done|2|||
127774733|NCT00985166|459801707|FG001|Overall Study|Test not done|0|||
127774734|NCT00985166|459801708|FG002|Overall Study|Test not done|4|||
127774735|NCT00985166|459801706|FG000|Overall Study|Other|1|||
127774736|NCT00985166|459801707|FG001|Overall Study|Other|0|||
127774737|NCT00985166|459801708|FG002|Overall Study|Other|1|||
127774738|NCT01028222|459801709|FG000|Overall Study|Protocol deviation|1|||
127774739|NCT01028222|459801710|FG001|Overall Study|Protocol deviation|0|||
127774740|NCT01028222|459801709|FG000|Overall Study|Disease progression|33|||
127774741|NCT01028222|459801710|FG001|Overall Study|Disease progression|9|||
127774742|NCT01028222|459801709|FG000|Overall Study|Administrative problems|1|||
127774743|NCT01028222|459801710|FG001|Overall Study|Administrative problems|1|||
127774744|NCT01028222|459801709|FG000|Overall Study|Lost to Follow-up|0|||
127774745|NCT01028222|459801710|FG001|Overall Study|Lost to Follow-up|1|||
127774746|NCT01028222|459801709|FG000|Overall Study|Withdrawal by Subject|1|||
127774747|NCT01028222|459801710|FG001|Overall Study|Withdrawal by Subject|0|||
127774748|NCT01028222|459801709|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
127774749|NCT01028222|459801710|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
127774750|NCT01028222|459801709|FG000|Overall Study|Adverse Event|2|||
127774751|NCT01028222|459801710|FG001|Overall Study|Adverse Event|0|||
127774752|NCT00146328|459801713|FG000|Overall Study|Adverse Event|39|||
127774753|NCT00146328|459801714|FG001|Overall Study|Adverse Event|48|||
127774754|NCT00146328|459801715|FG002|Overall Study|Adverse Event|79|||
127774755|NCT00146328|459801713|FG000|Overall Study|Protocol Violation|11|||
127774756|NCT00146328|459801714|FG001|Overall Study|Protocol Violation|6|||
127774757|NCT00146328|459801715|FG002|Overall Study|Protocol Violation|12|||
128023996|NCT02460380|460712637|FG000|Overall Study|Withdrawal by Subject|10|||
128023997|NCT02460380|460712638|FG001|Overall Study|Withdrawal by Subject|5|||
128023998|NCT01986751|460712639|FG000|Overall Study|improperly consented|10|||
128023999|NCT01986751|460712640|FG001|Overall Study|improperly consented|2|||
128024000|NCT01478087|460712641|FG000|Overall Study|due to sponsor closing study|1|||
128024001|NCT03566550|460712642|FG000|Overall Study|Withdrawal by Subject|0|||
128024002|NCT03566550|460712643|FG001|Overall Study|Withdrawal by Subject|1|||
128024003|NCT00052715|460712649|FG000|Overall Study|wrong histology|1|||
128024004|NCT01063881|460712650|FG000|Overall Study|Adverse Event|12|||
128024005|NCT01063881|460712651|FG001|Overall Study|Adverse Event|2|||
128024006|NCT01063881|460712652|FG002|Overall Study|Adverse Event|0|||
128024007|NCT01063881|460712650|FG000|Overall Study|Lost to Follow-up|13|||
128024008|NCT01063881|460712651|FG001|Overall Study|Lost to Follow-up|7|||
128024009|NCT01063881|460712652|FG002|Overall Study|Lost to Follow-up|1|||
128024010|NCT01063881|460712650|FG000|Overall Study|Withdrawal by Subject|25|||
128024011|NCT01063881|460712651|FG001|Overall Study|Withdrawal by Subject|1|||
128024012|NCT01063881|460712652|FG002|Overall Study|Withdrawal by Subject|0|||
128024013|NCT01063881|460712650|FG000|Overall Study|Reason for not completed not specified|5|||
128024014|NCT01063881|460712651|FG001|Overall Study|Reason for not completed not specified|1|||
128024015|NCT01063881|460712652|FG002|Overall Study|Reason for not completed not specified|0|||
128024016|NCT01489358|460712653|FG000|Overall Study|Lost to Follow-up|0|||
128024017|NCT01489358|460712654|FG001|Overall Study|Lost to Follow-up|0|||
128024018|NCT01489358|460712655|FG002|Overall Study|Lost to Follow-up|2|||
128024019|NCT00736476|460712656|FG000|Overall Study|Adverse Event|1|||
128024020|NCT00736476|460712657|FG001|Overall Study|Adverse Event|0|||
128024021|NCT03518203|460712662|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
128024022|NCT03518203|460712662|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
128024023|NCT03511066|460712663|FG000|Overall Study|Withdrawal by Subject|1|||
127560221|NCT00119678|459021629|FG000|Open-label Treatment Period|Pregnancy|1|||
127774758|NCT00146328|459801713|FG000|Overall Study|Lost to Follow-up|7|||
127774759|NCT00146328|459801714|FG001|Overall Study|Lost to Follow-up|4|||
127774760|NCT00146328|459801715|FG002|Overall Study|Lost to Follow-up|7|||
127774761|NCT00146328|459801713|FG000|Overall Study|Withdrawal by Subject|16|||
127774762|NCT00146328|459801714|FG001|Overall Study|Withdrawal by Subject|16|||
127881027|NCT02575807|460186107|FG003|Overall Study|Death|0|||
127774763|NCT00146328|459801715|FG002|Overall Study|Withdrawal by Subject|22|||
127774764|NCT00146328|459801713|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
127774765|NCT00146328|459801714|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
127774766|NCT00146328|459801715|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
127774767|NCT00146328|459801713|FG000|Overall Study|Trial ended/site closed|8|||
127774768|NCT00146328|459801714|FG001|Overall Study|Trial ended/site closed|2|||
127774769|NCT00146328|459801715|FG002|Overall Study|Trial ended/site closed|19|||
127774770|NCT00146328|459801713|FG000|Overall Study|Patient decision to end|0|||
127774771|NCT00146328|459801714|FG001|Overall Study|Patient decision to end|1|||
127774772|NCT00146328|459801715|FG002|Overall Study|Patient decision to end|6|||
127774773|NCT00146328|459801713|FG000|Overall Study|Enroll into other trial|2|||
127774774|NCT00146328|459801714|FG001|Overall Study|Enroll into other trial|4|||
127774775|NCT00146328|459801715|FG002|Overall Study|Enroll into other trial|2|||
127774776|NCT00146328|459801713|FG000|Overall Study|Death|0|||
127774777|NCT00146328|459801714|FG001|Overall Study|Death|1|||
127774778|NCT00146328|459801715|FG002|Overall Study|Death|1|||
127774779|NCT00146328|459801713|FG000|Overall Study|Moved|2|||
127774780|NCT00146328|459801714|FG001|Overall Study|Moved|0|||
127774781|NCT00146328|459801715|FG002|Overall Study|Moved|0|||
127774782|NCT00146328|459801713|FG000|Overall Study|Interaction with other medication|2|||
127774783|NCT00146328|459801714|FG001|Overall Study|Interaction with other medication|0|||
127774784|NCT00146328|459801715|FG002|Overall Study|Interaction with other medication|1|||
127774785|NCT00300781|459801716|FG000|Overall Study|Disease Progression|55|||
127774786|NCT00300781|459801717|FG001|Overall Study|Disease Progression|52|||
127774787|NCT00300781|459801716|FG000|Overall Study|Adverse Event|5|||
127774788|NCT00300781|459801717|FG001|Overall Study|Adverse Event|6|||
127774789|NCT00300781|459801716|FG000|Overall Study|Withdrawal by Subject|1|||
127774790|NCT00300781|459801717|FG001|Overall Study|Withdrawal by Subject|2|||
127774791|NCT00300781|459801716|FG000|Overall Study|Physician Decision|1|||
127774792|NCT00300781|459801717|FG001|Overall Study|Physician Decision|0|||
127774793|NCT00300781|459801716|FG000|Overall Study|Not Recorded|0|||
127774794|NCT00300781|459801717|FG001|Overall Study|Not Recorded|1|||
127774795|NCT00300781|459801716|FG000|Overall Study|Symptomatic Deterioration|1|||
127774796|NCT00300781|459801717|FG001|Overall Study|Symptomatic Deterioration|0|||
127774797|NCT00300781|459801716|FG000|Overall Study|Lost to Follow-up|0|||
127774798|NCT00300781|459801717|FG001|Overall Study|Lost to Follow-up|1|||
127774799|NCT02072434|459801718|FG000|Overall Study|Protocol Violation|10|||
127774800|NCT02072434|459801719|FG001|Overall Study|Protocol Violation|9|||
127774801|NCT02072434|459801718|FG000|Overall Study|Physician Decision|5|||
127774802|NCT02072434|459801719|FG001|Overall Study|Physician Decision|10|||
127774803|NCT02072434|459801718|FG000|Overall Study|Adverse event, serious fatal|1|||
127774804|NCT02072434|459801719|FG001|Overall Study|Adverse event, serious fatal|6|||
127774805|NCT02072434|459801718|FG000|Overall Study|Adverse Event|7|||
127774806|NCT02072434|459801719|FG001|Overall Study|Adverse Event|6|||
127774807|NCT02072434|459801718|FG000|Overall Study|Withdrawal by Subject|17|||
127774808|NCT02072434|459801719|FG001|Overall Study|Withdrawal by Subject|29|||
128024024|NCT03511066|460712664|FG001|Overall Study|Withdrawal by Subject|2|||
128024025|NCT03511066|460712665|FG002|Overall Study|Withdrawal by Subject|3|||
128024026|NCT03511066|460712663|FG000|Overall Study|Lost to Follow-up|2|||
128024027|NCT03511066|460712664|FG001|Overall Study|Lost to Follow-up|3|||
127560222|NCT00119678|459021630|FG001|Open-label Treatment Period|Pregnancy|0|||
127560223|NCT00119678|459021629|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
127560224|NCT00119678|459021630|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
127560225|NCT01761240|459021631|FG000|Overall Study|Progressive disease:radiology assessment|3|||
127560226|NCT01761240|459021632|FG001|Overall Study|Progressive disease:radiology assessment|3|||
127774809|NCT02072434|459801718|FG000|Overall Study|Other|14|||
127774810|NCT02072434|459801719|FG001|Overall Study|Other|29|||
127774811|NCT02072434|459801718|FG000|Overall Study|Lost to Follow-up|0|||
127774812|NCT02072434|459801719|FG001|Overall Study|Lost to Follow-up|1|||
127774813|NCT02170389|459801726|FG000|Overall Study|Study terminated prior to start of treat|1|||
127774814|NCT01008696|459801728|FG000|Overall Study|Participant's evasion of hospital visit|5|||
127774815|NCT01008696|459801729|FG001|Overall Study|Participant's evasion of hospital visit|4|||
127774816|NCT01008696|459801728|FG000|Overall Study|Withdrawal by Subject|2|||
127774817|NCT01008696|459801729|FG001|Overall Study|Withdrawal by Subject|4|||
127774818|NCT01008696|459801728|FG000|Overall Study|Physician Decision|5|||
127774819|NCT01008696|459801729|FG001|Overall Study|Physician Decision|1|||
127774820|NCT01008696|459801728|FG000|Overall Study|Adverse Event|1|||
127774821|NCT01008696|459801729|FG001|Overall Study|Adverse Event|0|||
127774822|NCT01008696|459801728|FG000|Overall Study|Participants' non-cooperation|2|||
127560227|NCT01761240|459021633|FG002|Overall Study|Progressive disease:radiology assessment|0|||
128024028|NCT03511066|460712665|FG002|Overall Study|Lost to Follow-up|0|||
127774823|NCT01008696|459801729|FG001|Overall Study|Participants' non-cooperation|3|||
127774824|NCT01008696|459801728|FG000|Overall Study|Other|2|||
127774825|NCT01008696|459801729|FG001|Overall Study|Other|3|||
127774826|NCT01008696|459801728|FG000|Overall Study|Other|0|||
127774827|NCT01008696|459801729|FG001|Overall Study|Other|2|||
127774828|NCT02960854|459801730|FG000|Overall Study|Not Disclosed|2|||
128024029|NCT04560309|460712669|FG000|Overall Study|Meet drop out criteria|1|||
128024030|NCT04560309|460712670|FG001|Overall Study|Meet drop out criteria|1|||
128024031|NCT05085405|460712671|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
128024032|NCT05085405|460712672|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
128024033|NCT05085405|460712673|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
128024034|NCT05085405|460712674|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
128024035|NCT05085405|460712675|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
128024036|NCT05085405|460712676|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
128024037|NCT05085405|460712671|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
128024038|NCT05085405|460712672|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
128024039|NCT05085405|460712673|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
128024040|NCT05085405|460712674|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
128024041|NCT05085405|460712675|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
128024042|NCT05085405|460712676|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
128024043|NCT04146909|460712677|FG000|Overall Study|Withdrawal by Subject|3|||
128024044|NCT04146909|460712677|FG000|Overall Study|Did not qualify after consented|1|||
128024045|NCT02362412|460712680|FG000|Treatment Period III|Lost to Follow-up|0|||
128024046|NCT02362412|460712681|FG001|Treatment Period III|Lost to Follow-up|1|||
128024047|NCT01541254|460712682|FG000|Overall Study|Withdrawal by Subject|1|||
128024048|NCT01541254|460712682|FG000|Overall Study|excluded - metal allergy|1|||
128024049|NCT01541254|460712682|FG000|Overall Study|enrolled after study closed|1|||
128024050|NCT01541254|460712682|FG000|Overall Study|GI bleed prior to procedure|1|||
127560228|NCT01761240|459021634|FG003|Overall Study|Progressive disease:radiology assessment|0|||
127560229|NCT01761240|459021635|FG004|Overall Study|Progressive disease:radiology assessment|0|||
127560230|NCT01761240|459021631|FG000|Overall Study|Progressive disease:clinical assessment|0|||
128024051|NCT01541254|460712682|FG000|Overall Study|stent not required|1|||
128024052|NCT01541254|460712682|FG000|Overall Study|alternate stent used|1|||
128024053|NCT05103332|460712683|FG000|Overall Study|Lost to Follow-up|0|||
128024054|NCT05103332|460712684|FG001|Overall Study|Lost to Follow-up|2|||
128024055|NCT05103332|460712685|FG002|Overall Study|Lost to Follow-up|1|||
128024056|NCT05103332|460712686|FG003|Overall Study|Lost to Follow-up|0|||
128024057|NCT05103332|460712687|FG004|Overall Study|Lost to Follow-up|0|||
128024058|NCT05103332|460712688|FG005|Overall Study|Lost to Follow-up|2|||
128024059|NCT05103332|460712683|FG000|Overall Study|Physician Decision|0|||
128024060|NCT05103332|460712684|FG001|Overall Study|Physician Decision|1|||
128024061|NCT05103332|460712685|FG002|Overall Study|Physician Decision|0|||
128024062|NCT05103332|460712686|FG003|Overall Study|Physician Decision|1|||
128024063|NCT05103332|460712687|FG004|Overall Study|Physician Decision|0|||
128024064|NCT05103332|460712688|FG005|Overall Study|Physician Decision|0|||
128024065|NCT05103332|460712683|FG000|Overall Study|Participant Stopped Participation in the Study|2|||
128024066|NCT05103332|460712684|FG001|Overall Study|Participant Stopped Participation in the Study|3|||
128024067|NCT05103332|460712685|FG002|Overall Study|Participant Stopped Participation in the Study|5|||
128024068|NCT05103332|460712686|FG003|Overall Study|Participant Stopped Participation in the Study|3|||
128024069|NCT05103332|460712687|FG004|Overall Study|Participant Stopped Participation in the Study|3|||
128024070|NCT05103332|460712688|FG005|Overall Study|Participant Stopped Participation in the Study|7|||
128024071|NCT05103332|460712683|FG000|Overall Study|Unspeccified|0|||
128024072|NCT05103332|460712684|FG001|Overall Study|Unspeccified|0|||
128024073|NCT05103332|460712685|FG002|Overall Study|Unspeccified|0|||
127686633|NCT01985334|459479679|FG003|Overall Study|Medication non-compliance|6|||
127686634|NCT01985334|459479680|FG004|Overall Study|Medication non-compliance|2|||
127686635|NCT01985334|459479681|FG005|Overall Study|Medication non-compliance|3|||
127686636|NCT01985334|459479682|FG006|Overall Study|Medication non-compliance|1|||
127686637|NCT01985334|459479683|FG007|Overall Study|Medication non-compliance|3|||
127686638|NCT01985334|459479676|FG000|Overall Study|Use of prohibited treatment|1|||
127686639|NCT01985334|459479677|FG001|Overall Study|Use of prohibited treatment|4|||
127686640|NCT01985334|459479678|FG002|Overall Study|Use of prohibited treatment|1|||
127686641|NCT01985334|459479679|FG003|Overall Study|Use of prohibited treatment|2|||
127686642|NCT01985334|459479680|FG004|Overall Study|Use of prohibited treatment|1|||
127686643|NCT01985334|459479681|FG005|Overall Study|Use of prohibited treatment|6|||
127686644|NCT01985334|459479682|FG006|Overall Study|Use of prohibited treatment|2|||
127686645|NCT01985334|459479683|FG007|Overall Study|Use of prohibited treatment|0|||
127686646|NCT01985334|459479676|FG000|Overall Study|Investigator decision|0|||
127686647|NCT01985334|459479677|FG001|Overall Study|Investigator decision|3|||
127560231|NCT01761240|459021632|FG001|Overall Study|Progressive disease:clinical assessment|0|||
127686648|NCT01985334|459479678|FG002|Overall Study|Investigator decision|0|||
127686649|NCT01985334|459479679|FG003|Overall Study|Investigator decision|7|||
128024074|NCT05103332|460712686|FG003|Overall Study|Unspeccified|1|||
128024075|NCT05103332|460712687|FG004|Overall Study|Unspeccified|0|||
127686650|NCT01985334|459479680|FG004|Overall Study|Investigator decision|1|||
127686651|NCT01985334|459479681|FG005|Overall Study|Investigator decision|1|||
127686652|NCT01985334|459479682|FG006|Overall Study|Investigator decision|0|||
128024076|NCT05103332|460712688|FG005|Overall Study|Unspeccified|0|||
128024077|NCT02218268|460712689|FG000|24 Hour Washout|Physician Decision|11|||
127774829|NCT02960854|459801731|FG001|Overall Study|Not Disclosed|2|||
127774830|NCT02960854|459801730|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
127774831|NCT02960854|459801731|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
127774832|NCT02960854|459801730|FG000|Overall Study|Subject Withdrew Consent|0|||
127774833|NCT02960854|459801731|FG001|Overall Study|Subject Withdrew Consent|1|||
127774834|NCT02960854|459801730|FG000|Overall Study|Death|4|||
127774835|NCT02960854|459801731|FG001|Overall Study|Death|6|||
127774836|NCT04263909|459801732|FG000|Overall Study|Physician Decision|1|||
127774837|NCT04263909|459801733|FG001|Overall Study|Physician Decision|0|||
127774838|NCT04263909|459801734|FG002|Overall Study|Physician Decision|0|||
127774839|NCT04263909|459801732|FG000|Overall Study|Adverse Event|3|||
127774840|NCT04263909|459801733|FG001|Overall Study|Adverse Event|0|||
127774841|NCT04263909|459801734|FG002|Overall Study|Adverse Event|0|||
127774842|NCT04263909|459801732|FG000|Overall Study|Protocol Violation|5|||
127774843|NCT04263909|459801733|FG001|Overall Study|Protocol Violation|0|||
127774844|NCT04263909|459801734|FG002|Overall Study|Protocol Violation|0|||
127774845|NCT04288778|459801735|FG000|Overall Study|Withdrawal by Subject|2|||
127774846|NCT04288778|459801735|FG000|Overall Study|Adverse Event|5|||
127774847|NCT04288778|459801735|FG000|Overall Study|Non-Compliance With Study Drug|1|||
127774848|NCT04288778|459801735|FG000|Overall Study|Other|1|||
127774849|NCT04288778|459801735|FG000|Overall Study|Started but not treated|2|||
127774850|NCT03118674|459801736|FG000|Overall Study|Lost to Follow-up|2|||
127774851|NCT03118674|459801736|FG000|Overall Study|Screen Faliure|8|||
127774852|NCT03118674|459801736|FG000|Overall Study|Withdrawal by Subject|5|||
127774853|NCT01067326|459801741|FG000|Overall Study|Adverse Event|0|||
127774854|NCT01067326|459801742|FG001|Overall Study|Adverse Event|2|||
127774855|NCT01067326|459801741|FG000|Overall Study|Withdrawal by Subject|1|||
127774856|NCT01067326|459801742|FG001|Overall Study|Withdrawal by Subject|0|||
127774857|NCT01067326|459801741|FG000|Overall Study|Early Study Termination|1|||
127774858|NCT01067326|459801742|FG001|Overall Study|Early Study Termination|1|||
127774859|NCT01230788|459801749|FG000|Overall Study|Prescribed exclusion drug|1|||
127774860|NCT00769860|459801750|FG000|Overall Study|Withdrawal by Subject|2|||
127774861|NCT00769860|459801751|FG001|Overall Study|Withdrawal by Subject|0|||
127774862|NCT01603082|459801752|FG000|Overall Study|Adverse Event|0|||
127774863|NCT01603082|459801753|FG001|Overall Study|Adverse Event|1|||
127774864|NCT01603082|459801752|FG000|Overall Study|Withdrawal by Subject|1|||
127774865|NCT01603082|459801753|FG001|Overall Study|Withdrawal by Subject|0|||
127774866|NCT01603082|459801752|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
128024078|NCT02218268|460712690|FG001|24 Hour Washout|Physician Decision|9|||
128024079|NCT03651336|460712691|FG000|Overall Study|Withdrawal by Subject|4|||
128024080|NCT01125748|460712694|FG000|Overall Study|Adverse Event|0|||
128024081|NCT01125748|460712695|FG001|Overall Study|Adverse Event|2|||
127686653|NCT01985334|459479683|FG007|Overall Study|Investigator decision|4|||
127686654|NCT01985334|459479676|FG000|Overall Study|Lost to Follow-up|0|||
127686655|NCT01985334|459479677|FG001|Overall Study|Lost to Follow-up|2|||
127686656|NCT01985334|459479678|FG002|Overall Study|Lost to Follow-up|0|||
127686657|NCT01985334|459479679|FG003|Overall Study|Lost to Follow-up|3|||
127686658|NCT01985334|459479680|FG004|Overall Study|Lost to Follow-up|1|||
127686659|NCT01985334|459479681|FG005|Overall Study|Lost to Follow-up|4|||
127686660|NCT01985334|459479682|FG006|Overall Study|Lost to Follow-up|0|||
127686661|NCT01985334|459479683|FG007|Overall Study|Lost to Follow-up|3|||
127686662|NCT00914589|459479684|FG000|Overall Study|Adverse Event|1|||
127686663|NCT00914589|459479685|FG001|Overall Study|Adverse Event|0|||
127686664|NCT00914589|459479686|FG002|Overall Study|Adverse Event|1|||
127686665|NCT00914589|459479684|FG000|Overall Study|Protocol Violation|8|||
127686666|NCT00914589|459479685|FG001|Overall Study|Protocol Violation|6|||
127686667|NCT00914589|459479686|FG002|Overall Study|Protocol Violation|3|||
127686668|NCT00914589|459479684|FG000|Overall Study|unclassified|16|||
127686669|NCT00914589|459479685|FG001|Overall Study|unclassified|9|||
127686670|NCT00914589|459479686|FG002|Overall Study|unclassified|7|||
127686671|NCT00914589|459479684|FG000|Overall Study|Death|0|||
127686672|NCT00914589|459479685|FG001|Overall Study|Death|1|||
128024082|NCT01125748|460712694|FG000|Overall Study|Lost to Follow-up|0|||
127686673|NCT00914589|459479686|FG002|Overall Study|Death|1|||
127686674|NCT01290341|459479687|FG000|Overall Study|Protocol Violation|7|||
127686675|NCT01290341|459479688|FG001|Overall Study|Protocol Violation|3|||
127686676|NCT01290341|459479687|FG000|Overall Study|Adverse Event|1|||
127686677|NCT01290341|459479688|FG001|Overall Study|Adverse Event|0|||
127774867|NCT01603082|459801753|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
127774868|NCT01019317|459801756|FG000|Overall Study|Not Eligible|4|||
127774869|NCT00986440|459801761|FG000|Overall Study|Progressive disease|27|||
127686678|NCT01290341|459479687|FG000|Overall Study|Lost to Follow-up|21|||
127686679|NCT01290341|459479688|FG001|Overall Study|Lost to Follow-up|10|||
127686680|NCT01290341|459479687|FG000|Overall Study|Withdrawal by Subject|19|||
127774870|NCT00986440|459801762|FG001|Overall Study|Progressive disease|37|||
127881028|NCT02575807|460186108|FG004|Overall Study|Death|1|||
128024083|NCT01125748|460712695|FG001|Overall Study|Lost to Follow-up|1|||
128024084|NCT01125748|460712694|FG000|Overall Study|Physician Decision|8|||
128024085|NCT01125748|460712695|FG001|Overall Study|Physician Decision|7|||
128024086|NCT01125748|460712694|FG000|Overall Study|Patient Decision to Withdraw|2|||
128024087|NCT01125748|460712695|FG001|Overall Study|Patient Decision to Withdraw|4|||
128024088|NCT02405962|460712696|FG000|Overall Study|Lost to Follow-up|1|||
128024089|NCT02405962|460712697|FG001|Overall Study|Lost to Follow-up|4|||
128024090|NCT02405962|460712696|FG000|Overall Study|A participant has moved to another place|0|||
128024091|NCT02405962|460712697|FG001|Overall Study|A participant has moved to another place|1|||
128024092|NCT01028391|460712698|FG000|Overall Study|Adverse Event|4|||
128024093|NCT01028391|460712699|FG001|Overall Study|Adverse Event|0|||
128024094|NCT01028391|460712698|FG000|Overall Study|Lack of Efficacy|0|||
128024095|NCT01028391|460712699|FG001|Overall Study|Lack of Efficacy|2|||
128024096|NCT01028391|460712698|FG000|Overall Study|Lost to Follow-up|3|||
128024097|NCT01028391|460712699|FG001|Overall Study|Lost to Follow-up|4|||
128024098|NCT01028391|460712698|FG000|Overall Study|Physician Decision|0|||
128024099|NCT01028391|460712699|FG001|Overall Study|Physician Decision|1|||
127560232|NCT01761240|459021633|FG002|Overall Study|Progressive disease:clinical assessment|3|||
128024100|NCT01028391|460712698|FG000|Overall Study|Withdrawal by Subject|6|||
128024101|NCT01028391|460712699|FG001|Overall Study|Withdrawal by Subject|3|||
128024102|NCT01028391|460712698|FG000|Overall Study|Needed excluded medication|1|||
128024103|NCT01028391|460712699|FG001|Overall Study|Needed excluded medication|1|||
128024104|NCT01227395|460712700|FG000|Overall Study|Protocol Violation|0|||
128024105|NCT01227395|460712701|FG001|Overall Study|Protocol Violation|1|||
127560233|NCT01761240|459021634|FG003|Overall Study|Progressive disease:clinical assessment|1|||
127560234|NCT01761240|459021635|FG004|Overall Study|Progressive disease:clinical assessment|0|||
127560235|NCT01761240|459021631|FG000|Overall Study|Withdrawal by Subject|0|||
127560236|NCT01761240|459021632|FG001|Overall Study|Withdrawal by Subject|0|||
127560237|NCT01761240|459021633|FG002|Overall Study|Withdrawal by Subject|0|||
127560238|NCT01761240|459021634|FG003|Overall Study|Withdrawal by Subject|3|||
127560239|NCT01761240|459021635|FG004|Overall Study|Withdrawal by Subject|1|||
127560240|NCT01761240|459021631|FG000|Overall Study|Adverse Event|0|||
127560241|NCT01761240|459021632|FG001|Overall Study|Adverse Event|0|||
127560242|NCT01761240|459021633|FG002|Overall Study|Adverse Event|0|||
127560243|NCT01761240|459021634|FG003|Overall Study|Adverse Event|1|||
127560244|NCT01761240|459021635|FG004|Overall Study|Adverse Event|6|||
127560245|NCT01761240|459021631|FG000|Overall Study|Death|0|||
127560246|NCT01761240|459021632|FG001|Overall Study|Death|1|||
127560247|NCT01761240|459021633|FG002|Overall Study|Death|1|||
127686681|NCT01290341|459479688|FG001|Overall Study|Withdrawal by Subject|5|||
127686682|NCT01290341|459479687|FG000|Overall Study|Negative baseline culture and others|44|||
127686683|NCT01290341|459479688|FG001|Overall Study|Negative baseline culture and others|11|||
127686684|NCT03036813|459479693|FG000|Overall Study|Adverse Event|6|||
127686685|NCT03036813|459479694|FG001|Overall Study|Adverse Event|11|||
127686686|NCT03036813|459479695|FG002|Overall Study|Adverse Event|6|||
127686687|NCT03036813|459479693|FG000|Overall Study|Withdrawal by Subject|12|||
127686688|NCT03036813|459479694|FG001|Overall Study|Withdrawal by Subject|6|||
127686689|NCT03036813|459479695|FG002|Overall Study|Withdrawal by Subject|10|||
127686690|NCT03036813|459479693|FG000|Overall Study|Lost to Follow-up|1|||
127686691|NCT03036813|459479694|FG001|Overall Study|Lost to Follow-up|1|||
127686692|NCT03036813|459479695|FG002|Overall Study|Lost to Follow-up|0|||
127686693|NCT03036813|459479693|FG000|Overall Study|Physician Decision|2|||
127686694|NCT03036813|459479694|FG001|Overall Study|Physician Decision|1|||
127686695|NCT03036813|459479695|FG002|Overall Study|Physician Decision|1|||
127686696|NCT03036813|459479693|FG000|Overall Study|Non-Compliance|1|||
127686697|NCT03036813|459479694|FG001|Overall Study|Non-Compliance|5|||
127686698|NCT03036813|459479695|FG002|Overall Study|Non-Compliance|3|||
127686699|NCT03036813|459479693|FG000|Overall Study|Pregnancy|0|||
127686700|NCT03036813|459479694|FG001|Overall Study|Pregnancy|0|||
127686701|NCT03036813|459479695|FG002|Overall Study|Pregnancy|1|||
127686702|NCT03036813|459479693|FG000|Overall Study|Other|0|||
127686703|NCT03036813|459479694|FG001|Overall Study|Other|3|||
127686704|NCT03036813|459479695|FG002|Overall Study|Other|5|||
127686705|NCT01102231|459479696|FG000|Overall Study|Protocol Violation|3|||
127686706|NCT01102231|459479696|FG000|Overall Study|Lack of Efficacy|2|||
127686707|NCT01102231|459479696|FG000|Overall Study|Death|2|||
127686708|NCT01102231|459479696|FG000|Overall Study|Adverse Event|3|||
127686709|NCT01102231|459479696|FG000|Overall Study|Withdrawal by Subject|1|||
127686710|NCT01102231|459479696|FG000|Overall Study|Did not received the treatment|4|||
128024106|NCT00105508|460712706|FG000|Overall Study|Prephase Dropout|1|||
128024107|NCT00105508|460712707|FG001|Overall Study|Prephase Dropout|0|||
127560248|NCT01761240|459021634|FG003|Overall Study|Death|2|||
127560249|NCT01761240|459021635|FG004|Overall Study|Death|1|||
127560250|NCT01761240|459021631|FG000|Overall Study|Non-compliance|0|||
127560251|NCT01761240|459021632|FG001|Overall Study|Non-compliance|0|||
127560252|NCT01761240|459021633|FG002|Overall Study|Non-compliance|1|||
127560253|NCT01761240|459021634|FG003|Overall Study|Non-compliance|0|||
127686711|NCT03903822|459479697|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
127686712|NCT03903822|459479698|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
128024108|NCT00105508|460712706|FG000|Overall Study|Adverse Event|16|||
127560254|NCT01761240|459021635|FG004|Overall Study|Non-compliance|0|||
127560255|NCT00509145|459021638|FG000|Overall Study|Death|0|||
127560256|NCT00509145|459021639|FG001|Overall Study|Death|2|||
127560257|NCT00509145|459021638|FG000|Overall Study|Adverse Event|42|||
127686713|NCT03903822|459479699|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
127686714|NCT03903822|459479700|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
127774871|NCT00986440|459801761|FG000|Overall Study|Serious adverse event or adverse event|9|||
127774872|NCT00986440|459801762|FG001|Overall Study|Serious adverse event or adverse event|2|||
127774873|NCT00986440|459801761|FG000|Overall Study|Withdrawal by Subject|1|||
127774874|NCT00986440|459801762|FG001|Overall Study|Withdrawal by Subject|2|||
127774875|NCT00986440|459801761|FG000|Overall Study|Screen failure (not dosed)|4|||
127774876|NCT00986440|459801762|FG001|Overall Study|Screen failure (not dosed)|2|||
127774877|NCT00372385|459801763|FG000|Overall Study|Adverse Event|6|||
127774878|NCT00372385|459801764|FG001|Overall Study|Adverse Event|11|||
127774879|NCT00372385|459801765|FG002|Overall Study|Adverse Event|9|||
127774880|NCT00372385|459801766|FG003|Overall Study|Adverse Event|7|||
127774881|NCT00372385|459801763|FG000|Overall Study|Noncompliance|0|||
127774882|NCT00372385|459801764|FG001|Overall Study|Noncompliance|1|||
127774883|NCT00372385|459801765|FG002|Overall Study|Noncompliance|1|||
127774884|NCT00372385|459801766|FG003|Overall Study|Noncompliance|1|||
127774885|NCT00372385|459801763|FG000|Overall Study|Physician Decision|1|||
127774886|NCT00372385|459801764|FG001|Overall Study|Physician Decision|0|||
127774887|NCT00372385|459801765|FG002|Overall Study|Physician Decision|0|||
127774888|NCT00372385|459801766|FG003|Overall Study|Physician Decision|0|||
127774889|NCT00372385|459801763|FG000|Overall Study|Lost to Follow-up|2|||
127774890|NCT00372385|459801764|FG001|Overall Study|Lost to Follow-up|0|||
127774891|NCT00372385|459801765|FG002|Overall Study|Lost to Follow-up|0|||
127774892|NCT00372385|459801766|FG003|Overall Study|Lost to Follow-up|0|||
127774893|NCT00372385|459801763|FG000|Overall Study|Withdrawal by Subject|2|||
127774894|NCT00372385|459801764|FG001|Overall Study|Withdrawal by Subject|1|||
127774895|NCT00372385|459801765|FG002|Overall Study|Withdrawal by Subject|0|||
127774896|NCT00372385|459801766|FG003|Overall Study|Withdrawal by Subject|0|||
127774897|NCT00372385|459801763|FG000|Overall Study|Refusal of Treatment|3|||
127774898|NCT00372385|459801764|FG001|Overall Study|Refusal of Treatment|6|||
127774899|NCT00372385|459801765|FG002|Overall Study|Refusal of Treatment|0|||
127774900|NCT00372385|459801766|FG003|Overall Study|Refusal of Treatment|0|||
127774901|NCT00372385|459801763|FG000|Overall Study|No Response|1|||
127774902|NCT00372385|459801764|FG001|Overall Study|No Response|1|||
127774903|NCT00372385|459801765|FG002|Overall Study|No Response|0|||
127774904|NCT00372385|459801766|FG003|Overall Study|No Response|0|||
127774905|NCT00372385|459801763|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
127774906|NCT00372385|459801764|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
127774907|NCT00372385|459801765|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
127774908|NCT00372385|459801766|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
127774909|NCT00372385|459801763|FG000|Overall Study|Virologic Stopping Rule|17|||
128024109|NCT00105508|460712707|FG001|Overall Study|Adverse Event|19|||
128024110|NCT00105508|460712706|FG000|Overall Study|Insufficient Efficacy|1|||
128024111|NCT00105508|460712707|FG001|Overall Study|Insufficient Efficacy|0|||
128024112|NCT00105508|460712706|FG000|Overall Study|Withdrawal by Subject|10|||
128024113|NCT00105508|460712707|FG001|Overall Study|Withdrawal by Subject|6|||
128024114|NCT00105508|460712706|FG000|Overall Study|Lost to Follow-up|3|||
128024115|NCT00105508|460712707|FG001|Overall Study|Lost to Follow-up|0|||
128024116|NCT00105508|460712706|FG000|Overall Study|Protocol Violation|1|||
128024117|NCT00105508|460712707|FG001|Overall Study|Protocol Violation|2|||
128024118|NCT00105508|460712706|FG000|Overall Study|Other|8|||
128024119|NCT00105508|460712707|FG001|Overall Study|Other|9|||
128024120|NCT00086307|460712708|FG000|Overall Study|Lack of Efficacy|1|||
128024121|NCT00086307|460712709|FG001|Overall Study|Lack of Efficacy|1|||
128024122|NCT00086307|460712710|FG002|Overall Study|Lack of Efficacy|2|||
128024123|NCT00086307|460712708|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
127686715|NCT03903822|459479701|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
127686716|NCT03903822|459479702|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
127686717|NCT03903822|459479703|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
127686718|NCT03903822|459479704|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
127686719|NCT03903822|459479697|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
127686720|NCT03903822|459479698|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
127686721|NCT03903822|459479699|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
127686722|NCT03903822|459479700|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
127686723|NCT03903822|459479701|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
127686724|NCT03903822|459479702|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
127686725|NCT03903822|459479703|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
127686726|NCT03903822|459479704|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
127774910|NCT00372385|459801764|FG001|Overall Study|Virologic Stopping Rule|0|||
127774911|NCT00372385|459801765|FG002|Overall Study|Virologic Stopping Rule|0|||
127774912|NCT00372385|459801766|FG003|Overall Study|Virologic Stopping Rule|0|||
127774913|NCT01699789|459801767|FG000|Overall Study|Withdrawal by Subject|18|||
127560258|NCT00509145|459021639|FG001|Overall Study|Adverse Event|28|||
127560259|NCT00509145|459021638|FG000|Overall Study|Withdrawal by Subject|32|||
127560260|NCT00509145|459021639|FG001|Overall Study|Withdrawal by Subject|38|||
127560261|NCT00509145|459021638|FG000|Overall Study|Physician Decision|11|||
127560262|NCT00509145|459021639|FG001|Overall Study|Physician Decision|14|||
127560263|NCT00509145|459021638|FG000|Overall Study|Protocol Violation|1|||
127560264|NCT00509145|459021639|FG001|Overall Study|Protocol Violation|6|||
127560265|NCT00509145|459021638|FG000|Overall Study|Pregnancy|3|||
127560266|NCT00509145|459021639|FG001|Overall Study|Pregnancy|8|||
127560267|NCT00509145|459021638|FG000|Overall Study|Lost to Follow-up|6|||
128024124|NCT00086307|460712709|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
128024125|NCT00086307|460712710|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
128024126|NCT00086307|460712708|FG000|Overall Study|Nausea and headaches|0|||
128024127|NCT00086307|460712709|FG001|Overall Study|Nausea and headaches|0|||
128024128|NCT00086307|460712710|FG002|Overall Study|Nausea and headaches|1|||
128024129|NCT00086307|460712708|FG000|Overall Study|Constipation and sleepiness|0|||
128024130|NCT00086307|460712709|FG001|Overall Study|Constipation and sleepiness|0|||
128024131|NCT00086307|460712710|FG002|Overall Study|Constipation and sleepiness|1|||
128024132|NCT00086307|460712708|FG000|Overall Study|Suicidal ideation|0|||
128024133|NCT00086307|460712709|FG001|Overall Study|Suicidal ideation|0|||
128024134|NCT00086307|460712710|FG002|Overall Study|Suicidal ideation|1|||
128024135|NCT00086307|460712708|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
128024136|NCT00086307|460712709|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
128024137|NCT00086307|460712710|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
128024138|NCT00086307|460712708|FG000|Overall Study|Withdrawal by Subject|0|||
128024139|NCT00086307|460712709|FG001|Overall Study|Withdrawal by Subject|0|||
128024140|NCT00086307|460712710|FG002|Overall Study|Withdrawal by Subject|2|||
128024141|NCT00683384|460712711|FG000|Overall Study|Death|1|||
128024142|NCT00683384|460712711|FG000|Overall Study|Adverse Event|1|||
128024143|NCT00120874|460712713|FG000|Overall Study|Death|0|||
128024144|NCT00120874|460712714|FG001|Overall Study|Death|1|||
128024145|NCT00300495|460712721|FG000|Overall Study|Protocol Violation|4|||
127686727|NCT03903822|459479697|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
127686728|NCT03903822|459479698|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
127686729|NCT03903822|459479699|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
127686730|NCT03903822|459479700|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
127686731|NCT03903822|459479701|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
127686732|NCT03903822|459479702|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
127686733|NCT03903822|459479703|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
127686734|NCT03903822|459479704|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
127686735|NCT03903822|459479697|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
127686736|NCT03903822|459479698|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
127686737|NCT03903822|459479699|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
127686738|NCT03903822|459479700|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
127686739|NCT03903822|459479701|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
127686740|NCT03903822|459479702|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
127686741|NCT03903822|459479703|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
127686742|NCT03903822|459479704|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
127686743|NCT03903822|459479697|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
127686744|NCT03903822|459479698|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
127686745|NCT03903822|459479699|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
127686746|NCT03903822|459479700|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
127686747|NCT03903822|459479701|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
127686748|NCT03903822|459479702|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
127686749|NCT03903822|459479703|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
127686750|NCT03903822|459479704|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
127686751|NCT03903822|459479697|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
127686752|NCT03903822|459479698|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
127686753|NCT03903822|459479699|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
127686754|NCT03903822|459479700|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
127686755|NCT03903822|459479701|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
128024146|NCT00300495|460712722|FG001|Overall Study|Protocol Violation|1|||
128024147|NCT03632720|460712723|FG000|Overall Study|Adverse Event|2|||
128024148|NCT03632720|460712724|FG001|Overall Study|Adverse Event|0|||
127560268|NCT00509145|459021639|FG001|Overall Study|Lost to Follow-up|5|||
127560269|NCT00509145|459021638|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
127686756|NCT03903822|459479702|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
128024149|NCT03632720|460712725|FG002|Overall Study|Adverse Event|0|||
128024150|NCT03632720|460712723|FG000|Overall Study|Lost to Follow-up|0|||
127560270|NCT00509145|459021639|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
127774914|NCT01699789|459801768|FG001|Overall Study|Withdrawal by Subject|23|||
127774915|NCT01699789|459801767|FG000|Overall Study|Death|1|||
127774916|NCT01699789|459801768|FG001|Overall Study|Death|2|||
127774917|NCT01699789|459801767|FG000|Overall Study|Lost to Follow-up|83|||
127774918|NCT01699789|459801768|FG001|Overall Study|Lost to Follow-up|101|||
127774919|NCT01323621|459801772|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
127774920|NCT01323621|459801773|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
127774921|NCT01323621|459801774|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
127774922|NCT01323621|459801772|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
127774923|NCT01323621|459801773|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
127774924|NCT01323621|459801774|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
127774925|NCT01323621|459801772|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
127774926|NCT01323621|459801773|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
127774927|NCT01323621|459801774|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
127774928|NCT01323621|459801772|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
127774929|NCT01323621|459801773|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
127774930|NCT01323621|459801774|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
127774931|NCT01323621|459801772|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
127774932|NCT01323621|459801773|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
127774933|NCT01323621|459801774|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
127686757|NCT03903822|459479703|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
127774934|NCT01323621|459801772|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
127774935|NCT01323621|459801773|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
127774936|NCT01323621|459801774|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
127774937|NCT01323621|459801772|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
127774938|NCT01323621|459801773|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
127774939|NCT01323621|459801774|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
127774940|NCT01323621|459801772|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
127774941|NCT01323621|459801773|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
127774942|NCT01323621|459801774|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
127774943|NCT01323621|459801772|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
127774944|NCT01323621|459801773|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
128024151|NCT03632720|460712724|FG001|Overall Study|Lost to Follow-up|1|||
128024152|NCT03632720|460712725|FG002|Overall Study|Lost to Follow-up|0|||
127686758|NCT03903822|459479704|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
127686759|NCT03903822|459479697|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
127686760|NCT03903822|459479698|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
127686761|NCT03903822|459479699|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
127686762|NCT03903822|459479700|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
127686763|NCT03903822|459479701|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
127686764|NCT03903822|459479702|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
127686765|NCT03903822|459479703|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
127686766|NCT03903822|459479704|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
127686767|NCT03903822|459479697|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
127686768|NCT03903822|459479698|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
127686769|NCT03903822|459479699|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
127686770|NCT03903822|459479700|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
127686771|NCT03903822|459479701|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
127686772|NCT03903822|459479702|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
127686773|NCT03903822|459479703|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
127686774|NCT03903822|459479704|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
128024153|NCT03632720|460712723|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
128024154|NCT03632720|460712724|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
128024155|NCT03632720|460712725|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
128024156|NCT03632720|460712723|FG000|Overall Study|Screen failure|0|||
128024157|NCT03632720|460712724|FG001|Overall Study|Screen failure|1|||
128024158|NCT03632720|460712725|FG002|Overall Study|Screen failure|0|||
128024159|NCT00682435|460712726|FG000|Overall Study|Insufficient data|5|||
128024160|NCT00682435|460712726|FG000|Overall Study|Erroneously enrolled twice|2|||
128024161|NCT00290238|460712727|FG000|Overall Study|Study terminated|27|||
128024162|NCT00290238|460712728|FG001|Overall Study|Study terminated|27|||
128024163|NCT00290238|460712727|FG000|Overall Study|Lost to Follow-up|0|||
128024164|NCT00290238|460712728|FG001|Overall Study|Lost to Follow-up|1|||
128024165|NCT00290238|460712727|FG000|Overall Study|Withdrawal by Subject|15|||
128024166|NCT00290238|460712728|FG001|Overall Study|Withdrawal by Subject|13|||
128024167|NCT02186171|460712729|FG000|Overall Study|Withdrawal by Subject|1|||
128024168|NCT02186171|460712730|FG001|Overall Study|Withdrawal by Subject|9|||
128024169|NCT02186171|460712729|FG000|Overall Study|Lost to Follow-up|2|||
127774945|NCT01323621|459801774|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
127774946|NCT01323621|459801772|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
127774947|NCT01323621|459801773|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
127774948|NCT01323621|459801774|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
127774949|NCT01323621|459801772|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
127774950|NCT01323621|459801773|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
127774951|NCT01323621|459801774|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
127774952|NCT01323621|459801772|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
127774953|NCT01323621|459801773|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
127774954|NCT01323621|459801774|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
127774955|NCT01557348|459801775|FG000|Overall Study|Adverse Event|6|||
127774956|NCT01557348|459801776|FG001|Overall Study|Adverse Event|16|||
127774957|NCT01557348|459801775|FG000|Overall Study|Infusion reaction event|5|||
127774958|NCT01557348|459801776|FG001|Overall Study|Infusion reaction event|5|||
127774959|NCT01557348|459801775|FG000|Overall Study|Death|7|||
127774960|NCT01557348|459801776|FG001|Overall Study|Death|4|||
127774961|NCT01557348|459801775|FG000|Overall Study|Insufficient Therapeutic Response|13|||
127774962|NCT01557348|459801776|FG001|Overall Study|Insufficient Therapeutic Response|28|||
127774963|NCT01557348|459801775|FG000|Overall Study|Withdrawal by Subject|5|||
127774964|NCT01557348|459801776|FG001|Overall Study|Withdrawal by Subject|4|||
127774965|NCT01557348|459801775|FG000|Overall Study|Lost to Follow-up|26|||
127774966|NCT01557348|459801776|FG001|Overall Study|Lost to Follow-up|22|||
127774967|NCT01557348|459801775|FG000|Overall Study|Administrative|18|||
127774968|NCT01557348|459801776|FG001|Overall Study|Administrative|11|||
127774969|NCT01891721|459801777|FG000|Overall Study|Lost to Follow-up|10|||
127774970|NCT01891721|459801778|FG001|Overall Study|Lost to Follow-up|5|||
127774971|NCT01891721|459801779|FG002|Overall Study|Lost to Follow-up|1|||
127774972|NCT02708095|459801780|FG000|Overall Study|Adverse Event|4|||
127774973|NCT02708095|459801781|FG001|Overall Study|Adverse Event|10|||
127774974|NCT02708095|459801782|FG002|Overall Study|Adverse Event|11|||
127774975|NCT02708095|459801780|FG000|Overall Study|Lack of Efficacy|9|||
127774976|NCT02708095|459801781|FG001|Overall Study|Lack of Efficacy|3|||
127774977|NCT02708095|459801782|FG002|Overall Study|Lack of Efficacy|0|||
127774978|NCT02708095|459801780|FG000|Overall Study|Lost to Follow-up|2|||
127774979|NCT02708095|459801781|FG001|Overall Study|Lost to Follow-up|0|||
127774980|NCT02708095|459801782|FG002|Overall Study|Lost to Follow-up|0|||
127774981|NCT02708095|459801780|FG000|Overall Study|Physician Decision|2|||
127774982|NCT02708095|459801781|FG001|Overall Study|Physician Decision|3|||
127774983|NCT02708095|459801782|FG002|Overall Study|Physician Decision|2|||
127774984|NCT02708095|459801780|FG000|Overall Study|Protocol Violation|0|||
127774985|NCT02708095|459801781|FG001|Overall Study|Protocol Violation|0|||
127774986|NCT02708095|459801782|FG002|Overall Study|Protocol Violation|1|||
127774987|NCT02708095|459801780|FG000|Overall Study|Withdrawal by Subject|5|||
127774988|NCT02708095|459801781|FG001|Overall Study|Withdrawal by Subject|3|||
127774989|NCT02708095|459801782|FG002|Overall Study|Withdrawal by Subject|4|||
127774990|NCT01313650|459801785|FG000|Overall Study|Adverse Event|9|||
127774991|NCT01313650|459801786|FG001|Overall Study|Adverse Event|34|||
127774992|NCT01313650|459801787|FG002|Overall Study|Adverse Event|24|||
127774993|NCT01313650|459801788|FG003|Overall Study|Adverse Event|23|||
127774994|NCT01313650|459801785|FG000|Overall Study|Lack of Efficacy|37|||
127774995|NCT01313650|459801786|FG001|Overall Study|Lack of Efficacy|20|||
127774996|NCT01313650|459801787|FG002|Overall Study|Lack of Efficacy|32|||
127774997|NCT01313650|459801788|FG003|Overall Study|Lack of Efficacy|20|||
127774998|NCT01313650|459801785|FG000|Overall Study|Lost to Follow-up|1|||
127774999|NCT01313650|459801786|FG001|Overall Study|Lost to Follow-up|0|||
127775000|NCT01313650|459801787|FG002|Overall Study|Lost to Follow-up|3|||
127775001|NCT01313650|459801788|FG003|Overall Study|Lost to Follow-up|2|||
127775002|NCT01313650|459801785|FG000|Overall Study|Withdrawal by Subject|16|||
127775003|NCT01313650|459801786|FG001|Overall Study|Withdrawal by Subject|20|||
128024170|NCT02186171|460712730|FG001|Overall Study|Lost to Follow-up|2|||
128024171|NCT02186171|460712729|FG000|Overall Study|Death|1|||
127775004|NCT01313650|459801787|FG002|Overall Study|Withdrawal by Subject|15|||
127775005|NCT01313650|459801788|FG003|Overall Study|Withdrawal by Subject|15|||
127775006|NCT01313650|459801785|FG000|Overall Study|Protocol Violation|4|||
128024172|NCT02186171|460712730|FG001|Overall Study|Death|2|||
127775007|NCT01313650|459801786|FG001|Overall Study|Protocol Violation|7|||
127775008|NCT01313650|459801787|FG002|Overall Study|Protocol Violation|5|||
127775009|NCT01313650|459801788|FG003|Overall Study|Protocol Violation|6|||
127775010|NCT01313650|459801785|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
127775011|NCT01313650|459801786|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
127775012|NCT01313650|459801787|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
127775013|NCT01313650|459801788|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
127775014|NCT05393037|459801789|FG000|Part A|Death|1|||
127775015|NCT05393037|459801790|FG001|Part A|Death|0|||
127775016|NCT05393037|459801789|FG000|Part A|Lost to Follow-up|1|||
128024173|NCT02186171|460712729|FG000|Overall Study|Protocol-specified Criteria|0|||
127775017|NCT05393037|459801790|FG001|Part A|Lost to Follow-up|1|||
128024174|NCT02186171|460712730|FG001|Overall Study|Protocol-specified Criteria|2|||
128024175|NCT06868667|460712731|FG000|Overall Study|Death|0|||
128024176|NCT06868667|460712732|FG001|Overall Study|Death|4|||
127560271|NCT00509145|459021638|FG000|Overall Study|Other|6|||
127560272|NCT00509145|459021639|FG001|Overall Study|Other|6|||
128024177|NCT06868667|460712731|FG000|Overall Study|Lost to Follow-up|0|||
128024178|NCT06868667|460712732|FG001|Overall Study|Lost to Follow-up|1|||
127560273|NCT01994889|459021640|FG000|Overall Study|Adverse Event|5|||
127686775|NCT03903822|459479697|FG000|Treatment Phase (6 Weeks)|Other|2|||
127686776|NCT03903822|459479698|FG001|Treatment Phase (6 Weeks)|Other|1|||
127686777|NCT03903822|459479699|FG002|Treatment Phase (6 Weeks)|Other|0|||
127686778|NCT03903822|459479700|FG003|Treatment Phase (6 Weeks)|Other|0|||
127686779|NCT03903822|459479701|FG004|Treatment Phase (6 Weeks)|Other|1|||
127686780|NCT03903822|459479702|FG005|Treatment Phase (6 Weeks)|Other|1|||
127686781|NCT03903822|459479703|FG006|Treatment Phase (6 Weeks)|Other|0|||
127686782|NCT03903822|459479704|FG007|Treatment Phase (6 Weeks)|Other|0|||
127686783|NCT03903822|459479697|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
127686784|NCT03903822|459479698|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
127686785|NCT03903822|459479699|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
127686786|NCT03903822|459479700|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
127686787|NCT03903822|459479701|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
127686788|NCT03903822|459479702|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
127686789|NCT03903822|459479703|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
127686790|NCT03903822|459479704|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
127686791|NCT03903822|459479697|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
127686792|NCT03903822|459479698|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
127686793|NCT03903822|459479699|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
127686794|NCT03903822|459479700|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
127686795|NCT03903822|459479701|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
127686796|NCT03903822|459479702|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
127686797|NCT03903822|459479703|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
127686798|NCT03903822|459479704|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
127686799|NCT03903822|459479697|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
127686800|NCT03903822|459479698|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
127686801|NCT03903822|459479699|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
127686802|NCT03903822|459479700|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
127686803|NCT03903822|459479701|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
127686804|NCT03903822|459479702|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
127686805|NCT03903822|459479703|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
127686806|NCT03903822|459479704|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
127686807|NCT03903822|459479697|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
127686808|NCT03903822|459479698|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
127686809|NCT03903822|459479699|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
127686810|NCT03903822|459479700|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
127686811|NCT03903822|459479701|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
127686812|NCT03903822|459479702|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
127686813|NCT03903822|459479703|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
127686814|NCT03903822|459479704|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
127686815|NCT03903822|459479697|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
127686816|NCT03903822|459479698|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
127686817|NCT03903822|459479699|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
127686818|NCT03903822|459479700|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
127686819|NCT03903822|459479701|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
127686820|NCT03903822|459479702|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
127686821|NCT03903822|459479703|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
127686822|NCT03903822|459479704|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
127686823|NCT03903822|459479697|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
127686824|NCT03903822|459479698|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
127686825|NCT03903822|459479699|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
127686826|NCT03903822|459479700|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
127686827|NCT03903822|459479701|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
127686828|NCT03903822|459479702|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
127686829|NCT03903822|459479703|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
127686830|NCT03903822|459479704|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
128024179|NCT06868667|460712731|FG000|Overall Study|Withdrawal by Subject|1|||
128024180|NCT06868667|460712732|FG001|Overall Study|Withdrawal by Subject|0|||
127560274|NCT01994889|459021641|FG001|Overall Study|Adverse Event|12|||
127560275|NCT01994889|459021642|FG002|Overall Study|Adverse Event|11|||
127686831|NCT03903822|459479697|FG000|Follow up Phase (4 Weeks)|Other|1|||
127686832|NCT03903822|459479698|FG001|Follow up Phase (4 Weeks)|Other|1|||
127686833|NCT03903822|459479699|FG002|Follow up Phase (4 Weeks)|Other|0|||
127686834|NCT03903822|459479700|FG003|Follow up Phase (4 Weeks)|Other|0|||
127686835|NCT03903822|459479701|FG004|Follow up Phase (4 Weeks)|Other|0|||
128024181|NCT06868667|460712731|FG000|Overall Study|Ongoing|9|||
128024182|NCT06868667|460712732|FG001|Overall Study|Ongoing|9|||
128024183|NCT05330429|460712735|FG000|Overall Study|Study Terminated by Sponsor|4|||
128024184|NCT05330429|460712736|FG001|Overall Study|Study Terminated by Sponsor|33|||
128024185|NCT05330429|460712737|FG002|Overall Study|Study Terminated by Sponsor|12|||
128024186|NCT05330429|460712735|FG000|Overall Study|Death|5|||
128024187|NCT05330429|460712736|FG001|Overall Study|Death|2|||
128024188|NCT05330429|460712737|FG002|Overall Study|Death|4|||
128024189|NCT05330429|460712735|FG000|Overall Study|Withdrew Consent|0|||
128024190|NCT05330429|460712736|FG001|Overall Study|Withdrew Consent|5|||
128024191|NCT05330429|460712737|FG002|Overall Study|Withdrew Consent|4|||
128024192|NCT05330429|460712735|FG000|Overall Study|Investigator's Discretion|0|||
128024193|NCT05330429|460712736|FG001|Overall Study|Investigator's Discretion|1|||
128024194|NCT05330429|460712737|FG002|Overall Study|Investigator's Discretion|3|||
127775018|NCT05393037|459801789|FG000|Part A|Withdrawal by Subject|2|||
127775019|NCT05393037|459801790|FG001|Part A|Withdrawal by Subject|4|||
127775020|NCT05393037|459801789|FG000|Part B|Lost to Follow-up|1|||
127775021|NCT05393037|459801790|FG001|Part B|Lost to Follow-up|0|||
127775022|NCT00458341|459801791|FG000|Cycle 1|Adverse Event|1|||
127775023|NCT00458341|459801792|FG001|Cycle 1|Adverse Event|0|||
127775024|NCT03471871|459801793|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
127775025|NCT03471871|459801794|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
127775026|NCT03471871|459801795|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
127775027|NCT03471871|459801796|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
127775028|NCT03471871|459801797|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
127775029|NCT03471871|459801793|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
127775030|NCT03471871|459801794|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
127775031|NCT03471871|459801795|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
127560276|NCT01994889|459021640|FG000|Overall Study|Cardiac Device Implantation|0|||
127560277|NCT01994889|459021641|FG001|Overall Study|Cardiac Device Implantation|2|||
127560278|NCT01994889|459021642|FG002|Overall Study|Cardiac Device Implantation|0|||
127560279|NCT01994889|459021640|FG000|Overall Study|Organ Transplantation|1|||
127775032|NCT03471871|459801796|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
127775033|NCT03471871|459801797|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
127775034|NCT03471871|459801793|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
127775035|NCT03471871|459801794|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
127775036|NCT03471871|459801795|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
127775037|NCT03471871|459801796|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
127775038|NCT03471871|459801797|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
127775039|NCT03471871|459801793|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
127775040|NCT03471871|459801794|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
127775041|NCT03471871|459801795|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
127775042|NCT03471871|459801796|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
127775043|NCT03471871|459801797|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
127775044|NCT03471871|459801793|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
127775045|NCT03471871|459801794|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
127775046|NCT03471871|459801795|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
127775047|NCT03471871|459801796|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
127775048|NCT03471871|459801797|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
127775049|NCT03236246|459803390|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
127775050|NCT03236246|459803391|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
127775051|NCT03236246|459803390|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
127775052|NCT03236246|459803391|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
127775053|NCT03236246|459803390|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
127775054|NCT03236246|459803391|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
127775055|NCT03236246|459803390|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
127775056|NCT03236246|459803391|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
127775057|NCT03236246|459803390|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
127775058|NCT03236246|459803391|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
127775059|NCT03236246|459803390|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
127775060|NCT03236246|459803391|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
127775061|NCT03236246|459803390|FG000|24-Week Dose Titration Period|Death|3|||
127775062|NCT03236246|459803391|FG001|24-Week Dose Titration Period|Death|1|||
128024195|NCT05330429|460712735|FG000|Overall Study|Subject Decision|1|||
128024196|NCT05330429|460712736|FG001|Overall Study|Subject Decision|2|||
128024197|NCT05330429|460712737|FG002|Overall Study|Subject Decision|0|||
128024198|NCT05330429|460712735|FG000|Overall Study|Lost to Follow-up|0|||
128024199|NCT05330429|460712736|FG001|Overall Study|Lost to Follow-up|1|||
128024200|NCT05330429|460712737|FG002|Overall Study|Lost to Follow-up|0|||
128024201|NCT03572218|460712739|FG000|Overall Study|Lost to Follow-up|3|||
128024202|NCT03572218|460712740|FG001|Overall Study|Lost to Follow-up|2|||
128024203|NCT03572218|460712739|FG000|Overall Study|No longer available for study visits|2|||
128024204|NCT03572218|460712740|FG001|Overall Study|No longer available for study visits|1|||
127775063|NCT03236246|459803390|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
127775064|NCT03236246|459803391|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
127775065|NCT03236246|459803390|FG000|24-Week Dose Titration Period|Adverse Event|7|||
127775066|NCT03236246|459803391|FG001|24-Week Dose Titration Period|Adverse Event|8|||
127775067|NCT03236246|459803390|FG000|24-Week Dose Titration Period|Captured as Other|1|||
127775068|NCT03236246|459803391|FG001|24-Week Dose Titration Period|Captured as Other|2|||
127775069|NCT03236246|459803390|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
127775070|NCT03236246|459803391|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
127775071|NCT03236246|459803390|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
127775072|NCT03236246|459803391|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
127775073|NCT03236246|459803390|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
127775074|NCT03236246|459803391|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
127775075|NCT03236246|459803390|FG000|24-Week Dose Maintenance Period|Death|0|||
127775076|NCT03236246|459803391|FG001|24-Week Dose Maintenance Period|Death|1|||
127775077|NCT03236246|459803390|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
127775078|NCT03236246|459803391|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
127775079|NCT02598557|459803392|FG000|Overall Study|Withdrawal by Subject|1|||
127775080|NCT02598557|459803393|FG001|Overall Study|Withdrawal by Subject|0|||
127775081|NCT02598557|459803394|FG002|Overall Study|Withdrawal by Subject|1|||
127775082|NCT02598557|459803392|FG000|Overall Study|Participant did not start treatment|2|||
127775083|NCT02598557|459803393|FG001|Overall Study|Participant did not start treatment|1|||
127775084|NCT02598557|459803394|FG002|Overall Study|Participant did not start treatment|1|||
127775085|NCT02598557|459803392|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
127775086|NCT02598557|459803393|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
127775087|NCT02598557|459803394|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
127775088|NCT02598557|459803392|FG000|Overall Study|Adverse Event|1|||
127775089|NCT02598557|459803393|FG001|Overall Study|Adverse Event|1|||
127775090|NCT02598557|459803394|FG002|Overall Study|Adverse Event|0|||
127775091|NCT01117454|459803395|FG000|Overall Study|Pregnancy|0|||
127775092|NCT01117454|459803396|FG001|Overall Study|Pregnancy|1|||
127775093|NCT00888433|459803399|FG000|Overall Study|Withdrawal by Subject|1|||
127775094|NCT00888433|459803400|FG001|Overall Study|Withdrawal by Subject|2|||
127775095|NCT00888433|459803399|FG000|Overall Study|Missed Visit|2|||
127775096|NCT00888433|459803400|FG001|Overall Study|Missed Visit|1|||
127775097|NCT01681628|459803401|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
127775098|NCT01681628|459803402|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
127775099|NCT01681628|459803401|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
127775100|NCT01681628|459803402|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
127775101|NCT01681628|459803401|FG000|19 Months Follow-up|Death|1|||
127775102|NCT01681628|459803402|FG001|19 Months Follow-up|Death|0|||
127775103|NCT01681628|459803401|FG000|19 Months Follow-up|Lost to Follow-up|61|||
127775104|NCT01681628|459803402|FG001|19 Months Follow-up|Lost to Follow-up|43|||
127775105|NCT01637623|459803409|FG000|Overall Study|Lost to Follow-up|0|||
127775106|NCT01637623|459803410|FG001|Overall Study|Lost to Follow-up|0|||
127775107|NCT01637623|459803411|FG002|Overall Study|Lost to Follow-up|2|||
127775108|NCT01637623|459803409|FG000|Overall Study|Physician Decision|1|||
127775109|NCT01637623|459803410|FG001|Overall Study|Physician Decision|0|||
127775110|NCT01637623|459803411|FG002|Overall Study|Physician Decision|1|||
127775111|NCT02076113|459803416|FG000|Overall Study|Lost to Follow-up|4|||
127775112|NCT02076113|459803417|FG001|Overall Study|Lost to Follow-up|1|||
127775113|NCT02076113|459803416|FG000|Overall Study|Withdrawal by Subject|2|||
127775114|NCT02076113|459803417|FG001|Overall Study|Withdrawal by Subject|3|||
127775115|NCT02076113|459803416|FG000|Overall Study|Death|1|||
127775116|NCT02076113|459803417|FG001|Overall Study|Death|3|||
127775117|NCT01383161|459803420|FG000|Overall Study|Adverse Event|5|||
127775118|NCT01383161|459803421|FG001|Overall Study|Adverse Event|1|||
127775119|NCT01383161|459803420|FG000|Overall Study|Withdrawal by Subject|0|||
127775120|NCT01383161|459803421|FG001|Overall Study|Withdrawal by Subject|2|||
127775121|NCT01383161|459803420|FG000|Overall Study|Lack of Efficacy|0|||
127775122|NCT01383161|459803421|FG001|Overall Study|Lack of Efficacy|1|||
127775123|NCT03942406|459803428|FG000|Overall Study|Lost to Follow-up|4|||
127775124|NCT03942406|459803429|FG001|Overall Study|Lost to Follow-up|5|||
127775125|NCT03942406|459803430|FG002|Overall Study|Lost to Follow-up|3|||
127775126|NCT03942406|459803431|FG003|Overall Study|Lost to Follow-up|7|||
127775127|NCT03942406|459803432|FG004|Overall Study|Lost to Follow-up|1|||
127775128|NCT03942406|459803433|FG005|Overall Study|Lost to Follow-up|0|||
127775129|NCT03942406|459803434|FG006|Overall Study|Lost to Follow-up|0|||
127775130|NCT03942406|459803428|FG000|Overall Study|Withdrawal by Subject|3|||
127775131|NCT03942406|459803429|FG001|Overall Study|Withdrawal by Subject|1|||
128024205|NCT03572218|460712739|FG000|Overall Study|No longer interested|1|||
128024206|NCT03572218|460712740|FG001|Overall Study|No longer interested|2|||
128024207|NCT00286455|460712741|FG000|Overall Study|Hyperglycemia rescue|19|||
127775132|NCT03942406|459803430|FG002|Overall Study|Withdrawal by Subject|1|||
127775133|NCT03942406|459803431|FG003|Overall Study|Withdrawal by Subject|3|||
127775134|NCT03942406|459803432|FG004|Overall Study|Withdrawal by Subject|0|||
127775135|NCT03942406|459803433|FG005|Overall Study|Withdrawal by Subject|0|||
127775136|NCT03942406|459803434|FG006|Overall Study|Withdrawal by Subject|0|||
127775137|NCT03942406|459803428|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
127775138|NCT03942406|459803429|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
127775139|NCT03942406|459803430|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
127775140|NCT03942406|459803431|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
127775141|NCT03942406|459803432|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
127775142|NCT03942406|459803433|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
127775143|NCT03942406|459803434|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
127775144|NCT01054144|459803435|FG000|Overall Study|Death|2|||
127775145|NCT05628285|459803436|FG000|Overall Study|Lost to Follow-up|1|||
127775146|NCT03801902|459803438|FG000|Overall Study|Did not receive protocol treatment.|1|||
127775147|NCT03801902|459803439|FG001|Overall Study|Did not receive protocol treatment.|0|||
127775148|NCT03801902|459803440|FG002|Overall Study|Did not receive protocol treatment.|0|||
127775149|NCT03801902|459803441|FG003|Overall Study|Did not receive protocol treatment.|0|||
127775150|NCT02310672|459803444|FG000|Overall Study|Death|1|||
127775151|NCT02310672|459803444|FG000|Overall Study|Lost to Follow-up|1|||
127775152|NCT02310672|459803444|FG000|Overall Study|Withdrawal by Subject|1|||
127775153|NCT02310672|459803444|FG000|Overall Study|Sponsor's decision|12|||
127775154|NCT01237340|459803445|FG000|Overall Study|Adverse Event|3|||
127775155|NCT01237340|459803445|FG000|Overall Study|Withdrawal by Subject|1|||
127775156|NCT01237340|459803445|FG000|Overall Study|Early termination of the trial|36|||
127775157|NCT02876835|459803448|FG000|Treatment Period (51.1 Month)|Other|1|||
127775158|NCT02876835|459803449|FG001|Treatment Period (51.1 Month)|Other|0|||
127775159|NCT02876835|459803448|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
127775160|NCT02876835|459803449|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
127775161|NCT02876835|459803448|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
127775162|NCT02876835|459803449|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
127775163|NCT02876835|459803448|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
127775164|NCT02876835|459803449|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
127775165|NCT02540538|459803450|FG000|Overall Study|Pregnancy|0|||
127775166|NCT02540538|459803451|FG001|Overall Study|Pregnancy|1|||
127775167|NCT02540538|459803452|FG002|Overall Study|Pregnancy|0|||
127775168|NCT00403754|459803453|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
127775169|NCT00403754|459803454|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
127686836|NCT03903822|459479702|FG005|Follow up Phase (4 Weeks)|Other|0|||
127686837|NCT03903822|459479703|FG006|Follow up Phase (4 Weeks)|Other|0|||
127686838|NCT03903822|459479704|FG007|Follow up Phase (4 Weeks)|Other|0|||
127686839|NCT00785512|459479705|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
127686840|NCT00785512|459479706|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
127686841|NCT00785512|459479705|FG000|Overall Study|Adverse Event|0|||
127686842|NCT00785512|459479706|FG001|Overall Study|Adverse Event|0|||
127686843|NCT00785512|459479705|FG000|Overall Study|Lack of Efficacy|0|||
127686844|NCT00785512|459479706|FG001|Overall Study|Lack of Efficacy|2|||
127775170|NCT00403754|459803455|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
127775171|NCT00403754|459803456|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
127775172|NCT00403754|459803453|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
127775173|NCT00403754|459803454|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
127775174|NCT00403754|459803455|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
127775175|NCT00403754|459803456|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
127775176|NCT02000427|459803459|FG000|Overall Study|Death|22|||
128024208|NCT00286455|460712742|FG001|Overall Study|Hyperglycemia rescue|13|||
128024209|NCT00286455|460712743|FG002|Overall Study|Hyperglycemia rescue|10|||
128024210|NCT00286455|460712741|FG000|Overall Study|Adverse Event|1|||
128024211|NCT00286455|460712742|FG001|Overall Study|Adverse Event|3|||
128024212|NCT00286455|460712743|FG002|Overall Study|Adverse Event|2|||
128024213|NCT00286455|460712741|FG000|Overall Study|Lost to Follow-up|0|||
128024214|NCT00286455|460712742|FG001|Overall Study|Lost to Follow-up|3|||
128024215|NCT00286455|460712743|FG002|Overall Study|Lost to Follow-up|3|||
128024216|NCT00286455|460712741|FG000|Overall Study|Physician Decision|3|||
128024217|NCT00286455|460712742|FG001|Overall Study|Physician Decision|0|||
128024218|NCT00286455|460712743|FG002|Overall Study|Physician Decision|2|||
128024219|NCT00286455|460712741|FG000|Overall Study|Protocol Violation|1|||
127775177|NCT04343248|459803460|FG000|Overall Study|Withdrawal by Subject|5|||
128024220|NCT00286455|460712742|FG001|Overall Study|Protocol Violation|1|||
128024221|NCT00286455|460712743|FG002|Overall Study|Protocol Violation|0|||
127686845|NCT00785512|459479705|FG000|Overall Study|Withdrawal by Subject|0|||
127686846|NCT00785512|459479706|FG001|Overall Study|Withdrawal by Subject|1|||
127686847|NCT00785512|459479705|FG000|Overall Study|Lost to Follow-up|3|||
128024222|NCT00286455|460712741|FG000|Overall Study|Participant Non-compliance|1|||
128024223|NCT00286455|460712742|FG001|Overall Study|Participant Non-compliance|0|||
128024224|NCT00286455|460712743|FG002|Overall Study|Participant Non-compliance|0|||
128024225|NCT00286455|460712741|FG000|Overall Study|Withdrawal by Subject|0|||
128024226|NCT00286455|460712742|FG001|Overall Study|Withdrawal by Subject|8|||
128024227|NCT00286455|460712743|FG002|Overall Study|Withdrawal by Subject|7|||
128024228|NCT03882801|460714324|FG000|Period 1|Adverse Event|0|||
127686848|NCT00785512|459479706|FG001|Overall Study|Lost to Follow-up|0|||
127686849|NCT00785512|459479705|FG000|Overall Study|Precedure Refused|0|||
127686850|NCT00785512|459479706|FG001|Overall Study|Precedure Refused|0|||
127686851|NCT00785512|459479705|FG000|Overall Study|IVRS Programing Error|0|||
127686852|NCT00785512|459479706|FG001|Overall Study|IVRS Programing Error|0|||
127686853|NCT00785512|459479705|FG000|Overall Study|Physician Decision|0|||
127686854|NCT00785512|459479706|FG001|Overall Study|Physician Decision|0|||
127686855|NCT00785512|459479705|FG000|Overall Study|Lack of compliance|0|||
127686856|NCT00785512|459479706|FG001|Overall Study|Lack of compliance|1|||
127686857|NCT00529100|459479712|FG000|Overall Study|Adverse Event|0|||
127686858|NCT00529100|459479713|FG001|Overall Study|Adverse Event|5|||
127686859|NCT00529100|459479712|FG000|Overall Study|Protocol Violation|0|||
127686860|NCT00529100|459479713|FG001|Overall Study|Protocol Violation|1|||
127686861|NCT00529100|459479712|FG000|Overall Study|Progressive Disease|0|||
127686862|NCT00529100|459479713|FG001|Overall Study|Progressive Disease|1|||
127686863|NCT00529100|459479712|FG000|Overall Study|Withdrawal by Subject|0|||
127686864|NCT00529100|459479713|FG001|Overall Study|Withdrawal by Subject|1|||
127686865|NCT00529100|459479712|FG000|Overall Study|Participant Ineligibility|0|||
127686866|NCT00529100|459479713|FG001|Overall Study|Participant Ineligibility|1|||
127686867|NCT01565148|459479714|FG000|Overall Study|Withdrawal by Subject|1|||
127686868|NCT01565148|459479715|FG001|Overall Study|Withdrawal by Subject|1|||
127686869|NCT01565148|459479716|FG002|Overall Study|Withdrawal by Subject|1|||
127686870|NCT01565148|459479717|FG003|Overall Study|Withdrawal by Subject|2|||
127686871|NCT01565148|459479714|FG000|Overall Study|Lost to Follow-up|4|||
127686872|NCT01565148|459479715|FG001|Overall Study|Lost to Follow-up|4|||
127686873|NCT01565148|459479716|FG002|Overall Study|Lost to Follow-up|0|||
127686874|NCT01565148|459479717|FG003|Overall Study|Lost to Follow-up|3|||
127686875|NCT01565148|459479714|FG000|Overall Study|Rescue Therapy|8|||
127686876|NCT01565148|459479715|FG001|Overall Study|Rescue Therapy|5|||
127686877|NCT01565148|459479716|FG002|Overall Study|Rescue Therapy|5|||
127686878|NCT01565148|459479717|FG003|Overall Study|Rescue Therapy|8|||
127686879|NCT01565148|459479714|FG000|Overall Study|Death|0|||
127686880|NCT01565148|459479715|FG001|Overall Study|Death|0|||
127686881|NCT01565148|459479716|FG002|Overall Study|Death|1|||
127686882|NCT01565148|459479717|FG003|Overall Study|Death|0|||
127686883|NCT01565148|459479714|FG000|Overall Study|Physician Decision|2|||
127686884|NCT01565148|459479715|FG001|Overall Study|Physician Decision|5|||
127686885|NCT01565148|459479716|FG002|Overall Study|Physician Decision|0|||
127686886|NCT01565148|459479717|FG003|Overall Study|Physician Decision|0|||
127686887|NCT01061671|459479719|FG000|Overall Study|Withdrawal by Subject|16|||
127686888|NCT01061671|459479720|FG001|Overall Study|Withdrawal by Subject|20|||
127686889|NCT01061671|459479719|FG000|Overall Study|Lost to Follow-up|3|||
127686890|NCT01061671|459479720|FG001|Overall Study|Lost to Follow-up|5|||
127686891|NCT01061671|459479719|FG000|Overall Study|Death|28|||
127686892|NCT01061671|459479720|FG001|Overall Study|Death|30|||
127686893|NCT05368831|459479721|FG000|200 mg NST-1024 (QD)|Adverse Event|3|||
127686894|NCT01199575|459479723|FG000|Overall Study|Withdrawal by Subject|5|||
127686895|NCT00223795|459479728|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
127686896|NCT00223795|459479729|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
127686897|NCT00223795|459479728|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
127686898|NCT00223795|459479729|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
127686899|NCT04732338|459479731|FG000|Overall Study|Lost to Follow-up|3|||
127686900|NCT04732338|459479732|FG001|Overall Study|Lost to Follow-up|3|||
127686901|NCT01803555|459479736|FG000|Overall Study|Adverse Event|3|||
127686902|NCT01803555|459479737|FG001|Overall Study|Adverse Event|2|||
127686903|NCT01803555|459479736|FG000|Overall Study|Withdrawal by Subject|3|||
127686904|NCT01803555|459479737|FG001|Overall Study|Withdrawal by Subject|3|||
127686905|NCT01803555|459479736|FG000|Overall Study|Non-compliance|1|||
127686906|NCT01803555|459479737|FG001|Overall Study|Non-compliance|1|||
127686907|NCT01803555|459479736|FG000|Overall Study|Protocol Violation|3|||
128024229|NCT03882801|460714325|FG001|Period 1|Adverse Event|1|||
128024230|NCT03882801|460714324|FG000|Period 1|Non-compliance with study drug|1|||
127686908|NCT01803555|459479737|FG001|Overall Study|Protocol Violation|5|||
127686909|NCT01803555|459479736|FG000|Overall Study|Lost to Follow-up|0|||
127686910|NCT01803555|459479737|FG001|Overall Study|Lost to Follow-up|2|||
127686911|NCT01803555|459479736|FG000|Overall Study|Other than specified|3|||
127686912|NCT01803555|459479737|FG001|Overall Study|Other than specified|5|||
127686913|NCT01551355|459479738|FG000|Overall Study|Lost to Follow-up|51|||
127686914|NCT01551355|459479739|FG001|Overall Study|Lost to Follow-up|49|||
127686915|NCT01551355|459479740|FG002|Overall Study|Lost to Follow-up|34|||
127686916|NCT01551355|459479741|FG003|Overall Study|Lost to Follow-up|24|||
127686917|NCT01551355|459479742|FG004|Overall Study|Lost to Follow-up|9|||
127686918|NCT01551355|459479743|FG005|Overall Study|Lost to Follow-up|6|||
128024231|NCT03882801|460714325|FG001|Period 1|Non-compliance with study drug|1|||
128024232|NCT03882801|460714324|FG000|Period 1|Never treated with study drug|1|||
127560280|NCT01994889|459021641|FG001|Overall Study|Organ Transplantation|5|||
127560281|NCT01994889|459021642|FG002|Overall Study|Organ Transplantation|5|||
127560282|NCT01994889|459021640|FG000|Overall Study|No longer willing to participate|8|||
127560283|NCT01994889|459021641|FG001|Overall Study|No longer willing to participate|17|||
127560284|NCT01994889|459021642|FG002|Overall Study|No longer willing to participate|37|||
127560285|NCT01994889|459021640|FG000|Overall Study|Lost to Follow-up|0|||
127560286|NCT01994889|459021641|FG001|Overall Study|Lost to Follow-up|1|||
127560287|NCT01994889|459021642|FG002|Overall Study|Lost to Follow-up|0|||
127775178|NCT04343248|459803461|FG001|Overall Study|Withdrawal by Subject|6|||
127775179|NCT04343248|459803460|FG000|Overall Study|Death|1|||
127775180|NCT04343248|459803461|FG001|Overall Study|Death|2|||
127775181|NCT04343248|459803460|FG000|Overall Study|Lost to Follow-up|9|||
127775182|NCT04343248|459803461|FG001|Overall Study|Lost to Follow-up|6|||
127775183|NCT04343248|459803460|FG000|Overall Study|Physician Decision|0|||
127775184|NCT04343248|459803461|FG001|Overall Study|Physician Decision|1|||
127775185|NCT04343248|459803460|FG000|Overall Study|Adverse Event|1|||
127775186|NCT04343248|459803461|FG001|Overall Study|Adverse Event|0|||
127775187|NCT03829319|459803462|FG000|Overall Study|Sponsor's Decision|4|||
127775188|NCT03829319|459803463|FG001|Overall Study|Sponsor's Decision|90|||
127775189|NCT03829319|459803464|FG002|Overall Study|Sponsor's Decision|102|||
127775190|NCT03829319|459803462|FG000|Overall Study|Withdrawal by Subject|1|||
127775191|NCT03829319|459803463|FG001|Overall Study|Withdrawal by Subject|5|||
127775192|NCT03829319|459803464|FG002|Overall Study|Withdrawal by Subject|4|||
127775193|NCT03829319|459803462|FG000|Overall Study|Physician Decision|0|||
127775194|NCT03829319|459803463|FG001|Overall Study|Physician Decision|3|||
127775195|NCT03829319|459803464|FG002|Overall Study|Physician Decision|0|||
127775196|NCT03829319|459803462|FG000|Overall Study|Lost to Follow-up|0|||
127775197|NCT03829319|459803463|FG001|Overall Study|Lost to Follow-up|0|||
127775198|NCT03829319|459803464|FG002|Overall Study|Lost to Follow-up|1|||
127775199|NCT03829319|459803462|FG000|Overall Study|Death|8|||
127775200|NCT03829319|459803463|FG001|Overall Study|Death|277|||
127775201|NCT03829319|459803464|FG002|Overall Study|Death|266|||
127775202|NCT04498832|459803465|FG000|Overall Study|Adverse Event|1|||
127775203|NCT04498832|459803466|FG001|Overall Study|Adverse Event|3|||
127775204|NCT04498832|459803465|FG000|Overall Study|Withdrawal by Subject|0|||
127775205|NCT04498832|459803466|FG001|Overall Study|Withdrawal by Subject|1|||
127775206|NCT01012739|459803467|FG000|Treatment Period 1|Adverse Event|0|||
127775207|NCT01012739|459803468|FG001|Treatment Period 1|Adverse Event|0|||
127775208|NCT01012739|459803469|FG002|Treatment Period 1|Adverse Event|0|||
127775209|NCT01012739|459803470|FG003|Treatment Period 1|Adverse Event|1|||
127775210|NCT01012739|459803467|FG000|Treatment Period 2|Abnormal test procedure results|0|||
127775211|NCT01012739|459803468|FG001|Treatment Period 2|Abnormal test procedure results|0|||
127775212|NCT01012739|459803469|FG002|Treatment Period 2|Abnormal test procedure results|0|||
127775213|NCT01012739|459803470|FG003|Treatment Period 2|Abnormal test procedure results|1|||
127775214|NCT04540133|459803471|FG000|Overall Study|Lost to Follow-up|1|||
127775215|NCT04540133|459803472|FG001|Overall Study|Lost to Follow-up|0|||
127775216|NCT03049735|459803477|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
127775217|NCT03049735|459803478|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
127775218|NCT03049735|459803479|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
127775219|NCT03049735|459803477|FG000|Overall Study|Other|5|||
127775220|NCT03049735|459803478|FG001|Overall Study|Other|3|||
127775221|NCT03049735|459803479|FG002|Overall Study|Other|1|||
127775222|NCT03049735|459803477|FG000|Overall Study|Lack of Efficacy|4|||
127775223|NCT03049735|459803478|FG001|Overall Study|Lack of Efficacy|0|||
127775224|NCT03049735|459803479|FG002|Overall Study|Lack of Efficacy|3|||
128024233|NCT03882801|460714325|FG001|Period 1|Never treated with study drug|0|||
128024234|NCT03882801|460714324|FG000|Washout Period|Physician Decision|0|||
128024235|NCT03882801|460714325|FG001|Washout Period|Physician Decision|1|||
127560288|NCT01994889|459021640|FG000|Overall Study|Protocol Violation|0|||
127560289|NCT01994889|459021641|FG001|Overall Study|Protocol Violation|1|||
127560290|NCT01994889|459021642|FG002|Overall Study|Protocol Violation|1|||
127775225|NCT03049735|459803477|FG000|Overall Study|Protocol deviation|1|||
127775226|NCT03049735|459803478|FG001|Overall Study|Protocol deviation|0|||
127775227|NCT03049735|459803479|FG002|Overall Study|Protocol deviation|0|||
127775228|NCT03049735|459803477|FG000|Overall Study|Pregnancy|0|||
127775229|NCT03049735|459803478|FG001|Overall Study|Pregnancy|0|||
128024236|NCT03882801|460714324|FG000|Period 2|Non-compliance with study drug|0|||
127560291|NCT01994889|459021640|FG000|Overall Study|Death|14|||
127560292|NCT01994889|459021641|FG001|Overall Study|Death|25|||
127560293|NCT01994889|459021642|FG002|Overall Study|Death|38|||
127775230|NCT03049735|459803479|FG002|Overall Study|Pregnancy|1|||
127775231|NCT03049735|459803477|FG000|Overall Study|Adverse Event|7|||
127775232|NCT03049735|459803478|FG001|Overall Study|Adverse Event|18|||
127775233|NCT03049735|459803479|FG002|Overall Study|Adverse Event|5|||
127775234|NCT03049735|459803477|FG000|Overall Study|Withdrawal by Subject|10|||
127775235|NCT03049735|459803478|FG001|Overall Study|Withdrawal by Subject|3|||
127881029|NCT02575807|460186104|FG000|Overall Study|Study terminated by Sponsor|0|||
127775236|NCT03049735|459803479|FG002|Overall Study|Withdrawal by Subject|7|||
127775237|NCT03049735|459803477|FG000|Overall Study|Lost to Follow-up|1|||
128024237|NCT03882801|460714325|FG001|Period 2|Non-compliance with study drug|1|||
127686919|NCT02409667|459479744|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
127686920|NCT02409667|459479745|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
127686921|NCT02409667|459479746|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
127686922|NCT02409667|459479747|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
127686923|NCT02409667|459479748|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
127686924|NCT02409667|459479744|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
127686925|NCT02409667|459479745|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
127686926|NCT02409667|459479746|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
127686927|NCT02409667|459479747|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
127686928|NCT02409667|459479748|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
127686929|NCT02409667|459479744|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
127686930|NCT02409667|459479745|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
127686931|NCT02409667|459479746|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
127686932|NCT02409667|459479747|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
127686933|NCT02409667|459479748|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
127686934|NCT02409667|459479744|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
127686935|NCT02409667|459479745|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
127686936|NCT02409667|459479746|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
127686937|NCT02409667|459479747|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
127686938|NCT02409667|459479748|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
127686939|NCT02409667|459479744|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
127686940|NCT02409667|459479745|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
127686941|NCT02409667|459479746|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
127686942|NCT02409667|459479747|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
127686943|NCT02409667|459479748|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
127686944|NCT02409667|459479744|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
127686945|NCT02409667|459479745|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
127686946|NCT02409667|459479746|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
127686947|NCT02409667|459479747|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
127686948|NCT02409667|459479748|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
127686949|NCT02409667|459479744|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
127686950|NCT02409667|459479745|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
127686951|NCT02409667|459479746|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
127686952|NCT02409667|459479747|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
127686953|NCT02409667|459479748|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
127686954|NCT02409667|459479744|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
127686955|NCT02409667|459479745|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
127686956|NCT02409667|459479746|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
127686957|NCT02409667|459479747|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
127686958|NCT02409667|459479748|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
127686959|NCT02409667|459479744|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
127686960|NCT02409667|459479745|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
127686961|NCT02409667|459479746|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
127686962|NCT02409667|459479747|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
127686963|NCT02409667|459479748|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
127686964|NCT02409667|459479744|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
127686965|NCT02409667|459479745|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
127686966|NCT02409667|459479746|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
127686967|NCT02409667|459479747|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
127686968|NCT02409667|459479748|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
127686969|NCT02409667|459479744|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
127686970|NCT02409667|459479745|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
127686971|NCT02409667|459479746|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
127686972|NCT02409667|459479747|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
127686973|NCT02409667|459479748|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
127686974|NCT02409667|459479744|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
127686975|NCT02409667|459479745|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
127686976|NCT02409667|459479746|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
127686977|NCT02409667|459479747|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
127686978|NCT02409667|459479748|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
127686979|NCT02409667|459479744|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
128024238|NCT03548415|460714332|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
127560294|NCT02969655|459021644|FG000|Overall Study|Withdrawal by Subject|3|||
127775238|NCT03049735|459803478|FG001|Overall Study|Lost to Follow-up|5|||
127775239|NCT03049735|459803479|FG002|Overall Study|Lost to Follow-up|5|||
127775240|NCT03153111|459803480|FG000|Overall Study|Death|2|||
127775241|NCT03153111|459803481|FG001|Overall Study|Death|5|||
127775242|NCT03153111|459803480|FG000|Overall Study|Lost to Follow-up|1|||
127775243|NCT03153111|459803481|FG001|Overall Study|Lost to Follow-up|0|||
127775244|NCT03153111|459803480|FG000|Overall Study|Physician Decision|5|||
127775245|NCT03153111|459803481|FG001|Overall Study|Physician Decision|1|||
127775246|NCT03153111|459803480|FG000|Overall Study|Withdrawal by Subject|3|||
127775247|NCT03153111|459803481|FG001|Overall Study|Withdrawal by Subject|3|||
127775248|NCT03891524|459803482|FG000|Overall Study|Death|0|||
127775249|NCT03891524|459803483|FG001|Overall Study|Death|0|||
127775250|NCT03891524|459803484|FG002|Overall Study|Death|0|||
127775251|NCT03891524|459803485|FG003|Overall Study|Death|0|||
127775252|NCT03891524|459803486|FG004|Overall Study|Death|0|||
127775253|NCT03891524|459803487|FG005|Overall Study|Death|0|||
128024239|NCT03548415|460714333|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
128024240|NCT03548415|460714334|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
128024241|NCT03548415|460714335|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
127775254|NCT03891524|459803488|FG006|Overall Study|Death|0|||
127775255|NCT03891524|459803489|FG007|Overall Study|Death|1|||
127775256|NCT03891524|459803482|FG000|Overall Study|Withdrawal by Subject|0|||
127775257|NCT03891524|459803483|FG001|Overall Study|Withdrawal by Subject|1|||
127775258|NCT03891524|459803484|FG002|Overall Study|Withdrawal by Subject|2|||
127775259|NCT03891524|459803485|FG003|Overall Study|Withdrawal by Subject|1|||
128024242|NCT03548415|460714336|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
128024243|NCT01803737|460714337|FG000|Overall Study|Lack of Time|1|||
128024244|NCT01803737|460714338|FG001|Overall Study|Lack of Time|0|||
128024245|NCT01803737|460714337|FG000|Overall Study|Medical Reason|0|||
128024246|NCT01803737|460714338|FG001|Overall Study|Medical Reason|1|||
128024247|NCT01803737|460714337|FG000|Overall Study|Lost to Follow-up|0|||
128024248|NCT01803737|460714338|FG001|Overall Study|Lost to Follow-up|2|||
128024249|NCT01560988|460714339|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
128024250|NCT01560988|460714340|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
128024251|NCT01560988|460714339|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
128024252|NCT01560988|460714340|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
128024253|NCT01560988|460714339|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
128024254|NCT01560988|460714340|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
128024255|NCT01346709|460714341|FG000|Overall Study|Protocol Violation|35|||
128024256|NCT01346709|460714341|FG000|Overall Study|Lost to Follow-up|31|||
128024257|NCT01346709|460714341|FG000|Overall Study|Missing data in candidate risk factor|285|||
128024258|NCT01292473|460714342|FG000|Overall Study|Adverse Event|1|||
127775260|NCT03891524|459803486|FG004|Overall Study|Withdrawal by Subject|2|||
127775261|NCT03891524|459803487|FG005|Overall Study|Withdrawal by Subject|2|||
127775262|NCT03891524|459803488|FG006|Overall Study|Withdrawal by Subject|2|||
127775263|NCT03891524|459803489|FG007|Overall Study|Withdrawal by Subject|1|||
128024259|NCT01292473|460714343|FG001|Overall Study|Adverse Event|0|||
128024260|NCT01292473|460714344|FG002|Overall Study|Adverse Event|1|||
128024261|NCT01292473|460714345|FG003|Overall Study|Adverse Event|1|||
128024262|NCT01292473|460714342|FG000|Overall Study|Lost to Follow-up|1|||
128024263|NCT01292473|460714343|FG001|Overall Study|Lost to Follow-up|1|||
128024264|NCT01292473|460714344|FG002|Overall Study|Lost to Follow-up|2|||
128024265|NCT01292473|460714345|FG003|Overall Study|Lost to Follow-up|2|||
128024266|NCT01292473|460714342|FG000|Overall Study|Withdrawal by Subject|3|||
128024267|NCT01292473|460714343|FG001|Overall Study|Withdrawal by Subject|4|||
128024268|NCT01292473|460714344|FG002|Overall Study|Withdrawal by Subject|3|||
128024269|NCT01292473|460714345|FG003|Overall Study|Withdrawal by Subject|3|||
128024270|NCT01292473|460714342|FG000|Overall Study|Physician Decision|0|||
128024271|NCT01292473|460714343|FG001|Overall Study|Physician Decision|1|||
128024272|NCT01292473|460714344|FG002|Overall Study|Physician Decision|0|||
128024273|NCT01292473|460714345|FG003|Overall Study|Physician Decision|0|||
128024274|NCT01292473|460714342|FG000|Overall Study|Disease Progression|0|||
128024275|NCT01292473|460714343|FG001|Overall Study|Disease Progression|1|||
128024276|NCT01292473|460714344|FG002|Overall Study|Disease Progression|3|||
128024277|NCT01292473|460714345|FG003|Overall Study|Disease Progression|6|||
128024278|NCT00458705|460714352|FG000|Overall Study|Adverse Event|4|||
128024279|NCT00458705|460714352|FG000|Overall Study|Not Treated|1|||
128024280|NCT00337194|460714353|FG000|Overall Study|Adverse Event|5|||
128024281|NCT00337194|460714354|FG001|Overall Study|Adverse Event|1|||
127560295|NCT02969655|459021645|FG001|Overall Study|Withdrawal by Subject|2|||
128024282|NCT00337194|460714353|FG000|Overall Study|Death|2|||
128024283|NCT00337194|460714354|FG001|Overall Study|Death|0|||
128024284|NCT00337194|460714353|FG000|Overall Study|Withdrawal by Subject|1|||
128024285|NCT00337194|460714354|FG001|Overall Study|Withdrawal by Subject|0|||
128024286|NCT00337194|460714353|FG000|Overall Study|Disease progression|1|||
128024287|NCT00337194|460714354|FG001|Overall Study|Disease progression|2|||
128024288|NCT00337194|460714353|FG000|Overall Study|Subsequent non-protocol therapy|3|||
127560296|NCT02969655|459021644|FG000|Overall Study|Physician Decision|4|||
127560297|NCT02969655|459021645|FG001|Overall Study|Physician Decision|3|||
127560298|NCT02969655|459021644|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
127560299|NCT02969655|459021645|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
127560300|NCT02969655|459021644|FG000|Overall Study|Adverse Event|10|||
127560301|NCT02969655|459021645|FG001|Overall Study|Adverse Event|8|||
127560302|NCT02674204|459021646|FG000|Overall Study|Adverse Event|1|||
127560303|NCT02674204|459021647|FG001|Overall Study|Adverse Event|0|||
127560304|NCT00486811|459021649|FG000|Overall Study|Adverse Event|28|||
127560305|NCT00486811|459021650|FG001|Overall Study|Adverse Event|60|||
127560306|NCT00486811|459021651|FG002|Overall Study|Adverse Event|135|||
127560307|NCT00486811|459021649|FG000|Overall Study|Lack of Efficacy|34|||
127560308|NCT00486811|459021650|FG001|Overall Study|Lack of Efficacy|14|||
127560309|NCT00486811|459021651|FG002|Overall Study|Lack of Efficacy|7|||
127560310|NCT00486811|459021649|FG000|Overall Study|Lost to Follow-up|4|||
127560311|NCT00486811|459021650|FG001|Overall Study|Lost to Follow-up|6|||
127560312|NCT00486811|459021651|FG002|Overall Study|Lost to Follow-up|4|||
127560313|NCT00486811|459021649|FG000|Overall Study|Withdrawal by Subject|33|||
127560314|NCT00486811|459021650|FG001|Overall Study|Withdrawal by Subject|44|||
127560315|NCT00486811|459021651|FG002|Overall Study|Withdrawal by Subject|58|||
127560316|NCT00486811|459021649|FG000|Overall Study|Study drug non-compliant|5|||
127560317|NCT00486811|459021650|FG001|Overall Study|Study drug non-compliant|6|||
127560318|NCT00486811|459021651|FG002|Overall Study|Study drug non-compliant|3|||
127560319|NCT00486811|459021649|FG000|Overall Study|All other|18|||
127560320|NCT00486811|459021650|FG001|Overall Study|All other|11|||
127560321|NCT00486811|459021651|FG002|Overall Study|All other|7|||
127560322|NCT01711216|459021655|FG000|Overall Study|Adverse Event|4|||
127560323|NCT01711216|459021655|FG000|Overall Study|Pregnancy|56|||
127560324|NCT01711216|459021655|FG000|Overall Study|Withdrawal by Subject|6|||
127560325|NCT01711216|459021655|FG000|Overall Study|Lost to Follow-up|46|||
127560326|NCT01711216|459021655|FG000|Overall Study|variety of other minor reasons|83|||
127560327|NCT01711216|459021655|FG000|Overall Study|no reason specified|22|||
127560328|NCT02929498|459021656|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
127560329|NCT02929498|459021657|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
127560330|NCT02929498|459021658|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
127560331|NCT02929498|459021656|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
127560332|NCT02929498|459021657|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
127775264|NCT00390910|459803490|FG000|Overall Study|Adverse Event|1|||
127560333|NCT02929498|459021658|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
127560334|NCT01642615|459021659|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
127560335|NCT01642615|459021660|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
127560336|NCT01642615|459021661|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
127560337|NCT01642615|459021659|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
127775265|NCT00390910|459803491|FG001|Overall Study|Adverse Event|0|||
127775266|NCT00390910|459803492|FG002|Overall Study|Adverse Event|0|||
127775267|NCT00390910|459803490|FG000|Overall Study|Lost to Follow-up|0|||
127775268|NCT00390910|459803491|FG001|Overall Study|Lost to Follow-up|1|||
127775269|NCT00390910|459803492|FG002|Overall Study|Lost to Follow-up|5|||
127775270|NCT00390910|459803490|FG000|Overall Study|Withdrawal by Subject|1|||
127775271|NCT00390910|459803491|FG001|Overall Study|Withdrawal by Subject|3|||
127881030|NCT02575807|460186105|FG001|Overall Study|Study terminated by Sponsor|1|||
128024289|NCT00337194|460714354|FG001|Overall Study|Subsequent non-protocol therapy|1|||
128024290|NCT03188705|460714355|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
128024291|NCT03188705|460714355|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
128024292|NCT01174459|460714356|FG000|Overall Study|case report form (CRF) not collected|5|||
128024293|NCT01717859|460714358|FG000|Overall Study|Adverse Event|5|||
128024294|NCT01717859|460714358|FG000|Overall Study|Moved out of state|1|||
127560338|NCT01642615|459021660|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
127560339|NCT01642615|459021661|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
127560340|NCT01642615|459021659|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
127560341|NCT01642615|459021660|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
127560342|NCT01642615|459021661|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
127560343|NCT01642615|459021659|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
127560344|NCT01642615|459021660|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
127560345|NCT01642615|459021661|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
127560346|NCT01642615|459021659|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
127560347|NCT01642615|459021660|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
127560348|NCT01642615|459021661|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
127560349|NCT01642615|459021659|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
127560350|NCT01642615|459021660|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
127560351|NCT01642615|459021661|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
127560352|NCT01642615|459021659|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
127560353|NCT01642615|459021660|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
127560354|NCT01642615|459021661|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
127560355|NCT01642615|459021659|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
127560356|NCT01642615|459021660|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
128024295|NCT01717859|460714358|FG000|Overall Study|Patient concerned about mental health|1|||
128024296|NCT01717859|460714358|FG000|Overall Study|Lost to Follow-up|1|||
128024297|NCT01717859|460714358|FG000|Overall Study|Withdrawal by Subject|2|||
128024298|NCT01623752|460714359|FG000|Phase 1 (78 Weeks)|No Data|249|||
128024299|NCT01623752|460714360|FG001|Phase 1 (78 Weeks)|No Data|66|||
128024300|NCT01623752|460714361|FG002|Phase 1 (78 Weeks)|No Data|2|||
128024301|NCT01623752|460714359|FG000|Phase 1 (78 Weeks)|Other|33|||
128024302|NCT01623752|460714360|FG001|Phase 1 (78 Weeks)|Other|20|||
128024303|NCT01623752|460714361|FG002|Phase 1 (78 Weeks)|Other|0|||
128024304|NCT01623752|460714359|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
128024305|NCT01623752|460714360|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
128024306|NCT01623752|460714361|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
128024307|NCT01623752|460714359|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
128024308|NCT01623752|460714360|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
128024309|NCT01623752|460714361|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
128024310|NCT01623752|460714359|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
128024311|NCT01623752|460714360|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
128024312|NCT01623752|460714361|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
128024313|NCT01623752|460714359|FG000|Phase 2 (78 Weeks)|Other|5|||
128024314|NCT01623752|460714360|FG001|Phase 2 (78 Weeks)|Other|1|||
127560357|NCT01642615|459021661|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
127560358|NCT01642615|459021659|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
127560359|NCT01642615|459021660|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
127642873|NCT01292239|459313203|FG000|Overall Study|Withdrawal by Subject|3|||
128024315|NCT01623752|460714361|FG002|Phase 2 (78 Weeks)|Other|0|||
128024316|NCT01623752|460714359|FG000|Phase 2 (78 Weeks)|No Data|43|||
128024317|NCT01623752|460714360|FG001|Phase 2 (78 Weeks)|No Data|11|||
128024318|NCT01623752|460714361|FG002|Phase 2 (78 Weeks)|No Data|0|||
128024319|NCT01623752|460714359|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
128024320|NCT01623752|460714360|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
128024321|NCT01623752|460714361|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
128024322|NCT04389671|460714362|FG000|Overall Study|Death|7|||
128024323|NCT01111292|460714363|FG000|Treatment|Physician Decision|1|||
127775272|NCT00390910|459803492|FG002|Overall Study|Withdrawal by Subject|2|||
127775273|NCT00390910|459803490|FG000|Overall Study|Migrated/moved from study area|0|||
127775274|NCT00390910|459803491|FG001|Overall Study|Migrated/moved from study area|0|||
127775275|NCT00390910|459803492|FG002|Overall Study|Migrated/moved from study area|3|||
127775276|NCT00174265|459803497|FG000|Overall Study|Adverse Event|7|||
127775277|NCT00174265|459803498|FG001|Overall Study|Adverse Event|4|||
127775278|NCT00174265|459803497|FG000|Overall Study|Lack of Efficacy|2|||
127775279|NCT00174265|459803498|FG001|Overall Study|Lack of Efficacy|2|||
127775280|NCT00174265|459803497|FG000|Overall Study|Withdrawal by Subject|3|||
127775281|NCT00174265|459803498|FG001|Overall Study|Withdrawal by Subject|5|||
127775282|NCT00174265|459803497|FG000|Overall Study|Lost to Follow-up|1|||
127775283|NCT00174265|459803498|FG001|Overall Study|Lost to Follow-up|0|||
127775284|NCT00174265|459803497|FG000|Overall Study|Other (Not specified)|16|||
127775285|NCT00174265|459803498|FG001|Overall Study|Other (Not specified)|10|||
127775286|NCT01572922|459803504|FG000|Overall Study|Adverse Event|1|||
127775287|NCT01572922|459803504|FG000|Overall Study|Protocol Violation|1|||
127775288|NCT01572922|459803504|FG000|Overall Study|Death|1|||
127775289|NCT03040622|459803505|FG000|Overall Study|unable to implant device|3|||
127775290|NCT00445068|459803506|FG000|Overall Study|Disease progression|26|||
127775291|NCT00445068|459803506|FG000|Overall Study|Adverse Event|5|||
127775292|NCT00445068|459803506|FG000|Overall Study|Abnormal laboratory value|2|||
127775293|NCT00445068|459803506|FG000|Overall Study|Withdrawal by Subject|2|||
127775294|NCT00445068|459803506|FG000|Overall Study|Death|1|||
127775295|NCT00447382|459803507|FG000|Overall Study|Adverse Event|1|||
127775296|NCT00447382|459803508|FG001|Overall Study|Adverse Event|1|||
127775297|NCT00447382|459803507|FG000|Overall Study|Lack of Efficacy|1|||
127775298|NCT00447382|459803508|FG001|Overall Study|Lack of Efficacy|0|||
127775299|NCT00447382|459803507|FG000|Overall Study|Protocol Violation|2|||
127775300|NCT00447382|459803508|FG001|Overall Study|Protocol Violation|0|||
127775301|NCT00447382|459803507|FG000|Overall Study|Unclassified|2|||
127775302|NCT00447382|459803508|FG001|Overall Study|Unclassified|5|||
127775303|NCT04600336|459803509|FG000|Initial Treatment|Withdrawal by Subject|1|||
127775304|NCT04600336|459803510|FG001|Initial Treatment|Withdrawal by Subject|2|||
127775305|NCT04600336|459803511|FG002|Initial Treatment|Withdrawal by Subject|0|||
127775306|NCT04600336|459803512|FG003|Initial Treatment|Withdrawal by Subject|0|||
127775307|NCT04600336|459803509|FG000|Initial Treatment|Adverse Event|0|||
127775308|NCT04600336|459803510|FG001|Initial Treatment|Adverse Event|2|||
127560360|NCT01642615|459021661|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
127560361|NCT01028300|459021662|FG000|Overall Study|Study Terminated|4|||
127560362|NCT01214395|459021663|FG000|Overall Study|All patients had infection|5|||
127560363|NCT00715910|459021664|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
127560364|NCT00715910|459021665|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
127560365|NCT00715910|459021666|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
127560366|NCT00715910|459021667|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
127560367|NCT00715910|459021668|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
127560368|NCT00715910|459021669|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
127560369|NCT00715910|459021664|FG000|Booster and ESFU Phase|Other|0|||
127560370|NCT00715910|459021665|FG001|Booster and ESFU Phase|Other|0|||
127560371|NCT00715910|459021666|FG002|Booster and ESFU Phase|Other|0|||
127560372|NCT00715910|459021667|FG003|Booster and ESFU Phase|Other|5|||
127560373|NCT00715910|459021668|FG004|Booster and ESFU Phase|Other|1|||
127560374|NCT00715910|459021669|FG005|Booster and ESFU Phase|Other|0|||
127560375|NCT04002908|459021675|FG000|Overall Study|Death|41|||
127560376|NCT04002908|459021676|FG001|Overall Study|Death|0|||
127560377|NCT04002908|459021677|FG002|Overall Study|Death|0|||
127560378|NCT04002908|459021678|FG003|Overall Study|Death|0|||
127560379|NCT04002908|459021675|FG000|Overall Study|Withdrawal by Subject|112|||
127560380|NCT04002908|459021676|FG001|Overall Study|Withdrawal by Subject|0|||
127560381|NCT04002908|459021677|FG002|Overall Study|Withdrawal by Subject|0|||
127560382|NCT04002908|459021678|FG003|Overall Study|Withdrawal by Subject|0|||
127560383|NCT04002908|459021675|FG000|Overall Study|Lost to Follow-up|72|||
127560384|NCT04002908|459021676|FG001|Overall Study|Lost to Follow-up|0|||
127560385|NCT04002908|459021677|FG002|Overall Study|Lost to Follow-up|0|||
127560386|NCT04002908|459021678|FG003|Overall Study|Lost to Follow-up|0|||
127775309|NCT04600336|459803511|FG002|Initial Treatment|Adverse Event|0|||
127775310|NCT04600336|459803512|FG003|Initial Treatment|Adverse Event|0|||
127775311|NCT04600336|459803509|FG000|Initial Treatment|Other complicating disease|0|||
128024324|NCT01111292|460714364|FG001|Treatment|Physician Decision|1|||
127560387|NCT04002908|459021675|FG000|Overall Study|Infant died, so mother withdrawn|34|||
127560388|NCT04002908|459021676|FG001|Overall Study|Infant died, so mother withdrawn|0|||
127560389|NCT04002908|459021677|FG002|Overall Study|Infant died, so mother withdrawn|0|||
127560390|NCT04002908|459021678|FG003|Overall Study|Infant died, so mother withdrawn|0|||
127775312|NCT04600336|459803510|FG001|Initial Treatment|Other complicating disease|0|||
127775313|NCT04600336|459803511|FG002|Initial Treatment|Other complicating disease|1|||
127775314|NCT04600336|459803512|FG003|Initial Treatment|Other complicating disease|0|||
127775315|NCT04600336|459803509|FG000|Crossover Treatment|Withdrawal by Subject|0|||
127775316|NCT04600336|459803510|FG001|Crossover Treatment|Withdrawal by Subject|0|||
128024325|NCT01217047|460714368|FG000|Overall Study|Lost to Follow-up|0|||
127775317|NCT04600336|459803511|FG002|Crossover Treatment|Withdrawal by Subject|2|||
127775318|NCT04600336|459803512|FG003|Crossover Treatment|Withdrawal by Subject|1|||
127775319|NCT04600336|459803509|FG000|Crossover Treatment|Adverse Event|0|||
127775320|NCT04600336|459803510|FG001|Crossover Treatment|Adverse Event|0|||
127775321|NCT04600336|459803511|FG002|Crossover Treatment|Adverse Event|1|||
127775322|NCT04600336|459803512|FG003|Crossover Treatment|Adverse Event|1|||
127775323|NCT03144804|459803513|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
127775324|NCT04091451|459803516|FG000|Overall Study|Adverse Event|15|||
127775325|NCT04091451|459803517|FG001|Overall Study|Adverse Event|10|||
127775326|NCT04091451|459803516|FG000|Overall Study|Lost to Follow-up|8|||
127775327|NCT04091451|459803517|FG001|Overall Study|Lost to Follow-up|8|||
127775328|NCT04091451|459803516|FG000|Overall Study|Protocol Violation|5|||
127775329|NCT04091451|459803517|FG001|Overall Study|Protocol Violation|4|||
127775330|NCT04091451|459803516|FG000|Overall Study|Withdrawal by Subject|21|||
127775331|NCT04091451|459803517|FG001|Overall Study|Withdrawal by Subject|27|||
127775332|NCT04091451|459803516|FG000|Overall Study|Non-emergency unblinding/Non-compliance|15|||
127775333|NCT04091451|459803517|FG001|Overall Study|Non-emergency unblinding/Non-compliance|18|||
127775334|NCT04091451|459803516|FG000|Overall Study|Migrated/moved from the study area|3|||
127775335|NCT04091451|459803517|FG001|Overall Study|Migrated/moved from the study area|5|||
127775336|NCT04091451|459803516|FG000|Overall Study|Suspected HZ episode|1|||
127775337|NCT04091451|459803517|FG001|Overall Study|Suspected HZ episode|0|||
127775338|NCT03769181|459805414|FG000|Overall Study|Adverse Event|1|||
127775339|NCT03769181|459805415|FG001|Overall Study|Adverse Event|0|||
127775340|NCT03769181|459805416|FG002|Overall Study|Adverse Event|2|||
127775341|NCT03769181|459805417|FG003|Overall Study|Adverse Event|4|||
127775342|NCT03769181|459805414|FG000|Overall Study|Withdrawal by Subject|1|||
127775343|NCT03769181|459805415|FG001|Overall Study|Withdrawal by Subject|0|||
127775344|NCT03769181|459805416|FG002|Overall Study|Withdrawal by Subject|2|||
127775345|NCT03769181|459805417|FG003|Overall Study|Withdrawal by Subject|1|||
127775346|NCT03769181|459805414|FG000|Overall Study|Progressive disease|9|||
127775347|NCT03769181|459805415|FG001|Overall Study|Progressive disease|7|||
127775348|NCT03769181|459805416|FG002|Overall Study|Progressive disease|13|||
127775349|NCT03769181|459805417|FG003|Overall Study|Progressive disease|6|||
127775350|NCT03769181|459805414|FG000|Overall Study|Other - Unspecified|2|||
127775351|NCT03769181|459805415|FG001|Overall Study|Other - Unspecified|1|||
127775352|NCT03769181|459805416|FG002|Overall Study|Other - Unspecified|0|||
127775353|NCT03769181|459805417|FG003|Overall Study|Other - Unspecified|0|||
127775354|NCT03078907|459805420|FG000|Overall Study|Adverse Event|2|||
127775355|NCT03078907|459805421|FG001|Overall Study|Adverse Event|0|||
127775356|NCT03078907|459805420|FG000|Overall Study|Other|1|||
127775357|NCT03078907|459805421|FG001|Overall Study|Other|0|||
127775358|NCT03078907|459805420|FG000|Overall Study|Protocol Violation|0|||
127775359|NCT03078907|459805421|FG001|Overall Study|Protocol Violation|1|||
127775360|NCT03338192|459805422|FG000|Year One to Year Two|High Blood Pressure|7|||
127775361|NCT03338192|459805423|FG001|Year One to Year Two|High Blood Pressure|1|||
128024326|NCT01217047|460714369|FG001|Overall Study|Lost to Follow-up|1|||
128024327|NCT01217047|460714370|FG002|Overall Study|Lost to Follow-up|0|||
128024328|NCT05529173|460714371|FG000|Overall Study|Physician Decision|3|||
128024329|NCT05529173|460714372|FG001|Overall Study|Physician Decision|6|||
128024330|NCT05529173|460714371|FG000|Overall Study|Sample shipment delay more than one day|4|||
128024331|NCT05529173|460714372|FG001|Overall Study|Sample shipment delay more than one day|0|||
127775362|NCT03338192|459805422|FG000|Year One to Year Two|HIV +|1|||
127775363|NCT03338192|459805423|FG001|Year One to Year Two|HIV +|0|||
127775364|NCT03338192|459805422|FG000|Year Two to Year Four|High Blood Pressure|1|||
127775365|NCT03338192|459805423|FG001|Year Two to Year Four|High Blood Pressure|0|||
127775366|NCT03338192|459805422|FG000|Year Two to Year Four|HIV +|2|||
127775367|NCT03338192|459805423|FG001|Year Two to Year Four|HIV +|0|||
127775368|NCT03338192|459805422|FG000|Year Four to Year Six|High Blood Pressure|2|||
127775369|NCT03338192|459805423|FG001|Year Four to Year Six|High Blood Pressure|1|||
127775370|NCT03808688|459805424|FG000|Overall Study|Adverse Event|13|||
127775371|NCT03808688|459805425|FG001|Overall Study|Adverse Event|17|||
127775372|NCT03808688|459805424|FG000|Overall Study|Lack of Efficacy|2|||
127775373|NCT03808688|459805425|FG001|Overall Study|Lack of Efficacy|0|||
127775374|NCT03808688|459805424|FG000|Overall Study|Lost to Follow-up|0|||
127775375|NCT03808688|459805425|FG001|Overall Study|Lost to Follow-up|2|||
127775376|NCT03808688|459805424|FG000|Overall Study|Withdrawal by Subject|1|||
127775377|NCT03808688|459805425|FG001|Overall Study|Withdrawal by Subject|0|||
127775378|NCT03808688|459805424|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
127775379|NCT03808688|459805425|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
127775380|NCT03808688|459805424|FG000|Overall Study|IOP Too High|1|||
127775381|NCT03808688|459805425|FG001|Overall Study|IOP Too High|1|||
128024332|NCT01530997|460714381|FG000|Overall Study|Physician Decision|1|||
127775382|NCT03808688|459805424|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
127775383|NCT03808688|459805425|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
127775384|NCT03808688|459805424|FG000|Overall Study|Visit Out of Window|0|||
127775385|NCT03808688|459805425|FG001|Overall Study|Visit Out of Window|1|||
128024333|NCT01530997|460714381|FG000|Overall Study|Withdrawal by Subject|1|||
127686980|NCT02409667|459479745|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
127775386|NCT03808688|459805424|FG000|Overall Study|Medication Non-Compliance|0|||
127775387|NCT03808688|459805425|FG001|Overall Study|Medication Non-Compliance|1|||
127775388|NCT03329196|459805426|FG000|Overall Study|Adverse Event|10|||
127775389|NCT03329196|459805427|FG001|Overall Study|Adverse Event|5|||
127775390|NCT03329196|459805426|FG000|Overall Study|Physician Decision|2|||
127775391|NCT03329196|459805427|FG001|Overall Study|Physician Decision|2|||
127775392|NCT03329196|459805426|FG000|Overall Study|Withdrawal by Subject|11|||
127775393|NCT03329196|459805427|FG001|Overall Study|Withdrawal by Subject|3|||
127775394|NCT03329196|459805426|FG000|Overall Study|Hepatic function abnormalities|0|||
127775395|NCT03329196|459805427|FG001|Overall Study|Hepatic function abnormalities|1|||
127775396|NCT03329196|459805426|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
127775397|NCT03329196|459805427|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
127775398|NCT03329196|459805426|FG000|Overall Study|Difficult to control Hb|2|||
127775399|NCT03329196|459805427|FG001|Overall Study|Difficult to control Hb|3|||
127775400|NCT03329196|459805426|FG000|Overall Study|Dialysis or renal transplant|13|||
127775401|NCT03329196|459805427|FG001|Overall Study|Dialysis or renal transplant|15|||
127775402|NCT04175808|459805428|FG000|Part A|Miscellaneous|2|||
127775403|NCT04175808|459805429|FG001|Part A|Miscellaneous|0|||
127775404|NCT04175808|459805430|FG002|Part A|Miscellaneous|0|||
127775405|NCT04175808|459805431|FG003|Part A|Miscellaneous|0|||
127775406|NCT04175808|459805432|FG004|Part A|Miscellaneous|0|||
127775407|NCT04175808|459805433|FG005|Part A|Miscellaneous|0|||
127775408|NCT04175808|459805434|FG006|Part A|Miscellaneous|0|||
127775409|NCT02993523|459805435|FG000|Overall Study|Withdrew Consent|0|||
127686981|NCT02409667|459479746|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
127686982|NCT02409667|459479747|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
127686983|NCT02409667|459479748|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
127686984|NCT02409667|459479744|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
127686985|NCT02409667|459479745|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
127686986|NCT02409667|459479746|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
127686987|NCT02409667|459479747|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
127686988|NCT02409667|459479748|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
127686989|NCT02409667|459479744|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
127686990|NCT02409667|459479745|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
127686991|NCT02409667|459479746|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
127686992|NCT02409667|459479747|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
127686993|NCT02409667|459479748|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
127686994|NCT02409667|459479744|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
127686995|NCT02409667|459479745|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
127686996|NCT02409667|459479746|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
127686997|NCT02409667|459479747|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
127686998|NCT02409667|459479748|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
127686999|NCT01925339|459479749|FG000|Overall Study|Adverse Event|2|||
127687000|NCT01925339|459479750|FG001|Overall Study|Adverse Event|0|||
127687001|NCT01538719|459479751|FG000|Overall Study|Lost to Follow-up|2|||
127687002|NCT01538719|459479752|FG001|Overall Study|Lost to Follow-up|0|||
127687003|NCT03482635|459479755|FG000|Overall Study|Lack of Efficacy|0|||
127687004|NCT03482635|459479756|FG001|Overall Study|Lack of Efficacy|0|||
127687005|NCT03482635|459479757|FG002|Overall Study|Lack of Efficacy|1|||
127687006|NCT03482635|459479758|FG003|Overall Study|Lack of Efficacy|3|||
127687007|NCT03482635|459479755|FG000|Overall Study|Adverse Event|2|||
127687008|NCT03482635|459479756|FG001|Overall Study|Adverse Event|2|||
127687009|NCT03482635|459479757|FG002|Overall Study|Adverse Event|0|||
127687010|NCT03482635|459479758|FG003|Overall Study|Adverse Event|3|||
127687011|NCT03482635|459479755|FG000|Overall Study|Withdrawal by Subject|2|||
127687012|NCT03482635|459479756|FG001|Overall Study|Withdrawal by Subject|1|||
127687013|NCT03482635|459479757|FG002|Overall Study|Withdrawal by Subject|0|||
127687014|NCT03482635|459479758|FG003|Overall Study|Withdrawal by Subject|1|||
127687015|NCT03482635|459479755|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
127687016|NCT03482635|459479756|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
127775410|NCT02993523|459805436|FG001|Overall Study|Withdrew Consent|0|||
127775411|NCT02993523|459805437|FG002|Overall Study|Withdrew Consent|2|||
127775412|NCT02993523|459805438|FG003|Overall Study|Withdrew Consent|9|||
127687017|NCT03482635|459479757|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
127687018|NCT03482635|459479758|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
127775413|NCT02993523|459805439|FG004|Overall Study|Withdrew Consent|0|||
127775414|NCT02993523|459805435|FG000|Overall Study|Lost to Follow-up|0|||
127775415|NCT02993523|459805436|FG001|Overall Study|Lost to Follow-up|0|||
127687019|NCT03482635|459479755|FG000|Overall Study|Not treated|0|||
127687020|NCT03482635|459479756|FG001|Overall Study|Not treated|0|||
127687021|NCT03482635|459479757|FG002|Overall Study|Not treated|0|||
127687022|NCT03482635|459479758|FG003|Overall Study|Not treated|1|||
127687023|NCT03237481|459480975|FG000|Overall Study|Lost to Follow-up|1|||
127687024|NCT03237481|459480976|FG001|Overall Study|Lost to Follow-up|0|||
127687025|NCT03237481|459480977|FG002|Overall Study|Lost to Follow-up|0|||
127687026|NCT03237481|459480975|FG000|Overall Study|Protocol Violation|1|||
127687027|NCT03237481|459480976|FG001|Overall Study|Protocol Violation|0|||
127687028|NCT03237481|459480977|FG002|Overall Study|Protocol Violation|0|||
127687029|NCT03237481|459480975|FG000|Overall Study|Withdrawal by Subject|3|||
127687030|NCT03237481|459480976|FG001|Overall Study|Withdrawal by Subject|2|||
127687031|NCT03237481|459480977|FG002|Overall Study|Withdrawal by Subject|1|||
127687032|NCT02581215|459480981|FG000|Overall Study|Screen Failure Before Therapy Start|0|||
127687033|NCT02581215|459480982|FG001|Overall Study|Screen Failure Before Therapy Start|1|||
127687034|NCT02581215|459480981|FG000|Overall Study|Eligibility Criteria Not Met|0|||
127687035|NCT02581215|459480982|FG001|Overall Study|Eligibility Criteria Not Met|1|||
127687036|NCT03112174|459480988|FG000|Overall Study|Withdrawal by Subject|3|||
127687037|NCT03112174|459480989|FG001|Overall Study|Withdrawal by Subject|0|||
127687038|NCT03112174|459480990|FG002|Overall Study|Withdrawal by Subject|11|||
127687039|NCT03112174|459480991|FG003|Overall Study|Withdrawal by Subject|9|||
127687040|NCT03112174|459480992|FG004|Overall Study|Withdrawal by Subject|7|||
127687041|NCT03112174|459480988|FG000|Overall Study|Lost to Follow-up|1|||
127687042|NCT03112174|459480989|FG001|Overall Study|Lost to Follow-up|1|||
127687043|NCT03112174|459480990|FG002|Overall Study|Lost to Follow-up|2|||
127687044|NCT03112174|459480991|FG003|Overall Study|Lost to Follow-up|3|||
127687045|NCT03112174|459480992|FG004|Overall Study|Lost to Follow-up|2|||
127687046|NCT03112174|459480988|FG000|Overall Study|Death|8|||
127687047|NCT03112174|459480989|FG001|Overall Study|Death|3|||
127687048|NCT03112174|459480990|FG002|Overall Study|Death|67|||
127687049|NCT03112174|459480991|FG003|Overall Study|Death|73|||
127687050|NCT03112174|459480992|FG004|Overall Study|Death|18|||
127687051|NCT03112174|459480988|FG000|Overall Study|Other, Not Specified|1|||
127687052|NCT03112174|459480989|FG001|Overall Study|Other, Not Specified|0|||
127687053|NCT03112174|459480990|FG002|Overall Study|Other, Not Specified|1|||
127687054|NCT03112174|459480991|FG003|Overall Study|Other, Not Specified|2|||
127687055|NCT03112174|459480992|FG004|Overall Study|Other, Not Specified|0|||
127687056|NCT04259450|459480996|FG000|Overall Study|Adverse event/ Toxicity|0|||
127687057|NCT04259450|459480997|FG001|Overall Study|Adverse event/ Toxicity|3|||
127687058|NCT04259450|459480998|FG002|Overall Study|Adverse event/ Toxicity|0|||
127687059|NCT04259450|459480999|FG003|Overall Study|Adverse event/ Toxicity|1|||
127687060|NCT04259450|459481000|FG004|Overall Study|Adverse event/ Toxicity|0|||
127687061|NCT04259450|459481001|FG005|Overall Study|Adverse event/ Toxicity|0|||
127687062|NCT04259450|459481002|FG006|Overall Study|Adverse event/ Toxicity|0|||
127687063|NCT04259450|459481003|FG007|Overall Study|Adverse event/ Toxicity|1|||
127687064|NCT04259450|459481004|FG008|Overall Study|Adverse event/ Toxicity|0|||
127687065|NCT04259450|459481005|FG009|Overall Study|Adverse event/ Toxicity|3|||
127687066|NCT04259450|459480996|FG000|Overall Study|Disease progression|2|||
127687067|NCT04259450|459480997|FG001|Overall Study|Disease progression|3|||
127687068|NCT04259450|459480998|FG002|Overall Study|Disease progression|4|||
127687069|NCT04259450|459480999|FG003|Overall Study|Disease progression|4|||
127687070|NCT04259450|459481000|FG004|Overall Study|Disease progression|6|||
127687071|NCT04259450|459481001|FG005|Overall Study|Disease progression|6|||
127687072|NCT04259450|459481002|FG006|Overall Study|Disease progression|6|||
127687073|NCT04259450|459481003|FG007|Overall Study|Disease progression|15|||
127687074|NCT04259450|459481004|FG008|Overall Study|Disease progression|6|||
127687075|NCT04259450|459481005|FG009|Overall Study|Disease progression|18|||
127687076|NCT04259450|459480996|FG000|Overall Study|Death|0|||
127687077|NCT04259450|459480997|FG001|Overall Study|Death|0|||
127687078|NCT04259450|459480998|FG002|Overall Study|Death|0|||
127687079|NCT04259450|459480999|FG003|Overall Study|Death|0|||
127687080|NCT04259450|459481000|FG004|Overall Study|Death|0|||
127687081|NCT04259450|459481001|FG005|Overall Study|Death|0|||
127687082|NCT04259450|459481002|FG006|Overall Study|Death|0|||
127687083|NCT04259450|459481003|FG007|Overall Study|Death|1|||
127687084|NCT04259450|459481004|FG008|Overall Study|Death|1|||
127687085|NCT04259450|459481005|FG009|Overall Study|Death|0|||
127687086|NCT04259450|459480996|FG000|Overall Study|Withdrawal by Subject|0|||
127687087|NCT04259450|459480997|FG001|Overall Study|Withdrawal by Subject|0|||
127687088|NCT04259450|459480998|FG002|Overall Study|Withdrawal by Subject|0|||
127560391|NCT00006289|459021681|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
127560392|NCT00006289|459021682|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
127687089|NCT04259450|459480999|FG003|Overall Study|Withdrawal by Subject|0|||
127687090|NCT04259450|459481000|FG004|Overall Study|Withdrawal by Subject|0|||
127687091|NCT04259450|459481001|FG005|Overall Study|Withdrawal by Subject|0|||
127687092|NCT04259450|459481002|FG006|Overall Study|Withdrawal by Subject|0|||
127687093|NCT04259450|459481003|FG007|Overall Study|Withdrawal by Subject|1|||
127687094|NCT04259450|459481004|FG008|Overall Study|Withdrawal by Subject|0|||
127687095|NCT04259450|459481005|FG009|Overall Study|Withdrawal by Subject|0|||
127687096|NCT04259450|459480996|FG000|Overall Study|Other than listed|0|||
127687097|NCT04259450|459480997|FG001|Overall Study|Other than listed|0|||
127687098|NCT04259450|459480998|FG002|Overall Study|Other than listed|0|||
127687099|NCT04259450|459480999|FG003|Overall Study|Other than listed|0|||
127687100|NCT04259450|459481000|FG004|Overall Study|Other than listed|0|||
127687101|NCT04259450|459481001|FG005|Overall Study|Other than listed|0|||
127687102|NCT04259450|459481002|FG006|Overall Study|Other than listed|0|||
127687103|NCT04259450|459481003|FG007|Overall Study|Other than listed|1|||
127687104|NCT04259450|459481004|FG008|Overall Study|Other than listed|1|||
127687105|NCT04259450|459481005|FG009|Overall Study|Other than listed|2|||
127687106|NCT01534494|459481006|FG000|Overall Study|Withdrawal by Subject|1|||
127687107|NCT00434304|459481012|FG000|Overall Study|Adverse Event|14|||
127687108|NCT00434304|459481012|FG000|Overall Study|Lack of Efficacy|2|||
127687109|NCT00434304|459481012|FG000|Overall Study|Withdrawal by Subject|4|||
127687110|NCT05262738|459481013|FG000|Overall Study|Withdrawal by Subject|1|||
127687111|NCT05262738|459481014|FG001|Overall Study|Withdrawal by Subject|0|||
127687112|NCT02374463|459481016|FG000|Overall Study|Withdrawal by Subject|3|||
127687113|NCT02374463|459481017|FG001|Overall Study|Withdrawal by Subject|3|||
127687114|NCT01471691|459481020|FG000|Overall Study|Lack of Efficacy|0|||
127687115|NCT01471691|459481021|FG001|Overall Study|Lack of Efficacy|1|||
127687116|NCT01808339|459481022|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
127687117|NCT01808339|459481023|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
127687118|NCT01808339|459481024|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
127687119|NCT01808339|459481025|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
127687120|NCT01808339|459481026|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
127687121|NCT01808339|459481027|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
127687122|NCT01808339|459481022|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
127687123|NCT01808339|459481023|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
127687124|NCT01808339|459481024|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
127687125|NCT01808339|459481025|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
127687126|NCT01808339|459481026|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
127687127|NCT01808339|459481027|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
127687128|NCT01808339|459481022|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
127687129|NCT01808339|459481023|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
127687130|NCT01808339|459481024|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
127687131|NCT01808339|459481025|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
127687132|NCT01808339|459481026|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
127687133|NCT01808339|459481027|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
127687134|NCT02622568|459481036|FG000|Overall Study|Lost to Follow-up|5|||
127687135|NCT02622568|459481037|FG001|Overall Study|Lost to Follow-up|5|||
127687136|NCT00858117|459481038|FG000|Treatment on Study|Adverse Event|2|||
127687137|NCT00858117|459481038|FG000|Follow up for 5 Years|Death|4|||
127687138|NCT00858117|459481038|FG000|Follow up for 5 Years|No further data collected for study|9|||
127687139|NCT00371787|459481039|FG000|Overall Study|Withdrawal by Subject|3|||
127687140|NCT00371787|459481040|FG001|Overall Study|Withdrawal by Subject|1|||
127687141|NCT01854385|459481044|FG000|Pre-Treatment|Withdrawal by Subject|4|||
127687142|NCT01854385|459481044|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
127687143|NCT01854385|459481044|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
127687144|NCT01854385|459481044|FG000|Pre-Treatment|Unable to come for study visits|1|||
127687145|NCT01854385|459481044|FG000|Treatment|Lost to Follow-up|1|||
127687146|NCT00277355|459481047|FG000|Overall Study|Withdrawal by Subject|3|||
127687147|NCT00277355|459481048|FG001|Overall Study|Withdrawal by Subject|3|||
127687148|NCT00277355|459481047|FG000|Overall Study|Lost to Follow-up|2|||
127687149|NCT00277355|459481048|FG001|Overall Study|Lost to Follow-up|2|||
127687150|NCT00277355|459481047|FG000|Overall Study|Adverse Event|5|||
127687151|NCT00277355|459481048|FG001|Overall Study|Adverse Event|0|||
127687152|NCT00277355|459481047|FG000|Overall Study|Death|3|||
127687153|NCT00277355|459481048|FG001|Overall Study|Death|0|||
127687154|NCT00277355|459481047|FG000|Overall Study|Physician Decision|1|||
127687155|NCT00277355|459481048|FG001|Overall Study|Physician Decision|0|||
127687156|NCT00421889|459481054|FG000|Overall Study|Adverse Event|1|||
127687157|NCT00421889|459481055|FG001|Overall Study|Adverse Event|0|||
127687158|NCT00421889|459481056|FG002|Overall Study|Adverse Event|1|||
128024334|NCT02181738|460714384|FG000|Overall Study|Participant Withdrew Consent|2|||
128024335|NCT02181738|460714385|FG001|Overall Study|Participant Withdrew Consent|1|||
128024336|NCT02181738|460714386|FG002|Overall Study|Participant Withdrew Consent|1|||
128024337|NCT02181738|460714387|FG003|Overall Study|Participant Withdrew Consent|1|||
128024338|NCT02181738|460714384|FG000|Overall Study|Lost to Follow-up|1|||
128024339|NCT02181738|460714385|FG001|Overall Study|Lost to Follow-up|2|||
128024340|NCT02181738|460714386|FG002|Overall Study|Lost to Follow-up|1|||
128024341|NCT02181738|460714387|FG003|Overall Study|Lost to Follow-up|1|||
127560393|NCT00006289|459021681|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
127560394|NCT00006289|459021682|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
127560395|NCT05092360|459021693|FG000|Overall Study|Withdrawal by Subject|21|||
127560396|NCT05092360|459021694|FG001|Overall Study|Withdrawal by Subject|4|||
127560397|NCT05092360|459021695|FG002|Overall Study|Withdrawal by Subject|9|||
127560398|NCT05092360|459021696|FG003|Overall Study|Withdrawal by Subject|26|||
127560399|NCT05092360|459021693|FG000|Overall Study|Death|97|||
127687159|NCT00421889|459481057|FG003|Overall Study|Adverse Event|1|||
127687160|NCT00421889|459481058|FG004|Overall Study|Adverse Event|1|||
127687161|NCT00421889|459481059|FG005|Overall Study|Adverse Event|4|||
127687162|NCT00421889|459481060|FG006|Overall Study|Adverse Event|1|||
127687163|NCT00421889|459481061|FG007|Overall Study|Adverse Event|0|||
127687164|NCT00421889|459481062|FG008|Overall Study|Adverse Event|2|||
127687165|NCT00421889|459481054|FG000|Overall Study|Withdrawal by Subject|1|||
127687166|NCT00421889|459481055|FG001|Overall Study|Withdrawal by Subject|3|||
127687167|NCT00421889|459481056|FG002|Overall Study|Withdrawal by Subject|0|||
127687168|NCT00421889|459481057|FG003|Overall Study|Withdrawal by Subject|0|||
127687169|NCT00421889|459481058|FG004|Overall Study|Withdrawal by Subject|2|||
127687170|NCT00421889|459481059|FG005|Overall Study|Withdrawal by Subject|0|||
127687171|NCT00421889|459481060|FG006|Overall Study|Withdrawal by Subject|0|||
127687172|NCT00421889|459481061|FG007|Overall Study|Withdrawal by Subject|0|||
127687173|NCT00421889|459481062|FG008|Overall Study|Withdrawal by Subject|0|||
127687174|NCT00421889|459481054|FG000|Overall Study|Death|0|||
127687175|NCT00421889|459481055|FG001|Overall Study|Death|0|||
127687176|NCT00421889|459481056|FG002|Overall Study|Death|0|||
127687177|NCT00421889|459481057|FG003|Overall Study|Death|0|||
127687178|NCT00421889|459481058|FG004|Overall Study|Death|1|||
127687179|NCT00421889|459481059|FG005|Overall Study|Death|1|||
127687180|NCT00421889|459481060|FG006|Overall Study|Death|0|||
127687181|NCT00421889|459481061|FG007|Overall Study|Death|0|||
127687182|NCT00421889|459481062|FG008|Overall Study|Death|0|||
127687183|NCT00421889|459481054|FG000|Overall Study|Progressive disease|3|||
127687184|NCT00421889|459481055|FG001|Overall Study|Progressive disease|2|||
127687185|NCT00421889|459481056|FG002|Overall Study|Progressive disease|2|||
127687186|NCT00421889|459481057|FG003|Overall Study|Progressive disease|3|||
127687187|NCT00421889|459481058|FG004|Overall Study|Progressive disease|2|||
127687188|NCT00421889|459481059|FG005|Overall Study|Progressive disease|21|||
127687189|NCT00421889|459481060|FG006|Overall Study|Progressive disease|3|||
127687190|NCT00421889|459481061|FG007|Overall Study|Progressive disease|1|||
127687191|NCT00421889|459481062|FG008|Overall Study|Progressive disease|5|||
127687192|NCT00421889|459481054|FG000|Overall Study|Patient/Investigator request|0|||
127687193|NCT00421889|459481055|FG001|Overall Study|Patient/Investigator request|0|||
127687194|NCT00421889|459481056|FG002|Overall Study|Patient/Investigator request|0|||
127687195|NCT00421889|459481057|FG003|Overall Study|Patient/Investigator request|0|||
127687196|NCT00421889|459481058|FG004|Overall Study|Patient/Investigator request|0|||
127687197|NCT00421889|459481059|FG005|Overall Study|Patient/Investigator request|9|||
127687198|NCT00421889|459481060|FG006|Overall Study|Patient/Investigator request|0|||
127687199|NCT00421889|459481061|FG007|Overall Study|Patient/Investigator request|1|||
127687200|NCT00421889|459481062|FG008|Overall Study|Patient/Investigator request|3|||
127687201|NCT00421889|459481054|FG000|Overall Study|Lost to Follow-up|0|||
127687202|NCT00421889|459481055|FG001|Overall Study|Lost to Follow-up|0|||
127687203|NCT00421889|459481056|FG002|Overall Study|Lost to Follow-up|0|||
127687204|NCT00421889|459481057|FG003|Overall Study|Lost to Follow-up|0|||
127687205|NCT00421889|459481058|FG004|Overall Study|Lost to Follow-up|0|||
127687206|NCT00421889|459481059|FG005|Overall Study|Lost to Follow-up|0|||
127687207|NCT00421889|459481060|FG006|Overall Study|Lost to Follow-up|0|||
127687208|NCT00421889|459481061|FG007|Overall Study|Lost to Follow-up|0|||
127687209|NCT00421889|459481062|FG008|Overall Study|Lost to Follow-up|1|||
127687210|NCT00350792|459481065|FG000|Overall Study|Adverse Event|11|||
127687211|NCT00350792|459481065|FG000|Overall Study|Death from Study Disease|1|||
127687212|NCT00350792|459481065|FG000|Overall Study|Death from Study Drug Toxicity|1|||
127687213|NCT00350792|459481065|FG000|Overall Study|Death Not Study Drug Related|2|||
127687214|NCT00350792|459481065|FG000|Overall Study|Protocol Violation|1|||
127560400|NCT05092360|459021694|FG001|Overall Study|Death|14|||
127687215|NCT00350792|459481065|FG000|Overall Study|Withdrawal by Subject|4|||
127687216|NCT00350792|459481065|FG000|Overall Study|Physician Decision|2|||
127687217|NCT00350792|459481065|FG000|Overall Study|Lack of Efficacy|11|||
127687218|NCT03988023|459481066|FG000|Overall Study|Non-compliance|3|||
128024342|NCT02181738|460714384|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
127775416|NCT02993523|459805437|FG002|Overall Study|Lost to Follow-up|3|||
127775417|NCT02993523|459805438|FG003|Overall Study|Lost to Follow-up|6|||
127775418|NCT02993523|459805439|FG004|Overall Study|Lost to Follow-up|0|||
127775419|NCT02993523|459805435|FG000|Overall Study|Death|1|||
127775420|NCT02993523|459805436|FG001|Overall Study|Death|1|||
127775421|NCT02993523|459805437|FG002|Overall Study|Death|138|||
127775422|NCT02993523|459805438|FG003|Overall Study|Death|222|||
127775423|NCT02993523|459805439|FG004|Overall Study|Death|6|||
127775424|NCT02993523|459805435|FG000|Overall Study|Reason not Specified|0|||
127775425|NCT02993523|459805436|FG001|Overall Study|Reason not Specified|0|||
127775426|NCT02993523|459805437|FG002|Overall Study|Reason not Specified|1|||
127775427|NCT02993523|459805438|FG003|Overall Study|Reason not Specified|1|||
127775428|NCT02993523|459805439|FG004|Overall Study|Reason not Specified|0|||
127775429|NCT03694418|459805440|FG000|Overall Study|Lost to Follow-up|115|||
127775430|NCT03694418|459805441|FG001|Overall Study|Lost to Follow-up|23|||
127775431|NCT03694418|459805442|FG002|Overall Study|Lost to Follow-up|12|||
127775432|NCT03694418|459805443|FG003|Overall Study|Lost to Follow-up|12|||
127775433|NCT03694418|459805444|FG004|Overall Study|Lost to Follow-up|13|||
127687219|NCT03988023|459481067|FG001|Overall Study|Non-compliance|0|||
127687220|NCT03988023|459481066|FG000|Overall Study|Withdrawal by Subject|39|||
127687221|NCT03988023|459481067|FG001|Overall Study|Withdrawal by Subject|37|||
127687222|NCT03988023|459481066|FG000|Overall Study|Adverse Event|0|||
127687223|NCT03988023|459481067|FG001|Overall Study|Adverse Event|2|||
127687224|NCT03988023|459481066|FG000|Overall Study|Physician Decision|0|||
127687225|NCT03988023|459481067|FG001|Overall Study|Physician Decision|1|||
127687226|NCT03988023|459481066|FG000|Overall Study|Lost to Follow-up|5|||
127687227|NCT03988023|459481067|FG001|Overall Study|Lost to Follow-up|8|||
127687228|NCT03988023|459481066|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
127687229|NCT03988023|459481067|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
127687230|NCT03988023|459481066|FG000|Overall Study|Lack of Efficacy|3|||
127687231|NCT03988023|459481067|FG001|Overall Study|Lack of Efficacy|1|||
127687232|NCT03988023|459481066|FG000|Overall Study|COVID-19 pandemic|225|||
127687233|NCT03988023|459481067|FG001|Overall Study|COVID-19 pandemic|227|||
127687234|NCT00396084|459481070|FG000|Overall Study|Adverse Event|0|||
127687235|NCT00396084|459481071|FG001|Overall Study|Adverse Event|0|||
127687236|NCT00396084|459481072|FG002|Overall Study|Adverse Event|0|||
127687237|NCT00396084|459481073|FG003|Overall Study|Adverse Event|0|||
127687238|NCT00396084|459481074|FG004|Overall Study|Adverse Event|1|||
127687239|NCT00396084|459481075|FG005|Overall Study|Adverse Event|2|||
127687240|NCT00396084|459481070|FG000|Overall Study|Withdrawal by Subject|0|||
127687241|NCT00396084|459481071|FG001|Overall Study|Withdrawal by Subject|0|||
127687242|NCT00396084|459481072|FG002|Overall Study|Withdrawal by Subject|0|||
127687243|NCT00396084|459481073|FG003|Overall Study|Withdrawal by Subject|1|||
127687244|NCT00396084|459481074|FG004|Overall Study|Withdrawal by Subject|0|||
127687245|NCT00396084|459481075|FG005|Overall Study|Withdrawal by Subject|0|||
127687246|NCT02708108|459481076|FG000|Overall Study|Death|1|||
127687247|NCT02708108|459481077|FG001|Overall Study|Death|2|||
127687248|NCT02708108|459481076|FG000|Overall Study|Regimen change|1|||
127687249|NCT02708108|459481077|FG001|Overall Study|Regimen change|0|||
127687250|NCT02708108|459481076|FG000|Overall Study|No MRD and no imaging available|0|||
127687251|NCT02708108|459481077|FG001|Overall Study|No MRD and no imaging available|1|||
127687252|NCT02568683|459481078|FG000|Overall Study|Death|0|||
127687253|NCT02568683|459481079|FG001|Overall Study|Death|2|||
127687254|NCT02568683|459481078|FG000|Overall Study|Withdrew Consent|1|||
127687255|NCT02568683|459481079|FG001|Overall Study|Withdrew Consent|0|||
127775434|NCT00528866|459805452|FG000|Overall Study|Protocol Violation|6|||
127687256|NCT02568683|459481078|FG000|Overall Study|Study Terminated By Sponsor|5|||
127687257|NCT02568683|459481079|FG001|Overall Study|Study Terminated By Sponsor|2|||
127687258|NCT01736215|459481080|FG000|Overall Study|Early termination of erythropoietin use|1|||
127687259|NCT01736215|459481080|FG000|Overall Study|Adverse Event|4|||
127687260|NCT01736215|459481080|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
127687261|NCT01736215|459481080|FG000|Overall Study|Insufficient data to perform analysis|8|||
127687262|NCT01248936|459481086|FG000|Overall Study|Sponsor Decision|259|||
127687263|NCT01248936|459481086|FG000|Overall Study|Progression of Disease|50|||
127687264|NCT01248936|459481086|FG000|Overall Study|Death|26|||
127775435|NCT01601847|459805453|FG000|Overall Study|Death|1|||
127560401|NCT05092360|459021695|FG002|Overall Study|Death|31|||
127560402|NCT05092360|459021696|FG003|Overall Study|Death|101|||
127687265|NCT01248936|459481086|FG000|Overall Study|Withdrawal of Consent|20|||
127687266|NCT01248936|459481086|FG000|Overall Study|Adverse Event|8|||
127687267|NCT01248936|459481086|FG000|Overall Study|Lost to Follow-up|7|||
127687268|NCT01248936|459481086|FG000|Overall Study|Refused Treatment|1|||
127687269|NCT01248936|459481086|FG000|Overall Study|Other reason|3|||
127687270|NCT04556981|459481087|FG000|Overall Study|Death|0|||
127687271|NCT04556981|459481088|FG001|Overall Study|Death|1|||
127687272|NCT04556981|459481087|FG000|Overall Study|Lost to Follow-up|2|||
127687273|NCT04556981|459481088|FG001|Overall Study|Lost to Follow-up|11|||
127687274|NCT04556981|459481087|FG000|Overall Study|Moved from the study area|1|||
127687275|NCT04556981|459481088|FG001|Overall Study|Moved from the study area|4|||
127687276|NCT04556981|459481087|FG000|Overall Study|Withdrawal by Subject|2|||
127687277|NCT04556981|459481088|FG001|Overall Study|Withdrawal by Subject|2|||
127687278|NCT04556981|459481087|FG000|Overall Study|Other|2|||
127687279|NCT04556981|459481088|FG001|Overall Study|Other|1|||
127687280|NCT00068601|459481090|FG000|Overall Study|Ineligible|11|||
127687281|NCT00068601|459481091|FG001|Overall Study|Ineligible|13|||
127687282|NCT00068601|459481090|FG000|Overall Study|Not evaluable: withdrew consent|5|||
127687283|NCT00068601|459481091|FG001|Overall Study|Not evaluable: withdrew consent|4|||
127687284|NCT00068601|459481090|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
127687285|NCT00068601|459481091|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
127687286|NCT00068601|459481090|FG000|Overall Study|Death|11|||
127687287|NCT00068601|459481091|FG001|Overall Study|Death|3|||
127687288|NCT00068601|459481090|FG000|Overall Study|Lost to Follow-up|3|||
127687289|NCT00068601|459481091|FG001|Overall Study|Lost to Follow-up|2|||
127687290|NCT00068601|459481090|FG000|Overall Study|Missing primary outcome data|30|||
127687291|NCT00068601|459481091|FG001|Overall Study|Missing primary outcome data|34|||
127687292|NCT00440011|459481102|FG000|Overall Study|Adverse Event|2|||
127687293|NCT00440011|459481103|FG001|Overall Study|Adverse Event|0|||
127687294|NCT00440011|459481102|FG000|Overall Study|Lost to Follow-up|0|||
127687295|NCT00440011|459481103|FG001|Overall Study|Lost to Follow-up|2|||
127687296|NCT00440011|459481102|FG000|Overall Study|Protocol Violation|1|||
127687297|NCT00440011|459481103|FG001|Overall Study|Protocol Violation|1|||
127687298|NCT00440011|459481102|FG000|Overall Study|Withdrawal by Subject|1|||
127687299|NCT00440011|459481103|FG001|Overall Study|Withdrawal by Subject|0|||
127687300|NCT03664960|459481113|FG000|Overall Study|Adverse Event|0|||
127687301|NCT03664960|459481114|FG001|Overall Study|Adverse Event|3|||
127687302|NCT03664960|459481113|FG000|Overall Study|Lost to Follow-up|3|||
127687303|NCT03664960|459481114|FG001|Overall Study|Lost to Follow-up|2|||
127687304|NCT03664960|459481113|FG000|Overall Study|Physician Decision|1|||
127687305|NCT03664960|459481114|FG001|Overall Study|Physician Decision|0|||
127687306|NCT03664960|459481113|FG000|Overall Study|Withdrawal by Subject|3|||
127687307|NCT03664960|459481114|FG001|Overall Study|Withdrawal by Subject|14|||
127687308|NCT03664960|459481113|FG000|Overall Study|Sponsor Decision|1|||
127687309|NCT03664960|459481114|FG001|Overall Study|Sponsor Decision|1|||
127687310|NCT03664960|459481113|FG000|Overall Study|Other|1|||
127687311|NCT03664960|459481114|FG001|Overall Study|Other|2|||
127687312|NCT00774852|459481116|FG000|Overall Study|Adverse Event|9|||
127687313|NCT00774852|459481117|FG001|Overall Study|Adverse Event|6|||
127687314|NCT00774852|459481116|FG000|Overall Study|Death|2|||
127687315|NCT00774852|459481117|FG001|Overall Study|Death|1|||
127687316|NCT00774852|459481116|FG000|Overall Study|Lack of Efficacy|3|||
127687317|NCT00774852|459481117|FG001|Overall Study|Lack of Efficacy|7|||
127687318|NCT00774852|459481116|FG000|Overall Study|Lost to Follow-up|9|||
127687319|NCT00774852|459481117|FG001|Overall Study|Lost to Follow-up|5|||
127687320|NCT00774852|459481116|FG000|Overall Study|Physician Decision|2|||
127687321|NCT00774852|459481117|FG001|Overall Study|Physician Decision|6|||
127687322|NCT00774852|459481116|FG000|Overall Study|Pregnancy|1|||
127687323|NCT00774852|459481117|FG001|Overall Study|Pregnancy|2|||
127687324|NCT00774852|459481116|FG000|Overall Study|Withdrawal by Subject|2|||
127687325|NCT00774852|459481117|FG001|Overall Study|Withdrawal by Subject|2|||
127687326|NCT00774852|459481116|FG000|Overall Study|Non-responder|15|||
127687327|NCT00774852|459481117|FG001|Overall Study|Non-responder|11|||
127687328|NCT00774852|459481116|FG000|Overall Study|Subject non-compliance|0|||
127687329|NCT00774852|459481117|FG001|Overall Study|Subject non-compliance|1|||
127560403|NCT05092360|459021693|FG000|Overall Study|Lost to Follow-up|1|||
127687330|NCT00774852|459481116|FG000|Overall Study|Protocol Violation|1|||
127687331|NCT00774852|459481117|FG001|Overall Study|Protocol Violation|0|||
127687332|NCT00774852|459481116|FG000|Overall Study|Subject received prohibited medication|1|||
127687333|NCT00774852|459481117|FG001|Overall Study|Subject received prohibited medication|0|||
127687334|NCT03997916|459481118|FG000|Overall Study|Protocol Violation|35|||
127687335|NCT03960463|459483487|FG000|Overall Study|Withdrawal by Subject|2|||
127687336|NCT03960463|459483488|FG001|Overall Study|Withdrawal by Subject|0|||
127687337|NCT05568615|459483489|FG000|Overall Study|Death|1|||
127687338|NCT05568615|459483489|FG000|Overall Study|Physician Decision|1|||
127687339|NCT03529110|459483490|FG000|Overall Study|Progressive Disease|66|||
127687340|NCT03529110|459483491|FG001|Overall Study|Progressive Disease|158|||
127687341|NCT03529110|459483490|FG000|Overall Study|Clinical Progression|4|||
127775436|NCT01601847|459805454|FG001|Overall Study|Death|0|||
127775437|NCT01601847|459805453|FG000|Overall Study|Withdrawal by Subject|11|||
127775438|NCT01601847|459805454|FG001|Overall Study|Withdrawal by Subject|7|||
127775439|NCT01601847|459805453|FG000|Overall Study|Lost to Follow-up|1|||
127775440|NCT01601847|459805454|FG001|Overall Study|Lost to Follow-up|3|||
127775441|NCT01284062|459805455|FG000|Overall Study|Adverse Event|4|||
127775442|NCT01284062|459805456|FG001|Overall Study|Adverse Event|5|||
127775443|NCT01284062|459805457|FG002|Overall Study|Adverse Event|0|||
127775444|NCT01284062|459805458|FG003|Overall Study|Adverse Event|5|||
127775445|NCT01284062|459805455|FG000|Overall Study|Lack of Efficacy|3|||
127775446|NCT01284062|459805456|FG001|Overall Study|Lack of Efficacy|2|||
127775447|NCT01284062|459805457|FG002|Overall Study|Lack of Efficacy|2|||
127775448|NCT01284062|459805458|FG003|Overall Study|Lack of Efficacy|1|||
127775449|NCT01284062|459805455|FG000|Overall Study|Medication error without adverse event|0|||
127775450|NCT01284062|459805456|FG001|Overall Study|Medication error without adverse event|0|||
127775451|NCT01284062|459805457|FG002|Overall Study|Medication error without adverse event|1|||
127775452|NCT01284062|459805458|FG003|Overall Study|Medication error without adverse event|0|||
127775453|NCT01284062|459805455|FG000|Overall Study|Protocol Violation|1|||
127775454|NCT01284062|459805456|FG001|Overall Study|Protocol Violation|0|||
127775455|NCT01284062|459805457|FG002|Overall Study|Protocol Violation|0|||
127775456|NCT01284062|459805458|FG003|Overall Study|Protocol Violation|2|||
127775457|NCT01284062|459805455|FG000|Overall Study|Withdrawal by Subject|3|||
127775458|NCT01284062|459805456|FG001|Overall Study|Withdrawal by Subject|1|||
127775459|NCT01284062|459805457|FG002|Overall Study|Withdrawal by Subject|2|||
127775460|NCT01284062|459805458|FG003|Overall Study|Withdrawal by Subject|5|||
127775461|NCT01284062|459805455|FG000|Overall Study|Other|0|||
127775462|NCT01284062|459805456|FG001|Overall Study|Other|0|||
127775463|NCT01284062|459805457|FG002|Overall Study|Other|0|||
127775464|NCT01284062|459805458|FG003|Overall Study|Other|1|||
127775465|NCT01284062|459805455|FG000|Overall Study|Site Closed|0|||
127775466|NCT01284062|459805456|FG001|Overall Study|Site Closed|0|||
127775467|NCT01284062|459805457|FG002|Overall Study|Site Closed|1|||
127775468|NCT01284062|459805458|FG003|Overall Study|Site Closed|0|||
127775469|NCT02234323|459805459|FG000|All Enrolled|Not Treated: Completed study in database|2|||
127775470|NCT02234323|459805459|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
127775471|NCT02234323|459805459|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
127775472|NCT02234323|459805459|FG000|All Treated|Death|1|||
127775473|NCT02234323|459805459|FG000|All Treated|Physician Decision|5|||
127775474|NCT02234323|459805459|FG000|All Treated|Lack of Efficacy|3|||
127775475|NCT02234323|459805459|FG000|All Treated|Exceeded lab value limit|2|||
127775476|NCT02234323|459805459|FG000|All Treated|Other|7|||
127775477|NCT00559585|459805460|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
127775478|NCT00559585|459805461|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
127775479|NCT00559585|459805460|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
127775480|NCT00559585|459805461|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
127775481|NCT00559585|459805460|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
127775482|NCT00559585|459805461|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
127775483|NCT00559585|459805460|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
127775484|NCT00559585|459805461|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
127775485|NCT00559585|459805460|FG000|Double Blind ST Period Main Study|Death|1|||
127775486|NCT00559585|459805461|FG001|Double Blind ST Period Main Study|Death|1|||
127775487|NCT00559585|459805460|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
127775488|NCT00559585|459805461|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
127775489|NCT00559585|459805460|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
127775490|NCT00559585|459805461|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
127775491|NCT00559585|459805460|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
127775492|NCT00559585|459805461|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
127775493|NCT00559585|459805460|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
127775494|NCT00559585|459805461|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
127775495|NCT00559585|459805460|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
127775496|NCT00559585|459805461|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
127775497|NCT00559585|459805460|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
127775498|NCT00559585|459805461|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
128024343|NCT02181738|460714385|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
127775499|NCT00559585|459805460|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
127775500|NCT00559585|459805461|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
127775501|NCT00559585|459805460|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
127775502|NCT00559585|459805461|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
127775503|NCT00559585|459805460|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
127775504|NCT00559585|459805461|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
127775505|NCT00559585|459805460|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
127775506|NCT00559585|459805461|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
127775507|NCT00559585|459805460|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
127775508|NCT00559585|459805461|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
127775509|NCT00559585|459805460|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
127775510|NCT00559585|459805461|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
127775511|NCT00559585|459805460|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
127775512|NCT00559585|459805461|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
127775513|NCT00559585|459805460|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
127775514|NCT00559585|459805461|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
127775515|NCT00559585|459805460|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
127775516|NCT00559585|459805461|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
127775517|NCT00559585|459805460|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
127775518|NCT00559585|459805461|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
127775519|NCT00559585|459805460|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
127775520|NCT00559585|459805461|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
127775521|NCT00559585|459805460|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
127775522|NCT00559585|459805461|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
127775523|NCT00559585|459805460|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
127775524|NCT00559585|459805461|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
127775525|NCT00559585|459805460|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
127775526|NCT00559585|459805461|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
127775527|NCT00559585|459805460|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
127775528|NCT00559585|459805461|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
127775529|NCT00559585|459805460|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
127775530|NCT00559585|459805461|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
127775531|NCT00559585|459805460|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
127775532|NCT00559585|459805461|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
127775533|NCT02644941|459805462|FG000|18 Months|Subjects lost graft during the study up to the data cut-off|49|||
127775534|NCT02644941|459805463|FG001|18 Months|Subjects lost graft during the study up to the data cut-off|52|||
127775535|NCT04614662|459805464|FG000|Overall Study|Withdrawal by Subject|0|||
127775536|NCT04614662|459805465|FG001|Overall Study|Withdrawal by Subject|1|||
127775537|NCT01717768|459805469|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
127775538|NCT01717768|459805470|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
127775539|NCT01717768|459805471|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
127775540|NCT01717768|459805472|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
127775541|NCT01717768|459805473|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
127775542|NCT01717768|459805474|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
127775543|NCT01717768|459805475|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
127775544|NCT01717768|459805476|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
127775545|NCT01717768|459805477|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
127775546|NCT01717768|459805478|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
127775547|NCT01717768|459805479|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
127775548|NCT01717768|459805480|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
127775549|NCT01717768|459805469|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
127775550|NCT01717768|459805470|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
127775551|NCT01717768|459805471|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
127775552|NCT01717768|459805472|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
127775553|NCT01717768|459805473|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
127775554|NCT01717768|459805474|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
127775555|NCT01717768|459805475|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
127775556|NCT01717768|459805476|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
127775557|NCT01717768|459805477|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
127775558|NCT01717768|459805478|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
127775559|NCT01717768|459805479|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
127775560|NCT01717768|459805480|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
127775561|NCT01717768|459805469|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
127775562|NCT01717768|459805470|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
127775563|NCT01717768|459805471|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
127775564|NCT01717768|459805472|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
127775565|NCT01717768|459805473|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
128024344|NCT02181738|460714386|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
127560404|NCT05092360|459021694|FG001|Overall Study|Lost to Follow-up|2|||
127560405|NCT05092360|459021695|FG002|Overall Study|Lost to Follow-up|2|||
127560406|NCT05092360|459021696|FG003|Overall Study|Lost to Follow-up|2|||
127560407|NCT05092360|459021693|FG000|Overall Study|Study terminated by sponsor|65|||
127560408|NCT05092360|459021694|FG001|Overall Study|Study terminated by sponsor|7|||
127775566|NCT01717768|459805474|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
127775567|NCT01717768|459805475|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
127775568|NCT01717768|459805476|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
127775569|NCT01717768|459805477|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
127775570|NCT01717768|459805478|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
127775571|NCT01717768|459805479|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
127775572|NCT01717768|459805480|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
127775573|NCT01717768|459805469|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
127775574|NCT01717768|459805470|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
127775575|NCT01717768|459805471|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
127775576|NCT01717768|459805472|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
127775577|NCT01717768|459805473|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
127775578|NCT01717768|459805474|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
127775579|NCT01717768|459805475|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
127775580|NCT01717768|459805476|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
127775581|NCT01717768|459805477|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
127775582|NCT01717768|459805478|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
127775583|NCT01717768|459805479|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
127775584|NCT01717768|459805480|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
127775585|NCT04195581|459805483|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
127775586|NCT04195581|459805483|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
127775587|NCT04195581|459805483|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
127775588|NCT04195581|459805483|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
127775589|NCT04195581|459805483|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
127775590|NCT04195581|459805483|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
127775591|NCT01843218|459805488|FG000|Overall Study|Withdrawal by Subject|5|||
127775592|NCT01136811|459805489|FG000|Overall Study|Physician Decision|11|||
127775593|NCT01009554|459805490|FG000|Overall Study|Adverse Event|1|||
127775594|NCT01009554|459805491|FG001|Overall Study|Adverse Event|1|||
127775595|NCT01009554|459805490|FG000|Overall Study|Withdrawal by Subject|1|||
127775596|NCT01009554|459805491|FG001|Overall Study|Withdrawal by Subject|3|||
127775597|NCT01009554|459805490|FG000|Overall Study|Noncompliant with Study Product|0|||
127775598|NCT01009554|459805491|FG001|Overall Study|Noncompliant with Study Product|3|||
127775599|NCT01605253|459805492|FG000|Overall Study|Physician Decision|3|||
127775600|NCT01605253|459805493|FG001|Overall Study|Physician Decision|2|||
127775601|NCT01605253|459805492|FG000|Overall Study|Lost to Follow-up|3|||
127775602|NCT01605253|459805493|FG001|Overall Study|Lost to Follow-up|1|||
127775603|NCT01906346|459805498|FG000|Overall Study|AEs|1|||
127775604|NCT04226833|459805499|FG000|Overall Study|Death|0|||
127775605|NCT04226833|459805500|FG001|Overall Study|Death|0|||
127775606|NCT04226833|459805501|FG002|Overall Study|Death|1|||
127775607|NCT04226833|459805502|FG003|Overall Study|Death|0|||
127775608|NCT03231943|459805509|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
127775609|NCT03231943|459805510|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
127775610|NCT03231943|459805511|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
127775611|NCT03231943|459805512|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
127775612|NCT03231943|459805513|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
127775613|NCT03231943|459805514|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
127775614|NCT03231943|459805515|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
127775615|NCT03231943|459805516|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
127775616|NCT03231943|459805517|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
127775617|NCT03231943|459805518|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
127775618|NCT03231943|459805519|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
127775619|NCT03231943|459805520|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
127775620|NCT03231943|459805521|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
127775621|NCT03231943|459805509|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
127775622|NCT03231943|459805510|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
127775623|NCT03231943|459805511|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
127775624|NCT03231943|459805512|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
127775625|NCT03231943|459805513|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
127775626|NCT03231943|459805514|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
127775627|NCT03231943|459805515|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
127775628|NCT03231943|459805516|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
127775629|NCT03231943|459805517|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
127775630|NCT03231943|459805518|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
127775631|NCT03231943|459805519|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
127775632|NCT03231943|459805520|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
127560409|NCT05092360|459021695|FG002|Overall Study|Study terminated by sponsor|13|||
127687342|NCT03529110|459483491|FG001|Overall Study|Clinical Progression|12|||
127687343|NCT03529110|459483490|FG000|Overall Study|Adverse Event|35|||
127687344|NCT03529110|459483491|FG001|Overall Study|Adverse Event|17|||
127687345|NCT03529110|459483490|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
127687346|NCT03529110|459483491|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
127687347|NCT03529110|459483490|FG000|Overall Study|Lack of Efficacy|3|||
127687348|NCT03529110|459483491|FG001|Overall Study|Lack of Efficacy|3|||
127687349|NCT03529110|459483490|FG000|Overall Study|Physician Decision|2|||
127687350|NCT03529110|459483491|FG001|Overall Study|Physician Decision|8|||
127687351|NCT03529110|459483490|FG000|Overall Study|Miscellaneous|2|||
127687352|NCT03529110|459483491|FG001|Overall Study|Miscellaneous|5|||
127687353|NCT04922021|459483494|FG000|Overall Study|Withdrawal by Subject|4|||
127687354|NCT04922021|459483495|FG001|Overall Study|Withdrawal by Subject|10|||
127687355|NCT04922021|459483494|FG000|Overall Study|Adverse Event|2|||
127687356|NCT04922021|459483495|FG001|Overall Study|Adverse Event|2|||
127687357|NCT04922021|459483494|FG000|Overall Study|Lack of Efficacy|0|||
127687358|NCT04922021|459483495|FG001|Overall Study|Lack of Efficacy|1|||
127687359|NCT04922021|459483494|FG000|Overall Study|Multiple reasons|1|||
127687360|NCT04922021|459483495|FG001|Overall Study|Multiple reasons|0|||
127687361|NCT04139668|459483505|FG000|Overall Study|Withdrawal by Subject|1|||
127687362|NCT03025789|459483510|FG000|Overall Study|Lack of Efficacy|6|||
127687363|NCT03025789|459483511|FG001|Overall Study|Lack of Efficacy|1|||
127687364|NCT03025789|459483510|FG000|Overall Study|Death|1|||
127687365|NCT03025789|459483511|FG001|Overall Study|Death|0|||
127687366|NCT03025789|459483510|FG000|Overall Study|Withdrawal by Subject|0|||
127687367|NCT03025789|459483511|FG001|Overall Study|Withdrawal by Subject|2|||
127687368|NCT02723955|459483513|FG000|Escalation Phase|Death|1|||
127687369|NCT02723955|459483514|FG001|Escalation Phase|Death|1|||
127687370|NCT02723955|459483515|FG002|Escalation Phase|Death|2|||
127687371|NCT02723955|459483516|FG003|Escalation Phase|Death|7|||
127687372|NCT02723955|459483517|FG004|Escalation Phase|Death|18|||
127687373|NCT02723955|459483518|FG005|Escalation Phase|Death|17|||
127687374|NCT02723955|459483519|FG006|Escalation Phase|Death|11|||
127687375|NCT02723955|459483520|FG007|Escalation Phase|Death|21|||
127687376|NCT02723955|459483521|FG008|Escalation Phase|Death|3|||
127687377|NCT02723955|459483522|FG009|Escalation Phase|Death|0|||
127687378|NCT02723955|459483523|FG010|Escalation Phase|Death|0|||
127687379|NCT02723955|459483524|FG011|Escalation Phase|Death|0|||
127687380|NCT02723955|459483525|FG012|Escalation Phase|Death|2|||
127687381|NCT02723955|459483526|FG013|Escalation Phase|Death|4|||
127687382|NCT02723955|459483527|FG014|Escalation Phase|Death|5|||
127687383|NCT02723955|459483528|FG015|Escalation Phase|Death|6|||
127687384|NCT02723955|459483529|FG016|Escalation Phase|Death|6|||
127687385|NCT02723955|459483530|FG017|Escalation Phase|Death|7|||
127687386|NCT02723955|459483531|FG018|Escalation Phase|Death|1|||
127687387|NCT02723955|459483532|FG019|Escalation Phase|Death|3|||
127687388|NCT02723955|459483533|FG020|Escalation Phase|Death|13|||
127687389|NCT02723955|459483534|FG021|Escalation Phase|Death|3|||
127687390|NCT02723955|459483535|FG022|Escalation Phase|Death|2|||
127687391|NCT02723955|459483536|FG023|Escalation Phase|Death|4|||
127687392|NCT02723955|459483537|FG024|Escalation Phase|Death|31|||
127687393|NCT02723955|459483538|FG025|Escalation Phase|Death|7|||
127687394|NCT02723955|459483539|FG026|Escalation Phase|Death|13|||
127687395|NCT02723955|459483540|FG027|Escalation Phase|Death|0|||
127687396|NCT02723955|459483541|FG028|Escalation Phase|Death|1|||
127687397|NCT02723955|459483542|FG029|Escalation Phase|Death|0|||
127687398|NCT02723955|459483543|FG030|Escalation Phase|Death|0|||
127687399|NCT02723955|459483544|FG031|Escalation Phase|Death|0|||
127687400|NCT02723955|459483545|FG032|Escalation Phase|Death|0|||
127687401|NCT02723955|459483546|FG033|Escalation Phase|Death|0|||
127687402|NCT02723955|459483547|FG034|Escalation Phase|Death|0|||
127687403|NCT02723955|459483548|FG035|Escalation Phase|Death|0|||
127687404|NCT02723955|459483549|FG036|Escalation Phase|Death|0|||
127687405|NCT02723955|459483550|FG037|Escalation Phase|Death|0|||
127687406|NCT02723955|459483551|FG038|Escalation Phase|Death|0|||
127687407|NCT02723955|459483552|FG039|Escalation Phase|Death|0|||
127687408|NCT02723955|459483553|FG040|Escalation Phase|Death|0|||
127687409|NCT02723955|459483554|FG041|Escalation Phase|Death|0|||
127687410|NCT02723955|459483555|FG042|Escalation Phase|Death|0|||
127687411|NCT02723955|459483513|FG000|Escalation Phase|Lost to Follow-up|0|||
127687412|NCT02723955|459483514|FG001|Escalation Phase|Lost to Follow-up|0|||
127687413|NCT02723955|459483515|FG002|Escalation Phase|Lost to Follow-up|0|||
127687414|NCT02723955|459483516|FG003|Escalation Phase|Lost to Follow-up|0|||
127687415|NCT02723955|459483517|FG004|Escalation Phase|Lost to Follow-up|0|||
127687416|NCT02723955|459483518|FG005|Escalation Phase|Lost to Follow-up|2|||
127687417|NCT02723955|459483519|FG006|Escalation Phase|Lost to Follow-up|1|||
127687418|NCT02723955|459483520|FG007|Escalation Phase|Lost to Follow-up|1|||
127687419|NCT02723955|459483521|FG008|Escalation Phase|Lost to Follow-up|1|||
127687420|NCT02723955|459483522|FG009|Escalation Phase|Lost to Follow-up|0|||
127687421|NCT02723955|459483523|FG010|Escalation Phase|Lost to Follow-up|0|||
127687422|NCT02723955|459483524|FG011|Escalation Phase|Lost to Follow-up|0|||
127687423|NCT02723955|459483525|FG012|Escalation Phase|Lost to Follow-up|1|||
127687424|NCT02723955|459483526|FG013|Escalation Phase|Lost to Follow-up|0|||
127775633|NCT03231943|459805521|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
127775634|NCT03231943|459805509|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
127775635|NCT03231943|459805510|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
127775636|NCT03231943|459805511|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
127775637|NCT03231943|459805512|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
127775638|NCT03231943|459805513|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
127775639|NCT03231943|459805514|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
127775640|NCT03231943|459805515|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
127775641|NCT03231943|459805516|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
127775642|NCT03231943|459805517|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
127775643|NCT03231943|459805518|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
127775644|NCT03231943|459805519|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
127775645|NCT03231943|459805520|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
127775646|NCT03231943|459805521|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
127775647|NCT03231943|459805509|FG000|Part 2|Adverse Event|0|||
127775648|NCT03231943|459805510|FG001|Part 2|Adverse Event|0|||
127775649|NCT03231943|459805511|FG002|Part 2|Adverse Event|0|||
127775650|NCT03231943|459805512|FG003|Part 2|Adverse Event|0|||
127775651|NCT03231943|459805513|FG004|Part 2|Adverse Event|0|||
127775652|NCT03231943|459805514|FG005|Part 2|Adverse Event|0|||
127775653|NCT03231943|459805515|FG006|Part 2|Adverse Event|0|||
127775654|NCT03231943|459805516|FG007|Part 2|Adverse Event|0|||
127775655|NCT03231943|459805517|FG008|Part 2|Adverse Event|0|||
127775656|NCT03231943|459805518|FG009|Part 2|Adverse Event|0|||
127775657|NCT03231943|459805519|FG010|Part 2|Adverse Event|1|||
127775658|NCT03231943|459805520|FG011|Part 2|Adverse Event|0|||
127775659|NCT03231943|459805521|FG012|Part 2|Adverse Event|0|||
127775660|NCT03231943|459805509|FG000|Part 2|Withdrawal by Subject|0|||
127775661|NCT03231943|459805510|FG001|Part 2|Withdrawal by Subject|0|||
127775662|NCT03231943|459805511|FG002|Part 2|Withdrawal by Subject|0|||
127775663|NCT03231943|459805512|FG003|Part 2|Withdrawal by Subject|0|||
127775664|NCT03231943|459805513|FG004|Part 2|Withdrawal by Subject|0|||
127775665|NCT03231943|459805514|FG005|Part 2|Withdrawal by Subject|0|||
127775666|NCT03231943|459805515|FG006|Part 2|Withdrawal by Subject|0|||
127775667|NCT03231943|459805516|FG007|Part 2|Withdrawal by Subject|0|||
127775668|NCT03231943|459805517|FG008|Part 2|Withdrawal by Subject|0|||
127775669|NCT03231943|459805518|FG009|Part 2|Withdrawal by Subject|0|||
127775670|NCT03231943|459805519|FG010|Part 2|Withdrawal by Subject|0|||
127775671|NCT03231943|459805520|FG011|Part 2|Withdrawal by Subject|1|||
127775672|NCT03231943|459805521|FG012|Part 2|Withdrawal by Subject|0|||
127775673|NCT04824521|459805524|FG000|Overall Study|Lost to Follow-up|1|||
127775674|NCT03434353|459806669|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
127775675|NCT03434353|459806670|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
127775676|NCT03434353|459806671|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
127775677|NCT03434353|459806672|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
127775678|NCT03434353|459806673|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
127775679|NCT03434353|459806669|FG000|Overall Study|Withdrew consent|1|||
127775680|NCT03434353|459806670|FG001|Overall Study|Withdrew consent|0|||
127775681|NCT03434353|459806671|FG002|Overall Study|Withdrew consent|3|||
127775682|NCT03434353|459806672|FG003|Overall Study|Withdrew consent|0|||
127775683|NCT03434353|459806673|FG004|Overall Study|Withdrew consent|0|||
127775684|NCT03434353|459806669|FG000|Overall Study|Adverse Event|1|||
127775685|NCT03434353|459806670|FG001|Overall Study|Adverse Event|0|||
127775686|NCT03434353|459806671|FG002|Overall Study|Adverse Event|0|||
127775687|NCT03434353|459806672|FG003|Overall Study|Adverse Event|0|||
127775688|NCT03434353|459806673|FG004|Overall Study|Adverse Event|1|||
127775689|NCT03434353|459806669|FG000|Overall Study|Lost to Follow-up|2|||
127775690|NCT03434353|459806670|FG001|Overall Study|Lost to Follow-up|0|||
127775691|NCT03434353|459806671|FG002|Overall Study|Lost to Follow-up|0|||
127775692|NCT03434353|459806672|FG003|Overall Study|Lost to Follow-up|0|||
127775693|NCT03434353|459806673|FG004|Overall Study|Lost to Follow-up|0|||
127775694|NCT01990534|459806676|FG000|Overall Study|Death|22|||
127775695|NCT01990534|459806676|FG000|Overall Study|Progressive disease|3|||
127775696|NCT01990534|459806676|FG000|Overall Study|Protocol Violation|1|||
127775697|NCT01990534|459806676|FG000|Overall Study|Withdrawal of Informed Consent|2|||
127775698|NCT01990534|459806676|FG000|Overall Study|Symptomatic Deterioration|1|||
127775699|NCT01990534|459806676|FG000|Overall Study|Withdrawal by Subject|3|||
127775700|NCT01990534|459806676|FG000|Overall Study|Reason not Specified|2|||
127775701|NCT01990534|459806676|FG000|Overall Study|Lost to Follow-up|1|||
127775702|NCT00234494|459806677|FG000|Overall Study|Protocol Violation|2|||
127775703|NCT01831544|459806680|FG000|Overall Study|Death|1|||
127775704|NCT01831544|459806680|FG000|Overall Study|Still on original MVAD device|2|||
127775705|NCT01521897|459806683|FG000|Overall Study|Protocol Violation|18|||
127775706|NCT01521897|459806683|FG000|Overall Study|Lost to Follow-up|5|||
127775707|NCT02194062|459806690|FG000|Overall Study|Lost to Follow-up|2|||
127775708|NCT02194062|459806691|FG001|Overall Study|Lost to Follow-up|2|||
127775709|NCT02194062|459806692|FG002|Overall Study|Lost to Follow-up|5|||
127775710|NCT02276872|459806693|FG000|Overall Study|Adverse Event|1|||
127775711|NCT02276872|459806694|FG001|Overall Study|Adverse Event|0|||
127775712|NCT02276872|459806695|FG002|Overall Study|Adverse Event|0|||
127775713|NCT02021292|459806699|FG000|Overall Study|Physician Decision|0|||
127775714|NCT02021292|459806700|FG001|Overall Study|Physician Decision|1|||
127775715|NCT02021292|459806699|FG000|Overall Study|Lost to Follow-up|0|||
127775716|NCT02021292|459806700|FG001|Overall Study|Lost to Follow-up|1|||
127775717|NCT02021292|459806699|FG000|Overall Study|Death|0|||
127775718|NCT02021292|459806700|FG001|Overall Study|Death|1|||
127775719|NCT04147234|459806701|FG000|Overall Study|Clinical deterioration|0|||
127775720|NCT04147234|459806702|FG001|Overall Study|Clinical deterioration|0|||
127775721|NCT04147234|459806703|FG002|Overall Study|Clinical deterioration|1|||
127775722|NCT04147234|459806704|FG003|Overall Study|Clinical deterioration|0|||
127775723|NCT04147234|459806705|FG004|Overall Study|Clinical deterioration|0|||
127775724|NCT04147234|459806706|FG005|Overall Study|Clinical deterioration|0|||
127775725|NCT04147234|459806707|FG006|Overall Study|Clinical deterioration|0|||
127775726|NCT04147234|459806701|FG000|Overall Study|Withdrawal by Subject|0|||
127775727|NCT04147234|459806702|FG001|Overall Study|Withdrawal by Subject|1|||
127775728|NCT04147234|459806703|FG002|Overall Study|Withdrawal by Subject|1|||
127775729|NCT04147234|459806704|FG003|Overall Study|Withdrawal by Subject|0|||
127775730|NCT04147234|459806705|FG004|Overall Study|Withdrawal by Subject|0|||
127775731|NCT04147234|459806706|FG005|Overall Study|Withdrawal by Subject|0|||
127775732|NCT04147234|459806707|FG006|Overall Study|Withdrawal by Subject|0|||
127775733|NCT04147234|459806701|FG000|Overall Study|Clinical disease progression|1|||
127775734|NCT04147234|459806702|FG001|Overall Study|Clinical disease progression|3|||
127775735|NCT04147234|459806703|FG002|Overall Study|Clinical disease progression|1|||
127775736|NCT04147234|459806704|FG003|Overall Study|Clinical disease progression|1|||
127775737|NCT04147234|459806705|FG004|Overall Study|Clinical disease progression|0|||
127775738|NCT04147234|459806706|FG005|Overall Study|Clinical disease progression|1|||
127775739|NCT04147234|459806707|FG006|Overall Study|Clinical disease progression|0|||
127775740|NCT04147234|459806701|FG000|Overall Study|Objective disease progression|6|||
127775741|NCT04147234|459806702|FG001|Overall Study|Objective disease progression|4|||
127775742|NCT04147234|459806703|FG002|Overall Study|Objective disease progression|3|||
127775743|NCT04147234|459806704|FG003|Overall Study|Objective disease progression|3|||
127775744|NCT04147234|459806705|FG004|Overall Study|Objective disease progression|5|||
127775745|NCT04147234|459806706|FG005|Overall Study|Objective disease progression|2|||
127775746|NCT04147234|459806707|FG006|Overall Study|Objective disease progression|3|||
127775747|NCT04147234|459806701|FG000|Overall Study|Adverse Event|0|||
127775748|NCT04147234|459806702|FG001|Overall Study|Adverse Event|0|||
127775749|NCT04147234|459806703|FG002|Overall Study|Adverse Event|0|||
127775750|NCT04147234|459806704|FG003|Overall Study|Adverse Event|0|||
127775751|NCT04147234|459806705|FG004|Overall Study|Adverse Event|1|||
127775752|NCT04147234|459806706|FG005|Overall Study|Adverse Event|0|||
127775753|NCT04147234|459806707|FG006|Overall Study|Adverse Event|0|||
127775754|NCT05972733|459806708|FG000|Overall Study|Lost to Follow-up|2|||
127775755|NCT05972733|459806708|FG000|Overall Study|Withdrawal by Subject|1|||
127775756|NCT04982588|459806711|FG000|Overall Study|Withdrawal by Subject|2|||
127775757|NCT02366728|459806712|FG000|Overall Study|Death|0|||
127775758|NCT02366728|459806713|FG001|Overall Study|Death|0|||
127775759|NCT02366728|459806714|FG002|Overall Study|Death|1|||
127775760|NCT02366728|459806712|FG000|Overall Study|Adverse Event|1|||
127775761|NCT02366728|459806713|FG001|Overall Study|Adverse Event|0|||
127775762|NCT02366728|459806714|FG002|Overall Study|Adverse Event|0|||
127775763|NCT02366728|459806712|FG000|Overall Study|Screen Failure|2|||
127775764|NCT02366728|459806713|FG001|Overall Study|Screen Failure|1|||
127775765|NCT02366728|459806714|FG002|Overall Study|Screen Failure|0|||
127775766|NCT02366728|459806712|FG000|Overall Study|Only yielded 2 vaccines|1|||
127775767|NCT02366728|459806713|FG001|Overall Study|Only yielded 2 vaccines|0|||
127775768|NCT02366728|459806714|FG002|Overall Study|Only yielded 2 vaccines|0|||
127775769|NCT00992511|459806716|FG000|Overall Study|Migrated/moved from study area|1|||
128024345|NCT02181738|460714387|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
128024346|NCT02181738|460714384|FG000|Overall Study|Poor/Non-Compliance|1|||
128024347|NCT02181738|460714385|FG001|Overall Study|Poor/Non-Compliance|0|||
128024348|NCT02181738|460714386|FG002|Overall Study|Poor/Non-Compliance|2|||
127775770|NCT00992511|459806717|FG001|Overall Study|Migrated/moved from study area|0|||
127775771|NCT00992511|459806718|FG002|Overall Study|Migrated/moved from study area|1|||
127775772|NCT00992511|459806719|FG003|Overall Study|Migrated/moved from study area|2|||
127775773|NCT00992511|459806716|FG000|Overall Study|Lost to Follow-up|1|||
127775774|NCT00992511|459806717|FG001|Overall Study|Lost to Follow-up|0|||
127775775|NCT00992511|459806718|FG002|Overall Study|Lost to Follow-up|0|||
128024349|NCT02181738|460714387|FG003|Overall Study|Poor/Non-Compliance|1|||
128024350|NCT02181738|460714384|FG000|Overall Study|Disease Progression|28|||
127775776|NCT00992511|459806719|FG003|Overall Study|Lost to Follow-up|2|||
127775777|NCT00992511|459806716|FG000|Overall Study|Withdrawal by Subject|0|||
127775778|NCT00992511|459806717|FG001|Overall Study|Withdrawal by Subject|0|||
127775779|NCT00992511|459806718|FG002|Overall Study|Withdrawal by Subject|1|||
128024351|NCT02181738|460714385|FG001|Overall Study|Disease Progression|35|||
128024352|NCT02181738|460714386|FG002|Overall Study|Disease Progression|40|||
127687425|NCT02723955|459483527|FG014|Escalation Phase|Lost to Follow-up|0|||
127687426|NCT02723955|459483528|FG015|Escalation Phase|Lost to Follow-up|0|||
127687427|NCT02723955|459483529|FG016|Escalation Phase|Lost to Follow-up|1|||
127687428|NCT02723955|459483530|FG017|Escalation Phase|Lost to Follow-up|2|||
127687429|NCT02723955|459483531|FG018|Escalation Phase|Lost to Follow-up|0|||
127687430|NCT02723955|459483532|FG019|Escalation Phase|Lost to Follow-up|1|||
127687431|NCT02723955|459483533|FG020|Escalation Phase|Lost to Follow-up|2|||
127687432|NCT02723955|459483534|FG021|Escalation Phase|Lost to Follow-up|1|||
127687433|NCT02723955|459483535|FG022|Escalation Phase|Lost to Follow-up|0|||
127687434|NCT02723955|459483536|FG023|Escalation Phase|Lost to Follow-up|0|||
127687435|NCT02723955|459483537|FG024|Escalation Phase|Lost to Follow-up|1|||
127687436|NCT02723955|459483538|FG025|Escalation Phase|Lost to Follow-up|1|||
127687437|NCT02723955|459483539|FG026|Escalation Phase|Lost to Follow-up|3|||
127687438|NCT02723955|459483540|FG027|Escalation Phase|Lost to Follow-up|0|||
127687439|NCT02723955|459483541|FG028|Escalation Phase|Lost to Follow-up|1|||
127687440|NCT02723955|459483542|FG029|Escalation Phase|Lost to Follow-up|0|||
127687441|NCT02723955|459483543|FG030|Escalation Phase|Lost to Follow-up|0|||
127687442|NCT02723955|459483544|FG031|Escalation Phase|Lost to Follow-up|0|||
127687443|NCT02723955|459483545|FG032|Escalation Phase|Lost to Follow-up|0|||
127687444|NCT02723955|459483546|FG033|Escalation Phase|Lost to Follow-up|0|||
127687445|NCT02723955|459483547|FG034|Escalation Phase|Lost to Follow-up|0|||
127687446|NCT02723955|459483548|FG035|Escalation Phase|Lost to Follow-up|0|||
127687447|NCT02723955|459483549|FG036|Escalation Phase|Lost to Follow-up|0|||
127687448|NCT02723955|459483550|FG037|Escalation Phase|Lost to Follow-up|0|||
127687449|NCT02723955|459483551|FG038|Escalation Phase|Lost to Follow-up|0|||
127687450|NCT02723955|459483552|FG039|Escalation Phase|Lost to Follow-up|0|||
127687451|NCT02723955|459483553|FG040|Escalation Phase|Lost to Follow-up|0|||
127687452|NCT02723955|459483554|FG041|Escalation Phase|Lost to Follow-up|0|||
127687453|NCT02723955|459483555|FG042|Escalation Phase|Lost to Follow-up|0|||
127687454|NCT02723955|459483513|FG000|Escalation Phase|Physician Decision|0|||
127687455|NCT02723955|459483514|FG001|Escalation Phase|Physician Decision|0|||
127687456|NCT02723955|459483515|FG002|Escalation Phase|Physician Decision|0|||
127687457|NCT02723955|459483516|FG003|Escalation Phase|Physician Decision|0|||
127687458|NCT02723955|459483517|FG004|Escalation Phase|Physician Decision|0|||
127687459|NCT02723955|459483518|FG005|Escalation Phase|Physician Decision|2|||
127687460|NCT02723955|459483519|FG006|Escalation Phase|Physician Decision|0|||
127687461|NCT02723955|459483520|FG007|Escalation Phase|Physician Decision|0|||
127687462|NCT02723955|459483521|FG008|Escalation Phase|Physician Decision|0|||
127687463|NCT02723955|459483522|FG009|Escalation Phase|Physician Decision|0|||
127687464|NCT02723955|459483523|FG010|Escalation Phase|Physician Decision|0|||
127687465|NCT02723955|459483524|FG011|Escalation Phase|Physician Decision|0|||
127775780|NCT00992511|459806719|FG003|Overall Study|Withdrawal by Subject|1|||
127775781|NCT04498169|459806720|FG000|Study Completion|Adverse Event|1|||
127775782|NCT04498169|459806721|FG001|Study Completion|Adverse Event|1|||
127775783|NCT04615247|459806722|FG000|Overall Study|Adverse Event|0|||
127775784|NCT04615247|459806723|FG001|Overall Study|Adverse Event|2|||
127775785|NCT04615247|459806722|FG000|Overall Study|Withdrawal by Subject|1|||
127775786|NCT04615247|459806723|FG001|Overall Study|Withdrawal by Subject|1|||
127775787|NCT02596620|459806728|FG000|Overall Study|Lost to Follow-up|1|||
127775788|NCT02596620|459806729|FG001|Overall Study|Lost to Follow-up|1|||
127775789|NCT00448435|459806730|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
127775790|NCT00448435|459806731|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
127775791|NCT01387230|459806732|FG000|Overall Study|Adverse Event|0|||
127775792|NCT01387230|459806733|FG001|Overall Study|Adverse Event|1|||
127775793|NCT01387230|459806734|FG002|Overall Study|Adverse Event|3|||
127775794|NCT01387230|459806732|FG000|Overall Study|Lack of Efficacy|8|||
127775795|NCT01387230|459806733|FG001|Overall Study|Lack of Efficacy|5|||
127775796|NCT01387230|459806734|FG002|Overall Study|Lack of Efficacy|4|||
127687466|NCT02723955|459483525|FG012|Escalation Phase|Physician Decision|0|||
127687467|NCT02723955|459483526|FG013|Escalation Phase|Physician Decision|0|||
127775797|NCT01387230|459806732|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
128024353|NCT02181738|460714387|FG003|Overall Study|Disease Progression|0|||
127687468|NCT02723955|459483527|FG014|Escalation Phase|Physician Decision|0|||
127687469|NCT02723955|459483528|FG015|Escalation Phase|Physician Decision|0|||
127687470|NCT02723955|459483529|FG016|Escalation Phase|Physician Decision|0|||
127687471|NCT02723955|459483530|FG017|Escalation Phase|Physician Decision|0|||
127687472|NCT02723955|459483531|FG018|Escalation Phase|Physician Decision|0|||
127687473|NCT02723955|459483532|FG019|Escalation Phase|Physician Decision|0|||
127687474|NCT02723955|459483533|FG020|Escalation Phase|Physician Decision|0|||
127687475|NCT02723955|459483534|FG021|Escalation Phase|Physician Decision|0|||
127687476|NCT02723955|459483535|FG022|Escalation Phase|Physician Decision|0|||
127687477|NCT02723955|459483536|FG023|Escalation Phase|Physician Decision|0|||
127775798|NCT01387230|459806733|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
127775799|NCT01387230|459806734|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
127775800|NCT01387230|459806732|FG000|Overall Study|Lost to Follow-up|0|||
127775801|NCT01387230|459806733|FG001|Overall Study|Lost to Follow-up|0|||
127560410|NCT05092360|459021696|FG003|Overall Study|Study terminated by sponsor|61|||
127560411|NCT00966875|459023467|FG000|Part A|Adverse Event|2|||
127560412|NCT00966875|459023468|FG001|Part A|Adverse Event|1|||
127560413|NCT00966875|459023469|FG002|Part A|Adverse Event|0|||
127560414|NCT00966875|459023470|FG003|Part A|Adverse Event|1|||
127560415|NCT00966875|459023471|FG004|Part A|Adverse Event|0|||
127560416|NCT00966875|459023472|FG005|Part A|Adverse Event|1|||
127560417|NCT00966875|459023473|FG006|Part A|Adverse Event|0|||
127560418|NCT00966875|459023474|FG007|Part A|Adverse Event|3|||
127560419|NCT00966875|459023475|FG008|Part A|Adverse Event|3|||
127560420|NCT00966875|459023467|FG000|Part A|Entry Criteria|0|||
127687478|NCT02723955|459483537|FG024|Escalation Phase|Physician Decision|0|||
127687479|NCT02723955|459483538|FG025|Escalation Phase|Physician Decision|0|||
127687480|NCT02723955|459483539|FG026|Escalation Phase|Physician Decision|2|||
127687481|NCT02723955|459483540|FG027|Escalation Phase|Physician Decision|0|||
127687482|NCT02723955|459483541|FG028|Escalation Phase|Physician Decision|0|||
128024354|NCT02181738|460714384|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
128024355|NCT02181738|460714385|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
127560421|NCT00966875|459023468|FG001|Part A|Entry Criteria|0|||
127560422|NCT00966875|459023469|FG002|Part A|Entry Criteria|0|||
127560423|NCT00966875|459023470|FG003|Part A|Entry Criteria|0|||
127687483|NCT02723955|459483542|FG029|Escalation Phase|Physician Decision|0|||
127687484|NCT02723955|459483543|FG030|Escalation Phase|Physician Decision|0|||
127687485|NCT02723955|459483544|FG031|Escalation Phase|Physician Decision|0|||
128024356|NCT02181738|460714386|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
128024357|NCT02181738|460714387|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
128024358|NCT02181738|460714384|FG000|Overall Study|Study Drug Toxicity|6|||
128024359|NCT02181738|460714385|FG001|Overall Study|Study Drug Toxicity|11|||
128024360|NCT02181738|460714386|FG002|Overall Study|Study Drug Toxicity|8|||
127560424|NCT00966875|459023471|FG004|Part A|Entry Criteria|0|||
127560425|NCT00966875|459023472|FG005|Part A|Entry Criteria|2|||
127560426|NCT00966875|459023473|FG006|Part A|Entry Criteria|0|||
127560427|NCT00966875|459023474|FG007|Part A|Entry Criteria|0|||
127560428|NCT00966875|459023475|FG008|Part A|Entry Criteria|0|||
127560429|NCT00966875|459023467|FG000|Part A|Lack of Efficacy|0|||
127687486|NCT02723955|459483545|FG032|Escalation Phase|Physician Decision|0|||
127687487|NCT02723955|459483546|FG033|Escalation Phase|Physician Decision|0|||
127687488|NCT02723955|459483547|FG034|Escalation Phase|Physician Decision|0|||
127687489|NCT02723955|459483548|FG035|Escalation Phase|Physician Decision|0|||
127687490|NCT02723955|459483549|FG036|Escalation Phase|Physician Decision|0|||
127687491|NCT02723955|459483550|FG037|Escalation Phase|Physician Decision|0|||
127687492|NCT02723955|459483551|FG038|Escalation Phase|Physician Decision|0|||
127687493|NCT02723955|459483552|FG039|Escalation Phase|Physician Decision|0|||
127687494|NCT02723955|459483553|FG040|Escalation Phase|Physician Decision|0|||
127687495|NCT02723955|459483554|FG041|Escalation Phase|Physician Decision|0|||
127687496|NCT02723955|459483555|FG042|Escalation Phase|Physician Decision|0|||
127687497|NCT02723955|459483513|FG000|Escalation Phase|Withdrawal by Subject|0|||
127687498|NCT02723955|459483514|FG001|Escalation Phase|Withdrawal by Subject|0|||
127687499|NCT02723955|459483515|FG002|Escalation Phase|Withdrawal by Subject|0|||
127687500|NCT02723955|459483516|FG003|Escalation Phase|Withdrawal by Subject|0|||
127687501|NCT02723955|459483517|FG004|Escalation Phase|Withdrawal by Subject|1|||
127687502|NCT02723955|459483518|FG005|Escalation Phase|Withdrawal by Subject|1|||
127687503|NCT02723955|459483519|FG006|Escalation Phase|Withdrawal by Subject|1|||
127687504|NCT02723955|459483520|FG007|Escalation Phase|Withdrawal by Subject|1|||
127687505|NCT02723955|459483521|FG008|Escalation Phase|Withdrawal by Subject|0|||
127687506|NCT02723955|459483522|FG009|Escalation Phase|Withdrawal by Subject|0|||
127687507|NCT02723955|459483523|FG010|Escalation Phase|Withdrawal by Subject|0|||
127687508|NCT02723955|459483524|FG011|Escalation Phase|Withdrawal by Subject|0|||
127687509|NCT02723955|459483525|FG012|Escalation Phase|Withdrawal by Subject|1|||
127687510|NCT02723955|459483526|FG013|Escalation Phase|Withdrawal by Subject|0|||
127687511|NCT02723955|459483527|FG014|Escalation Phase|Withdrawal by Subject|0|||
127687512|NCT02723955|459483528|FG015|Escalation Phase|Withdrawal by Subject|0|||
127687513|NCT02723955|459483529|FG016|Escalation Phase|Withdrawal by Subject|1|||
127687514|NCT02723955|459483530|FG017|Escalation Phase|Withdrawal by Subject|0|||
127687515|NCT02723955|459483531|FG018|Escalation Phase|Withdrawal by Subject|0|||
127687516|NCT02723955|459483532|FG019|Escalation Phase|Withdrawal by Subject|0|||
127687517|NCT02723955|459483533|FG020|Escalation Phase|Withdrawal by Subject|0|||
127687518|NCT02723955|459483534|FG021|Escalation Phase|Withdrawal by Subject|0|||
127687519|NCT02723955|459483535|FG022|Escalation Phase|Withdrawal by Subject|0|||
127687520|NCT02723955|459483536|FG023|Escalation Phase|Withdrawal by Subject|2|||
127687521|NCT02723955|459483537|FG024|Escalation Phase|Withdrawal by Subject|0|||
127687522|NCT02723955|459483538|FG025|Escalation Phase|Withdrawal by Subject|1|||
127687523|NCT02723955|459483539|FG026|Escalation Phase|Withdrawal by Subject|0|||
127687524|NCT02723955|459483540|FG027|Escalation Phase|Withdrawal by Subject|0|||
127687525|NCT02723955|459483541|FG028|Escalation Phase|Withdrawal by Subject|1|||
127687526|NCT02723955|459483542|FG029|Escalation Phase|Withdrawal by Subject|0|||
127687527|NCT02723955|459483543|FG030|Escalation Phase|Withdrawal by Subject|0|||
128024361|NCT02181738|460714387|FG003|Overall Study|Study Drug Toxicity|1|||
128024362|NCT02181738|460714384|FG000|Overall Study|Other Reasons|14|||
128024363|NCT02181738|460714385|FG001|Overall Study|Other Reasons|16|||
128024364|NCT02181738|460714386|FG002|Overall Study|Other Reasons|28|||
128024365|NCT02181738|460714387|FG003|Overall Study|Other Reasons|0|||
128024366|NCT02181738|460714384|FG000|Overall Study|Maximum Clinical Benefit|3|||
128024367|NCT02181738|460714385|FG001|Overall Study|Maximum Clinical Benefit|0|||
128024368|NCT02181738|460714386|FG002|Overall Study|Maximum Clinical Benefit|1|||
128024369|NCT02181738|460714387|FG003|Overall Study|Maximum Clinical Benefit|0|||
128024370|NCT02181738|460714384|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
128024371|NCT02181738|460714385|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
128024372|NCT02181738|460714386|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
128024373|NCT02181738|460714387|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
128024374|NCT01691482|460714391|FG000|Treatment Period 2|Adverse Event|0|||
128024375|NCT01691482|460714392|FG001|Treatment Period 2|Adverse Event|1|||
128024376|NCT01691482|460714391|FG000|Treatment Period 2|Protocol Violation|1|||
128024377|NCT01691482|460714392|FG001|Treatment Period 2|Protocol Violation|1|||
128024378|NCT00395512|460714393|FG000|Overall Study|Adverse Event|3|||
128024379|NCT00395512|460714394|FG001|Overall Study|Adverse Event|8|||
127560430|NCT00966875|459023468|FG001|Part A|Lack of Efficacy|1|||
127560431|NCT00966875|459023469|FG002|Part A|Lack of Efficacy|0|||
127560432|NCT00966875|459023470|FG003|Part A|Lack of Efficacy|0|||
127560433|NCT00966875|459023471|FG004|Part A|Lack of Efficacy|0|||
127560434|NCT00966875|459023472|FG005|Part A|Lack of Efficacy|0|||
127560435|NCT00966875|459023473|FG006|Part A|Lack of Efficacy|4|||
127560436|NCT00966875|459023474|FG007|Part A|Lack of Efficacy|0|||
127560437|NCT00966875|459023475|FG008|Part A|Lack of Efficacy|0|||
127560438|NCT00966875|459023467|FG000|Part A|Lost to Follow-up|2|||
127560439|NCT00966875|459023468|FG001|Part A|Lost to Follow-up|0|||
127560440|NCT00966875|459023469|FG002|Part A|Lost to Follow-up|0|||
127560441|NCT00966875|459023470|FG003|Part A|Lost to Follow-up|0|||
127560442|NCT00966875|459023471|FG004|Part A|Lost to Follow-up|0|||
127560443|NCT00966875|459023472|FG005|Part A|Lost to Follow-up|1|||
127560444|NCT00966875|459023473|FG006|Part A|Lost to Follow-up|0|||
127560445|NCT00966875|459023474|FG007|Part A|Lost to Follow-up|0|||
127560446|NCT00966875|459023475|FG008|Part A|Lost to Follow-up|0|||
127560447|NCT00966875|459023467|FG000|Part A|Parent/Caregiver Decision|0|||
127560448|NCT00966875|459023468|FG001|Part A|Parent/Caregiver Decision|0|||
127560449|NCT00966875|459023469|FG002|Part A|Parent/Caregiver Decision|0|||
127560450|NCT00966875|459023470|FG003|Part A|Parent/Caregiver Decision|1|||
127560451|NCT00966875|459023471|FG004|Part A|Parent/Caregiver Decision|0|||
127775802|NCT01387230|459806734|FG002|Overall Study|Lost to Follow-up|1|||
127775803|NCT01387230|459806732|FG000|Overall Study|Withdrawal by Subject|4|||
127775804|NCT01387230|459806733|FG001|Overall Study|Withdrawal by Subject|1|||
127775805|NCT01387230|459806734|FG002|Overall Study|Withdrawal by Subject|0|||
127775806|NCT02066051|459806737|FG000|Overall Study|Subject developed active GVHD|1|||
127775807|NCT03027557|459806743|FG000|Overall Study|Adverse Event|1|||
127775808|NCT03027557|459806744|FG001|Overall Study|Adverse Event|0|||
127775809|NCT03027557|459806745|FG002|Overall Study|Adverse Event|0|||
127775810|NCT01610687|459806746|FG000|Overall Study|Lack of Efficacy|26|||
127775811|NCT01610687|459806746|FG000|Overall Study|Adverse Event|18|||
127775812|NCT01610687|459806746|FG000|Overall Study|Moved out of area|6|||
127775813|NCT01610687|459806746|FG000|Overall Study|Withdrawal by Subject|7|||
127775814|NCT01610687|459806746|FG000|Overall Study|Lost to Follow-up|4|||
127775815|NCT01610687|459806746|FG000|Overall Study|Symptom control without study medication|2|||
127775816|NCT01610687|459806746|FG000|Overall Study|Unable to make journey|1|||
127775817|NCT01610687|459806746|FG000|Overall Study|Death|1|||
127775818|NCT01610687|459806746|FG000|Overall Study|Cannabis affecting job|1|||
127775819|NCT01610687|459806746|FG000|Overall Study|Felt more alter without study medication|1|||
127775820|NCT03836807|459806747|FG000|Overall Study|Physician Decision|1|||
127775821|NCT03836807|459806748|FG001|Overall Study|Physician Decision|0|||
127775822|NCT02430051|459806749|FG000|Overall Study|Withdrawal by Subject|6|||
127775823|NCT02430051|459806750|FG001|Overall Study|Withdrawal by Subject|3|||
127775824|NCT02430051|459806749|FG000|Overall Study|Dropped due to not meeting scheduling requirements|6|||
127775825|NCT02430051|459806750|FG001|Overall Study|Dropped due to not meeting scheduling requirements|9|||
127775826|NCT02430051|459806749|FG000|Overall Study|Protocol Violation|1|||
127775827|NCT02430051|459806750|FG001|Overall Study|Protocol Violation|0|||
127775828|NCT05579990|459806763|FG000|Overall Study|Lost to Follow-up|3|||
127775829|NCT02408861|459806764|FG000|Overall Study|Death|0|||
127775830|NCT02408861|459806765|FG001|Overall Study|Death|3|||
127775831|NCT02408861|459806766|FG002|Overall Study|Death|1|||
127775832|NCT02408861|459806767|FG003|Overall Study|Death|2|||
127775833|NCT02408861|459806768|FG004|Overall Study|Death|4|||
127775834|NCT02408861|459806769|FG005|Overall Study|Death|1|||
127775835|NCT02408861|459806770|FG006|Overall Study|Death|0|||
127775836|NCT02408861|459806764|FG000|Overall Study|Lost to Follow-up|0|||
127775837|NCT02408861|459806765|FG001|Overall Study|Lost to Follow-up|0|||
127775838|NCT02408861|459806766|FG002|Overall Study|Lost to Follow-up|1|||
127775839|NCT02408861|459806767|FG003|Overall Study|Lost to Follow-up|1|||
127775840|NCT02408861|459806768|FG004|Overall Study|Lost to Follow-up|4|||
127775841|NCT02408861|459806769|FG005|Overall Study|Lost to Follow-up|2|||
127775842|NCT02408861|459806770|FG006|Overall Study|Lost to Follow-up|1|||
127775843|NCT02408861|459806764|FG000|Overall Study|Disease Progression|0|||
127560452|NCT00966875|459023472|FG005|Part A|Parent/Caregiver Decision|0|||
127560453|NCT00966875|459023473|FG006|Part A|Parent/Caregiver Decision|0|||
127560454|NCT00966875|459023474|FG007|Part A|Parent/Caregiver Decision|0|||
127560455|NCT00966875|459023475|FG008|Part A|Parent/Caregiver Decision|0|||
127560456|NCT00966875|459023467|FG000|Part A|Physician Decision|0|||
127775844|NCT02408861|459806765|FG001|Overall Study|Disease Progression|0|||
127775845|NCT02408861|459806766|FG002|Overall Study|Disease Progression|1|||
127775846|NCT02408861|459806767|FG003|Overall Study|Disease Progression|0|||
127775847|NCT02408861|459806768|FG004|Overall Study|Disease Progression|3|||
127560457|NCT00966875|459023468|FG001|Part A|Physician Decision|0|||
127560458|NCT00966875|459023469|FG002|Part A|Physician Decision|0|||
127775848|NCT02408861|459806769|FG005|Overall Study|Disease Progression|1|||
127775849|NCT02408861|459806770|FG006|Overall Study|Disease Progression|1|||
127775850|NCT02408861|459806764|FG000|Overall Study|Adverse Event|1|||
127560459|NCT00966875|459023470|FG003|Part A|Physician Decision|0|||
127560460|NCT00966875|459023471|FG004|Part A|Physician Decision|1|||
127560461|NCT00966875|459023472|FG005|Part A|Physician Decision|0|||
127560462|NCT00966875|459023473|FG006|Part A|Physician Decision|1|||
127560463|NCT00966875|459023474|FG007|Part A|Physician Decision|0|||
128024380|NCT00395512|460714395|FG002|Overall Study|Adverse Event|6|||
128024381|NCT00395512|460714396|FG003|Overall Study|Adverse Event|6|||
127560464|NCT00966875|459023475|FG008|Part A|Physician Decision|2|||
127560465|NCT00966875|459023467|FG000|Part A|Sponsor Decision|0|||
127560466|NCT00966875|459023468|FG001|Part A|Sponsor Decision|0|||
127560467|NCT00966875|459023469|FG002|Part A|Sponsor Decision|1|||
127560468|NCT00966875|459023470|FG003|Part A|Sponsor Decision|0|||
127560469|NCT00966875|459023471|FG004|Part A|Sponsor Decision|1|||
127560470|NCT00966875|459023472|FG005|Part A|Sponsor Decision|0|||
127560471|NCT00966875|459023473|FG006|Part A|Sponsor Decision|0|||
127560472|NCT00966875|459023474|FG007|Part A|Sponsor Decision|2|||
127560473|NCT00966875|459023475|FG008|Part A|Sponsor Decision|1|||
127560474|NCT00966875|459023467|FG000|Part A|Withdrawal by Subject|2|||
127560475|NCT00966875|459023468|FG001|Part A|Withdrawal by Subject|2|||
128024382|NCT00395512|460714393|FG000|Overall Study|Protocol Violation|2|||
128024383|NCT00395512|460714394|FG001|Overall Study|Protocol Violation|3|||
128024384|NCT00395512|460714395|FG002|Overall Study|Protocol Violation|6|||
128024385|NCT00395512|460714396|FG003|Overall Study|Protocol Violation|7|||
128024386|NCT00395512|460714393|FG000|Overall Study|Lost to Follow-up|2|||
128024387|NCT00395512|460714394|FG001|Overall Study|Lost to Follow-up|6|||
128024388|NCT00395512|460714395|FG002|Overall Study|Lost to Follow-up|5|||
128024389|NCT00395512|460714396|FG003|Overall Study|Lost to Follow-up|5|||
128024390|NCT00395512|460714393|FG000|Overall Study|Withdrawal by Subject|6|||
128024391|NCT00395512|460714394|FG001|Overall Study|Withdrawal by Subject|5|||
128024392|NCT00395512|460714395|FG002|Overall Study|Withdrawal by Subject|5|||
128024393|NCT00395512|460714396|FG003|Overall Study|Withdrawal by Subject|12|||
128024394|NCT00395512|460714393|FG000|Overall Study|Physician Decision|6|||
128024395|NCT00395512|460714394|FG001|Overall Study|Physician Decision|4|||
128024396|NCT00395512|460714395|FG002|Overall Study|Physician Decision|2|||
128024397|NCT00395512|460714396|FG003|Overall Study|Physician Decision|2|||
128024398|NCT00395512|460714393|FG000|Overall Study|Other|1|||
128024399|NCT00395512|460714394|FG001|Overall Study|Other|1|||
128024400|NCT00395512|460714395|FG002|Overall Study|Other|0|||
128024401|NCT00395512|460714396|FG003|Overall Study|Other|0|||
128024402|NCT00395512|460714393|FG000|Overall Study|Hyperglycemic Rescue|18|||
128024403|NCT00395512|460714394|FG001|Overall Study|Hyperglycemic Rescue|10|||
128024404|NCT00395512|460714395|FG002|Overall Study|Hyperglycemic Rescue|4|||
128024405|NCT00395512|460714396|FG003|Overall Study|Hyperglycemic Rescue|6|||
128024406|NCT04576949|460714397|FG000|Overall Study|Adverse Event|1|||
128024407|NCT04576949|460714398|FG001|Overall Study|Adverse Event|3|||
128024408|NCT04576949|460714399|FG002|Overall Study|Adverse Event|2|||
128024409|NCT04576949|460714397|FG000|Overall Study|Withdrawal by Subject|41|||
128024410|NCT04576949|460714398|FG001|Overall Study|Withdrawal by Subject|26|||
128024411|NCT04576949|460714399|FG002|Overall Study|Withdrawal by Subject|18|||
128024412|NCT04576949|460714397|FG000|Overall Study|Physician Decision|3|||
128024413|NCT04576949|460714398|FG001|Overall Study|Physician Decision|0|||
127560476|NCT00966875|459023469|FG002|Part A|Withdrawal by Subject|1|||
127560477|NCT00966875|459023470|FG003|Part A|Withdrawal by Subject|1|||
127560478|NCT00966875|459023471|FG004|Part A|Withdrawal by Subject|3|||
127560479|NCT00966875|459023472|FG005|Part A|Withdrawal by Subject|0|||
127560480|NCT00966875|459023473|FG006|Part A|Withdrawal by Subject|5|||
127560481|NCT00966875|459023474|FG007|Part A|Withdrawal by Subject|1|||
127560482|NCT00966875|459023475|FG008|Part A|Withdrawal by Subject|1|||
127560483|NCT00966875|459023467|FG000|Part A|Protocol Violation|0|||
127560484|NCT00966875|459023468|FG001|Part A|Protocol Violation|0|||
127560485|NCT00966875|459023469|FG002|Part A|Protocol Violation|0|||
127560486|NCT00966875|459023470|FG003|Part A|Protocol Violation|0|||
127687528|NCT02723955|459483544|FG031|Escalation Phase|Withdrawal by Subject|0|||
127687529|NCT02723955|459483545|FG032|Escalation Phase|Withdrawal by Subject|0|||
128024414|NCT04576949|460714399|FG002|Overall Study|Physician Decision|0|||
128024415|NCT04576949|460714397|FG000|Overall Study|Death|0|||
127560487|NCT00966875|459023471|FG004|Part A|Protocol Violation|0|||
127560488|NCT00966875|459023472|FG005|Part A|Protocol Violation|0|||
127560489|NCT00966875|459023473|FG006|Part A|Protocol Violation|2|||
127560490|NCT00966875|459023474|FG007|Part A|Protocol Violation|1|||
127560491|NCT00966875|459023475|FG008|Part A|Protocol Violation|1|||
127560492|NCT00966875|459023467|FG000|Part B|Adverse Event|0|||
127560493|NCT00966875|459023468|FG001|Part B|Adverse Event|1|||
128024416|NCT04576949|460714398|FG001|Overall Study|Death|1|||
128024417|NCT04576949|460714399|FG002|Overall Study|Death|0|||
128024418|NCT04576949|460714397|FG000|Overall Study|Lost to Follow-up|29|||
128024419|NCT04576949|460714398|FG001|Overall Study|Lost to Follow-up|37|||
128024420|NCT04576949|460714399|FG002|Overall Study|Lost to Follow-up|24|||
128024421|NCT04576949|460714397|FG000|Overall Study|Other, Not Specified|2|||
128024422|NCT04576949|460714398|FG001|Overall Study|Other, Not Specified|3|||
128024423|NCT04576949|460714399|FG002|Overall Study|Other, Not Specified|1|||
128024424|NCT04576949|460714397|FG000|Overall Study|Other|1|||
128024425|NCT04576949|460714398|FG001|Overall Study|Other|0|||
128024426|NCT04576949|460714399|FG002|Overall Study|Other|0|||
128024427|NCT00407030|460714400|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
128024428|NCT00407030|460714401|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
127560494|NCT00966875|459023469|FG002|Part B|Adverse Event|1|||
127560495|NCT00966875|459023470|FG003|Part B|Adverse Event|0|||
127560496|NCT00966875|459023471|FG004|Part B|Adverse Event|1|||
127560497|NCT00966875|459023472|FG005|Part B|Adverse Event|0|||
127560498|NCT00966875|459023473|FG006|Part B|Adverse Event|5|||
128024429|NCT00407030|460714402|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
128024430|NCT00407030|460714400|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
127560499|NCT00966875|459023474|FG007|Part B|Adverse Event|2|||
127560500|NCT00966875|459023475|FG008|Part B|Adverse Event|2|||
127560501|NCT00966875|459023467|FG000|Part B|Death|0|||
127560502|NCT00966875|459023468|FG001|Part B|Death|0|||
127560503|NCT00966875|459023469|FG002|Part B|Death|1|||
127560504|NCT00966875|459023470|FG003|Part B|Death|0|||
127560505|NCT00966875|459023471|FG004|Part B|Death|0|||
127560506|NCT00966875|459023472|FG005|Part B|Death|0|||
127560507|NCT00966875|459023473|FG006|Part B|Death|0|||
127560508|NCT00966875|459023474|FG007|Part B|Death|1|||
127560509|NCT00966875|459023475|FG008|Part B|Death|0|||
127560510|NCT00966875|459023467|FG000|Part B|Lack of Efficacy|2|||
128024431|NCT00407030|460714401|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
128024432|NCT00407030|460714402|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
128024433|NCT00407030|460714400|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
128024434|NCT00407030|460714401|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
128024435|NCT00407030|460714402|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
128024436|NCT00407030|460714400|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
128024437|NCT00407030|460714401|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
128024438|NCT00407030|460714402|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
127560511|NCT00966875|459023468|FG001|Part B|Lack of Efficacy|1|||
127560512|NCT00966875|459023469|FG002|Part B|Lack of Efficacy|1|||
127560513|NCT00966875|459023470|FG003|Part B|Lack of Efficacy|1|||
127560514|NCT00966875|459023471|FG004|Part B|Lack of Efficacy|2|||
127560515|NCT00966875|459023472|FG005|Part B|Lack of Efficacy|3|||
127560516|NCT00966875|459023473|FG006|Part B|Lack of Efficacy|12|||
127560517|NCT00966875|459023474|FG007|Part B|Lack of Efficacy|9|||
127560518|NCT00966875|459023475|FG008|Part B|Lack of Efficacy|6|||
127560519|NCT00966875|459023467|FG000|Part B|Lost to Follow-up|0|||
127560520|NCT00966875|459023468|FG001|Part B|Lost to Follow-up|0|||
127560521|NCT00966875|459023469|FG002|Part B|Lost to Follow-up|0|||
127560522|NCT00966875|459023470|FG003|Part B|Lost to Follow-up|1|||
127560523|NCT00966875|459023471|FG004|Part B|Lost to Follow-up|0|||
127560524|NCT00966875|459023472|FG005|Part B|Lost to Follow-up|0|||
127560525|NCT00966875|459023473|FG006|Part B|Lost to Follow-up|0|||
127560526|NCT00966875|459023474|FG007|Part B|Lost to Follow-up|0|||
127560527|NCT00966875|459023475|FG008|Part B|Lost to Follow-up|1|||
127560528|NCT00966875|459023467|FG000|Part B|Physician Decision|0|||
127560529|NCT00966875|459023468|FG001|Part B|Physician Decision|0|||
127560530|NCT00966875|459023469|FG002|Part B|Physician Decision|1|||
127560531|NCT00966875|459023470|FG003|Part B|Physician Decision|0|||
127560532|NCT00966875|459023471|FG004|Part B|Physician Decision|2|||
127560533|NCT00966875|459023472|FG005|Part B|Physician Decision|1|||
127560534|NCT00966875|459023473|FG006|Part B|Physician Decision|0|||
127560535|NCT00966875|459023474|FG007|Part B|Physician Decision|0|||
127560536|NCT00966875|459023475|FG008|Part B|Physician Decision|2|||
127560537|NCT00966875|459023467|FG000|Part B|Sponsor Decision|1|||
127560538|NCT00966875|459023468|FG001|Part B|Sponsor Decision|0|||
127560539|NCT00966875|459023469|FG002|Part B|Sponsor Decision|0|||
127560540|NCT00966875|459023470|FG003|Part B|Sponsor Decision|0|||
127560541|NCT00966875|459023471|FG004|Part B|Sponsor Decision|0|||
127560542|NCT00966875|459023472|FG005|Part B|Sponsor Decision|1|||
127560543|NCT00966875|459023473|FG006|Part B|Sponsor Decision|0|||
127560544|NCT00966875|459023474|FG007|Part B|Sponsor Decision|2|||
127560545|NCT00966875|459023475|FG008|Part B|Sponsor Decision|1|||
127560546|NCT00966875|459023467|FG000|Part B|Withdrawal by Subject|2|||
127560547|NCT00966875|459023468|FG001|Part B|Withdrawal by Subject|1|||
127560548|NCT00966875|459023469|FG002|Part B|Withdrawal by Subject|2|||
127560549|NCT00966875|459023470|FG003|Part B|Withdrawal by Subject|1|||
127560550|NCT00966875|459023471|FG004|Part B|Withdrawal by Subject|2|||
127560551|NCT00966875|459023472|FG005|Part B|Withdrawal by Subject|1|||
127560552|NCT00966875|459023473|FG006|Part B|Withdrawal by Subject|4|||
127560553|NCT00966875|459023474|FG007|Part B|Withdrawal by Subject|5|||
127560554|NCT00966875|459023475|FG008|Part B|Withdrawal by Subject|5|||
127775851|NCT02408861|459806765|FG001|Overall Study|Adverse Event|0|||
127560555|NCT00966875|459023467|FG000|Part B|Entry Criteria|0|||
127560556|NCT00966875|459023468|FG001|Part B|Entry Criteria|0|||
127560557|NCT00966875|459023469|FG002|Part B|Entry Criteria|0|||
127560558|NCT00966875|459023470|FG003|Part B|Entry Criteria|0|||
127560559|NCT00966875|459023471|FG004|Part B|Entry Criteria|0|||
127560560|NCT00966875|459023472|FG005|Part B|Entry Criteria|0|||
127560561|NCT00966875|459023473|FG006|Part B|Entry Criteria|1|||
127560562|NCT00966875|459023474|FG007|Part B|Entry Criteria|0|||
128024439|NCT00407030|460714400|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
127775852|NCT02408861|459806766|FG002|Overall Study|Adverse Event|1|||
127775853|NCT02408861|459806767|FG003|Overall Study|Adverse Event|0|||
127775854|NCT02408861|459806768|FG004|Overall Study|Adverse Event|2|||
127775855|NCT02408861|459806769|FG005|Overall Study|Adverse Event|0|||
127775856|NCT02408861|459806770|FG006|Overall Study|Adverse Event|0|||
127775857|NCT02408861|459806764|FG000|Overall Study|Physician Decision|1|||
127775858|NCT02408861|459806765|FG001|Overall Study|Physician Decision|1|||
127775859|NCT02408861|459806766|FG002|Overall Study|Physician Decision|1|||
127775860|NCT02408861|459806767|FG003|Overall Study|Physician Decision|0|||
127775861|NCT02408861|459806768|FG004|Overall Study|Physician Decision|0|||
127775862|NCT02408861|459806769|FG005|Overall Study|Physician Decision|1|||
127775863|NCT02408861|459806770|FG006|Overall Study|Physician Decision|0|||
127775864|NCT02408861|459806764|FG000|Overall Study|Protocol Violation|1|||
128024440|NCT00407030|460714401|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
128024441|NCT00407030|460714402|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
128024442|NCT00407030|460714400|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
128024443|NCT00407030|460714401|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
128024444|NCT00407030|460714402|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
128024445|NCT00407030|460714400|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
128024446|NCT00407030|460714401|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
128024447|NCT00407030|460714402|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
128024448|NCT00407030|460714400|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
128024449|NCT00407030|460714401|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
128024450|NCT00407030|460714402|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
128024451|NCT00407030|460714400|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
128024452|NCT00407030|460714401|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
128024453|NCT00407030|460714402|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
128024454|NCT00407030|460714400|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
128024455|NCT00407030|460714401|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
128024456|NCT00407030|460714402|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
128024457|NCT00407030|460714400|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
128024458|NCT00407030|460714401|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
128024459|NCT00407030|460714402|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
128024460|NCT00407030|460714400|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
128024461|NCT00407030|460714401|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
128024462|NCT00407030|460714402|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
128024463|NCT00407030|460714400|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
128024464|NCT00407030|460714401|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
128024465|NCT00407030|460714402|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
128024466|NCT02829957|460714404|FG000|Overall Study|Lost to Follow-up|2|||
128024467|NCT02829957|460714405|FG001|Overall Study|Lost to Follow-up|1|||
128024468|NCT01370538|460714406|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
128024469|NCT01370538|460714407|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
128024470|NCT01370538|460714406|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
128024471|NCT01370538|460714407|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
128024472|NCT01370538|460714406|FG000|Overall Study|Adverse Event|1|||
128024473|NCT01370538|460714407|FG001|Overall Study|Adverse Event|0|||
128024474|NCT01370538|460714406|FG000|Overall Study|Protocol Violation|8|||
128024475|NCT01370538|460714407|FG001|Overall Study|Protocol Violation|5|||
128024476|NCT01370538|460714406|FG000|Overall Study|Development of study specific withdrawal|1|||
128024477|NCT01370538|460714407|FG001|Overall Study|Development of study specific withdrawal|1|||
128024478|NCT01370538|460714406|FG000|Overall Study|Lost to follow up|6|||
128024479|NCT01370538|460714407|FG001|Overall Study|Lost to follow up|10|||
128024480|NCT04193527|460714408|FG000|Overall Study|Other|1|||
128024481|NCT04193527|460714409|FG001|Overall Study|Other|1|||
128024482|NCT04193527|460714410|FG002|Overall Study|Other|0|||
128024483|NCT02366130|460714411|FG000|Overall Study|Withdrawal by Subject|3|||
128024484|NCT02366130|460714411|FG000|Overall Study|Ineligible|6|||
128024485|NCT00567112|460714412|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
128024486|NCT00567112|460714413|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
128024487|NCT00567112|460714414|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
128024488|NCT00567112|460714412|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
128024489|NCT00567112|460714413|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
128024490|NCT00567112|460714414|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
127775865|NCT02408861|459806765|FG001|Overall Study|Protocol Violation|0|||
127775866|NCT02408861|459806766|FG002|Overall Study|Protocol Violation|0|||
127775867|NCT02408861|459806767|FG003|Overall Study|Protocol Violation|0|||
127775868|NCT02408861|459806768|FG004|Overall Study|Protocol Violation|0|||
127775869|NCT02408861|459806769|FG005|Overall Study|Protocol Violation|0|||
127775870|NCT02408861|459806770|FG006|Overall Study|Protocol Violation|0|||
128024491|NCT00567112|460714412|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
128024492|NCT00567112|460714413|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
128024493|NCT00567112|460714414|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
128024494|NCT01945242|460714425|FG000|Overall Study|Physician Decision|3|||
128024495|NCT01945242|460714426|FG001|Overall Study|Physician Decision|3|||
128024496|NCT04913675|460714427|FG000|Main Study (Up to Week 36)|Death|0|||
128024497|NCT04913675|460714428|FG001|Main Study (Up to Week 36)|Death|2|||
128024498|NCT04913675|460714429|FG002|Main Study (Up to Week 36)|Death|2|||
128024499|NCT04913675|460714430|FG003|Main Study (Up to Week 36)|Death|0|||
128024500|NCT04913675|460714427|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
128024501|NCT04913675|460714428|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
128024502|NCT04913675|460714429|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
128024503|NCT04913675|460714430|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
128024504|NCT04913675|460714427|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
127560563|NCT00966875|459023475|FG008|Part B|Entry Criteria|1|||
127560564|NCT04657666|459023476|FG000|Period 1|Withdrawal of participant consent|2|||
127560565|NCT04657666|459023477|FG001|Period 1|Withdrawal of participant consent|1|||
127560566|NCT04657666|459023476|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
127560567|NCT04657666|459023477|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
127560568|NCT04657666|459023476|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
127560569|NCT04657666|459023477|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
127560570|NCT04657666|459023476|FG000|Period 2|Other|2|||
127560571|NCT04657666|459023477|FG001|Period 2|Other|0|||
127560572|NCT04657666|459023476|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
127560573|NCT04657666|459023477|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
127560574|NCT02386189|459023478|FG000|Overall Study|Lost to Follow-up|2|||
127560575|NCT02386189|459023479|FG001|Overall Study|Lost to Follow-up|3|||
127560576|NCT02386189|459023478|FG000|Overall Study|Withdrawal by Subject|1|||
127560577|NCT02386189|459023479|FG001|Overall Study|Withdrawal by Subject|0|||
127560578|NCT02386189|459023478|FG000|Overall Study|Death|1|||
127560579|NCT02386189|459023479|FG001|Overall Study|Death|0|||
127560580|NCT03700684|459023482|FG000|Overall Study|COVID-19|0|||
127560581|NCT03700684|459023483|FG001|Overall Study|COVID-19|0|||
127560582|NCT03700684|459023484|FG002|Overall Study|COVID-19|2|||
127560583|NCT00640224|459023485|FG000|Overall Study|Lost to Follow-up|5|||
127560584|NCT00640224|459023486|FG001|Overall Study|Lost to Follow-up|2|||
127560585|NCT00640224|459023487|FG002|Overall Study|Lost to Follow-up|0|||
127687530|NCT02723955|459483546|FG033|Escalation Phase|Withdrawal by Subject|0|||
127687531|NCT02723955|459483547|FG034|Escalation Phase|Withdrawal by Subject|0|||
128024505|NCT04913675|460714428|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
128024506|NCT04913675|460714429|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
128024507|NCT04913675|460714430|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
128024508|NCT04913675|460714427|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
127560586|NCT00640224|459023488|FG003|Overall Study|Lost to Follow-up|0|||
127560587|NCT00640224|459023485|FG000|Overall Study|Withdrawal by Subject|1|||
127560588|NCT00640224|459023486|FG001|Overall Study|Withdrawal by Subject|0|||
127560589|NCT00640224|459023487|FG002|Overall Study|Withdrawal by Subject|0|||
127687532|NCT02723955|459483548|FG035|Escalation Phase|Withdrawal by Subject|0|||
127687533|NCT02723955|459483549|FG036|Escalation Phase|Withdrawal by Subject|0|||
127687534|NCT02723955|459483550|FG037|Escalation Phase|Withdrawal by Subject|0|||
128024509|NCT04913675|460714428|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
128024510|NCT04913675|460714429|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
128024511|NCT04913675|460714430|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
128024512|NCT04913675|460714427|FG000|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
127560590|NCT00640224|459023488|FG003|Overall Study|Withdrawal by Subject|0|||
127560591|NCT00640224|459023485|FG000|Overall Study|Headaches|0|||
127687535|NCT02723955|459483551|FG038|Escalation Phase|Withdrawal by Subject|0|||
127687536|NCT02723955|459483552|FG039|Escalation Phase|Withdrawal by Subject|0|||
128024513|NCT04913675|460714428|FG001|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
127560592|NCT00640224|459023486|FG001|Overall Study|Headaches|1|||
127560593|NCT00640224|459023487|FG002|Overall Study|Headaches|0|||
127560594|NCT00640224|459023488|FG003|Overall Study|Headaches|0|||
127560595|NCT02937584|459023491|FG000|Period 1|Adverse Event|1|||
127560596|NCT02937584|459023492|FG001|Period 1|Adverse Event|2|||
127560597|NCT02937584|459023491|FG000|Washout|Adverse Event|0|||
127560598|NCT02937584|459023492|FG001|Washout|Adverse Event|1|||
127560599|NCT00635219|459023493|FG000|Overall Study|Adverse Event|12|||
127560600|NCT00635219|459023494|FG001|Overall Study|Adverse Event|10|||
127560601|NCT00635219|459023495|FG002|Overall Study|Adverse Event|18|||
127560602|NCT00635219|459023496|FG003|Overall Study|Adverse Event|15|||
127560603|NCT00635219|459023497|FG004|Overall Study|Adverse Event|19|||
127560604|NCT00635219|459023493|FG000|Overall Study|Lack of Efficacy|5|||
127560605|NCT00635219|459023494|FG001|Overall Study|Lack of Efficacy|6|||
127560606|NCT00635219|459023495|FG002|Overall Study|Lack of Efficacy|3|||
127560607|NCT00635219|459023496|FG003|Overall Study|Lack of Efficacy|4|||
127560608|NCT00635219|459023497|FG004|Overall Study|Lack of Efficacy|6|||
127560609|NCT00635219|459023493|FG000|Overall Study|Non-compliance With Study Product|0|||
127560610|NCT00635219|459023494|FG001|Overall Study|Non-compliance With Study Product|0|||
127560611|NCT00635219|459023495|FG002|Overall Study|Non-compliance With Study Product|0|||
127560612|NCT00635219|459023496|FG003|Overall Study|Non-compliance With Study Product|2|||
127560613|NCT00635219|459023497|FG004|Overall Study|Non-compliance With Study Product|1|||
127560614|NCT00635219|459023493|FG000|Overall Study|Protocol Violation|0|||
127560615|NCT00635219|459023494|FG001|Overall Study|Protocol Violation|2|||
127560616|NCT00635219|459023495|FG002|Overall Study|Protocol Violation|3|||
127560617|NCT00635219|459023496|FG003|Overall Study|Protocol Violation|2|||
127560618|NCT00635219|459023497|FG004|Overall Study|Protocol Violation|4|||
127560619|NCT00635219|459023493|FG000|Overall Study|Withdrawal of Consent|8|||
127560620|NCT00635219|459023494|FG001|Overall Study|Withdrawal of Consent|6|||
127560621|NCT00635219|459023495|FG002|Overall Study|Withdrawal of Consent|8|||
127560622|NCT00635219|459023496|FG003|Overall Study|Withdrawal of Consent|11|||
127560623|NCT00635219|459023497|FG004|Overall Study|Withdrawal of Consent|8|||
127560624|NCT00635219|459023493|FG000|Overall Study|Lost to Follow-up|0|||
127560625|NCT00635219|459023494|FG001|Overall Study|Lost to Follow-up|0|||
127560626|NCT00635219|459023495|FG002|Overall Study|Lost to Follow-up|2|||
127560627|NCT00635219|459023496|FG003|Overall Study|Lost to Follow-up|0|||
127560628|NCT00635219|459023497|FG004|Overall Study|Lost to Follow-up|3|||
127560629|NCT00635219|459023493|FG000|Overall Study|Administrative or Other Reasons|0|||
127560630|NCT00635219|459023494|FG001|Overall Study|Administrative or Other Reasons|1|||
127560631|NCT00635219|459023495|FG002|Overall Study|Administrative or Other Reasons|1|||
127560632|NCT00635219|459023496|FG003|Overall Study|Administrative or Other Reasons|0|||
127560633|NCT00635219|459023497|FG004|Overall Study|Administrative or Other Reasons|1|||
127560634|NCT04075734|459023498|FG000|Overall Study|Lost to Follow-up|1|||
127560635|NCT04075734|459023499|FG001|Overall Study|Lost to Follow-up|1|||
127560636|NCT04075734|459023500|FG002|Overall Study|Lost to Follow-up|0|||
127560637|NCT04075734|459023498|FG000|Overall Study|Withdrawal by Subject|3|||
127560638|NCT04075734|459023499|FG001|Overall Study|Withdrawal by Subject|0|||
127560639|NCT04075734|459023500|FG002|Overall Study|Withdrawal by Subject|0|||
127560640|NCT01598129|459023501|FG000|Overall Study|Disease progression|6|||
127775871|NCT02408861|459806764|FG000|Overall Study|Withdrawal by Subject|0|||
127775872|NCT02408861|459806765|FG001|Overall Study|Withdrawal by Subject|0|||
127775873|NCT02408861|459806766|FG002|Overall Study|Withdrawal by Subject|0|||
127775874|NCT02408861|459806767|FG003|Overall Study|Withdrawal by Subject|0|||
127775875|NCT02408861|459806768|FG004|Overall Study|Withdrawal by Subject|1|||
127775876|NCT02408861|459806769|FG005|Overall Study|Withdrawal by Subject|1|||
127775877|NCT02408861|459806770|FG006|Overall Study|Withdrawal by Subject|0|||
127775878|NCT02408861|459806764|FG000|Overall Study|Other Treatment|0|||
127775879|NCT02408861|459806765|FG001|Overall Study|Other Treatment|0|||
127560641|NCT01598129|459023501|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
127560642|NCT01598129|459023501|FG000|Overall Study|Withdrawal by Subject|1|||
127560643|NCT00591318|459023504|FG000|Overall Study|Lack of Efficacy|2|||
127560644|NCT00591318|459023505|FG001|Overall Study|Lack of Efficacy|0|||
127560645|NCT00591318|459023504|FG000|Overall Study|Adverse Event|2|||
127560646|NCT00591318|459023505|FG001|Overall Study|Adverse Event|0|||
127560647|NCT00388583|459023506|FG000|Overall Study|Protocol Violation|1|||
127775880|NCT02408861|459806766|FG002|Overall Study|Other Treatment|0|||
127775881|NCT02408861|459806767|FG003|Overall Study|Other Treatment|0|||
128024514|NCT04913675|460714429|FG002|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
128024515|NCT04913675|460714430|FG003|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|1|||
128024516|NCT05661734|460714433|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
128024517|NCT05661734|460714433|FG000|Overall Study|Lost to Follow-up|13|||
128024518|NCT05661734|460714433|FG000|Overall Study|Enrolled but not dosed|2|||
128024519|NCT01026038|460714434|FG000|Overall Study|Lost to Follow-up|1|||
127560648|NCT00388583|459023507|FG001|Overall Study|Protocol Violation|0|||
127560649|NCT00388583|459023506|FG000|Overall Study|Withdrawal by Subject|3|||
127560650|NCT00388583|459023507|FG001|Overall Study|Withdrawal by Subject|3|||
127775882|NCT02408861|459806768|FG004|Overall Study|Other Treatment|0|||
128024520|NCT01026038|460714435|FG001|Overall Study|Lost to Follow-up|1|||
127560651|NCT00388583|459023506|FG000|Overall Study|Serious Adverse Event|2|||
127560652|NCT00388583|459023507|FG001|Overall Study|Serious Adverse Event|0|||
127560653|NCT00388583|459023506|FG000|Overall Study|Did not receive vaccine|0|||
127560654|NCT00388583|459023507|FG001|Overall Study|Did not receive vaccine|1|||
127560655|NCT00322621|459023508|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
127560656|NCT00322621|459023509|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
127560657|NCT00322621|459023510|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
127560658|NCT00322621|459023508|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
127560659|NCT00322621|459023509|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
127560660|NCT00322621|459023510|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
127560661|NCT00322621|459023508|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
127560662|NCT00322621|459023509|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
127560663|NCT00322621|459023510|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
127560664|NCT00322621|459023508|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
127560665|NCT00322621|459023509|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
127560666|NCT00322621|459023510|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
127560667|NCT00322621|459023508|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
127560668|NCT00322621|459023509|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
127560669|NCT00322621|459023510|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
127560670|NCT00322621|459023508|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
127560671|NCT00322621|459023509|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
127560672|NCT00322621|459023510|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
127560673|NCT00322621|459023508|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
127560674|NCT00322621|459023509|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
127560675|NCT00322621|459023510|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
127560676|NCT00322621|459023508|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
127560677|NCT00322621|459023509|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
127560678|NCT00322621|459023510|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
127560679|NCT00322621|459023508|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
127560680|NCT00322621|459023509|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
127560681|NCT00322621|459023510|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
127560682|NCT00322621|459023508|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
127560683|NCT00322621|459023509|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
127560684|NCT00322621|459023510|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
127560685|NCT00322621|459023508|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
127560686|NCT00322621|459023509|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
127560687|NCT00322621|459023510|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
127560688|NCT02059291|459023511|FG000|Epoch 2|Lack of Efficacy|0|||
127560689|NCT02059291|459023512|FG001|Epoch 2|Lack of Efficacy|0|||
127560690|NCT02059291|459023513|FG002|Epoch 2|Lack of Efficacy|0|||
127560691|NCT02059291|459023514|FG003|Epoch 2|Lack of Efficacy|1|||
127560692|NCT02059291|459023515|FG004|Epoch 2|Lack of Efficacy|0|||
127560693|NCT02059291|459023516|FG005|Epoch 2|Lack of Efficacy|1|||
127560694|NCT02059291|459023517|FG006|Epoch 2|Lack of Efficacy|0|||
127560695|NCT02059291|459023518|FG007|Epoch 2|Lack of Efficacy|0|||
127560696|NCT02059291|459023519|FG008|Epoch 2|Lack of Efficacy|0|||
127560697|NCT02059291|459023520|FG009|Epoch 2|Lack of Efficacy|0|||
127560698|NCT02059291|459023521|FG010|Epoch 2|Lack of Efficacy|0|||
127560699|NCT02059291|459023522|FG011|Epoch 2|Lack of Efficacy|0|||
127560700|NCT02059291|459023523|FG012|Epoch 2|Lack of Efficacy|0|||
127560701|NCT02059291|459023524|FG013|Epoch 2|Lack of Efficacy|0|||
127560702|NCT02059291|459023525|FG014|Epoch 2|Lack of Efficacy|0|||
127560703|NCT02059291|459023526|FG015|Epoch 2|Lack of Efficacy|0|||
127560704|NCT02059291|459023527|FG016|Epoch 2|Lack of Efficacy|0|||
127560705|NCT02059291|459023528|FG017|Epoch 2|Lack of Efficacy|0|||
127560706|NCT02059291|459023529|FG018|Epoch 2|Lack of Efficacy|0|||
127687537|NCT02723955|459483553|FG040|Escalation Phase|Withdrawal by Subject|0|||
127687538|NCT02723955|459483554|FG041|Escalation Phase|Withdrawal by Subject|0|||
127687539|NCT02723955|459483555|FG042|Escalation Phase|Withdrawal by Subject|0|||
127687540|NCT02723955|459483513|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
127687541|NCT02723955|459483514|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
127687542|NCT02723955|459483515|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
127687543|NCT02723955|459483516|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
127560707|NCT02059291|459023530|FG019|Epoch 2|Lack of Efficacy|0|||
127560708|NCT02059291|459023531|FG020|Epoch 2|Lack of Efficacy|0|||
127560709|NCT02059291|459023532|FG021|Epoch 2|Lack of Efficacy|0|||
127560710|NCT02059291|459023533|FG022|Epoch 2|Lack of Efficacy|0|||
127560711|NCT02059291|459023534|FG023|Epoch 2|Lack of Efficacy|0|||
127560712|NCT02059291|459023535|FG024|Epoch 2|Lack of Efficacy|0|||
127560713|NCT02059291|459023511|FG000|Epoch 2|Adverse Event|0|||
127560714|NCT02059291|459023512|FG001|Epoch 2|Adverse Event|0|||
127560715|NCT02059291|459023513|FG002|Epoch 2|Adverse Event|1|||
127560716|NCT02059291|459023514|FG003|Epoch 2|Adverse Event|1|||
127560717|NCT02059291|459023515|FG004|Epoch 2|Adverse Event|0|||
127560718|NCT02059291|459023516|FG005|Epoch 2|Adverse Event|0|||
127560719|NCT02059291|459023517|FG006|Epoch 2|Adverse Event|0|||
127560720|NCT02059291|459023518|FG007|Epoch 2|Adverse Event|1|||
127560721|NCT02059291|459023519|FG008|Epoch 2|Adverse Event|1|||
127560722|NCT02059291|459023520|FG009|Epoch 2|Adverse Event|0|||
127560723|NCT02059291|459023521|FG010|Epoch 2|Adverse Event|0|||
127560724|NCT02059291|459023522|FG011|Epoch 2|Adverse Event|0|||
127560725|NCT02059291|459023523|FG012|Epoch 2|Adverse Event|0|||
127560726|NCT02059291|459023524|FG013|Epoch 2|Adverse Event|0|||
127560727|NCT02059291|459023525|FG014|Epoch 2|Adverse Event|0|||
127560728|NCT02059291|459023526|FG015|Epoch 2|Adverse Event|0|||
127560729|NCT02059291|459023527|FG016|Epoch 2|Adverse Event|0|||
127560730|NCT02059291|459023528|FG017|Epoch 2|Adverse Event|0|||
127560731|NCT02059291|459023529|FG018|Epoch 2|Adverse Event|0|||
127560732|NCT02059291|459023530|FG019|Epoch 2|Adverse Event|0|||
127560733|NCT02059291|459023531|FG020|Epoch 2|Adverse Event|0|||
127560734|NCT02059291|459023532|FG021|Epoch 2|Adverse Event|0|||
127560735|NCT02059291|459023533|FG022|Epoch 2|Adverse Event|0|||
127560736|NCT02059291|459023534|FG023|Epoch 2|Adverse Event|0|||
127560737|NCT02059291|459023535|FG024|Epoch 2|Adverse Event|0|||
127560738|NCT02059291|459023511|FG000|Epoch 2|Withdrawal by Subject|0|||
127560739|NCT02059291|459023512|FG001|Epoch 2|Withdrawal by Subject|1|||
127560740|NCT02059291|459023513|FG002|Epoch 2|Withdrawal by Subject|0|||
127560741|NCT02059291|459023514|FG003|Epoch 2|Withdrawal by Subject|0|||
127560742|NCT02059291|459023515|FG004|Epoch 2|Withdrawal by Subject|0|||
127560743|NCT02059291|459023516|FG005|Epoch 2|Withdrawal by Subject|1|||
127560744|NCT02059291|459023517|FG006|Epoch 2|Withdrawal by Subject|0|||
127560745|NCT02059291|459023518|FG007|Epoch 2|Withdrawal by Subject|0|||
127560746|NCT02059291|459023519|FG008|Epoch 2|Withdrawal by Subject|1|||
127560747|NCT02059291|459023520|FG009|Epoch 2|Withdrawal by Subject|0|||
127560748|NCT02059291|459023521|FG010|Epoch 2|Withdrawal by Subject|0|||
127775883|NCT02408861|459806769|FG005|Overall Study|Other Treatment|1|||
127775884|NCT02408861|459806770|FG006|Overall Study|Other Treatment|1|||
127775885|NCT04124614|459806771|FG000|Placebo Run-in Period|Not Randomized|34|||
127775886|NCT04124614|459806772|FG001|Placebo Run-in Period|Not Randomized|0|||
127775887|NCT04124614|459806773|FG002|Placebo Run-in Period|Not Randomized|0|||
127775888|NCT04124614|459806771|FG000|Double Blind Treatment Period|Adverse Event|0|||
127775889|NCT04124614|459806772|FG001|Double Blind Treatment Period|Adverse Event|7|||
127775890|NCT04124614|459806773|FG002|Double Blind Treatment Period|Adverse Event|22|||
127775891|NCT04124614|459806771|FG000|Double Blind Treatment Period|Death|0|||
127775892|NCT04124614|459806772|FG001|Double Blind Treatment Period|Death|0|||
127775893|NCT04124614|459806773|FG002|Double Blind Treatment Period|Death|1|||
127775894|NCT04124614|459806771|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
127775895|NCT04124614|459806772|FG001|Double Blind Treatment Period|Lost to Follow-up|18|||
127775896|NCT04124614|459806773|FG002|Double Blind Treatment Period|Lost to Follow-up|25|||
127775897|NCT04124614|459806771|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
127775898|NCT04124614|459806772|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
127775899|NCT04124614|459806773|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
127775900|NCT04124614|459806771|FG000|Double Blind Treatment Period|Physician Decision|0|||
127775901|NCT04124614|459806772|FG001|Double Blind Treatment Period|Physician Decision|0|||
127775902|NCT04124614|459806773|FG002|Double Blind Treatment Period|Physician Decision|3|||
127775903|NCT04124614|459806771|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
127775904|NCT04124614|459806772|FG001|Double Blind Treatment Period|Protocol Deviation|10|||
127775905|NCT04124614|459806773|FG002|Double Blind Treatment Period|Protocol Deviation|4|||
127775906|NCT04124614|459806771|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
127560749|NCT02059291|459023522|FG011|Epoch 2|Withdrawal by Subject|0|||
127560750|NCT02059291|459023523|FG012|Epoch 2|Withdrawal by Subject|0|||
127560751|NCT02059291|459023524|FG013|Epoch 2|Withdrawal by Subject|0|||
127560752|NCT02059291|459023525|FG014|Epoch 2|Withdrawal by Subject|0|||
127560753|NCT02059291|459023526|FG015|Epoch 2|Withdrawal by Subject|0|||
127560754|NCT02059291|459023527|FG016|Epoch 2|Withdrawal by Subject|0|||
127560755|NCT02059291|459023528|FG017|Epoch 2|Withdrawal by Subject|0|||
127560756|NCT02059291|459023529|FG018|Epoch 2|Withdrawal by Subject|0|||
127560757|NCT02059291|459023530|FG019|Epoch 2|Withdrawal by Subject|0|||
127560758|NCT02059291|459023531|FG020|Epoch 2|Withdrawal by Subject|0|||
127560759|NCT02059291|459023532|FG021|Epoch 2|Withdrawal by Subject|0|||
127560760|NCT02059291|459023533|FG022|Epoch 2|Withdrawal by Subject|0|||
127560761|NCT02059291|459023534|FG023|Epoch 2|Withdrawal by Subject|0|||
127560762|NCT02059291|459023535|FG024|Epoch 2|Withdrawal by Subject|0|||
127560763|NCT02059291|459023511|FG000|Epoch 3|Physician Decision|0|||
127560764|NCT02059291|459023512|FG001|Epoch 3|Physician Decision|0|||
127560765|NCT02059291|459023513|FG002|Epoch 3|Physician Decision|0|||
127560766|NCT02059291|459023514|FG003|Epoch 3|Physician Decision|0|||
127560767|NCT02059291|459023515|FG004|Epoch 3|Physician Decision|0|||
127560768|NCT02059291|459023516|FG005|Epoch 3|Physician Decision|0|||
127560769|NCT02059291|459023517|FG006|Epoch 3|Physician Decision|0|||
127560770|NCT02059291|459023518|FG007|Epoch 3|Physician Decision|0|||
127560771|NCT02059291|459023519|FG008|Epoch 3|Physician Decision|0|||
127560772|NCT02059291|459023520|FG009|Epoch 3|Physician Decision|0|||
127560773|NCT02059291|459023521|FG010|Epoch 3|Physician Decision|0|||
127560774|NCT02059291|459023522|FG011|Epoch 3|Physician Decision|0|||
127560775|NCT02059291|459023523|FG012|Epoch 3|Physician Decision|0|||
127560776|NCT02059291|459023524|FG013|Epoch 3|Physician Decision|1|||
127560777|NCT02059291|459023525|FG014|Epoch 3|Physician Decision|0|||
127560778|NCT02059291|459023526|FG015|Epoch 3|Physician Decision|1|||
127560779|NCT02059291|459023527|FG016|Epoch 3|Physician Decision|0|||
127560780|NCT02059291|459023528|FG017|Epoch 3|Physician Decision|0|||
127560781|NCT02059291|459023529|FG018|Epoch 3|Physician Decision|0|||
127560782|NCT02059291|459023530|FG019|Epoch 3|Physician Decision|0|||
127560783|NCT02059291|459023531|FG020|Epoch 3|Physician Decision|0|||
127560784|NCT02059291|459023532|FG021|Epoch 3|Physician Decision|0|||
127560785|NCT02059291|459023533|FG022|Epoch 3|Physician Decision|0|||
127560786|NCT02059291|459023534|FG023|Epoch 3|Physician Decision|0|||
127560787|NCT02059291|459023535|FG024|Epoch 3|Physician Decision|0|||
127560788|NCT02059291|459023511|FG000|Epoch 3|Adverse Event|0|||
127560789|NCT02059291|459023512|FG001|Epoch 3|Adverse Event|0|||
127560790|NCT02059291|459023513|FG002|Epoch 3|Adverse Event|0|||
127560791|NCT02059291|459023514|FG003|Epoch 3|Adverse Event|0|||
127560792|NCT02059291|459023515|FG004|Epoch 3|Adverse Event|0|||
127560793|NCT02059291|459023516|FG005|Epoch 3|Adverse Event|0|||
127560794|NCT02059291|459023517|FG006|Epoch 3|Adverse Event|0|||
127560795|NCT02059291|459023518|FG007|Epoch 3|Adverse Event|0|||
127560796|NCT02059291|459023519|FG008|Epoch 3|Adverse Event|0|||
127560797|NCT02059291|459023520|FG009|Epoch 3|Adverse Event|0|||
127560798|NCT02059291|459023521|FG010|Epoch 3|Adverse Event|0|||
127560799|NCT02059291|459023522|FG011|Epoch 3|Adverse Event|0|||
127560800|NCT02059291|459023523|FG012|Epoch 3|Adverse Event|0|||
127560801|NCT02059291|459023524|FG013|Epoch 3|Adverse Event|0|||
127560802|NCT02059291|459023525|FG014|Epoch 3|Adverse Event|0|||
127560803|NCT02059291|459023526|FG015|Epoch 3|Adverse Event|1|||
127560804|NCT02059291|459023527|FG016|Epoch 3|Adverse Event|0|||
127560805|NCT02059291|459023528|FG017|Epoch 3|Adverse Event|0|||
127560806|NCT02059291|459023529|FG018|Epoch 3|Adverse Event|0|||
127560807|NCT02059291|459023530|FG019|Epoch 3|Adverse Event|0|||
127687544|NCT02723955|459483517|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|5|||
127687545|NCT02723955|459483518|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
127687546|NCT02723955|459483519|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
127687547|NCT02723955|459483520|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|4|||
127687548|NCT02723955|459483521|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
127687549|NCT02723955|459483522|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
127687550|NCT02723955|459483523|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
127687551|NCT02723955|459483524|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
127687552|NCT02723955|459483525|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
127687553|NCT02723955|459483526|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
127687554|NCT02723955|459483527|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
127687555|NCT02723955|459483528|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
127687556|NCT02723955|459483529|FG016|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
127687557|NCT02723955|459483530|FG017|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
127687558|NCT02723955|459483531|FG018|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
127687559|NCT02723955|459483532|FG019|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
127687560|NCT02723955|459483533|FG020|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
127687561|NCT02723955|459483534|FG021|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
127687562|NCT02723955|459483535|FG022|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
127687563|NCT02723955|459483536|FG023|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
127560808|NCT02059291|459023531|FG020|Epoch 3|Adverse Event|0|||
127560809|NCT02059291|459023532|FG021|Epoch 3|Adverse Event|0|||
127560810|NCT02059291|459023533|FG022|Epoch 3|Adverse Event|0|||
127560811|NCT02059291|459023534|FG023|Epoch 3|Adverse Event|0|||
127560812|NCT02059291|459023535|FG024|Epoch 3|Adverse Event|0|||
127560813|NCT02059291|459023511|FG000|Epoch 3|Lack of Efficacy|0|||
127560814|NCT02059291|459023512|FG001|Epoch 3|Lack of Efficacy|0|||
127560815|NCT02059291|459023513|FG002|Epoch 3|Lack of Efficacy|0|||
127560816|NCT02059291|459023514|FG003|Epoch 3|Lack of Efficacy|0|||
127560817|NCT02059291|459023515|FG004|Epoch 3|Lack of Efficacy|0|||
127560818|NCT02059291|459023516|FG005|Epoch 3|Lack of Efficacy|0|||
127560819|NCT02059291|459023517|FG006|Epoch 3|Lack of Efficacy|0|||
127560820|NCT02059291|459023518|FG007|Epoch 3|Lack of Efficacy|0|||
127560821|NCT02059291|459023519|FG008|Epoch 3|Lack of Efficacy|0|||
127560822|NCT02059291|459023520|FG009|Epoch 3|Lack of Efficacy|0|||
127560823|NCT02059291|459023521|FG010|Epoch 3|Lack of Efficacy|0|||
127560824|NCT02059291|459023522|FG011|Epoch 3|Lack of Efficacy|0|||
127560825|NCT02059291|459023523|FG012|Epoch 3|Lack of Efficacy|0|||
127560826|NCT02059291|459023524|FG013|Epoch 3|Lack of Efficacy|0|||
127560827|NCT02059291|459023525|FG014|Epoch 3|Lack of Efficacy|0|||
127560828|NCT02059291|459023526|FG015|Epoch 3|Lack of Efficacy|3|||
127560829|NCT02059291|459023527|FG016|Epoch 3|Lack of Efficacy|0|||
127560830|NCT02059291|459023528|FG017|Epoch 3|Lack of Efficacy|0|||
127560831|NCT02059291|459023529|FG018|Epoch 3|Lack of Efficacy|0|||
127560832|NCT02059291|459023530|FG019|Epoch 3|Lack of Efficacy|0|||
127560833|NCT02059291|459023531|FG020|Epoch 3|Lack of Efficacy|0|||
127560834|NCT02059291|459023532|FG021|Epoch 3|Lack of Efficacy|0|||
127560835|NCT02059291|459023533|FG022|Epoch 3|Lack of Efficacy|0|||
127560836|NCT02059291|459023534|FG023|Epoch 3|Lack of Efficacy|0|||
127560837|NCT02059291|459023535|FG024|Epoch 3|Lack of Efficacy|0|||
127560838|NCT02059291|459023511|FG000|Epoch 3|Withdrawal by Subject|0|||
127560839|NCT02059291|459023512|FG001|Epoch 3|Withdrawal by Subject|0|||
127560840|NCT02059291|459023513|FG002|Epoch 3|Withdrawal by Subject|0|||
127560841|NCT02059291|459023514|FG003|Epoch 3|Withdrawal by Subject|0|||
127560842|NCT02059291|459023515|FG004|Epoch 3|Withdrawal by Subject|0|||
127560843|NCT02059291|459023516|FG005|Epoch 3|Withdrawal by Subject|0|||
127560844|NCT02059291|459023517|FG006|Epoch 3|Withdrawal by Subject|0|||
127560845|NCT02059291|459023518|FG007|Epoch 3|Withdrawal by Subject|0|||
127560846|NCT02059291|459023519|FG008|Epoch 3|Withdrawal by Subject|0|||
127560847|NCT02059291|459023520|FG009|Epoch 3|Withdrawal by Subject|0|||
127560848|NCT02059291|459023521|FG010|Epoch 3|Withdrawal by Subject|0|||
127560849|NCT02059291|459023522|FG011|Epoch 3|Withdrawal by Subject|0|||
127560850|NCT02059291|459023523|FG012|Epoch 3|Withdrawal by Subject|0|||
127560851|NCT02059291|459023524|FG013|Epoch 3|Withdrawal by Subject|0|||
127560852|NCT02059291|459023525|FG014|Epoch 3|Withdrawal by Subject|0|||
127560853|NCT02059291|459023526|FG015|Epoch 3|Withdrawal by Subject|1|||
127560854|NCT02059291|459023527|FG016|Epoch 3|Withdrawal by Subject|0|||
127560855|NCT02059291|459023528|FG017|Epoch 3|Withdrawal by Subject|0|||
127560856|NCT02059291|459023529|FG018|Epoch 3|Withdrawal by Subject|0|||
127560857|NCT02059291|459023530|FG019|Epoch 3|Withdrawal by Subject|0|||
127560858|NCT02059291|459023531|FG020|Epoch 3|Withdrawal by Subject|0|||
127560859|NCT02059291|459023532|FG021|Epoch 3|Withdrawal by Subject|0|||
127560860|NCT02059291|459023533|FG022|Epoch 3|Withdrawal by Subject|0|||
127560861|NCT02059291|459023534|FG023|Epoch 3|Withdrawal by Subject|0|||
127560862|NCT02059291|459023535|FG024|Epoch 3|Withdrawal by Subject|0|||
127560863|NCT02059291|459023511|FG000|Epoch 4|Adverse Event|0|||
127560864|NCT02059291|459023512|FG001|Epoch 4|Adverse Event|0|||
127560865|NCT02059291|459023513|FG002|Epoch 4|Adverse Event|0|||
127560866|NCT02059291|459023514|FG003|Epoch 4|Adverse Event|0|||
127560867|NCT02059291|459023515|FG004|Epoch 4|Adverse Event|0|||
127687564|NCT02723955|459483537|FG024|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
127687565|NCT02723955|459483538|FG025|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
127687566|NCT02723955|459483539|FG026|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
127687567|NCT02723955|459483540|FG027|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
127687568|NCT02723955|459483541|FG028|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
127687569|NCT02723955|459483542|FG029|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
127687570|NCT02723955|459483543|FG030|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
127687571|NCT02723955|459483544|FG031|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
127687572|NCT02723955|459483545|FG032|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
127687573|NCT02723955|459483546|FG033|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
127687574|NCT02723955|459483547|FG034|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
127687575|NCT02723955|459483548|FG035|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
127687576|NCT02723955|459483549|FG036|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
127687577|NCT02723955|459483550|FG037|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
127687578|NCT02723955|459483551|FG038|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
127560868|NCT02059291|459023516|FG005|Epoch 4|Adverse Event|0|||
127560869|NCT02059291|459023517|FG006|Epoch 4|Adverse Event|0|||
127560870|NCT02059291|459023518|FG007|Epoch 4|Adverse Event|0|||
127560871|NCT02059291|459023519|FG008|Epoch 4|Adverse Event|0|||
127560872|NCT02059291|459023520|FG009|Epoch 4|Adverse Event|0|||
127560873|NCT02059291|459023521|FG010|Epoch 4|Adverse Event|0|||
127560874|NCT02059291|459023522|FG011|Epoch 4|Adverse Event|0|||
127560875|NCT02059291|459023523|FG012|Epoch 4|Adverse Event|0|||
127560876|NCT02059291|459023524|FG013|Epoch 4|Adverse Event|0|||
127560877|NCT02059291|459023525|FG014|Epoch 4|Adverse Event|0|||
127560878|NCT02059291|459023526|FG015|Epoch 4|Adverse Event|0|||
127560879|NCT02059291|459023527|FG016|Epoch 4|Adverse Event|1|||
127560880|NCT02059291|459023528|FG017|Epoch 4|Adverse Event|0|||
127560881|NCT02059291|459023529|FG018|Epoch 4|Adverse Event|0|||
127560882|NCT02059291|459023530|FG019|Epoch 4|Adverse Event|0|||
127560883|NCT02059291|459023531|FG020|Epoch 4|Adverse Event|0|||
127560884|NCT02059291|459023532|FG021|Epoch 4|Adverse Event|0|||
127560885|NCT02059291|459023533|FG022|Epoch 4|Adverse Event|1|||
127560886|NCT02059291|459023534|FG023|Epoch 4|Adverse Event|0|||
127560887|NCT02059291|459023535|FG024|Epoch 4|Adverse Event|0|||
127560888|NCT02059291|459023511|FG000|Epoch 4|Pregnancy|0|||
127560889|NCT02059291|459023512|FG001|Epoch 4|Pregnancy|0|||
127560890|NCT02059291|459023513|FG002|Epoch 4|Pregnancy|0|||
127560891|NCT02059291|459023514|FG003|Epoch 4|Pregnancy|0|||
127560892|NCT02059291|459023515|FG004|Epoch 4|Pregnancy|0|||
127560893|NCT02059291|459023516|FG005|Epoch 4|Pregnancy|0|||
127560894|NCT02059291|459023517|FG006|Epoch 4|Pregnancy|0|||
127560895|NCT02059291|459023518|FG007|Epoch 4|Pregnancy|0|||
127560896|NCT02059291|459023519|FG008|Epoch 4|Pregnancy|0|||
127560897|NCT02059291|459023520|FG009|Epoch 4|Pregnancy|0|||
127560898|NCT02059291|459023521|FG010|Epoch 4|Pregnancy|0|||
127560899|NCT02059291|459023522|FG011|Epoch 4|Pregnancy|0|||
127560900|NCT02059291|459023523|FG012|Epoch 4|Pregnancy|0|||
127560901|NCT02059291|459023524|FG013|Epoch 4|Pregnancy|0|||
127560902|NCT02059291|459023525|FG014|Epoch 4|Pregnancy|0|||
127560903|NCT02059291|459023526|FG015|Epoch 4|Pregnancy|0|||
127560904|NCT02059291|459023527|FG016|Epoch 4|Pregnancy|1|||
127560905|NCT02059291|459023528|FG017|Epoch 4|Pregnancy|0|||
127560906|NCT02059291|459023529|FG018|Epoch 4|Pregnancy|0|||
127560907|NCT02059291|459023530|FG019|Epoch 4|Pregnancy|0|||
127560908|NCT02059291|459023531|FG020|Epoch 4|Pregnancy|0|||
127560909|NCT02059291|459023532|FG021|Epoch 4|Pregnancy|0|||
127560910|NCT02059291|459023533|FG022|Epoch 4|Pregnancy|0|||
127560911|NCT02059291|459023534|FG023|Epoch 4|Pregnancy|0|||
127560912|NCT02059291|459023535|FG024|Epoch 4|Pregnancy|0|||
127560913|NCT02059291|459023511|FG000|Epoch 4|Withdrawal by Subject|0|||
127560914|NCT02059291|459023512|FG001|Epoch 4|Withdrawal by Subject|0|||
127560915|NCT02059291|459023513|FG002|Epoch 4|Withdrawal by Subject|0|||
127560916|NCT02059291|459023514|FG003|Epoch 4|Withdrawal by Subject|0|||
127560917|NCT02059291|459023515|FG004|Epoch 4|Withdrawal by Subject|0|||
127560918|NCT02059291|459023516|FG005|Epoch 4|Withdrawal by Subject|0|||
127560919|NCT02059291|459023517|FG006|Epoch 4|Withdrawal by Subject|0|||
127560920|NCT02059291|459023518|FG007|Epoch 4|Withdrawal by Subject|0|||
127560921|NCT02059291|459023519|FG008|Epoch 4|Withdrawal by Subject|0|||
127560922|NCT02059291|459023520|FG009|Epoch 4|Withdrawal by Subject|0|||
127560923|NCT02059291|459023521|FG010|Epoch 4|Withdrawal by Subject|0|||
127560924|NCT02059291|459023522|FG011|Epoch 4|Withdrawal by Subject|0|||
127560925|NCT02059291|459023523|FG012|Epoch 4|Withdrawal by Subject|0|||
127560926|NCT02059291|459023524|FG013|Epoch 4|Withdrawal by Subject|0|||
127560927|NCT02059291|459023525|FG014|Epoch 4|Withdrawal by Subject|0|||
127560928|NCT02059291|459023526|FG015|Epoch 4|Withdrawal by Subject|0|||
127560929|NCT02059291|459023527|FG016|Epoch 4|Withdrawal by Subject|0|||
127560930|NCT02059291|459023528|FG017|Epoch 4|Withdrawal by Subject|0|||
127560931|NCT02059291|459023529|FG018|Epoch 4|Withdrawal by Subject|0|||
127560932|NCT02059291|459023530|FG019|Epoch 4|Withdrawal by Subject|0|||
127560933|NCT02059291|459023531|FG020|Epoch 4|Withdrawal by Subject|1|||
127560934|NCT02059291|459023532|FG021|Epoch 4|Withdrawal by Subject|0|||
127560935|NCT02059291|459023533|FG022|Epoch 4|Withdrawal by Subject|0|||
127560936|NCT02059291|459023534|FG023|Epoch 4|Withdrawal by Subject|0|||
127560937|NCT02059291|459023535|FG024|Epoch 4|Withdrawal by Subject|0|||
127560938|NCT02059291|459023511|FG000|Epoch 4|Lack of Efficacy|0|||
127560939|NCT02059291|459023512|FG001|Epoch 4|Lack of Efficacy|0|||
127560940|NCT02059291|459023513|FG002|Epoch 4|Lack of Efficacy|0|||
127560941|NCT02059291|459023514|FG003|Epoch 4|Lack of Efficacy|0|||
127560942|NCT02059291|459023515|FG004|Epoch 4|Lack of Efficacy|0|||
127560943|NCT02059291|459023516|FG005|Epoch 4|Lack of Efficacy|0|||
127560944|NCT02059291|459023517|FG006|Epoch 4|Lack of Efficacy|0|||
127687579|NCT02723955|459483552|FG039|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
127560945|NCT02059291|459023518|FG007|Epoch 4|Lack of Efficacy|0|||
127560946|NCT02059291|459023519|FG008|Epoch 4|Lack of Efficacy|0|||
127560947|NCT02059291|459023520|FG009|Epoch 4|Lack of Efficacy|0|||
127560948|NCT02059291|459023521|FG010|Epoch 4|Lack of Efficacy|0|||
127560949|NCT02059291|459023522|FG011|Epoch 4|Lack of Efficacy|0|||
127560950|NCT02059291|459023523|FG012|Epoch 4|Lack of Efficacy|0|||
127560951|NCT02059291|459023524|FG013|Epoch 4|Lack of Efficacy|0|||
127560952|NCT02059291|459023525|FG014|Epoch 4|Lack of Efficacy|0|||
127560953|NCT02059291|459023526|FG015|Epoch 4|Lack of Efficacy|0|||
127560954|NCT02059291|459023527|FG016|Epoch 4|Lack of Efficacy|0|||
127560955|NCT02059291|459023528|FG017|Epoch 4|Lack of Efficacy|0|||
127560956|NCT02059291|459023529|FG018|Epoch 4|Lack of Efficacy|0|||
127560957|NCT02059291|459023530|FG019|Epoch 4|Lack of Efficacy|0|||
127560958|NCT02059291|459023531|FG020|Epoch 4|Lack of Efficacy|0|||
127560959|NCT02059291|459023532|FG021|Epoch 4|Lack of Efficacy|0|||
127560960|NCT02059291|459023533|FG022|Epoch 4|Lack of Efficacy|0|||
127560961|NCT02059291|459023534|FG023|Epoch 4|Lack of Efficacy|1|||
127560962|NCT02059291|459023535|FG024|Epoch 4|Lack of Efficacy|0|||
127560963|NCT01433289|459023536|FG000|Overall Study|Pregnancy|0|||
127560964|NCT01433289|459023537|FG001|Overall Study|Pregnancy|1|||
127560965|NCT01433289|459023538|FG002|Overall Study|Pregnancy|0|||
127560966|NCT01433289|459023539|FG003|Overall Study|Pregnancy|0|||
128024521|NCT01026038|460714436|FG002|Overall Study|Lost to Follow-up|0|||
128024522|NCT03601052|460714437|FG000|Overall Study|Lost to Follow-up|2|||
128024523|NCT00837330|460714438|FG000|Overall Study|Lost to Follow-up|1|||
128024524|NCT00837330|460714439|FG001|Overall Study|Lost to Follow-up|3|||
128024525|NCT01348490|460714440|FG000|Overall Study|Death|1|||
128024526|NCT01348490|460714440|FG000|Overall Study|Adverse Event|3|||
128024527|NCT01348490|460714440|FG000|Overall Study|Consent withdrawn|7|||
128024528|NCT01348490|460714440|FG000|Overall Study|Disease progression|3|||
128024529|NCT01348490|460714440|FG000|Overall Study|Lost to Follow-up|1|||
128024530|NCT01348490|460714440|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
128024531|NCT01348490|460714440|FG000|Overall Study|Other Unspecified|8|||
128024532|NCT01184118|460714441|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
128024533|NCT01184118|460714441|FG000|Overall Study|No physiologic confirmation of asthma|8|||
128024534|NCT01184118|460714441|FG000|Overall Study|FEV1 <60% predicted|2|||
128024535|NCT01184118|460714441|FG000|Overall Study|Exclusionary medical condition|2|||
128024536|NCT01184118|460714441|FG000|Overall Study|Withdrawal by Subject|5|||
128024537|NCT01117350|460714445|FG000|Comparative Period|Not Treated|5|||
128024538|NCT01117350|460714446|FG001|Comparative Period|Not Treated|8|||
128024539|NCT01117350|460714445|FG000|Comparative Period|Adverse Event|6|||
128024540|NCT01117350|460714446|FG001|Comparative Period|Adverse Event|33|||
128024541|NCT01117350|460714445|FG000|Comparative Period|Lost to Follow-up|11|||
128024542|NCT01117350|460714446|FG001|Comparative Period|Lost to Follow-up|7|||
128024543|NCT01117350|460714445|FG000|Comparative Period|Withdrawal by Subject|9|||
128024544|NCT01117350|460714446|FG001|Comparative Period|Withdrawal by Subject|13|||
128024545|NCT01117350|460714445|FG000|Comparative Period|Protocol Violation|8|||
128024546|NCT01117350|460714446|FG001|Comparative Period|Protocol Violation|12|||
128024547|NCT01117350|460714445|FG000|Comparative Period|Lack of Efficacy|1|||
128024548|NCT01117350|460714446|FG001|Comparative Period|Lack of Efficacy|0|||
128024549|NCT01117350|460714445|FG000|Comparative Period|Physician Decision|0|||
128024550|NCT01117350|460714446|FG001|Comparative Period|Physician Decision|1|||
128024551|NCT01117350|460714445|FG000|Comparative Period|Move to another city/country|2|||
128024552|NCT01117350|460714446|FG001|Comparative Period|Move to another city/country|1|||
128024553|NCT01117350|460714445|FG000|Extension Period|Not included in extension, not treated|0|||
128024554|NCT01117350|460714446|FG001|Extension Period|Not included in extension, not treated|50|||
128024555|NCT01117350|460714445|FG000|Extension Period|Adverse Event|0|||
128024556|NCT01117350|460714446|FG001|Extension Period|Adverse Event|2|||
128024557|NCT01117350|460714445|FG000|Extension Period|Protocol Violation|0|||
128024558|NCT01117350|460714446|FG001|Extension Period|Protocol Violation|2|||
128024559|NCT01117350|460714445|FG000|Extension Period|Lost to Follow-up|0|||
128024560|NCT01117350|460714446|FG001|Extension Period|Lost to Follow-up|2|||
128024561|NCT01117350|460714445|FG000|Extension Period|Withdrawal by Subject|0|||
128024562|NCT01117350|460714446|FG001|Extension Period|Withdrawal by Subject|3|||
128024563|NCT01117350|460714445|FG000|Extension Period|Lack of Efficacy|0|||
128024564|NCT01117350|460714446|FG001|Extension Period|Lack of Efficacy|2|||
128024565|NCT01117350|460714445|FG000|Extension Period|Inclusion criteria not respected|0|||
128024566|NCT01117350|460714446|FG001|Extension Period|Inclusion criteria not respected|1|||
128024567|NCT01117350|460714445|FG000|Extension Period|Prohibited medication|0|||
128024568|NCT01117350|460714446|FG001|Extension Period|Prohibited medication|1|||
128024569|NCT01049828|460714452|FG000|Overall Study|Claustrophibia and Frustration|2|||
128024570|NCT02946996|460714454|FG000|Overall Study|non-evaluable|3|||
127687580|NCT02723955|459483553|FG040|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
127687581|NCT02723955|459483554|FG041|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
127687582|NCT02723955|459483555|FG042|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
127687583|NCT02723955|459483513|FG000|Escalation Phase|Site Closed|0|||
127687584|NCT02723955|459483514|FG001|Escalation Phase|Site Closed|0|||
127687585|NCT02723955|459483515|FG002|Escalation Phase|Site Closed|0|||
127687586|NCT02723955|459483516|FG003|Escalation Phase|Site Closed|0|||
127687587|NCT02723955|459483517|FG004|Escalation Phase|Site Closed|0|||
127687588|NCT02723955|459483518|FG005|Escalation Phase|Site Closed|0|||
127687589|NCT02723955|459483519|FG006|Escalation Phase|Site Closed|0|||
127687590|NCT02723955|459483520|FG007|Escalation Phase|Site Closed|0|||
127687591|NCT02723955|459483521|FG008|Escalation Phase|Site Closed|0|||
127687592|NCT02723955|459483522|FG009|Escalation Phase|Site Closed|0|||
127687593|NCT02723955|459483523|FG010|Escalation Phase|Site Closed|0|||
127687594|NCT02723955|459483524|FG011|Escalation Phase|Site Closed|0|||
127687595|NCT02723955|459483525|FG012|Escalation Phase|Site Closed|0|||
127687596|NCT02723955|459483526|FG013|Escalation Phase|Site Closed|0|||
127687597|NCT02723955|459483527|FG014|Escalation Phase|Site Closed|0|||
127687598|NCT02723955|459483528|FG015|Escalation Phase|Site Closed|1|||
127687599|NCT02723955|459483529|FG016|Escalation Phase|Site Closed|0|||
127687600|NCT02723955|459483530|FG017|Escalation Phase|Site Closed|2|||
127687601|NCT02723955|459483531|FG018|Escalation Phase|Site Closed|0|||
128024571|NCT02946996|460714455|FG001|Overall Study|non-evaluable|6|||
128024572|NCT02946996|460714456|FG002|Overall Study|non-evaluable|5|||
128024573|NCT06097273|460714459|FG000|Overall Study|Death|2|||
128024574|NCT06097273|460714460|FG001|Overall Study|Death|1|||
127560967|NCT01763996|459023540|FG000|Treatment Period 2|Adverse Event|0|||
127560968|NCT01763996|459023541|FG001|Treatment Period 2|Adverse Event|1|||
127560969|NCT00865280|459023542|FG000|Overall Study|Withdrawal by Subject|4|||
127560970|NCT00865280|459023543|FG001|Overall Study|Withdrawal by Subject|1|||
127560971|NCT00865280|459023542|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
127560972|NCT00865280|459023543|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
127560973|NCT00865280|459023542|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
127560974|NCT00865280|459023543|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
127560975|NCT00865280|459023542|FG000|Overall Study|Exclusion Condition|1|||
127560976|NCT00865280|459023543|FG001|Overall Study|Exclusion Condition|0|||
127560977|NCT00865280|459023542|FG000|Overall Study|Adverse Event|0|||
127560978|NCT00865280|459023543|FG001|Overall Study|Adverse Event|1|||
127560979|NCT01788215|459023546|FG000|Overall Study|Withdrawal by Subject|0|||
127560980|NCT01788215|459023547|FG001|Overall Study|Withdrawal by Subject|1|||
127560981|NCT01788215|459023546|FG000|Overall Study|Lost to Follow-up|2|||
127560982|NCT01788215|459023547|FG001|Overall Study|Lost to Follow-up|0|||
127560983|NCT00612105|459023550|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
127560984|NCT00612105|459023551|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
127560985|NCT00612105|459023550|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
127560986|NCT00612105|459023551|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
127560987|NCT00612105|459023550|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
127560988|NCT00612105|459023551|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
127560989|NCT00612105|459023550|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
127560990|NCT00612105|459023551|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
127560991|NCT00612105|459023550|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
127560992|NCT00612105|459023551|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
127560993|NCT00612105|459023550|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
127560994|NCT00612105|459023551|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
127560995|NCT00612105|459023550|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
127560996|NCT00612105|459023551|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
127560997|NCT00612105|459023550|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
127560998|NCT00612105|459023551|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
127560999|NCT00612105|459023550|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
127561000|NCT00612105|459023551|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
127561001|NCT00612105|459023550|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
127561002|NCT00612105|459023551|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
127561003|NCT00612105|459023550|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
127561004|NCT00612105|459023551|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
127561005|NCT00612105|459023550|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
127561006|NCT00612105|459023551|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
127561007|NCT01105767|459023552|FG000|Overall Study|Lost to Follow-up|1160|||
127561008|NCT01105767|459023553|FG001|Overall Study|Lost to Follow-up|1614|||
127561009|NCT01105767|459023554|FG002|Overall Study|Lost to Follow-up|1184|||
127561010|NCT00743106|459023555|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
127561011|NCT00743106|459023556|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
127561012|NCT02874144|459023563|FG000|Overall Study|Lost to Follow-up|3|||
127561013|NCT02874144|459023564|FG001|Overall Study|Lost to Follow-up|5|||
127561014|NCT03753789|459023566|FG000|Overall Study|Withdrawal by Subject|2|||
127561015|NCT01578850|459023570|FG000|Period 1|Insufficient Clinical Response|1|||
127561016|NCT01578850|459023571|FG001|Period 1|Insufficient Clinical Response|0|||
127561017|NCT01578850|459023572|FG002|Period 1|Insufficient Clinical Response|0|||
127561018|NCT01578850|459023570|FG000|Period 1|Adverse Event|11|||
127561019|NCT01578850|459023571|FG001|Period 1|Adverse Event|0|||
127561020|NCT01578850|459023572|FG002|Period 1|Adverse Event|0|||
127561021|NCT01578850|459023570|FG000|Period 1|Death|1|||
127561022|NCT01578850|459023571|FG001|Period 1|Death|0|||
127561023|NCT01578850|459023572|FG002|Period 1|Death|0|||
127561024|NCT01578850|459023570|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
127561025|NCT01578850|459023571|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
127561026|NCT01578850|459023572|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
127561027|NCT01578850|459023570|FG000|Period 1|Withdrawal by Subject|9|||
127561028|NCT01578850|459023571|FG001|Period 1|Withdrawal by Subject|0|||
127561029|NCT01578850|459023572|FG002|Period 1|Withdrawal by Subject|0|||
127561030|NCT01578850|459023570|FG000|Period 1|Study Terminated by Sponsor|3|||
127687602|NCT02723955|459483532|FG019|Escalation Phase|Site Closed|0|||
127561031|NCT01578850|459023571|FG001|Period 1|Study Terminated by Sponsor|0|||
127561032|NCT01578850|459023572|FG002|Period 1|Study Terminated by Sponsor|0|||
127561033|NCT01578850|459023570|FG000|Period 2|Insufficient Clinical Response|0|||
127561034|NCT01578850|459023571|FG001|Period 2|Insufficient Clinical Response|1|||
127561035|NCT01578850|459023572|FG002|Period 2|Insufficient Clinical Response|0|||
127561036|NCT01578850|459023570|FG000|Period 2|Adverse Event|0|||
127561037|NCT01578850|459023571|FG001|Period 2|Adverse Event|3|||
127561038|NCT01578850|459023572|FG002|Period 2|Adverse Event|6|||
127687603|NCT02723955|459483533|FG020|Escalation Phase|Site Closed|1|||
127687604|NCT02723955|459483534|FG021|Escalation Phase|Site Closed|0|||
127687605|NCT02723955|459483535|FG022|Escalation Phase|Site Closed|0|||
127687606|NCT02723955|459483536|FG023|Escalation Phase|Site Closed|0|||
127687607|NCT02723955|459483537|FG024|Escalation Phase|Site Closed|3|||
127687608|NCT02723955|459483538|FG025|Escalation Phase|Site Closed|1|||
127687609|NCT02723955|459483539|FG026|Escalation Phase|Site Closed|3|||
127687610|NCT02723955|459483540|FG027|Escalation Phase|Site Closed|1|||
127687611|NCT02723955|459483541|FG028|Escalation Phase|Site Closed|1|||
127687612|NCT02723955|459483542|FG029|Escalation Phase|Site Closed|0|||
127687613|NCT02723955|459483543|FG030|Escalation Phase|Site Closed|0|||
127687614|NCT02723955|459483544|FG031|Escalation Phase|Site Closed|0|||
127687615|NCT02723955|459483545|FG032|Escalation Phase|Site Closed|0|||
127687616|NCT02723955|459483546|FG033|Escalation Phase|Site Closed|0|||
127687617|NCT02723955|459483547|FG034|Escalation Phase|Site Closed|0|||
127687618|NCT02723955|459483548|FG035|Escalation Phase|Site Closed|0|||
127687619|NCT02723955|459483549|FG036|Escalation Phase|Site Closed|0|||
127687620|NCT02723955|459483550|FG037|Escalation Phase|Site Closed|0|||
127687621|NCT02723955|459483551|FG038|Escalation Phase|Site Closed|0|||
127687622|NCT02723955|459483552|FG039|Escalation Phase|Site Closed|0|||
127687623|NCT02723955|459483553|FG040|Escalation Phase|Site Closed|0|||
127687624|NCT02723955|459483554|FG041|Escalation Phase|Site Closed|0|||
127687625|NCT02723955|459483555|FG042|Escalation Phase|Site Closed|0|||
127687626|NCT02723955|459483513|FG000|Expansion Phase|Death|0|||
127687627|NCT02723955|459483514|FG001|Expansion Phase|Death|0|||
127687628|NCT02723955|459483515|FG002|Expansion Phase|Death|0|||
127687629|NCT02723955|459483516|FG003|Expansion Phase|Death|0|||
127687630|NCT02723955|459483517|FG004|Expansion Phase|Death|0|||
127687631|NCT02723955|459483518|FG005|Expansion Phase|Death|0|||
127687632|NCT02723955|459483519|FG006|Expansion Phase|Death|0|||
127687633|NCT02723955|459483520|FG007|Expansion Phase|Death|0|||
127687634|NCT02723955|459483521|FG008|Expansion Phase|Death|0|||
128024575|NCT06097273|460714461|FG002|Overall Study|Death|2|||
128024576|NCT06097273|460714462|FG003|Overall Study|Death|2|||
128024577|NCT06097273|460714459|FG000|Overall Study|Lost to Follow-up|27|||
128024578|NCT06097273|460714460|FG001|Overall Study|Lost to Follow-up|18|||
128024579|NCT06097273|460714461|FG002|Overall Study|Lost to Follow-up|36|||
128024580|NCT06097273|460714462|FG003|Overall Study|Lost to Follow-up|31|||
128024581|NCT06097273|460714459|FG000|Overall Study|Physician Decision|0|||
128024582|NCT06097273|460714460|FG001|Overall Study|Physician Decision|1|||
128024583|NCT06097273|460714461|FG002|Overall Study|Physician Decision|0|||
128024584|NCT06097273|460714462|FG003|Overall Study|Physician Decision|3|||
128024585|NCT06097273|460714459|FG000|Overall Study|Protocol Violation|1|||
127561039|NCT01578850|459023570|FG000|Period 2|Lost to Follow-up|0|||
127561040|NCT01578850|459023571|FG001|Period 2|Lost to Follow-up|1|||
127561041|NCT01578850|459023572|FG002|Period 2|Lost to Follow-up|2|||
127561042|NCT01578850|459023570|FG000|Period 2|Withdrawal by Subject|0|||
127561043|NCT01578850|459023571|FG001|Period 2|Withdrawal by Subject|2|||
127561044|NCT01578850|459023572|FG002|Period 2|Withdrawal by Subject|2|||
127561045|NCT01578850|459023570|FG000|Period 2|Study Terminated by Sponsor|0|||
127561046|NCT01578850|459023571|FG001|Period 2|Study Terminated by Sponsor|5|||
127561047|NCT01578850|459023572|FG002|Period 2|Study Terminated by Sponsor|4|||
127561048|NCT01578850|459023570|FG000|Period 2|Unspecified Reasons|0|||
127561049|NCT01578850|459023571|FG001|Period 2|Unspecified Reasons|1|||
127561050|NCT01578850|459023572|FG002|Period 2|Unspecified Reasons|0|||
127561051|NCT02744040|459023575|FG000|Overall Study|Withdrawal by Subject|3|||
127561052|NCT02744040|459023576|FG001|Overall Study|Withdrawal by Subject|2|||
127561053|NCT02744040|459023577|FG002|Overall Study|Withdrawal by Subject|2|||
127561054|NCT02744040|459023575|FG000|Overall Study|Physician Decision|0|||
127561055|NCT02744040|459023576|FG001|Overall Study|Physician Decision|8|||
127561056|NCT02744040|459023577|FG002|Overall Study|Physician Decision|13|||
127561057|NCT02744040|459023575|FG000|Overall Study|Lost to Follow-up|3|||
127561058|NCT02744040|459023576|FG001|Overall Study|Lost to Follow-up|1|||
127561059|NCT02744040|459023577|FG002|Overall Study|Lost to Follow-up|7|||
127561060|NCT00096356|459023578|FG000|Overall Study|Adverse Event|11|||
127561061|NCT00096356|459023579|FG001|Overall Study|Adverse Event|9|||
127561062|NCT00096356|459023578|FG000|Overall Study|Physician Decision|5|||
127561063|NCT00096356|459023579|FG001|Overall Study|Physician Decision|3|||
127561064|NCT00096356|459023578|FG000|Overall Study|Withdrawal by Subject|17|||
127561065|NCT00096356|459023579|FG001|Overall Study|Withdrawal by Subject|23|||
127561066|NCT00096356|459023578|FG000|Overall Study|Lack of Efficacy|1|||
127687635|NCT02723955|459483522|FG009|Expansion Phase|Death|25|||
127687636|NCT02723955|459483523|FG010|Expansion Phase|Death|69|||
127687637|NCT02723955|459483524|FG011|Expansion Phase|Death|48|||
128024586|NCT06097273|460714460|FG001|Overall Study|Protocol Violation|1|||
128024587|NCT06097273|460714461|FG002|Overall Study|Protocol Violation|2|||
128024588|NCT06097273|460714462|FG003|Overall Study|Protocol Violation|1|||
127687638|NCT02723955|459483525|FG012|Expansion Phase|Death|0|||
127687639|NCT02723955|459483526|FG013|Expansion Phase|Death|0|||
127687640|NCT02723955|459483527|FG014|Expansion Phase|Death|0|||
127687641|NCT02723955|459483528|FG015|Expansion Phase|Death|0|||
128024589|NCT06097273|460714459|FG000|Overall Study|Withdrawal by Subject|14|||
127561067|NCT00096356|459023579|FG001|Overall Study|Lack of Efficacy|0|||
127561068|NCT00096356|459023578|FG000|Overall Study|multiple reasons|10|||
127561069|NCT00096356|459023579|FG001|Overall Study|multiple reasons|18|||
127561070|NCT03288142|459023583|FG000|Overall Study|Lost to Follow-up|22|||
127561071|NCT03288142|459023584|FG001|Overall Study|Lost to Follow-up|15|||
127561072|NCT00946153|459023585|FG000|Phase 2|Adverse Event|0|||
127561073|NCT00946153|459023586|FG001|Phase 2|Adverse Event|0|||
127561074|NCT00946153|459023587|FG002|Phase 2|Adverse Event|0|||
127561075|NCT00946153|459023588|FG003|Phase 2|Adverse Event|0|||
127561076|NCT00946153|459023589|FG004|Phase 2|Adverse Event|6|||
127561077|NCT00946153|459023585|FG000|Phase 2|Need more reduction of dose|0|||
127561078|NCT00946153|459023586|FG001|Phase 2|Need more reduction of dose|0|||
127561079|NCT00946153|459023587|FG002|Phase 2|Need more reduction of dose|0|||
127561080|NCT00946153|459023588|FG003|Phase 2|Need more reduction of dose|0|||
127561081|NCT00946153|459023589|FG004|Phase 2|Need more reduction of dose|2|||
127561082|NCT00946153|459023585|FG000|Phase 2|Physician Decision|0|||
127561083|NCT00946153|459023586|FG001|Phase 2|Physician Decision|0|||
127561084|NCT00946153|459023587|FG002|Phase 2|Physician Decision|0|||
127561085|NCT00946153|459023588|FG003|Phase 2|Physician Decision|0|||
127561086|NCT00946153|459023589|FG004|Phase 2|Physician Decision|1|||
127561087|NCT00946153|459023585|FG000|Phase 2|14 days washout for recovery due to AE|0|||
127561088|NCT00946153|459023586|FG001|Phase 2|14 days washout for recovery due to AE|0|||
127561089|NCT00946153|459023587|FG002|Phase 2|14 days washout for recovery due to AE|0|||
127561090|NCT00946153|459023588|FG003|Phase 2|14 days washout for recovery due to AE|0|||
127561091|NCT00946153|459023589|FG004|Phase 2|14 days washout for recovery due to AE|4|||
127561092|NCT01030666|459023590|FG000|Overall Study|Lost to Follow-up|3|||
127561093|NCT01030666|459023591|FG001|Overall Study|Lost to Follow-up|2|||
127561094|NCT03698591|459023592|FG000|Overall Study|Withdrawal by Subject|2|||
127561095|NCT03698591|459023593|FG001|Overall Study|Withdrawal by Subject|2|||
127561096|NCT03698591|459023592|FG000|Overall Study|Failed drug screen|1|||
127561097|NCT03698591|459023593|FG001|Overall Study|Failed drug screen|1|||
127561098|NCT03698591|459023592|FG000|Overall Study|Failed health screen|0|||
127561099|NCT03698591|459023593|FG001|Overall Study|Failed health screen|1|||
127561100|NCT03698591|459023592|FG000|Overall Study|Ineligible for financial compensation|1|||
127561101|NCT03698591|459023593|FG001|Overall Study|Ineligible for financial compensation|0|||
127561102|NCT03698591|459023592|FG000|Overall Study|Equipment Error|1|||
127561103|NCT03698591|459023593|FG001|Overall Study|Equipment Error|0|||
127561104|NCT03698591|459023592|FG000|Overall Study|Could not establish TMS dosage|0|||
127561105|NCT03698591|459023593|FG001|Overall Study|Could not establish TMS dosage|1|||
127561106|NCT04359901|459023596|FG000|Overall Study|Withdrawal by Subject|0|||
127561107|NCT04359901|459023597|FG001|Overall Study|Withdrawal by Subject|1|||
127561108|NCT04359901|459023596|FG000|Overall Study|Death|6|||
127561109|NCT04359901|459023597|FG001|Overall Study|Death|2|||
127561110|NCT00557856|459023599|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
127561111|NCT00557856|459023600|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
127561112|NCT00557856|459023601|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
127561113|NCT00557856|459023602|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
127561114|NCT00557856|459023603|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
127561115|NCT00557856|459023604|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
127561116|NCT00557856|459023605|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
127561117|NCT00557856|459023606|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
127561118|NCT00557856|459023607|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
127561119|NCT00557856|459023599|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
127561120|NCT00557856|459023600|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
127561121|NCT00557856|459023601|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
127561122|NCT00557856|459023602|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
127561123|NCT00557856|459023603|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
127561124|NCT00557856|459023604|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
127561125|NCT00557856|459023605|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
127561126|NCT00557856|459023606|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
127561127|NCT00557856|459023607|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
127561128|NCT00557856|459023599|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
127561129|NCT00557856|459023600|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
127561130|NCT00557856|459023601|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
127561131|NCT00557856|459023602|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
127561132|NCT00557856|459023603|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
127561133|NCT00557856|459023604|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
127561134|NCT00557856|459023605|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
127561135|NCT00557856|459023606|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
127561136|NCT00557856|459023607|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
127561137|NCT00557856|459023599|FG000|Part 1: Dose Escalation Phase|Other|0|||
127561138|NCT00557856|459023600|FG001|Part 1: Dose Escalation Phase|Other|0|||
127561139|NCT00557856|459023601|FG002|Part 1: Dose Escalation Phase|Other|1|||
127561140|NCT00557856|459023602|FG003|Part 1: Dose Escalation Phase|Other|1|||
127561141|NCT00557856|459023603|FG004|Part 1: Dose Escalation Phase|Other|0|||
127561142|NCT00557856|459023604|FG005|Part 1: Dose Escalation Phase|Other|0|||
127561143|NCT00557856|459023605|FG006|Part 1: Dose Escalation Phase|Other|0|||
127561144|NCT00557856|459023606|FG007|Part 1: Dose Escalation Phase|Other|1|||
127561145|NCT00557856|459023607|FG008|Part 1: Dose Escalation Phase|Other|0|||
127561146|NCT00557856|459023599|FG000|Part 1: Dose Escalation Phase|Death|0|||
127561147|NCT00557856|459023600|FG001|Part 1: Dose Escalation Phase|Death|0|||
127561148|NCT00557856|459023601|FG002|Part 1: Dose Escalation Phase|Death|0|||
127561149|NCT00557856|459023602|FG003|Part 1: Dose Escalation Phase|Death|0|||
127561150|NCT00557856|459023603|FG004|Part 1: Dose Escalation Phase|Death|0|||
127561151|NCT00557856|459023604|FG005|Part 1: Dose Escalation Phase|Death|1|||
127561152|NCT00557856|459023605|FG006|Part 1: Dose Escalation Phase|Death|0|||
127561153|NCT00557856|459023606|FG007|Part 1: Dose Escalation Phase|Death|0|||
127561154|NCT00557856|459023607|FG008|Part 1: Dose Escalation Phase|Death|0|||
127561155|NCT00557856|459023599|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
127561156|NCT00557856|459023600|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
127561157|NCT00557856|459023601|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
127561158|NCT00557856|459023602|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
127561159|NCT00557856|459023603|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
127561160|NCT00557856|459023604|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
127561161|NCT00557856|459023605|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
127775907|NCT04124614|459806772|FG001|Double Blind Treatment Period|Withdrawal by Subject|26|||
127775908|NCT04124614|459806773|FG002|Double Blind Treatment Period|Withdrawal by Subject|22|||
127775909|NCT04124614|459806771|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
127775910|NCT04124614|459806772|FG001|Double Blind Treatment Period|Reason Not Specified|11|||
127775911|NCT04124614|459806773|FG002|Double Blind Treatment Period|Reason Not Specified|7|||
127775912|NCT01179672|459808285|FG000|Overall Study|Adverse Event|17|||
127775913|NCT01179672|459808286|FG001|Overall Study|Adverse Event|8|||
127775914|NCT01179672|459808285|FG000|Overall Study|Withdrawal by Subject|10|||
127775915|NCT01179672|459808286|FG001|Overall Study|Withdrawal by Subject|12|||
127775916|NCT01179672|459808285|FG000|Overall Study|Entry Criteria Not Met|0|||
127775917|NCT01179672|459808286|FG001|Overall Study|Entry Criteria Not Met|2|||
127775918|NCT01179672|459808285|FG000|Overall Study|Lost to Follow-up|0|||
127775919|NCT01179672|459808286|FG001|Overall Study|Lost to Follow-up|1|||
127775920|NCT01179672|459808285|FG000|Overall Study|Protocol Violation|2|||
127775921|NCT01179672|459808286|FG001|Overall Study|Protocol Violation|2|||
127775922|NCT01179672|459808285|FG000|Overall Study|Physician Decision|1|||
127775923|NCT01179672|459808286|FG001|Overall Study|Physician Decision|1|||
127775924|NCT02748018|459808289|FG000|Study Period|Adverse Event|1|||
127775925|NCT02748018|459808290|FG001|Study Period|Adverse Event|3|||
127775926|NCT02748018|459808291|FG002|Study Period|Adverse Event|4|||
127775927|NCT02748018|459808292|FG003|Study Period|Adverse Event|0|||
127775928|NCT02748018|459808293|FG004|Study Period|Adverse Event|3|||
127775929|NCT02748018|459808294|FG005|Study Period|Adverse Event|3|||
127775930|NCT02748018|459808289|FG000|Study Period|Withdrawal by Subject|7|||
127775931|NCT02748018|459808290|FG001|Study Period|Withdrawal by Subject|4|||
127775932|NCT02748018|459808291|FG002|Study Period|Withdrawal by Subject|4|||
127775933|NCT02748018|459808292|FG003|Study Period|Withdrawal by Subject|11|||
127775934|NCT02748018|459808293|FG004|Study Period|Withdrawal by Subject|12|||
127775935|NCT02748018|459808294|FG005|Study Period|Withdrawal by Subject|10|||
127775936|NCT02748018|459808289|FG000|Study Period|Pregnancy|0|||
127775937|NCT02748018|459808290|FG001|Study Period|Pregnancy|1|||
127775938|NCT02748018|459808291|FG002|Study Period|Pregnancy|0|||
127775939|NCT02748018|459808292|FG003|Study Period|Pregnancy|0|||
127775940|NCT02748018|459808293|FG004|Study Period|Pregnancy|1|||
127775941|NCT02748018|459808294|FG005|Study Period|Pregnancy|0|||
127775942|NCT02748018|459808289|FG000|Study Period|Physician Decision|2|||
127775943|NCT02748018|459808290|FG001|Study Period|Physician Decision|2|||
127775944|NCT02748018|459808291|FG002|Study Period|Physician Decision|1|||
127775945|NCT02748018|459808292|FG003|Study Period|Physician Decision|0|||
127775946|NCT02748018|459808293|FG004|Study Period|Physician Decision|2|||
127775947|NCT02748018|459808294|FG005|Study Period|Physician Decision|0|||
127775948|NCT02748018|459808289|FG000|Study Period|Lost to Follow-up|0|||
127775949|NCT02748018|459808290|FG001|Study Period|Lost to Follow-up|0|||
127775950|NCT02748018|459808291|FG002|Study Period|Lost to Follow-up|0|||
127775951|NCT02748018|459808292|FG003|Study Period|Lost to Follow-up|2|||
127561162|NCT00557856|459023606|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
127775952|NCT02748018|459808293|FG004|Study Period|Lost to Follow-up|0|||
127775953|NCT02748018|459808294|FG005|Study Period|Lost to Follow-up|1|||
127775954|NCT02748018|459808289|FG000|Continuation Period|Adverse Event|2|||
127775955|NCT02748018|459808290|FG001|Continuation Period|Adverse Event|0|||
127775956|NCT02748018|459808291|FG002|Continuation Period|Adverse Event|1|||
127775957|NCT02748018|459808292|FG003|Continuation Period|Adverse Event|1|||
127775958|NCT02748018|459808293|FG004|Continuation Period|Adverse Event|1|||
127561163|NCT00557856|459023607|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
127561164|NCT00557856|459023599|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
127561165|NCT00557856|459023600|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
127561166|NCT00557856|459023601|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
127561167|NCT00557856|459023602|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
127561168|NCT00557856|459023603|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
127561169|NCT00557856|459023604|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
127561170|NCT00557856|459023605|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
127561171|NCT00557856|459023606|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
127561172|NCT00557856|459023607|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
127561173|NCT00557856|459023599|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
127561174|NCT00557856|459023600|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
127561175|NCT00557856|459023601|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
127561176|NCT00557856|459023602|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
127561177|NCT00557856|459023603|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
127561178|NCT00557856|459023604|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
127561179|NCT00557856|459023605|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
127561180|NCT00557856|459023606|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
127561181|NCT00557856|459023607|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
127561182|NCT00557856|459023599|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
127561183|NCT00557856|459023600|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
127561184|NCT00557856|459023601|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
127561185|NCT00557856|459023602|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
127561186|NCT00557856|459023603|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
127561187|NCT00557856|459023604|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
127561188|NCT00557856|459023605|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
127561189|NCT00557856|459023606|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
127561190|NCT00557856|459023607|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
127561191|NCT00557856|459023599|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
127561192|NCT00557856|459023600|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
127561193|NCT00557856|459023601|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
127561194|NCT00557856|459023602|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
127561195|NCT00557856|459023603|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
127561196|NCT00557856|459023604|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
127561197|NCT00557856|459023605|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
127561198|NCT00557856|459023606|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
127561199|NCT00557856|459023607|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
127561200|NCT00557856|459023599|FG000|Part 2: Exploratory Phase|Other|0|||
127561201|NCT00557856|459023600|FG001|Part 2: Exploratory Phase|Other|0|||
127561202|NCT00557856|459023601|FG002|Part 2: Exploratory Phase|Other|0|||
127561203|NCT00557856|459023602|FG003|Part 2: Exploratory Phase|Other|0|||
127561204|NCT00557856|459023603|FG004|Part 2: Exploratory Phase|Other|0|||
127561205|NCT00557856|459023604|FG005|Part 2: Exploratory Phase|Other|0|||
127561206|NCT00557856|459023605|FG006|Part 2: Exploratory Phase|Other|0|||
127561207|NCT00557856|459023606|FG007|Part 2: Exploratory Phase|Other|0|||
127561208|NCT00557856|459023607|FG008|Part 2: Exploratory Phase|Other|1|||
127561209|NCT00557856|459023599|FG000|Part 2: Exploratory Phase|Death|0|||
127561210|NCT00557856|459023600|FG001|Part 2: Exploratory Phase|Death|0|||
127561211|NCT00557856|459023601|FG002|Part 2: Exploratory Phase|Death|0|||
127561212|NCT00557856|459023602|FG003|Part 2: Exploratory Phase|Death|0|||
127561213|NCT00557856|459023603|FG004|Part 2: Exploratory Phase|Death|0|||
127561214|NCT00557856|459023604|FG005|Part 2: Exploratory Phase|Death|0|||
127561215|NCT00557856|459023605|FG006|Part 2: Exploratory Phase|Death|0|||
127561216|NCT00557856|459023606|FG007|Part 2: Exploratory Phase|Death|0|||
127561217|NCT00557856|459023607|FG008|Part 2: Exploratory Phase|Death|2|||
127561218|NCT00557856|459023599|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
127561219|NCT00557856|459023600|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
127561220|NCT00557856|459023601|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
127561221|NCT00557856|459023602|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
127561222|NCT00557856|459023603|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
127561223|NCT00557856|459023604|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
127561224|NCT00557856|459023605|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
127561225|NCT00557856|459023606|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
127561226|NCT00557856|459023607|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
127561227|NCT01675167|459023608|FG000|Open-label Titration Phase|Adverse Event|81|||
127561228|NCT01675167|459023609|FG001|Open-label Titration Phase|Adverse Event|0|||
127561229|NCT01675167|459023610|FG002|Open-label Titration Phase|Adverse Event|0|||
127561230|NCT01675167|459023608|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
127561231|NCT01675167|459023609|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
127561232|NCT01675167|459023610|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
127561233|NCT01675167|459023608|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
127561234|NCT01675167|459023609|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
127561235|NCT01675167|459023610|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
127561236|NCT01675167|459023608|FG000|Open-label Titration Phase|Protocol Violation|43|||
127561237|NCT01675167|459023609|FG001|Open-label Titration Phase|Protocol Violation|0|||
127561238|NCT01675167|459023610|FG002|Open-label Titration Phase|Protocol Violation|0|||
127561239|NCT01675167|459023608|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
127561240|NCT01675167|459023609|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
127561241|NCT01675167|459023610|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
127561242|NCT01675167|459023608|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
127561243|NCT01675167|459023609|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
127561244|NCT01675167|459023610|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
127561245|NCT01675167|459023608|FG000|Open-label Titration Phase|Other|55|||
127561246|NCT01675167|459023609|FG001|Open-label Titration Phase|Other|0|||
127561247|NCT01675167|459023610|FG002|Open-label Titration Phase|Other|0|||
127561248|NCT01675167|459023608|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
127561249|NCT01675167|459023609|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
127561250|NCT01675167|459023610|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
127561251|NCT01675167|459023608|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
127561252|NCT01675167|459023609|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
127561253|NCT01675167|459023610|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
127561254|NCT01675167|459023608|FG000|Double-blind Treatment Phase|Adverse Event|0|||
127561255|NCT01675167|459023609|FG001|Double-blind Treatment Phase|Adverse Event|5|||
127561256|NCT01675167|459023610|FG002|Double-blind Treatment Phase|Adverse Event|13|||
127561257|NCT01675167|459023608|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
127561258|NCT01675167|459023609|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
127561259|NCT01675167|459023610|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
127561260|NCT01675167|459023608|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
127561261|NCT01675167|459023609|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
127561262|NCT01675167|459023610|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
127561263|NCT01675167|459023608|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
127561264|NCT01675167|459023609|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
127561265|NCT01675167|459023610|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
127561266|NCT01675167|459023608|FG000|Double-blind Treatment Phase|Other|0|||
127561267|NCT01675167|459023609|FG001|Double-blind Treatment Phase|Other|7|||
127561268|NCT01675167|459023610|FG002|Double-blind Treatment Phase|Other|5|||
127561269|NCT01525225|459023613|FG000|Enrollment|No longer met study criteria|1|||
127561270|NCT01525225|459023613|FG000|Enrollment|Other|1|||
127561271|NCT00243841|459023614|FG000|Overall Study|Physician Decision|0|||
127561272|NCT00243841|459023615|FG001|Overall Study|Physician Decision|0|||
127561273|NCT00243841|459023616|FG002|Overall Study|Physician Decision|1|||
127561274|NCT00243841|459023617|FG003|Overall Study|Physician Decision|0|||
127561275|NCT00243841|459023618|FG004|Overall Study|Physician Decision|0|||
127561276|NCT00243841|459023619|FG005|Overall Study|Physician Decision|2|||
127561277|NCT00363545|459023620|FG000|Overall Study|Serious Adverse Event|0|||
127561278|NCT00363545|459023621|FG001|Overall Study|Serious Adverse Event|1|||
127561279|NCT00363545|459023620|FG000|Overall Study|Withdrawal by Subject|12|||
127561280|NCT00363545|459023621|FG001|Overall Study|Withdrawal by Subject|15|||
127561281|NCT00363545|459023620|FG000|Overall Study|Migrated/moved from study area|3|||
127561282|NCT00363545|459023621|FG001|Overall Study|Migrated/moved from study area|6|||
127561283|NCT00363545|459023620|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
127561284|NCT00363545|459023621|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
127561285|NCT00363545|459023620|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
127561286|NCT00363545|459023621|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
127561287|NCT00363545|459023620|FG000|Overall Study|Others|1|||
127561288|NCT00363545|459023621|FG001|Overall Study|Others|0|||
127561289|NCT01182844|459023622|FG000|Overall Study|Withdrawal by Subject|0|||
127561290|NCT01182844|459023623|FG001|Overall Study|Withdrawal by Subject|2|||
127561291|NCT01379508|459023624|FG000|Treatment to Week 104|Adverse Event|2|||
127561292|NCT01379508|459023625|FG001|Treatment to Week 104|Adverse Event|0|||
127561293|NCT01379508|459023626|FG002|Treatment to Week 104|Adverse Event|5|||
127561294|NCT01379508|459023627|FG003|Treatment to Week 104|Adverse Event|0|||
127561295|NCT01379508|459023624|FG000|Treatment to Week 104|Abnormal lab value|1|||
127561296|NCT01379508|459023625|FG001|Treatment to Week 104|Abnormal lab value|0|||
127561297|NCT01379508|459023626|FG002|Treatment to Week 104|Abnormal lab value|0|||
127561298|NCT01379508|459023627|FG003|Treatment to Week 104|Abnormal lab value|0|||
127561299|NCT01379508|459023624|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
127561300|NCT01379508|459023625|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
127561301|NCT01379508|459023626|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
127561302|NCT01379508|459023627|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
127561303|NCT01379508|459023624|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
127561304|NCT01379508|459023625|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
127561305|NCT01379508|459023626|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
127561306|NCT01379508|459023627|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
127561307|NCT01379508|459023624|FG000|Treatment to Week 104|Lost to Follow-up|5|||
127561308|NCT01379508|459023625|FG001|Treatment to Week 104|Lost to Follow-up|0|||
127561309|NCT01379508|459023626|FG002|Treatment to Week 104|Lost to Follow-up|3|||
127561310|NCT01379508|459023627|FG003|Treatment to Week 104|Lost to Follow-up|0|||
127561311|NCT01379508|459023624|FG000|Treatment to Week 104|Administrative problems|3|||
127561312|NCT01379508|459023625|FG001|Treatment to Week 104|Administrative problems|1|||
127561313|NCT01379508|459023626|FG002|Treatment to Week 104|Administrative problems|0|||
127561314|NCT01379508|459023627|FG003|Treatment to Week 104|Administrative problems|0|||
127561315|NCT01379508|459023624|FG000|Treatment to Week 104|Protocol Violation|1|||
127561316|NCT01379508|459023625|FG001|Treatment to Week 104|Protocol Violation|1|||
127561317|NCT01379508|459023626|FG002|Treatment to Week 104|Protocol Violation|1|||
127561318|NCT01379508|459023627|FG003|Treatment to Week 104|Protocol Violation|0|||
127561319|NCT01379508|459023624|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
127561320|NCT01379508|459023625|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
127561321|NCT01379508|459023626|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
127561322|NCT01379508|459023627|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
127561323|NCT01379508|459023624|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
127561324|NCT01379508|459023625|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
127561325|NCT01379508|459023626|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
127561326|NCT01379508|459023627|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
127561327|NCT01379508|459023624|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
127561328|NCT01379508|459023625|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
127561329|NCT01379508|459023626|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
127561330|NCT01379508|459023627|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
127561331|NCT01379508|459023624|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
127561332|NCT01379508|459023625|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
127561333|NCT01379508|459023626|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
127561334|NCT01379508|459023627|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
127561335|NCT01457352|459023628|FG000|Period 1|Adverse Event|2|||
127561336|NCT01457352|459023629|FG001|Period 1|Adverse Event|0|||
127561337|NCT01457352|459023628|FG000|Period 1|Withdrawal by Subject|2|||
127561338|NCT01457352|459023629|FG001|Period 1|Withdrawal by Subject|0|||
127561339|NCT01457352|459023628|FG000|Period 1|Physician Decision|2|||
127561340|NCT01457352|459023629|FG001|Period 1|Physician Decision|0|||
127561341|NCT01457352|459023628|FG000|Period 1|MS related disease progression|1|||
127561342|NCT01457352|459023629|FG001|Period 1|MS related disease progression|0|||
127561343|NCT01457352|459023628|FG000|Period 1|Withdrawn|1|||
127561344|NCT01457352|459023629|FG001|Period 1|Withdrawn|0|||
127561345|NCT01457352|459023628|FG000|Period 1|withdrew per sponsor|1|||
127687642|NCT02723955|459483529|FG016|Expansion Phase|Death|0|||
127687643|NCT02723955|459483530|FG017|Expansion Phase|Death|0|||
127687644|NCT02723955|459483531|FG018|Expansion Phase|Death|0|||
127687645|NCT02723955|459483532|FG019|Expansion Phase|Death|0|||
128024590|NCT06097273|460714460|FG001|Overall Study|Withdrawal by Subject|11|||
128024591|NCT06097273|460714461|FG002|Overall Study|Withdrawal by Subject|14|||
128024592|NCT06097273|460714462|FG003|Overall Study|Withdrawal by Subject|15|||
128024593|NCT06097273|460714459|FG000|Overall Study|Other Than Specified|7|||
128024594|NCT06097273|460714460|FG001|Overall Study|Other Than Specified|3|||
127561346|NCT01457352|459023629|FG001|Period 1|withdrew per sponsor|0|||
127561347|NCT01457352|459023628|FG000|Period 1|Protocol Violation|4|||
127687646|NCT02723955|459483533|FG020|Expansion Phase|Death|0|||
127687647|NCT02723955|459483534|FG021|Expansion Phase|Death|0|||
127687648|NCT02723955|459483535|FG022|Expansion Phase|Death|0|||
127687649|NCT02723955|459483536|FG023|Expansion Phase|Death|0|||
127687650|NCT02723955|459483537|FG024|Expansion Phase|Death|0|||
127687651|NCT02723955|459483538|FG025|Expansion Phase|Death|0|||
127687652|NCT02723955|459483539|FG026|Expansion Phase|Death|0|||
127687653|NCT02723955|459483540|FG027|Expansion Phase|Death|0|||
127687654|NCT02723955|459483541|FG028|Expansion Phase|Death|0|||
127687655|NCT02723955|459483542|FG029|Expansion Phase|Death|12|||
127687656|NCT02723955|459483543|FG030|Expansion Phase|Death|202|||
127687657|NCT02723955|459483544|FG031|Expansion Phase|Death|31|||
128024595|NCT06097273|460714461|FG002|Overall Study|Other Than Specified|11|||
128024596|NCT06097273|460714462|FG003|Overall Study|Other Than Specified|6|||
128024597|NCT01902303|460715921|FG000|Overall Study|Adverse Event|0|||
127561348|NCT01457352|459023629|FG001|Period 1|Protocol Violation|0|||
127687658|NCT02723955|459483545|FG032|Expansion Phase|Death|17|||
127687659|NCT02723955|459483546|FG033|Expansion Phase|Death|2|||
127687660|NCT02723955|459483547|FG034|Expansion Phase|Death|3|||
127687661|NCT02723955|459483548|FG035|Expansion Phase|Death|3|||
127687662|NCT02723955|459483549|FG036|Expansion Phase|Death|1|||
127561349|NCT01457352|459023628|FG000|Period 1|Did not meet eligibility criteria|3|||
127561350|NCT01457352|459023629|FG001|Period 1|Did not meet eligibility criteria|0|||
127687663|NCT02723955|459483550|FG037|Expansion Phase|Death|0|||
127687664|NCT02723955|459483551|FG038|Expansion Phase|Death|0|||
127561351|NCT01457352|459023628|FG000|Period 2|Withdrawal by Subject|23|||
127561352|NCT01457352|459023629|FG001|Period 2|Withdrawal by Subject|0|||
127561353|NCT01457352|459023628|FG000|Period 2|Adverse Event|22|||
127561354|NCT01457352|459023629|FG001|Period 2|Adverse Event|0|||
127561355|NCT01457352|459023628|FG000|Period 2|no analysis|10|||
127561356|NCT01457352|459023629|FG001|Period 2|no analysis|0|||
127561357|NCT01457352|459023628|FG000|Period 2|Lack of Efficacy|8|||
127561358|NCT01457352|459023629|FG001|Period 2|Lack of Efficacy|0|||
127561359|NCT01457352|459023628|FG000|Period 2|Protocol Violation|4|||
127561360|NCT01457352|459023629|FG001|Period 2|Protocol Violation|0|||
127775959|NCT02748018|459808294|FG005|Continuation Period|Adverse Event|4|||
127775960|NCT02748018|459808289|FG000|Continuation Period|Withdrawal by Subject|3|||
127775961|NCT02748018|459808290|FG001|Continuation Period|Withdrawal by Subject|5|||
127775962|NCT02748018|459808291|FG002|Continuation Period|Withdrawal by Subject|3|||
127775963|NCT02748018|459808292|FG003|Continuation Period|Withdrawal by Subject|9|||
127775964|NCT02748018|459808293|FG004|Continuation Period|Withdrawal by Subject|11|||
127775965|NCT02748018|459808294|FG005|Continuation Period|Withdrawal by Subject|1|||
127775966|NCT02748018|459808289|FG000|Continuation Period|Lost to Follow-up|0|||
127775967|NCT02748018|459808290|FG001|Continuation Period|Lost to Follow-up|2|||
127775968|NCT02748018|459808291|FG002|Continuation Period|Lost to Follow-up|1|||
127775969|NCT02748018|459808292|FG003|Continuation Period|Lost to Follow-up|0|||
127775970|NCT02748018|459808293|FG004|Continuation Period|Lost to Follow-up|1|||
127775971|NCT02748018|459808294|FG005|Continuation Period|Lost to Follow-up|0|||
127775972|NCT02748018|459808289|FG000|Continuation Period|Pregnancy|1|||
127775973|NCT02748018|459808290|FG001|Continuation Period|Pregnancy|2|||
127775974|NCT02748018|459808291|FG002|Continuation Period|Pregnancy|0|||
127775975|NCT02748018|459808292|FG003|Continuation Period|Pregnancy|0|||
127775976|NCT02748018|459808293|FG004|Continuation Period|Pregnancy|0|||
127775977|NCT02748018|459808294|FG005|Continuation Period|Pregnancy|0|||
127775978|NCT02748018|459808289|FG000|Continuation Period|Physician Decision|0|||
127775979|NCT02748018|459808290|FG001|Continuation Period|Physician Decision|1|||
127775980|NCT02748018|459808291|FG002|Continuation Period|Physician Decision|2|||
127775981|NCT02748018|459808292|FG003|Continuation Period|Physician Decision|0|||
127775982|NCT02748018|459808293|FG004|Continuation Period|Physician Decision|2|||
127775983|NCT02748018|459808294|FG005|Continuation Period|Physician Decision|1|||
127775984|NCT02748018|459808289|FG000|Continuation Period|Protocol Violation|0|||
127775985|NCT02748018|459808290|FG001|Continuation Period|Protocol Violation|1|||
127775986|NCT02748018|459808291|FG002|Continuation Period|Protocol Violation|0|||
127775987|NCT02748018|459808292|FG003|Continuation Period|Protocol Violation|0|||
127775988|NCT02748018|459808293|FG004|Continuation Period|Protocol Violation|0|||
127775989|NCT02748018|459808294|FG005|Continuation Period|Protocol Violation|0|||
127775990|NCT01272947|459808295|FG000|Overall Study|Abnormal Laboratory Value|2|||
127775991|NCT01272947|459808296|FG001|Overall Study|Abnormal Laboratory Value|2|||
127775992|NCT02019420|459808298|FG000|Overall Study|Did not receive study drug|2|||
127775993|NCT02019420|459808299|FG001|Overall Study|Did not receive study drug|2|||
127775994|NCT02019420|459808298|FG000|Overall Study|Withdrawal by Subject|1|||
127775995|NCT02019420|459808299|FG001|Overall Study|Withdrawal by Subject|3|||
127775996|NCT02019420|459808298|FG000|Overall Study|At request of sponsor or investigator|0|||
127775997|NCT02019420|459808299|FG001|Overall Study|At request of sponsor or investigator|1|||
127775998|NCT02019420|459808298|FG000|Overall Study|Death|104|||
127775999|NCT02019420|459808299|FG001|Overall Study|Death|99|||
127561361|NCT01457352|459023628|FG000|Period 2|Sponsor's withdrawal|7|||
127561362|NCT01457352|459023629|FG001|Period 2|Sponsor's withdrawal|0|||
127561363|NCT01457352|459023628|FG000|Period 2|Lost to Follow-up|1|||
127561364|NCT01457352|459023629|FG001|Period 2|Lost to Follow-up|0|||
127687665|NCT02723955|459483552|FG039|Expansion Phase|Death|0|||
127687666|NCT02723955|459483553|FG040|Expansion Phase|Death|0|||
127687667|NCT02723955|459483554|FG041|Expansion Phase|Death|0|||
127687668|NCT02723955|459483555|FG042|Expansion Phase|Death|0|||
127687669|NCT02723955|459483513|FG000|Expansion Phase|Lost to Follow-up|0|||
127687670|NCT02723955|459483514|FG001|Expansion Phase|Lost to Follow-up|0|||
127687671|NCT02723955|459483515|FG002|Expansion Phase|Lost to Follow-up|0|||
127687672|NCT02723955|459483516|FG003|Expansion Phase|Lost to Follow-up|0|||
127776000|NCT02019420|459808298|FG000|Overall Study|Transferred to other care facility|1|||
127776001|NCT02019420|459808299|FG001|Overall Study|Transferred to other care facility|1|||
127776002|NCT02510560|459808300|FG000|Overall Study|Discontinued from Treatment|27|||
127687673|NCT02723955|459483517|FG004|Expansion Phase|Lost to Follow-up|0|||
127687674|NCT02723955|459483518|FG005|Expansion Phase|Lost to Follow-up|0|||
127687675|NCT02723955|459483519|FG006|Expansion Phase|Lost to Follow-up|0|||
127776003|NCT02510560|459808301|FG001|Overall Study|Discontinued from Treatment|18|||
127776004|NCT02510560|459808302|FG002|Overall Study|Discontinued from Treatment|19|||
127776005|NCT02510560|459808300|FG000|Overall Study|Other|4|||
127776006|NCT02510560|459808301|FG001|Overall Study|Other|4|||
127776007|NCT02510560|459808302|FG002|Overall Study|Other|3|||
127776008|NCT02554903|459808303|FG000|Overall Study|Death|1|||
127561365|NCT01457352|459023628|FG000|Period 2|dose change|1|||
127561366|NCT01457352|459023629|FG001|Period 2|dose change|0|||
127687676|NCT02723955|459483520|FG007|Expansion Phase|Lost to Follow-up|0|||
127687677|NCT02723955|459483521|FG008|Expansion Phase|Lost to Follow-up|0|||
127561367|NCT01457352|459023628|FG000|Period 2|Physician Decision|1|||
127561368|NCT01457352|459023629|FG001|Period 2|Physician Decision|0|||
127561369|NCT01457352|459023628|FG000|Period 2|Did not meet eligibility criteria|3|||
127561370|NCT01457352|459023629|FG001|Period 2|Did not meet eligibility criteria|0|||
127561371|NCT01457352|459023628|FG000|Period 3|Adverse Event|1|||
127561372|NCT01457352|459023629|FG001|Period 3|Adverse Event|1|||
127561373|NCT01457352|459023628|FG000|Period 3|Withdrawal by Subject|0|||
127561374|NCT01457352|459023629|FG001|Period 3|Withdrawal by Subject|2|||
127561375|NCT01457352|459023628|FG000|Period 3|incorrect treatment|0|||
127561376|NCT01457352|459023629|FG001|Period 3|incorrect treatment|1|||
127561377|NCT01457352|459023628|FG000|Period 3|Sponsor's withdrawal|0|||
127561378|NCT01457352|459023629|FG001|Period 3|Sponsor's withdrawal|1|||
127561379|NCT02537015|459023630|FG000|Overall Study|Adverse Event|3|||
127561380|NCT02537015|459023630|FG000|Overall Study|Withdrawal by Subject|2|||
127561381|NCT02537015|459023630|FG000|Overall Study|Other Miscellaneous Reasons|1|||
127561382|NCT04174365|459023631|FG000|Overall Study|Lost to Follow-up|1|||
127561383|NCT04174365|459023632|FG001|Overall Study|Lost to Follow-up|2|||
127561384|NCT04174365|459023631|FG000|Overall Study|Adverse Event|2|||
127561385|NCT04174365|459023632|FG001|Overall Study|Adverse Event|1|||
127561386|NCT04174365|459023631|FG000|Overall Study|Subject Withdrew Consent To Participate|1|||
127561387|NCT04174365|459023632|FG001|Overall Study|Subject Withdrew Consent To Participate|0|||
127561388|NCT04174365|459023631|FG000|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|2|||
127561389|NCT04174365|459023632|FG001|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|1|||
127561390|NCT04174365|459023631|FG000|Overall Study|Protocol Deviation|1|||
127561391|NCT04174365|459023632|FG001|Overall Study|Protocol Deviation|0|||
127561392|NCT04174365|459023631|FG000|Overall Study|Lack of Efficacy|0|||
127561393|NCT04174365|459023632|FG001|Overall Study|Lack of Efficacy|2|||
127561394|NCT04174365|459023631|FG000|Overall Study|Disease Relapse|1|||
127561395|NCT04174365|459023632|FG001|Overall Study|Disease Relapse|0|||
127561396|NCT04174365|459023631|FG000|Overall Study|Reason Not Specified|0|||
127561397|NCT04174365|459023632|FG001|Overall Study|Reason Not Specified|1|||
127561398|NCT01925131|459025927|FG000|Overall Study|Death|0|||
127561399|NCT01925131|459025928|FG001|Overall Study|Death|0|||
127561400|NCT01925131|459025929|FG002|Overall Study|Death|1|||
127561401|NCT01925131|459025930|FG003|Overall Study|Death|0|||
127561402|NCT01925131|459025931|FG004|Overall Study|Death|0|||
127561403|NCT01925131|459025932|FG005|Overall Study|Death|0|||
127561404|NCT01925131|459025927|FG000|Overall Study|Progression/Relapse|1|||
127561405|NCT01925131|459025928|FG001|Overall Study|Progression/Relapse|1|||
127561406|NCT01925131|459025929|FG002|Overall Study|Progression/Relapse|4|||
127561407|NCT01925131|459025930|FG003|Overall Study|Progression/Relapse|0|||
127561408|NCT01925131|459025931|FG004|Overall Study|Progression/Relapse|0|||
127561409|NCT01925131|459025932|FG005|Overall Study|Progression/Relapse|1|||
127561410|NCT01925131|459025927|FG000|Overall Study|Patient Refusal|1|||
127561411|NCT01925131|459025928|FG001|Overall Study|Patient Refusal|0|||
127561412|NCT01925131|459025929|FG002|Overall Study|Patient Refusal|0|||
127561413|NCT01925131|459025930|FG003|Overall Study|Patient Refusal|0|||
127561414|NCT01925131|459025931|FG004|Overall Study|Patient Refusal|0|||
127561415|NCT01925131|459025932|FG005|Overall Study|Patient Refusal|0|||
127561416|NCT01925131|459025927|FG000|Overall Study|Adverse Event|0|||
127561417|NCT01925131|459025928|FG001|Overall Study|Adverse Event|0|||
127561418|NCT01925131|459025929|FG002|Overall Study|Adverse Event|2|||
127561419|NCT01925131|459025930|FG003|Overall Study|Adverse Event|0|||
127561420|NCT01925131|459025931|FG004|Overall Study|Adverse Event|1|||
127561421|NCT01925131|459025932|FG005|Overall Study|Adverse Event|3|||
127561422|NCT01925131|459025927|FG000|Overall Study|Other - Not Protocol Specified|3|||
127561423|NCT01925131|459025928|FG001|Overall Study|Other - Not Protocol Specified|1|||
127561424|NCT01925131|459025929|FG002|Overall Study|Other - Not Protocol Specified|2|||
127561425|NCT01925131|459025930|FG003|Overall Study|Other - Not Protocol Specified|5|||
127561426|NCT01925131|459025931|FG004|Overall Study|Other - Not Protocol Specified|10|||
127561427|NCT01925131|459025932|FG005|Overall Study|Other - Not Protocol Specified|6|||
127561428|NCT01696929|459025936|FG000|Overall Study|Physician Decision|1|||
127561429|NCT02522624|459025937|FG000|Overall Study|Technical failure|1|||
127561430|NCT02522624|459025938|FG001|Overall Study|Technical failure|0|||
127561431|NCT02156271|459025939|FG000|Overall Study|Physician Decision|4|||
128024598|NCT01902303|460715922|FG001|Overall Study|Adverse Event|1|||
128024599|NCT01902303|460715921|FG000|Overall Study|Lost to Follow-up|0|||
127561432|NCT02156271|459025940|FG001|Overall Study|Physician Decision|3|||
127561433|NCT00109590|459025941|FG000|Overall Study|Lost to Follow-up|1|||
127561434|NCT00109590|459025942|FG001|Overall Study|Lost to Follow-up|0|||
127561435|NCT00109590|459025943|FG002|Overall Study|Lost to Follow-up|1|||
127561436|NCT00109590|459025941|FG000|Overall Study|Never Started Treatment|1|||
127561437|NCT00109590|459025942|FG001|Overall Study|Never Started Treatment|2|||
127561438|NCT00109590|459025943|FG002|Overall Study|Never Started Treatment|3|||
127561439|NCT00745849|459025944|FG000|First Intervention|Withdrawal by Subject|0|||
127561440|NCT00745849|459025945|FG001|First Intervention|Withdrawal by Subject|1|||
127561441|NCT00745849|459025944|FG000|First Intervention|Lost to Follow-up|1|||
127561442|NCT00745849|459025945|FG001|First Intervention|Lost to Follow-up|1|||
127561443|NCT00745849|459025944|FG000|Second Intervention|Lost to Follow-up|2|||
127561444|NCT00745849|459025945|FG001|Second Intervention|Lost to Follow-up|1|||
127561445|NCT01129583|459025951|FG000|Overall Study|Death|1|||
127561446|NCT01129583|459025952|FG001|Overall Study|Death|0|||
127561447|NCT01129583|459025951|FG000|Overall Study|Lost to Follow-up|1|||
127561448|NCT01129583|459025952|FG001|Overall Study|Lost to Follow-up|1|||
127561449|NCT01129583|459025951|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
127561450|NCT01129583|459025952|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
127561451|NCT02617485|459025965|FG000|Treatment and Observation Period|Adverse Event|9|||
127561452|NCT02617485|459025966|FG001|Treatment and Observation Period|Adverse Event|1|||
127561453|NCT02617485|459025965|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
127561454|NCT02617485|459025966|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
127561455|NCT02617485|459025965|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
127561456|NCT02617485|459025966|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
127561457|NCT02617485|459025965|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
127561458|NCT02617485|459025966|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
127561459|NCT02617485|459025965|FG000|Treatment and Observation Period|Physician Decision|0|||
127561460|NCT02617485|459025966|FG001|Treatment and Observation Period|Physician Decision|1|||
127561461|NCT02617485|459025965|FG000|Follow-up Period|Adverse Event|1|||
127561462|NCT02617485|459025966|FG001|Follow-up Period|Adverse Event|0|||
127561463|NCT02617485|459025965|FG000|Follow-up Period|Withdrawal by Subject|1|||
127561464|NCT02617485|459025966|FG001|Follow-up Period|Withdrawal by Subject|0|||
127561465|NCT02617485|459025965|FG000|Follow-up Period|Disease progression|2|||
127561466|NCT02617485|459025966|FG001|Follow-up Period|Disease progression|1|||
127561467|NCT02617485|459025965|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
127561468|NCT02617485|459025966|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
127561469|NCT02617485|459025965|FG000|Follow-up Period|Patient needed radiotherapy|9|||
127561470|NCT02617485|459025966|FG001|Follow-up Period|Patient needed radiotherapy|5|||
127561471|NCT02617485|459025965|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
127561472|NCT02617485|459025966|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
127561473|NCT00409331|459025967|FG000|Overall Study|Physician Decision|1|||
127561474|NCT01511055|459025972|FG000|Overall Study|Withdrawal by Subject|6|||
127561475|NCT00617669|459025973|FG000|Overall Study|Withdrawal by Subject|71|||
127561476|NCT00617669|459025974|FG001|Overall Study|Withdrawal by Subject|77|||
127561477|NCT00617669|459025973|FG000|Overall Study|Lost to Follow-up|3|||
127561478|NCT00617669|459025974|FG001|Overall Study|Lost to Follow-up|2|||
127561479|NCT00617669|459025973|FG000|Overall Study|Adverse Event|87|||
127561480|NCT00617669|459025974|FG001|Overall Study|Adverse Event|76|||
127561481|NCT00617669|459025973|FG000|Overall Study|Protocol Violation|2|||
127561482|NCT00617669|459025974|FG001|Overall Study|Protocol Violation|3|||
127561483|NCT00617669|459025973|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
127776009|NCT02554903|459808304|FG001|Overall Study|Death|1|||
127776010|NCT02554903|459808303|FG000|Overall Study|Physician Decision|2|||
127776011|NCT02554903|459808304|FG001|Overall Study|Physician Decision|2|||
127776012|NCT02554903|459808303|FG000|Overall Study|Heart Transplant|1|||
127776013|NCT02554903|459808304|FG001|Overall Study|Heart Transplant|2|||
127776014|NCT02742766|459808305|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
127776015|NCT02742766|459808306|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
127776016|NCT02742766|459808307|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
127776017|NCT02742766|459808308|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
127776018|NCT02742766|459808309|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
127776019|NCT02742766|459808310|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
127776020|NCT02742766|459808311|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
127776021|NCT02742766|459808312|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
127776022|NCT02742766|459808313|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
127776023|NCT02742766|459808314|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
127776024|NCT02742766|459808315|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
127776025|NCT02742766|459808316|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
127776026|NCT02742766|459808317|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
127776027|NCT02742766|459808318|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
128024600|NCT01902303|460715922|FG001|Overall Study|Lost to Follow-up|1|||
128024601|NCT01902303|460715921|FG000|Overall Study|Protocol Violation|2|||
127776028|NCT02742766|459808319|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
127776029|NCT02742766|459808320|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
127776030|NCT02742766|459808321|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
127776031|NCT02742766|459808322|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
127776032|NCT02742766|459808323|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
127561484|NCT00617669|459025974|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
127561485|NCT00617669|459025973|FG000|Overall Study|Patients randomized but not treated|2|||
127561486|NCT00617669|459025974|FG001|Overall Study|Patients randomized but not treated|3|||
127561487|NCT04590248|459025975|FG000|Overall Study|Lost to Follow-up|1|||
127561488|NCT04590248|459025975|FG000|Overall Study|Withdrawal by Subject|16|||
127561489|NCT04590248|459025975|FG000|Overall Study|Other|2|||
127561490|NCT02052414|459025978|FG000|Overall Study|Adverse Event|12|||
127561491|NCT02052414|459025978|FG000|Overall Study|Lack of Efficacy|2|||
127561492|NCT02052414|459025978|FG000|Overall Study|Withdrawal by Subject|3|||
127561493|NCT04605991|459025981|FG000|Overall Study|Adverse Event|5|||
127561494|NCT04605991|459025981|FG000|Overall Study|Lack of Efficacy|1|||
127561495|NCT04605991|459025981|FG000|Overall Study|Lost to Follow-up|8|||
127561496|NCT04605991|459025981|FG000|Overall Study|Physician Decision|4|||
127561497|NCT04605991|459025981|FG000|Overall Study|Withdrawal by Subject|14|||
127561498|NCT04605991|459025981|FG000|Overall Study|Non-compliance with study|1|||
127561499|NCT03263702|459025982|FG000|Overall Study|Lost to Follow-up|2|||
127561500|NCT03263702|459025983|FG001|Overall Study|Lost to Follow-up|2|||
127561501|NCT03263702|459025982|FG000|Overall Study|Withdrawal by Subject|1|||
127561502|NCT03263702|459025983|FG001|Overall Study|Withdrawal by Subject|2|||
127561503|NCT02527200|459025984|FG000|Overall Study|Withdrawal by Subject|3|||
127561504|NCT02527200|459025985|FG001|Overall Study|Withdrawal by Subject|2|||
127561505|NCT02527200|459025986|FG002|Overall Study|Withdrawal by Subject|1|||
127561506|NCT02527200|459025987|FG003|Overall Study|Withdrawal by Subject|0|||
127561507|NCT02527200|459025984|FG000|Overall Study|Unclassified|0|||
127561508|NCT02527200|459025985|FG001|Overall Study|Unclassified|1|||
127561509|NCT02527200|459025986|FG002|Overall Study|Unclassified|0|||
127561510|NCT02527200|459025987|FG003|Overall Study|Unclassified|0|||
127561511|NCT02527200|459025984|FG000|Overall Study|Lost to Follow-up|0|||
127561512|NCT02527200|459025985|FG001|Overall Study|Lost to Follow-up|0|||
127561513|NCT02527200|459025986|FG002|Overall Study|Lost to Follow-up|1|||
127561514|NCT02527200|459025987|FG003|Overall Study|Lost to Follow-up|0|||
127561515|NCT01589653|459025988|FG000|Overall Study|Protocol Violation|3|||
127561516|NCT01589653|459025989|FG001|Overall Study|Protocol Violation|1|||
127561517|NCT01589653|459025988|FG000|Overall Study|Withdrawal criteria|4|||
127561518|NCT01589653|459025989|FG001|Overall Study|Withdrawal criteria|7|||
127561519|NCT01589653|459025988|FG000|Overall Study|Unclassified|0|||
127561520|NCT01589653|459025989|FG001|Overall Study|Unclassified|3|||
127561521|NCT00668733|459025990|FG000|Overall Study|Lost to Follow-up|2|||
127561522|NCT00668733|459025991|FG001|Overall Study|Lost to Follow-up|3|||
127561523|NCT00668733|459025990|FG000|Overall Study|Withdrawal by Subject|0|||
127561524|NCT00668733|459025991|FG001|Overall Study|Withdrawal by Subject|4|||
127561525|NCT01909791|459025992|FG000|Overall Study|Death|9|||
127561526|NCT01909791|459025993|FG001|Overall Study|Death|8|||
127561527|NCT01909791|459025994|FG002|Overall Study|Death|4|||
127561528|NCT01909791|459025992|FG000|Overall Study|Withdrawal by Subject|5|||
127561529|NCT01909791|459025993|FG001|Overall Study|Withdrawal by Subject|9|||
127561530|NCT01909791|459025994|FG002|Overall Study|Withdrawal by Subject|13|||
127561531|NCT01909791|459025992|FG000|Overall Study|Lost to Follow-up|5|||
127561532|NCT01909791|459025993|FG001|Overall Study|Lost to Follow-up|11|||
127561533|NCT01909791|459025994|FG002|Overall Study|Lost to Follow-up|10|||
127561534|NCT01909791|459025992|FG000|Overall Study|Missed Visit|2|||
127561535|NCT01909791|459025993|FG001|Overall Study|Missed Visit|0|||
127561536|NCT01909791|459025994|FG002|Overall Study|Missed Visit|1|||
127561537|NCT01659554|459025995|FG000|Overall Study|Study Termination|4|||
127561538|NCT00945906|459025997|FG000|Overall Study|Withdrawal by Subject|1|||
127561539|NCT00945906|459025997|FG000|Overall Study|Did not want to return for last visit|2|||
127561540|NCT00945906|459025997|FG000|Overall Study|Unable to return for last visit|2|||
127561541|NCT00945906|459025997|FG000|Overall Study|Moved to another country|2|||
127561542|NCT04250077|459025998|FG000|Overall Study|Withdrawal by Subject|0|||
127561543|NCT04250077|459025999|FG001|Overall Study|Withdrawal by Subject|1|||
127561544|NCT04250077|459026000|FG002|Overall Study|Withdrawal by Subject|0|||
127561545|NCT04250077|459025998|FG000|Overall Study|Lost to Follow-up|2|||
127561546|NCT04250077|459025999|FG001|Overall Study|Lost to Follow-up|3|||
127561547|NCT04250077|459026000|FG002|Overall Study|Lost to Follow-up|0|||
127687678|NCT02723955|459483522|FG009|Expansion Phase|Lost to Follow-up|0|||
127687679|NCT02723955|459483523|FG010|Expansion Phase|Lost to Follow-up|4|||
127687680|NCT02723955|459483524|FG011|Expansion Phase|Lost to Follow-up|1|||
127687681|NCT02723955|459483525|FG012|Expansion Phase|Lost to Follow-up|0|||
127687682|NCT02723955|459483526|FG013|Expansion Phase|Lost to Follow-up|0|||
127687683|NCT02723955|459483527|FG014|Expansion Phase|Lost to Follow-up|0|||
127561548|NCT01022398|459026001|FG000|Overall Study|Study terminated|2|||
127561549|NCT01022398|459026002|FG001|Overall Study|Study terminated|2|||
127561550|NCT00361634|459026004|FG000|Overall Study|Lost to Follow-up|1|||
127561551|NCT00361634|459026004|FG000|Overall Study|Withdrawal by Subject|1|||
127687684|NCT02723955|459483528|FG015|Expansion Phase|Lost to Follow-up|0|||
127687685|NCT02723955|459483529|FG016|Expansion Phase|Lost to Follow-up|0|||
127561552|NCT00833417|459026005|FG000|Overall Study|Adverse Event|5|||
127561553|NCT00833417|459026006|FG001|Overall Study|Adverse Event|16|||
127561554|NCT00833417|459026005|FG000|Overall Study|Death|1|||
127561555|NCT00833417|459026006|FG001|Overall Study|Death|3|||
127561556|NCT00833417|459026005|FG000|Overall Study|Lost to Follow-up|1|||
127561557|NCT00833417|459026006|FG001|Overall Study|Lost to Follow-up|2|||
127561558|NCT00833417|459026005|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
127561559|NCT00833417|459026006|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
127687686|NCT02723955|459483530|FG017|Expansion Phase|Lost to Follow-up|0|||
127561560|NCT00833417|459026005|FG000|Overall Study|Patient Decision to Withdraw|4|||
127561561|NCT00833417|459026006|FG001|Overall Study|Patient Decision to Withdraw|23|||
127561562|NCT00833417|459026005|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
127561563|NCT00833417|459026006|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
127561564|NCT00833417|459026005|FG000|Overall Study|Disease Progression|18|||
127561565|NCT00833417|459026006|FG001|Overall Study|Disease Progression|17|||
127561566|NCT00833417|459026005|FG000|Overall Study|Reason Not Specified|0|||
127561567|NCT00833417|459026006|FG001|Overall Study|Reason Not Specified|1|||
127561568|NCT03330002|459026007|FG000|Overall Study|Lost to Follow-up|15|||
127561569|NCT03330002|459026007|FG000|Overall Study|Death|7|||
127561570|NCT00505076|459026008|FG000|Overall Study|Adverse Event|1|||
127561571|NCT00505076|459026009|FG001|Overall Study|Adverse Event|0|||
127561572|NCT00505076|459026010|FG002|Overall Study|Adverse Event|1|||
127561573|NCT00505076|459026008|FG000|Overall Study|Protocol Violation|2|||
127561574|NCT00505076|459026009|FG001|Overall Study|Protocol Violation|1|||
127561575|NCT00505076|459026010|FG002|Overall Study|Protocol Violation|2|||
127561576|NCT00505076|459026008|FG000|Overall Study|Withdrawal by Subject|0|||
127561577|NCT00505076|459026009|FG001|Overall Study|Withdrawal by Subject|1|||
127561578|NCT00505076|459026010|FG002|Overall Study|Withdrawal by Subject|2|||
127561579|NCT02745145|459026011|FG000|Overall Study|Adverse Event|1|||
127561580|NCT02745145|459026012|FG001|Overall Study|Adverse Event|0|||
127561581|NCT02745145|459026013|FG002|Overall Study|Adverse Event|0|||
127561582|NCT02745145|459026011|FG000|Overall Study|Death|0|||
127561583|NCT02745145|459026012|FG001|Overall Study|Death|1|||
127561584|NCT02745145|459026013|FG002|Overall Study|Death|0|||
127561585|NCT02745145|459026011|FG000|Overall Study|Progressive disease|0|||
127561586|NCT02745145|459026012|FG001|Overall Study|Progressive disease|0|||
127561587|NCT02745145|459026013|FG002|Overall Study|Progressive disease|1|||
127561588|NCT02745145|459026011|FG000|Overall Study|Withdrew consent|1|||
127561589|NCT02745145|459026012|FG001|Overall Study|Withdrew consent|1|||
127561590|NCT02745145|459026013|FG002|Overall Study|Withdrew consent|1|||
127561591|NCT02745145|459026011|FG000|Overall Study|Study Termination|8|||
127561592|NCT02745145|459026012|FG001|Overall Study|Study Termination|3|||
127561593|NCT02745145|459026013|FG002|Overall Study|Study Termination|7|||
127561594|NCT02366091|459026014|FG000|Overall Study|Withdrawal by Subject|3|||
127561595|NCT02366091|459026015|FG001|Overall Study|Withdrawal by Subject|7|||
127561596|NCT02366091|459026016|FG002|Overall Study|Withdrawal by Subject|3|||
127561597|NCT02366091|459026017|FG003|Overall Study|Withdrawal by Subject|1|||
127561598|NCT01155011|459026019|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
127561599|NCT01155011|459026020|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
127561600|NCT01155011|459026019|FG000|Baseline to 6 Months|investigator decision, moved|4|||
127561601|NCT01155011|459026020|FG001|Baseline to 6 Months|investigator decision, moved|5|||
127561602|NCT01155011|459026019|FG000|Baseline to 6 Months|Death|0|||
127561603|NCT01155011|459026020|FG001|Baseline to 6 Months|Death|1|||
127561604|NCT01155011|459026019|FG000|6 to 12 Months|Withdrawal by Subject|8|||
127561605|NCT01155011|459026020|FG001|6 to 12 Months|Withdrawal by Subject|5|||
127561606|NCT01155011|459026019|FG000|6 to 12 Months|Death|1|||
127561607|NCT01155011|459026020|FG001|6 to 12 Months|Death|5|||
127561608|NCT00653432|459026021|FG000|Overall Study|Adverse Event|4|||
127561609|NCT00653432|459026022|FG001|Overall Study|Adverse Event|1|||
127561610|NCT00653432|459026021|FG000|Overall Study|Withdrawal by Subject|4|||
127561611|NCT00653432|459026022|FG001|Overall Study|Withdrawal by Subject|5|||
127561612|NCT00653432|459026021|FG000|Overall Study|Lost to Follow-up|7|||
127561613|NCT00653432|459026022|FG001|Overall Study|Lost to Follow-up|6|||
127561614|NCT00653432|459026021|FG000|Overall Study|Use/Need of Con Therapy|2|||
127561615|NCT00653432|459026022|FG001|Overall Study|Use/Need of Con Therapy|1|||
127561616|NCT00653432|459026021|FG000|Overall Study|Other - Reason Not Provided|5|||
127561617|NCT00653432|459026022|FG001|Overall Study|Other - Reason Not Provided|3|||
128024602|NCT01902303|460715922|FG001|Overall Study|Protocol Violation|2|||
128024603|NCT01902303|460715921|FG000|Overall Study|subject lost investigational product|0|||
127561618|NCT01743001|459026023|FG000|Overall Study|Physician Decision|1|||
127561619|NCT01743001|459026024|FG001|Overall Study|Physician Decision|0|||
127561620|NCT01743001|459026023|FG000|Overall Study|Pregnancy|1|||
127561621|NCT01743001|459026024|FG001|Overall Study|Pregnancy|0|||
127561622|NCT01743001|459026023|FG000|Overall Study|Death|1|||
127561623|NCT01743001|459026024|FG001|Overall Study|Death|0|||
127561624|NCT01565343|459026027|FG000|Overall Study|Administrative decision/technical issues|1|||
127561625|NCT01565343|459026028|FG001|Overall Study|Administrative decision/technical issues|0|||
127561626|NCT01565343|459026029|FG002|Overall Study|Administrative decision/technical issues|0|||
127561627|NCT01853839|459026035|FG000|Overall Study|Violated inclusion criteria|2|||
127561628|NCT01853839|459026035|FG000|Overall Study|Not meet ITT population definition|58|||
127561629|NCT01853839|459026035|FG000|Overall Study|End of treatment visit too early|33|||
127561630|NCT01853839|459026035|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
127687687|NCT02723955|459483531|FG018|Expansion Phase|Lost to Follow-up|0|||
127687688|NCT02723955|459483532|FG019|Expansion Phase|Lost to Follow-up|0|||
127687689|NCT02723955|459483533|FG020|Expansion Phase|Lost to Follow-up|0|||
127687690|NCT02723955|459483534|FG021|Expansion Phase|Lost to Follow-up|0|||
127561631|NCT02709538|459026036|FG000|Overall Study|Adverse Event|13|||
127561632|NCT02709538|459026037|FG001|Overall Study|Adverse Event|2|||
127561633|NCT02709538|459026038|FG002|Overall Study|Adverse Event|3|||
127561634|NCT02709538|459026036|FG000|Overall Study|Lack of Efficacy|1|||
127561635|NCT02709538|459026037|FG001|Overall Study|Lack of Efficacy|0|||
127561636|NCT02709538|459026038|FG002|Overall Study|Lack of Efficacy|0|||
127561637|NCT02709538|459026036|FG000|Overall Study|Lost to Follow-up|24|||
127561638|NCT02709538|459026037|FG001|Overall Study|Lost to Follow-up|8|||
127561639|NCT02709538|459026038|FG002|Overall Study|Lost to Follow-up|4|||
127561640|NCT02709538|459026036|FG000|Overall Study|Physician Decision|1|||
127561641|NCT02709538|459026037|FG001|Overall Study|Physician Decision|0|||
127561642|NCT02709538|459026038|FG002|Overall Study|Physician Decision|0|||
127561643|NCT02709538|459026036|FG000|Overall Study|Withdrawal by Subject|40|||
127561644|NCT02709538|459026037|FG001|Overall Study|Withdrawal by Subject|7|||
127561645|NCT02709538|459026038|FG002|Overall Study|Withdrawal by Subject|4|||
127561646|NCT02709538|459026036|FG000|Overall Study|Non-compliance with study procedures|5|||
127561647|NCT02709538|459026037|FG001|Overall Study|Non-compliance with study procedures|0|||
127561648|NCT02709538|459026038|FG002|Overall Study|Non-compliance with study procedures|0|||
127561649|NCT02709538|459026036|FG000|Overall Study|Non-compliance with study drug|2|||
127561650|NCT02709538|459026037|FG001|Overall Study|Non-compliance with study drug|0|||
127561651|NCT02709538|459026038|FG002|Overall Study|Non-compliance with study drug|0|||
127561652|NCT02709538|459026036|FG000|Overall Study|Protocol deviation|10|||
127561653|NCT02709538|459026037|FG001|Overall Study|Protocol deviation|4|||
127561654|NCT02709538|459026038|FG002|Overall Study|Protocol deviation|4|||
127561655|NCT02709538|459026036|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
127561656|NCT02709538|459026037|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
127561657|NCT02709538|459026038|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
127561658|NCT02709538|459026036|FG000|Overall Study|Other|16|||
127561659|NCT02709538|459026037|FG001|Overall Study|Other|7|||
127561660|NCT02709538|459026038|FG002|Overall Study|Other|5|||
127561661|NCT00835211|459026039|FG000|First Intervention|Withdrawal by Subject|0|||
127561662|NCT00835211|459026040|FG001|First Intervention|Withdrawal by Subject|1|||
127561663|NCT00835211|459026039|FG000|Washout: 7 Days|Adverse Event|2|||
127561664|NCT00835211|459026040|FG001|Washout: 7 Days|Adverse Event|1|||
127561665|NCT00835211|459026039|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
127561666|NCT00835211|459026040|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
127561667|NCT02343549|459026041|FG000|Overall Study|Death|11|||
127561668|NCT02343549|459026041|FG000|Overall Study|Withdrawal by Subject|2|||
127561669|NCT02160041|459026042|FG000|Overall Study|Adverse Event|11|||
127561670|NCT02160041|459026042|FG000|Overall Study|Death|2|||
127561671|NCT02160041|459026042|FG000|Overall Study|disease progression|57|||
127561672|NCT02160041|459026042|FG000|Overall Study|Protocol Violation|1|||
127561673|NCT02160041|459026042|FG000|Overall Study|non-compliance with study|1|||
127561674|NCT02160041|459026042|FG000|Overall Study|Physician Decision|3|||
127561675|NCT02160041|459026042|FG000|Overall Study|Withdrawal by Subject|8|||
127561676|NCT02160041|459026042|FG000|Overall Study|study terminated by by sponsor|1|||
127561677|NCT01403948|459026043|FG000|Overall Study|Progressive disease|0|||
127561678|NCT01403948|459026044|FG001|Overall Study|Progressive disease|2|||
127561679|NCT01403948|459026045|FG002|Overall Study|Progressive disease|2|||
127561680|NCT01403948|459026046|FG003|Overall Study|Progressive disease|4|||
127561681|NCT01403948|459026047|FG004|Overall Study|Progressive disease|2|||
127561682|NCT01403948|459026048|FG005|Overall Study|Progressive disease|6|||
127687691|NCT02723955|459483535|FG022|Expansion Phase|Lost to Follow-up|0|||
127687692|NCT02723955|459483536|FG023|Expansion Phase|Lost to Follow-up|0|||
127687693|NCT02723955|459483537|FG024|Expansion Phase|Lost to Follow-up|0|||
127687694|NCT02723955|459483538|FG025|Expansion Phase|Lost to Follow-up|0|||
127687695|NCT02723955|459483539|FG026|Expansion Phase|Lost to Follow-up|0|||
127687696|NCT02723955|459483540|FG027|Expansion Phase|Lost to Follow-up|0|||
127687697|NCT02723955|459483541|FG028|Expansion Phase|Lost to Follow-up|0|||
127687698|NCT02723955|459483542|FG029|Expansion Phase|Lost to Follow-up|1|||
127687699|NCT02723955|459483543|FG030|Expansion Phase|Lost to Follow-up|19|||
127687700|NCT02723955|459483544|FG031|Expansion Phase|Lost to Follow-up|2|||
127687701|NCT02723955|459483545|FG032|Expansion Phase|Lost to Follow-up|1|||
127561683|NCT01403948|459026049|FG006|Overall Study|Progressive disease|2|||
127561684|NCT01403948|459026050|FG007|Overall Study|Progressive disease|4|||
127561685|NCT01403948|459026051|FG008|Overall Study|Progressive disease|5|||
127561686|NCT01403948|459026052|FG009|Overall Study|Progressive disease|5|||
127561687|NCT01403948|459026043|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
127561688|NCT01403948|459026044|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
127561689|NCT01403948|459026045|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
127561690|NCT01403948|459026046|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
127561691|NCT01403948|459026047|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
127687702|NCT02723955|459483546|FG033|Expansion Phase|Lost to Follow-up|0|||
127687703|NCT02723955|459483547|FG034|Expansion Phase|Lost to Follow-up|0|||
127687704|NCT02723955|459483548|FG035|Expansion Phase|Lost to Follow-up|0|||
127561692|NCT01403948|459026048|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
127687705|NCT02723955|459483549|FG036|Expansion Phase|Lost to Follow-up|0|||
127561693|NCT01403948|459026049|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
127561694|NCT01403948|459026050|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
127561695|NCT01403948|459026051|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
127561696|NCT01403948|459026052|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
127561697|NCT01403948|459026043|FG000|Overall Study|Lost to Follow-up|0|||
127561698|NCT01403948|459026044|FG001|Overall Study|Lost to Follow-up|0|||
127561699|NCT01403948|459026045|FG002|Overall Study|Lost to Follow-up|0|||
127561700|NCT01403948|459026046|FG003|Overall Study|Lost to Follow-up|0|||
127561701|NCT01403948|459026047|FG004|Overall Study|Lost to Follow-up|0|||
127561702|NCT01403948|459026048|FG005|Overall Study|Lost to Follow-up|0|||
127561703|NCT01403948|459026049|FG006|Overall Study|Lost to Follow-up|0|||
127561704|NCT01403948|459026050|FG007|Overall Study|Lost to Follow-up|0|||
127561705|NCT01403948|459026051|FG008|Overall Study|Lost to Follow-up|0|||
127561706|NCT01403948|459026052|FG009|Overall Study|Lost to Follow-up|1|||
127561707|NCT01403948|459026043|FG000|Overall Study|Refused cont. medication|0|||
127561708|NCT01403948|459026044|FG001|Overall Study|Refused cont. medication|0|||
127561709|NCT01403948|459026045|FG002|Overall Study|Refused cont. medication|0|||
127561710|NCT01403948|459026046|FG003|Overall Study|Refused cont. medication|0|||
127561711|NCT01403948|459026047|FG004|Overall Study|Refused cont. medication|1|||
127561712|NCT01403948|459026048|FG005|Overall Study|Refused cont. medication|0|||
127561713|NCT01403948|459026049|FG006|Overall Study|Refused cont. medication|0|||
127561714|NCT01403948|459026050|FG007|Overall Study|Refused cont. medication|0|||
127561715|NCT01403948|459026051|FG008|Overall Study|Refused cont. medication|0|||
127561716|NCT01403948|459026052|FG009|Overall Study|Refused cont. medication|1|||
127561717|NCT01403948|459026043|FG000|Overall Study|other than above|1|||
127561718|NCT01403948|459026044|FG001|Overall Study|other than above|2|||
127561719|NCT01403948|459026045|FG002|Overall Study|other than above|1|||
127561720|NCT01403948|459026046|FG003|Overall Study|other than above|0|||
127561721|NCT01403948|459026047|FG004|Overall Study|other than above|1|||
127561722|NCT01403948|459026048|FG005|Overall Study|other than above|1|||
127561723|NCT01403948|459026049|FG006|Overall Study|other than above|2|||
127561724|NCT01403948|459026050|FG007|Overall Study|other than above|0|||
127561725|NCT01403948|459026051|FG008|Overall Study|other than above|0|||
127561726|NCT01403948|459026052|FG009|Overall Study|other than above|0|||
127561727|NCT01090323|459026053|FG000|Overall Study|Adverse Event|12|||
127561728|NCT01090323|459026054|FG001|Overall Study|Adverse Event|2|||
127561729|NCT01090323|459026053|FG000|Overall Study|Abnormal Lab Values|3|||
127561730|NCT01090323|459026054|FG001|Overall Study|Abnormal Lab Values|1|||
127561731|NCT01090323|459026053|FG000|Overall Study|Abnormal Test Procedure Results|2|||
127561732|NCT01090323|459026054|FG001|Overall Study|Abnormal Test Procedure Results|0|||
127561733|NCT01090323|459026053|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
127561734|NCT01090323|459026054|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
127561735|NCT01090323|459026053|FG000|Overall Study|Condition no longer requires drug|5|||
127561736|NCT01090323|459026054|FG001|Overall Study|Condition no longer requires drug|4|||
127561737|NCT01090323|459026053|FG000|Overall Study|Protocol Violation|2|||
127561738|NCT01090323|459026054|FG001|Overall Study|Protocol Violation|1|||
127561739|NCT01090323|459026053|FG000|Overall Study|Withdrew consent|33|||
127687706|NCT02723955|459483550|FG037|Expansion Phase|Lost to Follow-up|0|||
127687707|NCT02723955|459483551|FG038|Expansion Phase|Lost to Follow-up|0|||
127687708|NCT02723955|459483552|FG039|Expansion Phase|Lost to Follow-up|0|||
127687709|NCT02723955|459483553|FG040|Expansion Phase|Lost to Follow-up|0|||
127687710|NCT02723955|459483554|FG041|Expansion Phase|Lost to Follow-up|0|||
127687711|NCT02723955|459483555|FG042|Expansion Phase|Lost to Follow-up|0|||
127687712|NCT02723955|459483513|FG000|Expansion Phase|Physician Decision|0|||
127687713|NCT02723955|459483514|FG001|Expansion Phase|Physician Decision|0|||
127687714|NCT02723955|459483515|FG002|Expansion Phase|Physician Decision|0|||
127687715|NCT02723955|459483516|FG003|Expansion Phase|Physician Decision|0|||
127687716|NCT02723955|459483517|FG004|Expansion Phase|Physician Decision|0|||
127687717|NCT02723955|459483518|FG005|Expansion Phase|Physician Decision|0|||
127687718|NCT02723955|459483519|FG006|Expansion Phase|Physician Decision|0|||
127687719|NCT02723955|459483520|FG007|Expansion Phase|Physician Decision|0|||
127687720|NCT02723955|459483521|FG008|Expansion Phase|Physician Decision|0|||
127687721|NCT02723955|459483522|FG009|Expansion Phase|Physician Decision|0|||
127687722|NCT02723955|459483523|FG010|Expansion Phase|Physician Decision|0|||
127687723|NCT02723955|459483524|FG011|Expansion Phase|Physician Decision|0|||
127687724|NCT02723955|459483525|FG012|Expansion Phase|Physician Decision|0|||
127687725|NCT02723955|459483526|FG013|Expansion Phase|Physician Decision|0|||
127561740|NCT01090323|459026054|FG001|Overall Study|Withdrew consent|11|||
127561741|NCT01090323|459026053|FG000|Overall Study|Lost to Follow-up|11|||
127561742|NCT01090323|459026054|FG001|Overall Study|Lost to Follow-up|6|||
127561743|NCT01090323|459026053|FG000|Overall Study|Administrative problems|6|||
127561744|NCT01090323|459026054|FG001|Overall Study|Administrative problems|4|||
127561745|NCT01090323|459026053|FG000|Overall Study|Death|1|||
127561746|NCT01090323|459026054|FG001|Overall Study|Death|2|||
127561747|NCT01090323|459026053|FG000|Overall Study|Stopped end of core|7|||
127687726|NCT02723955|459483527|FG014|Expansion Phase|Physician Decision|0|||
127687727|NCT02723955|459483528|FG015|Expansion Phase|Physician Decision|0|||
127776033|NCT02742766|459808305|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
127776034|NCT02742766|459808306|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
127561748|NCT01090323|459026054|FG001|Overall Study|Stopped end of core|0|||
127561749|NCT01090323|459026053|FG000|Overall Study|Stopped end of extension 1#|3|||
127561750|NCT01090323|459026054|FG001|Overall Study|Stopped end of extension 1#|1|||
127561751|NCT01864005|459026055|FG000|Overall Study|Protocol Violation|0|||
127561752|NCT01864005|459026056|FG001|Overall Study|Protocol Violation|1|||
127561753|NCT01864005|459026055|FG000|Overall Study|Withdrawal by Subject|0|||
127561754|NCT01864005|459026056|FG001|Overall Study|Withdrawal by Subject|1|||
127561755|NCT01864005|459026055|FG000|Overall Study|Incorrect enrolment|1|||
127561756|NCT01864005|459026056|FG001|Overall Study|Incorrect enrolment|0|||
127561757|NCT01864005|459026055|FG000|Overall Study|Disease need|1|||
127561758|NCT01864005|459026056|FG001|Overall Study|Disease need|1|||
127561759|NCT01864005|459026055|FG000|Overall Study|Need GP IIb/IIIa|1|||
127561760|NCT01864005|459026056|FG001|Overall Study|Need GP IIb/IIIa|3|||
127561761|NCT00763698|459026057|FG000|Overall Study|Unsuccessful Implant|5|||
127561762|NCT00763698|459026057|FG000|Overall Study|Death|4|||
127561763|NCT00763698|459026057|FG000|Overall Study|Withdrawal by Subject|1|||
127561764|NCT03241368|459026058|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
127561765|NCT03241368|459026058|FG000|Overall Study|Lost to Follow-up|1|||
127561766|NCT03241368|459026058|FG000|Overall Study|Physician Decision|6|||
127561767|NCT03241368|459026058|FG000|Overall Study|Withdrawal by Subject|6|||
127561768|NCT03241368|459026058|FG000|Overall Study|Protocol Violation|1|||
127561769|NCT00080899|459026063|FG000|Overall Study|Adverse Event|1|||
127561770|NCT00787267|459026065|FG000|Overall Study|Screen failure/Ineligible|10|||
127561771|NCT00787267|459026065|FG000|Overall Study|No Reason Provided|1|||
127561772|NCT00787267|459026065|FG000|Overall Study|Withdrawal by Subject|1|||
127687728|NCT02723955|459483529|FG016|Expansion Phase|Physician Decision|0|||
127687729|NCT02723955|459483530|FG017|Expansion Phase|Physician Decision|0|||
127687730|NCT02723955|459483531|FG018|Expansion Phase|Physician Decision|0|||
127687731|NCT02723955|459483532|FG019|Expansion Phase|Physician Decision|0|||
127687732|NCT02723955|459483533|FG020|Expansion Phase|Physician Decision|0|||
127687733|NCT02723955|459483534|FG021|Expansion Phase|Physician Decision|0|||
127687734|NCT02723955|459483535|FG022|Expansion Phase|Physician Decision|0|||
127687735|NCT02723955|459483536|FG023|Expansion Phase|Physician Decision|0|||
127687736|NCT02723955|459483537|FG024|Expansion Phase|Physician Decision|0|||
127687737|NCT02723955|459483538|FG025|Expansion Phase|Physician Decision|0|||
127687738|NCT02723955|459483539|FG026|Expansion Phase|Physician Decision|0|||
127687739|NCT02723955|459483540|FG027|Expansion Phase|Physician Decision|0|||
127687740|NCT02723955|459483541|FG028|Expansion Phase|Physician Decision|0|||
127687741|NCT02723955|459483542|FG029|Expansion Phase|Physician Decision|0|||
127687742|NCT02723955|459483543|FG030|Expansion Phase|Physician Decision|1|||
127687743|NCT02723955|459483544|FG031|Expansion Phase|Physician Decision|1|||
127687744|NCT02723955|459483545|FG032|Expansion Phase|Physician Decision|0|||
127687745|NCT02723955|459483546|FG033|Expansion Phase|Physician Decision|0|||
127687746|NCT02723955|459483547|FG034|Expansion Phase|Physician Decision|0|||
127687747|NCT02723955|459483548|FG035|Expansion Phase|Physician Decision|0|||
127687748|NCT02723955|459483549|FG036|Expansion Phase|Physician Decision|0|||
127687749|NCT02723955|459483550|FG037|Expansion Phase|Physician Decision|0|||
127687750|NCT02723955|459483551|FG038|Expansion Phase|Physician Decision|0|||
127687751|NCT02723955|459483552|FG039|Expansion Phase|Physician Decision|0|||
127687752|NCT02723955|459483553|FG040|Expansion Phase|Physician Decision|0|||
127687753|NCT02723955|459483554|FG041|Expansion Phase|Physician Decision|0|||
127687754|NCT02723955|459483555|FG042|Expansion Phase|Physician Decision|0|||
127687755|NCT02723955|459483513|FG000|Expansion Phase|Withdrawal by Subject|0|||
127687756|NCT02723955|459483514|FG001|Expansion Phase|Withdrawal by Subject|0|||
127687757|NCT02723955|459483515|FG002|Expansion Phase|Withdrawal by Subject|0|||
127687758|NCT02723955|459483516|FG003|Expansion Phase|Withdrawal by Subject|0|||
127687759|NCT02723955|459483517|FG004|Expansion Phase|Withdrawal by Subject|0|||
127687760|NCT02723955|459483518|FG005|Expansion Phase|Withdrawal by Subject|0|||
127687761|NCT02723955|459483519|FG006|Expansion Phase|Withdrawal by Subject|0|||
127687762|NCT02723955|459483520|FG007|Expansion Phase|Withdrawal by Subject|0|||
127687763|NCT02723955|459483521|FG008|Expansion Phase|Withdrawal by Subject|0|||
127687764|NCT02723955|459483522|FG009|Expansion Phase|Withdrawal by Subject|2|||
127561773|NCT04343235|459026066|FG000|Overall Study|Lost to Follow-up|3|||
127561774|NCT04343235|459026067|FG001|Overall Study|Lost to Follow-up|2|||
127561775|NCT03976648|459026068|FG000|Overall Study|Adverse Event|0|||
127561776|NCT03976648|459026069|FG001|Overall Study|Adverse Event|2|||
127561777|NCT03976648|459026068|FG000|Overall Study|Study terminated by sponsor|21|||
127561778|NCT03976648|459026069|FG001|Overall Study|Study terminated by sponsor|8|||
127687765|NCT02723955|459483523|FG010|Expansion Phase|Withdrawal by Subject|1|||
127687766|NCT02723955|459483524|FG011|Expansion Phase|Withdrawal by Subject|0|||
127687767|NCT02723955|459483525|FG012|Expansion Phase|Withdrawal by Subject|0|||
127687768|NCT02723955|459483526|FG013|Expansion Phase|Withdrawal by Subject|0|||
127687769|NCT02723955|459483527|FG014|Expansion Phase|Withdrawal by Subject|0|||
127687770|NCT02723955|459483528|FG015|Expansion Phase|Withdrawal by Subject|0|||
127561779|NCT00881868|459026070|FG000|Overall Study|Adverse Event|0|||
127561780|NCT00881868|459026071|FG001|Overall Study|Adverse Event|1|||
127561781|NCT00881868|459026070|FG000|Overall Study|Lost to Follow-up|2|||
127561782|NCT00881868|459026071|FG001|Overall Study|Lost to Follow-up|1|||
127561783|NCT00881868|459026070|FG000|Overall Study|Physician Decision|4|||
127561784|NCT00881868|459026071|FG001|Overall Study|Physician Decision|0|||
127561785|NCT00881868|459026070|FG000|Overall Study|Protocol Violation|2|||
127561786|NCT00881868|459026071|FG001|Overall Study|Protocol Violation|0|||
127561787|NCT01981551|459026072|FG000|Overall Study|Refused further treatment|8|||
127561788|NCT01981551|459026072|FG000|Overall Study|Adverse Event|1|||
127561789|NCT03255083|459026073|FG000|Overall Study|Clinical progression|1|||
127561790|NCT03255083|459026074|FG001|Overall Study|Clinical progression|0|||
127561791|NCT03255083|459026075|FG002|Overall Study|Clinical progression|0|||
127561792|NCT03255083|459026076|FG003|Overall Study|Clinical progression|0|||
127561793|NCT03255083|459026073|FG000|Overall Study|Adverse Event|0|||
127561794|NCT03255083|459026074|FG001|Overall Study|Adverse Event|1|||
127561795|NCT03255083|459026075|FG002|Overall Study|Adverse Event|0|||
127561796|NCT03255083|459026076|FG003|Overall Study|Adverse Event|0|||
127561797|NCT03255083|459026073|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
127561798|NCT03255083|459026074|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
127561799|NCT03255083|459026075|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
127561800|NCT03255083|459026076|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
127561801|NCT03255083|459026073|FG000|Overall Study|Withdrawal by Subject|1|||
127561802|NCT03255083|459026074|FG001|Overall Study|Withdrawal by Subject|1|||
127561803|NCT03255083|459026075|FG002|Overall Study|Withdrawal by Subject|1|||
127561804|NCT03255083|459026076|FG003|Overall Study|Withdrawal by Subject|0|||
127561805|NCT00960570|459026077|FG000|21 Day Washout Period|Adverse Event|1|||
127561806|NCT00960570|459026077|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
127561807|NCT00960570|459026077|FG000|1 Day Period Between Dosing|Adverse Event|2|||
127561808|NCT00960570|459026077|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
127561809|NCT01451437|459026078|FG000|Overall Study|Adverse Event|0|||
127561810|NCT01451437|459026079|FG001|Overall Study|Adverse Event|0|||
127561811|NCT01451437|459026080|FG002|Overall Study|Adverse Event|0|||
127561812|NCT01451437|459026081|FG003|Overall Study|Adverse Event|0|||
127561813|NCT01451437|459026082|FG004|Overall Study|Adverse Event|0|||
127561814|NCT01451437|459026083|FG005|Overall Study|Adverse Event|1|||
127561815|NCT01451437|459026084|FG006|Overall Study|Adverse Event|1|||
127561816|NCT01451437|459026085|FG007|Overall Study|Adverse Event|2|||
127561817|NCT01451437|459026086|FG008|Overall Study|Adverse Event|1|||
127561818|NCT01451437|459026078|FG000|Overall Study|Physician Decision|1|||
127561819|NCT01451437|459026079|FG001|Overall Study|Physician Decision|1|||
127561820|NCT01451437|459026080|FG002|Overall Study|Physician Decision|2|||
127561821|NCT01451437|459026081|FG003|Overall Study|Physician Decision|0|||
127561822|NCT01451437|459026082|FG004|Overall Study|Physician Decision|0|||
127561823|NCT01451437|459026083|FG005|Overall Study|Physician Decision|0|||
127561824|NCT01451437|459026084|FG006|Overall Study|Physician Decision|0|||
127561825|NCT01451437|459026085|FG007|Overall Study|Physician Decision|0|||
127561826|NCT01451437|459026086|FG008|Overall Study|Physician Decision|0|||
127561827|NCT01451437|459026078|FG000|Overall Study|Disease Progression|0|||
127561828|NCT01451437|459026079|FG001|Overall Study|Disease Progression|0|||
127561829|NCT01451437|459026080|FG002|Overall Study|Disease Progression|1|||
127561830|NCT01451437|459026081|FG003|Overall Study|Disease Progression|1|||
127561831|NCT01451437|459026082|FG004|Overall Study|Disease Progression|3|||
127561832|NCT01451437|459026083|FG005|Overall Study|Disease Progression|2|||
127561833|NCT01451437|459026084|FG006|Overall Study|Disease Progression|3|||
127561834|NCT01451437|459026085|FG007|Overall Study|Disease Progression|1|||
127561835|NCT01451437|459026086|FG008|Overall Study|Disease Progression|3|||
127561836|NCT01451437|459026078|FG000|Overall Study|Protocol Violation|0|||
127561837|NCT01451437|459026079|FG001|Overall Study|Protocol Violation|0|||
127561838|NCT01451437|459026080|FG002|Overall Study|Protocol Violation|0|||
127561839|NCT01451437|459026081|FG003|Overall Study|Protocol Violation|0|||
127561840|NCT01451437|459026082|FG004|Overall Study|Protocol Violation|0|||
127561841|NCT01451437|459026083|FG005|Overall Study|Protocol Violation|0|||
127561842|NCT01451437|459026084|FG006|Overall Study|Protocol Violation|1|||
127561843|NCT01451437|459026085|FG007|Overall Study|Protocol Violation|0|||
127561844|NCT01451437|459026086|FG008|Overall Study|Protocol Violation|0|||
127561845|NCT01451437|459026078|FG000|Overall Study|Withdrawal by Subject|0|||
127561846|NCT01451437|459026079|FG001|Overall Study|Withdrawal by Subject|0|||
127561847|NCT01451437|459026080|FG002|Overall Study|Withdrawal by Subject|0|||
127561848|NCT01451437|459026081|FG003|Overall Study|Withdrawal by Subject|0|||
127561849|NCT01451437|459026082|FG004|Overall Study|Withdrawal by Subject|1|||
127561850|NCT01451437|459026083|FG005|Overall Study|Withdrawal by Subject|0|||
127561851|NCT01451437|459026084|FG006|Overall Study|Withdrawal by Subject|1|||
127561852|NCT01451437|459026085|FG007|Overall Study|Withdrawal by Subject|0|||
127561853|NCT01451437|459026086|FG008|Overall Study|Withdrawal by Subject|0|||
127561854|NCT04236141|459027868|FG000|Overall Study|Death|18|||
127561855|NCT04236141|459027869|FG001|Overall Study|Death|10|||
127561856|NCT04236141|459027868|FG000|Overall Study|Withdrawal by Participant|1|||
127561857|NCT04236141|459027869|FG001|Overall Study|Withdrawal by Participant|0|||
127561858|NCT04236141|459027868|FG000|Overall Study|Reason not Specified|1|||
127561859|NCT04236141|459027869|FG001|Overall Study|Reason not Specified|0|||
127561860|NCT04236141|459027868|FG000|Overall Study|Study terminated by Sponsor|8|||
127561861|NCT04236141|459027869|FG001|Overall Study|Study terminated by Sponsor|4|||
127561862|NCT01948193|459027870|FG000|Overall Study|Serious event|2|||
127561863|NCT01948193|459027870|FG000|Overall Study|Lost to Follow-up|7|||
127561864|NCT01794338|459027871|FG000|Overall Study|Death|2|||
127561865|NCT01794338|459027872|FG001|Overall Study|Death|0|||
127561866|NCT01794338|459027871|FG000|Overall Study|Lost to Follow-up|6|||
127561867|NCT01794338|459027872|FG001|Overall Study|Lost to Follow-up|9|||
127561868|NCT01954927|459027873|FG000|Overall Study|Withdrawal by Subject|3|||
127561869|NCT01954927|459027874|FG001|Overall Study|Withdrawal by Subject|1|||
127561870|NCT03320824|459027875|FG000|Overall Study|Withdrawal by Subject|8|||
127561871|NCT03320824|459027876|FG001|Overall Study|Withdrawal by Subject|1|||
127561872|NCT03320824|459027875|FG000|Overall Study|Lost to Follow-up|10|||
127561873|NCT03320824|459027876|FG001|Overall Study|Lost to Follow-up|1|||
127561874|NCT03320824|459027875|FG000|Overall Study|moved out of state|0|||
127561875|NCT03320824|459027876|FG001|Overall Study|moved out of state|1|||
127561876|NCT03320824|459027875|FG000|Overall Study|could not complete final visit|0|||
127561877|NCT03320824|459027876|FG001|Overall Study|could not complete final visit|1|||
127561878|NCT00955305|459027877|FG000|Overall Study|Disease progression|39|||
127561879|NCT00955305|459027878|FG001|Overall Study|Disease progression|41|||
127561880|NCT00955305|459027877|FG000|Overall Study|Adverse Event|22|||
127561881|NCT00955305|459027878|FG001|Overall Study|Adverse Event|22|||
127561882|NCT00955305|459027877|FG000|Overall Study|Death|2|||
127561883|NCT00955305|459027878|FG001|Overall Study|Death|1|||
127561884|NCT00955305|459027877|FG000|Overall Study|Withdrawal by Subject|5|||
127561885|NCT00955305|459027878|FG001|Overall Study|Withdrawal by Subject|4|||
127561886|NCT00955305|459027877|FG000|Overall Study|Alternative therapy|4|||
127561887|NCT00955305|459027878|FG001|Overall Study|Alternative therapy|0|||
127561888|NCT00955305|459027877|FG000|Overall Study|Other complicating disease|2|||
127561889|NCT00955305|459027878|FG001|Overall Study|Other complicating disease|4|||
128024604|NCT01902303|460715922|FG001|Overall Study|subject lost investigational product|1|||
127561890|NCT00955305|459027877|FG000|Overall Study|Physician Decision|1|||
127561891|NCT00955305|459027878|FG001|Overall Study|Physician Decision|0|||
127561892|NCT00955305|459027877|FG000|Overall Study|Continued presence of residual disease|0|||
127561893|NCT00955305|459027878|FG001|Overall Study|Continued presence of residual disease|1|||
127561894|NCT00955305|459027877|FG000|Overall Study|Functional decline|2|||
127561895|NCT00955305|459027878|FG001|Overall Study|Functional decline|0|||
127561896|NCT00955305|459027877|FG000|Overall Study|Maximum response achieved|0|||
127561897|NCT00955305|459027878|FG001|Overall Study|Maximum response achieved|1|||
127561898|NCT00955305|459027877|FG000|Overall Study|Lost to Follow-up|0|||
127561899|NCT00955305|459027878|FG001|Overall Study|Lost to Follow-up|1|||
127561900|NCT00955305|459027877|FG000|Overall Study|No off-treatment reason submitted|1|||
127561901|NCT00955305|459027878|FG001|Overall Study|No off-treatment reason submitted|0|||
127561902|NCT00955305|459027877|FG000|Overall Study|Never started protocol treatment|5|||
127561903|NCT00955305|459027878|FG001|Overall Study|Never started protocol treatment|5|||
127561904|NCT00955305|459027877|FG000|Overall Study|Ineligible|5|||
127561905|NCT00955305|459027878|FG001|Overall Study|Ineligible|7|||
127561906|NCT03387111|459027879|FG000|Overall Study|Progressive Disease|3|||
127561907|NCT03387111|459027879|FG000|Overall Study|Other|1|||
127561908|NCT03254108|459027883|FG000|Overall Study|Adverse Event|0|||
127561909|NCT03254108|459027884|FG001|Overall Study|Adverse Event|2|||
127561910|NCT03254108|459027885|FG002|Overall Study|Adverse Event|0|||
127561911|NCT03254108|459027886|FG003|Overall Study|Adverse Event|1|||
127561912|NCT03254108|459027887|FG004|Overall Study|Adverse Event|1|||
127561913|NCT03254108|459027883|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
127561914|NCT03254108|459027884|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
127561915|NCT03254108|459027885|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
127561916|NCT03254108|459027886|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
127561917|NCT03254108|459027887|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
127561918|NCT00490529|459027895|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
127561919|NCT00490529|459027895|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
127561920|NCT00490529|459027895|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
127561921|NCT00490529|459027895|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
127561922|NCT00490529|459027895|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
127561923|NCT00490529|459027895|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
127561924|NCT03254459|459027896|FG000|Overall Study|Adverse Event|7|||
127776035|NCT02742766|459808307|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
127561925|NCT03254459|459027897|FG001|Overall Study|Adverse Event|20|||
127561926|NCT03254459|459027896|FG000|Overall Study|Withdrawal by Subject Consent|3|||
127776036|NCT02742766|459808308|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
127776037|NCT02742766|459808309|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
127561927|NCT03254459|459027897|FG001|Overall Study|Withdrawal by Subject Consent|1|||
127561928|NCT03254459|459027896|FG000|Overall Study|Lost to Follow-up|0|||
128024605|NCT01902303|460715921|FG000|Overall Study|Did not develop a cold sore|21|||
127561929|NCT03254459|459027897|FG001|Overall Study|Lost to Follow-up|1|||
127561930|NCT03254459|459027896|FG000|Overall Study|Miscellaneous|0|||
127561931|NCT03254459|459027897|FG001|Overall Study|Miscellaneous|1|||
127561932|NCT00727441|459027898|FG000|Overall Study|Disease Progression|11|||
127561933|NCT00727441|459027899|FG001|Overall Study|Disease Progression|14|||
127561934|NCT00727441|459027900|FG002|Overall Study|Disease Progression|17|||
127561935|NCT00727441|459027898|FG000|Overall Study|Eligibility|7|||
127561936|NCT00727441|459027899|FG001|Overall Study|Eligibility|5|||
127561937|NCT00727441|459027900|FG002|Overall Study|Eligibility|7|||
127561938|NCT00727441|459027898|FG000|Overall Study|Death|0|||
127561939|NCT00727441|459027899|FG001|Overall Study|Death|1|||
127561940|NCT00727441|459027900|FG002|Overall Study|Death|1|||
127561941|NCT00727441|459027898|FG000|Overall Study|Physician Decision|0|||
127561942|NCT00727441|459027899|FG001|Overall Study|Physician Decision|1|||
127561943|NCT00727441|459027900|FG002|Overall Study|Physician Decision|0|||
127561944|NCT00727441|459027898|FG000|Overall Study|Withdrawal by Subject|0|||
127561945|NCT00727441|459027899|FG001|Overall Study|Withdrawal by Subject|1|||
127687771|NCT02723955|459483529|FG016|Expansion Phase|Withdrawal by Subject|0|||
127687772|NCT02723955|459483530|FG017|Expansion Phase|Withdrawal by Subject|0|||
127687773|NCT02723955|459483531|FG018|Expansion Phase|Withdrawal by Subject|0|||
127687774|NCT02723955|459483532|FG019|Expansion Phase|Withdrawal by Subject|0|||
127687775|NCT02723955|459483533|FG020|Expansion Phase|Withdrawal by Subject|0|||
127687776|NCT02723955|459483534|FG021|Expansion Phase|Withdrawal by Subject|0|||
127561946|NCT00727441|459027900|FG002|Overall Study|Withdrawal by Subject|0|||
127561947|NCT00535288|459027901|FG000|Overall Study|Adverse Event|20|||
127561948|NCT00535288|459027902|FG001|Overall Study|Adverse Event|19|||
127561949|NCT00535288|459027903|FG002|Overall Study|Adverse Event|25|||
127561950|NCT00535288|459027904|FG003|Overall Study|Adverse Event|20|||
127561951|NCT00535288|459027905|FG004|Overall Study|Adverse Event|30|||
127561952|NCT00535288|459027901|FG000|Overall Study|Lost to Follow-up|0|||
127561953|NCT00535288|459027902|FG001|Overall Study|Lost to Follow-up|3|||
127561954|NCT00535288|459027903|FG002|Overall Study|Lost to Follow-up|0|||
127561955|NCT00535288|459027904|FG003|Overall Study|Lost to Follow-up|0|||
127687777|NCT02723955|459483535|FG022|Expansion Phase|Withdrawal by Subject|0|||
127687778|NCT02723955|459483536|FG023|Expansion Phase|Withdrawal by Subject|0|||
127687779|NCT02723955|459483537|FG024|Expansion Phase|Withdrawal by Subject|0|||
127687780|NCT02723955|459483538|FG025|Expansion Phase|Withdrawal by Subject|0|||
127687781|NCT02723955|459483539|FG026|Expansion Phase|Withdrawal by Subject|0|||
127687782|NCT02723955|459483540|FG027|Expansion Phase|Withdrawal by Subject|0|||
127687783|NCT02723955|459483541|FG028|Expansion Phase|Withdrawal by Subject|0|||
127687784|NCT02723955|459483542|FG029|Expansion Phase|Withdrawal by Subject|0|||
127687785|NCT02723955|459483543|FG030|Expansion Phase|Withdrawal by Subject|8|||
127687786|NCT02723955|459483544|FG031|Expansion Phase|Withdrawal by Subject|4|||
127687787|NCT02723955|459483545|FG032|Expansion Phase|Withdrawal by Subject|0|||
127687788|NCT02723955|459483546|FG033|Expansion Phase|Withdrawal by Subject|0|||
127687789|NCT02723955|459483547|FG034|Expansion Phase|Withdrawal by Subject|0|||
127687790|NCT02723955|459483548|FG035|Expansion Phase|Withdrawal by Subject|1|||
127687791|NCT02723955|459483549|FG036|Expansion Phase|Withdrawal by Subject|0|||
127687792|NCT02723955|459483550|FG037|Expansion Phase|Withdrawal by Subject|0|||
127687793|NCT02723955|459483551|FG038|Expansion Phase|Withdrawal by Subject|0|||
127687794|NCT02723955|459483552|FG039|Expansion Phase|Withdrawal by Subject|0|||
127687795|NCT02723955|459483553|FG040|Expansion Phase|Withdrawal by Subject|0|||
127687796|NCT02723955|459483554|FG041|Expansion Phase|Withdrawal by Subject|0|||
127687797|NCT02723955|459483555|FG042|Expansion Phase|Withdrawal by Subject|0|||
127687798|NCT02723955|459483513|FG000|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
127687799|NCT02723955|459483514|FG001|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
127687800|NCT02723955|459483515|FG002|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
127687801|NCT02723955|459483516|FG003|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
127687802|NCT02723955|459483517|FG004|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
127687803|NCT02723955|459483518|FG005|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
127687804|NCT02723955|459483519|FG006|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
127687805|NCT02723955|459483520|FG007|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
127705201|NCT01928394|459551581|FG014|Treatment Period|Lost to Follow-up|0|||
127561956|NCT00535288|459027905|FG004|Overall Study|Lost to Follow-up|0|||
127561957|NCT00535288|459027901|FG000|Overall Study|Lack of Efficacy|26|||
127561958|NCT00535288|459027902|FG001|Overall Study|Lack of Efficacy|3|||
127561959|NCT00535288|459027903|FG002|Overall Study|Lack of Efficacy|4|||
127561960|NCT00535288|459027904|FG003|Overall Study|Lack of Efficacy|4|||
127561961|NCT00535288|459027905|FG004|Overall Study|Lack of Efficacy|7|||
127561962|NCT00535288|459027901|FG000|Overall Study|Unwilling to cooperate|6|||
127561963|NCT00535288|459027902|FG001|Overall Study|Unwilling to cooperate|6|||
127561964|NCT00535288|459027903|FG002|Overall Study|Unwilling to cooperate|3|||
127561965|NCT00535288|459027904|FG003|Overall Study|Unwilling to cooperate|3|||
127561966|NCT00535288|459027905|FG004|Overall Study|Unwilling to cooperate|4|||
127561967|NCT00535288|459027901|FG000|Overall Study|Other|2|||
127561968|NCT00535288|459027902|FG001|Overall Study|Other|1|||
127561969|NCT00535288|459027903|FG002|Overall Study|Other|1|||
127561970|NCT00535288|459027904|FG003|Overall Study|Other|2|||
127561971|NCT00535288|459027905|FG004|Overall Study|Other|1|||
127561972|NCT02600871|459027906|FG000|Overall Study|Lost to Follow-up|13|||
127561973|NCT02600871|459027907|FG001|Overall Study|Lost to Follow-up|10|||
127561974|NCT00830869|459027917|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
127561975|NCT00830869|459027918|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
127561976|NCT00830869|459027919|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
127561977|NCT00830869|459027920|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
127561978|NCT00830869|459027921|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
127561979|NCT00830869|459027922|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
127561980|NCT00830869|459027923|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
127561981|NCT00830869|459027924|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
127561982|NCT00830869|459027925|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
127561983|NCT00830869|459027926|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
127561984|NCT00830869|459027927|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
127561985|NCT00830869|459027928|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
127561986|NCT00830869|459027917|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
127561987|NCT00830869|459027918|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
127561988|NCT00830869|459027919|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
127561989|NCT00830869|459027920|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
127561990|NCT00830869|459027921|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
127561991|NCT00830869|459027922|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
127561992|NCT00830869|459027923|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
127561993|NCT00830869|459027924|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
127561994|NCT00830869|459027925|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
127561995|NCT00830869|459027926|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
127561996|NCT00830869|459027927|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
127561997|NCT00830869|459027928|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
127561998|NCT00830869|459027917|FG000|Period 1: Part 1|Adverse Event|0|||
127561999|NCT00830869|459027918|FG001|Period 1: Part 1|Adverse Event|0|||
127562000|NCT00830869|459027919|FG002|Period 1: Part 1|Adverse Event|0|||
127562001|NCT00830869|459027920|FG003|Period 1: Part 1|Adverse Event|0|||
127562002|NCT00830869|459027921|FG004|Period 1: Part 1|Adverse Event|0|||
127562003|NCT00830869|459027922|FG005|Period 1: Part 1|Adverse Event|1|||
127562004|NCT00830869|459027923|FG006|Period 1: Part 1|Adverse Event|1|||
127562005|NCT00830869|459027924|FG007|Period 1: Part 1|Adverse Event|0|||
127562006|NCT00830869|459027925|FG008|Period 1: Part 1|Adverse Event|0|||
127562007|NCT00830869|459027926|FG009|Period 1: Part 1|Adverse Event|0|||
127562008|NCT00830869|459027927|FG010|Period 1: Part 1|Adverse Event|0|||
127562009|NCT00830869|459027928|FG011|Period 1: Part 1|Adverse Event|0|||
127562010|NCT00830869|459027917|FG000|Period 1: Part 1|Progressive disease|1|||
127562011|NCT00830869|459027918|FG001|Period 1: Part 1|Progressive disease|0|||
127562012|NCT00830869|459027919|FG002|Period 1: Part 1|Progressive disease|1|||
127562013|NCT00830869|459027920|FG003|Period 1: Part 1|Progressive disease|6|||
127562014|NCT00830869|459027921|FG004|Period 1: Part 1|Progressive disease|4|||
127562015|NCT00830869|459027922|FG005|Period 1: Part 1|Progressive disease|4|||
127562016|NCT00830869|459027923|FG006|Period 1: Part 1|Progressive disease|1|||
127562017|NCT00830869|459027924|FG007|Period 1: Part 1|Progressive disease|0|||
127705202|NCT01928394|459551582|FG015|Treatment Period|Lost to Follow-up|0|||
127562018|NCT00830869|459027925|FG008|Period 1: Part 1|Progressive disease|0|||
127562019|NCT00830869|459027926|FG009|Period 1: Part 1|Progressive disease|0|||
127562020|NCT00830869|459027927|FG010|Period 1: Part 1|Progressive disease|0|||
127562021|NCT00830869|459027928|FG011|Period 1: Part 1|Progressive disease|0|||
127562022|NCT00830869|459027917|FG000|Period 2: Part 2|Protocol Violation|0|||
127562023|NCT00830869|459027918|FG001|Period 2: Part 2|Protocol Violation|0|||
127562024|NCT00830869|459027919|FG002|Period 2: Part 2|Protocol Violation|0|||
127562025|NCT00830869|459027920|FG003|Period 2: Part 2|Protocol Violation|0|||
127562026|NCT00830869|459027921|FG004|Period 2: Part 2|Protocol Violation|0|||
127562027|NCT00830869|459027922|FG005|Period 2: Part 2|Protocol Violation|0|||
127562028|NCT00830869|459027923|FG006|Period 2: Part 2|Protocol Violation|0|||
127562029|NCT00830869|459027924|FG007|Period 2: Part 2|Protocol Violation|1|||
127562030|NCT00830869|459027925|FG008|Period 2: Part 2|Protocol Violation|0|||
127562031|NCT00830869|459027926|FG009|Period 2: Part 2|Protocol Violation|1|||
127562032|NCT00830869|459027927|FG010|Period 2: Part 2|Protocol Violation|0|||
127562033|NCT00830869|459027928|FG011|Period 2: Part 2|Protocol Violation|0|||
127562034|NCT00830869|459027917|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
127562035|NCT00830869|459027918|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
127562036|NCT00830869|459027919|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
127562037|NCT00830869|459027920|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
127562038|NCT00830869|459027921|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
127562039|NCT00830869|459027922|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
127562040|NCT00830869|459027923|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
127562041|NCT00830869|459027924|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
127562042|NCT00830869|459027925|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
127562043|NCT00830869|459027926|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
127562044|NCT00830869|459027927|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
127562045|NCT00830869|459027928|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
127562046|NCT00830869|459027917|FG000|Period 2: Part 2|Adverse Event|0|||
127562047|NCT00830869|459027918|FG001|Period 2: Part 2|Adverse Event|0|||
127562048|NCT00830869|459027919|FG002|Period 2: Part 2|Adverse Event|0|||
127562049|NCT00830869|459027920|FG003|Period 2: Part 2|Adverse Event|0|||
127562050|NCT00830869|459027921|FG004|Period 2: Part 2|Adverse Event|0|||
127562051|NCT00830869|459027922|FG005|Period 2: Part 2|Adverse Event|0|||
127562052|NCT00830869|459027923|FG006|Period 2: Part 2|Adverse Event|0|||
127562053|NCT00830869|459027924|FG007|Period 2: Part 2|Adverse Event|4|||
127562054|NCT00830869|459027925|FG008|Period 2: Part 2|Adverse Event|3|||
127562055|NCT00830869|459027926|FG009|Period 2: Part 2|Adverse Event|2|||
127562056|NCT00830869|459027927|FG010|Period 2: Part 2|Adverse Event|2|||
127562057|NCT00830869|459027928|FG011|Period 2: Part 2|Adverse Event|0|||
127562058|NCT00830869|459027917|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
127562059|NCT00830869|459027918|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
127562060|NCT00830869|459027919|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
127562061|NCT00830869|459027920|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
127562062|NCT00830869|459027921|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
127562063|NCT00830869|459027922|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
127562064|NCT00830869|459027923|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
127562065|NCT00830869|459027924|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
127562066|NCT00830869|459027925|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
127562067|NCT00830869|459027926|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
127562068|NCT00830869|459027927|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
127562069|NCT00830869|459027928|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
127562070|NCT00830869|459027917|FG000|Period 2: Part 2|Progressive disease|0|||
127562071|NCT00830869|459027918|FG001|Period 2: Part 2|Progressive disease|0|||
127562072|NCT00830869|459027919|FG002|Period 2: Part 2|Progressive disease|0|||
127562073|NCT00830869|459027920|FG003|Period 2: Part 2|Progressive disease|0|||
127562074|NCT00830869|459027921|FG004|Period 2: Part 2|Progressive disease|0|||
127562075|NCT00830869|459027922|FG005|Period 2: Part 2|Progressive disease|0|||
127562076|NCT00830869|459027923|FG006|Period 2: Part 2|Progressive disease|0|||
127562077|NCT00830869|459027924|FG007|Period 2: Part 2|Progressive disease|14|||
127562078|NCT00830869|459027925|FG008|Period 2: Part 2|Progressive disease|11|||
127562079|NCT00830869|459027926|FG009|Period 2: Part 2|Progressive disease|12|||
127562080|NCT00830869|459027927|FG010|Period 2: Part 2|Progressive disease|8|||
127562081|NCT00830869|459027928|FG011|Period 2: Part 2|Progressive disease|15|||
127562082|NCT00830869|459027917|FG000|Period 2: Part 2|Other|0|||
127562083|NCT00830869|459027918|FG001|Period 2: Part 2|Other|0|||
127562084|NCT00830869|459027919|FG002|Period 2: Part 2|Other|0|||
127562085|NCT00830869|459027920|FG003|Period 2: Part 2|Other|0|||
127562086|NCT00830869|459027921|FG004|Period 2: Part 2|Other|0|||
127562087|NCT00830869|459027922|FG005|Period 2: Part 2|Other|0|||
127562088|NCT00830869|459027923|FG006|Period 2: Part 2|Other|0|||
127562089|NCT00830869|459027924|FG007|Period 2: Part 2|Other|0|||
127562090|NCT00830869|459027925|FG008|Period 2: Part 2|Other|0|||
127562091|NCT00830869|459027926|FG009|Period 2: Part 2|Other|1|||
127562092|NCT00830869|459027927|FG010|Period 2: Part 2|Other|0|||
127562093|NCT00830869|459027928|FG011|Period 2: Part 2|Other|0|||
127562094|NCT03745820|459027929|FG000|Overall Study|Adverse Event|0|||
127562095|NCT03745820|459027930|FG001|Overall Study|Adverse Event|3|||
127562096|NCT03745820|459027931|FG002|Overall Study|Adverse Event|2|||
127562097|NCT03745820|459027929|FG000|Overall Study|Non-Compliance with Study Drug|4|||
127562098|NCT03745820|459027930|FG001|Overall Study|Non-Compliance with Study Drug|3|||
127562099|NCT03745820|459027931|FG002|Overall Study|Non-Compliance with Study Drug|0|||
127562100|NCT03745820|459027929|FG000|Overall Study|Withdrawal by Subject|4|||
127562101|NCT03745820|459027930|FG001|Overall Study|Withdrawal by Subject|4|||
127562102|NCT03745820|459027931|FG002|Overall Study|Withdrawal by Subject|4|||
127562103|NCT03745820|459027929|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
127562104|NCT03745820|459027930|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
127562105|NCT03745820|459027931|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
127562106|NCT03745820|459027929|FG000|Overall Study|Lost to Follow-up|2|||
127562107|NCT03745820|459027930|FG001|Overall Study|Lost to Follow-up|0|||
127562108|NCT03745820|459027931|FG002|Overall Study|Lost to Follow-up|3|||
127562109|NCT03745820|459027929|FG000|Overall Study|Reason not Specified|2|||
127562110|NCT03745820|459027930|FG001|Overall Study|Reason not Specified|4|||
127562111|NCT03745820|459027931|FG002|Overall Study|Reason not Specified|1|||
127562112|NCT00507728|459027932|FG000|Randomization to Month 3|Lost to Follow-up|15|||
127562113|NCT00507728|459027933|FG001|Randomization to Month 3|Lost to Follow-up|14|||
127562114|NCT00507728|459027934|FG002|Randomization to Month 3|Lost to Follow-up|20|||
127562115|NCT00507728|459027932|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
127562116|NCT00507728|459027933|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
127562117|NCT00507728|459027934|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
127562118|NCT03680742|459027935|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
127562119|NCT01410357|459027936|FG000|Overall Study|Death|2|||
127562120|NCT01410357|459027937|FG001|Overall Study|Death|1|||
127562121|NCT01410357|459027936|FG000|Overall Study|Withdrawal by Subject|1|||
127562122|NCT01410357|459027937|FG001|Overall Study|Withdrawal by Subject|2|||
127562123|NCT01410357|459027936|FG000|Overall Study|Lost to Follow-up|23|||
127562124|NCT01410357|459027937|FG001|Overall Study|Lost to Follow-up|21|||
127562125|NCT00615901|459027938|FG000|Overall Study|Withdrawal by Subject|2|||
127562126|NCT00615901|459027938|FG000|Overall Study|Adverse Event|7|||
127562127|NCT03598114|459027939|FG000|Overall Study|Staff turnover/left the program|3|||
127562128|NCT03598114|459027940|FG001|Overall Study|Staff turnover/left the program|39|||
127562129|NCT00233454|459027946|FG000|Overall Study|Death|6|||
127562130|NCT05498701|459027948|FG000|Period 3|Adverse Event|1|||
127562131|NCT05498701|459027949|FG001|Period 3|Adverse Event|0|||
127562132|NCT00638183|459027953|FG000|Overall Study|Adverse Event|23|||
127562133|NCT00638183|459027953|FG000|Overall Study|Lack of Efficacy|14|||
127562134|NCT00638183|459027953|FG000|Overall Study|Physician Decision|9|||
127562135|NCT00638183|459027953|FG000|Overall Study|Lost to Follow-up|46|||
127562136|NCT00638183|459027953|FG000|Overall Study|Other reason not defined above|27|||
127562137|NCT00006409|459027954|FG000|Baseline|Protocol Violation|48|||
127562138|NCT00006409|459027955|FG001|Baseline|Protocol Violation|70|||
127562139|NCT00006409|459027956|FG002|Baseline|Protocol Violation|0|||
127562140|NCT00006409|459027957|FG003|Baseline|Protocol Violation|0|||
127562141|NCT00006409|459027958|FG004|Baseline|Protocol Violation|0|||
127562142|NCT00006409|459027959|FG005|Baseline|Protocol Violation|0|||
127562143|NCT00006409|459027954|FG000|Post-2 Year Intervention|Protocol Violation|0|||
127562144|NCT00006409|459027955|FG001|Post-2 Year Intervention|Protocol Violation|0|||
127562145|NCT00006409|459027956|FG002|Post-2 Year Intervention|Protocol Violation|251|||
127776038|NCT02742766|459808310|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
127776039|NCT02742766|459808311|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
127776040|NCT02742766|459808312|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
127776041|NCT02742766|459808313|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
127776042|NCT02742766|459808314|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
127776043|NCT02742766|459808315|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
127776044|NCT02742766|459808316|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
127776045|NCT02742766|459808317|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
127776046|NCT02742766|459808318|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
127776047|NCT02742766|459808319|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
127776048|NCT02742766|459808320|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
127776049|NCT02742766|459808321|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
127776050|NCT02742766|459808322|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
127776051|NCT02742766|459808323|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
127776052|NCT04936841|459808326|FG000|Overall Study|Death|1|||
127776053|NCT03739437|459808327|FG000|Overall Study|Lost to Follow-up|2|||
127776054|NCT03739437|459808328|FG001|Overall Study|Lost to Follow-up|5|||
127776055|NCT01395316|459808331|FG000|Overall Study|Lost to Follow-up|2|||
127776056|NCT01395316|459808331|FG000|Overall Study|poor MRI quality|1|||
127776057|NCT03359590|459808333|FG000|First Intervention|Withdrawal by Subject|1|||
127776058|NCT03359590|459808334|FG001|First Intervention|Withdrawal by Subject|1|||
127776059|NCT03359590|459808333|FG000|First Intervention|Protocol Violation|0|||
127776060|NCT03359590|459808334|FG001|First Intervention|Protocol Violation|1|||
127776061|NCT02846532|459808335|FG000|Overall Study|Lost to Follow-up|0|||
127776062|NCT02846532|459808336|FG001|Overall Study|Lost to Follow-up|1|||
127776063|NCT02846532|459808337|FG002|Overall Study|Lost to Follow-up|1|||
127776064|NCT02846532|459808335|FG000|Overall Study|Withdrawal by Subject|1|||
127776065|NCT02846532|459808336|FG001|Overall Study|Withdrawal by Subject|2|||
127776066|NCT02846532|459808337|FG002|Overall Study|Withdrawal by Subject|0|||
127776067|NCT03951220|459808338|FG000|Overall Study|Withdrawal by Subject|9|||
127776068|NCT03951220|459808339|FG001|Overall Study|Withdrawal by Subject|2|||
127776069|NCT03951220|459808340|FG002|Overall Study|Withdrawal by Subject|0|||
127776070|NCT06132425|459808341|FG000|Overall Study|Withdrawal by Subject|3|||
127776071|NCT06132425|459808342|FG001|Overall Study|Withdrawal by Subject|0|||
127562146|NCT00006409|459027957|FG003|Post-2 Year Intervention|Protocol Violation|168|||
127562147|NCT00006409|459027958|FG004|Post-2 Year Intervention|Protocol Violation|0|||
127562148|NCT00006409|459027959|FG005|Post-2 Year Intervention|Protocol Violation|0|||
127776072|NCT06132425|459808341|FG000|Overall Study|Did not follow study instructions|0|||
127776073|NCT06132425|459808342|FG001|Overall Study|Did not follow study instructions|2|||
127776074|NCT06132425|459808341|FG000|Overall Study|Lost to Follow-up|3|||
127776075|NCT06132425|459808342|FG001|Overall Study|Lost to Follow-up|5|||
127562149|NCT00006409|459027954|FG000|Post-3 Year Intervention|Protocol Violation|0|||
127562150|NCT00006409|459027955|FG001|Post-3 Year Intervention|Protocol Violation|0|||
127562151|NCT00006409|459027956|FG002|Post-3 Year Intervention|Protocol Violation|0|||
127562152|NCT00006409|459027957|FG003|Post-3 Year Intervention|Protocol Violation|0|||
127562153|NCT00006409|459027958|FG004|Post-3 Year Intervention|Protocol Violation|62|||
127562154|NCT00006409|459027959|FG005|Post-3 Year Intervention|Protocol Violation|62|||
127562155|NCT02350764|459027960|FG000|Overall Study|Adverse Event|4|||
127562156|NCT02350764|459027960|FG000|Overall Study|Death|3|||
127562157|NCT02350764|459027960|FG000|Overall Study|Physician Decision|2|||
127562158|NCT02350764|459027960|FG000|Overall Study|Withdrawal by Subject|2|||
127562159|NCT03531632|459027961|FG000|Overall Study|Adverse Event|0|||
127562160|NCT03531632|459027962|FG001|Overall Study|Adverse Event|0|||
127562161|NCT03531632|459027963|FG002|Overall Study|Adverse Event|1|||
127562162|NCT03531632|459027961|FG000|Overall Study|Death|4|||
127562163|NCT03531632|459027962|FG001|Overall Study|Death|0|||
127562164|NCT03531632|459027963|FG002|Overall Study|Death|14|||
127562165|NCT03531632|459027961|FG000|Overall Study|Study Terminated|1|||
127562166|NCT03531632|459027962|FG001|Overall Study|Study Terminated|3|||
127562167|NCT03531632|459027963|FG002|Overall Study|Study Terminated|11|||
127562168|NCT00600119|459027964|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
127562169|NCT00600119|459027965|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
127562170|NCT00600119|459027966|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
127562171|NCT00600119|459027967|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
127562172|NCT00600119|459027968|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
127562173|NCT00600119|459027969|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
127562174|NCT00600119|459027964|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
127562175|NCT00600119|459027965|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
127562176|NCT00600119|459027966|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
127562177|NCT00600119|459027967|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
127562178|NCT00600119|459027968|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
127562179|NCT00600119|459027969|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
127562180|NCT00600119|459027964|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
127562181|NCT00600119|459027965|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
127562182|NCT00600119|459027966|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
127562183|NCT00600119|459027967|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
127562184|NCT00600119|459027968|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
127562185|NCT00600119|459027969|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
127562186|NCT00600119|459027964|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
127562187|NCT00600119|459027965|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
127562188|NCT00600119|459027966|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
127562189|NCT00600119|459027967|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
127562190|NCT00600119|459027968|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
127562191|NCT00600119|459027969|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
127562192|NCT00600119|459027964|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
127562193|NCT00600119|459027965|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
127562194|NCT00600119|459027966|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
127562195|NCT00600119|459027967|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
127562196|NCT00600119|459027968|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
127562197|NCT00600119|459027969|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
127562198|NCT00600119|459027964|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
127562199|NCT00600119|459027965|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
127562200|NCT00600119|459027966|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
127562201|NCT00600119|459027967|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
127562202|NCT00600119|459027968|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
127562203|NCT00600119|459027969|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
127562204|NCT00600119|459027964|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
127562205|NCT00600119|459027965|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
127562206|NCT00600119|459027966|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
127562207|NCT00600119|459027967|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
127562208|NCT00600119|459027968|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
127562209|NCT00600119|459027969|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
127562210|NCT00600119|459027964|FG000|Double-blind Treatment Period|Other|0|||
127562211|NCT00600119|459027965|FG001|Double-blind Treatment Period|Other|0|||
127562212|NCT00600119|459027966|FG002|Double-blind Treatment Period|Other|0|||
127562213|NCT00600119|459027967|FG003|Double-blind Treatment Period|Other|0|||
127687806|NCT02723955|459483521|FG008|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
127687807|NCT02723955|459483522|FG009|Expansion Phase|Participants were crossed over OR were re-treated following progression|10|||
127687808|NCT02723955|459483523|FG010|Expansion Phase|Participants were crossed over OR were re-treated following progression|36|||
127687809|NCT02723955|459483524|FG011|Expansion Phase|Participants were crossed over OR were re-treated following progression|1|||
127687810|NCT02723955|459483525|FG012|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
127687811|NCT02723955|459483526|FG013|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
128024606|NCT01902303|460715922|FG001|Overall Study|Did not develop a cold sore|19|||
128024607|NCT02821000|460715926|FG000|Overall Study|Death|89|||
128024608|NCT02821000|460715926|FG000|Overall Study|Sponsor Decision|12|||
127687812|NCT02723955|459483527|FG014|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
127687813|NCT02723955|459483528|FG015|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
127687814|NCT02723955|459483529|FG016|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
128024609|NCT02821000|460715926|FG000|Overall Study|Withdrawal by Subject|2|||
128024610|NCT00394472|460715927|FG000|Overall Study|Protocol Violation|1|||
128024611|NCT00394472|460715928|FG001|Overall Study|Protocol Violation|3|||
128024612|NCT00394472|460715927|FG000|Overall Study|incorrect enrolment|4|||
128024613|NCT00394472|460715928|FG001|Overall Study|incorrect enrolment|2|||
128024614|NCT00394472|460715927|FG000|Overall Study|Adverse Event|4|||
128024615|NCT00394472|460715928|FG001|Overall Study|Adverse Event|2|||
128024616|NCT00394472|460715927|FG000|Overall Study|Withdrawal by Subject|0|||
128024617|NCT00394472|460715928|FG001|Overall Study|Withdrawal by Subject|2|||
128024618|NCT00394472|460715927|FG000|Overall Study|Physician Decision|0|||
128024619|NCT00394472|460715928|FG001|Overall Study|Physician Decision|1|||
128024620|NCT00394472|460715927|FG000|Overall Study|Lost to Follow-up|0|||
128024621|NCT00394472|460715928|FG001|Overall Study|Lost to Follow-up|1|||
128024622|NCT04359680|460715929|FG000|Overall Study|Withdrawal by Subject|29|||
128024623|NCT04359680|460715930|FG001|Overall Study|Withdrawal by Subject|24|||
128024624|NCT04359680|460715929|FG000|Overall Study|Adverse Event|6|||
128024625|NCT04359680|460715930|FG001|Overall Study|Adverse Event|2|||
128024626|NCT04359680|460715929|FG000|Overall Study|Lost to Follow-up|56|||
128024627|NCT04359680|460715930|FG001|Overall Study|Lost to Follow-up|59|||
128024628|NCT04359680|460715929|FG000|Overall Study|Protocol Violation|3|||
128024629|NCT04359680|460715930|FG001|Overall Study|Protocol Violation|5|||
128024630|NCT04359680|460715929|FG000|Overall Study|Physician Decision|1|||
128024631|NCT04359680|460715930|FG001|Overall Study|Physician Decision|1|||
128024632|NCT04359680|460715929|FG000|Overall Study|Sponsor Decision|0|||
128024633|NCT04359680|460715930|FG001|Overall Study|Sponsor Decision|1|||
128024634|NCT03931785|460715932|FG000|Overall Study|Lost to Follow-up|4|||
128024635|NCT03931785|460715933|FG001|Overall Study|Lost to Follow-up|1|||
128024636|NCT03931785|460715934|FG002|Overall Study|Lost to Follow-up|4|||
128024637|NCT03931785|460715935|FG003|Overall Study|Lost to Follow-up|3|||
128024638|NCT03931785|460715932|FG000|Overall Study|Adverse Event|1|||
128024639|NCT03931785|460715933|FG001|Overall Study|Adverse Event|0|||
128024640|NCT03931785|460715934|FG002|Overall Study|Adverse Event|3|||
128024641|NCT03931785|460715935|FG003|Overall Study|Adverse Event|4|||
128024642|NCT03931785|460715932|FG000|Overall Study|Protocol Violation|0|||
128024643|NCT03931785|460715933|FG001|Overall Study|Protocol Violation|1|||
128024644|NCT03931785|460715934|FG002|Overall Study|Protocol Violation|0|||
128024645|NCT03931785|460715935|FG003|Overall Study|Protocol Violation|0|||
128024646|NCT03931785|460715932|FG000|Overall Study|Noncompliance With Study drug|0|||
128024647|NCT03931785|460715933|FG001|Overall Study|Noncompliance With Study drug|1|||
128024648|NCT03931785|460715934|FG002|Overall Study|Noncompliance With Study drug|0|||
128024649|NCT03931785|460715935|FG003|Overall Study|Noncompliance With Study drug|0|||
128024650|NCT03931785|460715932|FG000|Overall Study|Other Not specified|0|||
128024651|NCT03931785|460715933|FG001|Overall Study|Other Not specified|2|||
128024652|NCT03931785|460715934|FG002|Overall Study|Other Not specified|2|||
128024653|NCT03931785|460715935|FG003|Overall Study|Other Not specified|2|||
128024654|NCT03931785|460715932|FG000|Overall Study|Withdrawal by Subject|0|||
128024655|NCT03931785|460715933|FG001|Overall Study|Withdrawal by Subject|2|||
128024656|NCT03931785|460715934|FG002|Overall Study|Withdrawal by Subject|4|||
128024657|NCT03931785|460715935|FG003|Overall Study|Withdrawal by Subject|1|||
128024658|NCT03931785|460715932|FG000|Overall Study|Pregnancy|0|||
128024659|NCT03931785|460715933|FG001|Overall Study|Pregnancy|0|||
128024660|NCT03931785|460715934|FG002|Overall Study|Pregnancy|0|||
128024661|NCT03931785|460715935|FG003|Overall Study|Pregnancy|1|||
128024662|NCT04605588|460715938|FG000|Overall Study|Withdrawal by Subject|1|||
127776076|NCT04598477|459808344|FG000|Overall Study|Adverse Event|2|||
128024663|NCT04605588|460715939|FG001|Overall Study|Withdrawal by Subject|0|||
128024664|NCT01230814|460715940|FG000|Overall Study|Lost to Follow-up|11|||
128024665|NCT01230814|460715941|FG001|Overall Study|Lost to Follow-up|3|||
128024666|NCT01230814|460715940|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
128024667|NCT01230814|460715941|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
128024668|NCT01748552|460715946|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
128024669|NCT01748552|460715947|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
128024670|NCT01748552|460715948|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
128024671|NCT01748552|460715949|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
128024672|NCT01748552|460715950|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
128024673|NCT01748552|460715951|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
128024674|NCT01748552|460715952|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
128024675|NCT01748552|460715953|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
128024676|NCT01748552|460715954|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
128024677|NCT01748552|460715955|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
128024678|NCT01748552|460715956|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
128024679|NCT01748552|460715957|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
128024680|NCT01748552|460715946|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
128024681|NCT01748552|460715947|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
128024682|NCT01748552|460715948|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
128024683|NCT01748552|460715949|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
128024684|NCT01748552|460715950|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
128024685|NCT01748552|460715951|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
128024686|NCT01748552|460715952|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
128024687|NCT01748552|460715953|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
128024688|NCT01748552|460715954|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
128024689|NCT01748552|460715955|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
128024690|NCT01748552|460715956|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
128024691|NCT01748552|460715957|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
128024692|NCT02596893|460715960|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
127687815|NCT02723955|459483530|FG017|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
127687816|NCT02723955|459483531|FG018|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
127687817|NCT02723955|459483532|FG019|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
127687818|NCT02723955|459483533|FG020|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
127687819|NCT02723955|459483534|FG021|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
127687820|NCT02723955|459483535|FG022|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
127687821|NCT02723955|459483536|FG023|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
127687822|NCT02723955|459483537|FG024|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
127687823|NCT02723955|459483538|FG025|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
127687824|NCT02723955|459483539|FG026|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
127687825|NCT02723955|459483540|FG027|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
127687826|NCT02723955|459483541|FG028|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
127687827|NCT02723955|459483542|FG029|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
127687828|NCT02723955|459483543|FG030|Expansion Phase|Participants were crossed over OR were re-treated following progression|3|||
127687829|NCT02723955|459483544|FG031|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
127687830|NCT02723955|459483545|FG032|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
127687831|NCT02723955|459483546|FG033|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
127687832|NCT02723955|459483547|FG034|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
127687833|NCT02723955|459483548|FG035|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
127687834|NCT02723955|459483549|FG036|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
127687835|NCT02723955|459483550|FG037|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
127687836|NCT02723955|459483551|FG038|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
127687837|NCT02723955|459483552|FG039|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
127687838|NCT02723955|459483553|FG040|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
127687839|NCT02723955|459483554|FG041|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
127687840|NCT02723955|459483555|FG042|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
127687841|NCT02723955|459483513|FG000|Expansion Phase|Site Closed|0|||
127687842|NCT02723955|459483514|FG001|Expansion Phase|Site Closed|0|||
127687843|NCT02723955|459483515|FG002|Expansion Phase|Site Closed|0|||
127687844|NCT02723955|459483516|FG003|Expansion Phase|Site Closed|0|||
127687845|NCT02723955|459483517|FG004|Expansion Phase|Site Closed|0|||
127687846|NCT02723955|459483518|FG005|Expansion Phase|Site Closed|0|||
127687847|NCT02723955|459483519|FG006|Expansion Phase|Site Closed|0|||
127687848|NCT02723955|459483520|FG007|Expansion Phase|Site Closed|0|||
127687849|NCT02723955|459483521|FG008|Expansion Phase|Site Closed|0|||
127687850|NCT02723955|459483522|FG009|Expansion Phase|Site Closed|1|||
127687851|NCT02723955|459483523|FG010|Expansion Phase|Site Closed|2|||
127687852|NCT02723955|459483524|FG011|Expansion Phase|Site Closed|6|||
127687853|NCT02723955|459483525|FG012|Expansion Phase|Site Closed|0|||
127687854|NCT02723955|459483526|FG013|Expansion Phase|Site Closed|0|||
127687855|NCT02723955|459483527|FG014|Expansion Phase|Site Closed|0|||
127687856|NCT02723955|459483528|FG015|Expansion Phase|Site Closed|0|||
127687857|NCT02723955|459483529|FG016|Expansion Phase|Site Closed|0|||
127687858|NCT02723955|459483530|FG017|Expansion Phase|Site Closed|0|||
127562214|NCT00600119|459027968|FG004|Double-blind Treatment Period|Other|2|||
127562215|NCT00600119|459027969|FG005|Double-blind Treatment Period|Other|1|||
127562216|NCT00600119|459027964|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
127562217|NCT00600119|459027965|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
127562218|NCT00600119|459027966|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
127562219|NCT00600119|459027967|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
127562220|NCT00600119|459027968|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
127562221|NCT00600119|459027969|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
127562222|NCT00600119|459027964|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
127562223|NCT00600119|459027965|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
127562224|NCT00600119|459027966|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
127562225|NCT00600119|459027967|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
127562226|NCT00600119|459027968|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
127562227|NCT00600119|459027969|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
127562228|NCT00600119|459027964|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
127562229|NCT00600119|459027965|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
127562230|NCT00600119|459027966|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
127562231|NCT00600119|459027967|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
127562232|NCT00600119|459027968|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
127562233|NCT00600119|459027969|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
127562234|NCT00600119|459027964|FG000|Double-blind Treatment Period|Physician Decision|2|||
127562235|NCT00600119|459027965|FG001|Double-blind Treatment Period|Physician Decision|0|||
127562236|NCT00600119|459027966|FG002|Double-blind Treatment Period|Physician Decision|0|||
127562237|NCT00600119|459027967|FG003|Double-blind Treatment Period|Physician Decision|0|||
127562238|NCT00600119|459027968|FG004|Double-blind Treatment Period|Physician Decision|0|||
127562239|NCT00600119|459027969|FG005|Double-blind Treatment Period|Physician Decision|0|||
127562240|NCT00600119|459027964|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
127562241|NCT00600119|459027965|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
127562242|NCT00600119|459027966|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
127562243|NCT00600119|459027967|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
127562244|NCT00600119|459027968|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
127562245|NCT00600119|459027969|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
127562246|NCT00600119|459027964|FG000|Double-blind Treatment Period|Adverse Event|1|||
127562247|NCT00600119|459027965|FG001|Double-blind Treatment Period|Adverse Event|1|||
127562248|NCT00600119|459027966|FG002|Double-blind Treatment Period|Adverse Event|0|||
127562249|NCT00600119|459027967|FG003|Double-blind Treatment Period|Adverse Event|1|||
127562250|NCT00600119|459027968|FG004|Double-blind Treatment Period|Adverse Event|2|||
127562251|NCT00600119|459027969|FG005|Double-blind Treatment Period|Adverse Event|10|||
127562252|NCT00600119|459027964|FG000|Follow-up Period|Adverse Event|0|||
127562253|NCT00600119|459027965|FG001|Follow-up Period|Adverse Event|0|||
127562254|NCT00600119|459027966|FG002|Follow-up Period|Adverse Event|0|||
127562255|NCT00600119|459027967|FG003|Follow-up Period|Adverse Event|0|||
127562256|NCT00600119|459027968|FG004|Follow-up Period|Adverse Event|0|||
127562257|NCT00600119|459027969|FG005|Follow-up Period|Adverse Event|1|||
127687859|NCT02723955|459483531|FG018|Expansion Phase|Site Closed|0|||
127687860|NCT02723955|459483532|FG019|Expansion Phase|Site Closed|0|||
127687861|NCT02723955|459483533|FG020|Expansion Phase|Site Closed|0|||
127687862|NCT02723955|459483534|FG021|Expansion Phase|Site Closed|0|||
127687863|NCT02723955|459483535|FG022|Expansion Phase|Site Closed|0|||
127687864|NCT02723955|459483536|FG023|Expansion Phase|Site Closed|0|||
127687865|NCT02723955|459483537|FG024|Expansion Phase|Site Closed|0|||
127687866|NCT02723955|459483538|FG025|Expansion Phase|Site Closed|0|||
127687867|NCT02723955|459483539|FG026|Expansion Phase|Site Closed|0|||
127687868|NCT02723955|459483540|FG027|Expansion Phase|Site Closed|0|||
127687869|NCT02723955|459483541|FG028|Expansion Phase|Site Closed|0|||
127687870|NCT02723955|459483542|FG029|Expansion Phase|Site Closed|0|||
127687871|NCT02723955|459483543|FG030|Expansion Phase|Site Closed|8|||
127687872|NCT02723955|459483544|FG031|Expansion Phase|Site Closed|4|||
127687873|NCT02723955|459483545|FG032|Expansion Phase|Site Closed|2|||
127687874|NCT02723955|459483546|FG033|Expansion Phase|Site Closed|2|||
127687875|NCT02723955|459483547|FG034|Expansion Phase|Site Closed|0|||
127687876|NCT02723955|459483548|FG035|Expansion Phase|Site Closed|0|||
127687877|NCT02723955|459483549|FG036|Expansion Phase|Site Closed|0|||
127687878|NCT02723955|459483550|FG037|Expansion Phase|Site Closed|0|||
127687879|NCT02723955|459483551|FG038|Expansion Phase|Site Closed|0|||
127687880|NCT02723955|459483552|FG039|Expansion Phase|Site Closed|0|||
127687881|NCT02723955|459483553|FG040|Expansion Phase|Site Closed|0|||
127687882|NCT02723955|459483554|FG041|Expansion Phase|Site Closed|0|||
127687883|NCT02723955|459483555|FG042|Expansion Phase|Site Closed|0|||
127687884|NCT02723955|459483513|FG000|Crossover/ Re-treatment Phase|Death|0|||
127687885|NCT02723955|459483514|FG001|Crossover/ Re-treatment Phase|Death|0|||
127687886|NCT02723955|459483515|FG002|Crossover/ Re-treatment Phase|Death|0|||
127776077|NCT04598477|459808345|FG001|Overall Study|Adverse Event|0|||
127562258|NCT00600119|459027964|FG000|Follow-up Period|Other|1|||
127562259|NCT00600119|459027965|FG001|Follow-up Period|Other|0|||
127562260|NCT00600119|459027966|FG002|Follow-up Period|Other|0|||
127562261|NCT00600119|459027967|FG003|Follow-up Period|Other|0|||
127562262|NCT00600119|459027968|FG004|Follow-up Period|Other|0|||
127562263|NCT00600119|459027969|FG005|Follow-up Period|Other|0|||
127562264|NCT00729469|459027970|FG000|Overall Study|Adverse Event|14|||
127562265|NCT00729469|459027971|FG001|Overall Study|Adverse Event|25|||
127562266|NCT00729469|459027970|FG000|Overall Study|Lost to Follow-up|9|||
127562267|NCT00729469|459027971|FG001|Overall Study|Lost to Follow-up|9|||
127562268|NCT00729469|459027970|FG000|Overall Study|Protocol Violation|2|||
127562269|NCT00729469|459027971|FG001|Overall Study|Protocol Violation|1|||
127562270|NCT00729469|459027970|FG000|Overall Study|Withdrawal by Subject|19|||
127562271|NCT00729469|459027971|FG001|Overall Study|Withdrawal by Subject|8|||
127562272|NCT00729469|459027970|FG000|Overall Study|Other-Not mentioned|9|||
127562273|NCT00729469|459027971|FG001|Overall Study|Other-Not mentioned|4|||
127562274|NCT01270802|459027974|FG000|Overall Study|Withdrawal by Subject|1|||
127562275|NCT01270802|459027975|FG001|Overall Study|Withdrawal by Subject|0|||
127562276|NCT01270802|459027974|FG000|Overall Study|Adverse Event|1|||
127562277|NCT01270802|459027975|FG001|Overall Study|Adverse Event|0|||
127562278|NCT01270802|459027974|FG000|Overall Study|Lost to Follow-up|0|||
127562279|NCT01270802|459027975|FG001|Overall Study|Lost to Follow-up|1|||
127562280|NCT01960907|459027983|FG000|Overall Study|Death|4|||
127562281|NCT01960907|459027984|FG001|Overall Study|Death|3|||
127562282|NCT01960907|459027983|FG000|Overall Study|Withdrawal by Subject|32|||
127562283|NCT01960907|459027984|FG001|Overall Study|Withdrawal by Subject|42|||
127562284|NCT01616693|459027985|FG000|Evaluated for Safety|Physician Decision|1|||
127562285|NCT01616693|459027986|FG001|Evaluated for Safety|Physician Decision|0|||
127562286|NCT01616693|459027987|FG002|Evaluated for Safety|Physician Decision|1|||
127562287|NCT01616693|459027988|FG003|Evaluated for Safety|Physician Decision|0|||
127562288|NCT01616693|459027985|FG000|Received Both Vaccines|Adverse Event|2|||
127562289|NCT01616693|459027986|FG001|Received Both Vaccines|Adverse Event|0|||
127562290|NCT01616693|459027987|FG002|Received Both Vaccines|Adverse Event|0|||
127562291|NCT01616693|459027988|FG003|Received Both Vaccines|Adverse Event|0|||
127562292|NCT01616693|459027985|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
127562293|NCT01616693|459027986|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
127562294|NCT01616693|459027987|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
127562295|NCT01616693|459027988|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
127562296|NCT01616693|459027985|FG000|Received Both Vaccines|Lost to Follow-up|4|||
127562297|NCT01616693|459027986|FG001|Received Both Vaccines|Lost to Follow-up|3|||
127562298|NCT01616693|459027987|FG002|Received Both Vaccines|Lost to Follow-up|4|||
127562299|NCT01616693|459027988|FG003|Received Both Vaccines|Lost to Follow-up|4|||
127562300|NCT01616693|459027985|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
127562301|NCT01616693|459027986|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
127562302|NCT01616693|459027987|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
127562303|NCT01616693|459027988|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
127562304|NCT00832624|459027992|FG000|Overall Study|Study Terminated|10|||
127562305|NCT02395172|459027993|FG000|Overall Study|Participants randomized but not treated|3|||
127562306|NCT02395172|459027994|FG001|Overall Study|Participants randomized but not treated|31|||
127562307|NCT00653939|459027995|FG000|Overall Study|Adverse Event|1|||
127562308|NCT00653939|459027996|FG001|Overall Study|Adverse Event|3|||
127562309|NCT00653939|459027995|FG000|Overall Study|Withdrawal by Subject|3|||
127562310|NCT00653939|459027996|FG001|Overall Study|Withdrawal by Subject|3|||
127562311|NCT00653939|459027995|FG000|Overall Study|Physician Decision|4|||
127562312|NCT00653939|459027996|FG001|Overall Study|Physician Decision|0|||
127776078|NCT04598477|459808344|FG000|Overall Study|Death|0|||
127776079|NCT04598477|459808345|FG001|Overall Study|Death|1|||
127776080|NCT04598477|459808344|FG000|Overall Study|Lost to Follow-up|1|||
127776081|NCT04598477|459808345|FG001|Overall Study|Lost to Follow-up|0|||
127776082|NCT04598477|459808344|FG000|Overall Study|Physician Decision|7|||
127776083|NCT04598477|459808345|FG001|Overall Study|Physician Decision|2|||
127562313|NCT00653939|459027995|FG000|Overall Study|Disease Progression|2|||
127562314|NCT00653939|459027996|FG001|Overall Study|Disease Progression|3|||
127562315|NCT00653939|459027995|FG000|Overall Study|Other|2|||
127562316|NCT00653939|459027996|FG001|Overall Study|Other|6|||
127562317|NCT00717236|459027997|FG000|Double-Blind Period|Adverse Event|33|||
127562318|NCT00717236|459027998|FG001|Double-Blind Period|Adverse Event|6|||
127562319|NCT00717236|459027997|FG000|Double-Blind Period|Lack of Efficacy|6|||
127562320|NCT00717236|459027998|FG001|Double-Blind Period|Lack of Efficacy|6|||
127562321|NCT00717236|459027997|FG000|Double-Blind Period|Lost to Follow-up|3|||
127562322|NCT00717236|459027998|FG001|Double-Blind Period|Lost to Follow-up|5|||
127562323|NCT00717236|459027997|FG000|Double-Blind Period|Withdrawal by Subject|10|||
127562324|NCT00717236|459027998|FG001|Double-Blind Period|Withdrawal by Subject|2|||
127562325|NCT00717236|459027997|FG000|Double-Blind Period|Loss of efficacy|3|||
127562326|NCT00717236|459027998|FG001|Double-Blind Period|Loss of efficacy|0|||
127562327|NCT00717236|459027997|FG000|Double-Blind Period|Other: Death|1|||
127562328|NCT00717236|459027998|FG001|Double-Blind Period|Other: Death|0|||
127562329|NCT00717236|459027997|FG000|Double-Blind Period|Other: Pregnancy|1|||
127562330|NCT00717236|459027998|FG001|Double-Blind Period|Other: Pregnancy|0|||
127562331|NCT00717236|459027997|FG000|Double-Blind Period|Other: Protocol Violation|2|||
127562332|NCT00717236|459027998|FG001|Double-Blind Period|Other: Protocol Violation|0|||
127562333|NCT00717236|459027997|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
127562334|NCT00717236|459027998|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
127562335|NCT00717236|459027997|FG000|Double-Blind Period|Other: Site withdrew|2|||
127562336|NCT00717236|459027998|FG001|Double-Blind Period|Other: Site withdrew|0|||
127562337|NCT00717236|459027997|FG000|Double-Blind Period|Other: Screening failure|1|||
127562338|NCT00717236|459027998|FG001|Double-Blind Period|Other: Screening failure|0|||
127562339|NCT00717236|459027997|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
127562340|NCT00717236|459027998|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
127562341|NCT00717236|459027997|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
127562342|NCT00717236|459027998|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
127562343|NCT00717236|459027997|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
127562344|NCT00717236|459027998|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
127562345|NCT00717236|459027997|FG000|Double-Blind Period|Other: History of cancer|1|||
127562346|NCT00717236|459027998|FG001|Double-Blind Period|Other: History of cancer|0|||
127562347|NCT00717236|459027997|FG000|Double-Blind Period|Other: Sponsor request|1|||
127562348|NCT00717236|459027998|FG001|Double-Blind Period|Other: Sponsor request|0|||
127562349|NCT00717236|459027997|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
127562350|NCT00717236|459027998|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
127562351|NCT00717236|459027997|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
127562352|NCT00717236|459027998|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
127562353|NCT00717236|459027997|FG000|Double-Blind Period|Other: Subject moved|1|||
127562354|NCT00717236|459027998|FG001|Double-Blind Period|Other: Subject moved|1|||
127562355|NCT00717236|459027997|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
127562356|NCT00717236|459027998|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
127562357|NCT00717236|459027997|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
127562358|NCT00717236|459027998|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
127562359|NCT00717236|459027997|FG000|Double-Blind Period|Other: Transportation problems|0|||
127562360|NCT00717236|459027998|FG001|Double-Blind Period|Other: Transportation problems|1|||
127562361|NCT00717236|459027997|FG000|Double-Blind Period|Other: Investigator Decision|0|||
127562362|NCT00717236|459027998|FG001|Double-Blind Period|Other: Investigator Decision|1|||
127562363|NCT00717236|459027997|FG000|Open-Label Period|Adverse Event|29|||
127562364|NCT00717236|459027998|FG001|Open-Label Period|Adverse Event|4|||
127562365|NCT00717236|459027997|FG000|Open-Label Period|Lack of Efficacy|30|||
127562366|NCT00717236|459027998|FG001|Open-Label Period|Lack of Efficacy|8|||
127562367|NCT00717236|459027997|FG000|Open-Label Period|Lost to Follow-up|28|||
127562368|NCT00717236|459027998|FG001|Open-Label Period|Lost to Follow-up|4|||
127562369|NCT00717236|459027997|FG000|Open-Label Period|Withdrawal by Subject|20|||
127562370|NCT00717236|459027998|FG001|Open-Label Period|Withdrawal by Subject|2|||
127562371|NCT00717236|459027997|FG000|Open-Label Period|Loss of Efficacy|6|||
127562372|NCT00717236|459027998|FG001|Open-Label Period|Loss of Efficacy|1|||
127562373|NCT00717236|459027997|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
127562374|NCT00717236|459027998|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
127562375|NCT00717236|459027997|FG000|Open-Label Period|Other: Lack of Compliance|1|||
127562376|NCT00717236|459027998|FG001|Open-Label Period|Other: Lack of Compliance|1|||
127562377|NCT00717236|459027997|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
127562378|NCT00717236|459027998|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
127562379|NCT00717236|459027997|FG000|Open-Label Period|Other: Moved|1|||
127562380|NCT00717236|459027998|FG001|Open-Label Period|Other: Moved|0|||
127776084|NCT04598477|459808344|FG000|Overall Study|Pregnancy|0|||
127776085|NCT04598477|459808345|FG001|Overall Study|Pregnancy|1|||
127776086|NCT04598477|459808344|FG000|Overall Study|Requires Prohibited Medication|0|||
127776087|NCT04598477|459808345|FG001|Overall Study|Requires Prohibited Medication|1|||
127776088|NCT04598477|459808344|FG000|Overall Study|Study Terminated by Sponsor|18|||
127776089|NCT04598477|459808345|FG001|Overall Study|Study Terminated by Sponsor|12|||
127562381|NCT00717236|459027997|FG000|Open-Label Period|Other: Investigator Decision|1|||
127562382|NCT00717236|459027998|FG001|Open-Label Period|Other: Investigator Decision|0|||
127562383|NCT00717236|459027997|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
127562384|NCT00717236|459027998|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
127562385|NCT00717236|459027997|FG000|Open-Label Period|Other: Sponsor Request|3|||
127562386|NCT00717236|459027998|FG001|Open-Label Period|Other: Sponsor Request|0|||
127562387|NCT00717236|459027997|FG000|Open-Label Period|Other: Cataract Surgery|1|||
127562388|NCT00717236|459027998|FG001|Open-Label Period|Other: Cataract Surgery|0|||
127562389|NCT00717236|459027997|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
127562390|NCT00717236|459027998|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
127562391|NCT00717236|459027997|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
127562392|NCT00717236|459027998|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
127562393|NCT00717236|459027997|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
127687887|NCT02723955|459483516|FG003|Crossover/ Re-treatment Phase|Death|0|||
127687888|NCT02723955|459483517|FG004|Crossover/ Re-treatment Phase|Death|0|||
127687889|NCT02723955|459483518|FG005|Crossover/ Re-treatment Phase|Death|0|||
127687890|NCT02723955|459483519|FG006|Crossover/ Re-treatment Phase|Death|0|||
127687891|NCT02723955|459483520|FG007|Crossover/ Re-treatment Phase|Death|0|||
127562394|NCT00717236|459027998|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
127562395|NCT00475982|459027999|FG000|Overall Study|surgery rescheduled|7|||
127562396|NCT00475982|459028000|FG001|Overall Study|surgery rescheduled|3|||
127562397|NCT00783198|459028005|FG000|Overall Study|Adverse Event|15|||
127562398|NCT00783198|459028006|FG001|Overall Study|Adverse Event|19|||
127562399|NCT00783198|459028007|FG002|Overall Study|Adverse Event|3|||
127562400|NCT00783198|459028005|FG000|Overall Study|Lost to Follow-up|11|||
127687892|NCT02723955|459483521|FG008|Crossover/ Re-treatment Phase|Death|0|||
127687893|NCT02723955|459483522|FG009|Crossover/ Re-treatment Phase|Death|0|||
127562401|NCT00783198|459028006|FG001|Overall Study|Lost to Follow-up|1|||
127562402|NCT00783198|459028007|FG002|Overall Study|Lost to Follow-up|7|||
127562403|NCT00783198|459028005|FG000|Overall Study|Withdrawal by Subject|22|||
127562404|NCT00783198|459028006|FG001|Overall Study|Withdrawal by Subject|14|||
127562405|NCT00783198|459028007|FG002|Overall Study|Withdrawal by Subject|20|||
127562406|NCT00783198|459028005|FG000|Overall Study|Noncompliance with protocol|7|||
127562407|NCT00783198|459028006|FG001|Overall Study|Noncompliance with protocol|7|||
127562408|NCT00783198|459028007|FG002|Overall Study|Noncompliance with protocol|10|||
127562409|NCT00783198|459028005|FG000|Overall Study|Did not meet protocol eligibility|0|||
127562410|NCT00783198|459028006|FG001|Overall Study|Did not meet protocol eligibility|1|||
127562411|NCT00783198|459028007|FG002|Overall Study|Did not meet protocol eligibility|0|||
127562412|NCT00783198|459028005|FG000|Overall Study|Administrative|2|||
127562413|NCT00783198|459028006|FG001|Overall Study|Administrative|1|||
127562414|NCT00783198|459028007|FG002|Overall Study|Administrative|2|||
127687894|NCT02723955|459483523|FG010|Crossover/ Re-treatment Phase|Death|0|||
127562415|NCT03704636|459028008|FG000|Overall Study|Inadequate Venous Flow|3|||
127562416|NCT00539188|459028011|FG000|Overall Study|Withdrawal by Subject|1|||
127562417|NCT00539188|459028012|FG001|Overall Study|Withdrawal by Subject|0|||
127562418|NCT00539188|459028011|FG000|Overall Study|Lost to Follow-up|2|||
127562419|NCT00539188|459028012|FG001|Overall Study|Lost to Follow-up|1|||
127562420|NCT01546623|459028013|FG000|Overall Study|Adverse Event|2|||
127687895|NCT02723955|459483524|FG011|Crossover/ Re-treatment Phase|Death|0|||
127687896|NCT02723955|459483525|FG012|Crossover/ Re-treatment Phase|Death|0|||
127687897|NCT02723955|459483526|FG013|Crossover/ Re-treatment Phase|Death|0|||
127687898|NCT02723955|459483527|FG014|Crossover/ Re-treatment Phase|Death|0|||
127687899|NCT02723955|459483528|FG015|Crossover/ Re-treatment Phase|Death|0|||
127687900|NCT02723955|459483529|FG016|Crossover/ Re-treatment Phase|Death|0|||
127687901|NCT02723955|459483530|FG017|Crossover/ Re-treatment Phase|Death|0|||
127687902|NCT02723955|459483531|FG018|Crossover/ Re-treatment Phase|Death|0|||
127687903|NCT02723955|459483532|FG019|Crossover/ Re-treatment Phase|Death|0|||
127687904|NCT02723955|459483533|FG020|Crossover/ Re-treatment Phase|Death|0|||
127687905|NCT02723955|459483534|FG021|Crossover/ Re-treatment Phase|Death|0|||
127687906|NCT02723955|459483535|FG022|Crossover/ Re-treatment Phase|Death|0|||
127687907|NCT02723955|459483536|FG023|Crossover/ Re-treatment Phase|Death|0|||
127687908|NCT02723955|459483537|FG024|Crossover/ Re-treatment Phase|Death|0|||
127687909|NCT02723955|459483538|FG025|Crossover/ Re-treatment Phase|Death|0|||
127687910|NCT02723955|459483539|FG026|Crossover/ Re-treatment Phase|Death|0|||
127687911|NCT02723955|459483540|FG027|Crossover/ Re-treatment Phase|Death|0|||
127687912|NCT02723955|459483541|FG028|Crossover/ Re-treatment Phase|Death|0|||
127687913|NCT02723955|459483542|FG029|Crossover/ Re-treatment Phase|Death|0|||
127687914|NCT02723955|459483543|FG030|Crossover/ Re-treatment Phase|Death|0|||
127687915|NCT02723955|459483544|FG031|Crossover/ Re-treatment Phase|Death|0|||
127687916|NCT02723955|459483545|FG032|Crossover/ Re-treatment Phase|Death|0|||
127687917|NCT02723955|459483546|FG033|Crossover/ Re-treatment Phase|Death|0|||
127687918|NCT02723955|459483547|FG034|Crossover/ Re-treatment Phase|Death|0|||
127687919|NCT02723955|459483548|FG035|Crossover/ Re-treatment Phase|Death|0|||
127687920|NCT02723955|459483549|FG036|Crossover/ Re-treatment Phase|Death|0|||
127687921|NCT02723955|459483550|FG037|Crossover/ Re-treatment Phase|Death|1|||
127687922|NCT02723955|459483551|FG038|Crossover/ Re-treatment Phase|Death|14|||
127687923|NCT02723955|459483552|FG039|Crossover/ Re-treatment Phase|Death|32|||
127687924|NCT02723955|459483553|FG040|Crossover/ Re-treatment Phase|Death|2|||
127687925|NCT02723955|459483554|FG041|Crossover/ Re-treatment Phase|Death|1|||
127687926|NCT02723955|459483555|FG042|Crossover/ Re-treatment Phase|Death|0|||
127687927|NCT02723955|459483513|FG000|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
127687928|NCT02723955|459483514|FG001|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
127687929|NCT02723955|459483515|FG002|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
127687930|NCT02723955|459483516|FG003|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
127562421|NCT01546623|459028014|FG001|Overall Study|Adverse Event|3|||
127687931|NCT02723955|459483517|FG004|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
127687932|NCT02723955|459483518|FG005|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
127687933|NCT02723955|459483519|FG006|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
127562422|NCT01546623|459028013|FG000|Overall Study|Major Protocol Deviation|1|||
127562423|NCT01546623|459028014|FG001|Overall Study|Major Protocol Deviation|1|||
127562424|NCT01546623|459028013|FG000|Overall Study|High Prostate specific antigen|2|||
127562425|NCT01546623|459028014|FG001|Overall Study|High Prostate specific antigen|1|||
127562426|NCT01546623|459028013|FG000|Overall Study|Did Not Receive Study Drug|1|||
127562427|NCT01546623|459028014|FG001|Overall Study|Did Not Receive Study Drug|1|||
127562428|NCT01134705|459028015|FG000|Overall Study|Adverse Event|1|||
127562429|NCT01134705|459028016|FG001|Overall Study|Adverse Event|7|||
127562430|NCT01134705|459028015|FG000|Overall Study|Withdrawal by Subject|6|||
127562431|NCT01134705|459028016|FG001|Overall Study|Withdrawal by Subject|6|||
127562432|NCT01134705|459028015|FG000|Overall Study|Pregnancy|1|||
127562433|NCT01134705|459028016|FG001|Overall Study|Pregnancy|0|||
127562434|NCT01134705|459028015|FG000|Overall Study|Lost to Follow-up|5|||
127562435|NCT01134705|459028016|FG001|Overall Study|Lost to Follow-up|2|||
127562436|NCT01134705|459028015|FG000|Overall Study|Protocol Violation|1|||
127562437|NCT01134705|459028016|FG001|Overall Study|Protocol Violation|1|||
127562438|NCT01134705|459028015|FG000|Overall Study|Other|1|||
127562439|NCT01134705|459028016|FG001|Overall Study|Other|6|||
127562440|NCT04784442|459028017|FG000|Overall Study|Adverse Event|1|||
127562441|NCT04784442|459028018|FG001|Overall Study|Adverse Event|0|||
127562442|NCT04784442|459028019|FG002|Overall Study|Adverse Event|2|||
127562443|NCT04784442|459028020|FG003|Overall Study|Adverse Event|1|||
127562444|NCT04784442|459028017|FG000|Overall Study|Protocol Violation|1|||
127562445|NCT04784442|459028018|FG001|Overall Study|Protocol Violation|0|||
127562446|NCT04784442|459028019|FG002|Overall Study|Protocol Violation|0|||
127562447|NCT04784442|459028020|FG003|Overall Study|Protocol Violation|0|||
127562448|NCT04784442|459028017|FG000|Overall Study|Non-compliance with study drug|1|||
127562449|NCT04784442|459028018|FG001|Overall Study|Non-compliance with study drug|0|||
127562450|NCT04784442|459028019|FG002|Overall Study|Non-compliance with study drug|0|||
127562451|NCT04784442|459028020|FG003|Overall Study|Non-compliance with study drug|0|||
127562452|NCT01590758|459028023|FG000|Overall Study|Withdrawal by Subject|0|||
127562453|NCT01590758|459028024|FG001|Overall Study|Withdrawal by Subject|3|||
127562454|NCT01590758|459028023|FG000|Overall Study|Physician Decision|1|||
127562455|NCT01590758|459028024|FG001|Overall Study|Physician Decision|2|||
127562456|NCT01590758|459028023|FG000|Overall Study|Lost to Follow-up|4|||
127562457|NCT01590758|459028024|FG001|Overall Study|Lost to Follow-up|2|||
127562458|NCT02756806|459028025|FG000|Overall Study|Study terminated early|5|||
127562459|NCT02717832|459028026|FG000|Overall Study|Inability to place IV|3|||
127562460|NCT01008423|459028027|FG000|Overall Study|Adverse Event|13|||
127562461|NCT01008423|459028028|FG001|Overall Study|Adverse Event|6|||
127562462|NCT01008423|459028027|FG000|Overall Study|Withdrawal by Subject|4|||
127562463|NCT01008423|459028028|FG001|Overall Study|Withdrawal by Subject|7|||
127562464|NCT01008423|459028027|FG000|Overall Study|Lost to Follow-up|0|||
127562465|NCT01008423|459028028|FG001|Overall Study|Lost to Follow-up|2|||
127562466|NCT01008423|459028027|FG000|Overall Study|Low Cortisol|0|||
127562467|NCT01008423|459028028|FG001|Overall Study|Low Cortisol|1|||
127562468|NCT01008423|459028027|FG000|Overall Study|Lack of Efficacy|0|||
127562469|NCT01008423|459028028|FG001|Overall Study|Lack of Efficacy|5|||
128024693|NCT02596893|460715961|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
128024694|NCT02596893|460715962|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
128024695|NCT02596893|460715963|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
128024696|NCT02596893|460715960|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
128024697|NCT02596893|460715961|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
127562470|NCT01008423|459028027|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
127562471|NCT01008423|459028028|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
127562472|NCT01008423|459028027|FG000|Overall Study|Personal Conflict|1|||
127562473|NCT01008423|459028028|FG001|Overall Study|Personal Conflict|0|||
127562474|NCT01008423|459028027|FG000|Overall Study|Other|0|||
127562475|NCT01008423|459028028|FG001|Overall Study|Other|1|||
127687934|NCT02723955|459483520|FG007|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
127687935|NCT02723955|459483521|FG008|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
127687936|NCT02723955|459483522|FG009|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
127687937|NCT02723955|459483523|FG010|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
127687938|NCT02723955|459483524|FG011|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
127687939|NCT02723955|459483525|FG012|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
127687940|NCT02723955|459483526|FG013|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
127562476|NCT00934843|459028030|FG000|Overall Study|Protocol Violation|0|||
127562477|NCT00934843|459028031|FG001|Overall Study|Protocol Violation|1|||
127562478|NCT01144299|459028034|FG000|Overall Study|Lost to Follow-up|1|||
127562479|NCT01144299|459028035|FG001|Overall Study|Lost to Follow-up|0|||
127562480|NCT01144299|459028034|FG000|Overall Study|Withdrawal by Subject|1|||
127562481|NCT01144299|459028035|FG001|Overall Study|Withdrawal by Subject|0|||
127562482|NCT00831493|459028044|FG000|Overall Study|Intractable nausea and vomiting|1|||
127562483|NCT01031836|459029797|FG000|Stage I|Adverse Event|1|||
127562484|NCT01031836|459029798|FG001|Stage I|Adverse Event|1|||
127562485|NCT01031836|459029799|FG002|Stage I|Adverse Event|0|||
127562486|NCT01031836|459029800|FG003|Stage I|Adverse Event|0|||
127562487|NCT01031836|459029801|FG004|Stage I|Adverse Event|0|||
127562488|NCT01031836|459029802|FG005|Stage I|Adverse Event|0|||
127562489|NCT01031836|459029797|FG000|Stage I|Other|0|||
127562490|NCT01031836|459029798|FG001|Stage I|Other|1|||
127562491|NCT01031836|459029799|FG002|Stage I|Other|0|||
127562492|NCT01031836|459029800|FG003|Stage I|Other|0|||
127562493|NCT01031836|459029801|FG004|Stage I|Other|0|||
127562494|NCT01031836|459029802|FG005|Stage I|Other|1|||
127562495|NCT01031836|459029797|FG000|Stage II|Adverse Event|0|||
127562496|NCT01031836|459029798|FG001|Stage II|Adverse Event|0|||
127562497|NCT01031836|459029799|FG002|Stage II|Adverse Event|2|||
127562498|NCT01031836|459029800|FG003|Stage II|Adverse Event|2|||
127562499|NCT01031836|459029801|FG004|Stage II|Adverse Event|1|||
127562500|NCT01031836|459029802|FG005|Stage II|Adverse Event|1|||
127562501|NCT01031836|459029797|FG000|Stage II|Other|2|||
127562502|NCT01031836|459029798|FG001|Stage II|Other|0|||
127562503|NCT01031836|459029799|FG002|Stage II|Other|0|||
127562504|NCT01031836|459029800|FG003|Stage II|Other|1|||
127562505|NCT01031836|459029801|FG004|Stage II|Other|1|||
127562506|NCT01031836|459029802|FG005|Stage II|Other|0|||
127562507|NCT01964755|459029805|FG000|Overall Study|Death|2|||
127562508|NCT02894502|459029806|FG000|Baseline|Withdrawal by Subject|24|||
127562509|NCT02894502|459029807|FG001|Baseline|Withdrawal by Subject|31|||
127562510|NCT02894502|459029808|FG002|Baseline|Withdrawal by Subject|36|||
127562511|NCT02894502|459029806|FG000|Baseline|Death|3|||
127562512|NCT02894502|459029807|FG001|Baseline|Death|1|||
127562513|NCT02894502|459029808|FG002|Baseline|Death|9|||
127562514|NCT02894502|459029806|FG000|First Follow up|Withdrawal by Subject|32|||
127562515|NCT02894502|459029807|FG001|First Follow up|Withdrawal by Subject|29|||
127562516|NCT02894502|459029808|FG002|First Follow up|Withdrawal by Subject|37|||
127562517|NCT02894502|459029806|FG000|First Follow up|Death|2|||
127562518|NCT02894502|459029807|FG001|First Follow up|Death|2|||
127562519|NCT02894502|459029808|FG002|First Follow up|Death|3|||
127562520|NCT02894502|459029806|FG000|Second Follow up|Withdrawal by Subject|13|||
127776090|NCT04598477|459808344|FG000|Overall Study|Withdrawal by Subject|16|||
127776091|NCT04598477|459808345|FG001|Overall Study|Withdrawal by Subject|12|||
127776092|NCT04598477|459808344|FG000|Overall Study|Other|15|||
127776093|NCT04598477|459808345|FG001|Overall Study|Other|8|||
127776095|NCT02499770|459808349|FG000|Overall Study|Death|17|||
127776096|NCT02499770|459808350|FG001|Overall Study|Death|56|||
128024698|NCT02596893|460715962|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
128024699|NCT02596893|460715963|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
128024700|NCT02596893|460715960|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
128024701|NCT02596893|460715961|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
128024702|NCT02596893|460715962|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
127776097|NCT02499770|459808349|FG000|Overall Study|Study completion|1|||
127776098|NCT02499770|459808350|FG001|Overall Study|Study completion|10|||
127776099|NCT02499770|459808349|FG000|Overall Study|Withdrawal by Subject|0|||
127776100|NCT02499770|459808350|FG001|Overall Study|Withdrawal by Subject|7|||
127776101|NCT02499770|459808349|FG000|Overall Study|Lost to Follow-up|0|||
127776102|NCT02499770|459808350|FG001|Overall Study|Lost to Follow-up|2|||
127776103|NCT02499770|459808349|FG000|Overall Study|Subject declined further treatment|1|||
127776104|NCT02499770|459808350|FG001|Overall Study|Subject declined further treatment|0|||
127776105|NCT02499770|459808349|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
127776106|NCT02499770|459808350|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
127776107|NCT02499770|459808349|FG000|Overall Study|Randomized but not enrolled|0|||
127776108|NCT02499770|459808350|FG001|Overall Study|Randomized but not enrolled|1|||
127776109|NCT01019980|459808353|FG000|Overall Study|Drug not available.|2|||
127776110|NCT01019980|459808354|FG001|Overall Study|Drug not available.|0|||
127776111|NCT02038920|459808370|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
127776112|NCT02038920|459808371|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
128024703|NCT02596893|460715963|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
127776113|NCT02038920|459808372|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
128024704|NCT02596893|460715960|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
127881031|NCT02575807|460186106|FG002|Overall Study|Study terminated by Sponsor|7|||
127562521|NCT02894502|459029807|FG001|Second Follow up|Withdrawal by Subject|15|||
127562522|NCT02894502|459029808|FG002|Second Follow up|Withdrawal by Subject|13|||
127562523|NCT02894502|459029806|FG000|Second Follow up|Death|2|||
127562524|NCT02894502|459029807|FG001|Second Follow up|Death|3|||
127562525|NCT02894502|459029808|FG002|Second Follow up|Death|1|||
127562526|NCT02894502|459029806|FG000|Third Follow up|Withdrawal by Subject|5|||
127562527|NCT02894502|459029807|FG001|Third Follow up|Withdrawal by Subject|6|||
127562528|NCT02894502|459029808|FG002|Third Follow up|Withdrawal by Subject|3|||
127562529|NCT02894502|459029806|FG000|Third Follow up|Death|1|||
127562530|NCT02894502|459029807|FG001|Third Follow up|Death|1|||
127562531|NCT02894502|459029808|FG002|Third Follow up|Death|0|||
127562532|NCT01332799|459029812|FG000|Overall Study|Insufficient funding|10|||
127562533|NCT01332799|459029813|FG001|Overall Study|Insufficient funding|10|||
127562534|NCT02168387|459029816|FG000|Overall Study|Planned exubation|6|||
127562535|NCT02168387|459029817|FG001|Overall Study|Planned exubation|3|||
127562536|NCT02168387|459029816|FG000|Overall Study|Death|1|||
127562537|NCT02168387|459029817|FG001|Overall Study|Death|0|||
127562538|NCT03467152|459029818|FG000|Overall Study|Adverse Event|4|||
127562539|NCT03467152|459029819|FG001|Overall Study|Adverse Event|5|||
127562540|NCT03467152|459029820|FG002|Overall Study|Adverse Event|0|||
127562541|NCT03467152|459029818|FG000|Overall Study|Subject Choice|1|||
127562542|NCT03467152|459029819|FG001|Overall Study|Subject Choice|3|||
127562543|NCT03467152|459029820|FG002|Overall Study|Subject Choice|0|||
127562544|NCT03467152|459029818|FG000|Overall Study|Lost to Follow-up|1|||
127562545|NCT03467152|459029819|FG001|Overall Study|Lost to Follow-up|0|||
127562546|NCT03467152|459029820|FG002|Overall Study|Lost to Follow-up|0|||
127562547|NCT03467152|459029818|FG000|Overall Study|Withdrawal by Subject|4|||
127562548|NCT03467152|459029819|FG001|Overall Study|Withdrawal by Subject|2|||
127562549|NCT03467152|459029820|FG002|Overall Study|Withdrawal by Subject|0|||
127562550|NCT03467152|459029818|FG000|Overall Study|Others|3|||
127562551|NCT03467152|459029819|FG001|Overall Study|Others|0|||
127562552|NCT03467152|459029820|FG002|Overall Study|Others|0|||
127562553|NCT03467152|459029818|FG000|Overall Study|Not treated|3|||
127562554|NCT03467152|459029819|FG001|Overall Study|Not treated|1|||
127562555|NCT03467152|459029820|FG002|Overall Study|Not treated|6|||
127562556|NCT01236547|459029821|FG000|Overall Study|Protocol Violation|0|||
127562557|NCT01236547|459029822|FG001|Overall Study|Protocol Violation|1|||
127562558|NCT01236547|459029823|FG002|Overall Study|Protocol Violation|1|||
127562559|NCT01236547|459029824|FG003|Overall Study|Protocol Violation|6|||
127562560|NCT01236547|459029825|FG004|Overall Study|Protocol Violation|12|||
127562561|NCT00910624|459029826|FG000|Treatment Phase|Adverse Event|2|||
127562562|NCT00910624|459029827|FG001|Treatment Phase|Adverse Event|6|||
127562563|NCT00910624|459029828|FG002|Treatment Phase|Adverse Event|6|||
127562564|NCT00910624|459029829|FG003|Treatment Phase|Adverse Event|0|||
127562565|NCT00910624|459029826|FG000|Treatment Phase|Treatment Failure|23|||
127562566|NCT00910624|459029827|FG001|Treatment Phase|Treatment Failure|10|||
127562567|NCT00910624|459029828|FG002|Treatment Phase|Treatment Failure|0|||
127562568|NCT00910624|459029829|FG003|Treatment Phase|Treatment Failure|0|||
127562569|NCT00910624|459029826|FG000|Treatment Phase|Lost to Follow-up|0|||
127562570|NCT00910624|459029827|FG001|Treatment Phase|Lost to Follow-up|0|||
127562571|NCT00910624|459029828|FG002|Treatment Phase|Lost to Follow-up|1|||
127562572|NCT00910624|459029829|FG003|Treatment Phase|Lost to Follow-up|0|||
127562573|NCT00910624|459029826|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
127562574|NCT00910624|459029827|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
127562575|NCT00910624|459029828|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
127562576|NCT00910624|459029829|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
127562577|NCT00910624|459029826|FG000|Treatment Phase|Withdrawal by Subject|2|||
127562578|NCT00910624|459029827|FG001|Treatment Phase|Withdrawal by Subject|1|||
127562579|NCT00910624|459029828|FG002|Treatment Phase|Withdrawal by Subject|0|||
127562580|NCT00910624|459029829|FG003|Treatment Phase|Withdrawal by Subject|0|||
127562581|NCT00910624|459029826|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
127562582|NCT00910624|459029827|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
127562583|NCT00910624|459029828|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
127562584|NCT00910624|459029829|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
127562585|NCT00910624|459029826|FG000|Follow-Up Phase|Adverse Event|0|||
127562586|NCT00910624|459029827|FG001|Follow-Up Phase|Adverse Event|0|||
127562587|NCT00910624|459029828|FG002|Follow-Up Phase|Adverse Event|1|||
127562588|NCT00910624|459029829|FG003|Follow-Up Phase|Adverse Event|0|||
127687941|NCT02723955|459483527|FG014|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
127687942|NCT02723955|459483528|FG015|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
127687943|NCT02723955|459483529|FG016|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
127687944|NCT02723955|459483530|FG017|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
127687945|NCT02723955|459483531|FG018|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
127687946|NCT02723955|459483532|FG019|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
127687947|NCT02723955|459483533|FG020|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
127687948|NCT02723955|459483534|FG021|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
127687949|NCT02723955|459483535|FG022|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
127776114|NCT02038920|459808373|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
127776115|NCT02038920|459808374|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
127562589|NCT00910624|459029826|FG000|Follow-Up Phase|Lost to Follow-up|3|||
127562590|NCT00910624|459029827|FG001|Follow-Up Phase|Lost to Follow-up|1|||
127562591|NCT00910624|459029828|FG002|Follow-Up Phase|Lost to Follow-up|2|||
127562592|NCT00910624|459029829|FG003|Follow-Up Phase|Lost to Follow-up|0|||
127562593|NCT00910624|459029826|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
127562594|NCT00910624|459029827|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
127562595|NCT00910624|459029828|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
127562596|NCT00910624|459029829|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
127687950|NCT02723955|459483536|FG023|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
127687951|NCT02723955|459483537|FG024|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
127562597|NCT00910624|459029826|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
127562598|NCT00910624|459029827|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
127562599|NCT00910624|459029828|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
127562600|NCT00910624|459029829|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
127562601|NCT00910624|459029826|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
127562602|NCT00910624|459029827|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
127562603|NCT00910624|459029828|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
127562604|NCT00910624|459029829|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
127562605|NCT00910624|459029826|FG000|Follow-Up Phase|Administrative|0|||
127562606|NCT00910624|459029827|FG001|Follow-Up Phase|Administrative|1|||
127562607|NCT00910624|459029828|FG002|Follow-Up Phase|Administrative|1|||
127562608|NCT00910624|459029829|FG003|Follow-Up Phase|Administrative|0|||
127562609|NCT01713933|459029830|FG000|Overall Study|Lost to Follow-up|2|||
127562610|NCT01713933|459029830|FG000|Overall Study|Withdrawal by Subject|3|||
127562611|NCT01713933|459029830|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
127562612|NCT00412373|459029831|FG000|Overall Study|Adverse Event|8|||
127562613|NCT00412373|459029832|FG001|Overall Study|Adverse Event|13|||
127562614|NCT00412373|459029831|FG000|Overall Study|Lack of Efficacy|16|||
127562615|NCT00412373|459029832|FG001|Overall Study|Lack of Efficacy|22|||
127562616|NCT00412373|459029831|FG000|Overall Study|Lost to Follow-up|7|||
127562617|NCT00412373|459029832|FG001|Overall Study|Lost to Follow-up|13|||
127562618|NCT00412373|459029831|FG000|Overall Study|Withdrawal by Subject|8|||
127562619|NCT00412373|459029832|FG001|Overall Study|Withdrawal by Subject|27|||
127562620|NCT00412373|459029831|FG000|Overall Study|Other|2|||
127562621|NCT00412373|459029832|FG001|Overall Study|Other|2|||
127562622|NCT04022733|459029833|FG000|Overall Study|conversion to open surgery|3|||
127562623|NCT04022733|459029834|FG001|Overall Study|conversion to open surgery|2|||
127562624|NCT04022733|459029833|FG000|Overall Study|bradycardia|0|||
127562625|NCT04022733|459029834|FG001|Overall Study|bradycardia|1|||
127562626|NCT02855541|459029835|FG000|Overall Study|Change in health status|2|||
127562627|NCT02855541|459029835|FG000|Overall Study|Withdrawal by Subject|2|||
127562628|NCT00422513|459029836|FG000|Overall Study|Lack of Efficacy|4|||
127562629|NCT00422513|459029837|FG001|Overall Study|Lack of Efficacy|5|||
127562630|NCT00422513|459029836|FG000|Overall Study|Protocol Violation|23|||
127562631|NCT00422513|459029837|FG001|Overall Study|Protocol Violation|7|||
127562632|NCT00422513|459029836|FG000|Overall Study|Refused Treatment|4|||
127562633|NCT00422513|459029837|FG001|Overall Study|Refused Treatment|2|||
127562634|NCT00422513|459029836|FG000|Overall Study|Withdrawal by Subject|2|||
127562635|NCT00422513|459029837|FG001|Overall Study|Withdrawal by Subject|1|||
127562636|NCT00422513|459029836|FG000|Overall Study|early termination of the study|67|||
127562637|NCT00422513|459029837|FG001|Overall Study|early termination of the study|80|||
127562638|NCT00422513|459029836|FG000|Overall Study|Adverse Event|4|||
127562639|NCT00422513|459029837|FG001|Overall Study|Adverse Event|4|||
127562640|NCT00422513|459029836|FG000|Overall Study|Death|3|||
127562641|NCT00422513|459029837|FG001|Overall Study|Death|7|||
127562642|NCT03135119|459029838|FG000|Overall Study|Lost to Follow-up|2|||
127562643|NCT03135119|459029839|FG001|Overall Study|Lost to Follow-up|0|||
127562644|NCT03135119|459029838|FG000|Overall Study|Physician Decision|1|||
127562645|NCT03135119|459029839|FG001|Overall Study|Physician Decision|1|||
127562646|NCT03135119|459029838|FG000|Overall Study|COVID-19 Shutdown|2|||
127562647|NCT03135119|459029839|FG001|Overall Study|COVID-19 Shutdown|2|||
127562648|NCT05315908|459029844|FG000|Overall Study|Lost to Follow-up|4477|||
127562649|NCT05315908|459029845|FG001|Overall Study|Lost to Follow-up|4606|||
127562650|NCT01561898|459029846|FG000|Overall Study|Withdrawal by Subject|0|||
127562651|NCT01561898|459029847|FG001|Overall Study|Withdrawal by Subject|8|||
127562652|NCT01561898|459029848|FG002|Overall Study|Withdrawal by Subject|12|||
127562653|NCT01561898|459029849|FG003|Overall Study|Withdrawal by Subject|5|||
127776116|NCT02038920|459808375|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
127776117|NCT02038920|459808370|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
127776118|NCT02038920|459808371|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
127776119|NCT02038920|459808372|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
127776120|NCT02038920|459808373|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
127776121|NCT02038920|459808374|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
127776122|NCT02038920|459808375|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
127776123|NCT02038920|459808370|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
127562654|NCT01561898|459029846|FG000|Overall Study|Lack of Efficacy|0|||
127562655|NCT01561898|459029847|FG001|Overall Study|Lack of Efficacy|8|||
127562656|NCT01561898|459029848|FG002|Overall Study|Lack of Efficacy|10|||
127562657|NCT01561898|459029849|FG003|Overall Study|Lack of Efficacy|5|||
127562658|NCT01561898|459029846|FG000|Overall Study|Worsening of complications|0|||
127562659|NCT01561898|459029847|FG001|Overall Study|Worsening of complications|1|||
127562660|NCT01561898|459029848|FG002|Overall Study|Worsening of complications|0|||
127562661|NCT01561898|459029849|FG003|Overall Study|Worsening of complications|0|||
127562662|NCT01561898|459029846|FG000|Overall Study|Lost to Follow-up|0|||
127562663|NCT01561898|459029847|FG001|Overall Study|Lost to Follow-up|0|||
127562664|NCT01561898|459029848|FG002|Overall Study|Lost to Follow-up|1|||
127562665|NCT01561898|459029849|FG003|Overall Study|Lost to Follow-up|0|||
127562666|NCT01561898|459029846|FG000|Overall Study|Adverse Event|1|||
127562667|NCT01561898|459029847|FG001|Overall Study|Adverse Event|19|||
127562668|NCT01561898|459029848|FG002|Overall Study|Adverse Event|14|||
127562669|NCT01561898|459029849|FG003|Overall Study|Adverse Event|9|||
127562670|NCT01561898|459029846|FG000|Overall Study|Physician Decision|1|||
127562671|NCT01561898|459029847|FG001|Overall Study|Physician Decision|5|||
127562672|NCT01561898|459029848|FG002|Overall Study|Physician Decision|7|||
127562673|NCT01561898|459029849|FG003|Overall Study|Physician Decision|1|||
127562674|NCT00294762|459029850|FG000|Overall Study|Did not receive study treatment|3|||
127562675|NCT00294762|459029851|FG001|Overall Study|Did not receive study treatment|3|||
127562676|NCT01883453|459029852|FG000|Overall Study|No episode of common cold|25|||
127562677|NCT01883453|459029853|FG001|Overall Study|No episode of common cold|23|||
127562678|NCT02238080|459029854|FG000|Overall Study|Death|13|||
127562679|NCT02238080|459029854|FG000|Overall Study|Treatment interrupted|6|||
127562680|NCT02238080|459029854|FG000|Overall Study|Withdrawal by Subject|2|||
127562681|NCT02238080|459029854|FG000|Overall Study|Other|4|||
127562682|NCT01738646|459029855|FG000|Overall Study|Still Receiving Treatment|2|||
127562683|NCT04093024|459029858|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
127562684|NCT04093024|459029859|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
127562685|NCT04093024|459029858|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
127562686|NCT04093024|459029859|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
127562687|NCT04093024|459029858|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
127562688|NCT04093024|459029859|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
127562689|NCT04093024|459029858|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
127562690|NCT04093024|459029859|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
127562691|NCT00647270|459029864|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
127562692|NCT00647270|459029865|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
127562693|NCT00647270|459029866|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
127562694|NCT00647270|459029864|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
127562695|NCT00647270|459029865|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
127562696|NCT00647270|459029866|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
127562697|NCT00647270|459029864|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
127562698|NCT00647270|459029865|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
127562699|NCT00647270|459029866|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
127562700|NCT00647270|459029864|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
127562701|NCT00647270|459029865|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
127562702|NCT00647270|459029866|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
127562703|NCT00647270|459029864|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
127562704|NCT00647270|459029865|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
127562705|NCT00647270|459029866|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
127562706|NCT00647270|459029864|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
127562707|NCT00647270|459029865|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
127562708|NCT00647270|459029866|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
127562709|NCT00647270|459029864|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
127562710|NCT00647270|459029865|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
127562711|NCT00647270|459029866|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
127562712|NCT03337490|459029867|FG000|Overall Study|Withdrawal by Subject|1|||
127562713|NCT03337490|459029868|FG001|Overall Study|Withdrawal by Subject|0|||
127562714|NCT03337490|459029869|FG002|Overall Study|Withdrawal by Subject|0|||
127562715|NCT03337490|459029867|FG000|Overall Study|Lack of Efficacy|10|||
127562716|NCT03337490|459029868|FG001|Overall Study|Lack of Efficacy|12|||
127687952|NCT02723955|459483538|FG025|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
127687953|NCT02723955|459483539|FG026|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
127687954|NCT02723955|459483540|FG027|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
127687955|NCT02723955|459483541|FG028|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
127687956|NCT02723955|459483542|FG029|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
127687957|NCT02723955|459483543|FG030|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
127687958|NCT02723955|459483544|FG031|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
127687959|NCT02723955|459483545|FG032|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
127687960|NCT02723955|459483546|FG033|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
127562717|NCT03337490|459029869|FG002|Overall Study|Lack of Efficacy|35|||
127562718|NCT03337490|459029867|FG000|Overall Study|Physician Decision|0|||
127562719|NCT03337490|459029868|FG001|Overall Study|Physician Decision|1|||
127562720|NCT03337490|459029869|FG002|Overall Study|Physician Decision|0|||
127562721|NCT03337490|459029867|FG000|Overall Study|Lost to Follow-up|0|||
127562722|NCT03337490|459029868|FG001|Overall Study|Lost to Follow-up|1|||
127562723|NCT03337490|459029869|FG002|Overall Study|Lost to Follow-up|0|||
127687961|NCT02723955|459483547|FG034|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
127562724|NCT04493892|459029870|FG000|Overall Study|Withdrawal by Subject|15|||
127562725|NCT02267317|459029873|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
127562726|NCT02267317|459029874|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
127562727|NCT02267317|459029875|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
127562728|NCT02267317|459029876|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
127562729|NCT02267317|459029877|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
127562730|NCT02267317|459029878|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
127562731|NCT02267317|459029873|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
127562732|NCT02267317|459029874|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
127562733|NCT02267317|459029875|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
127562734|NCT02267317|459029876|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
127562735|NCT02267317|459029877|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
127562736|NCT02267317|459029878|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
127562737|NCT00796445|459029883|FG000|Overall Study|Protocol Violation|5|||
127562738|NCT00796445|459029884|FG001|Overall Study|Protocol Violation|3|||
127562739|NCT00796445|459029883|FG000|Overall Study|Adverse event, serious fatal|10|||
127562740|NCT00796445|459029884|FG001|Overall Study|Adverse event, serious fatal|5|||
127562741|NCT00796445|459029883|FG000|Overall Study|Adverse event, non-fatal|4|||
127562742|NCT00796445|459029884|FG001|Overall Study|Adverse event, non-fatal|0|||
127562743|NCT00796445|459029883|FG000|Overall Study|Disease progression/recurrence|537|||
127562744|NCT00796445|459029884|FG001|Overall Study|Disease progression/recurrence|268|||
127562745|NCT00796445|459029883|FG000|Overall Study|Other|10|||
127562746|NCT00796445|459029884|FG001|Overall Study|Other|7|||
127562747|NCT00796445|459029883|FG000|Overall Study|Withdrawal by Subject|18|||
127562748|NCT00796445|459029884|FG001|Overall Study|Withdrawal by Subject|9|||
127562749|NCT00796445|459029883|FG000|Overall Study|Invalid Informed Consent Form|1|||
127562750|NCT00796445|459029884|FG001|Overall Study|Invalid Informed Consent Form|0|||
127562751|NCT02208063|459029885|FG000|Overall Study|Death|3|||
127562752|NCT02208063|459029886|FG001|Overall Study|Death|5|||
127562753|NCT02208063|459029885|FG000|Overall Study|Not Specified in report|3|||
127562754|NCT02208063|459029886|FG001|Overall Study|Not Specified in report|4|||
127562755|NCT02208063|459029885|FG000|Overall Study|Withdrawal by Subject|5|||
127562756|NCT02208063|459029886|FG001|Overall Study|Withdrawal by Subject|2|||
127562757|NCT02208063|459029885|FG000|Overall Study|Lost to Follow-up|1|||
127562758|NCT02208063|459029886|FG001|Overall Study|Lost to Follow-up|0|||
127562759|NCT00917644|459029887|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
127562760|NCT00917644|459029888|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
127562761|NCT00917644|459029887|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
127562762|NCT00917644|459029888|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
127562763|NCT00917644|459029887|FG000|Period 2: Second Intervention|family emergency|1|||
127562764|NCT00917644|459029888|FG001|Period 2: Second Intervention|family emergency|0|||
127562765|NCT00422084|459029891|FG000|Overall Study|Adverse Event|21|||
127562766|NCT00422084|459029892|FG001|Overall Study|Adverse Event|7|||
127562767|NCT00422084|459029891|FG000|Overall Study|Withdrawal by Subject|12|||
127562768|NCT00422084|459029892|FG001|Overall Study|Withdrawal by Subject|9|||
127562769|NCT00422084|459029891|FG000|Overall Study|Lost to Follow-up|14|||
127562770|NCT00422084|459029892|FG001|Overall Study|Lost to Follow-up|9|||
127562771|NCT00422084|459029891|FG000|Overall Study|Protocol Violation|4|||
127562772|NCT00422084|459029892|FG001|Overall Study|Protocol Violation|1|||
127562773|NCT00422084|459029891|FG000|Overall Study|Lack of Efficacy|40|||
127562774|NCT00422084|459029892|FG001|Overall Study|Lack of Efficacy|42|||
127562775|NCT00422084|459029891|FG000|Overall Study|P. vivax infection|3|||
127562776|NCT00422084|459029892|FG001|Overall Study|P. vivax infection|6|||
127562777|NCT00422084|459029891|FG000|Overall Study|Cyesis|1|||
127562778|NCT00422084|459029892|FG001|Overall Study|Cyesis|0|||
127562779|NCT00422084|459029891|FG000|Overall Study|Withdrawn from study accidentally|1|||
127562780|NCT00422084|459029892|FG001|Overall Study|Withdrawn from study accidentally|0|||
127562781|NCT00422084|459029891|FG000|Overall Study|Non-compliance|1|||
127562782|NCT00422084|459029892|FG001|Overall Study|Non-compliance|0|||
127562783|NCT00422084|459029891|FG000|Overall Study|Re-location|0|||
127562784|NCT00422084|459029892|FG001|Overall Study|Re-location|1|||
127562785|NCT00422084|459029891|FG000|Overall Study|Not defined|1|||
127562786|NCT00422084|459029892|FG001|Overall Study|Not defined|1|||
127562787|NCT03774823|459029895|FG000|Overall Study|Withdrawal by Subject|1|||
127562788|NCT03774823|459029896|FG001|Overall Study|Withdrawal by Subject|1|||
127562789|NCT00958438|459029897|FG000|Overall Study|Protocol Violation|3|||
127562790|NCT00958438|459029898|FG001|Overall Study|Protocol Violation|2|||
127562791|NCT00958438|459029899|FG002|Overall Study|Protocol Violation|2|||
127562792|NCT00958438|459029897|FG000|Overall Study|Withdrawal by Subject|4|||
127562793|NCT00958438|459029898|FG001|Overall Study|Withdrawal by Subject|2|||
127562794|NCT00958438|459029899|FG002|Overall Study|Withdrawal by Subject|1|||
127562795|NCT00958438|459029897|FG000|Overall Study|Adverse Event|0|||
127562796|NCT00958438|459029898|FG001|Overall Study|Adverse Event|3|||
127562797|NCT00958438|459029899|FG002|Overall Study|Adverse Event|0|||
127562798|NCT00958438|459029897|FG000|Overall Study|Physician Decision|1|||
127562799|NCT00958438|459029898|FG001|Overall Study|Physician Decision|0|||
127562800|NCT00958438|459029899|FG002|Overall Study|Physician Decision|1|||
127562801|NCT00958438|459029897|FG000|Overall Study|Other than specified above|2|||
127562802|NCT00958438|459029898|FG001|Overall Study|Other than specified above|3|||
127562803|NCT00958438|459029899|FG002|Overall Study|Other than specified above|2|||
127562804|NCT00759564|459029900|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
127562805|NCT00759564|459029901|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
127562806|NCT00759564|459029902|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
127562807|NCT00759564|459029903|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
127562808|NCT00759564|459029904|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
127562809|NCT00329849|459029905|FG000|Overall Study|Withdrawal by Subject|6|||
127562810|NCT00329849|459029906|FG001|Overall Study|Withdrawal by Subject|4|||
127562811|NCT01782469|459029907|FG000|Overall Study|Lost to Follow-up|1|||
127562812|NCT01328444|459029910|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
127562813|NCT01328444|459029911|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
127562814|NCT01328444|459029912|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
127562815|NCT01328444|459029913|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
127562816|NCT01328444|459029914|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
127562817|NCT01328444|459029915|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
127562818|NCT01328444|459029910|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
127562819|NCT01328444|459029911|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
127562820|NCT01328444|459029912|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
127562821|NCT01328444|459029913|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
127562822|NCT01328444|459029914|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
127562823|NCT01328444|459029915|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
127562824|NCT01328444|459029910|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
127562825|NCT01328444|459029911|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
127562826|NCT01328444|459029912|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
127562827|NCT01328444|459029913|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
127562828|NCT01328444|459029914|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
127562829|NCT01328444|459029915|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
127562830|NCT01328444|459029910|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
127562831|NCT01328444|459029911|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
127562832|NCT01328444|459029912|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
127562833|NCT01328444|459029913|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
127562834|NCT01328444|459029914|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
127562835|NCT01328444|459029915|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
127562836|NCT01328444|459029910|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
127562837|NCT01328444|459029911|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
127562838|NCT01328444|459029912|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
127562839|NCT01328444|459029913|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
127562840|NCT01328444|459029914|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
127562841|NCT01328444|459029915|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
127562842|NCT01328444|459029910|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
127562843|NCT01328444|459029911|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
127562844|NCT01328444|459029912|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
127562845|NCT01328444|459029913|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
127562846|NCT01328444|459029914|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
127562847|NCT01328444|459029915|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
127562848|NCT01328444|459029910|FG000|Washout Period (14 Days)|Adverse Event|1|||
127562849|NCT01328444|459029911|FG001|Washout Period (14 Days)|Adverse Event|1|||
127562850|NCT01328444|459029912|FG002|Washout Period (14 Days)|Adverse Event|0|||
127562851|NCT01328444|459029913|FG003|Washout Period (14 Days)|Adverse Event|1|||
127562852|NCT01328444|459029914|FG004|Washout Period (14 Days)|Adverse Event|1|||
127562853|NCT01328444|459029915|FG005|Washout Period (14 Days)|Adverse Event|2|||
127776124|NCT02038920|459808371|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
127776125|NCT02038920|459808372|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
127776126|NCT02038920|459808373|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
127776127|NCT02038920|459808374|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
128024705|NCT02596893|460715961|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
128024706|NCT02596893|460715962|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
128024707|NCT02596893|460715963|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
128024708|NCT02596893|460715960|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
127562854|NCT01328444|459029910|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
127562855|NCT01328444|459029911|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
127562856|NCT01328444|459029912|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
127776128|NCT02038920|459808375|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
128024709|NCT02596893|460715961|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
128024710|NCT02596893|460715962|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
127562857|NCT01328444|459029913|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
127562858|NCT01328444|459029914|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
127562859|NCT01328444|459029915|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
127562860|NCT01328444|459029910|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
127562861|NCT01328444|459029911|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
127562862|NCT01328444|459029912|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
127562863|NCT01328444|459029913|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
127562864|NCT01328444|459029914|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
127562865|NCT01328444|459029915|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
127562866|NCT01328444|459029910|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
127562867|NCT01328444|459029911|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
127562868|NCT01328444|459029912|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
127562869|NCT01328444|459029913|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
127562870|NCT01328444|459029914|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
127562871|NCT01328444|459029915|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
127562872|NCT01328444|459029910|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
127562873|NCT01328444|459029911|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
127562874|NCT01328444|459029912|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
127562875|NCT01328444|459029913|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
127562876|NCT01328444|459029914|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
127562877|NCT01328444|459029915|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
127562878|NCT01328444|459029910|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
127562879|NCT01328444|459029911|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
127562880|NCT01328444|459029912|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
127562881|NCT01328444|459029913|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
127562882|NCT01328444|459029914|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
127562883|NCT01328444|459029915|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
127562884|NCT01328444|459029910|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
127562885|NCT01328444|459029911|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
127562886|NCT01328444|459029912|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
127562887|NCT01328444|459029913|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
127562888|NCT01328444|459029914|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
127562889|NCT01328444|459029915|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
127562890|NCT01328444|459029910|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
127562891|NCT01328444|459029911|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
127562892|NCT01328444|459029912|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
127562893|NCT01328444|459029913|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
127562894|NCT01328444|459029914|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
127562895|NCT01328444|459029915|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
127562896|NCT01328444|459029910|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
127562897|NCT01328444|459029911|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
127562898|NCT01328444|459029912|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
127562899|NCT01328444|459029913|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
127562900|NCT01328444|459029914|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
127562901|NCT01328444|459029915|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
127562902|NCT02743611|459029916|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
127562903|NCT02743611|459029917|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
127562904|NCT02743611|459029918|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
127562905|NCT02743611|459029919|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
127562906|NCT01566214|459029920|FG000|Overall Study|Lost to Follow-up|3|||
127562907|NCT01566214|459029921|FG001|Overall Study|Lost to Follow-up|0|||
127562908|NCT00561977|459029922|FG000|Overall Study|Withdrawal by Subject|0|||
127562909|NCT00561977|459029923|FG001|Overall Study|Withdrawal by Subject|2|||
127562910|NCT00561977|459029924|FG002|Overall Study|Withdrawal by Subject|1|||
127562911|NCT00561977|459029922|FG000|Overall Study|Pregnancy|0|||
127562912|NCT00561977|459029923|FG001|Overall Study|Pregnancy|1|||
127562913|NCT00561977|459029924|FG002|Overall Study|Pregnancy|1|||
127562914|NCT04620798|459029925|FG000|Overall Study|Lost to Follow-up|126|||
127562915|NCT04620798|459029926|FG001|Overall Study|Lost to Follow-up|138|||
127562916|NCT00852371|459029927|FG000|Overall Study|Lost to Follow-up|2|||
127562917|NCT00852371|459029928|FG001|Overall Study|Lost to Follow-up|3|||
127562918|NCT00852371|459029929|FG002|Overall Study|Lost to Follow-up|4|||
127562919|NCT00852371|459029930|FG003|Overall Study|Lost to Follow-up|2|||
127562920|NCT04525885|459029931|FG000|Overall Study|Screen Failure|1|||
127562921|NCT04525885|459029932|FG001|Overall Study|Screen Failure|0|||
127562922|NCT04525885|459029933|FG002|Overall Study|Screen Failure|0|||
127562923|NCT04525885|459029931|FG000|Overall Study|Withdrawal by Subject|14|||
127562924|NCT04525885|459029932|FG001|Overall Study|Withdrawal by Subject|6|||
127562925|NCT04525885|459029933|FG002|Overall Study|Withdrawal by Subject|20|||
127562926|NCT04525885|459029931|FG000|Overall Study|Physician Decision|1|||
127562927|NCT04525885|459029932|FG001|Overall Study|Physician Decision|0|||
127562928|NCT04525885|459029933|FG002|Overall Study|Physician Decision|1|||
127562929|NCT00439738|459029939|FG000|Overall Study|Withdrawal by Subject|16|||
127562930|NCT00439738|459029940|FG001|Overall Study|Withdrawal by Subject|13|||
127562931|NCT00439738|459029939|FG000|Overall Study|Adverse Event|6|||
127562932|NCT00439738|459029940|FG001|Overall Study|Adverse Event|4|||
127562933|NCT00439738|459029939|FG000|Overall Study|Lost to Follow-up|5|||
127562934|NCT00439738|459029940|FG001|Overall Study|Lost to Follow-up|6|||
127562935|NCT00439738|459029939|FG000|Overall Study|Protocol Violation|6|||
127562936|NCT00439738|459029940|FG001|Overall Study|Protocol Violation|3|||
127562937|NCT00439738|459029939|FG000|Overall Study|Lack of Efficacy|2|||
127562938|NCT00439738|459029940|FG001|Overall Study|Lack of Efficacy|2|||
127562939|NCT00439738|459029939|FG000|Overall Study|Abnormal Lab Values|1|||
127562940|NCT00439738|459029940|FG001|Overall Study|Abnormal Lab Values|0|||
127562941|NCT00978757|459029941|FG000|Overall Study|Physician Decision|1|||
127562942|NCT00978757|459029942|FG001|Overall Study|Physician Decision|3|||
127562943|NCT00402740|459029946|FG000|Overall Study|Withdrawal by Subject|18|||
127562944|NCT00402740|459029946|FG000|Overall Study|Death|50|||
127562945|NCT00402740|459029946|FG000|Overall Study|Lost to Follow-up|6|||
127562946|NCT00402740|459029946|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
127562947|NCT00402740|459029946|FG000|Overall Study|Subject disposition unknown.|1|||
127562948|NCT02270944|459029947|FG000|Overall Study|Lost to Follow-up|9|||
127562949|NCT02270944|459029948|FG001|Overall Study|Lost to Follow-up|4|||
127562950|NCT02270944|459029947|FG000|Overall Study|Withdrawal by Subject|2|||
127562951|NCT02270944|459029948|FG001|Overall Study|Withdrawal by Subject|1|||
127562952|NCT00095147|459029949|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
127562953|NCT00095147|459029950|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
127562954|NCT00095147|459029951|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
127562955|NCT00095147|459029952|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
127562956|NCT00095147|459029953|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
127562957|NCT00095147|459029949|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
127562958|NCT00095147|459029950|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
127562959|NCT00095147|459029951|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
127562960|NCT00095147|459029952|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
127562961|NCT00095147|459029953|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
127562962|NCT00095147|459029949|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
127562963|NCT00095147|459029950|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
127562964|NCT00095147|459029951|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
127562965|NCT00095147|459029952|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
127562966|NCT00095147|459029953|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
127562967|NCT00095147|459029949|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
127562968|NCT00095147|459029950|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
127562969|NCT00095147|459029951|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
127562970|NCT00095147|459029952|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
127562971|NCT00095147|459029953|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
127562972|NCT00095147|459029949|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
127562973|NCT00095147|459029950|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
127562974|NCT00095147|459029951|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
127562975|NCT00095147|459029952|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
127562976|NCT00095147|459029953|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
127562977|NCT00095147|459029949|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
127562978|NCT00095147|459029950|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
127562979|NCT00095147|459029951|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
127562980|NCT00095147|459029952|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
127562981|NCT00095147|459029953|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
127562982|NCT00095147|459029949|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
127562983|NCT00095147|459029950|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
127562984|NCT00095147|459029951|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
127562985|NCT00095147|459029952|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
127562986|NCT00095147|459029953|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
127562987|NCT00095147|459029949|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
127562988|NCT00095147|459029950|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
127562989|NCT00095147|459029951|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
127562990|NCT00095147|459029952|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
127562991|NCT00095147|459029953|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
127687962|NCT02723955|459483548|FG035|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
127687963|NCT02723955|459483549|FG036|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
127687964|NCT02723955|459483550|FG037|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
127687965|NCT02723955|459483551|FG038|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
127562992|NCT00095147|459029949|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
127562993|NCT00095147|459029950|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
127687966|NCT02723955|459483552|FG039|Crossover/ Re-treatment Phase|Lost to Follow-up|4|||
127562994|NCT00095147|459029951|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
127562995|NCT00095147|459029952|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
127562996|NCT00095147|459029953|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
127562997|NCT00095147|459029949|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
127562998|NCT00095147|459029950|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
127562999|NCT00095147|459029951|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
127563000|NCT00095147|459029952|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
127563001|NCT00095147|459029953|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
127563002|NCT00095147|459029949|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
127563003|NCT00095147|459029950|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
127563004|NCT00095147|459029951|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
127563005|NCT00095147|459029952|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
127563006|NCT00095147|459029953|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
127563007|NCT00095147|459029949|FG000|Long-term Extension Period|Death|0|||
127563008|NCT00095147|459029950|FG001|Long-term Extension Period|Death|0|||
127563009|NCT00095147|459029951|FG002|Long-term Extension Period|Death|0|||
127563010|NCT00095147|459029952|FG003|Long-term Extension Period|Death|0|||
127563011|NCT00095147|459029953|FG004|Long-term Extension Period|Death|3|||
127563012|NCT00095147|459029949|FG000|Long-term Extension Period|Adverse Event|0|||
127563013|NCT00095147|459029950|FG001|Long-term Extension Period|Adverse Event|0|||
127563014|NCT00095147|459029951|FG002|Long-term Extension Period|Adverse Event|0|||
127563015|NCT00095147|459029952|FG003|Long-term Extension Period|Adverse Event|0|||
127563016|NCT00095147|459029953|FG004|Long-term Extension Period|Adverse Event|11|||
127563017|NCT00095147|459029949|FG000|Long-term Extension Period|Lack of Efficacy|0|||
127563018|NCT00095147|459029950|FG001|Long-term Extension Period|Lack of Efficacy|0|||
127563019|NCT00095147|459029951|FG002|Long-term Extension Period|Lack of Efficacy|0|||
127563020|NCT00095147|459029952|FG003|Long-term Extension Period|Lack of Efficacy|0|||
127563021|NCT00095147|459029953|FG004|Long-term Extension Period|Lack of Efficacy|9|||
127563022|NCT00095147|459029949|FG000|Long-term Extension Period|Lost to Follow-up|0|||
127563023|NCT00095147|459029950|FG001|Long-term Extension Period|Lost to Follow-up|0|||
127563024|NCT00095147|459029951|FG002|Long-term Extension Period|Lost to Follow-up|0|||
127563025|NCT00095147|459029952|FG003|Long-term Extension Period|Lost to Follow-up|0|||
127563026|NCT00095147|459029953|FG004|Long-term Extension Period|Lost to Follow-up|6|||
127563027|NCT00095147|459029949|FG000|Long-term Extension Period|Withdrawal of consent|0|||
127563028|NCT00095147|459029950|FG001|Long-term Extension Period|Withdrawal of consent|0|||
127563029|NCT00095147|459029951|FG002|Long-term Extension Period|Withdrawal of consent|0|||
127563030|NCT00095147|459029952|FG003|Long-term Extension Period|Withdrawal of consent|0|||
127563031|NCT00095147|459029953|FG004|Long-term Extension Period|Withdrawal of consent|12|||
127563032|NCT00095147|459029949|FG000|Long-term Extension Period|Pregnancy|0|||
127563033|NCT00095147|459029950|FG001|Long-term Extension Period|Pregnancy|0|||
127563034|NCT00095147|459029951|FG002|Long-term Extension Period|Pregnancy|0|||
127563035|NCT00095147|459029952|FG003|Long-term Extension Period|Pregnancy|0|||
127563036|NCT00095147|459029953|FG004|Long-term Extension Period|Pregnancy|1|||
127563037|NCT00095147|459029949|FG000|Long-term Extension Period|No longer meets study criteria|0|||
127563038|NCT00095147|459029950|FG001|Long-term Extension Period|No longer meets study criteria|0|||
127563039|NCT00095147|459029951|FG002|Long-term Extension Period|No longer meets study criteria|0|||
127563040|NCT00095147|459029952|FG003|Long-term Extension Period|No longer meets study criteria|0|||
127563041|NCT00095147|459029953|FG004|Long-term Extension Period|No longer meets study criteria|1|||
127563042|NCT00095147|459029949|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
127563043|NCT00095147|459029950|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
127563044|NCT00095147|459029951|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
127563045|NCT00095147|459029952|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
127563046|NCT00095147|459029953|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
127563047|NCT00095147|459029949|FG000|Long-term Extension Period|Leaving country|0|||
127563048|NCT00095147|459029950|FG001|Long-term Extension Period|Leaving country|0|||
127563049|NCT00095147|459029951|FG002|Long-term Extension Period|Leaving country|0|||
127563050|NCT00095147|459029952|FG003|Long-term Extension Period|Leaving country|0|||
127563051|NCT00095147|459029953|FG004|Long-term Extension Period|Leaving country|1|||
127563052|NCT01375075|459029956|FG000|Overall Study|Adverse Event|0|||
127563053|NCT01375075|459029957|FG001|Overall Study|Adverse Event|0|||
127687967|NCT02723955|459483553|FG040|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
128024711|NCT02596893|460715963|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
128024712|NCT02596893|460715960|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
127687968|NCT02723955|459483554|FG041|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
127563054|NCT01375075|459029958|FG002|Overall Study|Adverse Event|3|||
127563055|NCT01375075|459029959|FG003|Overall Study|Adverse Event|1|||
127563056|NCT01375075|459029960|FG004|Overall Study|Adverse Event|0|||
127563057|NCT01375075|459029961|FG005|Overall Study|Adverse Event|1|||
127563058|NCT01375075|459029956|FG000|Overall Study|Entry Criterion Not Met|1|||
127563059|NCT01375075|459029957|FG001|Overall Study|Entry Criterion Not Met|0|||
127563060|NCT01375075|459029958|FG002|Overall Study|Entry Criterion Not Met|0|||
127563061|NCT01375075|459029959|FG003|Overall Study|Entry Criterion Not Met|0|||
127563062|NCT01375075|459029960|FG004|Overall Study|Entry Criterion Not Met|0|||
127563063|NCT01375075|459029961|FG005|Overall Study|Entry Criterion Not Met|1|||
127563064|NCT01375075|459029956|FG000|Overall Study|Withdrawal by Subject|0|||
127563065|NCT01375075|459029957|FG001|Overall Study|Withdrawal by Subject|1|||
127563066|NCT01375075|459029958|FG002|Overall Study|Withdrawal by Subject|0|||
127563067|NCT01375075|459029959|FG003|Overall Study|Withdrawal by Subject|0|||
127563068|NCT01375075|459029960|FG004|Overall Study|Withdrawal by Subject|0|||
127563069|NCT01375075|459029961|FG005|Overall Study|Withdrawal by Subject|1|||
127563070|NCT01011309|459029962|FG000|Overall Study|Adverse Event|2|||
127563071|NCT01011309|459029963|FG001|Overall Study|Adverse Event|1|||
127563072|NCT01011309|459029964|FG002|Overall Study|Adverse Event|2|||
127563073|NCT01011309|459029962|FG000|Overall Study|Lack of Efficacy|0|||
127563074|NCT01011309|459029963|FG001|Overall Study|Lack of Efficacy|1|||
127563075|NCT01011309|459029964|FG002|Overall Study|Lack of Efficacy|0|||
127563076|NCT01011309|459029962|FG000|Overall Study|Protocol Violation|0|||
127563077|NCT01011309|459029963|FG001|Overall Study|Protocol Violation|1|||
127563078|NCT01011309|459029964|FG002|Overall Study|Protocol Violation|3|||
127563079|NCT03472547|459029968|FG000|Overall Study|Withdrawal by Subject|30|||
127563080|NCT03137069|459031846|FG000|Overall Study|Withdrawal by Subject|1|||
127563081|NCT03137069|459031847|FG001|Overall Study|Withdrawal by Subject|2|||
127563082|NCT03137069|459031848|FG002|Overall Study|Withdrawal by Subject|2|||
127563083|NCT03137069|459031849|FG003|Overall Study|Withdrawal by Subject|2|||
127563084|NCT03137069|459031850|FG004|Overall Study|Withdrawal by Subject|0|||
127563085|NCT03137069|459031851|FG005|Overall Study|Withdrawal by Subject|0|||
127563086|NCT03137069|459031846|FG000|Overall Study|Adverse Event|0|||
127563087|NCT03137069|459031847|FG001|Overall Study|Adverse Event|3|||
127563088|NCT03137069|459031848|FG002|Overall Study|Adverse Event|1|||
127563089|NCT03137069|459031849|FG003|Overall Study|Adverse Event|1|||
127563090|NCT03137069|459031850|FG004|Overall Study|Adverse Event|0|||
127563091|NCT03137069|459031851|FG005|Overall Study|Adverse Event|1|||
127776129|NCT02038920|459808370|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
127776130|NCT02038920|459808371|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
127776131|NCT02038920|459808372|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
127776132|NCT02038920|459808373|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
127776133|NCT02038920|459808374|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
127563092|NCT03137069|459031846|FG000|Overall Study|Protocol Violation|0|||
127776134|NCT02038920|459808375|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
127776135|NCT02038920|459808370|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
127776136|NCT02038920|459808371|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
127776137|NCT02038920|459808372|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
127776138|NCT02038920|459808373|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
127776139|NCT02038920|459808374|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
127776140|NCT02038920|459808375|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
127776141|NCT02038920|459808370|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
127776142|NCT02038920|459808371|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
127776143|NCT02038920|459808372|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
127776144|NCT02038920|459808373|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
127776145|NCT02038920|459808374|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
127776146|NCT02038920|459808375|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
127776147|NCT02038920|459808370|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
127776148|NCT02038920|459808371|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
127776149|NCT02038920|459808372|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
127776150|NCT02038920|459808373|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
127776151|NCT02038920|459808374|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
127776152|NCT02038920|459808375|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
128024713|NCT02596893|460715961|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
128024714|NCT02596893|460715962|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
127563093|NCT03137069|459031847|FG001|Overall Study|Protocol Violation|1|||
127563094|NCT03137069|459031848|FG002|Overall Study|Protocol Violation|0|||
127776153|NCT02038920|459808370|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
127563095|NCT03137069|459031849|FG003|Overall Study|Protocol Violation|1|||
127563096|NCT03137069|459031850|FG004|Overall Study|Protocol Violation|1|||
127563097|NCT03137069|459031851|FG005|Overall Study|Protocol Violation|1|||
127563098|NCT03137069|459031846|FG000|Overall Study|Physician Decision|0|||
127563099|NCT03137069|459031847|FG001|Overall Study|Physician Decision|0|||
127563100|NCT03137069|459031848|FG002|Overall Study|Physician Decision|0|||
127563101|NCT03137069|459031849|FG003|Overall Study|Physician Decision|1|||
127563102|NCT03137069|459031850|FG004|Overall Study|Physician Decision|0|||
127563103|NCT03137069|459031851|FG005|Overall Study|Physician Decision|0|||
127563104|NCT03137069|459031846|FG000|Overall Study|Study Terminated by Sponsor|0|||
127563105|NCT03137069|459031847|FG001|Overall Study|Study Terminated by Sponsor|0|||
127563106|NCT03137069|459031848|FG002|Overall Study|Study Terminated by Sponsor|0|||
127563107|NCT03137069|459031849|FG003|Overall Study|Study Terminated by Sponsor|0|||
127563108|NCT03137069|459031850|FG004|Overall Study|Study Terminated by Sponsor|1|||
127563109|NCT03137069|459031851|FG005|Overall Study|Study Terminated by Sponsor|0|||
127563110|NCT03137069|459031846|FG000|Overall Study|Data Entry Error|0|||
127563111|NCT03137069|459031847|FG001|Overall Study|Data Entry Error|0|||
127563112|NCT03137069|459031848|FG002|Overall Study|Data Entry Error|0|||
127563113|NCT03137069|459031849|FG003|Overall Study|Data Entry Error|1|||
127563114|NCT03137069|459031850|FG004|Overall Study|Data Entry Error|0|||
127563115|NCT03137069|459031851|FG005|Overall Study|Data Entry Error|0|||
127563116|NCT02043899|459031853|FG000|Overall Study|Adverse Event|3|||
127563117|NCT02043899|459031853|FG000|Overall Study|Physician Decision|1|||
127563118|NCT02043899|459031853|FG000|Overall Study|Withdrawal by Subject|2|||
127563119|NCT02043899|459031853|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
127563120|NCT02043899|459031853|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
127563121|NCT02043899|459031853|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
127563122|NCT02043899|459031853|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
127563123|NCT02043899|459031853|FG000|Overall Study|Treatment delayed|1|||
127563124|NCT01325337|459031855|FG000|Overall Study|Adverse Event|0|||
127563125|NCT01325337|459031856|FG001|Overall Study|Adverse Event|2|||
127563126|NCT01325337|459031857|FG002|Overall Study|Adverse Event|2|||
127563127|NCT01325337|459031858|FG003|Overall Study|Adverse Event|1|||
127563128|NCT01325337|459031859|FG004|Overall Study|Adverse Event|2|||
127563129|NCT01325337|459031855|FG000|Overall Study|Lost to Follow-up|2|||
127563130|NCT01325337|459031856|FG001|Overall Study|Lost to Follow-up|2|||
127563131|NCT01325337|459031857|FG002|Overall Study|Lost to Follow-up|2|||
127563132|NCT01325337|459031858|FG003|Overall Study|Lost to Follow-up|1|||
127563133|NCT01325337|459031859|FG004|Overall Study|Lost to Follow-up|2|||
127563134|NCT01325337|459031855|FG000|Overall Study|Personal Reasons|2|||
127563135|NCT01325337|459031856|FG001|Overall Study|Personal Reasons|5|||
127563136|NCT01325337|459031857|FG002|Overall Study|Personal Reasons|4|||
127563137|NCT01325337|459031858|FG003|Overall Study|Personal Reasons|8|||
127563138|NCT01325337|459031859|FG004|Overall Study|Personal Reasons|3|||
127563139|NCT01325337|459031855|FG000|Overall Study|Withdrawal by Subject|1|||
127563140|NCT01325337|459031856|FG001|Overall Study|Withdrawal by Subject|0|||
127563141|NCT01325337|459031857|FG002|Overall Study|Withdrawal by Subject|1|||
127563142|NCT01325337|459031858|FG003|Overall Study|Withdrawal by Subject|0|||
127563143|NCT01325337|459031859|FG004|Overall Study|Withdrawal by Subject|1|||
127563144|NCT02434471|459031869|FG000|Overall Study|Physician Decision|9|||
127563145|NCT00369629|459031870|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
127563146|NCT00369629|459031871|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
127563147|NCT00369629|459031872|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
127563148|NCT00369629|459031873|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
127563149|NCT00369629|459031870|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
127563150|NCT00369629|459031871|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
127563151|NCT00369629|459031872|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
127563152|NCT00369629|459031873|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
127563153|NCT00369629|459031870|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
127563154|NCT00369629|459031871|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
127563155|NCT00369629|459031872|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
127563156|NCT00369629|459031873|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
127563157|NCT00369629|459031870|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
127563158|NCT00369629|459031871|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
127563159|NCT00369629|459031872|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
127563160|NCT00369629|459031873|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
127687969|NCT02723955|459483555|FG042|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
127687970|NCT02723955|459483513|FG000|Crossover/ Re-treatment Phase|Physician Decision|0|||
127687971|NCT02723955|459483514|FG001|Crossover/ Re-treatment Phase|Physician Decision|0|||
127687972|NCT02723955|459483515|FG002|Crossover/ Re-treatment Phase|Physician Decision|0|||
127687973|NCT02723955|459483516|FG003|Crossover/ Re-treatment Phase|Physician Decision|0|||
127687974|NCT02723955|459483517|FG004|Crossover/ Re-treatment Phase|Physician Decision|0|||
127687975|NCT02723955|459483518|FG005|Crossover/ Re-treatment Phase|Physician Decision|0|||
127687976|NCT02723955|459483519|FG006|Crossover/ Re-treatment Phase|Physician Decision|0|||
127687977|NCT02723955|459483520|FG007|Crossover/ Re-treatment Phase|Physician Decision|0|||
127687978|NCT02723955|459483521|FG008|Crossover/ Re-treatment Phase|Physician Decision|0|||
127687979|NCT02723955|459483522|FG009|Crossover/ Re-treatment Phase|Physician Decision|0|||
127687980|NCT02723955|459483523|FG010|Crossover/ Re-treatment Phase|Physician Decision|0|||
127687981|NCT02723955|459483524|FG011|Crossover/ Re-treatment Phase|Physician Decision|0|||
127687982|NCT02723955|459483525|FG012|Crossover/ Re-treatment Phase|Physician Decision|0|||
127563161|NCT00369629|459031870|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
127563162|NCT00369629|459031871|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
127563163|NCT00369629|459031872|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
127563164|NCT00369629|459031873|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
127563165|NCT00369629|459031870|FG000|Completed 4 More Cycles|Progressive disease|2|||
127563166|NCT00369629|459031871|FG001|Completed 4 More Cycles|Progressive disease|1|||
127563167|NCT00369629|459031872|FG002|Completed 4 More Cycles|Progressive disease|2|||
127563168|NCT00369629|459031873|FG003|Completed 4 More Cycles|Progressive disease|0|||
127563169|NCT00369629|459031870|FG000|Follow up for 1 Year|Death|2|||
127563170|NCT00369629|459031871|FG001|Follow up for 1 Year|Death|1|||
127563171|NCT00369629|459031872|FG002|Follow up for 1 Year|Death|1|||
127563172|NCT00369629|459031873|FG003|Follow up for 1 Year|Death|0|||
127563173|NCT00369629|459031870|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
127563174|NCT00369629|459031871|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
127563175|NCT00369629|459031872|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
127563176|NCT00369629|459031873|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
127563177|NCT00369629|459031870|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
127563178|NCT00369629|459031871|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
127563179|NCT00369629|459031872|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
127563180|NCT00369629|459031873|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
127563181|NCT02184455|459031874|FG000|Overall Study|Lost to Follow-up|1|||
127563182|NCT01347580|459031875|FG000|Overall Study|Withdrawal by Subject|13|||
127563183|NCT01347580|459031876|FG001|Overall Study|Withdrawal by Subject|23|||
127563184|NCT01347580|459031875|FG000|Overall Study|Death|30|||
127563185|NCT01347580|459031876|FG001|Overall Study|Death|19|||
127563186|NCT01347580|459031875|FG000|Overall Study|Protocol Violation|10|||
127563187|NCT01347580|459031876|FG001|Overall Study|Protocol Violation|7|||
127563188|NCT01347580|459031875|FG000|Overall Study|Lost to Follow-up|3|||
127563189|NCT01347580|459031876|FG001|Overall Study|Lost to Follow-up|1|||
127563190|NCT01347580|459031875|FG000|Overall Study|Had other reason|9|||
127563191|NCT01347580|459031876|FG001|Overall Study|Had other reason|6|||
127563192|NCT01250496|459031877|FG000|Overall Study|Study terminated|124|||
127563193|NCT01250496|459031878|FG001|Overall Study|Study terminated|124|||
127563194|NCT01425463|459031879|FG000|Overall Study|Adverse Event|5|||
127563195|NCT01425463|459031880|FG001|Overall Study|Adverse Event|7|||
127563196|NCT01425463|459031879|FG000|Overall Study|Lack of Efficacy|1|||
127563197|NCT01425463|459031880|FG001|Overall Study|Lack of Efficacy|1|||
127563198|NCT01425463|459031879|FG000|Overall Study|Protocol Violation|2|||
127563199|NCT01425463|459031880|FG001|Overall Study|Protocol Violation|2|||
127563200|NCT01425463|459031879|FG000|Overall Study|Lost to Follow-up|5|||
127563201|NCT01425463|459031880|FG001|Overall Study|Lost to Follow-up|2|||
127563202|NCT01425463|459031879|FG000|Overall Study|Withdrawal by Subject|7|||
127563203|NCT01425463|459031880|FG001|Overall Study|Withdrawal by Subject|5|||
127563204|NCT01425463|459031879|FG000|Overall Study|Unknown Reason|4|||
127563205|NCT01425463|459031880|FG001|Overall Study|Unknown Reason|7|||
127563206|NCT04140227|459031884|FG000|Overall Study|Withdrawal by Subject|26|||
127563207|NCT04140227|459031884|FG000|Overall Study|Lost to Follow-up|8|||
127563208|NCT04140227|459031884|FG000|Overall Study|Adverse Event|8|||
127563209|NCT04140227|459031884|FG000|Overall Study|Death|1|||
127563210|NCT04140227|459031884|FG000|Overall Study|Other|3|||
127563211|NCT04140227|459031884|FG000|Overall Study|Protocol Violation|2|||
127563212|NCT01104376|459031892|FG000|Overall Study|Withdrawal by Subject|15|||
127563213|NCT01104376|459031892|FG000|Overall Study|Consented but excluded after labs|13|||
127563214|NCT00797966|459031893|FG000|Phase A|Lost to Follow-up|0|||
127563215|NCT00797966|459031894|FG001|Phase A|Lost to Follow-up|0|||
127563216|NCT00797966|459031895|FG002|Phase A|Lost to Follow-up|0|||
127563217|NCT00797966|459031896|FG003|Phase A|Lost to Follow-up|0|||
127563218|NCT00797966|459031897|FG004|Phase A|Lost to Follow-up|33|||
127563219|NCT00797966|459031898|FG005|Phase A|Lost to Follow-up|0|||
127563220|NCT00797966|459031893|FG000|Phase A|Adverse Event|0|||
127563221|NCT00797966|459031894|FG001|Phase A|Adverse Event|0|||
127563222|NCT00797966|459031895|FG002|Phase A|Adverse Event|0|||
127563223|NCT00797966|459031896|FG003|Phase A|Adverse Event|0|||
127563224|NCT00797966|459031897|FG004|Phase A|Adverse Event|46|||
127563225|NCT00797966|459031898|FG005|Phase A|Adverse Event|0|||
127563226|NCT00797966|459031893|FG000|Phase A|Met withdrawal criteria|0|||
127563227|NCT00797966|459031894|FG001|Phase A|Met withdrawal criteria|0|||
127563228|NCT00797966|459031895|FG002|Phase A|Met withdrawal criteria|0|||
127563229|NCT00797966|459031896|FG003|Phase A|Met withdrawal criteria|0|||
127563230|NCT00797966|459031897|FG004|Phase A|Met withdrawal criteria|4|||
127563231|NCT00797966|459031898|FG005|Phase A|Met withdrawal criteria|0|||
127563232|NCT00797966|459031893|FG000|Phase A|Physician Decision|0|||
127563233|NCT00797966|459031894|FG001|Phase A|Physician Decision|0|||
127563234|NCT00797966|459031895|FG002|Phase A|Physician Decision|0|||
127563235|NCT00797966|459031896|FG003|Phase A|Physician Decision|0|||
127563236|NCT00797966|459031897|FG004|Phase A|Physician Decision|13|||
127563237|NCT00797966|459031898|FG005|Phase A|Physician Decision|0|||
127563238|NCT00797966|459031893|FG000|Phase A|Withdrawal by Subject|0|||
127563239|NCT00797966|459031894|FG001|Phase A|Withdrawal by Subject|0|||
127563240|NCT00797966|459031895|FG002|Phase A|Withdrawal by Subject|0|||
127563241|NCT00797966|459031896|FG003|Phase A|Withdrawal by Subject|0|||
127563242|NCT00797966|459031897|FG004|Phase A|Withdrawal by Subject|33|||
127563243|NCT00797966|459031898|FG005|Phase A|Withdrawal by Subject|0|||
127563244|NCT00797966|459031893|FG000|Phase A|Protocol deviation|0|||
127563245|NCT00797966|459031894|FG001|Phase A|Protocol deviation|0|||
127563246|NCT00797966|459031895|FG002|Phase A|Protocol deviation|0|||
127563247|NCT00797966|459031896|FG003|Phase A|Protocol deviation|0|||
127563248|NCT00797966|459031897|FG004|Phase A|Protocol deviation|56|||
127563249|NCT00797966|459031898|FG005|Phase A|Protocol deviation|0|||
127563250|NCT00797966|459031893|FG000|Phase B|Lost to Follow-up|0|||
127563251|NCT00797966|459031894|FG001|Phase B|Lost to Follow-up|1|||
127563252|NCT00797966|459031895|FG002|Phase B|Lost to Follow-up|3|||
127563253|NCT00797966|459031896|FG003|Phase B|Lost to Follow-up|0|||
127563254|NCT00797966|459031897|FG004|Phase B|Lost to Follow-up|0|||
127563255|NCT00797966|459031898|FG005|Phase B|Lost to Follow-up|0|||
127563256|NCT00797966|459031893|FG000|Phase B|Adverse Event|2|||
127563257|NCT00797966|459031894|FG001|Phase B|Adverse Event|1|||
127563258|NCT00797966|459031895|FG002|Phase B|Adverse Event|3|||
127563259|NCT00797966|459031896|FG003|Phase B|Adverse Event|1|||
127563260|NCT00797966|459031897|FG004|Phase B|Adverse Event|0|||
127563261|NCT00797966|459031898|FG005|Phase B|Adverse Event|0|||
127563262|NCT00797966|459031893|FG000|Phase B|Met Withdrawal Criteria|3|||
127563263|NCT00797966|459031894|FG001|Phase B|Met Withdrawal Criteria|3|||
127563264|NCT00797966|459031895|FG002|Phase B|Met Withdrawal Criteria|6|||
127563265|NCT00797966|459031896|FG003|Phase B|Met Withdrawal Criteria|1|||
127563266|NCT00797966|459031897|FG004|Phase B|Met Withdrawal Criteria|0|||
127563267|NCT00797966|459031898|FG005|Phase B|Met Withdrawal Criteria|0|||
127563268|NCT00797966|459031893|FG000|Phase B|Physician Decision|1|||
127563269|NCT00797966|459031894|FG001|Phase B|Physician Decision|0|||
127563270|NCT00797966|459031895|FG002|Phase B|Physician Decision|3|||
127563271|NCT00797966|459031896|FG003|Phase B|Physician Decision|1|||
127563272|NCT00797966|459031897|FG004|Phase B|Physician Decision|0|||
127563273|NCT00797966|459031898|FG005|Phase B|Physician Decision|0|||
127563274|NCT00797966|459031893|FG000|Phase B|Withdrawal by Subject|1|||
127563275|NCT00797966|459031894|FG001|Phase B|Withdrawal by Subject|4|||
127563276|NCT00797966|459031895|FG002|Phase B|Withdrawal by Subject|3|||
127563277|NCT00797966|459031896|FG003|Phase B|Withdrawal by Subject|3|||
127563278|NCT00797966|459031897|FG004|Phase B|Withdrawal by Subject|0|||
127563279|NCT00797966|459031898|FG005|Phase B|Withdrawal by Subject|0|||
127563280|NCT00797966|459031893|FG000|Phase B|Protocol Deviation|4|||
127563281|NCT00797966|459031894|FG001|Phase B|Protocol Deviation|8|||
127563282|NCT00797966|459031895|FG002|Phase B|Protocol Deviation|2|||
127563283|NCT00797966|459031896|FG003|Phase B|Protocol Deviation|6|||
127563284|NCT00797966|459031897|FG004|Phase B|Protocol Deviation|0|||
127563285|NCT00797966|459031898|FG005|Phase B|Protocol Deviation|0|||
127563286|NCT00797966|459031893|FG000|Phase B|Lack of Efficacy|0|||
127563287|NCT00797966|459031894|FG001|Phase B|Lack of Efficacy|1|||
127563288|NCT00797966|459031895|FG002|Phase B|Lack of Efficacy|1|||
127563289|NCT00797966|459031896|FG003|Phase B|Lack of Efficacy|4|||
127563290|NCT00797966|459031897|FG004|Phase B|Lack of Efficacy|0|||
127563291|NCT00797966|459031898|FG005|Phase B|Lack of Efficacy|0|||
127563292|NCT00797966|459031893|FG000|Phase A+|Lost to Follow-up|0|||
127563293|NCT00797966|459031894|FG001|Phase A+|Lost to Follow-up|0|||
127563294|NCT00797966|459031895|FG002|Phase A+|Lost to Follow-up|0|||
127687983|NCT02723955|459483526|FG013|Crossover/ Re-treatment Phase|Physician Decision|0|||
127687984|NCT02723955|459483527|FG014|Crossover/ Re-treatment Phase|Physician Decision|0|||
127687985|NCT02723955|459483528|FG015|Crossover/ Re-treatment Phase|Physician Decision|0|||
127687986|NCT02723955|459483529|FG016|Crossover/ Re-treatment Phase|Physician Decision|0|||
127687987|NCT02723955|459483530|FG017|Crossover/ Re-treatment Phase|Physician Decision|0|||
127687988|NCT02723955|459483531|FG018|Crossover/ Re-treatment Phase|Physician Decision|0|||
127687989|NCT02723955|459483532|FG019|Crossover/ Re-treatment Phase|Physician Decision|0|||
127687990|NCT02723955|459483533|FG020|Crossover/ Re-treatment Phase|Physician Decision|0|||
127563295|NCT00797966|459031896|FG003|Phase A+|Lost to Follow-up|0|||
127563296|NCT00797966|459031897|FG004|Phase A+|Lost to Follow-up|0|||
127563297|NCT00797966|459031898|FG005|Phase A+|Lost to Follow-up|9|||
127563298|NCT00797966|459031893|FG000|Phase A+|Met withdrawal criteria|0|||
127563299|NCT00797966|459031894|FG001|Phase A+|Met withdrawal criteria|0|||
127563300|NCT00797966|459031895|FG002|Phase A+|Met withdrawal criteria|0|||
127563301|NCT00797966|459031896|FG003|Phase A+|Met withdrawal criteria|0|||
127563302|NCT00797966|459031897|FG004|Phase A+|Met withdrawal criteria|0|||
127563303|NCT00797966|459031898|FG005|Phase A+|Met withdrawal criteria|5|||
127563304|NCT00797966|459031893|FG000|Phase A+|Withdrawal by Subject|0|||
127563305|NCT00797966|459031894|FG001|Phase A+|Withdrawal by Subject|0|||
127563306|NCT00797966|459031895|FG002|Phase A+|Withdrawal by Subject|0|||
127563307|NCT00797966|459031896|FG003|Phase A+|Withdrawal by Subject|0|||
127563308|NCT00797966|459031897|FG004|Phase A+|Withdrawal by Subject|0|||
127563309|NCT00797966|459031898|FG005|Phase A+|Withdrawal by Subject|6|||
127563310|NCT00797966|459031893|FG000|Phase A+|Adverse Event|0|||
127563311|NCT00797966|459031894|FG001|Phase A+|Adverse Event|0|||
127563312|NCT00797966|459031895|FG002|Phase A+|Adverse Event|0|||
127563313|NCT00797966|459031896|FG003|Phase A+|Adverse Event|0|||
127563314|NCT00797966|459031897|FG004|Phase A+|Adverse Event|0|||
127563315|NCT00797966|459031898|FG005|Phase A+|Adverse Event|4|||
127563316|NCT00797966|459031893|FG000|Phase A+|Protocol deviation|0|||
127563317|NCT00797966|459031894|FG001|Phase A+|Protocol deviation|0|||
127563318|NCT00797966|459031895|FG002|Phase A+|Protocol deviation|0|||
127563319|NCT00797966|459031896|FG003|Phase A+|Protocol deviation|0|||
127563320|NCT00797966|459031897|FG004|Phase A+|Protocol deviation|0|||
127563321|NCT00797966|459031898|FG005|Phase A+|Protocol deviation|4|||
127563322|NCT03859973|459031910|FG000|Overall Study|Other reason than listed|3|||
127563323|NCT03859973|459031911|FG001|Overall Study|Other reason than listed|2|||
127563324|NCT03859973|459031910|FG000|Overall Study|COVID-19 related, not due to AE|3|||
127563325|NCT03859973|459031911|FG001|Overall Study|COVID-19 related, not due to AE|4|||
127563326|NCT03859973|459031910|FG000|Overall Study|Withdrawal by Subject|8|||
127563327|NCT03859973|459031911|FG001|Overall Study|Withdrawal by Subject|9|||
127563328|NCT03859973|459031910|FG000|Overall Study|Lost to Follow-up|2|||
127563329|NCT03859973|459031911|FG001|Overall Study|Lost to Follow-up|3|||
127563330|NCT03859973|459031910|FG000|Overall Study|Protocol Violation|1|||
127563331|NCT03859973|459031911|FG001|Overall Study|Protocol Violation|3|||
127563332|NCT03859973|459031910|FG000|Overall Study|Adverse Event|3|||
127563333|NCT03859973|459031911|FG001|Overall Study|Adverse Event|5|||
127563334|NCT01478048|459031912|FG000|Overall Study|Disease Progression|52|||
127563335|NCT01478048|459031913|FG001|Overall Study|Disease Progression|35|||
127563336|NCT01478048|459031912|FG000|Overall Study|study drug toxicity|11|||
127563337|NCT01478048|459031913|FG001|Overall Study|study drug toxicity|14|||
127563338|NCT01478048|459031912|FG000|Overall Study|Adverse Event|2|||
127563339|NCT01478048|459031913|FG001|Overall Study|Adverse Event|11|||
127563340|NCT01478048|459031912|FG000|Overall Study|subject request to discontinue treatment|3|||
127563341|NCT01478048|459031913|FG001|Overall Study|subject request to discontinue treatment|5|||
127563342|NCT01478048|459031912|FG000|Overall Study|Withdrawal by Subject|2|||
127563343|NCT01478048|459031913|FG001|Overall Study|Withdrawal by Subject|5|||
127563344|NCT01478048|459031912|FG000|Overall Study|non-specified|6|||
127563345|NCT01478048|459031913|FG001|Overall Study|non-specified|4|||
127563346|NCT01478048|459031912|FG000|Overall Study|poor/non-compliance|0|||
127563347|NCT01478048|459031913|FG001|Overall Study|poor/non-compliance|1|||
127563348|NCT01478048|459031912|FG000|Overall Study|no longer meets study criteria|1|||
127563349|NCT01478048|459031913|FG001|Overall Study|no longer meets study criteria|0|||
127563350|NCT03032380|459031918|FG000|Overall Study|Adverse Event|0|||
127563351|NCT03032380|459031919|FG001|Overall Study|Adverse Event|1|||
127563352|NCT03032380|459031918|FG000|Overall Study|Lack of Efficacy|1|||
127687991|NCT02723955|459483534|FG021|Crossover/ Re-treatment Phase|Physician Decision|0|||
127776154|NCT02038920|459808371|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
127563353|NCT03032380|459031919|FG001|Overall Study|Lack of Efficacy|0|||
127563354|NCT03032380|459031918|FG000|Overall Study|Withdrawal by Subject|2|||
127563355|NCT03032380|459031919|FG001|Overall Study|Withdrawal by Subject|3|||
127563356|NCT03032380|459031918|FG000|Overall Study|Recovery|0|||
127563357|NCT03032380|459031919|FG001|Overall Study|Recovery|1|||
127687992|NCT02723955|459483535|FG022|Crossover/ Re-treatment Phase|Physician Decision|0|||
127687993|NCT02723955|459483536|FG023|Crossover/ Re-treatment Phase|Physician Decision|0|||
127563358|NCT03032380|459031918|FG000|Overall Study|Death|39|||
127687994|NCT02723955|459483537|FG024|Crossover/ Re-treatment Phase|Physician Decision|0|||
127563359|NCT03032380|459031919|FG001|Overall Study|Death|34|||
127687995|NCT02723955|459483538|FG025|Crossover/ Re-treatment Phase|Physician Decision|0|||
127687996|NCT02723955|459483539|FG026|Crossover/ Re-treatment Phase|Physician Decision|0|||
127687997|NCT02723955|459483540|FG027|Crossover/ Re-treatment Phase|Physician Decision|0|||
127687998|NCT02723955|459483541|FG028|Crossover/ Re-treatment Phase|Physician Decision|0|||
127563360|NCT03032380|459031918|FG000|Overall Study|Other - Miscellaneous|0|||
127563361|NCT03032380|459031919|FG001|Overall Study|Other - Miscellaneous|1|||
127563362|NCT01541397|459031926|FG000|Overall Study|Study ended prior to data collection|4|||
127563363|NCT01541397|459031927|FG001|Overall Study|Study ended prior to data collection|2|||
127563364|NCT01128621|459031928|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
127563365|NCT01128621|459031929|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
127563366|NCT01689532|459031930|FG000|Overall Study|Adverse Event|9|||
127563367|NCT01689532|459031931|FG001|Overall Study|Adverse Event|5|||
127563368|NCT01689532|459031930|FG000|Overall Study|Lack of Efficacy|2|||
127563369|NCT01689532|459031931|FG001|Overall Study|Lack of Efficacy|2|||
127563370|NCT01689532|459031930|FG000|Overall Study|Withdrawal by Subject|1|||
127563371|NCT01689532|459031931|FG001|Overall Study|Withdrawal by Subject|2|||
127563372|NCT01689532|459031930|FG000|Overall Study|Physician Decision|2|||
127563373|NCT01689532|459031931|FG001|Overall Study|Physician Decision|0|||
127563374|NCT01363349|459031932|FG000|Overall Study|Adverse Event|6|||
127563375|NCT01363349|459031933|FG001|Overall Study|Adverse Event|7|||
127563376|NCT01363349|459031932|FG000|Overall Study|Lack of Efficacy|3|||
127563377|NCT01363349|459031933|FG001|Overall Study|Lack of Efficacy|10|||
127563378|NCT01363349|459031932|FG000|Overall Study|Non compliance/Protocol deviations|2|||
127563379|NCT01363349|459031933|FG001|Overall Study|Non compliance/Protocol deviations|2|||
127563380|NCT01363349|459031932|FG000|Overall Study|Withdrawal by Subject|14|||
127563381|NCT01363349|459031933|FG001|Overall Study|Withdrawal by Subject|6|||
127563382|NCT01363349|459031932|FG000|Overall Study|Lost to Follow-up|5|||
127563383|NCT01363349|459031933|FG001|Overall Study|Lost to Follow-up|6|||
127563384|NCT01363349|459031932|FG000|Overall Study|Not reported|36|||
127563385|NCT01363349|459031933|FG001|Overall Study|Not reported|37|||
127563386|NCT01363349|459031932|FG000|Overall Study|missing|1|||
127563387|NCT01363349|459031933|FG001|Overall Study|missing|2|||
127563388|NCT01958489|459031934|FG000|Period 2|Adverse Event|0|||
127563389|NCT01958489|459031935|FG001|Period 2|Adverse Event|1|||
127563390|NCT00913458|459031936|FG000|Phase 1|Non-Responder|54|||
127563391|NCT00913458|459031937|FG001|Phase 1|Non-Responder|0|||
127563392|NCT00913458|459031938|FG002|Phase 1|Non-Responder|0|||
127563393|NCT00913458|459031939|FG003|Phase 1|Non-Responder|0|||
127563394|NCT00913458|459031940|FG004|Phase 1|Non-Responder|0|||
127563395|NCT00913458|459031941|FG005|Phase 1|Non-Responder|0|||
127563396|NCT00913458|459031942|FG006|Phase 1|Non-Responder|0|||
127563397|NCT00913458|459031936|FG000|Phase 1|Subject Request|17|||
127563398|NCT00913458|459031937|FG001|Phase 1|Subject Request|0|||
127563399|NCT00913458|459031938|FG002|Phase 1|Subject Request|0|||
127563400|NCT00913458|459031939|FG003|Phase 1|Subject Request|0|||
127563401|NCT00913458|459031940|FG004|Phase 1|Subject Request|0|||
127563402|NCT00913458|459031941|FG005|Phase 1|Subject Request|0|||
127563403|NCT00913458|459031942|FG006|Phase 1|Subject Request|0|||
127563404|NCT00913458|459031936|FG000|Phase 1|Adverse Event|20|||
127563405|NCT00913458|459031937|FG001|Phase 1|Adverse Event|0|||
127563406|NCT00913458|459031938|FG002|Phase 1|Adverse Event|0|||
127563407|NCT00913458|459031939|FG003|Phase 1|Adverse Event|0|||
127563408|NCT00913458|459031940|FG004|Phase 1|Adverse Event|0|||
127563409|NCT00913458|459031941|FG005|Phase 1|Adverse Event|0|||
127563410|NCT00913458|459031942|FG006|Phase 1|Adverse Event|0|||
127563411|NCT00913458|459031936|FG000|Phase 1|Lost to Follow-up|2|||
127563412|NCT00913458|459031937|FG001|Phase 1|Lost to Follow-up|0|||
127563413|NCT00913458|459031938|FG002|Phase 1|Lost to Follow-up|0|||
127563414|NCT00913458|459031939|FG003|Phase 1|Lost to Follow-up|0|||
127563415|NCT00913458|459031940|FG004|Phase 1|Lost to Follow-up|0|||
127563416|NCT00913458|459031941|FG005|Phase 1|Lost to Follow-up|0|||
127563417|NCT00913458|459031942|FG006|Phase 1|Lost to Follow-up|0|||
127563418|NCT00913458|459031936|FG000|Phase 1|Protocol Violation|10|||
127563419|NCT00913458|459031937|FG001|Phase 1|Protocol Violation|0|||
127563420|NCT00913458|459031938|FG002|Phase 1|Protocol Violation|0|||
127563421|NCT00913458|459031939|FG003|Phase 1|Protocol Violation|0|||
127563422|NCT00913458|459031940|FG004|Phase 1|Protocol Violation|0|||
127563423|NCT00913458|459031941|FG005|Phase 1|Protocol Violation|0|||
127563424|NCT00913458|459031942|FG006|Phase 1|Protocol Violation|0|||
127563425|NCT00913458|459031936|FG000|Phase 1|Sponsor|2|||
127563426|NCT00913458|459031937|FG001|Phase 1|Sponsor|0|||
127563427|NCT00913458|459031938|FG002|Phase 1|Sponsor|0|||
127563428|NCT00913458|459031939|FG003|Phase 1|Sponsor|0|||
127563429|NCT00913458|459031940|FG004|Phase 1|Sponsor|0|||
127563430|NCT00913458|459031941|FG005|Phase 1|Sponsor|0|||
127563431|NCT00913458|459031942|FG006|Phase 1|Sponsor|0|||
127563432|NCT00913458|459031936|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
127563433|NCT00913458|459031937|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
127563434|NCT00913458|459031938|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
127563435|NCT00913458|459031939|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
127563436|NCT00913458|459031940|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
127563437|NCT00913458|459031941|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
127563438|NCT00913458|459031942|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
127563439|NCT00913458|459031936|FG000|Phase 2|Non-Responder|0|||
127563440|NCT00913458|459031937|FG001|Phase 2|Non-Responder|5|||
127563441|NCT00913458|459031938|FG002|Phase 2|Non-Responder|7|||
127563442|NCT00913458|459031939|FG003|Phase 2|Non-Responder|12|||
127563443|NCT00913458|459031940|FG004|Phase 2|Non-Responder|0|||
127563444|NCT00913458|459031941|FG005|Phase 2|Non-Responder|0|||
127563445|NCT00913458|459031942|FG006|Phase 2|Non-Responder|0|||
127563446|NCT00913458|459031936|FG000|Phase 2|Subject Request|0|||
127563447|NCT00913458|459031937|FG001|Phase 2|Subject Request|0|||
127563448|NCT00913458|459031938|FG002|Phase 2|Subject Request|1|||
127563449|NCT00913458|459031939|FG003|Phase 2|Subject Request|2|||
127563450|NCT00913458|459031940|FG004|Phase 2|Subject Request|0|||
127563451|NCT00913458|459031941|FG005|Phase 2|Subject Request|0|||
127563452|NCT00913458|459031942|FG006|Phase 2|Subject Request|0|||
127563453|NCT00913458|459031936|FG000|Phase 2|Adverse Event|0|||
127563454|NCT00913458|459031937|FG001|Phase 2|Adverse Event|3|||
127563455|NCT00913458|459031938|FG002|Phase 2|Adverse Event|0|||
127563456|NCT00913458|459031939|FG003|Phase 2|Adverse Event|1|||
127563457|NCT00913458|459031940|FG004|Phase 2|Adverse Event|0|||
127563458|NCT00913458|459031941|FG005|Phase 2|Adverse Event|0|||
127563459|NCT00913458|459031942|FG006|Phase 2|Adverse Event|0|||
127563460|NCT00913458|459031936|FG000|Phase 2|Lost to Follow-up|0|||
127563461|NCT00913458|459031937|FG001|Phase 2|Lost to Follow-up|0|||
127563462|NCT00913458|459031938|FG002|Phase 2|Lost to Follow-up|0|||
127563463|NCT00913458|459031939|FG003|Phase 2|Lost to Follow-up|1|||
127563464|NCT00913458|459031940|FG004|Phase 2|Lost to Follow-up|0|||
127563465|NCT00913458|459031941|FG005|Phase 2|Lost to Follow-up|0|||
127563466|NCT00913458|459031942|FG006|Phase 2|Lost to Follow-up|0|||
127563467|NCT00913458|459031936|FG000|Phase 2|Protocol Violation|0|||
127563468|NCT00913458|459031937|FG001|Phase 2|Protocol Violation|2|||
127563469|NCT00913458|459031938|FG002|Phase 2|Protocol Violation|0|||
127563470|NCT00913458|459031939|FG003|Phase 2|Protocol Violation|0|||
127563471|NCT00913458|459031940|FG004|Phase 2|Protocol Violation|0|||
127563472|NCT00913458|459031941|FG005|Phase 2|Protocol Violation|0|||
127563473|NCT00913458|459031942|FG006|Phase 2|Protocol Violation|0|||
127563474|NCT00913458|459031936|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
127563475|NCT00913458|459031937|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
127563476|NCT00913458|459031938|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
127563477|NCT00913458|459031939|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
127563478|NCT00913458|459031940|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
127563479|NCT00913458|459031941|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
127563480|NCT00913458|459031942|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
127563481|NCT00913458|459031936|FG000|Phase 3|Adverse Event|0|||
127563482|NCT00913458|459031937|FG001|Phase 3|Adverse Event|0|||
127563483|NCT00913458|459031938|FG002|Phase 3|Adverse Event|0|||
127776155|NCT02038920|459808372|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
127776156|NCT02038920|459808373|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
127776157|NCT02038920|459808374|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
127776158|NCT02038920|459808375|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
127776159|NCT02038920|459808370|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
127776160|NCT02038920|459808371|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
127776161|NCT02038920|459808372|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
127776162|NCT02038920|459808373|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
127776163|NCT02038920|459808374|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
127563484|NCT00913458|459031939|FG003|Phase 3|Adverse Event|0|||
127563485|NCT00913458|459031940|FG004|Phase 3|Adverse Event|5|||
127563486|NCT00913458|459031941|FG005|Phase 3|Adverse Event|4|||
127776164|NCT02038920|459808375|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
127776165|NCT02038920|459808370|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
127776166|NCT02038920|459808371|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
127776167|NCT02038920|459808372|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
127563487|NCT00913458|459031942|FG006|Phase 3|Adverse Event|1|||
127563488|NCT00913458|459031936|FG000|Phase 3|Lost to Follow-up|0|||
127563489|NCT00913458|459031937|FG001|Phase 3|Lost to Follow-up|0|||
127563490|NCT00913458|459031938|FG002|Phase 3|Lost to Follow-up|0|||
127563491|NCT00913458|459031939|FG003|Phase 3|Lost to Follow-up|0|||
127563492|NCT00913458|459031940|FG004|Phase 3|Lost to Follow-up|2|||
127563493|NCT00913458|459031941|FG005|Phase 3|Lost to Follow-up|0|||
127563494|NCT00913458|459031942|FG006|Phase 3|Lost to Follow-up|0|||
127563495|NCT00913458|459031936|FG000|Phase 3|Non-Responder|0|||
127776168|NCT02038920|459808373|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
127563496|NCT00913458|459031937|FG001|Phase 3|Non-Responder|0|||
127563497|NCT00913458|459031938|FG002|Phase 3|Non-Responder|0|||
127563498|NCT00913458|459031939|FG003|Phase 3|Non-Responder|0|||
127776169|NCT02038920|459808374|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
127776170|NCT02038920|459808375|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
127776171|NCT02038920|459808370|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
127776172|NCT02038920|459808371|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
127563499|NCT00913458|459031940|FG004|Phase 3|Non-Responder|0|||
127563500|NCT00913458|459031941|FG005|Phase 3|Non-Responder|1|||
127563501|NCT00913458|459031942|FG006|Phase 3|Non-Responder|3|||
127563502|NCT00913458|459031936|FG000|Phase 3|Withdrawal by Subject|0|||
127563503|NCT00913458|459031937|FG001|Phase 3|Withdrawal by Subject|0|||
127563504|NCT00913458|459031938|FG002|Phase 3|Withdrawal by Subject|0|||
127563505|NCT00913458|459031939|FG003|Phase 3|Withdrawal by Subject|0|||
127563506|NCT00913458|459031940|FG004|Phase 3|Withdrawal by Subject|1|||
127563507|NCT00913458|459031941|FG005|Phase 3|Withdrawal by Subject|2|||
127563508|NCT00913458|459031942|FG006|Phase 3|Withdrawal by Subject|0|||
127563509|NCT00913458|459031936|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
127563510|NCT00913458|459031937|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
127563511|NCT00913458|459031938|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
127563512|NCT00913458|459031939|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
127563513|NCT00913458|459031940|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
127563514|NCT00913458|459031941|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
127563515|NCT00913458|459031942|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
127563516|NCT03595618|459031943|FG000|Overall Study|Adverse Event|16|||
127563517|NCT03595618|459031944|FG001|Overall Study|Adverse Event|17|||
127563518|NCT03595618|459031945|FG002|Overall Study|Adverse Event|20|||
127563519|NCT03595618|459031946|FG003|Overall Study|Adverse Event|8|||
127563520|NCT03595618|459031943|FG000|Overall Study|Withdrawal by Subject|12|||
127563521|NCT03595618|459031944|FG001|Overall Study|Withdrawal by Subject|14|||
127563522|NCT03595618|459031945|FG002|Overall Study|Withdrawal by Subject|14|||
127563523|NCT03595618|459031946|FG003|Overall Study|Withdrawal by Subject|10|||
127563524|NCT03595618|459031943|FG000|Overall Study|Lost to Follow-up|6|||
127563525|NCT03595618|459031944|FG001|Overall Study|Lost to Follow-up|4|||
127563526|NCT03595618|459031945|FG002|Overall Study|Lost to Follow-up|5|||
127563527|NCT03595618|459031946|FG003|Overall Study|Lost to Follow-up|6|||
127563528|NCT03595618|459031943|FG000|Overall Study|Protocol Violation|2|||
127563529|NCT03595618|459031944|FG001|Overall Study|Protocol Violation|0|||
127563530|NCT03595618|459031945|FG002|Overall Study|Protocol Violation|6|||
127563531|NCT03595618|459031946|FG003|Overall Study|Protocol Violation|2|||
127563532|NCT03595618|459031943|FG000|Overall Study|Physician Decision|0|||
127563533|NCT03595618|459031944|FG001|Overall Study|Physician Decision|0|||
127563534|NCT03595618|459031945|FG002|Overall Study|Physician Decision|1|||
127563535|NCT03595618|459031946|FG003|Overall Study|Physician Decision|2|||
127563536|NCT03595618|459031943|FG000|Overall Study|Miscellaneous|7|||
127563537|NCT03595618|459031944|FG001|Overall Study|Miscellaneous|5|||
127563538|NCT03595618|459031945|FG002|Overall Study|Miscellaneous|10|||
127563539|NCT03595618|459031946|FG003|Overall Study|Miscellaneous|6|||
127563540|NCT02338232|459031947|FG000|Overall Study|Screen Failure|3|||
127563541|NCT02338232|459031947|FG000|Overall Study|Withdrawal by Subject|6|||
127563542|NCT02338232|459031947|FG000|Overall Study|Adverse Event|2|||
127563543|NCT02279407|459031948|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
127563544|NCT02279407|459031949|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
127563545|NCT02279407|459031950|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
127563546|NCT02279407|459031951|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
127563547|NCT02279407|459031948|FG000|Overall Study|Withdrawal by Subject|1|||
127563548|NCT02279407|459031949|FG001|Overall Study|Withdrawal by Subject|0|||
127563549|NCT02279407|459031950|FG002|Overall Study|Withdrawal by Subject|1|||
127563550|NCT02279407|459031951|FG003|Overall Study|Withdrawal by Subject|1|||
127563551|NCT02279407|459031948|FG000|Overall Study|Adverse Event|1|||
127563552|NCT02279407|459031949|FG001|Overall Study|Adverse Event|1|||
127563553|NCT02279407|459031950|FG002|Overall Study|Adverse Event|2|||
127563554|NCT02279407|459031951|FG003|Overall Study|Adverse Event|0|||
127563555|NCT02500056|459031952|FG000|Overall Study|Lost to Follow-up|3|||
127563556|NCT02500056|459031953|FG001|Overall Study|Lost to Follow-up|7|||
127563557|NCT02500056|459031952|FG000|Overall Study|Recurrence|1|||
127563558|NCT02500056|459031953|FG001|Overall Study|Recurrence|0|||
127563559|NCT02500056|459031952|FG000|Overall Study|Death|3|||
127563560|NCT02500056|459031953|FG001|Overall Study|Death|1|||
127563561|NCT00864916|459031954|FG000|Overall Study|Lost to Follow-up|4|||
127563562|NCT00864916|459031955|FG001|Overall Study|Lost to Follow-up|4|||
127563563|NCT00864916|459031954|FG000|Overall Study|Protocol Violation|1|||
127563564|NCT00864916|459031955|FG001|Overall Study|Protocol Violation|0|||
127563565|NCT00864916|459031954|FG000|Overall Study|Withdrawal by Subject|1|||
127563566|NCT00864916|459031955|FG001|Overall Study|Withdrawal by Subject|0|||
127563567|NCT01087736|459031960|FG000|Overall Study|Lost to Follow-up|1|||
127563568|NCT01087736|459031961|FG001|Overall Study|Lost to Follow-up|0|||
127563569|NCT01087736|459031960|FG000|Overall Study|Death|0|||
127563570|NCT01087736|459031961|FG001|Overall Study|Death|1|||
127563571|NCT01087736|459031960|FG000|Overall Study|Withdrawal by Subject|0|||
127563572|NCT01087736|459031961|FG001|Overall Study|Withdrawal by Subject|1|||
127563573|NCT01253811|459031962|FG000|Overall Study|Withdrawal criteria|1|||
127563574|NCT02788279|459031967|FG000|Overall Study|Death|62|||
127776173|NCT02038920|459808372|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
127563575|NCT02788279|459031968|FG001|Overall Study|Death|136|||
127563576|NCT02788279|459031969|FG002|Overall Study|Death|72|||
127563577|NCT02788279|459031967|FG000|Overall Study|Withdrawal by Subject|10|||
127563578|NCT02788279|459031968|FG001|Overall Study|Withdrawal by Subject|15|||
127563579|NCT02788279|459031969|FG002|Overall Study|Withdrawal by Subject|5|||
127563580|NCT02788279|459031967|FG000|Overall Study|Lost to Follow-up|0|||
127563581|NCT02788279|459031968|FG001|Overall Study|Lost to Follow-up|3|||
127563582|NCT02788279|459031969|FG002|Overall Study|Lost to Follow-up|2|||
127563583|NCT02788279|459031967|FG000|Overall Study|Sponsor decision|18|||
127563584|NCT02788279|459031968|FG001|Overall Study|Sponsor decision|29|||
127563585|NCT02788279|459031969|FG002|Overall Study|Sponsor decision|11|||
127563586|NCT03996369|459031970|FG000|Overall Study|Protocol deviation|1|||
127563587|NCT03996369|459031971|FG001|Overall Study|Protocol deviation|1|||
127563588|NCT03996369|459031970|FG000|Overall Study|Physician Decision|4|||
127563589|NCT03996369|459031971|FG001|Overall Study|Physician Decision|2|||
127563590|NCT03996369|459031970|FG000|Overall Study|Participant decision|0|||
127563591|NCT03996369|459031971|FG001|Overall Study|Participant decision|1|||
127563592|NCT03996369|459031970|FG000|Overall Study|Lack of Efficacy|4|||
127563593|NCT03996369|459031971|FG001|Overall Study|Lack of Efficacy|0|||
127563594|NCT03996369|459031970|FG000|Overall Study|Adverse Event|9|||
127563595|NCT03996369|459031971|FG001|Overall Study|Adverse Event|0|||
127563596|NCT03996369|459031970|FG000|Overall Study|Withdrawal by Subject|6|||
127563597|NCT03996369|459031971|FG001|Overall Study|Withdrawal by Subject|8|||
127563598|NCT03996369|459031970|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
127563599|NCT03996369|459031971|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
127563600|NCT03996369|459031970|FG000|Overall Study|Lost to Follow-up|0|||
127563601|NCT03996369|459031971|FG001|Overall Study|Lost to Follow-up|1|||
127563602|NCT02238067|459031972|FG000|Overall Study|Not completed survey at Month 6|45|||
127563603|NCT02184572|459031978|FG000|Overall Study|Lost to Follow-up|29|||
127563604|NCT02184572|459031979|FG001|Overall Study|Lost to Follow-up|21|||
127563605|NCT02184572|459031978|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
127563606|NCT02184572|459031979|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
127563607|NCT02184572|459031978|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
127563608|NCT02184572|459031979|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
127563609|NCT02184572|459031978|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
127563610|NCT02184572|459031979|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
127563611|NCT02184572|459031978|FG000|Overall Study|Traveling Outside The Country|1|||
127563612|NCT02184572|459031979|FG001|Overall Study|Traveling Outside The Country|0|||
127563613|NCT02184572|459031978|FG000|Overall Study|Withdrawal by Subject|14|||
127563614|NCT02184572|459031979|FG001|Overall Study|Withdrawal by Subject|9|||
127563615|NCT03726996|459031980|FG000|Overall Study|Parent's decision|2|||
127563616|NCT03726996|459031980|FG000|Overall Study|Study early termination|2|||
127563617|NCT01700387|459031985|FG000|Overall Study|Withdrawal by Subject|1|||
127563618|NCT01700387|459031986|FG001|Overall Study|Withdrawal by Subject|2|||
127563619|NCT01700387|459031985|FG000|Overall Study|Adverse Event|1|||
127563620|NCT01700387|459031986|FG001|Overall Study|Adverse Event|1|||
127776174|NCT02038920|459808373|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
127776175|NCT02038920|459808374|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
127776176|NCT02038920|459808375|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
127776177|NCT02038920|459808370|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
127776178|NCT02038920|459808371|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
127776179|NCT02038920|459808372|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
127776180|NCT02038920|459808373|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
127776181|NCT02038920|459808374|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
127776182|NCT02038920|459808375|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
127776183|NCT00047320|459808376|FG000|Overall Study|Lack of Efficacy|8|||
127776184|NCT00047320|459808376|FG000|Overall Study|Lost to Follow-up|1|||
127776185|NCT00047320|459808376|FG000|Overall Study|Physician Decision|8|||
127776186|NCT00047320|459808376|FG000|Overall Study|Withdrawal by Subject|9|||
127776187|NCT00047320|459808376|FG000|Overall Study|Ineligible|2|||
127776188|NCT02383589|459808377|FG000|Treatment Period|Adverse Event|1|||
127776189|NCT02383589|459808378|FG001|Treatment Period|Adverse Event|3|||
127776190|NCT02383589|459808377|FG000|Treatment Period|Lost to Follow-up|0|||
127776191|NCT02383589|459808378|FG001|Treatment Period|Lost to Follow-up|1|||
127776192|NCT02383589|459808377|FG000|Treatment Period|Withdrawal by Subject|0|||
128024715|NCT02596893|460715963|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
128024716|NCT02596893|460715960|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
128024717|NCT02596893|460715961|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
128024718|NCT02596893|460715962|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
128024719|NCT02596893|460715963|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
127563621|NCT01700387|459031985|FG000|Overall Study|Lost to Follow-up|2|||
127563622|NCT01700387|459031986|FG001|Overall Study|Lost to Follow-up|1|||
127563623|NCT01185353|459031988|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
127563624|NCT01185353|459031989|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
127563625|NCT01185353|459031990|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
127563626|NCT01185353|459031991|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
127776193|NCT02383589|459808378|FG001|Treatment Period|Withdrawal by Subject|5|||
127776194|NCT02383589|459808377|FG000|Treatment Period|Non-compliance with study drug|0|||
127563627|NCT01185353|459031992|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
127563628|NCT01185353|459031993|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
127563629|NCT01185353|459031994|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
127563630|NCT01185353|459031995|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
127776195|NCT02383589|459808378|FG001|Treatment Period|Non-compliance with study drug|1|||
127776196|NCT02383589|459808377|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
127563631|NCT01185353|459031996|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
127563632|NCT01185353|459031997|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
127563633|NCT01185353|459031988|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
127563634|NCT01185353|459031989|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
127563635|NCT01185353|459031990|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
127563636|NCT01185353|459031991|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
127563637|NCT01185353|459031992|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
127563638|NCT01185353|459031993|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
127563639|NCT01185353|459031994|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
127563640|NCT01185353|459031995|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
127563641|NCT01185353|459031996|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
127563642|NCT01185353|459031997|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
127563643|NCT01185353|459031988|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
127563644|NCT01185353|459031989|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
127563645|NCT01185353|459031990|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
127563646|NCT01185353|459031991|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
127563647|NCT01185353|459031992|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
127563648|NCT01185353|459031993|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
127563649|NCT01185353|459031994|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
127563650|NCT01185353|459031995|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
127563651|NCT01185353|459031996|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
127563652|NCT01185353|459031997|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
127687999|NCT02723955|459483542|FG029|Crossover/ Re-treatment Phase|Physician Decision|0|||
127688000|NCT02723955|459483543|FG030|Crossover/ Re-treatment Phase|Physician Decision|0|||
127688001|NCT02723955|459483544|FG031|Crossover/ Re-treatment Phase|Physician Decision|0|||
127688002|NCT02723955|459483545|FG032|Crossover/ Re-treatment Phase|Physician Decision|0|||
127688003|NCT02723955|459483546|FG033|Crossover/ Re-treatment Phase|Physician Decision|0|||
127688004|NCT02723955|459483547|FG034|Crossover/ Re-treatment Phase|Physician Decision|0|||
127688005|NCT02723955|459483548|FG035|Crossover/ Re-treatment Phase|Physician Decision|0|||
127688006|NCT02723955|459483549|FG036|Crossover/ Re-treatment Phase|Physician Decision|0|||
127688007|NCT02723955|459483550|FG037|Crossover/ Re-treatment Phase|Physician Decision|0|||
127563653|NCT01185353|459031988|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
127563654|NCT01185353|459031989|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
127563655|NCT01185353|459031990|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
127563656|NCT01185353|459031991|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
127563657|NCT01185353|459031992|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
127563658|NCT01185353|459031993|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
127563659|NCT01185353|459031994|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
127563660|NCT01185353|459031995|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
127563661|NCT01185353|459031996|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
127563662|NCT01185353|459031997|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
127563663|NCT01185353|459031988|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
127563664|NCT01185353|459031989|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
127563665|NCT01185353|459031990|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
127563666|NCT01185353|459031991|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
127563667|NCT01185353|459031992|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
127563668|NCT01185353|459031993|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
127563669|NCT01185353|459031994|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
127563670|NCT01185353|459031995|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
127563671|NCT01185353|459031996|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
127563672|NCT01185353|459031997|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
127563673|NCT01185353|459031988|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
127563674|NCT01185353|459031989|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
127563675|NCT01185353|459031990|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
127563676|NCT01185353|459031991|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
127563677|NCT01185353|459031992|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
127688008|NCT02723955|459483551|FG038|Crossover/ Re-treatment Phase|Physician Decision|1|||
127688009|NCT02723955|459483552|FG039|Crossover/ Re-treatment Phase|Physician Decision|1|||
127688010|NCT02723955|459483553|FG040|Crossover/ Re-treatment Phase|Physician Decision|0|||
127688011|NCT02723955|459483554|FG041|Crossover/ Re-treatment Phase|Physician Decision|0|||
127688012|NCT02723955|459483555|FG042|Crossover/ Re-treatment Phase|Physician Decision|1|||
127688013|NCT02723955|459483513|FG000|Crossover/ Re-treatment Phase|Site Closed|0|||
127688014|NCT02723955|459483514|FG001|Crossover/ Re-treatment Phase|Site Closed|0|||
127688015|NCT02723955|459483515|FG002|Crossover/ Re-treatment Phase|Site Closed|0|||
127688016|NCT02723955|459483516|FG003|Crossover/ Re-treatment Phase|Site Closed|0|||
127688017|NCT02723955|459483517|FG004|Crossover/ Re-treatment Phase|Site Closed|0|||
127563678|NCT01185353|459031993|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
127688018|NCT02723955|459483518|FG005|Crossover/ Re-treatment Phase|Site Closed|0|||
127563679|NCT01185353|459031994|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
127563680|NCT01185353|459031995|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
127563681|NCT01185353|459031996|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
127563682|NCT01185353|459031997|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
127563683|NCT01185353|459031988|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
127563684|NCT01185353|459031989|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
127563685|NCT01185353|459031990|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
127563686|NCT01185353|459031991|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
127563687|NCT01185353|459031992|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
127563688|NCT01185353|459031993|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
127563689|NCT01185353|459031994|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
127563690|NCT01185353|459031995|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
127563691|NCT01185353|459031996|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
127563692|NCT01185353|459031997|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
127563693|NCT01185353|459031988|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
127563694|NCT01185353|459031989|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
127563695|NCT01185353|459031990|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
127563696|NCT01185353|459031991|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
127563697|NCT01185353|459031992|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
127563698|NCT01185353|459031993|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
127563699|NCT01185353|459031994|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
127563700|NCT01185353|459031995|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
127563701|NCT01185353|459031996|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
127563702|NCT01185353|459031997|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
127563703|NCT01185353|459031988|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
127563704|NCT01185353|459031989|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
127563705|NCT01185353|459031990|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
127563706|NCT01185353|459031991|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
127563707|NCT01185353|459031992|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
127563708|NCT01185353|459031993|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
127563709|NCT01185353|459031994|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
127563710|NCT01185353|459031995|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
127563711|NCT01185353|459031996|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
127563712|NCT01185353|459031997|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
127563713|NCT01185353|459031988|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
127563714|NCT01185353|459031989|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
127563715|NCT01185353|459031990|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
127563716|NCT01185353|459031991|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
127563717|NCT01185353|459031992|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
127563718|NCT01185353|459031993|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
127563719|NCT01185353|459031994|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
127563720|NCT01185353|459031995|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
127563721|NCT01185353|459031996|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
127563722|NCT01185353|459031997|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
127563723|NCT01185353|459031988|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
127563724|NCT01185353|459031989|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
127563725|NCT01185353|459031990|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
127563726|NCT01185353|459031991|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
127563727|NCT01185353|459031992|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
127563728|NCT01185353|459031993|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
127563729|NCT01185353|459031994|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
127563730|NCT01185353|459031995|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
127563731|NCT01185353|459031996|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
127563732|NCT01185353|459031997|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
127563733|NCT01185353|459031988|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
127563734|NCT01185353|459031989|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
127563735|NCT01185353|459031990|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
127563736|NCT01185353|459031991|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
127563737|NCT01185353|459031992|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
127563738|NCT01185353|459031993|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
127563739|NCT01185353|459031994|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
127563740|NCT01185353|459031995|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
127563741|NCT01185353|459031996|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
127563742|NCT01185353|459031997|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
127563743|NCT01185353|459031988|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
127563744|NCT01185353|459031989|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
127563745|NCT01185353|459031990|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
127563746|NCT01185353|459031991|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
127563747|NCT01185353|459031992|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
127563748|NCT01185353|459031993|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
127563749|NCT01185353|459031994|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
127563750|NCT01185353|459031995|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
127563751|NCT01185353|459031996|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
127563752|NCT01185353|459031997|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
127563753|NCT01185353|459031988|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
127563754|NCT01185353|459031989|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
127563755|NCT01185353|459031990|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
127563756|NCT01185353|459031991|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
127563757|NCT01185353|459031992|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
127563758|NCT01185353|459031993|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
127563759|NCT01185353|459031994|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
127563760|NCT01185353|459031995|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
127563761|NCT01185353|459031996|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
127563762|NCT01185353|459031997|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
127563763|NCT01185353|459031988|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
127563764|NCT01185353|459031989|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
127563765|NCT01185353|459031990|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
127563766|NCT01185353|459031991|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
127563767|NCT01185353|459031992|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
127563768|NCT01185353|459031993|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
127563769|NCT01185353|459031994|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
127563770|NCT01185353|459031995|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
127563771|NCT01185353|459031996|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
127563772|NCT01185353|459031997|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
127563773|NCT01185353|459031988|FG000|Part C (Weeks 24 Through 76)|Death|0|||
127563774|NCT01185353|459031989|FG001|Part C (Weeks 24 Through 76)|Death|0|||
127563775|NCT01185353|459031990|FG002|Part C (Weeks 24 Through 76)|Death|0|||
127563776|NCT01185353|459031991|FG003|Part C (Weeks 24 Through 76)|Death|0|||
127563777|NCT01185353|459031992|FG004|Part C (Weeks 24 Through 76)|Death|0|||
127563778|NCT01185353|459031993|FG005|Part C (Weeks 24 Through 76)|Death|0|||
127563779|NCT01185353|459031994|FG006|Part C (Weeks 24 Through 76)|Death|0|||
127563780|NCT01185353|459031995|FG007|Part C (Weeks 24 Through 76)|Death|0|||
127563781|NCT01185353|459031996|FG008|Part C (Weeks 24 Through 76)|Death|0|||
127563782|NCT01185353|459031997|FG009|Part C (Weeks 24 Through 76)|Death|1|||
127563783|NCT01185353|459031988|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
127563784|NCT01185353|459031989|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
127563785|NCT01185353|459031990|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
127563786|NCT01185353|459031991|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
127563787|NCT01185353|459031992|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
127563788|NCT01185353|459031993|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
127563789|NCT01185353|459031994|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
127563790|NCT01185353|459031995|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
127563791|NCT01185353|459031996|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
127563792|NCT01185353|459031997|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
127563793|NCT01185353|459031988|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
127563794|NCT01185353|459031989|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
127563795|NCT01185353|459031990|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
127563796|NCT01185353|459031991|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
127563797|NCT01185353|459031992|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
127563798|NCT01185353|459031993|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
127563799|NCT01185353|459031994|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
127563800|NCT01185353|459031995|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
127563801|NCT01185353|459031996|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
127688019|NCT02723955|459483519|FG006|Crossover/ Re-treatment Phase|Site Closed|0|||
127688020|NCT02723955|459483520|FG007|Crossover/ Re-treatment Phase|Site Closed|0|||
127688021|NCT02723955|459483521|FG008|Crossover/ Re-treatment Phase|Site Closed|0|||
128024720|NCT02596893|460715960|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
128024721|NCT02596893|460715961|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
127563802|NCT01185353|459031997|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
127563803|NCT01185353|459031988|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
127563804|NCT01185353|459031989|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
127563805|NCT01185353|459031990|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
127563806|NCT01185353|459031991|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
127563807|NCT01185353|459031992|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
127563808|NCT01185353|459031993|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
128024722|NCT02596893|460715962|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
128024723|NCT02596893|460715963|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
127563809|NCT01185353|459031994|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
127563810|NCT01185353|459031995|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
127563811|NCT01185353|459031996|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
127563812|NCT01185353|459031997|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
127563813|NCT01185353|459031988|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
127563814|NCT01185353|459031989|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
127563815|NCT01185353|459031990|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
127563816|NCT01185353|459031991|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
127563817|NCT01185353|459031992|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
127563818|NCT01185353|459031993|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
127563819|NCT01185353|459031994|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
127563820|NCT01185353|459031995|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
127563821|NCT01185353|459031996|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
127563822|NCT01185353|459031997|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
127563823|NCT01185353|459031988|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
127563824|NCT01185353|459031989|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
127563825|NCT01185353|459031990|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
127563826|NCT01185353|459031991|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
127563827|NCT01185353|459031992|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
127563828|NCT01185353|459031993|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
127563829|NCT01185353|459031994|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
127563830|NCT01185353|459031995|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
127563831|NCT01185353|459031996|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
127563832|NCT01185353|459031997|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
127563833|NCT01185353|459031988|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
127563834|NCT01185353|459031989|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
127563835|NCT01185353|459031990|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
127563836|NCT01185353|459031991|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
127563837|NCT01185353|459031992|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
127563838|NCT01185353|459031993|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
127563839|NCT01185353|459031994|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
127563840|NCT01185353|459031995|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
127563841|NCT01185353|459031996|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
127563842|NCT01185353|459031997|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
127563843|NCT03678870|459031998|FG000|Overall Study|prescribed non- protocol medications|10|||
127563844|NCT03678870|459031999|FG001|Overall Study|prescribed non- protocol medications|6|||
127563845|NCT03678870|459031998|FG000|Overall Study|Lost to Follow-up|3|||
127563846|NCT03678870|459031999|FG001|Overall Study|Lost to Follow-up|2|||
127563847|NCT01159431|459032001|FG000|Overall Study|Adverse Event|1|||
127563848|NCT01159431|459032002|FG001|Overall Study|Adverse Event|2|||
127563849|NCT01159431|459032001|FG000|Overall Study|non-compliance|1|||
127563850|NCT01159431|459032002|FG001|Overall Study|non-compliance|1|||
127563851|NCT01159431|459032001|FG000|Overall Study|Lack of Efficacy|0|||
127563852|NCT01159431|459032002|FG001|Overall Study|Lack of Efficacy|3|||
127563853|NCT01227629|459032003|FG000|Overall Study|Adverse Event|2|||
127563854|NCT01227629|459032004|FG001|Overall Study|Adverse Event|2|||
127563855|NCT01227629|459032005|FG002|Overall Study|Adverse Event|1|||
127563856|NCT01227629|459032006|FG003|Overall Study|Adverse Event|6|||
127563857|NCT01227629|459032007|FG004|Overall Study|Adverse Event|1|||
127563858|NCT01227629|459032008|FG005|Overall Study|Adverse Event|1|||
127563859|NCT01227629|459032009|FG006|Overall Study|Adverse Event|6|||
127563860|NCT01227629|459032010|FG007|Overall Study|Adverse Event|6|||
127563861|NCT01227629|459032011|FG008|Overall Study|Adverse Event|4|||
127688022|NCT02723955|459483522|FG009|Crossover/ Re-treatment Phase|Site Closed|0|||
127688023|NCT02723955|459483523|FG010|Crossover/ Re-treatment Phase|Site Closed|0|||
127688024|NCT02723955|459483524|FG011|Crossover/ Re-treatment Phase|Site Closed|0|||
127688025|NCT02723955|459483525|FG012|Crossover/ Re-treatment Phase|Site Closed|0|||
127688026|NCT02723955|459483526|FG013|Crossover/ Re-treatment Phase|Site Closed|0|||
127688027|NCT02723955|459483527|FG014|Crossover/ Re-treatment Phase|Site Closed|0|||
127688028|NCT02723955|459483528|FG015|Crossover/ Re-treatment Phase|Site Closed|0|||
127688029|NCT02723955|459483529|FG016|Crossover/ Re-treatment Phase|Site Closed|0|||
127688030|NCT02723955|459483530|FG017|Crossover/ Re-treatment Phase|Site Closed|0|||
127688031|NCT02723955|459483531|FG018|Crossover/ Re-treatment Phase|Site Closed|0|||
127688032|NCT02723955|459483532|FG019|Crossover/ Re-treatment Phase|Site Closed|0|||
127563862|NCT01227629|459032012|FG009|Overall Study|Adverse Event|0|||
127688033|NCT02723955|459483533|FG020|Crossover/ Re-treatment Phase|Site Closed|0|||
127688034|NCT02723955|459483534|FG021|Crossover/ Re-treatment Phase|Site Closed|0|||
127563863|NCT01227629|459032003|FG000|Overall Study|Protocol Violation|0|||
127563864|NCT01227629|459032004|FG001|Overall Study|Protocol Violation|0|||
127563865|NCT01227629|459032005|FG002|Overall Study|Protocol Violation|0|||
127563866|NCT01227629|459032006|FG003|Overall Study|Protocol Violation|1|||
127563867|NCT01227629|459032007|FG004|Overall Study|Protocol Violation|0|||
127563868|NCT01227629|459032008|FG005|Overall Study|Protocol Violation|0|||
127563869|NCT01227629|459032009|FG006|Overall Study|Protocol Violation|0|||
127563870|NCT01227629|459032010|FG007|Overall Study|Protocol Violation|0|||
127563871|NCT01227629|459032011|FG008|Overall Study|Protocol Violation|0|||
127563872|NCT01227629|459032012|FG009|Overall Study|Protocol Violation|0|||
127563873|NCT01227629|459032003|FG000|Overall Study|Lost to Follow-up|0|||
127563874|NCT01227629|459032004|FG001|Overall Study|Lost to Follow-up|0|||
127563875|NCT01227629|459032005|FG002|Overall Study|Lost to Follow-up|0|||
127563876|NCT01227629|459032006|FG003|Overall Study|Lost to Follow-up|0|||
127563877|NCT01227629|459032007|FG004|Overall Study|Lost to Follow-up|1|||
127563878|NCT01227629|459032008|FG005|Overall Study|Lost to Follow-up|0|||
127563879|NCT01227629|459032009|FG006|Overall Study|Lost to Follow-up|0|||
127563880|NCT01227629|459032010|FG007|Overall Study|Lost to Follow-up|0|||
127563881|NCT01227629|459032011|FG008|Overall Study|Lost to Follow-up|0|||
127563882|NCT01227629|459032012|FG009|Overall Study|Lost to Follow-up|0|||
127563883|NCT01227629|459032003|FG000|Overall Study|Withdrawal by Subject|0|||
127563884|NCT01227629|459032004|FG001|Overall Study|Withdrawal by Subject|0|||
127563885|NCT01227629|459032005|FG002|Overall Study|Withdrawal by Subject|0|||
127563886|NCT01227629|459032006|FG003|Overall Study|Withdrawal by Subject|0|||
127563887|NCT01227629|459032007|FG004|Overall Study|Withdrawal by Subject|0|||
127563888|NCT01227629|459032008|FG005|Overall Study|Withdrawal by Subject|0|||
127563889|NCT01227629|459032009|FG006|Overall Study|Withdrawal by Subject|2|||
127563890|NCT01227629|459032010|FG007|Overall Study|Withdrawal by Subject|0|||
127563891|NCT01227629|459032011|FG008|Overall Study|Withdrawal by Subject|0|||
127563892|NCT01227629|459032012|FG009|Overall Study|Withdrawal by Subject|1|||
127563893|NCT01227629|459032003|FG000|Overall Study|Other|0|||
127563894|NCT01227629|459032004|FG001|Overall Study|Other|0|||
127563895|NCT01227629|459032005|FG002|Overall Study|Other|0|||
127563896|NCT01227629|459032006|FG003|Overall Study|Other|1|||
127563897|NCT01227629|459032007|FG004|Overall Study|Other|0|||
127563898|NCT01227629|459032008|FG005|Overall Study|Other|0|||
127563899|NCT01227629|459032009|FG006|Overall Study|Other|0|||
127563900|NCT01227629|459032010|FG007|Overall Study|Other|0|||
127563901|NCT01227629|459032011|FG008|Overall Study|Other|2|||
127563902|NCT01227629|459032012|FG009|Overall Study|Other|1|||
127642506|NCT04124926|459313073|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
127642507|NCT04124926|459313074|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
127642508|NCT04124926|459313075|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
127642509|NCT04124926|459313076|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
127642510|NCT04124926|459313072|FG000|Healing Phase|Protocol Violation|0|||
127642511|NCT04124926|459313073|FG001|Healing Phase|Protocol Violation|1|||
127642512|NCT04124926|459313074|FG002|Healing Phase|Protocol Violation|0|||
127642513|NCT04124926|459313075|FG003|Healing Phase|Protocol Violation|0|||
127642514|NCT04124926|459313076|FG004|Healing Phase|Protocol Violation|0|||
127642515|NCT04124926|459313072|FG000|Healing Phase|Lost to Follow-up|5|||
127642516|NCT04124926|459313073|FG001|Healing Phase|Lost to Follow-up|4|||
127642517|NCT04124926|459313074|FG002|Healing Phase|Lost to Follow-up|0|||
127642518|NCT04124926|459313075|FG003|Healing Phase|Lost to Follow-up|0|||
127642519|NCT04124926|459313076|FG004|Healing Phase|Lost to Follow-up|0|||
127642520|NCT04124926|459313072|FG000|Healing Phase|Voluntary Withdrawal|10|||
127642521|NCT04124926|459313073|FG001|Healing Phase|Voluntary Withdrawal|7|||
127642522|NCT04124926|459313074|FG002|Healing Phase|Voluntary Withdrawal|0|||
127642523|NCT04124926|459313075|FG003|Healing Phase|Voluntary Withdrawal|0|||
127642524|NCT04124926|459313076|FG004|Healing Phase|Voluntary Withdrawal|0|||
127642525|NCT04124926|459313072|FG000|Healing Phase|Withdrawal of Consent|5|||
127642526|NCT04124926|459313073|FG001|Healing Phase|Withdrawal of Consent|3|||
127642527|NCT04124926|459313074|FG002|Healing Phase|Withdrawal of Consent|0|||
127642528|NCT04124926|459313075|FG003|Healing Phase|Withdrawal of Consent|0|||
127642529|NCT04124926|459313076|FG004|Healing Phase|Withdrawal of Consent|0|||
127642530|NCT04124926|459313072|FG000|Healing Phase|Miscellaneous|8|||
127642531|NCT04124926|459313073|FG001|Healing Phase|Miscellaneous|7|||
127642532|NCT04124926|459313074|FG002|Healing Phase|Miscellaneous|0|||
127642533|NCT04124926|459313075|FG003|Healing Phase|Miscellaneous|0|||
127642534|NCT04124926|459313076|FG004|Healing Phase|Miscellaneous|0|||
127642535|NCT04124926|459313072|FG000|Healing Phase|Randomized but not Treated|0|||
127642536|NCT04124926|459313073|FG001|Healing Phase|Randomized but not Treated|3|||
127642537|NCT04124926|459313074|FG002|Healing Phase|Randomized but not Treated|0|||
127642538|NCT04124926|459313075|FG003|Healing Phase|Randomized but not Treated|0|||
127642539|NCT04124926|459313076|FG004|Healing Phase|Randomized but not Treated|0|||
127642540|NCT04124926|459313072|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
127642541|NCT04124926|459313073|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
127642542|NCT04124926|459313074|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
127642543|NCT04124926|459313075|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
127642544|NCT04124926|459313076|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
127642545|NCT04124926|459313072|FG000|Maintenance Phase|Protocol Violation|0|||
127642546|NCT04124926|459313073|FG001|Maintenance Phase|Protocol Violation|0|||
127642547|NCT04124926|459313074|FG002|Maintenance Phase|Protocol Violation|3|||
127642548|NCT04124926|459313075|FG003|Maintenance Phase|Protocol Violation|0|||
127563903|NCT00362180|459033673|FG000|Treated Period|Withdrawal by Subject|1|||
127563904|NCT00362180|459033674|FG001|Treated Period|Withdrawal by Subject|0|||
127563905|NCT00362180|459033675|FG002|Treated Period|Withdrawal by Subject|0|||
127563906|NCT00362180|459033676|FG003|Treated Period|Withdrawal by Subject|0|||
127563907|NCT00362180|459033677|FG004|Treated Period|Withdrawal by Subject|0|||
127563908|NCT00362180|459033678|FG005|Treated Period|Withdrawal by Subject|0|||
127563909|NCT00362180|459033679|FG006|Treated Period|Withdrawal by Subject|0|||
127563910|NCT00362180|459033680|FG007|Treated Period|Withdrawal by Subject|0|||
127563911|NCT00362180|459033681|FG008|Treated Period|Withdrawal by Subject|0|||
127563912|NCT00362180|459033673|FG000|Treated Period|Adverse Event|0|||
127563913|NCT00362180|459033674|FG001|Treated Period|Adverse Event|0|||
127563914|NCT00362180|459033675|FG002|Treated Period|Adverse Event|0|||
127563915|NCT00362180|459033676|FG003|Treated Period|Adverse Event|0|||
127563916|NCT00362180|459033677|FG004|Treated Period|Adverse Event|0|||
127563917|NCT00362180|459033678|FG005|Treated Period|Adverse Event|1|||
127563918|NCT00362180|459033679|FG006|Treated Period|Adverse Event|0|||
127563919|NCT00362180|459033680|FG007|Treated Period|Adverse Event|1|||
127563920|NCT00362180|459033681|FG008|Treated Period|Adverse Event|0|||
127563921|NCT00843778|459033682|FG000|Overall Study|Adverse Event|15|||
127563922|NCT00843778|459033682|FG000|Overall Study|Lack of Efficacy|14|||
127563923|NCT00843778|459033682|FG000|Overall Study|Loss of efficacy|2|||
127563924|NCT00843778|459033682|FG000|Overall Study|Withdrawal by Subject|4|||
127563925|NCT01604278|459033683|FG000|Overall Study|Lack of Efficacy|0|||
127563926|NCT01604278|459033684|FG001|Overall Study|Lack of Efficacy|1|||
127563927|NCT01604278|459033683|FG000|Overall Study|Lost to Follow-up|1|||
127563928|NCT01604278|459033684|FG001|Overall Study|Lost to Follow-up|0|||
127563929|NCT01604278|459033683|FG000|Overall Study|Administrative problems|2|||
127563930|NCT01604278|459033684|FG001|Overall Study|Administrative problems|1|||
127563931|NCT01604278|459033683|FG000|Overall Study|Withdrawal by Subject|3|||
127563932|NCT01604278|459033684|FG001|Overall Study|Withdrawal by Subject|3|||
127563933|NCT01604278|459033683|FG000|Overall Study|Adverse Event|3|||
127563934|NCT01604278|459033684|FG001|Overall Study|Adverse Event|5|||
127563935|NCT01604278|459033683|FG000|Overall Study|Protocol Deviation|5|||
127563936|NCT01604278|459033684|FG001|Overall Study|Protocol Deviation|3|||
127563937|NCT02870933|459033687|FG000|Overall Study|Death|2|||
127563938|NCT02870933|459033688|FG001|Overall Study|Death|1|||
127563939|NCT02870933|459033687|FG000|Overall Study|Withdrawal by Subject|0|||
127563940|NCT02870933|459033688|FG001|Overall Study|Withdrawal by Subject|1|||
127563941|NCT03005873|459033689|FG000|Overall Study|Prohibited medication use post radnomization|1|||
127563942|NCT03005873|459033690|FG001|Overall Study|Prohibited medication use post radnomization|1|||
127563943|NCT03005873|459033691|FG002|Overall Study|Prohibited medication use post radnomization|1|||
127563944|NCT03005873|459033689|FG000|Overall Study|Withdrew consent|0|||
127563945|NCT03005873|459033690|FG001|Overall Study|Withdrew consent|1|||
127563946|NCT03005873|459033691|FG002|Overall Study|Withdrew consent|2|||
127563947|NCT03005873|459033689|FG000|Overall Study|Lost to Follow-up|0|||
127563948|NCT03005873|459033690|FG001|Overall Study|Lost to Follow-up|1|||
127563949|NCT03005873|459033691|FG002|Overall Study|Lost to Follow-up|0|||
127563950|NCT03005873|459033689|FG000|Overall Study|Ineligible post randomization|0|||
127563951|NCT03005873|459033690|FG001|Overall Study|Ineligible post randomization|0|||
127563952|NCT03005873|459033691|FG002|Overall Study|Ineligible post randomization|1|||
127563953|NCT04585009|459033692|FG000|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|1|||
127563954|NCT04585009|459033693|FG001|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
127563955|NCT04585009|459033694|FG002|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
127563956|NCT04585009|459033695|FG003|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
127563957|NCT04585009|459033696|FG004|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
127563958|NCT04585009|459033697|FG005|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
127563959|NCT04585009|459033698|FG006|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
127563960|NCT04585009|459033699|FG007|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
127563961|NCT04585009|459033700|FG008|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
127563962|NCT04585009|459033701|FG009|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
127563963|NCT04585009|459033702|FG010|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
127563964|NCT04585009|459033703|FG011|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
127563965|NCT04585009|459033692|FG000|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|1|||
127563966|NCT04585009|459033693|FG001|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
127563967|NCT04585009|459033694|FG002|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
127563968|NCT04585009|459033695|FG003|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
127563969|NCT04585009|459033696|FG004|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
127563970|NCT04585009|459033697|FG005|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
127563971|NCT04585009|459033698|FG006|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
127563972|NCT04585009|459033699|FG007|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
127563973|NCT04585009|459033700|FG008|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
127563974|NCT04585009|459033701|FG009|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
127563975|NCT04585009|459033702|FG010|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
127563976|NCT04585009|459033703|FG011|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
127563977|NCT04585009|459033692|FG000|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
127563978|NCT04585009|459033693|FG001|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
127563979|NCT04585009|459033694|FG002|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
127563980|NCT04585009|459033695|FG003|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
127563981|NCT04585009|459033696|FG004|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
127563982|NCT04585009|459033697|FG005|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
127563983|NCT04585009|459033698|FG006|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
127563984|NCT04585009|459033699|FG007|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|1|||
127563985|NCT04585009|459033700|FG008|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
127563986|NCT04585009|459033701|FG009|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
127563987|NCT04585009|459033702|FG010|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
127563988|NCT04585009|459033703|FG011|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
127563989|NCT04585009|459033692|FG000|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
127563990|NCT04585009|459033693|FG001|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
127563991|NCT04585009|459033694|FG002|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
127563992|NCT04585009|459033695|FG003|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
127563993|NCT04585009|459033696|FG004|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|1|||
127563994|NCT04585009|459033697|FG005|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
127563995|NCT04585009|459033698|FG006|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
127563996|NCT04585009|459033699|FG007|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
127563997|NCT04585009|459033700|FG008|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
127563998|NCT04585009|459033701|FG009|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
127563999|NCT04585009|459033702|FG010|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
127564000|NCT04585009|459033703|FG011|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
127564001|NCT04585009|459033692|FG000|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
127564002|NCT04585009|459033693|FG001|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
127564003|NCT04585009|459033694|FG002|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
127564004|NCT04585009|459033695|FG003|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
127564005|NCT04585009|459033696|FG004|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
127564006|NCT04585009|459033697|FG005|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
127564007|NCT04585009|459033698|FG006|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
127564008|NCT04585009|459033699|FG007|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
127564009|NCT04585009|459033700|FG008|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
127564010|NCT04585009|459033701|FG009|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|1|||
127564011|NCT04585009|459033702|FG010|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
127564012|NCT04585009|459033703|FG011|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
127564013|NCT04585009|459033692|FG000|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
127564014|NCT04585009|459033693|FG001|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
127564015|NCT04585009|459033694|FG002|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
127564016|NCT04585009|459033695|FG003|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
127564017|NCT04585009|459033696|FG004|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
127564018|NCT04585009|459033697|FG005|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
127564019|NCT04585009|459033698|FG006|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
127564020|NCT04585009|459033699|FG007|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
127564021|NCT04585009|459033700|FG008|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
127564022|NCT04585009|459033701|FG009|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
127564023|NCT04585009|459033702|FG010|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
127564024|NCT04585009|459033703|FG011|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|1|||
127564025|NCT00097981|459033712|FG000|Overall Study|Adverse Event|31|||
127564026|NCT00097981|459033713|FG001|Overall Study|Adverse Event|44|||
127564027|NCT00097981|459033712|FG000|Overall Study|Withdrawal by Subject|10|||
127564028|NCT00097981|459033713|FG001|Overall Study|Withdrawal by Subject|8|||
127564029|NCT00097981|459033712|FG000|Overall Study|Protocol Violation|1|||
127564030|NCT00097981|459033713|FG001|Overall Study|Protocol Violation|1|||
127564031|NCT00097981|459033712|FG000|Overall Study|Death|2|||
127564032|NCT00097981|459033713|FG001|Overall Study|Death|4|||
127564033|NCT00097981|459033712|FG000|Overall Study|Physician Decision|7|||
127564034|NCT00097981|459033713|FG001|Overall Study|Physician Decision|1|||
127564035|NCT00097981|459033712|FG000|Overall Study|Disease Progression|8|||
127564036|NCT00097981|459033713|FG001|Overall Study|Disease Progression|2|||
127564037|NCT00097981|459033712|FG000|Overall Study|Transplant planned|28|||
127564038|NCT00097981|459033713|FG001|Overall Study|Transplant planned|27|||
127564039|NCT00097981|459033712|FG000|Overall Study|Other|19|||
127564040|NCT00097981|459033713|FG001|Overall Study|Other|13|||
127564041|NCT00538785|459033714|FG000|Overall Study|Death|9|||
127564042|NCT00538785|459033715|FG001|Overall Study|Death|10|||
127564043|NCT00538785|459033714|FG000|Overall Study|Withdrawal of consent|9|||
127564044|NCT00538785|459033715|FG001|Overall Study|Withdrawal of consent|7|||
127564045|NCT00538785|459033714|FG000|Overall Study|Lost to Follow-up|1|||
127564046|NCT00538785|459033715|FG001|Overall Study|Lost to Follow-up|0|||
127564047|NCT01009840|459033716|FG000|Overall Study|Lost to Follow-up|1|||
127564048|NCT01009840|459033716|FG000|Overall Study|Adverse Event|4|||
127564049|NCT01009840|459033716|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
127564050|NCT01009840|459033716|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
127564051|NCT01009840|459033716|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
127564052|NCT01002820|459033719|FG000|Overall Study|Adverse Event|1|||
127564053|NCT01002820|459033719|FG000|Overall Study|Withdrawal by Subject|2|||
127688035|NCT02723955|459483535|FG022|Crossover/ Re-treatment Phase|Site Closed|0|||
127688036|NCT02723955|459483536|FG023|Crossover/ Re-treatment Phase|Site Closed|0|||
127688037|NCT02723955|459483537|FG024|Crossover/ Re-treatment Phase|Site Closed|0|||
127688038|NCT02723955|459483538|FG025|Crossover/ Re-treatment Phase|Site Closed|0|||
127688039|NCT02723955|459483539|FG026|Crossover/ Re-treatment Phase|Site Closed|0|||
127564054|NCT01002820|459033719|FG000|Overall Study|Lack of Efficacy|1|||
127564055|NCT01101308|459033724|FG000|Period 1|Adverse Event|2|||
127564056|NCT01101308|459033725|FG001|Period 1|Adverse Event|1|||
127564057|NCT01101308|459033724|FG000|Period 1|Positive for cotinine|1|||
127564058|NCT01101308|459033725|FG001|Period 1|Positive for cotinine|0|||
127564059|NCT00357760|459033731|FG000|Overall Study|Disease progression|44|||
127564060|NCT00357760|459033732|FG001|Overall Study|Disease progression|17|||
127564061|NCT00357760|459033731|FG000|Overall Study|Adverse Event|10|||
127564062|NCT00357760|459033732|FG001|Overall Study|Adverse Event|7|||
127564063|NCT00357760|459033731|FG000|Overall Study|Death|0|||
127564064|NCT00357760|459033732|FG001|Overall Study|Death|3|||
127564065|NCT00357760|459033731|FG000|Overall Study|Alternative therapy|1|||
127688040|NCT02723955|459483540|FG027|Crossover/ Re-treatment Phase|Site Closed|0|||
127688041|NCT02723955|459483541|FG028|Crossover/ Re-treatment Phase|Site Closed|0|||
127688042|NCT02723955|459483542|FG029|Crossover/ Re-treatment Phase|Site Closed|0|||
127564066|NCT00357760|459033732|FG001|Overall Study|Alternative therapy|0|||
127564067|NCT00357760|459033731|FG000|Overall Study|Withdrawal by Subject|0|||
127564068|NCT00357760|459033732|FG001|Overall Study|Withdrawal by Subject|2|||
127564069|NCT00357760|459033731|FG000|Overall Study|Never started treatment|2|||
127564070|NCT00357760|459033732|FG001|Overall Study|Never started treatment|1|||
127564071|NCT00357760|459033731|FG000|Overall Study|Ineligible|0|||
127564072|NCT00357760|459033732|FG001|Overall Study|Ineligible|2|||
127564073|NCT00357760|459033731|FG000|Overall Study|Physician Decision|2|||
127564074|NCT00357760|459033732|FG001|Overall Study|Physician Decision|1|||
127564075|NCT00357760|459033731|FG000|Overall Study|Protocol Violation|0|||
127564076|NCT00357760|459033732|FG001|Overall Study|Protocol Violation|1|||
127564077|NCT00357760|459033731|FG000|Overall Study|To receive hospice care|0|||
127564078|NCT00357760|459033732|FG001|Overall Study|To receive hospice care|1|||
127564079|NCT04136444|459033733|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
127564080|NCT04136444|459033734|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
127564081|NCT04905498|459033735|FG000|Overall Study|Lost to Follow-up|0|||
127564082|NCT04905498|459033736|FG001|Overall Study|Lost to Follow-up|2|||
127564083|NCT04905498|459033735|FG000|Overall Study|COVID lockdown|1|||
127564084|NCT04905498|459033736|FG001|Overall Study|COVID lockdown|0|||
127564085|NCT00869778|459033739|FG000|Overall Study|Adverse Event|2|||
127564086|NCT00869778|459033740|FG001|Overall Study|Adverse Event|0|||
127564087|NCT00869778|459033741|FG002|Overall Study|Adverse Event|0|||
127564088|NCT00869778|459033739|FG000|Overall Study|Withdrawal by Subject|3|||
127564089|NCT00869778|459033740|FG001|Overall Study|Withdrawal by Subject|4|||
127564090|NCT00869778|459033741|FG002|Overall Study|Withdrawal by Subject|5|||
127688043|NCT02723955|459483543|FG030|Crossover/ Re-treatment Phase|Site Closed|0|||
127688044|NCT02723955|459483544|FG031|Crossover/ Re-treatment Phase|Site Closed|0|||
127776197|NCT02383589|459808378|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
127776198|NCT02383589|459808377|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
127776199|NCT02383589|459808378|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
127776200|NCT02383589|459808377|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
128024724|NCT02596893|460715960|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
128024725|NCT02596893|460715961|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
128024726|NCT02596893|460715962|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
128024727|NCT02596893|460715963|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
128024728|NCT02596893|460715960|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
128024729|NCT02596893|460715961|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
128024730|NCT02596893|460715962|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
127564091|NCT00869778|459033739|FG000|Overall Study|Pregnancy|1|||
127564092|NCT00869778|459033740|FG001|Overall Study|Pregnancy|0|||
127564093|NCT00869778|459033741|FG002|Overall Study|Pregnancy|0|||
127564094|NCT00869778|459033739|FG000|Overall Study|Protocol Violation|5|||
127688045|NCT02723955|459483545|FG032|Crossover/ Re-treatment Phase|Site Closed|0|||
127688046|NCT02723955|459483546|FG033|Crossover/ Re-treatment Phase|Site Closed|0|||
127564095|NCT00869778|459033740|FG001|Overall Study|Protocol Violation|3|||
127564096|NCT00869778|459033741|FG002|Overall Study|Protocol Violation|5|||
127564097|NCT00869778|459033739|FG000|Overall Study|Unblinding|1|||
127564098|NCT00869778|459033740|FG001|Overall Study|Unblinding|0|||
127564099|NCT00869778|459033741|FG002|Overall Study|Unblinding|0|||
127564100|NCT03180619|459033742|FG000|Overall Study|Withdrew Consent|5|||
127564101|NCT03180619|459033743|FG001|Overall Study|Withdrew Consent|0|||
127564102|NCT03180619|459033744|FG002|Overall Study|Withdrew Consent|2|||
127564103|NCT03180619|459033742|FG000|Overall Study|Death|2|||
127564104|NCT03180619|459033743|FG001|Overall Study|Death|1|||
127564105|NCT03180619|459033744|FG002|Overall Study|Death|2|||
127564106|NCT03180619|459033742|FG000|Overall Study|Adverse Event|2|||
127564107|NCT03180619|459033743|FG001|Overall Study|Adverse Event|0|||
127564108|NCT03180619|459033744|FG002|Overall Study|Adverse Event|1|||
127564109|NCT03180619|459033742|FG000|Overall Study|Investigator's discretion|2|||
127564110|NCT03180619|459033743|FG001|Overall Study|Investigator's discretion|0|||
127564111|NCT03180619|459033744|FG002|Overall Study|Investigator's discretion|1|||
127564112|NCT03077087|459033747|FG000|Overall Study|Physician Decision|2|||
127564113|NCT02112045|459033753|FG000|Overall Study|Withdrawal by Subject|1|||
127564114|NCT02112045|459033754|FG001|Overall Study|Withdrawal by Subject|0|||
127564115|NCT00977080|459033756|FG000|Overall Study|Adverse Event|2|||
127564116|NCT00977080|459033757|FG001|Overall Study|Adverse Event|7|||
127564117|NCT00977080|459033758|FG002|Overall Study|Adverse Event|7|||
127564118|NCT00977080|459033759|FG003|Overall Study|Adverse Event|7|||
127564119|NCT00977080|459033756|FG000|Overall Study|Withdrawal by Subject|1|||
127564120|NCT00977080|459033757|FG001|Overall Study|Withdrawal by Subject|5|||
127564121|NCT00977080|459033758|FG002|Overall Study|Withdrawal by Subject|1|||
127564122|NCT00977080|459033759|FG003|Overall Study|Withdrawal by Subject|5|||
127564123|NCT00977080|459033756|FG000|Overall Study|Protocol Violation|7|||
127564124|NCT00977080|459033757|FG001|Overall Study|Protocol Violation|3|||
127564125|NCT00977080|459033758|FG002|Overall Study|Protocol Violation|4|||
127564126|NCT00977080|459033759|FG003|Overall Study|Protocol Violation|3|||
127564127|NCT00977080|459033756|FG000|Overall Study|Noncompliance|0|||
127564128|NCT00977080|459033757|FG001|Overall Study|Noncompliance|2|||
127564129|NCT00977080|459033758|FG002|Overall Study|Noncompliance|1|||
127564130|NCT00977080|459033759|FG003|Overall Study|Noncompliance|0|||
127564131|NCT00977080|459033756|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
127564132|NCT00977080|459033757|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
127564133|NCT00977080|459033758|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
127564134|NCT00977080|459033759|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
127564135|NCT00977080|459033756|FG000|Overall Study|Required kidney transplantation|1|||
127564136|NCT00977080|459033757|FG001|Overall Study|Required kidney transplantation|3|||
127564137|NCT00977080|459033758|FG002|Overall Study|Required kidney transplantation|3|||
127564138|NCT00977080|459033759|FG003|Overall Study|Required kidney transplantation|1|||
127564139|NCT00977080|459033756|FG000|Overall Study|Travel for family reasons|1|||
127564140|NCT00977080|459033757|FG001|Overall Study|Travel for family reasons|0|||
127564141|NCT00977080|459033758|FG002|Overall Study|Travel for family reasons|0|||
127564142|NCT00977080|459033759|FG003|Overall Study|Travel for family reasons|0|||
127564143|NCT00441116|459033762|FG000|Overall Study|Adverse Event|1|||
127564144|NCT00441116|459033763|FG001|Overall Study|Adverse Event|1|||
127564145|NCT00441116|459033762|FG000|Overall Study|Withdrawal by Subject|1|||
127564146|NCT00441116|459033763|FG001|Overall Study|Withdrawal by Subject|0|||
127564147|NCT00441116|459033762|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
127564148|NCT00441116|459033763|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
127564149|NCT01765218|459033775|FG000|Overall Study|Protocol Violation|1|||
127564150|NCT01765218|459033776|FG001|Overall Study|Protocol Violation|2|||
127564151|NCT00946985|459033777|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
127564152|NCT00946985|459033777|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
127564153|NCT00946985|459033777|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
127564154|NCT00946985|459033777|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
127564155|NCT00946985|459033777|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
127564156|NCT00946985|459033777|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
127564157|NCT00946985|459033777|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
127564158|NCT00946985|459033777|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
127564159|NCT00946985|459033777|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
127564160|NCT03148691|459033778|FG000|Overall Study|Protocol Violation|1|||
127564161|NCT03148691|459033779|FG001|Overall Study|Protocol Violation|2|||
127564162|NCT03148691|459033780|FG002|Overall Study|Protocol Violation|7|||
127564163|NCT03148691|459033778|FG000|Overall Study|Lost to Follow-up|0|||
127564164|NCT03148691|459033779|FG001|Overall Study|Lost to Follow-up|0|||
127564165|NCT03148691|459033780|FG002|Overall Study|Lost to Follow-up|1|||
127564166|NCT03148691|459033778|FG000|Overall Study|Other|1|||
127564167|NCT03148691|459033779|FG001|Overall Study|Other|0|||
127564168|NCT03148691|459033780|FG002|Overall Study|Other|0|||
127564169|NCT03148691|459033778|FG000|Overall Study|Withdrawal by Subject|1|||
127564170|NCT03148691|459033779|FG001|Overall Study|Withdrawal by Subject|0|||
127564171|NCT03148691|459033780|FG002|Overall Study|Withdrawal by Subject|0|||
127564172|NCT00171834|459033781|FG000|Overall Study|Adverse Event|2|||
127564173|NCT00171834|459033782|FG001|Overall Study|Adverse Event|1|||
127564174|NCT00171834|459033783|FG002|Overall Study|Adverse Event|3|||
127564175|NCT00171834|459033784|FG003|Overall Study|Adverse Event|2|||
127564176|NCT00171834|459033785|FG004|Overall Study|Adverse Event|2|||
127564177|NCT00171834|459033786|FG005|Overall Study|Adverse Event|15|||
127564178|NCT00171834|459033787|FG006|Overall Study|Adverse Event|1|||
127564179|NCT00171834|459033781|FG000|Overall Study|Withdrawal by Subject|0|||
127564180|NCT00171834|459033782|FG001|Overall Study|Withdrawal by Subject|2|||
127564181|NCT00171834|459033783|FG002|Overall Study|Withdrawal by Subject|0|||
127564182|NCT00171834|459033784|FG003|Overall Study|Withdrawal by Subject|1|||
127564183|NCT00171834|459033785|FG004|Overall Study|Withdrawal by Subject|1|||
127564184|NCT00171834|459033786|FG005|Overall Study|Withdrawal by Subject|1|||
127564185|NCT00171834|459033787|FG006|Overall Study|Withdrawal by Subject|0|||
127564186|NCT00171834|459033781|FG000|Overall Study|Death from study indication|0|||
127564187|NCT00171834|459033782|FG001|Overall Study|Death from study indication|1|||
127564188|NCT00171834|459033783|FG002|Overall Study|Death from study indication|0|||
127564189|NCT00171834|459033784|FG003|Overall Study|Death from study indication|0|||
127564190|NCT00171834|459033785|FG004|Overall Study|Death from study indication|1|||
127564191|NCT00171834|459033786|FG005|Overall Study|Death from study indication|0|||
127564192|NCT00171834|459033787|FG006|Overall Study|Death from study indication|0|||
127564193|NCT00171834|459033781|FG000|Overall Study|Disease Progression|4|||
127564194|NCT00171834|459033782|FG001|Overall Study|Disease Progression|8|||
127564195|NCT00171834|459033783|FG002|Overall Study|Disease Progression|8|||
127564196|NCT00171834|459033784|FG003|Overall Study|Disease Progression|9|||
127564197|NCT00171834|459033785|FG004|Overall Study|Disease Progression|2|||
127564198|NCT00171834|459033786|FG005|Overall Study|Disease Progression|18|||
127564199|NCT00171834|459033787|FG006|Overall Study|Disease Progression|3|||
127564200|NCT00171834|459033781|FG000|Overall Study|Treatment Duration Completed|0|||
127564201|NCT00171834|459033782|FG001|Overall Study|Treatment Duration Completed|0|||
127564202|NCT00171834|459033783|FG002|Overall Study|Treatment Duration Completed|1|||
127564203|NCT00171834|459033784|FG003|Overall Study|Treatment Duration Completed|0|||
127564204|NCT00171834|459033785|FG004|Overall Study|Treatment Duration Completed|2|||
127564205|NCT00171834|459033786|FG005|Overall Study|Treatment Duration Completed|1|||
127564206|NCT00171834|459033787|FG006|Overall Study|Treatment Duration Completed|0|||
127564207|NCT04345367|459033788|FG000|Overall Study|Other|3|||
127564208|NCT04345367|459033789|FG001|Overall Study|Other|4|||
127564209|NCT04345367|459033788|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
127564210|NCT04345367|459033789|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
127564211|NCT04345367|459033788|FG000|Overall Study|Withdrawal by Subject|11|||
127564212|NCT04345367|459033789|FG001|Overall Study|Withdrawal by Subject|11|||
127564213|NCT04345367|459033788|FG000|Overall Study|Protocol Violation|4|||
127564214|NCT04345367|459033789|FG001|Overall Study|Protocol Violation|3|||
127564215|NCT04345367|459033788|FG000|Overall Study|Lost to Follow-up|2|||
127564216|NCT04345367|459033789|FG001|Overall Study|Lost to Follow-up|4|||
127564217|NCT04345367|459033788|FG000|Overall Study|Lack of Efficacy|2|||
127564218|NCT04345367|459033789|FG001|Overall Study|Lack of Efficacy|0|||
127564219|NCT04345367|459033788|FG000|Overall Study|Death|2|||
127564220|NCT04345367|459033789|FG001|Overall Study|Death|0|||
127564221|NCT04345367|459033788|FG000|Overall Study|Adverse Event|10|||
127564222|NCT04345367|459033789|FG001|Overall Study|Adverse Event|9|||
127564223|NCT00796523|459033790|FG000|Overall Study|Lost to Follow-up|9|||
127564224|NCT00796523|459033791|FG001|Overall Study|Lost to Follow-up|7|||
127564225|NCT00781885|459033793|FG000|Overall Study|Physician Decision|1|||
127564226|NCT01755026|459033794|FG000|Overall Study|Adverse Event|1|||
127564227|NCT01755026|459033795|FG001|Overall Study|Adverse Event|0|||
127564228|NCT01755026|459033794|FG000|Overall Study|Withdrawal by Subject|1|||
127564229|NCT01755026|459033795|FG001|Overall Study|Withdrawal by Subject|1|||
127564230|NCT00392379|459033796|FG000|Overall Study|Withdrawal by Subject|17|||
127564231|NCT00392379|459033797|FG001|Overall Study|Withdrawal by Subject|28|||
127564232|NCT00392379|459033796|FG000|Overall Study|Lost to Follow-up|4|||
127564233|NCT00392379|459033797|FG001|Overall Study|Lost to Follow-up|9|||
127564234|NCT00392379|459033796|FG000|Overall Study|Adverse Event|1|||
127564235|NCT00392379|459033797|FG001|Overall Study|Adverse Event|1|||
127564236|NCT02365233|459033804|FG000|Overall Study|IRB withheld the data|1|||
127564237|NCT02365233|459033805|FG001|Overall Study|IRB withheld the data|2|||
127688047|NCT02723955|459483547|FG034|Crossover/ Re-treatment Phase|Site Closed|0|||
127688048|NCT02723955|459483548|FG035|Crossover/ Re-treatment Phase|Site Closed|0|||
127564238|NCT02365233|459033806|FG002|Overall Study|IRB withheld the data|2|||
127564239|NCT01978938|459033810|FG000|Overall Study|Lost to Follow-up|12|||
127564240|NCT01978938|459033811|FG001|Overall Study|Lost to Follow-up|6|||
127688049|NCT02723955|459483549|FG036|Crossover/ Re-treatment Phase|Site Closed|0|||
127688050|NCT02723955|459483550|FG037|Crossover/ Re-treatment Phase|Site Closed|0|||
127564241|NCT01978938|459033810|FG000|Overall Study|Withdrawal by Subject|8|||
127564242|NCT01978938|459033811|FG001|Overall Study|Withdrawal by Subject|4|||
127564243|NCT01978938|459033810|FG000|Overall Study|Adverse Event, non-fatal|2|||
127564244|NCT01978938|459033811|FG001|Overall Study|Adverse Event, non-fatal|1|||
127564245|NCT01978938|459033810|FG000|Overall Study|Participant noncompliance|1|||
127564246|NCT01978938|459033811|FG001|Overall Study|Participant noncompliance|1|||
127564247|NCT01978938|459033810|FG000|Overall Study|Did not meet inclusion criteria|0|||
127564248|NCT01978938|459033811|FG001|Overall Study|Did not meet inclusion criteria|1|||
127564249|NCT01978938|459033810|FG000|Overall Study|Previously scheduled procedure|0|||
127564250|NCT01978938|459033811|FG001|Overall Study|Previously scheduled procedure|1|||
127564251|NCT02342418|459033812|FG000|Overall Study|Adverse Event|0|||
127564252|NCT02342418|459033813|FG001|Overall Study|Adverse Event|1|||
127564253|NCT04255394|459033814|FG000|Overall Study|Death|35|||
127564254|NCT04255394|459033815|FG001|Overall Study|Death|25|||
127564255|NCT04255394|459033814|FG000|Overall Study|Device removed|2|||
127564256|NCT04255394|459033815|FG001|Overall Study|Device removed|10|||
127564257|NCT04255394|459033814|FG000|Overall Study|Withdrawal by Subject|9|||
127564258|NCT04255394|459033815|FG001|Overall Study|Withdrawal by Subject|8|||
127564259|NCT04255394|459033814|FG000|Overall Study|Screen Failure/Not treated|12|||
127564260|NCT04255394|459033815|FG001|Overall Study|Screen Failure/Not treated|8|||
127564261|NCT04255394|459033814|FG000|Overall Study|Lost to Follow-up|123|||
127564262|NCT04255394|459033815|FG001|Overall Study|Lost to Follow-up|265|||
127564263|NCT04255394|459033814|FG000|Overall Study|Adverse Event|1|||
127564264|NCT04255394|459033815|FG001|Overall Study|Adverse Event|3|||
127564265|NCT02285062|459033821|FG000|Pre-Treatment Period|Protocol Violation|0|||
127564266|NCT02285062|459033822|FG001|Pre-Treatment Period|Protocol Violation|2|||
127564267|NCT02285062|459033821|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
127564268|NCT02285062|459033822|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
127564269|NCT03041129|459033823|FG000|Overall Study|Withdrawal by Subject|2|||
127564270|NCT03041129|459033824|FG001|Overall Study|Withdrawal by Subject|0|||
127564271|NCT03041129|459033825|FG002|Overall Study|Withdrawal by Subject|0|||
127564272|NCT03041129|459033826|FG003|Overall Study|Withdrawal by Subject|0|||
127564273|NCT01947855|459033827|FG000|Overall Study|Withdrawal by Subject|1|||
127564274|NCT01947855|459033828|FG001|Overall Study|Withdrawal by Subject|0|||
127564275|NCT01947855|459033829|FG002|Overall Study|Withdrawal by Subject|0|||
127564276|NCT00821509|459033830|FG000|Overall Study|Withdrawal by Subject|12|||
127564277|NCT00821509|459033831|FG001|Overall Study|Withdrawal by Subject|11|||
127564278|NCT00821509|459033832|FG002|Overall Study|Withdrawal by Subject|34|||
127564279|NCT03104816|459033833|FG000|Overall Study|Lack of Efficacy|0|||
127564280|NCT03104816|459033834|FG001|Overall Study|Lack of Efficacy|2|||
127564281|NCT03104816|459033835|FG002|Overall Study|Lack of Efficacy|0|||
127564282|NCT03104816|459033833|FG000|Overall Study|Protocol Violation|2|||
127564283|NCT03104816|459033834|FG001|Overall Study|Protocol Violation|0|||
127564284|NCT03104816|459033835|FG002|Overall Study|Protocol Violation|2|||
127564285|NCT00534599|459033842|FG000|Overall Study|Adverse Event|25|||
127564286|NCT00534599|459033843|FG001|Overall Study|Adverse Event|4|||
127564287|NCT00534599|459033842|FG000|Overall Study|Incorrect enrollment|2|||
127564288|NCT00534599|459033843|FG001|Overall Study|Incorrect enrollment|1|||
127564289|NCT00534599|459033842|FG000|Overall Study|Mis-randomization|2|||
127564290|NCT00534599|459033843|FG001|Overall Study|Mis-randomization|2|||
127564291|NCT00534599|459033842|FG000|Overall Study|Developed study-specific d/c criteria|5|||
127564292|NCT00534599|459033843|FG001|Overall Study|Developed study-specific d/c criteria|0|||
127564293|NCT00534599|459033842|FG000|Overall Study|Lack of Efficacy|0|||
127564294|NCT00534599|459033843|FG001|Overall Study|Lack of Efficacy|1|||
127564295|NCT00534599|459033842|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
127564296|NCT00534599|459033843|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
127564297|NCT00534599|459033842|FG000|Overall Study|Protocol Violation|1|||
127564298|NCT00534599|459033843|FG001|Overall Study|Protocol Violation|3|||
127564299|NCT00534599|459033842|FG000|Overall Study|Lost to Follow-up|11|||
127564300|NCT00534599|459033843|FG001|Overall Study|Lost to Follow-up|14|||
127564301|NCT00534599|459033842|FG000|Overall Study|Withdrawal by Subject|4|||
127564302|NCT00534599|459033843|FG001|Overall Study|Withdrawal by Subject|6|||
127564303|NCT00534599|459033842|FG000|Overall Study|Other|7|||
127564304|NCT00534599|459033843|FG001|Overall Study|Other|0|||
127564305|NCT03645434|459033847|FG000|Period 1|Adverse Event|0|||
127564306|NCT03645434|459033848|FG001|Period 1|Adverse Event|0|||
127564307|NCT03645434|459033849|FG002|Period 1|Adverse Event|0|||
127564308|NCT03645434|459033850|FG003|Period 1|Adverse Event|1|||
127564309|NCT03645434|459033851|FG004|Period 1|Adverse Event|0|||
127564310|NCT03645434|459033852|FG005|Period 1|Adverse Event|0|||
127564311|NCT03645434|459033847|FG000|Period 1|COPD exacerbation|0|||
127564312|NCT03645434|459033848|FG001|Period 1|COPD exacerbation|0|||
127564313|NCT03645434|459033849|FG002|Period 1|COPD exacerbation|0|||
127564314|NCT03645434|459033850|FG003|Period 1|COPD exacerbation|0|||
127564315|NCT03645434|459033851|FG004|Period 1|COPD exacerbation|1|||
127564316|NCT03645434|459033852|FG005|Period 1|COPD exacerbation|0|||
127564317|NCT00336856|459035791|FG000|Overall Study|Withdrawal by Subject|3|||
127564318|NCT00336856|459035791|FG000|Overall Study|Found ineligible at time of analysis|1|||
127564319|NCT03338959|459035792|FG000|Overall Study|Patients remain in Long-Term Follow-Up|17|||
127564320|NCT03338959|459035792|FG000|Overall Study|Physician Decision|1|||
127564321|NCT00874939|459035794|FG000|Overall Study|Study terminated|4|||
127564322|NCT00003590|459035797|FG000|Overall Study|Ineligible Patient|1|||
127564323|NCT00003590|459035797|FG000|Overall Study|Adverse Event|7|||
127564324|NCT00003590|459035797|FG000|Overall Study|Withdrawal by Subject|1|||
127564325|NCT00003590|459035797|FG000|Overall Study|Lack of Efficacy|11|||
127564326|NCT00003590|459035797|FG000|Overall Study|Death|1|||
127564327|NCT00003590|459035797|FG000|Overall Study|Physician Decision|1|||
127564328|NCT00883688|459035798|FG000|Overall Study|Ineligible|2|||
127564329|NCT01328366|459035801|FG000|Overall Study|Death|1|||
127564330|NCT01328366|459035801|FG000|Overall Study|Withdrawal by Subject|2|||
127564331|NCT01328366|459035801|FG000|Overall Study|Lost to Follow-up|7|||
127564332|NCT01122264|459035805|FG000|Overall Study|Adverse Event|6|||
127564333|NCT01122264|459035806|FG001|Overall Study|Adverse Event|5|||
127564334|NCT01122264|459035807|FG002|Overall Study|Adverse Event|7|||
127688051|NCT02723955|459483551|FG038|Crossover/ Re-treatment Phase|Site Closed|4|||
127688052|NCT02723955|459483552|FG039|Crossover/ Re-treatment Phase|Site Closed|2|||
127688053|NCT02723955|459483553|FG040|Crossover/ Re-treatment Phase|Site Closed|0|||
127688054|NCT02723955|459483554|FG041|Crossover/ Re-treatment Phase|Site Closed|0|||
127688055|NCT02723955|459483555|FG042|Crossover/ Re-treatment Phase|Site Closed|0|||
127688056|NCT04999085|459483556|FG000|Overall Study|Death|1|||
127688057|NCT04907474|459483557|FG000|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|1|||
127688058|NCT04907474|459483558|FG001|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|0|||
127688059|NCT03873779|459483559|FG000|Overall Study|Withdrawal by Subject|1|||
127688060|NCT04279574|459483562|FG000|Overall Study|Death|1|||
127564335|NCT01122264|459035805|FG000|Overall Study|Death|1|||
127564336|NCT01122264|459035806|FG001|Overall Study|Death|0|||
127564337|NCT01122264|459035807|FG002|Overall Study|Death|0|||
127688061|NCT04279574|459483563|FG001|Overall Study|Death|0|||
127688062|NCT04279574|459483562|FG000|Overall Study|lost restoration, tooth fracture|1|||
127688063|NCT04279574|459483563|FG001|Overall Study|lost restoration, tooth fracture|0|||
127688064|NCT04279574|459483562|FG000|Overall Study|Lost to Follow-up|0|||
127564338|NCT01122264|459035805|FG000|Overall Study|Lost to Follow-up|5|||
127564339|NCT01122264|459035806|FG001|Overall Study|Lost to Follow-up|9|||
127564340|NCT01122264|459035807|FG002|Overall Study|Lost to Follow-up|13|||
127564341|NCT01122264|459035805|FG000|Overall Study|Entry Criteria Not Met|1|||
127564342|NCT01122264|459035806|FG001|Overall Study|Entry Criteria Not Met|0|||
127564343|NCT01122264|459035807|FG002|Overall Study|Entry Criteria Not Met|0|||
127564344|NCT01122264|459035805|FG000|Overall Study|Protocol Violation|7|||
127564345|NCT01122264|459035806|FG001|Overall Study|Protocol Violation|7|||
127564346|NCT01122264|459035807|FG002|Overall Study|Protocol Violation|9|||
127564347|NCT01122264|459035805|FG000|Overall Study|Withdrawal by Subject|6|||
127564348|NCT01122264|459035806|FG001|Overall Study|Withdrawal by Subject|6|||
127564349|NCT01122264|459035807|FG002|Overall Study|Withdrawal by Subject|16|||
127564350|NCT01122264|459035805|FG000|Overall Study|Physician Decision|3|||
127564351|NCT01122264|459035806|FG001|Overall Study|Physician Decision|1|||
127564352|NCT01122264|459035807|FG002|Overall Study|Physician Decision|1|||
127564353|NCT01122264|459035805|FG000|Overall Study|Lack of Efficacy|3|||
127564354|NCT01122264|459035806|FG001|Overall Study|Lack of Efficacy|1|||
127564355|NCT01122264|459035807|FG002|Overall Study|Lack of Efficacy|1|||
127564356|NCT00895011|459035811|FG000|Overall Study|Withdrawal by Subject|14|||
127688065|NCT04279574|459483563|FG001|Overall Study|Lost to Follow-up|1|||
127688066|NCT04188379|459483564|FG000|Overall Study|Withdrawal by Subject|10|||
127688067|NCT04188379|459483565|FG001|Overall Study|Withdrawal by Subject|3|||
127688068|NCT04188379|459483564|FG000|Overall Study|Physician Decision|0|||
127688069|NCT04188379|459483565|FG001|Overall Study|Physician Decision|1|||
127688070|NCT04188379|459483564|FG000|Overall Study|Adverse Event|3|||
127688071|NCT04188379|459483565|FG001|Overall Study|Adverse Event|1|||
127688072|NCT04188379|459483564|FG000|Overall Study|Pregnancy|1|||
127688073|NCT04188379|459483565|FG001|Overall Study|Pregnancy|0|||
127776201|NCT02383589|459808378|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
127776202|NCT00866697|459808379|FG000|Overall Study|Study closed/terminated|156|||
127776203|NCT00866697|459808380|FG001|Overall Study|Study closed/terminated|138|||
127776204|NCT00866697|459808379|FG000|Overall Study|Lost to Follow-up|22|||
127776205|NCT00866697|459808380|FG001|Overall Study|Lost to Follow-up|28|||
128024731|NCT02596893|460715963|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
128024732|NCT02596893|460715960|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
128024733|NCT02596893|460715961|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
128024734|NCT02596893|460715962|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
127564357|NCT00895011|459035812|FG001|Overall Study|Withdrawal by Subject|7|||
127564358|NCT00895011|459035813|FG002|Overall Study|Withdrawal by Subject|2|||
127564359|NCT00895011|459035811|FG000|Overall Study|Lost to Follow-up|5|||
127688074|NCT04188379|459483564|FG000|Overall Study|Lack of Efficacy|8|||
127688075|NCT04188379|459483565|FG001|Overall Study|Lack of Efficacy|5|||
127688076|NCT04188379|459483564|FG000|Overall Study|Other|0|||
128024735|NCT02596893|460715963|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
127564360|NCT00895011|459035812|FG001|Overall Study|Lost to Follow-up|4|||
127564361|NCT00895011|459035813|FG002|Overall Study|Lost to Follow-up|1|||
127564362|NCT00895011|459035811|FG000|Overall Study|Protocol Violation|3|||
127564363|NCT00895011|459035812|FG001|Overall Study|Protocol Violation|1|||
127564364|NCT00895011|459035813|FG002|Overall Study|Protocol Violation|3|||
127688077|NCT04188379|459483565|FG001|Overall Study|Other|3|||
127564365|NCT00895011|459035811|FG000|Overall Study|Adverse Event|1|||
127564366|NCT00895011|459035812|FG001|Overall Study|Adverse Event|2|||
127564367|NCT00895011|459035813|FG002|Overall Study|Adverse Event|2|||
127564368|NCT00895011|459035811|FG000|Overall Study|schedule conflict|1|||
127564369|NCT00895011|459035812|FG001|Overall Study|schedule conflict|0|||
127564370|NCT00895011|459035813|FG002|Overall Study|schedule conflict|0|||
127564371|NCT03085914|459035815|FG000|Overall Study|Death|6|||
127564372|NCT03085914|459035816|FG001|Overall Study|Death|6|||
127564373|NCT03085914|459035817|FG002|Overall Study|Death|4|||
127564374|NCT03085914|459035818|FG003|Overall Study|Death|1|||
127564375|NCT03085914|459035819|FG004|Overall Study|Death|5|||
127564376|NCT03085914|459035820|FG005|Overall Study|Death|2|||
127564377|NCT03085914|459035821|FG006|Overall Study|Death|2|||
127564378|NCT03085914|459035815|FG000|Overall Study|Withdrawal by Subject|1|||
127564379|NCT03085914|459035816|FG001|Overall Study|Withdrawal by Subject|1|||
127564380|NCT03085914|459035817|FG002|Overall Study|Withdrawal by Subject|2|||
127564381|NCT03085914|459035818|FG003|Overall Study|Withdrawal by Subject|2|||
127564382|NCT03085914|459035819|FG004|Overall Study|Withdrawal by Subject|2|||
127564383|NCT03085914|459035820|FG005|Overall Study|Withdrawal by Subject|0|||
127564384|NCT03085914|459035821|FG006|Overall Study|Withdrawal by Subject|1|||
127564385|NCT03085914|459035815|FG000|Overall Study|Lost to Follow-up|0|||
127564386|NCT03085914|459035816|FG001|Overall Study|Lost to Follow-up|0|||
127564387|NCT03085914|459035817|FG002|Overall Study|Lost to Follow-up|1|||
127564388|NCT03085914|459035818|FG003|Overall Study|Lost to Follow-up|0|||
127564389|NCT03085914|459035819|FG004|Overall Study|Lost to Follow-up|0|||
127564390|NCT03085914|459035820|FG005|Overall Study|Lost to Follow-up|1|||
127564391|NCT03085914|459035821|FG006|Overall Study|Lost to Follow-up|1|||
127564392|NCT03085914|459035815|FG000|Overall Study|Reason was not specified,|2|||
127564393|NCT03085914|459035816|FG001|Overall Study|Reason was not specified,|2|||
127564394|NCT03085914|459035817|FG002|Overall Study|Reason was not specified,|2|||
127564395|NCT03085914|459035818|FG003|Overall Study|Reason was not specified,|3|||
127564396|NCT03085914|459035819|FG004|Overall Study|Reason was not specified,|3|||
127564397|NCT03085914|459035820|FG005|Overall Study|Reason was not specified,|3|||
127564398|NCT03085914|459035821|FG006|Overall Study|Reason was not specified,|6|||
127564399|NCT03085914|459035815|FG000|Overall Study|Progressive Disease|0|||
127564400|NCT03085914|459035816|FG001|Overall Study|Progressive Disease|0|||
127564401|NCT03085914|459035817|FG002|Overall Study|Progressive Disease|2|||
127564402|NCT03085914|459035818|FG003|Overall Study|Progressive Disease|2|||
127564403|NCT03085914|459035819|FG004|Overall Study|Progressive Disease|1|||
127564404|NCT03085914|459035820|FG005|Overall Study|Progressive Disease|1|||
127564405|NCT03085914|459035821|FG006|Overall Study|Progressive Disease|1|||
127564406|NCT03085914|459035815|FG000|Overall Study|Study Terminated by the Sponsor|0|||
127564407|NCT03085914|459035816|FG001|Overall Study|Study Terminated by the Sponsor|0|||
127564408|NCT03085914|459035817|FG002|Overall Study|Study Terminated by the Sponsor|0|||
127564409|NCT03085914|459035818|FG003|Overall Study|Study Terminated by the Sponsor|1|||
127564410|NCT03085914|459035819|FG004|Overall Study|Study Terminated by the Sponsor|2|||
127564411|NCT03085914|459035820|FG005|Overall Study|Study Terminated by the Sponsor|1|||
127564412|NCT03085914|459035821|FG006|Overall Study|Study Terminated by the Sponsor|0|||
127564413|NCT01252667|459035823|FG000|Overall Study|Transplant aborted post-conditioning|0|||
127564414|NCT01252667|459035824|FG001|Overall Study|Transplant aborted post-conditioning|0|||
127564415|NCT01252667|459035825|FG002|Overall Study|Transplant aborted post-conditioning|0|||
127564416|NCT01252667|459035826|FG003|Overall Study|Transplant aborted post-conditioning|0|||
127564417|NCT01252667|459035827|FG004|Overall Study|Transplant aborted post-conditioning|0|||
127564418|NCT01252667|459035828|FG005|Overall Study|Transplant aborted post-conditioning|1|||
127564419|NCT04644315|459035829|FG000|Overall Study|Subject withdrawal of consent|1|||
127564420|NCT00331552|459035830|FG000|Period 3: Phase II|Neurological Symptoms|1|||
127564421|NCT00331552|459035831|FG001|Period 3: Phase II|Neurological Symptoms|0|||
127564422|NCT00331552|459035830|FG000|Period 3: Phase II|Severe Nausea|1|||
127564423|NCT00331552|459035831|FG001|Period 3: Phase II|Severe Nausea|0|||
127564424|NCT01445548|459035832|FG000|Overall Study|Adverse Event|1|||
127688078|NCT02566902|459483567|FG000|Overall Study|Protocol Violation|2|||
127688079|NCT02566902|459483568|FG001|Overall Study|Protocol Violation|1|||
127688080|NCT02411084|459483569|FG000|Overall Study|Lack of Efficacy|6|||
127688081|NCT02411084|459483570|FG001|Overall Study|Lack of Efficacy|3|||
127688082|NCT02411084|459483569|FG000|Overall Study|Death|5|||
127688083|NCT02411084|459483570|FG001|Overall Study|Death|4|||
127688084|NCT02411084|459483569|FG000|Overall Study|Adverse Event|2|||
127564425|NCT03642132|459035835|FG000|Chemotherapy Period|Adverse Event|1|||
127564426|NCT03642132|459035836|FG001|Chemotherapy Period|Adverse Event|1|||
127564427|NCT03642132|459035837|FG002|Chemotherapy Period|Adverse Event|0|||
127564428|NCT03642132|459035835|FG000|Chemotherapy Period|Physician's decision|4|||
127564429|NCT03642132|459035836|FG001|Chemotherapy Period|Physician's decision|1|||
127688085|NCT02411084|459483570|FG001|Overall Study|Adverse Event|1|||
127688086|NCT02411084|459483569|FG000|Overall Study|Other reasons|0|||
127564430|NCT03642132|459035837|FG002|Chemotherapy Period|Physician's decision|0|||
127564431|NCT03642132|459035835|FG000|Chemotherapy Period|Progressive disease|0|||
127564432|NCT03642132|459035836|FG001|Chemotherapy Period|Progressive disease|0|||
127564433|NCT03642132|459035837|FG002|Chemotherapy Period|Progressive disease|1|||
127564434|NCT03642132|459035835|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
127564435|NCT03642132|459035836|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
127564436|NCT03642132|459035837|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
127564437|NCT03642132|459035835|FG000|Chemotherapy Period|Other|1|||
127564438|NCT03642132|459035836|FG001|Chemotherapy Period|Other|0|||
127564439|NCT03642132|459035837|FG002|Chemotherapy Period|Other|2|||
127564440|NCT03642132|459035835|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
127564441|NCT03642132|459035836|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
127564442|NCT03642132|459035837|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
127564443|NCT03642132|459035835|FG000|Maintenance Period|Adverse Event|1|||
127564444|NCT03642132|459035836|FG001|Maintenance Period|Adverse Event|2|||
127564445|NCT03642132|459035837|FG002|Maintenance Period|Adverse Event|0|||
127564446|NCT03642132|459035835|FG000|Maintenance Period|Non-compliance with study drug|0|||
127564447|NCT03642132|459035836|FG001|Maintenance Period|Non-compliance with study drug|0|||
127564448|NCT03642132|459035837|FG002|Maintenance Period|Non-compliance with study drug|1|||
127564449|NCT03642132|459035835|FG000|Maintenance Period|Physician's decision|2|||
127564450|NCT03642132|459035836|FG001|Maintenance Period|Physician's decision|2|||
127564451|NCT03642132|459035837|FG002|Maintenance Period|Physician's decision|2|||
127564452|NCT03642132|459035835|FG000|Maintenance Period|Progressive disease|9|||
127564453|NCT03642132|459035836|FG001|Maintenance Period|Progressive disease|3|||
127564454|NCT03642132|459035837|FG002|Maintenance Period|Progressive disease|6|||
127564455|NCT03642132|459035835|FG000|Maintenance Period|Other|0|||
127564456|NCT03642132|459035836|FG001|Maintenance Period|Other|0|||
127564457|NCT03642132|459035837|FG002|Maintenance Period|Other|3|||
127564458|NCT03642132|459035835|FG000|Maintenance Period|Withdrawal by Subject|1|||
127564459|NCT03642132|459035836|FG001|Maintenance Period|Withdrawal by Subject|1|||
127564460|NCT03642132|459035837|FG002|Maintenance Period|Withdrawal by Subject|2|||
127564461|NCT03642132|459035835|FG000|Follow-up Period|Other|0|||
127564462|NCT03642132|459035836|FG001|Follow-up Period|Other|0|||
127564463|NCT03642132|459035837|FG002|Follow-up Period|Other|1|||
127564464|NCT03642132|459035835|FG000|Follow-up Period|Withdrawal by Subject|1|||
127564465|NCT03642132|459035836|FG001|Follow-up Period|Withdrawal by Subject|2|||
127564466|NCT03642132|459035837|FG002|Follow-up Period|Withdrawal by Subject|0|||
127564467|NCT03642132|459035835|FG000|Follow-up Period|Study terminated by sponsor|1|||
127564468|NCT03642132|459035836|FG001|Follow-up Period|Study terminated by sponsor|0|||
127564469|NCT03642132|459035837|FG002|Follow-up Period|Study terminated by sponsor|1|||
127564470|NCT03642132|459035835|FG000|Follow-up Period|Lack of Efficacy|1|||
127564471|NCT03642132|459035836|FG001|Follow-up Period|Lack of Efficacy|0|||
127564472|NCT03642132|459035837|FG002|Follow-up Period|Lack of Efficacy|0|||
127688087|NCT02411084|459483570|FG001|Overall Study|Other reasons|5|||
127688088|NCT05773313|459483573|FG000|Overall Study|Lost to Follow-up|3|||
127688089|NCT02748317|459483574|FG000|Overall Study|Withdrawal by Subject|14|||
127688090|NCT02748317|459483574|FG000|Overall Study|Lost to Follow-up|8|||
127688091|NCT02748317|459483574|FG000|Overall Study|Death|1|||
127688092|NCT00332241|459483575|FG000|Overall Study|Lack of Efficacy|6|||
127688093|NCT00332241|459483576|FG001|Overall Study|Lack of Efficacy|1|||
127688094|NCT00332241|459483575|FG000|Overall Study|Adverse Event|3|||
127688095|NCT00332241|459483576|FG001|Overall Study|Adverse Event|5|||
127688096|NCT00332241|459483575|FG000|Overall Study|Withdrawal by Subject|2|||
127688097|NCT00332241|459483576|FG001|Overall Study|Withdrawal by Subject|1|||
127688098|NCT00332241|459483575|FG000|Overall Study|Lost to Follow-up|4|||
127688099|NCT00332241|459483576|FG001|Overall Study|Lost to Follow-up|1|||
127688100|NCT00802464|459483577|FG000|Month 0 - Month 8|Adverse Event|0|||
127688101|NCT00802464|459483578|FG001|Month 0 - Month 8|Adverse Event|1|||
127688102|NCT00802464|459483579|FG002|Month 0 - Month 8|Adverse Event|1|||
127688103|NCT00802464|459483580|FG003|Month 0 - Month 8|Adverse Event|2|||
127688104|NCT00802464|459483577|FG000|Month 0 - Month 8|Protocol Violation|0|||
127688105|NCT00802464|459483578|FG001|Month 0 - Month 8|Protocol Violation|0|||
127688106|NCT00802464|459483579|FG002|Month 0 - Month 8|Protocol Violation|1|||
127688107|NCT00802464|459483580|FG003|Month 0 - Month 8|Protocol Violation|0|||
127688108|NCT00802464|459483577|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
127688109|NCT00802464|459483578|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
127688110|NCT00802464|459483579|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
127688111|NCT00802464|459483580|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
127688112|NCT00802464|459483577|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
127688113|NCT00802464|459483578|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
127564473|NCT03642132|459035835|FG000|Follow-up Period|Death|1|||
127564474|NCT03642132|459035836|FG001|Follow-up Period|Death|0|||
127564475|NCT03642132|459035837|FG002|Follow-up Period|Death|2|||
127564476|NCT03642132|459035835|FG000|Follow-up Period|Adverse Event|1|||
127564477|NCT03642132|459035836|FG001|Follow-up Period|Adverse Event|0|||
127564478|NCT03642132|459035837|FG002|Follow-up Period|Adverse Event|0|||
127688114|NCT00802464|459483579|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
127688115|NCT00802464|459483580|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
127688116|NCT00802464|459483577|FG000|Month 0 - Month 8|Other|0|||
127688117|NCT00802464|459483578|FG001|Month 0 - Month 8|Other|0|||
127688118|NCT00802464|459483579|FG002|Month 0 - Month 8|Other|1|||
127688119|NCT00802464|459483580|FG003|Month 0 - Month 8|Other|0|||
127688120|NCT00802464|459483577|FG000|Month 8 - Month 14|Adverse Event|0|||
127564479|NCT02577887|459035838|FG000|Overall Study|Death|93|||
127564480|NCT02577887|459035838|FG000|Overall Study|Protocol Violation|125|||
127564481|NCT02577887|459035838|FG000|Overall Study|Withdrawal by Subject|80|||
127564482|NCT03560518|459035839|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
127564483|NCT03560518|459035840|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
127564484|NCT03560518|459035841|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
127776206|NCT00866697|459808379|FG000|Overall Study|Physician Decision|3|||
127564485|NCT03560518|459035839|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
127564486|NCT03560518|459035840|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
127776207|NCT00866697|459808380|FG001|Overall Study|Physician Decision|5|||
127776208|NCT00866697|459808379|FG000|Overall Study|Withdrawal by Subject|33|||
127776209|NCT00866697|459808380|FG001|Overall Study|Withdrawal by Subject|57|||
127776210|NCT02906787|459808381|FG000|Overall Study|Withdrawal by Subject|12|||
127776211|NCT02906787|459808382|FG001|Overall Study|Withdrawal by Subject|10|||
127776212|NCT02906787|459808381|FG000|Overall Study|Missed|24|||
127776213|NCT02906787|459808382|FG001|Overall Study|Missed|22|||
127776214|NCT04376060|459808383|FG000|Overall Study|Physician Decision|1|||
127776215|NCT02818920|459808384|FG000|Overall Study|Unresectable|4|||
127776216|NCT02818920|459808384|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
127776217|NCT02818920|459808384|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
127776218|NCT02818920|459808384|FG000|Overall Study|Adverse Event|3|||
127776219|NCT02818920|459808384|FG000|Overall Study|Developed Other Disease|1|||
127776220|NCT02818920|459808384|FG000|Overall Study|Refused Further Treatment|1|||
127776221|NCT04275297|459808385|FG000|Overall Study|Lost to Follow-up|1|||
127776222|NCT04275297|459808386|FG001|Overall Study|Lost to Follow-up|1|||
127776223|NCT02673619|459808387|FG000|Overall Study|Lost to Follow-up|1|||
127776224|NCT02673619|459808388|FG001|Overall Study|Lost to Follow-up|0|||
127776225|NCT02673619|459808389|FG002|Overall Study|Lost to Follow-up|0|||
127776226|NCT02673619|459808390|FG003|Overall Study|Lost to Follow-up|0|||
127776227|NCT02673619|459808387|FG000|Overall Study|Withdrawal by Subject|1|||
127776228|NCT02673619|459808388|FG001|Overall Study|Withdrawal by Subject|1|||
127776229|NCT02673619|459808389|FG002|Overall Study|Withdrawal by Subject|1|||
127776230|NCT02673619|459808390|FG003|Overall Study|Withdrawal by Subject|0|||
127776231|NCT02673619|459808387|FG000|Overall Study|Adverse Event|0|||
127776232|NCT02673619|459808388|FG001|Overall Study|Adverse Event|0|||
127776233|NCT02673619|459808389|FG002|Overall Study|Adverse Event|1|||
127776234|NCT02673619|459808390|FG003|Overall Study|Adverse Event|0|||
127776235|NCT02673619|459808387|FG000|Overall Study|Lack of Efficacy|0|||
127776236|NCT02673619|459808388|FG001|Overall Study|Lack of Efficacy|0|||
127776237|NCT02673619|459808389|FG002|Overall Study|Lack of Efficacy|1|||
127776238|NCT02673619|459808390|FG003|Overall Study|Lack of Efficacy|0|||
127776239|NCT04225806|459808393|FG000|Overall Study|Trial termination|15|||
127776240|NCT05460273|459808396|FG000|Overall Study|Death|43|||
127776241|NCT05460273|459808397|FG001|Overall Study|Death|9|||
127776242|NCT05460273|459808396|FG000|Overall Study|Lost to Follow-up|7|||
127776243|NCT05460273|459808397|FG001|Overall Study|Lost to Follow-up|0|||
127776244|NCT05460273|459808396|FG000|Overall Study|Ongoing participants at NSCLC primary analysis DCO|0|||
127776245|NCT05460273|459808397|FG001|Overall Study|Ongoing participants at NSCLC primary analysis DCO|31|||
127776246|NCT03756350|459809558|FG000|Overall Study|Lost to Follow-up|1|||
127776247|NCT01096342|459809561|FG000|Overall Study|Protocol Violation|1|||
127776248|NCT04906616|459809562|FG000|Overall Study|Divorce|3|||
127776249|NCT04906616|459809563|FG001|Overall Study|Divorce|2|||
127776250|NCT02464228|459809564|FG000|Overall Study|Termination for Symptomatic Deterioration|1|||
127776251|NCT02464228|459809565|FG001|Overall Study|Termination for Symptomatic Deterioration|1|||
127776252|NCT02464228|459809566|FG002|Overall Study|Termination for Symptomatic Deterioration|0|||
127776253|NCT02464228|459809567|FG003|Overall Study|Termination for Symptomatic Deterioration|0|||
127776254|NCT02464228|459809564|FG000|Overall Study|Physician Decision|2|||
127564487|NCT03560518|459035841|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
127564488|NCT03560518|459035839|FG000|Double Blind Treatment Period|Protocol Violation|1|||
127564489|NCT03560518|459035840|FG001|Double Blind Treatment Period|Protocol Violation|2|||
127564490|NCT03560518|459035841|FG002|Double Blind Treatment Period|Protocol Violation|0|||
127776255|NCT02464228|459809565|FG001|Overall Study|Physician Decision|0|||
127776256|NCT02464228|459809566|FG002|Overall Study|Physician Decision|1|||
127776257|NCT02464228|459809567|FG003|Overall Study|Physician Decision|0|||
127776258|NCT02464228|459809564|FG000|Overall Study|Miscellaneous|1|||
127776259|NCT02464228|459809565|FG001|Overall Study|Miscellaneous|0|||
127776260|NCT02464228|459809566|FG002|Overall Study|Miscellaneous|1|||
127776261|NCT02464228|459809567|FG003|Overall Study|Miscellaneous|0|||
127776262|NCT02464228|459809564|FG000|Overall Study|Adverse Event|9|||
127776263|NCT02464228|459809565|FG001|Overall Study|Adverse Event|0|||
127776264|NCT02464228|459809566|FG002|Overall Study|Adverse Event|3|||
127776265|NCT02464228|459809567|FG003|Overall Study|Adverse Event|0|||
127776266|NCT02464228|459809564|FG000|Overall Study|Withdrawal by Subject|1|||
127776267|NCT02464228|459809565|FG001|Overall Study|Withdrawal by Subject|1|||
127776268|NCT02464228|459809566|FG002|Overall Study|Withdrawal by Subject|1|||
127776269|NCT02464228|459809567|FG003|Overall Study|Withdrawal by Subject|0|||
127564491|NCT03560518|459035839|FG000|Double Blind Treatment Period|Pregnancy|0|||
127564492|NCT03560518|459035840|FG001|Double Blind Treatment Period|Pregnancy|2|||
127564493|NCT03560518|459035841|FG002|Double Blind Treatment Period|Pregnancy|0|||
127564494|NCT03560518|459035839|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
127564495|NCT03560518|459035840|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
127564496|NCT03560518|459035841|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
127564497|NCT03560518|459035839|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
127564498|NCT03560518|459035840|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
127564499|NCT03560518|459035841|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
127564500|NCT03560518|459035839|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
127564501|NCT03560518|459035840|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
127564502|NCT03560518|459035841|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
127688121|NCT00802464|459483578|FG001|Month 8 - Month 14|Adverse Event|1|||
127688122|NCT00802464|459483579|FG002|Month 8 - Month 14|Adverse Event|0|||
127688123|NCT00802464|459483580|FG003|Month 8 - Month 14|Adverse Event|0|||
127688124|NCT00802464|459483577|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
127688125|NCT00802464|459483578|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
127688126|NCT00802464|459483579|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
127688127|NCT00802464|459483580|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
127564503|NCT03560518|459035839|FG000|Double Blind Treatment Period|Adverse Event|0|||
127564504|NCT03560518|459035840|FG001|Double Blind Treatment Period|Adverse Event|3|||
127564505|NCT03560518|459035841|FG002|Double Blind Treatment Period|Adverse Event|1|||
127564506|NCT02122783|459035847|FG000|Overall Study|Adverse Event|0|||
127564507|NCT02122783|459035848|FG001|Overall Study|Adverse Event|1|||
127564508|NCT01579812|459035850|FG000|Overall Study|Ineligible after treatment start|40|||
127564509|NCT01579812|459035850|FG000|Overall Study|Patient choice|3|||
127564510|NCT01579812|459035850|FG000|Overall Study|Noncompliance|3|||
127564511|NCT01579812|459035850|FG000|Overall Study|Withdrawal by Subject|6|||
127688128|NCT00802464|459483577|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
127688129|NCT00802464|459483578|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
127688130|NCT00802464|459483579|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
127688131|NCT00802464|459483580|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
127688132|NCT00402246|459483581|FG000|Overall Study|Death|62|||
127688133|NCT00402246|459483582|FG001|Overall Study|Death|58|||
127688134|NCT00402246|459483581|FG000|Overall Study|Lost to Follow-up|20|||
127688135|NCT00402246|459483582|FG001|Overall Study|Lost to Follow-up|28|||
127688136|NCT00402246|459483581|FG000|Overall Study|Withdrawal by Subject|72|||
127688137|NCT00402246|459483582|FG001|Overall Study|Withdrawal by Subject|87|||
127688138|NCT00402246|459483581|FG000|Overall Study|Physician Decision|24|||
127688139|NCT00402246|459483582|FG001|Overall Study|Physician Decision|26|||
127688140|NCT00402246|459483581|FG000|Overall Study|Protocol Violation|25|||
127688141|NCT00402246|459483582|FG001|Overall Study|Protocol Violation|24|||
127688142|NCT00402246|459483581|FG000|Overall Study|Missed Final Visit|1|||
127688143|NCT00402246|459483582|FG001|Overall Study|Missed Final Visit|2|||
127688144|NCT00402246|459483581|FG000|Overall Study|Insurance Issues|2|||
127688145|NCT00402246|459483582|FG001|Overall Study|Insurance Issues|1|||
127688146|NCT00402246|459483581|FG000|Overall Study|Heart Transplant|0|||
127688147|NCT00402246|459483582|FG001|Overall Study|Heart Transplant|1|||
127688148|NCT00402246|459483581|FG000|Overall Study|Patient's device explanted|6|||
127688149|NCT00402246|459483582|FG001|Overall Study|Patient's device explanted|2|||
127688150|NCT00402246|459483581|FG000|Overall Study|Center Closure|5|||
127688151|NCT00402246|459483582|FG001|Overall Study|Center Closure|3|||
127688152|NCT00402246|459483581|FG000|Overall Study|Deterioriating Condition|3|||
127688153|NCT00402246|459483582|FG001|Overall Study|Deterioriating Condition|2|||
127688154|NCT04425863|459483583|FG000|Overall Study|Death|0|||
127776270|NCT02464228|459809564|FG000|Overall Study|Disease Progression|22|||
127776271|NCT02464228|459809565|FG001|Overall Study|Disease Progression|12|||
127776272|NCT02464228|459809566|FG002|Overall Study|Disease Progression|5|||
127776273|NCT02464228|459809567|FG003|Overall Study|Disease Progression|2|||
127776274|NCT03308942|459809570|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
127776275|NCT03308942|459809571|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
127776276|NCT03308942|459809572|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
127881032|NCT02575807|460186107|FG003|Overall Study|Study terminated by Sponsor|0|||
127688155|NCT04425863|459483584|FG001|Overall Study|Death|0|||
127688156|NCT04425863|459483585|FG002|Overall Study|Death|1|||
127688157|NCT02597920|459483586|FG000|Overall Study|Worsening of other pre-existing disease|0|||
127688158|NCT02597920|459483587|FG001|Overall Study|Worsening of other pre-existing disease|1|||
127688159|NCT02597920|459483588|FG002|Overall Study|Worsening of other pre-existing disease|0|||
127688160|NCT02597920|459483586|FG000|Overall Study|Other adverse event|20|||
127688161|NCT02597920|459483587|FG001|Overall Study|Other adverse event|30|||
127688162|NCT02597920|459483588|FG002|Overall Study|Other adverse event|0|||
127688163|NCT02597920|459483586|FG000|Overall Study|Lost to Follow-up|7|||
127564512|NCT01133990|459035852|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
127564513|NCT01133990|459035853|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
127564514|NCT01133990|459035854|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
127881033|NCT02575807|460186108|FG004|Overall Study|Study terminated by Sponsor|1|||
128024736|NCT00004228|460715966|FG000|Overall Study|Adverse Event|0|||
128024737|NCT00004228|460715967|FG001|Overall Study|Adverse Event|1|||
128024738|NCT00004228|460715968|FG002|Overall Study|Adverse Event|0|||
128024739|NCT00004228|460715969|FG003|Overall Study|Adverse Event|0|||
128024740|NCT00004228|460715970|FG004|Overall Study|Adverse Event|1|||
127564515|NCT01133990|459035855|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
127564516|NCT01133990|459035856|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
127564517|NCT01133990|459035857|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
127564518|NCT01133990|459035852|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
127564519|NCT01133990|459035853|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
127564520|NCT01133990|459035854|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
127564521|NCT01133990|459035855|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
127564522|NCT01133990|459035856|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
127564523|NCT01133990|459035857|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
127564524|NCT01133990|459035852|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
127564525|NCT01133990|459035853|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
127564526|NCT01133990|459035854|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
127564527|NCT01133990|459035855|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
127564528|NCT01133990|459035856|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
127564529|NCT01133990|459035857|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
127564530|NCT01133990|459035852|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
127564531|NCT01133990|459035853|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
127564532|NCT01133990|459035854|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
127564533|NCT01133990|459035855|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
127564534|NCT01133990|459035856|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
127564535|NCT01133990|459035857|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
127564536|NCT05277337|459035858|FG000|Overall Study|Lost to Follow-up|2|||
127564537|NCT05277337|459035859|FG001|Overall Study|Lost to Follow-up|0|||
127564538|NCT05277337|459035858|FG000|Overall Study|Withdrawal by Subject|1|||
127564539|NCT05277337|459035859|FG001|Overall Study|Withdrawal by Subject|0|||
127564540|NCT02282345|459035861|FG000|Overall Study|Progression|0|||
127564541|NCT02282345|459035862|FG001|Overall Study|Progression|1|||
127564542|NCT01185301|459035863|FG000|Overall Study|Adverse Event|3|||
127564543|NCT01185301|459035864|FG001|Overall Study|Adverse Event|0|||
127564544|NCT01185301|459035865|FG002|Overall Study|Adverse Event|2|||
127564545|NCT01185301|459035866|FG003|Overall Study|Adverse Event|3|||
127564546|NCT01185301|459035863|FG000|Overall Study|Withdrawal by Subject|7|||
127564547|NCT01185301|459035864|FG001|Overall Study|Withdrawal by Subject|5|||
127564548|NCT01185301|459035865|FG002|Overall Study|Withdrawal by Subject|2|||
127564549|NCT01185301|459035866|FG003|Overall Study|Withdrawal by Subject|3|||
127564550|NCT01185301|459035863|FG000|Overall Study|Lost to Follow-up|2|||
127564551|NCT01185301|459035864|FG001|Overall Study|Lost to Follow-up|0|||
127564552|NCT01185301|459035865|FG002|Overall Study|Lost to Follow-up|0|||
127564553|NCT01185301|459035866|FG003|Overall Study|Lost to Follow-up|1|||
127564554|NCT01185301|459035863|FG000|Overall Study|Other Reason|3|||
127564555|NCT01185301|459035864|FG001|Overall Study|Other Reason|2|||
127564556|NCT01185301|459035865|FG002|Overall Study|Other Reason|2|||
127564557|NCT01185301|459035866|FG003|Overall Study|Other Reason|2|||
127564558|NCT02683746|459035867|FG000|Overall Study|Adverse Event|3|||
127564559|NCT02683746|459035868|FG001|Overall Study|Adverse Event|2|||
127564560|NCT02683746|459035867|FG000|Overall Study|Lost to Follow-up|5|||
127564561|NCT02683746|459035868|FG001|Overall Study|Lost to Follow-up|6|||
127564562|NCT02683746|459035867|FG000|Overall Study|Withdrawal by Subject|6|||
127564563|NCT02683746|459035868|FG001|Overall Study|Withdrawal by Subject|5|||
127564564|NCT02683746|459035867|FG000|Overall Study|Physician Decision|2|||
127564565|NCT02683746|459035868|FG001|Overall Study|Physician Decision|1|||
127564566|NCT04987944|459035869|FG000|Overall Study|Adverse Event|0|||
127564567|NCT04987944|459035870|FG001|Overall Study|Adverse Event|1|||
127564568|NCT04987944|459035869|FG000|Overall Study|Withdrawal by Subject|0|||
127688164|NCT02597920|459483587|FG001|Overall Study|Lost to Follow-up|9|||
127688165|NCT02597920|459483588|FG002|Overall Study|Lost to Follow-up|0|||
127688166|NCT02597920|459483586|FG000|Overall Study|Refuse to continue in the study|3|||
127688167|NCT02597920|459483587|FG001|Overall Study|Refuse to continue in the study|13|||
127688168|NCT02597920|459483588|FG002|Overall Study|Refuse to continue in the study|1|||
127688169|NCT02597920|459483586|FG000|Overall Study|Other than specified|10|||
128024741|NCT00004228|460715971|FG005|Overall Study|Adverse Event|0|||
128024742|NCT00004228|460715972|FG006|Overall Study|Adverse Event|0|||
127564569|NCT04987944|459035870|FG001|Overall Study|Withdrawal by Subject|1|||
127564570|NCT02353143|459035873|FG000|Overall Study|Withdrawal by Subject|1|||
127564571|NCT02353143|459035874|FG001|Overall Study|Withdrawal by Subject|0|||
127564572|NCT02353143|459035875|FG002|Overall Study|Withdrawal by Subject|0|||
127564573|NCT02353143|459035876|FG003|Overall Study|Withdrawal by Subject|0|||
127564574|NCT02353143|459035877|FG004|Overall Study|Withdrawal by Subject|1|||
127564575|NCT02353143|459035878|FG005|Overall Study|Withdrawal by Subject|0|||
127688170|NCT02597920|459483587|FG001|Overall Study|Other than specified|31|||
127564576|NCT02353143|459035879|FG006|Overall Study|Withdrawal by Subject|0|||
127564577|NCT02353143|459035880|FG007|Overall Study|Withdrawal by Subject|1|||
127564578|NCT02353143|459035881|FG008|Overall Study|Withdrawal by Subject|1|||
127564579|NCT02353143|459035873|FG000|Overall Study|Lack of Efficacy|2|||
127564580|NCT02353143|459035874|FG001|Overall Study|Lack of Efficacy|1|||
127564581|NCT02353143|459035875|FG002|Overall Study|Lack of Efficacy|2|||
127564582|NCT02353143|459035876|FG003|Overall Study|Lack of Efficacy|4|||
127564583|NCT02353143|459035877|FG004|Overall Study|Lack of Efficacy|13|||
127564584|NCT02353143|459035878|FG005|Overall Study|Lack of Efficacy|2|||
127564585|NCT02353143|459035879|FG006|Overall Study|Lack of Efficacy|2|||
127564586|NCT02353143|459035880|FG007|Overall Study|Lack of Efficacy|2|||
127564587|NCT02353143|459035881|FG008|Overall Study|Lack of Efficacy|1|||
127564588|NCT02353143|459035873|FG000|Overall Study|reason not specified|1|||
127564589|NCT02353143|459035874|FG001|Overall Study|reason not specified|2|||
127564590|NCT02353143|459035875|FG002|Overall Study|reason not specified|0|||
127564591|NCT02353143|459035876|FG003|Overall Study|reason not specified|0|||
127564592|NCT02353143|459035877|FG004|Overall Study|reason not specified|6|||
127564593|NCT02353143|459035878|FG005|Overall Study|reason not specified|1|||
127564594|NCT02353143|459035879|FG006|Overall Study|reason not specified|0|||
127564595|NCT02353143|459035880|FG007|Overall Study|reason not specified|3|||
127564596|NCT02353143|459035881|FG008|Overall Study|reason not specified|1|||
127564597|NCT02353143|459035873|FG000|Overall Study|Physician Decision|0|||
127776277|NCT03308942|459809573|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
127776278|NCT03308942|459809574|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
127776279|NCT03308942|459809570|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
127776280|NCT03308942|459809571|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
127776281|NCT03308942|459809572|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
127776282|NCT03308942|459809573|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
127776283|NCT03308942|459809574|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
127776284|NCT03308942|459809570|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
127776285|NCT03308942|459809571|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
127776286|NCT03308942|459809572|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
127776287|NCT03308942|459809573|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
127776288|NCT03308942|459809574|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
127776289|NCT03308942|459809570|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
127776290|NCT03308942|459809571|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
127776291|NCT03308942|459809572|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
127776292|NCT03308942|459809573|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
127776293|NCT03308942|459809574|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
127776294|NCT03308942|459809570|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
127776295|NCT03308942|459809571|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
127776296|NCT03308942|459809572|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
127776297|NCT03308942|459809573|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
127776298|NCT03308942|459809574|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
127776299|NCT03308942|459809570|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
127776300|NCT03308942|459809571|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
127776301|NCT03308942|459809572|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
127776302|NCT03308942|459809573|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
127776303|NCT03308942|459809574|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
127776304|NCT03308942|459809570|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
127776305|NCT03308942|459809571|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
127776306|NCT03308942|459809572|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
127776307|NCT03308942|459809573|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
127776308|NCT03308942|459809574|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
127776309|NCT01131351|459809575|FG000|Overall Study|Adverse Event|0|||
127776310|NCT01131351|459809576|FG001|Overall Study|Adverse Event|2|||
127776311|NCT01131351|459809575|FG000|Overall Study|Protocol Deviation|0|||
127776312|NCT01131351|459809576|FG001|Overall Study|Protocol Deviation|1|||
127776313|NCT03422172|459809579|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
127564598|NCT02353143|459035874|FG001|Overall Study|Physician Decision|4|||
127564599|NCT02353143|459035875|FG002|Overall Study|Physician Decision|2|||
127776314|NCT03422172|459809579|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
127776315|NCT03422172|459809579|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
127564600|NCT02353143|459035876|FG003|Overall Study|Physician Decision|3|||
127564601|NCT02353143|459035877|FG004|Overall Study|Physician Decision|4|||
127564602|NCT02353143|459035878|FG005|Overall Study|Physician Decision|0|||
127564603|NCT02353143|459035879|FG006|Overall Study|Physician Decision|1|||
127564604|NCT02353143|459035880|FG007|Overall Study|Physician Decision|2|||
127564605|NCT02353143|459035881|FG008|Overall Study|Physician Decision|0|||
128024743|NCT00004228|460715966|FG000|Overall Study|Death|0|||
128024744|NCT00004228|460715967|FG001|Overall Study|Death|1|||
128024745|NCT00004228|460715968|FG002|Overall Study|Death|2|||
128024746|NCT00004228|460715969|FG003|Overall Study|Death|0|||
128024747|NCT00004228|460715970|FG004|Overall Study|Death|1|||
128024748|NCT00004228|460715971|FG005|Overall Study|Death|0|||
128024749|NCT00004228|460715972|FG006|Overall Study|Death|0|||
128024750|NCT00004228|460715966|FG000|Overall Study|Lack of Efficacy|1|||
128024751|NCT00004228|460715967|FG001|Overall Study|Lack of Efficacy|6|||
128024752|NCT00004228|460715968|FG002|Overall Study|Lack of Efficacy|5|||
128024753|NCT00004228|460715969|FG003|Overall Study|Lack of Efficacy|3|||
128024754|NCT00004228|460715970|FG004|Overall Study|Lack of Efficacy|9|||
128024755|NCT00004228|460715971|FG005|Overall Study|Lack of Efficacy|8|||
128024756|NCT00004228|460715972|FG006|Overall Study|Lack of Efficacy|4|||
128024757|NCT00004228|460715966|FG000|Overall Study|Lost to Follow-up|0|||
128024758|NCT00004228|460715967|FG001|Overall Study|Lost to Follow-up|0|||
128024759|NCT00004228|460715968|FG002|Overall Study|Lost to Follow-up|1|||
128024760|NCT00004228|460715969|FG003|Overall Study|Lost to Follow-up|0|||
128024761|NCT00004228|460715970|FG004|Overall Study|Lost to Follow-up|0|||
128024762|NCT00004228|460715971|FG005|Overall Study|Lost to Follow-up|0|||
128024763|NCT00004228|460715972|FG006|Overall Study|Lost to Follow-up|0|||
128024764|NCT00004228|460715966|FG000|Overall Study|Physician Decision|1|||
128024765|NCT00004228|460715967|FG001|Overall Study|Physician Decision|0|||
128024766|NCT00004228|460715968|FG002|Overall Study|Physician Decision|3|||
128024767|NCT00004228|460715969|FG003|Overall Study|Physician Decision|2|||
128024768|NCT00004228|460715970|FG004|Overall Study|Physician Decision|1|||
128024769|NCT00004228|460715971|FG005|Overall Study|Physician Decision|1|||
128024770|NCT00004228|460715972|FG006|Overall Study|Physician Decision|1|||
128024771|NCT00004228|460715966|FG000|Overall Study|Protocol Violation|0|||
128024772|NCT00004228|460715967|FG001|Overall Study|Protocol Violation|5|||
128024773|NCT00004228|460715968|FG002|Overall Study|Protocol Violation|2|||
128024774|NCT00004228|460715969|FG003|Overall Study|Protocol Violation|1|||
128024775|NCT00004228|460715970|FG004|Overall Study|Protocol Violation|1|||
128024776|NCT00004228|460715971|FG005|Overall Study|Protocol Violation|2|||
128024777|NCT00004228|460715972|FG006|Overall Study|Protocol Violation|0|||
128024778|NCT00004228|460715966|FG000|Overall Study|Withdrawal by Subject|3|||
128024779|NCT00004228|460715967|FG001|Overall Study|Withdrawal by Subject|0|||
128024780|NCT00004228|460715968|FG002|Overall Study|Withdrawal by Subject|1|||
128024781|NCT00004228|460715969|FG003|Overall Study|Withdrawal by Subject|0|||
128024782|NCT00004228|460715970|FG004|Overall Study|Withdrawal by Subject|2|||
128024783|NCT00004228|460715971|FG005|Overall Study|Withdrawal by Subject|1|||
128024784|NCT00004228|460715972|FG006|Overall Study|Withdrawal by Subject|2|||
128024785|NCT00004228|460715966|FG000|Overall Study|Other|0|||
128024786|NCT00004228|460715967|FG001|Overall Study|Other|0|||
128024787|NCT00004228|460715968|FG002|Overall Study|Other|1|||
128024788|NCT00004228|460715969|FG003|Overall Study|Other|0|||
128024789|NCT00004228|460715970|FG004|Overall Study|Other|0|||
128024790|NCT00004228|460715971|FG005|Overall Study|Other|0|||
127688171|NCT02597920|459483588|FG002|Overall Study|Other than specified|5|||
127688172|NCT02597920|459483586|FG000|Overall Study|Other|1|||
128024791|NCT00004228|460715972|FG006|Overall Study|Other|0|||
128024792|NCT00004228|460715966|FG000|Overall Study|ineligible|4|||
128024793|NCT00004228|460715967|FG001|Overall Study|ineligible|2|||
128024794|NCT00004228|460715968|FG002|Overall Study|ineligible|4|||
128024795|NCT00004228|460715969|FG003|Overall Study|ineligible|1|||
128024796|NCT00004228|460715970|FG004|Overall Study|ineligible|1|||
128024797|NCT00004228|460715971|FG005|Overall Study|ineligible|2|||
128024798|NCT00004228|460715972|FG006|Overall Study|ineligible|5|||
128024799|NCT01529112|460715973|FG000|Overall Study|Adverse Event|2|||
128024800|NCT01529112|460715974|FG001|Overall Study|Adverse Event|0|||
128024801|NCT01529112|460715973|FG000|Overall Study|Death|59|||
128024802|NCT01529112|460715974|FG001|Overall Study|Death|38|||
128024803|NCT01529112|460715973|FG000|Overall Study|Protocol Violation|1|||
128024804|NCT01529112|460715974|FG001|Overall Study|Protocol Violation|0|||
128024805|NCT01529112|460715973|FG000|Overall Study|Withdrawal by Subject|7|||
128024806|NCT01529112|460715974|FG001|Overall Study|Withdrawal by Subject|3|||
128024807|NCT02255279|460715975|FG000|Overall Study|Lost to Follow-up|2|||
128024808|NCT02255279|460715976|FG001|Overall Study|Lost to Follow-up|2|||
128024809|NCT02255279|460715975|FG000|Overall Study|Protocol Violation|0|||
128024810|NCT02255279|460715976|FG001|Overall Study|Protocol Violation|1|||
128024811|NCT02255279|460715975|FG000|Overall Study|Withdrawal by Subject|3|||
128024812|NCT02255279|460715976|FG001|Overall Study|Withdrawal by Subject|6|||
128024813|NCT03607695|460715977|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
128024814|NCT03607695|460715977|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
128024815|NCT02741193|460715978|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
127688173|NCT02597920|459483587|FG001|Overall Study|Other|0|||
127688174|NCT02597920|459483588|FG002|Overall Study|Other|0|||
128024816|NCT02741193|460715978|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
128024817|NCT02502383|460715979|FG000|Overall Study|Lost to Follow-up|130|||
128024818|NCT02502383|460715980|FG001|Overall Study|Lost to Follow-up|131|||
127564606|NCT02353143|459035873|FG000|Overall Study|Adverse Event|0|||
127564607|NCT02353143|459035874|FG001|Overall Study|Adverse Event|0|||
127564608|NCT02353143|459035875|FG002|Overall Study|Adverse Event|1|||
127564609|NCT02353143|459035876|FG003|Overall Study|Adverse Event|0|||
127564610|NCT02353143|459035877|FG004|Overall Study|Adverse Event|1|||
127564611|NCT02353143|459035878|FG005|Overall Study|Adverse Event|1|||
127776316|NCT01423812|459809582|FG000|Overall Study|Lost to Follow-up|2|||
127776317|NCT01423812|459809583|FG001|Overall Study|Lost to Follow-up|2|||
127776318|NCT01423812|459809582|FG000|Overall Study|Withdrawal by Subject|1|||
127776319|NCT01423812|459809583|FG001|Overall Study|Withdrawal by Subject|2|||
127776320|NCT02315898|459809584|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
127776321|NCT02315898|459809585|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
127776322|NCT02315898|459809586|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
127776323|NCT02315898|459809587|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
127776324|NCT05352048|459809588|FG000|Overall Study|Lost to Follow-up|1|||
127776325|NCT05352048|459809588|FG000|Overall Study|did not get EMG-MMG readings intraoperatively|3|||
127776326|NCT01296035|459809608|FG000|Overall Study|Withdrawal by Subject|1|||
127776327|NCT05696236|459809613|FG000|Overall Study|Lost to Follow-up|1|||
127776328|NCT05696236|459809614|FG001|Overall Study|Lost to Follow-up|0|||
127776329|NCT05696236|459809613|FG000|Overall Study|Later determined to not be eligible for participation|0|||
127776330|NCT05696236|459809614|FG001|Overall Study|Later determined to not be eligible for participation|1|||
127776331|NCT05696236|459809613|FG000|Overall Study|Withdrawal by Subject|2|||
127776332|NCT05696236|459809614|FG001|Overall Study|Withdrawal by Subject|2|||
127776333|NCT00867113|459809617|FG000|Treatment Period|Adverse Event|15|||
127776334|NCT00867113|459809617|FG000|Treatment Period|Death|2|||
127776335|NCT00867113|459809617|FG000|Treatment Period|Withdrawal by Subject|19|||
127776336|NCT00867113|459809617|FG000|Treatment Period|Lost to Follow-up|3|||
127776337|NCT00867113|459809617|FG000|Treatment Period|Administrative problems|1|||
127776338|NCT00867113|459809617|FG000|Treatment Period|Disease progression/relapse|1|||
127776339|NCT00867113|459809617|FG000|Treatment Period|Protocol Violation|4|||
127776340|NCT00867113|459809617|FG000|Post Treatment After Survival Follow-up|Death|1|||
127776341|NCT00867113|459809617|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
127776342|NCT00867113|459809617|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
127776343|NCT00867113|459809617|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
127776344|NCT01145495|459809618|FG000|Overall Study|Adverse Event|6|||
127776345|NCT01145495|459809618|FG000|Overall Study|Withdrawal by Subject|6|||
127776346|NCT01145495|459809618|FG000|Overall Study|Disease progression after respone|2|||
127776347|NCT01886313|459809619|FG000|Overall Study|Adverse Event|1|||
127776348|NCT01886313|459809620|FG001|Overall Study|Adverse Event|1|||
127776349|NCT02378220|459809621|FG000|Overall Study|Death|6|||
127776350|NCT02378220|459809622|FG001|Overall Study|Death|1|||
127776351|NCT00578786|459809623|FG000|Overall Study|Adverse Event|27|||
127776352|NCT00578786|459809624|FG001|Overall Study|Adverse Event|37|||
127776353|NCT00578786|459809625|FG002|Overall Study|Adverse Event|17|||
127776354|NCT00578786|459809623|FG000|Overall Study|Lack of Efficacy|2|||
127776355|NCT00578786|459809624|FG001|Overall Study|Lack of Efficacy|5|||
127776356|NCT00578786|459809625|FG002|Overall Study|Lack of Efficacy|2|||
127776357|NCT00578786|459809623|FG000|Overall Study|Early Escape from Prior Study|2|||
127776358|NCT00578786|459809624|FG001|Overall Study|Early Escape from Prior Study|1|||
127776359|NCT00578786|459809625|FG002|Overall Study|Early Escape from Prior Study|2|||
127776360|NCT00578786|459809623|FG000|Overall Study|Withdrawal by Subject|7|||
127776361|NCT00578786|459809624|FG001|Overall Study|Withdrawal by Subject|8|||
127776362|NCT00578786|459809625|FG002|Overall Study|Withdrawal by Subject|5|||
127776363|NCT00578786|459809623|FG000|Overall Study|Protocol Violation|0|||
127776364|NCT00578786|459809624|FG001|Overall Study|Protocol Violation|3|||
127776365|NCT00578786|459809625|FG002|Overall Study|Protocol Violation|1|||
127776366|NCT00578786|459809623|FG000|Overall Study|Physician Decision|1|||
127776367|NCT00578786|459809624|FG001|Overall Study|Physician Decision|0|||
127776368|NCT00578786|459809625|FG002|Overall Study|Physician Decision|1|||
127776369|NCT00578786|459809623|FG000|Overall Study|Sponsor Decision|0|||
127776370|NCT00578786|459809624|FG001|Overall Study|Sponsor Decision|0|||
127776371|NCT00578786|459809625|FG002|Overall Study|Sponsor Decision|1|||
128024819|NCT02502383|460715979|FG000|Overall Study|Withdrawal by Subject|31|||
128024820|NCT02502383|460715980|FG001|Overall Study|Withdrawal by Subject|24|||
128024821|NCT00363467|460715981|FG000|Overall Study|Physician Decision|1|||
128024822|NCT00527748|460715984|FG000|Overall Study|Other|3|||
127776372|NCT00578786|459809623|FG000|Overall Study|Lost to Follow-up|0|||
127776373|NCT00578786|459809624|FG001|Overall Study|Lost to Follow-up|4|||
127776374|NCT00578786|459809625|FG002|Overall Study|Lost to Follow-up|0|||
127776375|NCT00578786|459809623|FG000|Overall Study|Pregnancy|0|||
127776376|NCT00578786|459809624|FG001|Overall Study|Pregnancy|1|||
128024823|NCT01093885|460715986|FG000|Overall Study|Adverse Event|4|||
128024824|NCT01093885|460715986|FG000|Overall Study|Lost to Follow-up|1|||
128024825|NCT02533674|460715987|FG000|Dose Level I|Progressive disease|1|||
127564612|NCT02353143|459035879|FG006|Overall Study|Adverse Event|0|||
128024826|NCT02533674|460715988|FG001|Dose Level I|Progressive disease|0|||
128024827|NCT02533674|460715989|FG002|Dose Level I|Progressive disease|0|||
128024828|NCT02533674|460715990|FG003|Dose Level I|Progressive disease|0|||
128024829|NCT02533674|460715991|FG004|Dose Level I|Progressive disease|0|||
128024830|NCT02533674|460715992|FG005|Dose Level I|Progressive disease|0|||
128024831|NCT02533674|460715993|FG006|Dose Level I|Progressive disease|0|||
128024832|NCT02533674|460715994|FG007|Dose Level I|Progressive disease|0|||
128024833|NCT02533674|460715987|FG000|Dose Level I|Withdrawal by Subject|1|||
128024834|NCT02533674|460715988|FG001|Dose Level I|Withdrawal by Subject|0|||
128024835|NCT02533674|460715989|FG002|Dose Level I|Withdrawal by Subject|0|||
128024836|NCT02533674|460715990|FG003|Dose Level I|Withdrawal by Subject|0|||
128024837|NCT02533674|460715991|FG004|Dose Level I|Withdrawal by Subject|0|||
128024838|NCT02533674|460715992|FG005|Dose Level I|Withdrawal by Subject|0|||
128024839|NCT02533674|460715993|FG006|Dose Level I|Withdrawal by Subject|0|||
128024840|NCT02533674|460715994|FG007|Dose Level I|Withdrawal by Subject|0|||
128024841|NCT02533674|460715987|FG000|Dose Level I|Physician Decision|1|||
128024842|NCT02533674|460715988|FG001|Dose Level I|Physician Decision|0|||
128024843|NCT02533674|460715989|FG002|Dose Level I|Physician Decision|0|||
128024844|NCT02533674|460715990|FG003|Dose Level I|Physician Decision|0|||
128024845|NCT02533674|460715991|FG004|Dose Level I|Physician Decision|0|||
128024846|NCT02533674|460715992|FG005|Dose Level I|Physician Decision|0|||
128024847|NCT02533674|460715993|FG006|Dose Level I|Physician Decision|0|||
128024848|NCT02533674|460715994|FG007|Dose Level I|Physician Decision|0|||
128024849|NCT02533674|460715987|FG000|Dose Level I|Death|1|||
128024850|NCT02533674|460715988|FG001|Dose Level I|Death|0|||
128024851|NCT02533674|460715989|FG002|Dose Level I|Death|0|||
128024852|NCT02533674|460715990|FG003|Dose Level I|Death|0|||
128024853|NCT02533674|460715991|FG004|Dose Level I|Death|0|||
128024854|NCT02533674|460715992|FG005|Dose Level I|Death|0|||
128024855|NCT02533674|460715993|FG006|Dose Level I|Death|0|||
128024856|NCT02533674|460715994|FG007|Dose Level I|Death|0|||
128024857|NCT02533674|460715987|FG000|Dose Level I|Never Treated|1|||
128024858|NCT02533674|460715988|FG001|Dose Level I|Never Treated|0|||
128024859|NCT02533674|460715989|FG002|Dose Level I|Never Treated|0|||
128024860|NCT02533674|460715990|FG003|Dose Level I|Never Treated|0|||
128024861|NCT02533674|460715991|FG004|Dose Level I|Never Treated|0|||
128024862|NCT02533674|460715992|FG005|Dose Level I|Never Treated|0|||
128024863|NCT02533674|460715993|FG006|Dose Level I|Never Treated|0|||
128024864|NCT02533674|460715994|FG007|Dose Level I|Never Treated|0|||
128024865|NCT02533674|460715987|FG000|Dose Level II|Progressive disease|0|||
128024866|NCT02533674|460715988|FG001|Dose Level II|Progressive disease|3|||
128024867|NCT02533674|460715989|FG002|Dose Level II|Progressive disease|0|||
128024868|NCT02533674|460715990|FG003|Dose Level II|Progressive disease|0|||
128024869|NCT02533674|460715991|FG004|Dose Level II|Progressive disease|0|||
128024870|NCT02533674|460715992|FG005|Dose Level II|Progressive disease|0|||
128024871|NCT02533674|460715993|FG006|Dose Level II|Progressive disease|0|||
128024872|NCT02533674|460715994|FG007|Dose Level II|Progressive disease|0|||
128024873|NCT02533674|460715987|FG000|Dose Level II|Withdrawal by Subject|0|||
128024874|NCT02533674|460715988|FG001|Dose Level II|Withdrawal by Subject|1|||
128024875|NCT02533674|460715989|FG002|Dose Level II|Withdrawal by Subject|0|||
128024876|NCT02533674|460715990|FG003|Dose Level II|Withdrawal by Subject|0|||
128024877|NCT02533674|460715991|FG004|Dose Level II|Withdrawal by Subject|0|||
128024878|NCT02533674|460715992|FG005|Dose Level II|Withdrawal by Subject|0|||
128024879|NCT02533674|460715993|FG006|Dose Level II|Withdrawal by Subject|0|||
128024880|NCT02533674|460715994|FG007|Dose Level II|Withdrawal by Subject|0|||
128024881|NCT02533674|460715987|FG000|Dose Level II|Treatment-related AE|0|||
128024882|NCT02533674|460715988|FG001|Dose Level II|Treatment-related AE|1|||
128024883|NCT02533674|460715989|FG002|Dose Level II|Treatment-related AE|0|||
128024884|NCT02533674|460715990|FG003|Dose Level II|Treatment-related AE|0|||
128024885|NCT02533674|460715991|FG004|Dose Level II|Treatment-related AE|0|||
128024886|NCT02533674|460715992|FG005|Dose Level II|Treatment-related AE|0|||
128024887|NCT02533674|460715993|FG006|Dose Level II|Treatment-related AE|0|||
128024888|NCT02533674|460715994|FG007|Dose Level II|Treatment-related AE|0|||
128024889|NCT02533674|460715987|FG000|Dose Level II|Physician Decision|0|||
128024890|NCT02533674|460715988|FG001|Dose Level II|Physician Decision|1|||
128024891|NCT02533674|460715989|FG002|Dose Level II|Physician Decision|0|||
128024892|NCT02533674|460715990|FG003|Dose Level II|Physician Decision|0|||
128024893|NCT02533674|460715991|FG004|Dose Level II|Physician Decision|0|||
128024894|NCT02533674|460715992|FG005|Dose Level II|Physician Decision|0|||
128024895|NCT02533674|460715993|FG006|Dose Level II|Physician Decision|0|||
128024896|NCT02533674|460715994|FG007|Dose Level II|Physician Decision|0|||
128024897|NCT02533674|460715987|FG000|Dose Level II|Non-treatment-related AE|0|||
128024898|NCT02533674|460715988|FG001|Dose Level II|Non-treatment-related AE|1|||
128024899|NCT02533674|460715989|FG002|Dose Level II|Non-treatment-related AE|0|||
128024900|NCT02533674|460715990|FG003|Dose Level II|Non-treatment-related AE|0|||
128024901|NCT02533674|460715991|FG004|Dose Level II|Non-treatment-related AE|0|||
128024902|NCT02533674|460715992|FG005|Dose Level II|Non-treatment-related AE|0|||
128024903|NCT02533674|460715993|FG006|Dose Level II|Non-treatment-related AE|0|||
128024904|NCT02533674|460715994|FG007|Dose Level II|Non-treatment-related AE|0|||
128024905|NCT02533674|460715987|FG000|Dose Level III|Progressive disease|0|||
128024906|NCT02533674|460715988|FG001|Dose Level III|Progressive disease|0|||
128024907|NCT02533674|460715989|FG002|Dose Level III|Progressive disease|2|||
128024908|NCT02533674|460715990|FG003|Dose Level III|Progressive disease|0|||
128024909|NCT02533674|460715991|FG004|Dose Level III|Progressive disease|0|||
128024910|NCT02533674|460715992|FG005|Dose Level III|Progressive disease|0|||
128024911|NCT02533674|460715993|FG006|Dose Level III|Progressive disease|0|||
128024912|NCT02533674|460715994|FG007|Dose Level III|Progressive disease|0|||
128024913|NCT02533674|460715987|FG000|Dose Level III|Withdrawal by Subject|0|||
128024914|NCT02533674|460715988|FG001|Dose Level III|Withdrawal by Subject|0|||
128024915|NCT02533674|460715989|FG002|Dose Level III|Withdrawal by Subject|1|||
128024916|NCT02533674|460715990|FG003|Dose Level III|Withdrawal by Subject|0|||
128024917|NCT02533674|460715991|FG004|Dose Level III|Withdrawal by Subject|0|||
128024918|NCT02533674|460715992|FG005|Dose Level III|Withdrawal by Subject|0|||
128024919|NCT02533674|460715993|FG006|Dose Level III|Withdrawal by Subject|0|||
128024920|NCT02533674|460715994|FG007|Dose Level III|Withdrawal by Subject|0|||
128024921|NCT02533674|460715987|FG000|Dose Level III|Treatment-related AE|0|||
128024922|NCT02533674|460715988|FG001|Dose Level III|Treatment-related AE|0|||
128024923|NCT02533674|460715989|FG002|Dose Level III|Treatment-related AE|1|||
128024924|NCT02533674|460715990|FG003|Dose Level III|Treatment-related AE|0|||
128024925|NCT02533674|460715991|FG004|Dose Level III|Treatment-related AE|0|||
128024926|NCT02533674|460715992|FG005|Dose Level III|Treatment-related AE|0|||
128024927|NCT02533674|460715993|FG006|Dose Level III|Treatment-related AE|0|||
128024928|NCT02533674|460715994|FG007|Dose Level III|Treatment-related AE|0|||
128024929|NCT02533674|460715987|FG000|Dose Level IV|Progressive disease|0|||
128024930|NCT02533674|460715988|FG001|Dose Level IV|Progressive disease|0|||
128024931|NCT02533674|460715989|FG002|Dose Level IV|Progressive disease|0|||
128024932|NCT02533674|460715990|FG003|Dose Level IV|Progressive disease|3|||
128024933|NCT02533674|460715991|FG004|Dose Level IV|Progressive disease|0|||
128024934|NCT02533674|460715992|FG005|Dose Level IV|Progressive disease|0|||
128024935|NCT02533674|460715993|FG006|Dose Level IV|Progressive disease|0|||
128024936|NCT02533674|460715994|FG007|Dose Level IV|Progressive disease|0|||
128024937|NCT02533674|460715987|FG000|Dose Level IV|Withdrawal by Subject|0|||
128024938|NCT02533674|460715988|FG001|Dose Level IV|Withdrawal by Subject|0|||
128024939|NCT02533674|460715989|FG002|Dose Level IV|Withdrawal by Subject|0|||
128024940|NCT02533674|460715990|FG003|Dose Level IV|Withdrawal by Subject|1|||
128024941|NCT02533674|460715991|FG004|Dose Level IV|Withdrawal by Subject|0|||
128024942|NCT02533674|460715992|FG005|Dose Level IV|Withdrawal by Subject|0|||
128024943|NCT02533674|460715993|FG006|Dose Level IV|Withdrawal by Subject|0|||
128024944|NCT02533674|460715994|FG007|Dose Level IV|Withdrawal by Subject|0|||
128024945|NCT02533674|460715987|FG000|Dose Level IV|Physician Decision|0|||
128024946|NCT02533674|460715988|FG001|Dose Level IV|Physician Decision|0|||
128024947|NCT02533674|460715989|FG002|Dose Level IV|Physician Decision|0|||
128024948|NCT02533674|460715990|FG003|Dose Level IV|Physician Decision|1|||
128024949|NCT02533674|460715991|FG004|Dose Level IV|Physician Decision|0|||
128024950|NCT02533674|460715992|FG005|Dose Level IV|Physician Decision|0|||
128024951|NCT02533674|460715993|FG006|Dose Level IV|Physician Decision|0|||
128024952|NCT02533674|460715994|FG007|Dose Level IV|Physician Decision|0|||
128024953|NCT02533674|460715987|FG000|Dose Level V|Progressive disease|0|||
128024954|NCT02533674|460715988|FG001|Dose Level V|Progressive disease|0|||
128024955|NCT02533674|460715989|FG002|Dose Level V|Progressive disease|0|||
128024956|NCT02533674|460715990|FG003|Dose Level V|Progressive disease|0|||
128024957|NCT02533674|460715991|FG004|Dose Level V|Progressive disease|3|||
128024958|NCT02533674|460715992|FG005|Dose Level V|Progressive disease|0|||
128024959|NCT02533674|460715993|FG006|Dose Level V|Progressive disease|0|||
128024960|NCT02533674|460715994|FG007|Dose Level V|Progressive disease|0|||
127564613|NCT02353143|459035880|FG007|Overall Study|Adverse Event|0|||
127564614|NCT02353143|459035881|FG008|Overall Study|Adverse Event|0|||
127564615|NCT02353143|459035873|FG000|Overall Study|patient receiving other treatment for AML|0|||
127564616|NCT02353143|459035874|FG001|Overall Study|patient receiving other treatment for AML|0|||
127564617|NCT02353143|459035875|FG002|Overall Study|patient receiving other treatment for AML|1|||
127564618|NCT02353143|459035876|FG003|Overall Study|patient receiving other treatment for AML|0|||
127564619|NCT02353143|459035877|FG004|Overall Study|patient receiving other treatment for AML|0|||
128024961|NCT02533674|460715987|FG000|Dose Level V|Withdrawal by Subject|0|||
128024962|NCT02533674|460715988|FG001|Dose Level V|Withdrawal by Subject|0|||
128024963|NCT02533674|460715989|FG002|Dose Level V|Withdrawal by Subject|0|||
128024964|NCT02533674|460715990|FG003|Dose Level V|Withdrawal by Subject|0|||
128024965|NCT02533674|460715991|FG004|Dose Level V|Withdrawal by Subject|1|||
128024966|NCT02533674|460715992|FG005|Dose Level V|Withdrawal by Subject|0|||
128024967|NCT02533674|460715993|FG006|Dose Level V|Withdrawal by Subject|0|||
128024968|NCT02533674|460715994|FG007|Dose Level V|Withdrawal by Subject|0|||
128024969|NCT02533674|460715987|FG000|Dose Level V|Physician Decision|0|||
127688175|NCT00642850|459483589|FG000|Overall Study|Death|7|||
127688176|NCT00642850|459483589|FG000|Overall Study|Adverse Event|2|||
127688177|NCT00642850|459483589|FG000|Overall Study|Lack of Efficacy|1|||
127688178|NCT00642850|459483589|FG000|Overall Study|Protocol Violation|2|||
127688179|NCT00642850|459483589|FG000|Overall Study|Kidney transplantation|8|||
127776377|NCT00578786|459809625|FG002|Overall Study|Pregnancy|0|||
127776378|NCT00578786|459809623|FG000|Overall Study|Not Otherwise Specified|0|||
127776379|NCT00578786|459809624|FG001|Overall Study|Not Otherwise Specified|4|||
127776380|NCT00578786|459809625|FG002|Overall Study|Not Otherwise Specified|1|||
127776381|NCT00578786|459809623|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
127776382|NCT00578786|459809624|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
127776383|NCT00578786|459809625|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
127776384|NCT00312221|459809626|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
127776385|NCT00312221|459809627|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
127776386|NCT00312221|459809628|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
127776387|NCT00312221|459809629|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
127776388|NCT00312221|459809626|FG000|Open-label Run-in Period|Adverse Event|74|||
127776389|NCT00312221|459809627|FG001|Open-label Run-in Period|Adverse Event|0|||
127776390|NCT00312221|459809628|FG002|Open-label Run-in Period|Adverse Event|0|||
127776391|NCT00312221|459809629|FG003|Open-label Run-in Period|Adverse Event|0|||
127776392|NCT00312221|459809626|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
127776393|NCT00312221|459809627|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
127776394|NCT00312221|459809628|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
127776395|NCT00312221|459809629|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
127776396|NCT00312221|459809626|FG000|Open-label Run-in Period|Administrative|42|||
127776397|NCT00312221|459809627|FG001|Open-label Run-in Period|Administrative|0|||
127776398|NCT00312221|459809628|FG002|Open-label Run-in Period|Administrative|0|||
127776399|NCT00312221|459809629|FG003|Open-label Run-in Period|Administrative|0|||
127776400|NCT00312221|459809626|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
128024970|NCT02533674|460715988|FG001|Dose Level V|Physician Decision|0|||
127564620|NCT02353143|459035878|FG005|Overall Study|patient receiving other treatment for AML|0|||
127564621|NCT02353143|459035879|FG006|Overall Study|patient receiving other treatment for AML|0|||
127564622|NCT02353143|459035880|FG007|Overall Study|patient receiving other treatment for AML|0|||
127564623|NCT02353143|459035881|FG008|Overall Study|patient receiving other treatment for AML|0|||
127564624|NCT02353143|459035873|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
127564625|NCT02353143|459035874|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
127564626|NCT02353143|459035875|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
127564627|NCT02353143|459035876|FG003|Overall Study|Dose limiting toxicity (DLT)|1|||
127564628|NCT02353143|459035877|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
127564629|NCT02353143|459035878|FG005|Overall Study|Dose limiting toxicity (DLT)|1|||
127564630|NCT02353143|459035879|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
127564631|NCT02353143|459035880|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
127564632|NCT02353143|459035881|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
127564633|NCT02946931|459035890|FG000|Overall Study|Did not require collection of CRFs|588|||
127564634|NCT02946931|459035890|FG000|Overall Study|Other than listed|37|||
127564635|NCT02946931|459035890|FG000|Overall Study|Discharge from hospital|118|||
127564636|NCT02946931|459035890|FG000|Overall Study|Adverse Event|81|||
127564637|NCT02946931|459035890|FG000|Overall Study|CRFs not valid|1|||
127688180|NCT00642850|459483589|FG000|Overall Study|Blood transfusion|6|||
127688181|NCT00642850|459483589|FG000|Overall Study|Other reasons|7|||
127688182|NCT02549170|459483590|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
127688183|NCT02549170|459483591|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
127688184|NCT02549170|459483592|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
127688185|NCT02549170|459483593|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
127688186|NCT02549170|459483594|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
127688187|NCT02549170|459483590|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
127688188|NCT02549170|459483591|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
127688189|NCT02549170|459483592|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
127688190|NCT02549170|459483593|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
127688191|NCT02549170|459483594|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
127688192|NCT02549170|459483590|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
127688193|NCT02549170|459483591|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
127688194|NCT02549170|459483592|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
127688195|NCT02549170|459483593|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
127776401|NCT00312221|459809627|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
127776402|NCT00312221|459809628|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
127776403|NCT00312221|459809629|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
127776404|NCT00312221|459809626|FG000|Open-label Run-in Period|Did not qualify|5|||
127776405|NCT00312221|459809627|FG001|Open-label Run-in Period|Did not qualify|0|||
127776406|NCT00312221|459809628|FG002|Open-label Run-in Period|Did not qualify|0|||
127776407|NCT00312221|459809629|FG003|Open-label Run-in Period|Did not qualify|0|||
127776408|NCT00312221|459809626|FG000|Double-blind Phase|Withdrawal by Subject|0|||
127776409|NCT00312221|459809627|FG001|Double-blind Phase|Withdrawal by Subject|6|||
127776410|NCT00312221|459809628|FG002|Double-blind Phase|Withdrawal by Subject|8|||
127776411|NCT00312221|459809629|FG003|Double-blind Phase|Withdrawal by Subject|7|||
127776412|NCT00312221|459809626|FG000|Double-blind Phase|Adverse Event|0|||
127776413|NCT00312221|459809627|FG001|Double-blind Phase|Adverse Event|10|||
127776414|NCT00312221|459809628|FG002|Double-blind Phase|Adverse Event|19|||
127776415|NCT00312221|459809629|FG003|Double-blind Phase|Adverse Event|18|||
127776416|NCT00312221|459809626|FG000|Double-blind Phase|Lost to Follow-up|0|||
127776417|NCT00312221|459809627|FG001|Double-blind Phase|Lost to Follow-up|0|||
127776418|NCT00312221|459809628|FG002|Double-blind Phase|Lost to Follow-up|2|||
127776419|NCT00312221|459809629|FG003|Double-blind Phase|Lost to Follow-up|2|||
127776420|NCT00312221|459809626|FG000|Double-blind Phase|Administrative|0|||
127776421|NCT00312221|459809627|FG001|Double-blind Phase|Administrative|26|||
127776422|NCT00312221|459809628|FG002|Double-blind Phase|Administrative|37|||
127776423|NCT00312221|459809629|FG003|Double-blind Phase|Administrative|33|||
127776424|NCT00312221|459809626|FG000|Double-blind Phase|Lack of Efficacy|0|||
127776425|NCT00312221|459809627|FG001|Double-blind Phase|Lack of Efficacy|17|||
127776426|NCT00312221|459809628|FG002|Double-blind Phase|Lack of Efficacy|6|||
127776427|NCT00312221|459809629|FG003|Double-blind Phase|Lack of Efficacy|10|||
127776428|NCT02060721|459809630|FG000|Overall Study|Lost to Follow-up|1|||
127776429|NCT02060721|459809630|FG000|Overall Study|Physician Decision|2|||
127776430|NCT02060721|459809630|FG000|Overall Study|Death|14|||
127776431|NCT02060721|459809630|FG000|Overall Study|Withdrawal by Subject|2|||
127776432|NCT02060721|459809630|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
127776433|NCT00117507|459809631|FG000|Overall Study|Adverse Event|4|||
127776434|NCT00117507|459809631|FG000|Overall Study|Abnormal laboratory values|3|||
127776435|NCT00117507|459809631|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
127776436|NCT00117507|459809631|FG000|Overall Study|Patient withdrew consent|4|||
127776437|NCT00117507|459809631|FG000|Overall Study|Death|3|||
127776438|NCT00866723|459809632|FG000|Overall Study|Withdrawal by Subject|1|||
127776439|NCT00866723|459809632|FG000|Overall Study|Disease Progression|4|||
127776440|NCT05105789|459809633|FG000|Overall Study|Laboratory's lab collection device damaged|1|||
127776441|NCT00323297|459809636|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
127776442|NCT00323297|459809637|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
127776443|NCT00323297|459809636|FG000|Part A (Double Blind Randomized)|Death|0|||
127776444|NCT00323297|459809637|FG001|Part A (Double Blind Randomized)|Death|1|||
127776445|NCT00323297|459809636|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
127776446|NCT00323297|459809637|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
127776447|NCT00323297|459809636|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
127776448|NCT00323297|459809637|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
127776449|NCT00323297|459809636|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
127776450|NCT00323297|459809637|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
127776451|NCT00323297|459809636|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
127776452|NCT00323297|459809637|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
127776453|NCT00323297|459809636|FG000|Part B (Open-label)|Death|0|||
127776454|NCT00323297|459809637|FG001|Part B (Open-label)|Death|1|||
127776455|NCT00323297|459809636|FG000|Part B (Open-label)|Reason unspecified|0|||
127776456|NCT00323297|459809637|FG001|Part B (Open-label)|Reason unspecified|1|||
127776457|NCT00323297|459809636|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
127776458|NCT00323297|459809637|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
127776459|NCT00323297|459809636|FG000|Part B (Open-label)|Lack of Efficacy|3|||
127776460|NCT00323297|459809637|FG001|Part B (Open-label)|Lack of Efficacy|1|||
127776461|NCT00323297|459809636|FG000|Part B (Open-label)|Adverse Event|5|||
127776462|NCT00323297|459809637|FG001|Part B (Open-label)|Adverse Event|5|||
127776463|NCT00323297|459809636|FG000|Part B (Open-label)|Protocol Violation|0|||
127776464|NCT00323297|459809637|FG001|Part B (Open-label)|Protocol Violation|1|||
127776465|NCT01003990|459809638|FG000|Overall Study|Adverse Event|8|||
127776466|NCT01003990|459809639|FG001|Overall Study|Adverse Event|5|||
127564638|NCT02946931|459035890|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
127564639|NCT03339297|459035891|FG000|Overall Study|Relapse of Hematologic Disease|1|||
127776467|NCT01003990|459809640|FG002|Overall Study|Adverse Event|11|||
127776468|NCT01003990|459809638|FG000|Overall Study|Death|0|||
127776469|NCT01003990|459809639|FG001|Overall Study|Death|8|||
127776470|NCT01003990|459809640|FG002|Overall Study|Death|1|||
127776471|NCT01003990|459809638|FG000|Overall Study|Lack of Efficacy|10|||
127776472|NCT01003990|459809639|FG001|Overall Study|Lack of Efficacy|2|||
127776473|NCT01003990|459809640|FG002|Overall Study|Lack of Efficacy|3|||
127776474|NCT01003990|459809638|FG000|Overall Study|Lost to Follow-up|30|||
127776475|NCT01003990|459809639|FG001|Overall Study|Lost to Follow-up|12|||
127776476|NCT01003990|459809640|FG002|Overall Study|Lost to Follow-up|7|||
127776477|NCT01003990|459809638|FG000|Overall Study|Reasons Not Identified|14|||
128024971|NCT02533674|460715989|FG002|Dose Level V|Physician Decision|0|||
128024972|NCT02533674|460715990|FG003|Dose Level V|Physician Decision|0|||
128024973|NCT02533674|460715991|FG004|Dose Level V|Physician Decision|1|||
128024974|NCT02533674|460715992|FG005|Dose Level V|Physician Decision|0|||
128024975|NCT02533674|460715993|FG006|Dose Level V|Physician Decision|0|||
128024976|NCT02533674|460715994|FG007|Dose Level V|Physician Decision|0|||
128024977|NCT02533674|460715987|FG000|Dose Level VI|Progressive disease|0|||
128024978|NCT02533674|460715988|FG001|Dose Level VI|Progressive disease|0|||
128024979|NCT02533674|460715989|FG002|Dose Level VI|Progressive disease|0|||
128024980|NCT02533674|460715990|FG003|Dose Level VI|Progressive disease|0|||
128024981|NCT02533674|460715991|FG004|Dose Level VI|Progressive disease|0|||
128024982|NCT02533674|460715992|FG005|Dose Level VI|Progressive disease|7|||
128024983|NCT02533674|460715993|FG006|Dose Level VI|Progressive disease|0|||
128024984|NCT02533674|460715994|FG007|Dose Level VI|Progressive disease|0|||
128024985|NCT02533674|460715987|FG000|Dose Level VI|Withdrawal by Subject|0|||
128024986|NCT02533674|460715988|FG001|Dose Level VI|Withdrawal by Subject|0|||
128024987|NCT02533674|460715989|FG002|Dose Level VI|Withdrawal by Subject|0|||
128024988|NCT02533674|460715990|FG003|Dose Level VI|Withdrawal by Subject|0|||
128024989|NCT02533674|460715991|FG004|Dose Level VI|Withdrawal by Subject|0|||
127564640|NCT03339297|459035892|FG001|Overall Study|Relapse of Hematologic Disease|0|||
127564641|NCT03339297|459035891|FG000|Overall Study|Death|10|||
127564642|NCT03339297|459035892|FG001|Overall Study|Death|7|||
127564643|NCT03339297|459035891|FG000|Overall Study|Hepatic Candidosis|1|||
127564644|NCT03339297|459035892|FG001|Overall Study|Hepatic Candidosis|0|||
128024990|NCT02533674|460715992|FG005|Dose Level VI|Withdrawal by Subject|1|||
128024991|NCT02533674|460715993|FG006|Dose Level VI|Withdrawal by Subject|0|||
128024992|NCT02533674|460715994|FG007|Dose Level VI|Withdrawal by Subject|0|||
128024993|NCT02533674|460715987|FG000|Dose Level VI|Treatment-related AE|0|||
128024994|NCT02533674|460715988|FG001|Dose Level VI|Treatment-related AE|0|||
128024995|NCT02533674|460715989|FG002|Dose Level VI|Treatment-related AE|0|||
128024996|NCT02533674|460715990|FG003|Dose Level VI|Treatment-related AE|0|||
128024997|NCT02533674|460715991|FG004|Dose Level VI|Treatment-related AE|0|||
128024998|NCT02533674|460715992|FG005|Dose Level VI|Treatment-related AE|1|||
128024999|NCT02533674|460715993|FG006|Dose Level VI|Treatment-related AE|0|||
128025000|NCT02533674|460715994|FG007|Dose Level VI|Treatment-related AE|0|||
128025001|NCT02533674|460715987|FG000|Dose Level VII|Progressive disease|0|||
128025002|NCT02533674|460715988|FG001|Dose Level VII|Progressive disease|0|||
128025003|NCT02533674|460715989|FG002|Dose Level VII|Progressive disease|0|||
128025004|NCT02533674|460715990|FG003|Dose Level VII|Progressive disease|0|||
128025005|NCT02533674|460715991|FG004|Dose Level VII|Progressive disease|0|||
128025006|NCT02533674|460715992|FG005|Dose Level VII|Progressive disease|0|||
128025007|NCT02533674|460715993|FG006|Dose Level VII|Progressive disease|10|||
128025008|NCT02533674|460715994|FG007|Dose Level VII|Progressive disease|0|||
128025009|NCT02533674|460715987|FG000|Dose Level VII|Withdrawal by Subject|0|||
128025010|NCT02533674|460715988|FG001|Dose Level VII|Withdrawal by Subject|0|||
128025011|NCT02533674|460715989|FG002|Dose Level VII|Withdrawal by Subject|0|||
128025012|NCT02533674|460715990|FG003|Dose Level VII|Withdrawal by Subject|0|||
128025013|NCT02533674|460715991|FG004|Dose Level VII|Withdrawal by Subject|0|||
128025014|NCT02533674|460715992|FG005|Dose Level VII|Withdrawal by Subject|0|||
128025015|NCT02533674|460715993|FG006|Dose Level VII|Withdrawal by Subject|3|||
128025016|NCT02533674|460715994|FG007|Dose Level VII|Withdrawal by Subject|0|||
128025017|NCT02533674|460715987|FG000|Dose Level VII|Treatment-related AE|0|||
128025018|NCT02533674|460715988|FG001|Dose Level VII|Treatment-related AE|0|||
128025019|NCT02533674|460715989|FG002|Dose Level VII|Treatment-related AE|0|||
128025020|NCT02533674|460715990|FG003|Dose Level VII|Treatment-related AE|0|||
128025021|NCT02533674|460715991|FG004|Dose Level VII|Treatment-related AE|0|||
128025022|NCT02533674|460715992|FG005|Dose Level VII|Treatment-related AE|0|||
128025023|NCT02533674|460715993|FG006|Dose Level VII|Treatment-related AE|1|||
128025024|NCT02533674|460715994|FG007|Dose Level VII|Treatment-related AE|0|||
128025025|NCT02533674|460715987|FG000|Dose Level VII|Death|0|||
128025026|NCT02533674|460715988|FG001|Dose Level VII|Death|0|||
127564645|NCT03339297|459035891|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
127564646|NCT03339297|459035892|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
127564647|NCT03339297|459035891|FG000|Overall Study|Consent Withdrawn by Participant|3|||
127564648|NCT03339297|459035892|FG001|Overall Study|Consent Withdrawn by Participant|3|||
127564649|NCT03339297|459035891|FG000|Overall Study|Disease Relapse|2|||
127564650|NCT03339297|459035892|FG001|Overall Study|Disease Relapse|0|||
127564651|NCT03339297|459035891|FG000|Overall Study|Physician Decision|1|||
128025027|NCT02533674|460715989|FG002|Dose Level VII|Death|0|||
128025028|NCT02533674|460715990|FG003|Dose Level VII|Death|0|||
128025029|NCT02533674|460715991|FG004|Dose Level VII|Death|0|||
128025030|NCT02533674|460715992|FG005|Dose Level VII|Death|0|||
128025031|NCT02533674|460715993|FG006|Dose Level VII|Death|2|||
128025032|NCT02533674|460715994|FG007|Dose Level VII|Death|0|||
128025033|NCT02533674|460715987|FG000|Dose Level VIII|Progressive disease|0|||
128025034|NCT02533674|460715988|FG001|Dose Level VIII|Progressive disease|0|||
128025035|NCT02533674|460715989|FG002|Dose Level VIII|Progressive disease|0|||
128025036|NCT02533674|460715990|FG003|Dose Level VIII|Progressive disease|0|||
127564652|NCT03339297|459035892|FG001|Overall Study|Physician Decision|1|||
127564653|NCT03339297|459035891|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
127564654|NCT03339297|459035892|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
127776478|NCT01003990|459809639|FG001|Overall Study|Reasons Not Identified|13|||
127776479|NCT01003990|459809640|FG002|Overall Study|Reasons Not Identified|8|||
127564655|NCT03339297|459035891|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
127688196|NCT02549170|459483594|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
127688197|NCT01266122|459483595|FG000|Overall Study|Lost to Follow-up|6|||
127688198|NCT01266122|459483596|FG001|Overall Study|Lost to Follow-up|6|||
127688199|NCT03756571|459483597|FG000|Overall Study|Lost to Follow-up|1|||
127688200|NCT03756571|459483598|FG001|Overall Study|Lost to Follow-up|1|||
127688201|NCT00978042|459483599|FG000|Initial Treatment Period|Treated in Error|0|||
127688202|NCT00978042|459483600|FG001|Initial Treatment Period|Treated in Error|3|||
127688203|NCT00978042|459483599|FG000|Initial Treatment Period|Ineligibility|1|||
127688204|NCT00978042|459483600|FG001|Initial Treatment Period|Ineligibility|0|||
127688205|NCT00978042|459483599|FG000|Initial Treatment Period|Lost to Follow-up|21|||
127688206|NCT00978042|459483600|FG001|Initial Treatment Period|Lost to Follow-up|3|||
127688207|NCT00978042|459483599|FG000|Initial Treatment Period|Adverse Event|2|||
127688208|NCT00978042|459483600|FG001|Initial Treatment Period|Adverse Event|0|||
127688209|NCT00978042|459483599|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
127688210|NCT00978042|459483600|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
127688211|NCT00978042|459483599|FG000|Initial Treatment Period|Consent withdrawn|22|||
127688212|NCT00978042|459483600|FG001|Initial Treatment Period|Consent withdrawn|9|||
127688213|NCT00978042|459483599|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
127688214|NCT00978042|459483600|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
127688215|NCT02379819|459483601|FG000|Overall Study|Withdrawal by Subject|10|||
127688216|NCT02379819|459483601|FG000|Overall Study|Death|2|||
127688217|NCT02379819|459483601|FG000|Overall Study|Lack of Efficacy|1|||
127688218|NCT02379819|459483601|FG000|Overall Study|Lost to Follow-up|1|||
127688219|NCT04452318|459483605|FG000|Overall Study|Physician Decision|1|||
127688220|NCT04452318|459483606|FG001|Overall Study|Physician Decision|2|||
127688221|NCT04452318|459483607|FG002|Overall Study|Physician Decision|0|||
127688222|NCT04452318|459483608|FG003|Overall Study|Physician Decision|2|||
127688223|NCT04452318|459483609|FG004|Overall Study|Physician Decision|0|||
127688224|NCT04452318|459483610|FG005|Overall Study|Physician Decision|2|||
127688225|NCT04452318|459483611|FG006|Overall Study|Physician Decision|5|||
127688226|NCT04452318|459483605|FG000|Overall Study|Death|2|||
127688227|NCT04452318|459483606|FG001|Overall Study|Death|3|||
127688228|NCT04452318|459483607|FG002|Overall Study|Death|0|||
127688229|NCT04452318|459483608|FG003|Overall Study|Death|0|||
127688230|NCT04452318|459483609|FG004|Overall Study|Death|0|||
127688231|NCT04452318|459483610|FG005|Overall Study|Death|0|||
127688232|NCT04452318|459483611|FG006|Overall Study|Death|0|||
127688233|NCT04452318|459483605|FG000|Overall Study|Lost to Follow-up|38|||
127688234|NCT04452318|459483606|FG001|Overall Study|Lost to Follow-up|28|||
127688235|NCT04452318|459483607|FG002|Overall Study|Lost to Follow-up|0|||
127688236|NCT04452318|459483608|FG003|Overall Study|Lost to Follow-up|3|||
127688237|NCT04452318|459483609|FG004|Overall Study|Lost to Follow-up|3|||
127688238|NCT04452318|459483610|FG005|Overall Study|Lost to Follow-up|2|||
127688239|NCT04452318|459483611|FG006|Overall Study|Lost to Follow-up|1|||
127688240|NCT04452318|459483605|FG000|Overall Study|Withdrawal by Subject|46|||
127688241|NCT04452318|459483606|FG001|Overall Study|Withdrawal by Subject|40|||
127688242|NCT04452318|459483607|FG002|Overall Study|Withdrawal by Subject|0|||
127688243|NCT04452318|459483608|FG003|Overall Study|Withdrawal by Subject|18|||
127688244|NCT04452318|459483609|FG004|Overall Study|Withdrawal by Subject|6|||
127688245|NCT04452318|459483610|FG005|Overall Study|Withdrawal by Subject|8|||
127688246|NCT04452318|459483611|FG006|Overall Study|Withdrawal by Subject|6|||
127688247|NCT00604669|459483612|FG000|Overall Study|lack of information in chart|7|||
127688248|NCT01695954|459483613|FG000|Overall Study|Withdrawal by Subject|4|||
127688249|NCT01695954|459483614|FG001|Overall Study|Withdrawal by Subject|0|||
127688250|NCT01695954|459483613|FG000|Overall Study|Adverse Event|0|||
127688251|NCT01695954|459483614|FG001|Overall Study|Adverse Event|2|||
127688252|NCT04328727|459483616|FG000|Overall Study|Guardian Decision|1|||
127688253|NCT04328727|459483616|FG000|Overall Study|Participant decision|4|||
127688254|NCT04328727|459483616|FG000|Overall Study|Death|3|||
127688255|NCT03684044|459483617|FG000|Overall Study|Adverse Event|3|||
127688256|NCT03684044|459483618|FG001|Overall Study|Adverse Event|0|||
127688257|NCT03684044|459483617|FG000|Overall Study|Death|4|||
127688258|NCT03684044|459483618|FG001|Overall Study|Death|7|||
127688259|NCT03684044|459483617|FG000|Overall Study|Lost to Follow-up|3|||
127688260|NCT03684044|459483618|FG001|Overall Study|Lost to Follow-up|2|||
127688261|NCT03684044|459483617|FG000|Overall Study|Patient Not Available|0|||
127564656|NCT03339297|459035892|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
127688262|NCT03684044|459483618|FG001|Overall Study|Patient Not Available|2|||
127688263|NCT03684044|459483617|FG000|Overall Study|Physician Decision|1|||
127688264|NCT03684044|459483618|FG001|Overall Study|Physician Decision|0|||
127688265|NCT03684044|459483617|FG000|Overall Study|Withdrawal by Subject|11|||
127776480|NCT01003990|459809638|FG000|Overall Study|Poor/Non-compliance|4|||
127776481|NCT01003990|459809639|FG001|Overall Study|Poor/Non-compliance|3|||
127776482|NCT01003990|459809640|FG002|Overall Study|Poor/Non-compliance|2|||
127776483|NCT01003990|459809638|FG000|Overall Study|Pregnancy|10|||
127776484|NCT01003990|459809639|FG001|Overall Study|Pregnancy|2|||
127776485|NCT01003990|459809640|FG002|Overall Study|Pregnancy|4|||
127776486|NCT01003990|459809638|FG000|Overall Study|No Longer Met Study Criteria|4|||
127776487|NCT01003990|459809639|FG001|Overall Study|No Longer Met Study Criteria|1|||
127776488|NCT01003990|459809640|FG002|Overall Study|No Longer Met Study Criteria|0|||
127776489|NCT01003990|459809638|FG000|Overall Study|Subject Withdrew Consent|12|||
127776490|NCT01003990|459809639|FG001|Overall Study|Subject Withdrew Consent|5|||
127776491|NCT01003990|459809640|FG002|Overall Study|Subject Withdrew Consent|7|||
127776492|NCT00634010|459809646|FG000|Overall Study|Adverse Event|2|||
127776493|NCT00634010|459809647|FG001|Overall Study|Adverse Event|5|||
127776494|NCT00634010|459809646|FG000|Overall Study|Withdrawal by Subject|5|||
127776495|NCT00634010|459809647|FG001|Overall Study|Withdrawal by Subject|6|||
127776496|NCT00634010|459809646|FG000|Overall Study|Physician Decision|1|||
127776497|NCT00634010|459809647|FG001|Overall Study|Physician Decision|1|||
127776498|NCT00634010|459809646|FG000|Overall Study|Disease Progression|1|||
127776499|NCT00634010|459809647|FG001|Overall Study|Disease Progression|1|||
127776500|NCT00634010|459809646|FG000|Overall Study|Non-Compliant|1|||
127776501|NCT00634010|459809647|FG001|Overall Study|Non-Compliant|1|||
127776502|NCT03690141|459809651|FG000|Overall Study|Adverse Event|5|||
127776503|NCT03690141|459809651|FG000|Overall Study|Withdrawal by Subject|3|||
127776504|NCT03690141|459809651|FG000|Overall Study|Physician Decision|4|||
127776505|NCT03690141|459809651|FG000|Overall Study|Disease progression|4|||
127776506|NCT01006265|459809652|FG000|Overall Study|Lost to Follow-up|1|||
127776507|NCT01006265|459809653|FG001|Overall Study|Lost to Follow-up|0|||
127776508|NCT01006265|459809654|FG002|Overall Study|Lost to Follow-up|1|||
127776509|NCT01006265|459809655|FG003|Overall Study|Lost to Follow-up|0|||
127776510|NCT01006265|459809652|FG000|Overall Study|Withdrawal by Subject|4|||
127776511|NCT01006265|459809653|FG001|Overall Study|Withdrawal by Subject|7|||
127776512|NCT01006265|459809654|FG002|Overall Study|Withdrawal by Subject|5|||
127776513|NCT01006265|459809655|FG003|Overall Study|Withdrawal by Subject|5|||
127776514|NCT01006265|459809652|FG000|Overall Study|Administrative reason|1|||
127776515|NCT01006265|459809653|FG001|Overall Study|Administrative reason|2|||
127776516|NCT01006265|459809654|FG002|Overall Study|Administrative reason|3|||
127776517|NCT01006265|459809655|FG003|Overall Study|Administrative reason|0|||
127776518|NCT00132496|459809658|FG000|Overall Study|Withdrawal by Subject|1|||
127776519|NCT00132496|459809659|FG001|Overall Study|Withdrawal by Subject|2|||
127776520|NCT00132496|459809658|FG000|Overall Study|Physician Decision|1|||
127776521|NCT00132496|459809659|FG001|Overall Study|Physician Decision|0|||
127776522|NCT01093625|459809664|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
127776523|NCT01093625|459809665|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
127776524|NCT01093625|459809664|FG000|2-Week Visit|Withdrawal by Subject|1|||
127776525|NCT01093625|459809665|FG001|2-Week Visit|Withdrawal by Subject|0|||
127776526|NCT01093625|459809664|FG000|1-Month Visit|Lost to Follow-up|2|||
127776527|NCT01093625|459809665|FG001|1-Month Visit|Lost to Follow-up|0|||
127776528|NCT01093625|459809664|FG000|3-Month Visit|Lost to Follow-up|2|||
127776529|NCT01093625|459809665|FG001|3-Month Visit|Lost to Follow-up|0|||
127776530|NCT01093625|459809664|FG000|6-Month Visit|Withdrawal by Subject|6|||
127776531|NCT01093625|459809665|FG001|6-Month Visit|Withdrawal by Subject|7|||
127776532|NCT01093625|459809664|FG000|6-Month Visit|Lost to Follow-up|2|||
127776533|NCT01093625|459809665|FG001|6-Month Visit|Lost to Follow-up|2|||
127776534|NCT01093625|459809664|FG000|1-Year Visit|Lost to Follow-up|5|||
127776535|NCT01093625|459809665|FG001|1-Year Visit|Lost to Follow-up|3|||
127776536|NCT02014740|459809666|FG000|Overall Study|Lost to Follow-up|4|||
127776537|NCT02014740|459809667|FG001|Overall Study|Lost to Follow-up|4|||
127776538|NCT02014740|459809666|FG000|Overall Study|Withdrawal by Subject|2|||
127776539|NCT02014740|459809667|FG001|Overall Study|Withdrawal by Subject|1|||
127776540|NCT01431534|459809668|FG000|Treatment Phase|Adverse Event|0|||
127776541|NCT01431534|459809669|FG001|Treatment Phase|Adverse Event|0|||
127776542|NCT01431534|459809670|FG002|Treatment Phase|Adverse Event|1|||
127776543|NCT01431534|459809668|FG000|Treatment Phase|Progressive Disease|4|||
127776544|NCT01431534|459809669|FG001|Treatment Phase|Progressive Disease|3|||
127776545|NCT01431534|459809670|FG002|Treatment Phase|Progressive Disease|10|||
127776546|NCT04427501|459809673|FG000|Overall Study|Death|0|||
127776547|NCT04427501|459809674|FG001|Overall Study|Death|0|||
127776548|NCT04427501|459809675|FG002|Overall Study|Death|0|||
127776549|NCT04427501|459809676|FG003|Overall Study|Death|0|||
127776550|NCT04427501|459809677|FG004|Overall Study|Death|0|||
127776551|NCT04427501|459809678|FG005|Overall Study|Death|15|||
127776552|NCT04427501|459809679|FG006|Overall Study|Death|0|||
127776553|NCT04427501|459809680|FG007|Overall Study|Death|0|||
127776554|NCT04427501|459809681|FG008|Overall Study|Death|0|||
127776555|NCT04427501|459809682|FG009|Overall Study|Death|0|||
127776556|NCT04427501|459809683|FG010|Overall Study|Death|0|||
127776557|NCT04427501|459809684|FG011|Overall Study|Death|0|||
127776558|NCT04427501|459809673|FG000|Overall Study|Lost to Follow-up|5|||
128025037|NCT02533674|460715991|FG004|Dose Level VIII|Progressive disease|0|||
128025038|NCT02533674|460715992|FG005|Dose Level VIII|Progressive disease|0|||
128025039|NCT02533674|460715993|FG006|Dose Level VIII|Progressive disease|0|||
128025040|NCT02533674|460715994|FG007|Dose Level VIII|Progressive disease|3|||
128025041|NCT02533674|460715987|FG000|Dose Level VIII|Withdrawal by Subject|0|||
128025042|NCT02533674|460715988|FG001|Dose Level VIII|Withdrawal by Subject|0|||
128025043|NCT02533674|460715989|FG002|Dose Level VIII|Withdrawal by Subject|0|||
128025044|NCT02533674|460715990|FG003|Dose Level VIII|Withdrawal by Subject|0|||
128025045|NCT02533674|460715991|FG004|Dose Level VIII|Withdrawal by Subject|0|||
128025046|NCT02533674|460715992|FG005|Dose Level VIII|Withdrawal by Subject|0|||
128025047|NCT02533674|460715993|FG006|Dose Level VIII|Withdrawal by Subject|0|||
128025048|NCT02533674|460715994|FG007|Dose Level VIII|Withdrawal by Subject|1|||
128025049|NCT02533674|460715987|FG000|Dose Level VIII|Treatment-related AE|0|||
128025050|NCT02533674|460715988|FG001|Dose Level VIII|Treatment-related AE|0|||
128025051|NCT02533674|460715989|FG002|Dose Level VIII|Treatment-related AE|0|||
128025052|NCT02533674|460715990|FG003|Dose Level VIII|Treatment-related AE|0|||
128025053|NCT02533674|460715991|FG004|Dose Level VIII|Treatment-related AE|0|||
128025054|NCT02533674|460715992|FG005|Dose Level VIII|Treatment-related AE|0|||
128025055|NCT02533674|460715993|FG006|Dose Level VIII|Treatment-related AE|0|||
128025056|NCT02533674|460715994|FG007|Dose Level VIII|Treatment-related AE|1|||
128025057|NCT02533674|460715987|FG000|Dose Level VIII|Never treated|0|||
128025058|NCT02533674|460715988|FG001|Dose Level VIII|Never treated|0|||
128025059|NCT02533674|460715989|FG002|Dose Level VIII|Never treated|0|||
128025060|NCT02533674|460715990|FG003|Dose Level VIII|Never treated|0|||
128025061|NCT02533674|460715991|FG004|Dose Level VIII|Never treated|0|||
128025062|NCT02533674|460715992|FG005|Dose Level VIII|Never treated|0|||
128025063|NCT02533674|460715993|FG006|Dose Level VIII|Never treated|0|||
128025064|NCT02533674|460715994|FG007|Dose Level VIII|Never treated|1|||
128025065|NCT04821245|460715998|FG000|Overall Study|Withdrawal by Subject|3|||
128025066|NCT04821245|460715998|FG000|Overall Study|Physician Decision|1|||
128025067|NCT04821245|460715998|FG000|Overall Study|Protocol Violation|5|||
128025068|NCT02123511|460715999|FG000|Overall Study|Cancelled treatment|1|||
128025069|NCT02123511|460716000|FG001|Overall Study|Cancelled treatment|0|||
128025070|NCT02123511|460715999|FG000|Overall Study|Incomplete data|1|||
127564657|NCT03339297|459035891|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
127564658|NCT03339297|459035892|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
127564659|NCT03339297|459035891|FG000|Overall Study|Adverse Event, Non-fatal|1|||
127564660|NCT03339297|459035892|FG001|Overall Study|Adverse Event, Non-fatal|0|||
127564661|NCT03339297|459035891|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
127564662|NCT03339297|459035892|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
127564663|NCT03339297|459035891|FG000|Overall Study|Patient Was Not Eligible|1|||
127564664|NCT03339297|459035892|FG001|Overall Study|Patient Was Not Eligible|0|||
127564665|NCT02213133|459035893|FG000|Overall Study|Participant discontinued study therapy|2|||
127564666|NCT02213133|459035894|FG001|Overall Study|Participant discontinued study therapy|0|||
127564667|NCT02213133|459035895|FG002|Overall Study|Participant discontinued study therapy|0|||
127564668|NCT02213133|459035893|FG000|Overall Study|Participant withdrew informed consent|2|||
127564669|NCT02213133|459035894|FG001|Overall Study|Participant withdrew informed consent|1|||
127564670|NCT02213133|459035895|FG002|Overall Study|Participant withdrew informed consent|2|||
127564671|NCT02213133|459035893|FG000|Overall Study|Disease progression|11|||
127564672|NCT02213133|459035894|FG001|Overall Study|Disease progression|2|||
127564673|NCT02213133|459035895|FG002|Overall Study|Disease progression|0|||
127564674|NCT02213133|459035893|FG000|Overall Study|Adverse Event (AE)|1|||
127564675|NCT02213133|459035894|FG001|Overall Study|Adverse Event (AE)|0|||
127564676|NCT02213133|459035895|FG002|Overall Study|Adverse Event (AE)|0|||
127564677|NCT02213133|459035893|FG000|Overall Study|Death|16|||
127564678|NCT02213133|459035894|FG001|Overall Study|Death|2|||
127564679|NCT02213133|459035895|FG002|Overall Study|Death|1|||
127564680|NCT02213133|459035893|FG000|Overall Study|Other|5|||
127564681|NCT02213133|459035894|FG001|Overall Study|Other|0|||
127564682|NCT02213133|459035895|FG002|Overall Study|Other|0|||
127564683|NCT04740905|459035902|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
127564684|NCT04740905|459035903|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|3|||
128025071|NCT02123511|460716000|FG001|Overall Study|Incomplete data|3|||
128025072|NCT02123511|460715999|FG000|Overall Study|Ineligible|0|||
127564685|NCT04740905|459035902|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|2|||
128025073|NCT02123511|460716000|FG001|Overall Study|Ineligible|1|||
128025074|NCT00604383|460716005|FG000|Overall Study|Withdrawal by Subject|33|||
128025075|NCT00604383|460716006|FG001|Overall Study|Withdrawal by Subject|31|||
128025076|NCT00604383|460716005|FG000|Overall Study|Lost to Follow-up|24|||
128025077|NCT00604383|460716006|FG001|Overall Study|Lost to Follow-up|19|||
128025078|NCT00604383|460716005|FG000|Overall Study|Death|14|||
127564686|NCT04740905|459035903|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
127776559|NCT04427501|459809674|FG001|Overall Study|Lost to Follow-up|1|||
128025079|NCT00604383|460716006|FG001|Overall Study|Death|22|||
128025080|NCT00604383|460716005|FG000|Overall Study|Adverse Event|16|||
128025081|NCT00604383|460716006|FG001|Overall Study|Adverse Event|9|||
128025082|NCT00604383|460716005|FG000|Overall Study|Physician Decision|0|||
128025083|NCT00604383|460716006|FG001|Overall Study|Physician Decision|3|||
128025084|NCT01122680|460716009|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
128025085|NCT01122680|460716010|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
128025086|NCT01122680|460716011|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
128025087|NCT01122680|460716012|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
128025088|NCT01122680|460716009|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
128025089|NCT01122680|460716010|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
128025090|NCT01122680|460716011|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
128025091|NCT01122680|460716012|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
128025092|NCT01122680|460716009|FG000|Period 1 (4 Weeks)|Other|1|||
128025093|NCT01122680|460716010|FG001|Period 1 (4 Weeks)|Other|1|||
128025094|NCT01122680|460716011|FG002|Period 1 (4 Weeks)|Other|0|||
128025095|NCT01122680|460716012|FG003|Period 1 (4 Weeks)|Other|0|||
128025096|NCT01122680|460716009|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
128025097|NCT01122680|460716010|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
128025098|NCT01122680|460716011|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
128025099|NCT01122680|460716012|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
128025100|NCT01122680|460716009|FG000|Period 2 (4 Weeks)|Other|1|||
128025101|NCT01122680|460716010|FG001|Period 2 (4 Weeks)|Other|0|||
128025102|NCT01122680|460716011|FG002|Period 2 (4 Weeks)|Other|0|||
128025103|NCT01122680|460716012|FG003|Period 2 (4 Weeks)|Other|0|||
128025104|NCT01122680|460716009|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
128025105|NCT01122680|460716010|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
128025106|NCT01122680|460716011|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
128025107|NCT01122680|460716012|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
128025108|NCT01122680|460716009|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
128025109|NCT01122680|460716010|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
128025110|NCT01122680|460716011|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
128025111|NCT01122680|460716012|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
128025112|NCT00576407|460716013|FG000|Overall Study|Death|7|||
128025113|NCT00576407|460716013|FG000|Overall Study|Physician Decision|1|||
128025114|NCT00225758|460716014|FG000|Overall Study|Adverse Event|4|||
128025115|NCT00756444|460716015|FG000|Overall Study|Adverse Event|1|||
128025116|NCT00756444|460716016|FG001|Overall Study|Adverse Event|1|||
128025117|NCT00756444|460716015|FG000|Overall Study|Withdrawal by Subject|6|||
128025118|NCT00756444|460716016|FG001|Overall Study|Withdrawal by Subject|8|||
128025119|NCT00756444|460716015|FG000|Overall Study|Lost to Follow-up|0|||
128025120|NCT00756444|460716016|FG001|Overall Study|Lost to Follow-up|1|||
128025121|NCT00756444|460716015|FG000|Overall Study|Death|5|||
128025122|NCT00756444|460716016|FG001|Overall Study|Death|4|||
128025123|NCT00756444|460716015|FG000|Overall Study|Disease Progression|2|||
128025124|NCT00756444|460716016|FG001|Overall Study|Disease Progression|7|||
128025125|NCT00756444|460716015|FG000|Overall Study|Ineligibility Determined|1|||
128025126|NCT00756444|460716016|FG001|Overall Study|Ineligibility Determined|0|||
128025127|NCT00564070|460716017|FG000|Overall Study|Lost to Follow-up|9|||
128025128|NCT00564070|460716018|FG001|Overall Study|Lost to Follow-up|7|||
128025129|NCT00564070|460716017|FG000|Overall Study|Worsening depression, referred to care|3|||
128025130|NCT00564070|460716018|FG001|Overall Study|Worsening depression, referred to care|0|||
128025131|NCT03142334|460716022|FG000|Overall Study|Death|18|||
128025132|NCT03142334|460716023|FG001|Overall Study|Death|33|||
128025133|NCT03142334|460716022|FG000|Overall Study|Withdrawal by Subject|15|||
128025134|NCT03142334|460716023|FG001|Overall Study|Withdrawal by Subject|11|||
128025135|NCT03142334|460716022|FG000|Overall Study|Ongoing on trial follow up|463|||
128025136|NCT03142334|460716023|FG001|Overall Study|Ongoing on trial follow up|454|||
128025137|NCT03071965|460716024|FG000|Overall Study|Adverse Event|0|||
128025138|NCT03071965|460716025|FG001|Overall Study|Adverse Event|0|||
128025139|NCT03071965|460716026|FG002|Overall Study|Adverse Event|1|||
128025140|NCT03071965|460716027|FG003|Overall Study|Adverse Event|0|||
128025141|NCT03071965|460716024|FG000|Overall Study|Death|0|||
128025142|NCT03071965|460716025|FG001|Overall Study|Death|0|||
127564687|NCT04740905|459035902|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
127776560|NCT04427501|459809675|FG002|Overall Study|Lost to Follow-up|2|||
127776561|NCT04427501|459809676|FG003|Overall Study|Lost to Follow-up|0|||
127776562|NCT04427501|459809677|FG004|Overall Study|Lost to Follow-up|2|||
128025143|NCT03071965|460716026|FG002|Overall Study|Death|1|||
128025144|NCT03071965|460716027|FG003|Overall Study|Death|1|||
127776563|NCT04427501|459809678|FG005|Overall Study|Lost to Follow-up|11|||
127776564|NCT04427501|459809679|FG006|Overall Study|Lost to Follow-up|10|||
128025145|NCT03071965|460716024|FG000|Overall Study|COVID-19|0|||
128025146|NCT03071965|460716025|FG001|Overall Study|COVID-19|1|||
128025147|NCT03071965|460716026|FG002|Overall Study|COVID-19|0|||
128025148|NCT03071965|460716027|FG003|Overall Study|COVID-19|1|||
128025149|NCT03071965|460716024|FG000|Overall Study|Other Health Reason|0|||
127776565|NCT04427501|459809680|FG007|Overall Study|Lost to Follow-up|10|||
128025150|NCT03071965|460716025|FG001|Overall Study|Other Health Reason|0|||
128025151|NCT03071965|460716026|FG002|Overall Study|Other Health Reason|0|||
128025152|NCT03071965|460716027|FG003|Overall Study|Other Health Reason|1|||
128025153|NCT05587998|460716028|FG000|Overall Study|Withdrawal by Subject|1|||
128025154|NCT05587998|460716029|FG001|Overall Study|Withdrawal by Subject|1|||
128025155|NCT05587998|460716028|FG000|Overall Study|Not treated|3|||
128025156|NCT05587998|460716029|FG001|Overall Study|Not treated|1|||
128025157|NCT05587998|460716028|FG000|Overall Study|Non-compliance with study procedures|0|||
128025158|NCT05587998|460716029|FG001|Overall Study|Non-compliance with study procedures|1|||
128025159|NCT03892915|460716030|FG000|Overall Study|Lost to Follow-up|6|||
128025160|NCT03892915|460716031|FG001|Overall Study|Lost to Follow-up|12|||
128025161|NCT03892915|460716030|FG000|Overall Study|Death|0|||
128025162|NCT03892915|460716031|FG001|Overall Study|Death|2|||
128025163|NCT03892915|460716030|FG000|Overall Study|Withdrawal by Subject|1|||
128025164|NCT03892915|460716031|FG001|Overall Study|Withdrawal by Subject|1|||
128025165|NCT03892915|460716030|FG000|Overall Study|unsuccessful delivery|13|||
128025166|NCT03892915|460716031|FG001|Overall Study|unsuccessful delivery|18|||
128025167|NCT01181128|460716032|FG000|Overall Study|Withdrawal by Subject|2|||
128025168|NCT01181128|460716033|FG001|Overall Study|Withdrawal by Subject|2|||
128025169|NCT01181128|460716034|FG002|Overall Study|Withdrawal by Subject|0|||
128025170|NCT01181128|460716032|FG000|Overall Study|Death|1|||
128025171|NCT01181128|460716033|FG001|Overall Study|Death|0|||
128025172|NCT01181128|460716034|FG002|Overall Study|Death|0|||
128025173|NCT01181128|460716032|FG000|Overall Study|Physician Decision|2|||
128025174|NCT01181128|460716033|FG001|Overall Study|Physician Decision|0|||
128025175|NCT01181128|460716034|FG002|Overall Study|Physician Decision|0|||
128025176|NCT01181128|460716032|FG000|Overall Study|Adverse Event|0|||
128025177|NCT01181128|460716033|FG001|Overall Study|Adverse Event|2|||
128025178|NCT01181128|460716034|FG002|Overall Study|Adverse Event|0|||
128025179|NCT01181128|460716032|FG000|Overall Study|Other|1|||
128025180|NCT01181128|460716033|FG001|Overall Study|Other|1|||
128025181|NCT01181128|460716034|FG002|Overall Study|Other|1|||
128025182|NCT01362270|460716037|FG000|Overall Study|Withdrawal by Subject|1|||
128025183|NCT01362270|460716038|FG001|Overall Study|Withdrawal by Subject|0|||
128025184|NCT01362270|460716037|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
128025185|NCT01362270|460716038|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
128025186|NCT01362270|460716037|FG000|Overall Study|Met excl. criteria before 1st session|1|||
128025187|NCT01362270|460716038|FG001|Overall Study|Met excl. criteria before 1st session|1|||
128025188|NCT02318277|460716039|FG000|Overall Study|Physician Decision|0|||
128025189|NCT02318277|460716040|FG001|Overall Study|Physician Decision|0|||
128025190|NCT02318277|460716041|FG002|Overall Study|Physician Decision|0|||
128025191|NCT02318277|460716042|FG003|Overall Study|Physician Decision|0|||
128025192|NCT02318277|460716043|FG004|Overall Study|Physician Decision|0|||
128025193|NCT02318277|460716044|FG005|Overall Study|Physician Decision|0|||
128025194|NCT02318277|460716045|FG006|Overall Study|Physician Decision|0|||
128025195|NCT02318277|460716046|FG007|Overall Study|Physician Decision|1|||
128025196|NCT02318277|460716039|FG000|Overall Study|Other|0|||
128025197|NCT02318277|460716040|FG001|Overall Study|Other|0|||
128025198|NCT02318277|460716041|FG002|Overall Study|Other|0|||
128025199|NCT02318277|460716042|FG003|Overall Study|Other|0|||
128025200|NCT02318277|460716043|FG004|Overall Study|Other|0|||
128025201|NCT02318277|460716044|FG005|Overall Study|Other|0|||
128025202|NCT02318277|460716045|FG006|Overall Study|Other|1|||
128025203|NCT02318277|460716046|FG007|Overall Study|Other|0|||
127564688|NCT04740905|459035903|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|0|||
127564689|NCT04740905|459035902|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|1|||
127564690|NCT04740905|459035903|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
127564691|NCT04740905|459035902|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
127776566|NCT04427501|459809681|FG008|Overall Study|Lost to Follow-up|2|||
127776567|NCT04427501|459809682|FG009|Overall Study|Lost to Follow-up|5|||
127776568|NCT04427501|459809683|FG010|Overall Study|Lost to Follow-up|2|||
127776569|NCT04427501|459809684|FG011|Overall Study|Lost to Follow-up|0|||
127776570|NCT04427501|459809673|FG000|Overall Study|Physician Decision|0|||
127564692|NCT04740905|459035903|FG001|Part 1 (Baseline up to Week 24)|Death|0|||
127776571|NCT04427501|459809674|FG001|Overall Study|Physician Decision|3|||
127776572|NCT04427501|459809675|FG002|Overall Study|Physician Decision|0|||
127776573|NCT04427501|459809676|FG003|Overall Study|Physician Decision|0|||
127776574|NCT04427501|459809677|FG004|Overall Study|Physician Decision|0|||
128025204|NCT02318277|460716039|FG000|Overall Study|Withdrawal by Subject|0|||
128025205|NCT02318277|460716040|FG001|Overall Study|Withdrawal by Subject|0|||
128025206|NCT02318277|460716041|FG002|Overall Study|Withdrawal by Subject|1|||
128025207|NCT02318277|460716042|FG003|Overall Study|Withdrawal by Subject|0|||
128025208|NCT02318277|460716043|FG004|Overall Study|Withdrawal by Subject|1|||
128025209|NCT02318277|460716044|FG005|Overall Study|Withdrawal by Subject|1|||
128025210|NCT02318277|460716045|FG006|Overall Study|Withdrawal by Subject|6|||
128025211|NCT02318277|460716046|FG007|Overall Study|Withdrawal by Subject|14|||
128025212|NCT02318277|460716039|FG000|Overall Study|Participant trial terminated by sponsor|0|||
128025213|NCT02318277|460716040|FG001|Overall Study|Participant trial terminated by sponsor|0|||
128025214|NCT02318277|460716041|FG002|Overall Study|Participant trial terminated by sponsor|1|||
128025215|NCT02318277|460716042|FG003|Overall Study|Participant trial terminated by sponsor|0|||
128025216|NCT02318277|460716043|FG004|Overall Study|Participant trial terminated by sponsor|1|||
128025217|NCT02318277|460716044|FG005|Overall Study|Participant trial terminated by sponsor|2|||
128025218|NCT02318277|460716045|FG006|Overall Study|Participant trial terminated by sponsor|5|||
127564693|NCT04740905|459035902|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|13|||
127564694|NCT04740905|459035903|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|12|||
127564695|NCT04740905|459035902|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|7|||
127564696|NCT04740905|459035903|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|6|||
127564697|NCT04740905|459035902|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|0|||
127564698|NCT04740905|459035903|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|4|||
127564699|NCT04740905|459035902|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|0|||
127564700|NCT04740905|459035903|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|4|||
127564701|NCT04740905|459035902|FG000|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
127564702|NCT04740905|459035903|FG001|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
127564703|NCT04740905|459035902|FG000|Part 2 (Week 24 to Week 72)|Death|1|||
127564704|NCT04740905|459035903|FG001|Part 2 (Week 24 to Week 72)|Death|2|||
127564705|NCT04740905|459035902|FG000|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|2|||
127564706|NCT04740905|459035903|FG001|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|1|||
127564707|NCT04740905|459035902|FG000|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|1|||
127564708|NCT04740905|459035903|FG001|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|0|||
127564709|NCT04740905|459035902|FG000|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|1|||
127564710|NCT04740905|459035903|FG001|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|0|||
127564711|NCT03051620|459035904|FG000|Overall Study|Lost to Follow-up|6|||
127564712|NCT03051620|459035904|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
127564713|NCT00393510|459035905|FG000|Overall Study|Physician Decision|3|||
127564714|NCT00393510|459035906|FG001|Overall Study|Physician Decision|9|||
127564715|NCT02412488|459035911|FG000|Overall Study|Lost to Follow-up|10|||
127564716|NCT02412488|459035911|FG000|Overall Study|Withdrawal by Subject|5|||
127564717|NCT02412488|459035911|FG000|Overall Study|Physician Decision|1|||
127564718|NCT02412488|459035911|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
127564719|NCT02412488|459035911|FG000|Overall Study|Reveal LINQ explant|1|||
127564720|NCT01989468|459035912|FG000|Overall Study|Adverse Event|10|||
127564721|NCT01989468|459035913|FG001|Overall Study|Adverse Event|15|||
127776575|NCT04427501|459809678|FG005|Overall Study|Physician Decision|0|||
127776576|NCT04427501|459809679|FG006|Overall Study|Physician Decision|2|||
127564722|NCT01989468|459035914|FG002|Overall Study|Adverse Event|4|||
127564723|NCT01989468|459035915|FG003|Overall Study|Adverse Event|5|||
127564724|NCT01989468|459035916|FG004|Overall Study|Adverse Event|4|||
127564725|NCT01989468|459035912|FG000|Overall Study|Lack of Efficacy|11|||
127564726|NCT01989468|459035913|FG001|Overall Study|Lack of Efficacy|11|||
127776577|NCT04427501|459809680|FG007|Overall Study|Physician Decision|0|||
127564727|NCT01989468|459035914|FG002|Overall Study|Lack of Efficacy|7|||
127564728|NCT01989468|459035915|FG003|Overall Study|Lack of Efficacy|4|||
127564729|NCT01989468|459035916|FG004|Overall Study|Lack of Efficacy|2|||
127564730|NCT01989468|459035912|FG000|Overall Study|Lost to Follow-up|5|||
127564731|NCT01989468|459035913|FG001|Overall Study|Lost to Follow-up|2|||
127564732|NCT01989468|459035914|FG002|Overall Study|Lost to Follow-up|0|||
127564733|NCT01989468|459035915|FG003|Overall Study|Lost to Follow-up|1|||
127564734|NCT01989468|459035916|FG004|Overall Study|Lost to Follow-up|1|||
127564735|NCT01989468|459035912|FG000|Overall Study|Physician Decision|4|||
127564736|NCT01989468|459035913|FG001|Overall Study|Physician Decision|1|||
127564737|NCT01989468|459035914|FG002|Overall Study|Physician Decision|0|||
127564738|NCT01989468|459035915|FG003|Overall Study|Physician Decision|1|||
127564739|NCT01989468|459035916|FG004|Overall Study|Physician Decision|0|||
127564740|NCT01989468|459035912|FG000|Overall Study|Pregnancy|0|||
127564741|NCT01989468|459035913|FG001|Overall Study|Pregnancy|1|||
127564742|NCT01989468|459035914|FG002|Overall Study|Pregnancy|0|||
127564743|NCT01989468|459035915|FG003|Overall Study|Pregnancy|0|||
127564744|NCT01989468|459035916|FG004|Overall Study|Pregnancy|0|||
127564745|NCT01989468|459035912|FG000|Overall Study|Technical Problems|3|||
127564746|NCT01989468|459035913|FG001|Overall Study|Technical Problems|1|||
127564747|NCT01989468|459035914|FG002|Overall Study|Technical Problems|3|||
127564748|NCT01989468|459035915|FG003|Overall Study|Technical Problems|1|||
127564749|NCT01989468|459035916|FG004|Overall Study|Technical Problems|0|||
127564750|NCT01989468|459035912|FG000|Overall Study|Subject Guardian Decision|11|||
127564751|NCT01989468|459035913|FG001|Overall Study|Subject Guardian Decision|6|||
127564752|NCT01989468|459035914|FG002|Overall Study|Subject Guardian Decision|4|||
127564753|NCT01989468|459035915|FG003|Overall Study|Subject Guardian Decision|4|||
127564754|NCT01989468|459035916|FG004|Overall Study|Subject Guardian Decision|1|||
127564755|NCT01989468|459035912|FG000|Overall Study|Death|3|||
127564756|NCT01989468|459035913|FG001|Overall Study|Death|0|||
127564757|NCT01989468|459035914|FG002|Overall Study|Death|1|||
127564758|NCT01989468|459035915|FG003|Overall Study|Death|0|||
127564759|NCT01989468|459035916|FG004|Overall Study|Death|0|||
127564760|NCT03222492|459035919|FG000|Overall Study|Withdrawal by Subject|0|||
127564761|NCT03222492|459035920|FG001|Overall Study|Withdrawal by Subject|0|||
127776578|NCT04427501|459809681|FG008|Overall Study|Physician Decision|0|||
127776579|NCT04427501|459809682|FG009|Overall Study|Physician Decision|0|||
127776580|NCT04427501|459809683|FG010|Overall Study|Physician Decision|0|||
127776581|NCT04427501|459809684|FG011|Overall Study|Physician Decision|0|||
127776582|NCT04427501|459809673|FG000|Overall Study|Withdrawal by Subject|9|||
127564762|NCT03222492|459035921|FG002|Overall Study|Withdrawal by Subject|1|||
127564763|NCT03222492|459035922|FG003|Overall Study|Withdrawal by Subject|0|||
127564764|NCT03222492|459035919|FG000|Overall Study|COVID-19 related|0|||
127564765|NCT03222492|459035920|FG001|Overall Study|COVID-19 related|0|||
127564766|NCT03222492|459035921|FG002|Overall Study|COVID-19 related|1|||
127564767|NCT03222492|459035922|FG003|Overall Study|COVID-19 related|0|||
127564768|NCT01224782|459035925|FG000|Overall Study|Lost to Follow-up|177|||
127564769|NCT01224782|459035925|FG000|Overall Study|Withdrawal by Subject|16|||
127564770|NCT01224782|459035925|FG000|Overall Study|Death|14|||
127564771|NCT01224782|459035925|FG000|Overall Study|Improvement|13|||
127564772|NCT01224782|459035925|FG000|Overall Study|Adverse Event|12|||
127564773|NCT01224782|459035925|FG000|Overall Study|Adverse Reaction|11|||
127564774|NCT01224782|459035925|FG000|Overall Study|Noncompliance|10|||
127564775|NCT01224782|459035925|FG000|Overall Study|Other|4|||
127564776|NCT01224782|459035925|FG000|Overall Study|Start of Dialysis|3|||
127564777|NCT01224782|459035925|FG000|Overall Study|Change of Treatment|1|||
127564778|NCT01224782|459035925|FG000|Overall Study|Financial Reasons|1|||
127564779|NCT01224782|459035925|FG000|Overall Study|Deterioration|1|||
127564780|NCT01224782|459035925|FG000|Overall Study|Transplantation|1|||
127564781|NCT00065429|459035928|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
127564782|NCT00065429|459035929|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
127564783|NCT00065429|459035930|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
127564784|NCT00065429|459035931|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
127564785|NCT00065429|459035932|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
127564786|NCT00065429|459035933|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
127564787|NCT00065429|459035934|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
127564788|NCT00065429|459035928|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
127564789|NCT00065429|459035929|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
127564790|NCT00065429|459035930|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
127564791|NCT00065429|459035931|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
127564792|NCT00065429|459035932|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
127564793|NCT00065429|459035933|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
127564794|NCT00065429|459035934|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
127564795|NCT00065429|459035928|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
127564796|NCT00065429|459035929|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
127564797|NCT00065429|459035930|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
127564798|NCT00065429|459035931|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
127564799|NCT00065429|459035932|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
127564800|NCT00065429|459035933|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
127564801|NCT00065429|459035934|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
127564802|NCT00065429|459035928|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
127564803|NCT00065429|459035929|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
127564804|NCT00065429|459035930|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
127564805|NCT00065429|459035931|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
127564806|NCT00065429|459035932|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
127564807|NCT00065429|459035933|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
127564808|NCT00065429|459035934|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
127564809|NCT00065429|459035928|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
127564810|NCT00065429|459035929|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
127564811|NCT00065429|459035930|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
127564812|NCT00065429|459035931|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
127564813|NCT00065429|459035932|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
127564814|NCT00065429|459035933|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
127564815|NCT00065429|459035934|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
127564816|NCT00065429|459035928|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
127564817|NCT00065429|459035929|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
127564818|NCT00065429|459035930|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
127564819|NCT00065429|459035931|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
127564820|NCT00065429|459035932|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
127688266|NCT03684044|459483618|FG001|Overall Study|Withdrawal by Subject|9|||
127688267|NCT03703336|459483619|FG000|Overall Study|Parent withdrew consent|29|||
127688268|NCT03703336|459483620|FG001|Overall Study|Parent withdrew consent|8|||
127564821|NCT00065429|459035933|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
127564822|NCT00065429|459035934|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
127564823|NCT00065429|459035928|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
127564824|NCT00065429|459035929|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
127564825|NCT00065429|459035930|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
127688269|NCT03703336|459483619|FG000|Overall Study|Migration|3|||
127564826|NCT00065429|459035931|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
127564827|NCT00065429|459035932|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
127688270|NCT03703336|459483620|FG001|Overall Study|Migration|3|||
127688271|NCT03703336|459483619|FG000|Overall Study|Protocol Violation|3|||
127688272|NCT03703336|459483620|FG001|Overall Study|Protocol Violation|1|||
127688273|NCT03703336|459483619|FG000|Overall Study|Physician Decision|2|||
127564828|NCT00065429|459035933|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
127564829|NCT00065429|459035934|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
127564830|NCT02509117|459035935|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
127564831|NCT02509117|459035936|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
127564832|NCT02509117|459035937|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
127564833|NCT02509117|459035938|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
127564834|NCT02509117|459035939|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
127564835|NCT02509117|459035940|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
127564836|NCT02509117|459035941|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
127564837|NCT02509117|459035942|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
127564838|NCT02509117|459035943|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
127564839|NCT02509117|459035944|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
127688274|NCT03703336|459483620|FG001|Overall Study|Physician Decision|0|||
127688275|NCT03703336|459483619|FG000|Overall Study|Adverse Event|0|||
127688276|NCT03703336|459483620|FG001|Overall Study|Adverse Event|2|||
127688277|NCT03703336|459483619|FG000|Overall Study|Lost to Follow-up|1|||
127688278|NCT03703336|459483620|FG001|Overall Study|Lost to Follow-up|0|||
127688279|NCT00595413|459483621|FG000|Overall Study|Adverse Event|0|||
127688280|NCT00595413|459483622|FG001|Overall Study|Adverse Event|2|||
127688281|NCT00595413|459483623|FG002|Overall Study|Adverse Event|1|||
127688282|NCT00595413|459483624|FG003|Overall Study|Adverse Event|1|||
127688283|NCT00595413|459483621|FG000|Overall Study|Lost to Follow-up|2|||
127688284|NCT00595413|459483622|FG001|Overall Study|Lost to Follow-up|2|||
127688285|NCT00595413|459483623|FG002|Overall Study|Lost to Follow-up|1|||
127688286|NCT00595413|459483624|FG003|Overall Study|Lost to Follow-up|3|||
127688287|NCT00595413|459483621|FG000|Overall Study|Death|0|||
127688288|NCT00595413|459483622|FG001|Overall Study|Death|0|||
127688289|NCT00595413|459483623|FG002|Overall Study|Death|1|||
127688290|NCT00595413|459483624|FG003|Overall Study|Death|0|||
127688291|NCT00595413|459483621|FG000|Overall Study|Other|5|||
127688292|NCT00595413|459483622|FG001|Overall Study|Other|1|||
127688293|NCT00595413|459483623|FG002|Overall Study|Other|5|||
127688294|NCT00595413|459483624|FG003|Overall Study|Other|0|||
127688295|NCT04149002|459483625|FG000|Overall Study|Lost to Follow-up|1|||
127688296|NCT04149002|459483626|FG001|Overall Study|Lost to Follow-up|0|||
127688297|NCT04149002|459483625|FG000|Overall Study|Withdrawal by Subject|1|||
127688298|NCT04149002|459483626|FG001|Overall Study|Withdrawal by Subject|0|||
127688299|NCT04629950|459483627|FG000|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
127688300|NCT04629950|459483628|FG001|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
127688301|NCT04629950|459483629|FG002|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
127688302|NCT04629950|459483630|FG003|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
127688303|NCT04629950|459483627|FG000|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
127688304|NCT04629950|459483628|FG001|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|2|||
127688305|NCT04629950|459483629|FG002|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
127688306|NCT04629950|459483630|FG003|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
127688307|NCT04629950|459483627|FG000|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
127688308|NCT04629950|459483628|FG001|Double-Blind Placebo Controlled Trial|Adverse Event|2|||
127688309|NCT04629950|459483629|FG002|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
127688310|NCT04629950|459483630|FG003|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
127688311|NCT04629950|459483627|FG000|Extension Study|Withdrawal by Subject|0|||
127688312|NCT04629950|459483628|FG001|Extension Study|Withdrawal by Subject|0|||
127688313|NCT04629950|459483629|FG002|Extension Study|Withdrawal by Subject|1|||
127688314|NCT04629950|459483630|FG003|Extension Study|Withdrawal by Subject|0|||
127688315|NCT04629950|459483627|FG000|Extension Study|Adverse Event|0|||
127688316|NCT04629950|459483628|FG001|Extension Study|Adverse Event|0|||
127688317|NCT04629950|459483629|FG002|Extension Study|Adverse Event|0|||
127688318|NCT04629950|459483630|FG003|Extension Study|Adverse Event|1|||
127688319|NCT03233633|459483631|FG000|Overall Study|Adverse Event|2|||
127688320|NCT03233633|459483631|FG000|Overall Study|Less Than 3 Days of Data|6|||
127688321|NCT02088853|459483632|FG000|Overall Study|Pregnancy|1|||
127688322|NCT02088853|459483633|FG001|Overall Study|Pregnancy|0|||
127688323|NCT01198145|459483635|FG000|Overall Study|Withdrawal by Subject|1|||
127688324|NCT01198145|459483636|FG001|Overall Study|Withdrawal by Subject|1|||
128025219|NCT02318277|460716046|FG007|Overall Study|Participant trial terminated by sponsor|16|||
128025220|NCT02318277|460716039|FG000|Overall Study|Lost to Follow-up|1|||
128025221|NCT02318277|460716040|FG001|Overall Study|Lost to Follow-up|0|||
128025222|NCT02318277|460716041|FG002|Overall Study|Lost to Follow-up|1|||
128025223|NCT02318277|460716042|FG003|Overall Study|Lost to Follow-up|0|||
128025224|NCT02318277|460716043|FG004|Overall Study|Lost to Follow-up|0|||
128025225|NCT02318277|460716044|FG005|Overall Study|Lost to Follow-up|0|||
128025226|NCT02318277|460716045|FG006|Overall Study|Lost to Follow-up|3|||
128025227|NCT02318277|460716046|FG007|Overall Study|Lost to Follow-up|4|||
128025228|NCT02318277|460716039|FG000|Overall Study|Death|5|||
128025229|NCT02318277|460716040|FG001|Overall Study|Death|3|||
128025230|NCT02318277|460716041|FG002|Overall Study|Death|1|||
128025231|NCT02318277|460716042|FG003|Overall Study|Death|4|||
128025232|NCT02318277|460716043|FG004|Overall Study|Death|6|||
128025233|NCT02318277|460716044|FG005|Overall Study|Death|5|||
128025234|NCT02318277|460716045|FG006|Overall Study|Death|34|||
128025235|NCT02318277|460716046|FG007|Overall Study|Death|58|||
128025236|NCT02318277|460716039|FG000|Overall Study|Transitioned to Hospice|0|||
128025237|NCT02318277|460716040|FG001|Overall Study|Transitioned to Hospice|0|||
128025238|NCT02318277|460716041|FG002|Overall Study|Transitioned to Hospice|0|||
128025239|NCT02318277|460716042|FG003|Overall Study|Transitioned to Hospice|0|||
128025240|NCT02318277|460716043|FG004|Overall Study|Transitioned to Hospice|0|||
128025241|NCT02318277|460716044|FG005|Overall Study|Transitioned to Hospice|1|||
128025242|NCT02318277|460716045|FG006|Overall Study|Transitioned to Hospice|0|||
128025243|NCT02318277|460716046|FG007|Overall Study|Transitioned to Hospice|0|||
128025244|NCT01520714|460716047|FG000|Overall Study|Protocol Violation|0|||
128025245|NCT01520714|460716048|FG001|Overall Study|Protocol Violation|3|||
128025246|NCT01520714|460716047|FG000|Overall Study|Adverse Event|0|||
128025247|NCT01520714|460716048|FG001|Overall Study|Adverse Event|2|||
128025248|NCT01520714|460716047|FG000|Overall Study|Lack of Efficacy|0|||
128025249|NCT01520714|460716048|FG001|Overall Study|Lack of Efficacy|1|||
128025250|NCT00754559|460716051|FG000|Overall Study|Adverse Event|15|||
128025251|NCT00754559|460716051|FG000|Overall Study|Protocol Violation|11|||
128025252|NCT00754559|460716051|FG000|Overall Study|Lack of Efficacy|10|||
128025253|NCT00754559|460716051|FG000|Overall Study|Lost to Follow-up|2|||
128025254|NCT00754559|460716051|FG000|Overall Study|Administrative reason|1|||
128025255|NCT00754559|460716051|FG000|Overall Study|Other|5|||
128025256|NCT00754559|460716051|FG000|Overall Study|Withdrawal by Subject|3|||
127564840|NCT02509117|459035935|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
127564841|NCT02509117|459035936|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
127564842|NCT02509117|459035937|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
127564843|NCT02509117|459035938|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
127564844|NCT02509117|459035939|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
127564845|NCT02509117|459035940|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
127564846|NCT02509117|459035941|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
127564847|NCT02509117|459035942|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
127564848|NCT02509117|459035943|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
128025257|NCT01663987|460716052|FG000|Overall Study|Adverse Event|7|||
128025258|NCT01663987|460716053|FG001|Overall Study|Adverse Event|2|||
128025259|NCT01663987|460716052|FG000|Overall Study|Lost to Follow-up|1|||
128025260|NCT01663987|460716053|FG001|Overall Study|Lost to Follow-up|1|||
128025261|NCT01663987|460716052|FG000|Overall Study|Withdrawal by Subject|2|||
128025262|NCT01663987|460716053|FG001|Overall Study|Withdrawal by Subject|3|||
128025263|NCT01663987|460716052|FG000|Overall Study|Other reason not defined above|3|||
128025264|NCT01663987|460716053|FG001|Overall Study|Other reason not defined above|0|||
128025265|NCT00676689|460716055|FG000|Overall Study|Screen Failure|2|||
128025266|NCT00676689|460716055|FG000|Overall Study|Death|2|||
128025267|NCT00676689|460716055|FG000|Overall Study|Lost to Follow-up|4|||
128025268|NCT00676689|460716055|FG000|Overall Study|Physician Decision|1|||
127776583|NCT04427501|459809674|FG001|Overall Study|Withdrawal by Subject|2|||
127776584|NCT04427501|459809675|FG002|Overall Study|Withdrawal by Subject|2|||
128025269|NCT00676689|460716055|FG000|Overall Study|Withdrawal by Subject|3|||
128025270|NCT00676689|460716055|FG000|Overall Study|Continuing FU|49|||
128025271|NCT03721965|460716056|FG000|Overall Study|Death|1|||
128025272|NCT03721965|460716056|FG000|Overall Study|Study Terminated by Sponsor|1|||
128025273|NCT00563316|460716057|FG000|Overall Study|Adverse Event|2|||
128025274|NCT00563316|460716057|FG000|Overall Study|Physician Decision|1|||
128025275|NCT00563316|460716057|FG000|Overall Study|Lost to Follow-up|2|||
128025276|NCT00563316|460716057|FG000|Overall Study|Death|1|||
128025277|NCT00563316|460716057|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
128025278|NCT00563316|460716057|FG000|Overall Study|Other|1|||
127776585|NCT04427501|459809676|FG003|Overall Study|Withdrawal by Subject|3|||
128025279|NCT04595370|460716062|FG000|Overall Study|Subjects randomised, not treated, Protocol Deviation|1|||
128025280|NCT04595370|460716063|FG001|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
128025281|NCT04595370|460716064|FG002|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
128025282|NCT04595370|460716065|FG003|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
128025283|NCT04595370|460716066|FG004|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
128025284|NCT04595370|460716067|FG005|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
128025285|NCT04595370|460716062|FG000|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
128025286|NCT04595370|460716063|FG001|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
128025287|NCT04595370|460716064|FG002|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|1|||
128025288|NCT04595370|460716065|FG003|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
128025289|NCT04595370|460716066|FG004|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
128025290|NCT04595370|460716067|FG005|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
128025291|NCT04595370|460716062|FG000|Overall Study|Adverse Event|0|||
128025292|NCT04595370|460716063|FG001|Overall Study|Adverse Event|4|||
128025293|NCT04595370|460716064|FG002|Overall Study|Adverse Event|3|||
128025294|NCT04595370|460716065|FG003|Overall Study|Adverse Event|1|||
128025295|NCT04595370|460716066|FG004|Overall Study|Adverse Event|1|||
128025296|NCT04595370|460716067|FG005|Overall Study|Adverse Event|1|||
128025297|NCT04595370|460716062|FG000|Overall Study|Withdrawal of Consent|1|||
128025298|NCT04595370|460716063|FG001|Overall Study|Withdrawal of Consent|1|||
127564849|NCT02509117|459035944|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
127564850|NCT02509117|459035935|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
127564851|NCT02509117|459035936|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
127564852|NCT02509117|459035937|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
127564853|NCT02509117|459035938|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
127564854|NCT02509117|459035939|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
127564855|NCT02509117|459035940|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
127564856|NCT02509117|459035941|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
127564857|NCT02509117|459035942|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
127564858|NCT02509117|459035943|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
127564859|NCT02509117|459035944|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
127564860|NCT00548184|459035947|FG000|Overall Study|Adverse Event|3|||
127564861|NCT00548184|459035947|FG000|Overall Study|took other drug|1|||
127564862|NCT00548184|459035947|FG000|Overall Study|Found Her2 negative|1|||
127564863|NCT00796991|459035948|FG000|Overall Study|Adverse Event|0|||
127564864|NCT00796991|459035949|FG001|Overall Study|Adverse Event|0|||
127564865|NCT00796991|459035950|FG002|Overall Study|Adverse Event|1|||
127564866|NCT00796991|459035948|FG000|Overall Study|Death|2|||
127564867|NCT00796991|459035949|FG001|Overall Study|Death|0|||
127564868|NCT00796991|459035950|FG002|Overall Study|Death|0|||
127564869|NCT00796991|459035948|FG000|Overall Study|Disease Progression|10|||
127564870|NCT00796991|459035949|FG001|Overall Study|Disease Progression|9|||
127564871|NCT00796991|459035950|FG002|Overall Study|Disease Progression|7|||
127688325|NCT01697969|459483639|FG000|Overall Study|Did not meet inc/exc criteria|3|||
127688326|NCT01561989|459483640|FG000|Overall Study|accural target not met.|5|||
127688327|NCT01561989|459483641|FG001|Overall Study|accural target not met.|6|||
127688328|NCT03447249|459483644|FG000|Overall Study|Adverse Event|1|||
127688329|NCT03447249|459483645|FG001|Overall Study|Adverse Event|0|||
127688330|NCT03447249|459483644|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
127688331|NCT03447249|459483645|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
127688332|NCT03447249|459483644|FG000|Overall Study|Other|3|||
127688333|NCT03447249|459483645|FG001|Overall Study|Other|0|||
127688334|NCT03930420|459483646|FG000|Overall Study|Withdrawal by Subject|7|||
127688335|NCT03930420|459483647|FG001|Overall Study|Withdrawal by Subject|9|||
127688336|NCT01388361|459483648|FG000|Overall Study|Adverse Event|0|||
127688337|NCT01388361|459483649|FG001|Overall Study|Adverse Event|5|||
127688338|NCT01388361|459483650|FG002|Overall Study|Adverse Event|1|||
127688339|NCT01388361|459483648|FG000|Overall Study|Protocol Violation|0|||
127688340|NCT01388361|459483649|FG001|Overall Study|Protocol Violation|0|||
127688341|NCT01388361|459483650|FG002|Overall Study|Protocol Violation|2|||
127688342|NCT01388361|459483648|FG000|Overall Study|Withdrawal criteria|12|||
127688343|NCT01388361|459483649|FG001|Overall Study|Withdrawal criteria|7|||
127688344|NCT01388361|459483650|FG002|Overall Study|Withdrawal criteria|10|||
127688345|NCT01388361|459483648|FG000|Overall Study|Unclassified|0|||
127688346|NCT01388361|459483649|FG001|Overall Study|Unclassified|0|||
127688347|NCT01388361|459483650|FG002|Overall Study|Unclassified|1|||
127688348|NCT01070069|459483651|FG000|Overall Study|Death|1|||
127688349|NCT01070069|459483652|FG001|Overall Study|Death|0|||
127688350|NCT01070069|459483653|FG002|Overall Study|Death|2|||
127688351|NCT01070069|459483654|FG003|Overall Study|Death|0|||
127688352|NCT01070069|459483655|FG004|Overall Study|Death|1|||
127688353|NCT01070069|459483651|FG000|Overall Study|Withdrawal by Subject|1|||
127688354|NCT01070069|459483652|FG001|Overall Study|Withdrawal by Subject|1|||
127688355|NCT01070069|459483653|FG002|Overall Study|Withdrawal by Subject|4|||
127688356|NCT01070069|459483654|FG003|Overall Study|Withdrawal by Subject|0|||
127688357|NCT01070069|459483655|FG004|Overall Study|Withdrawal by Subject|0|||
128025299|NCT04595370|460716064|FG002|Overall Study|Withdrawal of Consent|1|||
128025300|NCT04595370|460716065|FG003|Overall Study|Withdrawal of Consent|0|||
128025301|NCT04595370|460716066|FG004|Overall Study|Withdrawal of Consent|0|||
128025302|NCT04595370|460716067|FG005|Overall Study|Withdrawal of Consent|0|||
128025303|NCT04595370|460716062|FG000|Overall Study|Death|0|||
128025304|NCT04595370|460716063|FG001|Overall Study|Death|1|||
128025305|NCT04595370|460716064|FG002|Overall Study|Death|0|||
128025306|NCT04595370|460716065|FG003|Overall Study|Death|0|||
128025307|NCT04595370|460716066|FG004|Overall Study|Death|1|||
128025308|NCT04595370|460716067|FG005|Overall Study|Death|0|||
128025309|NCT04595370|460716062|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
128025310|NCT04595370|460716063|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
128025311|NCT04595370|460716064|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
128025312|NCT04595370|460716065|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
128025313|NCT04595370|460716066|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
127688358|NCT01070069|459483651|FG000|Overall Study|Lost to Follow-up|4|||
127688359|NCT01070069|459483652|FG001|Overall Study|Lost to Follow-up|1|||
127688360|NCT01070069|459483653|FG002|Overall Study|Lost to Follow-up|0|||
127688361|NCT01070069|459483654|FG003|Overall Study|Lost to Follow-up|0|||
127688362|NCT01070069|459483655|FG004|Overall Study|Lost to Follow-up|3|||
127688363|NCT00419341|459483656|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
127688364|NCT00419341|459483656|FG000|Wash in/Wash Out Period|Adverse Event|2|||
127688365|NCT00419341|459483656|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
127688366|NCT00419341|459483656|FG000|Efficacy Period|Withdrawal by Subject|6|||
127688367|NCT00419341|459483656|FG000|Efficacy Period|Protocol Violation|1|||
127688368|NCT00419341|459483656|FG000|Efficacy Period|Lost to Follow-up|1|||
127688369|NCT00419341|459483656|FG000|Efficacy Period|Non-compliance|1|||
127688370|NCT00419341|459483656|FG000|Efficacy Period|Termination of study site|1|||
127688371|NCT01499199|459483657|FG000|Overall Study|Adverse Event|1|||
127688372|NCT01499199|459483657|FG000|Overall Study|Lack of Efficacy|1|||
127688373|NCT02539225|459483664|FG000|Part A|Adverse Event|13|||
127688374|NCT02539225|459483665|FG001|Part A|Adverse Event|4|||
127688375|NCT02539225|459483664|FG000|Part A|Withdrawal by Subject|2|||
127688376|NCT02539225|459483665|FG001|Part A|Withdrawal by Subject|4|||
127688377|NCT02539225|459483664|FG000|Part A|Physician Decision|4|||
127688378|NCT02539225|459483665|FG001|Part A|Physician Decision|7|||
127688379|NCT02539225|459483664|FG000|Part A|Did Not Receive study Drug|1|||
127688380|NCT02539225|459483665|FG001|Part A|Did Not Receive study Drug|1|||
127688381|NCT02539225|459483664|FG000|Pre Treatment for Part B|Progressive disease|1|||
127688382|NCT02539225|459483665|FG001|Pre Treatment for Part B|Progressive disease|1|||
127688383|NCT02539225|459483664|FG000|Pre Treatment for Part B|Adverse Event|1|||
127688384|NCT02539225|459483665|FG001|Pre Treatment for Part B|Adverse Event|1|||
127688385|NCT02539225|459483664|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
127688386|NCT02539225|459483665|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
128025314|NCT04595370|460716067|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
128025315|NCT04595370|460716062|FG000|Overall Study|Withdrawal by Subject|0|||
127564872|NCT00796991|459035948|FG000|Overall Study|Study Drug Toxicity|3|||
127564873|NCT00796991|459035949|FG001|Overall Study|Study Drug Toxicity|3|||
127564874|NCT00796991|459035950|FG002|Overall Study|Study Drug Toxicity|5|||
127564875|NCT00796991|459035948|FG000|Overall Study|Withdrawal by Subject|0|||
127564876|NCT00796991|459035949|FG001|Overall Study|Withdrawal by Subject|0|||
127564877|NCT00796991|459035950|FG002|Overall Study|Withdrawal by Subject|1|||
127564878|NCT00313781|459035951|FG000|Before Crossover|Death|22|||
127564879|NCT00313781|459035952|FG001|Before Crossover|Death|8|||
127564880|NCT00313781|459035953|FG002|Before Crossover|Death|0|||
127564881|NCT00313781|459035951|FG000|Before Crossover|Lost to Follow-up|0|||
127564882|NCT00313781|459035952|FG001|Before Crossover|Lost to Follow-up|3|||
127564883|NCT00313781|459035953|FG002|Before Crossover|Lost to Follow-up|0|||
127564884|NCT00313781|459035951|FG000|Before Crossover|Withdrawal by Subject|3|||
127564885|NCT00313781|459035952|FG001|Before Crossover|Withdrawal by Subject|1|||
127564886|NCT00313781|459035953|FG002|Before Crossover|Withdrawal by Subject|0|||
127564887|NCT00313781|459035951|FG000|Before Crossover|Other|45|||
127564888|NCT00313781|459035952|FG001|Before Crossover|Other|30|||
127564889|NCT00313781|459035953|FG002|Before Crossover|Other|0|||
127564890|NCT00313781|459035951|FG000|Before Crossover|Crossover|0|||
127564891|NCT00313781|459035952|FG001|Before Crossover|Crossover|37|||
127564892|NCT00313781|459035953|FG002|Before Crossover|Crossover|0|||
127564893|NCT00313781|459035951|FG000|Before Crossover|Randomized, not treated|5|||
127564894|NCT00313781|459035952|FG001|Before Crossover|Randomized, not treated|0|||
127564895|NCT00313781|459035953|FG002|Before Crossover|Randomized, not treated|0|||
127564896|NCT00313781|459035951|FG000|After Crossover|Death|0|||
127564897|NCT00313781|459035952|FG001|After Crossover|Death|0|||
127564898|NCT00313781|459035953|FG002|After Crossover|Death|6|||
127564899|NCT00313781|459035951|FG000|After Crossover|Withdrawal by Subject|0|||
127564900|NCT00313781|459035952|FG001|After Crossover|Withdrawal by Subject|0|||
127564901|NCT00313781|459035953|FG002|After Crossover|Withdrawal by Subject|3|||
127564902|NCT00313781|459035951|FG000|After Crossover|Other|0|||
127564903|NCT00313781|459035952|FG001|After Crossover|Other|0|||
127564904|NCT00313781|459035953|FG002|After Crossover|Other|18|||
127564905|NCT03567343|459035955|FG000|Overall Study|Lost to Follow-up|2|||
127564906|NCT03567343|459035956|FG001|Overall Study|Lost to Follow-up|1|||
127564907|NCT03567343|459035955|FG000|Overall Study|No longer eligible|2|||
127564908|NCT03567343|459035956|FG001|Overall Study|No longer eligible|1|||
127564909|NCT03567343|459035955|FG000|Overall Study|Adverse Event|1|||
127564910|NCT03567343|459035956|FG001|Overall Study|Adverse Event|0|||
127564911|NCT03567343|459035955|FG000|Overall Study|Protocol Violation|1|||
127564912|NCT03567343|459035956|FG001|Overall Study|Protocol Violation|1|||
127564913|NCT00834080|459035957|FG000|Overall Study|Adverse Event|7|||
127564914|NCT00834080|459035957|FG000|Overall Study|Lost to Follow-up|7|||
127564915|NCT00834080|459035957|FG000|Overall Study|Withdrawal by Subject|5|||
127564916|NCT00834080|459035957|FG000|Overall Study|Other - Pregnancy|1|||
127564917|NCT00834080|459035957|FG000|Overall Study|Other - False positive tests of the UDS|1|||
127564918|NCT00834080|459035957|FG000|Overall Study|Physician Decision|1|||
127564919|NCT00834080|459035957|FG000|Overall Study|Subject Relocated|1|||
127564920|NCT03865316|459037979|FG000|Overall Study|Procedure Cancelled|4|||
127564921|NCT03865316|459037979|FG000|Overall Study|Equipment failure|4|||
127564922|NCT03658876|459037985|FG000|Overall Study|Protocol Violation|3|||
127776586|NCT04427501|459809677|FG004|Overall Study|Withdrawal by Subject|7|||
127776587|NCT04427501|459809678|FG005|Overall Study|Withdrawal by Subject|25|||
127776588|NCT04427501|459809679|FG006|Overall Study|Withdrawal by Subject|15|||
127776589|NCT04427501|459809680|FG007|Overall Study|Withdrawal by Subject|7|||
127776590|NCT04427501|459809681|FG008|Overall Study|Withdrawal by Subject|4|||
127776591|NCT04427501|459809682|FG009|Overall Study|Withdrawal by Subject|1|||
127776592|NCT04427501|459809683|FG010|Overall Study|Withdrawal by Subject|4|||
127776593|NCT04427501|459809684|FG011|Overall Study|Withdrawal by Subject|0|||
127776594|NCT04427501|459809673|FG000|Overall Study|Other - as reported by the investigator|1|||
127776595|NCT04427501|459809674|FG001|Overall Study|Other - as reported by the investigator|0|||
128025316|NCT04595370|460716063|FG001|Overall Study|Withdrawal by Subject|0|||
127564923|NCT03658876|459037986|FG001|Overall Study|Protocol Violation|2|||
127564924|NCT03658876|459037985|FG000|Overall Study|Withdrawal by Subject|2|||
127564925|NCT03658876|459037986|FG001|Overall Study|Withdrawal by Subject|0|||
127564926|NCT03658876|459037985|FG000|Overall Study|Death|0|||
127564927|NCT03658876|459037986|FG001|Overall Study|Death|1|||
127564928|NCT03658876|459037985|FG000|Overall Study|Intercurrent illness|6|||
127564929|NCT03658876|459037986|FG001|Overall Study|Intercurrent illness|4|||
127564930|NCT03658876|459037985|FG000|Overall Study|Transplantation/other operation|1|||
127564931|NCT03658876|459037986|FG001|Overall Study|Transplantation/other operation|5|||
127564932|NCT01330017|459037987|FG000|Overall Study|Adverse Event|0|||
127564933|NCT01330017|459037988|FG001|Overall Study|Adverse Event|1|||
127564934|NCT01330017|459037989|FG002|Overall Study|Adverse Event|1|||
127564935|NCT01330017|459037990|FG003|Overall Study|Adverse Event|4|||
127564936|NCT01330017|459037991|FG004|Overall Study|Adverse Event|0|||
127564937|NCT01330017|459037987|FG000|Overall Study|Withdrawal by Subject|0|||
127564938|NCT01330017|459037988|FG001|Overall Study|Withdrawal by Subject|0|||
127564939|NCT01330017|459037989|FG002|Overall Study|Withdrawal by Subject|1|||
127564940|NCT01330017|459037990|FG003|Overall Study|Withdrawal by Subject|0|||
127564941|NCT01330017|459037991|FG004|Overall Study|Withdrawal by Subject|1|||
127564942|NCT01330017|459037987|FG000|Overall Study|Lost to Follow-up|0|||
127564943|NCT01330017|459037988|FG001|Overall Study|Lost to Follow-up|0|||
127564944|NCT01330017|459037989|FG002|Overall Study|Lost to Follow-up|1|||
127776596|NCT04427501|459809675|FG002|Overall Study|Other - as reported by the investigator|0|||
127776597|NCT04427501|459809676|FG003|Overall Study|Other - as reported by the investigator|0|||
127776598|NCT04427501|459809677|FG004|Overall Study|Other - as reported by the investigator|0|||
127776599|NCT04427501|459809678|FG005|Overall Study|Other - as reported by the investigator|6|||
127776600|NCT04427501|459809679|FG006|Overall Study|Other - as reported by the investigator|6|||
127776601|NCT04427501|459809680|FG007|Overall Study|Other - as reported by the investigator|0|||
127776602|NCT04427501|459809681|FG008|Overall Study|Other - as reported by the investigator|0|||
127776603|NCT04427501|459809682|FG009|Overall Study|Other - as reported by the investigator|0|||
127776604|NCT04427501|459809683|FG010|Overall Study|Other - as reported by the investigator|0|||
127776605|NCT04427501|459809684|FG011|Overall Study|Other - as reported by the investigator|0|||
127776606|NCT04427501|459809673|FG000|Overall Study|Other|0|||
127776607|NCT04427501|459809674|FG001|Overall Study|Other|0|||
127776608|NCT04427501|459809675|FG002|Overall Study|Other|0|||
127776609|NCT04427501|459809676|FG003|Overall Study|Other|0|||
127776610|NCT04427501|459809677|FG004|Overall Study|Other|0|||
127776611|NCT04427501|459809678|FG005|Overall Study|Other|0|||
127776612|NCT04427501|459809679|FG006|Overall Study|Other|0|||
127776613|NCT04427501|459809680|FG007|Overall Study|Other|0|||
127776614|NCT04427501|459809681|FG008|Overall Study|Other|0|||
127776615|NCT04427501|459809682|FG009|Overall Study|Other|0|||
127776616|NCT04427501|459809683|FG010|Overall Study|Other|0|||
127776617|NCT04427501|459809684|FG011|Overall Study|Other|1|||
127776618|NCT00999713|459809685|FG000|Overall Study|Physician Decision|2|||
127776619|NCT00999713|459809686|FG001|Overall Study|Physician Decision|0|||
127776620|NCT00639223|459809687|FG000|Overall Study|Lost to Follow-up|0|||
127776621|NCT00639223|459809688|FG001|Overall Study|Lost to Follow-up|2|||
127776622|NCT07052682|459809691|FG000|Overall Study|Withdrawal by Subject|4|||
127776623|NCT04890054|459811553|FG000|Overall Study|Lost to Follow-up|202|||
127776624|NCT04890054|459811554|FG001|Overall Study|Lost to Follow-up|219|||
127776625|NCT01310803|459811558|FG000|Overall Study|Subject terminated by Sponsor|1|||
127776626|NCT01310803|459811559|FG001|Overall Study|Subject terminated by Sponsor|0|||
127776627|NCT01306890|459811560|FG000|Overall Study|Adverse Event|2|||
127776628|NCT01306890|459811560|FG000|Overall Study|Death|1223|||
127776629|NCT01306890|459811560|FG000|Overall Study|Lost to Follow-up|58|||
127776630|NCT01306890|459811560|FG000|Overall Study|Withdrawal by Subject|88|||
127776631|NCT01306890|459811560|FG000|Overall Study|Unspecified reasons|104|||
127776632|NCT01306890|459811560|FG000|Overall Study|Study Termination|3|||
127776633|NCT01306890|459811560|FG000|Overall Study|No discontinuation documentation|41|||
127776634|NCT01940354|459811565|FG000|Overall Study|Withdrawal by Subject|4|||
127776635|NCT01940354|459811566|FG001|Overall Study|Withdrawal by Subject|2|||
127776636|NCT03872453|459811567|FG000|Overall Study|Adverse Event|1|||
127776637|NCT03872453|459811568|FG001|Overall Study|Adverse Event|1|||
127776638|NCT03872453|459811569|FG002|Overall Study|Adverse Event|0|||
127776639|NCT03872453|459811570|FG003|Overall Study|Adverse Event|0|||
127776640|NCT03872453|459811567|FG000|Overall Study|Lost to Follow-up|8|||
127776641|NCT03872453|459811568|FG001|Overall Study|Lost to Follow-up|7|||
127776642|NCT03872453|459811569|FG002|Overall Study|Lost to Follow-up|4|||
127776643|NCT03872453|459811570|FG003|Overall Study|Lost to Follow-up|4|||
127776644|NCT03872453|459811567|FG000|Overall Study|Never Treated Migraine|19|||
127776645|NCT03872453|459811568|FG001|Overall Study|Never Treated Migraine|17|||
127776646|NCT03872453|459811569|FG002|Overall Study|Never Treated Migraine|13|||
127776647|NCT03872453|459811570|FG003|Overall Study|Never Treated Migraine|12|||
127776648|NCT03872453|459811567|FG000|Overall Study|Pregnancy|1|||
128025317|NCT04595370|460716064|FG002|Overall Study|Withdrawal by Subject|1|||
128025318|NCT04595370|460716065|FG003|Overall Study|Withdrawal by Subject|0|||
127564945|NCT01330017|459037990|FG003|Overall Study|Lost to Follow-up|0|||
127564946|NCT01330017|459037991|FG004|Overall Study|Lost to Follow-up|0|||
127564947|NCT01330017|459037987|FG000|Overall Study|Protocol Violation|0|||
127776649|NCT03872453|459811568|FG001|Overall Study|Pregnancy|0|||
127776650|NCT03872453|459811569|FG002|Overall Study|Pregnancy|0|||
127776651|NCT03872453|459811570|FG003|Overall Study|Pregnancy|0|||
127776652|NCT03872453|459811567|FG000|Overall Study|Protocol Deviation|2|||
127776653|NCT03872453|459811568|FG001|Overall Study|Protocol Deviation|0|||
127776654|NCT03872453|459811569|FG002|Overall Study|Protocol Deviation|0|||
127776655|NCT03872453|459811570|FG003|Overall Study|Protocol Deviation|2|||
127776656|NCT03872453|459811567|FG000|Overall Study|Withdrawal by Subject|0|||
127776657|NCT03872453|459811568|FG001|Overall Study|Withdrawal by Subject|1|||
127776658|NCT03872453|459811569|FG002|Overall Study|Withdrawal by Subject|2|||
127776659|NCT03872453|459811570|FG003|Overall Study|Withdrawal by Subject|0|||
127776660|NCT03872453|459811567|FG000|Overall Study|Other Than Specified|1|||
127776661|NCT03872453|459811568|FG001|Overall Study|Other Than Specified|0|||
127776662|NCT03872453|459811569|FG002|Overall Study|Other Than Specified|0|||
127776663|NCT03872453|459811570|FG003|Overall Study|Other Than Specified|0|||
127776664|NCT00352885|459811571|FG000|Overall Study|Withdrawal by Subject|0|||
127776665|NCT00352885|459811572|FG001|Overall Study|Withdrawal by Subject|3|||
127776666|NCT00352885|459811571|FG000|Overall Study|Development of major depression|0|||
127776667|NCT00352885|459811572|FG001|Overall Study|Development of major depression|1|||
127776668|NCT00352885|459811571|FG000|Overall Study|Progression of metastatic melanoma|5|||
127776669|NCT00352885|459811572|FG001|Overall Study|Progression of metastatic melanoma|3|||
127776670|NCT00352885|459811571|FG000|Overall Study|Side effects of IL-2 administration|1|||
127776671|NCT00352885|459811572|FG001|Overall Study|Side effects of IL-2 administration|0|||
127564948|NCT01330017|459037988|FG001|Overall Study|Protocol Violation|0|||
127564949|NCT01330017|459037989|FG002|Overall Study|Protocol Violation|0|||
127564950|NCT01330017|459037990|FG003|Overall Study|Protocol Violation|1|||
127564951|NCT01330017|459037991|FG004|Overall Study|Protocol Violation|0|||
127564952|NCT01330017|459037987|FG000|Overall Study|Unknown Reason|5|||
127564953|NCT01330017|459037988|FG001|Overall Study|Unknown Reason|3|||
127564954|NCT01330017|459037989|FG002|Overall Study|Unknown Reason|5|||
127564955|NCT01330017|459037990|FG003|Overall Study|Unknown Reason|7|||
127776672|NCT03873493|459811573|FG000|Overall Study|Withdrawal by Subject|1|||
127776673|NCT03873493|459811573|FG000|Overall Study|Death|9|||
127776674|NCT03873493|459811573|FG000|Overall Study|Lost to Follow-up|1|||
127776675|NCT03873493|459811573|FG000|Overall Study|Study Terminated by Sponsor|1|||
127776676|NCT03873493|459811573|FG000|Overall Study|Other|2|||
127776677|NCT00440700|459811575|FG000|Overall Study|Withdrawal by Subject|8|||
127776678|NCT00440700|459811576|FG001|Overall Study|Withdrawal by Subject|8|||
127776679|NCT00440700|459811577|FG002|Overall Study|Withdrawal by Subject|4|||
127776680|NCT03739762|459811578|FG000|Overall Study|Lost to Follow-up|1|||
127776681|NCT03739762|459811579|FG001|Overall Study|Lost to Follow-up|1|||
127776682|NCT03739762|459811578|FG000|Overall Study|Withdrawal by Subject|2|||
127776683|NCT03739762|459811579|FG001|Overall Study|Withdrawal by Subject|6|||
127776684|NCT02294682|459811580|FG000|Overall Study|Could not swallow pills|1|||
127776685|NCT02294682|459811581|FG001|Overall Study|Could not swallow pills|0|||
127776686|NCT02224599|459811582|FG000|Overall Study|Physician Decision|1|||
127776687|NCT02224599|459811582|FG000|Overall Study|Progression of Disease|1|||
127776688|NCT00733304|459811583|FG000|Overall Study|Adverse Event|3|||
127776689|NCT00733304|459811584|FG001|Overall Study|Adverse Event|0|||
127776690|NCT00733304|459811585|FG002|Overall Study|Adverse Event|0|||
127776691|NCT00733304|459811583|FG000|Overall Study|Lack of Efficacy|0|||
127776692|NCT00733304|459811584|FG001|Overall Study|Lack of Efficacy|0|||
127776693|NCT00733304|459811585|FG002|Overall Study|Lack of Efficacy|2|||
127776694|NCT00733304|459811583|FG000|Overall Study|Lost to Follow-up|0|||
127776695|NCT00733304|459811584|FG001|Overall Study|Lost to Follow-up|1|||
127776696|NCT00733304|459811585|FG002|Overall Study|Lost to Follow-up|0|||
127776697|NCT00733304|459811583|FG000|Overall Study|Physician Decision|3|||
127776698|NCT00733304|459811584|FG001|Overall Study|Physician Decision|1|||
127776699|NCT00733304|459811585|FG002|Overall Study|Physician Decision|3|||
127776700|NCT00733304|459811583|FG000|Overall Study|Withdrawal by Subject|1|||
127776701|NCT00733304|459811584|FG001|Overall Study|Withdrawal by Subject|1|||
127776702|NCT00733304|459811585|FG002|Overall Study|Withdrawal by Subject|0|||
127776703|NCT01187550|459811586|FG000|Overall Study|Protocol Violation|3|||
127776704|NCT01187550|459811587|FG001|Overall Study|Protocol Violation|1|||
127776705|NCT01187550|459811586|FG000|Overall Study|Other|3|||
127776706|NCT01187550|459811587|FG001|Overall Study|Other|0|||
127776707|NCT01187550|459811586|FG000|Overall Study|Randomized but not treated|8|||
127776708|NCT01187550|459811587|FG001|Overall Study|Randomized but not treated|0|||
127776709|NCT00129623|459811588|FG000|Overall Study|Adverse Event|3|||
127776710|NCT00129623|459811589|FG001|Overall Study|Adverse Event|7|||
127776711|NCT00129623|459811588|FG000|Overall Study|Refused Treatment|5|||
127776712|NCT00129623|459811589|FG001|Overall Study|Refused Treatment|3|||
127776713|NCT00129623|459811588|FG000|Overall Study|Failure to Return|1|||
128025319|NCT04595370|460716066|FG004|Overall Study|Withdrawal by Subject|2|||
128025320|NCT04595370|460716067|FG005|Overall Study|Withdrawal by Subject|0|||
127776714|NCT00129623|459811589|FG001|Overall Study|Failure to Return|1|||
128025321|NCT04595370|460716062|FG000|Overall Study|Lost to Follow-up|0|||
128025322|NCT04595370|460716063|FG001|Overall Study|Lost to Follow-up|0|||
127564956|NCT01330017|459037991|FG004|Overall Study|Unknown Reason|2|||
127564957|NCT02616146|459037992|FG000|Overall Study|Adverse Event|64|||
127776715|NCT00129623|459811588|FG000|Overall Study|Relocated job out of state|1|||
127776716|NCT00129623|459811589|FG001|Overall Study|Relocated job out of state|0|||
127776717|NCT00129623|459811588|FG000|Overall Study|Uncertainty to return|0|||
127776718|NCT00129623|459811589|FG001|Overall Study|Uncertainty to return|1|||
127776719|NCT03155373|459811590|FG000|Overall Study|No longer required surgery|1|||
127776720|NCT03155373|459811590|FG000|Overall Study|Protocol Violation|1|||
127776721|NCT03155373|459811590|FG000|Overall Study|Death|2|||
127776722|NCT03155373|459811590|FG000|Overall Study|Withdrawal by Subject|3|||
127776723|NCT02616614|459811591|FG000|Overall Study|Withdrawal by Subject|10|||
127776724|NCT02616614|459811592|FG001|Overall Study|Withdrawal by Subject|5|||
128025323|NCT04595370|460716064|FG002|Overall Study|Lost to Follow-up|0|||
128025324|NCT04595370|460716065|FG003|Overall Study|Lost to Follow-up|0|||
128025325|NCT04595370|460716066|FG004|Overall Study|Lost to Follow-up|1|||
128025326|NCT04595370|460716067|FG005|Overall Study|Lost to Follow-up|0|||
128025327|NCT04595370|460716062|FG000|Overall Study|Participants discontinued study treatment due to other reasons|0|||
128025328|NCT04595370|460716063|FG001|Overall Study|Participants discontinued study treatment due to other reasons|2|||
128025329|NCT04595370|460716064|FG002|Overall Study|Participants discontinued study treatment due to other reasons|2|||
128025330|NCT04595370|460716065|FG003|Overall Study|Participants discontinued study treatment due to other reasons|0|||
128025331|NCT04595370|460716066|FG004|Overall Study|Participants discontinued study treatment due to other reasons|1|||
128025332|NCT04595370|460716067|FG005|Overall Study|Participants discontinued study treatment due to other reasons|0|||
128025333|NCT01341990|460716068|FG000|Overall Study|Adverse Event|0|||
128025334|NCT01341990|460716069|FG001|Overall Study|Adverse Event|1|||
128025335|NCT01341990|460716068|FG000|Overall Study|Torn Study Lens|1|||
128025336|NCT01341990|460716069|FG001|Overall Study|Torn Study Lens|0|||
128025337|NCT01341990|460716068|FG000|Overall Study|Withdrawal by Subject|2|||
128025338|NCT01341990|460716069|FG001|Overall Study|Withdrawal by Subject|0|||
128025339|NCT01751685|460716071|FG000|6-mo Followup|Missed study visit|1|||
128025340|NCT01751685|460716072|FG001|6-mo Followup|Missed study visit|0|||
128025341|NCT01751685|460716071|FG000|6-mo Followup|Withdrawal by Subject|2|||
128025342|NCT01751685|460716072|FG001|6-mo Followup|Withdrawal by Subject|2|||
128025343|NCT01751685|460716071|FG000|6-mo Followup|Lost to Follow-up|0|||
128025344|NCT01751685|460716072|FG001|6-mo Followup|Lost to Follow-up|1|||
128025345|NCT01751685|460716071|FG000|12-mo Followup|Lost to Follow-up|5|||
128025346|NCT01751685|460716072|FG001|12-mo Followup|Lost to Follow-up|0|||
128025347|NCT00694161|460716073|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
128025348|NCT00694161|460716073|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
128025349|NCT00694161|460716073|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
128025350|NCT00800384|460716081|FG000|Overall Study|Withdrawal by Subject|24|||
128025351|NCT00800384|460716082|FG001|Overall Study|Withdrawal by Subject|17|||
128025352|NCT00800384|460716081|FG000|Overall Study|Lost to Follow-up|17|||
128025353|NCT00800384|460716082|FG001|Overall Study|Lost to Follow-up|26|||
128025354|NCT02562040|460717715|FG000|Overall Study|Lost to Follow-up|20|||
128025355|NCT02562040|460717716|FG001|Overall Study|Lost to Follow-up|28|||
128025356|NCT02562040|460717715|FG000|Overall Study|Withdrawal by Subject|8|||
128025357|NCT02562040|460717716|FG001|Overall Study|Withdrawal by Subject|7|||
128025358|NCT02562040|460717715|FG000|Overall Study|Adverse Event|1|||
128025359|NCT02562040|460717716|FG001|Overall Study|Adverse Event|0|||
128025360|NCT00903344|460717717|FG000|Overall Study|Pregnancy|2|||
128025361|NCT00903344|460717718|FG001|Overall Study|Pregnancy|3|||
128025362|NCT00903344|460717717|FG000|Overall Study|Lost to Follow-up|3|||
128025363|NCT00903344|460717718|FG001|Overall Study|Lost to Follow-up|0|||
128025364|NCT01524705|460717719|FG000|Overall Study|Adverse Event|2|||
128025365|NCT01524705|460717720|FG001|Overall Study|Adverse Event|0|||
128025366|NCT01524705|460717719|FG000|Overall Study|Death|1|||
128025367|NCT01524705|460717720|FG001|Overall Study|Death|0|||
128025368|NCT01524705|460717719|FG000|Overall Study|Lost to Follow-up|0|||
128025369|NCT01524705|460717720|FG001|Overall Study|Lost to Follow-up|1|||
128025370|NCT01524705|460717719|FG000|Overall Study|Withdrawal by Subject|0|||
128025371|NCT01524705|460717720|FG001|Overall Study|Withdrawal by Subject|1|||
128025372|NCT01524705|460717719|FG000|Overall Study|Pancreatic Cancer|0|||
128025373|NCT01524705|460717720|FG001|Overall Study|Pancreatic Cancer|1|||
128025374|NCT01755156|460717721|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
128025375|NCT01755156|460717722|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
128025376|NCT01755156|460717721|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
127564958|NCT02616146|459037993|FG001|Overall Study|Adverse Event|24|||
128025377|NCT01755156|460717722|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
128025378|NCT01755156|460717721|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
128025379|NCT01755156|460717722|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
128025380|NCT01755156|460717721|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
128025381|NCT01755156|460717722|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
128025382|NCT01755156|460717721|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
128025383|NCT01755156|460717722|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
128025384|NCT01755156|460717721|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
128025385|NCT01755156|460717722|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
128025386|NCT01755156|460717721|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
128025387|NCT01755156|460717722|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
127564959|NCT02616146|459037992|FG000|Overall Study|Lost to Follow-up|23|||
127776725|NCT02616614|459811593|FG002|Overall Study|Withdrawal by Subject|6|||
127776726|NCT02616614|459811591|FG000|Overall Study|Physician Decision|2|||
127776727|NCT02616614|459811592|FG001|Overall Study|Physician Decision|1|||
127776728|NCT02616614|459811593|FG002|Overall Study|Physician Decision|0|||
127776729|NCT02616614|459811591|FG000|Overall Study|Adverse Event|1|||
127776730|NCT02616614|459811592|FG001|Overall Study|Adverse Event|4|||
127776731|NCT02616614|459811593|FG002|Overall Study|Adverse Event|1|||
127776732|NCT02616614|459811591|FG000|Overall Study|Protocol Violation|0|||
127776733|NCT02616614|459811592|FG001|Overall Study|Protocol Violation|3|||
127776734|NCT02616614|459811593|FG002|Overall Study|Protocol Violation|1|||
127776735|NCT02616614|459811591|FG000|Overall Study|Prohibited Medication|12|||
127776736|NCT02616614|459811592|FG001|Overall Study|Prohibited Medication|9|||
127776737|NCT02616614|459811593|FG002|Overall Study|Prohibited Medication|5|||
127776738|NCT02616614|459811591|FG000|Overall Study|More than 3 applications missed|6|||
127776739|NCT02616614|459811592|FG001|Overall Study|More than 3 applications missed|8|||
127776740|NCT02616614|459811593|FG002|Overall Study|More than 3 applications missed|1|||
127776741|NCT02616614|459811591|FG000|Overall Study|Lost to Follow-up|31|||
127776742|NCT02616614|459811592|FG001|Overall Study|Lost to Follow-up|28|||
127776743|NCT02616614|459811593|FG002|Overall Study|Lost to Follow-up|13|||
127776744|NCT02616614|459811591|FG000|Overall Study|Pregnancy|2|||
127776745|NCT02616614|459811592|FG001|Overall Study|Pregnancy|0|||
127776746|NCT02616614|459811593|FG002|Overall Study|Pregnancy|1|||
127776747|NCT02616614|459811591|FG000|Overall Study|Other|1|||
127776748|NCT02616614|459811592|FG001|Overall Study|Other|2|||
127776749|NCT02616614|459811593|FG002|Overall Study|Other|1|||
127776750|NCT00596934|459811596|FG000|Overall Study|Protocol Violation|1|||
127776751|NCT00596934|459811596|FG000|Overall Study|Withdrawal by Subject|1|||
127776752|NCT02445755|459811597|FG000|Overall Study|Withdrawal by Subject|2|||
127776753|NCT02445755|459811597|FG000|Overall Study|Protocol Violation|6|||
127776754|NCT02445755|459811597|FG000|Overall Study|Screen Failure|5|||
127776755|NCT03239483|459811598|FG000|Overall Study|Lost to Follow-up|1|||
127776756|NCT03239483|459811599|FG001|Overall Study|Lost to Follow-up|0|||
127776757|NCT03239483|459811598|FG000|Overall Study|Withdrawal by Subject|1|||
127776758|NCT03239483|459811599|FG001|Overall Study|Withdrawal by Subject|0|||
127776759|NCT01214187|459811600|FG000|Overall Study|Adverse Event|6|||
127776760|NCT01214187|459811601|FG001|Overall Study|Adverse Event|2|||
127776761|NCT01214187|459811600|FG000|Overall Study|Death|1|||
127776762|NCT01214187|459811601|FG001|Overall Study|Death|1|||
127776763|NCT01214187|459811600|FG000|Overall Study|Withdrawal by Subject|0|||
127776764|NCT01214187|459811601|FG001|Overall Study|Withdrawal by Subject|3|||
127776765|NCT01233869|459811605|FG000|Initial Treatment Period (24 Months)|Death|1|||
127776766|NCT01233869|459811606|FG001|Initial Treatment Period (24 Months)|Death|0|||
127776767|NCT01233869|459811607|FG002|Initial Treatment Period (24 Months)|Death|0|||
127776768|NCT01233869|459811608|FG003|Initial Treatment Period (24 Months)|Death|0|||
127776769|NCT01233869|459811605|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
127776770|NCT01233869|459811606|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
127776771|NCT01233869|459811607|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
127776772|NCT01233869|459811608|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
127776773|NCT01233869|459811605|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
127776774|NCT01233869|459811606|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
127776775|NCT01233869|459811607|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
127776776|NCT01233869|459811608|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
127776777|NCT01233869|459811605|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
127776778|NCT01233869|459811606|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
127776779|NCT01233869|459811607|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
127776780|NCT01233869|459811608|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
127776781|NCT01233869|459811605|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
127776782|NCT01233869|459811606|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
127776783|NCT01233869|459811607|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
127776784|NCT01233869|459811608|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
127776785|NCT01233869|459811605|FG000|Extended Treatment Period (46 Months)|Other|3|||
127776786|NCT01233869|459811606|FG001|Extended Treatment Period (46 Months)|Other|0|||
127776787|NCT01233869|459811607|FG002|Extended Treatment Period (46 Months)|Other|0|||
127776788|NCT01233869|459811608|FG003|Extended Treatment Period (46 Months)|Other|3|||
127776789|NCT01233869|459811605|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
127776790|NCT01233869|459811606|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
127776791|NCT01233869|459811607|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
127776792|NCT01233869|459811608|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
127776793|NCT03678103|459811609|FG000|Overall Study|Withdrawn prior to completion|4|||
127776794|NCT00537485|459811610|FG000|Overall Study|Adverse Event|10|||
127776795|NCT00537485|459811611|FG001|Overall Study|Adverse Event|5|||
127776796|NCT00537485|459811610|FG000|Overall Study|Withdrawal by Subject|3|||
127776797|NCT00537485|459811611|FG001|Overall Study|Withdrawal by Subject|2|||
127564960|NCT02616146|459037993|FG001|Overall Study|Lost to Follow-up|13|||
127564961|NCT02616146|459037992|FG000|Overall Study|Non-compliance with study protocol|2|||
127564962|NCT02616146|459037993|FG001|Overall Study|Non-compliance with study protocol|0|||
127564963|NCT02616146|459037992|FG000|Overall Study|Non-compliance with study drug|4|||
127564964|NCT02616146|459037993|FG001|Overall Study|Non-compliance with study drug|2|||
127564965|NCT02616146|459037992|FG000|Overall Study|Pregnancy|2|||
127564966|NCT02616146|459037993|FG001|Overall Study|Pregnancy|2|||
127564967|NCT02616146|459037992|FG000|Overall Study|Pregnancy wish|3|||
127564968|NCT02616146|459037993|FG001|Overall Study|Pregnancy wish|0|||
127564969|NCT02616146|459037992|FG000|Overall Study|Protocol Violation|6|||
127564970|NCT02616146|459037993|FG001|Overall Study|Protocol Violation|3|||
127564971|NCT02616146|459037992|FG000|Overall Study|Study terminated by sponsor|1372|||
127564972|NCT02616146|459037993|FG001|Overall Study|Study terminated by sponsor|432|||
127564973|NCT02616146|459037992|FG000|Overall Study|Participant moved|4|||
127564974|NCT02616146|459037993|FG001|Overall Study|Participant moved|3|||
127564975|NCT02616146|459037992|FG000|Overall Study|Withdrawal by Subject|30|||
127564976|NCT02616146|459037993|FG001|Overall Study|Withdrawal by Subject|24|||
127564977|NCT02616146|459037992|FG000|Overall Study|Physician Decision|2|||
127564978|NCT02616146|459037993|FG001|Overall Study|Physician Decision|1|||
127688387|NCT02539225|459483664|FG000|Pre Treatment for Part B|Physician Decision|2|||
127688388|NCT02539225|459483665|FG001|Pre Treatment for Part B|Physician Decision|0|||
127688389|NCT02539225|459483664|FG000|Part B|Adverse Event|4|||
127688390|NCT02539225|459483665|FG001|Part B|Adverse Event|4|||
127688391|NCT02539225|459483664|FG000|Part B|Withdrawal by Subject|0|||
128025388|NCT01755156|460717721|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
128025389|NCT01755156|460717722|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
128025390|NCT01755156|460717721|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
127688392|NCT02539225|459483665|FG001|Part B|Withdrawal by Subject|3|||
127688393|NCT02539225|459483664|FG000|Part B|Physician Decision|0|||
127688394|NCT02539225|459483665|FG001|Part B|Physician Decision|9|||
127688395|NCT04766034|459483666|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
127688396|NCT04766034|459483667|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
127688397|NCT04766034|459483668|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
127688398|NCT04766034|459483669|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
127688399|NCT04766034|459483670|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
127688400|NCT04766034|459483666|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
127688401|NCT04766034|459483667|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
127688402|NCT04766034|459483668|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
127688403|NCT04766034|459483669|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
127688404|NCT04766034|459483670|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
127688405|NCT04766034|459483666|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
127688406|NCT04766034|459483667|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
127688407|NCT04766034|459483668|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
127688408|NCT04766034|459483669|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
127688409|NCT04766034|459483670|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
127688410|NCT04766034|459483666|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
127688411|NCT04766034|459483667|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
127688412|NCT04766034|459483668|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
127688413|NCT04766034|459483669|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
127688414|NCT04766034|459483670|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
127688415|NCT03783026|459484946|FG000|Treatment Phase|Adverse Event|15|||
127688416|NCT03783026|459484946|FG000|Treatment Phase|Lack of Efficacy|11|||
127688417|NCT03783026|459484946|FG000|Treatment Phase|Withdrawal by Subject|6|||
127688418|NCT03783026|459484946|FG000|Treatment Phase|Lost to Follow-up|2|||
127688419|NCT03783026|459484946|FG000|Treatment Phase|Protocol Deviation|8|||
127688420|NCT03783026|459484946|FG000|Treatment Phase|Did Not Receive Treatment|1|||
127688421|NCT03783026|459484946|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
127688422|NCT04814186|459484947|FG000|Treatment Phase|Adverse Event|1|||
127688423|NCT04814186|459484947|FG000|Treatment Phase|Death|6|||
127688424|NCT04814186|459484947|FG000|Treatment Phase|Withdrawal by Subject|2|||
127688425|NCT04814186|459484947|FG000|Treatment Phase|Other|1|||
127688426|NCT04814186|459484947|FG000|Follow-Up Phase|Adverse Event|1|||
127688427|NCT04814186|459484947|FG000|Follow-Up Phase|Death|6|||
128025391|NCT01755156|460717722|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
127564979|NCT01221272|459037994|FG000|Period 1|Adverse Event|2|||
127564980|NCT01221272|459037995|FG001|Period 1|Adverse Event|0|||
127564981|NCT01221272|459037994|FG000|Period 1|Consent Withdrawal|0|||
127564982|NCT01221272|459037995|FG001|Period 1|Consent Withdrawal|1|||
127564983|NCT01221272|459037994|FG000|Period 1|Significant Dosing Noncompliance|0|||
127564984|NCT01221272|459037995|FG001|Period 1|Significant Dosing Noncompliance|1|||
127564985|NCT01221272|459037994|FG000|Period 2|Adverse Event|0|||
127564986|NCT01221272|459037995|FG001|Period 2|Adverse Event|2|||
127564987|NCT01106092|459037998|FG000|Overall Study|Withdrawal by Subject|0|||
127564988|NCT01106092|459037999|FG001|Overall Study|Withdrawal by Subject|0|||
127564989|NCT01106092|459038000|FG002|Overall Study|Withdrawal by Subject|0|||
127564990|NCT01106092|459038001|FG003|Overall Study|Withdrawal by Subject|1|||
127564991|NCT04839562|459038008|FG000|Overall Study|Withdrawal by Subject|0|||
127564992|NCT04839562|459038009|FG001|Overall Study|Withdrawal by Subject|1|||
127564993|NCT04839562|459038008|FG000|Overall Study|Physician Decision|0|||
127564994|NCT04839562|459038009|FG001|Overall Study|Physician Decision|1|||
127564995|NCT01246466|459038012|FG000|Overall Study|Death|1|||
127564996|NCT01246466|459038012|FG000|Overall Study|Withdrawal by Subject|1|||
127564997|NCT00877773|459038013|FG000|Overall Study|Disease Progression|44|||
127564998|NCT03328182|459038016|FG000|Overall Study|Withdrawal by Subject|1|||
127564999|NCT03328182|459038016|FG000|Overall Study|Protocol Violation|2|||
127565000|NCT03328182|459038016|FG000|Overall Study|No Product Evaluated|1|||
127565001|NCT01012219|459038017|FG000|Period 1|Withdrawal by Subject|1|||
127565002|NCT01012219|459038017|FG000|Period 2|Withdrawal by Subject|1|||
127565003|NCT01350544|459038026|FG000|Overall Study|Administrative Withdrawal|0|||
127565004|NCT01350544|459038027|FG001|Overall Study|Administrative Withdrawal|1|||
127565005|NCT01350544|459038026|FG000|Overall Study|Death|1|||
127565006|NCT01350544|459038027|FG001|Overall Study|Death|2|||
127565007|NCT01350544|459038026|FG000|Overall Study|Moved out of LA County|2|||
127565008|NCT01350544|459038027|FG001|Overall Study|Moved out of LA County|2|||
127565009|NCT01350544|459038026|FG000|Overall Study|Medical Issues|1|||
127565010|NCT01350544|459038027|FG001|Overall Study|Medical Issues|1|||
127565011|NCT01350544|459038026|FG000|Overall Study|Withdrawal by Subject|0|||
127565012|NCT01350544|459038027|FG001|Overall Study|Withdrawal by Subject|1|||
127565013|NCT01350544|459038026|FG000|Overall Study|Incarceration|1|||
127565014|NCT01350544|459038027|FG001|Overall Study|Incarceration|0|||
127565015|NCT01350544|459038026|FG000|Overall Study|Lost to Follow-up|18|||
127565016|NCT01350544|459038027|FG001|Overall Study|Lost to Follow-up|15|||
127565017|NCT01444092|459038028|FG000|Overall Study|Adverse Event|8|||
127565018|NCT01444092|459038028|FG000|Overall Study|Protocol Violation|1|||
127565019|NCT01444092|459038028|FG000|Overall Study|Withdrawal by Subject|1|||
127565020|NCT01444092|459038028|FG000|Overall Study|Other Eligibility criteria|7|||
127776798|NCT00537485|459811610|FG000|Overall Study|Withdrawal by Subject|1|||
127776799|NCT00537485|459811611|FG001|Overall Study|Withdrawal by Subject|3|||
127565021|NCT01673347|459038029|FG000|Overall Study|failure of allograft|7|||
127565022|NCT02661178|459038031|FG000|Part 1|Protocol Violation|1|||
127565023|NCT02661178|459038032|FG001|Part 1|Protocol Violation|0|||
127565024|NCT02661178|459038033|FG002|Part 1|Protocol Violation|0|||
127565025|NCT02661178|459038034|FG003|Part 1|Protocol Violation|0|||
127565026|NCT02661178|459038035|FG004|Part 1|Protocol Violation|0|||
127565027|NCT02661178|459038036|FG005|Part 1|Protocol Violation|0|||
127565028|NCT02661178|459038037|FG006|Part 1|Protocol Violation|0|||
127565029|NCT02661178|459038038|FG007|Part 1|Protocol Violation|0|||
127565030|NCT02661178|459038039|FG008|Part 1|Protocol Violation|0|||
127565031|NCT02661178|459038040|FG009|Part 1|Protocol Violation|0|||
127688428|NCT04814186|459484947|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
127565032|NCT02661178|459038041|FG010|Part 1|Protocol Violation|0|||
127565033|NCT02661178|459038042|FG011|Part 1|Protocol Violation|0|||
127688429|NCT04814186|459484947|FG000|Follow-Up Phase|Other|1|||
127688430|NCT04043455|459484953|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
127688431|NCT04043455|459484954|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
127688432|NCT04043455|459484955|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
127688433|NCT04043455|459484956|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
127688434|NCT04043455|459484957|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
127688435|NCT04043455|459484958|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
127688436|NCT04043455|459484953|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
127688437|NCT04043455|459484954|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
127688438|NCT04043455|459484955|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
127776800|NCT00537485|459811610|FG000|Overall Study|Physician Decision|1|||
127776801|NCT00537485|459811611|FG001|Overall Study|Physician Decision|0|||
128025392|NCT01755156|460717721|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
128025393|NCT01755156|460717722|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
128025394|NCT01755156|460717721|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
128025395|NCT01755156|460717722|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
127565034|NCT02661178|459038043|FG012|Part 1|Protocol Violation|0|||
127565035|NCT02661178|459038044|FG013|Part 1|Protocol Violation|0|||
127565036|NCT02661178|459038045|FG014|Part 1|Protocol Violation|0|||
127565037|NCT01242813|459038047|FG000|Overall Study|Lost to Follow-up|2|||
127565038|NCT01369329|459038049|FG000|Overall Study|Withdrawal by Subject|8|||
127565039|NCT01369329|459038050|FG001|Overall Study|Withdrawal by Subject|6|||
127565040|NCT01369329|459038051|FG002|Overall Study|Withdrawal by Subject|10|||
128025396|NCT00090402|460717723|FG000|Overall Study|Death|1|||
128025397|NCT00090402|460717724|FG001|Overall Study|Death|1|||
128025398|NCT00090402|460717725|FG002|Overall Study|Death|0|||
128025399|NCT00090402|460717723|FG000|Overall Study|subject moved|0|||
127565041|NCT01369329|459038049|FG000|Overall Study|Lost to Follow-up|2|||
127565042|NCT01369329|459038050|FG001|Overall Study|Lost to Follow-up|2|||
127565043|NCT01369329|459038051|FG002|Overall Study|Lost to Follow-up|2|||
127565044|NCT01369329|459038049|FG000|Overall Study|Other|2|||
127565045|NCT01369329|459038050|FG001|Overall Study|Other|3|||
127565046|NCT01369329|459038051|FG002|Overall Study|Other|2|||
127565047|NCT01836276|459038052|FG000|Overall Study|Lost to Follow-up|28|||
127565048|NCT01836276|459038053|FG001|Overall Study|Lost to Follow-up|51|||
127565049|NCT01433250|459038056|FG000|Overall Study|Protocol Violation|0|||
127565050|NCT01433250|459038057|FG001|Overall Study|Protocol Violation|1|||
127565051|NCT01433250|459038056|FG000|Overall Study|Withdrawal by Subject|3|||
127565052|NCT01433250|459038057|FG001|Overall Study|Withdrawal by Subject|2|||
127565053|NCT02431260|459038058|FG000|Overall Study|Subject Decision|0|||
127565054|NCT02431260|459038059|FG001|Overall Study|Subject Decision|1|||
127565055|NCT02431260|459038060|FG002|Overall Study|Subject Decision|1|||
127565056|NCT02431260|459038061|FG003|Overall Study|Subject Decision|0|||
127565057|NCT02431260|459038062|FG004|Overall Study|Subject Decision|0|||
127565058|NCT02431260|459038063|FG005|Overall Study|Subject Decision|0|||
127565059|NCT02431260|459038064|FG006|Overall Study|Subject Decision|0|||
127565060|NCT02431260|459038065|FG007|Overall Study|Subject Decision|0|||
127565061|NCT02431260|459038066|FG008|Overall Study|Subject Decision|1|||
127565062|NCT02431260|459038067|FG009|Overall Study|Subject Decision|1|||
127565063|NCT02431260|459038068|FG010|Overall Study|Subject Decision|0|||
127565064|NCT02431260|459038069|FG011|Overall Study|Subject Decision|1|||
127565065|NCT02431260|459038070|FG012|Overall Study|Subject Decision|0|||
127565066|NCT02431260|459038071|FG013|Overall Study|Subject Decision|0|||
127565067|NCT02431260|459038058|FG000|Overall Study|Death|4|||
127565068|NCT02431260|459038059|FG001|Overall Study|Death|4|||
127565069|NCT02431260|459038060|FG002|Overall Study|Death|3|||
127565070|NCT02431260|459038061|FG003|Overall Study|Death|4|||
127565071|NCT02431260|459038062|FG004|Overall Study|Death|2|||
127565072|NCT02431260|459038063|FG005|Overall Study|Death|2|||
127565073|NCT02431260|459038064|FG006|Overall Study|Death|3|||
127565074|NCT02431260|459038065|FG007|Overall Study|Death|1|||
127565075|NCT02431260|459038066|FG008|Overall Study|Death|6|||
127565076|NCT02431260|459038067|FG009|Overall Study|Death|6|||
127565077|NCT02431260|459038068|FG010|Overall Study|Death|3|||
127565078|NCT02431260|459038069|FG011|Overall Study|Death|2|||
127565079|NCT02431260|459038070|FG012|Overall Study|Death|5|||
127565080|NCT02431260|459038071|FG013|Overall Study|Death|1|||
127565081|NCT02431260|459038058|FG000|Overall Study|Lost to Follow-up|0|||
127565082|NCT02431260|459038059|FG001|Overall Study|Lost to Follow-up|0|||
127565083|NCT02431260|459038060|FG002|Overall Study|Lost to Follow-up|0|||
127565084|NCT02431260|459038061|FG003|Overall Study|Lost to Follow-up|0|||
127565085|NCT02431260|459038062|FG004|Overall Study|Lost to Follow-up|0|||
127565086|NCT02431260|459038063|FG005|Overall Study|Lost to Follow-up|1|||
127565087|NCT02431260|459038064|FG006|Overall Study|Lost to Follow-up|0|||
127565088|NCT02431260|459038065|FG007|Overall Study|Lost to Follow-up|0|||
127565089|NCT02431260|459038066|FG008|Overall Study|Lost to Follow-up|0|||
127565090|NCT02431260|459038067|FG009|Overall Study|Lost to Follow-up|0|||
127565091|NCT02431260|459038068|FG010|Overall Study|Lost to Follow-up|0|||
127565092|NCT02431260|459038069|FG011|Overall Study|Lost to Follow-up|0|||
127565093|NCT02431260|459038070|FG012|Overall Study|Lost to Follow-up|0|||
127565094|NCT02431260|459038071|FG013|Overall Study|Lost to Follow-up|0|||
127565095|NCT02431260|459038058|FG000|Overall Study|Study Terminated by the Sponsor|0|||
127565096|NCT02431260|459038059|FG001|Overall Study|Study Terminated by the Sponsor|0|||
127565097|NCT02431260|459038060|FG002|Overall Study|Study Terminated by the Sponsor|2|||
127565098|NCT02431260|459038061|FG003|Overall Study|Study Terminated by the Sponsor|1|||
127565099|NCT02431260|459038062|FG004|Overall Study|Study Terminated by the Sponsor|1|||
127565100|NCT02431260|459038063|FG005|Overall Study|Study Terminated by the Sponsor|0|||
127565101|NCT02431260|459038064|FG006|Overall Study|Study Terminated by the Sponsor|1|||
127565102|NCT02431260|459038065|FG007|Overall Study|Study Terminated by the Sponsor|2|||
127565103|NCT02431260|459038066|FG008|Overall Study|Study Terminated by the Sponsor|1|||
127565104|NCT02431260|459038067|FG009|Overall Study|Study Terminated by the Sponsor|1|||
127565105|NCT02431260|459038068|FG010|Overall Study|Study Terminated by the Sponsor|1|||
127565106|NCT02431260|459038069|FG011|Overall Study|Study Terminated by the Sponsor|0|||
128025400|NCT00090402|460717724|FG001|Overall Study|subject moved|1|||
127565107|NCT02431260|459038070|FG012|Overall Study|Study Terminated by the Sponsor|4|||
127565108|NCT02431260|459038071|FG013|Overall Study|Study Terminated by the Sponsor|0|||
127565109|NCT02431260|459038058|FG000|Overall Study|Physician Decision|0|||
128025401|NCT00090402|460717725|FG002|Overall Study|subject moved|0|||
128025402|NCT00090402|460717723|FG000|Overall Study|stopped taking study medication|1|||
127565110|NCT02431260|459038059|FG001|Overall Study|Physician Decision|0|||
127565111|NCT02431260|459038060|FG002|Overall Study|Physician Decision|0|||
127565112|NCT02431260|459038061|FG003|Overall Study|Physician Decision|0|||
127565113|NCT02431260|459038062|FG004|Overall Study|Physician Decision|0|||
127565114|NCT02431260|459038063|FG005|Overall Study|Physician Decision|1|||
127565115|NCT02431260|459038064|FG006|Overall Study|Physician Decision|0|||
127565116|NCT02431260|459038065|FG007|Overall Study|Physician Decision|0|||
127565117|NCT02431260|459038066|FG008|Overall Study|Physician Decision|0|||
127565118|NCT02431260|459038067|FG009|Overall Study|Physician Decision|0|||
127565119|NCT02431260|459038068|FG010|Overall Study|Physician Decision|0|||
127565120|NCT02431260|459038069|FG011|Overall Study|Physician Decision|0|||
127565121|NCT02431260|459038070|FG012|Overall Study|Physician Decision|0|||
127776802|NCT01241552|459811612|FG000|Overall Study|Lack of Efficacy|1|||
127776803|NCT01241552|459811613|FG001|Overall Study|Lack of Efficacy|0|||
127776804|NCT01241552|459811614|FG002|Overall Study|Lack of Efficacy|0|||
127776805|NCT01241552|459811615|FG003|Overall Study|Lack of Efficacy|0|||
127776806|NCT01241552|459811612|FG000|Overall Study|Death|26|||
127776807|NCT01241552|459811613|FG001|Overall Study|Death|30|||
127776808|NCT01241552|459811614|FG002|Overall Study|Death|20|||
127776809|NCT01241552|459811615|FG003|Overall Study|Death|25|||
127776810|NCT01241552|459811612|FG000|Overall Study|Adverse Event|1|||
127776811|NCT01241552|459811613|FG001|Overall Study|Adverse Event|1|||
127776812|NCT01241552|459811614|FG002|Overall Study|Adverse Event|0|||
127776813|NCT01241552|459811615|FG003|Overall Study|Adverse Event|0|||
127565122|NCT02431260|459038071|FG013|Overall Study|Physician Decision|0|||
127776814|NCT01241552|459811612|FG000|Overall Study|Technical Problems|2|||
127776815|NCT01241552|459811613|FG001|Overall Study|Technical Problems|0|||
127776816|NCT01241552|459811614|FG002|Overall Study|Technical Problems|2|||
127776817|NCT01241552|459811615|FG003|Overall Study|Technical Problems|2|||
127776818|NCT01241552|459811612|FG000|Overall Study|Progressive Disease|0|||
127776819|NCT01241552|459811613|FG001|Overall Study|Progressive Disease|0|||
127776820|NCT01241552|459811614|FG002|Overall Study|Progressive Disease|1|||
127776821|NCT01241552|459811615|FG003|Overall Study|Progressive Disease|2|||
127776822|NCT01241552|459811612|FG000|Overall Study|Protocol Violation|0|||
127776823|NCT01241552|459811613|FG001|Overall Study|Protocol Violation|2|||
127776824|NCT01241552|459811614|FG002|Overall Study|Protocol Violation|6|||
127776825|NCT01241552|459811615|FG003|Overall Study|Protocol Violation|1|||
127776826|NCT01241552|459811612|FG000|Overall Study|Withdrawal by Subject|7|||
127776827|NCT01241552|459811613|FG001|Overall Study|Withdrawal by Subject|15|||
127776828|NCT01241552|459811614|FG002|Overall Study|Withdrawal by Subject|14|||
127776829|NCT01241552|459811615|FG003|Overall Study|Withdrawal by Subject|15|||
127776830|NCT01241552|459811612|FG000|Overall Study|Physician Decision|2|||
127776831|NCT01241552|459811613|FG001|Overall Study|Physician Decision|4|||
127776832|NCT01241552|459811614|FG002|Overall Study|Physician Decision|2|||
127776833|NCT01241552|459811615|FG003|Overall Study|Physician Decision|3|||
127776834|NCT01241552|459811612|FG000|Overall Study|Lost to Follow-up|2|||
127776835|NCT01241552|459811613|FG001|Overall Study|Lost to Follow-up|11|||
127776836|NCT01241552|459811614|FG002|Overall Study|Lost to Follow-up|15|||
127776837|NCT01241552|459811615|FG003|Overall Study|Lost to Follow-up|16|||
127776838|NCT04464265|459811616|FG000|Overall Study|Physician Decision|2|||
127776839|NCT01271803|459811617|FG000|Overall Study|Progressive disease|0|||
127776840|NCT01271803|459811618|FG001|Overall Study|Progressive disease|0|||
127776841|NCT01271803|459811619|FG002|Overall Study|Progressive disease|2|||
127776842|NCT01271803|459811617|FG000|Overall Study|Death|53|||
127776843|NCT01271803|459811618|FG001|Overall Study|Death|34|||
127776844|NCT01271803|459811619|FG002|Overall Study|Death|0|||
127776845|NCT01271803|459811617|FG000|Overall Study|Withdrawal by Subject|1|||
127776846|NCT01271803|459811618|FG001|Overall Study|Withdrawal by Subject|5|||
127776847|NCT01271803|459811619|FG002|Overall Study|Withdrawal by Subject|0|||
127776848|NCT01271803|459811617|FG000|Overall Study|Lost to Follow-up|1|||
127776849|NCT01271803|459811618|FG001|Overall Study|Lost to Follow-up|0|||
127776850|NCT01271803|459811619|FG002|Overall Study|Lost to Follow-up|0|||
127776851|NCT02178553|459811623|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
127776852|NCT02178553|459811624|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
127776853|NCT02178553|459811623|FG000|Overall Study|Physician Decision|0|||
127565123|NCT02431260|459038058|FG000|Overall Study|Other Unspecified|0|||
127565124|NCT02431260|459038059|FG001|Overall Study|Other Unspecified|0|||
127565125|NCT02431260|459038060|FG002|Overall Study|Other Unspecified|0|||
127565126|NCT02431260|459038061|FG003|Overall Study|Other Unspecified|0|||
127565127|NCT02431260|459038062|FG004|Overall Study|Other Unspecified|0|||
127776854|NCT02178553|459811624|FG001|Overall Study|Physician Decision|4|||
127776855|NCT02178553|459811623|FG000|Overall Study|Technical problem with injection|1|||
127776856|NCT02178553|459811624|FG001|Overall Study|Technical problem with injection|3|||
127776857|NCT01251120|459811626|FG000|Overall Study|Lack of Efficacy|0|||
127776858|NCT01251120|459811627|FG001|Overall Study|Lack of Efficacy|1|||
127776859|NCT01822522|459811628|FG000|Overall Study|Adverse Event|1|||
127776860|NCT01822522|459811629|FG001|Overall Study|Adverse Event|1|||
127776861|NCT01822522|459811630|FG002|Overall Study|Adverse Event|1|||
127776862|NCT01822522|459811631|FG003|Overall Study|Adverse Event|0|||
127776863|NCT01822522|459811632|FG004|Overall Study|Adverse Event|0|||
127776864|NCT01822522|459811633|FG005|Overall Study|Adverse Event|1|||
127776865|NCT01822522|459811628|FG000|Overall Study|Death|3|||
127776866|NCT01822522|459811629|FG001|Overall Study|Death|0|||
127776867|NCT01822522|459811630|FG002|Overall Study|Death|2|||
127776868|NCT01822522|459811631|FG003|Overall Study|Death|0|||
127776869|NCT01822522|459811632|FG004|Overall Study|Death|0|||
127776870|NCT01822522|459811633|FG005|Overall Study|Death|0|||
127776871|NCT01822522|459811628|FG000|Overall Study|Lost to Follow-up|0|||
127776872|NCT01822522|459811629|FG001|Overall Study|Lost to Follow-up|0|||
127776873|NCT01822522|459811630|FG002|Overall Study|Lost to Follow-up|1|||
127776874|NCT01822522|459811631|FG003|Overall Study|Lost to Follow-up|1|||
127776875|NCT01822522|459811632|FG004|Overall Study|Lost to Follow-up|0|||
127776876|NCT01822522|459811633|FG005|Overall Study|Lost to Follow-up|1|||
127776877|NCT01822522|459811628|FG000|Overall Study|Withdrawal by Subject|0|||
127776878|NCT01822522|459811629|FG001|Overall Study|Withdrawal by Subject|0|||
127776879|NCT01822522|459811630|FG002|Overall Study|Withdrawal by Subject|0|||
127776880|NCT01822522|459811631|FG003|Overall Study|Withdrawal by Subject|1|||
127776881|NCT01822522|459811632|FG004|Overall Study|Withdrawal by Subject|0|||
127776882|NCT01822522|459811633|FG005|Overall Study|Withdrawal by Subject|0|||
127776883|NCT01822522|459811628|FG000|Overall Study|Lack of Efficacy|0|||
127776884|NCT01822522|459811629|FG001|Overall Study|Lack of Efficacy|0|||
127776885|NCT01822522|459811630|FG002|Overall Study|Lack of Efficacy|0|||
127776886|NCT01822522|459811631|FG003|Overall Study|Lack of Efficacy|0|||
127565128|NCT02431260|459038063|FG005|Overall Study|Other Unspecified|0|||
127565129|NCT02431260|459038064|FG006|Overall Study|Other Unspecified|0|||
127565130|NCT02431260|459038065|FG007|Overall Study|Other Unspecified|0|||
127565131|NCT02431260|459038066|FG008|Overall Study|Other Unspecified|0|||
127565132|NCT02431260|459038067|FG009|Overall Study|Other Unspecified|0|||
127565133|NCT02431260|459038068|FG010|Overall Study|Other Unspecified|0|||
127688439|NCT04043455|459484956|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
127688440|NCT04043455|459484957|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
127688441|NCT04043455|459484958|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
127688442|NCT04043455|459484953|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
127688443|NCT04043455|459484954|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
127688444|NCT04043455|459484955|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
127688445|NCT04043455|459484956|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
127688446|NCT04043455|459484957|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
127688447|NCT04043455|459484958|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
127688448|NCT04043455|459484953|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
127688449|NCT04043455|459484954|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
127688450|NCT04043455|459484955|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
127688451|NCT04043455|459484956|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
127688452|NCT04043455|459484957|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
127688453|NCT04043455|459484958|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
127688454|NCT04043455|459484953|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
127688455|NCT04043455|459484954|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
127688456|NCT04043455|459484955|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
127688457|NCT04043455|459484956|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
127688458|NCT04043455|459484957|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
127688459|NCT04043455|459484958|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
127688460|NCT04043455|459484953|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
127688461|NCT04043455|459484954|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
127688462|NCT04043455|459484955|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
127688463|NCT04043455|459484956|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
127688464|NCT04043455|459484957|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
127688465|NCT04043455|459484958|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
127688466|NCT04043455|459484953|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
127688467|NCT04043455|459484954|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
127688468|NCT04043455|459484955|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
127688469|NCT04043455|459484956|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
127688470|NCT04043455|459484957|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
127688471|NCT04043455|459484958|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
127688472|NCT04043455|459484953|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
127688473|NCT04043455|459484954|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
127688474|NCT04043455|459484955|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
127688475|NCT04043455|459484956|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
127776887|NCT01822522|459811632|FG004|Overall Study|Lack of Efficacy|0|||
127776888|NCT01822522|459811633|FG005|Overall Study|Lack of Efficacy|2|||
127776889|NCT01807923|459811634|FG000|Overall Study|Adverse Event|2|||
127776890|NCT01807923|459811635|FG001|Overall Study|Adverse Event|1|||
127776891|NCT01807923|459811636|FG002|Overall Study|Adverse Event|2|||
127565134|NCT02431260|459038069|FG011|Overall Study|Other Unspecified|1|||
127776892|NCT01807923|459811634|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
127565135|NCT02431260|459038070|FG012|Overall Study|Other Unspecified|1|||
127565136|NCT02431260|459038071|FG013|Overall Study|Other Unspecified|0|||
127565137|NCT03007888|459038075|FG000|First Intervention (14 Days)|Adverse Event|1|||
127565138|NCT03007888|459038076|FG001|First Intervention (14 Days)|Adverse Event|0|||
127565139|NCT01806662|459038077|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
127565140|NCT01806662|459038078|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
127565141|NCT01806662|459038077|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
127565142|NCT01806662|459038078|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
127565143|NCT01806662|459038077|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
127565144|NCT01806662|459038078|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
127565145|NCT01806662|459038077|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
127565146|NCT01806662|459038078|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
127565147|NCT00827931|459038085|FG000|Overall Study|Death|3|||
127565148|NCT00827931|459038086|FG001|Overall Study|Death|5|||
127565149|NCT00827931|459038085|FG000|Overall Study|Adverse Event|1|||
127565150|NCT00827931|459038086|FG001|Overall Study|Adverse Event|0|||
127565151|NCT00827931|459038085|FG000|Overall Study|Lost to Follow-up|1|||
127565152|NCT00827931|459038086|FG001|Overall Study|Lost to Follow-up|0|||
127565153|NCT00827931|459038085|FG000|Overall Study|Withdrawal by Subject|0|||
127565154|NCT00827931|459038086|FG001|Overall Study|Withdrawal by Subject|1|||
127565155|NCT00827931|459038085|FG000|Overall Study|Other|1|||
127565156|NCT00827931|459038086|FG001|Overall Study|Other|0|||
127565157|NCT01917656|459038090|FG000|Overall Study|Adverse Event|11|||
127565158|NCT01917656|459038091|FG001|Overall Study|Adverse Event|0|||
127565159|NCT01917656|459038090|FG000|Overall Study|Withdrawal criteria|8|||
127565160|NCT01917656|459038091|FG001|Overall Study|Withdrawal criteria|14|||
127565161|NCT01917656|459038090|FG000|Overall Study|Unclassified|0|||
127565162|NCT01917656|459038091|FG001|Overall Study|Unclassified|3|||
127565163|NCT01917656|459038090|FG000|Overall Study|Withdrawal by Subject|4|||
127565164|NCT01917656|459038091|FG001|Overall Study|Withdrawal by Subject|3|||
127565165|NCT01917656|459038090|FG000|Overall Study|Lost to Follow-up|3|||
127565166|NCT01917656|459038091|FG001|Overall Study|Lost to Follow-up|4|||
127565167|NCT02081859|459038092|FG000|Overall Study|No fertilization|2|||
127565168|NCT02081859|459038093|FG001|Overall Study|No fertilization|2|||
127565169|NCT02081859|459038092|FG000|Overall Study|No sperm|1|||
127565170|NCT02081859|459038093|FG001|Overall Study|No sperm|0|||
127565171|NCT02081859|459038092|FG000|Overall Study|Unanticipated freeze all cycle|2|||
127688476|NCT04043455|459484957|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
127776893|NCT01807923|459811635|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
127776894|NCT01807923|459811636|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
127688477|NCT04043455|459484958|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
127688478|NCT04043455|459484953|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
127688479|NCT04043455|459484954|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
127688480|NCT04043455|459484955|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
127688481|NCT04043455|459484956|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
127688482|NCT04043455|459484957|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
127688483|NCT04043455|459484958|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
127688484|NCT04043455|459484953|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
127688485|NCT04043455|459484954|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
127688486|NCT04043455|459484955|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
127688487|NCT04043455|459484956|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
127688488|NCT04043455|459484957|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
127688489|NCT04043455|459484958|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
127688490|NCT04043455|459484953|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
127688491|NCT04043455|459484954|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
127688492|NCT04043455|459484955|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
127688493|NCT04043455|459484956|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
127688494|NCT04043455|459484957|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
127688495|NCT04043455|459484958|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
127688496|NCT05194917|459484959|FG000|Overall Study|Lost to Follow-up|7|||
127688497|NCT05194917|459484960|FG001|Overall Study|Lost to Follow-up|5|||
127688498|NCT05194917|459484961|FG002|Overall Study|Lost to Follow-up|6|||
127688499|NCT05194917|459484962|FG003|Overall Study|Lost to Follow-up|5|||
127688500|NCT02544074|459484965|FG000|Overall Study|Withdrawal by Subject|0|||
127565172|NCT02081859|459038093|FG001|Overall Study|Unanticipated freeze all cycle|6|||
127565173|NCT02081859|459038092|FG000|Overall Study|< 4 embryos|27|||
127565174|NCT02081859|459038093|FG001|Overall Study|< 4 embryos|23|||
127565175|NCT02081859|459038092|FG000|Overall Study|Other reasons|2|||
127565176|NCT02081859|459038093|FG001|Overall Study|Other reasons|0|||
127565177|NCT02015221|459038094|FG000|Overall Study|Withdrawal by Subject|8|||
127565178|NCT02015221|459038095|FG001|Overall Study|Withdrawal by Subject|6|||
127565179|NCT02015221|459038094|FG000|Overall Study|Lost to Follow-up|1|||
127565180|NCT02015221|459038095|FG001|Overall Study|Lost to Follow-up|0|||
128025403|NCT00090402|460717724|FG001|Overall Study|stopped taking study medication|0|||
128025404|NCT00090402|460717725|FG002|Overall Study|stopped taking study medication|1|||
128025405|NCT01530256|460717728|FG000|Overall Study|Death|2|||
128025406|NCT02004275|460717730|FG000|Phase 1|Ineligible|0|||
128025407|NCT02004275|460717731|FG001|Phase 1|Ineligible|0|||
127565181|NCT00995566|459038096|FG000|Overall Study|Adverse Event|2|||
127565182|NCT00995566|459038096|FG000|Overall Study|Early study termination|52|||
127565183|NCT01870076|459038097|FG000|Overall Study|Withdrawal by Subject|1|||
127565184|NCT01870076|459038098|FG001|Overall Study|Withdrawal by Subject|0|||
127565185|NCT01870076|459038099|FG002|Overall Study|Withdrawal by Subject|1|||
127565186|NCT01870076|459038100|FG003|Overall Study|Withdrawal by Subject|0|||
127565187|NCT00492063|459038101|FG000|Overall Study|Death|0|||
127565188|NCT00492063|459038102|FG001|Overall Study|Death|0|||
127565189|NCT00492063|459038103|FG002|Overall Study|Death|1|||
127565190|NCT00492063|459038104|FG003|Overall Study|Death|2|||
128025408|NCT02004275|460717732|FG002|Phase 1|Ineligible|0|||
128025409|NCT02004275|460717733|FG003|Phase 1|Ineligible|1|||
128025410|NCT02004275|460717734|FG004|Phase 1|Ineligible|1|||
128025411|NCT02004275|460717735|FG005|Phase 1|Ineligible|0|||
128025412|NCT02004275|460717730|FG000|Phase 1|Protocol Violation|0|||
128025413|NCT02004275|460717731|FG001|Phase 1|Protocol Violation|0|||
128025414|NCT02004275|460717732|FG002|Phase 1|Protocol Violation|0|||
128025415|NCT02004275|460717733|FG003|Phase 1|Protocol Violation|1|||
128025416|NCT02004275|460717734|FG004|Phase 1|Protocol Violation|0|||
128025417|NCT02004275|460717735|FG005|Phase 1|Protocol Violation|5|||
128025418|NCT02004275|460717730|FG000|Phase 2 Part 1|Ineligible|6|||
128025419|NCT02004275|460717731|FG001|Phase 2 Part 1|Ineligible|9|||
128025420|NCT02004275|460717732|FG002|Phase 2 Part 1|Ineligible|0|||
128025421|NCT02004275|460717733|FG003|Phase 2 Part 1|Ineligible|0|||
128025422|NCT02004275|460717734|FG004|Phase 2 Part 1|Ineligible|0|||
128025423|NCT02004275|460717735|FG005|Phase 2 Part 1|Ineligible|0|||
128025424|NCT02004275|460717730|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
128025425|NCT02004275|460717731|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
128025426|NCT02004275|460717732|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
128025427|NCT02004275|460717733|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
128025428|NCT02004275|460717734|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
128025429|NCT02004275|460717735|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
128025430|NCT04621786|460717738|FG000|Overall Study|Lost to Follow-up|9|||
128025431|NCT04621786|460717738|FG000|Overall Study|Protocol Violation|3|||
128025432|NCT00292370|460717739|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
128025433|NCT00292370|460717740|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
128025434|NCT00292370|460717741|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
128025435|NCT00292370|460717739|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
128025436|NCT00292370|460717740|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
128025437|NCT00292370|460717741|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
128025438|NCT00292370|460717739|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
128025439|NCT00292370|460717740|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
128025440|NCT00292370|460717741|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
128025441|NCT00292370|460717739|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
128025442|NCT00292370|460717740|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
127565191|NCT00492063|459038101|FG000|Overall Study|Withdrawal by Subject|4|||
127565192|NCT00492063|459038102|FG001|Overall Study|Withdrawal by Subject|3|||
127565193|NCT00492063|459038103|FG002|Overall Study|Withdrawal by Subject|5|||
127688501|NCT02544074|459484966|FG001|Overall Study|Withdrawal by Subject|1|||
127688502|NCT02544074|459484967|FG002|Overall Study|Withdrawal by Subject|0|||
127688503|NCT02544074|459484968|FG003|Overall Study|Withdrawal by Subject|0|||
128025443|NCT00292370|460717741|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
128025444|NCT00292370|460717739|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
128025445|NCT00292370|460717740|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
128025446|NCT00292370|460717741|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
128025447|NCT00292370|460717739|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
128025448|NCT00292370|460717740|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
128025449|NCT00292370|460717741|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
128025450|NCT01133977|460717751|FG000|Overall Study|Adverse Event|0|||
128025451|NCT01133977|460717752|FG001|Overall Study|Adverse Event|0|||
128025452|NCT01133977|460717753|FG002|Overall Study|Adverse Event|1|||
128025453|NCT01133977|460717754|FG003|Overall Study|Adverse Event|0|||
128025454|NCT01133977|460717755|FG004|Overall Study|Adverse Event|0|||
128025455|NCT01133977|460717751|FG000|Overall Study|Death|1|||
128025456|NCT01133977|460717752|FG001|Overall Study|Death|1|||
128025457|NCT01133977|460717753|FG002|Overall Study|Death|1|||
128025458|NCT01133977|460717754|FG003|Overall Study|Death|7|||
128025459|NCT01133977|460717755|FG004|Overall Study|Death|3|||
128025460|NCT01133977|460717751|FG000|Overall Study|Started a New Line of Therapy|2|||
128025461|NCT01133977|460717752|FG001|Overall Study|Started a New Line of Therapy|6|||
127565194|NCT00492063|459038104|FG003|Overall Study|Withdrawal by Subject|4|||
127776895|NCT01807923|459811634|FG000|Overall Study|Physician Decision|0|||
127776896|NCT01807923|459811635|FG001|Overall Study|Physician Decision|0|||
128025462|NCT01133977|460717753|FG002|Overall Study|Started a New Line of Therapy|4|||
127565195|NCT00492063|459038101|FG000|Overall Study|Lost to Follow-up|6|||
127565196|NCT00492063|459038102|FG001|Overall Study|Lost to Follow-up|11|||
127565197|NCT00492063|459038103|FG002|Overall Study|Lost to Follow-up|5|||
127565198|NCT00492063|459038104|FG003|Overall Study|Lost to Follow-up|3|||
127565199|NCT00492063|459038101|FG000|Overall Study|Protocol Violation|0|||
127565200|NCT00492063|459038102|FG001|Overall Study|Protocol Violation|0|||
127565201|NCT00492063|459038103|FG002|Overall Study|Protocol Violation|0|||
127565202|NCT00492063|459038104|FG003|Overall Study|Protocol Violation|1|||
127565203|NCT00510653|459038107|FG000|Overall Study|Withdrawal by Subject|8|||
127565204|NCT00510653|459038107|FG000|Overall Study|Monetary|3|||
127565205|NCT00436501|459038108|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
127565206|NCT00436501|459038109|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
127565207|NCT00436501|459038108|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
127565208|NCT00436501|459038109|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
127565209|NCT03011892|459038111|FG000|Double Blind (DB) Period|Adverse Event|0|||
127565210|NCT03011892|459038112|FG001|Double Blind (DB) Period|Adverse Event|1|||
127565211|NCT03011892|459038113|FG002|Double Blind (DB) Period|Adverse Event|1|||
127565212|NCT03011892|459038114|FG003|Double Blind (DB) Period|Adverse Event|0|||
127565213|NCT03011892|459038115|FG004|Double Blind (DB) Period|Adverse Event|0|||
127565214|NCT03011892|459038116|FG005|Double Blind (DB) Period|Adverse Event|0|||
127565215|NCT03011892|459038117|FG006|Double Blind (DB) Period|Adverse Event|0|||
127565216|NCT03011892|459038118|FG007|Double Blind (DB) Period|Adverse Event|0|||
127565217|NCT03011892|459038119|FG008|Double Blind (DB) Period|Adverse Event|0|||
127565218|NCT03011892|459038120|FG009|Double Blind (DB) Period|Adverse Event|0|||
127565219|NCT03011892|459038121|FG010|Double Blind (DB) Period|Adverse Event|0|||
127565220|NCT03011892|459038122|FG011|Double Blind (DB) Period|Adverse Event|0|||
127565221|NCT03011892|459038111|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
127565222|NCT03011892|459038112|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
127565223|NCT03011892|459038113|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
127565224|NCT03011892|459038114|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
128025463|NCT01133977|460717754|FG003|Overall Study|Started a New Line of Therapy|25|||
128025464|NCT01133977|460717755|FG004|Overall Study|Started a New Line of Therapy|33|||
128025465|NCT01133977|460717751|FG000|Overall Study|Lost to Follow-up|0|||
127565225|NCT03011892|459038115|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
127565226|NCT03011892|459038116|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
127688504|NCT02544074|459484969|FG004|Overall Study|Withdrawal by Subject|0|||
127688505|NCT02544074|459484970|FG005|Overall Study|Withdrawal by Subject|0|||
127688506|NCT02544074|459484971|FG006|Overall Study|Withdrawal by Subject|0|||
127688507|NCT02544074|459484972|FG007|Overall Study|Withdrawal by Subject|0|||
127688508|NCT02544074|459484973|FG008|Overall Study|Withdrawal by Subject|0|||
127688509|NCT02544074|459484974|FG009|Overall Study|Withdrawal by Subject|0|||
127688510|NCT02544074|459484975|FG010|Overall Study|Withdrawal by Subject|0|||
127688511|NCT02544074|459484976|FG011|Overall Study|Withdrawal by Subject|0|||
127688512|NCT02544074|459484977|FG012|Overall Study|Withdrawal by Subject|0|||
127688513|NCT02544074|459484978|FG013|Overall Study|Withdrawal by Subject|0|||
127688514|NCT02544074|459484979|FG014|Overall Study|Withdrawal by Subject|0|||
127688515|NCT02544074|459484980|FG015|Overall Study|Withdrawal by Subject|0|||
127688516|NCT02544074|459484981|FG016|Overall Study|Withdrawal by Subject|0|||
127688517|NCT02544074|459484982|FG017|Overall Study|Withdrawal by Subject|0|||
127688518|NCT02544074|459484983|FG018|Overall Study|Withdrawal by Subject|0|||
127688519|NCT02544074|459484984|FG019|Overall Study|Withdrawal by Subject|0|||
127688520|NCT02544074|459484985|FG020|Overall Study|Withdrawal by Subject|0|||
127688521|NCT02544074|459484965|FG000|Overall Study|Tablet error|0|||
127688522|NCT02544074|459484966|FG001|Overall Study|Tablet error|0|||
127688523|NCT02544074|459484967|FG002|Overall Study|Tablet error|0|||
127688524|NCT02544074|459484968|FG003|Overall Study|Tablet error|0|||
127688525|NCT02544074|459484969|FG004|Overall Study|Tablet error|0|||
127688526|NCT02544074|459484970|FG005|Overall Study|Tablet error|1|||
127688527|NCT02544074|459484971|FG006|Overall Study|Tablet error|0|||
127688528|NCT02544074|459484972|FG007|Overall Study|Tablet error|0|||
127688529|NCT02544074|459484973|FG008|Overall Study|Tablet error|0|||
128025466|NCT01133977|460717752|FG001|Overall Study|Lost to Follow-up|0|||
127565227|NCT03011892|459038117|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
127688530|NCT02544074|459484974|FG009|Overall Study|Tablet error|1|||
127688531|NCT02544074|459484975|FG010|Overall Study|Tablet error|0|||
127688532|NCT02544074|459484976|FG011|Overall Study|Tablet error|0|||
127688533|NCT02544074|459484977|FG012|Overall Study|Tablet error|0|||
127688534|NCT02544074|459484978|FG013|Overall Study|Tablet error|0|||
127688535|NCT02544074|459484979|FG014|Overall Study|Tablet error|0|||
127688536|NCT02544074|459484980|FG015|Overall Study|Tablet error|0|||
127565228|NCT03011892|459038118|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
127565229|NCT03011892|459038119|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
127565230|NCT03011892|459038120|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
127688537|NCT02544074|459484981|FG016|Overall Study|Tablet error|0|||
128025467|NCT01133977|460717753|FG002|Overall Study|Lost to Follow-up|0|||
128025468|NCT01133977|460717754|FG003|Overall Study|Lost to Follow-up|2|||
128025469|NCT01133977|460717755|FG004|Overall Study|Lost to Follow-up|1|||
127565231|NCT03011892|459038121|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
127565232|NCT03011892|459038122|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
127565233|NCT03011892|459038111|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
127565234|NCT03011892|459038112|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
127565235|NCT03011892|459038113|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
127565236|NCT03011892|459038114|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
127565237|NCT03011892|459038115|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
127565238|NCT03011892|459038116|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
127565239|NCT03011892|459038117|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
127565240|NCT03011892|459038118|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
127565241|NCT03011892|459038119|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
127565242|NCT03011892|459038120|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
127565243|NCT03011892|459038121|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
127565244|NCT03011892|459038122|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
127565245|NCT03011892|459038111|FG000|Double Blind (DB) Period|Other|1|||
127565246|NCT03011892|459038112|FG001|Double Blind (DB) Period|Other|1|||
127565247|NCT03011892|459038113|FG002|Double Blind (DB) Period|Other|1|||
127565248|NCT03011892|459038114|FG003|Double Blind (DB) Period|Other|0|||
127565249|NCT03011892|459038115|FG004|Double Blind (DB) Period|Other|1|||
127565250|NCT03011892|459038116|FG005|Double Blind (DB) Period|Other|0|||
127565251|NCT03011892|459038117|FG006|Double Blind (DB) Period|Other|0|||
127565252|NCT03011892|459038118|FG007|Double Blind (DB) Period|Other|0|||
127565253|NCT03011892|459038119|FG008|Double Blind (DB) Period|Other|0|||
127565254|NCT03011892|459038120|FG009|Double Blind (DB) Period|Other|0|||
127565255|NCT03011892|459038121|FG010|Double Blind (DB) Period|Other|0|||
127565256|NCT03011892|459038122|FG011|Double Blind (DB) Period|Other|0|||
127565257|NCT03011892|459038111|FG000|Double Blind (DB) Period|Physician Decision|1|||
127565258|NCT03011892|459038112|FG001|Double Blind (DB) Period|Physician Decision|0|||
127565259|NCT03011892|459038113|FG002|Double Blind (DB) Period|Physician Decision|1|||
127565260|NCT03011892|459038114|FG003|Double Blind (DB) Period|Physician Decision|0|||
127565261|NCT03011892|459038115|FG004|Double Blind (DB) Period|Physician Decision|0|||
127565262|NCT03011892|459038116|FG005|Double Blind (DB) Period|Physician Decision|0|||
127565263|NCT03011892|459038117|FG006|Double Blind (DB) Period|Physician Decision|0|||
127565264|NCT03011892|459038118|FG007|Double Blind (DB) Period|Physician Decision|0|||
127565265|NCT03011892|459038119|FG008|Double Blind (DB) Period|Physician Decision|0|||
127565266|NCT03011892|459038120|FG009|Double Blind (DB) Period|Physician Decision|0|||
127565267|NCT03011892|459038121|FG010|Double Blind (DB) Period|Physician Decision|0|||
127565268|NCT03011892|459038122|FG011|Double Blind (DB) Period|Physician Decision|0|||
127565269|NCT03011892|459038111|FG000|Double Blind (DB) Period|Pregnancy|0|||
127565270|NCT03011892|459038112|FG001|Double Blind (DB) Period|Pregnancy|0|||
127565271|NCT03011892|459038113|FG002|Double Blind (DB) Period|Pregnancy|0|||
127565272|NCT03011892|459038114|FG003|Double Blind (DB) Period|Pregnancy|0|||
127565273|NCT03011892|459038115|FG004|Double Blind (DB) Period|Pregnancy|1|||
127565274|NCT03011892|459038116|FG005|Double Blind (DB) Period|Pregnancy|0|||
127565275|NCT03011892|459038117|FG006|Double Blind (DB) Period|Pregnancy|0|||
127565276|NCT03011892|459038118|FG007|Double Blind (DB) Period|Pregnancy|0|||
127565277|NCT03011892|459038119|FG008|Double Blind (DB) Period|Pregnancy|0|||
127565278|NCT03011892|459038120|FG009|Double Blind (DB) Period|Pregnancy|0|||
127565279|NCT03011892|459038121|FG010|Double Blind (DB) Period|Pregnancy|0|||
127565280|NCT03011892|459038122|FG011|Double Blind (DB) Period|Pregnancy|0|||
127565281|NCT03011892|459038111|FG000|Double Blind (DB) Period|Protocol Violation|1|||
127565282|NCT03011892|459038112|FG001|Double Blind (DB) Period|Protocol Violation|0|||
127565283|NCT03011892|459038113|FG002|Double Blind (DB) Period|Protocol Violation|0|||
127565284|NCT03011892|459038114|FG003|Double Blind (DB) Period|Protocol Violation|0|||
127565285|NCT03011892|459038115|FG004|Double Blind (DB) Period|Protocol Violation|0|||
127565286|NCT03011892|459038116|FG005|Double Blind (DB) Period|Protocol Violation|0|||
127565287|NCT03011892|459038117|FG006|Double Blind (DB) Period|Protocol Violation|0|||
127565288|NCT03011892|459038118|FG007|Double Blind (DB) Period|Protocol Violation|0|||
127565289|NCT03011892|459038119|FG008|Double Blind (DB) Period|Protocol Violation|0|||
127565290|NCT03011892|459038120|FG009|Double Blind (DB) Period|Protocol Violation|0|||
127565291|NCT03011892|459038121|FG010|Double Blind (DB) Period|Protocol Violation|0|||
127565292|NCT03011892|459038122|FG011|Double Blind (DB) Period|Protocol Violation|0|||
127565293|NCT03011892|459038111|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
127565294|NCT03011892|459038112|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
127565295|NCT03011892|459038113|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
127565296|NCT03011892|459038114|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
127565297|NCT03011892|459038115|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
127565298|NCT03011892|459038116|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
127565299|NCT03011892|459038117|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
128025470|NCT01133977|460717751|FG000|Overall Study|Withdrawal by Subject|0|||
128025471|NCT01133977|460717752|FG001|Overall Study|Withdrawal by Subject|0|||
128025472|NCT01133977|460717753|FG002|Overall Study|Withdrawal by Subject|0|||
128025473|NCT01133977|460717754|FG003|Overall Study|Withdrawal by Subject|5|||
128025474|NCT01133977|460717755|FG004|Overall Study|Withdrawal by Subject|1|||
128025475|NCT00662038|460717760|FG000|Overall Study|Reason not specified|3|||
128025476|NCT00662038|460717760|FG000|Overall Study|Withdrawn consent|22|||
128025477|NCT00662038|460717760|FG000|Overall Study|Withdrawal by Subject|83|||
128025478|NCT00662038|460717760|FG000|Overall Study|Sponsor decision|1|||
128025479|NCT00662038|460717760|FG000|Overall Study|Physician Decision|19|||
128025480|NCT00662038|460717760|FG000|Overall Study|Lung transplantation|44|||
128025481|NCT00662038|460717760|FG000|Overall Study|Lost to Follow-up|1|||
128025482|NCT00662038|460717760|FG000|Overall Study|Death|95|||
128025483|NCT00662038|460717760|FG000|Overall Study|Adverse Event|358|||
128025484|NCT00662038|460717760|FG000|Overall Study|Continued treatment|5|||
128025485|NCT00397046|460717761|FG000|Overall Study|Disease Progression|3|||
128025486|NCT00397046|460717762|FG001|Overall Study|Disease Progression|3|||
128025487|NCT00397046|460717763|FG002|Overall Study|Disease Progression|10|||
128025488|NCT00397046|460717764|FG003|Overall Study|Disease Progression|5|||
128025489|NCT01975285|460717768|FG000|Overall Study|Failed Block and follow up|2|||
128025490|NCT01975285|460717769|FG001|Overall Study|Failed Block and follow up|2|||
128025491|NCT00474968|460717773|FG000|Overall Study|Withdrawal by Subject|8|||
128025492|NCT00474968|460717774|FG001|Overall Study|Withdrawal by Subject|7|||
128025493|NCT00474968|460717773|FG000|Overall Study|Protocol Violation|9|||
128025494|NCT00474968|460717774|FG001|Overall Study|Protocol Violation|8|||
128025495|NCT00474968|460717773|FG000|Overall Study|Sample not collected|1|||
128025496|NCT00474968|460717774|FG001|Overall Study|Sample not collected|1|||
128025497|NCT01750281|460717775|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
128025498|NCT01750281|460717776|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
128025499|NCT01750281|460717777|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
128025500|NCT01750281|460717775|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
128025501|NCT01750281|460717776|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
128025502|NCT01750281|460717777|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
128025503|NCT01750281|460717775|FG000|Overall Study|Did not receive treatment|0|||
127776897|NCT01807923|459811636|FG002|Overall Study|Physician Decision|1|||
127776898|NCT01807923|459811634|FG000|Overall Study|Not Eligible (Genotype)|0|||
127776899|NCT01807923|459811635|FG001|Overall Study|Not Eligible (Genotype)|0|||
127776900|NCT01807923|459811636|FG002|Overall Study|Not Eligible (Genotype)|1|||
127776901|NCT01807923|459811634|FG000|Overall Study|Randomized But Not Treated|3|||
127776902|NCT01807923|459811635|FG001|Overall Study|Randomized But Not Treated|2|||
127776903|NCT01807923|459811636|FG002|Overall Study|Randomized But Not Treated|5|||
127776904|NCT00890929|459811638|FG000|Overall Study|Death before treatment|2|||
127776905|NCT00890929|459811638|FG000|Overall Study|Withdrawal by Subject|3|||
127776906|NCT00890929|459811638|FG000|Overall Study|Physician Decision|1|||
127776907|NCT02558231|459811639|FG000|Overall Study|Death|4|||
127776908|NCT02558231|459811640|FG001|Overall Study|Death|12|||
127776909|NCT02558231|459811639|FG000|Overall Study|Lost to Follow-up|7|||
127776910|NCT02558231|459811640|FG001|Overall Study|Lost to Follow-up|4|||
127776911|NCT02558231|459811639|FG000|Overall Study|Withdrawal by Subject|7|||
127776912|NCT02558231|459811640|FG001|Overall Study|Withdrawal by Subject|4|||
127776913|NCT02558231|459811639|FG000|Overall Study|Physician Decision|7|||
127776914|NCT02558231|459811640|FG001|Overall Study|Physician Decision|5|||
127776915|NCT02558231|459811639|FG000|Overall Study|Sponsor Decision|0|||
127776916|NCT02558231|459811640|FG001|Overall Study|Sponsor Decision|1|||
127776917|NCT04233164|459811643|FG000|Overall Study|Unable to obtain specimen|0|||
127776918|NCT04233164|459811644|FG001|Overall Study|Unable to obtain specimen|1|||
127776919|NCT01840605|459811645|FG000|Overall Study|Adverse Event|0|||
127776920|NCT01840605|459811646|FG001|Overall Study|Adverse Event|1|||
127776921|NCT01840605|459811645|FG000|Overall Study|Physician Decision|2|||
127776922|NCT01840605|459811646|FG001|Overall Study|Physician Decision|1|||
127776923|NCT04029961|459811647|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
127776924|NCT04029961|459811648|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
127776925|NCT04029961|459811647|FG000|Overall Study|Change in Treatment Course|0|||
127776926|NCT04029961|459811648|FG001|Overall Study|Change in Treatment Course|1|||
128025504|NCT01750281|460717776|FG001|Overall Study|Did not receive treatment|1|||
128025505|NCT01750281|460717777|FG002|Overall Study|Did not receive treatment|0|||
128025506|NCT01061710|460717779|FG000|Overall Study|Protocol Violation|14|||
128025507|NCT03156621|460717781|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
128025508|NCT03156621|460717782|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
128025509|NCT03156621|460717781|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
128025510|NCT03156621|460717782|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
127776927|NCT05975840|459811649|FG000|Overall Study|Other|1|||
127776928|NCT05975840|459811650|FG001|Overall Study|Other|0|||
127776929|NCT05975840|459811651|FG002|Overall Study|Other|0|||
127776930|NCT05975840|459811652|FG003|Overall Study|Other|0|||
127776931|NCT05975840|459811653|FG004|Overall Study|Other|1|||
127776932|NCT05975840|459811654|FG005|Overall Study|Other|0|||
128025511|NCT03757715|460717783|FG000|Overall Study|Lost to Follow-up|4|||
128025512|NCT03757715|460717784|FG001|Overall Study|Lost to Follow-up|9|||
128025513|NCT03757715|460717783|FG000|Overall Study|Withdrawal by Subject|1|||
128025514|NCT03757715|460717784|FG001|Overall Study|Withdrawal by Subject|1|||
128025515|NCT00281580|460717785|FG000|Overall Study|Adverse Event|2|||
128025516|NCT00281580|460717786|FG001|Overall Study|Adverse Event|0|||
128025517|NCT00281580|460717787|FG002|Overall Study|Adverse Event|2|||
128025518|NCT00281580|460717788|FG003|Overall Study|Adverse Event|4|||
128025519|NCT00281580|460717789|FG004|Overall Study|Adverse Event|1|||
128025520|NCT00281580|460717790|FG005|Overall Study|Adverse Event|0|||
128025521|NCT00281580|460717791|FG006|Overall Study|Adverse Event|1|||
128025522|NCT00281580|460717792|FG007|Overall Study|Adverse Event|0|||
128025523|NCT00281580|460717793|FG008|Overall Study|Adverse Event|1|||
128025524|NCT00281580|460717794|FG009|Overall Study|Adverse Event|6|||
128025525|NCT00281580|460717795|FG010|Overall Study|Adverse Event|0|||
128025526|NCT00281580|460717796|FG011|Overall Study|Adverse Event|5|||
128025527|NCT00281580|460717797|FG012|Overall Study|Adverse Event|8|||
128025528|NCT00281580|460717798|FG013|Overall Study|Adverse Event|2|||
128025529|NCT00281580|460717799|FG014|Overall Study|Adverse Event|3|||
128025530|NCT00281580|460717800|FG015|Overall Study|Adverse Event|3|||
128025531|NCT00281580|460717785|FG000|Overall Study|Protocol Violation|0|||
128025532|NCT00281580|460717786|FG001|Overall Study|Protocol Violation|0|||
128025533|NCT00281580|460717787|FG002|Overall Study|Protocol Violation|1|||
128025534|NCT00281580|460717788|FG003|Overall Study|Protocol Violation|1|||
128025535|NCT00281580|460717789|FG004|Overall Study|Protocol Violation|0|||
128025536|NCT00281580|460717790|FG005|Overall Study|Protocol Violation|0|||
128025537|NCT00281580|460717791|FG006|Overall Study|Protocol Violation|1|||
128025538|NCT00281580|460717792|FG007|Overall Study|Protocol Violation|0|||
128025539|NCT00281580|460717793|FG008|Overall Study|Protocol Violation|2|||
128025540|NCT00281580|460717794|FG009|Overall Study|Protocol Violation|0|||
128025541|NCT00281580|460717795|FG010|Overall Study|Protocol Violation|1|||
128025542|NCT00281580|460717796|FG011|Overall Study|Protocol Violation|2|||
128025543|NCT00281580|460717797|FG012|Overall Study|Protocol Violation|0|||
128025544|NCT00281580|460717798|FG013|Overall Study|Protocol Violation|1|||
128025545|NCT00281580|460717799|FG014|Overall Study|Protocol Violation|1|||
128025546|NCT00281580|460717800|FG015|Overall Study|Protocol Violation|3|||
128025547|NCT00281580|460717785|FG000|Overall Study|Withdrawal by Subject|3|||
128025548|NCT00281580|460717786|FG001|Overall Study|Withdrawal by Subject|0|||
128025549|NCT00281580|460717787|FG002|Overall Study|Withdrawal by Subject|1|||
128025550|NCT00281580|460717788|FG003|Overall Study|Withdrawal by Subject|1|||
128025551|NCT00281580|460717789|FG004|Overall Study|Withdrawal by Subject|1|||
128025552|NCT00281580|460717790|FG005|Overall Study|Withdrawal by Subject|2|||
128025553|NCT00281580|460717791|FG006|Overall Study|Withdrawal by Subject|2|||
128025554|NCT00281580|460717792|FG007|Overall Study|Withdrawal by Subject|0|||
128025555|NCT00281580|460717793|FG008|Overall Study|Withdrawal by Subject|1|||
128025556|NCT00281580|460717794|FG009|Overall Study|Withdrawal by Subject|4|||
127565300|NCT03011892|459038118|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
127565301|NCT03011892|459038119|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
127565302|NCT03011892|459038120|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
127565303|NCT03011892|459038121|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
127565304|NCT03011892|459038122|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
127565305|NCT03011892|459038111|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
127565306|NCT03011892|459038112|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
127565307|NCT03011892|459038113|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
127565308|NCT03011892|459038114|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
127565309|NCT03011892|459038115|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
127565310|NCT03011892|459038116|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
127565311|NCT03011892|459038117|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
127565312|NCT03011892|459038118|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
127565313|NCT03011892|459038119|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
127565314|NCT03011892|459038120|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
127565315|NCT03011892|459038121|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
127688538|NCT02544074|459484982|FG017|Overall Study|Tablet error|0|||
127565316|NCT03011892|459038122|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
127688539|NCT02544074|459484983|FG018|Overall Study|Tablet error|0|||
127688540|NCT02544074|459484984|FG019|Overall Study|Tablet error|0|||
128025557|NCT00281580|460717795|FG010|Overall Study|Withdrawal by Subject|1|||
128025558|NCT00281580|460717796|FG011|Overall Study|Withdrawal by Subject|1|||
128025559|NCT00281580|460717797|FG012|Overall Study|Withdrawal by Subject|2|||
128025560|NCT00281580|460717798|FG013|Overall Study|Withdrawal by Subject|2|||
128025561|NCT00281580|460717799|FG014|Overall Study|Withdrawal by Subject|1|||
128025562|NCT00281580|460717800|FG015|Overall Study|Withdrawal by Subject|5|||
128025563|NCT00281580|460717785|FG000|Overall Study|Lack of Efficacy|2|||
128025564|NCT00281580|460717786|FG001|Overall Study|Lack of Efficacy|1|||
128025565|NCT00281580|460717787|FG002|Overall Study|Lack of Efficacy|1|||
128025566|NCT00281580|460717788|FG003|Overall Study|Lack of Efficacy|6|||
128025567|NCT00281580|460717789|FG004|Overall Study|Lack of Efficacy|2|||
128025568|NCT00281580|460717790|FG005|Overall Study|Lack of Efficacy|0|||
128025569|NCT00281580|460717791|FG006|Overall Study|Lack of Efficacy|0|||
128025570|NCT00281580|460717792|FG007|Overall Study|Lack of Efficacy|0|||
128025571|NCT00281580|460717793|FG008|Overall Study|Lack of Efficacy|0|||
128025572|NCT00281580|460717794|FG009|Overall Study|Lack of Efficacy|0|||
128025573|NCT00281580|460717795|FG010|Overall Study|Lack of Efficacy|0|||
128025574|NCT00281580|460717796|FG011|Overall Study|Lack of Efficacy|1|||
128025575|NCT00281580|460717797|FG012|Overall Study|Lack of Efficacy|0|||
128025576|NCT00281580|460717798|FG013|Overall Study|Lack of Efficacy|2|||
128025577|NCT00281580|460717799|FG014|Overall Study|Lack of Efficacy|1|||
128025578|NCT00281580|460717800|FG015|Overall Study|Lack of Efficacy|0|||
128025579|NCT00281580|460717785|FG000|Overall Study|Lost to Follow-up|0|||
128025580|NCT00281580|460717786|FG001|Overall Study|Lost to Follow-up|0|||
128025581|NCT00281580|460717787|FG002|Overall Study|Lost to Follow-up|0|||
128025582|NCT00281580|460717788|FG003|Overall Study|Lost to Follow-up|3|||
128025583|NCT00281580|460717789|FG004|Overall Study|Lost to Follow-up|0|||
128025584|NCT00281580|460717790|FG005|Overall Study|Lost to Follow-up|1|||
128025585|NCT00281580|460717791|FG006|Overall Study|Lost to Follow-up|0|||
128025586|NCT00281580|460717792|FG007|Overall Study|Lost to Follow-up|1|||
128025587|NCT00281580|460717793|FG008|Overall Study|Lost to Follow-up|2|||
128025588|NCT00281580|460717794|FG009|Overall Study|Lost to Follow-up|1|||
128025589|NCT00281580|460717795|FG010|Overall Study|Lost to Follow-up|1|||
128025590|NCT00281580|460717796|FG011|Overall Study|Lost to Follow-up|0|||
128025591|NCT00281580|460717797|FG012|Overall Study|Lost to Follow-up|1|||
127565317|NCT03011892|459038111|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
127565318|NCT03011892|459038112|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
127565319|NCT03011892|459038113|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
127565320|NCT03011892|459038114|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
127565321|NCT03011892|459038115|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
127565322|NCT03011892|459038116|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
127565323|NCT03011892|459038117|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
127565324|NCT03011892|459038118|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
127565325|NCT03011892|459038119|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
127565326|NCT03011892|459038120|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
127565327|NCT03011892|459038121|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
127565328|NCT03011892|459038122|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
127565329|NCT03011892|459038111|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
128025592|NCT00281580|460717798|FG013|Overall Study|Lost to Follow-up|0|||
128025593|NCT00281580|460717799|FG014|Overall Study|Lost to Follow-up|0|||
127565330|NCT03011892|459038112|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
127565331|NCT03011892|459038113|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
127688541|NCT02544074|459484985|FG020|Overall Study|Tablet error|0|||
127688542|NCT03189524|459484986|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
127688543|NCT03189524|459484987|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
127688544|NCT03189524|459484988|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
127688545|NCT03189524|459484986|FG000|Overall Study|Death|2|||
127688546|NCT03189524|459484987|FG001|Overall Study|Death|2|||
127688547|NCT03189524|459484988|FG002|Overall Study|Death|1|||
127688548|NCT03189524|459484986|FG000|Overall Study|Lost to Follow-up|1|||
127688549|NCT03189524|459484987|FG001|Overall Study|Lost to Follow-up|0|||
127688550|NCT03189524|459484988|FG002|Overall Study|Lost to Follow-up|8|||
127688551|NCT03189524|459484986|FG000|Overall Study|Withdrawal by Subject|1|||
127688552|NCT03189524|459484987|FG001|Overall Study|Withdrawal by Subject|1|||
127688553|NCT03189524|459484988|FG002|Overall Study|Withdrawal by Subject|3|||
127688554|NCT03189524|459484986|FG000|Overall Study|Progressive Disease|0|||
127688555|NCT03189524|459484987|FG001|Overall Study|Progressive Disease|2|||
127688556|NCT03189524|459484988|FG002|Overall Study|Progressive Disease|0|||
127688557|NCT02980276|459484989|FG000|Overall Study|Withdrawal by Subject|4|||
127688558|NCT02980276|459484990|FG001|Overall Study|Withdrawal by Subject|4|||
127688559|NCT02980276|459484989|FG000|Overall Study|Physician Decision|0|||
127688560|NCT02980276|459484990|FG001|Overall Study|Physician Decision|1|||
127688561|NCT02980276|459484989|FG000|Overall Study|Lost to Follow-up|18|||
127688562|NCT02980276|459484990|FG001|Overall Study|Lost to Follow-up|18|||
127688563|NCT02980276|459484989|FG000|Overall Study|Death|1|||
127688564|NCT02980276|459484990|FG001|Overall Study|Death|0|||
127688565|NCT02980276|459484989|FG000|Overall Study|Miscellaneous other|10|||
127688566|NCT02980276|459484990|FG001|Overall Study|Miscellaneous other|4|||
127688567|NCT04300647|459484991|FG000|Pre-Crossover|Death|19|||
127688568|NCT04300647|459484992|FG001|Pre-Crossover|Death|58|||
128025594|NCT00281580|460717800|FG015|Overall Study|Lost to Follow-up|0|||
128025595|NCT00281580|460717785|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
128025596|NCT00281580|460717786|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
128025597|NCT00281580|460717787|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
127565332|NCT03011892|459038114|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
127565333|NCT03011892|459038115|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
127565334|NCT03011892|459038116|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
127565335|NCT03011892|459038117|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
127565336|NCT03011892|459038118|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
127565337|NCT03011892|459038119|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
127565338|NCT03011892|459038120|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
127565339|NCT03011892|459038121|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
127565340|NCT03011892|459038122|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
127565341|NCT03011892|459038111|FG000|Open Label (OL) Period|Reason not specified|0|||
127565342|NCT03011892|459038112|FG001|Open Label (OL) Period|Reason not specified|0|||
127565343|NCT03011892|459038113|FG002|Open Label (OL) Period|Reason not specified|0|||
127565344|NCT03011892|459038114|FG003|Open Label (OL) Period|Reason not specified|0|||
127565345|NCT03011892|459038115|FG004|Open Label (OL) Period|Reason not specified|0|||
127565346|NCT03011892|459038116|FG005|Open Label (OL) Period|Reason not specified|0|||
127565347|NCT03011892|459038117|FG006|Open Label (OL) Period|Reason not specified|0|||
127565348|NCT03011892|459038118|FG007|Open Label (OL) Period|Reason not specified|1|||
127565349|NCT03011892|459038119|FG008|Open Label (OL) Period|Reason not specified|0|||
127565350|NCT03011892|459038120|FG009|Open Label (OL) Period|Reason not specified|0|||
127565351|NCT03011892|459038121|FG010|Open Label (OL) Period|Reason not specified|0|||
127565352|NCT03011892|459038122|FG011|Open Label (OL) Period|Reason not specified|0|||
127565353|NCT02312687|459038123|FG000|Overall Study|Other, Not Specified|1|||
127565354|NCT00384111|459038124|FG000|Overall Study|Disease Progression|3|||
127565355|NCT00384111|459038124|FG000|Overall Study|Adverse Event|1|||
127565356|NCT00384111|459038124|FG000|Overall Study|Investigator Decision|3|||
127565357|NCT00384111|459038124|FG000|Overall Study|Study Terminated by the Sponsor|19|||
127565358|NCT00217464|459038127|FG000|Overall Study|Progression|15|||
127688569|NCT04300647|459484993|FG002|Pre-Crossover|Death|0|||
127688570|NCT04300647|459484991|FG000|Pre-Crossover|Lost to Follow-up|0|||
127688571|NCT04300647|459484992|FG001|Pre-Crossover|Lost to Follow-up|3|||
127688572|NCT04300647|459484993|FG002|Pre-Crossover|Lost to Follow-up|0|||
127688573|NCT04300647|459484991|FG000|Pre-Crossover|Withdrawal by Subject|2|||
127688574|NCT04300647|459484992|FG001|Pre-Crossover|Withdrawal by Subject|4|||
127688575|NCT04300647|459484993|FG002|Pre-Crossover|Withdrawal by Subject|0|||
127688576|NCT04300647|459484991|FG000|Pre-Crossover|On-going in Study|24|||
127688577|NCT04300647|459484992|FG001|Pre-Crossover|On-going in Study|61|||
127688578|NCT04300647|459484993|FG002|Pre-Crossover|On-going in Study|0|||
127688579|NCT04300647|459484991|FG000|Post-Crossover|Death|0|||
127688580|NCT04300647|459484992|FG001|Post-Crossover|Death|0|||
127688581|NCT04300647|459484993|FG002|Post-Crossover|Death|3|||
127688582|NCT04300647|459484991|FG000|Post-Crossover|Lost to Follow-up|0|||
127688583|NCT04300647|459484992|FG001|Post-Crossover|Lost to Follow-up|0|||
127688584|NCT04300647|459484993|FG002|Post-Crossover|Lost to Follow-up|1|||
127688585|NCT04300647|459484991|FG000|Post-Crossover|Withdrawal by Subject|0|||
127688586|NCT04300647|459484992|FG001|Post-Crossover|Withdrawal by Subject|0|||
127688587|NCT04300647|459484993|FG002|Post-Crossover|Withdrawal by Subject|1|||
127688588|NCT04300647|459484991|FG000|Post-Crossover|On-going in Study|0|||
127688589|NCT04300647|459484992|FG001|Post-Crossover|On-going in Study|0|||
127688590|NCT04300647|459484993|FG002|Post-Crossover|On-going in Study|8|||
127688591|NCT02824029|459484998|FG000|Overall Study|Didn't receive treatment|2|||
127688592|NCT02824029|459484998|FG000|Overall Study|Patient decision to discontinue treatment|3|||
127688593|NCT02824029|459484998|FG000|Overall Study|Non-compliant|5|||
127688594|NCT02824029|459484998|FG000|Overall Study|Progression of disease|15|||
127688595|NCT02824029|459484998|FG000|Overall Study|Inadequate response to therapy|2|||
127688596|NCT02824029|459484998|FG000|Overall Study|Possible progression per treating physician|1|||
127688597|NCT03613740|459484999|FG000|Overall Study|Lost to Follow-up|1|||
127688598|NCT03613740|459485000|FG001|Overall Study|Lost to Follow-up|1|||
127688599|NCT01443845|459485001|FG000|Overall Study|Protocol Violation|43|||
127688600|NCT01443845|459485002|FG001|Overall Study|Protocol Violation|45|||
127688601|NCT01443845|459485001|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
127688602|NCT01443845|459485002|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
127688603|NCT01443845|459485001|FG000|Overall Study|Deterioration in pulmonary function|1|||
127688604|NCT01443845|459485002|FG001|Overall Study|Deterioration in pulmonary function|4|||
127688605|NCT01443845|459485001|FG000|Overall Study|Lack of Efficacy|10|||
127688606|NCT01443845|459485002|FG001|Overall Study|Lack of Efficacy|5|||
127688607|NCT01443845|459485001|FG000|Overall Study|Adverse Event|64|||
127688608|NCT01443845|459485002|FG001|Overall Study|Adverse Event|138|||
127688609|NCT01443845|459485001|FG000|Overall Study|Withdrawal by Subject|63|||
127565359|NCT00217464|459038127|FG000|Overall Study|Other|2|||
127565360|NCT03612856|459038128|FG000|Pre-dose Period|Physician Decision|0|||
127565361|NCT03612856|459038129|FG001|Pre-dose Period|Physician Decision|1|||
127565362|NCT03612856|459038130|FG002|Pre-dose Period|Physician Decision|1|||
127688610|NCT01443845|459485002|FG001|Overall Study|Withdrawal by Subject|67|||
127688611|NCT01443845|459485001|FG000|Overall Study|Military Conflict - Site Terminated|20|||
127688612|NCT01443845|459485002|FG001|Overall Study|Military Conflict - Site Terminated|21|||
128025598|NCT00281580|460717788|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
128025599|NCT00281580|460717789|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
128025600|NCT00281580|460717790|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
128025601|NCT00281580|460717791|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
128025602|NCT00281580|460717792|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
128025603|NCT00281580|460717793|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
128025604|NCT00281580|460717794|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
128025605|NCT00281580|460717795|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
127565363|NCT03612856|459038128|FG000|Pre-dose Period|Withdrawal by Subject|0|||
127565364|NCT03612856|459038129|FG001|Pre-dose Period|Withdrawal by Subject|1|||
127565365|NCT03612856|459038130|FG002|Pre-dose Period|Withdrawal by Subject|0|||
127565366|NCT01576159|459038131|FG000|Overall Study|Withdrawal by Subject|0|||
127565367|NCT01576159|459038132|FG001|Overall Study|Withdrawal by Subject|1|||
127565368|NCT01576159|459038133|FG002|Overall Study|Withdrawal by Subject|0|||
127565369|NCT01576159|459038134|FG003|Overall Study|Withdrawal by Subject|0|||
127565370|NCT01576159|459038131|FG000|Overall Study|Physician Decision|0|||
127565371|NCT01576159|459038132|FG001|Overall Study|Physician Decision|0|||
127565372|NCT01576159|459038133|FG002|Overall Study|Physician Decision|1|||
127565373|NCT01576159|459038134|FG003|Overall Study|Physician Decision|0|||
127565374|NCT01576159|459038131|FG000|Overall Study|Lost to Follow-up|0|||
127565375|NCT01576159|459038132|FG001|Overall Study|Lost to Follow-up|0|||
127565376|NCT01576159|459038133|FG002|Overall Study|Lost to Follow-up|0|||
127565377|NCT01576159|459038134|FG003|Overall Study|Lost to Follow-up|1|||
127565378|NCT01576159|459038131|FG000|Overall Study|Protocol Violation|1|||
127565379|NCT01576159|459038132|FG001|Overall Study|Protocol Violation|0|||
127565380|NCT01576159|459038133|FG002|Overall Study|Protocol Violation|0|||
127565381|NCT01576159|459038134|FG003|Overall Study|Protocol Violation|0|||
127565382|NCT00169442|459038135|FG000|Overall Study|Withdrawal by Subject|0|||
127565383|NCT00169442|459038136|FG001|Overall Study|Withdrawal by Subject|0|||
127565384|NCT00169442|459038137|FG002|Overall Study|Withdrawal by Subject|1|||
127565385|NCT00169442|459038138|FG003|Overall Study|Withdrawal by Subject|0|||
127565386|NCT00169442|459038139|FG004|Overall Study|Withdrawal by Subject|0|||
127565387|NCT00169442|459038140|FG005|Overall Study|Withdrawal by Subject|0|||
127565388|NCT00169442|459038135|FG000|Overall Study|Migrated/moved from study area|0|||
127565389|NCT00169442|459038136|FG001|Overall Study|Migrated/moved from study area|0|||
127565390|NCT00169442|459038137|FG002|Overall Study|Migrated/moved from study area|0|||
127565391|NCT00169442|459038138|FG003|Overall Study|Migrated/moved from study area|0|||
127565392|NCT00169442|459038139|FG004|Overall Study|Migrated/moved from study area|0|||
127565393|NCT00169442|459038140|FG005|Overall Study|Migrated/moved from study area|2|||
127565394|NCT00169442|459038135|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
127565395|NCT00169442|459038136|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
127565396|NCT00169442|459038137|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
127565397|NCT00169442|459038138|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
127565398|NCT00169442|459038139|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
127565399|NCT00169442|459038140|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
127565400|NCT00169442|459038135|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
127565401|NCT00169442|459038136|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
127565402|NCT00169442|459038137|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
127565403|NCT00169442|459038138|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
127565404|NCT00169442|459038139|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
127565405|NCT00169442|459038140|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
127565406|NCT01426789|459038141|FG000|Part 1|Protocol deviation|0|||
127565407|NCT01426789|459038142|FG001|Part 1|Protocol deviation|1|||
127565408|NCT01426789|459038143|FG002|Part 1|Protocol deviation|0|||
127565409|NCT01426789|459038144|FG003|Part 1|Protocol deviation|0|||
127565410|NCT01426789|459038145|FG004|Part 1|Protocol deviation|0|||
127565411|NCT01426789|459038146|FG005|Part 1|Protocol deviation|0|||
127565412|NCT01426789|459038141|FG000|Part 1|Lost to Follow-up|1|||
127565413|NCT01426789|459038142|FG001|Part 1|Lost to Follow-up|2|||
128025606|NCT00281580|460717796|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
127565414|NCT01426789|459038143|FG002|Part 1|Lost to Follow-up|0|||
127565415|NCT01426789|459038144|FG003|Part 1|Lost to Follow-up|0|||
127565416|NCT01426789|459038145|FG004|Part 1|Lost to Follow-up|0|||
127565417|NCT01426789|459038146|FG005|Part 1|Lost to Follow-up|0|||
127565418|NCT01426789|459038141|FG000|Part 1|Lack of Efficacy|2|||
127565419|NCT01426789|459038142|FG001|Part 1|Lack of Efficacy|1|||
127565420|NCT01426789|459038143|FG002|Part 1|Lack of Efficacy|0|||
127565421|NCT01426789|459038144|FG003|Part 1|Lack of Efficacy|0|||
127565422|NCT01426789|459038145|FG004|Part 1|Lack of Efficacy|0|||
127565423|NCT01426789|459038146|FG005|Part 1|Lack of Efficacy|0|||
127565424|NCT01426789|459038141|FG000|Part 1|Adverse Event|3|||
127565425|NCT01426789|459038142|FG001|Part 1|Adverse Event|0|||
127565426|NCT01426789|459038143|FG002|Part 1|Adverse Event|0|||
127565427|NCT01426789|459038144|FG003|Part 1|Adverse Event|0|||
127565428|NCT01426789|459038145|FG004|Part 1|Adverse Event|0|||
127565429|NCT01426789|459038146|FG005|Part 1|Adverse Event|0|||
127565430|NCT01426789|459038141|FG000|Part 2|Protocol deviation|0|||
127565431|NCT01426789|459038142|FG001|Part 2|Protocol deviation|0|||
127565432|NCT01426789|459038143|FG002|Part 2|Protocol deviation|1|||
127565433|NCT01426789|459038144|FG003|Part 2|Protocol deviation|0|||
127565434|NCT01426789|459038145|FG004|Part 2|Protocol deviation|0|||
127565435|NCT01426789|459038146|FG005|Part 2|Protocol deviation|0|||
127565436|NCT01426789|459038141|FG000|Part 2|Death|0|||
127565437|NCT01426789|459038142|FG001|Part 2|Death|0|||
127565438|NCT01426789|459038143|FG002|Part 2|Death|1|||
127565439|NCT01426789|459038144|FG003|Part 2|Death|0|||
127565440|NCT01426789|459038145|FG004|Part 2|Death|1|||
127565441|NCT01426789|459038146|FG005|Part 2|Death|0|||
127565442|NCT01426789|459038141|FG000|Part 2|Administrative problems|0|||
127565443|NCT01426789|459038142|FG001|Part 2|Administrative problems|0|||
127565444|NCT01426789|459038143|FG002|Part 2|Administrative problems|2|||
127565445|NCT01426789|459038144|FG003|Part 2|Administrative problems|0|||
127565446|NCT01426789|459038145|FG004|Part 2|Administrative problems|1|||
127565447|NCT01426789|459038146|FG005|Part 2|Administrative problems|0|||
127565448|NCT01426789|459038141|FG000|Part 2|Lost to Follow-up|0|||
127565449|NCT01426789|459038142|FG001|Part 2|Lost to Follow-up|0|||
127565450|NCT01426789|459038143|FG002|Part 2|Lost to Follow-up|4|||
127565451|NCT01426789|459038144|FG003|Part 2|Lost to Follow-up|0|||
127565452|NCT01426789|459038145|FG004|Part 2|Lost to Follow-up|1|||
127565453|NCT01426789|459038146|FG005|Part 2|Lost to Follow-up|0|||
127565454|NCT01426789|459038141|FG000|Part 2|Withdrawal by Subject|0|||
127565455|NCT01426789|459038142|FG001|Part 2|Withdrawal by Subject|0|||
127565456|NCT01426789|459038143|FG002|Part 2|Withdrawal by Subject|0|||
127565457|NCT01426789|459038144|FG003|Part 2|Withdrawal by Subject|1|||
127565458|NCT01426789|459038145|FG004|Part 2|Withdrawal by Subject|2|||
127565459|NCT01426789|459038146|FG005|Part 2|Withdrawal by Subject|0|||
127565460|NCT01426789|459038141|FG000|Part 2|Lack of Efficacy|0|||
127565461|NCT01426789|459038142|FG001|Part 2|Lack of Efficacy|0|||
127565462|NCT01426789|459038143|FG002|Part 2|Lack of Efficacy|5|||
127565463|NCT01426789|459038144|FG003|Part 2|Lack of Efficacy|0|||
127565464|NCT01426789|459038145|FG004|Part 2|Lack of Efficacy|2|||
127565465|NCT01426789|459038146|FG005|Part 2|Lack of Efficacy|0|||
127565466|NCT01426789|459038141|FG000|Part 2|Adverse Event|0|||
127565467|NCT01426789|459038142|FG001|Part 2|Adverse Event|0|||
127565468|NCT01426789|459038143|FG002|Part 2|Adverse Event|2|||
127565469|NCT01426789|459038144|FG003|Part 2|Adverse Event|0|||
127565470|NCT01426789|459038145|FG004|Part 2|Adverse Event|1|||
127565471|NCT01426789|459038146|FG005|Part 2|Adverse Event|0|||
127565472|NCT01181986|459038149|FG000|Phase 1|Lost to Follow-up|0|||
127565473|NCT01181986|459038150|FG001|Phase 1|Lost to Follow-up|1|||
127565474|NCT01181986|459038151|FG002|Phase 1|Lost to Follow-up|1|||
127565475|NCT01181986|459038149|FG000|Phase 1|Adverse Event|0|||
127565476|NCT01181986|459038150|FG001|Phase 1|Adverse Event|0|||
127565477|NCT01181986|459038151|FG002|Phase 1|Adverse Event|1|||
127565478|NCT01181986|459038149|FG000|Phase 1|Protocol Violation|1|||
127565479|NCT01181986|459038150|FG001|Phase 1|Protocol Violation|0|||
127565480|NCT01181986|459038151|FG002|Phase 1|Protocol Violation|0|||
127565481|NCT01181986|459038149|FG000|Phase 2|Adverse Event|0|||
127688613|NCT01443845|459485001|FG000|Overall Study|Lost to Follow-up|9|||
127688614|NCT01443845|459485002|FG001|Overall Study|Lost to Follow-up|13|||
127688615|NCT00520546|459485003|FG000|Overall Study|Withdrawal by Subject|1|||
127688616|NCT00520546|459485003|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
127688617|NCT02101281|459485004|FG000|Overall Study|Adverse Event|0|||
127688618|NCT02101281|459485005|FG001|Overall Study|Adverse Event|1|||
127688619|NCT00174382|459485006|FG000|Overall Study|Death|2|||
127688620|NCT00174382|459485006|FG000|Overall Study|Adverse Event|19|||
127688621|NCT00174382|459485006|FG000|Overall Study|Withdrawal by Subject|6|||
127565482|NCT01181986|459038150|FG001|Phase 2|Adverse Event|3|||
127565483|NCT01181986|459038151|FG002|Phase 2|Adverse Event|0|||
127565484|NCT01181986|459038149|FG000|Phase 2|Medical condition|0|||
127565485|NCT01181986|459038150|FG001|Phase 2|Medical condition|1|||
127565486|NCT01181986|459038151|FG002|Phase 2|Medical condition|0|||
127565487|NCT00311584|459038154|FG000|Overall Study|Death|1|||
127565488|NCT00311584|459038155|FG001|Overall Study|Death|0|||
127565489|NCT00311584|459038154|FG000|Overall Study|Lack of Efficacy|12|||
127565490|NCT00311584|459038155|FG001|Overall Study|Lack of Efficacy|15|||
127565491|NCT00311584|459038154|FG000|Overall Study|Physician Decision|4|||
127565492|NCT00311584|459038155|FG001|Overall Study|Physician Decision|5|||
127565493|NCT00311584|459038154|FG000|Overall Study|Withdrawal by Subject|1|||
127565494|NCT00311584|459038155|FG001|Overall Study|Withdrawal by Subject|1|||
127565495|NCT00311584|459038154|FG000|Overall Study|ineligible|2|||
127565496|NCT00311584|459038155|FG001|Overall Study|ineligible|2|||
127565497|NCT03720652|459038156|FG000|Overall Study|Withdrawal by Subject|2|||
127565498|NCT03720652|459038157|FG001|Overall Study|Withdrawal by Subject|7|||
127565499|NCT03720652|459038156|FG000|Overall Study|Lost to Follow-up|0|||
127565500|NCT03720652|459038157|FG001|Overall Study|Lost to Follow-up|4|||
127565501|NCT03073733|459038158|FG000|Overall Study|Lost to Follow-up|1|||
127565502|NCT03073733|459038159|FG001|Overall Study|Lost to Follow-up|0|||
127565503|NCT03073733|459038160|FG002|Overall Study|Lost to Follow-up|0|||
127565504|NCT03073733|459038158|FG000|Overall Study|Physician Decision|0|||
127565505|NCT03073733|459038159|FG001|Overall Study|Physician Decision|1|||
127565506|NCT03073733|459038160|FG002|Overall Study|Physician Decision|0|||
127565507|NCT03073733|459038158|FG000|Overall Study|Withdrawal by Subject|0|||
127565508|NCT03073733|459038159|FG001|Overall Study|Withdrawal by Subject|0|||
127565509|NCT03073733|459038160|FG002|Overall Study|Withdrawal by Subject|1|||
127565510|NCT01454778|459038165|FG000|Overall Study|Lost to Follow-up|2|||
127776933|NCT05975840|459811655|FG006|Overall Study|Other|0|||
127776934|NCT05975840|459811656|FG007|Overall Study|Other|0|||
127776935|NCT05975840|459811649|FG000|Overall Study|Lost to Follow-up|3|||
127776936|NCT05975840|459811650|FG001|Overall Study|Lost to Follow-up|6|||
127776937|NCT05975840|459811651|FG002|Overall Study|Lost to Follow-up|3|||
127776938|NCT05975840|459811652|FG003|Overall Study|Lost to Follow-up|1|||
128025607|NCT00281580|460717797|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
127776939|NCT05975840|459811653|FG004|Overall Study|Lost to Follow-up|4|||
127776940|NCT05975840|459811654|FG005|Overall Study|Lost to Follow-up|1|||
127776941|NCT05975840|459811655|FG006|Overall Study|Lost to Follow-up|2|||
127776942|NCT05975840|459811656|FG007|Overall Study|Lost to Follow-up|4|||
127776943|NCT05975840|459811649|FG000|Overall Study|Migrated/moved from the study area|1|||
127776944|NCT05975840|459811650|FG001|Overall Study|Migrated/moved from the study area|0|||
127776945|NCT05975840|459811651|FG002|Overall Study|Migrated/moved from the study area|0|||
127776946|NCT05975840|459811652|FG003|Overall Study|Migrated/moved from the study area|0|||
127776947|NCT05975840|459811653|FG004|Overall Study|Migrated/moved from the study area|0|||
127776948|NCT05975840|459811654|FG005|Overall Study|Migrated/moved from the study area|0|||
127776949|NCT05975840|459811655|FG006|Overall Study|Migrated/moved from the study area|0|||
127776950|NCT05975840|459811656|FG007|Overall Study|Migrated/moved from the study area|0|||
127776951|NCT05975840|459811649|FG000|Overall Study|Withdrawal by Subject|0|||
127776952|NCT05975840|459811650|FG001|Overall Study|Withdrawal by Subject|5|||
127776953|NCT05975840|459811651|FG002|Overall Study|Withdrawal by Subject|2|||
127776954|NCT05975840|459811652|FG003|Overall Study|Withdrawal by Subject|2|||
127776955|NCT05975840|459811653|FG004|Overall Study|Withdrawal by Subject|0|||
127776956|NCT05975840|459811654|FG005|Overall Study|Withdrawal by Subject|2|||
127776957|NCT05975840|459811655|FG006|Overall Study|Withdrawal by Subject|2|||
127776958|NCT05975840|459811656|FG007|Overall Study|Withdrawal by Subject|1|||
127776959|NCT05975840|459811649|FG000|Overall Study|Protocol Violation|0|||
127776960|NCT05975840|459811650|FG001|Overall Study|Protocol Violation|1|||
127776961|NCT05975840|459811651|FG002|Overall Study|Protocol Violation|0|||
127776962|NCT05975840|459811652|FG003|Overall Study|Protocol Violation|0|||
127776963|NCT05975840|459811653|FG004|Overall Study|Protocol Violation|0|||
127776964|NCT05975840|459811654|FG005|Overall Study|Protocol Violation|0|||
127776965|NCT05975840|459811655|FG006|Overall Study|Protocol Violation|0|||
128025608|NCT00281580|460717798|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
128025609|NCT00281580|460717799|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
128025610|NCT00281580|460717800|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
128025611|NCT03302936|460717801|FG000|Overall Study|Protocol Violation|3|||
128025612|NCT03302936|460717802|FG001|Overall Study|Protocol Violation|4|||
128025613|NCT01550965|460717803|FG000|Overall Study|Adverse Event|26|||
128025614|NCT01550965|460717803|FG000|Overall Study|Withdrawal by Subject|10|||
128025615|NCT01550965|460717803|FG000|Overall Study|Lost to Follow-up|2|||
128025616|NCT01550965|460717803|FG000|Overall Study|Lack of Efficacy|59|||
128025617|NCT01550965|460717803|FG000|Overall Study|Other|13|||
128025618|NCT03016403|460717806|FG000|Baseline|Death|5|||
128025619|NCT03016403|460717807|FG001|Baseline|Death|8|||
128025620|NCT03016403|460717808|FG002|Baseline|Death|1|||
128025621|NCT03016403|460717809|FG003|Baseline|Death|0|||
128025622|NCT03016403|460717806|FG000|Baseline|Withdrawal by Subject|2|||
128025623|NCT03016403|460717807|FG001|Baseline|Withdrawal by Subject|8|||
127776966|NCT05975840|459811656|FG007|Overall Study|Protocol Violation|0|||
128025624|NCT03016403|460717808|FG002|Baseline|Withdrawal by Subject|4|||
128025625|NCT03016403|460717809|FG003|Baseline|Withdrawal by Subject|10|||
127776967|NCT05975840|459811649|FG000|Overall Study|Adverse Event|0|||
127776968|NCT05975840|459811650|FG001|Overall Study|Adverse Event|0|||
127776969|NCT05975840|459811651|FG002|Overall Study|Adverse Event|0|||
127776970|NCT05975840|459811652|FG003|Overall Study|Adverse Event|1|||
127776971|NCT05975840|459811653|FG004|Overall Study|Adverse Event|0|||
127776972|NCT05975840|459811654|FG005|Overall Study|Adverse Event|0|||
128025626|NCT03016403|460717806|FG000|Baseline|Lost to Follow-up|9|||
128025627|NCT03016403|460717807|FG001|Baseline|Lost to Follow-up|11|||
128025628|NCT03016403|460717808|FG002|Baseline|Lost to Follow-up|6|||
127565511|NCT01454778|459038165|FG000|Overall Study|Death|1|||
127565512|NCT00835731|459038166|FG000|Overall Study|Withdrawal by Subject|1|||
127565513|NCT00835731|459038167|FG001|Overall Study|Withdrawal by Subject|0|||
127565514|NCT00835731|459038166|FG000|Overall Study|Physician Decision|1|||
127776973|NCT05975840|459811655|FG006|Overall Study|Adverse Event|0|||
127776974|NCT05975840|459811656|FG007|Overall Study|Adverse Event|0|||
127776975|NCT05975840|459811649|FG000|Overall Study|Death|0|||
127565515|NCT00835731|459038167|FG001|Overall Study|Physician Decision|1|||
127565516|NCT00348881|459038168|FG000|Overall Study|Lost to Follow-up|12|||
127565517|NCT00348881|459038169|FG001|Overall Study|Lost to Follow-up|6|||
127565518|NCT00348881|459038168|FG000|Overall Study|Withdrawal by Subject|3|||
127565519|NCT00348881|459038169|FG001|Overall Study|Withdrawal by Subject|4|||
127565520|NCT00348881|459038168|FG000|Overall Study|Adverse Event|2|||
127565521|NCT00348881|459038169|FG001|Overall Study|Adverse Event|0|||
127565522|NCT00348881|459038168|FG000|Overall Study|Serious Adverse Event|0|||
127565523|NCT00348881|459038169|FG001|Overall Study|Serious Adverse Event|2|||
127565524|NCT00167778|459038170|FG000|Overall Study|Withdrawal by Subject|1|||
127565525|NCT02654717|459038171|FG000|Overall Study|Adverse Event|2|||
127565526|NCT02654717|459038172|FG001|Overall Study|Adverse Event|2|||
127565527|NCT02654717|459038171|FG000|Overall Study|Protocol Violation|1|||
127565528|NCT02654717|459038172|FG001|Overall Study|Protocol Violation|2|||
127565529|NCT02654717|459038171|FG000|Overall Study|Withdrawal by Subject|0|||
127565530|NCT02654717|459038172|FG001|Overall Study|Withdrawal by Subject|1|||
127565531|NCT02654717|459038171|FG000|Overall Study|Non-permitted medication|3|||
127565532|NCT02654717|459038172|FG001|Overall Study|Non-permitted medication|0|||
127565533|NCT00576420|459039915|FG000|Overall Study|Death|0|||
127565534|NCT00576420|459039916|FG001|Overall Study|Death|0|||
127565535|NCT00576420|459039917|FG002|Overall Study|Death|1|||
127565536|NCT01340872|459039919|FG000|Double-blind Phase|Adverse Event|6|||
127565537|NCT01340872|459039920|FG001|Double-blind Phase|Adverse Event|4|||
127565538|NCT01340872|459039921|FG002|Double-blind Phase|Adverse Event|0|||
127565539|NCT01340872|459039922|FG003|Double-blind Phase|Adverse Event|0|||
127565540|NCT01340872|459039919|FG000|Double-blind Phase|Withdrawal by Subject|3|||
127565541|NCT01340872|459039920|FG001|Double-blind Phase|Withdrawal by Subject|5|||
127565542|NCT01340872|459039921|FG002|Double-blind Phase|Withdrawal by Subject|0|||
127565543|NCT01340872|459039922|FG003|Double-blind Phase|Withdrawal by Subject|0|||
127565544|NCT01340872|459039919|FG000|Double-blind Phase|Lost to Follow-up|0|||
127565545|NCT01340872|459039920|FG001|Double-blind Phase|Lost to Follow-up|1|||
127565546|NCT01340872|459039921|FG002|Double-blind Phase|Lost to Follow-up|0|||
127565547|NCT01340872|459039922|FG003|Double-blind Phase|Lost to Follow-up|0|||
127565548|NCT01340872|459039919|FG000|Double-blind Phase|Protocol Violation|0|||
127565549|NCT01340872|459039920|FG001|Double-blind Phase|Protocol Violation|1|||
127565550|NCT01340872|459039921|FG002|Double-blind Phase|Protocol Violation|0|||
127565551|NCT01340872|459039922|FG003|Double-blind Phase|Protocol Violation|0|||
127565552|NCT01340872|459039919|FG000|Open-label Phase|Physician Decision|0|||
127565553|NCT01340872|459039920|FG001|Open-label Phase|Physician Decision|0|||
127565554|NCT01340872|459039921|FG002|Open-label Phase|Physician Decision|2|||
127565555|NCT01340872|459039922|FG003|Open-label Phase|Physician Decision|1|||
127565556|NCT01340872|459039919|FG000|Open-label Phase|Pregnancy|0|||
127565557|NCT01340872|459039920|FG001|Open-label Phase|Pregnancy|0|||
127565558|NCT01340872|459039921|FG002|Open-label Phase|Pregnancy|1|||
127565559|NCT01340872|459039922|FG003|Open-label Phase|Pregnancy|0|||
127565560|NCT01340872|459039919|FG000|Open-label Phase|Adverse Event|0|||
127565561|NCT01340872|459039920|FG001|Open-label Phase|Adverse Event|0|||
127565562|NCT01340872|459039921|FG002|Open-label Phase|Adverse Event|8|||
127565563|NCT01340872|459039922|FG003|Open-label Phase|Adverse Event|4|||
127565564|NCT01340872|459039919|FG000|Open-label Phase|Withdrawal by Subject|0|||
127565565|NCT01340872|459039920|FG001|Open-label Phase|Withdrawal by Subject|0|||
127565566|NCT01340872|459039921|FG002|Open-label Phase|Withdrawal by Subject|1|||
127565567|NCT01340872|459039922|FG003|Open-label Phase|Withdrawal by Subject|6|||
127565568|NCT01340872|459039919|FG000|Open-label Phase|Worsening of IBD|0|||
127565569|NCT01340872|459039920|FG001|Open-label Phase|Worsening of IBD|0|||
127565570|NCT01340872|459039921|FG002|Open-label Phase|Worsening of IBD|1|||
127565571|NCT01340872|459039922|FG003|Open-label Phase|Worsening of IBD|0|||
127565572|NCT01771809|459039926|FG000|Overall Study|Adverse Event|4|||
127688622|NCT00174382|459485006|FG000|Overall Study|Protocol Violation|3|||
127688623|NCT00174382|459485006|FG000|Overall Study|Arrived early for last visit in error|1|||
127688624|NCT00174382|459485006|FG000|Overall Study|Subject felt pill not effective enough|1|||
127688625|NCT00174382|459485006|FG000|Overall Study|Lost to Follow-up|1|||
127565573|NCT01771809|459039927|FG001|Overall Study|Adverse Event|12|||
127565574|NCT01771809|459039926|FG000|Overall Study|Protocol Violation|0|||
127565575|NCT01771809|459039927|FG001|Overall Study|Protocol Violation|1|||
127565576|NCT01771809|459039926|FG000|Overall Study|Withdrawal by Subject|34|||
127688626|NCT00296036|459485007|FG000|Overall Study|Withdrawal by Subject|1|||
127688627|NCT00296036|459485008|FG001|Overall Study|Withdrawal by Subject|0|||
127688628|NCT00296036|459485009|FG002|Overall Study|Withdrawal by Subject|2|||
127688629|NCT00296036|459485010|FG003|Overall Study|Withdrawal by Subject|1|||
127688630|NCT00296036|459485011|FG004|Overall Study|Withdrawal by Subject|2|||
127565577|NCT01771809|459039927|FG001|Overall Study|Withdrawal by Subject|42|||
127565578|NCT01771809|459039926|FG000|Overall Study|Lost to Follow-up|1|||
127565579|NCT01771809|459039927|FG001|Overall Study|Lost to Follow-up|3|||
127565580|NCT01771809|459039926|FG000|Overall Study|Other (Insufficient clinical response)|22|||
127565581|NCT01771809|459039927|FG001|Overall Study|Other (Insufficient clinical response)|20|||
127565582|NCT01771809|459039926|FG000|Overall Study|Death|1|||
127565583|NCT01771809|459039927|FG001|Overall Study|Death|0|||
127565584|NCT01771809|459039926|FG000|Overall Study|Other (other)|9|||
127565585|NCT01771809|459039927|FG001|Overall Study|Other (other)|5|||
127565586|NCT03603509|459039928|FG000|Overall Study|Lost to Follow-up|3|||
127565587|NCT03603509|459039929|FG001|Overall Study|Lost to Follow-up|4|||
127565588|NCT02656680|459039932|FG000|Overall Study|Lost to Follow-up|0|||
127565589|NCT02656680|459039933|FG001|Overall Study|Lost to Follow-up|1|||
127565590|NCT02656680|459039934|FG002|Overall Study|Lost to Follow-up|7|||
127565591|NCT04966910|459039935|FG000|Baseline|Participant did not complete measure|0|||
127565592|NCT04966910|459039936|FG001|Baseline|Participant did not complete measure|0|||
127565593|NCT04966910|459039937|FG002|Baseline|Participant did not complete measure|1|||
127565594|NCT04966910|459039938|FG003|Baseline|Participant did not complete measure|0|||
127565595|NCT04966910|459039935|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
127565596|NCT04966910|459039936|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
127565597|NCT04966910|459039937|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
127565598|NCT04966910|459039938|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
127565599|NCT04966910|459039935|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
127565600|NCT04966910|459039936|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
127776976|NCT05975840|459811650|FG001|Overall Study|Death|1|||
127776977|NCT05975840|459811651|FG002|Overall Study|Death|0|||
127776978|NCT05975840|459811652|FG003|Overall Study|Death|0|||
127776979|NCT05975840|459811653|FG004|Overall Study|Death|0|||
127776980|NCT05975840|459811654|FG005|Overall Study|Death|0|||
127776981|NCT05975840|459811655|FG006|Overall Study|Death|0|||
127776982|NCT05975840|459811656|FG007|Overall Study|Death|1|||
127776983|NCT01130051|459811657|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
127776984|NCT01130051|459811658|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
127776985|NCT01130051|459811657|FG000|Washout Period of 14 Days|Protocol Violation|1|||
127776986|NCT01130051|459811658|FG001|Washout Period of 14 Days|Protocol Violation|1|||
127776987|NCT04252287|459811660|FG000|Overall Study|Death|5|||
127776988|NCT04252287|459811661|FG001|Overall Study|Death|3|||
127776989|NCT04252287|459811660|FG000|Overall Study|Lost to Follow-up|4|||
127776990|NCT04252287|459811661|FG001|Overall Study|Lost to Follow-up|6|||
127776991|NCT04252287|459811660|FG000|Overall Study|Withdrawal by Subject|19|||
127776992|NCT04252287|459811661|FG001|Overall Study|Withdrawal by Subject|16|||
127776993|NCT04252287|459811660|FG000|Overall Study|Protocol Violation|3|||
127776994|NCT04252287|459811661|FG001|Overall Study|Protocol Violation|4|||
127776995|NCT01298518|459811666|FG000|Overall Study|Withdrawal by Subject|0|||
127776996|NCT01298518|459811667|FG001|Overall Study|Withdrawal by Subject|0|||
127776997|NCT01298518|459811668|FG002|Overall Study|Withdrawal by Subject|1|||
127776998|NCT02273726|459811669|FG000|Overall Study|Death|70|||
127776999|NCT02273726|459811670|FG001|Overall Study|Death|62|||
127777000|NCT02273726|459811669|FG000|Overall Study|Withdrawal by Subject|41|||
127777001|NCT02273726|459811670|FG001|Overall Study|Withdrawal by Subject|29|||
127777002|NCT02273726|459811669|FG000|Overall Study|Kidney transplant|31|||
127777003|NCT02273726|459811670|FG001|Overall Study|Kidney transplant|39|||
127777004|NCT02273726|459811669|FG000|Overall Study|Physician Decision|30|||
127777005|NCT02273726|459811670|FG001|Overall Study|Physician Decision|15|||
127777006|NCT02273726|459811669|FG000|Overall Study|Adverse Event|27|||
127777007|NCT02273726|459811670|FG001|Overall Study|Adverse Event|9|||
127777008|NCT02273726|459811669|FG000|Overall Study|Lost to Follow-up|6|||
127777009|NCT02273726|459811670|FG001|Overall Study|Lost to Follow-up|3|||
127777010|NCT02273726|459811669|FG000|Overall Study|Lack of Efficacy|6|||
127777011|NCT02273726|459811670|FG001|Overall Study|Lack of Efficacy|1|||
127777012|NCT02273726|459811669|FG000|Overall Study|Protocol Violation|4|||
127777013|NCT02273726|459811670|FG001|Overall Study|Protocol Violation|0|||
127777014|NCT02273726|459811669|FG000|Overall Study|Other than specified|28|||
127777015|NCT02273726|459811670|FG001|Overall Study|Other than specified|30|||
127777016|NCT02129205|459811671|FG000|Overall Study|Withdrawal by Subject|0|||
127777017|NCT02129205|459811672|FG001|Overall Study|Withdrawal by Subject|0|||
127777018|NCT02129205|459811673|FG002|Overall Study|Withdrawal by Subject|0|||
127565601|NCT04966910|459039937|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
127565602|NCT04966910|459039938|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
127565603|NCT04966910|459039935|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
127565604|NCT04966910|459039936|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
127565605|NCT04966910|459039937|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
127565606|NCT04966910|459039938|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
127777019|NCT02129205|459811674|FG003|Overall Study|Withdrawal by Subject|0|||
127777020|NCT02129205|459811675|FG004|Overall Study|Withdrawal by Subject|1|||
127777021|NCT02129205|459811676|FG005|Overall Study|Withdrawal by Subject|1|||
127777022|NCT02129205|459811677|FG006|Overall Study|Withdrawal by Subject|1|||
127777023|NCT02129205|459811678|FG007|Overall Study|Withdrawal by Subject|0|||
127777024|NCT02129205|459811679|FG008|Overall Study|Withdrawal by Subject|1|||
127777025|NCT02129205|459811680|FG009|Overall Study|Withdrawal by Subject|0|||
127777026|NCT02129205|459811671|FG000|Overall Study|Other|1|||
127777027|NCT02129205|459811672|FG001|Overall Study|Other|0|||
127777028|NCT02129205|459811673|FG002|Overall Study|Other|0|||
127777029|NCT02129205|459811674|FG003|Overall Study|Other|0|||
127777030|NCT02129205|459811675|FG004|Overall Study|Other|2|||
127777031|NCT02129205|459811676|FG005|Overall Study|Other|3|||
127777032|NCT02129205|459811677|FG006|Overall Study|Other|3|||
127777033|NCT02129205|459811678|FG007|Overall Study|Other|2|||
127777034|NCT02129205|459811679|FG008|Overall Study|Other|1|||
127777035|NCT02129205|459811680|FG009|Overall Study|Other|0|||
127777036|NCT02877927|459811681|FG000|Overall Study|Adverse Event|1|||
127777037|NCT02877927|459811682|FG001|Overall Study|Adverse Event|0|||
127777038|NCT02877927|459811681|FG000|Overall Study|Lost to Follow-up|37|||
127777039|NCT02877927|459811682|FG001|Overall Study|Lost to Follow-up|38|||
127777040|NCT02877927|459811681|FG000|Overall Study|Withdrawal by Subject|11|||
127777041|NCT02877927|459811682|FG001|Overall Study|Withdrawal by Subject|12|||
127777042|NCT02877927|459811681|FG000|Overall Study|Physician Decision|0|||
127565607|NCT01142089|459039945|FG000|Overall Study|Physician Decision|1|||
127565608|NCT01142089|459039946|FG001|Overall Study|Physician Decision|0|||
127565609|NCT01142089|459039945|FG000|Overall Study|Withdrawal by Subject|1|||
127565610|NCT01142089|459039946|FG001|Overall Study|Withdrawal by Subject|2|||
127565611|NCT01142089|459039945|FG000|Overall Study|Use of prohibited medications|0|||
127565612|NCT01142089|459039946|FG001|Overall Study|Use of prohibited medications|1|||
127565613|NCT01142089|459039945|FG000|Overall Study|Noncompliance with study procedures|2|||
127565614|NCT01142089|459039946|FG001|Overall Study|Noncompliance with study procedures|1|||
127565615|NCT01142089|459039945|FG000|Overall Study|Patient required rescue medication|8|||
127565616|NCT01142089|459039946|FG001|Overall Study|Patient required rescue medication|17|||
127565617|NCT02230527|459039954|FG000|Overall Study|Withdrawal by Subject|1|||
127565618|NCT02230527|459039955|FG001|Overall Study|Withdrawal by Subject|1|||
127565619|NCT02230527|459039954|FG000|Overall Study|Death|1|||
127565620|NCT02230527|459039955|FG001|Overall Study|Death|0|||
127565621|NCT02230527|459039954|FG000|Overall Study|Lost to Follow-up|2|||
127565622|NCT02230527|459039955|FG001|Overall Study|Lost to Follow-up|1|||
127565623|NCT02230527|459039954|FG000|Overall Study|Other|1|||
127565624|NCT02230527|459039955|FG001|Overall Study|Other|0|||
127565625|NCT04461600|459039956|FG000|Overall Study|Death|6|||
127565626|NCT04461600|459039957|FG001|Overall Study|Death|5|||
127565627|NCT04461600|459039956|FG000|Overall Study|Withdrawal by Subject|0|||
127565628|NCT04461600|459039957|FG001|Overall Study|Withdrawal by Subject|1|||
127565629|NCT00775203|459039960|FG000|Overall Study|Adverse Event|25|||
127565630|NCT00775203|459039961|FG001|Overall Study|Adverse Event|6|||
127565631|NCT00775203|459039960|FG000|Overall Study|Lack of Efficacy|8|||
127565632|NCT00775203|459039961|FG001|Overall Study|Lack of Efficacy|9|||
127565633|NCT00775203|459039960|FG000|Overall Study|Withdrawal by Subject|11|||
127565634|NCT00775203|459039961|FG001|Overall Study|Withdrawal by Subject|9|||
127565635|NCT00775203|459039960|FG000|Overall Study|Lost to Follow-up|11|||
127565636|NCT00775203|459039961|FG001|Overall Study|Lost to Follow-up|15|||
127565637|NCT00775203|459039960|FG000|Overall Study|Administrative reason|2|||
127565638|NCT00775203|459039961|FG001|Overall Study|Administrative reason|0|||
127565639|NCT00775203|459039960|FG000|Overall Study|Noncompliance|4|||
127565640|NCT00775203|459039961|FG001|Overall Study|Noncompliance|2|||
127565641|NCT00775203|459039960|FG000|Overall Study|Protocol Violation|0|||
127565642|NCT00775203|459039961|FG001|Overall Study|Protocol Violation|1|||
127565643|NCT00775203|459039960|FG000|Overall Study|Entered other study|1|||
127565644|NCT00775203|459039961|FG001|Overall Study|Entered other study|0|||
127565645|NCT00775203|459039960|FG000|Overall Study|Physician Decision|0|||
127565646|NCT00775203|459039961|FG001|Overall Study|Physician Decision|1|||
127565647|NCT01105065|459039962|FG000|Overall Study|Adverse Event|5|||
127565648|NCT01105065|459039962|FG000|Overall Study|Technical Problems|1|||
127565649|NCT02984943|459039963|FG000|Overall Study|Withdrawal by Subject|3|||
127565650|NCT02984943|459039963|FG000|Overall Study|Physician Decision|1|||
127565651|NCT01038869|459039970|FG000|Overall Study|Withdrawal by Subject|1|||
127565652|NCT01038869|459039970|FG000|Overall Study|Lost to Follow-up|6|||
127565653|NCT04575597|459039971|FG000|Overall Study|Death|0|||
127777043|NCT02877927|459811682|FG001|Overall Study|Physician Decision|1|||
127777044|NCT02877927|459811681|FG000|Overall Study|Missed EOT/PTE Visit|5|||
127565654|NCT04575597|459039972|FG001|Overall Study|Death|0|||
127565655|NCT04575597|459039973|FG002|Overall Study|Death|0|||
127565656|NCT04575597|459039974|FG003|Overall Study|Death|1|||
127565657|NCT04575597|459039975|FG004|Overall Study|Death|3|||
127565658|NCT04575597|459039976|FG005|Overall Study|Death|14|||
127565659|NCT04575597|459039971|FG000|Overall Study|Lost to Follow-up|2|||
127565660|NCT04575597|459039972|FG001|Overall Study|Lost to Follow-up|1|||
127565661|NCT04575597|459039973|FG002|Overall Study|Lost to Follow-up|1|||
127565662|NCT04575597|459039974|FG003|Overall Study|Lost to Follow-up|2|||
127565663|NCT04575597|459039975|FG004|Overall Study|Lost to Follow-up|10|||
127565664|NCT04575597|459039976|FG005|Overall Study|Lost to Follow-up|8|||
127565665|NCT04575597|459039971|FG000|Overall Study|Withdrawal by Subject|2|||
127777045|NCT02877927|459811682|FG001|Overall Study|Missed EOT/PTE Visit|6|||
127777046|NCT04435782|459811684|FG000|Overall Study|Study terminated by sponsor|4|||
127565666|NCT04575597|459039972|FG001|Overall Study|Withdrawal by Subject|2|||
127565667|NCT04575597|459039973|FG002|Overall Study|Withdrawal by Subject|4|||
127565668|NCT04575597|459039974|FG003|Overall Study|Withdrawal by Subject|2|||
127565669|NCT04575597|459039975|FG004|Overall Study|Withdrawal by Subject|25|||
127565670|NCT04575597|459039976|FG005|Overall Study|Withdrawal by Subject|28|||
127565671|NCT04575597|459039971|FG000|Overall Study|Not Recorded|0|||
127565672|NCT04575597|459039972|FG001|Overall Study|Not Recorded|0|||
127565673|NCT04575597|459039973|FG002|Overall Study|Not Recorded|0|||
127565674|NCT04575597|459039974|FG003|Overall Study|Not Recorded|0|||
127565675|NCT04575597|459039975|FG004|Overall Study|Not Recorded|0|||
127565676|NCT04575597|459039976|FG005|Overall Study|Not Recorded|2|||
127565677|NCT04575597|459039971|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
127565678|NCT04575597|459039972|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
127565679|NCT04575597|459039973|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
127565680|NCT04575597|459039974|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
127565681|NCT04575597|459039975|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
127777047|NCT03672461|459811685|FG000|Overall Study|COVID Related|4|||
127777048|NCT03672461|459811686|FG001|Overall Study|COVID Related|2|||
127777049|NCT03672461|459811685|FG000|Overall Study|Adverse Event|2|||
127777050|NCT03672461|459811686|FG001|Overall Study|Adverse Event|0|||
127777051|NCT03672461|459811685|FG000|Overall Study|Serious Adverse Event|0|||
127777052|NCT03672461|459811686|FG001|Overall Study|Serious Adverse Event|1|||
127777053|NCT03672461|459811685|FG000|Overall Study|Too Busy|3|||
127777054|NCT03672461|459811686|FG001|Overall Study|Too Busy|1|||
127777055|NCT03672461|459811685|FG000|Overall Study|Lost to Follow-up|1|||
127777056|NCT03672461|459811686|FG001|Overall Study|Lost to Follow-up|2|||
127777057|NCT03672461|459811685|FG000|Overall Study|Family|2|||
127777058|NCT03672461|459811686|FG001|Overall Study|Family|2|||
127777059|NCT03672461|459811685|FG000|Overall Study|No remote technology access|0|||
127777060|NCT03672461|459811686|FG001|Overall Study|No remote technology access|1|||
127777061|NCT03672461|459811685|FG000|Overall Study|Withdrawal by Subject|1|||
127777062|NCT03672461|459811686|FG001|Overall Study|Withdrawal by Subject|0|||
127777063|NCT03672461|459811685|FG000|Overall Study|Cannot tolerate intervention|1|||
127777064|NCT03672461|459811686|FG001|Overall Study|Cannot tolerate intervention|0|||
127777065|NCT03672461|459811685|FG000|Overall Study|Incomplete outcome data|6|||
127777066|NCT03672461|459811686|FG001|Overall Study|Incomplete outcome data|1|||
127777067|NCT04667247|459811688|FG000|Overall Study|Withdrawal by Subject|0|||
127777068|NCT04667247|459811689|FG001|Overall Study|Withdrawal by Subject|1|||
127777069|NCT01444651|459813408|FG000|Overall Study|Adverse Event|3|||
127777070|NCT01444651|459813409|FG001|Overall Study|Adverse Event|2|||
127777071|NCT01444651|459813408|FG000|Overall Study|Lost to Follow-up|5|||
127777072|NCT01444651|459813409|FG001|Overall Study|Lost to Follow-up|5|||
127777073|NCT01444651|459813408|FG000|Overall Study|Non-fasting|2|||
127777074|NCT01444651|459813409|FG001|Overall Study|Non-fasting|1|||
127777075|NCT01444651|459813408|FG000|Overall Study|Missing data|1|||
127777076|NCT01444651|459813409|FG001|Overall Study|Missing data|1|||
127777077|NCT03047551|459813410|FG000|Overall Study|Did not receive TAS|1|||
127777078|NCT03047551|459813411|FG001|Overall Study|Did not receive TAS|0|||
127777079|NCT03047551|459813410|FG000|Overall Study|Physician Decision|1|||
127777080|NCT03047551|459813411|FG001|Overall Study|Physician Decision|0|||
127777081|NCT03047551|459813410|FG000|Overall Study|Withdrawal by Subject|0|||
127777082|NCT03047551|459813411|FG001|Overall Study|Withdrawal by Subject|1|||
127777083|NCT03047551|459813410|FG000|Overall Study|Probe malfunction|0|||
127777084|NCT03047551|459813411|FG001|Overall Study|Probe malfunction|1|||
127777085|NCT03047551|459813410|FG000|Overall Study|Ineligible|0|||
127777086|NCT03047551|459813411|FG001|Overall Study|Ineligible|1|||
127777087|NCT00726622|459813412|FG000|Overall Study|Withdrawal by Subject|16|||
127777088|NCT00726622|459813413|FG001|Overall Study|Withdrawal by Subject|2|||
127777089|NCT00726622|459813412|FG000|Overall Study|Physician Decision|0|||
127777090|NCT00726622|459813413|FG001|Overall Study|Physician Decision|1|||
127777091|NCT00726622|459813412|FG000|Overall Study|Metastasis|2|||
127777092|NCT00726622|459813413|FG001|Overall Study|Metastasis|0|||
127777093|NCT02462928|459813414|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
127565682|NCT04575597|459039976|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
127565683|NCT01119937|459039990|FG000|Overall Study|Adverse Event|11|||
127565684|NCT01119937|459039991|FG001|Overall Study|Adverse Event|5|||
127565685|NCT01119937|459039990|FG000|Overall Study|Protocol deviation|3|||
127777094|NCT02462928|459813415|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
127777095|NCT02462928|459813416|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
127777096|NCT02462928|459813414|FG000|Overall Study|Adverse Event|47|||
127777097|NCT02462928|459813415|FG001|Overall Study|Adverse Event|51|||
127777098|NCT02462928|459813416|FG002|Overall Study|Adverse Event|25|||
127777099|NCT02462928|459813414|FG000|Overall Study|Lack of Efficacy|3|||
127777100|NCT02462928|459813415|FG001|Overall Study|Lack of Efficacy|8|||
127777101|NCT02462928|459813416|FG002|Overall Study|Lack of Efficacy|3|||
127777102|NCT02462928|459813414|FG000|Overall Study|Lost to Follow-up|4|||
127777103|NCT02462928|459813415|FG001|Overall Study|Lost to Follow-up|4|||
127565686|NCT01119937|459039991|FG001|Overall Study|Protocol deviation|1|||
127777104|NCT02462928|459813416|FG002|Overall Study|Lost to Follow-up|1|||
127777105|NCT02462928|459813414|FG000|Overall Study|Withdrawal by Patient|31|||
127777106|NCT02462928|459813415|FG001|Overall Study|Withdrawal by Patient|21|||
127565687|NCT01119937|459039990|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
127565688|NCT01119937|459039991|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
127565689|NCT01119937|459039990|FG000|Overall Study|Withdrawal by Subject|2|||
127565690|NCT01119937|459039991|FG001|Overall Study|Withdrawal by Subject|1|||
127565691|NCT03316911|459039992|FG000|Overall Study|Lost to Follow-up|33|||
127565692|NCT03316911|459039993|FG001|Overall Study|Lost to Follow-up|29|||
127565693|NCT02536404|459039998|FG000|Overall Study|Adverse Event|5|||
127565694|NCT02536404|459039999|FG001|Overall Study|Adverse Event|0|||
127565695|NCT02536404|459039998|FG000|Overall Study|Withdrawal by Subject|4|||
127565696|NCT02536404|459039999|FG001|Overall Study|Withdrawal by Subject|1|||
127565697|NCT02536404|459039998|FG000|Overall Study|Physician Decision|10|||
127565698|NCT02536404|459039999|FG001|Overall Study|Physician Decision|0|||
127565699|NCT02536404|459039998|FG000|Overall Study|Sponsor decision|1|||
127565700|NCT02536404|459039999|FG001|Overall Study|Sponsor decision|0|||
127565701|NCT00770146|459040000|FG000|Treatment Period|Withdrawal by Subject|6|||
127565702|NCT00770146|459040001|FG001|Treatment Period|Withdrawal by Subject|13|||
127565703|NCT00770146|459040000|FG000|Treatment Period|Adverse Event|2|||
127565704|NCT00770146|459040001|FG001|Treatment Period|Adverse Event|26|||
127565705|NCT00770146|459040000|FG000|Treatment Period|Other|1|||
127565706|NCT00770146|459040001|FG001|Treatment Period|Other|5|||
127565707|NCT00770146|459040000|FG000|Treatment Period|Protocol non-compliance|0|||
127565708|NCT00770146|459040001|FG001|Treatment Period|Protocol non-compliance|1|||
127565709|NCT00770146|459040000|FG000|Follow-up Period|Withdrawal by Subject|7|||
127565710|NCT00770146|459040001|FG001|Follow-up Period|Withdrawal by Subject|13|||
127565711|NCT00770146|459040000|FG000|Follow-up Period|Adverse Event|0|||
127565712|NCT00770146|459040001|FG001|Follow-up Period|Adverse Event|2|||
127565713|NCT00770146|459040000|FG000|Follow-up Period|Other|4|||
127565714|NCT00770146|459040001|FG001|Follow-up Period|Other|5|||
127565715|NCT00816023|459040003|FG000|Overall Study|Lost to Follow-up|1|||
127565716|NCT00816023|459040004|FG001|Overall Study|Lost to Follow-up|1|||
127565717|NCT00816023|459040005|FG002|Overall Study|Lost to Follow-up|0|||
127565718|NCT00816023|459040006|FG003|Overall Study|Lost to Follow-up|0|||
127565719|NCT00816023|459040003|FG000|Overall Study|Withdrawal by Subject|1|||
127565720|NCT00816023|459040004|FG001|Overall Study|Withdrawal by Subject|0|||
127565721|NCT00816023|459040005|FG002|Overall Study|Withdrawal by Subject|0|||
127565722|NCT00816023|459040006|FG003|Overall Study|Withdrawal by Subject|0|||
127565723|NCT00816023|459040003|FG000|Overall Study|Physician Decision|0|||
127565724|NCT00816023|459040004|FG001|Overall Study|Physician Decision|0|||
127565725|NCT00816023|459040005|FG002|Overall Study|Physician Decision|1|||
127565726|NCT00816023|459040006|FG003|Overall Study|Physician Decision|0|||
127565727|NCT00816023|459040003|FG000|Overall Study|assessments complete prior to window|1|||
127565728|NCT00816023|459040004|FG001|Overall Study|assessments complete prior to window|1|||
127565729|NCT00816023|459040005|FG002|Overall Study|assessments complete prior to window|2|||
127565730|NCT00816023|459040006|FG003|Overall Study|assessments complete prior to window|1|||
127565731|NCT00816023|459040003|FG000|Overall Study|Randomized Not Treated|6|||
127565732|NCT00816023|459040004|FG001|Overall Study|Randomized Not Treated|4|||
127565733|NCT00816023|459040005|FG002|Overall Study|Randomized Not Treated|6|||
127565734|NCT00816023|459040006|FG003|Overall Study|Randomized Not Treated|11|||
127565735|NCT01525901|459040007|FG000|Period 2: 12 Weeks|Adverse Event|0|||
127565736|NCT01525901|459040008|FG001|Period 2: 12 Weeks|Adverse Event|1|||
127565737|NCT01525901|459040009|FG002|Period 2: 12 Weeks|Adverse Event|0|||
127565738|NCT01525901|459040010|FG003|Period 2: 12 Weeks|Adverse Event|0|||
127565739|NCT05027971|459040015|FG000|Overall Study|Physician Decision|7|||
127565740|NCT05027971|459040016|FG001|Overall Study|Physician Decision|3|||
127565741|NCT05027971|459040015|FG000|Overall Study|Lost to Follow-up|1|||
127688631|NCT00296036|459485012|FG005|Overall Study|Withdrawal by Subject|1|||
127688632|NCT00296036|459485007|FG000|Overall Study|Protocol Violation|0|||
127688633|NCT00296036|459485008|FG001|Overall Study|Protocol Violation|0|||
127565742|NCT05027971|459040016|FG001|Overall Study|Lost to Follow-up|1|||
127565743|NCT05027971|459040015|FG000|Overall Study|Withdrawal by Subject|0|||
127565744|NCT05027971|459040016|FG001|Overall Study|Withdrawal by Subject|2|||
127565745|NCT05027971|459040015|FG000|Overall Study|Non-study fiber used.|0|||
127688634|NCT00296036|459485009|FG002|Overall Study|Protocol Violation|0|||
127688635|NCT00296036|459485010|FG003|Overall Study|Protocol Violation|0|||
127688636|NCT00296036|459485011|FG004|Overall Study|Protocol Violation|0|||
127688637|NCT00296036|459485012|FG005|Overall Study|Protocol Violation|3|||
127688638|NCT03403413|459485013|FG000|Overall Study|Lack of Efficacy|2|||
127565746|NCT05027971|459040016|FG001|Overall Study|Non-study fiber used.|1|||
127565747|NCT05027971|459040015|FG000|Overall Study|Protocol Violation|0|||
127565748|NCT05027971|459040016|FG001|Overall Study|Protocol Violation|2|||
127565749|NCT02486627|459040017|FG000|Overall Study|Death|1|||
127565750|NCT02486627|459040018|FG001|Overall Study|Death|0|||
127565751|NCT02486627|459040017|FG000|Overall Study|Other Unspecified|0|||
127688639|NCT03655262|459485014|FG000|Overall Study|Withdrawal by Subject|0|||
127565752|NCT02486627|459040018|FG001|Overall Study|Other Unspecified|2|||
127688640|NCT03655262|459485015|FG001|Overall Study|Withdrawal by Subject|0|||
127565753|NCT02486627|459040017|FG000|Overall Study|Consent Withdrawn by Participant|4|||
127565754|NCT02486627|459040018|FG001|Overall Study|Consent Withdrawn by Participant|3|||
127565755|NCT02486627|459040017|FG000|Overall Study|Significant Participant Noncompliance|1|||
127565756|NCT02486627|459040018|FG001|Overall Study|Significant Participant Noncompliance|1|||
127565757|NCT02486627|459040017|FG000|Overall Study|Lost to Follow-up|1|||
127565758|NCT02486627|459040018|FG001|Overall Study|Lost to Follow-up|3|||
127565759|NCT01073462|459040019|FG000|Overall Study|Death|14|||
127565760|NCT01073462|459040019|FG000|Overall Study|Kidney transplant|10|||
127565761|NCT01073462|459040019|FG000|Overall Study|Low parathyroid hormone levels|8|||
127565762|NCT01073462|459040019|FG000|Overall Study|Serious adverse event|2|||
127565763|NCT01073462|459040019|FG000|Overall Study|Lost to Follow-up|7|||
127565764|NCT05395091|459040022|FG000|Baseline to Month 12|Adverse Event|7|||
127565765|NCT05395091|459040023|FG001|Baseline to Month 12|Adverse Event|2|||
127565766|NCT05395091|459040024|FG002|Baseline to Month 12|Adverse Event|0|||
127565767|NCT05395091|459040022|FG000|Baseline to Month 12|Death|3|||
128025629|NCT03016403|460717809|FG003|Baseline|Lost to Follow-up|24|||
127565768|NCT05395091|459040023|FG001|Baseline to Month 12|Death|1|||
127565769|NCT05395091|459040024|FG002|Baseline to Month 12|Death|0|||
127565770|NCT05395091|459040022|FG000|Baseline to Month 12|Withdrawal by Subject|11|||
127565771|NCT05395091|459040023|FG001|Baseline to Month 12|Withdrawal by Subject|16|||
127565772|NCT05395091|459040024|FG002|Baseline to Month 12|Withdrawal by Subject|0|||
127565773|NCT05395091|459040022|FG000|Baseline to Month 12|Protocol Violation|2|||
127565774|NCT05395091|459040023|FG001|Baseline to Month 12|Protocol Violation|3|||
127565775|NCT05395091|459040024|FG002|Baseline to Month 12|Protocol Violation|0|||
127565776|NCT05395091|459040022|FG000|Baseline to Month 12|Physician Decision|1|||
127565777|NCT05395091|459040023|FG001|Baseline to Month 12|Physician Decision|0|||
127565778|NCT05395091|459040024|FG002|Baseline to Month 12|Physician Decision|0|||
127565779|NCT05395091|459040022|FG000|Month 12 to Month 18|Death|1|||
127565780|NCT05395091|459040023|FG001|Month 12 to Month 18|Death|0|||
127565781|NCT05395091|459040024|FG002|Month 12 to Month 18|Death|0|||
127688641|NCT03655262|459485016|FG002|Overall Study|Withdrawal by Subject|1|||
127688642|NCT03951805|459485020|FG000|Overall Study|Adverse Event|1|||
127688643|NCT03951805|459485021|FG001|Overall Study|Adverse Event|0|||
127688644|NCT03951805|459485022|FG002|Overall Study|Adverse Event|0|||
127688645|NCT03951805|459485023|FG003|Overall Study|Adverse Event|0|||
127688646|NCT04583423|459485024|FG000|Overall Study|Lost to Follow-up|0|||
127688647|NCT04583423|459485025|FG001|Overall Study|Lost to Follow-up|1|||
127688648|NCT04583423|459485026|FG002|Overall Study|Lost to Follow-up|0|||
127688649|NCT04583423|459485027|FG003|Overall Study|Lost to Follow-up|2|||
127688650|NCT04583423|459485024|FG000|Overall Study|Study Terminated by Sponsor|32|||
127688651|NCT04583423|459485025|FG001|Overall Study|Study Terminated by Sponsor|35|||
127688652|NCT04583423|459485026|FG002|Overall Study|Study Terminated by Sponsor|36|||
127688653|NCT04583423|459485027|FG003|Overall Study|Study Terminated by Sponsor|33|||
127688654|NCT04583423|459485024|FG000|Overall Study|Withdrawal by Subject|3|||
127688655|NCT04583423|459485025|FG001|Overall Study|Withdrawal by Subject|1|||
127688656|NCT04583423|459485026|FG002|Overall Study|Withdrawal by Subject|2|||
127688657|NCT04583423|459485027|FG003|Overall Study|Withdrawal by Subject|1|||
127688658|NCT00603954|459485030|FG000|Overall Study|Protocol Violation|1|||
127688659|NCT00603954|459485031|FG001|Overall Study|Protocol Violation|2|||
127688660|NCT00580866|459485033|FG000|Overall Study|Lost to Follow-up|2|||
127688661|NCT00580866|459485034|FG001|Overall Study|Lost to Follow-up|2|||
127688662|NCT00609336|459485035|FG000|Overall Study|Protocol Violation|3|||
127688663|NCT00609336|459485035|FG000|Overall Study|Death|1|||
127688664|NCT00609336|459485035|FG000|Overall Study|LA or Met at Surgery|9|||
127688665|NCT02238483|459485036|FG000|Overall Study|Withdrawal by Subject|2|||
127688666|NCT02238483|459485037|FG001|Overall Study|Withdrawal by Subject|7|||
127688667|NCT02238483|459485036|FG000|Overall Study|Lost to Follow-up|1|||
127688668|NCT02238483|459485037|FG001|Overall Study|Lost to Follow-up|1|||
127688669|NCT02238483|459485036|FG000|Overall Study|Protocol Violation|1|||
127688670|NCT02238483|459485037|FG001|Overall Study|Protocol Violation|2|||
127688671|NCT02238483|459485036|FG000|Overall Study|Death|1|||
127688672|NCT02238483|459485037|FG001|Overall Study|Death|0|||
127688673|NCT02238483|459485036|FG000|Overall Study|Adverse Event|7|||
127688674|NCT02238483|459485037|FG001|Overall Study|Adverse Event|3|||
127688675|NCT02238483|459485036|FG000|Overall Study|Withdrawn due to physician decision|1|||
127688676|NCT02238483|459485037|FG001|Overall Study|Withdrawn due to physician decision|0|||
127688677|NCT02238483|459485036|FG000|Overall Study|Completion status not recorded|1|||
127688678|NCT02238483|459485037|FG001|Overall Study|Completion status not recorded|1|||
127688679|NCT02238483|459485036|FG000|Overall Study|Illness in family member|1|||
127688680|NCT02238483|459485037|FG001|Overall Study|Illness in family member|0|||
127688681|NCT02477605|459485038|FG000|Overall Study|Discontinued prior to treatment|1|||
127688682|NCT02477605|459485039|FG001|Overall Study|Discontinued prior to treatment|0|||
127688683|NCT02477605|459485038|FG000|Overall Study|Lost to Follow-up|0|||
127688684|NCT02477605|459485039|FG001|Overall Study|Lost to Follow-up|2|||
127565782|NCT05395091|459040022|FG000|Month 12 to Month 18|Withdrawal by Subject|3|||
127688685|NCT02477605|459485038|FG000|Overall Study|Withdrawal by Subject|0|||
127688686|NCT02477605|459485039|FG001|Overall Study|Withdrawal by Subject|1|||
127688687|NCT02477605|459485038|FG000|Overall Study|Administered gas during surgery|0|||
127688688|NCT02477605|459485039|FG001|Overall Study|Administered gas during surgery|1|||
127565783|NCT05395091|459040023|FG001|Month 12 to Month 18|Withdrawal by Subject|2|||
127565784|NCT05395091|459040024|FG002|Month 12 to Month 18|Withdrawal by Subject|1|||
127565785|NCT05395091|459040022|FG000|Month 12 to Month 18|Lost to Follow-up|1|||
127565786|NCT05395091|459040023|FG001|Month 12 to Month 18|Lost to Follow-up|0|||
127565787|NCT05395091|459040024|FG002|Month 12 to Month 18|Lost to Follow-up|1|||
127565788|NCT05395091|459040022|FG000|Month 12 to Month 18|Other reasons|0|||
127565789|NCT05395091|459040023|FG001|Month 12 to Month 18|Other reasons|0|||
127565790|NCT05395091|459040024|FG002|Month 12 to Month 18|Other reasons|1|||
127565791|NCT03554486|459040026|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
127565792|NCT03554486|459040027|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
127565793|NCT03554486|459040028|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
127565794|NCT03554486|459040026|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
127565795|NCT03554486|459040027|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
127565796|NCT03554486|459040028|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
127565797|NCT03554486|459040026|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
127565798|NCT03554486|459040027|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
127565799|NCT03554486|459040028|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
127565800|NCT01509053|459040029|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
127565801|NCT01509053|459040029|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
127565802|NCT01509053|459040029|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
127565803|NCT01509053|459040029|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
127565804|NCT01509053|459040029|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
127565805|NCT01509053|459040029|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
127565806|NCT01738477|459040031|FG000|Overall Study|Lost to Follow-up|1|||
127565807|NCT01738477|459040032|FG001|Overall Study|Lost to Follow-up|4|||
127565808|NCT01915303|459040033|FG000|Core Phase|Adverse Event|7|||
127565809|NCT01915303|459040033|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
127565810|NCT01915303|459040033|FG000|Core Phase|Death|2|||
127565811|NCT01915303|459040033|FG000|Core Phase|Protocol Violation|2|||
127565812|NCT01915303|459040033|FG000|Core Phase|Abnormal lab value|1|||
127565813|NCT01915303|459040033|FG000|Core Phase|Withdrawal by Subject|1|||
127565814|NCT01915303|459040033|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
127565815|NCT01915303|459040033|FG000|Extension Phase|Withdrawal by Subject|4|||
127565816|NCT01915303|459040033|FG000|Extension Phase|Adverse Event|3|||
127565817|NCT01915303|459040033|FG000|Extension Phase|Death|1|||
127565818|NCT01915303|459040033|FG000|Extension Phase|Protocol Violation|1|||
127565819|NCT02925338|459040034|FG000|Overall Study|Death|0|||
127565820|NCT02925338|459040035|FG001|Overall Study|Death|2|||
127565821|NCT02925338|459040036|FG002|Overall Study|Death|1|||
127565822|NCT02925338|459040037|FG003|Overall Study|Death|0|||
127565823|NCT02925338|459040038|FG004|Overall Study|Death|0|||
127565824|NCT02925338|459040034|FG000|Overall Study|Lost to Follow-up|30|||
127565825|NCT02925338|459040035|FG001|Overall Study|Lost to Follow-up|10|||
127565826|NCT02925338|459040036|FG002|Overall Study|Lost to Follow-up|1|||
127565827|NCT02925338|459040037|FG003|Overall Study|Lost to Follow-up|16|||
127565828|NCT02925338|459040038|FG004|Overall Study|Lost to Follow-up|3|||
127565829|NCT02925338|459040034|FG000|Overall Study|Withdrawal by Subject|3|||
127565830|NCT02925338|459040035|FG001|Overall Study|Withdrawal by Subject|0|||
127565831|NCT02925338|459040036|FG002|Overall Study|Withdrawal by Subject|3|||
127565832|NCT02925338|459040037|FG003|Overall Study|Withdrawal by Subject|2|||
127565833|NCT02925338|459040038|FG004|Overall Study|Withdrawal by Subject|2|||
127565834|NCT02925338|459040034|FG000|Overall Study|Missing|38|||
127565835|NCT02925338|459040035|FG001|Overall Study|Missing|27|||
127565836|NCT02925338|459040036|FG002|Overall Study|Missing|0|||
127565837|NCT02925338|459040037|FG003|Overall Study|Missing|3|||
127565838|NCT02925338|459040038|FG004|Overall Study|Missing|2|||
127565839|NCT02925338|459040034|FG000|Overall Study|Participant's Decision|11|||
127565840|NCT02925338|459040035|FG001|Overall Study|Participant's Decision|7|||
127688689|NCT02574455|459485040|FG000|Overall Study|Death|197|||
127688690|NCT02574455|459485041|FG001|Overall Study|Death|210|||
127688691|NCT02574455|459485040|FG000|Overall Study|Withdrawal of Consent|11|||
127688692|NCT02574455|459485041|FG001|Overall Study|Withdrawal of Consent|28|||
127688693|NCT02574455|459485040|FG000|Overall Study|Lost to Follow-up|4|||
127688694|NCT02574455|459485041|FG001|Overall Study|Lost to Follow-up|4|||
127565841|NCT02925338|459040036|FG002|Overall Study|Participant's Decision|3|||
127565842|NCT02925338|459040037|FG003|Overall Study|Participant's Decision|8|||
127565843|NCT02925338|459040038|FG004|Overall Study|Participant's Decision|1|||
127565844|NCT02925338|459040034|FG000|Overall Study|Treatment Discontinuation|144|||
127565845|NCT02925338|459040035|FG001|Overall Study|Treatment Discontinuation|65|||
127565846|NCT02925338|459040036|FG002|Overall Study|Treatment Discontinuation|56|||
127688695|NCT02574455|459485040|FG000|Overall Study|Sponsor's Decision|55|||
127688696|NCT02574455|459485041|FG001|Overall Study|Sponsor's Decision|20|||
127565847|NCT02925338|459040037|FG003|Overall Study|Treatment Discontinuation|131|||
127565848|NCT02925338|459040038|FG004|Overall Study|Treatment Discontinuation|22|||
127565849|NCT00636363|459040041|FG000|Overall Study|Conjunctivitis|0|||
127688697|NCT02677896|459485042|FG000|Double Blind Period (up to 35 Months)|Death|117|||
127565850|NCT00636363|459040042|FG001|Overall Study|Conjunctivitis|0|||
127565851|NCT00636363|459040043|FG002|Overall Study|Conjunctivitis|1|||
127565852|NCT00636363|459040041|FG000|Overall Study|Adverse Event|0|||
127565853|NCT00636363|459040042|FG001|Overall Study|Adverse Event|0|||
127565854|NCT00636363|459040043|FG002|Overall Study|Adverse Event|1|||
127565855|NCT00636363|459040041|FG000|Overall Study|Positive slit lamp finding|0|||
127565856|NCT00636363|459040042|FG001|Overall Study|Positive slit lamp finding|2|||
127565857|NCT00636363|459040043|FG002|Overall Study|Positive slit lamp finding|1|||
127565858|NCT00636363|459040041|FG000|Overall Study|Study related symptoms/complaints|8|||
127565859|NCT00636363|459040042|FG001|Overall Study|Study related symptoms/complaints|7|||
127565860|NCT00636363|459040043|FG002|Overall Study|Study related symptoms/complaints|4|||
127565861|NCT00636363|459040041|FG000|Overall Study|Met ineligibility criteria|0|||
127565862|NCT00636363|459040042|FG001|Overall Study|Met ineligibility criteria|0|||
127565863|NCT00636363|459040043|FG002|Overall Study|Met ineligibility criteria|3|||
127565864|NCT00636363|459040041|FG000|Overall Study|Missed > 1 visit|0|||
127565865|NCT00636363|459040042|FG001|Overall Study|Missed > 1 visit|1|||
127565866|NCT00636363|459040043|FG002|Overall Study|Missed > 1 visit|3|||
127565867|NCT00636363|459040041|FG000|Overall Study|Lack of motivation|1|||
127565868|NCT00636363|459040042|FG001|Overall Study|Lack of motivation|0|||
127565869|NCT00636363|459040043|FG002|Overall Study|Lack of motivation|1|||
127565870|NCT00636363|459040041|FG000|Overall Study|Protocol Violation|0|||
127565871|NCT00636363|459040042|FG001|Overall Study|Protocol Violation|3|||
127565872|NCT00636363|459040043|FG002|Overall Study|Protocol Violation|0|||
127565873|NCT00636363|459040041|FG000|Overall Study|Lost to Follow-up|3|||
127565874|NCT00636363|459040042|FG001|Overall Study|Lost to Follow-up|4|||
127565875|NCT00636363|459040043|FG002|Overall Study|Lost to Follow-up|2|||
127565876|NCT00636363|459040041|FG000|Overall Study|Withdrawal by Subject|1|||
127565877|NCT00636363|459040042|FG001|Overall Study|Withdrawal by Subject|3|||
127565878|NCT00636363|459040043|FG002|Overall Study|Withdrawal by Subject|2|||
127565879|NCT00280748|459040045|FG000|Overall Study|Decline in performance|3|||
127565880|NCT00280748|459040045|FG000|Overall Study|Extra-cranial disease progression|1|||
127565881|NCT00029146|459040046|FG000|Overall Study|Lost to Follow-up|2|||
127565882|NCT00029146|459040047|FG001|Overall Study|Lost to Follow-up|1|||
127565883|NCT00043550|459040050|FG000|Overall Study|Withdrawal by Subject|22|||
127565884|NCT00043550|459040051|FG001|Overall Study|Withdrawal by Subject|12|||
127565885|NCT00043550|459040052|FG002|Overall Study|Withdrawal by Subject|20|||
127565886|NCT01089361|459040062|FG000|Overall Study|Death|1|||
128025630|NCT03016403|460717806|FG000|6-week Follow-up|Death|1|||
128025631|NCT03016403|460717807|FG001|6-week Follow-up|Death|4|||
128025632|NCT03016403|460717808|FG002|6-week Follow-up|Death|0|||
128025633|NCT03016403|460717809|FG003|6-week Follow-up|Death|0|||
128025634|NCT03016403|460717806|FG000|6-week Follow-up|Lost to Follow-up|2|||
127565887|NCT01089361|459040063|FG001|Overall Study|Death|0|||
127565888|NCT04463069|459040064|FG000|Overall Study|Withdrawal by Subject|2|||
127565889|NCT04463069|459040065|FG001|Overall Study|Withdrawal by Subject|10|||
127565890|NCT04463069|459040064|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
127688698|NCT02677896|459485043|FG001|Double Blind Period (up to 35 Months)|Death|197|||
127688699|NCT02677896|459485042|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
127688700|NCT02677896|459485043|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|15|||
127688701|NCT02677896|459485042|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
127688702|NCT02677896|459485043|FG001|Double Blind Period (up to 35 Months)|Progressive disease|6|||
127688703|NCT02677896|459485042|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
127688704|NCT02677896|459485043|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|71|||
127688705|NCT02677896|459485042|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|30|||
127688706|NCT02677896|459485043|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|99|||
127688707|NCT02677896|459485042|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|370|||
127688708|NCT02677896|459485043|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|182|||
127688709|NCT02677896|459485042|FG000|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|1|||
127688710|NCT02677896|459485043|FG001|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|4|||
127688711|NCT02677896|459485042|FG000|Double Blind Period (up to 35 Months)|Randomized, Not Treated|0|||
127688712|NCT02677896|459485043|FG001|Double Blind Period (up to 35 Months)|Randomized, Not Treated|2|||
127688713|NCT02677896|459485042|FG000|Open-Label Extension (Approx. 66 Months)|Death|73|||
127688714|NCT02677896|459485043|FG001|Open-Label Extension (Approx. 66 Months)|Death|26|||
127688715|NCT02677896|459485042|FG000|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|8|||
127688716|NCT02677896|459485043|FG001|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|3|||
128025635|NCT03016403|460717807|FG001|6-week Follow-up|Lost to Follow-up|7|||
127565891|NCT04463069|459040065|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
127565892|NCT01155167|459040066|FG000|Overall Study|Insufficient ultrasound data|2|||
127565893|NCT01155167|459040067|FG001|Overall Study|Insufficient ultrasound data|0|||
127565894|NCT01155167|459040066|FG000|Overall Study|Access site changed to femoral artery|1|||
127565895|NCT01155167|459040067|FG001|Overall Study|Access site changed to femoral artery|0|||
127565896|NCT02907892|459041838|FG000|Overall Study|Lost to Follow-up|27|||
127777107|NCT02462928|459813416|FG002|Overall Study|Withdrawal by Patient|21|||
127777108|NCT02462928|459813414|FG000|Overall Study|Protocol Violation|0|||
127777109|NCT02462928|459813415|FG001|Overall Study|Protocol Violation|1|||
127777110|NCT02462928|459813416|FG002|Overall Study|Protocol Violation|0|||
127777111|NCT02462928|459813414|FG000|Overall Study|Reason not Specified|4|||
127777112|NCT02462928|459813415|FG001|Overall Study|Reason not Specified|6|||
127777113|NCT02462928|459813416|FG002|Overall Study|Reason not Specified|5|||
127777114|NCT01493557|459813417|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
127777115|NCT01493557|459813418|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
127777116|NCT01493557|459813419|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
127777117|NCT01493557|459813417|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
127777118|NCT01493557|459813418|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
127777119|NCT01493557|459813419|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
127777120|NCT01493557|459813417|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
127777121|NCT01493557|459813418|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
127777122|NCT01493557|459813419|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
127777123|NCT01493557|459813417|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
127777124|NCT01493557|459813418|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
127777125|NCT01493557|459813419|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
127777126|NCT01493557|459813417|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
127777127|NCT01493557|459813418|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
127777128|NCT01493557|459813419|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
127777129|NCT01493557|459813417|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
127777130|NCT01493557|459813418|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
127777131|NCT01493557|459813419|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
127777132|NCT01493557|459813417|FG000|Not Randomized to Management Strategies|Early termination|0|||
127777133|NCT01493557|459813418|FG001|Not Randomized to Management Strategies|Early termination|0|||
128025636|NCT03016403|460717808|FG002|6-week Follow-up|Lost to Follow-up|4|||
128025637|NCT03016403|460717809|FG003|6-week Follow-up|Lost to Follow-up|8|||
128025638|NCT03016403|460717806|FG000|6-week Follow-up|Withdrawal by Subject|0|||
128025639|NCT03016403|460717807|FG001|6-week Follow-up|Withdrawal by Subject|2|||
128025640|NCT03016403|460717808|FG002|6-week Follow-up|Withdrawal by Subject|0|||
127688717|NCT02677896|459485042|FG000|Open-Label Extension (Approx. 66 Months)|Progressive disease|22|||
127688718|NCT02677896|459485043|FG001|Open-Label Extension (Approx. 66 Months)|Progressive disease|10|||
127688719|NCT02677896|459485042|FG000|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|16|||
127688720|NCT02677896|459485043|FG001|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|13|||
127688721|NCT02677896|459485042|FG000|Open-Label Extension (Approx. 66 Months)|Miscellaneous|241|||
127688722|NCT02677896|459485043|FG001|Open-Label Extension (Approx. 66 Months)|Miscellaneous|125|||
127688723|NCT02677896|459485042|FG000|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|10|||
127688724|NCT02677896|459485043|FG001|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|5|||
127688725|NCT00539734|459485045|FG000|Overall Study|Protocol Violation|1|||
127688726|NCT03565315|459485048|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
127688727|NCT03565315|459485049|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
127688728|NCT03565315|459485050|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
127688729|NCT03565315|459485051|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
127688730|NCT01083316|459485052|FG000|Overall Study|Adverse Event|2|||
127688731|NCT01083316|459485052|FG000|Overall Study|Withdrawal by Subject|1|||
127688732|NCT04200365|459485053|FG000|Overall Study|Adverse Event|2|||
127688733|NCT04200365|459485053|FG000|Overall Study|Progressive Disease|4|||
127688734|NCT04200365|459485053|FG000|Overall Study|Lack of Efficacy|1|||
127688735|NCT04200365|459485053|FG000|Overall Study|Study Closure|4|||
127688736|NCT02692417|459485054|FG000|Overall Study|Withdrawal by Subject|5|||
127688737|NCT02692417|459485055|FG001|Overall Study|Withdrawal by Subject|1|||
127688738|NCT02692417|459485054|FG000|Overall Study|Adverse Event|1|||
127688739|NCT02692417|459485055|FG001|Overall Study|Adverse Event|0|||
127688740|NCT02318134|459485059|FG000|Overall Study|Withdrawal by Subject|2|||
127688741|NCT02318134|459485060|FG001|Overall Study|Withdrawal by Subject|1|||
127688742|NCT01255670|459485067|FG000|Overall Study|Adverse Event|10|||
127688743|NCT01255670|459485068|FG001|Overall Study|Adverse Event|10|||
127688744|NCT01255670|459485067|FG000|Overall Study|Lost to Follow-up|16|||
127688745|NCT01255670|459485068|FG001|Overall Study|Lost to Follow-up|10|||
127688746|NCT02269475|459485069|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
127688747|NCT02269475|459485070|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
127688748|NCT02269475|459485069|FG000|Overall Study|Withdrawal by Subject|0|||
127688749|NCT02269475|459485070|FG001|Overall Study|Withdrawal by Subject|1|||
127688750|NCT01207492|459485076|FG000|Overall Study|Still on study|1|||
127688751|NCT01207492|459485076|FG000|Overall Study|Withdrawal by Subject|9|||
127565897|NCT02907892|459041839|FG001|Overall Study|Lost to Follow-up|40|||
127688752|NCT01207492|459485076|FG000|Overall Study|Physician Decision|1|||
127565898|NCT01974765|459041840|FG000|Overall Study|Withdrawal by Subject|1|||
127565899|NCT01974765|459041840|FG000|Overall Study|Death|1|||
127565900|NCT01974765|459041840|FG000|Overall Study|Adverse Event|2|||
127565901|NCT00730028|459041844|FG000|Overall Study|Adverse Event|23|||
127565902|NCT00730028|459041845|FG001|Overall Study|Adverse Event|26|||
127565903|NCT00730028|459041846|FG002|Overall Study|Adverse Event|16|||
127565904|NCT00730028|459041847|FG003|Overall Study|Adverse Event|20|||
127565905|NCT00730028|459041848|FG004|Overall Study|Adverse Event|43|||
127565906|NCT00730028|459041844|FG000|Overall Study|Lost to Follow-up|13|||
127565907|NCT00730028|459041845|FG001|Overall Study|Lost to Follow-up|26|||
127688753|NCT01207492|459485076|FG000|Overall Study|Progressive disease|3|||
127688754|NCT01207492|459485076|FG000|Overall Study|Toxicity|1|||
127688755|NCT02769858|459485077|FG000|Overall Study|Withdrawal by Subject|2|||
127688756|NCT01853748|459486347|FG000|Allocation|Withdrawal by Subject|1|||
127688757|NCT01853748|459486348|FG001|Allocation|Withdrawal by Subject|13|||
127688758|NCT01853748|459486347|FG000|Allocation|not sufficient to receive intervention|0|||
127688759|NCT01853748|459486348|FG001|Allocation|not sufficient to receive intervention|1|||
127688760|NCT01853748|459486347|FG000|Follow-Up|Withdrawal by Subject|7|||
127688761|NCT01853748|459486348|FG001|Follow-Up|Withdrawal by Subject|6|||
127688762|NCT01853748|459486347|FG000|Follow-Up|Adverse Event|67|||
127688763|NCT01853748|459486348|FG001|Follow-Up|Adverse Event|7|||
127688764|NCT01853748|459486347|FG000|Follow-Up|not available for data collection|16|||
127688765|NCT01853748|459486348|FG001|Follow-Up|not available for data collection|4|||
127688766|NCT04688450|459486357|FG000|Overall Study|Unable to start software due to serial communication failure|1|||
127688767|NCT04688450|459486357|FG000|Overall Study|Withdrawal by Subject|1|||
127688768|NCT03346538|459486358|FG000|Overall Study|Physician Decision|0|||
127688769|NCT03346538|459486359|FG001|Overall Study|Physician Decision|1|||
127688770|NCT03346538|459486360|FG002|Overall Study|Physician Decision|0|||
127688771|NCT03346538|459486358|FG000|Overall Study|Withdrawal by Subject|3|||
127688772|NCT03346538|459486359|FG001|Overall Study|Withdrawal by Subject|2|||
127688773|NCT03346538|459486360|FG002|Overall Study|Withdrawal by Subject|0|||
127688774|NCT03346538|459486358|FG000|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
127688775|NCT03346538|459486359|FG001|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
127688776|NCT03346538|459486360|FG002|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|1|||
127688777|NCT01353313|459486361|FG000|Overall Study|Lost to Follow-up|22|||
127688778|NCT01353313|459486362|FG001|Overall Study|Lost to Follow-up|23|||
127688779|NCT01353313|459486361|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
127688780|NCT01353313|459486362|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
127688781|NCT04755660|459486363|FG000|Overall Study|Lost to Follow-up|1|||
127688782|NCT04755660|459486364|FG001|Overall Study|Lost to Follow-up|1|||
127688783|NCT04755660|459486365|FG002|Overall Study|Lost to Follow-up|0|||
127688784|NCT04755660|459486363|FG000|Overall Study|Withdrawal by Subject|0|||
127688785|NCT04755660|459486364|FG001|Overall Study|Withdrawal by Subject|1|||
127688786|NCT04755660|459486365|FG002|Overall Study|Withdrawal by Subject|1|||
127688787|NCT04755660|459486363|FG000|Overall Study|Physician Decision|0|||
127688788|NCT04755660|459486364|FG001|Overall Study|Physician Decision|0|||
127688789|NCT04755660|459486365|FG002|Overall Study|Physician Decision|1|||
127688790|NCT05672667|459486367|FG000|Overall Study|Vasovagal reaction with IV cannulation. Oxytocin was not infused and subject was withdrawn.|1|||
127688791|NCT04524390|459486368|FG000|Double Blind|Consent Withdrawal by subject|2|||
127688792|NCT04524390|459486369|FG001|Double Blind|Consent Withdrawal by subject|1|||
127688793|NCT04524390|459486370|FG002|Double Blind|Consent Withdrawal by subject|0|||
127688794|NCT04524390|459486368|FG000|Double Blind|Adverse Event|5|||
127688795|NCT04524390|459486369|FG001|Double Blind|Adverse Event|3|||
127688796|NCT04524390|459486370|FG002|Double Blind|Adverse Event|0|||
127688797|NCT04524390|459486368|FG000|Double Blind|Liver Transplant|5|||
127688798|NCT04524390|459486369|FG001|Double Blind|Liver Transplant|6|||
127688799|NCT04524390|459486370|FG002|Double Blind|Liver Transplant|0|||
127688800|NCT04524390|459486368|FG000|Double Blind|Disease Progression|0|||
127688801|NCT04524390|459486369|FG001|Double Blind|Disease Progression|1|||
127688802|NCT04524390|459486370|FG002|Double Blind|Disease Progression|0|||
127688803|NCT04524390|459486368|FG000|Open-Label|Drug interruption criteria|0|||
127688804|NCT04524390|459486369|FG001|Open-Label|Drug interruption criteria|0|||
127688805|NCT04524390|459486370|FG002|Open-Label|Drug interruption criteria|1|||
127688806|NCT04524390|459486368|FG000|Open-Label|Liver Transplant|0|||
127688807|NCT04524390|459486369|FG001|Open-Label|Liver Transplant|0|||
127688808|NCT04524390|459486370|FG002|Open-Label|Liver Transplant|1|||
127688809|NCT04524390|459486368|FG000|Open-Label|Disease Progression|0|||
127688810|NCT04524390|459486369|FG001|Open-Label|Disease Progression|0|||
127688811|NCT04524390|459486370|FG002|Open-Label|Disease Progression|1|||
127688812|NCT04524390|459486368|FG000|Open-Label|Adverse Event|0|||
127688813|NCT04524390|459486369|FG001|Open-Label|Adverse Event|0|||
127688814|NCT04524390|459486370|FG002|Open-Label|Adverse Event|3|||
127688815|NCT04524390|459486368|FG000|Open-Label|Study Termination by sponsor|0|||
127688816|NCT04524390|459486369|FG001|Open-Label|Study Termination by sponsor|0|||
127688817|NCT04524390|459486370|FG002|Open-Label|Study Termination by sponsor|45|||
128025641|NCT03016403|460717809|FG003|6-week Follow-up|Withdrawal by Subject|1|||
128025642|NCT03016403|460717806|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
128025643|NCT03016403|460717807|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
128025644|NCT03016403|460717808|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
128025645|NCT03016403|460717809|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
128025646|NCT03016403|460717806|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
128025647|NCT03016403|460717807|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
128025648|NCT03016403|460717808|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
128025649|NCT03016403|460717809|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
128025650|NCT03016403|460717806|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
128025651|NCT03016403|460717807|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
128025652|NCT03016403|460717808|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
128025653|NCT03016403|460717809|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
128025654|NCT05463705|460717810|FG000|Overall Study|Did not complete a visit during study intervention period|103|||
128025655|NCT05463705|460717811|FG001|Overall Study|Did not complete a visit during study intervention period|107|||
128025656|NCT05463705|460717812|FG002|Overall Study|Did not complete a visit during study intervention period|100|||
128025657|NCT05463705|460717813|FG003|Overall Study|Did not complete a visit during study intervention period|4|||
128025658|NCT05463705|460717814|FG004|Overall Study|Did not complete a visit during study intervention period|8|||
128025659|NCT05463705|460717815|FG005|Overall Study|Did not complete a visit during study intervention period|4|||
127688818|NCT04540913|459486385|FG000|Overall Study|Withdrawal by Subject|14|||
127688819|NCT04540913|459486386|FG001|Overall Study|Withdrawal by Subject|3|||
127688820|NCT01693120|459486388|FG000|Enrollment|Lost to Follow-up|1|||
127688821|NCT01693120|459486388|FG000|Enrollment|Withdrawal by Subject|10|||
127688822|NCT01693120|459486388|FG000|Enrollment|Protocol Violation|46|||
127688823|NCT01693120|459486388|FG000|Enrollment|Physician Decision|3|||
127688824|NCT01693120|459486388|FG000|Enrollment|Adverse Event|1|||
127688825|NCT01693120|459486388|FG000|Enrollment|Study closed|8|||
127688826|NCT01693120|459486388|FG000|Enrollment|Other|1|||
127688827|NCT01693120|459486388|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
127688828|NCT01693120|459486388|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
127688829|NCT01693120|459486388|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
127688830|NCT01693120|459486388|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
127688831|NCT01693120|459486388|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
127688832|NCT04153565|459486389|FG000|Overall Study|Death|13|||
127688833|NCT00505934|459486399|FG000|Overall Study|Adverse Event|1|||
127688834|NCT00505934|459486399|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
127688835|NCT00505934|459486399|FG000|Overall Study|Other: IV dose needed to be changed|1|||
127688836|NCT03050814|459486400|FG000|Overall Study|Screen failures|0|||
127688837|NCT03050814|459486401|FG001|Overall Study|Screen failures|0|||
127688838|NCT03050814|459486402|FG002|Overall Study|Screen failures|4|||
127688839|NCT05137236|459486406|FG000|Part A|Other than Specified|1|||
127688840|NCT05137236|459486407|FG001|Part A|Other than Specified|0|||
127688841|NCT05137236|459486408|FG002|Part A|Other than Specified|0|||
127688842|NCT05137236|459486409|FG003|Part A|Other than Specified|0|||
127688843|NCT05137236|459486410|FG004|Part A|Other than Specified|0|||
127688844|NCT05137236|459486411|FG005|Part A|Other than Specified|0|||
127688845|NCT05137236|459486412|FG006|Part A|Other than Specified|0|||
127688846|NCT05137236|459486413|FG007|Part A|Other than Specified|0|||
127688847|NCT05137236|459486406|FG000|Part A|Withdrawal by Subject|0|||
127688848|NCT05137236|459486407|FG001|Part A|Withdrawal by Subject|4|||
127688849|NCT05137236|459486408|FG002|Part A|Withdrawal by Subject|1|||
127688850|NCT05137236|459486409|FG003|Part A|Withdrawal by Subject|1|||
127688851|NCT05137236|459486410|FG004|Part A|Withdrawal by Subject|3|||
127688852|NCT05137236|459486411|FG005|Part A|Withdrawal by Subject|2|||
127688853|NCT05137236|459486412|FG006|Part A|Withdrawal by Subject|0|||
127688854|NCT05137236|459486413|FG007|Part A|Withdrawal by Subject|0|||
127688855|NCT05137236|459486406|FG000|Part A|Lost to Follow-up|5|||
127688856|NCT05137236|459486407|FG001|Part A|Lost to Follow-up|7|||
127688857|NCT05137236|459486408|FG002|Part A|Lost to Follow-up|1|||
127688858|NCT05137236|459486409|FG003|Part A|Lost to Follow-up|3|||
127688859|NCT05137236|459486410|FG004|Part A|Lost to Follow-up|3|||
127688860|NCT05137236|459486411|FG005|Part A|Lost to Follow-up|8|||
127688861|NCT05137236|459486412|FG006|Part A|Lost to Follow-up|0|||
127688862|NCT05137236|459486413|FG007|Part A|Lost to Follow-up|0|||
127688863|NCT05137236|459486406|FG000|Part B|Withdrawal by Subject|0|||
127688864|NCT05137236|459486407|FG001|Part B|Withdrawal by Subject|0|||
127688865|NCT05137236|459486408|FG002|Part B|Withdrawal by Subject|0|||
127688866|NCT05137236|459486409|FG003|Part B|Withdrawal by Subject|0|||
127688867|NCT05137236|459486410|FG004|Part B|Withdrawal by Subject|0|||
127688868|NCT05137236|459486411|FG005|Part B|Withdrawal by Subject|0|||
127688869|NCT05137236|459486412|FG006|Part B|Withdrawal by Subject|0|||
127688870|NCT05137236|459486413|FG007|Part B|Withdrawal by Subject|2|||
127688871|NCT05137236|459486406|FG000|Part B|Lost to Follow-up|0|||
127688872|NCT05137236|459486407|FG001|Part B|Lost to Follow-up|0|||
127688873|NCT05137236|459486408|FG002|Part B|Lost to Follow-up|0|||
127777134|NCT01493557|459813419|FG002|Not Randomized to Management Strategies|Early termination|34|||
127777135|NCT01493557|459813417|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
127777136|NCT01493557|459813418|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
127777137|NCT01493557|459813419|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
127777138|NCT01493557|459813417|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
127777139|NCT01493557|459813418|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
127777140|NCT01493557|459813419|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
127777141|NCT01493557|459813417|FG000|Randomized to Management Strategies|Other adverse event|8|||
127777142|NCT01493557|459813418|FG001|Randomized to Management Strategies|Other adverse event|5|||
127777143|NCT01493557|459813419|FG002|Randomized to Management Strategies|Other adverse event|0|||
127777144|NCT01493557|459813417|FG000|Randomized to Management Strategies|Protocol Violation|3|||
127777145|NCT01493557|459813418|FG001|Randomized to Management Strategies|Protocol Violation|0|||
127777146|NCT01493557|459813419|FG002|Randomized to Management Strategies|Protocol Violation|0|||
127777147|NCT01493557|459813417|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
127777148|NCT01493557|459813418|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
127777149|NCT01493557|459813419|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
127777150|NCT01493557|459813417|FG000|Randomized to Management Strategies|Other than stated above|1|||
127777151|NCT01493557|459813418|FG001|Randomized to Management Strategies|Other than stated above|3|||
127777152|NCT01493557|459813419|FG002|Randomized to Management Strategies|Other than stated above|0|||
127565908|NCT00730028|459041846|FG002|Overall Study|Lost to Follow-up|22|||
127565909|NCT00730028|459041847|FG003|Overall Study|Lost to Follow-up|26|||
127565910|NCT00730028|459041848|FG004|Overall Study|Lost to Follow-up|25|||
127565911|NCT00730028|459041844|FG000|Overall Study|Protocol Violation|6|||
127565912|NCT00730028|459041845|FG001|Overall Study|Protocol Violation|1|||
127565913|NCT00730028|459041846|FG002|Overall Study|Protocol Violation|1|||
127565914|NCT00730028|459041847|FG003|Overall Study|Protocol Violation|2|||
127565915|NCT00730028|459041848|FG004|Overall Study|Protocol Violation|0|||
127565916|NCT00730028|459041844|FG000|Overall Study|Withdrawal by Subject|9|||
127565917|NCT00730028|459041845|FG001|Overall Study|Withdrawal by Subject|5|||
127565918|NCT00730028|459041846|FG002|Overall Study|Withdrawal by Subject|4|||
127565919|NCT00730028|459041847|FG003|Overall Study|Withdrawal by Subject|5|||
127565920|NCT00730028|459041848|FG004|Overall Study|Withdrawal by Subject|9|||
127565921|NCT00730028|459041844|FG000|Overall Study|Physician Decision|3|||
127565922|NCT00730028|459041845|FG001|Overall Study|Physician Decision|3|||
127565923|NCT00730028|459041846|FG002|Overall Study|Physician Decision|2|||
127565924|NCT00730028|459041847|FG003|Overall Study|Physician Decision|3|||
127565925|NCT00730028|459041848|FG004|Overall Study|Physician Decision|2|||
127565926|NCT00730028|459041844|FG000|Overall Study|Treatment Failure|5|||
127565927|NCT00730028|459041845|FG001|Overall Study|Treatment Failure|5|||
127565928|NCT00730028|459041846|FG002|Overall Study|Treatment Failure|0|||
127565929|NCT00730028|459041847|FG003|Overall Study|Treatment Failure|0|||
127688874|NCT05137236|459486409|FG003|Part B|Lost to Follow-up|0|||
127688875|NCT05137236|459486410|FG004|Part B|Lost to Follow-up|0|||
127688876|NCT05137236|459486411|FG005|Part B|Lost to Follow-up|0|||
127688877|NCT05137236|459486412|FG006|Part B|Lost to Follow-up|5|||
127688878|NCT05137236|459486413|FG007|Part B|Lost to Follow-up|5|||
127688879|NCT05137236|459486406|FG000|Part B|Death|0|||
127688880|NCT05137236|459486407|FG001|Part B|Death|0|||
127688881|NCT05137236|459486408|FG002|Part B|Death|0|||
127688882|NCT05137236|459486409|FG003|Part B|Death|0|||
127688883|NCT05137236|459486410|FG004|Part B|Death|0|||
127688884|NCT05137236|459486411|FG005|Part B|Death|0|||
127688885|NCT05137236|459486412|FG006|Part B|Death|0|||
127688886|NCT05137236|459486413|FG007|Part B|Death|2|||
127688887|NCT05119855|459486414|FG000|Overall Study|Randomized by Mistake Without Study Treatment|0|||
127688888|NCT05119855|459486415|FG001|Overall Study|Randomized by Mistake Without Study Treatment|1|||
127688889|NCT05119855|459486414|FG000|Overall Study|Withdrawal By Parent/Guardian|10|||
127688890|NCT05119855|459486415|FG001|Overall Study|Withdrawal By Parent/Guardian|10|||
127688891|NCT05119855|459486414|FG000|Overall Study|Lost to Follow-up|6|||
127688892|NCT05119855|459486415|FG001|Overall Study|Lost to Follow-up|8|||
127688893|NCT01972724|459486416|FG000|Double-Blind|Rescue Criteria Met|1|||
127688894|NCT01972724|459486417|FG001|Double-Blind|Rescue Criteria Met|0|||
127688895|NCT01972724|459486418|FG002|Double-Blind|Rescue Criteria Met|0|||
127688896|NCT01972724|459486416|FG000|Double-Blind|Adverse Event|1|||
127688897|NCT01972724|459486417|FG001|Double-Blind|Adverse Event|0|||
127688898|NCT01972724|459486418|FG002|Double-Blind|Adverse Event|0|||
127565930|NCT00730028|459041848|FG004|Overall Study|Treatment Failure|1|||
127688899|NCT01972724|459486416|FG000|Double-Blind|Withdrawal of Consent|2|||
127688900|NCT01972724|459486417|FG001|Double-Blind|Withdrawal of Consent|1|||
127688901|NCT01972724|459486418|FG002|Double-Blind|Withdrawal of Consent|0|||
127688902|NCT01972724|459486416|FG000|Double-Blind|Significant Protocol Deviation|5|||
127688903|NCT01972724|459486417|FG001|Double-Blind|Significant Protocol Deviation|8|||
127688904|NCT01972724|459486418|FG002|Double-Blind|Significant Protocol Deviation|0|||
127688905|NCT01972724|459486416|FG000|Open-Label|Withdrew Consent|0|||
127688906|NCT01972724|459486417|FG001|Open-Label|Withdrew Consent|0|||
127777153|NCT01493557|459813417|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
127777154|NCT01493557|459813418|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
127777155|NCT01493557|459813419|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
127777156|NCT01493557|459813417|FG000|Adding the Second Strategy|Other adverse event|1|||
127777157|NCT01493557|459813418|FG001|Adding the Second Strategy|Other adverse event|2|||
127777158|NCT01493557|459813419|FG002|Adding the Second Strategy|Other adverse event|0|||
127777159|NCT01493557|459813417|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
127777160|NCT01493557|459813418|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
127777161|NCT01493557|459813419|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
127777162|NCT01890148|459813434|FG000|Overall Study|Adverse Event|1|||
127777163|NCT01215175|459813435|FG000|Overall Study|Lost to Follow-up|0|||
127777164|NCT01215175|459813436|FG001|Overall Study|Lost to Follow-up|1|||
127777165|NCT01215175|459813437|FG002|Overall Study|Lost to Follow-up|0|||
127777166|NCT01215175|459813438|FG003|Overall Study|Lost to Follow-up|1|||
127777167|NCT01215175|459813439|FG004|Overall Study|Lost to Follow-up|0|||
127777168|NCT01678209|459813440|FG000|Overall Study|could not scan twice|1|||
127777169|NCT01678209|459813441|FG001|Overall Study|could not scan twice|1|||
127777170|NCT01678209|459813442|FG002|Overall Study|could not scan twice|1|||
127777171|NCT01678209|459813440|FG000|Overall Study|scheduling conflicts|0|||
127777172|NCT01678209|459813441|FG001|Overall Study|scheduling conflicts|0|||
127777173|NCT01678209|459813442|FG002|Overall Study|scheduling conflicts|1|||
127777174|NCT01678209|459813440|FG000|Overall Study|screen fail|16|||
127777175|NCT01678209|459813441|FG001|Overall Study|screen fail|17|||
127777176|NCT01678209|459813442|FG002|Overall Study|screen fail|16|||
127777177|NCT00702845|459813443|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
127777178|NCT00702845|459813444|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
127777179|NCT00702845|459813443|FG000|Overall Study|Too high ovarian response|5|||
127777180|NCT00702845|459813444|FG001|Overall Study|Too high ovarian response|1|||
127777181|NCT00702845|459813443|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
127777182|NCT00702845|459813444|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
127777183|NCT00702845|459813443|FG000|Overall Study|Insufficient ovarian response|1|||
127777184|NCT00702845|459813444|FG001|Overall Study|Insufficient ovarian response|0|||
127777185|NCT00702845|459813443|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
127777186|NCT00702845|459813444|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
127777187|NCT00702845|459813443|FG000|Overall Study|No or abnormal fertilization|4|||
127777188|NCT00702845|459813444|FG001|Overall Study|No or abnormal fertilization|2|||
127777189|NCT00702845|459813443|FG000|Overall Study|Patient's decision|2|||
127777190|NCT00702845|459813444|FG001|Overall Study|Patient's decision|1|||
127777191|NCT00702845|459813443|FG000|Overall Study|Not randomized|0|||
127777192|NCT00702845|459813444|FG001|Overall Study|Not randomized|1|||
127777193|NCT02973425|459813445|FG000|Overall Study|Lost to Follow-up|49|||
127777194|NCT02973425|459813446|FG001|Overall Study|Lost to Follow-up|53|||
127777195|NCT03876171|459813447|FG000|Overall Study|Withdrawal by Subject|3|||
127777196|NCT03876171|459813448|FG001|Overall Study|Withdrawal by Subject|3|||
127777197|NCT03876171|459813447|FG000|Overall Study|Re-arrest|0|||
127777198|NCT03876171|459813448|FG001|Overall Study|Re-arrest|4|||
127777199|NCT01170039|459813451|FG000|Overall Study|Withdrawal by Subject|5|||
127777200|NCT01170039|459813452|FG001|Overall Study|Withdrawal by Subject|3|||
128025660|NCT00621322|460717816|FG000|Overall Study|Lost to Follow-up|0|||
127565931|NCT00730028|459041844|FG000|Overall Study|Randomization Error|1|||
127565932|NCT00730028|459041845|FG001|Overall Study|Randomization Error|0|||
127565933|NCT00730028|459041846|FG002|Overall Study|Randomization Error|0|||
127565934|NCT00730028|459041847|FG003|Overall Study|Randomization Error|0|||
127565935|NCT00730028|459041848|FG004|Overall Study|Randomization Error|2|||
127565936|NCT00003472|459041849|FG000|Overall Study|Not evaluable|3|||
127565937|NCT00528970|459041850|FG000|Overall Study|Adverse Event|6|||
127565938|NCT00528970|459041851|FG001|Overall Study|Adverse Event|8|||
127565939|NCT00528970|459041852|FG002|Overall Study|Adverse Event|5|||
127565940|NCT00528970|459041850|FG000|Overall Study|Lost to Follow-up|0|||
127565941|NCT00528970|459041851|FG001|Overall Study|Lost to Follow-up|0|||
128025661|NCT00621322|460717817|FG001|Overall Study|Lost to Follow-up|0|||
128025662|NCT00621322|460717818|FG002|Overall Study|Lost to Follow-up|0|||
127565942|NCT00528970|459041852|FG002|Overall Study|Lost to Follow-up|1|||
127777201|NCT01170039|459813451|FG000|Overall Study|Lack of funding, drug not available|3|||
127777202|NCT01170039|459813452|FG001|Overall Study|Lack of funding, drug not available|3|||
127777203|NCT00860951|459813453|FG000|Overall Study|Withdrawal by Subject|2|||
127777204|NCT00860951|459813453|FG000|Overall Study|Lost to Follow-up|5|||
127777205|NCT00727649|459813454|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
127777206|NCT00727649|459813455|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
127777207|NCT00727649|459813454|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
128025663|NCT00621322|460717819|FG003|Overall Study|Lost to Follow-up|0|||
128025664|NCT00621322|460717820|FG004|Overall Study|Lost to Follow-up|1|||
128025665|NCT00621322|460717821|FG005|Overall Study|Lost to Follow-up|0|||
127565943|NCT00528970|459041850|FG000|Overall Study|Other than specified|2|||
127565944|NCT00528970|459041851|FG001|Overall Study|Other than specified|3|||
128025666|NCT00621322|460717816|FG000|Overall Study|Physician Decision|0|||
127565945|NCT00528970|459041852|FG002|Overall Study|Other than specified|3|||
127565946|NCT00528970|459041850|FG000|Overall Study|Protocol Violation|2|||
127565947|NCT00528970|459041851|FG001|Overall Study|Protocol Violation|1|||
127565948|NCT00528970|459041852|FG002|Overall Study|Protocol Violation|4|||
127688907|NCT01972724|459486418|FG002|Open-Label|Withdrew Consent|3|||
127688908|NCT01972724|459486416|FG000|Open-Label|Significant Protocol Deviation|0|||
127688909|NCT01972724|459486417|FG001|Open-Label|Significant Protocol Deviation|0|||
127688910|NCT01972724|459486418|FG002|Open-Label|Significant Protocol Deviation|2|||
127688911|NCT00111813|459486425|FG000|Overall Study|Adverse Event|1|||
127688912|NCT00111813|459486426|FG001|Overall Study|Adverse Event|2|||
127688913|NCT00111813|459486427|FG002|Overall Study|Adverse Event|4|||
127688914|NCT00111813|459486428|FG003|Overall Study|Adverse Event|2|||
127688915|NCT00111813|459486429|FG004|Overall Study|Adverse Event|2|||
127688916|NCT00111813|459486430|FG005|Overall Study|Adverse Event|2|||
127688917|NCT00111813|459486425|FG000|Overall Study|Progressive disease|2|||
127688918|NCT00111813|459486426|FG001|Overall Study|Progressive disease|1|||
127688919|NCT00111813|459486427|FG002|Overall Study|Progressive disease|5|||
127688920|NCT00111813|459486428|FG003|Overall Study|Progressive disease|3|||
127688921|NCT00111813|459486429|FG004|Overall Study|Progressive disease|4|||
127688922|NCT00111813|459486430|FG005|Overall Study|Progressive disease|3|||
127688923|NCT00111813|459486425|FG000|Overall Study|Lack of Efficacy|0|||
127688924|NCT00111813|459486426|FG001|Overall Study|Lack of Efficacy|0|||
127688925|NCT00111813|459486427|FG002|Overall Study|Lack of Efficacy|0|||
127688926|NCT00111813|459486428|FG003|Overall Study|Lack of Efficacy|0|||
127688927|NCT00111813|459486429|FG004|Overall Study|Lack of Efficacy|0|||
127688928|NCT00111813|459486430|FG005|Overall Study|Lack of Efficacy|1|||
127688929|NCT00111813|459486425|FG000|Overall Study|Other|0|||
127688930|NCT00111813|459486426|FG001|Overall Study|Other|0|||
127688931|NCT00111813|459486427|FG002|Overall Study|Other|1|||
127688932|NCT00111813|459486428|FG003|Overall Study|Other|0|||
127688933|NCT00111813|459486429|FG004|Overall Study|Other|0|||
127688934|NCT00111813|459486430|FG005|Overall Study|Other|0|||
127688935|NCT00567489|459486433|FG000|Overall Study|Adverse Event|6|||
127688936|NCT00567489|459486434|FG001|Overall Study|Adverse Event|14|||
127688937|NCT00567489|459486433|FG000|Overall Study|Physician Decision|0|||
127688938|NCT00567489|459486434|FG001|Overall Study|Physician Decision|4|||
127688939|NCT00567489|459486433|FG000|Overall Study|Withdrawal by Subject|0|||
127688940|NCT00567489|459486434|FG001|Overall Study|Withdrawal by Subject|2|||
127688941|NCT00567489|459486433|FG000|Overall Study|Renal Transplantation|0|||
127688942|NCT00567489|459486434|FG001|Overall Study|Renal Transplantation|3|||
127688943|NCT00567489|459486433|FG000|Overall Study|Other|1|||
127688944|NCT00567489|459486434|FG001|Overall Study|Other|0|||
127688945|NCT02372253|459486439|FG000|Overall Study|Non Compliance|2|||
127688946|NCT02372253|459486440|FG001|Overall Study|Non Compliance|0|||
127688947|NCT01976312|459486447|FG000|Overall Study|Pregnancy|0|||
127688948|NCT01976312|459486448|FG001|Overall Study|Pregnancy|1|||
127688949|NCT01976312|459486447|FG000|Overall Study|Lost to Follow-up|2|||
127688950|NCT01976312|459486448|FG001|Overall Study|Lost to Follow-up|0|||
127688951|NCT01976312|459486447|FG000|Overall Study|Withdrawal by Subject|7|||
127688952|NCT01976312|459486448|FG001|Overall Study|Withdrawal by Subject|2|||
127688953|NCT01976312|459486447|FG000|Overall Study|Adverse Event|6|||
127688954|NCT01976312|459486448|FG001|Overall Study|Adverse Event|6|||
127688955|NCT01976312|459486447|FG000|Overall Study|Protocol Violation|2|||
127688956|NCT01976312|459486448|FG001|Overall Study|Protocol Violation|0|||
127688957|NCT04048382|459486449|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
127688958|NCT04048382|459486450|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
127688959|NCT04048382|459486449|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
127688960|NCT04048382|459486450|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
127688961|NCT04048382|459486449|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
127688962|NCT04048382|459486450|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
127688963|NCT01205048|459486451|FG000|Overall Study|Withdrawal by Subject|14|||
127688964|NCT01205048|459486451|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
127688965|NCT01205048|459486451|FG000|Overall Study|Lost to Follow-up|4|||
127688966|NCT01205048|459486451|FG000|Overall Study|Other|2|||
127688967|NCT01037985|459486452|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
127688968|NCT01037985|459486453|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
127688969|NCT01037985|459486452|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
127688970|NCT01037985|459486453|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
127688971|NCT01037985|459486452|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
127688972|NCT01037985|459486453|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
127688973|NCT01037985|459486452|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
127688974|NCT01037985|459486453|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
127688975|NCT02730871|459486454|FG000|Overall Study|Adverse Event|6|||
127688976|NCT02730871|459486455|FG001|Overall Study|Adverse Event|0|||
127688977|NCT00823472|459486456|FG000|Overall Study|Physician Decision|24|||
127688978|NCT00823472|459486457|FG001|Overall Study|Physician Decision|28|||
127688979|NCT01609218|459486458|FG000|Period 1|Adverse Event|3|||
127688980|NCT01609218|459486459|FG001|Period 1|Adverse Event|5|||
128025667|NCT00621322|460717817|FG001|Overall Study|Physician Decision|0|||
127565949|NCT00528970|459041850|FG000|Overall Study|Lack of Efficacy|0|||
127565950|NCT00528970|459041851|FG001|Overall Study|Lack of Efficacy|0|||
127565951|NCT00528970|459041852|FG002|Overall Study|Lack of Efficacy|1|||
127565952|NCT00528970|459041850|FG000|Overall Study|Withdrawal by Subject|4|||
127565953|NCT00528970|459041851|FG001|Overall Study|Withdrawal by Subject|3|||
127565954|NCT00528970|459041852|FG002|Overall Study|Withdrawal by Subject|5|||
127565955|NCT00528970|459041850|FG000|Overall Study|Randomized but not treated|0|||
127565956|NCT00528970|459041851|FG001|Overall Study|Randomized but not treated|0|||
127565957|NCT00528970|459041852|FG002|Overall Study|Randomized but not treated|1|||
127565958|NCT03860935|459041853|FG000|Overall Study|Withdrawal of Consent|15|||
127565959|NCT03860935|459041854|FG001|Overall Study|Withdrawal of Consent|6|||
127565960|NCT03860935|459041853|FG000|Overall Study|Death|75|||
127565961|NCT03860935|459041854|FG001|Overall Study|Death|51|||
127565962|NCT03086967|459041855|FG000|Overall Study|Screen Failure|2|||
127565963|NCT03086967|459041856|FG001|Overall Study|Screen Failure|2|||
127565964|NCT01430754|459041857|FG000|Run-In Phase|Circadian Period Ineligible|24|||
127565965|NCT01430754|459041858|FG001|Run-In Phase|Circadian Period Ineligible|0|||
127565966|NCT01430754|459041857|FG000|Run-In Phase|Protocol Violation|6|||
127565967|NCT01430754|459041858|FG001|Run-In Phase|Protocol Violation|0|||
127565968|NCT01430754|459041857|FG000|Run-In Phase|Adverse Event|2|||
127565969|NCT01430754|459041858|FG001|Run-In Phase|Adverse Event|0|||
127565970|NCT01430754|459041857|FG000|Run-In Phase|Other|2|||
127565971|NCT01430754|459041858|FG001|Run-In Phase|Other|0|||
127565972|NCT01430754|459041857|FG000|Run-In Phase|Withdrawal by Subject|2|||
127565973|NCT01430754|459041858|FG001|Run-In Phase|Withdrawal by Subject|0|||
127565974|NCT01430754|459041857|FG000|Run-In Phase|Lost to Follow-up|1|||
127565975|NCT01430754|459041858|FG001|Run-In Phase|Lost to Follow-up|0|||
127565976|NCT00704522|459041862|FG000|Overall Study|Lack of Efficacy|65|||
127565977|NCT00704522|459041863|FG001|Overall Study|Lack of Efficacy|17|||
127565978|NCT00704522|459041862|FG000|Overall Study|Failure to appear again at hospital|56|||
127565979|NCT00704522|459041863|FG001|Overall Study|Failure to appear again at hospital|10|||
127565980|NCT00704522|459041862|FG000|Overall Study|Withdrawal by Subject|17|||
127565981|NCT00704522|459041863|FG001|Overall Study|Withdrawal by Subject|8|||
127565982|NCT00704522|459041862|FG000|Overall Study|Adverse Event|9|||
127565983|NCT00704522|459041863|FG001|Overall Study|Adverse Event|1|||
127565984|NCT00704522|459041862|FG000|Overall Study|Undefined causes|9|||
127565985|NCT00704522|459041863|FG001|Overall Study|Undefined causes|7|||
127565986|NCT00704522|459041862|FG000|Overall Study|No information on therapy end|27|||
127565987|NCT00704522|459041863|FG001|Overall Study|No information on therapy end|2|||
127565988|NCT00701662|459041864|FG000|Overall Study|Lack of Efficacy|1|||
127565989|NCT00635024|459041865|FG000|Overall Study|Adverse Event|1|||
127565990|NCT01238588|459041867|FG000|Overall Study|Withdrawal by Subject|1|||
127565991|NCT01238588|459041867|FG000|Overall Study|Physician Decision|2|||
127565992|NCT00321646|459041868|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
127565993|NCT00321646|459041868|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
127565994|NCT00321646|459041868|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
127565995|NCT02576145|459041869|FG000|Overall Study|Adverse Event|1|||
127565996|NCT02576145|459041870|FG001|Overall Study|Adverse Event|0|||
127565997|NCT02576145|459041869|FG000|Overall Study|Withdrawal by Subject|1|||
127565998|NCT02576145|459041870|FG001|Overall Study|Withdrawal by Subject|0|||
127565999|NCT02576145|459041869|FG000|Overall Study|Acute rejection|1|||
127566000|NCT02576145|459041870|FG001|Overall Study|Acute rejection|0|||
127566001|NCT02576145|459041869|FG000|Overall Study|Tetanus Titers Decreased|0|||
127566002|NCT02576145|459041870|FG001|Overall Study|Tetanus Titers Decreased|1|||
127566003|NCT02660138|459041871|FG000|Overall Study|Adverse Event|0|||
127566004|NCT02660138|459041872|FG001|Overall Study|Adverse Event|3|||
127566005|NCT02660138|459041873|FG002|Overall Study|Adverse Event|2|||
127566006|NCT02660138|459041871|FG000|Overall Study|Lack of Efficacy|1|||
128025668|NCT00621322|460717818|FG002|Overall Study|Physician Decision|1|||
128025669|NCT00621322|460717819|FG003|Overall Study|Physician Decision|1|||
127566007|NCT02660138|459041872|FG001|Overall Study|Lack of Efficacy|2|||
127566008|NCT02660138|459041873|FG002|Overall Study|Lack of Efficacy|1|||
127566009|NCT02660138|459041871|FG000|Overall Study|Withdrawal by Subject|7|||
127566010|NCT02660138|459041872|FG001|Overall Study|Withdrawal by Subject|6|||
127566011|NCT02660138|459041873|FG002|Overall Study|Withdrawal by Subject|6|||
127566012|NCT02660138|459041871|FG000|Overall Study|Lost to Follow-up|4|||
128025670|NCT00621322|460717820|FG004|Overall Study|Physician Decision|0|||
128025671|NCT00621322|460717821|FG005|Overall Study|Physician Decision|0|||
128025672|NCT00621322|460717816|FG000|Overall Study|Withdrawal by Subject|0|||
127566013|NCT02660138|459041872|FG001|Overall Study|Lost to Follow-up|4|||
127566014|NCT02660138|459041873|FG002|Overall Study|Lost to Follow-up|1|||
127566015|NCT02660138|459041871|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
127566016|NCT02660138|459041872|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
127566017|NCT02660138|459041873|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
127566018|NCT02660138|459041871|FG000|Overall Study|Other|1|||
127566019|NCT02660138|459041872|FG001|Overall Study|Other|1|||
127566020|NCT02660138|459041873|FG002|Overall Study|Other|0|||
128025673|NCT00621322|460717817|FG001|Overall Study|Withdrawal by Subject|0|||
128025674|NCT00621322|460717818|FG002|Overall Study|Withdrawal by Subject|0|||
128025675|NCT00621322|460717819|FG003|Overall Study|Withdrawal by Subject|1|||
128025676|NCT00621322|460717820|FG004|Overall Study|Withdrawal by Subject|0|||
128025677|NCT00621322|460717821|FG005|Overall Study|Withdrawal by Subject|2|||
128025678|NCT00621322|460717816|FG000|Overall Study|Migrated/moved from study area|1|||
128025679|NCT00621322|460717817|FG001|Overall Study|Migrated/moved from study area|0|||
128025680|NCT00621322|460717818|FG002|Overall Study|Migrated/moved from study area|1|||
128025681|NCT00621322|460717819|FG003|Overall Study|Migrated/moved from study area|1|||
128025682|NCT00621322|460717820|FG004|Overall Study|Migrated/moved from study area|0|||
128025683|NCT00621322|460717821|FG005|Overall Study|Migrated/moved from study area|2|||
128025684|NCT01655069|460717827|FG000|Overall Study|Physician Decision|0|||
128025685|NCT01655069|460717828|FG001|Overall Study|Physician Decision|0|||
128025686|NCT01655069|460717829|FG002|Overall Study|Physician Decision|0|||
127566021|NCT02660138|459041871|FG000|Overall Study|Not treated|0|||
127566022|NCT02660138|459041872|FG001|Overall Study|Not treated|1|||
128025687|NCT01655069|460717830|FG003|Overall Study|Physician Decision|1|||
128025688|NCT01655069|460717827|FG000|Overall Study|Adverse Event|6|||
128025689|NCT01655069|460717828|FG001|Overall Study|Adverse Event|7|||
128025690|NCT01655069|460717829|FG002|Overall Study|Adverse Event|2|||
128025691|NCT01655069|460717830|FG003|Overall Study|Adverse Event|3|||
128025692|NCT01655069|460717827|FG000|Overall Study|Lack of Efficacy|0|||
128025693|NCT01655069|460717828|FG001|Overall Study|Lack of Efficacy|1|||
128025694|NCT01655069|460717829|FG002|Overall Study|Lack of Efficacy|0|||
128025695|NCT01655069|460717830|FG003|Overall Study|Lack of Efficacy|0|||
127566023|NCT02660138|459041873|FG002|Overall Study|Not treated|0|||
127566024|NCT00308581|459041875|FG000|Induction Phase|Adverse Event|0|||
127566025|NCT00308581|459041876|FG001|Induction Phase|Adverse Event|0|||
127566026|NCT00308581|459041877|FG002|Induction Phase|Adverse Event|37|||
127566027|NCT00308581|459041875|FG000|Induction Phase|Lack of Efficacy|0|||
127566028|NCT00308581|459041876|FG001|Induction Phase|Lack of Efficacy|0|||
127566029|NCT00308581|459041877|FG002|Induction Phase|Lack of Efficacy|121|||
127566030|NCT00308581|459041875|FG000|Induction Phase|Withdrawal by Subject|0|||
127566031|NCT00308581|459041876|FG001|Induction Phase|Withdrawal by Subject|0|||
127566032|NCT00308581|459041877|FG002|Induction Phase|Withdrawal by Subject|5|||
127566033|NCT00308581|459041875|FG000|Induction Phase|Unknown reason|0|||
127566034|NCT00308581|459041876|FG001|Induction Phase|Unknown reason|0|||
127566035|NCT00308581|459041877|FG002|Induction Phase|Unknown reason|3|||
127566036|NCT00308581|459041875|FG000|Randomized Maintenance Phase|Adverse Event|10|||
127566037|NCT00308581|459041876|FG001|Randomized Maintenance Phase|Adverse Event|17|||
127566038|NCT00308581|459041877|FG002|Randomized Maintenance Phase|Adverse Event|0|||
127566039|NCT00308581|459041875|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
127566040|NCT00308581|459041876|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
127566041|NCT00308581|459041877|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
127566042|NCT00308581|459041875|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
127566043|NCT00308581|459041876|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
127566044|NCT00308581|459041877|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
127566045|NCT00308581|459041875|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
127566046|NCT00308581|459041876|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
127566047|NCT00308581|459041877|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
127566048|NCT00308581|459041875|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
127566049|NCT00308581|459041876|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
127566050|NCT00308581|459041877|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
127566051|NCT00308581|459041875|FG000|Randomized Maintenance Phase|Unknown reason|3|||
127566052|NCT00308581|459041876|FG001|Randomized Maintenance Phase|Unknown reason|0|||
127566053|NCT00308581|459041877|FG002|Randomized Maintenance Phase|Unknown reason|0|||
127566054|NCT00899353|459041878|FG000|Overall Study|Adverse Event|2|||
127566055|NCT00899353|459041878|FG000|Overall Study|Lost to Follow-up|1|||
127566056|NCT00899353|459041878|FG000|Overall Study|Withdrawal by Subject|2|||
127566057|NCT02730793|459041880|FG000|Overall Study|Physician Decision|0|||
127566058|NCT02730793|459041881|FG001|Overall Study|Physician Decision|1|||
127566059|NCT02730793|459041880|FG000|Overall Study|Withdrawal by Subject|0|||
127566060|NCT02730793|459041881|FG001|Overall Study|Withdrawal by Subject|1|||
128025696|NCT01655069|460717827|FG000|Overall Study|No Treatment Needed|0|||
128025697|NCT01655069|460717828|FG001|Overall Study|No Treatment Needed|1|||
128025698|NCT01655069|460717829|FG002|Overall Study|No Treatment Needed|0|||
128025699|NCT01655069|460717830|FG003|Overall Study|No Treatment Needed|0|||
128025700|NCT01655069|460717827|FG000|Overall Study|Withdrawal by Subject|2|||
127566061|NCT02650921|459041882|FG000|Overall Study|Withdrawal by Subject|4|||
127566062|NCT02650921|459041882|FG000|Overall Study|Lost to Follow-up|2|||
127566063|NCT02650921|459041882|FG000|Overall Study|Adverse Event|1|||
127566064|NCT02650921|459041882|FG000|Overall Study|Due to Medical Condition|1|||
127566065|NCT00783302|459041883|FG000|Overall Study|Lost to Follow-up|17|||
127566066|NCT00783302|459041883|FG000|Overall Study|Technical Problems|11|||
127566067|NCT00783302|459041883|FG000|Overall Study|Protocol Violation|3|||
127566068|NCT00783302|459041883|FG000|Overall Study|Physician Decision|1|||
127566069|NCT00783302|459041883|FG000|Overall Study|Withdrawal by Subject|3|||
127566070|NCT01087788|459041884|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
127566071|NCT01087788|459041885|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
127566072|NCT01087788|459041886|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
127566073|NCT01087788|459041884|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
127566074|NCT01087788|459041885|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
127566075|NCT01087788|459041886|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
127566076|NCT01087788|459041884|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
127566077|NCT01087788|459041885|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
127566078|NCT01087788|459041886|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
127566079|NCT01087788|459041884|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
127566080|NCT01087788|459041885|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
127566081|NCT01087788|459041886|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
127566082|NCT01087788|459041884|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
127566083|NCT01087788|459041885|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
127566084|NCT01087788|459041886|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
127566085|NCT01087788|459041884|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
127566086|NCT01087788|459041885|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
127566087|NCT01087788|459041886|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
127566088|NCT01087788|459041884|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
127566089|NCT01087788|459041885|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
127566090|NCT01087788|459041886|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
127566091|NCT01087788|459041884|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
127566092|NCT01087788|459041885|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
127566093|NCT01087788|459041886|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
127566094|NCT01087788|459041884|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
127566095|NCT01087788|459041885|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
127566096|NCT01087788|459041886|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
127566097|NCT01087788|459041884|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
127566098|NCT01087788|459041885|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
127566099|NCT01087788|459041886|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
127566100|NCT01087788|459041884|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
127566101|NCT01087788|459041885|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
127566102|NCT01087788|459041886|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
127566103|NCT01087788|459041884|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
127566104|NCT01087788|459041885|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
127566105|NCT01087788|459041886|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
127566106|NCT01087788|459041884|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
127566107|NCT01087788|459041885|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
127566108|NCT01087788|459041886|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
127566109|NCT01087788|459041884|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
127566110|NCT01087788|459041885|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
127566111|NCT01087788|459041886|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
127566112|NCT01087788|459041884|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
127566113|NCT01087788|459041885|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
127566114|NCT01087788|459041886|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
127688981|NCT01609218|459486458|FG000|Period 1|Sponsor Decision|0|||
127688982|NCT01609218|459486459|FG001|Period 1|Sponsor Decision|1|||
127688983|NCT01609218|459486458|FG000|Period 2|Adverse Event|1|||
128025701|NCT01655069|460717828|FG001|Overall Study|Withdrawal by Subject|3|||
128025702|NCT01655069|460717829|FG002|Overall Study|Withdrawal by Subject|0|||
128025703|NCT01655069|460717830|FG003|Overall Study|Withdrawal by Subject|0|||
127688984|NCT01609218|459486459|FG001|Period 2|Adverse Event|0|||
127688985|NCT04428112|459486460|FG000|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|4|||
127688986|NCT04428112|459486461|FG001|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|5|||
127705203|NCT01928394|459551583|FG016|Treatment Period|Lost to Follow-up|0|||
128025704|NCT06399471|460717831|FG000|Overall Study|Withdrawal by Subject|1|||
128025705|NCT00986102|460717832|FG000|Overall Study|Lost to Follow-up|0|||
128025706|NCT00986102|460717833|FG001|Overall Study|Lost to Follow-up|1|||
128025707|NCT00986102|460717834|FG002|Overall Study|Lost to Follow-up|0|||
128025708|NCT00986102|460717835|FG003|Overall Study|Lost to Follow-up|1|||
128025709|NCT00986102|460717832|FG000|Overall Study|Withdrawal by Subject|1|||
128025710|NCT00986102|460717833|FG001|Overall Study|Withdrawal by Subject|1|||
128025711|NCT00986102|460717834|FG002|Overall Study|Withdrawal by Subject|0|||
128025712|NCT00986102|460717835|FG003|Overall Study|Withdrawal by Subject|0|||
128025713|NCT06083493|460717836|FG000|Overall Study|Technical issues with the interventional device|2|||
128025714|NCT06083493|460717837|FG001|Overall Study|Technical issues with the interventional device|2|||
128025715|NCT06083493|460717836|FG000|Overall Study|Performed incorrect visual task|1|||
128025716|NCT06083493|460717837|FG001|Overall Study|Performed incorrect visual task|0|||
128025717|NCT06083493|460717836|FG000|Overall Study|Insufficient baseline performance|0|||
128025718|NCT06083493|460717837|FG001|Overall Study|Insufficient baseline performance|1|||
128025719|NCT03225989|460717838|FG000|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|2|||
128025720|NCT03225989|460717839|FG001|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
128025721|NCT03225989|460717840|FG002|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
128025722|NCT03225989|460717838|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
128025723|NCT03225989|460717839|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|1|||
128025724|NCT03225989|460717840|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
128025725|NCT03225989|460717838|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
128025726|NCT03225989|460717839|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|1|||
128025727|NCT03225989|460717840|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
128025728|NCT03225989|460717838|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
128025729|NCT03225989|460717839|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|7|||
128025730|NCT03225989|460717840|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
128025731|NCT03225989|460717838|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
128025732|NCT03225989|460717839|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|1|||
128025733|NCT03225989|460717840|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
128025734|NCT03225989|460717838|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
128025735|NCT03225989|460717839|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
128025736|NCT03225989|460717840|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|1|||
128025737|NCT03225989|460717838|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
128025738|NCT03225989|460717839|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
128025739|NCT03225989|460717840|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|2|||
128025740|NCT03225989|460717838|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
128025741|NCT03225989|460717839|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
128025742|NCT03225989|460717840|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Death|4|||
128025743|NCT03225989|460717838|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
128025744|NCT03225989|460717839|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
128025745|NCT03225989|460717840|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|16|||
128025746|NCT03225989|460717838|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
128025747|NCT03225989|460717839|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
128025748|NCT03225989|460717840|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|1|||
128025749|NCT03225989|460717838|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
128025750|NCT03225989|460717839|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
128025751|NCT03225989|460717840|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|1|||
128025752|NCT03225989|460717838|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
128025753|NCT03225989|460717839|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
128025754|NCT03225989|460717840|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|1|||
128025755|NCT00601107|460717841|FG000|Overall Study|Adverse Event|0|||
128025756|NCT00601107|460717842|FG001|Overall Study|Adverse Event|1|||
128025757|NCT00601107|460717843|FG002|Overall Study|Adverse Event|3|||
128025758|NCT00601107|460717844|FG003|Overall Study|Adverse Event|0|||
128025759|NCT00601107|460717841|FG000|Overall Study|Withdrawal by Subject|5|||
128025760|NCT00601107|460717842|FG001|Overall Study|Withdrawal by Subject|4|||
128025761|NCT00601107|460717843|FG002|Overall Study|Withdrawal by Subject|7|||
128025762|NCT00601107|460717844|FG003|Overall Study|Withdrawal by Subject|4|||
128025763|NCT00601107|460717841|FG000|Overall Study|Lost to Follow-up|3|||
128025764|NCT00601107|460717842|FG001|Overall Study|Lost to Follow-up|3|||
128025765|NCT00601107|460717843|FG002|Overall Study|Lost to Follow-up|0|||
128025766|NCT00601107|460717844|FG003|Overall Study|Lost to Follow-up|3|||
128025767|NCT00601107|460717841|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
128025768|NCT00601107|460717842|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
128025769|NCT00601107|460717843|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
128025770|NCT00601107|460717844|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
128025771|NCT00601107|460717841|FG000|Overall Study|Worsening of Psoriasis|4|||
127566115|NCT01087788|459041884|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
127566116|NCT01087788|459041885|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
127566117|NCT01087788|459041886|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
127566118|NCT01087788|459041884|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
127566119|NCT01087788|459041885|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
127566120|NCT01087788|459041886|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
127688987|NCT04428112|459486460|FG000|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|68|||
127566121|NCT01087788|459041884|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
127566122|NCT01087788|459041885|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
127566123|NCT01087788|459041886|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
127566124|NCT01087788|459041884|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
127566125|NCT01087788|459041885|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
127777208|NCT00727649|459813455|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
127777209|NCT00727649|459813454|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
127777210|NCT00727649|459813455|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
127777211|NCT00727649|459813454|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
127777212|NCT00727649|459813455|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
127777213|NCT00727649|459813454|FG000|Second Intervention (4-weeks)|Death|1|||
127777214|NCT00727649|459813455|FG001|Second Intervention (4-weeks)|Death|0|||
127777215|NCT00727649|459813454|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
127777216|NCT00727649|459813455|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
127777217|NCT00727649|459813454|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
127777218|NCT00727649|459813455|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
127777219|NCT00385203|459813457|FG000|Overall Study|Adverse Event|5|||
127777220|NCT00385203|459813458|FG001|Overall Study|Adverse Event|4|||
127777221|NCT00385203|459813457|FG000|Overall Study|Death|1|||
127777222|NCT00385203|459813458|FG001|Overall Study|Death|0|||
127777223|NCT00385203|459813457|FG000|Overall Study|Condition under investigation worsened|18|||
127777224|NCT00385203|459813458|FG001|Overall Study|Condition under investigation worsened|3|||
127777225|NCT00385203|459813457|FG000|Overall Study|Incorrect enrollment|2|||
127777226|NCT00385203|459813458|FG001|Overall Study|Incorrect enrollment|0|||
127777227|NCT03823404|459813459|FG000|Overall Study|Lost to Follow-up|1|||
127777228|NCT03823404|459813460|FG001|Overall Study|Lost to Follow-up|2|||
127777229|NCT03823404|459813461|FG002|Overall Study|Lost to Follow-up|3|||
127777230|NCT03823404|459813459|FG000|Overall Study|Protocol Violation|2|||
127777231|NCT03823404|459813460|FG001|Overall Study|Protocol Violation|0|||
127777232|NCT03823404|459813461|FG002|Overall Study|Protocol Violation|2|||
127777233|NCT03823404|459813459|FG000|Overall Study|Adverse Event|35|||
127777234|NCT03823404|459813460|FG001|Overall Study|Adverse Event|38|||
127777235|NCT03823404|459813461|FG002|Overall Study|Adverse Event|8|||
127777236|NCT03823404|459813459|FG000|Overall Study|Withdrawal by Subject|38|||
127777237|NCT03823404|459813460|FG001|Overall Study|Withdrawal by Subject|40|||
127777238|NCT03823404|459813461|FG002|Overall Study|Withdrawal by Subject|35|||
127777239|NCT03823404|459813459|FG000|Overall Study|Death|4|||
127777240|NCT03823404|459813460|FG001|Overall Study|Death|0|||
127777241|NCT03823404|459813461|FG002|Overall Study|Death|0|||
127777242|NCT03823404|459813459|FG000|Overall Study|Other: Various reasons provided|5|||
127777243|NCT03823404|459813460|FG001|Overall Study|Other: Various reasons provided|5|||
127777244|NCT03823404|459813461|FG002|Overall Study|Other: Various reasons provided|6|||
127777245|NCT03383289|459813464|FG000|Overall Study|Death|83|||
127777246|NCT03383289|459813465|FG001|Overall Study|Death|78|||
127777247|NCT03383289|459813464|FG000|Overall Study|discharge from facility|84|||
127777248|NCT03383289|459813465|FG001|Overall Study|discharge from facility|84|||
127777249|NCT03383289|459813464|FG000|Overall Study|Withdrawal by Subject|4|||
127777250|NCT03383289|459813465|FG001|Overall Study|Withdrawal by Subject|1|||
127777251|NCT00832117|459813466|FG000|Overall Study|Death|1|||
127777252|NCT00832117|459813466|FG000|Overall Study|Disease Progression|11|||
127777253|NCT00404066|459813467|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
127777254|NCT00404066|459813467|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
127777255|NCT01524133|459813470|FG000|Treatment Phase|Withdrawal by Subject|13|||
127777256|NCT01524133|459813471|FG001|Treatment Phase|Withdrawal by Subject|28|||
127777257|NCT01524133|459813472|FG002|Treatment Phase|Withdrawal by Subject|31|||
127777258|NCT01524133|459813470|FG000|Treatment Phase|Physician Decision|6|||
127777259|NCT01524133|459813471|FG001|Treatment Phase|Physician Decision|3|||
127777260|NCT01524133|459813472|FG002|Treatment Phase|Physician Decision|3|||
127777261|NCT01524133|459813470|FG000|Treatment Phase|Lost to Follow-up|0|||
127777262|NCT01524133|459813471|FG001|Treatment Phase|Lost to Follow-up|1|||
127777263|NCT01524133|459813472|FG002|Treatment Phase|Lost to Follow-up|2|||
127566126|NCT01087788|459041886|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
127566127|NCT01087788|459041884|FG000|24-weeks Dose-blind Period|Patient moved|0|||
127566128|NCT01087788|459041885|FG001|24-weeks Dose-blind Period|Patient moved|0|||
127777264|NCT01524133|459813470|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
127777265|NCT01524133|459813471|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
127777266|NCT01524133|459813472|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
127566129|NCT01087788|459041886|FG002|24-weeks Dose-blind Period|Patient moved|1|||
127566130|NCT01087788|459041884|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
127566131|NCT01087788|459041885|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
127777267|NCT01524133|459813470|FG000|Overall Study 52 Weeks|Physician Decision|1|||
127777268|NCT01524133|459813471|FG001|Overall Study 52 Weeks|Physician Decision|0|||
127777269|NCT01524133|459813472|FG002|Overall Study 52 Weeks|Physician Decision|2|||
127777270|NCT01524133|459813470|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
127566132|NCT01087788|459041886|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
127566133|NCT01087788|459041884|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
127566134|NCT01087788|459041885|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
127566135|NCT01087788|459041886|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
127566136|NCT01087788|459041884|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
127566137|NCT01087788|459041885|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
127566138|NCT01087788|459041886|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
127566139|NCT01087788|459041884|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
127566140|NCT01087788|459041885|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
127566141|NCT01087788|459041886|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
127566142|NCT01087788|459041884|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
127566143|NCT01087788|459041885|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
127566144|NCT01087788|459041886|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
127566145|NCT01087788|459041884|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
127566146|NCT01087788|459041885|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
127566147|NCT01087788|459041886|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
127566148|NCT01087788|459041884|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
127566149|NCT01087788|459041885|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
127566150|NCT01087788|459041886|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
127566151|NCT01087788|459041884|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
127566152|NCT01087788|459041885|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
127566153|NCT01087788|459041886|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
127566154|NCT01087788|459041884|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
127566155|NCT01087788|459041885|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
127566156|NCT01087788|459041886|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
127566157|NCT01087788|459041884|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
127566158|NCT01087788|459041885|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
127566159|NCT01087788|459041886|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
127566160|NCT01087788|459041884|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
127566161|NCT01087788|459041885|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
127566162|NCT01087788|459041886|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
127566163|NCT01087788|459041884|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
127566164|NCT01087788|459041885|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
127566165|NCT01087788|459041886|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
127566166|NCT01087788|459041884|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
127566167|NCT01087788|459041885|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
127566168|NCT01087788|459041886|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
127566169|NCT04604132|459041887|FG000|Overall Study|Adverse Event|2|||
127566170|NCT04604132|459041888|FG001|Overall Study|Adverse Event|0|||
127566171|NCT04604132|459041889|FG002|Overall Study|Adverse Event|0|||
127566172|NCT04604132|459041890|FG003|Overall Study|Adverse Event|1|||
127566173|NCT04604132|459041891|FG004|Overall Study|Adverse Event|2|||
127566174|NCT04604132|459041887|FG000|Overall Study|Study terminated by sponsor|0|||
127566175|NCT04604132|459041888|FG001|Overall Study|Study terminated by sponsor|0|||
127688988|NCT04428112|459486461|FG001|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|29|||
127688989|NCT04428112|459486460|FG000|Overall Study|Withdrawal by Subject|9|||
127688990|NCT04428112|459486461|FG001|Overall Study|Withdrawal by Subject|4|||
127688991|NCT04428112|459486460|FG000|Overall Study|Lost to Follow-up|27|||
127688992|NCT04428112|459486461|FG001|Overall Study|Lost to Follow-up|7|||
127688993|NCT04992390|459486462|FG000|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
127688994|NCT04992390|459486463|FG001|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
127688995|NCT04992390|459486464|FG002|Run-In/Screening Week|Recorded fewer than three intrusive memories|7|||
127688996|NCT04992390|459486462|FG000|Run-In/Screening Week|Lost to Follow-up|0|||
127688997|NCT04992390|459486463|FG001|Run-In/Screening Week|Lost to Follow-up|0|||
127688998|NCT04992390|459486464|FG002|Run-In/Screening Week|Lost to Follow-up|6|||
127688999|NCT04992390|459486462|FG000|Run-In/Screening Week|Withdrawal by Subject|0|||
127689000|NCT04992390|459486463|FG001|Run-In/Screening Week|Withdrawal by Subject|0|||
127689001|NCT04992390|459486464|FG002|Run-In/Screening Week|Withdrawal by Subject|1|||
127689002|NCT04992390|459486462|FG000|Baseline Questionnaires|Lost to Follow-up|0|||
127689003|NCT04992390|459486463|FG001|Baseline Questionnaires|Lost to Follow-up|0|||
127689004|NCT04992390|459486464|FG002|Baseline Questionnaires|Lost to Follow-up|1|||
127689005|NCT04992390|459486462|FG000|Baseline Questionnaires|Withdrawal by Subject|0|||
127689006|NCT04992390|459486463|FG001|Baseline Questionnaires|Withdrawal by Subject|0|||
127566176|NCT04604132|459041889|FG002|Overall Study|Study terminated by sponsor|0|||
127566177|NCT04604132|459041890|FG003|Overall Study|Study terminated by sponsor|0|||
127689007|NCT04992390|459486464|FG002|Baseline Questionnaires|Withdrawal by Subject|1|||
127689008|NCT04992390|459486462|FG000|Week 4 Primary Outcome|Lost to Follow-up|3|||
127689009|NCT04992390|459486463|FG001|Week 4 Primary Outcome|Lost to Follow-up|2|||
127566178|NCT04604132|459041891|FG004|Overall Study|Study terminated by sponsor|1|||
127566179|NCT04604132|459041887|FG000|Overall Study|Progressive disease: Clinical progression|0|||
127566180|NCT04604132|459041888|FG001|Overall Study|Progressive disease: Clinical progression|0|||
127566181|NCT04604132|459041889|FG002|Overall Study|Progressive disease: Clinical progression|1|||
127566182|NCT04604132|459041890|FG003|Overall Study|Progressive disease: Clinical progression|0|||
127566183|NCT04604132|459041891|FG004|Overall Study|Progressive disease: Clinical progression|0|||
127566184|NCT04604132|459041887|FG000|Overall Study|Progressive disease: Radiological progression|8|||
127566185|NCT04604132|459041888|FG001|Overall Study|Progressive disease: Radiological progression|7|||
127566186|NCT04604132|459041889|FG002|Overall Study|Progressive disease: Radiological progression|10|||
127566187|NCT04604132|459041890|FG003|Overall Study|Progressive disease: Radiological progression|4|||
127566188|NCT04604132|459041891|FG004|Overall Study|Progressive disease: Radiological progression|3|||
127566189|NCT04604132|459041887|FG000|Overall Study|Death|3|||
127566190|NCT04604132|459041888|FG001|Overall Study|Death|1|||
127566191|NCT04604132|459041889|FG002|Overall Study|Death|2|||
127566192|NCT04604132|459041890|FG003|Overall Study|Death|1|||
127566193|NCT04604132|459041891|FG004|Overall Study|Death|0|||
127566194|NCT00160667|459041892|FG000|Overall Study|Adverse Event|3|||
127566195|NCT00160667|459041893|FG001|Overall Study|Adverse Event|1|||
127566196|NCT00160667|459041894|FG002|Overall Study|Adverse Event|4|||
127566197|NCT00160667|459041892|FG000|Overall Study|Withdrawal by Subject|2|||
127566198|NCT00160667|459041893|FG001|Overall Study|Withdrawal by Subject|0|||
127566199|NCT00160667|459041894|FG002|Overall Study|Withdrawal by Subject|1|||
127566200|NCT00160667|459041892|FG000|Overall Study|Lack of Efficacy|0|||
127566201|NCT00160667|459041893|FG001|Overall Study|Lack of Efficacy|1|||
127566202|NCT00160667|459041894|FG002|Overall Study|Lack of Efficacy|0|||
127566203|NCT00160667|459041892|FG000|Overall Study|Protocol Violation|0|||
127566204|NCT00160667|459041893|FG001|Overall Study|Protocol Violation|1|||
127566205|NCT00160667|459041894|FG002|Overall Study|Protocol Violation|0|||
127566206|NCT00160667|459041892|FG000|Overall Study|Patient decision|0|||
127566207|NCT00160667|459041893|FG001|Overall Study|Patient decision|0|||
127566208|NCT00160667|459041894|FG002|Overall Study|Patient decision|1|||
127566209|NCT00534313|459041898|FG000|Short-term Period|Adverse Event|1|||
127566210|NCT00534313|459041899|FG001|Short-term Period|Adverse Event|2|||
127566211|NCT00534313|459041900|FG002|Short-term Period|Adverse Event|1|||
127566212|NCT00534313|459041901|FG003|Short-term Period|Adverse Event|3|||
127566213|NCT00534313|459041898|FG000|Short-term Period|Lack of Efficacy|3|||
127566214|NCT00534313|459041899|FG001|Short-term Period|Lack of Efficacy|4|||
127566215|NCT00534313|459041900|FG002|Short-term Period|Lack of Efficacy|0|||
127566216|NCT00534313|459041901|FG003|Short-term Period|Lack of Efficacy|3|||
127566217|NCT00534313|459041898|FG000|Short-term Period|Participant not meeting study criteria|0|||
127566218|NCT00534313|459041899|FG001|Short-term Period|Participant not meeting study criteria|0|||
127566219|NCT00534313|459041900|FG002|Short-term Period|Participant not meeting study criteria|0|||
127689010|NCT04992390|459486464|FG002|Week 4 Primary Outcome|Lost to Follow-up|0|||
127689011|NCT04992390|459486462|FG000|Week 4 Primary Outcome|Withdrawal by Subject|0|||
127689012|NCT04992390|459486463|FG001|Week 4 Primary Outcome|Withdrawal by Subject|2|||
127689013|NCT04992390|459486464|FG002|Week 4 Primary Outcome|Withdrawal by Subject|0|||
127689014|NCT04992390|459486462|FG000|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|1|||
127689015|NCT04992390|459486463|FG001|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
127689016|NCT04992390|459486464|FG002|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
127689017|NCT04992390|459486462|FG000|Week 4 Secondary Outcomes|Lost to Follow-up|3|||
127689018|NCT04992390|459486463|FG001|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
127689019|NCT04992390|459486464|FG002|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
127689020|NCT04992390|459486462|FG000|Week 4 Secondary Outcomes|Withdrawal by Subject|1|||
127689021|NCT04992390|459486463|FG001|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
127689022|NCT04992390|459486464|FG002|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
127689023|NCT04992390|459486462|FG000|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|5|||
127689024|NCT04992390|459486463|FG001|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|1|||
127777271|NCT01524133|459813471|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
128025772|NCT00601107|460717842|FG001|Overall Study|Worsening of Psoriasis|1|||
128025773|NCT00601107|460717843|FG002|Overall Study|Worsening of Psoriasis|1|||
127566220|NCT00534313|459041901|FG003|Short-term Period|Participant not meeting study criteria|1|||
127566221|NCT00534313|459041898|FG000|Short-term Period|Participant withdrew consent|2|||
127566222|NCT00534313|459041899|FG001|Short-term Period|Participant withdrew consent|0|||
127566223|NCT00534313|459041900|FG002|Short-term Period|Participant withdrew consent|0|||
127566224|NCT00534313|459041901|FG003|Short-term Period|Participant withdrew consent|2|||
127566225|NCT00534313|459041898|FG000|Short-term Period|Pregnancy|0|||
127566226|NCT00534313|459041899|FG001|Short-term Period|Pregnancy|0|||
127566227|NCT00534313|459041900|FG002|Short-term Period|Pregnancy|1|||
127566228|NCT00534313|459041901|FG003|Short-term Period|Pregnancy|0|||
127566229|NCT00534313|459041898|FG000|Long-term Period|Adverse Event|2|||
127566230|NCT00534313|459041899|FG001|Long-term Period|Adverse Event|1|||
127566231|NCT00534313|459041900|FG002|Long-term Period|Adverse Event|0|||
128025774|NCT00601107|460717844|FG003|Overall Study|Worsening of Psoriasis|4|||
128025775|NCT00601107|460717841|FG000|Overall Study|Undefined|1|||
128025776|NCT00601107|460717842|FG001|Overall Study|Undefined|0|||
128025777|NCT00601107|460717843|FG002|Overall Study|Undefined|1|||
128025778|NCT00601107|460717844|FG003|Overall Study|Undefined|0|||
128025779|NCT00147537|460717845|FG000|Phase 1b|Death|0|||
128025780|NCT00147537|460717846|FG001|Phase 1b|Death|1|||
128025781|NCT00147537|460717847|FG002|Phase 1b|Death|2|||
128025782|NCT00147537|460717848|FG003|Phase 1b|Death|1|||
128025783|NCT00147537|460717849|FG004|Phase 1b|Death|2|||
128025784|NCT00147537|460717850|FG005|Phase 1b|Death|2|||
128025785|NCT00147537|460717851|FG006|Phase 1b|Death|1|||
128025786|NCT00147537|460717852|FG007|Phase 1b|Death|3|||
128025787|NCT00147537|460717853|FG008|Phase 1b|Death|9|||
128025788|NCT00147537|460717854|FG009|Phase 1b|Death|0|||
128025789|NCT00147537|460717855|FG010|Phase 1b|Death|0|||
128025790|NCT00147537|460717845|FG000|Phase 1b|Lost to Follow-up|2|||
128025791|NCT00147537|460717846|FG001|Phase 1b|Lost to Follow-up|1|||
128025792|NCT00147537|460717847|FG002|Phase 1b|Lost to Follow-up|0|||
128025793|NCT00147537|460717848|FG003|Phase 1b|Lost to Follow-up|0|||
128025794|NCT00147537|460717849|FG004|Phase 1b|Lost to Follow-up|0|||
128025795|NCT00147537|460717850|FG005|Phase 1b|Lost to Follow-up|0|||
128025796|NCT00147537|460717851|FG006|Phase 1b|Lost to Follow-up|2|||
128025797|NCT00147537|460717852|FG007|Phase 1b|Lost to Follow-up|0|||
128025798|NCT00147537|460717853|FG008|Phase 1b|Lost to Follow-up|1|||
128025799|NCT00147537|460717854|FG009|Phase 1b|Lost to Follow-up|0|||
128025800|NCT00147537|460717855|FG010|Phase 1b|Lost to Follow-up|0|||
128025801|NCT00147537|460717845|FG000|Phase 1b|Other|0|||
127566232|NCT00534313|459041901|FG003|Long-term Period|Adverse Event|1|||
127566233|NCT00534313|459041898|FG000|Long-term Period|Lack of Efficacy|14|||
127566234|NCT00534313|459041899|FG001|Long-term Period|Lack of Efficacy|10|||
127566235|NCT00534313|459041900|FG002|Long-term Period|Lack of Efficacy|14|||
127566236|NCT00534313|459041901|FG003|Long-term Period|Lack of Efficacy|12|||
127566237|NCT00534313|459041898|FG000|Long-term Period|Lost to Follow-up|1|||
127566238|NCT00534313|459041899|FG001|Long-term Period|Lost to Follow-up|2|||
127566239|NCT00534313|459041900|FG002|Long-term Period|Lost to Follow-up|0|||
127566240|NCT00534313|459041901|FG003|Long-term Period|Lost to Follow-up|0|||
128025802|NCT00147537|460717846|FG001|Phase 1b|Other|0|||
128025803|NCT00147537|460717847|FG002|Phase 1b|Other|2|||
128025804|NCT00147537|460717848|FG003|Phase 1b|Other|1|||
128025805|NCT00147537|460717849|FG004|Phase 1b|Other|1|||
127566241|NCT00534313|459041898|FG000|Long-term Period|Withdrawal by Subject|2|||
127566242|NCT00534313|459041899|FG001|Long-term Period|Withdrawal by Subject|2|||
127566243|NCT00534313|459041900|FG002|Long-term Period|Withdrawal by Subject|0|||
127566244|NCT00534313|459041901|FG003|Long-term Period|Withdrawal by Subject|0|||
127566245|NCT00534313|459041898|FG000|Long-term Period|No longer meets study criteria|0|||
127566246|NCT00534313|459041899|FG001|Long-term Period|No longer meets study criteria|1|||
127566247|NCT00534313|459041900|FG002|Long-term Period|No longer meets study criteria|0|||
127566248|NCT00534313|459041901|FG003|Long-term Period|No longer meets study criteria|0|||
127689025|NCT04992390|459486464|FG002|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|0|||
127689026|NCT04992390|459486462|FG000|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
127689027|NCT04992390|459486463|FG001|Delayed Arm Receive Intervention|Withdrawal by Subject|1|||
127689028|NCT04992390|459486464|FG002|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
127689029|NCT04992390|459486462|FG000|Week 8 Replication After Crossover|Lost to Follow-up|0|||
127689030|NCT04992390|459486463|FG001|Week 8 Replication After Crossover|Lost to Follow-up|4|||
127689031|NCT04992390|459486464|FG002|Week 8 Replication After Crossover|Lost to Follow-up|0|||
127689032|NCT04992390|459486462|FG000|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
127689033|NCT04992390|459486463|FG001|Week 8 Replication After Crossover|Withdrawal by Subject|2|||
127689034|NCT04992390|459486464|FG002|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
127689035|NCT04992390|459486462|FG000|Week 8 - Other Secondary Outcomes|Lost to Follow-up|2|||
127689036|NCT04992390|459486463|FG001|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
127777272|NCT01524133|459813472|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
127777273|NCT00059839|459813479|FG000|Overall Study|Death|1|||
128025806|NCT00147537|460717850|FG005|Phase 1b|Other|1|||
128025807|NCT00147537|460717851|FG006|Phase 1b|Other|14|||
128025808|NCT00147537|460717852|FG007|Phase 1b|Other|4|||
128025809|NCT00147537|460717853|FG008|Phase 1b|Other|4|||
128025810|NCT00147537|460717854|FG009|Phase 1b|Other|0|||
127566249|NCT00534313|459041898|FG000|Long-term Period|Poor compliance/noncompliance|0|||
127566250|NCT00534313|459041899|FG001|Long-term Period|Poor compliance/noncompliance|1|||
127566251|NCT00534313|459041900|FG002|Long-term Period|Poor compliance/noncompliance|1|||
128025811|NCT00147537|460717855|FG010|Phase 1b|Other|0|||
128025812|NCT00147537|460717845|FG000|Phase 1b|Withdrawal by Subject|0|||
128025813|NCT00147537|460717846|FG001|Phase 1b|Withdrawal by Subject|0|||
128025814|NCT00147537|460717847|FG002|Phase 1b|Withdrawal by Subject|0|||
128025815|NCT00147537|460717848|FG003|Phase 1b|Withdrawal by Subject|0|||
128025816|NCT00147537|460717849|FG004|Phase 1b|Withdrawal by Subject|0|||
128025817|NCT00147537|460717850|FG005|Phase 1b|Withdrawal by Subject|0|||
128025818|NCT00147537|460717851|FG006|Phase 1b|Withdrawal by Subject|0|||
128025819|NCT00147537|460717852|FG007|Phase 1b|Withdrawal by Subject|0|||
127566252|NCT00534313|459041901|FG003|Long-term Period|Poor compliance/noncompliance|0|||
127566253|NCT00534313|459041898|FG000|Long-term Period|Administrative reason by sponsor|17|||
127566254|NCT00534313|459041899|FG001|Long-term Period|Administrative reason by sponsor|15|||
127566255|NCT00534313|459041900|FG002|Long-term Period|Administrative reason by sponsor|26|||
127566256|NCT00534313|459041901|FG003|Long-term Period|Administrative reason by sponsor|18|||
127566257|NCT00534313|459041898|FG000|Long-term Period|Other|1|||
127566258|NCT00534313|459041899|FG001|Long-term Period|Other|2|||
127566259|NCT00534313|459041900|FG002|Long-term Period|Other|2|||
127566260|NCT00534313|459041901|FG003|Long-term Period|Other|2|||
127566261|NCT00927940|459041902|FG000|Overall Study|Death|1|||
127566262|NCT03709576|459041908|FG000|Overall Study|progression prior to enrollment|1|||
127566263|NCT03044574|459041909|FG000|Overall Study|Lost to Follow-up|37|||
127566264|NCT03044574|459041910|FG001|Overall Study|Lost to Follow-up|45|||
127566265|NCT00890045|459041911|FG000|Overall Study|Death|0|||
127566266|NCT00890045|459041912|FG001|Overall Study|Death|1|||
127566267|NCT00890045|459041911|FG000|Overall Study|Did not receive HeRO Graft|0|||
127566268|NCT00890045|459041912|FG001|Overall Study|Did not receive HeRO Graft|2|||
127566269|NCT00890045|459041911|FG000|Overall Study|Lost to Follow-up|5|||
127566270|NCT00890045|459041912|FG001|Overall Study|Lost to Follow-up|7|||
127566271|NCT00483756|459041917|FG000|Overall Study|Death|2|||
127566272|NCT00483756|459041918|FG001|Overall Study|Death|0|||
127566273|NCT00483756|459041919|FG002|Overall Study|Death|1|||
127566274|NCT00483756|459041917|FG000|Overall Study|Adverse Event|19|||
127566275|NCT00483756|459041918|FG001|Overall Study|Adverse Event|38|||
127566276|NCT00483756|459041919|FG002|Overall Study|Adverse Event|40|||
127566277|NCT00483756|459041917|FG000|Overall Study|Lack of Efficacy|1|||
127566278|NCT00483756|459041918|FG001|Overall Study|Lack of Efficacy|0|||
127566279|NCT00483756|459041919|FG002|Overall Study|Lack of Efficacy|0|||
127566280|NCT00483756|459041917|FG000|Overall Study|Lost to Follow-up|3|||
127566281|NCT00483756|459041918|FG001|Overall Study|Lost to Follow-up|1|||
127566282|NCT00483756|459041919|FG002|Overall Study|Lost to Follow-up|0|||
127566283|NCT00483756|459041917|FG000|Overall Study|Withdrawal by Subject|5|||
127566284|NCT00483756|459041918|FG001|Overall Study|Withdrawal by Subject|3|||
127566285|NCT00483756|459041919|FG002|Overall Study|Withdrawal by Subject|4|||
127566286|NCT00483756|459041917|FG000|Overall Study|Other|2|||
127566287|NCT00483756|459041918|FG001|Overall Study|Other|4|||
127566288|NCT00483756|459041919|FG002|Overall Study|Other|3|||
127566289|NCT00483756|459041917|FG000|Overall Study|Randomized, Not Treated|1|||
127566290|NCT00483756|459041918|FG001|Overall Study|Randomized, Not Treated|4|||
127566291|NCT00483756|459041919|FG002|Overall Study|Randomized, Not Treated|4|||
127566292|NCT00495040|459041921|FG000|Overall Study|Withdrawal by Subject|3|||
127566293|NCT01892384|459041922|FG000|Overall Study|Withdrawal by Subject|1|||
127566294|NCT01892384|459041923|FG001|Overall Study|Withdrawal by Subject|1|||
127566295|NCT01892384|459041924|FG002|Overall Study|Withdrawal by Subject|0|||
127566296|NCT01892384|459041925|FG003|Overall Study|Withdrawal by Subject|0|||
127566297|NCT00592774|459041926|FG000|Overall Study|Adverse Event|5|||
127566298|NCT00592774|459041927|FG001|Overall Study|Adverse Event|19|||
127566299|NCT00592774|459041928|FG002|Overall Study|Adverse Event|2|||
127566300|NCT00592774|459041929|FG003|Overall Study|Adverse Event|14|||
127566301|NCT00592774|459041930|FG004|Overall Study|Adverse Event|8|||
127566302|NCT00592774|459041926|FG000|Overall Study|Protocol Violation|0|||
127566303|NCT00592774|459041927|FG001|Overall Study|Protocol Violation|1|||
127566304|NCT00592774|459041928|FG002|Overall Study|Protocol Violation|0|||
127566305|NCT00592774|459041929|FG003|Overall Study|Protocol Violation|0|||
127566306|NCT00592774|459041930|FG004|Overall Study|Protocol Violation|1|||
127566307|NCT00592774|459041926|FG000|Overall Study|Withdrawal by Subject|3|||
127566308|NCT00592774|459041927|FG001|Overall Study|Withdrawal by Subject|7|||
127566309|NCT00592774|459041928|FG002|Overall Study|Withdrawal by Subject|0|||
127566310|NCT00592774|459041929|FG003|Overall Study|Withdrawal by Subject|0|||
127566311|NCT00592774|459041930|FG004|Overall Study|Withdrawal by Subject|0|||
127566312|NCT00592774|459041926|FG000|Overall Study|Lack of Efficacy|3|||
127566313|NCT00592774|459041927|FG001|Overall Study|Lack of Efficacy|3|||
127689037|NCT04992390|459486464|FG002|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
127566314|NCT00592774|459041928|FG002|Overall Study|Lack of Efficacy|0|||
127566315|NCT00592774|459041929|FG003|Overall Study|Lack of Efficacy|0|||
127566316|NCT00592774|459041930|FG004|Overall Study|Lack of Efficacy|2|||
127689038|NCT04992390|459486462|FG000|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
127566317|NCT00592774|459041926|FG000|Overall Study|Physician Decision|0|||
127566318|NCT00592774|459041927|FG001|Overall Study|Physician Decision|1|||
127566319|NCT00592774|459041928|FG002|Overall Study|Physician Decision|1|||
127566320|NCT00592774|459041929|FG003|Overall Study|Physician Decision|0|||
127566321|NCT00592774|459041930|FG004|Overall Study|Physician Decision|1|||
127566322|NCT00592774|459041926|FG000|Overall Study|Other|0|||
127566323|NCT00592774|459041927|FG001|Overall Study|Other|1|||
127566324|NCT00592774|459041928|FG002|Overall Study|Other|1|||
127566325|NCT00592774|459041929|FG003|Overall Study|Other|0|||
127566326|NCT00592774|459041930|FG004|Overall Study|Other|2|||
127566327|NCT00621621|459041937|FG000|Overall Study|Subjects were exited at EP study|30|||
127566328|NCT00621621|459041938|FG001|Overall Study|Subjects were exited at EP study|0|||
127566329|NCT00608569|459041939|FG000|Overall Study|Death|4|||
127566330|NCT00608569|459041940|FG001|Overall Study|Death|3|||
127566331|NCT00608569|459041939|FG000|Overall Study|Lost to Follow-up|4|||
127566332|NCT00608569|459041940|FG001|Overall Study|Lost to Follow-up|5|||
127566333|NCT00608569|459041939|FG000|Overall Study|Withdrawal by Subject|1|||
127566334|NCT00608569|459041940|FG001|Overall Study|Withdrawal by Subject|0|||
127566335|NCT00608569|459041939|FG000|Overall Study|Adverse Event|1|||
127566336|NCT00608569|459041940|FG001|Overall Study|Adverse Event|0|||
127566337|NCT00608569|459041939|FG000|Overall Study|Unable to adhere with study requirements|0|||
127566338|NCT00608569|459041940|FG001|Overall Study|Unable to adhere with study requirements|1|||
127566339|NCT02282293|459041941|FG000|Overall Study|Lost to Follow-up|2|||
127566340|NCT02282293|459041942|FG001|Overall Study|Lost to Follow-up|2|||
127566341|NCT02282293|459041941|FG000|Overall Study|Unable to comply with study procedures|1|||
127566342|NCT02282293|459041942|FG001|Overall Study|Unable to comply with study procedures|0|||
127566343|NCT02282293|459041941|FG000|Overall Study|Moved out of study area|0|||
127566344|NCT02282293|459041942|FG001|Overall Study|Moved out of study area|1|||
127566345|NCT01924429|459041955|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
127566346|NCT01924429|459041956|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
127566347|NCT00906971|459041957|FG000|Overall Study|Withdrawal by Subject|8|||
127566348|NCT00906971|459041958|FG001|Overall Study|Withdrawal by Subject|2|||
127566349|NCT00906971|459041957|FG000|Overall Study|Lost to Follow-up|0|||
127566350|NCT00906971|459041958|FG001|Overall Study|Lost to Follow-up|1|||
127566351|NCT00807573|459041959|FG000|Overall Study|Withdrawal by Subject|1|||
127566352|NCT00807573|459041959|FG000|Overall Study|Adverse Event|1|||
127566353|NCT04054947|459041960|FG000|Overall Study|Withdrawal by Subject|1|||
127566354|NCT04054947|459041961|FG001|Overall Study|Withdrawal by Subject|0|||
127566355|NCT04054947|459041960|FG000|Overall Study|Lost to Follow-up|2|||
127566356|NCT04054947|459041961|FG001|Overall Study|Lost to Follow-up|5|||
127566357|NCT01606878|459041962|FG000|Overall Study|Adverse Event|1|||
127566358|NCT01606878|459041963|FG001|Overall Study|Adverse Event|1|||
127566359|NCT01606878|459041964|FG002|Overall Study|Adverse Event|0|||
127566360|NCT01606878|459041965|FG003|Overall Study|Adverse Event|0|||
127566361|NCT01606878|459041966|FG004|Overall Study|Adverse Event|0|||
127566362|NCT01606878|459041967|FG005|Overall Study|Adverse Event|0|||
127566363|NCT01606878|459041968|FG006|Overall Study|Adverse Event|1|||
127566364|NCT01606878|459041969|FG007|Overall Study|Adverse Event|0|||
127566365|NCT01606878|459041970|FG008|Overall Study|Adverse Event|1|||
127566366|NCT01606878|459041971|FG009|Overall Study|Adverse Event|3|||
127566367|NCT01606878|459041972|FG010|Overall Study|Adverse Event|0|||
127566368|NCT01606878|459041962|FG000|Overall Study|Lack of Efficacy|1|||
127566369|NCT01606878|459041963|FG001|Overall Study|Lack of Efficacy|1|||
127566370|NCT01606878|459041964|FG002|Overall Study|Lack of Efficacy|1|||
127566371|NCT01606878|459041965|FG003|Overall Study|Lack of Efficacy|2|||
127566372|NCT01606878|459041966|FG004|Overall Study|Lack of Efficacy|1|||
127566373|NCT01606878|459041967|FG005|Overall Study|Lack of Efficacy|2|||
127566374|NCT01606878|459041968|FG006|Overall Study|Lack of Efficacy|1|||
127566375|NCT01606878|459041969|FG007|Overall Study|Lack of Efficacy|2|||
127566376|NCT01606878|459041970|FG008|Overall Study|Lack of Efficacy|2|||
127566377|NCT01606878|459041971|FG009|Overall Study|Lack of Efficacy|0|||
127566378|NCT01606878|459041972|FG010|Overall Study|Lack of Efficacy|1|||
127566379|NCT01606878|459041962|FG000|Overall Study|Physician Decision|1|||
127566380|NCT01606878|459041963|FG001|Overall Study|Physician Decision|0|||
127566381|NCT01606878|459041964|FG002|Overall Study|Physician Decision|2|||
127566382|NCT01606878|459041965|FG003|Overall Study|Physician Decision|1|||
127566383|NCT01606878|459041966|FG004|Overall Study|Physician Decision|1|||
127566384|NCT01606878|459041967|FG005|Overall Study|Physician Decision|1|||
127566385|NCT01606878|459041968|FG006|Overall Study|Physician Decision|2|||
127566386|NCT01606878|459041969|FG007|Overall Study|Physician Decision|0|||
127566387|NCT01606878|459041970|FG008|Overall Study|Physician Decision|1|||
127566388|NCT01606878|459041971|FG009|Overall Study|Physician Decision|0|||
127566389|NCT01606878|459041972|FG010|Overall Study|Physician Decision|0|||
127566390|NCT01606878|459041962|FG000|Overall Study|Withdrawal by Subject|3|||
127566391|NCT01606878|459041963|FG001|Overall Study|Withdrawal by Subject|2|||
127566392|NCT01606878|459041964|FG002|Overall Study|Withdrawal by Subject|2|||
127566393|NCT01606878|459041965|FG003|Overall Study|Withdrawal by Subject|0|||
127566394|NCT01606878|459041966|FG004|Overall Study|Withdrawal by Subject|1|||
127566395|NCT01606878|459041967|FG005|Overall Study|Withdrawal by Subject|1|||
127566396|NCT01606878|459041968|FG006|Overall Study|Withdrawal by Subject|2|||
127566397|NCT01606878|459041969|FG007|Overall Study|Withdrawal by Subject|1|||
127566398|NCT01606878|459041970|FG008|Overall Study|Withdrawal by Subject|2|||
127566399|NCT01606878|459041971|FG009|Overall Study|Withdrawal by Subject|0|||
127566400|NCT01606878|459041972|FG010|Overall Study|Withdrawal by Subject|2|||
127566401|NCT02880956|459041980|FG000|Overall Study|Adverse Event|3|||
127566402|NCT02880956|459041981|FG001|Overall Study|Adverse Event|6|||
127566403|NCT02880956|459041982|FG002|Overall Study|Adverse Event|5|||
127566404|NCT02880956|459041983|FG003|Overall Study|Adverse Event|4|||
127566405|NCT02880956|459041980|FG000|Overall Study|Withdrawal by Subject|9|||
127566406|NCT02880956|459041981|FG001|Overall Study|Withdrawal by Subject|4|||
128025820|NCT00147537|460717853|FG008|Phase 1b|Withdrawal by Subject|2|||
128025821|NCT00147537|460717854|FG009|Phase 1b|Withdrawal by Subject|0|||
128025822|NCT00147537|460717855|FG010|Phase 1b|Withdrawal by Subject|0|||
128025823|NCT00147537|460717845|FG000|Phase 1b|Randomized but not treated|0|||
127566407|NCT02880956|459041982|FG002|Overall Study|Withdrawal by Subject|6|||
127566408|NCT02880956|459041983|FG003|Overall Study|Withdrawal by Subject|11|||
127566409|NCT02880956|459041980|FG000|Overall Study|Lost to Follow-up|0|||
127566410|NCT02880956|459041981|FG001|Overall Study|Lost to Follow-up|1|||
127566411|NCT02880956|459041982|FG002|Overall Study|Lost to Follow-up|0|||
127566412|NCT02880956|459041983|FG003|Overall Study|Lost to Follow-up|0|||
127566413|NCT02880956|459041980|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
127566414|NCT02880956|459041981|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
127566415|NCT02880956|459041982|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
127566416|NCT02880956|459041983|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
127566417|NCT02880956|459041980|FG000|Overall Study|Other, Not Specified|4|||
127566418|NCT02880956|459041981|FG001|Overall Study|Other, Not Specified|2|||
127566419|NCT02880956|459041982|FG002|Overall Study|Other, Not Specified|0|||
127777274|NCT00059839|459813480|FG001|Overall Study|Death|1|||
127777275|NCT00059839|459813479|FG000|Overall Study|Lack of Efficacy|6|||
127777276|NCT00059839|459813480|FG001|Overall Study|Lack of Efficacy|5|||
127777277|NCT00059839|459813479|FG000|Overall Study|Lost to Follow-up|2|||
127777278|NCT00059839|459813480|FG001|Overall Study|Lost to Follow-up|0|||
127777279|NCT00059839|459813479|FG000|Overall Study|Physician Decision|1|||
127777280|NCT00059839|459813480|FG001|Overall Study|Physician Decision|2|||
127777281|NCT00059839|459813479|FG000|Overall Study|Withdrawal by Subject|1|||
127777282|NCT00059839|459813480|FG001|Overall Study|Withdrawal by Subject|6|||
127777283|NCT00059839|459813479|FG000|Overall Study|Ineligible|1|||
127777284|NCT00059839|459813480|FG001|Overall Study|Ineligible|3|||
127777285|NCT03842163|459813481|FG000|Overall Study|Did not meet inclusion criteria (age less than 50 years)|2|||
127566420|NCT02880956|459041983|FG003|Overall Study|Other, Not Specified|3|||
127566421|NCT00853970|459041984|FG000|Overall Study|Withdrawal by Subject|2|||
127566422|NCT00853970|459041985|FG001|Overall Study|Withdrawal by Subject|1|||
127566423|NCT00853970|459041984|FG000|Overall Study|Cancelled surgery|4|||
127566424|NCT00853970|459041985|FG001|Overall Study|Cancelled surgery|2|||
127566425|NCT02276027|459043755|FG000|Overall Study|Death|1|||
127566426|NCT02276027|459043756|FG001|Overall Study|Death|0|||
127566427|NCT02276027|459043757|FG002|Overall Study|Death|0|||
127566428|NCT02276027|459043758|FG003|Overall Study|Death|2|||
127566429|NCT02276027|459043755|FG000|Overall Study|Physician Decision|0|||
127566430|NCT02276027|459043756|FG001|Overall Study|Physician Decision|0|||
127566431|NCT02276027|459043757|FG002|Overall Study|Physician Decision|0|||
127566432|NCT02276027|459043758|FG003|Overall Study|Physician Decision|1|||
127566433|NCT02276027|459043755|FG000|Overall Study|Progressive disease|1|||
127566434|NCT02276027|459043756|FG001|Overall Study|Progressive disease|13|||
127566435|NCT02276027|459043757|FG002|Overall Study|Progressive disease|12|||
127777286|NCT03842163|459813481|FG000|Overall Study|Scintigraphy was not performed|44|||
127777287|NCT03829241|459813482|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
127777288|NCT03829241|459813483|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
127777289|NCT03829241|459813482|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
127777290|NCT03829241|459813483|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
128025824|NCT00147537|460717846|FG001|Phase 1b|Randomized but not treated|0|||
128025825|NCT00147537|460717847|FG002|Phase 1b|Randomized but not treated|0|||
128025826|NCT00147537|460717848|FG003|Phase 1b|Randomized but not treated|0|||
128025827|NCT00147537|460717849|FG004|Phase 1b|Randomized but not treated|0|||
128025828|NCT00147537|460717850|FG005|Phase 1b|Randomized but not treated|0|||
128025829|NCT00147537|460717851|FG006|Phase 1b|Randomized but not treated|1|||
128025830|NCT00147537|460717852|FG007|Phase 1b|Randomized but not treated|0|||
128025831|NCT00147537|460717853|FG008|Phase 1b|Randomized but not treated|1|||
128025832|NCT00147537|460717854|FG009|Phase 1b|Randomized but not treated|0|||
128025833|NCT00147537|460717855|FG010|Phase 1b|Randomized but not treated|0|||
128025834|NCT00147537|460717845|FG000|Phase 2|Death|0|||
128025835|NCT00147537|460717846|FG001|Phase 2|Death|0|||
128025836|NCT00147537|460717847|FG002|Phase 2|Death|0|||
128025837|NCT00147537|460717848|FG003|Phase 2|Death|0|||
127777291|NCT03829241|459813482|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
127777292|NCT03829241|459813483|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
127777293|NCT03829241|459813482|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
127777294|NCT03829241|459813483|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
127777295|NCT03829241|459813482|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
128025838|NCT00147537|460717849|FG004|Phase 2|Death|0|||
128025839|NCT00147537|460717850|FG005|Phase 2|Death|0|||
127566436|NCT02276027|459043758|FG003|Overall Study|Progressive disease|14|||
127566437|NCT02276027|459043755|FG000|Overall Study|Subject/guardian decision|0|||
128025840|NCT00147537|460717851|FG006|Phase 2|Death|0|||
127566438|NCT02276027|459043756|FG001|Overall Study|Subject/guardian decision|1|||
127566439|NCT02276027|459043757|FG002|Overall Study|Subject/guardian decision|0|||
127566440|NCT02276027|459043758|FG003|Overall Study|Subject/guardian decision|3|||
128025841|NCT00147537|460717852|FG007|Phase 2|Death|0|||
127566441|NCT02276027|459043755|FG000|Overall Study|Adverse Event|0|||
127566442|NCT02276027|459043756|FG001|Overall Study|Adverse Event|2|||
127566443|NCT02276027|459043757|FG002|Overall Study|Adverse Event|8|||
127566444|NCT02276027|459043758|FG003|Overall Study|Adverse Event|2|||
127566445|NCT03224598|459043759|FG000|Overall Study|Lost to Follow-up|0|||
127566446|NCT03224598|459043760|FG001|Overall Study|Lost to Follow-up|2|||
127566447|NCT03224598|459043761|FG002|Overall Study|Lost to Follow-up|0|||
127566448|NCT03224598|459043759|FG000|Overall Study|Other|0|||
127566449|NCT03224598|459043760|FG001|Overall Study|Other|1|||
127566450|NCT03224598|459043761|FG002|Overall Study|Other|0|||
127777296|NCT03829241|459813483|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
127777297|NCT03829241|459813482|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
127566451|NCT01527357|459043771|FG000|Overall Study|Death|8|||
127566452|NCT01527357|459043772|FG001|Overall Study|Death|2|||
127566453|NCT01527357|459043771|FG000|Overall Study|Lost to Follow-up|6|||
127566454|NCT01527357|459043772|FG001|Overall Study|Lost to Follow-up|4|||
127566455|NCT01527357|459043771|FG000|Overall Study|Withdrew Consent|1|||
127566456|NCT01527357|459043772|FG001|Overall Study|Withdrew Consent|1|||
127777298|NCT03829241|459813483|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
127777299|NCT03829241|459813482|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
127777300|NCT03829241|459813483|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
127777301|NCT03829241|459813482|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
127777302|NCT03829241|459813483|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
127777303|NCT03829241|459813482|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
127777304|NCT03829241|459813483|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
127777305|NCT03829241|459813482|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
127777306|NCT03829241|459813483|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
127777307|NCT03829241|459813482|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
127777308|NCT03829241|459813483|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
127777309|NCT03829241|459813482|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
127777310|NCT03829241|459813483|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
127777311|NCT03829241|459813482|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
127777312|NCT03829241|459813483|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
127777313|NCT03829241|459813482|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
127777314|NCT03829241|459813483|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
127777315|NCT00698451|459813484|FG000|Overall Study|Adverse Event|22|||
127777316|NCT00698451|459813484|FG000|Overall Study|Physician Decision|2|||
127777317|NCT00698451|459813484|FG000|Overall Study|Protocol Violation|6|||
127777318|NCT00698451|459813484|FG000|Overall Study|Withdrawal by Subject|6|||
127777319|NCT00698451|459813484|FG000|Overall Study|Disease progression|3|||
127777320|NCT02308007|459813496|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
127777321|NCT02308007|459813497|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
127777322|NCT02308007|459813498|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
127777323|NCT02308007|459813496|FG000|Overall Study|Positive for STD at Baseline|7|||
127777324|NCT02308007|459813497|FG001|Overall Study|Positive for STD at Baseline|11|||
127777325|NCT02308007|459813498|FG002|Overall Study|Positive for STD at Baseline|7|||
127777326|NCT02308007|459813496|FG000|Overall Study|Lost to Follow-up|3|||
127777327|NCT02308007|459813497|FG001|Overall Study|Lost to Follow-up|0|||
127777328|NCT02308007|459813498|FG002|Overall Study|Lost to Follow-up|1|||
127777329|NCT00528567|459813503|FG000|Overall Study|Death|4|||
127777330|NCT00528567|459813504|FG001|Overall Study|Death|5|||
127777331|NCT00528567|459813503|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
128025842|NCT00147537|460717853|FG008|Phase 2|Death|0|||
128025843|NCT00147537|460717854|FG009|Phase 2|Death|85|||
128025844|NCT00147537|460717855|FG010|Phase 2|Death|31|||
128025845|NCT00147537|460717845|FG000|Phase 2|Lost to Follow-up|0|||
128025846|NCT00147537|460717846|FG001|Phase 2|Lost to Follow-up|0|||
128025847|NCT00147537|460717847|FG002|Phase 2|Lost to Follow-up|0|||
128025848|NCT00147537|460717848|FG003|Phase 2|Lost to Follow-up|0|||
128025849|NCT00147537|460717849|FG004|Phase 2|Lost to Follow-up|0|||
128025850|NCT00147537|460717850|FG005|Phase 2|Lost to Follow-up|0|||
128025851|NCT00147537|460717851|FG006|Phase 2|Lost to Follow-up|0|||
128025852|NCT00147537|460717852|FG007|Phase 2|Lost to Follow-up|0|||
128025853|NCT00147537|460717853|FG008|Phase 2|Lost to Follow-up|0|||
128025854|NCT00147537|460717854|FG009|Phase 2|Lost to Follow-up|12|||
128025855|NCT00147537|460717855|FG010|Phase 2|Lost to Follow-up|4|||
128025856|NCT00147537|460717845|FG000|Phase 2|Other|0|||
127566457|NCT01527357|459043771|FG000|Overall Study|Non-compliance|0|||
127566458|NCT01527357|459043772|FG001|Overall Study|Non-compliance|1|||
127566459|NCT01527357|459043771|FG000|Overall Study|No Day 29 Visit|0|||
127566460|NCT01527357|459043772|FG001|Overall Study|No Day 29 Visit|1|||
127777332|NCT00528567|459813504|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
127566461|NCT01527357|459043771|FG000|Overall Study|Did Not Receive Treatment|2|||
127566462|NCT01527357|459043772|FG001|Overall Study|Did Not Receive Treatment|0|||
127566463|NCT02446171|459043773|FG000|Overall Study|Withdrawal by Subject|0|||
128025857|NCT00147537|460717846|FG001|Phase 2|Other|0|||
128025858|NCT00147537|460717847|FG002|Phase 2|Other|0|||
127777333|NCT00528567|459813503|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
127777334|NCT00528567|459813504|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
127777335|NCT00528567|459813503|FG000|Overall Study|Violation Criteria at Entry|3|||
127777336|NCT00528567|459813504|FG001|Overall Study|Violation Criteria at Entry|17|||
127777337|NCT00528567|459813503|FG000|Overall Study|Withdrew Consent|59|||
127777338|NCT00528567|459813504|FG001|Overall Study|Withdrew Consent|55|||
127777339|NCT00528567|459813503|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
127777340|NCT00528567|459813504|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
127777341|NCT00528567|459813503|FG000|Overall Study|Failure to Return|1|||
127777342|NCT00528567|459813504|FG001|Overall Study|Failure to Return|4|||
127777343|NCT00528567|459813503|FG000|Overall Study|Other Protocol Violation|5|||
127777344|NCT00528567|459813504|FG001|Overall Study|Other Protocol Violation|21|||
127777345|NCT00528567|459813503|FG000|Overall Study|Administrative/Other|22|||
127777346|NCT00528567|459813504|FG001|Overall Study|Administrative/Other|75|||
127777347|NCT00631189|459813507|FG000|Initial Phase|Protocol Violation|347|||
128025859|NCT00147537|460717848|FG003|Phase 2|Other|0|||
128025860|NCT00147537|460717849|FG004|Phase 2|Other|0|||
127566464|NCT02446171|459043774|FG001|Overall Study|Withdrawal by Subject|0|||
127566465|NCT02446171|459043775|FG002|Overall Study|Withdrawal by Subject|2|||
127566466|NCT02446171|459043776|FG003|Overall Study|Withdrawal by Subject|0|||
127566467|NCT04531462|459043777|FG000|Overall Study|Withdrawal by Subject|3|||
127566468|NCT04531462|459043778|FG001|Overall Study|Withdrawal by Subject|1|||
127566469|NCT04531462|459043777|FG000|Overall Study|Adverse Event|3|||
127566470|NCT04531462|459043778|FG001|Overall Study|Adverse Event|3|||
127566471|NCT00504582|459043779|FG000|Overall Study|Lost to Follow-up|1|||
127566472|NCT00504582|459043780|FG001|Overall Study|Lost to Follow-up|0|||
127566473|NCT00504582|459043781|FG002|Overall Study|Lost to Follow-up|0|||
127566474|NCT02292784|459043784|FG000|Overall Study|Lost to Follow-up|1|||
127566475|NCT02292784|459043785|FG001|Overall Study|Lost to Follow-up|17|||
127566476|NCT02292784|459043786|FG002|Overall Study|Lost to Follow-up|18|||
127566477|NCT02292784|459043784|FG000|Overall Study|Withdrawal by Subject|0|||
127566478|NCT02292784|459043785|FG001|Overall Study|Withdrawal by Subject|3|||
127566479|NCT02292784|459043786|FG002|Overall Study|Withdrawal by Subject|3|||
127566480|NCT00348933|459043787|FG000|Overall Study|Withdrawal by Subject|10|||
127566481|NCT00348933|459043787|FG000|Overall Study|Lost to Follow-up|6|||
127566482|NCT00348933|459043787|FG000|Overall Study|Protocol Violation|2|||
127566483|NCT00348933|459043787|FG000|Overall Study|Adverse Event|7|||
127566484|NCT01264081|459043788|FG000|Participants Screened|Screening failures|30|||
127566485|NCT01264081|459043788|FG000|Started Treatment|Withdrawal by Subject|1|||
127566486|NCT01264081|459043788|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
127566487|NCT01489111|459043789|FG000|Overall Study|Withdrawal criterion|1|||
127566488|NCT00134784|459043790|FG000|Overall Study|Withdrawal by Subject|2|||
127566489|NCT00134784|459043791|FG001|Overall Study|Withdrawal by Subject|2|||
127566490|NCT00134784|459043792|FG002|Overall Study|Withdrawal by Subject|2|||
127566491|NCT00134784|459043793|FG003|Overall Study|Withdrawal by Subject|1|||
127566492|NCT03811093|459043795|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
127566493|NCT03811093|459043796|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
127566494|NCT03811093|459043795|FG000|Overall Study|Unable to measure body fat percentage|2|||
127566495|NCT03811093|459043796|FG001|Overall Study|Unable to measure body fat percentage|0|||
127566496|NCT00464490|459043797|FG000|Overall Study|Physician Decision|11|||
127566497|NCT00464490|459043798|FG001|Overall Study|Physician Decision|11|||
127566498|NCT03188042|459043799|FG000|Overall Study|Withdrawal by Subject|1|||
127566499|NCT03188042|459043800|FG001|Overall Study|Withdrawal by Subject|1|||
127566500|NCT00779259|459043804|FG000|Quinine Alone|Adverse Event|2|||
127566501|NCT01534182|459043807|FG000|Overall Study|Administrative problems|1|||
127566502|NCT01534182|459043808|FG001|Overall Study|Administrative problems|0|||
127566503|NCT01534182|459043807|FG000|Overall Study|Withdrawal by Subject|4|||
127566504|NCT01534182|459043808|FG001|Overall Study|Withdrawal by Subject|7|||
127566505|NCT01534182|459043807|FG000|Overall Study|Adverse Event|7|||
127777348|NCT00631189|459813508|FG001|Initial Phase|Protocol Violation|0|||
127777349|NCT00631189|459813509|FG002|Initial Phase|Protocol Violation|0|||
127777350|NCT00631189|459813510|FG003|Initial Phase|Protocol Violation|0|||
127566506|NCT01534182|459043808|FG001|Overall Study|Adverse Event|3|||
127566507|NCT01944839|459043809|FG000|Overall Study|Physician Decision|2|||
127566508|NCT01944839|459043810|FG001|Overall Study|Physician Decision|2|||
127566509|NCT01944839|459043809|FG000|Overall Study|Protocol Violation|0|||
127566510|NCT01944839|459043810|FG001|Overall Study|Protocol Violation|1|||
127566511|NCT01944839|459043809|FG000|Overall Study|Adverse Event|10|||
127566512|NCT01944839|459043810|FG001|Overall Study|Adverse Event|5|||
127566513|NCT01944839|459043809|FG000|Overall Study|Withdrawal by Subject|9|||
127566514|NCT01944839|459043810|FG001|Overall Study|Withdrawal by Subject|17|||
127777351|NCT00631189|459813507|FG000|Initial Phase|Withdrawal by Subject|4|||
127566515|NCT01944839|459043809|FG000|Overall Study|Lost to Follow-up|1|||
127777352|NCT00631189|459813508|FG001|Initial Phase|Withdrawal by Subject|0|||
127881034|NCT02575807|460186104|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
128025861|NCT00147537|460717850|FG005|Phase 2|Other|0|||
127777353|NCT00631189|459813509|FG002|Initial Phase|Withdrawal by Subject|0|||
128025862|NCT00147537|460717851|FG006|Phase 2|Other|0|||
128025863|NCT00147537|460717852|FG007|Phase 2|Other|0|||
128025864|NCT00147537|460717853|FG008|Phase 2|Other|0|||
128025865|NCT00147537|460717854|FG009|Phase 2|Other|47|||
128025866|NCT00147537|460717855|FG010|Phase 2|Other|12|||
128025867|NCT00147537|460717845|FG000|Phase 2|Withdrawal by Subject|0|||
128025868|NCT00147537|460717846|FG001|Phase 2|Withdrawal by Subject|0|||
128025869|NCT00147537|460717847|FG002|Phase 2|Withdrawal by Subject|0|||
128025870|NCT00147537|460717848|FG003|Phase 2|Withdrawal by Subject|0|||
128025871|NCT00147537|460717849|FG004|Phase 2|Withdrawal by Subject|0|||
128025872|NCT00147537|460717850|FG005|Phase 2|Withdrawal by Subject|0|||
128025873|NCT00147537|460717851|FG006|Phase 2|Withdrawal by Subject|0|||
128025874|NCT00147537|460717852|FG007|Phase 2|Withdrawal by Subject|0|||
128025875|NCT00147537|460717853|FG008|Phase 2|Withdrawal by Subject|0|||
128025876|NCT00147537|460717854|FG009|Phase 2|Withdrawal by Subject|16|||
128025877|NCT00147537|460717855|FG010|Phase 2|Withdrawal by Subject|4|||
128025878|NCT00147537|460717845|FG000|Phase 2|Randomized but not treated|0|||
128025879|NCT00147537|460717846|FG001|Phase 2|Randomized but not treated|0|||
128025880|NCT00147537|460717847|FG002|Phase 2|Randomized but not treated|0|||
128025881|NCT00147537|460717848|FG003|Phase 2|Randomized but not treated|0|||
128025882|NCT00147537|460717849|FG004|Phase 2|Randomized but not treated|0|||
128025883|NCT00147537|460717850|FG005|Phase 2|Randomized but not treated|0|||
128025884|NCT00147537|460717851|FG006|Phase 2|Randomized but not treated|0|||
128025885|NCT00147537|460717852|FG007|Phase 2|Randomized but not treated|0|||
128025886|NCT00147537|460717853|FG008|Phase 2|Randomized but not treated|0|||
128025887|NCT00147537|460717854|FG009|Phase 2|Randomized but not treated|1|||
127566516|NCT01944839|459043810|FG001|Overall Study|Lost to Follow-up|0|||
127566517|NCT01944839|459043809|FG000|Overall Study|Subject non-compliance|0|||
127566518|NCT01944839|459043810|FG001|Overall Study|Subject non-compliance|3|||
127566519|NCT00924170|459043811|FG000|Overall Study|Refused further treatment|0|||
127566520|NCT00924170|459043812|FG001|Overall Study|Refused further treatment|1|||
127566521|NCT00924170|459043811|FG000|Overall Study|Physician Decision|0|||
127566522|NCT00924170|459043812|FG001|Overall Study|Physician Decision|1|||
127566523|NCT00924170|459043811|FG000|Overall Study|Progressive disease|3|||
127566524|NCT00924170|459043812|FG001|Overall Study|Progressive disease|6|||
127566525|NCT00924170|459043811|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
127566526|NCT00924170|459043812|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
127566527|NCT00924170|459043811|FG000|Overall Study|Death|1|||
127689039|NCT04992390|459486463|FG001|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|3|||
127689040|NCT04992390|459486464|FG002|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
127689041|NCT02807779|459486465|FG000|Overall Study|Lost to Follow-up|1|||
127689042|NCT02807779|459486466|FG001|Overall Study|Lost to Follow-up|0|||
127689043|NCT02807779|459486467|FG002|Overall Study|Lost to Follow-up|0|||
127689044|NCT02807779|459486465|FG000|Overall Study|Physician Decision|2|||
127689045|NCT02807779|459486466|FG001|Overall Study|Physician Decision|0|||
127689046|NCT02807779|459486467|FG002|Overall Study|Physician Decision|1|||
127689047|NCT02807779|459486465|FG000|Overall Study|Death|1|||
127689048|NCT02807779|459486466|FG001|Overall Study|Death|1|||
127689049|NCT02807779|459486467|FG002|Overall Study|Death|0|||
127689050|NCT04939246|459486468|FG000|After Treatment|Death|4|||
127689051|NCT04939246|459486468|FG000|After Treatment|Lost to Follow-up|1|||
127689052|NCT04939246|459486468|FG000|After Treatment|Discharged to hospice|2|||
127689053|NCT04994509|459486469|FG000|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1909|||
127689054|NCT04994509|459486470|FG001|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1910|||
127689055|NCT04994509|459486471|FG002|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|937|||
127689056|NCT04994509|459486469|FG000|Overall Study|Withdrew Consent|73|||
127689057|NCT04994509|459486470|FG001|Overall Study|Withdrew Consent|72|||
127689058|NCT04994509|459486471|FG002|Overall Study|Withdrew Consent|46|||
127689059|NCT04994509|459486469|FG000|Overall Study|Lost to Follow-up|39|||
127689060|NCT04994509|459486470|FG001|Overall Study|Lost to Follow-up|36|||
127689061|NCT04994509|459486471|FG002|Overall Study|Lost to Follow-up|26|||
128025888|NCT00147537|460717855|FG010|Phase 2|Randomized but not treated|1|||
128025889|NCT00345592|460717856|FG000|Overall Study|Death|14|||
128025890|NCT00345592|460717857|FG001|Overall Study|Death|16|||
128025891|NCT00345592|460717856|FG000|Overall Study|Withdrawal by Subject|11|||
128025892|NCT00345592|460717857|FG001|Overall Study|Withdrawal by Subject|8|||
128025893|NCT02006654|460717859|FG000|Overall Study|Withdrawal before treatment|4|||
127566528|NCT00924170|459043812|FG001|Overall Study|Death|0|||
127689062|NCT04994509|459486469|FG000|Overall Study|HIV-1 Infection|4|||
127689063|NCT04994509|459486470|FG001|Overall Study|HIV-1 Infection|20|||
127566529|NCT04098224|459043814|FG000|Overall Study|Adverse Event|1|||
127689064|NCT04994509|459486471|FG002|Overall Study|HIV-1 Infection|12|||
127689065|NCT04994509|459486469|FG000|Overall Study|Investigator's Discretion|9|||
128025894|NCT02006654|460717860|FG001|Overall Study|Withdrawal before treatment|2|||
128025895|NCT02006654|460717859|FG000|Overall Study|Adverse Event|16|||
128025896|NCT02006654|460717860|FG001|Overall Study|Adverse Event|17|||
128025897|NCT02006654|460717859|FG000|Overall Study|Death|1|||
128025898|NCT02006654|460717860|FG001|Overall Study|Death|0|||
128025899|NCT02006654|460717859|FG000|Overall Study|Withdrawal by Subject|14|||
128025900|NCT02006654|460717860|FG001|Overall Study|Withdrawal by Subject|12|||
128025901|NCT02006654|460717859|FG000|Overall Study|Protocol Violation|5|||
128025902|NCT02006654|460717860|FG001|Overall Study|Protocol Violation|8|||
128025903|NCT02006654|460717859|FG000|Overall Study|Lost to Follow-up|1|||
128025904|NCT02006654|460717860|FG001|Overall Study|Lost to Follow-up|0|||
128025905|NCT02006654|460717859|FG000|Overall Study|patient's will|2|||
128025906|NCT02006654|460717860|FG001|Overall Study|patient's will|1|||
128025907|NCT02006654|460717859|FG000|Overall Study|insufficient compliance|1|||
128025908|NCT02006654|460717860|FG001|Overall Study|insufficient compliance|0|||
128025909|NCT02006654|460717859|FG000|Overall Study|worsening cognitive condition|0|||
128025910|NCT02006654|460717860|FG001|Overall Study|worsening cognitive condition|1|||
128025911|NCT02006654|460717859|FG000|Overall Study|faecal incontinence|0|||
128025912|NCT02006654|460717860|FG001|Overall Study|faecal incontinence|1|||
128025913|NCT02006654|460717859|FG000|Overall Study|mood disorder|0|||
128025914|NCT02006654|460717860|FG001|Overall Study|mood disorder|1|||
128025915|NCT02006654|460717859|FG000|Overall Study|disallowed medication|1|||
128025916|NCT02006654|460717860|FG001|Overall Study|disallowed medication|0|||
128025917|NCT02006654|460717859|FG000|Overall Study|moving out of state|0|||
128025918|NCT02006654|460717860|FG001|Overall Study|moving out of state|1|||
128025919|NCT00478140|460717861|FG000|Overall Study|Clinical Disease Progression|1|||
128025920|NCT03438656|460717864|FG000|Overall Study|Lost to Follow-up|2|||
128025921|NCT02489045|460717868|FG000|Overall Study|unable to collect usable data|53|||
128025922|NCT02489045|460717868|FG000|Follow-up|Lost to Follow-up|10|||
128025923|NCT04401293|460717869|FG000|Overall Study|Withdrawal by Subject|1|||
128025924|NCT04401293|460717870|FG001|Overall Study|Withdrawal by Subject|3|||
128025925|NCT03111732|460717871|FG000|Overall Study|Enrolled in different study|1|||
128025926|NCT03111732|460717871|FG000|Overall Study|Progressive disease|3|||
128025927|NCT03111732|460717871|FG000|Overall Study|Withdrawal by Subject|1|||
128025928|NCT01108055|460717872|FG000|Overall Study|Ineligible|11|||
128025929|NCT01108055|460717872|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
128025930|NCT03339453|460717875|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
128025931|NCT03339453|460717876|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
128025932|NCT01027754|460720065|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
128025933|NCT01027754|460720066|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
128025934|NCT01027754|460720065|FG000|Overall Study|Withdrawal by Subject|0|||
128025935|NCT01027754|460720066|FG001|Overall Study|Withdrawal by Subject|5|||
128025936|NCT00326495|460720067|FG000|Overall Study|Switched to alternative treatment|1|||
128025937|NCT00326495|460720067|FG000|Overall Study|Disease progression before treatment|1|||
128025938|NCT00326495|460720067|FG000|Overall Study|Refused further treatment|2|||
128025939|NCT00326495|460720067|FG000|Overall Study|Subject off study before assessment|1|||
128025940|NCT01654250|460720068|FG000|Overall Study|Lost to Follow-up|1|||
128025941|NCT01654250|460720069|FG001|Overall Study|Lost to Follow-up|0|||
128025942|NCT01862029|460720070|FG000|Overall Study|Physician Decision|1|||
128025943|NCT00504556|460720072|FG000|Overall Study|Adverse Event|11|||
128025944|NCT00504556|460720073|FG001|Overall Study|Adverse Event|11|||
128025945|NCT00504556|460720074|FG002|Overall Study|Adverse Event|14|||
128025946|NCT00504556|460720075|FG003|Overall Study|Adverse Event|13|||
128025947|NCT00504556|460720076|FG004|Overall Study|Adverse Event|5|||
128025948|NCT00504556|460720072|FG000|Overall Study|Death|3|||
128025949|NCT00504556|460720073|FG001|Overall Study|Death|3|||
128025950|NCT00504556|460720074|FG002|Overall Study|Death|1|||
128025951|NCT00504556|460720075|FG003|Overall Study|Death|0|||
128025952|NCT00504556|460720076|FG004|Overall Study|Death|2|||
128025953|NCT00504556|460720072|FG000|Overall Study|Protocol Violation|1|||
128025954|NCT00504556|460720073|FG001|Overall Study|Protocol Violation|3|||
127689066|NCT04994509|459486470|FG001|Overall Study|Investigator's Discretion|8|||
128025955|NCT00504556|460720074|FG002|Overall Study|Protocol Violation|2|||
128025956|NCT00504556|460720075|FG003|Overall Study|Protocol Violation|1|||
128025957|NCT00504556|460720076|FG004|Overall Study|Protocol Violation|2|||
128025958|NCT00504556|460720072|FG000|Overall Study|Lost to Follow-up|0|||
128025959|NCT00504556|460720073|FG001|Overall Study|Lost to Follow-up|0|||
128025960|NCT00504556|460720074|FG002|Overall Study|Lost to Follow-up|1|||
128025961|NCT00504556|460720075|FG003|Overall Study|Lost to Follow-up|1|||
128025962|NCT00504556|460720076|FG004|Overall Study|Lost to Follow-up|1|||
128025963|NCT00504556|460720072|FG000|Overall Study|Withdrawal by Subject|16|||
128025964|NCT00504556|460720073|FG001|Overall Study|Withdrawal by Subject|16|||
128025965|NCT00504556|460720074|FG002|Overall Study|Withdrawal by Subject|7|||
128025966|NCT00504556|460720075|FG003|Overall Study|Withdrawal by Subject|8|||
128025967|NCT00504556|460720076|FG004|Overall Study|Withdrawal by Subject|12|||
128025968|NCT00504556|460720072|FG000|Overall Study|administrative reasons|0|||
128025969|NCT00504556|460720073|FG001|Overall Study|administrative reasons|2|||
128025970|NCT00504556|460720074|FG002|Overall Study|administrative reasons|2|||
128025971|NCT00504556|460720075|FG003|Overall Study|administrative reasons|1|||
128025972|NCT00504556|460720076|FG004|Overall Study|administrative reasons|2|||
128025973|NCT00504556|460720072|FG000|Overall Study|did not meet entry criteria|2|||
128025974|NCT00504556|460720073|FG001|Overall Study|did not meet entry criteria|0|||
128025975|NCT00504556|460720074|FG002|Overall Study|did not meet entry criteria|1|||
128025976|NCT00504556|460720075|FG003|Overall Study|did not meet entry criteria|1|||
128025977|NCT00504556|460720076|FG004|Overall Study|did not meet entry criteria|0|||
128025978|NCT00504556|460720072|FG000|Overall Study|data monitor committee decision|0|||
128025979|NCT00504556|460720073|FG001|Overall Study|data monitor committee decision|0|||
128025980|NCT00504556|460720074|FG002|Overall Study|data monitor committee decision|0|||
128025981|NCT00504556|460720075|FG003|Overall Study|data monitor committee decision|100|||
128025982|NCT00504556|460720076|FG004|Overall Study|data monitor committee decision|0|||
128025983|NCT00504556|460720072|FG000|Overall Study|Other|2|||
128025984|NCT00504556|460720073|FG001|Overall Study|Other|2|||
128025985|NCT00504556|460720074|FG002|Overall Study|Other|2|||
128025986|NCT00504556|460720075|FG003|Overall Study|Other|3|||
128025987|NCT00504556|460720076|FG004|Overall Study|Other|0|||
128025988|NCT00504556|460720072|FG000|Overall Study|not in safety analysis set|0|||
128025989|NCT00504556|460720073|FG001|Overall Study|not in safety analysis set|1|||
128025990|NCT00504556|460720074|FG002|Overall Study|not in safety analysis set|1|||
128025991|NCT00504556|460720075|FG003|Overall Study|not in safety analysis set|0|||
128025992|NCT00504556|460720076|FG004|Overall Study|not in safety analysis set|1|||
128025993|NCT03280615|460720077|FG000|Overall Study|Lost to Follow-up|1|||
128025994|NCT03280615|460720078|FG001|Overall Study|Lost to Follow-up|2|||
128025995|NCT03280615|460720077|FG000|Overall Study|Adverse Event|1|||
128025996|NCT03280615|460720078|FG001|Overall Study|Adverse Event|1|||
128025997|NCT03280615|460720077|FG000|Overall Study|Withdrawal by Subject|2|||
127566530|NCT04098224|459043815|FG001|Overall Study|Adverse Event|0|||
127566531|NCT04098224|459043814|FG000|Overall Study|Physician Decision|1|||
127566532|NCT04098224|459043815|FG001|Overall Study|Physician Decision|0|||
127566533|NCT04098224|459043814|FG000|Overall Study|Patient not required enteral feeding|1|||
127566534|NCT04098224|459043815|FG001|Overall Study|Patient not required enteral feeding|0|||
127566535|NCT04098224|459043814|FG000|Overall Study|Patient failure nasogastric tube|1|||
127566536|NCT04098224|459043815|FG001|Overall Study|Patient failure nasogastric tube|0|||
128025998|NCT03280615|460720078|FG001|Overall Study|Withdrawal by Subject|2|||
128025999|NCT01386645|460720081|FG000|Overall Study|Physician Decision|0|||
128026000|NCT01386645|460720082|FG001|Overall Study|Physician Decision|0|||
128026001|NCT01386645|460720083|FG002|Overall Study|Physician Decision|1|||
128026002|NCT01386645|460720081|FG000|Overall Study|Withdrawal by Subject|0|||
128026003|NCT01386645|460720082|FG001|Overall Study|Withdrawal by Subject|1|||
127566537|NCT04098224|459043814|FG000|Overall Study|Patient early extubation|1|||
127689067|NCT04994509|459486471|FG002|Overall Study|Investigator's Discretion|11|||
127689068|NCT04994509|459486469|FG000|Overall Study|Randomized but Never Treated|10|||
127689069|NCT04994509|459486470|FG001|Overall Study|Randomized but Never Treated|10|||
127689070|NCT04994509|459486471|FG002|Overall Study|Randomized but Never Treated|3|||
127689071|NCT04994509|459486469|FG000|Overall Study|Pregnancy|5|||
127689072|NCT04994509|459486470|FG001|Overall Study|Pregnancy|5|||
127689073|NCT04994509|459486471|FG002|Overall Study|Pregnancy|0|||
127689074|NCT04994509|459486469|FG000|Overall Study|Death|0|||
127689075|NCT04994509|459486470|FG001|Overall Study|Death|5|||
127689076|NCT04994509|459486471|FG002|Overall Study|Death|0|||
127689077|NCT04994509|459486469|FG000|Overall Study|Adverse Event|2|||
127689078|NCT04994509|459486470|FG001|Overall Study|Adverse Event|1|||
127689079|NCT04994509|459486471|FG002|Overall Study|Adverse Event|0|||
127689080|NCT04994509|459486469|FG000|Overall Study|Non-compliance With Study Drug|1|||
127689081|NCT04994509|459486470|FG001|Overall Study|Non-compliance With Study Drug|1|||
127689082|NCT04994509|459486471|FG002|Overall Study|Non-compliance With Study Drug|1|||
127689083|NCT04994509|459486469|FG000|Overall Study|Withdrew Assent|3|||
127689084|NCT04994509|459486470|FG001|Overall Study|Withdrew Assent|0|||
127689085|NCT04994509|459486471|FG002|Overall Study|Withdrew Assent|0|||
127689086|NCT04994509|459486469|FG000|Overall Study|Protocol Violation|1|||
127689087|NCT04994509|459486470|FG001|Overall Study|Protocol Violation|0|||
127689088|NCT04994509|459486471|FG002|Overall Study|Protocol Violation|0|||
128026004|NCT01386645|460720083|FG002|Overall Study|Withdrawal by Subject|1|||
127689089|NCT05505045|459488158|FG000|Overall Study|Withdrawal by Subject|2|||
127689090|NCT05505045|459488159|FG001|Overall Study|Withdrawal by Subject|1|||
127689091|NCT01643070|459488160|FG000|Overall Study|Withdrawal by Subject|3|||
127689092|NCT01643070|459488161|FG001|Overall Study|Withdrawal by Subject|1|||
127689093|NCT01643070|459488160|FG000|Overall Study|Death|1|||
127689094|NCT01643070|459488161|FG001|Overall Study|Death|0|||
128026005|NCT00432991|460720084|FG000|Overall Study|Protocol Violation|7|||
127689095|NCT01643070|459488160|FG000|Overall Study|Pregressive disease|0|||
127689096|NCT01643070|459488161|FG001|Overall Study|Pregressive disease|2|||
128026006|NCT00432991|460720085|FG001|Overall Study|Protocol Violation|12|||
128026007|NCT03142451|460720095|FG000|Overall Study|Adverse Event|5|||
128026008|NCT03142451|460720096|FG001|Overall Study|Adverse Event|2|||
128026009|NCT03142451|460720095|FG000|Overall Study|Lost to Follow-up|25|||
128026010|NCT03142451|460720096|FG001|Overall Study|Lost to Follow-up|8|||
128026011|NCT03142451|460720095|FG000|Overall Study|Participant request|24|||
127566538|NCT04098224|459043815|FG001|Overall Study|Patient early extubation|3|||
127566539|NCT02217527|459043816|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
127566540|NCT02217527|459043817|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
127566541|NCT02217527|459043816|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
127566542|NCT02217527|459043817|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
127566543|NCT01203852|459043821|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
127566544|NCT01203852|459043821|FG000|Washout 2 Weeks|Physician Decision|46|||
127566545|NCT00247611|459043827|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
127566546|NCT00247611|459043828|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
127566547|NCT00247611|459043827|FG000|Baselined|Completed baseline only|9|||
127566548|NCT00247611|459043828|FG001|Baselined|Completed baseline only|8|||
127566549|NCT01587898|459043829|FG000|Overall Study|Adverse Event|1|||
127566550|NCT01587898|459043830|FG001|Overall Study|Adverse Event|1|||
127566551|NCT01587898|459043831|FG002|Overall Study|Adverse Event|0|||
127566552|NCT01587898|459043832|FG003|Overall Study|Adverse Event|0|||
127566553|NCT01587898|459043829|FG000|Overall Study|Protocol Violation|0|||
127566554|NCT01587898|459043830|FG001|Overall Study|Protocol Violation|2|||
127566555|NCT01587898|459043831|FG002|Overall Study|Protocol Violation|1|||
127566556|NCT01587898|459043832|FG003|Overall Study|Protocol Violation|1|||
127566557|NCT01587898|459043829|FG000|Overall Study|Lost to Follow-up|0|||
127566558|NCT01587898|459043830|FG001|Overall Study|Lost to Follow-up|0|||
127566559|NCT01587898|459043831|FG002|Overall Study|Lost to Follow-up|0|||
127566560|NCT01587898|459043832|FG003|Overall Study|Lost to Follow-up|1|||
127566561|NCT01587898|459043829|FG000|Overall Study|Withdrawal by Subject|2|||
127566562|NCT01587898|459043830|FG001|Overall Study|Withdrawal by Subject|1|||
127566563|NCT01587898|459043831|FG002|Overall Study|Withdrawal by Subject|0|||
127566564|NCT01587898|459043832|FG003|Overall Study|Withdrawal by Subject|0|||
127566565|NCT01587898|459043829|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
127566566|NCT01587898|459043830|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
127566567|NCT01587898|459043831|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
127566568|NCT01587898|459043832|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
127566569|NCT00502203|459043833|FG000|Overall Study|Inevaluable|1|||
127566570|NCT01903252|459043836|FG000|Double-Blind Induction|Adverse Event|20|||
127566571|NCT01903252|459043837|FG001|Double-Blind Induction|Adverse Event|18|||
127566572|NCT01903252|459043838|FG002|Double-Blind Induction|Adverse Event|0|||
127566573|NCT01903252|459043839|FG003|Double-Blind Induction|Adverse Event|0|||
127566574|NCT01903252|459043840|FG004|Double-Blind Induction|Adverse Event|0|||
127566575|NCT01903252|459043841|FG005|Double-Blind Induction|Adverse Event|0|||
127566576|NCT01903252|459043836|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
127566577|NCT01903252|459043837|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
127566578|NCT01903252|459043838|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
127566579|NCT01903252|459043839|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
127566580|NCT01903252|459043840|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
127566581|NCT01903252|459043841|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
127566582|NCT01903252|459043836|FG000|Double-Blind Induction|Physician Decision|2|||
127566583|NCT01903252|459043837|FG001|Double-Blind Induction|Physician Decision|3|||
127689097|NCT04278586|459488162|FG000|Overall Study|Withdrawal by Subject|13|||
127689098|NCT04278586|459488163|FG001|Overall Study|Withdrawal by Subject|6|||
127689099|NCT04278586|459488162|FG000|Overall Study|Lost to Follow-up|37|||
127689100|NCT04278586|459488163|FG001|Overall Study|Lost to Follow-up|24|||
127689101|NCT04038957|459488171|FG000|Overall Study|Withdrawal by Subject|1|||
127689102|NCT04038957|459488171|FG000|Overall Study|SUBJECT WAS WITHDRAWN DUE TO SAFETY REASON|1|||
127689103|NCT01998984|459488176|FG000|Overall Study|Adverse Event|0|||
127689104|NCT01998984|459488177|FG001|Overall Study|Adverse Event|0|||
127689105|NCT01998984|459488178|FG002|Overall Study|Adverse Event|0|||
127689106|NCT01998984|459488179|FG003|Overall Study|Adverse Event|1|||
127689107|NCT01998984|459488176|FG000|Overall Study|Lost to Follow-up|0|||
127689108|NCT01998984|459488177|FG001|Overall Study|Lost to Follow-up|1|||
127689109|NCT01998984|459488178|FG002|Overall Study|Lost to Follow-up|0|||
127689110|NCT01998984|459488179|FG003|Overall Study|Lost to Follow-up|1|||
127689111|NCT01998984|459488176|FG000|Overall Study|Withdrawal by Subject|0|||
127689112|NCT01998984|459488177|FG001|Overall Study|Withdrawal by Subject|0|||
127689113|NCT01998984|459488178|FG002|Overall Study|Withdrawal by Subject|1|||
127689114|NCT01998984|459488179|FG003|Overall Study|Withdrawal by Subject|0|||
127689115|NCT01998984|459488176|FG000|Overall Study|Other|0|||
127689116|NCT01998984|459488177|FG001|Overall Study|Other|0|||
127689117|NCT01998984|459488178|FG002|Overall Study|Other|0|||
127689118|NCT01998984|459488179|FG003|Overall Study|Other|1|||
127689119|NCT01843374|459488181|FG000|Overall Study|Death|155|||
127566584|NCT01903252|459043838|FG002|Double-Blind Induction|Physician Decision|0|||
127566585|NCT01903252|459043839|FG003|Double-Blind Induction|Physician Decision|0|||
127566586|NCT01903252|459043840|FG004|Double-Blind Induction|Physician Decision|0|||
127566587|NCT01903252|459043841|FG005|Double-Blind Induction|Physician Decision|0|||
128026012|NCT03142451|460720096|FG001|Overall Study|Participant request|12|||
127777354|NCT00631189|459813510|FG003|Initial Phase|Withdrawal by Subject|0|||
127777355|NCT00631189|459813507|FG000|Treatment Phase|Withdrawal by Subject|0|||
127777356|NCT00631189|459813508|FG001|Treatment Phase|Withdrawal by Subject|2|||
127777357|NCT00631189|459813509|FG002|Treatment Phase|Withdrawal by Subject|1|||
127777358|NCT00631189|459813510|FG003|Treatment Phase|Withdrawal by Subject|1|||
127777359|NCT00631189|459813507|FG000|Treatment Phase|Protocol Violation|0|||
127777360|NCT00631189|459813508|FG001|Treatment Phase|Protocol Violation|1|||
127777361|NCT00631189|459813509|FG002|Treatment Phase|Protocol Violation|6|||
127777362|NCT00631189|459813510|FG003|Treatment Phase|Protocol Violation|2|||
127777363|NCT00631189|459813507|FG000|Treatment Phase|Adverse Event|0|||
127777364|NCT00631189|459813508|FG001|Treatment Phase|Adverse Event|3|||
127777365|NCT00631189|459813509|FG002|Treatment Phase|Adverse Event|2|||
127777366|NCT00631189|459813510|FG003|Treatment Phase|Adverse Event|4|||
127777367|NCT00631189|459813507|FG000|Treatment Phase|Lost to Follow-up|0|||
127777368|NCT00631189|459813508|FG001|Treatment Phase|Lost to Follow-up|1|||
127777369|NCT00631189|459813509|FG002|Treatment Phase|Lost to Follow-up|0|||
127777370|NCT00631189|459813510|FG003|Treatment Phase|Lost to Follow-up|0|||
127777371|NCT00631189|459813507|FG000|Treatment Phase|Pregnancy|0|||
127777372|NCT00631189|459813508|FG001|Treatment Phase|Pregnancy|0|||
127777373|NCT00631189|459813509|FG002|Treatment Phase|Pregnancy|1|||
127777374|NCT00631189|459813510|FG003|Treatment Phase|Pregnancy|0|||
127777375|NCT00631189|459813507|FG000|Treatment Phase|patient did not take pravastatin|0|||
127777376|NCT00631189|459813508|FG001|Treatment Phase|patient did not take pravastatin|0|||
127777377|NCT00631189|459813509|FG002|Treatment Phase|patient did not take pravastatin|1|||
127777378|NCT00631189|459813510|FG003|Treatment Phase|patient did not take pravastatin|0|||
127777379|NCT00974090|459813515|FG000|Period 1: Double Blind Period|Adverse Event|2|||
127777380|NCT00974090|459813516|FG001|Period 1: Double Blind Period|Adverse Event|1|||
127777381|NCT00974090|459813515|FG000|Period 1: Double Blind Period|Physician Decision|1|||
127777382|NCT00974090|459813516|FG001|Period 1: Double Blind Period|Physician Decision|0|||
127777383|NCT00974090|459813515|FG000|Period 2: Open-label Period|Adverse Event|4|||
127777384|NCT00974090|459813516|FG001|Period 2: Open-label Period|Adverse Event|6|||
127777385|NCT00974090|459813515|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
127777386|NCT00974090|459813516|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
127777387|NCT00974090|459813515|FG000|Period 2: Open-label Period|Physician Decision|0|||
127777388|NCT00974090|459813516|FG001|Period 2: Open-label Period|Physician Decision|3|||
127777389|NCT00974090|459813515|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
127777390|NCT00974090|459813516|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
127777391|NCT03189862|459813517|FG000|Overall Study|Withdrawal by Subject|1|||
127777392|NCT03189862|459813518|FG001|Overall Study|Withdrawal by Subject|0|||
127777393|NCT03189862|459813517|FG000|Overall Study|Lost to Follow-up|54|||
127777394|NCT03189862|459813518|FG001|Overall Study|Lost to Follow-up|62|||
127777395|NCT00056862|459813519|FG000|Overall Study|Protocol Violation|1|||
127777396|NCT00056862|459813520|FG001|Overall Study|Protocol Violation|0|||
127777397|NCT01829360|459813521|FG000|Overall Study|Protocol Violation|0|||
127777398|NCT01829360|459813522|FG001|Overall Study|Protocol Violation|0|||
127777399|NCT01829360|459813523|FG002|Overall Study|Protocol Violation|1|||
127777400|NCT01829360|459813524|FG003|Overall Study|Protocol Violation|0|||
128026013|NCT03142451|460720095|FG000|Overall Study|Protocol Violation|3|||
128026014|NCT03142451|460720096|FG001|Overall Study|Protocol Violation|1|||
128026015|NCT03142451|460720095|FG000|Overall Study|Other|1|||
127689120|NCT01843374|459488182|FG001|Overall Study|Death|313|||
127689121|NCT01843374|459488181|FG000|Overall Study|Withdrawal by Subject|14|||
127689122|NCT01843374|459488182|FG001|Overall Study|Withdrawal by Subject|20|||
127689123|NCT01843374|459488181|FG000|Overall Study|Withdrawing due to Other reason|20|||
127689124|NCT01843374|459488182|FG001|Overall Study|Withdrawing due to Other reason|46|||
127689125|NCT03397108|459488183|FG000|Overall Study|Lost to Follow-up|15|||
127689126|NCT03397108|459488184|FG001|Overall Study|Lost to Follow-up|0|||
127689127|NCT03397108|459488183|FG000|Overall Study|Insufficient milk production|3|||
127689128|NCT03397108|459488184|FG001|Overall Study|Insufficient milk production|2|||
127689129|NCT03397108|459488183|FG000|Overall Study|Withdrawal by Subject|2|||
127689130|NCT03397108|459488184|FG001|Overall Study|Withdrawal by Subject|0|||
127689131|NCT03624972|459488185|FG000|Overall Study|Lost to Follow-up|2|||
127689132|NCT03624972|459488186|FG001|Overall Study|Lost to Follow-up|0|||
127689133|NCT03624972|459488187|FG002|Overall Study|Lost to Follow-up|0|||
127689134|NCT03624972|459488185|FG000|Overall Study|Withdrawal by Subject|0|||
127689135|NCT03624972|459488186|FG001|Overall Study|Withdrawal by Subject|2|||
127689136|NCT03624972|459488187|FG002|Overall Study|Withdrawal by Subject|0|||
127689137|NCT03456076|459488188|FG000|Overall Study|Withdrawal by Subject|5|||
127689138|NCT03456076|459488189|FG001|Overall Study|Withdrawal by Subject|9|||
127689139|NCT03456076|459488188|FG000|Overall Study|Protocol deviation|0|||
127689140|NCT03456076|459488189|FG001|Overall Study|Protocol deviation|1|||
127689141|NCT03456076|459488188|FG000|Overall Study|Lost to Follow-up|0|||
127689142|NCT03456076|459488189|FG001|Overall Study|Lost to Follow-up|1|||
127777401|NCT03838198|459813529|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
127777402|NCT03838198|459813530|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
127777403|NCT03838198|459813531|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
127777404|NCT03838198|459813532|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
127777405|NCT03838198|459813529|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
127777406|NCT03838198|459813530|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
127689143|NCT03456076|459488188|FG000|Overall Study|Death|2|||
127689144|NCT03456076|459488189|FG001|Overall Study|Death|5|||
127689145|NCT03456076|459488188|FG000|Overall Study|Study ongoing|123|||
127689146|NCT03456076|459488189|FG001|Overall Study|Study ongoing|111|||
127689147|NCT03990649|459488190|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
127689148|NCT03990649|459488191|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
127689149|NCT03990649|459488192|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
127689150|NCT03990649|459488190|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
127689151|NCT03990649|459488191|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
127689152|NCT03990649|459488192|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
127689153|NCT03990649|459488190|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
127689154|NCT03990649|459488191|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
127689155|NCT03990649|459488192|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
127689156|NCT03990649|459488190|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
127689157|NCT03990649|459488191|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
127689158|NCT03990649|459488192|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
127689159|NCT03990649|459488190|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
127689160|NCT03990649|459488191|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
127689161|NCT03990649|459488192|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
127689162|NCT03990649|459488190|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
127689163|NCT03990649|459488191|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
127689164|NCT03990649|459488192|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
127689165|NCT03990649|459488190|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
127689166|NCT03990649|459488191|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
127689167|NCT03990649|459488192|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
127689168|NCT02724956|459488195|FG000|Overall Study|Physician Decision|1|||
127689169|NCT02724956|459488196|FG001|Overall Study|Physician Decision|0|||
127689170|NCT02724956|459488195|FG000|Overall Study|Lack of Efficacy|0|||
127689171|NCT02724956|459488196|FG001|Overall Study|Lack of Efficacy|1|||
127689172|NCT02724956|459488195|FG000|Overall Study|Withdrawal by Subject|0|||
127689173|NCT02724956|459488196|FG001|Overall Study|Withdrawal by Subject|1|||
127689174|NCT02647905|459488203|FG000|Overall Study|Lost to Follow-up|1|||
127689175|NCT02647905|459488203|FG000|Overall Study|Withdrawal by Subject|2|||
127689176|NCT02015520|459488204|FG000|Overall Study|Lack of Efficacy|1|||
127689177|NCT02015520|459488205|FG001|Overall Study|Lack of Efficacy|0|||
127689178|NCT02015520|459488206|FG002|Overall Study|Lack of Efficacy|3|||
127689179|NCT02015520|459488207|FG003|Overall Study|Lack of Efficacy|2|||
127689180|NCT02015520|459488204|FG000|Overall Study|Adverse Event|0|||
127689181|NCT02015520|459488205|FG001|Overall Study|Adverse Event|0|||
127689182|NCT02015520|459488206|FG002|Overall Study|Adverse Event|0|||
127689183|NCT02015520|459488207|FG003|Overall Study|Adverse Event|1|||
127689184|NCT02015520|459488204|FG000|Overall Study|Withdrawal by Subject|2|||
127689185|NCT02015520|459488205|FG001|Overall Study|Withdrawal by Subject|2|||
127689186|NCT02015520|459488206|FG002|Overall Study|Withdrawal by Subject|1|||
127689187|NCT02015520|459488207|FG003|Overall Study|Withdrawal by Subject|0|||
127689188|NCT02015520|459488204|FG000|Overall Study|Death|1|||
127689189|NCT02015520|459488205|FG001|Overall Study|Death|0|||
127689190|NCT02015520|459488206|FG002|Overall Study|Death|0|||
127689191|NCT02015520|459488207|FG003|Overall Study|Death|0|||
127689192|NCT02015520|459488204|FG000|Overall Study|Lost to Follow-up|0|||
127689193|NCT02015520|459488205|FG001|Overall Study|Lost to Follow-up|0|||
127689194|NCT02015520|459488206|FG002|Overall Study|Lost to Follow-up|1|||
127689195|NCT02015520|459488207|FG003|Overall Study|Lost to Follow-up|0|||
127689196|NCT02015520|459488204|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
127689197|NCT02015520|459488205|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
127689198|NCT02015520|459488206|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
127689199|NCT02015520|459488207|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
127689200|NCT02015520|459488204|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
127689201|NCT02015520|459488205|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
127689202|NCT02015520|459488206|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
127689203|NCT02015520|459488207|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
127689204|NCT02932579|459488208|FG000|Overall Study|Withdrawal by Subject|4|||
127689205|NCT02932579|459488209|FG001|Overall Study|Withdrawal by Subject|1|||
127689206|NCT01610297|459488211|FG000|Overall Study|Lost to Follow-up|1|||
127689207|NCT02121002|459488216|FG000|Overall Study|Physician Decision|2|||
128026016|NCT03142451|460720096|FG001|Overall Study|Other|1|||
128026017|NCT02365064|460720104|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
128026018|NCT02365064|460720105|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
128026019|NCT02365064|460720104|FG000|Overall Study|Withdrawal by Subject|6|||
128026020|NCT02365064|460720105|FG001|Overall Study|Withdrawal by Subject|9|||
128026021|NCT02365064|460720104|FG000|Overall Study|Treatment intolerance|2|||
128026022|NCT02365064|460720105|FG001|Overall Study|Treatment intolerance|4|||
128026023|NCT01716559|460720106|FG000|Overall Study|Adverse Event|11|||
128026024|NCT01716559|460720106|FG000|Overall Study|Death|21|||
128026025|NCT01716559|460720106|FG000|Overall Study|Withdrawal by Subject|4|||
128026026|NCT01716559|460720106|FG000|Overall Study|Other withdrawal reason|75|||
128026027|NCT02595437|460720107|FG000|Triferic Via IV|Withdrawal by Subject|1|||
128026028|NCT02773537|460720112|FG000|Overall Study|Lost to Follow-up|0|||
128026029|NCT02773537|460720113|FG001|Overall Study|Lost to Follow-up|1|||
128026030|NCT02773537|460720114|FG002|Overall Study|Lost to Follow-up|4|||
128026031|NCT01840163|460720115|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
128026032|NCT01840163|460720116|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
128026033|NCT01840163|460720115|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
128026034|NCT01840163|460720116|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
128026035|NCT01840163|460720115|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
128026036|NCT01840163|460720116|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
128026037|NCT03636269|460720118|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
128026038|NCT03636269|460720119|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
128026039|NCT03636269|460720120|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
128026040|NCT03636269|460720118|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
128026041|NCT03636269|460720119|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
128026042|NCT03636269|460720120|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
128026043|NCT03636269|460720118|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
128026044|NCT03636269|460720119|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
128026045|NCT03636269|460720120|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
128026046|NCT03636269|460720118|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
128026047|NCT03636269|460720119|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
128026048|NCT03636269|460720120|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
128026049|NCT03636269|460720118|FG000|Period 1: Double-blind Phase|Other|6|||
128026050|NCT03636269|460720119|FG001|Period 1: Double-blind Phase|Other|3|||
128026051|NCT03636269|460720120|FG002|Period 1: Double-blind Phase|Other|0|||
127566588|NCT01903252|459043836|FG000|Double-Blind Induction|non-compliance,|7|||
127566589|NCT01903252|459043837|FG001|Double-Blind Induction|non-compliance,|7|||
127777407|NCT03838198|459813531|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
127777408|NCT03838198|459813532|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
127777409|NCT05211739|459813535|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
128026052|NCT03636269|460720118|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
128026053|NCT03636269|460720119|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
128026054|NCT03636269|460720120|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
128026055|NCT03636269|460720118|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
127566590|NCT01903252|459043838|FG002|Double-Blind Induction|non-compliance,|0|||
127689208|NCT02121002|459488217|FG001|Overall Study|Physician Decision|0|||
127689209|NCT02121002|459488218|FG002|Overall Study|Physician Decision|0|||
127689210|NCT02121002|459488216|FG000|Overall Study|Withdrawal by Subject|3|||
127689211|NCT02121002|459488217|FG001|Overall Study|Withdrawal by Subject|1|||
127689212|NCT02121002|459488218|FG002|Overall Study|Withdrawal by Subject|4|||
127689213|NCT02121002|459488216|FG000|Overall Study|Protocol Violation|1|||
127689214|NCT02121002|459488217|FG001|Overall Study|Protocol Violation|2|||
127689215|NCT02121002|459488218|FG002|Overall Study|Protocol Violation|4|||
127689216|NCT02121002|459488216|FG000|Overall Study|Concomitant therapy|0|||
127689217|NCT02121002|459488217|FG001|Overall Study|Concomitant therapy|1|||
127689218|NCT02121002|459488218|FG002|Overall Study|Concomitant therapy|1|||
127689219|NCT02121002|459488216|FG000|Overall Study|Others|1|||
127689220|NCT02121002|459488217|FG001|Overall Study|Others|0|||
127689221|NCT02121002|459488218|FG002|Overall Study|Others|1|||
127689222|NCT01007396|459488222|FG000|Overall Study|Lost to Follow-up|47|||
127689223|NCT02590432|459488223|FG000|Open-label Treatment Period|Adverse Event|97|||
128026056|NCT03636269|460720119|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
128026057|NCT03636269|460720120|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
127566591|NCT01903252|459043839|FG003|Double-Blind Induction|non-compliance,|0|||
127689224|NCT02590432|459488224|FG001|Open-label Treatment Period|Adverse Event|79|||
127689225|NCT02590432|459488225|FG002|Open-label Treatment Period|Adverse Event|0|||
127689226|NCT02590432|459488226|FG003|Open-label Treatment Period|Adverse Event|0|||
127689227|NCT02590432|459488227|FG004|Open-label Treatment Period|Adverse Event|0|||
127689228|NCT02590432|459488228|FG005|Open-label Treatment Period|Adverse Event|0|||
127566592|NCT01903252|459043840|FG004|Double-Blind Induction|non-compliance,|0|||
128026058|NCT03636269|460720118|FG000|Period 2: Open-label Phase|Adverse Event|0|||
128026059|NCT03636269|460720119|FG001|Period 2: Open-label Phase|Adverse Event|0|||
128026060|NCT03636269|460720120|FG002|Period 2: Open-label Phase|Adverse Event|21|||
128026061|NCT03636269|460720118|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
128026062|NCT03636269|460720119|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
128026063|NCT03636269|460720120|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
128026064|NCT03636269|460720118|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
128026065|NCT03636269|460720119|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
128026066|NCT03636269|460720120|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
128026067|NCT03636269|460720118|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
128026068|NCT03636269|460720119|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
128026069|NCT03636269|460720120|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
128026070|NCT03636269|460720118|FG000|Period 2: Open-label Phase|Administrative|0|||
128026071|NCT03636269|460720119|FG001|Period 2: Open-label Phase|Administrative|0|||
128026072|NCT03636269|460720120|FG002|Period 2: Open-label Phase|Administrative|36|||
128026073|NCT03636269|460720118|FG000|Period 2: Open-label Phase|Other|0|||
128026074|NCT03636269|460720119|FG001|Period 2: Open-label Phase|Other|0|||
128026075|NCT03636269|460720120|FG002|Period 2: Open-label Phase|Other|9|||
128026076|NCT03636269|460720118|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
128026077|NCT03636269|460720119|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
128026078|NCT03636269|460720120|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
128026079|NCT00493285|460720128|FG000|Overall Study|Lost to Follow-up|0|||
128026080|NCT00493285|460720129|FG001|Overall Study|Lost to Follow-up|0|||
128026081|NCT00493285|460720130|FG002|Overall Study|Lost to Follow-up|0|||
128026082|NCT00493285|460720131|FG003|Overall Study|Lost to Follow-up|0|||
128026083|NCT00493285|460720132|FG004|Overall Study|Lost to Follow-up|1|||
128026084|NCT00493285|460720133|FG005|Overall Study|Lost to Follow-up|0|||
128026085|NCT04535362|460720134|FG000|Overall Study|Lost to Follow-up|3|||
128026086|NCT04535362|460720135|FG001|Overall Study|Lost to Follow-up|1|||
128026087|NCT03791060|460720136|FG000|Overall Study|Withdrawal by Subject|1|||
128026088|NCT03774810|460720137|FG000|Phase 1|Lack of Efficacy|21|||
128026089|NCT03774810|460720138|FG001|Phase 1|Lack of Efficacy|0|||
128026090|NCT03774810|460720139|FG002|Phase 1|Lack of Efficacy|0|||
128026091|NCT03774810|460720140|FG003|Phase 1|Lack of Efficacy|0|||
128026092|NCT03774810|460720141|FG004|Phase 1|Lack of Efficacy|0|||
128026093|NCT03774810|460720137|FG000|Phase 1|Withdrawal by Subject|9|||
128026094|NCT03774810|460720138|FG001|Phase 1|Withdrawal by Subject|0|||
128026095|NCT03774810|460720139|FG002|Phase 1|Withdrawal by Subject|0|||
128026096|NCT03774810|460720140|FG003|Phase 1|Withdrawal by Subject|0|||
128026097|NCT03774810|460720141|FG004|Phase 1|Withdrawal by Subject|0|||
128026098|NCT03774810|460720137|FG000|Phase 1|Lost to Follow-up|2|||
128026099|NCT03774810|460720138|FG001|Phase 1|Lost to Follow-up|0|||
128026100|NCT03774810|460720139|FG002|Phase 1|Lost to Follow-up|0|||
128026101|NCT03774810|460720140|FG003|Phase 1|Lost to Follow-up|0|||
128026102|NCT03774810|460720141|FG004|Phase 1|Lost to Follow-up|0|||
128026103|NCT03774810|460720137|FG000|Phase 2 (3 Months)|Lack of Efficacy|0|||
128026104|NCT03774810|460720138|FG001|Phase 2 (3 Months)|Lack of Efficacy|3|||
128026105|NCT03774810|460720139|FG002|Phase 2 (3 Months)|Lack of Efficacy|2|||
128026106|NCT03774810|460720140|FG003|Phase 2 (3 Months)|Lack of Efficacy|3|||
128026107|NCT03774810|460720141|FG004|Phase 2 (3 Months)|Lack of Efficacy|1|||
128026108|NCT03774810|460720137|FG000|Phase 2 (3 Months)|Withdrawal by Subject|0|||
128026109|NCT03774810|460720138|FG001|Phase 2 (3 Months)|Withdrawal by Subject|5|||
128026110|NCT03774810|460720139|FG002|Phase 2 (3 Months)|Withdrawal by Subject|2|||
128026111|NCT03774810|460720140|FG003|Phase 2 (3 Months)|Withdrawal by Subject|3|||
128026112|NCT03774810|460720141|FG004|Phase 2 (3 Months)|Withdrawal by Subject|1|||
128026113|NCT03774810|460720137|FG000|Phase 2 (3 Months)|Lost to Follow-up|0|||
128026114|NCT03774810|460720138|FG001|Phase 2 (3 Months)|Lost to Follow-up|1|||
128026115|NCT03774810|460720139|FG002|Phase 2 (3 Months)|Lost to Follow-up|0|||
128026116|NCT03774810|460720140|FG003|Phase 2 (3 Months)|Lost to Follow-up|0|||
128026117|NCT03774810|460720141|FG004|Phase 2 (3 Months)|Lost to Follow-up|0|||
128026118|NCT03774810|460720137|FG000|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|0|||
128026119|NCT03774810|460720138|FG001|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|3|||
128026120|NCT03774810|460720139|FG002|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
128026121|NCT03774810|460720140|FG003|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|1|||
128026122|NCT03774810|460720141|FG004|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
128026123|NCT03774810|460720137|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|0|||
128026124|NCT03774810|460720138|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|1|||
128026125|NCT03774810|460720139|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|3|||
128026126|NCT03774810|460720140|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|5|||
128026127|NCT03774810|460720141|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|2|||
128026128|NCT03774810|460720137|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
128026129|NCT03774810|460720138|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
128026130|NCT03774810|460720139|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
127566593|NCT01903252|459043841|FG005|Double-Blind Induction|non-compliance,|0|||
127566594|NCT01903252|459043836|FG000|Extended Induction, Open-Label|Adverse Event|0|||
127566595|NCT01903252|459043837|FG001|Extended Induction, Open-Label|Adverse Event|0|||
127566596|NCT01903252|459043838|FG002|Extended Induction, Open-Label|Adverse Event|17|||
127566597|NCT01903252|459043839|FG003|Extended Induction, Open-Label|Adverse Event|0|||
127566598|NCT01903252|459043840|FG004|Extended Induction, Open-Label|Adverse Event|0|||
127566599|NCT01903252|459043841|FG005|Extended Induction, Open-Label|Adverse Event|0|||
127566600|NCT01903252|459043836|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
127566601|NCT01903252|459043837|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
127566602|NCT01903252|459043838|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
127566603|NCT01903252|459043839|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
127566604|NCT01903252|459043840|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
127566605|NCT01903252|459043841|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
127566606|NCT01903252|459043836|FG000|Extended Induction, Open-Label|Physician Decision|0|||
127566607|NCT01903252|459043837|FG001|Extended Induction, Open-Label|Physician Decision|0|||
127566608|NCT01903252|459043838|FG002|Extended Induction, Open-Label|Physician Decision|1|||
127566609|NCT01903252|459043839|FG003|Extended Induction, Open-Label|Physician Decision|0|||
127566610|NCT01903252|459043840|FG004|Extended Induction, Open-Label|Physician Decision|0|||
127566611|NCT01903252|459043841|FG005|Extended Induction, Open-Label|Physician Decision|0|||
127566612|NCT01903252|459043836|FG000|Maintenance, Open-Label|Adverse Event|0|||
127566613|NCT01903252|459043837|FG001|Maintenance, Open-Label|Adverse Event|0|||
127566614|NCT01903252|459043838|FG002|Maintenance, Open-Label|Adverse Event|0|||
127566615|NCT01903252|459043839|FG003|Maintenance, Open-Label|Adverse Event|3|||
127566616|NCT01903252|459043840|FG004|Maintenance, Open-Label|Adverse Event|9|||
127566617|NCT01903252|459043841|FG005|Maintenance, Open-Label|Adverse Event|14|||
127566618|NCT01903252|459043836|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
127566619|NCT01903252|459043837|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
127566620|NCT01903252|459043838|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
127566621|NCT01903252|459043839|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
127566622|NCT01903252|459043840|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
127566623|NCT01903252|459043841|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
127566624|NCT01903252|459043836|FG000|Maintenance, Open-Label|Other|0|||
127566625|NCT01903252|459043837|FG001|Maintenance, Open-Label|Other|0|||
127566626|NCT01903252|459043838|FG002|Maintenance, Open-Label|Other|0|||
127566627|NCT01903252|459043839|FG003|Maintenance, Open-Label|Other|2|||
127566628|NCT01903252|459043840|FG004|Maintenance, Open-Label|Other|6|||
127566629|NCT01903252|459043841|FG005|Maintenance, Open-Label|Other|2|||
127566630|NCT02437110|459043842|FG000|Screening|Lost to Follow-up|3|||
127566631|NCT02437110|459043842|FG000|Screening|Physician Decision|1|||
127566632|NCT02437110|459043842|FG000|ART|Adverse Event|3|||
127566633|NCT02437110|459043842|FG000|ART|Protocol Violation|3|||
127566634|NCT02437110|459043842|FG000|ART|Withdrawal by Subject|4|||
127566635|NCT02437110|459043842|FG000|ART|Lost to follow-up prior to start of intervention|1|||
127689229|NCT02590432|459488229|FG006|Open-label Treatment Period|Adverse Event|0|||
127689230|NCT02590432|459488230|FG007|Open-label Treatment Period|Adverse Event|0|||
127689231|NCT02590432|459488231|FG008|Open-label Treatment Period|Adverse Event|0|||
127689232|NCT02590432|459488223|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
127689233|NCT02590432|459488224|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
127689234|NCT02590432|459488225|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
127689235|NCT02590432|459488226|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
127689236|NCT02590432|459488227|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
127689237|NCT02590432|459488228|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
127689238|NCT02590432|459488229|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
127689239|NCT02590432|459488230|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
127689240|NCT02590432|459488231|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
127689241|NCT02590432|459488223|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
127689242|NCT02590432|459488224|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
127689243|NCT02590432|459488225|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
127689244|NCT02590432|459488226|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
127689245|NCT02590432|459488227|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
127689246|NCT02590432|459488228|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
127689247|NCT02590432|459488229|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
127689248|NCT02590432|459488230|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
127689249|NCT02590432|459488231|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
127689250|NCT02590432|459488223|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
127689251|NCT02590432|459488224|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
128026131|NCT03774810|460720140|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|1|||
128026132|NCT03774810|460720141|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|2|||
127566636|NCT02437110|459043842|FG000|ART|Physician decision prior to start of intervention|2|||
127566637|NCT02437110|459043842|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
127566638|NCT02437110|459043842|FG000|Post-ART|Lost to Follow-up|3|||
127566639|NCT02437110|459043842|FG000|Post-ART|Protocol Violation|4|||
127566640|NCT02437110|459043842|FG000|Post-ART|Withdrawal by Subject|3|||
127566641|NCT01227824|459043847|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
127566642|NCT01227824|459043848|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
127566643|NCT01227824|459043849|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
127566644|NCT01227824|459043847|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
127566645|NCT01227824|459043848|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
127566646|NCT01227824|459043849|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
127566647|NCT01227824|459043847|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
127566648|NCT01227824|459043848|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
127566649|NCT01227824|459043849|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
127566650|NCT01227824|459043847|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
127566651|NCT01227824|459043848|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
127566652|NCT01227824|459043849|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
127566653|NCT01227824|459043847|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
127566654|NCT01227824|459043848|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
127566655|NCT01227824|459043849|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
127566656|NCT01227824|459043847|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
127689252|NCT02590432|459488225|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
127689253|NCT02590432|459488226|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
127777410|NCT05211739|459813536|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
128026133|NCT00290758|460720148|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
128026134|NCT00290758|460720149|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
128026135|NCT00290758|460720148|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
128026136|NCT00290758|460720149|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
128026137|NCT00290758|460720148|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
128026138|NCT00290758|460720149|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
128026139|NCT00290758|460720148|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
128026140|NCT00290758|460720149|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
128026141|NCT00290758|460720148|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
128026142|NCT00290758|460720149|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
128026143|NCT00290758|460720148|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
127689254|NCT02590432|459488227|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
127689255|NCT02590432|459488228|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
127689256|NCT02590432|459488229|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
127689257|NCT02590432|459488230|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
127689258|NCT02590432|459488231|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
127689259|NCT02590432|459488223|FG000|Open-label Treatment Period|Protocol Violation|10|||
127689260|NCT02590432|459488224|FG001|Open-label Treatment Period|Protocol Violation|4|||
127689261|NCT02590432|459488225|FG002|Open-label Treatment Period|Protocol Violation|0|||
127689262|NCT02590432|459488226|FG003|Open-label Treatment Period|Protocol Violation|0|||
127689263|NCT02590432|459488227|FG004|Open-label Treatment Period|Protocol Violation|0|||
127689264|NCT02590432|459488228|FG005|Open-label Treatment Period|Protocol Violation|0|||
127689265|NCT02590432|459488229|FG006|Open-label Treatment Period|Protocol Violation|0|||
127689266|NCT02590432|459488230|FG007|Open-label Treatment Period|Protocol Violation|0|||
127689267|NCT02590432|459488231|FG008|Open-label Treatment Period|Protocol Violation|0|||
127689268|NCT02590432|459488223|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
127689269|NCT02590432|459488224|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
127689270|NCT02590432|459488225|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
127689271|NCT02590432|459488226|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
127689272|NCT02590432|459488227|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
127689273|NCT02590432|459488228|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
127689274|NCT02590432|459488229|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
127689275|NCT02590432|459488230|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
127689276|NCT02590432|459488231|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
127689277|NCT02590432|459488223|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
127689278|NCT02590432|459488224|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
127689279|NCT02590432|459488225|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
127689280|NCT02590432|459488226|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
127689281|NCT02590432|459488227|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
127689282|NCT02590432|459488228|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
127689283|NCT02590432|459488229|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
127689284|NCT02590432|459488230|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
127689285|NCT02590432|459488231|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
127689286|NCT02590432|459488223|FG000|Double-blind Treatment Period|Adverse Event|0|||
127798473|NCT01789970|459885615|FG002|Open-label Titration Period|Lost to Follow-up|0|||
128026144|NCT00290758|460720149|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
128026145|NCT00290758|460720148|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
128026146|NCT00290758|460720149|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
128026147|NCT00290758|460720148|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
128026148|NCT00290758|460720149|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
128026149|NCT04914000|460720150|FG000|Overall Study|Lost to Follow-up|8|||
128026150|NCT04914000|460720150|FG000|Overall Study|Withdrawal by Subject|1|||
128026151|NCT01429623|460720151|FG000|Overall Study|Death|1|||
128026152|NCT01429623|460720152|FG001|Overall Study|Death|0|||
128026153|NCT01429623|460720151|FG000|Overall Study|Adverse Event|7|||
128026154|NCT01429623|460720152|FG001|Overall Study|Adverse Event|14|||
128026155|NCT01429623|460720151|FG000|Overall Study|Withdrawal by Subject|19|||
128026156|NCT01429623|460720152|FG001|Overall Study|Withdrawal by Subject|13|||
128026157|NCT01429623|460720151|FG000|Overall Study|Physician Decision|2|||
128026158|NCT01429623|460720152|FG001|Overall Study|Physician Decision|3|||
128026159|NCT01429623|460720151|FG000|Overall Study|Protocol Violation|3|||
128026160|NCT01429623|460720152|FG001|Overall Study|Protocol Violation|2|||
128026161|NCT01429623|460720151|FG000|Overall Study|Assorted|1|||
128026162|NCT01429623|460720152|FG001|Overall Study|Assorted|2|||
128026163|NCT01429623|460720151|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
128026164|NCT01429623|460720152|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
128026165|NCT01429623|460720151|FG000|Overall Study|No post baseline data|4|||
128026166|NCT01429623|460720152|FG001|Overall Study|No post baseline data|4|||
128026167|NCT01896986|460720153|FG000|Overall Study|samples lost|14|||
128026168|NCT01896986|460720154|FG001|Overall Study|samples lost|23|||
128026169|NCT04189588|460720155|FG000|Overall Study|Death|0|||
128026170|NCT04189588|460720156|FG001|Overall Study|Death|1|||
128026171|NCT04189588|460720155|FG000|Overall Study|Lost to Follow-up|0|||
128026172|NCT04189588|460720156|FG001|Overall Study|Lost to Follow-up|1|||
128026173|NCT01658735|460720159|FG000|Overall Study|Lack of Efficacy|1|||
128026174|NCT01658735|460720160|FG001|Overall Study|Lack of Efficacy|0|||
128026175|NCT01658735|460720161|FG002|Overall Study|Lack of Efficacy|1|||
127689287|NCT02590432|459488224|FG001|Double-blind Treatment Period|Adverse Event|0|||
127689288|NCT02590432|459488225|FG002|Double-blind Treatment Period|Adverse Event|14|||
127689289|NCT02590432|459488226|FG003|Double-blind Treatment Period|Adverse Event|12|||
127689290|NCT02590432|459488227|FG004|Double-blind Treatment Period|Adverse Event|6|||
127689291|NCT02590432|459488228|FG005|Double-blind Treatment Period|Adverse Event|22|||
127689292|NCT02590432|459488229|FG006|Double-blind Treatment Period|Adverse Event|20|||
127689293|NCT02590432|459488230|FG007|Double-blind Treatment Period|Adverse Event|0|||
127689294|NCT02590432|459488231|FG008|Double-blind Treatment Period|Adverse Event|0|||
127689295|NCT02590432|459488223|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
127689296|NCT02590432|459488224|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
127689297|NCT02590432|459488225|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
127689298|NCT02590432|459488226|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
127689299|NCT02590432|459488227|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
127689300|NCT02590432|459488228|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
127689301|NCT02590432|459488229|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
127689302|NCT02590432|459488230|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
127689303|NCT02590432|459488231|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
127689304|NCT02590432|459488223|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
127689305|NCT02590432|459488224|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
127689306|NCT02590432|459488225|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
127689307|NCT02590432|459488226|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
127689308|NCT02590432|459488227|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
127689309|NCT02590432|459488228|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
127689310|NCT02590432|459488229|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
127689311|NCT02590432|459488230|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
127689312|NCT02590432|459488231|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
127689313|NCT02590432|459488223|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
127689314|NCT02590432|459488224|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
128026176|NCT01658735|460720159|FG000|Overall Study|Lost to Follow-up|1|||
128026177|NCT01658735|460720160|FG001|Overall Study|Lost to Follow-up|1|||
128026178|NCT01658735|460720161|FG002|Overall Study|Lost to Follow-up|0|||
128026179|NCT01658735|460720159|FG000|Overall Study|Protocol Violation|0|||
128026180|NCT01658735|460720160|FG001|Overall Study|Protocol Violation|1|||
127689315|NCT02590432|459488225|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
127689316|NCT02590432|459488226|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
127689317|NCT02590432|459488227|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
127689318|NCT02590432|459488228|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
127689319|NCT02590432|459488229|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
127689320|NCT02590432|459488230|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
128026181|NCT01658735|460720161|FG002|Overall Study|Protocol Violation|0|||
128026182|NCT01658735|460720159|FG000|Overall Study|Withdrawal by Subject|3|||
128026183|NCT01658735|460720160|FG001|Overall Study|Withdrawal by Subject|5|||
128026184|NCT01658735|460720161|FG002|Overall Study|Withdrawal by Subject|3|||
128026185|NCT01259024|460720168|FG000|Overall Study|Physician Decision|1|||
128026186|NCT01657500|460720169|FG000|Overall Study|set impropperly matched|3|||
128026187|NCT01657500|460720170|FG001|Overall Study|set impropperly matched|3|||
128026188|NCT01657500|460720169|FG000|Overall Study|Lost to Follow-up|2|||
128026189|NCT01657500|460720170|FG001|Overall Study|Lost to Follow-up|2|||
128026190|NCT02067156|460720174|FG000|Overall Study|Lost to Follow-up|4|||
127689321|NCT02590432|459488231|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
127689322|NCT02590432|459488223|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
127689323|NCT02590432|459488224|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
127689324|NCT02590432|459488225|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
127689325|NCT02590432|459488226|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
127689326|NCT02590432|459488227|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
127689327|NCT02590432|459488228|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
127689328|NCT02590432|459488229|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
127689329|NCT02590432|459488230|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
127689330|NCT02590432|459488231|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
127689331|NCT02590432|459488223|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
127689332|NCT02590432|459488224|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
127689333|NCT02590432|459488225|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
127689334|NCT02590432|459488226|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
127689335|NCT02590432|459488227|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
127689336|NCT02590432|459488228|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
127689337|NCT02590432|459488229|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
127689338|NCT02590432|459488230|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
127689339|NCT02590432|459488231|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
127689340|NCT02590432|459488223|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
127689341|NCT02590432|459488224|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
127689342|NCT02590432|459488225|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
127689343|NCT02590432|459488226|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
127689344|NCT02590432|459488227|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
127689345|NCT02590432|459488228|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
127689346|NCT02590432|459488229|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
127689347|NCT02590432|459488230|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
127689348|NCT02590432|459488231|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
127689349|NCT02590432|459488223|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
127689350|NCT02590432|459488224|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
127689351|NCT02590432|459488225|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
127689352|NCT02590432|459488226|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
127689353|NCT02590432|459488227|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
127689354|NCT02590432|459488228|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
127689355|NCT02590432|459488229|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
127689356|NCT02590432|459488230|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
127689357|NCT02590432|459488231|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
127689358|NCT02590432|459488223|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
127689359|NCT02590432|459488224|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
127689360|NCT02590432|459488225|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
127689361|NCT02590432|459488226|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
127689362|NCT02590432|459488227|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
127689363|NCT02590432|459488228|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
127689364|NCT02590432|459488229|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
127689365|NCT02590432|459488230|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
127689366|NCT02590432|459488231|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
127689367|NCT02590432|459488223|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
127689368|NCT02590432|459488224|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
127689369|NCT02590432|459488225|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
127689370|NCT02590432|459488226|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
127689371|NCT02590432|459488227|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
127689372|NCT02590432|459488228|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
127689373|NCT02590432|459488229|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
127689374|NCT02590432|459488230|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
127689375|NCT02590432|459488231|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
127689376|NCT02590432|459488223|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
128026191|NCT04034056|460720175|FG000|Overall Study|Withdrawal by Subject|2|||
128026192|NCT04034056|460720175|FG000|Overall Study|Reason Not Specified|13|||
127566657|NCT01227824|459043848|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
127566658|NCT01227824|459043849|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
127566659|NCT01227824|459043847|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
127566660|NCT01227824|459043848|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
127566661|NCT01227824|459043849|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
127566662|NCT01227824|459043847|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
127566663|NCT01227824|459043848|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
127566664|NCT01227824|459043849|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
127566665|NCT01227824|459043847|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
127566666|NCT01227824|459043848|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
127566667|NCT01227824|459043849|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
127566668|NCT01227824|459043847|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
127566669|NCT01227824|459043848|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
127566670|NCT01227824|459043849|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
127566671|NCT01227824|459043847|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
127566672|NCT01227824|459043848|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
127566673|NCT01227824|459043849|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
127566674|NCT01227824|459043847|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
127566675|NCT01227824|459043848|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
127566676|NCT01227824|459043849|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
127566677|NCT01227824|459043847|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
127566678|NCT01227824|459043848|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
127566679|NCT01227824|459043849|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
127566680|NCT01227824|459043847|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
127566681|NCT01227824|459043848|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
127566682|NCT01227824|459043849|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
127566683|NCT01227824|459043847|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
127566684|NCT01227824|459043848|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
127566685|NCT01227824|459043849|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
127566686|NCT03836001|459043850|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
127566687|NCT03836001|459043851|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
127566688|NCT03836001|459043852|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
127566689|NCT03836001|459043850|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
127566690|NCT03836001|459043851|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
127566691|NCT03836001|459043852|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
127566692|NCT03836001|459043850|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
127566693|NCT03836001|459043851|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
127566694|NCT03836001|459043852|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
127566695|NCT03836001|459043850|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
127566696|NCT03836001|459043851|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
127566697|NCT03836001|459043852|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
127566698|NCT01381562|459043853|FG000|Overall Study|Adverse Event|0|||
127689377|NCT02590432|459488224|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
127689378|NCT02590432|459488225|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
127689379|NCT02590432|459488226|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
127689380|NCT02590432|459488227|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
127689381|NCT02590432|459488228|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
127689382|NCT02590432|459488229|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
127689383|NCT02590432|459488230|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
127689384|NCT02590432|459488231|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
127689385|NCT02590432|459488223|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
127689386|NCT02590432|459488224|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
127689387|NCT02590432|459488225|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
127689388|NCT02590432|459488226|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
127689389|NCT02590432|459488227|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
127689390|NCT02590432|459488228|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
127689391|NCT02590432|459488229|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
127689392|NCT02590432|459488230|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
127689393|NCT02590432|459488231|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
127689394|NCT03283371|459488232|FG000|Placebo-controlled|Adverse Event|1|||
127689395|NCT03283371|459488233|FG001|Placebo-controlled|Adverse Event|1|||
127689396|NCT03283371|459488234|FG002|Placebo-controlled|Adverse Event|0|||
127566699|NCT01381562|459043854|FG001|Overall Study|Adverse Event|1|||
127566700|NCT01381562|459043855|FG002|Overall Study|Adverse Event|0|||
127566701|NCT01642732|459043859|FG000|Overall Study|Withdrawal by Subject|1|||
127566702|NCT01284491|459043867|FG000|Overall Study|Study termination|13|||
127566703|NCT02694757|459043870|FG000|Overall Study|Lack of Efficacy|3|||
127566704|NCT02395302|459043873|FG000|Overall Study|Screen Failure|3|||
127566705|NCT02395302|459043873|FG000|Overall Study|Run In Failure|7|||
127566706|NCT02395302|459043873|FG000|Overall Study|Withdrawal by Subject|2|||
127566707|NCT02395302|459043873|FG000|Overall Study|Physician Decision|2|||
127566708|NCT00952380|459043874|FG000|Overall Study|Other|0|||
127566709|NCT00952380|459043875|FG001|Overall Study|Other|0|||
127566710|NCT00952380|459043876|FG002|Overall Study|Other|0|||
127566711|NCT00952380|459043877|FG003|Overall Study|Other|0|||
127566712|NCT00952380|459043878|FG004|Overall Study|Other|1|||
127566713|NCT00952380|459043874|FG000|Overall Study|Withdrawal by Subject|0|||
127566714|NCT00952380|459043875|FG001|Overall Study|Withdrawal by Subject|0|||
127566715|NCT00952380|459043876|FG002|Overall Study|Withdrawal by Subject|1|||
127566716|NCT00952380|459043877|FG003|Overall Study|Withdrawal by Subject|0|||
127566717|NCT00952380|459043878|FG004|Overall Study|Withdrawal by Subject|2|||
127566718|NCT00952380|459043874|FG000|Overall Study|Adverse Event|0|||
127566719|NCT00952380|459043875|FG001|Overall Study|Adverse Event|1|||
127566720|NCT00952380|459043876|FG002|Overall Study|Adverse Event|0|||
127566721|NCT00952380|459043877|FG003|Overall Study|Adverse Event|0|||
127566722|NCT00952380|459043878|FG004|Overall Study|Adverse Event|3|||
127566723|NCT00952380|459043874|FG000|Overall Study|Physician Decision|0|||
127566724|NCT00952380|459043875|FG001|Overall Study|Physician Decision|0|||
127566725|NCT00952380|459043876|FG002|Overall Study|Physician Decision|1|||
127566726|NCT00952380|459043877|FG003|Overall Study|Physician Decision|2|||
127566727|NCT00952380|459043878|FG004|Overall Study|Physician Decision|0|||
127566728|NCT00952380|459043874|FG000|Overall Study|Non-compliant to protocol|0|||
127566729|NCT00952380|459043875|FG001|Overall Study|Non-compliant to protocol|0|||
127566730|NCT00952380|459043876|FG002|Overall Study|Non-compliant to protocol|0|||
127566731|NCT00952380|459043877|FG003|Overall Study|Non-compliant to protocol|1|||
127566732|NCT00952380|459043878|FG004|Overall Study|Non-compliant to protocol|0|||
127566733|NCT03400956|459043879|FG000|Treatment Period 1|Adverse Event|0|||
127566734|NCT03400956|459043880|FG001|Treatment Period 1|Adverse Event|1|||
127566735|NCT03400956|459043881|FG002|Treatment Period 1|Adverse Event|0|||
127566736|NCT03400956|459043879|FG000|Treatment Period 1|Lost to Follow-up|0|||
127566737|NCT03400956|459043880|FG001|Treatment Period 1|Lost to Follow-up|0|||
127566738|NCT03400956|459043881|FG002|Treatment Period 1|Lost to Follow-up|1|||
127566739|NCT03400956|459043879|FG000|Treatment Period 1|Protocol Violation|0|||
127566740|NCT03400956|459043880|FG001|Treatment Period 1|Protocol Violation|2|||
127566741|NCT03400956|459043881|FG002|Treatment Period 1|Protocol Violation|0|||
127566742|NCT03400956|459043879|FG000|Treatment Period 1|Study terminated by sponsor|3|||
127566743|NCT03400956|459043880|FG001|Treatment Period 1|Study terminated by sponsor|1|||
127566744|NCT03400956|459043881|FG002|Treatment Period 1|Study terminated by sponsor|1|||
127566745|NCT03400956|459043879|FG000|Treatment Period 1|Withdrawal by Subject|0|||
127566746|NCT03400956|459043880|FG001|Treatment Period 1|Withdrawal by Subject|2|||
127566747|NCT03400956|459043881|FG002|Treatment Period 1|Withdrawal by Subject|4|||
127566748|NCT03400956|459043879|FG000|Treatment Period 1|Other|1|||
127566749|NCT03400956|459043880|FG001|Treatment Period 1|Other|2|||
127566750|NCT03400956|459043881|FG002|Treatment Period 1|Other|3|||
127566751|NCT03400956|459043879|FG000|Post-treatment Period 1|Adverse Event|0|||
127566752|NCT03400956|459043880|FG001|Post-treatment Period 1|Adverse Event|0|||
127566753|NCT03400956|459043881|FG002|Post-treatment Period 1|Adverse Event|1|||
127566754|NCT03400956|459043879|FG000|Post-treatment Period 1|Physician Decision|2|||
127566755|NCT03400956|459043880|FG001|Post-treatment Period 1|Physician Decision|3|||
127566756|NCT03400956|459043881|FG002|Post-treatment Period 1|Physician Decision|0|||
127566757|NCT03400956|459043879|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
127566758|NCT03400956|459043880|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
127566759|NCT03400956|459043881|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
127566760|NCT03400956|459043879|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
127566761|NCT03400956|459043880|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
127566762|NCT03400956|459043881|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
127566763|NCT03400956|459043879|FG000|Post-treatment Period 1|Other|4|||
127566764|NCT03400956|459043880|FG001|Post-treatment Period 1|Other|3|||
127566765|NCT03400956|459043881|FG002|Post-treatment Period 1|Other|4|||
127566766|NCT03400956|459043879|FG000|Treatment Period 2|Adverse Event|2|||
127566767|NCT03400956|459043880|FG001|Treatment Period 2|Adverse Event|1|||
127566768|NCT03400956|459043881|FG002|Treatment Period 2|Adverse Event|1|||
127566769|NCT03400956|459043879|FG000|Treatment Period 2|Lost to Follow-up|1|||
127566770|NCT03400956|459043880|FG001|Treatment Period 2|Lost to Follow-up|1|||
127566771|NCT03400956|459043881|FG002|Treatment Period 2|Lost to Follow-up|0|||
127566772|NCT03400956|459043879|FG000|Treatment Period 2|Withdrawal by Subject|0|||
127566773|NCT03400956|459043880|FG001|Treatment Period 2|Withdrawal by Subject|0|||
127566774|NCT03400956|459043881|FG002|Treatment Period 2|Withdrawal by Subject|3|||
127566775|NCT03400956|459043879|FG000|Treatment Period 2|Other|1|||
128026193|NCT04034056|460720175|FG000|Overall Study|Adverse Event|56|||
128026194|NCT01260311|460720186|FG000|Overall Study|Adverse Event|11|||
128026195|NCT01260311|460720186|FG000|Overall Study|Lack of Efficacy|4|||
128026196|NCT01260311|460720186|FG000|Overall Study|Lost to Follow-up|25|||
128026197|NCT01260311|460720186|FG000|Overall Study|Withdrawal by Subject|6|||
128026198|NCT01260311|460720186|FG000|Overall Study|Financial Constraints|77|||
128026199|NCT01260311|460720186|FG000|Overall Study|Gone to Province|2|||
128026200|NCT01260311|460720186|FG000|Overall Study|Medication Stopped|1|||
128026201|NCT01260311|460720186|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
128026202|NCT00066170|460720187|FG000|Overall Study|Adverse Event|2|||
128026203|NCT00066170|460720188|FG001|Overall Study|Adverse Event|4|||
128026204|NCT00066170|460720189|FG002|Overall Study|Adverse Event|1|||
128026205|NCT00066170|460720190|FG003|Overall Study|Adverse Event|7|||
128026206|NCT00066170|460720187|FG000|Overall Study|Serious Adverse Event|0|||
128026207|NCT00066170|460720188|FG001|Overall Study|Serious Adverse Event|0|||
128026208|NCT00066170|460720189|FG002|Overall Study|Serious Adverse Event|1|||
128026209|NCT00066170|460720190|FG003|Overall Study|Serious Adverse Event|1|||
128026210|NCT00066170|460720187|FG000|Overall Study|Lost to Follow-up|0|||
128026211|NCT00066170|460720188|FG001|Overall Study|Lost to Follow-up|1|||
127566776|NCT03400956|459043880|FG001|Treatment Period 2|Other|1|||
128026212|NCT00066170|460720189|FG002|Overall Study|Lost to Follow-up|0|||
128026213|NCT00066170|460720190|FG003|Overall Study|Lost to Follow-up|0|||
128026214|NCT00066170|460720187|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
128026215|NCT00066170|460720188|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
128026216|NCT00066170|460720189|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
128026217|NCT00066170|460720190|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
128026218|NCT00066170|460720187|FG000|Overall Study|Protocol Violation|3|||
128026219|NCT00066170|460720188|FG001|Overall Study|Protocol Violation|0|||
128026220|NCT00066170|460720189|FG002|Overall Study|Protocol Violation|0|||
128026221|NCT00066170|460720190|FG003|Overall Study|Protocol Violation|0|||
128026222|NCT00066170|460720187|FG000|Overall Study|Other|1|||
128026223|NCT00066170|460720188|FG001|Overall Study|Other|5|||
128026224|NCT00066170|460720189|FG002|Overall Study|Other|2|||
128026225|NCT00066170|460720190|FG003|Overall Study|Other|0|||
128026226|NCT00098293|460720191|FG000|Double-blind (DB) Phase|Adverse Event|14|||
128026227|NCT00098293|460720192|FG001|Double-blind (DB) Phase|Adverse Event|27|||
128026228|NCT00098293|460720193|FG002|Double-blind (DB) Phase|Adverse Event|60|||
128026229|NCT00098293|460720194|FG003|Double-blind (DB) Phase|Adverse Event|0|||
128026230|NCT00098293|460720195|FG004|Double-blind (DB) Phase|Adverse Event|0|||
128026231|NCT00098293|460720191|FG000|Double-blind (DB) Phase|Pregnancy|0|||
128026232|NCT00098293|460720192|FG001|Double-blind (DB) Phase|Pregnancy|7|||
128026233|NCT00098293|460720193|FG002|Double-blind (DB) Phase|Pregnancy|9|||
128026234|NCT00098293|460720194|FG003|Double-blind (DB) Phase|Pregnancy|0|||
128026235|NCT00098293|460720195|FG004|Double-blind (DB) Phase|Pregnancy|0|||
128026236|NCT00098293|460720191|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
127566777|NCT03400956|459043881|FG002|Treatment Period 2|Other|0|||
127566778|NCT03400956|459043879|FG000|Follow-up Period|Withdrawal by Subject|0|||
127566779|NCT03400956|459043880|FG001|Follow-up Period|Withdrawal by Subject|0|||
127566780|NCT03400956|459043881|FG002|Follow-up Period|Withdrawal by Subject|1|||
127566781|NCT03400956|459043879|FG000|Follow-up Period|Other|0|||
127566782|NCT03400956|459043880|FG001|Follow-up Period|Other|0|||
127566783|NCT03400956|459043881|FG002|Follow-up Period|Other|1|||
127566784|NCT01306929|459043884|FG000|Overall Study|Withdrawal by Subject|23|||
127566785|NCT01306929|459043884|FG000|Overall Study|Adverse Event|21|||
127566786|NCT01306929|459043884|FG000|Overall Study|Physician Decision|13|||
127566787|NCT01306929|459043884|FG000|Overall Study|Death|8|||
127566788|NCT01306929|459043884|FG000|Overall Study|Withdrawal by parent/guardian|5|||
127566789|NCT01306929|459043884|FG000|Overall Study|Protocol Violation|3|||
127566790|NCT01306929|459043884|FG000|Overall Study|Non-compliance with study drug|2|||
127566791|NCT01306929|459043884|FG000|Overall Study|Lost to Follow-up|2|||
127566792|NCT01306929|459043884|FG000|Overall Study|Various|17|||
127566793|NCT00710762|459043892|FG000|Overall Study|Progressive disease|27|||
127566794|NCT00710762|459043893|FG001|Overall Study|Progressive disease|30|||
127566795|NCT00710762|459043892|FG000|Overall Study|Adverse Event other disease worsening|2|||
127566796|NCT00710762|459043893|FG001|Overall Study|Adverse Event other disease worsening|1|||
128026237|NCT00098293|460720192|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
128026238|NCT00098293|460720193|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
128026239|NCT00098293|460720194|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
127566797|NCT00710762|459043892|FG000|Overall Study|Other Adverse Event|7|||
128026240|NCT00098293|460720195|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
127566798|NCT00710762|459043893|FG001|Overall Study|Other Adverse Event|7|||
127566799|NCT00710762|459043892|FG000|Overall Study|Lost to Follow-up|1|||
127566800|NCT00710762|459043893|FG001|Overall Study|Lost to Follow-up|0|||
127566801|NCT00710762|459043892|FG000|Overall Study|Reason other than listed above|2|||
128026241|NCT00098293|460720191|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
128026242|NCT00098293|460720192|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
128026243|NCT00098293|460720193|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
128026244|NCT00098293|460720194|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
127566802|NCT00710762|459043893|FG001|Overall Study|Reason other than listed above|2|||
127566803|NCT01700439|459043897|FG000|Overall Study|Lost to Follow-up|47|||
127566804|NCT01700439|459043897|FG000|Overall Study|Withdrawal by Subject|183|||
127566805|NCT01700439|459043897|FG000|Overall Study|Death|186|||
127566806|NCT01829243|459043902|FG000|First Intervention|Screen Failure|4|||
127566807|NCT01829243|459043903|FG001|First Intervention|Screen Failure|2|||
127566808|NCT00053898|459043914|FG000|Overall Study|No follow-up data from any source|9|||
127566809|NCT00053898|459043915|FG001|Overall Study|No follow-up data from any source|12|||
127566810|NCT00053898|459043914|FG000|Overall Study|Follow-up from telephone contact only|5|||
127566811|NCT00053898|459043915|FG001|Overall Study|Follow-up from telephone contact only|1|||
127566812|NCT01077375|459043920|FG000|Overall Study|Adverse Event|2|||
127566813|NCT01077375|459043921|FG001|Overall Study|Adverse Event|15|||
127566814|NCT01077375|459043920|FG000|Overall Study|Lack of Efficacy|6|||
127566815|NCT01077375|459043921|FG001|Overall Study|Lack of Efficacy|8|||
127566816|NCT01077375|459043920|FG000|Overall Study|Withdrawal by Subject|0|||
127566817|NCT01077375|459043921|FG001|Overall Study|Withdrawal by Subject|6|||
127566818|NCT01077375|459043920|FG000|Overall Study|Lost to Follow-up|2|||
127566819|NCT01077375|459043921|FG001|Overall Study|Lost to Follow-up|5|||
127566820|NCT01077375|459043920|FG000|Overall Study|Other Reason|0|||
127566821|NCT01077375|459043921|FG001|Overall Study|Other Reason|1|||
127566822|NCT00545129|459043922|FG000|Overall Study|Lack of Efficacy|2|||
127566823|NCT00545129|459043923|FG001|Overall Study|Lack of Efficacy|5|||
127566824|NCT00545129|459043922|FG000|Overall Study|Death|2|||
127566825|NCT00545129|459043923|FG001|Overall Study|Death|1|||
127566826|NCT00545129|459043922|FG000|Overall Study|Adverse Event|1|||
127566827|NCT00545129|459043923|FG001|Overall Study|Adverse Event|1|||
127566828|NCT00545129|459043922|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
127566829|NCT00545129|459043923|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
127566830|NCT00545129|459043922|FG000|Overall Study|Other|3|||
127566831|NCT00545129|459043923|FG001|Overall Study|Other|3|||
127566832|NCT02055365|459045464|FG000|Overall Study|Prematurely Withdrawn|1|||
127566833|NCT01258998|459045465|FG000|Overall Study|Ineligible|1|||
127566834|NCT01143389|459045468|FG000|Overall Study|Lost to Follow-up|26|||
127566835|NCT01143389|459045469|FG001|Overall Study|Lost to Follow-up|25|||
127566836|NCT03565367|459045470|FG000|Overall Study|No scan due to technical issues|4|||
127566837|NCT03565367|459045471|FG001|Overall Study|No scan due to technical issues|0|||
127566838|NCT00137839|459045475|FG000|Overall Study|Adverse Event|7|||
127566839|NCT00137839|459045475|FG000|Overall Study|Physician Decision|7|||
127566840|NCT00137839|459045475|FG000|Overall Study|Death|8|||
127566841|NCT00137839|459045475|FG000|Overall Study|Disease Progression|60|||
127566842|NCT00137839|459045475|FG000|Overall Study|Not Start Treatment|1|||
127566843|NCT00137839|459045475|FG000|Overall Study|Prolonged Treatment Delay|1|||
127566844|NCT02882152|459045476|FG000|Overall Study|Lost to Follow-up|1|||
127566845|NCT02882152|459045477|FG001|Overall Study|Lost to Follow-up|0|||
127566846|NCT01475071|459045484|FG000|Overall Study|Physician Decision|1|||
127566847|NCT01475071|459045484|FG000|Overall Study|Withdrawal by Subject|6|||
127566848|NCT01475071|459045484|FG000|Overall Study|Lost to Follow-up|1|||
127566849|NCT01343823|459045485|FG000|Overall Study|Study Terminated|1|||
127566850|NCT01343823|459045486|FG001|Overall Study|Study Terminated|0|||
127566851|NCT01343823|459045487|FG002|Overall Study|Study Terminated|0|||
127566852|NCT01343823|459045488|FG003|Overall Study|Study Terminated|1|||
127566853|NCT01343823|459045485|FG000|Overall Study|Withdrawal by Subject|1|||
127566854|NCT01343823|459045486|FG001|Overall Study|Withdrawal by Subject|0|||
127566855|NCT01343823|459045487|FG002|Overall Study|Withdrawal by Subject|0|||
127566856|NCT01343823|459045488|FG003|Overall Study|Withdrawal by Subject|0|||
127566857|NCT00923364|459045489|FG000|Overall Study|Death|3|||
127566858|NCT00923364|459045490|FG001|Overall Study|Death|0|||
127566859|NCT00923364|459045489|FG000|Overall Study|Did not go to transplant|1|||
127566860|NCT00923364|459045490|FG001|Overall Study|Did not go to transplant|0|||
127566861|NCT01011478|459045491|FG000|Overall Study|No follow up data|12|||
127566862|NCT01011478|459045492|FG001|Overall Study|No follow up data|7|||
127566863|NCT04352127|459045494|FG000|Overall Study|Unable to obtain readings|4|||
127566864|NCT04352127|459045495|FG001|Overall Study|Unable to obtain readings|1|||
127566865|NCT01437995|459045496|FG000|Overall Study|Lost to Follow-up|11|||
127566866|NCT01437995|459045497|FG001|Overall Study|Lost to Follow-up|18|||
127566867|NCT01437995|459045498|FG002|Overall Study|Lost to Follow-up|20|||
127566868|NCT05338671|459045499|FG000|Overall Study|Lost to Follow-up|2|||
127566869|NCT05338671|459045500|FG001|Overall Study|Lost to Follow-up|2|||
127566870|NCT05338671|459045499|FG000|Overall Study|Root canal completed in a single visit|1|||
127566871|NCT05338671|459045500|FG001|Overall Study|Root canal completed in a single visit|0|||
127566872|NCT04456673|459045501|FG000|Overall Study|Adverse Event|7|||
127566873|NCT04456673|459045502|FG001|Overall Study|Adverse Event|14|||
127566874|NCT04456673|459045501|FG000|Overall Study|Poor compliance to protocol|1|||
127566875|NCT04456673|459045502|FG001|Overall Study|Poor compliance to protocol|0|||
127566876|NCT04456673|459045501|FG000|Overall Study|Withdrawal by Subject|31|||
127566877|NCT04456673|459045502|FG001|Overall Study|Withdrawal by Subject|23|||
127566878|NCT04456673|459045501|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|4|||
127566879|NCT04456673|459045502|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|5|||
127566880|NCT04391049|459045503|FG000|Overall Study|Protocol Violation|1|||
127566881|NCT03874429|459045504|FG000|Overall Study|Adverse Event|2|||
127566882|NCT03874429|459045505|FG001|Overall Study|Adverse Event|2|||
127566883|NCT03874429|459045504|FG000|Overall Study|Lack of Efficacy|0|||
127566884|NCT03874429|459045505|FG001|Overall Study|Lack of Efficacy|1|||
127566885|NCT03874429|459045504|FG000|Overall Study|Covid-19 pandemic|4|||
127566886|NCT03874429|459045505|FG001|Overall Study|Covid-19 pandemic|2|||
127566887|NCT01215916|459045509|FG000|Overall Study|Progressive Disease|0|||
127566888|NCT01215916|459045510|FG001|Overall Study|Progressive Disease|2|||
127566889|NCT01215916|459045511|FG002|Overall Study|Progressive Disease|1|||
127566890|NCT01215916|459045512|FG003|Overall Study|Progressive Disease|2|||
127566891|NCT01215916|459045513|FG004|Overall Study|Progressive Disease|5|||
127566892|NCT01215916|459045514|FG005|Overall Study|Progressive Disease|4|||
127566893|NCT01215916|459045515|FG006|Overall Study|Progressive Disease|5|||
127566894|NCT01215916|459045516|FG007|Overall Study|Progressive Disease|3|||
127566895|NCT01215916|459045517|FG008|Overall Study|Progressive Disease|1|||
127566896|NCT01215916|459045509|FG000|Overall Study|Adverse Event|1|||
127566897|NCT01215916|459045510|FG001|Overall Study|Adverse Event|1|||
127566898|NCT01215916|459045511|FG002|Overall Study|Adverse Event|0|||
127566899|NCT01215916|459045512|FG003|Overall Study|Adverse Event|1|||
127566900|NCT01215916|459045513|FG004|Overall Study|Adverse Event|0|||
127566901|NCT01215916|459045514|FG005|Overall Study|Adverse Event|0|||
127566902|NCT01215916|459045515|FG006|Overall Study|Adverse Event|3|||
127566903|NCT01215916|459045516|FG007|Overall Study|Adverse Event|0|||
127566904|NCT01215916|459045517|FG008|Overall Study|Adverse Event|0|||
127566905|NCT01215916|459045509|FG000|Overall Study|Withdrawal by Subject|0|||
127566906|NCT01215916|459045510|FG001|Overall Study|Withdrawal by Subject|1|||
127566907|NCT01215916|459045511|FG002|Overall Study|Withdrawal by Subject|1|||
127566908|NCT01215916|459045512|FG003|Overall Study|Withdrawal by Subject|2|||
127566909|NCT01215916|459045513|FG004|Overall Study|Withdrawal by Subject|0|||
127566910|NCT01215916|459045514|FG005|Overall Study|Withdrawal by Subject|0|||
127566911|NCT01215916|459045515|FG006|Overall Study|Withdrawal by Subject|1|||
127566912|NCT01215916|459045516|FG007|Overall Study|Withdrawal by Subject|0|||
127566913|NCT01215916|459045517|FG008|Overall Study|Withdrawal by Subject|0|||
127566914|NCT01215916|459045509|FG000|Overall Study|Death|0|||
127566915|NCT01215916|459045510|FG001|Overall Study|Death|1|||
127566916|NCT01215916|459045511|FG002|Overall Study|Death|0|||
127566917|NCT01215916|459045512|FG003|Overall Study|Death|0|||
127566918|NCT01215916|459045513|FG004|Overall Study|Death|1|||
127566919|NCT01215916|459045514|FG005|Overall Study|Death|0|||
127566920|NCT01215916|459045515|FG006|Overall Study|Death|0|||
127566921|NCT01215916|459045516|FG007|Overall Study|Death|0|||
127566922|NCT01215916|459045517|FG008|Overall Study|Death|1|||
127566923|NCT01215916|459045509|FG000|Overall Study|Physician Decision|0|||
127566924|NCT01215916|459045510|FG001|Overall Study|Physician Decision|0|||
127566925|NCT01215916|459045511|FG002|Overall Study|Physician Decision|1|||
127566926|NCT01215916|459045512|FG003|Overall Study|Physician Decision|1|||
127566927|NCT01215916|459045513|FG004|Overall Study|Physician Decision|0|||
127566928|NCT01215916|459045514|FG005|Overall Study|Physician Decision|0|||
127566929|NCT01215916|459045515|FG006|Overall Study|Physician Decision|0|||
127566930|NCT01215916|459045516|FG007|Overall Study|Physician Decision|0|||
127566931|NCT01215916|459045517|FG008|Overall Study|Physician Decision|0|||
127566932|NCT05028361|459045518|FG000|Overall Study|Withdrawal by Subject|1|||
127566933|NCT05028361|459045519|FG001|Overall Study|Withdrawal by Subject|0|||
127566934|NCT02047318|459045525|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
127566935|NCT02047318|459045525|FG000|Core Study Period|Adverse Event|1|||
127566936|NCT02047318|459045525|FG000|Core Study Period|Withdrawal by caregiver|3|||
127566937|NCT02047318|459045525|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
127566938|NCT02296138|459045526|FG000|Overall Study|Adverse Event|348|||
127566939|NCT02296138|459045527|FG001|Overall Study|Adverse Event|259|||
127689397|NCT03283371|459488235|FG003|Placebo-controlled|Adverse Event|0|||
127689398|NCT03283371|459488232|FG000|Placebo-controlled|Lack of Efficacy|1|||
127689399|NCT03283371|459488233|FG001|Placebo-controlled|Lack of Efficacy|0|||
127566940|NCT02296138|459045526|FG000|Overall Study|Lack of Efficacy|59|||
127566941|NCT02296138|459045527|FG001|Overall Study|Lack of Efficacy|37|||
127566942|NCT02296138|459045526|FG000|Overall Study|Protocol Violation|35|||
127566943|NCT02296138|459045527|FG001|Overall Study|Protocol Violation|36|||
127566944|NCT02296138|459045526|FG000|Overall Study|Lost to Follow-up|9|||
127566945|NCT02296138|459045527|FG001|Overall Study|Lost to Follow-up|12|||
127566946|NCT02296138|459045526|FG000|Overall Study|Withdrawal by Subject|184|||
127566947|NCT02296138|459045527|FG001|Overall Study|Withdrawal by Subject|131|||
127566948|NCT02296138|459045526|FG000|Overall Study|Not Treated|1|||
127566949|NCT02296138|459045527|FG001|Overall Study|Not Treated|1|||
127566950|NCT02296138|459045526|FG000|Overall Study|Patients with data irregularities|10|||
127566951|NCT02296138|459045527|FG001|Overall Study|Patients with data irregularities|11|||
127566952|NCT02296138|459045526|FG000|Overall Study|Other than specified|15|||
127566953|NCT02296138|459045527|FG001|Overall Study|Other than specified|13|||
127566954|NCT00711516|459045528|FG000|Overall Study|Adverse Event|1|||
127566955|NCT00711516|459045529|FG001|Overall Study|Adverse Event|1|||
127689400|NCT03283371|459488234|FG002|Placebo-controlled|Lack of Efficacy|0|||
128026245|NCT00098293|460720195|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
128026246|NCT00098293|460720191|FG000|Double-blind (DB) Phase|Death|1|||
128026247|NCT00098293|460720192|FG001|Double-blind (DB) Phase|Death|2|||
128026248|NCT00098293|460720193|FG002|Double-blind (DB) Phase|Death|2|||
128026249|NCT00098293|460720194|FG003|Double-blind (DB) Phase|Death|0|||
128026250|NCT00098293|460720195|FG004|Double-blind (DB) Phase|Death|0|||
128026251|NCT00098293|460720191|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
128026252|NCT00098293|460720192|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
128026253|NCT00098293|460720193|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
128026254|NCT00098293|460720194|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
128026255|NCT00098293|460720195|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
128026256|NCT00098293|460720191|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
128026257|NCT00098293|460720192|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
128026258|NCT00098293|460720193|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
128026259|NCT00098293|460720194|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
128026260|NCT00098293|460720195|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
128026261|NCT00098293|460720191|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
128026262|NCT00098293|460720192|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
128026263|NCT00098293|460720193|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
128026264|NCT00098293|460720194|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
127566956|NCT00711516|459045528|FG000|Overall Study|Withdrawal by Subject|0|||
127566957|NCT00711516|459045529|FG001|Overall Study|Withdrawal by Subject|1|||
127566958|NCT00711516|459045528|FG000|Overall Study|Protocol Violation|0|||
127566959|NCT00711516|459045529|FG001|Overall Study|Protocol Violation|1|||
127566960|NCT02108262|459045533|FG000|Overall Study|Non-compliance|0|||
127566961|NCT02108262|459045534|FG001|Overall Study|Non-compliance|2|||
127566962|NCT02108262|459045535|FG002|Overall Study|Non-compliance|1|||
127566963|NCT02108262|459045536|FG003|Overall Study|Non-compliance|1|||
127566964|NCT02108262|459045533|FG000|Overall Study|Randomized by error/screen failure|0|||
127566965|NCT02108262|459045534|FG001|Overall Study|Randomized by error/screen failure|0|||
127566966|NCT02108262|459045535|FG002|Overall Study|Randomized by error/screen failure|1|||
127566967|NCT02108262|459045536|FG003|Overall Study|Randomized by error/screen failure|0|||
127566968|NCT02108262|459045533|FG000|Overall Study|Distance to center|0|||
127566969|NCT02108262|459045534|FG001|Overall Study|Distance to center|1|||
127566970|NCT02108262|459045535|FG002|Overall Study|Distance to center|1|||
127566971|NCT02108262|459045536|FG003|Overall Study|Distance to center|0|||
127566972|NCT02108262|459045533|FG000|Overall Study|Adverse Event|0|||
127566973|NCT02108262|459045534|FG001|Overall Study|Adverse Event|11|||
127566974|NCT02108262|459045535|FG002|Overall Study|Adverse Event|6|||
127566975|NCT02108262|459045536|FG003|Overall Study|Adverse Event|12|||
127566976|NCT02108262|459045533|FG000|Overall Study|Death|0|||
127566977|NCT02108262|459045534|FG001|Overall Study|Death|2|||
127566978|NCT02108262|459045535|FG002|Overall Study|Death|2|||
127566979|NCT02108262|459045536|FG003|Overall Study|Death|1|||
127566980|NCT02108262|459045533|FG000|Overall Study|Lost to Follow-up|0|||
128026265|NCT00098293|460720195|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
128026266|NCT00098293|460720191|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
128026267|NCT00098293|460720192|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
128026268|NCT00098293|460720193|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
128026269|NCT00098293|460720194|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
127566981|NCT02108262|459045534|FG001|Overall Study|Lost to Follow-up|0|||
127566982|NCT02108262|459045535|FG002|Overall Study|Lost to Follow-up|1|||
127566983|NCT02108262|459045536|FG003|Overall Study|Lost to Follow-up|0|||
127566984|NCT02108262|459045533|FG000|Overall Study|Physician Decision|0|||
127566985|NCT02108262|459045534|FG001|Overall Study|Physician Decision|0|||
127689401|NCT03283371|459488235|FG003|Placebo-controlled|Lack of Efficacy|0|||
127689402|NCT03283371|459488232|FG000|Placebo-controlled|Withdrawal by Subject|1|||
127689403|NCT03283371|459488233|FG001|Placebo-controlled|Withdrawal by Subject|1|||
127689404|NCT03283371|459488234|FG002|Placebo-controlled|Withdrawal by Subject|0|||
127689405|NCT03283371|459488235|FG003|Placebo-controlled|Withdrawal by Subject|0|||
127689406|NCT03283371|459488232|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
127689407|NCT03283371|459488233|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
127689408|NCT03283371|459488234|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
128026270|NCT00098293|460720195|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
128026271|NCT00098293|460720191|FG000|Open-label (OL) Phase|Adverse Event|0|||
127566986|NCT02108262|459045535|FG002|Overall Study|Physician Decision|2|||
127566987|NCT02108262|459045536|FG003|Overall Study|Physician Decision|0|||
127566988|NCT02108262|459045533|FG000|Overall Study|Withdrawal by Subject|0|||
127566989|NCT02108262|459045534|FG001|Overall Study|Withdrawal by Subject|7|||
127566990|NCT02108262|459045535|FG002|Overall Study|Withdrawal by Subject|3|||
127566991|NCT02108262|459045536|FG003|Overall Study|Withdrawal by Subject|4|||
127566992|NCT02108262|459045533|FG000|Overall Study|Due to key hepatic values|0|||
127566993|NCT02108262|459045534|FG001|Overall Study|Due to key hepatic values|1|||
127566994|NCT02108262|459045535|FG002|Overall Study|Due to key hepatic values|0|||
127566995|NCT02108262|459045536|FG003|Overall Study|Due to key hepatic values|0|||
127566996|NCT02108262|459045533|FG000|Overall Study|Unable to contact patient|0|||
127566997|NCT02108262|459045534|FG001|Overall Study|Unable to contact patient|3|||
127566998|NCT02108262|459045535|FG002|Overall Study|Unable to contact patient|1|||
127566999|NCT02108262|459045536|FG003|Overall Study|Unable to contact patient|2|||
127567000|NCT02108262|459045533|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
127567001|NCT02108262|459045534|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
127567002|NCT02108262|459045535|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
127567003|NCT02108262|459045536|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
127567004|NCT02108262|459045533|FG000|Overall Study|Patient did not want another infusion|0|||
127777411|NCT05211739|459813535|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
127777412|NCT05211739|459813536|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
127777413|NCT05211739|459813535|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
127777414|NCT05211739|459813536|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
127777415|NCT05211739|459813535|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
127777416|NCT05211739|459813536|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
127777417|NCT01862640|459813537|FG000|Overall Study|Adverse Event|4|||
127777418|NCT01862640|459813538|FG001|Overall Study|Adverse Event|10|||
127777419|NCT01862640|459813539|FG002|Overall Study|Adverse Event|6|||
127777420|NCT01862640|459813540|FG003|Overall Study|Adverse Event|8|||
127777421|NCT01862640|459813537|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
127777422|NCT01862640|459813538|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
127777423|NCT01862640|459813539|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
127777424|NCT01862640|459813540|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
127777425|NCT01862640|459813537|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
127777426|NCT01862640|459813538|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
127567005|NCT02108262|459045534|FG001|Overall Study|Patient did not want another infusion|3|||
127567006|NCT02108262|459045535|FG002|Overall Study|Patient did not want another infusion|3|||
127567007|NCT02108262|459045536|FG003|Overall Study|Patient did not want another infusion|2|||
127567008|NCT02108262|459045533|FG000|Overall Study|Vacation|0|||
127567009|NCT02108262|459045534|FG001|Overall Study|Vacation|1|||
127567010|NCT02108262|459045535|FG002|Overall Study|Vacation|0|||
127567011|NCT02108262|459045536|FG003|Overall Study|Vacation|0|||
127567012|NCT02108262|459045533|FG000|Overall Study|Patient decision|0|||
127567013|NCT02108262|459045534|FG001|Overall Study|Patient decision|7|||
127567014|NCT02108262|459045535|FG002|Overall Study|Patient decision|9|||
127567015|NCT02108262|459045536|FG003|Overall Study|Patient decision|14|||
127567016|NCT02108262|459045533|FG000|Overall Study|Missed IV due to pharmacy error|0|||
127567017|NCT02108262|459045534|FG001|Overall Study|Missed IV due to pharmacy error|0|||
127567018|NCT02108262|459045535|FG002|Overall Study|Missed IV due to pharmacy error|1|||
127567019|NCT02108262|459045536|FG003|Overall Study|Missed IV due to pharmacy error|0|||
127567020|NCT00868517|459045539|FG000|Overall Study|Withdrawal by Subject|3|||
127567021|NCT00868517|459045540|FG001|Overall Study|Withdrawal by Subject|3|||
127567022|NCT00868517|459045541|FG002|Overall Study|Withdrawal by Subject|2|||
127567023|NCT00868517|459045539|FG000|Overall Study|Protocol Violation|1|||
127567024|NCT00868517|459045540|FG001|Overall Study|Protocol Violation|1|||
127567025|NCT00868517|459045541|FG002|Overall Study|Protocol Violation|0|||
127567026|NCT00420641|459045544|FG000|Overall Study|Adverse Event|3|||
127567027|NCT00420641|459045545|FG001|Overall Study|Adverse Event|25|||
127567028|NCT00420641|459045546|FG002|Overall Study|Adverse Event|10|||
127567029|NCT00420641|459045544|FG000|Overall Study|Lost to Follow-up|2|||
127567030|NCT00420641|459045545|FG001|Overall Study|Lost to Follow-up|4|||
127567031|NCT00420641|459045546|FG002|Overall Study|Lost to Follow-up|2|||
127567032|NCT00420641|459045544|FG000|Overall Study|Protocol Violation|8|||
127567033|NCT00420641|459045545|FG001|Overall Study|Protocol Violation|8|||
127567034|NCT00420641|459045546|FG002|Overall Study|Protocol Violation|7|||
127567035|NCT00420641|459045544|FG000|Overall Study|Withdrawal by Subject|15|||
127689409|NCT03283371|459488235|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
127689410|NCT03283371|459488232|FG000|Open-label Phase|Adverse Event|0|||
127689411|NCT03283371|459488233|FG001|Open-label Phase|Adverse Event|0|||
127689412|NCT03283371|459488234|FG002|Open-label Phase|Adverse Event|2|||
127689413|NCT03283371|459488235|FG003|Open-label Phase|Adverse Event|0|||
127689414|NCT03283371|459488232|FG000|Open-label Phase|Withdrawal by Subject|0|||
127689415|NCT03283371|459488233|FG001|Open-label Phase|Withdrawal by Subject|0|||
127689416|NCT03283371|459488234|FG002|Open-label Phase|Withdrawal by Subject|1|||
127689417|NCT03283371|459488235|FG003|Open-label Phase|Withdrawal by Subject|0|||
127689418|NCT03283371|459488232|FG000|Open-label Phase|Other|0|||
127689419|NCT03283371|459488233|FG001|Open-label Phase|Other|0|||
127689420|NCT03283371|459488234|FG002|Open-label Phase|Other|1|||
127777427|NCT01862640|459813539|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
127777428|NCT01862640|459813540|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
127777429|NCT01862640|459813537|FG000|Overall Study|Withdrawal by Subject|2|||
127777430|NCT01862640|459813538|FG001|Overall Study|Withdrawal by Subject|4|||
127777431|NCT01862640|459813539|FG002|Overall Study|Withdrawal by Subject|8|||
127777432|NCT01862640|459813540|FG003|Overall Study|Withdrawal by Subject|5|||
127777433|NCT01862640|459813537|FG000|Overall Study|Protocol Deviation|0|||
127567036|NCT00420641|459045545|FG001|Overall Study|Withdrawal by Subject|21|||
127567037|NCT00420641|459045546|FG002|Overall Study|Withdrawal by Subject|14|||
127567038|NCT00420641|459045544|FG000|Overall Study|Lack of Efficacy|6|||
127567039|NCT00420641|459045545|FG001|Overall Study|Lack of Efficacy|5|||
127567040|NCT00420641|459045546|FG002|Overall Study|Lack of Efficacy|4|||
127567041|NCT00420641|459045544|FG000|Overall Study|Non-compliance|7|||
127567042|NCT00420641|459045545|FG001|Overall Study|Non-compliance|5|||
127567043|NCT00420641|459045546|FG002|Overall Study|Non-compliance|4|||
127567044|NCT00420641|459045544|FG000|Overall Study|Other|4|||
127567045|NCT00420641|459045545|FG001|Overall Study|Other|4|||
127567046|NCT00420641|459045546|FG002|Overall Study|Other|3|||
127567047|NCT03459690|459045547|FG000|Overall Study|Lost to Follow-up|0|||
127567048|NCT03459690|459045548|FG001|Overall Study|Lost to Follow-up|1|||
127777434|NCT01862640|459813538|FG001|Overall Study|Protocol Deviation|0|||
127777435|NCT01862640|459813539|FG002|Overall Study|Protocol Deviation|1|||
127777436|NCT01862640|459813540|FG003|Overall Study|Protocol Deviation|0|||
127777437|NCT01975428|459813543|FG000|Overall Study|Lost to Follow-up|17|||
127777438|NCT01975428|459813544|FG001|Overall Study|Lost to Follow-up|4|||
127777439|NCT01975428|459813543|FG000|Overall Study|Withdrawal by Subject|3|||
127777440|NCT01975428|459813544|FG001|Overall Study|Withdrawal by Subject|10|||
127777441|NCT02187809|459813545|FG000|Overall Study|The study was terminated|3|||
127777442|NCT05085665|459813546|FG000|Overall Study|Physician Decision|2|||
127777443|NCT01641809|459813547|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
127777444|NCT01641809|459813548|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
127777445|NCT01641809|459813549|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
127777446|NCT01641809|459813550|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
127777447|NCT01641809|459813547|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
127777448|NCT01641809|459813548|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
127777449|NCT01641809|459813549|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
127777450|NCT01641809|459813550|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
127777451|NCT01641809|459813547|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
127777452|NCT01641809|459813548|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
127777453|NCT01641809|459813549|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
127777454|NCT01641809|459813550|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
127777455|NCT01641809|459813547|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
127777456|NCT01641809|459813548|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
127777457|NCT01641809|459813549|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
127777458|NCT01641809|459813550|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
127777459|NCT01641809|459813547|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
127777460|NCT01641809|459813548|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
127777461|NCT01641809|459813549|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
127777462|NCT01641809|459813550|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
127777463|NCT01641809|459813547|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
127777464|NCT01641809|459813548|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
127777465|NCT01641809|459813549|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
127777466|NCT01641809|459813550|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
127777467|NCT01641809|459813547|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
127777468|NCT01641809|459813548|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
127777469|NCT01641809|459813549|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
127777470|NCT01641809|459813550|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
127777471|NCT01641809|459813547|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
127777472|NCT01641809|459813548|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
127777473|NCT01641809|459813549|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
127777474|NCT01641809|459813550|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
127777475|NCT01641809|459813547|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
127777476|NCT01641809|459813548|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
127777477|NCT01641809|459813549|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
128026272|NCT00098293|460720192|FG001|Open-label (OL) Phase|Adverse Event|3|||
128026273|NCT00098293|460720193|FG002|Open-label (OL) Phase|Adverse Event|7|||
128026274|NCT00098293|460720194|FG003|Open-label (OL) Phase|Adverse Event|6|||
127567049|NCT03459690|459045547|FG000|Overall Study|Withdrawal by Subject|1|||
127567050|NCT03459690|459045548|FG001|Overall Study|Withdrawal by Subject|1|||
127567051|NCT02586506|459045549|FG000|Overall Study|Protocol Violation|6|||
127567052|NCT02586506|459045549|FG000|Overall Study|Lost to Follow-up|1|||
127567053|NCT02586506|459045549|FG000|Overall Study|Other Reason|2|||
127567054|NCT02815280|459045552|FG000|Double-Blind Phase|Adverse Event|1|||
127777478|NCT01641809|459813550|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
127777479|NCT01641809|459813547|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
127777480|NCT01641809|459813548|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
127777481|NCT01641809|459813549|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
127567055|NCT02815280|459045553|FG001|Double-Blind Phase|Adverse Event|1|||
127567056|NCT02815280|459045552|FG000|Double-Blind Phase|Lost to Follow-up|10|||
127567057|NCT02815280|459045553|FG001|Double-Blind Phase|Lost to Follow-up|9|||
127567058|NCT02815280|459045552|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
127567059|NCT02815280|459045553|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
127567060|NCT02815280|459045552|FG000|Double-Blind Phase|Protocol Violation|2|||
127567061|NCT02815280|459045553|FG001|Double-Blind Phase|Protocol Violation|2|||
127567062|NCT02815280|459045552|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
127567063|NCT02815280|459045553|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
127777482|NCT01641809|459813550|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
127777483|NCT01641809|459813547|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
127567064|NCT02815280|459045552|FG000|Open-Label Phase|Adverse Event|2|||
127567065|NCT02815280|459045553|FG001|Open-Label Phase|Adverse Event|3|||
127567066|NCT02815280|459045552|FG000|Open-Label Phase|Lost to Follow-up|18|||
127567067|NCT02815280|459045553|FG001|Open-Label Phase|Lost to Follow-up|9|||
127567068|NCT02815280|459045552|FG000|Open-Label Phase|Withdrawal by Subject|33|||
127567069|NCT02815280|459045553|FG001|Open-Label Phase|Withdrawal by Subject|18|||
127567070|NCT02815280|459045552|FG000|Open-Label Phase|Protocol Violation|3|||
127567071|NCT02815280|459045553|FG001|Open-Label Phase|Protocol Violation|0|||
127689421|NCT03283371|459488235|FG003|Open-label Phase|Other|1|||
127689422|NCT00243503|459488238|FG000|Overall Study|Adverse Event|11|||
127689423|NCT00243503|459488238|FG000|Overall Study|Withdrawal by Subject|1|||
127689424|NCT00243503|459488238|FG000|Overall Study|Lack of Efficacy|44|||
127689425|NCT00243503|459488238|FG000|Overall Study|Death|1|||
127689426|NCT00243503|459488238|FG000|Overall Study|Other|1|||
127689427|NCT04600752|459488241|FG000|Overall Study|Physician Decision|0|||
127689428|NCT04600752|459488242|FG001|Overall Study|Physician Decision|0|||
127689429|NCT04600752|459488243|FG002|Overall Study|Physician Decision|1|||
127689430|NCT04600752|459488241|FG000|Overall Study|Adverse Event|0|||
127689431|NCT04600752|459488242|FG001|Overall Study|Adverse Event|1|||
127689432|NCT04600752|459488243|FG002|Overall Study|Adverse Event|0|||
127689433|NCT04600752|459488241|FG000|Overall Study|Withdrawal by Subject|2|||
127689434|NCT04600752|459488242|FG001|Overall Study|Withdrawal by Subject|1|||
127689435|NCT04600752|459488243|FG002|Overall Study|Withdrawal by Subject|0|||
127689436|NCT04600752|459488241|FG000|Overall Study|Lack of Efficacy|1|||
127689437|NCT04600752|459488242|FG001|Overall Study|Lack of Efficacy|0|||
127689438|NCT04600752|459488243|FG002|Overall Study|Lack of Efficacy|0|||
127689439|NCT03076515|459488244|FG000|Overall Study|DMC decision based on interim analysis|25|||
127689440|NCT03076515|459488245|FG001|Overall Study|DMC decision based on interim analysis|29|||
127689441|NCT02374307|459488246|FG000|3-months Follow-up|Lost to Follow-up|1|||
127689442|NCT02374307|459488247|FG001|3-months Follow-up|Lost to Follow-up|2|||
127689443|NCT02374307|459488246|FG000|3-months Follow-up|Withdrawal by Subject|1|||
127689444|NCT02374307|459488247|FG001|3-months Follow-up|Withdrawal by Subject|4|||
127689445|NCT02374307|459488246|FG000|3-months Follow-up|Death|1|||
127689446|NCT02374307|459488247|FG001|3-months Follow-up|Death|2|||
127689447|NCT02374307|459488246|FG000|3-months Follow-up|Missed first follow-up|5|||
127689448|NCT02374307|459488247|FG001|3-months Follow-up|Missed first follow-up|1|||
127689449|NCT02374307|459488246|FG000|6-months Follow-up|Lost to Follow-up|1|||
127689450|NCT02374307|459488247|FG001|6-months Follow-up|Lost to Follow-up|2|||
127689451|NCT02374307|459488246|FG000|6-months Follow-up|Death|2|||
127689452|NCT02374307|459488247|FG001|6-months Follow-up|Death|1|||
127689453|NCT02374307|459488246|FG000|6-months Follow-up|Withdrawal by Subject|0|||
127689454|NCT02374307|459488247|FG001|6-months Follow-up|Withdrawal by Subject|3|||
127689455|NCT00999167|459488248|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
127689456|NCT00999167|459488249|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
127689457|NCT00999167|459488250|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
127689458|NCT00999167|459488248|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
127777484|NCT01641809|459813548|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
127567072|NCT02815280|459045552|FG000|Open-Label Phase|Administrative|26|||
127567073|NCT02815280|459045553|FG001|Open-Label Phase|Administrative|12|||
127567074|NCT02815280|459045552|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
127567075|NCT02815280|459045553|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
127689459|NCT00999167|459488249|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
127689460|NCT00999167|459488250|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
127689461|NCT00999167|459488248|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
127689462|NCT00999167|459488249|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
127567076|NCT02514473|459045566|FG000|Overall Study|Adverse Event|0|||
127567077|NCT02514473|459045567|FG001|Overall Study|Adverse Event|2|||
127567078|NCT02514473|459045566|FG000|Overall Study|Withdrawal by Subject|2|||
127567079|NCT02514473|459045567|FG001|Overall Study|Withdrawal by Subject|1|||
127689463|NCT00999167|459488250|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
127689464|NCT00999167|459488248|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
127689465|NCT00999167|459488249|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
127689466|NCT00999167|459488250|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
127689467|NCT00999167|459488248|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
127689468|NCT00999167|459488249|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
127689469|NCT00999167|459488250|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
127689470|NCT00999167|459488248|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
127689471|NCT00999167|459488249|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
127689472|NCT00999167|459488250|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
127689473|NCT00999167|459488248|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
127689474|NCT00999167|459488249|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
127689475|NCT00999167|459488250|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
127689476|NCT00999167|459488248|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
127689477|NCT00999167|459488249|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
127689478|NCT00999167|459488250|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
127689479|NCT02554786|459488251|FG000|Overall Study|Subject/guardian decision|29|||
127689480|NCT02554786|459488252|FG001|Overall Study|Subject/guardian decision|17|||
127689481|NCT02554786|459488253|FG002|Overall Study|Subject/guardian decision|18|||
127689482|NCT02554786|459488254|FG003|Overall Study|Subject/guardian decision|30|||
127689483|NCT02554786|459488255|FG004|Overall Study|Subject/guardian decision|20|||
127689484|NCT02554786|459488251|FG000|Overall Study|Lost to Follow-up|4|||
127689485|NCT02554786|459488252|FG001|Overall Study|Lost to Follow-up|3|||
127689486|NCT02554786|459488253|FG002|Overall Study|Lost to Follow-up|4|||
127689487|NCT02554786|459488254|FG003|Overall Study|Lost to Follow-up|2|||
127689488|NCT02554786|459488255|FG004|Overall Study|Lost to Follow-up|2|||
127689489|NCT02554786|459488251|FG000|Overall Study|Protocol deviation|1|||
127689490|NCT02554786|459488252|FG001|Overall Study|Protocol deviation|3|||
127689491|NCT02554786|459488253|FG002|Overall Study|Protocol deviation|3|||
127689492|NCT02554786|459488254|FG003|Overall Study|Protocol deviation|4|||
127689493|NCT02554786|459488255|FG004|Overall Study|Protocol deviation|2|||
127689494|NCT02554786|459488251|FG000|Overall Study|Technical problems|1|||
127689495|NCT02554786|459488252|FG001|Overall Study|Technical problems|1|||
127689496|NCT02554786|459488253|FG002|Overall Study|Technical problems|0|||
127689497|NCT02554786|459488254|FG003|Overall Study|Technical problems|2|||
127689498|NCT02554786|459488255|FG004|Overall Study|Technical problems|1|||
127689499|NCT02554786|459488251|FG000|Overall Study|Adverse Event|0|||
127689500|NCT02554786|459488252|FG001|Overall Study|Adverse Event|0|||
127689501|NCT02554786|459488253|FG002|Overall Study|Adverse Event|0|||
127689502|NCT02554786|459488254|FG003|Overall Study|Adverse Event|0|||
127689503|NCT02554786|459488255|FG004|Overall Study|Adverse Event|2|||
127689504|NCT02554786|459488251|FG000|Overall Study|Death|0|||
127689505|NCT02554786|459488252|FG001|Overall Study|Death|0|||
127689506|NCT02554786|459488253|FG002|Overall Study|Death|0|||
127689507|NCT02554786|459488254|FG003|Overall Study|Death|1|||
127689508|NCT02554786|459488255|FG004|Overall Study|Death|0|||
127689509|NCT02554786|459488251|FG000|Overall Study|Non-compliance with study treatment|0|||
127689510|NCT02554786|459488252|FG001|Overall Study|Non-compliance with study treatment|1|||
127689511|NCT02554786|459488253|FG002|Overall Study|Non-compliance with study treatment|1|||
127689512|NCT02554786|459488254|FG003|Overall Study|Non-compliance with study treatment|0|||
127689513|NCT02554786|459488255|FG004|Overall Study|Non-compliance with study treatment|1|||
127689514|NCT02554786|459488251|FG000|Overall Study|Physician Decision|0|||
127689515|NCT02554786|459488252|FG001|Overall Study|Physician Decision|1|||
127689516|NCT02554786|459488253|FG002|Overall Study|Physician Decision|4|||
127689517|NCT02554786|459488254|FG003|Overall Study|Physician Decision|1|||
127689518|NCT02554786|459488255|FG004|Overall Study|Physician Decision|1|||
127689519|NCT02554786|459488251|FG000|Overall Study|Pregnancy|0|||
127689520|NCT02554786|459488252|FG001|Overall Study|Pregnancy|0|||
127689521|NCT02554786|459488253|FG002|Overall Study|Pregnancy|0|||
127689522|NCT02554786|459488254|FG003|Overall Study|Pregnancy|1|||
127689523|NCT02554786|459488255|FG004|Overall Study|Pregnancy|1|||
127689524|NCT05052996|459488256|FG000|Overall Study|Still on study|0|||
127689525|NCT05052996|459488257|FG001|Overall Study|Still on study|0|||
127689526|NCT05052996|459488258|FG002|Overall Study|Still on study|47|||
127689527|NCT05052996|459488259|FG003|Overall Study|Still on study|44|||
127689528|NCT05052996|459488256|FG000|Overall Study|Cohort terminated by sponsor|21|||
127689529|NCT05052996|459488257|FG001|Overall Study|Cohort terminated by sponsor|12|||
127689530|NCT05052996|459488258|FG002|Overall Study|Cohort terminated by sponsor|0|||
127689531|NCT05052996|459488259|FG003|Overall Study|Cohort terminated by sponsor|0|||
127689532|NCT05052996|459488256|FG000|Overall Study|Withdrew consent|1|||
127689533|NCT05052996|459488257|FG001|Overall Study|Withdrew consent|0|||
127689534|NCT05052996|459488258|FG002|Overall Study|Withdrew consent|1|||
127777485|NCT01641809|459813549|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
127777486|NCT01641809|459813550|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
127777487|NCT01641809|459813547|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
127777488|NCT01641809|459813548|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
127777489|NCT01641809|459813549|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
127777490|NCT01641809|459813550|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
127777491|NCT01641809|459813547|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
127777492|NCT01641809|459813548|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
127777493|NCT01641809|459813549|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
127777494|NCT01641809|459813550|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
127777495|NCT01641809|459813547|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
127777496|NCT01641809|459813548|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
127777497|NCT01641809|459813549|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
127777498|NCT01641809|459813550|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
127777499|NCT01641809|459813547|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
127777500|NCT01641809|459813548|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
127777501|NCT01641809|459813549|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
128026275|NCT00098293|460720195|FG004|Open-label (OL) Phase|Adverse Event|0|||
128026276|NCT00098293|460720191|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
128026277|NCT00098293|460720192|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
127567080|NCT02514473|459045566|FG000|Overall Study|Lost to Follow-up|0|||
127567081|NCT02514473|459045567|FG001|Overall Study|Lost to Follow-up|1|||
127567082|NCT02514473|459045566|FG000|Overall Study|Other|1|||
127567083|NCT02514473|459045567|FG001|Overall Study|Other|1|||
127567084|NCT02158364|459045568|FG000|Overall Study|Case report forms uncollected|10|||
127567085|NCT02158364|459045568|FG000|Overall Study|Protocol Deviation|50|||
127567086|NCT00674154|459045571|FG000|Overall Study|Withdrawal by Subject|3|||
127567087|NCT00674154|459045572|FG001|Overall Study|Withdrawal by Subject|1|||
127567088|NCT00674154|459045571|FG000|Overall Study|Did not want parathyroidectomy|0|||
127567089|NCT00674154|459045572|FG001|Overall Study|Did not want parathyroidectomy|2|||
127777502|NCT01641809|459813550|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
127777503|NCT01641809|459813547|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
127777504|NCT01641809|459813548|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
127777505|NCT01641809|459813549|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
127777506|NCT01641809|459813550|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
127777507|NCT01641809|459813547|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
127777508|NCT01641809|459813548|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
127777509|NCT01641809|459813549|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
127777510|NCT01641809|459813550|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
127777511|NCT01641809|459813547|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
128026278|NCT00098293|460720193|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
128026279|NCT00098293|460720194|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
128026280|NCT00098293|460720195|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
128026281|NCT00098293|460720191|FG000|Open-label (OL) Phase|Pregnancy|0|||
128026282|NCT00098293|460720192|FG001|Open-label (OL) Phase|Pregnancy|1|||
128026283|NCT00098293|460720193|FG002|Open-label (OL) Phase|Pregnancy|0|||
128026284|NCT00098293|460720194|FG003|Open-label (OL) Phase|Pregnancy|3|||
128026285|NCT00098293|460720195|FG004|Open-label (OL) Phase|Pregnancy|0|||
128026286|NCT00098293|460720191|FG000|Open-label (OL) Phase|Protocol Violation|0|||
128026287|NCT00098293|460720192|FG001|Open-label (OL) Phase|Protocol Violation|6|||
128026288|NCT00098293|460720193|FG002|Open-label (OL) Phase|Protocol Violation|13|||
128026289|NCT00098293|460720194|FG003|Open-label (OL) Phase|Protocol Violation|16|||
128026290|NCT00098293|460720195|FG004|Open-label (OL) Phase|Protocol Violation|0|||
128026291|NCT00098293|460720191|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
128026292|NCT00098293|460720192|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
128026293|NCT00098293|460720193|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
128026294|NCT00098293|460720194|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
127777512|NCT01641809|459813548|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
127777513|NCT01641809|459813549|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
127777514|NCT01641809|459813550|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
127777515|NCT00778622|459813551|FG000|Overall Study|Adverse Event|5|||
127777516|NCT00778622|459813552|FG001|Overall Study|Adverse Event|4|||
127777517|NCT00778622|459813553|FG002|Overall Study|Adverse Event|7|||
127777518|NCT00778622|459813551|FG000|Overall Study|Withdrawal by Subject|4|||
127777519|NCT00778622|459813552|FG001|Overall Study|Withdrawal by Subject|5|||
128026295|NCT00098293|460720195|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
128026296|NCT00098293|460720191|FG000|Open-label (OL) Phase|Death|0|||
128026297|NCT00098293|460720192|FG001|Open-label (OL) Phase|Death|2|||
127567090|NCT05093790|459045576|FG000|Overall Study|Failure to meet continuation criteria|0|||
128026298|NCT00098293|460720193|FG002|Open-label (OL) Phase|Death|3|||
128026299|NCT00098293|460720194|FG003|Open-label (OL) Phase|Death|0|||
128026300|NCT00098293|460720195|FG004|Open-label (OL) Phase|Death|0|||
128026301|NCT00098293|460720191|FG000|Supplemental Phase (SP)|Death|0|||
128026302|NCT00098293|460720192|FG001|Supplemental Phase (SP)|Death|0|||
128026303|NCT00098293|460720193|FG002|Supplemental Phase (SP)|Death|0|||
128026304|NCT00098293|460720194|FG003|Supplemental Phase (SP)|Death|0|||
128026305|NCT00098293|460720195|FG004|Supplemental Phase (SP)|Death|1|||
128026306|NCT00098293|460720191|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
128026307|NCT00098293|460720192|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
128026308|NCT00098293|460720193|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
128026309|NCT00098293|460720194|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
128026310|NCT00098293|460720195|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
128026311|NCT00098293|460720191|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
128026312|NCT00098293|460720192|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
128026313|NCT00098293|460720193|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
128026314|NCT00098293|460720194|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
128026315|NCT00098293|460720195|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
128026316|NCT00098293|460720191|FG000|Supplemental Phase (SP)|Other|0|||
128026317|NCT00098293|460720192|FG001|Supplemental Phase (SP)|Other|0|||
128026318|NCT00098293|460720193|FG002|Supplemental Phase (SP)|Other|0|||
128026319|NCT00098293|460720194|FG003|Supplemental Phase (SP)|Other|0|||
128026320|NCT00098293|460720195|FG004|Supplemental Phase (SP)|Other|22|||
128026321|NCT01370642|460720196|FG000|Overall Study|Adverse Event|2|||
128026322|NCT01370642|460720197|FG001|Overall Study|Adverse Event|1|||
128026323|NCT01370642|460720198|FG002|Overall Study|Adverse Event|1|||
128026324|NCT01370642|460720196|FG000|Overall Study|Detectable HCV RNA|0|||
128026325|NCT01370642|460720197|FG001|Overall Study|Detectable HCV RNA|0|||
128026326|NCT01370642|460720198|FG002|Overall Study|Detectable HCV RNA|22|||
128026327|NCT01370642|460720196|FG000|Overall Study|Lost to Follow-up|0|||
128026328|NCT01370642|460720197|FG001|Overall Study|Lost to Follow-up|0|||
128026329|NCT01370642|460720198|FG002|Overall Study|Lost to Follow-up|1|||
128026330|NCT01370642|460720196|FG000|Overall Study|Physician Decision|4|||
128026331|NCT01370642|460720197|FG001|Overall Study|Physician Decision|1|||
128026332|NCT01370642|460720198|FG002|Overall Study|Physician Decision|2|||
128026333|NCT01370642|460720196|FG000|Overall Study|Withdrawal by Subject|2|||
128026334|NCT01370642|460720197|FG001|Overall Study|Withdrawal by Subject|4|||
128026335|NCT01370642|460720198|FG002|Overall Study|Withdrawal by Subject|3|||
128026336|NCT01796470|460720205|FG000|Overall Study|Adverse Event|4|||
128026337|NCT01796470|460720206|FG001|Overall Study|Adverse Event|2|||
128026338|NCT01796470|460720207|FG002|Overall Study|Adverse Event|2|||
128026339|NCT01796470|460720208|FG003|Overall Study|Adverse Event|1|||
127777520|NCT00778622|459813553|FG002|Overall Study|Withdrawal by Subject|5|||
127777521|NCT00778622|459813551|FG000|Overall Study|Lost to Follow-up|3|||
127777522|NCT00778622|459813552|FG001|Overall Study|Lost to Follow-up|3|||
127777523|NCT00778622|459813553|FG002|Overall Study|Lost to Follow-up|2|||
127777524|NCT00778622|459813551|FG000|Overall Study|Protocol Violation|0|||
127777525|NCT00778622|459813552|FG001|Overall Study|Protocol Violation|3|||
127777526|NCT00778622|459813553|FG002|Overall Study|Protocol Violation|0|||
127777527|NCT00778622|459813551|FG000|Overall Study|Lack of Efficacy|2|||
127777528|NCT00778622|459813552|FG001|Overall Study|Lack of Efficacy|0|||
127777529|NCT00778622|459813553|FG002|Overall Study|Lack of Efficacy|0|||
127777530|NCT00778622|459813551|FG000|Overall Study|immigration|1|||
127777531|NCT00778622|459813552|FG001|Overall Study|immigration|0|||
127777532|NCT00778622|459813553|FG002|Overall Study|immigration|0|||
127777533|NCT00778622|459813551|FG000|Overall Study|Other|1|||
127777534|NCT00778622|459813552|FG001|Overall Study|Other|0|||
127777535|NCT00778622|459813553|FG002|Overall Study|Other|1|||
127777536|NCT02301936|459813560|FG000|Overall Study|Lost to Follow-up|1|||
127777537|NCT02301936|459813561|FG001|Overall Study|Lost to Follow-up|0|||
127777538|NCT03065023|459813562|FG000|Overall Study|Progressive Disease|0|||
127777539|NCT03065023|459813563|FG001|Overall Study|Progressive Disease|1|||
127777540|NCT03065023|459813564|FG002|Overall Study|Progressive Disease|0|||
127777541|NCT03065023|459813565|FG003|Overall Study|Progressive Disease|0|||
127777542|NCT03065023|459813566|FG004|Overall Study|Progressive Disease|0|||
127777543|NCT03065023|459813562|FG000|Overall Study|Death|2|||
127777544|NCT03065023|459813563|FG001|Overall Study|Death|0|||
127777545|NCT03065023|459813564|FG002|Overall Study|Death|1|||
127777546|NCT03065023|459813565|FG003|Overall Study|Death|1|||
128026340|NCT01796470|460720209|FG004|Overall Study|Adverse Event|3|||
128026341|NCT01796470|460720205|FG000|Overall Study|Death|2|||
128026342|NCT01796470|460720206|FG001|Overall Study|Death|0|||
128026343|NCT01796470|460720207|FG002|Overall Study|Death|0|||
128026344|NCT01796470|460720208|FG003|Overall Study|Death|0|||
128026345|NCT01796470|460720209|FG004|Overall Study|Death|1|||
128026346|NCT01796470|460720205|FG000|Overall Study|Initiated New Therapy|9|||
128026347|NCT01796470|460720206|FG001|Overall Study|Initiated New Therapy|0|||
128026348|NCT01796470|460720207|FG002|Overall Study|Initiated New Therapy|0|||
127777547|NCT03065023|459813566|FG004|Overall Study|Death|0|||
127777548|NCT03065023|459813562|FG000|Overall Study|Lost to Follow-up|0|||
127777549|NCT03065023|459813563|FG001|Overall Study|Lost to Follow-up|1|||
127777550|NCT03065023|459813564|FG002|Overall Study|Lost to Follow-up|0|||
128026349|NCT01796470|460720208|FG003|Overall Study|Initiated New Therapy|0|||
128026350|NCT01796470|460720209|FG004|Overall Study|Initiated New Therapy|2|||
127567091|NCT05093790|459045577|FG001|Overall Study|Failure to meet continuation criteria|0|||
127567092|NCT05093790|459045578|FG002|Overall Study|Failure to meet continuation criteria|1|||
127567093|NCT05093790|459045579|FG003|Overall Study|Failure to meet continuation criteria|0|||
127567094|NCT05093790|459045576|FG000|Overall Study|Adverse Event|1|||
127567095|NCT05093790|459045577|FG001|Overall Study|Adverse Event|0|||
127567096|NCT05093790|459045578|FG002|Overall Study|Adverse Event|0|||
127567097|NCT05093790|459045579|FG003|Overall Study|Adverse Event|0|||
127567098|NCT04449029|459045583|FG000|Overall Study|Adverse Event|0|||
127567099|NCT04449029|459045584|FG001|Overall Study|Adverse Event|1|||
127567100|NCT04449029|459045585|FG002|Overall Study|Adverse Event|1|||
127567101|NCT04449029|459045586|FG003|Overall Study|Adverse Event|0|||
127777551|NCT03065023|459813565|FG003|Overall Study|Lost to Follow-up|0|||
127777552|NCT03065023|459813566|FG004|Overall Study|Lost to Follow-up|0|||
127777553|NCT03065023|459813562|FG000|Overall Study|Participant Decision|0|||
127777554|NCT03065023|459813563|FG001|Overall Study|Participant Decision|0|||
127777555|NCT03065023|459813564|FG002|Overall Study|Participant Decision|0|||
128026351|NCT01796470|460720205|FG000|Overall Study|Lost to Follow-up|0|||
127777556|NCT03065023|459813565|FG003|Overall Study|Participant Decision|1|||
127777557|NCT03065023|459813566|FG004|Overall Study|Participant Decision|0|||
127777558|NCT03065023|459813562|FG000|Overall Study|Withdrawal by Subject|0|||
127777559|NCT03065023|459813563|FG001|Overall Study|Withdrawal by Subject|0|||
127777560|NCT03065023|459813564|FG002|Overall Study|Withdrawal by Subject|0|||
127777561|NCT03065023|459813565|FG003|Overall Study|Withdrawal by Subject|1|||
127777562|NCT03065023|459813566|FG004|Overall Study|Withdrawal by Subject|0|||
127777563|NCT03427125|459813567|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
127777564|NCT03427125|459813568|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
127777565|NCT03427125|459813569|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
127777566|NCT04014361|459813572|FG000|Period 2|Physician Decision|0|||
127777567|NCT04014361|459813573|FG001|Period 2|Physician Decision|0|||
127777568|NCT04014361|459813574|FG002|Period 2|Physician Decision|0|||
127777569|NCT04014361|459813575|FG003|Period 2|Physician Decision|1|||
127777570|NCT04014361|459813576|FG004|Period 2|Physician Decision|0|||
127777571|NCT04014361|459813577|FG005|Period 2|Physician Decision|0|||
127777572|NCT04014361|459813578|FG006|Period 2|Physician Decision|0|||
127777573|NCT04014361|459813579|FG007|Period 2|Physician Decision|0|||
127777574|NCT03610165|459813583|FG000|Overall Study|Device didn't work|0|||
127777575|NCT03610165|459813584|FG001|Overall Study|Device didn't work|1|||
127777576|NCT01810016|459813585|FG000|Overall Study|Progressive disease|1|||
127777577|NCT01810016|459813586|FG001|Overall Study|Progressive disease|1|||
127777578|NCT01810016|459813587|FG002|Overall Study|Progressive disease|0|||
127777579|NCT01810016|459813585|FG000|Overall Study|Death|0|||
127777580|NCT01810016|459813586|FG001|Overall Study|Death|0|||
127777581|NCT01810016|459813587|FG002|Overall Study|Death|1|||
127777582|NCT00708175|459813588|FG000|Overall Study|Adverse Event|4|||
127777583|NCT00708175|459813589|FG001|Overall Study|Adverse Event|5|||
127777584|NCT00708175|459813588|FG000|Overall Study|Protocol Violation|2|||
127777585|NCT00708175|459813589|FG001|Overall Study|Protocol Violation|3|||
127777586|NCT00708175|459813588|FG000|Overall Study|Lost to Follow-up|5|||
127777587|NCT00708175|459813589|FG001|Overall Study|Lost to Follow-up|3|||
127777588|NCT00708175|459813588|FG000|Overall Study|Withdrawal by Subject|5|||
127777589|NCT00708175|459813589|FG001|Overall Study|Withdrawal by Subject|7|||
127777590|NCT00708175|459813588|FG000|Overall Study|BMD loss >7%|2|||
127777591|NCT00708175|459813589|FG001|Overall Study|BMD loss >7%|3|||
127777592|NCT01436071|459815023|FG000|Overall Study|Adverse Event|1|||
127777593|NCT01436071|459815024|FG001|Overall Study|Adverse Event|0|||
127777594|NCT01436071|459815023|FG000|Overall Study|Lack of Efficacy|16|||
128026352|NCT01796470|460720206|FG001|Overall Study|Lost to Follow-up|1|||
128026353|NCT01796470|460720207|FG002|Overall Study|Lost to Follow-up|0|||
128026354|NCT01796470|460720208|FG003|Overall Study|Lost to Follow-up|0|||
127567102|NCT04449029|459045587|FG004|Overall Study|Adverse Event|1|||
127567103|NCT04449029|459045588|FG005|Overall Study|Adverse Event|0|||
127777595|NCT01436071|459815024|FG001|Overall Study|Lack of Efficacy|7|||
127777596|NCT01436071|459815023|FG000|Overall Study|Protocol Violation|0|||
127777597|NCT01436071|459815024|FG001|Overall Study|Protocol Violation|1|||
127777598|NCT01436071|459815023|FG000|Overall Study|Lost to Follow-up|3|||
127777599|NCT01436071|459815024|FG001|Overall Study|Lost to Follow-up|1|||
127777600|NCT01436071|459815023|FG000|Overall Study|Physician Decision|1|||
127777601|NCT01436071|459815024|FG001|Overall Study|Physician Decision|0|||
127777602|NCT01436071|459815023|FG000|Overall Study|Withdrawal by Subject|2|||
127777603|NCT01436071|459815024|FG001|Overall Study|Withdrawal by Subject|2|||
127567104|NCT04449029|459045589|FG006|Overall Study|Adverse Event|1|||
127567105|NCT04449029|459045590|FG007|Overall Study|Adverse Event|0|||
127567106|NCT04449029|459045583|FG000|Overall Study|Lost to Follow-up|0|||
127777604|NCT01436071|459815023|FG000|Overall Study|Did Not Receive Trial Medication|3|||
127777605|NCT01436071|459815024|FG001|Overall Study|Did Not Receive Trial Medication|3|||
127777606|NCT03503513|459815035|FG000|Overall Study|First cohort faced a clinical hold which caused disruption in treatment;|4|||
127777607|NCT03503513|459815035|FG000|Overall Study|Second cohort faced changes due to pandemic, resulting in declining participant count|2|||
127777608|NCT03503513|459815035|FG000|Overall Study|Physician Decision|3|||
127777609|NCT03503513|459815035|FG000|Overall Study|Withdrawal by Subject|2|||
127777610|NCT03503513|459815035|FG000|Overall Study|Lost to Follow-up|1|||
127777611|NCT00929656|459815036|FG000|Overall Study|Lost to Follow-up|0|||
127777612|NCT00929656|459815037|FG001|Overall Study|Lost to Follow-up|1|||
127777613|NCT00607880|459815038|FG000|Overall Study|Unable to place port due to occlusion|1|||
127777614|NCT00607880|459815039|FG001|Overall Study|Unable to place port due to occlusion|0|||
127777615|NCT00908583|459815040|FG000|Phase 1|Withdrawal by Subject|1|||
127777616|NCT00908583|459815040|FG000|Phase 1|Adverse Event|4|||
127777617|NCT00908583|459815040|FG000|Phase 2|Physician Decision|1|||
127777618|NCT00908583|459815040|FG000|Phase 2|Adverse Event|1|||
127777619|NCT00908583|459815040|FG000|Phase 3|Adverse Event|2|||
127777620|NCT00908583|459815040|FG000|Phase 4|Adverse Event|1|||
127777621|NCT00908583|459815040|FG000|Phase 4|Physician Decision|1|||
127777622|NCT00908583|459815040|FG000|Phase 5|Adverse Event|3|||
127777623|NCT00993954|459815041|FG000|Overall Study|Protocol Violation|21|||
127777624|NCT00993954|459815042|FG001|Overall Study|Protocol Violation|2|||
127777625|NCT00381563|459815045|FG000|Overall Study|Withdrawal by Subject|5|||
127777626|NCT00381563|459815046|FG001|Overall Study|Withdrawal by Subject|5|||
127777627|NCT00381563|459815045|FG000|Overall Study|Lost to Follow-up|2|||
127777628|NCT00381563|459815046|FG001|Overall Study|Lost to Follow-up|0|||
127777629|NCT00381563|459815045|FG000|Overall Study|Protocol Violation|0|||
127777630|NCT00381563|459815046|FG001|Overall Study|Protocol Violation|1|||
127777631|NCT00931944|459815047|FG000|Overall Study|Adverse Event|4|||
127777632|NCT00931944|459815047|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
127777633|NCT00931944|459815047|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
127777634|NCT00931944|459815047|FG000|Overall Study|Death|28|||
127777635|NCT00931944|459815047|FG000|Overall Study|Other|2|||
127777636|NCT01132612|459815048|FG000|Overall Study|Death|0|||
127777637|NCT01132612|459815049|FG001|Overall Study|Death|0|||
127777638|NCT01132612|459815050|FG002|Overall Study|Death|1|||
127777639|NCT01132612|459815048|FG000|Overall Study|Protocol deviation|0|||
127777640|NCT01132612|459815049|FG001|Overall Study|Protocol deviation|0|||
127777641|NCT01132612|459815050|FG002|Overall Study|Protocol deviation|3|||
127777642|NCT01132612|459815048|FG000|Overall Study|Lost to Follow-up|2|||
127777643|NCT01132612|459815049|FG001|Overall Study|Lost to Follow-up|2|||
127777644|NCT01132612|459815050|FG002|Overall Study|Lost to Follow-up|7|||
127777645|NCT01132612|459815048|FG000|Overall Study|Adverse Event|5|||
127777646|NCT01132612|459815049|FG001|Overall Study|Adverse Event|2|||
127777647|NCT01132612|459815050|FG002|Overall Study|Adverse Event|15|||
127777648|NCT01132612|459815048|FG000|Overall Study|Withdrawal by Subject|5|||
127777649|NCT01132612|459815049|FG001|Overall Study|Withdrawal by Subject|8|||
127777650|NCT01132612|459815050|FG002|Overall Study|Withdrawal by Subject|19|||
127777651|NCT01132612|459815048|FG000|Overall Study|Administrative problems|5|||
127777652|NCT01132612|459815049|FG001|Overall Study|Administrative problems|1|||
127777653|NCT01132612|459815050|FG002|Overall Study|Administrative problems|52|||
127777654|NCT01132612|459815048|FG000|Overall Study|Lack of Efficacy|23|||
127777655|NCT01132612|459815049|FG001|Overall Study|Lack of Efficacy|22|||
127777656|NCT01132612|459815050|FG002|Overall Study|Lack of Efficacy|73|||
127777657|NCT02252536|459815051|FG000|Overall Study|Lost to Follow-up|5|||
127777658|NCT02252536|459815052|FG001|Overall Study|Lost to Follow-up|3|||
127777659|NCT01438151|459815056|FG000|Overall Study|study terminated|8|||
127777660|NCT00006392|459815068|FG000|Overall Study|Ineligible|11|||
127777661|NCT00006392|459815069|FG001|Overall Study|Ineligible|3|||
127777662|NCT00006392|459815070|FG002|Overall Study|Ineligible|5|||
127777663|NCT00006392|459815071|FG003|Overall Study|Ineligible|5|||
127777664|NCT00006392|459815068|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
127777665|NCT00006392|459815069|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
127777666|NCT00006392|459815070|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
127777667|NCT00006392|459815071|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
127777668|NCT01186796|459815072|FG000|Overall Study|Adverse Event|3|||
127777669|NCT01186796|459815073|FG001|Overall Study|Adverse Event|0|||
127777670|NCT01186796|459815072|FG000|Overall Study|Withdrawal by Subject|1|||
127777671|NCT01186796|459815073|FG001|Overall Study|Withdrawal by Subject|1|||
127777672|NCT01186796|459815072|FG000|Overall Study|Protocol Violation|0|||
127777673|NCT01186796|459815073|FG001|Overall Study|Protocol Violation|1|||
127777674|NCT02459769|459815074|FG000|Overall Study|Withdrawal by Subject|7|||
127777675|NCT02459769|459815075|FG001|Overall Study|Withdrawal by Subject|4|||
127777676|NCT02459769|459815076|FG002|Overall Study|Withdrawal by Subject|8|||
127777677|NCT02459769|459815077|FG003|Overall Study|Withdrawal by Subject|5|||
127777678|NCT02459769|459815074|FG000|Overall Study|Lost to Follow-up|1|||
127777679|NCT02459769|459815075|FG001|Overall Study|Lost to Follow-up|0|||
127777680|NCT02459769|459815076|FG002|Overall Study|Lost to Follow-up|1|||
127777681|NCT02459769|459815077|FG003|Overall Study|Lost to Follow-up|0|||
127777682|NCT00728481|459815081|FG000|Overall Study|Withdrawal by Subject|0|||
127777683|NCT00728481|459815082|FG001|Overall Study|Withdrawal by Subject|1|||
127777684|NCT00728481|459815081|FG000|Overall Study|Adverse Event|0|||
127777685|NCT00728481|459815082|FG001|Overall Study|Adverse Event|1|||
127777686|NCT00728481|459815081|FG000|Overall Study|Study medication non-compliance|0|||
127567107|NCT04449029|459045584|FG001|Overall Study|Lost to Follow-up|1|||
127567108|NCT04449029|459045585|FG002|Overall Study|Lost to Follow-up|0|||
127567109|NCT04449029|459045586|FG003|Overall Study|Lost to Follow-up|0|||
127567110|NCT04449029|459045587|FG004|Overall Study|Lost to Follow-up|0|||
127567111|NCT04449029|459045588|FG005|Overall Study|Lost to Follow-up|0|||
127567112|NCT04449029|459045589|FG006|Overall Study|Lost to Follow-up|0|||
127567113|NCT04449029|459045590|FG007|Overall Study|Lost to Follow-up|0|||
127567114|NCT04449029|459045583|FG000|Overall Study|Protocol Violation|0|||
127567115|NCT04449029|459045584|FG001|Overall Study|Protocol Violation|1|||
127567116|NCT04449029|459045585|FG002|Overall Study|Protocol Violation|0|||
127567117|NCT04449029|459045586|FG003|Overall Study|Protocol Violation|0|||
127567118|NCT04449029|459045587|FG004|Overall Study|Protocol Violation|0|||
127567119|NCT04449029|459045588|FG005|Overall Study|Protocol Violation|0|||
127567120|NCT04449029|459045589|FG006|Overall Study|Protocol Violation|0|||
127567121|NCT04449029|459045590|FG007|Overall Study|Protocol Violation|0|||
127567122|NCT04449029|459045583|FG000|Overall Study|Physician Decision|0|||
127567123|NCT04449029|459045584|FG001|Overall Study|Physician Decision|0|||
127567124|NCT04449029|459045585|FG002|Overall Study|Physician Decision|0|||
127567125|NCT04449029|459045586|FG003|Overall Study|Physician Decision|0|||
127567126|NCT04449029|459045587|FG004|Overall Study|Physician Decision|0|||
127567127|NCT04449029|459045588|FG005|Overall Study|Physician Decision|1|||
127567128|NCT04449029|459045589|FG006|Overall Study|Physician Decision|0|||
127567129|NCT04449029|459045590|FG007|Overall Study|Physician Decision|0|||
127567130|NCT04449029|459045583|FG000|Overall Study|Withdrawal by Subject|3|||
127567131|NCT04449029|459045584|FG001|Overall Study|Withdrawal by Subject|0|||
127567132|NCT04449029|459045585|FG002|Overall Study|Withdrawal by Subject|1|||
127567133|NCT04449029|459045586|FG003|Overall Study|Withdrawal by Subject|1|||
127567134|NCT04449029|459045587|FG004|Overall Study|Withdrawal by Subject|5|||
127567135|NCT04449029|459045588|FG005|Overall Study|Withdrawal by Subject|1|||
127567136|NCT04449029|459045589|FG006|Overall Study|Withdrawal by Subject|4|||
127567137|NCT04449029|459045590|FG007|Overall Study|Withdrawal by Subject|0|||
127777687|NCT00728481|459815082|FG001|Overall Study|Study medication non-compliance|2|||
127777688|NCT00728481|459815081|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
127777689|NCT00728481|459815082|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
127777690|NCT02545322|459815083|FG000|Overall Study|Withdrawal by Subject|3|||
127777691|NCT01505010|459815084|FG000|Overall Study|Protocol Violation|0|||
127567138|NCT02025556|459045591|FG000|Overall Study|Adverse Event|0|||
127567139|NCT02025556|459045592|FG001|Overall Study|Adverse Event|4|||
127777692|NCT01505010|459815085|FG001|Overall Study|Protocol Violation|1|||
127567140|NCT02025556|459045593|FG002|Overall Study|Adverse Event|2|||
127567141|NCT02025556|459045591|FG000|Overall Study|Lack of Efficacy|2|||
127567142|NCT02025556|459045592|FG001|Overall Study|Lack of Efficacy|1|||
127567143|NCT02025556|459045593|FG002|Overall Study|Lack of Efficacy|0|||
127567144|NCT02025556|459045591|FG000|Overall Study|Protocol Violation|2|||
127567145|NCT02025556|459045592|FG001|Overall Study|Protocol Violation|1|||
127567146|NCT02025556|459045593|FG002|Overall Study|Protocol Violation|0|||
127567147|NCT02025556|459045591|FG000|Overall Study|Withdrawal by Subject|0|||
127567148|NCT02025556|459045592|FG001|Overall Study|Withdrawal by Subject|3|||
127567149|NCT02025556|459045593|FG002|Overall Study|Withdrawal by Subject|6|||
127567150|NCT02025556|459045591|FG000|Overall Study|Lost to Follow-up|2|||
127567151|NCT02025556|459045592|FG001|Overall Study|Lost to Follow-up|4|||
127567152|NCT02025556|459045593|FG002|Overall Study|Lost to Follow-up|0|||
127567153|NCT02025556|459045591|FG000|Overall Study|Reason not reported|0|||
127567154|NCT02025556|459045592|FG001|Overall Study|Reason not reported|0|||
127567155|NCT02025556|459045593|FG002|Overall Study|Reason not reported|1|||
127567156|NCT00627445|459045594|FG000|Overall Study|Adverse Event|3|||
127567157|NCT00627445|459045595|FG001|Overall Study|Adverse Event|3|||
127567158|NCT00627445|459045594|FG000|Overall Study|Lack of Efficacy|0|||
127567159|NCT00627445|459045595|FG001|Overall Study|Lack of Efficacy|1|||
127567160|NCT00627445|459045594|FG000|Overall Study|Other|6|||
127567161|NCT00627445|459045595|FG001|Overall Study|Other|8|||
127567162|NCT01894568|459045596|FG000|Overall Study|Adverse Event|2|||
127567163|NCT01894568|459045597|FG001|Overall Study|Adverse Event|3|||
127567164|NCT01894568|459045596|FG000|Overall Study|Protocol required discontinuation|2|||
127567165|NCT01894568|459045597|FG001|Overall Study|Protocol required discontinuation|1|||
127567166|NCT01894568|459045596|FG000|Overall Study|Withdrawal by Subject|5|||
127567167|NCT01894568|459045597|FG001|Overall Study|Withdrawal by Subject|5|||
127567168|NCT01894568|459045596|FG000|Overall Study|Physician Decision|1|||
128026355|NCT01796470|460720209|FG004|Overall Study|Lost to Follow-up|0|||
127567169|NCT01894568|459045597|FG001|Overall Study|Physician Decision|0|||
127567170|NCT01894568|459045596|FG000|Overall Study|Lost to Follow-up|0|||
127567171|NCT01894568|459045597|FG001|Overall Study|Lost to Follow-up|1|||
127567172|NCT01514370|459045600|FG000|Overall Study|Protocol Violation|2|||
127567173|NCT01514370|459045601|FG001|Overall Study|Protocol Violation|3|||
127567174|NCT01514370|459045600|FG000|Overall Study|Lost to Follow-up|0|||
127567175|NCT01514370|459045601|FG001|Overall Study|Lost to Follow-up|2|||
127567176|NCT01514370|459045600|FG000|Overall Study|Withdrawal by Subject|2|||
127567177|NCT01514370|459045601|FG001|Overall Study|Withdrawal by Subject|1|||
127567178|NCT01514370|459045600|FG000|Overall Study|Adverse Event|1|||
127567179|NCT01514370|459045601|FG001|Overall Study|Adverse Event|3|||
127567180|NCT01514370|459045600|FG000|Overall Study|Other|6|||
127567181|NCT01514370|459045601|FG001|Overall Study|Other|7|||
127567182|NCT01551420|459045602|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
127567183|NCT01551420|459045603|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
127567184|NCT01551420|459045602|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
127567185|NCT01551420|459045603|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
127567186|NCT01551420|459045602|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
127567187|NCT01551420|459045603|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
127567188|NCT01551420|459045602|FG000|Screened for Part B Eligibility|Declined participation|8|||
127567189|NCT01551420|459045603|FG001|Screened for Part B Eligibility|Declined participation|1|||
127567190|NCT01551420|459045602|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
127567191|NCT01551420|459045603|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
127567192|NCT01551420|459045602|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
127567193|NCT01551420|459045603|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
127567194|NCT01551420|459045602|FG000|Home Use (Part B)|Withdrawal by staff|0|||
127567195|NCT01551420|459045603|FG001|Home Use (Part B)|Withdrawal by staff|1|||
127567196|NCT03473548|459045604|FG000|Overall Study|Did not attempt HST testing|3|||
127567197|NCT03473548|459045605|FG001|Overall Study|Did not attempt HST testing|0|||
127567198|NCT00129311|459045606|FG000|Overall Study|Withdrawal by Subject|12|||
127567199|NCT00129311|459045607|FG001|Overall Study|Withdrawal by Subject|19|||
127567200|NCT03039621|459047076|FG000|Overall Study|Violation of inclusion criteria|3|||
127567201|NCT03039621|459047077|FG001|Overall Study|Violation of inclusion criteria|2|||
127567202|NCT03039621|459047076|FG000|Overall Study|Non-compliance with protocol requirement|4|||
127567203|NCT03039621|459047077|FG001|Overall Study|Non-compliance with protocol requirement|5|||
127567204|NCT03039621|459047076|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
127567205|NCT03039621|459047077|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
127567206|NCT03039621|459047076|FG000|Overall Study|Violation of non-inclusion criteria|1|||
127567207|NCT03039621|459047077|FG001|Overall Study|Violation of non-inclusion criteria|2|||
127567208|NCT00002931|459047080|FG000|Overall Study|rapidly progressing disease during|2|||
127567209|NCT01879579|459047081|FG000|Overall Study|Phone incompatible with texting platform|3|||
127567210|NCT01879579|459047082|FG001|Overall Study|Phone incompatible with texting platform|0|||
128026356|NCT01796470|460720205|FG000|Overall Study|Physician Decision|5|||
127567211|NCT01879579|459047081|FG000|Overall Study|Did not enroll in texting platform|1|||
127567212|NCT01879579|459047082|FG001|Overall Study|Did not enroll in texting platform|0|||
127567213|NCT01879579|459047081|FG000|Overall Study|Did not initiate insulin treatment|1|||
127567214|NCT01879579|459047082|FG001|Overall Study|Did not initiate insulin treatment|0|||
127567215|NCT01879579|459047081|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
127567216|NCT01879579|459047082|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
127567217|NCT01879579|459047081|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
127567218|NCT01879579|459047082|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
127567219|NCT02716896|459047083|FG000|Overall Study|Physician Decision|0|||
127567220|NCT02716896|459047084|FG001|Overall Study|Physician Decision|1|||
127567221|NCT02519855|459047087|FG000|Overall Study|Adverse Event|0|||
127567222|NCT02519855|459047088|FG001|Overall Study|Adverse Event|1|||
127567223|NCT02519855|459047087|FG000|Overall Study|Lost to Follow-up|3|||
127567224|NCT02519855|459047088|FG001|Overall Study|Lost to Follow-up|3|||
127567225|NCT00003830|459047102|FG000|Overall Study|No follow up data|3|||
128026357|NCT01796470|460720206|FG001|Overall Study|Physician Decision|4|||
128026358|NCT01796470|460720207|FG002|Overall Study|Physician Decision|1|||
128026359|NCT01796470|460720208|FG003|Overall Study|Physician Decision|0|||
127567226|NCT00003830|459047103|FG001|Overall Study|No follow up data|0|||
128026360|NCT01796470|460720209|FG004|Overall Study|Physician Decision|1|||
128026361|NCT01796470|460720205|FG000|Overall Study|Progressive Disease|7|||
128026362|NCT01796470|460720206|FG001|Overall Study|Progressive Disease|7|||
127689535|NCT05052996|459488259|FG003|Overall Study|Withdrew consent|2|||
127689536|NCT05052996|459488256|FG000|Overall Study|Lost to Follow-up|1|||
127689537|NCT05052996|459488257|FG001|Overall Study|Lost to Follow-up|0|||
127689538|NCT05052996|459488258|FG002|Overall Study|Lost to Follow-up|0|||
127689539|NCT05052996|459488259|FG003|Overall Study|Lost to Follow-up|2|||
127689540|NCT05052996|459488256|FG000|Overall Study|Adverse Event|0|||
127689541|NCT05052996|459488257|FG001|Overall Study|Adverse Event|0|||
127689542|NCT05052996|459488258|FG002|Overall Study|Adverse Event|2|||
127689543|NCT05052996|459488259|FG003|Overall Study|Adverse Event|0|||
127689544|NCT05052996|459488256|FG000|Overall Study|Randomized but never treated|0|||
127689545|NCT05052996|459488257|FG001|Overall Study|Randomized but never treated|0|||
127689546|NCT05052996|459488258|FG002|Overall Study|Randomized but never treated|1|||
127689547|NCT05052996|459488259|FG003|Overall Study|Randomized but never treated|1|||
127689548|NCT05052996|459488256|FG000|Overall Study|Protocol Violation|1|||
127689549|NCT05052996|459488257|FG001|Overall Study|Protocol Violation|0|||
127689550|NCT05052996|459488258|FG002|Overall Study|Protocol Violation|0|||
128026363|NCT01796470|460720207|FG002|Overall Study|Progressive Disease|3|||
127567227|NCT00003830|459047102|FG000|Overall Study|Sentinel node positive patients|829|||
127567228|NCT00003830|459047103|FG001|Overall Study|Sentinel node positive patients|793|||
127567229|NCT00603590|459047107|FG000|Overall Study|Did not attend study clinic|39|||
127567230|NCT00603590|459047108|FG001|Overall Study|Did not attend study clinic|30|||
127567231|NCT00603590|459047107|FG000|Overall Study|Refused blood test|5|||
127567232|NCT00603590|459047108|FG001|Overall Study|Refused blood test|1|||
127567233|NCT00603590|459047107|FG000|Overall Study|Patient discontinued study drug|22|||
127567234|NCT00603590|459047108|FG001|Overall Study|Patient discontinued study drug|15|||
127567235|NCT00603590|459047107|FG000|Overall Study|Adverse Event|2|||
127567236|NCT00603590|459047108|FG001|Overall Study|Adverse Event|0|||
127567237|NCT00603590|459047107|FG000|Overall Study|Lost to Follow-up|8|||
127567238|NCT00603590|459047108|FG001|Overall Study|Lost to Follow-up|4|||
127567239|NCT00603590|459047107|FG000|Overall Study|Cardiovascular event|0|||
127567240|NCT00603590|459047108|FG001|Overall Study|Cardiovascular event|1|||
127567241|NCT03699475|459047111|FG000|Overall Study|Death|1|||
127567242|NCT03739242|459047118|FG000|Overall Study|Withdrawal by Subject|1|||
127567243|NCT03739242|459047119|FG001|Overall Study|Withdrawal by Subject|1|||
127567244|NCT03739242|459047118|FG000|Overall Study|Protocol Violation|0|||
127567245|NCT03739242|459047119|FG001|Overall Study|Protocol Violation|1|||
127567246|NCT01752036|459047120|FG000|Overall Study|Death|2|||
127567247|NCT00045942|459047121|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
127567248|NCT00045942|459047122|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
127567249|NCT00045942|459047123|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
127567250|NCT00045942|459047124|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
127567251|NCT00045942|459047125|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
127567252|NCT00045942|459047126|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
127567253|NCT00045942|459047127|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
127567254|NCT00045942|459047128|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
127567255|NCT00045942|459047129|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
127567256|NCT00045942|459047121|FG000|PKC412A2104 (Core)|Adverse Event|5|||
127567257|NCT00045942|459047122|FG001|PKC412A2104 (Core)|Adverse Event|0|||
127567258|NCT00045942|459047123|FG002|PKC412A2104 (Core)|Adverse Event|0|||
127567259|NCT00045942|459047124|FG003|PKC412A2104 (Core)|Adverse Event|0|||
127567260|NCT00045942|459047125|FG004|PKC412A2104 (Core)|Adverse Event|0|||
127567261|NCT00045942|459047126|FG005|PKC412A2104 (Core)|Adverse Event|0|||
127567262|NCT00045942|459047127|FG006|PKC412A2104 (Core)|Adverse Event|0|||
127567263|NCT00045942|459047128|FG007|PKC412A2104 (Core)|Adverse Event|0|||
127567264|NCT00045942|459047129|FG008|PKC412A2104 (Core)|Adverse Event|0|||
127567265|NCT00045942|459047121|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
127567266|NCT00045942|459047122|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
127567267|NCT00045942|459047123|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
127567268|NCT00045942|459047124|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
127567269|NCT00045942|459047125|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
127567270|NCT00045942|459047126|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
127567271|NCT00045942|459047127|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
127567272|NCT00045942|459047128|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
127567273|NCT00045942|459047129|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
127567274|NCT00045942|459047121|FG000|PKC412A2104 (Core)|Death|1|||
127567275|NCT00045942|459047122|FG001|PKC412A2104 (Core)|Death|0|||
127567276|NCT00045942|459047123|FG002|PKC412A2104 (Core)|Death|0|||
127567277|NCT00045942|459047124|FG003|PKC412A2104 (Core)|Death|0|||
127567278|NCT00045942|459047125|FG004|PKC412A2104 (Core)|Death|0|||
127567279|NCT00045942|459047126|FG005|PKC412A2104 (Core)|Death|0|||
127567280|NCT00045942|459047127|FG006|PKC412A2104 (Core)|Death|0|||
127567281|NCT00045942|459047128|FG007|PKC412A2104 (Core)|Death|0|||
127567282|NCT00045942|459047129|FG008|PKC412A2104 (Core)|Death|0|||
127567283|NCT00045942|459047121|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
127567284|NCT00045942|459047122|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
127567285|NCT00045942|459047123|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
127567286|NCT00045942|459047124|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
127777693|NCT01505010|459815084|FG000|Overall Study|Lost to Follow-up|0|||
127777694|NCT01505010|459815085|FG001|Overall Study|Lost to Follow-up|1|||
127777695|NCT00108069|459815088|FG000|Overall Study|Never rec'd study drug|0|||
127777696|NCT00108069|459815089|FG001|Overall Study|Never rec'd study drug|1|||
127777697|NCT00108069|459815088|FG000|Overall Study|Adverse Event|1|||
127777698|NCT00108069|459815089|FG001|Overall Study|Adverse Event|1|||
127777699|NCT00108069|459815088|FG000|Overall Study|Withdrawal by Subject|1|||
127777700|NCT00108069|459815089|FG001|Overall Study|Withdrawal by Subject|0|||
127777701|NCT00108069|459815088|FG000|Overall Study|Death|1|||
127567287|NCT00045942|459047125|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
127567288|NCT00045942|459047126|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
127567289|NCT00045942|459047127|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
127567290|NCT00045942|459047128|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
127567291|NCT00045942|459047129|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
127567292|NCT00045942|459047121|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
127567293|NCT00045942|459047122|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
127567294|NCT00045942|459047123|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
127567295|NCT00045942|459047124|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
127777702|NCT00108069|459815089|FG001|Overall Study|Death|0|||
127777703|NCT00108069|459815088|FG000|Overall Study|Progessive disease|27|||
128026364|NCT01796470|460720208|FG003|Overall Study|Progressive Disease|2|||
128026365|NCT01796470|460720209|FG004|Overall Study|Progressive Disease|0|||
128026366|NCT01796470|460720205|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
128026367|NCT01796470|460720206|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
127567296|NCT00045942|459047125|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
127567297|NCT00045942|459047126|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
127567298|NCT00045942|459047127|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
127567299|NCT00045942|459047128|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
127567300|NCT00045942|459047129|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
127567301|NCT00045942|459047121|FG000|PKC412A2104E1|Lack of Efficacy|0|||
127567302|NCT00045942|459047122|FG001|PKC412A2104E1|Lack of Efficacy|11|||
127567303|NCT00045942|459047123|FG002|PKC412A2104E1|Lack of Efficacy|11|||
127567304|NCT00045942|459047124|FG003|PKC412A2104E1|Lack of Efficacy|23|||
127567305|NCT00045942|459047125|FG004|PKC412A2104E1|Lack of Efficacy|17|||
127567306|NCT00045942|459047126|FG005|PKC412A2104E1|Lack of Efficacy|0|||
127567307|NCT00045942|459047127|FG006|PKC412A2104E1|Lack of Efficacy|0|||
127567308|NCT00045942|459047128|FG007|PKC412A2104E1|Lack of Efficacy|0|||
127567309|NCT00045942|459047129|FG008|PKC412A2104E1|Lack of Efficacy|0|||
127567310|NCT00045942|459047121|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
127567311|NCT00045942|459047122|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
127567312|NCT00045942|459047123|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
127567313|NCT00045942|459047124|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
127567314|NCT00045942|459047125|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
127567315|NCT00045942|459047126|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
127567316|NCT00045942|459047127|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
127567317|NCT00045942|459047128|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
127567318|NCT00045942|459047129|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
127567319|NCT00045942|459047121|FG000|PKC412A2104E1|Adverse Event|0|||
127567320|NCT00045942|459047122|FG001|PKC412A2104E1|Adverse Event|1|||
127567321|NCT00045942|459047123|FG002|PKC412A2104E1|Adverse Event|1|||
127567322|NCT00045942|459047124|FG003|PKC412A2104E1|Adverse Event|3|||
127567323|NCT00045942|459047125|FG004|PKC412A2104E1|Adverse Event|6|||
127567324|NCT00045942|459047126|FG005|PKC412A2104E1|Adverse Event|0|||
127689551|NCT05052996|459488259|FG003|Overall Study|Protocol Violation|0|||
127689552|NCT04704284|459488265|FG000|Overall Study|Withdrawal by Subject|1|||
127689553|NCT03101930|459488270|FG000|Overall Study|Withdrawal by Subject|2|||
127689554|NCT03101930|459488271|FG001|Overall Study|Withdrawal by Subject|1|||
127689555|NCT03101930|459488272|FG002|Overall Study|Withdrawal by Subject|2|||
127689556|NCT00087139|459488273|FG000|Overall Study|Adverse Event|18|||
127689557|NCT00087139|459488274|FG001|Overall Study|Adverse Event|17|||
127689558|NCT00087139|459488275|FG002|Overall Study|Adverse Event|13|||
127689559|NCT00087139|459488273|FG000|Overall Study|Death|2|||
127689560|NCT00087139|459488274|FG001|Overall Study|Death|1|||
127689561|NCT00087139|459488275|FG002|Overall Study|Death|0|||
127689562|NCT00087139|459488273|FG000|Overall Study|Withdrawal by Subject|3|||
127689563|NCT00087139|459488274|FG001|Overall Study|Withdrawal by Subject|2|||
127689564|NCT00087139|459488275|FG002|Overall Study|Withdrawal by Subject|2|||
127689565|NCT00087139|459488273|FG000|Overall Study|Physician Decision|1|||
127689566|NCT00087139|459488274|FG001|Overall Study|Physician Decision|1|||
127689567|NCT00087139|459488275|FG002|Overall Study|Physician Decision|1|||
127689568|NCT00087139|459488273|FG000|Overall Study|Disease progression|9|||
127689569|NCT00087139|459488274|FG001|Overall Study|Disease progression|19|||
127689570|NCT00087139|459488275|FG002|Overall Study|Disease progression|12|||
127689571|NCT00087139|459488273|FG000|Overall Study|Ineligible|4|||
127689572|NCT00087139|459488274|FG001|Overall Study|Ineligible|7|||
127689573|NCT00087139|459488275|FG002|Overall Study|Ineligible|4|||
127689574|NCT00087139|459488273|FG000|Overall Study|Symptomatic deterioration|1|||
127689575|NCT00087139|459488274|FG001|Overall Study|Symptomatic deterioration|1|||
127689576|NCT00087139|459488275|FG002|Overall Study|Symptomatic deterioration|3|||
127689577|NCT00087139|459488273|FG000|Overall Study|Use of coumadin|1|||
127689578|NCT00087139|459488274|FG001|Overall Study|Use of coumadin|0|||
127689579|NCT00087139|459488275|FG002|Overall Study|Use of coumadin|0|||
127689580|NCT00087139|459488273|FG000|Overall Study|Response achieved|0|||
127689581|NCT00087139|459488274|FG001|Overall Study|Response achieved|1|||
127689582|NCT00087139|459488275|FG002|Overall Study|Response achieved|0|||
127689583|NCT00087139|459488273|FG000|Overall Study|Extradural disease|0|||
127689584|NCT00087139|459488274|FG001|Overall Study|Extradural disease|0|||
127689585|NCT00087139|459488275|FG002|Overall Study|Extradural disease|1|||
127689586|NCT03201562|459488283|FG000|Overall Study|Physician Decision|0|||
127689587|NCT03201562|459488284|FG001|Overall Study|Physician Decision|0|||
127689588|NCT03201562|459488285|FG002|Overall Study|Physician Decision|1|||
127689589|NCT03201562|459488283|FG000|Overall Study|Adverse Event|0|||
127689590|NCT03201562|459488284|FG001|Overall Study|Adverse Event|0|||
127689591|NCT03201562|459488285|FG002|Overall Study|Adverse Event|1|||
127689592|NCT03201562|459488283|FG000|Overall Study|Lost to Follow-up|0|||
127689593|NCT03201562|459488284|FG001|Overall Study|Lost to Follow-up|1|||
127689594|NCT03201562|459488285|FG002|Overall Study|Lost to Follow-up|2|||
128026368|NCT01796470|460720207|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
127567325|NCT00045942|459047127|FG006|PKC412A2104E1|Adverse Event|0|||
127567326|NCT00045942|459047128|FG007|PKC412A2104E1|Adverse Event|0|||
127567327|NCT00045942|459047129|FG008|PKC412A2104E1|Adverse Event|0|||
127567328|NCT00045942|459047121|FG000|PKC412A2104E1|Death|0|||
127567329|NCT00045942|459047122|FG001|PKC412A2104E1|Death|4|||
127567330|NCT00045942|459047123|FG002|PKC412A2104E1|Death|1|||
127567331|NCT00045942|459047124|FG003|PKC412A2104E1|Death|1|||
127567332|NCT00045942|459047125|FG004|PKC412A2104E1|Death|1|||
127777704|NCT00108069|459815089|FG001|Overall Study|Progessive disease|11|||
127567333|NCT00045942|459047126|FG005|PKC412A2104E1|Death|0|||
127567334|NCT00045942|459047127|FG006|PKC412A2104E1|Death|0|||
127567335|NCT00045942|459047128|FG007|PKC412A2104E1|Death|0|||
127567336|NCT00045942|459047129|FG008|PKC412A2104E1|Death|0|||
127567337|NCT00045942|459047121|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
127567338|NCT00045942|459047122|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
127567339|NCT00045942|459047123|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
127567340|NCT00045942|459047124|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
127567341|NCT00045942|459047125|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
127567342|NCT00045942|459047126|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
127567343|NCT00045942|459047127|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
127567344|NCT00045942|459047128|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
127567345|NCT00045942|459047129|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
127567346|NCT00045942|459047121|FG000|PKC412A2104E2|Lost to Follow-up|0|||
127567347|NCT00045942|459047122|FG001|PKC412A2104E2|Lost to Follow-up|0|||
127567348|NCT00045942|459047123|FG002|PKC412A2104E2|Lost to Follow-up|0|||
127567349|NCT00045942|459047124|FG003|PKC412A2104E2|Lost to Follow-up|0|||
127567350|NCT00045942|459047125|FG004|PKC412A2104E2|Lost to Follow-up|0|||
127567351|NCT00045942|459047126|FG005|PKC412A2104E2|Lost to Follow-up|0|||
127567352|NCT00045942|459047127|FG006|PKC412A2104E2|Lost to Follow-up|0|||
127567353|NCT00045942|459047128|FG007|PKC412A2104E2|Lost to Follow-up|3|||
127567354|NCT00045942|459047129|FG008|PKC412A2104E2|Lost to Follow-up|0|||
127567355|NCT00045942|459047121|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
127567356|NCT00045942|459047122|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
127567357|NCT00045942|459047123|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
127567358|NCT00045942|459047124|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
127567359|NCT00045942|459047125|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
127567360|NCT00045942|459047126|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
127567361|NCT00045942|459047127|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
127567362|NCT00045942|459047128|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
127777705|NCT00995007|459815090|FG000|Overall Study|Withdrew consent|1|||
127777706|NCT00995007|459815091|FG001|Overall Study|Withdrew consent|0|||
127777707|NCT00995007|459815090|FG000|Overall Study|Refused further treatment|8|||
127777708|NCT00995007|459815091|FG001|Overall Study|Refused further treatment|2|||
127777709|NCT00995007|459815090|FG000|Overall Study|Toxicity|8|||
127777710|NCT00995007|459815091|FG001|Overall Study|Toxicity|0|||
127777711|NCT01910116|459815092|FG000|Overall Study|Adverse Event|0|||
127777712|NCT01910116|459815093|FG001|Overall Study|Adverse Event|3|||
127777713|NCT01910116|459815092|FG000|Overall Study|Lack of Efficacy|3|||
127777714|NCT01910116|459815093|FG001|Overall Study|Lack of Efficacy|4|||
127777715|NCT01910116|459815092|FG000|Overall Study|Lost to Follow-up|1|||
127777716|NCT01910116|459815093|FG001|Overall Study|Lost to Follow-up|0|||
127777717|NCT01910116|459815092|FG000|Overall Study|Protocol Violation|1|||
127777718|NCT01910116|459815093|FG001|Overall Study|Protocol Violation|2|||
127777719|NCT01910116|459815092|FG000|Overall Study|Withdrawal by Subject|8|||
127777720|NCT01910116|459815093|FG001|Overall Study|Withdrawal by Subject|3|||
127777721|NCT01910116|459815092|FG000|Overall Study|uncertain allocation|1|||
127777722|NCT01910116|459815093|FG001|Overall Study|uncertain allocation|3|||
127777723|NCT01910116|459815092|FG000|Overall Study|incomplete data|0|||
127567363|NCT00045942|459047129|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
127567364|NCT00045942|459047121|FG000|PKC412A2104E2|Lack of Efficacy|0|||
127567365|NCT00045942|459047122|FG001|PKC412A2104E2|Lack of Efficacy|0|||
127567366|NCT00045942|459047123|FG002|PKC412A2104E2|Lack of Efficacy|0|||
127567367|NCT00045942|459047124|FG003|PKC412A2104E2|Lack of Efficacy|0|||
127567368|NCT00045942|459047125|FG004|PKC412A2104E2|Lack of Efficacy|0|||
127567369|NCT00045942|459047126|FG005|PKC412A2104E2|Lack of Efficacy|3|||
127777724|NCT01910116|459815093|FG001|Overall Study|incomplete data|1|||
127777725|NCT03606980|459815094|FG000|Overall Study|Lost to Follow-up|3|||
127777726|NCT03606980|459815095|FG001|Overall Study|Lost to Follow-up|2|||
127777727|NCT03606980|459815096|FG002|Overall Study|Lost to Follow-up|3|||
127777728|NCT03606980|459815094|FG000|Overall Study|Withdrawal by Subject|1|||
127567370|NCT00045942|459047127|FG006|PKC412A2104E2|Lack of Efficacy|2|||
127567371|NCT00045942|459047128|FG007|PKC412A2104E2|Lack of Efficacy|2|||
127567372|NCT00045942|459047129|FG008|PKC412A2104E2|Lack of Efficacy|6|||
127777729|NCT03606980|459815095|FG001|Overall Study|Withdrawal by Subject|0|||
127777730|NCT03606980|459815096|FG002|Overall Study|Withdrawal by Subject|4|||
127777731|NCT02469896|459815099|FG000|Overall Study|Withdrawal by Subject|2|||
127777732|NCT02469896|459815100|FG001|Overall Study|Withdrawal by Subject|0|||
127777733|NCT01294150|459815101|FG000|Overall Study|Physician Decision|2|||
127567373|NCT00045942|459047121|FG000|PKC412A2104E2|Adverse Event|0|||
127567374|NCT00045942|459047122|FG001|PKC412A2104E2|Adverse Event|0|||
127567375|NCT00045942|459047123|FG002|PKC412A2104E2|Adverse Event|0|||
127567376|NCT00045942|459047124|FG003|PKC412A2104E2|Adverse Event|0|||
127567377|NCT00045942|459047125|FG004|PKC412A2104E2|Adverse Event|0|||
127567378|NCT00045942|459047126|FG005|PKC412A2104E2|Adverse Event|4|||
127567379|NCT00045942|459047127|FG006|PKC412A2104E2|Adverse Event|3|||
127567380|NCT00045942|459047128|FG007|PKC412A2104E2|Adverse Event|1|||
127777734|NCT01294150|459815102|FG001|Overall Study|Physician Decision|2|||
127777735|NCT03675776|459815103|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
127777736|NCT03675776|459815104|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
127567381|NCT00045942|459047129|FG008|PKC412A2104E2|Adverse Event|0|||
127567382|NCT00045942|459047121|FG000|PKC412A2104E2|Death|0|||
127567383|NCT00045942|459047122|FG001|PKC412A2104E2|Death|0|||
127567384|NCT00045942|459047123|FG002|PKC412A2104E2|Death|0|||
127567385|NCT00045942|459047124|FG003|PKC412A2104E2|Death|0|||
127567386|NCT00045942|459047125|FG004|PKC412A2104E2|Death|0|||
127567387|NCT00045942|459047126|FG005|PKC412A2104E2|Death|1|||
127567388|NCT00045942|459047127|FG006|PKC412A2104E2|Death|2|||
127567389|NCT00045942|459047128|FG007|PKC412A2104E2|Death|0|||
127567390|NCT00045942|459047129|FG008|PKC412A2104E2|Death|0|||
127567391|NCT02095132|459047130|FG000|Overall Study|Adverse Event|0|||
127567392|NCT02095132|459047131|FG001|Overall Study|Adverse Event|0|||
127567393|NCT02095132|459047132|FG002|Overall Study|Adverse Event|0|||
127567394|NCT02095132|459047133|FG003|Overall Study|Adverse Event|0|||
127567395|NCT02095132|459047134|FG004|Overall Study|Adverse Event|1|||
127567396|NCT02095132|459047135|FG005|Overall Study|Adverse Event|0|||
127777737|NCT03675776|459815105|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
127777738|NCT03675776|459815103|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
127567397|NCT02095132|459047136|FG006|Overall Study|Adverse Event|1|||
127567398|NCT02095132|459047137|FG007|Overall Study|Adverse Event|0|||
127567399|NCT02095132|459047138|FG008|Overall Study|Adverse Event|0|||
127567400|NCT02095132|459047130|FG000|Overall Study|Death|0|||
127567401|NCT02095132|459047131|FG001|Overall Study|Death|0|||
127567402|NCT02095132|459047132|FG002|Overall Study|Death|0|||
127567403|NCT02095132|459047133|FG003|Overall Study|Death|0|||
127567404|NCT02095132|459047134|FG004|Overall Study|Death|0|||
127567405|NCT02095132|459047135|FG005|Overall Study|Death|0|||
127567406|NCT02095132|459047136|FG006|Overall Study|Death|1|||
127567407|NCT02095132|459047137|FG007|Overall Study|Death|0|||
127567408|NCT02095132|459047138|FG008|Overall Study|Death|0|||
127567409|NCT02095132|459047130|FG000|Overall Study|Lack of Efficacy|3|||
127567410|NCT02095132|459047131|FG001|Overall Study|Lack of Efficacy|5|||
127777739|NCT03675776|459815104|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
127777740|NCT03675776|459815105|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
127777741|NCT01351623|459815106|FG000|Overall Study|Protocol Violation|2|||
127777742|NCT01351623|459815106|FG000|Overall Study|Adverse Event|4|||
127777743|NCT01351623|459815106|FG000|Overall Study|Withdrawal by Subject|1|||
127567411|NCT02095132|459047132|FG002|Overall Study|Lack of Efficacy|2|||
127567412|NCT02095132|459047133|FG003|Overall Study|Lack of Efficacy|8|||
127567413|NCT02095132|459047134|FG004|Overall Study|Lack of Efficacy|3|||
127567414|NCT02095132|459047135|FG005|Overall Study|Lack of Efficacy|6|||
127567415|NCT02095132|459047136|FG006|Overall Study|Lack of Efficacy|10|||
127567416|NCT02095132|459047137|FG007|Overall Study|Lack of Efficacy|9|||
127567417|NCT02095132|459047138|FG008|Overall Study|Lack of Efficacy|8|||
127567418|NCT02095132|459047130|FG000|Overall Study|Physician Decision|1|||
127567419|NCT02095132|459047131|FG001|Overall Study|Physician Decision|0|||
127567420|NCT02095132|459047132|FG002|Overall Study|Physician Decision|0|||
127567421|NCT02095132|459047133|FG003|Overall Study|Physician Decision|0|||
127567422|NCT02095132|459047134|FG004|Overall Study|Physician Decision|0|||
127777744|NCT01351623|459815106|FG000|Overall Study|Death|2|||
127777745|NCT01130974|459815108|FG000|Overall Study|Protocol Violation|10|||
127567423|NCT02095132|459047135|FG005|Overall Study|Physician Decision|0|||
127567424|NCT02095132|459047136|FG006|Overall Study|Physician Decision|1|||
127567425|NCT02095132|459047137|FG007|Overall Study|Physician Decision|0|||
127567426|NCT02095132|459047138|FG008|Overall Study|Physician Decision|2|||
127567427|NCT02095132|459047130|FG000|Overall Study|Withdrawal by Subject|0|||
127567428|NCT02095132|459047131|FG001|Overall Study|Withdrawal by Subject|0|||
127567429|NCT02095132|459047132|FG002|Overall Study|Withdrawal by Subject|2|||
127567430|NCT02095132|459047133|FG003|Overall Study|Withdrawal by Subject|2|||
127567431|NCT02095132|459047134|FG004|Overall Study|Withdrawal by Subject|3|||
127567432|NCT02095132|459047135|FG005|Overall Study|Withdrawal by Subject|0|||
127777746|NCT01130974|459815109|FG001|Overall Study|Protocol Violation|10|||
127567433|NCT02095132|459047136|FG006|Overall Study|Withdrawal by Subject|5|||
127567434|NCT02095132|459047137|FG007|Overall Study|Withdrawal by Subject|0|||
127567435|NCT02095132|459047138|FG008|Overall Study|Withdrawal by Subject|0|||
127567436|NCT01029405|459047139|FG000|Overall Study|Withdrawal by Subject|0|||
127567437|NCT01029405|459047140|FG001|Overall Study|Withdrawal by Subject|1|||
127567438|NCT01029405|459047141|FG002|Overall Study|Withdrawal by Subject|2|||
127567439|NCT01029405|459047142|FG003|Overall Study|Withdrawal by Subject|0|||
127567440|NCT01029405|459047139|FG000|Overall Study|Protocol Violation|0|||
127567441|NCT01029405|459047140|FG001|Overall Study|Protocol Violation|0|||
127567442|NCT01029405|459047141|FG002|Overall Study|Protocol Violation|0|||
127567443|NCT01029405|459047142|FG003|Overall Study|Protocol Violation|1|||
127567444|NCT01029405|459047139|FG000|Overall Study|Adverse Event|0|||
127567445|NCT01029405|459047140|FG001|Overall Study|Adverse Event|0|||
127567446|NCT01029405|459047141|FG002|Overall Study|Adverse Event|1|||
127567447|NCT01029405|459047142|FG003|Overall Study|Adverse Event|1|||
127567448|NCT01029405|459047139|FG000|Overall Study|Lost to Follow-up|2|||
127567449|NCT01029405|459047140|FG001|Overall Study|Lost to Follow-up|1|||
127567450|NCT01029405|459047141|FG002|Overall Study|Lost to Follow-up|1|||
127567451|NCT01029405|459047142|FG003|Overall Study|Lost to Follow-up|2|||
127567452|NCT01029405|459047139|FG000|Overall Study|Other|0|||
127567453|NCT01029405|459047140|FG001|Overall Study|Other|1|||
127567454|NCT01029405|459047141|FG002|Overall Study|Other|0|||
127567455|NCT01029405|459047142|FG003|Overall Study|Other|1|||
127567456|NCT00409175|459047143|FG000|Overall Study|Adverse Event|4|||
127567457|NCT00409175|459047144|FG001|Overall Study|Adverse Event|3|||
127567458|NCT00409175|459047143|FG000|Overall Study|Withdrawal by Subject|1|||
127567459|NCT00409175|459047144|FG001|Overall Study|Withdrawal by Subject|2|||
127567460|NCT00409175|459047143|FG000|Overall Study|Negative genotype|0|||
127567461|NCT00409175|459047144|FG001|Overall Study|Negative genotype|1|||
127567462|NCT00409175|459047143|FG000|Overall Study|Liver transplantation|13|||
127567463|NCT00409175|459047144|FG001|Overall Study|Liver transplantation|13|||
127567464|NCT01895361|459047150|FG000|Overall Study|Adverse Event|1|||
127567465|NCT01895361|459047151|FG001|Overall Study|Adverse Event|1|||
127567466|NCT01895361|459047152|FG002|Overall Study|Adverse Event|3|||
127567467|NCT01895361|459047150|FG000|Overall Study|Death|2|||
127567468|NCT01895361|459047151|FG001|Overall Study|Death|1|||
127567469|NCT01895361|459047152|FG002|Overall Study|Death|2|||
128026369|NCT01796470|460720208|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
127567470|NCT01895361|459047150|FG000|Overall Study|Lost to Follow-up|4|||
127567471|NCT01895361|459047151|FG001|Overall Study|Lost to Follow-up|4|||
127567472|NCT01895361|459047152|FG002|Overall Study|Lost to Follow-up|6|||
127567473|NCT01895361|459047150|FG000|Overall Study|Non-compliance with study|1|||
127567474|NCT01895361|459047151|FG001|Overall Study|Non-compliance with study|3|||
127567475|NCT01895361|459047152|FG002|Overall Study|Non-compliance with study|1|||
127567476|NCT01895361|459047150|FG000|Overall Study|Physician Decision|2|||
127567477|NCT01895361|459047151|FG001|Overall Study|Physician Decision|2|||
127567478|NCT01895361|459047152|FG002|Overall Study|Physician Decision|2|||
127567479|NCT01895361|459047150|FG000|Overall Study|Withdrawal by Subject|7|||
127567480|NCT01895361|459047151|FG001|Overall Study|Withdrawal by Subject|6|||
127567481|NCT01895361|459047152|FG002|Overall Study|Withdrawal by Subject|6|||
127567482|NCT01895361|459047150|FG000|Overall Study|Lack of Efficacy|0|||
127567483|NCT01895361|459047151|FG001|Overall Study|Lack of Efficacy|1|||
127567484|NCT01895361|459047152|FG002|Overall Study|Lack of Efficacy|0|||
127567485|NCT01895361|459047150|FG000|Overall Study|Reasons different from categories above|7|||
127567486|NCT01895361|459047151|FG001|Overall Study|Reasons different from categories above|3|||
127567487|NCT01895361|459047152|FG002|Overall Study|Reasons different from categories above|4|||
127689595|NCT00393484|459488286|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
127689596|NCT00393484|459488287|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
127689597|NCT00393484|459488286|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
127689598|NCT00393484|459488287|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
127689599|NCT00393484|459488286|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
127689600|NCT00393484|459488287|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
127689601|NCT00393484|459488286|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
127689602|NCT00393484|459488287|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
127689603|NCT00393484|459488286|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
127689604|NCT00393484|459488287|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
127689605|NCT00393484|459488286|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
127689606|NCT00393484|459488287|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
127689607|NCT00393484|459488286|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
127689608|NCT00393484|459488287|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
127689609|NCT00393484|459488286|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
128026370|NCT01796470|460720209|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
128026371|NCT01796470|460720205|FG000|Overall Study|Withdrawal by Subject|7|||
127567488|NCT01209832|459047156|FG000|Period 1|Sponsor Decision and was not dosed|1|||
127689610|NCT00393484|459488287|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
127567489|NCT01209832|459047156|FG000|Period 2|Sponsor Decision|1|||
127567490|NCT01268579|459047157|FG000|Overall Study|Adverse Event|1|||
127567491|NCT01268579|459047157|FG000|Overall Study|Withdrawal by Subject|2|||
127567492|NCT00761150|459047158|FG000|Open-label Period|Adverse Event|36|||
127567493|NCT00761150|459047159|FG001|Open-label Period|Adverse Event|0|||
127567494|NCT00761150|459047160|FG002|Open-label Period|Adverse Event|0|||
127567495|NCT00761150|459047158|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
127567496|NCT00761150|459047159|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
127567497|NCT00761150|459047160|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
127777747|NCT01130974|459815108|FG000|Overall Study|Withdrawal by Subject|0|||
127777748|NCT01130974|459815109|FG001|Overall Study|Withdrawal by Subject|1|||
127777749|NCT01130974|459815108|FG000|Overall Study|Ineligibility criteria|5|||
127777750|NCT01130974|459815109|FG001|Overall Study|Ineligibility criteria|2|||
127777751|NCT01184053|459815110|FG000|Overall Study|progression while on treatment|3|||
127777752|NCT04399122|459815111|FG000|Overall Study|Lost to Follow-up|2|||
127777753|NCT04399122|459815112|FG001|Overall Study|Lost to Follow-up|0|||
127777754|NCT04399122|459815111|FG000|Overall Study|Withdrawal by Subject|1|||
127777755|NCT04399122|459815112|FG001|Overall Study|Withdrawal by Subject|0|||
127777756|NCT02536755|459815115|FG000|Overall Study|Adverse Event|4|||
127777757|NCT01174238|459815116|FG000|Overall Study|Lost to Follow-up|2|||
127777758|NCT01102803|459815118|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
127777759|NCT01102803|459815119|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
127777760|NCT01102803|459815118|FG000|Post to Follow-Up|Lost to Follow-up|1|||
127777761|NCT01102803|459815119|FG001|Post to Follow-Up|Lost to Follow-up|3|||
127777762|NCT02733185|459815120|FG000|Overall Study|Withdrawal by Subject|12|||
127777763|NCT02733185|459815121|FG001|Overall Study|Withdrawal by Subject|10|||
127777764|NCT02733185|459815122|FG002|Overall Study|Withdrawal by Subject|17|||
127777765|NCT02733185|459815123|FG003|Overall Study|Withdrawal by Subject|21|||
127777766|NCT02733185|459815120|FG000|Overall Study|Death|46|||
127777767|NCT02733185|459815121|FG001|Overall Study|Death|34|||
127777768|NCT02733185|459815122|FG002|Overall Study|Death|35|||
127777769|NCT02733185|459815123|FG003|Overall Study|Death|43|||
127777770|NCT02733185|459815120|FG000|Overall Study|Lost to Follow-up|17|||
127777771|NCT02733185|459815121|FG001|Overall Study|Lost to Follow-up|18|||
127777772|NCT02733185|459815122|FG002|Overall Study|Lost to Follow-up|16|||
127777773|NCT02733185|459815123|FG003|Overall Study|Lost to Follow-up|11|||
127777774|NCT02593786|459815124|FG000|Overall Study|Disease progression|12|||
127777775|NCT02593786|459815125|FG001|Overall Study|Disease progression|16|||
127777776|NCT02593786|459815126|FG002|Overall Study|Disease progression|10|||
127777777|NCT02593786|459815127|FG003|Overall Study|Disease progression|7|||
127777778|NCT02593786|459815124|FG000|Overall Study|Study drug toxicity|1|||
127777779|NCT02593786|459815125|FG001|Overall Study|Study drug toxicity|0|||
127777780|NCT02593786|459815126|FG002|Overall Study|Study drug toxicity|0|||
127777781|NCT02593786|459815127|FG003|Overall Study|Study drug toxicity|0|||
127777782|NCT02593786|459815124|FG000|Overall Study|Adverse event unrelated to study drug|1|||
127777783|NCT02593786|459815125|FG001|Overall Study|Adverse event unrelated to study drug|1|||
127777784|NCT02593786|459815126|FG002|Overall Study|Adverse event unrelated to study drug|1|||
127777785|NCT02593786|459815127|FG003|Overall Study|Adverse event unrelated to study drug|0|||
127777786|NCT02593786|459815124|FG000|Overall Study|Participant request to discontinue study therapy|0|||
127777787|NCT02593786|459815125|FG001|Overall Study|Participant request to discontinue study therapy|2|||
127777788|NCT02593786|459815126|FG002|Overall Study|Participant request to discontinue study therapy|0|||
127777789|NCT02593786|459815127|FG003|Overall Study|Participant request to discontinue study therapy|0|||
127777790|NCT02593786|459815124|FG000|Overall Study|Other reasons|1|||
127777791|NCT02593786|459815125|FG001|Overall Study|Other reasons|1|||
127777792|NCT02593786|459815126|FG002|Overall Study|Other reasons|0|||
127777793|NCT02593786|459815127|FG003|Overall Study|Other reasons|5|||
127777794|NCT00835120|459815130|FG000|Overall Study|Lack of Efficacy|1|||
127777795|NCT00835120|459815130|FG000|Overall Study|Lost to Follow-up|3|||
127777796|NCT00835120|459815130|FG000|Overall Study|Adverse Event|2|||
127777797|NCT00835120|459815130|FG000|Overall Study|Withdrawal by Subject|2|||
127777798|NCT01624259|459815131|FG000|Overall Study|Adverse Event|18|||
127777799|NCT01624259|459815132|FG001|Overall Study|Adverse Event|18|||
127777800|NCT01624259|459815131|FG000|Overall Study|Protocol Violation|1|||
127777801|NCT01624259|459815132|FG001|Overall Study|Protocol Violation|2|||
127777802|NCT01624259|459815131|FG000|Overall Study|Withdrawal by Subject|5|||
127777803|NCT01624259|459815132|FG001|Overall Study|Withdrawal by Subject|7|||
127777804|NCT01624259|459815131|FG000|Overall Study|Physician Decision|1|||
127777805|NCT01624259|459815132|FG001|Overall Study|Physician Decision|1|||
127777806|NCT01624259|459815131|FG000|Overall Study|Lost to Follow-up|2|||
127777807|NCT01624259|459815132|FG001|Overall Study|Lost to Follow-up|3|||
127777808|NCT01624259|459815131|FG000|Overall Study|Abnormal laboratory measure|3|||
127777809|NCT01624259|459815132|FG001|Overall Study|Abnormal laboratory measure|0|||
127777810|NCT00671554|459815133|FG000|Overall Study|Disease progression|3|||
127777811|NCT03828292|459815136|FG000|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
127777812|NCT03828292|459815137|FG001|Main Study: Part 1 (Up to 141 Weeks)|Death|1|||
127777813|NCT03828292|459815138|FG002|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
127777814|NCT03828292|459815139|FG003|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
127777815|NCT03828292|459815140|FG004|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
127777816|NCT03828292|459815141|FG005|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
127777817|NCT03828292|459815136|FG000|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
127777818|NCT03828292|459815137|FG001|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
127777819|NCT03828292|459815138|FG002|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|1|||
127777820|NCT03828292|459815139|FG003|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
127777821|NCT03828292|459815140|FG004|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
127567498|NCT00761150|459047158|FG000|Open-label Period|Lost to Follow-up|7|||
127777822|NCT03828292|459815141|FG005|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
127777823|NCT03828292|459815136|FG000|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
127777824|NCT03828292|459815137|FG001|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
127777825|NCT03828292|459815138|FG002|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
127777826|NCT03828292|459815139|FG003|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|1|||
127777827|NCT03828292|459815140|FG004|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
127777828|NCT03828292|459815141|FG005|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
127777829|NCT03828292|459815136|FG000|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
127777830|NCT03828292|459815137|FG001|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
127777831|NCT03828292|459815138|FG002|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
127777832|NCT03828292|459815139|FG003|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|1|||
127777833|NCT03828292|459815140|FG004|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
127777834|NCT03828292|459815141|FG005|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
127567499|NCT00761150|459047159|FG001|Open-label Period|Lost to Follow-up|0|||
127567500|NCT00761150|459047160|FG002|Open-label Period|Lost to Follow-up|0|||
127567501|NCT00761150|459047158|FG000|Open-label Period|Lack of Efficacy|4|||
127567502|NCT00761150|459047159|FG001|Open-label Period|Lack of Efficacy|0|||
127567503|NCT00761150|459047160|FG002|Open-label Period|Lack of Efficacy|0|||
127567504|NCT00761150|459047158|FG000|Open-label Period|Withdrawal by Subject|5|||
127567505|NCT00761150|459047159|FG001|Open-label Period|Withdrawal by Subject|0|||
127567506|NCT00761150|459047160|FG002|Open-label Period|Withdrawal by Subject|0|||
127567507|NCT00761150|459047158|FG000|Open-label Period|Noncompliance|2|||
127567508|NCT00761150|459047159|FG001|Open-label Period|Noncompliance|0|||
127567509|NCT00761150|459047160|FG002|Open-label Period|Noncompliance|0|||
127567510|NCT00761150|459047158|FG000|Open-label Period|Other|5|||
127567511|NCT00761150|459047159|FG001|Open-label Period|Other|0|||
127567512|NCT00761150|459047160|FG002|Open-label Period|Other|0|||
127567513|NCT00761150|459047158|FG000|Double-blind Period|Lack of Efficacy|0|||
127567514|NCT00761150|459047159|FG001|Double-blind Period|Lack of Efficacy|2|||
127567515|NCT00761150|459047160|FG002|Double-blind Period|Lack of Efficacy|19|||
127567516|NCT00761150|459047158|FG000|Double-blind Period|Adverse Event|0|||
127567517|NCT00761150|459047159|FG001|Double-blind Period|Adverse Event|3|||
127567518|NCT00761150|459047160|FG002|Double-blind Period|Adverse Event|3|||
127567519|NCT00761150|459047158|FG000|Double-blind Period|Withdrawal by Subject|0|||
127567520|NCT00761150|459047159|FG001|Double-blind Period|Withdrawal by Subject|3|||
127567521|NCT00761150|459047160|FG002|Double-blind Period|Withdrawal by Subject|2|||
127567522|NCT00761150|459047158|FG000|Double-blind Period|Lost to Follow-up|0|||
127567523|NCT00761150|459047159|FG001|Double-blind Period|Lost to Follow-up|2|||
127567524|NCT00761150|459047160|FG002|Double-blind Period|Lost to Follow-up|1|||
127567525|NCT00761150|459047158|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
127567526|NCT00761150|459047159|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
127567527|NCT00761150|459047160|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
127567528|NCT00761150|459047158|FG000|Double-blind Period|Noncompliance|0|||
127567529|NCT00761150|459047159|FG001|Double-blind Period|Noncompliance|1|||
127567530|NCT00761150|459047160|FG002|Double-blind Period|Noncompliance|0|||
127567531|NCT00761150|459047158|FG000|Double-blind Period|Other|0|||
127567532|NCT00761150|459047159|FG001|Double-blind Period|Other|3|||
127567533|NCT00761150|459047160|FG002|Double-blind Period|Other|3|||
127567534|NCT02692651|459047161|FG000|Study Treatment|Death|7|||
127567535|NCT02692651|459047162|FG001|Study Treatment|Death|3|||
127567536|NCT02692651|459047161|FG000|Study Treatment|comfort care|1|||
127567537|NCT02692651|459047162|FG001|Study Treatment|comfort care|1|||
127567538|NCT02692651|459047161|FG000|Study Treatment|Protocol violation per treating team preference|8|||
127567539|NCT02692651|459047162|FG001|Study Treatment|Protocol violation per treating team preference|6|||
127567540|NCT02692651|459047161|FG000|Post Study Treatment Follow-up|Death|4|||
127567541|NCT02692651|459047162|FG001|Post Study Treatment Follow-up|Death|4|||
127567542|NCT02480712|459047163|FG000|Overall Study|Enrolled but Never Treated|1|||
127567543|NCT02480712|459047163|FG000|Overall Study|Lost to Follow-up|5|||
127567544|NCT02480712|459047163|FG000|Overall Study|Withdrew Consent|3|||
127567545|NCT02480712|459047163|FG000|Overall Study|Death|1|||
127567546|NCT02480712|459047163|FG000|Overall Study|Lack of Efficacy|1|||
127777835|NCT03828292|459815136|FG000|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
127777836|NCT03828292|459815137|FG001|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
127567547|NCT01860846|459047164|FG000|Overall Study|Lost to Follow-up|33|||
127567548|NCT05463198|459047165|FG000|Overall Study|Withdrawal by Subject|19|||
127567549|NCT05463198|459047165|FG000|Overall Study|Procedure Notes Missing|18|||
127777837|NCT03828292|459815138|FG002|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
127567550|NCT02239120|459047166|FG000|Overall Study|Death|56|||
127567551|NCT02239120|459047167|FG001|Overall Study|Death|58|||
127567552|NCT02239120|459047166|FG000|Overall Study|Lost to Follow-up|19|||
127567553|NCT02239120|459047167|FG001|Overall Study|Lost to Follow-up|14|||
127567554|NCT01925989|459047168|FG000|Period 1|Sponsor Decision|1|||
127567555|NCT01925989|459047169|FG001|Period 1|Sponsor Decision|1|||
127567556|NCT01925989|459047170|FG002|Period 1|Sponsor Decision|0|||
128026372|NCT01796470|460720206|FG001|Overall Study|Withdrawal by Subject|0|||
127567557|NCT01925989|459047168|FG000|Period 1|Withdrawal by Subject|0|||
127567558|NCT01925989|459047169|FG001|Period 1|Withdrawal by Subject|1|||
127567559|NCT01925989|459047170|FG002|Period 1|Withdrawal by Subject|0|||
127567560|NCT01120067|459047181|FG000|Overall Study|Lost to Follow-up|3|||
127567561|NCT01120067|459047182|FG001|Overall Study|Lost to Follow-up|1|||
127567562|NCT01120067|459047181|FG000|Overall Study|fail to engage >3 sessions|2|||
127567563|NCT01120067|459047182|FG001|Overall Study|fail to engage >3 sessions|0|||
127567564|NCT00266877|459047183|FG000|Overall Study|Death|1|||
127567565|NCT00266877|459047184|FG001|Overall Study|Death|1|||
127567566|NCT00266877|459047185|FG002|Overall Study|Death|1|||
127567567|NCT00266877|459047183|FG000|Overall Study|Adverse Event|6|||
127567568|NCT00266877|459047184|FG001|Overall Study|Adverse Event|4|||
127567569|NCT00266877|459047185|FG002|Overall Study|Adverse Event|1|||
127567570|NCT00266877|459047183|FG000|Overall Study|Physician Decision|2|||
127567571|NCT00266877|459047184|FG001|Overall Study|Physician Decision|1|||
127567572|NCT00266877|459047185|FG002|Overall Study|Physician Decision|1|||
127567573|NCT00266877|459047183|FG000|Overall Study|Withdrawal by Subject|3|||
127567574|NCT00266877|459047184|FG001|Overall Study|Withdrawal by Subject|1|||
127567575|NCT00266877|459047185|FG002|Overall Study|Withdrawal by Subject|1|||
127567576|NCT00266877|459047183|FG000|Overall Study|Disease Progression|72|||
127567577|NCT00266877|459047184|FG001|Overall Study|Disease Progression|37|||
127567578|NCT00266877|459047185|FG002|Overall Study|Disease Progression|23|||
127567579|NCT00266877|459047183|FG000|Overall Study|Symptomatic Deterioration|6|||
127567580|NCT00266877|459047184|FG001|Overall Study|Symptomatic Deterioration|3|||
127567581|NCT00266877|459047185|FG002|Overall Study|Symptomatic Deterioration|1|||
127567582|NCT00266877|459047183|FG000|Overall Study|Hospitalization|1|||
127567583|NCT00266877|459047184|FG001|Overall Study|Hospitalization|0|||
127567584|NCT00266877|459047185|FG002|Overall Study|Hospitalization|0|||
127567585|NCT00266877|459047183|FG000|Overall Study|Concomitant Radiotherapy|0|||
127567586|NCT00266877|459047184|FG001|Overall Study|Concomitant Radiotherapy|1|||
127567587|NCT00266877|459047185|FG002|Overall Study|Concomitant Radiotherapy|0|||
127567588|NCT03985878|459047194|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
127689611|NCT00393484|459488286|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
127689612|NCT00393484|459488287|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
127689613|NCT00393484|459488286|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
127689614|NCT00393484|459488287|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
127689615|NCT00065260|459488288|FG000|Overall Study|Death|0|||
127689616|NCT00065260|459488289|FG001|Overall Study|Death|1|||
128026373|NCT01796470|460720207|FG002|Overall Study|Withdrawal by Subject|0|||
127567589|NCT03985878|459047194|FG000|Overall Study|Study Terminated by Sponsor|12|||
127567590|NCT03985878|459047194|FG000|Overall Study|Withdrawal by Subject|1|||
127689617|NCT00001277|459488290|FG000|Overall Study|Adverse Event|0|||
127689618|NCT00001277|459488291|FG001|Overall Study|Adverse Event|0|||
127689619|NCT00001277|459488292|FG002|Overall Study|Adverse Event|1|||
127689620|NCT00001277|459488290|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
127689621|NCT00001277|459488291|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
127689622|NCT00001277|459488292|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
127689623|NCT02178098|459488296|FG000|Overall Study|Withdrawal by Subject|0|||
127689624|NCT02178098|459488297|FG001|Overall Study|Withdrawal by Subject|6|||
127689625|NCT02178098|459488296|FG000|Overall Study|Adverse Event|1|||
127689626|NCT02178098|459488297|FG001|Overall Study|Adverse Event|2|||
127689627|NCT02178098|459488296|FG000|Overall Study|Protocol Violation|1|||
127689628|NCT02178098|459488297|FG001|Overall Study|Protocol Violation|1|||
127689629|NCT02178098|459488296|FG000|Overall Study|Lost to Follow-up|0|||
127689630|NCT02178098|459488297|FG001|Overall Study|Lost to Follow-up|1|||
127689631|NCT02178098|459488296|FG000|Overall Study|Sponsor Request|1|||
127689632|NCT02178098|459488297|FG001|Overall Study|Sponsor Request|0|||
127689633|NCT02178098|459488296|FG000|Overall Study|Other|2|||
127689634|NCT02178098|459488297|FG001|Overall Study|Other|2|||
127777838|NCT03828292|459815139|FG003|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
127777839|NCT03828292|459815140|FG004|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
127777840|NCT03828292|459815141|FG005|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
127567591|NCT00278915|459047197|FG000|Overall Study|Disease progression|1|||
127567592|NCT02520089|459047198|FG000|Overall Study|Lost to Follow-up|3|||
127567593|NCT02520089|459047199|FG001|Overall Study|Lost to Follow-up|4|||
127567594|NCT03353740|459047205|FG000|Overall Study|Images for these participants not viable|52|||
127567595|NCT02232880|459047207|FG000|Overall Study|study stopped prior to randomization|1|||
127567596|NCT02545543|459047208|FG000|Overall Study|Lost to Follow-up|67|||
127567597|NCT02545543|459047209|FG001|Overall Study|Lost to Follow-up|25|||
127567598|NCT02545543|459047208|FG000|Overall Study|Physician Decision|3|||
127567599|NCT02545543|459047209|FG001|Overall Study|Physician Decision|0|||
127689635|NCT01044303|459488298|FG000|Overall Study|Lost to Follow-up|2|||
127689636|NCT01109524|459488301|FG000|Overall Study|Disease Progression|29|||
127567600|NCT02545543|459047208|FG000|Overall Study|Withdrawal by Subject|9|||
127567601|NCT02545543|459047209|FG001|Overall Study|Withdrawal by Subject|8|||
127567602|NCT02545543|459047208|FG000|Overall Study|Noncomplaince|1|||
127567603|NCT02545543|459047209|FG001|Overall Study|Noncomplaince|0|||
127567604|NCT02545543|459047208|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
127567605|NCT02545543|459047209|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
127567606|NCT02829944|459047210|FG000|Overall Study|Physician Decision|0|||
127567607|NCT02829944|459047211|FG001|Overall Study|Physician Decision|1|||
127567608|NCT02829944|459047210|FG000|Overall Study|Screen Failure|2|||
127567609|NCT02829944|459047211|FG001|Overall Study|Screen Failure|2|||
127567610|NCT02829944|459047210|FG000|Overall Study|Inadequate Neuraxial Block|1|||
127567611|NCT02829944|459047211|FG001|Overall Study|Inadequate Neuraxial Block|1|||
127567612|NCT02829944|459047210|FG000|Overall Study|Withdrawal by Subject|2|||
127567613|NCT02829944|459047211|FG001|Overall Study|Withdrawal by Subject|1|||
127567614|NCT02829944|459047210|FG000|Overall Study|Catheter Displacement|1|||
127567615|NCT02829944|459047211|FG001|Overall Study|Catheter Displacement|0|||
127567616|NCT02829944|459047210|FG000|Overall Study|Catheter broke|0|||
127567617|NCT02829944|459047211|FG001|Overall Study|Catheter broke|1|||
127567618|NCT02829944|459047210|FG000|Overall Study|Staff unavailable|0|||
127567619|NCT02829944|459047211|FG001|Overall Study|Staff unavailable|1|||
127567620|NCT01395784|459047212|FG000|Overall Study|Lost to Follow-up|7|||
127567621|NCT01395784|459047212|FG000|Overall Study|Withdrawal by Subject|3|||
127567622|NCT01395784|459047212|FG000|Overall Study|Physician Decision|5|||
127567623|NCT04268823|459047213|FG000|Overall Study|Adverse Event|1|||
127567624|NCT04268823|459047214|FG001|Overall Study|Adverse Event|0|||
127777841|NCT06950879|459815145|FG000|Overall Study|Unable to complete task due to motor impairment|1|||
127777842|NCT04313153|459816937|FG000|Overall Study|Adverse Event (includes Death)|14|||
127777843|NCT04313153|459816938|FG001|Overall Study|Adverse Event (includes Death)|19|||
127777844|NCT04313153|459816939|FG002|Overall Study|Adverse Event (includes Death)|10|||
127777845|NCT04313153|459816937|FG000|Overall Study|Physician Decision|4|||
127777846|NCT04313153|459816938|FG001|Overall Study|Physician Decision|2|||
127777847|NCT04313153|459816939|FG002|Overall Study|Physician Decision|1|||
127777848|NCT04313153|459816937|FG000|Overall Study|Withdrawal by Subject|7|||
127777849|NCT04313153|459816938|FG001|Overall Study|Withdrawal by Subject|6|||
127777850|NCT04313153|459816939|FG002|Overall Study|Withdrawal by Subject|2|||
127777851|NCT04313153|459816937|FG000|Overall Study|Lack of Efficacy|3|||
127777852|NCT04313153|459816938|FG001|Overall Study|Lack of Efficacy|3|||
127777853|NCT04313153|459816939|FG002|Overall Study|Lack of Efficacy|0|||
127777854|NCT04313153|459816937|FG000|Overall Study|Lost to Follow-up|1|||
127777855|NCT04313153|459816938|FG001|Overall Study|Lost to Follow-up|0|||
128026374|NCT01796470|460720208|FG003|Overall Study|Withdrawal by Subject|0|||
128026375|NCT01796470|460720209|FG004|Overall Study|Withdrawal by Subject|1|||
128026376|NCT01927861|460720210|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
128026377|NCT01927861|460720211|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
127777856|NCT04313153|459816939|FG002|Overall Study|Lost to Follow-up|2|||
127777857|NCT04313153|459816937|FG000|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|0|||
127777858|NCT04313153|459816938|FG001|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|2|||
127777859|NCT04313153|459816939|FG002|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|3|||
128026378|NCT01927861|460720210|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
127777860|NCT04313153|459816937|FG000|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|16|||
127777861|NCT04313153|459816938|FG001|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|20|||
127777862|NCT04313153|459816939|FG002|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|19|||
127777863|NCT04313153|459816937|FG000|Overall Study|Change in Dialysis Modality|0|||
127777864|NCT04313153|459816938|FG001|Overall Study|Change in Dialysis Modality|1|||
127777865|NCT04313153|459816939|FG002|Overall Study|Change in Dialysis Modality|2|||
127777866|NCT04313153|459816937|FG000|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|1|||
127777867|NCT04313153|459816938|FG001|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
127777868|NCT04313153|459816939|FG002|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
127777869|NCT04313153|459816937|FG000|Overall Study|Other|5|||
127777870|NCT04313153|459816938|FG001|Overall Study|Other|3|||
127777871|NCT04313153|459816939|FG002|Overall Study|Other|2|||
127777872|NCT04752475|459816940|FG000|Overall Study|Withdrawal by Subject|1|||
127777873|NCT04752475|459816941|FG001|Overall Study|Withdrawal by Subject|1|||
127777874|NCT02113579|459816944|FG000|Overall Study|Adverse Event|1|||
127777875|NCT02113579|459816945|FG001|Overall Study|Adverse Event|0|||
127777876|NCT02113579|459816944|FG000|Overall Study|Withdrawal by Subject|3|||
127567625|NCT04268823|459047213|FG000|Overall Study|Participant Decision|1|||
127567626|NCT04268823|459047214|FG001|Overall Study|Participant Decision|0|||
127567627|NCT00336583|459048467|FG000|Overall Study|Lost to Follow-up|1|||
127567628|NCT00336583|459048467|FG000|Overall Study|Death|1|||
128026379|NCT01927861|460720211|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
128026380|NCT00987935|460720212|FG000|Overall Study|Progressive disease|3|||
127567629|NCT00910247|459048468|FG000|Overall Study|Adverse Event|15|||
127567630|NCT00910247|459048468|FG000|Overall Study|Death|2|||
128026381|NCT00987935|460720213|FG001|Overall Study|Progressive disease|2|||
128026382|NCT00987935|460720214|FG002|Overall Study|Progressive disease|3|||
128026383|NCT00987935|460720215|FG003|Overall Study|Progressive disease|2|||
128026384|NCT00987935|460720216|FG004|Overall Study|Progressive disease|5|||
128026385|NCT00987935|460720217|FG005|Overall Study|Progressive disease|3|||
128026386|NCT00987935|460720218|FG006|Overall Study|Progressive disease|9|||
128026387|NCT00987935|460720219|FG007|Overall Study|Progressive disease|48|||
128026388|NCT00987935|460720220|FG008|Overall Study|Progressive disease|23|||
128026389|NCT00987935|460720212|FG000|Overall Study|Adverse Event|0|||
128026390|NCT00987935|460720213|FG001|Overall Study|Adverse Event|1|||
128026391|NCT00987935|460720214|FG002|Overall Study|Adverse Event|0|||
127567631|NCT00910247|459048468|FG000|Overall Study|Lost to Follow-up|10|||
127567632|NCT00910247|459048468|FG000|Overall Study|Physician Decision|3|||
127689637|NCT01109524|459488301|FG000|Overall Study|Study Drug toxicity|6|||
127689638|NCT01109524|459488301|FG000|Overall Study|Adverse Event|4|||
127689639|NCT01109524|459488301|FG000|Overall Study|Withdrawal by Subject|2|||
127689640|NCT01109524|459488301|FG000|Overall Study|Maximum clinical benefit|3|||
127689641|NCT01109524|459488301|FG000|Overall Study|Death|2|||
127689642|NCT01109524|459488301|FG000|Overall Study|No longer meets criteria|2|||
127689643|NCT01109524|459488301|FG000|Overall Study|Participant requested to end treatment|4|||
127689644|NCT01109524|459488301|FG000|Overall Study|Other|5|||
127689645|NCT03101371|459488311|FG000|Overall Study|Physician Decision|0|||
127689646|NCT03101371|459488312|FG001|Overall Study|Physician Decision|1|||
127689647|NCT03101371|459488311|FG000|Overall Study|Lost to Follow-up|1|||
127689648|NCT03101371|459488312|FG001|Overall Study|Lost to Follow-up|4|||
127689649|NCT03101371|459488311|FG000|Overall Study|Did not meet eligibility criteria|2|||
127689650|NCT03101371|459488312|FG001|Overall Study|Did not meet eligibility criteria|1|||
127689651|NCT00031694|459488315|FG000|Overall Study|Adverse Event|12|||
127689652|NCT00031694|459488315|FG000|Overall Study|Death|2|||
127689653|NCT00031694|459488315|FG000|Overall Study|Withdrawal by Subject|5|||
127689654|NCT02556138|459488323|FG000|Overall Study|Withdrawal by Subject|1|||
127689655|NCT04019444|459488326|FG000|Overall Study|Withdrawal by Subject|0|||
127689656|NCT04019444|459488327|FG001|Overall Study|Withdrawal by Subject|1|||
127689657|NCT04019444|459488328|FG002|Overall Study|Withdrawal by Subject|0|||
127689658|NCT04019444|459488329|FG003|Overall Study|Withdrawal by Subject|1|||
127689659|NCT04019444|459488326|FG000|Overall Study|Solicited Event|0|||
127689660|NCT04019444|459488327|FG001|Overall Study|Solicited Event|0|||
127689661|NCT04019444|459488328|FG002|Overall Study|Solicited Event|2|||
127689662|NCT04019444|459488329|FG003|Overall Study|Solicited Event|0|||
127689663|NCT01303445|459488341|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
127689664|NCT01303445|459488342|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
127689665|NCT01303445|459488341|FG000|Second Intervention (7 Days)|Adverse Event|0|||
127689666|NCT01303445|459488342|FG001|Second Intervention (7 Days)|Adverse Event|2|||
127689667|NCT01303445|459488341|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
127689668|NCT01303445|459488342|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
127689669|NCT01303445|459488341|FG000|Washout (14 Days)|Protocol Violation|1|||
127689670|NCT01303445|459488342|FG001|Washout (14 Days)|Protocol Violation|0|||
127689671|NCT01303445|459488341|FG000|Washout (14 Days)|Lost to Follow-up|0|||
127689672|NCT01303445|459488342|FG001|Washout (14 Days)|Lost to Follow-up|2|||
127689673|NCT01303445|459488341|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
127689674|NCT01303445|459488342|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
127689675|NCT01303445|459488341|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
127689676|NCT01303445|459488342|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
127689677|NCT02576509|459490227|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
127689678|NCT02576509|459490228|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
127689679|NCT02576509|459490227|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
127689680|NCT02576509|459490228|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
127689681|NCT02576509|459490227|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
127689682|NCT02576509|459490228|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
127689683|NCT02576509|459490227|FG000|Treatment Period|Disease progression|263|||
127689684|NCT02576509|459490228|FG001|Treatment Period|Disease progression|244|||
127689685|NCT02576509|459490227|FG000|Treatment Period|Study drug toxicity|37|||
127689686|NCT02576509|459490228|FG001|Treatment Period|Study drug toxicity|41|||
127689687|NCT02576509|459490227|FG000|Treatment Period|Death|1|||
127689688|NCT02576509|459490228|FG001|Treatment Period|Death|1|||
127689689|NCT02576509|459490227|FG000|Treatment Period|Adverse event unrelated to study drug|39|||
127689690|NCT02576509|459490228|FG001|Treatment Period|Adverse event unrelated to study drug|41|||
127567633|NCT00910247|459048468|FG000|Overall Study|Protocol Violation|10|||
127689691|NCT02576509|459490227|FG000|Treatment Period|Participant request to stop treatment|8|||
127689692|NCT02576509|459490228|FG001|Treatment Period|Participant request to stop treatment|18|||
127689693|NCT02576509|459490227|FG000|Treatment Period|Participant withdrew consent|3|||
127689694|NCT02576509|459490228|FG001|Treatment Period|Participant withdrew consent|7|||
127689695|NCT02576509|459490227|FG000|Treatment Period|Lost to Follow-up|0|||
127689696|NCT02576509|459490228|FG001|Treatment Period|Lost to Follow-up|1|||
128026392|NCT00987935|460720215|FG003|Overall Study|Adverse Event|1|||
128026393|NCT00987935|460720216|FG004|Overall Study|Adverse Event|1|||
128026394|NCT00987935|460720217|FG005|Overall Study|Adverse Event|0|||
128026395|NCT00987935|460720218|FG006|Overall Study|Adverse Event|2|||
128026396|NCT00987935|460720219|FG007|Overall Study|Adverse Event|10|||
128026397|NCT00987935|460720220|FG008|Overall Study|Adverse Event|6|||
128026398|NCT00987935|460720212|FG000|Overall Study|Refused to continue taking trial med.|1|||
128026399|NCT00987935|460720213|FG001|Overall Study|Refused to continue taking trial med.|0|||
127567634|NCT00910247|459048468|FG000|Overall Study|Withdrawal by Subject|25|||
127689697|NCT02576509|459490227|FG000|Treatment Period|Maximum clinical benefit|1|||
127689698|NCT02576509|459490228|FG001|Treatment Period|Maximum clinical benefit|0|||
127689699|NCT02576509|459490227|FG000|Treatment Period|Poor/non-compliance|1|||
127689700|NCT02576509|459490228|FG001|Treatment Period|Poor/non-compliance|1|||
127689701|NCT02576509|459490227|FG000|Treatment Period|Participant no longer meets criteria|1|||
127689702|NCT02576509|459490228|FG001|Treatment Period|Participant no longer meets criteria|0|||
127689703|NCT02576509|459490227|FG000|Treatment Period|Other reason|12|||
127689704|NCT02576509|459490228|FG001|Treatment Period|Other reason|8|||
127689705|NCT02576509|459490227|FG000|Treatment Period|NOT REPORTED|1|||
127689706|NCT02576509|459490228|FG001|Treatment Period|NOT REPORTED|0|||
127689707|NCT02576509|459490227|FG000|Treatment Period|Administrative reason by sponsor|0|||
127689708|NCT02576509|459490228|FG001|Treatment Period|Administrative reason by sponsor|1|||
127689709|NCT03725722|459490234|FG000|Overall Study|Lack of Efficacy|2|||
127689710|NCT03725722|459490235|FG001|Overall Study|Lack of Efficacy|1|||
127689711|NCT03725722|459490236|FG002|Overall Study|Lack of Efficacy|2|||
127689712|NCT03725722|459490237|FG003|Overall Study|Lack of Efficacy|0|||
127689713|NCT03725722|459490238|FG004|Overall Study|Lack of Efficacy|2|||
127689714|NCT03725722|459490234|FG000|Overall Study|Adverse Event|2|||
127689715|NCT03725722|459490235|FG001|Overall Study|Adverse Event|2|||
127689716|NCT03725722|459490236|FG002|Overall Study|Adverse Event|1|||
127689717|NCT03725722|459490237|FG003|Overall Study|Adverse Event|0|||
127689718|NCT03725722|459490238|FG004|Overall Study|Adverse Event|6|||
127689719|NCT03725722|459490234|FG000|Overall Study|Withdrawal by Subject|4|||
127689720|NCT03725722|459490235|FG001|Overall Study|Withdrawal by Subject|1|||
127689721|NCT03725722|459490236|FG002|Overall Study|Withdrawal by Subject|0|||
127689722|NCT03725722|459490237|FG003|Overall Study|Withdrawal by Subject|4|||
127689723|NCT03725722|459490238|FG004|Overall Study|Withdrawal by Subject|4|||
127689724|NCT03725722|459490234|FG000|Overall Study|Lost to Follow-up|3|||
127689725|NCT03725722|459490235|FG001|Overall Study|Lost to Follow-up|1|||
127689726|NCT03725722|459490236|FG002|Overall Study|Lost to Follow-up|2|||
127689727|NCT03725722|459490237|FG003|Overall Study|Lost to Follow-up|2|||
127689728|NCT03725722|459490238|FG004|Overall Study|Lost to Follow-up|1|||
127689729|NCT03725722|459490234|FG000|Overall Study|Personal reasons|0|||
127689730|NCT03725722|459490235|FG001|Overall Study|Personal reasons|0|||
127689731|NCT03725722|459490236|FG002|Overall Study|Personal reasons|1|||
127689732|NCT03725722|459490237|FG003|Overall Study|Personal reasons|0|||
127689733|NCT03725722|459490238|FG004|Overall Study|Personal reasons|1|||
127689734|NCT03725722|459490234|FG000|Overall Study|COVID-19 situation|0|||
127689735|NCT03725722|459490235|FG001|Overall Study|COVID-19 situation|1|||
127689736|NCT03725722|459490236|FG002|Overall Study|COVID-19 situation|0|||
127689737|NCT03725722|459490237|FG003|Overall Study|COVID-19 situation|0|||
127689738|NCT03725722|459490238|FG004|Overall Study|COVID-19 situation|0|||
127689739|NCT01600014|459490239|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
127689740|NCT01600014|459490240|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
127689741|NCT01600014|459490239|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
127689742|NCT01600014|459490240|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
127689743|NCT01600014|459490239|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
127689744|NCT01600014|459490240|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
127689745|NCT01600014|459490239|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
127689746|NCT01600014|459490240|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
127689747|NCT01600014|459490239|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
127689748|NCT01600014|459490240|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
127689749|NCT01600014|459490239|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
127689750|NCT01600014|459490240|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
127689751|NCT01600014|459490239|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
127689752|NCT01600014|459490240|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
127689753|NCT01600014|459490239|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
127689754|NCT01600014|459490240|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
127689755|NCT01600014|459490239|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
127689756|NCT01600014|459490240|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
127689757|NCT01600014|459490239|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
127689758|NCT01600014|459490240|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
127689759|NCT01600014|459490239|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
127689760|NCT01600014|459490240|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
127689761|NCT01600014|459490239|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
127689762|NCT01600014|459490240|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
127777877|NCT02113579|459816945|FG001|Overall Study|Withdrawal by Subject|2|||
127777878|NCT02113579|459816944|FG000|Overall Study|Lost to Follow-up|6|||
127777879|NCT02113579|459816945|FG001|Overall Study|Lost to Follow-up|2|||
127777880|NCT00594516|459816948|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
127777881|NCT00594516|459816949|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
127777882|NCT00594516|459816950|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
127777883|NCT00594516|459816948|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
127777884|NCT00594516|459816949|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
127777885|NCT00594516|459816950|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
127777886|NCT00594516|459816948|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
127777887|NCT00594516|459816949|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
127777888|NCT00594516|459816950|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
127777889|NCT00594516|459816948|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
127777890|NCT00594516|459816949|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
127777891|NCT00594516|459816950|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
127777892|NCT00594516|459816948|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
127777893|NCT00594516|459816949|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
127777894|NCT00594516|459816950|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
127777895|NCT00594516|459816948|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
127777896|NCT00594516|459816949|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
127777897|NCT00594516|459816950|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
127777898|NCT00594516|459816948|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
127777899|NCT00594516|459816949|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
127777900|NCT00594516|459816950|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
127777901|NCT00594516|459816948|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
127777902|NCT00594516|459816949|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
127777903|NCT00594516|459816950|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
127777904|NCT00594516|459816948|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
127777905|NCT00594516|459816949|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
127777906|NCT00594516|459816950|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
127777907|NCT02217436|459816951|FG000|Overall Study|Protocol Violation|1|||
127777908|NCT02217436|459816952|FG001|Overall Study|Protocol Violation|1|||
127777909|NCT02217436|459816951|FG000|Overall Study|Incomplete data|0|||
127777910|NCT02217436|459816952|FG001|Overall Study|Incomplete data|1|||
127777911|NCT04641299|459816955|FG000|Overall Study|Adverse Event|0|||
127777912|NCT04641299|459816956|FG001|Overall Study|Adverse Event|0|||
127777913|NCT04641299|459816957|FG002|Overall Study|Adverse Event|2|||
127777914|NCT04641299|459816958|FG003|Overall Study|Adverse Event|0|||
127777915|NCT04641299|459816955|FG000|Overall Study|Lost to Follow-up|0|||
127777916|NCT04641299|459816956|FG001|Overall Study|Lost to Follow-up|1|||
127777917|NCT04641299|459816957|FG002|Overall Study|Lost to Follow-up|0|||
127777918|NCT04641299|459816958|FG003|Overall Study|Lost to Follow-up|0|||
128026400|NCT00987935|460720214|FG002|Overall Study|Refused to continue taking trial med.|0|||
128026401|NCT00987935|460720215|FG003|Overall Study|Refused to continue taking trial med.|0|||
128026402|NCT00987935|460720216|FG004|Overall Study|Refused to continue taking trial med.|1|||
127567635|NCT00910247|459048468|FG000|Overall Study|Not collected|4|||
127567636|NCT00976508|459048471|FG000|Overall Study|Death|7|||
127567637|NCT00976508|459048472|FG001|Overall Study|Death|1|||
127777919|NCT04641299|459816955|FG000|Overall Study|Withdrawal by Subject|1|||
127777920|NCT04641299|459816956|FG001|Overall Study|Withdrawal by Subject|0|||
127777921|NCT04641299|459816957|FG002|Overall Study|Withdrawal by Subject|0|||
127777922|NCT04641299|459816958|FG003|Overall Study|Withdrawal by Subject|0|||
127777923|NCT04641299|459816955|FG000|Overall Study|Reason not given|1|||
127777924|NCT04641299|459816956|FG001|Overall Study|Reason not given|0|||
127777925|NCT04641299|459816957|FG002|Overall Study|Reason not given|0|||
127777926|NCT04641299|459816958|FG003|Overall Study|Reason not given|0|||
127777927|NCT02460497|459816964|FG000|Overall Study|Participant Requested Withdrawal|4|||
127777928|NCT02460497|459816964|FG000|Overall Study|Non-Compliance|1|||
127777929|NCT02460497|459816964|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
127777930|NCT02460497|459816964|FG000|Overall Study|Lost to Follow-up|2|||
127777931|NCT02460497|459816964|FG000|Overall Study|Investigator Decision|1|||
127777932|NCT01448213|459816969|FG000|Overall Study|Lost to Follow-up|12|||
127777933|NCT01448213|459816970|FG001|Overall Study|Lost to Follow-up|10|||
127777934|NCT01448213|459816969|FG000|Overall Study|Adverse Event|4|||
127777935|NCT01448213|459816970|FG001|Overall Study|Adverse Event|10|||
127777936|NCT01448213|459816969|FG000|Overall Study|Protocol Violation|1|||
127777937|NCT01448213|459816970|FG001|Overall Study|Protocol Violation|2|||
127777938|NCT02012296|459816971|FG000|Overall Study|Lack of Efficacy|0|||
127777939|NCT02012296|459816972|FG001|Overall Study|Lack of Efficacy|0|||
127777940|NCT02012296|459816973|FG002|Overall Study|Lack of Efficacy|15|||
127777941|NCT02012296|459816971|FG000|Overall Study|Adverse Event|0|||
127777942|NCT02012296|459816972|FG001|Overall Study|Adverse Event|0|||
128026403|NCT00987935|460720217|FG005|Overall Study|Refused to continue taking trial med.|0|||
127777943|NCT02012296|459816973|FG002|Overall Study|Adverse Event|2|||
127777944|NCT02012296|459816971|FG000|Overall Study|Early study closure|0|||
127777945|NCT02012296|459816972|FG001|Overall Study|Early study closure|0|||
127777946|NCT02012296|459816973|FG002|Overall Study|Early study closure|5|||
127777947|NCT02012296|459816971|FG000|Overall Study|Protocol Violation|0|||
127777948|NCT02012296|459816972|FG001|Overall Study|Protocol Violation|1|||
127777949|NCT02012296|459816973|FG002|Overall Study|Protocol Violation|0|||
127777950|NCT01330914|459816974|FG000|Overall Study|Withdrawal by Subject|4|||
127777951|NCT01330914|459816974|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
127777952|NCT00659529|459816975|FG000|Overall Study|Withdrawal by Subject|4|||
127777953|NCT00659529|459816975|FG000|Overall Study|Protocol Violation|3|||
127777954|NCT00659529|459816975|FG000|Overall Study|Screen failure|9|||
127777955|NCT03627767|459816976|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
127777956|NCT03627767|459816977|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
127777957|NCT03627767|459816978|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
127777958|NCT03627767|459816979|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
127777959|NCT03627767|459816980|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
127777960|NCT03627767|459816976|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
127777961|NCT03627767|459816977|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
127777962|NCT03627767|459816978|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
127777963|NCT03627767|459816979|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
127777964|NCT03627767|459816980|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
127777965|NCT03627767|459816976|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
127777966|NCT03627767|459816977|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
127777967|NCT03627767|459816978|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
127777968|NCT03627767|459816979|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
127777969|NCT03627767|459816980|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
127777970|NCT03627767|459816976|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
127777971|NCT03627767|459816977|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
127777972|NCT03627767|459816978|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
127777973|NCT03627767|459816979|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
127777974|NCT03627767|459816980|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
127777975|NCT03627767|459816976|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
127777976|NCT03627767|459816977|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
127777977|NCT03627767|459816978|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
127777978|NCT03627767|459816979|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
127777979|NCT03627767|459816980|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
127777980|NCT03627767|459816976|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
127777981|NCT03627767|459816977|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
127777982|NCT03627767|459816978|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
127777983|NCT03627767|459816979|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
127777984|NCT03627767|459816980|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
127777985|NCT03627767|459816976|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
127777986|NCT03627767|459816977|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
127777987|NCT03627767|459816978|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
127777988|NCT03627767|459816979|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
127777989|NCT03627767|459816980|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
128026404|NCT00987935|460720218|FG006|Overall Study|Refused to continue taking trial med.|4|||
128026405|NCT00987935|460720219|FG007|Overall Study|Refused to continue taking trial med.|4|||
128026406|NCT00987935|460720220|FG008|Overall Study|Refused to continue taking trial med.|2|||
128026407|NCT00987935|460720212|FG000|Overall Study|Reason other than those specified above|0|||
128026408|NCT00987935|460720213|FG001|Overall Study|Reason other than those specified above|0|||
128026409|NCT00987935|460720214|FG002|Overall Study|Reason other than those specified above|0|||
128026410|NCT00987935|460720215|FG003|Overall Study|Reason other than those specified above|0|||
128026411|NCT00987935|460720216|FG004|Overall Study|Reason other than those specified above|0|||
128026412|NCT00987935|460720217|FG005|Overall Study|Reason other than those specified above|0|||
128026413|NCT00987935|460720218|FG006|Overall Study|Reason other than those specified above|0|||
128026414|NCT00987935|460720219|FG007|Overall Study|Reason other than those specified above|0|||
128026415|NCT00987935|460720220|FG008|Overall Study|Reason other than those specified above|1|||
128026416|NCT01089543|460720221|FG000|Overall Study|Withdrawal by Subject|2|||
128026417|NCT01089543|460720222|FG001|Overall Study|Withdrawal by Subject|3|||
128026418|NCT01089543|460720223|FG002|Overall Study|Withdrawal by Subject|3|||
127777990|NCT03627767|459816976|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
128026419|NCT01089543|460720224|FG003|Overall Study|Withdrawal by Subject|1|||
128026420|NCT01089543|460720221|FG000|Overall Study|Physician Decision|1|||
128026421|NCT01089543|460720222|FG001|Overall Study|Physician Decision|0|||
127567638|NCT00976508|459048471|FG000|Overall Study|Lost to Follow-up|1|||
127777991|NCT03627767|459816977|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
127777992|NCT03627767|459816978|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
127777993|NCT03627767|459816979|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
127777994|NCT03627767|459816980|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
127777995|NCT03627767|459816976|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
127777996|NCT03627767|459816977|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
127777997|NCT03627767|459816978|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
127777998|NCT03627767|459816979|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
127777999|NCT03627767|459816980|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
127778000|NCT03627767|459816976|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
127778001|NCT03627767|459816977|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
127778002|NCT03627767|459816978|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
127778003|NCT03627767|459816979|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
127567639|NCT00976508|459048472|FG001|Overall Study|Lost to Follow-up|0|||
127567640|NCT00976508|459048471|FG000|Overall Study|Withdrawal by Subject|1|||
127567641|NCT00976508|459048472|FG001|Overall Study|Withdrawal by Subject|0|||
127567642|NCT00976508|459048471|FG000|Overall Study|Disease Progression|4|||
127567643|NCT00976508|459048472|FG001|Overall Study|Disease Progression|4|||
127567644|NCT00976508|459048471|FG000|Overall Study|Subject Enrolled in Hospice|1|||
127567645|NCT00976508|459048472|FG001|Overall Study|Subject Enrolled in Hospice|0|||
127567646|NCT00976508|459048471|FG000|Overall Study|Terminated by the Sponsor|0|||
127567647|NCT00976508|459048472|FG001|Overall Study|Terminated by the Sponsor|1|||
127567648|NCT01205581|459048476|FG000|Overall Study|Withdrawal by Subject|1|||
127567649|NCT01205581|459048477|FG001|Overall Study|Withdrawal by Subject|0|||
127567650|NCT01205581|459048478|FG002|Overall Study|Withdrawal by Subject|0|||
127778004|NCT03627767|459816980|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
127778005|NCT03627767|459816976|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
127778006|NCT03627767|459816977|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
127778007|NCT03627767|459816978|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
127778008|NCT03627767|459816979|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
127778009|NCT03627767|459816980|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
127778010|NCT03627767|459816976|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
127778011|NCT03627767|459816977|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
127778012|NCT03627767|459816978|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
127778013|NCT03627767|459816979|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
127778014|NCT03627767|459816980|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
127778015|NCT03627767|459816976|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
127778016|NCT03627767|459816977|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
127778017|NCT03627767|459816978|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
127778018|NCT03627767|459816979|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
127778019|NCT03627767|459816980|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
127778020|NCT03627767|459816976|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
127778021|NCT03627767|459816977|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
127778022|NCT03627767|459816978|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
127778023|NCT03627767|459816979|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
127778024|NCT03627767|459816980|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
127778025|NCT03627767|459816976|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
127778026|NCT03627767|459816977|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
127778027|NCT03627767|459816978|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
127778028|NCT03627767|459816979|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
127778029|NCT03627767|459816980|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
127778030|NCT03627767|459816976|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
127778031|NCT03627767|459816977|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
127778032|NCT03627767|459816978|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
127778033|NCT03627767|459816979|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
127778034|NCT03627767|459816980|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
127778035|NCT03627767|459816976|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
127778036|NCT03627767|459816977|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
127778037|NCT03627767|459816978|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
127778038|NCT03627767|459816979|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
127778039|NCT03627767|459816980|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
127778040|NCT03627767|459816976|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
128026422|NCT01089543|460720223|FG002|Overall Study|Physician Decision|0|||
127567651|NCT01205581|459048479|FG003|Overall Study|Withdrawal by Subject|0|||
127567652|NCT01205581|459048480|FG004|Overall Study|Withdrawal by Subject|0|||
127567653|NCT01205581|459048481|FG005|Overall Study|Withdrawal by Subject|0|||
127778041|NCT03627767|459816977|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
127778042|NCT03627767|459816978|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
127778043|NCT03627767|459816979|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
127778044|NCT03627767|459816980|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
127778045|NCT03627767|459816976|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
127778046|NCT03627767|459816977|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
127778047|NCT03627767|459816978|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
127778048|NCT03627767|459816979|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
127778049|NCT03627767|459816980|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
127778050|NCT03627767|459816976|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
127778051|NCT03627767|459816977|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
127778052|NCT03627767|459816978|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
127778053|NCT03627767|459816979|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
127778054|NCT03627767|459816980|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
127778055|NCT01873417|459816981|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
127778056|NCT01873417|459816981|FG000|Overall Study|Adverse Event|24|||
127778057|NCT01873417|459816981|FG000|Overall Study|Lost to Follow-up|2|||
127778058|NCT01873417|459816981|FG000|Overall Study|Withdrawal by Subject|2|||
127778059|NCT01873417|459816981|FG000|Overall Study|Physician Decision|3|||
127778060|NCT03034460|459816982|FG000|Overall Study|Adverse Event|0|||
127778061|NCT03034460|459816983|FG001|Overall Study|Adverse Event|1|||
127778062|NCT03034460|459816982|FG000|Overall Study|Withdrawal by Subject|2|||
127778063|NCT03034460|459816983|FG001|Overall Study|Withdrawal by Subject|2|||
127778064|NCT03034460|459816982|FG000|Overall Study|Personal Reasons|1|||
127778065|NCT03034460|459816983|FG001|Overall Study|Personal Reasons|0|||
127778066|NCT00295633|459816984|FG000|Overall Study|Lack of Efficacy|19|||
127778067|NCT00295633|459816985|FG001|Overall Study|Lack of Efficacy|7|||
127778068|NCT00295633|459816986|FG002|Overall Study|Lack of Efficacy|16|||
127778069|NCT00295633|459816984|FG000|Overall Study|Withdrawal of consent by subject|16|||
127778070|NCT00295633|459816985|FG001|Overall Study|Withdrawal of consent by subject|16|||
127778071|NCT00295633|459816986|FG002|Overall Study|Withdrawal of consent by subject|26|||
127778072|NCT00295633|459816984|FG000|Overall Study|Adverse Event|9|||
127778073|NCT00295633|459816985|FG001|Overall Study|Adverse Event|17|||
127778074|NCT00295633|459816986|FG002|Overall Study|Adverse Event|9|||
127778075|NCT00295633|459816984|FG000|Overall Study|Lost to Follow-up|6|||
127778076|NCT00295633|459816985|FG001|Overall Study|Lost to Follow-up|11|||
127778077|NCT00295633|459816986|FG002|Overall Study|Lost to Follow-up|7|||
127778078|NCT00295633|459816984|FG000|Overall Study|Physician Decision|9|||
127778079|NCT00295633|459816985|FG001|Overall Study|Physician Decision|10|||
127778080|NCT00295633|459816986|FG002|Overall Study|Physician Decision|8|||
127778081|NCT00295633|459816984|FG000|Overall Study|Poor/Noncompliance|2|||
127778082|NCT00295633|459816985|FG001|Overall Study|Poor/Noncompliance|2|||
127778083|NCT00295633|459816986|FG002|Overall Study|Poor/Noncompliance|6|||
127778084|NCT00295633|459816984|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
127778085|NCT00295633|459816985|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
127778086|NCT00295633|459816986|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
127778087|NCT00295633|459816984|FG000|Overall Study|Death|1|||
127778088|NCT00295633|459816985|FG001|Overall Study|Death|1|||
127778089|NCT00295633|459816986|FG002|Overall Study|Death|0|||
127778090|NCT00295633|459816984|FG000|Overall Study|Administrative reason by sponsor|0|||
127778091|NCT00295633|459816985|FG001|Overall Study|Administrative reason by sponsor|0|||
127778092|NCT00295633|459816986|FG002|Overall Study|Administrative reason by sponsor|1|||
127778093|NCT01798992|459816987|FG000|Overall Study|Administrative withdrawal|0|||
127778094|NCT01798992|459816988|FG001|Overall Study|Administrative withdrawal|1|||
127778095|NCT01798992|459816989|FG002|Overall Study|Administrative withdrawal|0|||
127567654|NCT02278471|459048482|FG000|Overall Study|Lost to Follow-up|6|||
127567655|NCT02278471|459048483|FG001|Overall Study|Lost to Follow-up|15|||
127567656|NCT02278471|459048482|FG000|Overall Study|Death|2|||
127567657|NCT02278471|459048483|FG001|Overall Study|Death|2|||
127567658|NCT02278471|459048482|FG000|Overall Study|Withdrawal by Subject|0|||
127567659|NCT02278471|459048483|FG001|Overall Study|Withdrawal by Subject|3|||
127778096|NCT01798992|459816990|FG003|Overall Study|Administrative withdrawal|1|||
127778097|NCT01798992|459816987|FG000|Overall Study|Lost to Follow-up|0|||
127778098|NCT01798992|459816988|FG001|Overall Study|Lost to Follow-up|1|||
127567660|NCT00640835|459048484|FG000|Overall Study|Adverse Event|5|||
127567661|NCT00640835|459048485|FG001|Overall Study|Adverse Event|3|||
127567662|NCT00640835|459048484|FG000|Overall Study|Withdrawal by Subject|12|||
127778099|NCT01798992|459816989|FG002|Overall Study|Lost to Follow-up|1|||
127778100|NCT01798992|459816990|FG003|Overall Study|Lost to Follow-up|0|||
127778101|NCT01798992|459816987|FG000|Overall Study|Insufficient biopsy tissue|0|||
127778102|NCT01798992|459816988|FG001|Overall Study|Insufficient biopsy tissue|0|||
127778103|NCT01798992|459816989|FG002|Overall Study|Insufficient biopsy tissue|1|||
127778104|NCT01798992|459816990|FG003|Overall Study|Insufficient biopsy tissue|0|||
127778105|NCT00763971|459816991|FG000|Overall Study|Adverse Event|5|||
127567663|NCT00640835|459048485|FG001|Overall Study|Withdrawal by Subject|14|||
127778106|NCT00763971|459816992|FG001|Overall Study|Adverse Event|2|||
127778107|NCT00763971|459816993|FG002|Overall Study|Adverse Event|4|||
127778108|NCT00763971|459816991|FG000|Overall Study|Protocol Violation|3|||
127778109|NCT00763971|459816992|FG001|Overall Study|Protocol Violation|3|||
127778110|NCT00763971|459816993|FG002|Overall Study|Protocol Violation|2|||
127778111|NCT00763971|459816991|FG000|Overall Study|Withdrawal by Subject|4|||
127778112|NCT00763971|459816992|FG001|Overall Study|Withdrawal by Subject|5|||
127778113|NCT00763971|459816993|FG002|Overall Study|Withdrawal by Subject|5|||
127778114|NCT00763971|459816991|FG000|Overall Study|Lost to Follow-up|0|||
127778115|NCT00763971|459816992|FG001|Overall Study|Lost to Follow-up|1|||
127778116|NCT00763971|459816993|FG002|Overall Study|Lost to Follow-up|0|||
127778117|NCT00763971|459816991|FG000|Overall Study|Lack of Efficacy|11|||
127778118|NCT00763971|459816992|FG001|Overall Study|Lack of Efficacy|22|||
127778119|NCT00763971|459816993|FG002|Overall Study|Lack of Efficacy|54|||
127778120|NCT00763971|459816991|FG000|Overall Study|Unable to swallow capsule|2|||
127778121|NCT00763971|459816992|FG001|Overall Study|Unable to swallow capsule|1|||
127778122|NCT00763971|459816993|FG002|Overall Study|Unable to swallow capsule|1|||
127778123|NCT00763971|459816991|FG000|Overall Study|Personal reason|3|||
127778124|NCT00763971|459816992|FG001|Overall Study|Personal reason|0|||
127778125|NCT00763971|459816993|FG002|Overall Study|Personal reason|0|||
127778126|NCT00763971|459816991|FG000|Overall Study|Exclusion criteria met|1|||
127778127|NCT00763971|459816992|FG001|Overall Study|Exclusion criteria met|0|||
127778128|NCT00763971|459816993|FG002|Overall Study|Exclusion criteria met|0|||
127778129|NCT00763971|459816991|FG000|Overall Study|Sponsor decision|1|||
127778130|NCT00763971|459816992|FG001|Overall Study|Sponsor decision|0|||
127778131|NCT00763971|459816993|FG002|Overall Study|Sponsor decision|0|||
127778132|NCT00763971|459816991|FG000|Overall Study|Due to holiday season|2|||
127778133|NCT00763971|459816992|FG001|Overall Study|Due to holiday season|0|||
127778134|NCT00763971|459816993|FG002|Overall Study|Due to holiday season|1|||
127778135|NCT00763971|459816991|FG000|Overall Study|Randomization error|0|||
127778136|NCT00763971|459816992|FG001|Overall Study|Randomization error|0|||
127778137|NCT00763971|459816993|FG002|Overall Study|Randomization error|1|||
127778138|NCT00763971|459816991|FG000|Overall Study|Medical monitor decision|0|||
127778139|NCT00763971|459816992|FG001|Overall Study|Medical monitor decision|0|||
127778140|NCT00763971|459816993|FG002|Overall Study|Medical monitor decision|1|||
127778141|NCT00763971|459816991|FG000|Overall Study|Moved to another country|0|||
127778142|NCT00763971|459816992|FG001|Overall Study|Moved to another country|1|||
127778143|NCT00763971|459816993|FG002|Overall Study|Moved to another country|0|||
127778144|NCT00763971|459816991|FG000|Overall Study|Subject wanted dose reduction|0|||
127778145|NCT00763971|459816992|FG001|Overall Study|Subject wanted dose reduction|1|||
127778146|NCT00763971|459816993|FG002|Overall Study|Subject wanted dose reduction|0|||
127778147|NCT00763971|459816991|FG000|Overall Study|Lack of availability|0|||
127778148|NCT00763971|459816992|FG001|Overall Study|Lack of availability|1|||
127778149|NCT00763971|459816993|FG002|Overall Study|Lack of availability|0|||
127778150|NCT00763971|459816991|FG000|Overall Study|Performed final visit on phone|0|||
127778151|NCT00763971|459816992|FG001|Overall Study|Performed final visit on phone|1|||
127778152|NCT00763971|459816993|FG002|Overall Study|Performed final visit on phone|0|||
127778153|NCT00763971|459816991|FG000|Overall Study|Participation in 489-326 required|1|||
127778154|NCT00763971|459816992|FG001|Overall Study|Participation in 489-326 required|0|||
127778155|NCT00763971|459816993|FG002|Overall Study|Participation in 489-326 required|0|||
127778156|NCT04439071|459817003|FG000|Overall Study|Lost to Follow-up|0|||
127778157|NCT04439071|459817004|FG001|Overall Study|Lost to Follow-up|3|||
127778158|NCT04439071|459817003|FG000|Overall Study|Withdrawal by Subject|3|||
127778159|NCT04439071|459817004|FG001|Overall Study|Withdrawal by Subject|8|||
127778160|NCT04439071|459817003|FG000|Overall Study|Death|6|||
127778161|NCT04439071|459817004|FG001|Overall Study|Death|4|||
127778162|NCT04439071|459817003|FG000|Overall Study|Other than specified|3|||
127778163|NCT04439071|459817004|FG001|Overall Study|Other than specified|3|||
127778164|NCT04439071|459817003|FG000|Overall Study|Randomized but not treated|2|||
127778165|NCT04439071|459817004|FG001|Overall Study|Randomized but not treated|0|||
127778166|NCT04004429|459817005|FG000|Overall Study|Protocol Violation|1|||
127778167|NCT04004429|459817006|FG001|Overall Study|Protocol Violation|0|||
127778168|NCT04004429|459817007|FG002|Overall Study|Protocol Violation|0|||
127778169|NCT04004429|459817005|FG000|Overall Study|Physician Decision|0|||
127778170|NCT04004429|459817006|FG001|Overall Study|Physician Decision|1|||
127778171|NCT04004429|459817007|FG002|Overall Study|Physician Decision|1|||
127778172|NCT04004429|459817005|FG000|Overall Study|Withdrawal by Subject|1|||
127778173|NCT04004429|459817006|FG001|Overall Study|Withdrawal by Subject|1|||
127778174|NCT04004429|459817007|FG002|Overall Study|Withdrawal by Subject|1|||
127778175|NCT03085758|459817008|FG000|Overall Study|Death|26|||
127778176|NCT03085758|459817009|FG001|Overall Study|Death|24|||
127778177|NCT03085758|459817010|FG002|Overall Study|Death|53|||
127778178|NCT03085758|459817008|FG000|Overall Study|Lost to Follow-up|1|||
127778179|NCT03085758|459817009|FG001|Overall Study|Lost to Follow-up|1|||
127778180|NCT03085758|459817010|FG002|Overall Study|Lost to Follow-up|1|||
127778181|NCT03085758|459817008|FG000|Overall Study|Withdrawal by Subject|2|||
127778182|NCT03085758|459817009|FG001|Overall Study|Withdrawal by Subject|2|||
127778183|NCT03085758|459817010|FG002|Overall Study|Withdrawal by Subject|1|||
127778184|NCT03085758|459817008|FG000|Overall Study|Refusal to recall it up to day 90|0|||
127778185|NCT03085758|459817009|FG001|Overall Study|Refusal to recall it up to day 90|0|||
127778186|NCT03085758|459817010|FG002|Overall Study|Refusal to recall it up to day 90|1|||
127778187|NCT03085758|459817008|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
127778188|NCT03085758|459817009|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
127778189|NCT03085758|459817010|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
127778190|NCT01122576|459817011|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
127778191|NCT01122576|459817012|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
127778192|NCT01122576|459817013|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
127778193|NCT01122576|459817011|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
127778194|NCT01122576|459817012|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
127778195|NCT01122576|459817013|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
127778196|NCT01122576|459817011|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
127778197|NCT01122576|459817012|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
127778198|NCT01122576|459817013|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
127778199|NCT01109173|459817019|FG000|Overall Study|Adverse Event|15|||
127778200|NCT01109173|459817020|FG001|Overall Study|Adverse Event|17|||
127778201|NCT01109173|459817021|FG002|Overall Study|Adverse Event|9|||
127778202|NCT01109173|459817022|FG003|Overall Study|Adverse Event|6|||
127778203|NCT01109173|459817019|FG000|Overall Study|Lost to Follow-up|0|||
127778204|NCT01109173|459817020|FG001|Overall Study|Lost to Follow-up|1|||
127778205|NCT01109173|459817021|FG002|Overall Study|Lost to Follow-up|0|||
127778206|NCT01109173|459817022|FG003|Overall Study|Lost to Follow-up|0|||
127778207|NCT01109173|459817019|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
127778208|NCT01109173|459817020|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
127778209|NCT01109173|459817021|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
127778210|NCT01109173|459817022|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
127778211|NCT01109173|459817019|FG000|Overall Study|Noncompliance|0|||
127778212|NCT01109173|459817020|FG001|Overall Study|Noncompliance|1|||
127778213|NCT01109173|459817021|FG002|Overall Study|Noncompliance|0|||
127778214|NCT01109173|459817022|FG003|Overall Study|Noncompliance|0|||
127778215|NCT01109173|459817019|FG000|Overall Study|Treatment Failure|25|||
127778216|NCT01109173|459817020|FG001|Overall Study|Treatment Failure|32|||
127778217|NCT01109173|459817021|FG002|Overall Study|Treatment Failure|69|||
127778218|NCT01109173|459817022|FG003|Overall Study|Treatment Failure|64|||
127778219|NCT01109173|459817019|FG000|Overall Study|Protocol Violation|4|||
127778220|NCT01109173|459817020|FG001|Overall Study|Protocol Violation|5|||
127778221|NCT01109173|459817021|FG002|Overall Study|Protocol Violation|1|||
127778222|NCT01109173|459817022|FG003|Overall Study|Protocol Violation|2|||
127778223|NCT01109173|459817019|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
127778224|NCT01109173|459817020|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
127778225|NCT01109173|459817021|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
127778226|NCT01109173|459817022|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
127778227|NCT01109173|459817019|FG000|Overall Study|Not Specifiied|5|||
127778228|NCT01109173|459817020|FG001|Overall Study|Not Specifiied|4|||
127778229|NCT01109173|459817021|FG002|Overall Study|Not Specifiied|9|||
127778230|NCT01109173|459817022|FG003|Overall Study|Not Specifiied|14|||
127778231|NCT01287364|459817023|FG000|Overall Study|Adverse Event|0|||
127778232|NCT01287364|459817024|FG001|Overall Study|Adverse Event|3|||
127778233|NCT01287364|459817023|FG000|Overall Study|Protocol Violation|5|||
127778234|NCT01287364|459817024|FG001|Overall Study|Protocol Violation|5|||
127778235|NCT01287364|459817023|FG000|Overall Study|Other Reason|4|||
127778236|NCT01287364|459817024|FG001|Overall Study|Other Reason|2|||
127778237|NCT01026142|459817034|FG000|Overall Study|Death|136|||
127778238|NCT01026142|459817035|FG001|Overall Study|Death|134|||
127778239|NCT01026142|459817034|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
127778240|NCT01026142|459817035|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
127778241|NCT03681951|459817036|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
127778242|NCT03681951|459817037|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
127778243|NCT03681951|459817038|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
127778244|NCT03681951|459817039|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
127778245|NCT03681951|459817040|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
127778246|NCT03681951|459817041|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
127778247|NCT03681951|459817042|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
127778248|NCT03681951|459817043|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
127778249|NCT03681951|459817036|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
127778250|NCT03681951|459817037|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
127778251|NCT03681951|459817038|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
127778252|NCT03681951|459817039|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
127778253|NCT03681951|459817040|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
127778254|NCT03681951|459817041|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
127778255|NCT03681951|459817042|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
128026423|NCT01089543|460720224|FG003|Overall Study|Physician Decision|1|||
127567664|NCT00640835|459048484|FG000|Overall Study|Physician Decision|10|||
127567665|NCT00640835|459048485|FG001|Overall Study|Physician Decision|14|||
127689763|NCT01600014|459490239|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
127689764|NCT01600014|459490240|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
127689765|NCT01600014|459490239|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
127689766|NCT01600014|459490240|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
127689767|NCT01600014|459490239|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
127689768|NCT01600014|459490240|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
127689769|NCT01600014|459490239|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
127689770|NCT01600014|459490240|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
127689771|NCT01600014|459490239|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
127689772|NCT01600014|459490240|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
127689773|NCT03554265|459490241|FG000|Overall Study|Withdrawal by Subject|2|||
127689774|NCT03554265|459490242|FG001|Overall Study|Withdrawal by Subject|2|||
127689775|NCT03554265|459490243|FG002|Overall Study|Withdrawal by Subject|3|||
127689776|NCT03554265|459490241|FG000|Overall Study|Physician Decision|0|||
127689777|NCT03554265|459490242|FG001|Overall Study|Physician Decision|0|||
127689778|NCT03554265|459490243|FG002|Overall Study|Physician Decision|1|||
127689779|NCT05386238|459490244|FG000|Overall Study|Lost to Follow-up|3|||
127689780|NCT05386238|459490245|FG001|Overall Study|Lost to Follow-up|2|||
127689781|NCT05386238|459490244|FG000|Overall Study|Withdrawal by Subject|0|||
127689782|NCT05386238|459490245|FG001|Overall Study|Withdrawal by Subject|1|||
127689783|NCT05057897|459490246|FG000|Overall Study|Site closure|2|||
127689784|NCT05057897|459490247|FG001|Overall Study|Site closure|2|||
127689785|NCT05057897|459490246|FG000|Overall Study|Death|1|||
127689786|NCT05057897|459490247|FG001|Overall Study|Death|0|||
127689787|NCT04714320|459490248|FG000|Overall Study|Voluntary Withdrawal|4|||
127689788|NCT04714320|459490249|FG001|Overall Study|Voluntary Withdrawal|1|||
127689789|NCT04714320|459490250|FG002|Overall Study|Voluntary Withdrawal|2|||
127689790|NCT04714320|459490248|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
127689791|NCT04714320|459490249|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
127689792|NCT04714320|459490250|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
127689793|NCT04714320|459490248|FG000|Overall Study|Reason Not Specified|1|||
127689794|NCT04714320|459490249|FG001|Overall Study|Reason Not Specified|3|||
127689795|NCT04714320|459490250|FG002|Overall Study|Reason Not Specified|3|||
127689796|NCT03088813|459490251|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
127689797|NCT03088813|459490252|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
127689798|NCT03088813|459490253|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
127689799|NCT03088813|459490254|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
127689800|NCT03088813|459490251|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
127689801|NCT03088813|459490252|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
127689802|NCT03088813|459490253|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
127689803|NCT03088813|459490254|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
127689804|NCT03088813|459490251|FG000|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
127689805|NCT03088813|459490252|FG001|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
127689806|NCT03088813|459490253|FG002|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
127689807|NCT03088813|459490254|FG003|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
127689808|NCT03088813|459490251|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
127689809|NCT03088813|459490252|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
127689810|NCT03088813|459490253|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
127689811|NCT03088813|459490254|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|4|||
127689812|NCT03088813|459490251|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
127689813|NCT03088813|459490252|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
127689814|NCT03088813|459490253|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
127689815|NCT03088813|459490254|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|14|||
127689816|NCT03088813|459490251|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
127689817|NCT03088813|459490252|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
127689818|NCT03088813|459490253|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
127689819|NCT03088813|459490254|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
127689820|NCT03088813|459490251|FG000|Part 2: Randomized Study (Upto Week 197)|Other|0|||
127689821|NCT03088813|459490252|FG001|Part 2: Randomized Study (Upto Week 197)|Other|0|||
127689822|NCT03088813|459490253|FG002|Part 2: Randomized Study (Upto Week 197)|Other|3|||
127689823|NCT03088813|459490254|FG003|Part 2: Randomized Study (Upto Week 197)|Other|0|||
127689824|NCT04527146|459490255|FG000|Overall Study|Withdrawal by Subject|12|||
127689825|NCT04527146|459490256|FG001|Overall Study|Withdrawal by Subject|15|||
127778256|NCT03681951|459817043|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
127567666|NCT00640835|459048484|FG000|Overall Study|Sponsor's Decision|11|||
127778257|NCT03681951|459817036|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
127778258|NCT03681951|459817037|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
127778259|NCT03681951|459817038|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
127778260|NCT03681951|459817039|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
127778261|NCT03681951|459817040|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
127778262|NCT03681951|459817041|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
127778263|NCT03681951|459817042|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
127778264|NCT03681951|459817043|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
127778265|NCT00628251|459817044|FG000|Randomised Part|Withdrawal by Subject|0|||
127778266|NCT00628251|459817045|FG001|Randomised Part|Withdrawal by Subject|0|||
127778267|NCT00628251|459817046|FG002|Randomised Part|Withdrawal by Subject|1|||
127778268|NCT00628251|459817044|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
127778269|NCT00628251|459817045|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
127778270|NCT00628251|459817046|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
127778271|NCT00628251|459817044|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
127778272|NCT00628251|459817045|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
127778273|NCT00628251|459817046|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
127778274|NCT00628251|459817044|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
127778275|NCT00628251|459817045|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
127778276|NCT00628251|459817046|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
127778277|NCT00628251|459817044|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
127778278|NCT00628251|459817045|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
127778279|NCT00628251|459817046|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
127778280|NCT00628251|459817044|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
127778281|NCT00628251|459817045|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
127778282|NCT00628251|459817046|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
127778283|NCT01020448|459817047|FG000|Pre-assignment|Adverse Event|6|||
127778284|NCT01020448|459817047|FG000|Pre-assignment|Withdrawal by Subject|5|||
127778285|NCT01020448|459817047|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
127778286|NCT01020448|459817047|FG000|Treatment|Adverse Event|11|||
127778287|NCT01020448|459817047|FG000|Treatment|Consent Withdrawn|3|||
127778288|NCT01020448|459817047|FG000|Treatment|Disease Progression|2|||
127778289|NCT01020448|459817047|FG000|Treatment|Lack of Efficacy|8|||
127778290|NCT01020448|459817047|FG000|Treatment|Lost to Follow-up|2|||
127778291|NCT00041067|459817048|FG000|Overall Study|Adverse Event|20|||
127778292|NCT00041067|459817048|FG000|Overall Study|Progression|19|||
127778293|NCT00041067|459817048|FG000|Overall Study|Patient refusal|12|||
127778294|NCT00041067|459817048|FG000|Overall Study|Other reasons|23|||
127778295|NCT00041067|459817048|FG000|Overall Study|Ineligible|2|||
127778296|NCT01968070|459817050|FG000|Period 1|Withdrawal by Subject|0|||
127778297|NCT01968070|459817051|FG001|Period 1|Withdrawal by Subject|1|||
127778298|NCT01968070|459817052|FG002|Period 1|Withdrawal by Subject|0|||
127778299|NCT01968070|459817053|FG003|Period 1|Withdrawal by Subject|0|||
127778300|NCT01968070|459817054|FG004|Period 1|Withdrawal by Subject|0|||
127778301|NCT01968070|459817055|FG005|Period 1|Withdrawal by Subject|0|||
127778302|NCT01968070|459817056|FG006|Period 1|Withdrawal by Subject|1|||
127778303|NCT01968070|459817057|FG007|Period 1|Withdrawal by Subject|0|||
127778304|NCT01968070|459817058|FG008|Period 1|Withdrawal by Subject|0|||
127778305|NCT01968070|459817059|FG009|Period 1|Withdrawal by Subject|0|||
127778306|NCT01968070|459817060|FG010|Period 1|Withdrawal by Subject|0|||
127778307|NCT01968070|459817061|FG011|Period 1|Withdrawal by Subject|0|||
127778308|NCT01968070|459817062|FG012|Period 1|Withdrawal by Subject|0|||
127778309|NCT01968070|459817063|FG013|Period 1|Withdrawal by Subject|0|||
127778310|NCT01968070|459817064|FG014|Period 1|Withdrawal by Subject|0|||
127778311|NCT01968070|459817065|FG015|Period 1|Withdrawal by Subject|1|||
127778312|NCT01968070|459817066|FG016|Period 1|Withdrawal by Subject|0|||
127778313|NCT01968070|459817067|FG017|Period 1|Withdrawal by Subject|0|||
127778314|NCT01968070|459817050|FG000|Period 1|Protocol Violation|0|||
127778315|NCT01968070|459817051|FG001|Period 1|Protocol Violation|0|||
127778316|NCT01968070|459817052|FG002|Period 1|Protocol Violation|0|||
127778317|NCT01968070|459817053|FG003|Period 1|Protocol Violation|1|||
127778318|NCT01968070|459817054|FG004|Period 1|Protocol Violation|1|||
127778319|NCT01968070|459817055|FG005|Period 1|Protocol Violation|0|||
127778320|NCT01968070|459817056|FG006|Period 1|Protocol Violation|0|||
127778321|NCT01968070|459817057|FG007|Period 1|Protocol Violation|0|||
127778322|NCT01968070|459817058|FG008|Period 1|Protocol Violation|0|||
127778323|NCT01968070|459817059|FG009|Period 1|Protocol Violation|0|||
127778324|NCT01968070|459817060|FG010|Period 1|Protocol Violation|0|||
127778325|NCT01968070|459817061|FG011|Period 1|Protocol Violation|0|||
127778326|NCT01968070|459817062|FG012|Period 1|Protocol Violation|0|||
127778327|NCT01968070|459817063|FG013|Period 1|Protocol Violation|0|||
127778328|NCT01968070|459817064|FG014|Period 1|Protocol Violation|0|||
127778329|NCT01968070|459817065|FG015|Period 1|Protocol Violation|0|||
127778330|NCT01968070|459817066|FG016|Period 1|Protocol Violation|0|||
128026424|NCT01089543|460720221|FG000|Overall Study|Adverse Event|0|||
128026425|NCT01089543|460720222|FG001|Overall Study|Adverse Event|1|||
128026426|NCT01089543|460720223|FG002|Overall Study|Adverse Event|0|||
128026427|NCT01089543|460720224|FG003|Overall Study|Adverse Event|0|||
128026428|NCT01248468|460720226|FG000|Overall Study|Administrative problem|1|||
128026429|NCT01248468|460720227|FG001|Overall Study|Administrative problem|0|||
128026430|NCT01248468|460720228|FG002|Overall Study|Administrative problem|0|||
128026431|NCT01248468|460720226|FG000|Overall Study|Lost to Follow-up|9|||
128026432|NCT01248468|460720227|FG001|Overall Study|Lost to Follow-up|12|||
128026433|NCT01248468|460720228|FG002|Overall Study|Lost to Follow-up|4|||
128026434|NCT01248468|460720226|FG000|Overall Study|Pregnancy|1|||
128026435|NCT01248468|460720227|FG001|Overall Study|Pregnancy|0|||
128026436|NCT01248468|460720228|FG002|Overall Study|Pregnancy|0|||
128026437|NCT01248468|460720226|FG000|Overall Study|Withdrawal by Subject|4|||
128026438|NCT01248468|460720227|FG001|Overall Study|Withdrawal by Subject|2|||
128026439|NCT01248468|460720228|FG002|Overall Study|Withdrawal by Subject|0|||
128026440|NCT02176525|460720230|FG000|Overall Study|Adverse Event|0|||
128026441|NCT02176525|460720231|FG001|Overall Study|Adverse Event|0|||
128026442|NCT02176525|460720232|FG002|Overall Study|Adverse Event|0|||
128026443|NCT02176525|460720233|FG003|Overall Study|Adverse Event|1|||
128026444|NCT02176525|460720234|FG004|Overall Study|Adverse Event|1|||
128026445|NCT02176525|460720235|FG005|Overall Study|Adverse Event|0|||
128026446|NCT02176525|460720236|FG006|Overall Study|Adverse Event|1|||
128026447|NCT02176525|460720237|FG007|Overall Study|Adverse Event|0|||
128026448|NCT02176525|460720230|FG000|Overall Study|not treated|1|||
128026449|NCT02176525|460720231|FG001|Overall Study|not treated|0|||
128026450|NCT02176525|460720232|FG002|Overall Study|not treated|0|||
128026451|NCT02176525|460720233|FG003|Overall Study|not treated|0|||
128026452|NCT02176525|460720234|FG004|Overall Study|not treated|0|||
128026453|NCT02176525|460720235|FG005|Overall Study|not treated|1|||
128026454|NCT02176525|460720236|FG006|Overall Study|not treated|0|||
128026455|NCT02176525|460720237|FG007|Overall Study|not treated|0|||
128026456|NCT00468546|460720238|FG000|Week 24 Analysis|Lack of Efficacy|83|||
127567667|NCT00640835|459048485|FG001|Overall Study|Sponsor's Decision|7|||
128026457|NCT00468546|460720239|FG001|Week 24 Analysis|Lack of Efficacy|37|||
128026458|NCT00468546|460720238|FG000|Week 24 Analysis|Refused treatment|5|||
128026459|NCT00468546|460720239|FG001|Week 24 Analysis|Refused treatment|5|||
128026460|NCT00468546|460720238|FG000|Week 24 Analysis|Adverse Event|1|||
128026461|NCT00468546|460720239|FG001|Week 24 Analysis|Adverse Event|8|||
128026462|NCT00468546|460720238|FG000|Week 24 Analysis|Failure to return|3|||
128026463|NCT00468546|460720239|FG001|Week 24 Analysis|Failure to return|4|||
127567668|NCT00640835|459048484|FG000|Overall Study|Protocol Violation|2|||
127567669|NCT00640835|459048485|FG001|Overall Study|Protocol Violation|2|||
127567670|NCT00640835|459048484|FG000|Overall Study|Lost to Follow-up|17|||
127567671|NCT00640835|459048485|FG001|Overall Study|Lost to Follow-up|13|||
127567672|NCT00640835|459048484|FG000|Overall Study|Other Reason|19|||
127567673|NCT00640835|459048485|FG001|Overall Study|Other Reason|4|||
127689826|NCT04527146|459490257|FG002|Overall Study|Withdrawal by Subject|7|||
128026464|NCT00468546|460720238|FG000|Week 24 Analysis|Rescue therapy|2|||
128026465|NCT00468546|460720239|FG001|Week 24 Analysis|Rescue therapy|0|||
127567674|NCT03468543|459048486|FG000|Overall Study|Protocol stopping rules met|3|||
127689827|NCT04527146|459490258|FG003|Overall Study|Withdrawal by Subject|16|||
127689828|NCT04527146|459490255|FG000|Overall Study|Lost to Follow-up|13|||
127689829|NCT04527146|459490256|FG001|Overall Study|Lost to Follow-up|9|||
127689830|NCT04527146|459490257|FG002|Overall Study|Lost to Follow-up|16|||
127689831|NCT04527146|459490258|FG003|Overall Study|Lost to Follow-up|13|||
127689832|NCT04527146|459490255|FG000|Overall Study|Death|0|||
127689833|NCT04527146|459490256|FG001|Overall Study|Death|1|||
127689834|NCT04527146|459490257|FG002|Overall Study|Death|1|||
127689835|NCT04527146|459490258|FG003|Overall Study|Death|0|||
127689836|NCT04527146|459490255|FG000|Overall Study|Adverse Event|0|||
127689837|NCT04527146|459490256|FG001|Overall Study|Adverse Event|0|||
127689838|NCT04527146|459490257|FG002|Overall Study|Adverse Event|1|||
127689839|NCT04527146|459490258|FG003|Overall Study|Adverse Event|0|||
127689840|NCT04527146|459490255|FG000|Overall Study|Ineligible after randomization|2|||
127689841|NCT04527146|459490256|FG001|Overall Study|Ineligible after randomization|0|||
127689842|NCT04527146|459490257|FG002|Overall Study|Ineligible after randomization|2|||
127689843|NCT04527146|459490258|FG003|Overall Study|Ineligible after randomization|2|||
127567675|NCT00978432|459048488|FG000|Overall Study|Withdrawal by Subject|0|||
127567676|NCT00978432|459048489|FG001|Overall Study|Withdrawal by Subject|0|||
127689844|NCT04527146|459490255|FG000|Overall Study|Moved to a different group|6|||
127689845|NCT04527146|459490256|FG001|Overall Study|Moved to a different group|3|||
128026466|NCT00468546|460720238|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
128026467|NCT00468546|460720239|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
128026468|NCT00468546|460720238|FG000|Week 24 Analysis|Due to clinical hold|1|||
128026469|NCT00468546|460720239|FG001|Week 24 Analysis|Due to clinical hold|0|||
128026470|NCT00468546|460720238|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
128026471|NCT00468546|460720239|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
128026472|NCT00468546|460720238|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
128026473|NCT00468546|460720239|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
128026474|NCT00468546|460720238|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
128026475|NCT00468546|460720239|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
128026476|NCT00468546|460720238|FG000|Week 24 to Week 104 Analysis|Death|1|||
128026477|NCT00468546|460720239|FG001|Week 24 to Week 104 Analysis|Death|0|||
128026478|NCT00468546|460720238|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
128026479|NCT00468546|460720239|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
128026480|NCT00468546|460720238|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
128026481|NCT00468546|460720239|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
128026482|NCT00468546|460720238|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
128026483|NCT00468546|460720239|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
128026484|NCT00468546|460720238|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
128026485|NCT00468546|460720239|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
128026486|NCT00468546|460720238|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
128026487|NCT00468546|460720239|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
128026488|NCT00468546|460720238|FG000|Week 24 to Week 104 Analysis|Other|17|||
128026489|NCT00468546|460720239|FG001|Week 24 to Week 104 Analysis|Other|14|||
128026490|NCT01245049|460720247|FG000|Overall Study|Migrated/moved from study area|0|||
128026491|NCT01245049|460720248|FG001|Overall Study|Migrated/moved from study area|1|||
128026492|NCT01245049|460720247|FG000|Overall Study|Withdrawal by Subject|0|||
128026493|NCT01245049|460720248|FG001|Overall Study|Withdrawal by Subject|1|||
128026494|NCT01245049|460720247|FG000|Overall Study|Lost to Follow-up|1|||
128026495|NCT01245049|460720248|FG001|Overall Study|Lost to Follow-up|2|||
128026496|NCT00450749|460720249|FG000|Overall Study|Withdrawal by Subject|0|||
128026497|NCT00450749|460720250|FG001|Overall Study|Withdrawal by Subject|0|||
128026498|NCT00450749|460720251|FG002|Overall Study|Withdrawal by Subject|2|||
128026499|NCT00450749|460720249|FG000|Overall Study|Noncompliant|0|||
128026500|NCT00450749|460720250|FG001|Overall Study|Noncompliant|1|||
128026501|NCT00450749|460720251|FG002|Overall Study|Noncompliant|0|||
128026502|NCT02151604|460720252|FG000|Overall Study|Lost to Follow-up|3|||
128026503|NCT02151604|460720252|FG000|Overall Study|Withdrawal by Subject|2|||
128026504|NCT02151604|460720252|FG000|Overall Study|Physician Decision|3|||
128026505|NCT02151604|460720252|FG000|Overall Study|Death|1|||
128026506|NCT04495478|460720253|FG000|Overall Study|Withdrawal by Subject|0|||
128026507|NCT04495478|460720254|FG001|Overall Study|Withdrawal by Subject|0|||
128026508|NCT04495478|460720255|FG002|Overall Study|Withdrawal by Subject|0|||
128026509|NCT04495478|460720256|FG003|Overall Study|Withdrawal by Subject|1|||
128026510|NCT04495478|460720257|FG004|Overall Study|Withdrawal by Subject|0|||
128026511|NCT04495478|460720258|FG005|Overall Study|Withdrawal by Subject|0|||
128026512|NCT04495478|460720259|FG006|Overall Study|Withdrawal by Subject|0|||
127778331|NCT01968070|459817067|FG017|Period 1|Protocol Violation|0|||
127778332|NCT01968070|459817050|FG000|Period 1|Lost to Follow-up|0|||
127778333|NCT01968070|459817051|FG001|Period 1|Lost to Follow-up|0|||
127778334|NCT01968070|459817052|FG002|Period 1|Lost to Follow-up|0|||
127778335|NCT01968070|459817053|FG003|Period 1|Lost to Follow-up|1|||
127778336|NCT01968070|459817054|FG004|Period 1|Lost to Follow-up|0|||
127778337|NCT01968070|459817055|FG005|Period 1|Lost to Follow-up|0|||
127778338|NCT01968070|459817056|FG006|Period 1|Lost to Follow-up|0|||
127778339|NCT01968070|459817057|FG007|Period 1|Lost to Follow-up|0|||
127778340|NCT01968070|459817058|FG008|Period 1|Lost to Follow-up|0|||
127778341|NCT01968070|459817059|FG009|Period 1|Lost to Follow-up|0|||
128026513|NCT04495478|460720253|FG000|Overall Study|Physician Decision|0|||
128026514|NCT04495478|460720254|FG001|Overall Study|Physician Decision|1|||
128026515|NCT04495478|460720255|FG002|Overall Study|Physician Decision|0|||
128026516|NCT04495478|460720256|FG003|Overall Study|Physician Decision|0|||
128026517|NCT04495478|460720257|FG004|Overall Study|Physician Decision|1|||
128026518|NCT04495478|460720258|FG005|Overall Study|Physician Decision|0|||
128026519|NCT04495478|460720259|FG006|Overall Study|Physician Decision|0|||
128026520|NCT03004183|460722126|FG000|Overall Study|Adverse Event|7|||
128026521|NCT03004183|460722126|FG000|Overall Study|Lost to Follow-up|1|||
128026522|NCT03004183|460722126|FG000|Overall Study|Physician Decision|40|||
128026523|NCT03004183|460722126|FG000|Overall Study|Withdrawal by Subject|1|||
127778342|NCT01968070|459817060|FG010|Period 1|Lost to Follow-up|0|||
127778343|NCT01968070|459817061|FG011|Period 1|Lost to Follow-up|0|||
128026524|NCT03004183|460722126|FG000|Overall Study|COVID-19|1|||
128026525|NCT01213251|460722127|FG000|Overall Study|Death|2|||
128026526|NCT01213251|460722128|FG001|Overall Study|Death|1|||
128026527|NCT01213251|460722129|FG002|Overall Study|Death|2|||
128026528|NCT01213251|460722127|FG000|Overall Study|Exit|3|||
128026529|NCT01213251|460722128|FG001|Overall Study|Exit|2|||
128026530|NCT01213251|460722129|FG002|Overall Study|Exit|8|||
128026531|NCT01213251|460722127|FG000|Overall Study|Protocol Violation|1|||
128026532|NCT01213251|460722128|FG001|Overall Study|Protocol Violation|1|||
128026533|NCT01213251|460722129|FG002|Overall Study|Protocol Violation|0|||
128026534|NCT01213251|460722127|FG000|Overall Study|Missed 18-Month Follow-up|0|||
127778344|NCT01968070|459817062|FG012|Period 1|Lost to Follow-up|0|||
128026535|NCT01213251|460722128|FG001|Overall Study|Missed 18-Month Follow-up|0|||
127567677|NCT00978432|459048490|FG002|Overall Study|Withdrawal by Subject|1|||
127567678|NCT00978432|459048488|FG000|Overall Study|Lack of Efficacy|1|||
127567679|NCT00978432|459048489|FG001|Overall Study|Lack of Efficacy|1|||
127567680|NCT00978432|459048490|FG002|Overall Study|Lack of Efficacy|3|||
127567681|NCT00978432|459048488|FG000|Overall Study|Adverse Event|2|||
127567682|NCT00978432|459048489|FG001|Overall Study|Adverse Event|0|||
127567683|NCT00978432|459048490|FG002|Overall Study|Adverse Event|1|||
127567684|NCT04618770|459048491|FG000|Overall Study|Censored from Analysis|12|||
127567685|NCT04618770|459048491|FG000|Overall Study|Early Termination|25|||
127567686|NCT02160002|459048496|FG000|Overall Study|Withdrawal by Subject|2|||
127567687|NCT02160002|459048497|FG001|Overall Study|Withdrawal by Subject|1|||
127567688|NCT00246571|459048498|FG000|Overall Study|Adverse Event|7|||
127567689|NCT00246571|459048499|FG001|Overall Study|Adverse Event|0|||
127567690|NCT00246571|459048498|FG000|Overall Study|Protocol Violation|0|||
127567691|NCT00246571|459048499|FG001|Overall Study|Protocol Violation|1|||
127567692|NCT00246571|459048498|FG000|Overall Study|Withdrawal by Subject|2|||
127567693|NCT00246571|459048499|FG001|Overall Study|Withdrawal by Subject|3|||
127567694|NCT00246571|459048498|FG000|Overall Study|Lack of Efficacy|84|||
127567695|NCT00246571|459048499|FG001|Overall Study|Lack of Efficacy|21|||
127567696|NCT00246571|459048498|FG000|Overall Study|Death|17|||
127567697|NCT00246571|459048499|FG001|Overall Study|Death|3|||
127567698|NCT00246571|459048498|FG000|Overall Study|Sponsor|0|||
127567699|NCT00246571|459048499|FG001|Overall Study|Sponsor|1|||
127567700|NCT00246571|459048498|FG000|Overall Study|Did not meet entrance criteria|2|||
127567701|NCT00246571|459048499|FG001|Overall Study|Did not meet entrance criteria|1|||
127567702|NCT00246571|459048498|FG000|Overall Study|Laboratory abnormalities|1|||
127567703|NCT00246571|459048499|FG001|Overall Study|Laboratory abnormalities|0|||
127567704|NCT00246571|459048498|FG000|Overall Study|Crossover participants|0|||
127567705|NCT00246571|459048499|FG001|Overall Study|Crossover participants|74|||
127567706|NCT04896229|459048500|FG000|Overall Study|Lost to Follow-up|113|||
127567707|NCT04896229|459048501|FG001|Overall Study|Lost to Follow-up|113|||
127567708|NCT04418661|459048502|FG000|Overall Study|Adverse Event|0|||
127567709|NCT04418661|459048503|FG001|Overall Study|Adverse Event|1|||
127567710|NCT04418661|459048504|FG002|Overall Study|Adverse Event|5|||
127567711|NCT04418661|459048505|FG003|Overall Study|Adverse Event|3|||
127567712|NCT04418661|459048506|FG004|Overall Study|Adverse Event|0|||
127567713|NCT04418661|459048507|FG005|Overall Study|Adverse Event|2|||
127567714|NCT04418661|459048502|FG000|Overall Study|Progressive disease|4|||
127567715|NCT04418661|459048503|FG001|Overall Study|Progressive disease|11|||
127567716|NCT04418661|459048504|FG002|Overall Study|Progressive disease|6|||
127567717|NCT04418661|459048505|FG003|Overall Study|Progressive disease|11|||
127567718|NCT04418661|459048506|FG004|Overall Study|Progressive disease|1|||
127567719|NCT04418661|459048507|FG005|Overall Study|Progressive disease|12|||
127567720|NCT04418661|459048502|FG000|Overall Study|Withdrawal by Subject|0|||
127567721|NCT04418661|459048503|FG001|Overall Study|Withdrawal by Subject|1|||
127567722|NCT04418661|459048504|FG002|Overall Study|Withdrawal by Subject|0|||
127567723|NCT04418661|459048505|FG003|Overall Study|Withdrawal by Subject|1|||
127567724|NCT04418661|459048506|FG004|Overall Study|Withdrawal by Subject|0|||
127567725|NCT04418661|459048507|FG005|Overall Study|Withdrawal by Subject|0|||
127567726|NCT04418661|459048502|FG000|Overall Study|Other|0|||
127567727|NCT04418661|459048503|FG001|Overall Study|Other|0|||
127567728|NCT04418661|459048504|FG002|Overall Study|Other|1|||
127567729|NCT04418661|459048505|FG003|Overall Study|Other|3|||
127567730|NCT04418661|459048506|FG004|Overall Study|Other|0|||
127567731|NCT04418661|459048507|FG005|Overall Study|Other|1|||
127567732|NCT00159822|459048508|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
127567733|NCT00159822|459048508|FG000|Voriconazole Treatment Period|Adverse Event|9|||
127689846|NCT04527146|459490257|FG002|Overall Study|Moved to a different group|0|||
127689847|NCT04527146|459490258|FG003|Overall Study|Moved to a different group|2|||
127689848|NCT01903811|459490267|FG000|Overall Study|No measurable disease|1|||
127689849|NCT01903811|459490268|FG001|Overall Study|No measurable disease|1|||
127689850|NCT01903811|459490267|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
127689851|NCT01903811|459490268|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
127689852|NCT01903811|459490267|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
127689853|NCT01903811|459490268|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
127689854|NCT01903811|459490267|FG000|Overall Study|Withdrawal by Subject|0|||
127689855|NCT01903811|459490268|FG001|Overall Study|Withdrawal by Subject|1|||
127689856|NCT04468776|459490269|FG000|Overall Study|Lost to Follow-up|4|||
127689857|NCT04468776|459490270|FG001|Overall Study|Lost to Follow-up|3|||
127689858|NCT04468776|459490271|FG002|Overall Study|Lost to Follow-up|4|||
127689859|NCT04468776|459490269|FG000|Overall Study|Withdrawal by Subject|1|||
127689860|NCT04468776|459490270|FG001|Overall Study|Withdrawal by Subject|10|||
127689861|NCT04468776|459490271|FG002|Overall Study|Withdrawal by Subject|4|||
127689862|NCT04468776|459490269|FG000|Overall Study|Physician Decision|0|||
127567734|NCT00159822|459048508|FG000|Voriconazole Treatment Period|Death|4|||
127567735|NCT00159822|459048508|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
127567736|NCT00159822|459048508|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
127567737|NCT00159822|459048508|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
127567738|NCT00159822|459048508|FG000|Post-treatment Follow-up Period|Death|1|||
127567739|NCT00159822|459048508|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
127567740|NCT00159822|459048508|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
127567741|NCT00713310|459048511|FG000|Overall Study|Adverse Event|5|||
127567742|NCT00713310|459048512|FG001|Overall Study|Adverse Event|2|||
127567743|NCT00713310|459048511|FG000|Overall Study|Lack of Efficacy|0|||
127567744|NCT00713310|459048512|FG001|Overall Study|Lack of Efficacy|2|||
127567745|NCT00713310|459048511|FG000|Overall Study|Withdrawal by Subject|0|||
127567746|NCT00713310|459048512|FG001|Overall Study|Withdrawal by Subject|2|||
127567747|NCT00275821|459048514|FG000|Overall Study|Adverse Event|4|||
127567748|NCT00275821|459048515|FG001|Overall Study|Adverse Event|12|||
127567749|NCT00275821|459048516|FG002|Overall Study|Adverse Event|5|||
127567750|NCT00275821|459048514|FG000|Overall Study|Administrative problems|3|||
127567751|NCT00275821|459048515|FG001|Overall Study|Administrative problems|4|||
127567752|NCT00275821|459048516|FG002|Overall Study|Administrative problems|4|||
127567753|NCT00275821|459048514|FG000|Overall Study|Withdrawal by Subject|0|||
127567754|NCT00275821|459048515|FG001|Overall Study|Withdrawal by Subject|2|||
127567755|NCT00275821|459048516|FG002|Overall Study|Withdrawal by Subject|1|||
127567756|NCT00275821|459048514|FG000|Overall Study|Lost to Follow-up|0|||
127567757|NCT00275821|459048515|FG001|Overall Study|Lost to Follow-up|1|||
127567758|NCT00275821|459048516|FG002|Overall Study|Lost to Follow-up|1|||
127567759|NCT00275821|459048514|FG000|Overall Study|Death|0|||
127567760|NCT00275821|459048515|FG001|Overall Study|Death|2|||
127567761|NCT00275821|459048516|FG002|Overall Study|Death|1|||
127567762|NCT00275821|459048514|FG000|Overall Study|Lack of Efficacy|2|||
127567763|NCT00275821|459048515|FG001|Overall Study|Lack of Efficacy|1|||
127689863|NCT04468776|459490270|FG001|Overall Study|Physician Decision|1|||
127689864|NCT04468776|459490271|FG002|Overall Study|Physician Decision|1|||
127689865|NCT03438188|459490275|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
127689866|NCT03438188|459490276|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
127689867|NCT03438188|459490277|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
127689868|NCT03438188|459490275|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|4|||
127689869|NCT03438188|459490276|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|3|||
127689870|NCT03438188|459490277|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|2|||
127689871|NCT03438188|459490275|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|3|||
127689872|NCT03438188|459490276|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|4|||
127689873|NCT03438188|459490277|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|1|||
127689874|NCT03438188|459490275|FG000|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
127689875|NCT03438188|459490276|FG001|Washout Period (Smoking or Abstinent)|Lost to Follow-up|2|||
127689876|NCT03438188|459490277|FG002|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
127689877|NCT03438188|459490275|FG000|Washout Period (Smoking or Abstinent)|change in eligibility|3|||
127689878|NCT03438188|459490276|FG001|Washout Period (Smoking or Abstinent)|change in eligibility|2|||
127689879|NCT03438188|459490277|FG002|Washout Period (Smoking or Abstinent)|change in eligibility|0|||
127689880|NCT05986565|459490278|FG000|Overall Study|Lost to Follow-up|8|||
127689881|NCT05986565|459490279|FG001|Overall Study|Lost to Follow-up|3|||
127689882|NCT05986565|459490278|FG000|Overall Study|Withdrawal by Subject|0|||
127689883|NCT05986565|459490279|FG001|Overall Study|Withdrawal by Subject|1|||
127689884|NCT00670046|459490280|FG000|Overall Study|Lost to Follow-up|1|||
127689885|NCT00670046|459490281|FG001|Overall Study|Lost to Follow-up|1|||
127689886|NCT00670046|459490280|FG000|Overall Study|Withdrawal by Subject|0|||
127689887|NCT00670046|459490281|FG001|Overall Study|Withdrawal by Subject|1|||
127689888|NCT02300298|459490284|FG000|Disposition for Nintedanib|Progressive disease|10|||
127689889|NCT02300298|459490285|FG001|Disposition for Nintedanib|Progressive disease|0|||
127689890|NCT02300298|459490284|FG000|Disposition for Docetaxel|Progressive disease|0|||
127689891|NCT02300298|459490285|FG001|Disposition for Docetaxel|Progressive disease|6|||
127689892|NCT02300298|459490284|FG000|Disposition for Docetaxel|other adverse event|0|||
127689893|NCT02300298|459490285|FG001|Disposition for Docetaxel|other adverse event|4|||
127689894|NCT03285763|459490286|FG000|Overall Study|Death|470|||
127689895|NCT03285763|459490286|FG000|Overall Study|Lost to Follow-up|18|||
127689896|NCT03285763|459490286|FG000|Overall Study|Physician Decision|2|||
127689897|NCT03285763|459490286|FG000|Overall Study|Study Terminated By Sponsor|79|||
127689898|NCT03285763|459490286|FG000|Overall Study|Withdrawal by Subject|33|||
127689899|NCT00431834|459490291|FG000|Overall Study|Withdrawal by Subject|7|||
127689900|NCT00431834|459490291|FG000|Overall Study|Death|3|||
127689901|NCT00431834|459490291|FG000|Overall Study|Missed Endpoint Visit|2|||
127689902|NCT00431834|459490291|FG000|Overall Study|Lost to Follow-up|1|||
127567764|NCT00275821|459048516|FG002|Overall Study|Lack of Efficacy|0|||
127567765|NCT00275821|459048514|FG000|Overall Study|Protocol Violation|5|||
127567766|NCT00275821|459048515|FG001|Overall Study|Protocol Violation|1|||
127567767|NCT00275821|459048516|FG002|Overall Study|Protocol Violation|0|||
127567768|NCT00329901|459048517|FG000|Overall Study|Withdrawal by Subject|4|||
127567769|NCT00329901|459048518|FG001|Overall Study|Withdrawal by Subject|3|||
127567770|NCT00329901|459048519|FG002|Overall Study|Withdrawal by Subject|2|||
127567771|NCT00329901|459048517|FG000|Overall Study|Lost to Follow-up|2|||
127567772|NCT00329901|459048518|FG001|Overall Study|Lost to Follow-up|0|||
127567773|NCT00329901|459048519|FG002|Overall Study|Lost to Follow-up|1|||
127567774|NCT00329901|459048517|FG000|Overall Study|Protocol Violation|1|||
127778345|NCT01968070|459817063|FG013|Period 1|Lost to Follow-up|0|||
127778346|NCT01968070|459817064|FG014|Period 1|Lost to Follow-up|0|||
127778347|NCT01968070|459817065|FG015|Period 1|Lost to Follow-up|0|||
127778348|NCT01968070|459817066|FG016|Period 1|Lost to Follow-up|0|||
127778349|NCT01968070|459817067|FG017|Period 1|Lost to Follow-up|0|||
127778350|NCT01968070|459817050|FG000|Period 1|Adverse Event|0|||
127778351|NCT01968070|459817051|FG001|Period 1|Adverse Event|0|||
127778352|NCT01968070|459817052|FG002|Period 1|Adverse Event|0|||
127778353|NCT01968070|459817053|FG003|Period 1|Adverse Event|0|||
127778354|NCT01968070|459817054|FG004|Period 1|Adverse Event|0|||
127778355|NCT01968070|459817055|FG005|Period 1|Adverse Event|0|||
127778356|NCT01968070|459817056|FG006|Period 1|Adverse Event|1|||
127778357|NCT01968070|459817057|FG007|Period 1|Adverse Event|0|||
127778358|NCT01968070|459817058|FG008|Period 1|Adverse Event|0|||
127778359|NCT01968070|459817059|FG009|Period 1|Adverse Event|0|||
127778360|NCT01968070|459817060|FG010|Period 1|Adverse Event|0|||
127778361|NCT01968070|459817061|FG011|Period 1|Adverse Event|0|||
127778362|NCT01968070|459817062|FG012|Period 1|Adverse Event|0|||
127778363|NCT01968070|459817063|FG013|Period 1|Adverse Event|0|||
127778364|NCT01968070|459817064|FG014|Period 1|Adverse Event|0|||
127778365|NCT01968070|459817065|FG015|Period 1|Adverse Event|0|||
127778366|NCT01968070|459817066|FG016|Period 1|Adverse Event|0|||
127778367|NCT01968070|459817067|FG017|Period 1|Adverse Event|0|||
127567775|NCT00329901|459048518|FG001|Overall Study|Protocol Violation|0|||
127567776|NCT00329901|459048519|FG002|Overall Study|Protocol Violation|1|||
127567777|NCT00329901|459048517|FG000|Overall Study|Unable to classify|2|||
127567778|NCT00329901|459048518|FG001|Overall Study|Unable to classify|2|||
127567779|NCT00329901|459048519|FG002|Overall Study|Unable to classify|0|||
127567780|NCT00992589|459048520|FG000|Open-Label Phase|Adverse Event|4|||
127567781|NCT00992589|459048521|FG001|Open-Label Phase|Adverse Event|0|||
127567782|NCT00992589|459048522|FG002|Open-Label Phase|Adverse Event|0|||
127567783|NCT00992589|459048523|FG003|Open-Label Phase|Adverse Event|0|||
127567784|NCT00992589|459048520|FG000|Open-Label Phase|Withdrawal by Subject|20|||
127567785|NCT00992589|459048521|FG001|Open-Label Phase|Withdrawal by Subject|0|||
127567786|NCT00992589|459048522|FG002|Open-Label Phase|Withdrawal by Subject|0|||
127567787|NCT00992589|459048523|FG003|Open-Label Phase|Withdrawal by Subject|0|||
127567788|NCT00992589|459048520|FG000|Open-Label Phase|Lost to Follow-up|1|||
127567789|NCT00992589|459048521|FG001|Open-Label Phase|Lost to Follow-up|0|||
127567790|NCT00992589|459048522|FG002|Open-Label Phase|Lost to Follow-up|0|||
127778368|NCT01968070|459817050|FG000|Period 1|Physician Decision|0|||
127778369|NCT01968070|459817051|FG001|Period 1|Physician Decision|0|||
127778370|NCT01968070|459817052|FG002|Period 1|Physician Decision|0|||
127778371|NCT01968070|459817053|FG003|Period 1|Physician Decision|0|||
127778372|NCT01968070|459817054|FG004|Period 1|Physician Decision|0|||
127778373|NCT01968070|459817055|FG005|Period 1|Physician Decision|0|||
127778374|NCT01968070|459817056|FG006|Period 1|Physician Decision|0|||
127778375|NCT01968070|459817057|FG007|Period 1|Physician Decision|0|||
127778376|NCT01968070|459817058|FG008|Period 1|Physician Decision|0|||
127778377|NCT01968070|459817059|FG009|Period 1|Physician Decision|0|||
127778378|NCT01968070|459817060|FG010|Period 1|Physician Decision|0|||
127778379|NCT01968070|459817061|FG011|Period 1|Physician Decision|1|||
127778380|NCT01968070|459817062|FG012|Period 1|Physician Decision|0|||
127778381|NCT01968070|459817063|FG013|Period 1|Physician Decision|0|||
127778382|NCT01968070|459817064|FG014|Period 1|Physician Decision|0|||
127778383|NCT01968070|459817065|FG015|Period 1|Physician Decision|0|||
127567791|NCT00992589|459048523|FG003|Open-Label Phase|Lost to Follow-up|0|||
127567792|NCT00992589|459048520|FG000|Open-Label Phase|Protocol Violation|3|||
127778384|NCT01968070|459817066|FG016|Period 1|Physician Decision|0|||
127567793|NCT00992589|459048521|FG001|Open-Label Phase|Protocol Violation|0|||
127567794|NCT00992589|459048522|FG002|Open-Label Phase|Protocol Violation|0|||
127567795|NCT00992589|459048523|FG003|Open-Label Phase|Protocol Violation|0|||
127778385|NCT01968070|459817067|FG017|Period 1|Physician Decision|0|||
127778386|NCT01968070|459817050|FG000|Period 2|Withdrawal by Subject|0|||
127778387|NCT01968070|459817051|FG001|Period 2|Withdrawal by Subject|0|||
127778388|NCT01968070|459817052|FG002|Period 2|Withdrawal by Subject|0|||
127567796|NCT00992589|459048520|FG000|Open-Label Phase|Physician Decision|4|||
127778389|NCT01968070|459817053|FG003|Period 2|Withdrawal by Subject|0|||
127778390|NCT01968070|459817054|FG004|Period 2|Withdrawal by Subject|1|||
127778391|NCT01968070|459817055|FG005|Period 2|Withdrawal by Subject|0|||
127778392|NCT01968070|459817056|FG006|Period 2|Withdrawal by Subject|0|||
127778393|NCT01968070|459817057|FG007|Period 2|Withdrawal by Subject|0|||
127778394|NCT01968070|459817058|FG008|Period 2|Withdrawal by Subject|0|||
127567797|NCT00992589|459048521|FG001|Open-Label Phase|Physician Decision|0|||
127567798|NCT00992589|459048522|FG002|Open-Label Phase|Physician Decision|0|||
127567799|NCT00992589|459048523|FG003|Open-Label Phase|Physician Decision|0|||
127567800|NCT00992589|459048520|FG000|Open-Label Phase|Other|45|||
127567801|NCT00992589|459048521|FG001|Open-Label Phase|Other|0|||
127567802|NCT00992589|459048522|FG002|Open-Label Phase|Other|0|||
127567803|NCT00992589|459048523|FG003|Open-Label Phase|Other|0|||
127567804|NCT00992589|459048520|FG000|Double-Blind Phase|Adverse Event|0|||
127567805|NCT00992589|459048521|FG001|Double-Blind Phase|Adverse Event|6|||
127567806|NCT00992589|459048522|FG002|Double-Blind Phase|Adverse Event|2|||
127567807|NCT00992589|459048523|FG003|Double-Blind Phase|Adverse Event|3|||
127567808|NCT00992589|459048520|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
127567809|NCT00992589|459048521|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
127567810|NCT00992589|459048522|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
127567811|NCT00992589|459048523|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
127567812|NCT00992589|459048520|FG000|Double-Blind Phase|Lost to Follow-up|0|||
127567813|NCT00992589|459048521|FG001|Double-Blind Phase|Lost to Follow-up|0|||
127567814|NCT00992589|459048522|FG002|Double-Blind Phase|Lost to Follow-up|0|||
127567815|NCT00992589|459048523|FG003|Double-Blind Phase|Lost to Follow-up|2|||
127567816|NCT00992589|459048520|FG000|Double-Blind Phase|Other|0|||
127567817|NCT00992589|459048521|FG001|Double-Blind Phase|Other|1|||
127567818|NCT00992589|459048522|FG002|Double-Blind Phase|Other|6|||
127567819|NCT00992589|459048523|FG003|Double-Blind Phase|Other|3|||
127567820|NCT02142387|459048524|FG000|Overall Study|<19 years old|49|||
127567821|NCT02142387|459048525|FG001|Overall Study|<19 years old|326|||
127567822|NCT02142387|459048524|FG000|Overall Study|non-cardiac etiology|504|||
127567823|NCT02142387|459048525|FG001|Overall Study|non-cardiac etiology|3431|||
127567824|NCT02142387|459048524|FG000|Overall Study|CPR not performed|74|||
127567825|NCT02142387|459048525|FG001|Overall Study|CPR not performed|473|||
127567826|NCT02142387|459048524|FG000|Overall Study|witnessed by paramedic|139|||
127567827|NCT02142387|459048525|FG001|Overall Study|witnessed by paramedic|917|||
127567828|NCT02142387|459048524|FG000|Overall Study|incomplete data|1|||
127567829|NCT02142387|459048525|FG001|Overall Study|incomplete data|9|||
127567830|NCT02142387|459048524|FG000|Overall Study|occurred not at home|298|||
127567831|NCT02142387|459048525|FG001|Overall Study|occurred not at home|2474|||
127567832|NCT00761748|459048528|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
127567833|NCT00761748|459048529|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
127567834|NCT00761748|459048528|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
127567835|NCT00761748|459048529|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
127778395|NCT01968070|459817059|FG009|Period 2|Withdrawal by Subject|0|||
127778396|NCT01968070|459817060|FG010|Period 2|Withdrawal by Subject|0|||
127778397|NCT01968070|459817061|FG011|Period 2|Withdrawal by Subject|0|||
127778398|NCT01968070|459817062|FG012|Period 2|Withdrawal by Subject|0|||
127778399|NCT01968070|459817063|FG013|Period 2|Withdrawal by Subject|0|||
127778400|NCT01968070|459817064|FG014|Period 2|Withdrawal by Subject|0|||
127778401|NCT01968070|459817065|FG015|Period 2|Withdrawal by Subject|0|||
127778402|NCT01968070|459817066|FG016|Period 2|Withdrawal by Subject|0|||
127778403|NCT01968070|459817067|FG017|Period 2|Withdrawal by Subject|0|||
127778404|NCT02401412|459817071|FG000|Overall Study|Lost to Follow-up|1|||
127778405|NCT02401412|459817072|FG001|Overall Study|Lost to Follow-up|0|||
127778406|NCT02401412|459817071|FG000|Overall Study|Discontinued Intervention|15|||
127778407|NCT02401412|459817072|FG001|Overall Study|Discontinued Intervention|21|||
127778408|NCT02401412|459817071|FG000|Overall Study|Withdrawal by Subject|4|||
127778409|NCT02401412|459817072|FG001|Overall Study|Withdrawal by Subject|4|||
127778410|NCT02401412|459817071|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
127778411|NCT02401412|459817072|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
127778412|NCT02401412|459817071|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
127778413|NCT02401412|459817072|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
127778414|NCT00882310|459817073|FG000|Overall Study|Screen Failure|10|||
127778415|NCT00882310|459817073|FG000|Overall Study|Never received treatment|1|||
127778416|NCT00882310|459817073|FG000|Overall Study|Death|6|||
127778417|NCT00882310|459817073|FG000|Overall Study|Progression of disease|4|||
128026536|NCT01213251|460722129|FG002|Overall Study|Missed 18-Month Follow-up|1|||
128026537|NCT02529488|460722130|FG000|Overall Study|Adverse Event|1|||
128026538|NCT02529488|460722130|FG000|Overall Study|Death|3|||
127567836|NCT00466687|459048532|FG000|Overall Study|Adverse Event|1|||
127778418|NCT00882310|459817073|FG000|Overall Study|Adverse Event|1|||
127778419|NCT04246801|459817076|FG000|Overall Study|Adverse Event|1|||
128026539|NCT02698787|460722131|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
127567837|NCT00466687|459048532|FG000|Overall Study|Other complicating illness|3|||
127567838|NCT00466687|459048532|FG000|Overall Study|Withdrawal by Subject|1|||
127567839|NCT00466687|459048532|FG000|Overall Study|Disease progression|29|||
127567840|NCT04381988|459048535|FG000|Overall Study|The study was terminated|4|||
127567841|NCT04381988|459048536|FG001|Overall Study|The study was terminated|0|||
127567842|NCT01107379|459048537|FG000|Overall Study|Withdrawal by Subject|18|||
127567843|NCT01107379|459048537|FG000|Overall Study|Lost to Follow-up|3|||
127778420|NCT04246801|459817077|FG001|Overall Study|Adverse Event|1|||
127778421|NCT04246801|459817076|FG000|Overall Study|Protocol Violation|1|||
128026540|NCT02698787|460722132|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
128026541|NCT01557244|460722141|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
128026542|NCT01557244|460722142|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
128026543|NCT01557244|460722143|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
128026544|NCT01557244|460722144|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
128026545|NCT01557244|460722145|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
128026546|NCT01557244|460722146|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
128026547|NCT01557244|460722147|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
128026548|NCT01557244|460722141|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
128026549|NCT01557244|460722142|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
128026550|NCT01557244|460722143|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
128026551|NCT01557244|460722144|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
128026552|NCT01557244|460722145|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
128026553|NCT01557244|460722146|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
128026554|NCT01557244|460722147|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
128026555|NCT01557244|460722141|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
128026556|NCT01557244|460722142|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
128026557|NCT01557244|460722143|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
127567844|NCT04559529|459048538|FG000|First Intervention (1 Day)|Adverse Event|0|||
127567845|NCT04559529|459048539|FG001|First Intervention (1 Day)|Adverse Event|0|||
127567846|NCT04559529|459048540|FG002|First Intervention (1 Day)|Adverse Event|0|||
127689903|NCT02461628|459490295|FG000|Overall Study|Refused to complete survey|4|||
128026558|NCT01557244|460722144|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
128026559|NCT01557244|460722145|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
128026560|NCT01557244|460722146|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
128026561|NCT01557244|460722147|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
128026562|NCT01557244|460722141|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
128026563|NCT01557244|460722142|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
128026564|NCT01557244|460722143|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
128026565|NCT01557244|460722144|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
128026566|NCT01557244|460722145|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
128026567|NCT01557244|460722146|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
128026568|NCT01557244|460722147|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
128026569|NCT01557244|460722141|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
128026570|NCT01557244|460722142|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
128026571|NCT01557244|460722143|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
127689904|NCT02461628|459490296|FG001|Overall Study|Refused to complete survey|7|||
127689905|NCT00792636|459490299|FG000|Overall Study|Protocol Violation|17|||
127689906|NCT00792636|459490300|FG001|Overall Study|Protocol Violation|23|||
127689907|NCT00792636|459490301|FG002|Overall Study|Protocol Violation|20|||
127689908|NCT00792636|459490299|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
127689909|NCT00792636|459490300|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
127689910|NCT00792636|459490301|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
127689911|NCT00792636|459490299|FG000|Overall Study|Lost to Follow-up|13|||
127689912|NCT00792636|459490300|FG001|Overall Study|Lost to Follow-up|19|||
127689913|NCT00792636|459490301|FG002|Overall Study|Lost to Follow-up|14|||
127689914|NCT00792636|459490299|FG000|Overall Study|Withdrew Consent|10|||
127689915|NCT00792636|459490300|FG001|Overall Study|Withdrew Consent|13|||
127689916|NCT00792636|459490301|FG002|Overall Study|Withdrew Consent|9|||
127689917|NCT00792636|459490299|FG000|Overall Study|Lack of Efficacy|3|||
127689918|NCT00792636|459490300|FG001|Overall Study|Lack of Efficacy|4|||
127689919|NCT00792636|459490301|FG002|Overall Study|Lack of Efficacy|13|||
127689920|NCT00792636|459490299|FG000|Overall Study|Adverse Event|4|||
127689921|NCT00792636|459490300|FG001|Overall Study|Adverse Event|2|||
127689922|NCT00792636|459490301|FG002|Overall Study|Adverse Event|3|||
127689923|NCT00792636|459490299|FG000|Overall Study|Investigator Discretion|2|||
127689924|NCT00792636|459490300|FG001|Overall Study|Investigator Discretion|0|||
127689925|NCT00792636|459490301|FG002|Overall Study|Investigator Discretion|2|||
127689926|NCT04579250|459490303|FG000|Overall Study|Withdrawal by Subject|1|||
127689927|NCT04579250|459490304|FG001|Overall Study|Withdrawal by Subject|1|||
127689928|NCT04579250|459490305|FG002|Overall Study|Withdrawal by Subject|0|||
127689929|NCT04579250|459490303|FG000|Overall Study|Lost to Follow-up|1|||
127689930|NCT04579250|459490304|FG001|Overall Study|Lost to Follow-up|1|||
127689931|NCT04579250|459490305|FG002|Overall Study|Lost to Follow-up|0|||
127689932|NCT04579250|459490303|FG000|Overall Study|Moved from area|0|||
127689933|NCT04579250|459490304|FG001|Overall Study|Moved from area|1|||
127689934|NCT04579250|459490305|FG002|Overall Study|Moved from area|2|||
127689935|NCT04711135|459490310|FG000|Overall Study|Physician Decision|0|||
127567847|NCT04559529|459048541|FG003|First Intervention (1 Day)|Adverse Event|1|||
127567848|NCT04559529|459048538|FG000|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
127567849|NCT04559529|459048539|FG001|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
127567850|NCT04559529|459048540|FG002|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|1|||
127567851|NCT04559529|459048541|FG003|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
127567852|NCT04559529|459048538|FG000|Second Intervention (1 Day)|Lost to Follow-up|0|||
127567853|NCT04559529|459048539|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
127567854|NCT04559529|459048540|FG002|Second Intervention (1 Day)|Lost to Follow-up|1|||
127567855|NCT04559529|459048541|FG003|Second Intervention (1 Day)|Lost to Follow-up|0|||
127567856|NCT00609362|459048542|FG000|Overall Study|Withdrawal by Subject|2|||
127567857|NCT00609362|459048543|FG001|Overall Study|Withdrawal by Subject|1|||
127567858|NCT00609362|459048542|FG000|Overall Study|Adverse Event|1|||
127567859|NCT00609362|459048543|FG001|Overall Study|Adverse Event|0|||
127567860|NCT01009281|459048544|FG000|Overall Study|Administrative problems|7|||
127567861|NCT00548405|459048545|FG000|Overall Study|Adverse Event|6|||
127567862|NCT00548405|459048546|FG001|Overall Study|Adverse Event|2|||
127567863|NCT00548405|459048547|FG002|Overall Study|Adverse Event|0|||
127567864|NCT00548405|459048545|FG000|Overall Study|Lack of Efficacy|6|||
127689936|NCT04711135|459490311|FG001|Overall Study|Physician Decision|1|||
127689937|NCT04711135|459490310|FG000|Overall Study|Ongoing treatment|0|||
127689938|NCT04711135|459490311|FG001|Overall Study|Ongoing treatment|1|||
127689939|NCT00998881|459490312|FG000|Overall Study|Adverse Event|2|||
127689940|NCT00998881|459490313|FG001|Overall Study|Adverse Event|2|||
127689941|NCT00998881|459490312|FG000|Overall Study|Lack of Efficacy|1|||
127689942|NCT00998881|459490313|FG001|Overall Study|Lack of Efficacy|0|||
127689943|NCT00998881|459490312|FG000|Overall Study|Physician Decision|3|||
127689944|NCT00998881|459490313|FG001|Overall Study|Physician Decision|0|||
127689945|NCT00998881|459490312|FG000|Overall Study|Withdrawal by Subject|1|||
127689946|NCT00998881|459490313|FG001|Overall Study|Withdrawal by Subject|0|||
127689947|NCT00998881|459490312|FG000|Overall Study|Personal matter|1|||
127689948|NCT00998881|459490313|FG001|Overall Study|Personal matter|0|||
127689949|NCT02006758|459490314|FG000|Overall Study|Protocol Violation|1|||
127689950|NCT02006758|459490314|FG000|Overall Study|Death|1|||
127689951|NCT02006758|459490314|FG000|Overall Study|Lost to Follow-up|4|||
127689952|NCT02006758|459490314|FG000|Overall Study|Withdrawal by Subject|4|||
127689953|NCT02006758|459490314|FG000|Overall Study|Procedurally excluded|1|||
127689954|NCT02006758|459490314|FG000|Overall Study|Other|2|||
127689955|NCT04788641|459490320|FG000|Treatment Period 2 (4 Days)|Protocol Violation|0|||
127689956|NCT04788641|459490321|FG001|Treatment Period 2 (4 Days)|Protocol Violation|0|||
127689957|NCT04788641|459490322|FG002|Treatment Period 2 (4 Days)|Protocol Violation|1|||
127689958|NCT04788641|459490323|FG003|Treatment Period 2 (4 Days)|Protocol Violation|0|||
127689959|NCT04788641|459490320|FG000|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|1|||
127689960|NCT04788641|459490321|FG001|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
127689961|NCT04788641|459490322|FG002|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
127689962|NCT04788641|459490323|FG003|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
127689963|NCT04788641|459490320|FG000|Treatment Period 2 (4 Days)|Adverse Event|0|||
127689964|NCT04788641|459490321|FG001|Treatment Period 2 (4 Days)|Adverse Event|0|||
127689965|NCT04788641|459490322|FG002|Treatment Period 2 (4 Days)|Adverse Event|1|||
127689966|NCT04788641|459490323|FG003|Treatment Period 2 (4 Days)|Adverse Event|0|||
127689967|NCT02740231|459490324|FG000|Overall Study|Withdrawal by Subject|1|||
127689968|NCT02740231|459490325|FG001|Overall Study|Withdrawal by Subject|1|||
127689969|NCT02740231|459490326|FG002|Overall Study|Withdrawal by Subject|1|||
127689970|NCT02740231|459490327|FG003|Overall Study|Withdrawal by Subject|0|||
127689971|NCT02740231|459490324|FG000|Overall Study|Lack of Efficacy|0|||
127689972|NCT02740231|459490325|FG001|Overall Study|Lack of Efficacy|1|||
127689973|NCT02740231|459490326|FG002|Overall Study|Lack of Efficacy|0|||
127689974|NCT02740231|459490327|FG003|Overall Study|Lack of Efficacy|4|||
127689975|NCT02740231|459490324|FG000|Overall Study|Lost to Follow-up|1|||
127689976|NCT02740231|459490325|FG001|Overall Study|Lost to Follow-up|3|||
127689977|NCT02740231|459490326|FG002|Overall Study|Lost to Follow-up|0|||
127689978|NCT02740231|459490327|FG003|Overall Study|Lost to Follow-up|3|||
127689979|NCT02740231|459490324|FG000|Overall Study|Adverse Event|0|||
127689980|NCT02740231|459490325|FG001|Overall Study|Adverse Event|1|||
127689981|NCT02740231|459490326|FG002|Overall Study|Adverse Event|0|||
127689982|NCT02740231|459490327|FG003|Overall Study|Adverse Event|1|||
127689983|NCT02462759|459490328|FG000|Part 1: Double Blind|Death|1|||
127689984|NCT02462759|459490329|FG001|Part 1: Double Blind|Death|0|||
127689985|NCT02462759|459490330|FG002|Part 1: Double Blind|Death|0|||
127689986|NCT01000480|459490332|FG000|Induction Phase|Adverse Event|2|||
127778422|NCT04246801|459817077|FG001|Overall Study|Protocol Violation|1|||
127567865|NCT00548405|459048546|FG001|Overall Study|Lack of Efficacy|0|||
127567866|NCT00548405|459048547|FG002|Overall Study|Lack of Efficacy|0|||
127567867|NCT00548405|459048545|FG000|Overall Study|Physician Decision|3|||
127778423|NCT04246801|459817076|FG000|Overall Study|Lack of Efficacy|0|||
128026572|NCT01557244|460722144|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
128026573|NCT01557244|460722145|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
128026574|NCT01557244|460722146|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
128026575|NCT01557244|460722147|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
128026576|NCT01557244|460722141|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
128026577|NCT01557244|460722142|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
128026578|NCT01557244|460722143|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
128026579|NCT01557244|460722144|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
128026580|NCT01557244|460722145|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
128026581|NCT01557244|460722146|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
128026582|NCT01557244|460722147|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
128026583|NCT01557244|460722141|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
128026584|NCT01557244|460722142|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
128026585|NCT01557244|460722143|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
128026586|NCT01557244|460722144|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
128026587|NCT01557244|460722145|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
128026588|NCT01557244|460722146|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
128026589|NCT01557244|460722147|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
128026590|NCT01557244|460722141|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
128026591|NCT01557244|460722142|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
128026592|NCT01557244|460722143|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
128026593|NCT01557244|460722144|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
128026594|NCT01557244|460722145|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
128026595|NCT01557244|460722146|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
128026596|NCT01557244|460722147|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
128026597|NCT01557244|460722141|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
128026598|NCT01557244|460722142|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
128026599|NCT01557244|460722143|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
128026600|NCT01557244|460722144|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
128026601|NCT01557244|460722145|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
128026602|NCT01557244|460722146|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
128026603|NCT01557244|460722147|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
128026604|NCT01557244|460722141|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
128026605|NCT01557244|460722142|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
128026606|NCT01557244|460722143|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
128026607|NCT01557244|460722144|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
128026608|NCT01557244|460722145|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
128026609|NCT01557244|460722146|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
128026610|NCT01557244|460722147|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
128026611|NCT01557244|460722141|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
128026612|NCT01557244|460722142|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
128026613|NCT01557244|460722143|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
128026614|NCT01557244|460722144|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
128026615|NCT01557244|460722145|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
128026616|NCT01557244|460722146|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
128026617|NCT01557244|460722147|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
128026618|NCT01557244|460722141|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
128026619|NCT01557244|460722142|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
128026620|NCT01557244|460722143|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
128026621|NCT01557244|460722144|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
128026622|NCT01557244|460722145|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
128026623|NCT01557244|460722146|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
128026624|NCT01557244|460722147|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
128026625|NCT01313676|460722148|FG000|Overall Study|Adverse Event|395|||
128026626|NCT01313676|460722149|FG001|Overall Study|Adverse Event|365|||
128026627|NCT01313676|460722150|FG002|Overall Study|Adverse Event|372|||
128026628|NCT01313676|460722151|FG003|Overall Study|Adverse Event|333|||
128026629|NCT01313676|460722148|FG000|Overall Study|Lack of Efficacy|98|||
128026630|NCT01313676|460722149|FG001|Overall Study|Lack of Efficacy|90|||
128026631|NCT01313676|460722150|FG002|Overall Study|Lack of Efficacy|65|||
128026632|NCT01313676|460722151|FG003|Overall Study|Lack of Efficacy|46|||
128026633|NCT01313676|460722148|FG000|Overall Study|Protocol Violation|37|||
128026634|NCT01313676|460722149|FG001|Overall Study|Protocol Violation|44|||
128026635|NCT01313676|460722150|FG002|Overall Study|Protocol Violation|46|||
128026636|NCT01313676|460722151|FG003|Overall Study|Protocol Violation|44|||
128026637|NCT01313676|460722148|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
128026638|NCT01313676|460722149|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
128026639|NCT01313676|460722150|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
128026640|NCT01313676|460722151|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
128026641|NCT01313676|460722148|FG000|Overall Study|Study Closed/terminated|7|||
128026642|NCT01313676|460722149|FG001|Overall Study|Study Closed/terminated|6|||
128026643|NCT01313676|460722150|FG002|Overall Study|Study Closed/terminated|9|||
128026644|NCT01313676|460722151|FG003|Overall Study|Study Closed/terminated|9|||
128026645|NCT01313676|460722148|FG000|Overall Study|Lost to Follow-up|0|||
128026646|NCT01313676|460722149|FG001|Overall Study|Lost to Follow-up|0|||
128026647|NCT01313676|460722150|FG002|Overall Study|Lost to Follow-up|1|||
128026648|NCT01313676|460722151|FG003|Overall Study|Lost to Follow-up|0|||
128026649|NCT01313676|460722148|FG000|Overall Study|Physician Decision|53|||
128026650|NCT01313676|460722149|FG001|Overall Study|Physician Decision|64|||
127778424|NCT04246801|459817077|FG001|Overall Study|Lack of Efficacy|2|||
127778425|NCT04246801|459817076|FG000|Overall Study|Lost to Follow-up|1|||
127778426|NCT04246801|459817077|FG001|Overall Study|Lost to Follow-up|1|||
127778427|NCT04246801|459817076|FG000|Overall Study|Withdrawal by Subject|2|||
127778428|NCT04246801|459817077|FG001|Overall Study|Withdrawal by Subject|1|||
127778429|NCT03684642|459817078|FG000|Overall Study|Adverse Event|6|||
127778430|NCT03684642|459817079|FG001|Overall Study|Adverse Event|15|||
127778431|NCT03684642|459817080|FG002|Overall Study|Adverse Event|11|||
127778432|NCT03684642|459817078|FG000|Overall Study|Withdrawal by Subject|35|||
127778433|NCT03684642|459817079|FG001|Overall Study|Withdrawal by Subject|53|||
127778434|NCT03684642|459817080|FG002|Overall Study|Withdrawal by Subject|23|||
127778435|NCT03684642|459817078|FG000|Overall Study|Lack of Efficacy|0|||
127778436|NCT03684642|459817079|FG001|Overall Study|Lack of Efficacy|0|||
127778437|NCT03684642|459817080|FG002|Overall Study|Lack of Efficacy|1|||
127778438|NCT03684642|459817078|FG000|Overall Study|Poor compliance to protocol|0|||
127778439|NCT03684642|459817079|FG001|Overall Study|Poor compliance to protocol|4|||
127778440|NCT03684642|459817080|FG002|Overall Study|Poor compliance to protocol|1|||
127778441|NCT03684642|459817078|FG000|Overall Study|Other than specified|62|||
127778442|NCT03684642|459817079|FG001|Overall Study|Other than specified|60|||
127778443|NCT03684642|459817080|FG002|Overall Study|Other than specified|67|||
127778444|NCT03684642|459817078|FG000|Overall Study|Randomized and not treated|0|||
127778445|NCT03684642|459817079|FG001|Overall Study|Randomized and not treated|0|||
127778446|NCT03684642|459817080|FG002|Overall Study|Randomized and not treated|1|||
128026651|NCT01313676|460722150|FG002|Overall Study|Physician Decision|62|||
128026652|NCT01313676|460722151|FG003|Overall Study|Physician Decision|48|||
128026653|NCT01313676|460722148|FG000|Overall Study|Decision by Participant or Proxy|643|||
128026654|NCT01313676|460722149|FG001|Overall Study|Decision by Participant or Proxy|527|||
128026655|NCT01313676|460722150|FG002|Overall Study|Decision by Participant or Proxy|515|||
128026656|NCT01313676|460722151|FG003|Overall Study|Decision by Participant or Proxy|492|||
128026657|NCT01313676|460722148|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
128026658|NCT01313676|460722149|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
128026659|NCT01313676|460722150|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
128026660|NCT01313676|460722151|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
128026661|NCT01313676|460722148|FG000|Overall Study|Investigator Site Closed|12|||
128026662|NCT01313676|460722149|FG001|Overall Study|Investigator Site Closed|11|||
128026663|NCT01313676|460722150|FG002|Overall Study|Investigator Site Closed|15|||
128026664|NCT01313676|460722151|FG003|Overall Study|Investigator Site Closed|10|||
128026665|NCT01313676|460722148|FG000|Overall Study|Missing|1|||
128026666|NCT01313676|460722149|FG001|Overall Study|Missing|1|||
128026667|NCT01313676|460722150|FG002|Overall Study|Missing|1|||
128026668|NCT01313676|460722151|FG003|Overall Study|Missing|0|||
128026669|NCT03312114|460722152|FG000|Overall Study|All the five enrolled dropped out of the|5|||
128026670|NCT00944645|460722153|FG000|Period 2|Adverse Event|1|||
128026671|NCT00944645|460722154|FG001|Period 2|Adverse Event|0|||
128026672|NCT00944645|460722153|FG000|Period 2|Lost to Follow-up|0|||
128026673|NCT00944645|460722154|FG001|Period 2|Lost to Follow-up|3|||
128026674|NCT00944645|460722153|FG000|Period 2|Withdrawal by Subject|7|||
128026675|NCT00944645|460722154|FG001|Period 2|Withdrawal by Subject|6|||
128026676|NCT03537729|460722155|FG000|Overall Study|Death|2|||
128026677|NCT03537729|460722156|FG001|Overall Study|Death|2|||
128026678|NCT03537729|460722157|FG002|Overall Study|Death|7|||
128026679|NCT03537729|460722155|FG000|Overall Study|Withdrawal by Subject|3|||
128026680|NCT03537729|460722156|FG001|Overall Study|Withdrawal by Subject|3|||
128026681|NCT03537729|460722157|FG002|Overall Study|Withdrawal by Subject|0|||
128026682|NCT03537729|460722155|FG000|Overall Study|Subject Moved|8|||
127778447|NCT03684642|459817078|FG000|Overall Study|Missing completion status but alive at last contact|0|||
127778448|NCT03684642|459817079|FG001|Overall Study|Missing completion status but alive at last contact|1|||
127778449|NCT03684642|459817080|FG002|Overall Study|Missing completion status but alive at last contact|2|||
128026683|NCT03537729|460722156|FG001|Overall Study|Subject Moved|5|||
128026684|NCT03537729|460722157|FG002|Overall Study|Subject Moved|4|||
128026685|NCT03537729|460722155|FG000|Overall Study|Investigator determined not in best interest for subject to continue|1|||
127567868|NCT00548405|459048546|FG001|Overall Study|Physician Decision|4|||
127567869|NCT00548405|459048547|FG002|Overall Study|Physician Decision|1|||
127567870|NCT00548405|459048545|FG000|Overall Study|Pregnancy|1|||
127567871|NCT00548405|459048546|FG001|Overall Study|Pregnancy|0|||
127567872|NCT00548405|459048547|FG002|Overall Study|Pregnancy|0|||
127567873|NCT00548405|459048545|FG000|Overall Study|Protocol Violation|1|||
127567874|NCT00548405|459048546|FG001|Overall Study|Protocol Violation|0|||
127567875|NCT00548405|459048547|FG002|Overall Study|Protocol Violation|0|||
127567876|NCT00548405|459048545|FG000|Overall Study|Withdrawal by Subject|36|||
127567877|NCT00548405|459048546|FG001|Overall Study|Withdrawal by Subject|12|||
127567878|NCT00548405|459048547|FG002|Overall Study|Withdrawal by Subject|5|||
127567879|NCT00548405|459048545|FG000|Overall Study|Lost to Follow-up|1|||
127567880|NCT00548405|459048546|FG001|Overall Study|Lost to Follow-up|1|||
127567881|NCT00548405|459048547|FG002|Overall Study|Lost to Follow-up|2|||
127567882|NCT00548405|459048545|FG000|Overall Study|Death|0|||
127567883|NCT00548405|459048546|FG001|Overall Study|Death|1|||
127567884|NCT00548405|459048547|FG002|Overall Study|Death|1|||
127567885|NCT00548405|459048545|FG000|Overall Study|Sponsor decision|1|||
127567886|NCT00548405|459048546|FG001|Overall Study|Sponsor decision|0|||
127567887|NCT00548405|459048547|FG002|Overall Study|Sponsor decision|0|||
127567888|NCT00548405|459048545|FG000|Overall Study|Randomized but not treated|1|||
127567889|NCT00548405|459048546|FG001|Overall Study|Randomized but not treated|0|||
127567890|NCT00548405|459048547|FG002|Overall Study|Randomized but not treated|0|||
127567891|NCT01624870|459048549|FG000|Overall Study|Death|19|||
127567892|NCT01624870|459048549|FG000|Overall Study|Withdrawal by Subject|1|||
127567893|NCT01624870|459048549|FG000|Overall Study|CoreValve not implanted|6|||
127567894|NCT01624870|459048549|FG000|Overall Study|Lost to follow up|1|||
127567895|NCT02582684|459048553|FG000|Overall Study|Unable to contact subject/parent|4|||
127567896|NCT02582684|459048553|FG000|Overall Study|Subject not able to get to clinic|10|||
127567897|NCT02582684|459048553|FG000|Overall Study|Subject withdrew consent|1|||
127567898|NCT02582684|459048553|FG000|Overall Study|Found to be ineligible after enrollment|2|||
127567899|NCT01878149|459048554|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
127567900|NCT01878149|459048555|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
127567901|NCT00899392|459048565|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
127567902|NCT00899392|459048566|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
127567903|NCT01261780|459048573|FG000|Overall Study|Withdrawal by Subject|1|||
127567904|NCT01261780|459048574|FG001|Overall Study|Withdrawal by Subject|0|||
127567905|NCT01261780|459048573|FG000|Overall Study|Event not related to subject|1|||
127567906|NCT01261780|459048574|FG001|Overall Study|Event not related to subject|2|||
127778450|NCT04201821|459817089|FG000|Overall Study|Withdrawal by Subject|2|||
127778451|NCT00387764|459817090|FG000|Overall Study|Adverse Event|12|||
127778452|NCT00387764|459817090|FG000|Overall Study|Withdrawal by Subject|8|||
127778453|NCT00387764|459817090|FG000|Overall Study|Sponsor Terminated Study|1|||
127778454|NCT00387764|459817090|FG000|Overall Study|Physician Decision|1|||
127778455|NCT00387764|459817090|FG000|Overall Study|Other|2|||
127778456|NCT00387764|459817090|FG000|Overall Study|Death|7|||
127881035|NCT02575807|460186105|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
127881036|NCT02575807|460186106|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
127881037|NCT02575807|460186107|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
127881038|NCT02575807|460186108|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
127881039|NCT02575807|460186104|FG000|Overall Study|Terminated due to physician decision|0|||
127881040|NCT02575807|460186105|FG001|Overall Study|Terminated due to physician decision|0|||
127881041|NCT02575807|460186106|FG002|Overall Study|Terminated due to physician decision|1|||
127881042|NCT02575807|460186107|FG003|Overall Study|Terminated due to physician decision|0|||
127881043|NCT02575807|460186108|FG004|Overall Study|Terminated due to physician decision|0|||
127881044|NCT02575807|460186104|FG000|Overall Study|Subject ineligible - medical implant|0|||
127881045|NCT02575807|460186105|FG001|Overall Study|Subject ineligible - medical implant|0|||
127778457|NCT02374021|459817091|FG000|Overall Study|Adverse Event|1|||
127778458|NCT02374021|459817092|FG001|Overall Study|Adverse Event|0|||
127567907|NCT01239732|459048575|FG000|Overall Study|Termination of study per protocol|667|||
127567908|NCT01239732|459048575|FG000|Overall Study|Death|226|||
127567909|NCT01239732|459048575|FG000|Overall Study|Withdrawal by Subject|87|||
127567910|NCT01239732|459048575|FG000|Overall Study|Adverse Event|6|||
127567911|NCT01239732|459048575|FG000|Overall Study|Protocol Violation|3|||
127567912|NCT01239732|459048575|FG000|Overall Study|Participant non compliance|5|||
127778459|NCT02374021|459817091|FG000|Overall Study|Lost to Follow-up|3|||
127778460|NCT02374021|459817092|FG001|Overall Study|Lost to Follow-up|2|||
127778461|NCT02374021|459817091|FG000|Overall Study|Physician Decision|0|||
127567913|NCT01239732|459048575|FG000|Overall Study|Study termination by sponsor|2|||
127567914|NCT01239732|459048575|FG000|Overall Study|Investigator's decision|4|||
127567915|NCT01239732|459048575|FG000|Overall Study|Treatment failure|2|||
127567916|NCT01239732|459048575|FG000|Overall Study|Other|19|||
127567917|NCT00732940|459048576|FG000|Overall Study|Withdrawal by Subject|1|||
127778462|NCT02374021|459817092|FG001|Overall Study|Physician Decision|3|||
127778463|NCT02374021|459817091|FG000|Overall Study|Withdrawal by Subject|6|||
127567918|NCT00732940|459048577|FG001|Overall Study|Withdrawal by Subject|2|||
127567919|NCT00732940|459048576|FG000|Overall Study|Adverse Event|0|||
127567920|NCT00732940|459048577|FG001|Overall Study|Adverse Event|1|||
127567921|NCT00732940|459048576|FG000|Overall Study|Lost to Follow-up|1|||
127567922|NCT00732940|459048577|FG001|Overall Study|Lost to Follow-up|0|||
127567923|NCT02241889|459048578|FG000|Overall Study|device issues|0|||
127567924|NCT02241889|459048579|FG001|Overall Study|device issues|0|||
127567925|NCT02241889|459048580|FG002|Overall Study|device issues|1|||
127567926|NCT02241889|459048581|FG003|Overall Study|device issues|0|||
127567927|NCT02241889|459048582|FG004|Overall Study|device issues|0|||
127567928|NCT02241889|459048583|FG005|Overall Study|device issues|0|||
127567929|NCT02241889|459048578|FG000|Overall Study|Withdrawal by Subject|0|||
127567930|NCT02241889|459048579|FG001|Overall Study|Withdrawal by Subject|0|||
127567931|NCT02241889|459048580|FG002|Overall Study|Withdrawal by Subject|0|||
127567932|NCT02241889|459048581|FG003|Overall Study|Withdrawal by Subject|0|||
127567933|NCT02241889|459048582|FG004|Overall Study|Withdrawal by Subject|0|||
127567934|NCT02241889|459048583|FG005|Overall Study|Withdrawal by Subject|1|||
127567935|NCT02048241|459048584|FG000|Overall Study|Withdrawal by Subject|0|||
127567936|NCT02048241|459048585|FG001|Overall Study|Withdrawal by Subject|1|||
127567937|NCT00402233|459048586|FG000|Overall Study|Adverse Event|1|||
127567938|NCT00402233|459048587|FG001|Overall Study|Adverse Event|7|||
127567939|NCT00402233|459048588|FG002|Overall Study|Adverse Event|9|||
127567940|NCT00402233|459048589|FG003|Overall Study|Adverse Event|9|||
127567941|NCT00402233|459048586|FG000|Overall Study|Protocol Violation|0|||
127567942|NCT00402233|459048587|FG001|Overall Study|Protocol Violation|1|||
127778464|NCT02374021|459817092|FG001|Overall Study|Withdrawal by Subject|5|||
127778465|NCT02374021|459817091|FG000|Overall Study|Poor Adherence|0|||
127778466|NCT02374021|459817092|FG001|Overall Study|Poor Adherence|1|||
127778467|NCT02374021|459817091|FG000|Overall Study|Scan protocol not followed|0|||
127778468|NCT02374021|459817092|FG001|Overall Study|Scan protocol not followed|1|||
127778469|NCT02374021|459817091|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
127778470|NCT02374021|459817092|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
127778471|NCT02684279|459817095|FG000|Overall Study|Adverse Event|87|||
127778472|NCT02684279|459817095|FG000|Overall Study|Lack of Efficacy|4|||
127778473|NCT02684279|459817095|FG000|Overall Study|Lost to Follow-up|61|||
127778474|NCT02684279|459817095|FG000|Overall Study|Protocol Violation|6|||
127778475|NCT02684279|459817095|FG000|Overall Study|Pregnancy|8|||
127778476|NCT02684279|459817095|FG000|Overall Study|Withdrawal by Subject|92|||
127778477|NCT02684279|459817095|FG000|Overall Study|non-compliance with study drug|9|||
127778478|NCT02684279|459817095|FG000|Overall Study|non compliance with study visits|2|||
127778479|NCT02684279|459817095|FG000|Overall Study|subject to have surgery|1|||
127778480|NCT02684279|459817095|FG000|Overall Study|family emergency|1|||
127778481|NCT02684279|459817095|FG000|Overall Study|Site closures|7|||
127778482|NCT02684279|459817095|FG000|Overall Study|Physician Decision|1|||
127778483|NCT01162239|459817096|FG000|Treatment Phase|Withdrawal by Subject|1|||
127567943|NCT00402233|459048588|FG002|Overall Study|Protocol Violation|0|||
127778484|NCT01162239|459817097|FG001|Treatment Phase|Withdrawal by Subject|3|||
127778485|NCT01162239|459817098|FG002|Treatment Phase|Withdrawal by Subject|2|||
127778486|NCT01162239|459817099|FG003|Treatment Phase|Withdrawal by Subject|3|||
127778487|NCT01162239|459817096|FG000|Treatment Phase|Death|0|||
127778488|NCT01162239|459817097|FG001|Treatment Phase|Death|0|||
127778489|NCT01162239|459817098|FG002|Treatment Phase|Death|0|||
127778490|NCT01162239|459817099|FG003|Treatment Phase|Death|1|||
127778491|NCT01162239|459817096|FG000|Treatment Phase|Lost to Follow-up|5|||
127778492|NCT01162239|459817097|FG001|Treatment Phase|Lost to Follow-up|4|||
127778493|NCT01162239|459817098|FG002|Treatment Phase|Lost to Follow-up|2|||
127778494|NCT01162239|459817099|FG003|Treatment Phase|Lost to Follow-up|1|||
127778495|NCT01162239|459817096|FG000|Extended Follow-up|Lost to Follow-up|8|||
127778496|NCT01162239|459817097|FG001|Extended Follow-up|Lost to Follow-up|13|||
127778497|NCT01162239|459817098|FG002|Extended Follow-up|Lost to Follow-up|8|||
127778498|NCT01162239|459817099|FG003|Extended Follow-up|Lost to Follow-up|6|||
127778499|NCT00228566|459817100|FG000|Overall Study|Adverse Event|31|||
127567944|NCT00402233|459048589|FG003|Overall Study|Protocol Violation|0|||
127567945|NCT00402233|459048586|FG000|Overall Study|Withdrawal by Subject|2|||
127778500|NCT00228566|459817100|FG000|Overall Study|Lack of Efficacy|14|||
127567946|NCT00402233|459048587|FG001|Overall Study|Withdrawal by Subject|1|||
127567947|NCT00402233|459048588|FG002|Overall Study|Withdrawal by Subject|2|||
127567948|NCT00402233|459048589|FG003|Overall Study|Withdrawal by Subject|2|||
127567949|NCT00402233|459048586|FG000|Overall Study|Worsening of disease under study|2|||
127567950|NCT00402233|459048587|FG001|Overall Study|Worsening of disease under study|0|||
127567951|NCT00402233|459048588|FG002|Overall Study|Worsening of disease under study|0|||
127778501|NCT00228566|459817100|FG000|Overall Study|Lost to Follow-up|16|||
127567952|NCT00402233|459048589|FG003|Overall Study|Worsening of disease under study|0|||
127778502|NCT00228566|459817100|FG000|Overall Study|Physician Decision|5|||
127778503|NCT00228566|459817100|FG000|Overall Study|Withdrawal by Subject|4|||
127778504|NCT00228566|459817100|FG000|Overall Study|Miscellaneous|1|||
127778505|NCT04448756|459817101|FG000|Overall Study|Adverse Event|0|||
127778506|NCT04448756|459817102|FG001|Overall Study|Adverse Event|1|||
127567953|NCT00402233|459048586|FG000|Overall Study|Worsening of other pre-existing disease|0|||
127567954|NCT00402233|459048587|FG001|Overall Study|Worsening of other pre-existing disease|1|||
127778507|NCT04448756|459817103|FG002|Overall Study|Adverse Event|0|||
127778508|NCT04448756|459817101|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
127778509|NCT04448756|459817102|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
127778510|NCT04448756|459817103|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
127778511|NCT04448756|459817101|FG000|Overall Study|Withdrawal by Subject|0|||
127778512|NCT04448756|459817102|FG001|Overall Study|Withdrawal by Subject|3|||
127778513|NCT04448756|459817103|FG002|Overall Study|Withdrawal by Subject|1|||
127778514|NCT04448756|459817101|FG000|Overall Study|Death|2|||
127778515|NCT04448756|459817102|FG001|Overall Study|Death|1|||
127778516|NCT04448756|459817103|FG002|Overall Study|Death|0|||
127778517|NCT00232141|459817104|FG000|Overall Study|Adverse Event|9|||
127778518|NCT00232141|459817105|FG001|Overall Study|Adverse Event|4|||
127778519|NCT00232141|459817104|FG000|Overall Study|Lack of Efficacy|0|||
127778520|NCT00232141|459817105|FG001|Overall Study|Lack of Efficacy|3|||
127778521|NCT00232141|459817104|FG000|Overall Study|Lost to Follow-up|9|||
127778522|NCT00232141|459817105|FG001|Overall Study|Lost to Follow-up|6|||
127778523|NCT00232141|459817104|FG000|Overall Study|Other|8|||
127778524|NCT00232141|459817105|FG001|Overall Study|Other|10|||
127778525|NCT00232141|459817104|FG000|Overall Study|Withdrawal by Subject|5|||
127778526|NCT00232141|459817105|FG001|Overall Study|Withdrawal by Subject|3|||
127778527|NCT01479829|459817109|FG000|Overall Study|Withdrawal by Subject|8|||
127778528|NCT01479829|459817110|FG001|Overall Study|Withdrawal by Subject|10|||
127778529|NCT00601250|459817111|FG000|Overall Study|Adverse Event|3|||
127567955|NCT00402233|459048588|FG002|Overall Study|Worsening of other pre-existing disease|0|||
127567956|NCT00402233|459048589|FG003|Overall Study|Worsening of other pre-existing disease|0|||
127778530|NCT00601250|459817112|FG001|Overall Study|Adverse Event|9|||
127778531|NCT00601250|459817111|FG000|Overall Study|Protocol Violation|3|||
127778532|NCT00601250|459817112|FG001|Overall Study|Protocol Violation|2|||
127778533|NCT00601250|459817111|FG000|Overall Study|Lost to Follow-up|2|||
127778534|NCT00601250|459817112|FG001|Overall Study|Lost to Follow-up|6|||
127778535|NCT00601250|459817111|FG000|Overall Study|Withdrawal by Subject|4|||
127778536|NCT00601250|459817112|FG001|Overall Study|Withdrawal by Subject|13|||
127778537|NCT00601250|459817111|FG000|Overall Study|Other incl. lack of efficacy|2|||
127778538|NCT00601250|459817112|FG001|Overall Study|Other incl. lack of efficacy|9|||
127778539|NCT01791803|459817113|FG000|Overall Study|Withdrawal by Subject|0|||
127778540|NCT01791803|459817114|FG001|Overall Study|Withdrawal by Subject|0|||
127778541|NCT01791803|459817115|FG002|Overall Study|Withdrawal by Subject|0|||
127778542|NCT01791803|459817116|FG003|Overall Study|Withdrawal by Subject|2|||
127778543|NCT01791803|459817113|FG000|Overall Study|Physician Decision|0|||
127778544|NCT01791803|459817114|FG001|Overall Study|Physician Decision|2|||
127778545|NCT01791803|459817115|FG002|Overall Study|Physician Decision|0|||
127778546|NCT01791803|459817116|FG003|Overall Study|Physician Decision|1|||
127778547|NCT01791803|459817113|FG000|Overall Study|Death|0|||
127778548|NCT01791803|459817114|FG001|Overall Study|Death|0|||
127778549|NCT01791803|459817115|FG002|Overall Study|Death|2|||
127778550|NCT01791803|459817116|FG003|Overall Study|Death|2|||
127778551|NCT04572854|459817117|FG000|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
127778552|NCT04572854|459817118|FG001|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
127778553|NCT04572854|459817119|FG002|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
127778554|NCT04572854|459817120|FG003|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
127778555|NCT04572854|459817117|FG000|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
127778556|NCT04572854|459817118|FG001|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
127778557|NCT04572854|459817119|FG002|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|1|||
127778558|NCT04572854|459817120|FG003|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
127778559|NCT01093326|459817122|FG000|Overall Study|Death|0|||
127778560|NCT01093326|459817123|FG001|Overall Study|Death|1|||
127778561|NCT01093326|459817124|FG002|Overall Study|Death|0|||
127778562|NCT01093326|459817122|FG000|Overall Study|Lack of Efficacy|7|||
127778563|NCT01093326|459817123|FG001|Overall Study|Lack of Efficacy|6|||
127778564|NCT01093326|459817124|FG002|Overall Study|Lack of Efficacy|3|||
127778565|NCT01093326|459817122|FG000|Overall Study|Lost to Follow-up|2|||
127778566|NCT01093326|459817123|FG001|Overall Study|Lost to Follow-up|5|||
127778567|NCT01093326|459817124|FG002|Overall Study|Lost to Follow-up|4|||
127778568|NCT01093326|459817122|FG000|Overall Study|Physician Decision|3|||
127778569|NCT01093326|459817123|FG001|Overall Study|Physician Decision|1|||
127778570|NCT01093326|459817124|FG002|Overall Study|Physician Decision|3|||
127778571|NCT01093326|459817122|FG000|Overall Study|Withdrawal by Subject|30|||
127778572|NCT01093326|459817123|FG001|Overall Study|Withdrawal by Subject|27|||
127778573|NCT01093326|459817124|FG002|Overall Study|Withdrawal by Subject|26|||
127778574|NCT01093326|459817122|FG000|Overall Study|Adverse Event|2|||
127778575|NCT01093326|459817123|FG001|Overall Study|Adverse Event|1|||
127778576|NCT01093326|459817124|FG002|Overall Study|Adverse Event|4|||
127778577|NCT01093326|459817122|FG000|Overall Study|Other|0|||
127778578|NCT01093326|459817123|FG001|Overall Study|Other|0|||
127778579|NCT01093326|459817124|FG002|Overall Study|Other|1|||
127778580|NCT01444456|459817125|FG000|Overall Study|Withdrawal by Subject|21|||
127778581|NCT01444456|459817125|FG000|Overall Study|Physician Decision|9|||
127567957|NCT04658940|459048592|FG000|Overall Study|Withdrawal by Subject|1|||
127567958|NCT03579602|459048593|FG000|Overall Study|Subject unable to receive study drug|0|||
127567959|NCT03579602|459048594|FG001|Overall Study|Subject unable to receive study drug|2|||
127567960|NCT03579602|459048593|FG000|Overall Study|Subject did not complete all study visits as planned|0|||
127567961|NCT03579602|459048594|FG001|Overall Study|Subject did not complete all study visits as planned|1|||
127567962|NCT02518464|459048595|FG000|Overall Study|Adverse Event|2|||
127567963|NCT00604214|459048619|FG000|Baseline to Day 28|Death|223|||
127567964|NCT00604214|459048620|FG001|Baseline to Day 28|Death|202|||
127567965|NCT00604214|459048619|FG000|Baseline to Day 28|Lost to Follow-up|2|||
127567966|NCT00604214|459048620|FG001|Baseline to Day 28|Lost to Follow-up|4|||
127567967|NCT00604214|459048619|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
127567968|NCT00604214|459048620|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
127567969|NCT00604214|459048619|FG000|Day 29 to Day 90|Death|64|||
127567970|NCT00604214|459048620|FG001|Day 29 to Day 90|Death|67|||
127567971|NCT00604214|459048619|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
127567972|NCT00604214|459048620|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
127567973|NCT00604214|459048619|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
127567974|NCT00604214|459048620|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
127567975|NCT00604214|459048619|FG000|Day 91 to Day 180|Death|19|||
127567976|NCT00604214|459048620|FG001|Day 91 to Day 180|Death|23|||
127567977|NCT00604214|459048619|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
127567978|NCT00604214|459048620|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
127567979|NCT00604214|459048619|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
127567980|NCT00604214|459048620|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
127567981|NCT00130442|459050080|FG000|Overall Study|Withdrawal by Subject|0|||
127567982|NCT00130442|459050081|FG001|Overall Study|Withdrawal by Subject|1|||
127567983|NCT00130442|459050080|FG000|Overall Study|did not meet criteria|1|||
127567984|NCT00130442|459050081|FG001|Overall Study|did not meet criteria|1|||
127567985|NCT00814333|459050083|FG000|Enrollment|Lost to Follow-up|1|||
127567986|NCT00814333|459050084|FG001|Enrollment|Lost to Follow-up|0|||
127567987|NCT02233946|459050085|FG000|Baseline|Withdrawal by Subject|2|||
127567988|NCT02233946|459050086|FG001|Baseline|Withdrawal by Subject|0|||
127567989|NCT02233946|459050085|FG000|3-months Follow-up|Lost to Follow-up|53|||
127567990|NCT02233946|459050086|FG001|3-months Follow-up|Lost to Follow-up|29|||
127567991|NCT02233946|459050085|FG000|6-months Follow-up|Lost to Follow-up|21|||
127567992|NCT02233946|459050086|FG001|6-months Follow-up|Lost to Follow-up|2|||
127567993|NCT02233946|459050085|FG000|9-month Follow-up|Lost to Follow-up|20|||
127567994|NCT02233946|459050086|FG001|9-month Follow-up|Lost to Follow-up|11|||
127567995|NCT02233946|459050085|FG000|12-month Follow-up|Lost to Follow-up|28|||
127567996|NCT02233946|459050086|FG001|12-month Follow-up|Lost to Follow-up|11|||
127567997|NCT02927067|459050087|FG000|Overall Study|Withdrawn Consent|20|||
127567998|NCT02927067|459050088|FG001|Overall Study|Withdrawn Consent|12|||
127567999|NCT02927067|459050087|FG000|Overall Study|Death|18|||
127568000|NCT02927067|459050088|FG001|Overall Study|Death|31|||
127689987|NCT01000480|459490332|FG000|Induction Phase|Lost to Follow-up|1|||
127689988|NCT01000480|459490332|FG000|Induction Phase|Physician Decision|1|||
127689989|NCT01000480|459490332|FG000|Induction Phase|Entry Criteria Not Met|3|||
127689990|NCT01000480|459490332|FG000|Concurrent Therapy Phase|Adverse Event|4|||
127689991|NCT01000480|459490332|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
127689992|NCT01000480|459490332|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
127689993|NCT01000480|459490332|FG000|Concurrent Therapy Phase|Physician Decision|1|||
127689994|NCT00522951|459490340|FG000|Period 1|body motion|0|||
127689995|NCT00522951|459490341|FG001|Period 1|body motion|1|||
127689996|NCT00522951|459490340|FG000|Washout Period|Adverse Event|0|||
127689997|NCT00522951|459490341|FG001|Washout Period|Adverse Event|1|||
127689998|NCT00522951|459490340|FG000|Washout Period|Death|0|||
127689999|NCT00522951|459490341|FG001|Washout Period|Death|1|||
127690000|NCT00522951|459490340|FG000|Period 2|Withdrawal by Subject|1|||
127690001|NCT00522951|459490341|FG001|Period 2|Withdrawal by Subject|0|||
127690002|NCT00522951|459490340|FG000|Period 2|residual contrast medium|1|||
127690003|NCT00522951|459490341|FG001|Period 2|residual contrast medium|1|||
127690004|NCT01771731|459490342|FG000|Overall Study|Physician Decision|1|||
127690005|NCT01771731|459490343|FG001|Overall Study|Physician Decision|0|||
127690006|NCT01771731|459490342|FG000|Overall Study|Protocol Violation|0|||
127778582|NCT01444456|459817125|FG000|Overall Study|Lost to Follow-up|37|||
127690007|NCT01771731|459490343|FG001|Overall Study|Protocol Violation|1|||
127690008|NCT01771731|459490342|FG000|Overall Study|Adverse event: Pain Crisis|1|||
127690009|NCT01771731|459490343|FG001|Overall Study|Adverse event: Pain Crisis|1|||
127690010|NCT01747486|459490344|FG000|Stage 1|Physician Decision|3|||
127568001|NCT02927067|459050087|FG000|Overall Study|Adverse Event|13|||
127568002|NCT02927067|459050088|FG001|Overall Study|Adverse Event|10|||
127568003|NCT02927067|459050087|FG000|Overall Study|Noncompliance|5|||
127690011|NCT01747486|459490345|FG001|Stage 1|Physician Decision|0|||
127690012|NCT01747486|459490344|FG000|Stage 1|Withdrawal by Subject|4|||
127778583|NCT01444456|459817125|FG000|Overall Study|Death|73|||
127568004|NCT02927067|459050088|FG001|Overall Study|Noncompliance|2|||
127568005|NCT02927067|459050087|FG000|Overall Study|Reason not Specified|4|||
127568006|NCT02927067|459050088|FG001|Overall Study|Reason not Specified|6|||
127568007|NCT01727700|459050091|FG000|Overall Study|Adverse Event|0|||
127568008|NCT01727700|459050092|FG001|Overall Study|Adverse Event|7|||
127568009|NCT01727700|459050093|FG002|Overall Study|Adverse Event|1|||
127568010|NCT01727700|459050091|FG000|Overall Study|Particpant withdrew consent|0|||
127568011|NCT01727700|459050092|FG001|Overall Study|Particpant withdrew consent|3|||
127568012|NCT01727700|459050093|FG002|Overall Study|Particpant withdrew consent|1|||
127568013|NCT01727700|459050091|FG000|Overall Study|Protocol Violation|2|||
127568014|NCT01727700|459050092|FG001|Overall Study|Protocol Violation|0|||
127568015|NCT01727700|459050093|FG002|Overall Study|Protocol Violation|0|||
127690013|NCT01747486|459490345|FG001|Stage 1|Withdrawal by Subject|3|||
127690014|NCT01747486|459490344|FG000|Stage 1|Disease progression|4|||
127690015|NCT01747486|459490345|FG001|Stage 1|Disease progression|9|||
127690016|NCT01747486|459490344|FG000|Stage 1|Death|1|||
127690017|NCT01747486|459490345|FG001|Stage 1|Death|1|||
127690018|NCT01747486|459490344|FG000|Stage 2|Physician Decision|2|||
127690019|NCT01747486|459490345|FG001|Stage 2|Physician Decision|0|||
127690020|NCT01747486|459490344|FG000|Stage 2|Withdrawal by Subject|1|||
127690021|NCT01747486|459490345|FG001|Stage 2|Withdrawal by Subject|0|||
127690022|NCT01747486|459490344|FG000|Stage 2|New Cancer Therapy|3|||
127690023|NCT01747486|459490345|FG001|Stage 2|New Cancer Therapy|0|||
127690024|NCT01747486|459490344|FG000|Stage 2|Disease Progression|3|||
127690025|NCT01747486|459490345|FG001|Stage 2|Disease Progression|0|||
127690026|NCT00976495|459490346|FG000|Overall Study|Withdrawal by Subject|0|||
127690027|NCT00976495|459490347|FG001|Overall Study|Withdrawal by Subject|1|||
127690028|NCT00976495|459490348|FG002|Overall Study|Withdrawal by Subject|0|||
127690029|NCT00331136|459490349|FG000|Overall Study|Adverse Event|3|||
127690030|NCT00331136|459490350|FG001|Overall Study|Adverse Event|5|||
127690031|NCT00331136|459490351|FG002|Overall Study|Adverse Event|0|||
127690032|NCT00331136|459490352|FG003|Overall Study|Adverse Event|1|||
127690033|NCT00331136|459490349|FG000|Overall Study|Withdrawal by Subject|0|||
127690034|NCT00331136|459490350|FG001|Overall Study|Withdrawal by Subject|1|||
127690035|NCT00331136|459490351|FG002|Overall Study|Withdrawal by Subject|0|||
127690036|NCT00331136|459490352|FG003|Overall Study|Withdrawal by Subject|0|||
127690037|NCT00331136|459490349|FG000|Overall Study|Lost to Follow-up|0|||
127690038|NCT00331136|459490350|FG001|Overall Study|Lost to Follow-up|1|||
127690039|NCT00331136|459490351|FG002|Overall Study|Lost to Follow-up|0|||
127690040|NCT00331136|459490352|FG003|Overall Study|Lost to Follow-up|0|||
127690041|NCT00331136|459490349|FG000|Overall Study|Protocol Violation|1|||
127690042|NCT00331136|459490350|FG001|Overall Study|Protocol Violation|0|||
127690043|NCT00331136|459490351|FG002|Overall Study|Protocol Violation|0|||
127690044|NCT00331136|459490352|FG003|Overall Study|Protocol Violation|0|||
127690045|NCT00331136|459490349|FG000|Overall Study|Not treated|1|||
127690046|NCT00331136|459490350|FG001|Overall Study|Not treated|0|||
127690047|NCT00331136|459490351|FG002|Overall Study|Not treated|0|||
127690048|NCT00331136|459490352|FG003|Overall Study|Not treated|0|||
127690049|NCT02321514|459490353|FG000|Overall Study|Death|15|||
127690050|NCT02321514|459490353|FG000|Overall Study|Missed Visit|7|||
127690051|NCT02321514|459490353|FG000|Overall Study|Study Exit|3|||
127690052|NCT04484935|459490356|FG000|Overall Study|Other|0|||
127690053|NCT04484935|459490357|FG001|Overall Study|Other|1|||
127690054|NCT04484935|459490356|FG000|Overall Study|Withdrawal by parent/guardian|0|||
127690055|NCT04484935|459490357|FG001|Overall Study|Withdrawal by parent/guardian|1|||
127690056|NCT04484935|459490356|FG000|Overall Study|Lost to Follow-up|1|||
127690057|NCT04484935|459490357|FG001|Overall Study|Lost to Follow-up|0|||
127690058|NCT04484935|459490356|FG000|Overall Study|Death|2|||
127690059|NCT04484935|459490357|FG001|Overall Study|Death|1|||
127690060|NCT03432858|459490358|FG000|Overall Study|Protocol Violation|2|||
127690061|NCT03432858|459490359|FG001|Overall Study|Protocol Violation|1|||
127690062|NCT03432858|459490360|FG002|Overall Study|Protocol Violation|9|||
127690063|NCT03432858|459490358|FG000|Overall Study|Withdrawal by Subject|0|||
127690064|NCT03432858|459490359|FG001|Overall Study|Withdrawal by Subject|1|||
127690065|NCT03432858|459490360|FG002|Overall Study|Withdrawal by Subject|1|||
127690066|NCT03432858|459490358|FG000|Overall Study|Procedure canceled/rescheduled|0|||
127690067|NCT03432858|459490359|FG001|Overall Study|Procedure canceled/rescheduled|9|||
127690068|NCT03432858|459490360|FG002|Overall Study|Procedure canceled/rescheduled|6|||
127690069|NCT03432858|459490358|FG000|Overall Study|Required postop mobilization with splinting|0|||
127690070|NCT03432858|459490359|FG001|Overall Study|Required postop mobilization with splinting|0|||
127690071|NCT03432858|459490360|FG002|Overall Study|Required postop mobilization with splinting|1|||
127690072|NCT01094184|459490364|FG000|Overall Study|Death|35|||
127690073|NCT01094184|459490365|FG001|Overall Study|Death|11|||
127690074|NCT03892564|459490366|FG000|Overall Study|Withdrawal by Subject|2|||
127690075|NCT01216176|459492219|FG000|Overall Study|Adverse Event|0|||
127568016|NCT01757691|459050097|FG000|Overall Study|Administrative problems|2|||
127568017|NCT01757691|459050098|FG001|Overall Study|Administrative problems|0|||
127690076|NCT01216176|459492220|FG001|Overall Study|Adverse Event|8|||
127690077|NCT01216176|459492221|FG002|Overall Study|Adverse Event|0|||
127690078|NCT01216176|459492219|FG000|Overall Study|Physician Decision|0|||
127568018|NCT02054481|459050101|FG000|Overall Study|Adverse Event|1|||
127568019|NCT02054481|459050102|FG001|Overall Study|Adverse Event|1|||
127568020|NCT02054481|459050103|FG002|Overall Study|Adverse Event|0|||
127568021|NCT02054481|459050104|FG003|Overall Study|Adverse Event|1|||
127568022|NCT02054481|459050101|FG000|Overall Study|Lost to Follow-up|1|||
127568023|NCT02054481|459050102|FG001|Overall Study|Lost to Follow-up|0|||
127568024|NCT02054481|459050103|FG002|Overall Study|Lost to Follow-up|0|||
127568025|NCT02054481|459050104|FG003|Overall Study|Lost to Follow-up|0|||
127568026|NCT02054481|459050101|FG000|Overall Study|Other reason|2|||
127568027|NCT02054481|459050102|FG001|Overall Study|Other reason|1|||
127568028|NCT02054481|459050103|FG002|Overall Study|Other reason|2|||
127568029|NCT02054481|459050104|FG003|Overall Study|Other reason|0|||
127568030|NCT00773383|459050105|FG000|Overall Study|Adverse Event|4|||
127568031|NCT00773383|459050105|FG000|Overall Study|Death|1|||
127568032|NCT00773383|459050105|FG000|Overall Study|Progression of Disease|23|||
127568033|NCT00773383|459050105|FG000|Overall Study|Other|2|||
127568034|NCT00773383|459050105|FG000|Overall Study|No study dose received|1|||
127568035|NCT03384693|459050106|FG000|Overall Study|Adverse Event|3|||
127568036|NCT02919969|459050107|FG000|Overall Study|Lack of Efficacy|22|||
127568037|NCT02919969|459050107|FG000|Overall Study|Death|4|||
127568038|NCT02919969|459050107|FG000|Overall Study|Physician Decision|3|||
127568039|NCT02919969|459050107|FG000|Overall Study|Withdrawal by Subject|2|||
127568040|NCT03621475|459050108|FG000|Overall Study|No longer required restraints at initiation|0|||
127568041|NCT03621475|459050109|FG001|Overall Study|No longer required restraints at initiation|1|||
127568042|NCT01842633|459050110|FG000|Overall Study|Screen Failure|1|||
127568043|NCT01842633|459050111|FG001|Overall Study|Screen Failure|0|||
127568044|NCT01842633|459050112|FG002|Overall Study|Screen Failure|0|||
127568045|NCT01842633|459050110|FG000|Overall Study|Adverse Event|1|||
127568046|NCT01842633|459050111|FG001|Overall Study|Adverse Event|1|||
127690079|NCT01216176|459492220|FG001|Overall Study|Physician Decision|0|||
127690080|NCT01216176|459492221|FG002|Overall Study|Physician Decision|1|||
127690081|NCT03398148|459492224|FG000|Substudy 1 Period 1|Adverse Event|5|||
127690082|NCT03398148|459492225|FG001|Substudy 1 Period 1|Adverse Event|2|||
127690083|NCT03398148|459492226|FG002|Substudy 1 Period 1|Adverse Event|2|||
127690084|NCT03398148|459492227|FG003|Substudy 1 Period 1|Adverse Event|0|||
127690085|NCT03398148|459492228|FG004|Substudy 1 Period 1|Adverse Event|8|||
127690086|NCT03398148|459492229|FG005|Substudy 1 Period 1|Adverse Event|0|||
127690087|NCT03398148|459492230|FG006|Substudy 1 Period 1|Adverse Event|0|||
127690088|NCT03398148|459492231|FG007|Substudy 1 Period 1|Adverse Event|0|||
127690089|NCT03398148|459492232|FG008|Substudy 1 Period 1|Adverse Event|0|||
127690090|NCT03398148|459492233|FG009|Substudy 1 Period 1|Adverse Event|0|||
127690091|NCT03398148|459492234|FG010|Substudy 1 Period 1|Adverse Event|0|||
127690092|NCT03398148|459492235|FG011|Substudy 1 Period 1|Adverse Event|0|||
127690093|NCT03398148|459492236|FG012|Substudy 1 Period 1|Adverse Event|0|||
127690094|NCT03398148|459492237|FG013|Substudy 1 Period 1|Adverse Event|0|||
127690095|NCT03398148|459492238|FG014|Substudy 1 Period 1|Adverse Event|0|||
127690096|NCT03398148|459492224|FG000|Substudy 1 Period 1|WITHDREW CONSENT|1|||
127690097|NCT03398148|459492225|FG001|Substudy 1 Period 1|WITHDREW CONSENT|2|||
127690098|NCT03398148|459492226|FG002|Substudy 1 Period 1|WITHDREW CONSENT|0|||
127690099|NCT03398148|459492227|FG003|Substudy 1 Period 1|WITHDREW CONSENT|1|||
127690100|NCT03398148|459492228|FG004|Substudy 1 Period 1|WITHDREW CONSENT|3|||
127690101|NCT03398148|459492229|FG005|Substudy 1 Period 1|WITHDREW CONSENT|0|||
127690102|NCT03398148|459492230|FG006|Substudy 1 Period 1|WITHDREW CONSENT|0|||
127690103|NCT03398148|459492231|FG007|Substudy 1 Period 1|WITHDREW CONSENT|0|||
127690104|NCT03398148|459492232|FG008|Substudy 1 Period 1|WITHDREW CONSENT|0|||
127690105|NCT03398148|459492233|FG009|Substudy 1 Period 1|WITHDREW CONSENT|0|||
127690106|NCT03398148|459492234|FG010|Substudy 1 Period 1|WITHDREW CONSENT|0|||
127690107|NCT03398148|459492235|FG011|Substudy 1 Period 1|WITHDREW CONSENT|0|||
127690108|NCT03398148|459492236|FG012|Substudy 1 Period 1|WITHDREW CONSENT|0|||
127690109|NCT03398148|459492237|FG013|Substudy 1 Period 1|WITHDREW CONSENT|0|||
127690110|NCT03398148|459492238|FG014|Substudy 1 Period 1|WITHDREW CONSENT|0|||
127690111|NCT03398148|459492224|FG000|Substudy 1 Period 1|Lack of Efficacy|1|||
127690112|NCT03398148|459492225|FG001|Substudy 1 Period 1|Lack of Efficacy|1|||
127690113|NCT03398148|459492226|FG002|Substudy 1 Period 1|Lack of Efficacy|1|||
127690114|NCT03398148|459492227|FG003|Substudy 1 Period 1|Lack of Efficacy|0|||
127690115|NCT03398148|459492228|FG004|Substudy 1 Period 1|Lack of Efficacy|20|||
127690116|NCT03398148|459492229|FG005|Substudy 1 Period 1|Lack of Efficacy|0|||
127690117|NCT03398148|459492230|FG006|Substudy 1 Period 1|Lack of Efficacy|0|||
127690118|NCT03398148|459492231|FG007|Substudy 1 Period 1|Lack of Efficacy|0|||
127690119|NCT03398148|459492232|FG008|Substudy 1 Period 1|Lack of Efficacy|0|||
127690120|NCT03398148|459492233|FG009|Substudy 1 Period 1|Lack of Efficacy|0|||
127568047|NCT01842633|459050112|FG002|Overall Study|Adverse Event|0|||
127568048|NCT01842633|459050110|FG000|Overall Study|Withdrawal by Subject|0|||
127568049|NCT01842633|459050111|FG001|Overall Study|Withdrawal by Subject|1|||
127568050|NCT01842633|459050112|FG002|Overall Study|Withdrawal by Subject|0|||
127568051|NCT01842633|459050110|FG000|Overall Study|Technical issues|1|||
127568052|NCT01842633|459050111|FG001|Overall Study|Technical issues|0|||
127568053|NCT01842633|459050112|FG002|Overall Study|Technical issues|0|||
127568054|NCT01095094|459050114|FG000|Overall Study|Withdrawal by Subject|1|||
127568055|NCT01095094|459050114|FG000|Overall Study|Death|1|||
127568056|NCT01095094|459050114|FG000|Overall Study|Physician Decision|1|||
127568057|NCT05347147|459050115|FG000|Overall Study|Lost to Follow-up|0|||
127568058|NCT05347147|459050116|FG001|Overall Study|Lost to Follow-up|1|||
127568059|NCT05347147|459050115|FG000|Overall Study|Sponsor request|3|||
127568060|NCT05347147|459050116|FG001|Overall Study|Sponsor request|3|||
127568061|NCT05347147|459050115|FG000|Overall Study|Study termination|2|||
127568062|NCT05347147|459050116|FG001|Overall Study|Study termination|1|||
127568063|NCT02093351|459050117|FG000|Part A|Adverse Event|0|||
127568064|NCT02093351|459050118|FG001|Part A|Adverse Event|1|||
127568065|NCT02093351|459050119|FG002|Part A|Adverse Event|1|||
127568066|NCT02093351|459050120|FG003|Part A|Adverse Event|0|||
127568067|NCT02093351|459050117|FG000|Part A|Condition under investigation worsened|2|||
127568068|NCT02093351|459050118|FG001|Part A|Condition under investigation worsened|0|||
127568069|NCT02093351|459050119|FG002|Part A|Condition under investigation worsened|2|||
127568070|NCT02093351|459050120|FG003|Part A|Condition under investigation worsened|0|||
127568071|NCT02093351|459050117|FG000|Part A|Death|0|||
127568072|NCT02093351|459050118|FG001|Part A|Death|1|||
127568073|NCT02093351|459050119|FG002|Part A|Death|0|||
127568074|NCT02093351|459050120|FG003|Part A|Death|0|||
127568075|NCT02093351|459050117|FG000|Part B|Patient decision|0|||
127568076|NCT02093351|459050118|FG001|Part B|Patient decision|0|||
127568077|NCT02093351|459050119|FG002|Part B|Patient decision|0|||
127568078|NCT02093351|459050120|FG003|Part B|Patient decision|3|||
127568079|NCT02093351|459050117|FG000|Part B|Disease progression|0|||
127568080|NCT02093351|459050118|FG001|Part B|Disease progression|0|||
127568081|NCT02093351|459050119|FG002|Part B|Disease progression|0|||
127568082|NCT02093351|459050120|FG003|Part B|Disease progression|4|||
127568083|NCT02093351|459050117|FG000|Part B|Complete response|0|||
127568084|NCT02093351|459050118|FG001|Part B|Complete response|0|||
127568085|NCT02093351|459050119|FG002|Part B|Complete response|0|||
127568086|NCT02093351|459050120|FG003|Part B|Complete response|1|||
127568087|NCT02093351|459050117|FG000|Part B|Adverse event + disease progression|0|||
127568088|NCT02093351|459050118|FG001|Part B|Adverse event + disease progression|0|||
127568089|NCT02093351|459050119|FG002|Part B|Adverse event + disease progression|0|||
127568090|NCT02093351|459050120|FG003|Part B|Adverse event + disease progression|1|||
127568091|NCT02093351|459050117|FG000|Part B|Lack of therapeutic response|0|||
127568092|NCT02093351|459050118|FG001|Part B|Lack of therapeutic response|0|||
127568093|NCT02093351|459050119|FG002|Part B|Lack of therapeutic response|0|||
127568094|NCT02093351|459050120|FG003|Part B|Lack of therapeutic response|12|||
127568095|NCT02093351|459050117|FG000|Part B|Condition under investigation worsened|0|||
127568096|NCT02093351|459050118|FG001|Part B|Condition under investigation worsened|0|||
127568097|NCT02093351|459050119|FG002|Part B|Condition under investigation worsened|0|||
127568098|NCT02093351|459050120|FG003|Part B|Condition under investigation worsened|39|||
127568099|NCT02093351|459050117|FG000|Part B|Adverse Event|0|||
127568100|NCT02093351|459050118|FG001|Part B|Adverse Event|0|||
127568101|NCT02093351|459050119|FG002|Part B|Adverse Event|0|||
127568102|NCT02093351|459050120|FG003|Part B|Adverse Event|2|||
127690121|NCT03398148|459492234|FG010|Substudy 1 Period 1|Lack of Efficacy|0|||
127690122|NCT03398148|459492235|FG011|Substudy 1 Period 1|Lack of Efficacy|0|||
127690123|NCT03398148|459492236|FG012|Substudy 1 Period 1|Lack of Efficacy|0|||
127690124|NCT03398148|459492237|FG013|Substudy 1 Period 1|Lack of Efficacy|0|||
127690125|NCT03398148|459492238|FG014|Substudy 1 Period 1|Lack of Efficacy|0|||
127690126|NCT03398148|459492224|FG000|Substudy 1 Period 1|Other|0|||
127568103|NCT02093351|459050117|FG000|Part B|Death|0|||
127568104|NCT02093351|459050118|FG001|Part B|Death|0|||
127568105|NCT02093351|459050119|FG002|Part B|Death|0|||
127568106|NCT02093351|459050120|FG003|Part B|Death|1|||
127568107|NCT02446743|459050121|FG000|Overall Study|Withdrawal by Subject|1|||
127568108|NCT02446743|459050122|FG001|Overall Study|Withdrawal by Subject|1|||
127568109|NCT02446743|459050121|FG000|Overall Study|Lost to Follow-up|1|||
127568110|NCT02446743|459050122|FG001|Overall Study|Lost to Follow-up|0|||
127568111|NCT02446743|459050121|FG000|Overall Study|Adverse Event|1|||
127568112|NCT02446743|459050122|FG001|Overall Study|Adverse Event|1|||
127568113|NCT02446743|459050121|FG000|Overall Study|Other|2|||
127568114|NCT02446743|459050122|FG001|Overall Study|Other|3|||
127568115|NCT03718299|459050123|FG000|Overall Study|Adverse Event|1|||
127568116|NCT03718299|459050123|FG000|Overall Study|Withdrawal by Subject|6|||
127568117|NCT03718299|459050123|FG000|Overall Study|Physician Decision|2|||
127568118|NCT03718299|459050123|FG000|Overall Study|Lost to Follow-up|1|||
127568119|NCT04535167|459050126|FG000|Treatment|Adverse Event|0|||
127568120|NCT04535167|459050127|FG001|Treatment|Adverse Event|0|||
127568121|NCT04535167|459050128|FG002|Treatment|Adverse Event|0|||
127778584|NCT01444456|459817125|FG000|Overall Study|Ineligibility determined|23|||
127778585|NCT01444456|459817125|FG000|Overall Study|Other|18|||
127778586|NCT01444456|459817125|FG000|Overall Study|Not treated|104|||
127778587|NCT04263896|459817126|FG000|Overall Study|Withdrawal by Subject|2|||
127778588|NCT04263896|459817127|FG001|Overall Study|Withdrawal by Subject|4|||
127778589|NCT04263896|459817126|FG000|Overall Study|converted to open procedure|0|||
127778590|NCT04263896|459817127|FG001|Overall Study|converted to open procedure|1|||
127778591|NCT04263896|459817126|FG000|Overall Study|Lost to Follow-up|9|||
127778592|NCT04263896|459817127|FG001|Overall Study|Lost to Follow-up|11|||
127778593|NCT04263896|459817126|FG000|Overall Study|surveys lost in mail|5|||
127778594|NCT04263896|459817127|FG001|Overall Study|surveys lost in mail|3|||
127778595|NCT04263896|459817126|FG000|Overall Study|excluded from analysis|1|||
127778596|NCT04263896|459817127|FG001|Overall Study|excluded from analysis|0|||
127778597|NCT01016964|459818655|FG000|Overall Study|Lost to Follow-up|3|||
127778598|NCT01016964|459818656|FG001|Overall Study|Lost to Follow-up|3|||
127778599|NCT01920594|459818657|FG000|Overall Study|Adverse Event|4|||
127778600|NCT01920594|459818658|FG001|Overall Study|Adverse Event|2|||
127778601|NCT01920594|459818657|FG000|Overall Study|Lost to Follow-up|1|||
127778602|NCT01920594|459818658|FG001|Overall Study|Lost to Follow-up|0|||
127778603|NCT01920594|459818657|FG000|Overall Study|Recovery|2|||
127778604|NCT01920594|459818658|FG001|Overall Study|Recovery|0|||
127778605|NCT01920594|459818657|FG000|Overall Study|Investigator discretion|0|||
127778606|NCT01920594|459818658|FG001|Overall Study|Investigator discretion|1|||
127778607|NCT00928564|459818659|FG000|Overall Study|Lost to Follow-up|6|||
127778608|NCT00928564|459818660|FG001|Overall Study|Lost to Follow-up|0|||
127778609|NCT02615470|459818661|FG000|Overall Study|Lost to Follow-up|21|||
127778610|NCT02615470|459818662|FG001|Overall Study|Lost to Follow-up|32|||
127778611|NCT01650285|459818665|FG000|Overall Study|Adverse Event|1|||
127778612|NCT04163900|459818672|FG000|Overall Study|Radiological disease progression|112|||
127778613|NCT04163900|459818673|FG001|Overall Study|Radiological disease progression|127|||
127778614|NCT04163900|459818672|FG000|Overall Study|Study closure|98|||
127778615|NCT04163900|459818673|FG001|Overall Study|Study closure|133|||
127778616|NCT04163900|459818672|FG000|Overall Study|Adverse Event|78|||
127778617|NCT04163900|459818673|FG001|Overall Study|Adverse Event|32|||
127778618|NCT04163900|459818672|FG000|Overall Study|Withdrawal by Subject|37|||
127778619|NCT04163900|459818673|FG001|Overall Study|Withdrawal by Subject|34|||
127778620|NCT04163900|459818672|FG000|Overall Study|Death|29|||
127778621|NCT04163900|459818673|FG001|Overall Study|Death|16|||
127778622|NCT04163900|459818672|FG000|Overall Study|Physician Decision|17|||
127778623|NCT04163900|459818673|FG001|Overall Study|Physician Decision|25|||
127778624|NCT04163900|459818672|FG000|Overall Study|Clinical disease progression|14|||
127778625|NCT04163900|459818673|FG001|Overall Study|Clinical disease progression|13|||
127778626|NCT04163900|459818672|FG000|Overall Study|Protocol Violation|3|||
127778627|NCT04163900|459818673|FG001|Overall Study|Protocol Violation|4|||
127778628|NCT04163900|459818672|FG000|Overall Study|Lost to Follow-up|0|||
127778629|NCT04163900|459818673|FG001|Overall Study|Lost to Follow-up|1|||
127778630|NCT00785044|459818674|FG000|Overall Study|Dosed at non-participating sites|152|||
127778631|NCT00785044|459818674|FG000|Overall Study|Death|77|||
127778632|NCT00785044|459818674|FG000|Overall Study|Lost to Follow-up|266|||
127778633|NCT00785044|459818674|FG000|Overall Study|Withdrawal by Subject|1|||
127778634|NCT01830855|459818675|FG000|Overall Study|Other|7|||
127778635|NCT01830855|459818676|FG001|Overall Study|Other|1|||
127778636|NCT01830855|459818677|FG002|Overall Study|Other|4|||
127778637|NCT01830855|459818678|FG003|Overall Study|Other|4|||
127568122|NCT04535167|459050129|FG003|Treatment|Adverse Event|0|||
127778638|NCT01830855|459818675|FG000|Overall Study|Medication error without associated AE|1|||
127778639|NCT01830855|459818676|FG001|Overall Study|Medication error without associated AE|0|||
127778640|NCT01830855|459818677|FG002|Overall Study|Medication error without associated AE|0|||
127778641|NCT01830855|459818678|FG003|Overall Study|Medication error without associated AE|1|||
127778642|NCT01830855|459818675|FG000|Overall Study|Pregnancy|3|||
128026686|NCT03537729|460722156|FG001|Overall Study|Investigator determined not in best interest for subject to continue|0|||
128026687|NCT03537729|460722157|FG002|Overall Study|Investigator determined not in best interest for subject to continue|0|||
128026688|NCT03537729|460722155|FG000|Overall Study|COVID-19 Site Restrictions|11|||
128026689|NCT03537729|460722156|FG001|Overall Study|COVID-19 Site Restrictions|15|||
127778643|NCT01830855|459818676|FG001|Overall Study|Pregnancy|1|||
127778644|NCT01830855|459818677|FG002|Overall Study|Pregnancy|2|||
127778645|NCT01830855|459818678|FG003|Overall Study|Pregnancy|1|||
127778646|NCT01830855|459818675|FG000|Overall Study|No longer meets eligibility criteria|11|||
127568123|NCT04535167|459050130|FG004|Treatment|Adverse Event|0|||
127568124|NCT04535167|459050131|FG005|Treatment|Adverse Event|0|||
127778647|NCT01830855|459818676|FG001|Overall Study|No longer meets eligibility criteria|2|||
127778648|NCT01830855|459818677|FG002|Overall Study|No longer meets eligibility criteria|3|||
127778649|NCT01830855|459818678|FG003|Overall Study|No longer meets eligibility criteria|5|||
127778650|NCT01830855|459818675|FG000|Overall Study|Adverse Event|11|||
127778651|NCT01830855|459818676|FG001|Overall Study|Adverse Event|5|||
127778652|NCT01830855|459818677|FG002|Overall Study|Adverse Event|6|||
127778653|NCT01830855|459818678|FG003|Overall Study|Adverse Event|3|||
127568125|NCT04535167|459050132|FG006|Treatment|Adverse Event|1|||
127568126|NCT04535167|459050126|FG000|Follow-Up|Death|0|||
127568127|NCT04535167|459050127|FG001|Follow-Up|Death|0|||
127568128|NCT04535167|459050128|FG002|Follow-Up|Death|0|||
127568129|NCT04535167|459050129|FG003|Follow-Up|Death|0|||
127568130|NCT04535167|459050130|FG004|Follow-Up|Death|0|||
127568131|NCT04535167|459050131|FG005|Follow-Up|Death|0|||
127568132|NCT04535167|459050132|FG006|Follow-Up|Death|1|||
127568133|NCT04535167|459050126|FG000|Follow-Up|Lost to Follow-up|0|||
127568134|NCT04535167|459050127|FG001|Follow-Up|Lost to Follow-up|0|||
127568135|NCT04535167|459050128|FG002|Follow-Up|Lost to Follow-up|0|||
127568136|NCT04535167|459050129|FG003|Follow-Up|Lost to Follow-up|1|||
127568137|NCT04535167|459050130|FG004|Follow-Up|Lost to Follow-up|0|||
127568138|NCT04535167|459050131|FG005|Follow-Up|Lost to Follow-up|0|||
127568139|NCT04535167|459050132|FG006|Follow-Up|Lost to Follow-up|0|||
127568140|NCT04972630|459050134|FG000|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
127568141|NCT04972630|459050135|FG001|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
127568142|NCT04972630|459050136|FG002|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|0|||
127568143|NCT00075270|459050137|FG000|Overall Study|Withdrawal by Subject|28|||
127568144|NCT00075270|459050138|FG001|Overall Study|Withdrawal by Subject|21|||
127568145|NCT00075270|459050137|FG000|Overall Study|Lost to Follow-up|25|||
127568146|NCT00075270|459050138|FG001|Overall Study|Lost to Follow-up|28|||
127568147|NCT00075270|459050137|FG000|Overall Study|Protocol Violation|0|||
127568148|NCT00075270|459050138|FG001|Overall Study|Protocol Violation|2|||
127568149|NCT00075270|459050137|FG000|Overall Study|Death|198|||
127568150|NCT00075270|459050138|FG001|Overall Study|Death|215|||
127568151|NCT00075270|459050137|FG000|Overall Study|Other/Unknown|9|||
127568152|NCT00075270|459050138|FG001|Overall Study|Other/Unknown|5|||
127568153|NCT00075270|459050137|FG000|Overall Study|Missing|26|||
127568154|NCT00075270|459050138|FG001|Overall Study|Missing|13|||
127568155|NCT04656275|459050142|FG000|Overall Study|Study terminated by sponsor|2|||
127568156|NCT04656275|459050143|FG001|Overall Study|Study terminated by sponsor|4|||
127568157|NCT01129024|459050150|FG000|Overall Study|Physician Decision|5|||
127568158|NCT01129024|459050150|FG000|Overall Study|Study Terminated by Sponsor|8|||
127568159|NCT01129024|459050150|FG000|Overall Study|Withdrawal by Subject|2|||
127568160|NCT01129024|459050150|FG000|Overall Study|Lack of Efficacy|3|||
127568161|NCT01129024|459050150|FG000|Overall Study|Needed a Platelet Transfusion|1|||
127568162|NCT00686634|459050156|FG000|Overall Study|Protocol Violation|6|||
127568163|NCT02361580|459050159|FG000|Overall Study|Lost to Follow-up|6|||
127568164|NCT02361580|459050160|FG001|Overall Study|Lost to Follow-up|3|||
127568165|NCT00924781|459050161|FG000|Overall Study|Study terminated by sponsor|12|||
127568166|NCT00924781|459050162|FG001|Overall Study|Study terminated by sponsor|10|||
127568167|NCT00708201|459050163|FG000|Overall Study|Adverse Event|4|||
127568168|NCT00708201|459050164|FG001|Overall Study|Adverse Event|4|||
127568169|NCT00708201|459050163|FG000|Overall Study|Withdrawal by Subject|1|||
127568170|NCT00708201|459050164|FG001|Overall Study|Withdrawal by Subject|1|||
127568171|NCT00708201|459050163|FG000|Overall Study|Lost to Follow-up|2|||
127568172|NCT00708201|459050164|FG001|Overall Study|Lost to Follow-up|0|||
127568173|NCT00708201|459050163|FG000|Overall Study|Protocol Violation|0|||
128026690|NCT03537729|460722157|FG002|Overall Study|COVID-19 Site Restrictions|18|||
128026691|NCT03537729|460722155|FG000|Overall Study|Decline in Health|5|||
128026692|NCT03537729|460722156|FG001|Overall Study|Decline in Health|9|||
128026693|NCT03537729|460722157|FG002|Overall Study|Decline in Health|4|||
128026694|NCT03537729|460722155|FG000|Overall Study|Determined Ineligible|0|||
128026695|NCT03537729|460722156|FG001|Overall Study|Determined Ineligible|0|||
127568174|NCT00708201|459050164|FG001|Overall Study|Protocol Violation|1|||
127568175|NCT01653132|459050165|FG000|First Intervention|Protocol Violation|1|||
127568176|NCT01653132|459050166|FG001|First Intervention|Protocol Violation|0|||
127568177|NCT03828370|459050167|FG000|3 Month Follow-up|Lost to Follow-up|4|||
127568178|NCT03828370|459050168|FG001|3 Month Follow-up|Lost to Follow-up|12|||
127568179|NCT03828370|459050167|FG000|9 Month Follow up|Lost to Follow-up|12|||
127690127|NCT03398148|459492225|FG001|Substudy 1 Period 1|Other|1|||
127690128|NCT03398148|459492226|FG002|Substudy 1 Period 1|Other|0|||
127690129|NCT03398148|459492227|FG003|Substudy 1 Period 1|Other|0|||
127690130|NCT03398148|459492228|FG004|Substudy 1 Period 1|Other|3|||
127690131|NCT03398148|459492229|FG005|Substudy 1 Period 1|Other|0|||
127690132|NCT03398148|459492230|FG006|Substudy 1 Period 1|Other|0|||
127690133|NCT03398148|459492231|FG007|Substudy 1 Period 1|Other|0|||
127690134|NCT03398148|459492232|FG008|Substudy 1 Period 1|Other|0|||
127690135|NCT03398148|459492233|FG009|Substudy 1 Period 1|Other|0|||
127690136|NCT03398148|459492234|FG010|Substudy 1 Period 1|Other|0|||
127690137|NCT03398148|459492235|FG011|Substudy 1 Period 1|Other|0|||
127690138|NCT03398148|459492236|FG012|Substudy 1 Period 1|Other|0|||
127568180|NCT03828370|459050168|FG001|9 Month Follow up|Lost to Follow-up|20|||
127568181|NCT02677324|459050169|FG000|Overall Study|Disease Progression|6|||
127568182|NCT02677324|459050169|FG000|Overall Study|Inability to Swallow pills|1|||
127568183|NCT02677324|459050169|FG000|Overall Study|Non-compliance|1|||
127690139|NCT03398148|459492237|FG013|Substudy 1 Period 1|Other|0|||
127568184|NCT02677324|459050169|FG000|Overall Study|Lack of Efficacy|1|||
127690140|NCT03398148|459492238|FG014|Substudy 1 Period 1|Other|0|||
127568185|NCT02677324|459050169|FG000|Overall Study|Medical insurance coverage|1|||
127568186|NCT02677324|459050169|FG000|Overall Study|Adverse Event|1|||
127568187|NCT02677324|459050169|FG000|Overall Study|IgM Myeloma diagnosis|1|||
127568188|NCT03312751|459050172|FG000|Overall Study|Death|7|||
127778654|NCT01830855|459818675|FG000|Overall Study|Protocol deviation|10|||
127778655|NCT01830855|459818676|FG001|Overall Study|Protocol deviation|5|||
127778656|NCT01830855|459818677|FG002|Overall Study|Protocol deviation|6|||
127778657|NCT01830855|459818678|FG003|Overall Study|Protocol deviation|6|||
127778658|NCT01830855|459818675|FG000|Overall Study|Withdrawal by Subject|33|||
127778659|NCT01830855|459818676|FG001|Overall Study|Withdrawal by Subject|14|||
127778660|NCT01830855|459818677|FG002|Overall Study|Withdrawal by Subject|10|||
127778661|NCT01830855|459818678|FG003|Overall Study|Withdrawal by Subject|12|||
127778662|NCT01830855|459818675|FG000|Overall Study|No longer willing to participate|32|||
127778663|NCT01830855|459818676|FG001|Overall Study|No longer willing to participate|13|||
127778664|NCT01830855|459818677|FG002|Overall Study|No longer willing to participate|12|||
127778665|NCT01830855|459818678|FG003|Overall Study|No longer willing to participate|17|||
127778666|NCT01830855|459818675|FG000|Overall Study|Lost to Follow-up|47|||
127778667|NCT01830855|459818676|FG001|Overall Study|Lost to Follow-up|20|||
127778668|NCT01830855|459818677|FG002|Overall Study|Lost to Follow-up|23|||
127778669|NCT01830855|459818678|FG003|Overall Study|Lost to Follow-up|33|||
127778670|NCT01667081|459818679|FG000|Overall Study|Death|43|||
127778671|NCT01667081|459818680|FG001|Overall Study|Death|3|||
127778672|NCT01667081|459818679|FG000|Overall Study|Lost to Follow-up|99|||
127778673|NCT01667081|459818680|FG001|Overall Study|Lost to Follow-up|48|||
127778674|NCT01667081|459818679|FG000|Overall Study|Physician Decision|16|||
127778675|NCT01667081|459818680|FG001|Overall Study|Physician Decision|2|||
127778676|NCT01667081|459818679|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
127778677|NCT01667081|459818680|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
127778678|NCT01667081|459818679|FG000|Overall Study|Withdrawal by Subject|90|||
127568189|NCT03312751|459050173|FG001|Overall Study|Death|9|||
127568190|NCT03312751|459050172|FG000|Overall Study|Study discontinuation due to other reason|0|||
127568191|NCT03312751|459050173|FG001|Overall Study|Study discontinuation due to other reason|1|||
127568192|NCT03490981|459050174|FG000|Overall Study|Lost to Follow-up|1|||
127568193|NCT03490981|459050175|FG001|Overall Study|Lost to Follow-up|2|||
127568194|NCT00282464|459050182|FG000|Overall Study|Adverse Event|26|||
127568195|NCT00282464|459050183|FG001|Overall Study|Adverse Event|20|||
127568196|NCT00282464|459050182|FG000|Overall Study|Lack of Efficacy|8|||
127568197|NCT00282464|459050183|FG001|Overall Study|Lack of Efficacy|8|||
127568198|NCT00282464|459050182|FG000|Overall Study|Lost to Follow-up|10|||
127778679|NCT01667081|459818680|FG001|Overall Study|Withdrawal by Subject|35|||
127778680|NCT03523728|459818681|FG000|Stage 1 (24 Months)|Adverse Event|2|||
127778681|NCT03523728|459818682|FG001|Stage 1 (24 Months)|Adverse Event|2|||
127778682|NCT03523728|459818683|FG002|Stage 1 (24 Months)|Adverse Event|4|||
127778683|NCT03523728|459818684|FG003|Stage 1 (24 Months)|Adverse Event|0|||
127778684|NCT03523728|459818685|FG004|Stage 1 (24 Months)|Adverse Event|0|||
127778685|NCT03523728|459818681|FG000|Stage 1 (24 Months)|Progressive disease|0|||
127778686|NCT03523728|459818682|FG001|Stage 1 (24 Months)|Progressive disease|0|||
127778687|NCT03523728|459818683|FG002|Stage 1 (24 Months)|Progressive disease|1|||
127778688|NCT03523728|459818684|FG003|Stage 1 (24 Months)|Progressive disease|0|||
127778689|NCT03523728|459818685|FG004|Stage 1 (24 Months)|Progressive disease|0|||
128026696|NCT03537729|460722157|FG002|Overall Study|Determined Ineligible|1|||
127568199|NCT00282464|459050183|FG001|Overall Study|Lost to Follow-up|10|||
127568200|NCT00282464|459050182|FG000|Overall Study|Withdrawal by Subject|24|||
127568201|NCT00282464|459050183|FG001|Overall Study|Withdrawal by Subject|10|||
127568202|NCT00282464|459050182|FG000|Overall Study|laboratory abnormality|1|||
127568203|NCT00282464|459050183|FG001|Overall Study|laboratory abnormality|2|||
127568204|NCT00282464|459050182|FG000|Overall Study|Protocol Violation|0|||
127568205|NCT00282464|459050183|FG001|Overall Study|Protocol Violation|7|||
127568206|NCT00282464|459050182|FG000|Overall Study|Patient moved|1|||
127568207|NCT00282464|459050183|FG001|Overall Study|Patient moved|0|||
127568208|NCT00282464|459050182|FG000|Overall Study|patient non-compliant|3|||
127778690|NCT03523728|459818681|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
127568209|NCT00282464|459050183|FG001|Overall Study|patient non-compliant|0|||
127568210|NCT00282464|459050182|FG000|Overall Study|patient no show|0|||
127568211|NCT00282464|459050183|FG001|Overall Study|patient no show|1|||
127778691|NCT03523728|459818682|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
127778692|NCT03523728|459818683|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
127568212|NCT00282464|459050182|FG000|Overall Study|patient incarcerated|0|||
127568213|NCT00282464|459050183|FG001|Overall Study|patient incarcerated|1|||
127568214|NCT00282464|459050182|FG000|Overall Study|family crisis|0|||
127568215|NCT00282464|459050183|FG001|Overall Study|family crisis|1|||
127568216|NCT00282464|459050182|FG000|Overall Study|dispensed wrong kit|0|||
127568217|NCT00282464|459050183|FG001|Overall Study|dispensed wrong kit|1|||
127778693|NCT03523728|459818684|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
127778694|NCT03523728|459818685|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
127778695|NCT03523728|459818681|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
127568218|NCT00282464|459050182|FG000|Overall Study|dropped due to missed visits|0|||
127568219|NCT00282464|459050183|FG001|Overall Study|dropped due to missed visits|1|||
127568220|NCT00475423|459050184|FG000|Overall Study|Protocol Violation|5|||
127568221|NCT00475423|459050184|FG000|Overall Study|Adverse Event|4|||
127568222|NCT00475423|459050184|FG000|Overall Study|Withdrawal by Subject|6|||
127568223|NCT00475423|459050184|FG000|Overall Study|Lack of Efficacy|8|||
127568224|NCT00475423|459050184|FG000|Overall Study|Death|1|||
127568225|NCT00475423|459050184|FG000|Overall Study|Reason not specified|1|||
127568226|NCT00475423|459050184|FG000|Overall Study|Lost to Follow-up|7|||
127568227|NCT00046891|459050185|FG000|Overall Study|Cancels|5|||
127568228|NCT00046891|459050186|FG001|Overall Study|Cancels|9|||
127568229|NCT00046891|459050185|FG000|Overall Study|Ineligible|1|||
127568230|NCT00046891|459050186|FG001|Overall Study|Ineligible|1|||
127568231|NCT00046891|459050185|FG000|Overall Study|Withdrawal by Subject|18|||
127568232|NCT00046891|459050186|FG001|Overall Study|Withdrawal by Subject|15|||
127568233|NCT00046891|459050185|FG000|Overall Study|Adverse Event|5|||
127568234|NCT00046891|459050186|FG001|Overall Study|Adverse Event|5|||
127568235|NCT02496676|459050187|FG000|Phase 1 - Period 1|Adverse Event|0|||
127568236|NCT02496676|459050188|FG001|Phase 1 - Period 1|Adverse Event|1|||
127568237|NCT02496676|459050187|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
127568238|NCT02496676|459050188|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
127568239|NCT04672252|459050194|FG000|Overall Study|Protocol Violation|1|||
127568240|NCT04672252|459050195|FG001|Overall Study|Protocol Violation|0|||
127568241|NCT04391569|459050196|FG000|Overall Study|Death|15|||
127568242|NCT04391569|459050197|FG001|Overall Study|Death|10|||
127568243|NCT04391569|459050196|FG000|Overall Study|Withdrawal by Subject|1|||
127778696|NCT03523728|459818682|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
127778697|NCT03523728|459818683|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
127778698|NCT03523728|459818684|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
127778699|NCT03523728|459818685|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
127568244|NCT04391569|459050197|FG001|Overall Study|Withdrawal by Subject|0|||
127568245|NCT04391569|459050196|FG000|Overall Study|Lost to Follow-up|3|||
127568246|NCT04391569|459050197|FG001|Overall Study|Lost to Follow-up|2|||
127568247|NCT04391569|459050196|FG000|Overall Study|Lack of Efficacy|0|||
127568248|NCT04391569|459050197|FG001|Overall Study|Lack of Efficacy|1|||
127568249|NCT04391569|459050196|FG000|Overall Study|Participant discharged to hospice facility|0|||
127568250|NCT04391569|459050197|FG001|Overall Study|Participant discharged to hospice facility|1|||
127568251|NCT04391569|459050196|FG000|Overall Study|Participant family decision|1|||
127568252|NCT04391569|459050197|FG001|Overall Study|Participant family decision|0|||
127568253|NCT04391569|459050196|FG000|Overall Study|Participant discharged prematurely|1|||
127568254|NCT04391569|459050197|FG001|Overall Study|Participant discharged prematurely|0|||
127568255|NCT03025035|459050198|FG000|Overall Study|Death|2|||
127568256|NCT03025035|459050198|FG000|Overall Study|Disease progression and was taken off study. Only received pembrolizumab & is not evaluable.|1|||
127568257|NCT01431638|459050199|FG000|Overall Study|Adverse Event|1|||
127568258|NCT01431638|459050200|FG001|Overall Study|Adverse Event|3|||
127568259|NCT01431638|459050201|FG002|Overall Study|Adverse Event|1|||
127778700|NCT03523728|459818681|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
127778701|NCT03523728|459818682|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
127778702|NCT03523728|459818683|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
127778703|NCT03523728|459818684|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
127568260|NCT01431638|459050199|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
127568261|NCT01431638|459050200|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
127568262|NCT01431638|459050201|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
127568263|NCT01431638|459050199|FG000|Overall Study|Participants condition no longer requires study drug|0|||
127568264|NCT01431638|459050200|FG001|Overall Study|Participants condition no longer requires study drug|1|||
127568265|NCT01431638|459050201|FG002|Overall Study|Participants condition no longer requires study drug|0|||
127568266|NCT01431638|459050199|FG000|Overall Study|Participant withdrew consent|14|||
127778704|NCT03523728|459818685|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
127778705|NCT03523728|459818681|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
127778706|NCT03523728|459818682|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
127568267|NCT01431638|459050200|FG001|Overall Study|Participant withdrew consent|5|||
127568268|NCT01431638|459050201|FG002|Overall Study|Participant withdrew consent|8|||
127568269|NCT01431638|459050199|FG000|Overall Study|Lost to Follow-up|7|||
127568270|NCT01431638|459050200|FG001|Overall Study|Lost to Follow-up|9|||
127568271|NCT01431638|459050201|FG002|Overall Study|Lost to Follow-up|7|||
127568272|NCT01431638|459050199|FG000|Overall Study|Administrative problems|1|||
127778707|NCT03523728|459818683|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
127778708|NCT03523728|459818684|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
127778709|NCT03523728|459818685|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
127568273|NCT01431638|459050200|FG001|Overall Study|Administrative problems|4|||
127568274|NCT01431638|459050201|FG002|Overall Study|Administrative problems|6|||
127568275|NCT01431638|459050199|FG000|Overall Study|Death|1|||
127778710|NCT03523728|459818681|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
127778711|NCT03523728|459818682|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
127568276|NCT01431638|459050200|FG001|Overall Study|Death|0|||
127568277|NCT01431638|459050201|FG002|Overall Study|Death|0|||
127568278|NCT01431638|459050199|FG000|Overall Study|Protocol deviation|1|||
127568279|NCT01431638|459050200|FG001|Overall Study|Protocol deviation|1|||
127568280|NCT01431638|459050201|FG002|Overall Study|Protocol deviation|4|||
127568281|NCT01431638|459050199|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
127568282|NCT01431638|459050200|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
127568283|NCT01431638|459050201|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
127568284|NCT00686998|459050202|FG000|Overall Study|Adverse Event|3|||
127568285|NCT00686998|459050203|FG001|Overall Study|Adverse Event|2|||
127568286|NCT00686998|459050204|FG002|Overall Study|Adverse Event|1|||
127568287|NCT00686998|459050202|FG000|Overall Study|Withdrawal by Subject|2|||
127568288|NCT00686998|459050203|FG001|Overall Study|Withdrawal by Subject|1|||
127568289|NCT00686998|459050204|FG002|Overall Study|Withdrawal by Subject|2|||
127568290|NCT00686998|459050202|FG000|Overall Study|Lack of Efficacy|7|||
127568291|NCT00686998|459050203|FG001|Overall Study|Lack of Efficacy|5|||
127568292|NCT00686998|459050204|FG002|Overall Study|Lack of Efficacy|0|||
127568293|NCT00686998|459050202|FG000|Overall Study|Other|0|||
127568294|NCT00686998|459050203|FG001|Overall Study|Other|0|||
127568295|NCT00686998|459050204|FG002|Overall Study|Other|1|||
127568296|NCT00686998|459050202|FG000|Overall Study|Safety Reasons|1|||
127568297|NCT00686998|459050203|FG001|Overall Study|Safety Reasons|0|||
127568298|NCT00686998|459050204|FG002|Overall Study|Safety Reasons|0|||
127568299|NCT02320903|459051525|FG000|Overall Study|Withdrawal by Subject|0|||
127568300|NCT02320903|459051526|FG001|Overall Study|Withdrawal by Subject|9|||
127568301|NCT02320903|459051527|FG002|Overall Study|Withdrawal by Subject|9|||
127568302|NCT02320903|459051525|FG000|Overall Study|Exited therapy; no longer eligible|8|||
127568303|NCT02320903|459051526|FG001|Overall Study|Exited therapy; no longer eligible|2|||
127568304|NCT02320903|459051527|FG002|Overall Study|Exited therapy; no longer eligible|2|||
127568305|NCT02320903|459051525|FG000|Overall Study|Lost to Follow-up|0|||
127568306|NCT02320903|459051526|FG001|Overall Study|Lost to Follow-up|5|||
127568307|NCT02320903|459051527|FG002|Overall Study|Lost to Follow-up|5|||
127568308|NCT01099709|459051530|FG000|Period 1|Withdrawal by Subject|0|||
127568309|NCT01099709|459051531|FG001|Period 1|Withdrawal by Subject|1|||
127568310|NCT01099709|459051530|FG000|Period 1|Positive cotinine test|0|||
127568311|NCT01099709|459051531|FG001|Period 1|Positive cotinine test|1|||
127568312|NCT01099709|459051530|FG000|Period 1|Adverse Event|1|||
127568313|NCT01099709|459051531|FG001|Period 1|Adverse Event|0|||
127568314|NCT01122394|459051539|FG000|Overall Study|Withdrawal by Subject|1|||
127568315|NCT01122394|459051540|FG001|Overall Study|Withdrawal by Subject|1|||
127568316|NCT01122394|459051539|FG000|Overall Study|Lost to Follow-up|2|||
127568317|NCT01122394|459051540|FG001|Overall Study|Lost to Follow-up|2|||
127568318|NCT01122394|459051539|FG000|Overall Study|Adverse Event|0|||
127568319|NCT01122394|459051540|FG001|Overall Study|Adverse Event|1|||
127568320|NCT00039871|459051541|FG000|Overall Study|Adverse Event|165|||
127568321|NCT00039871|459051541|FG000|Overall Study|Lost to Follow-up|18|||
127568322|NCT00039871|459051541|FG000|Overall Study|Protocol Violation|24|||
127568323|NCT00039871|459051541|FG000|Overall Study|Withdrawal by Subject|97|||
127568324|NCT00039871|459051541|FG000|Overall Study|Did not meet eligibility criteria|11|||
127568325|NCT00039871|459051541|FG000|Overall Study|Administrative|1|||
127568326|NCT00039871|459051541|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
127568327|NCT00039871|459051541|FG000|Overall Study|Never entered follow-up|7|||
127568328|NCT00718081|459051546|FG000|Overall Study|Adverse Event|0|||
127568329|NCT00718081|459051547|FG001|Overall Study|Adverse Event|1|||
127568330|NCT00718081|459051548|FG002|Overall Study|Adverse Event|0|||
127568331|NCT00718081|459051546|FG000|Overall Study|Lack of Efficacy|7|||
127568332|NCT00718081|459051547|FG001|Overall Study|Lack of Efficacy|3|||
127568333|NCT00718081|459051548|FG002|Overall Study|Lack of Efficacy|21|||
127568334|NCT01397825|459051550|FG000|Overall Study|Progressive Disease|10|||
127778712|NCT03523728|459818683|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
127778713|NCT03523728|459818684|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
127568335|NCT01397825|459051551|FG001|Overall Study|Progressive Disease|3|||
127568336|NCT01397825|459051552|FG002|Overall Study|Progressive Disease|11|||
127568337|NCT01397825|459051553|FG003|Overall Study|Progressive Disease|1|||
127568338|NCT01397825|459051554|FG004|Overall Study|Progressive Disease|0|||
127568339|NCT01397825|459051550|FG000|Overall Study|Symptomatic Deterioration|2|||
127568340|NCT01397825|459051551|FG001|Overall Study|Symptomatic Deterioration|0|||
127778714|NCT03523728|459818685|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
127778715|NCT03523728|459818681|FG000|Stage 2 (24 Months)|Adverse Event|0|||
127568341|NCT01397825|459051552|FG002|Overall Study|Symptomatic Deterioration|4|||
127568342|NCT01397825|459051553|FG003|Overall Study|Symptomatic Deterioration|0|||
127568343|NCT01397825|459051554|FG004|Overall Study|Symptomatic Deterioration|0|||
127568344|NCT01397825|459051550|FG000|Overall Study|Adverse Event|0|||
127568345|NCT01397825|459051551|FG001|Overall Study|Adverse Event|1|||
127568346|NCT01397825|459051552|FG002|Overall Study|Adverse Event|5|||
127568347|NCT01397825|459051553|FG003|Overall Study|Adverse Event|1|||
127568348|NCT01397825|459051554|FG004|Overall Study|Adverse Event|0|||
127568349|NCT01397825|459051550|FG000|Overall Study|Withdrawal by Subject|1|||
127778716|NCT03523728|459818682|FG001|Stage 2 (24 Months)|Adverse Event|0|||
127778717|NCT03523728|459818683|FG002|Stage 2 (24 Months)|Adverse Event|0|||
127778718|NCT03523728|459818684|FG003|Stage 2 (24 Months)|Adverse Event|1|||
127778719|NCT03523728|459818685|FG004|Stage 2 (24 Months)|Adverse Event|2|||
127778720|NCT03523728|459818681|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
127778721|NCT03523728|459818682|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
127778722|NCT03523728|459818683|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
127778723|NCT03523728|459818684|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
127778724|NCT03523728|459818685|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
127778725|NCT03523728|459818681|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
127778726|NCT03523728|459818682|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
127778727|NCT03523728|459818683|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
127881046|NCT02575807|460186106|FG002|Overall Study|Subject ineligible - medical implant|0|||
127778728|NCT03523728|459818684|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
127778729|NCT03523728|459818685|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
127881047|NCT02575807|460186107|FG003|Overall Study|Subject ineligible - medical implant|1|||
127778730|NCT03523728|459818681|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
127778731|NCT03523728|459818682|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
127778732|NCT03523728|459818683|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
127778733|NCT03523728|459818684|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
127778734|NCT03523728|459818685|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
127778735|NCT03523728|459818681|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
127778736|NCT03523728|459818682|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
127778737|NCT03523728|459818683|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
127778738|NCT03523728|459818684|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
127778739|NCT03523728|459818685|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
127778740|NCT00621751|459818686|FG000|Overall Study|Adverse Event|0|||
127778741|NCT00621751|459818687|FG001|Overall Study|Adverse Event|1|||
127778742|NCT00419120|459818689|FG000|Long Term Follow up Period|study ongoing|10|||
127778743|NCT01950247|459818690|FG000|Overall Study|Withdrawal by Subject|28|||
127778744|NCT01950247|459818691|FG001|Overall Study|Withdrawal by Subject|13|||
127778745|NCT01950247|459818690|FG000|Overall Study|Lost to Follow-up|18|||
127778746|NCT01950247|459818691|FG001|Overall Study|Lost to Follow-up|16|||
127778747|NCT01950247|459818690|FG000|Overall Study|Physician Decision|3|||
127778748|NCT01950247|459818691|FG001|Overall Study|Physician Decision|4|||
127778749|NCT01950247|459818690|FG000|Overall Study|Adverse Event|3|||
127778750|NCT01950247|459818691|FG001|Overall Study|Adverse Event|2|||
127778751|NCT01950247|459818690|FG000|Overall Study|Death|1|||
127778752|NCT01950247|459818691|FG001|Overall Study|Death|1|||
127778753|NCT01950247|459818690|FG000|Overall Study|Not Defined|4|||
127568350|NCT01397825|459051551|FG001|Overall Study|Withdrawal by Subject|0|||
127568351|NCT01397825|459051552|FG002|Overall Study|Withdrawal by Subject|5|||
127568352|NCT01397825|459051553|FG003|Overall Study|Withdrawal by Subject|1|||
127568353|NCT01397825|459051554|FG004|Overall Study|Withdrawal by Subject|0|||
127568354|NCT01931670|459051555|FG000|Treatment Period|Exclusionary Medication Received|1|||
127778754|NCT01950247|459818691|FG001|Overall Study|Not Defined|10|||
127778755|NCT00710879|459818692|FG000|Overall Study|Lost to Follow-up|2|||
127778756|NCT00710879|459818693|FG001|Overall Study|Lost to Follow-up|1|||
127778757|NCT00710879|459818692|FG000|Overall Study|Protocol Violation|0|||
127778758|NCT00710879|459818693|FG001|Overall Study|Protocol Violation|3|||
127778759|NCT01809132|459818694|FG000|Overall Study|Withdrawal by Subject|0|||
127778760|NCT01809132|459818695|FG001|Overall Study|Withdrawal by Subject|0|||
127778761|NCT01809132|459818696|FG002|Overall Study|Withdrawal by Subject|1|||
127778762|NCT03349775|459818697|FG000|Overall Study|Side Effects|1|||
127778763|NCT03349775|459818698|FG001|Overall Study|Side Effects|2|||
127778764|NCT03349775|459818697|FG000|Overall Study|Withdrawal by Subject|1|||
127778765|NCT03349775|459818698|FG001|Overall Study|Withdrawal by Subject|1|||
127778766|NCT03349775|459818697|FG000|Overall Study|No primary outcome measurements|0|||
127778767|NCT03349775|459818698|FG001|Overall Study|No primary outcome measurements|1|||
127778768|NCT01516970|459818699|FG000|Overall Study|Lost to Follow-up|7|||
127778769|NCT01516970|459818700|FG001|Overall Study|Lost to Follow-up|8|||
127778770|NCT01516970|459818699|FG000|Overall Study|Adverse Event|1|||
127778771|NCT01516970|459818700|FG001|Overall Study|Adverse Event|5|||
127778772|NCT01516970|459818699|FG000|Overall Study|Withdrawal by Subject|1|||
127778773|NCT01516970|459818700|FG001|Overall Study|Withdrawal by Subject|1|||
127778774|NCT01516970|459818699|FG000|Overall Study|Other|9|||
127778775|NCT01516970|459818700|FG001|Overall Study|Other|7|||
127778776|NCT00434421|459818701|FG000|Overall Study|Withdrawal by Subject|1|||
127778777|NCT00434421|459818701|FG000|Overall Study|Non-compliance with study treatment|1|||
127778778|NCT01756040|459818702|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
127568355|NCT01931670|459051556|FG001|Treatment Period|Exclusionary Medication Received|1|||
127568356|NCT01931670|459051557|FG002|Treatment Period|Exclusionary Medication Received|1|||
127568357|NCT01931670|459051555|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
127568358|NCT01931670|459051556|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
127568359|NCT01931670|459051557|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
127778779|NCT01756040|459818702|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
127778780|NCT01756040|459818702|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
127568360|NCT01931670|459051555|FG000|Treatment Period|Subject Noncompliant|4|||
127778781|NCT00892177|459818703|FG000|Phase II|Ineligible|0|||
127778782|NCT00892177|459818704|FG001|Phase II|Ineligible|0|||
127778783|NCT00892177|459818705|FG002|Phase II|Ineligible|0|||
127778784|NCT00892177|459818706|FG003|Phase II|Ineligible|0|||
127778785|NCT00892177|459818707|FG004|Phase II|Ineligible|1|||
127778786|NCT00892177|459818708|FG005|Phase II|Ineligible|1|||
127778787|NCT00892177|459818703|FG000|Phase II|Withdrawal by Subject|0|||
127778788|NCT00892177|459818704|FG001|Phase II|Withdrawal by Subject|0|||
127778789|NCT00892177|459818705|FG002|Phase II|Withdrawal by Subject|0|||
127778790|NCT00892177|459818706|FG003|Phase II|Withdrawal by Subject|0|||
127778791|NCT00892177|459818707|FG004|Phase II|Withdrawal by Subject|4|||
127778792|NCT00892177|459818708|FG005|Phase II|Withdrawal by Subject|1|||
127778793|NCT01446016|459818711|FG000|Overall Study|Lost to Follow-up|3|||
127778794|NCT01446016|459818711|FG000|Overall Study|Withdrawal by Subject|1|||
127778795|NCT01446016|459818711|FG000|Overall Study|Toxicity|3|||
127778796|NCT01087957|459818721|FG000|Overall Study|Death|2|||
127778797|NCT01087957|459818722|FG001|Overall Study|Death|2|||
127778798|NCT01087957|459818721|FG000|Overall Study|Lost to Follow-up|3|||
127778799|NCT01087957|459818722|FG001|Overall Study|Lost to Follow-up|4|||
127778800|NCT01087957|459818721|FG000|Overall Study|Protocol Violation|13|||
127778801|NCT01087957|459818722|FG001|Overall Study|Protocol Violation|25|||
127778802|NCT01087957|459818721|FG000|Overall Study|Withdrawal by Subject|18|||
127778803|NCT01087957|459818722|FG001|Overall Study|Withdrawal by Subject|15|||
127568361|NCT01931670|459051556|FG001|Treatment Period|Subject Noncompliant|9|||
127568362|NCT01931670|459051557|FG002|Treatment Period|Subject Noncompliant|5|||
127568363|NCT01931670|459051555|FG000|Treatment Period|Adverse Event|19|||
127568364|NCT01931670|459051556|FG001|Treatment Period|Adverse Event|8|||
127568365|NCT01931670|459051557|FG002|Treatment Period|Adverse Event|21|||
127568366|NCT01931670|459051555|FG000|Treatment Period|Lack of Efficacy|11|||
127568367|NCT01931670|459051556|FG001|Treatment Period|Lack of Efficacy|2|||
127568368|NCT01931670|459051557|FG002|Treatment Period|Lack of Efficacy|2|||
127568369|NCT01931670|459051555|FG000|Treatment Period|Pregnancy|7|||
127568370|NCT01931670|459051556|FG001|Treatment Period|Pregnancy|2|||
127690141|NCT03398148|459492224|FG000|Substudy 1 Period 1|Enrolled but not Treated|0|||
127690142|NCT03398148|459492225|FG001|Substudy 1 Period 1|Enrolled but not Treated|0|||
127690143|NCT03398148|459492226|FG002|Substudy 1 Period 1|Enrolled but not Treated|0|||
127690144|NCT03398148|459492227|FG003|Substudy 1 Period 1|Enrolled but not Treated|0|||
127690145|NCT03398148|459492228|FG004|Substudy 1 Period 1|Enrolled but not Treated|1|||
127690146|NCT03398148|459492229|FG005|Substudy 1 Period 1|Enrolled but not Treated|0|||
127690147|NCT03398148|459492230|FG006|Substudy 1 Period 1|Enrolled but not Treated|0|||
127690148|NCT03398148|459492231|FG007|Substudy 1 Period 1|Enrolled but not Treated|0|||
127690149|NCT03398148|459492232|FG008|Substudy 1 Period 1|Enrolled but not Treated|0|||
127690150|NCT03398148|459492233|FG009|Substudy 1 Period 1|Enrolled but not Treated|0|||
127690151|NCT03398148|459492234|FG010|Substudy 1 Period 1|Enrolled but not Treated|0|||
127690152|NCT03398148|459492235|FG011|Substudy 1 Period 1|Enrolled but not Treated|0|||
127690153|NCT03398148|459492236|FG012|Substudy 1 Period 1|Enrolled but not Treated|0|||
127690154|NCT03398148|459492237|FG013|Substudy 1 Period 1|Enrolled but not Treated|0|||
127690155|NCT03398148|459492238|FG014|Substudy 1 Period 1|Enrolled but not Treated|0|||
127690156|NCT03398148|459492224|FG000|Substudy 1 Period 2|Adverse Event|0|||
127690157|NCT03398148|459492225|FG001|Substudy 1 Period 2|Adverse Event|0|||
127690158|NCT03398148|459492226|FG002|Substudy 1 Period 2|Adverse Event|0|||
127690159|NCT03398148|459492227|FG003|Substudy 1 Period 2|Adverse Event|0|||
127690160|NCT03398148|459492228|FG004|Substudy 1 Period 2|Adverse Event|0|||
127690161|NCT03398148|459492229|FG005|Substudy 1 Period 2|Adverse Event|2|||
127690162|NCT03398148|459492230|FG006|Substudy 1 Period 2|Adverse Event|4|||
127690163|NCT03398148|459492231|FG007|Substudy 1 Period 2|Adverse Event|0|||
127690164|NCT03398148|459492232|FG008|Substudy 1 Period 2|Adverse Event|0|||
127690165|NCT03398148|459492233|FG009|Substudy 1 Period 2|Adverse Event|0|||
127690166|NCT03398148|459492234|FG010|Substudy 1 Period 2|Adverse Event|0|||
127690167|NCT03398148|459492235|FG011|Substudy 1 Period 2|Adverse Event|0|||
127690168|NCT03398148|459492236|FG012|Substudy 1 Period 2|Adverse Event|0|||
127690169|NCT03398148|459492237|FG013|Substudy 1 Period 2|Adverse Event|0|||
127690170|NCT03398148|459492238|FG014|Substudy 1 Period 2|Adverse Event|0|||
127690171|NCT03398148|459492224|FG000|Substudy 1 Period 2|WITHDREW CONSENT|0|||
127690172|NCT03398148|459492225|FG001|Substudy 1 Period 2|WITHDREW CONSENT|0|||
127690173|NCT03398148|459492226|FG002|Substudy 1 Period 2|WITHDREW CONSENT|0|||
127690174|NCT03398148|459492227|FG003|Substudy 1 Period 2|WITHDREW CONSENT|0|||
127690175|NCT03398148|459492228|FG004|Substudy 1 Period 2|WITHDREW CONSENT|0|||
127690176|NCT03398148|459492229|FG005|Substudy 1 Period 2|WITHDREW CONSENT|0|||
127690177|NCT03398148|459492230|FG006|Substudy 1 Period 2|WITHDREW CONSENT|1|||
127690178|NCT03398148|459492231|FG007|Substudy 1 Period 2|WITHDREW CONSENT|2|||
127690179|NCT03398148|459492232|FG008|Substudy 1 Period 2|WITHDREW CONSENT|0|||
127690180|NCT03398148|459492233|FG009|Substudy 1 Period 2|WITHDREW CONSENT|0|||
127690181|NCT03398148|459492234|FG010|Substudy 1 Period 2|WITHDREW CONSENT|0|||
127690182|NCT03398148|459492235|FG011|Substudy 1 Period 2|WITHDREW CONSENT|0|||
127690183|NCT03398148|459492236|FG012|Substudy 1 Period 2|WITHDREW CONSENT|0|||
127690184|NCT03398148|459492237|FG013|Substudy 1 Period 2|WITHDREW CONSENT|0|||
127690185|NCT03398148|459492238|FG014|Substudy 1 Period 2|WITHDREW CONSENT|0|||
127690186|NCT03398148|459492224|FG000|Substudy 1 Period 2|Lack of Efficacy|0|||
127690187|NCT03398148|459492225|FG001|Substudy 1 Period 2|Lack of Efficacy|0|||
127690188|NCT03398148|459492226|FG002|Substudy 1 Period 2|Lack of Efficacy|0|||
127568371|NCT01931670|459051557|FG002|Treatment Period|Pregnancy|0|||
127568372|NCT01931670|459051555|FG000|Treatment Period|Other|8|||
127568373|NCT01931670|459051556|FG001|Treatment Period|Other|7|||
127690189|NCT03398148|459492227|FG003|Substudy 1 Period 2|Lack of Efficacy|0|||
127778804|NCT01087957|459818721|FG000|Overall Study|Physician Decision|5|||
127568374|NCT01931670|459051557|FG002|Treatment Period|Other|2|||
127568375|NCT01931670|459051555|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
127690190|NCT03398148|459492228|FG004|Substudy 1 Period 2|Lack of Efficacy|0|||
127690191|NCT03398148|459492229|FG005|Substudy 1 Period 2|Lack of Efficacy|5|||
127690192|NCT03398148|459492230|FG006|Substudy 1 Period 2|Lack of Efficacy|5|||
127690193|NCT03398148|459492231|FG007|Substudy 1 Period 2|Lack of Efficacy|0|||
127778805|NCT01087957|459818722|FG001|Overall Study|Physician Decision|9|||
127568376|NCT01931670|459051556|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
127568377|NCT01931670|459051557|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
127568378|NCT01931670|459051555|FG000|Treatment Period|Lost to Follow-up|19|||
127568379|NCT01931670|459051556|FG001|Treatment Period|Lost to Follow-up|5|||
127568380|NCT01931670|459051557|FG002|Treatment Period|Lost to Follow-up|7|||
127568381|NCT01931670|459051555|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
127568382|NCT01931670|459051556|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
127568383|NCT01931670|459051557|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
127568384|NCT01931670|459051555|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
127568385|NCT01931670|459051556|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
127568386|NCT01931670|459051557|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
127568387|NCT01931670|459051555|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
127568388|NCT01931670|459051556|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
127568389|NCT01931670|459051557|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
127568390|NCT01931670|459051555|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
127568391|NCT01931670|459051556|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
127568392|NCT01931670|459051557|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
127568393|NCT01931670|459051555|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
127568394|NCT01931670|459051556|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
127568395|NCT01931670|459051557|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
127568396|NCT01931670|459051555|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
127568397|NCT01931670|459051556|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
127568398|NCT01931670|459051557|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
127568399|NCT00815516|459051558|FG000|Overall Study|Death|3|||
127568400|NCT00815516|459051559|FG001|Overall Study|Death|1|||
127568401|NCT00815516|459051558|FG000|Overall Study|Physician Decision|1|||
127568402|NCT00815516|459051559|FG001|Overall Study|Physician Decision|0|||
127568403|NCT01736657|459051564|FG000|Overall Study|insufficient vascular access|1|||
127568404|NCT01992159|459051577|FG000|Overall Study|Withdrawal by Subject|4|||
127568405|NCT01992159|459051578|FG001|Overall Study|Withdrawal by Subject|7|||
127568406|NCT01992159|459051579|FG002|Overall Study|Withdrawal by Subject|0|||
127568407|NCT01992159|459051580|FG003|Overall Study|Withdrawal by Subject|3|||
127568408|NCT01992159|459051577|FG000|Overall Study|Adverse Event|0|||
127568409|NCT01992159|459051578|FG001|Overall Study|Adverse Event|1|||
127568410|NCT01992159|459051579|FG002|Overall Study|Adverse Event|0|||
127568411|NCT01992159|459051580|FG003|Overall Study|Adverse Event|1|||
127568412|NCT01992159|459051577|FG000|Overall Study|Death|0|||
127568413|NCT01992159|459051578|FG001|Overall Study|Death|0|||
127568414|NCT01992159|459051579|FG002|Overall Study|Death|1|||
127568415|NCT01992159|459051580|FG003|Overall Study|Death|0|||
127568416|NCT03023046|459051581|FG000|Overall Study|Withdrawal by Subject|1|||
127568417|NCT01741012|459051586|FG000|Overall Study|Lost to Follow-up|1|||
127568418|NCT01741012|459051586|FG000|Overall Study|Withdrawal by Subject|2|||
127568419|NCT01249118|459051587|FG000|First Washout Period|Physician Decision|0|||
127568420|NCT01249118|459051588|FG001|First Washout Period|Physician Decision|1|||
127568421|NCT01249118|459051589|FG002|First Washout Period|Physician Decision|0|||
127568422|NCT00880685|459051590|FG000|Memantine 10mg|Lost to Follow-up|2|||
127568423|NCT00880685|459051590|FG000|Memantine 20mg|Withdrawal by Subject|1|||
127568424|NCT00997438|459051591|FG000|Overall Study|Blood draw difficulty|2|||
127568425|NCT00997438|459051592|FG001|Overall Study|Blood draw difficulty|0|||
127568426|NCT00997438|459051593|FG002|Overall Study|Blood draw difficulty|1|||
127568427|NCT00997438|459051591|FG000|Overall Study|Withdrawal by Subject|1|||
127568428|NCT00997438|459051592|FG001|Overall Study|Withdrawal by Subject|1|||
127568429|NCT00997438|459051593|FG002|Overall Study|Withdrawal by Subject|0|||
127568430|NCT00997438|459051591|FG000|Overall Study|Exclusion criteria at visit 1|2|||
127568431|NCT00997438|459051592|FG001|Overall Study|Exclusion criteria at visit 1|2|||
127568432|NCT00997438|459051593|FG002|Overall Study|Exclusion criteria at visit 1|3|||
127568433|NCT01236118|459051594|FG000|Overall Study|Adverse Event|2|||
127568434|NCT01236118|459051595|FG001|Overall Study|Adverse Event|0|||
127568435|NCT01236118|459051596|FG002|Overall Study|Adverse Event|2|||
127568436|NCT01236118|459051594|FG000|Overall Study|Physician Decision|0|||
127568437|NCT01236118|459051595|FG001|Overall Study|Physician Decision|1|||
127778806|NCT00616434|459818723|FG000|Overall Study|Adverse Event|5|||
128026697|NCT02933151|460722159|FG000|Overall Study|Lost to Follow-up|19|||
127568438|NCT01236118|459051596|FG002|Overall Study|Physician Decision|0|||
127568439|NCT01236118|459051594|FG000|Overall Study|Withdrawal by Subject|0|||
128026698|NCT02933151|460722160|FG001|Overall Study|Lost to Follow-up|18|||
127568440|NCT01236118|459051595|FG001|Overall Study|Withdrawal by Subject|0|||
127568441|NCT01236118|459051596|FG002|Overall Study|Withdrawal by Subject|1|||
127568442|NCT00095238|459051597|FG000|Overall Study|Lack of Efficacy|9|||
127568443|NCT00095238|459051598|FG001|Overall Study|Lack of Efficacy|9|||
127568444|NCT00095238|459051597|FG000|Overall Study|Adverse Event|331|||
127568445|NCT00095238|459051598|FG001|Overall Study|Adverse Event|287|||
128026699|NCT02933151|460722159|FG000|Overall Study|Death|1732|||
127568446|NCT00095238|459051597|FG000|Overall Study|Subject Withdrew Consent|208|||
127568447|NCT00095238|459051598|FG001|Overall Study|Subject Withdrew Consent|223|||
127568448|NCT00095238|459051597|FG000|Overall Study|Death|154|||
127568449|NCT00095238|459051598|FG001|Overall Study|Death|170|||
127568450|NCT00095238|459051597|FG000|Overall Study|Lost to Follow-up|19|||
127568451|NCT00095238|459051598|FG001|Overall Study|Lost to Follow-up|24|||
127568452|NCT00095238|459051597|FG000|Overall Study|Noncompliance|44|||
127568453|NCT00095238|459051598|FG001|Overall Study|Noncompliance|45|||
127568454|NCT00095238|459051597|FG000|Overall Study|No longer met study criteria|4|||
127568455|NCT00095238|459051598|FG001|Overall Study|No longer met study criteria|5|||
127568456|NCT00095238|459051597|FG000|Overall Study|Study terminated by sponsor|0|||
127568457|NCT00095238|459051598|FG001|Overall Study|Study terminated by sponsor|1|||
127568458|NCT00095238|459051597|FG000|Overall Study|Missing|1|||
127568459|NCT00095238|459051598|FG001|Overall Study|Missing|0|||
127568460|NCT00095238|459051597|FG000|Overall Study|Other Reasons|87|||
127568461|NCT00095238|459051598|FG001|Overall Study|Other Reasons|88|||
127568462|NCT04393298|459051601|FG000|Overall Study|Adverse Event|0|||
127568463|NCT04393298|459051602|FG001|Overall Study|Adverse Event|0|||
127568464|NCT04393298|459051603|FG002|Overall Study|Adverse Event|0|||
127568465|NCT04393298|459051604|FG003|Overall Study|Adverse Event|0|||
127568466|NCT04393298|459051605|FG004|Overall Study|Adverse Event|1|||
127568467|NCT04393298|459051606|FG005|Overall Study|Adverse Event|0|||
127568468|NCT04393298|459051607|FG006|Overall Study|Adverse Event|0|||
127568469|NCT04393298|459051608|FG007|Overall Study|Adverse Event|0|||
127568470|NCT04393298|459051609|FG008|Overall Study|Adverse Event|2|||
127568471|NCT04393298|459051610|FG009|Overall Study|Adverse Event|0|||
127568472|NCT04393298|459051611|FG010|Overall Study|Adverse Event|0|||
127568473|NCT04393298|459051612|FG011|Overall Study|Adverse Event|0|||
127568474|NCT04393298|459051613|FG012|Overall Study|Adverse Event|1|||
127568475|NCT04393298|459051614|FG013|Overall Study|Adverse Event|1|||
127568476|NCT04393298|459051615|FG014|Overall Study|Adverse Event|0|||
127568477|NCT04393298|459051601|FG000|Overall Study|Consent withdrawn by participant, not due to AE|0|||
127568478|NCT04393298|459051602|FG001|Overall Study|Consent withdrawn by participant, not due to AE|0|||
127568479|NCT04393298|459051603|FG002|Overall Study|Consent withdrawn by participant, not due to AE|1|||
127568480|NCT04393298|459051604|FG003|Overall Study|Consent withdrawn by participant, not due to AE|0|||
127568481|NCT04393298|459051605|FG004|Overall Study|Consent withdrawn by participant, not due to AE|0|||
127568482|NCT04393298|459051606|FG005|Overall Study|Consent withdrawn by participant, not due to AE|0|||
127568483|NCT04393298|459051607|FG006|Overall Study|Consent withdrawn by participant, not due to AE|0|||
127568484|NCT04393298|459051608|FG007|Overall Study|Consent withdrawn by participant, not due to AE|0|||
127568485|NCT04393298|459051609|FG008|Overall Study|Consent withdrawn by participant, not due to AE|0|||
127690194|NCT03398148|459492232|FG008|Substudy 1 Period 2|Lack of Efficacy|2|||
127690195|NCT03398148|459492233|FG009|Substudy 1 Period 2|Lack of Efficacy|0|||
127690196|NCT03398148|459492234|FG010|Substudy 1 Period 2|Lack of Efficacy|0|||
127690197|NCT03398148|459492235|FG011|Substudy 1 Period 2|Lack of Efficacy|0|||
127690198|NCT03398148|459492236|FG012|Substudy 1 Period 2|Lack of Efficacy|0|||
127690199|NCT03398148|459492237|FG013|Substudy 1 Period 2|Lack of Efficacy|0|||
127690200|NCT03398148|459492238|FG014|Substudy 1 Period 2|Lack of Efficacy|0|||
127690201|NCT03398148|459492224|FG000|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
127690202|NCT03398148|459492225|FG001|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
127690203|NCT03398148|459492226|FG002|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
127690204|NCT03398148|459492227|FG003|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
127690205|NCT03398148|459492228|FG004|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
127690206|NCT03398148|459492229|FG005|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
127690207|NCT03398148|459492230|FG006|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|1|||
127690208|NCT03398148|459492231|FG007|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
127690209|NCT03398148|459492232|FG008|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
127690210|NCT03398148|459492233|FG009|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
127690211|NCT03398148|459492234|FG010|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
127690212|NCT03398148|459492235|FG011|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
127690213|NCT03398148|459492236|FG012|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
127690214|NCT03398148|459492237|FG013|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
127690215|NCT03398148|459492238|FG014|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
127690216|NCT03398148|459492224|FG000|Substudy 1 Period 2|Other|0|||
127690217|NCT03398148|459492225|FG001|Substudy 1 Period 2|Other|0|||
127690218|NCT03398148|459492226|FG002|Substudy 1 Period 2|Other|0|||
127690219|NCT03398148|459492227|FG003|Substudy 1 Period 2|Other|0|||
127690220|NCT03398148|459492228|FG004|Substudy 1 Period 2|Other|0|||
127690221|NCT03398148|459492229|FG005|Substudy 1 Period 2|Other|0|||
127690222|NCT03398148|459492230|FG006|Substudy 1 Period 2|Other|1|||
127568486|NCT04393298|459051610|FG009|Overall Study|Consent withdrawn by participant, not due to AE|0|||
127568487|NCT04393298|459051611|FG010|Overall Study|Consent withdrawn by participant, not due to AE|0|||
127690223|NCT03398148|459492231|FG007|Substudy 1 Period 2|Other|0|||
127690224|NCT03398148|459492232|FG008|Substudy 1 Period 2|Other|0|||
127690225|NCT03398148|459492233|FG009|Substudy 1 Period 2|Other|0|||
127568488|NCT04393298|459051612|FG011|Overall Study|Consent withdrawn by participant, not due to AE|0|||
127568489|NCT04393298|459051613|FG012|Overall Study|Consent withdrawn by participant, not due to AE|0|||
127568490|NCT04393298|459051614|FG013|Overall Study|Consent withdrawn by participant, not due to AE|0|||
127568491|NCT04393298|459051615|FG014|Overall Study|Consent withdrawn by participant, not due to AE|3|||
127568492|NCT04393298|459051601|FG000|Overall Study|Lack of Efficacy|0|||
128026700|NCT02933151|460722160|FG001|Overall Study|Death|1827|||
128026701|NCT02933151|460722159|FG000|Overall Study|Transplant|210|||
127568493|NCT04393298|459051602|FG001|Overall Study|Lack of Efficacy|0|||
127568494|NCT04393298|459051603|FG002|Overall Study|Lack of Efficacy|0|||
127568495|NCT04393298|459051604|FG003|Overall Study|Lack of Efficacy|0|||
127568496|NCT04393298|459051605|FG004|Overall Study|Lack of Efficacy|0|||
127568497|NCT04393298|459051606|FG005|Overall Study|Lack of Efficacy|0|||
127568498|NCT04393298|459051607|FG006|Overall Study|Lack of Efficacy|0|||
127568499|NCT04393298|459051608|FG007|Overall Study|Lack of Efficacy|0|||
127568500|NCT04393298|459051609|FG008|Overall Study|Lack of Efficacy|0|||
127568501|NCT04393298|459051610|FG009|Overall Study|Lack of Efficacy|0|||
127568502|NCT04393298|459051611|FG010|Overall Study|Lack of Efficacy|0|||
127568503|NCT04393298|459051612|FG011|Overall Study|Lack of Efficacy|0|||
127568504|NCT04393298|459051613|FG012|Overall Study|Lack of Efficacy|0|||
127568505|NCT04393298|459051614|FG013|Overall Study|Lack of Efficacy|0|||
127568506|NCT04393298|459051615|FG014|Overall Study|Lack of Efficacy|1|||
127568507|NCT04393298|459051601|FG000|Overall Study|Progression|1|||
127568508|NCT04393298|459051602|FG001|Overall Study|Progression|0|||
127568509|NCT04393298|459051603|FG002|Overall Study|Progression|0|||
128026702|NCT02933151|460722160|FG001|Overall Study|Transplant|278|||
127568510|NCT04393298|459051604|FG003|Overall Study|Progression|0|||
127568511|NCT04393298|459051605|FG004|Overall Study|Progression|0|||
127568512|NCT04393298|459051606|FG005|Overall Study|Progression|0|||
127568513|NCT04393298|459051607|FG006|Overall Study|Progression|0|||
127568514|NCT04393298|459051608|FG007|Overall Study|Progression|0|||
127568515|NCT04393298|459051609|FG008|Overall Study|Progression|0|||
127568516|NCT04393298|459051610|FG009|Overall Study|Progression|0|||
127568517|NCT04393298|459051611|FG010|Overall Study|Progression|1|||
127568518|NCT04393298|459051612|FG011|Overall Study|Progression|1|||
127568519|NCT04393298|459051613|FG012|Overall Study|Progression|0|||
127568520|NCT04393298|459051614|FG013|Overall Study|Progression|0|||
127568521|NCT04393298|459051615|FG014|Overall Study|Progression|0|||
127568522|NCT04393298|459051601|FG000|Overall Study|Passed Away on The 30 Oct 2020|1|||
127568523|NCT04393298|459051602|FG001|Overall Study|Passed Away on The 30 Oct 2020|0|||
127568524|NCT04393298|459051603|FG002|Overall Study|Passed Away on The 30 Oct 2020|0|||
127568525|NCT04393298|459051604|FG003|Overall Study|Passed Away on The 30 Oct 2020|0|||
127568526|NCT04393298|459051605|FG004|Overall Study|Passed Away on The 30 Oct 2020|0|||
127568527|NCT04393298|459051606|FG005|Overall Study|Passed Away on The 30 Oct 2020|0|||
127568528|NCT04393298|459051607|FG006|Overall Study|Passed Away on The 30 Oct 2020|0|||
127568529|NCT04393298|459051608|FG007|Overall Study|Passed Away on The 30 Oct 2020|0|||
127568530|NCT04393298|459051609|FG008|Overall Study|Passed Away on The 30 Oct 2020|0|||
127568531|NCT04393298|459051610|FG009|Overall Study|Passed Away on The 30 Oct 2020|0|||
127568532|NCT04393298|459051611|FG010|Overall Study|Passed Away on The 30 Oct 2020|0|||
127568533|NCT04393298|459051612|FG011|Overall Study|Passed Away on The 30 Oct 2020|0|||
127568534|NCT04393298|459051613|FG012|Overall Study|Passed Away on The 30 Oct 2020|0|||
127568535|NCT04393298|459051614|FG013|Overall Study|Passed Away on The 30 Oct 2020|0|||
127568536|NCT04393298|459051615|FG014|Overall Study|Passed Away on The 30 Oct 2020|0|||
127690226|NCT03398148|459492234|FG010|Substudy 1 Period 2|Other|0|||
127690227|NCT03398148|459492235|FG011|Substudy 1 Period 2|Other|0|||
127690228|NCT03398148|459492236|FG012|Substudy 1 Period 2|Other|0|||
127690229|NCT03398148|459492237|FG013|Substudy 1 Period 2|Other|0|||
127690230|NCT03398148|459492238|FG014|Substudy 1 Period 2|Other|0|||
128026703|NCT02933151|460722159|FG000|Overall Study|Withdrawal from HD (Death equivalent analytically)|24|||
128026704|NCT02933151|460722160|FG001|Overall Study|Withdrawal from HD (Death equivalent analytically)|29|||
127568537|NCT04393298|459051601|FG000|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
127690231|NCT03398148|459492224|FG000|Substudy 1 Period 2|Enrolled but not Treated|0|||
127690232|NCT03398148|459492225|FG001|Substudy 1 Period 2|Enrolled but not Treated|0|||
127690233|NCT03398148|459492226|FG002|Substudy 1 Period 2|Enrolled but not Treated|0|||
127568538|NCT04393298|459051602|FG001|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|1|||
127568539|NCT04393298|459051603|FG002|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
127568540|NCT04393298|459051604|FG003|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
127568541|NCT04393298|459051605|FG004|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
127568542|NCT04393298|459051606|FG005|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
127568543|NCT04393298|459051607|FG006|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
127568544|NCT04393298|459051608|FG007|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
127568545|NCT04393298|459051609|FG008|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
127568546|NCT04393298|459051610|FG009|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
127690234|NCT03398148|459492227|FG003|Substudy 1 Period 2|Enrolled but not Treated|0|||
127690235|NCT03398148|459492228|FG004|Substudy 1 Period 2|Enrolled but not Treated|0|||
127568547|NCT04393298|459051611|FG010|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
127568548|NCT04393298|459051612|FG011|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
127568549|NCT04393298|459051613|FG012|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
127568550|NCT04393298|459051614|FG013|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
127568551|NCT04393298|459051615|FG014|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
127568552|NCT04393298|459051601|FG000|Overall Study|Clinical Progression|0|||
127568553|NCT04393298|459051602|FG001|Overall Study|Clinical Progression|2|||
127568554|NCT04393298|459051603|FG002|Overall Study|Clinical Progression|0|||
127568555|NCT04393298|459051604|FG003|Overall Study|Clinical Progression|0|||
127568556|NCT04393298|459051605|FG004|Overall Study|Clinical Progression|0|||
127568557|NCT04393298|459051606|FG005|Overall Study|Clinical Progression|0|||
127568558|NCT04393298|459051607|FG006|Overall Study|Clinical Progression|0|||
127568559|NCT04393298|459051608|FG007|Overall Study|Clinical Progression|0|||
127568560|NCT04393298|459051609|FG008|Overall Study|Clinical Progression|0|||
127568561|NCT04393298|459051610|FG009|Overall Study|Clinical Progression|0|||
127568562|NCT04393298|459051611|FG010|Overall Study|Clinical Progression|0|||
127568563|NCT04393298|459051612|FG011|Overall Study|Clinical Progression|0|||
127568564|NCT04393298|459051613|FG012|Overall Study|Clinical Progression|0|||
127568565|NCT04393298|459051614|FG013|Overall Study|Clinical Progression|0|||
127568566|NCT04393298|459051615|FG014|Overall Study|Clinical Progression|0|||
127568567|NCT04393298|459051601|FG000|Overall Study|Disease Progression|0|||
127568568|NCT04393298|459051602|FG001|Overall Study|Disease Progression|1|||
127568569|NCT04393298|459051603|FG002|Overall Study|Disease Progression|0|||
127568570|NCT04393298|459051604|FG003|Overall Study|Disease Progression|0|||
127568571|NCT04393298|459051605|FG004|Overall Study|Disease Progression|0|||
127568572|NCT04393298|459051606|FG005|Overall Study|Disease Progression|3|||
127568573|NCT04393298|459051607|FG006|Overall Study|Disease Progression|2|||
127568574|NCT04393298|459051608|FG007|Overall Study|Disease Progression|1|||
127568575|NCT04393298|459051609|FG008|Overall Study|Disease Progression|2|||
127568576|NCT04393298|459051610|FG009|Overall Study|Disease Progression|1|||
127568577|NCT04393298|459051611|FG010|Overall Study|Disease Progression|0|||
127568578|NCT04393298|459051612|FG011|Overall Study|Disease Progression|3|||
127568579|NCT04393298|459051613|FG012|Overall Study|Disease Progression|0|||
127568580|NCT04393298|459051614|FG013|Overall Study|Disease Progression|0|||
127568581|NCT04393298|459051615|FG014|Overall Study|Disease Progression|1|||
127568582|NCT04393298|459051601|FG000|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
127568583|NCT04393298|459051602|FG001|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
127690236|NCT03398148|459492229|FG005|Substudy 1 Period 2|Enrolled but not Treated|0|||
127690237|NCT03398148|459492230|FG006|Substudy 1 Period 2|Enrolled but not Treated|1|||
127690238|NCT03398148|459492231|FG007|Substudy 1 Period 2|Enrolled but not Treated|0|||
127690239|NCT03398148|459492232|FG008|Substudy 1 Period 2|Enrolled but not Treated|0|||
127690240|NCT03398148|459492233|FG009|Substudy 1 Period 2|Enrolled but not Treated|0|||
127690241|NCT03398148|459492234|FG010|Substudy 1 Period 2|Enrolled but not Treated|0|||
127690242|NCT03398148|459492235|FG011|Substudy 1 Period 2|Enrolled but not Treated|0|||
127690243|NCT03398148|459492236|FG012|Substudy 1 Period 2|Enrolled but not Treated|0|||
127690244|NCT03398148|459492237|FG013|Substudy 1 Period 2|Enrolled but not Treated|0|||
127690245|NCT03398148|459492238|FG014|Substudy 1 Period 2|Enrolled but not Treated|0|||
127690246|NCT03398148|459492224|FG000|Substudy 2 Period 1|Adverse Event|0|||
127690247|NCT03398148|459492225|FG001|Substudy 2 Period 1|Adverse Event|0|||
127690248|NCT03398148|459492226|FG002|Substudy 2 Period 1|Adverse Event|0|||
127690249|NCT03398148|459492227|FG003|Substudy 2 Period 1|Adverse Event|0|||
127690250|NCT03398148|459492228|FG004|Substudy 2 Period 1|Adverse Event|0|||
127690251|NCT03398148|459492229|FG005|Substudy 2 Period 1|Adverse Event|0|||
127690252|NCT03398148|459492230|FG006|Substudy 2 Period 1|Adverse Event|0|||
127690253|NCT03398148|459492231|FG007|Substudy 2 Period 1|Adverse Event|0|||
127690254|NCT03398148|459492232|FG008|Substudy 2 Period 1|Adverse Event|0|||
127690255|NCT03398148|459492233|FG009|Substudy 2 Period 1|Adverse Event|12|||
127690256|NCT03398148|459492234|FG010|Substudy 2 Period 1|Adverse Event|2|||
127690257|NCT03398148|459492235|FG011|Substudy 2 Period 1|Adverse Event|0|||
127690258|NCT03398148|459492236|FG012|Substudy 2 Period 1|Adverse Event|0|||
127778807|NCT00616434|459818724|FG001|Overall Study|Adverse Event|2|||
127690259|NCT03398148|459492237|FG013|Substudy 2 Period 1|Adverse Event|0|||
127690260|NCT03398148|459492238|FG014|Substudy 2 Period 1|Adverse Event|0|||
127690261|NCT03398148|459492224|FG000|Substudy 2 Period 1|WITHDREW CONSENT|0|||
127690262|NCT03398148|459492225|FG001|Substudy 2 Period 1|WITHDREW CONSENT|0|||
127778808|NCT00616434|459818723|FG000|Overall Study|Physician Decision|0|||
127568584|NCT04393298|459051603|FG002|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|1|||
127568585|NCT04393298|459051604|FG003|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
127568586|NCT04393298|459051605|FG004|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
127568587|NCT04393298|459051606|FG005|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
127568588|NCT04393298|459051607|FG006|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
127568589|NCT04393298|459051608|FG007|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
127568590|NCT04393298|459051609|FG008|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
127778809|NCT00616434|459818724|FG001|Overall Study|Physician Decision|4|||
127778810|NCT00616434|459818723|FG000|Overall Study|Withdrawal by Subject|1|||
127778811|NCT00616434|459818724|FG001|Overall Study|Withdrawal by Subject|1|||
127778812|NCT00616434|459818723|FG000|Overall Study|Protocol deviation|0|||
127778813|NCT00616434|459818724|FG001|Overall Study|Protocol deviation|1|||
127778814|NCT01754857|459818725|FG000|Overall Study|Adverse Event|7|||
127778815|NCT01754857|459818725|FG000|Overall Study|Disease progression|3|||
127778816|NCT01754857|459818725|FG000|Overall Study|Physician Decision|2|||
127778817|NCT01754857|459818725|FG000|Overall Study|Withdrawal by Subject|3|||
127778818|NCT01754857|459818725|FG000|Overall Study|other complicating disease|1|||
127778819|NCT01754857|459818725|FG000|Overall Study|ineligible to continue onto maintenance|1|||
127778820|NCT01754857|459818725|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
127778821|NCT01754857|459818725|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
127778822|NCT01509079|459818726|FG000|Overall Study|Lack of Efficacy|0|||
127778823|NCT01509079|459818727|FG001|Overall Study|Lack of Efficacy|2|||
127778824|NCT01509079|459818726|FG000|Overall Study|started an excluded medication|0|||
127778825|NCT01509079|459818727|FG001|Overall Study|started an excluded medication|1|||
127778826|NCT01399190|459818730|FG000|Overall Study|Not Eligible for Final Analysis|5|||
127778827|NCT01399190|459818730|FG000|Overall Study|Adverse Event|8|||
127778828|NCT01399190|459818730|FG000|Overall Study|Participant's Request|5|||
127778829|NCT01399190|459818730|FG000|Overall Study|Physician Decision|2|||
127778830|NCT00436618|459818734|FG000|Overall Study|Withdrawal by Subject|5|||
127778831|NCT00436618|459818735|FG001|Overall Study|Withdrawal by Subject|8|||
127778832|NCT00436618|459818736|FG002|Overall Study|Withdrawal by Subject|11|||
127778833|NCT00436618|459818734|FG000|Overall Study|Adverse Event|8|||
127778834|NCT00436618|459818735|FG001|Overall Study|Adverse Event|8|||
127778835|NCT00436618|459818736|FG002|Overall Study|Adverse Event|9|||
127778836|NCT00436618|459818734|FG000|Overall Study|Alternate Treatment|3|||
127778837|NCT00436618|459818735|FG001|Overall Study|Alternate Treatment|4|||
127778838|NCT00436618|459818736|FG002|Overall Study|Alternate Treatment|12|||
127778839|NCT00436618|459818734|FG000|Overall Study|Other Medical Problems|3|||
127778840|NCT00436618|459818735|FG001|Overall Study|Other Medical Problems|1|||
127778841|NCT00436618|459818736|FG002|Overall Study|Other Medical Problems|7|||
127778842|NCT00436618|459818734|FG000|Overall Study|Death|4|||
127778843|NCT00436618|459818735|FG001|Overall Study|Death|2|||
127778844|NCT00436618|459818736|FG002|Overall Study|Death|3|||
127778845|NCT00436618|459818734|FG000|Overall Study|New Primary or Other Reasons|6|||
127778846|NCT00436618|459818735|FG001|Overall Study|New Primary or Other Reasons|2|||
127778847|NCT00436618|459818736|FG002|Overall Study|New Primary or Other Reasons|12|||
127778848|NCT00436618|459818734|FG000|Overall Study|Still on treatment|1|||
127778849|NCT00436618|459818735|FG001|Overall Study|Still on treatment|2|||
127778850|NCT00436618|459818736|FG002|Overall Study|Still on treatment|7|||
127778851|NCT00698204|459818737|FG000|Overall Study|Withdrawal by Subject|1|||
127778852|NCT00698204|459818738|FG001|Overall Study|Withdrawal by Subject|0|||
127778853|NCT00314249|459818739|FG000|Overall Study|Adverse Event|73|||
127778854|NCT00314249|459818740|FG001|Overall Study|Adverse Event|94|||
127778855|NCT00314249|459818739|FG000|Overall Study|Lack of Efficacy|33|||
127778856|NCT00314249|459818740|FG001|Overall Study|Lack of Efficacy|24|||
127778857|NCT00314249|459818739|FG000|Overall Study|Withdrawal by Subject|21|||
127778858|NCT00314249|459818740|FG001|Overall Study|Withdrawal by Subject|28|||
127778859|NCT00314249|459818739|FG000|Overall Study|Lost to Follow-up|15|||
127778860|NCT00314249|459818740|FG001|Overall Study|Lost to Follow-up|9|||
127778861|NCT00314249|459818739|FG000|Overall Study|Physician Decision|1|||
127778862|NCT00314249|459818740|FG001|Overall Study|Physician Decision|1|||
127778863|NCT00314249|459818739|FG000|Overall Study|Withdrawn for other reasons|4|||
127778864|NCT00314249|459818740|FG001|Overall Study|Withdrawn for other reasons|1|||
127778865|NCT00314249|459818739|FG000|Overall Study|Non-Compliant|5|||
127778866|NCT00314249|459818740|FG001|Overall Study|Non-Compliant|6|||
127778867|NCT01949155|459818741|FG000|Overall Study|Lost to Follow-up|1|||
127778868|NCT01949155|459818742|FG001|Overall Study|Lost to Follow-up|0|||
127778869|NCT01949155|459818741|FG000|Overall Study|Protocol Violation|1|||
127778870|NCT01949155|459818742|FG001|Overall Study|Protocol Violation|0|||
127778871|NCT00210184|459818743|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
127778872|NCT01118325|459818746|FG000|Overall Study|Adverse Event|1|||
127778873|NCT01118325|459818747|FG001|Overall Study|Adverse Event|0|||
127778874|NCT01118325|459818748|FG002|Overall Study|Adverse Event|1|||
127778875|NCT03334409|459818749|FG000|Overall Study|Did not meet inclusion criteria|1|||
127778876|NCT03334409|459818750|FG001|Overall Study|Did not meet inclusion criteria|0|||
127778877|NCT00975715|459818751|FG000|Titration Period|Adverse Event|6|||
127778878|NCT00975715|459818752|FG001|Titration Period|Adverse Event|0|||
127778879|NCT00975715|459818751|FG000|Titration Period|Protocol Violation|1|||
127778880|NCT00975715|459818752|FG001|Titration Period|Protocol Violation|0|||
127778881|NCT00975715|459818751|FG000|Maintenance Period|Adverse Event|2|||
127778882|NCT00975715|459818752|FG001|Maintenance Period|Adverse Event|1|||
127778883|NCT01674712|459818754|FG000|Overall Study|Adverse Event|5|||
127778884|NCT01674712|459818755|FG001|Overall Study|Adverse Event|6|||
127778885|NCT01674712|459818756|FG002|Overall Study|Adverse Event|3|||
127778886|NCT01674712|459818757|FG003|Overall Study|Adverse Event|4|||
127778887|NCT01674712|459818758|FG004|Overall Study|Adverse Event|6|||
127778888|NCT01674712|459818754|FG000|Overall Study|Lost to Follow-up|1|||
127778889|NCT01674712|459818755|FG001|Overall Study|Lost to Follow-up|0|||
127778890|NCT01674712|459818756|FG002|Overall Study|Lost to Follow-up|0|||
127778891|NCT01674712|459818757|FG003|Overall Study|Lost to Follow-up|0|||
128026705|NCT02933151|460722159|FG000|Overall Study|Transferred to PD or a non-DCI facility|516|||
128026706|NCT02933151|460722160|FG001|Overall Study|Transferred to PD or a non-DCI facility|632|||
127568591|NCT04393298|459051610|FG009|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
127568592|NCT04393298|459051611|FG010|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
127568593|NCT04393298|459051612|FG011|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
127568594|NCT04393298|459051613|FG012|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
127568595|NCT04393298|459051614|FG013|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
127568596|NCT04393298|459051615|FG014|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
127568597|NCT04393298|459051601|FG000|Overall Study|Further Deterioration Noted at Clinic review|0|||
127568598|NCT04393298|459051602|FG001|Overall Study|Further Deterioration Noted at Clinic review|0|||
127568599|NCT04393298|459051603|FG002|Overall Study|Further Deterioration Noted at Clinic review|1|||
127568600|NCT04393298|459051604|FG003|Overall Study|Further Deterioration Noted at Clinic review|0|||
127568601|NCT04393298|459051605|FG004|Overall Study|Further Deterioration Noted at Clinic review|0|||
127568602|NCT04393298|459051606|FG005|Overall Study|Further Deterioration Noted at Clinic review|0|||
127568603|NCT04393298|459051607|FG006|Overall Study|Further Deterioration Noted at Clinic review|0|||
127568604|NCT04393298|459051608|FG007|Overall Study|Further Deterioration Noted at Clinic review|0|||
127568605|NCT04393298|459051609|FG008|Overall Study|Further Deterioration Noted at Clinic review|0|||
127568606|NCT04393298|459051610|FG009|Overall Study|Further Deterioration Noted at Clinic review|0|||
127568607|NCT04393298|459051611|FG010|Overall Study|Further Deterioration Noted at Clinic review|0|||
127568608|NCT04393298|459051612|FG011|Overall Study|Further Deterioration Noted at Clinic review|0|||
127568609|NCT04393298|459051613|FG012|Overall Study|Further Deterioration Noted at Clinic review|0|||
127568610|NCT04393298|459051614|FG013|Overall Study|Further Deterioration Noted at Clinic review|0|||
127568611|NCT04393298|459051615|FG014|Overall Study|Further Deterioration Noted at Clinic review|0|||
127568612|NCT04393298|459051601|FG000|Overall Study|Progressive Disease (PD)|0|||
127568613|NCT04393298|459051602|FG001|Overall Study|Progressive Disease (PD)|0|||
127568614|NCT04393298|459051603|FG002|Overall Study|Progressive Disease (PD)|0|||
127568615|NCT04393298|459051604|FG003|Overall Study|Progressive Disease (PD)|3|||
127568616|NCT04393298|459051605|FG004|Overall Study|Progressive Disease (PD)|0|||
127568617|NCT04393298|459051606|FG005|Overall Study|Progressive Disease (PD)|0|||
127690263|NCT03398148|459492226|FG002|Substudy 2 Period 1|WITHDREW CONSENT|0|||
127690264|NCT03398148|459492227|FG003|Substudy 2 Period 1|WITHDREW CONSENT|0|||
127690265|NCT03398148|459492228|FG004|Substudy 2 Period 1|WITHDREW CONSENT|0|||
127690266|NCT03398148|459492229|FG005|Substudy 2 Period 1|WITHDREW CONSENT|0|||
127690267|NCT03398148|459492230|FG006|Substudy 2 Period 1|WITHDREW CONSENT|0|||
127690268|NCT03398148|459492231|FG007|Substudy 2 Period 1|WITHDREW CONSENT|0|||
127690269|NCT03398148|459492232|FG008|Substudy 2 Period 1|WITHDREW CONSENT|0|||
127690270|NCT03398148|459492233|FG009|Substudy 2 Period 1|WITHDREW CONSENT|6|||
127690271|NCT03398148|459492234|FG010|Substudy 2 Period 1|WITHDREW CONSENT|4|||
127690272|NCT03398148|459492235|FG011|Substudy 2 Period 1|WITHDREW CONSENT|0|||
127690273|NCT03398148|459492236|FG012|Substudy 2 Period 1|WITHDREW CONSENT|0|||
127690274|NCT03398148|459492237|FG013|Substudy 2 Period 1|WITHDREW CONSENT|0|||
127690275|NCT03398148|459492238|FG014|Substudy 2 Period 1|WITHDREW CONSENT|0|||
127690276|NCT03398148|459492224|FG000|Substudy 2 Period 1|Lack of Efficacy|0|||
127690277|NCT03398148|459492225|FG001|Substudy 2 Period 1|Lack of Efficacy|0|||
127690278|NCT03398148|459492226|FG002|Substudy 2 Period 1|Lack of Efficacy|0|||
127690279|NCT03398148|459492227|FG003|Substudy 2 Period 1|Lack of Efficacy|0|||
127690280|NCT03398148|459492228|FG004|Substudy 2 Period 1|Lack of Efficacy|0|||
127690281|NCT03398148|459492229|FG005|Substudy 2 Period 1|Lack of Efficacy|0|||
127690282|NCT03398148|459492230|FG006|Substudy 2 Period 1|Lack of Efficacy|0|||
127690283|NCT03398148|459492231|FG007|Substudy 2 Period 1|Lack of Efficacy|0|||
127690284|NCT03398148|459492232|FG008|Substudy 2 Period 1|Lack of Efficacy|0|||
127690285|NCT03398148|459492233|FG009|Substudy 2 Period 1|Lack of Efficacy|6|||
127690286|NCT03398148|459492234|FG010|Substudy 2 Period 1|Lack of Efficacy|1|||
127690287|NCT03398148|459492235|FG011|Substudy 2 Period 1|Lack of Efficacy|0|||
127690288|NCT03398148|459492236|FG012|Substudy 2 Period 1|Lack of Efficacy|0|||
127778892|NCT01674712|459818758|FG004|Overall Study|Lost to Follow-up|0|||
128026707|NCT02933151|460722159|FG000|Overall Study|Recovered Kidney Function|47|||
128026708|NCT02933151|460722160|FG001|Overall Study|Recovered Kidney Function|29|||
128026709|NCT01013870|460722161|FG000|Overall Study|Lost to Follow-up|1|||
127568618|NCT04393298|459051607|FG006|Overall Study|Progressive Disease (PD)|0|||
127690289|NCT03398148|459492237|FG013|Substudy 2 Period 1|Lack of Efficacy|0|||
127690290|NCT03398148|459492238|FG014|Substudy 2 Period 1|Lack of Efficacy|0|||
127690291|NCT03398148|459492224|FG000|Substudy 2 Period 1|COVID-19 INFECTION|0|||
127778893|NCT01674712|459818754|FG000|Overall Study|Protocol Violation|2|||
127778894|NCT01674712|459818755|FG001|Overall Study|Protocol Violation|0|||
127568619|NCT04393298|459051608|FG007|Overall Study|Progressive Disease (PD)|0|||
127568620|NCT04393298|459051609|FG008|Overall Study|Progressive Disease (PD)|0|||
127568621|NCT04393298|459051610|FG009|Overall Study|Progressive Disease (PD)|0|||
127568622|NCT04393298|459051611|FG010|Overall Study|Progressive Disease (PD)|0|||
127568623|NCT04393298|459051612|FG011|Overall Study|Progressive Disease (PD)|0|||
127568624|NCT04393298|459051613|FG012|Overall Study|Progressive Disease (PD)|0|||
127568625|NCT04393298|459051614|FG013|Overall Study|Progressive Disease (PD)|0|||
127568626|NCT04393298|459051615|FG014|Overall Study|Progressive Disease (PD)|0|||
127568627|NCT04393298|459051601|FG000|Overall Study|Started a New Cancer Treatment|0|||
127568628|NCT04393298|459051602|FG001|Overall Study|Started a New Cancer Treatment|0|||
127568629|NCT04393298|459051603|FG002|Overall Study|Started a New Cancer Treatment|0|||
127568630|NCT04393298|459051604|FG003|Overall Study|Started a New Cancer Treatment|0|||
127568631|NCT04393298|459051605|FG004|Overall Study|Started a New Cancer Treatment|1|||
127568632|NCT04393298|459051606|FG005|Overall Study|Started a New Cancer Treatment|0|||
127568633|NCT04393298|459051607|FG006|Overall Study|Started a New Cancer Treatment|0|||
127568634|NCT04393298|459051608|FG007|Overall Study|Started a New Cancer Treatment|0|||
127568635|NCT04393298|459051609|FG008|Overall Study|Started a New Cancer Treatment|0|||
127568636|NCT04393298|459051610|FG009|Overall Study|Started a New Cancer Treatment|0|||
127568637|NCT04393298|459051611|FG010|Overall Study|Started a New Cancer Treatment|0|||
127568638|NCT04393298|459051612|FG011|Overall Study|Started a New Cancer Treatment|0|||
127568639|NCT04393298|459051613|FG012|Overall Study|Started a New Cancer Treatment|0|||
127568640|NCT04393298|459051614|FG013|Overall Study|Started a New Cancer Treatment|0|||
127568641|NCT04393298|459051615|FG014|Overall Study|Started a New Cancer Treatment|0|||
127568642|NCT04393298|459051601|FG000|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
127568643|NCT04393298|459051602|FG001|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
127568644|NCT04393298|459051603|FG002|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
127568645|NCT04393298|459051604|FG003|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
127568646|NCT04393298|459051605|FG004|Overall Study|Sponsor decision- sepsis (treatment delay)|1|||
127568647|NCT04393298|459051606|FG005|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
127568648|NCT04393298|459051607|FG006|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
127568649|NCT04393298|459051608|FG007|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
127568650|NCT04393298|459051609|FG008|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
127568651|NCT04393298|459051610|FG009|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
127568652|NCT04393298|459051611|FG010|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
127568653|NCT04393298|459051612|FG011|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
127568654|NCT04393298|459051613|FG012|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
127568655|NCT04393298|459051614|FG013|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
127568656|NCT04393298|459051615|FG014|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
127568657|NCT04393298|459051601|FG000|Overall Study|Due to symptoms (New Brain Metastases)|0|||
127568658|NCT04393298|459051602|FG001|Overall Study|Due to symptoms (New Brain Metastases)|0|||
127568659|NCT04393298|459051603|FG002|Overall Study|Due to symptoms (New Brain Metastases)|0|||
127568660|NCT04393298|459051604|FG003|Overall Study|Due to symptoms (New Brain Metastases)|0|||
127568661|NCT04393298|459051605|FG004|Overall Study|Due to symptoms (New Brain Metastases)|0|||
127568662|NCT04393298|459051606|FG005|Overall Study|Due to symptoms (New Brain Metastases)|1|||
127568663|NCT04393298|459051607|FG006|Overall Study|Due to symptoms (New Brain Metastases)|0|||
127778895|NCT01674712|459818756|FG002|Overall Study|Protocol Violation|0|||
127778896|NCT01674712|459818757|FG003|Overall Study|Protocol Violation|0|||
127778897|NCT01674712|459818758|FG004|Overall Study|Protocol Violation|0|||
127778898|NCT01674712|459818754|FG000|Overall Study|Withdrawal by Subject|2|||
127778899|NCT01674712|459818755|FG001|Overall Study|Withdrawal by Subject|2|||
127778900|NCT01674712|459818756|FG002|Overall Study|Withdrawal by Subject|5|||
127778901|NCT01674712|459818757|FG003|Overall Study|Withdrawal by Subject|4|||
127778902|NCT01674712|459818758|FG004|Overall Study|Withdrawal by Subject|3|||
127778903|NCT01674712|459818754|FG000|Overall Study|Administrative|0|||
127778904|NCT01674712|459818755|FG001|Overall Study|Administrative|1|||
127778905|NCT01674712|459818756|FG002|Overall Study|Administrative|0|||
127778906|NCT01674712|459818757|FG003|Overall Study|Administrative|0|||
127568664|NCT04393298|459051608|FG007|Overall Study|Due to symptoms (New Brain Metastases)|0|||
127778907|NCT01674712|459818758|FG004|Overall Study|Administrative|1|||
127778908|NCT01674712|459818754|FG000|Overall Study|Lack of Efficacy|0|||
127778909|NCT01674712|459818755|FG001|Overall Study|Lack of Efficacy|0|||
128026710|NCT01013870|460722162|FG001|Overall Study|Lost to Follow-up|3|||
128026711|NCT03048019|460722163|FG000|Overall Study|Adverse Event|1|||
128026712|NCT03048019|460722164|FG001|Overall Study|Adverse Event|0|||
128026713|NCT03400787|460722165|FG000|Overall Study|Lost to Follow-up|1|||
128026714|NCT03400787|460722166|FG001|Overall Study|Lost to Follow-up|0|||
127568665|NCT04393298|459051609|FG008|Overall Study|Due to symptoms (New Brain Metastases)|0|||
127568666|NCT04393298|459051610|FG009|Overall Study|Due to symptoms (New Brain Metastases)|0|||
127568667|NCT04393298|459051611|FG010|Overall Study|Due to symptoms (New Brain Metastases)|0|||
127568668|NCT04393298|459051612|FG011|Overall Study|Due to symptoms (New Brain Metastases)|0|||
128026715|NCT03400787|460722165|FG000|Overall Study|Death|1|||
127778910|NCT01674712|459818756|FG002|Overall Study|Lack of Efficacy|1|||
127778911|NCT01674712|459818757|FG003|Overall Study|Lack of Efficacy|0|||
127778912|NCT01674712|459818758|FG004|Overall Study|Lack of Efficacy|1|||
127568669|NCT04393298|459051613|FG012|Overall Study|Due to symptoms (New Brain Metastases)|0|||
127568670|NCT04393298|459051614|FG013|Overall Study|Due to symptoms (New Brain Metastases)|0|||
127568671|NCT04393298|459051615|FG014|Overall Study|Due to symptoms (New Brain Metastases)|0|||
127568672|NCT04393298|459051601|FG000|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
127568673|NCT04393298|459051602|FG001|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
127568674|NCT04393298|459051603|FG002|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
127568675|NCT04393298|459051604|FG003|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
127568676|NCT04393298|459051605|FG004|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
127568677|NCT04393298|459051606|FG005|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
127568678|NCT04393298|459051607|FG006|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
127568679|NCT04393298|459051608|FG007|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
127568680|NCT04393298|459051609|FG008|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
127568681|NCT04393298|459051610|FG009|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
127568682|NCT04393298|459051611|FG010|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
127568683|NCT04393298|459051612|FG011|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
127568684|NCT04393298|459051613|FG012|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
127568685|NCT04393298|459051614|FG013|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
127568686|NCT04393298|459051615|FG014|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
127568687|NCT04393298|459051601|FG000|Overall Study|Death|0|||
127568688|NCT04393298|459051602|FG001|Overall Study|Death|0|||
127568689|NCT04393298|459051603|FG002|Overall Study|Death|0|||
127568690|NCT04393298|459051604|FG003|Overall Study|Death|0|||
127568691|NCT04393298|459051605|FG004|Overall Study|Death|0|||
127568692|NCT04393298|459051606|FG005|Overall Study|Death|1|||
127568693|NCT04393298|459051607|FG006|Overall Study|Death|1|||
127568694|NCT04393298|459051608|FG007|Overall Study|Death|0|||
127568695|NCT04393298|459051609|FG008|Overall Study|Death|1|||
127568696|NCT04393298|459051610|FG009|Overall Study|Death|1|||
127568697|NCT04393298|459051611|FG010|Overall Study|Death|0|||
127568698|NCT04393298|459051612|FG011|Overall Study|Death|1|||
127568699|NCT04393298|459051613|FG012|Overall Study|Death|1|||
127568700|NCT04393298|459051614|FG013|Overall Study|Death|0|||
127568701|NCT04393298|459051615|FG014|Overall Study|Death|1|||
127568702|NCT04393298|459051601|FG000|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
127568703|NCT04393298|459051602|FG001|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
127568704|NCT04393298|459051603|FG002|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
127568705|NCT04393298|459051604|FG003|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
127568706|NCT04393298|459051605|FG004|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
127568707|NCT04393298|459051606|FG005|Overall Study|Progressive Disease - New Brain Mets on CT Head|1|||
127568708|NCT04393298|459051607|FG006|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
127568709|NCT04393298|459051608|FG007|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
127568710|NCT04393298|459051609|FG008|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
127568711|NCT04393298|459051610|FG009|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
127568712|NCT04393298|459051611|FG010|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
127568713|NCT04393298|459051612|FG011|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
127568714|NCT04393298|459051613|FG012|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
127568715|NCT04393298|459051614|FG013|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
127568716|NCT04393298|459051615|FG014|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
127568717|NCT04393298|459051601|FG000|Overall Study|Progressive Disease and Subsequent Death|0|||
127568718|NCT04393298|459051602|FG001|Overall Study|Progressive Disease and Subsequent Death|0|||
127568719|NCT04393298|459051603|FG002|Overall Study|Progressive Disease and Subsequent Death|0|||
127568720|NCT04393298|459051604|FG003|Overall Study|Progressive Disease and Subsequent Death|0|||
127568721|NCT04393298|459051605|FG004|Overall Study|Progressive Disease and Subsequent Death|0|||
127568722|NCT04393298|459051606|FG005|Overall Study|Progressive Disease and Subsequent Death|0|||
127568723|NCT04393298|459051607|FG006|Overall Study|Progressive Disease and Subsequent Death|1|||
127568724|NCT04393298|459051608|FG007|Overall Study|Progressive Disease and Subsequent Death|0|||
127778913|NCT03974334|459818759|FG000|Overall Study|Lost to Follow-up|1|||
127778914|NCT00024167|459818760|FG000|Overall Study|Death|53|||
127778915|NCT00024167|459818761|FG001|Overall Study|Death|47|||
127568725|NCT04393298|459051609|FG008|Overall Study|Progressive Disease and Subsequent Death|0|||
127778916|NCT01379573|459818771|FG000|Overall Study|Lost to Follow-up|1|||
127778917|NCT01379573|459818771|FG000|Overall Study|Screen Failure|10|||
127778918|NCT00962390|459818772|FG000|Overall Study|Adverse Event|0|||
128026716|NCT03400787|460722166|FG001|Overall Study|Death|0|||
128026717|NCT03400787|460722165|FG000|Overall Study|Protocol Violation|0|||
127568726|NCT04393298|459051610|FG009|Overall Study|Progressive Disease and Subsequent Death|0|||
127568727|NCT04393298|459051611|FG010|Overall Study|Progressive Disease and Subsequent Death|0|||
128026718|NCT03400787|460722166|FG001|Overall Study|Protocol Violation|2|||
128026719|NCT03400787|460722165|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
128026720|NCT03400787|460722166|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
128026721|NCT00348374|460722174|FG000|Overall Study|Adverse Event|1|||
128026722|NCT00348374|460722175|FG001|Overall Study|Adverse Event|4|||
128026723|NCT00348374|460722174|FG000|Overall Study|Lost to Follow-up|1|||
128026724|NCT00348374|460722175|FG001|Overall Study|Lost to Follow-up|3|||
128026725|NCT00348374|460722174|FG000|Overall Study|Withdrawal by Subject|5|||
128026726|NCT00348374|460722175|FG001|Overall Study|Withdrawal by Subject|5|||
128026727|NCT00348374|460722174|FG000|Overall Study|Other|11|||
128026728|NCT00348374|460722175|FG001|Overall Study|Other|12|||
128026729|NCT00348374|460722174|FG000|Overall Study|ongoing at date of cutoff|1|||
128026730|NCT00348374|460722175|FG001|Overall Study|ongoing at date of cutoff|1|||
128026731|NCT00348374|460722174|FG000|Overall Study|randomized but did not receive treatment|0|||
128026732|NCT00348374|460722175|FG001|Overall Study|randomized but did not receive treatment|7|||
128026733|NCT02070380|460722184|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
128026734|NCT02070380|460722185|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
128026735|NCT02070380|460722186|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
128026736|NCT02070380|460722187|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
128026737|NCT02070380|460722184|FG000|Second Injection|Image sets missing or technically inadeq|0|||
128026738|NCT02070380|460722185|FG001|Second Injection|Image sets missing or technically inadeq|1|||
128026739|NCT02070380|460722186|FG002|Second Injection|Image sets missing or technically inadeq|0|||
128026740|NCT02070380|460722187|FG003|Second Injection|Image sets missing or technically inadeq|0|||
128026741|NCT02070380|460722184|FG000|Second Injection|Protocol Violation|0|||
128026742|NCT02070380|460722185|FG001|Second Injection|Protocol Violation|1|||
128026743|NCT02070380|460722186|FG002|Second Injection|Protocol Violation|1|||
128026744|NCT02070380|460722187|FG003|Second Injection|Protocol Violation|5|||
128026745|NCT02105012|460722200|FG000|Overall Study|Withdrawal by Subject|11|||
128026746|NCT02105012|460722200|FG000|Overall Study|Protocol Specified Criteria|9|||
128026747|NCT02105012|460722200|FG000|Overall Study|Lost to Follow-up|4|||
128026748|NCT02105012|460722200|FG000|Overall Study|Protocol Violation|4|||
128026749|NCT02105012|460722200|FG000|Overall Study|Physician Decision|3|||
128026750|NCT02105012|460722200|FG000|Overall Study|Adverse Event|1|||
128026751|NCT02105012|460722200|FG000|Overall Study|Lack of Efficacy|1|||
128026752|NCT03436420|460722201|FG000|Overall Study|Lack of Efficacy|3|||
128026753|NCT02619812|460722202|FG000|Overall Study|Withdrawal by Subject|0|||
128026754|NCT02619812|460722203|FG001|Overall Study|Withdrawal by Subject|0|||
128026755|NCT02619812|460722204|FG002|Overall Study|Withdrawal by Subject|1|||
128026756|NCT02619812|460722205|FG003|Overall Study|Withdrawal by Subject|2|||
128026757|NCT00981175|460722206|FG000|Primary Dose Vaccination|Adverse Event|1|||
128026758|NCT00981175|460722207|FG001|Primary Dose Vaccination|Adverse Event|0|||
128026759|NCT00981175|460722206|FG000|Primary Dose Vaccination|Protocol Violation|0|||
128026760|NCT00981175|460722207|FG001|Primary Dose Vaccination|Protocol Violation|1|||
128026761|NCT00981175|460722206|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
128026762|NCT00981175|460722207|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
128026763|NCT00981175|460722206|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
128026764|NCT00981175|460722207|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
127690292|NCT03398148|459492225|FG001|Substudy 2 Period 1|COVID-19 INFECTION|0|||
127690293|NCT03398148|459492226|FG002|Substudy 2 Period 1|COVID-19 INFECTION|0|||
127690294|NCT03398148|459492227|FG003|Substudy 2 Period 1|COVID-19 INFECTION|0|||
127690295|NCT03398148|459492228|FG004|Substudy 2 Period 1|COVID-19 INFECTION|0|||
127690296|NCT03398148|459492229|FG005|Substudy 2 Period 1|COVID-19 INFECTION|0|||
128026765|NCT01379937|460722211|FG000|Overall Study|Protocol Violation|0|||
128026766|NCT01379937|460722212|FG001|Overall Study|Protocol Violation|0|||
128026767|NCT01379937|460722213|FG002|Overall Study|Protocol Violation|0|||
128026768|NCT01379937|460722214|FG003|Overall Study|Protocol Violation|1|||
128026769|NCT01379937|460722211|FG000|Overall Study|Consent withdrawal|0|||
128026770|NCT01379937|460722212|FG001|Overall Study|Consent withdrawal|1|||
128026771|NCT01379937|460722213|FG002|Overall Study|Consent withdrawal|0|||
128026772|NCT01379937|460722214|FG003|Overall Study|Consent withdrawal|0|||
127690297|NCT03398148|459492230|FG006|Substudy 2 Period 1|COVID-19 INFECTION|0|||
127690298|NCT03398148|459492231|FG007|Substudy 2 Period 1|COVID-19 INFECTION|0|||
127690299|NCT03398148|459492232|FG008|Substudy 2 Period 1|COVID-19 INFECTION|0|||
128026773|NCT01379937|460722211|FG000|Overall Study|Lost to Follow-up|1|||
128026774|NCT01379937|460722212|FG001|Overall Study|Lost to Follow-up|2|||
127690300|NCT03398148|459492233|FG009|Substudy 2 Period 1|COVID-19 INFECTION|0|||
127690301|NCT03398148|459492234|FG010|Substudy 2 Period 1|COVID-19 INFECTION|1|||
127690302|NCT03398148|459492235|FG011|Substudy 2 Period 1|COVID-19 INFECTION|0|||
127778919|NCT00962390|459818773|FG001|Overall Study|Adverse Event|0|||
128026775|NCT01379937|460722213|FG002|Overall Study|Lost to Follow-up|2|||
128026776|NCT01379937|460722214|FG003|Overall Study|Lost to Follow-up|0|||
128026777|NCT01104870|460722215|FG000|Overall Study|Adverse Event|1|||
128026778|NCT01104870|460722216|FG001|Overall Study|Adverse Event|1|||
128026779|NCT01104870|460722217|FG002|Overall Study|Adverse Event|0|||
128026780|NCT01104870|460722215|FG000|Overall Study|Death|0|||
128026781|NCT01104870|460722216|FG001|Overall Study|Death|0|||
127568728|NCT04393298|459051612|FG011|Overall Study|Progressive Disease and Subsequent Death|0|||
127568729|NCT04393298|459051613|FG012|Overall Study|Progressive Disease and Subsequent Death|0|||
127568730|NCT04393298|459051614|FG013|Overall Study|Progressive Disease and Subsequent Death|0|||
127568731|NCT04393298|459051615|FG014|Overall Study|Progressive Disease and Subsequent Death|0|||
127568732|NCT04393298|459051601|FG000|Overall Study|Patient Passed Away|0|||
127568733|NCT04393298|459051602|FG001|Overall Study|Patient Passed Away|0|||
127568734|NCT04393298|459051603|FG002|Overall Study|Patient Passed Away|0|||
127568735|NCT04393298|459051604|FG003|Overall Study|Patient Passed Away|0|||
127568736|NCT04393298|459051605|FG004|Overall Study|Patient Passed Away|0|||
127568737|NCT04393298|459051606|FG005|Overall Study|Patient Passed Away|0|||
127568738|NCT04393298|459051607|FG006|Overall Study|Patient Passed Away|0|||
127568739|NCT04393298|459051608|FG007|Overall Study|Patient Passed Away|1|||
127568740|NCT04393298|459051609|FG008|Overall Study|Patient Passed Away|0|||
127568741|NCT04393298|459051610|FG009|Overall Study|Patient Passed Away|0|||
127568742|NCT04393298|459051611|FG010|Overall Study|Patient Passed Away|0|||
127568743|NCT04393298|459051612|FG011|Overall Study|Patient Passed Away|0|||
127568744|NCT04393298|459051613|FG012|Overall Study|Patient Passed Away|0|||
127568745|NCT04393298|459051614|FG013|Overall Study|Patient Passed Away|0|||
127568746|NCT04393298|459051615|FG014|Overall Study|Patient Passed Away|0|||
127568747|NCT04393298|459051601|FG000|Overall Study|Patient Deceased|0|||
127568748|NCT04393298|459051602|FG001|Overall Study|Patient Deceased|0|||
127568749|NCT04393298|459051603|FG002|Overall Study|Patient Deceased|0|||
127568750|NCT04393298|459051604|FG003|Overall Study|Patient Deceased|0|||
127568751|NCT04393298|459051605|FG004|Overall Study|Patient Deceased|0|||
127568752|NCT04393298|459051606|FG005|Overall Study|Patient Deceased|0|||
127778920|NCT00962390|459818774|FG002|Overall Study|Adverse Event|3|||
127778921|NCT00962390|459818775|FG003|Overall Study|Adverse Event|1|||
127568753|NCT04393298|459051607|FG006|Overall Study|Patient Deceased|0|||
127568754|NCT04393298|459051608|FG007|Overall Study|Patient Deceased|1|||
127568755|NCT04393298|459051609|FG008|Overall Study|Patient Deceased|0|||
127568756|NCT04393298|459051610|FG009|Overall Study|Patient Deceased|0|||
127568757|NCT04393298|459051611|FG010|Overall Study|Patient Deceased|0|||
127778922|NCT00962390|459818772|FG000|Overall Study|Lost to Follow-up|2|||
127778923|NCT00962390|459818773|FG001|Overall Study|Lost to Follow-up|2|||
127778924|NCT00962390|459818774|FG002|Overall Study|Lost to Follow-up|0|||
127778925|NCT00962390|459818775|FG003|Overall Study|Lost to Follow-up|0|||
127778926|NCT00962390|459818772|FG000|Overall Study|Protocol Violation|1|||
127778927|NCT00962390|459818773|FG001|Overall Study|Protocol Violation|0|||
127778928|NCT00962390|459818774|FG002|Overall Study|Protocol Violation|0|||
127778929|NCT00962390|459818775|FG003|Overall Study|Protocol Violation|0|||
127778930|NCT00962390|459818772|FG000|Overall Study|Withdrawal by Subject|1|||
127568758|NCT04393298|459051612|FG011|Overall Study|Patient Deceased|0|||
127568759|NCT04393298|459051613|FG012|Overall Study|Patient Deceased|0|||
127568760|NCT04393298|459051614|FG013|Overall Study|Patient Deceased|0|||
127568761|NCT04393298|459051615|FG014|Overall Study|Patient Deceased|0|||
127568762|NCT04393298|459051601|FG000|Overall Study|Patient Discharged to Hospice|0|||
127778931|NCT00962390|459818773|FG001|Overall Study|Withdrawal by Subject|1|||
127778932|NCT00962390|459818774|FG002|Overall Study|Withdrawal by Subject|1|||
127778933|NCT00962390|459818775|FG003|Overall Study|Withdrawal by Subject|0|||
127778934|NCT00770770|459818780|FG000|Overall Study|Lost to Follow-up|1|||
127778935|NCT00770770|459818781|FG001|Overall Study|Lost to Follow-up|0|||
127778936|NCT00770770|459818780|FG000|Overall Study|Withdrawal by Subject|1|||
127778937|NCT00770770|459818781|FG001|Overall Study|Withdrawal by Subject|0|||
127568763|NCT04393298|459051602|FG001|Overall Study|Patient Discharged to Hospice|0|||
127568764|NCT04393298|459051603|FG002|Overall Study|Patient Discharged to Hospice|0|||
127690303|NCT03398148|459492236|FG012|Substudy 2 Period 1|COVID-19 INFECTION|0|||
127690304|NCT03398148|459492237|FG013|Substudy 2 Period 1|COVID-19 INFECTION|0|||
127690305|NCT03398148|459492238|FG014|Substudy 2 Period 1|COVID-19 INFECTION|0|||
127690306|NCT03398148|459492224|FG000|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
127690307|NCT03398148|459492225|FG001|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
127690308|NCT03398148|459492226|FG002|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
127690309|NCT03398148|459492227|FG003|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
127778938|NCT00770770|459818780|FG000|Overall Study|Death|0|||
127568765|NCT04393298|459051604|FG003|Overall Study|Patient Discharged to Hospice|0|||
127568766|NCT04393298|459051605|FG004|Overall Study|Patient Discharged to Hospice|0|||
127778939|NCT00770770|459818781|FG001|Overall Study|Death|1|||
128026782|NCT01104870|460722217|FG002|Overall Study|Death|1|||
128026783|NCT01104870|460722215|FG000|Overall Study|Withdrawal by Subject|0|||
127568767|NCT04393298|459051606|FG005|Overall Study|Patient Discharged to Hospice|0|||
127568768|NCT04393298|459051607|FG006|Overall Study|Patient Discharged to Hospice|0|||
127690310|NCT03398148|459492228|FG004|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
127568769|NCT04393298|459051608|FG007|Overall Study|Patient Discharged to Hospice|0|||
127778940|NCT00770770|459818780|FG000|Overall Study|Study Terminated|8|||
127778941|NCT00770770|459818781|FG001|Overall Study|Study Terminated|0|||
127568770|NCT04393298|459051609|FG008|Overall Study|Patient Discharged to Hospice|1|||
127778942|NCT05372653|459818783|FG000|Overall Study|Study treatment terminated by parent/guardian|1|||
128026784|NCT01104870|460722216|FG001|Overall Study|Withdrawal by Subject|0|||
127778943|NCT05372653|459818784|FG001|Overall Study|Study treatment terminated by parent/guardian|3|||
127778944|NCT05372653|459818783|FG000|Overall Study|Adverse Event|0|||
127778945|NCT05372653|459818784|FG001|Overall Study|Adverse Event|1|||
127778946|NCT00711529|459818791|FG000|Overall Study|Protocol Violation|2|||
127778947|NCT00711529|459818792|FG001|Overall Study|Protocol Violation|0|||
128026785|NCT01104870|460722217|FG002|Overall Study|Withdrawal by Subject|1|||
128026786|NCT04985682|460722218|FG000|Overall Study|Withdrawal by Subject|1|||
128026787|NCT00079781|460722228|FG000|Pre-implant Period|Withdrawal by Subject|2|||
128026788|NCT00079781|460722229|FG001|Pre-implant Period|Withdrawal by Subject|0|||
128026789|NCT00079781|460722230|FG002|Pre-implant Period|Withdrawal by Subject|0|||
128026790|NCT00079781|460722228|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
128026791|NCT00079781|460722229|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
128026792|NCT00079781|460722230|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
128026793|NCT00079781|460722228|FG000|Follow-up Period|Withdrawal by Subject|3|||
128026794|NCT00079781|460722229|FG001|Follow-up Period|Withdrawal by Subject|0|||
128026795|NCT00079781|460722230|FG002|Follow-up Period|Withdrawal by Subject|1|||
128026796|NCT00079781|460722228|FG000|Follow-up Period|Lost to Follow-up|1|||
127568771|NCT04393298|459051610|FG009|Overall Study|Patient Discharged to Hospice|0|||
127568772|NCT04393298|459051611|FG010|Overall Study|Patient Discharged to Hospice|0|||
127568773|NCT04393298|459051612|FG011|Overall Study|Patient Discharged to Hospice|0|||
127568774|NCT04393298|459051613|FG012|Overall Study|Patient Discharged to Hospice|0|||
127568775|NCT04393298|459051614|FG013|Overall Study|Patient Discharged to Hospice|0|||
127568776|NCT04393298|459051615|FG014|Overall Study|Patient Discharged to Hospice|0|||
127568777|NCT04393298|459051601|FG000|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
127568778|NCT04393298|459051602|FG001|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
127568779|NCT04393298|459051603|FG002|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
127568780|NCT04393298|459051604|FG003|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
127568781|NCT04393298|459051605|FG004|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
127568782|NCT04393298|459051606|FG005|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
127568783|NCT04393298|459051607|FG006|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
127568784|NCT04393298|459051608|FG007|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
127568785|NCT04393298|459051609|FG008|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
127568786|NCT04393298|459051610|FG009|Overall Study|Symptomatic Cancer - Unfit to take a call|1|||
127568787|NCT04393298|459051611|FG010|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
127568788|NCT04393298|459051612|FG011|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
127568789|NCT04393298|459051613|FG012|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
127778948|NCT00711529|459818791|FG000|Overall Study|Withdrawal by Subject|2|||
127778949|NCT00711529|459818792|FG001|Overall Study|Withdrawal by Subject|6|||
127778950|NCT03740997|459818796|FG000|Overall Study|Withdrawal by Subject|1|||
127778951|NCT03740997|459818797|FG001|Overall Study|Withdrawal by Subject|0|||
127778952|NCT03740997|459818796|FG000|Overall Study|Participant was unable to complete study procedures|1|||
127778953|NCT03740997|459818797|FG001|Overall Study|Participant was unable to complete study procedures|0|||
127778954|NCT01829425|459818799|FG000|Overall Study|Withdrawal by Subject|4|||
127778955|NCT01829425|459818800|FG001|Overall Study|Withdrawal by Subject|3|||
127778956|NCT01829425|459818799|FG000|Overall Study|Lost to Follow-up|2|||
128026797|NCT00079781|460722229|FG001|Follow-up Period|Lost to Follow-up|0|||
128026798|NCT00079781|460722230|FG002|Follow-up Period|Lost to Follow-up|0|||
128026799|NCT00079781|460722228|FG000|Follow-up Period|Death|0|||
128026800|NCT00079781|460722229|FG001|Follow-up Period|Death|0|||
128026801|NCT00079781|460722230|FG002|Follow-up Period|Death|1|||
128026802|NCT04641975|460722231|FG000|Overall Study|Protocol Violation|1|||
127568790|NCT04393298|459051614|FG013|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
127568791|NCT04393298|459051615|FG014|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
127690311|NCT03398148|459492229|FG005|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
127690312|NCT03398148|459492230|FG006|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
127690313|NCT03398148|459492231|FG007|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
127690314|NCT03398148|459492232|FG008|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
127690315|NCT03398148|459492233|FG009|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
127690316|NCT03398148|459492234|FG010|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|1|||
127690317|NCT03398148|459492235|FG011|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
127690318|NCT03398148|459492236|FG012|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
128026803|NCT04641975|460722232|FG001|Overall Study|Protocol Violation|2|||
128026804|NCT04641975|460722233|FG002|Overall Study|Protocol Violation|0|||
127568792|NCT04393298|459051601|FG000|Overall Study|Clinical Progression in Combination with AE|0|||
128026805|NCT04641975|460722234|FG003|Overall Study|Protocol Violation|0|||
128026806|NCT04641975|460722231|FG000|Overall Study|Adverse Event|0|||
128026807|NCT04641975|460722232|FG001|Overall Study|Adverse Event|0|||
128026808|NCT04641975|460722233|FG002|Overall Study|Adverse Event|1|||
128026809|NCT04641975|460722234|FG003|Overall Study|Adverse Event|1|||
128026810|NCT04641975|460722231|FG000|Overall Study|Withdrawal by Subject|1|||
127568793|NCT04393298|459051602|FG001|Overall Study|Clinical Progression in Combination with AE|0|||
128026811|NCT04641975|460722232|FG001|Overall Study|Withdrawal by Subject|0|||
128026812|NCT04641975|460722233|FG002|Overall Study|Withdrawal by Subject|0|||
128026813|NCT04641975|460722234|FG003|Overall Study|Withdrawal by Subject|0|||
128026814|NCT01546987|460722238|FG000|Overall Study|Protocol Violation|3|||
128026815|NCT01546987|460722239|FG001|Overall Study|Protocol Violation|4|||
128026816|NCT03596983|460722240|FG000|Overall Study|Withdrawal by Subject|3|||
128026817|NCT05287685|460722241|FG000|Pilot Randomized Controlled Trial|Withdrawal by Subject|2|||
128026818|NCT05287685|460722242|FG001|Pilot Randomized Controlled Trial|Withdrawal by Subject|1|||
127690319|NCT03398148|459492237|FG013|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
127690320|NCT03398148|459492238|FG014|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
127690321|NCT03398148|459492224|FG000|Substudy 2 Period 1|Other|0|||
127690322|NCT03398148|459492225|FG001|Substudy 2 Period 1|Other|0|||
127690323|NCT03398148|459492226|FG002|Substudy 2 Period 1|Other|0|||
127690324|NCT03398148|459492227|FG003|Substudy 2 Period 1|Other|0|||
127690325|NCT03398148|459492228|FG004|Substudy 2 Period 1|Other|0|||
127690326|NCT03398148|459492229|FG005|Substudy 2 Period 1|Other|0|||
127690327|NCT03398148|459492230|FG006|Substudy 2 Period 1|Other|0|||
127690328|NCT03398148|459492231|FG007|Substudy 2 Period 1|Other|0|||
127690329|NCT03398148|459492232|FG008|Substudy 2 Period 1|Other|0|||
127690330|NCT03398148|459492233|FG009|Substudy 2 Period 1|Other|4|||
127690331|NCT03398148|459492234|FG010|Substudy 2 Period 1|Other|4|||
127690332|NCT03398148|459492235|FG011|Substudy 2 Period 1|Other|0|||
127690333|NCT03398148|459492236|FG012|Substudy 2 Period 1|Other|0|||
127690334|NCT03398148|459492237|FG013|Substudy 2 Period 1|Other|0|||
127690335|NCT03398148|459492238|FG014|Substudy 2 Period 1|Other|0|||
127690336|NCT03398148|459492224|FG000|Substudy 2 Period 1|Enrolled but not Treated|0|||
127690337|NCT03398148|459492225|FG001|Substudy 2 Period 1|Enrolled but not Treated|0|||
127690338|NCT03398148|459492226|FG002|Substudy 2 Period 1|Enrolled but not Treated|0|||
127690339|NCT03398148|459492227|FG003|Substudy 2 Period 1|Enrolled but not Treated|0|||
127690340|NCT03398148|459492228|FG004|Substudy 2 Period 1|Enrolled but not Treated|0|||
127690341|NCT03398148|459492229|FG005|Substudy 2 Period 1|Enrolled but not Treated|0|||
127690342|NCT03398148|459492230|FG006|Substudy 2 Period 1|Enrolled but not Treated|0|||
127690343|NCT03398148|459492231|FG007|Substudy 2 Period 1|Enrolled but not Treated|0|||
127690344|NCT03398148|459492232|FG008|Substudy 2 Period 1|Enrolled but not Treated|0|||
127690345|NCT03398148|459492233|FG009|Substudy 2 Period 1|Enrolled but not Treated|0|||
127690346|NCT03398148|459492234|FG010|Substudy 2 Period 1|Enrolled but not Treated|2|||
127690347|NCT03398148|459492235|FG011|Substudy 2 Period 1|Enrolled but not Treated|0|||
127690348|NCT03398148|459492236|FG012|Substudy 2 Period 1|Enrolled but not Treated|0|||
127690349|NCT03398148|459492237|FG013|Substudy 2 Period 1|Enrolled but not Treated|0|||
127690350|NCT03398148|459492238|FG014|Substudy 2 Period 1|Enrolled but not Treated|0|||
127690351|NCT03398148|459492224|FG000|Substudy 2 Period 2|Adverse Event|0|||
127690352|NCT03398148|459492225|FG001|Substudy 2 Period 2|Adverse Event|0|||
127690353|NCT03398148|459492226|FG002|Substudy 2 Period 2|Adverse Event|0|||
127690354|NCT03398148|459492227|FG003|Substudy 2 Period 2|Adverse Event|0|||
127690355|NCT03398148|459492228|FG004|Substudy 2 Period 2|Adverse Event|0|||
127690356|NCT03398148|459492229|FG005|Substudy 2 Period 2|Adverse Event|0|||
127690357|NCT03398148|459492230|FG006|Substudy 2 Period 2|Adverse Event|0|||
127690358|NCT03398148|459492231|FG007|Substudy 2 Period 2|Adverse Event|0|||
127690359|NCT03398148|459492232|FG008|Substudy 2 Period 2|Adverse Event|0|||
127690360|NCT03398148|459492233|FG009|Substudy 2 Period 2|Adverse Event|0|||
127690361|NCT03398148|459492234|FG010|Substudy 2 Period 2|Adverse Event|0|||
127690362|NCT03398148|459492235|FG011|Substudy 2 Period 2|Adverse Event|0|||
127690363|NCT03398148|459492236|FG012|Substudy 2 Period 2|Adverse Event|0|||
127690364|NCT03398148|459492237|FG013|Substudy 2 Period 2|Adverse Event|1|||
127690365|NCT03398148|459492238|FG014|Substudy 2 Period 2|Adverse Event|3|||
127690366|NCT03398148|459492224|FG000|Substudy 2 Period 2|Lost to Follow-up|0|||
127690367|NCT03398148|459492225|FG001|Substudy 2 Period 2|Lost to Follow-up|0|||
127690368|NCT03398148|459492226|FG002|Substudy 2 Period 2|Lost to Follow-up|0|||
127690369|NCT03398148|459492227|FG003|Substudy 2 Period 2|Lost to Follow-up|0|||
127690370|NCT03398148|459492228|FG004|Substudy 2 Period 2|Lost to Follow-up|0|||
127690371|NCT03398148|459492229|FG005|Substudy 2 Period 2|Lost to Follow-up|0|||
127778957|NCT01829425|459818800|FG001|Overall Study|Lost to Follow-up|1|||
127778958|NCT04178967|459818801|FG000|Induction Period|Adverse Event|4|||
127690372|NCT03398148|459492230|FG006|Substudy 2 Period 2|Lost to Follow-up|0|||
127690373|NCT03398148|459492231|FG007|Substudy 2 Period 2|Lost to Follow-up|0|||
127690374|NCT03398148|459492232|FG008|Substudy 2 Period 2|Lost to Follow-up|0|||
127690375|NCT03398148|459492233|FG009|Substudy 2 Period 2|Lost to Follow-up|0|||
127778959|NCT04178967|459818802|FG001|Induction Period|Adverse Event|6|||
127690376|NCT03398148|459492234|FG010|Substudy 2 Period 2|Lost to Follow-up|0|||
127690377|NCT03398148|459492235|FG011|Substudy 2 Period 2|Lost to Follow-up|1|||
127690378|NCT03398148|459492236|FG012|Substudy 2 Period 2|Lost to Follow-up|1|||
127690379|NCT03398148|459492237|FG013|Substudy 2 Period 2|Lost to Follow-up|0|||
127690380|NCT03398148|459492238|FG014|Substudy 2 Period 2|Lost to Follow-up|0|||
127690381|NCT03398148|459492224|FG000|Substudy 2 Period 2|WITHDREW CONSENT|0|||
127690382|NCT03398148|459492225|FG001|Substudy 2 Period 2|WITHDREW CONSENT|0|||
127690383|NCT03398148|459492226|FG002|Substudy 2 Period 2|WITHDREW CONSENT|0|||
127690384|NCT03398148|459492227|FG003|Substudy 2 Period 2|WITHDREW CONSENT|0|||
128026819|NCT05287685|460722241|FG000|Pilot Randomized Controlled Trial|Lost to Follow-up|1|||
128026820|NCT05287685|460722242|FG001|Pilot Randomized Controlled Trial|Lost to Follow-up|0|||
128026821|NCT03093870|460722243|FG000|Overall Study|Withdrawal by Subject|2|||
128026822|NCT03093870|460722244|FG001|Overall Study|Withdrawal by Subject|6|||
128026823|NCT03093870|460722245|FG002|Overall Study|Withdrawal by Subject|5|||
128026824|NCT03093870|460722243|FG000|Overall Study|Death|1|||
127778960|NCT04178967|459818803|FG002|Induction Period|Adverse Event|0|||
127778961|NCT04178967|459818804|FG003|Induction Period|Adverse Event|0|||
127778962|NCT04178967|459818805|FG004|Induction Period|Adverse Event|0|||
127778963|NCT04178967|459818806|FG005|Induction Period|Adverse Event|0|||
127778964|NCT04178967|459818807|FG006|Induction Period|Adverse Event|0|||
127778965|NCT04178967|459818808|FG007|Induction Period|Adverse Event|0|||
127778966|NCT04178967|459818809|FG008|Induction Period|Adverse Event|0|||
127778967|NCT04178967|459818810|FG009|Induction Period|Adverse Event|0|||
127778968|NCT04178967|459818811|FG010|Induction Period|Adverse Event|0|||
127778969|NCT04178967|459818801|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
127778970|NCT04178967|459818802|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
127778971|NCT04178967|459818803|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
127778972|NCT04178967|459818804|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
127778973|NCT04178967|459818805|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
127778974|NCT04178967|459818806|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
127778975|NCT04178967|459818807|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
127778976|NCT04178967|459818808|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
127778977|NCT04178967|459818809|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
127778978|NCT04178967|459818810|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
127778979|NCT04178967|459818811|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
128026825|NCT03093870|460722244|FG001|Overall Study|Death|35|||
128026826|NCT03093870|460722245|FG002|Overall Study|Death|35|||
128026827|NCT03093870|460722243|FG000|Overall Study|Radiographic disease progression|10|||
127778980|NCT04178967|459818801|FG000|Induction Period|Lack of Efficacy|4|||
127778981|NCT04178967|459818802|FG001|Induction Period|Lack of Efficacy|1|||
127778982|NCT04178967|459818803|FG002|Induction Period|Lack of Efficacy|0|||
127778983|NCT04178967|459818804|FG003|Induction Period|Lack of Efficacy|0|||
127778984|NCT04178967|459818805|FG004|Induction Period|Lack of Efficacy|0|||
127778985|NCT04178967|459818806|FG005|Induction Period|Lack of Efficacy|0|||
127778986|NCT04178967|459818807|FG006|Induction Period|Lack of Efficacy|0|||
127778987|NCT04178967|459818808|FG007|Induction Period|Lack of Efficacy|0|||
127778988|NCT04178967|459818809|FG008|Induction Period|Lack of Efficacy|0|||
127778989|NCT04178967|459818810|FG009|Induction Period|Lack of Efficacy|0|||
127778990|NCT04178967|459818811|FG010|Induction Period|Lack of Efficacy|0|||
127778991|NCT04178967|459818801|FG000|Induction Period|Protocol Violation|0|||
127778992|NCT04178967|459818802|FG001|Induction Period|Protocol Violation|6|||
127778993|NCT04178967|459818803|FG002|Induction Period|Protocol Violation|0|||
127778994|NCT04178967|459818804|FG003|Induction Period|Protocol Violation|0|||
127778995|NCT04178967|459818805|FG004|Induction Period|Protocol Violation|0|||
127778996|NCT04178967|459818806|FG005|Induction Period|Protocol Violation|0|||
127778997|NCT04178967|459818807|FG006|Induction Period|Protocol Violation|0|||
127778998|NCT04178967|459818808|FG007|Induction Period|Protocol Violation|0|||
127778999|NCT04178967|459818809|FG008|Induction Period|Protocol Violation|0|||
127779000|NCT04178967|459818810|FG009|Induction Period|Protocol Violation|0|||
127779001|NCT04178967|459818811|FG010|Induction Period|Protocol Violation|0|||
127779002|NCT04178967|459818801|FG000|Induction Period|Withdrawal by Subject|6|||
127779003|NCT04178967|459818802|FG001|Induction Period|Withdrawal by Subject|4|||
127779004|NCT04178967|459818803|FG002|Induction Period|Withdrawal by Subject|0|||
127779005|NCT04178967|459818804|FG003|Induction Period|Withdrawal by Subject|0|||
127779006|NCT04178967|459818805|FG004|Induction Period|Withdrawal by Subject|0|||
127779007|NCT04178967|459818806|FG005|Induction Period|Withdrawal by Subject|0|||
127779008|NCT04178967|459818807|FG006|Induction Period|Withdrawal by Subject|0|||
127779009|NCT04178967|459818808|FG007|Induction Period|Withdrawal by Subject|0|||
127779010|NCT04178967|459818809|FG008|Induction Period|Withdrawal by Subject|0|||
127779011|NCT04178967|459818810|FG009|Induction Period|Withdrawal by Subject|0|||
127779012|NCT04178967|459818811|FG010|Induction Period|Withdrawal by Subject|0|||
127779013|NCT04178967|459818801|FG000|Induction Period|Lost to Follow-up|2|||
128026828|NCT03093870|460722244|FG001|Overall Study|Radiographic disease progression|0|||
127779014|NCT04178967|459818802|FG001|Induction Period|Lost to Follow-up|0|||
127779015|NCT04178967|459818803|FG002|Induction Period|Lost to Follow-up|0|||
128026829|NCT03093870|460722245|FG002|Overall Study|Radiographic disease progression|0|||
127779016|NCT04178967|459818804|FG003|Induction Period|Lost to Follow-up|0|||
127779017|NCT04178967|459818805|FG004|Induction Period|Lost to Follow-up|0|||
127779018|NCT04178967|459818806|FG005|Induction Period|Lost to Follow-up|0|||
127779019|NCT04178967|459818807|FG006|Induction Period|Lost to Follow-up|0|||
127779020|NCT04178967|459818808|FG007|Induction Period|Lost to Follow-up|0|||
127779021|NCT04178967|459818809|FG008|Induction Period|Lost to Follow-up|0|||
128026830|NCT03093870|460722243|FG000|Overall Study|Clinical disease progression|1|||
128026831|NCT03093870|460722244|FG001|Overall Study|Clinical disease progression|0|||
128026832|NCT03093870|460722245|FG002|Overall Study|Clinical disease progression|0|||
128026833|NCT03093870|460722243|FG000|Overall Study|Physician Decision|2|||
128026834|NCT03093870|460722244|FG001|Overall Study|Physician Decision|0|||
127779022|NCT04178967|459818810|FG009|Induction Period|Lost to Follow-up|0|||
127779023|NCT04178967|459818811|FG010|Induction Period|Lost to Follow-up|0|||
127779024|NCT04178967|459818801|FG000|Induction Period|Participant Missed Study Visits|0|||
127779025|NCT04178967|459818802|FG001|Induction Period|Participant Missed Study Visits|1|||
127779026|NCT04178967|459818803|FG002|Induction Period|Participant Missed Study Visits|0|||
127779027|NCT04178967|459818804|FG003|Induction Period|Participant Missed Study Visits|0|||
127779028|NCT04178967|459818805|FG004|Induction Period|Participant Missed Study Visits|0|||
127779029|NCT04178967|459818806|FG005|Induction Period|Participant Missed Study Visits|0|||
127779030|NCT04178967|459818807|FG006|Induction Period|Participant Missed Study Visits|0|||
127779031|NCT04178967|459818808|FG007|Induction Period|Participant Missed Study Visits|0|||
127779032|NCT04178967|459818809|FG008|Induction Period|Participant Missed Study Visits|0|||
127779033|NCT04178967|459818810|FG009|Induction Period|Participant Missed Study Visits|0|||
127779034|NCT04178967|459818811|FG010|Induction Period|Participant Missed Study Visits|0|||
127779035|NCT04178967|459818801|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
127779036|NCT04178967|459818802|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
127779037|NCT04178967|459818803|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
127779038|NCT04178967|459818804|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
127779039|NCT04178967|459818805|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
127779040|NCT04178967|459818806|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
127779041|NCT04178967|459818807|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
127779042|NCT04178967|459818808|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
127779043|NCT04178967|459818809|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
127779044|NCT04178967|459818810|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
127779045|NCT04178967|459818811|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
127779046|NCT04178967|459818801|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
127779047|NCT04178967|459818802|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
127779048|NCT04178967|459818803|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
127779049|NCT04178967|459818804|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
127779050|NCT04178967|459818805|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
127779051|NCT04178967|459818806|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
127779052|NCT04178967|459818807|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
127779053|NCT04178967|459818808|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
127779054|NCT04178967|459818809|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
127779055|NCT04178967|459818810|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
127779056|NCT04178967|459818811|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
127779057|NCT04178967|459818801|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
127779058|NCT04178967|459818802|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
127779059|NCT04178967|459818803|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
127779060|NCT04178967|459818804|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
127779061|NCT04178967|459818805|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
127779062|NCT04178967|459818806|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
127779063|NCT04178967|459818807|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
127779064|NCT04178967|459818808|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
127779065|NCT04178967|459818809|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
127779066|NCT04178967|459818810|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
127779067|NCT04178967|459818811|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
127779068|NCT04178967|459818801|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
127779069|NCT04178967|459818802|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
127779070|NCT04178967|459818803|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
127779071|NCT04178967|459818804|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
127779072|NCT04178967|459818805|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
127779073|NCT04178967|459818806|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
127779074|NCT04178967|459818807|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
127779075|NCT04178967|459818808|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
127779076|NCT04178967|459818809|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
127779077|NCT04178967|459818810|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
127779078|NCT04178967|459818811|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
127779079|NCT04178967|459818801|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
127779080|NCT04178967|459818802|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
127779081|NCT04178967|459818803|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
127779082|NCT04178967|459818804|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
127779083|NCT04178967|459818805|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
128026835|NCT03093870|460722245|FG002|Overall Study|Physician Decision|0|||
128026836|NCT03093870|460722243|FG000|Overall Study|Adverse Event|7|||
128026837|NCT03093870|460722244|FG001|Overall Study|Adverse Event|0|||
128026838|NCT03093870|460722245|FG002|Overall Study|Adverse Event|0|||
127568794|NCT04393298|459051603|FG002|Overall Study|Clinical Progression in Combination with AE|0|||
127568795|NCT04393298|459051604|FG003|Overall Study|Clinical Progression in Combination with AE|0|||
127568796|NCT04393298|459051605|FG004|Overall Study|Clinical Progression in Combination with AE|0|||
127568797|NCT04393298|459051606|FG005|Overall Study|Clinical Progression in Combination with AE|0|||
127568798|NCT04393298|459051607|FG006|Overall Study|Clinical Progression in Combination with AE|0|||
127568799|NCT04393298|459051608|FG007|Overall Study|Clinical Progression in Combination with AE|0|||
127568800|NCT04393298|459051609|FG008|Overall Study|Clinical Progression in Combination with AE|0|||
127568801|NCT04393298|459051610|FG009|Overall Study|Clinical Progression in Combination with AE|1|||
127568802|NCT04393298|459051611|FG010|Overall Study|Clinical Progression in Combination with AE|0|||
127568803|NCT04393298|459051612|FG011|Overall Study|Clinical Progression in Combination with AE|0|||
127568804|NCT04393298|459051613|FG012|Overall Study|Clinical Progression in Combination with AE|0|||
127568805|NCT04393298|459051614|FG013|Overall Study|Clinical Progression in Combination with AE|0|||
127568806|NCT04393298|459051615|FG014|Overall Study|Clinical Progression in Combination with AE|0|||
127568807|NCT02311582|459051616|FG000|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
127568808|NCT02311582|459051617|FG001|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
127568809|NCT02311582|459051618|FG002|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
127568810|NCT02311582|459051619|FG003|Overall Study|Was enrolled but did not receive any MK-3475 treatment|6|||
127568811|NCT02311582|459051620|FG004|Overall Study|Was enrolled but did not receive any MK-3475 treatment|4|||
127568812|NCT00723203|459051621|FG000|Overall Study|Withdrawal by Subject|3|||
127568813|NCT01721577|459051622|FG000|Overall Study|Lack of Efficacy|1|||
127568814|NCT01721577|459051623|FG001|Overall Study|Lack of Efficacy|0|||
127568815|NCT01721577|459051622|FG000|Overall Study|Death|1|||
127568816|NCT01721577|459051623|FG001|Overall Study|Death|0|||
127568817|NCT01721577|459051622|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
127568818|NCT01721577|459051623|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
127568819|NCT01721577|459051622|FG000|Overall Study|Adverse Event|0|||
127568820|NCT01721577|459051623|FG001|Overall Study|Adverse Event|2|||
127568821|NCT01903525|459051626|FG000|Overall Study|Lost to Follow-up|5|||
127568822|NCT01903525|459051627|FG001|Overall Study|Lost to Follow-up|9|||
127568823|NCT01903525|459051626|FG000|Overall Study|Adverse Event|0|||
127568824|NCT01903525|459051627|FG001|Overall Study|Adverse Event|1|||
127568825|NCT02106923|459051632|FG000|Overall Study|Protocol Violation|0|||
127568826|NCT02106923|459051633|FG001|Overall Study|Protocol Violation|0|||
127690385|NCT03398148|459492228|FG004|Substudy 2 Period 2|WITHDREW CONSENT|0|||
127690386|NCT03398148|459492229|FG005|Substudy 2 Period 2|WITHDREW CONSENT|0|||
127690387|NCT03398148|459492230|FG006|Substudy 2 Period 2|WITHDREW CONSENT|0|||
127690388|NCT03398148|459492231|FG007|Substudy 2 Period 2|WITHDREW CONSENT|0|||
127690389|NCT03398148|459492232|FG008|Substudy 2 Period 2|WITHDREW CONSENT|0|||
127690390|NCT03398148|459492233|FG009|Substudy 2 Period 2|WITHDREW CONSENT|0|||
127690391|NCT03398148|459492234|FG010|Substudy 2 Period 2|WITHDREW CONSENT|0|||
127690392|NCT03398148|459492235|FG011|Substudy 2 Period 2|WITHDREW CONSENT|4|||
127690393|NCT03398148|459492236|FG012|Substudy 2 Period 2|WITHDREW CONSENT|0|||
127690394|NCT03398148|459492237|FG013|Substudy 2 Period 2|WITHDREW CONSENT|2|||
127690395|NCT03398148|459492238|FG014|Substudy 2 Period 2|WITHDREW CONSENT|1|||
127690396|NCT03398148|459492224|FG000|Substudy 2 Period 2|Lack of Efficacy|0|||
127690397|NCT03398148|459492225|FG001|Substudy 2 Period 2|Lack of Efficacy|0|||
127690398|NCT03398148|459492226|FG002|Substudy 2 Period 2|Lack of Efficacy|0|||
127690399|NCT03398148|459492227|FG003|Substudy 2 Period 2|Lack of Efficacy|0|||
127690400|NCT03398148|459492228|FG004|Substudy 2 Period 2|Lack of Efficacy|0|||
127690401|NCT03398148|459492229|FG005|Substudy 2 Period 2|Lack of Efficacy|0|||
127690402|NCT03398148|459492230|FG006|Substudy 2 Period 2|Lack of Efficacy|0|||
127690403|NCT03398148|459492231|FG007|Substudy 2 Period 2|Lack of Efficacy|0|||
127690404|NCT03398148|459492232|FG008|Substudy 2 Period 2|Lack of Efficacy|0|||
127690405|NCT03398148|459492233|FG009|Substudy 2 Period 2|Lack of Efficacy|0|||
127690406|NCT03398148|459492234|FG010|Substudy 2 Period 2|Lack of Efficacy|0|||
127690407|NCT03398148|459492235|FG011|Substudy 2 Period 2|Lack of Efficacy|1|||
127690408|NCT03398148|459492236|FG012|Substudy 2 Period 2|Lack of Efficacy|4|||
127690409|NCT03398148|459492237|FG013|Substudy 2 Period 2|Lack of Efficacy|3|||
127690410|NCT03398148|459492238|FG014|Substudy 2 Period 2|Lack of Efficacy|4|||
127690411|NCT03398148|459492224|FG000|Substudy 2 Period 2|Other|0|||
127690412|NCT03398148|459492225|FG001|Substudy 2 Period 2|Other|0|||
127690413|NCT03398148|459492226|FG002|Substudy 2 Period 2|Other|0|||
127690414|NCT03398148|459492227|FG003|Substudy 2 Period 2|Other|0|||
127690415|NCT03398148|459492228|FG004|Substudy 2 Period 2|Other|0|||
127690416|NCT03398148|459492229|FG005|Substudy 2 Period 2|Other|0|||
127690417|NCT03398148|459492230|FG006|Substudy 2 Period 2|Other|0|||
127690418|NCT03398148|459492231|FG007|Substudy 2 Period 2|Other|0|||
127690419|NCT03398148|459492232|FG008|Substudy 2 Period 2|Other|0|||
127690420|NCT03398148|459492233|FG009|Substudy 2 Period 2|Other|0|||
127690421|NCT03398148|459492234|FG010|Substudy 2 Period 2|Other|0|||
127690422|NCT03398148|459492235|FG011|Substudy 2 Period 2|Other|0|||
127690423|NCT03398148|459492236|FG012|Substudy 2 Period 2|Other|0|||
127690424|NCT03398148|459492237|FG013|Substudy 2 Period 2|Other|1|||
127690425|NCT03398148|459492238|FG014|Substudy 2 Period 2|Other|1|||
127690426|NCT03398148|459492224|FG000|Substudy 2 Period 2|Enrolled but not Treated|0|||
127568827|NCT02106923|459051634|FG002|Overall Study|Protocol Violation|0|||
127568828|NCT02106923|459051635|FG003|Overall Study|Protocol Violation|0|||
127568829|NCT02106923|459051636|FG004|Overall Study|Protocol Violation|0|||
127568830|NCT02106923|459051637|FG005|Overall Study|Protocol Violation|1|||
127568831|NCT03485495|459051638|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
127690427|NCT03398148|459492225|FG001|Substudy 2 Period 2|Enrolled but not Treated|0|||
127690428|NCT03398148|459492226|FG002|Substudy 2 Period 2|Enrolled but not Treated|0|||
127690429|NCT03398148|459492227|FG003|Substudy 2 Period 2|Enrolled but not Treated|0|||
127690430|NCT03398148|459492228|FG004|Substudy 2 Period 2|Enrolled but not Treated|0|||
127690431|NCT03398148|459492229|FG005|Substudy 2 Period 2|Enrolled but not Treated|0|||
127690432|NCT03398148|459492230|FG006|Substudy 2 Period 2|Enrolled but not Treated|0|||
127690433|NCT03398148|459492231|FG007|Substudy 2 Period 2|Enrolled but not Treated|0|||
127690434|NCT03398148|459492232|FG008|Substudy 2 Period 2|Enrolled but not Treated|0|||
127690435|NCT03398148|459492233|FG009|Substudy 2 Period 2|Enrolled but not Treated|0|||
127690436|NCT03398148|459492234|FG010|Substudy 2 Period 2|Enrolled but not Treated|0|||
127690437|NCT03398148|459492235|FG011|Substudy 2 Period 2|Enrolled but not Treated|0|||
127690438|NCT03398148|459492236|FG012|Substudy 2 Period 2|Enrolled but not Treated|1|||
127690439|NCT03398148|459492237|FG013|Substudy 2 Period 2|Enrolled but not Treated|0|||
127690440|NCT03398148|459492238|FG014|Substudy 2 Period 2|Enrolled but not Treated|1|||
127690441|NCT02791230|459492239|FG000|Overall Study|Adverse Event|10|||
127690442|NCT02791230|459492240|FG001|Overall Study|Adverse Event|9|||
127690443|NCT02791230|459492241|FG002|Overall Study|Adverse Event|66|||
127690444|NCT02791230|459492239|FG000|Overall Study|Death|38|||
127690445|NCT02791230|459492240|FG001|Overall Study|Death|25|||
127690446|NCT02791230|459492241|FG002|Overall Study|Death|184|||
127690447|NCT02791230|459492239|FG000|Overall Study|Lack of Efficacy|1|||
127690448|NCT02791230|459492240|FG001|Overall Study|Lack of Efficacy|0|||
127690449|NCT02791230|459492241|FG002|Overall Study|Lack of Efficacy|3|||
127690450|NCT02791230|459492239|FG000|Overall Study|Lost to Follow-up|0|||
127690451|NCT02791230|459492240|FG001|Overall Study|Lost to Follow-up|0|||
127690452|NCT02791230|459492241|FG002|Overall Study|Lost to Follow-up|10|||
127690453|NCT02791230|459492239|FG000|Overall Study|Failure to Meet Randomization Criteria|3|||
127690454|NCT02791230|459492240|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
127690455|NCT02791230|459492241|FG002|Overall Study|Failure to Meet Randomization Criteria|15|||
127690456|NCT02791230|459492239|FG000|Overall Study|Medication Error Without Associated Adverse Event|0|||
127690457|NCT02791230|459492240|FG001|Overall Study|Medication Error Without Associated Adverse Event|1|||
127690458|NCT02791230|459492241|FG002|Overall Study|Medication Error Without Associated Adverse Event|1|||
127690459|NCT02791230|459492239|FG000|Overall Study|Study sites terminated by sponsor|1|||
127690460|NCT02791230|459492240|FG001|Overall Study|Study sites terminated by sponsor|0|||
127690461|NCT02791230|459492241|FG002|Overall Study|Study sites terminated by sponsor|5|||
127690462|NCT02791230|459492239|FG000|Overall Study|Other|9|||
127690463|NCT02791230|459492240|FG001|Overall Study|Other|1|||
127690464|NCT02791230|459492241|FG002|Overall Study|Other|28|||
127690465|NCT02791230|459492239|FG000|Overall Study|Protocol Violation|0|||
127690466|NCT02791230|459492240|FG001|Overall Study|Protocol Violation|0|||
127690467|NCT02791230|459492241|FG002|Overall Study|Protocol Violation|4|||
127690468|NCT02791230|459492239|FG000|Overall Study|Withdrawal by Subject|24|||
127690469|NCT02791230|459492240|FG001|Overall Study|Withdrawal by Subject|13|||
127690470|NCT02791230|459492241|FG002|Overall Study|Withdrawal by Subject|172|||
127690471|NCT02791230|459492239|FG000|Overall Study|Enrolled but not treated|0|||
127690472|NCT02791230|459492240|FG001|Overall Study|Enrolled but not treated|0|||
127690473|NCT02791230|459492241|FG002|Overall Study|Enrolled but not treated|5|||
127690474|NCT01259401|459492242|FG000|4-month Follow-up|Death|0|||
127690475|NCT01259401|459492243|FG001|4-month Follow-up|Death|1|||
127690476|NCT01259401|459492242|FG000|4-month Follow-up|Lost to Follow-up|0|||
127690477|NCT01259401|459492243|FG001|4-month Follow-up|Lost to Follow-up|1|||
127690478|NCT04201834|459492251|FG000|Overall Study|Screen fail|1|||
127690479|NCT00212355|459492252|FG000|Overall Study|Adverse Event|1|||
127690480|NCT00212355|459492252|FG000|Overall Study|Withdrawal by Subject|1|||
127690481|NCT00212355|459492252|FG000|Overall Study|A change of address|1|||
127690482|NCT04310735|459492256|FG000|Overall Study|Withdrawal by Subject|1|||
127690483|NCT04310735|459492257|FG001|Overall Study|Withdrawal by Subject|3|||
127690484|NCT04310735|459492258|FG002|Overall Study|Withdrawal by Subject|8|||
127690485|NCT04310735|459492256|FG000|Overall Study|Equipment malfunction|0|||
127690486|NCT04310735|459492257|FG001|Overall Study|Equipment malfunction|1|||
127690487|NCT04310735|459492258|FG002|Overall Study|Equipment malfunction|0|||
127690488|NCT04104321|459492259|FG000|Overall Study|didn't take the study drug|3|||
127690489|NCT03481777|459492260|FG000|Overall Study|Withdrawal by Subject|36|||
127690490|NCT03481777|459492261|FG001|Overall Study|Withdrawal by Subject|31|||
127690491|NCT03481777|459492260|FG000|Overall Study|Non stroke = non target population|277|||
127690492|NCT03481777|459492261|FG001|Overall Study|Non stroke = non target population|254|||
127690493|NCT05696080|459492262|FG000|Overall Study|Lost to Follow-up|2|||
127690494|NCT05696080|459492263|FG001|Overall Study|Lost to Follow-up|1|||
127690495|NCT05696080|459492262|FG000|Overall Study|Physician Decision|1|||
127690496|NCT05696080|459492263|FG001|Overall Study|Physician Decision|0|||
127568832|NCT03485495|459051639|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
127568833|NCT01056380|459051642|FG000|Overall Study|Lost to Follow-up|2|||
127690497|NCT05696080|459492262|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
127690498|NCT05696080|459492263|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
127690499|NCT05696080|459492262|FG000|Overall Study|Withdrawal by Subject|12|||
127690500|NCT05696080|459492263|FG001|Overall Study|Withdrawal by Subject|0|||
127690501|NCT03954184|459492266|FG000|Overall Study|Lost to Follow-up|500|||
127690502|NCT03954184|459492267|FG001|Overall Study|Lost to Follow-up|0|||
127690503|NCT03398200|459492268|FG000|Overall Study|Withdrawal by Subject|0|||
127690504|NCT03398200|459492269|FG001|Overall Study|Withdrawal by Subject|1|||
127690505|NCT05478525|459492270|FG000|Overall Study|Withdrawal by Subject|0|||
127690506|NCT05478525|459492271|FG001|Overall Study|Withdrawal by Subject|1|||
127690507|NCT05478525|459492272|FG002|Overall Study|Withdrawal by Subject|2|||
127690508|NCT05478525|459492273|FG003|Overall Study|Withdrawal by Subject|0|||
127690509|NCT05478525|459492270|FG000|Overall Study|COVID-19 Infection|2|||
127690510|NCT05478525|459492271|FG001|Overall Study|COVID-19 Infection|0|||
127690511|NCT05478525|459492272|FG002|Overall Study|COVID-19 Infection|1|||
127690512|NCT05478525|459492273|FG003|Overall Study|COVID-19 Infection|1|||
127690513|NCT01649271|459492274|FG000|Overall Study|Progressive disease|4|||
127690514|NCT01649271|459492275|FG001|Overall Study|Progressive disease|5|||
127690515|NCT01649271|459492274|FG000|Overall Study|Other Adverse Event|0|||
127690516|NCT01649271|459492275|FG001|Overall Study|Other Adverse Event|2|||
127690517|NCT01649271|459492274|FG000|Overall Study|Withdrawal by Subject|1|||
127690518|NCT01649271|459492275|FG001|Overall Study|Withdrawal by Subject|0|||
127690519|NCT01649271|459492274|FG000|Overall Study|Other than stated above|1|||
127690520|NCT01649271|459492275|FG001|Overall Study|Other than stated above|0|||
127690521|NCT05644002|459492278|FG000|Overall Study|Lost to Follow-up|1|||
127690522|NCT05644002|459492279|FG001|Overall Study|Lost to Follow-up|2|||
127690523|NCT05644002|459492278|FG000|Overall Study|Withdrawal by Subject|0|||
127690524|NCT05644002|459492279|FG001|Overall Study|Withdrawal by Subject|1|||
127690525|NCT04842500|459492280|FG000|Overall Study|Withdrawal by Subject|4|||
127690526|NCT04842500|459492281|FG001|Overall Study|Withdrawal by Subject|1|||
127690527|NCT04842500|459492282|FG002|Overall Study|Withdrawal by Subject|2|||
127690528|NCT04842500|459492283|FG003|Overall Study|Withdrawal by Subject|3|||
127690529|NCT04842500|459492280|FG000|Overall Study|Protocol Violation|1|||
127690530|NCT04842500|459492281|FG001|Overall Study|Protocol Violation|0|||
127690531|NCT04842500|459492282|FG002|Overall Study|Protocol Violation|0|||
127690532|NCT04842500|459492283|FG003|Overall Study|Protocol Violation|1|||
127690533|NCT05756075|459492286|FG000|Overall Study|Withdrawal by Subject|16|||
127690534|NCT05756075|459492287|FG001|Overall Study|Withdrawal by Subject|9|||
127690535|NCT03821844|459492289|FG000|Overall Study|Death|37|||
127690536|NCT03821844|459492290|FG001|Overall Study|Death|31|||
127690537|NCT03821844|459492289|FG000|Overall Study|Discharged|10|||
127690538|NCT03821844|459492290|FG001|Overall Study|Discharged|14|||
127690539|NCT03821844|459492289|FG000|Overall Study|Not present in facility at followup|2|||
127690540|NCT03821844|459492290|FG001|Overall Study|Not present in facility at followup|3|||
127690541|NCT02605837|459492291|FG000|Overall Study|Adverse Event|3|||
127690542|NCT02605837|459492292|FG001|Overall Study|Adverse Event|1|||
127690543|NCT02605837|459492291|FG000|Overall Study|Non-Compliance with Study Drug|0|||
127690544|NCT02605837|459492292|FG001|Overall Study|Non-Compliance with Study Drug|1|||
127690545|NCT02605837|459492291|FG000|Overall Study|Withdrawal by Subject|8|||
127690546|NCT02605837|459492292|FG001|Overall Study|Withdrawal by Subject|8|||
127690547|NCT02605837|459492291|FG000|Overall Study|Physician Decision|0|||
127690548|NCT02605837|459492292|FG001|Overall Study|Physician Decision|1|||
127690549|NCT02652260|459492293|FG000|Base Study|Pregnancy|0|||
127690550|NCT02652260|459492294|FG001|Base Study|Pregnancy|1|||
127690551|NCT02652260|459492293|FG000|Base Study|Withdrawal by Subject|0|||
127690552|NCT02652260|459492294|FG001|Base Study|Withdrawal by Subject|1|||
128026839|NCT03093870|460722243|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
128026840|NCT03093870|460722244|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
128026841|NCT03093870|460722245|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
128026842|NCT03093870|460722243|FG000|Overall Study|Lost to Follow-up|0|||
128026843|NCT03093870|460722244|FG001|Overall Study|Lost to Follow-up|0|||
127568834|NCT01056380|459051643|FG001|Overall Study|Lost to Follow-up|3|||
127690553|NCT02652260|459492293|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|1|||
127690554|NCT02652260|459492294|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|2|||
127690555|NCT02652260|459492293|FG000|Study Extension 1 (Open-Label)|Pregnancy|1|||
127690556|NCT02652260|459492294|FG001|Study Extension 1 (Open-Label)|Pregnancy|1|||
127690557|NCT02652260|459492293|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
127690558|NCT02652260|459492294|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
127690559|NCT02652260|459492293|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
127690560|NCT02652260|459492294|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
127690561|NCT02652260|459492293|FG000|Study Extension 1 (Open-Label)|Adverse Event|0|||
127690562|NCT02652260|459492294|FG001|Study Extension 1 (Open-Label)|Adverse Event|2|||
127779084|NCT04178967|459818806|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
127779085|NCT04178967|459818807|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
127779086|NCT04178967|459818808|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
127779087|NCT04178967|459818809|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
127779088|NCT04178967|459818810|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
127779089|NCT04178967|459818811|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
127779090|NCT04178967|459818801|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
127779091|NCT04178967|459818802|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
127779092|NCT04178967|459818803|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
127779093|NCT04178967|459818804|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
127779094|NCT04178967|459818805|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
127779095|NCT04178967|459818806|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
127779096|NCT04178967|459818807|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
127779097|NCT04178967|459818808|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
127779098|NCT04178967|459818809|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
127779099|NCT04178967|459818810|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
127779100|NCT04178967|459818811|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
127779101|NCT04178967|459818801|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
127779102|NCT04178967|459818802|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
127779103|NCT04178967|459818803|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
127779104|NCT04178967|459818804|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
127779105|NCT04178967|459818805|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
127779106|NCT04178967|459818806|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
127779107|NCT04178967|459818807|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
127779108|NCT04178967|459818808|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
127779109|NCT04178967|459818809|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
127779110|NCT04178967|459818810|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
127779111|NCT04178967|459818811|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
127779112|NCT04178967|459818801|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
127779113|NCT04178967|459818802|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
127779114|NCT04178967|459818803|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
127779115|NCT04178967|459818804|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
127779116|NCT04178967|459818805|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
127779117|NCT04178967|459818806|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
127779118|NCT04178967|459818807|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
127779119|NCT04178967|459818808|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
127779120|NCT04178967|459818809|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
127779121|NCT04178967|459818810|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
127779122|NCT04178967|459818811|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
127779123|NCT04178967|459818801|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
127779124|NCT04178967|459818802|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
127779125|NCT04178967|459818803|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
127779126|NCT04178967|459818804|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
127779127|NCT04178967|459818805|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
127779128|NCT04178967|459818806|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
127779129|NCT04178967|459818807|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
127779130|NCT04178967|459818808|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
127779131|NCT04178967|459818809|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
127779132|NCT04178967|459818810|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
127779133|NCT04178967|459818811|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
127779134|NCT04178967|459818801|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
127779135|NCT04178967|459818802|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
127779136|NCT04178967|459818803|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
127779137|NCT04178967|459818804|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
127779138|NCT04178967|459818805|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
127779139|NCT04178967|459818806|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
127779140|NCT04178967|459818807|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
127779141|NCT04178967|459818808|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
127779142|NCT04178967|459818809|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
127779143|NCT04178967|459818810|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
127779144|NCT04178967|459818811|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
127779145|NCT04178967|459818801|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
127779146|NCT04178967|459818802|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
127779147|NCT04178967|459818803|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
127779148|NCT04178967|459818804|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
127779149|NCT04178967|459818805|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
127779150|NCT04178967|459818806|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
127779151|NCT04178967|459818807|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
127779152|NCT04178967|459818808|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
127779153|NCT04178967|459818809|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
127779154|NCT04178967|459818810|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
127779155|NCT04178967|459818811|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
127779156|NCT04178967|459818801|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
127779157|NCT04178967|459818802|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
127779158|NCT04178967|459818803|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
127779159|NCT04178967|459818804|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
127779160|NCT04178967|459818805|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
127779161|NCT04178967|459818806|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
127779162|NCT04178967|459818807|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
127779163|NCT04178967|459818808|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
127779164|NCT04178967|459818809|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
127779165|NCT04178967|459818810|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
127779166|NCT04178967|459818811|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
127779167|NCT04178967|459818801|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
127779168|NCT04178967|459818802|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
127779169|NCT04178967|459818803|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
127779170|NCT04178967|459818804|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
127779171|NCT04178967|459818805|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
127779172|NCT04178967|459818806|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
127779173|NCT04178967|459818807|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
127779174|NCT04178967|459818808|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
127779175|NCT04178967|459818809|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
127779176|NCT04178967|459818810|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
127779177|NCT04178967|459818811|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
127779178|NCT00685685|459818812|FG000|Washout Period of 7 Days|Adverse Event|2|||
127779179|NCT00685685|459818813|FG001|Washout Period of 7 Days|Adverse Event|0|||
127779180|NCT00685685|459818812|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
127779181|NCT00685685|459818813|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
127779182|NCT02966223|459818816|FG000|Overall Study|Physician Decision|3|||
127779183|NCT02966223|459818816|FG000|Overall Study|Withdrawal by Subject|11|||
127779184|NCT02966223|459818816|FG000|Overall Study|Lost to Follow-up|1|||
127779185|NCT01326728|459818817|FG000|Overall Study|Death|13|||
127779186|NCT01326728|459818818|FG001|Overall Study|Death|0|||
127779187|NCT01326728|459818817|FG000|Overall Study|Early closure of study|34|||
127779188|NCT01326728|459818818|FG001|Overall Study|Early closure of study|9|||
127779189|NCT03785678|459818819|FG000|Overall Study|Death|44|||
127779190|NCT03785678|459818820|FG001|Overall Study|Death|42|||
127779191|NCT03785678|459818819|FG000|Overall Study|Lost to Follow-up|4|||
127779192|NCT03785678|459818820|FG001|Overall Study|Lost to Follow-up|2|||
127779193|NCT03785678|459818819|FG000|Overall Study|Physician Decision|0|||
127779194|NCT03785678|459818820|FG001|Overall Study|Physician Decision|2|||
127779195|NCT03785678|459818819|FG000|Overall Study|Withdrawal by Subject|5|||
127779196|NCT03785678|459818820|FG001|Overall Study|Withdrawal by Subject|3|||
127779197|NCT00805025|459818824|FG000|Overall Study|Screened but not enrolled/treated|42|||
127779198|NCT00805025|459818824|FG000|Overall Study|Adverse Event|4|||
127779199|NCT00805025|459818824|FG000|Overall Study|Withdrawal by Subject|2|||
127779200|NCT00805025|459818824|FG000|Overall Study|Physician Decision|1|||
127779201|NCT00375219|459818825|FG000|Overall Study|Failure to achieve a response|16|||
127779202|NCT00375219|459818826|FG001|Overall Study|Failure to achieve a response|2|||
127568835|NCT03901456|459051644|FG000|Overall Study|Withdrawal by Subject|0|||
127568836|NCT03901456|459051645|FG001|Overall Study|Withdrawal by Subject|0|||
127568837|NCT03901456|459051646|FG002|Overall Study|Withdrawal by Subject|1|||
127568838|NCT03901456|459051644|FG000|Overall Study|Lost to Follow-up|0|||
127568839|NCT03901456|459051645|FG001|Overall Study|Lost to Follow-up|1|||
127568840|NCT03901456|459051646|FG002|Overall Study|Lost to Follow-up|0|||
127568841|NCT00773838|459051648|FG000|Overall Study|Adverse Event|29|||
127568842|NCT00773838|459051648|FG000|Overall Study|Lost to Follow-up|1|||
127779203|NCT00375219|459818827|FG002|Overall Study|Failure to achieve a response|0|||
127779204|NCT00375219|459818825|FG000|Overall Study|Adverse Event|8|||
127779205|NCT00375219|459818826|FG001|Overall Study|Adverse Event|2|||
127568843|NCT00773838|459051648|FG000|Overall Study|Physician Decision|8|||
127568844|NCT00773838|459051648|FG000|Overall Study|Progressive Disease|82|||
127568845|NCT00773838|459051648|FG000|Overall Study|Protocol Violation|2|||
127568846|NCT00773838|459051648|FG000|Overall Study|Withdrawal by Subject|21|||
127779206|NCT00375219|459818827|FG002|Overall Study|Adverse Event|1|||
127779207|NCT00375219|459818825|FG000|Overall Study|Protocol Violation|1|||
127568847|NCT03562767|459051654|FG000|Overall Study|Physician Decision|2|||
127568848|NCT03562767|459051655|FG001|Overall Study|Physician Decision|0|||
127568849|NCT03562767|459051656|FG002|Overall Study|Physician Decision|0|||
127568850|NCT03562767|459051654|FG000|Overall Study|Logistic Reason|1|||
127568851|NCT03562767|459051655|FG001|Overall Study|Logistic Reason|3|||
127568852|NCT03562767|459051656|FG002|Overall Study|Logistic Reason|0|||
127568853|NCT01589770|459051659|FG000|Overall Study|EGFR <60ml/min|6|||
127568854|NCT01589770|459051660|FG001|Overall Study|EGFR <60ml/min|4|||
127568855|NCT01589770|459051659|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
127568856|NCT01589770|459051660|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
127568857|NCT01658813|459051663|FG000|Overall Study|Disease progression|3|||
127568858|NCT00938886|459051664|FG000|Overall Study|Death|0|||
127568859|NCT00938886|459051665|FG001|Overall Study|Death|1|||
127568860|NCT00938886|459051664|FG000|Overall Study|Withdrawal by Subject|4|||
127568861|NCT00938886|459051665|FG001|Overall Study|Withdrawal by Subject|7|||
127568862|NCT00938886|459051664|FG000|Overall Study|Lost to Follow-up|3|||
127568863|NCT00938886|459051665|FG001|Overall Study|Lost to Follow-up|2|||
127568864|NCT02674854|459051666|FG000|Overall Study|Adverse Event|17|||
127568865|NCT02674854|459051667|FG001|Overall Study|Adverse Event|15|||
127568866|NCT02674854|459051668|FG002|Overall Study|Adverse Event|5|||
127568867|NCT02674854|459051666|FG000|Overall Study|Withdrawal by Subject|1|||
127568868|NCT02674854|459051667|FG001|Overall Study|Withdrawal by Subject|5|||
127568869|NCT02674854|459051668|FG002|Overall Study|Withdrawal by Subject|4|||
127568870|NCT02674854|459051666|FG000|Overall Study|No-compliant subject|1|||
127568871|NCT02674854|459051667|FG001|Overall Study|No-compliant subject|0|||
127568872|NCT02674854|459051668|FG002|Overall Study|No-compliant subject|1|||
127568873|NCT02674854|459051666|FG000|Overall Study|Lost to Follow-up|1|||
127568874|NCT02674854|459051667|FG001|Overall Study|Lost to Follow-up|0|||
127568875|NCT02674854|459051668|FG002|Overall Study|Lost to Follow-up|2|||
127568876|NCT02674854|459051666|FG000|Overall Study|Lack of Efficacy|0|||
127568877|NCT02674854|459051667|FG001|Overall Study|Lack of Efficacy|3|||
127568878|NCT02674854|459051668|FG002|Overall Study|Lack of Efficacy|0|||
127568879|NCT02674854|459051666|FG000|Overall Study|Disallowed Concurrent Medication|2|||
127568880|NCT02674854|459051667|FG001|Overall Study|Disallowed Concurrent Medication|2|||
127568881|NCT02674854|459051668|FG002|Overall Study|Disallowed Concurrent Medication|0|||
127568882|NCT02674854|459051666|FG000|Overall Study|Protocol Violation|1|||
127568883|NCT02674854|459051667|FG001|Overall Study|Protocol Violation|1|||
127568884|NCT02674854|459051668|FG002|Overall Study|Protocol Violation|2|||
127568885|NCT02674854|459051666|FG000|Overall Study|Death|0|||
127568886|NCT02674854|459051667|FG001|Overall Study|Death|1|||
127568887|NCT02674854|459051668|FG002|Overall Study|Death|0|||
127568888|NCT02674854|459051666|FG000|Overall Study|Subject missed V6.2|1|||
127568889|NCT02674854|459051667|FG001|Overall Study|Subject missed V6.2|0|||
127568890|NCT02674854|459051668|FG002|Overall Study|Subject missed V6.2|0|||
127568891|NCT00913692|459051669|FG000|Screening (4 Months)|Physician Decision|3|||
127568892|NCT00913692|459051669|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
127568893|NCT00913692|459051669|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
127568894|NCT02889562|459051670|FG000|Overall Study|Physician Decision|0|||
127568895|NCT02889562|459051671|FG001|Overall Study|Physician Decision|1|||
127568896|NCT02889562|459051670|FG000|Overall Study|Withdrawal by Subject|0|||
127568897|NCT02889562|459051671|FG001|Overall Study|Withdrawal by Subject|1|||
127568898|NCT01470989|459051674|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
127568899|NCT01470989|459051675|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
127568900|NCT01470989|459051674|FG000|Overall Study|Adverse Event|2|||
127568901|NCT01470989|459051675|FG001|Overall Study|Adverse Event|5|||
127568902|NCT01470989|459051674|FG000|Overall Study|Abnormal laboratory value|1|||
127568903|NCT01470989|459051675|FG001|Overall Study|Abnormal laboratory value|1|||
127568904|NCT01470989|459051674|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
127568905|NCT01470989|459051675|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
127568906|NCT01470989|459051674|FG000|Overall Study|Withdrawal by Subject|19|||
127568907|NCT01470989|459051675|FG001|Overall Study|Withdrawal by Subject|17|||
127568908|NCT01470989|459051674|FG000|Overall Study|Lost to Follow-up|18|||
127568909|NCT01470989|459051675|FG001|Overall Study|Lost to Follow-up|13|||
127568910|NCT01470989|459051674|FG000|Overall Study|Administrative problems|2|||
127568911|NCT01470989|459051675|FG001|Overall Study|Administrative problems|4|||
127568912|NCT01470989|459051674|FG000|Overall Study|Death|2|||
127568913|NCT01470989|459051675|FG001|Overall Study|Death|2|||
127568914|NCT01470989|459051674|FG000|Overall Study|Protocol deviation|1|||
127568915|NCT01470989|459051675|FG001|Overall Study|Protocol deviation|2|||
127568916|NCT00969280|459051676|FG000|Overall Study|Protocol Violation|2|||
127568917|NCT00969280|459051677|FG001|Overall Study|Protocol Violation|1|||
127568918|NCT00969280|459051676|FG000|Overall Study|Withdrawal by Subject|0|||
127568919|NCT00969280|459051677|FG001|Overall Study|Withdrawal by Subject|1|||
127568920|NCT00969280|459051676|FG000|Overall Study|infection of influenza A(H1N1)|0|||
127568921|NCT00969280|459051677|FG001|Overall Study|infection of influenza A(H1N1)|1|||
127568922|NCT02119676|459051678|FG000|Overall Study|Adverse Event|9|||
127568923|NCT02119676|459051679|FG001|Overall Study|Adverse Event|17|||
127568924|NCT02119676|459051680|FG002|Overall Study|Adverse Event|10|||
127568925|NCT02119676|459051681|FG003|Overall Study|Adverse Event|10|||
127568926|NCT02119676|459051678|FG000|Overall Study|Disease progression|53|||
127568927|NCT02119676|459051679|FG001|Overall Study|Disease progression|55|||
127568928|NCT02119676|459051680|FG002|Overall Study|Disease progression|68|||
127568929|NCT02119676|459051681|FG003|Overall Study|Disease progression|73|||
127568930|NCT02119676|459051678|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
127568931|NCT02119676|459051679|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
127568932|NCT02119676|459051680|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
127568933|NCT02119676|459051681|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
127568934|NCT02119676|459051678|FG000|Overall Study|Physician Decision|4|||
127568935|NCT02119676|459051679|FG001|Overall Study|Physician Decision|2|||
127568936|NCT02119676|459051680|FG002|Overall Study|Physician Decision|3|||
127568937|NCT02119676|459051681|FG003|Overall Study|Physician Decision|2|||
127568938|NCT02119676|459051678|FG000|Overall Study|Death|9|||
127568939|NCT02119676|459051679|FG001|Overall Study|Death|3|||
127568940|NCT02119676|459051680|FG002|Overall Study|Death|2|||
127568941|NCT02119676|459051681|FG003|Overall Study|Death|1|||
127568942|NCT02119676|459051678|FG000|Overall Study|Noncompliance|0|||
127568943|NCT02119676|459051679|FG001|Overall Study|Noncompliance|1|||
127568944|NCT02119676|459051680|FG002|Overall Study|Noncompliance|0|||
127568945|NCT02119676|459051681|FG003|Overall Study|Noncompliance|0|||
127568946|NCT02119676|459051678|FG000|Overall Study|Lost to Follow-up|0|||
127568947|NCT02119676|459051679|FG001|Overall Study|Lost to Follow-up|0|||
127568948|NCT02119676|459051680|FG002|Overall Study|Lost to Follow-up|1|||
127568949|NCT02119676|459051681|FG003|Overall Study|Lost to Follow-up|0|||
127568950|NCT02119676|459051678|FG000|Overall Study|Protocol deviation|0|||
127568951|NCT02119676|459051679|FG001|Overall Study|Protocol deviation|0|||
127568952|NCT02119676|459051680|FG002|Overall Study|Protocol deviation|1|||
127568953|NCT02119676|459051681|FG003|Overall Study|Protocol deviation|0|||
127568954|NCT02119676|459051678|FG000|Overall Study|Other, unspecified|2|||
127568955|NCT02119676|459051679|FG001|Overall Study|Other, unspecified|1|||
127568956|NCT02119676|459051680|FG002|Overall Study|Other, unspecified|3|||
127568957|NCT02119676|459051681|FG003|Overall Study|Other, unspecified|4|||
127568958|NCT02119676|459051678|FG000|Overall Study|Did not receive study med|2|||
127568959|NCT02119676|459051679|FG001|Overall Study|Did not receive study med|2|||
127568960|NCT02119676|459051680|FG002|Overall Study|Did not receive study med|4|||
127568961|NCT02119676|459051681|FG003|Overall Study|Did not receive study med|5|||
127568962|NCT02216812|459051682|FG000|Overall Study|Lost to Follow-up|10|||
127568963|NCT02216812|459051683|FG001|Overall Study|Lost to Follow-up|5|||
127568964|NCT00266864|459051684|FG000|Overall Study|Lost to Follow-up|4|||
127568965|NCT00266864|459051685|FG001|Overall Study|Lost to Follow-up|1|||
127568966|NCT00266864|459051684|FG000|Overall Study|Withdrawal by Subject|1|||
127568967|NCT00266864|459051685|FG001|Overall Study|Withdrawal by Subject|1|||
127568968|NCT01077154|459051686|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
127568969|NCT01077154|459051687|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
127568970|NCT01077154|459051686|FG000|Overall Study|Withdrawal by Subject|369|||
127568971|NCT01077154|459051687|FG001|Overall Study|Withdrawal by Subject|385|||
127568972|NCT01077154|459051686|FG000|Overall Study|Death|215|||
127568973|NCT01077154|459051687|FG001|Overall Study|Death|214|||
127568974|NCT01077154|459051686|FG000|Overall Study|Lost to Follow-up|43|||
127568975|NCT01077154|459051687|FG001|Overall Study|Lost to Follow-up|35|||
127568976|NCT01077154|459051686|FG000|Overall Study|Noncompliance|22|||
127568977|NCT01077154|459051687|FG001|Overall Study|Noncompliance|20|||
127568978|NCT01077154|459051686|FG000|Overall Study|Disease Progression|18|||
127568979|NCT01077154|459051687|FG001|Overall Study|Disease Progression|20|||
127568980|NCT01077154|459051686|FG000|Overall Study|Ineligibility Determined|10|||
127568981|NCT01077154|459051687|FG001|Overall Study|Ineligibility Determined|14|||
127568982|NCT01077154|459051686|FG000|Overall Study|Other|14|||
127568983|NCT01077154|459051687|FG001|Overall Study|Other|11|||
127568984|NCT01077154|459051686|FG000|Overall Study|Adverse Event|9|||
127568985|NCT01077154|459051687|FG001|Overall Study|Adverse Event|9|||
127568986|NCT01077154|459051686|FG000|Overall Study|Administrative Decision|1|||
127568987|NCT01077154|459051687|FG001|Overall Study|Administrative Decision|6|||
127568988|NCT01077154|459051686|FG000|Overall Study|Protocol Deviation|1|||
127568989|NCT01077154|459051687|FG001|Overall Study|Protocol Deviation|0|||
127568990|NCT04085367|459053346|FG000|Overall Study|Adverse Event|1|||
127568991|NCT04085367|459053347|FG001|Overall Study|Adverse Event|1|||
127568992|NCT04085367|459053346|FG000|Overall Study|Withdrawal by Subject|13|||
127568993|NCT04085367|459053347|FG001|Overall Study|Withdrawal by Subject|4|||
127568994|NCT04085367|459053346|FG000|Overall Study|Lost to Follow-up|3|||
127568995|NCT04085367|459053347|FG001|Overall Study|Lost to Follow-up|1|||
127568996|NCT04085367|459053346|FG000|Overall Study|Other unspecified|2|||
127568997|NCT04085367|459053347|FG001|Overall Study|Other unspecified|1|||
127568998|NCT04085367|459053346|FG000|Overall Study|Status Unknown|1|||
127568999|NCT04085367|459053347|FG001|Overall Study|Status Unknown|1|||
127569000|NCT00706849|459053358|FG000|Treatment Period|Adverse Event|0|||
127569001|NCT00706849|459053359|FG001|Treatment Period|Adverse Event|9|||
127569002|NCT00706849|459053358|FG000|Treatment Period|Other|0|||
127569003|NCT00706849|459053359|FG001|Treatment Period|Other|1|||
127569004|NCT00706849|459053358|FG000|Follow-up Period|Withdrawal by Subject|0|||
127569005|NCT00706849|459053359|FG001|Follow-up Period|Withdrawal by Subject|2|||
127569006|NCT00706849|459053358|FG000|Follow-up Period|Protocol non-compliance|0|||
127569007|NCT00706849|459053359|FG001|Follow-up Period|Protocol non-compliance|1|||
127569008|NCT01611454|459053361|FG000|Overall Study|Lack of Efficacy|18|||
127569009|NCT01611454|459053362|FG001|Overall Study|Lack of Efficacy|10|||
127569010|NCT03269552|459053363|FG000|Overall Study|Adverse Event|2|||
127569011|NCT00920907|459053364|FG000|Induction Period|Adverse Event|0|||
127569012|NCT00920907|459053365|FG001|Induction Period|Adverse Event|2|||
127569013|NCT00920907|459053364|FG000|Induction Period|Death|1|||
127569014|NCT00920907|459053365|FG001|Induction Period|Death|1|||
127569015|NCT00920907|459053364|FG000|Induction Period|Disease Progression|12|||
128026844|NCT03093870|460722245|FG002|Overall Study|Lost to Follow-up|1|||
128026845|NCT04008069|460722246|FG000|Open-Label Period|Adverse Event|1|||
128026846|NCT04008069|460722247|FG001|Open-Label Period|Adverse Event|0|||
128026847|NCT04008069|460722248|FG002|Open-Label Period|Adverse Event|0|||
128026848|NCT04008069|460722246|FG000|Open-Label Period|Lack of Efficacy|4|||
128026849|NCT04008069|460722247|FG001|Open-Label Period|Lack of Efficacy|0|||
128026850|NCT04008069|460722248|FG002|Open-Label Period|Lack of Efficacy|0|||
128026851|NCT04008069|460722246|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
128026852|NCT04008069|460722247|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
128026853|NCT04008069|460722248|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
128026854|NCT04008069|460722246|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
128026855|NCT04008069|460722247|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
128026856|NCT04008069|460722248|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
128026857|NCT02134028|460722250|FG000|Overall Study|Lack of Efficacy|1|||
128026858|NCT02134028|460722251|FG001|Overall Study|Lack of Efficacy|0|||
128026859|NCT02134028|460722252|FG002|Overall Study|Lack of Efficacy|3|||
128026860|NCT02134028|460722253|FG003|Overall Study|Lack of Efficacy|2|||
128026861|NCT02134028|460722254|FG004|Overall Study|Lack of Efficacy|1|||
128026862|NCT02134028|460722255|FG005|Overall Study|Lack of Efficacy|2|||
128026863|NCT02134028|460722256|FG006|Overall Study|Lack of Efficacy|1|||
128026864|NCT02134028|460722257|FG007|Overall Study|Lack of Efficacy|0|||
128026865|NCT02134028|460722250|FG000|Overall Study|Poor compliance to protocol|1|||
128026866|NCT02134028|460722251|FG001|Overall Study|Poor compliance to protocol|1|||
128026867|NCT02134028|460722252|FG002|Overall Study|Poor compliance to protocol|3|||
128026868|NCT02134028|460722253|FG003|Overall Study|Poor compliance to protocol|7|||
128026869|NCT02134028|460722254|FG004|Overall Study|Poor compliance to protocol|1|||
128026870|NCT02134028|460722255|FG005|Overall Study|Poor compliance to protocol|1|||
128026871|NCT02134028|460722256|FG006|Overall Study|Poor compliance to protocol|0|||
128026872|NCT02134028|460722257|FG007|Overall Study|Poor compliance to protocol|0|||
128026873|NCT02134028|460722250|FG000|Overall Study|Other unspecified|4|||
128026874|NCT02134028|460722251|FG001|Overall Study|Other unspecified|22|||
128026875|NCT02134028|460722252|FG002|Overall Study|Other unspecified|33|||
128026876|NCT02134028|460722253|FG003|Overall Study|Other unspecified|64|||
128026877|NCT02134028|460722254|FG004|Overall Study|Other unspecified|8|||
128026878|NCT02134028|460722255|FG005|Overall Study|Other unspecified|6|||
128026879|NCT02134028|460722256|FG006|Overall Study|Other unspecified|2|||
128026880|NCT02134028|460722257|FG007|Overall Study|Other unspecified|1|||
128026881|NCT02134028|460722250|FG000|Overall Study|Adverse Event|3|||
128026882|NCT02134028|460722251|FG001|Overall Study|Adverse Event|19|||
128026883|NCT02134028|460722252|FG002|Overall Study|Adverse Event|13|||
128026884|NCT02134028|460722253|FG003|Overall Study|Adverse Event|32|||
128026885|NCT02134028|460722254|FG004|Overall Study|Adverse Event|4|||
128026886|NCT02134028|460722255|FG005|Overall Study|Adverse Event|5|||
127569016|NCT00920907|459053365|FG001|Induction Period|Disease Progression|11|||
127569017|NCT00920907|459053364|FG000|Induction Period|Study Drug Toxicity|8|||
127569018|NCT00920907|459053365|FG001|Induction Period|Study Drug Toxicity|6|||
127569019|NCT00920907|459053364|FG000|Induction Period|No longer meets study criteria|0|||
127569020|NCT00920907|459053365|FG001|Induction Period|No longer meets study criteria|1|||
127569021|NCT00920907|459053364|FG000|Induction Period|Withdrawal by Subject|1|||
127569022|NCT00920907|459053365|FG001|Induction Period|Withdrawal by Subject|1|||
127569023|NCT00920907|459053364|FG000|Maintenance Period|Disease Progression|3|||
127569024|NCT00920907|459053365|FG001|Maintenance Period|Disease Progression|7|||
127569025|NCT00920907|459053364|FG000|Maintenance Period|Administrative (study closure)|7|||
127569026|NCT00920907|459053365|FG001|Maintenance Period|Administrative (study closure)|2|||
128026887|NCT02134028|460722256|FG006|Overall Study|Adverse Event|1|||
128026888|NCT02134028|460722257|FG007|Overall Study|Adverse Event|2|||
128026889|NCT00819832|460722258|FG000|Overall Study|Sponsor Termination of Study|3|||
128026890|NCT00819832|460722259|FG001|Overall Study|Sponsor Termination of Study|0|||
128026891|NCT00819832|460722260|FG002|Overall Study|Sponsor Termination of Study|0|||
128026892|NCT00819832|460722261|FG003|Overall Study|Sponsor Termination of Study|0|||
128026893|NCT00819832|460722262|FG004|Overall Study|Sponsor Termination of Study|0|||
128026894|NCT00819832|460722263|FG005|Overall Study|Sponsor Termination of Study|0|||
128026895|NCT01452789|460722269|FG000|Overall Study|Withdrawal by Subject|3|||
127569027|NCT00920907|459053364|FG000|Maintenance Period|Study Drug Toxicity|0|||
127569028|NCT00920907|459053365|FG001|Maintenance Period|Study Drug Toxicity|2|||
127569029|NCT00920907|459053364|FG000|Maintenance Period|Death|1|||
127569030|NCT00920907|459053365|FG001|Maintenance Period|Death|1|||
127569031|NCT00920907|459053364|FG000|Maintenance Period|Withdrawal by Subject|1|||
127569032|NCT00920907|459053365|FG001|Maintenance Period|Withdrawal by Subject|0|||
127569033|NCT00920907|459053364|FG000|Maintenance Period|Adverse Event|0|||
127569034|NCT00920907|459053365|FG001|Maintenance Period|Adverse Event|1|||
127569035|NCT02616601|459053366|FG000|Overall Study|Withdrawal by Subject|4|||
127569036|NCT02616601|459053367|FG001|Overall Study|Withdrawal by Subject|4|||
127569037|NCT02616601|459053368|FG002|Overall Study|Withdrawal by Subject|3|||
127569038|NCT02616601|459053366|FG000|Overall Study|Adverse Event|2|||
127569039|NCT02616601|459053367|FG001|Overall Study|Adverse Event|0|||
127569040|NCT02616601|459053368|FG002|Overall Study|Adverse Event|2|||
127569041|NCT02616601|459053366|FG000|Overall Study|Death|1|||
127569042|NCT02616601|459053367|FG001|Overall Study|Death|0|||
127569043|NCT02616601|459053368|FG002|Overall Study|Death|0|||
127569044|NCT02616601|459053366|FG000|Overall Study|Lost to Follow-up|1|||
127569045|NCT02616601|459053367|FG001|Overall Study|Lost to Follow-up|0|||
127569046|NCT02616601|459053368|FG002|Overall Study|Lost to Follow-up|1|||
127569047|NCT02616601|459053366|FG000|Overall Study|Non-Compliance with Test Article|1|||
127569048|NCT02616601|459053367|FG001|Overall Study|Non-Compliance with Test Article|0|||
127569049|NCT02616601|459053368|FG002|Overall Study|Non-Compliance with Test Article|1|||
127569050|NCT02186301|459053369|FG000|Overall Study|Progressive Disease|7|||
127569051|NCT02186301|459053370|FG001|Overall Study|Progressive Disease|22|||
127569052|NCT02186301|459053371|FG002|Overall Study|Progressive Disease|27|||
127569053|NCT02186301|459053369|FG000|Overall Study|Adverse Event|5|||
127569054|NCT02186301|459053370|FG001|Overall Study|Adverse Event|5|||
127569055|NCT02186301|459053371|FG002|Overall Study|Adverse Event|5|||
127569056|NCT02186301|459053369|FG000|Overall Study|Death|1|||
127569057|NCT02186301|459053370|FG001|Overall Study|Death|0|||
127569058|NCT02186301|459053371|FG002|Overall Study|Death|0|||
127569059|NCT02186301|459053369|FG000|Overall Study|Withdrawal by Subject|5|||
127569060|NCT02186301|459053370|FG001|Overall Study|Withdrawal by Subject|1|||
127569061|NCT02186301|459053371|FG002|Overall Study|Withdrawal by Subject|3|||
127569062|NCT02186301|459053369|FG000|Overall Study|Physician Decision|1|||
127569063|NCT02186301|459053370|FG001|Overall Study|Physician Decision|0|||
127569064|NCT02186301|459053371|FG002|Overall Study|Physician Decision|1|||
127569065|NCT02186301|459053369|FG000|Overall Study|Study Terminated by Sponsor|1|||
127569066|NCT02186301|459053370|FG001|Overall Study|Study Terminated by Sponsor|0|||
127569067|NCT02186301|459053371|FG002|Overall Study|Study Terminated by Sponsor|11|||
127569068|NCT02186301|459053369|FG000|Overall Study|Protocol Deviation|0|||
127569069|NCT02186301|459053370|FG001|Overall Study|Protocol Deviation|2|||
127569070|NCT02186301|459053371|FG002|Overall Study|Protocol Deviation|0|||
127569071|NCT02186301|459053369|FG000|Overall Study|Missing|0|||
127569072|NCT02186301|459053370|FG001|Overall Study|Missing|0|||
127569073|NCT02186301|459053371|FG002|Overall Study|Missing|2|||
127569074|NCT02186301|459053369|FG000|Overall Study|Other|0|||
127569075|NCT02186301|459053370|FG001|Overall Study|Other|0|||
127569076|NCT02186301|459053371|FG002|Overall Study|Other|1|||
127569077|NCT00371761|459053372|FG000|Overall Study|Adverse Event|1|||
127569078|NCT00371761|459053373|FG001|Overall Study|Adverse Event|1|||
127569079|NCT00371761|459053372|FG000|Overall Study|Withdrawal by Subject|1|||
127569080|NCT00371761|459053373|FG001|Overall Study|Withdrawal by Subject|3|||
127569081|NCT00371761|459053372|FG000|Overall Study|Investigator Judgment|2|||
127569082|NCT00371761|459053373|FG001|Overall Study|Investigator Judgment|3|||
127690563|NCT02652260|459492293|FG000|Study Extension 2 (Open-Label)|Adverse Event|1|||
127690564|NCT02652260|459492294|FG001|Study Extension 2 (Open-Label)|Adverse Event|0|||
127690565|NCT02652260|459492293|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|18|||
127569083|NCT00371761|459053372|FG000|Overall Study|Study termination|4|||
127569084|NCT00371761|459053373|FG001|Overall Study|Study termination|3|||
127569085|NCT03560739|459053375|FG000|Overall Study|Adverse Event|0|||
127569086|NCT03560739|459053376|FG001|Overall Study|Adverse Event|1|||
127569087|NCT03560739|459053377|FG002|Overall Study|Adverse Event|0|||
127569088|NCT03560739|459053378|FG003|Overall Study|Adverse Event|0|||
127569089|NCT03361176|459053379|FG000|Overall Study|Lost to Follow-up|1|||
127569090|NCT03361176|459053380|FG001|Overall Study|Lost to Follow-up|2|||
127569091|NCT03361176|459053379|FG000|Overall Study|Adverse Event|0|||
127569092|NCT03361176|459053380|FG001|Overall Study|Adverse Event|2|||
127569093|NCT03361176|459053379|FG000|Overall Study|Withdrawal by Subject|0|||
127569094|NCT03361176|459053380|FG001|Overall Study|Withdrawal by Subject|1|||
127569095|NCT04389970|459053381|FG000|Overall Study|Lost to Follow-up|1|||
127690566|NCT02652260|459492294|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|13|||
127569096|NCT03123185|459053382|FG000|Overall Study|Withdrawal by Subject|0|||
127569097|NCT03123185|459053383|FG001|Overall Study|Withdrawal by Subject|0|||
127569098|NCT03123185|459053384|FG002|Overall Study|Withdrawal by Subject|0|||
127690567|NCT02652260|459492293|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
127690568|NCT02652260|459492294|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|0|||
127569099|NCT03123185|459053385|FG003|Overall Study|Withdrawal by Subject|0|||
127569100|NCT03123185|459053386|FG004|Overall Study|Withdrawal by Subject|0|||
127569101|NCT03123185|459053387|FG005|Overall Study|Withdrawal by Subject|0|||
127569102|NCT03123185|459053388|FG006|Overall Study|Withdrawal by Subject|0|||
127569103|NCT03123185|459053389|FG007|Overall Study|Withdrawal by Subject|0|||
127569104|NCT03123185|459053390|FG008|Overall Study|Withdrawal by Subject|0|||
127569105|NCT03123185|459053391|FG009|Overall Study|Withdrawal by Subject|0|||
127569106|NCT03123185|459053392|FG010|Overall Study|Withdrawal by Subject|0|||
127569107|NCT03123185|459053393|FG011|Overall Study|Withdrawal by Subject|0|||
127569108|NCT03123185|459053394|FG012|Overall Study|Withdrawal by Subject|1|||
127569109|NCT03123185|459053395|FG013|Overall Study|Withdrawal by Subject|0|||
127569110|NCT00470158|459053396|FG000|Overall Study|Death|0|||
127569111|NCT00470158|459053397|FG001|Overall Study|Death|0|||
127569112|NCT00470158|459053398|FG002|Overall Study|Death|0|||
127569113|NCT00470158|459053399|FG003|Overall Study|Death|0|||
127569114|NCT00470158|459053400|FG004|Overall Study|Death|2|||
127569115|NCT00470158|459053396|FG000|Overall Study|Lost to Follow-up|7|||
127569116|NCT00470158|459053397|FG001|Overall Study|Lost to Follow-up|8|||
127569117|NCT00470158|459053398|FG002|Overall Study|Lost to Follow-up|8|||
127569118|NCT00470158|459053399|FG003|Overall Study|Lost to Follow-up|5|||
127569119|NCT00470158|459053400|FG004|Overall Study|Lost to Follow-up|4|||
127569120|NCT00470158|459053396|FG000|Overall Study|Protocol Violation|1|||
127569121|NCT00470158|459053397|FG001|Overall Study|Protocol Violation|0|||
127569122|NCT00470158|459053398|FG002|Overall Study|Protocol Violation|0|||
127569123|NCT00470158|459053399|FG003|Overall Study|Protocol Violation|0|||
127569124|NCT00470158|459053400|FG004|Overall Study|Protocol Violation|0|||
127569125|NCT04179890|459053401|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
127569126|NCT04179890|459053402|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
127569127|NCT04179890|459053401|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
127569128|NCT04179890|459053402|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
127569129|NCT04179890|459053401|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
127569130|NCT04179890|459053402|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
127569131|NCT04179890|459053401|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
127569132|NCT04179890|459053402|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
127569133|NCT04179890|459053401|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
127569134|NCT04179890|459053402|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
127569135|NCT04179890|459053401|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
127569136|NCT04179890|459053402|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
127569137|NCT04179890|459053401|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
127569138|NCT04179890|459053402|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
127569139|NCT04179890|459053401|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
127569140|NCT04179890|459053402|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
127569141|NCT04179890|459053401|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
127569142|NCT04179890|459053402|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
127569143|NCT03505671|459053403|FG000|Overall Study|Withdrawal by Subject|2|||
127569144|NCT03505671|459053404|FG001|Overall Study|Withdrawal by Subject|1|||
127569145|NCT03505671|459053403|FG000|Overall Study|Lost to Follow-up|1|||
127569146|NCT03505671|459053404|FG001|Overall Study|Lost to Follow-up|0|||
127569147|NCT02038829|459053405|FG000|Washout Period 1|Death|0|||
127569148|NCT02038829|459053406|FG001|Washout Period 1|Death|0|||
127569149|NCT02038829|459053407|FG002|Washout Period 1|Death|0|||
127569150|NCT02038829|459053408|FG003|Washout Period 1|Death|0|||
127569151|NCT02038829|459053409|FG004|Washout Period 1|Death|1|||
127569152|NCT02038829|459053410|FG005|Washout Period 1|Death|0|||
127569153|NCT02038829|459053411|FG006|Washout Period 1|Death|0|||
127569154|NCT02038829|459053412|FG007|Washout Period 1|Death|0|||
127569155|NCT02038829|459053413|FG008|Washout Period 1|Death|0|||
127569156|NCT02038829|459053414|FG009|Washout Period 1|Death|0|||
127569157|NCT02038829|459053415|FG010|Washout Period 1|Death|0|||
127569158|NCT02038829|459053416|FG011|Washout Period 1|Death|0|||
127569159|NCT02038829|459053405|FG000|Treatment Period 2|Adverse Event|0|||
127569160|NCT02038829|459053406|FG001|Treatment Period 2|Adverse Event|0|||
127569161|NCT02038829|459053407|FG002|Treatment Period 2|Adverse Event|0|||
127569162|NCT02038829|459053408|FG003|Treatment Period 2|Adverse Event|0|||
127569163|NCT02038829|459053409|FG004|Treatment Period 2|Adverse Event|0|||
127569164|NCT02038829|459053410|FG005|Treatment Period 2|Adverse Event|0|||
127569165|NCT02038829|459053411|FG006|Treatment Period 2|Adverse Event|0|||
127569166|NCT02038829|459053412|FG007|Treatment Period 2|Adverse Event|0|||
127569167|NCT02038829|459053413|FG008|Treatment Period 2|Adverse Event|0|||
127569168|NCT02038829|459053414|FG009|Treatment Period 2|Adverse Event|0|||
127569169|NCT02038829|459053415|FG010|Treatment Period 2|Adverse Event|1|||
127569170|NCT02038829|459053416|FG011|Treatment Period 2|Adverse Event|0|||
127569171|NCT02038829|459053405|FG000|Treatment Period 2|Withdrawal by Subject|1|||
127569172|NCT02038829|459053406|FG001|Treatment Period 2|Withdrawal by Subject|0|||
127569173|NCT02038829|459053407|FG002|Treatment Period 2|Withdrawal by Subject|0|||
127569174|NCT02038829|459053408|FG003|Treatment Period 2|Withdrawal by Subject|0|||
127569175|NCT02038829|459053409|FG004|Treatment Period 2|Withdrawal by Subject|0|||
127569176|NCT02038829|459053410|FG005|Treatment Period 2|Withdrawal by Subject|0|||
127569177|NCT02038829|459053411|FG006|Treatment Period 2|Withdrawal by Subject|0|||
127569178|NCT02038829|459053412|FG007|Treatment Period 2|Withdrawal by Subject|0|||
127569179|NCT02038829|459053413|FG008|Treatment Period 2|Withdrawal by Subject|0|||
127569180|NCT02038829|459053414|FG009|Treatment Period 2|Withdrawal by Subject|0|||
127569181|NCT02038829|459053415|FG010|Treatment Period 2|Withdrawal by Subject|0|||
127569182|NCT02038829|459053416|FG011|Treatment Period 2|Withdrawal by Subject|0|||
127569183|NCT02038829|459053405|FG000|Washout Period 2|Adverse Event|0|||
127569184|NCT02038829|459053406|FG001|Washout Period 2|Adverse Event|0|||
127569185|NCT02038829|459053407|FG002|Washout Period 2|Adverse Event|0|||
127569186|NCT02038829|459053408|FG003|Washout Period 2|Adverse Event|0|||
127569187|NCT02038829|459053409|FG004|Washout Period 2|Adverse Event|0|||
127569188|NCT02038829|459053410|FG005|Washout Period 2|Adverse Event|0|||
127569189|NCT02038829|459053411|FG006|Washout Period 2|Adverse Event|0|||
127569190|NCT02038829|459053412|FG007|Washout Period 2|Adverse Event|0|||
127569191|NCT02038829|459053413|FG008|Washout Period 2|Adverse Event|1|||
127569192|NCT02038829|459053414|FG009|Washout Period 2|Adverse Event|0|||
127569193|NCT02038829|459053415|FG010|Washout Period 2|Adverse Event|0|||
127569194|NCT02038829|459053416|FG011|Washout Period 2|Adverse Event|0|||
127569195|NCT02038829|459053405|FG000|Washout Period 2|Withdrawal by Subject|0|||
127569196|NCT02038829|459053406|FG001|Washout Period 2|Withdrawal by Subject|0|||
127569197|NCT02038829|459053407|FG002|Washout Period 2|Withdrawal by Subject|0|||
127569198|NCT02038829|459053408|FG003|Washout Period 2|Withdrawal by Subject|0|||
127569199|NCT02038829|459053409|FG004|Washout Period 2|Withdrawal by Subject|0|||
127569200|NCT02038829|459053410|FG005|Washout Period 2|Withdrawal by Subject|1|||
127569201|NCT02038829|459053411|FG006|Washout Period 2|Withdrawal by Subject|0|||
127569202|NCT02038829|459053412|FG007|Washout Period 2|Withdrawal by Subject|0|||
127569203|NCT02038829|459053413|FG008|Washout Period 2|Withdrawal by Subject|0|||
127569204|NCT02038829|459053414|FG009|Washout Period 2|Withdrawal by Subject|0|||
127569205|NCT02038829|459053415|FG010|Washout Period 2|Withdrawal by Subject|0|||
127569206|NCT02038829|459053416|FG011|Washout Period 2|Withdrawal by Subject|0|||
127569207|NCT02038829|459053405|FG000|Treatment Period 4|Adverse Event|0|||
127569208|NCT02038829|459053406|FG001|Treatment Period 4|Adverse Event|1|||
127569209|NCT02038829|459053407|FG002|Treatment Period 4|Adverse Event|0|||
127569210|NCT02038829|459053408|FG003|Treatment Period 4|Adverse Event|0|||
127569211|NCT02038829|459053409|FG004|Treatment Period 4|Adverse Event|0|||
127569212|NCT02038829|459053410|FG005|Treatment Period 4|Adverse Event|0|||
127569213|NCT02038829|459053411|FG006|Treatment Period 4|Adverse Event|0|||
127569214|NCT02038829|459053412|FG007|Treatment Period 4|Adverse Event|0|||
127569215|NCT02038829|459053413|FG008|Treatment Period 4|Adverse Event|0|||
127569216|NCT02038829|459053414|FG009|Treatment Period 4|Adverse Event|0|||
127569217|NCT02038829|459053415|FG010|Treatment Period 4|Adverse Event|0|||
127569218|NCT02038829|459053416|FG011|Treatment Period 4|Adverse Event|0|||
127569219|NCT02038829|459053405|FG000|Washout Period 4|Adverse Event|0|||
127569220|NCT02038829|459053406|FG001|Washout Period 4|Adverse Event|0|||
127569221|NCT02038829|459053407|FG002|Washout Period 4|Adverse Event|0|||
127569222|NCT02038829|459053408|FG003|Washout Period 4|Adverse Event|0|||
127569223|NCT02038829|459053409|FG004|Washout Period 4|Adverse Event|0|||
127569224|NCT02038829|459053410|FG005|Washout Period 4|Adverse Event|0|||
127569225|NCT02038829|459053411|FG006|Washout Period 4|Adverse Event|1|||
127569226|NCT02038829|459053412|FG007|Washout Period 4|Adverse Event|0|||
127569227|NCT02038829|459053413|FG008|Washout Period 4|Adverse Event|0|||
127569228|NCT02038829|459053414|FG009|Washout Period 4|Adverse Event|0|||
127569229|NCT02038829|459053415|FG010|Washout Period 4|Adverse Event|0|||
127569230|NCT02038829|459053416|FG011|Washout Period 4|Adverse Event|0|||
127569231|NCT02038829|459053405|FG000|Treatment Period 6|Adverse Event|0|||
127569232|NCT02038829|459053406|FG001|Treatment Period 6|Adverse Event|0|||
127569233|NCT02038829|459053407|FG002|Treatment Period 6|Adverse Event|1|||
127569234|NCT02038829|459053408|FG003|Treatment Period 6|Adverse Event|0|||
127569235|NCT02038829|459053409|FG004|Treatment Period 6|Adverse Event|0|||
127569236|NCT02038829|459053410|FG005|Treatment Period 6|Adverse Event|0|||
127569237|NCT02038829|459053411|FG006|Treatment Period 6|Adverse Event|0|||
127569238|NCT02038829|459053412|FG007|Treatment Period 6|Adverse Event|0|||
127569239|NCT02038829|459053413|FG008|Treatment Period 6|Adverse Event|0|||
127569240|NCT02038829|459053414|FG009|Treatment Period 6|Adverse Event|0|||
127569241|NCT02038829|459053415|FG010|Treatment Period 6|Adverse Event|0|||
127569242|NCT02038829|459053416|FG011|Treatment Period 6|Adverse Event|0|||
127569243|NCT02579928|459053417|FG000|Overall Study|Withdrawal by Subject|1|||
127569244|NCT02579928|459053418|FG001|Overall Study|Withdrawal by Subject|0|||
127569245|NCT03754972|459053421|FG000|Overall Study|Protocol Violation|25|||
127569246|NCT03422627|459053422|FG000|Overall Study|Protocol-specified Criteria|1|||
127569247|NCT03422627|459053423|FG001|Overall Study|Protocol-specified Criteria|1|||
127569248|NCT03422627|459053424|FG002|Overall Study|Protocol-specified Criteria|0|||
127569249|NCT03422627|459053425|FG003|Overall Study|Protocol-specified Criteria|0|||
127569250|NCT03422627|459053426|FG004|Overall Study|Protocol-specified Criteria|2|||
127569251|NCT03422627|459053422|FG000|Overall Study|Requirement for Alternative Therapy|1|||
127569252|NCT03422627|459053423|FG001|Overall Study|Requirement for Alternative Therapy|1|||
127569253|NCT03422627|459053424|FG002|Overall Study|Requirement for Alternative Therapy|2|||
127569254|NCT03422627|459053425|FG003|Overall Study|Requirement for Alternative Therapy|0|||
127569255|NCT03422627|459053426|FG004|Overall Study|Requirement for Alternative Therapy|0|||
127569256|NCT03422627|459053422|FG000|Overall Study|Disease Progression|1|||
127569257|NCT03422627|459053423|FG001|Overall Study|Disease Progression|0|||
127569258|NCT03422627|459053424|FG002|Overall Study|Disease Progression|1|||
127569259|NCT03422627|459053425|FG003|Overall Study|Disease Progression|2|||
127569260|NCT03422627|459053426|FG004|Overall Study|Disease Progression|0|||
127569261|NCT03422627|459053422|FG000|Overall Study|Adverse Event|2|||
127569262|NCT03422627|459053423|FG001|Overall Study|Adverse Event|1|||
127569263|NCT03422627|459053424|FG002|Overall Study|Adverse Event|0|||
127569264|NCT03422627|459053425|FG003|Overall Study|Adverse Event|0|||
127569265|NCT03422627|459053426|FG004|Overall Study|Adverse Event|2|||
127569266|NCT03422627|459053422|FG000|Overall Study|Ineligibility Determined|0|||
127569267|NCT03422627|459053423|FG001|Overall Study|Ineligibility Determined|1|||
127569268|NCT03422627|459053424|FG002|Overall Study|Ineligibility Determined|0|||
127569269|NCT03422627|459053425|FG003|Overall Study|Ineligibility Determined|0|||
127569270|NCT03422627|459053426|FG004|Overall Study|Ineligibility Determined|0|||
127569271|NCT03422627|459053422|FG000|Overall Study|Death|0|||
127569272|NCT03422627|459053423|FG001|Overall Study|Death|1|||
127569273|NCT03422627|459053424|FG002|Overall Study|Death|1|||
127569274|NCT03422627|459053425|FG003|Overall Study|Death|0|||
127569275|NCT03422627|459053426|FG004|Overall Study|Death|0|||
127569276|NCT03422627|459053422|FG000|Overall Study|Withdrawal by Subject|0|||
127569277|NCT03422627|459053423|FG001|Overall Study|Withdrawal by Subject|0|||
127569278|NCT03422627|459053424|FG002|Overall Study|Withdrawal by Subject|0|||
127569279|NCT03422627|459053425|FG003|Overall Study|Withdrawal by Subject|1|||
127569280|NCT03422627|459053426|FG004|Overall Study|Withdrawal by Subject|0|||
127569281|NCT00934648|459053429|FG000|Overall Study|Failure to return|8|||
127569282|NCT00934648|459053429|FG000|Overall Study|Withdrawal by Subject|1|||
127569283|NCT01993836|459053430|FG000|Overall Study|Surgery Cancelled|3|||
127569284|NCT01993836|459053431|FG001|Overall Study|Surgery Cancelled|0|||
127569285|NCT01993836|459053432|FG002|Overall Study|Surgery Cancelled|0|||
127569286|NCT01993836|459053430|FG000|Overall Study|Physician Decision|2|||
127569287|NCT01993836|459053431|FG001|Overall Study|Physician Decision|1|||
127569288|NCT01993836|459053432|FG002|Overall Study|Physician Decision|0|||
127569289|NCT01993836|459053430|FG000|Overall Study|Death|0|||
127569290|NCT01993836|459053431|FG001|Overall Study|Death|2|||
127569291|NCT01993836|459053432|FG002|Overall Study|Death|0|||
127569292|NCT01993836|459053430|FG000|Overall Study|Withdrawal by Subject|12|||
127569293|NCT01993836|459053431|FG001|Overall Study|Withdrawal by Subject|10|||
127569294|NCT01993836|459053432|FG002|Overall Study|Withdrawal by Subject|5|||
127569295|NCT02195687|459053434|FG000|Overall Study|Personal Reasons|1|||
127569296|NCT02195687|459053435|FG001|Overall Study|Personal Reasons|1|||
127569297|NCT02195687|459053434|FG000|Overall Study|Lost to Follow-up|4|||
127569298|NCT02195687|459053435|FG001|Overall Study|Lost to Follow-up|1|||
127569299|NCT04369924|459053438|FG000|Overall Study|Lost to Follow-up|302|||
127569300|NCT04369924|459053439|FG001|Overall Study|Lost to Follow-up|339|||
127569301|NCT02554279|459053440|FG000|Overall Study|Adverse Event|2|||
127569302|NCT02554279|459053441|FG001|Overall Study|Adverse Event|5|||
127569303|NCT02554279|459053440|FG000|Overall Study|Lost to Follow-up|3|||
127569304|NCT02554279|459053441|FG001|Overall Study|Lost to Follow-up|2|||
127569305|NCT02554279|459053440|FG000|Overall Study|Withdrawal by Subject|6|||
127569306|NCT02554279|459053441|FG001|Overall Study|Withdrawal by Subject|4|||
127569307|NCT02554279|459053440|FG000|Overall Study|Protocol Violation|2|||
127569308|NCT02554279|459053441|FG001|Overall Study|Protocol Violation|1|||
127569309|NCT02554279|459053440|FG000|Overall Study|Other reason|19|||
127569310|NCT02554279|459053441|FG001|Overall Study|Other reason|6|||
127569311|NCT00812487|459053442|FG000|Overall Study|Lost to Follow-up|2|||
127569312|NCT00812487|459053443|FG001|Overall Study|Lost to Follow-up|0|||
127569313|NCT00812487|459053442|FG000|Overall Study|Withdrawal by Subject|3|||
127569314|NCT00812487|459053443|FG001|Overall Study|Withdrawal by Subject|2|||
127569315|NCT00812487|459053442|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
127569316|NCT00812487|459053443|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
127690569|NCT02652260|459492293|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|1|||
127690570|NCT02652260|459492294|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
127569317|NCT00812487|459053442|FG000|Overall Study|Protocol Violation|0|||
127569318|NCT00812487|459053443|FG001|Overall Study|Protocol Violation|1|||
127569319|NCT02360605|459053444|FG000|Overall Study|Withdrawal by Subject|4|||
127569320|NCT02360605|459053445|FG001|Overall Study|Withdrawal by Subject|9|||
127569321|NCT02360605|459053444|FG000|Overall Study|Lost to Follow-up|7|||
127569322|NCT02360605|459053445|FG001|Overall Study|Lost to Follow-up|8|||
127569323|NCT02360605|459053444|FG000|Overall Study|Death|0|||
127569324|NCT02360605|459053445|FG001|Overall Study|Death|1|||
127569325|NCT00290407|459053448|FG000|Overall Study|Physician Decision|2|||
127569326|NCT01933789|459053449|FG000|Overall Study|Death|0|||
127569327|NCT01933789|459053450|FG001|Overall Study|Death|0|||
127569328|NCT01933789|459053451|FG002|Overall Study|Death|0|||
127569329|NCT01933789|459053452|FG003|Overall Study|Death|0|||
127569330|NCT01933789|459053453|FG004|Overall Study|Death|21|||
127569331|NCT01933789|459053454|FG005|Overall Study|Death|32|||
127569332|NCT01933789|459053455|FG006|Overall Study|Death|0|||
127569333|NCT01933789|459053456|FG007|Overall Study|Death|0|||
127569334|NCT01933789|459053457|FG008|Overall Study|Death|0|||
127569335|NCT01933789|459053449|FG000|Overall Study|Lost to Follow-up|0|||
127569336|NCT01933789|459053450|FG001|Overall Study|Lost to Follow-up|0|||
127569337|NCT01933789|459053451|FG002|Overall Study|Lost to Follow-up|0|||
127569338|NCT01933789|459053452|FG003|Overall Study|Lost to Follow-up|1|||
127569339|NCT01933789|459053453|FG004|Overall Study|Lost to Follow-up|8|||
127569340|NCT01933789|459053454|FG005|Overall Study|Lost to Follow-up|9|||
127569341|NCT01933789|459053455|FG006|Overall Study|Lost to Follow-up|1|||
127569342|NCT01933789|459053456|FG007|Overall Study|Lost to Follow-up|4|||
127569343|NCT01933789|459053457|FG008|Overall Study|Lost to Follow-up|0|||
127569344|NCT01933789|459053449|FG000|Overall Study|Withdrawal by Subject|2|||
127569345|NCT01933789|459053450|FG001|Overall Study|Withdrawal by Subject|1|||
127569346|NCT01933789|459053451|FG002|Overall Study|Withdrawal by Subject|0|||
127569347|NCT01933789|459053452|FG003|Overall Study|Withdrawal by Subject|0|||
127569348|NCT01933789|459053453|FG004|Overall Study|Withdrawal by Subject|17|||
127569349|NCT01933789|459053454|FG005|Overall Study|Withdrawal by Subject|16|||
127569350|NCT01933789|459053455|FG006|Overall Study|Withdrawal by Subject|1|||
127569351|NCT01933789|459053456|FG007|Overall Study|Withdrawal by Subject|4|||
127569352|NCT01933789|459053457|FG008|Overall Study|Withdrawal by Subject|0|||
127569353|NCT01933789|459053449|FG000|Overall Study|Became Ineligible|4|||
127569354|NCT01933789|459053450|FG001|Overall Study|Became Ineligible|0|||
127569355|NCT01933789|459053451|FG002|Overall Study|Became Ineligible|0|||
127569356|NCT01933789|459053452|FG003|Overall Study|Became Ineligible|0|||
127569357|NCT01933789|459053453|FG004|Overall Study|Became Ineligible|13|||
127569358|NCT01933789|459053454|FG005|Overall Study|Became Ineligible|10|||
127569359|NCT01933789|459053455|FG006|Overall Study|Became Ineligible|13|||
127569360|NCT01933789|459053456|FG007|Overall Study|Became Ineligible|6|||
127569361|NCT01933789|459053457|FG008|Overall Study|Became Ineligible|0|||
127569362|NCT01117792|459053459|FG000|Overall Study|Death|1|||
127569363|NCT01117792|459053459|FG000|Overall Study|Adverse Event|3|||
127569364|NCT00740051|459053462|FG000|Overall Study|Lack of Efficacy|2|||
127569365|NCT00740051|459053463|FG001|Overall Study|Lack of Efficacy|5|||
127569366|NCT00740051|459053462|FG000|Overall Study|Adverse Event|1|||
127569367|NCT00740051|459053463|FG001|Overall Study|Adverse Event|4|||
127569368|NCT00740051|459053462|FG000|Overall Study|Protocol Violation|2|||
127569369|NCT00740051|459053463|FG001|Overall Study|Protocol Violation|6|||
127569370|NCT00740051|459053462|FG000|Overall Study|Lost to Follow-up|3|||
127569371|NCT00740051|459053463|FG001|Overall Study|Lost to Follow-up|8|||
127569372|NCT00740051|459053462|FG000|Overall Study|Withdrawal by Subject|6|||
127569373|NCT00740051|459053463|FG001|Overall Study|Withdrawal by Subject|8|||
127569374|NCT00740051|459053462|FG000|Overall Study|Other reason (not specified)|4|||
127569375|NCT00740051|459053463|FG001|Overall Study|Other reason (not specified)|1|||
127569376|NCT00274924|459053464|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
127569377|NCT00274924|459053465|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
127569378|NCT00274924|459053466|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
127569379|NCT00274924|459053464|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
127569380|NCT00274924|459053465|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
127569381|NCT00274924|459053466|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
127569382|NCT00274924|459053464|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
127569383|NCT00274924|459053465|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
127569384|NCT00274924|459053466|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
127569385|NCT00274924|459053464|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
127569386|NCT00274924|459053465|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
127569387|NCT00274924|459053466|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
127569388|NCT00274924|459053464|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
127569389|NCT00274924|459053465|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
127569390|NCT00274924|459053466|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
127569391|NCT00274924|459053464|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
127569392|NCT00274924|459053465|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
127569393|NCT00274924|459053466|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
127569394|NCT00274924|459053464|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
127569395|NCT00274924|459053465|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
127569396|NCT00274924|459053466|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
127569397|NCT00274924|459053464|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
127569398|NCT00274924|459053465|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
127569399|NCT00274924|459053466|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
127569400|NCT00274924|459053464|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
127569401|NCT00274924|459053465|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
127569402|NCT00274924|459053466|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
127569403|NCT00274924|459053464|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
127569404|NCT00274924|459053465|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
127569405|NCT00274924|459053466|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
127569406|NCT00274924|459053464|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
127569407|NCT00274924|459053465|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
127569408|NCT00274924|459053466|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
127569409|NCT00274924|459053464|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
127569410|NCT00274924|459053465|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
127569411|NCT00274924|459053466|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
127569412|NCT00274924|459053464|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
127569413|NCT00274924|459053465|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
127569414|NCT00274924|459053466|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
127569415|NCT01055496|459053468|FG000|Overall Study|Withdrawal by Subject|2|||
127569416|NCT01055496|459053469|FG001|Overall Study|Withdrawal by Subject|4|||
127569417|NCT01055496|459053468|FG000|Overall Study|Death|13|||
127569418|NCT01055496|459053469|FG001|Overall Study|Death|23|||
127569419|NCT01055496|459053468|FG000|Overall Study|Lost to Follow-up|0|||
127569420|NCT01055496|459053469|FG001|Overall Study|Lost to Follow-up|2|||
127569421|NCT01055496|459053468|FG000|Overall Study|Other - Unspecified|0|||
127569422|NCT01055496|459053469|FG001|Overall Study|Other - Unspecified|1|||
127569423|NCT01966432|459053470|FG000|Overall Study|Lost to Follow-up|3|||
127569424|NCT01966432|459053471|FG001|Overall Study|Lost to Follow-up|2|||
127569425|NCT01966432|459053472|FG002|Overall Study|Lost to Follow-up|5|||
127569426|NCT01966432|459053470|FG000|Overall Study|Withdrawal by Subject|1|||
127569427|NCT01966432|459053471|FG001|Overall Study|Withdrawal by Subject|3|||
127569428|NCT01966432|459053472|FG002|Overall Study|Withdrawal by Subject|0|||
127569429|NCT01966432|459053470|FG000|Overall Study|Subject Incarcerated|0|||
127569430|NCT01966432|459053471|FG001|Overall Study|Subject Incarcerated|0|||
127569431|NCT01966432|459053472|FG002|Overall Study|Subject Incarcerated|1|||
127569432|NCT01966432|459053470|FG000|Overall Study|SBIRT program ended|1|||
127569433|NCT01966432|459053471|FG001|Overall Study|SBIRT program ended|8|||
127569434|NCT01966432|459053472|FG002|Overall Study|SBIRT program ended|20|||
127569435|NCT01673282|459053474|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
127569436|NCT01673282|459053475|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
127569437|NCT01673282|459053474|FG000|Overall Study|Lack of Efficacy|9|||
127569438|NCT01673282|459053475|FG001|Overall Study|Lack of Efficacy|2|||
127569439|NCT01673282|459053474|FG000|Overall Study|Lost to Follow-up|11|||
127569440|NCT01673282|459053475|FG001|Overall Study|Lost to Follow-up|10|||
127569441|NCT01673282|459053474|FG000|Overall Study|Withdrawal by Subject|3|||
127569442|NCT01673282|459053475|FG001|Overall Study|Withdrawal by Subject|3|||
127569443|NCT01673282|459053474|FG000|Overall Study|Other|1|||
127569444|NCT01673282|459053475|FG001|Overall Study|Other|6|||
127569445|NCT01323920|459053481|FG000|Overall Study|Death|5|||
127569446|NCT01323920|459053481|FG000|Overall Study|Withdrawal by Subject|1|||
127569447|NCT02915874|459053482|FG000|Overall Study|Lost to Follow-up|5|||
127569448|NCT02915874|459053483|FG001|Overall Study|Lost to Follow-up|4|||
127569449|NCT02915874|459053482|FG000|Overall Study|Withdrawal by Subject|1|||
127569450|NCT02915874|459053483|FG001|Overall Study|Withdrawal by Subject|1|||
127569451|NCT02915874|459053482|FG000|Overall Study|Started New Anxiety Medication|0|||
127569452|NCT02915874|459053483|FG001|Overall Study|Started New Anxiety Medication|1|||
127569453|NCT04231981|459053484|FG000|Overall Study|Adverse Event|1|||
127569454|NCT04231981|459053484|FG000|Overall Study|Death|16|||
127569455|NCT04231981|459053484|FG000|Overall Study|Lost to Follow-up|1|||
127569456|NCT00570232|459053485|FG000|Overall Study|Adverse Event|10|||
127569457|NCT00570232|459053485|FG000|Overall Study|discontinued due to medical condition|3|||
127569458|NCT00570232|459053485|FG000|Overall Study|discontinued due to recurrence|8|||
127569459|NCT00570232|459053485|FG000|Overall Study|discontinued due to noncompliance|2|||
127569460|NCT01585584|459053486|FG000|Overall Study|Lack of Efficacy|1|||
127569461|NCT01585584|459053486|FG000|Overall Study|Withdrawal by Subject|1|||
127569462|NCT01585584|459053486|FG000|Overall Study|Physician Decision|2|||
127569463|NCT00527488|459053487|FG000|Overall Study|Withdrawn prior to dosing|0|||
127569464|NCT00527488|459053488|FG001|Overall Study|Withdrawn prior to dosing|1|||
127569465|NCT00527488|459053489|FG002|Overall Study|Withdrawn prior to dosing|1|||
127569466|NCT00527488|459053490|FG003|Overall Study|Withdrawn prior to dosing|0|||
127779208|NCT00375219|459818826|FG001|Overall Study|Protocol Violation|0|||
127569467|NCT01958827|459053491|FG000|Overall Study|Adverse Event|3|||
127779209|NCT00375219|459818827|FG002|Overall Study|Protocol Violation|1|||
127569468|NCT01958827|459053491|FG000|Overall Study|Lack of Efficacy|6|||
127569469|NCT01958827|459053491|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
127569470|NCT03036800|459053492|FG000|Overall Study|Protocol Violation|1|||
127569471|NCT03036800|459053493|FG001|Overall Study|Protocol Violation|0|||
128026896|NCT01452789|460722270|FG001|Overall Study|Withdrawal by Subject|2|||
127569472|NCT03036800|459053492|FG000|Overall Study|Non-compliance|1|||
127779210|NCT00375219|459818825|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
127569473|NCT03036800|459053493|FG001|Overall Study|Non-compliance|0|||
127569474|NCT03036800|459053492|FG000|Overall Study|Lost to Follow-up|1|||
127569475|NCT03036800|459053493|FG001|Overall Study|Lost to Follow-up|0|||
127569476|NCT03036800|459053492|FG000|Overall Study|Death|1|||
127569477|NCT03036800|459053493|FG001|Overall Study|Death|0|||
127569478|NCT03036800|459053492|FG000|Overall Study|Tolerance|5|||
127569479|NCT03036800|459053493|FG001|Overall Study|Tolerance|0|||
127569480|NCT03036800|459053492|FG000|Overall Study|Unknown/no reason given|50|||
127569481|NCT03036800|459053493|FG001|Overall Study|Unknown/no reason given|39|||
127569482|NCT05985980|459053494|FG000|Overall Study|Withdrawal by Subject|1|||
127569483|NCT05985980|459053494|FG000|Overall Study|Withdrawal by Subject|1|||
127569484|NCT05985980|459053494|FG000|Overall Study|Withdrawal by Subject|1|||
127569485|NCT05985980|459053494|FG000|Overall Study|Withdrawal by Subject|1|||
127569486|NCT01163318|459053502|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
127569487|NCT01163318|459053502|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
127569488|NCT01163318|459053502|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
127569489|NCT01163318|459053502|FG000|Overall Study|Participants Without Case Report Form|7|||
127569490|NCT01163318|459053502|FG000|Overall Study|Multiple Reasons Per Participant|224|||
127569491|NCT01006603|459053503|FG000|Overall Study|Withdrawal by Subject|17|||
127569492|NCT01006603|459053504|FG001|Overall Study|Withdrawal by Subject|19|||
127569493|NCT01006603|459053503|FG000|Overall Study|Lost to Follow-up|0|||
127569494|NCT01006603|459053504|FG001|Overall Study|Lost to Follow-up|1|||
127569495|NCT01006603|459053503|FG000|Overall Study|Safety reason|1|||
127569496|NCT01006603|459053504|FG001|Overall Study|Safety reason|1|||
127569497|NCT01006603|459053503|FG000|Overall Study|Protocol Violation|1|||
127569498|NCT01006603|459053504|FG001|Overall Study|Protocol Violation|3|||
127569499|NCT01006603|459053503|FG000|Overall Study|Incorrect enrolment|0|||
127569500|NCT01006603|459053504|FG001|Overall Study|Incorrect enrolment|2|||
127569501|NCT01006603|459053503|FG000|Overall Study|Adverse Event|15|||
127569502|NCT01006603|459053504|FG001|Overall Study|Adverse Event|7|||
127569503|NCT01006603|459053503|FG000|Overall Study|Death|1|||
127569504|NCT01006603|459053504|FG001|Overall Study|Death|1|||
127569505|NCT01006603|459053503|FG000|Overall Study|Study specific discontinuation criteria|33|||
127569506|NCT01006603|459053504|FG001|Overall Study|Study specific discontinuation criteria|34|||
127569507|NCT01006603|459053503|FG000|Overall Study|Other|3|||
127569508|NCT01006603|459053504|FG001|Overall Study|Other|7|||
127569509|NCT01275339|459055123|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
127569510|NCT01275339|459055124|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
127569511|NCT01275339|459055125|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
127569512|NCT01275339|459055126|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
127569513|NCT01275339|459055123|FG000|Overall Study|Withdrawal by Subject|0|||
127569514|NCT01275339|459055124|FG001|Overall Study|Withdrawal by Subject|0|||
127569515|NCT01275339|459055125|FG002|Overall Study|Withdrawal by Subject|1|||
127569516|NCT01275339|459055126|FG003|Overall Study|Withdrawal by Subject|0|||
127569517|NCT02478398|459055127|FG000|Overall Study|Adverse Event|20|||
127569518|NCT02478398|459055128|FG001|Overall Study|Adverse Event|5|||
127569519|NCT02478398|459055127|FG000|Overall Study|Lost to Follow-up|5|||
127569520|NCT02478398|459055128|FG001|Overall Study|Lost to Follow-up|4|||
127569521|NCT02478398|459055127|FG000|Overall Study|Non-Compliance With Study Drug|5|||
127569522|NCT02478398|459055128|FG001|Overall Study|Non-Compliance With Study Drug|1|||
127569523|NCT02478398|459055127|FG000|Overall Study|Protocol Violation|3|||
127569524|NCT02478398|459055128|FG001|Overall Study|Protocol Violation|1|||
127569525|NCT02478398|459055127|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
127569526|NCT02478398|459055128|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
127569527|NCT02478398|459055127|FG000|Overall Study|Withdrawal By Participant|10|||
127569528|NCT02478398|459055128|FG001|Overall Study|Withdrawal By Participant|4|||
127569529|NCT02522871|459055137|FG000|Overall Study|Protocol Violation|1|||
127569530|NCT02522871|459055138|FG001|Overall Study|Protocol Violation|4|||
127569531|NCT02522871|459055137|FG000|Overall Study|Treated without randomization|1|||
127569532|NCT02522871|459055138|FG001|Overall Study|Treated without randomization|0|||
127569533|NCT02522871|459055137|FG000|Overall Study|Death|9|||
128026897|NCT01340170|460722271|FG000|Overall Study|Lost to Follow-up|2|||
128026898|NCT01340170|460722272|FG001|Overall Study|Lost to Follow-up|4|||
128026899|NCT01340170|460722273|FG002|Overall Study|Lost to Follow-up|0|||
127569534|NCT02522871|459055138|FG001|Overall Study|Death|9|||
127569535|NCT02522871|459055137|FG000|Overall Study|Died in operating room prior to transplant|0|||
127569536|NCT02522871|459055138|FG001|Overall Study|Died in operating room prior to transplant|1|||
127569537|NCT00509262|459055139|FG000|Overall Study|Adverse Event|16|||
127569538|NCT00509262|459055140|FG001|Overall Study|Adverse Event|18|||
127569539|NCT00509262|459055139|FG000|Overall Study|Other|2|||
127569540|NCT00509262|459055140|FG001|Overall Study|Other|2|||
127569541|NCT00509262|459055139|FG000|Overall Study|Lack of Efficacy|1|||
127569542|NCT00509262|459055140|FG001|Overall Study|Lack of Efficacy|0|||
127569543|NCT00509262|459055139|FG000|Overall Study|Lost to Follow-up|1|||
127569544|NCT00509262|459055140|FG001|Overall Study|Lost to Follow-up|6|||
127569545|NCT00509262|459055139|FG000|Overall Study|Physician Decision|1|||
127569546|NCT00509262|459055140|FG001|Overall Study|Physician Decision|3|||
127569547|NCT00509262|459055139|FG000|Overall Study|Protocol Violation|2|||
127569548|NCT00509262|459055140|FG001|Overall Study|Protocol Violation|2|||
127569549|NCT00509262|459055139|FG000|Overall Study|Withdrawal by Subject|24|||
127569550|NCT00509262|459055140|FG001|Overall Study|Withdrawal by Subject|11|||
127569551|NCT00725842|459055141|FG000|Overall Study|Lost to Follow-up|19|||
127569552|NCT00725842|459055141|FG000|Overall Study|Death|1|||
127569553|NCT00725842|459055141|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
127569554|NCT00725842|459055141|FG000|Overall Study|Consent date prior to study start date|5|||
127569555|NCT00725842|459055141|FG000|Overall Study|Inclusion criterion not met|1|||
127569556|NCT00725842|459055141|FG000|Overall Study|No Visit 1 data|1|||
127569557|NCT01853618|459055142|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
127569558|NCT01853618|459055143|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
127569559|NCT01853618|459055144|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
127569560|NCT01853618|459055145|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
127569561|NCT01853618|459055146|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
127569562|NCT01853618|459055142|FG000|Overall Study|Progressive disease|1|||
127569563|NCT01853618|459055143|FG001|Overall Study|Progressive disease|1|||
127569564|NCT01853618|459055144|FG002|Overall Study|Progressive disease|1|||
127569565|NCT01853618|459055145|FG003|Overall Study|Progressive disease|1|||
127569566|NCT01853618|459055146|FG004|Overall Study|Progressive disease|2|||
127569567|NCT01853618|459055142|FG000|Overall Study|Physician Decision|0|||
127569568|NCT01853618|459055143|FG001|Overall Study|Physician Decision|1|||
127569569|NCT01853618|459055144|FG002|Overall Study|Physician Decision|1|||
127569570|NCT01853618|459055145|FG003|Overall Study|Physician Decision|0|||
127569571|NCT01853618|459055146|FG004|Overall Study|Physician Decision|0|||
127569572|NCT01853618|459055142|FG000|Overall Study|Refused further treatment|0|||
127569573|NCT01853618|459055143|FG001|Overall Study|Refused further treatment|0|||
127569574|NCT01853618|459055144|FG002|Overall Study|Refused further treatment|0|||
127569575|NCT01853618|459055145|FG003|Overall Study|Refused further treatment|0|||
127569576|NCT01853618|459055146|FG004|Overall Study|Refused further treatment|1|||
127569577|NCT01715129|459055153|FG000|Overall Study|Adverse Event, fatal|1|||
127569578|NCT01715129|459055153|FG000|Overall Study|Lack of Efficacy|3|||
127569579|NCT01715129|459055153|FG000|Overall Study|Protocol Violation|1|||
127569580|NCT01715129|459055153|FG000|Overall Study|Consent Withdrawn|2|||
127569581|NCT01715129|459055153|FG000|Overall Study|Lost to Follow-up|1|||
127569582|NCT01715129|459055153|FG000|Overall Study|Other|1|||
127569583|NCT02793622|459055154|FG000|Overall Study|Lost to Follow-up|31|||
127569584|NCT02793622|459055155|FG001|Overall Study|Lost to Follow-up|19|||
127569585|NCT02793622|459055154|FG000|Overall Study|Withdrawal by Subject|21|||
127569586|NCT02793622|459055155|FG001|Overall Study|Withdrawal by Subject|17|||
127569587|NCT02793622|459055154|FG000|Overall Study|Adverse Event|0|||
127569588|NCT02793622|459055155|FG001|Overall Study|Adverse Event|1|||
127569589|NCT02793622|459055154|FG000|Overall Study|Protocol Violation|1|||
127569590|NCT02793622|459055155|FG001|Overall Study|Protocol Violation|5|||
127569591|NCT01146860|459055156|FG000|Overall Study|Withdrawal by Subject|0|||
127569592|NCT01146860|459055157|FG001|Overall Study|Withdrawal by Subject|1|||
127569593|NCT01092832|459055158|FG000|Overall Study|Other|1|||
127569594|NCT01092832|459055159|FG001|Overall Study|Other|0|||
127569595|NCT00722371|459055160|FG000|Overall Study|Adverse Event|6|||
127569596|NCT00722371|459055161|FG001|Overall Study|Adverse Event|13|||
127569597|NCT00722371|459055162|FG002|Overall Study|Adverse Event|9|||
127569598|NCT00722371|459055163|FG003|Overall Study|Adverse Event|10|||
127569599|NCT00722371|459055164|FG004|Overall Study|Adverse Event|6|||
127569600|NCT00722371|459055165|FG005|Overall Study|Adverse Event|8|||
127569601|NCT00722371|459055166|FG006|Overall Study|Adverse Event|4|||
127569602|NCT00722371|459055160|FG000|Overall Study|Contraindication|0|||
127569603|NCT00722371|459055161|FG001|Overall Study|Contraindication|0|||
127690571|NCT02652260|459492293|FG000|Study Extension 2 (Open-Label)|Pregnancy|1|||
127690572|NCT02652260|459492294|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
127690573|NCT02652260|459492293|FG000|Study Extension 3 (Open-Label)|Physician Decision|7|||
127690574|NCT02652260|459492294|FG001|Study Extension 3 (Open-Label)|Physician Decision|10|||
127690575|NCT02652260|459492293|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
127690576|NCT02652260|459492294|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
127690577|NCT05056246|459492295|FG000|Overall Study|Adverse Event|0|||
127690578|NCT05056246|459492296|FG001|Overall Study|Adverse Event|0|||
127690579|NCT05056246|459492297|FG002|Overall Study|Adverse Event|0|||
127779211|NCT00375219|459818826|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
127779212|NCT00375219|459818827|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
127569604|NCT00722371|459055162|FG002|Overall Study|Contraindication|1|||
127569605|NCT00722371|459055163|FG003|Overall Study|Contraindication|0|||
127569606|NCT00722371|459055164|FG004|Overall Study|Contraindication|0|||
127569607|NCT00722371|459055165|FG005|Overall Study|Contraindication|0|||
127569608|NCT00722371|459055166|FG006|Overall Study|Contraindication|0|||
127569609|NCT00722371|459055160|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
127569610|NCT00722371|459055161|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
127569611|NCT00722371|459055162|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
127690580|NCT05056246|459492298|FG003|Overall Study|Adverse Event|0|||
127690581|NCT05056246|459492299|FG004|Overall Study|Adverse Event|1|||
127690582|NCT05056246|459492295|FG000|Overall Study|Lost to Follow-up|0|||
127690583|NCT05056246|459492296|FG001|Overall Study|Lost to Follow-up|0|||
127690584|NCT05056246|459492297|FG002|Overall Study|Lost to Follow-up|0|||
127690585|NCT05056246|459492298|FG003|Overall Study|Lost to Follow-up|2|||
127690586|NCT05056246|459492299|FG004|Overall Study|Lost to Follow-up|0|||
127690587|NCT05056246|459492295|FG000|Overall Study|Withdrawal by Subject|0|||
127690588|NCT05056246|459492296|FG001|Overall Study|Withdrawal by Subject|1|||
127690589|NCT05056246|459492297|FG002|Overall Study|Withdrawal by Subject|0|||
127690590|NCT05056246|459492298|FG003|Overall Study|Withdrawal by Subject|0|||
127690591|NCT05056246|459492299|FG004|Overall Study|Withdrawal by Subject|0|||
127690592|NCT03899961|459492310|FG000|Overall Study|-delivery prior to|2|||
127690593|NCT03899961|459492311|FG001|Overall Study|-delivery prior to|7|||
127690594|NCT03899961|459492310|FG000|Overall Study|req general anesth|1|||
127690595|NCT03899961|459492311|FG001|Overall Study|req general anesth|2|||
127690596|NCT03899961|459492310|FG000|Overall Study|capacity|5|||
127690597|NCT03899961|459492311|FG001|Overall Study|capacity|6|||
127690598|NCT03899961|459492310|FG000|Overall Study|Withdrawal by Subject|1|||
127690599|NCT03899961|459492311|FG001|Overall Study|Withdrawal by Subject|1|||
127690600|NCT05656911|459492312|FG000|Treatment Phase|Physician Decision|2|||
127690601|NCT05656911|459492313|FG001|Treatment Phase|Physician Decision|0|||
127690602|NCT05656911|459492312|FG000|Treatment Phase|Lack of Efficacy|6|||
127569612|NCT00722371|459055163|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
127569613|NCT00722371|459055164|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
127690603|NCT05656911|459492313|FG001|Treatment Phase|Lack of Efficacy|3|||
127690604|NCT05656911|459492312|FG000|Treatment Phase|Subject Decision|4|||
127690605|NCT05656911|459492313|FG001|Treatment Phase|Subject Decision|2|||
127690606|NCT05656911|459492312|FG000|Treatment Phase|Other Reasons|1|||
127690607|NCT05656911|459492313|FG001|Treatment Phase|Other Reasons|0|||
127690608|NCT05656911|459492312|FG000|Treatment Phase|Adverse Event|3|||
127690609|NCT05656911|459492313|FG001|Treatment Phase|Adverse Event|1|||
127690610|NCT05656911|459492312|FG000|Follow-up Phase|Subject Decision|0|||
127569614|NCT00722371|459055165|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
127569615|NCT00722371|459055166|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
127569616|NCT00722371|459055160|FG000|Overall Study|Excluded medication|0|||
127569617|NCT00722371|459055161|FG001|Overall Study|Excluded medication|1|||
127569618|NCT00722371|459055162|FG002|Overall Study|Excluded medication|1|||
127569619|NCT00722371|459055163|FG003|Overall Study|Excluded medication|0|||
127569620|NCT00722371|459055164|FG004|Overall Study|Excluded medication|0|||
127569621|NCT00722371|459055165|FG005|Overall Study|Excluded medication|0|||
127569622|NCT00722371|459055166|FG006|Overall Study|Excluded medication|1|||
127569623|NCT00722371|459055160|FG000|Overall Study|Hyperglycemia|2|||
127569624|NCT00722371|459055161|FG001|Overall Study|Hyperglycemia|6|||
127569625|NCT00722371|459055162|FG002|Overall Study|Hyperglycemia|4|||
127569626|NCT00722371|459055163|FG003|Overall Study|Hyperglycemia|2|||
127569627|NCT00722371|459055164|FG004|Overall Study|Hyperglycemia|5|||
127569628|NCT00722371|459055165|FG005|Overall Study|Hyperglycemia|1|||
127569629|NCT00722371|459055166|FG006|Overall Study|Hyperglycemia|1|||
127690611|NCT05656911|459492313|FG001|Follow-up Phase|Subject Decision|1|||
127690612|NCT05656911|459492312|FG000|Follow-up Phase|Missing|1|||
127690613|NCT05656911|459492313|FG001|Follow-up Phase|Missing|0|||
127690614|NCT02780388|459492314|FG000|Overall Study|Lost to Follow-up|0|||
127690615|NCT02780388|459492315|FG001|Overall Study|Lost to Follow-up|1|||
127569630|NCT00722371|459055160|FG000|Overall Study|Hypoglycemia|1|||
127569631|NCT00722371|459055161|FG001|Overall Study|Hypoglycemia|0|||
127690616|NCT02780388|459492316|FG002|Overall Study|Lost to Follow-up|0|||
127690617|NCT02780388|459492317|FG003|Overall Study|Lost to Follow-up|0|||
127569632|NCT00722371|459055162|FG002|Overall Study|Hypoglycemia|0|||
127569633|NCT00722371|459055163|FG003|Overall Study|Hypoglycemia|0|||
127569634|NCT00722371|459055164|FG004|Overall Study|Hypoglycemia|0|||
127569635|NCT00722371|459055165|FG005|Overall Study|Hypoglycemia|0|||
127690618|NCT02780388|459492318|FG004|Overall Study|Lost to Follow-up|0|||
127690619|NCT02780388|459492314|FG000|Overall Study|Withdrawal by Subject|1|||
127690620|NCT02780388|459492315|FG001|Overall Study|Withdrawal by Subject|1|||
127569636|NCT00722371|459055166|FG006|Overall Study|Hypoglycemia|0|||
127569637|NCT00722371|459055160|FG000|Overall Study|Lack of Efficacy|4|||
127569638|NCT00722371|459055161|FG001|Overall Study|Lack of Efficacy|6|||
127569639|NCT00722371|459055162|FG002|Overall Study|Lack of Efficacy|6|||
127569640|NCT00722371|459055163|FG003|Overall Study|Lack of Efficacy|6|||
127569641|NCT00722371|459055164|FG004|Overall Study|Lack of Efficacy|2|||
127569642|NCT00722371|459055165|FG005|Overall Study|Lack of Efficacy|3|||
127569643|NCT00722371|459055166|FG006|Overall Study|Lack of Efficacy|0|||
127569644|NCT00722371|459055160|FG000|Overall Study|Lost to Follow-up|11|||
127569645|NCT00722371|459055161|FG001|Overall Study|Lost to Follow-up|14|||
127569646|NCT00722371|459055162|FG002|Overall Study|Lost to Follow-up|21|||
127569647|NCT00722371|459055163|FG003|Overall Study|Lost to Follow-up|13|||
127779213|NCT00375219|459818825|FG000|Overall Study|Lost to Follow-up|1|||
127569648|NCT00722371|459055164|FG004|Overall Study|Lost to Follow-up|8|||
127569649|NCT00722371|459055165|FG005|Overall Study|Lost to Follow-up|16|||
127569650|NCT00722371|459055166|FG006|Overall Study|Lost to Follow-up|13|||
127779214|NCT00375219|459818826|FG001|Overall Study|Lost to Follow-up|1|||
127779215|NCT00375219|459818827|FG002|Overall Study|Lost to Follow-up|0|||
127779216|NCT00375219|459818825|FG000|Overall Study|Disease progression|18|||
127779217|NCT00375219|459818826|FG001|Overall Study|Disease progression|9|||
128026900|NCT01340170|460722271|FG000|Overall Study|Implant failure|1|||
128026901|NCT01340170|460722272|FG001|Overall Study|Implant failure|3|||
128026902|NCT01340170|460722273|FG002|Overall Study|Implant failure|0|||
128026903|NCT03878602|460722274|FG000|Overall Study|cord blood donation|7|||
128026904|NCT03878602|460722275|FG001|Overall Study|cord blood donation|1|||
128026905|NCT03878602|460722274|FG000|Overall Study|incomplete data collection|2|||
128026906|NCT03878602|460722275|FG001|Overall Study|incomplete data collection|0|||
128026907|NCT03722030|460722276|FG000|Overall Study|Withdrawal by Subject|1|||
128026908|NCT03722030|460722277|FG001|Overall Study|Withdrawal by Subject|0|||
128026909|NCT00472641|460722279|FG000|Overall Study|Lack of Efficacy|3|||
128026910|NCT00472641|460722279|FG000|Overall Study|Adverse Event|3|||
128026911|NCT00472641|460722279|FG000|Overall Study|Lost to Follow-up|1|||
128026912|NCT01189227|460722280|FG000|Overall Study|Study terminated due to low accrual|6|||
128026913|NCT01189227|460722281|FG001|Overall Study|Study terminated due to low accrual|3|||
128026914|NCT03211832|460722282|FG000|Overall Study|No longer with agency|32|||
128026915|NCT03211832|460722283|FG001|Overall Study|No longer with agency|49|||
127569651|NCT00722371|459055160|FG000|Overall Study|Physician Decision|5|||
127779218|NCT00375219|459818827|FG002|Overall Study|Disease progression|12|||
128026916|NCT03211832|460722284|FG002|Overall Study|No longer with agency|30|||
128026917|NCT03211832|460722282|FG000|Overall Study|Declined survey|3|||
128026918|NCT03211832|460722283|FG001|Overall Study|Declined survey|3|||
128026919|NCT03211832|460722284|FG002|Overall Study|Declined survey|2|||
127569652|NCT00722371|459055161|FG001|Overall Study|Physician Decision|2|||
127569653|NCT00722371|459055162|FG002|Overall Study|Physician Decision|2|||
127569654|NCT00722371|459055163|FG003|Overall Study|Physician Decision|5|||
127569655|NCT00722371|459055164|FG004|Overall Study|Physician Decision|2|||
127569656|NCT00722371|459055165|FG005|Overall Study|Physician Decision|3|||
127569657|NCT00722371|459055166|FG006|Overall Study|Physician Decision|4|||
127569658|NCT00722371|459055160|FG000|Overall Study|Pregnancy|1|||
127569659|NCT00722371|459055161|FG001|Overall Study|Pregnancy|1|||
127569660|NCT00722371|459055162|FG002|Overall Study|Pregnancy|0|||
127569661|NCT00722371|459055163|FG003|Overall Study|Pregnancy|0|||
127569662|NCT00722371|459055164|FG004|Overall Study|Pregnancy|0|||
127569663|NCT00722371|459055165|FG005|Overall Study|Pregnancy|1|||
127569664|NCT00722371|459055166|FG006|Overall Study|Pregnancy|0|||
128026920|NCT03211832|460722282|FG000|Overall Study|Not available during data collection|1|||
127569665|NCT00722371|459055160|FG000|Overall Study|Protocol Violation|6|||
127569666|NCT00722371|459055161|FG001|Overall Study|Protocol Violation|1|||
127569667|NCT00722371|459055162|FG002|Overall Study|Protocol Violation|0|||
127569668|NCT00722371|459055163|FG003|Overall Study|Protocol Violation|1|||
127569669|NCT00722371|459055164|FG004|Overall Study|Protocol Violation|4|||
127569670|NCT00722371|459055165|FG005|Overall Study|Protocol Violation|2|||
127569671|NCT00722371|459055166|FG006|Overall Study|Protocol Violation|1|||
127569672|NCT00722371|459055160|FG000|Overall Study|Withdrawal by Subject|18|||
127569673|NCT00722371|459055161|FG001|Overall Study|Withdrawal by Subject|27|||
127569674|NCT00722371|459055162|FG002|Overall Study|Withdrawal by Subject|19|||
127569675|NCT00722371|459055163|FG003|Overall Study|Withdrawal by Subject|23|||
127569676|NCT00722371|459055164|FG004|Overall Study|Withdrawal by Subject|19|||
127569677|NCT00722371|459055165|FG005|Overall Study|Withdrawal by Subject|18|||
127569678|NCT00722371|459055166|FG006|Overall Study|Withdrawal by Subject|26|||
127569679|NCT01075191|459055167|FG000|Overall Study|Death|1|||
127569680|NCT01075191|459055167|FG000|Overall Study|Intensification|3|||
127569681|NCT01075191|459055167|FG000|Overall Study|Co-morbidities|1|||
127569682|NCT01075191|459055167|FG000|Overall Study|Adverse Event|4|||
127569683|NCT01075191|459055167|FG000|Overall Study|Noncompliance|3|||
127569684|NCT01075191|459055167|FG000|Overall Study|Therapy Break|3|||
127569685|NCT01075191|459055167|FG000|Overall Study|Patient's Wish|2|||
127569686|NCT01075191|459055167|FG000|Overall Study|Unknown Reasons|1|||
127569687|NCT02068768|459055172|FG000|Overall Study|Lost to Follow-up|5|||
127569688|NCT02068768|459055172|FG000|Overall Study|Early Termination by Sponsor|2|||
127569689|NCT00555425|459055173|FG000|Overall Study|Missed Medication > 1 wk|34|||
127569690|NCT00555425|459055174|FG001|Overall Study|Missed Medication > 1 wk|15|||
127569691|NCT00555425|459055173|FG000|Overall Study|Missed 3 physician management visits|1|||
127569692|NCT00555425|459055174|FG001|Overall Study|Missed 3 physician management visits|0|||
127569693|NCT00555425|459055173|FG000|Overall Study|Met criteria for protective transfer|16|||
127569694|NCT00555425|459055174|FG001|Overall Study|Met criteria for protective transfer|3|||
127569695|NCT00555425|459055173|FG000|Overall Study|Became pregnant and transferred care|0|||
127569696|NCT00555425|459055174|FG001|Overall Study|Became pregnant and transferred care|1|||
127569697|NCT02635646|459055176|FG000|Overall Study|Lost to Follow-up|24|||
127569698|NCT02635646|459055177|FG001|Overall Study|Lost to Follow-up|25|||
127569699|NCT02635646|459055176|FG000|Overall Study|Pregnancy|1|||
127569700|NCT02635646|459055177|FG001|Overall Study|Pregnancy|1|||
127569701|NCT00400153|459055185|FG000|Overall Study|AE due to study disease worsening|14|||
127569702|NCT00400153|459055186|FG001|Overall Study|AE due to study disease worsening|19|||
127569703|NCT00400153|459055187|FG002|Overall Study|AE due to study disease worsening|20|||
127569704|NCT00400153|459055185|FG000|Overall Study|AE due to other disease worsening|2|||
127569705|NCT00400153|459055186|FG001|Overall Study|AE due to other disease worsening|1|||
127690621|NCT02780388|459492316|FG002|Overall Study|Withdrawal by Subject|0|||
127569706|NCT00400153|459055187|FG002|Overall Study|AE due to other disease worsening|0|||
127569707|NCT00400153|459055185|FG000|Overall Study|AE due to other condition|3|||
127569708|NCT00400153|459055186|FG001|Overall Study|AE due to other condition|14|||
127569709|NCT00400153|459055187|FG002|Overall Study|AE due to other condition|15|||
127690622|NCT02780388|459492317|FG003|Overall Study|Withdrawal by Subject|0|||
127690623|NCT02780388|459492318|FG004|Overall Study|Withdrawal by Subject|0|||
127690624|NCT05107401|459492319|FG000|Overall Study|Lost to Follow-up|13|||
127690625|NCT05107401|459492320|FG001|Overall Study|Lost to Follow-up|12|||
127690626|NCT04440176|459492325|FG000|Overall Study|Withdrawal by Subject|5|||
127690627|NCT04440176|459492326|FG001|Overall Study|Withdrawal by Subject|3|||
127690628|NCT04440176|459492325|FG000|Overall Study|Withdrawal by parent/guardian|4|||
128026921|NCT03211832|460722283|FG001|Overall Study|Not available during data collection|0|||
127569710|NCT00400153|459055185|FG000|Overall Study|Protocol Violation|7|||
127569711|NCT00400153|459055186|FG001|Overall Study|Protocol Violation|4|||
127569712|NCT00400153|459055187|FG002|Overall Study|Protocol Violation|9|||
127569713|NCT00400153|459055185|FG000|Overall Study|Lost to Follow-up|2|||
127569714|NCT00400153|459055186|FG001|Overall Study|Lost to Follow-up|1|||
127569715|NCT00400153|459055187|FG002|Overall Study|Lost to Follow-up|4|||
127569716|NCT00400153|459055185|FG000|Overall Study|Withdrawal by Subject|12|||
127569717|NCT00400153|459055186|FG001|Overall Study|Withdrawal by Subject|11|||
127569718|NCT00400153|459055187|FG002|Overall Study|Withdrawal by Subject|10|||
127569719|NCT00400153|459055185|FG000|Overall Study|Other reasons - not mentioned above|8|||
127569720|NCT00400153|459055186|FG001|Overall Study|Other reasons - not mentioned above|5|||
127569721|NCT00400153|459055187|FG002|Overall Study|Other reasons - not mentioned above|3|||
127569722|NCT00393042|459055188|FG000|First Intervention|Withdrawal by Subject|1|||
127569723|NCT00393042|459055189|FG001|First Intervention|Withdrawal by Subject|2|||
127569724|NCT00393042|459055188|FG000|First Intervention|Lost to Follow-up|3|||
127569725|NCT00393042|459055189|FG001|First Intervention|Lost to Follow-up|3|||
127569726|NCT00393042|459055188|FG000|First Intervention|Protocol Violation|1|||
127569727|NCT00393042|459055189|FG001|First Intervention|Protocol Violation|0|||
127569728|NCT00393042|459055188|FG000|First Intervention|Adverse Event|0|||
128026922|NCT03211832|460722284|FG002|Overall Study|Not available during data collection|2|||
128026923|NCT01608308|460722286|FG000|Overall Study|pretreatment medical and billing reasons|0|||
127569729|NCT00393042|459055189|FG001|First Intervention|Adverse Event|1|||
127569730|NCT00393042|459055188|FG000|Second Intervetion|Adverse Event|0|||
127569731|NCT00393042|459055189|FG001|Second Intervetion|Adverse Event|3|||
127569732|NCT00393042|459055188|FG000|Second Intervetion|Withdrawal by Subject|0|||
127569733|NCT00393042|459055189|FG001|Second Intervetion|Withdrawal by Subject|2|||
127569734|NCT00393042|459055188|FG000|Second Intervetion|Lack of Efficacy|1|||
127569735|NCT00393042|459055189|FG001|Second Intervetion|Lack of Efficacy|0|||
127569736|NCT00393042|459055188|FG000|Second Intervetion|Lost to Follow-up|0|||
127569737|NCT00393042|459055189|FG001|Second Intervetion|Lost to Follow-up|2|||
127569738|NCT00393042|459055188|FG000|Second Intervetion|Protocol Violation|1|||
127569739|NCT00393042|459055189|FG001|Second Intervetion|Protocol Violation|1|||
127569740|NCT01150474|459055191|FG000|Overall Study|Withdrawal by Subject|5|||
127569741|NCT01150474|459055192|FG001|Overall Study|Withdrawal by Subject|2|||
127569742|NCT01150474|459055191|FG000|Overall Study|Cancer found|1|||
127569743|NCT01150474|459055192|FG001|Overall Study|Cancer found|0|||
127569744|NCT01150474|459055191|FG000|Overall Study|Multiple Studies|0|||
127569745|NCT01150474|459055192|FG001|Overall Study|Multiple Studies|1|||
127569746|NCT01150474|459055191|FG000|Overall Study|Rectotomy|1|||
127569747|NCT01150474|459055192|FG001|Overall Study|Rectotomy|0|||
127569748|NCT01150474|459055191|FG000|Overall Study|Drug did not arrive in time|1|||
127569749|NCT01150474|459055192|FG001|Overall Study|Drug did not arrive in time|0|||
127569750|NCT01150474|459055191|FG000|Overall Study|Drug not administered|1|||
127569751|NCT01150474|459055192|FG001|Overall Study|Drug not administered|0|||
127569752|NCT01150474|459055191|FG000|Overall Study|Surgery Changed|1|||
127569753|NCT01150474|459055192|FG001|Overall Study|Surgery Changed|0|||
127569754|NCT01423604|459055193|FG000|Safety Run-In|Adverse Event|3|||
127569755|NCT01423604|459055194|FG001|Safety Run-In|Adverse Event|0|||
127569756|NCT01423604|459055193|FG000|Safety Run-In|Death|1|||
127569757|NCT01423604|459055194|FG001|Safety Run-In|Death|0|||
127569758|NCT01423604|459055193|FG000|Safety Run-In|Physician Decision|1|||
127569759|NCT01423604|459055194|FG001|Safety Run-In|Physician Decision|0|||
127569760|NCT01423604|459055193|FG000|Safety Run-In|Disease progression|3|||
127569761|NCT01423604|459055194|FG001|Safety Run-In|Disease progression|0|||
127569762|NCT01423604|459055193|FG000|Safety Run-In|Patient decision|1|||
127569763|NCT01423604|459055194|FG001|Safety Run-In|Patient decision|0|||
127569764|NCT01423604|459055193|FG000|Randomized|Adverse Event|4|||
127569765|NCT01423604|459055194|FG001|Randomized|Adverse Event|10|||
127569766|NCT01423604|459055193|FG000|Randomized|Death|1|||
127569767|NCT01423604|459055194|FG001|Randomized|Death|0|||
127569768|NCT01423604|459055193|FG000|Randomized|Physician Decision|16|||
127569769|NCT01423604|459055194|FG001|Randomized|Physician Decision|13|||
127569770|NCT01423604|459055193|FG000|Randomized|Other - unspecified|37|||
127569771|NCT01423604|459055194|FG001|Randomized|Other - unspecified|31|||
127569772|NCT01423604|459055193|FG000|Randomized|Patient decision|5|||
127569773|NCT01423604|459055194|FG001|Randomized|Patient decision|9|||
127569774|NCT00424255|459055195|FG000|Overall Study|Death|115|||
127569775|NCT00424255|459055196|FG001|Overall Study|Death|111|||
127569776|NCT00424255|459055195|FG000|Overall Study|Lost to Follow-up|26|||
127569777|NCT00424255|459055196|FG001|Overall Study|Lost to Follow-up|20|||
127569778|NCT00424255|459055195|FG000|Overall Study|Protocol Violation|0|||
127569779|NCT00424255|459055196|FG001|Overall Study|Protocol Violation|1|||
127569780|NCT00424255|459055195|FG000|Overall Study|Withdrawal by Subject|34|||
127569781|NCT00424255|459055196|FG001|Overall Study|Withdrawal by Subject|38|||
127569782|NCT00424255|459055195|FG000|Overall Study|Physician Decision|3|||
127569783|NCT00424255|459055196|FG001|Overall Study|Physician Decision|7|||
127569784|NCT00424255|459055195|FG000|Overall Study|Cognitive Disturbance|1|||
127569785|NCT00424255|459055196|FG001|Overall Study|Cognitive Disturbance|0|||
127569786|NCT00424255|459055195|FG000|Overall Study|Non-compliance by Participants|1|||
127569787|NCT00424255|459055196|FG001|Overall Study|Non-compliance by Participants|0|||
127569788|NCT00424255|459055195|FG000|Overall Study|Fatigue|1|||
127569789|NCT00424255|459055196|FG001|Overall Study|Fatigue|0|||
127569790|NCT00424255|459055195|FG000|Overall Study|Disease Progression|0|||
127569791|NCT00424255|459055196|FG001|Overall Study|Disease Progression|2|||
127569792|NCT00424255|459055195|FG000|Overall Study|Sponsor Terminated Study|161|||
127569793|NCT00424255|459055196|FG001|Overall Study|Sponsor Terminated Study|167|||
127569794|NCT04738318|459055197|FG000|Overall Study|Protocol Violation|1|||
127569795|NCT04738318|459055198|FG001|Overall Study|Protocol Violation|0|||
127569796|NCT01226121|459055199|FG000|Overall Study|Lost to Follow-up|2|||
127569797|NCT01226121|459055200|FG001|Overall Study|Lost to Follow-up|0|||
127569798|NCT01226121|459055201|FG002|Overall Study|Lost to Follow-up|1|||
127569799|NCT02290431|459055202|FG000|Overall Study|Adverse Event|20|||
127569800|NCT02290431|459055202|FG000|Overall Study|Progressive disease|4|||
127569801|NCT02290431|459055202|FG000|Overall Study|Study terminated by Sponsor|1|||
127569802|NCT02290431|459055202|FG000|Overall Study|Physician Decision|2|||
127569803|NCT00821327|459055205|FG000|Overall Study|Adverse Event|13|||
127569804|NCT00821327|459055205|FG000|Overall Study|Patient Request|1|||
127569805|NCT00821327|459055205|FG000|Overall Study|Investigator Request|2|||
127569806|NCT00821327|459055205|FG000|Overall Study|Sponsor Request|1|||
127569807|NCT00821327|459055205|FG000|Overall Study|Disease Progression|13|||
127569808|NCT00821327|459055205|FG000|Overall Study|Other/Unknown|5|||
127569809|NCT00459979|459055208|FG000|Overall Study|Withdrawal by Subject|1|||
127569810|NCT00459979|459055208|FG000|Overall Study|Protocol Violation|1|||
127569811|NCT00219544|459055209|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
127569812|NCT00219544|459055210|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
127569813|NCT00219544|459055209|FG000|Single Blind Treatment Period|Adverse Event|9|||
127569814|NCT00219544|459055210|FG001|Single Blind Treatment Period|Adverse Event|0|||
127569815|NCT00219544|459055209|FG000|Single Blind Treatment Period|Protocol Violation|4|||
127569816|NCT00219544|459055210|FG001|Single Blind Treatment Period|Protocol Violation|0|||
127569817|NCT00219544|459055209|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
127569818|NCT00219544|459055210|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
127569819|NCT00219544|459055209|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
127569820|NCT00219544|459055210|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
127569821|NCT00219544|459055209|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
127569822|NCT00219544|459055210|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
127569823|NCT01007253|459055213|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
127569824|NCT01007253|459055214|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
127569825|NCT01007253|459055215|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
127569826|NCT01007253|459055216|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
127569827|NCT00814801|459055217|FG000|Overall Study|Adverse Event|15|||
127569828|NCT00814801|459055218|FG001|Overall Study|Adverse Event|16|||
127569829|NCT00814801|459055219|FG002|Overall Study|Adverse Event|19|||
127569830|NCT00814801|459055217|FG000|Overall Study|Withdrawal by Subject|9|||
127569831|NCT00814801|459055218|FG001|Overall Study|Withdrawal by Subject|11|||
127569832|NCT00814801|459055219|FG002|Overall Study|Withdrawal by Subject|14|||
127569833|NCT00814801|459055217|FG000|Overall Study|Inappropriate as a subject|1|||
127569834|NCT00814801|459055218|FG001|Overall Study|Inappropriate as a subject|1|||
127569835|NCT00814801|459055219|FG002|Overall Study|Inappropriate as a subject|1|||
127569836|NCT00814801|459055217|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
127569837|NCT00814801|459055218|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
127569838|NCT00814801|459055219|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
127569839|NCT00814801|459055217|FG000|Overall Study|Missing or change of caregiver|6|||
127569840|NCT00814801|459055218|FG001|Overall Study|Missing or change of caregiver|2|||
127569841|NCT00814801|459055219|FG002|Overall Study|Missing or change of caregiver|4|||
127569842|NCT00814801|459055217|FG000|Overall Study|Non-compliance|0|||
127569843|NCT00814801|459055218|FG001|Overall Study|Non-compliance|1|||
127569844|NCT00814801|459055219|FG002|Overall Study|Non-compliance|1|||
127569845|NCT00814801|459055217|FG000|Overall Study|Other|2|||
127569846|NCT00814801|459055218|FG001|Overall Study|Other|6|||
127569847|NCT00814801|459055219|FG002|Overall Study|Other|4|||
127569848|NCT00586664|459055220|FG000|Overall Study|Withdrawal by Subject|3|||
127569849|NCT00586664|459055221|FG001|Overall Study|Withdrawal by Subject|7|||
127569850|NCT00586664|459055222|FG002|Overall Study|Withdrawal by Subject|1|||
127569851|NCT00586664|459055220|FG000|Overall Study|Exclusion criteria met|2|||
127569852|NCT00586664|459055221|FG001|Overall Study|Exclusion criteria met|0|||
127690629|NCT04440176|459492326|FG001|Overall Study|Withdrawal by parent/guardian|5|||
127690630|NCT04440176|459492325|FG000|Overall Study|Adverse Event|2|||
127690631|NCT04440176|459492326|FG001|Overall Study|Adverse Event|6|||
127569853|NCT00586664|459055222|FG002|Overall Study|Exclusion criteria met|0|||
127569854|NCT02751931|459055223|FG000|Overall Study|Adverse Event|3|||
127569855|NCT02751931|459055224|FG001|Overall Study|Adverse Event|0|||
127569856|NCT02751931|459055223|FG000|Overall Study|Other: Miscelleneous|10|||
127690632|NCT04440176|459492325|FG000|Overall Study|Lost to Follow-up|22|||
127690633|NCT04440176|459492326|FG001|Overall Study|Lost to Follow-up|23|||
127690634|NCT04440176|459492325|FG000|Overall Study|Medication error without associated adverse event|0|||
127569857|NCT02751931|459055224|FG001|Overall Study|Other: Miscelleneous|8|||
127569858|NCT01037088|459055225|FG000|Overall Study|Withdrawal by Subject|3|||
127569859|NCT00817479|459055229|FG000|Overall Study|Physician Decision|1|||
127569860|NCT00817479|459055230|FG001|Overall Study|Physician Decision|1|||
127690635|NCT04440176|459492326|FG001|Overall Study|Medication error without associated adverse event|1|||
127690636|NCT04440176|459492325|FG000|Overall Study|No longer met eligibility criteria|7|||
127690637|NCT04440176|459492326|FG001|Overall Study|No longer met eligibility criteria|1|||
127569861|NCT04030026|459055232|FG000|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|0|||
127569862|NCT04030026|459055233|FG001|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|1|||
127569863|NCT04030026|459055232|FG000|Treatment Period 1 (22 Days)|Withdrawal by Participant|1|||
127569864|NCT04030026|459055233|FG001|Treatment Period 1 (22 Days)|Withdrawal by Participant|0|||
127569865|NCT04030026|459055232|FG000|Treatment Period 1 (22 Days)|Protocol Deviation|0|||
127569866|NCT04030026|459055233|FG001|Treatment Period 1 (22 Days)|Protocol Deviation|1|||
127569867|NCT04030026|459055232|FG000|Treatment Period 1 (22 Days)|Physician Decision|1|||
127569868|NCT04030026|459055233|FG001|Treatment Period 1 (22 Days)|Physician Decision|0|||
127569869|NCT04030026|459055232|FG000|Treatment Period 2 (22 Days)|Adverse Event|0|||
127569870|NCT04030026|459055233|FG001|Treatment Period 2 (22 Days)|Adverse Event|6|||
127569871|NCT04030026|459055232|FG000|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
127569872|NCT04030026|459055233|FG001|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
127569873|NCT04030026|459055232|FG000|Treatment Period 2 (22 Days)|Withdrawal by Participant|0|||
127569874|NCT04030026|459055233|FG001|Treatment Period 2 (22 Days)|Withdrawal by Participant|2|||
127569875|NCT02207946|459055234|FG000|Overall Study|Lost to Follow-up|1|||
127569876|NCT02207946|459055235|FG001|Overall Study|Lost to Follow-up|0|||
127569877|NCT02207946|459055234|FG000|Overall Study|Adverse Event|0|||
127569878|NCT02207946|459055235|FG001|Overall Study|Adverse Event|1|||
127569879|NCT00523367|459055236|FG000|Overall Study|19 screen failures|19|||
127569880|NCT00523367|459055236|FG000|Overall Study|4 Withdrawn by PI|4|||
127569881|NCT00811642|459055237|FG000|Overall Study|Adverse Event|3|||
127569882|NCT00811642|459055237|FG000|Overall Study|Protocol Violation|1|||
127569883|NCT00811642|459055237|FG000|Overall Study|Death|2|||
127690638|NCT04440176|459492325|FG000|Overall Study|Other|1|||
127690639|NCT04440176|459492326|FG001|Overall Study|Other|2|||
127690640|NCT04440176|459492325|FG000|Overall Study|Protocol deviation|6|||
127690641|NCT04440176|459492326|FG001|Overall Study|Protocol deviation|8|||
127690642|NCT04440176|459492325|FG000|Overall Study|Randomized but not vaccinated|6|||
127690643|NCT04440176|459492326|FG001|Overall Study|Randomized but not vaccinated|3|||
127690644|NCT04608045|459492327|FG000|Overall Study|Physician Decision|1|||
127690645|NCT03575052|459492328|FG000|Overall Study|Adverse Event|6|||
127690646|NCT03575052|459492329|FG001|Overall Study|Adverse Event|10|||
127690647|NCT03575052|459492328|FG000|Overall Study|Not further specified|5|||
127690648|NCT03575052|459492329|FG001|Overall Study|Not further specified|7|||
127690649|NCT03575052|459492328|FG000|Overall Study|Withdrawal by Subject|5|||
127690650|NCT03575052|459492329|FG001|Overall Study|Withdrawal by Subject|6|||
127690651|NCT03575052|459492328|FG000|Overall Study|Lost to Follow-up|3|||
127690652|NCT03575052|459492329|FG001|Overall Study|Lost to Follow-up|0|||
127690653|NCT03575052|459492328|FG000|Overall Study|Death|2|||
127690654|NCT03575052|459492329|FG001|Overall Study|Death|1|||
127690655|NCT03575052|459492328|FG000|Overall Study|Lack of Efficacy|2|||
127690656|NCT03575052|459492329|FG001|Overall Study|Lack of Efficacy|1|||
127690657|NCT03575052|459492328|FG000|Overall Study|Study drug noncompliance|1|||
127690658|NCT03575052|459492329|FG001|Overall Study|Study drug noncompliance|2|||
127690659|NCT03575052|459492328|FG000|Overall Study|Protocol Violation|0|||
127690660|NCT03575052|459492329|FG001|Overall Study|Protocol Violation|2|||
127690661|NCT03575052|459492328|FG000|Overall Study|Physician Decision|1|||
127690662|NCT03575052|459492329|FG001|Overall Study|Physician Decision|0|||
127690663|NCT03103321|459492330|FG000|Overall Study|Protocol Violation|1|||
127690664|NCT03103321|459492331|FG001|Overall Study|Protocol Violation|1|||
127690665|NCT03103321|459492332|FG002|Overall Study|Protocol Violation|1|||
127690666|NCT03103321|459492333|FG003|Overall Study|Protocol Violation|0|||
127690667|NCT04247542|459492334|FG000|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
127690668|NCT04247542|459492335|FG001|2B: Double-Blind Active-Controlled|Did not receive study drug|1|||
127690669|NCT04247542|459492336|FG002|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
127690670|NCT04247542|459492334|FG000|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|0|||
127690671|NCT04247542|459492335|FG001|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
127690672|NCT04247542|459492336|FG002|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
127690673|NCT04118452|459492337|FG000|Overall Study|Lost to Follow-up|5|||
127690674|NCT04118452|459492338|FG001|Overall Study|Lost to Follow-up|5|||
127690675|NCT04118452|459492337|FG000|Overall Study|Withdrawal by Subject|17|||
127690676|NCT04118452|459492338|FG001|Overall Study|Withdrawal by Subject|17|||
127690677|NCT05288283|459492339|FG000|Overall Study|Study Terminated Early|1|||
127690678|NCT05288283|459492340|FG001|Overall Study|Study Terminated Early|1|||
127690679|NCT05086744|459492341|FG000|Part A|Adverse Event|0|||
127690680|NCT05086744|459492342|FG001|Part A|Adverse Event|1|||
127690681|NCT05086744|459492341|FG000|Part A|Lack of Efficacy|3|||
127690682|NCT05086744|459492342|FG001|Part A|Lack of Efficacy|0|||
127690683|NCT05086744|459492341|FG000|Part A|Protocol deviation|1|||
127690684|NCT05086744|459492342|FG001|Part A|Protocol deviation|0|||
127690685|NCT05086744|459492341|FG000|Part A|Subject decision|1|||
127690686|NCT05086744|459492342|FG001|Part A|Subject decision|0|||
127690687|NCT05086744|459492341|FG000|Part B|Adverse Event|0|||
127690688|NCT05086744|459492342|FG001|Part B|Adverse Event|1|||
127690689|NCT05086744|459492341|FG000|Part B|Lack of Efficacy|0|||
127569884|NCT00811642|459055237|FG000|Overall Study|Withdrawal by Subject|7|||
127569885|NCT00811642|459055237|FG000|Overall Study|Cumulative use of antifungal agent|2|||
127569886|NCT02361346|459055242|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
127569887|NCT02361346|459055243|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
127569888|NCT02361346|459055244|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
127569889|NCT02361346|459055245|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
127569890|NCT02361346|459055246|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
127569891|NCT02361346|459055247|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
127569892|NCT02361346|459055248|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
127569893|NCT02361346|459055249|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
127569894|NCT02361346|459055250|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
127569895|NCT02361346|459055242|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
127569896|NCT02361346|459055243|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
127569897|NCT02361346|459055244|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
127569898|NCT02361346|459055245|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
127569899|NCT02361346|459055246|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
127569900|NCT02361346|459055247|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
127569901|NCT02361346|459055248|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
127569902|NCT02361346|459055249|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
127569903|NCT02361346|459055250|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
127569904|NCT02361346|459055242|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
127569905|NCT02361346|459055243|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
127569906|NCT02361346|459055244|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
127569907|NCT02361346|459055245|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
127569908|NCT02361346|459055246|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
127569909|NCT02361346|459055247|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
127569910|NCT02361346|459055248|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
127569911|NCT02361346|459055249|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
127569912|NCT02361346|459055250|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
127569913|NCT02361346|459055242|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
127569914|NCT02361346|459055243|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
127569915|NCT02361346|459055244|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
127569916|NCT02361346|459055245|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
127569917|NCT02361346|459055246|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
127569918|NCT02361346|459055247|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
127569919|NCT02361346|459055248|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
127569920|NCT02361346|459055249|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
127569921|NCT02361346|459055250|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
127569922|NCT02361346|459055242|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
127569923|NCT02361346|459055243|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
127569924|NCT02361346|459055244|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
127569925|NCT02361346|459055245|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
127569926|NCT02361346|459055246|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
127569927|NCT02361346|459055247|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
127569928|NCT02361346|459055248|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
127569929|NCT02361346|459055249|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
127569930|NCT02361346|459055250|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
127569931|NCT02361346|459055242|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
127569932|NCT02361346|459055243|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
127569933|NCT02361346|459055244|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
127569934|NCT02361346|459055245|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
127569935|NCT02361346|459055246|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
127779219|NCT00375219|459818825|FG000|Overall Study|Death|4|||
127779220|NCT00375219|459818826|FG001|Overall Study|Death|3|||
127779221|NCT00375219|459818827|FG002|Overall Study|Death|7|||
127779222|NCT00375219|459818825|FG000|Overall Study|Hematologic resistance|1|||
127779223|NCT00375219|459818826|FG001|Overall Study|Hematologic resistance|0|||
127779224|NCT00375219|459818827|FG002|Overall Study|Hematologic resistance|0|||
127779225|NCT00375219|459818825|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
127779226|NCT00375219|459818826|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
127779227|NCT00375219|459818827|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
127779228|NCT00375219|459818825|FG000|Overall Study|Allograft|2|||
127569936|NCT02361346|459055247|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
127569937|NCT02361346|459055248|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
127569938|NCT02361346|459055249|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
127569939|NCT02361346|459055250|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
127569940|NCT05772702|459055258|FG000|Overall Study|Adverse Event|1|||
127779229|NCT00375219|459818826|FG001|Overall Study|Allograft|0|||
127779230|NCT00375219|459818827|FG002|Overall Study|Allograft|0|||
127779231|NCT00375219|459818825|FG000|Overall Study|Cord blood transplantation|1|||
127569941|NCT03387150|459056958|FG000|Overall Study|Withdrawal by Subject|3|||
127569942|NCT03387150|459056959|FG001|Overall Study|Withdrawal by Subject|0|||
127569943|NCT03387150|459056960|FG002|Overall Study|Withdrawal by Subject|3|||
127569944|NCT03387150|459056961|FG003|Overall Study|Withdrawal by Subject|4|||
127569945|NCT03387150|459056962|FG004|Overall Study|Withdrawal by Subject|1|||
127569946|NCT03387150|459056963|FG005|Overall Study|Withdrawal by Subject|2|||
127569947|NCT03387150|459056964|FG006|Overall Study|Withdrawal by Subject|0|||
127569948|NCT03387150|459056958|FG000|Overall Study|Lost to Follow-up|3|||
127569949|NCT03387150|459056959|FG001|Overall Study|Lost to Follow-up|2|||
127569950|NCT03387150|459056960|FG002|Overall Study|Lost to Follow-up|2|||
127569951|NCT03387150|459056961|FG003|Overall Study|Lost to Follow-up|3|||
127569952|NCT03387150|459056962|FG004|Overall Study|Lost to Follow-up|3|||
127569953|NCT03387150|459056963|FG005|Overall Study|Lost to Follow-up|3|||
127569954|NCT03387150|459056964|FG006|Overall Study|Lost to Follow-up|0|||
127569955|NCT03387150|459056958|FG000|Overall Study|Participant unable to adhere to visit|0|||
127569956|NCT03387150|459056959|FG001|Overall Study|Participant unable to adhere to visit|1|||
127569957|NCT03387150|459056960|FG002|Overall Study|Participant unable to adhere to visit|0|||
127569958|NCT03387150|459056961|FG003|Overall Study|Participant unable to adhere to visit|0|||
127569959|NCT03387150|459056962|FG004|Overall Study|Participant unable to adhere to visit|2|||
127569960|NCT03387150|459056963|FG005|Overall Study|Participant unable to adhere to visit|2|||
127569961|NCT03387150|459056964|FG006|Overall Study|Participant unable to adhere to visit|0|||
127569962|NCT01362595|459056966|FG000|Overall Study|Screen failure|10|||
127569963|NCT01362595|459056966|FG000|Overall Study|Withdrawal by Subject|2|||
127569964|NCT02469038|459056967|FG000|Overall Study|Physician Decision|4|||
127569965|NCT02469038|459056968|FG001|Overall Study|Physician Decision|5|||
127569966|NCT02448680|459056969|FG000|Overall Study|Physician Decision|1|||
127569967|NCT02448680|459056970|FG001|Overall Study|Physician Decision|1|||
127569968|NCT02448680|459056969|FG000|Overall Study|Withdrawal by Subject|0|||
127569969|NCT02448680|459056970|FG001|Overall Study|Withdrawal by Subject|2|||
127569970|NCT00636987|459056971|FG000|Overall Study|Death|44|||
127569971|NCT00636987|459056971|FG000|Overall Study|Explanted|13|||
127569972|NCT00636987|459056971|FG000|Overall Study|Lost to Follow-up|63|||
127569973|NCT00636987|459056971|FG000|Overall Study|5 year visit window not complete|69|||
127569974|NCT01251146|459056972|FG000|Overall Study|Lost to Follow-up|3|||
127569975|NCT01251146|459056973|FG001|Overall Study|Lost to Follow-up|10|||
127569976|NCT01739400|459056974|FG000|Overall Study|Physician Decision|3|||
127569977|NCT01739400|459056975|FG001|Overall Study|Physician Decision|0|||
127569978|NCT01739400|459056974|FG000|Overall Study|Lost to Follow-up|2|||
127569979|NCT01739400|459056975|FG001|Overall Study|Lost to Follow-up|0|||
127569980|NCT01739400|459056974|FG000|Overall Study|Death|5|||
127569981|NCT01739400|459056975|FG001|Overall Study|Death|2|||
127569982|NCT01739400|459056974|FG000|Overall Study|Withdrawal by Subject|7|||
127569983|NCT01739400|459056975|FG001|Overall Study|Withdrawal by Subject|7|||
127569984|NCT01083173|459056982|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
127569985|NCT01083173|459056983|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
127569986|NCT01083173|459056982|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
127569987|NCT01083173|459056983|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
127569988|NCT01083173|459056982|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
127569989|NCT01083173|459056983|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
127569990|NCT01083173|459056982|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
127569991|NCT01083173|459056983|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
127569992|NCT01083173|459056982|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
127569993|NCT01083173|459056983|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
127569994|NCT01083173|459056982|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
127569995|NCT01083173|459056983|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
127569996|NCT01083173|459056982|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
127569997|NCT01083173|459056983|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
127569998|NCT01083173|459056982|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
127569999|NCT01083173|459056983|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
127570000|NCT01083173|459056982|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
127570001|NCT01083173|459056983|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
127570002|NCT01083173|459056982|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
127570003|NCT01083173|459056983|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
127570004|NCT01083173|459056982|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
127570005|NCT01083173|459056983|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
127570006|NCT01850602|459056988|FG000|Overall Study|Adverse Event|7|||
127570007|NCT01850602|459056989|FG001|Overall Study|Adverse Event|10|||
127779232|NCT00375219|459818826|FG001|Overall Study|Cord blood transplantation|0|||
127779233|NCT00375219|459818827|FG002|Overall Study|Cord blood transplantation|0|||
127570008|NCT01850602|459056988|FG000|Overall Study|Physician Decision|2|||
127570009|NCT01850602|459056989|FG001|Overall Study|Physician Decision|1|||
127570010|NCT01850602|459056988|FG000|Overall Study|Withdrawal by Subject|2|||
127570011|NCT01850602|459056989|FG001|Overall Study|Withdrawal by Subject|4|||
127570012|NCT01850602|459056988|FG000|Overall Study|Decrease in serum calcium|2|||
127570013|NCT01850602|459056989|FG001|Overall Study|Decrease in serum calcium|3|||
127570014|NCT01850602|459056988|FG000|Overall Study|Increase in serum ferritin|1|||
127570015|NCT01850602|459056989|FG001|Overall Study|Increase in serum ferritin|0|||
127570016|NCT01857310|459056990|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
127570017|NCT01857310|459056991|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
127570018|NCT02497976|459057006|FG000|Overall Study|Withdrawal by Subject|2|||
127570019|NCT02497976|459057007|FG001|Overall Study|Withdrawal by Subject|0|||
127570020|NCT02497976|459057006|FG000|Overall Study|Moved out of area|0|||
127570021|NCT02497976|459057007|FG001|Overall Study|Moved out of area|1|||
127570022|NCT00584740|459057008|FG000|Overall Study|Adverse Event|1|||
127570023|NCT00584740|459057009|FG001|Overall Study|Adverse Event|1|||
127570024|NCT00584740|459057008|FG000|Overall Study|Lack of Efficacy|8|||
127570025|NCT00584740|459057009|FG001|Overall Study|Lack of Efficacy|2|||
127570026|NCT00584740|459057008|FG000|Overall Study|Withdrawal by Subject|3|||
127570027|NCT00584740|459057009|FG001|Overall Study|Withdrawal by Subject|2|||
127570028|NCT00584740|459057008|FG000|Overall Study|Lost to Follow-up|0|||
127570029|NCT00584740|459057009|FG001|Overall Study|Lost to Follow-up|1|||
127570030|NCT00930982|459057010|FG000|Overall Study|Adverse Event|19|||
127570031|NCT00930982|459057011|FG001|Overall Study|Adverse Event|23|||
127570032|NCT00930982|459057010|FG000|Overall Study|Protocol Violation|1|||
127570033|NCT00930982|459057011|FG001|Overall Study|Protocol Violation|5|||
127570034|NCT00930982|459057010|FG000|Overall Study|Withdrawal by Subject|1|||
127570035|NCT00930982|459057011|FG001|Overall Study|Withdrawal by Subject|1|||
127570036|NCT03915860|459057012|FG000|Overall Study|Adverse Event|3|||
127570037|NCT03915860|459057012|FG000|Overall Study|Withdrawal by Subject|6|||
127570038|NCT03915860|459057012|FG000|Overall Study|Lost to Follow-up|2|||
127570039|NCT03915860|459057012|FG000|Overall Study|Other than specified|3|||
127570040|NCT02195011|459057013|FG000|Overall Study|Adverse Event|4|||
127570041|NCT02195011|459057014|FG001|Overall Study|Adverse Event|0|||
127570042|NCT02195011|459057013|FG000|Overall Study|Progressive Disease|18|||
127570043|NCT02195011|459057014|FG001|Overall Study|Progressive Disease|1|||
127570044|NCT02195011|459057013|FG000|Overall Study|Withdrawal by Subject|3|||
127570045|NCT02195011|459057014|FG001|Overall Study|Withdrawal by Subject|0|||
127570046|NCT01609478|459057015|FG000|Overall Study|Adverse Event|3|||
127570047|NCT01609478|459057016|FG001|Overall Study|Adverse Event|1|||
127570048|NCT01609478|459057017|FG002|Overall Study|Adverse Event|5|||
127570049|NCT01609478|459057015|FG000|Overall Study|Protocol Deviation|0|||
127570050|NCT01609478|459057016|FG001|Overall Study|Protocol Deviation|1|||
127570051|NCT01609478|459057017|FG002|Overall Study|Protocol Deviation|1|||
127570052|NCT01609478|459057015|FG000|Overall Study|Non-Compliance with study treatment|1|||
127570053|NCT01609478|459057016|FG001|Overall Study|Non-Compliance with study treatment|0|||
127570054|NCT01609478|459057017|FG002|Overall Study|Non-Compliance with study treatment|0|||
127570055|NCT01609478|459057015|FG000|Overall Study|Physician Decision|1|||
127570056|NCT01609478|459057016|FG001|Overall Study|Physician Decision|0|||
127570057|NCT01609478|459057017|FG002|Overall Study|Physician Decision|1|||
127570058|NCT01609478|459057015|FG000|Overall Study|Withdrawal by Subject|2|||
127570059|NCT01609478|459057016|FG001|Overall Study|Withdrawal by Subject|0|||
127570060|NCT01609478|459057017|FG002|Overall Study|Withdrawal by Subject|2|||
127570061|NCT04966741|459057018|FG000|Overall Study|Lost to Follow-up|1|||
127570062|NCT04966741|459057019|FG001|Overall Study|Lost to Follow-up|0|||
127570063|NCT02953509|459057021|FG000|Overall Study|Death|1|||
127570064|NCT02953509|459057022|FG001|Overall Study|Death|3|||
127570065|NCT02953509|459057023|FG002|Overall Study|Death|3|||
127570066|NCT02953509|459057024|FG003|Overall Study|Death|4|||
127570067|NCT02953509|459057025|FG004|Overall Study|Death|12|||
127570068|NCT02953509|459057026|FG005|Overall Study|Death|3|||
128026924|NCT01608308|460722287|FG001|Overall Study|pretreatment medical and billing reasons|2|||
127570069|NCT02953509|459057027|FG006|Overall Study|Death|25|||
127570070|NCT02953509|459057028|FG007|Overall Study|Death|10|||
128026925|NCT06048705|460722290|FG000|Overall Study|Physician Decision|1|||
127570071|NCT02953509|459057029|FG008|Overall Study|Death|21|||
127570072|NCT02953509|459057030|FG009|Overall Study|Death|20|||
127570073|NCT02953509|459057021|FG000|Overall Study|Reason Not Specified|0|||
127570074|NCT02953509|459057022|FG001|Overall Study|Reason Not Specified|2|||
127690690|NCT05086744|459492342|FG001|Part B|Lack of Efficacy|1|||
128026926|NCT06048705|460722291|FG001|Overall Study|Physician Decision|0|||
128026927|NCT06048705|460722292|FG002|Overall Study|Physician Decision|0|||
127570075|NCT02953509|459057023|FG002|Overall Study|Reason Not Specified|8|||
127570076|NCT02953509|459057024|FG003|Overall Study|Reason Not Specified|2|||
127570077|NCT02953509|459057025|FG004|Overall Study|Reason Not Specified|11|||
127570078|NCT02953509|459057026|FG005|Overall Study|Reason Not Specified|4|||
127570079|NCT02953509|459057027|FG006|Overall Study|Reason Not Specified|12|||
127570080|NCT02953509|459057028|FG007|Overall Study|Reason Not Specified|2|||
127570081|NCT02953509|459057029|FG008|Overall Study|Reason Not Specified|7|||
127570082|NCT02953509|459057030|FG009|Overall Study|Reason Not Specified|2|||
127570083|NCT02953509|459057021|FG000|Overall Study|Consent Withdrawn|1|||
127570084|NCT02953509|459057022|FG001|Overall Study|Consent Withdrawn|1|||
127570085|NCT02953509|459057023|FG002|Overall Study|Consent Withdrawn|2|||
127570086|NCT02953509|459057024|FG003|Overall Study|Consent Withdrawn|1|||
127570087|NCT02953509|459057025|FG004|Overall Study|Consent Withdrawn|3|||
127570088|NCT02953509|459057026|FG005|Overall Study|Consent Withdrawn|0|||
127570089|NCT02953509|459057027|FG006|Overall Study|Consent Withdrawn|4|||
127570090|NCT02953509|459057028|FG007|Overall Study|Consent Withdrawn|1|||
127570091|NCT02953509|459057029|FG008|Overall Study|Consent Withdrawn|1|||
127570092|NCT02953509|459057030|FG009|Overall Study|Consent Withdrawn|4|||
127570093|NCT02953509|459057021|FG000|Overall Study|Lost to Follow-up|0|||
127570094|NCT02953509|459057022|FG001|Overall Study|Lost to Follow-up|0|||
127570095|NCT02953509|459057023|FG002|Overall Study|Lost to Follow-up|0|||
127570096|NCT02953509|459057024|FG003|Overall Study|Lost to Follow-up|0|||
127570097|NCT02953509|459057025|FG004|Overall Study|Lost to Follow-up|0|||
127570098|NCT02953509|459057026|FG005|Overall Study|Lost to Follow-up|0|||
127570099|NCT02953509|459057027|FG006|Overall Study|Lost to Follow-up|1|||
127570100|NCT02953509|459057028|FG007|Overall Study|Lost to Follow-up|1|||
127570101|NCT02953509|459057029|FG008|Overall Study|Lost to Follow-up|1|||
127570102|NCT02953509|459057030|FG009|Overall Study|Lost to Follow-up|1|||
127570103|NCT02953509|459057021|FG000|Overall Study|Study terminated by sponsor|1|||
127570104|NCT02953509|459057022|FG001|Overall Study|Study terminated by sponsor|0|||
127570105|NCT02953509|459057023|FG002|Overall Study|Study terminated by sponsor|0|||
127570106|NCT02953509|459057024|FG003|Overall Study|Study terminated by sponsor|0|||
127570107|NCT02953509|459057025|FG004|Overall Study|Study terminated by sponsor|0|||
127570108|NCT02953509|459057026|FG005|Overall Study|Study terminated by sponsor|0|||
127570109|NCT02953509|459057027|FG006|Overall Study|Study terminated by sponsor|1|||
127570110|NCT02953509|459057028|FG007|Overall Study|Study terminated by sponsor|0|||
127570111|NCT02953509|459057029|FG008|Overall Study|Study terminated by sponsor|1|||
127570112|NCT02953509|459057030|FG009|Overall Study|Study terminated by sponsor|1|||
127570113|NCT00484185|459057031|FG000|Overall Study|Lost to Follow-up|44|||
127570114|NCT00484185|459057031|FG000|Overall Study|Other|20|||
127570115|NCT00484185|459057031|FG000|Overall Study|Randomized but not treated|5|||
127570116|NCT00484185|459057031|FG000|Overall Study|Death|2|||
127570117|NCT00645788|459057032|FG000|Overall Study|Did not receive study drug|1|||
127570118|NCT00645788|459057033|FG001|Overall Study|Did not receive study drug|1|||
127570119|NCT00645788|459057034|FG002|Overall Study|Did not receive study drug|0|||
127570120|NCT00645788|459057035|FG003|Overall Study|Did not receive study drug|0|||
127570121|NCT00645788|459057032|FG000|Overall Study|Adverse Event|4|||
127570122|NCT00645788|459057033|FG001|Overall Study|Adverse Event|9|||
127570123|NCT00645788|459057034|FG002|Overall Study|Adverse Event|5|||
127570124|NCT00645788|459057035|FG003|Overall Study|Adverse Event|3|||
127570125|NCT00645788|459057032|FG000|Overall Study|Lost to Follow-up|1|||
127570126|NCT00645788|459057033|FG001|Overall Study|Lost to Follow-up|0|||
127570127|NCT00645788|459057034|FG002|Overall Study|Lost to Follow-up|0|||
127570128|NCT00645788|459057035|FG003|Overall Study|Lost to Follow-up|0|||
127570129|NCT00645788|459057032|FG000|Overall Study|Protocol Violation|1|||
127570130|NCT00645788|459057033|FG001|Overall Study|Protocol Violation|0|||
127570131|NCT00645788|459057034|FG002|Overall Study|Protocol Violation|2|||
127570132|NCT00645788|459057035|FG003|Overall Study|Protocol Violation|0|||
127570133|NCT00645788|459057032|FG000|Overall Study|Withdrawal by Subject|0|||
127570134|NCT00645788|459057033|FG001|Overall Study|Withdrawal by Subject|1|||
127570135|NCT00645788|459057034|FG002|Overall Study|Withdrawal by Subject|0|||
127570136|NCT00645788|459057035|FG003|Overall Study|Withdrawal by Subject|2|||
127570137|NCT00645788|459057032|FG000|Overall Study|Pulmonary exacerbation|13|||
127570138|NCT00645788|459057033|FG001|Overall Study|Pulmonary exacerbation|16|||
127570139|NCT00645788|459057034|FG002|Overall Study|Pulmonary exacerbation|11|||
127570140|NCT00645788|459057035|FG003|Overall Study|Pulmonary exacerbation|9|||
127570141|NCT03149848|459057036|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
127570142|NCT03149848|459057036|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
127779234|NCT00375219|459818825|FG000|Overall Study|Withdrawal by Subject|1|||
127570143|NCT01244490|459057037|FG000|Overall Study|Lack of Efficacy|14|||
127570144|NCT01244490|459057038|FG001|Overall Study|Lack of Efficacy|5|||
127570145|NCT01244490|459057039|FG002|Overall Study|Lack of Efficacy|5|||
127570146|NCT01244490|459057037|FG000|Overall Study|Withdrawal by Subject|4|||
127570147|NCT01244490|459057038|FG001|Overall Study|Withdrawal by Subject|4|||
127570148|NCT01244490|459057039|FG002|Overall Study|Withdrawal by Subject|9|||
127570149|NCT01244490|459057037|FG000|Overall Study|Adverse Event|1|||
127570150|NCT01244490|459057038|FG001|Overall Study|Adverse Event|9|||
127570151|NCT01244490|459057039|FG002|Overall Study|Adverse Event|5|||
127570152|NCT01244490|459057037|FG000|Overall Study|Lost to Follow-up|0|||
127570153|NCT01244490|459057038|FG001|Overall Study|Lost to Follow-up|6|||
127570154|NCT01244490|459057039|FG002|Overall Study|Lost to Follow-up|3|||
127779235|NCT00375219|459818826|FG001|Overall Study|Withdrawal by Subject|0|||
127570155|NCT01244490|459057037|FG000|Overall Study|Other|0|||
127570156|NCT01244490|459057038|FG001|Overall Study|Other|0|||
127570157|NCT01244490|459057039|FG002|Overall Study|Other|1|||
127570158|NCT00327470|459057048|FG000|Overall Study|Randomized, but not treated|0|||
127570159|NCT00327470|459057049|FG001|Overall Study|Randomized, but not treated|2|||
127570160|NCT00327470|459057048|FG000|Overall Study|Adverse Event|9|||
127570161|NCT00327470|459057049|FG001|Overall Study|Adverse Event|14|||
127570162|NCT00327470|459057048|FG000|Overall Study|Lack of Efficacy|7|||
127570163|NCT00327470|459057049|FG001|Overall Study|Lack of Efficacy|19|||
127570164|NCT00327470|459057048|FG000|Overall Study|Other|5|||
127570165|NCT00327470|459057049|FG001|Overall Study|Other|9|||
127570166|NCT00327470|459057048|FG000|Overall Study|Lost to Follow-up|1|||
127570167|NCT00327470|459057049|FG001|Overall Study|Lost to Follow-up|3|||
127570168|NCT00327470|459057048|FG000|Overall Study|Withdrawal by Subject|6|||
127570169|NCT00327470|459057049|FG001|Overall Study|Withdrawal by Subject|12|||
127570170|NCT00327470|459057048|FG000|Overall Study|Death|1|||
127570171|NCT00327470|459057049|FG001|Overall Study|Death|4|||
127570172|NCT02581943|459057050|FG000|Overall Study|Death|5|||
127570173|NCT02581943|459057051|FG001|Overall Study|Death|2|||
127570174|NCT02581943|459057050|FG000|Overall Study|Disease Progression|12|||
127570175|NCT02581943|459057051|FG001|Overall Study|Disease Progression|15|||
127570176|NCT02581943|459057050|FG000|Overall Study|Withdrawal by Subject|1|||
127570177|NCT02581943|459057051|FG001|Overall Study|Withdrawal by Subject|2|||
127570178|NCT03021564|459057052|FG000|Overall Study|Death|84|||
127570179|NCT03021564|459057053|FG001|Overall Study|Death|466|||
127570180|NCT03021564|459057052|FG000|Overall Study|Lost to Follow-up|0|||
127570181|NCT03021564|459057053|FG001|Overall Study|Lost to Follow-up|2|||
127570182|NCT00745615|459057060|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
127570183|NCT00745615|459057061|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
127570184|NCT00745615|459057062|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
127570185|NCT00745615|459057063|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
127570186|NCT00745615|459057064|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
127570187|NCT00745615|459057065|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
127570188|NCT00745615|459057060|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
127570189|NCT00745615|459057061|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
127570190|NCT00745615|459057062|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
127570191|NCT00745615|459057063|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
127570192|NCT00745615|459057064|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
127570193|NCT00745615|459057065|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
127570194|NCT00745615|459057060|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
127570195|NCT00745615|459057061|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
127570196|NCT00745615|459057062|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
127570197|NCT00745615|459057063|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
127570198|NCT00745615|459057064|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
127570199|NCT00745615|459057065|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
127570200|NCT00745615|459057060|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
127570201|NCT00745615|459057061|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
127570202|NCT00745615|459057062|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
127570203|NCT00745615|459057063|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
127570204|NCT00745615|459057064|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
127570205|NCT00745615|459057065|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
127570206|NCT00745615|459057060|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
127570207|NCT00745615|459057061|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
127570208|NCT00745615|459057062|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
127570209|NCT00745615|459057063|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
127570210|NCT00745615|459057064|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
127570211|NCT00745615|459057065|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
128026928|NCT06048705|460722290|FG000|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
128026929|NCT06048705|460722291|FG001|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
128026930|NCT06048705|460722292|FG002|Overall Study|Did not meet Inclusion/Exclusion Criteria|1|||
128026931|NCT06048705|460722290|FG000|Overall Study|Death prior to lymphodepletion|0|||
128026932|NCT06048705|460722291|FG001|Overall Study|Death prior to lymphodepletion|0|||
128026933|NCT06048705|460722292|FG002|Overall Study|Death prior to lymphodepletion|1|||
128026934|NCT01016015|460722293|FG000|Overall Study|Not Treated|3|||
128026935|NCT01016015|460722293|FG000|Overall Study|Withdrawal by Subject|1|||
127570212|NCT00745615|459057060|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
127570213|NCT00745615|459057061|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
127570214|NCT00745615|459057062|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
127570215|NCT00745615|459057063|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
127570216|NCT00745615|459057064|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
127570217|NCT00745615|459057065|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
127570218|NCT00745615|459057060|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
127570219|NCT00745615|459057061|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
128026936|NCT01016015|460722293|FG000|Overall Study|Adverse Event|15|||
127570220|NCT00745615|459057062|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
127570221|NCT00745615|459057063|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
127570222|NCT00745615|459057064|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
127570223|NCT00745615|459057065|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
127570224|NCT00745615|459057060|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
127570225|NCT00745615|459057061|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
127570226|NCT00745615|459057062|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
127570227|NCT00745615|459057063|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
127570228|NCT00745615|459057064|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
127570229|NCT00745615|459057065|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
127570230|NCT00745615|459057060|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
127570231|NCT00745615|459057061|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
127570232|NCT00745615|459057062|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
127570233|NCT00745615|459057063|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
127570234|NCT00745615|459057064|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
127570235|NCT00745615|459057065|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
127570236|NCT00745615|459057060|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
127570237|NCT00745615|459057061|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
127570238|NCT00745615|459057062|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
127570239|NCT00745615|459057063|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
127570240|NCT00745615|459057064|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
127570241|NCT00745615|459057065|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
127570242|NCT00745615|459057060|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
127570243|NCT00745615|459057061|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
127570244|NCT00745615|459057062|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
127570245|NCT00745615|459057063|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
127570246|NCT00745615|459057064|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
127570247|NCT00745615|459057065|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
127570248|NCT00745615|459057060|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
127570249|NCT00745615|459057061|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
127570250|NCT00745615|459057062|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
127570251|NCT00745615|459057063|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
127570252|NCT00745615|459057064|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
127570253|NCT00745615|459057065|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
127570254|NCT00745615|459057060|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
127570255|NCT00745615|459057061|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
127570256|NCT00745615|459057062|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
127570257|NCT00745615|459057063|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
127570258|NCT00745615|459057064|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
127779236|NCT00375219|459818827|FG002|Overall Study|Withdrawal by Subject|0|||
127779237|NCT01667107|459818828|FG000|Overall Study|Adverse Event|4|||
127779238|NCT01667107|459818829|FG001|Overall Study|Adverse Event|3|||
127779239|NCT01667107|459818828|FG000|Overall Study|Tolerability issues|0|||
127779240|NCT01667107|459818829|FG001|Overall Study|Tolerability issues|2|||
127779241|NCT01667107|459818828|FG000|Overall Study|Protocol Violation|0|||
127779242|NCT01667107|459818829|FG001|Overall Study|Protocol Violation|1|||
127779243|NCT01667107|459818828|FG000|Overall Study|Lack of Efficacy|0|||
127779244|NCT01667107|459818829|FG001|Overall Study|Lack of Efficacy|1|||
127779245|NCT05586269|459819774|FG000|First Intervention (6 Weeks)|Lost to Follow-up|4|||
127779246|NCT05586269|459819775|FG001|First Intervention (6 Weeks)|Lost to Follow-up|4|||
127779247|NCT05586269|459819776|FG002|First Intervention (6 Weeks)|Lost to Follow-up|3|||
127779248|NCT05586269|459819777|FG003|First Intervention (6 Weeks)|Lost to Follow-up|3|||
127779249|NCT05586269|459819774|FG000|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
127779250|NCT05586269|459819775|FG001|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
127779251|NCT05586269|459819776|FG002|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
127779252|NCT05586269|459819777|FG003|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
127779253|NCT00332839|459819778|FG000|Core (Months 0 - 12)|Administrative problems|1|||
127779254|NCT00332839|459819779|FG001|Core (Months 0 - 12)|Administrative problems|1|||
127779255|NCT00332839|459819778|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
127779256|NCT00332839|459819779|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
127779257|NCT00332839|459819778|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
127779258|NCT00332839|459819779|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
127570259|NCT00745615|459057065|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
127570260|NCT00745615|459057060|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
127570261|NCT00745615|459057061|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
127570262|NCT00745615|459057062|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
127779259|NCT00332839|459819778|FG000|Core (Months 0 - 12)|Adverse Event|5|||
127779260|NCT00332839|459819779|FG001|Core (Months 0 - 12)|Adverse Event|15|||
127779261|NCT00332839|459819778|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
127570263|NCT00745615|459057063|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
127570264|NCT00745615|459057064|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
127570265|NCT00745615|459057065|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
127570266|NCT01163032|459057069|FG000|Randomization Phase|Withdrawal by Subject|2|||
127570267|NCT01163032|459057070|FG001|Randomization Phase|Withdrawal by Subject|3|||
127570268|NCT01163032|459057071|FG002|Randomization Phase|Withdrawal by Subject|0|||
127570269|NCT01163032|459057069|FG000|Randomization Phase|Adverse Event|3|||
127570270|NCT01163032|459057070|FG001|Randomization Phase|Adverse Event|3|||
127570271|NCT01163032|459057071|FG002|Randomization Phase|Adverse Event|0|||
127570272|NCT01163032|459057069|FG000|Randomization Phase|Protocol Violation|0|||
127570273|NCT01163032|459057070|FG001|Randomization Phase|Protocol Violation|1|||
127570274|NCT01163032|459057071|FG002|Randomization Phase|Protocol Violation|0|||
127570275|NCT01163032|459057069|FG000|Randomization Phase|Various*|5|||
127570276|NCT01163032|459057070|FG001|Randomization Phase|Various*|4|||
127570277|NCT01163032|459057071|FG002|Randomization Phase|Various*|0|||
127570278|NCT01163032|459057069|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
127570279|NCT01163032|459057070|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
127570280|NCT01163032|459057071|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
127570281|NCT01163032|459057069|FG000|Open Label Extension Phase|Adverse Event|0|||
127570282|NCT01163032|459057070|FG001|Open Label Extension Phase|Adverse Event|0|||
127570283|NCT01163032|459057071|FG002|Open Label Extension Phase|Adverse Event|3|||
127570284|NCT01163032|459057069|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
127570285|NCT01163032|459057070|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
127570286|NCT01163032|459057071|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
127570287|NCT01163032|459057069|FG000|Open Label Extension Phase|Protocol Violation|0|||
127570288|NCT01163032|459057070|FG001|Open Label Extension Phase|Protocol Violation|0|||
127570289|NCT01163032|459057071|FG002|Open Label Extension Phase|Protocol Violation|1|||
127570290|NCT01163032|459057069|FG000|Open Label Extension Phase|Study Termination|0|||
127570291|NCT01163032|459057070|FG001|Open Label Extension Phase|Study Termination|0|||
127570292|NCT01163032|459057071|FG002|Open Label Extension Phase|Study Termination|7|||
127570293|NCT01163032|459057069|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
127570294|NCT01163032|459057070|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
127570295|NCT01163032|459057071|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
127570296|NCT01307020|459057074|FG000|Overall Study|Lost to Follow-up|0|||
127570297|NCT01307020|459057075|FG001|Overall Study|Lost to Follow-up|0|||
127570298|NCT01307020|459057076|FG002|Overall Study|Lost to Follow-up|1|||
127570299|NCT01307020|459057077|FG003|Overall Study|Lost to Follow-up|1|||
127570300|NCT01307020|459057078|FG004|Overall Study|Lost to Follow-up|0|||
127570301|NCT01307020|459057079|FG005|Overall Study|Lost to Follow-up|0|||
127570302|NCT01307020|459057080|FG006|Overall Study|Lost to Follow-up|1|||
127570303|NCT01307020|459057081|FG007|Overall Study|Lost to Follow-up|0|||
127570304|NCT01307020|459057082|FG008|Overall Study|Lost to Follow-up|0|||
127570305|NCT01307020|459057083|FG009|Overall Study|Lost to Follow-up|0|||
127570306|NCT01307020|459057074|FG000|Overall Study|Electronic data capture failure|0|||
127570307|NCT01307020|459057075|FG001|Overall Study|Electronic data capture failure|1|||
127570308|NCT01307020|459057076|FG002|Overall Study|Electronic data capture failure|0|||
127570309|NCT01307020|459057077|FG003|Overall Study|Electronic data capture failure|0|||
127570310|NCT01307020|459057078|FG004|Overall Study|Electronic data capture failure|0|||
127570311|NCT01307020|459057079|FG005|Overall Study|Electronic data capture failure|0|||
127570312|NCT01307020|459057080|FG006|Overall Study|Electronic data capture failure|0|||
127570313|NCT01307020|459057081|FG007|Overall Study|Electronic data capture failure|0|||
127570314|NCT01307020|459057082|FG008|Overall Study|Electronic data capture failure|0|||
127779262|NCT00332839|459819779|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
127779263|NCT00332839|459819778|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
127779264|NCT00332839|459819779|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
127779265|NCT00332839|459819778|FG000|Follow-up (Months 12 - 60)|Death|1|||
127779266|NCT00332839|459819779|FG001|Follow-up (Months 12 - 60)|Death|1|||
127779267|NCT00088907|459819780|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
127779268|NCT00088907|459819781|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
127779269|NCT00088907|459819780|FG000|Randomized Study (Step 1)|Adverse Event|14|||
127779270|NCT00088907|459819781|FG001|Randomized Study (Step 1)|Adverse Event|19|||
127779271|NCT00088907|459819780|FG000|Randomized Study (Step 1)|Death|11|||
127881048|NCT02575807|460186108|FG004|Overall Study|Subject ineligible - medical implant|0|||
127570315|NCT01307020|459057083|FG009|Overall Study|Electronic data capture failure|0|||
127570316|NCT02380690|459057084|FG000|Overall Study|Lost to Follow-up|14|||
127570317|NCT02380690|459057085|FG001|Overall Study|Lost to Follow-up|4|||
127570318|NCT02380690|459057084|FG000|Overall Study|Withdrawal by Subject|20|||
127570319|NCT02380690|459057085|FG001|Overall Study|Withdrawal by Subject|8|||
127570320|NCT00727532|459057086|FG000|Overall Study|Adverse Event|1|||
127570321|NCT00727532|459057086|FG000|Overall Study|Withdrawal by Subject|1|||
127779272|NCT00088907|459819781|FG001|Randomized Study (Step 1)|Death|12|||
127881049|NCT02575807|460186104|FG000|Overall Study|Withdrawal by Subject|0|||
127570322|NCT00829933|459057087|FG000|Overall Study|Adverse Event|2|||
127570323|NCT00829933|459057088|FG001|Overall Study|Adverse Event|3|||
127570324|NCT00829933|459057089|FG002|Overall Study|Adverse Event|2|||
127570325|NCT00829933|459057090|FG003|Overall Study|Adverse Event|1|||
127570326|NCT00829933|459057087|FG000|Overall Study|Death|0|||
127570327|NCT00829933|459057088|FG001|Overall Study|Death|0|||
127570328|NCT00829933|459057089|FG002|Overall Study|Death|1|||
127570329|NCT00829933|459057090|FG003|Overall Study|Death|1|||
127570330|NCT00829933|459057087|FG000|Overall Study|Lack of Efficacy|0|||
127570331|NCT00829933|459057088|FG001|Overall Study|Lack of Efficacy|1|||
127570332|NCT00829933|459057089|FG002|Overall Study|Lack of Efficacy|0|||
127570333|NCT00829933|459057090|FG003|Overall Study|Lack of Efficacy|0|||
127570334|NCT00829933|459057087|FG000|Overall Study|Physician Decision|5|||
127570335|NCT00829933|459057088|FG001|Overall Study|Physician Decision|7|||
127570336|NCT00829933|459057089|FG002|Overall Study|Physician Decision|8|||
127570337|NCT00829933|459057090|FG003|Overall Study|Physician Decision|1|||
127570338|NCT00829933|459057087|FG000|Overall Study|Pregnancy|0|||
127570339|NCT00829933|459057088|FG001|Overall Study|Pregnancy|0|||
127570340|NCT00829933|459057089|FG002|Overall Study|Pregnancy|0|||
127570341|NCT00829933|459057090|FG003|Overall Study|Pregnancy|2|||
127570342|NCT00829933|459057087|FG000|Overall Study|Protocol Violation|2|||
127570343|NCT00829933|459057088|FG001|Overall Study|Protocol Violation|1|||
127570344|NCT00829933|459057089|FG002|Overall Study|Protocol Violation|0|||
127570345|NCT00829933|459057090|FG003|Overall Study|Protocol Violation|0|||
127570346|NCT00829933|459057087|FG000|Overall Study|withdrew before treatment started|5|||
127570347|NCT00829933|459057088|FG001|Overall Study|withdrew before treatment started|1|||
127570348|NCT00829933|459057089|FG002|Overall Study|withdrew before treatment started|2|||
127570349|NCT00829933|459057090|FG003|Overall Study|withdrew before treatment started|9|||
127570350|NCT01986933|459057095|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
127570351|NCT01986933|459057096|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
127570352|NCT01986933|459057097|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
127570353|NCT01986933|459057098|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
127570354|NCT01986933|459057099|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
127570355|NCT01986933|459057095|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
128026937|NCT04648241|460722294|FG000|Overall Study|Lost to Follow-up|1|||
127570356|NCT01986933|459057096|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
127570357|NCT01986933|459057097|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
127570358|NCT01986933|459057098|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
127570359|NCT01986933|459057099|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
127570360|NCT01986933|459057095|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
127570361|NCT01986933|459057096|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
127570362|NCT01986933|459057097|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
127570363|NCT01986933|459057098|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
127570364|NCT01986933|459057099|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
127570365|NCT01986933|459057095|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
127570366|NCT01986933|459057096|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
127570367|NCT01986933|459057097|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
127570368|NCT01986933|459057098|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
127570369|NCT01986933|459057099|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
127570370|NCT01986933|459057095|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
127570371|NCT01986933|459057096|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
127570372|NCT01986933|459057097|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
127570373|NCT01986933|459057098|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
127570374|NCT01986933|459057099|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
127570375|NCT01986933|459057095|FG000|Active-to-active (Part B)|Adverse Event|0|||
127570376|NCT01986933|459057096|FG001|Active-to-active (Part B)|Adverse Event|2|||
127690691|NCT05086744|459492341|FG000|Part B|Study terminated by sponsor|1|||
127690692|NCT05086744|459492342|FG001|Part B|Study terminated by sponsor|6|||
127690693|NCT01704079|459492343|FG000|Overall Study|Withdrawal by Subject|5|||
127690694|NCT01704079|459492344|FG001|Overall Study|Withdrawal by Subject|7|||
127690695|NCT01704079|459492343|FG000|Overall Study|Lost to Follow-up|2|||
127690696|NCT01704079|459492344|FG001|Overall Study|Lost to Follow-up|5|||
128026938|NCT04648241|460722295|FG001|Overall Study|Lost to Follow-up|0|||
127690697|NCT01704079|459492343|FG000|Overall Study|Adverse Event|4|||
128026939|NCT02057666|460722296|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
128026940|NCT02057666|460722297|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
127570377|NCT01986933|459057097|FG002|Active-to-active (Part B)|Adverse Event|0|||
127570378|NCT01986933|459057098|FG003|Active-to-active (Part B)|Adverse Event|1|||
127570379|NCT01986933|459057099|FG004|Active-to-active (Part B)|Adverse Event|3|||
127570380|NCT01986933|459057095|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
127570381|NCT01986933|459057096|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
128026941|NCT02057666|460722296|FG000|Double Blind Treatment Period|Poor tolerability|7|||
127570382|NCT01986933|459057097|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
127570383|NCT01986933|459057098|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
127690698|NCT01704079|459492344|FG001|Overall Study|Adverse Event|7|||
127570384|NCT01986933|459057099|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
127570385|NCT01986933|459057095|FG000|Active-to-active (Part B)|Pregnancy|0|||
127570386|NCT01986933|459057096|FG001|Active-to-active (Part B)|Pregnancy|0|||
127570387|NCT01986933|459057097|FG002|Active-to-active (Part B)|Pregnancy|0|||
127570388|NCT01986933|459057098|FG003|Active-to-active (Part B)|Pregnancy|0|||
127570389|NCT01986933|459057099|FG004|Active-to-active (Part B)|Pregnancy|1|||
127570390|NCT01986933|459057095|FG000|Active-to-active (Part B)|Physician Decision|0|||
127570391|NCT01986933|459057096|FG001|Active-to-active (Part B)|Physician Decision|0|||
127570392|NCT01986933|459057097|FG002|Active-to-active (Part B)|Physician Decision|1|||
127570393|NCT01986933|459057098|FG003|Active-to-active (Part B)|Physician Decision|1|||
127570394|NCT01986933|459057099|FG004|Active-to-active (Part B)|Physician Decision|0|||
127570395|NCT01986933|459057095|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
127570396|NCT01986933|459057096|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
127570397|NCT01986933|459057097|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
127570398|NCT01986933|459057098|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
127570399|NCT01986933|459057099|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
127570400|NCT01986933|459057095|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
127570401|NCT01986933|459057096|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
127779273|NCT00088907|459819780|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
127570402|NCT01986933|459057097|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
127570403|NCT01986933|459057098|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
127570404|NCT01986933|459057099|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
127570405|NCT01986933|459057095|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
127779274|NCT00088907|459819781|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
127779275|NCT00088907|459819780|FG000|Randomized Study (Step 1)|complicating disease|3|||
127779276|NCT00088907|459819781|FG001|Randomized Study (Step 1)|complicating disease|1|||
127779277|NCT00088907|459819780|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
127779278|NCT00088907|459819781|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
127779279|NCT00088907|459819780|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
127779280|NCT00088907|459819781|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
127779281|NCT00088907|459819780|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
128026942|NCT02057666|460722297|FG001|Double Blind Treatment Period|Poor tolerability|2|||
127570406|NCT01986933|459057096|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
127570407|NCT01986933|459057097|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
127570408|NCT01986933|459057098|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
127570409|NCT01986933|459057099|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
127570410|NCT01986933|459057095|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
127570411|NCT01986933|459057096|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
127570412|NCT01986933|459057097|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
127570413|NCT01986933|459057098|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
127570414|NCT01986933|459057099|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
127570415|NCT01986933|459057095|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
127570416|NCT01986933|459057096|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
127570417|NCT01986933|459057097|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
127570418|NCT01986933|459057098|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
127570419|NCT01986933|459057099|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
127570420|NCT01986933|459057095|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
127570421|NCT01986933|459057096|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
127570422|NCT01986933|459057097|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
127570423|NCT01986933|459057098|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
127570424|NCT01986933|459057099|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
127570425|NCT01986933|459057095|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
127570426|NCT01986933|459057096|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
127570427|NCT01986933|459057097|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
127570428|NCT01986933|459057098|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
127570429|NCT01986933|459057099|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
127570430|NCT01986933|459057095|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
127570431|NCT01986933|459057096|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
127570432|NCT01986933|459057097|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
128026943|NCT02057666|460722296|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
127570433|NCT01986933|459057098|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
127570434|NCT01986933|459057099|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
127570435|NCT03119701|459057100|FG000|6-day Dosing|Death|4|||
127779282|NCT00088907|459819781|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
127570436|NCT03119701|459057101|FG001|6-day Dosing|Death|1|||
127779283|NCT00088907|459819780|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
127570437|NCT03119701|459057100|FG000|6-day Dosing|Adverse Event|3|||
127570438|NCT03119701|459057101|FG001|6-day Dosing|Adverse Event|0|||
127570439|NCT03119701|459057100|FG000|6-day Dosing|Physician Decision|0|||
127570440|NCT03119701|459057101|FG001|6-day Dosing|Physician Decision|1|||
127570441|NCT03119701|459057100|FG000|6-day Dosing|Withdrawal by Subject|0|||
127570442|NCT03119701|459057101|FG001|6-day Dosing|Withdrawal by Subject|1|||
127570443|NCT03119701|459057100|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
127570444|NCT03119701|459057101|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
127570445|NCT00782795|459057110|FG000|Overall Study|Withdrawal by Subject|1|||
127570446|NCT00782795|459057111|FG001|Overall Study|Withdrawal by Subject|2|||
127570447|NCT04480424|459057112|FG000|Overall Study|Withdrawal by Subject|0|||
127570448|NCT04480424|459057113|FG001|Overall Study|Withdrawal by Subject|2|||
127570449|NCT04480424|459057112|FG000|Overall Study|Lost to Follow-up|3|||
127570450|NCT04480424|459057113|FG001|Overall Study|Lost to Follow-up|3|||
127570451|NCT04480424|459057112|FG000|Overall Study|Death|14|||
127570452|NCT04480424|459057113|FG001|Overall Study|Death|16|||
127570453|NCT04480424|459057112|FG000|Overall Study|Reason not Specified|5|||
127570454|NCT04480424|459057113|FG001|Overall Study|Reason not Specified|5|||
127570455|NCT02782923|459057114|FG000|Overall Study|Lost to Follow-up|15|||
127570456|NCT02418156|459057115|FG000|Overall Study|Lost to Follow-up|12|||
127570457|NCT02418156|459057115|FG000|Overall Study|Death|2|||
127570458|NCT02418156|459057115|FG000|Overall Study|Physician Decision|1|||
127570459|NCT02418156|459057115|FG000|Overall Study|Withdrawal by Subject|1|||
127570460|NCT02418156|459057115|FG000|Overall Study|Subject refused to return|1|||
127570461|NCT00993044|459057118|FG000|Irinotecan 50 mg|Physician Decision|1|||
127570462|NCT00734747|459057119|FG000|SRS Procedure|No staples placed|3|||
127570463|NCT00734747|459057119|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
127570464|NCT01909453|459057122|FG000|Overall Study|Ongoing|118|||
127570465|NCT01909453|459057123|FG001|Overall Study|Ongoing|103|||
127570466|NCT01909453|459057124|FG002|Overall Study|Ongoing|83|||
127570467|NCT01909453|459057125|FG003|Overall Study|Ongoing|164|||
127570468|NCT01909453|459057126|FG004|Overall Study|Ongoing|50|||
127570469|NCT01909453|459057122|FG000|Overall Study|Death|69|||
127570470|NCT01909453|459057123|FG001|Overall Study|Death|74|||
127570471|NCT01909453|459057124|FG002|Overall Study|Death|88|||
127570472|NCT01909453|459057125|FG003|Overall Study|Death|86|||
127570473|NCT01909453|459057126|FG004|Overall Study|Death|29|||
127570474|NCT01909453|459057122|FG000|Overall Study|Lost to Follow-up|3|||
127570475|NCT01909453|459057123|FG001|Overall Study|Lost to Follow-up|4|||
127570476|NCT01909453|459057124|FG002|Overall Study|Lost to Follow-up|4|||
127570477|NCT01909453|459057125|FG003|Overall Study|Lost to Follow-up|3|||
127570478|NCT01909453|459057126|FG004|Overall Study|Lost to Follow-up|3|||
127570479|NCT01909453|459057122|FG000|Overall Study|Withdrawal by Subject|2|||
127570480|NCT01909453|459057123|FG001|Overall Study|Withdrawal by Subject|13|||
127570481|NCT01909453|459057124|FG002|Overall Study|Withdrawal by Subject|16|||
127570482|NCT01909453|459057125|FG003|Overall Study|Withdrawal by Subject|5|||
127570483|NCT01909453|459057126|FG004|Overall Study|Withdrawal by Subject|4|||
127570484|NCT00884377|459058411|FG000|Overall Study|Withdrawal by Subject|1|||
127570485|NCT00884377|459058412|FG001|Overall Study|Withdrawal by Subject|0|||
127570486|NCT00884377|459058411|FG000|Overall Study|Could not confirm diagnosis|1|||
127570487|NCT00884377|459058412|FG001|Overall Study|Could not confirm diagnosis|0|||
127570488|NCT00884377|459058411|FG000|Overall Study|Physician Decision|0|||
127570489|NCT00884377|459058412|FG001|Overall Study|Physician Decision|1|||
127570490|NCT02003365|459058413|FG000|Overall Study|Lost to Follow-up|0|||
127570491|NCT02003365|459058414|FG001|Overall Study|Lost to Follow-up|0|||
127570492|NCT02003365|459058415|FG002|Overall Study|Lost to Follow-up|1|||
127570493|NCT00622739|459058416|FG000|Overall Study|Physician Decision|1|||
127570494|NCT00622739|459058417|FG001|Overall Study|Physician Decision|0|||
127570495|NCT00622739|459058416|FG000|Overall Study|Adverse Event|1|||
127570496|NCT00622739|459058417|FG001|Overall Study|Adverse Event|2|||
127570497|NCT00622739|459058416|FG000|Overall Study|Lack of Efficacy|0|||
127570498|NCT00622739|459058417|FG001|Overall Study|Lack of Efficacy|2|||
127570499|NCT00622739|459058416|FG000|Overall Study|Withdrawal by Subject|0|||
127570500|NCT00622739|459058417|FG001|Overall Study|Withdrawal by Subject|1|||
127570501|NCT00622739|459058416|FG000|Overall Study|Lost to Follow-up|0|||
127779284|NCT00088907|459819781|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
127779285|NCT00088907|459819780|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
127570502|NCT00622739|459058417|FG001|Overall Study|Lost to Follow-up|1|||
127570503|NCT03150485|459058418|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
127570504|NCT03150485|459058419|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
127570505|NCT03150485|459058420|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
127570506|NCT03150485|459058421|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
127570507|NCT03150485|459058422|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
127570508|NCT03150485|459058423|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
127570509|NCT01394718|459058426|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
127570510|NCT01394718|459058427|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
127570511|NCT04078178|459058428|FG000|Lead-In Period (4-Weeks)|Withdrawal by Subject|0|||
127570512|NCT04078178|459058429|FG001|Lead-In Period (4-Weeks)|Withdrawal by Subject|1|||
127570513|NCT04078178|459058428|FG000|Lead-In Period (4-Weeks)|Screen Fail|1|||
127570514|NCT04078178|459058429|FG001|Lead-In Period (4-Weeks)|Screen Fail|2|||
127570515|NCT04078178|459058428|FG000|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|1|||
127570516|NCT04078178|459058429|FG001|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|2|||
127570517|NCT04078178|459058428|FG000|Baseline/Initial Treatment (8 Weeks)|Early Termination|1|||
127570518|NCT04078178|459058429|FG001|Baseline/Initial Treatment (8 Weeks)|Early Termination|0|||
127570519|NCT04078178|459058428|FG000|Crossover Treatment (8 Weeks)|Early Termination|0|||
127570520|NCT04078178|459058429|FG001|Crossover Treatment (8 Weeks)|Early Termination|1|||
127570521|NCT04617795|459058430|FG000|Main Study|Lost to Follow-up|1|||
127570522|NCT04617795|459058431|FG001|Main Study|Lost to Follow-up|0|||
127570523|NCT00472459|459058432|FG000|Overall Study|Adverse Event|13|||
127570524|NCT00472459|459058433|FG001|Overall Study|Adverse Event|13|||
127570525|NCT00472459|459058432|FG000|Overall Study|Withdrawal by Subject|5|||
127570526|NCT00472459|459058433|FG001|Overall Study|Withdrawal by Subject|5|||
127570527|NCT00472459|459058432|FG000|Overall Study|Protocol Violation|3|||
127570528|NCT00472459|459058433|FG001|Overall Study|Protocol Violation|3|||
127570529|NCT00472459|459058432|FG000|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
127570530|NCT00472459|459058433|FG001|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
127570531|NCT00472459|459058432|FG000|Overall Study|Lost to Follow-up|1|||
127570532|NCT00472459|459058433|FG001|Overall Study|Lost to Follow-up|1|||
127570533|NCT03442764|459058434|FG000|Overall Study|Adverse Event|1|||
127570534|NCT03442764|459058435|FG001|Overall Study|Adverse Event|0|||
127570535|NCT03442764|459058436|FG002|Overall Study|Adverse Event|0|||
127570536|NCT02395016|459058437|FG000|Overall Study|Adverse Event|4|||
127570537|NCT02395016|459058438|FG001|Overall Study|Adverse Event|3|||
127570538|NCT02395016|459058437|FG000|Overall Study|Withdrawal by Subject|9|||
127570539|NCT02395016|459058438|FG001|Overall Study|Withdrawal by Subject|6|||
127570540|NCT02395016|459058437|FG000|Overall Study|Protocol Violation|2|||
127570541|NCT02395016|459058438|FG001|Overall Study|Protocol Violation|3|||
127570542|NCT01547780|459058439|FG000|Baseline PET Scan|Physician Decision|1|||
127570543|NCT01547780|459058440|FG001|Baseline PET Scan|Physician Decision|0|||
127570544|NCT01547780|459058441|FG002|Baseline PET Scan|Physician Decision|1|||
127570545|NCT01547780|459058442|FG003|Baseline PET Scan|Physician Decision|0|||
127570546|NCT01547780|459058439|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
127570547|NCT01547780|459058440|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
127570548|NCT01547780|459058441|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
127570549|NCT01547780|459058442|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
127570550|NCT00814879|459058444|FG000|By Week 24|Cancer Diagnosis|1|||
127570551|NCT00814879|459058445|FG001|By Week 24|Cancer Diagnosis|0|||
127570552|NCT00814879|459058444|FG000|By Week 24|Incarceration|0|||
127570553|NCT00814879|459058445|FG001|By Week 24|Incarceration|1|||
127570554|NCT00814879|459058444|FG000|By Week 48|Lost to Follow-up|2|||
127570555|NCT00814879|459058445|FG001|By Week 48|Lost to Follow-up|2|||
127570556|NCT00814879|459058444|FG000|By Week 48|Death|0|||
127570557|NCT00814879|459058445|FG001|By Week 48|Death|1|||
127570558|NCT01461057|459058446|FG000|Overall Study|Death|10|||
127570559|NCT01461057|459058447|FG001|Overall Study|Death|9|||
127570560|NCT01461057|459058446|FG000|Overall Study|Withdrawal by Subject|2|||
127570561|NCT01461057|459058447|FG001|Overall Study|Withdrawal by Subject|3|||
127570562|NCT01461057|459058446|FG000|Overall Study|Physician Decision|0|||
127570563|NCT01461057|459058447|FG001|Overall Study|Physician Decision|2|||
127570564|NCT01461057|459058446|FG000|Overall Study|Adverse Event|0|||
127570565|NCT01461057|459058447|FG001|Overall Study|Adverse Event|1|||
127570566|NCT01461057|459058446|FG000|Overall Study|Progression of Disease|1|||
127570567|NCT01461057|459058447|FG001|Overall Study|Progression of Disease|0|||
127570568|NCT01461057|459058446|FG000|Overall Study|Study Terminated by Sponsor|2|||
127570569|NCT01461057|459058447|FG001|Overall Study|Study Terminated by Sponsor|0|||
127570570|NCT01288976|459058448|FG000|Overall Study|Withdrawal by Subject|58|||
127570571|NCT01288976|459058449|FG001|Overall Study|Withdrawal by Subject|12|||
127570572|NCT01288976|459058450|FG002|Overall Study|Withdrawal by Subject|9|||
127570573|NCT01288976|459058448|FG000|Overall Study|Death|98|||
127570574|NCT01288976|459058449|FG001|Overall Study|Death|6|||
127570575|NCT01288976|459058450|FG002|Overall Study|Death|4|||
127570576|NCT01288976|459058448|FG000|Overall Study|Data unavailable|22|||
127570577|NCT01288976|459058449|FG001|Overall Study|Data unavailable|9|||
127570578|NCT01288976|459058450|FG002|Overall Study|Data unavailable|7|||
127690699|NCT01704079|459492343|FG000|Overall Study|Protocol Violation|1|||
127690700|NCT01704079|459492344|FG001|Overall Study|Protocol Violation|0|||
127690701|NCT01704079|459492343|FG000|Overall Study|Subject noncompliance|2|||
127570579|NCT00478881|459058457|FG000|Overall Study|Adverse Event|31|||
127570580|NCT00478881|459058458|FG001|Overall Study|Adverse Event|12|||
127570581|NCT00478881|459058457|FG000|Overall Study|Lack of Efficacy|0|||
127570582|NCT00478881|459058458|FG001|Overall Study|Lack of Efficacy|3|||
127570583|NCT00478881|459058457|FG000|Overall Study|Lost to Follow-up|0|||
127570584|NCT00478881|459058458|FG001|Overall Study|Lost to Follow-up|1|||
127570585|NCT00478881|459058457|FG000|Overall Study|Protocol Violation|2|||
127570586|NCT00478881|459058458|FG001|Overall Study|Protocol Violation|2|||
127570587|NCT00478881|459058457|FG000|Overall Study|Withdrawal by Subject|6|||
127570588|NCT00478881|459058458|FG001|Overall Study|Withdrawal by Subject|2|||
127570589|NCT00478881|459058457|FG000|Overall Study|Non-Compliance with Study Medication|0|||
127570590|NCT00478881|459058458|FG001|Overall Study|Non-Compliance with Study Medication|2|||
127690702|NCT01704079|459492344|FG001|Overall Study|Subject noncompliance|3|||
127570591|NCT00737464|459058459|FG000|Overall Study|Adverse Event|1|||
127570592|NCT00737464|459058459|FG000|Overall Study|Death|6|||
127570593|NCT00737464|459058459|FG000|Overall Study|Other - Failure to Return|1|||
127570594|NCT00737464|459058459|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
127570595|NCT00737464|459058459|FG000|Overall Study|Other reasons|4|||
127570596|NCT03410823|459058462|FG000|Overall Study|Death|1|||
127570597|NCT03410823|459058462|FG000|Overall Study|Withdrawal by Subject|2|||
127570598|NCT03410823|459058462|FG000|Overall Study|Withdraw due to COVID-19 shutdown|2|||
127570599|NCT03569293|459058463|FG000|Overall Study|Adverse Event|4|||
127570600|NCT03569293|459058464|FG001|Overall Study|Adverse Event|1|||
127570601|NCT03569293|459058465|FG002|Overall Study|Adverse Event|5|||
127570602|NCT03569293|459058466|FG003|Overall Study|Adverse Event|1|||
127570603|NCT03569293|459058467|FG004|Overall Study|Adverse Event|0|||
127570604|NCT03569293|459058468|FG005|Overall Study|Adverse Event|0|||
127570605|NCT03569293|459058463|FG000|Overall Study|Withdrawal by Subject|16|||
127570606|NCT03569293|459058464|FG001|Overall Study|Withdrawal by Subject|2|||
127570607|NCT03569293|459058465|FG002|Overall Study|Withdrawal by Subject|4|||
127570608|NCT03569293|459058466|FG003|Overall Study|Withdrawal by Subject|1|||
127570609|NCT03569293|459058467|FG004|Overall Study|Withdrawal by Subject|0|||
127570610|NCT03569293|459058468|FG005|Overall Study|Withdrawal by Subject|0|||
127570611|NCT03569293|459058463|FG000|Overall Study|Lost to Follow-up|1|||
127570612|NCT03569293|459058464|FG001|Overall Study|Lost to Follow-up|3|||
127570613|NCT03569293|459058465|FG002|Overall Study|Lost to Follow-up|1|||
127570614|NCT03569293|459058466|FG003|Overall Study|Lost to Follow-up|1|||
127570615|NCT03569293|459058467|FG004|Overall Study|Lost to Follow-up|0|||
127570616|NCT03569293|459058468|FG005|Overall Study|Lost to Follow-up|0|||
127570617|NCT03569293|459058463|FG000|Overall Study|Other|8|||
127570618|NCT03569293|459058464|FG001|Overall Study|Other|2|||
127570619|NCT03569293|459058465|FG002|Overall Study|Other|1|||
127570620|NCT03569293|459058466|FG003|Overall Study|Other|1|||
127570621|NCT03569293|459058467|FG004|Overall Study|Other|0|||
127570622|NCT03569293|459058468|FG005|Overall Study|Other|0|||
127570623|NCT03569293|459058463|FG000|Overall Study|Ongoing at Time of Analysis|8|||
127690703|NCT01704079|459492343|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
127690704|NCT01704079|459492344|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
128026944|NCT02057666|460722297|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
128026945|NCT02057666|460722296|FG000|Double Blind Treatment Period|Physician Decision|1|||
128026946|NCT02057666|460722297|FG001|Double Blind Treatment Period|Physician Decision|0|||
128026947|NCT02057666|460722296|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
128026948|NCT02057666|460722297|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
128026949|NCT02057666|460722296|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
128026950|NCT02057666|460722297|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
128026951|NCT02057666|460722296|FG000|Double Blind Treatment Period|Sponsor's request|70|||
128026952|NCT02057666|460722297|FG001|Double Blind Treatment Period|Sponsor's request|34|||
128026953|NCT02057666|460722296|FG000|Open-Label Treatment Period|Poor tolerability|0|||
127690705|NCT04300231|459492345|FG000|Overall Study|Protocol Violation|4|||
127690706|NCT04300231|459492346|FG001|Overall Study|Protocol Violation|3|||
127690707|NCT04300231|459492347|FG002|Overall Study|Protocol Violation|0|||
127690708|NCT04300231|459492348|FG003|Overall Study|Protocol Violation|2|||
127690709|NCT02991807|459492356|FG000|Overall Study|Withdrawal by Subject|2|||
127690710|NCT02991807|459492357|FG001|Overall Study|Withdrawal by Subject|1|||
127690711|NCT02991807|459492356|FG000|Overall Study|Physician Decision|0|||
127690712|NCT02991807|459492357|FG001|Overall Study|Physician Decision|1|||
127690713|NCT02991807|459492356|FG000|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|1|||
127690714|NCT02991807|459492357|FG001|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|0|||
127690715|NCT02058108|459492359|FG000|Overall Study|Abnormal Laboratory Values|0|||
127690716|NCT02058108|459492360|FG001|Overall Study|Abnormal Laboratory Values|1|||
127690717|NCT02058108|459492359|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
127690718|NCT02058108|459492360|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
127690719|NCT02058108|459492359|FG000|Overall Study|No longer requires study drug|0|||
127690720|NCT02058108|459492360|FG001|Overall Study|No longer requires study drug|1|||
127690721|NCT02058108|459492359|FG000|Overall Study|Withdrawal by Subject|1|||
127690722|NCT02058108|459492360|FG001|Overall Study|Withdrawal by Subject|0|||
127690723|NCT02058108|459492359|FG000|Overall Study|Administrative problems|3|||
127690724|NCT02058108|459492360|FG001|Overall Study|Administrative problems|3|||
127690725|NCT02058108|459492359|FG000|Overall Study|Protocol Violation|0|||
127570624|NCT03569293|459058464|FG001|Overall Study|Ongoing at Time of Analysis|1|||
127570625|NCT03569293|459058465|FG002|Overall Study|Ongoing at Time of Analysis|3|||
127570626|NCT03569293|459058466|FG003|Overall Study|Ongoing at Time of Analysis|0|||
127570627|NCT03569293|459058467|FG004|Overall Study|Ongoing at Time of Analysis|0|||
127570628|NCT03569293|459058468|FG005|Overall Study|Ongoing at Time of Analysis|0|||
127690726|NCT02058108|459492360|FG001|Overall Study|Protocol Violation|1|||
127570629|NCT05128929|459058470|FG000|Overall Study|Adverse Event|0|||
127570630|NCT05128929|459058471|FG001|Overall Study|Adverse Event|1|||
127570631|NCT02742246|459058472|FG000|Overall Study|Never initiated treatment|5|||
127570632|NCT02742246|459058473|FG001|Overall Study|Never initiated treatment|3|||
127570633|NCT02742246|459058474|FG002|Overall Study|Never initiated treatment|1|||
127570634|NCT02742246|459058472|FG000|Overall Study|dropped out during treatment|7|||
127570635|NCT02742246|459058473|FG001|Overall Study|dropped out during treatment|13|||
127570636|NCT02742246|459058474|FG002|Overall Study|dropped out during treatment|10|||
127570637|NCT02742246|459058472|FG000|Overall Study|Death|1|||
127570638|NCT02742246|459058473|FG001|Overall Study|Death|0|||
127570639|NCT02742246|459058474|FG002|Overall Study|Death|0|||
127570640|NCT03553836|459058475|FG000|Overall Study|Ongoing in Study|460|||
127570641|NCT03553836|459058476|FG001|Overall Study|Ongoing in Study|459|||
127570642|NCT03553836|459058475|FG000|Overall Study|Withdrawal by Subject|9|||
127570643|NCT03553836|459058476|FG001|Overall Study|Withdrawal by Subject|10|||
127570644|NCT03553836|459058475|FG000|Overall Study|Lost to Follow-up|1|||
127570645|NCT03553836|459058476|FG001|Overall Study|Lost to Follow-up|3|||
127570646|NCT03553836|459058475|FG000|Overall Study|Death|17|||
127570647|NCT03553836|459058476|FG001|Overall Study|Death|17|||
127570648|NCT03220438|459058477|FG000|Overall Study|Lost to Follow-up|0|||
127570649|NCT03220438|459058478|FG001|Overall Study|Lost to Follow-up|0|||
127570650|NCT03220438|459058479|FG002|Overall Study|Lost to Follow-up|1|||
127570651|NCT03220438|459058480|FG003|Overall Study|Lost to Follow-up|0|||
127570652|NCT04062123|459058481|FG000|Overall Study|Withdrawal by Subject|0|||
127570653|NCT04062123|459058482|FG001|Overall Study|Withdrawal by Subject|1|||
127570654|NCT04062123|459058483|FG002|Overall Study|Withdrawal by Subject|0|||
127570655|NCT03584373|459058485|FG000|Overall Study|Lost to Follow-up|7|||
127570656|NCT03584373|459058486|FG001|Overall Study|Lost to Follow-up|8|||
127570657|NCT01487577|459058487|FG000|Overall Study|Became ineligible after signing consent|1|||
127570658|NCT00662532|459058492|FG000|Overall Study|Adverse Event|0|||
127570659|NCT00662532|459058493|FG001|Overall Study|Adverse Event|1|||
127570660|NCT00662532|459058492|FG000|Overall Study|Lost to Follow-up|0|||
127570661|NCT00662532|459058493|FG001|Overall Study|Lost to Follow-up|1|||
127690727|NCT04759833|459492364|FG000|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|1|||
127690728|NCT04759833|459492365|FG001|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|4|||
127690729|NCT04759833|459492366|FG002|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|2|||
127690730|NCT04759833|459492367|FG003|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
127690731|NCT04759833|459492368|FG004|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
127690732|NCT04759833|459492364|FG000|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
127690733|NCT04759833|459492365|FG001|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
127690734|NCT04759833|459492366|FG002|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|1|||
127690735|NCT04759833|459492367|FG003|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
127690736|NCT04759833|459492368|FG004|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
127690737|NCT04759833|459492364|FG000|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
127690738|NCT04759833|459492365|FG001|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|1|||
127690739|NCT04759833|459492366|FG002|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
127690740|NCT04759833|459492367|FG003|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
127690741|NCT04759833|459492368|FG004|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
127690742|NCT04759833|459492364|FG000|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
127690743|NCT04759833|459492365|FG001|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|2|||
127690744|NCT04759833|459492366|FG002|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|3|||
127690745|NCT04759833|459492367|FG003|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
127690746|NCT04759833|459492368|FG004|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
127690747|NCT04759833|459492364|FG000|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|5|||
127690748|NCT04759833|459492365|FG001|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|3|||
127690749|NCT04759833|459492366|FG002|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|9|||
127690750|NCT04759833|459492367|FG003|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
127690751|NCT04759833|459492368|FG004|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
127690752|NCT04759833|459492364|FG000|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
127690753|NCT04759833|459492365|FG001|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
127690754|NCT04759833|459492366|FG002|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|1|||
127705204|NCT01928394|459551584|FG017|Treatment Period|Lost to Follow-up|0|||
127570662|NCT00367770|459058494|FG000|Overall Study|Adverse Event|1|||
127570663|NCT00367770|459058494|FG000|Overall Study|Withdrawal by Subject|1|||
127570664|NCT01155479|459058495|FG000|Part I|Adverse Event|13|||
127570665|NCT01155479|459058496|FG001|Part I|Adverse Event|8|||
127570666|NCT01155479|459058497|FG002|Part I|Adverse Event|18|||
127570667|NCT01155479|459058498|FG003|Part I|Adverse Event|7|||
127570668|NCT01155479|459058499|FG004|Part I|Adverse Event|6|||
127570669|NCT01155479|459058495|FG000|Part I|Administrative|2|||
127570670|NCT01155479|459058496|FG001|Part I|Administrative|2|||
127570671|NCT01155479|459058497|FG002|Part I|Administrative|2|||
127570672|NCT01155479|459058498|FG003|Part I|Administrative|0|||
127570673|NCT01155479|459058499|FG004|Part I|Administrative|0|||
127570674|NCT01155479|459058495|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
127570675|NCT01155479|459058496|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
127570676|NCT01155479|459058497|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
127570677|NCT01155479|459058498|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
127570678|NCT01155479|459058499|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
127570679|NCT01155479|459058495|FG000|Part I|Withdrawal by Subject|11|||
127570680|NCT01155479|459058496|FG001|Part I|Withdrawal by Subject|13|||
127570681|NCT01155479|459058497|FG002|Part I|Withdrawal by Subject|8|||
127570682|NCT01155479|459058498|FG003|Part I|Withdrawal by Subject|8|||
127570683|NCT01155479|459058499|FG004|Part I|Withdrawal by Subject|9|||
127570684|NCT01155479|459058495|FG000|Part I|Lost to Follow-up|0|||
127570685|NCT01155479|459058496|FG001|Part I|Lost to Follow-up|0|||
127570686|NCT01155479|459058497|FG002|Part I|Lost to Follow-up|1|||
127570687|NCT01155479|459058498|FG003|Part I|Lost to Follow-up|1|||
127570688|NCT01155479|459058499|FG004|Part I|Lost to Follow-up|0|||
127570689|NCT01155479|459058495|FG000|Part I|Treatment Failure|3|||
127570690|NCT01155479|459058496|FG001|Part I|Treatment Failure|0|||
127570691|NCT01155479|459058497|FG002|Part I|Treatment Failure|3|||
127570692|NCT01155479|459058498|FG003|Part I|Treatment Failure|1|||
127570693|NCT01155479|459058499|FG004|Part I|Treatment Failure|2|||
127570694|NCT01155479|459058495|FG000|Part I|Did Not Receive Treatment|4|||
127570695|NCT01155479|459058496|FG001|Part I|Did Not Receive Treatment|2|||
127570696|NCT01155479|459058497|FG002|Part I|Did Not Receive Treatment|2|||
127570697|NCT01155479|459058498|FG003|Part I|Did Not Receive Treatment|6|||
127570698|NCT01155479|459058499|FG004|Part I|Did Not Receive Treatment|1|||
127570699|NCT01155479|459058495|FG000|Part I|Non-Compliance with Protocol|2|||
127570700|NCT01155479|459058496|FG001|Part I|Non-Compliance with Protocol|1|||
127570701|NCT01155479|459058497|FG002|Part I|Non-Compliance with Protocol|3|||
127570702|NCT01155479|459058498|FG003|Part I|Non-Compliance with Protocol|3|||
127570703|NCT01155479|459058499|FG004|Part I|Non-Compliance with Protocol|2|||
127570704|NCT01155479|459058495|FG000|Part II|Adverse Event|7|||
127570705|NCT01155479|459058496|FG001|Part II|Adverse Event|6|||
127570706|NCT01155479|459058497|FG002|Part II|Adverse Event|8|||
127570707|NCT01155479|459058498|FG003|Part II|Adverse Event|3|||
127570708|NCT01155479|459058499|FG004|Part II|Adverse Event|4|||
127570709|NCT01155479|459058495|FG000|Part II|Administrative|43|||
127570710|NCT01155479|459058496|FG001|Part II|Administrative|49|||
127570711|NCT01155479|459058497|FG002|Part II|Administrative|36|||
127570712|NCT01155479|459058498|FG003|Part II|Administrative|38|||
127570713|NCT01155479|459058499|FG004|Part II|Administrative|46|||
127570714|NCT01155479|459058495|FG000|Part II|Withdrawal by Subject|8|||
127570715|NCT01155479|459058496|FG001|Part II|Withdrawal by Subject|4|||
127570716|NCT01155479|459058497|FG002|Part II|Withdrawal by Subject|12|||
127570717|NCT01155479|459058498|FG003|Part II|Withdrawal by Subject|7|||
127570718|NCT01155479|459058499|FG004|Part II|Withdrawal by Subject|3|||
127570719|NCT01155479|459058495|FG000|Part II|Lost to Follow-up|1|||
127570720|NCT01155479|459058496|FG001|Part II|Lost to Follow-up|0|||
127570721|NCT01155479|459058497|FG002|Part II|Lost to Follow-up|0|||
127570722|NCT01155479|459058498|FG003|Part II|Lost to Follow-up|0|||
127570723|NCT01155479|459058499|FG004|Part II|Lost to Follow-up|1|||
127570724|NCT01155479|459058495|FG000|Part II|Treatment Failure|0|||
127570725|NCT01155479|459058496|FG001|Part II|Treatment Failure|1|||
127570726|NCT01155479|459058497|FG002|Part II|Treatment Failure|2|||
127570727|NCT01155479|459058498|FG003|Part II|Treatment Failure|0|||
127570728|NCT01155479|459058499|FG004|Part II|Treatment Failure|1|||
127570729|NCT01155479|459058495|FG000|Part II|Non-Compliance with Protocol|0|||
127690755|NCT04759833|459492367|FG003|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
127690756|NCT04759833|459492368|FG004|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
127690757|NCT04759833|459492364|FG000|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
127690758|NCT04759833|459492365|FG001|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|1|||
127690759|NCT04759833|459492366|FG002|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
127690760|NCT04759833|459492367|FG003|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
127690761|NCT04759833|459492368|FG004|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
127690762|NCT04759833|459492364|FG000|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
127570730|NCT01155479|459058496|FG001|Part II|Non-Compliance with Protocol|1|||
127570731|NCT01155479|459058497|FG002|Part II|Non-Compliance with Protocol|0|||
127570732|NCT01155479|459058498|FG003|Part II|Non-Compliance with Protocol|2|||
127570733|NCT01155479|459058499|FG004|Part II|Non-Compliance with Protocol|0|||
127570734|NCT00998764|459058500|FG000|Overall Study|Lack of Efficacy|3|||
127570735|NCT00998764|459058501|FG001|Overall Study|Lack of Efficacy|6|||
127570736|NCT00998764|459058500|FG000|Overall Study|Adverse Event|17|||
127570737|NCT00998764|459058501|FG001|Overall Study|Adverse Event|12|||
127570738|NCT00998764|459058500|FG000|Overall Study|Withdrawal by Subject|19|||
127570739|NCT00998764|459058501|FG001|Overall Study|Withdrawal by Subject|25|||
127570740|NCT00998764|459058500|FG000|Overall Study|Physician Decision|3|||
127570741|NCT00998764|459058501|FG001|Overall Study|Physician Decision|3|||
127570742|NCT00998764|459058500|FG000|Overall Study|Death|3|||
127570743|NCT00998764|459058501|FG001|Overall Study|Death|1|||
127779286|NCT00088907|459819781|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
127779287|NCT00088907|459819780|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
127779288|NCT00088907|459819781|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
127779289|NCT03426787|459819786|FG000|Overall Study|Withdrawal by Subject|6|||
127779290|NCT03426787|459819786|FG000|Overall Study|Lost to Follow-up|7|||
127779291|NCT03426787|459819786|FG000|Overall Study|Unrelated to intervention death|1|||
127779292|NCT02020863|459819787|FG000|Overall Study|Discovery of Metastatic disease|4|||
127779293|NCT02020863|459819787|FG000|Overall Study|Team chose not to place an a line|1|||
127779294|NCT00907257|459819791|FG000|Overall Study|Adverse Event|0|||
127779295|NCT00907257|459819792|FG001|Overall Study|Adverse Event|4|||
127779296|NCT00907257|459819791|FG000|Overall Study|Protocol Violation|1|||
127779297|NCT00907257|459819792|FG001|Overall Study|Protocol Violation|2|||
127779298|NCT00907257|459819791|FG000|Overall Study|Lost to Follow-up|3|||
127779299|NCT00907257|459819792|FG001|Overall Study|Lost to Follow-up|3|||
127779300|NCT00907257|459819791|FG000|Overall Study|Withdrawal by Subject|1|||
127779301|NCT00907257|459819792|FG001|Overall Study|Withdrawal by Subject|2|||
127779302|NCT00907257|459819791|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
127779303|NCT00907257|459819792|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
127779304|NCT00907257|459819791|FG000|Overall Study|Moved|1|||
127779305|NCT00907257|459819792|FG001|Overall Study|Moved|0|||
127779306|NCT00907257|459819791|FG000|Overall Study|Personal Reasons|6|||
127779307|NCT00907257|459819792|FG001|Overall Study|Personal Reasons|1|||
127779308|NCT00283049|459819793|FG000|Overall Study|Adverse Event|6|||
127779309|NCT00283049|459819794|FG001|Overall Study|Adverse Event|1|||
127779310|NCT00283049|459819795|FG002|Overall Study|Adverse Event|4|||
127779311|NCT00283049|459819793|FG000|Overall Study|Protocol Violation|3|||
127779312|NCT00283049|459819794|FG001|Overall Study|Protocol Violation|0|||
127779313|NCT00283049|459819795|FG002|Overall Study|Protocol Violation|3|||
127779314|NCT00283049|459819793|FG000|Overall Study|Death|1|||
127779315|NCT00283049|459819794|FG001|Overall Study|Death|1|||
127779316|NCT00283049|459819795|FG002|Overall Study|Death|1|||
127779317|NCT00283049|459819793|FG000|Overall Study|Lack of Efficacy|0|||
127779318|NCT00283049|459819794|FG001|Overall Study|Lack of Efficacy|1|||
127779319|NCT00283049|459819795|FG002|Overall Study|Lack of Efficacy|1|||
127779320|NCT00283049|459819793|FG000|Overall Study|Lost to Follow-up|4|||
127779321|NCT00283049|459819794|FG001|Overall Study|Lost to Follow-up|2|||
127779322|NCT00283049|459819795|FG002|Overall Study|Lost to Follow-up|5|||
127779323|NCT00283049|459819793|FG000|Overall Study|Withdrawal by Subject|26|||
127779324|NCT00283049|459819794|FG001|Overall Study|Withdrawal by Subject|24|||
127779325|NCT00283049|459819795|FG002|Overall Study|Withdrawal by Subject|19|||
127779326|NCT00283049|459819793|FG000|Overall Study|Discontinuation of Study|18|||
127779327|NCT00283049|459819794|FG001|Overall Study|Discontinuation of Study|16|||
127779328|NCT00283049|459819795|FG002|Overall Study|Discontinuation of Study|20|||
127779329|NCT00283049|459819793|FG000|Overall Study|No longer requires study treatment|0|||
127779330|NCT00283049|459819794|FG001|Overall Study|No longer requires study treatment|0|||
127690763|NCT04759833|459492365|FG001|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
127690764|NCT04759833|459492366|FG002|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
127690765|NCT04759833|459492367|FG003|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
127690766|NCT04759833|459492368|FG004|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
127690767|NCT04759833|459492364|FG000|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
127690768|NCT04759833|459492365|FG001|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
127690769|NCT04759833|459492366|FG002|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
127690770|NCT04759833|459492367|FG003|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
127690771|NCT04759833|459492368|FG004|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|1|||
127690772|NCT04759833|459492364|FG000|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
127690773|NCT04759833|459492365|FG001|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
127690774|NCT04759833|459492366|FG002|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
127690775|NCT04759833|459492367|FG003|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|1|||
127690776|NCT04759833|459492368|FG004|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|3|||
127690777|NCT04759833|459492364|FG000|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
127690778|NCT04759833|459492365|FG001|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
127690779|NCT04759833|459492366|FG002|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
127690780|NCT04759833|459492367|FG003|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|21|||
127690781|NCT04759833|459492368|FG004|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|16|||
127690782|NCT04759833|459492364|FG000|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
127690783|NCT04759833|459492365|FG001|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
127779331|NCT00283049|459819795|FG002|Overall Study|No longer requires study treatment|1|||
127779332|NCT00930722|459819796|FG000|Overall Study|Lost to Follow-up|16|||
127779333|NCT00930722|459819796|FG000|Overall Study|No longer willing to participate|9|||
127779334|NCT00930722|459819796|FG000|Overall Study|Study terminated by sponsor|2|||
127570744|NCT00998764|459058500|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
127570745|NCT00998764|459058501|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
127570746|NCT00998764|459058500|FG000|Overall Study|Protocol Violation|0|||
127570747|NCT00998764|459058501|FG001|Overall Study|Protocol Violation|1|||
127570748|NCT00998764|459058500|FG000|Overall Study|Failed to Return|1|||
127570749|NCT00998764|459058501|FG001|Overall Study|Failed to Return|1|||
127570750|NCT00998764|459058500|FG000|Overall Study|Lost to Follow-up|1|||
127570751|NCT00998764|459058501|FG001|Overall Study|Lost to Follow-up|1|||
127570752|NCT00998764|459058500|FG000|Overall Study|Loss of Caregiver|0|||
127570753|NCT00998764|459058501|FG001|Overall Study|Loss of Caregiver|3|||
127570754|NCT00998764|459058500|FG000|Overall Study|Other|4|||
127570755|NCT00998764|459058501|FG001|Overall Study|Other|4|||
127570756|NCT00998764|459058500|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
127570757|NCT00998764|459058501|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
127570758|NCT04761627|459058502|FG000|Run-in Period|Death|1|||
127570759|NCT04761627|459058503|FG001|Run-in Period|Death|0|||
127570760|NCT04761627|459058504|FG002|Run-in Period|Death|0|||
127570761|NCT04761627|459058502|FG000|Run-in Period|Required alternative therapy|2|||
127570762|NCT04761627|459058503|FG001|Run-in Period|Required alternative therapy|0|||
127570763|NCT04761627|459058504|FG002|Run-in Period|Required alternative therapy|0|||
127570764|NCT04761627|459058502|FG000|Run-in Period|Lost to Follow-up|2|||
127570765|NCT04761627|459058503|FG001|Run-in Period|Lost to Follow-up|0|||
127570766|NCT04761627|459058504|FG002|Run-in Period|Lost to Follow-up|0|||
127570767|NCT04761627|459058502|FG000|Run-in Period|Protocol Violation|3|||
127570768|NCT04761627|459058503|FG001|Run-in Period|Protocol Violation|0|||
127570769|NCT04761627|459058504|FG002|Run-in Period|Protocol Violation|0|||
127570770|NCT04761627|459058502|FG000|Run-in Period|Abnormal liver function|1|||
127570771|NCT04761627|459058503|FG001|Run-in Period|Abnormal liver function|0|||
127570772|NCT04761627|459058504|FG002|Run-in Period|Abnormal liver function|0|||
127570773|NCT04761627|459058502|FG000|Run-in Period|Adverse Event|6|||
127570774|NCT04761627|459058503|FG001|Run-in Period|Adverse Event|0|||
127570775|NCT04761627|459058504|FG002|Run-in Period|Adverse Event|0|||
127570776|NCT04761627|459058502|FG000|Run-in Period|Withdrawal by Subject|7|||
127570777|NCT04761627|459058503|FG001|Run-in Period|Withdrawal by Subject|0|||
127570778|NCT04761627|459058504|FG002|Run-in Period|Withdrawal by Subject|0|||
127570779|NCT04761627|459058502|FG000|Run-in Period|Did not meet PASI 50|15|||
127570780|NCT04761627|459058503|FG001|Run-in Period|Did not meet PASI 50|0|||
127570781|NCT04761627|459058504|FG002|Run-in Period|Did not meet PASI 50|0|||
127570782|NCT04761627|459058502|FG000|Run-in Period|Study site closure|2|||
127570783|NCT04761627|459058503|FG001|Run-in Period|Study site closure|0|||
127570784|NCT04761627|459058504|FG002|Run-in Period|Study site closure|0|||
127570785|NCT04761627|459058502|FG000|Run-in Period|Pregnancy|2|||
127570786|NCT04761627|459058503|FG001|Run-in Period|Pregnancy|0|||
127570787|NCT04761627|459058504|FG002|Run-in Period|Pregnancy|0|||
127570788|NCT04761627|459058502|FG000|Post-randomization Period|Military service|0|||
127570789|NCT04761627|459058503|FG001|Post-randomization Period|Military service|1|||
127570790|NCT04761627|459058504|FG002|Post-randomization Period|Military service|0|||
127570791|NCT04761627|459058502|FG000|Post-randomization Period|Adverse Event|0|||
127570792|NCT04761627|459058503|FG001|Post-randomization Period|Adverse Event|4|||
127570793|NCT04761627|459058504|FG002|Post-randomization Period|Adverse Event|2|||
127570794|NCT04761627|459058502|FG000|Post-randomization Period|Lost to Follow-up|0|||
127570795|NCT04761627|459058503|FG001|Post-randomization Period|Lost to Follow-up|6|||
127570796|NCT04761627|459058504|FG002|Post-randomization Period|Lost to Follow-up|6|||
127570797|NCT04761627|459058502|FG000|Post-randomization Period|Withdrawal by Subject|0|||
127570798|NCT04761627|459058503|FG001|Post-randomization Period|Withdrawal by Subject|7|||
127570799|NCT04761627|459058504|FG002|Post-randomization Period|Withdrawal by Subject|6|||
127570800|NCT04761627|459058502|FG000|Post-randomization Period|Pregnancy|0|||
127570801|NCT04761627|459058503|FG001|Post-randomization Period|Pregnancy|0|||
127570802|NCT04761627|459058504|FG002|Post-randomization Period|Pregnancy|1|||
127570803|NCT04761627|459058502|FG000|Post-randomization Period|Study site closure|0|||
127570804|NCT04761627|459058503|FG001|Post-randomization Period|Study site closure|0|||
127570805|NCT04761627|459058504|FG002|Post-randomization Period|Study site closure|1|||
127570806|NCT04761627|459058502|FG000|Post-randomization Period|Family planning|0|||
127570807|NCT04761627|459058503|FG001|Post-randomization Period|Family planning|1|||
127570808|NCT04761627|459058504|FG002|Post-randomization Period|Family planning|0|||
127570809|NCT01214174|459058505|FG000|Overall Study|Withdrawal by Subject|0|||
127690784|NCT04759833|459492366|FG002|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
127690785|NCT04759833|459492367|FG003|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|4|||
127690786|NCT04759833|459492368|FG004|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|8|||
127570810|NCT01214174|459058506|FG001|Overall Study|Withdrawal by Subject|0|||
127570811|NCT01214174|459058507|FG002|Overall Study|Withdrawal by Subject|1|||
127570812|NCT01634178|459058510|FG000|Treatment Period 1|Adverse Event|0|||
127570813|NCT01634178|459058511|FG001|Treatment Period 1|Adverse Event|1|||
127570814|NCT01634178|459058510|FG000|Treatment Period 2|Adverse Event|1|||
127570815|NCT01634178|459058511|FG001|Treatment Period 2|Adverse Event|0|||
127570816|NCT00991952|459058512|FG000|Overall Study|Adverse Event|0|||
127570817|NCT00991952|459058513|FG001|Overall Study|Adverse Event|1|||
127570818|NCT00582816|459058515|FG000|Overall Study|Engraftment Failure|3|||
127570819|NCT00768469|459058519|FG000|Overall Study|Adverse Event|0|||
127570820|NCT00768469|459058520|FG001|Overall Study|Adverse Event|2|||
127570821|NCT00768469|459058519|FG000|Overall Study|Disease Progression|3|||
127570822|NCT00768469|459058520|FG001|Overall Study|Disease Progression|4|||
127570823|NCT00768469|459058519|FG000|Overall Study|Withdrawal by Subject|0|||
127570824|NCT00768469|459058520|FG001|Overall Study|Withdrawal by Subject|1|||
127570825|NCT00459056|459058523|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
127570826|NCT00459056|459058524|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
127570827|NCT03189381|459058525|FG000|Overall Study|Death|1|||
127570828|NCT03189381|459058526|FG001|Overall Study|Death|0|||
127570829|NCT03761797|459058527|FG000|Overall Study|Changing hospital|11|||
127570830|NCT03761797|459058527|FG000|Overall Study|Improvement/remission|6|||
127570831|NCT03761797|459058527|FG000|Overall Study|Withdrawal by Subject|19|||
127570832|NCT03761797|459058527|FG000|Overall Study|Lost to Follow-up|33|||
127570833|NCT03761797|459058527|FG000|Overall Study|Adverse Event|37|||
127570834|NCT03761797|459058527|FG000|Overall Study|Case report form (CRF) not collected|5|||
127570835|NCT03761797|459058527|FG000|Overall Study|No patient visit after entry|13|||
127570836|NCT03761797|459058527|FG000|Overall Study|Switch to other diabetes medication|10|||
127570837|NCT03761797|459058527|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
127570838|NCT03761797|459058527|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
127570839|NCT03761797|459058527|FG000|Overall Study|Insufficient effectives|2|||
127570840|NCT03761797|459058527|FG000|Overall Study|Excessive alcohol intake|1|||
127570841|NCT00251004|459058528|FG000|Overall Study|Withdrawal by Subject|23|||
127570842|NCT00251004|459058529|FG001|Overall Study|Withdrawal by Subject|16|||
127779343|NCT01205438|459819799|FG000|Overall Study|Adverse Event|19|||
127779344|NCT01205438|459819800|FG001|Overall Study|Adverse Event|17|||
127779345|NCT01205438|459819801|FG002|Overall Study|Adverse Event|24|||
127779346|NCT01205438|459819799|FG000|Overall Study|Death|1|||
127779347|NCT01205438|459819800|FG001|Overall Study|Death|1|||
127779348|NCT01205438|459819801|FG002|Overall Study|Death|3|||
127779349|NCT01205438|459819799|FG000|Overall Study|Entry Criteria Not Met|16|||
127779350|NCT01205438|459819800|FG001|Overall Study|Entry Criteria Not Met|15|||
127779351|NCT01205438|459819801|FG002|Overall Study|Entry Criteria Not Met|13|||
127779352|NCT01205438|459819799|FG000|Overall Study|Lack of Efficacy|14|||
127779353|NCT01205438|459819800|FG001|Overall Study|Lack of Efficacy|11|||
127779354|NCT01205438|459819801|FG002|Overall Study|Lack of Efficacy|14|||
127779355|NCT01205438|459819799|FG000|Overall Study|Lost to Follow-up|6|||
127779356|NCT01205438|459819800|FG001|Overall Study|Lost to Follow-up|7|||
127779357|NCT01205438|459819801|FG002|Overall Study|Lost to Follow-up|8|||
127779358|NCT01205438|459819799|FG000|Overall Study|Withdrawal by Subject|19|||
127779359|NCT01205438|459819800|FG001|Overall Study|Withdrawal by Subject|25|||
127779360|NCT01205438|459819801|FG002|Overall Study|Withdrawal by Subject|19|||
127779361|NCT01205438|459819799|FG000|Overall Study|Physician Decision|0|||
127779362|NCT01205438|459819800|FG001|Overall Study|Physician Decision|3|||
127779363|NCT01205438|459819801|FG002|Overall Study|Physician Decision|2|||
127779364|NCT01205438|459819799|FG000|Overall Study|Protocol Violation|2|||
127779365|NCT01205438|459819800|FG001|Overall Study|Protocol Violation|7|||
127779366|NCT01205438|459819801|FG002|Overall Study|Protocol Violation|4|||
127570843|NCT00251004|459058530|FG002|Overall Study|Withdrawal by Subject|14|||
127570844|NCT00251004|459058528|FG000|Overall Study|Death|9|||
127570845|NCT00251004|459058529|FG001|Overall Study|Death|10|||
127570846|NCT00251004|459058530|FG002|Overall Study|Death|8|||
127570847|NCT00251004|459058528|FG000|Overall Study|Lost to Follow-up|1|||
127570848|NCT00251004|459058529|FG001|Overall Study|Lost to Follow-up|2|||
127570849|NCT00251004|459058530|FG002|Overall Study|Lost to Follow-up|1|||
127570850|NCT00251004|459058528|FG000|Overall Study|Graft Loss|12|||
127570851|NCT00251004|459058529|FG001|Overall Study|Graft Loss|13|||
127570852|NCT00251004|459058530|FG002|Overall Study|Graft Loss|8|||
127570853|NCT00256282|459058531|FG000|Overall Study|Disease progression, relapse during acti|12|||
127570854|NCT00256282|459058531|FG000|Overall Study|Adverse Event|3|||
127570855|NCT00256282|459058531|FG000|Overall Study|Physician Decision|1|||
127570856|NCT02021656|459058534|FG000|Overall Study|Adverse Event|1|||
127570857|NCT02021656|459058534|FG000|Overall Study|Lack of Efficacy|2|||
127779367|NCT01205438|459819799|FG000|Overall Study|Sponsor Decision|0|||
127779368|NCT01205438|459819800|FG001|Overall Study|Sponsor Decision|1|||
127779369|NCT01205438|459819801|FG002|Overall Study|Sponsor Decision|1|||
127779370|NCT03631667|459819806|FG000|Overall Study|Withdrawal by Subject|3|||
127779371|NCT01186939|459819807|FG000|Overall Study|Death|7|||
127779372|NCT01186939|459819807|FG000|Overall Study|Withdrawal by Subject|2|||
127779373|NCT01186939|459819807|FG000|Overall Study|No longer receiving clinical benefit|17|||
127570858|NCT02021656|459058534|FG000|Overall Study|Lost to Follow-up|1|||
127570859|NCT02021656|459058534|FG000|Overall Study|Withdrew Consent|2|||
127570860|NCT00596362|459058535|FG000|Overall Study|Progressive Disease|1|||
127570861|NCT00282347|459058538|FG000|Treatment Period|Death|2|||
127570862|NCT00282347|459058539|FG001|Treatment Period|Death|0|||
127570863|NCT00282347|459058538|FG000|Treatment Period|Lost to Follow-up|2|||
127570864|NCT00282347|459058539|FG001|Treatment Period|Lost to Follow-up|5|||
127570865|NCT00282347|459058538|FG000|Treatment Period|Withdrawal by Subject|1|||
127570866|NCT00282347|459058539|FG001|Treatment Period|Withdrawal by Subject|3|||
127570867|NCT00282347|459058538|FG000|Treatment Period|Physician Decision|0|||
127570868|NCT00282347|459058539|FG001|Treatment Period|Physician Decision|1|||
127570869|NCT00282347|459058538|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
127570870|NCT00282347|459058539|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
127570871|NCT00282347|459058538|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
127570872|NCT00282347|459058539|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
127570873|NCT00282347|459058538|FG000|Safety Follow-up Period|Physician Decision|1|||
127570874|NCT00282347|459058539|FG001|Safety Follow-up Period|Physician Decision|1|||
127570875|NCT00282347|459058538|FG000|Safety Follow-up Period|Protocol Deviation|0|||
127570876|NCT00282347|459058539|FG001|Safety Follow-up Period|Protocol Deviation|2|||
127570877|NCT00282347|459058538|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
127570878|NCT00282347|459058539|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
127570879|NCT00282347|459058538|FG000|B Cell Follow-up Period|Physician Decision|1|||
127570880|NCT00282347|459058539|FG001|B Cell Follow-up Period|Physician Decision|0|||
127570881|NCT00282347|459058538|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
127570882|NCT00282347|459058539|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
127570883|NCT00356122|459058540|FG000|TREATMENT|Lack of Efficacy|26|||
127570884|NCT00356122|459058540|FG000|TREATMENT|Adverse Event|10|||
127570885|NCT00356122|459058540|FG000|TREATMENT|Subject's request|4|||
127570886|NCT00356122|459058540|FG000|TREATMENT|Other|4|||
127570887|NCT00356122|459058540|FG000|TREATMENT|Did not receive study medication|1|||
127570888|NCT00356122|459058540|FG000|FOLLOW-UP|Death|37|||
127570889|NCT00356122|459058540|FG000|FOLLOW-UP|Lost to Follow-up|2|||
127570890|NCT00356122|459058540|FG000|FOLLOW-UP|Other|2|||
127570891|NCT00491556|459058541|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
127570892|NCT00491556|459058542|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
127570893|NCT00491556|459058541|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
127570894|NCT00491556|459058542|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
127570895|NCT00491556|459058541|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
127570896|NCT00491556|459058542|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
127570897|NCT00491556|459058541|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
127570898|NCT00491556|459058542|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
127570899|NCT00491556|459058541|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
127570900|NCT00491556|459058542|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
127570901|NCT00491556|459058541|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
127570902|NCT00491556|459058542|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
127570903|NCT00491556|459058541|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
127570904|NCT00491556|459058542|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
127570905|NCT00491556|459058541|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
127570906|NCT00491556|459058542|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
127570907|NCT00491556|459058541|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
127570908|NCT00491556|459058542|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
127570909|NCT00491556|459058541|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
127570910|NCT00491556|459058542|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
128026954|NCT02057666|460722297|FG001|Open-Label Treatment Period|Poor tolerability|1|||
128026955|NCT02057666|460722296|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
128026956|NCT02057666|460722297|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
128026957|NCT02057666|460722296|FG000|Open-Label Treatment Period|Sponsor's request|0|||
128026958|NCT02057666|460722297|FG001|Open-Label Treatment Period|Sponsor's request|4|||
128026959|NCT01926509|460724149|FG000|Overall Study|vital sign met discontinuation criteria|1|||
128026960|NCT01926509|460724150|FG001|Overall Study|vital sign met discontinuation criteria|0|||
127570911|NCT00491556|459058541|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
127570912|NCT00491556|459058542|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
127570913|NCT00491556|459058541|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
127570914|NCT00491556|459058542|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
127570915|NCT00491556|459058541|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
127570916|NCT00491556|459058542|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
127570917|NCT00491556|459058541|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
127570918|NCT00491556|459058542|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
127570919|NCT00491556|459058541|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
127570920|NCT00491556|459058542|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
127779374|NCT01186939|459819807|FG000|Overall Study|Program closed|5|||
127779375|NCT01186939|459819807|FG000|Overall Study|Sponsor decision|4|||
127779376|NCT01186939|459819807|FG000|Overall Study|Started additional treatment|1|||
127779377|NCT01186939|459819807|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
127779378|NCT01186939|459819807|FG000|Overall Study|Myocardial infarction|1|||
127779379|NCT01186939|459819807|FG000|Overall Study|Bone marrow transplant|1|||
127779380|NCT01186939|459819807|FG000|Overall Study|Transformation to AML|1|||
127779381|NCT03083847|459819808|FG000|Main|Physician Decision|0|||
127779382|NCT03083847|459819809|FG001|Main|Physician Decision|0|||
127779383|NCT03083847|459819810|FG002|Main|Physician Decision|0|||
127779384|NCT03083847|459819811|FG003|Main|Physician Decision|0|||
128026961|NCT01926509|460724151|FG002|Overall Study|vital sign met discontinuation criteria|0|||
128026962|NCT01926509|460724152|FG003|Overall Study|vital sign met discontinuation criteria|0|||
128026963|NCT01882829|460724153|FG000|Overall Study|Adverse Event|4|||
128026964|NCT01882829|460724153|FG000|Overall Study|Protocol Violation|1|||
127570921|NCT00491556|459058541|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
127570922|NCT00491556|459058542|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
127570923|NCT00491556|459058541|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
127570924|NCT00491556|459058542|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
127570925|NCT00491556|459058541|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
127570926|NCT00491556|459058542|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
127570927|NCT00491556|459058541|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
127570928|NCT00491556|459058542|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
127570929|NCT00491556|459058541|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
127570930|NCT00491556|459058542|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
127570931|NCT04854642|459060199|FG000|Overall Study|Adverse Event|1|||
127570932|NCT04854642|459060200|FG001|Overall Study|Adverse Event|2|||
127570933|NCT04854642|459060199|FG000|Overall Study|Withdrawal by Subject|0|||
127570934|NCT04854642|459060200|FG001|Overall Study|Withdrawal by Subject|1|||
127570935|NCT00562627|459060201|FG000|Overall Study|Protocol Violation|1|||
127570936|NCT00562627|459060202|FG001|Overall Study|Protocol Violation|1|||
127570937|NCT00562627|459060203|FG002|Overall Study|Protocol Violation|1|||
127570938|NCT00625742|459060204|FG000|Overall Study|Disease Progression|2|||
127570939|NCT00625742|459060204|FG000|Overall Study|Withdrawal by Subject|1|||
127570940|NCT00625742|459060204|FG000|Overall Study|Adverse Event|4|||
127570941|NCT00625742|459060204|FG000|Overall Study|Lost to Follow-up|4|||
128026965|NCT01882829|460724153|FG000|Overall Study|Withdrawal by Subject|1|||
128026966|NCT02469961|460724155|FG000|Overall Study|Physician Decision|4|||
128026967|NCT02469961|460724156|FG001|Overall Study|Physician Decision|1|||
128026968|NCT06844812|460724159|FG000|Overall Study|Lost to Follow-up|5|||
128026969|NCT06844812|460724159|FG000|Overall Study|stigmatization concerns|2|||
128026970|NCT06844812|460724159|FG000|Overall Study|medication refusal|2|||
128026971|NCT06844812|460724159|FG000|Overall Study|concerns about possible side effects|2|||
128026972|NCT06844812|460724159|FG000|Overall Study|wanting to seek another specialist opinion|2|||
128026973|NCT06844812|460724159|FG000|Overall Study|side effects (dizziness)|1|||
128026974|NCT00368849|460724160|FG000|Overall Study|Withdrawal by Subject|0|||
128026975|NCT00368849|460724161|FG001|Overall Study|Withdrawal by Subject|1|||
128026976|NCT00368849|460724160|FG000|Overall Study|Physician Decision|0|||
128026977|NCT00368849|460724161|FG001|Overall Study|Physician Decision|1|||
128026978|NCT03635996|460724162|FG000|Overall Study|Study terminated by Sponsor|94|||
128026979|NCT03635996|460724162|FG000|Overall Study|Withdrawal by Subject|20|||
128026980|NCT03635996|460724162|FG000|Overall Study|Ablation|26|||
128026981|NCT03635996|460724162|FG000|Overall Study|Adverse Event|7|||
127570942|NCT00625742|459060204|FG000|Overall Study|Ineligible|1|||
127570943|NCT01709578|459060205|FG000|Overall Study|Rescued and entered in long term safety|63|||
127570944|NCT01709578|459060206|FG001|Overall Study|Rescued and entered in long term safety|25|||
127570945|NCT01709578|459060207|FG002|Overall Study|Rescued and entered in long term safety|26|||
127779385|NCT03083847|459819812|FG004|Main|Physician Decision|0|||
127779386|NCT03083847|459819813|FG005|Main|Physician Decision|1|||
127779387|NCT03083847|459819814|FG006|Main|Physician Decision|0|||
127779388|NCT03083847|459819815|FG007|Main|Physician Decision|0|||
127779389|NCT03083847|459819816|FG008|Main|Physician Decision|0|||
128026982|NCT03635996|460724162|FG000|Overall Study|Physician Decision|3|||
128026983|NCT03635996|460724162|FG000|Overall Study|Prohibited medication|5|||
128026984|NCT03635996|460724162|FG000|Overall Study|Did not meet eligibility criteria|5|||
127570946|NCT01709578|459060205|FG000|Overall Study|Adverse Event|9|||
127570947|NCT01709578|459060206|FG001|Overall Study|Adverse Event|18|||
127570948|NCT01709578|459060207|FG002|Overall Study|Adverse Event|17|||
127570949|NCT01709578|459060205|FG000|Overall Study|Lack of Efficacy|5|||
127570950|NCT01709578|459060206|FG001|Overall Study|Lack of Efficacy|4|||
127570951|NCT01709578|459060207|FG002|Overall Study|Lack of Efficacy|2|||
127779390|NCT03083847|459819817|FG009|Main|Physician Decision|0|||
127779391|NCT03083847|459819808|FG000|Main|Pregnancy|0|||
127779392|NCT03083847|459819809|FG001|Main|Pregnancy|0|||
127779393|NCT03083847|459819810|FG002|Main|Pregnancy|0|||
128026985|NCT03635996|460724162|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
127779394|NCT03083847|459819811|FG003|Main|Pregnancy|0|||
127779395|NCT03083847|459819812|FG004|Main|Pregnancy|0|||
127779396|NCT03083847|459819813|FG005|Main|Pregnancy|0|||
127779397|NCT03083847|459819814|FG006|Main|Pregnancy|0|||
127779398|NCT03083847|459819815|FG007|Main|Pregnancy|1|||
127779399|NCT03083847|459819816|FG008|Main|Pregnancy|0|||
127779400|NCT03083847|459819817|FG009|Main|Pregnancy|0|||
127779401|NCT03083847|459819808|FG000|Main|Adverse Event|0|||
127779402|NCT03083847|459819809|FG001|Main|Adverse Event|0|||
127779403|NCT03083847|459819810|FG002|Main|Adverse Event|0|||
127779404|NCT03083847|459819811|FG003|Main|Adverse Event|0|||
127779405|NCT03083847|459819812|FG004|Main|Adverse Event|0|||
127779406|NCT03083847|459819813|FG005|Main|Adverse Event|0|||
127570952|NCT01709578|459060205|FG000|Overall Study|Poor compliance to protocol|1|||
127570953|NCT01709578|459060206|FG001|Overall Study|Poor compliance to protocol|2|||
127570954|NCT01709578|459060207|FG002|Overall Study|Poor compliance to protocol|1|||
127570955|NCT01709578|459060205|FG000|Overall Study|Other, not related to safety or efficacy|2|||
127570956|NCT01709578|459060206|FG001|Overall Study|Other, not related to safety or efficacy|7|||
127570957|NCT01709578|459060207|FG002|Overall Study|Other, not related to safety or efficacy|5|||
127570958|NCT04050371|459060208|FG000|Overall Study|Withdrawal by Subject|1|||
127570959|NCT04050371|459060209|FG001|Overall Study|Withdrawal by Subject|0|||
127570960|NCT01107418|459060210|FG000|Overall Study|Disease Progression|45|||
127570961|NCT01107418|459060210|FG000|Overall Study|Adverse Event|3|||
127570962|NCT01107418|459060210|FG000|Overall Study|Withdrawal by Subject|1|||
127570963|NCT01107418|459060210|FG000|Overall Study|Study Closing|1|||
127570964|NCT01107418|459060210|FG000|Overall Study|Started Other Therapy|1|||
127570965|NCT01107418|459060210|FG000|Overall Study|Entered Extension Study|1|||
127570966|NCT00597701|459060211|FG000|Overall Study|Withdrawal by Subject|5|||
127570967|NCT00597701|459060212|FG001|Overall Study|Withdrawal by Subject|5|||
127570968|NCT00597701|459060211|FG000|Overall Study|Death|0|||
127570969|NCT00597701|459060212|FG001|Overall Study|Death|1|||
127570970|NCT00597701|459060211|FG000|Overall Study|Physician Decision|2|||
127779407|NCT03083847|459819814|FG006|Main|Adverse Event|0|||
127779408|NCT03083847|459819815|FG007|Main|Adverse Event|2|||
127779409|NCT03083847|459819816|FG008|Main|Adverse Event|0|||
127779410|NCT03083847|459819817|FG009|Main|Adverse Event|0|||
127779411|NCT03083847|459819808|FG000|Main|Withdrawal by Subject|0|||
127779412|NCT03083847|459819809|FG001|Main|Withdrawal by Subject|0|||
127779413|NCT03083847|459819810|FG002|Main|Withdrawal by Subject|0|||
127779414|NCT03083847|459819811|FG003|Main|Withdrawal by Subject|0|||
127779415|NCT03083847|459819812|FG004|Main|Withdrawal by Subject|0|||
127779416|NCT03083847|459819813|FG005|Main|Withdrawal by Subject|0|||
127779417|NCT03083847|459819814|FG006|Main|Withdrawal by Subject|1|||
127779418|NCT03083847|459819815|FG007|Main|Withdrawal by Subject|1|||
127779419|NCT03083847|459819816|FG008|Main|Withdrawal by Subject|0|||
127779420|NCT03083847|459819817|FG009|Main|Withdrawal by Subject|0|||
127779421|NCT00874770|459819824|FG000|Overall Study|Lack of Efficacy|2|||
127779422|NCT00874770|459819825|FG001|Overall Study|Lack of Efficacy|0|||
127779423|NCT00874770|459819826|FG002|Overall Study|Lack of Efficacy|0|||
127779424|NCT00874770|459819827|FG003|Overall Study|Lack of Efficacy|2|||
127779425|NCT00874770|459819824|FG000|Overall Study|Adverse Event|1|||
127779426|NCT00874770|459819825|FG001|Overall Study|Adverse Event|1|||
127779427|NCT00874770|459819826|FG002|Overall Study|Adverse Event|4|||
127779428|NCT00874770|459819827|FG003|Overall Study|Adverse Event|2|||
127779429|NCT00874770|459819824|FG000|Overall Study|Lost to Follow-up|1|||
127779430|NCT00874770|459819825|FG001|Overall Study|Lost to Follow-up|0|||
127779431|NCT00874770|459819826|FG002|Overall Study|Lost to Follow-up|0|||
127779432|NCT00874770|459819827|FG003|Overall Study|Lost to Follow-up|1|||
127779433|NCT00874770|459819824|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
127779434|NCT00874770|459819825|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
127779435|NCT00874770|459819826|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
127779436|NCT00874770|459819827|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
127779437|NCT05395104|459819828|FG000|Overall Study|Met Liver Stopping Criteria|1|||
127779438|NCT05395104|459819828|FG000|Overall Study|Withdrawal by Subject|1|||
127779439|NCT02613884|459819835|FG000|Overall Study|Death|1|||
127779440|NCT02613884|459819835|FG000|Overall Study|Lost to Follow-up|1|||
127779441|NCT01230554|459819836|FG000|Overall Study|Lost to Follow-up|2|||
127779442|NCT01230554|459819836|FG000|Overall Study|Inability to maintain visit schedule|1|||
127779443|NCT03933397|459819837|FG000|Overall Study|No emergency department visit|65|||
127570971|NCT00597701|459060212|FG001|Overall Study|Physician Decision|0|||
127570972|NCT00597701|459060211|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
127570973|NCT00597701|459060212|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
127570974|NCT00301821|459060219|FG000|Overall Study|Ineligible|25|||
127570975|NCT00301821|459060219|FG000|Overall Study|Cancel|1|||
127570976|NCT01314911|459060222|FG000|Overall Study|Lost to Follow-up|3|||
127570977|NCT01314911|459060223|FG001|Overall Study|Lost to Follow-up|2|||
127570978|NCT01314911|459060222|FG000|Overall Study|Withdrawal by Subject|1|||
127779444|NCT03933397|459819838|FG001|Overall Study|No emergency department visit|71|||
127779445|NCT03933397|459819837|FG000|Overall Study|Missed emergency department visit|25|||
128026986|NCT03635996|460724162|FG000|Overall Study|Protocol Violation|1|||
127570979|NCT01314911|459060223|FG001|Overall Study|Withdrawal by Subject|3|||
127570980|NCT01314911|459060222|FG000|Overall Study|Received Non-randomized Study Drug|0|||
127570981|NCT01314911|459060223|FG001|Overall Study|Received Non-randomized Study Drug|1|||
127570982|NCT01314911|459060222|FG000|Overall Study|Never Started Treatment|1|||
127570983|NCT01314911|459060223|FG001|Overall Study|Never Started Treatment|0|||
127570984|NCT04006119|459060231|FG000|Run in Cemiplimab Period|Lack of Efficacy|1|||
127570985|NCT04006119|459060231|FG000|End of Treatment Veledimex|Adverse Event|2|||
127570986|NCT04006119|459060231|FG000|Adjuvant Cemiplimab Period|Lack of Efficacy|28|||
127570987|NCT04006119|459060231|FG000|Adjuvant Cemiplimab Period|Adverse Event|3|||
127570988|NCT04006119|459060231|FG000|Adjuvant Cemiplimab Period|Withdrawal by Subject|4|||
127570989|NCT04006119|459060231|FG000|Adjuvant Cemiplimab Period|Sponsor Study Termination rollover to Compassionate Use|2|||
127570990|NCT04850313|459060232|FG000|Overall Study|Withdrawal by Subject|0|||
127570991|NCT04850313|459060233|FG001|Overall Study|Withdrawal by Subject|1|||
127570992|NCT01277042|459060234|FG000|Overall Study|Adverse Event|4|||
127779446|NCT03933397|459819838|FG001|Overall Study|Missed emergency department visit|30|||
127779447|NCT03933397|459819837|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
127779448|NCT03933397|459819838|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
127779449|NCT03933397|459819837|FG000|Overall Study|Withdrawal by Subject|1|||
127779450|NCT03933397|459819838|FG001|Overall Study|Withdrawal by Subject|0|||
127779451|NCT03933397|459819837|FG000|Overall Study|Physician Decision|1|||
127779452|NCT03933397|459819838|FG001|Overall Study|Physician Decision|1|||
127779453|NCT03933397|459819837|FG000|Overall Study|missing pain score|1|||
127779454|NCT03933397|459819838|FG001|Overall Study|missing pain score|1|||
127779455|NCT03933397|459819837|FG000|Overall Study|Confirmed COVID-19|1|||
127779456|NCT03933397|459819838|FG001|Overall Study|Confirmed COVID-19|2|||
127779457|NCT04029116|459819839|FG000|Overall Study|Adverse Event|0|||
127779458|NCT04029116|459819840|FG001|Overall Study|Adverse Event|2|||
127779459|NCT04029116|459819839|FG000|Overall Study|Lost to Follow-up|3|||
127779460|NCT04029116|459819840|FG001|Overall Study|Lost to Follow-up|5|||
127779461|NCT04029116|459819839|FG000|Overall Study|Physician Decision|2|||
127779462|NCT04029116|459819840|FG001|Overall Study|Physician Decision|0|||
127779463|NCT04029116|459819839|FG000|Overall Study|Pregnancy|1|||
127779464|NCT04029116|459819840|FG001|Overall Study|Pregnancy|2|||
127779465|NCT04029116|459819839|FG000|Overall Study|Withdrawal by Subject|4|||
127779466|NCT04029116|459819840|FG001|Overall Study|Withdrawal by Subject|6|||
127779467|NCT04029116|459819839|FG000|Overall Study|Other|2|||
127779468|NCT04029116|459819840|FG001|Overall Study|Other|1|||
127779469|NCT04513665|459819841|FG000|Overall Study|Adverse Event|2|||
127779470|NCT04513665|459819842|FG001|Overall Study|Adverse Event|0|||
127779471|NCT04513665|459819841|FG000|Overall Study|Lack of Efficacy|14|||
127779472|NCT04513665|459819842|FG001|Overall Study|Lack of Efficacy|0|||
127779473|NCT02608879|459819844|FG000|Overall Study|Lost to Follow-up|1|||
127779474|NCT02608879|459819845|FG001|Overall Study|Lost to Follow-up|0|||
127779475|NCT02608879|459819846|FG002|Overall Study|Lost to Follow-up|0|||
127779476|NCT02608879|459819844|FG000|Overall Study|Did not meet continuation criteria|0|||
127779477|NCT02608879|459819845|FG001|Overall Study|Did not meet continuation criteria|0|||
127779478|NCT02608879|459819846|FG002|Overall Study|Did not meet continuation criteria|3|||
127779479|NCT00760669|459819847|FG000|Overall Study|Not assessed for overall improvement|18|||
127779480|NCT00760669|459819847|FG000|Overall Study|Participants missing efficacy assessment|6|||
127779481|NCT00760669|459819847|FG000|Overall Study|Participants with overlapping cases|1|||
127779482|NCT00760669|459819847|FG000|Overall Study|Took drug before entering in contract|5|||
127779483|NCT01572675|459819848|FG000|Overall Study|End of prescribed treatment|140|||
127779484|NCT01572675|459819849|FG001|Overall Study|End of prescribed treatment|118|||
127779485|NCT01572675|459819848|FG000|Overall Study|Recovery|16|||
127779486|NCT01572675|459819849|FG001|Overall Study|Recovery|23|||
127779487|NCT01572675|459819848|FG000|Overall Study|Lack of Efficacy|31|||
127779488|NCT01572675|459819849|FG001|Overall Study|Lack of Efficacy|31|||
127779489|NCT01572675|459819848|FG000|Overall Study|Intolerance|6|||
127779490|NCT01572675|459819849|FG001|Overall Study|Intolerance|5|||
127779491|NCT01572675|459819848|FG000|Overall Study|Improved symptoms|8|||
127779492|NCT01572675|459819849|FG001|Overall Study|Improved symptoms|2|||
127779493|NCT01572675|459819848|FG000|Overall Study|Surgical intervention|3|||
127779494|NCT01572675|459819849|FG001|Overall Study|Surgical intervention|6|||
127570993|NCT01277042|459060235|FG001|Overall Study|Adverse Event|3|||
127570994|NCT01277042|459060234|FG000|Overall Study|Lost to Follow-up|2|||
127779495|NCT01572675|459819848|FG000|Overall Study|Withdrawal by Subject|5|||
127779496|NCT01572675|459819849|FG001|Overall Study|Withdrawal by Subject|1|||
127779497|NCT01572675|459819848|FG000|Overall Study|Physician Decision|2|||
127779498|NCT01572675|459819849|FG001|Overall Study|Physician Decision|2|||
127779499|NCT01572675|459819848|FG000|Overall Study|Death unrelated to coxibs|1|||
127779500|NCT01572675|459819849|FG001|Overall Study|Death unrelated to coxibs|1|||
127779501|NCT01572675|459819848|FG000|Overall Study|Other disease detected|1|||
127779502|NCT01572675|459819849|FG001|Overall Study|Other disease detected|1|||
127779503|NCT01572675|459819848|FG000|Overall Study|Unknown reason|1|||
127779504|NCT01572675|459819849|FG001|Overall Study|Unknown reason|1|||
127779505|NCT01572675|459819848|FG000|Overall Study|Rheumatologist new evaluation|0|||
127779506|NCT01572675|459819849|FG001|Overall Study|Rheumatologist new evaluation|1|||
127779507|NCT01572675|459819848|FG000|Overall Study|Missing data|1|||
127779508|NCT01572675|459819849|FG001|Overall Study|Missing data|4|||
127779509|NCT01572675|459819848|FG000|Overall Study|Lost to Follow-up|22|||
127779510|NCT01572675|459819849|FG001|Overall Study|Lost to Follow-up|27|||
127779511|NCT02003014|459819852|FG000|Overall Study|Case report forms uncollected|9|||
127779512|NCT02003014|459819852|FG000|Overall Study|Treatment started after contract period|1|||
127779513|NCT02003014|459819852|FG000|Overall Study|Patient did not visit the study site|5|||
127779514|NCT02003014|459819852|FG000|Overall Study|Investigator's transfer|4|||
127779515|NCT01660451|459819853|FG000|Overall Study|Protocol Violation|0|||
127779516|NCT01660451|459819854|FG001|Overall Study|Protocol Violation|1|||
127779517|NCT01660451|459819855|FG002|Overall Study|Protocol Violation|1|||
127779518|NCT01660451|459819853|FG000|Overall Study|AE not associated with clinical disease progression|13|||
127779519|NCT01660451|459819854|FG001|Overall Study|AE not associated with clinical disease progression|10|||
127779520|NCT01660451|459819855|FG002|Overall Study|AE not associated with clinical disease progression|40|||
127779521|NCT01660451|459819853|FG000|Overall Study|AE associated with clinical disease progression|1|||
127779522|NCT01660451|459819854|FG001|Overall Study|AE associated with clinical disease progression|3|||
127779523|NCT01660451|459819855|FG002|Overall Study|AE associated with clinical disease progression|11|||
127779524|NCT01660451|459819853|FG000|Overall Study|Sponsor Decision|0|||
127779525|NCT01660451|459819854|FG001|Overall Study|Sponsor Decision|0|||
127779526|NCT01660451|459819855|FG002|Overall Study|Sponsor Decision|1|||
127779527|NCT01660451|459819853|FG000|Overall Study|Protocol Deviation|0|||
127779528|NCT01660451|459819854|FG001|Overall Study|Protocol Deviation|0|||
127779529|NCT01660451|459819855|FG002|Overall Study|Protocol Deviation|1|||
127779530|NCT01660451|459819853|FG000|Overall Study|Physician Decision|1|||
127779531|NCT01660451|459819854|FG001|Overall Study|Physician Decision|2|||
127779532|NCT01660451|459819855|FG002|Overall Study|Physician Decision|5|||
127779533|NCT01660451|459819853|FG000|Overall Study|Withdrawal by Subject|1|||
127779534|NCT01660451|459819854|FG001|Overall Study|Withdrawal by Subject|1|||
127779535|NCT01660451|459819855|FG002|Overall Study|Withdrawal by Subject|20|||
127779536|NCT01660451|459819853|FG000|Overall Study|Trial closure.|0|||
127779537|NCT01660451|459819854|FG001|Overall Study|Trial closure.|0|||
127779538|NCT01660451|459819855|FG002|Overall Study|Trial closure.|1|||
127779539|NCT01660451|459819853|FG000|Overall Study|Switching to other therapy|0|||
127779540|NCT01660451|459819854|FG001|Overall Study|Switching to other therapy|1|||
127779541|NCT01660451|459819855|FG002|Overall Study|Switching to other therapy|1|||
127779542|NCT01660451|459819853|FG000|Overall Study|Progressive disease - clinical progression|4|||
127779543|NCT01660451|459819854|FG001|Overall Study|Progressive disease - clinical progression|10|||
127779544|NCT01660451|459819855|FG002|Overall Study|Progressive disease - clinical progression|9|||
127779545|NCT01660451|459819853|FG000|Overall Study|Progressive disease - radiological progression|12|||
127779546|NCT01660451|459819854|FG001|Overall Study|Progressive disease - radiological progression|23|||
127779547|NCT01660451|459819855|FG002|Overall Study|Progressive disease - radiological progression|50|||
127779548|NCT01660451|459819853|FG000|Overall Study|Death|1|||
127779549|NCT01660451|459819854|FG001|Overall Study|Death|0|||
127779550|NCT01660451|459819855|FG002|Overall Study|Death|1|||
127779551|NCT01660451|459819853|FG000|Overall Study|Other|0|||
127779552|NCT01660451|459819854|FG001|Overall Study|Other|0|||
127779553|NCT01660451|459819855|FG002|Overall Study|Other|1|||
127779554|NCT02281357|459819856|FG000|Overall Study|Adverse Event|2|||
127779555|NCT02281357|459819857|FG001|Overall Study|Adverse Event|1|||
127779556|NCT02281357|459819856|FG000|Overall Study|Lost to Follow-up|1|||
127779557|NCT02281357|459819857|FG001|Overall Study|Lost to Follow-up|0|||
127779558|NCT02281357|459819856|FG000|Overall Study|Withdrawal by Subject|4|||
127779559|NCT02281357|459819857|FG001|Overall Study|Withdrawal by Subject|3|||
127779560|NCT00482703|459819862|FG000|Overall Study|Poor compliance|1|||
127779561|NCT00482703|459819863|FG001|Overall Study|Poor compliance|0|||
127779562|NCT00972777|459819866|FG000|Overall Study|Adverse Event|3|||
127779563|NCT00972777|459819867|FG001|Overall Study|Adverse Event|2|||
127779564|NCT00972777|459819866|FG000|Overall Study|Lost to Follow-up|0|||
127779565|NCT00972777|459819867|FG001|Overall Study|Lost to Follow-up|4|||
127779566|NCT00972777|459819866|FG000|Overall Study|Withdrawal by Subject|4|||
127779567|NCT00972777|459819867|FG001|Overall Study|Withdrawal by Subject|5|||
127779568|NCT00972777|459819866|FG000|Overall Study|Physician Decision|4|||
127779569|NCT00972777|459819867|FG001|Overall Study|Physician Decision|0|||
127779570|NCT00972777|459819866|FG000|Overall Study|Protocol Violation|0|||
127779571|NCT00972777|459819867|FG001|Overall Study|Protocol Violation|2|||
127779572|NCT00972777|459819866|FG000|Overall Study|Screening Failure|2|||
127779573|NCT00972777|459819867|FG001|Overall Study|Screening Failure|1|||
127779574|NCT00972777|459819866|FG000|Overall Study|Missed visit|1|||
127779575|NCT00972777|459819867|FG001|Overall Study|Missed visit|0|||
127779576|NCT00729378|459821348|FG000|Baseline|Did not complete study measurements|72|||
127779577|NCT00729378|459821349|FG001|Baseline|Did not complete study measurements|33|||
127779578|NCT00729378|459821348|FG000|Baseline|Withdrawal by Subject|66|||
127779579|NCT00729378|459821349|FG001|Baseline|Withdrawal by Subject|59|||
127779580|NCT00729378|459821348|FG000|12-months|Lost to Follow-up|100|||
127779581|NCT00729378|459821349|FG001|12-months|Lost to Follow-up|65|||
127779582|NCT00729378|459821348|FG000|24-months|Lost to Follow-up|72|||
127779583|NCT00729378|459821349|FG001|24-months|Lost to Follow-up|51|||
127779584|NCT00729378|459821348|FG000|36-months|Lost to Follow-up|15|||
127779585|NCT00729378|459821349|FG001|36-months|Lost to Follow-up|6|||
127779586|NCT02246582|459821352|FG000|Overall Study|Withdrawal by Subject|3|||
127779587|NCT02246582|459821353|FG001|Overall Study|Withdrawal by Subject|4|||
127779588|NCT00523718|459821355|FG000|Overall Study|Withdrawal by Subject|1|||
127779589|NCT00523718|459821356|FG001|Overall Study|Withdrawal by Subject|0|||
127570995|NCT01277042|459060235|FG001|Overall Study|Lost to Follow-up|2|||
127570996|NCT01277042|459060234|FG000|Overall Study|Withdrawal by Subject|2|||
127570997|NCT01277042|459060235|FG001|Overall Study|Withdrawal by Subject|0|||
127690787|NCT04759833|459492364|FG000|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
127690788|NCT04759833|459492365|FG001|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
127690789|NCT04759833|459492366|FG002|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
127690790|NCT04759833|459492367|FG003|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|8|||
127690791|NCT04759833|459492368|FG004|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|5|||
127690792|NCT00818246|459492371|FG000|Overall Study|Impossible to match pictures|5|||
127690793|NCT01121991|459492372|FG000|Overall Study|Lack of Ovarian Response|2|||
127690794|NCT01121991|459492372|FG000|Overall Study|No Oocytes Retrieved|3|||
127690795|NCT01121991|459492372|FG000|Overall Study|No Fertilization|1|||
127690796|NCT00409838|459492373|FG000|Short-term Period|Adverse Event|0|||
127690797|NCT00409838|459492374|FG001|Short-term Period|Adverse Event|1|||
127690798|NCT00409838|459492373|FG000|Short-term Period|Lost to Follow-up|0|||
127690799|NCT00409838|459492374|FG001|Short-term Period|Lost to Follow-up|1|||
127690800|NCT00409838|459492373|FG000|Short-term Period|Withdrawal by Subject|2|||
127690801|NCT00409838|459492374|FG001|Short-term Period|Withdrawal by Subject|3|||
127690802|NCT00409838|459492373|FG000|Short-term Period|Never Treated|1|||
127690803|NCT00409838|459492374|FG001|Short-term Period|Never Treated|0|||
127690804|NCT00409838|459492373|FG000|Long-term Extension Period|Adverse Event|10|||
127690805|NCT00409838|459492374|FG001|Long-term Extension Period|Adverse Event|0|||
127690806|NCT00409838|459492373|FG000|Long-term Extension Period|Death|1|||
127690807|NCT00409838|459492374|FG001|Long-term Extension Period|Death|0|||
127690808|NCT00409838|459492373|FG000|Long-term Extension Period|Lack of Efficacy|2|||
127690809|NCT00409838|459492374|FG001|Long-term Extension Period|Lack of Efficacy|0|||
127690810|NCT00409838|459492373|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
127690811|NCT00409838|459492374|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
127690812|NCT00409838|459492373|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
127690813|NCT00409838|459492374|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
127690814|NCT00409838|459492373|FG000|Long-term Extension Period|Pregnancy|1|||
127690815|NCT00409838|459492374|FG001|Long-term Extension Period|Pregnancy|0|||
127690816|NCT01619410|459492375|FG000|Overall Study|Lost to Follow-up|7|||
127690817|NCT01619410|459492376|FG001|Overall Study|Lost to Follow-up|4|||
127690818|NCT01250769|459492377|FG000|Overall Study|Withdrawal by Subject|0|||
127690819|NCT01250769|459492378|FG001|Overall Study|Withdrawal by Subject|1|||
127690820|NCT01250769|459492379|FG002|Overall Study|Withdrawal by Subject|1|||
127690821|NCT01250769|459492380|FG003|Overall Study|Withdrawal by Subject|0|||
127690822|NCT01250769|459492377|FG000|Overall Study|Adverse Event|0|||
127690823|NCT01250769|459492378|FG001|Overall Study|Adverse Event|0|||
127779590|NCT00523718|459821355|FG000|Overall Study|Protocol Violation|2|||
127779591|NCT00523718|459821356|FG001|Overall Study|Protocol Violation|0|||
127690824|NCT01250769|459492379|FG002|Overall Study|Adverse Event|1|||
127690825|NCT01250769|459492380|FG003|Overall Study|Adverse Event|0|||
127690826|NCT02538341|459492383|FG000|Overall Study|Lost to Follow-up|51|||
127690827|NCT02538341|459492384|FG001|Overall Study|Lost to Follow-up|46|||
127690828|NCT02538341|459492383|FG000|Overall Study|Withdrawal by Subject|3|||
127690829|NCT02538341|459492384|FG001|Overall Study|Withdrawal by Subject|1|||
127690830|NCT02538341|459492383|FG000|Overall Study|Death|2|||
127690831|NCT02538341|459492384|FG001|Overall Study|Death|0|||
127690832|NCT04402294|459492385|FG000|Washout (at Least 7 Days)|Withdrawal by Subject|1|||
127690833|NCT04402294|459492386|FG001|Washout (at Least 7 Days)|Withdrawal by Subject|0|||
127690834|NCT04402294|459492385|FG000|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|0|||
127690835|NCT04402294|459492386|FG001|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|1|||
127690836|NCT03481660|459494820|FG000|Overall Study|Adverse Event|5|||
127690837|NCT03481660|459494821|FG001|Overall Study|Adverse Event|4|||
127690838|NCT03481660|459494820|FG000|Overall Study|Death|13|||
127690839|NCT03481660|459494821|FG001|Overall Study|Death|9|||
127690840|NCT03481660|459494820|FG000|Overall Study|Lost to Follow-up|2|||
127690841|NCT03481660|459494821|FG001|Overall Study|Lost to Follow-up|2|||
127690842|NCT03481660|459494820|FG000|Overall Study|Physician Decision|2|||
127690843|NCT03481660|459494821|FG001|Overall Study|Physician Decision|3|||
127690844|NCT03481660|459494820|FG000|Overall Study|Withdrawal by Subject|14|||
127690845|NCT03481660|459494821|FG001|Overall Study|Withdrawal by Subject|7|||
127690846|NCT04065048|459494822|FG000|Overall Study|Withdrawal by Subject|1|||
127690847|NCT04065048|459494823|FG001|Overall Study|Withdrawal by Subject|2|||
127690848|NCT04065048|459494824|FG002|Overall Study|Withdrawal by Subject|1|||
127690849|NCT04065048|459494825|FG003|Overall Study|Withdrawal by Subject|1|||
127690850|NCT04065048|459494822|FG000|Overall Study|Adverse Event|1|||
127690851|NCT04065048|459494823|FG001|Overall Study|Adverse Event|0|||
127690852|NCT04065048|459494824|FG002|Overall Study|Adverse Event|1|||
127690853|NCT04065048|459494825|FG003|Overall Study|Adverse Event|0|||
127690854|NCT05104697|459494827|FG000|Overall Study|Withdrawal by Subject|0|||
127690855|NCT05104697|459494828|FG001|Overall Study|Withdrawal by Subject|1|||
127690856|NCT03845465|459494829|FG000|Baseline Through Intervention|Withdrawal by Subject|4|||
127690857|NCT03845465|459494830|FG001|Baseline Through Intervention|Withdrawal by Subject|0|||
127690858|NCT03845465|459494829|FG000|6-month Data Collection|Withdrawal by Subject|0|||
127570998|NCT00588952|459060236|FG000|Overall Study|Adverse Event|0|||
127779592|NCT02060383|459821357|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
127779593|NCT02060383|459821358|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
127779594|NCT02060383|459821359|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
127779595|NCT02060383|459821360|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
127779596|NCT02060383|459821361|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
127779597|NCT02060383|459821357|FG000|Core Phase|Adverse Event|2|||
127779598|NCT02060383|459821358|FG001|Core Phase|Adverse Event|0|||
127779599|NCT02060383|459821359|FG002|Core Phase|Adverse Event|0|||
127779600|NCT02060383|459821360|FG003|Core Phase|Adverse Event|2|||
127779601|NCT02060383|459821361|FG004|Core Phase|Adverse Event|6|||
127779602|NCT02060383|459821357|FG000|Core Phase|Administrative problems|0|||
127779603|NCT02060383|459821358|FG001|Core Phase|Administrative problems|1|||
127779604|NCT02060383|459821359|FG002|Core Phase|Administrative problems|0|||
127779605|NCT02060383|459821360|FG003|Core Phase|Administrative problems|0|||
127779606|NCT02060383|459821361|FG004|Core Phase|Administrative problems|0|||
127779607|NCT02060383|459821357|FG000|Core Phase|Protocol Violation|0|||
127779608|NCT02060383|459821358|FG001|Core Phase|Protocol Violation|0|||
127779609|NCT02060383|459821359|FG002|Core Phase|Protocol Violation|0|||
127779610|NCT02060383|459821360|FG003|Core Phase|Protocol Violation|1|||
127779611|NCT02060383|459821361|FG004|Core Phase|Protocol Violation|0|||
127779612|NCT02060383|459821357|FG000|Core Phase|Withdrawal by Subject|0|||
127779613|NCT02060383|459821358|FG001|Core Phase|Withdrawal by Subject|0|||
127779614|NCT02060383|459821359|FG002|Core Phase|Withdrawal by Subject|0|||
127779615|NCT02060383|459821360|FG003|Core Phase|Withdrawal by Subject|4|||
127779616|NCT02060383|459821361|FG004|Core Phase|Withdrawal by Subject|2|||
127779617|NCT02060383|459821357|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
127779618|NCT02060383|459821358|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
127779619|NCT02060383|459821359|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
127779620|NCT02060383|459821360|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
127779621|NCT02060383|459821361|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
127779622|NCT02060383|459821357|FG000|Extension Phase|Adverse Event|1|||
127779623|NCT02060383|459821358|FG001|Extension Phase|Adverse Event|1|||
127779624|NCT02060383|459821359|FG002|Extension Phase|Adverse Event|2|||
127779625|NCT02060383|459821360|FG003|Extension Phase|Adverse Event|0|||
127779626|NCT02060383|459821361|FG004|Extension Phase|Adverse Event|1|||
127779627|NCT02060383|459821357|FG000|Extension Phase|Withdrawal by Subject|0|||
127779628|NCT02060383|459821358|FG001|Extension Phase|Withdrawal by Subject|1|||
127779629|NCT02060383|459821359|FG002|Extension Phase|Withdrawal by Subject|0|||
127779630|NCT02060383|459821360|FG003|Extension Phase|Withdrawal by Subject|0|||
127779631|NCT02060383|459821361|FG004|Extension Phase|Withdrawal by Subject|2|||
127779632|NCT02060383|459821357|FG000|Extension Phase|Administrative problems|1|||
127779633|NCT02060383|459821358|FG001|Extension Phase|Administrative problems|0|||
127779634|NCT02060383|459821359|FG002|Extension Phase|Administrative problems|0|||
127779635|NCT02060383|459821360|FG003|Extension Phase|Administrative problems|0|||
127779636|NCT02060383|459821361|FG004|Extension Phase|Administrative problems|0|||
127779637|NCT02060383|459821357|FG000|Extension Phase|Death|0|||
127779638|NCT02060383|459821358|FG001|Extension Phase|Death|0|||
127779639|NCT02060383|459821359|FG002|Extension Phase|Death|1|||
127779640|NCT02060383|459821360|FG003|Extension Phase|Death|0|||
127779641|NCT02060383|459821361|FG004|Extension Phase|Death|1|||
127779642|NCT02060383|459821357|FG000|Extension Phase|Protocol Violation|0|||
127779643|NCT02060383|459821358|FG001|Extension Phase|Protocol Violation|0|||
127779644|NCT02060383|459821359|FG002|Extension Phase|Protocol Violation|0|||
127779645|NCT02060383|459821360|FG003|Extension Phase|Protocol Violation|0|||
127779646|NCT02060383|459821361|FG004|Extension Phase|Protocol Violation|1|||
127779647|NCT03441334|459821362|FG000|Overall Study|Withdrawal by Subject|1|||
127779648|NCT03441334|459821363|FG001|Overall Study|Withdrawal by Subject|0|||
127779649|NCT00395863|459821365|FG000|Overall Study|Patients did not complete both exams|2|||
127779650|NCT00395863|459821366|FG001|Overall Study|Patients did not complete both exams|3|||
127779651|NCT02592551|459821369|FG000|Overall Study|Not evaluable|1|||
127779652|NCT02592551|459821370|FG001|Overall Study|Not evaluable|3|||
127779653|NCT02592551|459821371|FG002|Overall Study|Not evaluable|0|||
127779654|NCT01876251|459821372|FG000|Overall Study|Clinical progression|1|||
127779655|NCT01876251|459821373|FG001|Overall Study|Clinical progression|0|||
127779656|NCT01876251|459821374|FG002|Overall Study|Clinical progression|0|||
127779657|NCT01876251|459821372|FG000|Overall Study|Death|2|||
127779658|NCT01876251|459821373|FG001|Overall Study|Death|0|||
127779659|NCT01876251|459821374|FG002|Overall Study|Death|1|||
127779660|NCT01876251|459821372|FG000|Overall Study|Participant started new treatment|1|||
127779661|NCT01876251|459821373|FG001|Overall Study|Participant started new treatment|0|||
127779662|NCT01876251|459821374|FG002|Overall Study|Participant started new treatment|1|||
127779663|NCT01876251|459821372|FG000|Overall Study|Participant refused further follow-up|0|||
127779664|NCT01876251|459821373|FG001|Overall Study|Participant refused further follow-up|0|||
127779665|NCT01876251|459821374|FG002|Overall Study|Participant refused further follow-up|1|||
127779666|NCT01876251|459821372|FG000|Overall Study|Study terminated|1|||
127779667|NCT01876251|459821373|FG001|Overall Study|Study terminated|0|||
127779668|NCT01876251|459821374|FG002|Overall Study|Study terminated|0|||
128026987|NCT03635996|460724162|FG000|Overall Study|Lost to Follow-up|1|||
128026988|NCT05058456|460724163|FG000|Overall Study|Death|1|||
128026989|NCT05058456|460724163|FG000|Overall Study|End of Study data not yet due for release|34|||
128026990|NCT01428713|460724166|FG000|Overall Study|Non-compliance|2|||
128026991|NCT01428713|460724167|FG001|Overall Study|Non-compliance|2|||
128026992|NCT01428713|460724166|FG000|Overall Study|Withdrawal by Subject|1|||
128026993|NCT01428713|460724167|FG001|Overall Study|Withdrawal by Subject|1|||
128026994|NCT01428713|460724166|FG000|Overall Study|Adverse Event|0|||
128026995|NCT01428713|460724167|FG001|Overall Study|Adverse Event|2|||
128026996|NCT00862277|460724168|FG000|Overall Study|Protocol Violation|1|||
128026997|NCT00862277|460724169|FG001|Overall Study|Protocol Violation|2|||
128026998|NCT00862277|460724170|FG002|Overall Study|Protocol Violation|5|||
128026999|NCT01052428|460724171|FG000|Overall Study|Death|1|||
128027000|NCT01052428|460724172|FG001|Overall Study|Death|0|||
128027001|NCT01052428|460724171|FG000|Overall Study|Withdrawal by Subject|0|||
128027002|NCT01052428|460724172|FG001|Overall Study|Withdrawal by Subject|1|||
128027003|NCT00871000|460724173|FG000|Overall Study|Withdrawal by Subject|1|||
128027004|NCT00871000|460724174|FG001|Overall Study|Withdrawal by Subject|0|||
128027005|NCT04432298|460724177|FG000|Overall Study|Other than specified|1|||
128027006|NCT04432298|460724178|FG001|Overall Study|Other than specified|0|||
128027007|NCT04432298|460724177|FG000|Overall Study|Lost to Follow-up|0|||
128027008|NCT04432298|460724178|FG001|Overall Study|Lost to Follow-up|1|||
128027009|NCT04432298|460724177|FG000|Overall Study|Death|3|||
128027010|NCT04432298|460724178|FG001|Overall Study|Death|2|||
128027011|NCT04432298|460724177|FG000|Overall Study|Withdrawal by Subject|2|||
128027012|NCT04432298|460724178|FG001|Overall Study|Withdrawal by Subject|0|||
128027013|NCT02451007|460724179|FG000|Overall Study|Withdrawal by Subject|4|||
128027014|NCT02451007|460724179|FG000|Overall Study|Adverse Event|1|||
128027015|NCT02451007|460724179|FG000|Overall Study|Disease Progression|2|||
128027016|NCT01034657|460724181|FG000|Core Phase|Withdrawal by Subject|1|||
128027017|NCT01034657|460724182|FG001|Core Phase|Withdrawal by Subject|0|||
128027018|NCT01034657|460724183|FG002|Core Phase|Withdrawal by Subject|0|||
128027019|NCT01034657|460724181|FG000|Core Phase|Lack of Efficacy|2|||
128027020|NCT01034657|460724182|FG001|Core Phase|Lack of Efficacy|0|||
128027021|NCT01034657|460724183|FG002|Core Phase|Lack of Efficacy|0|||
128027022|NCT01034657|460724181|FG000|Core Phase|Abnormal laboratory value|1|||
128027023|NCT01034657|460724182|FG001|Core Phase|Abnormal laboratory value|0|||
128027024|NCT01034657|460724183|FG002|Core Phase|Abnormal laboratory value|0|||
128027025|NCT01034657|460724181|FG000|Core Phase|Adverse Event|8|||
128027026|NCT01034657|460724182|FG001|Core Phase|Adverse Event|0|||
128027027|NCT01034657|460724183|FG002|Core Phase|Adverse Event|0|||
128027028|NCT01034657|460724181|FG000|Core Phase|Protocol Violation|2|||
128027029|NCT01034657|460724182|FG001|Core Phase|Protocol Violation|0|||
128027030|NCT01034657|460724183|FG002|Core Phase|Protocol Violation|0|||
128027031|NCT01034657|460724181|FG000|Randomized Phase|Withdrawal by Subject|0|||
128027032|NCT01034657|460724182|FG001|Randomized Phase|Withdrawal by Subject|2|||
127570999|NCT00588952|459060237|FG001|Overall Study|Adverse Event|2|||
127690859|NCT03845465|459494830|FG001|6-month Data Collection|Withdrawal by Subject|2|||
127690860|NCT03845465|459494829|FG000|12-month Data Collection|Withdrawal by Subject|0|||
127690861|NCT03845465|459494830|FG001|12-month Data Collection|Withdrawal by Subject|2|||
127690862|NCT05307978|459494833|FG000|Overall Study|Lost to Follow-up|0|||
127690863|NCT05307978|459494834|FG001|Overall Study|Lost to Follow-up|1|||
127690864|NCT05307978|459494835|FG002|Overall Study|Lost to Follow-up|0|||
127690865|NCT05307978|459494836|FG003|Overall Study|Lost to Follow-up|4|||
127690866|NCT05307978|459494837|FG004|Overall Study|Lost to Follow-up|0|||
127690867|NCT05307978|459494838|FG005|Overall Study|Lost to Follow-up|0|||
127690868|NCT05307978|459494839|FG006|Overall Study|Lost to Follow-up|1|||
127690869|NCT05075408|459494840|FG000|Overall Study|Withdrawal by Subject|5|||
127690870|NCT05075408|459494841|FG001|Overall Study|Withdrawal by Subject|3|||
127690871|NCT05075408|459494842|FG002|Overall Study|Withdrawal by Subject|4|||
127690872|NCT05075408|459494840|FG000|Overall Study|Adverse Event|5|||
127690873|NCT05075408|459494841|FG001|Overall Study|Adverse Event|7|||
127690874|NCT05075408|459494842|FG002|Overall Study|Adverse Event|8|||
127690875|NCT05075408|459494840|FG000|Overall Study|Protocol Violation|0|||
127690876|NCT05075408|459494841|FG001|Overall Study|Protocol Violation|1|||
127690877|NCT05075408|459494842|FG002|Overall Study|Protocol Violation|0|||
127690878|NCT05075408|459494840|FG000|Overall Study|Lost to Follow-up|2|||
127690879|NCT05075408|459494841|FG001|Overall Study|Lost to Follow-up|1|||
127690880|NCT05075408|459494842|FG002|Overall Study|Lost to Follow-up|1|||
127690881|NCT05075408|459494840|FG000|Overall Study|Physician Decision|1|||
127690882|NCT05075408|459494841|FG001|Overall Study|Physician Decision|0|||
128027033|NCT01034657|460724183|FG002|Randomized Phase|Withdrawal by Subject|0|||
128027034|NCT01034657|460724181|FG000|Randomized Phase|Lack of Efficacy|5|||
128027035|NCT01034657|460724182|FG001|Randomized Phase|Lack of Efficacy|1|||
128027036|NCT01034657|460724183|FG002|Randomized Phase|Lack of Efficacy|0|||
128027037|NCT01034657|460724181|FG000|Randomized Phase|Abnormal laboratory value|0|||
128027038|NCT01034657|460724182|FG001|Randomized Phase|Abnormal laboratory value|1|||
128027039|NCT01034657|460724183|FG002|Randomized Phase|Abnormal laboratory value|0|||
128027040|NCT01034657|460724181|FG000|Randomized Phase|Adverse Event|0|||
127881050|NCT02575807|460186105|FG001|Overall Study|Withdrawal by Subject|0|||
128027041|NCT01034657|460724182|FG001|Randomized Phase|Adverse Event|2|||
128027042|NCT01034657|460724183|FG002|Randomized Phase|Adverse Event|1|||
128027043|NCT01791205|460724184|FG000|Phase II|Lack of Efficacy|6|||
128027044|NCT01791205|460724185|FG001|Phase II|Lack of Efficacy|0|||
128027045|NCT01791205|460724184|FG000|Phase II|Adverse Event|2|||
128027046|NCT01791205|460724185|FG001|Phase II|Adverse Event|0|||
128027047|NCT01791205|460724184|FG000|Phase II|Safety|1|||
128027048|NCT01791205|460724185|FG001|Phase II|Safety|0|||
128027049|NCT01791205|460724184|FG000|Phase II|Lost to Follow-up|1|||
127690883|NCT05075408|459494842|FG002|Overall Study|Physician Decision|0|||
127690884|NCT05075408|459494840|FG000|Overall Study|Other-unspecified|3|||
127690885|NCT05075408|459494841|FG001|Overall Study|Other-unspecified|2|||
127690886|NCT05075408|459494842|FG002|Overall Study|Other-unspecified|0|||
127690887|NCT02837510|459494843|FG000|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
127690888|NCT02837510|459494844|FG001|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
127690889|NCT02837510|459494843|FG000|Washout (2 Weeks)|Adverse Event|0|||
127690890|NCT02837510|459494844|FG001|Washout (2 Weeks)|Adverse Event|1|||
127690891|NCT02837510|459494843|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
127690892|NCT02837510|459494844|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
127690893|NCT02837510|459494843|FG000|2nd Pretreatment fMRI Session|Adverse Event|1|||
127690894|NCT02837510|459494844|FG001|2nd Pretreatment fMRI Session|Adverse Event|0|||
127690895|NCT02837510|459494843|FG000|2nd Pretreatment fMRI Session|Lost to Follow-up|0|||
127690896|NCT02837510|459494844|FG001|2nd Pretreatment fMRI Session|Lost to Follow-up|1|||
127690897|NCT02837510|459494843|FG000|Quit Attempt (6 Months)|Adverse Event|2|||
127690898|NCT02837510|459494844|FG001|Quit Attempt (6 Months)|Adverse Event|2|||
127690899|NCT05419505|459494845|FG000|Overall Study|Adverse Event|0|||
127690900|NCT05419505|459494846|FG001|Overall Study|Adverse Event|0|||
127690901|NCT05419505|459494847|FG002|Overall Study|Adverse Event|0|||
127690902|NCT05419505|459494848|FG003|Overall Study|Adverse Event|1|||
127690903|NCT05419505|459494849|FG004|Overall Study|Adverse Event|0|||
127690904|NCT05419505|459494850|FG005|Overall Study|Adverse Event|0|||
127690905|NCT05419505|459494851|FG006|Overall Study|Adverse Event|0|||
127690906|NCT05419505|459494852|FG007|Overall Study|Adverse Event|0|||
127690907|NCT05419505|459494845|FG000|Overall Study|Withdrawal by Subject|1|||
127690908|NCT05419505|459494846|FG001|Overall Study|Withdrawal by Subject|2|||
127690909|NCT05419505|459494847|FG002|Overall Study|Withdrawal by Subject|0|||
127690910|NCT05419505|459494848|FG003|Overall Study|Withdrawal by Subject|0|||
127690911|NCT05419505|459494849|FG004|Overall Study|Withdrawal by Subject|0|||
127690912|NCT05419505|459494850|FG005|Overall Study|Withdrawal by Subject|0|||
127690913|NCT05419505|459494851|FG006|Overall Study|Withdrawal by Subject|1|||
127690914|NCT05419505|459494852|FG007|Overall Study|Withdrawal by Subject|0|||
127690915|NCT05419505|459494845|FG000|Overall Study|Lost to Follow-up|2|||
127690916|NCT05419505|459494846|FG001|Overall Study|Lost to Follow-up|1|||
127690917|NCT05419505|459494847|FG002|Overall Study|Lost to Follow-up|0|||
127690918|NCT05419505|459494848|FG003|Overall Study|Lost to Follow-up|0|||
127690919|NCT05419505|459494849|FG004|Overall Study|Lost to Follow-up|1|||
127690920|NCT05419505|459494850|FG005|Overall Study|Lost to Follow-up|2|||
127690921|NCT05419505|459494851|FG006|Overall Study|Lost to Follow-up|0|||
127690922|NCT05419505|459494852|FG007|Overall Study|Lost to Follow-up|1|||
127690923|NCT03358875|459494855|FG000|Overall Study|Death|409|||
127690924|NCT03358875|459494856|FG001|Overall Study|Death|223|||
127690925|NCT03358875|459494855|FG000|Overall Study|Study Closed by Sponsor|66|||
127690926|NCT03358875|459494856|FG001|Overall Study|Study Closed by Sponsor|29|||
127690927|NCT03358875|459494855|FG000|Overall Study|Withdrawal by Subject|13|||
127690928|NCT03358875|459494856|FG001|Overall Study|Withdrawal by Subject|16|||
127690929|NCT03358875|459494855|FG000|Overall Study|Lost to Follow-up|13|||
127690930|NCT03358875|459494856|FG001|Overall Study|Lost to Follow-up|2|||
127690931|NCT03358875|459494855|FG000|Overall Study|Miscellaneous|33|||
127690932|NCT03358875|459494856|FG001|Overall Study|Miscellaneous|0|||
127690933|NCT03358875|459494855|FG000|Overall Study|Remained on Study|1|||
127690934|NCT03358875|459494856|FG001|Overall Study|Remained on Study|0|||
127690935|NCT06194214|459494861|FG000|Overall Study|Adverse Event|1|||
127690936|NCT03517553|459494871|FG000|Overall Study|Withdrawal by Subject|2|||
127690937|NCT03271151|459494872|FG000|Overall Study|Lost to Follow-up|1|||
127690938|NCT03271151|459494873|FG001|Overall Study|Lost to Follow-up|3|||
127690939|NCT03271151|459494872|FG000|Overall Study|Withdrawal by Subject|1|||
127690940|NCT03271151|459494873|FG001|Overall Study|Withdrawal by Subject|0|||
127690941|NCT04847999|459494874|FG000|Overall Study|Lost to Follow-up|0|||
127690942|NCT04847999|459494875|FG001|Overall Study|Lost to Follow-up|1|||
127690943|NCT02879448|459494876|FG000|Overall Study|Death|251|||
127690944|NCT02879448|459494877|FG001|Overall Study|Death|263|||
127690945|NCT02879448|459494876|FG000|Overall Study|Lost to Follow-up|23|||
127690946|NCT02879448|459494877|FG001|Overall Study|Lost to Follow-up|28|||
127690947|NCT02879448|459494876|FG000|Overall Study|Withdrawal by Subject|42|||
127690948|NCT02879448|459494877|FG001|Overall Study|Withdrawal by Subject|79|||
127690949|NCT02879448|459494876|FG000|Overall Study|Other Reasons|8|||
127690950|NCT02879448|459494877|FG001|Overall Study|Other Reasons|12|||
127690951|NCT05952076|459494878|FG000|Overall Study|Death|1|||
127690952|NCT05952076|459494879|FG001|Overall Study|Death|1|||
127690953|NCT05952076|459494878|FG000|Overall Study|Lost to Follow-up|0|||
127690954|NCT05952076|459494879|FG001|Overall Study|Lost to Follow-up|1|||
127690955|NCT01046136|459494880|FG000|Overall Study|Withdrawal by Subject|0|||
127690956|NCT01046136|459494881|FG001|Overall Study|Withdrawal by Subject|4|||
127690957|NCT01046136|459494880|FG000|Overall Study|Physician Decision|1|||
127690958|NCT01046136|459494881|FG001|Overall Study|Physician Decision|1|||
127690959|NCT01046136|459494880|FG000|Overall Study|Lost to Follow-up|3|||
127690960|NCT01046136|459494881|FG001|Overall Study|Lost to Follow-up|3|||
127690961|NCT00727909|459494882|FG000|Overall Study|Withdrawal by Subject|5|||
127690962|NCT00727909|459494883|FG001|Overall Study|Withdrawal by Subject|11|||
127690963|NCT00727909|459494884|FG002|Overall Study|Withdrawal by Subject|8|||
127690964|NCT00727909|459494885|FG003|Overall Study|Withdrawal by Subject|5|||
127690965|NCT00727909|459494882|FG000|Overall Study|Death|0|||
127690966|NCT00727909|459494883|FG001|Overall Study|Death|0|||
127690967|NCT00727909|459494884|FG002|Overall Study|Death|1|||
127690968|NCT00727909|459494885|FG003|Overall Study|Death|0|||
127690969|NCT03446157|459494886|FG000|Overall Study|Death|11|||
127690970|NCT03446157|459494887|FG001|Overall Study|Death|9|||
127690971|NCT03446157|459494886|FG000|Overall Study|Lost to Follow-up|0|||
127690972|NCT03446157|459494887|FG001|Overall Study|Lost to Follow-up|1|||
127690973|NCT03446157|459494886|FG000|Overall Study|Withdrawal by Subject|2|||
127690974|NCT03446157|459494887|FG001|Overall Study|Withdrawal by Subject|1|||
127690975|NCT00411151|459494888|FG000|Overall Study|Death|38|||
127690976|NCT00411151|459494888|FG000|Overall Study|Withdrawal by Subject|2|||
127690977|NCT00411151|459494888|FG000|Overall Study|Lost to Follow-up|2|||
127690978|NCT00411151|459494888|FG000|Overall Study|Protocol Violation|1|||
127690979|NCT00411151|459494888|FG000|Overall Study|Trial prematurely closed|4|||
127690980|NCT04110054|459494889|FG000|Overall Study|COVID-19 reason other than AE|0|||
127690981|NCT04110054|459494890|FG001|Overall Study|COVID-19 reason other than AE|0|||
127690982|NCT04110054|459494891|FG002|Overall Study|COVID-19 reason other than AE|2|||
127690983|NCT04110054|459494892|FG003|Overall Study|COVID-19 reason other than AE|0|||
127690984|NCT04110054|459494889|FG000|Overall Study|Withdrawal by Subject|0|||
127690985|NCT04110054|459494890|FG001|Overall Study|Withdrawal by Subject|3|||
127690986|NCT04110054|459494891|FG002|Overall Study|Withdrawal by Subject|2|||
127690987|NCT04110054|459494892|FG003|Overall Study|Withdrawal by Subject|0|||
127690988|NCT04110054|459494889|FG000|Overall Study|Adverse Event|1|||
127690989|NCT04110054|459494890|FG001|Overall Study|Adverse Event|1|||
127690990|NCT04110054|459494891|FG002|Overall Study|Adverse Event|4|||
127690991|NCT04110054|459494892|FG003|Overall Study|Adverse Event|3|||
127690992|NCT00093015|459494893|FG000|Overall Study|Withdrawal by Subject|194|||
127690993|NCT00093015|459494894|FG001|Overall Study|Withdrawal by Subject|171|||
127690994|NCT00093015|459494893|FG000|Overall Study|Lost to Follow-up|96|||
127690995|NCT00093015|459494894|FG001|Overall Study|Lost to Follow-up|108|||
127690996|NCT00093015|459494893|FG000|Overall Study|Death|375|||
127690997|NCT00093015|459494894|FG001|Overall Study|Death|385|||
127690998|NCT00632203|459494896|FG000|Overall Study|Did not start study treatment|1|||
127690999|NCT00632203|459494897|FG001|Overall Study|Did not start study treatment|0|||
127691000|NCT04287985|459494905|FG000|Overall Study|Adverse Event|1|||
127691001|NCT04287985|459494906|FG001|Overall Study|Adverse Event|0|||
127691002|NCT04287985|459494907|FG002|Overall Study|Adverse Event|0|||
127691003|NCT04287985|459494908|FG003|Overall Study|Adverse Event|0|||
127691004|NCT04287985|459494905|FG000|Overall Study|Protocol Violation|0|||
127691005|NCT04287985|459494906|FG001|Overall Study|Protocol Violation|1|||
127691006|NCT04287985|459494907|FG002|Overall Study|Protocol Violation|0|||
127691007|NCT04287985|459494908|FG003|Overall Study|Protocol Violation|0|||
127691008|NCT04287985|459494905|FG000|Overall Study|Physician Decision|0|||
127691009|NCT04287985|459494906|FG001|Overall Study|Physician Decision|0|||
127691010|NCT04287985|459494907|FG002|Overall Study|Physician Decision|0|||
127691011|NCT04287985|459494908|FG003|Overall Study|Physician Decision|1|||
127691012|NCT04287985|459494905|FG000|Overall Study|Withdrawal by Subject|2|||
127691013|NCT04287985|459494906|FG001|Overall Study|Withdrawal by Subject|1|||
127691014|NCT04287985|459494907|FG002|Overall Study|Withdrawal by Subject|1|||
127691015|NCT04287985|459494908|FG003|Overall Study|Withdrawal by Subject|2|||
127691016|NCT02638337|459494913|FG000|Overall Study|Adverse Event|6|||
127691017|NCT02638337|459494914|FG001|Overall Study|Adverse Event|10|||
127691018|NCT02638337|459494913|FG000|Overall Study|Protocol Violation|3|||
127691019|NCT02638337|459494914|FG001|Overall Study|Protocol Violation|0|||
127691020|NCT02638337|459494913|FG000|Overall Study|Withdrawal by Subject|13|||
127691021|NCT02638337|459494914|FG001|Overall Study|Withdrawal by Subject|16|||
127691022|NCT02638337|459494913|FG000|Overall Study|Lost to Follow-up|7|||
127691023|NCT02638337|459494914|FG001|Overall Study|Lost to Follow-up|7|||
127691024|NCT02638337|459494913|FG000|Overall Study|Other - Miscellaneous|4|||
127691025|NCT02638337|459494914|FG001|Overall Study|Other - Miscellaneous|3|||
127691026|NCT01340066|459494915|FG000|Placebo Run in Period|Screen Failures|27|||
127691027|NCT01340066|459494916|FG001|Placebo Run in Period|Screen Failures|0|||
127691028|NCT01340066|459494917|FG002|Placebo Run in Period|Screen Failures|0|||
128027050|NCT01791205|460724185|FG001|Phase II|Lost to Follow-up|0|||
128027051|NCT01791205|460724184|FG000|Phase II|Remission of disease|1|||
127691029|NCT01340066|459494915|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
127691030|NCT01340066|459494916|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
127691031|NCT01340066|459494917|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
127691032|NCT01340066|459494915|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
127691033|NCT01340066|459494916|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
127691034|NCT01340066|459494917|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
127691035|NCT01340066|459494915|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
127691036|NCT01340066|459494916|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
127691037|NCT01340066|459494917|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
127691038|NCT02789020|459494918|FG000|Overall Study|Withdrawal by Subject|6|||
127691039|NCT02789020|459494919|FG001|Overall Study|Withdrawal by Subject|5|||
127691040|NCT04238247|459494928|FG000|Phase 1: Baseline Intervention|Withdrawal by Subject|3|||
127691041|NCT04238247|459494929|FG001|Phase 1: Baseline Intervention|Withdrawal by Subject|19|||
127691042|NCT04238247|459494930|FG002|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
127691043|NCT04238247|459494931|FG003|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
127691044|NCT04238247|459494928|FG000|Phase 1: Baseline Intervention|Lost to Follow-up|11|||
127691045|NCT04238247|459494929|FG001|Phase 1: Baseline Intervention|Lost to Follow-up|49|||
127691046|NCT04238247|459494930|FG002|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
127691047|NCT04238247|459494931|FG003|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
127691048|NCT04238247|459494928|FG000|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
127691049|NCT04238247|459494929|FG001|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|1|||
127691050|NCT04238247|459494930|FG002|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
127691051|NCT04238247|459494931|FG003|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|2|||
127691052|NCT04238247|459494928|FG000|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|7|||
127691053|NCT04238247|459494929|FG001|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|11|||
127691054|NCT04238247|459494930|FG002|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|8|||
127691055|NCT04238247|459494931|FG003|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|4|||
127691056|NCT03092726|459494932|FG000|Overall Study|Adverse Event|3|||
127691057|NCT03092726|459494933|FG001|Overall Study|Adverse Event|10|||
127691058|NCT03092726|459494932|FG000|Overall Study|Lack of Efficacy|0|||
127691059|NCT03092726|459494933|FG001|Overall Study|Lack of Efficacy|1|||
127691060|NCT03092726|459494932|FG000|Overall Study|Lost to Follow-up|1|||
127691061|NCT03092726|459494933|FG001|Overall Study|Lost to Follow-up|0|||
127691062|NCT03092726|459494932|FG000|Overall Study|Withdrawal by Subject|5|||
127691063|NCT03092726|459494933|FG001|Overall Study|Withdrawal by Subject|3|||
127691064|NCT04950127|459494934|FG000|Part A (Day 1 to Week 24)|Adverse Event|4|||
127691065|NCT04950127|459494935|FG001|Part A (Day 1 to Week 24)|Adverse Event|2|||
127691066|NCT04950127|459494936|FG002|Part A (Day 1 to Week 24)|Adverse Event|0|||
127691067|NCT04950127|459494937|FG003|Part A (Day 1 to Week 24)|Adverse Event|0|||
127691068|NCT04950127|459494938|FG004|Part A (Day 1 to Week 24)|Adverse Event|0|||
127691069|NCT04950127|459494939|FG005|Part A (Day 1 to Week 24)|Adverse Event|0|||
127691070|NCT04950127|459494934|FG000|Part A (Day 1 to Week 24)|Physician Decision|3|||
127691071|NCT04950127|459494935|FG001|Part A (Day 1 to Week 24)|Physician Decision|2|||
127691072|NCT04950127|459494936|FG002|Part A (Day 1 to Week 24)|Physician Decision|0|||
127691073|NCT04950127|459494937|FG003|Part A (Day 1 to Week 24)|Physician Decision|0|||
127691074|NCT04950127|459494938|FG004|Part A (Day 1 to Week 24)|Physician Decision|0|||
127691075|NCT04950127|459494939|FG005|Part A (Day 1 to Week 24)|Physician Decision|0|||
127691076|NCT04950127|459494934|FG000|Part A (Day 1 to Week 24)|Withdrawal by Subject|9|||
127691077|NCT04950127|459494935|FG001|Part A (Day 1 to Week 24)|Withdrawal by Subject|7|||
127691078|NCT04950127|459494936|FG002|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
127691079|NCT04950127|459494937|FG003|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
127691080|NCT04950127|459494938|FG004|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
127691081|NCT04950127|459494939|FG005|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
127691082|NCT04950127|459494934|FG000|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
127691083|NCT04950127|459494935|FG001|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
127691084|NCT04950127|459494936|FG002|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
127691085|NCT04950127|459494937|FG003|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
127691086|NCT04950127|459494938|FG004|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
127691087|NCT04950127|459494939|FG005|Part B (Week 24 to Week 32)|Withdrawal by Subject|4|||
127691088|NCT04950127|459494934|FG000|Part B (Week 24 to Week 32)|Physician Decision|0|||
127691089|NCT04950127|459494935|FG001|Part B (Week 24 to Week 32)|Physician Decision|0|||
127691090|NCT04950127|459494936|FG002|Part B (Week 24 to Week 32)|Physician Decision|0|||
127691091|NCT04950127|459494937|FG003|Part B (Week 24 to Week 32)|Physician Decision|0|||
127691092|NCT04950127|459494938|FG004|Part B (Week 24 to Week 32)|Physician Decision|0|||
127691093|NCT04950127|459494939|FG005|Part B (Week 24 to Week 32)|Physician Decision|1|||
127691094|NCT03330795|459494940|FG000|Overall Study|Death|3|||
127691095|NCT03330795|459494940|FG000|Overall Study|No longer eligible to receive transplants or study interventions due to medical contraindication|1|||
128027052|NCT01791205|460724185|FG001|Phase II|Remission of disease|0|||
127691096|NCT05064735|459494941|FG000|Overall Study|Withdrawal by Subject|7|||
127691097|NCT05064735|459494942|FG001|Overall Study|Withdrawal by Subject|8|||
127691098|NCT05064735|459494941|FG000|Overall Study|Lost to Follow-up|7|||
127691099|NCT05064735|459494942|FG001|Overall Study|Lost to Follow-up|2|||
127691100|NCT05064735|459494941|FG000|Overall Study|Physician Decision|2|||
127691101|NCT05064735|459494942|FG001|Overall Study|Physician Decision|1|||
127691102|NCT05064735|459494941|FG000|Overall Study|Failing to Meet Randomization Requirements|2|||
127691103|NCT05064735|459494942|FG001|Overall Study|Failing to Meet Randomization Requirements|1|||
127691104|NCT05064735|459494941|FG000|Overall Study|Site Closure|7|||
127691105|NCT05064735|459494942|FG001|Overall Study|Site Closure|2|||
127691106|NCT03380390|459494943|FG000|Overall Study|Adverse Event|3|||
127691107|NCT02886286|459494944|FG000|Overall Study|pump motor stall|0|||
127691108|NCT02886286|459494945|FG001|Overall Study|pump motor stall|1|||
127691109|NCT02376790|459494946|FG000|Overall Study|Withdrawal by Subject|43|||
127691110|NCT02376790|459494947|FG001|Overall Study|Withdrawal by Subject|36|||
127691111|NCT02376790|459494948|FG002|Overall Study|Withdrawal by Subject|37|||
127691112|NCT02376790|459494946|FG000|Overall Study|Decision by Sponsor|2|||
127691113|NCT02376790|459494947|FG001|Overall Study|Decision by Sponsor|1|||
127691114|NCT02376790|459494948|FG002|Overall Study|Decision by Sponsor|4|||
127691115|NCT02376790|459494946|FG000|Overall Study|Lost to Follow-up|15|||
127691116|NCT02376790|459494947|FG001|Overall Study|Lost to Follow-up|10|||
127691117|NCT02376790|459494948|FG002|Overall Study|Lost to Follow-up|12|||
127691118|NCT03014453|459494949|FG000|Overall Study|Lost to Follow-up|12|||
127691119|NCT03014453|459494949|FG000|Overall Study|Discontinued GER|3|||
127691120|NCT03014453|459494949|FG000|Overall Study|Excluded|19|||
127691121|NCT03014453|459494949|FG000|Overall Study|Refused to take part in|37|||
127691122|NCT05450458|459494950|FG000|Overall Study|Lost to Follow-up|4|||
127691123|NCT02794480|459494951|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
127691124|NCT02794480|459494952|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
127691125|NCT02794480|459494953|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
127691126|NCT02794480|459494954|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
127691127|NCT02794480|459494951|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
127691128|NCT02794480|459494952|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
127691129|NCT02794480|459494953|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
127691130|NCT02794480|459494954|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
127691131|NCT02794480|459494951|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
127691132|NCT02794480|459494952|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
127691133|NCT02794480|459494953|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
127691134|NCT02794480|459494954|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
127691135|NCT02794480|459494951|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
127691136|NCT02794480|459494952|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
127691137|NCT02794480|459494953|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
127691138|NCT02794480|459494954|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
127691139|NCT02794480|459494951|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
127691140|NCT02794480|459494952|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
127691141|NCT02794480|459494953|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
127691142|NCT02794480|459494954|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
127691143|NCT00262301|459494955|FG000|Double-blind Phase|Lost to Follow-up|1|||
127691144|NCT00262301|459494956|FG001|Double-blind Phase|Lost to Follow-up|0|||
127691145|NCT00262301|459494957|FG002|Double-blind Phase|Lost to Follow-up|0|||
127691146|NCT00262301|459494955|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
127691147|NCT00262301|459494956|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
127691148|NCT00262301|459494957|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
127691149|NCT01017146|459494958|FG000|Overall Study|Adverse Event|11|||
127691150|NCT01017146|459494959|FG001|Overall Study|Adverse Event|1|||
127691151|NCT01017146|459494958|FG000|Overall Study|Lost to Follow-up|14|||
127691152|NCT01017146|459494959|FG001|Overall Study|Lost to Follow-up|14|||
127691153|NCT01017146|459494958|FG000|Overall Study|Noncompliance with Study Product|1|||
127691154|NCT01017146|459494959|FG001|Overall Study|Noncompliance with Study Product|1|||
127691155|NCT01017146|459494958|FG000|Overall Study|Withdrawal by Subject|32|||
127691156|NCT01017146|459494959|FG001|Overall Study|Withdrawal by Subject|16|||
127691157|NCT01017146|459494958|FG000|Overall Study|Relocation|0|||
127691158|NCT01017146|459494959|FG001|Overall Study|Relocation|4|||
127691159|NCT01017146|459494958|FG000|Overall Study|Pregnancy|2|||
127691160|NCT01017146|459494959|FG001|Overall Study|Pregnancy|1|||
127691161|NCT01017146|459494958|FG000|Overall Study|Protocol Violation|2|||
127691162|NCT01017146|459494959|FG001|Overall Study|Protocol Violation|0|||
127691163|NCT01017146|459494958|FG000|Overall Study|Took Excluded Medication|2|||
127691164|NCT01017146|459494959|FG001|Overall Study|Took Excluded Medication|0|||
127691165|NCT01017146|459494958|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
127691166|NCT01017146|459494959|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
127691167|NCT01017146|459494958|FG000|Overall Study|Change in Work Situation|1|||
127691168|NCT01017146|459494959|FG001|Overall Study|Change in Work Situation|0|||
127779669|NCT01876251|459821372|FG000|Overall Study|Objective progression or relapse|10|||
127779670|NCT01876251|459821373|FG001|Overall Study|Objective progression or relapse|3|||
127779671|NCT01876251|459821374|FG002|Overall Study|Objective progression or relapse|8|||
127779672|NCT00268437|459821375|FG000|Overall Study|Ineligible|1|||
127779673|NCT01628107|459821379|FG000|Overall Study|Withdrawal by Subject|17|||
127779674|NCT01628107|459821379|FG000|Overall Study|Lost to Follow-up|4|||
127779675|NCT01628107|459821379|FG000|Overall Study|Adverse Event|33|||
127779676|NCT01628107|459821379|FG000|Overall Study|Physician Decision|2|||
127779677|NCT01628107|459821379|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
127779678|NCT01628107|459821379|FG000|Overall Study|Non-compliant with Study Procedures|10|||
127779679|NCT01628107|459821379|FG000|Overall Study|Not Treated|8|||
127779680|NCT01628107|459821379|FG000|Overall Study|Sponsor Decision|11|||
127779681|NCT01628107|459821379|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
127779682|NCT01628107|459821379|FG000|Overall Study|Relocated|8|||
127779683|NCT01628107|459821379|FG000|Overall Study|Kidney Transplant|9|||
127779684|NCT01628107|459821379|FG000|Overall Study|Use of Standard of Care|9|||
127779685|NCT01086410|459821380|FG000|Overall Study|Adverse Event|1|||
127779686|NCT01086410|459821381|FG001|Overall Study|Adverse Event|0|||
127779687|NCT01086410|459821382|FG002|Overall Study|Adverse Event|0|||
127779688|NCT01086410|459821383|FG003|Overall Study|Adverse Event|2|||
127779689|NCT01086410|459821380|FG000|Overall Study|Lack of Efficacy|1|||
127779690|NCT01086410|459821381|FG001|Overall Study|Lack of Efficacy|1|||
127779691|NCT01086410|459821382|FG002|Overall Study|Lack of Efficacy|0|||
127779692|NCT01086410|459821383|FG003|Overall Study|Lack of Efficacy|0|||
127779693|NCT01086410|459821380|FG000|Overall Study|Protocol Violation|1|||
127779694|NCT01086410|459821381|FG001|Overall Study|Protocol Violation|1|||
127779695|NCT01086410|459821382|FG002|Overall Study|Protocol Violation|0|||
127779696|NCT01086410|459821383|FG003|Overall Study|Protocol Violation|0|||
127779697|NCT01086410|459821380|FG000|Overall Study|Lost to Follow-up|0|||
127779698|NCT01086410|459821381|FG001|Overall Study|Lost to Follow-up|0|||
127779699|NCT01086410|459821382|FG002|Overall Study|Lost to Follow-up|1|||
127779700|NCT01086410|459821383|FG003|Overall Study|Lost to Follow-up|0|||
127779701|NCT02953639|459821384|FG000|Overall Study|Adverse Event|2|||
127779702|NCT02953639|459821385|FG001|Overall Study|Adverse Event|0|||
127779703|NCT02953639|459821386|FG002|Overall Study|Adverse Event|1|||
127779704|NCT02953639|459821384|FG000|Overall Study|Lost to Follow-up|8|||
127779705|NCT02953639|459821385|FG001|Overall Study|Lost to Follow-up|4|||
127779706|NCT02953639|459821386|FG002|Overall Study|Lost to Follow-up|3|||
127779707|NCT02953639|459821384|FG000|Overall Study|Non-Compliance With Study Drug|0|||
127779708|NCT02953639|459821385|FG001|Overall Study|Non-Compliance With Study Drug|2|||
127779709|NCT02953639|459821386|FG002|Overall Study|Non-Compliance With Study Drug|1|||
127779710|NCT02953639|459821384|FG000|Overall Study|Multiple Reasons|1|||
127779711|NCT02953639|459821385|FG001|Overall Study|Multiple Reasons|0|||
127779712|NCT02953639|459821386|FG002|Overall Study|Multiple Reasons|1|||
127779713|NCT02953639|459821384|FG000|Overall Study|Physician Decision|1|||
127779714|NCT02953639|459821385|FG001|Overall Study|Physician Decision|0|||
127779715|NCT02953639|459821386|FG002|Overall Study|Physician Decision|0|||
127779716|NCT02953639|459821384|FG000|Overall Study|Withdrawal by Subject|7|||
127779717|NCT02953639|459821385|FG001|Overall Study|Withdrawal by Subject|8|||
127779718|NCT02953639|459821386|FG002|Overall Study|Withdrawal by Subject|10|||
127779719|NCT02953639|459821384|FG000|Overall Study|Completed or Discontinued information is missing|1|||
127779720|NCT02953639|459821385|FG001|Overall Study|Completed or Discontinued information is missing|0|||
127779721|NCT02953639|459821386|FG002|Overall Study|Completed or Discontinued information is missing|0|||
127779722|NCT04196803|459821388|FG000|Overall Study|Withdrawal by Subject|1|||
127779723|NCT04196803|459821389|FG001|Overall Study|Withdrawal by Subject|3|||
127779724|NCT04196803|459821388|FG000|Overall Study|Adverse Event|4|||
127779725|NCT04196803|459821389|FG001|Overall Study|Adverse Event|2|||
127779726|NCT04196803|459821388|FG000|Overall Study|Lost to Follow-up|0|||
127779727|NCT04196803|459821389|FG001|Overall Study|Lost to Follow-up|1|||
127779728|NCT01022996|459821390|FG000|Overall Study|Adverse Event|14|||
128027053|NCT01791205|460724184|FG000|Phase II|Physician's decision|1|||
128027054|NCT01791205|460724185|FG001|Phase II|Physician's decision|0|||
127779729|NCT01022996|459821390|FG000|Overall Study|Withdrawal by Subject|3|||
128027055|NCT02242903|460724186|FG000|Overall Study|Withdrawal by Subject|1|||
127779730|NCT01022996|459821390|FG000|Overall Study|Lost to Follow-up|1|||
127779731|NCT01022996|459821390|FG000|Overall Study|Administrative problems|6|||
127779732|NCT01022996|459821390|FG000|Overall Study|Disease Progression|32|||
128027056|NCT02242903|460724187|FG001|Overall Study|Withdrawal by Subject|0|||
128027057|NCT02242903|460724188|FG002|Overall Study|Withdrawal by Subject|0|||
127779733|NCT01022996|459821390|FG000|Overall Study|Protocol Violation|1|||
127779734|NCT01069120|459821393|FG000|Overall Study|Study prematurely terminated|27|||
127779735|NCT00884325|459821394|FG000|Overall Study|Lost to Follow-up|1|||
127779736|NCT00884325|459821395|FG001|Overall Study|Lost to Follow-up|2|||
127779737|NCT00884325|459821394|FG000|Overall Study|Lack of Efficacy|0|||
127779738|NCT00884325|459821395|FG001|Overall Study|Lack of Efficacy|1|||
127779739|NCT00884325|459821394|FG000|Overall Study|Withdrawal by Subject|1|||
128027058|NCT02242903|460724189|FG003|Overall Study|Withdrawal by Subject|0|||
128027059|NCT02242903|460724190|FG004|Overall Study|Withdrawal by Subject|0|||
127779740|NCT00884325|459821395|FG001|Overall Study|Withdrawal by Subject|1|||
127779741|NCT00884325|459821394|FG000|Overall Study|Not provided|1|||
127779742|NCT00884325|459821395|FG001|Overall Study|Not provided|0|||
127779743|NCT05097716|459821401|FG000|Period 1|Adverse Event|1|||
127779744|NCT05097716|459821401|FG000|Period 1|Close contact with highly-transmissible infection|1|||
127779745|NCT03945591|459821404|FG000|Overall Study|Participant not transplanted|1|||
127779746|NCT03945591|459821404|FG000|Overall Study|Change in treatment plan|3|||
127779747|NCT03945591|459821404|FG000|Overall Study|Adverse Event|1|||
127779748|NCT00058552|459821405|FG000|Overall Study|Died prior to receiving treatment|4|||
127779749|NCT00058552|459821406|FG001|Overall Study|Died prior to receiving treatment|2|||
127779750|NCT00058552|459821405|FG000|Overall Study|Disease progression|52|||
127779751|NCT00058552|459821406|FG001|Overall Study|Disease progression|44|||
127779752|NCT00058552|459821405|FG000|Overall Study|Adverse Event|4|||
127779753|NCT00058552|459821406|FG001|Overall Study|Adverse Event|2|||
127779754|NCT00058552|459821405|FG000|Overall Study|Withdrawal by Subject|3|||
127779755|NCT00058552|459821406|FG001|Overall Study|Withdrawal by Subject|5|||
127779756|NCT00058552|459821405|FG000|Overall Study|Physician Decision|2|||
127779757|NCT00058552|459821406|FG001|Overall Study|Physician Decision|5|||
127779758|NCT00058552|459821405|FG000|Overall Study|Clinical disease progression|0|||
127779759|NCT00058552|459821406|FG001|Overall Study|Clinical disease progression|4|||
127779760|NCT02319668|459821407|FG000|Overall Study|Other (Not specified)|0|||
127779761|NCT02319668|459821408|FG001|Overall Study|Other (Not specified)|2|||
127779762|NCT02316340|459821411|FG000|First Progression|Clinical progression|2|||
127779763|NCT02316340|459821412|FG001|First Progression|Clinical progression|1|||
127779764|NCT02316340|459821411|FG000|First Progression|Withdrawal by Subject|1|||
127779765|NCT02316340|459821412|FG001|First Progression|Withdrawal by Subject|0|||
127571000|NCT00588952|459060236|FG000|Overall Study|Withdrawal by Subject|3|||
127571001|NCT00588952|459060237|FG001|Overall Study|Withdrawal by Subject|5|||
127571002|NCT00959374|459060240|FG000|Overall Study|Withdrawal by Subject|2|||
127779766|NCT01986920|459821413|FG000|A- 101 25%|Withdrawal by Subject|1|||
127779767|NCT01986920|459821414|FG001|A- 101 25%|Withdrawal by Subject|0|||
127779768|NCT01986920|459821415|FG002|A- 101 25%|Withdrawal by Subject|0|||
127779769|NCT01986920|459821416|FG003|A- 101 25%|Withdrawal by Subject|0|||
127779770|NCT01986920|459821413|FG000|A-101 32.5%|Withdrawal by Subject|0|||
127779771|NCT01986920|459821414|FG001|A-101 32.5%|Withdrawal by Subject|1|||
127779772|NCT01986920|459821415|FG002|A-101 32.5%|Withdrawal by Subject|0|||
127779773|NCT01986920|459821416|FG003|A-101 32.5%|Withdrawal by Subject|0|||
127779774|NCT01986920|459821413|FG000|A-101 40%|Withdrawal by Subject|0|||
127779775|NCT01986920|459821414|FG001|A-101 40%|Withdrawal by Subject|0|||
127779776|NCT01986920|459821415|FG002|A-101 40%|Withdrawal by Subject|1|||
127779777|NCT01986920|459821416|FG003|A-101 40%|Withdrawal by Subject|0|||
127779778|NCT01986920|459821413|FG000|Placebo|Withdrawal by Subject|0|||
127779779|NCT01986920|459821414|FG001|Placebo|Withdrawal by Subject|0|||
127779780|NCT01986920|459821415|FG002|Placebo|Withdrawal by Subject|0|||
127779781|NCT01986920|459821416|FG003|Placebo|Withdrawal by Subject|1|||
127779782|NCT03781323|459821417|FG000|Overall Study|Withdrawal by Subject|1|||
127779783|NCT01338415|459821418|FG000|Core + Extension|Adverse Event|8|||
127779784|NCT01338415|459821419|FG001|Core + Extension|Adverse Event|6|||
127779785|NCT01338415|459821420|FG002|Core + Extension|Adverse Event|0|||
127779786|NCT01338415|459821418|FG000|Core + Extension|Withdrawal by Subject|1|||
127779787|NCT01338415|459821419|FG001|Core + Extension|Withdrawal by Subject|1|||
127779788|NCT01338415|459821420|FG002|Core + Extension|Withdrawal by Subject|0|||
127779789|NCT01338415|459821418|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
127779790|NCT01338415|459821419|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
127779791|NCT01338415|459821420|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
127779792|NCT01338415|459821418|FG000|Core + Extension|Other (administrative reason)|1|||
127779793|NCT01338415|459821419|FG001|Core + Extension|Other (administrative reason)|0|||
127779794|NCT01338415|459821420|FG002|Core + Extension|Other (administrative reason)|0|||
127779795|NCT01338415|459821418|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
127779796|NCT01338415|459821419|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
127571003|NCT00959374|459060240|FG000|Overall Study|Lost to Follow-up|14|||
127779797|NCT01338415|459821420|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
127779798|NCT01338415|459821418|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
127779799|NCT01338415|459821419|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
127779800|NCT01338415|459821420|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
127779801|NCT01338415|459821418|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
127571004|NCT00959374|459060240|FG000|Overall Study|Death|1|||
127779802|NCT01338415|459821419|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
127779803|NCT01338415|459821420|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
127779804|NCT01338415|459821418|FG000|Exceptional Use Treatment Period|Death|0|||
127779805|NCT01338415|459821419|FG001|Exceptional Use Treatment Period|Death|0|||
127571005|NCT00959374|459060240|FG000|Overall Study|Protocol Violation|1|||
127779806|NCT01338415|459821420|FG002|Exceptional Use Treatment Period|Death|1|||
127779807|NCT04880447|459821424|FG000|Overall Study|No vaccination information|1|||
127779808|NCT04880447|459821424|FG000|Overall Study|No adverse event information (missing information)|1|||
127691169|NCT00901901|459494963|FG000|Treatment Period|Adverse Event|120|||
127691170|NCT00901901|459494964|FG001|Treatment Period|Adverse Event|128|||
127691171|NCT00901901|459494963|FG000|Treatment Period|Withdrawal by Subject|26|||
127691172|NCT00901901|459494964|FG001|Treatment Period|Withdrawal by Subject|24|||
127691173|NCT00901901|459494963|FG000|Treatment Period|Physician Decision|2|||
127691174|NCT00901901|459494964|FG001|Treatment Period|Physician Decision|2|||
127691175|NCT00901901|459494963|FG000|Treatment Period|Lost to Follow-up|3|||
127691176|NCT00901901|459494964|FG001|Treatment Period|Lost to Follow-up|5|||
127691177|NCT00901901|459494963|FG000|Treatment Period|Noncompliance with study medication|4|||
127691178|NCT00901901|459494964|FG001|Treatment Period|Noncompliance with study medication|1|||
127691179|NCT00901901|459494963|FG000|Treatment Period|Missing|1|||
127691180|NCT00901901|459494964|FG001|Treatment Period|Missing|0|||
127691181|NCT00901901|459494963|FG000|Treatment Period|Never treated|0|||
127691182|NCT00901901|459494964|FG001|Treatment Period|Never treated|3|||
127691183|NCT00901901|459494963|FG000|Treatment Period|Protocol driven decision point|0|||
127691184|NCT00901901|459494964|FG001|Treatment Period|Protocol driven decision point|2|||
127691185|NCT00901901|459494963|FG000|Treatment Period|Study terminated by sponsor|2|||
127691186|NCT00901901|459494964|FG001|Treatment Period|Study terminated by sponsor|0|||
127691187|NCT00901901|459494963|FG000|Treatment Period|Protocol Violation|5|||
127691188|NCT00901901|459494964|FG001|Treatment Period|Protocol Violation|9|||
127691189|NCT00901901|459494963|FG000|Treatment Period|Switch to commercial drug|1|||
127691190|NCT00901901|459494964|FG001|Treatment Period|Switch to commercial drug|1|||
127691191|NCT00901901|459494963|FG000|Treatment Period|Transfer to treatment continuation study|5|||
127691192|NCT00901901|459494964|FG001|Treatment Period|Transfer to treatment continuation study|2|||
127691193|NCT00901901|459494963|FG000|Follow-up Period|Death|181|||
127691194|NCT00901901|459494964|FG001|Follow-up Period|Death|208|||
127691195|NCT00901901|459494963|FG000|Follow-up Period|Protocol driven decision point|47|||
127691196|NCT00901901|459494964|FG001|Follow-up Period|Protocol driven decision point|36|||
127691197|NCT00901901|459494963|FG000|Follow-up Period|Withdrawal by Subject|6|||
127691198|NCT00901901|459494964|FG001|Follow-up Period|Withdrawal by Subject|9|||
127691199|NCT00901901|459494963|FG000|Follow-up Period|Lost to Follow-up|12|||
127691200|NCT00901901|459494964|FG001|Follow-up Period|Lost to Follow-up|8|||
127691201|NCT00901901|459494963|FG000|Follow-up Period|Missing|94|||
127691202|NCT00901901|459494964|FG001|Follow-up Period|Missing|80|||
127691203|NCT05171777|459494967|FG000|Treatment Crossover Period|Adverse Event|9|||
127691204|NCT05171777|459494968|FG001|Treatment Crossover Period|Adverse Event|6|||
127691205|NCT05171777|459494969|FG002|Treatment Crossover Period|Adverse Event|0|||
127691206|NCT05171777|459494970|FG003|Treatment Crossover Period|Adverse Event|0|||
127691207|NCT05171777|459494967|FG000|Treatment Crossover Period|Death|5|||
127691208|NCT05171777|459494968|FG001|Treatment Crossover Period|Death|5|||
127691209|NCT05171777|459494969|FG002|Treatment Crossover Period|Death|0|||
127691210|NCT05171777|459494970|FG003|Treatment Crossover Period|Death|0|||
127691211|NCT05171777|459494967|FG000|Treatment Crossover Period|Disease Relapse|0|||
127691212|NCT05171777|459494968|FG001|Treatment Crossover Period|Disease Relapse|1|||
127691213|NCT05171777|459494969|FG002|Treatment Crossover Period|Disease Relapse|0|||
127691214|NCT05171777|459494970|FG003|Treatment Crossover Period|Disease Relapse|0|||
127691215|NCT05171777|459494967|FG000|Treatment Crossover Period|Reason not Specified|2|||
127691216|NCT05171777|459494968|FG001|Treatment Crossover Period|Reason not Specified|1|||
127691217|NCT05171777|459494969|FG002|Treatment Crossover Period|Reason not Specified|0|||
127691218|NCT05171777|459494970|FG003|Treatment Crossover Period|Reason not Specified|0|||
127691219|NCT05171777|459494967|FG000|Treatment Crossover Period|Physician Decision|0|||
127691220|NCT05171777|459494968|FG001|Treatment Crossover Period|Physician Decision|1|||
127691221|NCT05171777|459494969|FG002|Treatment Crossover Period|Physician Decision|0|||
127691222|NCT05171777|459494970|FG003|Treatment Crossover Period|Physician Decision|0|||
127691223|NCT05171777|459494967|FG000|Treatment Crossover Period|Progressive Disease|13|||
127691224|NCT05171777|459494968|FG001|Treatment Crossover Period|Progressive Disease|9|||
127691225|NCT05171777|459494969|FG002|Treatment Crossover Period|Progressive Disease|0|||
127691226|NCT05171777|459494970|FG003|Treatment Crossover Period|Progressive Disease|0|||
127691227|NCT05171777|459494967|FG000|Treatment Crossover Period|Protocol Violation|0|||
127691228|NCT05171777|459494968|FG001|Treatment Crossover Period|Protocol Violation|2|||
127691229|NCT05171777|459494969|FG002|Treatment Crossover Period|Protocol Violation|0|||
127779809|NCT04880447|459821424|FG000|Overall Study|Disease not covered in this study|35|||
127691230|NCT05171777|459494970|FG003|Treatment Crossover Period|Protocol Violation|0|||
127779810|NCT01970488|459821425|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
127691231|NCT05171777|459494967|FG000|Treatment Crossover Period|Symptomatic Deterioration|0|||
127691232|NCT05171777|459494968|FG001|Treatment Crossover Period|Symptomatic Deterioration|1|||
127691233|NCT05171777|459494969|FG002|Treatment Crossover Period|Symptomatic Deterioration|0|||
127691234|NCT05171777|459494970|FG003|Treatment Crossover Period|Symptomatic Deterioration|0|||
127691235|NCT05171777|459494967|FG000|Treatment Crossover Period|Withdrawal by Subject|4|||
127691236|NCT05171777|459494968|FG001|Treatment Crossover Period|Withdrawal by Subject|4|||
127779811|NCT01970488|459821426|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
127779812|NCT01970488|459821427|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
127779813|NCT01970488|459821428|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
127779814|NCT01970488|459821429|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
127779815|NCT01970488|459821425|FG000|Part 1: Through Week 16|Protocol Violation|1|||
127779816|NCT01970488|459821426|FG001|Part 1: Through Week 16|Protocol Violation|2|||
127779817|NCT01970488|459821427|FG002|Part 1: Through Week 16|Protocol Violation|0|||
127779818|NCT01970488|459821428|FG003|Part 1: Through Week 16|Protocol Violation|0|||
127779819|NCT01970488|459821429|FG004|Part 1: Through Week 16|Protocol Violation|0|||
127691237|NCT05171777|459494969|FG002|Treatment Crossover Period|Withdrawal by Subject|0|||
127691238|NCT05171777|459494970|FG003|Treatment Crossover Period|Withdrawal by Subject|0|||
127691239|NCT05171777|459494967|FG000|Treatment Crossover Period|Ongoing in the Crossover Period|3|||
127691240|NCT05171777|459494968|FG001|Treatment Crossover Period|Ongoing in the Crossover Period|6|||
127691241|NCT05171777|459494969|FG002|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
127691242|NCT05171777|459494970|FG003|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
127691243|NCT05171777|459494967|FG000|Treatment Continuation Period|Death|0|||
127691244|NCT05171777|459494968|FG001|Treatment Continuation Period|Death|0|||
127691245|NCT05171777|459494969|FG002|Treatment Continuation Period|Death|1|||
127691246|NCT05171777|459494970|FG003|Treatment Continuation Period|Death|6|||
127691247|NCT05171777|459494967|FG000|Treatment Continuation Period|Ongoing in Continuation Period|0|||
127691248|NCT05171777|459494968|FG001|Treatment Continuation Period|Ongoing in Continuation Period|0|||
127691249|NCT05171777|459494969|FG002|Treatment Continuation Period|Ongoing in Continuation Period|21|||
127691250|NCT05171777|459494970|FG003|Treatment Continuation Period|Ongoing in Continuation Period|79|||
127691251|NCT00632749|459494971|FG000|Overall Study|Progressive disease|3|||
127691252|NCT00632749|459494972|FG001|Overall Study|Progressive disease|2|||
127691253|NCT00632749|459494973|FG002|Overall Study|Progressive disease|2|||
127691254|NCT00632749|459494974|FG003|Overall Study|Progressive disease|2|||
127691255|NCT00632749|459494975|FG004|Overall Study|Progressive disease|4|||
127691256|NCT00632749|459494976|FG005|Overall Study|Progressive disease|4|||
127691257|NCT00632749|459494977|FG006|Overall Study|Progressive disease|3|||
127691258|NCT00632749|459494978|FG007|Overall Study|Progressive disease|2|||
127691259|NCT00632749|459494979|FG008|Overall Study|Progressive disease|3|||
127691260|NCT00632749|459494980|FG009|Overall Study|Progressive disease|2|||
127691261|NCT00632749|459494981|FG010|Overall Study|Progressive disease|4|||
127691262|NCT00632749|459494982|FG011|Overall Study|Progressive disease|3|||
127691263|NCT00632749|459494983|FG012|Overall Study|Progressive disease|2|||
127691264|NCT00632749|459494984|FG013|Overall Study|Progressive disease|4|||
127691265|NCT00632749|459494971|FG000|Overall Study|Other Adverse event|1|||
127691266|NCT00632749|459494972|FG001|Overall Study|Other Adverse event|1|||
127691267|NCT00632749|459494973|FG002|Overall Study|Other Adverse event|1|||
127691268|NCT00632749|459494974|FG003|Overall Study|Other Adverse event|1|||
127691269|NCT00632749|459494975|FG004|Overall Study|Other Adverse event|2|||
127691270|NCT00632749|459494976|FG005|Overall Study|Other Adverse event|4|||
127691271|NCT00632749|459494977|FG006|Overall Study|Other Adverse event|1|||
127691272|NCT00632749|459494978|FG007|Overall Study|Other Adverse event|2|||
127691273|NCT00632749|459494979|FG008|Overall Study|Other Adverse event|2|||
127691274|NCT00632749|459494980|FG009|Overall Study|Other Adverse event|0|||
127691275|NCT00632749|459494981|FG010|Overall Study|Other Adverse event|1|||
127691276|NCT00632749|459494982|FG011|Overall Study|Other Adverse event|0|||
127691277|NCT00632749|459494983|FG012|Overall Study|Other Adverse event|1|||
127691278|NCT00632749|459494984|FG013|Overall Study|Other Adverse event|0|||
127691279|NCT00632749|459494971|FG000|Overall Study|Refuse to continue medication|0|||
127691280|NCT00632749|459494972|FG001|Overall Study|Refuse to continue medication|0|||
127691281|NCT00632749|459494973|FG002|Overall Study|Refuse to continue medication|0|||
127691282|NCT00632749|459494974|FG003|Overall Study|Refuse to continue medication|1|||
127691283|NCT00632749|459494975|FG004|Overall Study|Refuse to continue medication|0|||
127691284|NCT00632749|459494976|FG005|Overall Study|Refuse to continue medication|0|||
127691285|NCT00632749|459494977|FG006|Overall Study|Refuse to continue medication|0|||
127691286|NCT00632749|459494978|FG007|Overall Study|Refuse to continue medication|0|||
127691287|NCT00632749|459494979|FG008|Overall Study|Refuse to continue medication|0|||
127691288|NCT00632749|459494980|FG009|Overall Study|Refuse to continue medication|1|||
127691289|NCT00632749|459494981|FG010|Overall Study|Refuse to continue medication|0|||
127691290|NCT00632749|459494982|FG011|Overall Study|Refuse to continue medication|0|||
127691291|NCT00632749|459494983|FG012|Overall Study|Refuse to continue medication|0|||
127691292|NCT00632749|459494984|FG013|Overall Study|Refuse to continue medication|0|||
127691293|NCT00632749|459494971|FG000|Overall Study|Reason other than those specified above|0|||
127691294|NCT00632749|459494972|FG001|Overall Study|Reason other than those specified above|2|||
127691295|NCT00632749|459494973|FG002|Overall Study|Reason other than those specified above|0|||
127691296|NCT00632749|459494974|FG003|Overall Study|Reason other than those specified above|0|||
127691297|NCT00632749|459494975|FG004|Overall Study|Reason other than those specified above|1|||
127691298|NCT00632749|459494976|FG005|Overall Study|Reason other than those specified above|0|||
127691299|NCT00632749|459494977|FG006|Overall Study|Reason other than those specified above|1|||
127779820|NCT01970488|459821425|FG000|Part 1: Through Week 16|Adverse Event|6|||
127779821|NCT01970488|459821426|FG001|Part 1: Through Week 16|Adverse Event|5|||
127779822|NCT01970488|459821427|FG002|Part 1: Through Week 16|Adverse Event|0|||
127779823|NCT01970488|459821428|FG003|Part 1: Through Week 16|Adverse Event|0|||
127779824|NCT01970488|459821429|FG004|Part 1: Through Week 16|Adverse Event|0|||
127779825|NCT01970488|459821425|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
127779826|NCT01970488|459821426|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
127779827|NCT01970488|459821427|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
127779828|NCT01970488|459821428|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
128027060|NCT02242903|460724191|FG005|Overall Study|Withdrawal by Subject|0|||
128027061|NCT02242903|460724192|FG006|Overall Study|Withdrawal by Subject|0|||
128027062|NCT02191397|460724195|FG000|Overall Study|Adverse Event|28|||
128027063|NCT02191397|460724196|FG001|Overall Study|Adverse Event|17|||
127779829|NCT01970488|459821429|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
127779830|NCT01970488|459821425|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
127779831|NCT01970488|459821426|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
127779832|NCT01970488|459821427|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
127779833|NCT01970488|459821428|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
127779834|NCT01970488|459821429|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
127779835|NCT01970488|459821425|FG000|Part 2: Post Week 16|Physician Decision|0|||
127779836|NCT01970488|459821426|FG001|Part 2: Post Week 16|Physician Decision|0|||
127779837|NCT01970488|459821427|FG002|Part 2: Post Week 16|Physician Decision|0|||
127779838|NCT01970488|459821428|FG003|Part 2: Post Week 16|Physician Decision|0|||
127779839|NCT01970488|459821429|FG004|Part 2: Post Week 16|Physician Decision|1|||
127779840|NCT01970488|459821425|FG000|Part 2: Post Week 16|Non-compliance|0|||
127779841|NCT01970488|459821426|FG001|Part 2: Post Week 16|Non-compliance|0|||
127779842|NCT01970488|459821427|FG002|Part 2: Post Week 16|Non-compliance|1|||
127779843|NCT01970488|459821428|FG003|Part 2: Post Week 16|Non-compliance|0|||
127779844|NCT01970488|459821429|FG004|Part 2: Post Week 16|Non-compliance|0|||
127779845|NCT01970488|459821425|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
127779846|NCT01970488|459821426|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
127779847|NCT01970488|459821427|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
127779848|NCT01970488|459821428|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
127779849|NCT01970488|459821429|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
127779850|NCT01970488|459821425|FG000|Part 2: Post Week 16|Adverse Event|0|||
127779851|NCT01970488|459821426|FG001|Part 2: Post Week 16|Adverse Event|0|||
127779852|NCT01970488|459821427|FG002|Part 2: Post Week 16|Adverse Event|5|||
127779853|NCT01970488|459821428|FG003|Part 2: Post Week 16|Adverse Event|1|||
127779854|NCT01970488|459821429|FG004|Part 2: Post Week 16|Adverse Event|1|||
127779855|NCT01970488|459821425|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
127779856|NCT01970488|459821426|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
127779857|NCT01970488|459821427|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
127779858|NCT01970488|459821428|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
127779859|NCT01970488|459821429|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
127779860|NCT01970488|459821425|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
127779861|NCT01970488|459821426|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
127779862|NCT01970488|459821427|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
127779863|NCT01970488|459821428|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
127779864|NCT01970488|459821429|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
127779865|NCT02486653|459821430|FG000|Overall Study|Withdrawal by Subject|1|||
127779866|NCT02486653|459821431|FG001|Overall Study|Withdrawal by Subject|3|||
127779867|NCT02486653|459821430|FG000|Overall Study|Protocol Violation|1|||
127779868|NCT02486653|459821431|FG001|Overall Study|Protocol Violation|0|||
127779869|NCT02486653|459821430|FG000|Overall Study|surgery cancelled|4|||
127779870|NCT02486653|459821431|FG001|Overall Study|surgery cancelled|1|||
127779871|NCT01177384|459821432|FG000|Overall Study|Adverse Event|6|||
127779872|NCT01177384|459821433|FG001|Overall Study|Adverse Event|4|||
127779873|NCT01177384|459821432|FG000|Overall Study|Lack of Efficacy|0|||
127779874|NCT01177384|459821433|FG001|Overall Study|Lack of Efficacy|1|||
127779875|NCT01177384|459821432|FG000|Overall Study|Lost to Follow-up|3|||
127779876|NCT01177384|459821433|FG001|Overall Study|Lost to Follow-up|4|||
127779877|NCT01177384|459821432|FG000|Overall Study|Physician Decision|0|||
127779878|NCT01177384|459821433|FG001|Overall Study|Physician Decision|3|||
127779879|NCT01177384|459821432|FG000|Overall Study|Protocol Violation|0|||
128027064|NCT02191397|460724195|FG000|Overall Study|Lack of Efficacy|10|||
127779880|NCT01177384|459821433|FG001|Overall Study|Protocol Violation|2|||
127779881|NCT01177384|459821432|FG000|Overall Study|Withdrawal by Subject|5|||
127779882|NCT01177384|459821433|FG001|Overall Study|Withdrawal by Subject|12|||
128027065|NCT02191397|460724196|FG001|Overall Study|Lack of Efficacy|5|||
128027066|NCT02191397|460724195|FG000|Overall Study|Protocol Violation|0|||
127779883|NCT01849497|459821434|FG000|Overall Study|Withdrawal by Subject|1|||
127779884|NCT01849497|459821435|FG001|Overall Study|Withdrawal by Subject|2|||
127779885|NCT01849497|459821434|FG000|Overall Study|Sponsor Decision|0|||
127779886|NCT01849497|459821435|FG001|Overall Study|Sponsor Decision|1|||
128027067|NCT02191397|460724196|FG001|Overall Study|Protocol Violation|3|||
127779887|NCT01849497|459821434|FG000|Overall Study|Lost to Follow-up|0|||
127779888|NCT01849497|459821435|FG001|Overall Study|Lost to Follow-up|1|||
127779889|NCT01514136|459821436|FG000|Test Period 1; Test A|Protocol Violation|1|||
127779890|NCT01514136|459821437|FG001|Test Period 1; Test A|Protocol Violation|0|||
127779891|NCT01514136|459821438|FG002|Test Period 1; Test A|Protocol Violation|0|||
127779892|NCT01514136|459821439|FG003|Test Period 1; Test A|Protocol Violation|0|||
127779893|NCT01514136|459821440|FG004|Test Period 1; Test A|Protocol Violation|0|||
127779894|NCT01514136|459821441|FG005|Test Period 1; Test A|Protocol Violation|0|||
127779895|NCT01514136|459821442|FG006|Test Period 1; Test A|Protocol Violation|0|||
127779896|NCT01514136|459821443|FG007|Test Period 1; Test A|Protocol Violation|0|||
128027068|NCT02191397|460724195|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
128027069|NCT02191397|460724196|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
128027070|NCT02191397|460724195|FG000|Overall Study|Lost to Follow-up|10|||
128027071|NCT02191397|460724196|FG001|Overall Study|Lost to Follow-up|11|||
128027072|NCT02191397|460724195|FG000|Overall Study|Physician Decision|8|||
128027073|NCT02191397|460724196|FG001|Overall Study|Physician Decision|3|||
128027074|NCT02191397|460724195|FG000|Overall Study|Withdrawal by Subject|22|||
128027075|NCT02191397|460724196|FG001|Overall Study|Withdrawal by Subject|27|||
127691300|NCT00632749|459494978|FG007|Overall Study|Reason other than those specified above|0|||
127691301|NCT00632749|459494979|FG008|Overall Study|Reason other than those specified above|0|||
127691302|NCT00632749|459494980|FG009|Overall Study|Reason other than those specified above|0|||
127691303|NCT00632749|459494981|FG010|Overall Study|Reason other than those specified above|2|||
127691304|NCT00632749|459494982|FG011|Overall Study|Reason other than those specified above|1|||
127691305|NCT00632749|459494983|FG012|Overall Study|Reason other than those specified above|0|||
127691306|NCT00632749|459494984|FG013|Overall Study|Reason other than those specified above|2|||
127691307|NCT01136876|459494985|FG000|Overall Study|Lost to Follow-up|0|||
127691308|NCT01136876|459494986|FG001|Overall Study|Lost to Follow-up|1|||
127691309|NCT01136876|459494985|FG000|Overall Study|Physician Decision|3|||
127691310|NCT01136876|459494986|FG001|Overall Study|Physician Decision|5|||
127691311|NCT01136876|459494985|FG000|Overall Study|Missing NGAL measurement|2|||
127691312|NCT01136876|459494986|FG001|Overall Study|Missing NGAL measurement|5|||
127691313|NCT04128319|459494989|FG000|Overall Study|Death|3|||
127691314|NCT00976937|459494992|FG000|Overall Study|Adverse Event|4|||
127691315|NCT00976937|459494993|FG001|Overall Study|Adverse Event|5|||
127691316|NCT00976937|459494992|FG000|Overall Study|Lost to Follow-up|2|||
127691317|NCT00976937|459494993|FG001|Overall Study|Lost to Follow-up|1|||
127691318|NCT00976937|459494992|FG000|Overall Study|Withdrawal by Subject|5|||
127691319|NCT00976937|459494993|FG001|Overall Study|Withdrawal by Subject|3|||
127691320|NCT00976937|459494992|FG000|Overall Study|Poor compliance to protocol|3|||
127691321|NCT00976937|459494993|FG001|Overall Study|Poor compliance to protocol|0|||
127691322|NCT00976937|459494992|FG000|Overall Study|Personal and Familial Reason|2|||
127691323|NCT00976937|459494993|FG001|Overall Study|Personal and Familial Reason|2|||
127691324|NCT01011946|459494994|FG000|Overall Study|Transferred to another hospital|2|||
127691325|NCT01011946|459494994|FG000|Overall Study|No pathological lab value|1|||
127691326|NCT03988842|459494995|FG000|Overall Study|Death|1|||
127691327|NCT01227265|459494997|FG000|Overall Study|Did Not Receive Treatment|1|||
127691328|NCT01227265|459494998|FG001|Overall Study|Did Not Receive Treatment|2|||
127691329|NCT01227265|459494999|FG002|Overall Study|Did Not Receive Treatment|0|||
127691330|NCT01227265|459494997|FG000|Overall Study|Administrative|1|||
127691331|NCT01227265|459494998|FG001|Overall Study|Administrative|0|||
127691332|NCT01227265|459494999|FG002|Overall Study|Administrative|2|||
127691333|NCT01227265|459494997|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
127691334|NCT01227265|459494998|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
127691335|NCT01227265|459494999|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
127691336|NCT01227265|459494997|FG000|Overall Study|Protocol Violation|2|||
127691337|NCT01227265|459494998|FG001|Overall Study|Protocol Violation|1|||
127691338|NCT01227265|459494999|FG002|Overall Study|Protocol Violation|0|||
127691339|NCT01227265|459494997|FG000|Overall Study|Withdrawal by Subject|7|||
127691340|NCT01227265|459494998|FG001|Overall Study|Withdrawal by Subject|7|||
127691341|NCT01227265|459494999|FG002|Overall Study|Withdrawal by Subject|3|||
127691342|NCT01227265|459494997|FG000|Overall Study|Lost to Follow-up|2|||
127691343|NCT01227265|459494998|FG001|Overall Study|Lost to Follow-up|0|||
127691344|NCT01227265|459494999|FG002|Overall Study|Lost to Follow-up|3|||
127691345|NCT01227265|459494997|FG000|Overall Study|Adverse Event|6|||
127691346|NCT01227265|459494998|FG001|Overall Study|Adverse Event|10|||
127691347|NCT01227265|459494999|FG002|Overall Study|Adverse Event|5|||
127691348|NCT05028582|459495000|FG000|Overall Study|Lost to Follow-up|11|||
127691349|NCT05028582|459495001|FG001|Overall Study|Lost to Follow-up|9|||
127691350|NCT05028582|459495000|FG000|Overall Study|Withdrawal by Subject|9|||
127691351|NCT05028582|459495001|FG001|Overall Study|Withdrawal by Subject|10|||
127691352|NCT05028582|459495000|FG000|Overall Study|Adverse Event|5|||
127691353|NCT05028582|459495001|FG001|Overall Study|Adverse Event|2|||
127691354|NCT05028582|459495000|FG000|Overall Study|Miscellaneous|3|||
127779897|NCT01514136|459821436|FG000|Test Period 1; Test A|Break from study holiday|2|||
127779898|NCT01514136|459821437|FG001|Test Period 1; Test A|Break from study holiday|0|||
128027076|NCT04629521|460724197|FG000|Overall Study|Death|1|||
127691355|NCT05028582|459495001|FG001|Overall Study|Miscellaneous|2|||
127691356|NCT05028582|459495000|FG000|Overall Study|Lack of Efficacy|3|||
127691357|NCT05028582|459495001|FG001|Overall Study|Lack of Efficacy|1|||
127691358|NCT05028582|459495000|FG000|Overall Study|Physician Decision|0|||
127691359|NCT05028582|459495001|FG001|Overall Study|Physician Decision|1|||
127691360|NCT00186992|459496498|FG000|Overall Study|Withdrawal by Subject|5|||
127691361|NCT00186992|459496498|FG000|Overall Study|Physician's discretion|13|||
127691362|NCT00186992|459496498|FG000|Overall Study|PI Discretion|4|||
127691363|NCT00186992|459496498|FG000|Overall Study|Ineligible|2|||
127691364|NCT00186992|459496498|FG000|Overall Study|Lost to Follow-up|2|||
127691365|NCT00186992|459496498|FG000|Overall Study|Still on Study|9|||
127691366|NCT03683069|459496499|FG000|Overall Study|see limitations|12|||
127691367|NCT03683069|459496500|FG001|Overall Study|see limitations|13|||
127691368|NCT03769168|459496501|FG000|Overall Study|Adverse Event|0|||
127691369|NCT03769168|459496502|FG001|Overall Study|Adverse Event|1|||
127691370|NCT03769168|459496501|FG000|Overall Study|Lack of Efficacy|2|||
127691371|NCT03769168|459496502|FG001|Overall Study|Lack of Efficacy|4|||
127691372|NCT03769168|459496501|FG000|Overall Study|Post study access to treatment|3|||
127691373|NCT03769168|459496502|FG001|Overall Study|Post study access to treatment|11|||
127691374|NCT03769168|459496501|FG000|Overall Study|Physician Decision|1|||
127691375|NCT03769168|459496502|FG001|Overall Study|Physician Decision|4|||
127691376|NCT03769168|459496501|FG000|Overall Study|Subject Decision|2|||
127691377|NCT03769168|459496502|FG001|Overall Study|Subject Decision|4|||
127691378|NCT03769168|459496501|FG000|Overall Study|Guardian decision|1|||
127691379|NCT03769168|459496502|FG001|Overall Study|Guardian decision|0|||
127691380|NCT04941287|459496503|FG000|Overall Study|Rapid decline before starting treatment|3|||
127691381|NCT04941287|459496504|FG001|Overall Study|Rapid decline before starting treatment|1|||
127691382|NCT03324984|459496509|FG000|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|1|||
127691383|NCT03324984|459496510|FG001|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|4|||
127691384|NCT03547908|459496511|FG000|Blinded Phase|Lost to Follow-up|3|||
127691385|NCT03547908|459496512|FG001|Blinded Phase|Lost to Follow-up|3|||
127691386|NCT03547908|459496513|FG002|Blinded Phase|Lost to Follow-up|0|||
127691387|NCT03547908|459496514|FG003|Blinded Phase|Lost to Follow-up|0|||
127691388|NCT03547908|459496511|FG000|Blinded Phase|Withdrew Consent|2|||
127691389|NCT03547908|459496512|FG001|Blinded Phase|Withdrew Consent|3|||
127691390|NCT03547908|459496513|FG002|Blinded Phase|Withdrew Consent|0|||
127691391|NCT03547908|459496514|FG003|Blinded Phase|Withdrew Consent|0|||
127691392|NCT03547908|459496511|FG000|Blinded Phase|Investigator's Discretion|2|||
127691393|NCT03547908|459496512|FG001|Blinded Phase|Investigator's Discretion|1|||
127691394|NCT03547908|459496513|FG002|Blinded Phase|Investigator's Discretion|0|||
127691395|NCT03547908|459496514|FG003|Blinded Phase|Investigator's Discretion|0|||
127691396|NCT03547908|459496511|FG000|Blinded Phase|Death|2|||
127691397|NCT03547908|459496512|FG001|Blinded Phase|Death|0|||
127691398|NCT03547908|459496513|FG002|Blinded Phase|Death|0|||
127691399|NCT03547908|459496514|FG003|Blinded Phase|Death|0|||
127691400|NCT03547908|459496511|FG000|Blinded Phase|Non-compliance With Study Drug|0|||
127691401|NCT03547908|459496512|FG001|Blinded Phase|Non-compliance With Study Drug|2|||
127691402|NCT03547908|459496513|FG002|Blinded Phase|Non-compliance With Study Drug|0|||
127691403|NCT03547908|459496514|FG003|Blinded Phase|Non-compliance With Study Drug|0|||
127691404|NCT03547908|459496511|FG000|Blinded Phase|Adverse Event|1|||
127691405|NCT03547908|459496512|FG001|Blinded Phase|Adverse Event|0|||
127691406|NCT03547908|459496513|FG002|Blinded Phase|Adverse Event|0|||
127691407|NCT03547908|459496514|FG003|Blinded Phase|Adverse Event|0|||
127691408|NCT03547908|459496511|FG000|Blinded Phase|Randomized But Never Treated|1|||
127691409|NCT03547908|459496512|FG001|Blinded Phase|Randomized But Never Treated|0|||
127691410|NCT03547908|459496513|FG002|Blinded Phase|Randomized But Never Treated|0|||
127691411|NCT03547908|459496514|FG003|Blinded Phase|Randomized But Never Treated|0|||
127691412|NCT03547908|459496511|FG000|Open-label Extension Phase|Lost to Follow-up|0|||
127691413|NCT03547908|459496512|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
127691414|NCT03547908|459496513|FG002|Open-label Extension Phase|Lost to Follow-up|3|||
127691415|NCT03547908|459496514|FG003|Open-label Extension Phase|Lost to Follow-up|1|||
127691416|NCT03547908|459496511|FG000|Open-label Extension Phase|Death|0|||
127691417|NCT03547908|459496512|FG001|Open-label Extension Phase|Death|0|||
127691418|NCT03547908|459496513|FG002|Open-label Extension Phase|Death|1|||
127691419|NCT03547908|459496514|FG003|Open-label Extension Phase|Death|0|||
127691420|NCT03416023|459496523|FG000|Overall Study|Exclusion criteria failure|1|||
127691421|NCT03416023|459496523|FG000|Overall Study|Withdrawal by Subject|6|||
127691422|NCT03416023|459496523|FG000|Overall Study|Explanted|7|||
127691423|NCT03416023|459496523|FG000|Overall Study|Physician Decision|1|||
127779899|NCT01514136|459821438|FG002|Test Period 1; Test A|Break from study holiday|0|||
127691424|NCT03416023|459496523|FG000|Overall Study|Lost to Follow-up|1|||
127691425|NCT03416023|459496523|FG000|Overall Study|Death|1|||
127691426|NCT02152137|459496525|FG000|Overall Study|Withdrawal by Subject|1|||
127691427|NCT02152137|459496525|FG000|Overall Study|Originally assigned to Arm B|3|||
127691428|NCT04878354|459496526|FG000|Overall Study|Adverse Event|4|||
127691429|NCT04878354|459496527|FG001|Overall Study|Adverse Event|13|||
127691430|NCT04878354|459496526|FG000|Overall Study|Withdrawal by Subject|14|||
127779900|NCT01514136|459821439|FG003|Test Period 1; Test A|Break from study holiday|0|||
127779901|NCT01514136|459821440|FG004|Test Period 1; Test A|Break from study holiday|0|||
127779902|NCT01514136|459821441|FG005|Test Period 1; Test A|Break from study holiday|0|||
127571006|NCT00959374|459060240|FG000|Overall Study|Implant Removed/Not Replaced|4|||
127571007|NCT00959374|459060240|FG000|Overall Study|Physician Decision|1|||
127571008|NCT03350984|459060241|FG000|Overall Study|Death|1|||
127571009|NCT03350984|459060242|FG001|Overall Study|Death|0|||
127571010|NCT03350984|459060241|FG000|Overall Study|Lost to Follow-up|5|||
127571011|NCT03350984|459060242|FG001|Overall Study|Lost to Follow-up|6|||
127571012|NCT03350984|459060241|FG000|Overall Study|Protocol Violation|1|||
127571013|NCT03350984|459060242|FG001|Overall Study|Protocol Violation|2|||
127571014|NCT03350984|459060241|FG000|Overall Study|Physician Decision|1|||
127571015|NCT03350984|459060242|FG001|Overall Study|Physician Decision|0|||
127571016|NCT00642473|459060243|FG000|Overall Study|Withdrawal by Subject|0|||
127571017|NCT00642473|459060244|FG001|Overall Study|Withdrawal by Subject|5|||
127571018|NCT00642473|459060243|FG000|Overall Study|Progression or death|2|||
127571019|NCT00642473|459060244|FG001|Overall Study|Progression or death|4|||
127571020|NCT00642473|459060243|FG000|Overall Study|Other|2|||
127571021|NCT00642473|459060244|FG001|Overall Study|Other|2|||
127571022|NCT02284178|459060245|FG000|Overall Study|Met exclusion criteria|49|||
127571023|NCT02284178|459060246|FG001|Overall Study|Met exclusion criteria|54|||
127571024|NCT01483690|459060250|FG000|Overall Study|Adverse Event|1|||
127571025|NCT01483690|459060251|FG001|Overall Study|Adverse Event|2|||
127571026|NCT01483690|459060250|FG000|Overall Study|clinical deterioration|1|||
127571027|NCT01483690|459060251|FG001|Overall Study|clinical deterioration|0|||
127571028|NCT01483690|459060250|FG000|Overall Study|Physician Decision|0|||
127571029|NCT01483690|459060251|FG001|Overall Study|Physician Decision|2|||
127571030|NCT01483690|459060250|FG000|Overall Study|exclusionary procedure|0|||
127571031|NCT01483690|459060251|FG001|Overall Study|exclusionary procedure|1|||
127571032|NCT04251156|459060261|FG000|Overall Study|Lost to Follow-up|1|||
127571033|NCT04251156|459060262|FG001|Overall Study|Lost to Follow-up|1|||
127571034|NCT04251156|459060261|FG000|Overall Study|Withdrawal by Subject|4|||
127571035|NCT04251156|459060262|FG001|Overall Study|Withdrawal by Subject|4|||
127571036|NCT01041495|459060263|FG000|Overall Study|Withdrawal by Subject|2|||
127571037|NCT01041495|459060264|FG001|Overall Study|Withdrawal by Subject|5|||
127571038|NCT01041495|459060263|FG000|Overall Study|Adverse Event|2|||
127571039|NCT01041495|459060264|FG001|Overall Study|Adverse Event|1|||
127571040|NCT01041495|459060263|FG000|Overall Study|Lost to Follow-up|0|||
127571041|NCT01041495|459060264|FG001|Overall Study|Lost to Follow-up|1|||
127571042|NCT01479985|459060268|FG000|Overall Study|Tablet malfunction, no data saved|1|||
127571043|NCT01479985|459060269|FG001|Overall Study|Tablet malfunction, no data saved|1|||
127571044|NCT01479985|459060268|FG000|Overall Study|No decisional conflict scale responses|0|||
127571045|NCT01479985|459060269|FG001|Overall Study|No decisional conflict scale responses|2|||
127571046|NCT01479985|459060268|FG000|Overall Study|No post-visit survey|5|||
127571047|NCT01479985|459060269|FG001|Overall Study|No post-visit survey|3|||
127571048|NCT05867342|459060270|FG000|Overall Study|Investigator Decision|3|||
127571049|NCT05867342|459060271|FG001|Overall Study|Investigator Decision|3|||
127571050|NCT00470184|459060272|FG000|Overall Study|Not Treated(became ineligible)|4|||
127571051|NCT00470184|459060272|FG000|Overall Study|Not treated (other)|1|||
127571052|NCT00470184|459060272|FG000|Overall Study|disease Progression|4|||
127571053|NCT00470184|459060272|FG000|Overall Study|Adverse Event|3|||
127691431|NCT04878354|459496527|FG001|Overall Study|Withdrawal by Subject|12|||
127691432|NCT04878354|459496526|FG000|Overall Study|Lost to Follow-up|4|||
127691433|NCT04878354|459496527|FG001|Overall Study|Lost to Follow-up|1|||
127691434|NCT04878354|459496526|FG000|Overall Study|Lack of Efficacy|1|||
127691435|NCT04878354|459496527|FG001|Overall Study|Lack of Efficacy|0|||
127691436|NCT04878354|459496526|FG000|Overall Study|Protocol Violation|0|||
127691437|NCT04878354|459496527|FG001|Overall Study|Protocol Violation|1|||
127691438|NCT04878354|459496526|FG000|Overall Study|"Reason stated as other in CRF"|2|||
127691439|NCT04878354|459496527|FG001|Overall Study|"Reason stated as other in CRF"|3|||
127779903|NCT01514136|459821442|FG006|Test Period 1; Test A|Break from study holiday|0|||
127571054|NCT00470184|459060272|FG000|Overall Study|Withdrawal by Subject|4|||
127571055|NCT00470184|459060272|FG000|Overall Study|other|5|||
127571056|NCT00470184|459060272|FG000|Overall Study|recurrence|1|||
127571057|NCT02483533|459060274|FG000|Overall Study|Lack of Efficacy|50|||
127571058|NCT02483533|459060275|FG001|Overall Study|Lack of Efficacy|50|||
127571059|NCT03452527|459060276|FG000|Overall Study|Withdrawal by Subject|1|||
127571060|NCT03452527|459060277|FG001|Overall Study|Withdrawal by Subject|1|||
127571061|NCT03452527|459060276|FG000|Overall Study|Study Terminated|2|||
127571062|NCT03452527|459060277|FG001|Overall Study|Study Terminated|3|||
127571063|NCT00174291|459060289|FG000|Overall Study|Lost to Follow-up|1|||
127571064|NCT00174291|459060290|FG001|Overall Study|Lost to Follow-up|1|||
127571065|NCT00174291|459060289|FG000|Overall Study|Protocol Violation|0|||
127571066|NCT00174291|459060290|FG001|Overall Study|Protocol Violation|2|||
127571067|NCT00174291|459060289|FG000|Overall Study|Study terminated by sponsor|1|||
127779904|NCT01514136|459821443|FG007|Test Period 1; Test A|Break from study holiday|0|||
127571068|NCT00174291|459060290|FG001|Overall Study|Study terminated by sponsor|0|||
127571069|NCT00174291|459060289|FG000|Overall Study|Withdrawal by Subject|3|||
127571070|NCT00174291|459060290|FG001|Overall Study|Withdrawal by Subject|3|||
127571071|NCT03116347|459060293|FG000|Overall Study|Withdrawal by Subject|1|||
127571072|NCT03116347|459060294|FG001|Overall Study|Withdrawal by Subject|2|||
127571073|NCT00476047|459060295|FG000|Overall Study|Lost to Follow-up|1|||
127571074|NCT03170232|459060296|FG000|Overall Study|Adverse Event|0|||
127571075|NCT03170232|459060297|FG001|Overall Study|Adverse Event|1|||
127571076|NCT03170232|459060296|FG000|Overall Study|Protocol Violation|0|||
127571077|NCT03170232|459060297|FG001|Overall Study|Protocol Violation|1|||
127571078|NCT03170232|459060296|FG000|Overall Study|Lack of Efficacy|0|||
127571079|NCT03170232|459060297|FG001|Overall Study|Lack of Efficacy|1|||
127571080|NCT03170232|459060296|FG000|Overall Study|Study closed/terminated|26|||
127571081|NCT03170232|459060297|FG001|Overall Study|Study closed/terminated|23|||
127571082|NCT03170232|459060296|FG000|Overall Study|Lost to Follow-up|1|||
127571083|NCT03170232|459060297|FG001|Overall Study|Lost to Follow-up|0|||
127571084|NCT03170232|459060296|FG000|Overall Study|Withdrawal by Subject|0|||
127571085|NCT03170232|459060297|FG001|Overall Study|Withdrawal by Subject|1|||
127571086|NCT00586326|459060298|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
127571087|NCT00586326|459060298|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
127571088|NCT00586326|459060298|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
127571089|NCT00586326|459060298|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
127571090|NCT00586326|459060298|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
127571091|NCT00586326|459060298|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
127571092|NCT00586326|459060298|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
127571093|NCT00586326|459060298|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
127571094|NCT00586326|459060298|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
127571095|NCT00586326|459060298|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
127571096|NCT00586326|459060298|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
127571097|NCT00586326|459060298|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
127571098|NCT00586326|459060298|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
127571099|NCT00586326|459060298|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
127571100|NCT00586326|459060298|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
127571101|NCT00586326|459060298|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
127571102|NCT00586326|459060298|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
127571103|NCT01439347|459060299|FG000|Overall Study|Death|10|||
127571104|NCT01439347|459060300|FG001|Overall Study|Death|9|||
127571105|NCT01439347|459060299|FG000|Overall Study|Withdrawal by Subject|0|||
127691440|NCT05510232|459496528|FG000|Overall Study|Withdrawal by Subject|2|||
127691441|NCT05510232|459496529|FG001|Overall Study|Withdrawal by Subject|7|||
127691442|NCT05510232|459496530|FG002|Overall Study|Withdrawal by Subject|6|||
127691443|NCT01631214|459496531|FG000|Overall Study|Withdrawal by Subject|276|||
127691444|NCT01631214|459496532|FG001|Overall Study|Withdrawal by Subject|290|||
127691445|NCT01631214|459496531|FG000|Overall Study|Death|113|||
127691446|NCT01631214|459496532|FG001|Overall Study|Death|106|||
127691447|NCT01631214|459496531|FG000|Overall Study|Lost to Follow-up|54|||
127691448|NCT01631214|459496532|FG001|Overall Study|Lost to Follow-up|40|||
127691449|NCT01631214|459496531|FG000|Overall Study|Adverse Event|45|||
127691450|NCT01631214|459496532|FG001|Overall Study|Adverse Event|45|||
127691451|NCT01631214|459496531|FG000|Overall Study|Other|22|||
127691452|NCT01631214|459496532|FG001|Overall Study|Other|19|||
127691453|NCT01631214|459496531|FG000|Overall Study|Noncompliance|16|||
127691454|NCT01631214|459496532|FG001|Overall Study|Noncompliance|15|||
127691455|NCT01631214|459496531|FG000|Overall Study|Requirement for Alternative Therapy|8|||
127691456|NCT01631214|459496532|FG001|Overall Study|Requirement for Alternative Therapy|3|||
127691457|NCT01631214|459496531|FG000|Overall Study|Protocol Deviation|4|||
127691458|NCT01631214|459496532|FG001|Overall Study|Protocol Deviation|3|||
127691459|NCT01631214|459496531|FG000|Overall Study|Ineligibility determined|5|||
127691460|NCT01631214|459496532|FG001|Overall Study|Ineligibility determined|2|||
127691461|NCT01631214|459496531|FG000|Overall Study|Administrative Decision|1|||
127691462|NCT01631214|459496532|FG001|Overall Study|Administrative Decision|0|||
127571106|NCT01439347|459060300|FG001|Overall Study|Withdrawal by Subject|1|||
127571107|NCT01439347|459060299|FG000|Overall Study|Physician Decision|1|||
127571108|NCT01439347|459060300|FG001|Overall Study|Physician Decision|0|||
127571109|NCT01439347|459060299|FG000|Overall Study|Sponsor Terminated Study|2|||
127571110|NCT01439347|459060300|FG001|Overall Study|Sponsor Terminated Study|3|||
127571111|NCT04068896|459060301|FG000|Overall Study|Adverse Event|2|||
127691463|NCT04112316|459496538|FG000|First Period (8 Weeks)|Protocol Violation|1|||
127691464|NCT04112316|459496539|FG001|First Period (8 Weeks)|Protocol Violation|0|||
127691465|NCT04112316|459496538|FG000|First Period (8 Weeks)|Lost to Follow-up|1|||
127691466|NCT04112316|459496539|FG001|First Period (8 Weeks)|Lost to Follow-up|0|||
127691467|NCT03857620|459496540|FG000|Overall Study|Death|4|||
127691468|NCT03857620|459496541|FG001|Overall Study|Death|5|||
127571112|NCT04068896|459060302|FG001|Overall Study|Adverse Event|0|||
127571113|NCT04068896|459060303|FG002|Overall Study|Adverse Event|1|||
127571114|NCT04068896|459060304|FG003|Overall Study|Adverse Event|0|||
127571115|NCT04068896|459060305|FG004|Overall Study|Adverse Event|0|||
127571116|NCT04068896|459060306|FG005|Overall Study|Adverse Event|0|||
127571117|NCT04068896|459060301|FG000|Overall Study|Death|3|||
127571118|NCT04068896|459060302|FG001|Overall Study|Death|1|||
127571119|NCT04068896|459060303|FG002|Overall Study|Death|3|||
127571120|NCT04068896|459060304|FG003|Overall Study|Death|19|||
127571121|NCT04068896|459060305|FG004|Overall Study|Death|17|||
127571122|NCT04068896|459060306|FG005|Overall Study|Death|0|||
127571123|NCT04068896|459060301|FG000|Overall Study|Physician Decision|0|||
127571124|NCT04068896|459060302|FG001|Overall Study|Physician Decision|0|||
127571125|NCT04068896|459060303|FG002|Overall Study|Physician Decision|0|||
127571126|NCT04068896|459060304|FG003|Overall Study|Physician Decision|1|||
127571127|NCT04068896|459060305|FG004|Overall Study|Physician Decision|0|||
127571128|NCT04068896|459060306|FG005|Overall Study|Physician Decision|0|||
127571129|NCT04068896|459060301|FG000|Overall Study|progressive disease|3|||
127571130|NCT04068896|459060302|FG001|Overall Study|progressive disease|5|||
127571131|NCT04068896|459060303|FG002|Overall Study|progressive disease|3|||
127571132|NCT04068896|459060304|FG003|Overall Study|progressive disease|2|||
127571133|NCT04068896|459060305|FG004|Overall Study|progressive disease|1|||
127571134|NCT04068896|459060306|FG005|Overall Study|progressive disease|2|||
127571135|NCT04068896|459060301|FG000|Overall Study|Study terminated by sponsor|0|||
127691469|NCT03857620|459496542|FG002|Overall Study|Death|7|||
127691470|NCT03857620|459496540|FG000|Overall Study|Lost to Follow-up|2|||
127691471|NCT03857620|459496541|FG001|Overall Study|Lost to Follow-up|5|||
127691472|NCT03857620|459496542|FG002|Overall Study|Lost to Follow-up|3|||
127691473|NCT03857620|459496540|FG000|Overall Study|Disease progression or relapse after study registration|1|||
127691474|NCT03857620|459496541|FG001|Overall Study|Disease progression or relapse after study registration|5|||
127691475|NCT03857620|459496542|FG002|Overall Study|Disease progression or relapse after study registration|1|||
127691476|NCT03857620|459496540|FG000|Overall Study|Ineligible|5|||
127691477|NCT03857620|459496541|FG001|Overall Study|Ineligible|0|||
127691478|NCT03857620|459496542|FG002|Overall Study|Ineligible|2|||
127691479|NCT03857620|459496540|FG000|Overall Study|No malignancy|1|||
127691480|NCT03857620|459496541|FG001|Overall Study|No malignancy|0|||
127691481|NCT03857620|459496542|FG002|Overall Study|No malignancy|1|||
127691482|NCT03857620|459496540|FG000|Overall Study|Patient withdrawal/refusal prior to surgery|2|||
127691483|NCT03857620|459496541|FG001|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
127691484|NCT03857620|459496542|FG002|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
127691485|NCT03857620|459496540|FG000|Overall Study|Patient withdrawal/refusal after surgery performed|4|||
127691486|NCT03857620|459496541|FG001|Overall Study|Patient withdrawal/refusal after surgery performed|7|||
127691487|NCT03857620|459496542|FG002|Overall Study|Patient withdrawal/refusal after surgery performed|2|||
127691488|NCT03857620|459496540|FG000|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
127691489|NCT03857620|459496541|FG001|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
127691490|NCT03857620|459496542|FG002|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|3|||
127691491|NCT03857620|459496540|FG000|Overall Study|Surgery not performed, patient decision|0|||
127691492|NCT03857620|459496541|FG001|Overall Study|Surgery not performed, patient decision|3|||
127691493|NCT03857620|459496542|FG002|Overall Study|Surgery not performed, patient decision|1|||
127691494|NCT03857620|459496540|FG000|Overall Study|Surgery not performed, other reason|3|||
127691495|NCT03857620|459496541|FG001|Overall Study|Surgery not performed, other reason|1|||
127691496|NCT03857620|459496542|FG002|Overall Study|Surgery not performed, other reason|4|||
127691497|NCT03857620|459496540|FG000|Overall Study|Worsening performance status after surgery performed|0|||
127691498|NCT03857620|459496541|FG001|Overall Study|Worsening performance status after surgery performed|1|||
127691499|NCT03857620|459496542|FG002|Overall Study|Worsening performance status after surgery performed|1|||
127691500|NCT02473250|459496543|FG000|Overall Study|Lost to Follow-up|10|||
127691501|NCT02473250|459496543|FG000|Overall Study|Physician Decision|5|||
127691502|NCT02473250|459496543|FG000|Overall Study|Did not tolerate medication washout|3|||
127691503|NCT02473250|459496543|FG000|Overall Study|Antidepressant effect of divalproex|2|||
127691504|NCT04093362|459496544|FG000|Overall Study|Study Termination|1|||
127691505|NCT04093362|459496545|FG001|Overall Study|Study Termination|1|||
127691506|NCT04093362|459496544|FG000|Overall Study|Withdrawal of Consent|1|||
127691507|NCT04093362|459496545|FG001|Overall Study|Withdrawal of Consent|0|||
127691508|NCT04093362|459496544|FG000|Overall Study|Death|1|||
127691509|NCT04093362|459496545|FG001|Overall Study|Death|3|||
127691510|NCT04093362|459496544|FG000|Overall Study|Reason not Specified|1|||
127691511|NCT04093362|459496545|FG001|Overall Study|Reason not Specified|2|||
127571136|NCT04068896|459060302|FG001|Overall Study|Study terminated by sponsor|0|||
127571137|NCT04068896|459060303|FG002|Overall Study|Study terminated by sponsor|1|||
127691512|NCT03433339|459496548|FG000|Overall Study|Lost to Follow-up|2|||
127691513|NCT03433339|459496549|FG001|Overall Study|Lost to Follow-up|0|||
127691514|NCT03433339|459496548|FG000|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|0|||
127691515|NCT03433339|459496549|FG001|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|2|||
127779905|NCT01514136|459821436|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
127779906|NCT01514136|459821437|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
127779907|NCT01514136|459821438|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
127779908|NCT01514136|459821439|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
127779909|NCT01514136|459821440|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
127779910|NCT01514136|459821441|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
127779911|NCT01514136|459821442|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
127779912|NCT01514136|459821443|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
127779913|NCT01514136|459821436|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
127779914|NCT01514136|459821437|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
127779915|NCT01514136|459821438|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
127779916|NCT01514136|459821439|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
127779917|NCT01514136|459821440|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
127779918|NCT01514136|459821441|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
127779919|NCT01514136|459821442|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
127779920|NCT01514136|459821443|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
127779921|NCT01514136|459821436|FG000|Test Period 2; Test A*|Adverse Event|0|||
127779922|NCT01514136|459821437|FG001|Test Period 2; Test A*|Adverse Event|0|||
127779923|NCT01514136|459821438|FG002|Test Period 2; Test A*|Adverse Event|0|||
127779924|NCT01514136|459821439|FG003|Test Period 2; Test A*|Adverse Event|0|||
127779925|NCT01514136|459821440|FG004|Test Period 2; Test A*|Adverse Event|1|||
127779926|NCT01514136|459821441|FG005|Test Period 2; Test A*|Adverse Event|0|||
127779927|NCT01514136|459821442|FG006|Test Period 2; Test A*|Adverse Event|0|||
127779928|NCT01514136|459821443|FG007|Test Period 2; Test A*|Adverse Event|0|||
127779929|NCT01514136|459821436|FG000|Test Period 2; Test A*|Holiday|0|||
127779930|NCT01514136|459821437|FG001|Test Period 2; Test A*|Holiday|0|||
127779931|NCT01514136|459821438|FG002|Test Period 2; Test A*|Holiday|0|||
127779932|NCT01514136|459821439|FG003|Test Period 2; Test A*|Holiday|0|||
127779933|NCT01514136|459821440|FG004|Test Period 2; Test A*|Holiday|1|||
127779934|NCT01514136|459821441|FG005|Test Period 2; Test A*|Holiday|0|||
127779935|NCT01514136|459821442|FG006|Test Period 2; Test A*|Holiday|0|||
127779936|NCT01514136|459821443|FG007|Test Period 2; Test A*|Holiday|0|||
127779937|NCT01514136|459821436|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
127779938|NCT01514136|459821437|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
127779939|NCT01514136|459821438|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
127779940|NCT01514136|459821439|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
127779941|NCT01514136|459821440|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
127779942|NCT01514136|459821441|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
127779943|NCT01514136|459821442|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
127571138|NCT04068896|459060304|FG003|Overall Study|Study terminated by sponsor|2|||
127571139|NCT04068896|459060305|FG004|Overall Study|Study terminated by sponsor|1|||
127571140|NCT04068896|459060306|FG005|Overall Study|Study terminated by sponsor|4|||
127571141|NCT04068896|459060301|FG000|Overall Study|Protocol Violation|0|||
127571142|NCT04068896|459060302|FG001|Overall Study|Protocol Violation|0|||
127571143|NCT04068896|459060303|FG002|Overall Study|Protocol Violation|0|||
127571144|NCT04068896|459060304|FG003|Overall Study|Protocol Violation|1|||
127571145|NCT04068896|459060305|FG004|Overall Study|Protocol Violation|0|||
127691516|NCT03433339|459496548|FG000|Overall Study|Withdrawal by Subject|0|||
127691517|NCT03433339|459496549|FG001|Overall Study|Withdrawal by Subject|2|||
127691518|NCT01898494|459496565|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
127691519|NCT01898494|459496566|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
127691520|NCT01898494|459496567|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
127691521|NCT01898494|459496568|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
127691522|NCT01898494|459496569|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
127691523|NCT01898494|459496565|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
127691524|NCT01898494|459496566|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
127691525|NCT01898494|459496567|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
127691526|NCT01898494|459496568|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
127691527|NCT01898494|459496569|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
127691528|NCT01898494|459496565|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
127691529|NCT01898494|459496566|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
127691530|NCT01898494|459496567|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
127691531|NCT01898494|459496568|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
127691532|NCT01898494|459496569|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
127691533|NCT01898494|459496565|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
127691534|NCT01898494|459496566|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
127779944|NCT01514136|459821443|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
127779945|NCT01514136|459821436|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
127779946|NCT01514136|459821437|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
127779947|NCT01514136|459821438|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
127779948|NCT01514136|459821439|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
127571146|NCT04068896|459060306|FG005|Overall Study|Protocol Violation|0|||
127571147|NCT04068896|459060301|FG000|Overall Study|Withdrawal by Subject|0|||
127571148|NCT04068896|459060302|FG001|Overall Study|Withdrawal by Subject|3|||
127571149|NCT04068896|459060303|FG002|Overall Study|Withdrawal by Subject|0|||
127571150|NCT04068896|459060304|FG003|Overall Study|Withdrawal by Subject|2|||
127571151|NCT04068896|459060305|FG004|Overall Study|Withdrawal by Subject|1|||
127571152|NCT04068896|459060306|FG005|Overall Study|Withdrawal by Subject|0|||
127571153|NCT04068896|459060301|FG000|Overall Study|Symptomatic deterioration|2|||
127571154|NCT04068896|459060302|FG001|Overall Study|Symptomatic deterioration|0|||
127571155|NCT04068896|459060303|FG002|Overall Study|Symptomatic deterioration|0|||
127571156|NCT04068896|459060304|FG003|Overall Study|Symptomatic deterioration|0|||
127571157|NCT04068896|459060305|FG004|Overall Study|Symptomatic deterioration|0|||
127571158|NCT04068896|459060306|FG005|Overall Study|Symptomatic deterioration|0|||
127571159|NCT02283177|459060307|FG000|Overall Study|Withdrawal by Subject|1|||
127571160|NCT02283177|459060308|FG001|Overall Study|Withdrawal by Subject|1|||
127571161|NCT01101191|459060309|FG000|Period 1|Withdrawal by Subject|1|||
127571162|NCT01101191|459060310|FG001|Period 1|Withdrawal by Subject|0|||
127571163|NCT01101191|459060309|FG000|Period 1|Adverse Event|1|||
127571164|NCT01101191|459060310|FG001|Period 1|Adverse Event|2|||
127571165|NCT02009384|459060311|FG000|Overall Study|Death|2|||
127571166|NCT00718237|459060313|FG000|Overall Study|Adverse Event|1|||
127571167|NCT00718237|459060314|FG001|Overall Study|Adverse Event|3|||
127571168|NCT00718237|459060313|FG000|Overall Study|Lost to Follow-up|2|||
127571169|NCT00718237|459060314|FG001|Overall Study|Lost to Follow-up|2|||
127571170|NCT00718237|459060313|FG000|Overall Study|Physician Decision|1|||
127571171|NCT00718237|459060314|FG001|Overall Study|Physician Decision|0|||
127571172|NCT00718237|459060313|FG000|Overall Study|Withdrawal by Subject|9|||
127571173|NCT00718237|459060314|FG001|Overall Study|Withdrawal by Subject|10|||
127571174|NCT02694718|459060315|FG000|Overall Study|Death|1|||
127571175|NCT02694718|459060315|FG000|Overall Study|Withdrawal by Subject|1|||
127571176|NCT02925793|459060316|FG000|Overall Study|Adverse Event|3|||
127571177|NCT02925793|459060317|FG001|Overall Study|Adverse Event|3|||
127571178|NCT02925793|459060318|FG002|Overall Study|Adverse Event|6|||
127571179|NCT02925793|459060316|FG000|Overall Study|Withdrawal by Subject|16|||
127571180|NCT02925793|459060317|FG001|Overall Study|Withdrawal by Subject|15|||
127571181|NCT02925793|459060318|FG002|Overall Study|Withdrawal by Subject|13|||
127571182|NCT02925793|459060316|FG000|Overall Study|Investigator Discretion|0|||
127571183|NCT02925793|459060317|FG001|Overall Study|Investigator Discretion|1|||
127571184|NCT02925793|459060318|FG002|Overall Study|Investigator Discretion|1|||
127571185|NCT02925793|459060316|FG000|Overall Study|Lost to Follow-up|2|||
127571186|NCT02925793|459060317|FG001|Overall Study|Lost to Follow-up|3|||
127571187|NCT02925793|459060318|FG002|Overall Study|Lost to Follow-up|1|||
127571188|NCT02925793|459060316|FG000|Overall Study|Lack of Efficacy|2|||
127571189|NCT02925793|459060317|FG001|Overall Study|Lack of Efficacy|6|||
127571190|NCT02925793|459060318|FG002|Overall Study|Lack of Efficacy|4|||
127571191|NCT02925793|459060316|FG000|Overall Study|Other:|2|||
127571192|NCT02925793|459060317|FG001|Overall Study|Other:|1|||
127571193|NCT02925793|459060318|FG002|Overall Study|Other:|3|||
127571194|NCT00879879|459060319|FG000|Overall Study|Death|1|||
127571195|NCT00879879|459060319|FG000|Overall Study|Withdrawal by Subject|1|||
128027077|NCT04629521|460724197|FG000|Overall Study|Lost to Follow-up|3|||
128027078|NCT04629521|460724197|FG000|Overall Study|Subject withdrew consent|3|||
127571196|NCT00879879|459060319|FG000|Overall Study|Physician Decision|1|||
127571197|NCT00667446|459060322|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
127571198|NCT00667446|459060323|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
127571199|NCT00667446|459060322|FG000|Treatment Period (36 Months)|Other|2|||
127571200|NCT00667446|459060323|FG001|Treatment Period (36 Months)|Other|2|||
127571201|NCT00667446|459060322|FG000|Treatment Period (36 Months)|Personal reasons|2|||
127571202|NCT00667446|459060323|FG001|Treatment Period (36 Months)|Personal reasons|2|||
127571203|NCT00667446|459060322|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
127571204|NCT00667446|459060323|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
127571205|NCT00667446|459060322|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
127571206|NCT00667446|459060323|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
127571207|NCT00667446|459060322|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
127571208|NCT00667446|459060323|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
127571209|NCT00667446|459060322|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
127571210|NCT00667446|459060323|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
127571211|NCT00667446|459060322|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
127571212|NCT00667446|459060323|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
127571213|NCT00667446|459060322|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
127571214|NCT00667446|459060323|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
127571215|NCT01343901|459060324|FG000|Overall Study|Death|85|||
127571216|NCT01343901|459060324|FG000|Overall Study|Physician Decision|4|||
127571217|NCT01343901|459060324|FG000|Overall Study|Lost to Follow-up|12|||
127571218|NCT01343901|459060324|FG000|Overall Study|Management by another medical team|11|||
128027079|NCT04629521|460724197|FG000|Overall Study|Enrolled in error|1|||
127691535|NCT01898494|459496567|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
127691536|NCT01898494|459496568|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
127691537|NCT01898494|459496569|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
127691538|NCT01898494|459496565|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
127691539|NCT01898494|459496566|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
127691540|NCT01898494|459496567|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
127691541|NCT01898494|459496568|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
127691542|NCT01898494|459496569|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
127691543|NCT01898494|459496565|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
127691544|NCT01898494|459496566|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
127691545|NCT01898494|459496567|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
127691546|NCT01898494|459496568|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
127691547|NCT01898494|459496569|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
127691548|NCT01898494|459496565|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
127691549|NCT01898494|459496566|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
127691550|NCT01898494|459496567|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
127691551|NCT01898494|459496568|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
127691552|NCT01898494|459496569|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
127691553|NCT01898494|459496565|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
127691554|NCT01898494|459496566|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
127691555|NCT01898494|459496567|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
127691556|NCT01898494|459496568|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
127691557|NCT01898494|459496569|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
127691558|NCT01898494|459496565|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
127691559|NCT01898494|459496566|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
127691560|NCT01898494|459496567|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
127691561|NCT01898494|459496568|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
127691562|NCT01898494|459496569|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
127691563|NCT01898494|459496565|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
127691564|NCT01898494|459496566|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
127691565|NCT01898494|459496567|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
127691566|NCT01898494|459496568|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
127691567|NCT01898494|459496569|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
127691568|NCT01898494|459496565|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
127691569|NCT01898494|459496566|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
127691570|NCT01898494|459496567|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
127691571|NCT01898494|459496568|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
127691572|NCT01898494|459496569|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
127691573|NCT01898494|459496565|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
127691574|NCT01898494|459496566|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
127691575|NCT01898494|459496567|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
127691576|NCT01898494|459496568|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
127691577|NCT01898494|459496569|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
127691578|NCT01898494|459496565|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
127691579|NCT01898494|459496566|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
127691580|NCT01898494|459496567|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
127691581|NCT01898494|459496568|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
127691582|NCT01898494|459496569|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
127691583|NCT01898494|459496565|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
127691584|NCT01898494|459496566|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
127691585|NCT01898494|459496567|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
127691586|NCT01898494|459496568|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
127691587|NCT01898494|459496569|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
127691588|NCT03263026|459496570|FG000|Overall Study|Withdrawal by Subject|1|||
127691589|NCT03263026|459496571|FG001|Overall Study|Withdrawal by Subject|0|||
127691590|NCT03263026|459496570|FG000|Overall Study|Death|1|||
127691591|NCT03263026|459496571|FG001|Overall Study|Death|0|||
127691592|NCT03263026|459496570|FG000|Overall Study|Other/ Various|41|||
127691593|NCT03263026|459496571|FG001|Overall Study|Other/ Various|29|||
127691594|NCT03739996|459496572|FG000|Step 1 (Oral CAB + 2 NRTIs)|Determined to be ineligible|1|||
127691595|NCT03739996|459496572|FG000|Step 2 (CAB LA + VRC07-523LS)|Death|1|||
127691596|NCT03739996|459496572|FG000|Step 2 (CAB LA + VRC07-523LS)|Adverse Event|1|||
127691597|NCT03739996|459496572|FG000|Step 2 (CAB LA + VRC07-523LS)|Withdrawal by Subject|1|||
127691598|NCT03739996|459496572|FG000|Step 2 (CAB LA + VRC07-523LS)|Virologic failure, as defined by the protocol|5|||
127691599|NCT03739996|459496572|FG000|Step 2 (CAB LA + VRC07-523LS)|Participant refusal to remain on long-acting treatment|3|||
127571219|NCT01343901|459060324|FG000|Overall Study|Participant decision|1|||
127571220|NCT03324581|459060328|FG000|Overall Study|Adverse Event|18|||
127571221|NCT03324581|459060329|FG001|Overall Study|Adverse Event|11|||
127571222|NCT03324581|459060330|FG002|Overall Study|Adverse Event|7|||
127571223|NCT03324581|459060328|FG000|Overall Study|Lack of Efficacy|0|||
127571224|NCT03324581|459060329|FG001|Overall Study|Lack of Efficacy|1|||
127571225|NCT03324581|459060330|FG002|Overall Study|Lack of Efficacy|0|||
127571226|NCT03324581|459060328|FG000|Overall Study|Lost to Follow-up|5|||
127571227|NCT03324581|459060329|FG001|Overall Study|Lost to Follow-up|3|||
127571228|NCT03324581|459060330|FG002|Overall Study|Lost to Follow-up|6|||
127571229|NCT03324581|459060328|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
127571230|NCT03324581|459060329|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
127571231|NCT03324581|459060330|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
127571232|NCT03324581|459060328|FG000|Overall Study|Physician Decision|0|||
127571233|NCT03324581|459060329|FG001|Overall Study|Physician Decision|1|||
127571234|NCT03324581|459060330|FG002|Overall Study|Physician Decision|2|||
127571235|NCT03324581|459060328|FG000|Overall Study|Protocol Deviation|8|||
127571236|NCT03324581|459060329|FG001|Overall Study|Protocol Deviation|9|||
127571237|NCT03324581|459060330|FG002|Overall Study|Protocol Deviation|4|||
127571238|NCT03324581|459060328|FG000|Overall Study|Withdrawal by Subject|6|||
127571239|NCT03324581|459060329|FG001|Overall Study|Withdrawal by Subject|8|||
127571240|NCT03324581|459060330|FG002|Overall Study|Withdrawal by Subject|6|||
127571241|NCT03324581|459060328|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
127571242|NCT03324581|459060329|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
127571243|NCT03324581|459060330|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
127571244|NCT03783702|459060331|FG000|Overall Study|Lost to Follow-up|6|||
127691600|NCT03739996|459496572|FG000|Step 3 (SOC ART)|Death|1|||
127691601|NCT03739996|459496572|FG000|Step 3 (SOC ART)|Participant moved|1|||
127691602|NCT02553642|459496573|FG000|Overall Study|Withdrawal by Subject|0|||
127691603|NCT02553642|459496574|FG001|Overall Study|Withdrawal by Subject|3|||
127691604|NCT02553642|459496573|FG000|Overall Study|Physician Decision|0|||
127691605|NCT02553642|459496574|FG001|Overall Study|Physician Decision|1|||
127691606|NCT02553642|459496573|FG000|Overall Study|Additional cancer dx|0|||
127691607|NCT02553642|459496574|FG001|Overall Study|Additional cancer dx|1|||
127691608|NCT02553642|459496573|FG000|Overall Study|Never started treatment|0|||
127691609|NCT02553642|459496574|FG001|Overall Study|Never started treatment|1|||
127691610|NCT00894543|459496577|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
127691611|NCT00894543|459496578|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
127691612|NCT00894543|459496577|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
127691613|NCT00894543|459496578|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
127691614|NCT01989455|459496581|FG000|Overall Study|Adverse Event|0|||
127691615|NCT01989455|459496582|FG001|Overall Study|Adverse Event|1|||
127691616|NCT01989455|459496583|FG002|Overall Study|Adverse Event|0|||
127691617|NCT01989455|459496584|FG003|Overall Study|Adverse Event|0|||
127691618|NCT01989455|459496585|FG004|Overall Study|Adverse Event|0|||
127691619|NCT01989455|459496581|FG000|Overall Study|Withdrawal by Subject|0|||
127691620|NCT01989455|459496582|FG001|Overall Study|Withdrawal by Subject|1|||
127691621|NCT01989455|459496583|FG002|Overall Study|Withdrawal by Subject|0|||
127691622|NCT01989455|459496584|FG003|Overall Study|Withdrawal by Subject|0|||
127691623|NCT01989455|459496585|FG004|Overall Study|Withdrawal by Subject|0|||
127691624|NCT01989455|459496581|FG000|Overall Study|Technical problems with infusion|0|||
127691625|NCT01989455|459496582|FG001|Overall Study|Technical problems with infusion|0|||
127691626|NCT01989455|459496583|FG002|Overall Study|Technical problems with infusion|1|||
127691627|NCT01989455|459496584|FG003|Overall Study|Technical problems with infusion|0|||
127691628|NCT01989455|459496585|FG004|Overall Study|Technical problems with infusion|1|||
127691629|NCT00448669|459496586|FG000|Overall Study|Lost to Follow-up|52|||
127691630|NCT00448669|459496587|FG001|Overall Study|Lost to Follow-up|63|||
127691631|NCT00448669|459496586|FG000|Overall Study|Withdrawal by Subject|90|||
127691632|NCT00448669|459496587|FG001|Overall Study|Withdrawal by Subject|74|||
127691633|NCT00448669|459496586|FG000|Overall Study|Relocated|49|||
127691634|NCT00448669|459496587|FG001|Overall Study|Relocated|36|||
127691635|NCT00448669|459496586|FG000|Overall Study|Were withdrawn by investigator|10|||
127691636|NCT00448669|459496587|FG001|Overall Study|Were withdrawn by investigator|6|||
127691637|NCT00448669|459496586|FG000|Overall Study|Death|2|||
127571245|NCT03783702|459060332|FG001|Overall Study|Lost to Follow-up|8|||
127571246|NCT03783702|459060331|FG000|Overall Study|Protocol Violation|1|||
127571247|NCT03783702|459060332|FG001|Overall Study|Protocol Violation|3|||
127571248|NCT04473482|459060333|FG000|Overall Study|Death|0|||
127571249|NCT04473482|459060334|FG001|Overall Study|Death|3|||
127571250|NCT04473482|459060333|FG000|Overall Study|Lost to Follow-up|9|||
127691638|NCT00448669|459496587|FG001|Overall Study|Death|4|||
127691639|NCT00448669|459496586|FG000|Overall Study|Had other reasons|5|||
127691640|NCT00448669|459496587|FG001|Overall Study|Had other reasons|6|||
127691641|NCT00448669|459496586|FG000|Overall Study|HIV-infected at enrollment|1|||
127691642|NCT00448669|459496587|FG001|Overall Study|HIV-infected at enrollment|2|||
127691643|NCT00448669|459496586|FG000|Overall Study|Never started drug|9|||
127571251|NCT04473482|459060334|FG001|Overall Study|Lost to Follow-up|7|||
127571252|NCT04473482|459060333|FG000|Overall Study|Withdrawal by Subject|2|||
127571253|NCT04473482|459060334|FG001|Overall Study|Withdrawal by Subject|1|||
127571254|NCT00769483|459060336|FG000|Overall Study|Withdrawal by Subject|0|||
127571255|NCT00769483|459060337|FG001|Overall Study|Withdrawal by Subject|1|||
127571256|NCT00769483|459060338|FG002|Overall Study|Withdrawal by Subject|0|||
127571257|NCT00769483|459060339|FG003|Overall Study|Withdrawal by Subject|0|||
127571258|NCT00769483|459060340|FG004|Overall Study|Withdrawal by Subject|1|||
127571259|NCT00769483|459060341|FG005|Overall Study|Withdrawal by Subject|0|||
127571260|NCT03455764|459060342|FG000|Overall Study|Adverse Event|1|||
127571261|NCT03455764|459060343|FG001|Overall Study|Adverse Event|0|||
127571262|NCT03455764|459060344|FG002|Overall Study|Adverse Event|0|||
127571263|NCT03455764|459060345|FG003|Overall Study|Adverse Event|0|||
127571264|NCT03455764|459060346|FG004|Overall Study|Adverse Event|0|||
127571265|NCT03455764|459060342|FG000|Overall Study|Disease Progression|4|||
127571266|NCT03455764|459060343|FG001|Overall Study|Disease Progression|0|||
127571267|NCT03455764|459060344|FG002|Overall Study|Disease Progression|0|||
127571268|NCT03455764|459060345|FG003|Overall Study|Disease Progression|0|||
127571269|NCT03455764|459060346|FG004|Overall Study|Disease Progression|0|||
127571270|NCT03455764|459060342|FG000|Overall Study|On Treatment|1|||
127571271|NCT03455764|459060343|FG001|Overall Study|On Treatment|0|||
127571272|NCT03455764|459060344|FG002|Overall Study|On Treatment|0|||
127571273|NCT03455764|459060345|FG003|Overall Study|On Treatment|0|||
127571274|NCT03455764|459060346|FG004|Overall Study|On Treatment|0|||
127571275|NCT01076075|459060347|FG000|Overall Study|Adverse Event|3|||
127571276|NCT01076075|459060348|FG001|Overall Study|Adverse Event|9|||
127571277|NCT01076075|459060347|FG000|Overall Study|Lack of Efficacy|5|||
127571278|NCT01076075|459060348|FG001|Overall Study|Lack of Efficacy|4|||
127571279|NCT01076075|459060347|FG000|Overall Study|Lost to Follow-up|6|||
127571280|NCT01076075|459060348|FG001|Overall Study|Lost to Follow-up|5|||
127571281|NCT01076075|459060347|FG000|Overall Study|other|19|||
127571282|NCT01076075|459060348|FG001|Overall Study|other|9|||
127571283|NCT01076075|459060347|FG000|Overall Study|Protocol Violation|0|||
127571284|NCT01076075|459060348|FG001|Overall Study|Protocol Violation|1|||
127571285|NCT01076075|459060347|FG000|Overall Study|Withdrawal by Subject|8|||
127571286|NCT01076075|459060348|FG001|Overall Study|Withdrawal by Subject|19|||
127571287|NCT04285580|459062084|FG000|Overall Study|Protocol Violation|0|||
127571288|NCT04285580|459062085|FG001|Overall Study|Protocol Violation|1|||
127571289|NCT00076024|459062086|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
127571290|NCT00076024|459062087|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
127571291|NCT00076024|459062088|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
127571292|NCT00076024|459062089|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
127571293|NCT00076024|459062086|FG000|Phase 1, Lead-in|Adverse Event|1|||
127571294|NCT00076024|459062087|FG001|Phase 1, Lead-in|Adverse Event|0|||
127571295|NCT00076024|459062088|FG002|Phase 1, Lead-in|Adverse Event|0|||
127571296|NCT00076024|459062089|FG003|Phase 1, Lead-in|Adverse Event|0|||
127571297|NCT00076024|459062086|FG000|Phase 1, Lead-in|Clinical progression|1|||
127571298|NCT00076024|459062087|FG001|Phase 1, Lead-in|Clinical progression|0|||
127571299|NCT00076024|459062088|FG002|Phase 1, Lead-in|Clinical progression|0|||
127571300|NCT00076024|459062089|FG003|Phase 1, Lead-in|Clinical progression|0|||
127571301|NCT00076024|459062086|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
127571302|NCT00076024|459062087|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
127571303|NCT00076024|459062088|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
127571304|NCT00076024|459062089|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
127571305|NCT00076024|459062086|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
127571306|NCT00076024|459062087|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
127571307|NCT00076024|459062088|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
127571308|NCT00076024|459062089|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
127571309|NCT00076024|459062086|FG000|Phase 2, Double-blind|Adverse Event|0|||
127571310|NCT00076024|459062087|FG001|Phase 2, Double-blind|Adverse Event|25|||
127571311|NCT00076024|459062088|FG002|Phase 2, Double-blind|Adverse Event|6|||
127571312|NCT00076024|459062089|FG003|Phase 2, Double-blind|Adverse Event|0|||
127571313|NCT00076024|459062086|FG000|Phase 2, Double-blind|Un-specified|0|||
127571314|NCT00076024|459062087|FG001|Phase 2, Double-blind|Un-specified|14|||
127571315|NCT00076024|459062088|FG002|Phase 2, Double-blind|Un-specified|6|||
127571316|NCT00076024|459062089|FG003|Phase 2, Double-blind|Un-specified|0|||
127571317|NCT00076024|459062086|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
127571318|NCT00076024|459062087|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
127571319|NCT00076024|459062088|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
127571320|NCT00076024|459062089|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
127571321|NCT00076024|459062086|FG000|Phase 2, Open-label|Adverse Event|0|||
127571322|NCT00076024|459062087|FG001|Phase 2, Open-label|Adverse Event|0|||
127571323|NCT00076024|459062088|FG002|Phase 2, Open-label|Adverse Event|0|||
127571324|NCT00076024|459062089|FG003|Phase 2, Open-label|Adverse Event|2|||
127571325|NCT00076024|459062086|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
127571326|NCT00076024|459062087|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
127571327|NCT00076024|459062088|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
127571328|NCT00076024|459062089|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
127571329|NCT00076024|459062086|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
127571330|NCT00076024|459062087|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
127571331|NCT00076024|459062088|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
127571332|NCT00076024|459062089|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
127571333|NCT00076024|459062086|FG000|Phase 2, Open-label|Other|0|||
127571334|NCT00076024|459062087|FG001|Phase 2, Open-label|Other|0|||
127571335|NCT00076024|459062088|FG002|Phase 2, Open-label|Other|0|||
127571336|NCT00076024|459062089|FG003|Phase 2, Open-label|Other|2|||
127571337|NCT03981822|459062096|FG000|Overall Study|Lost to Follow-up|0|||
127571338|NCT03981822|459062097|FG001|Overall Study|Lost to Follow-up|1|||
127571339|NCT03981822|459062098|FG002|Overall Study|Lost to Follow-up|1|||
127571340|NCT03981822|459062099|FG003|Overall Study|Lost to Follow-up|0|||
127571341|NCT03981822|459062100|FG004|Overall Study|Lost to Follow-up|6|||
127571342|NCT03981822|459062101|FG005|Overall Study|Lost to Follow-up|4|||
127571343|NCT03981822|459062102|FG006|Overall Study|Lost to Follow-up|4|||
127571344|NCT03981822|459062103|FG007|Overall Study|Lost to Follow-up|2|||
127571345|NCT03981822|459062096|FG000|Overall Study|Withdrawal by Subject|0|||
127571346|NCT03981822|459062097|FG001|Overall Study|Withdrawal by Subject|1|||
127571347|NCT03981822|459062098|FG002|Overall Study|Withdrawal by Subject|0|||
127571348|NCT03981822|459062099|FG003|Overall Study|Withdrawal by Subject|0|||
127571349|NCT03981822|459062100|FG004|Overall Study|Withdrawal by Subject|0|||
127571350|NCT03981822|459062101|FG005|Overall Study|Withdrawal by Subject|1|||
127571351|NCT03981822|459062102|FG006|Overall Study|Withdrawal by Subject|0|||
127571352|NCT03981822|459062103|FG007|Overall Study|Withdrawal by Subject|2|||
127571353|NCT03981822|459062096|FG000|Overall Study|COVID-19 Related|0|||
127571354|NCT03981822|459062097|FG001|Overall Study|COVID-19 Related|0|||
127571355|NCT03981822|459062098|FG002|Overall Study|COVID-19 Related|0|||
127571356|NCT03981822|459062099|FG003|Overall Study|COVID-19 Related|0|||
127571357|NCT03981822|459062100|FG004|Overall Study|COVID-19 Related|2|||
127571358|NCT03981822|459062101|FG005|Overall Study|COVID-19 Related|1|||
127571359|NCT03981822|459062102|FG006|Overall Study|COVID-19 Related|2|||
127571360|NCT03981822|459062103|FG007|Overall Study|COVID-19 Related|1|||
127571361|NCT06460493|459062104|FG000|Overall Study|Withdrawal by Subject|2|||
127571362|NCT02987660|459062107|FG000|Overall Study|Study terminated by sponsor|10|||
127571363|NCT02987660|459062108|FG001|Overall Study|Study terminated by sponsor|10|||
127571364|NCT03707184|459062109|FG000|Overall Study|Withdrawal by Subject|2|||
127571365|NCT04704154|459062110|FG000|Overall Study|Adverse Event|3|||
127571366|NCT04704154|459062111|FG001|Overall Study|Adverse Event|2|||
127571367|NCT04704154|459062112|FG002|Overall Study|Adverse Event|4|||
127571368|NCT04704154|459062113|FG003|Overall Study|Adverse Event|2|||
127571369|NCT04704154|459062114|FG004|Overall Study|Adverse Event|3|||
127571370|NCT04704154|459062115|FG005|Overall Study|Adverse Event|0|||
127571371|NCT04704154|459062110|FG000|Overall Study|Death|3|||
127571372|NCT04704154|459062111|FG001|Overall Study|Death|0|||
127571373|NCT04704154|459062112|FG002|Overall Study|Death|0|||
127571374|NCT04704154|459062113|FG003|Overall Study|Death|0|||
127571375|NCT04704154|459062114|FG004|Overall Study|Death|3|||
127571376|NCT04704154|459062115|FG005|Overall Study|Death|0|||
127571377|NCT04704154|459062110|FG000|Overall Study|Physician Decision|1|||
127571378|NCT04704154|459062111|FG001|Overall Study|Physician Decision|0|||
127779949|NCT01514136|459821440|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
127571379|NCT04704154|459062112|FG002|Overall Study|Physician Decision|1|||
127571380|NCT04704154|459062113|FG003|Overall Study|Physician Decision|0|||
127691644|NCT00448669|459496587|FG001|Overall Study|Never started drug|7|||
127691645|NCT03771352|459496594|FG000|Overall Study|Screen failure|2|||
127691646|NCT03771352|459496594|FG000|Overall Study|Withdrawal by Subject|2|||
127691647|NCT03338816|459496600|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
127691648|NCT03338816|459496601|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
127691649|NCT03338816|459496602|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
127691650|NCT03338816|459496603|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
127691651|NCT03338816|459496600|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
127691652|NCT03338816|459496601|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
127691653|NCT03338816|459496602|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
127691654|NCT03338816|459496603|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
127691655|NCT03338816|459496600|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
127691656|NCT03338816|459496601|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
127691657|NCT03338816|459496602|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
127691658|NCT03338816|459496603|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
127691659|NCT03338816|459496600|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
127691660|NCT03338816|459496601|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
127571381|NCT04704154|459062114|FG004|Overall Study|Physician Decision|2|||
127571382|NCT04704154|459062115|FG005|Overall Study|Physician Decision|0|||
127571383|NCT04704154|459062110|FG000|Overall Study|Participant Decision|1|||
127571384|NCT04704154|459062111|FG001|Overall Study|Participant Decision|1|||
127571385|NCT04704154|459062112|FG002|Overall Study|Participant Decision|0|||
127571386|NCT04704154|459062113|FG003|Overall Study|Participant Decision|0|||
127571387|NCT04704154|459062114|FG004|Overall Study|Participant Decision|0|||
127571388|NCT04704154|459062115|FG005|Overall Study|Participant Decision|0|||
127571389|NCT04704154|459062110|FG000|Overall Study|Progressive Disease|19|||
127571390|NCT04704154|459062111|FG001|Overall Study|Progressive Disease|17|||
127571391|NCT04704154|459062112|FG002|Overall Study|Progressive Disease|20|||
127571392|NCT04704154|459062113|FG003|Overall Study|Progressive Disease|18|||
127571393|NCT04704154|459062114|FG004|Overall Study|Progressive Disease|36|||
127571394|NCT04704154|459062115|FG005|Overall Study|Progressive Disease|30|||
127571395|NCT04704154|459062110|FG000|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|2|||
127571396|NCT04704154|459062111|FG001|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
127571397|NCT04704154|459062112|FG002|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
127571398|NCT04704154|459062113|FG003|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
127571399|NCT04704154|459062114|FG004|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
127571400|NCT04704154|459062115|FG005|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
127571401|NCT04704154|459062110|FG000|Overall Study|Patient continued in rollover study for regorafenib|1|||
127571402|NCT04704154|459062111|FG001|Overall Study|Patient continued in rollover study for regorafenib|0|||
127571403|NCT04704154|459062112|FG002|Overall Study|Patient continued in rollover study for regorafenib|4|||
127571404|NCT04704154|459062113|FG003|Overall Study|Patient continued in rollover study for regorafenib|0|||
127571405|NCT04704154|459062114|FG004|Overall Study|Patient continued in rollover study for regorafenib|0|||
127571406|NCT04704154|459062115|FG005|Overall Study|Patient continued in rollover study for regorafenib|0|||
127571407|NCT03780400|459062116|FG000|Overall Study|Lost to Follow-up|5|||
127571408|NCT03780400|459062116|FG000|Overall Study|Withdrawal by Subject|2|||
127571409|NCT01653782|459062117|FG000|Overall Study|Withdrawal by Subject|9|||
127571410|NCT01653782|459062118|FG001|Overall Study|Withdrawal by Subject|15|||
127571411|NCT01653782|459062119|FG002|Overall Study|Withdrawal by Subject|4|||
127571412|NCT01653782|459062117|FG000|Overall Study|Lost to Follow-up|7|||
127571413|NCT01653782|459062118|FG001|Overall Study|Lost to Follow-up|3|||
127779950|NCT01514136|459821441|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
128027080|NCT01905267|460724198|FG000|Overall Study|Physician Decision|2|||
128027081|NCT01905267|460724199|FG001|Overall Study|Physician Decision|2|||
128027082|NCT03888482|460724200|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
128027083|NCT03888482|460724201|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
128027084|NCT03888482|460724200|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
128027085|NCT03888482|460724201|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
128027086|NCT03721107|460724202|FG000|Overall Study|Adverse Event|1|||
128027087|NCT03721107|460724203|FG001|Overall Study|Adverse Event|1|||
128027088|NCT03721107|460724204|FG002|Overall Study|Adverse Event|6|||
127779951|NCT01514136|459821442|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
127779952|NCT01514136|459821443|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
127779953|NCT01514136|459821436|FG000|Test Period 2; Test C*|holiday|0|||
127779954|NCT01514136|459821437|FG001|Test Period 2; Test C*|holiday|0|||
127779955|NCT01514136|459821438|FG002|Test Period 2; Test C*|holiday|0|||
127779956|NCT01514136|459821439|FG003|Test Period 2; Test C*|holiday|0|||
127779957|NCT01514136|459821440|FG004|Test Period 2; Test C*|holiday|0|||
127779958|NCT01514136|459821441|FG005|Test Period 2; Test C*|holiday|0|||
127779959|NCT01514136|459821442|FG006|Test Period 2; Test C*|holiday|1|||
127779960|NCT01514136|459821443|FG007|Test Period 2; Test C*|holiday|0|||
127779961|NCT01514136|459821436|FG000|Test Period 2; Test C*|Protocol Violation|0|||
127779962|NCT01514136|459821437|FG001|Test Period 2; Test C*|Protocol Violation|0|||
127779963|NCT01514136|459821438|FG002|Test Period 2; Test C*|Protocol Violation|0|||
128027089|NCT03721107|460724205|FG003|Overall Study|Adverse Event|5|||
128027090|NCT03721107|460724202|FG000|Overall Study|Lost to Follow-up|2|||
128027091|NCT03721107|460724203|FG001|Overall Study|Lost to Follow-up|0|||
128027092|NCT03721107|460724204|FG002|Overall Study|Lost to Follow-up|3|||
128027093|NCT03721107|460724205|FG003|Overall Study|Lost to Follow-up|0|||
128027094|NCT03721107|460724202|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
128027095|NCT03721107|460724203|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
128027096|NCT03721107|460724204|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
128027097|NCT03721107|460724205|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
128027098|NCT03721107|460724202|FG000|Overall Study|Physician Decision|0|||
128027099|NCT03721107|460724203|FG001|Overall Study|Physician Decision|1|||
128027100|NCT03721107|460724204|FG002|Overall Study|Physician Decision|0|||
128027101|NCT03721107|460724205|FG003|Overall Study|Physician Decision|0|||
128027102|NCT03721107|460724202|FG000|Overall Study|Pregnancy|0|||
128027103|NCT03721107|460724203|FG001|Overall Study|Pregnancy|0|||
127779964|NCT01514136|459821439|FG003|Test Period 2; Test C*|Protocol Violation|0|||
127779965|NCT01514136|459821440|FG004|Test Period 2; Test C*|Protocol Violation|0|||
127779966|NCT01514136|459821441|FG005|Test Period 2; Test C*|Protocol Violation|0|||
127779967|NCT01514136|459821442|FG006|Test Period 2; Test C*|Protocol Violation|1|||
128027104|NCT03721107|460724204|FG002|Overall Study|Pregnancy|1|||
128027105|NCT03721107|460724205|FG003|Overall Study|Pregnancy|0|||
128027106|NCT03721107|460724202|FG000|Overall Study|Withdrawal by Subject|1|||
128027107|NCT03721107|460724203|FG001|Overall Study|Withdrawal by Subject|1|||
128027108|NCT03721107|460724204|FG002|Overall Study|Withdrawal by Subject|5|||
128027109|NCT03721107|460724205|FG003|Overall Study|Withdrawal by Subject|5|||
128027110|NCT03721107|460724202|FG000|Overall Study|Other|1|||
128027111|NCT03721107|460724203|FG001|Overall Study|Other|0|||
128027112|NCT03721107|460724204|FG002|Overall Study|Other|0|||
128027113|NCT03721107|460724205|FG003|Overall Study|Other|1|||
128027114|NCT02554474|460724208|FG000|Overall Study|Protocol Violation|1|||
128027115|NCT02554474|460724209|FG001|Overall Study|Protocol Violation|1|||
128027116|NCT02554474|460724208|FG000|Overall Study|Health issue not related to the study|1|||
128027117|NCT02554474|460724209|FG001|Overall Study|Health issue not related to the study|0|||
128027118|NCT02554474|460724208|FG000|Overall Study|Withdrawal by Subject|1|||
128027119|NCT02554474|460724209|FG001|Overall Study|Withdrawal by Subject|1|||
128027120|NCT02991859|460724216|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
128027121|NCT02991859|460724217|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
128027122|NCT02991859|460724218|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
128027123|NCT02991859|460724219|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
128027124|NCT02991859|460724220|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
128027125|NCT02991859|460724221|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
128027126|NCT02991859|460724222|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
128027127|NCT02991859|460724223|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
128027128|NCT02991859|460724224|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
128027129|NCT02991859|460724225|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
128027130|NCT02991859|460724226|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
128027131|NCT02991859|460724227|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
127779968|NCT01514136|459821443|FG007|Test Period 2; Test C*|Protocol Violation|0|||
127779969|NCT02941926|459821444|FG000|Core Phase|Progressive disease|1109|||
127779970|NCT02941926|459821444|FG000|Core Phase|Adverse Event|504|||
127779971|NCT02941926|459821444|FG000|Core Phase|Subject/guardian decision|127|||
127779972|NCT02941926|459821444|FG000|Core Phase|Physician Decision|112|||
127779973|NCT02941926|459821444|FG000|Core Phase|Death|46|||
127779974|NCT02941926|459821444|FG000|Core Phase|Protocol deviation|34|||
127779975|NCT02941926|459821444|FG000|Core Phase|Lost to Follow-up|8|||
127779976|NCT02941926|459821444|FG000|Core Phase|Technical problems|5|||
127779977|NCT02941926|459821444|FG000|Extension Phase|Physician Decision|155|||
127779978|NCT02941926|459821444|FG000|Extension Phase|Progressive disease|115|||
127779979|NCT02941926|459821444|FG000|Extension Phase|Adverse Event|13|||
127779980|NCT02941926|459821444|FG000|Extension Phase|Subject/Guardian decision|12|||
127779981|NCT02941926|459821444|FG000|Extension Phase|Death|6|||
127779982|NCT02729740|459821445|FG000|Overall Study|Early Termination|130|||
127779983|NCT02729740|459821445|FG000|Overall Study|Other|1|||
127779984|NCT00307333|459821446|FG000|Overall Study|Lost to Follow-up|11|||
127779985|NCT00307333|459821447|FG001|Overall Study|Lost to Follow-up|3|||
127779986|NCT00601705|459821451|FG000|Overall Study|Withdrawal by Subject|1|||
127779987|NCT01621542|459821454|FG000|Overall Study|Adverse Event|0|||
127779988|NCT01621542|459821455|FG001|Overall Study|Adverse Event|0|||
127779989|NCT01621542|459821456|FG002|Overall Study|Adverse Event|1|||
127881051|NCT02575807|460186106|FG002|Overall Study|Withdrawal by Subject|1|||
128027132|NCT02991859|460724228|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
128027133|NCT02991859|460724229|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
128027134|NCT02991859|460724230|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
128027135|NCT02991859|460724231|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
128027136|NCT02991859|460724232|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
128027137|NCT02991859|460724216|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
128027138|NCT02991859|460724217|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
128027139|NCT02991859|460724218|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
128027140|NCT02991859|460724219|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
128027141|NCT02991859|460724220|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
128027142|NCT02991859|460724221|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
128027143|NCT02991859|460724222|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
128027144|NCT02991859|460724223|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
128027145|NCT02991859|460724224|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
128027146|NCT02991859|460724225|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
128027147|NCT02991859|460724226|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
127571414|NCT01653782|459062119|FG002|Overall Study|Lost to Follow-up|2|||
127779990|NCT01621542|459821457|FG003|Overall Study|Adverse Event|3|||
127779991|NCT01621542|459821458|FG004|Overall Study|Adverse Event|0|||
127779992|NCT01621542|459821459|FG005|Overall Study|Adverse Event|0|||
127779993|NCT01621542|459821454|FG000|Overall Study|Death|0|||
127779994|NCT01621542|459821455|FG001|Overall Study|Death|1|||
127779995|NCT01621542|459821456|FG002|Overall Study|Death|0|||
127779996|NCT01621542|459821457|FG003|Overall Study|Death|0|||
128027148|NCT02991859|460724227|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
128027149|NCT02991859|460724228|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
128027150|NCT02991859|460724229|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
128027151|NCT02991859|460724230|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
128027152|NCT02991859|460724231|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
128027153|NCT02991859|460724232|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
128027154|NCT02991859|460724216|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
128027155|NCT02991859|460724217|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
128027156|NCT02991859|460724218|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
128027157|NCT02991859|460724219|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
128027158|NCT02991859|460724220|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
128027159|NCT02991859|460724221|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
128027160|NCT02991859|460724222|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
128027161|NCT02991859|460724223|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
128027162|NCT02991859|460724224|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
128027163|NCT02991859|460724225|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
128027164|NCT02991859|460724226|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
128027165|NCT02991859|460724227|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
128027166|NCT02991859|460724228|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
128027167|NCT02991859|460724229|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
128027168|NCT02991859|460724230|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
128027169|NCT02991859|460724231|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
128027170|NCT02991859|460724232|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
128027171|NCT02991859|460724216|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
128027172|NCT02991859|460724217|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
128027173|NCT02991859|460724218|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
128027174|NCT02991859|460724219|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
128027175|NCT02991859|460724220|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
128027176|NCT02991859|460724221|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
128027177|NCT02991859|460724222|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
128027178|NCT02991859|460724223|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
128027179|NCT02991859|460724224|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
128027180|NCT02991859|460724225|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
128027181|NCT02991859|460724226|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
128027182|NCT02991859|460724227|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
128027183|NCT02991859|460724228|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
128027184|NCT02991859|460724229|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
128027185|NCT02991859|460724230|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
128027186|NCT02991859|460724231|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
127571415|NCT01142128|459062120|FG000|Overall Study|Physician Decision|1|||
127571416|NCT01142128|459062120|FG000|Overall Study|Lost to Follow-up|1|||
127571417|NCT01142128|459062120|FG000|Overall Study|Withdrawal by Subject|2|||
127571418|NCT00442468|459062121|FG000|Overall Study|Adverse Event|4|||
127571419|NCT00442468|459062121|FG000|Overall Study|Withdrawal by Subject|91|||
128027187|NCT02991859|460724232|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
128027188|NCT02991859|460724216|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
128027189|NCT02991859|460724217|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
128027190|NCT02991859|460724218|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
128027191|NCT02991859|460724219|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
128027192|NCT02991859|460724220|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
127571420|NCT00442468|459062121|FG000|Overall Study|Did not complete all study procedures|88|||
127571421|NCT03823378|459062126|FG000|Overall Study|Adverse Event|2|||
127571422|NCT03823378|459062127|FG001|Overall Study|Adverse Event|2|||
127691661|NCT03338816|459496602|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
127691662|NCT03338816|459496603|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
127691663|NCT03338816|459496600|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
127691664|NCT03338816|459496601|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
127691665|NCT03338816|459496602|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
127691666|NCT03338816|459496603|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
127691667|NCT03338816|459496600|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
127691668|NCT03338816|459496601|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
127691669|NCT03338816|459496602|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
127691670|NCT03338816|459496603|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
128027193|NCT02991859|460724221|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
128027194|NCT02991859|460724222|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
127571423|NCT03823378|459062128|FG002|Overall Study|Adverse Event|0|||
127571424|NCT03823378|459062129|FG003|Overall Study|Adverse Event|0|||
127571425|NCT03823378|459062130|FG004|Overall Study|Adverse Event|0|||
127571426|NCT03823378|459062131|FG005|Overall Study|Adverse Event|0|||
127571427|NCT03823378|459062126|FG000|Overall Study|Lost to Follow-up|0|||
127571428|NCT03823378|459062127|FG001|Overall Study|Lost to Follow-up|1|||
127571429|NCT03823378|459062128|FG002|Overall Study|Lost to Follow-up|0|||
127571430|NCT03823378|459062129|FG003|Overall Study|Lost to Follow-up|0|||
127571431|NCT03823378|459062130|FG004|Overall Study|Lost to Follow-up|1|||
127571432|NCT03823378|459062131|FG005|Overall Study|Lost to Follow-up|0|||
127571433|NCT03823378|459062126|FG000|Overall Study|Withdrawal by Subject|0|||
127571434|NCT03823378|459062127|FG001|Overall Study|Withdrawal by Subject|1|||
127571435|NCT03823378|459062128|FG002|Overall Study|Withdrawal by Subject|4|||
127571436|NCT03823378|459062129|FG003|Overall Study|Withdrawal by Subject|2|||
127571437|NCT03823378|459062130|FG004|Overall Study|Withdrawal by Subject|0|||
127571438|NCT03823378|459062131|FG005|Overall Study|Withdrawal by Subject|1|||
127571439|NCT03823378|459062126|FG000|Overall Study|Other, not specified|19|||
127571440|NCT03823378|459062127|FG001|Overall Study|Other, not specified|12|||
127571441|NCT03823378|459062128|FG002|Overall Study|Other, not specified|6|||
127571442|NCT03823378|459062129|FG003|Overall Study|Other, not specified|8|||
127571443|NCT03823378|459062130|FG004|Overall Study|Other, not specified|17|||
127571444|NCT03823378|459062131|FG005|Overall Study|Other, not specified|7|||
127571445|NCT05442775|459062133|FG000|Overall Study|Trial terminated|61|||
127571446|NCT05442775|459062133|FG000|Overall Study|Lack of Efficacy|4|||
127571447|NCT05442775|459062133|FG000|Overall Study|Withdrawal by Subject|4|||
127571448|NCT05442775|459062133|FG000|Overall Study|Death|1|||
127571449|NCT05442775|459062133|FG000|Overall Study|Participant removed at Sponsor request|1|||
127571450|NCT01282203|459062134|FG000|Overall Study|Adverse Event|1|||
127571451|NCT00058539|459062137|FG000|Overall Study|Disease progression|24|||
127571452|NCT00058539|459062137|FG000|Overall Study|Adverse Event|3|||
127571453|NCT00058539|459062137|FG000|Overall Study|Withdrawal by Subject|5|||
127571454|NCT00058539|459062137|FG000|Overall Study|Physician Decision|9|||
127571455|NCT00058539|459062137|FG000|Overall Study|Death|1|||
127571456|NCT03190369|459062138|FG000|Overall Study|Poor compliance to protocol|0|||
127571457|NCT03190369|459062139|FG001|Overall Study|Poor compliance to protocol|1|||
127571458|NCT03190369|459062138|FG000|Overall Study|Withdraw before treatment|1|||
127779997|NCT01621542|459821458|FG004|Overall Study|Death|0|||
128027195|NCT02991859|460724223|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
128027196|NCT02991859|460724224|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
128027197|NCT02991859|460724225|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
128027198|NCT02991859|460724226|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
128027199|NCT02991859|460724227|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
128027200|NCT02991859|460724228|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
128027201|NCT02991859|460724229|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
128027202|NCT02991859|460724230|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
128027203|NCT02991859|460724231|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
127779998|NCT01621542|459821459|FG005|Overall Study|Death|0|||
127779999|NCT01621542|459821454|FG000|Overall Study|Physician Decision|1|||
128027204|NCT02991859|460724232|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
128027205|NCT01065766|460724233|FG000|Overall Study|Assessed before the contracted date|1|||
128027206|NCT01065766|460724233|FG000|Overall Study|Contraindication to administration|6|||
128027207|NCT01065766|460724233|FG000|Overall Study|Violated dosage/administration|25|||
127780000|NCT01621542|459821455|FG001|Overall Study|Physician Decision|0|||
127780001|NCT01621542|459821456|FG002|Overall Study|Physician Decision|1|||
127780002|NCT01621542|459821457|FG003|Overall Study|Physician Decision|13|||
127780003|NCT01621542|459821458|FG004|Overall Study|Physician Decision|3|||
127780004|NCT01621542|459821459|FG005|Overall Study|Physician Decision|1|||
127780005|NCT01621542|459821454|FG000|Overall Study|Withdrawal by Subject|2|||
127780006|NCT01621542|459821455|FG001|Overall Study|Withdrawal by Subject|0|||
127780007|NCT01621542|459821456|FG002|Overall Study|Withdrawal by Subject|1|||
128027208|NCT04223687|460724239|FG000|Overall Study|Missing primary outcome|1|||
128027209|NCT04223687|460724240|FG001|Overall Study|Missing primary outcome|0|||
128027210|NCT00425854|460724241|FG000|Overall Study|Progressive Disease|19|||
128027211|NCT00425854|460724242|FG001|Overall Study|Progressive Disease|12|||
128027212|NCT00425854|460724241|FG000|Overall Study|Dose reduction toxicity AE|8|||
128027213|NCT00425854|460724242|FG001|Overall Study|Dose reduction toxicity AE|7|||
128027214|NCT00425854|460724241|FG000|Overall Study|Other Adverse Event|2|||
128027215|NCT00425854|460724242|FG001|Overall Study|Other Adverse Event|2|||
128027216|NCT05652140|460724249|FG000|Overall Study|Lost to Follow-up|7|||
128027217|NCT05652140|460724250|FG001|Overall Study|Lost to Follow-up|16|||
127780008|NCT01621542|459821457|FG003|Overall Study|Withdrawal by Subject|3|||
128027218|NCT05652140|460724251|FG002|Overall Study|Lost to Follow-up|22|||
127571459|NCT03190369|459062139|FG001|Overall Study|Withdraw before treatment|5|||
127571460|NCT03190369|459062138|FG000|Overall Study|Randomized but not treated|0|||
127571461|NCT03190369|459062139|FG001|Overall Study|Randomized but not treated|2|||
127571462|NCT02963831|459062140|FG000|Overall Study|Progressive Disease|3|||
127571463|NCT02963831|459062141|FG001|Overall Study|Progressive Disease|3|||
127571464|NCT02963831|459062142|FG002|Overall Study|Progressive Disease|16|||
127571465|NCT02963831|459062143|FG003|Overall Study|Progressive Disease|27|||
128027219|NCT05652140|460724252|FG003|Overall Study|Lost to Follow-up|31|||
128027220|NCT03163264|460724253|FG000|Overall Study|Withdrawal by Subject|13|||
128027221|NCT03163264|460724254|FG001|Overall Study|Withdrawal by Subject|3|||
128027222|NCT03163264|460724255|FG002|Overall Study|Withdrawal by Subject|4|||
128027223|NCT03163264|460724256|FG003|Overall Study|Withdrawal by Subject|2|||
128027224|NCT03163264|460724253|FG000|Overall Study|Lost to Follow-up|17|||
128027225|NCT03163264|460724254|FG001|Overall Study|Lost to Follow-up|20|||
128027226|NCT03163264|460724255|FG002|Overall Study|Lost to Follow-up|0|||
128027227|NCT03163264|460724256|FG003|Overall Study|Lost to Follow-up|0|||
128027228|NCT03163264|460724253|FG000|Overall Study|Death|0|||
128027229|NCT03163264|460724254|FG001|Overall Study|Death|2|||
128027230|NCT03163264|460724255|FG002|Overall Study|Death|0|||
127780009|NCT01621542|459821458|FG004|Overall Study|Withdrawal by Subject|3|||
127780010|NCT01621542|459821459|FG005|Overall Study|Withdrawal by Subject|3|||
127780011|NCT01621542|459821454|FG000|Overall Study|progression/treatment failure|2|||
127780012|NCT01621542|459821455|FG001|Overall Study|progression/treatment failure|4|||
127780013|NCT01621542|459821456|FG002|Overall Study|progression/treatment failure|3|||
127780014|NCT01621542|459821457|FG003|Overall Study|progression/treatment failure|7|||
127780015|NCT01621542|459821458|FG004|Overall Study|progression/treatment failure|3|||
127780016|NCT01621542|459821459|FG005|Overall Study|progression/treatment failure|5|||
127780017|NCT01621542|459821454|FG000|Overall Study|Protocol Violation|0|||
127780018|NCT01621542|459821455|FG001|Overall Study|Protocol Violation|0|||
127780019|NCT01621542|459821456|FG002|Overall Study|Protocol Violation|0|||
128027231|NCT03163264|460724256|FG003|Overall Study|Death|0|||
128027232|NCT05259722|460724257|FG000|Overall Study|Adverse Event|2|||
128027233|NCT05259722|460724258|FG001|Overall Study|Adverse Event|24|||
128027234|NCT05259722|460724257|FG000|Overall Study|Lost to Follow-up|5|||
128027235|NCT05259722|460724258|FG001|Overall Study|Lost to Follow-up|1|||
128027236|NCT05259722|460724257|FG000|Overall Study|Lack of Efficacy|8|||
128027237|NCT05259722|460724258|FG001|Overall Study|Lack of Efficacy|26|||
128027238|NCT05259722|460724257|FG000|Overall Study|Withdrawal by Subject|15|||
128027239|NCT05259722|460724258|FG001|Overall Study|Withdrawal by Subject|33|||
128027240|NCT05259722|460724257|FG000|Overall Study|Various reasons|3|||
128027241|NCT05259722|460724258|FG001|Overall Study|Various reasons|9|||
128027242|NCT05259722|460724257|FG000|Overall Study|Not exposed to IMP|1|||
128027243|NCT05259722|460724258|FG001|Overall Study|Not exposed to IMP|12|||
128027244|NCT05259722|460724257|FG000|Overall Study|Discontinuation of IMP, related to COVID-19|1|||
128027245|NCT05259722|460724258|FG001|Overall Study|Discontinuation of IMP, related to COVID-19|0|||
128027246|NCT00962650|460724259|FG000|Overall Study|Transgastric DP was not completed|2|||
128027247|NCT01185366|460724261|FG000|First Line Therapy|Insurance Coverage Denied|1|||
128027248|NCT01185366|460724262|FG001|First Line Therapy|Insurance Coverage Denied|1|||
128027249|NCT01185366|460724261|FG000|First Line Therapy|Withdrawal by Subject|1|||
128027250|NCT01185366|460724262|FG001|First Line Therapy|Withdrawal by Subject|0|||
128027251|NCT01185366|460724261|FG000|First Line Therapy|Lack of Metastatic Site|1|||
128027252|NCT01185366|460724262|FG001|First Line Therapy|Lack of Metastatic Site|0|||
127780020|NCT01621542|459821457|FG003|Overall Study|Protocol Violation|1|||
127780021|NCT01621542|459821458|FG004|Overall Study|Protocol Violation|0|||
127780022|NCT01621542|459821459|FG005|Overall Study|Protocol Violation|0|||
127780023|NCT01621542|459821454|FG000|Overall Study|study stopped by sponsor|0|||
128027253|NCT01185366|460724261|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
128027254|NCT01185366|460724262|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
128027255|NCT01185366|460724261|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
127780024|NCT01621542|459821455|FG001|Overall Study|study stopped by sponsor|0|||
127780025|NCT01621542|459821456|FG002|Overall Study|study stopped by sponsor|0|||
128027256|NCT01185366|460724262|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
128027257|NCT01185366|460724261|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
128027258|NCT01185366|460724262|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
128027259|NCT01185366|460724261|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
128027260|NCT01185366|460724262|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
128027261|NCT02774278|460724263|FG000|Overall Study|Lack of Efficacy|199|||
128027262|NCT02774278|460724263|FG000|Overall Study|Death|29|||
128027263|NCT02774278|460724263|FG000|Overall Study|Adverse event/intercurrent illness|16|||
128027264|NCT02774278|460724263|FG000|Overall Study|Refused treatment/did not cooperate|9|||
128027265|NCT02774278|460724263|FG000|Overall Study|Administrative reasons|6|||
128027266|NCT02774278|460724263|FG000|Overall Study|Withdrawal by Subject|3|||
128027267|NCT02774278|460724263|FG000|Overall Study|Protocol Violation|2|||
128027268|NCT00127933|460724270|FG000|Overall Study|Randomized but not dosed|1|||
128027269|NCT00127933|460724271|FG001|Overall Study|Randomized but not dosed|0|||
128027270|NCT01783938|460724273|FG000|Overall Study|Disease Progression|18|||
128027271|NCT01783938|460724274|FG001|Overall Study|Disease Progression|41|||
128027272|NCT01783938|460724273|FG000|Overall Study|Study Drug Toxicity|27|||
127571466|NCT02963831|459062140|FG000|Overall Study|Withdrawal by Subject|1|||
127571467|NCT02963831|459062141|FG001|Overall Study|Withdrawal by Subject|0|||
127780026|NCT01621542|459821457|FG003|Overall Study|study stopped by sponsor|1|||
127780027|NCT01621542|459821458|FG004|Overall Study|study stopped by sponsor|0|||
127780028|NCT01621542|459821459|FG005|Overall Study|study stopped by sponsor|0|||
127780029|NCT02632721|459821463|FG000|Overall Study|Adverse Event|0|||
127780030|NCT02632721|459821464|FG001|Overall Study|Adverse Event|0|||
127780031|NCT02632721|459821465|FG002|Overall Study|Adverse Event|2|||
127780032|NCT02632721|459821466|FG003|Overall Study|Adverse Event|5|||
127780033|NCT02632721|459821467|FG004|Overall Study|Adverse Event|3|||
127780034|NCT02632721|459821463|FG000|Overall Study|Dose limiting toxicity|0|||
127780035|NCT02632721|459821464|FG001|Overall Study|Dose limiting toxicity|0|||
127780036|NCT02632721|459821465|FG002|Overall Study|Dose limiting toxicity|0|||
127780037|NCT02632721|459821466|FG003|Overall Study|Dose limiting toxicity|1|||
127780038|NCT02632721|459821467|FG004|Overall Study|Dose limiting toxicity|0|||
127780039|NCT02632721|459821463|FG000|Overall Study|Progressive disease|3|||
127780040|NCT02632721|459821464|FG001|Overall Study|Progressive disease|0|||
127780041|NCT02632721|459821465|FG002|Overall Study|Progressive disease|4|||
127780042|NCT02632721|459821466|FG003|Overall Study|Progressive disease|6|||
127780043|NCT02632721|459821467|FG004|Overall Study|Progressive disease|5|||
127780044|NCT02632721|459821463|FG000|Overall Study|Refused to continue taking trial medication|0|||
127780045|NCT02632721|459821464|FG001|Overall Study|Refused to continue taking trial medication|1|||
127780046|NCT02632721|459821465|FG002|Overall Study|Refused to continue taking trial medication|1|||
127780047|NCT02632721|459821466|FG003|Overall Study|Refused to continue taking trial medication|1|||
127780048|NCT02632721|459821467|FG004|Overall Study|Refused to continue taking trial medication|2|||
127780049|NCT02632721|459821463|FG000|Overall Study|Inadequate clinical condition|0|||
127780050|NCT02632721|459821464|FG001|Overall Study|Inadequate clinical condition|0|||
127780051|NCT02632721|459821465|FG002|Overall Study|Inadequate clinical condition|0|||
127780052|NCT02632721|459821466|FG003|Overall Study|Inadequate clinical condition|0|||
127780053|NCT02632721|459821467|FG004|Overall Study|Inadequate clinical condition|1|||
127780054|NCT02632721|459821463|FG000|Overall Study|No meet eligibility|0|||
127780055|NCT02632721|459821464|FG001|Overall Study|No meet eligibility|0|||
127780056|NCT02632721|459821465|FG002|Overall Study|No meet eligibility|0|||
127780057|NCT02632721|459821466|FG003|Overall Study|No meet eligibility|0|||
127780058|NCT02632721|459821467|FG004|Overall Study|No meet eligibility|1|||
127780059|NCT02632721|459821463|FG000|Overall Study|Allergic reaction|0|||
127780060|NCT02632721|459821464|FG001|Overall Study|Allergic reaction|0|||
127780061|NCT02632721|459821465|FG002|Overall Study|Allergic reaction|0|||
127780062|NCT02632721|459821466|FG003|Overall Study|Allergic reaction|1|||
127780063|NCT02632721|459821467|FG004|Overall Study|Allergic reaction|0|||
127780064|NCT02632721|459821463|FG000|Overall Study|Receiving Decitabine locally|0|||
127780065|NCT02632721|459821464|FG001|Overall Study|Receiving Decitabine locally|0|||
127780066|NCT02632721|459821465|FG002|Overall Study|Receiving Decitabine locally|1|||
127780067|NCT02632721|459821466|FG003|Overall Study|Receiving Decitabine locally|0|||
127780068|NCT02632721|459821467|FG004|Overall Study|Receiving Decitabine locally|0|||
127780069|NCT02632721|459821463|FG000|Overall Study|No benefit from study treatment|1|||
127780070|NCT02632721|459821464|FG001|Overall Study|No benefit from study treatment|1|||
127780071|NCT02632721|459821465|FG002|Overall Study|No benefit from study treatment|0|||
127780072|NCT02632721|459821466|FG003|Overall Study|No benefit from study treatment|0|||
127780073|NCT02632721|459821467|FG004|Overall Study|No benefit from study treatment|1|||
127780074|NCT02632721|459821463|FG000|Overall Study|Patient wish for other treatment|0|||
127780075|NCT02632721|459821464|FG001|Overall Study|Patient wish for other treatment|1|||
127780076|NCT02632721|459821465|FG002|Overall Study|Patient wish for other treatment|0|||
127571468|NCT02963831|459062142|FG002|Overall Study|Withdrawal by Subject|2|||
127571469|NCT02963831|459062143|FG003|Overall Study|Withdrawal by Subject|4|||
127780077|NCT02632721|459821466|FG003|Overall Study|Patient wish for other treatment|0|||
127780078|NCT02632721|459821467|FG004|Overall Study|Patient wish for other treatment|0|||
127780079|NCT02632721|459821463|FG000|Overall Study|Relapsed Pneumonia|0|||
127780080|NCT02632721|459821464|FG001|Overall Study|Relapsed Pneumonia|0|||
127780081|NCT02632721|459821465|FG002|Overall Study|Relapsed Pneumonia|0|||
127780082|NCT02632721|459821466|FG003|Overall Study|Relapsed Pneumonia|0|||
128027273|NCT01783938|460724274|FG001|Overall Study|Study Drug Toxicity|14|||
128027274|NCT01783938|460724273|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
128027275|NCT01783938|460724274|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
127780083|NCT02632721|459821467|FG004|Overall Study|Relapsed Pneumonia|1|||
127780084|NCT02632721|459821463|FG000|Overall Study|Therapy refractory AML|0|||
127780085|NCT02632721|459821464|FG001|Overall Study|Therapy refractory AML|0|||
127780086|NCT02632721|459821465|FG002|Overall Study|Therapy refractory AML|0|||
127780087|NCT02632721|459821466|FG003|Overall Study|Therapy refractory AML|0|||
127780088|NCT02632721|459821467|FG004|Overall Study|Therapy refractory AML|1|||
127780089|NCT02632721|459821463|FG000|Overall Study|Increase of white blood cell count|0|||
127780090|NCT02632721|459821464|FG001|Overall Study|Increase of white blood cell count|0|||
127780091|NCT02632721|459821465|FG002|Overall Study|Increase of white blood cell count|0|||
128027276|NCT01783938|460724273|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
128027277|NCT01783938|460724274|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
128027278|NCT01783938|460724273|FG000|Overall Study|Participant Withdrew Consent|2|||
128027279|NCT01783938|460724274|FG001|Overall Study|Participant Withdrew Consent|0|||
128027280|NCT01783938|460724273|FG000|Overall Study|Maximum Clinical Benefit|1|||
128027281|NCT01783938|460724274|FG001|Overall Study|Maximum Clinical Benefit|0|||
128027282|NCT01783938|460724273|FG000|Overall Study|Other Reasons|3|||
128027283|NCT01783938|460724274|FG001|Overall Study|Other Reasons|1|||
128027284|NCT00498485|460724275|FG000|Overall Study|Adverse Event|1|||
128027285|NCT00498485|460724276|FG001|Overall Study|Adverse Event|5|||
128027286|NCT03072875|460724281|FG000|Overall Study|Lost to Follow-up|1|||
128027287|NCT03478787|460724282|FG000|Overall Study|Adverse Event|5|||
128027288|NCT03478787|460724283|FG001|Overall Study|Adverse Event|1|||
128027289|NCT03478787|460724282|FG000|Overall Study|Protocol Violation|3|||
128027290|NCT03478787|460724283|FG001|Overall Study|Protocol Violation|0|||
128027291|NCT03478787|460724282|FG000|Overall Study|Lack of Efficacy|7|||
128027292|NCT03478787|460724283|FG001|Overall Study|Lack of Efficacy|1|||
128027293|NCT03478787|460724282|FG000|Overall Study|Lost to Follow-up|9|||
128027294|NCT03478787|460724283|FG001|Overall Study|Lost to Follow-up|5|||
128027295|NCT03478787|460724282|FG000|Overall Study|Withdrawal by Subject|2|||
128027296|NCT03478787|460724283|FG001|Overall Study|Withdrawal by Subject|6|||
128027297|NCT03478787|460724282|FG000|Overall Study|Other, Not Specified|3|||
128027298|NCT03478787|460724283|FG001|Overall Study|Other, Not Specified|0|||
128027299|NCT01539525|460724284|FG000|Overall Study|Lost to Follow-up|19|||
128027300|NCT01539525|460724285|FG001|Overall Study|Lost to Follow-up|12|||
128027301|NCT01539525|460724286|FG002|Overall Study|Lost to Follow-up|11|||
128027302|NCT01539525|460724284|FG000|Overall Study|Withdrawal by Subject|0|||
128027303|NCT01539525|460724285|FG001|Overall Study|Withdrawal by Subject|3|||
128027304|NCT01539525|460724286|FG002|Overall Study|Withdrawal by Subject|2|||
128027305|NCT01539525|460724284|FG000|Overall Study|Protocol Violation|1|||
128027306|NCT01539525|460724285|FG001|Overall Study|Protocol Violation|1|||
128027307|NCT01539525|460724286|FG002|Overall Study|Protocol Violation|4|||
128027308|NCT01712074|460724287|FG000|Placebo Run-in Period|Adverse Event|2|||
128027309|NCT01712074|460724288|FG001|Placebo Run-in Period|Adverse Event|0|||
128027310|NCT01712074|460724289|FG002|Placebo Run-in Period|Adverse Event|0|||
128027311|NCT01712074|460724287|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
128027312|NCT01712074|460724288|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
128027313|NCT01712074|460724289|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
128027314|NCT01712074|460724287|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
128027315|NCT01712074|460724288|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
128027316|NCT01712074|460724289|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
127571470|NCT02963831|459062140|FG000|Overall Study|Adverse Event|0|||
127571471|NCT02963831|459062141|FG001|Overall Study|Adverse Event|1|||
127780092|NCT02632721|459821466|FG003|Overall Study|Increase of white blood cell count|0|||
127780093|NCT02632721|459821467|FG004|Overall Study|Increase of white blood cell count|1|||
127780094|NCT02632721|459821463|FG000|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
127780095|NCT02632721|459821464|FG001|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
127780096|NCT02632721|459821465|FG002|Overall Study|Allogeneic peripheral blood stem cell transplantation|1|||
127780097|NCT02632721|459821466|FG003|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
127780098|NCT02632721|459821467|FG004|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
127780099|NCT00544648|459821468|FG000|Overall Study|Withdrawal by Subject|1|||
127780100|NCT00544648|459821469|FG001|Overall Study|Withdrawal by Subject|0|||
127780101|NCT00544648|459821468|FG000|Overall Study|Adverse Event|1|||
127780102|NCT00544648|459821469|FG001|Overall Study|Adverse Event|1|||
127780103|NCT00544648|459821468|FG000|Overall Study|progression of disease|1|||
128027317|NCT01712074|460724287|FG000|Placebo Run-in Period|Other|1|||
128027318|NCT01712074|460724288|FG001|Placebo Run-in Period|Other|0|||
128027319|NCT01712074|460724289|FG002|Placebo Run-in Period|Other|0|||
127780104|NCT00544648|459821469|FG001|Overall Study|progression of disease|0|||
128027320|NCT01712074|460724287|FG000|Placebo Run-in Period|No longer willing to participate|1|||
128027321|NCT01712074|460724288|FG001|Placebo Run-in Period|No longer willing to participate|0|||
128027322|NCT01712074|460724289|FG002|Placebo Run-in Period|No longer willing to participate|0|||
128027323|NCT01712074|460724287|FG000|Double Blind Period|Adverse Event|0|||
128027324|NCT01712074|460724288|FG001|Double Blind Period|Adverse Event|2|||
128027325|NCT01712074|460724289|FG002|Double Blind Period|Adverse Event|1|||
128027326|NCT01712074|460724287|FG000|Double Blind Period|No longer willing to participate|0|||
128027327|NCT01712074|460724288|FG001|Double Blind Period|No longer willing to participate|2|||
128027328|NCT01712074|460724289|FG002|Double Blind Period|No longer willing to participate|4|||
128027329|NCT01712074|460724287|FG000|Double Blind Period|Death|0|||
128027330|NCT01712074|460724288|FG001|Double Blind Period|Death|1|||
127780105|NCT02663271|459821470|FG000|Overall Study|Withdrawal by Subject|5|||
127780106|NCT02663271|459821470|FG000|Overall Study|Lack of Efficacy|1|||
127780107|NCT03346057|459821472|FG000|Overall Study|Death|1|||
127780108|NCT03346057|459821473|FG001|Overall Study|Death|2|||
127780109|NCT03346057|459821474|FG002|Overall Study|Death|0|||
127780110|NCT03346057|459821475|FG003|Overall Study|Death|0|||
127780111|NCT03346057|459821472|FG000|Overall Study|Lost to Follow-up|0|||
127780112|NCT03346057|459821473|FG001|Overall Study|Lost to Follow-up|2|||
127780113|NCT03346057|459821474|FG002|Overall Study|Lost to Follow-up|1|||
127780114|NCT03346057|459821475|FG003|Overall Study|Lost to Follow-up|0|||
127780115|NCT03346057|459821472|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
127780116|NCT03346057|459821473|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
127780117|NCT03346057|459821474|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
127780118|NCT03346057|459821475|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
127780119|NCT03346057|459821472|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
127780120|NCT03346057|459821473|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
127780121|NCT03346057|459821474|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
127780122|NCT03346057|459821475|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
127780123|NCT03346057|459821472|FG000|Overall Study|Physician Decision|3|||
127780124|NCT03346057|459821473|FG001|Overall Study|Physician Decision|2|||
127780125|NCT03346057|459821474|FG002|Overall Study|Physician Decision|0|||
127780126|NCT03346057|459821475|FG003|Overall Study|Physician Decision|2|||
127780127|NCT03346057|459821472|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
127780128|NCT03346057|459821473|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
127780129|NCT03346057|459821474|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
127780130|NCT03346057|459821475|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
127780131|NCT03346057|459821472|FG000|Overall Study|Withdrawal by Subject|1|||
127780132|NCT03346057|459821473|FG001|Overall Study|Withdrawal by Subject|0|||
127780133|NCT03346057|459821474|FG002|Overall Study|Withdrawal by Subject|0|||
127780134|NCT03346057|459821475|FG003|Overall Study|Withdrawal by Subject|0|||
127780135|NCT02456662|459821477|FG000|Overall Study|Lost to Follow-up|2|||
127780136|NCT02456662|459821478|FG001|Overall Study|Lost to Follow-up|1|||
127780137|NCT00732251|459821479|FG000|Overall Study|Lost to Follow-up|3|||
127780138|NCT00732251|459821479|FG000|Overall Study|Withdrawal by Subject|3|||
127780139|NCT00732251|459821479|FG000|Overall Study|Early Term due to Site Closure|1|||
127780140|NCT00521053|459821480|FG000|Observation Phase|Disease Progression|55|||
127780141|NCT00521053|459821480|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
127780142|NCT00521053|459821480|FG000|Observation Phase|Death|2|||
127780143|NCT00521053|459821480|FG000|Observation Phase|Adverse Event|1|||
127780144|NCT00521053|459821480|FG000|Observation Phase|Other non-study melanoma treatment|1|||
127780145|NCT00521053|459821480|FG000|Observation Phase|Physician Decision|1|||
127780146|NCT03519867|459821485|FG000|Overall Study|Adverse Event|1|||
127780147|NCT03519867|459821486|FG001|Overall Study|Adverse Event|1|||
127780148|NCT03519867|459821487|FG002|Overall Study|Adverse Event|0|||
127780149|NCT03519867|459821488|FG003|Overall Study|Adverse Event|0|||
127780150|NCT03519867|459821489|FG004|Overall Study|Adverse Event|0|||
127780151|NCT03519867|459821490|FG005|Overall Study|Adverse Event|0|||
127780152|NCT03519867|459821491|FG006|Overall Study|Adverse Event|0|||
127780153|NCT03519867|459821492|FG007|Overall Study|Adverse Event|0|||
127780154|NCT03519867|459821493|FG008|Overall Study|Adverse Event|0|||
127780155|NCT03519867|459821494|FG009|Overall Study|Adverse Event|0|||
127780156|NCT03519867|459821485|FG000|Overall Study|Protocol Violation|0|||
127780157|NCT03519867|459821486|FG001|Overall Study|Protocol Violation|0|||
128027331|NCT01712074|460724289|FG002|Double Blind Period|Death|0|||
128027332|NCT01712074|460724287|FG000|Double Blind Period|Lost to Follow-up|0|||
127571472|NCT02963831|459062142|FG002|Overall Study|Adverse Event|1|||
127780158|NCT03519867|459821487|FG002|Overall Study|Protocol Violation|0|||
127780159|NCT03519867|459821488|FG003|Overall Study|Protocol Violation|0|||
127780160|NCT03519867|459821489|FG004|Overall Study|Protocol Violation|0|||
127780161|NCT03519867|459821490|FG005|Overall Study|Protocol Violation|1|||
127780162|NCT03519867|459821491|FG006|Overall Study|Protocol Violation|0|||
127780163|NCT03519867|459821492|FG007|Overall Study|Protocol Violation|0|||
127780164|NCT03519867|459821493|FG008|Overall Study|Protocol Violation|0|||
127780165|NCT03519867|459821494|FG009|Overall Study|Protocol Violation|0|||
127780166|NCT03519867|459821485|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
127780167|NCT03519867|459821486|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
127780168|NCT03519867|459821487|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
127780169|NCT03519867|459821488|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
127780170|NCT03519867|459821489|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
127780171|NCT03519867|459821490|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
128027333|NCT01712074|460724288|FG001|Double Blind Period|Lost to Follow-up|2|||
128027334|NCT01712074|460724289|FG002|Double Blind Period|Lost to Follow-up|1|||
128027335|NCT01712074|460724287|FG000|Double Blind Period|Other|0|||
128027336|NCT01712074|460724288|FG001|Double Blind Period|Other|4|||
128027337|NCT01712074|460724289|FG002|Double Blind Period|Other|1|||
128027338|NCT01712074|460724287|FG000|Double Blind Period|Protocol Violation|0|||
128027339|NCT01712074|460724288|FG001|Double Blind Period|Protocol Violation|0|||
128027340|NCT01712074|460724289|FG002|Double Blind Period|Protocol Violation|1|||
128027341|NCT01712074|460724287|FG000|Double Blind Period|No longer met eligibility criteria|0|||
128027342|NCT01712074|460724288|FG001|Double Blind Period|No longer met eligibility criteria|3|||
128027343|NCT01712074|460724289|FG002|Double Blind Period|No longer met eligibility criteria|0|||
128027344|NCT02268851|460724290|FG000|Overall Study|Death|0|||
128027345|NCT02268851|460724291|FG001|Overall Study|Death|0|||
128027346|NCT02268851|460724292|FG002|Overall Study|Death|0|||
128027347|NCT02268851|460724293|FG003|Overall Study|Death|1|||
128027348|NCT02268851|460724294|FG004|Overall Study|Death|2|||
128027349|NCT02268851|460724295|FG005|Overall Study|Death|1|||
127691671|NCT03338816|459496600|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
127691672|NCT03338816|459496601|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
127691673|NCT03338816|459496602|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
127691674|NCT03338816|459496603|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
127691675|NCT03833167|459496613|FG000|Overall Study|Withdrawal by Subject|4|||
127691676|NCT03833167|459496614|FG001|Overall Study|Withdrawal by Subject|6|||
127691677|NCT03833167|459496613|FG000|Overall Study|Ongoing|186|||
127691678|NCT03833167|459496614|FG001|Overall Study|Ongoing|194|||
127691679|NCT03833167|459496613|FG000|Overall Study|Lost to Follow-up|1|||
127691680|NCT03833167|459496614|FG001|Overall Study|Lost to Follow-up|1|||
127691681|NCT03833167|459496613|FG000|Overall Study|Physician Decision|0|||
127691682|NCT03833167|459496614|FG001|Overall Study|Physician Decision|2|||
127691683|NCT03833167|459496613|FG000|Overall Study|Death|34|||
127691684|NCT03833167|459496614|FG001|Overall Study|Death|22|||
127691685|NCT01948661|459496616|FG000|Overall Study|Withdrawal by Subject|2|||
127691686|NCT01948661|459496617|FG001|Overall Study|Withdrawal by Subject|4|||
127691687|NCT03271489|459496618|FG000|Double-Blind (DB) Period|Adverse Event|4|||
127691688|NCT03271489|459496619|FG001|Double-Blind (DB) Period|Adverse Event|1|||
127691689|NCT03271489|459496618|FG000|Double-Blind (DB) Period|Withdrawal by Subject|13|||
127691690|NCT03271489|459496619|FG001|Double-Blind (DB) Period|Withdrawal by Subject|10|||
127691691|NCT03271489|459496618|FG000|Double-Blind (DB) Period|Lost to Follow-up|9|||
127691692|NCT03271489|459496619|FG001|Double-Blind (DB) Period|Lost to Follow-up|9|||
127691693|NCT03271489|459496618|FG000|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
127691694|NCT03271489|459496619|FG001|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|2|||
127691695|NCT03271489|459496618|FG000|Double-Blind (DB) Period|Non-compliance with study procedures|0|||
127691696|NCT03271489|459496619|FG001|Double-Blind (DB) Period|Non-compliance with study procedures|1|||
127691697|NCT03271489|459496618|FG000|Double-Blind (DB) Period|Other|6|||
127691698|NCT03271489|459496619|FG001|Double-Blind (DB) Period|Other|1|||
127691699|NCT03271489|459496618|FG000|Double-Blind (DB) Period|Missing|1|||
127691700|NCT03271489|459496619|FG001|Double-Blind (DB) Period|Missing|0|||
127691701|NCT03271489|459496618|FG000|Open-Label (OL) Period|Adverse Event|2|||
127691702|NCT03271489|459496619|FG001|Open-Label (OL) Period|Adverse Event|0|||
127691703|NCT03271489|459496618|FG000|Open-Label (OL) Period|Withdrawal by Subject|14|||
127691704|NCT03271489|459496619|FG001|Open-Label (OL) Period|Withdrawal by Subject|8|||
127691705|NCT03271489|459496618|FG000|Open-Label (OL) Period|Lost to Follow-up|10|||
127691706|NCT03271489|459496619|FG001|Open-Label (OL) Period|Lost to Follow-up|5|||
127691707|NCT03271489|459496618|FG000|Open-Label (OL) Period|Non-compliance with study procedures|4|||
127691708|NCT03271489|459496619|FG001|Open-Label (OL) Period|Non-compliance with study procedures|1|||
127691709|NCT03271489|459496618|FG000|Open-Label (OL) Period|No Specified|2|||
127691710|NCT03271489|459496619|FG001|Open-Label (OL) Period|No Specified|2|||
127691711|NCT03271489|459496618|FG000|Open-Label (OL) Period|Missing|2|||
127691712|NCT03271489|459496619|FG001|Open-Label (OL) Period|Missing|0|||
127691713|NCT03271489|459496618|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|16|||
127691714|NCT03271489|459496619|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|6|||
127691715|NCT03271489|459496618|FG000|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|40|||
127691716|NCT03271489|459496619|FG001|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|26|||
127691717|NCT03271489|459496618|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|35|||
127691718|NCT03271489|459496619|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|24|||
128027350|NCT02268851|460724290|FG000|Overall Study|Adverse Event|0|||
128027351|NCT02268851|460724291|FG001|Overall Study|Adverse Event|0|||
128027352|NCT02268851|460724292|FG002|Overall Study|Adverse Event|0|||
128027353|NCT02268851|460724293|FG003|Overall Study|Adverse Event|0|||
127705205|NCT01928394|459551585|FG018|Treatment Period|Lost to Follow-up|0|||
128027354|NCT02268851|460724294|FG004|Overall Study|Adverse Event|2|||
128027355|NCT02268851|460724295|FG005|Overall Study|Adverse Event|2|||
128027356|NCT02268851|460724290|FG000|Overall Study|Withdrawal by Subject|0|||
128027357|NCT02268851|460724291|FG001|Overall Study|Withdrawal by Subject|0|||
128027358|NCT02268851|460724292|FG002|Overall Study|Withdrawal by Subject|0|||
128027359|NCT02268851|460724293|FG003|Overall Study|Withdrawal by Subject|2|||
128027360|NCT02268851|460724294|FG004|Overall Study|Withdrawal by Subject|0|||
128027361|NCT02268851|460724295|FG005|Overall Study|Withdrawal by Subject|1|||
128027362|NCT02268851|460724290|FG000|Overall Study|Progressive Disease|1|||
128027363|NCT02268851|460724291|FG001|Overall Study|Progressive Disease|3|||
128027364|NCT02268851|460724292|FG002|Overall Study|Progressive Disease|0|||
128027365|NCT02268851|460724293|FG003|Overall Study|Progressive Disease|0|||
128027366|NCT02268851|460724294|FG004|Overall Study|Progressive Disease|1|||
128027367|NCT02268851|460724295|FG005|Overall Study|Progressive Disease|4|||
128027368|NCT02268851|460724290|FG000|Overall Study|Physician Decision|0|||
128027369|NCT02268851|460724291|FG001|Overall Study|Physician Decision|0|||
128027370|NCT02268851|460724292|FG002|Overall Study|Physician Decision|1|||
128027371|NCT02268851|460724293|FG003|Overall Study|Physician Decision|0|||
128027372|NCT02268851|460724294|FG004|Overall Study|Physician Decision|0|||
128027373|NCT02268851|460724295|FG005|Overall Study|Physician Decision|1|||
128027374|NCT02268851|460724290|FG000|Overall Study|Patient Compliance|0|||
128027375|NCT02268851|460724291|FG001|Overall Study|Patient Compliance|0|||
127571473|NCT02963831|459062143|FG003|Overall Study|Adverse Event|2|||
127571474|NCT02963831|459062140|FG000|Overall Study|Death|0|||
127780172|NCT03519867|459821491|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
127780173|NCT03519867|459821492|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
127780174|NCT03519867|459821493|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
127780175|NCT03519867|459821494|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
127780176|NCT03519867|459821485|FG000|Overall Study|Admin. of other reversal agent|1|||
127780177|NCT03519867|459821486|FG001|Overall Study|Admin. of other reversal agent|1|||
127780178|NCT03519867|459821487|FG002|Overall Study|Admin. of other reversal agent|0|||
127780179|NCT03519867|459821488|FG003|Overall Study|Admin. of other reversal agent|0|||
127780180|NCT03519867|459821489|FG004|Overall Study|Admin. of other reversal agent|0|||
127780181|NCT03519867|459821490|FG005|Overall Study|Admin. of other reversal agent|1|||
127780182|NCT03519867|459821491|FG006|Overall Study|Admin. of other reversal agent|0|||
127780183|NCT03519867|459821492|FG007|Overall Study|Admin. of other reversal agent|0|||
127780184|NCT03519867|459821493|FG008|Overall Study|Admin. of other reversal agent|0|||
127780185|NCT03519867|459821494|FG009|Overall Study|Admin. of other reversal agent|0|||
127780186|NCT03519867|459821485|FG000|Overall Study|Reason not provided|1|||
127780187|NCT03519867|459821486|FG001|Overall Study|Reason not provided|1|||
127780188|NCT03519867|459821487|FG002|Overall Study|Reason not provided|1|||
127780189|NCT03519867|459821488|FG003|Overall Study|Reason not provided|1|||
127780190|NCT03519867|459821489|FG004|Overall Study|Reason not provided|0|||
127780191|NCT03519867|459821490|FG005|Overall Study|Reason not provided|1|||
127780192|NCT03519867|459821491|FG006|Overall Study|Reason not provided|0|||
127780193|NCT03519867|459821492|FG007|Overall Study|Reason not provided|1|||
127780194|NCT03519867|459821493|FG008|Overall Study|Reason not provided|1|||
127780195|NCT03519867|459821494|FG009|Overall Study|Reason not provided|0|||
127780196|NCT03007979|459821496|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
127780197|NCT01428661|459821497|FG000|Double-Masked Phase|Protocol Violation|9|||
127780198|NCT01428661|459821498|FG001|Double-Masked Phase|Protocol Violation|4|||
127780199|NCT01428661|459821499|FG002|Double-Masked Phase|Protocol Violation|0|||
127780200|NCT01428661|459821497|FG000|Double-Masked Phase|Adverse Event|13|||
127780201|NCT01428661|459821498|FG001|Double-Masked Phase|Adverse Event|4|||
127780202|NCT01428661|459821499|FG002|Double-Masked Phase|Adverse Event|0|||
127780203|NCT01428661|459821497|FG000|Double-Masked Phase|Lost to Follow-up|14|||
127780204|NCT01428661|459821498|FG001|Double-Masked Phase|Lost to Follow-up|14|||
127780205|NCT01428661|459821499|FG002|Double-Masked Phase|Lost to Follow-up|0|||
127780206|NCT01428661|459821497|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
127780207|NCT01428661|459821498|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
127780208|NCT01428661|459821499|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
127780209|NCT01428661|459821497|FG000|Double-Masked Phase|Lack of Efficacy|2|||
127780210|NCT01428661|459821498|FG001|Double-Masked Phase|Lack of Efficacy|1|||
127780211|NCT01428661|459821499|FG002|Double-Masked Phase|Lack of Efficacy|0|||
127780212|NCT01428661|459821497|FG000|Double-Masked Phase|*Various|1|||
128027376|NCT02268851|460724292|FG002|Overall Study|Patient Compliance|0|||
128027377|NCT02268851|460724293|FG003|Overall Study|Patient Compliance|0|||
128027378|NCT02268851|460724294|FG004|Overall Study|Patient Compliance|1|||
128027379|NCT02268851|460724295|FG005|Overall Study|Patient Compliance|1|||
127780213|NCT01428661|459821498|FG001|Double-Masked Phase|*Various|6|||
127780214|NCT01428661|459821499|FG002|Double-Masked Phase|*Various|0|||
127780215|NCT01428661|459821497|FG000|Open Label Extension|Protocol Violation|0|||
127780216|NCT01428661|459821498|FG001|Open Label Extension|Protocol Violation|0|||
128027380|NCT02268851|460724290|FG000|Overall Study|Co-Morbid Condition|0|||
128027381|NCT02268851|460724291|FG001|Overall Study|Co-Morbid Condition|0|||
128027382|NCT02268851|460724292|FG002|Overall Study|Co-Morbid Condition|0|||
128027383|NCT02268851|460724293|FG003|Overall Study|Co-Morbid Condition|0|||
128027384|NCT02268851|460724294|FG004|Overall Study|Co-Morbid Condition|1|||
128027385|NCT02268851|460724295|FG005|Overall Study|Co-Morbid Condition|1|||
128027386|NCT02539394|460724298|FG000|Overall Study|Protocol Violation|1|||
128027387|NCT02539394|460724299|FG001|Overall Study|Protocol Violation|3|||
128027388|NCT02539394|460724298|FG000|Overall Study|Lost to Follow-up|1|||
128027389|NCT02539394|460724299|FG001|Overall Study|Lost to Follow-up|2|||
128027390|NCT02539394|460724298|FG000|Overall Study|Incomplete dataset|6|||
128027391|NCT02539394|460724299|FG001|Overall Study|Incomplete dataset|6|||
128027392|NCT01472835|460724300|FG000|Overall Study|Lost to Follow-up|2|||
128027393|NCT01472835|460724301|FG001|Overall Study|Lost to Follow-up|0|||
127571475|NCT02963831|459062141|FG001|Overall Study|Death|0|||
127571476|NCT02963831|459062142|FG002|Overall Study|Death|0|||
127571477|NCT02963831|459062143|FG003|Overall Study|Death|2|||
127571478|NCT01606254|459062144|FG000|Overall Study|Withdrawal by Subject|1|||
127571479|NCT01606254|459062145|FG001|Overall Study|Withdrawal by Subject|3|||
127571480|NCT01606254|459062146|FG002|Overall Study|Withdrawal by Subject|0|||
127571481|NCT01606254|459062147|FG003|Overall Study|Withdrawal by Subject|2|||
127571482|NCT01606254|459062144|FG000|Overall Study|Adverse Event|1|||
128027394|NCT02205359|460724318|FG000|Overall Study|Death|293|||
128027395|NCT02205359|460724319|FG001|Overall Study|Death|327|||
128027396|NCT02205359|460724318|FG000|Overall Study|Lost to Follow-up|182|||
128027397|NCT02205359|460724319|FG001|Overall Study|Lost to Follow-up|162|||
128027398|NCT02205359|460724318|FG000|Overall Study|Physician Decision|51|||
128027399|NCT02205359|460724319|FG001|Overall Study|Physician Decision|53|||
128027400|NCT02205359|460724318|FG000|Overall Study|Withdrawal by Subject|167|||
128027401|NCT02205359|460724319|FG001|Overall Study|Withdrawal by Subject|169|||
128027402|NCT00236197|460724322|FG000|Overall Study|Withdrawal by Subject|3|||
128027403|NCT00236197|460724323|FG001|Overall Study|Withdrawal by Subject|2|||
128027404|NCT00236197|460724322|FG000|Overall Study|Lost to Follow-up|1|||
128027405|NCT00236197|460724323|FG001|Overall Study|Lost to Follow-up|5|||
128027406|NCT00236197|460724322|FG000|Overall Study|Protocol Violation|0|||
128027407|NCT00236197|460724323|FG001|Overall Study|Protocol Violation|3|||
128027408|NCT00236197|460724322|FG000|Overall Study|Medication non-compliance|1|||
128027409|NCT00236197|460724323|FG001|Overall Study|Medication non-compliance|2|||
127571483|NCT01606254|459062145|FG001|Overall Study|Adverse Event|1|||
127571484|NCT01606254|459062146|FG002|Overall Study|Adverse Event|0|||
127571485|NCT01606254|459062147|FG003|Overall Study|Adverse Event|1|||
127571486|NCT04543409|459062148|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
127571487|NCT04543409|459062149|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
127571488|NCT04543409|459062148|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
128027410|NCT00236197|460724322|FG000|Overall Study|Other|0|||
128027411|NCT00236197|460724323|FG001|Overall Study|Other|2|||
127571489|NCT04543409|459062149|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
127571490|NCT04543409|459062148|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
127571491|NCT04543409|459062149|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
127571492|NCT04543409|459062148|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
127571493|NCT04543409|459062149|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
127571494|NCT04543409|459062148|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
127571495|NCT04543409|459062149|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
127571496|NCT04543409|459062148|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
127571497|NCT04543409|459062149|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
127571498|NCT04543409|459062148|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
127571499|NCT04543409|459062149|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
127571500|NCT04543409|459062148|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
127571501|NCT04543409|459062149|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
127691719|NCT03271489|459496618|FG000|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|5|||
127691720|NCT03271489|459496619|FG001|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
127780217|NCT01428661|459821499|FG002|Open Label Extension|Protocol Violation|9|||
127780218|NCT01428661|459821497|FG000|Open Label Extension|Adverse Event|0|||
128027412|NCT02792257|460724328|FG000|Overall Study|Lost to Follow-up|3|||
127691721|NCT03271489|459496618|FG000|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|9|||
127691722|NCT03271489|459496619|FG001|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|2|||
127691723|NCT03271489|459496618|FG000|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|1|||
127691724|NCT03271489|459496619|FG001|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|0|||
127691725|NCT03271489|459496618|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|21|||
127691726|NCT03271489|459496619|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|10|||
127780219|NCT01428661|459821498|FG001|Open Label Extension|Adverse Event|0|||
127780220|NCT01428661|459821499|FG002|Open Label Extension|Adverse Event|15|||
128027413|NCT02792257|460724329|FG001|Overall Study|Lost to Follow-up|4|||
128027414|NCT02792257|460724328|FG000|Overall Study|Allergy|0|||
128027415|NCT02792257|460724329|FG001|Overall Study|Allergy|1|||
128027416|NCT02792257|460724328|FG000|Overall Study|Protocol Violation|2|||
128027417|NCT02792257|460724329|FG001|Overall Study|Protocol Violation|0|||
128027418|NCT02792257|460724328|FG000|Overall Study|Excessive Agitation|0|||
128027419|NCT02792257|460724329|FG001|Overall Study|Excessive Agitation|1|||
128027420|NCT02792257|460724328|FG000|Overall Study|Not Feeling Well|0|||
127571502|NCT04543409|459062148|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
127571503|NCT04543409|459062149|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
127571504|NCT04543409|459062148|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
128027421|NCT02792257|460724329|FG001|Overall Study|Not Feeling Well|1|||
128027422|NCT00553475|460724330|FG000|Overall Study|Adverse Event|7|||
128027423|NCT00553475|460724331|FG001|Overall Study|Adverse Event|17|||
128027424|NCT00553475|460724332|FG002|Overall Study|Adverse Event|13|||
128027425|NCT00553475|460724330|FG000|Overall Study|Lack of Efficacy|7|||
128027426|NCT00553475|460724331|FG001|Overall Study|Lack of Efficacy|1|||
128027427|NCT00553475|460724332|FG002|Overall Study|Lack of Efficacy|0|||
128027428|NCT00553475|460724330|FG000|Overall Study|Withdrawal by Subject|1|||
128027429|NCT00553475|460724331|FG001|Overall Study|Withdrawal by Subject|1|||
128027430|NCT00553475|460724332|FG002|Overall Study|Withdrawal by Subject|0|||
127571505|NCT04543409|459062149|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
127571506|NCT04543409|459062148|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
127571507|NCT04543409|459062149|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
127571508|NCT03977454|459062150|FG000|Overall Study|immediate postoperative revision|2|||
127571509|NCT03977454|459062151|FG001|Overall Study|immediate postoperative revision|2|||
127571510|NCT02093026|459062152|FG000|Overall Study|Adverse Event|26|||
127571511|NCT02093026|459062152|FG000|Overall Study|Death|10|||
127571512|NCT02093026|459062152|FG000|Overall Study|Other|157|||
127571513|NCT04365257|459062153|FG000|Overall Study|Physician Decision|1|||
127571514|NCT04365257|459062154|FG001|Overall Study|Physician Decision|0|||
128027431|NCT00553475|460724330|FG000|Overall Study|Physician Decision|1|||
128027432|NCT00553475|460724331|FG001|Overall Study|Physician Decision|0|||
128027433|NCT00553475|460724332|FG002|Overall Study|Physician Decision|0|||
128027434|NCT00553475|460724330|FG000|Overall Study|Due to moving|0|||
128027435|NCT00553475|460724331|FG001|Overall Study|Due to moving|1|||
128027436|NCT00553475|460724332|FG002|Overall Study|Due to moving|0|||
127571515|NCT04365257|459062153|FG000|Overall Study|Patient Noncompliance|1|||
127571516|NCT04365257|459062154|FG001|Overall Study|Patient Noncompliance|0|||
127571517|NCT04365257|459062153|FG000|Overall Study|Withdrawal by Subject|0|||
127691727|NCT03271489|459496618|FG000|Post-Treatment Follow-Up (PTFU) Period|Missing|3|||
127691728|NCT03271489|459496619|FG001|Post-Treatment Follow-Up (PTFU) Period|Missing|2|||
127691729|NCT02860130|459496620|FG000|Overall Study|Adverse Event|2|||
127691730|NCT02860130|459496621|FG001|Overall Study|Adverse Event|3|||
127691731|NCT02860130|459496620|FG000|Overall Study|Protocol Violation|1|||
127691732|NCT02860130|459496621|FG001|Overall Study|Protocol Violation|1|||
127691733|NCT02860130|459496620|FG000|Overall Study|Withdrawal by Subject|0|||
127691734|NCT02860130|459496621|FG001|Overall Study|Withdrawal by Subject|2|||
127691735|NCT02860130|459496620|FG000|Overall Study|Physician Decision|2|||
127691736|NCT02860130|459496621|FG001|Overall Study|Physician Decision|2|||
127691737|NCT02860130|459496620|FG000|Overall Study|Other|2|||
127691738|NCT02860130|459496621|FG001|Overall Study|Other|1|||
127691739|NCT02272816|459496622|FG000|Overall Study|Adverse Event|1|||
128027437|NCT01905683|460724337|FG000|Overall Study|Protocol Violation|1|||
128027438|NCT01905683|460724337|FG000|Overall Study|Re-injection criteria not met; others|13|||
128027439|NCT01905683|460724337|FG000|Overall Study|Physician Decision|1|||
128027440|NCT01905683|460724337|FG000|Overall Study|Lack of Efficacy|8|||
128027441|NCT01905683|460724337|FG000|Overall Study|Withdrawal by Subject|20|||
128027442|NCT01905683|460724337|FG000|Overall Study|Adverse Event|4|||
127691740|NCT00709098|459496627|FG000|Double-blind Period|Withdrawal of consent|3|||
127691741|NCT00709098|459496628|FG001|Double-blind Period|Withdrawal of consent|3|||
127571518|NCT04365257|459062154|FG001|Overall Study|Withdrawal by Subject|1|||
127691742|NCT00709098|459496629|FG002|Double-blind Period|Withdrawal of consent|0|||
128027443|NCT01905683|460724337|FG000|Overall Study|Lost to Follow-up|4|||
128027444|NCT00992394|460724338|FG000|Overall Study|Lack of Efficacy|6|||
128027445|NCT00992394|460724339|FG001|Overall Study|Lack of Efficacy|3|||
128027446|NCT00992394|460724338|FG000|Overall Study|Adverse Event|4|||
127571519|NCT00518973|459062155|FG000|Overall Study|Withdrawal by Subject|3|||
127571520|NCT00518973|459062156|FG001|Overall Study|Withdrawal by Subject|2|||
127571521|NCT02129777|459062157|FG000|Double-Blind Period|Adverse Event|0|||
127571522|NCT02129777|459062158|FG001|Double-Blind Period|Adverse Event|0|||
127571523|NCT02129777|459062159|FG002|Double-Blind Period|Adverse Event|0|||
127571524|NCT02129777|459062160|FG003|Double-Blind Period|Adverse Event|0|||
127571525|NCT02129777|459062161|FG004|Double-Blind Period|Adverse Event|1|||
127571526|NCT02129777|459062162|FG005|Double-Blind Period|Adverse Event|0|||
127571527|NCT02129777|459062163|FG006|Double-Blind Period|Adverse Event|0|||
127571528|NCT02129777|459062157|FG000|Double-Blind Period|Lost to Follow-up|1|||
127571529|NCT02129777|459062158|FG001|Double-Blind Period|Lost to Follow-up|1|||
127571530|NCT02129777|459062159|FG002|Double-Blind Period|Lost to Follow-up|1|||
127571531|NCT02129777|459062160|FG003|Double-Blind Period|Lost to Follow-up|2|||
127691743|NCT00709098|459496627|FG000|Double-blind Period|Administrative reason|1|||
127571532|NCT02129777|459062161|FG004|Double-Blind Period|Lost to Follow-up|0|||
127691744|NCT00709098|459496628|FG001|Double-blind Period|Administrative reason|3|||
128027447|NCT00992394|460724339|FG001|Overall Study|Adverse Event|5|||
128027448|NCT00992394|460724338|FG000|Overall Study|Withdrawal by Subject|8|||
128027449|NCT00992394|460724339|FG001|Overall Study|Withdrawal by Subject|2|||
128027450|NCT00992394|460724338|FG000|Overall Study|Physician Decision|1|||
128027451|NCT00992394|460724339|FG001|Overall Study|Physician Decision|0|||
128027452|NCT00992394|460724338|FG000|Overall Study|Protocol Violation|2|||
128027453|NCT00992394|460724339|FG001|Overall Study|Protocol Violation|4|||
128027454|NCT00992394|460724338|FG000|Overall Study|Lost to Follow-up|2|||
128027455|NCT00992394|460724339|FG001|Overall Study|Lost to Follow-up|0|||
128027456|NCT00992394|460724338|FG000|Overall Study|Other event|1|||
128027457|NCT00992394|460724339|FG001|Overall Study|Other event|0|||
128027458|NCT00537082|460724341|FG000|Overall Study|Adverse Event|6|||
128027459|NCT00537082|460724342|FG001|Overall Study|Adverse Event|6|||
128027460|NCT00537082|460724343|FG002|Overall Study|Adverse Event|3|||
128027461|NCT00537082|460724341|FG000|Overall Study|Protocol Violation|0|||
128027462|NCT00537082|460724342|FG001|Overall Study|Protocol Violation|2|||
127691745|NCT00709098|459496629|FG002|Double-blind Period|Administrative reason|0|||
127691746|NCT00709098|459496627|FG000|Double-blind Period|Death|1|||
127691747|NCT00709098|459496628|FG001|Double-blind Period|Death|1|||
127691748|NCT00709098|459496629|FG002|Double-blind Period|Death|0|||
127691749|NCT00709098|459496627|FG000|Double-blind Period|Lost to Follow-up|1|||
127691750|NCT00709098|459496628|FG001|Double-blind Period|Lost to Follow-up|1|||
127691751|NCT00709098|459496629|FG002|Double-blind Period|Lost to Follow-up|0|||
127691752|NCT00709098|459496627|FG000|Open-label Period|Withdrawal of consent|0|||
127691753|NCT00709098|459496628|FG001|Open-label Period|Withdrawal of consent|0|||
127691754|NCT00709098|459496629|FG002|Open-label Period|Withdrawal of consent|7|||
127691755|NCT00709098|459496627|FG000|Open-label Period|Administrative reason|0|||
127691756|NCT00709098|459496628|FG001|Open-label Period|Administrative reason|0|||
127691757|NCT00709098|459496629|FG002|Open-label Period|Administrative reason|5|||
127691758|NCT00709098|459496627|FG000|Open-label Period|Death|0|||
127691759|NCT00709098|459496628|FG001|Open-label Period|Death|0|||
127691760|NCT00709098|459496629|FG002|Open-label Period|Death|1|||
127691761|NCT00709098|459496627|FG000|Open-label Period|Lost to Follow-up|0|||
127691762|NCT00709098|459496628|FG001|Open-label Period|Lost to Follow-up|0|||
127691763|NCT00709098|459496629|FG002|Open-label Period|Lost to Follow-up|1|||
127691764|NCT03481816|459496631|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
127691765|NCT03481816|459496632|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
127691766|NCT03481816|459496631|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
127691767|NCT03481816|459496632|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
128027463|NCT00537082|460724343|FG002|Overall Study|Protocol Violation|1|||
128027464|NCT00537082|460724341|FG000|Overall Study|Lack of Efficacy|0|||
128027465|NCT00537082|460724342|FG001|Overall Study|Lack of Efficacy|0|||
128027466|NCT00537082|460724343|FG002|Overall Study|Lack of Efficacy|2|||
128027467|NCT00537082|460724341|FG000|Overall Study|Withdrawal by Subject|0|||
128027468|NCT00537082|460724342|FG001|Overall Study|Withdrawal by Subject|1|||
127571533|NCT02129777|459062162|FG005|Double-Blind Period|Lost to Follow-up|0|||
127691768|NCT03481816|459496631|FG000|Dose Expansion|Withdrawal by Subject|0|||
127691769|NCT03481816|459496632|FG001|Dose Expansion|Withdrawal by Subject|2|||
127691770|NCT03481816|459496631|FG000|Dose Expansion|Physician Decision|0|||
127691771|NCT03481816|459496632|FG001|Dose Expansion|Physician Decision|5|||
127691772|NCT03582722|459496638|FG000|Overall Study|Lost to Follow-up|1|||
127691773|NCT03582722|459496639|FG001|Overall Study|Lost to Follow-up|4|||
127691774|NCT03582722|459496638|FG000|Overall Study|Withdrawal by Subject|3|||
128027469|NCT00537082|460724343|FG002|Overall Study|Withdrawal by Subject|0|||
128027470|NCT00537082|460724341|FG000|Overall Study|Discontinued before initiating treatment|3|||
128027471|NCT00537082|460724342|FG001|Overall Study|Discontinued before initiating treatment|0|||
128027472|NCT00537082|460724343|FG002|Overall Study|Discontinued before initiating treatment|0|||
128027473|NCT02568254|460724344|FG000|Period 2|Adverse Event|0|||
128027474|NCT02568254|460724345|FG001|Period 2|Adverse Event|0|||
128027475|NCT02568254|460724346|FG002|Period 2|Adverse Event|1|||
128027476|NCT02568254|460724347|FG003|Period 2|Adverse Event|0|||
128027477|NCT02568254|460724348|FG004|Period 2|Adverse Event|0|||
128027478|NCT02568254|460724349|FG005|Period 2|Adverse Event|0|||
128027479|NCT02568254|460724344|FG000|Period 3|Unstatisfactory Lens fitting|0|||
128027480|NCT02568254|460724345|FG001|Period 3|Unstatisfactory Lens fitting|0|||
128027481|NCT02568254|460724346|FG002|Period 3|Unstatisfactory Lens fitting|0|||
128027482|NCT02568254|460724347|FG003|Period 3|Unstatisfactory Lens fitting|0|||
127780221|NCT01428661|459821497|FG000|Open Label Extension|Lost to Follow-up|0|||
127780222|NCT01428661|459821498|FG001|Open Label Extension|Lost to Follow-up|0|||
127780223|NCT01428661|459821499|FG002|Open Label Extension|Lost to Follow-up|38|||
127780224|NCT01428661|459821497|FG000|Open Label Extension|Withdrawal by Subject|0|||
127780225|NCT01428661|459821498|FG001|Open Label Extension|Withdrawal by Subject|0|||
127780226|NCT01428661|459821499|FG002|Open Label Extension|Withdrawal by Subject|49|||
127780227|NCT01428661|459821497|FG000|Open Label Extension|Lack of Efficacy|0|||
127780228|NCT01428661|459821498|FG001|Open Label Extension|Lack of Efficacy|0|||
127780229|NCT01428661|459821499|FG002|Open Label Extension|Lack of Efficacy|24|||
127780230|NCT01428661|459821497|FG000|Open Label Extension|**Various|0|||
127780231|NCT01428661|459821498|FG001|Open Label Extension|**Various|0|||
127780232|NCT01428661|459821499|FG002|Open Label Extension|**Various|185|||
127780233|NCT04223791|459821501|FG000|Overall Study|Lost to Follow-up|0|||
127780234|NCT04223791|459821502|FG001|Overall Study|Lost to Follow-up|4|||
127780235|NCT04223791|459821501|FG000|Overall Study|Physician Decision|5|||
127780236|NCT04223791|459821502|FG001|Overall Study|Physician Decision|1|||
127780237|NCT04223791|459821501|FG000|Overall Study|Protocol Violation|1|||
127780238|NCT04223791|459821502|FG001|Overall Study|Protocol Violation|1|||
127780239|NCT04223791|459821501|FG000|Overall Study|Withdrawal by Subject|10|||
127780240|NCT04223791|459821502|FG001|Overall Study|Withdrawal by Subject|12|||
127780241|NCT04223791|459821501|FG000|Overall Study|Pregnancy|1|||
127780242|NCT04223791|459821502|FG001|Overall Study|Pregnancy|1|||
127780243|NCT04223791|459821501|FG000|Overall Study|Ongoing in Study|305|||
127780244|NCT04223791|459821502|FG001|Overall Study|Ongoing in Study|302|||
127780245|NCT01372150|459823405|FG000|Overall Study|Lack of Efficacy|3|||
127780246|NCT01372150|459823406|FG001|Overall Study|Lack of Efficacy|0|||
127780247|NCT01372150|459823407|FG002|Overall Study|Lack of Efficacy|1|||
127780248|NCT01372150|459823405|FG000|Overall Study|Lost to Follow-up|4|||
127780249|NCT01372150|459823406|FG001|Overall Study|Lost to Follow-up|5|||
127780250|NCT01372150|459823407|FG002|Overall Study|Lost to Follow-up|6|||
127780251|NCT01372150|459823405|FG000|Overall Study|Protocol Violation|1|||
127780252|NCT01372150|459823406|FG001|Overall Study|Protocol Violation|0|||
127780253|NCT01372150|459823407|FG002|Overall Study|Protocol Violation|3|||
127780254|NCT01372150|459823405|FG000|Overall Study|Withdrawal by Subject|2|||
127780255|NCT01372150|459823406|FG001|Overall Study|Withdrawal by Subject|7|||
127780256|NCT01372150|459823407|FG002|Overall Study|Withdrawal by Subject|2|||
127780257|NCT01372150|459823405|FG000|Overall Study|Other|1|||
127780258|NCT01372150|459823406|FG001|Overall Study|Other|0|||
127780259|NCT01372150|459823407|FG002|Overall Study|Other|2|||
127780260|NCT01372150|459823405|FG000|Overall Study|Adverse Event|2|||
127780261|NCT01372150|459823406|FG001|Overall Study|Adverse Event|1|||
127780262|NCT01372150|459823407|FG002|Overall Study|Adverse Event|2|||
127780263|NCT01372150|459823405|FG000|Overall Study|Randomized but not treated|0|||
127780264|NCT01372150|459823406|FG001|Overall Study|Randomized but not treated|1|||
127780265|NCT01372150|459823407|FG002|Overall Study|Randomized but not treated|0|||
127780266|NCT01526551|459823408|FG000|Overall Study|Lack of returned parental consent form|424|||
127780267|NCT05215262|459823409|FG000|Overall Study|Lost to Follow-up|12|||
127780268|NCT05215262|459823410|FG001|Overall Study|Lost to Follow-up|0|||
127780269|NCT00718549|459823415|FG000|Induction Phase|Disease Progression|1|||
127780270|NCT00718549|459823416|FG001|Induction Phase|Disease Progression|0|||
127780271|NCT00718549|459823417|FG002|Induction Phase|Disease Progression|0|||
128027483|NCT02568254|460724348|FG004|Period 3|Unstatisfactory Lens fitting|1|||
127780272|NCT00718549|459823415|FG000|Induction Phase|Eligibility Criteria Violation|2|||
127780273|NCT00718549|459823416|FG001|Induction Phase|Eligibility Criteria Violation|0|||
127780274|NCT00718549|459823417|FG002|Induction Phase|Eligibility Criteria Violation|0|||
127780275|NCT00718549|459823415|FG000|Induction Phase|Early Termination - No Additional Info|59|||
128027484|NCT02568254|460724349|FG005|Period 3|Unstatisfactory Lens fitting|0|||
128027485|NCT00655746|460724350|FG000|Overall Study|Withdrawal by Subject|1|||
128027486|NCT01793129|460725891|FG000|Overall Study|Lost to Follow-up|3|||
128027487|NCT01793129|460725892|FG001|Overall Study|Lost to Follow-up|7|||
127780276|NCT00718549|459823416|FG001|Induction Phase|Early Termination - No Additional Info|0|||
127780277|NCT00718549|459823417|FG002|Induction Phase|Early Termination - No Additional Info|0|||
128027488|NCT01793129|460725891|FG000|Overall Study|Withdrawal by Subject|0|||
128027489|NCT01793129|460725892|FG001|Overall Study|Withdrawal by Subject|2|||
128027490|NCT03681093|460725893|FG000|Overall Study|Subject decision|0|||
128027491|NCT03681093|460725894|FG001|Overall Study|Subject decision|2|||
128027492|NCT03681093|460725895|FG002|Overall Study|Subject decision|1|||
128027493|NCT05130281|460725900|FG000|Overall Study|Withdrawal by Subject|0|||
128027494|NCT05130281|460725901|FG001|Overall Study|Withdrawal by Subject|0|||
128027495|NCT05130281|460725902|FG002|Overall Study|Withdrawal by Subject|1|||
128027496|NCT01699685|460725908|FG000|Period 1|Adverse Event|1|||
128027497|NCT01699685|460725909|FG001|Period 1|Adverse Event|1|||
128027498|NCT01699685|460725908|FG000|Period 1|Medical or ethical, noncompliance|2|||
127691775|NCT03582722|459496639|FG001|Overall Study|Withdrawal by Subject|3|||
127691776|NCT03690206|459496640|FG000|Overall Study|Withdrawal by Subject|2|||
127691777|NCT03690206|459496641|FG001|Overall Study|Withdrawal by Subject|0|||
127691778|NCT03690206|459496642|FG002|Overall Study|Withdrawal by Subject|0|||
127691779|NCT03690206|459496640|FG000|Overall Study|ICF withdrawal|2|||
127691780|NCT03690206|459496641|FG001|Overall Study|ICF withdrawal|0|||
127691781|NCT03690206|459496642|FG002|Overall Study|ICF withdrawal|0|||
127691782|NCT06024174|459496643|FG000|Overall Study|Other Reasons|1|||
127691783|NCT06024174|459496643|FG000|Overall Study|Study terminated by Sponsor|4|||
127691784|NCT04567615|459496644|FG000|Randomization|Participant withdrew consent|1|||
127691785|NCT04567615|459496645|FG001|Randomization|Participant withdrew consent|0|||
127691786|NCT04567615|459496646|FG002|Randomization|Participant withdrew consent|0|||
127691787|NCT04567615|459496644|FG000|Randomization|Adverse event unrelated to study drug|0|||
127691788|NCT04567615|459496645|FG001|Randomization|Adverse event unrelated to study drug|1|||
127691789|NCT04567615|459496646|FG002|Randomization|Adverse event unrelated to study drug|0|||
127691790|NCT04567615|459496644|FG000|Treatment Period|Participant Withdrew Consent|2|||
127691791|NCT04567615|459496645|FG001|Treatment Period|Participant Withdrew Consent|5|||
127691792|NCT04567615|459496646|FG002|Treatment Period|Participant Withdrew Consent|1|||
127691793|NCT04567615|459496644|FG000|Treatment Period|Death|1|||
127691794|NCT04567615|459496645|FG001|Treatment Period|Death|2|||
127691795|NCT04567615|459496646|FG002|Treatment Period|Death|0|||
127691796|NCT04567615|459496644|FG000|Treatment Period|Lost to Follow-up|0|||
127691797|NCT04567615|459496645|FG001|Treatment Period|Lost to Follow-up|1|||
127691798|NCT04567615|459496646|FG002|Treatment Period|Lost to Follow-up|0|||
127691799|NCT04567615|459496644|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
127691800|NCT04567615|459496645|FG001|Treatment Period|Participant No Longer Meets Study Criteria|1|||
127691801|NCT04567615|459496646|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
127691802|NCT04567615|459496644|FG000|Treatment Period|Disease Progression|85|||
127691803|NCT04567615|459496645|FG001|Treatment Period|Disease Progression|63|||
127691804|NCT04567615|459496646|FG002|Treatment Period|Disease Progression|16|||
127691805|NCT04567615|459496644|FG000|Treatment Period|Study Drug Toxicity|3|||
127691806|NCT04567615|459496645|FG001|Treatment Period|Study Drug Toxicity|10|||
127691807|NCT04567615|459496646|FG002|Treatment Period|Study Drug Toxicity|4|||
127691808|NCT04567615|459496644|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|11|||
127691809|NCT04567615|459496645|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|6|||
127691810|NCT04567615|459496646|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
127691811|NCT04567615|459496644|FG000|Treatment Period|Other Reasons|1|||
127691812|NCT04567615|459496645|FG001|Treatment Period|Other Reasons|2|||
127691813|NCT04567615|459496646|FG002|Treatment Period|Other Reasons|0|||
127691814|NCT04567615|459496644|FG000|Treatment Period|Still On-going Treatment|21|||
127691815|NCT04567615|459496645|FG001|Treatment Period|Still On-going Treatment|22|||
127691816|NCT04567615|459496646|FG002|Treatment Period|Still On-going Treatment|2|||
127691817|NCT01959698|459496647|FG000|Overall Study|Adverse Event|0|||
127691818|NCT01959698|459496648|FG001|Overall Study|Adverse Event|0|||
127691819|NCT01959698|459496649|FG002|Overall Study|Adverse Event|0|||
127691820|NCT01959698|459496650|FG003|Overall Study|Adverse Event|0|||
127691821|NCT01959698|459496651|FG004|Overall Study|Adverse Event|0|||
127691822|NCT01959698|459496652|FG005|Overall Study|Adverse Event|0|||
127691823|NCT01959698|459496653|FG006|Overall Study|Adverse Event|1|||
128027499|NCT01699685|460725909|FG001|Period 1|Medical or ethical, noncompliance|0|||
128027500|NCT01699685|460725908|FG000|Period 1|Other|0|||
128027501|NCT01699685|460725909|FG001|Period 1|Other|1|||
128027502|NCT01699685|460725908|FG000|Period 1|Patient request|0|||
128027503|NCT01699685|460725909|FG001|Period 1|Patient request|1|||
128027504|NCT01699685|460725908|FG000|Period 2|Lost to Follow-up|1|||
128027505|NCT01699685|460725909|FG001|Period 2|Lost to Follow-up|0|||
127571534|NCT02129777|459062163|FG006|Double-Blind Period|Lost to Follow-up|0|||
127691824|NCT01959698|459496647|FG000|Overall Study|Physician Decision|1|||
127691825|NCT01959698|459496648|FG001|Overall Study|Physician Decision|0|||
127691826|NCT01959698|459496649|FG002|Overall Study|Physician Decision|1|||
127691827|NCT01959698|459496650|FG003|Overall Study|Physician Decision|2|||
127691828|NCT01959698|459496651|FG004|Overall Study|Physician Decision|0|||
127691829|NCT01959698|459496652|FG005|Overall Study|Physician Decision|3|||
127691830|NCT01959698|459496653|FG006|Overall Study|Physician Decision|3|||
127691831|NCT03012841|459498692|FG000|Overall Study|Protocol Violation|0|||
127691832|NCT03012841|459498693|FG001|Overall Study|Protocol Violation|10|||
127691833|NCT03012841|459498692|FG000|Overall Study|Lost to Follow-up|6|||
128027506|NCT01832038|460725910|FG000|Overall Study|Death|5|||
128027507|NCT01832038|460725910|FG000|Overall Study|Adverse Event|50|||
128027508|NCT01832038|460725910|FG000|Overall Study|Lack of Efficacy|81|||
127780278|NCT00718549|459823415|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
127780279|NCT00718549|459823416|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
127780280|NCT00718549|459823417|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
127780281|NCT00718549|459823415|FG000|Maintenance/ Observation Phase|Death|0|||
127780282|NCT00718549|459823416|FG001|Maintenance/ Observation Phase|Death|1|||
127780283|NCT00718549|459823417|FG002|Maintenance/ Observation Phase|Death|2|||
127780284|NCT00718549|459823415|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
127780285|NCT00718549|459823416|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
127780286|NCT00718549|459823417|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
127780287|NCT00718549|459823415|FG000|Maintenance/ Observation Phase|Progression|0|||
127780288|NCT00718549|459823416|FG001|Maintenance/ Observation Phase|Progression|5|||
127780289|NCT00718549|459823417|FG002|Maintenance/ Observation Phase|Progression|14|||
127780290|NCT00718549|459823415|FG000|Maintenance/ Observation Phase|Relapse|0|||
127780291|NCT00718549|459823416|FG001|Maintenance/ Observation Phase|Relapse|3|||
127780292|NCT00718549|459823417|FG002|Maintenance/ Observation Phase|Relapse|2|||
127780293|NCT01353508|459823418|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
127780294|NCT01353508|459823419|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
127780295|NCT01353508|459823420|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
127780296|NCT01353508|459823421|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
127780297|NCT01353508|459823418|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
127780298|NCT01353508|459823419|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
127780299|NCT01353508|459823420|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
127780300|NCT01353508|459823421|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
127780301|NCT02092350|459823426|FG000|Overall Study|Adverse Event|0|||
127780302|NCT02092350|459823427|FG001|Overall Study|Adverse Event|3|||
127780303|NCT02092350|459823426|FG000|Overall Study|Death|2|||
127780304|NCT02092350|459823427|FG001|Overall Study|Death|5|||
127780305|NCT02092350|459823426|FG000|Overall Study|Lost to Follow-up|3|||
127780306|NCT02092350|459823427|FG001|Overall Study|Lost to Follow-up|1|||
127780307|NCT02092350|459823426|FG000|Overall Study|Protocol Violation|1|||
127780308|NCT02092350|459823427|FG001|Overall Study|Protocol Violation|0|||
127780309|NCT02092350|459823426|FG000|Overall Study|Physician Decision|1|||
127780310|NCT02092350|459823427|FG001|Overall Study|Physician Decision|1|||
127780311|NCT02092350|459823426|FG000|Overall Study|Screen Failure|1|||
127780312|NCT02092350|459823427|FG001|Overall Study|Screen Failure|0|||
127780313|NCT02092350|459823426|FG000|Overall Study|Withdrawal by Subject|2|||
127780314|NCT02092350|459823427|FG001|Overall Study|Withdrawal by Subject|2|||
127780315|NCT00239226|459823428|FG000|Overall Study|permAF during stabilization period|0|||
127780316|NCT00239226|459823429|FG001|Overall Study|permAF during stabilization period|0|||
127780317|NCT00239226|459823430|FG002|Overall Study|permAF during stabilization period|0|||
127780318|NCT00239226|459823431|FG003|Overall Study|permAF during stabilization period|3|||
127780319|NCT00239226|459823428|FG000|Overall Study|Lost to Follow-up|1|||
127780320|NCT00239226|459823429|FG001|Overall Study|Lost to Follow-up|0|||
127780321|NCT00239226|459823430|FG002|Overall Study|Lost to Follow-up|1|||
127780322|NCT00239226|459823431|FG003|Overall Study|Lost to Follow-up|0|||
127780323|NCT00646906|459823433|FG000|Crossover Period 1|Withdrawal by Subject|1|||
127780324|NCT00646906|459823434|FG001|Crossover Period 1|Withdrawal by Subject|0|||
127780325|NCT00646906|459823435|FG002|Crossover Period 1|Withdrawal by Subject|0|||
127780326|NCT00646906|459823436|FG003|Crossover Period 1|Withdrawal by Subject|0|||
127780327|NCT00646906|459823437|FG004|Crossover Period 1|Withdrawal by Subject|0|||
127780328|NCT00646906|459823438|FG005|Crossover Period 1|Withdrawal by Subject|1|||
127780329|NCT00646906|459823439|FG006|Crossover Period 1|Withdrawal by Subject|0|||
127780330|NCT00646906|459823433|FG000|Crossover Period 2|Withdrawal by Subject|0|||
127780331|NCT00646906|459823434|FG001|Crossover Period 2|Withdrawal by Subject|1|||
127780332|NCT00646906|459823435|FG002|Crossover Period 2|Withdrawal by Subject|2|||
127780333|NCT00646906|459823436|FG003|Crossover Period 2|Withdrawal by Subject|1|||
127780334|NCT00646906|459823437|FG004|Crossover Period 2|Withdrawal by Subject|0|||
127881052|NCT02575807|460186107|FG003|Overall Study|Withdrawal by Subject|1|||
127571535|NCT02129777|459062157|FG000|Double-Blind Period|Withdrawal by Subject|2|||
128027509|NCT01832038|460725910|FG000|Overall Study|Protocol Violation|7|||
128027510|NCT01832038|460725910|FG000|Overall Study|Lost to Follow-up|10|||
128027511|NCT01832038|460725910|FG000|Overall Study|Withdrawal by Subject|49|||
128027512|NCT01832038|460725910|FG000|Overall Study|Visit non-compliance|2|||
128027513|NCT01832038|460725910|FG000|Overall Study|Subject refused to return visit|2|||
128027514|NCT01832038|460725910|FG000|Overall Study|Not convenient to come back to site|2|||
128027515|NCT01832038|460725910|FG000|Overall Study|Participant was asked to quit|5|||
128027516|NCT01832038|460725910|FG000|Overall Study|Back home|1|||
128027517|NCT01832038|460725910|FG000|Overall Study|Pregnancy|1|||
128027518|NCT01832038|460725910|FG000|Overall Study|Low compliance|3|||
128027519|NCT01832038|460725910|FG000|Overall Study|Prohibit procedure|2|||
128027520|NCT01832038|460725910|FG000|Overall Study|Not possible to visit the hospital|1|||
128027521|NCT01832038|460725910|FG000|Overall Study|Changes of implementation system|3|||
128027522|NCT01832038|460725910|FG000|Overall Study|Plan to pregnancy|7|||
128027523|NCT01832038|460725910|FG000|Overall Study|Bad mood and has suicidal thought|1|||
128027524|NCT01832038|460725910|FG000|Overall Study|Prohibited concomitant medication|1|||
128027525|NCT01832038|460725910|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
128027526|NCT01832038|460725910|FG000|Overall Study|Subject considered the efficacy was poor|1|||
128027527|NCT00101400|460725915|FG000|Survival Follow-Up|Alive|7|||
128027528|NCT05333965|460725936|FG000|First Intervention|Adverse Event|0|||
128027529|NCT05333965|460725937|FG001|First Intervention|Adverse Event|1|||
128027530|NCT05333965|460725936|FG000|First Intervention|Withdrawal by Subject|0|||
128027531|NCT05333965|460725937|FG001|First Intervention|Withdrawal by Subject|1|||
128027532|NCT00382863|460725938|FG000|Overall Study|Death|9|||
128027533|NCT00382863|460725939|FG001|Overall Study|Death|9|||
128027534|NCT00382863|460725938|FG000|Overall Study|Lost to Follow-up|1|||
128027535|NCT00382863|460725939|FG001|Overall Study|Lost to Follow-up|2|||
128027536|NCT00382863|460725938|FG000|Overall Study|Withdrawal by Subject|5|||
128027537|NCT00382863|460725939|FG001|Overall Study|Withdrawal by Subject|25|||
128027538|NCT02168439|460725940|FG000|Overall Study|Protocol Violation|0|||
128027539|NCT02168439|460725941|FG001|Overall Study|Protocol Violation|2|||
128027540|NCT00605657|460725943|FG000|Overall Study|Adverse Event|1|||
128027541|NCT00605657|460725943|FG000|Overall Study|Protocol Violation|1|||
128027542|NCT02180672|460725944|FG000|Overall Study|Lost to Follow-up|5|||
128027543|NCT02180672|460725945|FG001|Overall Study|Lost to Follow-up|7|||
128027544|NCT02837952|460725946|FG000|Overall Study|Adverse Event|0|||
128027545|NCT02837952|460725947|FG001|Overall Study|Adverse Event|1|||
128027546|NCT02837952|460725946|FG000|Overall Study|Withdrawal by Subject|4|||
128027547|NCT02837952|460725947|FG001|Overall Study|Withdrawal by Subject|5|||
128027548|NCT02837952|460725946|FG000|Overall Study|Medication Error|1|||
128027549|NCT02837952|460725947|FG001|Overall Study|Medication Error|0|||
128027550|NCT01362530|460725948|FG000|Base Study (Cycle 1)|Adverse Event|2|||
128027551|NCT01362530|460725949|FG001|Base Study (Cycle 1)|Adverse Event|0|||
128027552|NCT01362530|460725948|FG000|Base Study (Cycle 1)|Physician Decision|0|||
128027553|NCT01362530|460725949|FG001|Base Study (Cycle 1)|Physician Decision|1|||
128027554|NCT01362530|460725948|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
128027555|NCT01362530|460725949|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
128027556|NCT01362530|460725948|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
128027557|NCT01362530|460725949|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
128027558|NCT01362530|460725948|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
128027559|NCT01362530|460725949|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
128027560|NCT01362530|460725948|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
128027561|NCT01362530|460725949|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
128027562|NCT01362530|460725948|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
128027563|NCT01362530|460725949|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
128027564|NCT01362530|460725948|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
128027565|NCT01362530|460725949|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
128027566|NCT01362530|460725948|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
128027567|NCT01362530|460725949|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
128027568|NCT01362530|460725948|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
127571536|NCT02129777|459062158|FG001|Double-Blind Period|Withdrawal by Subject|4|||
127571537|NCT02129777|459062159|FG002|Double-Blind Period|Withdrawal by Subject|3|||
127571538|NCT02129777|459062160|FG003|Double-Blind Period|Withdrawal by Subject|2|||
127571539|NCT02129777|459062161|FG004|Double-Blind Period|Withdrawal by Subject|3|||
128027569|NCT01362530|460725949|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
128027570|NCT01362530|460725948|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
128027571|NCT01362530|460725949|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
128027572|NCT01362530|460725948|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
127571540|NCT02129777|459062162|FG005|Double-Blind Period|Withdrawal by Subject|0|||
128027573|NCT01362530|460725949|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
128027574|NCT01362530|460725948|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
128027575|NCT01362530|460725949|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
128027576|NCT03021005|460725961|FG000|Overall Study|Lost to Follow-up|39|||
128027577|NCT03021005|460725962|FG001|Overall Study|Lost to Follow-up|26|||
128027578|NCT00276380|460725967|FG000|Overall Study|Adverse Event|5|||
128027579|NCT00276380|460725968|FG001|Overall Study|Adverse Event|3|||
128027580|NCT00276380|460725967|FG000|Overall Study|Lost to Follow-up|1|||
128027581|NCT00276380|460725968|FG001|Overall Study|Lost to Follow-up|1|||
128027582|NCT00276380|460725967|FG000|Overall Study|Withdrawal by Subject|3|||
128027583|NCT00276380|460725968|FG001|Overall Study|Withdrawal by Subject|6|||
128027584|NCT00276380|460725967|FG000|Overall Study|Death|5|||
128027585|NCT00276380|460725968|FG001|Overall Study|Death|3|||
128027586|NCT00276380|460725967|FG000|Overall Study|Abnormal aPPT Levels|0|||
128027587|NCT00276380|460725968|FG001|Overall Study|Abnormal aPPT Levels|1|||
128027588|NCT03473301|460725969|FG000|Overall Study|Protocol Violation|4|||
128027589|NCT03473301|460725970|FG001|Overall Study|Protocol Violation|0|||
128027590|NCT03473301|460725971|FG002|Overall Study|Protocol Violation|0|||
128027591|NCT03473301|460725969|FG000|Overall Study|Withdrawal by Subject|0|||
128027592|NCT03473301|460725970|FG001|Overall Study|Withdrawal by Subject|1|||
128027593|NCT03473301|460725971|FG002|Overall Study|Withdrawal by Subject|0|||
128027594|NCT03473301|460725969|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
128027595|NCT03473301|460725970|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
128027596|NCT03473301|460725971|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
128027597|NCT04829214|460725972|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
128027598|NCT04829214|460725973|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
128027599|NCT04829214|460725972|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
128027600|NCT04829214|460725973|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
128027601|NCT02571244|460725975|FG000|Overall Study|Lost to Follow-up|0|||
127571541|NCT02129777|459062163|FG006|Double-Blind Period|Withdrawal by Subject|0|||
127571542|NCT02129777|459062157|FG000|Double-Blind Period|Pregnancy|0|||
127571543|NCT02129777|459062158|FG001|Double-Blind Period|Pregnancy|0|||
127571544|NCT02129777|459062159|FG002|Double-Blind Period|Pregnancy|0|||
127571545|NCT02129777|459062160|FG003|Double-Blind Period|Pregnancy|0|||
127571546|NCT02129777|459062161|FG004|Double-Blind Period|Pregnancy|1|||
127571547|NCT02129777|459062162|FG005|Double-Blind Period|Pregnancy|0|||
127571548|NCT02129777|459062163|FG006|Double-Blind Period|Pregnancy|0|||
127571549|NCT02129777|459062157|FG000|Double-Blind Period|Lack of Efficacy|3|||
127571550|NCT02129777|459062158|FG001|Double-Blind Period|Lack of Efficacy|1|||
127571551|NCT02129777|459062159|FG002|Double-Blind Period|Lack of Efficacy|0|||
127571552|NCT02129777|459062160|FG003|Double-Blind Period|Lack of Efficacy|3|||
127571553|NCT02129777|459062161|FG004|Double-Blind Period|Lack of Efficacy|2|||
127571554|NCT02129777|459062162|FG005|Double-Blind Period|Lack of Efficacy|0|||
127571555|NCT02129777|459062163|FG006|Double-Blind Period|Lack of Efficacy|0|||
127571556|NCT02129777|459062157|FG000|Double-Blind Period|Other|1|||
127571557|NCT02129777|459062158|FG001|Double-Blind Period|Other|2|||
127571558|NCT02129777|459062159|FG002|Double-Blind Period|Other|0|||
127571559|NCT02129777|459062160|FG003|Double-Blind Period|Other|0|||
127571560|NCT02129777|459062161|FG004|Double-Blind Period|Other|0|||
127571561|NCT02129777|459062162|FG005|Double-Blind Period|Other|0|||
127571562|NCT02129777|459062163|FG006|Double-Blind Period|Other|0|||
127571563|NCT02129777|459062157|FG000|Open-Label Period|Lack of Efficacy|0|||
127571564|NCT02129777|459062158|FG001|Open-Label Period|Lack of Efficacy|0|||
127571565|NCT02129777|459062159|FG002|Open-Label Period|Lack of Efficacy|0|||
127571566|NCT02129777|459062160|FG003|Open-Label Period|Lack of Efficacy|0|||
127571567|NCT02129777|459062161|FG004|Open-Label Period|Lack of Efficacy|0|||
127571568|NCT02129777|459062162|FG005|Open-Label Period|Lack of Efficacy|0|||
127571569|NCT02129777|459062163|FG006|Open-Label Period|Lack of Efficacy|5|||
127571570|NCT02129777|459062157|FG000|Open-Label Period|Lost to Follow-up|0|||
127571571|NCT02129777|459062158|FG001|Open-Label Period|Lost to Follow-up|0|||
127571572|NCT02129777|459062159|FG002|Open-Label Period|Lost to Follow-up|0|||
127571573|NCT02129777|459062160|FG003|Open-Label Period|Lost to Follow-up|0|||
127571574|NCT02129777|459062161|FG004|Open-Label Period|Lost to Follow-up|0|||
127571575|NCT02129777|459062162|FG005|Open-Label Period|Lost to Follow-up|1|||
127571576|NCT02129777|459062163|FG006|Open-Label Period|Lost to Follow-up|1|||
127571577|NCT02129777|459062157|FG000|Open-Label Period|Withdrawal by Subject|0|||
127571578|NCT02129777|459062158|FG001|Open-Label Period|Withdrawal by Subject|0|||
127691834|NCT03012841|459498693|FG001|Overall Study|Lost to Follow-up|1|||
127691835|NCT03012841|459498692|FG000|Overall Study|Withdrawal by Subject|6|||
127691836|NCT03012841|459498693|FG001|Overall Study|Withdrawal by Subject|0|||
128027602|NCT02571244|460725976|FG001|Overall Study|Lost to Follow-up|1|||
128027603|NCT02571244|460725975|FG000|Overall Study|Unable to reach out post discharge|3|||
127571579|NCT02129777|459062159|FG002|Open-Label Period|Withdrawal by Subject|0|||
127571580|NCT02129777|459062160|FG003|Open-Label Period|Withdrawal by Subject|0|||
127571581|NCT02129777|459062161|FG004|Open-Label Period|Withdrawal by Subject|0|||
127571582|NCT02129777|459062162|FG005|Open-Label Period|Withdrawal by Subject|1|||
127571583|NCT02129777|459062163|FG006|Open-Label Period|Withdrawal by Subject|3|||
127571584|NCT02129777|459062157|FG000|Open-Label Period|Study Termination|0|||
128027604|NCT02571244|460725976|FG001|Overall Study|Unable to reach out post discharge|0|||
128027605|NCT01696214|460725978|FG000|Overall Study|Lost to Follow-up|1|||
127571585|NCT02129777|459062158|FG001|Open-Label Period|Study Termination|0|||
127571586|NCT02129777|459062159|FG002|Open-Label Period|Study Termination|0|||
127571587|NCT02129777|459062160|FG003|Open-Label Period|Study Termination|0|||
127571588|NCT02129777|459062161|FG004|Open-Label Period|Study Termination|0|||
127571589|NCT02129777|459062162|FG005|Open-Label Period|Study Termination|10|||
127571590|NCT02129777|459062163|FG006|Open-Label Period|Study Termination|39|||
127571591|NCT01001299|459062164|FG000|Overall Study|Insufficient Therapeutic Response|20|||
127571592|NCT01001299|459062164|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
127571593|NCT01001299|459062164|FG000|Overall Study|Death|1|||
127571594|NCT01001299|459062164|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
127571595|NCT01001299|459062164|FG000|Overall Study|Withdrew Consent|1|||
127571596|NCT01565499|459062169|FG000|Overall Study|Physician Decision|1|||
127571597|NCT01565499|459062169|FG000|Overall Study|Adverse Event|5|||
127571598|NCT01565499|459062169|FG000|Overall Study|Withdrawal by Subject|2|||
127571599|NCT01923168|459062173|FG000|Overall Study|Protocol Violation|1|||
127571600|NCT01923168|459062174|FG001|Overall Study|Protocol Violation|1|||
127571601|NCT01923168|459062175|FG002|Overall Study|Protocol Violation|0|||
127571602|NCT01923168|459062173|FG000|Overall Study|Subject/guardian decision|14|||
127571603|NCT01923168|459062174|FG001|Overall Study|Subject/guardian decision|14|||
127571604|NCT01923168|459062175|FG002|Overall Study|Subject/guardian decision|4|||
127571605|NCT01923168|459062173|FG000|Overall Study|Adverse Event|12|||
127571606|NCT01923168|459062174|FG001|Overall Study|Adverse Event|12|||
127571607|NCT01923168|459062175|FG002|Overall Study|Adverse Event|0|||
127571608|NCT01923168|459062173|FG000|Overall Study|Physician Decision|6|||
127571609|NCT01923168|459062174|FG001|Overall Study|Physician Decision|9|||
127571610|NCT01923168|459062175|FG002|Overall Study|Physician Decision|5|||
127571611|NCT01923168|459062173|FG000|Overall Study|Progressive disease|4|||
127571612|NCT01923168|459062174|FG001|Overall Study|Progressive disease|3|||
127571613|NCT01923168|459062175|FG002|Overall Study|Progressive disease|7|||
127571614|NCT01923168|459062173|FG000|Overall Study|Death|0|||
127571615|NCT01923168|459062174|FG001|Overall Study|Death|0|||
127571616|NCT01923168|459062175|FG002|Overall Study|Death|1|||
127571617|NCT03418571|459062176|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
127571618|NCT03418571|459062177|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
127571619|NCT02376829|459062178|FG000|Overall Study|Withdrawal by Subject|27|||
127571620|NCT02376829|459062179|FG001|Overall Study|Withdrawal by Subject|44|||
127571621|NCT01255787|459062180|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
127571622|NCT01255787|459062181|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
127571623|NCT01255787|459062182|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
127571624|NCT01255787|459062183|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
127571625|NCT01255787|459062180|FG000|Overall Study|Major Protocol Deviation|1|||
127571626|NCT01255787|459062181|FG001|Overall Study|Major Protocol Deviation|1|||
127571627|NCT01255787|459062182|FG002|Overall Study|Major Protocol Deviation|0|||
127571628|NCT01255787|459062183|FG003|Overall Study|Major Protocol Deviation|4|||
127571629|NCT01255787|459062180|FG000|Overall Study|Lost to Follow-up|1|||
127571630|NCT01255787|459062181|FG001|Overall Study|Lost to Follow-up|2|||
127691837|NCT03012841|459498692|FG000|Overall Study|Unable to complete 12 month visit|6|||
127691838|NCT03012841|459498693|FG001|Overall Study|Unable to complete 12 month visit|0|||
127691839|NCT03012841|459498692|FG000|Overall Study|Subject relocation|1|||
127691840|NCT03012841|459498693|FG001|Overall Study|Subject relocation|0|||
127691841|NCT03012841|459498692|FG000|Overall Study|Seasonal winter travel|1|||
127691842|NCT03012841|459498693|FG001|Overall Study|Seasonal winter travel|0|||
127691843|NCT03012841|459498692|FG000|Overall Study|Physician Decision|0|||
127780335|NCT00646906|459823438|FG005|Crossover Period 2|Withdrawal by Subject|0|||
127780336|NCT00646906|459823439|FG006|Crossover Period 2|Withdrawal by Subject|0|||
127780337|NCT00646906|459823433|FG000|Crossover Period 2|Physician Decision|0|||
127780338|NCT00646906|459823434|FG001|Crossover Period 2|Physician Decision|0|||
127780339|NCT00646906|459823435|FG002|Crossover Period 2|Physician Decision|0|||
127780340|NCT00646906|459823436|FG003|Crossover Period 2|Physician Decision|0|||
127571631|NCT01255787|459062182|FG002|Overall Study|Lost to Follow-up|4|||
127571632|NCT01255787|459062183|FG003|Overall Study|Lost to Follow-up|2|||
127571633|NCT01255787|459062180|FG000|Overall Study|Withdrawal of Consent|3|||
127571634|NCT01255787|459062181|FG001|Overall Study|Withdrawal of Consent|9|||
127571635|NCT01255787|459062182|FG002|Overall Study|Withdrawal of Consent|3|||
127691844|NCT03012841|459498693|FG001|Overall Study|Physician Decision|2|||
127780341|NCT00646906|459823437|FG004|Crossover Period 2|Physician Decision|0|||
127780342|NCT00646906|459823438|FG005|Crossover Period 2|Physician Decision|0|||
127691845|NCT03012841|459498692|FG000|Overall Study|No ablation performed|0|||
127691846|NCT03012841|459498693|FG001|Overall Study|No ablation performed|2|||
127691847|NCT03012841|459498692|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
127780343|NCT00646906|459823439|FG006|Crossover Period 2|Physician Decision|1|||
127571636|NCT01255787|459062183|FG003|Overall Study|Withdrawal of Consent|4|||
127571637|NCT01255787|459062180|FG000|Overall Study|Pregnancy|0|||
127571638|NCT01255787|459062181|FG001|Overall Study|Pregnancy|0|||
127571639|NCT01255787|459062182|FG002|Overall Study|Pregnancy|0|||
127571640|NCT01255787|459062183|FG003|Overall Study|Pregnancy|1|||
127571641|NCT01255787|459062180|FG000|Overall Study|Lack of Efficacy|2|||
127571642|NCT01255787|459062181|FG001|Overall Study|Lack of Efficacy|2|||
127571643|NCT01255787|459062182|FG002|Overall Study|Lack of Efficacy|2|||
127571644|NCT01255787|459062183|FG003|Overall Study|Lack of Efficacy|2|||
127571645|NCT01255787|459062180|FG000|Overall Study|Noncompliance with Study Drug|3|||
127571646|NCT01255787|459062181|FG001|Overall Study|Noncompliance with Study Drug|1|||
127571647|NCT01255787|459062182|FG002|Overall Study|Noncompliance with Study Drug|0|||
127571648|NCT01255787|459062183|FG003|Overall Study|Noncompliance with Study Drug|0|||
127571649|NCT03882008|459062184|FG000|Overall Study|Withdrawal by Subject|1|||
127571650|NCT03882008|459062184|FG000|Overall Study|Lost to Follow-up|1|||
127571651|NCT05153473|459062185|FG000|Overall Study|Death|46|||
127571652|NCT05153473|459062185|FG000|Overall Study|Lost to Follow-up|3|||
127780344|NCT02448225|459823442|FG000|Overall Study|Withdrawal by Subject|1|||
127780345|NCT02448225|459823442|FG000|Overall Study|Did not get FSPG scan|18|||
127780346|NCT02448225|459823442|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
127780347|NCT04060563|459823443|FG000|Overall Study|Lost to Follow-up|1|||
127780348|NCT04060563|459823444|FG001|Overall Study|Lost to Follow-up|1|||
127780349|NCT04060563|459823443|FG000|Overall Study|Physician Decision|0|||
127780350|NCT04060563|459823444|FG001|Overall Study|Physician Decision|1|||
127780351|NCT00851682|459823445|FG000|Overall Study|screen failure|5|||
127780352|NCT00851682|459823446|FG001|Overall Study|screen failure|0|||
127780353|NCT00433914|459823452|FG000|Overall Study|Withdrawal by Subject|0|||
127780354|NCT00433914|459823453|FG001|Overall Study|Withdrawal by Subject|2|||
127780355|NCT00433914|459823452|FG000|Overall Study|Lost to Follow-up|0|||
127780356|NCT00433914|459823453|FG001|Overall Study|Lost to Follow-up|1|||
127780357|NCT02678416|459823464|FG000|Part 1|Withdrawal by Subject|1|||
127780358|NCT02678416|459823464|FG000|Part 2|Adverse Event|2|||
127780359|NCT02678416|459823464|FG000|Part 2|Withdrawal by Subject|1|||
127780360|NCT01848353|459823465|FG000|Phase 1|Withdrawal by Subject|3|||
127780361|NCT01848353|459823466|FG001|Phase 1|Withdrawal by Subject|1|||
127780362|NCT01848353|459823467|FG002|Phase 1|Withdrawal by Subject|0|||
127780363|NCT01848353|459823468|FG003|Phase 1|Withdrawal by Subject|0|||
127780364|NCT01848353|459823465|FG000|Phase 2|Withdrawal by Subject|3|||
127780365|NCT01848353|459823466|FG001|Phase 2|Withdrawal by Subject|2|||
127780366|NCT01848353|459823467|FG002|Phase 2|Withdrawal by Subject|0|||
127780367|NCT01848353|459823468|FG003|Phase 2|Withdrawal by Subject|0|||
127780368|NCT01848353|459823465|FG000|Phase 3|Withdrawal by Subject|1|||
127780369|NCT01848353|459823466|FG001|Phase 3|Withdrawal by Subject|1|||
127780370|NCT01848353|459823467|FG002|Phase 3|Withdrawal by Subject|0|||
127780371|NCT01848353|459823468|FG003|Phase 3|Withdrawal by Subject|0|||
127780372|NCT00935272|459823469|FG000|Overall Study|Lost to Follow-up|10|||
127780373|NCT00935272|459823470|FG001|Overall Study|Lost to Follow-up|3|||
127780374|NCT00935272|459823469|FG000|Overall Study|Withdrawal by Subject|8|||
127571653|NCT03519386|459062186|FG000|Overall Study|Withdrawal by Subject|4|||
127571654|NCT03519386|459062187|FG001|Overall Study|Withdrawal by Subject|1|||
127571655|NCT03519386|459062188|FG002|Overall Study|Withdrawal by Subject|2|||
127571656|NCT03519386|459062186|FG000|Overall Study|Physician Decision|1|||
127571657|NCT03519386|459062187|FG001|Overall Study|Physician Decision|1|||
127571658|NCT03519386|459062188|FG002|Overall Study|Physician Decision|1|||
127571659|NCT03519386|459062186|FG000|Overall Study|Lost to Follow-up|0|||
127691848|NCT03012841|459498693|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
127691849|NCT03012841|459498692|FG000|Overall Study|Insurance change|0|||
127691850|NCT03012841|459498693|FG001|Overall Study|Insurance change|1|||
127691851|NCT05096819|459498696|FG000|Overall Study|Withdrawal by Subject|3|||
127691852|NCT05096819|459498697|FG001|Overall Study|Withdrawal by Subject|0|||
127691853|NCT04607044|459498698|FG000|Overall Study|Study Early Termination by Sponsor.|40|||
127691854|NCT04607044|459498698|FG000|Overall Study|Adverse Event|1|||
127691855|NCT04607044|459498698|FG000|Overall Study|Did not receive study device|3|||
127691856|NCT04607044|459498698|FG000|Overall Study|Death|1|||
127691857|NCT04059354|459498701|FG000|Overall Study|COVID-19 pandemic|3|||
127691858|NCT05403801|459498702|FG000|Overall Study|Withdrawal by Subject|2|||
127691859|NCT03651895|459498704|FG000|First Drug Assignment|Adverse Event|4|||
127691860|NCT03651895|459498705|FG001|First Drug Assignment|Adverse Event|5|||
127691861|NCT03651895|459498704|FG000|Second Drug Assignment - Crossover|Adverse Event|1|||
127691862|NCT03651895|459498705|FG001|Second Drug Assignment - Crossover|Adverse Event|1|||
127691863|NCT02525692|459498706|FG000|Overall Study|Withdrawal by Subject|1|||
127691864|NCT02525692|459498707|FG001|Overall Study|Withdrawal by Subject|1|||
127691865|NCT02525692|459498708|FG002|Overall Study|Withdrawal by Subject|0|||
127691866|NCT02525692|459498709|FG003|Overall Study|Withdrawal by Subject|5|||
127780375|NCT00935272|459823470|FG001|Overall Study|Withdrawal by Subject|2|||
127571660|NCT03519386|459062187|FG001|Overall Study|Lost to Follow-up|1|||
127571661|NCT03519386|459062188|FG002|Overall Study|Lost to Follow-up|1|||
127571662|NCT03519386|459062186|FG000|Overall Study|Death|1|||
127691867|NCT02525692|459498710|FG004|Overall Study|Withdrawal by Subject|0|||
127691868|NCT02525692|459498711|FG005|Overall Study|Withdrawal by Subject|1|||
127571663|NCT03519386|459062187|FG001|Overall Study|Death|0|||
127691869|NCT02525692|459498706|FG000|Overall Study|Death|16|||
127780376|NCT00935272|459823469|FG000|Overall Study|Physician Decision|1|||
127780377|NCT00935272|459823470|FG001|Overall Study|Physician Decision|0|||
127571664|NCT03519386|459062188|FG002|Overall Study|Death|4|||
127571665|NCT03519386|459062186|FG000|Overall Study|Adverse Event|2|||
127571666|NCT03519386|459062187|FG001|Overall Study|Adverse Event|1|||
127571667|NCT03519386|459062188|FG002|Overall Study|Adverse Event|2|||
127571668|NCT03519386|459062186|FG000|Overall Study|Explanted|2|||
127571669|NCT03519386|459062187|FG001|Overall Study|Explanted|1|||
127571670|NCT03519386|459062188|FG002|Overall Study|Explanted|0|||
127571671|NCT03519386|459062186|FG000|Overall Study|Ongoing in study|190|||
127571672|NCT03519386|459062187|FG001|Overall Study|Ongoing in study|192|||
127571673|NCT03519386|459062188|FG002|Overall Study|Ongoing in study|183|||
127571674|NCT04341662|459062190|FG000|Overall Study|Did not have source-verified blood loss data|423|||
128027606|NCT01696214|460725979|FG001|Overall Study|Lost to Follow-up|0|||
128027607|NCT01696214|460725980|FG002|Overall Study|Lost to Follow-up|0|||
128027608|NCT01696214|460725981|FG003|Overall Study|Lost to Follow-up|0|||
128027609|NCT00452530|460725985|FG000|Overall Study|Death|1|||
128027610|NCT00452530|460725986|FG001|Overall Study|Death|0|||
128027611|NCT00452530|460725985|FG000|Overall Study|Adverse Event|40|||
128027612|NCT00452530|460725986|FG001|Overall Study|Adverse Event|44|||
128027613|NCT00452530|460725985|FG000|Overall Study|Withdrawal by Subject|68|||
128027614|NCT00452530|460725986|FG001|Overall Study|Withdrawal by Subject|57|||
128027615|NCT00452530|460725985|FG000|Overall Study|Lost to Follow-up|1|||
128027616|NCT00452530|460725986|FG001|Overall Study|Lost to Follow-up|0|||
128027617|NCT00452530|460725985|FG000|Overall Study|Poor compliance/noncompliance|1|||
128027618|NCT00452530|460725986|FG001|Overall Study|Poor compliance/noncompliance|2|||
128027619|NCT00452530|460725985|FG000|Overall Study|No longer met study criteria|18|||
128027620|NCT00452530|460725986|FG001|Overall Study|No longer met study criteria|22|||
128027621|NCT00452530|460725985|FG000|Overall Study|Other|7|||
127571675|NCT04341662|459062191|FG001|Overall Study|Did not have source-verified blood loss data|514|||
127571676|NCT03101267|459062192|FG000|Primary Study Period|Withdrawal by Subject|1|||
127571677|NCT03101267|459062193|FG001|Primary Study Period|Withdrawal by Subject|2|||
127571678|NCT03101267|459062194|FG002|Primary Study Period|Withdrawal by Subject|3|||
127571679|NCT03101267|459062192|FG000|Primary Study Period|Miscellaneous|2|||
127571680|NCT03101267|459062193|FG001|Primary Study Period|Miscellaneous|0|||
127780378|NCT00935272|459823469|FG000|Overall Study|Protocol Violation|0|||
127780379|NCT00935272|459823470|FG001|Overall Study|Protocol Violation|1|||
128027622|NCT00452530|460725986|FG001|Overall Study|Other|11|||
128027623|NCT01618708|460725987|FG000|Overall Study|Adverse Event|10|||
128027624|NCT01618708|460725988|FG001|Overall Study|Adverse Event|10|||
128027625|NCT01618708|460725987|FG000|Overall Study|Lost to Follow-up|3|||
128027626|NCT01618708|460725988|FG001|Overall Study|Lost to Follow-up|3|||
128027627|NCT01618708|460725987|FG000|Overall Study|Withdrawal by Subject|17|||
128027628|NCT01618708|460725988|FG001|Overall Study|Withdrawal by Subject|22|||
128027629|NCT01618708|460725987|FG000|Overall Study|Lack of Efficacy|8|||
128027630|NCT01618708|460725988|FG001|Overall Study|Lack of Efficacy|8|||
128027631|NCT01618708|460725987|FG000|Overall Study|Technical problems|2|||
128027632|NCT01618708|460725988|FG001|Overall Study|Technical problems|0|||
128027633|NCT01618708|460725987|FG000|Overall Study|Other than specified above|1|||
128027634|NCT01618708|460725988|FG001|Overall Study|Other than specified above|1|||
128027635|NCT01618708|460725987|FG000|Overall Study|Randomized but not treated|3|||
128027636|NCT01618708|460725988|FG001|Overall Study|Randomized but not treated|2|||
128027637|NCT04128228|460725990|FG000|Overall Study|Withdrawal by Subject|3|||
128027638|NCT04128228|460725991|FG001|Overall Study|Withdrawal by Subject|3|||
128027639|NCT04128228|460725992|FG002|Overall Study|Withdrawal by Subject|0|||
128027640|NCT04128228|460725993|FG003|Overall Study|Withdrawal by Subject|0|||
128027641|NCT04128228|460725990|FG000|Overall Study|noncompliance|2|||
128027642|NCT04128228|460725991|FG001|Overall Study|noncompliance|2|||
128027643|NCT04128228|460725992|FG002|Overall Study|noncompliance|0|||
128027644|NCT04128228|460725993|FG003|Overall Study|noncompliance|0|||
128027645|NCT00215657|460725996|FG000|Overall Study|Adverse Event|5|||
127780380|NCT03492554|459823477|FG000|Overall Study|Protocol Violation|0|||
127780381|NCT03492554|459823478|FG001|Overall Study|Protocol Violation|14|||
127780382|NCT01478360|459823481|FG000|Overall Study|Lost to Follow-up|1|||
128027646|NCT00215657|460725997|FG001|Overall Study|Adverse Event|1|||
127571681|NCT03101267|459062194|FG002|Primary Study Period|Miscellaneous|0|||
127571682|NCT01222403|459062195|FG000|Overall Study|Inappropriate enrollment|0|||
127780383|NCT01478360|459823482|FG001|Overall Study|Lost to Follow-up|0|||
128027647|NCT00215657|460725998|FG002|Overall Study|Adverse Event|3|||
128027648|NCT00215657|460725999|FG003|Overall Study|Adverse Event|0|||
128027649|NCT00215657|460726000|FG004|Overall Study|Adverse Event|3|||
128027650|NCT00215657|460726001|FG005|Overall Study|Adverse Event|1|||
128027651|NCT00215657|460726002|FG006|Overall Study|Adverse Event|0|||
128027652|NCT00215657|460726003|FG007|Overall Study|Adverse Event|3|||
127571683|NCT01222403|459062196|FG001|Overall Study|Inappropriate enrollment|2|||
127571684|NCT02398227|459062197|FG000|Overall Study|Lost to Follow-up|21|||
128027653|NCT00215657|460725996|FG000|Overall Study|Withdrawal by Subject|6|||
128027654|NCT00215657|460725997|FG001|Overall Study|Withdrawal by Subject|3|||
128027655|NCT00215657|460725998|FG002|Overall Study|Withdrawal by Subject|3|||
127571685|NCT02398227|459062198|FG001|Overall Study|Lost to Follow-up|12|||
128027656|NCT00215657|460725999|FG003|Overall Study|Withdrawal by Subject|1|||
128027657|NCT00215657|460726000|FG004|Overall Study|Withdrawal by Subject|6|||
128027658|NCT00215657|460726001|FG005|Overall Study|Withdrawal by Subject|1|||
128027659|NCT00215657|460726002|FG006|Overall Study|Withdrawal by Subject|10|||
128027660|NCT00215657|460726003|FG007|Overall Study|Withdrawal by Subject|3|||
128027661|NCT00215657|460725996|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
128027662|NCT00215657|460725997|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
128027663|NCT00215657|460725998|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
128027664|NCT00215657|460725999|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
128027665|NCT00215657|460726000|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
128027666|NCT00215657|460726001|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
128027667|NCT00215657|460726002|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
128027668|NCT00215657|460726003|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
128027669|NCT00215657|460725996|FG000|Overall Study|Insufficient testosterone response|5|||
127571686|NCT02398227|459062197|FG000|Overall Study|Withdrawal by Subject|5|||
127571687|NCT02398227|459062198|FG001|Overall Study|Withdrawal by Subject|6|||
127571688|NCT02398227|459062197|FG000|Overall Study|Removed from treatment and dropped out|1|||
127691870|NCT02525692|459498707|FG001|Overall Study|Death|18|||
127691871|NCT02525692|459498708|FG002|Overall Study|Death|7|||
128027670|NCT00215657|460725997|FG001|Overall Study|Insufficient testosterone response|4|||
128027671|NCT00215657|460725998|FG002|Overall Study|Insufficient testosterone response|1|||
128027672|NCT00215657|460725999|FG003|Overall Study|Insufficient testosterone response|12|||
128027673|NCT00215657|460726000|FG004|Overall Study|Insufficient testosterone response|8|||
128027674|NCT00215657|460726001|FG005|Overall Study|Insufficient testosterone response|12|||
128027675|NCT00215657|460726002|FG006|Overall Study|Insufficient testosterone response|4|||
128027676|NCT00215657|460726003|FG007|Overall Study|Insufficient testosterone response|7|||
128027677|NCT00215657|460725996|FG000|Overall Study|Other|3|||
128027678|NCT00215657|460725997|FG001|Overall Study|Other|1|||
128027679|NCT00215657|460725998|FG002|Overall Study|Other|2|||
128027680|NCT00215657|460725999|FG003|Overall Study|Other|3|||
128027681|NCT00215657|460726000|FG004|Overall Study|Other|5|||
128027682|NCT00215657|460726001|FG005|Overall Study|Other|4|||
128027683|NCT00215657|460726002|FG006|Overall Study|Other|6|||
128027684|NCT00215657|460726003|FG007|Overall Study|Other|1|||
128027685|NCT03769467|460726004|FG000|Overall Study|Adverse Event|1|||
128027686|NCT03769467|460726005|FG001|Overall Study|Adverse Event|1|||
128027687|NCT03769467|460726006|FG002|Overall Study|Adverse Event|0|||
128027688|NCT03769467|460726004|FG000|Overall Study|Death|3|||
128027689|NCT03769467|460726005|FG001|Overall Study|Death|3|||
128027690|NCT03769467|460726006|FG002|Overall Study|Death|0|||
128027691|NCT03769467|460726004|FG000|Overall Study|Study Terminated By Sponsor|2|||
128027692|NCT03769467|460726005|FG001|Overall Study|Study Terminated By Sponsor|1|||
128027693|NCT03769467|460726006|FG002|Overall Study|Study Terminated By Sponsor|0|||
128027694|NCT03769467|460726004|FG000|Overall Study|Withdrawal by Subject|0|||
128027695|NCT03769467|460726005|FG001|Overall Study|Withdrawal by Subject|1|||
128027696|NCT03769467|460726006|FG002|Overall Study|Withdrawal by Subject|0|||
127571689|NCT02398227|459062198|FG001|Overall Study|Removed from treatment and dropped out|0|||
127691872|NCT02525692|459498709|FG003|Overall Study|Death|20|||
127691873|NCT02525692|459498710|FG004|Overall Study|Death|3|||
127691874|NCT02525692|459498711|FG005|Overall Study|Death|6|||
127691875|NCT02525692|459498706|FG000|Overall Study|Lost to Follow-up|0|||
127691876|NCT02525692|459498707|FG001|Overall Study|Lost to Follow-up|0|||
127691877|NCT02525692|459498708|FG002|Overall Study|Lost to Follow-up|1|||
127691878|NCT02525692|459498709|FG003|Overall Study|Lost to Follow-up|5|||
127691879|NCT02525692|459498710|FG004|Overall Study|Lost to Follow-up|0|||
127691880|NCT02525692|459498711|FG005|Overall Study|Lost to Follow-up|0|||
127691881|NCT02396199|459498712|FG000|Overall Study|Lost to Follow-up|1|||
127691882|NCT02396199|459498712|FG000|Overall Study|Death|4|||
127691883|NCT05307783|459498722|FG000|Overall Study|Death|7|||
127691884|NCT05307783|459498722|FG000|Overall Study|Lost to Follow-up|4|||
127691885|NCT04883645|459498723|FG000|Overall Study|Death|1|||
127691886|NCT05687903|459498724|FG000|Overall Study|Protocol Deviation|1|||
127691887|NCT05687903|459498725|FG001|Overall Study|Protocol Deviation|1|||
128027697|NCT02614066|460726007|FG000|Overall Study|Death|6|||
128027698|NCT02614066|460726008|FG001|Overall Study|Death|14|||
128027699|NCT02614066|460726009|FG002|Overall Study|Death|11|||
128027700|NCT02614066|460726010|FG003|Overall Study|Death|29|||
127571690|NCT01028378|459062200|FG000|Overall Study|Lost to Follow-up|12|||
127691888|NCT05687903|459498726|FG002|Overall Study|Protocol Deviation|0|||
127691889|NCT05687903|459498727|FG003|Overall Study|Protocol Deviation|1|||
127691890|NCT05687903|459498728|FG004|Overall Study|Protocol Deviation|0|||
127691891|NCT04855760|459498729|FG000|Overall Study|Adverse Event|21|||
127691892|NCT04855760|459498729|FG000|Overall Study|Withdrawal by Subject|116|||
127691893|NCT04855760|459498729|FG000|Overall Study|Lack of Efficacy|21|||
128027701|NCT02614066|460726007|FG000|Overall Study|Full consent withdrawn|0|||
128027702|NCT02614066|460726008|FG001|Overall Study|Full consent withdrawn|1|||
128027703|NCT02614066|460726009|FG002|Overall Study|Full consent withdrawn|0|||
128027704|NCT02614066|460726010|FG003|Overall Study|Full consent withdrawn|8|||
128027705|NCT02614066|460726007|FG000|Overall Study|Lost to Follow-up|0|||
128027706|NCT02614066|460726008|FG001|Overall Study|Lost to Follow-up|2|||
128027707|NCT02614066|460726009|FG002|Overall Study|Lost to Follow-up|2|||
128027708|NCT02614066|460726010|FG003|Overall Study|Lost to Follow-up|2|||
128027709|NCT02614066|460726007|FG000|Overall Study|Enrolled but did not Initiate KTE-X19|0|||
128027710|NCT02614066|460726008|FG001|Overall Study|Enrolled but did not Initiate KTE-X19|5|||
128027711|NCT02614066|460726009|FG002|Overall Study|Enrolled but did not Initiate KTE-X19|4|||
128027712|NCT02614066|460726010|FG003|Overall Study|Enrolled but did not Initiate KTE-X19|16|||
128027713|NCT02614066|460726007|FG000|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|0|||
128027714|NCT02614066|460726008|FG001|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|4|||
128027715|NCT02614066|460726009|FG002|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|2|||
128027716|NCT02614066|460726010|FG003|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|15|||
128027717|NCT02614066|460726007|FG000|Overall Study|Reason not specified|0|||
128027718|NCT02614066|460726008|FG001|Overall Study|Reason not specified|2|||
128027719|NCT02614066|460726009|FG002|Overall Study|Reason not specified|1|||
128027720|NCT02614066|460726010|FG003|Overall Study|Reason not specified|1|||
128027721|NCT03624036|460726017|FG000|Overall Study|Death|2|||
128027722|NCT03624036|460726018|FG001|Overall Study|Death|3|||
128027723|NCT03624036|460726019|FG002|Overall Study|Death|0|||
128027724|NCT03624036|460726020|FG003|Overall Study|Death|1|||
128027725|NCT03624036|460726017|FG000|Overall Study|Withdrawal by Subject|1|||
128027726|NCT03624036|460726018|FG001|Overall Study|Withdrawal by Subject|0|||
128027727|NCT03624036|460726019|FG002|Overall Study|Withdrawal by Subject|1|||
128027728|NCT03624036|460726020|FG003|Overall Study|Withdrawal by Subject|0|||
128027729|NCT03624036|460726017|FG000|Overall Study|Enrolled but Never Treated|1|||
128027730|NCT03624036|460726018|FG001|Overall Study|Enrolled but Never Treated|0|||
128027731|NCT03624036|460726019|FG002|Overall Study|Enrolled but Never Treated|0|||
127780384|NCT01478360|459823481|FG000|Overall Study|Adverse Event|0|||
127780385|NCT01478360|459823482|FG001|Overall Study|Adverse Event|1|||
128027732|NCT03624036|460726020|FG003|Overall Study|Enrolled but Never Treated|0|||
128027733|NCT03624036|460726017|FG000|Overall Study|Reason not Specified|3|||
128027734|NCT03624036|460726018|FG001|Overall Study|Reason not Specified|0|||
128027735|NCT03624036|460726019|FG002|Overall Study|Reason not Specified|2|||
128027736|NCT03624036|460726020|FG003|Overall Study|Reason not Specified|2|||
128027737|NCT02413346|460726027|FG000|Overall Study|Adverse Event|6|||
128027738|NCT02413346|460726028|FG001|Overall Study|Adverse Event|6|||
128027739|NCT02413346|460726027|FG000|Overall Study|Withdrawal by Subject|30|||
128027740|NCT02413346|460726028|FG001|Overall Study|Withdrawal by Subject|40|||
128027741|NCT02413346|460726027|FG000|Overall Study|Lost to Follow-up|17|||
128027742|NCT02413346|460726028|FG001|Overall Study|Lost to Follow-up|21|||
128027743|NCT02413346|460726027|FG000|Overall Study|Protocol Violation|2|||
127780386|NCT01478360|459823481|FG000|Overall Study|Administrative problems|1|||
127780387|NCT01478360|459823482|FG001|Overall Study|Administrative problems|2|||
127780388|NCT02289352|459823483|FG000|Overall Study|Withdrawal by Subject|1|||
127780389|NCT02289352|459823484|FG001|Overall Study|Withdrawal by Subject|1|||
127780390|NCT02289352|459823485|FG002|Overall Study|Withdrawal by Subject|0|||
127780391|NCT00911625|459823511|FG000|Overall Study|Lost to Follow-up|7|||
127780392|NCT00911625|459823512|FG001|Overall Study|Lost to Follow-up|0|||
127780393|NCT02463071|459823520|FG000|Overall Study|Adverse Event|3|||
127780394|NCT02463071|459823521|FG001|Overall Study|Adverse Event|5|||
127780395|NCT02463071|459823522|FG002|Overall Study|Adverse Event|1|||
127780396|NCT02463071|459823520|FG000|Overall Study|Death|1|||
127780397|NCT02463071|459823521|FG001|Overall Study|Death|0|||
127780398|NCT02463071|459823522|FG002|Overall Study|Death|0|||
127780399|NCT02463071|459823520|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
127780400|NCT02463071|459823521|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
127780401|NCT02463071|459823522|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
128027744|NCT02413346|460726028|FG001|Overall Study|Protocol Violation|0|||
128027745|NCT02413346|460726027|FG000|Overall Study|Other Miscellaneous Reasons|4|||
128027746|NCT02413346|460726028|FG001|Overall Study|Other Miscellaneous Reasons|3|||
128027747|NCT01316900|460726032|FG000|Overall Study|Adverse Event|10|||
128027748|NCT01316900|460726033|FG001|Overall Study|Adverse Event|10|||
128027749|NCT01316900|460726034|FG002|Overall Study|Adverse Event|15|||
128027750|NCT01316900|460726035|FG003|Overall Study|Adverse Event|9|||
128027751|NCT01316900|460726032|FG000|Overall Study|Lack of Efficacy|17|||
128027752|NCT01316900|460726033|FG001|Overall Study|Lack of Efficacy|9|||
128027753|NCT01316900|460726034|FG002|Overall Study|Lack of Efficacy|5|||
128027754|NCT01316900|460726035|FG003|Overall Study|Lack of Efficacy|7|||
128027755|NCT01316900|460726032|FG000|Overall Study|Protocol Violation|7|||
128027756|NCT01316900|460726033|FG001|Overall Study|Protocol Violation|1|||
128027757|NCT01316900|460726034|FG002|Overall Study|Protocol Violation|4|||
128027758|NCT01316900|460726035|FG003|Overall Study|Protocol Violation|0|||
127780402|NCT02463071|459823520|FG000|Overall Study|Reason not specified|7|||
127780403|NCT02463071|459823521|FG001|Overall Study|Reason not specified|9|||
127780404|NCT02463071|459823522|FG002|Overall Study|Reason not specified|4|||
127780405|NCT02463071|459823520|FG000|Overall Study|Protocol Violation|0|||
128027759|NCT01316900|460726032|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
128027760|NCT01316900|460726033|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
128027761|NCT01316900|460726034|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
128027762|NCT01316900|460726035|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
128027763|NCT01316900|460726032|FG000|Overall Study|Lost to Follow-up|1|||
128027764|NCT01316900|460726033|FG001|Overall Study|Lost to Follow-up|0|||
128027765|NCT01316900|460726034|FG002|Overall Study|Lost to Follow-up|1|||
128027766|NCT01316900|460726035|FG003|Overall Study|Lost to Follow-up|1|||
128027767|NCT01316900|460726032|FG000|Overall Study|Withdrawal by Subject|7|||
128027768|NCT01316900|460726033|FG001|Overall Study|Withdrawal by Subject|8|||
128027769|NCT01316900|460726034|FG002|Overall Study|Withdrawal by Subject|6|||
128027770|NCT01316900|460726035|FG003|Overall Study|Withdrawal by Subject|9|||
128027771|NCT01684033|460726036|FG000|Period 1, First 30 Days|Adverse Event|1|||
128027772|NCT01684033|460726037|FG001|Period 1, First 30 Days|Adverse Event|1|||
128027773|NCT01684033|460726036|FG000|Period 1, First 30 Days|Noncompliance|1|||
128027774|NCT01684033|460726037|FG001|Period 1, First 30 Days|Noncompliance|0|||
128027775|NCT01684033|460726036|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
128027776|NCT01684033|460726037|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
128027777|NCT01684033|460726036|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
128027778|NCT01684033|460726037|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
128027779|NCT01684033|460726036|FG000|Period 2, Second 30 Days|Adverse Event|1|||
128027780|NCT01684033|460726037|FG001|Period 2, Second 30 Days|Adverse Event|0|||
128027781|NCT00954538|460726040|FG000|Part III|Withdrawal by Subject|0|||
128027782|NCT00954538|460726041|FG001|Part III|Withdrawal by Subject|0|||
128027783|NCT00954538|460726042|FG002|Part III|Withdrawal by Subject|0|||
128027784|NCT00954538|460726043|FG003|Part III|Withdrawal by Subject|0|||
128027785|NCT00954538|460726044|FG004|Part III|Withdrawal by Subject|1|||
128027786|NCT00954538|460726045|FG005|Part III|Withdrawal by Subject|0|||
128027787|NCT02931539|460726050|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
128027788|NCT02931539|460726051|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
128027789|NCT02931539|460726052|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
128027790|NCT02931539|460726050|FG000|Period 1: Treatment Phase|Adverse Event|5|||
128027791|NCT02931539|460726051|FG001|Period 1: Treatment Phase|Adverse Event|1|||
128027792|NCT02931539|460726052|FG002|Period 1: Treatment Phase|Adverse Event|0|||
128027793|NCT02931539|460726050|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
127691894|NCT04855760|459498729|FG000|Overall Study|Lost to Follow-up|49|||
127691895|NCT04855760|459498729|FG000|Overall Study|Protocol Violation|2|||
127691896|NCT04855760|459498729|FG000|Overall Study|Physician Decision|5|||
127691897|NCT04855760|459498729|FG000|Overall Study|Pregnancy|1|||
127691898|NCT04855760|459498729|FG000|Overall Study|Non-Compliance with Study Drug|11|||
127691899|NCT04855760|459498729|FG000|Overall Study|Non-Compliance with Study Schedule|4|||
127691900|NCT04855760|459498729|FG000|Overall Study|Study Completed by Sponsor|202|||
127691901|NCT04855760|459498729|FG000|Overall Study|Other|13|||
127691902|NCT05613205|459498730|FG000|Overall Study|Lost to Follow-up|0|||
127691903|NCT05613205|459498731|FG001|Overall Study|Lost to Follow-up|0|||
127691904|NCT05613205|459498732|FG002|Overall Study|Lost to Follow-up|1|||
127691905|NCT05613205|459498733|FG003|Overall Study|Lost to Follow-up|1|||
127691906|NCT05613205|459498734|FG004|Overall Study|Lost to Follow-up|0|||
127691907|NCT05613205|459498730|FG000|Overall Study|Withdrawal by Subject|0|||
127691908|NCT05613205|459498731|FG001|Overall Study|Withdrawal by Subject|0|||
127691909|NCT05613205|459498732|FG002|Overall Study|Withdrawal by Subject|1|||
127691910|NCT05613205|459498733|FG003|Overall Study|Withdrawal by Subject|1|||
127691911|NCT05613205|459498734|FG004|Overall Study|Withdrawal by Subject|0|||
127691912|NCT04869982|459498742|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
127691913|NCT04869982|459498743|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
127691914|NCT04869982|459498742|FG000|Overall Study|Migrated / moved from the study area|1|||
127691915|NCT04869982|459498743|FG001|Overall Study|Migrated / moved from the study area|1|||
127691916|NCT04869982|459498742|FG000|Overall Study|Adverse event requiring expedited reporting|13|||
127691917|NCT04869982|459498743|FG001|Overall Study|Adverse event requiring expedited reporting|11|||
127691918|NCT04869982|459498742|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
127691919|NCT04869982|459498743|FG001|Overall Study|Unsolicited non-serious adverse event|1|||
127691920|NCT04869982|459498742|FG000|Overall Study|Solicited adverse event|2|||
127691921|NCT04869982|459498743|FG001|Overall Study|Solicited adverse event|1|||
127691922|NCT02201108|459498746|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
127691923|NCT02201108|459498747|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
127691924|NCT02201108|459498748|FG002|Double-blind Period (up to Week 96)|Adverse Event|0|||
127691925|NCT02201108|459498746|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
127691926|NCT02201108|459498747|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
127780406|NCT02463071|459823521|FG001|Overall Study|Protocol Violation|2|||
128027794|NCT02931539|460726051|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
128027795|NCT02931539|460726052|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
128027796|NCT02931539|460726050|FG000|Period 1: Treatment Phase|Death|8|||
128027797|NCT02931539|460726051|FG001|Period 1: Treatment Phase|Death|24|||
128027798|NCT02931539|460726052|FG002|Period 1: Treatment Phase|Death|0|||
128027799|NCT02931539|460726050|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
128027800|NCT02931539|460726051|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
128027801|NCT02931539|460726052|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
128027802|NCT02931539|460726050|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
128027803|NCT02931539|460726051|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
128027804|NCT02931539|460726052|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
128027805|NCT02931539|460726050|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
128027806|NCT02931539|460726051|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
128027807|NCT02931539|460726052|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
128027808|NCT02931539|460726050|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
128027809|NCT02931539|460726051|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
128027810|NCT02931539|460726052|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
128027811|NCT03178942|460726055|FG000|Overall Study|Withdrawal by Subject|2|||
128027812|NCT03178942|460726056|FG001|Overall Study|Withdrawal by Subject|0|||
128027813|NCT03178942|460726055|FG000|Overall Study|Lost to Follow-up|1|||
128027814|NCT03178942|460726056|FG001|Overall Study|Lost to Follow-up|2|||
128027815|NCT03061214|460726060|FG000|Overall Study|Withdrawal by Subject|21|||
128027816|NCT03061214|460726061|FG001|Overall Study|Withdrawal by Subject|26|||
128027817|NCT03061214|460726062|FG002|Overall Study|Withdrawal by Subject|9|||
128027818|NCT03061214|460726060|FG000|Overall Study|Lost to Follow-up|3|||
128027819|NCT03061214|460726061|FG001|Overall Study|Lost to Follow-up|1|||
128027820|NCT03061214|460726062|FG002|Overall Study|Lost to Follow-up|1|||
128027821|NCT03061214|460726060|FG000|Overall Study|Death|1|||
128027822|NCT03061214|460726061|FG001|Overall Study|Death|1|||
128027823|NCT03061214|460726062|FG002|Overall Study|Death|0|||
128027824|NCT03810365|460728360|FG000|Overall Study|Lost to Follow-up|2|||
128027825|NCT03810365|460728361|FG001|Overall Study|Lost to Follow-up|2|||
128027826|NCT03810365|460728360|FG000|Overall Study|Withdrawal by Subject|4|||
128027827|NCT03810365|460728361|FG001|Overall Study|Withdrawal by Subject|5|||
128027828|NCT00107614|460728368|FG000|Overall Study|Physician Decision|10|||
128027829|NCT00107614|460728368|FG000|Overall Study|Death|2|||
128027830|NCT02094885|460728377|FG000|Overall Study|Death|1|||
128027831|NCT02094885|460728378|FG001|Overall Study|Death|5|||
128027832|NCT02094885|460728377|FG000|Overall Study|Withdrawn due to age|1|||
128027833|NCT02094885|460728378|FG001|Overall Study|Withdrawn due to age|0|||
128027834|NCT00215553|460728385|FG000|Overall Study|Adverse Event|0|||
128027835|NCT00215553|460728386|FG001|Overall Study|Adverse Event|1|||
128027836|NCT00215553|460728387|FG002|Overall Study|Adverse Event|2|||
128027837|NCT00215553|460728388|FG003|Overall Study|Adverse Event|1|||
128027838|NCT00215553|460728389|FG004|Overall Study|Adverse Event|2|||
128027839|NCT00215553|460728390|FG005|Overall Study|Adverse Event|6|||
128027840|NCT00215553|460728391|FG006|Overall Study|Adverse Event|0|||
128027841|NCT00756314|460728392|FG000|Overall Study|Lost to Follow-up|2|||
128027842|NCT00756314|460728393|FG001|Overall Study|Lost to Follow-up|59|||
128027843|NCT02605967|460728395|FG000|Overall Study|subject / guardian decision|1|||
128027844|NCT02605967|460728396|FG001|Overall Study|subject / guardian decision|2|||
128027845|NCT02605967|460728395|FG000|Overall Study|Physician Decision|10|||
128027846|NCT02605967|460728396|FG001|Overall Study|Physician Decision|1|||
128027847|NCT02605967|460728395|FG000|Overall Study|Death|4|||
127571691|NCT01028378|459062200|FG000|Overall Study|Withdrawal by Subject|1|||
127571692|NCT01028378|459062200|FG000|Overall Study|Adminstrative Reasons|4|||
127571693|NCT01262352|459062201|FG000|Period 1|Illness after randomization|1|||
127571694|NCT01262352|459062202|FG001|Period 1|Illness after randomization|0|||
127571695|NCT01262352|459062201|FG000|Washout|Adverse Event|1|||
127571696|NCT01262352|459062202|FG001|Washout|Adverse Event|1|||
127571697|NCT01262352|459062201|FG000|Washout|Extended Washout|0|||
127571698|NCT01262352|459062202|FG001|Washout|Extended Washout|1|||
127571699|NCT01185834|459062206|FG000|Overall Study|Lost to Follow-up|2|||
127571700|NCT01185834|459062206|FG000|Overall Study|Discomfort|4|||
127780407|NCT02463071|459823522|FG002|Overall Study|Protocol Violation|0|||
128027848|NCT02605967|460728396|FG001|Overall Study|Death|2|||
128027849|NCT02605967|460728395|FG000|Overall Study|Adverse Event|1|||
128027850|NCT02605967|460728396|FG001|Overall Study|Adverse Event|0|||
128027851|NCT02605967|460728395|FG000|Overall Study|progressive disease|66|||
128027852|NCT02605967|460728396|FG001|Overall Study|progressive disease|35|||
127571701|NCT01185834|459062206|FG000|Overall Study|Biomicroscopy|4|||
127571702|NCT01185834|459062206|FG000|Overall Study|Time/Job Conflict|2|||
127571703|NCT01185834|459062206|FG000|Overall Study|Early exit - Site error|2|||
128027853|NCT00159874|460728398|FG000|Overall Study|Adverse Event|2|||
128027854|NCT00159874|460728399|FG001|Overall Study|Adverse Event|2|||
128027855|NCT00159874|460728400|FG002|Overall Study|Adverse Event|5|||
128027856|NCT00159874|460728401|FG003|Overall Study|Adverse Event|1|||
128027857|NCT00159874|460728402|FG004|Overall Study|Adverse Event|1|||
128027858|NCT00159874|460728403|FG005|Overall Study|Adverse Event|2|||
128027859|NCT00159874|460728404|FG006|Overall Study|Adverse Event|0|||
128027860|NCT00159874|460728398|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
128027861|NCT00159874|460728399|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
128027862|NCT00159874|460728400|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
128027863|NCT00159874|460728401|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
128027864|NCT00159874|460728402|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
128027865|NCT00159874|460728403|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
128027866|NCT00159874|460728404|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
128027867|NCT00159874|460728398|FG000|Overall Study|Lack of Efficacy|2|||
128027868|NCT00159874|460728399|FG001|Overall Study|Lack of Efficacy|0|||
128027869|NCT00159874|460728400|FG002|Overall Study|Lack of Efficacy|1|||
128027870|NCT00159874|460728401|FG003|Overall Study|Lack of Efficacy|1|||
128027871|NCT00159874|460728402|FG004|Overall Study|Lack of Efficacy|0|||
128027872|NCT00159874|460728403|FG005|Overall Study|Lack of Efficacy|3|||
128027873|NCT00159874|460728404|FG006|Overall Study|Lack of Efficacy|0|||
128027874|NCT00159874|460728398|FG000|Overall Study|Lost to Follow-up|1|||
128027875|NCT00159874|460728399|FG001|Overall Study|Lost to Follow-up|0|||
128027876|NCT00159874|460728400|FG002|Overall Study|Lost to Follow-up|3|||
128027877|NCT00159874|460728401|FG003|Overall Study|Lost to Follow-up|0|||
128027878|NCT00159874|460728402|FG004|Overall Study|Lost to Follow-up|1|||
128027879|NCT00159874|460728403|FG005|Overall Study|Lost to Follow-up|2|||
128027880|NCT00159874|460728404|FG006|Overall Study|Lost to Follow-up|1|||
128027881|NCT00159874|460728398|FG000|Overall Study|Other|8|||
128027882|NCT00159874|460728399|FG001|Overall Study|Other|8|||
128027883|NCT00159874|460728400|FG002|Overall Study|Other|8|||
128027884|NCT00159874|460728401|FG003|Overall Study|Other|0|||
128027885|NCT00159874|460728402|FG004|Overall Study|Other|2|||
128027886|NCT00159874|460728403|FG005|Overall Study|Other|1|||
128027887|NCT00159874|460728404|FG006|Overall Study|Other|3|||
128027888|NCT00159874|460728398|FG000|Overall Study|Protocol Violation|0|||
128027889|NCT00159874|460728399|FG001|Overall Study|Protocol Violation|5|||
128027890|NCT00159874|460728400|FG002|Overall Study|Protocol Violation|2|||
128027891|NCT00159874|460728401|FG003|Overall Study|Protocol Violation|0|||
128027892|NCT00159874|460728402|FG004|Overall Study|Protocol Violation|0|||
128027893|NCT00159874|460728403|FG005|Overall Study|Protocol Violation|0|||
128027894|NCT00159874|460728404|FG006|Overall Study|Protocol Violation|0|||
127571704|NCT01975831|459062207|FG000|Overall Study|Adverse Event|1|||
127571705|NCT01975831|459062208|FG001|Overall Study|Adverse Event|2|||
127571706|NCT01975831|459062209|FG002|Overall Study|Adverse Event|2|||
127691927|NCT02201108|459498748|FG002|Double-blind Period (up to Week 96)|Lack of Efficacy|0|||
127691928|NCT02201108|459498746|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
128027895|NCT00159874|460728398|FG000|Overall Study|Death|3|||
128027896|NCT00159874|460728399|FG001|Overall Study|Death|8|||
128027897|NCT00159874|460728400|FG002|Overall Study|Death|15|||
128027898|NCT00159874|460728401|FG003|Overall Study|Death|0|||
128027899|NCT00159874|460728402|FG004|Overall Study|Death|1|||
128027900|NCT00159874|460728403|FG005|Overall Study|Death|2|||
128027901|NCT00159874|460728404|FG006|Overall Study|Death|0|||
128027902|NCT00159874|460728398|FG000|Overall Study|Withdrawal by Subject|2|||
128027903|NCT00159874|460728399|FG001|Overall Study|Withdrawal by Subject|6|||
128027904|NCT00159874|460728400|FG002|Overall Study|Withdrawal by Subject|8|||
128027905|NCT00159874|460728401|FG003|Overall Study|Withdrawal by Subject|4|||
128027906|NCT00159874|460728402|FG004|Overall Study|Withdrawal by Subject|3|||
128027907|NCT00159874|460728403|FG005|Overall Study|Withdrawal by Subject|2|||
128027908|NCT00159874|460728404|FG006|Overall Study|Withdrawal by Subject|1|||
127691929|NCT02201108|459498747|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
127691930|NCT02201108|459498748|FG002|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
127691931|NCT02201108|459498746|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
127691932|NCT02201108|459498747|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
127691933|NCT02201108|459498748|FG002|Open Label Period (up to Week 192)|Lack of Efficacy|0|||
127691934|NCT02201108|459498746|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
127691935|NCT02201108|459498747|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
127691936|NCT02201108|459498748|FG002|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
127691937|NCT02201108|459498746|FG000|Open Label Period (up to Week 192)|Other reason|4|||
128027909|NCT00159874|460728398|FG000|Overall Study|Pregnancy|1|||
128027910|NCT00159874|460728399|FG001|Overall Study|Pregnancy|1|||
128027911|NCT00159874|460728400|FG002|Overall Study|Pregnancy|0|||
128027912|NCT00159874|460728401|FG003|Overall Study|Pregnancy|0|||
128027913|NCT00159874|460728402|FG004|Overall Study|Pregnancy|0|||
127571707|NCT01975831|459062210|FG003|Overall Study|Adverse Event|0|||
127571708|NCT01975831|459062211|FG004|Overall Study|Adverse Event|1|||
127691938|NCT02201108|459498747|FG001|Open Label Period (up to Week 192)|Other reason|7|||
128027914|NCT00159874|460728403|FG005|Overall Study|Pregnancy|0|||
128027915|NCT00159874|460728404|FG006|Overall Study|Pregnancy|0|||
128027916|NCT01475825|460728408|FG000|Overall Study|Adverse Event|41|||
128027917|NCT01475825|460728409|FG001|Overall Study|Adverse Event|15|||
128027918|NCT01475825|460728410|FG002|Overall Study|Adverse Event|27|||
128027919|NCT01475825|460728411|FG003|Overall Study|Adverse Event|11|||
128027920|NCT01475825|460728408|FG000|Overall Study|Death|1|||
128027921|NCT01475825|460728409|FG001|Overall Study|Death|0|||
128027922|NCT01475825|460728410|FG002|Overall Study|Death|1|||
128027923|NCT01475825|460728411|FG003|Overall Study|Death|0|||
128027924|NCT01475825|460728408|FG000|Overall Study|Lack of Efficacy|0|||
128027925|NCT01475825|460728409|FG001|Overall Study|Lack of Efficacy|0|||
128027926|NCT01475825|460728410|FG002|Overall Study|Lack of Efficacy|1|||
127571709|NCT01975831|459062212|FG005|Overall Study|Adverse Event|1|||
127571710|NCT01975831|459062213|FG006|Overall Study|Adverse Event|3|||
127571711|NCT01975831|459062214|FG007|Overall Study|Adverse Event|4|||
127571712|NCT01975831|459062215|FG008|Overall Study|Adverse Event|1|||
127571713|NCT01975831|459062207|FG000|Overall Study|Death|1|||
127571714|NCT01975831|459062208|FG001|Overall Study|Death|1|||
127571715|NCT01975831|459062209|FG002|Overall Study|Death|0|||
127571716|NCT01975831|459062210|FG003|Overall Study|Death|0|||
127571717|NCT01975831|459062211|FG004|Overall Study|Death|1|||
127571718|NCT01975831|459062212|FG005|Overall Study|Death|0|||
127571719|NCT01975831|459062213|FG006|Overall Study|Death|1|||
127571720|NCT01975831|459062214|FG007|Overall Study|Death|0|||
127571721|NCT01975831|459062215|FG008|Overall Study|Death|0|||
127571722|NCT01975831|459062207|FG000|Overall Study|Progressive Disease|1|||
127571723|NCT01975831|459062208|FG001|Overall Study|Progressive Disease|3|||
127571724|NCT01975831|459062209|FG002|Overall Study|Progressive Disease|2|||
127571725|NCT01975831|459062210|FG003|Overall Study|Progressive Disease|4|||
127571726|NCT01975831|459062211|FG004|Overall Study|Progressive Disease|13|||
127571727|NCT01975831|459062212|FG005|Overall Study|Progressive Disease|9|||
127571728|NCT01975831|459062213|FG006|Overall Study|Progressive Disease|10|||
127571729|NCT01975831|459062214|FG007|Overall Study|Progressive Disease|8|||
127571730|NCT01975831|459062215|FG008|Overall Study|Progressive Disease|10|||
127571731|NCT01975831|459062207|FG000|Overall Study|Withdrawal by Subject|0|||
127571732|NCT01975831|459062208|FG001|Overall Study|Withdrawal by Subject|3|||
128027927|NCT01475825|460728411|FG003|Overall Study|Lack of Efficacy|0|||
128027928|NCT01475825|460728408|FG000|Overall Study|Lost to Follow-up|0|||
128027929|NCT01475825|460728409|FG001|Overall Study|Lost to Follow-up|0|||
128027930|NCT01475825|460728410|FG002|Overall Study|Lost to Follow-up|3|||
128027931|NCT01475825|460728411|FG003|Overall Study|Lost to Follow-up|1|||
128027932|NCT01475825|460728408|FG000|Overall Study|Non-compliance with Study Drug|1|||
128027933|NCT01475825|460728409|FG001|Overall Study|Non-compliance with Study Drug|2|||
128027934|NCT01475825|460728410|FG002|Overall Study|Non-compliance with Study Drug|4|||
128027935|NCT01475825|460728411|FG003|Overall Study|Non-compliance with Study Drug|0|||
128027936|NCT01475825|460728408|FG000|Overall Study|Other: Not available|0|||
128027937|NCT01475825|460728409|FG001|Overall Study|Other: Not available|0|||
128027938|NCT01475825|460728410|FG002|Overall Study|Other: Not available|2|||
128027939|NCT01475825|460728411|FG003|Overall Study|Other: Not available|0|||
128027940|NCT01475825|460728408|FG000|Overall Study|Protocol Violation|1|||
128027941|NCT01475825|460728409|FG001|Overall Study|Protocol Violation|0|||
128027942|NCT01475825|460728410|FG002|Overall Study|Protocol Violation|0|||
128027943|NCT01475825|460728411|FG003|Overall Study|Protocol Violation|0|||
128027944|NCT01475825|460728408|FG000|Overall Study|Physician Decision|0|||
127571733|NCT01975831|459062209|FG002|Overall Study|Withdrawal by Subject|0|||
127571734|NCT01975831|459062210|FG003|Overall Study|Withdrawal by Subject|0|||
127571735|NCT01975831|459062211|FG004|Overall Study|Withdrawal by Subject|3|||
127571736|NCT01975831|459062212|FG005|Overall Study|Withdrawal by Subject|1|||
127571737|NCT01975831|459062213|FG006|Overall Study|Withdrawal by Subject|1|||
127571738|NCT01975831|459062214|FG007|Overall Study|Withdrawal by Subject|0|||
127571739|NCT01975831|459062215|FG008|Overall Study|Withdrawal by Subject|0|||
127571740|NCT01975831|459062207|FG000|Overall Study|Physician Decision|0|||
127571741|NCT01975831|459062208|FG001|Overall Study|Physician Decision|0|||
127571742|NCT01975831|459062209|FG002|Overall Study|Physician Decision|0|||
127571743|NCT01975831|459062210|FG003|Overall Study|Physician Decision|0|||
127571744|NCT01975831|459062211|FG004|Overall Study|Physician Decision|0|||
127571745|NCT01975831|459062212|FG005|Overall Study|Physician Decision|1|||
127571746|NCT01975831|459062213|FG006|Overall Study|Physician Decision|0|||
127571747|NCT01975831|459062214|FG007|Overall Study|Physician Decision|1|||
127571748|NCT01975831|459062215|FG008|Overall Study|Physician Decision|0|||
127571749|NCT01975831|459062207|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
127571750|NCT01975831|459062208|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
127571751|NCT01975831|459062209|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
128027945|NCT01475825|460728409|FG001|Overall Study|Physician Decision|1|||
128027946|NCT01475825|460728410|FG002|Overall Study|Physician Decision|0|||
128027947|NCT01475825|460728411|FG003|Overall Study|Physician Decision|0|||
128027948|NCT01475825|460728408|FG000|Overall Study|Withdrawal by Subject|8|||
128027949|NCT01475825|460728409|FG001|Overall Study|Withdrawal by Subject|3|||
127571752|NCT01975831|459062210|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
127571753|NCT01975831|459062211|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
127571754|NCT01975831|459062212|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
128027950|NCT01475825|460728410|FG002|Overall Study|Withdrawal by Subject|11|||
128027951|NCT01475825|460728411|FG003|Overall Study|Withdrawal by Subject|7|||
127571755|NCT01975831|459062213|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
127571756|NCT01975831|459062214|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
127571757|NCT01975831|459062215|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
127691939|NCT02201108|459498748|FG002|Open Label Period (up to Week 192)|Other reason|0|||
127691940|NCT02201108|459498746|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
127691941|NCT02201108|459498747|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
127691942|NCT02201108|459498748|FG002|Open Label Period (up to Week 192)|Adverse Event|0|||
127691943|NCT02201108|459498746|FG000|Extension Period (Up to Week 492)|Adverse Event|0|||
127691944|NCT02201108|459498747|FG001|Extension Period (Up to Week 492)|Adverse Event|0|||
127691945|NCT02201108|459498748|FG002|Extension Period (Up to Week 492)|Adverse Event|2|||
127691946|NCT02201108|459498746|FG000|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
127571758|NCT01975831|459062207|FG000|Overall Study|Entered Hospice|0|||
127571759|NCT01975831|459062208|FG001|Overall Study|Entered Hospice|0|||
127571760|NCT01975831|459062209|FG002|Overall Study|Entered Hospice|0|||
127571761|NCT01975831|459062210|FG003|Overall Study|Entered Hospice|0|||
127571762|NCT01975831|459062211|FG004|Overall Study|Entered Hospice|0|||
127571763|NCT01975831|459062212|FG005|Overall Study|Entered Hospice|1|||
127780408|NCT02463071|459823520|FG000|Overall Study|Lost to Follow-up|0|||
127780409|NCT02463071|459823521|FG001|Overall Study|Lost to Follow-up|0|||
127780410|NCT02463071|459823522|FG002|Overall Study|Lost to Follow-up|1|||
127780411|NCT00698932|459823523|FG000|Overall Study|Adverse Event|0|||
127780412|NCT00698932|459823524|FG001|Overall Study|Adverse Event|2|||
127780413|NCT00698932|459823523|FG000|Overall Study|Incorrect enrollment|0|||
127780414|NCT00698932|459823524|FG001|Overall Study|Incorrect enrollment|2|||
127780415|NCT00698932|459823523|FG000|Overall Study|Study specific discontinuation criteria|3|||
127780416|NCT00698932|459823524|FG001|Overall Study|Study specific discontinuation criteria|4|||
127780417|NCT00698932|459823523|FG000|Overall Study|Withdrawal by Subject|11|||
127780418|NCT00698932|459823524|FG001|Overall Study|Withdrawal by Subject|23|||
127780419|NCT00698932|459823523|FG000|Overall Study|Lost to Follow-up|6|||
127780420|NCT00698932|459823524|FG001|Overall Study|Lost to Follow-up|1|||
127780421|NCT00698932|459823523|FG000|Overall Study|Severe non-compliance to protocol|1|||
127780422|NCT00698932|459823524|FG001|Overall Study|Severe non-compliance to protocol|2|||
127780423|NCT00698932|459823523|FG000|Overall Study|Safety reasons|0|||
127780424|NCT00698932|459823524|FG001|Overall Study|Safety reasons|2|||
127780425|NCT00698932|459823523|FG000|Overall Study|Death|1|||
127780426|NCT00698932|459823524|FG001|Overall Study|Death|0|||
127780427|NCT01245387|459823525|FG000|Overall Study|Lost to Follow-up|106|||
127780428|NCT01245387|459823525|FG000|Overall Study|Lack of Efficacy|195|||
127780429|NCT01245387|459823525|FG000|Overall Study|Adverse Event|9|||
127780430|NCT01245387|459823525|FG000|Overall Study|Death|3|||
127780431|NCT01245387|459823525|FG000|Overall Study|Other|131|||
127780432|NCT01245387|459823525|FG000|Overall Study|Missing discontinuation status|369|||
127780433|NCT00757003|459823526|FG000|Overall Study|Death|33|||
127780434|NCT00757003|459823526|FG000|Overall Study|Lost to Follow-up|9|||
127780435|NCT00757003|459823526|FG000|Overall Study|Withdrawal by Subject|4|||
127780436|NCT00757003|459823526|FG000|Overall Study|Surgically explanted|2|||
127780437|NCT00757003|459823526|FG000|Overall Study|Not implanted|1|||
127780438|NCT02146599|459823544|FG000|Overall Study|Failed to meet inclusion criteria|5|||
128027952|NCT01475825|460728408|FG000|Overall Study|Did not enter OLC|15|||
128027953|NCT01475825|460728409|FG001|Overall Study|Did not enter OLC|11|||
128027954|NCT01475825|460728410|FG002|Overall Study|Did not enter OLC|15|||
128027955|NCT01475825|460728411|FG003|Overall Study|Did not enter OLC|11|||
128027956|NCT00309946|460728414|FG000|Overall Study|Withdrawal by Subject|1|||
128027957|NCT02662582|460728418|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
128027958|NCT02662582|460728419|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
128027959|NCT02662582|460728418|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
128027960|NCT02662582|460728419|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
128027961|NCT02662582|460728418|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
128027962|NCT02662582|460728419|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
128027963|NCT02662582|460728418|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
128027964|NCT02662582|460728419|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
128027965|NCT04135352|460728420|FG000|Overall Study|Not treated-randomization error|0|||
128027966|NCT04135352|460728421|FG001|Overall Study|Not treated-randomization error|0|||
128027967|NCT04135352|460728422|FG002|Overall Study|Not treated-randomization error|1|||
128027968|NCT04135352|460728423|FG003|Overall Study|Not treated-randomization error|0|||
128027969|NCT04135352|460728424|FG004|Overall Study|Not treated-randomization error|0|||
128027970|NCT04135352|460728425|FG005|Overall Study|Not treated-randomization error|0|||
128027971|NCT04135352|460728426|FG006|Overall Study|Not treated-randomization error|0|||
128027972|NCT04135352|460728427|FG007|Overall Study|Not treated-randomization error|0|||
128027973|NCT04135352|460728420|FG000|Overall Study|Withdrawal by Subject|0|||
128027974|NCT04135352|460728421|FG001|Overall Study|Withdrawal by Subject|0|||
127571764|NCT01975831|459062213|FG006|Overall Study|Entered Hospice|0|||
127780439|NCT03061175|459823548|FG000|Baseline|Participant was deemed ineligible|1|||
127571765|NCT01975831|459062214|FG007|Overall Study|Entered Hospice|0|||
127780440|NCT03061175|459823549|FG001|Baseline|Participant was deemed ineligible|0|||
127780441|NCT03061175|459823548|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
127780442|NCT03061175|459823549|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
127780443|NCT03061175|459823548|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
128027975|NCT04135352|460728422|FG002|Overall Study|Withdrawal by Subject|2|||
128027976|NCT04135352|460728423|FG003|Overall Study|Withdrawal by Subject|0|||
128027977|NCT04135352|460728424|FG004|Overall Study|Withdrawal by Subject|0|||
128027978|NCT04135352|460728425|FG005|Overall Study|Withdrawal by Subject|0|||
127780444|NCT03061175|459823549|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
127780445|NCT03061175|459823548|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
127571766|NCT01975831|459062215|FG008|Overall Study|Entered Hospice|0|||
127780446|NCT03061175|459823549|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
128027979|NCT04135352|460728426|FG006|Overall Study|Withdrawal by Subject|0|||
128027980|NCT04135352|460728427|FG007|Overall Study|Withdrawal by Subject|0|||
128027981|NCT04135352|460728420|FG000|Overall Study|Sponsor Decision|0|||
128027982|NCT04135352|460728421|FG001|Overall Study|Sponsor Decision|0|||
128027983|NCT04135352|460728422|FG002|Overall Study|Sponsor Decision|2|||
128027984|NCT04135352|460728423|FG003|Overall Study|Sponsor Decision|5|||
128027985|NCT04135352|460728424|FG004|Overall Study|Sponsor Decision|1|||
128027986|NCT04135352|460728425|FG005|Overall Study|Sponsor Decision|4|||
128027987|NCT04135352|460728426|FG006|Overall Study|Sponsor Decision|0|||
128027988|NCT04135352|460728427|FG007|Overall Study|Sponsor Decision|0|||
128027989|NCT04135352|460728420|FG000|Overall Study|Physician Decision|0|||
128027990|NCT04135352|460728421|FG001|Overall Study|Physician Decision|0|||
128027991|NCT04135352|460728422|FG002|Overall Study|Physician Decision|1|||
128027992|NCT04135352|460728423|FG003|Overall Study|Physician Decision|0|||
127571767|NCT01975831|459062207|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
128027993|NCT04135352|460728424|FG004|Overall Study|Physician Decision|1|||
127571768|NCT01975831|459062208|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
127780447|NCT02243865|459823552|FG000|Overall Study|Protocol Violation|1|||
127780448|NCT02243865|459823553|FG001|Overall Study|Protocol Violation|3|||
127780449|NCT02243865|459823552|FG000|Overall Study|Lost to Follow-up|1|||
127780450|NCT02243865|459823553|FG001|Overall Study|Lost to Follow-up|1|||
127780451|NCT02243865|459823552|FG000|Overall Study|Withdrawal by Subject|1|||
127780452|NCT02243865|459823553|FG001|Overall Study|Withdrawal by Subject|0|||
127780453|NCT02243865|459823552|FG000|Overall Study|Adverse Event|1|||
127780454|NCT02243865|459823553|FG001|Overall Study|Adverse Event|1|||
127780455|NCT03044249|459823554|FG000|Overall Study|Adverse Event|4|||
127780456|NCT03044249|459823555|FG001|Overall Study|Adverse Event|9|||
127780457|NCT03044249|459823554|FG000|Overall Study|Lost to Follow-up|1|||
127780458|NCT03044249|459823555|FG001|Overall Study|Lost to Follow-up|0|||
127780459|NCT03044249|459823554|FG000|Overall Study|Non-compliance with Study Drug|1|||
127780460|NCT03044249|459823555|FG001|Overall Study|Non-compliance with Study Drug|0|||
127780461|NCT03044249|459823554|FG000|Overall Study|Study Terminated by Sponsor|2|||
127780462|NCT03044249|459823555|FG001|Overall Study|Study Terminated by Sponsor|0|||
127780463|NCT03044249|459823554|FG000|Overall Study|Withdrawal by Subject|2|||
127780464|NCT03044249|459823555|FG001|Overall Study|Withdrawal by Subject|5|||
127780465|NCT02101021|459823556|FG000|Overall Study|Death|4|||
127780466|NCT02101021|459823557|FG001|Overall Study|Death|3|||
127780467|NCT02101021|459823558|FG002|Overall Study|Death|6|||
127780468|NCT02101021|459823559|FG003|Overall Study|Death|0|||
127780469|NCT02101021|459823560|FG004|Overall Study|Death|3|||
127780470|NCT02101021|459823556|FG000|Overall Study|Withdrew Consent from study|1|||
127780471|NCT02101021|459823557|FG001|Overall Study|Withdrew Consent from study|1|||
127780472|NCT02101021|459823558|FG002|Overall Study|Withdrew Consent from study|0|||
127780473|NCT02101021|459823559|FG003|Overall Study|Withdrew Consent from study|2|||
127780474|NCT02101021|459823560|FG004|Overall Study|Withdrew Consent from study|0|||
127780475|NCT02101021|459823556|FG000|Overall Study|Lost to Follow-up|1|||
127780476|NCT02101021|459823557|FG001|Overall Study|Lost to Follow-up|0|||
127780477|NCT02101021|459823558|FG002|Overall Study|Lost to Follow-up|0|||
127780478|NCT02101021|459823559|FG003|Overall Study|Lost to Follow-up|0|||
127780479|NCT02101021|459823560|FG004|Overall Study|Lost to Follow-up|0|||
127780480|NCT02101021|459823556|FG000|Overall Study|Study Terminated by Sponsor|1|||
127780481|NCT02101021|459823557|FG001|Overall Study|Study Terminated by Sponsor|0|||
127780482|NCT02101021|459823558|FG002|Overall Study|Study Terminated by Sponsor|1|||
128027994|NCT04135352|460728425|FG005|Overall Study|Physician Decision|0|||
128027995|NCT04135352|460728426|FG006|Overall Study|Physician Decision|0|||
128027996|NCT04135352|460728427|FG007|Overall Study|Physician Decision|0|||
128027997|NCT04135352|460728420|FG000|Overall Study|Death|3|||
128027998|NCT04135352|460728421|FG001|Overall Study|Death|4|||
128027999|NCT04135352|460728422|FG002|Overall Study|Death|7|||
127571769|NCT01975831|459062209|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
127571770|NCT01975831|459062210|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
127571771|NCT01975831|459062211|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
127780483|NCT02101021|459823559|FG003|Overall Study|Study Terminated by Sponsor|1|||
127780484|NCT02101021|459823560|FG004|Overall Study|Study Terminated by Sponsor|1|||
127780485|NCT01368042|459823561|FG000|Overall Study|Death|14|||
128028000|NCT04135352|460728423|FG003|Overall Study|Death|0|||
128028001|NCT04135352|460728424|FG004|Overall Study|Death|3|||
127571772|NCT01975831|459062212|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
127780486|NCT01368042|459823561|FG000|Overall Study|Protocol Violation|11|||
127780487|NCT01368042|459823561|FG000|Overall Study|Lost to Follow-up|4|||
127780488|NCT01368042|459823561|FG000|Overall Study|Transplanted|1|||
127780489|NCT00955279|459823562|FG000|Overall Study|Other|0|||
128028002|NCT04135352|460728425|FG005|Overall Study|Death|1|||
128028003|NCT04135352|460728426|FG006|Overall Study|Death|0|||
127780490|NCT00955279|459823563|FG001|Overall Study|Other|0|||
127780491|NCT00955279|459823564|FG002|Overall Study|Other|3|||
127780492|NCT00955279|459823562|FG000|Overall Study|Death|1|||
127780493|NCT00955279|459823563|FG001|Overall Study|Death|1|||
128028004|NCT04135352|460728427|FG007|Overall Study|Death|0|||
127780494|NCT00955279|459823564|FG002|Overall Study|Death|1|||
127780495|NCT00955279|459823562|FG000|Overall Study|Lost to Follow-up|0|||
127780496|NCT00955279|459823563|FG001|Overall Study|Lost to Follow-up|3|||
127780497|NCT00955279|459823564|FG002|Overall Study|Lost to Follow-up|1|||
127780498|NCT00955279|459823562|FG000|Overall Study|Withdrawal by Subject|2|||
127780499|NCT00955279|459823563|FG001|Overall Study|Withdrawal by Subject|0|||
127780500|NCT00955279|459823564|FG002|Overall Study|Withdrawal by Subject|3|||
127780501|NCT01235793|459823568|FG000|Overall Study|Death|6|||
127780502|NCT04166383|459823574|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
127780503|NCT04166383|459823574|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
127780504|NCT04166383|459823574|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
127780505|NCT03044886|459823576|FG000|Overall Study|Lost to Follow-up|15|||
127780506|NCT03044886|459823577|FG001|Overall Study|Lost to Follow-up|10|||
127780507|NCT03044886|459823578|FG002|Overall Study|Lost to Follow-up|12|||
127780508|NCT02921269|459823579|FG000|Overall Study|Did not complete DLT period|1|||
127780509|NCT01159912|459823589|FG000|Overall Study|Adverse Event|2|||
127780510|NCT01159912|459823590|FG001|Overall Study|Adverse Event|2|||
127780511|NCT01159912|459823591|FG002|Overall Study|Adverse Event|3|||
127780512|NCT01159912|459823589|FG000|Overall Study|Lack of Efficacy|23|||
127780513|NCT01159912|459823590|FG001|Overall Study|Lack of Efficacy|15|||
127780514|NCT01159912|459823591|FG002|Overall Study|Lack of Efficacy|14|||
127780515|NCT01159912|459823589|FG000|Overall Study|Protocol Violation|1|||
127571773|NCT01975831|459062213|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
127571774|NCT01975831|459062214|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
127571775|NCT01975831|459062215|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
127571776|NCT00107952|459062216|FG000|Overall Study|Death|75|||
127571777|NCT00107952|459062217|FG001|Overall Study|Death|61|||
127571778|NCT00107952|459062216|FG000|Overall Study|Lost to Follow-up|0|||
127571779|NCT00107952|459062217|FG001|Overall Study|Lost to Follow-up|3|||
127571780|NCT00107952|459062216|FG000|Overall Study|Withdrawal by Subject|9|||
127571781|NCT00107952|459062217|FG001|Overall Study|Withdrawal by Subject|6|||
127571782|NCT00107952|459062216|FG000|Overall Study|Other|2|||
127571783|NCT00107952|459062217|FG001|Overall Study|Other|5|||
127780516|NCT01159912|459823590|FG001|Overall Study|Protocol Violation|2|||
127780517|NCT01159912|459823591|FG002|Overall Study|Protocol Violation|3|||
127780518|NCT01159912|459823589|FG000|Overall Study|Lost to Follow-up|4|||
128028005|NCT00511199|460728428|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
128028006|NCT00511199|460728429|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
128028007|NCT00511199|460728428|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
128028008|NCT00511199|460728429|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
128028009|NCT00511199|460728428|FG000|Overall Study|Withdrawal of Informed Consent|19|||
128028010|NCT00511199|460728429|FG001|Overall Study|Withdrawal of Informed Consent|4|||
128028011|NCT00511199|460728428|FG000|Overall Study|Pregnancy|6|||
128028012|NCT00511199|460728429|FG001|Overall Study|Pregnancy|3|||
128028013|NCT00511199|460728428|FG000|Overall Study|Pregnancy Wish|16|||
128028014|NCT00511199|460728429|FG001|Overall Study|Pregnancy Wish|8|||
128028015|NCT00511199|460728428|FG000|Overall Study|Lost to Follow-up|40|||
128028016|NCT00511199|460728429|FG001|Overall Study|Lost to Follow-up|17|||
128028017|NCT00511199|460728428|FG000|Overall Study|Other Reason|78|||
128028018|NCT00511199|460728429|FG001|Overall Study|Other Reason|37|||
128028019|NCT02739828|460728435|FG000|Overall Study|Adverse Event|1|||
128028020|NCT02739828|460728435|FG000|Overall Study|Lost to Follow-up|4|||
128028021|NCT01953354|460728436|FG000|Overall Study|Withdrawal by Subject|0|||
128028022|NCT01953354|460728437|FG001|Overall Study|Withdrawal by Subject|1|||
128028023|NCT01953354|460728436|FG000|Overall Study|Decision of Sponsor|0|||
128028024|NCT01953354|460728437|FG001|Overall Study|Decision of Sponsor|1|||
128028025|NCT01953354|460728436|FG000|Overall Study|Disease Exacerbation|1|||
128028026|NCT01953354|460728437|FG001|Overall Study|Disease Exacerbation|0|||
128028027|NCT01392495|460728438|FG000|Overall Study|Death|3|||
128028028|NCT01392495|460728438|FG000|Overall Study|Administrative problems|8|||
128028029|NCT01392495|460728438|FG000|Overall Study|Withdrawal by Subject|2|||
128028030|NCT01392495|460728438|FG000|Overall Study|Adverse Event|3|||
127571784|NCT00107952|459062216|FG000|Overall Study|Never received study treatment|9|||
127780519|NCT01159912|459823590|FG001|Overall Study|Lost to Follow-up|0|||
127780520|NCT01159912|459823591|FG002|Overall Study|Lost to Follow-up|0|||
127780521|NCT01159912|459823589|FG000|Overall Study|Physician Decision|0|||
127780522|NCT01159912|459823590|FG001|Overall Study|Physician Decision|0|||
127780523|NCT01159912|459823591|FG002|Overall Study|Physician Decision|3|||
127780524|NCT01159912|459823589|FG000|Overall Study|Withdrawal by Subject|10|||
128028031|NCT01570192|460728439|FG000|Overall Study|no qualifying organism|6|||
128028032|NCT01570192|460728440|FG001|Overall Study|no qualifying organism|12|||
128028033|NCT01570192|460728439|FG000|Overall Study|changed to palliative care|1|||
128028034|NCT01570192|460728440|FG001|Overall Study|changed to palliative care|0|||
128028035|NCT01570192|460728439|FG000|Overall Study|Physician Decision|0|||
127571785|NCT00107952|459062217|FG001|Overall Study|Never received study treatment|6|||
127780525|NCT01159912|459823590|FG001|Overall Study|Withdrawal by Subject|3|||
127571786|NCT01401959|459062218|FG000|Enrolled|Withdrawal by Subject|1|||
128028036|NCT01570192|460728440|FG001|Overall Study|Physician Decision|1|||
128028037|NCT00806026|460728441|FG000|Overall Study|Death|0|||
128028038|NCT00806026|460728442|FG001|Overall Study|Death|0|||
128028039|NCT00806026|460728443|FG002|Overall Study|Death|0|||
128028040|NCT00806026|460728444|FG003|Overall Study|Death|1|||
128028041|NCT00806026|460728445|FG004|Overall Study|Death|0|||
128028042|NCT00806026|460728446|FG005|Overall Study|Death|0|||
128028043|NCT00806026|460728441|FG000|Overall Study|Did not meet entrance criteria|4|||
128028044|NCT00806026|460728442|FG001|Overall Study|Did not meet entrance criteria|1|||
128028045|NCT00806026|460728443|FG002|Overall Study|Did not meet entrance criteria|2|||
128028046|NCT00806026|460728444|FG003|Overall Study|Did not meet entrance criteria|1|||
128028047|NCT00806026|460728445|FG004|Overall Study|Did not meet entrance criteria|0|||
128028048|NCT00806026|460728446|FG005|Overall Study|Did not meet entrance criteria|0|||
128028049|NCT00806026|460728441|FG000|Overall Study|Lack of Efficacy|5|||
128028050|NCT00806026|460728442|FG001|Overall Study|Lack of Efficacy|18|||
128028051|NCT00806026|460728443|FG002|Overall Study|Lack of Efficacy|13|||
128028052|NCT00806026|460728444|FG003|Overall Study|Lack of Efficacy|4|||
128028053|NCT00806026|460728445|FG004|Overall Study|Lack of Efficacy|8|||
128028054|NCT00806026|460728446|FG005|Overall Study|Lack of Efficacy|7|||
128028055|NCT00806026|460728441|FG000|Overall Study|Lost to Follow-up|8|||
128028056|NCT00806026|460728442|FG001|Overall Study|Lost to Follow-up|15|||
128028057|NCT00806026|460728443|FG002|Overall Study|Lost to Follow-up|8|||
128028058|NCT00806026|460728444|FG003|Overall Study|Lost to Follow-up|2|||
128028059|NCT00806026|460728445|FG004|Overall Study|Lost to Follow-up|6|||
128028060|NCT00806026|460728446|FG005|Overall Study|Lost to Follow-up|6|||
128028061|NCT00806026|460728441|FG000|Overall Study|Withdrawal by Subject|14|||
127691947|NCT02201108|459498747|FG001|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
127691948|NCT02201108|459498748|FG002|Extension Period (Up to Week 492)|Poor compliance to protocol|1|||
127691949|NCT04143061|459498750|FG000|Overall Study|Protocol Deviation|0|||
127691950|NCT04143061|459498751|FG001|Overall Study|Protocol Deviation|0|||
127691951|NCT04143061|459498752|FG002|Overall Study|Protocol Deviation|0|||
127691952|NCT04143061|459498753|FG003|Overall Study|Protocol Deviation|0|||
127691953|NCT04143061|459498754|FG004|Overall Study|Protocol Deviation|0|||
127691954|NCT04143061|459498755|FG005|Overall Study|Protocol Deviation|0|||
127691955|NCT04143061|459498756|FG006|Overall Study|Protocol Deviation|5|||
127691956|NCT04143061|459498757|FG007|Overall Study|Protocol Deviation|5|||
127691957|NCT04143061|459498750|FG000|Overall Study|Withdrawal by Subject|2|||
127691958|NCT04143061|459498751|FG001|Overall Study|Withdrawal by Subject|0|||
127691959|NCT04143061|459498752|FG002|Overall Study|Withdrawal by Subject|0|||
127691960|NCT04143061|459498753|FG003|Overall Study|Withdrawal by Subject|0|||
127691961|NCT04143061|459498754|FG004|Overall Study|Withdrawal by Subject|0|||
127691962|NCT04143061|459498755|FG005|Overall Study|Withdrawal by Subject|1|||
127691963|NCT04143061|459498756|FG006|Overall Study|Withdrawal by Subject|0|||
127691964|NCT04143061|459498757|FG007|Overall Study|Withdrawal by Subject|0|||
127691965|NCT04143061|459498750|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
127691966|NCT04143061|459498751|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
127691967|NCT04143061|459498752|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
127691968|NCT04143061|459498753|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
127691969|NCT04143061|459498754|FG004|Overall Study|Withdrawal by Parent/Guardian|8|||
127691970|NCT04143061|459498755|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
127691971|NCT04143061|459498756|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
127691972|NCT04143061|459498757|FG007|Overall Study|Withdrawal by Parent/Guardian|7|||
127691973|NCT03602014|459498758|FG000|Overall Study|Lost to Follow-up|2|||
127691974|NCT03602014|459498759|FG001|Overall Study|Lost to Follow-up|0|||
127691975|NCT03602014|459498760|FG002|Overall Study|Lost to Follow-up|0|||
127691976|NCT03289039|459498763|FG000|Overall Study|Withdrawal by Subject|0|||
127691977|NCT03289039|459498764|FG001|Overall Study|Withdrawal by Subject|1|||
127691978|NCT03289039|459498763|FG000|Overall Study|Became ineligible prior to treatment start|0|||
127691979|NCT03289039|459498764|FG001|Overall Study|Became ineligible prior to treatment start|1|||
127691980|NCT03289039|459498763|FG000|Overall Study|progressed before treatment start|1|||
127691981|NCT03289039|459498764|FG001|Overall Study|progressed before treatment start|0|||
127691982|NCT04732494|459498765|FG000|Overall Study|Death|39|||
127691983|NCT04732494|459498766|FG001|Overall Study|Death|36|||
127691984|NCT04732494|459498765|FG000|Overall Study|Study Closed by Sponsor|20|||
127691985|NCT04732494|459498766|FG001|Overall Study|Study Closed by Sponsor|15|||
127691986|NCT04732494|459498765|FG000|Overall Study|Withdrawal by Subject|2|||
127691987|NCT04732494|459498766|FG001|Overall Study|Withdrawal by Subject|7|||
127691988|NCT04732494|459498765|FG000|Overall Study|Lost to Follow-up|1|||
127780526|NCT01159912|459823591|FG002|Overall Study|Withdrawal by Subject|3|||
127691989|NCT04732494|459498766|FG001|Overall Study|Lost to Follow-up|5|||
127691990|NCT01673984|459498771|FG000|Overall Study|Adverse Event|1|||
127691991|NCT01673984|459498772|FG001|Overall Study|Adverse Event|0|||
128028062|NCT00806026|460728442|FG001|Overall Study|Withdrawal by Subject|17|||
127691992|NCT01673984|459498771|FG000|Overall Study|Study termination|9|||
127691993|NCT01673984|459498772|FG001|Overall Study|Study termination|6|||
127780527|NCT00504153|459823599|FG000|Overall Study|Withdrawal by Subject|1|||
127780528|NCT00504153|459823599|FG000|Overall Study|Adverse Event|4|||
127780529|NCT00504153|459823599|FG000|Overall Study|Death|1|||
127780530|NCT00074581|459823601|FG000|Overall Study|Death|15|||
127780531|NCT00074581|459823602|FG001|Overall Study|Death|16|||
127780532|NCT00074581|459823601|FG000|Overall Study|Withdrawal by Subject|50|||
127780533|NCT00074581|459823602|FG001|Overall Study|Withdrawal by Subject|49|||
127780534|NCT00074581|459823601|FG000|Overall Study|Unable to adhere to visit schedule|13|||
127780535|NCT00074581|459823602|FG001|Overall Study|Unable to adhere to visit schedule|14|||
127780536|NCT00074581|459823601|FG000|Overall Study|Relocated|14|||
127780537|NCT00074581|459823602|FG001|Overall Study|Relocated|9|||
127780538|NCT00074581|459823601|FG000|Overall Study|Were withdrawn by investigator|5|||
127780539|NCT00074581|459823602|FG001|Overall Study|Were withdrawn by investigator|2|||
127780540|NCT00074581|459823601|FG000|Overall Study|Lost to Follow-up|16|||
127780541|NCT00074581|459823602|FG001|Overall Study|Lost to Follow-up|11|||
127780542|NCT00074581|459823601|FG000|Overall Study|Ended relationship w. index participant|117|||
127780543|NCT00074581|459823602|FG001|Overall Study|Ended relationship w. index participant|106|||
127780544|NCT00074581|459823601|FG000|Overall Study|Other|14|||
127780545|NCT00074581|459823602|FG001|Overall Study|Other|19|||
127780546|NCT02322229|459823605|FG000|Overall Study|Physician Decision|2|||
127780547|NCT00705432|459823608|FG000|Treatment Period|Adverse Event|45|||
127780548|NCT00705432|459823609|FG001|Treatment Period|Adverse Event|37|||
127780549|NCT00705432|459823610|FG002|Treatment Period|Adverse Event|51|||
127780550|NCT00705432|459823611|FG003|Treatment Period|Adverse Event|12|||
127780551|NCT00705432|459823612|FG004|Treatment Period|Adverse Event|8|||
127780552|NCT00705432|459823613|FG005|Treatment Period|Adverse Event|9|||
127780553|NCT00705432|459823608|FG000|Treatment Period|Treatment failure|92|||
127780554|NCT00705432|459823609|FG001|Treatment Period|Treatment failure|42|||
128028063|NCT00806026|460728443|FG002|Overall Study|Withdrawal by Subject|9|||
128028064|NCT00806026|460728444|FG003|Overall Study|Withdrawal by Subject|2|||
128028065|NCT00806026|460728445|FG004|Overall Study|Withdrawal by Subject|5|||
127780555|NCT00705432|459823610|FG002|Treatment Period|Treatment failure|33|||
127780556|NCT00705432|459823611|FG003|Treatment Period|Treatment failure|25|||
127780557|NCT00705432|459823612|FG004|Treatment Period|Treatment failure|13|||
127780558|NCT00705432|459823613|FG005|Treatment Period|Treatment failure|14|||
127780559|NCT00705432|459823608|FG000|Treatment Period|Non medical reason|26|||
127780560|NCT00705432|459823609|FG001|Treatment Period|Non medical reason|32|||
127780561|NCT00705432|459823610|FG002|Treatment Period|Non medical reason|37|||
127780562|NCT00705432|459823611|FG003|Treatment Period|Non medical reason|4|||
127780563|NCT00705432|459823612|FG004|Treatment Period|Non medical reason|7|||
127780564|NCT00705432|459823613|FG005|Treatment Period|Non medical reason|7|||
128028066|NCT00806026|460728446|FG005|Overall Study|Withdrawal by Subject|3|||
128028067|NCT00806026|460728441|FG000|Overall Study|Other|3|||
128028068|NCT00806026|460728442|FG001|Overall Study|Other|6|||
128028069|NCT00806026|460728443|FG002|Overall Study|Other|8|||
128028070|NCT00806026|460728444|FG003|Overall Study|Other|2|||
128028071|NCT00806026|460728445|FG004|Overall Study|Other|0|||
128028072|NCT00806026|460728446|FG005|Overall Study|Other|4|||
128028073|NCT00806026|460728441|FG000|Overall Study|Protocol Violation|6|||
128028074|NCT00806026|460728442|FG001|Overall Study|Protocol Violation|9|||
128028075|NCT00806026|460728443|FG002|Overall Study|Protocol Violation|9|||
128028076|NCT00806026|460728444|FG003|Overall Study|Protocol Violation|0|||
128028077|NCT00806026|460728445|FG004|Overall Study|Protocol Violation|2|||
128028078|NCT00806026|460728446|FG005|Overall Study|Protocol Violation|3|||
128028079|NCT00806026|460728441|FG000|Overall Study|Adverse Event|52|||
128028080|NCT00806026|460728442|FG001|Overall Study|Adverse Event|35|||
128028081|NCT00806026|460728443|FG002|Overall Study|Adverse Event|44|||
128028082|NCT00806026|460728444|FG003|Overall Study|Adverse Event|17|||
128028083|NCT00806026|460728445|FG004|Overall Study|Adverse Event|9|||
128028084|NCT00806026|460728446|FG005|Overall Study|Adverse Event|9|||
128028085|NCT03180138|460728447|FG000|Overall Study|Mobile-phone could not be verified|2|||
128028086|NCT03180138|460728448|FG001|Overall Study|Mobile-phone could not be verified|13|||
128028087|NCT03180138|460728449|FG002|Overall Study|Mobile-phone could not be verified|15|||
128028088|NCT03180138|460728447|FG000|Overall Study|No prior immunization records|17|||
128028089|NCT03180138|460728448|FG001|Overall Study|No prior immunization records|0|||
128028090|NCT03180138|460728449|FG002|Overall Study|No prior immunization records|6|||
128028091|NCT03180138|460728447|FG000|Overall Study|Found to be >24 mon after randomization|3|||
128028092|NCT03180138|460728448|FG001|Overall Study|Found to be >24 mon after randomization|0|||
128028093|NCT03180138|460728449|FG002|Overall Study|Found to be >24 mon after randomization|3|||
128028094|NCT02100644|460728450|FG000|LTG Escalation Phase|Adverse Event|9|||
128028095|NCT02100644|460728451|FG001|LTG Escalation Phase|Adverse Event|0|||
128028096|NCT02100644|460728452|FG002|LTG Escalation Phase|Adverse Event|0|||
127780565|NCT00705432|459823608|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
127780566|NCT00705432|459823609|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
127780567|NCT00705432|459823610|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
127780568|NCT00705432|459823611|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
127780569|NCT00705432|459823612|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
127780570|NCT00705432|459823613|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
128028097|NCT02100644|460728450|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
127780571|NCT00705432|459823608|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
127780572|NCT00705432|459823609|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
127780573|NCT00705432|459823610|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
127780574|NCT00705432|459823611|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
127780575|NCT00705432|459823612|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
127780576|NCT00705432|459823613|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
127780577|NCT04411628|459823614|FG000|Overall Study|Withdrawal by Subject|1|||
128028098|NCT02100644|460728451|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
127780578|NCT04411628|459823615|FG001|Overall Study|Withdrawal by Subject|1|||
127780579|NCT04411628|459823616|FG002|Overall Study|Withdrawal by Subject|2|||
127780580|NCT04411628|459823617|FG003|Overall Study|Withdrawal by Subject|0|||
127780581|NCT04411628|459823614|FG000|Overall Study|Lost to Follow-up|0|||
128028099|NCT02100644|460728452|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
128028100|NCT02100644|460728450|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
128028101|NCT02100644|460728451|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
128028102|NCT02100644|460728452|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
128028103|NCT00728182|460728453|FG000|Overall Study|Adverse Event|1|||
128028104|NCT00728182|460728454|FG001|Overall Study|Adverse Event|0|||
128028105|NCT00728182|460728453|FG000|Overall Study|Lost to Follow-up|2|||
128028106|NCT00728182|460728454|FG001|Overall Study|Lost to Follow-up|0|||
128028107|NCT00728182|460728453|FG000|Overall Study|Death|0|||
128028108|NCT00728182|460728454|FG001|Overall Study|Death|2|||
128028109|NCT00728182|460728453|FG000|Overall Study|Protocol Noncompliance|0|||
128028110|NCT00728182|460728454|FG001|Overall Study|Protocol Noncompliance|1|||
128028111|NCT01898091|460728456|FG000|Overall Study|Lost to Follow-up|1|||
128028112|NCT01898091|460728457|FG001|Overall Study|Lost to Follow-up|1|||
128028113|NCT01898091|460728456|FG000|Overall Study|Withdrawal by Subject|1|||
128028114|NCT01898091|460728457|FG001|Overall Study|Withdrawal by Subject|5|||
128028115|NCT01630811|460728459|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
128028116|NCT01630811|460728460|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
128028117|NCT04818086|460728463|FG000|Overall Study|Physician Decision|1|||
128028118|NCT04818086|460728464|FG001|Overall Study|Physician Decision|0|||
128028119|NCT04818086|460728463|FG000|Overall Study|Withdrawal by Subject|0|||
128028120|NCT04818086|460728464|FG001|Overall Study|Withdrawal by Subject|1|||
128028121|NCT01725308|460728465|FG000|Treatment Period I|Did Not Receive Drug|1|||
128028122|NCT01725308|460728466|FG001|Treatment Period I|Did Not Receive Drug|0|||
128028123|NCT01725308|460728467|FG002|Treatment Period I|Did Not Receive Drug|0|||
128028124|NCT01725308|460728465|FG000|Treatment Period I|Adverse Event|5|||
128028125|NCT01725308|460728466|FG001|Treatment Period I|Adverse Event|4|||
128028126|NCT01725308|460728467|FG002|Treatment Period I|Adverse Event|21|||
128028127|NCT01725308|460728465|FG000|Treatment Period I|Insufficient Response|7|||
128028128|NCT01725308|460728466|FG001|Treatment Period I|Insufficient Response|0|||
128028129|NCT01725308|460728467|FG002|Treatment Period I|Insufficient Response|5|||
128028130|NCT01725308|460728465|FG000|Treatment Period I|Worsening of the Target Disease|8|||
128028131|NCT01725308|460728466|FG001|Treatment Period I|Worsening of the Target Disease|0|||
128028132|NCT01725308|460728467|FG002|Treatment Period I|Worsening of the Target Disease|2|||
128028133|NCT01725308|460728465|FG000|Treatment Period I|Changes in the Episodes|3|||
128028134|NCT01725308|460728466|FG001|Treatment Period I|Changes in the Episodes|0|||
128028135|NCT01725308|460728467|FG002|Treatment Period I|Changes in the Episodes|2|||
128028136|NCT01725308|460728465|FG000|Treatment Period I|Withdrawal of Consent|12|||
128028137|NCT01725308|460728466|FG001|Treatment Period I|Withdrawal of Consent|7|||
128028138|NCT01725308|460728467|FG002|Treatment Period I|Withdrawal of Consent|5|||
128028139|NCT01725308|460728465|FG000|Treatment Period I|Lost to Follow-up|3|||
128028140|NCT01725308|460728466|FG001|Treatment Period I|Lost to Follow-up|2|||
128028141|NCT01725308|460728467|FG002|Treatment Period I|Lost to Follow-up|2|||
128028142|NCT01725308|460728465|FG000|Treatment Period I|Protocol Deviations|3|||
128028143|NCT01725308|460728466|FG001|Treatment Period I|Protocol Deviations|1|||
128028144|NCT01725308|460728467|FG002|Treatment Period I|Protocol Deviations|1|||
128028145|NCT01725308|460728465|FG000|Treatment Period I|Miscellaneous|2|||
128028146|NCT01725308|460728466|FG001|Treatment Period I|Miscellaneous|0|||
128028147|NCT01725308|460728467|FG002|Treatment Period I|Miscellaneous|3|||
128028148|NCT01725308|460728465|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
127780582|NCT04411628|459823615|FG001|Overall Study|Lost to Follow-up|1|||
127780583|NCT04411628|459823616|FG002|Overall Study|Lost to Follow-up|0|||
127780584|NCT04411628|459823617|FG003|Overall Study|Lost to Follow-up|0|||
127780585|NCT01034540|459823618|FG000|Overall Study|Adverse Event|0|||
127780586|NCT01034540|459823619|FG001|Overall Study|Adverse Event|1|||
127780587|NCT01252810|459823620|FG000|Overall Study|Withdrawal by Subject|4|||
128028149|NCT01725308|460728466|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
128028150|NCT01725308|460728467|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
128028151|NCT01725308|460728465|FG000|Treatment Period II|Did Not Receive Drug|4|||
128028152|NCT01725308|460728466|FG001|Treatment Period II|Did Not Receive Drug|0|||
128028153|NCT01725308|460728467|FG002|Treatment Period II|Did Not Receive Drug|0|||
128028154|NCT01725308|460728465|FG000|Treatment Period II|Adverse Event|13|||
127780588|NCT01252810|459823621|FG001|Overall Study|Withdrawal by Subject|1|||
127780589|NCT01252810|459823620|FG000|Overall Study|Lost to Follow-up|0|||
127780590|NCT01252810|459823621|FG001|Overall Study|Lost to Follow-up|1|||
127780591|NCT01252810|459823620|FG000|Overall Study|Physician Decision|2|||
127780592|NCT01252810|459823621|FG001|Overall Study|Physician Decision|1|||
127780593|NCT01252810|459823620|FG000|Overall Study|Various reasons|8|||
127780594|NCT01252810|459823621|FG001|Overall Study|Various reasons|0|||
127780595|NCT00761306|459825755|FG000|Overall Study|Adverse Event|5|||
128028155|NCT01725308|460728466|FG001|Treatment Period II|Adverse Event|8|||
128028156|NCT01725308|460728467|FG002|Treatment Period II|Adverse Event|20|||
128028157|NCT01725308|460728465|FG000|Treatment Period II|Insufficient Response|2|||
128028158|NCT01725308|460728466|FG001|Treatment Period II|Insufficient Response|4|||
128028159|NCT01725308|460728467|FG002|Treatment Period II|Insufficient Response|6|||
128028160|NCT01725308|460728465|FG000|Treatment Period II|Worsening of the Target Disease|1|||
128028161|NCT01725308|460728466|FG001|Treatment Period II|Worsening of the Target Disease|4|||
128028162|NCT01725308|460728467|FG002|Treatment Period II|Worsening of the Target Disease|2|||
128028163|NCT01725308|460728465|FG000|Treatment Period II|Changes in the Episodes|1|||
128028164|NCT01725308|460728466|FG001|Treatment Period II|Changes in the Episodes|0|||
128028165|NCT01725308|460728467|FG002|Treatment Period II|Changes in the Episodes|5|||
128028166|NCT01725308|460728465|FG000|Treatment Period II|Withdrawal of Consent|28|||
128028167|NCT01725308|460728466|FG001|Treatment Period II|Withdrawal of Consent|2|||
128028168|NCT01725308|460728467|FG002|Treatment Period II|Withdrawal of Consent|16|||
128028169|NCT01725308|460728465|FG000|Treatment Period II|Lost to Follow-up|1|||
128028170|NCT01725308|460728466|FG001|Treatment Period II|Lost to Follow-up|5|||
128028171|NCT01725308|460728467|FG002|Treatment Period II|Lost to Follow-up|3|||
128028172|NCT01725308|460728465|FG000|Treatment Period II|Protocol Deviations|0|||
128028173|NCT01725308|460728466|FG001|Treatment Period II|Protocol Deviations|0|||
128028174|NCT01725308|460728467|FG002|Treatment Period II|Protocol Deviations|1|||
128028175|NCT01725308|460728465|FG000|Treatment Period II|Miscellaneous|5|||
128028176|NCT01725308|460728466|FG001|Treatment Period II|Miscellaneous|3|||
128028177|NCT01725308|460728467|FG002|Treatment Period II|Miscellaneous|7|||
128028178|NCT03511209|460728471|FG000|Overall Study|Withdrawal by Subject|2|||
128028179|NCT03511209|460728472|FG001|Overall Study|Withdrawal by Subject|4|||
128028180|NCT03511209|460728471|FG000|Overall Study|Death|1|||
128028181|NCT03511209|460728472|FG001|Overall Study|Death|0|||
128028182|NCT03511209|460728471|FG000|Overall Study|Lost to Follow-up|0|||
128028183|NCT03511209|460728472|FG001|Overall Study|Lost to Follow-up|2|||
128028184|NCT01602666|460728473|FG000|Induction Chemotherapy|Death|2|||
128028185|NCT01602666|460728474|FG001|Induction Chemotherapy|Death|1|||
128028186|NCT01602666|460728473|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
128028187|NCT01602666|460728474|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
128028188|NCT01602666|460728473|FG000|Induction Chemotherapy|Physician Decision|12|||
128028189|NCT01602666|460728474|FG001|Induction Chemotherapy|Physician Decision|5|||
128028190|NCT01602666|460728473|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
128028191|NCT01602666|460728474|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
128028192|NCT01602666|460728473|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
128028193|NCT01602666|460728474|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
128028194|NCT01602666|460728473|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
128028195|NCT01602666|460728474|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
128028196|NCT01602666|460728473|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
128028197|NCT01602666|460728474|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
128028198|NCT01602666|460728473|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
128028199|NCT01602666|460728474|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
128028200|NCT01602666|460728473|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
128028201|NCT01602666|460728474|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
128028202|NCT01602666|460728473|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
128028203|NCT01602666|460728474|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
128028204|NCT01602666|460728473|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
128028205|NCT01602666|460728474|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
128028206|NCT04754399|460728477|FG000|Overall Study|Adverse Event|5|||
128028207|NCT04754399|460728477|FG000|Overall Study|Withdrawal by Subject|6|||
128028208|NCT04565756|460728478|FG000|Overall Study|Withdrawal by Subject|0|||
128028209|NCT04565756|460728479|FG001|Overall Study|Withdrawal by Subject|0|||
128028210|NCT04565756|460728480|FG002|Overall Study|Withdrawal by Subject|0|||
128028211|NCT04565756|460728481|FG003|Overall Study|Withdrawal by Subject|0|||
128028212|NCT04565756|460728482|FG004|Overall Study|Withdrawal by Subject|1|||
128028213|NCT04565756|460728483|FG005|Overall Study|Withdrawal by Subject|0|||
128028214|NCT04565756|460728478|FG000|Overall Study|Protocol Violation|0|||
128028215|NCT04565756|460728479|FG001|Overall Study|Protocol Violation|0|||
128028216|NCT04565756|460728480|FG002|Overall Study|Protocol Violation|0|||
128028217|NCT04565756|460728481|FG003|Overall Study|Protocol Violation|0|||
128028218|NCT04565756|460728482|FG004|Overall Study|Protocol Violation|0|||
127780596|NCT00761306|459825755|FG000|Overall Study|Lack of Efficacy|4|||
127780597|NCT00761306|459825755|FG000|Overall Study|Protocol Violation|2|||
127780598|NCT00761306|459825755|FG000|Overall Study|Withdrawal of Consent|3|||
127780599|NCT00761306|459825755|FG000|Overall Study|Lost to Follow-up|1|||
127780600|NCT00761306|459825755|FG000|Overall Study|Administrative or Other Reasons|5|||
127780601|NCT05162027|459825756|FG000|Overall Study|Adverse Event|1|||
127780602|NCT05162027|459825757|FG001|Overall Study|Adverse Event|0|||
127780603|NCT03713034|459825758|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
127780604|NCT03713034|459825759|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
127780605|NCT02982239|459825762|FG000|Overall Study|Lost to Follow-up|3|||
127780606|NCT02982239|459825763|FG001|Overall Study|Lost to Follow-up|2|||
127780607|NCT02767323|459825767|FG000|Overall Study|Withdrawal by Subject|17|||
127780608|NCT02767323|459825768|FG001|Overall Study|Withdrawal by Subject|5|||
127780609|NCT02767323|459825769|FG002|Overall Study|Withdrawal by Subject|13|||
127780610|NCT02767323|459825770|FG003|Overall Study|Withdrawal by Subject|0|||
127780611|NCT02767323|459825767|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
127780612|NCT02767323|459825768|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
127780613|NCT02767323|459825769|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
127780614|NCT02767323|459825770|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
127780615|NCT04479436|459825772|FG000|Overall Study|Progressive disease|26|||
127780616|NCT04479436|459825773|FG001|Overall Study|Progressive disease|1|||
127780617|NCT04479436|459825772|FG000|Overall Study|Adverse Event|6|||
127780618|NCT04479436|459825773|FG001|Overall Study|Adverse Event|0|||
127780619|NCT04479436|459825772|FG000|Overall Study|Withdrawal by Subject|5|||
127780620|NCT04479436|459825773|FG001|Overall Study|Withdrawal by Subject|0|||
127780621|NCT04479436|459825772|FG000|Overall Study|Clinical progression|1|||
127780622|NCT04479436|459825773|FG001|Overall Study|Clinical progression|0|||
127780623|NCT04479436|459825772|FG000|Overall Study|Physician Decision|1|||
127780624|NCT04479436|459825773|FG001|Overall Study|Physician Decision|0|||
127780625|NCT01641237|459825788|FG000|Period II|Withdrawal by Subject|1|||
127780626|NCT01641237|459825789|FG001|Period II|Withdrawal by Subject|0|||
127780627|NCT01641237|459825790|FG002|Period II|Withdrawal by Subject|0|||
127780628|NCT01641237|459825791|FG003|Period II|Withdrawal by Subject|0|||
127780629|NCT01641237|459825788|FG000|Period III|Lost to Follow-up|1|||
127780630|NCT01641237|459825789|FG001|Period III|Lost to Follow-up|0|||
127780631|NCT01641237|459825790|FG002|Period III|Lost to Follow-up|0|||
127780632|NCT01641237|459825791|FG003|Period III|Lost to Follow-up|0|||
128028219|NCT04565756|460728483|FG005|Overall Study|Protocol Violation|1|||
128028220|NCT03069937|460728486|FG000|Overall Study|Second primary malignancy noted|1|||
128028221|NCT00231465|460728487|FG000|Overall Study|Completed only one cycle|1|||
128028222|NCT00231465|460728487|FG000|Overall Study|Did not have follow up CT scans|1|||
128028223|NCT00968968|460728488|FG000|Overall Study|Study closed/terminated|10|||
128028224|NCT00968968|460728489|FG001|Overall Study|Study closed/terminated|10|||
128028225|NCT00968968|460728488|FG000|Overall Study|Protocol defined stopping criteria|3|||
128028226|NCT00968968|460728489|FG001|Overall Study|Protocol defined stopping criteria|1|||
128028227|NCT00968968|460728488|FG000|Overall Study|Withdrawal by Subject|2|||
128028228|NCT00968968|460728489|FG001|Overall Study|Withdrawal by Subject|0|||
128028229|NCT00968968|460728488|FG000|Overall Study|Physician Decision|1|||
128028230|NCT00968968|460728489|FG001|Overall Study|Physician Decision|2|||
128028231|NCT00968968|460728488|FG000|Overall Study|Lost to Follow-up|0|||
128028232|NCT00968968|460728489|FG001|Overall Study|Lost to Follow-up|1|||
128028233|NCT00930176|460728491|FG000|Overall Study|Death|1|||
128028234|NCT00401830|460728495|FG000|Overall Study|Adverse Event|10|||
128028235|NCT00401830|460728496|FG001|Overall Study|Adverse Event|18|||
128028236|NCT00401830|460728495|FG000|Overall Study|Lack of Efficacy|11|||
128028237|NCT00401830|460728496|FG001|Overall Study|Lack of Efficacy|5|||
128028238|NCT00401830|460728495|FG000|Overall Study|Withdrawal by Subject|4|||
128028239|NCT00401830|460728496|FG001|Overall Study|Withdrawal by Subject|3|||
128028240|NCT00401830|460728495|FG000|Overall Study|Protocol Violation|3|||
128028241|NCT00401830|460728496|FG001|Overall Study|Protocol Violation|3|||
128028242|NCT00401830|460728495|FG000|Overall Study|Non-compliance with drug study|1|||
128028243|NCT00401830|460728496|FG001|Overall Study|Non-compliance with drug study|0|||
128028244|NCT00401830|460728495|FG000|Overall Study|Lost to Follow-up|1|||
128028245|NCT00401830|460728496|FG001|Overall Study|Lost to Follow-up|3|||
128028246|NCT00401830|460728495|FG000|Overall Study|Other: Personal / Family problems|1|||
128028247|NCT00401830|460728496|FG001|Overall Study|Other: Personal / Family problems|0|||
128028248|NCT03378635|460728498|FG000|Overall Study|Adverse Event|1|||
128028249|NCT03378635|460728499|FG001|Overall Study|Adverse Event|0|||
128028250|NCT03378635|460728500|FG002|Overall Study|Adverse Event|0|||
128028251|NCT03378635|460728498|FG000|Overall Study|Withdrawal by Subject|1|||
127780633|NCT03593850|459825800|FG000|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|2|||
127780634|NCT03593850|459825801|FG001|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|3|||
127780635|NCT01735279|459825802|FG000|Overall Study|Lost to Follow-up|11|||
127780636|NCT01735279|459825803|FG001|Overall Study|Lost to Follow-up|8|||
127780637|NCT01195090|459825809|FG000|Overall Study|Adverse Event|1|||
128028252|NCT03378635|460728499|FG001|Overall Study|Withdrawal by Subject|0|||
127780638|NCT01195090|459825810|FG001|Overall Study|Adverse Event|2|||
127780639|NCT01195090|459825809|FG000|Overall Study|Lost to Follow-up|2|||
127780640|NCT01195090|459825810|FG001|Overall Study|Lost to Follow-up|2|||
128028253|NCT03378635|460728500|FG002|Overall Study|Withdrawal by Subject|0|||
128028254|NCT02496156|460728502|FG000|Overall Study|Lost to Follow-up|5|||
128028255|NCT02496156|460728503|FG001|Overall Study|Lost to Follow-up|0|||
128028256|NCT02496156|460728502|FG000|Overall Study|13SDM dyads did not access Decision Aids|0|||
128028257|NCT02496156|460728503|FG001|Overall Study|13SDM dyads did not access Decision Aids|13|||
128028258|NCT00089583|460728504|FG000|Overall Study|Adverse Event|0|||
128028259|NCT00089583|460728505|FG001|Overall Study|Adverse Event|3|||
128028260|NCT00089583|460728504|FG000|Overall Study|Insufficient Viral Load Response|5|||
128028261|NCT00089583|460728505|FG001|Overall Study|Insufficient Viral Load Response|5|||
128028262|NCT00089583|460728504|FG000|Overall Study|Withdrawal by Subject|0|||
128028263|NCT00089583|460728505|FG001|Overall Study|Withdrawal by Subject|4|||
128028264|NCT00089583|460728504|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
128028265|NCT00089583|460728505|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
128028266|NCT00089583|460728504|FG000|Overall Study|Participant Refused Study Medication|0|||
128028267|NCT00089583|460728505|FG001|Overall Study|Participant Refused Study Medication|2|||
128028268|NCT00089583|460728504|FG000|Overall Study|Non-Compliance|0|||
128028269|NCT00089583|460728505|FG001|Overall Study|Non-Compliance|4|||
128028270|NCT00089583|460728504|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
128028271|NCT00089583|460728505|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
128028272|NCT00089583|460728504|FG000|Overall Study|Participant Management Criteria Met|0|||
128028273|NCT00089583|460728505|FG001|Overall Study|Participant Management Criteria Met|1|||
128028274|NCT00089583|460728504|FG000|Overall Study|Reason Not Provided|0|||
128028275|NCT00089583|460728505|FG001|Overall Study|Reason Not Provided|1|||
128028276|NCT00089583|460728504|FG000|Overall Study|Protocol Violation|0|||
128028277|NCT00089583|460728505|FG001|Overall Study|Protocol Violation|3|||
128028278|NCT00089583|460728504|FG000|Overall Study|Principal Investigator Decision|0|||
128028279|NCT00089583|460728505|FG001|Overall Study|Principal Investigator Decision|10|||
128028280|NCT00089583|460728504|FG000|Overall Study|Start of Disallowed Medication|0|||
128028281|NCT00089583|460728505|FG001|Overall Study|Start of Disallowed Medication|1|||
128028282|NCT00089583|460728504|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
128028283|NCT00089583|460728505|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
128028284|NCT00089583|460728504|FG000|Overall Study|Participant Incarcerated|0|||
128028285|NCT00089583|460728505|FG001|Overall Study|Participant Incarcerated|1|||
128028286|NCT00507507|460728506|FG000|Treatment Period|Lost to Follow-up|0|||
128028287|NCT00507507|460728507|FG001|Treatment Period|Lost to Follow-up|2|||
128028288|NCT00507507|460728506|FG000|Treatment Period|Physician Decision|4|||
128028289|NCT00507507|460728507|FG001|Treatment Period|Physician Decision|1|||
128028290|NCT00507507|460728506|FG000|Treatment Period|Protocol Violation|1|||
128028291|NCT00507507|460728507|FG001|Treatment Period|Protocol Violation|2|||
128028292|NCT00507507|460728506|FG000|Treatment Period|Adverse Event|1|||
128028293|NCT00507507|460728507|FG001|Treatment Period|Adverse Event|1|||
128028294|NCT00507507|460728506|FG000|Treatment Period|Withdrawal by Subject|46|||
128028295|NCT00507507|460728507|FG001|Treatment Period|Withdrawal by Subject|47|||
128028296|NCT00507507|460728506|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
128028297|NCT00507507|460728507|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
128028298|NCT00507507|460728506|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
127780641|NCT01195090|459825809|FG000|Overall Study|Protocol Violation|3|||
127571787|NCT01401959|459062219|FG001|Enrolled|Withdrawal by Subject|0|||
128028299|NCT00507507|460728507|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
128028300|NCT00507507|460728506|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
128028301|NCT00507507|460728507|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
128028302|NCT02916433|460728508|FG000|Overall Study|Withdrawal by Subject|1|||
128028303|NCT02916433|460728509|FG001|Overall Study|Withdrawal by Subject|0|||
128028304|NCT02916433|460728508|FG000|Overall Study|Physician Decision|1|||
128028305|NCT02916433|460728509|FG001|Overall Study|Physician Decision|0|||
128028306|NCT03760666|460728510|FG000|Overall Study|Adverse Event|2|||
128028307|NCT03760666|460728511|FG001|Overall Study|Adverse Event|4|||
128028308|NCT03760666|460728512|FG002|Overall Study|Adverse Event|1|||
128028309|NCT03760666|460728510|FG000|Overall Study|AML Disease Progression|3|||
128028310|NCT03760666|460728511|FG001|Overall Study|AML Disease Progression|3|||
128028311|NCT03760666|460728512|FG002|Overall Study|AML Disease Progression|0|||
128028312|NCT03760666|460728510|FG000|Overall Study|Physician Decision|0|||
128028313|NCT03760666|460728511|FG001|Overall Study|Physician Decision|3|||
128028314|NCT03760666|460728512|FG002|Overall Study|Physician Decision|0|||
128028315|NCT03760666|460728510|FG000|Overall Study|Withdrawal by Subject|0|||
128028316|NCT03760666|460728511|FG001|Overall Study|Withdrawal by Subject|1|||
128028317|NCT03760666|460728512|FG002|Overall Study|Withdrawal by Subject|0|||
128028318|NCT01412983|460728513|FG000|1st Period|Ineligible|0|||
128028319|NCT01412983|460728514|FG001|1st Period|Ineligible|1|||
128028320|NCT01412983|460728513|FG000|1st Period|Positive slit lamp finding|0|||
128028321|NCT01412983|460728514|FG001|1st Period|Positive slit lamp finding|1|||
128028322|NCT01412983|460728513|FG000|1st Period|Unacceptable lens movement|0|||
128028323|NCT01412983|460728514|FG001|1st Period|Unacceptable lens movement|1|||
128028324|NCT01412983|460728513|FG000|1st Period|Inability to maintain wear|0|||
128028325|NCT01412983|460728514|FG001|1st Period|Inability to maintain wear|1|||
128028326|NCT01623154|460728515|FG000|Overall Study|Did not drink Pranactin Citric|4|||
128028327|NCT00890097|460728516|FG000|Overall Study|Adverse Event|21|||
128028328|NCT00890097|460728517|FG001|Overall Study|Adverse Event|32|||
128028329|NCT00890097|460728518|FG002|Overall Study|Adverse Event|28|||
128028330|NCT00890097|460728516|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
128028331|NCT00890097|460728517|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
128028332|NCT00890097|460728518|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
128028333|NCT00890097|460728516|FG000|Overall Study|Withdrew Consent|9|||
128028334|NCT00890097|460728517|FG001|Overall Study|Withdrew Consent|6|||
128028335|NCT00890097|460728518|FG002|Overall Study|Withdrew Consent|9|||
128028336|NCT00890097|460728516|FG000|Overall Study|Lost to Follow-up|5|||
128028337|NCT00890097|460728517|FG001|Overall Study|Lost to Follow-up|5|||
128028338|NCT00890097|460728518|FG002|Overall Study|Lost to Follow-up|5|||
128028339|NCT00890097|460728516|FG000|Overall Study|Noncompliance|0|||
128028340|NCT00890097|460728517|FG001|Overall Study|Noncompliance|4|||
128028341|NCT00890097|460728518|FG002|Overall Study|Noncompliance|4|||
128028342|NCT00890097|460728516|FG000|Overall Study|Sponsor Decision|7|||
128028343|NCT00890097|460728517|FG001|Overall Study|Sponsor Decision|11|||
128028344|NCT00890097|460728518|FG002|Overall Study|Sponsor Decision|7|||
128028345|NCT00890097|460728516|FG000|Overall Study|Did not attend final visit|2|||
128028346|NCT00890097|460728517|FG001|Overall Study|Did not attend final visit|3|||
128028347|NCT00890097|460728518|FG002|Overall Study|Did not attend final visit|0|||
128028348|NCT00890097|460728516|FG000|Overall Study|Subject Decision|3|||
128028349|NCT00890097|460728517|FG001|Overall Study|Subject Decision|2|||
128028350|NCT00890097|460728518|FG002|Overall Study|Subject Decision|6|||
128028351|NCT00890097|460728516|FG000|Overall Study|Randomization Error|2|||
128028352|NCT00890097|460728517|FG001|Overall Study|Randomization Error|0|||
128028353|NCT00890097|460728518|FG002|Overall Study|Randomization Error|0|||
128028354|NCT00890097|460728516|FG000|Overall Study|Failed inclusion criteria|3|||
128028355|NCT00890097|460728517|FG001|Overall Study|Failed inclusion criteria|4|||
128028356|NCT00890097|460728518|FG002|Overall Study|Failed inclusion criteria|0|||
128028357|NCT00890097|460728516|FG000|Overall Study|Transportation|0|||
127691994|NCT04437433|459498773|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|7|||
127691995|NCT04437433|459498774|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|0|||
127691996|NCT04437433|459498773|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|1|||
127691997|NCT04437433|459498774|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|0|||
128028358|NCT00890097|460728517|FG001|Overall Study|Transportation|2|||
128028359|NCT00890097|460728518|FG002|Overall Study|Transportation|0|||
128028360|NCT00890097|460728516|FG000|Overall Study|Subject Moved|0|||
128028361|NCT00890097|460728517|FG001|Overall Study|Subject Moved|4|||
128028362|NCT00890097|460728518|FG002|Overall Study|Subject Moved|0|||
128028363|NCT00890097|460728516|FG000|Overall Study|Protocol Deviation|1|||
128028364|NCT00890097|460728517|FG001|Overall Study|Protocol Deviation|1|||
128028365|NCT00890097|460728518|FG002|Overall Study|Protocol Deviation|1|||
128028366|NCT01694771|460728519|FG000|Overall Study|Adverse Event|18|||
128028367|NCT01694771|460728520|FG001|Overall Study|Adverse Event|16|||
128028368|NCT01694771|460728519|FG000|Overall Study|Lack of Efficacy|1|||
128028369|NCT01694771|460728520|FG001|Overall Study|Lack of Efficacy|0|||
127691998|NCT04437433|459498773|FG000|Overall Study|Adverse Event|9|||
127691999|NCT04437433|459498774|FG001|Overall Study|Adverse Event|0|||
127692000|NCT04437433|459498773|FG000|Overall Study|Lack of Efficacy|4|||
127692001|NCT04437433|459498774|FG001|Overall Study|Lack of Efficacy|0|||
127692002|NCT04437433|459498773|FG000|Overall Study|Withdrawal by Subject|4|||
127692003|NCT04437433|459498774|FG001|Overall Study|Withdrawal by Subject|1|||
127692004|NCT04437433|459498773|FG000|Overall Study|Protocol Deviation|0|||
127692005|NCT04437433|459498774|FG001|Overall Study|Protocol Deviation|1|||
127692006|NCT04437433|459498773|FG000|Overall Study|Other, not specified|0|||
127692007|NCT04437433|459498774|FG001|Overall Study|Other, not specified|1|||
127692008|NCT04048681|459498775|FG000|Overall Study|family emergency|0|||
127692009|NCT04048681|459498776|FG001|Overall Study|family emergency|0|||
127692010|NCT04048681|459498777|FG002|Overall Study|family emergency|0|||
127692011|NCT04048681|459498778|FG003|Overall Study|family emergency|1|||
127692012|NCT04048681|459498779|FG004|Overall Study|family emergency|0|||
127692013|NCT01532388|459498780|FG000|3-month Follow-up|Lost to Follow-up|68|||
127692014|NCT01532388|459498781|FG001|3-month Follow-up|Lost to Follow-up|68|||
127692015|NCT01532388|459498780|FG000|6-month Follow-up|Lost to Follow-up|74|||
127692016|NCT01532388|459498781|FG001|6-month Follow-up|Lost to Follow-up|66|||
127692017|NCT01532388|459498780|FG000|12-month Follow-up|Lost to Follow-up|69|||
127692018|NCT01532388|459498781|FG001|12-month Follow-up|Lost to Follow-up|67|||
127692019|NCT02919449|459498782|FG000|Overall Study|Withdrawal by Subject|1|||
127692020|NCT02919449|459498782|FG000|Overall Study|Investigator decision|1|||
127692021|NCT02697136|459498786|FG000|Overall Study|Adverse Event|3|||
127692022|NCT02697136|459498787|FG001|Overall Study|Adverse Event|0|||
127692023|NCT02538900|459498790|FG000|Overall Study|Death|2|||
128028370|NCT01694771|460728519|FG000|Overall Study|Non compliance protocol|7|||
128028371|NCT01694771|460728520|FG001|Overall Study|Non compliance protocol|6|||
128028372|NCT01694771|460728519|FG000|Overall Study|Lost to Follow-up|2|||
128028373|NCT01694771|460728520|FG001|Overall Study|Lost to Follow-up|3|||
128028374|NCT01694771|460728519|FG000|Overall Study|Consent withdrawn|7|||
128028375|NCT01694771|460728520|FG001|Overall Study|Consent withdrawn|9|||
127692024|NCT02538900|459498791|FG001|Overall Study|Death|2|||
127692025|NCT02538900|459498792|FG002|Overall Study|Death|2|||
127692026|NCT02538900|459498790|FG000|Overall Study|Withdrawal by Subject|18|||
127692027|NCT02538900|459498791|FG001|Overall Study|Withdrawal by Subject|16|||
127692028|NCT02538900|459498792|FG002|Overall Study|Withdrawal by Subject|15|||
127692029|NCT02874534|459498793|FG000|Overall Study|Withdrawal by Subject|5|||
127692030|NCT02874534|459498794|FG001|Overall Study|Withdrawal by Subject|8|||
127692031|NCT02874534|459498793|FG000|Overall Study|Lost to Follow-up|2|||
127692032|NCT02874534|459498794|FG001|Overall Study|Lost to Follow-up|2|||
128028376|NCT01694771|460728519|FG000|Overall Study|Other reasons|5|||
128028377|NCT01694771|460728520|FG001|Overall Study|Other reasons|6|||
128028378|NCT00289900|460728524|FG000|Overall Study|Adverse Event|28|||
128028379|NCT00289900|460728525|FG001|Overall Study|Adverse Event|40|||
128028380|NCT00289900|460728526|FG002|Overall Study|Adverse Event|13|||
128028381|NCT00289900|460728527|FG003|Overall Study|Adverse Event|19|||
128028382|NCT00289900|460728528|FG004|Overall Study|Adverse Event|20|||
128028383|NCT00289900|460728529|FG005|Overall Study|Adverse Event|33|||
128028384|NCT00289900|460728524|FG000|Overall Study|Lost to Follow-up|7|||
128028385|NCT00289900|460728525|FG001|Overall Study|Lost to Follow-up|7|||
128028386|NCT00289900|460728526|FG002|Overall Study|Lost to Follow-up|8|||
128028387|NCT00289900|460728527|FG003|Overall Study|Lost to Follow-up|8|||
128028388|NCT00289900|460728528|FG004|Overall Study|Lost to Follow-up|4|||
128028389|NCT00289900|460728529|FG005|Overall Study|Lost to Follow-up|8|||
128028390|NCT00289900|460728524|FG000|Overall Study|Participant had flushing|18|||
128028391|NCT00289900|460728525|FG001|Overall Study|Participant had flushing|42|||
128028392|NCT00289900|460728526|FG002|Overall Study|Participant had flushing|1|||
128028393|NCT00289900|460728527|FG003|Overall Study|Participant had flushing|2|||
128028394|NCT00289900|460728528|FG004|Overall Study|Participant had flushing|0|||
128028395|NCT00289900|460728529|FG005|Overall Study|Participant had flushing|4|||
128028396|NCT00289900|460728524|FG000|Overall Study|Other|0|||
128028397|NCT00289900|460728525|FG001|Overall Study|Other|0|||
128028398|NCT00289900|460728526|FG002|Overall Study|Other|0|||
128028399|NCT00289900|460728527|FG003|Overall Study|Other|5|||
128028400|NCT00289900|460728528|FG004|Overall Study|Other|1|||
128028401|NCT00289900|460728529|FG005|Overall Study|Other|0|||
128028402|NCT00289900|460728524|FG000|Overall Study|Participant moved|1|||
128028403|NCT00289900|460728525|FG001|Overall Study|Participant moved|0|||
127692033|NCT02874534|459498793|FG000|Overall Study|Ongoing in study|1|||
127692034|NCT02874534|459498794|FG001|Overall Study|Ongoing in study|1|||
127692035|NCT02923180|459498795|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
127692036|NCT02923180|459498795|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
127692037|NCT05198310|459498796|FG000|Overall Study|Lost to Follow-up|0|||
127692038|NCT05198310|459498797|FG001|Overall Study|Lost to Follow-up|1|||
127692039|NCT05198310|459498798|FG002|Overall Study|Lost to Follow-up|0|||
127692040|NCT05198310|459498799|FG003|Overall Study|Lost to Follow-up|0|||
128028404|NCT00289900|460728526|FG002|Overall Study|Participant moved|0|||
128028405|NCT00289900|460728527|FG003|Overall Study|Participant moved|1|||
128028406|NCT00289900|460728528|FG004|Overall Study|Participant moved|1|||
127780642|NCT01195090|459825810|FG001|Overall Study|Protocol Violation|4|||
127780643|NCT05111041|459825811|FG000|Overall Study|Lost to Follow-up|6|||
127780644|NCT05111041|459825812|FG001|Overall Study|Lost to Follow-up|7|||
127780645|NCT05111041|459825811|FG000|Overall Study|Withdrawal by Subject|1|||
127780646|NCT05111041|459825812|FG001|Overall Study|Withdrawal by Subject|0|||
127780647|NCT01205230|459825813|FG000|Overall Study|Adverse Event|4|||
127780648|NCT01205230|459825814|FG001|Overall Study|Adverse Event|0|||
127780649|NCT01205230|459825813|FG000|Overall Study|Physician Decision|1|||
127780650|NCT01205230|459825814|FG001|Overall Study|Physician Decision|0|||
127780651|NCT00791258|459825815|FG000|Overall Study|Adverse Event|87|||
127780652|NCT00791258|459825815|FG000|Overall Study|Lost to Follow-up|18|||
127780653|NCT00791258|459825815|FG000|Overall Study|Protocol Violation|109|||
127780654|NCT00791258|459825815|FG000|Overall Study|Withdrawal by Subject|40|||
127780655|NCT00791258|459825815|FG000|Overall Study|Did not take medication for >3 days|1|||
127780656|NCT00791258|459825815|FG000|Overall Study|subject left area|2|||
127780657|NCT00791258|459825815|FG000|Overall Study|non-compliance|3|||
127780658|NCT00791258|459825815|FG000|Overall Study|Subject incarcerated|1|||
127780659|NCT00791258|459825815|FG000|Overall Study|Subject required restricted medication|1|||
127780660|NCT00791258|459825815|FG000|Overall Study|Lack of Efficacy|1|||
127780661|NCT00922480|459825816|FG000|Main Study|Protocol Violation|3|||
128028407|NCT00289900|460728529|FG005|Overall Study|Participant moved|1|||
128028408|NCT00289900|460728524|FG000|Overall Study|Withdrawal by Subject|10|||
128028409|NCT00289900|460728525|FG001|Overall Study|Withdrawal by Subject|21|||
128028410|NCT00289900|460728526|FG002|Overall Study|Withdrawal by Subject|8|||
128028411|NCT00289900|460728527|FG003|Overall Study|Withdrawal by Subject|18|||
128028412|NCT00289900|460728528|FG004|Overall Study|Withdrawal by Subject|12|||
128028413|NCT00289900|460728529|FG005|Overall Study|Withdrawal by Subject|11|||
128028414|NCT00289900|460728524|FG000|Overall Study|Protocol Violation|3|||
128028415|NCT00289900|460728525|FG001|Overall Study|Protocol Violation|9|||
128028416|NCT00289900|460728526|FG002|Overall Study|Protocol Violation|2|||
128028417|NCT00289900|460728527|FG003|Overall Study|Protocol Violation|6|||
128028418|NCT00289900|460728528|FG004|Overall Study|Protocol Violation|7|||
128028419|NCT00289900|460728529|FG005|Overall Study|Protocol Violation|4|||
128028420|NCT00289900|460728524|FG000|Overall Study|site terminated|1|||
128028421|NCT00289900|460728525|FG001|Overall Study|site terminated|0|||
128028422|NCT00289900|460728526|FG002|Overall Study|site terminated|1|||
128028423|NCT00289900|460728527|FG003|Overall Study|site terminated|0|||
128028424|NCT00289900|460728528|FG004|Overall Study|site terminated|0|||
128028425|NCT00289900|460728529|FG005|Overall Study|site terminated|0|||
128028426|NCT00289900|460728524|FG000|Overall Study|Not treated|0|||
128028427|NCT00289900|460728525|FG001|Overall Study|Not treated|1|||
128028428|NCT00289900|460728526|FG002|Overall Study|Not treated|0|||
128028429|NCT00289900|460728527|FG003|Overall Study|Not treated|0|||
128028430|NCT00289900|460728528|FG004|Overall Study|Not treated|0|||
128028431|NCT00289900|460728529|FG005|Overall Study|Not treated|0|||
128028432|NCT01152385|460728530|FG000|Overall Study|Withdrawal by Subject|3|||
128028433|NCT01152385|460728531|FG001|Overall Study|Withdrawal by Subject|1|||
128028434|NCT01152385|460728532|FG002|Overall Study|Withdrawal by Subject|1|||
128028435|NCT01152385|460728533|FG003|Overall Study|Withdrawal by Subject|1|||
128028436|NCT01152385|460728530|FG000|Overall Study|Protocol Violation|0|||
128028437|NCT01152385|460728531|FG001|Overall Study|Protocol Violation|0|||
128028438|NCT01152385|460728532|FG002|Overall Study|Protocol Violation|0|||
128028439|NCT01152385|460728533|FG003|Overall Study|Protocol Violation|1|||
128028440|NCT01152385|460728530|FG000|Overall Study|Adverse Event|1|||
128028441|NCT01152385|460728531|FG001|Overall Study|Adverse Event|1|||
128028442|NCT01152385|460728532|FG002|Overall Study|Adverse Event|0|||
128028443|NCT01152385|460728533|FG003|Overall Study|Adverse Event|0|||
128028444|NCT01152385|460728530|FG000|Overall Study|Study-specific withdrawal criteria|1|||
127571788|NCT01401959|459062220|FG002|Enrolled|Withdrawal by Subject|0|||
127571789|NCT01401959|459062218|FG000|Treated|Disease Progression|2|||
127571790|NCT01401959|459062219|FG001|Treated|Disease Progression|2|||
127571791|NCT01401959|459062220|FG002|Treated|Disease Progression|1|||
127571792|NCT01401959|459062218|FG000|Treated|Adverse Event|4|||
128028445|NCT01152385|460728531|FG001|Overall Study|Study-specific withdrawal criteria|1|||
128028446|NCT01152385|460728532|FG002|Overall Study|Study-specific withdrawal criteria|2|||
128028447|NCT01152385|460728533|FG003|Overall Study|Study-specific withdrawal criteria|0|||
128028448|NCT01152385|460728530|FG000|Overall Study|Other|4|||
128028449|NCT01152385|460728531|FG001|Overall Study|Other|3|||
127571793|NCT01401959|459062219|FG001|Treated|Adverse Event|3|||
127571794|NCT01401959|459062220|FG002|Treated|Adverse Event|2|||
127571795|NCT01401959|459062218|FG000|Treated|Withdrawal by Subject|1|||
127571796|NCT01401959|459062219|FG001|Treated|Withdrawal by Subject|2|||
127780662|NCT00922480|459825817|FG001|Main Study|Protocol Violation|6|||
127780663|NCT00922480|459825816|FG000|Main Study|Adverse Event|6|||
127780664|NCT00922480|459825817|FG001|Main Study|Adverse Event|7|||
127780665|NCT00922480|459825816|FG000|Main Study|Lack of Efficacy|3|||
127780666|NCT00922480|459825817|FG001|Main Study|Lack of Efficacy|0|||
127780667|NCT00922480|459825816|FG000|Main Study|Withdrawal by Subject|20|||
128028450|NCT01152385|460728532|FG002|Overall Study|Other|2|||
128028451|NCT01152385|460728533|FG003|Overall Study|Other|3|||
127571797|NCT01401959|459062220|FG002|Treated|Withdrawal by Subject|2|||
127571798|NCT01401959|459062218|FG000|Treated|Protocol Violation|0|||
127571799|NCT01401959|459062219|FG001|Treated|Protocol Violation|1|||
127571800|NCT01401959|459062220|FG002|Treated|Protocol Violation|0|||
127571801|NCT00887744|459062221|FG000|Overall Study|Adverse Event|3|||
127692041|NCT05198310|459498800|FG004|Overall Study|Lost to Follow-up|0|||
127692042|NCT05198310|459498801|FG005|Overall Study|Lost to Follow-up|0|||
127692043|NCT05198310|459498802|FG006|Overall Study|Lost to Follow-up|0|||
127692044|NCT05198310|459498803|FG007|Overall Study|Lost to Follow-up|0|||
127692045|NCT05198310|459498796|FG000|Overall Study|Withdrawal by Subject|0|||
127692046|NCT05198310|459498797|FG001|Overall Study|Withdrawal by Subject|0|||
127692047|NCT05198310|459498798|FG002|Overall Study|Withdrawal by Subject|0|||
127692048|NCT05198310|459498799|FG003|Overall Study|Withdrawal by Subject|2|||
127692049|NCT05198310|459498800|FG004|Overall Study|Withdrawal by Subject|0|||
127692050|NCT05198310|459498801|FG005|Overall Study|Withdrawal by Subject|2|||
127692051|NCT05198310|459498802|FG006|Overall Study|Withdrawal by Subject|1|||
127692052|NCT05198310|459498803|FG007|Overall Study|Withdrawal by Subject|3|||
127692053|NCT04436107|459498804|FG000|Overall Study|Sponsor Ended Study|2|||
127692054|NCT04436107|459498805|FG001|Overall Study|Sponsor Ended Study|4|||
127692055|NCT04436107|459498806|FG002|Overall Study|Sponsor Ended Study|8|||
127692056|NCT04436107|459498807|FG003|Overall Study|Sponsor Ended Study|20|||
127692057|NCT04436107|459498804|FG000|Overall Study|Death|3|||
127692058|NCT04436107|459498805|FG001|Overall Study|Death|5|||
127692059|NCT04436107|459498806|FG002|Overall Study|Death|3|||
127692060|NCT04436107|459498807|FG003|Overall Study|Death|18|||
127692061|NCT04436107|459498804|FG000|Overall Study|Withdrawal by Subject|1|||
127692062|NCT04436107|459498805|FG001|Overall Study|Withdrawal by Subject|1|||
127692063|NCT04436107|459498806|FG002|Overall Study|Withdrawal by Subject|0|||
127692064|NCT04436107|459498807|FG003|Overall Study|Withdrawal by Subject|1|||
127692065|NCT01095796|459498808|FG000|Overall Study|Randomized but Not Treated|5|||
127692066|NCT01095796|459498809|FG001|Overall Study|Randomized but Not Treated|2|||
127692067|NCT01095796|459498808|FG000|Overall Study|Adverse Event|9|||
127692068|NCT01095796|459498809|FG001|Overall Study|Adverse Event|19|||
127692069|NCT01095796|459498808|FG000|Overall Study|Death|3|||
127692070|NCT01095796|459498809|FG001|Overall Study|Death|2|||
127692071|NCT01095796|459498808|FG000|Overall Study|Pregnancy|2|||
127692072|NCT01095796|459498809|FG001|Overall Study|Pregnancy|0|||
127692073|NCT01095796|459498808|FG000|Overall Study|Lack of Efficacy|5|||
127692074|NCT01095796|459498809|FG001|Overall Study|Lack of Efficacy|3|||
127692075|NCT01095796|459498808|FG000|Overall Study|Investigator's Discretion|7|||
127692076|NCT01095796|459498809|FG001|Overall Study|Investigator's Discretion|2|||
127692077|NCT01095796|459498808|FG000|Overall Study|Withdrew Consent|16|||
127692078|NCT01095796|459498809|FG001|Overall Study|Withdrew Consent|22|||
127692079|NCT01095796|459498808|FG000|Overall Study|Lost to Follow-up|27|||
127692080|NCT01095796|459498809|FG001|Overall Study|Lost to Follow-up|29|||
128028452|NCT05486065|460728534|FG000|Overall Study|Withdrawal by Subject|1|||
128028453|NCT05486065|460728535|FG001|Overall Study|Withdrawal by Subject|5|||
128028454|NCT05486065|460728536|FG002|Overall Study|Withdrawal by Subject|4|||
128028455|NCT05486065|460728537|FG003|Overall Study|Withdrawal by Subject|3|||
128028456|NCT05486065|460728534|FG000|Overall Study|Lost to Follow-up|4|||
128028457|NCT05486065|460728535|FG001|Overall Study|Lost to Follow-up|2|||
128028458|NCT05486065|460728536|FG002|Overall Study|Lost to Follow-up|2|||
128028459|NCT05486065|460728537|FG003|Overall Study|Lost to Follow-up|2|||
128028460|NCT05486065|460728534|FG000|Overall Study|Physician Decision|0|||
128028461|NCT05486065|460728535|FG001|Overall Study|Physician Decision|1|||
128028462|NCT05486065|460728536|FG002|Overall Study|Physician Decision|1|||
128028463|NCT05486065|460728537|FG003|Overall Study|Physician Decision|0|||
128028464|NCT05486065|460728534|FG000|Overall Study|Failure to meet randomization criteria|0|||
128028465|NCT05486065|460728535|FG001|Overall Study|Failure to meet randomization criteria|0|||
128028466|NCT05486065|460728536|FG002|Overall Study|Failure to meet randomization criteria|0|||
128028467|NCT05486065|460728537|FG003|Overall Study|Failure to meet randomization criteria|1|||
128028468|NCT02656173|460728538|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
128028469|NCT02656173|460728539|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
128028470|NCT02656173|460728538|FG000|Overall Study|Adverse Event|7|||
128028471|NCT02656173|460728539|FG001|Overall Study|Adverse Event|5|||
127571802|NCT00887744|459062221|FG000|Overall Study|Death|1|||
127692081|NCT01095796|459498808|FG000|Overall Study|Participant Noncompliance|5|||
127692082|NCT01095796|459498809|FG001|Overall Study|Participant Noncompliance|10|||
127692083|NCT01095796|459498808|FG000|Overall Study|Protocol Violation|1|||
127692084|NCT01095796|459498809|FG001|Overall Study|Protocol Violation|0|||
127692085|NCT01095796|459498808|FG000|Overall Study|Participant Transferred to Another Study|215|||
127692086|NCT01095796|459498809|FG001|Overall Study|Participant Transferred to Another Study|200|||
127692087|NCT05512962|459498812|FG000|Overall Study|Withdrawal by Subject|1|||
127692088|NCT05512962|459498813|FG001|Overall Study|Withdrawal by Subject|0|||
128028472|NCT02656173|460728538|FG000|Overall Study|Withdrawal by Subject|1|||
128028473|NCT02656173|460728539|FG001|Overall Study|Withdrawal by Subject|3|||
128028474|NCT02656173|460728538|FG000|Overall Study|Protocol Violation|0|||
128028475|NCT02656173|460728539|FG001|Overall Study|Protocol Violation|1|||
127571803|NCT00887744|459062221|FG000|Overall Study|Lost to Follow-up|3|||
127571804|NCT00887744|459062221|FG000|Overall Study|Withdrawal by Subject|18|||
127571805|NCT00887744|459062221|FG000|Overall Study|Various reasons|9|||
127571806|NCT02274038|459062228|FG000|Overall Study|Death|1|||
127571807|NCT00321893|459062229|FG000|Overall Study|Non-Compliance/Refusal|16|||
127571808|NCT00321893|459062230|FG001|Overall Study|Non-Compliance/Refusal|10|||
127571809|NCT00321893|459062229|FG000|Overall Study|Lost to Follow-up|2|||
127571810|NCT00321893|459062230|FG001|Overall Study|Lost to Follow-up|1|||
127571811|NCT00321893|459062229|FG000|Overall Study|Adverse Event|6|||
127571812|NCT00321893|459062230|FG001|Overall Study|Adverse Event|3|||
127571813|NCT01306877|459062231|FG000|Overall Study|Lost to Follow-up|3|||
127571814|NCT01306877|459062232|FG001|Overall Study|Lost to Follow-up|3|||
128028476|NCT02656173|460728538|FG000|Overall Study|Miscellaneous|2|||
128028477|NCT02656173|460728539|FG001|Overall Study|Miscellaneous|0|||
128028478|NCT01064622|460728540|FG000|Randomized Phase II|Withdrawal by Subject|2|||
128028479|NCT01064622|460728541|FG001|Randomized Phase II|Withdrawal by Subject|2|||
128028480|NCT01064622|460728540|FG000|Randomized Phase II|Protocol Violation|0|||
128028481|NCT01064622|460728541|FG001|Randomized Phase II|Protocol Violation|1|||
128028482|NCT03289741|460728546|FG000|Overall Study|Adverse Event|1|||
128028483|NCT03289741|460728547|FG001|Overall Study|Adverse Event|1|||
128028484|NCT03289741|460728546|FG000|Overall Study|Physician Decision|2|||
128028485|NCT03289741|460728547|FG001|Overall Study|Physician Decision|2|||
128028486|NCT03289741|460728546|FG000|Overall Study|Withdrawal by Subject|1|||
128028487|NCT03289741|460728547|FG001|Overall Study|Withdrawal by Subject|0|||
128028488|NCT02536339|460728548|FG000|Overall Study|Death|20|||
128028489|NCT02536339|460728548|FG000|Overall Study|Withdrawal by Subject|3|||
128028490|NCT02536339|460728548|FG000|Overall Study|Lost to Follow-up|2|||
128028491|NCT02536339|460728548|FG000|Overall Study|Treatment discontinued|2|||
128028492|NCT02536339|460728548|FG000|Overall Study|Physician Decision|1|||
128028493|NCT03449147|460728549|FG000|52-week Treatment Period|Death|0|||
128028494|NCT03449147|460728550|FG001|52-week Treatment Period|Death|1|||
128028495|NCT03449147|460728551|FG002|52-week Treatment Period|Death|0|||
128028496|NCT03449147|460728549|FG000|52-week Treatment Period|Lost to Follow-up|6|||
128028497|NCT03449147|460728550|FG001|52-week Treatment Period|Lost to Follow-up|2|||
128028498|NCT03449147|460728551|FG002|52-week Treatment Period|Lost to Follow-up|5|||
128028499|NCT03449147|460728549|FG000|52-week Treatment Period|Other|0|||
128028500|NCT03449147|460728550|FG001|52-week Treatment Period|Other|1|||
128028501|NCT03449147|460728551|FG002|52-week Treatment Period|Other|2|||
128028502|NCT03449147|460728549|FG000|52-week Treatment Period|Physician Decision|1|||
128028503|NCT03449147|460728550|FG001|52-week Treatment Period|Physician Decision|0|||
128028504|NCT03449147|460728551|FG002|52-week Treatment Period|Physician Decision|3|||
128028505|NCT03449147|460728549|FG000|52-week Treatment Period|Screen Failure|1|||
128028506|NCT03449147|460728550|FG001|52-week Treatment Period|Screen Failure|2|||
128028507|NCT03449147|460728551|FG002|52-week Treatment Period|Screen Failure|0|||
128028508|NCT03449147|460728549|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
128028509|NCT03449147|460728550|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
128028510|NCT03449147|460728551|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
128028511|NCT03449147|460728549|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
128028512|NCT03449147|460728550|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
128028513|NCT03449147|460728551|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
128028514|NCT03449147|460728549|FG000|12-Week Off-Treatment Durability Period|Other|0|||
128028515|NCT03449147|460728550|FG001|12-Week Off-Treatment Durability Period|Other|1|||
128028516|NCT03449147|460728551|FG002|12-Week Off-Treatment Durability Period|Other|0|||
128028517|NCT02037984|460728552|FG000|Overall Study|Lack of Efficacy|0|||
128028518|NCT02037984|460728553|FG001|Overall Study|Lack of Efficacy|0|||
128028519|NCT02037984|460728554|FG002|Overall Study|Lack of Efficacy|3|||
128028520|NCT02037984|460728555|FG003|Overall Study|Lack of Efficacy|10|||
128028521|NCT02037984|460728556|FG004|Overall Study|Lack of Efficacy|2|||
128028522|NCT02037984|460728557|FG005|Overall Study|Lack of Efficacy|2|||
128028523|NCT02037984|460728558|FG006|Overall Study|Lack of Efficacy|4|||
128028524|NCT02037984|460728559|FG007|Overall Study|Lack of Efficacy|3|||
128028525|NCT02037984|460728552|FG000|Overall Study|Lost to Follow-up|1|||
128028526|NCT02037984|460728553|FG001|Overall Study|Lost to Follow-up|0|||
128028527|NCT02037984|460728554|FG002|Overall Study|Lost to Follow-up|3|||
128028528|NCT02037984|460728555|FG003|Overall Study|Lost to Follow-up|5|||
128028529|NCT02037984|460728556|FG004|Overall Study|Lost to Follow-up|2|||
128028530|NCT02037984|460728557|FG005|Overall Study|Lost to Follow-up|2|||
128028531|NCT02037984|460728558|FG006|Overall Study|Lost to Follow-up|2|||
128028532|NCT02037984|460728559|FG007|Overall Study|Lost to Follow-up|4|||
128028533|NCT02037984|460728552|FG000|Overall Study|Physician Decision|0|||
128028534|NCT02037984|460728553|FG001|Overall Study|Physician Decision|0|||
127571815|NCT01306877|459062231|FG000|Overall Study|Physician Decision|0|||
127571816|NCT01306877|459062232|FG001|Overall Study|Physician Decision|1|||
127571817|NCT00999921|459062237|FG000|Overall Study|Lost to Follow-up|10|||
127571818|NCT00999921|459062238|FG001|Overall Study|Lost to Follow-up|19|||
128028535|NCT02037984|460728554|FG002|Overall Study|Physician Decision|0|||
128028536|NCT02037984|460728555|FG003|Overall Study|Physician Decision|0|||
127780668|NCT00922480|459825817|FG001|Main Study|Withdrawal by Subject|15|||
127780669|NCT00922480|459825816|FG000|Main Study|Lost to Follow-up|5|||
127780670|NCT00922480|459825817|FG001|Main Study|Lost to Follow-up|0|||
127780671|NCT00922480|459825816|FG000|Main Study|Physician Decision|0|||
127780672|NCT00922480|459825817|FG001|Main Study|Physician Decision|1|||
127780673|NCT00922480|459825816|FG000|Extension Study|Protocol Violation|3|||
127780674|NCT00922480|459825817|FG001|Extension Study|Protocol Violation|0|||
127780675|NCT00922480|459825816|FG000|Extension Study|Adverse Event|1|||
127780676|NCT00922480|459825817|FG001|Extension Study|Adverse Event|1|||
127780677|NCT00922480|459825816|FG000|Extension Study|Withdrawal by Subject|1|||
127780678|NCT00922480|459825817|FG001|Extension Study|Withdrawal by Subject|1|||
127780679|NCT00922480|459825816|FG000|Extension Study|Others|0|||
127780680|NCT00922480|459825817|FG001|Extension Study|Others|1|||
127780681|NCT04784897|459825818|FG000|Overall Study|Death|4|||
127780682|NCT04784897|459825819|FG001|Overall Study|Death|2|||
127780683|NCT04784897|459825820|FG002|Overall Study|Death|1|||
127780684|NCT04784897|459825818|FG000|Overall Study|Withdrawal by Subject|0|||
127780685|NCT04784897|459825819|FG001|Overall Study|Withdrawal by Subject|0|||
127780686|NCT04784897|459825820|FG002|Overall Study|Withdrawal by Subject|1|||
127780687|NCT04667377|459825821|FG000|Dose Escalation Period|Other not specified below|3|||
127780688|NCT04667377|459825822|FG001|Dose Escalation Period|Other not specified below|3|||
127780689|NCT04667377|459825823|FG002|Dose Escalation Period|Other not specified below|2|||
127780690|NCT04667377|459825824|FG003|Dose Escalation Period|Other not specified below|1|||
127780691|NCT04667377|459825825|FG004|Dose Escalation Period|Other not specified below|3|||
127780692|NCT04667377|459825821|FG000|Dose Escalation Period|Protocol Violation|2|||
127780693|NCT04667377|459825822|FG001|Dose Escalation Period|Protocol Violation|2|||
127780694|NCT04667377|459825823|FG002|Dose Escalation Period|Protocol Violation|0|||
127780695|NCT04667377|459825824|FG003|Dose Escalation Period|Protocol Violation|2|||
127780696|NCT04667377|459825825|FG004|Dose Escalation Period|Protocol Violation|1|||
127780697|NCT04667377|459825821|FG000|Dose Escalation Period|Burden of study procedures|2|||
127780698|NCT04667377|459825822|FG001|Dose Escalation Period|Burden of study procedures|1|||
128028537|NCT02037984|460728556|FG004|Overall Study|Physician Decision|0|||
128028538|NCT02037984|460728557|FG005|Overall Study|Physician Decision|0|||
128028539|NCT02037984|460728558|FG006|Overall Study|Physician Decision|1|||
127780699|NCT04667377|459825823|FG002|Dose Escalation Period|Burden of study procedures|1|||
127780700|NCT04667377|459825824|FG003|Dose Escalation Period|Burden of study procedures|1|||
127780701|NCT04667377|459825825|FG004|Dose Escalation Period|Burden of study procedures|5|||
127780702|NCT04667377|459825821|FG000|Dose Escalation Period|Change of residence|0|||
127780703|NCT04667377|459825822|FG001|Dose Escalation Period|Change of residence|0|||
127780704|NCT04667377|459825823|FG002|Dose Escalation Period|Change of residence|1|||
127780705|NCT04667377|459825824|FG003|Dose Escalation Period|Change of residence|0|||
127780706|NCT04667377|459825825|FG004|Dose Escalation Period|Change of residence|0|||
127780707|NCT04667377|459825821|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
127780708|NCT04667377|459825822|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
127780709|NCT04667377|459825823|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
127780710|NCT04667377|459825824|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
127780711|NCT04667377|459825825|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
127780712|NCT04667377|459825821|FG000|Dose Escalation Period|Adverse Event|9|||
127780713|NCT04667377|459825822|FG001|Dose Escalation Period|Adverse Event|10|||
127780714|NCT04667377|459825823|FG002|Dose Escalation Period|Adverse Event|12|||
127780715|NCT04667377|459825824|FG003|Dose Escalation Period|Adverse Event|17|||
127780716|NCT04667377|459825825|FG004|Dose Escalation Period|Adverse Event|3|||
127780717|NCT04667377|459825821|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
127780718|NCT04667377|459825822|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
127780719|NCT04667377|459825823|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
127780720|NCT04667377|459825824|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
127780721|NCT04667377|459825825|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
128028540|NCT02037984|460728559|FG007|Overall Study|Physician Decision|0|||
128028541|NCT02037984|460728552|FG000|Overall Study|Protocol Violation|0|||
127780722|NCT04667377|459825821|FG000|Dose Escalation Period|Not treated|1|||
127780723|NCT04667377|459825822|FG001|Dose Escalation Period|Not treated|0|||
128028542|NCT02037984|460728553|FG001|Overall Study|Protocol Violation|0|||
128028543|NCT02037984|460728554|FG002|Overall Study|Protocol Violation|0|||
128028544|NCT02037984|460728555|FG003|Overall Study|Protocol Violation|0|||
127780724|NCT04667377|459825823|FG002|Dose Escalation Period|Not treated|0|||
127780725|NCT04667377|459825824|FG003|Dose Escalation Period|Not treated|0|||
127780726|NCT04667377|459825825|FG004|Dose Escalation Period|Not treated|0|||
127780727|NCT04667377|459825821|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
127780728|NCT04667377|459825822|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
127780729|NCT04667377|459825823|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
127780730|NCT04667377|459825824|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
127780731|NCT04667377|459825825|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
127780732|NCT04667377|459825821|FG000|Dose Escalation Period|Lost to Follow-up|0|||
128028545|NCT02037984|460728556|FG004|Overall Study|Protocol Violation|0|||
128028546|NCT02037984|460728557|FG005|Overall Study|Protocol Violation|1|||
128028547|NCT02037984|460728558|FG006|Overall Study|Protocol Violation|2|||
128028548|NCT02037984|460728559|FG007|Overall Study|Protocol Violation|0|||
128028549|NCT02037984|460728552|FG000|Overall Study|Technical Problems|0|||
128028550|NCT02037984|460728553|FG001|Overall Study|Technical Problems|0|||
128028551|NCT02037984|460728554|FG002|Overall Study|Technical Problems|3|||
128028552|NCT02037984|460728555|FG003|Overall Study|Technical Problems|3|||
128028553|NCT02037984|460728556|FG004|Overall Study|Technical Problems|2|||
128028554|NCT02037984|460728557|FG005|Overall Study|Technical Problems|3|||
128028555|NCT02037984|460728558|FG006|Overall Study|Technical Problems|4|||
128028556|NCT02037984|460728559|FG007|Overall Study|Technical Problems|2|||
128028557|NCT02037984|460728552|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
128028558|NCT02037984|460728553|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
128028559|NCT02037984|460728554|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
128028560|NCT02037984|460728555|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
128028561|NCT02037984|460728556|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
128028562|NCT02037984|460728557|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
128028563|NCT02037984|460728558|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
128028564|NCT02037984|460728559|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
128028565|NCT02037984|460728552|FG000|Overall Study|Withdrawal by Subject|0|||
128028566|NCT02037984|460728553|FG001|Overall Study|Withdrawal by Subject|0|||
128028567|NCT02037984|460728554|FG002|Overall Study|Withdrawal by Subject|0|||
128028568|NCT02037984|460728555|FG003|Overall Study|Withdrawal by Subject|1|||
128028569|NCT02037984|460728556|FG004|Overall Study|Withdrawal by Subject|1|||
128028570|NCT02037984|460728557|FG005|Overall Study|Withdrawal by Subject|3|||
128028571|NCT02037984|460728558|FG006|Overall Study|Withdrawal by Subject|0|||
128028572|NCT02037984|460728559|FG007|Overall Study|Withdrawal by Subject|1|||
128028573|NCT00974233|460728563|FG000|Induction Chemoimmunotherapy|Death|2|||
128028574|NCT00974233|460728563|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
128028575|NCT00974233|460728563|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
128028576|NCT00974233|460728563|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
128028577|NCT00974233|460728563|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
128028578|NCT00974233|460728563|FG000|Maintenance Lenalidomide|Adverse Event|8|||
128028579|NCT01691092|460728564|FG000|Overall Study|Lost to Follow-up|10|||
128028580|NCT01691092|460728564|FG000|Overall Study|Physician Decision|4|||
128028581|NCT01691092|460728564|FG000|Overall Study|Withdrawal by Subject|3|||
128028582|NCT01691092|460728564|FG000|Overall Study|non-compliance|3|||
128028583|NCT01691092|460728564|FG000|Overall Study|used for different study|2|||
128028584|NCT01691092|460728564|FG000|Overall Study|screen fail|19|||
128028585|NCT01657942|460728565|FG000|Overall Study|Alternative Treatment|7|||
128028586|NCT01657942|460728565|FG000|Overall Study|Lost to Follow-up|1|||
128028587|NCT01569763|460730397|FG000|Overall Study|Lack of Efficacy|2|||
128028588|NCT01569763|460730398|FG001|Overall Study|Lack of Efficacy|7|||
128028589|NCT01569763|460730397|FG000|Overall Study|Adverse Event|1|||
128028590|NCT01569763|460730398|FG001|Overall Study|Adverse Event|0|||
128028591|NCT03211858|460730399|FG000|Overall Study|Adverse Event|8|||
128028592|NCT03211858|460730400|FG001|Overall Study|Adverse Event|6|||
128028593|NCT03211858|460730399|FG000|Overall Study|Lack of Efficacy|0|||
128028594|NCT03211858|460730400|FG001|Overall Study|Lack of Efficacy|4|||
128028595|NCT03211858|460730399|FG000|Overall Study|Poor compliance to protocol|6|||
128028596|NCT03211858|460730400|FG001|Overall Study|Poor compliance to protocol|2|||
128028597|NCT03211858|460730399|FG000|Overall Study|Non-serious Hypoglycemia|1|||
128028598|NCT03211858|460730400|FG001|Overall Study|Non-serious Hypoglycemia|0|||
127692089|NCT05575076|459498815|FG000|Overall Study|Adverse Event|24|||
127692090|NCT05575076|459498815|FG000|Overall Study|Death|7|||
127692091|NCT05575076|459498815|FG000|Overall Study|Lost to Follow-up|16|||
127692092|NCT05575076|459498815|FG000|Overall Study|Non-Compliance|3|||
127692093|NCT05575076|459498815|FG000|Overall Study|Physician Decision|6|||
127692094|NCT05575076|459498815|FG000|Overall Study|Sponsor Requests to be Withdrawn|7|||
127692095|NCT05575076|459498815|FG000|Overall Study|Withdrawal by Subject|71|||
127692096|NCT05575076|459498815|FG000|Overall Study|Study Terminated by Sponsor|630|||
127692097|NCT05575076|459498815|FG000|Overall Study|Other|17|||
127692098|NCT01127373|459498816|FG000|Overall Study|Not Treated|3|||
127692099|NCT01127373|459498816|FG000|Overall Study|Lost to Follow-up|7|||
127692100|NCT01127373|459498816|FG000|Overall Study|Withdrawal by Subject|1|||
127692101|NCT01127373|459498816|FG000|Overall Study|Disease progression|1|||
127692102|NCT01426412|459498823|FG000|Overall Study|Withdrawal by Subject|1|||
127692103|NCT01426412|459498824|FG001|Overall Study|Withdrawal by Subject|0|||
127692104|NCT01426412|459498825|FG002|Overall Study|Withdrawal by Subject|0|||
128028599|NCT03211858|460730399|FG000|Overall Study|Other than specified above|22|||
128028600|NCT03211858|460730400|FG001|Overall Study|Other than specified above|21|||
128028601|NCT00185614|460730401|FG000|Inter-treatment Period|Physician Decision|1|||
128028602|NCT00185614|460730401|FG000|Inter-treatment Period|Relapse|2|||
127692105|NCT01426412|459498826|FG003|Overall Study|Withdrawal by Subject|0|||
127692106|NCT01426412|459498827|FG004|Overall Study|Withdrawal by Subject|1|||
127692107|NCT01426412|459498828|FG005|Overall Study|Withdrawal by Subject|0|||
127692108|NCT01426412|459498829|FG006|Overall Study|Withdrawal by Subject|0|||
128028603|NCT00185614|460730401|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
127780733|NCT04667377|459825822|FG001|Dose Escalation Period|Lost to Follow-up|1|||
128028604|NCT03160573|460730402|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
128028605|NCT03160573|460730403|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
128028606|NCT03160573|460730404|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
128028607|NCT03160573|460730405|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
128028608|NCT02402907|460730406|FG000|Overall Study|Delivered vaginally|9|||
128028609|NCT02402907|460730407|FG001|Overall Study|Delivered vaginally|3|||
128028610|NCT02402907|460730406|FG000|Overall Study|Delivered outside of Sinai|1|||
128028611|NCT02402907|460730407|FG001|Overall Study|Delivered outside of Sinai|1|||
128028612|NCT02402907|460730406|FG000|Overall Study|Lost to follow up after C-Section|10|||
128028613|NCT02402907|460730407|FG001|Overall Study|Lost to follow up after C-Section|23|||
128028614|NCT00449787|460730408|FG000|Overall Study|Lost to Follow-up|10|||
128028615|NCT00449787|460730409|FG001|Overall Study|Lost to Follow-up|8|||
128028616|NCT00449787|460730408|FG000|Overall Study|Did not require medication|95|||
128028617|NCT00449787|460730409|FG001|Overall Study|Did not require medication|92|||
128028618|NCT03701074|460730410|FG000|Overall Study|Physician Decision|1|||
128028619|NCT03701074|460730411|FG001|Overall Study|Physician Decision|0|||
128028620|NCT01423084|460730412|FG000|Overall Study|Adverse Event|0|||
128028621|NCT01423084|460730413|FG001|Overall Study|Adverse Event|1|||
128028622|NCT01423084|460730412|FG000|Overall Study|Withdrawal by Subject|2|||
128028623|NCT01423084|460730413|FG001|Overall Study|Withdrawal by Subject|3|||
128028624|NCT00661687|460730417|FG000|Overall Study|Study related symptoms and complaints|5|||
128028625|NCT00661687|460730417|FG000|Overall Study|Positive slit lamp findings|4|||
128028626|NCT00661687|460730417|FG000|Overall Study|Inability to maintain wearing schedule|3|||
128028627|NCT00661687|460730417|FG000|Overall Study|Physician Decision|1|||
128028628|NCT00661687|460730417|FG000|Overall Study|Adverse Event|2|||
128028629|NCT03574389|460730418|FG000|Vaccination Period|Noncompliance With Investigational Product|3|||
128028630|NCT03574389|460730419|FG001|Vaccination Period|Noncompliance With Investigational Product|0|||
128028631|NCT03574389|460730420|FG002|Vaccination Period|Noncompliance With Investigational Product|0|||
128028632|NCT03574389|460730421|FG003|Vaccination Period|Noncompliance With Investigational Product|0|||
128028633|NCT03574389|460730422|FG004|Vaccination Period|Noncompliance With Investigational Product|0|||
128028634|NCT03574389|460730423|FG005|Vaccination Period|Noncompliance With Investigational Product|0|||
128028635|NCT03574389|460730424|FG006|Vaccination Period|Noncompliance With Investigational Product|0|||
128028636|NCT03574389|460730418|FG000|Vaccination Period|Withdrawal by Parent/guardian|26|||
128028637|NCT03574389|460730419|FG001|Vaccination Period|Withdrawal by Parent/guardian|21|||
128028638|NCT03574389|460730420|FG002|Vaccination Period|Withdrawal by Parent/guardian|10|||
128028639|NCT03574389|460730421|FG003|Vaccination Period|Withdrawal by Parent/guardian|19|||
128028640|NCT03574389|460730422|FG004|Vaccination Period|Withdrawal by Parent/guardian|0|||
128028641|NCT03574389|460730423|FG005|Vaccination Period|Withdrawal by Parent/guardian|0|||
128028642|NCT03574389|460730424|FG006|Vaccination Period|Withdrawal by Parent/guardian|0|||
128028643|NCT03574389|460730418|FG000|Vaccination Period|Other|6|||
128028644|NCT03574389|460730419|FG001|Vaccination Period|Other|0|||
128028645|NCT03574389|460730420|FG002|Vaccination Period|Other|0|||
128028646|NCT03574389|460730421|FG003|Vaccination Period|Other|0|||
128028647|NCT03574389|460730422|FG004|Vaccination Period|Other|0|||
128028648|NCT03574389|460730423|FG005|Vaccination Period|Other|0|||
128028649|NCT03574389|460730424|FG006|Vaccination Period|Other|0|||
128028650|NCT03574389|460730418|FG000|Vaccination Period|Adverse Event|0|||
128028651|NCT03574389|460730419|FG001|Vaccination Period|Adverse Event|1|||
128028652|NCT03574389|460730420|FG002|Vaccination Period|Adverse Event|0|||
128028653|NCT03574389|460730421|FG003|Vaccination Period|Adverse Event|0|||
128028654|NCT03574389|460730422|FG004|Vaccination Period|Adverse Event|0|||
128028655|NCT03574389|460730423|FG005|Vaccination Period|Adverse Event|0|||
128028656|NCT03574389|460730424|FG006|Vaccination Period|Adverse Event|0|||
128028657|NCT03574389|460730418|FG000|Follow-up Period|Withdrawal by parent/guardian|1|||
128028658|NCT03574389|460730419|FG001|Follow-up Period|Withdrawal by parent/guardian|13|||
128028659|NCT03574389|460730420|FG002|Follow-up Period|Withdrawal by parent/guardian|9|||
128028660|NCT03574389|460730421|FG003|Follow-up Period|Withdrawal by parent/guardian|9|||
128028661|NCT03574389|460730422|FG004|Follow-up Period|Withdrawal by parent/guardian|7|||
128028662|NCT03574389|460730423|FG005|Follow-up Period|Withdrawal by parent/guardian|7|||
128028663|NCT03574389|460730424|FG006|Follow-up Period|Withdrawal by parent/guardian|1|||
128028664|NCT02715856|460730425|FG000|Overall Study|Software Issues|12|||
128028665|NCT02715856|460730426|FG001|Overall Study|Software Issues|7|||
127780734|NCT04667377|459825823|FG002|Dose Escalation Period|Lost to Follow-up|0|||
127780735|NCT04667377|459825824|FG003|Dose Escalation Period|Lost to Follow-up|0|||
127780736|NCT04667377|459825825|FG004|Dose Escalation Period|Lost to Follow-up|0|||
128028666|NCT02715856|460730425|FG000|Overall Study|Death|6|||
128028667|NCT02715856|460730426|FG001|Overall Study|Death|5|||
128028668|NCT02715856|460730425|FG000|Overall Study|Non- Compliant|0|||
128028669|NCT02715856|460730426|FG001|Overall Study|Non- Compliant|40|||
128028670|NCT02462057|460730427|FG000|Overall Study|Left Vitality|32|||
127780737|NCT04667377|459825821|FG000|Maintenance Period|Perceived lack of efficacy|0|||
127780738|NCT04667377|459825822|FG001|Maintenance Period|Perceived lack of efficacy|2|||
128028671|NCT02462057|460730428|FG001|Overall Study|Left Vitality|27|||
128028672|NCT02462057|460730429|FG002|Overall Study|Left Vitality|23|||
128028673|NCT02462057|460730430|FG003|Overall Study|Left Vitality|35|||
128028674|NCT02462057|460730431|FG004|Overall Study|Left Vitality|33|||
128028675|NCT02462057|460730427|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
128028676|NCT02462057|460730428|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
128028677|NCT02462057|460730429|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
128028678|NCT02462057|460730430|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
128028679|NCT02462057|460730431|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
128028680|NCT01682603|460730432|FG000|Overall Study|Lost to Follow-up|3|||
128028681|NCT02336555|460730433|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
128028682|NCT02336555|460730434|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
128028683|NCT02336555|460730433|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
128028684|NCT02336555|460730434|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
128028685|NCT02336555|460730433|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
128028686|NCT02336555|460730434|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
128028687|NCT00993473|460730435|FG000|Overall Study|Adverse Event|0|||
128028688|NCT00993473|460730436|FG001|Overall Study|Adverse Event|2|||
128028689|NCT00993473|460730435|FG000|Overall Study|Protocol Violation|1|||
128028690|NCT00993473|460730436|FG001|Overall Study|Protocol Violation|2|||
128028691|NCT00993473|460730435|FG000|Overall Study|Lost to Follow-up|1|||
128028692|NCT00993473|460730436|FG001|Overall Study|Lost to Follow-up|0|||
128028693|NCT00993473|460730435|FG000|Overall Study|Withdrawal by Subject|1|||
128028694|NCT00993473|460730436|FG001|Overall Study|Withdrawal by Subject|5|||
128028695|NCT00993473|460730435|FG000|Overall Study|Technical problem with CGM device|0|||
128028696|NCT00993473|460730436|FG001|Overall Study|Technical problem with CGM device|1|||
128028697|NCT00993473|460730435|FG000|Overall Study|Family event|1|||
128028698|NCT00993473|460730436|FG001|Overall Study|Family event|0|||
128028699|NCT01772693|460730437|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
128028700|NCT01772693|460730438|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
128028701|NCT01772693|460730437|FG000|Overall Study|Withdrawal by Subject|2|||
128028702|NCT01772693|460730438|FG001|Overall Study|Withdrawal by Subject|0|||
128028703|NCT01772693|460730437|FG000|Overall Study|Alternative Treatment|2|||
128028704|NCT01772693|460730438|FG001|Overall Study|Alternative Treatment|0|||
128028705|NCT01633112|460730439|FG000|Overall Study|Lack of Efficacy|1|||
128028706|NCT01633112|460730440|FG001|Overall Study|Lack of Efficacy|6|||
128028707|NCT01633112|460730441|FG002|Overall Study|Lack of Efficacy|13|||
128028708|NCT01633112|460730439|FG000|Overall Study|Abnormal laboratory value(s)|3|||
128028709|NCT01633112|460730440|FG001|Overall Study|Abnormal laboratory value(s)|1|||
128028710|NCT01633112|460730441|FG002|Overall Study|Abnormal laboratory value(s)|0|||
128028711|NCT01633112|460730439|FG000|Overall Study|Abnormal test procedure result(s)|0|||
128028712|NCT01633112|460730440|FG001|Overall Study|Abnormal test procedure result(s)|1|||
128028713|NCT01633112|460730441|FG002|Overall Study|Abnormal test procedure result(s)|0|||
128028714|NCT01633112|460730439|FG000|Overall Study|Administrative problems|1|||
128028715|NCT01633112|460730440|FG001|Overall Study|Administrative problems|2|||
128028716|NCT01633112|460730441|FG002|Overall Study|Administrative problems|5|||
128028717|NCT01633112|460730439|FG000|Overall Study|Adverse Event|16|||
128028718|NCT01633112|460730440|FG001|Overall Study|Adverse Event|18|||
128028719|NCT01633112|460730441|FG002|Overall Study|Adverse Event|20|||
128028720|NCT01633112|460730439|FG000|Overall Study|Lost to Follow-up|7|||
128028721|NCT01633112|460730440|FG001|Overall Study|Lost to Follow-up|19|||
128028722|NCT01633112|460730441|FG002|Overall Study|Lost to Follow-up|6|||
128028723|NCT01633112|460730439|FG000|Overall Study|Protocol Violation|4|||
128028724|NCT01633112|460730440|FG001|Overall Study|Protocol Violation|0|||
128028725|NCT01633112|460730441|FG002|Overall Study|Protocol Violation|2|||
128028726|NCT01633112|460730439|FG000|Overall Study|Subject no longer requires study drug|0|||
128028727|NCT01633112|460730440|FG001|Overall Study|Subject no longer requires study drug|0|||
128028728|NCT01633112|460730441|FG002|Overall Study|Subject no longer requires study drug|1|||
128028729|NCT01633112|460730439|FG000|Overall Study|Withdrawal by Subject|20|||
128028730|NCT01633112|460730440|FG001|Overall Study|Withdrawal by Subject|12|||
128028731|NCT01633112|460730441|FG002|Overall Study|Withdrawal by Subject|41|||
128028732|NCT01633112|460730439|FG000|Overall Study|missing Study Completion CRF|1|||
128028733|NCT01633112|460730440|FG001|Overall Study|missing Study Completion CRF|1|||
128028734|NCT01633112|460730441|FG002|Overall Study|missing Study Completion CRF|4|||
128028735|NCT01959919|460730442|FG000|Overall Study|Did not meet the eligibility criteria|2|||
128028736|NCT01908699|460730443|FG000|Overall Study|Adverse Event|8|||
128028737|NCT01908699|460730444|FG001|Overall Study|Adverse Event|12|||
128028738|NCT01908699|460730443|FG000|Overall Study|Lack of Efficacy|2|||
128028739|NCT01908699|460730444|FG001|Overall Study|Lack of Efficacy|2|||
128028740|NCT01908699|460730443|FG000|Overall Study|Lost to Follow-up|2|||
128028741|NCT01908699|460730444|FG001|Overall Study|Lost to Follow-up|4|||
128028742|NCT01908699|460730443|FG000|Overall Study|Physician Decision|8|||
128028743|NCT01908699|460730444|FG001|Overall Study|Physician Decision|8|||
128028744|NCT01908699|460730443|FG000|Overall Study|Withdrawal by Subject|15|||
128028745|NCT01908699|460730444|FG001|Overall Study|Withdrawal by Subject|10|||
128028746|NCT01908699|460730443|FG000|Overall Study|Pregnancy|0|||
128028747|NCT01908699|460730444|FG001|Overall Study|Pregnancy|1|||
128028748|NCT01908699|460730443|FG000|Overall Study|Randomized in Error|1|||
128028749|NCT01908699|460730444|FG001|Overall Study|Randomized in Error|0|||
128028750|NCT01908699|460730443|FG000|Overall Study|Death|9|||
128028751|NCT01908699|460730444|FG001|Overall Study|Death|12|||
128028752|NCT01908699|460730443|FG000|Overall Study|Progressive Disease|30|||
128028753|NCT01908699|460730444|FG001|Overall Study|Progressive Disease|29|||
128028754|NCT01697501|460730445|FG000|Overall Study|Protocol Violation|2|||
128028755|NCT03439072|460730446|FG000|Overall Study|Withdrawal by Subject|2|||
128028756|NCT03439072|460730447|FG001|Overall Study|Withdrawal by Subject|3|||
128028757|NCT03439072|460730446|FG000|Overall Study|Physician Decision|0|||
128028758|NCT03439072|460730447|FG001|Overall Study|Physician Decision|1|||
128028759|NCT03707821|460730450|FG000|Overall Study|Protocol Violation|0|||
128028760|NCT03707821|460730451|FG001|Overall Study|Protocol Violation|1|||
128028761|NCT03707821|460730450|FG000|Overall Study|Unsatisfactory Visual Response|1|||
128028762|NCT03707821|460730451|FG001|Overall Study|Unsatisfactory Visual Response|0|||
128028763|NCT03707821|460730450|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
128028764|NCT03707821|460730451|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
128028765|NCT00889005|460730452|FG000|Overall Study|Lost to Follow-up|4|||
128028766|NCT00889005|460730453|FG001|Overall Study|Lost to Follow-up|2|||
128028767|NCT00889005|460730452|FG000|Overall Study|Withdrawal by Subject|4|||
128028768|NCT00889005|460730453|FG001|Overall Study|Withdrawal by Subject|0|||
128028769|NCT00128492|460730454|FG000|Overall Study|AE unrelated to study|2|||
128028770|NCT00128492|460730455|FG001|Overall Study|AE unrelated to study|9|||
128028771|NCT00128492|460730454|FG000|Overall Study|Study drug intolerance (AE)|2|||
128028772|NCT00128492|460730455|FG001|Overall Study|Study drug intolerance (AE)|8|||
128028773|NCT00128492|460730454|FG000|Overall Study|AE related to study|1|||
128028774|NCT00128492|460730455|FG001|Overall Study|AE related to study|4|||
128028775|NCT00128492|460730454|FG000|Overall Study|Death|1|||
128028776|NCT00128492|460730455|FG001|Overall Study|Death|0|||
128028777|NCT00128492|460730454|FG000|Overall Study|Lost to Follow-up|1|||
128028778|NCT00128492|460730455|FG001|Overall Study|Lost to Follow-up|5|||
128028779|NCT00128492|460730454|FG000|Overall Study|Noncompliance|0|||
128028780|NCT00128492|460730455|FG001|Overall Study|Noncompliance|5|||
128028781|NCT00128492|460730454|FG000|Overall Study|Personal or administrative|10|||
128028782|NCT00128492|460730455|FG001|Overall Study|Personal or administrative|22|||
128028783|NCT00128492|460730454|FG000|Overall Study|Withdrawal by Subject|3|||
128028784|NCT00128492|460730455|FG001|Overall Study|Withdrawal by Subject|5|||
128028785|NCT00128492|460730454|FG000|Overall Study|Pregnancy|0|||
128028786|NCT00128492|460730455|FG001|Overall Study|Pregnancy|1|||
128028787|NCT05122143|460730462|FG000|Overall Study|Adverse Event|1|||
128028788|NCT05122143|460730463|FG001|Overall Study|Adverse Event|0|||
128028789|NCT05122143|460730464|FG002|Overall Study|Adverse Event|0|||
128028790|NCT05122143|460730465|FG003|Overall Study|Adverse Event|0|||
128028791|NCT05122143|460730466|FG004|Overall Study|Adverse Event|1|||
128028792|NCT05122143|460730467|FG005|Overall Study|Adverse Event|0|||
128028793|NCT05122143|460730462|FG000|Overall Study|Protocol non-compliance|0|||
128028794|NCT05122143|460730463|FG001|Overall Study|Protocol non-compliance|0|||
128028795|NCT05122143|460730464|FG002|Overall Study|Protocol non-compliance|1|||
128028796|NCT05122143|460730465|FG003|Overall Study|Protocol non-compliance|0|||
128028797|NCT05122143|460730466|FG004|Overall Study|Protocol non-compliance|0|||
128028798|NCT05122143|460730467|FG005|Overall Study|Protocol non-compliance|0|||
128028799|NCT05122143|460730462|FG000|Overall Study|Covid contact|0|||
128028800|NCT05122143|460730463|FG001|Overall Study|Covid contact|0|||
128028801|NCT05122143|460730464|FG002|Overall Study|Covid contact|0|||
128028802|NCT05122143|460730465|FG003|Overall Study|Covid contact|0|||
128028803|NCT05122143|460730466|FG004|Overall Study|Covid contact|1|||
128028804|NCT05122143|460730467|FG005|Overall Study|Covid contact|0|||
128028805|NCT00692237|460730468|FG000|Overall Study|Withdrawal by Subject|1|||
128028806|NCT00692237|460730469|FG001|Overall Study|Withdrawal by Subject|3|||
128028807|NCT00692237|460730468|FG000|Overall Study|Adverse Event|0|||
127692109|NCT01426412|459498830|FG007|Overall Study|Withdrawal by Subject|3|||
127692110|NCT01426412|459498831|FG008|Overall Study|Withdrawal by Subject|1|||
127692111|NCT01084707|459498833|FG000|Overall Study|Withdrawal by Subject|6|||
127692112|NCT02671435|459498838|FG000|Overall Study|Death|1|||
127692113|NCT02671435|459498839|FG001|Overall Study|Death|3|||
128028808|NCT00692237|460730469|FG001|Overall Study|Adverse Event|1|||
128028809|NCT01347086|460730470|FG000|Overall Study|failed screening visit|0|||
128028810|NCT01347086|460730471|FG001|Overall Study|failed screening visit|0|||
128028811|NCT01347086|460730472|FG002|Overall Study|failed screening visit|1|||
128028812|NCT01347086|460730473|FG003|Overall Study|failed screening visit|0|||
128028813|NCT01347086|460730474|FG004|Overall Study|failed screening visit|0|||
128028814|NCT01347086|460730475|FG005|Overall Study|failed screening visit|0|||
128028815|NCT01347086|460730476|FG006|Overall Study|failed screening visit|1|||
128028816|NCT01347086|460730477|FG007|Overall Study|failed screening visit|1|||
128028817|NCT01347086|460730478|FG008|Overall Study|failed screening visit|0|||
128028818|NCT01347086|460730479|FG009|Overall Study|failed screening visit|1|||
128028819|NCT00395447|460730480|FG000|Overall Study|Death|37|||
128028820|NCT00395447|460730481|FG001|Overall Study|Death|32|||
128028821|NCT00395447|460730480|FG000|Overall Study|Lost to Follow-up|52|||
127780739|NCT04667377|459825823|FG002|Maintenance Period|Perceived lack of efficacy|1|||
127780740|NCT04667377|459825824|FG003|Maintenance Period|Perceived lack of efficacy|0|||
127780741|NCT04667377|459825825|FG004|Maintenance Period|Perceived lack of efficacy|1|||
127780742|NCT04667377|459825821|FG000|Maintenance Period|Adverse Event|2|||
127780743|NCT04667377|459825822|FG001|Maintenance Period|Adverse Event|8|||
127780744|NCT04667377|459825823|FG002|Maintenance Period|Adverse Event|5|||
127780745|NCT04667377|459825824|FG003|Maintenance Period|Adverse Event|4|||
127780746|NCT04667377|459825825|FG004|Maintenance Period|Adverse Event|1|||
127780747|NCT04667377|459825821|FG000|Maintenance Period|Adverse event: COVID infection|0|||
127780748|NCT04667377|459825822|FG001|Maintenance Period|Adverse event: COVID infection|1|||
127780749|NCT04667377|459825823|FG002|Maintenance Period|Adverse event: COVID infection|0|||
127780750|NCT04667377|459825824|FG003|Maintenance Period|Adverse event: COVID infection|0|||
127780751|NCT04667377|459825825|FG004|Maintenance Period|Adverse event: COVID infection|0|||
127780752|NCT04667377|459825821|FG000|Maintenance Period|COVID-related|0|||
127780753|NCT04667377|459825822|FG001|Maintenance Period|COVID-related|0|||
127780754|NCT04667377|459825823|FG002|Maintenance Period|COVID-related|1|||
127780755|NCT04667377|459825824|FG003|Maintenance Period|COVID-related|1|||
128028822|NCT00395447|460730481|FG001|Overall Study|Lost to Follow-up|43|||
128028823|NCT00395447|460730480|FG000|Overall Study|Withdrawal by Subject|24|||
128028824|NCT00395447|460730481|FG001|Overall Study|Withdrawal by Subject|19|||
128028825|NCT00395447|460730480|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
127780756|NCT04667377|459825825|FG004|Maintenance Period|COVID-related|0|||
127780757|NCT04667377|459825821|FG000|Maintenance Period|Protocol Violation|1|||
127780758|NCT04667377|459825822|FG001|Maintenance Period|Protocol Violation|0|||
127780759|NCT04667377|459825823|FG002|Maintenance Period|Protocol Violation|0|||
127780760|NCT04667377|459825824|FG003|Maintenance Period|Protocol Violation|0|||
128028826|NCT00395447|460730481|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
128028827|NCT02624687|460730483|FG000|Overall Study|Withdrawal by Subject|1|||
128028828|NCT02624687|460730484|FG001|Overall Study|Withdrawal by Subject|1|||
128028829|NCT02624687|460730483|FG000|Overall Study|medical leave from work|0|||
128028830|NCT02624687|460730484|FG001|Overall Study|medical leave from work|1|||
128028831|NCT03111108|460730485|FG000|Overall Study|Death|0|||
128028832|NCT03111108|460730486|FG001|Overall Study|Death|1|||
128028833|NCT03111108|460730485|FG000|Overall Study|Withdrawal by Subject|1|||
128028834|NCT03111108|460730486|FG001|Overall Study|Withdrawal by Subject|0|||
128028835|NCT02771145|460730487|FG000|Overall Study|Adverse Event|3|||
128028836|NCT02771145|460730487|FG000|Overall Study|Lost to Follow-up|1|||
128028837|NCT02264821|460730488|FG000|Overall Study|Protocol Violation|1|||
128028838|NCT02264821|460730489|FG001|Overall Study|Protocol Violation|3|||
128028839|NCT02264821|460730490|FG002|Overall Study|Protocol Violation|6|||
128028840|NCT05071027|460730491|FG000|Overall Study|Lost to Follow-up|1|||
128028841|NCT05071027|460730492|FG001|Overall Study|Lost to Follow-up|4|||
128028842|NCT02314247|460730493|FG000|Overall Study|Adverse Event|2|||
128028843|NCT02314247|460730494|FG001|Overall Study|Adverse Event|1|||
128028844|NCT02314247|460730495|FG002|Overall Study|Adverse Event|0|||
128028845|NCT02314247|460730493|FG000|Overall Study|Withdrawal by Subject|1|||
128028846|NCT02314247|460730494|FG001|Overall Study|Withdrawal by Subject|3|||
128028847|NCT02314247|460730495|FG002|Overall Study|Withdrawal by Subject|1|||
128028848|NCT02314247|460730493|FG000|Overall Study|Progression of Disease|6|||
128028849|NCT02314247|460730494|FG001|Overall Study|Progression of Disease|2|||
128028850|NCT02314247|460730495|FG002|Overall Study|Progression of Disease|0|||
128028851|NCT02965976|460730496|FG000|Overall Study|Withdrawal by Subject|2|||
128028852|NCT02965976|460730497|FG001|Overall Study|Withdrawal by Subject|0|||
128028853|NCT01687595|460730498|FG000|Overall Study|Withdrawal by Subject|8|||
128028854|NCT01687595|460730499|FG001|Overall Study|Withdrawal by Subject|0|||
128028855|NCT01687595|460730498|FG000|Overall Study|Lost to Follow-up|3|||
128028856|NCT01687595|460730499|FG001|Overall Study|Lost to Follow-up|1|||
128028857|NCT01687595|460730498|FG000|Overall Study|Investigator's decision|1|||
128028858|NCT01687595|460730499|FG001|Overall Study|Investigator's decision|0|||
128028859|NCT01687595|460730498|FG000|Overall Study|Sponsor's decision|1|||
128028860|NCT01687595|460730499|FG001|Overall Study|Sponsor's decision|0|||
128028861|NCT01687595|460730498|FG000|Overall Study|Noncompliance|1|||
128028862|NCT01687595|460730499|FG001|Overall Study|Noncompliance|2|||
128028863|NCT01687595|460730498|FG000|Overall Study|Other than specified|56|||
128028864|NCT01687595|460730499|FG001|Overall Study|Other than specified|7|||
127780761|NCT04667377|459825825|FG004|Maintenance Period|Protocol Violation|1|||
127780762|NCT04667377|459825821|FG000|Maintenance Period|Burden of study procedures|1|||
127780763|NCT04667377|459825822|FG001|Maintenance Period|Burden of study procedures|2|||
127780764|NCT04667377|459825823|FG002|Maintenance Period|Burden of study procedures|0|||
127780765|NCT04667377|459825824|FG003|Maintenance Period|Burden of study procedures|1|||
127780766|NCT04667377|459825825|FG004|Maintenance Period|Burden of study procedures|0|||
128028865|NCT00489359|460730502|FG000|Overall Study|Death|0|||
127780767|NCT04667377|459825821|FG000|Maintenance Period|Change of residence|0|||
128028866|NCT00489359|460730503|FG001|Overall Study|Death|2|||
128028867|NCT00489359|460730502|FG000|Overall Study|Progressive Disease|5|||
128028868|NCT00489359|460730503|FG001|Overall Study|Progressive Disease|6|||
128028869|NCT00489359|460730502|FG000|Overall Study|Lost to Follow-up|1|||
127780768|NCT04667377|459825822|FG001|Maintenance Period|Change of residence|1|||
127780769|NCT04667377|459825823|FG002|Maintenance Period|Change of residence|0|||
127780770|NCT04667377|459825824|FG003|Maintenance Period|Change of residence|0|||
127780771|NCT04667377|459825825|FG004|Maintenance Period|Change of residence|1|||
127780772|NCT04667377|459825821|FG000|Maintenance Period|Missing|1|||
127780773|NCT04667377|459825822|FG001|Maintenance Period|Missing|0|||
127780774|NCT04667377|459825823|FG002|Maintenance Period|Missing|0|||
127780775|NCT04667377|459825824|FG003|Maintenance Period|Missing|0|||
127780776|NCT04667377|459825825|FG004|Maintenance Period|Missing|0|||
127780777|NCT04667377|459825821|FG000|Maintenance Period|Other than listed above|2|||
127780778|NCT04667377|459825822|FG001|Maintenance Period|Other than listed above|0|||
127780779|NCT04667377|459825823|FG002|Maintenance Period|Other than listed above|3|||
127780780|NCT04667377|459825824|FG003|Maintenance Period|Other than listed above|2|||
127780781|NCT04667377|459825825|FG004|Maintenance Period|Other than listed above|6|||
127780782|NCT04667377|459825821|FG000|Maintenance Period|Withdrawal by Subject|0|||
127780783|NCT04667377|459825822|FG001|Maintenance Period|Withdrawal by Subject|1|||
127780784|NCT04667377|459825823|FG002|Maintenance Period|Withdrawal by Subject|0|||
127780785|NCT04667377|459825824|FG003|Maintenance Period|Withdrawal by Subject|0|||
127780786|NCT04667377|459825825|FG004|Maintenance Period|Withdrawal by Subject|0|||
127780787|NCT04667377|459825821|FG000|Maintenance Period|Lost to Follow-up|1|||
127780788|NCT04667377|459825822|FG001|Maintenance Period|Lost to Follow-up|0|||
127780789|NCT04667377|459825823|FG002|Maintenance Period|Lost to Follow-up|1|||
127780790|NCT04667377|459825824|FG003|Maintenance Period|Lost to Follow-up|0|||
127780791|NCT04667377|459825825|FG004|Maintenance Period|Lost to Follow-up|1|||
127780792|NCT01011439|459825826|FG000|Overall Study|Death|37|||
127780793|NCT01011439|459825826|FG000|Overall Study|Lost to Follow-up|4|||
127780794|NCT01011439|459825826|FG000|Overall Study|Withdrawal by Subject|1|||
127780795|NCT01011439|459825826|FG000|Overall Study|Sponsor's decision|15|||
127780796|NCT02428855|459825827|FG000|Overall Study|Withdrawal by Subject|2|||
127780797|NCT02066311|459825828|FG000|Overall Study|Adverse Event|4|||
127780798|NCT02066311|459825828|FG000|Overall Study|Withdrawal by Subject|1|||
127780799|NCT03198520|459825833|FG000|Overall Study|Physician Decision|2|||
127780800|NCT03198520|459825833|FG000|Overall Study|Protocol Violation|2|||
127780801|NCT03198520|459825833|FG000|Overall Study|Withdrawal by Subject|1|||
127780802|NCT03198520|459825833|FG000|Overall Study|Study Ended|1|||
127780803|NCT01670539|459825834|FG000|Overall Study|Death|3|||
127780804|NCT01670539|459825835|FG001|Overall Study|Death|5|||
127780805|NCT01670539|459825834|FG000|Overall Study|Withdrawal by Subject|3|||
127780806|NCT01670539|459825835|FG001|Overall Study|Withdrawal by Subject|0|||
127780807|NCT00536809|459825836|FG000|Phase II|Adverse Event|1|||
127780808|NCT00536809|459825836|FG000|Phase II|Referred for surgical resection|1|||
127780809|NCT02606461|459825837|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
127780810|NCT02606461|459825838|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
127780811|NCT02606461|459825839|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
127780812|NCT02606461|459825840|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
127780813|NCT02606461|459825841|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
127780814|NCT02606461|459825842|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
127780815|NCT01303965|459825844|FG000|Overall Study|Adverse Event|1|||
127571819|NCT00989573|459062242|FG000|Overall Study|Adverse Event|8|||
127571820|NCT00989573|459062243|FG001|Overall Study|Adverse Event|12|||
127780816|NCT01303965|459825845|FG001|Overall Study|Adverse Event|1|||
127780817|NCT01303965|459825844|FG000|Overall Study|Death|0|||
127780818|NCT01303965|459825845|FG001|Overall Study|Death|3|||
127780819|NCT01303965|459825844|FG000|Overall Study|Withdrawal by Subject|1|||
127780820|NCT01303965|459825845|FG001|Overall Study|Withdrawal by Subject|0|||
127780821|NCT01303965|459825844|FG000|Overall Study|Disease Progression|1|||
127780822|NCT01303965|459825845|FG001|Overall Study|Disease Progression|6|||
127780823|NCT04422990|459825846|FG000|Overall Study|Withdrawal by Subject|0|||
127780824|NCT04422990|459825847|FG001|Overall Study|Withdrawal by Subject|1|||
127780825|NCT04422990|459825846|FG000|Overall Study|Travel|3|||
127780826|NCT04422990|459825847|FG001|Overall Study|Travel|0|||
127692114|NCT02671435|459498840|FG002|Overall Study|Death|0|||
127692115|NCT02671435|459498841|FG003|Overall Study|Death|16|||
127692116|NCT02671435|459498842|FG004|Overall Study|Death|14|||
127692117|NCT02671435|459498843|FG005|Overall Study|Death|29|||
127692118|NCT02671435|459498844|FG006|Overall Study|Death|34|||
127692119|NCT02671435|459498845|FG007|Overall Study|Death|28|||
127692120|NCT02671435|459498846|FG008|Overall Study|Death|19|||
127780827|NCT02844920|459825850|FG000|Overall Study|Lost to Follow-up|2|||
127780828|NCT00766090|459825861|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
127780829|NCT00766090|459825862|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
127780830|NCT00766090|459825863|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
127780831|NCT00766090|459825864|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
127780832|NCT00766090|459825865|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
127780833|NCT00766090|459825866|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
127780834|NCT00766090|459825867|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
128028870|NCT00489359|460730503|FG001|Overall Study|Lost to Follow-up|0|||
128028871|NCT00489359|460730502|FG000|Overall Study|Withdrawal by Subject|1|||
128028872|NCT00489359|460730503|FG001|Overall Study|Withdrawal by Subject|5|||
128028873|NCT00489359|460730502|FG000|Overall Study|Adverse Event|0|||
128028874|NCT00489359|460730503|FG001|Overall Study|Adverse Event|16|||
128028875|NCT01903733|460730505|FG000|Overall Study|Death|23|||
128028876|NCT01903733|460730506|FG001|Overall Study|Death|54|||
128028877|NCT01903733|460730507|FG002|Overall Study|Death|30|||
128028878|NCT01903733|460730508|FG003|Overall Study|Death|98|||
128028879|NCT01903733|460730505|FG000|Overall Study|Participant refused further follow-up|35|||
128028880|NCT01903733|460730506|FG001|Overall Study|Participant refused further follow-up|38|||
128028881|NCT01903733|460730507|FG002|Overall Study|Participant refused further follow-up|13|||
128028882|NCT01903733|460730508|FG003|Overall Study|Participant refused further follow-up|9|||
128028883|NCT01903733|460730505|FG000|Overall Study|Lost to Follow-up|18|||
128028884|NCT01903733|460730506|FG001|Overall Study|Lost to Follow-up|19|||
128028885|NCT01903733|460730507|FG002|Overall Study|Lost to Follow-up|6|||
128028886|NCT01903733|460730508|FG003|Overall Study|Lost to Follow-up|9|||
128028887|NCT01903733|460730505|FG000|Overall Study|Other|10|||
128028888|NCT01903733|460730506|FG001|Overall Study|Other|15|||
127780835|NCT00766090|459825868|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
127780836|NCT00766090|459825869|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
128028889|NCT01903733|460730507|FG002|Overall Study|Other|12|||
128028890|NCT01903733|460730508|FG003|Overall Study|Other|3|||
128028891|NCT01903733|460730505|FG000|Overall Study|Missing|2|||
128028892|NCT01903733|460730506|FG001|Overall Study|Missing|0|||
128028893|NCT01903733|460730507|FG002|Overall Study|Missing|0|||
128028894|NCT01903733|460730508|FG003|Overall Study|Missing|0|||
128028895|NCT01903733|460730505|FG000|Overall Study|Investigator request|18|||
128028896|NCT01903733|460730506|FG001|Overall Study|Investigator request|0|||
128028897|NCT01903733|460730507|FG002|Overall Study|Investigator request|0|||
128028898|NCT01903733|460730508|FG003|Overall Study|Investigator request|0|||
128028899|NCT02294019|460730510|FG000|Overall Study|Adverse Event|2|||
128028900|NCT02294019|460730510|FG000|Overall Study|Protocol Violation|68|||
128028901|NCT02294019|460730510|FG000|Overall Study|Lost to Follow-up|31|||
128028902|NCT02294019|460730510|FG000|Overall Study|Other|1|||
128028903|NCT02294019|460730510|FG000|Overall Study|Withdrawal by Subject|1|||
128028904|NCT02369159|460730511|FG000|Overall Study|Adverse Event|0|||
128028905|NCT02369159|460730512|FG001|Overall Study|Adverse Event|1|||
128028906|NCT02369159|460730511|FG000|Overall Study|Lost to Follow-up|1|||
128028907|NCT02369159|460730512|FG001|Overall Study|Lost to Follow-up|1|||
128028908|NCT02369159|460730511|FG000|Overall Study|Withdrawal by Subject|7|||
128028909|NCT02369159|460730512|FG001|Overall Study|Withdrawal by Subject|0|||
128028910|NCT03769116|460730513|FG000|Part 3 - Open Label|Study Terminated by Sponsor|1|||
127571821|NCT00989573|459062244|FG002|Overall Study|Adverse Event|4|||
127692121|NCT02671435|459498847|FG009|Overall Study|Death|10|||
127692122|NCT02671435|459498848|FG010|Overall Study|Death|8|||
127692123|NCT02671435|459498849|FG011|Overall Study|Death|29|||
127692124|NCT02671435|459498850|FG012|Overall Study|Death|29|||
127692125|NCT02671435|459498851|FG013|Overall Study|Death|29|||
127692126|NCT02671435|459498852|FG014|Overall Study|Death|27|||
127692127|NCT02671435|459498838|FG000|Overall Study|Lost to Follow-up|0|||
127692128|NCT02671435|459498839|FG001|Overall Study|Lost to Follow-up|0|||
127780837|NCT00766090|459825870|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
127692129|NCT02671435|459498840|FG002|Overall Study|Lost to Follow-up|1|||
127692130|NCT02671435|459498841|FG003|Overall Study|Lost to Follow-up|0|||
127692131|NCT02671435|459498842|FG004|Overall Study|Lost to Follow-up|1|||
127780838|NCT00766090|459825871|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
128028911|NCT03769116|460730514|FG001|Part 3 - Open Label|Study Terminated by Sponsor|2|||
128028912|NCT03769116|460730513|FG000|Part 3 - Open Label|Physician Decision|1|||
128028913|NCT03769116|460730514|FG001|Part 3 - Open Label|Physician Decision|0|||
128028914|NCT03769116|460730513|FG000|Part 3 - Open Label|Withdrawal by Subject|1|||
127692132|NCT02671435|459498843|FG005|Overall Study|Lost to Follow-up|1|||
128028915|NCT03769116|460730514|FG001|Part 3 - Open Label|Withdrawal by Subject|0|||
128028916|NCT01887600|460730520|FG000|Overall Study|Death|39|||
127692133|NCT02671435|459498844|FG006|Overall Study|Lost to Follow-up|2|||
127692134|NCT02671435|459498845|FG007|Overall Study|Lost to Follow-up|2|||
127692135|NCT02671435|459498846|FG008|Overall Study|Lost to Follow-up|0|||
127692136|NCT02671435|459498847|FG009|Overall Study|Lost to Follow-up|2|||
127692137|NCT02671435|459498848|FG010|Overall Study|Lost to Follow-up|0|||
127692138|NCT02671435|459498849|FG011|Overall Study|Lost to Follow-up|3|||
127692139|NCT02671435|459498850|FG012|Overall Study|Lost to Follow-up|3|||
127692140|NCT02671435|459498851|FG013|Overall Study|Lost to Follow-up|2|||
127692141|NCT02671435|459498852|FG014|Overall Study|Lost to Follow-up|0|||
127780839|NCT00766090|459825872|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
127780840|NCT00766090|459825861|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
127780841|NCT00766090|459825862|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
127780842|NCT00766090|459825863|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
127780843|NCT00766090|459825864|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
127780844|NCT00766090|459825865|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
127780845|NCT00766090|459825866|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
127780846|NCT00766090|459825867|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
127780847|NCT00766090|459825868|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
127780848|NCT00766090|459825869|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
128028917|NCT01887600|460730521|FG001|Overall Study|Death|16|||
128028918|NCT01887600|460730520|FG000|Overall Study|Lack of Efficacy|3|||
128028919|NCT01887600|460730521|FG001|Overall Study|Lack of Efficacy|26|||
128028920|NCT01887600|460730520|FG000|Overall Study|Lost to Follow-up|5|||
128028921|NCT01887600|460730521|FG001|Overall Study|Lost to Follow-up|1|||
128028922|NCT01887600|460730520|FG000|Overall Study|Physician Decision|7|||
128028923|NCT01887600|460730521|FG001|Overall Study|Physician Decision|8|||
128028924|NCT01887600|460730520|FG000|Overall Study|Protocol Deviation|3|||
128028925|NCT01887600|460730521|FG001|Overall Study|Protocol Deviation|0|||
128028926|NCT01887600|460730520|FG000|Overall Study|Withdrawal by Subject|58|||
128028927|NCT01887600|460730521|FG001|Overall Study|Withdrawal by Subject|52|||
128028928|NCT01887600|460730520|FG000|Overall Study|Adverse Event|21|||
128028929|NCT01887600|460730521|FG001|Overall Study|Adverse Event|9|||
128028930|NCT01887600|460730520|FG000|Overall Study|Non-compliance with study drug|3|||
128028931|NCT01887600|460730521|FG001|Overall Study|Non-compliance with study drug|0|||
128028932|NCT01887600|460730520|FG000|Overall Study|Miscellaneous|6|||
128028933|NCT01887600|460730521|FG001|Overall Study|Miscellaneous|2|||
128028934|NCT01887600|460730520|FG000|Overall Study|Progressive Disease|1|||
128028935|NCT01887600|460730521|FG001|Overall Study|Progressive Disease|0|||
128028936|NCT03688139|460730522|FG000|Overall Study|Lost to Follow-up|2|||
128028937|NCT03688139|460730523|FG001|Overall Study|Lost to Follow-up|0|||
128028938|NCT03688139|460730522|FG000|Overall Study|Physician Decision|0|||
128028939|NCT03688139|460730523|FG001|Overall Study|Physician Decision|1|||
128028940|NCT03688139|460730522|FG000|Overall Study|Withdrawal by Subject|2|||
128028941|NCT03688139|460730523|FG001|Overall Study|Withdrawal by Subject|3|||
128028942|NCT01390584|460730530|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
128028943|NCT01390584|460730531|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
128028944|NCT01390584|460730532|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
128028945|NCT00025233|460730533|FG000|Overall Study|Ineligible: wrong cell type|1|||
128028946|NCT00025233|460730533|FG000|Overall Study|Ineligible: wrong primary|1|||
128028947|NCT00025233|460730533|FG000|Overall Study|Ineligible: improper prior treatment|1|||
128028948|NCT00025233|460730533|FG000|Overall Study|Never treated|1|||
128028949|NCT00452400|460730534|FG000|Overall Study|Adverse Event|1|||
128028950|NCT00452400|460730535|FG001|Overall Study|Adverse Event|1|||
128028951|NCT00452400|460730536|FG002|Overall Study|Adverse Event|5|||
128028952|NCT00452400|460730537|FG003|Overall Study|Adverse Event|0|||
128028953|NCT00452400|460730538|FG004|Overall Study|Adverse Event|2|||
128028954|NCT00452400|460730534|FG000|Overall Study|Protocol Violation|0|||
128028955|NCT00452400|460730535|FG001|Overall Study|Protocol Violation|0|||
128028956|NCT00452400|460730536|FG002|Overall Study|Protocol Violation|1|||
128028957|NCT00452400|460730537|FG003|Overall Study|Protocol Violation|0|||
128028958|NCT00452400|460730538|FG004|Overall Study|Protocol Violation|0|||
128028959|NCT00452400|460730534|FG000|Overall Study|Lost to Follow-up|1|||
128028960|NCT00452400|460730535|FG001|Overall Study|Lost to Follow-up|0|||
128028961|NCT00452400|460730536|FG002|Overall Study|Lost to Follow-up|0|||
128028962|NCT00452400|460730537|FG003|Overall Study|Lost to Follow-up|0|||
128028963|NCT00452400|460730538|FG004|Overall Study|Lost to Follow-up|0|||
128028964|NCT00452400|460730534|FG000|Overall Study|Withdrawal by Subject|1|||
128028965|NCT00452400|460730535|FG001|Overall Study|Withdrawal by Subject|0|||
127692142|NCT02671435|459498838|FG000|Overall Study|Withdrawal by Subject|2|||
127692143|NCT02671435|459498839|FG001|Overall Study|Withdrawal by Subject|0|||
127780849|NCT00766090|459825870|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
127780850|NCT00766090|459825871|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
128028966|NCT00452400|460730536|FG002|Overall Study|Withdrawal by Subject|1|||
128028967|NCT00452400|460730537|FG003|Overall Study|Withdrawal by Subject|0|||
128028968|NCT00452400|460730538|FG004|Overall Study|Withdrawal by Subject|0|||
127780851|NCT00766090|459825872|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
127780852|NCT00766090|459825861|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
127780853|NCT00766090|459825862|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
127780854|NCT00766090|459825863|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
127780855|NCT00766090|459825864|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
127780856|NCT00766090|459825865|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
127780857|NCT00766090|459825866|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
127780858|NCT00766090|459825867|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
127780859|NCT00766090|459825868|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
127780860|NCT00766090|459825869|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
127780861|NCT00766090|459825870|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
127780862|NCT00766090|459825871|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
127780863|NCT00766090|459825872|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
127780864|NCT00766090|459825861|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
127780865|NCT00766090|459825862|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
127780866|NCT00766090|459825863|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
127780867|NCT00766090|459825864|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
127780868|NCT00766090|459825865|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
127780869|NCT00766090|459825866|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
127780870|NCT00766090|459825867|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
127780871|NCT00766090|459825868|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
127780872|NCT00766090|459825869|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
127780873|NCT00766090|459825870|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
127780874|NCT00766090|459825871|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
127780875|NCT00766090|459825872|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
127780876|NCT00766090|459825861|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
127780877|NCT00766090|459825862|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
128028969|NCT00452400|460730534|FG000|Overall Study|Lack of Efficacy|2|||
128028970|NCT00452400|460730535|FG001|Overall Study|Lack of Efficacy|0|||
128028971|NCT00452400|460730536|FG002|Overall Study|Lack of Efficacy|0|||
128028972|NCT00452400|460730537|FG003|Overall Study|Lack of Efficacy|0|||
128028973|NCT00452400|460730538|FG004|Overall Study|Lack of Efficacy|0|||
128028974|NCT00452400|460730534|FG000|Overall Study|Other reasons not listed above|0|||
128028975|NCT00452400|460730535|FG001|Overall Study|Other reasons not listed above|0|||
128028976|NCT00452400|460730536|FG002|Overall Study|Other reasons not listed above|0|||
128028977|NCT00452400|460730537|FG003|Overall Study|Other reasons not listed above|1|||
128028978|NCT00452400|460730538|FG004|Overall Study|Other reasons not listed above|1|||
128028979|NCT01943825|460730539|FG000|Overall Study|Lost to Follow-up|9|||
128028980|NCT01943825|460730540|FG001|Overall Study|Lost to Follow-up|3|||
128028981|NCT01943825|460730541|FG002|Overall Study|Lost to Follow-up|12|||
128028982|NCT01943825|460730542|FG003|Overall Study|Lost to Follow-up|8|||
128028983|NCT01943825|460730539|FG000|Overall Study|Withdrawal by Subject|1|||
128028984|NCT01943825|460730540|FG001|Overall Study|Withdrawal by Subject|0|||
128028985|NCT01943825|460730541|FG002|Overall Study|Withdrawal by Subject|3|||
128028986|NCT01943825|460730542|FG003|Overall Study|Withdrawal by Subject|2|||
128028987|NCT01943825|460730539|FG000|Overall Study|Other than specified above|0|||
128028988|NCT01943825|460730540|FG001|Overall Study|Other than specified above|1|||
128028989|NCT01943825|460730541|FG002|Overall Study|Other than specified above|0|||
128028990|NCT01943825|460730542|FG003|Overall Study|Other than specified above|1|||
128028991|NCT01720602|460730543|FG000|Overall Study|Adverse Event|3|||
128028992|NCT01720602|460730543|FG000|Overall Study|Progressive disease on therapy|2|||
128028993|NCT03425188|460730544|FG000|Overall Study|Withdrawal by Subject|1|||
128028994|NCT01835431|460730545|FG000|Overall Study|Adverse Event|1|||
128028995|NCT01835431|460730546|FG001|Overall Study|Adverse Event|0|||
128028996|NCT01835431|460730545|FG000|Overall Study|other|0|||
128028997|NCT01835431|460730546|FG001|Overall Study|other|2|||
128028998|NCT01835431|460730545|FG000|Overall Study|Withdrawal by Subject|6|||
128028999|NCT01835431|460730546|FG001|Overall Study|Withdrawal by Subject|10|||
128029000|NCT01835431|460730545|FG000|Overall Study|Protocol Violation|1|||
128029001|NCT01835431|460730546|FG001|Overall Study|Protocol Violation|0|||
128029002|NCT00562861|460730549|FG000|Overall Study|Adverse Event|1|||
128029003|NCT00562861|460730550|FG001|Overall Study|Adverse Event|1|||
128029004|NCT00562861|460730549|FG000|Overall Study|Lack of Efficacy|5|||
128029005|NCT00562861|460730550|FG001|Overall Study|Lack of Efficacy|5|||
128029006|NCT00562861|460730549|FG000|Overall Study|noncompliance, moved|7|||
128029007|NCT00562861|460730550|FG001|Overall Study|noncompliance, moved|2|||
128029008|NCT00562861|460730549|FG000|Overall Study|Lost to Follow-up|7|||
128029009|NCT00562861|460730550|FG001|Overall Study|Lost to Follow-up|3|||
128029010|NCT00655356|460730551|FG000|Overall Study|Withdrawal by Subject|3|||
127780878|NCT00766090|459825863|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
127780879|NCT00766090|459825864|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
127780880|NCT00766090|459825865|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
128029011|NCT00655356|460730552|FG001|Overall Study|Withdrawal by Subject|4|||
128029012|NCT00655356|460730551|FG000|Overall Study|Sponsor Request|10|||
128029013|NCT00655356|460730552|FG001|Overall Study|Sponsor Request|4|||
128029014|NCT00655356|460730551|FG000|Overall Study|Adverse Event|1|||
128029015|NCT00655356|460730552|FG001|Overall Study|Adverse Event|1|||
128029016|NCT00655356|460730551|FG000|Overall Study|Protocol Violation|2|||
128029017|NCT00655356|460730552|FG001|Overall Study|Protocol Violation|1|||
128029018|NCT00655356|460730551|FG000|Overall Study|Other Reason|1|||
128029019|NCT00655356|460730552|FG001|Overall Study|Other Reason|0|||
128029020|NCT04349098|460730553|FG000|Overall Study|Death|16|||
128029021|NCT04349098|460730554|FG001|Overall Study|Death|8|||
128029022|NCT04349098|460730553|FG000|Overall Study|Lost to Follow-up|11|||
128029023|NCT04349098|460730554|FG001|Overall Study|Lost to Follow-up|8|||
128029024|NCT04349098|460730553|FG000|Overall Study|Withdrawal by Subject|8|||
128029025|NCT04349098|460730554|FG001|Overall Study|Withdrawal by Subject|5|||
128029026|NCT04349098|460730553|FG000|Overall Study|Other|3|||
128029027|NCT04349098|460730554|FG001|Overall Study|Other|5|||
128029028|NCT01703221|460730555|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
128029029|NCT01703221|460730556|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
128029030|NCT01703221|460730557|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
128029031|NCT01703221|460730555|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
128029032|NCT01703221|460730556|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
128029033|NCT01703221|460730557|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
128029034|NCT01703221|460730555|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
128029035|NCT01703221|460730556|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
128029036|NCT01703221|460730557|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
128029037|NCT01703221|460730555|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
128029038|NCT01703221|460730556|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
128029039|NCT01703221|460730557|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
128029040|NCT01703221|460730555|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
128029041|NCT01703221|460730556|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
128029042|NCT01703221|460730557|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
128029043|NCT01703221|460730555|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
128029044|NCT01703221|460730556|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
128029045|NCT01703221|460730557|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
128029046|NCT01703221|460730555|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
128029047|NCT01703221|460730556|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
128029048|NCT01703221|460730557|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
128029049|NCT01703221|460730555|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
128029050|NCT01703221|460730556|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
128029051|NCT01703221|460730557|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
128029052|NCT03927846|460730559|FG000|Overall Study|Lost to Follow-up|10|||
128029053|NCT03927846|460730560|FG001|Overall Study|Lost to Follow-up|11|||
128029054|NCT03878069|460730561|FG000|Overall Study|Death|0|||
128029055|NCT03878069|460730562|FG001|Overall Study|Death|1|||
128029056|NCT03878069|460730563|FG002|Overall Study|Death|0|||
128029057|NCT00834587|460730564|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
128029058|NCT00834587|460730565|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
128029059|NCT03810495|460730566|FG000|Overall Study|Lost to Follow-up|2|||
128029060|NCT03810495|460730566|FG000|Overall Study|Withdrawal by Subject|1|||
128029061|NCT02730169|460732057|FG000|Overall Study|Protocol Violation|1|||
128029062|NCT02730169|460732058|FG001|Overall Study|Protocol Violation|0|||
128029063|NCT02730169|460732059|FG002|Overall Study|Protocol Violation|0|||
128029064|NCT02730169|460732060|FG003|Overall Study|Protocol Violation|1|||
128029065|NCT02730169|460732057|FG000|Overall Study|Adverse Event|2|||
128029066|NCT02730169|460732058|FG001|Overall Study|Adverse Event|3|||
128029067|NCT02730169|460732059|FG002|Overall Study|Adverse Event|3|||
128029068|NCT02730169|460732060|FG003|Overall Study|Adverse Event|0|||
128029069|NCT02730169|460732057|FG000|Overall Study|Adverse Event of Special Interest|0|||
128029070|NCT02730169|460732058|FG001|Overall Study|Adverse Event of Special Interest|1|||
128029071|NCT02730169|460732059|FG002|Overall Study|Adverse Event of Special Interest|2|||
128029072|NCT02730169|460732060|FG003|Overall Study|Adverse Event of Special Interest|0|||
128029073|NCT02730169|460732057|FG000|Overall Study|Withdrawal by Subject|6|||
128029074|NCT02730169|460732058|FG001|Overall Study|Withdrawal by Subject|11|||
128029075|NCT02730169|460732059|FG002|Overall Study|Withdrawal by Subject|6|||
128029076|NCT02730169|460732060|FG003|Overall Study|Withdrawal by Subject|8|||
128029077|NCT02730169|460732057|FG000|Overall Study|Lost to Follow-up|5|||
128029078|NCT02730169|460732058|FG001|Overall Study|Lost to Follow-up|6|||
128029079|NCT02730169|460732059|FG002|Overall Study|Lost to Follow-up|5|||
128029080|NCT02730169|460732060|FG003|Overall Study|Lost to Follow-up|6|||
128029081|NCT02730169|460732057|FG000|Overall Study|Other|0|||
128029082|NCT02730169|460732058|FG001|Overall Study|Other|0|||
128029083|NCT02730169|460732059|FG002|Overall Study|Other|1|||
128029084|NCT02730169|460732060|FG003|Overall Study|Other|1|||
128029085|NCT02457546|460732067|FG000|Overall Study|Other reasons|4|||
128029086|NCT02457546|460732068|FG001|Overall Study|Other reasons|1|||
128029087|NCT02457546|460732067|FG000|Overall Study|Refused to complete study/procedures|1|||
128029088|NCT02457546|460732068|FG001|Overall Study|Refused to complete study/procedures|1|||
128029089|NCT02457546|460732067|FG000|Overall Study|Lost to Follow-up|4|||
128029090|NCT02457546|460732068|FG001|Overall Study|Lost to Follow-up|1|||
128029091|NCT02457546|460732067|FG000|Overall Study|Adverse Event|0|||
128029092|NCT02457546|460732068|FG001|Overall Study|Adverse Event|1|||
128029093|NCT02144337|460732069|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
128029094|NCT02144337|460732070|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
128029095|NCT02144337|460732069|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
128029096|NCT02144337|460732070|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
128029097|NCT02144337|460732069|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
128029098|NCT02144337|460732070|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
128029099|NCT02144337|460732069|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
128029100|NCT02144337|460732070|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
128029101|NCT02144337|460732069|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
128029102|NCT02144337|460732070|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
128029103|NCT01730729|460732073|FG000|Overall Study|Adverse Event|1|||
128029104|NCT01730729|460732073|FG000|Overall Study|Death|1|||
128029105|NCT01730729|460732073|FG000|Overall Study|Progressive Disease|12|||
128029106|NCT01661595|460732074|FG000|Phase 1: Week 0-4|Adverse Event|1|||
128029107|NCT01661595|460732075|FG001|Phase 1: Week 0-4|Adverse Event|0|||
128029108|NCT01661595|460732076|FG002|Phase 1: Week 0-4|Adverse Event|0|||
128029109|NCT01661595|460732077|FG003|Phase 1: Week 0-4|Adverse Event|0|||
127692144|NCT02671435|459498840|FG002|Overall Study|Withdrawal by Subject|2|||
127692145|NCT02671435|459498841|FG003|Overall Study|Withdrawal by Subject|2|||
127692146|NCT02671435|459498842|FG004|Overall Study|Withdrawal by Subject|2|||
127692147|NCT02671435|459498843|FG005|Overall Study|Withdrawal by Subject|7|||
127692148|NCT02671435|459498844|FG006|Overall Study|Withdrawal by Subject|2|||
127692149|NCT02671435|459498845|FG007|Overall Study|Withdrawal by Subject|7|||
127692150|NCT02671435|459498846|FG008|Overall Study|Withdrawal by Subject|1|||
127692151|NCT02671435|459498847|FG009|Overall Study|Withdrawal by Subject|1|||
127692152|NCT02671435|459498848|FG010|Overall Study|Withdrawal by Subject|2|||
127692153|NCT02671435|459498849|FG011|Overall Study|Withdrawal by Subject|4|||
127692154|NCT02671435|459498850|FG012|Overall Study|Withdrawal by Subject|4|||
127692155|NCT02671435|459498851|FG013|Overall Study|Withdrawal by Subject|4|||
127692156|NCT02671435|459498852|FG014|Overall Study|Withdrawal by Subject|2|||
127692157|NCT02671435|459498838|FG000|Overall Study|Un-specified|0|||
127692158|NCT02671435|459498839|FG001|Overall Study|Un-specified|0|||
127692159|NCT02671435|459498840|FG002|Overall Study|Un-specified|0|||
127692160|NCT02671435|459498841|FG003|Overall Study|Un-specified|0|||
127692161|NCT02671435|459498842|FG004|Overall Study|Un-specified|1|||
127692162|NCT02671435|459498843|FG005|Overall Study|Un-specified|3|||
127692163|NCT02671435|459498844|FG006|Overall Study|Un-specified|2|||
127692164|NCT02671435|459498845|FG007|Overall Study|Un-specified|3|||
127692165|NCT02671435|459498846|FG008|Overall Study|Un-specified|0|||
127692166|NCT02671435|459498847|FG009|Overall Study|Un-specified|5|||
127692167|NCT02671435|459498848|FG010|Overall Study|Un-specified|8|||
127692168|NCT02671435|459498849|FG011|Overall Study|Un-specified|4|||
127692169|NCT02671435|459498850|FG012|Overall Study|Un-specified|5|||
127692170|NCT02671435|459498851|FG013|Overall Study|Un-specified|9|||
127692171|NCT02671435|459498852|FG014|Overall Study|Un-specified|8|||
127692172|NCT02412748|459498855|FG000|Overall Study|Lost to Follow-up|38|||
127692173|NCT02412748|459498856|FG001|Overall Study|Lost to Follow-up|39|||
127692174|NCT03069313|459498857|FG000|Overall Study|Adverse Event|5|||
127692175|NCT04820686|459498861|FG000|Overall Study|Withdrawal by Subject|5|||
127692176|NCT04820686|459498862|FG001|Overall Study|Withdrawal by Subject|2|||
127692177|NCT04820686|459498863|FG002|Overall Study|Withdrawal by Subject|3|||
127692178|NCT04820686|459498861|FG000|Overall Study|Study Termination|25|||
127692179|NCT04820686|459498862|FG001|Overall Study|Study Termination|13|||
127692180|NCT04820686|459498863|FG002|Overall Study|Study Termination|14|||
127692181|NCT04820686|459498861|FG000|Overall Study|Adverse Event|0|||
127692182|NCT04820686|459498862|FG001|Overall Study|Adverse Event|1|||
127692183|NCT04820686|459498863|FG002|Overall Study|Adverse Event|0|||
128029110|NCT01661595|460732074|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
128029111|NCT01661595|460732075|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
128029112|NCT01661595|460732076|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
128029113|NCT01661595|460732077|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
127692184|NCT01872078|459498864|FG000|Overall Study|Adverse Event|0|||
127692185|NCT01872078|459498865|FG001|Overall Study|Adverse Event|0|||
127692186|NCT01872078|459498866|FG002|Overall Study|Adverse Event|1|||
127692187|NCT01872078|459498867|FG003|Overall Study|Adverse Event|0|||
127692188|NCT01872078|459498864|FG000|Overall Study|Dose administration non-compliance|0|||
127692189|NCT01872078|459498865|FG001|Overall Study|Dose administration non-compliance|0|||
127692190|NCT01872078|459498866|FG002|Overall Study|Dose administration non-compliance|0|||
127692191|NCT01872078|459498867|FG003|Overall Study|Dose administration non-compliance|1|||
127692192|NCT01872078|459498864|FG000|Overall Study|Protocol Violation|0|||
127571822|NCT00989573|459062242|FG000|Overall Study|Physician Decision|0|||
128029114|NCT00912509|460732078|FG000|Overall Study|Lost to Follow-up|1|||
127692193|NCT01872078|459498865|FG001|Overall Study|Protocol Violation|0|||
128029115|NCT00912509|460732079|FG001|Overall Study|Lost to Follow-up|0|||
128029116|NCT00912509|460732078|FG000|Overall Study|Lack of Efficacy|4|||
128029117|NCT00912509|460732079|FG001|Overall Study|Lack of Efficacy|3|||
128029118|NCT01537432|460732081|FG000|Overall Study|Lost to Follow-up|3|||
128029119|NCT01537432|460732082|FG001|Overall Study|Lost to Follow-up|1|||
128029120|NCT01537432|460732081|FG000|Overall Study|Withdrawal by Subject|0|||
128029121|NCT01537432|460732082|FG001|Overall Study|Withdrawal by Subject|1|||
127692194|NCT01872078|459498866|FG002|Overall Study|Protocol Violation|1|||
127692195|NCT01872078|459498867|FG003|Overall Study|Protocol Violation|0|||
127692196|NCT01872078|459498864|FG000|Overall Study|Withdrawal by Subject|0|||
127692197|NCT01872078|459498865|FG001|Overall Study|Withdrawal by Subject|0|||
127692198|NCT01872078|459498866|FG002|Overall Study|Withdrawal by Subject|1|||
127692199|NCT01872078|459498867|FG003|Overall Study|Withdrawal by Subject|0|||
127692200|NCT01872078|459498864|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
127692201|NCT01872078|459498865|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
127692202|NCT01872078|459498866|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
127692203|NCT01872078|459498867|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
127692204|NCT01424670|459498868|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
127692205|NCT01424670|459498869|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
127692206|NCT01424670|459498868|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
127692207|NCT01424670|459498869|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
127692208|NCT01424670|459498868|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
127692209|NCT01424670|459498869|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
127692210|NCT01424670|459498868|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
127692211|NCT01424670|459498869|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
127692212|NCT01424670|459498868|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
127692213|NCT01424670|459498869|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
127692214|NCT01424670|459498868|FG000|Continuation Period|Adverse Event|13|||
127692215|NCT01424670|459498869|FG001|Continuation Period|Adverse Event|5|||
127692216|NCT01424670|459498868|FG000|Continuation Period|Lost to Follow-up|2|||
127780881|NCT00766090|459825866|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
128029122|NCT01537432|460732081|FG000|Overall Study|Administrative problems|1|||
128029123|NCT01537432|460732082|FG001|Overall Study|Administrative problems|0|||
128029124|NCT01537432|460732081|FG000|Overall Study|Adverse Event|1|||
127692217|NCT01424670|459498869|FG001|Continuation Period|Lost to Follow-up|0|||
127692218|NCT01424670|459498868|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
127692219|NCT01424670|459498869|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
127692220|NCT01424670|459498868|FG000|Continuation Period|Physician Decision|5|||
128029125|NCT01537432|460732082|FG001|Overall Study|Adverse Event|0|||
128029126|NCT01537432|460732081|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
128029127|NCT01537432|460732082|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
128029128|NCT05166902|460732083|FG000|First Intervention|Lost to Follow-up|0|||
128029129|NCT05166902|460732084|FG001|First Intervention|Lost to Follow-up|1|||
128029130|NCT00779909|460732085|FG000|Overall Study|Lost to Follow-up|1|||
128029131|NCT00779909|460732086|FG001|Overall Study|Lost to Follow-up|0|||
128029132|NCT00779909|460732087|FG002|Overall Study|Lost to Follow-up|0|||
128029133|NCT00779909|460732088|FG003|Overall Study|Lost to Follow-up|1|||
128029134|NCT00779909|460732085|FG000|Overall Study|Withdrawal by Subject|0|||
128029135|NCT00779909|460732086|FG001|Overall Study|Withdrawal by Subject|1|||
128029136|NCT00779909|460732087|FG002|Overall Study|Withdrawal by Subject|0|||
128029137|NCT00779909|460732088|FG003|Overall Study|Withdrawal by Subject|0|||
128029138|NCT03523585|460732089|FG000|Overall Study|Progressive Disease|174|||
128029139|NCT03523585|460732090|FG001|Overall Study|Progressive Disease|64|||
128029140|NCT03523585|460732091|FG002|Overall Study|Progressive Disease|77|||
127571823|NCT00989573|459062243|FG001|Overall Study|Physician Decision|2|||
127571824|NCT00989573|459062244|FG002|Overall Study|Physician Decision|0|||
127571825|NCT00989573|459062242|FG000|Overall Study|Protocol Violation|1|||
127571826|NCT00989573|459062243|FG001|Overall Study|Protocol Violation|1|||
128029141|NCT03523585|460732089|FG000|Overall Study|Adverse Event|74|||
128029142|NCT03523585|460732090|FG001|Overall Study|Adverse Event|5|||
128029143|NCT03523585|460732091|FG002|Overall Study|Adverse Event|9|||
128029144|NCT03523585|460732089|FG000|Overall Study|Withdrawal by Subject|30|||
128029145|NCT03523585|460732090|FG001|Overall Study|Withdrawal by Subject|11|||
128029146|NCT03523585|460732091|FG002|Overall Study|Withdrawal by Subject|6|||
128029147|NCT03523585|460732089|FG000|Overall Study|Clinical Progression|23|||
128029148|NCT03523585|460732090|FG001|Overall Study|Clinical Progression|5|||
128029149|NCT03523585|460732091|FG002|Overall Study|Clinical Progression|10|||
128029150|NCT03523585|460732089|FG000|Overall Study|Death|4|||
127571827|NCT00989573|459062244|FG002|Overall Study|Protocol Violation|1|||
127571828|NCT00989573|459062242|FG000|Overall Study|Withdrawal by Subject|4|||
127571829|NCT00989573|459062243|FG001|Overall Study|Withdrawal by Subject|7|||
127571830|NCT00989573|459062244|FG002|Overall Study|Withdrawal by Subject|3|||
127571831|NCT00995865|459062246|FG000|Overall Study|Protocol Violation|2|||
127571832|NCT00995865|459062247|FG001|Overall Study|Protocol Violation|0|||
128029151|NCT03523585|460732090|FG001|Overall Study|Death|0|||
127571833|NCT00995865|459062248|FG002|Overall Study|Protocol Violation|0|||
127571834|NCT00995865|459062246|FG000|Overall Study|Lost to Follow-up|0|||
127571835|NCT00995865|459062247|FG001|Overall Study|Lost to Follow-up|0|||
127692221|NCT01424670|459498869|FG001|Continuation Period|Physician Decision|4|||
127692222|NCT01424670|459498868|FG000|Continuation Period|Withdrawal by Subject|13|||
127692223|NCT01424670|459498869|FG001|Continuation Period|Withdrawal by Subject|4|||
127692224|NCT00761189|459498870|FG000|Overall Study|Adverse Event|42|||
127692225|NCT00761189|459498870|FG000|Overall Study|Lack of Efficacy|45|||
127692226|NCT00761189|459498870|FG000|Overall Study|Lost to Follow-up|36|||
127692227|NCT00761189|459498870|FG000|Overall Study|Withdrawal by Subject|49|||
127692228|NCT00761189|459498870|FG000|Overall Study|Other|13|||
127692229|NCT01494922|459498871|FG000|Overall Study|Adverse Event|1|||
127692230|NCT02891915|459498872|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
127692231|NCT02891915|459498873|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
127692232|NCT02891915|459498872|FG000|Overall Study|Withdrawal by Subject|3|||
127692233|NCT02891915|459498873|FG001|Overall Study|Withdrawal by Subject|3|||
127692234|NCT02891915|459498872|FG000|Overall Study|Became Ineligible After Enrollment|2|||
127692235|NCT02891915|459498873|FG001|Overall Study|Became Ineligible After Enrollment|1|||
127692236|NCT02891915|459498872|FG000|Overall Study|Lost to Follow-up|1|||
127692237|NCT02891915|459498873|FG001|Overall Study|Lost to Follow-up|4|||
127692238|NCT02891915|459498872|FG000|Overall Study|Physician Decision|1|||
127692239|NCT02891915|459498873|FG001|Overall Study|Physician Decision|0|||
127692240|NCT01091168|459498874|FG000|Overall Study|Progressive disease|250|||
127692241|NCT01091168|459498875|FG001|Overall Study|Progressive disease|234|||
127692242|NCT01091168|459498874|FG000|Overall Study|Adverse Event|21|||
127692243|NCT01091168|459498875|FG001|Overall Study|Adverse Event|24|||
127692244|NCT01091168|459498874|FG000|Overall Study|Lost to Follow-up|0|||
128029152|NCT03523585|460732091|FG002|Overall Study|Death|1|||
127571836|NCT00995865|459062248|FG002|Overall Study|Lost to Follow-up|1|||
127571837|NCT05080660|459062250|FG000|Overall Study|Adverse Event|4|||
127692245|NCT01091168|459498875|FG001|Overall Study|Lost to Follow-up|1|||
127692246|NCT01091168|459498874|FG000|Overall Study|Physician, patient's decision, other|27|||
127692247|NCT01091168|459498875|FG001|Overall Study|Physician, patient's decision, other|37|||
127692248|NCT03744312|459500035|FG000|Overall Study|Withdrawal by Subject|0|||
127692249|NCT03744312|459500036|FG001|Overall Study|Withdrawal by Subject|1|||
127692250|NCT03744312|459500035|FG000|Overall Study|Screen fail|0|||
128029153|NCT03523585|460732089|FG000|Overall Study|Physician Decision|2|||
128029154|NCT03523585|460732090|FG001|Overall Study|Physician Decision|1|||
128029155|NCT03523585|460732091|FG002|Overall Study|Physician Decision|0|||
128029156|NCT03523585|460732089|FG000|Overall Study|Lost to Follow-up|1|||
127692251|NCT03744312|459500036|FG001|Overall Study|Screen fail|1|||
127692252|NCT04924062|459500037|FG000|Overall Study|Death|49|||
127780882|NCT00766090|459825867|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
127780883|NCT00766090|459825868|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
127780884|NCT00766090|459825869|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
127780885|NCT00766090|459825870|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
127780886|NCT00766090|459825871|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
127780887|NCT00766090|459825872|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
127780888|NCT00766090|459825861|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
127780889|NCT00766090|459825862|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
127780890|NCT00766090|459825863|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
127780891|NCT00766090|459825864|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
127780892|NCT00766090|459825865|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
127780893|NCT00766090|459825866|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
127780894|NCT00766090|459825867|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
127780895|NCT00766090|459825868|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
127571838|NCT05080660|459062251|FG001|Overall Study|Adverse Event|0|||
127571839|NCT05080660|459062250|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
127571840|NCT05080660|459062251|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
127571841|NCT05080660|459062250|FG000|Overall Study|Physician Decision|1|||
127571842|NCT05080660|459062251|FG001|Overall Study|Physician Decision|0|||
127571843|NCT05080660|459062250|FG000|Overall Study|Protocol Deviation|2|||
127571844|NCT05080660|459062251|FG001|Overall Study|Protocol Deviation|0|||
127571845|NCT05080660|459062250|FG000|Overall Study|Withdrawal by Subject|5|||
127571846|NCT05080660|459062251|FG001|Overall Study|Withdrawal by Subject|2|||
127571847|NCT04221230|459062261|FG000|Overall Study|Lost to Follow-up|12|||
127571848|NCT04221230|459062262|FG001|Overall Study|Lost to Follow-up|12|||
127571849|NCT04221230|459062261|FG000|Overall Study|Protocol Violation|2|||
127571850|NCT04221230|459062262|FG001|Overall Study|Protocol Violation|2|||
127571851|NCT04221230|459062261|FG000|Overall Study|Adverse Event|0|||
127571852|NCT04221230|459062262|FG001|Overall Study|Adverse Event|8|||
127571853|NCT04221230|459062261|FG000|Overall Study|Physician Decision|1|||
127571854|NCT04221230|459062262|FG001|Overall Study|Physician Decision|0|||
127571855|NCT04221230|459062261|FG000|Overall Study|Withdrawal by Subject|13|||
127571856|NCT04221230|459062262|FG001|Overall Study|Withdrawal by Subject|11|||
127571857|NCT04221230|459062261|FG000|Overall Study|Non-Compliance with Study Drug|1|||
127571858|NCT04221230|459062262|FG001|Overall Study|Non-Compliance with Study Drug|1|||
127571859|NCT04221230|459062261|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
127571860|NCT04221230|459062262|FG001|Overall Study|Unsatisfactory Therapeutic Effect|1|||
127571861|NCT04221230|459062261|FG000|Overall Study|Pregnancy|0|||
127571862|NCT04221230|459062262|FG001|Overall Study|Pregnancy|1|||
127571863|NCT04221230|459062261|FG000|Overall Study|Other|1|||
127571864|NCT04221230|459062262|FG001|Overall Study|Other|2|||
127571865|NCT03687970|459062264|FG000|Overall Study|visit scheduling conflicts|2|||
127571866|NCT03687970|459062265|FG001|Overall Study|visit scheduling conflicts|0|||
127571867|NCT02582255|459063792|FG000|Overall Study|Protocol Violation|0|||
127571868|NCT02582255|459063793|FG001|Overall Study|Protocol Violation|3|||
127571869|NCT01155219|459063798|FG000|Overall Study|Adverse Event|3|||
127571870|NCT01155219|459063799|FG001|Overall Study|Adverse Event|1|||
127571871|NCT01155219|459063798|FG000|Overall Study|non-medical reason|1|||
127571872|NCT01155219|459063799|FG001|Overall Study|non-medical reason|2|||
127571873|NCT00719264|459063800|FG000|Overall Study|Adverse Event|41|||
127571874|NCT00719264|459063801|FG001|Overall Study|Adverse Event|49|||
127571875|NCT00719264|459063800|FG000|Overall Study|Death|13|||
127571876|NCT00719264|459063801|FG001|Overall Study|Death|10|||
127571877|NCT00719264|459063800|FG000|Overall Study|Administrative Problems|6|||
127571878|NCT00719264|459063801|FG001|Overall Study|Administrative Problems|4|||
127571879|NCT00719264|459063800|FG000|Overall Study|Lost to Follow-up|1|||
127571880|NCT00719264|459063801|FG001|Overall Study|Lost to Follow-up|1|||
127571881|NCT00719264|459063800|FG000|Overall Study|Withdrawal by Subject|12|||
127571882|NCT00719264|459063801|FG001|Overall Study|Withdrawal by Subject|7|||
127571883|NCT00719264|459063800|FG000|Overall Study|Protocol Deviation|1|||
127571884|NCT00719264|459063801|FG001|Overall Study|Protocol Deviation|3|||
127571885|NCT00719264|459063800|FG000|Overall Study|New Cancer Therapy|4|||
127571886|NCT00719264|459063801|FG001|Overall Study|New Cancer Therapy|2|||
127571887|NCT00719264|459063800|FG000|Overall Study|Disease Progression|104|||
127571888|NCT00719264|459063801|FG001|Overall Study|Disease Progression|107|||
127571889|NCT03034200|459063802|FG000|Overall Study|Disease progression|8|||
127571890|NCT03034200|459063803|FG001|Overall Study|Disease progression|10|||
127571891|NCT03034200|459063804|FG002|Overall Study|Disease progression|4|||
127571892|NCT03034200|459063802|FG000|Overall Study|Physician Decision|2|||
127571893|NCT03034200|459063803|FG001|Overall Study|Physician Decision|0|||
127571894|NCT03034200|459063804|FG002|Overall Study|Physician Decision|3|||
127571895|NCT03034200|459063802|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
127571896|NCT03034200|459063803|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
127571897|NCT03034200|459063804|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
127571898|NCT03034200|459063802|FG000|Overall Study|Adjuvant Therapy|0|||
127571899|NCT03034200|459063803|FG001|Overall Study|Adjuvant Therapy|0|||
127571900|NCT03034200|459063804|FG002|Overall Study|Adjuvant Therapy|1|||
127571901|NCT00064298|459063807|FG000|Overall Study|Withdrawal by Subject|2|||
127571902|NCT00064298|459063808|FG001|Overall Study|Withdrawal by Subject|1|||
127571903|NCT00064298|459063807|FG000|Overall Study|Lost to Follow-up|2|||
127571904|NCT00064298|459063808|FG001|Overall Study|Lost to Follow-up|2|||
127571905|NCT00064298|459063807|FG000|Overall Study|Death|0|||
127571906|NCT00064298|459063808|FG001|Overall Study|Death|1|||
127571907|NCT00064298|459063807|FG000|Overall Study|Disease Progression|2|||
127571908|NCT00064298|459063808|FG001|Overall Study|Disease Progression|1|||
127571909|NCT03614975|459063809|FG000|Overall Study|Physician Decision|7|||
127571910|NCT03614975|459063810|FG001|Overall Study|Physician Decision|5|||
127571911|NCT03614975|459063809|FG000|Overall Study|Withdrawal by Subject|2|||
127571912|NCT03614975|459063810|FG001|Overall Study|Withdrawal by Subject|2|||
127571913|NCT03614975|459063809|FG000|Overall Study|Specimens not in lab batch shipment|1|||
127571914|NCT03614975|459063810|FG001|Overall Study|Specimens not in lab batch shipment|1|||
127571915|NCT00450385|459063811|FG000|Overall Study|Death|3|||
127571916|NCT00450385|459063811|FG000|Overall Study|Protocol Violation|1|||
127571917|NCT00450385|459063811|FG000|Overall Study|Withdrawal by Subject|2|||
127571918|NCT00450385|459063811|FG000|Overall Study|Lack of Efficacy|2|||
127571919|NCT00450385|459063811|FG000|Overall Study|Adverse Event|1|||
127571920|NCT00450385|459063811|FG000|Overall Study|Physician Decision|1|||
127571921|NCT00450385|459063811|FG000|Overall Study|Other|3|||
127571922|NCT01569464|459063812|FG000|Overall Study|Adverse Event|4|||
127571923|NCT01569464|459063813|FG001|Overall Study|Adverse Event|0|||
127571924|NCT01569464|459063812|FG000|Overall Study|Lack of Efficacy|1|||
127571925|NCT01569464|459063813|FG001|Overall Study|Lack of Efficacy|0|||
127571926|NCT01569464|459063812|FG000|Overall Study|Protocol Violation|1|||
127571927|NCT01569464|459063813|FG001|Overall Study|Protocol Violation|0|||
127571928|NCT01569464|459063812|FG000|Overall Study|Lost to Follow-up|2|||
127571929|NCT01569464|459063813|FG001|Overall Study|Lost to Follow-up|3|||
127571930|NCT01569464|459063812|FG000|Overall Study|Withdrawal by Subject|1|||
127571931|NCT01569464|459063813|FG001|Overall Study|Withdrawal by Subject|1|||
127571932|NCT01569464|459063812|FG000|Overall Study|Other|1|||
127571933|NCT01569464|459063813|FG001|Overall Study|Other|1|||
127571934|NCT01390220|459063819|FG000|Test Dose Phase|Adverse Event|17|||
127571935|NCT01390220|459063820|FG001|Test Dose Phase|Adverse Event|0|||
127571936|NCT01390220|459063821|FG002|Test Dose Phase|Adverse Event|0|||
127571937|NCT01390220|459063819|FG000|Test Dose Phase|Withdrawal by Subject|8|||
127571938|NCT01390220|459063820|FG001|Test Dose Phase|Withdrawal by Subject|0|||
127571939|NCT01390220|459063821|FG002|Test Dose Phase|Withdrawal by Subject|0|||
127571940|NCT01390220|459063819|FG000|Test Dose Phase|Lost to Follow-up|2|||
127571941|NCT01390220|459063820|FG001|Test Dose Phase|Lost to Follow-up|0|||
127571942|NCT01390220|459063821|FG002|Test Dose Phase|Lost to Follow-up|0|||
127571943|NCT01390220|459063819|FG000|Test Dose Phase|Protocol Violation|8|||
127571944|NCT01390220|459063820|FG001|Test Dose Phase|Protocol Violation|0|||
127571945|NCT01390220|459063821|FG002|Test Dose Phase|Protocol Violation|0|||
127571946|NCT01390220|459063819|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
127571947|NCT01390220|459063820|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
127571948|NCT01390220|459063821|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
127571949|NCT01390220|459063819|FG000|Test Dose Phase|Study/Site closure|6|||
127571950|NCT01390220|459063820|FG001|Test Dose Phase|Study/Site closure|0|||
127571951|NCT01390220|459063821|FG002|Test Dose Phase|Study/Site closure|0|||
127571952|NCT01390220|459063819|FG000|Test Dose Phase|Caregiver no longer available|5|||
127571953|NCT01390220|459063820|FG001|Test Dose Phase|Caregiver no longer available|0|||
127780896|NCT00766090|459825869|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
127780897|NCT00766090|459825870|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
127780898|NCT00766090|459825871|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
127780899|NCT00766090|459825872|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
127780900|NCT00766090|459825861|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
127780901|NCT00766090|459825862|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
127780902|NCT00766090|459825863|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
127780903|NCT00766090|459825864|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
127571954|NCT01390220|459063821|FG002|Test Dose Phase|Caregiver no longer available|0|||
127780904|NCT00766090|459825865|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
127780905|NCT00766090|459825866|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
127780906|NCT00766090|459825867|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
127780907|NCT00766090|459825868|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
127780908|NCT00766090|459825869|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
127780909|NCT00766090|459825870|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
127780910|NCT00766090|459825871|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
127780911|NCT00766090|459825872|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
127780912|NCT00766090|459825861|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
127780913|NCT00766090|459825862|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
127780914|NCT00766090|459825863|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
127780915|NCT00766090|459825864|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
127571955|NCT01390220|459063819|FG000|Test Dose Phase|Noncompliance|2|||
127780916|NCT00766090|459825865|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
127780917|NCT00766090|459825866|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
127571956|NCT01390220|459063820|FG001|Test Dose Phase|Noncompliance|0|||
127571957|NCT01390220|459063821|FG002|Test Dose Phase|Noncompliance|0|||
127780918|NCT00766090|459825867|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
127571958|NCT01390220|459063819|FG000|Test Dose Phase|Logistical|6|||
127571959|NCT01390220|459063820|FG001|Test Dose Phase|Logistical|0|||
127571960|NCT01390220|459063821|FG002|Test Dose Phase|Logistical|0|||
127571961|NCT01390220|459063819|FG000|Comparative Phase|Withdrawal by Subject|0|||
127571962|NCT01390220|459063820|FG001|Comparative Phase|Withdrawal by Subject|1|||
127571963|NCT01390220|459063821|FG002|Comparative Phase|Withdrawal by Subject|0|||
127780919|NCT00766090|459825868|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
127780920|NCT00766090|459825869|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
127780921|NCT00766090|459825870|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
127571964|NCT02045303|459063822|FG000|Overall Study|Protocol Violation|2|||
128029157|NCT03523585|460732090|FG001|Overall Study|Lost to Follow-up|0|||
127780922|NCT00766090|459825871|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
127780923|NCT00766090|459825872|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
127780924|NCT00766090|459825861|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
128029158|NCT03523585|460732091|FG002|Overall Study|Lost to Follow-up|0|||
128029159|NCT03523585|460732089|FG000|Overall Study|Miscellaneous|1|||
128029160|NCT03523585|460732090|FG001|Overall Study|Miscellaneous|0|||
128029161|NCT03523585|460732091|FG002|Overall Study|Miscellaneous|0|||
128029162|NCT03523585|460732089|FG000|Overall Study|Protocol Deviation|1|||
128029163|NCT03523585|460732090|FG001|Overall Study|Protocol Deviation|0|||
128029164|NCT03523585|460732091|FG002|Overall Study|Protocol Deviation|1|||
128029165|NCT03523585|460732089|FG000|Overall Study|Randomized But Not Treated|2|||
128029166|NCT03523585|460732090|FG001|Overall Study|Randomized But Not Treated|4|||
128029167|NCT03523585|460732091|FG002|Overall Study|Randomized But Not Treated|3|||
128029168|NCT03766906|460732095|FG000|Overall Study|Withdrawal by Subject|6|||
128029169|NCT00552279|460732096|FG000|Overall Study|Adverse Event|0|||
128029170|NCT00552279|460732097|FG001|Overall Study|Adverse Event|1|||
128029171|NCT00552279|460732096|FG000|Overall Study|Withdrawal by Subject|12|||
128029172|NCT00552279|460732097|FG001|Overall Study|Withdrawal by Subject|1|||
128029173|NCT00552279|460732096|FG000|Overall Study|Lost to Follow-up|1|||
128029174|NCT00552279|460732097|FG001|Overall Study|Lost to Follow-up|0|||
128029175|NCT00552279|460732096|FG000|Overall Study|Other|1|||
128029176|NCT00552279|460732097|FG001|Overall Study|Other|1|||
128029177|NCT02150863|460732099|FG000|Overall Study|Lost to Follow-up|0|||
128029178|NCT02150863|460732100|FG001|Overall Study|Lost to Follow-up|1|||
128029179|NCT02150863|460732101|FG002|Overall Study|Lost to Follow-up|0|||
128029180|NCT01651208|460732102|FG000|Overall Study|Lost to Follow-up|14|||
128029181|NCT01651208|460732103|FG001|Overall Study|Lost to Follow-up|16|||
128029182|NCT00836901|460732104|FG000|First Intervention|Withdrawal by Subject|1|||
128029183|NCT00836901|460732105|FG001|First Intervention|Withdrawal by Subject|0|||
128029184|NCT03760081|460732106|FG000|Overall Study|Miscellaneous|0|||
128029185|NCT03760081|460732107|FG001|Overall Study|Miscellaneous|1|||
128029186|NCT03760081|460732106|FG000|Overall Study|Progressive Disease|5|||
128029187|NCT03760081|460732107|FG001|Overall Study|Progressive Disease|10|||
128029188|NCT03760081|460732106|FG000|Overall Study|Death|1|||
128029189|NCT03760081|460732107|FG001|Overall Study|Death|1|||
128029190|NCT05261490|460732111|FG000|Overall Study|Other|1|||
128029191|NCT05261490|460732112|FG001|Overall Study|Other|0|||
128029192|NCT05261490|460732113|FG002|Overall Study|Other|0|||
128029193|NCT05261490|460732111|FG000|Overall Study|Study Terminated by Sponsor|1|||
128029194|NCT05261490|460732112|FG001|Overall Study|Study Terminated by Sponsor|1|||
128029195|NCT05261490|460732113|FG002|Overall Study|Study Terminated by Sponsor|4|||
128029196|NCT05261490|460732111|FG000|Overall Study|Death|1|||
128029197|NCT05261490|460732112|FG001|Overall Study|Death|2|||
128029198|NCT05261490|460732113|FG002|Overall Study|Death|0|||
128029199|NCT04191733|460732126|FG000|Overall Study|Withdrawn due to study closure|13|||
128029200|NCT04191733|460732127|FG001|Overall Study|Withdrawn due to study closure|14|||
128029201|NCT04191733|460732126|FG000|Overall Study|Withdrawal by Subject|2|||
128029202|NCT04191733|460732127|FG001|Overall Study|Withdrawal by Subject|4|||
128029203|NCT04191733|460732126|FG000|Overall Study|Physician Decision|1|||
128029204|NCT04191733|460732127|FG001|Overall Study|Physician Decision|1|||
128029205|NCT04191733|460732126|FG000|Overall Study|Lost to Follow-up|5|||
128029206|NCT04191733|460732127|FG001|Overall Study|Lost to Follow-up|6|||
128029207|NCT04191733|460732126|FG000|Overall Study|Death|0|||
128029208|NCT04191733|460732127|FG001|Overall Study|Death|1|||
128029209|NCT01714063|460732130|FG000|Overall Study|Equipment malfunction|2|||
128029210|NCT01646216|460732131|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
128029211|NCT01646216|460732132|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
128029212|NCT01646216|460732131|FG000|Overall Study|Did not complete training|0|||
128029213|NCT01646216|460732132|FG001|Overall Study|Did not complete training|2|||
128029214|NCT01646216|460732131|FG000|Overall Study|Investigator decision|1|||
128029215|NCT01646216|460732132|FG001|Overall Study|Investigator decision|1|||
128029216|NCT02395627|460732133|FG000|Overall Study|Withdrawal by Subject|0|||
128029217|NCT02395627|460732134|FG001|Overall Study|Withdrawal by Subject|2|||
128029218|NCT02395627|460732135|FG002|Overall Study|Withdrawal by Subject|0|||
128029219|NCT02395627|460732133|FG000|Overall Study|Did not receive pembrolizumab|3|||
127571965|NCT02045303|459063823|FG001|Overall Study|Protocol Violation|1|||
127780925|NCT00766090|459825862|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
128029220|NCT02395627|460732134|FG001|Overall Study|Did not receive pembrolizumab|1|||
128029221|NCT02395627|460732135|FG002|Overall Study|Did not receive pembrolizumab|0|||
128029222|NCT02633527|460732136|FG000|Overall Study|Failed to meet eligibility|0|||
128029223|NCT02633527|460732137|FG001|Overall Study|Failed to meet eligibility|1|||
128029224|NCT02633527|460732138|FG002|Overall Study|Failed to meet eligibility|1|||
128029225|NCT02633527|460732139|FG003|Overall Study|Failed to meet eligibility|0|||
128029226|NCT02633527|460732140|FG004|Overall Study|Failed to meet eligibility|1|||
128029227|NCT02633527|460732136|FG000|Overall Study|Adverse Event|0|||
128029228|NCT02633527|460732137|FG001|Overall Study|Adverse Event|4|||
128029229|NCT02633527|460732138|FG002|Overall Study|Adverse Event|3|||
127571966|NCT02045303|459063824|FG002|Overall Study|Protocol Violation|0|||
127571967|NCT02045303|459063822|FG000|Overall Study|Withdrawal by Subject|0|||
127571968|NCT02045303|459063823|FG001|Overall Study|Withdrawal by Subject|2|||
127571969|NCT02045303|459063824|FG002|Overall Study|Withdrawal by Subject|0|||
127571970|NCT03063203|459063825|FG000|Overall Study|Chose alternative therapy|3|||
127571971|NCT03063203|459063825|FG000|Overall Study|Death|2|||
127571972|NCT03063203|459063825|FG000|Overall Study|Disease progression|4|||
127571973|NCT03063203|459063825|FG000|Overall Study|Physician Decision|5|||
127571974|NCT01856023|459063826|FG000|Overall Study|Death|1|||
127571975|NCT01856023|459063827|FG001|Overall Study|Death|2|||
127571976|NCT01856023|459063826|FG000|Overall Study|Adverse Event|2|||
127571977|NCT01856023|459063827|FG001|Overall Study|Adverse Event|1|||
127571978|NCT01856023|459063826|FG000|Overall Study|Lack of Efficacy|5|||
127571979|NCT01856023|459063827|FG001|Overall Study|Lack of Efficacy|5|||
127571980|NCT01856023|459063826|FG000|Overall Study|non compliance, study closure|1|||
127571981|NCT01856023|459063827|FG001|Overall Study|non compliance, study closure|3|||
127571982|NCT01856023|459063826|FG000|Overall Study|Withdrawal by Subject|1|||
127571983|NCT01856023|459063827|FG001|Overall Study|Withdrawal by Subject|1|||
127571984|NCT00829283|459063830|FG000|Overall Study|Lost to Follow-up|7|||
127571985|NCT00829283|459063831|FG001|Overall Study|Lost to Follow-up|25|||
127571986|NCT04718103|459063832|FG000|Overall Study|Adverse Event|1|||
127571987|NCT04718103|459063833|FG001|Overall Study|Adverse Event|1|||
127571988|NCT04718103|459063832|FG000|Overall Study|Lack of Efficacy|4|||
127571989|NCT04718103|459063833|FG001|Overall Study|Lack of Efficacy|1|||
127571990|NCT04718103|459063832|FG000|Overall Study|Lost to Follow-up|2|||
127571991|NCT04718103|459063833|FG001|Overall Study|Lost to Follow-up|2|||
127571992|NCT04718103|459063832|FG000|Overall Study|Physician Decision|2|||
127571993|NCT04718103|459063833|FG001|Overall Study|Physician Decision|0|||
127571994|NCT04718103|459063832|FG000|Overall Study|Pregnancy|0|||
127571995|NCT04718103|459063833|FG001|Overall Study|Pregnancy|1|||
127571996|NCT04718103|459063832|FG000|Overall Study|Withdrawal by Subject|10|||
127571997|NCT04718103|459063833|FG001|Overall Study|Withdrawal by Subject|6|||
127571998|NCT04718103|459063832|FG000|Overall Study|Randomized, not treated|4|||
127571999|NCT04718103|459063833|FG001|Overall Study|Randomized, not treated|1|||
127572000|NCT04718103|459063832|FG000|Overall Study|GCP violations|7|||
127572001|NCT04718103|459063833|FG001|Overall Study|GCP violations|5|||
127572002|NCT00322153|459063834|FG000|Overall Study|Adverse Event|21|||
127572003|NCT00322153|459063835|FG001|Overall Study|Adverse Event|34|||
127572004|NCT00322153|459063834|FG000|Overall Study|Protocol Violation|6|||
127572005|NCT00322153|459063835|FG001|Overall Study|Protocol Violation|14|||
127572006|NCT00322153|459063834|FG000|Overall Study|Withdrawal by Subject|18|||
127572007|NCT00322153|459063835|FG001|Overall Study|Withdrawal by Subject|10|||
127572008|NCT00322153|459063834|FG000|Overall Study|Lack of Efficacy|8|||
127572009|NCT00322153|459063835|FG001|Overall Study|Lack of Efficacy|3|||
127572010|NCT00322153|459063834|FG000|Overall Study|Lost to Follow-up|5|||
127572011|NCT00322153|459063835|FG001|Overall Study|Lost to Follow-up|4|||
127572012|NCT00322153|459063834|FG000|Overall Study|Withdrawn for other reasons|5|||
127572013|NCT00322153|459063835|FG001|Overall Study|Withdrawn for other reasons|4|||
127572014|NCT00136604|459063836|FG000|Overall Study|Lost to Follow-up|1|||
127572015|NCT00136604|459063837|FG001|Overall Study|Lost to Follow-up|0|||
127572016|NCT00136604|459063838|FG002|Overall Study|Lost to Follow-up|0|||
127572017|NCT00136604|459063839|FG003|Overall Study|Lost to Follow-up|0|||
127572018|NCT00136604|459063840|FG004|Overall Study|Lost to Follow-up|1|||
127572019|NCT00136604|459063836|FG000|Overall Study|Migrated/moved from study area|0|||
127572020|NCT00136604|459063837|FG001|Overall Study|Migrated/moved from study area|1|||
127572021|NCT00136604|459063838|FG002|Overall Study|Migrated/moved from study area|0|||
127572022|NCT00136604|459063839|FG003|Overall Study|Migrated/moved from study area|0|||
127572023|NCT00136604|459063840|FG004|Overall Study|Migrated/moved from study area|0|||
127572024|NCT01309893|459063845|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
127572025|NCT01309893|459063846|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
127572026|NCT01309893|459063845|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
127572027|NCT01309893|459063846|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
127572028|NCT00591578|459063847|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
127572029|NCT00591578|459063848|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
127572030|NCT00591578|459063849|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
127572031|NCT00591578|459063847|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
127572032|NCT00591578|459063848|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
127572033|NCT00591578|459063849|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
127572034|NCT00591578|459063847|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
127572035|NCT00591578|459063848|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
127572036|NCT00591578|459063849|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
127572037|NCT00591578|459063847|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
127572038|NCT00591578|459063848|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
127572039|NCT00591578|459063849|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
127572040|NCT00591578|459063847|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
127572041|NCT00591578|459063848|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
127572042|NCT00591578|459063849|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
127572043|NCT00591578|459063847|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
127572044|NCT00591578|459063848|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
127572045|NCT00591578|459063849|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
127572046|NCT00591578|459063847|FG000|Double-Blind Treatment Phase|Other|4|||
127572047|NCT00591578|459063848|FG001|Double-Blind Treatment Phase|Other|9|||
127572048|NCT00591578|459063849|FG002|Double-Blind Treatment Phase|Other|4|||
127572049|NCT00591578|459063847|FG000|Open-Label Extension Phase|Adverse Event|3|||
127572050|NCT00591578|459063848|FG001|Open-Label Extension Phase|Adverse Event|5|||
127572051|NCT00591578|459063849|FG002|Open-Label Extension Phase|Adverse Event|0|||
127572052|NCT00591578|459063847|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
127572053|NCT00591578|459063848|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
127572054|NCT00591578|459063849|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
127572055|NCT00591578|459063847|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
127572056|NCT00591578|459063848|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
127572057|NCT00591578|459063849|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
127572058|NCT00591578|459063847|FG000|Open-Label Extension Phase|Other|1|||
127572059|NCT00591578|459063848|FG001|Open-Label Extension Phase|Other|0|||
127572060|NCT00591578|459063849|FG002|Open-Label Extension Phase|Other|0|||
127572061|NCT02632838|459063850|FG000|Overall Study|Withdrawal by Subject|3|||
127572062|NCT02632838|459063851|FG001|Overall Study|Withdrawal by Subject|0|||
127572063|NCT02632838|459063850|FG000|Overall Study|Lost to Follow-up|0|||
127572064|NCT02632838|459063851|FG001|Overall Study|Lost to Follow-up|2|||
127572065|NCT03631355|459063852|FG000|Overall Study|Lost to Follow-up|1|||
127572066|NCT03631355|459063853|FG001|Overall Study|Lost to Follow-up|2|||
127572067|NCT02810340|459063854|FG000|Overall Study|Withdrawal by Subject|1|||
127572068|NCT02810340|459063855|FG001|Overall Study|Withdrawal by Subject|0|||
127572069|NCT02810340|459063856|FG002|Overall Study|Withdrawal by Subject|0|||
127572070|NCT02810340|459063854|FG000|Overall Study|Incarceration|0|||
127572071|NCT02810340|459063855|FG001|Overall Study|Incarceration|1|||
127572072|NCT02810340|459063856|FG002|Overall Study|Incarceration|0|||
127572073|NCT02810340|459063854|FG000|Overall Study|Lost to Follow-up|0|||
127572074|NCT02810340|459063855|FG001|Overall Study|Lost to Follow-up|0|||
127572075|NCT02810340|459063856|FG002|Overall Study|Lost to Follow-up|1|||
127572076|NCT03945175|459063857|FG000|Overall Study|Did not meet inclusion criteria|31|||
127572077|NCT03945175|459063857|FG000|Overall Study|Withdrew consent|2|||
127572078|NCT03945175|459063857|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
127572079|NCT03945175|459063857|FG000|Overall Study|Early termination during Mydayis treatment|1|||
127572080|NCT00870233|459063858|FG000|Overall Study|Withdrawal by Subject|18|||
127572081|NCT00870233|459063858|FG000|Overall Study|Did not undergo laparotomy|3|||
127572082|NCT00870233|459063858|FG000|Overall Study|Incompatible internet browser|2|||
127572083|NCT00870233|459063858|FG000|Overall Study|Death|1|||
127572084|NCT00378079|459063860|FG000|Overall Study|Lost to Follow-up|6|||
127572085|NCT00378079|459063861|FG001|Overall Study|Lost to Follow-up|1|||
127572086|NCT00378079|459063862|FG002|Overall Study|Lost to Follow-up|0|||
127572087|NCT01233687|459063863|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
127572088|NCT01233687|459063863|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
127572089|NCT01233687|459063863|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
127572090|NCT00006389|459063864|FG000|Overall Study|Adverse Event|1|||
127572091|NCT01445886|459063873|FG000|Overall Study|Lost to Follow-up|2|||
127572092|NCT01445886|459063873|FG000|Overall Study|Protocol Violation|3|||
127572093|NCT03500679|459063874|FG000|Overall Study|Lost to Follow-up|6|||
127572094|NCT03500679|459063875|FG001|Overall Study|Lost to Follow-up|3|||
127692253|NCT04924062|459500038|FG001|Overall Study|Death|63|||
127692254|NCT04924062|459500037|FG000|Overall Study|Participant On-going|26|||
127692255|NCT04924062|459500038|FG001|Overall Study|Participant On-going|20|||
127692256|NCT04337372|459500041|FG000|Day 1: Eye-tracking Measures|Protocol Violation|1|||
127692257|NCT04337372|459500042|FG001|Day 1: Eye-tracking Measures|Protocol Violation|3|||
127692258|NCT04337372|459500043|FG002|Day 1: Eye-tracking Measures|Protocol Violation|7|||
127692259|NCT04337372|459500044|FG003|Day 1: Eye-tracking Measures|Protocol Violation|11|||
127692260|NCT04337372|459500041|FG000|Day 1: Eye-tracking Measures|Equipment Failure|0|||
127692261|NCT04337372|459500042|FG001|Day 1: Eye-tracking Measures|Equipment Failure|0|||
127692262|NCT04337372|459500043|FG002|Day 1: Eye-tracking Measures|Equipment Failure|2|||
127572095|NCT03500679|459063874|FG000|Overall Study|Withdrawal by Subject|3|||
127572096|NCT03500679|459063875|FG001|Overall Study|Withdrawal by Subject|0|||
127572097|NCT01962922|459063876|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
127572098|NCT01962922|459063877|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
127572099|NCT01962922|459063876|FG000|PK Portion Day 7|non-compliance|1|||
127572100|NCT01962922|459063877|FG001|PK Portion Day 7|non-compliance|0|||
127572101|NCT01962922|459063876|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
127572102|NCT01962922|459063877|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
127572103|NCT01962922|459063876|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
127692263|NCT04337372|459500044|FG003|Day 1: Eye-tracking Measures|Equipment Failure|2|||
127692264|NCT04337372|459500041|FG000|Day 2: EEG Measures|Lost to Follow-up|0|||
127572104|NCT01962922|459063877|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
127572105|NCT03224546|459063878|FG000|Overall Study|Lost to Follow-up|9|||
127572106|NCT03224546|459063879|FG001|Overall Study|Lost to Follow-up|8|||
127572107|NCT03224546|459063880|FG002|Overall Study|Lost to Follow-up|3|||
127572108|NCT03224546|459063878|FG000|Overall Study|Withdrawal by Subject|7|||
127572109|NCT03224546|459063879|FG001|Overall Study|Withdrawal by Subject|14|||
127572110|NCT03224546|459063880|FG002|Overall Study|Withdrawal by Subject|12|||
127572111|NCT02730208|459063881|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
127572112|NCT02730208|459063882|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
127572113|NCT00510952|459063888|FG000|Overall Study|Adverse Event|1|||
127572114|NCT00510952|459063889|FG001|Overall Study|Adverse Event|0|||
127572115|NCT00510952|459063888|FG000|Overall Study|Entry Criteria Not Met|3|||
127572116|NCT00510952|459063889|FG001|Overall Study|Entry Criteria Not Met|1|||
127572117|NCT00510952|459063888|FG000|Overall Study|Lost to Follow-up|5|||
127572118|NCT00510952|459063889|FG001|Overall Study|Lost to Follow-up|3|||
127572119|NCT00510952|459063888|FG000|Overall Study|Physician Decision|1|||
127572120|NCT00510952|459063889|FG001|Overall Study|Physician Decision|1|||
127572121|NCT00510952|459063888|FG000|Overall Study|Protocol Violation|7|||
127572122|NCT00510952|459063889|FG001|Overall Study|Protocol Violation|4|||
127572123|NCT00510952|459063888|FG000|Overall Study|Sponsor Decision|1|||
127572124|NCT00510952|459063889|FG001|Overall Study|Sponsor Decision|0|||
127572125|NCT00510952|459063888|FG000|Overall Study|Withdrawal by Subject|6|||
127572126|NCT00510952|459063889|FG001|Overall Study|Withdrawal by Subject|7|||
127572127|NCT00510952|459063888|FG000|Overall Study|Did Not Receive Study Drug|2|||
127572128|NCT00510952|459063889|FG001|Overall Study|Did Not Receive Study Drug|0|||
127572129|NCT02793128|459063896|FG000|Overall Study|Death|4|||
127572130|NCT02793128|459063896|FG000|Overall Study|Withdrawal by Subject|2|||
127572131|NCT02793128|459063896|FG000|Overall Study|Physician Decision|1|||
127572132|NCT02793128|459063896|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
127572133|NCT02793128|459063896|FG000|Overall Study|Patient elected nephroureterectomy|1|||
127572134|NCT02359851|459063900|FG000|Overall Study|Death|1|||
127572135|NCT02359851|459063900|FG000|Overall Study|Disease progression|1|||
127572136|NCT01888003|459063901|FG000|Overall Study|Study Terminated|5|||
127572137|NCT01888003|459063902|FG001|Overall Study|Study Terminated|6|||
127572138|NCT01888003|459063903|FG002|Overall Study|Study Terminated|40|||
127572139|NCT00055471|459063904|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
127572140|NCT00055471|459063905|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
127572141|NCT00055471|459063906|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
127572142|NCT00055471|459063904|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
127572143|NCT00055471|459063905|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
127572144|NCT00055471|459063906|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
127572145|NCT00055471|459063904|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
127572146|NCT00055471|459063905|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
127572147|NCT00055471|459063906|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
127572148|NCT01854944|459063907|FG000|Overall Study|Withdrawal by Subject|0|||
127572149|NCT01854944|459063908|FG001|Overall Study|Withdrawal by Subject|0|||
127572150|NCT01854944|459063909|FG002|Overall Study|Withdrawal by Subject|1|||
127572151|NCT02101112|459063910|FG000|Overall Study|Adverse Event|0|||
127572152|NCT02101112|459063911|FG001|Overall Study|Adverse Event|0|||
127572153|NCT02101112|459063912|FG002|Overall Study|Adverse Event|1|||
127572154|NCT02101112|459063913|FG003|Overall Study|Adverse Event|0|||
127572155|NCT02101112|459063914|FG004|Overall Study|Adverse Event|0|||
127572156|NCT02101112|459063915|FG005|Overall Study|Adverse Event|0|||
127572157|NCT02101112|459063910|FG000|Overall Study|Withdrawal by Subject|0|||
127572158|NCT02101112|459063911|FG001|Overall Study|Withdrawal by Subject|0|||
127572159|NCT02101112|459063912|FG002|Overall Study|Withdrawal by Subject|0|||
127572160|NCT02101112|459063913|FG003|Overall Study|Withdrawal by Subject|0|||
127572161|NCT02101112|459063914|FG004|Overall Study|Withdrawal by Subject|1|||
127572162|NCT02101112|459063915|FG005|Overall Study|Withdrawal by Subject|0|||
127572163|NCT04340063|459063916|FG000|Overall Study|Withdrawal by Subject|1|||
127572164|NCT04340063|459063917|FG001|Overall Study|Withdrawal by Subject|2|||
127572165|NCT04340063|459063916|FG000|Overall Study|Lost to Follow-up|3|||
127692265|NCT04337372|459500042|FG001|Day 2: EEG Measures|Lost to Follow-up|3|||
127692266|NCT04337372|459500043|FG002|Day 2: EEG Measures|Lost to Follow-up|2|||
127692267|NCT04337372|459500044|FG003|Day 2: EEG Measures|Lost to Follow-up|5|||
127692268|NCT04337372|459500041|FG000|Day 2: EEG Measures|Protocol Violation|6|||
127572166|NCT04340063|459063917|FG001|Overall Study|Lost to Follow-up|1|||
127572167|NCT04340063|459063916|FG000|Overall Study|Protocol Violation|0|||
127572168|NCT04340063|459063917|FG001|Overall Study|Protocol Violation|1|||
127572169|NCT01857583|459063918|FG000|Overall Study|Adverse Event|0|||
127572170|NCT01857583|459063919|FG001|Overall Study|Adverse Event|0|||
127572171|NCT01857583|459063920|FG002|Overall Study|Adverse Event|1|||
127572172|NCT01857583|459063921|FG003|Overall Study|Adverse Event|1|||
127572173|NCT01857583|459063918|FG000|Overall Study|Death|0|||
127572174|NCT01857583|459063919|FG001|Overall Study|Death|1|||
127572175|NCT01857583|459063920|FG002|Overall Study|Death|1|||
127572176|NCT01857583|459063921|FG003|Overall Study|Death|0|||
127572177|NCT01857583|459063918|FG000|Overall Study|Physician Decision|0|||
127572178|NCT01857583|459063919|FG001|Overall Study|Physician Decision|0|||
127572179|NCT01857583|459063920|FG002|Overall Study|Physician Decision|0|||
127572180|NCT01857583|459063921|FG003|Overall Study|Physician Decision|1|||
127572181|NCT01857583|459063918|FG000|Overall Study|Withdrawal by Subject|1|||
127572182|NCT01857583|459063919|FG001|Overall Study|Withdrawal by Subject|0|||
127572183|NCT01857583|459063920|FG002|Overall Study|Withdrawal by Subject|1|||
127572184|NCT01857583|459063921|FG003|Overall Study|Withdrawal by Subject|2|||
127572185|NCT00458536|459063924|FG000|Overall Study|Disease progression prior to treatment|7|||
127572186|NCT00458536|459063924|FG000|Overall Study|Unable to make vaccine|3|||
127572187|NCT00458536|459063924|FG000|Overall Study|No measurable disease after surgery|2|||
127572188|NCT00458536|459063924|FG000|Overall Study|Did not have renal cell carcinoma|2|||
127572189|NCT00458536|459063924|FG000|Overall Study|Patient did not have surgery|1|||
127572190|NCT00458536|459063924|FG000|Overall Study|Ineligible due to toxicity|1|||
127572191|NCT00458536|459063924|FG000|Overall Study|Withdrawal by Subject|1|||
127572192|NCT00458536|459063924|FG000|Overall Study|Progressive disease during treatment|2|||
127572193|NCT03670836|459063926|FG000|Intent-to-treat Population (ITT)|Withdrawal by Subject|1|||
127572194|NCT03670836|459063927|FG001|Intent-to-treat Population (ITT)|Withdrawal by Subject|3|||
127572195|NCT03670836|459063926|FG000|Per Protocol Population (PP)|Physician Decision|9|||
127572196|NCT03670836|459063927|FG001|Per Protocol Population (PP)|Physician Decision|10|||
127572197|NCT03670836|459063926|FG000|Per Protocol Population (PP)|Physician Decision|4|||
127572198|NCT03670836|459063927|FG001|Per Protocol Population (PP)|Physician Decision|6|||
127572199|NCT03670836|459063926|FG000|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
127572200|NCT03670836|459063927|FG001|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
127572201|NCT03287635|459063928|FG000|Overall Study|Lost to Follow-up|5|||
127572202|NCT03287635|459063928|FG000|Overall Study|Withdrawal by Subject|1|||
127572203|NCT03287635|459063928|FG000|Overall Study|Physician Decision|1|||
127572204|NCT05523323|459065845|FG000|Overall Study|Death|26|||
127572205|NCT05523323|459065846|FG001|Overall Study|Death|21|||
127572206|NCT05523323|459065845|FG000|Overall Study|Ongoing participants|35|||
127572207|NCT05523323|459065846|FG001|Overall Study|Ongoing participants|30|||
127572208|NCT03435640|459065847|FG000|Overall Study|Withdrawal by Subject|0|||
127572209|NCT03435640|459065848|FG001|Overall Study|Withdrawal by Subject|1|||
127572210|NCT03435640|459065849|FG002|Overall Study|Withdrawal by Subject|0|||
127572211|NCT03435640|459065850|FG003|Overall Study|Withdrawal by Subject|2|||
127572212|NCT03435640|459065851|FG004|Overall Study|Withdrawal by Subject|0|||
128029230|NCT02633527|460732139|FG003|Overall Study|Adverse Event|1|||
128029231|NCT02633527|460732140|FG004|Overall Study|Adverse Event|5|||
127572213|NCT03435640|459065852|FG005|Overall Study|Withdrawal by Subject|0|||
127572214|NCT03435640|459065853|FG006|Overall Study|Withdrawal by Subject|3|||
127572215|NCT03435640|459065854|FG007|Overall Study|Withdrawal by Subject|0|||
127572216|NCT03435640|459065855|FG008|Overall Study|Withdrawal by Subject|0|||
127572217|NCT03435640|459065856|FG009|Overall Study|Withdrawal by Subject|2|||
127572218|NCT03435640|459065857|FG010|Overall Study|Withdrawal by Subject|3|||
127572219|NCT03435640|459065847|FG000|Overall Study|Lost to Follow-up|0|||
127572220|NCT03435640|459065848|FG001|Overall Study|Lost to Follow-up|0|||
127572221|NCT03435640|459065849|FG002|Overall Study|Lost to Follow-up|1|||
127572222|NCT03435640|459065850|FG003|Overall Study|Lost to Follow-up|0|||
127692269|NCT04337372|459500042|FG001|Day 2: EEG Measures|Protocol Violation|6|||
127692270|NCT04337372|459500043|FG002|Day 2: EEG Measures|Protocol Violation|5|||
127692271|NCT04337372|459500044|FG003|Day 2: EEG Measures|Protocol Violation|17|||
127692272|NCT00567398|459500045|FG000|Overall Study|Adverse Event|6|||
127692273|NCT00567398|459500046|FG001|Overall Study|Adverse Event|14|||
127692274|NCT00567398|459500045|FG000|Overall Study|Physician Decision|0|||
127692275|NCT00567398|459500046|FG001|Overall Study|Physician Decision|4|||
127692276|NCT00567398|459500045|FG000|Overall Study|Withdrawal by Subject|0|||
127692277|NCT00567398|459500046|FG001|Overall Study|Withdrawal by Subject|2|||
127692278|NCT00567398|459500045|FG000|Overall Study|Renal Transplantation|0|||
127692279|NCT00567398|459500046|FG001|Overall Study|Renal Transplantation|3|||
127692280|NCT00567398|459500045|FG000|Overall Study|Other|1|||
127692281|NCT00567398|459500046|FG001|Overall Study|Other|0|||
127692282|NCT03055377|459500056|FG000|Treatment Phase|Lost to Follow-up|28|||
127692283|NCT03055377|459500057|FG001|Treatment Phase|Lost to Follow-up|24|||
127692284|NCT03055377|459500056|FG000|Post-Treatment Follow-Up|Lost to Follow-up|26|||
127692285|NCT03055377|459500057|FG001|Post-Treatment Follow-Up|Lost to Follow-up|21|||
128029232|NCT02633527|460732136|FG000|Overall Study|Lost to Follow-up|1|||
127692286|NCT01718743|459500058|FG000|Overall Study|Physician Decision|7|||
127692287|NCT01718743|459500058|FG000|Overall Study|Withdrawal by Subject|14|||
127692288|NCT01718743|459500058|FG000|Overall Study|Progressive Disease|22|||
127692289|NCT01718743|459500058|FG000|Overall Study|Toxicity|1|||
127692290|NCT01718743|459500058|FG000|Overall Study|Malignancy|1|||
127780926|NCT00766090|459825863|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
127572223|NCT03435640|459065851|FG004|Overall Study|Lost to Follow-up|0|||
127572224|NCT03435640|459065852|FG005|Overall Study|Lost to Follow-up|0|||
127572225|NCT03435640|459065853|FG006|Overall Study|Lost to Follow-up|0|||
127572226|NCT03435640|459065854|FG007|Overall Study|Lost to Follow-up|0|||
127572227|NCT03435640|459065855|FG008|Overall Study|Lost to Follow-up|0|||
127572228|NCT03435640|459065856|FG009|Overall Study|Lost to Follow-up|0|||
127572229|NCT03435640|459065857|FG010|Overall Study|Lost to Follow-up|0|||
127572230|NCT00920829|459065865|FG000|Allocation|No post randomization data|3|||
127572231|NCT00920829|459065866|FG001|Allocation|No post randomization data|1|||
127572232|NCT00920829|459065867|FG002|Allocation|No post randomization data|0|||
127572233|NCT00920829|459065868|FG003|Allocation|No post randomization data|2|||
127572234|NCT00920829|459065865|FG000|Available for Analysis|Withdrawal by Subject|6|||
127572235|NCT00920829|459065866|FG001|Available for Analysis|Withdrawal by Subject|6|||
127572236|NCT00920829|459065867|FG002|Available for Analysis|Withdrawal by Subject|6|||
127572237|NCT00920829|459065868|FG003|Available for Analysis|Withdrawal by Subject|10|||
127572238|NCT00920829|459065865|FG000|Available for Analysis|Required Medical Treatment|0|||
127572239|NCT00920829|459065866|FG001|Available for Analysis|Required Medical Treatment|1|||
127572240|NCT00920829|459065867|FG002|Available for Analysis|Required Medical Treatment|2|||
127572241|NCT00920829|459065868|FG003|Available for Analysis|Required Medical Treatment|0|||
127572242|NCT00920829|459065865|FG000|Available for Analysis|Adverse Event|1|||
127572243|NCT00920829|459065866|FG001|Available for Analysis|Adverse Event|2|||
127572244|NCT00920829|459065867|FG002|Available for Analysis|Adverse Event|1|||
127572245|NCT00920829|459065868|FG003|Available for Analysis|Adverse Event|0|||
127572246|NCT00920829|459065865|FG000|Available for Analysis|Death|1|||
127572247|NCT00920829|459065866|FG001|Available for Analysis|Death|0|||
127572248|NCT00920829|459065867|FG002|Available for Analysis|Death|0|||
127572249|NCT00920829|459065868|FG003|Available for Analysis|Death|0|||
127572250|NCT00920829|459065865|FG000|Available for Analysis|Protocol Violation|0|||
127572251|NCT00920829|459065866|FG001|Available for Analysis|Protocol Violation|0|||
127572252|NCT00920829|459065867|FG002|Available for Analysis|Protocol Violation|1|||
127572253|NCT00920829|459065868|FG003|Available for Analysis|Protocol Violation|0|||
127572254|NCT00920829|459065865|FG000|Available for Analysis|Required more treatment|0|||
127572255|NCT00920829|459065866|FG001|Available for Analysis|Required more treatment|2|||
127572256|NCT00920829|459065867|FG002|Available for Analysis|Required more treatment|0|||
127572257|NCT00920829|459065868|FG003|Available for Analysis|Required more treatment|1|||
127572258|NCT04533880|459065869|FG000|Overall Study|Lost to Follow-up|0|||
127572259|NCT04533880|459065870|FG001|Overall Study|Lost to Follow-up|1|||
127572260|NCT04533880|459065871|FG002|Overall Study|Lost to Follow-up|1|||
127572261|NCT01711879|459065876|FG000|Overall Study|Death|1|||
127572262|NCT01711879|459065877|FG001|Overall Study|Death|0|||
127572263|NCT02239224|459065882|FG000|Overall Study|Administrative|0|||
127572264|NCT02239224|459065883|FG001|Overall Study|Administrative|0|||
127572265|NCT02239224|459065884|FG002|Overall Study|Administrative|3|||
127572266|NCT02239224|459065885|FG003|Overall Study|Administrative|1|||
127572267|NCT03183778|459065887|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
127572268|NCT01466179|459065888|FG000|Overall Study|Ongoing in core study|2|||
127572269|NCT01466179|459065888|FG000|Overall Study|Physician Decision|46|||
127572270|NCT01466179|459065888|FG000|Overall Study|Progressive disease|43|||
127572271|NCT01466179|459065888|FG000|Overall Study|Adverse Event|32|||
127572272|NCT01466179|459065888|FG000|Overall Study|Disease relapse|23|||
127572273|NCT01466179|459065888|FG000|Overall Study|Lack of Efficacy|14|||
127572274|NCT01466179|459065888|FG000|Overall Study|Death|7|||
127572275|NCT01466179|459065888|FG000|Overall Study|Withdrawal by Subject|7|||
127572276|NCT01466179|459065888|FG000|Overall Study|Protocol Violation|2|||
127572277|NCT01466179|459065888|FG000|Overall Study|Other|3|||
127780927|NCT00766090|459825864|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
127780928|NCT00766090|459825865|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
127780929|NCT00766090|459825866|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
127780930|NCT00766090|459825867|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
127572278|NCT03489551|459065889|FG000|Overall Study|Withdrawal by Subject|2|||
127572279|NCT00054717|459065890|FG000|Overall Study|Randomized but not treated|2|||
127572280|NCT00054717|459065891|FG001|Overall Study|Randomized but not treated|8|||
127572281|NCT00054717|459065890|FG000|Overall Study|Adverse Event|70|||
127572282|NCT00054717|459065891|FG001|Overall Study|Adverse Event|22|||
127572283|NCT00054717|459065890|FG000|Overall Study|Protocol Violation|18|||
127572284|NCT00054717|459065891|FG001|Overall Study|Protocol Violation|19|||
127572285|NCT00054717|459065890|FG000|Overall Study|Lost to Follow-up|23|||
127572286|NCT00054717|459065891|FG001|Overall Study|Lost to Follow-up|13|||
127572287|NCT00054717|459065890|FG000|Overall Study|Withdrawal by Subject|32|||
127572288|NCT00054717|459065891|FG001|Overall Study|Withdrawal by Subject|20|||
127572289|NCT00054717|459065890|FG000|Overall Study|Other reason not defined above|117|||
127572290|NCT00054717|459065891|FG001|Overall Study|Other reason not defined above|217|||
127572291|NCT04209426|459065892|FG000|Overall Study|Lost to Follow-up|3|||
127572292|NCT04209426|459065893|FG001|Overall Study|Lost to Follow-up|2|||
127572293|NCT04423939|459065894|FG000|Overall Study|Still on study (but completed primary endpoint)|8|||
127780931|NCT00766090|459825868|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
128029233|NCT02633527|460732137|FG001|Overall Study|Lost to Follow-up|2|||
127780932|NCT00766090|459825869|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
127780933|NCT00766090|459825870|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
127780934|NCT00766090|459825871|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
127780935|NCT00766090|459825872|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
127780936|NCT00766090|459825861|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
127780937|NCT00766090|459825862|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
127780938|NCT00766090|459825863|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
127780939|NCT00766090|459825864|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
127780940|NCT00766090|459825865|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
127780941|NCT00766090|459825866|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
127780942|NCT00766090|459825867|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
127780943|NCT00766090|459825868|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
127780944|NCT00766090|459825869|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
127780945|NCT00766090|459825870|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
127780946|NCT00766090|459825871|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
127780947|NCT00766090|459825872|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
127780948|NCT00800436|459825873|FG000|Overall Study|Withdrawal by Subject|0|||
127780949|NCT00800436|459825874|FG001|Overall Study|Withdrawal by Subject|0|||
127780950|NCT00800436|459825875|FG002|Overall Study|Withdrawal by Subject|1|||
127780951|NCT00800436|459825876|FG003|Overall Study|Withdrawal by Subject|1|||
127780952|NCT00800436|459825877|FG004|Overall Study|Withdrawal by Subject|0|||
127780953|NCT00800436|459825878|FG005|Overall Study|Withdrawal by Subject|0|||
127780954|NCT00800436|459825879|FG006|Overall Study|Withdrawal by Subject|0|||
127780955|NCT01106027|459825886|FG000|Overall Study|Lost graft early, discontinued|1|||
127780956|NCT02871778|459825887|FG000|Part A: Treatment Period 1|Adverse Event|1|||
127780957|NCT02871778|459825888|FG001|Part A: Treatment Period 1|Adverse Event|1|||
127780958|NCT02871778|459825889|FG002|Part A: Treatment Period 1|Adverse Event|1|||
127780959|NCT02871778|459825890|FG003|Part A: Treatment Period 1|Adverse Event|0|||
127780960|NCT02871778|459825891|FG004|Part A: Treatment Period 1|Adverse Event|0|||
127780961|NCT02871778|459825892|FG005|Part A: Treatment Period 1|Adverse Event|0|||
127780962|NCT02871778|459825893|FG006|Part A: Treatment Period 1|Adverse Event|0|||
127780963|NCT02871778|459825894|FG007|Part A: Treatment Period 1|Adverse Event|0|||
127780964|NCT02871778|459825887|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
127780965|NCT02871778|459825888|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
127780966|NCT02871778|459825889|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
127780967|NCT02871778|459825890|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
127780968|NCT02871778|459825891|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
127780969|NCT02871778|459825892|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
127780970|NCT02871778|459825893|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
127780971|NCT02871778|459825894|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
127780972|NCT02871778|459825887|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
127780973|NCT02871778|459825888|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
127780974|NCT02871778|459825889|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
127780975|NCT02871778|459825890|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
127780976|NCT02871778|459825891|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
127780977|NCT02871778|459825892|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
127780978|NCT02871778|459825893|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
127780979|NCT02871778|459825894|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
127780980|NCT02871778|459825887|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
127780981|NCT02871778|459825888|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
127780982|NCT02871778|459825889|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
127780983|NCT02871778|459825890|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
127780984|NCT02871778|459825891|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
127780985|NCT02871778|459825892|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
127780986|NCT02871778|459825893|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
127780987|NCT02871778|459825894|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
127780988|NCT02871778|459825887|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
127780989|NCT02871778|459825888|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
128029234|NCT02633527|460732138|FG002|Overall Study|Lost to Follow-up|5|||
128029235|NCT02633527|460732139|FG003|Overall Study|Lost to Follow-up|5|||
127780990|NCT02871778|459825889|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
127780991|NCT02871778|459825890|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
127780992|NCT02871778|459825891|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
127780993|NCT02871778|459825892|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
127780994|NCT02871778|459825893|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
128029236|NCT02633527|460732140|FG004|Overall Study|Lost to Follow-up|4|||
128029237|NCT02633527|460732136|FG000|Overall Study|Withdrawal by Subject|0|||
128029238|NCT02633527|460732137|FG001|Overall Study|Withdrawal by Subject|3|||
127572294|NCT04423939|459065895|FG001|Overall Study|Still on study (but completed primary endpoint)|8|||
127572295|NCT04423939|459065894|FG000|Overall Study|Death|3|||
127572296|NCT04423939|459065895|FG001|Overall Study|Death|0|||
127572297|NCT04423939|459065894|FG000|Overall Study|Withdrawal by Subject|3|||
127572298|NCT04423939|459065895|FG001|Overall Study|Withdrawal by Subject|0|||
127572299|NCT04423939|459065894|FG000|Overall Study|Caregiver to patient who died|0|||
127572300|NCT04423939|459065895|FG001|Overall Study|Caregiver to patient who died|3|||
127572301|NCT04423939|459065894|FG000|Overall Study|Caregiver to patient who withdrew|0|||
127572302|NCT04423939|459065895|FG001|Overall Study|Caregiver to patient who withdrew|3|||
127572303|NCT04626310|459065898|FG000|Overall Study|4-miss from treatment|6|||
127572304|NCT04626310|459065899|FG001|Overall Study|4-miss from treatment|5|||
127572305|NCT04626310|459065900|FG002|Overall Study|4-miss from treatment|5|||
127572306|NCT04626310|459065898|FG000|Overall Study|Withdrawal by Subject|1|||
127572307|NCT04626310|459065899|FG001|Overall Study|Withdrawal by Subject|0|||
127572308|NCT04626310|459065900|FG002|Overall Study|Withdrawal by Subject|3|||
127572309|NCT02278341|459065901|FG000|Overall Study|Randomized but never received study drug|1|||
127572310|NCT02278341|459065902|FG001|Overall Study|Randomized but never received study drug|1|||
127572311|NCT02278341|459065901|FG000|Overall Study|Adverse Event|3|||
127572312|NCT02278341|459065902|FG001|Overall Study|Adverse Event|0|||
127572313|NCT02278341|459065901|FG000|Overall Study|Death|68|||
127572314|NCT02278341|459065902|FG001|Overall Study|Death|56|||
127572315|NCT02278341|459065901|FG000|Overall Study|Withdrawal by Subject|30|||
127572316|NCT02278341|459065902|FG001|Overall Study|Withdrawal by Subject|19|||
127572317|NCT02278341|459065901|FG000|Overall Study|Lost to Follow-up|0|||
127572318|NCT02278341|459065902|FG001|Overall Study|Lost to Follow-up|1|||
127572319|NCT02278341|459065901|FG000|Overall Study|Physician Decision|1|||
127572320|NCT02278341|459065902|FG001|Overall Study|Physician Decision|1|||
127572321|NCT02278341|459065901|FG000|Overall Study|Miscellaneous|15|||
127572322|NCT02278341|459065902|FG001|Overall Study|Miscellaneous|14|||
127572323|NCT02604017|459065903|FG000|Overall Study|Withdrew Consent|0|||
127572324|NCT02604017|459065904|FG001|Overall Study|Withdrew Consent|2|||
127572325|NCT02604017|459065903|FG000|Overall Study|Lost to Follow-up|5|||
127572326|NCT02604017|459065904|FG001|Overall Study|Lost to Follow-up|6|||
127572327|NCT02604017|459065903|FG000|Overall Study|Other|1|||
127572328|NCT02604017|459065904|FG001|Overall Study|Other|0|||
127572329|NCT00740246|459065905|FG000|Overall Study|Received Blood Transfusion|0|||
127572330|NCT00740246|459065906|FG001|Overall Study|Received Blood Transfusion|1|||
127572331|NCT00740246|459065905|FG000|Overall Study|Adverse Event|1|||
127572332|NCT00740246|459065906|FG001|Overall Study|Adverse Event|2|||
127572333|NCT00740246|459065905|FG000|Overall Study|Selection Criteria/Study Compliance|2|||
127572334|NCT00740246|459065906|FG001|Overall Study|Selection Criteria/Study Compliance|0|||
127572335|NCT00740246|459065905|FG000|Overall Study|Lost to Follow-up|2|||
127572336|NCT00740246|459065906|FG001|Overall Study|Lost to Follow-up|2|||
127572337|NCT00740246|459065905|FG000|Overall Study|Withdrawal by Subject|4|||
127572338|NCT00740246|459065906|FG001|Overall Study|Withdrawal by Subject|3|||
127692291|NCT03157167|459500062|FG000|Overall Study|Withdrawal by Subject|1|||
127692292|NCT03157167|459500063|FG001|Overall Study|Withdrawal by Subject|0|||
127692293|NCT03157167|459500064|FG002|Overall Study|Withdrawal by Subject|0|||
127692294|NCT04905407|459500066|FG000|Part 1 and Part 2|Withdrawal by Subject|2|||
127692295|NCT04905407|459500067|FG001|Part 1 and Part 2|Withdrawal by Subject|1|||
127692296|NCT04905407|459500068|FG002|Part 1 and Part 2|Withdrawal by Subject|1|||
127692297|NCT04905407|459500069|FG003|Part 1 and Part 2|Withdrawal by Subject|0|||
127692298|NCT04905407|459500066|FG000|Part 1 and Part 2|Death|7|||
127692299|NCT04905407|459500067|FG001|Part 1 and Part 2|Death|7|||
127692300|NCT04905407|459500068|FG002|Part 1 and Part 2|Death|7|||
127692301|NCT04905407|459500069|FG003|Part 1 and Part 2|Death|0|||
127692302|NCT04905407|459500066|FG000|Part 1 and Part 2|Other than specified|0|||
127692303|NCT04905407|459500067|FG001|Part 1 and Part 2|Other than specified|0|||
127692304|NCT04905407|459500068|FG002|Part 1 and Part 2|Other than specified|1|||
127692305|NCT04905407|459500069|FG003|Part 1 and Part 2|Other than specified|0|||
127692306|NCT04905407|459500066|FG000|Part 3|Death|0|||
127692307|NCT04905407|459500067|FG001|Part 3|Death|0|||
127692308|NCT04905407|459500068|FG002|Part 3|Death|0|||
127692309|NCT04905407|459500069|FG003|Part 3|Death|2|||
127692310|NCT05136404|459500070|FG000|Period 1|Adverse Event|0|||
127692311|NCT05136404|459500071|FG001|Period 1|Adverse Event|1|||
127692312|NCT05136404|459500072|FG002|Period 1|Adverse Event|1|||
127692313|NCT05136404|459500070|FG000|Period 2|Inappropriate Behavior|0|||
127692314|NCT05136404|459500071|FG001|Period 2|Inappropriate Behavior|0|||
127692315|NCT05136404|459500072|FG002|Period 2|Inappropriate Behavior|1|||
127692316|NCT05136404|459500070|FG000|Period 3|Adverse Event|0|||
127692317|NCT05136404|459500071|FG001|Period 3|Adverse Event|0|||
127572339|NCT00740246|459065905|FG000|Overall Study|Withdrawn By Site Due To non-compliance|1|||
127572340|NCT00740246|459065906|FG001|Overall Study|Withdrawn By Site Due To non-compliance|0|||
127572341|NCT00740246|459065905|FG000|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
127692318|NCT05136404|459500072|FG002|Period 3|Adverse Event|1|||
127572342|NCT00740246|459065906|FG001|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
127572343|NCT00740246|459065905|FG000|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|1|||
127572344|NCT00740246|459065906|FG001|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|0|||
127572345|NCT00740246|459065905|FG000|Overall Study|Unable To Comply With Study Visits|2|||
127572346|NCT00740246|459065906|FG001|Overall Study|Unable To Comply With Study Visits|0|||
127572347|NCT00740246|459065905|FG000|Overall Study|Unable to Access Vein|0|||
127572348|NCT00740246|459065906|FG001|Overall Study|Unable to Access Vein|2|||
127572349|NCT00740246|459065905|FG000|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|0|||
127572350|NCT00740246|459065906|FG001|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|1|||
127572351|NCT00366340|459065910|FG000|Infant Series|Protocol Violation|3|||
127572352|NCT00366340|459065911|FG001|Infant Series|Protocol Violation|4|||
127572353|NCT00366340|459065910|FG000|Infant Series|Withdrawal by Subject|3|||
127572354|NCT00366340|459065911|FG001|Infant Series|Withdrawal by Subject|3|||
127572355|NCT00366340|459065910|FG000|Infant Series|Adverse Event|0|||
127572356|NCT00366340|459065911|FG001|Infant Series|Adverse Event|2|||
127572357|NCT00366340|459065910|FG000|Infant Series|Lost to Follow-up|1|||
127572358|NCT00366340|459065911|FG001|Infant Series|Lost to Follow-up|1|||
127572359|NCT00366340|459065910|FG000|Infant Series|Failure to return|1|||
127572360|NCT00366340|459065911|FG001|Infant Series|Failure to return|0|||
127572361|NCT00366340|459065910|FG000|After the Infant Series|Parent/legal guardian request|1|||
127572362|NCT00366340|459065911|FG001|After the Infant Series|Parent/legal guardian request|1|||
127572363|NCT00366340|459065910|FG000|After the Infant Series|Failed to return|0|||
127572364|NCT00366340|459065911|FG001|After the Infant Series|Failed to return|1|||
127572365|NCT00366340|459065910|FG000|After the Infant Series|Protocol Violation|2|||
127572366|NCT00366340|459065911|FG001|After the Infant Series|Protocol Violation|2|||
127572367|NCT00366340|459065910|FG000|After the Infant Series|Adverse Event|0|||
127572368|NCT00366340|459065911|FG001|After the Infant Series|Adverse Event|1|||
127572369|NCT00366340|459065910|FG000|After the Infant Series|Lost to Follow-up|0|||
127572370|NCT00366340|459065911|FG001|After the Infant Series|Lost to Follow-up|1|||
127572371|NCT00366340|459065910|FG000|Toddler Dose|Failed to return|1|||
127572372|NCT00366340|459065911|FG001|Toddler Dose|Failed to return|0|||
127572373|NCT00366340|459065910|FG000|Toddler Dose|Parent/legal guardian request|0|||
127572374|NCT00366340|459065911|FG001|Toddler Dose|Parent/legal guardian request|1|||
127572375|NCT01315236|459065915|FG000|Double-blind Phase|Death|1|||
127572376|NCT01315236|459065916|FG001|Double-blind Phase|Death|0|||
127572377|NCT01315236|459065915|FG000|Double-blind Phase|Adverse Event|1|||
127692319|NCT01894061|459500075|FG000|Overall Study|Screen failure|1|||
127692320|NCT01894061|459500075|FG000|Overall Study|Withdrawal by Subject|1|||
127692321|NCT05444192|459500078|FG000|Overall Study|Lost to Follow-up|1|||
127692322|NCT05444192|459500079|FG001|Overall Study|Lost to Follow-up|0|||
127692323|NCT05623345|459500081|FG000|Overall Study|Withdrawal by Subject|14|||
127692324|NCT05623345|459500082|FG001|Overall Study|Withdrawal by Subject|0|||
127780995|NCT02871778|459825894|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
127780996|NCT02871778|459825887|FG000|Part A: Treatment Period 2|Adverse Event|2|||
127780997|NCT02871778|459825888|FG001|Part A: Treatment Period 2|Adverse Event|2|||
127780998|NCT02871778|459825889|FG002|Part A: Treatment Period 2|Adverse Event|0|||
127780999|NCT02871778|459825890|FG003|Part A: Treatment Period 2|Adverse Event|0|||
127781000|NCT02871778|459825891|FG004|Part A: Treatment Period 2|Adverse Event|0|||
127781001|NCT02871778|459825892|FG005|Part A: Treatment Period 2|Adverse Event|0|||
127781002|NCT02871778|459825893|FG006|Part A: Treatment Period 2|Adverse Event|0|||
127781003|NCT02871778|459825894|FG007|Part A: Treatment Period 2|Adverse Event|0|||
127781004|NCT02871778|459825887|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
127781005|NCT02871778|459825888|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
127781006|NCT02871778|459825889|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
127781007|NCT02871778|459825890|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
127781008|NCT02871778|459825891|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
127781009|NCT02871778|459825892|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
127781010|NCT02871778|459825893|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
127781011|NCT02871778|459825894|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
127781012|NCT02871778|459825887|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
127572378|NCT01315236|459065916|FG001|Double-blind Phase|Adverse Event|0|||
127692325|NCT05623345|459500083|FG002|Overall Study|Withdrawal by Subject|9|||
127572379|NCT01315236|459065915|FG000|Double-blind Phase|Withdrawal of Consent|1|||
127572380|NCT01315236|459065916|FG001|Double-blind Phase|Withdrawal of Consent|0|||
127572381|NCT01315236|459065915|FG000|Double-blind Phase|Lost to Follow-up|1|||
127692326|NCT05623345|459500084|FG003|Overall Study|Withdrawal by Subject|20|||
127572382|NCT01315236|459065916|FG001|Double-blind Phase|Lost to Follow-up|0|||
127692327|NCT05623345|459500081|FG000|Overall Study|Lost to Follow-up|3|||
127781013|NCT02871778|459825888|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
127781014|NCT02871778|459825889|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
127572383|NCT01315236|459065915|FG000|Open-label Phase|Death|1|||
127781015|NCT02871778|459825890|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
127781016|NCT02871778|459825891|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
127781017|NCT02871778|459825892|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
127781018|NCT02871778|459825893|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
127781019|NCT02871778|459825894|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
127781020|NCT02871778|459825887|FG000|Part B: Treatment Period 3|Adverse Event|0|||
127781021|NCT02871778|459825888|FG001|Part B: Treatment Period 3|Adverse Event|0|||
127781022|NCT02871778|459825889|FG002|Part B: Treatment Period 3|Adverse Event|0|||
127781023|NCT02871778|459825890|FG003|Part B: Treatment Period 3|Adverse Event|0|||
127781024|NCT02871778|459825891|FG004|Part B: Treatment Period 3|Adverse Event|1|||
127781025|NCT02871778|459825892|FG005|Part B: Treatment Period 3|Adverse Event|1|||
127781026|NCT02871778|459825893|FG006|Part B: Treatment Period 3|Adverse Event|1|||
127781027|NCT02871778|459825894|FG007|Part B: Treatment Period 3|Adverse Event|0|||
127781028|NCT02653300|459825895|FG000|Overall Study|Withdrawal by Subject|2|||
127781029|NCT02170779|459825896|FG000|Overall Study|Withdrawal by Subject|1|||
127781030|NCT02170779|459825897|FG001|Overall Study|Withdrawal by Subject|0|||
127781031|NCT02170779|459825896|FG000|Overall Study|Lost to Follow-up|0|||
127781032|NCT02170779|459825897|FG001|Overall Study|Lost to Follow-up|1|||
127572384|NCT01315236|459065916|FG001|Open-label Phase|Death|0|||
127572385|NCT01315236|459065915|FG000|Open-label Phase|Adverse Event|0|||
127572386|NCT01315236|459065916|FG001|Open-label Phase|Adverse Event|1|||
127572387|NCT01315236|459065915|FG000|Open-label Phase|Other|0|||
127572388|NCT01315236|459065916|FG001|Open-label Phase|Other|1|||
127572389|NCT01315236|459065915|FG000|12-Month Follow-up Period|Death|0|||
127781033|NCT00369785|459825909|FG000|Overall Study|Physician Decision|3|||
127781034|NCT00369785|459825910|FG001|Overall Study|Physician Decision|2|||
127781035|NCT00369785|459825909|FG000|Overall Study|Death|1|||
127781036|NCT00369785|459825910|FG001|Overall Study|Death|2|||
127781037|NCT00369785|459825909|FG000|Overall Study|Withdrawal by Subject|7|||
127781038|NCT00369785|459825910|FG001|Overall Study|Withdrawal by Subject|6|||
127781039|NCT00369785|459825909|FG000|Overall Study|Toxicity|6|||
127781040|NCT00369785|459825910|FG001|Overall Study|Toxicity|4|||
127781041|NCT00369785|459825909|FG000|Overall Study|Never started|0|||
127781042|NCT00369785|459825910|FG001|Overall Study|Never started|2|||
127781043|NCT00369785|459825909|FG000|Overall Study|Progression|4|||
127572390|NCT01315236|459065916|FG001|12-Month Follow-up Period|Death|1|||
127572391|NCT01315236|459065915|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
127572392|NCT01315236|459065916|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
127572393|NCT00521001|459065919|FG000|Overall Study|Ineligible|1|||
127781044|NCT00369785|459825910|FG001|Overall Study|Progression|4|||
127781045|NCT00369785|459825909|FG000|Overall Study|Multiple reasons|6|||
127781046|NCT00369785|459825910|FG001|Overall Study|Multiple reasons|5|||
127781047|NCT00800683|459825911|FG000|Overall Study|Adverse Event|11|||
127781048|NCT00800683|459825912|FG001|Overall Study|Adverse Event|8|||
127781049|NCT00800683|459825911|FG000|Overall Study|Lost to Follow-up|3|||
127781050|NCT00800683|459825912|FG001|Overall Study|Lost to Follow-up|1|||
127572394|NCT02821910|459065920|FG000|Overall Study|Withdrawal by Subject|0|||
127572395|NCT02821910|459065921|FG001|Overall Study|Withdrawal by Subject|0|||
127572396|NCT02821910|459065922|FG002|Overall Study|Withdrawal by Subject|1|||
127572397|NCT02821910|459065923|FG003|Overall Study|Withdrawal by Subject|0|||
127572398|NCT02821910|459065924|FG004|Overall Study|Withdrawal by Subject|0|||
127572399|NCT02821910|459065925|FG005|Overall Study|Withdrawal by Subject|1|||
127572400|NCT02821910|459065920|FG000|Overall Study|Other than specified|1|||
127572401|NCT02821910|459065921|FG001|Overall Study|Other than specified|0|||
127572402|NCT02821910|459065922|FG002|Overall Study|Other than specified|1|||
127572403|NCT02821910|459065923|FG003|Overall Study|Other than specified|0|||
127572404|NCT02821910|459065924|FG004|Overall Study|Other than specified|0|||
127572405|NCT02821910|459065925|FG005|Overall Study|Other than specified|0|||
127572406|NCT00287079|459065926|FG000|Overall Study|Qualifying relapse|12|||
127572407|NCT00287079|459065927|FG001|Overall Study|Qualifying relapse|1|||
127572408|NCT00287079|459065926|FG000|Overall Study|Non-qualifying relapse|1|||
127572409|NCT00287079|459065927|FG001|Overall Study|Non-qualifying relapse|0|||
127572410|NCT00287079|459065926|FG000|Overall Study|Adverse Event|5|||
127572411|NCT00287079|459065927|FG001|Overall Study|Adverse Event|0|||
127572412|NCT00287079|459065926|FG000|Overall Study|Protocol Violation|1|||
127572413|NCT00287079|459065927|FG001|Overall Study|Protocol Violation|0|||
127572414|NCT00287079|459065926|FG000|Overall Study|Other|3|||
127572415|NCT00287079|459065927|FG001|Overall Study|Other|0|||
127572416|NCT01082640|459065930|FG000|Overall Study|Adverse Event|9|||
127572417|NCT01082640|459065931|FG001|Overall Study|Adverse Event|5|||
127572418|NCT01082640|459065932|FG002|Overall Study|Adverse Event|3|||
127572419|NCT01082640|459065930|FG000|Overall Study|Withdrawal by Subject|3|||
127572420|NCT01082640|459065931|FG001|Overall Study|Withdrawal by Subject|3|||
127572421|NCT01082640|459065932|FG002|Overall Study|Withdrawal by Subject|2|||
127572422|NCT01082640|459065930|FG000|Overall Study|Major protocol deviation|3|||
127572423|NCT01082640|459065931|FG001|Overall Study|Major protocol deviation|3|||
127572424|NCT01082640|459065932|FG002|Overall Study|Major protocol deviation|0|||
127572425|NCT01082640|459065930|FG000|Overall Study|Lost to Follow-up|0|||
127572426|NCT01082640|459065931|FG001|Overall Study|Lost to Follow-up|3|||
127572427|NCT01082640|459065932|FG002|Overall Study|Lost to Follow-up|0|||
127572428|NCT01082640|459065930|FG000|Overall Study|Other|2|||
127572429|NCT01082640|459065931|FG001|Overall Study|Other|1|||
127572430|NCT01082640|459065932|FG002|Overall Study|Other|3|||
127572431|NCT02011893|459065935|FG000|Enrollment to Randomization|Adverse Event|2|||
127572432|NCT02011893|459065936|FG001|Enrollment to Randomization|Adverse Event|0|||
127572433|NCT02011893|459065937|FG002|Enrollment to Randomization|Adverse Event|0|||
127572434|NCT02011893|459065935|FG000|Enrollment to Randomization|Physician Decision|10|||
127572435|NCT02011893|459065936|FG001|Enrollment to Randomization|Physician Decision|0|||
127781051|NCT00800683|459825911|FG000|Overall Study|Withdrawal by Subject|1|||
127781052|NCT00800683|459825912|FG001|Overall Study|Withdrawal by Subject|7|||
127781053|NCT00800683|459825911|FG000|Overall Study|Lack of Efficacy|1|||
127781054|NCT00800683|459825912|FG001|Overall Study|Lack of Efficacy|1|||
127781055|NCT00800683|459825911|FG000|Overall Study|Other|1|||
127781056|NCT00800683|459825912|FG001|Overall Study|Other|2|||
127781057|NCT04556136|459825917|FG000|Overall Study|Lost to Follow-up|6|||
127781058|NCT04556136|459825918|FG001|Overall Study|Lost to Follow-up|6|||
127781059|NCT04556136|459825917|FG000|Overall Study|Physician Decision|2|||
127781060|NCT04556136|459825918|FG001|Overall Study|Physician Decision|1|||
127781061|NCT04556136|459825917|FG000|Overall Study|Withdrawal by Subject|2|||
127781062|NCT04556136|459825918|FG001|Overall Study|Withdrawal by Subject|1|||
127781063|NCT01221727|459825919|FG000|Overall Study|Physician Decision|2|||
127781064|NCT01221727|459825920|FG001|Overall Study|Physician Decision|0|||
127781065|NCT01221727|459825919|FG000|Overall Study|Withdrawal by Subject|1|||
127781066|NCT01221727|459825920|FG001|Overall Study|Withdrawal by Subject|1|||
127781067|NCT00529451|459825923|FG000|Overall Study|Subject withdrew consent|16|||
127781068|NCT00529451|459825924|FG001|Overall Study|Subject withdrew consent|21|||
127781069|NCT00529451|459825925|FG002|Overall Study|Subject withdrew consent|13|||
127781070|NCT00529451|459825926|FG003|Overall Study|Subject withdrew consent|12|||
127572436|NCT02011893|459065937|FG002|Enrollment to Randomization|Physician Decision|0|||
127572437|NCT02011893|459065935|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
127572438|NCT02011893|459065936|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
127572439|NCT02011893|459065937|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
127781071|NCT00529451|459825923|FG000|Overall Study|Adverse Event|9|||
127781072|NCT00529451|459825924|FG001|Overall Study|Adverse Event|16|||
127781073|NCT00529451|459825925|FG002|Overall Study|Adverse Event|14|||
127781074|NCT00529451|459825926|FG003|Overall Study|Adverse Event|8|||
127781075|NCT00529451|459825923|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
127781076|NCT00529451|459825924|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
127572440|NCT02011893|459065935|FG000|Enrollment to Randomization|Screening Failure|29|||
127572441|NCT02011893|459065936|FG001|Enrollment to Randomization|Screening Failure|0|||
127572442|NCT02011893|459065937|FG002|Enrollment to Randomization|Screening Failure|0|||
127572443|NCT02011893|459065935|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
127572444|NCT02011893|459065936|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
127572445|NCT02011893|459065937|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
127572446|NCT02011893|459065935|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
127572447|NCT02011893|459065936|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
127572448|NCT02011893|459065937|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
127572449|NCT02011893|459065935|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
127572450|NCT02011893|459065936|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
127572451|NCT02011893|459065937|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
127572452|NCT02011893|459065935|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
127572453|NCT02011893|459065936|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
127572454|NCT02011893|459065937|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
127572455|NCT02011893|459065935|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
127572456|NCT02011893|459065936|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
127572457|NCT02011893|459065937|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
127572458|NCT01289782|459065938|FG000|Overall Study|Lost to Follow-up|14|||
127572459|NCT01289782|459065939|FG001|Overall Study|Lost to Follow-up|7|||
127572460|NCT01289782|459065938|FG000|Overall Study|Protocol Violation|1|||
127572461|NCT01289782|459065939|FG001|Overall Study|Protocol Violation|1|||
127572462|NCT01289782|459065938|FG000|Overall Study|Withdrawal by Subject|8|||
127572463|NCT01289782|459065939|FG001|Overall Study|Withdrawal by Subject|2|||
127572464|NCT01289782|459065938|FG000|Overall Study|Sponsor's Decision|1|||
127572465|NCT01289782|459065939|FG001|Overall Study|Sponsor's Decision|0|||
127572466|NCT01289782|459065938|FG000|Overall Study|Reason not specified|1|||
127572467|NCT01289782|459065939|FG001|Overall Study|Reason not specified|2|||
127572468|NCT01241240|459065940|FG000|Overall Study|Adverse Event|5|||
127572469|NCT01241240|459065941|FG001|Overall Study|Adverse Event|4|||
127572470|NCT01241240|459065940|FG000|Overall Study|Lost to Follow-up|2|||
127572471|NCT01241240|459065941|FG001|Overall Study|Lost to Follow-up|4|||
127572472|NCT01241240|459065940|FG000|Overall Study|Personal Reasons|1|||
127572473|NCT01241240|459065941|FG001|Overall Study|Personal Reasons|1|||
127572474|NCT01025154|459065945|FG000|Overall Study|Lost to Follow-up|1|||
127572475|NCT01025154|459065945|FG000|Overall Study|Withdrawal by Subject|1|||
127572476|NCT00542451|459065950|FG000|Overall Study|Adverse Event|31|||
127572477|NCT00542451|459065950|FG000|Overall Study|Withdrawal by Subject|30|||
127572478|NCT00542451|459065950|FG000|Overall Study|Physician Decision|4|||
127572479|NCT00542451|459065950|FG000|Overall Study|Recurrent disease|1|||
127572480|NCT00542451|459065950|FG000|Overall Study|unknown reason|1|||
127572481|NCT00542451|459065950|FG000|Overall Study|Death|2|||
127572482|NCT00542451|459065950|FG000|Overall Study|Lost to Follow-up|10|||
127572483|NCT01582854|459065951|FG000|Overall Study|Death|8|||
127572484|NCT01582854|459065952|FG001|Overall Study|Death|5|||
127572485|NCT01582854|459065951|FG000|Overall Study|Adverse Event|2|||
127572486|NCT01582854|459065952|FG001|Overall Study|Adverse Event|3|||
127572487|NCT01582854|459065951|FG000|Overall Study|Withdrawal by Participant|8|||
127572488|NCT01582854|459065952|FG001|Overall Study|Withdrawal by Participant|11|||
127572489|NCT01582854|459065951|FG000|Overall Study|Lost to Follow-up|1|||
127572490|NCT01582854|459065952|FG001|Overall Study|Lost to Follow-up|2|||
127692328|NCT05623345|459500082|FG001|Overall Study|Lost to Follow-up|0|||
127692329|NCT05623345|459500083|FG002|Overall Study|Lost to Follow-up|7|||
127692330|NCT05623345|459500084|FG003|Overall Study|Lost to Follow-up|2|||
127692331|NCT05623345|459500081|FG000|Overall Study|Termination of Study By Sponsor|37|||
127692332|NCT05623345|459500082|FG001|Overall Study|Termination of Study By Sponsor|4|||
127692333|NCT05623345|459500083|FG002|Overall Study|Termination of Study By Sponsor|40|||
128029239|NCT02633527|460732138|FG002|Overall Study|Withdrawal by Subject|5|||
128029240|NCT02633527|460732139|FG003|Overall Study|Withdrawal by Subject|4|||
128029241|NCT02633527|460732140|FG004|Overall Study|Withdrawal by Subject|4|||
128029242|NCT02633527|460732136|FG000|Overall Study|Protocol Violation|0|||
128029243|NCT02633527|460732137|FG001|Overall Study|Protocol Violation|1|||
128029244|NCT02633527|460732138|FG002|Overall Study|Protocol Violation|1|||
127572491|NCT01582854|459065951|FG000|Overall Study|Physician Decision|0|||
127572492|NCT01582854|459065952|FG001|Overall Study|Physician Decision|1|||
127572493|NCT01582854|459065951|FG000|Overall Study|Recurrent Stroke|13|||
127572494|NCT01582854|459065952|FG001|Overall Study|Recurrent Stroke|8|||
127572495|NCT01582854|459065951|FG000|Overall Study|Disallowed Concomitant Medication|3|||
127572496|NCT01582854|459065952|FG001|Overall Study|Disallowed Concomitant Medication|2|||
127692334|NCT05623345|459500084|FG003|Overall Study|Termination of Study By Sponsor|38|||
128029245|NCT02633527|460732139|FG003|Overall Study|Protocol Violation|1|||
128029246|NCT02633527|460732140|FG004|Overall Study|Protocol Violation|1|||
127572497|NCT01582854|459065951|FG000|Overall Study|Carotid or Neurosurgery|0|||
127572498|NCT01582854|459065952|FG001|Overall Study|Carotid or Neurosurgery|1|||
127572499|NCT01582854|459065951|FG000|Overall Study|General Anaesthesia|0|||
127572500|NCT01582854|459065952|FG001|Overall Study|General Anaesthesia|1|||
127572501|NCT01582854|459065951|FG000|Overall Study|Other Miscellaneous Reason|1|||
127572502|NCT01582854|459065952|FG001|Overall Study|Other Miscellaneous Reason|0|||
127572503|NCT02652767|459065957|FG000|Overall Study|Death|2|||
127572504|NCT02652767|459065957|FG000|Overall Study|Lost to Follow-up|1|||
127572505|NCT02652767|459065957|FG000|Overall Study|Withdrawal by Subject|1|||
127572506|NCT01642407|459065966|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
127572507|NCT01642407|459065966|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
127572508|NCT01642407|459065966|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
127572509|NCT03533686|459065967|FG000|Overall Study|Withdrawal by Subject|1|||
127572510|NCT03533686|459065968|FG001|Overall Study|Withdrawal by Subject|0|||
127572511|NCT03533686|459065969|FG002|Overall Study|Withdrawal by Subject|0|||
127572512|NCT03533686|459065970|FG003|Overall Study|Withdrawal by Subject|3|||
127572513|NCT03533686|459065971|FG004|Overall Study|Withdrawal by Subject|5|||
127572514|NCT03533686|459065972|FG005|Overall Study|Withdrawal by Subject|1|||
127572515|NCT03533686|459065967|FG000|Overall Study|Lost to Follow-up|0|||
127572516|NCT03533686|459065968|FG001|Overall Study|Lost to Follow-up|1|||
127572517|NCT03533686|459065969|FG002|Overall Study|Lost to Follow-up|0|||
127781077|NCT00529451|459825925|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
127781078|NCT00529451|459825926|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
127781079|NCT00529451|459825923|FG000|Overall Study|Lost to Follow-up|4|||
127781080|NCT00529451|459825924|FG001|Overall Study|Lost to Follow-up|7|||
127781081|NCT00529451|459825925|FG002|Overall Study|Lost to Follow-up|4|||
127781082|NCT00529451|459825926|FG003|Overall Study|Lost to Follow-up|4|||
127781083|NCT00529451|459825923|FG000|Overall Study|Protocol deviation|1|||
127781084|NCT00529451|459825924|FG001|Overall Study|Protocol deviation|1|||
127781085|NCT00529451|459825925|FG002|Overall Study|Protocol deviation|4|||
127781086|NCT00529451|459825926|FG003|Overall Study|Protocol deviation|1|||
127781087|NCT00529451|459825923|FG000|Overall Study|Administrative problems|1|||
127781088|NCT00529451|459825924|FG001|Overall Study|Administrative problems|1|||
127781089|NCT00529451|459825925|FG002|Overall Study|Administrative problems|0|||
127781090|NCT00529451|459825926|FG003|Overall Study|Administrative problems|2|||
127781091|NCT00773136|459825927|FG000|Overall Study|Physician Decision|2|||
127781092|NCT00888381|459825932|FG000|Overall Study|Lost to Follow-up|0|||
127781093|NCT00888381|459825933|FG001|Overall Study|Lost to Follow-up|1|||
127781094|NCT00097773|459825934|FG000|Overall Study|Lost to Follow-up|2|||
127781095|NCT00097773|459825935|FG001|Overall Study|Lost to Follow-up|2|||
127781096|NCT00097773|459825936|FG002|Overall Study|Lost to Follow-up|0|||
127781097|NCT00097773|459825937|FG003|Overall Study|Lost to Follow-up|1|||
127781098|NCT00097773|459825934|FG000|Overall Study|Physician Decision|2|||
127781099|NCT00097773|459825935|FG001|Overall Study|Physician Decision|2|||
127781100|NCT00097773|459825936|FG002|Overall Study|Physician Decision|3|||
127781101|NCT00097773|459825937|FG003|Overall Study|Physician Decision|1|||
127781102|NCT00097773|459825934|FG000|Overall Study|Withdrawal by Subject|3|||
127781103|NCT00097773|459825935|FG001|Overall Study|Withdrawal by Subject|3|||
127781104|NCT00097773|459825936|FG002|Overall Study|Withdrawal by Subject|3|||
127781105|NCT00097773|459825937|FG003|Overall Study|Withdrawal by Subject|1|||
127781106|NCT00097773|459825934|FG000|Overall Study|Adverse Event|0|||
127781107|NCT00097773|459825935|FG001|Overall Study|Adverse Event|1|||
127781108|NCT00097773|459825936|FG002|Overall Study|Adverse Event|0|||
127781109|NCT00097773|459825937|FG003|Overall Study|Adverse Event|0|||
127781110|NCT00097773|459825934|FG000|Overall Study|Other|1|||
127781111|NCT00097773|459825935|FG001|Overall Study|Other|0|||
127781112|NCT00097773|459825936|FG002|Overall Study|Other|2|||
127781113|NCT00097773|459825937|FG003|Overall Study|Other|0|||
127781114|NCT00003702|459825938|FG000|Overall Study|Ineligible cell types|2|||
127781115|NCT00003702|459825939|FG001|Overall Study|Ineligible cell types|2|||
127781116|NCT00003702|459825938|FG000|Overall Study|Did not meet criteria for persistence|8|||
127781117|NCT00003702|459825939|FG001|Overall Study|Did not meet criteria for persistence|5|||
127781118|NCT00003702|459825938|FG000|Overall Study|WHO score > 6|2|||
127781119|NCT00003702|459825939|FG001|Overall Study|WHO score > 6|1|||
127781120|NCT00003702|459825938|FG000|Overall Study|Inadequate documentation of disease|1|||
127781121|NCT00003702|459825939|FG001|Overall Study|Inadequate documentation of disease|3|||
127781122|NCT01009034|459825940|FG000|Overall Study|Lost to Follow-up|2|||
127781123|NCT01009034|459825940|FG000|Overall Study|Withdrawal by Subject|2|||
127781124|NCT01494350|459825941|FG000|Overall Study|Worsening of lesion|1|||
127572518|NCT03533686|459065970|FG003|Overall Study|Lost to Follow-up|0|||
127572519|NCT03533686|459065971|FG004|Overall Study|Lost to Follow-up|2|||
127572520|NCT03533686|459065972|FG005|Overall Study|Lost to Follow-up|0|||
127572521|NCT03533686|459065967|FG000|Overall Study|Screen Failure|0|||
127572522|NCT03533686|459065968|FG001|Overall Study|Screen Failure|0|||
127781125|NCT02054325|459825943|FG000|Overall Study|Lost to Follow-up|8|||
127781126|NCT02054325|459825944|FG001|Overall Study|Lost to Follow-up|5|||
127781127|NCT00617604|459825945|FG000|Overall Study|Death|2|||
127572523|NCT03533686|459065969|FG002|Overall Study|Screen Failure|0|||
127572524|NCT03533686|459065970|FG003|Overall Study|Screen Failure|2|||
127781128|NCT00617604|459825946|FG001|Overall Study|Death|1|||
127781129|NCT00617604|459825945|FG000|Overall Study|Lost to Follow-up|1|||
127781130|NCT00617604|459825946|FG001|Overall Study|Lost to Follow-up|0|||
127781131|NCT00617604|459825945|FG000|Overall Study|Miscellaneous Reasons|8|||
127781132|NCT00617604|459825946|FG001|Overall Study|Miscellaneous Reasons|10|||
127781133|NCT00617604|459825945|FG000|Overall Study|Withdrawal by Subject|4|||
127781134|NCT00617604|459825946|FG001|Overall Study|Withdrawal by Subject|6|||
127781135|NCT00617604|459825945|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
127781136|NCT00617604|459825946|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
127781137|NCT03250832|459825947|FG000|Part 1 (Up to Approximately 51 Months)|Death|1|||
127781138|NCT03250832|459825948|FG001|Part 1 (Up to Approximately 51 Months)|Death|6|||
127781139|NCT03250832|459825949|FG002|Part 1 (Up to Approximately 51 Months)|Death|5|||
127781140|NCT03250832|459825950|FG003|Part 1 (Up to Approximately 51 Months)|Death|5|||
127781141|NCT03250832|459825951|FG004|Part 1 (Up to Approximately 51 Months)|Death|3|||
127781142|NCT03250832|459825952|FG005|Part 1 (Up to Approximately 51 Months)|Death|6|||
127781143|NCT03250832|459825953|FG006|Part 1 (Up to Approximately 51 Months)|Death|3|||
127781144|NCT03250832|459825954|FG007|Part 1 (Up to Approximately 51 Months)|Death|0|||
127781145|NCT03250832|459825955|FG008|Part 1 (Up to Approximately 51 Months)|Death|0|||
127781146|NCT03250832|459825956|FG009|Part 1 (Up to Approximately 51 Months)|Death|0|||
127781147|NCT03250832|459825957|FG010|Part 1 (Up to Approximately 51 Months)|Death|0|||
127781148|NCT03250832|459825958|FG011|Part 1 (Up to Approximately 51 Months)|Death|0|||
127781149|NCT03250832|459825947|FG000|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
127781150|NCT03250832|459825948|FG001|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|4|||
127781151|NCT03250832|459825949|FG002|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
127781152|NCT03250832|459825950|FG003|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
127781153|NCT03250832|459825951|FG004|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
127781154|NCT03250832|459825952|FG005|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|1|||
127781155|NCT03250832|459825953|FG006|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|3|||
127781156|NCT03250832|459825954|FG007|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
127781157|NCT03250832|459825955|FG008|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
127781158|NCT03250832|459825956|FG009|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
127781159|NCT03250832|459825957|FG010|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
127781160|NCT03250832|459825958|FG011|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
127781161|NCT03250832|459825947|FG000|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
127781162|NCT03250832|459825948|FG001|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
127781163|NCT03250832|459825949|FG002|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|1|||
127781164|NCT03250832|459825950|FG003|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
127781165|NCT03250832|459825951|FG004|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
127781166|NCT03250832|459825952|FG005|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
127781167|NCT03250832|459825953|FG006|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
127781168|NCT03250832|459825954|FG007|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
127781169|NCT03250832|459825955|FG008|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
127781170|NCT03250832|459825956|FG009|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
127781171|NCT03250832|459825957|FG010|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
127781172|NCT03250832|459825958|FG011|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
127781173|NCT03250832|459825947|FG000|Part 2A (Up to Approximately 30 Months)|Death|0|||
127781174|NCT03250832|459825948|FG001|Part 2A (Up to Approximately 30 Months)|Death|0|||
127781175|NCT03250832|459825949|FG002|Part 2A (Up to Approximately 30 Months)|Death|0|||
127781176|NCT03250832|459825950|FG003|Part 2A (Up to Approximately 30 Months)|Death|0|||
127781177|NCT03250832|459825951|FG004|Part 2A (Up to Approximately 30 Months)|Death|0|||
127781178|NCT03250832|459825952|FG005|Part 2A (Up to Approximately 30 Months)|Death|0|||
127781179|NCT03250832|459825953|FG006|Part 2A (Up to Approximately 30 Months)|Death|0|||
127781180|NCT03250832|459825954|FG007|Part 2A (Up to Approximately 30 Months)|Death|18|||
127781181|NCT03250832|459825955|FG008|Part 2A (Up to Approximately 30 Months)|Death|0|||
127781182|NCT03250832|459825956|FG009|Part 2A (Up to Approximately 30 Months)|Death|0|||
127781183|NCT03250832|459825957|FG010|Part 2A (Up to Approximately 30 Months)|Death|0|||
127781184|NCT03250832|459825958|FG011|Part 2A (Up to Approximately 30 Months)|Death|0|||
127781185|NCT03250832|459825947|FG000|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
127781186|NCT03250832|459825948|FG001|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
127781187|NCT03250832|459825949|FG002|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
127781188|NCT03250832|459825950|FG003|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
127781189|NCT03250832|459825951|FG004|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
127781190|NCT03250832|459825952|FG005|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
127781191|NCT03250832|459825953|FG006|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
127781192|NCT03250832|459825954|FG007|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|3|||
127781193|NCT03250832|459825955|FG008|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
127781194|NCT03250832|459825956|FG009|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
127781195|NCT03250832|459825957|FG010|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
128029247|NCT02633527|460732136|FG000|Overall Study|Physician Decision|0|||
127781196|NCT03250832|459825958|FG011|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
127781197|NCT03250832|459825947|FG000|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
128029248|NCT02633527|460732137|FG001|Overall Study|Physician Decision|0|||
127572525|NCT03533686|459065971|FG004|Overall Study|Screen Failure|0|||
127572526|NCT03533686|459065972|FG005|Overall Study|Screen Failure|0|||
127572527|NCT00245583|459065973|FG000|Overall Study|Lost to Follow-up|1|||
127572528|NCT00245583|459065974|FG001|Overall Study|Lost to Follow-up|5|||
127572529|NCT00245583|459065973|FG000|Overall Study|Adverse Event|2|||
127572530|NCT00245583|459065974|FG001|Overall Study|Adverse Event|1|||
127572531|NCT00245583|459065973|FG000|Overall Study|Lack of Efficacy|1|||
127572532|NCT00245583|459065974|FG001|Overall Study|Lack of Efficacy|0|||
127572533|NCT00245583|459065973|FG000|Overall Study|Withdrawal by Subject|2|||
127572534|NCT00245583|459065974|FG001|Overall Study|Withdrawal by Subject|3|||
127781198|NCT03250832|459825948|FG001|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
127781199|NCT03250832|459825949|FG002|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
127781200|NCT03250832|459825950|FG003|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
127781201|NCT03250832|459825951|FG004|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
127781202|NCT03250832|459825952|FG005|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
127781203|NCT03250832|459825953|FG006|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
127781204|NCT03250832|459825954|FG007|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|8|||
127781205|NCT03250832|459825955|FG008|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
127781206|NCT03250832|459825956|FG009|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
127781207|NCT03250832|459825957|FG010|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
127781208|NCT03250832|459825958|FG011|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
127781209|NCT03250832|459825947|FG000|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
127781210|NCT03250832|459825948|FG001|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
127781211|NCT03250832|459825949|FG002|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
127781212|NCT03250832|459825950|FG003|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
127781213|NCT03250832|459825951|FG004|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
127781214|NCT03250832|459825952|FG005|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
127781215|NCT03250832|459825953|FG006|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
127781216|NCT03250832|459825954|FG007|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|3|||
127781217|NCT03250832|459825955|FG008|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
127781218|NCT03250832|459825956|FG009|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
127781219|NCT03250832|459825957|FG010|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
127781220|NCT03250832|459825958|FG011|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
127781221|NCT03250832|459825947|FG000|Part 2A (Up to Approximately 30 Months)|Other|0|||
127781222|NCT03250832|459825948|FG001|Part 2A (Up to Approximately 30 Months)|Other|0|||
127781223|NCT03250832|459825949|FG002|Part 2A (Up to Approximately 30 Months)|Other|0|||
127781224|NCT03250832|459825950|FG003|Part 2A (Up to Approximately 30 Months)|Other|0|||
127781225|NCT03250832|459825951|FG004|Part 2A (Up to Approximately 30 Months)|Other|0|||
127781226|NCT03250832|459825952|FG005|Part 2A (Up to Approximately 30 Months)|Other|0|||
127572535|NCT02414139|459065975|FG000|Treatment Period|Adverse Event|11|||
127692335|NCT05384730|459500085|FG000|Overall Study|Adverse Event|1|||
127692336|NCT05384730|459500086|FG001|Overall Study|Adverse Event|0|||
127692337|NCT05384730|459500085|FG000|Overall Study|Lack of social support|2|||
127692338|NCT05384730|459500086|FG001|Overall Study|Lack of social support|0|||
127692339|NCT05384730|459500085|FG000|Overall Study|Hospital readmission|2|||
127692340|NCT05384730|459500086|FG001|Overall Study|Hospital readmission|0|||
127692341|NCT05384730|459500085|FG000|Overall Study|Disease progression|5|||
127692342|NCT05384730|459500086|FG001|Overall Study|Disease progression|0|||
127692343|NCT05384730|459500085|FG000|Overall Study|Overwhelmed with College commitments|0|||
127692344|NCT05384730|459500086|FG001|Overall Study|Overwhelmed with College commitments|2|||
127692345|NCT01772472|459500087|FG000|Overall Study|Death|126|||
127692346|NCT01772472|459500088|FG001|Overall Study|Death|94|||
127692347|NCT01772472|459500087|FG000|Overall Study|Lost to Follow-up|51|||
127692348|NCT01772472|459500088|FG001|Overall Study|Lost to Follow-up|50|||
127692349|NCT01772472|459500087|FG000|Overall Study|Other|9|||
127692350|NCT01772472|459500088|FG001|Overall Study|Other|7|||
127692351|NCT01772472|459500087|FG000|Overall Study|Physician Decision|1|||
127692352|NCT01772472|459500088|FG001|Overall Study|Physician Decision|7|||
127692353|NCT01772472|459500087|FG000|Overall Study|Withdrawal by Subject|115|||
127692354|NCT01772472|459500088|FG001|Overall Study|Withdrawal by Subject|90|||
127692355|NCT01772472|459500087|FG000|Overall Study|Follow-up Terminated by Sponsor|441|||
127692356|NCT01772472|459500088|FG001|Overall Study|Follow-up Terminated by Sponsor|495|||
127692357|NCT03578536|459500097|FG000|Overall Study|Lost to Follow-up|1|||
127692358|NCT04431726|459500098|FG000|Overall Study|Ongoing in the Study|55|||
127692359|NCT04116736|459500099|FG000|Overall Study|Withdrew consent during study|3|||
127692360|NCT04116736|459500100|FG001|Overall Study|Withdrew consent during study|1|||
127692361|NCT04116736|459500099|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
127781227|NCT03250832|459825953|FG006|Part 2A (Up to Approximately 30 Months)|Other|0|||
127781228|NCT03250832|459825954|FG007|Part 2A (Up to Approximately 30 Months)|Other|1|||
127572536|NCT02414139|459065976|FG001|Treatment Period|Adverse Event|6|||
127572537|NCT02414139|459065977|FG002|Treatment Period|Adverse Event|8|||
128029249|NCT02633527|460732138|FG002|Overall Study|Physician Decision|0|||
127572538|NCT02414139|459065978|FG003|Treatment Period|Adverse Event|5|||
127572539|NCT02414139|459065979|FG004|Treatment Period|Adverse Event|14|||
127572540|NCT02414139|459065980|FG005|Treatment Period|Adverse Event|3|||
127572541|NCT02414139|459065981|FG006|Treatment Period|Adverse Event|6|||
127572542|NCT02414139|459065982|FG007|Treatment Period|Adverse Event|1|||
127572543|NCT02414139|459065983|FG008|Treatment Period|Adverse Event|6|||
127572544|NCT02414139|459065984|FG009|Treatment Period|Adverse Event|8|||
127572545|NCT02414139|459065975|FG000|Treatment Period|Death|0|||
127572546|NCT02414139|459065976|FG001|Treatment Period|Death|0|||
127572547|NCT02414139|459065977|FG002|Treatment Period|Death|1|||
127572548|NCT02414139|459065978|FG003|Treatment Period|Death|1|||
127572549|NCT02414139|459065979|FG004|Treatment Period|Death|0|||
127572550|NCT02414139|459065980|FG005|Treatment Period|Death|0|||
127572551|NCT02414139|459065981|FG006|Treatment Period|Death|0|||
128029250|NCT02633527|460732139|FG003|Overall Study|Physician Decision|0|||
128029251|NCT02633527|460732140|FG004|Overall Study|Physician Decision|1|||
127572552|NCT02414139|459065982|FG007|Treatment Period|Death|0|||
127572553|NCT02414139|459065983|FG008|Treatment Period|Death|0|||
127572554|NCT02414139|459065984|FG009|Treatment Period|Death|1|||
127572555|NCT02414139|459065975|FG000|Treatment Period|Physician Decision|5|||
127572556|NCT02414139|459065976|FG001|Treatment Period|Physician Decision|4|||
127572557|NCT02414139|459065977|FG002|Treatment Period|Physician Decision|6|||
127572558|NCT02414139|459065978|FG003|Treatment Period|Physician Decision|1|||
127572559|NCT02414139|459065979|FG004|Treatment Period|Physician Decision|4|||
127572560|NCT02414139|459065980|FG005|Treatment Period|Physician Decision|0|||
127572561|NCT02414139|459065981|FG006|Treatment Period|Physician Decision|2|||
127572562|NCT02414139|459065982|FG007|Treatment Period|Physician Decision|0|||
127572563|NCT02414139|459065983|FG008|Treatment Period|Physician Decision|1|||
127572564|NCT02414139|459065984|FG009|Treatment Period|Physician Decision|4|||
127572565|NCT02414139|459065975|FG000|Treatment Period|Progressive disease|48|||
127572566|NCT02414139|459065976|FG001|Treatment Period|Progressive disease|31|||
127572567|NCT02414139|459065977|FG002|Treatment Period|Progressive disease|37|||
127572568|NCT02414139|459065978|FG003|Treatment Period|Progressive disease|21|||
127572569|NCT02414139|459065979|FG004|Treatment Period|Progressive disease|43|||
127572570|NCT02414139|459065980|FG005|Treatment Period|Progressive disease|12|||
127572571|NCT02414139|459065981|FG006|Treatment Period|Progressive disease|16|||
127572572|NCT02414139|459065982|FG007|Treatment Period|Progressive disease|2|||
127572573|NCT02414139|459065983|FG008|Treatment Period|Progressive disease|20|||
127572574|NCT02414139|459065984|FG009|Treatment Period|Progressive disease|14|||
127572575|NCT02414139|459065975|FG000|Treatment Period|Protocol deviation|0|||
127572576|NCT02414139|459065976|FG001|Treatment Period|Protocol deviation|0|||
127572577|NCT02414139|459065977|FG002|Treatment Period|Protocol deviation|1|||
127692362|NCT04116736|459500100|FG001|Overall Study|Subject no longer meets eligibility criteria|4|||
127692363|NCT04116736|459500099|FG000|Overall Study|Subject withdrawn due to non-compliance to protocol|11|||
127692364|NCT04116736|459500100|FG001|Overall Study|Subject withdrawn due to non-compliance to protocol|7|||
127692365|NCT04116736|459500099|FG000|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|1|||
127692366|NCT04116736|459500100|FG001|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|0|||
127692367|NCT04116736|459500099|FG000|Overall Study|Subject was enrolled in error|2|||
127692368|NCT04116736|459500100|FG001|Overall Study|Subject was enrolled in error|0|||
127692369|NCT04116736|459500099|FG000|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|1|||
127692370|NCT04116736|459500100|FG001|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|0|||
127692371|NCT04116736|459500099|FG000|Overall Study|Subject did not like the lenses graduation change|1|||
127692372|NCT04116736|459500100|FG001|Overall Study|Subject did not like the lenses graduation change|0|||
127692373|NCT04116736|459500099|FG000|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|1|||
127692374|NCT04116736|459500100|FG001|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|0|||
127692375|NCT04093752|459500104|FG000|Overall Study|Adverse Event|7|||
127692376|NCT04093752|459500105|FG001|Overall Study|Adverse Event|19|||
127692377|NCT04093752|459500106|FG002|Overall Study|Adverse Event|18|||
127692378|NCT04093752|459500107|FG003|Overall Study|Adverse Event|4|||
127692379|NCT04093752|459500104|FG000|Overall Study|Withdrawal by Subject|6|||
127692380|NCT04093752|459500105|FG001|Overall Study|Withdrawal by Subject|6|||
127692381|NCT04093752|459500106|FG002|Overall Study|Withdrawal by Subject|8|||
127692382|NCT04093752|459500107|FG003|Overall Study|Withdrawal by Subject|20|||
127692383|NCT04093752|459500104|FG000|Overall Study|Lost to Follow-up|2|||
127692384|NCT04093752|459500105|FG001|Overall Study|Lost to Follow-up|1|||
127692385|NCT04093752|459500106|FG002|Overall Study|Lost to Follow-up|1|||
127692386|NCT04093752|459500107|FG003|Overall Study|Lost to Follow-up|1|||
127692387|NCT04093752|459500104|FG000|Overall Study|Death|0|||
128029252|NCT02633527|460732136|FG000|Overall Study|Administrative reason|1|||
127572578|NCT02414139|459065978|FG003|Treatment Period|Protocol deviation|0|||
127572579|NCT02414139|459065979|FG004|Treatment Period|Protocol deviation|0|||
127572580|NCT02414139|459065980|FG005|Treatment Period|Protocol deviation|0|||
127572581|NCT02414139|459065981|FG006|Treatment Period|Protocol deviation|0|||
127572582|NCT02414139|459065982|FG007|Treatment Period|Protocol deviation|0|||
127572583|NCT02414139|459065983|FG008|Treatment Period|Protocol deviation|0|||
127572584|NCT02414139|459065984|FG009|Treatment Period|Protocol deviation|0|||
128029253|NCT02633527|460732137|FG001|Overall Study|Administrative reason|0|||
127572585|NCT02414139|459065975|FG000|Treatment Period|Subject/Guardian decision|5|||
127572586|NCT02414139|459065976|FG001|Treatment Period|Subject/Guardian decision|1|||
127572587|NCT02414139|459065977|FG002|Treatment Period|Subject/Guardian decision|1|||
127572588|NCT02414139|459065978|FG003|Treatment Period|Subject/Guardian decision|2|||
127572589|NCT02414139|459065979|FG004|Treatment Period|Subject/Guardian decision|5|||
127572590|NCT02414139|459065980|FG005|Treatment Period|Subject/Guardian decision|0|||
127572591|NCT02414139|459065981|FG006|Treatment Period|Subject/Guardian decision|2|||
127572592|NCT02414139|459065982|FG007|Treatment Period|Subject/Guardian decision|0|||
127572593|NCT02414139|459065983|FG008|Treatment Period|Subject/Guardian decision|1|||
127572594|NCT02414139|459065984|FG009|Treatment Period|Subject/Guardian decision|1|||
127572595|NCT02414139|459065975|FG000|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
127572596|NCT02414139|459065976|FG001|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
127572597|NCT02414139|459065977|FG002|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
127572598|NCT02414139|459065978|FG003|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
127572599|NCT02414139|459065979|FG004|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
127572600|NCT02414139|459065980|FG005|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
127572601|NCT02414139|459065981|FG006|Treatment Period|Study terminated (as per protocol) by Sponsor|2|||
127572602|NCT02414139|459065982|FG007|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
127572603|NCT02414139|459065983|FG008|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
127572604|NCT02414139|459065984|FG009|Treatment Period|Study terminated (as per protocol) by Sponsor|4|||
127572605|NCT02414139|459065975|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
127572606|NCT02414139|459065976|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
127572607|NCT02414139|459065977|FG002|Post-treatment Efficacy Follow-up|Adverse Event|0|||
127572608|NCT02414139|459065978|FG003|Post-treatment Efficacy Follow-up|Adverse Event|0|||
127572609|NCT02414139|459065979|FG004|Post-treatment Efficacy Follow-up|Adverse Event|2|||
127572610|NCT02414139|459065980|FG005|Post-treatment Efficacy Follow-up|Adverse Event|0|||
127572611|NCT02414139|459065981|FG006|Post-treatment Efficacy Follow-up|Adverse Event|0|||
127572612|NCT02414139|459065982|FG007|Post-treatment Efficacy Follow-up|Adverse Event|0|||
127572613|NCT02414139|459065983|FG008|Post-treatment Efficacy Follow-up|Adverse Event|0|||
127572614|NCT02414139|459065984|FG009|Post-treatment Efficacy Follow-up|Adverse Event|0|||
127572615|NCT02414139|459065975|FG000|Post-treatment Efficacy Follow-up|Death|0|||
127572616|NCT02414139|459065976|FG001|Post-treatment Efficacy Follow-up|Death|1|||
127572617|NCT02414139|459065977|FG002|Post-treatment Efficacy Follow-up|Death|0|||
127572618|NCT02414139|459065978|FG003|Post-treatment Efficacy Follow-up|Death|0|||
127572619|NCT02414139|459065979|FG004|Post-treatment Efficacy Follow-up|Death|1|||
127572620|NCT02414139|459065980|FG005|Post-treatment Efficacy Follow-up|Death|0|||
128029254|NCT02633527|460732138|FG002|Overall Study|Administrative reason|0|||
128029255|NCT02633527|460732139|FG003|Overall Study|Administrative reason|1|||
127692388|NCT04093752|459500105|FG001|Overall Study|Death|0|||
127692389|NCT04093752|459500106|FG002|Overall Study|Death|1|||
127692390|NCT04093752|459500107|FG003|Overall Study|Death|2|||
127692391|NCT04093752|459500104|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
127692392|NCT04093752|459500105|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
127692393|NCT04093752|459500106|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
127692394|NCT04093752|459500107|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
127692395|NCT04093752|459500104|FG000|Overall Study|Covid 19|0|||
127692396|NCT04093752|459500105|FG001|Overall Study|Covid 19|0|||
127692397|NCT04093752|459500106|FG002|Overall Study|Covid 19|0|||
127692398|NCT04093752|459500107|FG003|Overall Study|Covid 19|1|||
127692399|NCT04093752|459500104|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
127692400|NCT04093752|459500105|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
127692401|NCT04093752|459500106|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
127692402|NCT04093752|459500107|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
127692403|NCT04093752|459500104|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
127692404|NCT04093752|459500105|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
127692405|NCT04093752|459500106|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
127692406|NCT04093752|459500107|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
127692407|NCT04093752|459500104|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
127692408|NCT04093752|459500105|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
127692409|NCT04093752|459500106|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
127692410|NCT04093752|459500107|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
127692411|NCT01101451|459500108|FG000|Overall Study|Eligible and never treated|0|||
127781229|NCT03250832|459825955|FG008|Part 2A (Up to Approximately 30 Months)|Other|0|||
127781230|NCT03250832|459825956|FG009|Part 2A (Up to Approximately 30 Months)|Other|0|||
128029256|NCT02633527|460732140|FG004|Overall Study|Administrative reason|0|||
127572621|NCT02414139|459065981|FG006|Post-treatment Efficacy Follow-up|Death|0|||
127572622|NCT02414139|459065982|FG007|Post-treatment Efficacy Follow-up|Death|0|||
127572623|NCT02414139|459065983|FG008|Post-treatment Efficacy Follow-up|Death|0|||
127572624|NCT02414139|459065984|FG009|Post-treatment Efficacy Follow-up|Death|1|||
127572625|NCT02414139|459065975|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
127572626|NCT02414139|459065976|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
127781231|NCT03250832|459825957|FG010|Part 2A (Up to Approximately 30 Months)|Other|0|||
127781232|NCT03250832|459825958|FG011|Part 2A (Up to Approximately 30 Months)|Other|0|||
127781233|NCT03250832|459825947|FG000|Part 2B (Up to Approximately 29 Months)|Death|0|||
127781234|NCT03250832|459825948|FG001|Part 2B (Up to Approximately 29 Months)|Death|0|||
127781235|NCT03250832|459825949|FG002|Part 2B (Up to Approximately 29 Months)|Death|0|||
127781236|NCT03250832|459825950|FG003|Part 2B (Up to Approximately 29 Months)|Death|0|||
127781237|NCT03250832|459825951|FG004|Part 2B (Up to Approximately 29 Months)|Death|0|||
127781238|NCT03250832|459825952|FG005|Part 2B (Up to Approximately 29 Months)|Death|0|||
127572627|NCT02414139|459065977|FG002|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
127572628|NCT02414139|459065978|FG003|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
127572629|NCT02414139|459065979|FG004|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
127572630|NCT02414139|459065980|FG005|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
127572631|NCT02414139|459065981|FG006|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
127572632|NCT02414139|459065982|FG007|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
127572633|NCT02414139|459065983|FG008|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
127572634|NCT02414139|459065984|FG009|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
127572635|NCT02414139|459065975|FG000|Post-treatment Efficacy Follow-up|Physician Decision|4|||
127572636|NCT02414139|459065976|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
127572637|NCT02414139|459065977|FG002|Post-treatment Efficacy Follow-up|Physician Decision|4|||
127572638|NCT02414139|459065978|FG003|Post-treatment Efficacy Follow-up|Physician Decision|2|||
127692412|NCT01101451|459500109|FG001|Overall Study|Eligible and never treated|5|||
127692413|NCT01101451|459500108|FG000|Overall Study|Ineligible and treated|12|||
127692414|NCT01101451|459500109|FG001|Overall Study|Ineligible and treated|8|||
127692415|NCT01101451|459500108|FG000|Overall Study|Ineligible and never treated|2|||
127692416|NCT01101451|459500109|FG001|Overall Study|Ineligible and never treated|2|||
127572639|NCT02414139|459065979|FG004|Post-treatment Efficacy Follow-up|Physician Decision|4|||
127572640|NCT02414139|459065980|FG005|Post-treatment Efficacy Follow-up|Physician Decision|0|||
127692417|NCT04157348|459500110|FG000|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
127692418|NCT04157348|459500111|FG001|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
127692419|NCT04157348|459500110|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
127692420|NCT04157348|459500111|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
127692421|NCT04157348|459500110|FG000|Double-blind Treatment Period|Adverse Event|0|||
127692422|NCT04157348|459500111|FG001|Double-blind Treatment Period|Adverse Event|1|||
127692423|NCT04157348|459500110|FG000|Open-label Extension Period|Adverse Event|1|||
127692424|NCT04157348|459500111|FG001|Open-label Extension Period|Adverse Event|1|||
127692425|NCT04157348|459500110|FG000|Open-label Extension Period|Death|0|||
127692426|NCT04157348|459500111|FG001|Open-label Extension Period|Death|1|||
127692427|NCT04157348|459500110|FG000|Open-label Extension Period|Lack of Efficacy|2|||
127692428|NCT04157348|459500111|FG001|Open-label Extension Period|Lack of Efficacy|2|||
127692429|NCT04157348|459500110|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
127692430|NCT04157348|459500111|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
127692431|NCT04157348|459500110|FG000|Open-label Extension Period|Ongoing|60|||
127692432|NCT04157348|459500111|FG001|Open-label Extension Period|Ongoing|57|||
127692433|NCT04157348|459500110|FG000|Open-label Extension Period|other reasons|1|||
127692434|NCT04157348|459500111|FG001|Open-label Extension Period|other reasons|1|||
127692435|NCT04854096|459500112|FG000|Overall Study|Adverse Event|1|||
127692436|NCT04854096|459500113|FG001|Overall Study|Adverse Event|0|||
127692437|NCT04854096|459500112|FG000|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
127692438|NCT04854096|459500113|FG001|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
127692439|NCT04854096|459500112|FG000|Overall Study|Withdrawal by Subject|1|||
127692440|NCT04854096|459500113|FG001|Overall Study|Withdrawal by Subject|0|||
127692441|NCT04854096|459500112|FG000|Overall Study|Other reasons|1|||
127692442|NCT04854096|459500113|FG001|Overall Study|Other reasons|0|||
127692443|NCT04757610|459500114|FG000|Overall Study|Adverse Event|13|||
127692444|NCT04757610|459500115|FG001|Overall Study|Adverse Event|10|||
127692445|NCT04757610|459500116|FG002|Overall Study|Adverse Event|5|||
127692446|NCT04757610|459500114|FG000|Overall Study|Death|5|||
127692447|NCT04757610|459500115|FG001|Overall Study|Death|13|||
127692448|NCT04757610|459500116|FG002|Overall Study|Death|8|||
127692449|NCT04757610|459500114|FG000|Overall Study|Lack of Efficacy|1|||
127692450|NCT04757610|459500115|FG001|Overall Study|Lack of Efficacy|2|||
127572641|NCT02414139|459065981|FG006|Post-treatment Efficacy Follow-up|Physician Decision|1|||
127692451|NCT04757610|459500116|FG002|Overall Study|Lack of Efficacy|3|||
127692452|NCT04757610|459500114|FG000|Overall Study|Lost to Follow-up|7|||
127692453|NCT04757610|459500115|FG001|Overall Study|Lost to Follow-up|2|||
127781239|NCT03250832|459825953|FG006|Part 2B (Up to Approximately 29 Months)|Death|0|||
127781240|NCT03250832|459825954|FG007|Part 2B (Up to Approximately 29 Months)|Death|0|||
127781241|NCT03250832|459825955|FG008|Part 2B (Up to Approximately 29 Months)|Death|1|||
127781242|NCT03250832|459825956|FG009|Part 2B (Up to Approximately 29 Months)|Death|7|||
127781243|NCT03250832|459825957|FG010|Part 2B (Up to Approximately 29 Months)|Death|0|||
127781244|NCT03250832|459825958|FG011|Part 2B (Up to Approximately 29 Months)|Death|0|||
127781245|NCT03250832|459825947|FG000|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
127781246|NCT03250832|459825948|FG001|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
127781247|NCT03250832|459825949|FG002|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
127781248|NCT03250832|459825950|FG003|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
127781249|NCT03250832|459825951|FG004|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
127781250|NCT03250832|459825952|FG005|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
127781251|NCT03250832|459825953|FG006|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
127781252|NCT03250832|459825954|FG007|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
127781253|NCT03250832|459825955|FG008|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|2|||
127781254|NCT03250832|459825956|FG009|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|7|||
127781255|NCT03250832|459825957|FG010|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
127781256|NCT03250832|459825958|FG011|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
127781257|NCT03250832|459825947|FG000|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
127781258|NCT03250832|459825948|FG001|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
127781259|NCT03250832|459825949|FG002|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
127781260|NCT03250832|459825950|FG003|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
127781261|NCT03250832|459825951|FG004|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
127781262|NCT03250832|459825952|FG005|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
127781263|NCT03250832|459825953|FG006|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
127781264|NCT03250832|459825954|FG007|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
127781265|NCT03250832|459825955|FG008|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|1|||
127781266|NCT03250832|459825956|FG009|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|6|||
127781267|NCT03250832|459825957|FG010|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
127781268|NCT03250832|459825958|FG011|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
127781269|NCT03250832|459825947|FG000|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
127781270|NCT03250832|459825948|FG001|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
127781271|NCT03250832|459825949|FG002|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
127781272|NCT03250832|459825950|FG003|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
127781273|NCT03250832|459825951|FG004|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
127781274|NCT03250832|459825952|FG005|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
127781275|NCT03250832|459825953|FG006|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
127781276|NCT03250832|459825954|FG007|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
127781277|NCT03250832|459825955|FG008|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
127781278|NCT03250832|459825956|FG009|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
127781279|NCT03250832|459825957|FG010|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
127781280|NCT03250832|459825958|FG011|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|1|||
127781281|NCT02303704|459825959|FG000|Overall Study|Protocol Violation|5|||
127781282|NCT02303704|459825960|FG001|Overall Study|Protocol Violation|9|||
127781283|NCT01984164|459825962|FG000|Overall Study|Withdrawal by Subject|4|||
127781284|NCT01984164|459825963|FG001|Overall Study|Withdrawal by Subject|3|||
127781285|NCT01984164|459825962|FG000|Overall Study|Adverse Event|5|||
127781286|NCT01984164|459825963|FG001|Overall Study|Adverse Event|19|||
127781287|NCT01984164|459825962|FG000|Overall Study|Lost to Follow-up|1|||
127781288|NCT01984164|459825963|FG001|Overall Study|Lost to Follow-up|3|||
127781289|NCT05293743|459825964|FG000|Overall Study|Withdrawal by Subject|1|||
127781290|NCT05293743|459825965|FG001|Overall Study|Withdrawal by Subject|0|||
127781291|NCT00667823|459825966|FG000|Overall Study|Lost to Follow-up|5|||
127781292|NCT00667823|459825966|FG000|Overall Study|Adverse Event|7|||
127781293|NCT00667823|459825966|FG000|Overall Study|Death|182|||
127781294|NCT00667823|459825966|FG000|Overall Study|Withdrawal by Subject|12|||
127781295|NCT00667823|459825966|FG000|Overall Study|Other|8|||
127781296|NCT00667823|459825966|FG000|Overall Study|Missing (completion page missing)|2|||
127781297|NCT00583024|459825967|FG000|Overall Study|Lost to Follow-up|4|||
127781298|NCT04376827|459825973|FG000|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
127781299|NCT04376827|459825974|FG001|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
127781300|NCT04376827|459825973|FG000|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|6|||
127781301|NCT04376827|459825974|FG001|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|8|||
127781302|NCT04376827|459825973|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|1|||
127781303|NCT04376827|459825974|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|0|||
127781304|NCT04376827|459825973|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|0|||
127781305|NCT04376827|459825974|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|1|||
127572642|NCT02414139|459065982|FG007|Post-treatment Efficacy Follow-up|Physician Decision|0|||
127572643|NCT02414139|459065983|FG008|Post-treatment Efficacy Follow-up|Physician Decision|0|||
127572644|NCT02414139|459065984|FG009|Post-treatment Efficacy Follow-up|Physician Decision|1|||
127572645|NCT02414139|459065975|FG000|Post-treatment Efficacy Follow-up|Progressive disease|6|||
127572646|NCT02414139|459065976|FG001|Post-treatment Efficacy Follow-up|Progressive disease|5|||
127692454|NCT04757610|459500116|FG002|Overall Study|Lost to Follow-up|7|||
127692455|NCT04757610|459500114|FG000|Overall Study|Physician Decision|4|||
127692456|NCT04757610|459500115|FG001|Overall Study|Physician Decision|1|||
127692457|NCT04757610|459500116|FG002|Overall Study|Physician Decision|2|||
127692458|NCT04757610|459500114|FG000|Overall Study|Withdrawal by Subject|26|||
127692459|NCT04757610|459500115|FG001|Overall Study|Withdrawal by Subject|25|||
127692460|NCT04757610|459500116|FG002|Overall Study|Withdrawal by Subject|25|||
127692461|NCT04757610|459500114|FG000|Overall Study|Study Terminated by Sponsor|105|||
127692462|NCT04757610|459500115|FG001|Overall Study|Study Terminated by Sponsor|105|||
127692463|NCT04757610|459500116|FG002|Overall Study|Study Terminated by Sponsor|110|||
127692464|NCT04757610|459500114|FG000|Overall Study|Randomized in Error|1|||
127692465|NCT04757610|459500115|FG001|Overall Study|Randomized in Error|0|||
127692466|NCT04757610|459500116|FG002|Overall Study|Randomized in Error|0|||
127692467|NCT02965846|459500117|FG000|Overall Study|Lost to Follow-up|1|||
127692468|NCT02965846|459500118|FG001|Overall Study|Lost to Follow-up|0|||
127692469|NCT02965846|459500119|FG002|Overall Study|Lost to Follow-up|0|||
127692470|NCT02965846|459500117|FG000|Overall Study|Withdrawal by Subject|0|||
127692471|NCT02965846|459500118|FG001|Overall Study|Withdrawal by Subject|1|||
127692472|NCT02965846|459500119|FG002|Overall Study|Withdrawal by Subject|0|||
127692473|NCT02965846|459500117|FG000|Overall Study|Study Terminated By Sponsor|4|||
127692474|NCT02965846|459500118|FG001|Overall Study|Study Terminated By Sponsor|4|||
127692475|NCT02965846|459500119|FG002|Overall Study|Study Terminated By Sponsor|0|||
127692476|NCT02965846|459500117|FG000|Overall Study|Participants not randomized|0|||
127692477|NCT02965846|459500118|FG001|Overall Study|Participants not randomized|0|||
127692478|NCT02965846|459500119|FG002|Overall Study|Participants not randomized|33|||
127692479|NCT00879333|459500120|FG000|Overall Study|Adverse Event|94|||
127692480|NCT00879333|459500121|FG001|Overall Study|Adverse Event|34|||
127692481|NCT00879333|459500120|FG000|Overall Study|Abnormal Laboratory Value|1|||
127692482|NCT00879333|459500121|FG001|Overall Study|Abnormal Laboratory Value|0|||
127692483|NCT00879333|459500120|FG000|Overall Study|Withdrawal by Subject|20|||
127692484|NCT00879333|459500121|FG001|Overall Study|Withdrawal by Subject|7|||
127692485|NCT00879333|459500120|FG000|Overall Study|Lost to Follow-up|2|||
127692486|NCT00879333|459500121|FG001|Overall Study|Lost to Follow-up|1|||
127692487|NCT00879333|459500120|FG000|Overall Study|Administrative Problems|2|||
127692488|NCT00879333|459500121|FG001|Overall Study|Administrative Problems|0|||
127692489|NCT00879333|459500120|FG000|Overall Study|Death|16|||
127692490|NCT00879333|459500121|FG001|Overall Study|Death|5|||
127692491|NCT00879333|459500120|FG000|Overall Study|Disease Progression|292|||
127692492|NCT00879333|459500121|FG001|Overall Study|Disease Progression|169|||
127692493|NCT00879333|459500120|FG000|Overall Study|Protocol Violation|1|||
127692494|NCT00879333|459500121|FG001|Overall Study|Protocol Violation|1|||
128029257|NCT02633527|460732136|FG000|Overall Study|Multiple reasons|1|||
127572647|NCT02414139|459065977|FG002|Post-treatment Efficacy Follow-up|Progressive disease|9|||
127692495|NCT04154384|459500122|FG000|Overall Study|Lost to Follow-up|24|||
127692496|NCT04154384|459500123|FG001|Overall Study|Lost to Follow-up|33|||
127692497|NCT04154384|459500124|FG002|Overall Study|Lost to Follow-up|0|||
127692498|NCT04154384|459500122|FG000|Overall Study|Withdrawal by Subject|7|||
127692499|NCT04154384|459500123|FG001|Overall Study|Withdrawal by Subject|18|||
127692500|NCT04154384|459500124|FG002|Overall Study|Withdrawal by Subject|0|||
127692501|NCT04154384|459500122|FG000|Overall Study|Missing outcome data|1|||
127692502|NCT04154384|459500123|FG001|Overall Study|Missing outcome data|0|||
127692503|NCT04154384|459500124|FG002|Overall Study|Missing outcome data|0|||
127692504|NCT05048186|459500125|FG000|Overall Study|inconsistent answers for main decision for adhd treatment|9|||
127692505|NCT05048186|459500126|FG001|Overall Study|inconsistent answers for main decision for adhd treatment|0|||
127692506|NCT05048186|459500125|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|1|||
127692507|NCT05048186|459500126|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|4|||
127692508|NCT00951379|459500127|FG000|Overall Study|Adverse Event|4|||
127692509|NCT00951379|459500128|FG001|Overall Study|Adverse Event|1|||
127692510|NCT00951379|459500127|FG000|Overall Study|Withdrawal by Subject|1|||
127692511|NCT00951379|459500128|FG001|Overall Study|Withdrawal by Subject|0|||
127692512|NCT00951379|459500127|FG000|Overall Study|Noncompliance|1|||
127692513|NCT00951379|459500128|FG001|Overall Study|Noncompliance|0|||
127692514|NCT00951379|459500127|FG000|Overall Study|Disease Progression|0|||
127692515|NCT00951379|459500128|FG001|Overall Study|Disease Progression|1|||
127692516|NCT04218266|459500130|FG000|Overall Study|Death|1|||
127692517|NCT04218266|459500131|FG001|Overall Study|Death|2|||
127692518|NCT04218266|459500132|FG002|Overall Study|Death|3|||
127692519|NCT04218266|459500130|FG000|Overall Study|Adverse Event|13|||
127692520|NCT04218266|459500131|FG001|Overall Study|Adverse Event|14|||
127692521|NCT04218266|459500132|FG002|Overall Study|Adverse Event|11|||
127692522|NCT04218266|459500130|FG000|Overall Study|Other|7|||
127781306|NCT04376827|459825973|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|3|||
127781307|NCT04376827|459825974|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|0|||
127781308|NCT03335163|459827748|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
127781309|NCT03335163|459827748|FG000|Overall Study|Withdrawal by Subject|18|||
127781310|NCT02553265|459827750|FG000|Enrollment|Death|0|||
127781311|NCT02553265|459827751|FG001|Enrollment|Death|0|||
127781312|NCT02553265|459827752|FG002|Enrollment|Death|1|||
127781313|NCT02553265|459827750|FG000|First Intervention (28 Days)|Adverse Event|1|||
127781314|NCT02553265|459827751|FG001|First Intervention (28 Days)|Adverse Event|0|||
127781315|NCT02553265|459827752|FG002|First Intervention (28 Days)|Adverse Event|0|||
127781316|NCT02553265|459827750|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
127781317|NCT02553265|459827751|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
127781318|NCT02553265|459827752|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
127781319|NCT02553265|459827750|FG000|Second Intervention (28 Days)|Adverse Event|1|||
127781320|NCT02553265|459827751|FG001|Second Intervention (28 Days)|Adverse Event|0|||
127781321|NCT02553265|459827752|FG002|Second Intervention (28 Days)|Adverse Event|0|||
127781322|NCT02553265|459827750|FG000|Third Intervention (28 Days)|Adverse Event|1|||
127781323|NCT02553265|459827751|FG001|Third Intervention (28 Days)|Adverse Event|0|||
127781324|NCT02553265|459827752|FG002|Third Intervention (28 Days)|Adverse Event|0|||
127781325|NCT02553265|459827750|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
127781326|NCT02553265|459827751|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
127781327|NCT02553265|459827752|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
127781328|NCT04042740|459827755|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Lost to Follow-up|2|||
127781329|NCT04042740|459827755|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Withdrawal by Subject|1|||
127781330|NCT00880555|459827762|FG000|Overall Study|Physician Decision|0|||
127781331|NCT00880555|459827763|FG001|Overall Study|Physician Decision|8|||
127781332|NCT00880555|459827764|FG002|Overall Study|Physician Decision|0|||
127781333|NCT00880555|459827765|FG003|Overall Study|Physician Decision|2|||
127781334|NCT00880555|459827766|FG004|Overall Study|Physician Decision|1|||
127781335|NCT00880555|459827767|FG005|Overall Study|Physician Decision|0|||
127781336|NCT00880555|459827762|FG000|Overall Study|Withdrawal by Subject|1|||
127781337|NCT00880555|459827763|FG001|Overall Study|Withdrawal by Subject|1|||
127781338|NCT00880555|459827764|FG002|Overall Study|Withdrawal by Subject|0|||
127781339|NCT00880555|459827765|FG003|Overall Study|Withdrawal by Subject|0|||
127781340|NCT00880555|459827766|FG004|Overall Study|Withdrawal by Subject|0|||
127781341|NCT00880555|459827767|FG005|Overall Study|Withdrawal by Subject|0|||
127781342|NCT00880555|459827762|FG000|Overall Study|Lack of resources (hired rater)|9|||
127781343|NCT00880555|459827763|FG001|Overall Study|Lack of resources (hired rater)|7|||
127781344|NCT00880555|459827764|FG002|Overall Study|Lack of resources (hired rater)|5|||
127781345|NCT00880555|459827765|FG003|Overall Study|Lack of resources (hired rater)|0|||
127781346|NCT00880555|459827766|FG004|Overall Study|Lack of resources (hired rater)|0|||
127781347|NCT00880555|459827767|FG005|Overall Study|Lack of resources (hired rater)|0|||
127781348|NCT00880555|459827762|FG000|Overall Study|Death|0|||
127781349|NCT00880555|459827763|FG001|Overall Study|Death|0|||
127781350|NCT00880555|459827764|FG002|Overall Study|Death|0|||
127781351|NCT00880555|459827765|FG003|Overall Study|Death|0|||
127781352|NCT00880555|459827766|FG004|Overall Study|Death|0|||
127781353|NCT00880555|459827767|FG005|Overall Study|Death|1|||
127781354|NCT00880555|459827762|FG000|Overall Study|Lost to Follow-up|0|||
127781355|NCT00880555|459827763|FG001|Overall Study|Lost to Follow-up|1|||
127781356|NCT00880555|459827764|FG002|Overall Study|Lost to Follow-up|0|||
127781357|NCT00880555|459827765|FG003|Overall Study|Lost to Follow-up|0|||
127781358|NCT00880555|459827766|FG004|Overall Study|Lost to Follow-up|0|||
127781359|NCT00880555|459827767|FG005|Overall Study|Lost to Follow-up|0|||
127781360|NCT02982590|459827769|FG000|Overall Study|Lost to Follow-up|0|||
127781361|NCT02982590|459827770|FG001|Overall Study|Lost to Follow-up|1|||
127781362|NCT02982590|459827769|FG000|Overall Study|Death|4|||
127781363|NCT02982590|459827770|FG001|Overall Study|Death|0|||
127781364|NCT02285920|459827777|FG000|Overall Study|Kidney transplantation|2|||
127781365|NCT02285920|459827778|FG001|Overall Study|Kidney transplantation|2|||
127781366|NCT02285920|459827779|FG002|Overall Study|Kidney transplantation|2|||
127781367|NCT02285920|459827780|FG003|Overall Study|Kidney transplantation|0|||
127781368|NCT02285920|459827777|FG000|Overall Study|Change to peritoneal dialysis|0|||
127781369|NCT02285920|459827778|FG001|Overall Study|Change to peritoneal dialysis|0|||
127781370|NCT02285920|459827779|FG002|Overall Study|Change to peritoneal dialysis|1|||
127781371|NCT02285920|459827780|FG003|Overall Study|Change to peritoneal dialysis|0|||
127781372|NCT02285920|459827777|FG000|Overall Study|Transfer to non-participating unit|0|||
127781373|NCT02285920|459827778|FG001|Overall Study|Transfer to non-participating unit|1|||
127781374|NCT02285920|459827779|FG002|Overall Study|Transfer to non-participating unit|0|||
127781375|NCT02285920|459827780|FG003|Overall Study|Transfer to non-participating unit|0|||
127781376|NCT02285920|459827777|FG000|Overall Study|Dialysis discontinuation|0|||
127781377|NCT02285920|459827778|FG001|Overall Study|Dialysis discontinuation|1|||
127781378|NCT02285920|459827779|FG002|Overall Study|Dialysis discontinuation|0|||
127781379|NCT02285920|459827780|FG003|Overall Study|Dialysis discontinuation|0|||
127781380|NCT02285920|459827777|FG000|Overall Study|Death|2|||
127781381|NCT02285920|459827778|FG001|Overall Study|Death|0|||
127781382|NCT02285920|459827779|FG002|Overall Study|Death|2|||
127781383|NCT02285920|459827780|FG003|Overall Study|Death|1|||
127781384|NCT01480284|459827781|FG000|Overall Study|Withdrawal by Subject|2|||
127781385|NCT01480284|459827782|FG001|Overall Study|Withdrawal by Subject|0|||
127781386|NCT01480284|459827781|FG000|Overall Study|Adverse Event|1|||
127781387|NCT01480284|459827782|FG001|Overall Study|Adverse Event|0|||
127781388|NCT01480284|459827781|FG000|Overall Study|Study closed/terminated|3|||
127781389|NCT01480284|459827782|FG001|Overall Study|Study closed/terminated|0|||
127781390|NCT01480284|459827781|FG000|Overall Study|Lost to Follow-up|1|||
127781391|NCT01480284|459827782|FG001|Overall Study|Lost to Follow-up|0|||
127781392|NCT01480284|459827781|FG000|Overall Study|Physician Decision|1|||
127781393|NCT01480284|459827782|FG001|Overall Study|Physician Decision|0|||
127781394|NCT00709111|459827783|FG000|Overall Study|Withdrawal by Subject|1|||
127781395|NCT00709111|459827783|FG000|Overall Study|Unable to attend clinic visits|1|||
127781396|NCT02716675|459827784|FG000|Overall Study|Death|2|||
127781397|NCT02716675|459827785|FG001|Overall Study|Death|3|||
127781398|NCT02716675|459827786|FG002|Overall Study|Death|0|||
127781399|NCT02716675|459827784|FG000|Overall Study|Physician Decision|2|||
127781400|NCT02716675|459827785|FG001|Overall Study|Physician Decision|1|||
127781401|NCT02716675|459827786|FG002|Overall Study|Physician Decision|1|||
127781402|NCT02716675|459827784|FG000|Overall Study|Lost to Follow-up|100|||
127781403|NCT02716675|459827785|FG001|Overall Study|Lost to Follow-up|87|||
127781404|NCT02716675|459827786|FG002|Overall Study|Lost to Follow-up|99|||
127781405|NCT02716675|459827784|FG000|Overall Study|Withdrawal by Subject|22|||
127781406|NCT02716675|459827785|FG001|Overall Study|Withdrawal by Subject|25|||
127781407|NCT02716675|459827786|FG002|Overall Study|Withdrawal by Subject|20|||
127781408|NCT02716675|459827784|FG000|Overall Study|Protocol Violation|0|||
127781409|NCT02716675|459827785|FG001|Overall Study|Protocol Violation|3|||
127781410|NCT02716675|459827786|FG002|Overall Study|Protocol Violation|1|||
127781411|NCT02716675|459827784|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
127781412|NCT02716675|459827785|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
127781413|NCT02716675|459827786|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
127781414|NCT02716675|459827784|FG000|Overall Study|Other|38|||
127781415|NCT02716675|459827785|FG001|Overall Study|Other|47|||
127781416|NCT02716675|459827786|FG002|Overall Study|Other|48|||
127781417|NCT00915772|459827787|FG000|Overall Study|Adverse Event|12|||
127781418|NCT00915772|459827788|FG001|Overall Study|Adverse Event|13|||
127781419|NCT00915772|459827789|FG002|Overall Study|Adverse Event|11|||
127781420|NCT00915772|459827787|FG000|Overall Study|Protocol Violation|4|||
127781421|NCT00915772|459827788|FG001|Overall Study|Protocol Violation|1|||
127781422|NCT00915772|459827789|FG002|Overall Study|Protocol Violation|2|||
127781423|NCT00915772|459827787|FG000|Overall Study|Lost to Follow-up|1|||
127781424|NCT00915772|459827788|FG001|Overall Study|Lost to Follow-up|2|||
127781425|NCT00915772|459827789|FG002|Overall Study|Lost to Follow-up|2|||
127781426|NCT00915772|459827787|FG000|Overall Study|Lack of Efficacy|9|||
127781427|NCT00915772|459827788|FG001|Overall Study|Lack of Efficacy|15|||
127781428|NCT00915772|459827789|FG002|Overall Study|Lack of Efficacy|3|||
127781429|NCT00915772|459827787|FG000|Overall Study|Refused to continue trial medication|6|||
127781430|NCT00915772|459827788|FG001|Overall Study|Refused to continue trial medication|8|||
127781431|NCT00915772|459827789|FG002|Overall Study|Refused to continue trial medication|4|||
127781432|NCT00915772|459827787|FG000|Overall Study|Any other reason|4|||
127781433|NCT00915772|459827788|FG001|Overall Study|Any other reason|7|||
127781434|NCT00915772|459827789|FG002|Overall Study|Any other reason|7|||
127781435|NCT01383096|459827790|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
127781436|NCT01383096|459827791|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
127781437|NCT01383096|459827792|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
127781438|NCT01383096|459827790|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
127781439|NCT01383096|459827791|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
127781440|NCT01383096|459827792|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
128029258|NCT02633527|460732137|FG001|Overall Study|Multiple reasons|0|||
128029259|NCT02633527|460732138|FG002|Overall Study|Multiple reasons|2|||
128029260|NCT02633527|460732139|FG003|Overall Study|Multiple reasons|2|||
127781441|NCT01383096|459827790|FG000|Third Intervention (8 Days)|Elevated AST|0|||
127781442|NCT01383096|459827791|FG001|Third Intervention (8 Days)|Elevated AST|1|||
128029261|NCT02633527|460732140|FG004|Overall Study|Multiple reasons|1|||
128029262|NCT01681849|460732141|FG000|Overall Study|Protocol Violation|2|||
128029263|NCT01681849|460732142|FG001|Overall Study|Protocol Violation|0|||
127781443|NCT01383096|459827792|FG002|Third Intervention (8 Days)|Elevated AST|0|||
127781444|NCT01383096|459827790|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
127781445|NCT01383096|459827791|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
128029264|NCT01681849|460732143|FG002|Overall Study|Protocol Violation|0|||
127781446|NCT01383096|459827792|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
127781447|NCT01383096|459827790|FG000|Third Intervention (8 Days)|Adverse Event|1|||
128029265|NCT01681849|460732141|FG000|Overall Study|Withdrawal by Subject|3|||
128029266|NCT01681849|460732142|FG001|Overall Study|Withdrawal by Subject|5|||
127781448|NCT01383096|459827791|FG001|Third Intervention (8 Days)|Adverse Event|0|||
127781449|NCT01383096|459827792|FG002|Third Intervention (8 Days)|Adverse Event|0|||
127781450|NCT01383096|459827790|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
127781451|NCT01383096|459827791|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
127781452|NCT01383096|459827792|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
127781453|NCT01383096|459827790|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
127781454|NCT01383096|459827791|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
127781455|NCT01383096|459827792|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
127781456|NCT01383096|459827790|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
127781457|NCT01383096|459827791|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
127781458|NCT01383096|459827792|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
127781459|NCT01383096|459827790|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
127781460|NCT01383096|459827791|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
127781461|NCT01383096|459827792|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
127781462|NCT01383096|459827790|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
127781463|NCT01383096|459827791|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
127781464|NCT01383096|459827792|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
127781465|NCT01383096|459827790|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
127781466|NCT01383096|459827791|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
127781467|NCT01383096|459827792|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
127781468|NCT01211535|459827793|FG000|Overall Study|Adverse Event|0|||
127781469|NCT01211535|459827794|FG001|Overall Study|Adverse Event|1|||
127781470|NCT00467779|459827797|FG000|Stage 1|Adverse Event|1|||
127781471|NCT00467779|459827798|FG001|Stage 1|Adverse Event|0|||
127781472|NCT00467779|459827799|FG002|Stage 1|Adverse Event|0|||
127781473|NCT00467779|459827800|FG003|Stage 1|Adverse Event|0|||
127781474|NCT00467779|459827801|FG004|Stage 1|Adverse Event|0|||
127781475|NCT00467779|459827802|FG005|Stage 1|Adverse Event|1|||
127781476|NCT00467779|459827803|FG006|Stage 1|Adverse Event|2|||
127781477|NCT00467779|459827804|FG007|Stage 1|Adverse Event|1|||
127781478|NCT00467779|459827805|FG008|Stage 1|Adverse Event|0|||
127781479|NCT00467779|459827806|FG009|Stage 1|Adverse Event|0|||
127781480|NCT00467779|459827807|FG010|Stage 1|Adverse Event|0|||
127781481|NCT00467779|459827808|FG011|Stage 1|Adverse Event|0|||
127781482|NCT00467779|459827809|FG012|Stage 1|Adverse Event|0|||
127781483|NCT00467779|459827810|FG013|Stage 1|Adverse Event|0|||
127781484|NCT00467779|459827811|FG014|Stage 1|Adverse Event|0|||
127781485|NCT00467779|459827797|FG000|Stage 1|Disease Progression|2|||
127781486|NCT00467779|459827798|FG001|Stage 1|Disease Progression|2|||
127781487|NCT00467779|459827799|FG002|Stage 1|Disease Progression|2|||
127781488|NCT00467779|459827800|FG003|Stage 1|Disease Progression|3|||
127781489|NCT00467779|459827801|FG004|Stage 1|Disease Progression|2|||
127781490|NCT00467779|459827802|FG005|Stage 1|Disease Progression|2|||
127781491|NCT00467779|459827803|FG006|Stage 1|Disease Progression|4|||
127781492|NCT00467779|459827804|FG007|Stage 1|Disease Progression|5|||
127781493|NCT00467779|459827805|FG008|Stage 1|Disease Progression|0|||
127781494|NCT00467779|459827806|FG009|Stage 1|Disease Progression|0|||
127781495|NCT00467779|459827807|FG010|Stage 1|Disease Progression|0|||
127781496|NCT00467779|459827808|FG011|Stage 1|Disease Progression|0|||
127781497|NCT00467779|459827809|FG012|Stage 1|Disease Progression|0|||
127781498|NCT00467779|459827810|FG013|Stage 1|Disease Progression|0|||
127781499|NCT00467779|459827811|FG014|Stage 1|Disease Progression|0|||
127781500|NCT00467779|459827797|FG000|Stage 1|Unspecified Reason|1|||
127781501|NCT00467779|459827798|FG001|Stage 1|Unspecified Reason|0|||
127781502|NCT00467779|459827799|FG002|Stage 1|Unspecified Reason|1|||
127781503|NCT00467779|459827800|FG003|Stage 1|Unspecified Reason|0|||
127781504|NCT00467779|459827801|FG004|Stage 1|Unspecified Reason|1|||
127781505|NCT00467779|459827802|FG005|Stage 1|Unspecified Reason|2|||
127781506|NCT00467779|459827803|FG006|Stage 1|Unspecified Reason|0|||
127781507|NCT00467779|459827804|FG007|Stage 1|Unspecified Reason|0|||
127781508|NCT00467779|459827805|FG008|Stage 1|Unspecified Reason|0|||
127781509|NCT00467779|459827806|FG009|Stage 1|Unspecified Reason|0|||
127781510|NCT00467779|459827807|FG010|Stage 1|Unspecified Reason|0|||
127781511|NCT00467779|459827808|FG011|Stage 1|Unspecified Reason|0|||
127781512|NCT00467779|459827809|FG012|Stage 1|Unspecified Reason|0|||
127781513|NCT00467779|459827810|FG013|Stage 1|Unspecified Reason|0|||
127781514|NCT00467779|459827811|FG014|Stage 1|Unspecified Reason|0|||
127781515|NCT00467779|459827797|FG000|Stage 1|Physician Decision|0|||
127781516|NCT00467779|459827798|FG001|Stage 1|Physician Decision|1|||
127781517|NCT00467779|459827799|FG002|Stage 1|Physician Decision|0|||
127781518|NCT00467779|459827800|FG003|Stage 1|Physician Decision|0|||
127781519|NCT00467779|459827801|FG004|Stage 1|Physician Decision|0|||
127781520|NCT00467779|459827802|FG005|Stage 1|Physician Decision|0|||
127781521|NCT00467779|459827803|FG006|Stage 1|Physician Decision|0|||
127781522|NCT00467779|459827804|FG007|Stage 1|Physician Decision|0|||
127781523|NCT00467779|459827805|FG008|Stage 1|Physician Decision|0|||
127781524|NCT00467779|459827806|FG009|Stage 1|Physician Decision|0|||
127781525|NCT00467779|459827807|FG010|Stage 1|Physician Decision|0|||
127781526|NCT00467779|459827808|FG011|Stage 1|Physician Decision|0|||
127781527|NCT00467779|459827809|FG012|Stage 1|Physician Decision|0|||
127781528|NCT00467779|459827810|FG013|Stage 1|Physician Decision|0|||
127781529|NCT00467779|459827811|FG014|Stage 1|Physician Decision|0|||
127572648|NCT02414139|459065978|FG003|Post-treatment Efficacy Follow-up|Progressive disease|5|||
127572649|NCT02414139|459065979|FG004|Post-treatment Efficacy Follow-up|Progressive disease|15|||
127572650|NCT02414139|459065980|FG005|Post-treatment Efficacy Follow-up|Progressive disease|4|||
127572651|NCT02414139|459065981|FG006|Post-treatment Efficacy Follow-up|Progressive disease|5|||
127572652|NCT02414139|459065982|FG007|Post-treatment Efficacy Follow-up|Progressive disease|1|||
127572653|NCT02414139|459065983|FG008|Post-treatment Efficacy Follow-up|Progressive disease|3|||
127781530|NCT00467779|459827797|FG000|Stage 1|Withdrawal by Subject|0|||
127781531|NCT00467779|459827798|FG001|Stage 1|Withdrawal by Subject|0|||
127572654|NCT02414139|459065984|FG009|Post-treatment Efficacy Follow-up|Progressive disease|3|||
127572655|NCT02414139|459065975|FG000|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
127572656|NCT02414139|459065976|FG001|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
127572657|NCT02414139|459065977|FG002|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
127572658|NCT02414139|459065978|FG003|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
127572659|NCT02414139|459065979|FG004|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
127572660|NCT02414139|459065980|FG005|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
127781532|NCT00467779|459827799|FG002|Stage 1|Withdrawal by Subject|0|||
127781533|NCT00467779|459827800|FG003|Stage 1|Withdrawal by Subject|0|||
127781534|NCT00467779|459827801|FG004|Stage 1|Withdrawal by Subject|0|||
127781535|NCT00467779|459827802|FG005|Stage 1|Withdrawal by Subject|0|||
127781536|NCT00467779|459827803|FG006|Stage 1|Withdrawal by Subject|1|||
127781537|NCT00467779|459827804|FG007|Stage 1|Withdrawal by Subject|1|||
127781538|NCT00467779|459827805|FG008|Stage 1|Withdrawal by Subject|0|||
127781539|NCT00467779|459827806|FG009|Stage 1|Withdrawal by Subject|0|||
127781540|NCT00467779|459827807|FG010|Stage 1|Withdrawal by Subject|0|||
127781541|NCT00467779|459827808|FG011|Stage 1|Withdrawal by Subject|0|||
127781542|NCT00467779|459827809|FG012|Stage 1|Withdrawal by Subject|0|||
127781543|NCT00467779|459827810|FG013|Stage 1|Withdrawal by Subject|0|||
127781544|NCT00467779|459827811|FG014|Stage 1|Withdrawal by Subject|0|||
127781545|NCT00467779|459827797|FG000|Stage 1A|Adverse Event|0|||
127781546|NCT00467779|459827798|FG001|Stage 1A|Adverse Event|0|||
127781547|NCT00467779|459827799|FG002|Stage 1A|Adverse Event|0|||
127781548|NCT00467779|459827800|FG003|Stage 1A|Adverse Event|0|||
127572661|NCT02414139|459065981|FG006|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
127572662|NCT02414139|459065982|FG007|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
127572663|NCT02414139|459065983|FG008|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
127572664|NCT02414139|459065984|FG009|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
127572665|NCT02414139|459065975|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|4|||
127572666|NCT02414139|459065976|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
127572667|NCT02414139|459065977|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|3|||
127781549|NCT00467779|459827801|FG004|Stage 1A|Adverse Event|0|||
127781550|NCT00467779|459827802|FG005|Stage 1A|Adverse Event|0|||
127781551|NCT00467779|459827803|FG006|Stage 1A|Adverse Event|0|||
127781552|NCT00467779|459827804|FG007|Stage 1A|Adverse Event|0|||
127781553|NCT00467779|459827805|FG008|Stage 1A|Adverse Event|0|||
127781554|NCT00467779|459827806|FG009|Stage 1A|Adverse Event|0|||
127781555|NCT00467779|459827807|FG010|Stage 1A|Adverse Event|0|||
127781556|NCT00467779|459827808|FG011|Stage 1A|Adverse Event|0|||
127781557|NCT00467779|459827809|FG012|Stage 1A|Adverse Event|1|||
127781558|NCT00467779|459827810|FG013|Stage 1A|Adverse Event|0|||
127781559|NCT00467779|459827811|FG014|Stage 1A|Adverse Event|0|||
127781560|NCT00467779|459827797|FG000|Stage 1A|Death|0|||
127781561|NCT00467779|459827798|FG001|Stage 1A|Death|0|||
127781562|NCT00467779|459827799|FG002|Stage 1A|Death|0|||
127572668|NCT02414139|459065978|FG003|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
127781563|NCT00467779|459827800|FG003|Stage 1A|Death|0|||
127781564|NCT00467779|459827801|FG004|Stage 1A|Death|0|||
127781565|NCT00467779|459827802|FG005|Stage 1A|Death|0|||
127781566|NCT00467779|459827803|FG006|Stage 1A|Death|0|||
127781567|NCT00467779|459827804|FG007|Stage 1A|Death|0|||
127781568|NCT00467779|459827805|FG008|Stage 1A|Death|0|||
127781569|NCT00467779|459827806|FG009|Stage 1A|Death|0|||
127781570|NCT00467779|459827807|FG010|Stage 1A|Death|0|||
127781571|NCT00467779|459827808|FG011|Stage 1A|Death|1|||
127781572|NCT00467779|459827809|FG012|Stage 1A|Death|1|||
127781573|NCT00467779|459827810|FG013|Stage 1A|Death|0|||
127781574|NCT00467779|459827811|FG014|Stage 1A|Death|0|||
127781575|NCT00467779|459827797|FG000|Stage 1A|Disease Progression|0|||
127781576|NCT00467779|459827798|FG001|Stage 1A|Disease Progression|0|||
127781577|NCT00467779|459827799|FG002|Stage 1A|Disease Progression|0|||
127781578|NCT00467779|459827800|FG003|Stage 1A|Disease Progression|0|||
127781579|NCT00467779|459827801|FG004|Stage 1A|Disease Progression|0|||
127781580|NCT00467779|459827802|FG005|Stage 1A|Disease Progression|0|||
127781581|NCT00467779|459827803|FG006|Stage 1A|Disease Progression|0|||
127781582|NCT00467779|459827804|FG007|Stage 1A|Disease Progression|0|||
127781583|NCT00467779|459827805|FG008|Stage 1A|Disease Progression|0|||
127572669|NCT02414139|459065979|FG004|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
127572670|NCT02414139|459065980|FG005|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
127572671|NCT02414139|459065981|FG006|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
127572672|NCT02414139|459065982|FG007|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
127572673|NCT02414139|459065983|FG008|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
127572674|NCT02414139|459065984|FG009|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
127572675|NCT00772070|459065989|FG000|Overall Study|Lost to Follow-up|0|||
127572676|NCT00772070|459065990|FG001|Overall Study|Lost to Follow-up|8|||
127572677|NCT00772070|459065989|FG000|Overall Study|Withdrawal by Subject|0|||
127572678|NCT00772070|459065990|FG001|Overall Study|Withdrawal by Subject|2|||
127572679|NCT00772070|459065989|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
127572680|NCT00772070|459065990|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
127572681|NCT01017575|459065991|FG000|Overall Study|Lack of Efficacy|0|||
127572682|NCT01017575|459065992|FG001|Overall Study|Lack of Efficacy|1|||
127572683|NCT01017575|459065993|FG002|Overall Study|Lack of Efficacy|0|||
127572684|NCT01017575|459065994|FG003|Overall Study|Lack of Efficacy|1|||
127572685|NCT01017575|459065995|FG004|Overall Study|Lack of Efficacy|1|||
127572686|NCT01017575|459065991|FG000|Overall Study|Adverse Event|0|||
127572687|NCT01017575|459065992|FG001|Overall Study|Adverse Event|1|||
127572688|NCT01017575|459065993|FG002|Overall Study|Adverse Event|0|||
127572689|NCT01017575|459065994|FG003|Overall Study|Adverse Event|0|||
127572690|NCT01017575|459065995|FG004|Overall Study|Adverse Event|2|||
127572691|NCT01017575|459065991|FG000|Overall Study|Withdrawal by Subject|1|||
127572692|NCT01017575|459065992|FG001|Overall Study|Withdrawal by Subject|0|||
127572693|NCT01017575|459065993|FG002|Overall Study|Withdrawal by Subject|0|||
127572694|NCT01017575|459065994|FG003|Overall Study|Withdrawal by Subject|0|||
127572695|NCT01017575|459065995|FG004|Overall Study|Withdrawal by Subject|0|||
127572696|NCT01476644|459065996|FG000|Overall Study|Death|5|||
127572697|NCT01476644|459065996|FG000|Overall Study|moved to another state|2|||
127572698|NCT01476644|459065996|FG000|Overall Study|Lost to Follow-up|19|||
127572699|NCT01476644|459065996|FG000|Overall Study|Withdrawal by Subject|13|||
127572700|NCT00095628|459065997|FG000|Overall Study|Disease progression prior to treatment|1|||
127572701|NCT04271280|459065998|FG000|Overall Study|Lost to Follow-up|300|||
127572702|NCT04271280|459065998|FG000|Overall Study|Death|153|||
127572703|NCT04271280|459065998|FG000|Overall Study|Withdrawal of consent by patient|59|||
127572704|NCT04271280|459065998|FG000|Overall Study|Other|51|||
127572705|NCT04271280|459065998|FG000|Overall Study|No end of study information|42|||
127572706|NCT00495131|459065999|FG000|Overall Study|Adverse Event|6|||
127572707|NCT00495131|459066000|FG001|Overall Study|Adverse Event|2|||
127572708|NCT00495131|459065999|FG000|Overall Study|Lack of Efficacy|0|||
127572709|NCT00495131|459066000|FG001|Overall Study|Lack of Efficacy|2|||
127572710|NCT00495131|459065999|FG000|Overall Study|Lost to Follow-up|0|||
127572711|NCT00495131|459066000|FG001|Overall Study|Lost to Follow-up|2|||
127572712|NCT00495131|459065999|FG000|Overall Study|Withdrawal by Subject|1|||
127572713|NCT00495131|459066000|FG001|Overall Study|Withdrawal by Subject|0|||
127572714|NCT00744471|459066001|FG000|Overall Study|Randomized but not treated|1|||
127572715|NCT00744471|459066002|FG001|Overall Study|Randomized but not treated|1|||
127572716|NCT00744471|459066003|FG002|Overall Study|Randomized but not treated|4|||
127572717|NCT00744471|459066004|FG003|Overall Study|Randomized but not treated|0|||
127572718|NCT00744471|459066001|FG000|Overall Study|Death|0|||
127572719|NCT00744471|459066002|FG001|Overall Study|Death|0|||
127572720|NCT00744471|459066003|FG002|Overall Study|Death|0|||
127572721|NCT00744471|459066004|FG003|Overall Study|Death|1|||
127572722|NCT00744471|459066001|FG000|Overall Study|Adverse Event|6|||
127572723|NCT00744471|459066002|FG001|Overall Study|Adverse Event|7|||
127572724|NCT00744471|459066003|FG002|Overall Study|Adverse Event|5|||
127572725|NCT00744471|459066004|FG003|Overall Study|Adverse Event|9|||
127572726|NCT00744471|459066001|FG000|Overall Study|Withdrawal by Subject|9|||
127572727|NCT00744471|459066002|FG001|Overall Study|Withdrawal by Subject|9|||
127572728|NCT00744471|459066003|FG002|Overall Study|Withdrawal by Subject|15|||
127572729|NCT00744471|459066004|FG003|Overall Study|Withdrawal by Subject|12|||
127572730|NCT00744471|459066001|FG000|Overall Study|Protocol Violation|1|||
127572731|NCT00744471|459066002|FG001|Overall Study|Protocol Violation|4|||
127572732|NCT00744471|459066003|FG002|Overall Study|Protocol Violation|1|||
127572733|NCT00744471|459066004|FG003|Overall Study|Protocol Violation|2|||
127572734|NCT00744471|459066001|FG000|Overall Study|Entered extension study|41|||
127572735|NCT00744471|459066002|FG001|Overall Study|Entered extension study|84|||
127781584|NCT00467779|459827806|FG009|Stage 1A|Disease Progression|2|||
127572736|NCT00744471|459066003|FG002|Overall Study|Entered extension study|100|||
127572737|NCT00744471|459066004|FG003|Overall Study|Entered extension study|91|||
127572738|NCT00744471|459066001|FG000|Overall Study|Other|2|||
127572739|NCT00744471|459066002|FG001|Overall Study|Other|3|||
127572740|NCT00744471|459066003|FG002|Overall Study|Other|6|||
127572741|NCT00744471|459066004|FG003|Overall Study|Other|2|||
127572742|NCT00744471|459066001|FG000|Overall Study|Lack of Efficacy|83|||
127572743|NCT00744471|459066002|FG001|Overall Study|Lack of Efficacy|37|||
127572744|NCT00744471|459066003|FG002|Overall Study|Lack of Efficacy|19|||
128029267|NCT01681849|460732143|FG002|Overall Study|Withdrawal by Subject|33|||
128029268|NCT01681849|460732141|FG000|Overall Study|Lost to Follow-up|3|||
128029269|NCT01681849|460732142|FG001|Overall Study|Lost to Follow-up|2|||
128029270|NCT01681849|460732143|FG002|Overall Study|Lost to Follow-up|6|||
128029271|NCT02852005|460732144|FG000|Overall Study|Lost to Follow-up|0|||
128029272|NCT02852005|460732145|FG001|Overall Study|Lost to Follow-up|0|||
128029273|NCT02852005|460732146|FG002|Overall Study|Lost to Follow-up|0|||
128029274|NCT02852005|460732147|FG003|Overall Study|Lost to Follow-up|0|||
128029275|NCT02852005|460732148|FG004|Overall Study|Lost to Follow-up|1|||
128029276|NCT02852005|460732144|FG000|Overall Study|Withdrawal by Subject|1|||
128029277|NCT02852005|460732145|FG001|Overall Study|Withdrawal by Subject|0|||
128029278|NCT02852005|460732146|FG002|Overall Study|Withdrawal by Subject|0|||
128029279|NCT02852005|460732147|FG003|Overall Study|Withdrawal by Subject|0|||
128029280|NCT02852005|460732148|FG004|Overall Study|Withdrawal by Subject|0|||
128029281|NCT02420314|460732151|FG000|Overall Study|Withdrawal by Subject|1|||
128029282|NCT02420314|460732151|FG000|Overall Study|Protocol Violation|1|||
127572745|NCT00744471|459066004|FG003|Overall Study|Lack of Efficacy|31|||
127572746|NCT00744471|459066001|FG000|Overall Study|Lost to Follow-up|0|||
127572747|NCT00744471|459066002|FG001|Overall Study|Lost to Follow-up|0|||
127572748|NCT00744471|459066003|FG002|Overall Study|Lost to Follow-up|2|||
127572749|NCT00744471|459066004|FG003|Overall Study|Lost to Follow-up|0|||
127572750|NCT04706416|459066009|FG000|Overall Study|Lost to Follow-up|2|||
127572751|NCT04706416|459066010|FG001|Overall Study|Lost to Follow-up|0|||
127572752|NCT01539317|459066014|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
127572753|NCT01539317|459066015|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
127572754|NCT00976573|459066022|FG000|Overall Study|Ineligible|0|||
127572755|NCT00976573|459066023|FG001|Overall Study|Ineligible|1|||
127572756|NCT00976573|459066022|FG000|Overall Study|Cancel prior to receiving treatment|4|||
127572757|NCT00976573|459066023|FG001|Overall Study|Cancel prior to receiving treatment|2|||
127572758|NCT02117427|459066024|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
127572759|NCT02117427|459066025|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
127572760|NCT02117427|459066026|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
127572761|NCT02117427|459066024|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
127572762|NCT02117427|459066025|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
127572763|NCT02117427|459066026|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
127572764|NCT02117427|459066024|FG000|Overall Study|Physician Decision|0|||
127572765|NCT02117427|459066025|FG001|Overall Study|Physician Decision|2|||
127572766|NCT02117427|459066026|FG002|Overall Study|Physician Decision|0|||
127572767|NCT02117427|459066024|FG000|Overall Study|No longer meets inclusion criteria|0|||
127572768|NCT02117427|459066025|FG001|Overall Study|No longer meets inclusion criteria|1|||
127572769|NCT02117427|459066026|FG002|Overall Study|No longer meets inclusion criteria|0|||
127572770|NCT02117427|459066024|FG000|Overall Study|Death|0|||
127572771|NCT02117427|459066025|FG001|Overall Study|Death|1|||
127572772|NCT02117427|459066026|FG002|Overall Study|Death|0|||
127572773|NCT02125604|459066027|FG000|Overall Study|Other|4|||
127572774|NCT02125604|459066027|FG000|Overall Study|Investigator Decision|1|||
127572775|NCT02125604|459066027|FG000|Overall Study|Lost to Follow-up|2|||
127572776|NCT02125604|459066027|FG000|Overall Study|Consent Withdrawn|4|||
127572777|NCT02125604|459066027|FG000|Overall Study|Adverse Event|20|||
127572778|NCT01876810|459066028|FG000|Overall Study|Physician Decision|0|||
127572779|NCT01876810|459066029|FG001|Overall Study|Physician Decision|1|||
127572780|NCT00323869|459066033|FG000|Overall Study|Death|1|||
127572781|NCT01683019|459067502|FG000|Overall Study|Withdrawal by Subject|2|||
127572782|NCT01683019|459067503|FG001|Overall Study|Withdrawal by Subject|1|||
127572783|NCT01683019|459067504|FG002|Overall Study|Withdrawal by Subject|4|||
127572784|NCT00543855|459067505|FG000|Overall Study|Adverse Event|3|||
127572785|NCT00543855|459067506|FG001|Overall Study|Adverse Event|1|||
127572786|NCT00543855|459067507|FG002|Overall Study|Adverse Event|3|||
127572787|NCT00543855|459067508|FG003|Overall Study|Adverse Event|4|||
127572788|NCT00543855|459067505|FG000|Overall Study|Lost to Follow-up|0|||
127572789|NCT00543855|459067506|FG001|Overall Study|Lost to Follow-up|0|||
127572790|NCT00543855|459067507|FG002|Overall Study|Lost to Follow-up|1|||
127572791|NCT00543855|459067508|FG003|Overall Study|Lost to Follow-up|0|||
127572792|NCT00543855|459067505|FG000|Overall Study|Withdrawal by Subject|0|||
127572793|NCT00543855|459067506|FG001|Overall Study|Withdrawal by Subject|1|||
128029283|NCT03760068|460732153|FG000|Overall Study|Withdrawal by Subject|7|||
127572794|NCT00543855|459067507|FG002|Overall Study|Withdrawal by Subject|2|||
127572795|NCT00543855|459067508|FG003|Overall Study|Withdrawal by Subject|0|||
127572796|NCT00543855|459067505|FG000|Overall Study|Protocol Violation|1|||
127692523|NCT04218266|459500131|FG001|Overall Study|Other|5|||
127572797|NCT00543855|459067506|FG001|Overall Study|Protocol Violation|0|||
127572798|NCT00543855|459067507|FG002|Overall Study|Protocol Violation|0|||
127572799|NCT00543855|459067508|FG003|Overall Study|Protocol Violation|0|||
127572800|NCT04444895|459067510|FG000|Overall Study|Adverse Event|2|||
128029284|NCT03760068|460732154|FG001|Overall Study|Withdrawal by Subject|8|||
128029285|NCT03760068|460732153|FG000|Overall Study|Adverse Event|1|||
128029286|NCT03760068|460732154|FG001|Overall Study|Adverse Event|2|||
128029287|NCT03760068|460732153|FG000|Overall Study|Administrative Decision by Sponsor|0|||
127572801|NCT04444895|459067510|FG000|Overall Study|Lost to Follow-up|2|||
127572802|NCT04444895|459067510|FG000|Overall Study|Withdrawal by Subject|5|||
127572803|NCT00749580|459067511|FG000|Overall Study|Lost to Follow-up|4|||
127572804|NCT00749580|459067512|FG001|Overall Study|Lost to Follow-up|8|||
127572805|NCT00749580|459067511|FG000|Overall Study|Adverse Event|0|||
127572806|NCT00749580|459067512|FG001|Overall Study|Adverse Event|1|||
127572807|NCT03954041|459067522|FG000|Overall Study|Lost to Follow-up|3|||
127572808|NCT03954041|459067523|FG001|Overall Study|Lost to Follow-up|3|||
127572809|NCT03954041|459067524|FG002|Overall Study|Lost to Follow-up|6|||
127572810|NCT03954041|459067522|FG000|Overall Study|Death|4|||
127572811|NCT03954041|459067523|FG001|Overall Study|Death|0|||
127572812|NCT03954041|459067524|FG002|Overall Study|Death|1|||
127572813|NCT03954041|459067522|FG000|Overall Study|Death by neurologic criteria|0|||
127572814|NCT03954041|459067523|FG001|Overall Study|Death by neurologic criteria|0|||
127572815|NCT03954041|459067524|FG002|Overall Study|Death by neurologic criteria|1|||
127572816|NCT03954041|459067522|FG000|Overall Study|Reason not specified|7|||
127572817|NCT03954041|459067523|FG001|Overall Study|Reason not specified|4|||
127572818|NCT03954041|459067524|FG002|Overall Study|Reason not specified|2|||
127572819|NCT03954041|459067522|FG000|Overall Study|Withdrew prior to dosing|4|||
127572820|NCT03954041|459067523|FG001|Overall Study|Withdrew prior to dosing|2|||
127572821|NCT03954041|459067524|FG002|Overall Study|Withdrew prior to dosing|0|||
127572822|NCT03868124|459067527|FG000|Overall Study|Withdrawal by Subject|4|||
127572823|NCT03868124|459067528|FG001|Overall Study|Withdrawal by Subject|0|||
127572824|NCT03868124|459067529|FG002|Overall Study|Withdrawal by Subject|1|||
127572825|NCT03868124|459067527|FG000|Overall Study|Physician Decision|1|||
127572826|NCT03868124|459067528|FG001|Overall Study|Physician Decision|0|||
127572827|NCT03868124|459067529|FG002|Overall Study|Physician Decision|1|||
127572828|NCT03868124|459067527|FG000|Overall Study|Lost to Follow-up|1|||
127572829|NCT03868124|459067528|FG001|Overall Study|Lost to Follow-up|1|||
127572830|NCT03868124|459067529|FG002|Overall Study|Lost to Follow-up|2|||
127572831|NCT03868124|459067527|FG000|Overall Study|Death|1|||
127572832|NCT03868124|459067528|FG001|Overall Study|Death|1|||
127572833|NCT03868124|459067529|FG002|Overall Study|Death|2|||
127572834|NCT03868124|459067527|FG000|Overall Study|Adverse Event|0|||
127572835|NCT03868124|459067528|FG001|Overall Study|Adverse Event|0|||
127572836|NCT03868124|459067529|FG002|Overall Study|Adverse Event|3|||
127572837|NCT03868124|459067527|FG000|Overall Study|Explanted|2|||
127572838|NCT03868124|459067528|FG001|Overall Study|Explanted|1|||
127572839|NCT03868124|459067529|FG002|Overall Study|Explanted|0|||
127572840|NCT03868124|459067527|FG000|Overall Study|Ongoing in study|176|||
127572841|NCT03868124|459067528|FG001|Overall Study|Ongoing in study|180|||
127572842|NCT03868124|459067529|FG002|Overall Study|Ongoing in study|183|||
127572843|NCT04565236|459067531|FG000|Overall Study|Patient/Guardian Decision|0|||
127572844|NCT04565236|459067532|FG001|Overall Study|Patient/Guardian Decision|0|||
127572845|NCT04565236|459067533|FG002|Overall Study|Patient/Guardian Decision|1|||
127572846|NCT04565236|459067534|FG003|Overall Study|Patient/Guardian Decision|0|||
127572847|NCT04902326|459067535|FG000|Overall Study|Withdrawal by Subject|1|||
127572848|NCT04902326|459067536|FG001|Overall Study|Withdrawal by Subject|3|||
127572849|NCT04902326|459067537|FG002|Overall Study|Withdrawal by Subject|0|||
127572850|NCT04902326|459067538|FG003|Overall Study|Withdrawal by Subject|1|||
127572851|NCT04902326|459067535|FG000|Overall Study|Lost to Follow-up|14|||
127572852|NCT04902326|459067536|FG001|Overall Study|Lost to Follow-up|14|||
127572853|NCT04902326|459067537|FG002|Overall Study|Lost to Follow-up|14|||
127572854|NCT04902326|459067538|FG003|Overall Study|Lost to Follow-up|6|||
127572855|NCT01117051|459067539|FG000|Overall Study|Withdrawal by Subject|5|||
127572856|NCT01117051|459067540|FG001|Overall Study|Withdrawal by Subject|3|||
127572857|NCT01117051|459067539|FG000|Overall Study|Adverse Event|4|||
127572858|NCT01117051|459067540|FG001|Overall Study|Adverse Event|3|||
127572859|NCT01117051|459067539|FG000|Overall Study|Lost to Follow-up|0|||
127572860|NCT01117051|459067540|FG001|Overall Study|Lost to Follow-up|1|||
127572861|NCT01117051|459067539|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
127572862|NCT01117051|459067540|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
127572863|NCT01117051|459067539|FG000|Overall Study|Sponsor's decision|3|||
127572864|NCT01117051|459067540|FG001|Overall Study|Sponsor's decision|1|||
127572865|NCT01117051|459067539|FG000|Overall Study|Surgical procedure|0|||
127692524|NCT04218266|459500132|FG002|Overall Study|Other|14|||
128029288|NCT03760068|460732154|FG001|Overall Study|Administrative Decision by Sponsor|2|||
128029289|NCT03760068|460732153|FG000|Overall Study|Physician Decision|1|||
127572866|NCT01117051|459067540|FG001|Overall Study|Surgical procedure|1|||
127572867|NCT01117051|459067539|FG000|Overall Study|Randomized by mistake|0|||
127572868|NCT01117051|459067540|FG001|Overall Study|Randomized by mistake|1|||
127572869|NCT01117051|459067539|FG000|Overall Study|Convenience issue|1|||
128029290|NCT03760068|460732154|FG001|Overall Study|Physician Decision|2|||
127572870|NCT01117051|459067540|FG001|Overall Study|Convenience issue|0|||
127572871|NCT00206076|459067542|FG000|Overall Study|Physician Decision|2|||
127572872|NCT00206076|459067543|FG001|Overall Study|Physician Decision|0|||
127572873|NCT00206076|459067542|FG000|Overall Study|Withdrawal by Subject|1|||
127572874|NCT00206076|459067543|FG001|Overall Study|Withdrawal by Subject|1|||
127572875|NCT03355664|459067545|FG000|Overall Study|Adverse Event|1|||
127572876|NCT03355664|459067546|FG001|Overall Study|Adverse Event|2|||
127572877|NCT03355664|459067545|FG000|Overall Study|Lost to Follow-up|11|||
127572878|NCT03355664|459067546|FG001|Overall Study|Lost to Follow-up|7|||
127572879|NCT03355664|459067545|FG000|Overall Study|Protocol Violation|1|||
127572880|NCT03355664|459067546|FG001|Overall Study|Protocol Violation|2|||
127572881|NCT03355664|459067545|FG000|Overall Study|Withdrawal by Subject|2|||
127572882|NCT03355664|459067546|FG001|Overall Study|Withdrawal by Subject|1|||
127572883|NCT01751802|459067549|FG000|Overall Study|Adverse Event|4|||
127572884|NCT01751802|459067550|FG001|Overall Study|Adverse Event|2|||
127572885|NCT00589784|459067552|FG000|Overall Study|Withdrawal by Subject|0|||
127572886|NCT00589784|459067553|FG001|Overall Study|Withdrawal by Subject|6|||
127572887|NCT00589784|459067552|FG000|Overall Study|Patient inevaluable|1|||
127572888|NCT00589784|459067553|FG001|Overall Study|Patient inevaluable|0|||
127572889|NCT00589784|459067552|FG000|Overall Study|Adverse Event|0|||
127572890|NCT00589784|459067553|FG001|Overall Study|Adverse Event|4|||
127572891|NCT00423670|459067556|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
127572892|NCT00423670|459067557|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
127692525|NCT04218266|459500130|FG000|Overall Study|Physician Decision|1|||
127692526|NCT04218266|459500131|FG001|Overall Study|Physician Decision|3|||
127692527|NCT04218266|459500132|FG002|Overall Study|Physician Decision|2|||
127692528|NCT04218266|459500130|FG000|Overall Study|Non-compliance with study drug|0|||
127692529|NCT04218266|459500131|FG001|Overall Study|Non-compliance with study drug|0|||
127692530|NCT04218266|459500132|FG002|Overall Study|Non-compliance with study drug|1|||
127692531|NCT04218266|459500130|FG000|Overall Study|Withdrawal by Subject|1|||
127692532|NCT04218266|459500131|FG001|Overall Study|Withdrawal by Subject|3|||
127692533|NCT04218266|459500132|FG002|Overall Study|Withdrawal by Subject|1|||
127692534|NCT04218266|459500130|FG000|Overall Study|Study drug never administered|2|||
127692535|NCT04218266|459500131|FG001|Overall Study|Study drug never administered|0|||
127692536|NCT04218266|459500132|FG002|Overall Study|Study drug never administered|0|||
127692537|NCT02742519|459500133|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
127692538|NCT02742519|459500134|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
127692539|NCT02742519|459500135|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
127692540|NCT02742519|459500133|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
127692541|NCT02742519|459500134|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
127692542|NCT02742519|459500135|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
127692543|NCT02742519|459500133|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
127692544|NCT02742519|459500134|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
127692545|NCT02742519|459500135|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
127692546|NCT02759016|459500136|FG000|Overall Study|Not treated with BI 836826|1|||
127692547|NCT02759016|459500137|FG001|Overall Study|Not treated with BI 836826|0|||
127692548|NCT02759016|459500136|FG000|Overall Study|Progressive disease|1|||
127692549|NCT02759016|459500137|FG001|Overall Study|Progressive disease|0|||
127692550|NCT02759016|459500136|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
127692551|NCT02759016|459500137|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
127692552|NCT02759016|459500136|FG000|Overall Study|Other not defined above|2|||
127692553|NCT02759016|459500137|FG001|Overall Study|Other not defined above|1|||
127692554|NCT04377308|459500138|FG000|Overall Study|Withdrawal by Subject|0|||
127692555|NCT04377308|459500139|FG001|Overall Study|Withdrawal by Subject|1|||
127692556|NCT03939312|459500140|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
127692557|NCT03939312|459500140|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
127692558|NCT03939312|459500140|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
127692559|NCT03939312|459500140|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
127692560|NCT03939312|459500140|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
127692561|NCT03939312|459500140|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
127781585|NCT00467779|459827807|FG010|Stage 1A|Disease Progression|2|||
127781586|NCT00467779|459827808|FG011|Stage 1A|Disease Progression|5|||
127572893|NCT00423670|459067558|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
127572894|NCT00423670|459067559|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
127692562|NCT03939312|459500140|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
127692563|NCT03939312|459500140|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
127692564|NCT03939312|459500140|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
127692565|NCT03939312|459500140|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
127692566|NCT03939312|459500140|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
127692567|NCT03939312|459500140|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
127692568|NCT02119650|459500141|FG000|Overall Study|Adverse Event|3|||
127692569|NCT02119650|459500142|FG001|Overall Study|Adverse Event|4|||
127692570|NCT02119650|459500141|FG000|Overall Study|Subject decision|2|||
127692571|NCT02119650|459500142|FG001|Overall Study|Subject decision|3|||
127692572|NCT02119650|459500141|FG000|Overall Study|Disease progression|11|||
127692573|NCT02119650|459500142|FG001|Overall Study|Disease progression|14|||
127692574|NCT02119650|459500141|FG000|Overall Study|Death|5|||
127692575|NCT02119650|459500142|FG001|Overall Study|Death|1|||
127781587|NCT00467779|459827809|FG012|Stage 1A|Disease Progression|2|||
127572895|NCT00423670|459067560|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
127572896|NCT00423670|459067561|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
127572897|NCT00423670|459067562|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
127572898|NCT00423670|459067563|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
127572899|NCT00423670|459067556|FG000|Treatment Period|Adverse Event|8|||
127572900|NCT00423670|459067557|FG001|Treatment Period|Adverse Event|12|||
127572901|NCT00423670|459067558|FG002|Treatment Period|Adverse Event|15|||
127572902|NCT00423670|459067559|FG003|Treatment Period|Adverse Event|20|||
127572903|NCT00423670|459067560|FG004|Treatment Period|Adverse Event|9|||
127572904|NCT00423670|459067561|FG005|Treatment Period|Adverse Event|4|||
127572905|NCT00423670|459067562|FG006|Treatment Period|Adverse Event|7|||
127781588|NCT00467779|459827810|FG013|Stage 1A|Disease Progression|0|||
127781589|NCT00467779|459827811|FG014|Stage 1A|Disease Progression|0|||
127781590|NCT00467779|459827797|FG000|Stage 1A|Physician Decision|0|||
127781591|NCT00467779|459827798|FG001|Stage 1A|Physician Decision|0|||
127781592|NCT00467779|459827799|FG002|Stage 1A|Physician Decision|0|||
127572906|NCT00423670|459067563|FG007|Treatment Period|Adverse Event|2|||
127572907|NCT00423670|459067556|FG000|Treatment Period|Protocol-defined clinical event|0|||
127572908|NCT00423670|459067557|FG001|Treatment Period|Protocol-defined clinical event|7|||
127572909|NCT00423670|459067558|FG002|Treatment Period|Protocol-defined clinical event|4|||
127572910|NCT00423670|459067559|FG003|Treatment Period|Protocol-defined clinical event|12|||
127572911|NCT00423670|459067560|FG004|Treatment Period|Protocol-defined clinical event|5|||
127572912|NCT00423670|459067561|FG005|Treatment Period|Protocol-defined clinical event|4|||
127572913|NCT00423670|459067562|FG006|Treatment Period|Protocol-defined clinical event|16|||
127572914|NCT00423670|459067563|FG007|Treatment Period|Protocol-defined clinical event|15|||
127572915|NCT00423670|459067556|FG000|Treatment Period|Lost to Follow-up|2|||
127572916|NCT00423670|459067557|FG001|Treatment Period|Lost to Follow-up|1|||
127572917|NCT00423670|459067558|FG002|Treatment Period|Lost to Follow-up|3|||
127572918|NCT00423670|459067559|FG003|Treatment Period|Lost to Follow-up|1|||
127572919|NCT00423670|459067560|FG004|Treatment Period|Lost to Follow-up|6|||
127572920|NCT00423670|459067561|FG005|Treatment Period|Lost to Follow-up|0|||
127572921|NCT00423670|459067562|FG006|Treatment Period|Lost to Follow-up|3|||
127572922|NCT00423670|459067563|FG007|Treatment Period|Lost to Follow-up|1|||
127572923|NCT00423670|459067556|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
127572924|NCT00423670|459067557|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
127572925|NCT00423670|459067558|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
127572926|NCT00423670|459067559|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
127572927|NCT00423670|459067560|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
127572928|NCT00423670|459067561|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
127572929|NCT00423670|459067562|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
127572930|NCT00423670|459067563|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
127781593|NCT00467779|459827800|FG003|Stage 1A|Physician Decision|0|||
127781594|NCT00467779|459827801|FG004|Stage 1A|Physician Decision|0|||
127781595|NCT00467779|459827802|FG005|Stage 1A|Physician Decision|0|||
127781596|NCT00467779|459827803|FG006|Stage 1A|Physician Decision|0|||
127781597|NCT00467779|459827804|FG007|Stage 1A|Physician Decision|0|||
127781598|NCT00467779|459827805|FG008|Stage 1A|Physician Decision|0|||
127781599|NCT00467779|459827806|FG009|Stage 1A|Physician Decision|1|||
127781600|NCT00467779|459827807|FG010|Stage 1A|Physician Decision|0|||
127781601|NCT00467779|459827808|FG011|Stage 1A|Physician Decision|0|||
127781602|NCT00467779|459827809|FG012|Stage 1A|Physician Decision|0|||
127781603|NCT00467779|459827810|FG013|Stage 1A|Physician Decision|0|||
127781604|NCT00467779|459827811|FG014|Stage 1A|Physician Decision|0|||
127781605|NCT00467779|459827797|FG000|Stage 1A|Withdrawal by Subject|0|||
127572931|NCT00423670|459067556|FG000|Treatment Period|Investigator decision|0|||
127572932|NCT00423670|459067557|FG001|Treatment Period|Investigator decision|0|||
127572933|NCT00423670|459067558|FG002|Treatment Period|Investigator decision|0|||
127572934|NCT00423670|459067559|FG003|Treatment Period|Investigator decision|0|||
127572935|NCT00423670|459067560|FG004|Treatment Period|Investigator decision|0|||
127572936|NCT00423670|459067561|FG005|Treatment Period|Investigator decision|0|||
127572937|NCT00423670|459067562|FG006|Treatment Period|Investigator decision|0|||
127572938|NCT00423670|459067563|FG007|Treatment Period|Investigator decision|1|||
127572939|NCT00423670|459067556|FG000|Treatment Period|Non-compliance with protocol|3|||
127781606|NCT00467779|459827798|FG001|Stage 1A|Withdrawal by Subject|0|||
127572940|NCT00423670|459067557|FG001|Treatment Period|Non-compliance with protocol|1|||
127572941|NCT00423670|459067558|FG002|Treatment Period|Non-compliance with protocol|1|||
127572942|NCT00423670|459067559|FG003|Treatment Period|Non-compliance with protocol|3|||
127572943|NCT00423670|459067560|FG004|Treatment Period|Non-compliance with protocol|2|||
127572944|NCT00423670|459067561|FG005|Treatment Period|Non-compliance with protocol|0|||
127572945|NCT00423670|459067562|FG006|Treatment Period|Non-compliance with protocol|2|||
127572946|NCT00423670|459067563|FG007|Treatment Period|Non-compliance with protocol|2|||
127781607|NCT00467779|459827799|FG002|Stage 1A|Withdrawal by Subject|0|||
127781608|NCT00467779|459827800|FG003|Stage 1A|Withdrawal by Subject|0|||
127781609|NCT00467779|459827801|FG004|Stage 1A|Withdrawal by Subject|0|||
127781610|NCT00467779|459827802|FG005|Stage 1A|Withdrawal by Subject|0|||
127572947|NCT00423670|459067556|FG000|Follow-up Period|Lost to Follow-up|0|||
127572948|NCT00423670|459067557|FG001|Follow-up Period|Lost to Follow-up|12|||
127572949|NCT00423670|459067558|FG002|Follow-up Period|Lost to Follow-up|8|||
127572950|NCT00423670|459067559|FG003|Follow-up Period|Lost to Follow-up|3|||
127572951|NCT00423670|459067560|FG004|Follow-up Period|Lost to Follow-up|1|||
127572952|NCT00423670|459067561|FG005|Follow-up Period|Lost to Follow-up|0|||
127572953|NCT00423670|459067562|FG006|Follow-up Period|Lost to Follow-up|5|||
127572954|NCT00423670|459067563|FG007|Follow-up Period|Lost to Follow-up|0|||
127572955|NCT00423670|459067556|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
127572956|NCT00423670|459067557|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
127572957|NCT00423670|459067558|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
127572958|NCT00423670|459067559|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
127572959|NCT00423670|459067560|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
127572960|NCT00423670|459067561|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
127572961|NCT00423670|459067562|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
127572962|NCT00423670|459067563|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
127572963|NCT00423670|459067556|FG000|Follow-up Period|Non-compliance with protocol|2|||
127572964|NCT00423670|459067557|FG001|Follow-up Period|Non-compliance with protocol|0|||
127572965|NCT00423670|459067558|FG002|Follow-up Period|Non-compliance with protocol|1|||
127572966|NCT00423670|459067559|FG003|Follow-up Period|Non-compliance with protocol|1|||
127572967|NCT00423670|459067560|FG004|Follow-up Period|Non-compliance with protocol|0|||
127572968|NCT00423670|459067561|FG005|Follow-up Period|Non-compliance with protocol|0|||
127572969|NCT00423670|459067562|FG006|Follow-up Period|Non-compliance with protocol|3|||
127572970|NCT00423670|459067563|FG007|Follow-up Period|Non-compliance with protocol|2|||
127572971|NCT00450112|459067564|FG000|Overall Study|Other Treatment Required|5|||
127572972|NCT00450112|459067565|FG001|Overall Study|Other Treatment Required|1|||
127572973|NCT00450112|459067564|FG000|Overall Study|Withdrawal by Subject|4|||
127572974|NCT00450112|459067565|FG001|Overall Study|Withdrawal by Subject|1|||
127572975|NCT00450112|459067564|FG000|Overall Study|Lost to Follow-up|2|||
127572976|NCT00450112|459067565|FG001|Overall Study|Lost to Follow-up|1|||
127572977|NCT00450112|459067564|FG000|Overall Study|Others|2|||
127572978|NCT00450112|459067565|FG001|Overall Study|Others|3|||
127572979|NCT02962765|459067566|FG000|Overall Study|Protocol Violation|9|||
127572980|NCT02962765|459067566|FG000|Overall Study|Withdrawal by Subject|3|||
127572981|NCT02962765|459067566|FG000|Overall Study|Lost to Follow-up|1|||
127572982|NCT02962765|459067566|FG000|Overall Study|Death|1|||
127572983|NCT02962765|459067566|FG000|Overall Study|Limited access to study medication|3|||
127572984|NCT00750880|459067570|FG000|Overall Study|Adverse Event|76|||
127572985|NCT00750880|459067570|FG000|Overall Study|Death|4|||
127572986|NCT00750880|459067570|FG000|Overall Study|Lack of Efficacy|46|||
127572987|NCT00750880|459067570|FG000|Overall Study|Lost to Follow-up|10|||
127572988|NCT00750880|459067570|FG000|Overall Study|Protocol Violation|15|||
127572989|NCT00750880|459067570|FG000|Overall Study|Withdrawal by Subject|33|||
127572990|NCT00750880|459067570|FG000|Overall Study|Physician Decision|20|||
127572991|NCT00750880|459067570|FG000|Overall Study|Administrative|11|||
127572992|NCT02964507|459067571|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
127572993|NCT02964507|459067572|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
127572994|NCT02964507|459067573|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
127572995|NCT02964507|459067574|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
127572996|NCT02964507|459067575|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
127572997|NCT02964507|459067576|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
127572998|NCT02964507|459067577|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
127572999|NCT02964507|459067578|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
127573000|NCT02964507|459067571|FG000|Overall Study|Study terminated by Sponsor|9|||
127573001|NCT02964507|459067572|FG001|Overall Study|Study terminated by Sponsor|1|||
127573002|NCT02964507|459067573|FG002|Overall Study|Study terminated by Sponsor|9|||
127573003|NCT02964507|459067574|FG003|Overall Study|Study terminated by Sponsor|3|||
127573004|NCT02964507|459067575|FG004|Overall Study|Study terminated by Sponsor|3|||
127573005|NCT02964507|459067576|FG005|Overall Study|Study terminated by Sponsor|2|||
127573006|NCT02964507|459067577|FG006|Overall Study|Study terminated by Sponsor|0|||
127573007|NCT02964507|459067578|FG007|Overall Study|Study terminated by Sponsor|0|||
127573008|NCT02964507|459067571|FG000|Overall Study|Other|3|||
127573009|NCT02964507|459067572|FG001|Overall Study|Other|0|||
127573010|NCT02964507|459067573|FG002|Overall Study|Other|0|||
127573011|NCT02964507|459067574|FG003|Overall Study|Other|0|||
127573012|NCT02964507|459067575|FG004|Overall Study|Other|1|||
127573013|NCT02964507|459067576|FG005|Overall Study|Other|0|||
127573014|NCT02964507|459067577|FG006|Overall Study|Other|0|||
127573015|NCT02964507|459067578|FG007|Overall Study|Other|0|||
127573016|NCT02964507|459067571|FG000|Overall Study|Death|11|||
127573017|NCT02964507|459067572|FG001|Overall Study|Death|9|||
127573018|NCT02964507|459067573|FG002|Overall Study|Death|12|||
127573019|NCT02964507|459067574|FG003|Overall Study|Death|2|||
127573020|NCT02964507|459067575|FG004|Overall Study|Death|10|||
127573021|NCT02964507|459067576|FG005|Overall Study|Death|5|||
127573022|NCT02964507|459067577|FG006|Overall Study|Death|0|||
128029291|NCT03760068|460732153|FG000|Overall Study|Lost to Follow-up|4|||
128029292|NCT03760068|460732154|FG001|Overall Study|Lost to Follow-up|9|||
128029293|NCT03760068|460732153|FG000|Overall Study|Subject Moved Out of State|1|||
127781611|NCT00467779|459827803|FG006|Stage 1A|Withdrawal by Subject|0|||
127781612|NCT00467779|459827804|FG007|Stage 1A|Withdrawal by Subject|0|||
127573023|NCT02964507|459067578|FG007|Overall Study|Death|0|||
127573024|NCT02964507|459067571|FG000|Overall Study|Withdrawal by Subject|1|||
127573025|NCT02964507|459067572|FG001|Overall Study|Withdrawal by Subject|0|||
127573026|NCT02964507|459067573|FG002|Overall Study|Withdrawal by Subject|1|||
127573027|NCT02964507|459067574|FG003|Overall Study|Withdrawal by Subject|1|||
127573028|NCT02964507|459067575|FG004|Overall Study|Withdrawal by Subject|0|||
127573029|NCT02964507|459067576|FG005|Overall Study|Withdrawal by Subject|1|||
127573030|NCT02964507|459067577|FG006|Overall Study|Withdrawal by Subject|0|||
127573031|NCT02964507|459067578|FG007|Overall Study|Withdrawal by Subject|0|||
127573032|NCT02964507|459067571|FG000|Overall Study|Physician Decision|2|||
127573033|NCT02964507|459067572|FG001|Overall Study|Physician Decision|0|||
127573034|NCT02964507|459067573|FG002|Overall Study|Physician Decision|3|||
127573035|NCT02964507|459067574|FG003|Overall Study|Physician Decision|0|||
127573036|NCT02964507|459067575|FG004|Overall Study|Physician Decision|1|||
127573037|NCT02964507|459067576|FG005|Overall Study|Physician Decision|0|||
127573038|NCT02964507|459067577|FG006|Overall Study|Physician Decision|0|||
127573039|NCT02964507|459067578|FG007|Overall Study|Physician Decision|0|||
127573040|NCT01484938|459067579|FG000|Overall Study|Adverse Event|2|||
127573041|NCT01484938|459067579|FG000|Overall Study|Lost to Follow-up|1|||
127573042|NCT01484938|459067579|FG000|Overall Study|Noncompliance|1|||
127573043|NCT02942576|459067580|FG000|Overall Study|Adverse Event|28|||
127573044|NCT02942576|459067581|FG001|Overall Study|Adverse Event|6|||
127573045|NCT02942576|459067580|FG000|Overall Study|Withdrawal by Subject|7|||
127573046|NCT02942576|459067581|FG001|Overall Study|Withdrawal by Subject|5|||
127573047|NCT02942576|459067580|FG000|Overall Study|Physician Decision|1|||
127573048|NCT02942576|459067581|FG001|Overall Study|Physician Decision|4|||
127573049|NCT02942576|459067580|FG000|Overall Study|Other|10|||
127573050|NCT02942576|459067581|FG001|Overall Study|Other|8|||
127573051|NCT00938964|459067582|FG000|Overall Study|Death|3|||
127573052|NCT00938964|459067583|FG001|Overall Study|Death|3|||
127573053|NCT00938964|459067582|FG000|Overall Study|Lost to Follow-up|2|||
127573054|NCT00938964|459067583|FG001|Overall Study|Lost to Follow-up|3|||
127573055|NCT00938964|459067582|FG000|Overall Study|Withdrawal by Subject|22|||
127573056|NCT00938964|459067583|FG001|Overall Study|Withdrawal by Subject|18|||
127781613|NCT00467779|459827805|FG008|Stage 1A|Withdrawal by Subject|0|||
127781614|NCT00467779|459827806|FG009|Stage 1A|Withdrawal by Subject|0|||
127781615|NCT00467779|459827807|FG010|Stage 1A|Withdrawal by Subject|1|||
127781616|NCT00467779|459827808|FG011|Stage 1A|Withdrawal by Subject|1|||
127781617|NCT00467779|459827809|FG012|Stage 1A|Withdrawal by Subject|1|||
127781618|NCT00467779|459827810|FG013|Stage 1A|Withdrawal by Subject|0|||
127781619|NCT00467779|459827811|FG014|Stage 1A|Withdrawal by Subject|0|||
127781620|NCT00467779|459827797|FG000|Stage 1A|Unspecified Reason|0|||
127781621|NCT00467779|459827798|FG001|Stage 1A|Unspecified Reason|0|||
128029294|NCT03760068|460732154|FG001|Overall Study|Subject Moved Out of State|0|||
128029295|NCT03460704|460732158|FG000|Overall Study|Withdrawal by Subject|11|||
128029296|NCT03460704|460732159|FG001|Overall Study|Withdrawal by Subject|14|||
128029297|NCT03460704|460732158|FG000|Overall Study|Study terminated by the Sponsor|29|||
128029298|NCT03460704|460732159|FG001|Overall Study|Study terminated by the Sponsor|19|||
128029299|NCT03460704|460732158|FG000|Overall Study|Adverse Event|10|||
128029300|NCT03460704|460732159|FG001|Overall Study|Adverse Event|5|||
128029301|NCT03460704|460732158|FG000|Overall Study|Death|3|||
127573057|NCT00938964|459067582|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
127573058|NCT00938964|459067583|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
127573059|NCT01227564|459067589|FG000|Overall Study|No Longer Willing to Participate|4|||
127573060|NCT01227564|459067590|FG001|Overall Study|No Longer Willing to Participate|2|||
127573061|NCT01227564|459067591|FG002|Overall Study|No Longer Willing to Participate|5|||
127573062|NCT01227564|459067589|FG000|Overall Study|Participant moved to another town|0|||
127573063|NCT01227564|459067590|FG001|Overall Study|Participant moved to another town|0|||
127573064|NCT01227564|459067591|FG002|Overall Study|Participant moved to another town|1|||
127573065|NCT02862600|459067597|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
127573066|NCT02862600|459067597|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
127573067|NCT02862600|459067597|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
127573068|NCT02862600|459067597|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
127573069|NCT01309308|459067616|FG000|Overall Study|Lost to Follow-up|6|||
127573070|NCT01309308|459067617|FG001|Overall Study|Lost to Follow-up|4|||
127573071|NCT01574079|459067620|FG000|Overall Study|Physician Decision|0|||
127573072|NCT01574079|459067621|FG001|Overall Study|Physician Decision|2|||
127573073|NCT01574079|459067620|FG000|Overall Study|Lost to Follow-up|1|||
128029302|NCT03460704|460732159|FG001|Overall Study|Death|2|||
128029303|NCT03460704|460732158|FG000|Overall Study|Non-Compliance with Study Drug|3|||
127573074|NCT01574079|459067621|FG001|Overall Study|Lost to Follow-up|0|||
127781622|NCT00467779|459827799|FG002|Stage 1A|Unspecified Reason|0|||
127573075|NCT03640559|459067624|FG000|Overall Study|Physician Decision|1|||
127573076|NCT03640559|459067625|FG001|Overall Study|Physician Decision|1|||
127573077|NCT03640559|459067624|FG000|Overall Study|Withdrawal by Subject|1|||
127573078|NCT03640559|459067625|FG001|Overall Study|Withdrawal by Subject|0|||
127573079|NCT01436162|459067626|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
127573080|NCT01436162|459067627|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
127573081|NCT01436162|459067628|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
127573082|NCT01436162|459067626|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
127573083|NCT01436162|459067627|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
127573084|NCT01436162|459067628|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
127573085|NCT01436162|459067626|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
127573086|NCT01436162|459067627|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
127573087|NCT01436162|459067628|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
127573088|NCT01436162|459067626|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
127573089|NCT01436162|459067627|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
127573090|NCT01436162|459067628|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
127573091|NCT01436162|459067626|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
127573092|NCT01436162|459067627|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
127573093|NCT01436162|459067628|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
127573094|NCT01436162|459067626|FG000|Single-blind Lead-in Phase|Other|107|||
127573095|NCT01436162|459067627|FG001|Single-blind Lead-in Phase|Other|0|||
127573096|NCT01436162|459067628|FG002|Single-blind Lead-in Phase|Other|0|||
127573097|NCT01436162|459067626|FG000|Randomized Phase|Adverse Event|1|||
127573098|NCT01436162|459067627|FG001|Randomized Phase|Adverse Event|5|||
127573099|NCT01436162|459067628|FG002|Randomized Phase|Adverse Event|6|||
127573100|NCT01436162|459067626|FG000|Randomized Phase|Protocol Violation|4|||
127573101|NCT01436162|459067627|FG001|Randomized Phase|Protocol Violation|4|||
127573102|NCT01436162|459067628|FG002|Randomized Phase|Protocol Violation|2|||
127573103|NCT01436162|459067626|FG000|Randomized Phase|Withdrawal by Subject|16|||
127573104|NCT01436162|459067627|FG001|Randomized Phase|Withdrawal by Subject|9|||
127573105|NCT01436162|459067628|FG002|Randomized Phase|Withdrawal by Subject|8|||
127573106|NCT01436162|459067626|FG000|Randomized Phase|Lost to Follow-up|17|||
127573107|NCT01436162|459067627|FG001|Randomized Phase|Lost to Follow-up|5|||
127573108|NCT01436162|459067628|FG002|Randomized Phase|Lost to Follow-up|4|||
127573109|NCT01436162|459067626|FG000|Randomized Phase|Lack of Efficacy|0|||
127573110|NCT01436162|459067627|FG001|Randomized Phase|Lack of Efficacy|1|||
127573111|NCT01436162|459067628|FG002|Randomized Phase|Lack of Efficacy|1|||
127573112|NCT01436162|459067626|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
127573113|NCT01436162|459067627|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
127781623|NCT00467779|459827800|FG003|Stage 1A|Unspecified Reason|0|||
127781624|NCT00467779|459827801|FG004|Stage 1A|Unspecified Reason|0|||
127781625|NCT00467779|459827802|FG005|Stage 1A|Unspecified Reason|0|||
127781626|NCT00467779|459827803|FG006|Stage 1A|Unspecified Reason|0|||
127781627|NCT00467779|459827804|FG007|Stage 1A|Unspecified Reason|0|||
127781628|NCT00467779|459827805|FG008|Stage 1A|Unspecified Reason|0|||
127781629|NCT00467779|459827806|FG009|Stage 1A|Unspecified Reason|0|||
127781630|NCT00467779|459827807|FG010|Stage 1A|Unspecified Reason|0|||
127781631|NCT00467779|459827808|FG011|Stage 1A|Unspecified Reason|1|||
127781632|NCT00467779|459827809|FG012|Stage 1A|Unspecified Reason|1|||
127781633|NCT00467779|459827810|FG013|Stage 1A|Unspecified Reason|0|||
127781634|NCT00467779|459827811|FG014|Stage 1A|Unspecified Reason|0|||
127781635|NCT00467779|459827797|FG000|Stage 2|Adverse Event|0|||
127781636|NCT00467779|459827798|FG001|Stage 2|Adverse Event|0|||
127781637|NCT00467779|459827799|FG002|Stage 2|Adverse Event|0|||
127781638|NCT00467779|459827800|FG003|Stage 2|Adverse Event|0|||
127573114|NCT01436162|459067628|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
127573115|NCT01436162|459067626|FG000|Randomized Phase|Other|2|||
127573116|NCT01436162|459067627|FG001|Randomized Phase|Other|5|||
127573117|NCT01436162|459067628|FG002|Randomized Phase|Other|4|||
127573118|NCT02211638|459067629|FG000|Overall Study|Case Report Forms Uncollected|291|||
127573119|NCT02211638|459067629|FG000|Overall Study|Protocol Violation|692|||
127573120|NCT04041700|459067632|FG000|Overall Study|Pregnancy|1|||
127573121|NCT04041700|459067632|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
127573122|NCT02775903|459067633|FG000|Overall Study|Death|7|||
127573123|NCT02775903|459067634|FG001|Overall Study|Death|11|||
127573124|NCT02775903|459067635|FG002|Overall Study|Death|12|||
127573125|NCT02775903|459067636|FG003|Overall Study|Death|11|||
127573126|NCT02775903|459067633|FG000|Overall Study|Adverse Event|0|||
127781639|NCT00467779|459827801|FG004|Stage 2|Adverse Event|0|||
127573127|NCT02775903|459067634|FG001|Overall Study|Adverse Event|1|||
127573128|NCT02775903|459067635|FG002|Overall Study|Adverse Event|12|||
127573129|NCT02775903|459067636|FG003|Overall Study|Adverse Event|3|||
127573130|NCT02775903|459067633|FG000|Overall Study|Progressive disease|15|||
127573131|NCT02775903|459067634|FG001|Overall Study|Progressive disease|14|||
127573132|NCT02775903|459067635|FG002|Overall Study|Progressive disease|30|||
127573133|NCT02775903|459067636|FG003|Overall Study|Progressive disease|20|||
127573134|NCT02775903|459067633|FG000|Overall Study|Lack of Efficacy|2|||
127573135|NCT02775903|459067634|FG001|Overall Study|Lack of Efficacy|2|||
127573136|NCT02775903|459067635|FG002|Overall Study|Lack of Efficacy|2|||
127573137|NCT02775903|459067636|FG003|Overall Study|Lack of Efficacy|6|||
127573138|NCT02775903|459067633|FG000|Overall Study|Withdrawal by Subject|7|||
127573139|NCT02775903|459067634|FG001|Overall Study|Withdrawal by Subject|5|||
127573140|NCT02775903|459067635|FG002|Overall Study|Withdrawal by Subject|5|||
127573141|NCT02775903|459067636|FG003|Overall Study|Withdrawal by Subject|8|||
127573142|NCT02775903|459067633|FG000|Overall Study|Other reasons|7|||
127573143|NCT02775903|459067634|FG001|Overall Study|Other reasons|8|||
127573144|NCT02775903|459067635|FG002|Overall Study|Other reasons|2|||
127573145|NCT02775903|459067636|FG003|Overall Study|Other reasons|12|||
127573146|NCT04571515|459067639|FG000|Overall Study|Physician Decision|0|||
127573147|NCT04571515|459067640|FG001|Overall Study|Physician Decision|0|||
127573148|NCT04571515|459067641|FG002|Overall Study|Physician Decision|0|||
127573149|NCT04571515|459067642|FG003|Overall Study|Physician Decision|0|||
127573150|NCT04571515|459067643|FG004|Overall Study|Physician Decision|1|||
127573151|NCT04571515|459067639|FG000|Overall Study|Withdrawal by Subject|0|||
127573152|NCT04571515|459067640|FG001|Overall Study|Withdrawal by Subject|0|||
127573153|NCT04571515|459067641|FG002|Overall Study|Withdrawal by Subject|0|||
127573154|NCT04571515|459067642|FG003|Overall Study|Withdrawal by Subject|0|||
127573155|NCT04571515|459067643|FG004|Overall Study|Withdrawal by Subject|1|||
127573156|NCT04571515|459067639|FG000|Overall Study|insufficient pain|1|||
127573157|NCT04571515|459067640|FG001|Overall Study|insufficient pain|0|||
127573158|NCT04571515|459067641|FG002|Overall Study|insufficient pain|0|||
127573159|NCT04571515|459067642|FG003|Overall Study|insufficient pain|0|||
127573160|NCT04571515|459067643|FG004|Overall Study|insufficient pain|1|||
127573161|NCT05140382|459067644|FG000|Overall Study|Death|3|||
127781640|NCT00467779|459827802|FG005|Stage 2|Adverse Event|0|||
127781641|NCT00467779|459827803|FG006|Stage 2|Adverse Event|0|||
127781642|NCT00467779|459827804|FG007|Stage 2|Adverse Event|0|||
127781643|NCT00467779|459827805|FG008|Stage 2|Adverse Event|1|||
127781644|NCT00467779|459827806|FG009|Stage 2|Adverse Event|0|||
127781645|NCT00467779|459827807|FG010|Stage 2|Adverse Event|0|||
127573162|NCT05140382|459067645|FG001|Overall Study|Death|0|||
127573163|NCT05140382|459067646|FG002|Overall Study|Death|0|||
127573164|NCT05140382|459067644|FG000|Overall Study|Investigator decision|1|||
127573165|NCT05140382|459067645|FG001|Overall Study|Investigator decision|0|||
127573166|NCT05140382|459067646|FG002|Overall Study|Investigator decision|0|||
127573167|NCT05140382|459067644|FG000|Overall Study|Other|4|||
127573168|NCT05140382|459067645|FG001|Overall Study|Other|0|||
127573169|NCT05140382|459067646|FG002|Overall Study|Other|1|||
127781646|NCT00467779|459827808|FG011|Stage 2|Adverse Event|0|||
127781647|NCT00467779|459827809|FG012|Stage 2|Adverse Event|0|||
127781648|NCT00467779|459827810|FG013|Stage 2|Adverse Event|0|||
127781649|NCT00467779|459827811|FG014|Stage 2|Adverse Event|0|||
127781650|NCT00467779|459827797|FG000|Stage 2|Death|0|||
127781651|NCT00467779|459827798|FG001|Stage 2|Death|0|||
127781652|NCT00467779|459827799|FG002|Stage 2|Death|0|||
127781653|NCT00467779|459827800|FG003|Stage 2|Death|0|||
127781654|NCT00467779|459827801|FG004|Stage 2|Death|0|||
127781655|NCT00467779|459827802|FG005|Stage 2|Death|0|||
127781656|NCT00467779|459827803|FG006|Stage 2|Death|0|||
127781657|NCT00467779|459827804|FG007|Stage 2|Death|0|||
127781658|NCT00467779|459827805|FG008|Stage 2|Death|1|||
127781659|NCT00467779|459827806|FG009|Stage 2|Death|0|||
127781660|NCT00467779|459827807|FG010|Stage 2|Death|0|||
127781661|NCT00467779|459827808|FG011|Stage 2|Death|0|||
127573170|NCT05140382|459067644|FG000|Overall Study|Progressive disease|20|||
127573171|NCT05140382|459067645|FG001|Overall Study|Progressive disease|1|||
127573172|NCT05140382|459067646|FG002|Overall Study|Progressive disease|12|||
127573173|NCT05140382|459067644|FG000|Overall Study|Subjective disease progression|2|||
127573174|NCT05140382|459067645|FG001|Overall Study|Subjective disease progression|1|||
127573175|NCT05140382|459067646|FG002|Overall Study|Subjective disease progression|0|||
127781662|NCT00467779|459827809|FG012|Stage 2|Death|0|||
127573176|NCT05140382|459067644|FG000|Overall Study|Unknown at data cut-off|0|||
127573177|NCT05140382|459067645|FG001|Overall Study|Unknown at data cut-off|0|||
127573178|NCT05140382|459067646|FG002|Overall Study|Unknown at data cut-off|1|||
127781663|NCT00467779|459827810|FG013|Stage 2|Death|0|||
127781664|NCT00467779|459827811|FG014|Stage 2|Death|0|||
127781665|NCT00467779|459827797|FG000|Stage 2|Disease Progression|0|||
127781666|NCT00467779|459827798|FG001|Stage 2|Disease Progression|0|||
127781667|NCT00467779|459827799|FG002|Stage 2|Disease Progression|0|||
127781668|NCT00467779|459827800|FG003|Stage 2|Disease Progression|0|||
127781669|NCT00467779|459827801|FG004|Stage 2|Disease Progression|0|||
127781670|NCT00467779|459827802|FG005|Stage 2|Disease Progression|0|||
127573179|NCT05140382|459067644|FG000|Overall Study|Withdrawal by Subject|1|||
127573180|NCT05140382|459067645|FG001|Overall Study|Withdrawal by Subject|0|||
127573181|NCT05140382|459067646|FG002|Overall Study|Withdrawal by Subject|4|||
127573182|NCT05140382|459067644|FG000|Overall Study|Withdrawal of consent|0|||
127573183|NCT05140382|459067645|FG001|Overall Study|Withdrawal of consent|0|||
127573184|NCT05140382|459067646|FG002|Overall Study|Withdrawal of consent|1|||
127573185|NCT02294773|459069144|FG000|Overall Study|Withdrawal by Subject|0|||
127573186|NCT02294773|459069145|FG001|Overall Study|Withdrawal by Subject|2|||
127573187|NCT03052764|459069146|FG000|Double-Blind Treatment Period|Adverse Event|2|||
127573188|NCT03052764|459069147|FG001|Double-Blind Treatment Period|Adverse Event|0|||
127573189|NCT03052764|459069146|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
127573190|NCT03052764|459069147|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
127573191|NCT03052764|459069146|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
127573192|NCT03052764|459069147|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
127573193|NCT03052764|459069146|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
127573194|NCT03052764|459069147|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
127573195|NCT03052764|459069146|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
127573196|NCT03052764|459069147|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
127573197|NCT05828095|459069148|FG000|Overall Study|Lost to Follow-up|1|||
127573198|NCT05828095|459069149|FG001|Overall Study|Lost to Follow-up|0|||
127573199|NCT05828095|459069148|FG000|Overall Study|Reactogenicity symptom|0|||
127573200|NCT05828095|459069149|FG001|Overall Study|Reactogenicity symptom|1|||
127573201|NCT03206073|459069150|FG000|Overall Study|Participant Noncompliance|0|||
127573202|NCT03206073|459069151|FG001|Overall Study|Participant Noncompliance|1|||
127573203|NCT03206073|459069152|FG002|Overall Study|Participant Noncompliance|0|||
127573204|NCT03206073|459069153|FG003|Overall Study|Participant Noncompliance|0|||
127573205|NCT03206073|459069150|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
127573206|NCT03206073|459069151|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
127573207|NCT03206073|459069152|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
127573208|NCT03206073|459069153|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
127573209|NCT03206073|459069150|FG000|Overall Study|Death|0|||
127573210|NCT03206073|459069151|FG001|Overall Study|Death|0|||
127573211|NCT03206073|459069152|FG002|Overall Study|Death|1|||
127573212|NCT03206073|459069153|FG003|Overall Study|Death|0|||
127573213|NCT03206073|459069150|FG000|Overall Study|Taken off active treatment|0|||
127573214|NCT03206073|459069151|FG001|Overall Study|Taken off active treatment|0|||
127573215|NCT03206073|459069152|FG002|Overall Study|Taken off active treatment|3|||
127573216|NCT03206073|459069153|FG003|Overall Study|Taken off active treatment|0|||
127573217|NCT03332771|459069154|FG000|Overall Study|Adverse Event|6|||
127573218|NCT03332771|459069155|FG001|Overall Study|Adverse Event|4|||
127573219|NCT03332771|459069156|FG002|Overall Study|Adverse Event|1|||
127573220|NCT03332771|459069157|FG003|Overall Study|Adverse Event|3|||
127573221|NCT03332771|459069154|FG000|Overall Study|Poor Compliance to Protocol|0|||
127573222|NCT03332771|459069155|FG001|Overall Study|Poor Compliance to Protocol|1|||
127573223|NCT03332771|459069156|FG002|Overall Study|Poor Compliance to Protocol|0|||
127573224|NCT03332771|459069157|FG003|Overall Study|Poor Compliance to Protocol|1|||
127573225|NCT03332771|459069154|FG000|Overall Study|Lost to Follow-up|2|||
127573226|NCT03332771|459069155|FG001|Overall Study|Lost to Follow-up|2|||
127573227|NCT03332771|459069156|FG002|Overall Study|Lost to Follow-up|1|||
127573228|NCT03332771|459069157|FG003|Overall Study|Lost to Follow-up|2|||
127573229|NCT03332771|459069154|FG000|Overall Study|At the Participant's own request|20|||
127573230|NCT03332771|459069155|FG001|Overall Study|At the Participant's own request|26|||
127573231|NCT03332771|459069156|FG002|Overall Study|At the Participant's own request|14|||
127573232|NCT03332771|459069157|FG003|Overall Study|At the Participant's own request|23|||
127573233|NCT03332771|459069154|FG000|Overall Study|Reason Not Specified|6|||
127573234|NCT03332771|459069155|FG001|Overall Study|Reason Not Specified|18|||
127573235|NCT03332771|459069156|FG002|Overall Study|Reason Not Specified|16|||
127573236|NCT03332771|459069157|FG003|Overall Study|Reason Not Specified|19|||
127573237|NCT00096954|459069158|FG000|Overall Study|Adverse Event|3|||
127573238|NCT00096954|459069159|FG001|Overall Study|Adverse Event|1|||
127573239|NCT00096954|459069158|FG000|Overall Study|Withdrawal by Subject|9|||
127573240|NCT00096954|459069159|FG001|Overall Study|Withdrawal by Subject|8|||
127692576|NCT02119650|459500141|FG000|Overall Study|Noncompliance with study treatment|1|||
127692577|NCT02119650|459500142|FG001|Overall Study|Noncompliance with study treatment|1|||
127692578|NCT02119650|459500141|FG000|Overall Study|Study terminated by the sponsor|1|||
127692579|NCT02119650|459500142|FG001|Overall Study|Study terminated by the sponsor|0|||
127692580|NCT02119650|459500141|FG000|Overall Study|Physician Decision|0|||
127692581|NCT02119650|459500142|FG001|Overall Study|Physician Decision|2|||
127692582|NCT02119650|459500141|FG000|Overall Study|Multiple reasons for termination|2|||
127692583|NCT02119650|459500142|FG001|Overall Study|Multiple reasons for termination|1|||
127573241|NCT00096954|459069158|FG000|Overall Study|Physician Decision|1|||
127573242|NCT00096954|459069159|FG001|Overall Study|Physician Decision|1|||
127573243|NCT00096954|459069158|FG000|Overall Study|Sponsors Decision|1|||
127692584|NCT01721291|459500143|FG000|Overall Study|Withdrawal by Subject|1|||
127573244|NCT00096954|459069159|FG001|Overall Study|Sponsors Decision|1|||
127573245|NCT00096954|459069158|FG000|Overall Study|Pregnancy|1|||
127573246|NCT00096954|459069159|FG001|Overall Study|Pregnancy|1|||
127573247|NCT00096954|459069158|FG000|Overall Study|Initiation of immunotherapy|1|||
127573248|NCT00096954|459069159|FG001|Overall Study|Initiation of immunotherapy|0|||
127573249|NCT00096954|459069158|FG000|Overall Study|Non-compliance|0|||
127573250|NCT00096954|459069159|FG001|Overall Study|Non-compliance|3|||
127573251|NCT00096954|459069158|FG000|Overall Study|Lost to Follow-up|8|||
127573252|NCT00096954|459069159|FG001|Overall Study|Lost to Follow-up|5|||
127573253|NCT04478123|459069161|FG000|Overall Study|Pt withdrawal or refusal before begin prot txt|2|||
127573254|NCT04478123|459069161|FG000|Overall Study|NE|1|||
127573255|NCT03581786|459069164|FG000|Overall Study|Death|67|||
127573256|NCT03581786|459069165|FG001|Overall Study|Death|47|||
127573257|NCT03581786|459069164|FG000|Overall Study|Withdrawal by Subject|2|||
127573258|NCT03581786|459069165|FG001|Overall Study|Withdrawal by Subject|5|||
127573259|NCT03581786|459069164|FG000|Overall Study|Lost to Follow-up|7|||
127573260|NCT03581786|459069165|FG001|Overall Study|Lost to Follow-up|4|||
127573261|NCT03581786|459069164|FG000|Overall Study|reason other than specified above|0|||
127573262|NCT03581786|459069165|FG001|Overall Study|reason other than specified above|1|||
127573263|NCT01347307|459069168|FG000|Overall Study|Death|0|||
127573264|NCT01347307|459069169|FG001|Overall Study|Death|4|||
127573265|NCT01347307|459069168|FG000|Overall Study|Physician Decision|0|||
127573266|NCT01347307|459069169|FG001|Overall Study|Physician Decision|1|||
127573267|NCT04123665|459069174|FG000|Overall Study|Withdrawal by Subject|7|||
127573268|NCT04123665|459069175|FG001|Overall Study|Withdrawal by Subject|0|||
127573269|NCT04123665|459069174|FG000|Overall Study|Lost to Follow-up|1|||
127573270|NCT04123665|459069175|FG001|Overall Study|Lost to Follow-up|0|||
127573271|NCT02237911|459069176|FG000|Overall Study|Withdrawal by Subject|4|||
127573272|NCT02237911|459069177|FG001|Overall Study|Withdrawal by Subject|7|||
127573273|NCT02237911|459069178|FG002|Overall Study|Withdrawal by Subject|2|||
127573274|NCT02237911|459069176|FG000|Overall Study|Lost to Follow-up|3|||
127573275|NCT02237911|459069177|FG001|Overall Study|Lost to Follow-up|1|||
127573276|NCT02237911|459069178|FG002|Overall Study|Lost to Follow-up|1|||
127573277|NCT00053365|459069179|FG000|Overall Study|Incorrect cell type|1|||
127573278|NCT00053365|459069179|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
127573279|NCT00053365|459069179|FG000|Overall Study|Never treated|4|||
127573280|NCT00958789|459069184|FG000|Overall Study|Death|5|||
127573281|NCT00958789|459069184|FG000|Overall Study|Lost to Follow-up|14|||
127573282|NCT00958789|459069184|FG000|Overall Study|Withdrawal by Subject|17|||
127573283|NCT00958789|459069184|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
127573284|NCT00958789|459069184|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
127573285|NCT00958789|459069184|FG000|Overall Study|Subject terminated|2|||
127573286|NCT00958789|459069184|FG000|Overall Study|Revision|7|||
127573287|NCT00427960|459069185|FG000|Overall Study|Adverse Event|2|||
127573288|NCT00427960|459069186|FG001|Overall Study|Adverse Event|0|||
127573289|NCT00427960|459069185|FG000|Overall Study|Withdrawal by Subject|0|||
127573290|NCT00427960|459069186|FG001|Overall Study|Withdrawal by Subject|3|||
127573291|NCT00427960|459069185|FG000|Overall Study|Other|0|||
127573292|NCT00427960|459069186|FG001|Overall Study|Other|1|||
127573293|NCT03282565|459069188|FG000|Overall Study|COVID-19 Research Shutdown|0|||
127573294|NCT03282565|459069189|FG001|Overall Study|COVID-19 Research Shutdown|2|||
127573295|NCT03282565|459069190|FG002|Overall Study|COVID-19 Research Shutdown|2|||
127573296|NCT04163718|459069191|FG000|Overall Study|Study terminated|12|||
127573297|NCT02131532|459069192|FG000|Overall Study|Withdrawal by Subject|1|||
127573298|NCT02131532|459069192|FG000|Overall Study|Physician Decision|1|||
127573299|NCT02131532|459069192|FG000|Overall Study|Other health conditions|2|||
127573300|NCT01264016|459069193|FG000|Overall Study|Withdrawal by Subject|1|||
127573301|NCT01264016|459069193|FG000|Overall Study|Felt faint at sight of blood|1|||
127573302|NCT00417482|459069194|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
127573303|NCT00417482|459069195|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
127573304|NCT00417482|459069196|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
127573305|NCT00417482|459069194|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
127573306|NCT00417482|459069195|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
127573307|NCT00417482|459069196|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
127781671|NCT00467779|459827803|FG006|Stage 2|Disease Progression|0|||
127573308|NCT00417482|459069194|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
127573309|NCT00417482|459069195|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
127573310|NCT00417482|459069196|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
127573311|NCT00417482|459069194|FG000|Phase B 1st 16 Weeks|Death|1|||
127573312|NCT00417482|459069195|FG001|Phase B 1st 16 Weeks|Death|0|||
127573313|NCT00417482|459069196|FG002|Phase B 1st 16 Weeks|Death|0|||
127573314|NCT00417482|459069194|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
127573315|NCT00417482|459069195|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
127573316|NCT00417482|459069196|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
127573317|NCT00417482|459069194|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
127573318|NCT00417482|459069195|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
127573319|NCT00417482|459069196|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
127573320|NCT00417482|459069194|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
127573321|NCT00417482|459069195|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
127573322|NCT00417482|459069196|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
127573323|NCT00417482|459069194|FG000|Phase B 2nd 16 Weeks|Death|1|||
127573324|NCT00417482|459069195|FG001|Phase B 2nd 16 Weeks|Death|1|||
127573325|NCT00417482|459069196|FG002|Phase B 2nd 16 Weeks|Death|0|||
127573326|NCT06400979|459069199|FG000|Overall Study|Lost to Follow-up|29|||
127573327|NCT06400979|459069199|FG000|Overall Study|Withdrawal by Subject|1|||
127573328|NCT03739840|459069200|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
127573329|NCT03739840|459069201|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
127573330|NCT03739840|459069202|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
127573331|NCT03739840|459069203|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
127573332|NCT03739840|459069200|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
127573333|NCT03739840|459069201|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
127573334|NCT03739840|459069202|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
127573335|NCT03739840|459069203|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
127573336|NCT03739840|459069200|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
127573337|NCT03739840|459069201|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
127573338|NCT03739840|459069202|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
127573339|NCT03739840|459069203|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
127573340|NCT03739840|459069200|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
127573341|NCT03739840|459069201|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
127573342|NCT03739840|459069202|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
127573343|NCT03739840|459069203|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
127573344|NCT03739840|459069200|FG000|Treatment Period: Wk0-16|Program Termination|3|||
127573345|NCT03739840|459069201|FG001|Treatment Period: Wk0-16|Program Termination|0|||
127573346|NCT03739840|459069202|FG002|Treatment Period: Wk0-16|Program Termination|1|||
127573347|NCT03739840|459069203|FG003|Treatment Period: Wk0-16|Program Termination|1|||
127573348|NCT03739840|459069200|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
127573349|NCT03739840|459069201|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
127573350|NCT03739840|459069202|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
127573351|NCT03739840|459069203|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
127573352|NCT03739840|459069200|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
127573353|NCT03739840|459069201|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
127573354|NCT03739840|459069202|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
127573355|NCT03739840|459069203|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
127573356|NCT03739840|459069200|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
127573357|NCT03739840|459069201|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
127573358|NCT03739840|459069202|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
127573359|NCT03739840|459069203|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
127573360|NCT03739840|459069200|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
127573361|NCT03739840|459069201|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
127573362|NCT03739840|459069202|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
127573363|NCT03739840|459069203|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
127573364|NCT03739840|459069200|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
127573365|NCT03739840|459069201|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
127573366|NCT03739840|459069202|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
127573367|NCT03739840|459069203|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
127692585|NCT01721291|459500144|FG001|Overall Study|Withdrawal by Subject|0|||
127692586|NCT01721291|459500143|FG000|Overall Study|did not like the treatment|1|||
128029304|NCT03460704|460732159|FG001|Overall Study|Non-Compliance with Study Drug|0|||
128029305|NCT03460704|460732158|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
128029306|NCT03460704|460732159|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
128029307|NCT03460704|460732158|FG000|Overall Study|Other|2|||
128029308|NCT03460704|460732159|FG001|Overall Study|Other|1|||
128029309|NCT02913326|460732164|FG000|Overall Study|Reason not listed|0|||
128029310|NCT02913326|460732165|FG001|Overall Study|Reason not listed|1|||
128029311|NCT02913326|460732164|FG000|Overall Study|Lost to Follow-up|0|||
128029312|NCT02913326|460732165|FG001|Overall Study|Lost to Follow-up|1|||
128029313|NCT02913326|460732164|FG000|Overall Study|Adverse Event|1|||
128029314|NCT02913326|460732165|FG001|Overall Study|Adverse Event|0|||
128029315|NCT01767857|460732166|FG000|Overall Study|Adverse Event|27|||
128029316|NCT01767857|460732167|FG001|Overall Study|Adverse Event|7|||
128029317|NCT01767857|460732166|FG000|Overall Study|Death|28|||
128029318|NCT01767857|460732167|FG001|Overall Study|Death|13|||
127573368|NCT03739840|459069200|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
127573369|NCT03739840|459069201|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
127573370|NCT03739840|459069202|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
127573371|NCT03739840|459069203|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
127573372|NCT03739840|459069200|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
127573373|NCT03739840|459069201|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
128029319|NCT01767857|460732166|FG000|Overall Study|Lack of Efficacy|299|||
128029320|NCT01767857|460732167|FG001|Overall Study|Lack of Efficacy|151|||
127573374|NCT03739840|459069202|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
127573375|NCT03739840|459069203|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
127573376|NCT03739840|459069200|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
127573377|NCT03739840|459069201|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
127573378|NCT03739840|459069202|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
127573379|NCT03739840|459069203|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
127573380|NCT03739840|459069200|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
127573381|NCT03739840|459069201|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
127573382|NCT03739840|459069202|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
127573383|NCT03739840|459069203|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
128029321|NCT01767857|460732166|FG000|Overall Study|Lost to Follow-up|1|||
128029322|NCT01767857|460732167|FG001|Overall Study|Lost to Follow-up|1|||
128029323|NCT01767857|460732166|FG000|Overall Study|Withdrawal by Subject|38|||
128029324|NCT01767857|460732167|FG001|Overall Study|Withdrawal by Subject|18|||
128029325|NCT01767857|460732166|FG000|Overall Study|Physician Decision|17|||
128029326|NCT01767857|460732167|FG001|Overall Study|Physician Decision|10|||
128029327|NCT01767857|460732166|FG000|Overall Study|Protocol Terminated|1|||
128029328|NCT01767857|460732167|FG001|Overall Study|Protocol Terminated|0|||
128029329|NCT01767857|460732166|FG000|Overall Study|Randomized But Never Treated|19|||
128029330|NCT01767857|460732167|FG001|Overall Study|Randomized But Never Treated|13|||
128029331|NCT00420056|460732184|FG000|Overall Study|Objective progression or relapse|17|||
128029332|NCT01044459|460732193|FG000|Overall Study|Withdrawal by Subject|21|||
128029333|NCT01044459|460732194|FG001|Overall Study|Withdrawal by Subject|28|||
128029334|NCT01044459|460732193|FG000|Overall Study|Terminated by Sponsor|22|||
128029335|NCT01044459|460732194|FG001|Overall Study|Terminated by Sponsor|21|||
128029336|NCT01044459|460732193|FG000|Overall Study|Adverse Event|22|||
128029337|NCT01044459|460732194|FG001|Overall Study|Adverse Event|20|||
128029338|NCT01044459|460732193|FG000|Overall Study|Lack of Efficacy|23|||
128029339|NCT01044459|460732194|FG001|Overall Study|Lack of Efficacy|12|||
128029340|NCT01044459|460732193|FG000|Overall Study|Protocol Violation|11|||
128029341|NCT01044459|460732194|FG001|Overall Study|Protocol Violation|16|||
128029342|NCT01044459|460732193|FG000|Overall Study|Other Reason|7|||
128029343|NCT01044459|460732194|FG001|Overall Study|Other Reason|14|||
128029344|NCT01044459|460732193|FG000|Overall Study|COPD exacerbation|9|||
128029345|NCT01044459|460732194|FG001|Overall Study|COPD exacerbation|8|||
128029346|NCT01044459|460732193|FG000|Overall Study|Lost to Follow-up|18|||
128029347|NCT01044459|460732194|FG001|Overall Study|Lost to Follow-up|12|||
128029348|NCT04634331|460732195|FG000|Overall Study|Withdrawal by Subject|2|||
128029349|NCT04634331|460732196|FG001|Overall Study|Withdrawal by Subject|2|||
128029350|NCT05069415|460733546|FG000|Overall Study|Withdrawal by Subject|2|||
128029351|NCT05069415|460733547|FG001|Overall Study|Withdrawal by Subject|0|||
128029352|NCT05069415|460733546|FG000|Overall Study|Adverse Event|2|||
128029353|NCT05069415|460733547|FG001|Overall Study|Adverse Event|0|||
128029354|NCT00203242|460733548|FG000|Overall Study|Lost to Follow-up|1|||
128029355|NCT00866775|460733549|FG000|Overall Study|Adverse Event|5|||
128029356|NCT00866775|460733550|FG001|Overall Study|Adverse Event|19|||
128029357|NCT00866775|460733549|FG000|Overall Study|Death|1|||
128029358|NCT00866775|460733550|FG001|Overall Study|Death|0|||
128029359|NCT00866775|460733549|FG000|Overall Study|Lost to Follow-up|0|||
128029360|NCT00866775|460733550|FG001|Overall Study|Lost to Follow-up|4|||
128029361|NCT00866775|460733549|FG000|Overall Study|Physician Decision|0|||
128029362|NCT00866775|460733550|FG001|Overall Study|Physician Decision|3|||
128029363|NCT00866775|460733549|FG000|Overall Study|Protocol Violation|3|||
128029364|NCT00866775|460733550|FG001|Overall Study|Protocol Violation|4|||
128029365|NCT00866775|460733549|FG000|Overall Study|Withdrawal by Subject|4|||
128029366|NCT00866775|460733550|FG001|Overall Study|Withdrawal by Subject|4|||
128029367|NCT00866775|460733549|FG000|Overall Study|met exit criteria|23|||
128029368|NCT00866775|460733550|FG001|Overall Study|met exit criteria|17|||
127573384|NCT03739840|459069200|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
127573385|NCT03739840|459069201|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
128029369|NCT00866775|460733549|FG000|Overall Study|discontinued due to communication error|0|||
128029370|NCT00866775|460733550|FG001|Overall Study|discontinued due to communication error|1|||
128029371|NCT01500135|460733551|FG000|Overall Study|Withdrawal of Consent|4|||
128029372|NCT01500135|460733552|FG001|Overall Study|Withdrawal of Consent|0|||
128029373|NCT01500135|460733551|FG000|Overall Study|Lost to Follow-up|6|||
128029374|NCT01500135|460733552|FG001|Overall Study|Lost to Follow-up|4|||
128029375|NCT01500135|460733551|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
128029376|NCT01500135|460733552|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
127573386|NCT03739840|459069202|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
127573387|NCT03739840|459069203|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
127573388|NCT03739840|459069200|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
127573389|NCT03739840|459069201|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
127573390|NCT03739840|459069202|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
127573391|NCT03739840|459069203|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
127573392|NCT03739840|459069200|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
127573393|NCT03739840|459069201|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
127573394|NCT03739840|459069202|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
127573395|NCT03739840|459069203|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
127573396|NCT03739840|459069200|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
127573397|NCT03739840|459069201|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
127573398|NCT03739840|459069202|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
127573399|NCT03739840|459069203|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
127573400|NCT03739840|459069200|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
127573401|NCT03739840|459069201|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
127573402|NCT03739840|459069202|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
127573403|NCT03739840|459069203|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
127573404|NCT03739840|459069200|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
127573405|NCT03739840|459069201|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
127573406|NCT03739840|459069202|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
127573407|NCT03739840|459069203|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
127573408|NCT03739840|459069200|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
127573409|NCT03739840|459069201|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
127573410|NCT03739840|459069202|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
127573411|NCT03739840|459069203|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
127573412|NCT03739840|459069200|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
127573413|NCT03739840|459069201|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
127573414|NCT03739840|459069202|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
127573415|NCT03739840|459069203|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
127573416|NCT03739840|459069200|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
127573417|NCT03739840|459069201|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
127573418|NCT03739840|459069202|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
127573419|NCT03739840|459069203|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
127573420|NCT03739840|459069200|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
127573421|NCT03739840|459069201|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
127573422|NCT03739840|459069202|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
127573423|NCT03739840|459069203|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
127573424|NCT03739840|459069200|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
127573425|NCT03739840|459069201|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
127573426|NCT03739840|459069202|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
127573427|NCT03739840|459069203|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
127573428|NCT01058265|459069206|FG000|Overall Study|Lost to Follow-up|11|||
127573429|NCT01058265|459069207|FG001|Overall Study|Lost to Follow-up|12|||
127573430|NCT02169284|459069210|FG000|Overall Study|Physician Decision|0|||
127573431|NCT02169284|459069211|FG001|Overall Study|Physician Decision|1|||
127573432|NCT00984568|459069212|FG000|Overall Study|Withdrawal by Subject|1|||
127573433|NCT00984568|459069213|FG001|Overall Study|Withdrawal by Subject|2|||
127573434|NCT00984568|459069212|FG000|Overall Study|Lack of Efficacy|2|||
127573435|NCT00984568|459069213|FG001|Overall Study|Lack of Efficacy|0|||
127573436|NCT00984568|459069212|FG000|Overall Study|Adverse Event|2|||
127573437|NCT00984568|459069213|FG001|Overall Study|Adverse Event|0|||
127573438|NCT00984568|459069212|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
128029377|NCT01500135|460733551|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
128029378|NCT01500135|460733552|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
127573439|NCT00984568|459069213|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
127573440|NCT00984568|459069212|FG000|Overall Study|Lost to Follow-up|0|||
127573441|NCT00984568|459069213|FG001|Overall Study|Lost to Follow-up|1|||
127573442|NCT00984568|459069212|FG000|Overall Study|Opportunistic Infection|1|||
127573443|NCT00984568|459069213|FG001|Overall Study|Opportunistic Infection|0|||
127573444|NCT00984568|459069212|FG000|Overall Study|Unknown Reason|1|||
127573445|NCT00984568|459069213|FG001|Overall Study|Unknown Reason|3|||
127573446|NCT03583073|459069214|FG000|Overall Study|Lost to Follow-up|8|||
127573447|NCT03583073|459069215|FG001|Overall Study|Lost to Follow-up|12|||
127573448|NCT01367119|459069216|FG000|Overall Study|Adverse Event|1|||
128029379|NCT01500135|460733551|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
128029380|NCT01500135|460733552|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
128029381|NCT01500135|460733551|FG000|Overall Study|Participant was a Safety Concern|1|||
128029382|NCT01500135|460733552|FG001|Overall Study|Participant was a Safety Concern|0|||
128029383|NCT01500135|460733551|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
128029384|NCT01500135|460733552|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
128029385|NCT01998477|460733553|FG000|Overall Study|Lost to Follow-up|4|||
128029386|NCT01998477|460733554|FG001|Overall Study|Lost to Follow-up|5|||
127573449|NCT01367119|459069217|FG001|Overall Study|Adverse Event|0|||
127573450|NCT01367119|459069216|FG000|Overall Study|Withdrawal by Subject|1|||
127573451|NCT01367119|459069217|FG001|Overall Study|Withdrawal by Subject|1|||
127573452|NCT03180684|459069218|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
127573453|NCT03180684|459069219|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
127573454|NCT03180684|459069218|FG000|Overall Study|Physician Decision|1|||
127573455|NCT03180684|459069219|FG001|Overall Study|Physician Decision|0|||
127573456|NCT03180684|459069218|FG000|Overall Study|Lost to Follow-up|1|||
127573457|NCT03180684|459069219|FG001|Overall Study|Lost to Follow-up|0|||
127573458|NCT03180684|459069218|FG000|Overall Study|Progressive Disease|1|||
127573459|NCT03180684|459069219|FG001|Overall Study|Progressive Disease|0|||
127573460|NCT02675231|459069220|FG000|Overall Study|Withdrawal by Subject|2|||
127573461|NCT02675231|459069221|FG001|Overall Study|Withdrawal by Subject|4|||
127573462|NCT02675231|459069222|FG002|Overall Study|Withdrawal by Subject|2|||
127573463|NCT02675231|459069220|FG000|Overall Study|Lost to Follow-up|3|||
127573464|NCT02675231|459069221|FG001|Overall Study|Lost to Follow-up|4|||
127573465|NCT02675231|459069222|FG002|Overall Study|Lost to Follow-up|3|||
127573466|NCT02495233|459069225|FG000|Overall Study|Miscellaneous|0|||
127573467|NCT02495233|459069226|FG001|Overall Study|Miscellaneous|1|||
127573468|NCT03880461|459069228|FG000|Overall Study|Determined ineligible after enrollment|45|||
127573469|NCT03880461|459069229|FG001|Overall Study|Determined ineligible after enrollment|44|||
127573470|NCT03880461|459069228|FG000|Overall Study|No weight measurement after enrollment|24|||
127573471|NCT03880461|459069229|FG001|Overall Study|No weight measurement after enrollment|17|||
127573472|NCT04025710|459069233|FG000|Overall Study|Death|3|||
127573473|NCT04025710|459069233|FG000|Overall Study|Lost to Follow-up|5|||
128029387|NCT01998477|460733553|FG000|Overall Study|Withdrawal by Subject|6|||
128029388|NCT01998477|460733554|FG001|Overall Study|Withdrawal by Subject|0|||
128029389|NCT05345405|460733555|FG000|Overall Study|Withdrawal by Subject|2|||
127692587|NCT01721291|459500144|FG001|Overall Study|did not like the treatment|0|||
127692588|NCT04774237|459500155|FG000|Visit 2 First Intervention|Withdrawal by Subject|0|||
127692589|NCT04774237|459500156|FG001|Visit 2 First Intervention|Withdrawal by Subject|0|||
127573474|NCT04025710|459069233|FG000|Overall Study|Withdrawal by Subject|1|||
127573475|NCT04025710|459069233|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
127573476|NCT04025710|459069233|FG000|Overall Study|Drop-out according to protocol|34|||
127573477|NCT02431247|459069234|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
127573478|NCT02431247|459069235|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
127573479|NCT02431247|459069236|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
127573480|NCT02431247|459069234|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
127692590|NCT04774237|459500157|FG002|Visit 2 First Intervention|Withdrawal by Subject|0|||
127692591|NCT04774237|459500158|FG003|Visit 2 First Intervention|Withdrawal by Subject|0|||
127573481|NCT02431247|459069235|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
127573482|NCT02431247|459069236|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
127573483|NCT02431247|459069234|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
127573484|NCT02431247|459069235|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
127573485|NCT02431247|459069236|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
127573486|NCT02431247|459069234|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
127573487|NCT02431247|459069235|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
127573488|NCT02431247|459069236|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
127573489|NCT02431247|459069234|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
127573490|NCT02431247|459069235|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
127573491|NCT02431247|459069236|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
127573492|NCT02431247|459069234|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
127573493|NCT02431247|459069235|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
127573494|NCT02431247|459069236|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
127573495|NCT02431247|459069234|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
127573496|NCT02431247|459069235|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
127692592|NCT04774237|459500159|FG004|Visit 2 First Intervention|Withdrawal by Subject|1|||
127573497|NCT02431247|459069236|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
127573498|NCT02431247|459069234|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
127692593|NCT04774237|459500160|FG005|Visit 2 First Intervention|Withdrawal by Subject|0|||
128029390|NCT05345405|460733556|FG001|Overall Study|Withdrawal by Subject|0|||
128029391|NCT05345405|460733557|FG002|Overall Study|Withdrawal by Subject|0|||
128029392|NCT05345405|460733555|FG000|Overall Study|Did not meet eligibility criteria|0|||
127781672|NCT00467779|459827804|FG007|Stage 2|Disease Progression|0|||
127573499|NCT02431247|459069235|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
127573500|NCT02431247|459069236|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
127573501|NCT02431247|459069234|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
127573502|NCT02431247|459069235|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
127573503|NCT02431247|459069236|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
127573504|NCT02431247|459069234|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
127573505|NCT02431247|459069235|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
127573506|NCT02431247|459069236|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
127573507|NCT02431247|459069234|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
127573508|NCT02431247|459069235|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
127573509|NCT02431247|459069236|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
127573510|NCT02431247|459069234|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
127573511|NCT02431247|459069235|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
127781673|NCT00467779|459827805|FG008|Stage 2|Disease Progression|16|||
127781674|NCT00467779|459827806|FG009|Stage 2|Disease Progression|0|||
127781675|NCT00467779|459827807|FG010|Stage 2|Disease Progression|0|||
127781676|NCT00467779|459827808|FG011|Stage 2|Disease Progression|0|||
127781677|NCT00467779|459827809|FG012|Stage 2|Disease Progression|0|||
127781678|NCT00467779|459827810|FG013|Stage 2|Disease Progression|0|||
127781679|NCT00467779|459827811|FG014|Stage 2|Disease Progression|0|||
127781680|NCT00467779|459827797|FG000|Stage 2|Unspecified Reason|0|||
127781681|NCT00467779|459827798|FG001|Stage 2|Unspecified Reason|0|||
127573512|NCT02431247|459069236|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
127781682|NCT00467779|459827799|FG002|Stage 2|Unspecified Reason|0|||
127781683|NCT00467779|459827800|FG003|Stage 2|Unspecified Reason|0|||
127781684|NCT00467779|459827801|FG004|Stage 2|Unspecified Reason|0|||
127781685|NCT00467779|459827802|FG005|Stage 2|Unspecified Reason|0|||
127781686|NCT00467779|459827803|FG006|Stage 2|Unspecified Reason|0|||
127781687|NCT00467779|459827804|FG007|Stage 2|Unspecified Reason|0|||
127781688|NCT00467779|459827805|FG008|Stage 2|Unspecified Reason|3|||
127573513|NCT02431247|459069234|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
127573514|NCT02431247|459069235|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
127573515|NCT02431247|459069236|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
127573516|NCT02431247|459069234|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
127573517|NCT02431247|459069235|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
127573518|NCT02431247|459069236|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
127573519|NCT01562873|459069237|FG000|Overall Study|Disease Progression per RECIST|10|||
127781689|NCT00467779|459827806|FG009|Stage 2|Unspecified Reason|0|||
127781690|NCT00467779|459827807|FG010|Stage 2|Unspecified Reason|0|||
127781691|NCT00467779|459827808|FG011|Stage 2|Unspecified Reason|0|||
127781692|NCT00467779|459827809|FG012|Stage 2|Unspecified Reason|0|||
127781693|NCT00467779|459827810|FG013|Stage 2|Unspecified Reason|0|||
127781694|NCT00467779|459827811|FG014|Stage 2|Unspecified Reason|0|||
127781695|NCT00467779|459827797|FG000|Stage 2A|Adverse Event|0|||
127781696|NCT00467779|459827798|FG001|Stage 2A|Adverse Event|0|||
127781697|NCT00467779|459827799|FG002|Stage 2A|Adverse Event|0|||
127781698|NCT00467779|459827800|FG003|Stage 2A|Adverse Event|0|||
127781699|NCT00467779|459827801|FG004|Stage 2A|Adverse Event|0|||
127781700|NCT00467779|459827802|FG005|Stage 2A|Adverse Event|0|||
128029393|NCT05345405|460733556|FG001|Overall Study|Did not meet eligibility criteria|2|||
128029394|NCT05345405|460733557|FG002|Overall Study|Did not meet eligibility criteria|0|||
128029395|NCT05345405|460733555|FG000|Overall Study|Lost to Follow-up|0|||
128029396|NCT05345405|460733556|FG001|Overall Study|Lost to Follow-up|0|||
128029397|NCT05345405|460733557|FG002|Overall Study|Lost to Follow-up|1|||
128029398|NCT02872142|460733560|FG000|Overall Study|Adverse Event|2|||
127573520|NCT01562873|459069238|FG001|Overall Study|Disease Progression per RECIST|0|||
127573521|NCT01562873|459069237|FG000|Overall Study|Adverse Event|1|||
127573522|NCT01562873|459069238|FG001|Overall Study|Adverse Event|0|||
127573523|NCT01562873|459069237|FG000|Overall Study|Clinical Disease Progression|9|||
127573524|NCT01562873|459069238|FG001|Overall Study|Clinical Disease Progression|0|||
127573525|NCT01562873|459069237|FG000|Overall Study|Clinical PD and adverse event|1|||
127573526|NCT01562873|459069238|FG001|Overall Study|Clinical PD and adverse event|0|||
127573527|NCT01369485|459069239|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
127573528|NCT01369485|459069240|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
127781701|NCT00467779|459827803|FG006|Stage 2A|Adverse Event|0|||
127781702|NCT00467779|459827804|FG007|Stage 2A|Adverse Event|0|||
127781703|NCT00467779|459827805|FG008|Stage 2A|Adverse Event|0|||
128029399|NCT02872142|460733560|FG000|Overall Study|Death|1|||
127573529|NCT01369485|459069239|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
127573530|NCT01369485|459069240|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
127573531|NCT01369485|459069239|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
127781704|NCT00467779|459827806|FG009|Stage 2A|Adverse Event|0|||
127781705|NCT00467779|459827807|FG010|Stage 2A|Adverse Event|0|||
127781706|NCT00467779|459827808|FG011|Stage 2A|Adverse Event|0|||
127781707|NCT00467779|459827809|FG012|Stage 2A|Adverse Event|0|||
127781708|NCT00467779|459827810|FG013|Stage 2A|Adverse Event|2|||
127781709|NCT00467779|459827811|FG014|Stage 2A|Adverse Event|0|||
127781710|NCT00467779|459827797|FG000|Stage 2A|Death|0|||
127781711|NCT00467779|459827798|FG001|Stage 2A|Death|0|||
127781712|NCT00467779|459827799|FG002|Stage 2A|Death|0|||
127781713|NCT00467779|459827800|FG003|Stage 2A|Death|0|||
127781714|NCT00467779|459827801|FG004|Stage 2A|Death|0|||
127781715|NCT00467779|459827802|FG005|Stage 2A|Death|0|||
128029400|NCT02872142|460733560|FG000|Overall Study|Participant Decision|3|||
128029401|NCT01903720|460733561|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
128029402|NCT01903720|460733561|FG000|Overall Study|Adverse Event|1|||
128029403|NCT01903720|460733561|FG000|Overall Study|Rescinding of informed consent|2|||
128029404|NCT01903720|460733561|FG000|Overall Study|Lost to Follow-up|2|||
127573532|NCT01369485|459069240|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
127573533|NCT01369485|459069239|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
127573534|NCT01369485|459069240|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
127573535|NCT01369485|459069239|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
127573536|NCT01369485|459069240|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
127573537|NCT01369485|459069239|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
127573538|NCT01369485|459069240|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
127573539|NCT01369485|459069239|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
127573540|NCT01369485|459069240|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
127573541|NCT01369485|459069239|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
127573542|NCT01369485|459069240|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
127573543|NCT01369485|459069239|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
127573544|NCT01369485|459069240|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
127573545|NCT01369485|459069239|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
127573546|NCT01369485|459069240|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
127573547|NCT01858636|459069242|FG000|Overall Study|No Device Deployment Attempted|24|||
127573548|NCT01858636|459069242|FG000|Overall Study|Physician Decision|1|||
127573549|NCT01858636|459069242|FG000|Overall Study|Death|1|||
127573550|NCT01858636|459069242|FG000|Overall Study|Lost to Follow-up|1|||
127573551|NCT01858636|459069242|FG000|Overall Study|Withdrawal by Subject|1|||
127573552|NCT03523000|459069244|FG000|Overall Study|Withdrawal by Subject|3|||
127573553|NCT03523000|459069245|FG001|Overall Study|Withdrawal by Subject|0|||
127573554|NCT03523000|459069244|FG000|Overall Study|Unsuccessful trial|2|||
127573555|NCT03523000|459069245|FG001|Overall Study|Unsuccessful trial|0|||
127692594|NCT05134337|459501569|FG000|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|3|||
127692595|NCT05134337|459501570|FG001|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|0|||
127692596|NCT02349412|459501573|FG000|Overall Study|Withdrawal by Subject|7|||
127692597|NCT02349412|459501574|FG001|Overall Study|Withdrawal by Subject|7|||
127692598|NCT03460236|459501575|FG000|Overall Study|failed radiographic screening|16|||
127692599|NCT03460236|459501575|FG000|Overall Study|Withdrawal by Subject|11|||
127692600|NCT00979576|459501578|FG000|Combination Treatment Phase|Progressive disease|3|||
127692601|NCT00979576|459501579|FG001|Combination Treatment Phase|Progressive disease|1|||
127692602|NCT00979576|459501580|FG002|Combination Treatment Phase|Progressive disease|5|||
127692603|NCT00979576|459501578|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
127692604|NCT00979576|459501579|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
127692605|NCT00979576|459501580|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
127692606|NCT00979576|459501578|FG000|Combination Treatment Phase|Adverse Event|0|||
127692607|NCT00979576|459501579|FG001|Combination Treatment Phase|Adverse Event|2|||
127692608|NCT00979576|459501580|FG002|Combination Treatment Phase|Adverse Event|2|||
127692609|NCT00979576|459501578|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
127692610|NCT00979576|459501579|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
127692611|NCT00979576|459501580|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
127692612|NCT04840199|459501581|FG000|Overall Study|Study Terminated by Sponsor|8|||
127692613|NCT04840199|459501582|FG001|Overall Study|Study Terminated by Sponsor|9|||
127692614|NCT04840199|459501581|FG000|Overall Study|Lost to Follow-up|0|||
127692615|NCT04840199|459501582|FG001|Overall Study|Lost to Follow-up|2|||
127692616|NCT04840199|459501581|FG000|Overall Study|Withdrawal by Subject|2|||
127692617|NCT04840199|459501582|FG001|Overall Study|Withdrawal by Subject|0|||
127692618|NCT04840199|459501581|FG000|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
127692619|NCT04840199|459501582|FG001|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
127692620|NCT05215847|459501583|FG000|Overall Study|Lost to Follow-up|1|||
127692621|NCT02728557|459501588|FG000|Overall Study|Dissatisfaction with assigned treatment|1|||
127692622|NCT02728557|459501589|FG001|Overall Study|Dissatisfaction with assigned treatment|3|||
127781716|NCT00467779|459827803|FG006|Stage 2A|Death|0|||
127781717|NCT00467779|459827804|FG007|Stage 2A|Death|0|||
127573556|NCT00937391|459069259|FG000|Stage 2|Withdrawal by Subject|1|||
127692623|NCT02728557|459501588|FG000|Overall Study|Dissatisfaction with research tasks|0|||
127781718|NCT00467779|459827805|FG008|Stage 2A|Death|0|||
127781719|NCT00467779|459827806|FG009|Stage 2A|Death|0|||
128029405|NCT01903720|460733561|FG000|Overall Study|Treatment with alternative drug|1|||
128029406|NCT02244957|460733562|FG000|Overall Study|Lack of Efficacy|1|||
128029407|NCT02244957|460733563|FG001|Overall Study|Lack of Efficacy|0|||
127781720|NCT00467779|459827807|FG010|Stage 2A|Death|0|||
127781721|NCT00467779|459827808|FG011|Stage 2A|Death|0|||
127781722|NCT00467779|459827809|FG012|Stage 2A|Death|0|||
127781723|NCT00467779|459827810|FG013|Stage 2A|Death|1|||
127781724|NCT00467779|459827811|FG014|Stage 2A|Death|0|||
127781725|NCT00467779|459827797|FG000|Stage 2A|Disease Progression|0|||
127781726|NCT00467779|459827798|FG001|Stage 2A|Disease Progression|0|||
127781727|NCT00467779|459827799|FG002|Stage 2A|Disease Progression|0|||
127781728|NCT00467779|459827800|FG003|Stage 2A|Disease Progression|0|||
127781729|NCT00467779|459827801|FG004|Stage 2A|Disease Progression|0|||
127781730|NCT00467779|459827802|FG005|Stage 2A|Disease Progression|0|||
127781731|NCT00467779|459827803|FG006|Stage 2A|Disease Progression|0|||
127781732|NCT00467779|459827804|FG007|Stage 2A|Disease Progression|0|||
127781733|NCT00467779|459827805|FG008|Stage 2A|Disease Progression|0|||
127781734|NCT00467779|459827806|FG009|Stage 2A|Disease Progression|0|||
127781735|NCT00467779|459827807|FG010|Stage 2A|Disease Progression|0|||
127781736|NCT00467779|459827808|FG011|Stage 2A|Disease Progression|0|||
127781737|NCT00467779|459827809|FG012|Stage 2A|Disease Progression|0|||
127781738|NCT00467779|459827810|FG013|Stage 2A|Disease Progression|10|||
127781739|NCT00467779|459827811|FG014|Stage 2A|Disease Progression|0|||
127781740|NCT00467779|459827797|FG000|Stage 2A|Unspecified Reason|0|||
127781741|NCT00467779|459827798|FG001|Stage 2A|Unspecified Reason|0|||
127781742|NCT00467779|459827799|FG002|Stage 2A|Unspecified Reason|0|||
127781743|NCT00467779|459827800|FG003|Stage 2A|Unspecified Reason|0|||
127781744|NCT00467779|459827801|FG004|Stage 2A|Unspecified Reason|0|||
127781745|NCT00467779|459827802|FG005|Stage 2A|Unspecified Reason|0|||
127781746|NCT00467779|459827803|FG006|Stage 2A|Unspecified Reason|0|||
127781747|NCT00467779|459827804|FG007|Stage 2A|Unspecified Reason|0|||
127781748|NCT00467779|459827805|FG008|Stage 2A|Unspecified Reason|0|||
127781749|NCT00467779|459827806|FG009|Stage 2A|Unspecified Reason|0|||
127781750|NCT00467779|459827807|FG010|Stage 2A|Unspecified Reason|0|||
127781751|NCT00467779|459827808|FG011|Stage 2A|Unspecified Reason|0|||
127781752|NCT00467779|459827809|FG012|Stage 2A|Unspecified Reason|0|||
127781753|NCT00467779|459827810|FG013|Stage 2A|Unspecified Reason|7|||
127781754|NCT00467779|459827811|FG014|Stage 2A|Unspecified Reason|0|||
127781755|NCT00467779|459827797|FG000|Stage 2A|Withdrawal by Subject|0|||
127781756|NCT00467779|459827798|FG001|Stage 2A|Withdrawal by Subject|0|||
127781757|NCT00467779|459827799|FG002|Stage 2A|Withdrawal by Subject|0|||
127781758|NCT00467779|459827800|FG003|Stage 2A|Withdrawal by Subject|0|||
127781759|NCT00467779|459827801|FG004|Stage 2A|Withdrawal by Subject|0|||
127781760|NCT00467779|459827802|FG005|Stage 2A|Withdrawal by Subject|0|||
127781761|NCT00467779|459827803|FG006|Stage 2A|Withdrawal by Subject|0|||
127781762|NCT00467779|459827804|FG007|Stage 2A|Withdrawal by Subject|0|||
127781763|NCT00467779|459827805|FG008|Stage 2A|Withdrawal by Subject|0|||
127781764|NCT00467779|459827806|FG009|Stage 2A|Withdrawal by Subject|0|||
127781765|NCT00467779|459827807|FG010|Stage 2A|Withdrawal by Subject|0|||
127781766|NCT00467779|459827808|FG011|Stage 2A|Withdrawal by Subject|0|||
127781767|NCT00467779|459827809|FG012|Stage 2A|Withdrawal by Subject|0|||
127781768|NCT00467779|459827810|FG013|Stage 2A|Withdrawal by Subject|1|||
127781769|NCT00467779|459827811|FG014|Stage 2A|Withdrawal by Subject|0|||
127781770|NCT00467779|459827797|FG000|Stage 3|Adverse Event|0|||
127781771|NCT00467779|459827798|FG001|Stage 3|Adverse Event|0|||
127781772|NCT00467779|459827799|FG002|Stage 3|Adverse Event|0|||
127781773|NCT00467779|459827800|FG003|Stage 3|Adverse Event|0|||
127781774|NCT00467779|459827801|FG004|Stage 3|Adverse Event|0|||
127781775|NCT00467779|459827802|FG005|Stage 3|Adverse Event|0|||
127781776|NCT00467779|459827803|FG006|Stage 3|Adverse Event|0|||
127781777|NCT00467779|459827804|FG007|Stage 3|Adverse Event|0|||
127781778|NCT00467779|459827805|FG008|Stage 3|Adverse Event|0|||
127781779|NCT00467779|459827806|FG009|Stage 3|Adverse Event|0|||
127781780|NCT00467779|459827807|FG010|Stage 3|Adverse Event|0|||
127781781|NCT00467779|459827808|FG011|Stage 3|Adverse Event|0|||
127781782|NCT00467779|459827809|FG012|Stage 3|Adverse Event|0|||
127781783|NCT00467779|459827810|FG013|Stage 3|Adverse Event|0|||
127781784|NCT00467779|459827811|FG014|Stage 3|Adverse Event|2|||
127781785|NCT00467779|459827797|FG000|Stage 3|Death|0|||
127781786|NCT00467779|459827798|FG001|Stage 3|Death|0|||
127781787|NCT00467779|459827799|FG002|Stage 3|Death|0|||
127781788|NCT00467779|459827800|FG003|Stage 3|Death|0|||
127781789|NCT00467779|459827801|FG004|Stage 3|Death|0|||
127781790|NCT00467779|459827802|FG005|Stage 3|Death|0|||
127781791|NCT00467779|459827803|FG006|Stage 3|Death|0|||
128029408|NCT00830336|460733564|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
127781792|NCT00467779|459827804|FG007|Stage 3|Death|0|||
127781793|NCT00467779|459827805|FG008|Stage 3|Death|0|||
127781794|NCT00467779|459827806|FG009|Stage 3|Death|0|||
127781795|NCT00467779|459827807|FG010|Stage 3|Death|0|||
127781796|NCT00467779|459827808|FG011|Stage 3|Death|0|||
127781797|NCT00467779|459827809|FG012|Stage 3|Death|0|||
127781798|NCT00467779|459827810|FG013|Stage 3|Death|0|||
127781799|NCT00467779|459827811|FG014|Stage 3|Death|1|||
127781800|NCT00467779|459827797|FG000|Stage 3|Disease Progression|0|||
127573557|NCT03194490|459069278|FG000|Overall Study|Lost to Follow-up|1|||
127573558|NCT03194490|459069279|FG001|Overall Study|Lost to Follow-up|3|||
127573559|NCT03194490|459069278|FG000|Overall Study|participant developed specific neck pain|1|||
127573560|NCT03194490|459069279|FG001|Overall Study|participant developed specific neck pain|0|||
127573561|NCT01758289|459069280|FG000|Overall Study|Premature Study Termination|44|||
127573562|NCT01758289|459069280|FG000|Overall Study|Adverse Event|9|||
127573563|NCT01931202|459069285|FG000|Overall Study|Withdrawal by Subject|0|||
127573564|NCT01931202|459069286|FG001|Overall Study|Withdrawal by Subject|0|||
127573565|NCT01931202|459069287|FG002|Overall Study|Withdrawal by Subject|2|||
127573566|NCT01931202|459069285|FG000|Overall Study|Lost to Follow-up|0|||
127573567|NCT01931202|459069286|FG001|Overall Study|Lost to Follow-up|5|||
127573568|NCT01931202|459069287|FG002|Overall Study|Lost to Follow-up|2|||
127573569|NCT00721123|459070912|FG000|Overall Study|Adverse Event|96|||
127573570|NCT00721123|459070912|FG000|Overall Study|Death|10|||
127573571|NCT00721123|459070912|FG000|Overall Study|Insufficient Therapeutic Response|21|||
127573572|NCT00721123|459070912|FG000|Overall Study|Protocol Violation|1|||
127573573|NCT00721123|459070912|FG000|Overall Study|Refused Treatment|41|||
127573574|NCT00721123|459070912|FG000|Overall Study|Failure to Return|9|||
127573575|NCT00721123|459070912|FG000|Overall Study|Withdrawal by Subject|5|||
127573576|NCT04177355|459070916|FG000|Overall Study|Lost to Follow-up|0|||
127573577|NCT04177355|459070917|FG001|Overall Study|Lost to Follow-up|2|||
127573578|NCT04177355|459070918|FG002|Overall Study|Lost to Follow-up|0|||
127573579|NCT04177355|459070919|FG003|Overall Study|Lost to Follow-up|1|||
127573580|NCT04177355|459070920|FG004|Overall Study|Lost to Follow-up|2|||
127573581|NCT04177355|459070921|FG005|Overall Study|Lost to Follow-up|0|||
127573582|NCT04177355|459070922|FG006|Overall Study|Lost to Follow-up|1|||
127573583|NCT04177355|459070923|FG007|Overall Study|Lost to Follow-up|0|||
127573584|NCT04177355|459070924|FG008|Overall Study|Lost to Follow-up|0|||
127573585|NCT04177355|459070925|FG009|Overall Study|Lost to Follow-up|0|||
127573586|NCT04177355|459070926|FG010|Overall Study|Lost to Follow-up|0|||
127573587|NCT04177355|459070916|FG000|Overall Study|Withdrawal by Subject|0|||
127573588|NCT04177355|459070917|FG001|Overall Study|Withdrawal by Subject|0|||
127573589|NCT04177355|459070918|FG002|Overall Study|Withdrawal by Subject|0|||
128029409|NCT00830336|460733565|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
128029410|NCT00104884|460733572|FG000|Overall Study|Disease progression|4|||
128029411|NCT04893811|460733575|FG000|Vaccination Phase|Death|1|||
128029412|NCT04893811|460733576|FG001|Vaccination Phase|Death|0|||
128029413|NCT04893811|460733575|FG000|Vaccination Phase|Lost to Follow-up|1|||
128029414|NCT04893811|460733576|FG001|Vaccination Phase|Lost to Follow-up|1|||
128029415|NCT04893811|460733575|FG000|Vaccination Phase|Protocol Violation|2|||
128029416|NCT04893811|460733576|FG001|Vaccination Phase|Protocol Violation|0|||
128029417|NCT04893811|460733575|FG000|Vaccination Phase|Withdrawal by Subject|2|||
128029418|NCT04893811|460733576|FG001|Vaccination Phase|Withdrawal by Subject|1|||
128029419|NCT04893811|460733575|FG000|Vaccination Phase|Other|0|||
128029420|NCT04893811|460733576|FG001|Vaccination Phase|Other|1|||
128029421|NCT04893811|460733575|FG000|Vaccination Phase|No longer met eligibility criteria|0|||
128029422|NCT04893811|460733576|FG001|Vaccination Phase|No longer met eligibility criteria|1|||
128029423|NCT04893811|460733575|FG000|Follow-up Phase|Lost to Follow-up|0|||
128029424|NCT04893811|460733576|FG001|Follow-up Phase|Lost to Follow-up|1|||
128029425|NCT03268499|460733577|FG000|Overall Study|Withdrawal by Subject|2|||
128029426|NCT03268499|460733578|FG001|Overall Study|Withdrawal by Subject|1|||
128029427|NCT03533491|460733582|FG000|Overall Study|Lost to Follow-up|2|||
128029428|NCT01725282|460733585|FG000|Overall Study|Adverse Event|1|||
128029429|NCT01725282|460733586|FG001|Overall Study|Adverse Event|3|||
128029430|NCT01725282|460733587|FG002|Overall Study|Adverse Event|6|||
128029431|NCT01725282|460733588|FG003|Overall Study|Adverse Event|4|||
128029432|NCT01725282|460733585|FG000|Overall Study|Exacerbation of Target Disease|1|||
128029433|NCT01725282|460733586|FG001|Overall Study|Exacerbation of Target Disease|0|||
128029434|NCT01725282|460733587|FG002|Overall Study|Exacerbation of Target Disease|0|||
128029435|NCT01725282|460733588|FG003|Overall Study|Exacerbation of Target Disease|1|||
128029436|NCT01725282|460733585|FG000|Overall Study|Met Exclusion Criteria|0|||
128029437|NCT01725282|460733586|FG001|Overall Study|Met Exclusion Criteria|0|||
128029438|NCT01725282|460733587|FG002|Overall Study|Met Exclusion Criteria|1|||
128029439|NCT01725282|460733588|FG003|Overall Study|Met Exclusion Criteria|0|||
128029440|NCT01725282|460733585|FG000|Overall Study|Study Site Withdrawal|0|||
128029441|NCT01725282|460733586|FG001|Overall Study|Study Site Withdrawal|1|||
128029442|NCT01725282|460733587|FG002|Overall Study|Study Site Withdrawal|0|||
128029443|NCT01725282|460733588|FG003|Overall Study|Study Site Withdrawal|0|||
128029444|NCT01725282|460733585|FG000|Overall Study|Withdrawal by Subject|0|||
128029445|NCT01725282|460733586|FG001|Overall Study|Withdrawal by Subject|0|||
128029446|NCT01725282|460733587|FG002|Overall Study|Withdrawal by Subject|1|||
128029447|NCT01725282|460733588|FG003|Overall Study|Withdrawal by Subject|1|||
128029448|NCT01725282|460733585|FG000|Overall Study|Lack of Efficacy|0|||
127573590|NCT04177355|459070919|FG003|Overall Study|Withdrawal by Subject|1|||
128029449|NCT01725282|460733586|FG001|Overall Study|Lack of Efficacy|1|||
128029450|NCT01725282|460733587|FG002|Overall Study|Lack of Efficacy|0|||
128029451|NCT01725282|460733588|FG003|Overall Study|Lack of Efficacy|1|||
127573591|NCT04177355|459070920|FG004|Overall Study|Withdrawal by Subject|1|||
127573592|NCT04177355|459070921|FG005|Overall Study|Withdrawal by Subject|0|||
127573593|NCT04177355|459070922|FG006|Overall Study|Withdrawal by Subject|0|||
127573594|NCT04177355|459070923|FG007|Overall Study|Withdrawal by Subject|0|||
127573595|NCT04177355|459070924|FG008|Overall Study|Withdrawal by Subject|1|||
127573596|NCT04177355|459070925|FG009|Overall Study|Withdrawal by Subject|0|||
127573597|NCT04177355|459070926|FG010|Overall Study|Withdrawal by Subject|0|||
127573598|NCT00397943|459070927|FG000|Overall Study|Unspecified reasons|12|||
127573599|NCT00397943|459070928|FG001|Overall Study|Unspecified reasons|9|||
127573600|NCT00397943|459070929|FG002|Overall Study|Unspecified reasons|0|||
127573601|NCT00397943|459070930|FG003|Overall Study|Unspecified reasons|0|||
127573602|NCT00397943|459070931|FG004|Overall Study|Unspecified reasons|0|||
127573603|NCT04521777|459070932|FG000|Overall Study|Death|2|||
127573604|NCT04521777|459070932|FG000|Overall Study|Withdrawal by Subject|2|||
127573605|NCT00433511|459070935|FG000|Step 1|Adverse Event|50|||
127573606|NCT00433511|459070936|FG001|Step 1|Adverse Event|157|||
127573607|NCT00433511|459070937|FG002|Step 1|Adverse Event|153|||
127573608|NCT00433511|459070935|FG000|Step 1|Withdrawal by Subject|45|||
127573609|NCT00433511|459070936|FG001|Step 1|Withdrawal by Subject|143|||
127573610|NCT00433511|459070937|FG002|Step 1|Withdrawal by Subject|154|||
127573611|NCT00433511|459070935|FG000|Step 1|Death|3|||
127573612|NCT00433511|459070936|FG001|Step 1|Death|1|||
127573613|NCT00433511|459070937|FG002|Step 1|Death|1|||
127573614|NCT00433511|459070935|FG000|Step 1|Physician Decision|1|||
127573615|NCT00433511|459070936|FG001|Step 1|Physician Decision|4|||
127573616|NCT00433511|459070937|FG002|Step 1|Physician Decision|3|||
127573617|NCT00433511|459070935|FG000|Step 1|Never started protocol therapy|28|||
127573618|NCT00433511|459070936|FG001|Step 1|Never started protocol therapy|64|||
127573619|NCT00433511|459070937|FG002|Step 1|Never started protocol therapy|66|||
127573620|NCT00433511|459070935|FG000|Step 1|Alternative therapy|2|||
127573621|NCT00433511|459070936|FG001|Step 1|Alternative therapy|1|||
127573622|NCT00433511|459070937|FG002|Step 1|Alternative therapy|3|||
127573623|NCT00433511|459070935|FG000|Step 1|Disease progression, relapse|5|||
127573624|NCT00433511|459070936|FG001|Step 1|Disease progression, relapse|3|||
127573625|NCT00433511|459070937|FG002|Step 1|Disease progression, relapse|3|||
127573626|NCT00433511|459070935|FG000|Step 1|Other complicating disease|2|||
127573627|NCT00433511|459070936|FG001|Step 1|Other complicating disease|6|||
127573628|NCT00433511|459070937|FG002|Step 1|Other complicating disease|3|||
127573629|NCT00433511|459070935|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
127573630|NCT00433511|459070936|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
127573631|NCT00433511|459070937|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
127573632|NCT00433511|459070935|FG000|Step 1|Suspected recurrence|0|||
127573633|NCT00433511|459070936|FG001|Step 1|Suspected recurrence|1|||
127573634|NCT00433511|459070937|FG002|Step 1|Suspected recurrence|0|||
127573635|NCT00433511|459070935|FG000|Step 1|Insurance/drug distribution issues|0|||
127573636|NCT00433511|459070936|FG001|Step 1|Insurance/drug distribution issues|1|||
127573637|NCT00433511|459070937|FG002|Step 1|Insurance/drug distribution issues|2|||
127573638|NCT00433511|459070935|FG000|Step 1|Patient moved|0|||
127573639|NCT00433511|459070936|FG001|Step 1|Patient moved|0|||
127573640|NCT00433511|459070937|FG002|Step 1|Patient moved|1|||
127573641|NCT00433511|459070935|FG000|Step 2 (Arm D)|Adverse Event|0|||
127573642|NCT00433511|459070936|FG001|Step 2 (Arm D)|Adverse Event|0|||
127573643|NCT00433511|459070937|FG002|Step 2 (Arm D)|Adverse Event|135|||
127573644|NCT00433511|459070935|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
127573645|NCT00433511|459070936|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
127573646|NCT00433511|459070937|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
127573647|NCT00433511|459070935|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
127573648|NCT00433511|459070936|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
127573649|NCT00433511|459070937|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
127573650|NCT00433511|459070935|FG000|Step 2 (Arm D)|Physician Decision|0|||
127573651|NCT00433511|459070936|FG001|Step 2 (Arm D)|Physician Decision|0|||
127573652|NCT00433511|459070937|FG002|Step 2 (Arm D)|Physician Decision|9|||
127573653|NCT00433511|459070935|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
127573654|NCT00433511|459070936|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
127573655|NCT00433511|459070937|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
127573656|NCT00433511|459070935|FG000|Step 2 (Arm D)|Other complicating disease|0|||
127573657|NCT00433511|459070936|FG001|Step 2 (Arm D)|Other complicating disease|0|||
127573658|NCT00433511|459070937|FG002|Step 2 (Arm D)|Other complicating disease|3|||
127573659|NCT00433511|459070935|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
127573660|NCT00433511|459070936|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
127573661|NCT00433511|459070937|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
127573662|NCT00433511|459070935|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
127573663|NCT00433511|459070936|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
127573664|NCT00433511|459070937|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
127573665|NCT00433511|459070935|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
127573666|NCT00433511|459070936|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
127573667|NCT00433511|459070937|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
127573668|NCT00433511|459070935|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
127573669|NCT00433511|459070936|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
127573670|NCT00433511|459070937|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
127573671|NCT03139604|459070938|FG000|Overall Study|Other|7|||
127573672|NCT03139604|459070939|FG001|Overall Study|Other|3|||
127573673|NCT03139604|459070938|FG000|Overall Study|Withdrawal by Subject|16|||
127573674|NCT03139604|459070939|FG001|Overall Study|Withdrawal by Subject|17|||
127573675|NCT03139604|459070938|FG000|Overall Study|Physician Decision|1|||
127573676|NCT03139604|459070939|FG001|Overall Study|Physician Decision|2|||
127573677|NCT03139604|459070938|FG000|Overall Study|Lost to Follow-up|3|||
127573678|NCT03139604|459070939|FG001|Overall Study|Lost to Follow-up|1|||
127573679|NCT03139604|459070938|FG000|Overall Study|Death|65|||
127573680|NCT03139604|459070939|FG001|Overall Study|Death|67|||
127573681|NCT03139604|459070938|FG000|Overall Study|Study Terminated by Sponsor|122|||
127573682|NCT03139604|459070939|FG001|Overall Study|Study Terminated by Sponsor|127|||
127573683|NCT03139604|459070938|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
127573684|NCT03139604|459070939|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
127573685|NCT04950608|459070940|FG000|Overall Study|Withdrawal by Subject|2|||
127573686|NCT04950608|459070940|FG000|Overall Study|Physician Decision|3|||
127573687|NCT05007717|459070941|FG000|Overall Study|Death|3|||
127573688|NCT05007717|459070942|FG001|Overall Study|Death|2|||
127573689|NCT02806973|459070944|FG000|Period 1|Withdrawal by Subject|0|||
127573690|NCT02806973|459070945|FG001|Period 1|Withdrawal by Subject|2|||
127573691|NCT02806973|459070946|FG002|Period 1|Withdrawal by Subject|1|||
127573692|NCT02806973|459070947|FG003|Period 1|Withdrawal by Subject|1|||
127573693|NCT02806973|459070944|FG000|Period 1|Adverse Event|0|||
127573694|NCT02806973|459070945|FG001|Period 1|Adverse Event|0|||
127573695|NCT02806973|459070946|FG002|Period 1|Adverse Event|0|||
127573696|NCT02806973|459070947|FG003|Period 1|Adverse Event|1|||
127573697|NCT02806973|459070944|FG000|Period 3|Withdrawal by Subject|0|||
127573698|NCT02806973|459070945|FG001|Period 3|Withdrawal by Subject|0|||
127573699|NCT02806973|459070946|FG002|Period 3|Withdrawal by Subject|0|||
127573700|NCT02806973|459070947|FG003|Period 3|Withdrawal by Subject|3|||
127573701|NCT02806973|459070944|FG000|Period 3|Adverse Event|0|||
127573702|NCT02806973|459070945|FG001|Period 3|Adverse Event|0|||
127573703|NCT02806973|459070946|FG002|Period 3|Adverse Event|1|||
127573704|NCT02806973|459070947|FG003|Period 3|Adverse Event|0|||
127573705|NCT02007512|459070953|FG000|Double Blind Treatment Period|Adverse Event|4|||
127573706|NCT02007512|459070954|FG001|Double Blind Treatment Period|Adverse Event|6|||
127573707|NCT02007512|459070955|FG002|Double Blind Treatment Period|Adverse Event|2|||
127573708|NCT02007512|459070956|FG003|Double Blind Treatment Period|Adverse Event|2|||
127573709|NCT02007512|459070953|FG000|Double Blind Treatment Period|Death|1|||
127573710|NCT02007512|459070954|FG001|Double Blind Treatment Period|Death|0|||
127573711|NCT02007512|459070955|FG002|Double Blind Treatment Period|Death|0|||
127573712|NCT02007512|459070956|FG003|Double Blind Treatment Period|Death|0|||
127573713|NCT02007512|459070953|FG000|Double Blind Treatment Period|Disease progression|51|||
127573714|NCT02007512|459070954|FG001|Double Blind Treatment Period|Disease progression|50|||
127573715|NCT02007512|459070955|FG002|Double Blind Treatment Period|Disease progression|57|||
127573716|NCT02007512|459070956|FG003|Double Blind Treatment Period|Disease progression|52|||
127573717|NCT02007512|459070953|FG000|Double Blind Treatment Period|Withdrawal by Subject|3|||
127573718|NCT02007512|459070954|FG001|Double Blind Treatment Period|Withdrawal by Subject|3|||
127573719|NCT02007512|459070955|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
127573720|NCT02007512|459070956|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
127573721|NCT02007512|459070953|FG000|Double Blind Treatment Period|Protocol Violation|1|||
127573722|NCT02007512|459070954|FG001|Double Blind Treatment Period|Protocol Violation|0|||
127573723|NCT02007512|459070955|FG002|Double Blind Treatment Period|Protocol Violation|0|||
127573724|NCT02007512|459070956|FG003|Double Blind Treatment Period|Protocol Violation|1|||
127573725|NCT02007512|459070953|FG000|Double Blind Treatment Period|Other|2|||
127573726|NCT02007512|459070954|FG001|Double Blind Treatment Period|Other|1|||
127573727|NCT02007512|459070955|FG002|Double Blind Treatment Period|Other|1|||
127573728|NCT02007512|459070956|FG003|Double Blind Treatment Period|Other|2|||
127573729|NCT02007512|459070953|FG000|Double Blind Treatment Period|Randomized but not treated|1|||
127573730|NCT02007512|459070954|FG001|Double Blind Treatment Period|Randomized but not treated|0|||
127573731|NCT02007512|459070955|FG002|Double Blind Treatment Period|Randomized but not treated|1|||
127573732|NCT02007512|459070956|FG003|Double Blind Treatment Period|Randomized but not treated|0|||
127573733|NCT02007512|459070953|FG000|Open Label Treatment Period|Adverse Event|1|||
127573734|NCT02007512|459070954|FG001|Open Label Treatment Period|Adverse Event|0|||
127573735|NCT02007512|459070955|FG002|Open Label Treatment Period|Adverse Event|0|||
127573736|NCT02007512|459070956|FG003|Open Label Treatment Period|Adverse Event|0|||
127573737|NCT02007512|459070953|FG000|Open Label Treatment Period|Other|1|||
127781801|NCT00467779|459827798|FG001|Stage 3|Disease Progression|0|||
127573738|NCT02007512|459070954|FG001|Open Label Treatment Period|Other|1|||
127781802|NCT00467779|459827799|FG002|Stage 3|Disease Progression|0|||
127573739|NCT02007512|459070955|FG002|Open Label Treatment Period|Other|0|||
127573740|NCT02007512|459070956|FG003|Open Label Treatment Period|Other|0|||
127573741|NCT02007512|459070953|FG000|Open Label Treatment Period|Disease progression|23|||
127573742|NCT02007512|459070954|FG001|Open Label Treatment Period|Disease progression|11|||
127573743|NCT02007512|459070955|FG002|Open Label Treatment Period|Disease progression|0|||
127573744|NCT02007512|459070956|FG003|Open Label Treatment Period|Disease progression|0|||
127573745|NCT00900601|459070961|FG000|Overall Study|Physician Decision|1|||
127573746|NCT00608543|459070962|FG000|Overall Study|Adverse Event|4|||
127573747|NCT03026088|459070964|FG000|Overall Study|Study termination|20|||
127573748|NCT01466595|459070966|FG000|Overall Study|Withdrawal by Subject|0|||
127573749|NCT01466595|459070967|FG001|Overall Study|Withdrawal by Subject|1|||
127573750|NCT02147184|459070968|FG000|Overall Study|Lost to Follow-up|28|||
127573751|NCT02147184|459070969|FG001|Overall Study|Lost to Follow-up|15|||
127573752|NCT02147184|459070968|FG000|Overall Study|Study Burden|11|||
127573753|NCT02147184|459070969|FG001|Overall Study|Study Burden|7|||
127573754|NCT02147184|459070968|FG000|Overall Study|Pregnancy|6|||
127573755|NCT02147184|459070969|FG001|Overall Study|Pregnancy|0|||
127573756|NCT02147184|459070968|FG000|Overall Study|Moved out of state|3|||
127573757|NCT02147184|459070969|FG001|Overall Study|Moved out of state|3|||
127573758|NCT02147184|459070968|FG000|Overall Study|Physician Decision|0|||
127573759|NCT02147184|459070969|FG001|Overall Study|Physician Decision|2|||
127573760|NCT02147184|459070968|FG000|Overall Study|Other|1|||
127573761|NCT02147184|459070969|FG001|Overall Study|Other|0|||
127573762|NCT02117414|459070970|FG000|Overall Study|Death|5|||
127573763|NCT02117414|459070971|FG001|Overall Study|Death|2|||
127692624|NCT02728557|459501589|FG001|Overall Study|Dissatisfaction with research tasks|1|||
127692625|NCT02728557|459501588|FG000|Overall Study|Scheduling or change in availability|1|||
127692626|NCT02728557|459501589|FG001|Overall Study|Scheduling or change in availability|1|||
127692627|NCT03897686|459501590|FG000|Overall Study|Protocol Violation|1|||
127692628|NCT03897686|459501591|FG001|Overall Study|Protocol Violation|1|||
127692629|NCT03897686|459501590|FG000|Overall Study|Withdrawal by Subject|1|||
127692630|NCT03897686|459501591|FG001|Overall Study|Withdrawal by Subject|1|||
127692631|NCT04052516|459501592|FG000|Overall Study|Withdrawal by Subject|4|||
127692632|NCT04052516|459501593|FG001|Overall Study|Withdrawal by Subject|5|||
127692633|NCT04052516|459501594|FG002|Overall Study|Withdrawal by Subject|6|||
127692634|NCT04052516|459501592|FG000|Overall Study|Adverse Event|3|||
127692635|NCT04052516|459501593|FG001|Overall Study|Adverse Event|2|||
127692636|NCT04052516|459501594|FG002|Overall Study|Adverse Event|8|||
127692637|NCT04052516|459501592|FG000|Overall Study|Lost to Follow-up|2|||
127692638|NCT04052516|459501593|FG001|Overall Study|Lost to Follow-up|5|||
127692639|NCT04052516|459501594|FG002|Overall Study|Lost to Follow-up|3|||
127692640|NCT04052516|459501592|FG000|Overall Study|Protocol Violation|1|||
127692641|NCT04052516|459501593|FG001|Overall Study|Protocol Violation|1|||
127692642|NCT04052516|459501594|FG002|Overall Study|Protocol Violation|0|||
127692643|NCT04052516|459501592|FG000|Overall Study|Death|1|||
127692644|NCT04052516|459501593|FG001|Overall Study|Death|0|||
127692645|NCT04052516|459501594|FG002|Overall Study|Death|0|||
127692646|NCT04052516|459501592|FG000|Overall Study|Physician Decision|0|||
127692647|NCT04052516|459501593|FG001|Overall Study|Physician Decision|1|||
127692648|NCT04052516|459501594|FG002|Overall Study|Physician Decision|0|||
127692649|NCT04052516|459501592|FG000|Overall Study|Pregnancy|1|||
127692650|NCT04052516|459501593|FG001|Overall Study|Pregnancy|0|||
127692651|NCT04052516|459501594|FG002|Overall Study|Pregnancy|0|||
127692652|NCT04052516|459501592|FG000|Overall Study|Requirement of prohibited concomitant medication|1|||
127692653|NCT04052516|459501593|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
127692654|NCT04052516|459501594|FG002|Overall Study|Requirement of prohibited concomitant medication|0|||
127692655|NCT04052516|459501592|FG000|Overall Study|Reason not recorded|0|||
127692656|NCT04052516|459501593|FG001|Overall Study|Reason not recorded|1|||
127692657|NCT04052516|459501594|FG002|Overall Study|Reason not recorded|0|||
127692658|NCT03416010|459501595|FG000|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|11|||
127692659|NCT03416010|459501596|FG001|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|32|||
127692660|NCT03416010|459501595|FG000|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|27|||
127692661|NCT03416010|459501596|FG001|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|38|||
127692662|NCT03416010|459501595|FG000|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|11|||
127692663|NCT03416010|459501596|FG001|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|12|||
127692664|NCT03416010|459501595|FG000|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|1|||
127692665|NCT03416010|459501596|FG001|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|0|||
127692666|NCT03416010|459501595|FG000|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|1|||
127692667|NCT03416010|459501596|FG001|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|3|||
127692668|NCT03416010|459501595|FG000|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|1|||
127692669|NCT03416010|459501596|FG001|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|3|||
127692670|NCT03416010|459501595|FG000|Timepoint 3 (6 Months Postpartum)|Missing Data|2|||
127692671|NCT03416010|459501596|FG001|Timepoint 3 (6 Months Postpartum)|Missing Data|3|||
127573764|NCT02117414|459070970|FG000|Overall Study|Withdrawal by Subject|10|||
127573765|NCT02117414|459070971|FG001|Overall Study|Withdrawal by Subject|4|||
127573766|NCT03555435|459070972|FG000|Overall Study|Lost to Follow-up|17|||
127573767|NCT03555435|459070973|FG001|Overall Study|Lost to Follow-up|19|||
127573768|NCT03555435|459070974|FG002|Overall Study|Lost to Follow-up|8|||
127573769|NCT02869438|459070975|FG000|Overall Study|Lost to Follow-up|1|||
127573770|NCT02869438|459070976|FG001|Overall Study|Lost to Follow-up|0|||
127573771|NCT02869438|459070975|FG000|Overall Study|Adverse Event|1|||
127573772|NCT02869438|459070976|FG001|Overall Study|Adverse Event|0|||
127573773|NCT02869438|459070975|FG000|Overall Study|Withdrawal by Subject|1|||
127573774|NCT02869438|459070976|FG001|Overall Study|Withdrawal by Subject|2|||
127573799|NCT01115803|459070988|FG000|Overall Study|Withdrawal by Subject|0|||
127573800|NCT01115803|459070989|FG001|Overall Study|Withdrawal by Subject|0|||
127573801|NCT01115803|459070990|FG002|Overall Study|Withdrawal by Subject|0|||
127573802|NCT01115803|459070991|FG003|Overall Study|Withdrawal by Subject|0|||
127573803|NCT01115803|459070992|FG004|Overall Study|Withdrawal by Subject|0|||
127573804|NCT01115803|459070993|FG005|Overall Study|Withdrawal by Subject|0|||
127573805|NCT01115803|459070994|FG006|Overall Study|Withdrawal by Subject|1|||
127573806|NCT01115803|459070988|FG000|Overall Study|Lost to Follow-up|0|||
127573807|NCT01115803|459070989|FG001|Overall Study|Lost to Follow-up|0|||
127573808|NCT01115803|459070990|FG002|Overall Study|Lost to Follow-up|1|||
127573809|NCT01115803|459070991|FG003|Overall Study|Lost to Follow-up|0|||
127573810|NCT01115803|459070992|FG004|Overall Study|Lost to Follow-up|0|||
127573811|NCT01115803|459070993|FG005|Overall Study|Lost to Follow-up|0|||
127573812|NCT01115803|459070994|FG006|Overall Study|Lost to Follow-up|0|||
127573813|NCT01115803|459070988|FG000|Overall Study|Progressive Disease during Cycle1|0|||
127573814|NCT01115803|459070989|FG001|Overall Study|Progressive Disease during Cycle1|0|||
127573815|NCT01115803|459070990|FG002|Overall Study|Progressive Disease during Cycle1|0|||
127573816|NCT01115803|459070991|FG003|Overall Study|Progressive Disease during Cycle1|0|||
127573817|NCT01115803|459070992|FG004|Overall Study|Progressive Disease during Cycle1|0|||
127573818|NCT01115803|459070993|FG005|Overall Study|Progressive Disease during Cycle1|0|||
127573819|NCT01115803|459070994|FG006|Overall Study|Progressive Disease during Cycle1|1|||
127573820|NCT03475875|459070995|FG000|Period 1|Lost to Follow-up|1|||
127573821|NCT03475875|459070996|FG001|Period 1|Lost to Follow-up|0|||
127573822|NCT03475875|459070995|FG000|Period 1|Adverse Event|2|||
127573823|NCT03475875|459070996|FG001|Period 1|Adverse Event|1|||
127573824|NCT03475875|459070995|FG000|Period 2|Adverse Event|3|||
127573825|NCT03475875|459070996|FG001|Period 2|Adverse Event|0|||
127573826|NCT03475875|459070995|FG000|Period 2|Protocol Violation|0|||
127573827|NCT03475875|459070996|FG001|Period 2|Protocol Violation|1|||
127573828|NCT00194675|459071007|FG000|Overall Study|Lost to Follow-up|1|||
127573829|NCT00194675|459071008|FG001|Overall Study|Lost to Follow-up|1|||
127573830|NCT00194675|459071007|FG000|Overall Study|lack of interest|1|||
127573831|NCT00194675|459071008|FG001|Overall Study|lack of interest|1|||
127573832|NCT00194675|459071007|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
127573833|NCT00194675|459071008|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
127573834|NCT00194675|459071007|FG000|Overall Study|Protocol Violation|1|||
127573835|NCT00194675|459071008|FG001|Overall Study|Protocol Violation|0|||
128029452|NCT04064567|460733589|FG000|Overall Study|Lost to Follow-up|23|||
127573836|NCT00194675|459071007|FG000|Overall Study|Death|1|||
127573837|NCT00194675|459071008|FG001|Overall Study|Death|0|||
127573838|NCT00704808|459071009|FG000|Overall Study|Discontinued prior to starting treatment|14|||
127573839|NCT00704808|459071009|FG000|Overall Study|Death|7|||
127573840|NCT00704808|459071009|FG000|Overall Study|Tumor progression|80|||
127573841|NCT00704808|459071009|FG000|Overall Study|Patient's decision|11|||
127573842|NCT00704808|459071009|FG000|Overall Study|Early therapy discontinuation|16|||
127573843|NCT00704808|459071009|FG000|Overall Study|Adverse Event|1|||
127573844|NCT00704808|459071009|FG000|Overall Study|Lost to Follow-up|1|||
127573845|NCT00704808|459071009|FG000|Overall Study|Treatment change|1|||
127573846|NCT01285960|459071010|FG000|Overall Study|Withdrawal by Subject|2|||
127573847|NCT01285960|459071010|FG000|Overall Study|Lost to Follow-up|2|||
127573848|NCT01285960|459071010|FG000|Overall Study|2 subjects received less 10 sonications|2|||
127573849|NCT02280473|459071014|FG000|Overall Study|Adverse Event|1|||
127573850|NCT02280473|459071015|FG001|Overall Study|Adverse Event|1|||
127573851|NCT02280473|459071014|FG000|Overall Study|Lack of Efficacy|0|||
127573852|NCT02280473|459071015|FG001|Overall Study|Lack of Efficacy|1|||
127573853|NCT02280473|459071014|FG000|Overall Study|Lost to Follow-up|0|||
127573854|NCT02280473|459071015|FG001|Overall Study|Lost to Follow-up|1|||
127573855|NCT01484054|459071016|FG000|Period 1|Withdrawal by Subject|0|||
127573856|NCT01484054|459071017|FG001|Period 1|Withdrawal by Subject|1|||
127573857|NCT01610271|459071018|FG000|Overall Study|Surgery not complete|0|||
127573858|NCT01610271|459071019|FG001|Overall Study|Surgery not complete|1|||
127573859|NCT01610271|459071018|FG000|Overall Study|Prosthesis not implanted|2|||
127573860|NCT01610271|459071019|FG001|Overall Study|Prosthesis not implanted|3|||
127573861|NCT00364130|459071020|FG000|Intervention Period|Lost to Follow-up|4|||
127573862|NCT00364130|459071021|FG001|Intervention Period|Lost to Follow-up|3|||
127573863|NCT00364130|459071020|FG000|Intervention Period|Pregnancy|1|||
127573864|NCT00364130|459071021|FG001|Intervention Period|Pregnancy|0|||
127573865|NCT00364130|459071020|FG000|Intervention Period|Withdrawal by Subject|4|||
127573866|NCT00364130|459071021|FG001|Intervention Period|Withdrawal by Subject|5|||
127573867|NCT00364130|459071020|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
127573868|NCT00364130|459071021|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
127573869|NCT05281601|459071022|FG000|Overall Study|Physician Decision|2|||
127573870|NCT05281601|459071023|FG001|Overall Study|Physician Decision|0|||
127573871|NCT05281601|459071022|FG000|Overall Study|Lost to Follow-up|2|||
127573872|NCT05281601|459071023|FG001|Overall Study|Lost to Follow-up|0|||
127573873|NCT05281601|459071022|FG000|Overall Study|Death|1|||
127573874|NCT05281601|459071023|FG001|Overall Study|Death|0|||
127573875|NCT05281601|459071022|FG000|Overall Study|Withdrawal by parent/guardian|2|||
127573876|NCT05281601|459071023|FG001|Overall Study|Withdrawal by parent/guardian|1|||
127573877|NCT00586846|459071024|FG000|Overall Study|Physician Decision|1|||
127573878|NCT00586846|459071024|FG000|Overall Study|Death|1|||
127573879|NCT00586846|459071024|FG000|Overall Study|Evaluable for Toxicity Only|4|||
127573880|NCT00410202|459071025|FG000|On-Treatment|Continuing treatment|69|||
127573881|NCT00410202|459071026|FG001|On-Treatment|Continuing treatment|71|||
127573882|NCT00410202|459071027|FG002|On-Treatment|Continuing treatment|66|||
127573883|NCT00410202|459071025|FG000|On-Treatment|Adverse Event|1|||
127573884|NCT00410202|459071026|FG001|On-Treatment|Adverse Event|3|||
127573885|NCT00410202|459071027|FG002|On-Treatment|Adverse Event|2|||
127573886|NCT00410202|459071025|FG000|On-Treatment|Death|1|||
127573887|NCT00410202|459071026|FG001|On-Treatment|Death|0|||
127573888|NCT00410202|459071027|FG002|On-Treatment|Death|0|||
127573889|NCT00410202|459071025|FG000|On-Treatment|Lost to Follow-up|1|||
127573890|NCT00410202|459071026|FG001|On-Treatment|Lost to Follow-up|0|||
127573891|NCT00410202|459071027|FG002|On-Treatment|Lost to Follow-up|1|||
127573892|NCT00410202|459071025|FG000|On-Treatment|Lack of Efficacy|1|||
127573893|NCT00410202|459071026|FG001|On-Treatment|Lack of Efficacy|4|||
127573894|NCT00410202|459071027|FG002|On-Treatment|Lack of Efficacy|0|||
127573895|NCT00410202|459071025|FG000|On-Treatment|Withdrawal by Subject|2|||
127573896|NCT00410202|459071026|FG001|On-Treatment|Withdrawal by Subject|1|||
127573897|NCT00410202|459071027|FG002|On-Treatment|Withdrawal by Subject|1|||
127573898|NCT00410202|459071025|FG000|On-Treatment|Other Reason|0|||
127573899|NCT00410202|459071026|FG001|On-Treatment|Other Reason|0|||
127573900|NCT00410202|459071027|FG002|On-Treatment|Other Reason|1|||
127573901|NCT00410202|459071025|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
127573902|NCT00410202|459071026|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
127573903|NCT00410202|459071027|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
127573904|NCT00410202|459071025|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
127573905|NCT00410202|459071026|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
127573906|NCT00410202|459071027|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
127573907|NCT00410202|459071025|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
127692672|NCT03948763|459501597|FG000|Overall Study|Sponsor's decision|0|||
127692673|NCT03948763|459501598|FG001|Overall Study|Sponsor's decision|2|||
127692674|NCT03948763|459501599|FG002|Overall Study|Sponsor's decision|6|||
127573908|NCT00410202|459071026|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
127573909|NCT00410202|459071027|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
127573910|NCT00144027|459071029|FG000|Overall Study|Lost to Follow-up|1|||
127573911|NCT00144027|459071030|FG001|Overall Study|Lost to Follow-up|3|||
127573912|NCT00144027|459071029|FG000|Overall Study|Withdrawal by Subject|2|||
127692675|NCT03948763|459501600|FG003|Overall Study|Sponsor's decision|4|||
127692676|NCT03948763|459501601|FG004|Overall Study|Sponsor's decision|0|||
127573913|NCT00144027|459071030|FG001|Overall Study|Withdrawal by Subject|2|||
127573914|NCT00144027|459071029|FG000|Overall Study|did not complete baseline assessment|0|||
127573915|NCT00144027|459071030|FG001|Overall Study|did not complete baseline assessment|6|||
127573916|NCT04597918|459071031|FG000|Overall Study|Withdrawal by Subject|6|||
127573917|NCT04597918|459071031|FG000|Overall Study|Lost to Follow-up|3|||
127573918|NCT04597918|459071031|FG000|Overall Study|Death|1|||
127573919|NCT00395538|459071032|FG000|Overall Study|Did not re-consent to revised protocol|1|||
127573920|NCT00395538|459071033|FG001|Overall Study|Did not re-consent to revised protocol|10|||
127573921|NCT00395538|459071034|FG002|Overall Study|Did not re-consent to revised protocol|0|||
127781803|NCT00467779|459827800|FG003|Stage 3|Disease Progression|0|||
127781804|NCT00467779|459827801|FG004|Stage 3|Disease Progression|0|||
127573922|NCT00395538|459071032|FG000|Overall Study|FDA partial hold on PTH|0|||
127573923|NCT00395538|459071033|FG001|Overall Study|FDA partial hold on PTH|0|||
127573924|NCT00395538|459071034|FG002|Overall Study|FDA partial hold on PTH|11|||
127781805|NCT00467779|459827802|FG005|Stage 3|Disease Progression|0|||
127781806|NCT00467779|459827803|FG006|Stage 3|Disease Progression|0|||
127781807|NCT00467779|459827804|FG007|Stage 3|Disease Progression|0|||
127781808|NCT00467779|459827805|FG008|Stage 3|Disease Progression|0|||
127781809|NCT00467779|459827806|FG009|Stage 3|Disease Progression|0|||
127781810|NCT00467779|459827807|FG010|Stage 3|Disease Progression|0|||
127781811|NCT00467779|459827808|FG011|Stage 3|Disease Progression|0|||
127781812|NCT00467779|459827809|FG012|Stage 3|Disease Progression|0|||
127781813|NCT00467779|459827810|FG013|Stage 3|Disease Progression|0|||
127781814|NCT00467779|459827811|FG014|Stage 3|Disease Progression|9|||
127781815|NCT00467779|459827797|FG000|Stage 3|Unspecified Reason|0|||
127781816|NCT00467779|459827798|FG001|Stage 3|Unspecified Reason|0|||
127573925|NCT00395538|459071032|FG000|Overall Study|Failed screening|0|||
127573926|NCT00395538|459071033|FG001|Overall Study|Failed screening|0|||
127573927|NCT00395538|459071034|FG002|Overall Study|Failed screening|4|||
127573928|NCT00395538|459071032|FG000|Overall Study|Switch to Natpara|0|||
127573929|NCT00395538|459071033|FG001|Overall Study|Switch to Natpara|0|||
127573930|NCT00395538|459071034|FG002|Overall Study|Switch to Natpara|3|||
127573931|NCT00395538|459071032|FG000|Overall Study|Adverse Event|1|||
127573932|NCT00395538|459071033|FG001|Overall Study|Adverse Event|0|||
127573933|NCT00395538|459071034|FG002|Overall Study|Adverse Event|2|||
127573934|NCT00395538|459071032|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
127573935|NCT00395538|459071033|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
127573936|NCT00395538|459071034|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
127573937|NCT00395538|459071032|FG000|Overall Study|Non-compliance with study protocol|0|||
127573938|NCT00395538|459071033|FG001|Overall Study|Non-compliance with study protocol|1|||
127573939|NCT00395538|459071034|FG002|Overall Study|Non-compliance with study protocol|0|||
127781817|NCT00467779|459827799|FG002|Stage 3|Unspecified Reason|0|||
127781818|NCT00467779|459827800|FG003|Stage 3|Unspecified Reason|0|||
127781819|NCT00467779|459827801|FG004|Stage 3|Unspecified Reason|0|||
127781820|NCT00467779|459827802|FG005|Stage 3|Unspecified Reason|0|||
127781821|NCT00467779|459827803|FG006|Stage 3|Unspecified Reason|0|||
127781822|NCT00467779|459827804|FG007|Stage 3|Unspecified Reason|0|||
127781823|NCT00467779|459827805|FG008|Stage 3|Unspecified Reason|0|||
127781824|NCT00467779|459827806|FG009|Stage 3|Unspecified Reason|0|||
127781825|NCT00467779|459827807|FG010|Stage 3|Unspecified Reason|0|||
127781826|NCT00467779|459827808|FG011|Stage 3|Unspecified Reason|0|||
127573940|NCT00395538|459071032|FG000|Overall Study|PTH resistance|0|||
127573941|NCT00395538|459071033|FG001|Overall Study|PTH resistance|0|||
127573942|NCT00395538|459071034|FG002|Overall Study|PTH resistance|1|||
127573943|NCT00395538|459071032|FG000|Overall Study|Pregnancy|1|||
127573944|NCT00395538|459071033|FG001|Overall Study|Pregnancy|0|||
127573945|NCT00395538|459071034|FG002|Overall Study|Pregnancy|0|||
127573946|NCT00395538|459071032|FG000|Overall Study|Partial recovery of parathyroid function|0|||
127573947|NCT00395538|459071033|FG001|Overall Study|Partial recovery of parathyroid function|0|||
127573948|NCT00395538|459071034|FG002|Overall Study|Partial recovery of parathyroid function|1|||
127573949|NCT00395538|459071032|FG000|Overall Study|Participant elected to discontinue|0|||
127573950|NCT00395538|459071033|FG001|Overall Study|Participant elected to discontinue|0|||
127573951|NCT00395538|459071034|FG002|Overall Study|Participant elected to discontinue|1|||
127573952|NCT01074047|459071035|FG000|Treatment Phase|Adverse Event|89|||
127573953|NCT01074047|459071036|FG001|Treatment Phase|Adverse Event|66|||
127573954|NCT01074047|459071035|FG000|Treatment Phase|Disease Progression|16|||
127573955|NCT01074047|459071036|FG001|Treatment Phase|Disease Progression|21|||
127573956|NCT01074047|459071035|FG000|Treatment Phase|Withdrawal by Subject|27|||
127573957|NCT01074047|459071036|FG001|Treatment Phase|Withdrawal by Subject|48|||
127573958|NCT01074047|459071035|FG000|Treatment Phase|Death|53|||
127781827|NCT00467779|459827809|FG012|Stage 3|Unspecified Reason|0|||
127781828|NCT00467779|459827810|FG013|Stage 3|Unspecified Reason|0|||
127573959|NCT01074047|459071036|FG001|Treatment Phase|Death|58|||
127573960|NCT01074047|459071035|FG000|Treatment Phase|Lost to Follow-up|0|||
127573961|NCT01074047|459071036|FG001|Treatment Phase|Lost to Follow-up|1|||
127573962|NCT01074047|459071035|FG000|Treatment Phase|Protocol Violation|0|||
127573963|NCT01074047|459071036|FG001|Treatment Phase|Protocol Violation|1|||
127781829|NCT00467779|459827811|FG014|Stage 3|Unspecified Reason|5|||
127573964|NCT01074047|459071035|FG000|Treatment Phase|Miscellaneous|32|||
127573965|NCT01074047|459071036|FG001|Treatment Phase|Miscellaneous|39|||
127781830|NCT04353596|459827816|FG000|Overall Study|Protocol Violation|4|||
127781831|NCT04353596|459827817|FG001|Overall Study|Protocol Violation|4|||
127781832|NCT04353596|459827816|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
127781833|NCT04353596|459827817|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
127573966|NCT01074047|459071035|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
127573967|NCT01074047|459071036|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
127573968|NCT01074047|459071035|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
127573969|NCT01074047|459071036|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
127573970|NCT01074047|459071035|FG000|Survival Follow-Up Phase|Death|116|||
127573971|NCT01074047|459071036|FG001|Survival Follow-Up Phase|Death|124|||
127573972|NCT01074047|459071035|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
127573973|NCT01074047|459071036|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
127573974|NCT01074047|459071035|FG000|Extension Phase|Physician Decision|1|||
127573975|NCT01074047|459071036|FG001|Extension Phase|Physician Decision|0|||
127573976|NCT01074047|459071035|FG000|Extension Phase|Adverse Event|5|||
127573977|NCT01074047|459071036|FG001|Extension Phase|Adverse Event|0|||
127573978|NCT01074047|459071035|FG000|Extension Phase|Disease Progression|9|||
127573979|NCT01074047|459071036|FG001|Extension Phase|Disease Progression|0|||
127573980|NCT01074047|459071035|FG000|Extension Phase|Withdrawal by Subject|2|||
127573981|NCT01074047|459071036|FG001|Extension Phase|Withdrawal by Subject|0|||
127573982|NCT01074047|459071035|FG000|Extension Phase|Death|5|||
127573983|NCT01074047|459071036|FG001|Extension Phase|Death|0|||
127573984|NCT00285207|459071039|FG000|Overall Study|Lost to Follow-up|3|||
127573985|NCT00285207|459071040|FG001|Overall Study|Lost to Follow-up|2|||
127573986|NCT00285207|459071039|FG000|Overall Study|Withdrawal by Subject|5|||
127573987|NCT00285207|459071040|FG001|Overall Study|Withdrawal by Subject|2|||
127573988|NCT00285207|459071039|FG000|Overall Study|Pregnancy|1|||
127573989|NCT00285207|459071040|FG001|Overall Study|Pregnancy|1|||
127573990|NCT00285207|459071039|FG000|Overall Study|non-compliance|0|||
127573991|NCT00285207|459071040|FG001|Overall Study|non-compliance|1|||
127573992|NCT05063318|459071041|FG000|Overall Study|Progressive disease|2|||
127573993|NCT05063318|459071042|FG001|Overall Study|Progressive disease|0|||
127573994|NCT05063318|459071043|FG002|Overall Study|Progressive disease|3|||
127573995|NCT05063318|459071041|FG000|Overall Study|Compassionate use|1|||
127573996|NCT05063318|459071042|FG001|Overall Study|Compassionate use|3|||
127573997|NCT05063318|459071043|FG002|Overall Study|Compassionate use|3|||
127573998|NCT05063318|459071041|FG000|Overall Study|Adverse Event|0|||
127573999|NCT05063318|459071042|FG001|Overall Study|Adverse Event|1|||
127574000|NCT05063318|459071043|FG002|Overall Study|Adverse Event|0|||
127574001|NCT05063318|459071041|FG000|Overall Study|Withdrawal by Subject|0|||
127574002|NCT05063318|459071042|FG001|Overall Study|Withdrawal by Subject|1|||
127574003|NCT05063318|459071043|FG002|Overall Study|Withdrawal by Subject|0|||
127574004|NCT01659658|459072665|FG000|Overall Study|Withdrawal by Patient|18|||
127574005|NCT01659658|459072666|FG001|Overall Study|Withdrawal by Patient|4|||
127574006|NCT01659658|459072667|FG002|Overall Study|Withdrawal by Patient|2|||
127574007|NCT01659658|459072668|FG003|Overall Study|Withdrawal by Patient|0|||
127574008|NCT01659658|459072669|FG004|Overall Study|Withdrawal by Patient|11|||
127574009|NCT01659658|459072665|FG000|Overall Study|Study Terminated by Sponsor|9|||
127574010|NCT01659658|459072666|FG001|Overall Study|Study Terminated by Sponsor|7|||
127574011|NCT01659658|459072667|FG002|Overall Study|Study Terminated by Sponsor|0|||
127574012|NCT01659658|459072668|FG003|Overall Study|Study Terminated by Sponsor|1|||
127574013|NCT01659658|459072669|FG004|Overall Study|Study Terminated by Sponsor|4|||
127574014|NCT01659658|459072665|FG000|Overall Study|Reason not Specified|61|||
127574015|NCT01659658|459072666|FG001|Overall Study|Reason not Specified|15|||
127574016|NCT01659658|459072667|FG002|Overall Study|Reason not Specified|8|||
127574017|NCT01659658|459072668|FG003|Overall Study|Reason not Specified|1|||
127574018|NCT01659658|459072669|FG004|Overall Study|Reason not Specified|34|||
127574019|NCT01659658|459072665|FG000|Overall Study|Lost to Follow-up|2|||
127574020|NCT01659658|459072666|FG001|Overall Study|Lost to Follow-up|0|||
127574021|NCT01659658|459072667|FG002|Overall Study|Lost to Follow-up|0|||
127692677|NCT03948763|459501597|FG000|Overall Study|Physician Decision|0|||
127692678|NCT03948763|459501598|FG001|Overall Study|Physician Decision|0|||
127692679|NCT03948763|459501599|FG002|Overall Study|Physician Decision|1|||
127692680|NCT03948763|459501600|FG003|Overall Study|Physician Decision|0|||
127692681|NCT03948763|459501601|FG004|Overall Study|Physician Decision|0|||
127692682|NCT03948763|459501597|FG000|Overall Study|Lost to Follow-up|0|||
127692683|NCT03948763|459501598|FG001|Overall Study|Lost to Follow-up|0|||
127692684|NCT03948763|459501599|FG002|Overall Study|Lost to Follow-up|0|||
127692685|NCT03948763|459501600|FG003|Overall Study|Lost to Follow-up|0|||
127574022|NCT01659658|459072668|FG003|Overall Study|Lost to Follow-up|0|||
127574023|NCT01659658|459072669|FG004|Overall Study|Lost to Follow-up|0|||
127574024|NCT00215683|459072671|FG000|Overall Study|Adverse Event|15|||
127574025|NCT00215683|459072672|FG001|Overall Study|Adverse Event|16|||
127692686|NCT03948763|459501601|FG004|Overall Study|Lost to Follow-up|1|||
127574026|NCT00215683|459072673|FG002|Overall Study|Adverse Event|15|||
127574027|NCT00215683|459072671|FG000|Overall Study|Lack of Efficacy|5|||
127574028|NCT00215683|459072672|FG001|Overall Study|Lack of Efficacy|1|||
127574029|NCT00215683|459072673|FG002|Overall Study|Lack of Efficacy|2|||
127574030|NCT00215683|459072671|FG000|Overall Study|Lost to Follow-up|0|||
127574031|NCT00215683|459072672|FG001|Overall Study|Lost to Follow-up|2|||
127574032|NCT00215683|459072673|FG002|Overall Study|Lost to Follow-up|1|||
127574033|NCT00215683|459072671|FG000|Overall Study|Withdrawal by Subject|9|||
127692687|NCT03948763|459501597|FG000|Overall Study|Death|2|||
127692688|NCT03948763|459501598|FG001|Overall Study|Death|12|||
127574034|NCT00215683|459072672|FG001|Overall Study|Withdrawal by Subject|4|||
127574035|NCT00215683|459072673|FG002|Overall Study|Withdrawal by Subject|13|||
127574036|NCT00215683|459072671|FG000|Overall Study|Physician Decision|0|||
127574037|NCT00215683|459072672|FG001|Overall Study|Physician Decision|0|||
127574038|NCT00215683|459072673|FG002|Overall Study|Physician Decision|1|||
127574039|NCT00215683|459072671|FG000|Overall Study|Difficult to attend visits|0|||
127574040|NCT00215683|459072672|FG001|Overall Study|Difficult to attend visits|1|||
127574041|NCT00215683|459072673|FG002|Overall Study|Difficult to attend visits|0|||
127574042|NCT00215683|459072671|FG000|Overall Study|No study drug available|0|||
127574043|NCT00215683|459072672|FG001|Overall Study|No study drug available|1|||
127574044|NCT00215683|459072673|FG002|Overall Study|No study drug available|0|||
127574045|NCT00215683|459072671|FG000|Overall Study|Intermittent therapy required|0|||
127574046|NCT00215683|459072672|FG001|Overall Study|Intermittent therapy required|1|||
127574047|NCT00215683|459072673|FG002|Overall Study|Intermittent therapy required|0|||
127574048|NCT04493333|459072680|FG000|Overall Study|Withdrawal by Subject|1|||
127574049|NCT04493333|459072681|FG001|Overall Study|Withdrawal by Subject|1|||
127574050|NCT04493333|459072680|FG000|Overall Study|Ineligible|0|||
127574051|NCT04493333|459072681|FG001|Overall Study|Ineligible|1|||
127574052|NCT04493333|459072680|FG000|Overall Study|Noncompliance|2|||
127574053|NCT04493333|459072681|FG001|Overall Study|Noncompliance|1|||
127574054|NCT00451451|459072682|FG000|Overall Study|Adverse Event|11|||
127574055|NCT00451451|459072683|FG001|Overall Study|Adverse Event|21|||
127692689|NCT03948763|459501599|FG002|Overall Study|Death|13|||
127692690|NCT03948763|459501600|FG003|Overall Study|Death|10|||
127692691|NCT03948763|459501601|FG004|Overall Study|Death|11|||
127692692|NCT03948763|459501597|FG000|Overall Study|Withdrawal by Subject|1|||
127692693|NCT03948763|459501598|FG001|Overall Study|Withdrawal by Subject|1|||
127692694|NCT03948763|459501599|FG002|Overall Study|Withdrawal by Subject|0|||
127692695|NCT03948763|459501600|FG003|Overall Study|Withdrawal by Subject|2|||
127692696|NCT03948763|459501601|FG004|Overall Study|Withdrawal by Subject|4|||
127692697|NCT05415436|459501605|FG000|Overall Study|Surgeon cancelled procedure|1|||
127692698|NCT05415436|459501606|FG001|Overall Study|Surgeon cancelled procedure|0|||
127574056|NCT00451451|459072684|FG002|Overall Study|Adverse Event|26|||
127574057|NCT00451451|459072685|FG003|Overall Study|Adverse Event|10|||
127574058|NCT00451451|459072682|FG000|Overall Study|Lost to Follow-up|11|||
127574059|NCT00451451|459072683|FG001|Overall Study|Lost to Follow-up|9|||
127574060|NCT00451451|459072684|FG002|Overall Study|Lost to Follow-up|8|||
127574061|NCT00451451|459072685|FG003|Overall Study|Lost to Follow-up|11|||
127574062|NCT00451451|459072682|FG000|Overall Study|Consent Withdrawn|14|||
127574063|NCT00451451|459072683|FG001|Overall Study|Consent Withdrawn|9|||
127574064|NCT00451451|459072684|FG002|Overall Study|Consent Withdrawn|17|||
127574065|NCT00451451|459072685|FG003|Overall Study|Consent Withdrawn|17|||
127574066|NCT00451451|459072682|FG000|Overall Study|Investigator Decision|6|||
127574067|NCT00451451|459072683|FG001|Overall Study|Investigator Decision|2|||
127574068|NCT00451451|459072684|FG002|Overall Study|Investigator Decision|1|||
127574069|NCT00451451|459072685|FG003|Overall Study|Investigator Decision|2|||
127692699|NCT05415436|459501605|FG000|Overall Study|Death|1|||
127692700|NCT05415436|459501606|FG001|Overall Study|Death|0|||
127692701|NCT03819686|459501613|FG000|Overall Study|Lost to Follow-up|2|||
127692702|NCT03819686|459501614|FG001|Overall Study|Lost to Follow-up|3|||
127574070|NCT00451451|459072682|FG000|Overall Study|Subject Non-Compliance|8|||
127574071|NCT00451451|459072683|FG001|Overall Study|Subject Non-Compliance|4|||
127574072|NCT00451451|459072684|FG002|Overall Study|Subject Non-Compliance|3|||
127574073|NCT00451451|459072685|FG003|Overall Study|Subject Non-Compliance|3|||
127574074|NCT00451451|459072682|FG000|Overall Study|Death|1|||
127692703|NCT06023082|459501624|FG000|Overall Study|Withdrawal by Subject|2|||
127692704|NCT06023082|459501624|FG000|Overall Study|Lost to Follow-up|15|||
127692705|NCT06023082|459501624|FG000|Overall Study|Side effects|5|||
127574075|NCT00451451|459072683|FG001|Overall Study|Death|0|||
127692706|NCT03584516|459501625|FG000|Part 1|Death|2|||
127692707|NCT03584516|459501626|FG001|Part 1|Death|3|||
128029453|NCT04064567|460733590|FG001|Overall Study|Lost to Follow-up|22|||
127574076|NCT00451451|459072684|FG002|Overall Study|Death|0|||
127574077|NCT00451451|459072685|FG003|Overall Study|Death|1|||
127692708|NCT03584516|459501627|FG002|Part 1|Death|0|||
127574078|NCT00451451|459072682|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
127574079|NCT00451451|459072683|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
127574080|NCT00451451|459072684|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
127574081|NCT00451451|459072685|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
127574082|NCT00084838|459072686|FG000|Overall Study|Death|1|||
127574083|NCT00084838|459072686|FG000|Overall Study|Adverse Event|2|||
127574084|NCT00084838|459072686|FG000|Overall Study|Withdrawal by Subject|1|||
127574085|NCT00084838|459072686|FG000|Overall Study|Progressive Disease|4|||
127574086|NCT00084838|459072686|FG000|Overall Study|Pt Non-Compliance|1|||
127574087|NCT00084838|459072686|FG000|Overall Study|Ineligible|4|||
127574088|NCT00122278|459072687|FG000|Overall Study|Lost to Follow-up|2|||
127692709|NCT03584516|459501628|FG003|Part 1|Death|0|||
127692710|NCT03584516|459501629|FG004|Part 1|Death|0|||
127692711|NCT03584516|459501630|FG005|Part 1|Death|0|||
128029454|NCT04064567|460733589|FG000|Overall Study|Withdrawal by Subject|0|||
127574089|NCT00122278|459072688|FG001|Overall Study|Lost to Follow-up|0|||
127574090|NCT01865084|459072689|FG000|Double Blind Period (DB)|Adverse Event|2|||
127574091|NCT01865084|459072690|FG001|Double Blind Period (DB)|Adverse Event|2|||
127574092|NCT01865084|459072691|FG002|Double Blind Period (DB)|Adverse Event|1|||
127574093|NCT01865084|459072689|FG000|Double Blind Period (DB)|Protocol Violation|0|||
127574094|NCT01865084|459072690|FG001|Double Blind Period (DB)|Protocol Violation|0|||
127574095|NCT01865084|459072691|FG002|Double Blind Period (DB)|Protocol Violation|1|||
127574096|NCT01865084|459072689|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
127574097|NCT01865084|459072690|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
127574098|NCT01865084|459072691|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
127574099|NCT01865084|459072689|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
127574100|NCT01865084|459072690|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
127574101|NCT01865084|459072691|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
127574102|NCT01865084|459072689|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
127574103|NCT01865084|459072690|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
127574104|NCT01865084|459072691|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
127574105|NCT01865084|459072689|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
127574106|NCT01865084|459072690|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
127574107|NCT01865084|459072691|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
127574108|NCT01865084|459072689|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
127574109|NCT01865084|459072690|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
127574110|NCT01865084|459072691|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
127574111|NCT01865084|459072689|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
127574112|NCT01865084|459072690|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
127574113|NCT01865084|459072691|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
127574114|NCT01865084|459072689|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
127574115|NCT01865084|459072690|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
127574116|NCT01865084|459072691|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
127574117|NCT01994590|459072692|FG000|Overall Study|Adverse Event|1|||
127574118|NCT01994590|459072692|FG000|Overall Study|Trial Terminated|1|||
127574119|NCT01869725|459072693|FG000|Overall Study|ineligible after registration|1|||
127574120|NCT01869725|459072693|FG000|Overall Study|Death|1|||
127574121|NCT01869725|459072693|FG000|Overall Study|Lost to Follow-up|2|||
127574122|NCT01143207|459072694|FG000|Overall Study|Lost to Follow-up|2|||
127574123|NCT03463031|459072707|FG000|Overall Study|Withdrawal by Subject|4|||
127574124|NCT03463031|459072708|FG001|Overall Study|Withdrawal by Subject|2|||
127574125|NCT03463031|459072707|FG000|Overall Study|Investigator/Sponsor Decision|0|||
127574126|NCT03463031|459072708|FG001|Overall Study|Investigator/Sponsor Decision|1|||
127574127|NCT03463031|459072707|FG000|Overall Study|Lost to Follow-up|1|||
127574128|NCT03463031|459072708|FG001|Overall Study|Lost to Follow-up|1|||
127574129|NCT03463031|459072707|FG000|Overall Study|Adverse Event|4|||
127574130|NCT03463031|459072708|FG001|Overall Study|Adverse Event|1|||
127574131|NCT03463031|459072707|FG000|Overall Study|Use of prohibited medication by subject|1|||
127574132|NCT03463031|459072708|FG001|Overall Study|Use of prohibited medication by subject|0|||
127574133|NCT01933217|459072711|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
127574134|NCT01933217|459072712|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
127574135|NCT01933217|459072711|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
127574136|NCT01933217|459072712|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
127574137|NCT03583164|459072718|FG000|Overall Study|Death in Main Phase|35|||
127574138|NCT03583164|459072718|FG000|Overall Study|Lost to Follow up in Main Phase|1|||
127574139|NCT03583164|459072718|FG000|Overall Study|Lost to follow up in Extended Phase|3|||
127574140|NCT03583164|459072718|FG000|Overall Study|Clinically significant lab value in Main Phase|2|||
127574141|NCT03583164|459072718|FG000|Overall Study|Clinically significant lab value in Extended Phase|4|||
127574142|NCT03583164|459072718|FG000|Overall Study|Physician decision in Main Phase|1|||
127574143|NCT03583164|459072718|FG000|Overall Study|Physician decision in Extended Phase|2|||
127574144|NCT03583164|459072718|FG000|Overall Study|Death in Extended Phase|13|||
127574145|NCT03583164|459072718|FG000|Overall Study|Intolerable adverse event in Main Phase|3|||
127574146|NCT03583164|459072718|FG000|Overall Study|Intolerable adverse event in Extended Phase|1|||
127574147|NCT03583164|459072718|FG000|Overall Study|Lack of compliance in Extended Phase|2|||
127692712|NCT03584516|459501625|FG000|Part 1|Withdrawal by Subject|2|||
127574148|NCT03583164|459072718|FG000|Overall Study|Treatment failure in Main Phase|2|||
127692713|NCT03584516|459501626|FG001|Part 1|Withdrawal by Subject|0|||
127692714|NCT03584516|459501627|FG002|Part 1|Withdrawal by Subject|0|||
127692715|NCT03584516|459501628|FG003|Part 1|Withdrawal by Subject|0|||
127692716|NCT03584516|459501629|FG004|Part 1|Withdrawal by Subject|0|||
127574149|NCT03583164|459072718|FG000|Overall Study|Treatment failure in Extended Phase|4|||
127574150|NCT03583164|459072718|FG000|Overall Study|Withdrawal of consent in Extended Phase|2|||
127574151|NCT03583164|459072718|FG000|Overall Study|Other not specified reason in Main Phase|2|||
127574152|NCT00057954|459072719|FG000|Overall Study|Death|1|||
127574153|NCT00057954|459072719|FG000|Overall Study|Disease progression|1|||
127692717|NCT03584516|459501630|FG005|Part 1|Withdrawal by Subject|0|||
127574154|NCT00559754|459072720|FG000|Overall Study|Disease progression|1|||
127574155|NCT00559754|459072720|FG000|Overall Study|Adverse Event|5|||
127574156|NCT00559754|459072720|FG000|Overall Study|Protocol Violation|1|||
127574157|NCT00559754|459072720|FG000|Overall Study|Investigator criteria|2|||
127574158|NCT00559754|459072720|FG000|Overall Study|Withdrawal by Subject|2|||
127574159|NCT00214500|459072725|FG000|Treatment Period|Adverse Event|1|||
127574160|NCT00214500|459072725|FG000|Extension Period|Withdrawal by Subject|2|||
127574161|NCT00147251|459072726|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
127574162|NCT00147251|459072727|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
127574163|NCT01629706|459072728|FG000|Phase 1 PureVision|Screen Failure|4|||
127574164|NCT01629706|459072728|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
127574165|NCT01629706|459072728|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
127574166|NCT01629706|459072728|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
127574167|NCT01629706|459072728|FG000|Phase 2 Habitual|Screen Failure|6|||
127574168|NCT01629706|459072728|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
127574169|NCT01629706|459072728|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
127574170|NCT01629706|459072728|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
127574171|NCT01629706|459072728|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
127574172|NCT02537574|459072730|FG000|Overall Study|Adverse Event|1|||
127574173|NCT02537574|459072731|FG001|Overall Study|Adverse Event|3|||
127574174|NCT02537574|459072732|FG002|Overall Study|Adverse Event|2|||
127574175|NCT02537574|459072730|FG000|Overall Study|Lost to Follow-up|40|||
127574176|NCT02537574|459072731|FG001|Overall Study|Lost to Follow-up|51|||
127574177|NCT02537574|459072732|FG002|Overall Study|Lost to Follow-up|55|||
127574178|NCT02537574|459072730|FG000|Overall Study|Noncompliance with study drug|0|||
127574179|NCT02537574|459072731|FG001|Overall Study|Noncompliance with study drug|1|||
127574180|NCT02537574|459072732|FG002|Overall Study|Noncompliance with study drug|1|||
127574181|NCT02537574|459072730|FG000|Overall Study|Physician Decision|2|||
127574182|NCT02537574|459072731|FG001|Overall Study|Physician Decision|0|||
127574183|NCT02537574|459072732|FG002|Overall Study|Physician Decision|0|||
127574184|NCT02537574|459072730|FG000|Overall Study|Protocol Violation|4|||
127574185|NCT02537574|459072731|FG001|Overall Study|Protocol Violation|2|||
127574186|NCT02537574|459072732|FG002|Overall Study|Protocol Violation|3|||
127574187|NCT02537574|459072730|FG000|Overall Study|Withdrawal by Subject|37|||
127574188|NCT02537574|459072731|FG001|Overall Study|Withdrawal by Subject|27|||
127574189|NCT02537574|459072732|FG002|Overall Study|Withdrawal by Subject|29|||
127574190|NCT02537574|459072730|FG000|Overall Study|Lack of Efficacy|14|||
127574191|NCT02537574|459072731|FG001|Overall Study|Lack of Efficacy|16|||
127574192|NCT02537574|459072732|FG002|Overall Study|Lack of Efficacy|15|||
127574193|NCT02537574|459072730|FG000|Overall Study|Duplicate Patient|1|||
127574194|NCT02537574|459072731|FG001|Overall Study|Duplicate Patient|0|||
127574195|NCT02537574|459072732|FG002|Overall Study|Duplicate Patient|0|||
127574196|NCT02537574|459072730|FG000|Overall Study|Patient not Stable|0|||
127574197|NCT02537574|459072731|FG001|Overall Study|Patient not Stable|1|||
127574198|NCT02537574|459072732|FG002|Overall Study|Patient not Stable|0|||
127574199|NCT02537574|459072730|FG000|Overall Study|Incarceration|0|||
127781834|NCT02665052|459827820|FG000|Overall Study|Lost to Follow-up|1|||
127781835|NCT02665052|459827821|FG001|Overall Study|Lost to Follow-up|0|||
127574200|NCT02537574|459072731|FG001|Overall Study|Incarceration|1|||
127574201|NCT02537574|459072732|FG002|Overall Study|Incarceration|0|||
127574202|NCT02537574|459072730|FG000|Overall Study|Failed Naloxone Challenge|0|||
127574203|NCT02537574|459072731|FG001|Overall Study|Failed Naloxone Challenge|1|||
127574204|NCT02537574|459072732|FG002|Overall Study|Failed Naloxone Challenge|0|||
127574205|NCT02537574|459072730|FG000|Overall Study|Transportation Issues|0|||
127574206|NCT02537574|459072731|FG001|Overall Study|Transportation Issues|0|||
127574207|NCT02537574|459072732|FG002|Overall Study|Transportation Issues|1|||
127574208|NCT02537574|459072730|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
127574209|NCT02537574|459072731|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
127574210|NCT02537574|459072732|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
127574211|NCT02537574|459072730|FG000|Overall Study|Noncompliance with Protocol|0|||
127574212|NCT02537574|459072731|FG001|Overall Study|Noncompliance with Protocol|0|||
127574213|NCT02537574|459072732|FG002|Overall Study|Noncompliance with Protocol|1|||
127574214|NCT02663687|459072733|FG000|Overall Study|Adverse Event|1|||
127574215|NCT02663687|459072734|FG001|Overall Study|Adverse Event|0|||
127574216|NCT02663687|459072735|FG002|Overall Study|Adverse Event|0|||
127574217|NCT02663687|459072736|FG003|Overall Study|Adverse Event|0|||
127574218|NCT02663687|459072737|FG004|Overall Study|Adverse Event|0|||
127574219|NCT02663687|459072733|FG000|Overall Study|Other|1|||
127574220|NCT02663687|459072734|FG001|Overall Study|Other|0|||
127574221|NCT02663687|459072735|FG002|Overall Study|Other|1|||
127574222|NCT02663687|459072736|FG003|Overall Study|Other|0|||
127574223|NCT02663687|459072737|FG004|Overall Study|Other|0|||
127574224|NCT03595774|459072738|FG000|Overall Study|Adverse Event|1|||
127574225|NCT03595774|459072739|FG001|Overall Study|Adverse Event|0|||
127574226|NCT03595774|459072740|FG002|Overall Study|Adverse Event|1|||
127574227|NCT03595774|459072741|FG003|Overall Study|Adverse Event|0|||
127574228|NCT03595774|459072738|FG000|Overall Study|screen failure|0|||
127574229|NCT03595774|459072739|FG001|Overall Study|screen failure|1|||
127574230|NCT03595774|459072740|FG002|Overall Study|screen failure|0|||
127574231|NCT03595774|459072741|FG003|Overall Study|screen failure|1|||
127574232|NCT01151098|459072742|FG000|Overall Study|Adverse Event|82|||
127574233|NCT01151098|459072742|FG000|Overall Study|Lost to Follow-up|6|||
127574234|NCT01151098|459072742|FG000|Overall Study|Lack of Efficacy|15|||
127574235|NCT01151098|459072742|FG000|Overall Study|Protocol Violation|1|||
127574236|NCT01151098|459072742|FG000|Overall Study|Miscellaneous|13|||
127574237|NCT00116168|459072745|FG000|Overall Study|Lost to Follow-up|6|||
127574238|NCT00116168|459072746|FG001|Overall Study|Lost to Follow-up|5|||
127574239|NCT00116168|459072747|FG002|Overall Study|Lost to Follow-up|0|||
127574240|NCT00116168|459072748|FG003|Overall Study|Lost to Follow-up|0|||
127574241|NCT02788474|459072749|FG000|Double Blind Treatment Period|Not treated|1|||
127574242|NCT02788474|459072750|FG001|Double Blind Treatment Period|Not treated|0|||
127574243|NCT02788474|459072749|FG000|Double Blind Treatment Period|Patient's refusal|3|||
127574244|NCT02788474|459072750|FG001|Double Blind Treatment Period|Patient's refusal|0|||
127574245|NCT02788474|459072749|FG000|Double Blind Treatment Period|Adverse Event|6|||
127574246|NCT02788474|459072750|FG001|Double Blind Treatment Period|Adverse Event|4|||
127574247|NCT02788474|459072749|FG000|Open Label Treatment Period|Adverse Event|29|||
127574248|NCT02788474|459072750|FG001|Open Label Treatment Period|Adverse Event|9|||
127574249|NCT02788474|459072749|FG000|Open Label Treatment Period|Other than reason specified|1|||
127574250|NCT02788474|459072750|FG001|Open Label Treatment Period|Other than reason specified|0|||
127574251|NCT02788474|459072749|FG000|Open Label Treatment Period|Patient's refusal|1|||
127574252|NCT02788474|459072750|FG001|Open Label Treatment Period|Patient's refusal|3|||
127574253|NCT02788474|459072749|FG000|Open Label Treatment Period|Non-compliance|1|||
127574254|NCT02788474|459072750|FG001|Open Label Treatment Period|Non-compliance|0|||
127574255|NCT00117286|459072752|FG000|Overall Study|Adverse Event|12|||
127574256|NCT00117286|459072753|FG001|Overall Study|Adverse Event|6|||
127574257|NCT00117286|459072752|FG000|Overall Study|Lost to Follow-up|2|||
127574258|NCT00117286|459072753|FG001|Overall Study|Lost to Follow-up|0|||
127574259|NCT00117286|459072752|FG000|Overall Study|Protocol Violation|3|||
127574260|NCT00117286|459072753|FG001|Overall Study|Protocol Violation|3|||
127574261|NCT00117286|459072752|FG000|Overall Study|Withdrawal by Subject|6|||
127574262|NCT00117286|459072753|FG001|Overall Study|Withdrawal by Subject|2|||
127574263|NCT00117286|459072752|FG000|Overall Study|Physician Decision|3|||
127574264|NCT00117286|459072753|FG001|Overall Study|Physician Decision|7|||
127574265|NCT00117286|459072752|FG000|Overall Study|Lack of Efficacy|2|||
127574266|NCT00117286|459072753|FG001|Overall Study|Lack of Efficacy|1|||
127781836|NCT02665052|459827822|FG002|Overall Study|Lost to Follow-up|0|||
127781837|NCT02665052|459827823|FG003|Overall Study|Lost to Follow-up|0|||
127781838|NCT02665052|459827820|FG000|Overall Study|Withdrawal by Subject|1|||
127781839|NCT02665052|459827821|FG001|Overall Study|Withdrawal by Subject|1|||
127574267|NCT00117286|459072752|FG000|Overall Study|Research site closing|0|||
127574268|NCT00117286|459072753|FG001|Overall Study|Research site closing|2|||
127574269|NCT00048061|459072754|FG000|Overall Study|Adverse Event|41|||
127574270|NCT00048061|459072755|FG001|Overall Study|Adverse Event|32|||
127574271|NCT00048061|459072756|FG002|Overall Study|Adverse Event|44|||
127574272|NCT00048061|459072757|FG003|Overall Study|Adverse Event|37|||
127574273|NCT00048061|459072754|FG000|Overall Study|Lost to Follow-up|3|||
127574274|NCT00048061|459072755|FG001|Overall Study|Lost to Follow-up|2|||
127574275|NCT00048061|459072756|FG002|Overall Study|Lost to Follow-up|4|||
127574276|NCT00048061|459072757|FG003|Overall Study|Lost to Follow-up|5|||
127574277|NCT00048061|459072754|FG000|Overall Study|Withdrawal by Subject|20|||
127781840|NCT02665052|459827822|FG002|Overall Study|Withdrawal by Subject|0|||
127781841|NCT02665052|459827823|FG003|Overall Study|Withdrawal by Subject|5|||
127781842|NCT02665052|459827820|FG000|Overall Study|Adverse Event|1|||
127781843|NCT02665052|459827821|FG001|Overall Study|Adverse Event|1|||
127781844|NCT02665052|459827822|FG002|Overall Study|Adverse Event|0|||
127781845|NCT02665052|459827823|FG003|Overall Study|Adverse Event|0|||
127781846|NCT00823823|459827824|FG000|Overall Study|Lost to Follow-up|3|||
128029455|NCT04064567|460733590|FG001|Overall Study|Withdrawal by Subject|1|||
127574278|NCT00048061|459072755|FG001|Overall Study|Withdrawal by Subject|29|||
127574279|NCT00048061|459072756|FG002|Overall Study|Withdrawal by Subject|29|||
127574280|NCT00048061|459072757|FG003|Overall Study|Withdrawal by Subject|32|||
127574281|NCT00048061|459072754|FG000|Overall Study|Did not follow-up|5|||
127574282|NCT00048061|459072755|FG001|Overall Study|Did not follow-up|5|||
127574283|NCT00048061|459072756|FG002|Overall Study|Did not follow-up|4|||
127574284|NCT00048061|459072757|FG003|Overall Study|Did not follow-up|5|||
127574285|NCT00048061|459072754|FG000|Overall Study|Early improvement|6|||
127574286|NCT00048061|459072755|FG001|Overall Study|Early improvement|5|||
127574287|NCT00048061|459072756|FG002|Overall Study|Early improvement|3|||
127574288|NCT00048061|459072757|FG003|Overall Study|Early improvement|0|||
127574289|NCT01323946|459072758|FG000|Overall Study|Lost to Follow-up|0|||
127574290|NCT01323946|459072759|FG001|Overall Study|Lost to Follow-up|1|||
127574291|NCT01323946|459072760|FG002|Overall Study|Lost to Follow-up|0|||
127574292|NCT01323946|459072758|FG000|Overall Study|Parents refused the last blood draw|1|||
127574293|NCT01323946|459072759|FG001|Overall Study|Parents refused the last blood draw|0|||
127574294|NCT01323946|459072760|FG002|Overall Study|Parents refused the last blood draw|0|||
127574295|NCT01323946|459072758|FG000|Overall Study|Withdrawal by Subject|2|||
127574296|NCT01323946|459072759|FG001|Overall Study|Withdrawal by Subject|2|||
127574297|NCT01323946|459072760|FG002|Overall Study|Withdrawal by Subject|0|||
127574298|NCT01272661|459072763|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
127574299|NCT01272661|459072764|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
127574300|NCT01272661|459072765|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
127574301|NCT00573248|459072766|FG000|Overall Study|scheduling conflicts|15|||
127574302|NCT00573248|459072767|FG001|Overall Study|scheduling conflicts|11|||
127574303|NCT02017171|459072768|FG000|Overall Study|Death|10|||
127574304|NCT02017171|459072769|FG001|Overall Study|Death|4|||
127574305|NCT02017171|459072768|FG000|Overall Study|Withdrawal by Subject|23|||
127574306|NCT02017171|459072769|FG001|Overall Study|Withdrawal by Subject|17|||
127574307|NCT02017171|459072768|FG000|Overall Study|Lost to Follow-up|21|||
127574308|NCT02017171|459072769|FG001|Overall Study|Lost to Follow-up|20|||
127574309|NCT02017171|459072768|FG000|Overall Study|ESKD|6|||
127574310|NCT02017171|459072769|FG001|Overall Study|ESKD|2|||
127574311|NCT02017171|459072768|FG000|Overall Study|Miscellaneous|2|||
127574312|NCT02017171|459072769|FG001|Overall Study|Miscellaneous|3|||
127574313|NCT03370289|459072770|FG000|Overall Study|Screen Failure|1|||
127574314|NCT03370289|459072770|FG000|Overall Study|Sample Size Sufficient|4|||
127574315|NCT02220998|459072771|FG000|Overall Study|Randomized but Never Treated|1|||
127574316|NCT02220998|459072772|FG001|Overall Study|Randomized but Never Treated|2|||
127574317|NCT02220998|459072771|FG000|Overall Study|Death|2|||
127574318|NCT02220998|459072772|FG001|Overall Study|Death|0|||
127574319|NCT02220998|459072771|FG000|Overall Study|Lack of Efficacy|0|||
127574320|NCT02220998|459072772|FG001|Overall Study|Lack of Efficacy|5|||
127574321|NCT02220998|459072771|FG000|Overall Study|Lost to Follow-up|4|||
127574322|NCT02220998|459072772|FG001|Overall Study|Lost to Follow-up|4|||
127574323|NCT02314143|459072773|FG000|Overall Study|Adverse Event|0|||
127574324|NCT02314143|459072774|FG001|Overall Study|Adverse Event|6|||
127781847|NCT00823823|459827825|FG001|Overall Study|Lost to Follow-up|1|||
128029456|NCT04064567|460733589|FG000|Overall Study|Reincarcerated|7|||
128029457|NCT04064567|460733590|FG001|Overall Study|Reincarcerated|10|||
128029458|NCT04064567|460733589|FG000|Overall Study|Moved out of U.S.|0|||
128029459|NCT04064567|460733590|FG001|Overall Study|Moved out of U.S.|1|||
128029460|NCT04576481|460733592|FG000|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|0|||
127574325|NCT02314143|459072775|FG002|Overall Study|Adverse Event|4|||
127574326|NCT02314143|459072773|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
127574327|NCT02314143|459072774|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
127574328|NCT02314143|459072775|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
127781848|NCT00823823|459827824|FG000|Overall Study|Protocol Violation|5|||
127574329|NCT02314143|459072773|FG000|Overall Study|Physician Decision|2|||
127574330|NCT02314143|459072774|FG001|Overall Study|Physician Decision|1|||
127574331|NCT02314143|459072775|FG002|Overall Study|Physician Decision|0|||
127574332|NCT02314143|459072773|FG000|Overall Study|Withdrawal by Subject|1|||
127574333|NCT02314143|459072774|FG001|Overall Study|Withdrawal by Subject|0|||
128029461|NCT04576481|460733593|FG001|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
127574334|NCT02314143|459072775|FG002|Overall Study|Withdrawal by Subject|1|||
127781849|NCT00823823|459827825|FG001|Overall Study|Protocol Violation|5|||
127781850|NCT02234284|459827826|FG000|Overall Study|Death|4|||
127574335|NCT00873860|459072776|FG000|Overall Study|Lost to Follow-up|1|||
127574336|NCT00873860|459072777|FG001|Overall Study|Lost to Follow-up|0|||
127781851|NCT02234284|459827827|FG001|Overall Study|Death|2|||
128029462|NCT04576481|460733594|FG002|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|3|||
127574337|NCT00873860|459072778|FG002|Overall Study|Lost to Follow-up|0|||
127574338|NCT00873860|459072779|FG003|Overall Study|Lost to Follow-up|1|||
127574339|NCT00873860|459072776|FG000|Overall Study|Withdrawal by Subject|1|||
127574340|NCT00873860|459072777|FG001|Overall Study|Withdrawal by Subject|0|||
127574341|NCT00873860|459072778|FG002|Overall Study|Withdrawal by Subject|2|||
127574342|NCT00873860|459072779|FG003|Overall Study|Withdrawal by Subject|0|||
127574343|NCT00873860|459072776|FG000|Overall Study|Death|1|||
127574344|NCT00873860|459072777|FG001|Overall Study|Death|0|||
127574345|NCT00873860|459072778|FG002|Overall Study|Death|0|||
127574346|NCT00873860|459072779|FG003|Overall Study|Death|0|||
127574347|NCT00873860|459072776|FG000|Overall Study|Other|1|||
127574348|NCT00873860|459072777|FG001|Overall Study|Other|0|||
127574349|NCT00873860|459072778|FG002|Overall Study|Other|1|||
127574350|NCT00873860|459072779|FG003|Overall Study|Other|0|||
127574351|NCT02140775|459072781|FG000|Overall Study|Withdrawal by Subject|30|||
127574352|NCT02140775|459072782|FG001|Overall Study|Withdrawal by Subject|7|||
127574353|NCT01172275|459072785|FG000|Overall Study|Lost to Follow-up|1|||
127574354|NCT01172275|459072786|FG001|Overall Study|Lost to Follow-up|0|||
127574355|NCT01172275|459072785|FG000|Overall Study|Protocol Violation|1|||
127574356|NCT01172275|459072786|FG001|Overall Study|Protocol Violation|0|||
127574357|NCT04650854|459072791|FG000|Overall Study|Adverse Event|1|||
127574358|NCT04650854|459072792|FG001|Overall Study|Adverse Event|12|||
127574359|NCT04650854|459072793|FG002|Overall Study|Adverse Event|14|||
127574360|NCT04650854|459072791|FG000|Overall Study|Lack of Efficacy|1|||
127574361|NCT04650854|459072792|FG001|Overall Study|Lack of Efficacy|3|||
127574362|NCT04650854|459072793|FG002|Overall Study|Lack of Efficacy|6|||
127574363|NCT04650854|459072791|FG000|Overall Study|Lost to Follow-up|1|||
127574364|NCT04650854|459072792|FG001|Overall Study|Lost to Follow-up|1|||
127574365|NCT04650854|459072793|FG002|Overall Study|Lost to Follow-up|0|||
127574366|NCT04650854|459072791|FG000|Overall Study|Withdrawal by Subject|2|||
127574367|NCT04650854|459072792|FG001|Overall Study|Withdrawal by Subject|17|||
127574368|NCT04650854|459072793|FG002|Overall Study|Withdrawal by Subject|9|||
127574369|NCT04650854|459072791|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines|0|||
127574370|NCT04650854|459072792|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines|12|||
127574371|NCT04650854|459072793|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines|6|||
127574372|NCT04650854|459072791|FG000|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
127574373|NCT04650854|459072792|FG001|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
127574374|NCT04650854|459072793|FG002|Overall Study|Participant Withdrawn After Drug Approved By FDA|1|||
127574375|NCT04650854|459072791|FG000|Overall Study|Pi Withdrew the Patients From the Study|0|||
127574376|NCT04650854|459072792|FG001|Overall Study|Pi Withdrew the Patients From the Study|0|||
127574377|NCT04650854|459072793|FG002|Overall Study|Pi Withdrew the Patients From the Study|1|||
127574378|NCT04650854|459072791|FG000|Overall Study|Withdraw Per Sponsor's Directive|0|||
127574379|NCT04650854|459072792|FG001|Overall Study|Withdraw Per Sponsor's Directive|1|||
127574380|NCT04650854|459072793|FG002|Overall Study|Withdraw Per Sponsor's Directive|0|||
127574381|NCT04650854|459072791|FG000|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
127574382|NCT04650854|459072792|FG001|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
127574383|NCT04650854|459072793|FG002|Overall Study|Withdrawal Due to Prohibited Treatment|1|||
127574384|NCT04650854|459072791|FG000|Overall Study|Use of Rescue Medication|0|||
127574385|NCT04650854|459072792|FG001|Overall Study|Use of Rescue Medication|0|||
127574386|NCT04650854|459072793|FG002|Overall Study|Use of Rescue Medication|1|||
127574387|NCT04650854|459072791|FG000|Overall Study|Last Treatment Per Sponsor|0|||
127574388|NCT04650854|459072792|FG001|Overall Study|Last Treatment Per Sponsor|0|||
127574389|NCT04650854|459072793|FG002|Overall Study|Last Treatment Per Sponsor|2|||
127574390|NCT04650854|459072791|FG000|Overall Study|Rescue Medication|0|||
127574391|NCT04650854|459072792|FG001|Overall Study|Rescue Medication|0|||
127574392|NCT04650854|459072793|FG002|Overall Study|Rescue Medication|1|||
127574393|NCT04650854|459072791|FG000|Overall Study|Participant Want to Start a Family|0|||
127574394|NCT04650854|459072792|FG001|Overall Study|Participant Want to Start a Family|0|||
127574395|NCT04650854|459072793|FG002|Overall Study|Participant Want to Start a Family|1|||
127574396|NCT04650854|459072791|FG000|Overall Study|Withdraw Based on Sponsor Decision|0|||
127574397|NCT04650854|459072792|FG001|Overall Study|Withdraw Based on Sponsor Decision|0|||
127574398|NCT04650854|459072793|FG002|Overall Study|Withdraw Based on Sponsor Decision|1|||
127574399|NCT04650854|459072791|FG000|Overall Study|Participant Screened For MG0020|0|||
127574400|NCT04650854|459072792|FG001|Overall Study|Participant Screened For MG0020|2|||
127574401|NCT04650854|459072793|FG002|Overall Study|Participant Screened For MG0020|3|||
127574402|NCT04650854|459072791|FG000|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
127574403|NCT04650854|459072792|FG001|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|1|||
127574404|NCT04650854|459072793|FG002|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
127574405|NCT04650854|459072791|FG000|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
127574406|NCT04650854|459072792|FG001|Overall Study|Subject Performed PEOT, Not a Completed Subject|1|||
127574407|NCT04650854|459072793|FG002|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
127574408|NCT04650854|459072791|FG000|Overall Study|Participant to Be Screened for MG0020 Study|0|||
127574409|NCT04650854|459072792|FG001|Overall Study|Participant to Be Screened for MG0020 Study|4|||
127781852|NCT02234284|459827826|FG000|Overall Study|Withdrawal by Subject|1|||
127781853|NCT02234284|459827827|FG001|Overall Study|Withdrawal by Subject|0|||
127781854|NCT02234284|459827826|FG000|Overall Study|Lost to Follow-up|20|||
127781855|NCT02234284|459827827|FG001|Overall Study|Lost to Follow-up|7|||
127781856|NCT00233363|459827833|FG000|Overall Study|Adverse Event|1|||
127781857|NCT00233363|459827834|FG001|Overall Study|Adverse Event|2|||
127781858|NCT00233363|459827833|FG000|Overall Study|Lack of Efficacy|0|||
127781859|NCT00233363|459827834|FG001|Overall Study|Lack of Efficacy|2|||
127781860|NCT00233363|459827833|FG000|Overall Study|Withdrawal by Subject|1|||
127781861|NCT00233363|459827834|FG001|Overall Study|Withdrawal by Subject|1|||
127781862|NCT00233363|459827833|FG000|Overall Study|Aggravation of complication|1|||
127781863|NCT00233363|459827834|FG001|Overall Study|Aggravation of complication|0|||
127781864|NCT01576172|459827835|FG000|Overall Study|Ineligible|2|||
127781865|NCT01576172|459827836|FG001|Overall Study|Ineligible|1|||
127781866|NCT01576172|459827835|FG000|Overall Study|Withdrawal by Subject|2|||
127781867|NCT01576172|459827836|FG001|Overall Study|Withdrawal by Subject|0|||
127781868|NCT01576172|459827835|FG000|Overall Study|Insurance issue|1|||
127781869|NCT01576172|459827836|FG001|Overall Study|Insurance issue|0|||
127781870|NCT01490814|459827841|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
127781871|NCT01490814|459827842|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
127781872|NCT01490814|459827841|FG000|Overall Study|Physician Decision|1|||
127781873|NCT01490814|459827842|FG001|Overall Study|Physician Decision|0|||
127781874|NCT01490814|459827841|FG000|Overall Study|Withdrawal by Subject|0|||
127781875|NCT01490814|459827842|FG001|Overall Study|Withdrawal by Subject|5|||
127781876|NCT03024970|459827846|FG000|First Intervention|Adverse Event|1|||
127781877|NCT03024970|459827847|FG001|First Intervention|Adverse Event|0|||
127781878|NCT03024970|459827846|FG000|Second Intervention|Lost to Follow-up|1|||
127781879|NCT03024970|459827847|FG001|Second Intervention|Lost to Follow-up|0|||
127781880|NCT04340557|459827854|FG000|Overall Study|Transferred to ICU and/or death|1|||
127781881|NCT04340557|459827855|FG001|Overall Study|Transferred to ICU and/or death|2|||
127781882|NCT01289821|459827856|FG000|Treatment Period|Withdrawal by Subject|1|||
127781883|NCT01289821|459827856|FG000|Treatment Period|Physician Decision|3|||
127781884|NCT01289821|459827856|FG000|Treatment Period|Adverse Event|4|||
127781885|NCT01289821|459827856|FG000|Treatment Period|Radiological Progression|43|||
127781886|NCT01289821|459827856|FG000|Treatment Period|Clinical Progression|2|||
127781887|NCT01289821|459827856|FG000|Treatment Period|Therapeutic procedure required|1|||
127781888|NCT01289821|459827856|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
127781889|NCT01289821|459827856|FG000|Safety Follow-up Period|Protocol Violation|3|||
127781890|NCT01289821|459827856|FG000|Safety Follow-up Period|Unspecified reason|1|||
127781891|NCT01289821|459827856|FG000|Survival Follow-up Period|Protocol Violation|1|||
127781892|NCT01289821|459827856|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
127781893|NCT01289821|459827856|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
127781894|NCT00590044|459827860|FG000|Overall Study|Withdrawal by Subject|2|||
127781895|NCT00590044|459827861|FG001|Overall Study|Withdrawal by Subject|2|||
127781896|NCT00590044|459827860|FG000|Overall Study|wrong insulin arm assigned|1|||
127781897|NCT00590044|459827861|FG001|Overall Study|wrong insulin arm assigned|0|||
127781898|NCT00590044|459827860|FG000|Overall Study|Protocol Violation|1|||
127781899|NCT00590044|459827861|FG001|Overall Study|Protocol Violation|0|||
127781900|NCT01010633|459827864|FG000|Overall Study|Adverse Event|1|||
127781901|NCT01010633|459827865|FG001|Overall Study|Adverse Event|1|||
127781902|NCT01010633|459827864|FG000|Overall Study|Protocol Violation|1|||
127781903|NCT01010633|459827865|FG001|Overall Study|Protocol Violation|2|||
127781904|NCT01010633|459827864|FG000|Overall Study|Withdrawal by Subject|2|||
127781905|NCT01010633|459827865|FG001|Overall Study|Withdrawal by Subject|1|||
127781906|NCT01010633|459827864|FG000|Overall Study|Investigator decision|0|||
127781907|NCT01010633|459827865|FG001|Overall Study|Investigator decision|1|||
127781908|NCT02790138|459827866|FG000|Overall Study|Adverse Event|5|||
128029463|NCT04576481|460733595|FG003|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
128029464|NCT05463952|460733596|FG000|Treatment|Progressive disease|4|||
128029465|NCT05463952|460733596|FG000|Treatment|Ongoing|2|||
128029466|NCT01682720|460733598|FG000|Overall Study|Randomized but Not Treated|0|||
128029467|NCT01682720|460733599|FG001|Overall Study|Randomized but Not Treated|1|||
127574410|NCT04650854|459072793|FG002|Overall Study|Participant to Be Screened for MG0020 Study|5|||
127781909|NCT02790138|459827867|FG001|Overall Study|Adverse Event|2|||
127781910|NCT02790138|459827866|FG000|Overall Study|Significant Protocol Deviation|0|||
127781911|NCT02790138|459827867|FG001|Overall Study|Significant Protocol Deviation|1|||
127781912|NCT02790138|459827866|FG000|Overall Study|Lost to Follow-up|1|||
127781913|NCT02790138|459827867|FG001|Overall Study|Lost to Follow-up|0|||
127781914|NCT02790138|459827866|FG000|Overall Study|Voluntary Withdrawal|8|||
127781915|NCT02790138|459827867|FG001|Overall Study|Voluntary Withdrawal|9|||
127781916|NCT02790138|459827866|FG000|Overall Study|Lack of Efficacy|6|||
127781917|NCT02790138|459827867|FG001|Overall Study|Lack of Efficacy|7|||
127781918|NCT02790138|459827866|FG000|Overall Study|Reason not Specified|1|||
127781919|NCT02790138|459827867|FG001|Overall Study|Reason not Specified|0|||
127781920|NCT01786603|459827868|FG000|Overall Study|Death|5|||
128029468|NCT01682720|460733600|FG002|Overall Study|Randomized but Not Treated|1|||
127574411|NCT04650854|459072791|FG000|Overall Study|End Of Study|0|||
127574412|NCT04650854|459072792|FG001|Overall Study|End Of Study|2|||
127574413|NCT04650854|459072793|FG002|Overall Study|End Of Study|1|||
127574414|NCT04650854|459072791|FG000|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
127574415|NCT04650854|459072792|FG001|Overall Study|Wish To Continue Study IMP in Patient Programme|1|||
127574416|NCT04650854|459072793|FG002|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
127574417|NCT04650854|459072791|FG000|Overall Study|Participant Received Rescue Medication|0|||
127574418|NCT04650854|459072792|FG001|Overall Study|Participant Received Rescue Medication|1|||
127574419|NCT04650854|459072793|FG002|Overall Study|Participant Received Rescue Medication|0|||
127574420|NCT04650854|459072791|FG000|Overall Study|Patient Withdrawn; Lack of IMP Shipments|0|||
127574421|NCT04650854|459072792|FG001|Overall Study|Patient Withdrawn; Lack of IMP Shipments|2|||
127574422|NCT04650854|459072793|FG002|Overall Study|Patient Withdrawn; Lack of IMP Shipments|1|||
127574423|NCT04650854|459072791|FG000|Overall Study|Last Treatment Per Lplv, Screened For MG0020|0|||
127574424|NCT04650854|459072792|FG001|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
127574425|NCT04650854|459072793|FG002|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
127574426|NCT04650854|459072791|FG000|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
127574427|NCT04650854|459072792|FG001|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
127574428|NCT04650854|459072793|FG002|Overall Study|Discontinued Due to Chronic Heart Failure|1|||
127574429|NCT04650854|459072791|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|0|||
127574430|NCT04650854|459072792|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
127574431|NCT04650854|459072793|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
127574432|NCT04650854|459072791|FG000|Overall Study|Enrollment Cup|0|||
127574433|NCT04650854|459072792|FG001|Overall Study|Enrollment Cup|0|||
127574434|NCT04650854|459072793|FG002|Overall Study|Enrollment Cup|1|||
127574435|NCT05308290|459072794|FG000|Overall Study|Death|1|||
127574436|NCT05308290|459072795|FG001|Overall Study|Death|0|||
127574437|NCT05308290|459072794|FG000|Overall Study|Lost to Follow-up|2|||
127574438|NCT05308290|459072795|FG001|Overall Study|Lost to Follow-up|1|||
127574439|NCT05308290|459072794|FG000|Overall Study|still in study followup|0|||
127574440|NCT05308290|459072795|FG001|Overall Study|still in study followup|1|||
127574441|NCT04437368|459072796|FG000|Overall Study|Death|3|||
127574442|NCT04437368|459072797|FG001|Overall Study|Death|0|||
127574443|NCT04437368|459072798|FG002|Overall Study|Death|2|||
127574444|NCT04437368|459072796|FG000|Overall Study|Study terminated by sponsor|16|||
127574445|NCT04437368|459072797|FG001|Overall Study|Study terminated by sponsor|1|||
127574446|NCT04437368|459072798|FG002|Overall Study|Study terminated by sponsor|25|||
127574447|NCT04437368|459072796|FG000|Overall Study|Withdrawal by Subject|4|||
127574448|NCT04437368|459072797|FG001|Overall Study|Withdrawal by Subject|0|||
127574449|NCT04437368|459072798|FG002|Overall Study|Withdrawal by Subject|3|||
127574450|NCT04437368|459072796|FG000|Overall Study|Sponsor instructions|23|||
127574451|NCT04437368|459072797|FG001|Overall Study|Sponsor instructions|0|||
127574452|NCT04437368|459072798|FG002|Overall Study|Sponsor instructions|0|||
127574453|NCT01280955|459072802|FG000|Overall Study|Death|2|||
127574454|NCT01280955|459072802|FG000|Overall Study|Withdrawal by Subject|1|||
127574455|NCT04223232|459072804|FG000|Overall Study|Withdrawal by Subject|1|||
127574456|NCT01674634|459072805|FG000|Overall Study|Withdrawal by Subject|3|||
127574457|NCT01674634|459072805|FG000|Overall Study|Lost to Follow-up|3|||
127574458|NCT01721070|459072806|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
127574459|NCT02204007|459072807|FG000|Overall Study|Surgery Canceled|1|||
127574460|NCT02204007|459072808|FG001|Overall Study|Surgery Canceled|1|||
127574461|NCT03172910|459074621|FG000|Overall Study|Adverse Event|0|||
127574462|NCT03172910|459074622|FG001|Overall Study|Adverse Event|0|||
127574463|NCT03172910|459074623|FG002|Overall Study|Adverse Event|0|||
127574464|NCT03172910|459074624|FG003|Overall Study|Adverse Event|0|||
127574465|NCT03172910|459074625|FG004|Overall Study|Adverse Event|1|||
127574466|NCT01927341|459074627|FG000|Phase 1b|Lost to Follow-up|1|||
127574467|NCT01927341|459074628|FG001|Phase 1b|Lost to Follow-up|0|||
127574468|NCT01927341|459074629|FG002|Phase 1b|Lost to Follow-up|0|||
127574469|NCT01927341|459074630|FG003|Phase 1b|Lost to Follow-up|0|||
127692718|NCT03584516|459501625|FG000|Part 1|Lost to Follow-up|1|||
127692719|NCT03584516|459501626|FG001|Part 1|Lost to Follow-up|0|||
127692720|NCT03584516|459501627|FG002|Part 1|Lost to Follow-up|0|||
127692721|NCT03584516|459501628|FG003|Part 1|Lost to Follow-up|0|||
127692722|NCT03584516|459501629|FG004|Part 1|Lost to Follow-up|0|||
127574470|NCT01927341|459074631|FG004|Phase 1b|Lost to Follow-up|0|||
127574471|NCT01927341|459074627|FG000|Phase 1b|Death|2|||
127574472|NCT01927341|459074628|FG001|Phase 1b|Death|0|||
127574473|NCT01927341|459074629|FG002|Phase 1b|Death|0|||
127574474|NCT01927341|459074630|FG003|Phase 1b|Death|0|||
127574475|NCT01927341|459074631|FG004|Phase 1b|Death|0|||
127574476|NCT01927341|459074627|FG000|Phase 1b|Follow-up completed|7|||
127574477|NCT01927341|459074628|FG001|Phase 1b|Follow-up completed|0|||
127574478|NCT01927341|459074629|FG002|Phase 1b|Follow-up completed|0|||
127574479|NCT01927341|459074630|FG003|Phase 1b|Follow-up completed|0|||
127692723|NCT03584516|459501630|FG005|Part 1|Lost to Follow-up|0|||
127692724|NCT03584516|459501625|FG000|Part 1|Study Terminated by Sponsor|0|||
127574480|NCT01927341|459074631|FG004|Phase 1b|Follow-up completed|0|||
127574481|NCT01927341|459074627|FG000|Phase 2|Lost to Follow-up|0|||
127574482|NCT01927341|459074628|FG001|Phase 2|Lost to Follow-up|1|||
127574483|NCT01927341|459074629|FG002|Phase 2|Lost to Follow-up|0|||
127574484|NCT01927341|459074630|FG003|Phase 2|Lost to Follow-up|0|||
127574485|NCT01927341|459074631|FG004|Phase 2|Lost to Follow-up|0|||
127574486|NCT01927341|459074627|FG000|Phase 2|Participant withdrew consent|0|||
127574487|NCT01927341|459074628|FG001|Phase 2|Participant withdrew consent|2|||
127574488|NCT01927341|459074629|FG002|Phase 2|Participant withdrew consent|1|||
127574489|NCT01927341|459074630|FG003|Phase 2|Participant withdrew consent|2|||
127574490|NCT01927341|459074631|FG004|Phase 2|Participant withdrew consent|3|||
127574491|NCT01927341|459074627|FG000|Phase 2|Death|0|||
127574492|NCT01927341|459074628|FG001|Phase 2|Death|4|||
127574493|NCT01927341|459074629|FG002|Phase 2|Death|0|||
127574494|NCT01927341|459074630|FG003|Phase 2|Death|3|||
127574495|NCT01927341|459074631|FG004|Phase 2|Death|2|||
127574496|NCT01927341|459074627|FG000|Phase 2|New cancer therapy|0|||
127574497|NCT01927341|459074628|FG001|Phase 2|New cancer therapy|1|||
127574498|NCT01927341|459074629|FG002|Phase 2|New cancer therapy|0|||
127574499|NCT01927341|459074630|FG003|Phase 2|New cancer therapy|4|||
127574500|NCT01927341|459074631|FG004|Phase 2|New cancer therapy|1|||
127574501|NCT01927341|459074627|FG000|Phase 2|Disease progression|0|||
127574502|NCT01927341|459074628|FG001|Phase 2|Disease progression|1|||
127574503|NCT01927341|459074629|FG002|Phase 2|Disease progression|1|||
127574504|NCT01927341|459074630|FG003|Phase 2|Disease progression|1|||
127574505|NCT01927341|459074631|FG004|Phase 2|Disease progression|0|||
127574506|NCT01927341|459074627|FG000|Phase 2|Follow-up completed|0|||
127574507|NCT01927341|459074628|FG001|Phase 2|Follow-up completed|6|||
127574508|NCT01927341|459074629|FG002|Phase 2|Follow-up completed|3|||
127574509|NCT01927341|459074630|FG003|Phase 2|Follow-up completed|5|||
127574510|NCT01927341|459074631|FG004|Phase 2|Follow-up completed|2|||
127574511|NCT01397201|459074632|FG000|Overall Study|Not treated|0|||
127574512|NCT01397201|459074633|FG001|Overall Study|Not treated|0|||
127574513|NCT01397201|459074634|FG002|Overall Study|Not treated|1|||
127574514|NCT01397201|459074635|FG003|Overall Study|Not treated|0|||
127574515|NCT01397201|459074636|FG004|Overall Study|Not treated|0|||
127574516|NCT01397201|459074632|FG000|Overall Study|Not yet defined|3|||
127574517|NCT01397201|459074633|FG001|Overall Study|Not yet defined|6|||
127574518|NCT01397201|459074634|FG002|Overall Study|Not yet defined|5|||
127574519|NCT01397201|459074635|FG003|Overall Study|Not yet defined|5|||
127574520|NCT01397201|459074636|FG004|Overall Study|Not yet defined|4|||
127574521|NCT01397201|459074632|FG000|Overall Study|Adverse Event|2|||
127574522|NCT01397201|459074633|FG001|Overall Study|Adverse Event|0|||
127574523|NCT01397201|459074634|FG002|Overall Study|Adverse Event|0|||
127574524|NCT01397201|459074635|FG003|Overall Study|Adverse Event|0|||
127574525|NCT01397201|459074636|FG004|Overall Study|Adverse Event|0|||
127574526|NCT01083485|459074637|FG000|Overall Study|Adverse Event|0|||
127574527|NCT01083485|459074638|FG001|Overall Study|Adverse Event|1|||
127574528|NCT01083485|459074637|FG000|Overall Study|Protocol Violation|1|||
127574529|NCT01083485|459074638|FG001|Overall Study|Protocol Violation|0|||
127574530|NCT01083485|459074637|FG000|Overall Study|Withdrawal by Subject|5|||
127574531|NCT01083485|459074638|FG001|Overall Study|Withdrawal by Subject|2|||
127574532|NCT01083485|459074637|FG000|Overall Study|Other|1|||
127574533|NCT01083485|459074638|FG001|Overall Study|Other|0|||
127574534|NCT03607422|459074641|FG000|Overall Study|Adverse Event|7|||
127574535|NCT03607422|459074642|FG001|Overall Study|Adverse Event|3|||
127574536|NCT03607422|459074643|FG002|Overall Study|Adverse Event|2|||
127574537|NCT03607422|459074644|FG003|Overall Study|Adverse Event|0|||
127574538|NCT03607422|459074645|FG004|Overall Study|Adverse Event|2|||
127574539|NCT03607422|459074646|FG005|Overall Study|Adverse Event|0|||
128029469|NCT01682720|460733601|FG003|Overall Study|Randomized but Not Treated|0|||
128029470|NCT01682720|460733598|FG000|Overall Study|Terminated by Sponsor|83|||
128029471|NCT01682720|460733599|FG001|Overall Study|Terminated by Sponsor|0|||
127574540|NCT03607422|459074641|FG000|Overall Study|Withdrawal by Subject|11|||
127574541|NCT03607422|459074642|FG001|Overall Study|Withdrawal by Subject|3|||
128029472|NCT01682720|460733600|FG002|Overall Study|Terminated by Sponsor|0|||
128029473|NCT01682720|460733601|FG003|Overall Study|Terminated by Sponsor|0|||
128029474|NCT01682720|460733598|FG000|Overall Study|Efficacy Failure|0|||
128029475|NCT01682720|460733599|FG001|Overall Study|Efficacy Failure|3|||
127692725|NCT03584516|459501626|FG001|Part 1|Study Terminated by Sponsor|2|||
127692726|NCT03584516|459501627|FG002|Part 1|Study Terminated by Sponsor|0|||
127574542|NCT03607422|459074643|FG002|Overall Study|Withdrawal by Subject|6|||
128029476|NCT01682720|460733600|FG002|Overall Study|Efficacy Failure|3|||
128029477|NCT01682720|460733601|FG003|Overall Study|Efficacy Failure|30|||
127574543|NCT03607422|459074644|FG003|Overall Study|Withdrawal by Subject|2|||
127574544|NCT03607422|459074645|FG004|Overall Study|Withdrawal by Subject|0|||
127574545|NCT03607422|459074646|FG005|Overall Study|Withdrawal by Subject|0|||
127574546|NCT03607422|459074641|FG000|Overall Study|Lost to Follow-up|0|||
127574547|NCT03607422|459074642|FG001|Overall Study|Lost to Follow-up|0|||
127574548|NCT03607422|459074643|FG002|Overall Study|Lost to Follow-up|1|||
127574549|NCT03607422|459074644|FG003|Overall Study|Lost to Follow-up|0|||
127781921|NCT01786603|459827869|FG001|Overall Study|Death|1|||
127781922|NCT01786603|459827868|FG000|Overall Study|Adverse Event|6|||
127781923|NCT01786603|459827869|FG001|Overall Study|Adverse Event|2|||
127781924|NCT01786603|459827868|FG000|Overall Study|Physician decision to withdraw|6|||
127781925|NCT01786603|459827869|FG001|Overall Study|Physician decision to withdraw|7|||
127781926|NCT01786603|459827868|FG000|Overall Study|Lost to Follow-up|1|||
127781927|NCT01786603|459827869|FG001|Overall Study|Lost to Follow-up|2|||
127781928|NCT01226459|459827870|FG000|Overall Study|Adverse Event|2|||
127781929|NCT01226459|459827871|FG001|Overall Study|Adverse Event|8|||
127781930|NCT01226459|459827870|FG000|Overall Study|Protocol Violation|4|||
127781931|NCT01226459|459827871|FG001|Overall Study|Protocol Violation|3|||
127781932|NCT01226459|459827870|FG000|Overall Study|Withdrawal by Subject|10|||
127781933|NCT01226459|459827871|FG001|Overall Study|Withdrawal by Subject|13|||
127781934|NCT01226459|459827870|FG000|Overall Study|Lost to Follow-up|4|||
127781935|NCT01226459|459827871|FG001|Overall Study|Lost to Follow-up|8|||
127781936|NCT01226459|459827870|FG000|Overall Study|Pregnancy|1|||
127781937|NCT01226459|459827871|FG001|Overall Study|Pregnancy|0|||
127781938|NCT00474708|459827872|FG000|Overall Study|Lack of Efficacy|11|||
127781939|NCT00474708|459827873|FG001|Overall Study|Lack of Efficacy|5|||
127781940|NCT00474708|459827872|FG000|Overall Study|Suicide ideation/behavior|0|||
127781941|NCT00474708|459827873|FG001|Overall Study|Suicide ideation/behavior|1|||
127781942|NCT00474708|459827872|FG000|Overall Study|Withdrawal by Subject|7|||
127781943|NCT00474708|459827873|FG001|Overall Study|Withdrawal by Subject|0|||
127781944|NCT00474708|459827872|FG000|Overall Study|Lack of compliance|12|||
127781945|NCT00474708|459827873|FG001|Overall Study|Lack of compliance|4|||
127781946|NCT00474708|459827872|FG000|Overall Study|Lost to Follow-up|18|||
127781947|NCT00474708|459827873|FG001|Overall Study|Lost to Follow-up|9|||
127781948|NCT00474708|459827872|FG000|Overall Study|Physician Decision|9|||
127781949|NCT00474708|459827873|FG001|Overall Study|Physician Decision|6|||
127781950|NCT03700320|459827874|FG000|Overall Study|Adverse Event|5|||
127781951|NCT03700320|459827875|FG001|Overall Study|Adverse Event|31|||
127781952|NCT03700320|459827874|FG000|Overall Study|Lack of Efficacy|2|||
127781953|NCT03700320|459827875|FG001|Overall Study|Lack of Efficacy|5|||
127574550|NCT03607422|459074645|FG004|Overall Study|Lost to Follow-up|0|||
127574551|NCT03607422|459074646|FG005|Overall Study|Lost to Follow-up|0|||
127574552|NCT03607422|459074641|FG000|Overall Study|Other|12|||
127574553|NCT03607422|459074642|FG001|Overall Study|Other|4|||
127574554|NCT03607422|459074643|FG002|Overall Study|Other|1|||
127574555|NCT03607422|459074644|FG003|Overall Study|Other|2|||
127574556|NCT03607422|459074645|FG004|Overall Study|Other|0|||
127574557|NCT03607422|459074646|FG005|Overall Study|Other|2|||
127574558|NCT03607422|459074641|FG000|Overall Study|Ongoing at Time of Analysis|8|||
127574559|NCT03607422|459074642|FG001|Overall Study|Ongoing at Time of Analysis|0|||
127574560|NCT03607422|459074643|FG002|Overall Study|Ongoing at Time of Analysis|2|||
127574561|NCT03607422|459074644|FG003|Overall Study|Ongoing at Time of Analysis|1|||
127574562|NCT03607422|459074645|FG004|Overall Study|Ongoing at Time of Analysis|1|||
127574563|NCT03607422|459074646|FG005|Overall Study|Ongoing at Time of Analysis|1|||
127781954|NCT03700320|459827874|FG000|Overall Study|Withdrawal by Subject|29|||
127781955|NCT03700320|459827875|FG001|Overall Study|Withdrawal by Subject|75|||
127781956|NCT03700320|459827874|FG000|Overall Study|Lost to Follow-up|16|||
127781957|NCT03700320|459827875|FG001|Overall Study|Lost to Follow-up|23|||
127781958|NCT03700320|459827874|FG000|Overall Study|Pregnancy|2|||
127781959|NCT03700320|459827875|FG001|Overall Study|Pregnancy|4|||
127781960|NCT03700320|459827874|FG000|Overall Study|Protocol Deviation|7|||
127781961|NCT03700320|459827875|FG001|Overall Study|Protocol Deviation|31|||
127781962|NCT03700320|459827874|FG000|Overall Study|Non-compliance with Study Drug|1|||
127781963|NCT03700320|459827875|FG001|Overall Study|Non-compliance with Study Drug|3|||
127781964|NCT03700320|459827874|FG000|Overall Study|Reason not Specified|0|||
127781965|NCT03700320|459827875|FG001|Overall Study|Reason not Specified|1|||
127781966|NCT00175877|459827879|FG000|Overall Study|Adverse Event|136|||
127781967|NCT00175877|459827879|FG000|Overall Study|Withdrawal by Subject|141|||
127781968|NCT00175877|459827879|FG000|Overall Study|Lost to Follow-up|9|||
127574564|NCT03693170|459074647|FG000|Overall Study|Disease Progression|48|||
127574565|NCT03693170|459074647|FG000|Overall Study|Adverse Event|16|||
127574566|NCT03693170|459074647|FG000|Overall Study|Physician Decision|6|||
127781969|NCT00175877|459827879|FG000|Overall Study|Lack of Efficacy|26|||
127781970|NCT00175877|459827879|FG000|Overall Study|Protocol Violation|15|||
127781971|NCT00175877|459827879|FG000|Overall Study|Other Reason|20|||
127781972|NCT00175877|459827879|FG000|Overall Study|AE & Other|1|||
127781973|NCT00175877|459827879|FG000|Overall Study|Withdrawal by subject & Other|1|||
127781974|NCT01092143|459827882|FG000|Overall Study|Adverse Event|10|||
127781975|NCT01092143|459827883|FG001|Overall Study|Adverse Event|5|||
127781976|NCT01092143|459827884|FG002|Overall Study|Adverse Event|1|||
127574567|NCT03693170|459074647|FG000|Overall Study|Protocol Violation|2|||
127574568|NCT03693170|459074647|FG000|Overall Study|Death|1|||
127781977|NCT01092143|459827885|FG003|Overall Study|Adverse Event|4|||
127781978|NCT01092143|459827886|FG004|Overall Study|Adverse Event|3|||
127781979|NCT01092143|459827882|FG000|Overall Study|Lost to Follow-up|1|||
127781980|NCT01092143|459827883|FG001|Overall Study|Lost to Follow-up|0|||
127781981|NCT01092143|459827884|FG002|Overall Study|Lost to Follow-up|1|||
127574569|NCT03693170|459074647|FG000|Overall Study|Non compliance with study drug|1|||
127574570|NCT03693170|459074647|FG000|Overall Study|Withdrawal by Subject|1|||
127574571|NCT01442038|459074650|FG000|Overall Study|Death|35|||
127574572|NCT01442038|459074651|FG001|Overall Study|Death|29|||
127574573|NCT01442038|459074650|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
127574574|NCT01442038|459074651|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
128029478|NCT01682720|460733598|FG000|Overall Study|Lost to Follow-up|1|||
128029479|NCT01682720|460733599|FG001|Overall Study|Lost to Follow-up|1|||
128029480|NCT01682720|460733600|FG002|Overall Study|Lost to Follow-up|0|||
128029481|NCT01682720|460733601|FG003|Overall Study|Lost to Follow-up|6|||
128029482|NCT01682720|460733598|FG000|Overall Study|Subject Withdrew Consent|0|||
128029483|NCT01682720|460733599|FG001|Overall Study|Subject Withdrew Consent|0|||
127574575|NCT01442038|459074650|FG000|Overall Study|Participant Withdrew Consent|137|||
127574576|NCT01442038|459074651|FG001|Overall Study|Participant Withdrew Consent|102|||
127574577|NCT01442038|459074650|FG000|Overall Study|Lost to Follow-up|37|||
127574578|NCT01442038|459074651|FG001|Overall Study|Lost to Follow-up|51|||
127574579|NCT01442038|459074650|FG000|Overall Study|Adverse Event|26|||
127574580|NCT01442038|459074651|FG001|Overall Study|Adverse Event|15|||
127574581|NCT01442038|459074650|FG000|Overall Study|Protocol Deviation|9|||
127574582|NCT01442038|459074651|FG001|Overall Study|Protocol Deviation|20|||
127574583|NCT01442038|459074650|FG000|Overall Study|Investigator's Discretion|13|||
127574584|NCT01442038|459074651|FG001|Overall Study|Investigator's Discretion|16|||
127574585|NCT01442038|459074650|FG000|Overall Study|Study Terminated By Sponsor|2|||
127574586|NCT01442038|459074651|FG001|Overall Study|Study Terminated By Sponsor|3|||
127574587|NCT00089284|459074652|FG000|Overall Study|Adverse event before starting treatment|0|||
127574588|NCT00089284|459074653|FG001|Overall Study|Adverse event before starting treatment|0|||
127574589|NCT00089284|459074654|FG002|Overall Study|Adverse event before starting treatment|0|||
127574590|NCT00089284|459074655|FG003|Overall Study|Adverse event before starting treatment|0|||
127574591|NCT00089284|459074656|FG004|Overall Study|Adverse event before starting treatment|0|||
127574592|NCT00089284|459074657|FG005|Overall Study|Adverse event before starting treatment|0|||
127574593|NCT00089284|459074658|FG006|Overall Study|Adverse event before starting treatment|1|||
127574594|NCT03228420|459074668|FG000|Overall Study|Lost to Follow-up|5|||
127574595|NCT03228420|459074669|FG001|Overall Study|Lost to Follow-up|3|||
127574596|NCT03228420|459074668|FG000|Overall Study|Withdrawal by Subject|10|||
127574597|NCT03228420|459074669|FG001|Overall Study|Withdrawal by Subject|0|||
127574598|NCT03228420|459074668|FG000|Overall Study|Adverse Event|5|||
127574599|NCT03228420|459074669|FG001|Overall Study|Adverse Event|2|||
127574600|NCT02428608|459074670|FG000|Overall Study|Pregnancy|2|||
127574601|NCT02428608|459074670|FG000|Overall Study|Lost to Follow-up|37|||
127574602|NCT02428608|459074670|FG000|Overall Study|Withdrawal by Subject|2|||
127574603|NCT02428608|459074670|FG000|Overall Study|scheduling conflicts|15|||
127574604|NCT02428608|459074670|FG000|Overall Study|moved away|10|||
127574605|NCT02428608|459074670|FG000|Overall Study|Death|1|||
127574606|NCT02428608|459074670|FG000|Overall Study|various|16|||
127574607|NCT03468985|459074673|FG000|Overall Study|Adverse Event|0|||
127574608|NCT03468985|459074674|FG001|Overall Study|Adverse Event|2|||
127574609|NCT03468985|459074675|FG002|Overall Study|Adverse Event|0|||
127574610|NCT03468985|459074676|FG003|Overall Study|Adverse Event|0|||
127574611|NCT03468985|459074673|FG000|Overall Study|Withdrawal by Subject|0|||
127574612|NCT03468985|459074674|FG001|Overall Study|Withdrawal by Subject|0|||
127574613|NCT03468985|459074675|FG002|Overall Study|Withdrawal by Subject|0|||
127574614|NCT03468985|459074676|FG003|Overall Study|Withdrawal by Subject|1|||
127574615|NCT04060862|459074677|FG000|Overall Study|Symptomatic Deterioration|1|||
127574616|NCT04060862|459074677|FG000|Overall Study|Un-specified|6|||
127574617|NCT04060862|459074677|FG000|Overall Study|Progressive disease|12|||
127574618|NCT04060862|459074677|FG000|Overall Study|Physician Decision|1|||
127574619|NCT03416374|459074678|FG000|Between Treatment Period I and II|Other|0|||
127574620|NCT03416374|459074679|FG001|Between Treatment Period I and II|Other|9|||
127574621|NCT03416374|459074678|FG000|Treatment Period II|Lack of Efficacy|3|||
127574622|NCT03416374|459074679|FG001|Treatment Period II|Lack of Efficacy|11|||
127574623|NCT03416374|459074678|FG000|Treatment Period II|Adverse Event|1|||
127574624|NCT03416374|459074679|FG001|Treatment Period II|Adverse Event|4|||
127574625|NCT03416374|459074678|FG000|Treatment Period II|Death|0|||
127574626|NCT03416374|459074679|FG001|Treatment Period II|Death|1|||
127574627|NCT03416374|459074678|FG000|Treatment Period II|Other|0|||
127574628|NCT03416374|459074679|FG001|Treatment Period II|Other|2|||
127574629|NCT01052844|459074680|FG000|Overall Study|Adverse Event|0|||
127574630|NCT01052844|459074681|FG001|Overall Study|Adverse Event|1|||
128029484|NCT01682720|460733600|FG002|Overall Study|Subject Withdrew Consent|2|||
127574631|NCT01068652|459074685|FG000|Overall Study|Adverse Event|4|||
127574632|NCT01068652|459074686|FG001|Overall Study|Adverse Event|0|||
127574633|NCT01068652|459074685|FG000|Overall Study|Lack of Efficacy|0|||
127574634|NCT01068652|459074686|FG001|Overall Study|Lack of Efficacy|2|||
127574635|NCT01068652|459074685|FG000|Overall Study|Lost to Follow-up|2|||
127574636|NCT01068652|459074686|FG001|Overall Study|Lost to Follow-up|1|||
127574637|NCT01068652|459074685|FG000|Overall Study|Protocol Violation|3|||
127574638|NCT01068652|459074686|FG001|Overall Study|Protocol Violation|6|||
128029485|NCT01682720|460733601|FG003|Overall Study|Subject Withdrew Consent|2|||
127574639|NCT01068652|459074685|FG000|Overall Study|Withdrawal criteria|1|||
127574640|NCT01068652|459074686|FG001|Overall Study|Withdrawal criteria|2|||
127574641|NCT01068652|459074685|FG000|Overall Study|Patient was not eligible|1|||
127574642|NCT01068652|459074686|FG001|Overall Study|Patient was not eligible|0|||
127574643|NCT01068652|459074685|FG000|Overall Study|Unclassified|7|||
127574644|NCT01068652|459074686|FG001|Overall Study|Unclassified|4|||
127574645|NCT03343067|459074691|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
127574646|NCT03343067|459074692|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
127574647|NCT03343067|459074693|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
127574648|NCT01243671|459074695|FG000|Overall Study|Adverse Event|3|||
127574649|NCT01243671|459074695|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
127574650|NCT01243671|459074695|FG000|Overall Study|Other|1|||
127574651|NCT04505540|459074698|FG000|Baseline|Protocol Violation|10|||
127574652|NCT04505540|459074698|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
127574653|NCT04505540|459074698|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
127574654|NCT04505540|459074698|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
127574655|NCT04505540|459074698|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
127574656|NCT04505540|459074698|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
127574657|NCT04505540|459074698|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
127574658|NCT04505540|459074698|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
127574659|NCT04505540|459074698|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
127574660|NCT04505540|459074698|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
127574661|NCT04505540|459074698|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
127574662|NCT04505540|459074698|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
127574663|NCT04505540|459074698|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
127574664|NCT05342532|459074699|FG000|Overall Study|Adverse Event|5|||
127574665|NCT05342532|459074700|FG001|Overall Study|Adverse Event|20|||
127574666|NCT05342532|459074699|FG000|Overall Study|Lost to Follow-up|10|||
127574667|NCT05342532|459074700|FG001|Overall Study|Lost to Follow-up|15|||
127574668|NCT02057393|459074703|FG000|Overall Study|Withdrawal by Subject|1|||
127574669|NCT02057393|459074703|FG000|Overall Study|Patient did not meet criteria|1|||
127574670|NCT05323656|459074704|FG000|Overall Study|Still On-Treatment|6|||
127574671|NCT05323656|459074705|FG001|Overall Study|Still On-Treatment|6|||
127574672|NCT05323656|459074704|FG000|Overall Study|Progressive Disease|15|||
127574673|NCT05323656|459074705|FG001|Overall Study|Progressive Disease|14|||
127574674|NCT05323656|459074704|FG000|Overall Study|Adverse Event|2|||
127574675|NCT05323656|459074705|FG001|Overall Study|Adverse Event|3|||
127574676|NCT05323656|459074704|FG000|Overall Study|Death|1|||
127574677|NCT05323656|459074705|FG001|Overall Study|Death|2|||
127574678|NCT05323656|459074704|FG000|Overall Study|Withdrawal by Subject|1|||
127574679|NCT05323656|459074705|FG001|Overall Study|Withdrawal by Subject|0|||
127574680|NCT05323656|459074704|FG000|Overall Study|Clinical disease progression|0|||
127574681|NCT05323656|459074705|FG001|Overall Study|Clinical disease progression|1|||
127574682|NCT05323656|459074704|FG000|Overall Study|Patient and Investigator decision|1|||
127574683|NCT05323656|459074705|FG001|Overall Study|Patient and Investigator decision|0|||
127574684|NCT05323656|459074704|FG000|Overall Study|Physician Decision|0|||
127574685|NCT05323656|459074705|FG001|Overall Study|Physician Decision|1|||
127574686|NCT03091777|459074707|FG000|Overall Study|Pregnancy|2|||
127574687|NCT03091777|459074708|FG001|Overall Study|Pregnancy|1|||
127574688|NCT03091777|459074709|FG002|Overall Study|Pregnancy|0|||
127574689|NCT03091777|459074707|FG000|Overall Study|Adverse Event|2|||
127574690|NCT03091777|459074708|FG001|Overall Study|Adverse Event|1|||
127574691|NCT03091777|459074709|FG002|Overall Study|Adverse Event|4|||
127574692|NCT03091777|459074707|FG000|Overall Study|Withdrawal by Subject|4|||
127574693|NCT03091777|459074708|FG001|Overall Study|Withdrawal by Subject|2|||
127574694|NCT03091777|459074709|FG002|Overall Study|Withdrawal by Subject|6|||
127574695|NCT03091777|459074707|FG000|Overall Study|Protocol Violation|2|||
127574696|NCT03091777|459074708|FG001|Overall Study|Protocol Violation|1|||
127574697|NCT03091777|459074709|FG002|Overall Study|Protocol Violation|1|||
127574698|NCT03091777|459074707|FG000|Overall Study|Lost to Follow-up|12|||
127574699|NCT03091777|459074708|FG001|Overall Study|Lost to Follow-up|14|||
127574700|NCT03091777|459074709|FG002|Overall Study|Lost to Follow-up|7|||
127574701|NCT03091777|459074707|FG000|Overall Study|Lack of Efficacy|0|||
127574702|NCT03091777|459074708|FG001|Overall Study|Lack of Efficacy|0|||
127574703|NCT03091777|459074709|FG002|Overall Study|Lack of Efficacy|5|||
127574704|NCT03091777|459074707|FG000|Overall Study|Noncompliance with study drug|2|||
127574705|NCT03091777|459074708|FG001|Overall Study|Noncompliance with study drug|3|||
127574706|NCT03091777|459074709|FG002|Overall Study|Noncompliance with study drug|1|||
127574707|NCT03091777|459074707|FG000|Overall Study|Physician Decision|1|||
127574708|NCT03091777|459074708|FG001|Overall Study|Physician Decision|0|||
127574709|NCT03091777|459074709|FG002|Overall Study|Physician Decision|1|||
127574710|NCT03091777|459074707|FG000|Overall Study|Abnormal Laboratory Value|7|||
127574711|NCT03091777|459074708|FG001|Overall Study|Abnormal Laboratory Value|11|||
127574712|NCT03091777|459074709|FG002|Overall Study|Abnormal Laboratory Value|12|||
127781982|NCT01092143|459827885|FG003|Overall Study|Lost to Follow-up|0|||
127574713|NCT02536833|459074710|FG000|Overall Study|Discontinued Before Treatment|0|||
127574714|NCT02536833|459074711|FG001|Overall Study|Discontinued Before Treatment|0|||
127574715|NCT02536833|459074712|FG002|Overall Study|Discontinued Before Treatment|1|||
127574716|NCT02536833|459074713|FG003|Overall Study|Discontinued Before Treatment|2|||
127574717|NCT02536833|459074710|FG000|Overall Study|Adverse Event|1|||
127574718|NCT02536833|459074711|FG001|Overall Study|Adverse Event|3|||
127574719|NCT02536833|459074712|FG002|Overall Study|Adverse Event|4|||
127574720|NCT02536833|459074713|FG003|Overall Study|Adverse Event|1|||
127574721|NCT02536833|459074710|FG000|Overall Study|Lost to Follow-up|2|||
127574722|NCT02536833|459074711|FG001|Overall Study|Lost to Follow-up|1|||
127574723|NCT02536833|459074712|FG002|Overall Study|Lost to Follow-up|2|||
127574724|NCT02536833|459074713|FG003|Overall Study|Lost to Follow-up|2|||
127574725|NCT02536833|459074710|FG000|Overall Study|Physician Decision|0|||
127574726|NCT02536833|459074711|FG001|Overall Study|Physician Decision|0|||
127574727|NCT02536833|459074712|FG002|Overall Study|Physician Decision|0|||
127574728|NCT02536833|459074713|FG003|Overall Study|Physician Decision|1|||
127574729|NCT02536833|459074710|FG000|Overall Study|Site Terminated by Sponsor|2|||
127574730|NCT02536833|459074711|FG001|Overall Study|Site Terminated by Sponsor|2|||
127574731|NCT02536833|459074712|FG002|Overall Study|Site Terminated by Sponsor|2|||
127574732|NCT02536833|459074713|FG003|Overall Study|Site Terminated by Sponsor|2|||
127574733|NCT02536833|459074710|FG000|Overall Study|Subject Non-Compliance|0|||
127574734|NCT02536833|459074711|FG001|Overall Study|Subject Non-Compliance|1|||
127574735|NCT02536833|459074712|FG002|Overall Study|Subject Non-Compliance|1|||
127574736|NCT02536833|459074713|FG003|Overall Study|Subject Non-Compliance|0|||
127574737|NCT02536833|459074710|FG000|Overall Study|Withdrawal by Subject|4|||
127574738|NCT02536833|459074711|FG001|Overall Study|Withdrawal by Subject|3|||
127574739|NCT02536833|459074712|FG002|Overall Study|Withdrawal by Subject|5|||
127574740|NCT02536833|459074713|FG003|Overall Study|Withdrawal by Subject|11|||
127574741|NCT02764190|459074716|FG000|Overall Study|Lost to Follow-up|17|||
127574742|NCT02764190|459074717|FG001|Overall Study|Lost to Follow-up|13|||
127574743|NCT01982331|459074722|FG000|Received Vaccination 2|Adverse Event|1|||
127574744|NCT01982331|459074723|FG001|Received Vaccination 2|Adverse Event|2|||
127574745|NCT01982331|459074722|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
127574746|NCT01982331|459074723|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
127574747|NCT01982331|459074722|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
127574748|NCT01982331|459074723|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
127574749|NCT02393690|459074731|FG000|Overall Study|Ineligible|0|||
127574750|NCT02393690|459074732|FG001|Overall Study|Ineligible|1|||
127574751|NCT00591266|459074733|FG000|Overall Study|Adverse Event|2|||
127574752|NCT00591266|459074734|FG001|Overall Study|Adverse Event|2|||
127574753|NCT00591266|459074735|FG002|Overall Study|Adverse Event|3|||
127574754|NCT00591266|459074733|FG000|Overall Study|Lost to Follow-up|0|||
127574755|NCT00591266|459074734|FG001|Overall Study|Lost to Follow-up|1|||
127574756|NCT00591266|459074735|FG002|Overall Study|Lost to Follow-up|0|||
127574757|NCT00591266|459074733|FG000|Overall Study|Protocol Violation|0|||
127574758|NCT00591266|459074734|FG001|Overall Study|Protocol Violation|0|||
127574759|NCT00591266|459074735|FG002|Overall Study|Protocol Violation|1|||
127574760|NCT00591266|459074733|FG000|Overall Study|Withdrawal by Subject|6|||
127574761|NCT00591266|459074734|FG001|Overall Study|Withdrawal by Subject|2|||
127574762|NCT00591266|459074735|FG002|Overall Study|Withdrawal by Subject|5|||
127574763|NCT00591266|459074733|FG000|Overall Study|Lack of Efficacy|0|||
127574764|NCT00591266|459074734|FG001|Overall Study|Lack of Efficacy|2|||
127574765|NCT00591266|459074735|FG002|Overall Study|Lack of Efficacy|0|||
127574766|NCT00591266|459074733|FG000|Overall Study|Other|1|||
127574767|NCT00591266|459074734|FG001|Overall Study|Other|4|||
127574768|NCT00591266|459074735|FG002|Overall Study|Other|5|||
127574769|NCT03497676|459074737|FG000|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
127574770|NCT03497676|459074738|FG001|Cohort 1 Treatment Initiation to Week 16|Adverse Event|1|||
127574771|NCT03497676|459074739|FG002|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
127574772|NCT03497676|459074740|FG003|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
127574773|NCT03497676|459074737|FG000|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
127574774|NCT03497676|459074738|FG001|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
127574775|NCT03497676|459074739|FG002|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
127574776|NCT03497676|459074740|FG003|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
127574777|NCT03497676|459074737|FG000|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
127574778|NCT03497676|459074738|FG001|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
127574779|NCT03497676|459074739|FG002|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
127574780|NCT03497676|459074740|FG003|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
127574781|NCT03497676|459074737|FG000|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
127574782|NCT03497676|459074738|FG001|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|1|||
127574783|NCT03497676|459074739|FG002|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
127574784|NCT03497676|459074740|FG003|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
127574785|NCT03497676|459074737|FG000|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
127574786|NCT03497676|459074738|FG001|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
127574787|NCT03497676|459074739|FG002|Cohort 2 Treatment Initiation to Week 24|Pregnancy|1|||
127574788|NCT03497676|459074740|FG003|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
127574789|NCT03497676|459074737|FG000|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
127574790|NCT03497676|459074738|FG001|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
127574791|NCT03497676|459074739|FG002|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|1|||
127574792|NCT03497676|459074740|FG003|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
128029486|NCT01682720|460733598|FG000|Overall Study|Adverse Event|1|||
128029487|NCT01682720|460733599|FG001|Overall Study|Adverse Event|0|||
128029488|NCT01682720|460733600|FG002|Overall Study|Adverse Event|1|||
128029489|NCT01682720|460733601|FG003|Overall Study|Adverse Event|1|||
128029490|NCT04204902|460733602|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
128029491|NCT04204902|460733603|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
128029492|NCT00069953|460733609|FG000|Overall Study|Protocol Violation|2|||
128029493|NCT02034565|460733610|FG000|Overall Study|Adverse Event|1|||
128029494|NCT02034565|460733611|FG001|Overall Study|Adverse Event|0|||
128029495|NCT00113373|460733612|FG000|Overall Study|Ineligible: wrong primary|1|||
128029496|NCT00113373|460733612|FG000|Overall Study|Ineligible: second primary|1|||
128029497|NCT00113373|460733612|FG000|Overall Study|Never Treated|1|||
128029498|NCT04525183|460733618|FG000|Overall Study|Withdrawal by Subject|0|||
128029499|NCT04525183|460733619|FG001|Overall Study|Withdrawal by Subject|0|||
128029500|NCT04525183|460733620|FG002|Overall Study|Withdrawal by Subject|3|||
128029501|NCT04525183|460733618|FG000|Overall Study|Study non-compliance|0|||
128029502|NCT04525183|460733619|FG001|Overall Study|Study non-compliance|0|||
128029503|NCT04525183|460733620|FG002|Overall Study|Study non-compliance|1|||
128029504|NCT04525183|460733618|FG000|Overall Study|Recurrent disease before starting on study|0|||
128029505|NCT04525183|460733619|FG001|Overall Study|Recurrent disease before starting on study|0|||
128029506|NCT04525183|460733620|FG002|Overall Study|Recurrent disease before starting on study|1|||
128029507|NCT00979407|460733621|FG000|Overall Study|Withdrawal by Subject|3|||
128029508|NCT00979407|460733622|FG001|Overall Study|Withdrawal by Subject|4|||
128029509|NCT00979407|460733621|FG000|Overall Study|Lost to Follow-up|3|||
128029510|NCT00979407|460733622|FG001|Overall Study|Lost to Follow-up|3|||
128029511|NCT01166646|460733623|FG000|Overall Study|Protocol Violation|0|||
128029512|NCT01166646|460733624|FG001|Overall Study|Protocol Violation|1|||
128029513|NCT01166646|460733623|FG000|Overall Study|Adverse Event|1|||
127574793|NCT03497676|459074737|FG000|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
128029514|NCT01166646|460733624|FG001|Overall Study|Adverse Event|0|||
128029515|NCT01335685|460733628|FG000|Overall Study|Study Terminated by Sponsor|2|||
128029516|NCT01335685|460733629|FG001|Overall Study|Study Terminated by Sponsor|1|||
128029517|NCT01335685|460733630|FG002|Overall Study|Study Terminated by Sponsor|1|||
127574794|NCT03497676|459074738|FG001|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
127574795|NCT03497676|459074739|FG002|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|1|||
127574796|NCT03497676|459074740|FG003|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
127574797|NCT03497676|459074737|FG000|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
127574798|NCT03497676|459074738|FG001|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
127574799|NCT03497676|459074739|FG002|Cohort 2 Week 24 to Week 48|Lost to Follow-up|1|||
127574800|NCT03497676|459074740|FG003|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
127574801|NCT01226043|459074741|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
127574802|NCT01226043|459074742|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
127574803|NCT01226043|459074743|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
127574804|NCT01226043|459074744|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
127574805|NCT01226043|459074741|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
127574806|NCT01226043|459074742|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
127574807|NCT01226043|459074743|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
127574808|NCT01226043|459074744|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
127574809|NCT01226043|459074741|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
127574810|NCT01226043|459074742|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
127574811|NCT01226043|459074743|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
127574812|NCT01226043|459074744|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
127574813|NCT01226043|459074741|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
127574814|NCT01226043|459074742|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
127574815|NCT01226043|459074743|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
127574816|NCT01226043|459074744|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
127574817|NCT01226043|459074741|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
127574818|NCT01226043|459074742|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
127574819|NCT01226043|459074743|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
127574820|NCT01226043|459074744|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
127574821|NCT01226043|459074741|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
127574822|NCT01226043|459074742|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
127574823|NCT01226043|459074743|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
127574824|NCT01226043|459074744|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
127574825|NCT01226043|459074741|FG000|6-week Re-randomization Phase|Adverse Event|0|||
127574826|NCT01226043|459074742|FG001|6-week Re-randomization Phase|Adverse Event|0|||
127574827|NCT01226043|459074743|FG002|6-week Re-randomization Phase|Adverse Event|1|||
127574828|NCT01226043|459074744|FG003|6-week Re-randomization Phase|Adverse Event|1|||
127574829|NCT01226043|459074741|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
127574830|NCT01226043|459074742|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
127574831|NCT01226043|459074743|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
127574832|NCT01226043|459074744|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
127574833|NCT01226043|459074741|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
127574834|NCT01226043|459074742|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
127574835|NCT01226043|459074743|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
127574836|NCT01226043|459074744|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
127574837|NCT01226043|459074741|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
127574838|NCT01226043|459074742|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
127574839|NCT01226043|459074743|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
127574840|NCT01226043|459074744|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
127574841|NCT01226043|459074741|FG000|6-week Re-randomization Phase|Physician Decision|0|||
127574842|NCT01226043|459074742|FG001|6-week Re-randomization Phase|Physician Decision|0|||
127574843|NCT01226043|459074743|FG002|6-week Re-randomization Phase|Physician Decision|3|||
127574844|NCT01226043|459074744|FG003|6-week Re-randomization Phase|Physician Decision|2|||
127574845|NCT01226043|459074741|FG000|6-week Re-randomization Phase|completed in error|0|||
127574846|NCT01226043|459074742|FG001|6-week Re-randomization Phase|completed in error|0|||
127574847|NCT01226043|459074743|FG002|6-week Re-randomization Phase|completed in error|0|||
127574848|NCT01226043|459074744|FG003|6-week Re-randomization Phase|completed in error|1|||
127574849|NCT01226043|459074741|FG000|30-week Observational Phase|Adverse Event|0|||
127574850|NCT01226043|459074742|FG001|30-week Observational Phase|Adverse Event|0|||
127574851|NCT01226043|459074743|FG002|30-week Observational Phase|Adverse Event|1|||
127574852|NCT01226043|459074744|FG003|30-week Observational Phase|Adverse Event|1|||
127574853|NCT01226043|459074741|FG000|30-week Observational Phase|Protocol Violation|0|||
127574854|NCT01226043|459074742|FG001|30-week Observational Phase|Protocol Violation|0|||
127574855|NCT01226043|459074743|FG002|30-week Observational Phase|Protocol Violation|0|||
127692727|NCT03584516|459501628|FG003|Part 1|Study Terminated by Sponsor|0|||
127692728|NCT03584516|459501629|FG004|Part 1|Study Terminated by Sponsor|0|||
127574856|NCT01226043|459074744|FG003|30-week Observational Phase|Protocol Violation|1|||
127692729|NCT03584516|459501630|FG005|Part 1|Study Terminated by Sponsor|0|||
127692730|NCT03584516|459501625|FG000|Part 1 Expansion|Death|0|||
127574857|NCT01226043|459074741|FG000|30-week Observational Phase|Lost to Follow-up|0|||
127574858|NCT01226043|459074742|FG001|30-week Observational Phase|Lost to Follow-up|0|||
127574859|NCT01226043|459074743|FG002|30-week Observational Phase|Lost to Follow-up|2|||
127574860|NCT01226043|459074744|FG003|30-week Observational Phase|Lost to Follow-up|2|||
127574861|NCT01226043|459074741|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
127574862|NCT01226043|459074742|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
127574863|NCT01226043|459074743|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
127574864|NCT01226043|459074744|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
127574865|NCT01226043|459074741|FG000|30-week Observational Phase|Physician Decision|0|||
127574866|NCT01226043|459074742|FG001|30-week Observational Phase|Physician Decision|0|||
127574867|NCT01226043|459074743|FG002|30-week Observational Phase|Physician Decision|2|||
127574868|NCT01226043|459074744|FG003|30-week Observational Phase|Physician Decision|2|||
127574869|NCT00910988|459074745|FG000|Overall Study|Lost to Follow-up|2|||
127574870|NCT00910988|459074746|FG001|Overall Study|Lost to Follow-up|4|||
127574871|NCT00910988|459074747|FG002|Overall Study|Lost to Follow-up|3|||
127574872|NCT00910988|459074748|FG003|Overall Study|Lost to Follow-up|0|||
127574873|NCT03004443|459074749|FG000|Overall Study|Pregnancy|0|||
127574874|NCT03004443|459074750|FG001|Overall Study|Pregnancy|1|||
127574875|NCT00828854|459074751|FG000|Overall Study|Disease Progression|17|||
127574876|NCT00828854|459074751|FG000|Overall Study|Adverse Event|9|||
127574877|NCT00828854|459074751|FG000|Overall Study|Reason not Specified|1|||
127574878|NCT00191646|459074753|FG000|Overall Study|Toxicity|26|||
127574879|NCT00191646|459074754|FG001|Overall Study|Toxicity|37|||
127574880|NCT00191646|459074753|FG000|Overall Study|Disease Progression|5|||
127574881|NCT00191646|459074754|FG001|Overall Study|Disease Progression|6|||
127574882|NCT00191646|459074753|FG000|Overall Study|Physician Decision|20|||
127574883|NCT00191646|459074754|FG001|Overall Study|Physician Decision|11|||
127574884|NCT00191646|459074753|FG000|Overall Study|Withdrawal by Subject|58|||
127574885|NCT00191646|459074754|FG001|Overall Study|Withdrawal by Subject|39|||
127574886|NCT00191646|459074753|FG000|Overall Study|Protocol Violation|5|||
127574887|NCT00191646|459074754|FG001|Overall Study|Protocol Violation|7|||
127574888|NCT00191646|459074753|FG000|Overall Study|Death|6|||
127574889|NCT00191646|459074754|FG001|Overall Study|Death|8|||
127574890|NCT00191646|459074753|FG000|Overall Study|Other|33|||
127574891|NCT00191646|459074754|FG001|Overall Study|Other|34|||
127574892|NCT00191646|459074753|FG000|Overall Study|Missing Data|18|||
127574893|NCT00191646|459074754|FG001|Overall Study|Missing Data|11|||
127574894|NCT05211284|459074759|FG000|Overall Study|Study Terminated|3|||
127574895|NCT05211284|459074760|FG001|Overall Study|Study Terminated|1|||
127574896|NCT03911843|459074761|FG000|Overall Study|Adverse Event|2|||
127574897|NCT03911843|459074762|FG001|Overall Study|Adverse Event|0|||
127574898|NCT03911843|459074761|FG000|Overall Study|Protocol Violation|2|||
127574899|NCT03911843|459074762|FG001|Overall Study|Protocol Violation|0|||
127574900|NCT03911843|459074761|FG000|Overall Study|Lost to Follow-up|0|||
127574901|NCT03911843|459074762|FG001|Overall Study|Lost to Follow-up|1|||
127574902|NCT01907100|459074763|FG000|Overall Study|PD based on modified RECIST criteria|31|||
127574903|NCT01907100|459074764|FG001|Overall Study|PD based on modified RECIST criteria|32|||
127574904|NCT01907100|459074765|FG002|Overall Study|PD based on modified RECIST criteria|95|||
127574905|NCT01907100|459074766|FG003|Overall Study|PD based on modified RECIST criteria|92|||
127574906|NCT01907100|459074763|FG000|Overall Study|Withdrawal by Subject|2|||
127574907|NCT01907100|459074764|FG001|Overall Study|Withdrawal by Subject|5|||
127574908|NCT01907100|459074765|FG002|Overall Study|Withdrawal by Subject|10|||
127574909|NCT01907100|459074766|FG003|Overall Study|Withdrawal by Subject|13|||
127574910|NCT01907100|459074763|FG000|Overall Study|Protocol Violation|0|||
127574911|NCT01907100|459074764|FG001|Overall Study|Protocol Violation|0|||
127574912|NCT01907100|459074765|FG002|Overall Study|Protocol Violation|1|||
127574913|NCT01907100|459074766|FG003|Overall Study|Protocol Violation|1|||
127574914|NCT01907100|459074763|FG000|Overall Study|Lost to Follow-up|0|||
127692731|NCT03584516|459501626|FG001|Part 1 Expansion|Death|0|||
127692732|NCT03584516|459501627|FG002|Part 1 Expansion|Death|9|||
128029518|NCT01335685|460733631|FG003|Overall Study|Study Terminated by Sponsor|10|||
127692733|NCT03584516|459501628|FG003|Part 1 Expansion|Death|8|||
127574915|NCT01907100|459074764|FG001|Overall Study|Lost to Follow-up|0|||
127574916|NCT01907100|459074765|FG002|Overall Study|Lost to Follow-up|0|||
127574917|NCT01907100|459074766|FG003|Overall Study|Lost to Follow-up|1|||
127574918|NCT01907100|459074763|FG000|Overall Study|Not treated|2|||
127692734|NCT03584516|459501629|FG004|Part 1 Expansion|Death|4|||
127574919|NCT01907100|459074764|FG001|Overall Study|Not treated|0|||
127574920|NCT01907100|459074765|FG002|Overall Study|Not treated|1|||
127574921|NCT01907100|459074766|FG003|Overall Study|Not treated|2|||
127574922|NCT01907100|459074763|FG000|Overall Study|Other than reasons specified|1|||
127574923|NCT01907100|459074764|FG001|Overall Study|Other than reasons specified|0|||
127574924|NCT01907100|459074765|FG002|Overall Study|Other than reasons specified|10|||
127692735|NCT03584516|459501630|FG005|Part 1 Expansion|Death|5|||
127574925|NCT01907100|459074766|FG003|Overall Study|Other than reasons specified|6|||
127574926|NCT01907100|459074763|FG000|Overall Study|Adverse event (AE)|6|||
127574927|NCT01907100|459074764|FG001|Overall Study|Adverse event (AE)|3|||
127574928|NCT01907100|459074765|FG002|Overall Study|Adverse event (AE)|22|||
127781983|NCT01092143|459827886|FG004|Overall Study|Lost to Follow-up|0|||
127574929|NCT01907100|459074766|FG003|Overall Study|Adverse event (AE)|23|||
127574930|NCT01907100|459074763|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
127574931|NCT01907100|459074764|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
127574932|NCT01907100|459074765|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
127574933|NCT01907100|459074766|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
127574934|NCT02059005|459074767|FG000|Overall Study|Death|1|||
127574935|NCT02059005|459074768|FG001|Overall Study|Death|3|||
127574936|NCT02059005|459074767|FG000|Overall Study|Lost to Follow-up|19|||
128029519|NCT01335685|460733632|FG004|Overall Study|Study Terminated by Sponsor|0|||
128029520|NCT01335685|460733633|FG005|Overall Study|Study Terminated by Sponsor|4|||
128029521|NCT01335685|460733634|FG006|Overall Study|Study Terminated by Sponsor|2|||
128029522|NCT01335685|460733635|FG007|Overall Study|Study Terminated by Sponsor|3|||
128029523|NCT01335685|460733628|FG000|Overall Study|Withdrawal by Subject|1|||
128029524|NCT01335685|460733629|FG001|Overall Study|Withdrawal by Subject|0|||
128029525|NCT01335685|460733630|FG002|Overall Study|Withdrawal by Subject|0|||
128029526|NCT01335685|460733631|FG003|Overall Study|Withdrawal by Subject|1|||
128029527|NCT01335685|460733632|FG004|Overall Study|Withdrawal by Subject|0|||
128029528|NCT01335685|460733633|FG005|Overall Study|Withdrawal by Subject|0|||
128029529|NCT01335685|460733634|FG006|Overall Study|Withdrawal by Subject|0|||
128029530|NCT01335685|460733635|FG007|Overall Study|Withdrawal by Subject|0|||
128029531|NCT01335685|460733628|FG000|Overall Study|Reason not Specified|0|||
128029532|NCT01335685|460733629|FG001|Overall Study|Reason not Specified|0|||
128029533|NCT01335685|460733630|FG002|Overall Study|Reason not Specified|1|||
128029534|NCT01335685|460733631|FG003|Overall Study|Reason not Specified|0|||
127574937|NCT02059005|459074768|FG001|Overall Study|Lost to Follow-up|19|||
127574938|NCT02059005|459074767|FG000|Overall Study|Incarceration|0|||
127574939|NCT02059005|459074768|FG001|Overall Study|Incarceration|1|||
127781984|NCT01092143|459827882|FG000|Overall Study|Consent withdrawn|2|||
127781985|NCT01092143|459827883|FG001|Overall Study|Consent withdrawn|1|||
127781986|NCT01092143|459827884|FG002|Overall Study|Consent withdrawn|0|||
127781987|NCT01092143|459827885|FG003|Overall Study|Consent withdrawn|1|||
127781988|NCT01092143|459827886|FG004|Overall Study|Consent withdrawn|3|||
127781989|NCT01092143|459827882|FG000|Overall Study|Not treated|0|||
127781990|NCT01092143|459827883|FG001|Overall Study|Not treated|0|||
127781991|NCT01092143|459827884|FG002|Overall Study|Not treated|1|||
127781992|NCT01092143|459827885|FG003|Overall Study|Not treated|0|||
127781993|NCT01092143|459827886|FG004|Overall Study|Not treated|0|||
127781994|NCT01092143|459827882|FG000|Overall Study|did not reversibility criteria|0|||
127781995|NCT01092143|459827883|FG001|Overall Study|did not reversibility criteria|0|||
128029535|NCT01335685|460733632|FG004|Overall Study|Reason not Specified|0|||
127574940|NCT02059005|459074767|FG000|Overall Study|Inpatient|0|||
127574941|NCT02059005|459074768|FG001|Overall Study|Inpatient|1|||
127574942|NCT02142803|459074769|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
128029536|NCT01335685|460733633|FG005|Overall Study|Reason not Specified|1|||
128029537|NCT01335685|460733634|FG006|Overall Study|Reason not Specified|0|||
127781996|NCT01092143|459827884|FG002|Overall Study|did not reversibility criteria|1|||
128029538|NCT01335685|460733635|FG007|Overall Study|Reason not Specified|0|||
128029539|NCT03777020|460733638|FG000|Overall Study|Withdrawal by Subject|4|||
127692736|NCT03584516|459501625|FG000|Part 1 Expansion|Lost to Follow-up|0|||
127692737|NCT03584516|459501626|FG001|Part 1 Expansion|Lost to Follow-up|0|||
127692738|NCT03584516|459501627|FG002|Part 1 Expansion|Lost to Follow-up|0|||
127692739|NCT03584516|459501628|FG003|Part 1 Expansion|Lost to Follow-up|1|||
127692740|NCT03584516|459501629|FG004|Part 1 Expansion|Lost to Follow-up|0|||
127692741|NCT03584516|459501630|FG005|Part 1 Expansion|Lost to Follow-up|0|||
127692742|NCT03584516|459501625|FG000|Part 1 Expansion|Physician Decision|0|||
127692743|NCT03584516|459501626|FG001|Part 1 Expansion|Physician Decision|0|||
127692744|NCT03584516|459501627|FG002|Part 1 Expansion|Physician Decision|4|||
127692745|NCT03584516|459501628|FG003|Part 1 Expansion|Physician Decision|3|||
127692746|NCT03584516|459501629|FG004|Part 1 Expansion|Physician Decision|2|||
127692747|NCT03584516|459501630|FG005|Part 1 Expansion|Physician Decision|3|||
127692748|NCT03584516|459501625|FG000|Part 1 Expansion|Study Terminated by Sponsor|0|||
127692749|NCT03584516|459501626|FG001|Part 1 Expansion|Study Terminated by Sponsor|0|||
127692750|NCT03584516|459501627|FG002|Part 1 Expansion|Study Terminated by Sponsor|17|||
127692751|NCT03584516|459501628|FG003|Part 1 Expansion|Study Terminated by Sponsor|20|||
127692752|NCT03584516|459501629|FG004|Part 1 Expansion|Study Terminated by Sponsor|20|||
127692753|NCT03584516|459501630|FG005|Part 1 Expansion|Study Terminated by Sponsor|23|||
127692754|NCT03584516|459501625|FG000|Part 1 Expansion|Withdrawal by Subject|0|||
127692755|NCT03584516|459501626|FG001|Part 1 Expansion|Withdrawal by Subject|0|||
127692756|NCT03584516|459501627|FG002|Part 1 Expansion|Withdrawal by Subject|2|||
127692757|NCT03584516|459501628|FG003|Part 1 Expansion|Withdrawal by Subject|4|||
127692758|NCT03584516|459501629|FG004|Part 1 Expansion|Withdrawal by Subject|2|||
127692759|NCT03584516|459501630|FG005|Part 1 Expansion|Withdrawal by Subject|3|||
127692760|NCT03584516|459501625|FG000|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
127574943|NCT02142803|459074770|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
127574944|NCT02142803|459074771|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
127574945|NCT02142803|459074772|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
127574946|NCT02718300|459074778|FG000|Overall Study|Death|4|||
127574947|NCT02718300|459074779|FG001|Overall Study|Death|5|||
127574948|NCT02718300|459074780|FG002|Overall Study|Death|17|||
127574949|NCT02718300|459074778|FG000|Overall Study|Lost to Follow-up|1|||
127574950|NCT02718300|459074779|FG001|Overall Study|Lost to Follow-up|0|||
127574951|NCT02718300|459074780|FG002|Overall Study|Lost to Follow-up|2|||
127574952|NCT02718300|459074778|FG000|Overall Study|Physician Decision|1|||
127574953|NCT02718300|459074779|FG001|Overall Study|Physician Decision|0|||
127574954|NCT02718300|459074780|FG002|Overall Study|Physician Decision|2|||
127574955|NCT02718300|459074778|FG000|Overall Study|Study Terminated by Sponsor|6|||
127574956|NCT02718300|459074779|FG001|Overall Study|Study Terminated by Sponsor|3|||
127574957|NCT02718300|459074780|FG002|Overall Study|Study Terminated by Sponsor|4|||
127574958|NCT02718300|459074778|FG000|Overall Study|Withdrawal by Subject|0|||
127574959|NCT02718300|459074779|FG001|Overall Study|Withdrawal by Subject|4|||
127574960|NCT02718300|459074780|FG002|Overall Study|Withdrawal by Subject|3|||
127574961|NCT02718300|459074778|FG000|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
127574962|NCT02718300|459074779|FG001|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
127574963|NCT02718300|459074780|FG002|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|4|||
127574964|NCT03120624|459074781|FG000|Overall Study|Withdrawal by Subject|0|||
127574965|NCT03120624|459074782|FG001|Overall Study|Withdrawal by Subject|1|||
127574966|NCT03120624|459074783|FG002|Overall Study|Withdrawal by Subject|0|||
127574967|NCT03120624|459074784|FG003|Overall Study|Withdrawal by Subject|0|||
127574968|NCT03120624|459074785|FG004|Overall Study|Withdrawal by Subject|0|||
127574969|NCT03120624|459074786|FG005|Overall Study|Withdrawal by Subject|0|||
127574970|NCT03120624|459074787|FG006|Overall Study|Withdrawal by Subject|0|||
127574971|NCT03120624|459074788|FG007|Overall Study|Withdrawal by Subject|0|||
127574972|NCT00085709|459076329|FG000|Overall Study|Adverse Event|8|||
127574973|NCT00085709|459076330|FG001|Overall Study|Adverse Event|0|||
127574974|NCT00085709|459076329|FG000|Overall Study|Death|8|||
127692761|NCT03584516|459501626|FG001|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
128029540|NCT03777020|460733639|FG001|Overall Study|Withdrawal by Subject|4|||
128029541|NCT03777020|460733638|FG000|Overall Study|No longer met inclusion criteria at initial visit|0|||
128029542|NCT03777020|460733639|FG001|Overall Study|No longer met inclusion criteria at initial visit|1|||
128029543|NCT00489476|460733640|FG000|Overall Study|Lost to Follow-up|0|||
127574975|NCT00085709|459076330|FG001|Overall Study|Death|2|||
127574976|NCT00085709|459076329|FG000|Overall Study|Refusal unrelated to adverse events|1|||
127692762|NCT03584516|459501627|FG002|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
128029544|NCT00489476|460733641|FG001|Overall Study|Lost to Follow-up|1|||
128029545|NCT00489476|460733642|FG002|Overall Study|Lost to Follow-up|0|||
127574977|NCT00085709|459076330|FG001|Overall Study|Refusal unrelated to adverse events|2|||
127574978|NCT00085709|459076329|FG000|Overall Study|Progression|3|||
127574979|NCT00085709|459076330|FG001|Overall Study|Progression|4|||
127574980|NCT00085709|459076329|FG000|Overall Study|Not protocol specified|12|||
127574981|NCT00085709|459076330|FG001|Overall Study|Not protocol specified|22|||
127574982|NCT00085709|459076329|FG000|Overall Study|Not eligible|19|||
127574983|NCT00085709|459076330|FG001|Overall Study|Not eligible|19|||
127574984|NCT00085709|459076329|FG000|Overall Study|Withdrawal by Subject|2|||
127574985|NCT00085709|459076330|FG001|Overall Study|Withdrawal by Subject|1|||
127574986|NCT03646643|459076331|FG000|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
127574987|NCT03646643|459076332|FG001|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
127574988|NCT03646643|459076331|FG000|Overall Study|Lost to Follow-up|0|||
127574989|NCT03646643|459076332|FG001|Overall Study|Lost to Follow-up|1|||
127574990|NCT04131556|459076333|FG000|Overall Study|Adverse Event|1|||
127574991|NCT04131556|459076333|FG000|Overall Study|Withdrawal by Subject|1|||
127574992|NCT04629508|459076336|FG000|Overall Study|Adverse Event|1|||
127574993|NCT04629508|459076336|FG000|Overall Study|Death|2|||
127574994|NCT04629508|459076336|FG000|Overall Study|Protocol-specified withdrawal criterion met|1|||
127574995|NCT00760214|459076344|FG000|Overall Study|Adverse Event|8|||
127574996|NCT00760214|459076345|FG001|Overall Study|Adverse Event|9|||
127574997|NCT00760214|459076346|FG002|Overall Study|Adverse Event|12|||
127574998|NCT00760214|459076344|FG000|Overall Study|Protocol Violation|3|||
127574999|NCT00760214|459076345|FG001|Overall Study|Protocol Violation|0|||
127575000|NCT00760214|459076346|FG002|Overall Study|Protocol Violation|3|||
127575001|NCT00760214|459076344|FG000|Overall Study|Lost to Follow-up|0|||
127575002|NCT00760214|459076345|FG001|Overall Study|Lost to Follow-up|0|||
127575003|NCT00760214|459076346|FG002|Overall Study|Lost to Follow-up|1|||
127575004|NCT00760214|459076344|FG000|Overall Study|Withdrawal by Subject|12|||
127575005|NCT00760214|459076345|FG001|Overall Study|Withdrawal by Subject|14|||
127575006|NCT00760214|459076346|FG002|Overall Study|Withdrawal by Subject|13|||
127575007|NCT00760214|459076344|FG000|Overall Study|Lack of Efficacy|3|||
127575008|NCT00760214|459076345|FG001|Overall Study|Lack of Efficacy|2|||
127575009|NCT00760214|459076346|FG002|Overall Study|Lack of Efficacy|4|||
127575010|NCT00760214|459076344|FG000|Overall Study|Pregnancy|0|||
127575011|NCT00760214|459076345|FG001|Overall Study|Pregnancy|0|||
127575012|NCT00760214|459076346|FG002|Overall Study|Pregnancy|1|||
127575013|NCT00760214|459076344|FG000|Overall Study|Physician Decision|1|||
127781997|NCT01092143|459827885|FG003|Overall Study|did not reversibility criteria|0|||
127781998|NCT01092143|459827886|FG004|Overall Study|did not reversibility criteria|0|||
127781999|NCT01092143|459827882|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
127782000|NCT01092143|459827883|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
127782001|NCT01092143|459827884|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
127575014|NCT00760214|459076345|FG001|Overall Study|Physician Decision|1|||
127575015|NCT00760214|459076346|FG002|Overall Study|Physician Decision|1|||
127575016|NCT00760214|459076344|FG000|Overall Study|Other|3|||
127575017|NCT00760214|459076345|FG001|Overall Study|Other|4|||
127575018|NCT00760214|459076346|FG002|Overall Study|Other|6|||
127575019|NCT03960554|459076350|FG000|Overall Study|Due to the pandemic, this study was terminated early|4|||
127575020|NCT03960554|459076351|FG001|Overall Study|Due to the pandemic, this study was terminated early|4|||
127575021|NCT02545075|459076352|FG000|Randomization|Lost to Follow-up|0|||
127575022|NCT02545075|459076353|FG001|Randomization|Lost to Follow-up|1|||
127575023|NCT02545075|459076352|FG000|Randomization|Withdrawal by Subject|0|||
127575024|NCT02545075|459076353|FG001|Randomization|Withdrawal by Subject|6|||
127575025|NCT02545075|459076352|FG000|Treatment|Disease progression|71|||
127575026|NCT02545075|459076353|FG001|Treatment|Disease progression|32|||
127575027|NCT02545075|459076352|FG000|Treatment|Participant dicontinued study treatment|7|||
127575028|NCT02545075|459076353|FG001|Treatment|Participant dicontinued study treatment|9|||
127575029|NCT02545075|459076352|FG000|Treatment|Withdrawal by Subject|1|||
127575030|NCT02545075|459076353|FG001|Treatment|Withdrawal by Subject|0|||
127575031|NCT02545075|459076352|FG000|Treatment|Adverse event not related to study drug|1|||
127575032|NCT02545075|459076353|FG001|Treatment|Adverse event not related to study drug|0|||
127575033|NCT02545075|459076352|FG000|Treatment|Death|1|||
127575034|NCT02545075|459076353|FG001|Treatment|Death|0|||
127575035|NCT02545075|459076352|FG000|Treatment|Participant drug toxicity|1|||
127575036|NCT02545075|459076353|FG001|Treatment|Participant drug toxicity|0|||
127575037|NCT02545075|459076352|FG000|Treatment|Completed treatment|40|||
127575038|NCT02545075|459076353|FG001|Treatment|Completed treatment|12|||
127575039|NCT00736879|459076354|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
127575040|NCT00736879|459076355|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
127575041|NCT00736879|459076356|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
127575042|NCT00736879|459076357|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
127575043|NCT00736879|459076354|FG000|Double Blind Treatment Period|Adverse Event|0|||
127575044|NCT00736879|459076355|FG001|Double Blind Treatment Period|Adverse Event|1|||
127575045|NCT00736879|459076356|FG002|Double Blind Treatment Period|Adverse Event|1|||
127575046|NCT00736879|459076357|FG003|Double Blind Treatment Period|Adverse Event|0|||
127575047|NCT00736879|459076354|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
127575048|NCT00736879|459076355|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
127575049|NCT00736879|459076356|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
127575050|NCT00736879|459076357|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
127575051|NCT00736879|459076354|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
127575052|NCT00736879|459076355|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
127575053|NCT00736879|459076356|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
127575054|NCT00736879|459076357|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
127575055|NCT00736879|459076354|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
127575056|NCT00736879|459076355|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
127575057|NCT00736879|459076356|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
127575058|NCT00736879|459076357|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
127575059|NCT00736879|459076354|FG000|Double Blind Treatment Period|No longer met criteria|0|||
127575060|NCT00736879|459076355|FG001|Double Blind Treatment Period|No longer met criteria|1|||
127575061|NCT00736879|459076356|FG002|Double Blind Treatment Period|No longer met criteria|0|||
127575062|NCT00736879|459076357|FG003|Double Blind Treatment Period|No longer met criteria|0|||
127575063|NCT00736879|459076354|FG000|Double Blind Treatment Period|non-specified|0|||
127575064|NCT00736879|459076355|FG001|Double Blind Treatment Period|non-specified|1|||
127575065|NCT00736879|459076356|FG002|Double Blind Treatment Period|non-specified|0|||
127575066|NCT00736879|459076357|FG003|Double Blind Treatment Period|non-specified|0|||
127575067|NCT00736879|459076354|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
127575068|NCT00736879|459076355|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
127575069|NCT00736879|459076356|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
127575070|NCT00736879|459076357|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
127575071|NCT00736879|459076354|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
127575072|NCT00736879|459076355|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
127575073|NCT00736879|459076356|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
127575074|NCT00736879|459076357|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
127575075|NCT01810432|459076360|FG000|Washout|Protocol Violation|0|||
127575076|NCT01810432|459076361|FG001|Washout|Protocol Violation|1|||
127575077|NCT01810432|459076360|FG000|Washout|Adverse Event|1|||
127575078|NCT01810432|459076361|FG001|Washout|Adverse Event|0|||
127692763|NCT03584516|459501628|FG003|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|1|||
127692764|NCT03584516|459501629|FG004|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
127692765|NCT03584516|459501630|FG005|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
127692766|NCT03584516|459501625|FG000|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
127692767|NCT03584516|459501626|FG001|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
127692768|NCT03584516|459501627|FG002|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
127692769|NCT03584516|459501628|FG003|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
127692770|NCT03584516|459501629|FG004|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
127692771|NCT03584516|459501630|FG005|Part 1 Expansion|Disease Progression; cGVHD Flare|1|||
127692772|NCT04868110|459501631|FG000|Overall Study|Withdrawal by Subject|3|||
127692773|NCT04868110|459501632|FG001|Overall Study|Withdrawal by Subject|4|||
127692774|NCT04823611|459501633|FG000|Overall Study|Adverse Event|2|||
127692775|NCT04823611|459501634|FG001|Overall Study|Adverse Event|0|||
127692776|NCT04823611|459501635|FG002|Overall Study|Adverse Event|1|||
127575079|NCT01810432|459076360|FG000|Period 2|Withdrawal by Subject|2|||
127575080|NCT01810432|459076361|FG001|Period 2|Withdrawal by Subject|1|||
127575081|NCT01810432|459076360|FG000|Period 2|Physician Decision|1|||
127575082|NCT01810432|459076361|FG001|Period 2|Physician Decision|0|||
127575083|NCT01810432|459076360|FG000|Period 2|Lost to Follow-up|1|||
127575084|NCT01810432|459076361|FG001|Period 2|Lost to Follow-up|1|||
127575085|NCT02360111|459076362|FG000|Overall Study|Death|2|||
127575086|NCT03923738|459076365|FG000|Period 1|Adverse Event|1|||
127575087|NCT03923738|459076365|FG000|Period 1|Withdrawal by Subject|1|||
127575088|NCT00735254|459076367|FG000|Overall Study|Protocol Violation|1|||
127575089|NCT00735254|459076368|FG001|Overall Study|Protocol Violation|1|||
127575090|NCT00735254|459076369|FG002|Overall Study|Protocol Violation|1|||
127575091|NCT00735254|459076370|FG003|Overall Study|Protocol Violation|0|||
127575092|NCT01251744|459076371|FG000|Overall Study|Lost to Follow-up|1|||
127575093|NCT01251744|459076372|FG001|Overall Study|Lost to Follow-up|0|||
127575094|NCT00751621|459076373|FG000|Overall Study|Adverse Event|1|||
127575095|NCT00751621|459076373|FG000|Overall Study|Withdrawal by Subject|1|||
127575096|NCT00751621|459076373|FG000|Overall Study|Subject moved to another country|1|||
127575097|NCT00751621|459076373|FG000|Overall Study|Poor adherence to asthma treatment|1|||
127575098|NCT02310321|459076374|FG000|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|1|||
127575099|NCT02310321|459076375|FG001|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
127575100|NCT02310321|459076376|FG002|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
127575101|NCT02310321|459076374|FG000|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|1|||
127575102|NCT02310321|459076375|FG001|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
127575103|NCT02310321|459076376|FG002|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
127575104|NCT02310321|459076374|FG000|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|1|||
127575105|NCT02310321|459076375|FG001|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
127575106|NCT02310321|459076376|FG002|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
127575107|NCT02310321|459076374|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
127575108|NCT02310321|459076375|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|1|||
127575109|NCT02310321|459076376|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
127575110|NCT02310321|459076374|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
127575111|NCT02310321|459076375|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|4|||
127575112|NCT02310321|459076376|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
127575113|NCT02310321|459076374|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
127575114|NCT02310321|459076375|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|1|||
127575115|NCT02310321|459076376|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
127575116|NCT02310321|459076374|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
127575117|NCT02310321|459076375|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|1|||
127575118|NCT02310321|459076376|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
127575119|NCT02310321|459076374|FG000|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
127575120|NCT02310321|459076375|FG001|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|3|||
127575121|NCT02310321|459076376|FG002|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
127575122|NCT02310321|459076374|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
127575123|NCT02310321|459076375|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
127575124|NCT02310321|459076376|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|2|||
127575125|NCT02310321|459076374|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
127575126|NCT02310321|459076375|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
127575127|NCT02310321|459076376|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|2|||
127575128|NCT02310321|459076374|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
127575129|NCT02310321|459076375|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
127575130|NCT02310321|459076376|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|6|||
127575131|NCT02310321|459076374|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
127575132|NCT02310321|459076375|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
127575133|NCT02310321|459076376|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|4|||
127575134|NCT02310321|459076374|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
127575135|NCT02310321|459076375|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
127575136|NCT02310321|459076376|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|3|||
127575137|NCT02310321|459076374|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
127575138|NCT02310321|459076375|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
127782002|NCT01092143|459827885|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
127782003|NCT01092143|459827886|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
127575139|NCT02310321|459076376|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|3|||
127575140|NCT02310321|459076374|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
127575141|NCT02310321|459076375|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
127575142|NCT02310321|459076376|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|2|||
127575143|NCT02310321|459076374|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
127575144|NCT02310321|459076375|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
127575145|NCT02310321|459076376|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|7|||
127575146|NCT02310321|459076374|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
127575147|NCT02310321|459076375|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
127575148|NCT02310321|459076376|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|4|||
127575149|NCT02310321|459076374|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
127575150|NCT02310321|459076375|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
127782004|NCT01092143|459827882|FG000|Overall Study|Ineligible patient|1|||
127575151|NCT02310321|459076376|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|4|||
127575152|NCT02310321|459076374|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
127575153|NCT02310321|459076375|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
127575154|NCT02310321|459076376|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|11|||
127575155|NCT02310321|459076374|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
127575156|NCT02310321|459076375|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
127575157|NCT02310321|459076376|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|2|||
127575158|NCT02310321|459076374|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
127575159|NCT02310321|459076375|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
127575160|NCT02310321|459076376|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|3|||
127575161|NCT02310321|459076374|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
127575162|NCT02310321|459076375|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
127575163|NCT02310321|459076376|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|1|||
127575164|NCT02310321|459076374|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
127782005|NCT01092143|459827883|FG001|Overall Study|Ineligible patient|0|||
128029546|NCT00489476|460733643|FG003|Overall Study|Lost to Follow-up|0|||
128029547|NCT01514422|460733644|FG000|Overall Study|Lost to Follow-up|1|||
128029548|NCT04126174|460733645|FG000|Overall Study|Lost to Follow-up|3|||
128029549|NCT04126174|460733646|FG001|Overall Study|Lost to Follow-up|3|||
128029550|NCT04105725|460733647|FG000|Primary Intervention|Lost to Follow-up|0|||
128029551|NCT04105725|460733648|FG001|Primary Intervention|Lost to Follow-up|2|||
128029552|NCT04105725|460733647|FG000|Primary Intervention|Withdrawal by Subject|0|||
128029553|NCT04105725|460733648|FG001|Primary Intervention|Withdrawal by Subject|1|||
128029554|NCT00480025|460733649|FG000|Overall Study|Protocol Violation|12|||
128029555|NCT00480025|460733650|FG001|Overall Study|Protocol Violation|7|||
128029556|NCT00480025|460733649|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
128029557|NCT00480025|460733650|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
128029558|NCT00480025|460733649|FG000|Overall Study|Disease Progression / Recurrence|449|||
128029559|NCT00480025|460733650|FG001|Overall Study|Disease Progression / Recurrence|224|||
128029560|NCT00480025|460733649|FG000|Overall Study|Adverse Event|44|||
128029561|NCT00480025|460733650|FG001|Overall Study|Adverse Event|12|||
128029562|NCT00480025|460733649|FG000|Overall Study|Other|70|||
128029563|NCT00480025|460733650|FG001|Overall Study|Other|29|||
128029564|NCT00480025|460733649|FG000|Overall Study|SAE including intercurrent illness|76|||
128029565|NCT00480025|460733650|FG001|Overall Study|SAE including intercurrent illness|42|||
128029566|NCT03726879|460733655|FG000|Overall Study|Death|11|||
128029567|NCT03726879|460733656|FG001|Overall Study|Death|13|||
128029568|NCT03726879|460733655|FG000|Overall Study|Physician Decision|0|||
128029569|NCT03726879|460733656|FG001|Overall Study|Physician Decision|2|||
128029570|NCT03726879|460733655|FG000|Overall Study|Protocol Violation|0|||
128029571|NCT03726879|460733656|FG001|Overall Study|Protocol Violation|1|||
128029572|NCT03726879|460733655|FG000|Overall Study|Withdrawal by Subject|5|||
128029573|NCT03726879|460733656|FG001|Overall Study|Withdrawal by Subject|6|||
128029574|NCT03726879|460733655|FG000|Overall Study|TSH result is unstable|0|||
128029575|NCT03726879|460733656|FG001|Overall Study|TSH result is unstable|1|||
128029576|NCT03726879|460733655|FG000|Overall Study|Disease relapse|1|||
128029577|NCT03726879|460733656|FG001|Overall Study|Disease relapse|0|||
128029578|NCT03726879|460733655|FG000|Overall Study|Lost to Follow-up|3|||
128029579|NCT03726879|460733656|FG001|Overall Study|Lost to Follow-up|0|||
128029580|NCT02766478|460733657|FG000|Overall Study|Withdrawal by Subject|1|||
128029581|NCT02766478|460733658|FG001|Overall Study|Withdrawal by Subject|1|||
128029582|NCT01093573|460733659|FG000|Overall Study|Physician Decision|0|||
128029583|NCT01093573|460733660|FG001|Overall Study|Physician Decision|0|||
128029584|NCT01093573|460733661|FG002|Overall Study|Physician Decision|1|||
128029585|NCT01093573|460733659|FG000|Overall Study|Insurance Denied|0|||
128029586|NCT01093573|460733660|FG001|Overall Study|Insurance Denied|0|||
128029587|NCT01093573|460733661|FG002|Overall Study|Insurance Denied|1|||
128029588|NCT05626686|460733662|FG000|Overall Study|Protocol Violation|3|||
128029589|NCT05626686|460733662|FG000|Overall Study|Withdrawal by Subject|3|||
128029590|NCT00176254|460733664|FG000|Overall Study|Lost to Follow-up|1|||
128029591|NCT01197300|460735026|FG000|Overall Study|Lost to Follow-up|0|||
127782006|NCT01092143|459827884|FG002|Overall Study|Ineligible patient|0|||
127782007|NCT01092143|459827885|FG003|Overall Study|Ineligible patient|0|||
128029592|NCT01197300|460735027|FG001|Overall Study|Lost to Follow-up|1|||
128029593|NCT01197300|460735026|FG000|Overall Study|Protocol Violation|0|||
128029594|NCT01197300|460735027|FG001|Overall Study|Protocol Violation|1|||
128029595|NCT02113878|460735028|FG000|Overall Study|Adverse Event|1|||
128029596|NCT02113878|460735029|FG001|Overall Study|Adverse Event|0|||
128029597|NCT02113878|460735028|FG000|Overall Study|Withdrawal by Subject|1|||
128029598|NCT02113878|460735029|FG001|Overall Study|Withdrawal by Subject|0|||
128029599|NCT02113878|460735028|FG000|Overall Study|patient non-compliance|1|||
128029600|NCT02113878|460735029|FG001|Overall Study|patient non-compliance|0|||
128029601|NCT00581100|460735030|FG000|Overall Study|Death|1|||
128029602|NCT00581100|460735031|FG001|Overall Study|Death|0|||
128029603|NCT00581100|460735030|FG000|Overall Study|Adverse Event|2|||
127575165|NCT02310321|459076375|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
127575166|NCT02310321|459076376|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|6|||
127575167|NCT01698905|459076377|FG000|Overall Study|Adverse Event|4|||
127575168|NCT01698905|459076377|FG000|Overall Study|Physician Decision|2|||
127575169|NCT01698905|459076377|FG000|Overall Study|Pregnancy|1|||
127575170|NCT01698905|459076377|FG000|Overall Study|Protocol Violation|1|||
127575171|NCT01698905|459076377|FG000|Overall Study|Subject/guardian decision|2|||
127575172|NCT01698905|459076377|FG000|Overall Study|Death|1|||
127575173|NCT02325791|459076380|FG000|Overall Study|Adverse Event|0|||
127575174|NCT02325791|459076381|FG001|Overall Study|Adverse Event|1|||
127575175|NCT02325791|459076382|FG002|Overall Study|Adverse Event|1|||
127575176|NCT02325791|459076383|FG003|Overall Study|Adverse Event|0|||
127575177|NCT02325791|459076380|FG000|Overall Study|Death|0|||
127575178|NCT02325791|459076381|FG001|Overall Study|Death|3|||
127575179|NCT02325791|459076382|FG002|Overall Study|Death|0|||
127575180|NCT02325791|459076383|FG003|Overall Study|Death|1|||
127575181|NCT02325791|459076380|FG000|Overall Study|Lost to Follow-up|0|||
127575182|NCT02325791|459076381|FG001|Overall Study|Lost to Follow-up|15|||
127575183|NCT02325791|459076382|FG002|Overall Study|Lost to Follow-up|14|||
127575184|NCT02325791|459076383|FG003|Overall Study|Lost to Follow-up|9|||
127575185|NCT02325791|459076380|FG000|Overall Study|Physician Decision|0|||
127575186|NCT02325791|459076381|FG001|Overall Study|Physician Decision|1|||
127575187|NCT02325791|459076382|FG002|Overall Study|Physician Decision|1|||
127575188|NCT02325791|459076383|FG003|Overall Study|Physician Decision|0|||
127575189|NCT02325791|459076380|FG000|Overall Study|Protocol Violation|0|||
127575190|NCT02325791|459076381|FG001|Overall Study|Protocol Violation|0|||
127575191|NCT02325791|459076382|FG002|Overall Study|Protocol Violation|1|||
127575192|NCT02325791|459076383|FG003|Overall Study|Protocol Violation|0|||
127575193|NCT02325791|459076380|FG000|Overall Study|Withdrawal by Subject|0|||
127575194|NCT02325791|459076381|FG001|Overall Study|Withdrawal by Subject|5|||
127575195|NCT02325791|459076382|FG002|Overall Study|Withdrawal by Subject|8|||
127575196|NCT02325791|459076383|FG003|Overall Study|Withdrawal by Subject|16|||
127575197|NCT03953183|459076384|FG000|Overall Study|Physician Decision|0|||
127575198|NCT03953183|459076385|FG001|Overall Study|Physician Decision|1|||
127575199|NCT03953183|459076384|FG000|Overall Study|Withdrawal by Subject|0|||
127575200|NCT03953183|459076385|FG001|Overall Study|Withdrawal by Subject|1|||
127575201|NCT00249288|459076386|FG000|Overall Study|Lost to Follow-up|3|||
127575202|NCT00249288|459076387|FG001|Overall Study|Lost to Follow-up|3|||
127575203|NCT00249288|459076386|FG000|Overall Study|Withdrawal by Subject|2|||
127575204|NCT00249288|459076387|FG001|Overall Study|Withdrawal by Subject|2|||
127575205|NCT03059446|459076388|FG000|Overall Study|Adverse Event|11|||
127575206|NCT03059446|459076388|FG000|Overall Study|Withdrawal of Consent|16|||
127575207|NCT03059446|459076388|FG000|Overall Study|Lost to Follow-up|3|||
127575208|NCT03059446|459076388|FG000|Overall Study|Protocol Violation|1|||
127575209|NCT03059446|459076388|FG000|Overall Study|Study Terminated by Sponsor|131|||
127575210|NCT03059446|459076388|FG000|Overall Study|Reason not Specified|5|||
127575211|NCT02273739|459076389|FG000|Overall Study|Progression of Disease|3|||
127575212|NCT02273739|459076390|FG001|Overall Study|Progression of Disease|4|||
127575213|NCT02273739|459076391|FG002|Overall Study|Progression of Disease|5|||
127575214|NCT02273739|459076392|FG003|Overall Study|Progression of Disease|2|||
128029604|NCT00581100|460735031|FG001|Overall Study|Adverse Event|1|||
128029605|NCT00581100|460735030|FG000|Overall Study|Withdrawal by Subject|1|||
127575215|NCT02273739|459076389|FG000|Overall Study|Death|0|||
127575216|NCT02273739|459076390|FG001|Overall Study|Death|0|||
127575217|NCT02273739|459076391|FG002|Overall Study|Death|0|||
127575218|NCT02273739|459076392|FG003|Overall Study|Death|2|||
127575219|NCT02273739|459076389|FG000|Overall Study|Adverse Event|0|||
127575220|NCT02273739|459076390|FG001|Overall Study|Adverse Event|0|||
127575221|NCT02273739|459076391|FG002|Overall Study|Adverse Event|0|||
127575222|NCT02273739|459076392|FG003|Overall Study|Adverse Event|1|||
127575223|NCT02273739|459076389|FG000|Overall Study|Withdrawal by Subject|0|||
127575224|NCT02273739|459076390|FG001|Overall Study|Withdrawal by Subject|0|||
127575225|NCT02273739|459076391|FG002|Overall Study|Withdrawal by Subject|2|||
127692777|NCT04823611|459501636|FG003|Overall Study|Adverse Event|0|||
127692778|NCT04823611|459501637|FG004|Overall Study|Adverse Event|0|||
127692779|NCT04823611|459501638|FG005|Overall Study|Adverse Event|0|||
127692780|NCT04823611|459501639|FG006|Overall Study|Adverse Event|0|||
127692781|NCT04511702|459501644|FG000|Overall Study|Lost to Follow-up|3|||
127692782|NCT04511702|459501645|FG001|Overall Study|Lost to Follow-up|0|||
127692783|NCT04511702|459501646|FG002|Overall Study|Lost to Follow-up|4|||
127692784|NCT04511702|459501644|FG000|Overall Study|Withdrawal by Subject|17|||
127692785|NCT04511702|459501645|FG001|Overall Study|Withdrawal by Subject|1|||
127692786|NCT04511702|459501646|FG002|Overall Study|Withdrawal by Subject|8|||
127692787|NCT02840474|459501647|FG000|Overall Study|Lost to Follow-up|1|||
127692788|NCT02840474|459501648|FG001|Overall Study|Lost to Follow-up|0|||
127575226|NCT02273739|459076392|FG003|Overall Study|Withdrawal by Subject|1|||
127575227|NCT02273739|459076389|FG000|Overall Study|Physician Decision|0|||
127575228|NCT02273739|459076390|FG001|Overall Study|Physician Decision|0|||
127575229|NCT02273739|459076391|FG002|Overall Study|Physician Decision|0|||
127575230|NCT02273739|459076392|FG003|Overall Study|Physician Decision|1|||
127575231|NCT04795622|459076393|FG000|Overall Study|Adverse Event|1|||
127575232|NCT04795622|459076394|FG001|Overall Study|Adverse Event|0|||
127575233|NCT04795622|459076393|FG000|Overall Study|Withdrawal by Subject|3|||
127575234|NCT04795622|459076394|FG001|Overall Study|Withdrawal by Subject|3|||
127575235|NCT04795622|459076393|FG000|Overall Study|Protocol Violation|0|||
127575236|NCT04795622|459076394|FG001|Overall Study|Protocol Violation|2|||
127575237|NCT04795622|459076393|FG000|Overall Study|Lost to Follow-up|2|||
127575238|NCT04795622|459076394|FG001|Overall Study|Lost to Follow-up|3|||
127575239|NCT04795622|459076393|FG000|Overall Study|Other|7|||
127575240|NCT04795622|459076394|FG001|Overall Study|Other|8|||
127575241|NCT03309046|459076397|FG000|Overall Study|Withdrawal by Subject|4|||
127575242|NCT03309046|459076398|FG001|Overall Study|Withdrawal by Subject|17|||
127575243|NCT00089674|459076399|FG000|Overall Study|Physician Decision|4|||
127575244|NCT00089674|459076400|FG001|Overall Study|Physician Decision|2|||
127575245|NCT00089674|459076399|FG000|Overall Study|Adverse Event|23|||
127575246|NCT00089674|459076400|FG001|Overall Study|Adverse Event|29|||
127575247|NCT00089674|459076399|FG000|Overall Study|Withdrawal by Subject|143|||
127575248|NCT00089674|459076400|FG001|Overall Study|Withdrawal by Subject|127|||
127575249|NCT00089674|459076399|FG000|Overall Study|Death|43|||
127575250|NCT00089674|459076400|FG001|Overall Study|Death|43|||
127575251|NCT00089674|459076399|FG000|Overall Study|Disease progression|21|||
127575252|NCT00089674|459076400|FG001|Overall Study|Disease progression|23|||
127575253|NCT00089674|459076399|FG000|Overall Study|Ineligibility determined|8|||
127575254|NCT00089674|459076400|FG001|Overall Study|Ineligibility determined|10|||
127575255|NCT00089674|459076399|FG000|Overall Study|Lost to Follow-up|21|||
127575256|NCT00089674|459076400|FG001|Overall Study|Lost to Follow-up|17|||
127575257|NCT00089674|459076399|FG000|Overall Study|Noncompliance|7|||
127575258|NCT00089674|459076400|FG001|Overall Study|Noncompliance|3|||
127575259|NCT00089674|459076399|FG000|Overall Study|Other|5|||
127575260|NCT00089674|459076400|FG001|Overall Study|Other|9|||
127575261|NCT00089674|459076399|FG000|Overall Study|Requirement for alternative therapy|14|||
127575262|NCT00089674|459076400|FG001|Overall Study|Requirement for alternative therapy|4|||
127575263|NCT03963401|459076401|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
127575264|NCT03963401|459076402|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
127575265|NCT03963401|459076403|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
127575266|NCT03963401|459076404|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
127575267|NCT03963401|459076405|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
127575268|NCT03963401|459076406|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
127575269|NCT03963401|459076401|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
127575270|NCT03963401|459076402|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
127575271|NCT03963401|459076403|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
127575272|NCT03963401|459076404|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
127575273|NCT03963401|459076405|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
127575274|NCT03963401|459076406|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
127575275|NCT03963401|459076401|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
128029606|NCT00581100|460735031|FG001|Overall Study|Withdrawal by Subject|4|||
128029607|NCT00581100|460735030|FG000|Overall Study|Other|3|||
128029608|NCT00581100|460735031|FG001|Overall Study|Other|0|||
128029609|NCT03058952|460735034|FG000|Overall Study|Adverse Event|1|||
128029610|NCT03058952|460735035|FG001|Overall Study|Adverse Event|0|||
128029611|NCT03058952|460735034|FG000|Overall Study|Lost to Follow-up|15|||
127575276|NCT03963401|459076402|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
127575277|NCT03963401|459076403|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
127575278|NCT03963401|459076404|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
127575279|NCT03963401|459076405|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
127575280|NCT03963401|459076406|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
127575281|NCT03963401|459076401|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
127575282|NCT03963401|459076402|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
127575283|NCT03963401|459076403|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
127575284|NCT03963401|459076404|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
127575285|NCT03963401|459076405|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
127575286|NCT03963401|459076406|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
127575287|NCT03963401|459076401|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
127575288|NCT03963401|459076402|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
127575289|NCT03963401|459076403|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
127575290|NCT03963401|459076404|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
127575291|NCT03963401|459076405|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
127782008|NCT01092143|459827886|FG004|Overall Study|Ineligible patient|0|||
127782009|NCT01092143|459827882|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
128029612|NCT03058952|460735035|FG001|Overall Study|Lost to Follow-up|15|||
128029613|NCT03058952|460735034|FG000|Overall Study|Withdrawal by Subject|7|||
128029614|NCT03058952|460735035|FG001|Overall Study|Withdrawal by Subject|11|||
127575292|NCT03963401|459076406|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
127782010|NCT01092143|459827883|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
127782011|NCT01092143|459827884|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
127782012|NCT01092143|459827885|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
127782013|NCT01092143|459827886|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
127782014|NCT01092143|459827882|FG000|Overall Study|Patient travel|0|||
127782015|NCT01092143|459827883|FG001|Overall Study|Patient travel|0|||
127782016|NCT01092143|459827884|FG002|Overall Study|Patient travel|0|||
127782017|NCT01092143|459827885|FG003|Overall Study|Patient travel|0|||
127782018|NCT01092143|459827886|FG004|Overall Study|Patient travel|1|||
127782019|NCT01092143|459827882|FG000|Overall Study|Non compliance with study medication|0|||
127782020|NCT01092143|459827883|FG001|Overall Study|Non compliance with study medication|0|||
127782021|NCT01092143|459827884|FG002|Overall Study|Non compliance with study medication|0|||
127782022|NCT01092143|459827885|FG003|Overall Study|Non compliance with study medication|0|||
127782023|NCT01092143|459827886|FG004|Overall Study|Non compliance with study medication|1|||
127782024|NCT01092143|459827882|FG000|Overall Study|Randomized by mistake|0|||
127782025|NCT01092143|459827883|FG001|Overall Study|Randomized by mistake|0|||
127782026|NCT01092143|459827884|FG002|Overall Study|Randomized by mistake|0|||
127782027|NCT01092143|459827885|FG003|Overall Study|Randomized by mistake|1|||
127782028|NCT01092143|459827886|FG004|Overall Study|Randomized by mistake|0|||
127782029|NCT01092143|459827882|FG000|Overall Study|Pregnancy|0|||
127782030|NCT01092143|459827883|FG001|Overall Study|Pregnancy|0|||
127782031|NCT01092143|459827884|FG002|Overall Study|Pregnancy|0|||
127782032|NCT01092143|459827885|FG003|Overall Study|Pregnancy|1|||
127782033|NCT01092143|459827886|FG004|Overall Study|Pregnancy|0|||
127782034|NCT03986866|459827887|FG000|Overall Study|Withdrawal by Subject|0|||
127782035|NCT03986866|459827888|FG001|Overall Study|Withdrawal by Subject|3|||
127782036|NCT03986866|459827887|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
127782037|NCT03986866|459827888|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
127782038|NCT05093322|459827891|FG000|Overall Study|Death|6|||
127782039|NCT05093322|459827892|FG001|Overall Study|Death|2|||
127782040|NCT05093322|459827891|FG000|Overall Study|Other|4|||
127782041|NCT05093322|459827892|FG001|Overall Study|Other|1|||
127782042|NCT00397033|459827898|FG000|Overall Study|Adverse Event|7|||
127782043|NCT00397033|459827899|FG001|Overall Study|Adverse Event|10|||
127782044|NCT00397033|459827900|FG002|Overall Study|Adverse Event|4|||
127782045|NCT00397033|459827898|FG000|Overall Study|Lack of Efficacy|22|||
127782046|NCT00397033|459827899|FG001|Overall Study|Lack of Efficacy|12|||
127782047|NCT00397033|459827900|FG002|Overall Study|Lack of Efficacy|9|||
127782048|NCT00397033|459827898|FG000|Overall Study|Lost to Follow-up|3|||
127782049|NCT00397033|459827899|FG001|Overall Study|Lost to Follow-up|3|||
127782050|NCT00397033|459827900|FG002|Overall Study|Lost to Follow-up|3|||
127782051|NCT00397033|459827898|FG000|Overall Study|Withdrawal by Subject|12|||
127782052|NCT00397033|459827899|FG001|Overall Study|Withdrawal by Subject|7|||
127782053|NCT00397033|459827900|FG002|Overall Study|Withdrawal by Subject|5|||
127782054|NCT00397033|459827898|FG000|Overall Study|Other|0|||
127782055|NCT00397033|459827899|FG001|Overall Study|Other|5|||
127782056|NCT00397033|459827900|FG002|Overall Study|Other|2|||
127782057|NCT02229539|459829642|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
127782058|NCT02229539|459829643|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
127782059|NCT02229539|459829644|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
127782060|NCT02229539|459829642|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
127782061|NCT02229539|459829643|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
127782062|NCT02229539|459829644|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
127782063|NCT02229539|459829642|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
127782064|NCT02229539|459829643|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
127782065|NCT02229539|459829644|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
127782066|NCT02229539|459829642|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
127782067|NCT02229539|459829643|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
127782068|NCT02229539|459829644|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|8|||
127575293|NCT03963401|459076401|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
127782069|NCT02229539|459829642|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
127782070|NCT02229539|459829643|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
127782071|NCT02229539|459829644|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
127782072|NCT02229539|459829642|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
127782073|NCT02229539|459829643|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
127782074|NCT02229539|459829644|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|2|||
127782075|NCT00682448|459829645|FG000|Overall Study|Adverse Event|1|||
127782076|NCT00682448|459829646|FG001|Overall Study|Adverse Event|2|||
127782077|NCT00682448|459829645|FG000|Overall Study|Lack of Efficacy|1|||
127782078|NCT00682448|459829646|FG001|Overall Study|Lack of Efficacy|0|||
127782079|NCT00682448|459829645|FG000|Overall Study|Lost to Follow-up|1|||
127782080|NCT00682448|459829646|FG001|Overall Study|Lost to Follow-up|3|||
127782081|NCT00682448|459829645|FG000|Overall Study|Pregnancy|0|||
127782082|NCT00682448|459829646|FG001|Overall Study|Pregnancy|1|||
127575294|NCT03963401|459076402|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
127575295|NCT03963401|459076403|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
127575296|NCT03963401|459076404|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
127575297|NCT03963401|459076405|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
127575298|NCT03963401|459076406|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
127575299|NCT03963401|459076401|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
127575300|NCT03963401|459076402|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
127575301|NCT03963401|459076403|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
127575302|NCT03963401|459076404|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
127575303|NCT03963401|459076405|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
127575304|NCT03963401|459076406|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
127575305|NCT03963401|459076401|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
127575306|NCT03963401|459076402|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
127575307|NCT03963401|459076403|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
127575308|NCT03963401|459076404|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
127575309|NCT03963401|459076405|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
127575310|NCT03963401|459076406|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
127575311|NCT03963401|459076401|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
127575312|NCT03963401|459076402|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
127575313|NCT03963401|459076403|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
127575314|NCT03963401|459076404|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
127575315|NCT03963401|459076405|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
127575316|NCT03963401|459076406|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
127575317|NCT03963401|459076401|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
127575318|NCT03963401|459076402|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
127575319|NCT03963401|459076403|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
127575320|NCT03963401|459076404|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
127575321|NCT03963401|459076405|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
127575322|NCT03963401|459076406|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
127782083|NCT00682448|459829645|FG000|Overall Study|Withdrawal by Subject|2|||
127782084|NCT00682448|459829646|FG001|Overall Study|Withdrawal by Subject|0|||
127782085|NCT00257166|459829650|FG000|Overall Study|Adverse Event|18|||
127782086|NCT00257166|459829651|FG001|Overall Study|Adverse Event|13|||
127782087|NCT00257166|459829650|FG000|Overall Study|Laboratory abnormality|1|||
127782088|NCT00257166|459829651|FG001|Overall Study|Laboratory abnormality|0|||
127782089|NCT00257166|459829650|FG000|Overall Study|Lost to Follow-up|8|||
127782090|NCT00257166|459829651|FG001|Overall Study|Lost to Follow-up|1|||
127782091|NCT00257166|459829650|FG000|Overall Study|Withdrawal by Subject|9|||
127782092|NCT00257166|459829651|FG001|Overall Study|Withdrawal by Subject|2|||
127782093|NCT00257166|459829650|FG000|Overall Study|Other|16|||
127782094|NCT00257166|459829651|FG001|Overall Study|Other|21|||
127782095|NCT00257166|459829650|FG000|Overall Study|Randomized, but not treated|1|||
127782096|NCT00257166|459829651|FG001|Overall Study|Randomized, but not treated|0|||
127782097|NCT02737852|459829654|FG000|Overall Study|Withdrawal by Subject|2|||
127782098|NCT04050670|459829657|FG000|Period 3|Physician Decision|0|||
127782099|NCT04050670|459829658|FG001|Period 3|Physician Decision|1|||
127782100|NCT04050670|459829659|FG002|Period 3|Physician Decision|0|||
127782101|NCT00525044|459829666|FG000|Overall Study|Lost to Follow-up|0|||
127782102|NCT00525044|459829667|FG001|Overall Study|Lost to Follow-up|1|||
127782103|NCT01168973|459829668|FG000|Overall Study|Progressive Disease|341|||
127782104|NCT01168973|459829669|FG001|Overall Study|Progressive Disease|429|||
127782105|NCT01168973|459829668|FG000|Overall Study|Adverse Event|94|||
127782106|NCT01168973|459829669|FG001|Overall Study|Adverse Event|55|||
127782107|NCT01168973|459829668|FG000|Overall Study|Withdrawal by Subject|90|||
127782108|NCT01168973|459829669|FG001|Overall Study|Withdrawal by Subject|53|||
127782109|NCT01168973|459829668|FG000|Overall Study|Death|42|||
127782110|NCT01168973|459829669|FG001|Overall Study|Death|45|||
127782111|NCT01168973|459829668|FG000|Overall Study|Physician Decision|37|||
127782112|NCT01168973|459829669|FG001|Overall Study|Physician Decision|19|||
127782113|NCT01168973|459829668|FG000|Overall Study|Sponsor Decision|2|||
127782114|NCT01168973|459829669|FG001|Overall Study|Sponsor Decision|1|||
127782115|NCT01168973|459829668|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
127782116|NCT01168973|459829669|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
127782117|NCT02230254|459829670|FG000|Overall Study|Lost to Follow-up|3|||
127782118|NCT02023242|459829671|FG000|Overall Study|Lost to Follow-up|3|||
127782119|NCT02023242|459829672|FG001|Overall Study|Lost to Follow-up|1|||
127782120|NCT02023242|459829671|FG000|Overall Study|Death|0|||
127782121|NCT02023242|459829672|FG001|Overall Study|Death|1|||
127782122|NCT00388505|459829675|FG000|Overall Study|Adverse Event or Death|43|||
127782123|NCT00388505|459829676|FG001|Overall Study|Adverse Event or Death|17|||
127782124|NCT00388505|459829675|FG000|Overall Study|Withdrawal by Subject|24|||
127575323|NCT03963401|459076401|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
127575324|NCT03963401|459076402|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
127575325|NCT03963401|459076403|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
127575326|NCT03963401|459076404|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
127575327|NCT03963401|459076405|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
127575328|NCT03963401|459076406|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
127575329|NCT02961218|459076407|FG000|Overall Study|Lost to Follow-up|0|||
127575330|NCT02961218|459076408|FG001|Overall Study|Lost to Follow-up|2|||
127575331|NCT02961218|459076407|FG000|Overall Study|Physician Decision|0|||
127575332|NCT02961218|459076408|FG001|Overall Study|Physician Decision|2|||
127575333|NCT02961218|459076407|FG000|Overall Study|Subject/Guardian Decision|3|||
127575334|NCT02961218|459076408|FG001|Overall Study|Subject/Guardian Decision|1|||
127575335|NCT03488927|459076409|FG000|Overall Study|Withdrawal by Subject|44|||
127575336|NCT03488927|459076410|FG001|Overall Study|Withdrawal by Subject|118|||
127575337|NCT03488927|459076411|FG002|Overall Study|Withdrawal by Subject|217|||
127575338|NCT00901927|459076414|FG000|Overall Study|Lack of Efficacy|1|||
127575339|NCT00901927|459076414|FG000|Overall Study|Protocol Violation|3|||
127575340|NCT00901927|459076414|FG000|Overall Study|Withdrawal by Subject|2|||
127575341|NCT05298306|459076415|FG000|Overall Study|Physician Decision|0|||
127575342|NCT05298306|459076416|FG001|Overall Study|Physician Decision|0|||
127575343|NCT05298306|459076417|FG002|Overall Study|Physician Decision|0|||
127575344|NCT05298306|459076418|FG003|Overall Study|Physician Decision|1|||
127575345|NCT05298306|459076419|FG004|Overall Study|Physician Decision|0|||
127575346|NCT05298306|459076420|FG005|Overall Study|Physician Decision|0|||
127575347|NCT02676466|459076426|FG000|Overall Study|Death|0|||
127575348|NCT02676466|459076427|FG001|Overall Study|Death|2|||
127575349|NCT02676466|459076428|FG002|Overall Study|Death|1|||
127575350|NCT02676466|459076429|FG003|Overall Study|Death|0|||
127575351|NCT02676466|459076430|FG004|Overall Study|Death|0|||
127575352|NCT02676466|459076431|FG005|Overall Study|Death|0|||
127575353|NCT02676466|459076432|FG006|Overall Study|Death|0|||
127575354|NCT02676466|459076433|FG007|Overall Study|Death|0|||
127575355|NCT02676466|459076426|FG000|Overall Study|Withdrawal by Subject|4|||
127575356|NCT02676466|459076427|FG001|Overall Study|Withdrawal by Subject|3|||
127575357|NCT02676466|459076428|FG002|Overall Study|Withdrawal by Subject|1|||
127575358|NCT02676466|459076429|FG003|Overall Study|Withdrawal by Subject|0|||
127575359|NCT02676466|459076430|FG004|Overall Study|Withdrawal by Subject|3|||
127575360|NCT02676466|459076431|FG005|Overall Study|Withdrawal by Subject|1|||
127575361|NCT02676466|459076432|FG006|Overall Study|Withdrawal by Subject|1|||
127575362|NCT02676466|459076433|FG007|Overall Study|Withdrawal by Subject|1|||
127575363|NCT01178073|459076436|FG000|Overall Study|Adverse Event|34|||
127575364|NCT01178073|459076437|FG001|Overall Study|Adverse Event|27|||
127575365|NCT01178073|459076438|FG002|Overall Study|Adverse Event|24|||
127575366|NCT01178073|459076436|FG000|Overall Study|Protocol Violation|1|||
127575367|NCT01178073|459076437|FG001|Overall Study|Protocol Violation|1|||
127575368|NCT01178073|459076438|FG002|Overall Study|Protocol Violation|1|||
127575369|NCT01178073|459076436|FG000|Overall Study|Lost to Follow-up|2|||
127575370|NCT01178073|459076437|FG001|Overall Study|Lost to Follow-up|0|||
127575371|NCT01178073|459076438|FG002|Overall Study|Lost to Follow-up|3|||
127575372|NCT01178073|459076436|FG000|Overall Study|Physician Decision|14|||
127575373|NCT01178073|459076437|FG001|Overall Study|Physician Decision|10|||
127575374|NCT01178073|459076438|FG002|Overall Study|Physician Decision|10|||
127575375|NCT01178073|459076436|FG000|Overall Study|Withdrawal by Subject|10|||
127575376|NCT01178073|459076437|FG001|Overall Study|Withdrawal by Subject|6|||
127692789|NCT03192891|459501649|FG000|Overall Study|Lost to Follow-up|55|||
127692790|NCT05141903|459501650|FG000|Overall Study|Withdrawal by Subject|0|||
127692791|NCT05141903|459501651|FG001|Overall Study|Withdrawal by Subject|1|||
127692792|NCT05141903|459501652|FG002|Overall Study|Withdrawal by Subject|1|||
127692793|NCT05141903|459501653|FG003|Overall Study|Withdrawal by Subject|0|||
127692794|NCT05141903|459501654|FG004|Overall Study|Withdrawal by Subject|0|||
127692795|NCT05141903|459501650|FG000|Overall Study|Other|1|||
127575377|NCT01178073|459076438|FG002|Overall Study|Withdrawal by Subject|8|||
127575378|NCT01178073|459076436|FG000|Overall Study|Missing Completion Status|1|||
127575379|NCT01178073|459076437|FG001|Overall Study|Missing Completion Status|0|||
127575380|NCT01178073|459076438|FG002|Overall Study|Missing Completion Status|0|||
127575381|NCT00739596|459076452|FG000|Overall Study|Adverse Event|12|||
127575382|NCT00739596|459076453|FG001|Overall Study|Adverse Event|6|||
127575383|NCT00739596|459076452|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
127575384|NCT00739596|459076453|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
127575385|NCT00739596|459076452|FG000|Overall Study|Patient Withdrew Consent|8|||
127575386|NCT00739596|459076453|FG001|Overall Study|Patient Withdrew Consent|8|||
127692796|NCT05141903|459501651|FG001|Overall Study|Other|1|||
127692797|NCT05141903|459501652|FG002|Overall Study|Other|0|||
127692798|NCT05141903|459501653|FG003|Overall Study|Other|0|||
127575387|NCT00739596|459076452|FG000|Overall Study|Lost to Follow-up|0|||
127575388|NCT00739596|459076453|FG001|Overall Study|Lost to Follow-up|2|||
127575389|NCT00739596|459076452|FG000|Overall Study|Protocol Deviation|1|||
127575390|NCT00739596|459076453|FG001|Overall Study|Protocol Deviation|1|||
127692799|NCT05141903|459501654|FG004|Overall Study|Other|0|||
127575391|NCT00908011|459076454|FG000|Overall Study|Withdrawal by Subject|2|||
127575392|NCT00908011|459076455|FG001|Overall Study|Withdrawal by Subject|2|||
127575393|NCT00644228|459076456|FG000|Randomization & Eligibility|Ineligible|31|||
127575394|NCT00644228|459076457|FG001|Randomization & Eligibility|Ineligible|21|||
127575395|NCT00644228|459076456|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
127575396|NCT00644228|459076457|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
127575397|NCT00644228|459076456|FG000|Randomization & Eligibility|Invalid Consent|0|||
127575398|NCT00644228|459076457|FG001|Randomization & Eligibility|Invalid Consent|1|||
127575399|NCT00644228|459076456|FG000|Induction Therapy|Adverse Event|22|||
127575400|NCT00644228|459076457|FG001|Induction Therapy|Adverse Event|55|||
127575401|NCT00644228|459076456|FG000|Induction Therapy|Withdrawal by Subject|10|||
127575402|NCT00644228|459076457|FG001|Induction Therapy|Withdrawal by Subject|3|||
127575403|NCT00644228|459076456|FG000|Induction Therapy|Progression/Relapse|24|||
127575404|NCT00644228|459076457|FG001|Induction Therapy|Progression/Relapse|12|||
127575405|NCT00644228|459076456|FG000|Induction Therapy|Death|3|||
127575406|NCT00644228|459076457|FG001|Induction Therapy|Death|7|||
127575407|NCT00644228|459076456|FG000|Induction Therapy|Not Protocol-Specified|24|||
127575408|NCT00644228|459076457|FG001|Induction Therapy|Not Protocol-Specified|28|||
127575409|NCT00644228|459076456|FG000|Maintenance|Adverse Event|27|||
127575410|NCT00644228|459076457|FG001|Maintenance|Adverse Event|31|||
127575411|NCT00644228|459076456|FG000|Maintenance|Withdrawal by Subject|6|||
127575412|NCT00644228|459076457|FG001|Maintenance|Withdrawal by Subject|4|||
127575413|NCT00644228|459076456|FG000|Maintenance|Progression/Relapse|67|||
127575414|NCT00644228|459076457|FG001|Maintenance|Progression/Relapse|42|||
127575415|NCT00644228|459076456|FG000|Maintenance|Death|3|||
127575416|NCT00644228|459076457|FG001|Maintenance|Death|3|||
127575417|NCT00644228|459076456|FG000|Maintenance|Not Protocol-Specified|14|||
127575418|NCT00644228|459076457|FG001|Maintenance|Not Protocol-Specified|15|||
127575419|NCT00644228|459076456|FG000|Maintenance|On Treatment|26|||
127575420|NCT00644228|459076457|FG001|Maintenance|On Treatment|40|||
127575421|NCT00760084|459076458|FG000|Overall Study|Physician Decision|5|||
127575422|NCT00760084|459076458|FG000|Overall Study|Withdrawal by Subject|2|||
127575423|NCT00760084|459076458|FG000|Overall Study|Progressive Disease|3|||
127575424|NCT02567552|459076459|FG000|Overall Study|Adverse Event|0|||
127575425|NCT02567552|459076460|FG001|Overall Study|Adverse Event|1|||
127575426|NCT03187756|459076461|FG000|Overall Study|Termination of study|4|||
127575427|NCT03635788|459076462|FG000|Step 1|Death|1|||
127575428|NCT03635788|459076463|FG001|Step 1|Death|0|||
127575429|NCT03635788|459076464|FG002|Step 1|Death|0|||
127575430|NCT03635788|459076462|FG000|Step 1|Lost to Follow-up|31|||
127575431|NCT03635788|459076463|FG001|Step 1|Lost to Follow-up|0|||
127575432|NCT03635788|459076464|FG002|Step 1|Lost to Follow-up|0|||
127575433|NCT03635788|459076462|FG000|Step 1|Pregnancy|1|||
127575434|NCT03635788|459076463|FG001|Step 1|Pregnancy|0|||
127575435|NCT03635788|459076464|FG002|Step 1|Pregnancy|0|||
127575436|NCT03635788|459076462|FG000|Step 1|Protocol Violation|8|||
127575437|NCT03635788|459076463|FG001|Step 1|Protocol Violation|0|||
127575438|NCT03635788|459076464|FG002|Step 1|Protocol Violation|0|||
127575439|NCT03635788|459076462|FG000|Step 1|Withdrawal by Subject|13|||
127575440|NCT03635788|459076463|FG001|Step 1|Withdrawal by Subject|0|||
127575441|NCT03635788|459076464|FG002|Step 1|Withdrawal by Subject|0|||
127575442|NCT03635788|459076462|FG000|Step 1|Other reasons|12|||
127575443|NCT03635788|459076463|FG001|Step 1|Other reasons|0|||
127575444|NCT03635788|459076464|FG002|Step 1|Other reasons|0|||
127575445|NCT03635788|459076462|FG000|Step 1|On Step 1 as of February 12, 2024|27|||
127575446|NCT03635788|459076463|FG001|Step 1|On Step 1 as of February 12, 2024|0|||
127575447|NCT03635788|459076464|FG002|Step 1|On Step 1 as of February 12, 2024|0|||
127575448|NCT03635788|459076462|FG000|Step 2|Lost to Follow-up|0|||
127575449|NCT03635788|459076463|FG001|Step 2|Lost to Follow-up|8|||
127575450|NCT03635788|459076464|FG002|Step 2|Lost to Follow-up|15|||
127575451|NCT03635788|459076462|FG000|Step 2|Withdrawal by Subject|0|||
127575452|NCT03635788|459076463|FG001|Step 2|Withdrawal by Subject|6|||
127575453|NCT03635788|459076464|FG002|Step 2|Withdrawal by Subject|6|||
127575454|NCT03635788|459076462|FG000|Step 2|Death|0|||
127575455|NCT03635788|459076463|FG001|Step 2|Death|2|||
127575456|NCT03635788|459076464|FG002|Step 2|Death|0|||
127575457|NCT03635788|459076462|FG000|Step 2|Incarceration|0|||
127575458|NCT03635788|459076463|FG001|Step 2|Incarceration|2|||
127575459|NCT03635788|459076464|FG002|Step 2|Incarceration|0|||
127692800|NCT01707030|459501658|FG000|Overall Study|Death|1|||
127575460|NCT03635788|459076462|FG000|Step 2|Non-Compliance With Study Requirements|0|||
127575461|NCT03635788|459076463|FG001|Step 2|Non-Compliance With Study Requirements|1|||
127575462|NCT03635788|459076464|FG002|Step 2|Non-Compliance With Study Requirements|1|||
127575463|NCT03635788|459076462|FG000|Step 2|Confounding Medical Condition|0|||
127575464|NCT03635788|459076463|FG001|Step 2|Confounding Medical Condition|0|||
127692801|NCT01707030|459501659|FG001|Overall Study|Death|1|||
127575465|NCT03635788|459076464|FG002|Step 2|Confounding Medical Condition|1|||
127575466|NCT03635788|459076462|FG000|Step 2|Out Of State With No Plan To Return|0|||
127575467|NCT03635788|459076463|FG001|Step 2|Out Of State With No Plan To Return|1|||
127575468|NCT03635788|459076464|FG002|Step 2|Out Of State With No Plan To Return|0|||
127575469|NCT03635788|459076462|FG000|Step 2|Switched To Injectables|0|||
127782125|NCT00388505|459829676|FG001|Overall Study|Withdrawal by Subject|9|||
127782126|NCT00388505|459829675|FG000|Overall Study|Lost to Follow-up|5|||
127782127|NCT00388505|459829676|FG001|Overall Study|Lost to Follow-up|3|||
127782128|NCT00388505|459829675|FG000|Overall Study|Inappropriate Enrollment|0|||
127782129|NCT00388505|459829676|FG001|Overall Study|Inappropriate Enrollment|1|||
127782130|NCT00388505|459829675|FG000|Overall Study|Administrative Reason|1|||
127782131|NCT00388505|459829676|FG001|Overall Study|Administrative Reason|0|||
127782132|NCT00388505|459829675|FG000|Overall Study|Protocol Violation|6|||
127782133|NCT00388505|459829676|FG001|Overall Study|Protocol Violation|5|||
127782134|NCT00388505|459829675|FG000|Overall Study|Unable to classify|4|||
127782135|NCT00388505|459829676|FG001|Overall Study|Unable to classify|3|||
127782136|NCT04854434|459829682|FG000|Overall Study|Death|1|||
127782137|NCT04854434|459829683|FG001|Overall Study|Death|3|||
127782138|NCT04854434|459829684|FG002|Overall Study|Death|4|||
127782139|NCT04854434|459829682|FG000|Overall Study|Study Terminated by Sponsor|2|||
127782140|NCT04854434|459829683|FG001|Overall Study|Study Terminated by Sponsor|0|||
127782141|NCT04854434|459829684|FG002|Overall Study|Study Terminated by Sponsor|0|||
127782142|NCT04854434|459829682|FG000|Overall Study|Other|1|||
127782143|NCT04854434|459829683|FG001|Overall Study|Other|1|||
127782144|NCT04854434|459829684|FG002|Overall Study|Other|0|||
127782145|NCT02667275|459829685|FG000|Overall Study|Protocol Violation|11|||
127782146|NCT02667275|459829686|FG001|Overall Study|Protocol Violation|7|||
127782147|NCT02667275|459829685|FG000|Overall Study|Lost to Follow-up|0|||
127782148|NCT02667275|459829686|FG001|Overall Study|Lost to Follow-up|2|||
127782149|NCT02667275|459829685|FG000|Overall Study|Withdrawal by Subject|0|||
127782150|NCT02667275|459829686|FG001|Overall Study|Withdrawal by Subject|5|||
128029615|NCT04744831|460735036|FG000|Overall Study|Progressive Disease|31|||
128029616|NCT04744831|460735037|FG001|Overall Study|Progressive Disease|27|||
128029617|NCT04744831|460735038|FG002|Overall Study|Progressive Disease|25|||
128029618|NCT04744831|460735036|FG000|Overall Study|Adverse Event|3|||
128029619|NCT04744831|460735037|FG001|Overall Study|Adverse Event|3|||
128029620|NCT04744831|460735038|FG002|Overall Study|Adverse Event|3|||
127782151|NCT02667275|459829685|FG000|Overall Study|Discontinued early without completing|0|||
127782152|NCT02667275|459829686|FG001|Overall Study|Discontinued early without completing|1|||
127782153|NCT01274715|459829687|FG000|Overall Study|Lost to Follow-up|1|||
127782154|NCT01274715|459829687|FG000|Overall Study|After consent, met exclusion criteria.|1|||
127782155|NCT01274715|459829687|FG000|Overall Study|After consent, met exclusion criteria.|1|||
127782156|NCT01274715|459829687|FG000|Overall Study|After consent, met exclusion criteria.|1|||
127782157|NCT02357134|459829689|FG000|Overall Study|Lost to Follow-up|1|||
127782158|NCT02357134|459829690|FG001|Overall Study|Lost to Follow-up|0|||
127782159|NCT02357134|459829691|FG002|Overall Study|Lost to Follow-up|0|||
127782160|NCT02357134|459829692|FG003|Overall Study|Lost to Follow-up|0|||
127782161|NCT01301456|459829693|FG000|Stage 1|Withdrawal by Subject|0|||
127782162|NCT01301456|459829694|FG001|Stage 1|Withdrawal by Subject|0|||
127782163|NCT01301456|459829695|FG002|Stage 1|Withdrawal by Subject|1|||
127782164|NCT01301456|459829696|FG003|Stage 1|Withdrawal by Subject|0|||
127782165|NCT01301456|459829697|FG004|Stage 1|Withdrawal by Subject|1|||
127782166|NCT01301456|459829698|FG005|Stage 1|Withdrawal by Subject|0|||
127782167|NCT01301456|459829699|FG006|Stage 1|Withdrawal by Subject|0|||
127782168|NCT01301456|459829700|FG007|Stage 1|Withdrawal by Subject|0|||
127782169|NCT01301456|459829701|FG008|Stage 1|Withdrawal by Subject|0|||
127782170|NCT01301456|459829702|FG009|Stage 1|Withdrawal by Subject|0|||
127782171|NCT01301456|459829703|FG010|Stage 1|Withdrawal by Subject|0|||
127782172|NCT01301456|459829704|FG011|Stage 1|Withdrawal by Subject|0|||
127782173|NCT01301456|459829693|FG000|Stage 1|Randomized but not treated|0|||
127782174|NCT01301456|459829694|FG001|Stage 1|Randomized but not treated|0|||
127782175|NCT01301456|459829695|FG002|Stage 1|Randomized but not treated|0|||
127782176|NCT01301456|459829696|FG003|Stage 1|Randomized but not treated|0|||
127782177|NCT01301456|459829697|FG004|Stage 1|Randomized but not treated|0|||
127782178|NCT01301456|459829698|FG005|Stage 1|Randomized but not treated|0|||
127782179|NCT01301456|459829699|FG006|Stage 1|Randomized but not treated|1|||
127782180|NCT01301456|459829700|FG007|Stage 1|Randomized but not treated|0|||
127782181|NCT01301456|459829701|FG008|Stage 1|Randomized but not treated|0|||
127782182|NCT01301456|459829702|FG009|Stage 1|Randomized but not treated|0|||
127782183|NCT01301456|459829703|FG010|Stage 1|Randomized but not treated|0|||
128029621|NCT04744831|460735036|FG000|Overall Study|Clinical Progression|3|||
128029622|NCT04744831|460735037|FG001|Overall Study|Clinical Progression|2|||
127782184|NCT01301456|459829704|FG011|Stage 1|Randomized but not treated|0|||
127782185|NCT01301456|459829693|FG000|Stage 2|Adverse Event|0|||
127782186|NCT01301456|459829694|FG001|Stage 2|Adverse Event|0|||
127782187|NCT01301456|459829695|FG002|Stage 2|Adverse Event|0|||
127782188|NCT01301456|459829696|FG003|Stage 2|Adverse Event|0|||
127782189|NCT01301456|459829697|FG004|Stage 2|Adverse Event|0|||
127782190|NCT01301456|459829698|FG005|Stage 2|Adverse Event|0|||
127782191|NCT01301456|459829699|FG006|Stage 2|Adverse Event|0|||
127782192|NCT01301456|459829700|FG007|Stage 2|Adverse Event|0|||
127782193|NCT01301456|459829701|FG008|Stage 2|Adverse Event|0|||
128029623|NCT04744831|460735038|FG002|Overall Study|Clinical Progression|5|||
127782194|NCT01301456|459829702|FG009|Stage 2|Adverse Event|0|||
127575470|NCT03635788|459076463|FG001|Step 2|Switched To Injectables|0|||
127575471|NCT03635788|459076464|FG002|Step 2|Switched To Injectables|1|||
127575472|NCT03635788|459076462|FG000|Step 2|On Step 2 as of February 12, 2024|0|||
128029624|NCT04744831|460735036|FG000|Overall Study|Other|0|||
128029625|NCT04744831|460735037|FG001|Overall Study|Other|2|||
127575473|NCT03635788|459076463|FG001|Step 2|On Step 2 as of February 12, 2024|56|||
128029626|NCT04744831|460735038|FG002|Overall Study|Other|1|||
128029627|NCT04744831|460735036|FG000|Overall Study|Death|0|||
128029628|NCT04744831|460735037|FG001|Overall Study|Death|2|||
127575474|NCT03635788|459076464|FG002|Step 2|On Step 2 as of February 12, 2024|56|||
127575475|NCT04382755|459076465|FG000|Overall Study|Withdrawal by Subject|1|||
127575476|NCT04382755|459076466|FG001|Overall Study|Withdrawal by Subject|0|||
127575477|NCT04382755|459076465|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
127575478|NCT04382755|459076466|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
127575479|NCT04382755|459076465|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
127575480|NCT04382755|459076466|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
127575481|NCT02160782|459078025|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
127575482|NCT02160782|459078026|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
127692802|NCT01707030|459501658|FG000|Overall Study|Withdrawal by Subject|2|||
127692803|NCT01707030|459501659|FG001|Overall Study|Withdrawal by Subject|3|||
127692804|NCT01707030|459501658|FG000|Overall Study|Lost to Follow-up|8|||
127692805|NCT01707030|459501659|FG001|Overall Study|Lost to Follow-up|13|||
127692806|NCT04820855|459501660|FG000|Overall Study|Lost to Follow-up|6|||
127692807|NCT04820855|459501661|FG001|Overall Study|Lost to Follow-up|9|||
127692808|NCT02140645|459501664|FG000|Overall Study|Not linked|5489|||
127692809|NCT02140645|459501665|FG001|Overall Study|Not linked|61654|||
127692810|NCT02140645|459501666|FG002|Overall Study|Not linked|4236|||
127692811|NCT02140645|459501667|FG003|Overall Study|Not linked|13833|||
127692812|NCT02140645|459501668|FG004|Overall Study|Not linked|3286|||
127692813|NCT02140645|459501669|FG005|Overall Study|Not linked|70896|||
127692814|NCT00073749|459501670|FG000|Overall Study|Disease Progression|2|||
127692815|NCT00073749|459501671|FG001|Overall Study|Disease Progression|0|||
127692816|NCT00073749|459501672|FG002|Overall Study|Disease Progression|3|||
127692817|NCT00073749|459501673|FG003|Overall Study|Disease Progression|2|||
127692818|NCT00073749|459501674|FG004|Overall Study|Disease Progression|3|||
127692819|NCT00073749|459501675|FG005|Overall Study|Disease Progression|1|||
127692820|NCT00073749|459501676|FG006|Overall Study|Disease Progression|3|||
127692821|NCT00073749|459501670|FG000|Overall Study|Death|0|||
127692822|NCT00073749|459501671|FG001|Overall Study|Death|1|||
127692823|NCT00073749|459501672|FG002|Overall Study|Death|1|||
127692824|NCT00073749|459501673|FG003|Overall Study|Death|0|||
127692825|NCT00073749|459501674|FG004|Overall Study|Death|0|||
127692826|NCT00073749|459501675|FG005|Overall Study|Death|0|||
127692827|NCT00073749|459501676|FG006|Overall Study|Death|29|||
127692828|NCT00073749|459501670|FG000|Overall Study|Adverse Event|0|||
127692829|NCT00073749|459501671|FG001|Overall Study|Adverse Event|3|||
127692830|NCT00073749|459501672|FG002|Overall Study|Adverse Event|6|||
127692831|NCT00073749|459501673|FG003|Overall Study|Adverse Event|4|||
127692832|NCT00073749|459501674|FG004|Overall Study|Adverse Event|2|||
127692833|NCT00073749|459501675|FG005|Overall Study|Adverse Event|1|||
127692834|NCT00073749|459501676|FG006|Overall Study|Adverse Event|0|||
127692835|NCT00073749|459501670|FG000|Overall Study|Physician Decision|0|||
127692836|NCT00073749|459501671|FG001|Overall Study|Physician Decision|0|||
127692837|NCT00073749|459501672|FG002|Overall Study|Physician Decision|1|||
127692838|NCT00073749|459501673|FG003|Overall Study|Physician Decision|0|||
127692839|NCT00073749|459501674|FG004|Overall Study|Physician Decision|0|||
127692840|NCT00073749|459501675|FG005|Overall Study|Physician Decision|2|||
127692841|NCT00073749|459501676|FG006|Overall Study|Physician Decision|0|||
127692842|NCT00073749|459501670|FG000|Overall Study|Withdrawal by Subject|0|||
127692843|NCT00073749|459501671|FG001|Overall Study|Withdrawal by Subject|1|||
127692844|NCT00073749|459501672|FG002|Overall Study|Withdrawal by Subject|0|||
127692845|NCT00073749|459501673|FG003|Overall Study|Withdrawal by Subject|0|||
127692846|NCT00073749|459501674|FG004|Overall Study|Withdrawal by Subject|1|||
127692847|NCT00073749|459501675|FG005|Overall Study|Withdrawal by Subject|0|||
127692848|NCT00073749|459501676|FG006|Overall Study|Withdrawal by Subject|2|||
127692849|NCT00073749|459501670|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
127692850|NCT00073749|459501671|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
127692851|NCT00073749|459501672|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
127692852|NCT00073749|459501673|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
127692853|NCT00073749|459501674|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
127692854|NCT00073749|459501675|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
127692855|NCT00073749|459501676|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
127692856|NCT00073749|459501670|FG000|Overall Study|Lost to Follow-up|0|||
127692857|NCT00073749|459501671|FG001|Overall Study|Lost to Follow-up|0|||
127692858|NCT00073749|459501672|FG002|Overall Study|Lost to Follow-up|0|||
127692859|NCT00073749|459501673|FG003|Overall Study|Lost to Follow-up|0|||
127692860|NCT00073749|459501674|FG004|Overall Study|Lost to Follow-up|0|||
128029629|NCT04744831|460735038|FG002|Overall Study|Death|1|||
128029630|NCT03837509|460735039|FG000|Phase 1|Death|5|||
128029631|NCT03837509|460735040|FG001|Phase 1|Death|2|||
128029632|NCT03837509|460735041|FG002|Phase 1|Death|0|||
128029633|NCT03837509|460735042|FG003|Phase 1|Death|0|||
128029634|NCT03837509|460735043|FG004|Phase 1|Death|0|||
128029635|NCT03837509|460735039|FG000|Phase 2|Death|0|||
128029636|NCT03837509|460735040|FG001|Phase 2|Death|0|||
128029637|NCT03837509|460735041|FG002|Phase 2|Death|0|||
128029638|NCT03837509|460735042|FG003|Phase 2|Death|1|||
128029639|NCT03837509|460735043|FG004|Phase 2|Death|1|||
128029640|NCT00530257|460735055|FG000|Overall Study|Lost to Follow-up|1|||
128029641|NCT05401409|460735059|FG000|Overall Study|Lost to Follow-up|1|||
128029642|NCT05401409|460735060|FG001|Overall Study|Lost to Follow-up|0|||
128029643|NCT02371889|460735061|FG000|Overall Study|Adverse medication effect|11|||
128029644|NCT02371889|460735062|FG001|Overall Study|Adverse medication effect|2|||
128029645|NCT02371889|460735061|FG000|Overall Study|Lost to Follow-up|6|||
128029646|NCT02371889|460735062|FG001|Overall Study|Lost to Follow-up|5|||
128029647|NCT02371889|460735061|FG000|Overall Study|Personal time constraints|2|||
128029648|NCT02371889|460735062|FG001|Overall Study|Personal time constraints|4|||
127575483|NCT02160782|459078027|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
127575484|NCT02160782|459078028|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
127575485|NCT02160782|459078029|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
127575486|NCT02160782|459078025|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
127575487|NCT02160782|459078026|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
127575488|NCT02160782|459078027|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
127575489|NCT02160782|459078028|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
127575490|NCT02160782|459078029|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
127575491|NCT02160782|459078025|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
127575492|NCT02160782|459078026|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
127575493|NCT02160782|459078027|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
127575494|NCT02160782|459078028|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
127575495|NCT02160782|459078029|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
127575496|NCT02160782|459078025|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
127575497|NCT02160782|459078026|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
127575498|NCT02160782|459078027|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
127575499|NCT02160782|459078028|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
127575500|NCT02160782|459078029|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
127575501|NCT02160782|459078025|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
127575502|NCT02160782|459078026|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
127575503|NCT02160782|459078027|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
127782195|NCT01301456|459829703|FG010|Stage 2|Adverse Event|1|||
127782196|NCT01301456|459829704|FG011|Stage 2|Adverse Event|0|||
127782197|NCT03583450|459829705|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
127782198|NCT03583450|459829706|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
127782199|NCT03374995|459829707|FG000|Overall Study|Withdrawal by Subject|0|||
127782200|NCT03374995|459829708|FG001|Overall Study|Withdrawal by Subject|1|||
127782201|NCT01380730|459829709|FG000|Overall Study|Death|0|||
127782202|NCT01380730|459829710|FG001|Overall Study|Death|0|||
127782203|NCT01380730|459829711|FG002|Overall Study|Death|0|||
127782204|NCT01380730|459829712|FG003|Overall Study|Death|0|||
127782205|NCT01380730|459829713|FG004|Overall Study|Death|1|||
127782206|NCT01380730|459829714|FG005|Overall Study|Death|0|||
127782207|NCT01380730|459829715|FG006|Overall Study|Death|0|||
127782208|NCT01380730|459829716|FG007|Overall Study|Death|0|||
127782209|NCT00041080|459829717|FG000|Overall Study|Adverse Event|21|||
127782210|NCT00041080|459829718|FG001|Overall Study|Adverse Event|1|||
127782211|NCT00041080|459829717|FG000|Overall Study|Withdrawal by Subject|6|||
127782212|NCT00041080|459829718|FG001|Overall Study|Withdrawal by Subject|6|||
127782213|NCT00041080|459829717|FG000|Overall Study|Concommitant Illness/Other|1|||
127782214|NCT00041080|459829718|FG001|Overall Study|Concommitant Illness/Other|2|||
127782215|NCT00041080|459829717|FG000|Overall Study|Did not start therapy|1|||
127782216|NCT00041080|459829718|FG001|Overall Study|Did not start therapy|1|||
127782217|NCT00041080|459829717|FG000|Overall Study|Ineligible|1|||
128029649|NCT02371889|460735061|FG000|Overall Study|Lack of Efficacy|0|||
128029650|NCT02371889|460735062|FG001|Overall Study|Lack of Efficacy|2|||
128029651|NCT02371889|460735061|FG000|Overall Study|Relapse|0|||
128029652|NCT02371889|460735062|FG001|Overall Study|Relapse|1|||
128029653|NCT05520333|460735063|FG000|Overall Study|Lost to Follow-up|3|||
128029654|NCT05520333|460735064|FG001|Overall Study|Lost to Follow-up|6|||
128029655|NCT02579759|460735065|FG000|Overall Study|Protocol Violation|2|||
128029656|NCT02579759|460735066|FG001|Overall Study|Protocol Violation|0|||
127881053|NCT02575807|460186108|FG004|Overall Study|Withdrawal by Subject|2|||
127881054|NCT03014570|460186111|FG000|Overall Study|COVID-19 Restrictions|38|||
127881055|NCT03014570|460186112|FG001|Overall Study|COVID-19 Restrictions|24|||
127881056|NCT03014570|460186111|FG000|Overall Study|Death|70|||
127881057|NCT03014570|460186112|FG001|Overall Study|Death|79|||
127881058|NCT03014570|460186111|FG000|Overall Study|Transfer from facility|11|||
127881059|NCT03014570|460186112|FG001|Overall Study|Transfer from facility|14|||
127881060|NCT03014570|460186111|FG000|Overall Study|Hospitalized|5|||
127881061|NCT03014570|460186112|FG001|Overall Study|Hospitalized|3|||
127881062|NCT03014570|460186111|FG000|Overall Study|Transfer within facility|1|||
127881063|NCT03014570|460186112|FG001|Overall Study|Transfer within facility|0|||
127881064|NCT03014570|460186111|FG000|Overall Study|Site refusal|0|||
127881065|NCT03014570|460186112|FG001|Overall Study|Site refusal|11|||
127881066|NCT03332212|460186118|FG000|Overall Study|Not treated|0|||
127881067|NCT03332212|460186119|FG001|Overall Study|Not treated|1|||
127881068|NCT03332212|460186120|FG002|Overall Study|Not treated|0|||
127881069|NCT03332212|460186121|FG003|Overall Study|Not treated|0|||
127881070|NCT03332212|460186118|FG000|Overall Study|Adverse Event|0|||
127881071|NCT03332212|460186119|FG001|Overall Study|Adverse Event|0|||
127881072|NCT03332212|460186120|FG002|Overall Study|Adverse Event|0|||
127881073|NCT03332212|460186121|FG003|Overall Study|Adverse Event|1|||
127881074|NCT03332212|460186118|FG000|Overall Study|worsening of disease under study|1|||
127881075|NCT03332212|460186119|FG001|Overall Study|worsening of disease under study|1|||
127881076|NCT03332212|460186120|FG002|Overall Study|worsening of disease under study|0|||
127881077|NCT03332212|460186121|FG003|Overall Study|worsening of disease under study|0|||
127881078|NCT05473247|460186127|FG000|Overall Study|One participant ceased contact with the research study team after the initial, pre-testing appt.|1|||
127881079|NCT02392559|460186128|FG000|Overall Study|Withdrawal by Subject|0|||
127881080|NCT02392559|460186129|FG001|Overall Study|Withdrawal by Subject|1|||
127881081|NCT00402779|460186130|FG000|Overall Study|Screen Failure|77|||
127881082|NCT00402779|460186131|FG001|Overall Study|Screen Failure|76|||
127881083|NCT02149199|460186133|FG000|Overall Study|Study specific withdrawal criteria|4|||
127881084|NCT02149199|460186134|FG001|Overall Study|Study specific withdrawal criteria|21|||
127881085|NCT02149199|460186135|FG002|Overall Study|Study specific withdrawal criteria|6|||
127881086|NCT02149199|460186133|FG000|Overall Study|Other|20|||
127881087|NCT02149199|460186134|FG001|Overall Study|Other|25|||
127881088|NCT02149199|460186135|FG002|Overall Study|Other|20|||
127881089|NCT02149199|460186133|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
127881090|NCT02149199|460186134|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
127881091|NCT02149199|460186135|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
127881092|NCT02149199|460186133|FG000|Overall Study|Withdrawal by Subject|75|||
127881093|NCT02149199|460186134|FG001|Overall Study|Withdrawal by Subject|93|||
127881094|NCT02149199|460186135|FG002|Overall Study|Withdrawal by Subject|77|||
127881095|NCT02149199|460186133|FG000|Overall Study|Protocol Violation|16|||
127881096|NCT02149199|460186134|FG001|Overall Study|Protocol Violation|13|||
127881097|NCT02149199|460186135|FG002|Overall Study|Protocol Violation|15|||
127881098|NCT02149199|460186133|FG000|Overall Study|Lost to Follow-up|3|||
127881099|NCT02149199|460186134|FG001|Overall Study|Lost to Follow-up|12|||
127881100|NCT02149199|460186135|FG002|Overall Study|Lost to Follow-up|11|||
127881101|NCT02149199|460186133|FG000|Overall Study|Death|0|||
127881102|NCT02149199|460186134|FG001|Overall Study|Death|0|||
127881103|NCT02149199|460186135|FG002|Overall Study|Death|1|||
128029657|NCT02579759|460735067|FG002|Overall Study|Protocol Violation|0|||
128029658|NCT02579759|460735065|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
128029659|NCT02579759|460735066|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
128029660|NCT02579759|460735067|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
127575504|NCT02160782|459078028|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
127692861|NCT00073749|459501675|FG005|Overall Study|Lost to Follow-up|0|||
127575505|NCT02160782|459078029|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
127575506|NCT02160782|459078025|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
127575507|NCT02160782|459078026|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
127575508|NCT02160782|459078027|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
127575509|NCT02160782|459078028|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
127575510|NCT02160782|459078029|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
127692862|NCT00073749|459501676|FG006|Overall Study|Lost to Follow-up|2|||
127692863|NCT00073749|459501670|FG000|Overall Study|Other|0|||
127692864|NCT00073749|459501671|FG001|Overall Study|Other|0|||
127881104|NCT02149199|460186133|FG000|Overall Study|Adverse Event|6|||
127881105|NCT02149199|460186134|FG001|Overall Study|Adverse Event|15|||
127881106|NCT02149199|460186135|FG002|Overall Study|Adverse Event|9|||
127881107|NCT03252756|460186136|FG000|Overall Study|Protocol Violation|2|||
127881108|NCT03252756|460186137|FG001|Overall Study|Protocol Violation|4|||
128029661|NCT02579759|460735065|FG000|Overall Study|BfArM hold|13|||
127881109|NCT03252756|460186136|FG000|Overall Study|COVID-19 Pandemic|1|||
127881110|NCT03252756|460186137|FG001|Overall Study|COVID-19 Pandemic|1|||
127881111|NCT03252756|460186136|FG000|Overall Study|Study Drug Expiration|0|||
127881112|NCT03252756|460186137|FG001|Overall Study|Study Drug Expiration|1|||
127881113|NCT01500434|460186140|FG000|Overall Study|Death|1|||
127575511|NCT02160782|459078025|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
127575512|NCT02160782|459078026|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
127575513|NCT02160782|459078027|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
127575514|NCT02160782|459078028|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
127575515|NCT02160782|459078029|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
127575516|NCT01104701|459078032|FG000|Overall Study|Withdrawal by Subject|0|||
127575517|NCT01104701|459078033|FG001|Overall Study|Withdrawal by Subject|1|||
127575518|NCT01104701|459078034|FG002|Overall Study|Withdrawal by Subject|2|||
127575519|NCT01104701|459078035|FG003|Overall Study|Withdrawal by Subject|1|||
127575520|NCT01104701|459078032|FG000|Overall Study|Adverse Event|0|||
127575521|NCT01104701|459078033|FG001|Overall Study|Adverse Event|0|||
127575522|NCT01104701|459078034|FG002|Overall Study|Adverse Event|0|||
127575523|NCT01104701|459078035|FG003|Overall Study|Adverse Event|1|||
127575524|NCT01104701|459078032|FG000|Overall Study|Physician Decision|0|||
127575525|NCT01104701|459078033|FG001|Overall Study|Physician Decision|2|||
127575526|NCT01104701|459078034|FG002|Overall Study|Physician Decision|0|||
127575527|NCT01104701|459078035|FG003|Overall Study|Physician Decision|0|||
127575528|NCT03437512|459078036|FG000|Randomized|Withdrawal by Subject|0|||
127575529|NCT03437512|459078037|FG001|Randomized|Withdrawal by Subject|2|||
127575530|NCT03437512|459078036|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
127575531|NCT03437512|459078037|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
127575532|NCT00674973|459078038|FG000|Overall Study|Insufficient Therapeutic Response|77|||
127575533|NCT00674973|459078039|FG001|Overall Study|Insufficient Therapeutic Response|72|||
127575534|NCT00674973|459078038|FG000|Overall Study|Refused Treatment|1|||
127575535|NCT00674973|459078039|FG001|Overall Study|Refused Treatment|5|||
127575536|NCT00674973|459078038|FG000|Overall Study|Failure to Return|1|||
127575537|NCT00674973|459078039|FG001|Overall Study|Failure to Return|0|||
127575538|NCT00674973|459078038|FG000|Overall Study|Adverse Event|2|||
127575539|NCT00674973|459078039|FG001|Overall Study|Adverse Event|9|||
127575540|NCT00674973|459078038|FG000|Overall Study|Death|19|||
127575541|NCT00674973|459078039|FG001|Overall Study|Death|15|||
127575542|NCT00674973|459078038|FG000|Overall Study|Protocol Violation|0|||
127575543|NCT00674973|459078039|FG001|Overall Study|Protocol Violation|1|||
127575544|NCT01002482|459078042|FG000|Overall Study|Withdrawal by Subject|14|||
127575545|NCT01002482|459078043|FG001|Overall Study|Withdrawal by Subject|21|||
127575546|NCT01002482|459078042|FG000|Overall Study|Included twice|1|||
127575547|NCT01002482|459078043|FG001|Overall Study|Included twice|0|||
127575548|NCT05036369|459078047|FG000|Overall Study|Run In non compliance|1|||
127575549|NCT05036369|459078048|FG001|Overall Study|Run In non compliance|2|||
127575550|NCT05036369|459078047|FG000|Overall Study|Change in eligibility criteria|0|||
127575551|NCT05036369|459078048|FG001|Overall Study|Change in eligibility criteria|1|||
127575552|NCT00401531|459078051|FG000|Overall Study|Adverse Event|2|||
127575553|NCT00401531|459078052|FG001|Overall Study|Adverse Event|0|||
127575554|NCT00401531|459078051|FG000|Overall Study|Protocol Violation|3|||
127575555|NCT00401531|459078052|FG001|Overall Study|Protocol Violation|7|||
127575556|NCT00401531|459078051|FG000|Overall Study|Lost to Follow-up|1|||
127575557|NCT00401531|459078052|FG001|Overall Study|Lost to Follow-up|1|||
127575558|NCT00401531|459078051|FG000|Overall Study|Withdrawal by Subject|3|||
127575559|NCT00401531|459078052|FG001|Overall Study|Withdrawal by Subject|2|||
127575560|NCT01801072|459078053|FG000|Overall Study|Lost to Follow-up|17|||
127575561|NCT01801072|459078054|FG001|Overall Study|Lost to Follow-up|14|||
127575562|NCT01801072|459078053|FG000|Overall Study|Physician Decision|2|||
127575563|NCT01801072|459078054|FG001|Overall Study|Physician Decision|3|||
127575564|NCT01801072|459078053|FG000|Overall Study|Withdrawal by Subject|1|||
127575565|NCT01801072|459078054|FG001|Overall Study|Withdrawal by Subject|0|||
127575566|NCT01801072|459078053|FG000|Overall Study|Protocol Violation|2|||
127575567|NCT01801072|459078054|FG001|Overall Study|Protocol Violation|0|||
127575568|NCT01801072|459078053|FG000|Overall Study|Death|7|||
127575569|NCT01801072|459078054|FG001|Overall Study|Death|8|||
127575570|NCT02247531|459078055|FG000|Overall Study|Adverse Event|3|||
127575571|NCT02247531|459078056|FG001|Overall Study|Adverse Event|4|||
127575572|NCT02247531|459078057|FG002|Overall Study|Adverse Event|9|||
127575573|NCT02247531|459078055|FG000|Overall Study|Death|8|||
127575574|NCT02247531|459078056|FG001|Overall Study|Death|9|||
127575575|NCT02247531|459078057|FG002|Overall Study|Death|5|||
128029662|NCT02579759|460735066|FG001|Overall Study|BfArM hold|12|||
127575576|NCT02247531|459078055|FG000|Overall Study|Lost to Follow-up|1|||
127575577|NCT02247531|459078056|FG001|Overall Study|Lost to Follow-up|8|||
127575578|NCT02247531|459078057|FG002|Overall Study|Lost to Follow-up|3|||
127575579|NCT02247531|459078055|FG000|Overall Study|Non-compliance|2|||
127575580|NCT02247531|459078056|FG001|Overall Study|Non-compliance|2|||
127575581|NCT02247531|459078057|FG002|Overall Study|Non-compliance|0|||
127575582|NCT02247531|459078055|FG000|Overall Study|Withdrawal by Subject|26|||
127692865|NCT00073749|459501672|FG002|Overall Study|Other|0|||
127575583|NCT02247531|459078056|FG001|Overall Study|Withdrawal by Subject|31|||
127575584|NCT02247531|459078057|FG002|Overall Study|Withdrawal by Subject|25|||
127575585|NCT02247531|459078055|FG000|Overall Study|Study Terminated by Sponsor|64|||
128029663|NCT02579759|460735067|FG002|Overall Study|BfArM hold|12|||
127575586|NCT02247531|459078056|FG001|Overall Study|Study Terminated by Sponsor|66|||
127575587|NCT02247531|459078057|FG002|Overall Study|Study Terminated by Sponsor|62|||
127575588|NCT02247531|459078055|FG000|Overall Study|Physician Decision|0|||
127575589|NCT02247531|459078056|FG001|Overall Study|Physician Decision|2|||
127575590|NCT02247531|459078057|FG002|Overall Study|Physician Decision|2|||
127575591|NCT02247531|459078055|FG000|Overall Study|Unspecified Reason|2|||
127575592|NCT02247531|459078056|FG001|Overall Study|Unspecified Reason|3|||
127575593|NCT02247531|459078057|FG002|Overall Study|Unspecified Reason|4|||
127575594|NCT03906461|459078058|FG000|Completed 12-month Follow-up|Withdrawal by Subject|4|||
127575595|NCT03906461|459078058|FG000|Completed 12-month Follow-up|Missed Visit|6|||
127575596|NCT00510874|459078059|FG000|Overall Study|Withdrawal by Subject|1|||
127575597|NCT00510874|459078060|FG001|Overall Study|Withdrawal by Subject|1|||
127782218|NCT00041080|459829718|FG001|Overall Study|Ineligible|0|||
127782219|NCT05418673|459829719|FG000|Overall Study|Study Terminated by Sponsor|2|||
127782220|NCT05418673|459829720|FG001|Overall Study|Study Terminated by Sponsor|4|||
127782221|NCT05418673|459829719|FG000|Overall Study|Lost to Follow-up|1|||
127782222|NCT05418673|459829720|FG001|Overall Study|Lost to Follow-up|0|||
127782223|NCT03199040|459829722|FG000|Overall Study|Lack of Efficacy|2|||
127782224|NCT03199040|459829723|FG001|Overall Study|Lack of Efficacy|0|||
127782225|NCT03199040|459829722|FG000|Overall Study|Withdrawal by Subject|2|||
127782226|NCT03199040|459829723|FG001|Overall Study|Withdrawal by Subject|0|||
127782227|NCT03199040|459829722|FG000|Overall Study|Adverse Event|0|||
127782228|NCT03199040|459829723|FG001|Overall Study|Adverse Event|1|||
127782229|NCT03199040|459829722|FG000|Overall Study|Only completed 5 out of 6 vaccines|0|||
127782230|NCT03199040|459829723|FG001|Overall Study|Only completed 5 out of 6 vaccines|1|||
127782231|NCT00199836|459829724|FG000|Overall Study|Progressive Disease|5|||
127782232|NCT00199836|459829724|FG000|Overall Study|Death|1|||
127782233|NCT01854645|459829730|FG000|Overall Study|Protocol-Specified Criteria|13|||
127782234|NCT01854645|459829731|FG001|Overall Study|Protocol-Specified Criteria|10|||
127782235|NCT01854645|459829732|FG002|Overall Study|Protocol-Specified Criteria|8|||
127782236|NCT01854645|459829733|FG003|Overall Study|Protocol-Specified Criteria|5|||
127782237|NCT01854645|459829734|FG004|Overall Study|Protocol-Specified Criteria|7|||
127782238|NCT01854645|459829730|FG000|Overall Study|Administrative Reasons / Missing|0|||
127782239|NCT01854645|459829731|FG001|Overall Study|Administrative Reasons / Missing|0|||
127782240|NCT01854645|459829732|FG002|Overall Study|Administrative Reasons / Missing|0|||
127782241|NCT01854645|459829733|FG003|Overall Study|Administrative Reasons / Missing|1|||
127782242|NCT01854645|459829734|FG004|Overall Study|Administrative Reasons / Missing|1|||
127782243|NCT01854645|459829730|FG000|Overall Study|Protocol Violation|3|||
127782244|NCT01854645|459829731|FG001|Overall Study|Protocol Violation|0|||
127782245|NCT01854645|459829732|FG002|Overall Study|Protocol Violation|5|||
127782246|NCT01854645|459829733|FG003|Overall Study|Protocol Violation|4|||
127782247|NCT01854645|459829734|FG004|Overall Study|Protocol Violation|1|||
127782248|NCT01854645|459829730|FG000|Overall Study|Lost to Follow-up|10|||
127782249|NCT01854645|459829731|FG001|Overall Study|Lost to Follow-up|7|||
127782250|NCT01854645|459829732|FG002|Overall Study|Lost to Follow-up|8|||
127782251|NCT01854645|459829733|FG003|Overall Study|Lost to Follow-up|5|||
127782252|NCT01854645|459829734|FG004|Overall Study|Lost to Follow-up|0|||
127782253|NCT01854645|459829730|FG000|Overall Study|Physician Decision|1|||
127782254|NCT01854645|459829731|FG001|Overall Study|Physician Decision|5|||
127782255|NCT01854645|459829732|FG002|Overall Study|Physician Decision|3|||
127782256|NCT01854645|459829733|FG003|Overall Study|Physician Decision|3|||
127782257|NCT01854645|459829734|FG004|Overall Study|Physician Decision|7|||
127782258|NCT01854645|459829730|FG000|Overall Study|Withdrawal by Subject|31|||
127782259|NCT01854645|459829731|FG001|Overall Study|Withdrawal by Subject|41|||
127782260|NCT01854645|459829732|FG002|Overall Study|Withdrawal by Subject|30|||
127782261|NCT01854645|459829733|FG003|Overall Study|Withdrawal by Subject|21|||
127782262|NCT01854645|459829734|FG004|Overall Study|Withdrawal by Subject|24|||
127782263|NCT01854645|459829730|FG000|Overall Study|Lack of Efficacy|7|||
127782264|NCT01854645|459829731|FG001|Overall Study|Lack of Efficacy|12|||
127782265|NCT01854645|459829732|FG002|Overall Study|Lack of Efficacy|9|||
127782266|NCT01854645|459829733|FG003|Overall Study|Lack of Efficacy|3|||
127782267|NCT01854645|459829734|FG004|Overall Study|Lack of Efficacy|9|||
127782268|NCT01854645|459829730|FG000|Overall Study|Adverse Event|33|||
127782269|NCT01854645|459829731|FG001|Overall Study|Adverse Event|31|||
127782270|NCT01854645|459829732|FG002|Overall Study|Adverse Event|19|||
127782271|NCT01854645|459829733|FG003|Overall Study|Adverse Event|20|||
127782272|NCT01854645|459829734|FG004|Overall Study|Adverse Event|11|||
127782273|NCT00430482|459829735|FG000|Completed Treatment|Insufficient Treatment|7|||
127782274|NCT00430482|459829736|FG001|Completed Treatment|Insufficient Treatment|11|||
127782275|NCT00555477|459829737|FG000|Overall Study|Adverse Event|0|||
127782276|NCT00555477|459829738|FG001|Overall Study|Adverse Event|9|||
127782277|NCT00555477|459829737|FG000|Overall Study|Withdrawal by Subject|1|||
127575598|NCT00510874|459078061|FG002|Overall Study|Withdrawal by Subject|0|||
127575599|NCT00510874|459078062|FG003|Overall Study|Withdrawal by Subject|0|||
127575600|NCT00510874|459078063|FG004|Overall Study|Withdrawal by Subject|3|||
127782278|NCT00555477|459829738|FG001|Overall Study|Withdrawal by Subject|2|||
127782279|NCT00555477|459829737|FG000|Overall Study|Physician Decision|1|||
127782280|NCT00555477|459829738|FG001|Overall Study|Physician Decision|2|||
127575601|NCT00510874|459078064|FG005|Overall Study|Withdrawal by Subject|0|||
127575602|NCT00510874|459078065|FG006|Overall Study|Withdrawal by Subject|0|||
127575603|NCT00510874|459078059|FG000|Overall Study|Lost to Follow-up|2|||
127575604|NCT00510874|459078060|FG001|Overall Study|Lost to Follow-up|3|||
127575605|NCT00510874|459078061|FG002|Overall Study|Lost to Follow-up|1|||
127575606|NCT00510874|459078062|FG003|Overall Study|Lost to Follow-up|3|||
127575607|NCT00510874|459078063|FG004|Overall Study|Lost to Follow-up|4|||
127575608|NCT00510874|459078064|FG005|Overall Study|Lost to Follow-up|0|||
127575609|NCT00510874|459078065|FG006|Overall Study|Lost to Follow-up|1|||
127575610|NCT03875118|459078066|FG000|Overall Study|Withdrawal by Subject|4|||
127575611|NCT03875118|459078067|FG001|Overall Study|Withdrawal by Subject|4|||
127575612|NCT02423109|459078070|FG000|Lens 1|Adverse Event|1|||
127575613|NCT02423109|459078071|FG001|Lens 1|Adverse Event|0|||
127575614|NCT03956056|459078072|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
127575615|NCT03956056|459078072|FG000|Overall Study|Lack of Efficacy|1|||
127575616|NCT03403374|459078073|FG000|Overall Study|Lost to Follow-up|1|||
127575617|NCT01298531|459078074|FG000|Overall Study|Lack of Efficacy|0|||
127575618|NCT01298531|459078075|FG001|Overall Study|Lack of Efficacy|1|||
127575619|NCT01298531|459078074|FG000|Overall Study|Lost to Follow-up|2|||
127575620|NCT01298531|459078075|FG001|Overall Study|Lost to Follow-up|0|||
127575621|NCT01298531|459078074|FG000|Overall Study|Protocol Violation|1|||
127575622|NCT01298531|459078075|FG001|Overall Study|Protocol Violation|1|||
127575623|NCT01298531|459078074|FG000|Overall Study|Adverse Event|4|||
127575624|NCT01298531|459078075|FG001|Overall Study|Adverse Event|3|||
127575625|NCT01298531|459078074|FG000|Overall Study|Does not meet entrance criteria|0|||
127575626|NCT01298531|459078075|FG001|Overall Study|Does not meet entrance criteria|1|||
127575627|NCT01298531|459078074|FG000|Overall Study|Other|2|||
127575628|NCT01298531|459078075|FG001|Overall Study|Other|1|||
127575629|NCT01134315|459078080|FG000|Overall Study|Adverse Event|1|||
127575630|NCT01134315|459078081|FG001|Overall Study|Adverse Event|2|||
127575631|NCT01134315|459078080|FG000|Overall Study|Other Reason|8|||
127575632|NCT01134315|459078081|FG001|Overall Study|Other Reason|17|||
127575633|NCT02694523|459078082|FG000|Part A|Adverse Event|7|||
127575634|NCT02694523|459078083|FG001|Part A|Adverse Event|3|||
127575635|NCT02694523|459078084|FG002|Part A|Adverse Event|0|||
127575636|NCT02694523|459078085|FG003|Part A|Adverse Event|0|||
127575637|NCT02694523|459078086|FG004|Part A|Adverse Event|0|||
127575638|NCT02694523|459078087|FG005|Part A|Adverse Event|0|||
127575639|NCT02694523|459078088|FG006|Part A|Adverse Event|0|||
127575640|NCT02694523|459078082|FG000|Part A|Protocol Violation|1|||
127575641|NCT02694523|459078083|FG001|Part A|Protocol Violation|0|||
127575642|NCT02694523|459078084|FG002|Part A|Protocol Violation|0|||
127575643|NCT02694523|459078085|FG003|Part A|Protocol Violation|0|||
127575644|NCT02694523|459078086|FG004|Part A|Protocol Violation|0|||
127575645|NCT02694523|459078087|FG005|Part A|Protocol Violation|0|||
127575646|NCT02694523|459078088|FG006|Part A|Protocol Violation|0|||
127575647|NCT02694523|459078082|FG000|Part A|Lost to Follow-up|1|||
127575648|NCT02694523|459078083|FG001|Part A|Lost to Follow-up|2|||
127575649|NCT02694523|459078084|FG002|Part A|Lost to Follow-up|0|||
127575650|NCT02694523|459078085|FG003|Part A|Lost to Follow-up|0|||
127575651|NCT02694523|459078086|FG004|Part A|Lost to Follow-up|0|||
127575652|NCT02694523|459078087|FG005|Part A|Lost to Follow-up|0|||
127575653|NCT02694523|459078088|FG006|Part A|Lost to Follow-up|0|||
127575654|NCT02694523|459078082|FG000|Part A|Withdrawal by Subject|3|||
127575655|NCT02694523|459078083|FG001|Part A|Withdrawal by Subject|1|||
127575656|NCT02694523|459078084|FG002|Part A|Withdrawal by Subject|0|||
127575657|NCT02694523|459078085|FG003|Part A|Withdrawal by Subject|0|||
127575658|NCT02694523|459078086|FG004|Part A|Withdrawal by Subject|0|||
127575659|NCT02694523|459078087|FG005|Part A|Withdrawal by Subject|0|||
127575660|NCT02694523|459078088|FG006|Part A|Withdrawal by Subject|0|||
127575661|NCT02694523|459078082|FG000|Part A|Other|1|||
127575662|NCT02694523|459078083|FG001|Part A|Other|1|||
127575663|NCT02694523|459078084|FG002|Part A|Other|0|||
127575664|NCT02694523|459078085|FG003|Part A|Other|0|||
127575665|NCT02694523|459078086|FG004|Part A|Other|0|||
127575666|NCT02694523|459078087|FG005|Part A|Other|0|||
127575667|NCT02694523|459078088|FG006|Part A|Other|0|||
127575668|NCT02694523|459078082|FG000|Part B|Adverse Event|0|||
127575669|NCT02694523|459078083|FG001|Part B|Adverse Event|0|||
127575670|NCT02694523|459078084|FG002|Part B|Adverse Event|7|||
127575671|NCT02694523|459078085|FG003|Part B|Adverse Event|1|||
127575672|NCT02694523|459078086|FG004|Part B|Adverse Event|1|||
127575673|NCT02694523|459078087|FG005|Part B|Adverse Event|2|||
127575674|NCT02694523|459078088|FG006|Part B|Adverse Event|0|||
127575675|NCT02694523|459078082|FG000|Part B|Protocol Violation|0|||
127575676|NCT02694523|459078083|FG001|Part B|Protocol Violation|0|||
127575677|NCT02694523|459078084|FG002|Part B|Protocol Violation|1|||
127575678|NCT02694523|459078085|FG003|Part B|Protocol Violation|0|||
127575679|NCT02694523|459078086|FG004|Part B|Protocol Violation|0|||
127575680|NCT02694523|459078087|FG005|Part B|Protocol Violation|0|||
127575681|NCT02694523|459078088|FG006|Part B|Protocol Violation|0|||
127575682|NCT02694523|459078082|FG000|Part B|Lost to Follow-up|0|||
127575683|NCT02694523|459078083|FG001|Part B|Lost to Follow-up|0|||
127575684|NCT02694523|459078084|FG002|Part B|Lost to Follow-up|2|||
127575685|NCT02694523|459078085|FG003|Part B|Lost to Follow-up|3|||
127881114|NCT01500434|460186140|FG000|Overall Study|Withdrawal by Subject|1|||
127881115|NCT01500434|460186140|FG000|Overall Study|Missed 12-month follow-up|5|||
127881116|NCT01966107|460186144|FG000|Overall Study|excluded from FAS|21|||
127881117|NCT01966107|460186145|FG001|Overall Study|excluded from FAS|20|||
127881118|NCT01966107|460186144|FG000|Overall Study|discontinued treatment|345|||
127881119|NCT01966107|460186145|FG001|Overall Study|discontinued treatment|372|||
127881120|NCT01966107|460186144|FG000|Overall Study|due to study closure|164|||
127881121|NCT01966107|460186145|FG001|Overall Study|due to study closure|186|||
127881122|NCT01966107|460186144|FG000|Overall Study|withdrew from the study|272|||
127881123|NCT01966107|460186145|FG001|Overall Study|withdrew from the study|303|||
127881124|NCT00532779|460186146|FG000|Overall Study|Adverse Event|122|||
127881125|NCT00532779|460186147|FG001|Overall Study|Adverse Event|112|||
127881126|NCT00532779|460186148|FG002|Overall Study|Adverse Event|56|||
127881127|NCT00532779|460186146|FG000|Overall Study|Lost to Follow-up|76|||
127881128|NCT00532779|460186147|FG001|Overall Study|Lost to Follow-up|65|||
127881129|NCT00532779|460186148|FG002|Overall Study|Lost to Follow-up|66|||
127881130|NCT00532779|460186146|FG000|Overall Study|Withdrawal by Subject|63|||
127881131|NCT00532779|460186147|FG001|Overall Study|Withdrawal by Subject|60|||
127881132|NCT00532779|460186148|FG002|Overall Study|Withdrawal by Subject|90|||
127881133|NCT00532779|460186146|FG000|Overall Study|Lack of Efficacy|12|||
127881134|NCT00532779|460186147|FG001|Overall Study|Lack of Efficacy|12|||
127881135|NCT00532779|460186148|FG002|Overall Study|Lack of Efficacy|40|||
127881136|NCT00532779|460186146|FG000|Overall Study|Protocol Violation|5|||
127881137|NCT00532779|460186147|FG001|Overall Study|Protocol Violation|9|||
127881138|NCT00532779|460186148|FG002|Overall Study|Protocol Violation|7|||
127881139|NCT00532779|460186146|FG000|Overall Study|Pregnancy|2|||
127881140|NCT00532779|460186147|FG001|Overall Study|Pregnancy|5|||
127881141|NCT00532779|460186148|FG002|Overall Study|Pregnancy|3|||
127881142|NCT00532779|460186146|FG000|Overall Study|Death|0|||
127881143|NCT00532779|460186147|FG001|Overall Study|Death|1|||
127881144|NCT00532779|460186148|FG002|Overall Study|Death|0|||
127881145|NCT00532779|460186146|FG000|Overall Study|Drug noncompliance, moved, other|14|||
127881146|NCT00532779|460186147|FG001|Overall Study|Drug noncompliance, moved, other|23|||
127881147|NCT00532779|460186148|FG002|Overall Study|Drug noncompliance, moved, other|29|||
127881148|NCT02662556|460186149|FG000|Overall Study|Adverse Event|4|||
127881149|NCT02662556|460186149|FG000|Overall Study|Lack of Efficacy|4|||
128029664|NCT02579759|460735065|FG000|Overall Study|Sponsor stopped Dose 2|0|||
127575686|NCT02694523|459078086|FG004|Part B|Lost to Follow-up|2|||
127575687|NCT02694523|459078087|FG005|Part B|Lost to Follow-up|0|||
127575688|NCT02694523|459078088|FG006|Part B|Lost to Follow-up|1|||
127575689|NCT02694523|459078082|FG000|Part B|Withdrawal by Subject|0|||
127575690|NCT02694523|459078083|FG001|Part B|Withdrawal by Subject|0|||
127575691|NCT02694523|459078084|FG002|Part B|Withdrawal by Subject|9|||
127575692|NCT02694523|459078085|FG003|Part B|Withdrawal by Subject|0|||
127575693|NCT02694523|459078086|FG004|Part B|Withdrawal by Subject|1|||
127575694|NCT02694523|459078087|FG005|Part B|Withdrawal by Subject|3|||
127575695|NCT02694523|459078088|FG006|Part B|Withdrawal by Subject|0|||
127575696|NCT02694523|459078082|FG000|Part B|Other|0|||
127575697|NCT02694523|459078083|FG001|Part B|Other|0|||
127575698|NCT02694523|459078084|FG002|Part B|Other|1|||
127575699|NCT02694523|459078085|FG003|Part B|Other|0|||
127575700|NCT02694523|459078086|FG004|Part B|Other|0|||
127575701|NCT02694523|459078087|FG005|Part B|Other|0|||
127575702|NCT02694523|459078088|FG006|Part B|Other|1|||
127575703|NCT05896748|459078090|FG000|Screening Phase (Week -4 up to Day 1)|Passed away due to unknown reasons|1|||
127575704|NCT05896748|459078090|FG000|SC Injection Phase (Day 1 up to Week 12)|Adverse Event|2|||
127575705|NCT05896748|459078090|FG000|SC Injection Phase (Day 1 up to Week 12)|Protocol Violation|1|||
127575706|NCT05896748|459078090|FG000|SC Injection Phase (Day 1 up to Week 12)|Withdrawal by Subject|3|||
127575707|NCT05896748|459078090|FG000|Return to IM Glu Inj Phase(Week12-Week20|Protocol Violation|1|||
127575708|NCT00764504|459078091|FG000|Overall Study|Death|12|||
127575709|NCT00764504|459078092|FG001|Overall Study|Death|6|||
127575710|NCT00764504|459078093|FG002|Overall Study|Death|13|||
127575711|NCT00764504|459078091|FG000|Overall Study|Revision of Device|12|||
127575712|NCT00764504|459078092|FG001|Overall Study|Revision of Device|23|||
127575713|NCT00764504|459078093|FG002|Overall Study|Revision of Device|14|||
127575714|NCT00764504|459078091|FG000|Overall Study|Physician Decision|1|||
127881150|NCT00689273|460186150|FG000|Overall Study|Adverse Event|3|||
127881151|NCT00689273|460186151|FG001|Overall Study|Adverse Event|1|||
127881152|NCT00689273|460186150|FG000|Overall Study|Lack of Efficacy|3|||
127881153|NCT00689273|460186151|FG001|Overall Study|Lack of Efficacy|0|||
127881154|NCT00689273|460186150|FG000|Overall Study|Lost to Follow-up|0|||
127575715|NCT00764504|459078092|FG001|Overall Study|Physician Decision|0|||
127575716|NCT00764504|459078093|FG002|Overall Study|Physician Decision|0|||
127881155|NCT00689273|460186151|FG001|Overall Study|Lost to Follow-up|2|||
127881156|NCT00689273|460186150|FG000|Overall Study|Other|6|||
127881157|NCT00689273|460186151|FG001|Overall Study|Other|2|||
127881158|NCT00689273|460186150|FG000|Overall Study|Randomized but not Treated|1|||
128029665|NCT02579759|460735066|FG001|Overall Study|Sponsor stopped Dose 2|41|||
127575717|NCT00764504|459078091|FG000|Overall Study|Withdrawal by Subject|1|||
127692866|NCT00073749|459501673|FG003|Overall Study|Other|0|||
128029666|NCT02579759|460735067|FG002|Overall Study|Sponsor stopped Dose 2|0|||
128029667|NCT02579759|460735065|FG000|Overall Study|Non compliance|0|||
128029668|NCT02579759|460735066|FG001|Overall Study|Non compliance|1|||
128029669|NCT02579759|460735067|FG002|Overall Study|Non compliance|0|||
128029670|NCT02579759|460735065|FG000|Overall Study|Pregnancy|0|||
127575718|NCT00764504|459078092|FG001|Overall Study|Withdrawal by Subject|7|||
127575719|NCT00764504|459078093|FG002|Overall Study|Withdrawal by Subject|4|||
127575720|NCT00764504|459078091|FG000|Overall Study|Lost to Follow-up|40|||
127575721|NCT00764504|459078092|FG001|Overall Study|Lost to Follow-up|34|||
127575722|NCT00764504|459078093|FG002|Overall Study|Lost to Follow-up|72|||
127575723|NCT01465191|459078094|FG000|Overall Study|Protocol Violation|6|||
127575724|NCT01465191|459078095|FG001|Overall Study|Protocol Violation|3|||
127575725|NCT01465191|459078096|FG002|Overall Study|Protocol Violation|3|||
127575726|NCT01465191|459078094|FG000|Overall Study|Lost to Follow-up|3|||
127575727|NCT01465191|459078095|FG001|Overall Study|Lost to Follow-up|6|||
127575728|NCT01465191|459078096|FG002|Overall Study|Lost to Follow-up|4|||
127575729|NCT01298193|459078097|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
127575730|NCT01298193|459078097|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
127575731|NCT01298193|459078097|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
127575732|NCT01298193|459078097|FG000|Efficacy Phase (Second Cycle)|Death|1|||
127575733|NCT04010539|459078098|FG000|Overall Study|Withdrawal by Subject|4|||
127575734|NCT04010539|459078099|FG001|Overall Study|Withdrawal by Subject|1|||
127575735|NCT04010539|459078098|FG000|Overall Study|Physician Decision|0|||
127575736|NCT04010539|459078099|FG001|Overall Study|Physician Decision|2|||
127575737|NCT04010539|459078098|FG000|Overall Study|Lost to Follow-up|10|||
127575738|NCT04010539|459078099|FG001|Overall Study|Lost to Follow-up|14|||
127575739|NCT04010539|459078098|FG000|Overall Study|Adverse Event|3|||
127575740|NCT04010539|459078099|FG001|Overall Study|Adverse Event|0|||
127575741|NCT04010539|459078098|FG000|Overall Study|Participant Did Not Receive IP|0|||
127575742|NCT04010539|459078099|FG001|Overall Study|Participant Did Not Receive IP|1|||
127575743|NCT04010539|459078098|FG000|Overall Study|Protocol Deviation|0|||
127575744|NCT04010539|459078099|FG001|Overall Study|Protocol Deviation|1|||
127575745|NCT04010539|459078098|FG000|Overall Study|Randomized in Error/ Mistake|2|||
127575746|NCT04010539|459078099|FG001|Overall Study|Randomized in Error/ Mistake|0|||
127575747|NCT04010539|459078098|FG000|Overall Study|Eligibility Criteria Unable to Evaluate|1|||
127575748|NCT04010539|459078099|FG001|Overall Study|Eligibility Criteria Unable to Evaluate|0|||
127575749|NCT01070043|459078103|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
127575750|NCT01070043|459078104|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
127575751|NCT01070043|459078105|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
127575752|NCT01070043|459078103|FG000|Double-Blind Treatment|Adverse Event|0|||
127575753|NCT01070043|459078104|FG001|Double-Blind Treatment|Adverse Event|0|||
127575754|NCT01070043|459078105|FG002|Double-Blind Treatment|Adverse Event|2|||
127575755|NCT00473746|459078107|FG000|Period 1 (Phase 1)|Adverse Event|1|||
127575756|NCT00473746|459078108|FG001|Period 1 (Phase 1)|Adverse Event|0|||
127575757|NCT00473746|459078109|FG002|Period 1 (Phase 1)|Adverse Event|0|||
127575758|NCT00473746|459078110|FG003|Period 1 (Phase 1)|Adverse Event|0|||
127575759|NCT00473746|459078111|FG004|Period 1 (Phase 1)|Adverse Event|0|||
127575760|NCT00473746|459078107|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
127575761|NCT00473746|459078108|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
127575762|NCT00473746|459078109|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
127575763|NCT00473746|459078110|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
127575764|NCT00473746|459078111|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
127575765|NCT00473746|459078107|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
127575766|NCT00473746|459078108|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
127575767|NCT00473746|459078109|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
127575768|NCT00473746|459078110|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
127575769|NCT00473746|459078111|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
127575770|NCT00473746|459078107|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
127575771|NCT00473746|459078108|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
127575772|NCT00473746|459078109|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
128029671|NCT02579759|460735066|FG001|Overall Study|Pregnancy|1|||
128029672|NCT02579759|460735067|FG002|Overall Study|Pregnancy|0|||
127575773|NCT00473746|459078110|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
127575774|NCT00473746|459078111|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
127575775|NCT00473746|459078107|FG000|Period 1 (Phase 1)|Reason not specified|0|||
127575776|NCT00473746|459078108|FG001|Period 1 (Phase 1)|Reason not specified|1|||
127575777|NCT00473746|459078109|FG002|Period 1 (Phase 1)|Reason not specified|0|||
127575778|NCT00473746|459078110|FG003|Period 1 (Phase 1)|Reason not specified|0|||
127575779|NCT00473746|459078111|FG004|Period 1 (Phase 1)|Reason not specified|0|||
127575780|NCT00473746|459078107|FG000|Period 2 (Phase 2)|Adverse Event|0|||
127692867|NCT00073749|459501674|FG004|Overall Study|Other|0|||
128029673|NCT02579759|460735065|FG000|Overall Study|Inclusion/exclusion criteria|0|||
128029674|NCT02579759|460735066|FG001|Overall Study|Inclusion/exclusion criteria|0|||
127575781|NCT00473746|459078108|FG001|Period 2 (Phase 2)|Adverse Event|0|||
127575782|NCT00473746|459078109|FG002|Period 2 (Phase 2)|Adverse Event|0|||
127575783|NCT00473746|459078110|FG003|Period 2 (Phase 2)|Adverse Event|0|||
127575784|NCT00473746|459078111|FG004|Period 2 (Phase 2)|Adverse Event|3|||
127575785|NCT00473746|459078107|FG000|Period 2 (Phase 2)|Death|0|||
127575786|NCT00473746|459078108|FG001|Period 2 (Phase 2)|Death|0|||
127575787|NCT00473746|459078109|FG002|Period 2 (Phase 2)|Death|0|||
127575788|NCT00473746|459078110|FG003|Period 2 (Phase 2)|Death|0|||
127575789|NCT00473746|459078111|FG004|Period 2 (Phase 2)|Death|1|||
127575790|NCT00473746|459078107|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
127782281|NCT00545402|459829739|FG000|Overall Study|Discontinuation of treatment|17|||
127782282|NCT00545402|459829740|FG001|Overall Study|Discontinuation of treatment|9|||
127782283|NCT00545402|459829739|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
127782284|NCT00545402|459829740|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
127782285|NCT00545402|459829739|FG000|Overall Study|Death|5|||
127782286|NCT00545402|459829740|FG001|Overall Study|Death|7|||
127782287|NCT00545402|459829739|FG000|Overall Study|Graft loss|2|||
127782288|NCT00545402|459829740|FG001|Overall Study|Graft loss|4|||
127782289|NCT00545402|459829739|FG000|Overall Study|Withdrawal by Subject|0|||
127575791|NCT00473746|459078108|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
127575792|NCT00473746|459078109|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
127692868|NCT00073749|459501675|FG005|Overall Study|Other|2|||
127692869|NCT00073749|459501676|FG006|Overall Study|Other|0|||
127692870|NCT03580369|459501677|FG000|Overall Study|No treatment due to mis-randomization|1|||
127692871|NCT03580369|459501678|FG001|Overall Study|No treatment due to mis-randomization|0|||
127692872|NCT03580369|459501679|FG002|Overall Study|No treatment due to mis-randomization|0|||
127692873|NCT03580369|459501680|FG003|Overall Study|No treatment due to mis-randomization|0|||
127692874|NCT03580369|459501681|FG004|Overall Study|No treatment due to mis-randomization|3|||
127692875|NCT03580369|459501682|FG005|Overall Study|No treatment due to mis-randomization|0|||
127692876|NCT03580369|459501683|FG006|Overall Study|No treatment due to mis-randomization|0|||
127692877|NCT03580369|459501684|FG007|Overall Study|No treatment due to mis-randomization|0|||
127692878|NCT03580369|459501677|FG000|Overall Study|Reason unknown|0|||
127692879|NCT03580369|459501678|FG001|Overall Study|Reason unknown|0|||
127692880|NCT03580369|459501679|FG002|Overall Study|Reason unknown|1|||
127692881|NCT03580369|459501680|FG003|Overall Study|Reason unknown|0|||
127692882|NCT03580369|459501681|FG004|Overall Study|Reason unknown|0|||
127692883|NCT03580369|459501682|FG005|Overall Study|Reason unknown|0|||
127692884|NCT03580369|459501683|FG006|Overall Study|Reason unknown|0|||
127692885|NCT03580369|459501684|FG007|Overall Study|Reason unknown|0|||
127692886|NCT03580369|459501677|FG000|Overall Study|Technical problems|0|||
127692887|NCT03580369|459501678|FG001|Overall Study|Technical problems|0|||
127692888|NCT03580369|459501679|FG002|Overall Study|Technical problems|0|||
127692889|NCT03580369|459501680|FG003|Overall Study|Technical problems|0|||
127692890|NCT03580369|459501681|FG004|Overall Study|Technical problems|1|||
127692891|NCT03580369|459501682|FG005|Overall Study|Technical problems|0|||
127692892|NCT03580369|459501683|FG006|Overall Study|Technical problems|2|||
127692893|NCT03580369|459501684|FG007|Overall Study|Technical problems|0|||
127692894|NCT03580369|459501677|FG000|Overall Study|Pregnancy|2|||
127692895|NCT03580369|459501678|FG001|Overall Study|Pregnancy|0|||
127692896|NCT03580369|459501679|FG002|Overall Study|Pregnancy|3|||
127692897|NCT03580369|459501680|FG003|Overall Study|Pregnancy|0|||
127692898|NCT03580369|459501681|FG004|Overall Study|Pregnancy|2|||
127692899|NCT03580369|459501682|FG005|Overall Study|Pregnancy|0|||
127692900|NCT03580369|459501683|FG006|Overall Study|Pregnancy|0|||
127692901|NCT03580369|459501684|FG007|Overall Study|Pregnancy|0|||
127692902|NCT03580369|459501677|FG000|Overall Study|Lost to Follow-up|2|||
127692903|NCT03580369|459501678|FG001|Overall Study|Lost to Follow-up|0|||
127692904|NCT03580369|459501679|FG002|Overall Study|Lost to Follow-up|2|||
127692905|NCT03580369|459501680|FG003|Overall Study|Lost to Follow-up|0|||
127692906|NCT03580369|459501681|FG004|Overall Study|Lost to Follow-up|3|||
127692907|NCT03580369|459501682|FG005|Overall Study|Lost to Follow-up|0|||
127692908|NCT03580369|459501683|FG006|Overall Study|Lost to Follow-up|1|||
127692909|NCT03580369|459501684|FG007|Overall Study|Lost to Follow-up|0|||
127692910|NCT03580369|459501677|FG000|Overall Study|Physician Decision|4|||
127692911|NCT03580369|459501678|FG001|Overall Study|Physician Decision|0|||
127692912|NCT03580369|459501679|FG002|Overall Study|Physician Decision|4|||
127692913|NCT03580369|459501680|FG003|Overall Study|Physician Decision|1|||
127692914|NCT03580369|459501681|FG004|Overall Study|Physician Decision|1|||
127692915|NCT03580369|459501682|FG005|Overall Study|Physician Decision|0|||
127692916|NCT03580369|459501683|FG006|Overall Study|Physician Decision|0|||
127692917|NCT03580369|459501684|FG007|Overall Study|Physician Decision|0|||
127692918|NCT03580369|459501677|FG000|Overall Study|Lack of Efficacy|3|||
127692919|NCT03580369|459501678|FG001|Overall Study|Lack of Efficacy|0|||
127782290|NCT00545402|459829740|FG001|Overall Study|Withdrawal by Subject|1|||
127575793|NCT00473746|459078110|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
127692920|NCT03580369|459501679|FG002|Overall Study|Lack of Efficacy|7|||
127692921|NCT03580369|459501680|FG003|Overall Study|Lack of Efficacy|0|||
127692922|NCT03580369|459501681|FG004|Overall Study|Lack of Efficacy|2|||
127692923|NCT03580369|459501682|FG005|Overall Study|Lack of Efficacy|0|||
127782291|NCT00545402|459829739|FG000|Overall Study|Protocol Violation|1|||
128029675|NCT02579759|460735067|FG002|Overall Study|Inclusion/exclusion criteria|1|||
127575794|NCT00473746|459078111|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
127575795|NCT00473746|459078107|FG000|Period 2 (Phase 2)|Reason not specified|0|||
127575796|NCT00473746|459078108|FG001|Period 2 (Phase 2)|Reason not specified|0|||
127575797|NCT00473746|459078109|FG002|Period 2 (Phase 2)|Reason not specified|0|||
127575798|NCT00473746|459078110|FG003|Period 2 (Phase 2)|Reason not specified|0|||
127575799|NCT00473746|459078111|FG004|Period 2 (Phase 2)|Reason not specified|3|||
127575800|NCT00667420|459078115|FG000|Overall Study|Adverse Event|2|||
127575801|NCT00667420|459078115|FG000|Overall Study|Lack of Efficacy|5|||
127575802|NCT00667420|459078115|FG000|Overall Study|Physician Decision|1|||
127575803|NCT00667420|459078115|FG000|Overall Study|Withdrawal by Subject|2|||
127575804|NCT01528215|459078116|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
127575805|NCT01528215|459078117|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
127575806|NCT01528215|459078116|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
127575807|NCT01528215|459078117|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
127575808|NCT01528215|459078116|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
127575809|NCT01528215|459078117|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
127575810|NCT01528215|459078116|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
127575811|NCT01528215|459078117|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
127575812|NCT01462227|459078118|FG000|Second Assignment|Lost to Follow-up|1|||
127575813|NCT01462227|459078119|FG001|Second Assignment|Lost to Follow-up|0|||
127575814|NCT01462227|459078120|FG002|Second Assignment|Lost to Follow-up|0|||
127575815|NCT01462227|459078121|FG003|Second Assignment|Lost to Follow-up|0|||
127575816|NCT01462227|459078118|FG000|Second Assignment|Protocol Violation|0|||
127575817|NCT01462227|459078119|FG001|Second Assignment|Protocol Violation|1|||
127575818|NCT01462227|459078120|FG002|Second Assignment|Protocol Violation|1|||
127575819|NCT01462227|459078121|FG003|Second Assignment|Protocol Violation|0|||
127575820|NCT00880165|459078129|FG000|Overall Study|Withdrawal by Subject|27|||
127575821|NCT00880165|459078130|FG001|Overall Study|Withdrawal by Subject|23|||
127575822|NCT00880165|459078129|FG000|Overall Study|Not diagnosed with OSA|14|||
127575823|NCT00880165|459078130|FG001|Overall Study|Not diagnosed with OSA|8|||
127575824|NCT00880165|459078129|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
127575825|NCT00880165|459078130|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
127575826|NCT00880165|459078129|FG000|Overall Study|Lost to follow|9|||
127575827|NCT00880165|459078130|FG001|Overall Study|Lost to follow|15|||
127575828|NCT00667602|459078131|FG000|Overall Study|Withdrawal by Subject|4|||
127575829|NCT00667602|459078132|FG001|Overall Study|Withdrawal by Subject|9|||
127575830|NCT00667602|459078133|FG002|Overall Study|Withdrawal by Subject|10|||
127575831|NCT00667602|459078131|FG000|Overall Study|Lost to Follow-up|4|||
127575832|NCT00667602|459078132|FG001|Overall Study|Lost to Follow-up|5|||
127575833|NCT00667602|459078133|FG002|Overall Study|Lost to Follow-up|6|||
127575834|NCT00667602|459078131|FG000|Overall Study|Administrative reason|0|||
127575835|NCT00667602|459078132|FG001|Overall Study|Administrative reason|0|||
127575836|NCT00667602|459078133|FG002|Overall Study|Administrative reason|2|||
127575837|NCT00667602|459078131|FG000|Overall Study|Protocol Violation|0|||
127575838|NCT00667602|459078132|FG001|Overall Study|Protocol Violation|1|||
127575839|NCT00667602|459078133|FG002|Overall Study|Protocol Violation|0|||
127575840|NCT00973349|459078138|FG000|Overall Study|Adverse Event|0|||
127575841|NCT00973349|459078139|FG001|Overall Study|Adverse Event|0|||
127575842|NCT00973349|459078140|FG002|Overall Study|Adverse Event|0|||
127575843|NCT00973349|459078141|FG003|Overall Study|Adverse Event|0|||
127575844|NCT00973349|459078142|FG004|Overall Study|Adverse Event|1|||
127575845|NCT00973349|459078143|FG005|Overall Study|Adverse Event|0|||
127575846|NCT00973349|459078144|FG006|Overall Study|Adverse Event|0|||
127575847|NCT00973349|459078145|FG007|Overall Study|Adverse Event|0|||
127575848|NCT00973349|459078146|FG008|Overall Study|Adverse Event|1|||
127575849|NCT00973349|459078147|FG009|Overall Study|Adverse Event|0|||
127575850|NCT00973349|459078148|FG010|Overall Study|Adverse Event|0|||
127692924|NCT03580369|459501683|FG006|Overall Study|Lack of Efficacy|3|||
127692925|NCT03580369|459501684|FG007|Overall Study|Lack of Efficacy|0|||
127692926|NCT03580369|459501677|FG000|Overall Study|Protocol Violation|6|||
127692927|NCT03580369|459501678|FG001|Overall Study|Protocol Violation|0|||
127692928|NCT03580369|459501679|FG002|Overall Study|Protocol Violation|6|||
127692929|NCT03580369|459501680|FG003|Overall Study|Protocol Violation|1|||
127575851|NCT00973349|459078149|FG011|Overall Study|Adverse Event|0|||
127575852|NCT00973349|459078150|FG012|Overall Study|Adverse Event|0|||
127692930|NCT03580369|459501681|FG004|Overall Study|Protocol Violation|8|||
127692931|NCT03580369|459501682|FG005|Overall Study|Protocol Violation|2|||
127575853|NCT00973349|459078151|FG013|Overall Study|Adverse Event|0|||
127575854|NCT00973349|459078152|FG014|Overall Study|Adverse Event|1|||
127575855|NCT00973349|459078153|FG015|Overall Study|Adverse Event|0|||
127575856|NCT00973349|459078138|FG000|Overall Study|Withdrawal by Subject|1|||
127575857|NCT00973349|459078139|FG001|Overall Study|Withdrawal by Subject|2|||
127575858|NCT00973349|459078140|FG002|Overall Study|Withdrawal by Subject|2|||
127575859|NCT00973349|459078141|FG003|Overall Study|Withdrawal by Subject|3|||
127692932|NCT03580369|459501683|FG006|Overall Study|Protocol Violation|1|||
127575860|NCT00973349|459078142|FG004|Overall Study|Withdrawal by Subject|2|||
128029676|NCT02579759|460735065|FG000|Overall Study|Adverse Event|4|||
128029677|NCT02579759|460735066|FG001|Overall Study|Adverse Event|3|||
128029678|NCT02579759|460735067|FG002|Overall Study|Adverse Event|1|||
127575861|NCT00973349|459078143|FG005|Overall Study|Withdrawal by Subject|0|||
127575862|NCT00973349|459078144|FG006|Overall Study|Withdrawal by Subject|2|||
127575863|NCT00973349|459078145|FG007|Overall Study|Withdrawal by Subject|2|||
127575864|NCT00973349|459078146|FG008|Overall Study|Withdrawal by Subject|0|||
127575865|NCT00973349|459078147|FG009|Overall Study|Withdrawal by Subject|2|||
127575866|NCT00973349|459078148|FG010|Overall Study|Withdrawal by Subject|0|||
127575867|NCT00973349|459078149|FG011|Overall Study|Withdrawal by Subject|1|||
127575868|NCT00973349|459078150|FG012|Overall Study|Withdrawal by Subject|0|||
127575869|NCT00973349|459078151|FG013|Overall Study|Withdrawal by Subject|0|||
127575870|NCT00973349|459078152|FG014|Overall Study|Withdrawal by Subject|0|||
127575871|NCT00973349|459078153|FG015|Overall Study|Withdrawal by Subject|0|||
127575872|NCT00973349|459078138|FG000|Overall Study|Lost to Follow-up|3|||
127575873|NCT00973349|459078139|FG001|Overall Study|Lost to Follow-up|1|||
127575874|NCT00973349|459078140|FG002|Overall Study|Lost to Follow-up|2|||
127575875|NCT00973349|459078141|FG003|Overall Study|Lost to Follow-up|2|||
127575876|NCT00973349|459078142|FG004|Overall Study|Lost to Follow-up|1|||
127575877|NCT00973349|459078143|FG005|Overall Study|Lost to Follow-up|3|||
127575878|NCT00973349|459078144|FG006|Overall Study|Lost to Follow-up|0|||
127575879|NCT00973349|459078145|FG007|Overall Study|Lost to Follow-up|1|||
127575880|NCT00973349|459078146|FG008|Overall Study|Lost to Follow-up|2|||
127575881|NCT00973349|459078147|FG009|Overall Study|Lost to Follow-up|1|||
127575882|NCT00973349|459078148|FG010|Overall Study|Lost to Follow-up|0|||
127575883|NCT00973349|459078149|FG011|Overall Study|Lost to Follow-up|1|||
127575884|NCT00973349|459078150|FG012|Overall Study|Lost to Follow-up|0|||
127575885|NCT00973349|459078151|FG013|Overall Study|Lost to Follow-up|0|||
127575886|NCT00973349|459078152|FG014|Overall Study|Lost to Follow-up|0|||
127575887|NCT00973349|459078153|FG015|Overall Study|Lost to Follow-up|1|||
127575888|NCT00973349|459078138|FG000|Overall Study|Inappropriate enrolment|0|||
127575889|NCT00973349|459078139|FG001|Overall Study|Inappropriate enrolment|0|||
127575890|NCT00973349|459078140|FG002|Overall Study|Inappropriate enrolment|1|||
127575891|NCT00973349|459078141|FG003|Overall Study|Inappropriate enrolment|0|||
127575892|NCT00973349|459078142|FG004|Overall Study|Inappropriate enrolment|0|||
127575893|NCT00973349|459078143|FG005|Overall Study|Inappropriate enrolment|0|||
127575894|NCT00973349|459078144|FG006|Overall Study|Inappropriate enrolment|0|||
127575895|NCT00973349|459078145|FG007|Overall Study|Inappropriate enrolment|0|||
127575896|NCT00973349|459078146|FG008|Overall Study|Inappropriate enrolment|0|||
127575897|NCT00973349|459078147|FG009|Overall Study|Inappropriate enrolment|2|||
127575898|NCT00973349|459078148|FG010|Overall Study|Inappropriate enrolment|0|||
127575899|NCT00973349|459078149|FG011|Overall Study|Inappropriate enrolment|0|||
127575900|NCT00973349|459078150|FG012|Overall Study|Inappropriate enrolment|1|||
127575901|NCT00973349|459078151|FG013|Overall Study|Inappropriate enrolment|0|||
127575902|NCT00973349|459078152|FG014|Overall Study|Inappropriate enrolment|1|||
127575903|NCT00973349|459078153|FG015|Overall Study|Inappropriate enrolment|1|||
127575904|NCT00973349|459078138|FG000|Overall Study|Protocol Violation|0|||
127575905|NCT00973349|459078139|FG001|Overall Study|Protocol Violation|0|||
127575906|NCT00973349|459078140|FG002|Overall Study|Protocol Violation|0|||
127575907|NCT00973349|459078141|FG003|Overall Study|Protocol Violation|0|||
127575908|NCT00973349|459078142|FG004|Overall Study|Protocol Violation|0|||
127575909|NCT00973349|459078143|FG005|Overall Study|Protocol Violation|0|||
127575910|NCT00973349|459078144|FG006|Overall Study|Protocol Violation|0|||
127575911|NCT00973349|459078145|FG007|Overall Study|Protocol Violation|0|||
127575912|NCT00973349|459078146|FG008|Overall Study|Protocol Violation|1|||
127575913|NCT00973349|459078147|FG009|Overall Study|Protocol Violation|0|||
127575914|NCT00973349|459078148|FG010|Overall Study|Protocol Violation|0|||
127575915|NCT00973349|459078149|FG011|Overall Study|Protocol Violation|0|||
127575916|NCT00973349|459078150|FG012|Overall Study|Protocol Violation|0|||
127575917|NCT00973349|459078151|FG013|Overall Study|Protocol Violation|0|||
128029679|NCT02579759|460735065|FG000|Overall Study|Withdrawal by Subject|3|||
128029680|NCT02579759|460735066|FG001|Overall Study|Withdrawal by Subject|3|||
128029681|NCT02579759|460735067|FG002|Overall Study|Withdrawal by Subject|5|||
127575918|NCT00973349|459078152|FG014|Overall Study|Protocol Violation|0|||
127575919|NCT00973349|459078153|FG015|Overall Study|Protocol Violation|0|||
127575920|NCT00973349|459078138|FG000|Overall Study|Unable to classify|0|||
127782292|NCT00545402|459829740|FG001|Overall Study|Protocol Violation|0|||
127575921|NCT00973349|459078139|FG001|Overall Study|Unable to classify|0|||
127575922|NCT00973349|459078140|FG002|Overall Study|Unable to classify|0|||
127575923|NCT00973349|459078141|FG003|Overall Study|Unable to classify|0|||
127575924|NCT00973349|459078142|FG004|Overall Study|Unable to classify|1|||
127575925|NCT00973349|459078143|FG005|Overall Study|Unable to classify|1|||
127575926|NCT00973349|459078144|FG006|Overall Study|Unable to classify|0|||
127575927|NCT00973349|459078145|FG007|Overall Study|Unable to classify|0|||
127575928|NCT00973349|459078146|FG008|Overall Study|Unable to classify|0|||
127575929|NCT00973349|459078147|FG009|Overall Study|Unable to classify|1|||
128029682|NCT02579759|460735065|FG000|Overall Study|Lost to Follow-up|2|||
128029683|NCT02579759|460735066|FG001|Overall Study|Lost to Follow-up|2|||
127575930|NCT00973349|459078148|FG010|Overall Study|Unable to classify|0|||
127575931|NCT00973349|459078149|FG011|Overall Study|Unable to classify|0|||
127575932|NCT00973349|459078150|FG012|Overall Study|Unable to classify|0|||
127575933|NCT00973349|459078151|FG013|Overall Study|Unable to classify|0|||
127575934|NCT00973349|459078152|FG014|Overall Study|Unable to classify|0|||
127575935|NCT00973349|459078153|FG015|Overall Study|Unable to classify|0|||
127575936|NCT02301988|459078154|FG000|Overall Study|Withdrawal by Subject|2|||
127575937|NCT02301988|459078155|FG001|Overall Study|Withdrawal by Subject|1|||
127575938|NCT02301988|459078154|FG000|Overall Study|Physician Decision|2|||
127575939|NCT02301988|459078155|FG001|Overall Study|Physician Decision|2|||
127575940|NCT02301988|459078154|FG000|Overall Study|Unknown Reason|1|||
127575941|NCT02301988|459078155|FG001|Overall Study|Unknown Reason|3|||
127575942|NCT02301988|459078154|FG000|Overall Study|Lack of Efficacy|3|||
127575943|NCT02301988|459078155|FG001|Overall Study|Lack of Efficacy|2|||
127575944|NCT02301988|459078154|FG000|Overall Study|Death|1|||
127575945|NCT02301988|459078155|FG001|Overall Study|Death|0|||
127575946|NCT02301988|459078154|FG000|Overall Study|Adverse Event|1|||
127575947|NCT02301988|459078155|FG001|Overall Study|Adverse Event|1|||
127575948|NCT02750943|459078156|FG000|Overall Study|Lost to Follow-up|1|||
127575949|NCT02750943|459078157|FG001|Overall Study|Lost to Follow-up|2|||
127575950|NCT02750943|459078156|FG000|Overall Study|Withdrawal by Subject|5|||
127575951|NCT02750943|459078157|FG001|Overall Study|Withdrawal by Subject|7|||
127575952|NCT00171054|459078158|FG000|Overall Study|Protocol Violation|1|||
127575953|NCT00171054|459078159|FG001|Overall Study|Protocol Violation|2|||
127575954|NCT00171054|459078158|FG000|Overall Study|Patient withdrew consent|1|||
127575955|NCT00171054|459078159|FG001|Overall Study|Patient withdrew consent|0|||
127575956|NCT00171054|459078158|FG000|Overall Study|Lost to Follow-up|0|||
127575957|NCT00171054|459078159|FG001|Overall Study|Lost to Follow-up|1|||
127575958|NCT00171054|459078158|FG000|Overall Study|Adverse Event|8|||
127575959|NCT00171054|459078159|FG001|Overall Study|Adverse Event|8|||
127575960|NCT00171054|459078158|FG000|Overall Study|Condition no longer required study drug|0|||
127575961|NCT00171054|459078159|FG001|Overall Study|Condition no longer required study drug|1|||
127575962|NCT04669535|459078163|FG000|Overall Study|Death|1|||
127575963|NCT04669535|459078164|FG001|Overall Study|Death|1|||
127575964|NCT04669535|459078165|FG002|Overall Study|Death|0|||
127575965|NCT04669535|459078166|FG003|Overall Study|Death|0|||
127575966|NCT02452697|459078167|FG000|Overall Study|Physician Decision|4|||
127575967|NCT02452697|459078168|FG001|Overall Study|Physician Decision|4|||
127575968|NCT02452697|459078169|FG002|Overall Study|Physician Decision|3|||
127575969|NCT02452697|459078170|FG003|Overall Study|Physician Decision|2|||
127575970|NCT02452697|459078167|FG000|Overall Study|Withdrawal by Subject|1|||
127575971|NCT02452697|459078168|FG001|Overall Study|Withdrawal by Subject|0|||
127575972|NCT02452697|459078169|FG002|Overall Study|Withdrawal by Subject|0|||
127575973|NCT02452697|459078170|FG003|Overall Study|Withdrawal by Subject|0|||
127575974|NCT02452697|459078167|FG000|Overall Study|still in follow-up|2|||
127575975|NCT02452697|459078168|FG001|Overall Study|still in follow-up|2|||
127575976|NCT02452697|459078169|FG002|Overall Study|still in follow-up|1|||
127575977|NCT02452697|459078170|FG003|Overall Study|still in follow-up|3|||
127575978|NCT03552965|459078172|FG000|Overall Study|Death|1|||
127692933|NCT03580369|459501684|FG007|Overall Study|Protocol Violation|0|||
127692934|NCT03580369|459501677|FG000|Overall Study|Adverse Event|7|||
127692935|NCT03580369|459501678|FG001|Overall Study|Adverse Event|0|||
127692936|NCT03580369|459501679|FG002|Overall Study|Adverse Event|14|||
127575979|NCT03552965|459078173|FG001|Overall Study|Death|1|||
127575980|NCT03552965|459078172|FG000|Overall Study|Lost to Follow-up|1|||
127575981|NCT03552965|459078173|FG001|Overall Study|Lost to Follow-up|1|||
127575982|NCT03552965|459078172|FG000|Overall Study|Physician Decision|1|||
127575983|NCT03552965|459078173|FG001|Overall Study|Physician Decision|1|||
127692937|NCT03580369|459501680|FG003|Overall Study|Adverse Event|1|||
127692938|NCT03580369|459501681|FG004|Overall Study|Adverse Event|6|||
127692939|NCT03580369|459501682|FG005|Overall Study|Adverse Event|0|||
127692940|NCT03580369|459501683|FG006|Overall Study|Adverse Event|1|||
127692941|NCT03580369|459501684|FG007|Overall Study|Adverse Event|0|||
127692942|NCT03580369|459501677|FG000|Overall Study|Withdrawal by Subject|19|||
127692943|NCT03580369|459501678|FG001|Overall Study|Withdrawal by Subject|0|||
127692944|NCT03580369|459501679|FG002|Overall Study|Withdrawal by Subject|17|||
127881159|NCT00689273|460186151|FG001|Overall Study|Randomized but not Treated|0|||
127575984|NCT03552965|459078172|FG000|Overall Study|Withdrawal by Subject|0|||
127575985|NCT03552965|459078173|FG001|Overall Study|Withdrawal by Subject|2|||
127692945|NCT03580369|459501680|FG003|Overall Study|Withdrawal by Subject|0|||
127692946|NCT03580369|459501681|FG004|Overall Study|Withdrawal by Subject|16|||
127692947|NCT03580369|459501682|FG005|Overall Study|Withdrawal by Subject|1|||
127881160|NCT01556165|460186152|FG000|Overall Study|Adverse Event|5|||
127881161|NCT01556165|460186153|FG001|Overall Study|Adverse Event|3|||
127575986|NCT03552965|459078172|FG000|Overall Study|Continuation not in patient best interest|1|||
127575987|NCT03552965|459078173|FG001|Overall Study|Continuation not in patient best interest|0|||
127575988|NCT03552965|459078172|FG000|Overall Study|Patient opted to be treated elsewhere|1|||
127575989|NCT03552965|459078173|FG001|Overall Study|Patient opted to be treated elsewhere|0|||
127575990|NCT02477696|459078174|FG000|Overall Study|Death|89|||
127575991|NCT02477696|459078175|FG001|Overall Study|Death|106|||
127575992|NCT02477696|459078174|FG000|Overall Study|Lost to Follow-up|7|||
127575993|NCT02477696|459078175|FG001|Overall Study|Lost to Follow-up|5|||
127575994|NCT02477696|459078174|FG000|Overall Study|Withdrawal by Subject|37|||
127575995|NCT02477696|459078175|FG001|Overall Study|Withdrawal by Subject|34|||
127575996|NCT02477696|459078174|FG000|Overall Study|Physician Decision|7|||
127575997|NCT02477696|459078175|FG001|Overall Study|Physician Decision|9|||
127575998|NCT02477696|459078174|FG000|Overall Study|Study terminated by sponsor|103|||
127575999|NCT02477696|459078175|FG001|Overall Study|Study terminated by sponsor|99|||
127576000|NCT02477696|459078174|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
127576001|NCT02477696|459078175|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
127576002|NCT02477696|459078174|FG000|Overall Study|Missing/Unknown|2|||
127576003|NCT02477696|459078175|FG001|Overall Study|Missing/Unknown|0|||
127576004|NCT05419908|459078177|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
127576005|NCT05419908|459078178|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
127576006|NCT05419908|459078177|FG000|Overall Study|Serious Adverse Event|0|||
127576007|NCT05419908|459078178|FG001|Overall Study|Serious Adverse Event|2|||
127576008|NCT05419908|459078177|FG000|Overall Study|Withdrawal by Subject|2|||
127576009|NCT05419908|459078178|FG001|Overall Study|Withdrawal by Subject|0|||
127576010|NCT05419908|459078177|FG000|Overall Study|Miscellaneous|1|||
127576011|NCT05419908|459078178|FG001|Overall Study|Miscellaneous|1|||
127576012|NCT00426231|459079249|FG000|Overall Study|Withdrawal by Subject|9|||
127576013|NCT00426231|459079250|FG001|Overall Study|Withdrawal by Subject|12|||
127576014|NCT01795638|459079251|FG000|Overall Study|Death|0|||
127576015|NCT01795638|459079252|FG001|Overall Study|Death|3|||
127576016|NCT01795638|459079251|FG000|Overall Study|transferred to quaternary hospital|2|||
127576017|NCT01795638|459079252|FG001|Overall Study|transferred to quaternary hospital|3|||
127576018|NCT01795638|459079251|FG000|Overall Study|Protocol Violation|3|||
127576019|NCT01795638|459079252|FG001|Overall Study|Protocol Violation|0|||
127576020|NCT01795638|459079251|FG000|Overall Study|discharged from hospital|7|||
127576021|NCT01795638|459079252|FG001|Overall Study|discharged from hospital|5|||
127576022|NCT01795638|459079251|FG000|Overall Study|Withdrawal by Subject|1|||
127576023|NCT01795638|459079252|FG001|Overall Study|Withdrawal by Subject|0|||
127576024|NCT02360995|459079253|FG000|Overall Study|Lost to Follow-up|2|||
127576025|NCT02360995|459079254|FG001|Overall Study|Lost to Follow-up|0|||
127576026|NCT02360995|459079255|FG002|Overall Study|Lost to Follow-up|2|||
127576027|NCT02360995|459079253|FG000|Overall Study|Withdrawal by Subject|0|||
127576028|NCT02360995|459079254|FG001|Overall Study|Withdrawal by Subject|1|||
127576029|NCT02360995|459079255|FG002|Overall Study|Withdrawal by Subject|0|||
127576030|NCT02611960|459079256|FG000|Overall Study|Adverse Event|7|||
127576031|NCT02611960|459079257|FG001|Overall Study|Adverse Event|8|||
127576032|NCT02611960|459079256|FG000|Overall Study|Death|98|||
127576033|NCT02611960|459079257|FG001|Overall Study|Death|92|||
127576034|NCT02611960|459079256|FG000|Overall Study|Withdrawal by Subject|1|||
127576035|NCT02611960|459079257|FG001|Overall Study|Withdrawal by Subject|5|||
127576036|NCT02611960|459079256|FG000|Overall Study|Sponsor Decision|11|||
127576037|NCT02611960|459079257|FG001|Overall Study|Sponsor Decision|11|||
127576038|NCT02395666|459079258|FG000|Overall Study|Physician Decision|3|||
127576039|NCT02395666|459079259|FG001|Overall Study|Physician Decision|0|||
127576040|NCT02395666|459079258|FG000|Overall Study|Lost to Follow-up|1|||
127576041|NCT02395666|459079259|FG001|Overall Study|Lost to Follow-up|0|||
127576042|NCT02395666|459079258|FG000|Overall Study|Withdrawal by Subject|2|||
127576043|NCT02395666|459079259|FG001|Overall Study|Withdrawal by Subject|1|||
127576044|NCT00293215|459079260|FG000|Overall Study|Progressive disease|3|||
127576045|NCT00293215|459079261|FG001|Overall Study|Progressive disease|1|||
127576046|NCT00293215|459079260|FG000|Overall Study|Adverse Event|2|||
127576047|NCT00293215|459079261|FG001|Overall Study|Adverse Event|2|||
127576048|NCT01409434|459079262|FG000|Overall Study|Protocol Violation|4|||
127576049|NCT01229371|459079265|FG000|Overall Study|Withdrawal by Subject|0|||
127576050|NCT01229371|459079266|FG001|Overall Study|Withdrawal by Subject|1|||
127576051|NCT01229371|459079267|FG002|Overall Study|Withdrawal by Subject|0|||
127576052|NCT01229371|459079268|FG003|Overall Study|Withdrawal by Subject|0|||
127576053|NCT02213042|459079269|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
127576054|NCT02213042|459079270|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
127782293|NCT00545402|459829739|FG000|Overall Study|Reason not specified|1|||
127782294|NCT00545402|459829740|FG001|Overall Study|Reason not specified|1|||
127782295|NCT01721876|459829741|FG000|Overall Study|Not treated|1|||
127782296|NCT01721876|459829742|FG001|Overall Study|Not treated|4|||
127782297|NCT01721876|459829741|FG000|Overall Study|Disease progression / relapse|123|||
127782298|NCT01721876|459829742|FG001|Overall Study|Disease progression / relapse|156|||
127576055|NCT02213042|459079271|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
127576056|NCT02213042|459079269|FG000|Overall Study|Adverse Event|2|||
127576057|NCT02213042|459079270|FG001|Overall Study|Adverse Event|1|||
127576058|NCT02213042|459079271|FG002|Overall Study|Adverse Event|0|||
127782299|NCT01721876|459829741|FG000|Overall Study|Death|6|||
127782300|NCT01721876|459829742|FG001|Overall Study|Death|13|||
127576059|NCT02213042|459079269|FG000|Overall Study|Withdrawal by Subject|0|||
127576060|NCT02213042|459079270|FG001|Overall Study|Withdrawal by Subject|1|||
127576061|NCT02213042|459079271|FG002|Overall Study|Withdrawal by Subject|1|||
127576062|NCT02213042|459079269|FG000|Overall Study|Protocol Violation|1|||
127576063|NCT02213042|459079270|FG001|Overall Study|Protocol Violation|0|||
127576064|NCT02213042|459079271|FG002|Overall Study|Protocol Violation|0|||
127576065|NCT02213042|459079269|FG000|Overall Study|Investigator discretion|0|||
127576066|NCT02213042|459079270|FG001|Overall Study|Investigator discretion|0|||
127576067|NCT02213042|459079271|FG002|Overall Study|Investigator discretion|1|||
127576068|NCT04622735|459079272|FG000|Overall Study|Lost to Follow-up|1|||
127576069|NCT04622735|459079273|FG001|Overall Study|Lost to Follow-up|2|||
127576070|NCT04622735|459079274|FG002|Overall Study|Lost to Follow-up|1|||
127576071|NCT04622735|459079272|FG000|Overall Study|Adverse Event|0|||
127576072|NCT04622735|459079273|FG001|Overall Study|Adverse Event|0|||
127576073|NCT04622735|459079274|FG002|Overall Study|Adverse Event|1|||
127576074|NCT04622735|459079272|FG000|Overall Study|Protocol Violation|1|||
127576075|NCT04622735|459079273|FG001|Overall Study|Protocol Violation|0|||
127576076|NCT04622735|459079274|FG002|Overall Study|Protocol Violation|0|||
127576077|NCT05314478|459079275|FG000|Overall Study|Physician Decision|1|||
127576078|NCT04073368|459079276|FG000|Overall Study|Adverse Event|2|||
127576079|NCT04073368|459079277|FG001|Overall Study|Adverse Event|0|||
127576080|NCT04073368|459079278|FG002|Overall Study|Adverse Event|1|||
127576081|NCT04073368|459079279|FG003|Overall Study|Adverse Event|1|||
127576082|NCT04073368|459079276|FG000|Overall Study|Withdrawal by Subject|2|||
127576083|NCT04073368|459079277|FG001|Overall Study|Withdrawal by Subject|2|||
127576084|NCT04073368|459079278|FG002|Overall Study|Withdrawal by Subject|1|||
127576085|NCT04073368|459079279|FG003|Overall Study|Withdrawal by Subject|1|||
127576086|NCT04073368|459079276|FG000|Overall Study|Lost to Follow-up|1|||
127576087|NCT04073368|459079277|FG001|Overall Study|Lost to Follow-up|1|||
127576088|NCT04073368|459079278|FG002|Overall Study|Lost to Follow-up|1|||
127576089|NCT04073368|459079279|FG003|Overall Study|Lost to Follow-up|0|||
127576090|NCT04073368|459079276|FG000|Overall Study|Protocol Violation|0|||
127576091|NCT04073368|459079277|FG001|Overall Study|Protocol Violation|1|||
127576092|NCT04073368|459079278|FG002|Overall Study|Protocol Violation|0|||
127576093|NCT04073368|459079279|FG003|Overall Study|Protocol Violation|0|||
127576094|NCT04073368|459079276|FG000|Overall Study|Subject noncompliance|7|||
127576095|NCT04073368|459079277|FG001|Overall Study|Subject noncompliance|4|||
127576096|NCT04073368|459079278|FG002|Overall Study|Subject noncompliance|0|||
127576097|NCT04073368|459079279|FG003|Overall Study|Subject noncompliance|0|||
127576098|NCT01229397|459079280|FG000|Overall Study|Withdrawal by Subject|3|||
127576099|NCT01229397|459079281|FG001|Overall Study|Withdrawal by Subject|3|||
127576100|NCT01229397|459079280|FG000|Overall Study|Lost to Follow-up|7|||
127576101|NCT01229397|459079281|FG001|Overall Study|Lost to Follow-up|6|||
127576102|NCT01229397|459079280|FG000|Overall Study|Migrated/moved from study area|1|||
127576103|NCT01229397|459079281|FG001|Overall Study|Migrated/moved from study area|0|||
127576104|NCT02476422|459079282|FG000|Overall Study|Subject/guardian decision|0|||
127576105|NCT02476422|459079283|FG001|Overall Study|Subject/guardian decision|1|||
127576106|NCT00857415|459079284|FG000|Overall Study|Image acquisition failure|2|||
127576107|NCT00857415|459079285|FG001|Overall Study|Image acquisition failure|0|||
127576108|NCT00857415|459079284|FG000|Overall Study|Invalid image or not imaged|3|||
127576109|NCT00857415|459079285|FG001|Overall Study|Invalid image or not imaged|0|||
127576110|NCT00857415|459079284|FG000|Overall Study|Subject still living at end of study|110|||
127576111|NCT00857415|459079285|FG001|Overall Study|Subject still living at end of study|0|||
127576112|NCT00857415|459079284|FG000|Overall Study|Deceased with no autopsy|2|||
127576113|NCT00857415|459079285|FG001|Overall Study|Deceased with no autopsy|0|||
127576114|NCT01130103|459079286|FG000|Randomized Treatment|Adverse Event|1|||
127576115|NCT01130103|459079287|FG001|Randomized Treatment|Adverse Event|1|||
127576116|NCT01130103|459079286|FG000|Randomized Treatment|Lost to Follow-up|1|||
127576117|NCT01130103|459079287|FG001|Randomized Treatment|Lost to Follow-up|0|||
127576118|NCT01130103|459079286|FG000|Randomized Treatment|Protocol Violation|3|||
127576119|NCT01130103|459079287|FG001|Randomized Treatment|Protocol Violation|2|||
127576120|NCT01130103|459079286|FG000|Randomized Treatment|Withdrawal by Subject|1|||
127576121|NCT01130103|459079287|FG001|Randomized Treatment|Withdrawal by Subject|2|||
127576122|NCT01130103|459079286|FG000|Maintenance Treatment|Lack of Efficacy|0|||
127576123|NCT01130103|459079287|FG001|Maintenance Treatment|Lack of Efficacy|1|||
127576124|NCT01130103|459079286|FG000|Maintenance Treatment|Lost to Follow-up|1|||
127576125|NCT01130103|459079287|FG001|Maintenance Treatment|Lost to Follow-up|1|||
127576126|NCT01130103|459079286|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
127576127|NCT01130103|459079287|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
127576128|NCT04508140|459079288|FG000|Overall Study|Adverse Event|2|||
127576129|NCT04508140|459079289|FG001|Overall Study|Adverse Event|2|||
127576130|NCT04508140|459079288|FG000|Overall Study|Withdrawal by Subject|0|||
127576131|NCT04508140|459079289|FG001|Overall Study|Withdrawal by Subject|2|||
127576132|NCT04508140|459079288|FG000|Overall Study|progressive disease|9|||
127576133|NCT04508140|459079289|FG001|Overall Study|progressive disease|3|||
127576134|NCT02992132|459079293|FG000|Overall Study|Adverse Event|4|||
127576135|NCT02992132|459079294|FG001|Overall Study|Adverse Event|1|||
127576136|NCT02992132|459079295|FG002|Overall Study|Adverse Event|3|||
127576137|NCT02992132|459079293|FG000|Overall Study|Lack of Efficacy|2|||
127576138|NCT02992132|459079294|FG001|Overall Study|Lack of Efficacy|0|||
127576139|NCT02992132|459079295|FG002|Overall Study|Lack of Efficacy|0|||
127576140|NCT02992132|459079293|FG000|Overall Study|Non-compliance with study drug|2|||
127576141|NCT02992132|459079294|FG001|Overall Study|Non-compliance with study drug|0|||
127576142|NCT02992132|459079295|FG002|Overall Study|Non-compliance with study drug|0|||
127576143|NCT02992132|459079293|FG000|Overall Study|Progressive disease|1|||
127576144|NCT02992132|459079294|FG001|Overall Study|Progressive disease|0|||
127576145|NCT02992132|459079295|FG002|Overall Study|Progressive disease|0|||
127576146|NCT02992132|459079293|FG000|Overall Study|Protocol Violation|2|||
127576147|NCT02992132|459079294|FG001|Overall Study|Protocol Violation|2|||
127576148|NCT02992132|459079295|FG002|Overall Study|Protocol Violation|0|||
127576149|NCT02992132|459079293|FG000|Overall Study|Caregiver withdrew consent|2|||
127576150|NCT02992132|459079294|FG001|Overall Study|Caregiver withdrew consent|3|||
127576151|NCT02992132|459079295|FG002|Overall Study|Caregiver withdrew consent|2|||
127576152|NCT02992132|459079293|FG000|Overall Study|Withdrawal by Subject|0|||
127576153|NCT02992132|459079294|FG001|Overall Study|Withdrawal by Subject|2|||
127576154|NCT02992132|459079295|FG002|Overall Study|Withdrawal by Subject|1|||
127576155|NCT02992132|459079293|FG000|Overall Study|Physician Decision|0|||
127576156|NCT02992132|459079294|FG001|Overall Study|Physician Decision|0|||
127576157|NCT02992132|459079295|FG002|Overall Study|Physician Decision|1|||
127576158|NCT01437878|459079299|FG000|Overall Study|Withdrawal by Subject|1|||
127576159|NCT01437878|459079300|FG001|Overall Study|Withdrawal by Subject|0|||
127576160|NCT03538431|459079301|FG000|Overall Study|Physician Decision|0|||
127576161|NCT03538431|459079302|FG001|Overall Study|Physician Decision|1|||
127576162|NCT03538431|459079301|FG000|Overall Study|Withdrawal by Subject|1|||
127576163|NCT03538431|459079302|FG001|Overall Study|Withdrawal by Subject|0|||
127576164|NCT00620464|459079303|FG000|Overall Study|Adverse Event|15|||
127576165|NCT00620464|459079304|FG001|Overall Study|Adverse Event|17|||
127576166|NCT00620464|459079303|FG000|Overall Study|Lost to Follow-up|1|||
127576167|NCT00620464|459079304|FG001|Overall Study|Lost to Follow-up|1|||
127576168|NCT00620464|459079303|FG000|Overall Study|Planning Pregnancy|1|||
127576169|NCT00620464|459079304|FG001|Overall Study|Planning Pregnancy|4|||
127576170|NCT00620464|459079303|FG000|Overall Study|Personal|2|||
127576171|NCT00620464|459079304|FG001|Overall Study|Personal|2|||
127576172|NCT00620464|459079303|FG000|Overall Study|Used prohibited medication|1|||
127576173|NCT00620464|459079304|FG001|Overall Study|Used prohibited medication|0|||
127576174|NCT00586066|459079305|FG000|Overall Study|Lost to Follow-up|6|||
127576175|NCT00586066|459079306|FG001|Overall Study|Lost to Follow-up|3|||
127576176|NCT00586066|459079305|FG000|Overall Study|Lack of Efficacy|5|||
127576177|NCT00586066|459079306|FG001|Overall Study|Lack of Efficacy|3|||
127576178|NCT00586066|459079305|FG000|Overall Study|Adverse Event|2|||
127576179|NCT00586066|459079306|FG001|Overall Study|Adverse Event|2|||
127576180|NCT00586066|459079305|FG000|Overall Study|Physician Decision|1|||
127576181|NCT00586066|459079306|FG001|Overall Study|Physician Decision|0|||
127576182|NCT00586066|459079305|FG000|Overall Study|Withdrawal of consent|4|||
127576183|NCT00586066|459079306|FG001|Overall Study|Withdrawal of consent|2|||
127576184|NCT00467610|459079309|FG000|Overall Study|Withdrawal by Subject|1|||
127576185|NCT01369615|459079310|FG000|Overall Study|Withdrawal by Subject|0|||
127576186|NCT01369615|459079311|FG001|Overall Study|Withdrawal by Subject|1|||
127576187|NCT01369615|459079310|FG000|Overall Study|Lost to Follow-up|0|||
127576188|NCT01369615|459079311|FG001|Overall Study|Lost to Follow-up|1|||
127576189|NCT04263454|459079312|FG000|Overall Study|Adverse Event|0|||
127576190|NCT04263454|459079313|FG001|Overall Study|Adverse Event|2|||
127576191|NCT04263454|459079312|FG000|Overall Study|Physician Decision|3|||
127576192|NCT04263454|459079313|FG001|Overall Study|Physician Decision|5|||
127576193|NCT04263454|459079312|FG000|Overall Study|Poor Data Quality|0|||
127576194|NCT04263454|459079313|FG001|Overall Study|Poor Data Quality|1|||
127576195|NCT03911154|459079314|FG000|Overall Study|Withdrawal by Subject|1|||
127576196|NCT00986479|459079315|FG000|Period 1|Improved mood|1|||
127576197|NCT00986479|459079316|FG001|Period 1|Improved mood|0|||
127576198|NCT00986479|459079315|FG000|Period 1|Administrative reasons|1|||
127576199|NCT00986479|459079316|FG001|Period 1|Administrative reasons|0|||
127576200|NCT02035475|459079317|FG000|Overall Study|Withdrawal by Subject|4|||
127576201|NCT02035475|459079317|FG000|Overall Study|Physician Decision|1|||
127576202|NCT02035475|459079317|FG000|Overall Study|Equipment Error|1|||
127576203|NCT01231347|459079318|FG000|Overall Study|Full Consent withdrawn|19|||
127576204|NCT01231347|459079319|FG001|Overall Study|Full Consent withdrawn|19|||
127576205|NCT01231347|459079320|FG002|Overall Study|Full Consent withdrawn|11|||
127576206|NCT01231347|459079318|FG000|Overall Study|Lost to Follow-up|4|||
127782301|NCT01721876|459829741|FG000|Overall Study|Adverse Event|41|||
127576207|NCT01231347|459079319|FG001|Overall Study|Lost to Follow-up|2|||
127576208|NCT01231347|459079320|FG002|Overall Study|Lost to Follow-up|2|||
127576209|NCT01231347|459079318|FG000|Overall Study|Death|202|||
127576210|NCT01231347|459079319|FG001|Overall Study|Death|210|||
127576211|NCT01231347|459079320|FG002|Overall Study|Death|101|||
127576212|NCT01231347|459079318|FG000|Overall Study|other event|7|||
127576213|NCT01231347|459079319|FG001|Overall Study|other event|9|||
127576214|NCT01231347|459079320|FG002|Overall Study|other event|3|||
127576215|NCT02322021|459079321|FG000|Core Phase|Adverse Event|1|||
127576216|NCT02322021|459079322|FG001|Core Phase|Adverse Event|3|||
127576217|NCT02322021|459079323|FG002|Core Phase|Adverse Event|4|||
127576218|NCT02322021|459079324|FG003|Core Phase|Adverse Event|2|||
127576219|NCT02322021|459079325|FG004|Core Phase|Adverse Event|0|||
127576220|NCT02322021|459079321|FG000|Core Phase|Participant Choice|4|||
127576221|NCT02322021|459079322|FG001|Core Phase|Participant Choice|5|||
127576222|NCT02322021|459079323|FG002|Core Phase|Participant Choice|4|||
127576223|NCT02322021|459079324|FG003|Core Phase|Participant Choice|2|||
127576224|NCT02322021|459079325|FG004|Core Phase|Participant Choice|0|||
127576225|NCT02322021|459079321|FG000|Core Phase|Lost to Follow-up|0|||
127576226|NCT02322021|459079322|FG001|Core Phase|Lost to Follow-up|0|||
127576227|NCT02322021|459079323|FG002|Core Phase|Lost to Follow-up|0|||
127576228|NCT02322021|459079324|FG003|Core Phase|Lost to Follow-up|1|||
127576229|NCT02322021|459079325|FG004|Core Phase|Lost to Follow-up|0|||
127576230|NCT02322021|459079321|FG000|Core Phase|Other|0|||
127576231|NCT02322021|459079322|FG001|Core Phase|Other|0|||
127576232|NCT02322021|459079323|FG002|Core Phase|Other|1|||
127576233|NCT02322021|459079324|FG003|Core Phase|Other|0|||
127576234|NCT02322021|459079325|FG004|Core Phase|Other|0|||
127576235|NCT02322021|459079321|FG000|Extension Phase|Adverse Event|0|||
127576236|NCT02322021|459079322|FG001|Extension Phase|Adverse Event|0|||
127576237|NCT02322021|459079323|FG002|Extension Phase|Adverse Event|0|||
127576238|NCT02322021|459079324|FG003|Extension Phase|Adverse Event|0|||
127576239|NCT02322021|459079325|FG004|Extension Phase|Adverse Event|3|||
127576240|NCT02322021|459079321|FG000|Extension Phase|Participant Choice|0|||
127576241|NCT02322021|459079322|FG001|Extension Phase|Participant Choice|0|||
127576242|NCT02322021|459079323|FG002|Extension Phase|Participant Choice|0|||
127576243|NCT02322021|459079324|FG003|Extension Phase|Participant Choice|0|||
127576244|NCT02322021|459079325|FG004|Extension Phase|Participant Choice|6|||
127576245|NCT02322021|459079321|FG000|Extension Phase|Other|0|||
127576246|NCT02322021|459079322|FG001|Extension Phase|Other|0|||
127576247|NCT02322021|459079323|FG002|Extension Phase|Other|0|||
127576248|NCT02322021|459079324|FG003|Extension Phase|Other|0|||
127576249|NCT02322021|459079325|FG004|Extension Phase|Other|3|||
127576250|NCT02322021|459079321|FG000|Extension Phase|Lost to Follow-up|0|||
127576251|NCT02322021|459079322|FG001|Extension Phase|Lost to Follow-up|0|||
127576252|NCT02322021|459079323|FG002|Extension Phase|Lost to Follow-up|0|||
127576253|NCT02322021|459079324|FG003|Extension Phase|Lost to Follow-up|0|||
127576254|NCT02322021|459079325|FG004|Extension Phase|Lost to Follow-up|1|||
127576255|NCT02322021|459079321|FG000|Extension Phase|Study terminated by sponsor|0|||
127576256|NCT02322021|459079322|FG001|Extension Phase|Study terminated by sponsor|0|||
127576257|NCT02322021|459079323|FG002|Extension Phase|Study terminated by sponsor|0|||
127576258|NCT02322021|459079324|FG003|Extension Phase|Study terminated by sponsor|0|||
127576259|NCT02322021|459079325|FG004|Extension Phase|Study terminated by sponsor|28|||
127576260|NCT01702571|459079326|FG000|Overall Study|Death|1067|||
127576261|NCT01702571|459079327|FG001|Overall Study|Death|76|||
127576262|NCT01702571|459079326|FG000|Overall Study|Lost to Follow-up|144|||
127576263|NCT01702571|459079327|FG001|Overall Study|Lost to Follow-up|10|||
127576264|NCT01702571|459079326|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
127576265|NCT01702571|459079327|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
127576266|NCT01702571|459079326|FG000|Overall Study|Investigator Decision|5|||
127576267|NCT01702571|459079327|FG001|Overall Study|Investigator Decision|0|||
127576268|NCT01702571|459079326|FG000|Overall Study|Not Classifiable|1|||
127576269|NCT01702571|459079327|FG001|Overall Study|Not Classifiable|0|||
127576270|NCT01702571|459079326|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
127576271|NCT01702571|459079327|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
127576272|NCT01702571|459079326|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
127576273|NCT01702571|459079327|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
127576274|NCT01702571|459079326|FG000|Overall Study|Progressive Disease|3|||
127576275|NCT01702571|459079327|FG001|Overall Study|Progressive Disease|0|||
127576276|NCT01702571|459079326|FG000|Overall Study|Protocol Violation|2|||
127576277|NCT01702571|459079327|FG001|Overall Study|Protocol Violation|0|||
127576278|NCT01702571|459079326|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
127576279|NCT01702571|459079327|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
127576280|NCT01702571|459079326|FG000|Overall Study|Termination By Sponsor|4|||
127576281|NCT01702571|459079327|FG001|Overall Study|Termination By Sponsor|0|||
127692948|NCT03580369|459501683|FG006|Overall Study|Withdrawal by Subject|7|||
127692949|NCT03580369|459501684|FG007|Overall Study|Withdrawal by Subject|0|||
127692950|NCT03912831|459501685|FG000|Overall Study|Death|1|||
127692951|NCT03912831|459501686|FG001|Overall Study|Death|1|||
127692952|NCT03912831|459501687|FG002|Overall Study|Death|1|||
127692953|NCT03912831|459501688|FG003|Overall Study|Death|1|||
127576282|NCT01702571|459079326|FG000|Overall Study|Withdrawal by Subject|177|||
127576283|NCT01702571|459079327|FG001|Overall Study|Withdrawal by Subject|29|||
127576284|NCT02047227|459079328|FG000|Overall Study|Adverse Event|2|||
127576285|NCT02047227|459079329|FG001|Overall Study|Adverse Event|4|||
127576286|NCT02047227|459079328|FG000|Overall Study|Lost to Follow-up|0|||
127692954|NCT03912831|459501689|FG004|Overall Study|Death|1|||
127692955|NCT03912831|459501690|FG005|Overall Study|Death|1|||
127576287|NCT02047227|459079329|FG001|Overall Study|Lost to Follow-up|3|||
127576288|NCT02047227|459079328|FG000|Overall Study|Protocol Violation|1|||
127576289|NCT02047227|459079329|FG001|Overall Study|Protocol Violation|0|||
128029684|NCT02579759|460735067|FG002|Overall Study|Lost to Follow-up|2|||
128029685|NCT01897896|460735070|FG000|Overall Study|Death|1|||
127576290|NCT02047227|459079328|FG000|Overall Study|Spontaneous pregnancy|1|||
127576291|NCT02047227|459079329|FG001|Overall Study|Spontaneous pregnancy|0|||
127576292|NCT02047227|459079328|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
127576293|NCT02047227|459079329|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
127576294|NCT02047227|459079328|FG000|Overall Study|No oocytes retrieved|21|||
127576295|NCT02047227|459079329|FG001|Overall Study|No oocytes retrieved|20|||
127576296|NCT02047227|459079328|FG000|Overall Study|No fertilization|61|||
127576297|NCT02047227|459079329|FG001|Overall Study|No fertilization|51|||
127576298|NCT02047227|459079328|FG000|Overall Study|Intention to freeze all embryos|1|||
127576299|NCT02047227|459079329|FG001|Overall Study|Intention to freeze all embryos|0|||
127576300|NCT02047227|459079328|FG000|Overall Study|All embryos discarded|12|||
127576301|NCT02047227|459079329|FG001|Overall Study|All embryos discarded|11|||
127576302|NCT02047227|459079328|FG000|Overall Study|Other|10|||
127576303|NCT02047227|459079329|FG001|Overall Study|Other|9|||
127576304|NCT01977937|459079338|FG000|Overall Study|Withdrawal by Subject|2|||
127576305|NCT01977937|459079339|FG001|Overall Study|Withdrawal by Subject|1|||
127576306|NCT01977937|459079338|FG000|Overall Study|Adverse Event|1|||
127576307|NCT01977937|459079339|FG001|Overall Study|Adverse Event|0|||
127576308|NCT01977937|459079338|FG000|Overall Study|Physician Decision|0|||
127576309|NCT01977937|459079339|FG001|Overall Study|Physician Decision|1|||
127576310|NCT00915356|459079340|FG000|Overall Study|Withdrawal by Subject|1|||
128029686|NCT01897896|460735071|FG001|Overall Study|Death|0|||
128029687|NCT01897896|460735070|FG000|Overall Study|Adverse Event|11|||
127576311|NCT00915356|459079341|FG001|Overall Study|Withdrawal by Subject|0|||
127576312|NCT00915356|459079342|FG002|Overall Study|Withdrawal by Subject|0|||
127576313|NCT00915356|459079343|FG003|Overall Study|Withdrawal by Subject|0|||
127576314|NCT00915356|459079344|FG004|Overall Study|Withdrawal by Subject|0|||
127576315|NCT00771316|459079347|FG000|Overall Study|Adverse Event|0|||
127576316|NCT00771316|459079348|FG001|Overall Study|Adverse Event|1|||
127576317|NCT00771316|459079347|FG000|Overall Study|Patient withdrew consent|1|||
127576318|NCT00771316|459079348|FG001|Overall Study|Patient withdrew consent|0|||
127576319|NCT00771316|459079347|FG000|Overall Study|Discontinued due to early termination|1|||
127576320|NCT00771316|459079348|FG001|Overall Study|Discontinued due to early termination|0|||
127576321|NCT02027376|459079349|FG000|Overall Study|Death|1|||
128029688|NCT01897896|460735071|FG001|Overall Study|Adverse Event|1|||
128029689|NCT01897896|460735070|FG000|Overall Study|Lost to Follow-up|1|||
127576322|NCT02027376|459079350|FG001|Overall Study|Death|0|||
127576323|NCT02027376|459079351|FG002|Overall Study|Death|0|||
127576324|NCT01278160|459079357|FG000|Overall Study|Adverse Event|1|||
127576325|NCT01278160|459079358|FG001|Overall Study|Adverse Event|1|||
127576326|NCT01278160|459079357|FG000|Overall Study|Lost to Follow-up|0|||
127576327|NCT01278160|459079358|FG001|Overall Study|Lost to Follow-up|1|||
127576328|NCT01278160|459079357|FG000|Overall Study|Withdrawal by Subject|3|||
127576329|NCT01278160|459079358|FG001|Overall Study|Withdrawal by Subject|2|||
127576330|NCT01278160|459079357|FG000|Overall Study|Unclassified|1|||
127576331|NCT01278160|459079358|FG001|Overall Study|Unclassified|2|||
127576332|NCT02819518|459079362|FG000|Overall Study|Death|9|||
127576333|NCT02819518|459079363|FG001|Overall Study|Death|12|||
127576334|NCT02819518|459079364|FG002|Overall Study|Death|9|||
127576335|NCT02819518|459079365|FG003|Overall Study|Death|475|||
127576336|NCT02819518|459079366|FG004|Overall Study|Death|244|||
127576337|NCT02819518|459079362|FG000|Overall Study|Withdrawal by Subject|0|||
127576338|NCT02819518|459079363|FG001|Overall Study|Withdrawal by Subject|0|||
127576339|NCT02819518|459079364|FG002|Overall Study|Withdrawal by Subject|0|||
127576340|NCT02819518|459079365|FG003|Overall Study|Withdrawal by Subject|25|||
127576341|NCT02819518|459079366|FG004|Overall Study|Withdrawal by Subject|8|||
127576342|NCT02819518|459079362|FG000|Overall Study|Lost to Follow-up|0|||
127576343|NCT02819518|459079363|FG001|Overall Study|Lost to Follow-up|0|||
127576344|NCT02819518|459079364|FG002|Overall Study|Lost to Follow-up|0|||
127576345|NCT02819518|459079365|FG003|Overall Study|Lost to Follow-up|0|||
127576346|NCT02819518|459079366|FG004|Overall Study|Lost to Follow-up|1|||
127881162|NCT01556165|460186152|FG000|Overall Study|Protocol Violation|0|||
127576347|NCT02819518|459079362|FG000|Overall Study|Sponsor Decision|1|||
127576348|NCT02819518|459079363|FG001|Overall Study|Sponsor Decision|1|||
127576349|NCT02819518|459079364|FG002|Overall Study|Sponsor Decision|0|||
128029690|NCT01897896|460735071|FG001|Overall Study|Lost to Follow-up|0|||
127576350|NCT02819518|459079365|FG003|Overall Study|Sponsor Decision|34|||
127576351|NCT02819518|459079366|FG004|Overall Study|Sponsor Decision|17|||
127576352|NCT02819518|459079362|FG000|Overall Study|Transferred to extension study|1|||
127576353|NCT02819518|459079363|FG001|Overall Study|Transferred to extension study|1|||
128029691|NCT01897896|460735070|FG000|Overall Study|Non-compliance with study drug dosing|1|||
127576354|NCT02819518|459079364|FG002|Overall Study|Transferred to extension study|1|||
127576355|NCT02819518|459079365|FG003|Overall Study|Transferred to extension study|32|||
127576356|NCT02819518|459079366|FG004|Overall Study|Transferred to extension study|11|||
127576357|NCT01505647|459079367|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
127576358|NCT01505647|459079368|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
127576359|NCT01505647|459079367|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
127576360|NCT01505647|459079368|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
127576361|NCT01505647|459079367|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
127576362|NCT01505647|459079368|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
127576363|NCT01505647|459079367|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
127576364|NCT01505647|459079368|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
127576365|NCT01505647|459079367|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
127576366|NCT01505647|459079368|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
127576367|NCT05069259|459079376|FG000|Overall Study|Withdrawal by Subject|1|||
127576368|NCT05069259|459079376|FG000|Overall Study|Sponsor decision|1|||
127576369|NCT05098938|459079377|FG000|Overall Study|Adverse Event|4|||
128029692|NCT01897896|460735071|FG001|Overall Study|Non-compliance with study drug dosing|1|||
128029693|NCT01897896|460735070|FG000|Overall Study|Withdrawal by Subject|7|||
128029694|NCT01897896|460735071|FG001|Overall Study|Withdrawal by Subject|1|||
128029695|NCT01897896|460735070|FG000|Overall Study|Require drug that interfere with study|1|||
128029696|NCT01897896|460735071|FG001|Overall Study|Require drug that interfere with study|4|||
128029697|NCT01897896|460735070|FG000|Overall Study|Protocol Violation|1|||
128029698|NCT01897896|460735071|FG001|Overall Study|Protocol Violation|1|||
128029699|NCT01897896|460735070|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
128029700|NCT01897896|460735071|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
128029701|NCT01897896|460735070|FG000|Overall Study|Caregiver can no longer participate|0|||
128029702|NCT01897896|460735071|FG001|Overall Study|Caregiver can no longer participate|2|||
128029703|NCT01897896|460735070|FG000|Overall Study|Other than specified|2|||
128029704|NCT01897896|460735071|FG001|Overall Study|Other than specified|1|||
128029705|NCT02003898|460735081|FG000|Overall Study|Death|3|||
128029706|NCT02003898|460735081|FG000|Overall Study|Lost to Follow-up|12|||
128029707|NCT02003898|460735081|FG000|Overall Study|Withdrawal by Subject|52|||
128029708|NCT03412591|460735082|FG000|Overall Study|Withdrawal by Subject|1|||
128029709|NCT03412591|460735083|FG001|Overall Study|Withdrawal by Subject|8|||
128029710|NCT03412591|460735082|FG000|Overall Study|Adverse Event|0|||
128029711|NCT03412591|460735083|FG001|Overall Study|Adverse Event|1|||
128029712|NCT01853280|460735091|FG000|Overall Study|Lack of Efficacy|2|||
128029713|NCT01853280|460735092|FG001|Overall Study|Lack of Efficacy|2|||
128029714|NCT01853280|460735091|FG000|Overall Study|Lost to Follow-up|0|||
128029715|NCT01853280|460735092|FG001|Overall Study|Lost to Follow-up|1|||
128029716|NCT01853280|460735091|FG000|Overall Study|Physician Decision|0|||
128029717|NCT01853280|460735092|FG001|Overall Study|Physician Decision|1|||
128029718|NCT01853280|460735091|FG000|Overall Study|Withdrawal by Subject|0|||
128029719|NCT01853280|460735092|FG001|Overall Study|Withdrawal by Subject|1|||
128029720|NCT01853280|460735091|FG000|Overall Study|Ineligible|0|||
128029721|NCT01853280|460735092|FG001|Overall Study|Ineligible|1|||
128029722|NCT03032484|460735093|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
128029723|NCT03032484|460735094|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
128029724|NCT03032484|460735093|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
128029725|NCT03032484|460735094|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
128029726|NCT01229111|460735095|FG000|Overall Study|Death|1|||
128029727|NCT01689649|460735096|FG000|Overall Study|Lack of Efficacy|3|||
128029728|NCT01689649|460735096|FG000|Overall Study|Non-compliance|11|||
128029729|NCT01689649|460735096|FG000|Overall Study|Protocol Violation|3|||
128029730|NCT01689649|460735096|FG000|Overall Study|Lost to Follow-up|5|||
128029731|NCT00595075|460735102|FG000|Overall Study|Withdrawal by Subject|1|||
128029732|NCT00595075|460735103|FG001|Overall Study|Withdrawal by Subject|0|||
128029733|NCT01946880|460735104|FG000|Overall Study|Lost to Follow-up|1|||
128029734|NCT01946880|460735105|FG001|Overall Study|Lost to Follow-up|0|||
128029735|NCT01946880|460735104|FG000|Overall Study|Physician Decision|1|||
128029736|NCT01946880|460735105|FG001|Overall Study|Physician Decision|1|||
128029737|NCT01946880|460735104|FG000|Overall Study|Withdrawal by Subject|3|||
128029738|NCT01946880|460735105|FG001|Overall Study|Withdrawal by Subject|2|||
128029739|NCT01946880|460735104|FG000|Overall Study|Met Primary Endpoint|1|||
127576370|NCT05098938|459079378|FG001|Overall Study|Adverse Event|3|||
127576371|NCT05098938|459079377|FG000|Overall Study|inclusion/exclusion criteria change|11|||
127576372|NCT05098938|459079378|FG001|Overall Study|inclusion/exclusion criteria change|5|||
128029740|NCT01946880|460735105|FG001|Overall Study|Met Primary Endpoint|0|||
128029741|NCT01946880|460735104|FG000|Overall Study|Personal and Family Issues|1|||
128029742|NCT01946880|460735105|FG001|Overall Study|Personal and Family Issues|0|||
128029743|NCT00456365|460735107|FG000|Overall Study|Lost to Follow-up|1|||
128029744|NCT00456365|460735108|FG001|Overall Study|Lost to Follow-up|3|||
128029745|NCT00456365|460735107|FG000|Overall Study|Withdrawal by Subject|4|||
128029746|NCT00456365|460735108|FG001|Overall Study|Withdrawal by Subject|7|||
128029747|NCT00456365|460735107|FG000|Overall Study|Pregnancy|1|||
128029748|NCT00456365|460735108|FG001|Overall Study|Pregnancy|1|||
128029749|NCT00456365|460735107|FG000|Overall Study|oncologic diagnosis|1|||
128029750|NCT00456365|460735108|FG001|Overall Study|oncologic diagnosis|1|||
127576373|NCT05098938|459079377|FG000|Overall Study|lack of compliance|26|||
127576374|NCT05098938|459079378|FG001|Overall Study|lack of compliance|19|||
127576375|NCT05098938|459079377|FG000|Overall Study|Lost to Follow-up|37|||
127576376|NCT05098938|459079378|FG001|Overall Study|Lost to Follow-up|40|||
127576377|NCT05098938|459079377|FG000|Overall Study|Lost in treatment period|17|||
127576378|NCT05098938|459079378|FG001|Overall Study|Lost in treatment period|13|||
127576379|NCT05098938|459079377|FG000|Overall Study|Met an exclusion criterion|0|||
127576380|NCT05098938|459079378|FG001|Overall Study|Met an exclusion criterion|3|||
127576381|NCT05098938|459079377|FG000|Overall Study|no prodromal symptoms after 6 months|1|||
127576382|NCT05098938|459079378|FG001|Overall Study|no prodromal symptoms after 6 months|0|||
127576383|NCT05098938|459079377|FG000|Overall Study|Physician Decision|25|||
127576384|NCT05098938|459079378|FG001|Overall Study|Physician Decision|32|||
127576385|NCT05098938|459079377|FG000|Overall Study|Run in failure in treatment phase|1|||
127576386|NCT05098938|459079378|FG001|Overall Study|Run in failure in treatment phase|1|||
127576387|NCT05098938|459079377|FG000|Overall Study|Withdrawal by Subject|0|||
127576388|NCT05098938|459079378|FG001|Overall Study|Withdrawal by Subject|3|||
127576389|NCT05098938|459079377|FG000|Overall Study|Run-in Failure in early study|505|||
127576390|NCT05098938|459079378|FG001|Overall Study|Run-in Failure in early study|514|||
127576391|NCT05098938|459079377|FG000|Overall Study|IMP delivery missed|1|||
127576392|NCT05098938|459079378|FG001|Overall Study|IMP delivery missed|5|||
127576393|NCT05098938|459079377|FG000|Overall Study|6 months visit was missed|2|||
127576394|NCT05098938|459079378|FG001|Overall Study|6 months visit was missed|0|||
127576395|NCT05098938|459079377|FG000|Overall Study|fit for use was not completed within window|3|||
127576396|NCT05098938|459079378|FG001|Overall Study|fit for use was not completed within window|0|||
127576397|NCT05098938|459079377|FG000|Overall Study|V2 visit was not completed within window|0|||
127576398|NCT05098938|459079378|FG001|Overall Study|V2 visit was not completed within window|1|||
127576399|NCT05098938|459079377|FG000|Overall Study|exclusionary medication use|1|||
127576400|NCT05098938|459079378|FG001|Overall Study|exclusionary medication use|2|||
127576401|NCT05098938|459079377|FG000|Overall Study|change in medication|1|||
127576402|NCT05098938|459079378|FG001|Overall Study|change in medication|0|||
127576403|NCT05098938|459079377|FG000|Overall Study|treatment failure|2|||
127576404|NCT05098938|459079378|FG001|Overall Study|treatment failure|1|||
127576405|NCT00518687|459080622|FG000|Overall Study|Adverse Event|201|||
127576406|NCT00518687|459080623|FG001|Overall Study|Adverse Event|177|||
127576407|NCT00518687|459080622|FG000|Overall Study|Lost to Follow-up|144|||
127576408|NCT00518687|459080623|FG001|Overall Study|Lost to Follow-up|155|||
127576409|NCT00518687|459080622|FG000|Overall Study|Physician Decision|42|||
127576410|NCT00518687|459080623|FG001|Overall Study|Physician Decision|48|||
127576411|NCT00518687|459080622|FG000|Overall Study|Progressive disease|2|||
127576412|NCT00518687|459080623|FG001|Overall Study|Progressive disease|2|||
127576413|NCT00518687|459080622|FG000|Overall Study|Protocol Violation|8|||
127576414|NCT00518687|459080623|FG001|Overall Study|Protocol Violation|10|||
127576415|NCT00518687|459080622|FG000|Overall Study|Study terminated by sponsor|930|||
127576416|NCT00518687|459080623|FG001|Overall Study|Study terminated by sponsor|918|||
127576417|NCT00518687|459080622|FG000|Overall Study|Withdrawal by Subject|110|||
127576418|NCT00518687|459080623|FG001|Overall Study|Withdrawal by Subject|110|||
127576419|NCT05108922|459080624|FG000|Overall Study|Adverse Event|2|||
127576420|NCT05108922|459080625|FG001|Overall Study|Adverse Event|3|||
127576421|NCT05108922|459080624|FG000|Overall Study|Lost to Follow-up|2|||
127782302|NCT01721876|459829742|FG001|Overall Study|Adverse Event|165|||
127782303|NCT01721876|459829741|FG000|Overall Study|Protocol Violation|2|||
127782304|NCT01721876|459829742|FG001|Overall Study|Protocol Violation|1|||
127782305|NCT01721876|459829741|FG000|Overall Study|Withdrawal by Subject|15|||
127782306|NCT01721876|459829742|FG001|Overall Study|Withdrawal by Subject|38|||
127782307|NCT01721876|459829741|FG000|Overall Study|Reason not listed|34|||
127782308|NCT01721876|459829742|FG001|Overall Study|Reason not listed|63|||
127782309|NCT01721876|459829741|FG000|Overall Study|Sponsor terminated trial|0|||
127782310|NCT01721876|459829742|FG001|Overall Study|Sponsor terminated trial|4|||
127782311|NCT01721057|459829745|FG000|Treatment Period|Withdrawal by Subject|11|||
127782312|NCT01721057|459829746|FG001|Treatment Period|Withdrawal by Subject|5|||
127782313|NCT01721057|459829747|FG002|Treatment Period|Withdrawal by Subject|8|||
127782314|NCT01721057|459829748|FG003|Treatment Period|Withdrawal by Subject|0|||
127782315|NCT01721057|459829749|FG004|Treatment Period|Withdrawal by Subject|0|||
127782316|NCT01721057|459829750|FG005|Treatment Period|Withdrawal by Subject|0|||
127782317|NCT01721057|459829751|FG006|Treatment Period|Withdrawal by Subject|0|||
127576422|NCT05108922|459080625|FG001|Overall Study|Lost to Follow-up|1|||
127782318|NCT01721057|459829745|FG000|Treatment Period|Adverse Event|7|||
127881163|NCT01556165|460186153|FG001|Overall Study|Protocol Violation|3|||
127576423|NCT05108922|459080624|FG000|Overall Study|Inadvertent enrollment|0|||
127576424|NCT05108922|459080625|FG001|Overall Study|Inadvertent enrollment|1|||
127576425|NCT05108922|459080624|FG000|Overall Study|Physician Decision|2|||
127576426|NCT05108922|459080625|FG001|Overall Study|Physician Decision|3|||
127576427|NCT05108922|459080624|FG000|Overall Study|Protocol deviation|1|||
127576428|NCT05108922|459080625|FG001|Overall Study|Protocol deviation|0|||
127576429|NCT05108922|459080624|FG000|Overall Study|Screen failure|1|||
127782319|NCT01721057|459829746|FG001|Treatment Period|Adverse Event|10|||
127576430|NCT05108922|459080625|FG001|Overall Study|Screen failure|0|||
127576431|NCT05108922|459080624|FG000|Overall Study|Withdrawal by Subject|11|||
127576432|NCT05108922|459080625|FG001|Overall Study|Withdrawal by Subject|8|||
127576433|NCT00398411|459080630|FG000|Overall Study|Death|0|||
127576434|NCT00398411|459080631|FG001|Overall Study|Death|1|||
127576435|NCT02095223|459080632|FG000|Overall Study|Withdrawal by Subject|1|||
127576436|NCT02095223|459080633|FG001|Overall Study|Withdrawal by Subject|0|||
127576437|NCT01397162|459080634|FG000|Overall Study|Adverse Event|4|||
127576438|NCT01397162|459080635|FG001|Overall Study|Adverse Event|0|||
127576439|NCT01397162|459080636|FG002|Overall Study|Adverse Event|0|||
127576440|NCT01397162|459080637|FG003|Overall Study|Adverse Event|0|||
127576441|NCT01397162|459080638|FG004|Overall Study|Adverse Event|0|||
127576442|NCT01397162|459080634|FG000|Overall Study|Not yet defined|3|||
127576443|NCT01397162|459080635|FG001|Overall Study|Not yet defined|4|||
127576444|NCT01397162|459080636|FG002|Overall Study|Not yet defined|3|||
127576445|NCT01397162|459080637|FG003|Overall Study|Not yet defined|5|||
127576446|NCT01397162|459080638|FG004|Overall Study|Not yet defined|3|||
127576447|NCT00282412|459080641|FG000|Overall Study|Death|2|||
127576448|NCT01507298|459080642|FG000|Overall Study|Protocol Violation|0|||
127576449|NCT01507298|459080643|FG001|Overall Study|Protocol Violation|6|||
127782320|NCT01721057|459829747|FG002|Treatment Period|Adverse Event|12|||
127576450|NCT00537238|459080644|FG000|Overall Study|Death|1|||
127576451|NCT00537238|459080645|FG001|Overall Study|Death|2|||
127576452|NCT00537238|459080644|FG000|Overall Study|Adverse Event|31|||
127576453|NCT00537238|459080645|FG001|Overall Study|Adverse Event|22|||
127576454|NCT00537238|459080644|FG000|Overall Study|Lack of Efficacy|20|||
127576455|NCT00537238|459080645|FG001|Overall Study|Lack of Efficacy|21|||
127576456|NCT00537238|459080644|FG000|Overall Study|Lost to Follow-up|12|||
127576457|NCT00537238|459080645|FG001|Overall Study|Lost to Follow-up|8|||
127576458|NCT00537238|459080644|FG000|Overall Study|Withdrawal by Subject|51|||
127576459|NCT00537238|459080645|FG001|Overall Study|Withdrawal by Subject|47|||
127576460|NCT00537238|459080644|FG000|Overall Study|Protocol Violation|15|||
127576461|NCT00537238|459080645|FG001|Overall Study|Protocol Violation|19|||
127576462|NCT00537238|459080644|FG000|Overall Study|Does not meet entrance criteria|0|||
127576463|NCT00537238|459080645|FG001|Overall Study|Does not meet entrance criteria|2|||
127576464|NCT00537238|459080644|FG000|Overall Study|Other|44|||
127576465|NCT00537238|459080645|FG001|Overall Study|Other|52|||
127576466|NCT03911713|459080648|FG000|Overall Study|Lost to Follow-up|0|||
127576467|NCT03911713|459080649|FG001|Overall Study|Lost to Follow-up|2|||
127576468|NCT03911713|459080650|FG002|Overall Study|Lost to Follow-up|0|||
127576469|NCT03911713|459080651|FG003|Overall Study|Lost to Follow-up|0|||
127576470|NCT03911713|459080652|FG004|Overall Study|Lost to Follow-up|0|||
127576471|NCT03911713|459080648|FG000|Overall Study|Other|0|||
127576472|NCT03911713|459080649|FG001|Overall Study|Other|0|||
127576473|NCT03911713|459080650|FG002|Overall Study|Other|0|||
127576474|NCT03911713|459080651|FG003|Overall Study|Other|1|||
127576475|NCT03911713|459080652|FG004|Overall Study|Other|0|||
127576476|NCT03911713|459080648|FG000|Overall Study|Randomized, Never Dosed|1|||
127576477|NCT03911713|459080649|FG001|Overall Study|Randomized, Never Dosed|0|||
127576478|NCT03911713|459080650|FG002|Overall Study|Randomized, Never Dosed|0|||
127576479|NCT03911713|459080651|FG003|Overall Study|Randomized, Never Dosed|1|||
127576480|NCT03911713|459080652|FG004|Overall Study|Randomized, Never Dosed|0|||
127576481|NCT01845818|459080653|FG000|Overall Study|Withdrawal by Subject|0|||
127576482|NCT01845818|459080654|FG001|Overall Study|Withdrawal by Subject|1|||
127576483|NCT01845818|459080653|FG000|Overall Study|Lost to Follow-up|7|||
127576484|NCT01845818|459080654|FG001|Overall Study|Lost to Follow-up|5|||
127576485|NCT01845818|459080653|FG000|Overall Study|Administrative Reasons|3|||
127576486|NCT01845818|459080654|FG001|Overall Study|Administrative Reasons|1|||
127576487|NCT01845818|459080653|FG000|Overall Study|Serious Adverse Event|1|||
127576488|NCT01845818|459080654|FG001|Overall Study|Serious Adverse Event|1|||
127576489|NCT01845818|459080653|FG000|Overall Study|Other|25|||
127576490|NCT01845818|459080654|FG001|Overall Study|Other|8|||
127576491|NCT01845818|459080653|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
127576492|NCT01845818|459080654|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
127576493|NCT01845818|459080653|FG000|Overall Study|No Follow-Up Data Available|4|||
127576494|NCT01845818|459080654|FG001|Overall Study|No Follow-Up Data Available|1|||
127576495|NCT00422097|459080655|FG000|Dose Level 2|Still on treatment|0|||
127576496|NCT00422097|459080656|FG001|Dose Level 2|Still on treatment|1|||
127576497|NCT00422097|459080657|FG002|Dose Level 2|Still on treatment|0|||
127576498|NCT00422097|459080658|FG003|Dose Level 2|Still on treatment|0|||
127576499|NCT00422097|459080659|FG004|Dose Level 2|Still on treatment|0|||
127576500|NCT00422097|459080660|FG005|Dose Level 2|Still on treatment|0|||
127576501|NCT00422097|459080661|FG006|Dose Level 2|Still on treatment|0|||
127576502|NCT00422097|459080662|FG007|Dose Level 2|Still on treatment|0|||
127576503|NCT00736957|459080663|FG000|Overall Study|Adverse Event|43|||
127576504|NCT00736957|459080663|FG000|Overall Study|Withdrawal by Subject|49|||
127576505|NCT00736957|459080663|FG000|Overall Study|violation of eligibility criteria|2|||
127576506|NCT00736957|459080663|FG000|Overall Study|did not attend hospital appointments|1|||
127782321|NCT01721057|459829748|FG003|Treatment Period|Adverse Event|0|||
128029751|NCT05451329|460735109|FG000|Overall Study|Adverse Event|1|||
128029752|NCT05451329|460735110|FG001|Overall Study|Adverse Event|1|||
128029753|NCT05451329|460735111|FG002|Overall Study|Adverse Event|0|||
128029754|NCT05451329|460735109|FG000|Overall Study|Withdrawal by Subject|1|||
128029755|NCT05451329|460735110|FG001|Overall Study|Withdrawal by Subject|0|||
128029756|NCT05451329|460735111|FG002|Overall Study|Withdrawal by Subject|0|||
128029757|NCT05451329|460735109|FG000|Overall Study|Investigational Product Lot exchange|1|||
127576507|NCT00736957|459080663|FG000|Overall Study|not eligible for Treatment Period I|22|||
127576508|NCT00736957|459080663|FG000|Overall Study|Physician Decision|5|||
127576509|NCT05061966|459080676|FG000|Overall Study|Lost to Follow-up|13|||
127576510|NCT05061966|459080677|FG001|Overall Study|Lost to Follow-up|13|||
127576511|NCT02923427|459080683|FG000|Overall Study|convert to laparatomy|2|||
127576512|NCT02923427|459080684|FG001|Overall Study|convert to laparatomy|2|||
127576513|NCT02923427|459080683|FG000|Overall Study|destaturation|1|||
127576514|NCT02923427|459080684|FG001|Overall Study|destaturation|0|||
127576515|NCT02923427|459080683|FG000|Overall Study|can not replace LMA|1|||
127576516|NCT02923427|459080684|FG001|Overall Study|can not replace LMA|0|||
127576517|NCT01325623|459080685|FG000|Overall Study|Withdrawal by Subject|3|||
127576518|NCT00145600|459080686|FG000|Overall Study|Death|1|||
127576519|NCT00145600|459080687|FG001|Overall Study|Death|2|||
127576520|NCT00145600|459080688|FG002|Overall Study|Death|2|||
127576521|NCT00145600|459080689|FG003|Overall Study|Death|6|||
127576522|NCT00145600|459080686|FG000|Overall Study|Ineligible|3|||
127576523|NCT00145600|459080687|FG001|Overall Study|Ineligible|0|||
127576524|NCT00145600|459080688|FG002|Overall Study|Ineligible|1|||
127576525|NCT00145600|459080689|FG003|Overall Study|Ineligible|5|||
127576526|NCT00145600|459080686|FG000|Overall Study|Lost to Follow-up|2|||
127576527|NCT00145600|459080687|FG001|Overall Study|Lost to Follow-up|6|||
127576528|NCT00145600|459080688|FG002|Overall Study|Lost to Follow-up|2|||
127576529|NCT00145600|459080689|FG003|Overall Study|Lost to Follow-up|4|||
127576530|NCT00145600|459080686|FG000|Overall Study|Noncompliance|1|||
127576531|NCT00145600|459080687|FG001|Overall Study|Noncompliance|0|||
127576532|NCT00145600|459080688|FG002|Overall Study|Noncompliance|0|||
127576533|NCT00145600|459080689|FG003|Overall Study|Noncompliance|0|||
127576534|NCT00145600|459080686|FG000|Overall Study|Withdrawal by Subject|1|||
127576535|NCT00145600|459080687|FG001|Overall Study|Withdrawal by Subject|2|||
127576536|NCT00145600|459080688|FG002|Overall Study|Withdrawal by Subject|0|||
127576537|NCT00145600|459080689|FG003|Overall Study|Withdrawal by Subject|1|||
127576538|NCT00950911|459080695|FG000|Overall Study|Adverse Event|0|||
127782322|NCT01721057|459829749|FG004|Treatment Period|Adverse Event|0|||
127782323|NCT01721057|459829750|FG005|Treatment Period|Adverse Event|0|||
127782324|NCT01721057|459829751|FG006|Treatment Period|Adverse Event|0|||
127782325|NCT01721057|459829745|FG000|Treatment Period|Lack of Efficacy|7|||
127782326|NCT01721057|459829746|FG001|Treatment Period|Lack of Efficacy|3|||
127782327|NCT01721057|459829747|FG002|Treatment Period|Lack of Efficacy|0|||
127782328|NCT01721057|459829748|FG003|Treatment Period|Lack of Efficacy|0|||
127782329|NCT01721057|459829749|FG004|Treatment Period|Lack of Efficacy|0|||
127782330|NCT01721057|459829750|FG005|Treatment Period|Lack of Efficacy|0|||
127782331|NCT01721057|459829751|FG006|Treatment Period|Lack of Efficacy|0|||
127782332|NCT01721057|459829745|FG000|Treatment Period|Lost to Follow-up|1|||
127782333|NCT01721057|459829746|FG001|Treatment Period|Lost to Follow-up|0|||
127782334|NCT01721057|459829747|FG002|Treatment Period|Lost to Follow-up|0|||
127782335|NCT01721057|459829748|FG003|Treatment Period|Lost to Follow-up|0|||
127782336|NCT01721057|459829749|FG004|Treatment Period|Lost to Follow-up|0|||
127782337|NCT01721057|459829750|FG005|Treatment Period|Lost to Follow-up|0|||
127782338|NCT01721057|459829751|FG006|Treatment Period|Lost to Follow-up|0|||
127782339|NCT01721057|459829745|FG000|Treatment Period|Physician Decision|0|||
127782340|NCT01721057|459829746|FG001|Treatment Period|Physician Decision|1|||
128029758|NCT05451329|460735110|FG001|Overall Study|Investigational Product Lot exchange|1|||
127576539|NCT00950911|459080696|FG001|Overall Study|Adverse Event|2|||
127576540|NCT00950911|459080695|FG000|Overall Study|Death|4|||
127782341|NCT01721057|459829747|FG002|Treatment Period|Physician Decision|3|||
127782342|NCT01721057|459829748|FG003|Treatment Period|Physician Decision|0|||
127782343|NCT01721057|459829749|FG004|Treatment Period|Physician Decision|0|||
127782344|NCT01721057|459829750|FG005|Treatment Period|Physician Decision|0|||
127782345|NCT01721057|459829751|FG006|Treatment Period|Physician Decision|0|||
128029759|NCT05451329|460735111|FG002|Overall Study|Investigational Product Lot exchange|0|||
127576541|NCT00950911|459080696|FG001|Overall Study|Death|6|||
127576542|NCT00950911|459080695|FG000|Overall Study|Disease progression|2|||
127576543|NCT00950911|459080696|FG001|Overall Study|Disease progression|2|||
127576544|NCT00950911|459080695|FG000|Overall Study|Consent withdrawn|1|||
127576545|NCT00950911|459080696|FG001|Overall Study|Consent withdrawn|3|||
127576546|NCT00950911|459080695|FG000|Overall Study|Administrative decision|3|||
127782346|NCT01721057|459829745|FG000|Treatment Period|Death|2|||
127782347|NCT01721057|459829746|FG001|Treatment Period|Death|0|||
127576547|NCT00950911|459080696|FG001|Overall Study|Administrative decision|1|||
127881164|NCT01556165|460186152|FG000|Overall Study|Withdrawal of Consent|7|||
127576548|NCT00950911|459080695|FG000|Overall Study|Ineligibility determined|1|||
127576549|NCT00950911|459080696|FG001|Overall Study|Ineligibility determined|0|||
127576550|NCT00950911|459080695|FG000|Overall Study|Noncompliance|1|||
127576551|NCT00950911|459080696|FG001|Overall Study|Noncompliance|0|||
127576552|NCT00950911|459080695|FG000|Overall Study|Poor performance status|0|||
127881165|NCT01556165|460186153|FG001|Overall Study|Withdrawal of Consent|1|||
127881166|NCT01238172|460186154|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
127881167|NCT01238172|460186155|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
127881168|NCT01238172|460186154|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
127881169|NCT01238172|460186155|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
127881170|NCT02531698|460186156|FG000|Overall Study|Adverse Event|2|||
127881171|NCT02531698|460186157|FG001|Overall Study|Adverse Event|1|||
127881172|NCT02531698|460186156|FG000|Overall Study|Withdrawal by Subject|6|||
127881173|NCT02531698|460186157|FG001|Overall Study|Withdrawal by Subject|1|||
127881174|NCT02531698|460186156|FG000|Overall Study|Protocol Violation|2|||
127881175|NCT02531698|460186157|FG001|Overall Study|Protocol Violation|0|||
127881176|NCT02531698|460186156|FG000|Overall Study|Lost to Follow-up|1|||
127881177|NCT02531698|460186157|FG001|Overall Study|Lost to Follow-up|0|||
127881178|NCT00701558|460186158|FG000|Overall Study|Death|7|||
127881179|NCT00701558|460186158|FG000|Overall Study|Lost to Follow-up|8|||
127881180|NCT00131937|460186159|FG000|Overall Study|Adverse Event|3|||
127881181|NCT00131937|460186159|FG000|Overall Study|Withdrawal by Subject|2|||
127881182|NCT00131937|460186159|FG000|Overall Study|Physician Decision|1|||
127576553|NCT00950911|459080696|FG001|Overall Study|Poor performance status|1|||
127576554|NCT02600351|459080699|FG000|Overall Study|Lack of Efficacy|3|||
127576555|NCT02600351|459080700|FG001|Overall Study|Lack of Efficacy|0|||
127576556|NCT02600351|459080701|FG002|Overall Study|Lack of Efficacy|5|||
127576557|NCT02600351|459080702|FG003|Overall Study|Lack of Efficacy|2|||
127576558|NCT02600351|459080699|FG000|Overall Study|Lost to Follow-up|1|||
127576559|NCT02600351|459080700|FG001|Overall Study|Lost to Follow-up|0|||
127576560|NCT02600351|459080701|FG002|Overall Study|Lost to Follow-up|0|||
127576561|NCT02600351|459080702|FG003|Overall Study|Lost to Follow-up|0|||
127576562|NCT02600351|459080699|FG000|Overall Study|Randomized but Not Treated|1|||
127576563|NCT02600351|459080700|FG001|Overall Study|Randomized but Not Treated|0|||
127576564|NCT02600351|459080701|FG002|Overall Study|Randomized but Not Treated|1|||
127881183|NCT00131937|460186159|FG000|Overall Study|Disease Progression|7|||
127881184|NCT00131937|460186159|FG000|Overall Study|Alternative therapy|1|||
127881185|NCT01640964|460186160|FG000|Overall Study|Lost to Follow-up|0|||
127576565|NCT02600351|459080702|FG003|Overall Study|Randomized but Not Treated|3|||
127576566|NCT04087213|459080703|FG000|In-Facility Introduction|Withdrawal by Subject|1|||
127576567|NCT04087213|459080703|FG000|In-Facility Introduction|Adverse Event|1|||
127576568|NCT04087213|459080703|FG000|Assisted Evaluable Period|Withdrawal by Subject|2|||
127576569|NCT04087213|459080703|FG000|Assisted Evaluable Period|Personal reasons|3|||
127576570|NCT04087213|459080703|FG000|Transition Period B|Renal Transplantation|1|||
127881186|NCT01640964|460186161|FG001|Overall Study|Lost to Follow-up|0|||
127881187|NCT01640964|460186162|FG002|Overall Study|Lost to Follow-up|1|||
127576571|NCT02556203|459080710|FG000|Overall Study|Withdrawal by Subject|21|||
127576572|NCT02556203|459080711|FG001|Overall Study|Withdrawal by Subject|21|||
127881188|NCT01640964|460186160|FG000|Overall Study|Protocol Deviation|1|||
127881189|NCT01640964|460186161|FG001|Overall Study|Protocol Deviation|1|||
127881190|NCT01640964|460186162|FG002|Overall Study|Protocol Deviation|2|||
128029760|NCT02202577|460735112|FG000|Overall Study|Lost to Follow-up|6|||
128029761|NCT02202577|460735113|FG001|Overall Study|Lost to Follow-up|16|||
128029762|NCT02202577|460735112|FG000|Overall Study|Protocol Violation|7|||
128029763|NCT02202577|460735113|FG001|Overall Study|Protocol Violation|3|||
128029764|NCT00829868|460735114|FG000|Washout|Physician Decision|1|||
128029765|NCT00829868|460735115|FG001|Washout|Physician Decision|0|||
128029766|NCT02799043|460735116|FG000|Overall Study|Adverse Event|0|||
127576573|NCT02556203|459080710|FG000|Overall Study|Lost to Follow-up|5|||
127576574|NCT02556203|459080711|FG001|Overall Study|Lost to Follow-up|5|||
127576575|NCT02556203|459080710|FG000|Overall Study|Adverse Event|1|||
127576576|NCT02556203|459080711|FG001|Overall Study|Adverse Event|0|||
127576577|NCT03875768|459080712|FG000|Overall Study|Lost to Follow-up|16|||
127576578|NCT03875768|459080713|FG001|Overall Study|Lost to Follow-up|13|||
127576579|NCT03875768|459080712|FG000|Overall Study|Withdrawal by Subject|10|||
127576580|NCT03875768|459080713|FG001|Overall Study|Withdrawal by Subject|21|||
127576581|NCT03875768|459080712|FG000|Overall Study|Did not complete assessment|21|||
127576582|NCT03875768|459080713|FG001|Overall Study|Did not complete assessment|12|||
127576583|NCT03875768|459080712|FG000|Overall Study|Became ineligible|1|||
127576584|NCT03875768|459080713|FG001|Overall Study|Became ineligible|0|||
127576585|NCT00580970|459080714|FG000|Pre-treatment|Non-compliance|1|||
127576586|NCT00580970|459080714|FG000|Treatment (Lovastatin)|Non-compliance|6|||
127576587|NCT00580970|459080714|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
127576588|NCT00580970|459080714|FG000|Treatment (Lovastatin)|Physician Decision|4|||
127576589|NCT00580970|459080714|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
127576590|NCT00580970|459080714|FG000|Treatment (Lovastatin)|Death|1|||
127576591|NCT01086423|459080715|FG000|Overall Study|Protocol Violation|0|||
127576592|NCT01086423|459080716|FG001|Overall Study|Protocol Violation|0|||
127576593|NCT01086423|459080717|FG002|Overall Study|Protocol Violation|1|||
127576594|NCT01086423|459080715|FG000|Overall Study|Migrated/moved from study area|2|||
127692956|NCT03912831|459501685|FG000|Overall Study|Reason not Specified|0|||
127692957|NCT03912831|459501686|FG001|Overall Study|Reason not Specified|0|||
127692958|NCT03912831|459501687|FG002|Overall Study|Reason not Specified|0|||
127692959|NCT03912831|459501688|FG003|Overall Study|Reason not Specified|0|||
127692960|NCT03912831|459501689|FG004|Overall Study|Reason not Specified|1|||
127692961|NCT03912831|459501690|FG005|Overall Study|Reason not Specified|0|||
127692962|NCT03912831|459501685|FG000|Overall Study|Withdrawal by Participant|0|||
127692963|NCT03912831|459501686|FG001|Overall Study|Withdrawal by Participant|0|||
127692964|NCT03912831|459501687|FG002|Overall Study|Withdrawal by Participant|0|||
127692965|NCT03912831|459501688|FG003|Overall Study|Withdrawal by Participant|0|||
127692966|NCT03912831|459501689|FG004|Overall Study|Withdrawal by Participant|1|||
127692967|NCT03912831|459501690|FG005|Overall Study|Withdrawal by Participant|0|||
127692968|NCT04442126|459501696|FG000|Overall Study|Withdrawal by Subject|0|||
127692969|NCT04442126|459501697|FG001|Overall Study|Withdrawal by Subject|0|||
127692970|NCT04442126|459501698|FG002|Overall Study|Withdrawal by Subject|0|||
127692971|NCT04442126|459501699|FG003|Overall Study|Withdrawal by Subject|2|||
127692972|NCT04442126|459501700|FG004|Overall Study|Withdrawal by Subject|1|||
127692973|NCT04442126|459501701|FG005|Overall Study|Withdrawal by Subject|0|||
127692974|NCT04442126|459501702|FG006|Overall Study|Withdrawal by Subject|1|||
127692975|NCT04442126|459501703|FG007|Overall Study|Withdrawal by Subject|1|||
127692976|NCT04442126|459501704|FG008|Overall Study|Withdrawal by Subject|3|||
127692977|NCT04442126|459501696|FG000|Overall Study|Death|1|||
127692978|NCT04442126|459501697|FG001|Overall Study|Death|0|||
127692979|NCT04442126|459501698|FG002|Overall Study|Death|0|||
127692980|NCT04442126|459501699|FG003|Overall Study|Death|1|||
127692981|NCT04442126|459501700|FG004|Overall Study|Death|2|||
127692982|NCT04442126|459501701|FG005|Overall Study|Death|2|||
127692983|NCT04442126|459501702|FG006|Overall Study|Death|4|||
127692984|NCT04442126|459501703|FG007|Overall Study|Death|1|||
127692985|NCT04442126|459501704|FG008|Overall Study|Death|5|||
127692986|NCT04442126|459501696|FG000|Overall Study|Study Terminated by Sponsor|0|||
127692987|NCT04442126|459501697|FG001|Overall Study|Study Terminated by Sponsor|0|||
127692988|NCT04442126|459501698|FG002|Overall Study|Study Terminated by Sponsor|0|||
127692989|NCT04442126|459501699|FG003|Overall Study|Study Terminated by Sponsor|0|||
127692990|NCT04442126|459501700|FG004|Overall Study|Study Terminated by Sponsor|0|||
127692991|NCT04442126|459501701|FG005|Overall Study|Study Terminated by Sponsor|1|||
127692992|NCT04442126|459501702|FG006|Overall Study|Study Terminated by Sponsor|4|||
127881191|NCT02787746|460186163|FG000|Overall Study|Adverse Event|42|||
127576595|NCT01086423|459080716|FG001|Overall Study|Migrated/moved from study area|0|||
128029767|NCT02799043|460735117|FG001|Overall Study|Adverse Event|1|||
128029768|NCT02799043|460735116|FG000|Overall Study|Death|1|||
128029769|NCT02799043|460735117|FG001|Overall Study|Death|1|||
127576596|NCT01086423|459080717|FG002|Overall Study|Migrated/moved from study area|4|||
127692993|NCT04442126|459501703|FG007|Overall Study|Study Terminated by Sponsor|2|||
127692994|NCT04442126|459501704|FG008|Overall Study|Study Terminated by Sponsor|10|||
127692995|NCT04442126|459501696|FG000|Overall Study|Lost to Follow-up|0|||
127692996|NCT04442126|459501697|FG001|Overall Study|Lost to Follow-up|0|||
127692997|NCT04442126|459501698|FG002|Overall Study|Lost to Follow-up|0|||
127692998|NCT04442126|459501699|FG003|Overall Study|Lost to Follow-up|0|||
128029770|NCT02799043|460735116|FG000|Overall Study|Lost to Follow-up|3|||
128029771|NCT02799043|460735117|FG001|Overall Study|Lost to Follow-up|6|||
128029772|NCT02799043|460735116|FG000|Overall Study|Withdrawal by Subject|4|||
128029773|NCT02799043|460735117|FG001|Overall Study|Withdrawal by Subject|4|||
128029774|NCT02799043|460735116|FG000|Overall Study|Moved to different country|0|||
128029775|NCT02799043|460735117|FG001|Overall Study|Moved to different country|1|||
128029776|NCT02799043|460735116|FG000|Overall Study|Trial Screen Failure|1|||
128029777|NCT02799043|460735117|FG001|Overall Study|Trial Screen Failure|0|||
127576597|NCT01086423|459080715|FG000|Overall Study|Adverse event, fatal|1|||
127576598|NCT01086423|459080716|FG001|Overall Study|Adverse event, fatal|1|||
128029778|NCT02799043|460735116|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
127576599|NCT01086423|459080717|FG002|Overall Study|Adverse event, fatal|0|||
127576600|NCT01086423|459080715|FG000|Overall Study|Adverse event, non-fatal|2|||
127576601|NCT01086423|459080716|FG001|Overall Study|Adverse event, non-fatal|1|||
127576602|NCT01086423|459080717|FG002|Overall Study|Adverse event, non-fatal|0|||
127576603|NCT01086423|459080715|FG000|Overall Study|Withdrawal by Subject|5|||
127576604|NCT01086423|459080716|FG001|Overall Study|Withdrawal by Subject|1|||
127576605|NCT01086423|459080717|FG002|Overall Study|Withdrawal by Subject|3|||
127576606|NCT01086423|459080715|FG000|Overall Study|Lost to Follow-up|0|||
127576607|NCT01086423|459080716|FG001|Overall Study|Lost to Follow-up|0|||
127576608|NCT01086423|459080717|FG002|Overall Study|Lost to Follow-up|1|||
127576609|NCT01225887|459080718|FG000|Overall Study|Ineligible:required test not done|2|||
127576610|NCT01225887|459080718|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
127576611|NCT01225887|459080718|FG000|Overall Study|Ineligible:inadequate pathology|2|||
127576612|NCT00925990|459080719|FG000|Overall Study|Adverse Event|1|||
127576613|NCT00925990|459080720|FG001|Overall Study|Adverse Event|3|||
127576614|NCT00925990|459080719|FG000|Overall Study|Withdrawal by Subject|2|||
127576615|NCT00925990|459080720|FG001|Overall Study|Withdrawal by Subject|2|||
127576616|NCT00925990|459080719|FG000|Overall Study|Lost to Follow-up|1|||
127576617|NCT00925990|459080720|FG001|Overall Study|Lost to Follow-up|3|||
127576618|NCT00925990|459080719|FG000|Overall Study|Physician Decision|1|||
127576619|NCT00925990|459080720|FG001|Overall Study|Physician Decision|1|||
127576620|NCT00925990|459080719|FG000|Overall Study|moved out of state, missed medication|0|||
127576621|NCT00925990|459080720|FG001|Overall Study|moved out of state, missed medication|2|||
127576622|NCT00737438|459080727|FG000|Overall Study|Withdrawal by Subject|2|||
127576623|NCT00737438|459080727|FG000|Overall Study|Patient ineligible|1|||
127576624|NCT02791594|459080729|FG000|Overall Study|Physician Decision|2|||
127576625|NCT04950166|459080735|FG000|Overall Study|Withdrawal by Subject|1|||
127576626|NCT02001181|459080739|FG000|Overall Study|Adverse Event|0|||
127576627|NCT02001181|459080740|FG001|Overall Study|Adverse Event|2|||
127576628|NCT02001181|459080739|FG000|Overall Study|Lost to Follow-up|1|||
127576629|NCT02001181|459080740|FG001|Overall Study|Lost to Follow-up|0|||
127576630|NCT02001181|459080739|FG000|Overall Study|Withdrawal by Subject|0|||
127576631|NCT02001181|459080740|FG001|Overall Study|Withdrawal by Subject|1|||
127576632|NCT00292318|459080742|FG000|Overall Study|Study terminated by officials|2|||
127576633|NCT00292318|459080743|FG001|Overall Study|Study terminated by officials|1|||
127576634|NCT00406718|459080744|FG000|Overall Study|Withdrawal by Subject|2|||
127576635|NCT00406718|459080745|FG001|Overall Study|Withdrawal by Subject|9|||
127576636|NCT00406718|459080746|FG002|Overall Study|Withdrawal by Subject|4|||
127782348|NCT01721057|459829747|FG002|Treatment Period|Death|0|||
127782349|NCT01721057|459829748|FG003|Treatment Period|Death|0|||
127782350|NCT01721057|459829749|FG004|Treatment Period|Death|0|||
127782351|NCT01721057|459829750|FG005|Treatment Period|Death|0|||
127782352|NCT01721057|459829751|FG006|Treatment Period|Death|0|||
127782353|NCT01721057|459829745|FG000|Rescue Period|Adverse Event|0|||
127782354|NCT01721057|459829746|FG001|Rescue Period|Adverse Event|0|||
127782355|NCT01721057|459829747|FG002|Rescue Period|Adverse Event|0|||
127782356|NCT01721057|459829748|FG003|Rescue Period|Adverse Event|1|||
127782357|NCT01721057|459829749|FG004|Rescue Period|Adverse Event|0|||
127782358|NCT01721057|459829750|FG005|Rescue Period|Adverse Event|0|||
127782359|NCT01721057|459829751|FG006|Rescue Period|Adverse Event|0|||
127782360|NCT01721057|459829745|FG000|Rescue Period|Lack of Efficacy|0|||
127782361|NCT01721057|459829746|FG001|Rescue Period|Lack of Efficacy|0|||
127782362|NCT01721057|459829747|FG002|Rescue Period|Lack of Efficacy|0|||
127782363|NCT01721057|459829748|FG003|Rescue Period|Lack of Efficacy|2|||
127782364|NCT01721057|459829749|FG004|Rescue Period|Lack of Efficacy|0|||
127782365|NCT01721057|459829750|FG005|Rescue Period|Lack of Efficacy|0|||
127782366|NCT01721057|459829751|FG006|Rescue Period|Lack of Efficacy|0|||
127782367|NCT01202279|459829752|FG000|Overall Study|Adverse Event|8|||
127782368|NCT01202279|459829753|FG001|Overall Study|Adverse Event|6|||
127576637|NCT00406718|459080744|FG000|Overall Study|Lost to Follow-up|2|||
127576638|NCT00406718|459080745|FG001|Overall Study|Lost to Follow-up|5|||
127576639|NCT00406718|459080746|FG002|Overall Study|Lost to Follow-up|4|||
127576640|NCT02898116|459080748|FG000|Overall Study|Adverse Event|1|||
127576641|NCT02898116|459080748|FG000|Overall Study|Progressive disease|1|||
127576642|NCT04755283|459080753|FG000|Overall Study|Withdrawal by Subject|14|||
127782369|NCT01202279|459829752|FG000|Overall Study|Withdrawal by Subject|13|||
128029779|NCT02799043|460735117|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
128029780|NCT06091956|460735118|FG000|Overall Study|Withdrawal by Subject|1|||
127576643|NCT04755283|459080754|FG001|Overall Study|Withdrawal by Subject|3|||
127576644|NCT04755283|459080755|FG002|Overall Study|Withdrawal by Subject|6|||
127576645|NCT04755283|459080753|FG000|Overall Study|Lost to Follow-up|0|||
127576646|NCT04755283|459080754|FG001|Overall Study|Lost to Follow-up|0|||
127576647|NCT04755283|459080755|FG002|Overall Study|Lost to Follow-up|1|||
127576648|NCT04755283|459080753|FG000|Overall Study|Death|31|||
127576649|NCT04755283|459080754|FG001|Overall Study|Death|36|||
127576650|NCT04755283|459080755|FG002|Overall Study|Death|34|||
127576651|NCT05597020|459080756|FG000|Washout|Forbidden medication|2|||
127576652|NCT05597020|459080757|FG001|Washout|Forbidden medication|0|||
127576653|NCT05597020|459080756|FG000|Treatment Period II|Advice from primary care physician|1|||
127576654|NCT05597020|459080757|FG001|Treatment Period II|Advice from primary care physician|0|||
127576655|NCT05597020|459080756|FG000|Treatment Period II|Subject lost investigational product|1|||
127576656|NCT05597020|459080757|FG001|Treatment Period II|Subject lost investigational product|0|||
127576657|NCT05597020|459080756|FG000|Treatment Period II|Private reasons|0|||
127576658|NCT05597020|459080757|FG001|Treatment Period II|Private reasons|1|||
127576659|NCT05169567|459080758|FG000|Overall Study|On study treatment|116|||
127576660|NCT05169567|459080759|FG001|Overall Study|On study treatment|128|||
127576661|NCT05169567|459080758|FG000|Overall Study|Lost to Follow-up|1|||
127576662|NCT05169567|459080759|FG001|Overall Study|Lost to Follow-up|0|||
127576663|NCT05169567|459080758|FG000|Overall Study|Withdrawal by Subject|25|||
127576664|NCT05169567|459080759|FG001|Overall Study|Withdrawal by Subject|21|||
127782370|NCT01202279|459829753|FG001|Overall Study|Withdrawal by Subject|10|||
127782371|NCT01202279|459829752|FG000|Overall Study|Physician Decision|0|||
127782372|NCT01202279|459829753|FG001|Overall Study|Physician Decision|1|||
127782373|NCT01202279|459829752|FG000|Overall Study|Lost to Follow-up|10|||
127782374|NCT01202279|459829753|FG001|Overall Study|Lost to Follow-up|7|||
127782375|NCT01202279|459829752|FG000|Overall Study|Protocol Violation|1|||
127782376|NCT01202279|459829753|FG001|Overall Study|Protocol Violation|1|||
127782377|NCT01202279|459829752|FG000|Overall Study|study compliance|5|||
127782378|NCT01202279|459829753|FG001|Overall Study|study compliance|2|||
127782379|NCT02546765|459829756|FG000|Overall Study|Withdrawal by Subject|0|||
127782380|NCT02546765|459829757|FG001|Overall Study|Withdrawal by Subject|1|||
127782381|NCT02546765|459829758|FG002|Overall Study|Withdrawal by Subject|0|||
127782382|NCT02546765|459829759|FG003|Overall Study|Withdrawal by Subject|0|||
127782383|NCT00475722|459829760|FG000|Overall Study|Withdrawal by Subject|12|||
127782384|NCT00475722|459829761|FG001|Overall Study|Withdrawal by Subject|12|||
127782385|NCT00475722|459829760|FG000|Overall Study|Protocol Violation|3|||
127782386|NCT00475722|459829761|FG001|Overall Study|Protocol Violation|0|||
127782387|NCT00916279|459829762|FG000|Overall Study|Death|2|||
127782388|NCT00916279|459829762|FG000|Overall Study|Lost to Follow-up|2|||
127782389|NCT02064920|459829763|FG000|Overall Study|Adverse Event|0|||
127782390|NCT02064920|459829764|FG001|Overall Study|Adverse Event|4|||
127782391|NCT02064920|459829763|FG000|Overall Study|Physician Decision|0|||
127782392|NCT02064920|459829764|FG001|Overall Study|Physician Decision|1|||
127782393|NCT02064920|459829763|FG000|Overall Study|Technical Problems|0|||
127782394|NCT02064920|459829764|FG001|Overall Study|Technical Problems|1|||
127782395|NCT02064920|459829763|FG000|Overall Study|Withdrawal by Subject|1|||
127782396|NCT02064920|459829764|FG001|Overall Study|Withdrawal by Subject|3|||
127782397|NCT02109562|459829765|FG000|Overall Study|Insufficient clinical response|2|||
127782398|NCT02109562|459829766|FG001|Overall Study|Insufficient clinical response|0|||
127782399|NCT02109562|459829767|FG002|Overall Study|Insufficient clinical response|4|||
127782400|NCT02109562|459829765|FG000|Overall Study|Adverse Event|0|||
127782401|NCT02109562|459829766|FG001|Overall Study|Adverse Event|2|||
127782402|NCT02109562|459829767|FG002|Overall Study|Adverse Event|3|||
127782403|NCT02109562|459829765|FG000|Overall Study|Lost to Follow-up|1|||
127782404|NCT02109562|459829766|FG001|Overall Study|Lost to Follow-up|0|||
127782405|NCT02109562|459829767|FG002|Overall Study|Lost to Follow-up|1|||
127782406|NCT02109562|459829765|FG000|Overall Study|Protocol Violation|0|||
127782407|NCT02109562|459829766|FG001|Overall Study|Protocol Violation|3|||
127782408|NCT02109562|459829767|FG002|Overall Study|Protocol Violation|1|||
127782409|NCT02109562|459829765|FG000|Overall Study|Withdrawal by Subject|20|||
127782410|NCT02109562|459829766|FG001|Overall Study|Withdrawal by Subject|25|||
127782411|NCT02109562|459829767|FG002|Overall Study|Withdrawal by Subject|21|||
127782412|NCT02109562|459829765|FG000|Overall Study|Physician Decision|3|||
127576665|NCT01015131|459080760|FG000|Overall Study|Physician Decision|1|||
127576666|NCT01015131|459080760|FG000|Overall Study|Protocol Violation|1|||
127576667|NCT01015131|459080760|FG000|Overall Study|Withdrawal by Subject|2|||
127782413|NCT02109562|459829766|FG001|Overall Study|Physician Decision|4|||
127782414|NCT02109562|459829767|FG002|Overall Study|Physician Decision|5|||
127782415|NCT00310804|459829768|FG000|Overall Study|Lost to Follow-up|2|||
127782416|NCT00310804|459829769|FG001|Overall Study|Lost to Follow-up|0|||
128029781|NCT06091956|460735118|FG000|Overall Study|Complicating Disease|1|||
127782417|NCT00310804|459829768|FG000|Overall Study|Withdrawal by Subject|3|||
127782418|NCT00310804|459829769|FG001|Overall Study|Withdrawal by Subject|0|||
127576668|NCT01015131|459080760|FG000|Overall Study|Other Protocol Specified Criteria|4|||
127576669|NCT05430022|459080761|FG000|Overall Study|Withdrawal by Subject|4|||
127576670|NCT05430022|459080762|FG001|Overall Study|Withdrawal by Subject|4|||
127576671|NCT02445391|459080773|FG000|Overall Study|No active protocol treatment|3|||
127576672|NCT02445391|459080774|FG001|Overall Study|No active protocol treatment|0|||
127576673|NCT02445391|459080775|FG002|Overall Study|No active protocol treatment|0|||
127576674|NCT02445391|459080773|FG000|Overall Study|Adverse Event|0|||
127576675|NCT02445391|459080774|FG001|Overall Study|Adverse Event|21|||
127576676|NCT02445391|459080775|FG002|Overall Study|Adverse Event|12|||
127576677|NCT02445391|459080773|FG000|Overall Study|Alternative therapy|0|||
127576678|NCT02445391|459080774|FG001|Overall Study|Alternative therapy|0|||
127576679|NCT02445391|459080775|FG002|Overall Study|Alternative therapy|1|||
127576680|NCT02445391|459080773|FG000|Overall Study|Disease progression|0|||
127576681|NCT02445391|459080774|FG001|Overall Study|Disease progression|7|||
127576682|NCT02445391|459080775|FG002|Overall Study|Disease progression|22|||
127576683|NCT02445391|459080773|FG000|Overall Study|Complicating disease|0|||
127576684|NCT02445391|459080774|FG001|Overall Study|Complicating disease|2|||
127576685|NCT02445391|459080775|FG002|Overall Study|Complicating disease|1|||
127576686|NCT02445391|459080773|FG000|Overall Study|Withdrawal by Subject|0|||
127576687|NCT02445391|459080774|FG001|Overall Study|Withdrawal by Subject|4|||
127576688|NCT02445391|459080775|FG002|Overall Study|Withdrawal by Subject|9|||
127576689|NCT02445391|459080773|FG000|Overall Study|Financial issue|0|||
127576690|NCT02445391|459080774|FG001|Overall Study|Financial issue|0|||
127576691|NCT02445391|459080775|FG002|Overall Study|Financial issue|2|||
127576692|NCT02445391|459080773|FG000|Overall Study|Still on treatment|0|||
127576693|NCT02445391|459080774|FG001|Overall Study|Still on treatment|7|||
127576694|NCT02445391|459080775|FG002|Overall Study|Still on treatment|16|||
127576695|NCT02445391|459080773|FG000|Overall Study|Not start protocol therapy|0|||
127576696|NCT02445391|459080774|FG001|Overall Study|Not start protocol therapy|12|||
127576697|NCT02445391|459080775|FG002|Overall Study|Not start protocol therapy|9|||
127576698|NCT03148275|459080777|FG000|Overall Study|Death|6|||
127576699|NCT03148275|459080777|FG000|Overall Study|Adverse Event|3|||
127576700|NCT03148275|459080777|FG000|Overall Study|Liver transplant|2|||
127576701|NCT03148275|459080777|FG000|Overall Study|Patient decision|5|||
127576702|NCT03148275|459080777|FG000|Overall Study|transition to commercial drug|1|||
127576703|NCT03148275|459080777|FG000|Overall Study|subjects withdrew from the trial after registration, but before starting study treatment|2|||
127692999|NCT04442126|459501700|FG004|Overall Study|Lost to Follow-up|0|||
127693000|NCT04442126|459501701|FG005|Overall Study|Lost to Follow-up|0|||
127693001|NCT04442126|459501702|FG006|Overall Study|Lost to Follow-up|0|||
127693002|NCT04442126|459501703|FG007|Overall Study|Lost to Follow-up|1|||
127693003|NCT04442126|459501704|FG008|Overall Study|Lost to Follow-up|2|||
127693004|NCT04442126|459501696|FG000|Overall Study|Progressive Disease|0|||
127693005|NCT04442126|459501697|FG001|Overall Study|Progressive Disease|1|||
127693006|NCT04442126|459501698|FG002|Overall Study|Progressive Disease|3|||
127693007|NCT04442126|459501699|FG003|Overall Study|Progressive Disease|0|||
127693008|NCT04442126|459501700|FG004|Overall Study|Progressive Disease|3|||
127693009|NCT04442126|459501701|FG005|Overall Study|Progressive Disease|0|||
127693010|NCT04442126|459501702|FG006|Overall Study|Progressive Disease|0|||
127693011|NCT04442126|459501703|FG007|Overall Study|Progressive Disease|0|||
127693012|NCT04442126|459501704|FG008|Overall Study|Progressive Disease|0|||
127693013|NCT04442126|459501696|FG000|Overall Study|Other|0|||
127693014|NCT04442126|459501697|FG001|Overall Study|Other|0|||
127693015|NCT04442126|459501698|FG002|Overall Study|Other|0|||
127693016|NCT04442126|459501699|FG003|Overall Study|Other|0|||
127693017|NCT04442126|459501700|FG004|Overall Study|Other|0|||
127693018|NCT04442126|459501701|FG005|Overall Study|Other|0|||
127693019|NCT04442126|459501702|FG006|Overall Study|Other|0|||
127693020|NCT04442126|459501703|FG007|Overall Study|Other|0|||
127693021|NCT04442126|459501704|FG008|Overall Study|Other|1|||
127693022|NCT06450405|459501705|FG000|Overall Study|Study funding terminated.|0|||
127693023|NCT06450405|459501706|FG001|Overall Study|Study funding terminated.|2|||
127693024|NCT03152786|459503262|FG000|Overall Study|Withdrawal by Subject|2|||
127693025|NCT03152786|459503263|FG001|Overall Study|Withdrawal by Subject|1|||
127782419|NCT00688155|459829774|FG000|Overall Study|Withdrawal by Subject|2|||
127782420|NCT00688155|459829775|FG001|Overall Study|Withdrawal by Subject|2|||
127782421|NCT00688155|459829776|FG002|Overall Study|Withdrawal by Subject|1|||
127576704|NCT01828320|459080778|FG000|Overall Study|Lost to Follow-up|1|||
127576705|NCT01828320|459080779|FG001|Overall Study|Lost to Follow-up|3|||
127576706|NCT01828320|459080778|FG000|Overall Study|Withdrawal by Subject|7|||
127576707|NCT01828320|459080779|FG001|Overall Study|Withdrawal by Subject|2|||
127576708|NCT00492050|459080780|FG000|Overall Study|Adverse Event|1|||
127576709|NCT00492050|459080780|FG000|Overall Study|Lack of Efficacy|1|||
127576710|NCT00492050|459080780|FG000|Overall Study|Withdrawal by Subject|3|||
127693026|NCT04923347|459503264|FG000|Overall Study|Withdrawal by Subject|14|||
127693027|NCT03424811|459503265|FG000|Overall Study|Lost to Follow-up|9|||
127693028|NCT03424811|459503266|FG001|Overall Study|Lost to Follow-up|0|||
127693029|NCT00753090|459503278|FG000|Overall Study|Withdrawal by Subject|10|||
127693030|NCT00753090|459503279|FG001|Overall Study|Withdrawal by Subject|10|||
127693031|NCT00753090|459503278|FG000|Overall Study|Death|17|||
127693032|NCT00753090|459503279|FG001|Overall Study|Death|6|||
128029782|NCT01421459|460735129|FG000|Overall Study|Adverse Event|6|||
127576711|NCT00492050|459080780|FG000|Overall Study|Unable to collect SCT|2|||
127576712|NCT00492050|459080780|FG000|Overall Study|Progressive Disease|2|||
127576713|NCT01897714|459082205|FG000|Phase I (Dose Escalation)|Disease progression|3|||
127576714|NCT01897714|459082206|FG001|Phase I (Dose Escalation)|Disease progression|5|||
127576715|NCT01897714|459082207|FG002|Phase I (Dose Escalation)|Disease progression|1|||
127576716|NCT01897714|459082208|FG003|Phase I (Dose Escalation)|Disease progression|3|||
127576717|NCT01897714|459082209|FG004|Phase I (Dose Escalation)|Disease progression|0|||
127576718|NCT01897714|459082210|FG005|Phase I (Dose Escalation)|Disease progression|0|||
127576719|NCT01897714|459082205|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
127576720|NCT01897714|459082206|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
127576721|NCT01897714|459082207|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
127576722|NCT01897714|459082208|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
127576723|NCT01897714|459082209|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
127576724|NCT01897714|459082210|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
127576725|NCT01897714|459082205|FG000|Phase I (Dose Escalation)|Other|0|||
127576726|NCT01897714|459082206|FG001|Phase I (Dose Escalation)|Other|1|||
127576727|NCT01897714|459082207|FG002|Phase I (Dose Escalation)|Other|0|||
127576728|NCT01897714|459082208|FG003|Phase I (Dose Escalation)|Other|0|||
127576729|NCT01897714|459082209|FG004|Phase I (Dose Escalation)|Other|0|||
127576730|NCT01897714|459082210|FG005|Phase I (Dose Escalation)|Other|0|||
127576731|NCT01897714|459082205|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
127576732|NCT01897714|459082206|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
127576733|NCT01897714|459082207|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
127576734|NCT01897714|459082208|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
127576735|NCT01897714|459082209|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
127576736|NCT01897714|459082210|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
127576737|NCT01897714|459082205|FG000|Phase II (MTD)|Lost to Follow-up|0|||
127576738|NCT01897714|459082206|FG001|Phase II (MTD)|Lost to Follow-up|0|||
127576739|NCT01897714|459082207|FG002|Phase II (MTD)|Lost to Follow-up|0|||
127576740|NCT01897714|459082208|FG003|Phase II (MTD)|Lost to Follow-up|0|||
127576741|NCT01897714|459082209|FG004|Phase II (MTD)|Lost to Follow-up|1|||
127576742|NCT01897714|459082210|FG005|Phase II (MTD)|Lost to Follow-up|0|||
127576743|NCT01897714|459082205|FG000|Phase II (MTD)|Death|0|||
127576744|NCT01897714|459082206|FG001|Phase II (MTD)|Death|0|||
127576745|NCT01897714|459082207|FG002|Phase II (MTD)|Death|0|||
127576746|NCT01897714|459082208|FG003|Phase II (MTD)|Death|0|||
127576747|NCT01897714|459082209|FG004|Phase II (MTD)|Death|25|||
127576748|NCT01897714|459082210|FG005|Phase II (MTD)|Death|10|||
127576749|NCT01897714|459082205|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
127576750|NCT01897714|459082206|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
127576751|NCT01897714|459082207|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
127576752|NCT01897714|459082208|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
127576753|NCT01897714|459082209|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
127576754|NCT01897714|459082210|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
127576755|NCT01897714|459082205|FG000|Phase II (MTD)|Other|0|||
127576756|NCT01897714|459082206|FG001|Phase II (MTD)|Other|0|||
127576757|NCT01897714|459082207|FG002|Phase II (MTD)|Other|0|||
127693033|NCT00753090|459503278|FG000|Overall Study|Study Prosthesis Removed|12|||
127693034|NCT00753090|459503279|FG001|Overall Study|Study Prosthesis Removed|3|||
127693035|NCT00753090|459503278|FG000|Overall Study|Lost to Follow-up|2|||
127693036|NCT00753090|459503279|FG001|Overall Study|Lost to Follow-up|2|||
127693037|NCT00753090|459503278|FG000|Overall Study|Other|127|||
127693038|NCT00753090|459503279|FG001|Overall Study|Other|75|||
127693039|NCT06066541|459503286|FG000|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|107|||
127693040|NCT06066541|459503287|FG001|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|122|||
127693041|NCT06066541|459503288|FG002|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|128|||
127693042|NCT06066541|459503289|FG003|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|110|||
127693043|NCT06066541|459503290|FG004|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|125|||
127693044|NCT06066541|459503291|FG005|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
127693045|NCT06066541|459503292|FG006|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
127693046|NCT06066541|459503286|FG000|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|6|||
127693047|NCT06066541|459503287|FG001|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|9|||
127693048|NCT06066541|459503288|FG002|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|3|||
127693049|NCT06066541|459503289|FG003|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|8|||
127693050|NCT06066541|459503290|FG004|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|7|||
128029783|NCT01421459|460735130|FG001|Overall Study|Adverse Event|10|||
127576758|NCT01897714|459082208|FG003|Phase II (MTD)|Other|0|||
127576759|NCT01897714|459082209|FG004|Phase II (MTD)|Other|3|||
127576760|NCT01897714|459082210|FG005|Phase II (MTD)|Other|0|||
127576761|NCT00423722|459082211|FG000|Overall Study|Death|4|||
127576762|NCT00423722|459082212|FG001|Overall Study|Death|4|||
127576763|NCT00423722|459082211|FG000|Overall Study|Declined to participate|2|||
127576764|NCT00423722|459082212|FG001|Overall Study|Declined to participate|3|||
127881192|NCT02787746|460186163|FG000|Overall Study|Withdrawal by Subject|65|||
127881193|NCT02787746|460186163|FG000|Overall Study|Failure to up-titrate to 10mg/day: 12 patients; Other reasons: 30 patients|41|||
127881194|NCT02038959|460187331|FG000|Overall Study|Withdrawal by Subject|6|||
127881195|NCT02038959|460187332|FG001|Overall Study|Withdrawal by Subject|8|||
127881196|NCT00424515|460187340|FG000|Overall Study|Progressive Disease|10|||
127881197|NCT00424515|460187341|FG001|Overall Study|Progressive Disease|11|||
127881198|NCT00424515|460187340|FG000|Overall Study|Adverse Event|0|||
127881199|NCT00424515|460187341|FG001|Overall Study|Adverse Event|1|||
127881200|NCT00424515|460187340|FG000|Overall Study|Intercurrent Illness|0|||
127881201|NCT00424515|460187341|FG001|Overall Study|Intercurrent Illness|1|||
127881202|NCT00424515|460187340|FG000|Overall Study|Withdrawal by Subject|1|||
127881203|NCT00424515|460187341|FG001|Overall Study|Withdrawal by Subject|0|||
127881204|NCT00267020|460187342|FG000|Overall Study|Adverse Event|22|||
127881205|NCT00267020|460187343|FG001|Overall Study|Adverse Event|5|||
127881206|NCT00267020|460187342|FG000|Overall Study|Death|2|||
127881207|NCT00267020|460187343|FG001|Overall Study|Death|1|||
127881208|NCT00267020|460187342|FG000|Overall Study|Withdrawal by Subject|17|||
127881209|NCT00267020|460187343|FG001|Overall Study|Withdrawal by Subject|7|||
127881210|NCT00267020|460187342|FG000|Overall Study|Physician Decision|3|||
127881211|NCT00267020|460187343|FG001|Overall Study|Physician Decision|2|||
127881212|NCT00267020|460187342|FG000|Overall Study|Disease Progression|39|||
127881213|NCT00267020|460187343|FG001|Overall Study|Disease Progression|25|||
127881214|NCT00267020|460187342|FG000|Overall Study|Unrelated Complication|1|||
127881215|NCT00267020|460187343|FG001|Overall Study|Unrelated Complication|1|||
127881216|NCT00267020|460187342|FG000|Overall Study|Sponsor Request|1|||
127881217|NCT00267020|460187343|FG001|Overall Study|Sponsor Request|0|||
127881218|NCT00267020|460187342|FG000|Overall Study|Other|1|||
127881219|NCT00267020|460187343|FG001|Overall Study|Other|2|||
127881220|NCT02428231|460187349|FG000|Overall Study|Other|10|||
127881221|NCT02428231|460187350|FG001|Overall Study|Other|16|||
127881222|NCT02428231|460187349|FG000|Overall Study|Required Symptomatic Therapy|0|||
127881223|NCT02428231|460187350|FG001|Overall Study|Required Symptomatic Therapy|1|||
127881224|NCT02428231|460187349|FG000|Overall Study|Adverse Event|3|||
127881225|NCT02428231|460187350|FG001|Overall Study|Adverse Event|0|||
127881226|NCT01784419|460187353|FG000|Overall Study|Adverse Event|3|||
127881227|NCT02253654|460187354|FG000|Overall Study|Withdrawal by Subject|12|||
127881228|NCT02253654|460187355|FG001|Overall Study|Withdrawal by Subject|4|||
127881229|NCT02253654|460187354|FG000|Overall Study|Decision by Sponsor|1|||
127881230|NCT02253654|460187355|FG001|Overall Study|Decision by Sponsor|1|||
127881231|NCT02253654|460187354|FG000|Overall Study|Lost to Follow-up|2|||
127881232|NCT02253654|460187355|FG001|Overall Study|Lost to Follow-up|5|||
127881233|NCT02253654|460187354|FG000|Overall Study|Death|4|||
127881234|NCT02253654|460187355|FG001|Overall Study|Death|7|||
127881235|NCT02253654|460187354|FG000|Overall Study|Did Not Receive Study Treatment|4|||
127881236|NCT02253654|460187355|FG001|Overall Study|Did Not Receive Study Treatment|1|||
127881237|NCT00765999|460187358|FG000|Overall Study|Adverse Event|203|||
127881238|NCT00765999|460187358|FG000|Overall Study|Insufficient Therapeutic Response|100|||
127881239|NCT00765999|460187358|FG000|Overall Study|Protocol Violation|95|||
127881240|NCT00765999|460187358|FG000|Overall Study|Consent Withdrawn|202|||
127881241|NCT00765999|460187358|FG000|Overall Study|Lost to Follow-up|131|||
127881242|NCT00765999|460187358|FG000|Overall Study|Study Terminated by Sponsor|2|||
127881243|NCT00765999|460187358|FG000|Overall Study|Other Miscellaneous Reasons|51|||
127881244|NCT00902265|460187359|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
127881245|NCT00902265|460187359|FG000|Overall Study|Adverse Event|2|||
127881246|NCT00902265|460187359|FG000|Overall Study|Lack of Efficacy|2|||
127881247|NCT00902265|460187359|FG000|Overall Study|Protocol Violation|1|||
127881248|NCT04701658|460187360|FG000|Overall Study|Lost to Follow-up|6|||
127881249|NCT03747939|460187361|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
127881250|NCT03747939|460187362|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
127881251|NCT03747939|460187363|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
127881252|NCT03747939|460187364|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
127881253|NCT03747939|460187361|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
127881254|NCT03747939|460187362|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
127881255|NCT03747939|460187363|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
127881256|NCT03747939|460187364|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
127881257|NCT03747939|460187361|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
127881258|NCT03747939|460187362|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
127881259|NCT03747939|460187363|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
127881260|NCT03747939|460187364|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
127881261|NCT03747939|460187361|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
127881262|NCT03747939|460187362|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
127881263|NCT03747939|460187363|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
127881264|NCT03747939|460187364|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
127881265|NCT03747939|460187361|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
127881266|NCT03747939|460187362|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
127881267|NCT03747939|460187363|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
127881268|NCT03747939|460187364|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
127881269|NCT03747939|460187361|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
127881270|NCT03747939|460187362|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
127881271|NCT03747939|460187363|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
127881272|NCT03747939|460187364|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
127881273|NCT03747939|460187361|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
127881274|NCT03747939|460187362|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
127881275|NCT03747939|460187363|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
127881276|NCT03747939|460187364|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
127881277|NCT03747939|460187361|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
127881278|NCT03747939|460187362|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
127881279|NCT03747939|460187363|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
127881280|NCT03747939|460187364|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
127881281|NCT03747939|460187361|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
127881282|NCT03747939|460187362|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
127881283|NCT03747939|460187363|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
127881284|NCT03747939|460187364|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
127881285|NCT03747939|460187361|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
127881286|NCT03747939|460187362|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
127881287|NCT03747939|460187363|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
127881288|NCT03747939|460187364|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
127881289|NCT03747939|460187361|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
127881290|NCT03747939|460187362|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
127881291|NCT03747939|460187363|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
127881292|NCT03747939|460187364|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
127881293|NCT03747939|460187361|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
127576765|NCT00423722|459082211|FG000|Overall Study|Unable to complete questionnaires|4|||
127576766|NCT00423722|459082212|FG001|Overall Study|Unable to complete questionnaires|4|||
127576767|NCT00423722|459082211|FG000|Overall Study|Withdrawal by Subject|4|||
127576768|NCT00423722|459082212|FG001|Overall Study|Withdrawal by Subject|2|||
127576769|NCT01846104|459082214|FG000|Overall Study|Withdrawal by Subject|1|||
127576770|NCT00851630|459082218|FG000|Overall Study|Death|2|||
127576771|NCT00851630|459082219|FG001|Overall Study|Death|1|||
127576772|NCT00851630|459082218|FG000|Overall Study|Clinical failure|0|||
127576773|NCT00851630|459082219|FG001|Overall Study|Clinical failure|1|||
127576774|NCT02349061|459082220|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
127576775|NCT02349061|459082221|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
127782422|NCT00688155|459829777|FG003|Overall Study|Withdrawal by Subject|1|||
127782423|NCT01889238|459829780|FG000|Overall Study|Death|1|||
127782424|NCT01889238|459829780|FG000|Overall Study|Withdrawal by Subject|1|||
127782425|NCT01889238|459829780|FG000|Overall Study|Adverse Event|6|||
127782426|NCT01889238|459829780|FG000|Overall Study|Disease Progression|104|||
127782427|NCT01889238|459829780|FG000|Overall Study|Other|6|||
127782428|NCT04136184|459829781|FG000|Overall Study|Lost to Follow-up|0|||
127782429|NCT04136184|459829782|FG001|Overall Study|Lost to Follow-up|3|||
127782430|NCT04136184|459829781|FG000|Overall Study|Voluntary Withdrawal (including enrolled OLE)|23|||
127782431|NCT04136184|459829782|FG001|Overall Study|Voluntary Withdrawal (including enrolled OLE)|119|||
127576776|NCT02349061|459082222|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
127576777|NCT02349061|459082220|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
127576778|NCT02349061|459082221|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
127576779|NCT02349061|459082222|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
127576780|NCT02349061|459082220|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
127576781|NCT02349061|459082221|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
127576782|NCT02349061|459082222|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
127576783|NCT02349061|459082220|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
127576784|NCT02349061|459082221|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
127576785|NCT02349061|459082222|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
127782432|NCT01200238|459829784|FG000|Overall Study|Adverse Event|2|||
127782433|NCT01200238|459829785|FG001|Overall Study|Adverse Event|1|||
127881294|NCT03747939|460187362|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
127881295|NCT03747939|460187363|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
127576786|NCT02349061|459082220|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
127881296|NCT03747939|460187364|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
127881297|NCT03747939|460187361|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
128029784|NCT01421459|460735129|FG000|Overall Study|Death|1|||
127576787|NCT02349061|459082221|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
127576788|NCT02349061|459082222|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
127782434|NCT01200238|459829784|FG000|Overall Study|Progressive Disease|5|||
127782435|NCT01200238|459829785|FG001|Overall Study|Progressive Disease|8|||
127782436|NCT01200238|459829784|FG000|Overall Study|Withdrawal by Subject|0|||
127782437|NCT01200238|459829785|FG001|Overall Study|Withdrawal by Subject|1|||
127782438|NCT02717754|459829786|FG000|Overall Study|Incorrect Infusion Duration|0|||
127782439|NCT02717754|459829787|FG001|Overall Study|Incorrect Infusion Duration|0|||
127782440|NCT02717754|459829788|FG002|Overall Study|Incorrect Infusion Duration|0|||
127782441|NCT02717754|459829789|FG003|Overall Study|Incorrect Infusion Duration|10|||
127782442|NCT02717754|459829790|FG004|Overall Study|Incorrect Infusion Duration|20|||
127782443|NCT02717754|459829791|FG005|Overall Study|Incorrect Infusion Duration|20|||
127782444|NCT03734016|459829795|FG000|Overall Study|Sponsor Ended Study|225|||
127782445|NCT03734016|459829796|FG001|Overall Study|Sponsor Ended Study|200|||
127782446|NCT03734016|459829795|FG000|Overall Study|Death|69|||
127782447|NCT03734016|459829796|FG001|Overall Study|Death|83|||
127782448|NCT03734016|459829795|FG000|Overall Study|Withdrawal by Subject|21|||
127782449|NCT03734016|459829796|FG001|Overall Study|Withdrawal by Subject|27|||
127782450|NCT03734016|459829795|FG000|Overall Study|Physician Decision|1|||
127782451|NCT03734016|459829796|FG001|Overall Study|Physician Decision|12|||
127782452|NCT03734016|459829795|FG000|Overall Study|Lost to Follow-up|6|||
127782453|NCT03734016|459829796|FG001|Overall Study|Lost to Follow-up|2|||
127782454|NCT03734016|459829795|FG000|Overall Study|Miscellaneous|5|||
127782455|NCT03734016|459829796|FG001|Overall Study|Miscellaneous|1|||
127782456|NCT01979835|459829797|FG000|Primary Outcome SA Measurment|failed insertion|18|||
127782457|NCT01979835|459829797|FG000|Follow-up|Lost to Follow-up|32|||
127782458|NCT02592018|459829800|FG000|Overall Study|Adverse Event|1|||
127782459|NCT02592018|459829800|FG000|Overall Study|Lost to Follow-up|1|||
127782460|NCT02710136|459829803|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
127782461|NCT02710136|459829804|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
127782462|NCT00418665|459829805|FG000|Treatment Period|Ineligibility determined|1|||
127782463|NCT00418665|459829806|FG001|Treatment Period|Ineligibility determined|1|||
127782464|NCT00418665|459829807|FG002|Treatment Period|Ineligibility determined|0|||
127782465|NCT00418665|459829805|FG000|Treatment Period|Adverse Event|2|||
127782466|NCT00418665|459829806|FG001|Treatment Period|Adverse Event|2|||
127782467|NCT00418665|459829807|FG002|Treatment Period|Adverse Event|0|||
127782468|NCT00418665|459829805|FG000|Treatment Period|Withdrawal by Subject|0|||
127782469|NCT00418665|459829806|FG001|Treatment Period|Withdrawal by Subject|3|||
127782470|NCT00418665|459829807|FG002|Treatment Period|Withdrawal by Subject|1|||
127782471|NCT00418665|459829805|FG000|Treatment Period|Requirement for alternative therapy|1|||
127782472|NCT00418665|459829806|FG001|Treatment Period|Requirement for alternative therapy|0|||
127782473|NCT00418665|459829807|FG002|Treatment Period|Requirement for alternative therapy|0|||
127782474|NCT00418665|459829805|FG000|Treatment Period|Physician Decision|1|||
127782475|NCT00418665|459829806|FG001|Treatment Period|Physician Decision|0|||
127782476|NCT00418665|459829807|FG002|Treatment Period|Physician Decision|3|||
127782477|NCT00418665|459829805|FG000|Treatment Extension|Adverse Event|1|||
127782478|NCT00418665|459829806|FG001|Treatment Extension|Adverse Event|0|||
127782479|NCT00418665|459829807|FG002|Treatment Extension|Adverse Event|0|||
127782480|NCT00418665|459829805|FG000|Treatment Extension|Withdrawal by Subject|1|||
128029785|NCT01421459|460735130|FG001|Overall Study|Death|1|||
128029786|NCT01421459|460735129|FG000|Overall Study|Lack of Efficacy|1|||
128029787|NCT01421459|460735130|FG001|Overall Study|Lack of Efficacy|2|||
127576789|NCT02349061|459082220|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
127576790|NCT02349061|459082221|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
127576791|NCT02349061|459082222|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
127576792|NCT02349061|459082220|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
127576793|NCT02349061|459082221|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
127576794|NCT02349061|459082222|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
127576795|NCT02349061|459082220|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
127576796|NCT02349061|459082221|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
127576797|NCT02349061|459082222|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
127576798|NCT02349061|459082220|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
127576799|NCT02349061|459082221|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
127576800|NCT02349061|459082222|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
127576801|NCT02349061|459082220|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
127576802|NCT02349061|459082221|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
127576803|NCT02349061|459082222|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
127782481|NCT00418665|459829806|FG001|Treatment Extension|Withdrawal by Subject|0|||
127782482|NCT00418665|459829807|FG002|Treatment Extension|Withdrawal by Subject|0|||
127782483|NCT00418665|459829805|FG000|Treatment Extension|Requirement for alternative therapy|2|||
127782484|NCT00418665|459829806|FG001|Treatment Extension|Requirement for alternative therapy|2|||
127782485|NCT00418665|459829807|FG002|Treatment Extension|Requirement for alternative therapy|0|||
127782486|NCT00418665|459829805|FG000|Treatment Extension|Physician Decision|2|||
127782487|NCT00418665|459829806|FG001|Treatment Extension|Physician Decision|2|||
128029788|NCT01421459|460735129|FG000|Overall Study|Lost to Follow-up|8|||
127576804|NCT02349061|459082220|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
127782488|NCT00418665|459829807|FG002|Treatment Extension|Physician Decision|1|||
127782489|NCT00418665|459829805|FG000|Treatment Extension|Death|0|||
127576805|NCT02349061|459082221|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
127576806|NCT02349061|459082222|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
127576807|NCT02349061|459082220|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
127576808|NCT02349061|459082221|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
127576809|NCT02349061|459082222|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
127576810|NCT02349061|459082220|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
127576811|NCT02349061|459082221|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
127576812|NCT02349061|459082222|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
127576813|NCT02339285|459082223|FG000|Overall Study|Withdrawal by Subject|0|||
127576814|NCT02339285|459082224|FG001|Overall Study|Withdrawal by Subject|1|||
127576815|NCT02339285|459082225|FG002|Overall Study|Withdrawal by Subject|1|||
127576816|NCT02339285|459082223|FG000|Overall Study|Lost to Follow-up|1|||
127576817|NCT02339285|459082224|FG001|Overall Study|Lost to Follow-up|1|||
127576818|NCT02339285|459082225|FG002|Overall Study|Lost to Follow-up|1|||
127576819|NCT02339285|459082223|FG000|Overall Study|Protocol Deviation|0|||
127576820|NCT02339285|459082224|FG001|Overall Study|Protocol Deviation|1|||
127576821|NCT02339285|459082225|FG002|Overall Study|Protocol Deviation|0|||
127576822|NCT03061097|459082226|FG000|Overall Study|Withdrawal by Subject|0|||
127576823|NCT03061097|459082227|FG001|Overall Study|Withdrawal by Subject|3|||
127576824|NCT00137631|459082228|FG000|Overall Study|Lost to Follow-up|37|||
128029789|NCT01421459|460735130|FG001|Overall Study|Lost to Follow-up|9|||
127576825|NCT00137631|459082229|FG001|Overall Study|Lost to Follow-up|41|||
127576826|NCT00761579|459082230|FG000|Overall Study|Adverse Event|10|||
127576827|NCT00761579|459082230|FG000|Overall Study|Death|2|||
127576828|NCT00761579|459082230|FG000|Overall Study|Lack of Efficacy|21|||
127576829|NCT00761579|459082230|FG000|Overall Study|Lost to Follow-up|16|||
127576830|NCT00761579|459082230|FG000|Overall Study|Pregnancy|1|||
127576831|NCT00761579|459082230|FG000|Overall Study|Withdrawal by Subject|34|||
127576832|NCT00761579|459082230|FG000|Overall Study|Lack of compliance|2|||
127576833|NCT00761579|459082230|FG000|Overall Study|Protocol deviation|1|||
127576834|NCT00761579|459082230|FG000|Overall Study|Drug overdose|1|||
127576835|NCT00761579|459082230|FG000|Overall Study|Aggravation of depression|1|||
127576836|NCT00761579|459082230|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
127576837|NCT00761579|459082230|FG000|Overall Study|Lost survey form|1|||
127576838|NCT00761579|459082230|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
127576839|NCT00598702|459082231|FG000|Overall Study|Other|0|||
127576840|NCT00598702|459082232|FG001|Overall Study|Other|2|||
127576841|NCT00598702|459082233|FG002|Overall Study|Other|0|||
127576842|NCT00598702|459082234|FG003|Overall Study|Other|0|||
127576843|NCT00598702|459082235|FG004|Overall Study|Other|0|||
127576844|NCT00598702|459082236|FG005|Overall Study|Other|1|||
127576845|NCT00598702|459082237|FG006|Overall Study|Other|0|||
127576846|NCT00598702|459082238|FG007|Overall Study|Other|0|||
127576847|NCT00598702|459082231|FG000|Overall Study|Early discharge from hospital|0|||
127576848|NCT00598702|459082232|FG001|Overall Study|Early discharge from hospital|0|||
127576849|NCT00598702|459082233|FG002|Overall Study|Early discharge from hospital|2|||
127576850|NCT00598702|459082234|FG003|Overall Study|Early discharge from hospital|5|||
127576851|NCT00598702|459082235|FG004|Overall Study|Early discharge from hospital|0|||
127576852|NCT00598702|459082236|FG005|Overall Study|Early discharge from hospital|10|||
127576853|NCT00598702|459082237|FG006|Overall Study|Early discharge from hospital|1|||
127576854|NCT00598702|459082238|FG007|Overall Study|Early discharge from hospital|0|||
127576855|NCT00598702|459082231|FG000|Overall Study|Adverse Event|0|||
127576856|NCT00598702|459082232|FG001|Overall Study|Adverse Event|0|||
127576857|NCT00598702|459082233|FG002|Overall Study|Adverse Event|0|||
127576858|NCT00598702|459082234|FG003|Overall Study|Adverse Event|1|||
127693051|NCT06066541|459503291|FG005|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|11|||
127693052|NCT06066541|459503292|FG006|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|5|||
127693053|NCT02819843|459503293|FG000|Overall Study|Disease progression before RT|0|||
127693054|NCT02819843|459503294|FG001|Overall Study|Disease progression before RT|1|||
127693055|NCT03055858|459503296|FG000|Overall Study|Death|9|||
127693056|NCT03055858|459503296|FG000|Overall Study|Withdrawal by Subject|11|||
127693057|NCT03055858|459503296|FG000|Overall Study|Lost to Follow-up|6|||
127693058|NCT03055858|459503296|FG000|Overall Study|Missed Follow-Up Visits|18|||
127693059|NCT04586920|459503297|FG000|Overall Study|Lost to Follow-up|0|||
127693060|NCT04586920|459503298|FG001|Overall Study|Lost to Follow-up|0|||
127693061|NCT04586920|459503299|FG002|Overall Study|Lost to Follow-up|0|||
127693062|NCT04586920|459503300|FG003|Overall Study|Lost to Follow-up|0|||
128029790|NCT01421459|460735129|FG000|Overall Study|Physician Decision|9|||
127576859|NCT00598702|459082235|FG004|Overall Study|Adverse Event|0|||
127576860|NCT00598702|459082236|FG005|Overall Study|Adverse Event|0|||
127576861|NCT00598702|459082237|FG006|Overall Study|Adverse Event|0|||
127576862|NCT00598702|459082238|FG007|Overall Study|Adverse Event|0|||
127576863|NCT00598702|459082231|FG000|Overall Study|Withdrawal by Subject|0|||
127576864|NCT00598702|459082232|FG001|Overall Study|Withdrawal by Subject|0|||
127576865|NCT00598702|459082233|FG002|Overall Study|Withdrawal by Subject|0|||
127693063|NCT04586920|459503301|FG004|Overall Study|Lost to Follow-up|0|||
127576866|NCT00598702|459082234|FG003|Overall Study|Withdrawal by Subject|1|||
127576867|NCT00598702|459082235|FG004|Overall Study|Withdrawal by Subject|1|||
127576868|NCT00598702|459082236|FG005|Overall Study|Withdrawal by Subject|0|||
127576869|NCT00598702|459082237|FG006|Overall Study|Withdrawal by Subject|0|||
127576870|NCT00598702|459082238|FG007|Overall Study|Withdrawal by Subject|0|||
127576871|NCT00598702|459082231|FG000|Overall Study|Physician Decision|0|||
127576872|NCT00598702|459082232|FG001|Overall Study|Physician Decision|0|||
127576873|NCT00598702|459082233|FG002|Overall Study|Physician Decision|0|||
127576874|NCT00598702|459082234|FG003|Overall Study|Physician Decision|0|||
127576875|NCT00598702|459082235|FG004|Overall Study|Physician Decision|1|||
127576876|NCT00598702|459082236|FG005|Overall Study|Physician Decision|0|||
127576877|NCT00598702|459082237|FG006|Overall Study|Physician Decision|0|||
127576878|NCT00598702|459082238|FG007|Overall Study|Physician Decision|0|||
127576879|NCT00598702|459082231|FG000|Overall Study|Dose limiting toxicity|0|||
127576880|NCT00598702|459082232|FG001|Overall Study|Dose limiting toxicity|0|||
127576881|NCT00598702|459082233|FG002|Overall Study|Dose limiting toxicity|0|||
127576882|NCT00598702|459082234|FG003|Overall Study|Dose limiting toxicity|1|||
127576883|NCT00598702|459082235|FG004|Overall Study|Dose limiting toxicity|1|||
127576884|NCT00598702|459082236|FG005|Overall Study|Dose limiting toxicity|1|||
127576885|NCT00598702|459082237|FG006|Overall Study|Dose limiting toxicity|0|||
127576886|NCT00598702|459082238|FG007|Overall Study|Dose limiting toxicity|0|||
127576887|NCT01859143|459082241|FG000|Overall Study|Lost to Follow-up|2|||
127576888|NCT01859143|459082242|FG001|Overall Study|Lost to Follow-up|0|||
127576889|NCT02413372|459082246|FG000|Treatment|Lost to Follow-up|0|||
127576890|NCT02413372|459082247|FG001|Treatment|Lost to Follow-up|2|||
127576891|NCT02413372|459082248|FG002|Treatment|Lost to Follow-up|1|||
127576892|NCT02413372|459082246|FG000|Treatment|Withdrawal by Subject|1|||
127576893|NCT02413372|459082247|FG001|Treatment|Withdrawal by Subject|0|||
127576894|NCT02413372|459082248|FG002|Treatment|Withdrawal by Subject|0|||
127576895|NCT02413372|459082246|FG000|Follow-up|Lost to Follow-up|1|||
127576896|NCT02413372|459082247|FG001|Follow-up|Lost to Follow-up|1|||
127576897|NCT02413372|459082248|FG002|Follow-up|Lost to Follow-up|0|||
127576898|NCT02413372|459082246|FG000|Follow-up|Subject Withdrew Consent|1|||
127576899|NCT02413372|459082247|FG001|Follow-up|Subject Withdrew Consent|0|||
127576900|NCT02413372|459082248|FG002|Follow-up|Subject Withdrew Consent|1|||
127576901|NCT02413372|459082246|FG000|Follow-up|Subject unable to return for visit|0|||
127576902|NCT02413372|459082247|FG001|Follow-up|Subject unable to return for visit|0|||
127576903|NCT02413372|459082248|FG002|Follow-up|Subject unable to return for visit|1|||
127576904|NCT04587271|459082249|FG000|Overall Study|Lost to Follow-up|2|||
127576905|NCT04587271|459082250|FG001|Overall Study|Lost to Follow-up|2|||
127576906|NCT04587271|459082251|FG002|Overall Study|Lost to Follow-up|0|||
127576907|NCT04587271|459082252|FG003|Overall Study|Lost to Follow-up|2|||
127576908|NCT04587271|459082253|FG004|Overall Study|Lost to Follow-up|2|||
127576909|NCT04587271|459082254|FG005|Overall Study|Lost to Follow-up|0|||
127576910|NCT04587271|459082249|FG000|Overall Study|Caregiver brought child to visits|0|||
127576911|NCT04587271|459082250|FG001|Overall Study|Caregiver brought child to visits|0|||
127576912|NCT04587271|459082251|FG002|Overall Study|Caregiver brought child to visits|0|||
127576913|NCT04587271|459082252|FG003|Overall Study|Caregiver brought child to visits|1|||
127576914|NCT04587271|459082253|FG004|Overall Study|Caregiver brought child to visits|0|||
127576915|NCT04587271|459082254|FG005|Overall Study|Caregiver brought child to visits|0|||
127576916|NCT02180165|459082260|FG000|Overall Study|Not Treated|0|||
127782490|NCT00418665|459829806|FG001|Treatment Extension|Death|0|||
127782491|NCT00418665|459829807|FG002|Treatment Extension|Death|1|||
127782492|NCT01129921|459829810|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
127782493|NCT01129921|459829811|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
127782494|NCT01129921|459829810|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
127782495|NCT01129921|459829811|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
127782496|NCT01129921|459829810|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
127782497|NCT01129921|459829811|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
127782498|NCT01129921|459829810|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
127782499|NCT01129921|459829811|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
127782500|NCT05050318|459831310|FG000|Overall Study|Protocol Deviation|1|||
127782501|NCT05050318|459831311|FG001|Overall Study|Protocol Deviation|0|||
127782502|NCT05050318|459831312|FG002|Overall Study|Protocol Deviation|0|||
128029791|NCT01421459|460735130|FG001|Overall Study|Physician Decision|9|||
127782503|NCT00574145|459831317|FG000|Overall Study|Withdrawal by Subject|2|||
127576917|NCT02180165|459082261|FG001|Overall Study|Not Treated|0|||
127576918|NCT02180165|459082262|FG002|Overall Study|Not Treated|1|||
127576919|NCT02180165|459082263|FG003|Overall Study|Not Treated|0|||
127782504|NCT00574145|459831318|FG001|Overall Study|Withdrawal by Subject|1|||
127782505|NCT03227471|459831322|FG000|Overall Study|Withdrawal by Subject|0|||
128029792|NCT01421459|460735129|FG000|Overall Study|Protocol Violation|8|||
128029793|NCT01421459|460735130|FG001|Overall Study|Protocol Violation|5|||
128029794|NCT01421459|460735129|FG000|Overall Study|Withdrawal by Subject|12|||
127576920|NCT02180165|459082260|FG000|Overall Study|Adverse Event|7|||
127576921|NCT02180165|459082261|FG001|Overall Study|Adverse Event|0|||
127576922|NCT02180165|459082262|FG002|Overall Study|Adverse Event|18|||
127576923|NCT02180165|459082263|FG003|Overall Study|Adverse Event|3|||
127576924|NCT02180165|459082260|FG000|Overall Study|Lack of Efficacy|0|||
127576925|NCT02180165|459082261|FG001|Overall Study|Lack of Efficacy|1|||
127576926|NCT02180165|459082262|FG002|Overall Study|Lack of Efficacy|3|||
127576927|NCT02180165|459082263|FG003|Overall Study|Lack of Efficacy|2|||
127576928|NCT02180165|459082260|FG000|Overall Study|Physician Decision|1|||
127576929|NCT02180165|459082261|FG001|Overall Study|Physician Decision|0|||
127576930|NCT02180165|459082262|FG002|Overall Study|Physician Decision|5|||
128029795|NCT01421459|460735130|FG001|Overall Study|Withdrawal by Subject|16|||
128029796|NCT00803049|460735131|FG000|Overall Study|Adverse Event|21|||
128029797|NCT00803049|460735132|FG001|Overall Study|Adverse Event|33|||
127576931|NCT02180165|459082263|FG003|Overall Study|Physician Decision|0|||
127576932|NCT02180165|459082260|FG000|Overall Study|Withdrawal by Subject|3|||
127576933|NCT02180165|459082261|FG001|Overall Study|Withdrawal by Subject|0|||
127576934|NCT02180165|459082262|FG002|Overall Study|Withdrawal by Subject|2|||
127576935|NCT02180165|459082263|FG003|Overall Study|Withdrawal by Subject|1|||
127576936|NCT02943460|459082265|FG000|Blinded Study Phase|Adverse Event|3|||
127576937|NCT02943460|459082266|FG001|Blinded Study Phase|Adverse Event|0|||
127576938|NCT02943460|459082267|FG002|Blinded Study Phase|Adverse Event|0|||
128029798|NCT00803049|460735133|FG002|Overall Study|Adverse Event|13|||
128029799|NCT00803049|460735134|FG003|Overall Study|Adverse Event|27|||
128029800|NCT00803049|460735131|FG000|Overall Study|Lack of Efficacy|10|||
128029801|NCT00803049|460735132|FG001|Overall Study|Lack of Efficacy|19|||
128029802|NCT00803049|460735133|FG002|Overall Study|Lack of Efficacy|6|||
127576939|NCT02943460|459082265|FG000|Blinded Study Phase|Withdrew Consent|0|||
127576940|NCT02943460|459082266|FG001|Blinded Study Phase|Withdrew Consent|1|||
127576941|NCT02943460|459082267|FG002|Blinded Study Phase|Withdrew Consent|0|||
127576942|NCT02943460|459082265|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
127576943|NCT02943460|459082266|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
127693064|NCT04586920|459503302|FG005|Overall Study|Lost to Follow-up|0|||
127693065|NCT04586920|459503303|FG006|Overall Study|Lost to Follow-up|1|||
127693066|NCT04586920|459503304|FG007|Overall Study|Lost to Follow-up|1|||
127693067|NCT04586920|459503305|FG008|Overall Study|Lost to Follow-up|0|||
127693068|NCT04586920|459503306|FG009|Overall Study|Lost to Follow-up|1|||
127693069|NCT04586920|459503307|FG010|Overall Study|Lost to Follow-up|0|||
127693070|NCT04586920|459503308|FG011|Overall Study|Lost to Follow-up|0|||
127693071|NCT04586920|459503309|FG012|Overall Study|Lost to Follow-up|0|||
127693072|NCT04586920|459503310|FG013|Overall Study|Lost to Follow-up|1|||
127693073|NCT04586920|459503311|FG014|Overall Study|Lost to Follow-up|0|||
127693074|NCT04586920|459503312|FG015|Overall Study|Lost to Follow-up|0|||
127693075|NCT04586920|459503313|FG016|Overall Study|Lost to Follow-up|0|||
127693076|NCT04586920|459503314|FG017|Overall Study|Lost to Follow-up|0|||
127693077|NCT04586920|459503297|FG000|Overall Study|Withdrawal by Subject|0|||
127693078|NCT04586920|459503298|FG001|Overall Study|Withdrawal by Subject|0|||
127693079|NCT04586920|459503299|FG002|Overall Study|Withdrawal by Subject|0|||
127693080|NCT04586920|459503300|FG003|Overall Study|Withdrawal by Subject|0|||
127693081|NCT04586920|459503301|FG004|Overall Study|Withdrawal by Subject|0|||
127693082|NCT04586920|459503302|FG005|Overall Study|Withdrawal by Subject|0|||
127693083|NCT04586920|459503303|FG006|Overall Study|Withdrawal by Subject|0|||
127693084|NCT04586920|459503304|FG007|Overall Study|Withdrawal by Subject|1|||
127693085|NCT04586920|459503305|FG008|Overall Study|Withdrawal by Subject|0|||
127693086|NCT04586920|459503306|FG009|Overall Study|Withdrawal by Subject|1|||
127693087|NCT04586920|459503307|FG010|Overall Study|Withdrawal by Subject|0|||
127693088|NCT04586920|459503308|FG011|Overall Study|Withdrawal by Subject|1|||
127693089|NCT04586920|459503309|FG012|Overall Study|Withdrawal by Subject|0|||
127693090|NCT04586920|459503310|FG013|Overall Study|Withdrawal by Subject|0|||
127693091|NCT04586920|459503311|FG014|Overall Study|Withdrawal by Subject|0|||
127693092|NCT04586920|459503312|FG015|Overall Study|Withdrawal by Subject|0|||
127693093|NCT04586920|459503313|FG016|Overall Study|Withdrawal by Subject|0|||
127693094|NCT04586920|459503314|FG017|Overall Study|Withdrawal by Subject|0|||
127693095|NCT01938547|459503333|FG000|Overall Study|Physician Decision|1|||
127693096|NCT05038566|459503336|FG000|Overall Study|Technical Difficulties with the Device|0|||
127693097|NCT05038566|459503337|FG001|Overall Study|Technical Difficulties with the Device|1|||
127693098|NCT05110495|459503338|FG000|Overall Study|Lost to Follow-up|1|||
127693099|NCT05110495|459503338|FG000|Overall Study|Completed treatment with IMP but disease progressed prior to surgery.|1|||
127693100|NCT04716634|459503340|FG000|Overall Study|Death|24|||
127693101|NCT04716634|459503341|FG001|Overall Study|Death|24|||
127693102|NCT04716634|459503342|FG002|Overall Study|Death|8|||
127693103|NCT04716634|459503340|FG000|Overall Study|Closed by Sponsor|4|||
127693104|NCT04716634|459503341|FG001|Overall Study|Closed by Sponsor|4|||
127693105|NCT04716634|459503342|FG002|Overall Study|Closed by Sponsor|5|||
127693106|NCT04716634|459503340|FG000|Overall Study|Lost to Follow-up|1|||
127693107|NCT04716634|459503341|FG001|Overall Study|Lost to Follow-up|0|||
127693108|NCT04716634|459503342|FG002|Overall Study|Lost to Follow-up|1|||
127693109|NCT04716634|459503340|FG000|Overall Study|Withdrawal by Subject|0|||
127576944|NCT02943460|459082267|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
127576945|NCT02943460|459082265|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
127576946|NCT02943460|459082266|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
127576947|NCT02943460|459082267|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
127576948|NCT02943460|459082265|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
127576949|NCT02943460|459082266|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
127576950|NCT02943460|459082267|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
127576951|NCT01925274|459082268|FG000|Overall Study|Death|1|||
127576952|NCT01925274|459082269|FG001|Overall Study|Death|0|||
127576953|NCT01925274|459082270|FG002|Overall Study|Death|0|||
127576954|NCT01925274|459082268|FG000|Overall Study|Lost to Follow-up|0|||
127576955|NCT01925274|459082269|FG001|Overall Study|Lost to Follow-up|1|||
127576956|NCT01925274|459082270|FG002|Overall Study|Lost to Follow-up|0|||
127576957|NCT01925274|459082268|FG000|Overall Study|Withdrawal by Subject|1|||
127576958|NCT01925274|459082269|FG001|Overall Study|Withdrawal by Subject|2|||
127576959|NCT01925274|459082270|FG002|Overall Study|Withdrawal by Subject|0|||
127576960|NCT01925274|459082268|FG000|Overall Study|Study terminated by sponsor|4|||
127576961|NCT01925274|459082269|FG001|Overall Study|Study terminated by sponsor|0|||
127576962|NCT01925274|459082270|FG002|Overall Study|Study terminated by sponsor|0|||
127576963|NCT01925274|459082268|FG000|Overall Study|Protocol amendment|1|||
127576964|NCT01925274|459082269|FG001|Overall Study|Protocol amendment|3|||
127576965|NCT01925274|459082270|FG002|Overall Study|Protocol amendment|6|||
127576966|NCT01031381|459082273|FG000|Overall Study|Physician Decision|3|||
127576967|NCT01031381|459082273|FG000|Overall Study|Withdrawal by Subject|6|||
127576968|NCT00723398|459082274|FG000|Overall Study|Withdrawal by Subject|2|||
127576969|NCT00723398|459082275|FG001|Overall Study|Withdrawal by Subject|6|||
127576970|NCT00723398|459082276|FG002|Overall Study|Withdrawal by Subject|4|||
127576971|NCT00723398|459082277|FG003|Overall Study|Withdrawal by Subject|4|||
127576972|NCT00723398|459082278|FG004|Overall Study|Withdrawal by Subject|4|||
127576973|NCT00723398|459082274|FG000|Overall Study|Protocol Violation|2|||
127576974|NCT00723398|459082275|FG001|Overall Study|Protocol Violation|1|||
127782506|NCT03227471|459831323|FG001|Overall Study|Withdrawal by Subject|0|||
127782507|NCT03227471|459831324|FG002|Overall Study|Withdrawal by Subject|0|||
127782508|NCT03227471|459831325|FG003|Overall Study|Withdrawal by Subject|0|||
127782509|NCT03227471|459831326|FG004|Overall Study|Withdrawal by Subject|1|||
127782510|NCT03227471|459831327|FG005|Overall Study|Withdrawal by Subject|0|||
127782511|NCT03227471|459831328|FG006|Overall Study|Withdrawal by Subject|0|||
127782512|NCT03227471|459831329|FG007|Overall Study|Withdrawal by Subject|0|||
127782513|NCT03227471|459831330|FG008|Overall Study|Withdrawal by Subject|0|||
127782514|NCT03227471|459831331|FG009|Overall Study|Withdrawal by Subject|0|||
127782515|NCT03227471|459831332|FG010|Overall Study|Withdrawal by Subject|0|||
127782516|NCT03227471|459831333|FG011|Overall Study|Withdrawal by Subject|0|||
127782517|NCT03227471|459831334|FG012|Overall Study|Withdrawal by Subject|1|||
127782518|NCT03227471|459831335|FG013|Overall Study|Withdrawal by Subject|0|||
127782519|NCT03227471|459831336|FG014|Overall Study|Withdrawal by Subject|0|||
127782520|NCT03227471|459831322|FG000|Overall Study|Randomized, Never Dosed|0|||
127782521|NCT03227471|459831323|FG001|Overall Study|Randomized, Never Dosed|0|||
127782522|NCT03227471|459831324|FG002|Overall Study|Randomized, Never Dosed|0|||
127782523|NCT03227471|459831325|FG003|Overall Study|Randomized, Never Dosed|0|||
127782524|NCT03227471|459831326|FG004|Overall Study|Randomized, Never Dosed|0|||
127782525|NCT03227471|459831327|FG005|Overall Study|Randomized, Never Dosed|0|||
127782526|NCT03227471|459831328|FG006|Overall Study|Randomized, Never Dosed|0|||
127782527|NCT03227471|459831329|FG007|Overall Study|Randomized, Never Dosed|0|||
127576975|NCT00723398|459082276|FG002|Overall Study|Protocol Violation|5|||
127576976|NCT00723398|459082277|FG003|Overall Study|Protocol Violation|0|||
127576977|NCT00723398|459082278|FG004|Overall Study|Protocol Violation|0|||
127576978|NCT00723398|459082274|FG000|Overall Study|Physician Decision|2|||
127576979|NCT00723398|459082275|FG001|Overall Study|Physician Decision|2|||
127576980|NCT00723398|459082276|FG002|Overall Study|Physician Decision|5|||
127576981|NCT00723398|459082277|FG003|Overall Study|Physician Decision|0|||
127576982|NCT00723398|459082278|FG004|Overall Study|Physician Decision|1|||
127576983|NCT00723398|459082274|FG000|Overall Study|Adverse Event|0|||
127782528|NCT03227471|459831330|FG008|Overall Study|Randomized, Never Dosed|0|||
127576984|NCT00723398|459082275|FG001|Overall Study|Adverse Event|5|||
127782529|NCT03227471|459831331|FG009|Overall Study|Randomized, Never Dosed|0|||
127782530|NCT03227471|459831332|FG010|Overall Study|Randomized, Never Dosed|0|||
127782531|NCT03227471|459831333|FG011|Overall Study|Randomized, Never Dosed|0|||
127782532|NCT03227471|459831334|FG012|Overall Study|Randomized, Never Dosed|0|||
127576985|NCT00723398|459082276|FG002|Overall Study|Adverse Event|3|||
127576986|NCT00723398|459082277|FG003|Overall Study|Adverse Event|1|||
127576987|NCT00723398|459082278|FG004|Overall Study|Adverse Event|4|||
127782533|NCT03227471|459831335|FG013|Overall Study|Randomized, Never Dosed|0|||
128029803|NCT00803049|460735134|FG003|Overall Study|Lack of Efficacy|13|||
127576988|NCT00723398|459082274|FG000|Overall Study|Lost to Follow-up|0|||
127576989|NCT00723398|459082275|FG001|Overall Study|Lost to Follow-up|1|||
127576990|NCT00723398|459082276|FG002|Overall Study|Lost to Follow-up|0|||
127576991|NCT00723398|459082277|FG003|Overall Study|Lost to Follow-up|0|||
127576992|NCT00723398|459082278|FG004|Overall Study|Lost to Follow-up|0|||
127576993|NCT00777205|459082281|FG000|Overall Study|Lost to Follow-up|25|||
127576994|NCT00777205|459082282|FG001|Overall Study|Lost to Follow-up|9|||
127576995|NCT00777205|459082281|FG000|Overall Study|Withdrawal by Subject|6|||
127576996|NCT00777205|459082282|FG001|Overall Study|Withdrawal by Subject|4|||
127576997|NCT00777205|459082281|FG000|Overall Study|Death|0|||
127576998|NCT00777205|459082282|FG001|Overall Study|Death|2|||
127576999|NCT00777205|459082281|FG000|Overall Study|Protocol Violation|0|||
127577000|NCT00777205|459082282|FG001|Overall Study|Protocol Violation|56|||
127577001|NCT01578330|459082285|FG000|Overall Study|Adverse Event|2|||
127577002|NCT01578330|459082285|FG000|Overall Study|Protocol Violation|5|||
127577003|NCT01676727|459082286|FG000|Overall Study|Death|18|||
127577004|NCT01676727|459082286|FG000|Overall Study|Withdrawal by Subject|6|||
127577005|NCT01676727|459082286|FG000|Overall Study|Screening failure|5|||
127577006|NCT01676727|459082286|FG000|Overall Study|Not willing to attend 1-year visit|2|||
127577007|NCT01676727|459082286|FG000|Overall Study|Valve explanted|1|||
127577008|NCT03053271|459082289|FG000|Overall Study|Did not meet randomization criteria|3|||
127577009|NCT03053271|459082289|FG000|Overall Study|Withdrawal by Subject|1|||
127577010|NCT03114488|459082290|FG000|Time Period 2|Withdrawal by Subject|1|||
127577011|NCT03114488|459082291|FG001|Time Period 2|Withdrawal by Subject|3|||
127577012|NCT01669928|459082293|FG000|First Intervention|Withdrawal by Subject|3|||
127577013|NCT01669928|459082294|FG001|First Intervention|Withdrawal by Subject|5|||
127577014|NCT01199731|459082296|FG000|Overall Study|Adverse Event|0|||
127577015|NCT01199731|459082297|FG001|Overall Study|Adverse Event|1|||
127577016|NCT01199731|459082298|FG002|Overall Study|Adverse Event|0|||
127577017|NCT01199731|459082296|FG000|Overall Study|Study closed/terminated|7|||
127577018|NCT01199731|459082297|FG001|Overall Study|Study closed/terminated|9|||
127577019|NCT01199731|459082298|FG002|Overall Study|Study closed/terminated|7|||
127577020|NCT01199731|459082296|FG000|Overall Study|Lost to Follow-up|0|||
127577021|NCT01199731|459082297|FG001|Overall Study|Lost to Follow-up|0|||
127577022|NCT01199731|459082298|FG002|Overall Study|Lost to Follow-up|2|||
127577023|NCT01199731|459082296|FG000|Overall Study|Physician Decision|0|||
127577024|NCT01199731|459082297|FG001|Overall Study|Physician Decision|1|||
127577025|NCT01199731|459082298|FG002|Overall Study|Physician Decision|1|||
127577026|NCT01199731|459082296|FG000|Overall Study|Withdrawal by Subject|2|||
127577027|NCT01199731|459082297|FG001|Overall Study|Withdrawal by Subject|0|||
127577028|NCT01199731|459082298|FG002|Overall Study|Withdrawal by Subject|0|||
127577029|NCT01822678|459082301|FG000|Overall Study|Withdrawal by Subject|5|||
127577030|NCT01822678|459082302|FG001|Overall Study|Withdrawal by Subject|4|||
127577031|NCT01822678|459082303|FG002|Overall Study|Withdrawal by Subject|4|||
127577032|NCT01822678|459082301|FG000|Overall Study|Adverse Event|4|||
127577033|NCT01822678|459082302|FG001|Overall Study|Adverse Event|3|||
127577034|NCT01822678|459082303|FG002|Overall Study|Adverse Event|1|||
127577035|NCT01822678|459082301|FG000|Overall Study|Lack of Efficacy|3|||
127577036|NCT01822678|459082302|FG001|Overall Study|Lack of Efficacy|6|||
127577037|NCT01822678|459082303|FG002|Overall Study|Lack of Efficacy|5|||
127577038|NCT01822678|459082301|FG000|Overall Study|Lost to Follow-up|0|||
127577039|NCT01822678|459082302|FG001|Overall Study|Lost to Follow-up|2|||
127577040|NCT01822678|459082303|FG002|Overall Study|Lost to Follow-up|1|||
127577041|NCT00943124|459082304|FG000|Period 1|Withdrawal by Subject|1|||
127577042|NCT00943124|459082305|FG001|Period 1|Withdrawal by Subject|1|||
127577043|NCT00943124|459082304|FG000|Period 1|Did Not Follow Study Procedures|1|||
127577044|NCT00943124|459082305|FG001|Period 1|Did Not Follow Study Procedures|0|||
127577045|NCT00943124|459082304|FG000|Period 1|Personal Reasons|0|||
127577046|NCT00943124|459082305|FG001|Period 1|Personal Reasons|1|||
127577047|NCT00381381|459082310|FG000|Overall Study|Adverse Event|3|||
127577048|NCT00381381|459082310|FG000|Overall Study|Lost to Follow-up|52|||
127577049|NCT00381381|459082310|FG000|Overall Study|Withdrawal by Subject|9|||
127577050|NCT01916967|459082311|FG000|Overall Study|Adverse Event|0|||
127577051|NCT01916967|459082312|FG001|Overall Study|Adverse Event|0|||
127577052|NCT01916967|459082313|FG002|Overall Study|Adverse Event|2|||
127577053|NCT01916967|459082311|FG000|Overall Study|Lack of Efficacy|0|||
127577054|NCT01916967|459082312|FG001|Overall Study|Lack of Efficacy|0|||
127693110|NCT04716634|459503341|FG001|Overall Study|Withdrawal by Subject|0|||
127693111|NCT04716634|459503342|FG002|Overall Study|Withdrawal by Subject|1|||
127577055|NCT01916967|459082313|FG002|Overall Study|Lack of Efficacy|6|||
127577056|NCT01916967|459082311|FG000|Overall Study|Physician Decision|0|||
127577057|NCT01916967|459082312|FG001|Overall Study|Physician Decision|0|||
127577058|NCT01916967|459082313|FG002|Overall Study|Physician Decision|1|||
127577059|NCT01916967|459082311|FG000|Overall Study|Protocol Violation|0|||
127693112|NCT05387447|459503348|FG000|Overall Study|Participants changed their minds about study participation.|3|||
127577060|NCT01916967|459082312|FG001|Overall Study|Protocol Violation|1|||
127577061|NCT01916967|459082313|FG002|Overall Study|Protocol Violation|0|||
127577062|NCT01912963|459082318|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
127577063|NCT01912963|459082319|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
127577064|NCT01912963|459082320|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
127577065|NCT01912963|459082318|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
127693113|NCT05387447|459503349|FG001|Overall Study|Participants changed their minds about study participation.|5|||
127577066|NCT01912963|459082319|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
127577067|NCT01912963|459082320|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
127577068|NCT01912963|459082318|FG000|Overall Study|Adverse Event|0|||
127577069|NCT01912963|459082319|FG001|Overall Study|Adverse Event|1|||
127577070|NCT01912963|459082320|FG002|Overall Study|Adverse Event|1|||
127577071|NCT01912963|459082318|FG000|Overall Study|Withdrawal by Subject|0|||
127577072|NCT01912963|459082319|FG001|Overall Study|Withdrawal by Subject|1|||
127577073|NCT01912963|459082320|FG002|Overall Study|Withdrawal by Subject|0|||
127577074|NCT01912963|459082318|FG000|Overall Study|Sought treatment locally|0|||
127577075|NCT01912963|459082319|FG001|Overall Study|Sought treatment locally|1|||
127577076|NCT01912963|459082320|FG002|Overall Study|Sought treatment locally|0|||
127577077|NCT01638819|459082323|FG000|Overall Study|Lost to Follow-up|1|||
127577078|NCT01638819|459082324|FG001|Overall Study|Lost to Follow-up|0|||
127577079|NCT00237185|459082325|FG000|Core|Adverse Event|3|||
127577080|NCT00237185|459082326|FG001|Core|Adverse Event|4|||
127577081|NCT00237185|459082325|FG000|Core|Abnormal laboratory value|0|||
127577082|NCT00237185|459082326|FG001|Core|Abnormal laboratory value|4|||
127577083|NCT00237185|459082325|FG000|Core|Abnormal test procedure results|1|||
127577084|NCT00237185|459082326|FG001|Core|Abnormal test procedure results|0|||
127577085|NCT00237185|459082325|FG000|Core|Lack of Efficacy|30|||
127577086|NCT00237185|459082326|FG001|Core|Lack of Efficacy|23|||
127577087|NCT00237185|459082325|FG000|Core|Protocol Violation|1|||
127577088|NCT00237185|459082326|FG001|Core|Protocol Violation|1|||
127577089|NCT00237185|459082325|FG000|Core|Withdrawal by Subject|4|||
127577090|NCT00237185|459082326|FG001|Core|Withdrawal by Subject|4|||
127577091|NCT00237185|459082325|FG000|Core|Administrative problems|0|||
127577092|NCT00237185|459082326|FG001|Core|Administrative problems|1|||
127577093|NCT00237185|459082325|FG000|Core|Death|4|||
127577094|NCT00237185|459082326|FG001|Core|Death|0|||
127577095|NCT00237185|459082325|FG000|Core|Determined ineligible post randomization|1|||
127577096|NCT00237185|459082326|FG001|Core|Determined ineligible post randomization|0|||
127577097|NCT00237185|459082325|FG000|Extension|Adverse Event|1|||
127577098|NCT00237185|459082326|FG001|Extension|Adverse Event|0|||
127577099|NCT00237185|459082325|FG000|Extension|Abnormal laboratory value|0|||
127577100|NCT00237185|459082326|FG001|Extension|Abnormal laboratory value|1|||
127577101|NCT00237185|459082325|FG000|Extension|Lack of Efficacy|9|||
127577102|NCT00237185|459082326|FG001|Extension|Lack of Efficacy|14|||
127577103|NCT00237185|459082325|FG000|Extension|Condition no longer required study drug|0|||
127577104|NCT00237185|459082326|FG001|Extension|Condition no longer required study drug|1|||
127577105|NCT00237185|459082325|FG000|Extension|Withdrawal by Subject|3|||
127577106|NCT00237185|459082326|FG001|Extension|Withdrawal by Subject|2|||
127577107|NCT00237185|459082325|FG000|Extension|Lost to Follow-up|1|||
127577108|NCT00237185|459082326|FG001|Extension|Lost to Follow-up|0|||
127577109|NCT00237185|459082325|FG000|Extension|Administrative problems|1|||
127577110|NCT00237185|459082326|FG001|Extension|Administrative problems|0|||
127577111|NCT00237185|459082325|FG000|Extension|Death|1|||
127577112|NCT00237185|459082326|FG001|Extension|Death|1|||
127577113|NCT03112590|459082331|FG000|Overall Study|Adverse Event|0|||
127577114|NCT03112590|459082332|FG001|Overall Study|Adverse Event|1|||
127577115|NCT03112590|459082333|FG002|Overall Study|Adverse Event|0|||
127577116|NCT00843726|459082334|FG000|Overall Study|Death|1|||
127577117|NCT00843726|459082335|FG001|Overall Study|Death|0|||
127577118|NCT00843726|459082334|FG000|Overall Study|Withdrawal by Subject|0|||
127577119|NCT00843726|459082335|FG001|Overall Study|Withdrawal by Subject|1|||
127577120|NCT05156073|459082336|FG000|Overall Study|Patient canceled appointment with PCP|1|||
127577121|NCT02891161|459082339|FG000|Study Treatment|Disease Progression|2|||
127577122|NCT02891161|459082340|FG001|Study Treatment|Disease Progression|4|||
127577123|NCT02891161|459082339|FG000|Study Treatment|AE/Side Effects/Complications|1|||
127577124|NCT02891161|459082340|FG001|Study Treatment|AE/Side Effects/Complications|5|||
127782534|NCT03227471|459831336|FG014|Overall Study|Randomized, Never Dosed|1|||
127782535|NCT00382720|459831337|FG000|Overall Study|Adverse Event|21|||
127782536|NCT00382720|459831338|FG001|Overall Study|Adverse Event|23|||
127782537|NCT00382720|459831339|FG002|Overall Study|Adverse Event|15|||
127782538|NCT00382720|459831337|FG000|Overall Study|Protocol Violation|2|||
127782539|NCT00382720|459831338|FG001|Overall Study|Protocol Violation|5|||
127782540|NCT00382720|459831339|FG002|Overall Study|Protocol Violation|1|||
127782541|NCT00382720|459831337|FG000|Overall Study|Death|0|||
127782542|NCT00382720|459831338|FG001|Overall Study|Death|1|||
127782543|NCT00382720|459831339|FG002|Overall Study|Death|2|||
127577125|NCT02891161|459082339|FG000|Study Treatment|Patient withdrawal After Therapy Start|1|||
127577126|NCT02891161|459082340|FG001|Study Treatment|Patient withdrawal After Therapy Start|4|||
127577127|NCT02891161|459082339|FG000|Follow up|Death|4|||
127577128|NCT02891161|459082340|FG001|Follow up|Death|8|||
127782544|NCT00382720|459831337|FG000|Overall Study|Progressive disease|37|||
127577129|NCT02891161|459082339|FG000|Follow up|Refused to Follow up|0|||
127577130|NCT02891161|459082340|FG001|Follow up|Refused to Follow up|2|||
127577131|NCT02891161|459082339|FG000|Follow up|Symptomatic deterioration|0|||
127577132|NCT02891161|459082340|FG001|Follow up|Symptomatic deterioration|1|||
127782545|NCT00382720|459831338|FG001|Overall Study|Progressive disease|28|||
127782546|NCT00382720|459831339|FG002|Overall Study|Progressive disease|38|||
127577133|NCT02891161|459082339|FG000|Follow up|Study terminated|0|||
127577134|NCT02891161|459082340|FG001|Follow up|Study terminated|6|||
127577135|NCT02734433|459082342|FG000|Overall Study|Disease progression|1|||
127577136|NCT02734433|459082343|FG001|Overall Study|Disease progression|5|||
127577137|NCT02734433|459082342|FG000|Overall Study|Clinical progression|0|||
127577138|NCT02734433|459082343|FG001|Overall Study|Clinical progression|1|||
127577139|NCT02734433|459082342|FG000|Overall Study|Withdrawal by Subject|1|||
127577140|NCT02734433|459082343|FG001|Overall Study|Withdrawal by Subject|2|||
127577141|NCT05521906|459082350|FG000|Overall Study|removed by researchers for offensive or deceptive behavior|9|||
127577142|NCT05521906|459082351|FG001|Overall Study|removed by researchers for offensive or deceptive behavior|1|||
127577143|NCT00560885|459082352|FG000|Overall Study|Death|7|||
127577144|NCT00560885|459082352|FG000|Overall Study|Withdrawal by Subject|1|||
127577145|NCT03803683|459082353|FG000|Overall Study|Lost to Follow-up|41|||
127577146|NCT03803683|459082354|FG001|Overall Study|Lost to Follow-up|18|||
127577147|NCT03803683|459082355|FG002|Overall Study|Lost to Follow-up|12|||
127577148|NCT03803683|459082353|FG000|Overall Study|Withdrawal by Subject|9|||
127577149|NCT03803683|459082354|FG001|Overall Study|Withdrawal by Subject|1|||
127577150|NCT03803683|459082355|FG002|Overall Study|Withdrawal by Subject|4|||
127577151|NCT00891462|459084426|FG000|Overall Study|Withdrawal by Subject|9|||
127577152|NCT00891462|459084427|FG001|Overall Study|Withdrawal by Subject|6|||
127577153|NCT00891462|459084428|FG002|Overall Study|Withdrawal by Subject|7|||
127577154|NCT00891462|459084426|FG000|Overall Study|Adverse Event|7|||
127577155|NCT00891462|459084427|FG001|Overall Study|Adverse Event|8|||
127577156|NCT00891462|459084428|FG002|Overall Study|Adverse Event|7|||
127577157|NCT00891462|459084426|FG000|Overall Study|Lack of Efficacy|10|||
127577158|NCT00891462|459084427|FG001|Overall Study|Lack of Efficacy|5|||
127577159|NCT00891462|459084428|FG002|Overall Study|Lack of Efficacy|1|||
127577160|NCT00891462|459084426|FG000|Overall Study|COPD exacerbation|7|||
127577161|NCT00891462|459084427|FG001|Overall Study|COPD exacerbation|4|||
127693114|NCT03089398|459503353|FG000|Overall Study|Death|4|||
127693115|NCT03089398|459503354|FG001|Overall Study|Death|9|||
127693116|NCT03089398|459503353|FG000|Overall Study|Lost to Follow-up|21|||
127693117|NCT03089398|459503354|FG001|Overall Study|Lost to Follow-up|30|||
127693118|NCT03089398|459503353|FG000|Overall Study|Withdrawal by Subject|2|||
127693119|NCT03089398|459503354|FG001|Overall Study|Withdrawal by Subject|2|||
127693120|NCT05062265|459503355|FG000|Overall Study|Withdrawal by Subject|1|||
127693121|NCT05062265|459503356|FG001|Overall Study|Withdrawal by Subject|0|||
127693122|NCT05439603|459503357|FG000|Overall Study|met withdrawal criteria|2|||
127693123|NCT02682316|459503362|FG000|Overall Study|Benign Final Pathology|27|||
127693124|NCT02682316|459503363|FG001|Overall Study|Benign Final Pathology|26|||
127693125|NCT02682316|459503362|FG000|Overall Study|Reoperation before 30 days|7|||
127693126|NCT02682316|459503363|FG001|Overall Study|Reoperation before 30 days|6|||
127693127|NCT02682316|459503362|FG000|Overall Study|Ineligible|1|||
127693128|NCT02682316|459503363|FG001|Overall Study|Ineligible|0|||
127693129|NCT02682316|459503362|FG000|Overall Study|Death|1|||
127693130|NCT02682316|459503363|FG001|Overall Study|Death|0|||
127693131|NCT02682316|459503362|FG000|Overall Study|Lost to Follow-up|7|||
127693132|NCT02682316|459503363|FG001|Overall Study|Lost to Follow-up|3|||
127693133|NCT00150813|459503365|FG000|Overall Study|Adverse Event|1|||
127693134|NCT00150813|459503365|FG000|Overall Study|Lack of Efficacy|1|||
127693135|NCT00150813|459503365|FG000|Overall Study|Lost to Follow-up|5|||
127693136|NCT00150813|459503365|FG000|Overall Study|Withdrawal by Subject|5|||
127693137|NCT00150813|459503365|FG000|Overall Study|Remission|3|||
127693138|NCT00150813|459503365|FG000|Overall Study|Planned pregancy|1|||
127693139|NCT00150813|459503365|FG000|Overall Study|Switch to commercially available LEV|2|||
127693140|NCT03052608|459503367|FG000|Treatment Phase|Adverse Event|10|||
127693141|NCT03052608|459503368|FG001|Treatment Phase|Adverse Event|12|||
127881298|NCT03747939|460187362|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
127577162|NCT00891462|459084428|FG002|Overall Study|COPD exacerbation|1|||
127577163|NCT00891462|459084426|FG000|Overall Study|Other Reason|2|||
127577164|NCT00891462|459084427|FG001|Overall Study|Other Reason|5|||
127577165|NCT00891462|459084428|FG002|Overall Study|Other Reason|3|||
127693142|NCT03052608|459503367|FG000|Treatment Phase|Death|6|||
127693143|NCT03052608|459503368|FG001|Treatment Phase|Death|4|||
127693144|NCT03052608|459503367|FG000|Treatment Phase|Withdrawal by Subject|4|||
127693145|NCT03052608|459503368|FG001|Treatment Phase|Withdrawal by Subject|12|||
127693146|NCT03052608|459503367|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
127577166|NCT00891462|459084426|FG000|Overall Study|Protocol Violation|2|||
127577167|NCT00891462|459084427|FG001|Overall Study|Protocol Violation|1|||
127577168|NCT00891462|459084428|FG002|Overall Study|Protocol Violation|3|||
127577169|NCT00891462|459084426|FG000|Overall Study|Inclusion/exclusion criteria|0|||
127577170|NCT00891462|459084427|FG001|Overall Study|Inclusion/exclusion criteria|2|||
127577171|NCT00891462|459084428|FG002|Overall Study|Inclusion/exclusion criteria|2|||
127577172|NCT00891462|459084426|FG000|Overall Study|Lost to Follow-up|0|||
127577173|NCT00891462|459084427|FG001|Overall Study|Lost to Follow-up|2|||
127577174|NCT00891462|459084428|FG002|Overall Study|Lost to Follow-up|0|||
127693147|NCT03052608|459503368|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
127693148|NCT03052608|459503367|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
127693149|NCT03052608|459503368|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
127693150|NCT03052608|459503367|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
127693151|NCT03052608|459503368|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
127693152|NCT03052608|459503367|FG000|Treatment Phase|Ongoing|103|||
127693153|NCT03052608|459503368|FG001|Treatment Phase|Ongoing|31|||
127693154|NCT03052608|459503367|FG000|Long-Term Follow-up Phase|Death|23|||
127693155|NCT03052608|459503368|FG001|Long-Term Follow-up Phase|Death|28|||
127693156|NCT03052608|459503367|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
127693157|NCT03052608|459503368|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
127693158|NCT03052608|459503367|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
127693159|NCT03052608|459503368|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
127693160|NCT03052608|459503367|FG000|Long-Term Follow-up Phase|Ongoing|122|||
127693161|NCT03052608|459503368|FG001|Long-Term Follow-up Phase|Ongoing|99|||
127693162|NCT03113500|459503369|FG000|Overall Study|Withdrawal by Subject|1|||
127693163|NCT05249439|459503372|FG000|Overall Study|Withdrawal by Subject|2|||
127693164|NCT05249439|459503373|FG001|Overall Study|Withdrawal by Subject|5|||
127693165|NCT05249439|459503372|FG000|Overall Study|Physician Decision|3|||
127693166|NCT05249439|459503373|FG001|Overall Study|Physician Decision|1|||
127693167|NCT01376700|459503374|FG000|Overall Study|Sponsor terminated study early|8|||
127693168|NCT01376700|459503374|FG000|Overall Study|Low or high titer inhibitor|8|||
127693169|NCT00601900|459503386|FG000|Overall Study|Withdrawal by Subject|0|||
127693170|NCT00601900|459503387|FG001|Overall Study|Withdrawal by Subject|3|||
127693171|NCT02500758|459503391|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
127693172|NCT02500758|459503392|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
127693173|NCT02500758|459503391|FG000|Washout (1 Week)|Lost to Follow-up|2|||
127693174|NCT02500758|459503392|FG001|Washout (1 Week)|Lost to Follow-up|2|||
127693175|NCT02500758|459503391|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
127693176|NCT02500758|459503392|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
127693177|NCT02500758|459503391|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
127693178|NCT02500758|459503392|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
127693179|NCT02500758|459503391|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
127693180|NCT02500758|459503392|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
127693181|NCT00274469|459503394|FG000|Overall Study|Death|63|||
127693182|NCT00274469|459503395|FG001|Overall Study|Death|74|||
127693183|NCT00274469|459503394|FG000|Overall Study|Did not consent to OS follow-up|16|||
127693184|NCT00274469|459503395|FG001|Overall Study|Did not consent to OS follow-up|19|||
127693185|NCT00593489|459503403|FG000|Allocation|did not attend workshop; allocation not|2|||
127693186|NCT00593489|459503404|FG001|Allocation|did not attend workshop; allocation not|1|||
127693187|NCT00611559|459503405|FG000|Overall Study|Lost to Follow-up|0|||
127693188|NCT00611559|459503406|FG001|Overall Study|Lost to Follow-up|1|||
127693189|NCT00611559|459503407|FG002|Overall Study|Lost to Follow-up|0|||
127693190|NCT00611559|459503405|FG000|Overall Study|Protocol Violation|1|||
127693191|NCT00611559|459503406|FG001|Overall Study|Protocol Violation|0|||
127693192|NCT00611559|459503407|FG002|Overall Study|Protocol Violation|1|||
127693193|NCT04095104|459503408|FG000|Overall Study|Withdrawal by Subject|0|||
127693194|NCT04095104|459503409|FG001|Overall Study|Withdrawal by Subject|1|||
127693195|NCT04533022|459504441|FG000|Overall Study|Withdrawal by Subject|15|||
127693196|NCT04533022|459504441|FG000|Overall Study|Adverse Event|6|||
127693197|NCT04533022|459504441|FG000|Overall Study|Death|1|||
127693198|NCT04533022|459504441|FG000|Overall Study|FVC decline and FVCpp<60%|2|||
127693199|NCT04533022|459504441|FG000|Overall Study|FVC decline, FVCpp<60% and worsening of respiratory symptoms|1|||
127693200|NCT02163447|459504442|FG000|Overall Study|Withdrawal by Subject|2|||
127577175|NCT00257608|459084434|FG000|Chemotherapy Phase|Adverse Event|138|||
127577176|NCT00257608|459084435|FG001|Chemotherapy Phase|Adverse Event|0|||
127577177|NCT00257608|459084436|FG002|Chemotherapy Phase|Adverse Event|0|||
127693201|NCT02163447|459504443|FG001|Overall Study|Withdrawal by Subject|0|||
127693202|NCT02163447|459504444|FG002|Overall Study|Withdrawal by Subject|1|||
127693203|NCT02163447|459504442|FG000|Overall Study|Lost to Follow-up|1|||
127693204|NCT02163447|459504443|FG001|Overall Study|Lost to Follow-up|3|||
127693205|NCT02163447|459504444|FG002|Overall Study|Lost to Follow-up|0|||
127693206|NCT02163447|459504442|FG000|Overall Study|Moved out of study area|2|||
127693207|NCT02163447|459504443|FG001|Overall Study|Moved out of study area|3|||
127693208|NCT02163447|459504444|FG002|Overall Study|Moved out of study area|2|||
127881299|NCT03747939|460187363|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
127881300|NCT03747939|460187364|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
127881301|NCT03747939|460187361|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
127881302|NCT03747939|460187362|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
127693209|NCT02163447|459504442|FG000|Overall Study|Became HIV infected at time of delivery|1|||
127693210|NCT02163447|459504443|FG001|Overall Study|Became HIV infected at time of delivery|0|||
127693211|NCT02163447|459504444|FG002|Overall Study|Became HIV infected at time of delivery|0|||
127693212|NCT05113966|459504446|FG000|Overall Study|Death|21|||
127693213|NCT05113966|459504446|FG000|Overall Study|Study Terminated by Sponsor|9|||
127693214|NCT05386355|459504447|FG000|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
127693215|NCT05386355|459504448|FG001|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
127693216|NCT05386355|459504449|FG002|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
127693217|NCT05386355|459504450|FG003|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
127693218|NCT06143670|459504451|FG000|Overall Study|Lost to Follow-up|0|||
127693219|NCT06143670|459504452|FG001|Overall Study|Lost to Follow-up|1|||
127693220|NCT06143670|459504451|FG000|Overall Study|Withdrawal by Subject|3|||
127693221|NCT06143670|459504452|FG001|Overall Study|Withdrawal by Subject|0|||
127693222|NCT03747484|459504453|FG000|Overall Study|Lack of Efficacy|0|||
127693223|NCT03747484|459504454|FG001|Overall Study|Lack of Efficacy|1|||
127693224|NCT03747484|459504455|FG002|Overall Study|Lack of Efficacy|1|||
127693225|NCT03747484|459504456|FG003|Overall Study|Lack of Efficacy|2|||
127693226|NCT03747484|459504457|FG004|Overall Study|Lack of Efficacy|2|||
127693227|NCT02597946|459504459|FG000|Overall Study|Withdrawal by Subject|1|||
127693228|NCT02597946|459504459|FG000|Overall Study|Progressive disease|16|||
127693229|NCT02597946|459504459|FG000|Overall Study|Other than above|1|||
127693230|NCT05058391|459504466|FG000|Overall Study|Adverse Event|1|||
127693231|NCT03833245|459504467|FG000|Overall Study|Death|0|||
127693232|NCT03833245|459504468|FG001|Overall Study|Death|1|||
127693233|NCT03775109|459504470|FG000|Overall Study|Adverse Event|1|||
127693234|NCT03775109|459504471|FG001|Overall Study|Adverse Event|0|||
127693235|NCT03775109|459504470|FG000|Overall Study|COVID-19 outbreak|2|||
127693236|NCT03775109|459504471|FG001|Overall Study|COVID-19 outbreak|0|||
127693237|NCT03775109|459504470|FG000|Overall Study|Lost to Follow-up|0|||
127693238|NCT03775109|459504471|FG001|Overall Study|Lost to Follow-up|2|||
127693239|NCT03775109|459504470|FG000|Overall Study|Withdrawal by Subject|1|||
127693240|NCT03775109|459504471|FG001|Overall Study|Withdrawal by Subject|1|||
127693241|NCT03775109|459504470|FG000|Overall Study|Death|0|||
127693242|NCT03775109|459504471|FG001|Overall Study|Death|1|||
127693243|NCT03775109|459504470|FG000|Overall Study|Lack of Efficacy|1|||
127693244|NCT03775109|459504471|FG001|Overall Study|Lack of Efficacy|0|||
127693245|NCT03347383|459504472|FG000|Overall Study|Death|39|||
127693246|NCT03347383|459504472|FG000|Overall Study|Withdrawal by Subject|3|||
127693247|NCT03347383|459504472|FG000|Overall Study|Lost to Follow-up|9|||
127693248|NCT05691452|459504474|FG000|Overall Study|Withdrawal by Subject|1|||
127693249|NCT05691452|459504475|FG001|Overall Study|Withdrawal by Subject|1|||
127693250|NCT05691452|459504476|FG002|Overall Study|Withdrawal by Subject|0|||
127693251|NCT05691452|459504474|FG000|Overall Study|Physician Decision|1|||
127693252|NCT05691452|459504475|FG001|Overall Study|Physician Decision|0|||
127693253|NCT05691452|459504476|FG002|Overall Study|Physician Decision|0|||
127693254|NCT05691452|459504474|FG000|Overall Study|Lost to Follow-up|0|||
127693255|NCT05691452|459504475|FG001|Overall Study|Lost to Follow-up|0|||
127693256|NCT05691452|459504476|FG002|Overall Study|Lost to Follow-up|1|||
127693257|NCT05691452|459504474|FG000|Overall Study|Adverse Event|0|||
127693258|NCT05691452|459504475|FG001|Overall Study|Adverse Event|0|||
127693259|NCT05691452|459504476|FG002|Overall Study|Adverse Event|1|||
127693260|NCT04842643|459504477|FG000|Overall Study|Physician Decision|1|||
127693261|NCT04842643|459504477|FG000|Overall Study|Other|1|||
127693262|NCT00739648|459504480|FG000|Overall Study|Adverse Event|3|||
127693263|NCT00739648|459504481|FG001|Overall Study|Adverse Event|15|||
127693264|NCT00739648|459504480|FG000|Overall Study|Withdrawal by Subject|13|||
127693265|NCT00739648|459504481|FG001|Overall Study|Withdrawal by Subject|25|||
127693266|NCT00739648|459504480|FG000|Overall Study|Lost to Follow-up|4|||
127693267|NCT00739648|459504481|FG001|Overall Study|Lost to Follow-up|7|||
127693268|NCT00739648|459504480|FG000|Overall Study|Death|2|||
127693269|NCT00739648|459504481|FG001|Overall Study|Death|0|||
127693270|NCT00739648|459504480|FG000|Overall Study|Do not know|4|||
127693271|NCT00739648|459504481|FG001|Overall Study|Do not know|6|||
127693272|NCT04173663|459504482|FG000|Overall Study|Withdrawal by Subject|1|||
127693273|NCT04173663|459504483|FG001|Overall Study|Withdrawal by Subject|6|||
127693274|NCT04173663|459504482|FG000|Overall Study|Lost to Follow-up|17|||
127693275|NCT04173663|459504483|FG001|Overall Study|Lost to Follow-up|24|||
127693276|NCT02630823|459504489|FG000|Overall Study|Withdrawal by Subject|1|||
127693277|NCT02630823|459504489|FG000|Overall Study|Did not undergo cytoreductive surgery due to pre-operative disease progression|1|||
127693278|NCT03391466|459504490|FG000|Overall Study|Death|82|||
127693279|NCT03391466|459504491|FG001|Overall Study|Death|85|||
127577178|NCT00257608|459084434|FG000|Chemotherapy Phase|Disease progression|139|||
127577179|NCT00257608|459084435|FG001|Chemotherapy Phase|Disease progression|0|||
127577180|NCT00257608|459084436|FG002|Chemotherapy Phase|Disease progression|0|||
127577181|NCT00257608|459084434|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
127577182|NCT00257608|459084435|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
127577183|NCT00257608|459084436|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
127577184|NCT00257608|459084434|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
127782547|NCT00382720|459831337|FG000|Overall Study|Withdrew consent|1|||
127782548|NCT00382720|459831338|FG001|Overall Study|Withdrew consent|1|||
127782549|NCT00382720|459831339|FG002|Overall Study|Withdrew consent|2|||
127782550|NCT00382720|459831337|FG000|Overall Study|Withdrawal by Subject|11|||
127782551|NCT00382720|459831338|FG001|Overall Study|Withdrawal by Subject|20|||
127782552|NCT00382720|459831339|FG002|Overall Study|Withdrawal by Subject|12|||
127782553|NCT00382720|459831337|FG000|Overall Study|Surgery|1|||
127782554|NCT00382720|459831338|FG001|Overall Study|Surgery|1|||
127782555|NCT00382720|459831339|FG002|Overall Study|Surgery|4|||
127782556|NCT00382720|459831337|FG000|Overall Study|Patient did not receive study medication|1|||
127782557|NCT00382720|459831338|FG001|Overall Study|Patient did not receive study medication|1|||
127782558|NCT00382720|459831339|FG002|Overall Study|Patient did not receive study medication|4|||
127782559|NCT00382720|459831337|FG000|Overall Study|Clinically progressive disease|0|||
127782560|NCT00382720|459831338|FG001|Overall Study|Clinically progressive disease|1|||
127782561|NCT00382720|459831339|FG002|Overall Study|Clinically progressive disease|0|||
127782562|NCT00382720|459831337|FG000|Overall Study|Good prognosis|0|||
127782563|NCT00382720|459831338|FG001|Overall Study|Good prognosis|1|||
127782564|NCT00382720|459831339|FG002|Overall Study|Good prognosis|0|||
127782565|NCT00382720|459831337|FG000|Overall Study|Investigator/Clinical decision|5|||
127782566|NCT00382720|459831338|FG001|Overall Study|Investigator/Clinical decision|6|||
127782567|NCT00382720|459831339|FG002|Overall Study|Investigator/Clinical decision|6|||
127782568|NCT00382720|459831337|FG000|Overall Study|Discontinued at end of study|0|||
127782569|NCT00382720|459831338|FG001|Overall Study|Discontinued at end of study|1|||
127782570|NCT00382720|459831339|FG002|Overall Study|Discontinued at end of study|2|||
127782571|NCT02713542|459831341|FG000|Overall Study|Use of prohibited medication|14|||
127782572|NCT02713542|459831342|FG001|Overall Study|Use of prohibited medication|5|||
127782573|NCT02713542|459831341|FG000|Overall Study|Withdrawal by Subject|4|||
127782574|NCT02713542|459831342|FG001|Overall Study|Withdrawal by Subject|1|||
127782575|NCT00066742|459831343|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
127782576|NCT00066742|459831343|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
127782577|NCT00066742|459831343|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
127782578|NCT00066742|459831343|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
127782579|NCT00066742|459831343|FG000|Induction Chemoradiotherapy|Ineligible|3|||
127782580|NCT00066742|459831343|FG000|Consolidation Chemotherapy|not protocol specified|1|||
127782581|NCT00066742|459831343|FG000|Consolidation Chemotherapy|Ineligible|2|||
127782582|NCT01994382|459831349|FG000|Overall Study|Informed consent withdrawn|0|||
127782583|NCT01994382|459831350|FG001|Overall Study|Informed consent withdrawn|0|||
127782584|NCT01994382|459831351|FG002|Overall Study|Informed consent withdrawn|0|||
127782585|NCT01994382|459831352|FG003|Overall Study|Informed consent withdrawn|0|||
127782586|NCT01994382|459831353|FG004|Overall Study|Informed consent withdrawn|0|||
127782587|NCT01994382|459831354|FG005|Overall Study|Informed consent withdrawn|0|||
127782588|NCT01994382|459831355|FG006|Overall Study|Informed consent withdrawn|1|||
127782589|NCT01994382|459831356|FG007|Overall Study|Informed consent withdrawn|0|||
127782590|NCT01994382|459831357|FG008|Overall Study|Informed consent withdrawn|0|||
127782591|NCT01994382|459831358|FG009|Overall Study|Informed consent withdrawn|0|||
127782592|NCT01994382|459831359|FG010|Overall Study|Informed consent withdrawn|0|||
127782593|NCT01994382|459831360|FG011|Overall Study|Informed consent withdrawn|0|||
127782594|NCT01994382|459831361|FG012|Overall Study|Informed consent withdrawn|0|||
127782595|NCT01994382|459831362|FG013|Overall Study|Informed consent withdrawn|0|||
127782596|NCT01994382|459831363|FG014|Overall Study|Informed consent withdrawn|0|||
127782597|NCT01994382|459831364|FG015|Overall Study|Informed consent withdrawn|0|||
127782598|NCT01994382|459831365|FG016|Overall Study|Informed consent withdrawn|0|||
127782599|NCT01994382|459831349|FG000|Overall Study|Progressive disease|3|||
127782600|NCT01994382|459831350|FG001|Overall Study|Progressive disease|4|||
127782601|NCT01994382|459831351|FG002|Overall Study|Progressive disease|4|||
127782602|NCT01994382|459831352|FG003|Overall Study|Progressive disease|3|||
127782603|NCT01994382|459831353|FG004|Overall Study|Progressive disease|2|||
127782604|NCT01994382|459831354|FG005|Overall Study|Progressive disease|3|||
127782605|NCT01994382|459831355|FG006|Overall Study|Progressive disease|3|||
127782606|NCT01994382|459831356|FG007|Overall Study|Progressive disease|6|||
127782607|NCT01994382|459831357|FG008|Overall Study|Progressive disease|2|||
127782608|NCT01994382|459831358|FG009|Overall Study|Progressive disease|2|||
127782609|NCT01994382|459831359|FG010|Overall Study|Progressive disease|13|||
127782610|NCT01994382|459831360|FG011|Overall Study|Progressive disease|8|||
127782611|NCT01994382|459831361|FG012|Overall Study|Progressive disease|7|||
127782612|NCT01994382|459831362|FG013|Overall Study|Progressive disease|3|||
127782613|NCT01994382|459831363|FG014|Overall Study|Progressive disease|6|||
127782614|NCT01994382|459831364|FG015|Overall Study|Progressive disease|44|||
127577185|NCT00257608|459084435|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
127577186|NCT00257608|459084436|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
127577187|NCT00257608|459084434|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
127577188|NCT00257608|459084435|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
127577189|NCT00257608|459084436|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
127577190|NCT00257608|459084434|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
127782615|NCT01994382|459831365|FG016|Overall Study|Progressive disease|28|||
127782616|NCT01994382|459831349|FG000|Overall Study|Physician Decision|0|||
127782617|NCT01994382|459831350|FG001|Overall Study|Physician Decision|1|||
127782618|NCT01994382|459831351|FG002|Overall Study|Physician Decision|0|||
127782619|NCT01994382|459831352|FG003|Overall Study|Physician Decision|0|||
127782620|NCT01994382|459831353|FG004|Overall Study|Physician Decision|0|||
127782621|NCT01994382|459831354|FG005|Overall Study|Physician Decision|0|||
127782622|NCT01994382|459831355|FG006|Overall Study|Physician Decision|0|||
127782623|NCT01994382|459831356|FG007|Overall Study|Physician Decision|0|||
127782624|NCT01994382|459831357|FG008|Overall Study|Physician Decision|0|||
127782625|NCT01994382|459831358|FG009|Overall Study|Physician Decision|0|||
127782626|NCT01994382|459831359|FG010|Overall Study|Physician Decision|3|||
127782627|NCT01994382|459831360|FG011|Overall Study|Physician Decision|1|||
127782628|NCT01994382|459831361|FG012|Overall Study|Physician Decision|1|||
127782629|NCT01994382|459831362|FG013|Overall Study|Physician Decision|0|||
127782630|NCT01994382|459831363|FG014|Overall Study|Physician Decision|1|||
127782631|NCT01994382|459831364|FG015|Overall Study|Physician Decision|4|||
127782632|NCT01994382|459831365|FG016|Overall Study|Physician Decision|2|||
127782633|NCT01994382|459831349|FG000|Overall Study|Death|0|||
127782634|NCT01994382|459831350|FG001|Overall Study|Death|0|||
127782635|NCT01994382|459831351|FG002|Overall Study|Death|0|||
127782636|NCT01994382|459831352|FG003|Overall Study|Death|0|||
127782637|NCT01994382|459831353|FG004|Overall Study|Death|1|||
127782638|NCT01994382|459831354|FG005|Overall Study|Death|0|||
127782639|NCT01994382|459831355|FG006|Overall Study|Death|0|||
127782640|NCT01994382|459831356|FG007|Overall Study|Death|0|||
127782641|NCT01994382|459831357|FG008|Overall Study|Death|1|||
127782642|NCT01994382|459831358|FG009|Overall Study|Death|1|||
127782643|NCT01994382|459831359|FG010|Overall Study|Death|0|||
127782644|NCT01994382|459831360|FG011|Overall Study|Death|0|||
127782645|NCT01994382|459831361|FG012|Overall Study|Death|0|||
127782646|NCT01994382|459831362|FG013|Overall Study|Death|0|||
127782647|NCT01994382|459831363|FG014|Overall Study|Death|0|||
127782648|NCT01994382|459831364|FG015|Overall Study|Death|1|||
127782649|NCT01994382|459831365|FG016|Overall Study|Death|0|||
127782650|NCT01994382|459831349|FG000|Overall Study|Adverse Event|0|||
127782651|NCT01994382|459831350|FG001|Overall Study|Adverse Event|1|||
127782652|NCT01994382|459831351|FG002|Overall Study|Adverse Event|2|||
127782653|NCT01994382|459831352|FG003|Overall Study|Adverse Event|0|||
127782654|NCT01994382|459831353|FG004|Overall Study|Adverse Event|0|||
127782655|NCT01994382|459831354|FG005|Overall Study|Adverse Event|0|||
127782656|NCT01994382|459831355|FG006|Overall Study|Adverse Event|0|||
127782657|NCT01994382|459831356|FG007|Overall Study|Adverse Event|0|||
127782658|NCT01994382|459831357|FG008|Overall Study|Adverse Event|0|||
127577191|NCT00257608|459084435|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
127577192|NCT00257608|459084436|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
127577193|NCT00257608|459084434|FG000|Chemotherapy Phase|Physician Decision|28|||
127577194|NCT00257608|459084435|FG001|Chemotherapy Phase|Physician Decision|0|||
127577195|NCT00257608|459084436|FG002|Chemotherapy Phase|Physician Decision|0|||
127577196|NCT00257608|459084434|FG000|Post Chemotherapy Phase|Adverse Event|0|||
127577197|NCT00257608|459084435|FG001|Post Chemotherapy Phase|Adverse Event|34|||
127577198|NCT00257608|459084436|FG002|Post Chemotherapy Phase|Adverse Event|38|||
127577199|NCT00257608|459084434|FG000|Post Chemotherapy Phase|Disease progression|0|||
127577200|NCT00257608|459084435|FG001|Post Chemotherapy Phase|Disease progression|204|||
127782659|NCT01994382|459831358|FG009|Overall Study|Adverse Event|0|||
127782660|NCT01994382|459831359|FG010|Overall Study|Adverse Event|15|||
127782661|NCT01994382|459831360|FG011|Overall Study|Adverse Event|2|||
127782662|NCT01994382|459831361|FG012|Overall Study|Adverse Event|7|||
127782663|NCT01994382|459831362|FG013|Overall Study|Adverse Event|3|||
127782664|NCT01994382|459831363|FG014|Overall Study|Adverse Event|17|||
127782665|NCT01994382|459831364|FG015|Overall Study|Adverse Event|6|||
127782666|NCT01994382|459831365|FG016|Overall Study|Adverse Event|3|||
127577201|NCT00257608|459084436|FG002|Post Chemotherapy Phase|Disease progression|168|||
127782667|NCT01994382|459831349|FG000|Overall Study|Other than specified|0|||
127782668|NCT01994382|459831350|FG001|Overall Study|Other than specified|0|||
127782669|NCT01994382|459831351|FG002|Overall Study|Other than specified|0|||
127782670|NCT01994382|459831352|FG003|Overall Study|Other than specified|0|||
127782671|NCT01994382|459831353|FG004|Overall Study|Other than specified|0|||
127782672|NCT01994382|459831354|FG005|Overall Study|Other than specified|0|||
127782673|NCT01994382|459831355|FG006|Overall Study|Other than specified|0|||
127782674|NCT01994382|459831356|FG007|Overall Study|Other than specified|0|||
127782675|NCT01994382|459831357|FG008|Overall Study|Other than specified|0|||
127782676|NCT01994382|459831358|FG009|Overall Study|Other than specified|0|||
127577202|NCT00257608|459084434|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
127577203|NCT00257608|459084435|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
127577204|NCT00257608|459084436|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
127577205|NCT00257608|459084434|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
127577206|NCT00257608|459084435|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
127577207|NCT00257608|459084436|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
127577208|NCT00257608|459084434|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
127577209|NCT00257608|459084435|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
127577210|NCT00257608|459084436|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
127577211|NCT00257608|459084434|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
127577212|NCT00257608|459084435|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
127577213|NCT00257608|459084436|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
127577214|NCT00257608|459084434|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
127577215|NCT00257608|459084435|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
127577216|NCT00257608|459084436|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
127577217|NCT00257608|459084434|FG000|Post Chemotherapy Phase|Physician Decision|0|||
127577218|NCT00257608|459084435|FG001|Post Chemotherapy Phase|Physician Decision|8|||
127577219|NCT00257608|459084436|FG002|Post Chemotherapy Phase|Physician Decision|11|||
127577220|NCT00257608|459084434|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
127577221|NCT00257608|459084435|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
127577222|NCT00257608|459084436|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
127577223|NCT00257608|459084434|FG000|Post Chemotherapy Phase|Not treated|0|||
127577224|NCT00257608|459084435|FG001|Post Chemotherapy Phase|Not treated|4|||
127577225|NCT00257608|459084436|FG002|Post Chemotherapy Phase|Not treated|7|||
127693280|NCT03391466|459504490|FG000|Overall Study|Still on study|93|||
127693281|NCT03391466|459504491|FG001|Overall Study|Still on study|74|||
127693282|NCT03391466|459504490|FG000|Overall Study|Subject withdrawal of consent from further follow-up|0|||
127693283|NCT03391466|459504491|FG001|Overall Study|Subject withdrawal of consent from further follow-up|13|||
127693284|NCT03391466|459504490|FG000|Overall Study|Lost to Follow-up|5|||
127693285|NCT03391466|459504491|FG001|Overall Study|Lost to Follow-up|5|||
127693286|NCT03391466|459504490|FG000|Overall Study|Investigator decision|0|||
127693287|NCT03391466|459504491|FG001|Overall Study|Investigator decision|1|||
127693288|NCT03391466|459504490|FG000|Overall Study|Other|0|||
127693289|NCT03391466|459504491|FG001|Overall Study|Other|1|||
127693290|NCT03655132|459504494|FG000|Overall Study|Lost to Follow-up|2|||
127693291|NCT03655132|459504495|FG001|Overall Study|Lost to Follow-up|1|||
127693292|NCT03655132|459504494|FG000|Overall Study|Withdrawal by Subject|0|||
127693293|NCT03655132|459504495|FG001|Overall Study|Withdrawal by Subject|1|||
127693294|NCT03655132|459504494|FG000|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|0|||
127693295|NCT03655132|459504495|FG001|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|1|||
127693296|NCT05919082|459504500|FG000|Overall Study|Adverse Event|3|||
127693297|NCT05919082|459504501|FG001|Overall Study|Adverse Event|0|||
127693298|NCT05919082|459504500|FG000|Overall Study|Lost to Follow-up|0|||
127693299|NCT05919082|459504501|FG001|Overall Study|Lost to Follow-up|1|||
127693300|NCT05919082|459504500|FG000|Overall Study|Withdrawal by Subject|8|||
127693301|NCT05919082|459504501|FG001|Overall Study|Withdrawal by Subject|9|||
127693302|NCT05919082|459504500|FG000|Overall Study|Lack of Efficacy|0|||
127693303|NCT05919082|459504501|FG001|Overall Study|Lack of Efficacy|1|||
127693304|NCT05919082|459504500|FG000|Overall Study|Investigator Decision|1|||
127693305|NCT05919082|459504501|FG001|Overall Study|Investigator Decision|0|||
127693306|NCT03526861|459504513|FG000|Initial Treatment Period|Not dosed|1|||
127693307|NCT03526861|459504514|FG001|Initial Treatment Period|Not dosed|1|||
127693308|NCT03526861|459504515|FG002|Initial Treatment Period|Not dosed|1|||
127693309|NCT03526861|459504516|FG003|Initial Treatment Period|Not dosed|0|||
127693310|NCT03526861|459504517|FG004|Initial Treatment Period|Not dosed|0|||
127693311|NCT03526861|459504518|FG005|Initial Treatment Period|Not dosed|0|||
127693312|NCT03526861|459504519|FG006|Initial Treatment Period|Not dosed|0|||
127693313|NCT03526861|459504520|FG007|Initial Treatment Period|Not dosed|0|||
127693314|NCT03526861|459504521|FG008|Initial Treatment Period|Not dosed|0|||
127693315|NCT03526861|459504513|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
127693316|NCT03526861|459504514|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
127693317|NCT03526861|459504515|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
127693318|NCT03526861|459504516|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
127693319|NCT03526861|459504517|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
127693320|NCT03526861|459504518|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
127693321|NCT03526861|459504519|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
128029804|NCT00803049|460735131|FG000|Overall Study|Lost to Follow-up|0|||
127577226|NCT02171065|459084437|FG000|Overall Study|Withdrawal by Subject|1|||
127577227|NCT02171065|459084438|FG001|Overall Study|Withdrawal by Subject|0|||
127577228|NCT02171065|459084439|FG002|Overall Study|Withdrawal by Subject|0|||
127577229|NCT02171065|459084437|FG000|Overall Study|Lost to Follow-up|0|||
127577230|NCT02171065|459084438|FG001|Overall Study|Lost to Follow-up|0|||
127577231|NCT02171065|459084439|FG002|Overall Study|Lost to Follow-up|1|||
127577232|NCT01614600|459084442|FG000|Overall Study|Unacceptable fit|1|||
127577233|NCT01614600|459084442|FG000|Overall Study|Discomfort|1|||
127577234|NCT01614600|459084442|FG000|Overall Study|Unable to remove lens at the end of day|1|||
127577235|NCT01614600|459084442|FG000|Overall Study|Protocol deviation|1|||
127577236|NCT02437513|459084443|FG000|Overall Study|Withdrawal by Subject|2|||
127577237|NCT03347188|459084444|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
127577238|NCT03347188|459084445|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
127577239|NCT03347188|459084444|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
127577240|NCT03347188|459084445|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
127577241|NCT03347188|459084444|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
127577242|NCT03347188|459084445|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
127782677|NCT01994382|459831359|FG010|Overall Study|Other than specified|2|||
127782678|NCT01994382|459831360|FG011|Overall Study|Other than specified|0|||
127782679|NCT01994382|459831361|FG012|Overall Study|Other than specified|2|||
127782680|NCT01994382|459831362|FG013|Overall Study|Other than specified|0|||
127782681|NCT01994382|459831363|FG014|Overall Study|Other than specified|0|||
127782682|NCT01994382|459831364|FG015|Overall Study|Other than specified|4|||
127782683|NCT01994382|459831365|FG016|Overall Study|Other than specified|4|||
127782684|NCT01994382|459831349|FG000|Overall Study|Withdrawal by Subject|0|||
127782685|NCT01994382|459831350|FG001|Overall Study|Withdrawal by Subject|0|||
127782686|NCT01994382|459831351|FG002|Overall Study|Withdrawal by Subject|0|||
127782687|NCT01994382|459831352|FG003|Overall Study|Withdrawal by Subject|0|||
127782688|NCT01994382|459831353|FG004|Overall Study|Withdrawal by Subject|0|||
127782689|NCT01994382|459831354|FG005|Overall Study|Withdrawal by Subject|0|||
127782690|NCT01994382|459831355|FG006|Overall Study|Withdrawal by Subject|0|||
127782691|NCT01994382|459831356|FG007|Overall Study|Withdrawal by Subject|0|||
127782692|NCT01994382|459831357|FG008|Overall Study|Withdrawal by Subject|0|||
127782693|NCT01994382|459831358|FG009|Overall Study|Withdrawal by Subject|0|||
127782694|NCT01994382|459831359|FG010|Overall Study|Withdrawal by Subject|6|||
127782695|NCT01994382|459831360|FG011|Overall Study|Withdrawal by Subject|0|||
127782696|NCT01994382|459831361|FG012|Overall Study|Withdrawal by Subject|2|||
127782697|NCT01994382|459831362|FG013|Overall Study|Withdrawal by Subject|0|||
127782698|NCT01994382|459831363|FG014|Overall Study|Withdrawal by Subject|4|||
127782699|NCT01994382|459831364|FG015|Overall Study|Withdrawal by Subject|3|||
127782700|NCT01994382|459831365|FG016|Overall Study|Withdrawal by Subject|0|||
127782701|NCT01994382|459831349|FG000|Overall Study|Lost to Follow-up|0|||
127782702|NCT01994382|459831350|FG001|Overall Study|Lost to Follow-up|0|||
127782703|NCT01994382|459831351|FG002|Overall Study|Lost to Follow-up|0|||
127782704|NCT01994382|459831352|FG003|Overall Study|Lost to Follow-up|0|||
127782705|NCT01994382|459831353|FG004|Overall Study|Lost to Follow-up|0|||
127782706|NCT01994382|459831354|FG005|Overall Study|Lost to Follow-up|0|||
127782707|NCT01994382|459831355|FG006|Overall Study|Lost to Follow-up|0|||
127782708|NCT01994382|459831356|FG007|Overall Study|Lost to Follow-up|0|||
127782709|NCT01994382|459831357|FG008|Overall Study|Lost to Follow-up|0|||
127782710|NCT01994382|459831358|FG009|Overall Study|Lost to Follow-up|0|||
127782711|NCT01994382|459831359|FG010|Overall Study|Lost to Follow-up|1|||
127782712|NCT01994382|459831360|FG011|Overall Study|Lost to Follow-up|0|||
127782713|NCT01994382|459831361|FG012|Overall Study|Lost to Follow-up|0|||
127782714|NCT01994382|459831362|FG013|Overall Study|Lost to Follow-up|0|||
127782715|NCT01994382|459831363|FG014|Overall Study|Lost to Follow-up|0|||
127782716|NCT01994382|459831364|FG015|Overall Study|Lost to Follow-up|0|||
127782717|NCT01994382|459831365|FG016|Overall Study|Lost to Follow-up|0|||
127782718|NCT01994382|459831349|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
127782719|NCT01994382|459831350|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
127782720|NCT01994382|459831351|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
127577243|NCT03347188|459084444|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
127577244|NCT03347188|459084445|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
127782721|NCT01994382|459831352|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
127782722|NCT01994382|459831353|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
127782723|NCT01994382|459831354|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
127782724|NCT01994382|459831355|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
127782725|NCT01994382|459831356|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
127782726|NCT01994382|459831357|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
127881303|NCT03747939|460187363|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
127577245|NCT03347188|459084444|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
127577246|NCT03347188|459084445|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
127881304|NCT03747939|460187364|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
127881305|NCT02494583|460187367|FG000|Overall Study|Death|224|||
127881306|NCT02494583|460187368|FG001|Overall Study|Death|214|||
127881307|NCT02494583|460187369|FG002|Overall Study|Death|225|||
127577247|NCT03347188|459084444|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
127577248|NCT03347188|459084445|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
127577249|NCT03347188|459084444|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
127577250|NCT03347188|459084445|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
127577251|NCT03347188|459084444|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
127577252|NCT03347188|459084445|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
127881308|NCT02494583|460187367|FG000|Overall Study|Lost to Follow-up|1|||
127881309|NCT02494583|460187368|FG001|Overall Study|Lost to Follow-up|0|||
127881310|NCT02494583|460187369|FG002|Overall Study|Lost to Follow-up|0|||
127881311|NCT02494583|460187367|FG000|Overall Study|Protocol Violation|1|||
127881312|NCT02494583|460187368|FG001|Overall Study|Protocol Violation|2|||
127881313|NCT02494583|460187369|FG002|Overall Study|Protocol Violation|0|||
127881314|NCT02494583|460187367|FG000|Overall Study|Screen Failure|0|||
127881315|NCT02494583|460187368|FG001|Overall Study|Screen Failure|1|||
127881316|NCT02494583|460187369|FG002|Overall Study|Screen Failure|0|||
127881317|NCT02494583|460187367|FG000|Overall Study|Transferred to Extension Study|15|||
127881318|NCT02494583|460187368|FG001|Overall Study|Transferred to Extension Study|15|||
127881319|NCT02494583|460187369|FG002|Overall Study|Transferred to Extension Study|6|||
127881320|NCT02494583|460187367|FG000|Overall Study|Did Not Continue on Extension Study|8|||
127881321|NCT02494583|460187368|FG001|Overall Study|Did Not Continue on Extension Study|10|||
127881322|NCT02494583|460187369|FG002|Overall Study|Did Not Continue on Extension Study|4|||
127881323|NCT02494583|460187367|FG000|Overall Study|Withdrawal by Subject|7|||
127881324|NCT02494583|460187368|FG001|Overall Study|Withdrawal by Subject|15|||
127881325|NCT02494583|460187369|FG002|Overall Study|Withdrawal by Subject|15|||
127881326|NCT02180659|460187370|FG000|Overall Study|Adverse Event|1|||
127881327|NCT02180659|460187371|FG001|Overall Study|Adverse Event|0|||
127881328|NCT02180659|460187370|FG000|Overall Study|Lost to Follow-up|4|||
127881329|NCT02180659|460187371|FG001|Overall Study|Lost to Follow-up|2|||
127881330|NCT02180659|460187370|FG000|Overall Study|Subject incarcerated during conduct|1|||
127881331|NCT02180659|460187371|FG001|Overall Study|Subject incarcerated during conduct|0|||
127881332|NCT02180659|460187370|FG000|Overall Study|Withdrawal by Subject|0|||
127881333|NCT02180659|460187371|FG001|Overall Study|Withdrawal by Subject|2|||
127881334|NCT02180659|460187370|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
127881335|NCT02180659|460187371|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
127881336|NCT00481871|460187374|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
127881337|NCT00481871|460187375|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
127881338|NCT00481871|460187376|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
127881339|NCT00481871|460187377|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
127881340|NCT00481871|460187378|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
127881341|NCT03151707|460187379|FG000|Overall Study|Lost to Follow-up|6|||
127881342|NCT01308762|460187380|FG000|Overall Study|Protocol Violation|0|||
127881343|NCT01308762|460187381|FG001|Overall Study|Protocol Violation|1|||
127881344|NCT01308762|460187382|FG002|Overall Study|Protocol Violation|0|||
127881345|NCT02362646|460187386|FG000|Overall Study|Death|15|||
127881346|NCT02362646|460187387|FG001|Overall Study|Death|8|||
127881347|NCT02362646|460187386|FG000|Overall Study|Withdrawal by Subject|2|||
127577253|NCT00195273|459084446|FG000|Overall Study|Adverse Event|9|||
127577254|NCT00195273|459084447|FG001|Overall Study|Adverse Event|9|||
127577255|NCT00195273|459084446|FG000|Overall Study|Protocol deviation|0|||
127577256|NCT00195273|459084447|FG001|Overall Study|Protocol deviation|1|||
127577257|NCT00195273|459084446|FG000|Overall Study|Lack of Efficacy|3|||
127577258|NCT00195273|459084447|FG001|Overall Study|Lack of Efficacy|1|||
127881348|NCT02362646|460187387|FG001|Overall Study|Withdrawal by Subject|2|||
127881349|NCT02362646|460187386|FG000|Overall Study|received transplant|21|||
127881350|NCT02362646|460187387|FG001|Overall Study|received transplant|14|||
127881351|NCT00865306|460187388|FG000|Controlled Trial|Lost to Follow-up|1|||
127577259|NCT00195273|459084446|FG000|Overall Study|Procedural complications|9|||
127577260|NCT00195273|459084447|FG001|Overall Study|Procedural complications|3|||
127577261|NCT02186873|459084448|FG000|Overall Study|Adverse Event|1|||
127881352|NCT00865306|460187389|FG001|Controlled Trial|Lost to Follow-up|1|||
127881353|NCT00865306|460187388|FG000|Controlled Trial|Difficulty commuting|2|||
127881354|NCT00865306|460187389|FG001|Controlled Trial|Difficulty commuting|0|||
127881355|NCT00865306|460187388|FG000|Controlled Trial|Improved btw baseline and first session|1|||
127881356|NCT00865306|460187389|FG001|Controlled Trial|Improved btw baseline and first session|0|||
127881357|NCT00865306|460187388|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
127881358|NCT00865306|460187389|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
127881359|NCT00865306|460187388|FG000|Controlled Trial|Withdrawal by Subject|0|||
127881360|NCT00865306|460187389|FG001|Controlled Trial|Withdrawal by Subject|1|||
127881361|NCT02058368|460187391|FG000|Overall Study|Adverse Event|15|||
127881362|NCT02058368|460187392|FG001|Overall Study|Adverse Event|20|||
127577262|NCT02186873|459084449|FG001|Overall Study|Adverse Event|3|||
127577263|NCT02186873|459084448|FG000|Overall Study|Lack of Efficacy|0|||
127577264|NCT02186873|459084449|FG001|Overall Study|Lack of Efficacy|1|||
127577265|NCT02186873|459084448|FG000|Overall Study|Lost to Follow-up|1|||
127577266|NCT02186873|459084449|FG001|Overall Study|Lost to Follow-up|2|||
127577267|NCT02186873|459084448|FG000|Overall Study|Withdrawal by Subject|7|||
127577268|NCT02186873|459084449|FG001|Overall Study|Withdrawal by Subject|2|||
127577269|NCT01680965|459084450|FG000|Overall Study|Death|0|||
127577270|NCT01680965|459084451|FG001|Overall Study|Death|0|||
127577271|NCT01680965|459084452|FG002|Overall Study|Death|0|||
127577272|NCT01680965|459084453|FG003|Overall Study|Death|6|||
127577273|NCT00595465|459084454|FG000|Overall Study|Adverse Event|4|||
127577274|NCT00595465|459084455|FG001|Overall Study|Adverse Event|3|||
127577275|NCT00595465|459084456|FG002|Overall Study|Adverse Event|3|||
127577276|NCT00595465|459084454|FG000|Overall Study|Pregnancy|0|||
127577277|NCT00595465|459084455|FG001|Overall Study|Pregnancy|0|||
127577278|NCT00595465|459084456|FG002|Overall Study|Pregnancy|1|||
127577279|NCT00595465|459084454|FG000|Overall Study|Protocol Violation|2|||
127577280|NCT00595465|459084455|FG001|Overall Study|Protocol Violation|1|||
127577281|NCT00595465|459084456|FG002|Overall Study|Protocol Violation|0|||
127577282|NCT00595465|459084454|FG000|Overall Study|Lost to Follow-up|0|||
127577283|NCT00595465|459084455|FG001|Overall Study|Lost to Follow-up|0|||
127577284|NCT00595465|459084456|FG002|Overall Study|Lost to Follow-up|2|||
127577285|NCT00595465|459084454|FG000|Overall Study|administrative reason|0|||
127577286|NCT00595465|459084455|FG001|Overall Study|administrative reason|0|||
127577287|NCT00595465|459084456|FG002|Overall Study|administrative reason|1|||
127577288|NCT02595970|459084457|FG000|Overall Study|Withdrawal by Subject|2|||
127577289|NCT02595970|459084457|FG000|Overall Study|Physician Decision|2|||
127577290|NCT02595970|459084457|FG000|Overall Study|Protocol Violation|4|||
127577291|NCT02595970|459084457|FG000|Overall Study|Adverse Event|5|||
127577292|NCT02595970|459084457|FG000|Overall Study|Lack of Efficacy|7|||
127577293|NCT00107783|459084458|FG000|Overall Study|Adverse Event|0|||
127577294|NCT00107783|459084459|FG001|Overall Study|Adverse Event|2|||
127577295|NCT00107783|459084458|FG000|Overall Study|Death|0|||
127577296|NCT00107783|459084459|FG001|Overall Study|Death|1|||
127577297|NCT00107783|459084458|FG000|Overall Study|Withdrawal by Subject|2|||
127577298|NCT00107783|459084459|FG001|Overall Study|Withdrawal by Subject|0|||
127577299|NCT00107783|459084458|FG000|Overall Study|Second hip replacement|1|||
127577300|NCT00107783|459084459|FG001|Overall Study|Second hip replacement|1|||
127577301|NCT01051466|459084462|FG000|Overall Study|Adverse Event|1|||
127577302|NCT01051466|459084463|FG001|Overall Study|Adverse Event|0|||
127577303|NCT01051466|459084462|FG000|Overall Study|Lost to Follow-up|1|||
127577304|NCT01051466|459084463|FG001|Overall Study|Lost to Follow-up|1|||
127577305|NCT01051466|459084462|FG000|Overall Study|Withdrawal by Subject|5|||
127577306|NCT01051466|459084463|FG001|Overall Study|Withdrawal by Subject|1|||
127577307|NCT01051466|459084462|FG000|Overall Study|Entry Criteria Not Met|0|||
127577308|NCT01051466|459084463|FG001|Overall Study|Entry Criteria Not Met|3|||
127577309|NCT01051466|459084462|FG000|Overall Study|Physician Decision|1|||
127577310|NCT01051466|459084463|FG001|Overall Study|Physician Decision|0|||
127577311|NCT02231918|459084464|FG000|Overall Study|Withdrawal by Subject|0|||
127577312|NCT02231918|459084465|FG001|Overall Study|Withdrawal by Subject|1|||
127577313|NCT02231918|459084466|FG002|Overall Study|Withdrawal by Subject|0|||
127577314|NCT02231918|459084464|FG000|Overall Study|Adverse Event|0|||
127577315|NCT02231918|459084465|FG001|Overall Study|Adverse Event|0|||
127577316|NCT02231918|459084466|FG002|Overall Study|Adverse Event|1|||
127577317|NCT00331864|459084472|FG000|Overall Study|Adverse Event|30|||
127577318|NCT00331864|459084473|FG001|Overall Study|Adverse Event|1|||
127577319|NCT00331864|459084472|FG000|Overall Study|Lack of Efficacy|4|||
127577320|NCT00331864|459084473|FG001|Overall Study|Lack of Efficacy|0|||
127577321|NCT00331864|459084472|FG000|Overall Study|Protocol Violation|3|||
127577322|NCT00331864|459084473|FG001|Overall Study|Protocol Violation|0|||
127577323|NCT00331864|459084472|FG000|Overall Study|Withdrawal by Subject|10|||
127577324|NCT00331864|459084473|FG001|Overall Study|Withdrawal by Subject|0|||
127577325|NCT00331864|459084472|FG000|Overall Study|Lost to Follow-up|4|||
127693322|NCT03526861|459504520|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
127693323|NCT03526861|459504521|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
127693324|NCT03526861|459504513|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
127693325|NCT03526861|459504514|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
127577326|NCT00331864|459084473|FG001|Overall Study|Lost to Follow-up|3|||
127577327|NCT00331864|459084472|FG000|Overall Study|Administrative Problems|1|||
127577328|NCT00331864|459084473|FG001|Overall Study|Administrative Problems|0|||
127577329|NCT00331864|459084472|FG000|Overall Study|Death|6|||
127577330|NCT00331864|459084473|FG001|Overall Study|Death|0|||
127577331|NCT01092507|459084474|FG000|Overall Study|Withdrawal by Subject|2|||
127577332|NCT01092507|459084475|FG001|Overall Study|Withdrawal by Subject|0|||
127577333|NCT01871142|459084477|FG000|Overall Study|Adverse Event|1|||
127577334|NCT01539642|459084479|FG000|Overall Study|Lack of Efficacy|20|||
127577335|NCT01539642|459084480|FG001|Overall Study|Lack of Efficacy|18|||
127577336|NCT01539642|459084479|FG000|Overall Study|Patient ready for early discharge|8|||
127577337|NCT01539642|459084480|FG001|Overall Study|Patient ready for early discharge|7|||
127577338|NCT01539642|459084479|FG000|Overall Study|Adverse Event|6|||
127577339|NCT01539642|459084480|FG001|Overall Study|Adverse Event|4|||
127577340|NCT01539642|459084479|FG000|Overall Study|Withdrawal by Subject|2|||
127577341|NCT01539642|459084480|FG001|Overall Study|Withdrawal by Subject|2|||
127577342|NCT00122109|459084482|FG000|Overall Study|Did not meet criteria|6|||
127577343|NCT00122109|459084483|FG001|Overall Study|Did not meet criteria|7|||
127577344|NCT00809354|459084488|FG000|Overall Study|Adverse Event|32|||
127577345|NCT00809354|459084489|FG001|Overall Study|Adverse Event|45|||
127577346|NCT00809354|459084490|FG002|Overall Study|Adverse Event|37|||
127577347|NCT00809354|459084491|FG003|Overall Study|Adverse Event|53|||
127577348|NCT00809354|459084492|FG004|Overall Study|Adverse Event|26|||
127577349|NCT00809354|459084493|FG005|Overall Study|Adverse Event|33|||
127577350|NCT00809354|459084494|FG006|Overall Study|Adverse Event|44|||
127577351|NCT00809354|459084495|FG007|Overall Study|Adverse Event|40|||
127577352|NCT00809354|459084496|FG008|Overall Study|Adverse Event|46|||
127577353|NCT00809354|459084497|FG009|Overall Study|Adverse Event|26|||
127577354|NCT00809354|459084488|FG000|Overall Study|Lack of Efficacy|23|||
127577355|NCT00809354|459084489|FG001|Overall Study|Lack of Efficacy|23|||
127577356|NCT00809354|459084490|FG002|Overall Study|Lack of Efficacy|22|||
127577357|NCT00809354|459084491|FG003|Overall Study|Lack of Efficacy|15|||
127577358|NCT00809354|459084492|FG004|Overall Study|Lack of Efficacy|40|||
127577359|NCT00809354|459084493|FG005|Overall Study|Lack of Efficacy|19|||
127577360|NCT00809354|459084494|FG006|Overall Study|Lack of Efficacy|21|||
127577361|NCT00809354|459084495|FG007|Overall Study|Lack of Efficacy|15|||
127577362|NCT00809354|459084496|FG008|Overall Study|Lack of Efficacy|18|||
127577363|NCT00809354|459084497|FG009|Overall Study|Lack of Efficacy|38|||
127577364|NCT00809354|459084488|FG000|Overall Study|Lost to Follow-up|10|||
127577365|NCT00809354|459084489|FG001|Overall Study|Lost to Follow-up|11|||
127577366|NCT00809354|459084490|FG002|Overall Study|Lost to Follow-up|8|||
127577367|NCT00809354|459084491|FG003|Overall Study|Lost to Follow-up|13|||
127577368|NCT00809354|459084492|FG004|Overall Study|Lost to Follow-up|6|||
127577369|NCT00809354|459084493|FG005|Overall Study|Lost to Follow-up|2|||
127577370|NCT00809354|459084494|FG006|Overall Study|Lost to Follow-up|0|||
127577371|NCT00809354|459084495|FG007|Overall Study|Lost to Follow-up|5|||
127577372|NCT00809354|459084496|FG008|Overall Study|Lost to Follow-up|4|||
127577373|NCT00809354|459084497|FG009|Overall Study|Lost to Follow-up|0|||
127577374|NCT00809354|459084488|FG000|Overall Study|Protocol Violation|7|||
127577375|NCT00809354|459084489|FG001|Overall Study|Protocol Violation|14|||
127782727|NCT01994382|459831358|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
127782728|NCT01994382|459831359|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
127782729|NCT01994382|459831360|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
127782730|NCT01994382|459831361|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
127782731|NCT01994382|459831362|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
127782732|NCT01994382|459831363|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
127782733|NCT01994382|459831364|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
127782734|NCT01994382|459831365|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
127782735|NCT01994382|459831349|FG000|Overall Study|Protocol violation/noncompliance|0|||
127782736|NCT01994382|459831350|FG001|Overall Study|Protocol violation/noncompliance|0|||
127782737|NCT01994382|459831351|FG002|Overall Study|Protocol violation/noncompliance|0|||
127782738|NCT01994382|459831352|FG003|Overall Study|Protocol violation/noncompliance|0|||
127782739|NCT01994382|459831353|FG004|Overall Study|Protocol violation/noncompliance|0|||
127782740|NCT01994382|459831354|FG005|Overall Study|Protocol violation/noncompliance|0|||
127782741|NCT01994382|459831355|FG006|Overall Study|Protocol violation/noncompliance|0|||
127782742|NCT01994382|459831356|FG007|Overall Study|Protocol violation/noncompliance|0|||
127782743|NCT01994382|459831357|FG008|Overall Study|Protocol violation/noncompliance|0|||
127782744|NCT01994382|459831358|FG009|Overall Study|Protocol violation/noncompliance|0|||
127782745|NCT01994382|459831359|FG010|Overall Study|Protocol violation/noncompliance|0|||
127782746|NCT01994382|459831360|FG011|Overall Study|Protocol violation/noncompliance|1|||
127577376|NCT00809354|459084490|FG002|Overall Study|Protocol Violation|14|||
127577377|NCT00809354|459084491|FG003|Overall Study|Protocol Violation|12|||
127577378|NCT00809354|459084492|FG004|Overall Study|Protocol Violation|14|||
127577379|NCT00809354|459084493|FG005|Overall Study|Protocol Violation|6|||
127577380|NCT00809354|459084494|FG006|Overall Study|Protocol Violation|4|||
127782747|NCT01994382|459831361|FG012|Overall Study|Protocol violation/noncompliance|0|||
127577381|NCT00809354|459084495|FG007|Overall Study|Protocol Violation|6|||
127577382|NCT00809354|459084496|FG008|Overall Study|Protocol Violation|9|||
127577383|NCT00809354|459084497|FG009|Overall Study|Protocol Violation|3|||
127577384|NCT00809354|459084488|FG000|Overall Study|Withdrawal by Subject|32|||
127577385|NCT00809354|459084489|FG001|Overall Study|Withdrawal by Subject|27|||
127577386|NCT00809354|459084490|FG002|Overall Study|Withdrawal by Subject|31|||
127577387|NCT00809354|459084491|FG003|Overall Study|Withdrawal by Subject|33|||
127577388|NCT00809354|459084492|FG004|Overall Study|Withdrawal by Subject|34|||
127577389|NCT00809354|459084493|FG005|Overall Study|Withdrawal by Subject|29|||
127577390|NCT00809354|459084494|FG006|Overall Study|Withdrawal by Subject|27|||
127577391|NCT00809354|459084495|FG007|Overall Study|Withdrawal by Subject|19|||
127577392|NCT00809354|459084496|FG008|Overall Study|Withdrawal by Subject|18|||
127577393|NCT00809354|459084497|FG009|Overall Study|Withdrawal by Subject|20|||
127577394|NCT00809354|459084488|FG000|Overall Study|Other|10|||
127577395|NCT00809354|459084489|FG001|Overall Study|Other|2|||
127577396|NCT00809354|459084490|FG002|Overall Study|Other|7|||
127577397|NCT00809354|459084491|FG003|Overall Study|Other|10|||
127577398|NCT00809354|459084492|FG004|Overall Study|Other|5|||
127577399|NCT00809354|459084493|FG005|Overall Study|Other|3|||
127577400|NCT00809354|459084494|FG006|Overall Study|Other|2|||
127577401|NCT00809354|459084495|FG007|Overall Study|Other|3|||
127577402|NCT00809354|459084496|FG008|Overall Study|Other|4|||
127577403|NCT00809354|459084497|FG009|Overall Study|Other|3|||
127577404|NCT00809354|459084488|FG000|Overall Study|Study terminated by sponsor|138|||
127577405|NCT00809354|459084489|FG001|Overall Study|Study terminated by sponsor|134|||
127577406|NCT00809354|459084490|FG002|Overall Study|Study terminated by sponsor|129|||
127577407|NCT00809354|459084491|FG003|Overall Study|Study terminated by sponsor|120|||
127577408|NCT00809354|459084492|FG004|Overall Study|Study terminated by sponsor|126|||
127577409|NCT00809354|459084493|FG005|Overall Study|Study terminated by sponsor|133|||
127577410|NCT00809354|459084494|FG006|Overall Study|Study terminated by sponsor|124|||
127577411|NCT00809354|459084495|FG007|Overall Study|Study terminated by sponsor|148|||
127577412|NCT00809354|459084496|FG008|Overall Study|Study terminated by sponsor|127|||
127577413|NCT00809354|459084497|FG009|Overall Study|Study terminated by sponsor|135|||
127577414|NCT00809354|459084488|FG000|Overall Study|Withdrawn due to pregnancy|0|||
127577415|NCT00809354|459084489|FG001|Overall Study|Withdrawn due to pregnancy|1|||
127577416|NCT00809354|459084490|FG002|Overall Study|Withdrawn due to pregnancy|0|||
127577417|NCT00809354|459084491|FG003|Overall Study|Withdrawn due to pregnancy|0|||
127577418|NCT00809354|459084492|FG004|Overall Study|Withdrawn due to pregnancy|0|||
127577419|NCT00809354|459084493|FG005|Overall Study|Withdrawn due to pregnancy|0|||
127577420|NCT00809354|459084494|FG006|Overall Study|Withdrawn due to pregnancy|0|||
127577421|NCT00809354|459084495|FG007|Overall Study|Withdrawn due to pregnancy|0|||
127577422|NCT00809354|459084496|FG008|Overall Study|Withdrawn due to pregnancy|0|||
127577423|NCT00809354|459084497|FG009|Overall Study|Withdrawn due to pregnancy|0|||
127577424|NCT00809354|459084488|FG000|Overall Study|Randomized but not Treated|3|||
127577425|NCT00809354|459084489|FG001|Overall Study|Randomized but not Treated|1|||
127577426|NCT00809354|459084490|FG002|Overall Study|Randomized but not Treated|6|||
127577427|NCT00809354|459084491|FG003|Overall Study|Randomized but not Treated|0|||
127577428|NCT00809354|459084492|FG004|Overall Study|Randomized but not Treated|5|||
127577429|NCT00809354|459084493|FG005|Overall Study|Randomized but not Treated|0|||
127577430|NCT00809354|459084494|FG006|Overall Study|Randomized but not Treated|1|||
127577431|NCT00809354|459084495|FG007|Overall Study|Randomized but not Treated|1|||
127577432|NCT00809354|459084496|FG008|Overall Study|Randomized but not Treated|2|||
127577433|NCT00809354|459084497|FG009|Overall Study|Randomized but not Treated|1|||
127577434|NCT00809354|459084488|FG000|Overall Study|Death|0|||
127577435|NCT00809354|459084489|FG001|Overall Study|Death|0|||
127577436|NCT00809354|459084490|FG002|Overall Study|Death|0|||
127577437|NCT00809354|459084491|FG003|Overall Study|Death|0|||
127693326|NCT03526861|459504515|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
127693327|NCT03526861|459504516|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
127693328|NCT03526861|459504517|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
127693329|NCT03526861|459504518|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
127693330|NCT03526861|459504519|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
127693331|NCT03526861|459504520|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
127693332|NCT03526861|459504521|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
127693333|NCT03526861|459504513|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
127693334|NCT03526861|459504514|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
127693335|NCT03526861|459504515|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
127693336|NCT03526861|459504516|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
127693337|NCT03526861|459504517|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
127693338|NCT03526861|459504518|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
127693339|NCT03526861|459504519|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
127693340|NCT03526861|459504520|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
127693341|NCT03526861|459504521|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
127693342|NCT03526861|459504513|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
127577438|NCT00809354|459084492|FG004|Overall Study|Death|0|||
127577439|NCT00809354|459084493|FG005|Overall Study|Death|0|||
127577440|NCT00809354|459084494|FG006|Overall Study|Death|0|||
127577441|NCT00809354|459084495|FG007|Overall Study|Death|1|||
127577442|NCT00809354|459084496|FG008|Overall Study|Death|0|||
127577443|NCT00809354|459084497|FG009|Overall Study|Death|0|||
127577444|NCT00267189|459084498|FG000|Overall Study|Patient withdrew consent|1|||
127782748|NCT01994382|459831362|FG013|Overall Study|Protocol violation/noncompliance|0|||
127782749|NCT01994382|459831363|FG014|Overall Study|Protocol violation/noncompliance|0|||
127782750|NCT01994382|459831364|FG015|Overall Study|Protocol violation/noncompliance|0|||
127782751|NCT01994382|459831365|FG016|Overall Study|Protocol violation/noncompliance|2|||
127782752|NCT01994382|459831349|FG000|Overall Study|Rolled over to Phase 2a|0|||
127782753|NCT01994382|459831350|FG001|Overall Study|Rolled over to Phase 2a|0|||
128029805|NCT00803049|460735132|FG001|Overall Study|Lost to Follow-up|2|||
128029806|NCT00803049|460735133|FG002|Overall Study|Lost to Follow-up|0|||
128029807|NCT00803049|460735134|FG003|Overall Study|Lost to Follow-up|3|||
127577445|NCT00267189|459084499|FG001|Overall Study|Patient withdrew consent|1|||
127577446|NCT00267189|459084498|FG000|Overall Study|Death|1|||
127577447|NCT00267189|459084499|FG001|Overall Study|Death|0|||
127577448|NCT00267189|459084498|FG000|Overall Study|Missing|3|||
127577449|NCT00267189|459084499|FG001|Overall Study|Missing|0|||
127577450|NCT00100178|459084500|FG000|Overall Study|Lost to Follow-up|0|||
127577451|NCT00100178|459084501|FG001|Overall Study|Lost to Follow-up|6|||
127577452|NCT00100178|459084502|FG002|Overall Study|Lost to Follow-up|5|||
127577453|NCT00100178|459084500|FG000|Overall Study|Adverse Event|2|||
127577454|NCT00100178|459084501|FG001|Overall Study|Adverse Event|2|||
127577455|NCT00100178|459084502|FG002|Overall Study|Adverse Event|1|||
127577456|NCT00100178|459084500|FG000|Overall Study|Withdrawal by Subject|1|||
127577457|NCT00100178|459084501|FG001|Overall Study|Withdrawal by Subject|1|||
127577458|NCT00100178|459084502|FG002|Overall Study|Withdrawal by Subject|1|||
127577459|NCT00100178|459084500|FG000|Overall Study|Physician Decision|6|||
127577460|NCT00100178|459084501|FG001|Overall Study|Physician Decision|1|||
127577461|NCT00100178|459084502|FG002|Overall Study|Physician Decision|3|||
127577462|NCT01439568|459084509|FG000|Overall Study|Lost to Follow-up|1|||
127577463|NCT01439568|459084510|FG001|Overall Study|Lost to Follow-up|0|||
127577464|NCT01439568|459084509|FG000|Overall Study|Withdrawal by Subject|2|||
127577465|NCT01439568|459084510|FG001|Overall Study|Withdrawal by Subject|2|||
127577466|NCT04137224|459084511|FG000|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|1|||
127577467|NCT04137224|459084512|FG001|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|0|||
127577468|NCT04137224|459084511|FG000|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|0|||
127577469|NCT04137224|459084512|FG001|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|1|||
127577470|NCT04137224|459084511|FG000|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|0|||
127577471|NCT04137224|459084512|FG001|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|1|||
127577472|NCT00566501|459084515|FG000|Overall Study|Adverse Event|68|||
127577473|NCT00566501|459084516|FG001|Overall Study|Adverse Event|59|||
127577474|NCT00566501|459084515|FG000|Overall Study|Medication Non-compliance|5|||
127577475|NCT00566501|459084516|FG001|Overall Study|Medication Non-compliance|0|||
127577476|NCT00566501|459084515|FG000|Overall Study|Protocol Violation|2|||
127577477|NCT00566501|459084516|FG001|Overall Study|Protocol Violation|2|||
127577478|NCT00566501|459084515|FG000|Overall Study|Request of Investigator or Sponsor|6|||
127577479|NCT00566501|459084516|FG001|Overall Study|Request of Investigator or Sponsor|7|||
127577480|NCT00566501|459084515|FG000|Overall Study|Withdrawal by Subject|33|||
127577481|NCT00566501|459084516|FG001|Overall Study|Withdrawal by Subject|30|||
127577482|NCT00566501|459084515|FG000|Overall Study|Lack of Efficacy|8|||
127577483|NCT00566501|459084516|FG001|Overall Study|Lack of Efficacy|3|||
127577484|NCT00566501|459084515|FG000|Overall Study|Other|25|||
127577485|NCT00566501|459084516|FG001|Overall Study|Other|21|||
127577486|NCT00679055|459084519|FG000|Overall Study|Adverse Event|0|||
127577487|NCT00679055|459084520|FG001|Overall Study|Adverse Event|1|||
127577488|NCT00679055|459084519|FG000|Overall Study|Other|0|||
127577489|NCT00679055|459084520|FG001|Overall Study|Other|3|||
127577490|NCT00679055|459084519|FG000|Overall Study|Study Terminated|2|||
127577491|NCT00679055|459084520|FG001|Overall Study|Study Terminated|1|||
127577492|NCT01368432|459084521|FG000|Overall Study|Lost to Follow-up|0|||
127577493|NCT01368432|459084522|FG001|Overall Study|Lost to Follow-up|1|||
127782754|NCT01994382|459831351|FG002|Overall Study|Rolled over to Phase 2a|1|||
127782755|NCT01994382|459831352|FG003|Overall Study|Rolled over to Phase 2a|0|||
127782756|NCT01994382|459831353|FG004|Overall Study|Rolled over to Phase 2a|0|||
127577494|NCT01008150|459084524|FG000|Overall Study|did not receive study drug|1|||
127577495|NCT01008150|459084525|FG001|Overall Study|did not receive study drug|1|||
127577496|NCT01008150|459084526|FG002|Overall Study|did not receive study drug|1|||
127577497|NCT01008150|459084527|FG003|Overall Study|did not receive study drug|0|||
127577498|NCT00437320|459084528|FG000|Overall Study|Participant request|2|||
127577499|NCT00437320|459084529|FG001|Overall Study|Participant request|1|||
127782757|NCT01994382|459831354|FG005|Overall Study|Rolled over to Phase 2a|0|||
128029808|NCT00803049|460735131|FG000|Overall Study|Death|2|||
128029809|NCT00803049|460735132|FG001|Overall Study|Death|1|||
128029810|NCT00803049|460735133|FG002|Overall Study|Death|0|||
127577500|NCT00437320|459084530|FG002|Overall Study|Participant request|4|||
127577501|NCT01938573|459084531|FG000|Overall Study|Lack of Efficacy|1|||
127577502|NCT01938573|459084532|FG001|Overall Study|Lack of Efficacy|0|||
127577503|NCT01938573|459084531|FG000|Overall Study|Operation at other hospital|1|||
127577504|NCT01938573|459084532|FG001|Overall Study|Operation at other hospital|0|||
127577505|NCT03845543|459084542|FG000|Overall Study|Death|25|||
127577506|NCT03845543|459084542|FG000|Overall Study|Withdrawal by Subject|2|||
127577507|NCT03845543|459084542|FG000|Overall Study|Lost to Follow-up|12|||
127577508|NCT03845543|459084542|FG000|Overall Study|Adverse Event|17|||
127577509|NCT01400815|459084545|FG000|Overall Study|Adverse Event|3|||
127577510|NCT01400815|459084546|FG001|Overall Study|Adverse Event|0|||
127577511|NCT01400815|459084545|FG000|Overall Study|Death|0|||
127577512|NCT01400815|459084546|FG001|Overall Study|Death|1|||
127577513|NCT01400815|459084545|FG000|Overall Study|Lost to Follow-up|18|||
127577514|NCT01400815|459084546|FG001|Overall Study|Lost to Follow-up|11|||
127577515|NCT01400815|459084545|FG000|Overall Study|Protocol Violation|0|||
127577516|NCT01400815|459084546|FG001|Overall Study|Protocol Violation|1|||
127577517|NCT01400815|459084545|FG000|Overall Study|Physician Decision|1|||
127577518|NCT01400815|459084546|FG001|Overall Study|Physician Decision|0|||
127577519|NCT01400815|459084545|FG000|Overall Study|Withdrawal by Subject|15|||
127577520|NCT01400815|459084546|FG001|Overall Study|Withdrawal by Subject|8|||
127577521|NCT01400815|459084545|FG000|Overall Study|Subject in jail|1|||
127577522|NCT01400815|459084546|FG001|Overall Study|Subject in jail|0|||
127577523|NCT01123850|459084551|FG000|Overall Study|Slow enrollment|45|||
127577524|NCT02448810|459084553|FG000|Overall Study|Adverse Event|0|||
127577525|NCT02448810|459084554|FG001|Overall Study|Adverse Event|0|||
127577526|NCT02448810|459084555|FG002|Overall Study|Adverse Event|1|||
127577527|NCT02448810|459084556|FG003|Overall Study|Adverse Event|0|||
127577528|NCT02448810|459084557|FG004|Overall Study|Adverse Event|0|||
127577529|NCT02448810|459084558|FG005|Overall Study|Adverse Event|0|||
127577530|NCT02448810|459084559|FG006|Overall Study|Adverse Event|0|||
127577531|NCT02448810|459084560|FG007|Overall Study|Adverse Event|0|||
127577532|NCT02448810|459084553|FG000|Overall Study|Withdrawal by Subject|0|||
127577533|NCT02448810|459084554|FG001|Overall Study|Withdrawal by Subject|0|||
127577534|NCT02448810|459084555|FG002|Overall Study|Withdrawal by Subject|1|||
127577535|NCT02448810|459084556|FG003|Overall Study|Withdrawal by Subject|0|||
127577536|NCT02448810|459084557|FG004|Overall Study|Withdrawal by Subject|3|||
127577537|NCT02448810|459084558|FG005|Overall Study|Withdrawal by Subject|5|||
127577538|NCT02448810|459084559|FG006|Overall Study|Withdrawal by Subject|0|||
127577539|NCT02448810|459084560|FG007|Overall Study|Withdrawal by Subject|2|||
127577540|NCT02448810|459084553|FG000|Overall Study|Other (study terminated by sponsor)|0|||
127577541|NCT02448810|459084554|FG001|Overall Study|Other (study terminated by sponsor)|0|||
127577542|NCT02448810|459084555|FG002|Overall Study|Other (study terminated by sponsor)|0|||
127577543|NCT02448810|459084556|FG003|Overall Study|Other (study terminated by sponsor)|0|||
127577544|NCT02448810|459084557|FG004|Overall Study|Other (study terminated by sponsor)|4|||
127577545|NCT02448810|459084558|FG005|Overall Study|Other (study terminated by sponsor)|2|||
127577546|NCT02448810|459084559|FG006|Overall Study|Other (study terminated by sponsor)|2|||
127577547|NCT02448810|459084560|FG007|Overall Study|Other (study terminated by sponsor)|1|||
127577548|NCT02448810|459084553|FG000|Overall Study|Death|1|||
127577549|NCT02448810|459084554|FG001|Overall Study|Death|0|||
127577550|NCT02448810|459084555|FG002|Overall Study|Death|1|||
127577551|NCT02448810|459084556|FG003|Overall Study|Death|0|||
127782758|NCT01994382|459831355|FG006|Overall Study|Rolled over to Phase 2a|0|||
127782759|NCT01994382|459831356|FG007|Overall Study|Rolled over to Phase 2a|0|||
127782760|NCT01994382|459831357|FG008|Overall Study|Rolled over to Phase 2a|0|||
127577552|NCT02448810|459084557|FG004|Overall Study|Death|1|||
127577553|NCT02448810|459084558|FG005|Overall Study|Death|0|||
127577554|NCT02448810|459084559|FG006|Overall Study|Death|0|||
127577555|NCT02448810|459084560|FG007|Overall Study|Death|0|||
127577556|NCT02448810|459084553|FG000|Overall Study|Other (Progressive disease)|2|||
127577557|NCT02448810|459084554|FG001|Overall Study|Other (Progressive disease)|2|||
127577558|NCT02448810|459084555|FG002|Overall Study|Other (Progressive disease)|0|||
127577559|NCT02448810|459084556|FG003|Overall Study|Other (Progressive disease)|3|||
127577560|NCT02448810|459084557|FG004|Overall Study|Other (Progressive disease)|23|||
127577561|NCT02448810|459084558|FG005|Overall Study|Other (Progressive disease)|9|||
127577562|NCT02448810|459084559|FG006|Overall Study|Other (Progressive disease)|14|||
127577563|NCT02448810|459084560|FG007|Overall Study|Other (Progressive disease)|5|||
127577564|NCT02448810|459084553|FG000|Overall Study|Lost to Follow-up|0|||
127577565|NCT02448810|459084554|FG001|Overall Study|Lost to Follow-up|1|||
127577566|NCT02448810|459084555|FG002|Overall Study|Lost to Follow-up|0|||
127782761|NCT01994382|459831358|FG009|Overall Study|Rolled over to Phase 2a|2|||
127782762|NCT01994382|459831359|FG010|Overall Study|Rolled over to Phase 2a|0|||
127782763|NCT01994382|459831360|FG011|Overall Study|Rolled over to Phase 2a|0|||
127782764|NCT01994382|459831361|FG012|Overall Study|Rolled over to Phase 2a|0|||
127577567|NCT02448810|459084556|FG003|Overall Study|Lost to Follow-up|0|||
127577568|NCT02448810|459084557|FG004|Overall Study|Lost to Follow-up|0|||
127577569|NCT02448810|459084558|FG005|Overall Study|Lost to Follow-up|0|||
127577570|NCT02448810|459084559|FG006|Overall Study|Lost to Follow-up|0|||
127577571|NCT02448810|459084560|FG007|Overall Study|Lost to Follow-up|0|||
127577572|NCT02448810|459084553|FG000|Overall Study|Other (unspecified)|0|||
127577573|NCT02448810|459084554|FG001|Overall Study|Other (unspecified)|0|||
127577574|NCT02448810|459084555|FG002|Overall Study|Other (unspecified)|0|||
127577575|NCT02448810|459084556|FG003|Overall Study|Other (unspecified)|0|||
127577576|NCT02448810|459084557|FG004|Overall Study|Other (unspecified)|0|||
127577577|NCT02448810|459084558|FG005|Overall Study|Other (unspecified)|0|||
127577578|NCT02448810|459084559|FG006|Overall Study|Other (unspecified)|2|||
127693343|NCT03526861|459504514|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
127693344|NCT03526861|459504515|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
127577579|NCT02448810|459084560|FG007|Overall Study|Other (unspecified)|0|||
127577580|NCT00470847|459084563|FG000|Overall Study|Pt still receiving treatment|1|||
127577581|NCT00568685|459084570|FG000|Overall Study|Adverse Event|2|||
127577582|NCT00568685|459084571|FG001|Overall Study|Adverse Event|3|||
127577583|NCT00568685|459084572|FG002|Overall Study|Adverse Event|3|||
127577584|NCT00568685|459084570|FG000|Overall Study|Withdrawal by Subject|7|||
127577585|NCT00568685|459084571|FG001|Overall Study|Withdrawal by Subject|2|||
127577586|NCT00568685|459084572|FG002|Overall Study|Withdrawal by Subject|2|||
127577587|NCT00568685|459084570|FG000|Overall Study|Protocol Violation|1|||
127577588|NCT00568685|459084571|FG001|Overall Study|Protocol Violation|0|||
127693345|NCT03526861|459504516|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
127693346|NCT03526861|459504517|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
127693347|NCT03526861|459504518|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
127693348|NCT03526861|459504519|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
127693349|NCT03526861|459504520|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
127693350|NCT03526861|459504521|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
127693351|NCT03526861|459504513|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
127693352|NCT03526861|459504514|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
127693353|NCT03526861|459504515|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
127577589|NCT00568685|459084572|FG002|Overall Study|Protocol Violation|0|||
127577590|NCT01147172|459084574|FG000|Overall Study|Withdrawal by Subject|2|||
127693354|NCT03526861|459504516|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
127782765|NCT01994382|459831362|FG013|Overall Study|Rolled over to Phase 2a|0|||
127782766|NCT01994382|459831363|FG014|Overall Study|Rolled over to Phase 2a|0|||
127577591|NCT01147172|459084574|FG000|Overall Study|Lost to Follow-up|2|||
127782767|NCT01994382|459831364|FG015|Overall Study|Rolled over to Phase 2a|0|||
127782768|NCT01994382|459831365|FG016|Overall Study|Rolled over to Phase 2a|0|||
127782769|NCT00873366|459831368|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
127577592|NCT02787551|459084575|FG000|Core Period: 26 Weeks|Adverse Event|10|||
127577593|NCT02787551|459084576|FG001|Core Period: 26 Weeks|Adverse Event|0|||
127577594|NCT02787551|459084575|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
127577595|NCT02787551|459084576|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
127577596|NCT02787551|459084575|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
127577597|NCT02787551|459084576|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
127577598|NCT02787551|459084575|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
127577599|NCT02787551|459084576|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
127577600|NCT02787551|459084575|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
127693355|NCT03526861|459504517|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
127782770|NCT00873366|459831368|FG000|Overall Study|Off tamoxifen due to side effects|2|||
127782771|NCT00873366|459831368|FG000|Overall Study|Refused to continue DM-BT testing|3|||
127782772|NCT01537198|459831375|FG000|Overall Study|RSV infection|2|||
127782773|NCT01537198|459831375|FG000|Overall Study|Adverse Event|4|||
127782774|NCT01537198|459831375|FG000|Overall Study|No Further Visits to the Clinic|37|||
127782775|NCT01537198|459831375|FG000|Overall Study|Other|111|||
127782776|NCT01231659|459831376|FG000|Overall Study|Adverse Event|9|||
127782777|NCT01231659|459831376|FG000|Overall Study|Disease Progression|48|||
127782778|NCT01231659|459831376|FG000|Overall Study|Death|2|||
127782779|NCT01231659|459831376|FG000|Overall Study|Patient refused to complete study visit|1|||
127782780|NCT01231659|459831376|FG000|Overall Study|Other protocol defined criteria|12|||
127782781|NCT00356889|459831377|FG000|Overall Study|Protocol Violation|2|||
127782782|NCT00356889|459831377|FG000|Overall Study|Adverse Event|1|||
127782783|NCT02247960|459831378|FG000|Patient Consent and Randomization|Physician Decision|2|||
127782784|NCT02247960|459831379|FG001|Patient Consent and Randomization|Physician Decision|2|||
127782785|NCT02247960|459831378|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
127782786|NCT02247960|459831379|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
127782787|NCT02247960|459831378|FG000|Catheter Removed|Lost to Follow-up|7|||
127782788|NCT02247960|459831379|FG001|Catheter Removed|Lost to Follow-up|10|||
127782789|NCT00702325|459831380|FG000|Overall Study|Adverse Event|1|||
127782790|NCT00702325|459831381|FG001|Overall Study|Adverse Event|0|||
127782791|NCT00702325|459831380|FG000|Overall Study|Withdrawal by Subject|7|||
127782792|NCT00702325|459831381|FG001|Overall Study|Withdrawal by Subject|7|||
127782793|NCT00702325|459831380|FG000|Overall Study|Lost to Follow-up|3|||
127881363|NCT02058368|460187391|FG000|Overall Study|Lack of Efficacy|0|||
127881364|NCT02058368|460187392|FG001|Overall Study|Lack of Efficacy|1|||
127577601|NCT02787551|459084576|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
127577602|NCT02787551|459084575|FG000|Core Period: 26 Weeks|Other than specified|3|||
127577603|NCT02787551|459084576|FG001|Core Period: 26 Weeks|Other than specified|1|||
127693356|NCT03526861|459504518|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
127693357|NCT03526861|459504519|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
127693358|NCT03526861|459504520|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
127693359|NCT03526861|459504521|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
127693360|NCT03526861|459504513|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
127693361|NCT03526861|459504514|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
127693362|NCT03526861|459504515|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
127693363|NCT03526861|459504516|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
127693364|NCT03526861|459504517|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
127693365|NCT03526861|459504518|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
127693366|NCT03526861|459504519|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
127693367|NCT03526861|459504520|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
127693368|NCT03526861|459504521|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
127693369|NCT03526861|459504513|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
127693370|NCT03526861|459504514|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
127693371|NCT03526861|459504515|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
127693372|NCT03526861|459504516|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
127693373|NCT03526861|459504517|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
127693374|NCT03526861|459504518|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
127693375|NCT03526861|459504519|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
127693376|NCT03526861|459504520|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
127693377|NCT03526861|459504521|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
127693378|NCT03526861|459504513|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
127693379|NCT03526861|459504514|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
127693380|NCT03526861|459504515|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
127693381|NCT03526861|459504516|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
127693382|NCT03526861|459504517|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
127693383|NCT03526861|459504518|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
127693384|NCT03526861|459504519|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
127693385|NCT03526861|459504520|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
127693386|NCT03526861|459504521|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
127693387|NCT00650104|459504523|FG000|Overall Study|Adverse Event|17|||
127693388|NCT00650104|459504523|FG000|Overall Study|Death|2|||
127693389|NCT00650104|459504523|FG000|Overall Study|Withdrawal by Subject|11|||
127693390|NCT00650104|459504523|FG000|Overall Study|Physician Decision|7|||
127693391|NCT00650104|459504523|FG000|Overall Study|Lost to Follow-up|1|||
127693392|NCT00650104|459504523|FG000|Overall Study|Non-compliance|2|||
127693393|NCT00650104|459504523|FG000|Overall Study|Sponsor Terminated Dosing|1|||
127693394|NCT04999592|459504528|FG000|Overall Study|Withdrawal by Subject|1|||
127782794|NCT00702325|459831381|FG001|Overall Study|Lost to Follow-up|4|||
127782795|NCT00702325|459831380|FG000|Overall Study|Incorrect enrollment|5|||
127782796|NCT00702325|459831381|FG001|Overall Study|Incorrect enrollment|7|||
127782797|NCT00702325|459831380|FG000|Overall Study|Developed study discontinuation criteria|18|||
127782798|NCT00702325|459831381|FG001|Overall Study|Developed study discontinuation criteria|28|||
127782799|NCT00702325|459831380|FG000|Overall Study|Severe noncompliance to protocol|3|||
127782800|NCT00702325|459831381|FG001|Overall Study|Severe noncompliance to protocol|3|||
127782801|NCT00702325|459831380|FG000|Overall Study|Termination due to lab results|1|||
127782802|NCT00702325|459831381|FG001|Overall Study|Termination due to lab results|0|||
127782803|NCT00702325|459831380|FG000|Overall Study|Didn't follow study medication dosage|0|||
127782804|NCT00702325|459831381|FG001|Overall Study|Didn't follow study medication dosage|2|||
128029811|NCT00803049|460735134|FG003|Overall Study|Death|2|||
128029812|NCT00803049|460735131|FG000|Overall Study|Progressive Disease|6|||
128029813|NCT00803049|460735132|FG001|Overall Study|Progressive Disease|10|||
128029814|NCT00803049|460735133|FG002|Overall Study|Progressive Disease|6|||
128029815|NCT00803049|460735134|FG003|Overall Study|Progressive Disease|6|||
127577604|NCT02787551|459084575|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
127577605|NCT02787551|459084576|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
127577606|NCT02787551|459084575|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
127577607|NCT02787551|459084576|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
127577608|NCT02787551|459084575|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
127577609|NCT02787551|459084576|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
127577610|NCT02038452|459084577|FG000|Overall Study|Withdrawal by Subject|7|||
127577611|NCT02038452|459084578|FG001|Overall Study|Withdrawal by Subject|9|||
127577612|NCT02038452|459084577|FG000|Overall Study|Lost to Follow-up|31|||
127577613|NCT02038452|459084578|FG001|Overall Study|Lost to Follow-up|28|||
127577614|NCT01090973|459084581|FG000|Overall Study|Disease progression|1|||
127577615|NCT03805646|459084585|FG000|Overall Study|Death|40|||
127577616|NCT03805646|459084586|FG001|Overall Study|Death|49|||
127577617|NCT03805646|459084585|FG000|Overall Study|Not reached on phone/ Did not consent|614|||
127577618|NCT03805646|459084586|FG001|Overall Study|Not reached on phone/ Did not consent|936|||
127577619|NCT02887859|459084589|FG000|Overall Study|Ongoing|6|||
127577620|NCT02887859|459084589|FG000|Overall Study|Adverse Event|7|||
127577621|NCT02887859|459084589|FG000|Overall Study|Death|1|||
127577622|NCT02887859|459084589|FG000|Overall Study|Physician Decision|1|||
127577623|NCT01920555|459086459|FG000|Overall Study|Physician Decision|1|||
127577624|NCT01920555|459086460|FG001|Overall Study|Physician Decision|2|||
127577625|NCT01920555|459086461|FG002|Overall Study|Physician Decision|1|||
127577626|NCT01920555|459086462|FG003|Overall Study|Physician Decision|2|||
127577627|NCT01920555|459086463|FG004|Overall Study|Physician Decision|0|||
127577628|NCT01920555|459086459|FG000|Overall Study|Lack of Efficacy|2|||
127577629|NCT01920555|459086460|FG001|Overall Study|Lack of Efficacy|0|||
127577630|NCT01920555|459086461|FG002|Overall Study|Lack of Efficacy|0|||
127577631|NCT01920555|459086462|FG003|Overall Study|Lack of Efficacy|0|||
127577632|NCT01920555|459086463|FG004|Overall Study|Lack of Efficacy|0|||
127577633|NCT01920555|459086459|FG000|Overall Study|Travel Difficulties|1|||
127577634|NCT01920555|459086460|FG001|Overall Study|Travel Difficulties|1|||
127577635|NCT01920555|459086461|FG002|Overall Study|Travel Difficulties|0|||
127577636|NCT01920555|459086462|FG003|Overall Study|Travel Difficulties|0|||
127577637|NCT01920555|459086463|FG004|Overall Study|Travel Difficulties|1|||
127577638|NCT01920555|459086459|FG000|Overall Study|Lost to Follow-up|0|||
127577639|NCT01920555|459086460|FG001|Overall Study|Lost to Follow-up|1|||
127577640|NCT01920555|459086461|FG002|Overall Study|Lost to Follow-up|0|||
127577641|NCT01920555|459086462|FG003|Overall Study|Lost to Follow-up|1|||
127577642|NCT01920555|459086463|FG004|Overall Study|Lost to Follow-up|0|||
127577643|NCT00697073|459086464|FG000|Overall Study|Withdrawal by Subject|2|||
127577644|NCT00697073|459086464|FG000|Overall Study|Pregnancy|1|||
127577645|NCT00697073|459086464|FG000|Overall Study|non compliance and other|6|||
127577646|NCT03265665|459086467|FG000|24-week Data Collection|Withdrawal by Subject|2|||
127577647|NCT03265665|459086468|FG001|24-week Data Collection|Withdrawal by Subject|2|||
127577648|NCT03265665|459086467|FG000|24-week Data Collection|Lost to Follow-up|4|||
127577649|NCT03265665|459086468|FG001|24-week Data Collection|Lost to Follow-up|5|||
127577650|NCT03265665|459086467|FG000|36-week Data Collection|Lost to Follow-up|6|||
127577651|NCT03265665|459086468|FG001|36-week Data Collection|Lost to Follow-up|8|||
127577652|NCT01193660|459086471|FG000|Overall Study|Withdrawal by Subject|2|||
127577653|NCT01193660|459086472|FG001|Overall Study|Withdrawal by Subject|3|||
127577654|NCT01193660|459086473|FG002|Overall Study|Withdrawal by Subject|1|||
127577655|NCT01193660|459086471|FG000|Overall Study|Death|1|||
127577656|NCT01193660|459086472|FG001|Overall Study|Death|0|||
127577657|NCT01193660|459086473|FG002|Overall Study|Death|0|||
127577658|NCT01193660|459086471|FG000|Overall Study|Physician Decision|1|||
127577659|NCT01193660|459086472|FG001|Overall Study|Physician Decision|0|||
127577660|NCT01193660|459086473|FG002|Overall Study|Physician Decision|1|||
127577661|NCT01886716|459086474|FG000|Week 1|Lost to Follow-up|0|||
127577662|NCT01886716|459086475|FG001|Week 1|Lost to Follow-up|0|||
127577663|NCT01886716|459086476|FG002|Week 1|Lost to Follow-up|2|||
127577664|NCT01886716|459086477|FG003|Week 1|Lost to Follow-up|2|||
127782805|NCT00702325|459831380|FG000|Overall Study|Withdrew consent|0|||
127782806|NCT00702325|459831381|FG001|Overall Study|Withdrew consent|1|||
127782807|NCT00702325|459831380|FG000|Overall Study|Incorrectly Discontinued|0|||
127782808|NCT00702325|459831381|FG001|Overall Study|Incorrectly Discontinued|1|||
127782809|NCT00736034|459831382|FG000|Overall Study|Adverse Event|2|||
127782810|NCT01022502|459831386|FG000|Overall Study|Adverse Event|1|||
127577665|NCT01886716|459086474|FG000|Week 2|Lost to Follow-up|3|||
127577666|NCT01886716|459086475|FG001|Week 2|Lost to Follow-up|2|||
127577667|NCT01886716|459086476|FG002|Week 2|Lost to Follow-up|1|||
127577668|NCT01886716|459086477|FG003|Week 2|Lost to Follow-up|3|||
127577669|NCT01886716|459086474|FG000|Week 3|Lost to Follow-up|1|||
127577670|NCT01886716|459086475|FG001|Week 3|Lost to Follow-up|1|||
127577671|NCT01886716|459086476|FG002|Week 3|Lost to Follow-up|0|||
127577672|NCT01886716|459086477|FG003|Week 3|Lost to Follow-up|1|||
127577673|NCT04879225|459086478|FG000|Mint, Menthol, Tobacco|Lost to Follow-up|1|||
127577674|NCT04879225|459086478|FG000|Menthol and Tobacco|Lost to Follow-up|1|||
127577675|NCT02367131|459086481|FG000|Overall Study|Adverse Event|64|||
127577676|NCT02367131|459086481|FG000|Overall Study|No visit since the first visit|3|||
127693395|NCT04999592|459504529|FG001|Overall Study|Withdrawal by Subject|0|||
127693396|NCT03527160|459504531|FG000|Overall Study|No urine collected|13|||
127693397|NCT03527160|459504531|FG000|Overall Study|No clinical serum creatinine collected|6|||
127693398|NCT03527160|459504531|FG000|Overall Study|Did not meet inclusion|2|||
127693399|NCT02910713|459504532|FG000|Overall Study|Protocol Violation|2|||
127693400|NCT02910713|459504532|FG000|Overall Study|Subject Choice|4|||
127693401|NCT02910713|459504532|FG000|Overall Study|Received One Application|10|||
127693402|NCT02910713|459504532|FG000|Overall Study|Received Neither Application|18|||
127693403|NCT02910713|459504532|FG000|Overall Study|Enrollment cap|7|||
127693404|NCT02910713|459504532|FG000|Overall Study|Investigator Discretion|1|||
127693405|NCT03767517|459504533|FG000|Overall Study|Lost to Follow-up|16|||
127693406|NCT03767517|459504534|FG001|Overall Study|Lost to Follow-up|10|||
127693407|NCT03767517|459504533|FG000|Overall Study|Death|2|||
127693408|NCT03767517|459504534|FG001|Overall Study|Death|3|||
127693409|NCT05792423|459504535|FG000|Overall Study|Withdrawal by Subject|2|||
127693410|NCT04521478|459505763|FG000|Overall Study|Protocol Violation|2|||
127693411|NCT04521478|459505764|FG001|Overall Study|Protocol Violation|0|||
127693412|NCT04521478|459505765|FG002|Overall Study|Protocol Violation|1|||
127693413|NCT04521478|459505766|FG003|Overall Study|Protocol Violation|0|||
127693414|NCT04521478|459505767|FG004|Overall Study|Protocol Violation|0|||
127693415|NCT04521478|459505768|FG005|Overall Study|Protocol Violation|0|||
127693416|NCT04521478|459505763|FG000|Overall Study|Technical Problems|0|||
127693417|NCT04521478|459505764|FG001|Overall Study|Technical Problems|0|||
127693418|NCT04521478|459505765|FG002|Overall Study|Technical Problems|0|||
127693419|NCT04521478|459505766|FG003|Overall Study|Technical Problems|1|||
127693420|NCT04521478|459505767|FG004|Overall Study|Technical Problems|0|||
127693421|NCT04521478|459505768|FG005|Overall Study|Technical Problems|0|||
127693422|NCT04521478|459505763|FG000|Overall Study|Burden of Study Procedures|1|||
127693423|NCT04521478|459505764|FG001|Overall Study|Burden of Study Procedures|0|||
127693424|NCT04521478|459505765|FG002|Overall Study|Burden of Study Procedures|0|||
127693425|NCT04521478|459505766|FG003|Overall Study|Burden of Study Procedures|1|||
127693426|NCT04521478|459505767|FG004|Overall Study|Burden of Study Procedures|0|||
127693427|NCT04521478|459505768|FG005|Overall Study|Burden of Study Procedures|1|||
127693428|NCT04521478|459505763|FG000|Overall Study|Lack of Efficacy|0|||
127693429|NCT04521478|459505764|FG001|Overall Study|Lack of Efficacy|0|||
127693430|NCT04521478|459505765|FG002|Overall Study|Lack of Efficacy|0|||
127693431|NCT04521478|459505766|FG003|Overall Study|Lack of Efficacy|0|||
127693432|NCT04521478|459505767|FG004|Overall Study|Lack of Efficacy|1|||
127693433|NCT04521478|459505768|FG005|Overall Study|Lack of Efficacy|1|||
127693434|NCT04521478|459505763|FG000|Overall Study|Adverse Event|7|||
127693435|NCT04521478|459505764|FG001|Overall Study|Adverse Event|0|||
127693436|NCT04521478|459505765|FG002|Overall Study|Adverse Event|2|||
127693437|NCT04521478|459505766|FG003|Overall Study|Adverse Event|1|||
127693438|NCT04521478|459505767|FG004|Overall Study|Adverse Event|2|||
127693439|NCT04521478|459505768|FG005|Overall Study|Adverse Event|7|||
127693440|NCT04521478|459505763|FG000|Overall Study|No Reason Available|0|||
127693441|NCT04521478|459505764|FG001|Overall Study|No Reason Available|2|||
127693442|NCT04521478|459505765|FG002|Overall Study|No Reason Available|0|||
127693443|NCT04521478|459505766|FG003|Overall Study|No Reason Available|0|||
127693444|NCT04521478|459505767|FG004|Overall Study|No Reason Available|1|||
127782811|NCT01022502|459831386|FG000|Overall Study|employment related reasons|1|||
127782812|NCT01022502|459831386|FG000|Overall Study|Withdrawal by Subject|1|||
127782813|NCT03716050|459831387|FG000|Overall Study|Lost to Follow-up|0|||
128029816|NCT00803049|460735131|FG000|Overall Study|Withdrawal by Subject|19|||
128029817|NCT00803049|460735132|FG001|Overall Study|Withdrawal by Subject|43|||
128029818|NCT00803049|460735133|FG002|Overall Study|Withdrawal by Subject|16|||
128029819|NCT00803049|460735134|FG003|Overall Study|Withdrawal by Subject|44|||
128029820|NCT00803049|460735131|FG000|Overall Study|Protocol Violation|0|||
128029821|NCT00803049|460735132|FG001|Overall Study|Protocol Violation|1|||
128029822|NCT00803049|460735133|FG002|Overall Study|Protocol Violation|1|||
128029823|NCT00803049|460735134|FG003|Overall Study|Protocol Violation|0|||
128029824|NCT00803049|460735131|FG000|Overall Study|Randomized and Not Treated|0|||
128029825|NCT00803049|460735132|FG001|Overall Study|Randomized and Not Treated|0|||
128029826|NCT00803049|460735133|FG002|Overall Study|Randomized and Not Treated|0|||
128029827|NCT00803049|460735134|FG003|Overall Study|Randomized and Not Treated|2|||
128029828|NCT00803049|460735131|FG000|Overall Study|Other than Specified Above|3|||
128029829|NCT00803049|460735132|FG001|Overall Study|Other than Specified Above|9|||
128029830|NCT00803049|460735133|FG002|Overall Study|Other than Specified Above|2|||
127693445|NCT04521478|459505768|FG005|Overall Study|No Reason Available|0|||
127693446|NCT04521478|459505763|FG000|Overall Study|Other than listed|3|||
127693447|NCT04521478|459505764|FG001|Overall Study|Other than listed|3|||
127693448|NCT04521478|459505765|FG002|Overall Study|Other than listed|3|||
128029831|NCT00803049|460735134|FG003|Overall Study|Other than Specified Above|5|||
127693449|NCT04521478|459505766|FG003|Overall Study|Other than listed|2|||
127693450|NCT04521478|459505767|FG004|Overall Study|Other than listed|3|||
127693451|NCT04521478|459505768|FG005|Overall Study|Other than listed|3|||
128029832|NCT04003142|460735149|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
128029833|NCT04003142|460735150|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
127577677|NCT02367131|459086481|FG000|Overall Study|Request by patient|53|||
127577678|NCT02367131|459086481|FG000|Overall Study|Improvement/remission|2|||
127577679|NCT02367131|459086481|FG000|Overall Study|No change/progressive disease|78|||
127577680|NCT02367131|459086481|FG000|Overall Study|Other than stated above|20|||
127577681|NCT02367131|459086481|FG000|Overall Study|Not treated|2|||
127577682|NCT02572388|459086482|FG000|Overall Study|Withdrawal by Subject|1|||
127577683|NCT02572388|459086483|FG001|Overall Study|Withdrawal by Subject|1|||
127577684|NCT02572388|459086484|FG002|Overall Study|Withdrawal by Subject|2|||
128029834|NCT04003142|460735151|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
128029835|NCT04003142|460735152|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
128029836|NCT04003142|460735153|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
127577685|NCT02572388|459086485|FG003|Overall Study|Withdrawal by Subject|2|||
127577686|NCT01973569|459086488|FG000|Overall Study|Adverse Event|9|||
127577687|NCT01973569|459086489|FG001|Overall Study|Adverse Event|2|||
127577688|NCT01973569|459086490|FG002|Overall Study|Adverse Event|4|||
127577689|NCT01973569|459086488|FG000|Overall Study|Protocol Violation|2|||
127577690|NCT01973569|459086489|FG001|Overall Study|Protocol Violation|1|||
127577691|NCT01973569|459086490|FG002|Overall Study|Protocol Violation|3|||
127577692|NCT01973569|459086488|FG000|Overall Study|Withdrawal by Subject|7|||
127577693|NCT01973569|459086489|FG001|Overall Study|Withdrawal by Subject|5|||
127577694|NCT01973569|459086490|FG002|Overall Study|Withdrawal by Subject|2|||
127577695|NCT01973569|459086488|FG000|Overall Study|Invasive dental treatment|3|||
127577696|NCT01973569|459086489|FG001|Overall Study|Invasive dental treatment|5|||
127577697|NCT01973569|459086490|FG002|Overall Study|Invasive dental treatment|6|||
127577698|NCT01973569|459086488|FG000|Overall Study|Prohibited concomitant d|1|||
127577699|NCT01973569|459086489|FG001|Overall Study|Prohibited concomitant d|5|||
127577700|NCT01973569|459086490|FG002|Overall Study|Prohibited concomitant d|0|||
128029837|NCT04003142|460735149|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
127577701|NCT01973569|459086488|FG000|Overall Study|Disease progression|0|||
127577702|NCT01973569|459086489|FG001|Overall Study|Disease progression|3|||
128029838|NCT04003142|460735150|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
128029839|NCT04003142|460735151|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
128029840|NCT04003142|460735152|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
128029841|NCT04003142|460735153|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
128029842|NCT04003142|460735149|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
128029843|NCT04003142|460735150|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
128029844|NCT04003142|460735151|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
128029845|NCT04003142|460735152|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
128029846|NCT04003142|460735153|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
128029847|NCT04003142|460735149|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
127577703|NCT01973569|459086490|FG002|Overall Study|Disease progression|0|||
127577704|NCT01973569|459086488|FG000|Overall Study|Other|1|||
127577705|NCT01973569|459086489|FG001|Overall Study|Other|1|||
127577706|NCT01973569|459086490|FG002|Overall Study|Other|0|||
127577707|NCT01973569|459086488|FG000|Overall Study|Did not receive study drug|6|||
127577708|NCT01973569|459086489|FG001|Overall Study|Did not receive study drug|3|||
127577709|NCT01973569|459086490|FG002|Overall Study|Did not receive study drug|3|||
127577710|NCT00810108|459086491|FG000|Overall Study|Withdrawal by Subject|1|||
127577711|NCT00810108|459086492|FG001|Overall Study|Withdrawal by Subject|0|||
127577712|NCT02486302|459086496|FG000|Overall Study|Discontinued prematurely|410|||
127577713|NCT02486302|459086496|FG000|Overall Study|Documentation not completed|255|||
127577714|NCT02486302|459086496|FG000|Overall Study|Excluded due to legal reasons|8|||
127577715|NCT02486302|459086496|FG000|Overall Study|Not treated|3|||
127577716|NCT03611010|459086501|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
127577717|NCT03611010|459086502|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
127577718|NCT03611010|459086503|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
127577719|NCT03611010|459086504|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
127577720|NCT02063880|459086505|FG000|Overall Study|Death|21|||
127577721|NCT02063880|459086506|FG001|Overall Study|Death|18|||
127577722|NCT02063880|459086505|FG000|Overall Study|Lost to Follow-up|7|||
127577723|NCT02063880|459086506|FG001|Overall Study|Lost to Follow-up|7|||
127577724|NCT02063880|459086505|FG000|Overall Study|Ineligible|0|||
128029848|NCT04003142|460735150|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
127693452|NCT04521478|459505763|FG000|Overall Study|Not treated|0|||
127693453|NCT04521478|459505764|FG001|Overall Study|Not treated|0|||
127693454|NCT04521478|459505765|FG002|Overall Study|Not treated|0|||
127577725|NCT02063880|459086506|FG001|Overall Study|Ineligible|2|||
127577726|NCT00567593|459086507|FG000|Overall Study|Adverse Event|1|||
127577727|NCT00567593|459086507|FG000|Overall Study|Physician Decision|1|||
127577728|NCT02106910|459086510|FG000|Overall Study|Lost to Follow-up|1|||
127577729|NCT02106910|459086511|FG001|Overall Study|Lost to Follow-up|1|||
127577730|NCT01675427|459086512|FG000|Overall Study|Withdrawal by Subject|7|||
127577731|NCT01675427|459086512|FG000|Overall Study|Participant Refused Sample Collection|18|||
127577732|NCT01675427|459086512|FG000|Overall Study|Sample not Collected by Mistake|2|||
127693455|NCT04521478|459505766|FG003|Overall Study|Not treated|0|||
127577733|NCT01675427|459086512|FG000|Overall Study|Lost to Follow-up|5|||
127577734|NCT01675427|459086512|FG000|Overall Study|Other|2|||
127577735|NCT00700570|459086513|FG000|Overall Study|Adverse Event|2|||
127577736|NCT00700570|459086514|FG001|Overall Study|Adverse Event|6|||
127577737|NCT00700570|459086513|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
127577738|NCT00700570|459086514|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
127577739|NCT00700570|459086513|FG000|Overall Study|Disease Progression|8|||
127577740|NCT00700570|459086514|FG001|Overall Study|Disease Progression|11|||
127577741|NCT00700570|459086513|FG000|Overall Study|Withdrawal by Subject|1|||
127577742|NCT00700570|459086514|FG001|Overall Study|Withdrawal by Subject|6|||
127577743|NCT00611533|459086515|FG000|First Intervention (6 Weeks)|Never started study|0|||
127577744|NCT00611533|459086516|FG001|First Intervention (6 Weeks)|Never started study|1|||
127577745|NCT00611533|459086515|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
127577746|NCT00611533|459086516|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
127577747|NCT00611533|459086515|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
127577748|NCT00611533|459086516|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
127577749|NCT05246397|459086519|FG000|Overall Study|3 were excluded due to protocol deviation|3|||
127577750|NCT04327674|459086525|FG000|Overall Study|Protocol Violation|19|||
127577751|NCT01461980|459086526|FG000|Overall Study|Other|9|||
127577752|NCT01461980|459086527|FG001|Overall Study|Other|8|||
127577753|NCT01461980|459086528|FG002|Overall Study|Other|6|||
127577754|NCT01461980|459086526|FG000|Overall Study|Medication error|7|||
127577755|NCT01461980|459086527|FG001|Overall Study|Medication error|5|||
127577756|NCT01461980|459086528|FG002|Overall Study|Medication error|6|||
127577757|NCT01461980|459086526|FG000|Overall Study|Adverse Event|12|||
127577758|NCT01461980|459086527|FG001|Overall Study|Adverse Event|5|||
127577759|NCT01461980|459086528|FG002|Overall Study|Adverse Event|6|||
127577760|NCT01461980|459086526|FG000|Overall Study|Protocol Violation|12|||
127577761|NCT01461980|459086527|FG001|Overall Study|Protocol Violation|19|||
127577762|NCT01461980|459086528|FG002|Overall Study|Protocol Violation|16|||
127577763|NCT01461980|459086526|FG000|Overall Study|No longer meets eligibility criteria|18|||
127577764|NCT01461980|459086527|FG001|Overall Study|No longer meets eligibility criteria|9|||
127577765|NCT01461980|459086528|FG002|Overall Study|No longer meets eligibility criteria|19|||
127577766|NCT01461980|459086526|FG000|Overall Study|Lost to Follow-up|52|||
127577767|NCT01461980|459086527|FG001|Overall Study|Lost to Follow-up|53|||
127577768|NCT01461980|459086528|FG002|Overall Study|Lost to Follow-up|51|||
127577769|NCT01461980|459086526|FG000|Overall Study|No longer willing to participate|52|||
127577770|NCT01461980|459086527|FG001|Overall Study|No longer willing to participate|38|||
127577771|NCT01461980|459086528|FG002|Overall Study|No longer willing to participate|54|||
127577772|NCT01461980|459086526|FG000|Overall Study|Randomized but not vaccinated|4|||
127577773|NCT01461980|459086527|FG001|Overall Study|Randomized but not vaccinated|8|||
127577774|NCT01461980|459086528|FG002|Overall Study|Randomized but not vaccinated|7|||
127577775|NCT03257371|459086529|FG000|Overall Study|Lost to Follow-up|1|||
127577776|NCT02477839|459086530|FG000|Overall Study|Adverse Event|0|||
127577777|NCT02477839|459086531|FG001|Overall Study|Adverse Event|1|||
127577778|NCT02477839|459086530|FG000|Overall Study|Protocol Violation|0|||
127577779|NCT02477839|459086531|FG001|Overall Study|Protocol Violation|2|||
127782814|NCT03716050|459831388|FG001|Overall Study|Lost to Follow-up|0|||
127782815|NCT03716050|459831389|FG002|Overall Study|Lost to Follow-up|1|||
127782816|NCT03716050|459831390|FG003|Overall Study|Lost to Follow-up|0|||
127782817|NCT03716050|459831391|FG004|Overall Study|Lost to Follow-up|0|||
127782818|NCT03716050|459831392|FG005|Overall Study|Lost to Follow-up|0|||
127782819|NCT03716050|459831393|FG006|Overall Study|Lost to Follow-up|0|||
127782820|NCT03716050|459831394|FG007|Overall Study|Lost to Follow-up|0|||
127782821|NCT03716050|459831387|FG000|Overall Study|Physician Decision|0|||
127782822|NCT03716050|459831388|FG001|Overall Study|Physician Decision|0|||
127782823|NCT03716050|459831389|FG002|Overall Study|Physician Decision|0|||
127782824|NCT03716050|459831390|FG003|Overall Study|Physician Decision|1|||
127782825|NCT03716050|459831391|FG004|Overall Study|Physician Decision|0|||
127782826|NCT03716050|459831392|FG005|Overall Study|Physician Decision|0|||
127782827|NCT03716050|459831393|FG006|Overall Study|Physician Decision|0|||
127782828|NCT03716050|459831394|FG007|Overall Study|Physician Decision|0|||
127782829|NCT03716050|459831387|FG000|Overall Study|Protocol Violation|0|||
127782830|NCT03716050|459831388|FG001|Overall Study|Protocol Violation|0|||
127782831|NCT03716050|459831389|FG002|Overall Study|Protocol Violation|0|||
127577780|NCT02477839|459086530|FG000|Overall Study|Withdrawal by Subject|3|||
127577781|NCT02477839|459086531|FG001|Overall Study|Withdrawal by Subject|3|||
127577782|NCT02477839|459086530|FG000|Overall Study|Participant had PGS during V6|0|||
127577783|NCT02477839|459086531|FG001|Overall Study|Participant had PGS during V6|1|||
127577784|NCT02477839|459086530|FG000|Overall Study|Parents decided to stop medication|0|||
127577785|NCT02477839|459086531|FG001|Overall Study|Parents decided to stop medication|1|||
127577786|NCT02477839|459086530|FG000|Overall Study|Lack of tolerability|0|||
127577787|NCT02477839|459086531|FG001|Overall Study|Lack of tolerability|1|||
127577788|NCT02477839|459086530|FG000|Overall Study|Exclusion criterion|0|||
127782832|NCT03716050|459831390|FG003|Overall Study|Protocol Violation|1|||
127782833|NCT03716050|459831391|FG004|Overall Study|Protocol Violation|0|||
127782834|NCT03716050|459831392|FG005|Overall Study|Protocol Violation|0|||
127577789|NCT02477839|459086531|FG001|Overall Study|Exclusion criterion|1|||
127577790|NCT02607930|459086537|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
127577791|NCT02607930|459086538|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
127577792|NCT02607930|459086539|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
127577793|NCT02607930|459086540|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
127577794|NCT02607930|459086537|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
127577795|NCT02607930|459086538|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
127577796|NCT02607930|459086539|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
127577797|NCT02607930|459086540|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
128029849|NCT04003142|460735151|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
128029850|NCT04003142|460735152|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
128029851|NCT04003142|460735153|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
128029852|NCT04003142|460735149|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
128029853|NCT04003142|460735150|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
128029854|NCT04003142|460735151|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
128029855|NCT04003142|460735152|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
128029856|NCT04003142|460735153|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
128029857|NCT04003142|460735149|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
128029858|NCT04003142|460735150|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
128029859|NCT04003142|460735151|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
128029860|NCT04003142|460735152|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
128029861|NCT04003142|460735153|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
127577798|NCT02607930|459086537|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
127577799|NCT02607930|459086538|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
127577800|NCT02607930|459086539|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
127577801|NCT02607930|459086540|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
127577802|NCT02607930|459086537|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
127577803|NCT02607930|459086538|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
127577804|NCT02607930|459086539|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
127577805|NCT02607930|459086540|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
127577806|NCT02607930|459086537|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
127577807|NCT02607930|459086538|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
127577808|NCT02607930|459086539|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
127577809|NCT02607930|459086540|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
127577810|NCT02607930|459086537|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
127577811|NCT02607930|459086538|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
127577812|NCT02607930|459086539|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
127577813|NCT02607930|459086540|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
127577814|NCT02607930|459086537|FG000|Double-Blinded Treatment Phase|Death|2|||
127577815|NCT02607930|459086538|FG001|Double-Blinded Treatment Phase|Death|1|||
127577816|NCT02607930|459086539|FG002|Double-Blinded Treatment Phase|Death|0|||
127577817|NCT02607930|459086540|FG003|Double-Blinded Treatment Phase|Death|0|||
127577818|NCT02607930|459086537|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
127577819|NCT02607930|459086538|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
127577820|NCT02607930|459086539|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
127577821|NCT02607930|459086540|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
127577822|NCT02607930|459086537|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
127577823|NCT02607930|459086538|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
127577824|NCT02607930|459086539|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
127577825|NCT02607930|459086540|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
127577826|NCT02607930|459086537|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
127577827|NCT02607930|459086538|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
127577828|NCT02607930|459086539|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
127577829|NCT02607930|459086540|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
127577830|NCT02607930|459086537|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
127577831|NCT02607930|459086538|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
127577832|NCT02607930|459086539|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
127577833|NCT02607930|459086540|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
127577834|NCT02607930|459086537|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
127693456|NCT04521478|459505767|FG004|Overall Study|Not treated|0|||
128029862|NCT04003142|460735149|FG000|Extension Period (40 Weeks)|Death|0|||
128029863|NCT04003142|460735150|FG001|Extension Period (40 Weeks)|Death|0|||
128029864|NCT04003142|460735151|FG002|Extension Period (40 Weeks)|Death|0|||
127693457|NCT04521478|459505768|FG005|Overall Study|Not treated|1|||
127693458|NCT03625882|459505769|FG000|Overall Study|Protocol Violation|3|||
127693459|NCT05320432|459505774|FG000|Overall Study|Withdrawal by Subject|0|||
127693460|NCT05320432|459505775|FG001|Overall Study|Withdrawal by Subject|2|||
127693461|NCT03484702|459505776|FG000|Treatment Period|Death|3|||
127693462|NCT03484702|459505777|FG001|Treatment Period|Death|1|||
127693463|NCT03484702|459505778|FG002|Treatment Period|Death|0|||
127577835|NCT02607930|459086538|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
127577836|NCT02607930|459086539|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
127577837|NCT02607930|459086540|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
127577838|NCT02607930|459086537|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
127577839|NCT02607930|459086538|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
127577840|NCT02607930|459086539|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
127577841|NCT02607930|459086540|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
127577842|NCT02607930|459086537|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
127577843|NCT02607930|459086538|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
127577844|NCT02607930|459086539|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
127577845|NCT02607930|459086540|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
127577846|NCT02607930|459086537|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
127577847|NCT02607930|459086538|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
127577848|NCT02607930|459086539|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
127577849|NCT02607930|459086540|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
127577850|NCT02607930|459086537|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
127577851|NCT02607930|459086538|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
127693464|NCT03484702|459505779|FG003|Treatment Period|Death|0|||
127693465|NCT03484702|459505780|FG004|Treatment Period|Death|0|||
127693466|NCT03484702|459505781|FG005|Treatment Period|Death|0|||
127693467|NCT03484702|459505776|FG000|Treatment Period|Adverse Event|1|||
127693468|NCT03484702|459505777|FG001|Treatment Period|Adverse Event|0|||
127693469|NCT03484702|459505778|FG002|Treatment Period|Adverse Event|0|||
127693470|NCT03484702|459505779|FG003|Treatment Period|Adverse Event|0|||
127693471|NCT03484702|459505780|FG004|Treatment Period|Adverse Event|0|||
127693472|NCT03484702|459505781|FG005|Treatment Period|Adverse Event|0|||
127693473|NCT03484702|459505776|FG000|Treatment Period|Participant Withdrew from Study|0|||
127693474|NCT03484702|459505777|FG001|Treatment Period|Participant Withdrew from Study|1|||
127693475|NCT03484702|459505778|FG002|Treatment Period|Participant Withdrew from Study|0|||
127693476|NCT03484702|459505779|FG003|Treatment Period|Participant Withdrew from Study|0|||
127693477|NCT03484702|459505780|FG004|Treatment Period|Participant Withdrew from Study|0|||
127693478|NCT03484702|459505781|FG005|Treatment Period|Participant Withdrew from Study|0|||
127693479|NCT03484702|459505776|FG000|Treatment Period|Physician Decision|0|||
127693480|NCT03484702|459505777|FG001|Treatment Period|Physician Decision|1|||
127693481|NCT03484702|459505778|FG002|Treatment Period|Physician Decision|0|||
127693482|NCT03484702|459505779|FG003|Treatment Period|Physician Decision|0|||
127693483|NCT03484702|459505780|FG004|Treatment Period|Physician Decision|0|||
127693484|NCT03484702|459505781|FG005|Treatment Period|Physician Decision|1|||
127693485|NCT01757665|459505789|FG000|Overall Study|Still on Study - Visit Completed|240|||
127693486|NCT01757665|459505790|FG001|Overall Study|Still on Study - Visit Completed|30|||
127693487|NCT01757665|459505789|FG000|Overall Study|Still on Study - Visit Pending|398|||
128029865|NCT04003142|460735152|FG003|Extension Period (40 Weeks)|Death|0|||
128029866|NCT04003142|460735153|FG004|Extension Period (40 Weeks)|Death|1|||
128029867|NCT04003142|460735149|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
128029868|NCT04003142|460735150|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
128029869|NCT04003142|460735151|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
128029870|NCT04003142|460735152|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
128029871|NCT04003142|460735153|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
128029872|NCT04003142|460735149|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
128029873|NCT04003142|460735150|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
128029874|NCT04003142|460735151|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
128029875|NCT04003142|460735152|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
128029876|NCT04003142|460735153|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
128029877|NCT04003142|460735149|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
128029878|NCT04003142|460735150|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
128029879|NCT04003142|460735151|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
128029880|NCT04003142|460735152|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
128029881|NCT04003142|460735153|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
128029882|NCT04003142|460735149|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
128029883|NCT04003142|460735150|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
128029884|NCT04003142|460735151|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
128029885|NCT04003142|460735152|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
128029886|NCT04003142|460735153|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
128029887|NCT04042311|460735154|FG000|Overall Study|Abnormal cardiopulmonary exercise test (CPET) or unable to achieve a maximal test|9|||
128029888|NCT04042311|460735154|FG000|Overall Study|Unable to tolerate|4|||
128029889|NCT04042311|460735154|FG000|Overall Study|Concurrent illness|2|||
128029890|NCT04042311|460735154|FG000|Overall Study|Adverse Event|2|||
128029891|NCT04042311|460735154|FG000|Overall Study|No longer meeting inclusion criteria|2|||
127577852|NCT02607930|459086539|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
127577853|NCT02607930|459086540|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
127577854|NCT03198078|459086541|FG000|Overall Study|Adverse Event|0|||
127577855|NCT03198078|459086542|FG001|Overall Study|Adverse Event|1|||
127577856|NCT03198078|459086543|FG002|Overall Study|Adverse Event|2|||
127577857|NCT03198078|459086541|FG000|Overall Study|Lack of Efficacy|0|||
127577858|NCT03198078|459086542|FG001|Overall Study|Lack of Efficacy|0|||
127577859|NCT03198078|459086543|FG002|Overall Study|Lack of Efficacy|3|||
127577860|NCT03198078|459086541|FG000|Overall Study|Lost to Follow-up|1|||
127577861|NCT03198078|459086542|FG001|Overall Study|Lost to Follow-up|0|||
127577862|NCT03198078|459086543|FG002|Overall Study|Lost to Follow-up|0|||
127577863|NCT03198078|459086541|FG000|Overall Study|Pregnancy|0|||
127577864|NCT03198078|459086542|FG001|Overall Study|Pregnancy|1|||
127577865|NCT03198078|459086543|FG002|Overall Study|Pregnancy|0|||
127577866|NCT03198078|459086541|FG000|Overall Study|Withdrawal by Subject|1|||
127577867|NCT03198078|459086542|FG001|Overall Study|Withdrawal by Subject|0|||
127577868|NCT03198078|459086543|FG002|Overall Study|Withdrawal by Subject|2|||
127577869|NCT03198078|459086541|FG000|Overall Study|Withdrawal by Caregiver|1|||
127577870|NCT03198078|459086542|FG001|Overall Study|Withdrawal by Caregiver|3|||
127577871|NCT03198078|459086543|FG002|Overall Study|Withdrawal by Caregiver|5|||
127577872|NCT00057876|459086544|FG000|Overall Study|Adverse Event|8|||
127577873|NCT00057876|459086545|FG001|Overall Study|Adverse Event|8|||
127577874|NCT00057876|459086544|FG000|Overall Study|Death|2|||
127577875|NCT00057876|459086545|FG001|Overall Study|Death|1|||
127577876|NCT00057876|459086544|FG000|Overall Study|Withdrawal by Subject|5|||
127577877|NCT00057876|459086545|FG001|Overall Study|Withdrawal by Subject|6|||
127577878|NCT00057876|459086544|FG000|Overall Study|Lack of Efficacy|10|||
127577879|NCT00057876|459086545|FG001|Overall Study|Lack of Efficacy|8|||
127577880|NCT00057876|459086544|FG000|Overall Study|Ineligible|1|||
127577881|NCT00057876|459086545|FG001|Overall Study|Ineligible|2|||
127577882|NCT00057876|459086544|FG000|Overall Study|other reason|2|||
127577883|NCT00057876|459086545|FG001|Overall Study|other reason|2|||
127577884|NCT00057876|459086544|FG000|Overall Study|other complicating disease|1|||
127577885|NCT00057876|459086545|FG001|Overall Study|other complicating disease|0|||
127577886|NCT01649804|459086546|FG000|Overall Study|Administrative/Other|8|||
127577887|NCT01626495|459086554|FG000|Overall Study|Adverse Event|3|||
127577888|NCT01626495|459086554|FG000|Overall Study|Disease progression|27|||
127577889|NCT01626495|459086554|FG000|Overall Study|Withdrawal by Subject|1|||
127577890|NCT01626495|459086554|FG000|Overall Study|Administrative problem|1|||
127577891|NCT01626495|459086554|FG000|Overall Study|Death|2|||
127577892|NCT01626495|459086554|FG000|Overall Study|Physician Decision|1|||
127577893|NCT01626495|459086554|FG000|Overall Study|New cancer therapy|16|||
127577894|NCT01626495|459086554|FG000|Overall Study|Manufacturing failure|1|||
127577895|NCT01934972|459086555|FG000|Overall Study|Withdrawal by Subject|9|||
127577896|NCT01934972|459086556|FG001|Overall Study|Withdrawal by Subject|6|||
127577897|NCT03131453|459086557|FG000|Overall Study|Study terminated by Sponsor|424|||
127577898|NCT03131453|459086558|FG001|Overall Study|Study terminated by Sponsor|222|||
127577899|NCT03131453|459086559|FG002|Overall Study|Study terminated by Sponsor|438|||
127577900|NCT03131453|459086557|FG000|Overall Study|Withdrawal by Subject|18|||
127577901|NCT03131453|459086558|FG001|Overall Study|Withdrawal by Subject|7|||
127577902|NCT03131453|459086559|FG002|Overall Study|Withdrawal by Subject|13|||
127577903|NCT03131453|459086557|FG000|Overall Study|Adverse Event|10|||
127577904|NCT03131453|459086558|FG001|Overall Study|Adverse Event|3|||
127577905|NCT03131453|459086559|FG002|Overall Study|Adverse Event|3|||
127577906|NCT03131453|459086557|FG000|Overall Study|Lost to Follow-up|1|||
127577907|NCT03131453|459086558|FG001|Overall Study|Lost to Follow-up|0|||
127881365|NCT02058368|460187391|FG000|Overall Study|Protocol Violation|0|||
127881366|NCT02058368|460187392|FG001|Overall Study|Protocol Violation|4|||
127881367|NCT02058368|460187391|FG000|Overall Study|Lost to Follow-up|2|||
127881368|NCT02058368|460187392|FG001|Overall Study|Lost to Follow-up|0|||
127881369|NCT02058368|460187391|FG000|Overall Study|Physician Decision|2|||
127881370|NCT02058368|460187392|FG001|Overall Study|Physician Decision|3|||
127881371|NCT02058368|460187391|FG000|Overall Study|Withdrawal by Subject|22|||
128029892|NCT04042311|460735154|FG000|Overall Study|No reason given|1|||
128029893|NCT04042311|460735154|FG000|Overall Study|Withdrawal by Subject|4|||
128029894|NCT03382873|460735155|FG000|Overall Study|Lost to Follow-up|9|||
127577908|NCT03131453|459086559|FG002|Overall Study|Lost to Follow-up|1|||
127577909|NCT03131453|459086557|FG000|Overall Study|Physician Decision|1|||
127577910|NCT03131453|459086558|FG001|Overall Study|Physician Decision|0|||
127577911|NCT03131453|459086559|FG002|Overall Study|Physician Decision|1|||
127577912|NCT03131453|459086557|FG000|Overall Study|Non-compliance with study treatment|1|||
127577913|NCT03131453|459086558|FG001|Overall Study|Non-compliance with study treatment|0|||
127577914|NCT03131453|459086559|FG002|Overall Study|Non-compliance with study treatment|0|||
127577915|NCT03131453|459086557|FG000|Overall Study|Technical problems|1|||
127577916|NCT03131453|459086558|FG001|Overall Study|Technical problems|0|||
127577917|NCT03131453|459086559|FG002|Overall Study|Technical problems|0|||
127577918|NCT03131453|459086557|FG000|Overall Study|Protocol deviation|0|||
127577919|NCT03131453|459086558|FG001|Overall Study|Protocol deviation|1|||
127577920|NCT03131453|459086559|FG002|Overall Study|Protocol deviation|0|||
127577921|NCT02770170|459086562|FG000|Overall Study|Withdrawal by Subject|0|||
127881372|NCT02058368|460187392|FG001|Overall Study|Withdrawal by Subject|26|||
127577922|NCT02770170|459086563|FG001|Overall Study|Withdrawal by Subject|0|||
127577923|NCT02770170|459086564|FG002|Overall Study|Withdrawal by Subject|0|||
127577924|NCT02770170|459086565|FG003|Overall Study|Withdrawal by Subject|2|||
127577925|NCT02770170|459086562|FG000|Overall Study|due to pregnancy|1|||
127577926|NCT02770170|459086563|FG001|Overall Study|due to pregnancy|0|||
127577927|NCT02770170|459086564|FG002|Overall Study|due to pregnancy|0|||
127577928|NCT02770170|459086565|FG003|Overall Study|due to pregnancy|0|||
127577929|NCT02770170|459086562|FG000|Overall Study|Lack of Efficacy|2|||
127577930|NCT02770170|459086563|FG001|Overall Study|Lack of Efficacy|0|||
127577931|NCT02770170|459086564|FG002|Overall Study|Lack of Efficacy|0|||
127577932|NCT02770170|459086565|FG003|Overall Study|Lack of Efficacy|1|||
127577933|NCT02770170|459086562|FG000|Overall Study|Adverse Event|4|||
127577934|NCT02770170|459086563|FG001|Overall Study|Adverse Event|3|||
127577935|NCT02770170|459086564|FG002|Overall Study|Adverse Event|5|||
127577936|NCT02770170|459086565|FG003|Overall Study|Adverse Event|3|||
127577937|NCT02770170|459086562|FG000|Overall Study|due to disease worsening|0|||
127577938|NCT02770170|459086563|FG001|Overall Study|due to disease worsening|0|||
127577939|NCT02770170|459086564|FG002|Overall Study|due to disease worsening|0|||
127577940|NCT02770170|459086565|FG003|Overall Study|due to disease worsening|1|||
127577941|NCT00445978|459086566|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
127577942|NCT00445978|459086566|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
127577943|NCT00445978|459086566|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
127577944|NCT00445978|459086566|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
127577945|NCT00445978|459086566|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
127577946|NCT00445978|459086566|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
127577947|NCT00445978|459086566|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
127577948|NCT00445978|459086566|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
127577949|NCT00445978|459086566|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
127577950|NCT01822496|459086569|FG000|Overall Study|Protocol Violation|2|||
127577951|NCT01822496|459086570|FG001|Overall Study|Protocol Violation|2|||
127577952|NCT01822496|459086571|FG002|Overall Study|Protocol Violation|0|||
127577953|NCT01822496|459086572|FG003|Overall Study|Protocol Violation|1|||
127577954|NCT01822496|459086569|FG000|Overall Study|Withdrawal by Subject|0|||
127577955|NCT01822496|459086570|FG001|Overall Study|Withdrawal by Subject|0|||
127577956|NCT01822496|459086571|FG002|Overall Study|Withdrawal by Subject|0|||
127577957|NCT01822496|459086572|FG003|Overall Study|Withdrawal by Subject|3|||
127577958|NCT00304239|459086573|FG000|Overall Study|Protocol Deviations/Violations|15|||
127577959|NCT00304239|459086574|FG001|Overall Study|Protocol Deviations/Violations|0|||
127577960|NCT00304239|459086573|FG000|Overall Study|Adverse Event|2|||
127577961|NCT00304239|459086574|FG001|Overall Study|Adverse Event|0|||
127577962|NCT02979197|459086575|FG000|Overall Study|Adverse Event|4|||
127577963|NCT02979197|459086576|FG001|Overall Study|Adverse Event|2|||
127577964|NCT02979197|459086577|FG002|Overall Study|Adverse Event|0|||
127577965|NCT02979197|459086575|FG000|Overall Study|Protocol Violation|0|||
127577966|NCT02979197|459086576|FG001|Overall Study|Protocol Violation|1|||
127577967|NCT02979197|459086577|FG002|Overall Study|Protocol Violation|0|||
127577968|NCT02979197|459086575|FG000|Overall Study|Subject unable to commit to study dates|0|||
127577969|NCT02979197|459086576|FG001|Overall Study|Subject unable to commit to study dates|1|||
127577970|NCT02979197|459086577|FG002|Overall Study|Subject unable to commit to study dates|0|||
127577971|NCT03643159|459086578|FG000|Overall Study|Adverse Event|1|||
127577972|NCT03643159|459086578|FG000|Overall Study|Withdrawal by Subject|1|||
127577973|NCT03438383|459086579|FG000|Overall Study|Protocol Violation|9|||
127577974|NCT03438383|459086580|FG001|Overall Study|Protocol Violation|3|||
127577975|NCT02766465|459086581|FG000|Overall Study|Withdrawal by Subject|0|||
127577976|NCT02766465|459086582|FG001|Overall Study|Withdrawal by Subject|10|||
127577977|NCT01528033|459086583|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
127577978|NCT01528033|459086584|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
127577979|NCT01528033|459086583|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
127577980|NCT01528033|459086584|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
127577981|NCT01528033|459086583|FG000|Primary Endpoint Assessment ITT|Death|2|||
127577982|NCT01528033|459086584|FG001|Primary Endpoint Assessment ITT|Death|2|||
127577983|NCT01528033|459086583|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
128029895|NCT03382873|460735156|FG001|Overall Study|Lost to Follow-up|10|||
128029896|NCT03382873|460735155|FG000|Overall Study|Withdrawal by Subject|6|||
127577984|NCT01528033|459086584|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
127577985|NCT01528033|459086583|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
127577986|NCT01528033|459086584|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
127577987|NCT01528033|459086583|FG000|Follow Up|No data available|46|||
127577988|NCT01528033|459086584|FG001|Follow Up|No data available|44|||
127577989|NCT02520661|459086585|FG000|Overall Study|Lost to Follow-up|7|||
127577990|NCT02520661|459086586|FG001|Overall Study|Lost to Follow-up|3|||
127577991|NCT02520661|459086585|FG000|Overall Study|Admitted from ED|49|||
127577992|NCT02520661|459086586|FG001|Overall Study|Admitted from ED|48|||
128029897|NCT03382873|460735156|FG001|Overall Study|Withdrawal by Subject|11|||
127577993|NCT02520661|459086585|FG000|Overall Study|ED greater than 24 hours|29|||
127577994|NCT02520661|459086586|FG001|Overall Study|ED greater than 24 hours|38|||
127577995|NCT02520661|459086585|FG000|Overall Study|other ineligibility|14|||
127577996|NCT02520661|459086586|FG001|Overall Study|other ineligibility|22|||
127577997|NCT02520661|459086585|FG000|Overall Study|Withdrawal by Subject|7|||
127577998|NCT02520661|459086586|FG001|Overall Study|Withdrawal by Subject|16|||
127577999|NCT00932737|459086596|FG000|Overall Study|Not treated in second episode|1|||
127578000|NCT00932737|459086597|FG001|Overall Study|Not treated in second episode|0|||
127578001|NCT00932737|459086596|FG000|Overall Study|Adverse Event|0|||
127578002|NCT00932737|459086597|FG001|Overall Study|Adverse Event|1|||
127578003|NCT04399837|459086598|FG000|Overall Study|Other than listed|0|||
127578004|NCT04399837|459086599|FG001|Overall Study|Other than listed|2|||
127578005|NCT04399837|459086600|FG002|Overall Study|Other than listed|2|||
127578006|NCT04399837|459086601|FG003|Overall Study|Other than listed|3|||
127578007|NCT04399837|459086598|FG000|Overall Study|Withdrawal by Subject|1|||
127578008|NCT04399837|459086599|FG001|Overall Study|Withdrawal by Subject|2|||
127578009|NCT04399837|459086600|FG002|Overall Study|Withdrawal by Subject|1|||
127578010|NCT04399837|459086601|FG003|Overall Study|Withdrawal by Subject|1|||
127578011|NCT02628769|459086613|FG000|First Intervention|Adverse Event|1|||
127578012|NCT02628769|459086614|FG001|First Intervention|Adverse Event|0|||
127578013|NCT02628769|459086613|FG000|First Intervention|Withdrawal by Subject|0|||
127578014|NCT02628769|459086614|FG001|First Intervention|Withdrawal by Subject|1|||
127578015|NCT02628769|459086613|FG000|Second Intervention|Adverse Event|2|||
127578016|NCT02628769|459086614|FG001|Second Intervention|Adverse Event|0|||
127578017|NCT02628769|459086613|FG000|Second Intervention|Physician Decision|0|||
127578018|NCT02628769|459086614|FG001|Second Intervention|Physician Decision|1|||
127578019|NCT02024555|459086615|FG000|Overall Study|Lost to Follow-up|1|||
127578020|NCT02024555|459086616|FG001|Overall Study|Lost to Follow-up|1|||
127578021|NCT02024555|459086615|FG000|Overall Study|Withdrawal by Subject|5|||
127578022|NCT02024555|459086616|FG001|Overall Study|Withdrawal by Subject|1|||
127578023|NCT02719327|459086619|FG000|Overall Study|Withdrawal by Subject|11|||
127578024|NCT02719327|459086620|FG001|Overall Study|Withdrawal by Subject|8|||
127578025|NCT03350620|459086621|FG000|Stage 2|Adverse Event|0|||
127578026|NCT03350620|459086622|FG001|Stage 2|Adverse Event|1|||
127578027|NCT03350620|459086623|FG002|Stage 2|Adverse Event|1|||
127578028|NCT03350620|459086621|FG000|Stage 2|Lack of Efficacy|0|||
127578029|NCT03350620|459086622|FG001|Stage 2|Lack of Efficacy|2|||
127578030|NCT03350620|459086623|FG002|Stage 2|Lack of Efficacy|0|||
127578031|NCT03350620|459086621|FG000|Stage 2|Lost to Follow-up|1|||
127578032|NCT03350620|459086622|FG001|Stage 2|Lost to Follow-up|2|||
127578033|NCT03350620|459086623|FG002|Stage 2|Lost to Follow-up|2|||
127578034|NCT03350620|459086621|FG000|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|2|||
127578035|NCT03350620|459086622|FG001|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|4|||
127578036|NCT03350620|459086623|FG002|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|0|||
127578037|NCT01066000|459086626|FG000|Overall Study|Protocol Violation|4|||
127578038|NCT01066000|459086626|FG000|Overall Study|Death|3|||
127578039|NCT01066000|459086626|FG000|Overall Study|Withdrawal by Subject|1|||
127578040|NCT01066000|459086626|FG000|Overall Study|Adverse Event|1|||
127578041|NCT05268055|459086627|FG000|Overall Study|Lost to Follow-up|68|||
127578042|NCT05268055|459086628|FG001|Overall Study|Lost to Follow-up|68|||
127578043|NCT05268055|459086627|FG000|Overall Study|Withdrawal by Subject|12|||
127578044|NCT05268055|459086628|FG001|Overall Study|Withdrawal by Subject|8|||
127578045|NCT02203071|459087997|FG000|Overall Study|Lost to Follow-up|3|||
127578046|NCT02203071|459087998|FG001|Overall Study|Lost to Follow-up|1|||
127578047|NCT03793556|459087999|FG000|Overall Study|Withdrawal by Subject|12|||
127578048|NCT03793556|459088000|FG001|Overall Study|Withdrawal by Subject|1|||
127578049|NCT03793556|459087999|FG000|Overall Study|Lost to Follow-up|1|||
127578050|NCT03793556|459088000|FG001|Overall Study|Lost to Follow-up|1|||
127578051|NCT04416633|459088001|FG000|Overall Study|Death|1|||
127578052|NCT04416633|459088001|FG000|Overall Study|Disease progression as per investigator's clinical and imaging assessment|17|||
127578053|NCT04416633|459088001|FG000|Overall Study|AE greater than Grade 3 related to study drug|1|||
127578054|NCT04416633|459088001|FG000|Overall Study|Adverse Event|6|||
127693488|NCT01757665|459505790|FG001|Overall Study|Still on Study - Visit Pending|40|||
127693489|NCT01757665|459505789|FG000|Overall Study|Still on Study - Missed Visit|14|||
127578055|NCT04416633|459088001|FG000|Overall Study|Withdrawal by Subject|6|||
127578056|NCT04612790|459088002|FG000|DB Period (Up to 36 Weeks)|Death|1|||
127578057|NCT04612790|459088003|FG001|DB Period (Up to 36 Weeks)|Death|1|||
127578058|NCT04612790|459088004|FG002|DB Period (Up to 36 Weeks)|Death|0|||
127578059|NCT04612790|459088005|FG003|DB Period (Up to 36 Weeks)|Death|0|||
127578060|NCT04612790|459088002|FG000|DB Period (Up to 36 Weeks)|Adverse Event|2|||
127578061|NCT04612790|459088003|FG001|DB Period (Up to 36 Weeks)|Adverse Event|0|||
127578062|NCT04612790|459088004|FG002|DB Period (Up to 36 Weeks)|Adverse Event|0|||
127578063|NCT04612790|459088005|FG003|DB Period (Up to 36 Weeks)|Adverse Event|0|||
127578064|NCT04612790|459088002|FG000|DB Period (Up to 36 Weeks)|Study terminated by sponsor|8|||
127578065|NCT04612790|459088003|FG001|DB Period (Up to 36 Weeks)|Study terminated by sponsor|6|||
127693490|NCT01757665|459505790|FG001|Overall Study|Still on Study - Missed Visit|1|||
127693491|NCT01757665|459505789|FG000|Overall Study|Death|25|||
127693492|NCT01757665|459505790|FG001|Overall Study|Death|8|||
127578066|NCT04612790|459088004|FG002|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
127578067|NCT04612790|459088005|FG003|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
127578068|NCT04612790|459088002|FG000|DB Period (Up to 36 Weeks)|Withdrawal by Subject|2|||
127578069|NCT04612790|459088003|FG001|DB Period (Up to 36 Weeks)|Withdrawal by Subject|4|||
127578070|NCT04612790|459088004|FG002|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
127578071|NCT04612790|459088005|FG003|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
127578072|NCT04612790|459088002|FG000|DB Period (Up to 36 Weeks)|Physician Decision|4|||
127578073|NCT04612790|459088003|FG001|DB Period (Up to 36 Weeks)|Physician Decision|3|||
127578074|NCT04612790|459088004|FG002|DB Period (Up to 36 Weeks)|Physician Decision|0|||
127578075|NCT04612790|459088005|FG003|DB Period (Up to 36 Weeks)|Physician Decision|0|||
127578076|NCT04612790|459088002|FG000|DB Period (Up to 36 Weeks)|Other|1|||
127578077|NCT04612790|459088003|FG001|DB Period (Up to 36 Weeks)|Other|0|||
127578078|NCT04612790|459088004|FG002|DB Period (Up to 36 Weeks)|Other|0|||
127578079|NCT04612790|459088005|FG003|DB Period (Up to 36 Weeks)|Other|0|||
127578080|NCT04612790|459088002|FG000|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
127578081|NCT04612790|459088003|FG001|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
127578082|NCT04612790|459088004|FG002|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
127578083|NCT04612790|459088005|FG003|OLE Period (Up to 1 Year)|Withdrawal by Subject|1|||
127578084|NCT04612790|459088002|FG000|OLE Period (Up to 1 Year)|Investigator decision|0|||
127578085|NCT04612790|459088003|FG001|OLE Period (Up to 1 Year)|Investigator decision|0|||
127578086|NCT04612790|459088004|FG002|OLE Period (Up to 1 Year)|Investigator decision|2|||
127578087|NCT04612790|459088005|FG003|OLE Period (Up to 1 Year)|Investigator decision|1|||
127578088|NCT04612790|459088002|FG000|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
127578089|NCT04612790|459088003|FG001|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
127578090|NCT04612790|459088004|FG002|OLE Period (Up to 1 Year)|Study terminated by sponsor|14|||
127578091|NCT04612790|459088005|FG003|OLE Period (Up to 1 Year)|Study terminated by sponsor|15|||
127578092|NCT04612790|459088002|FG000|OLE Period (Up to 1 Year)|Other|0|||
127693493|NCT01757665|459505789|FG000|Overall Study|Explant|1|||
127693494|NCT01757665|459505790|FG001|Overall Study|Explant|2|||
127693495|NCT01757665|459505789|FG000|Overall Study|Withdrawal by Subject|10|||
127578093|NCT04612790|459088003|FG001|OLE Period (Up to 1 Year)|Other|0|||
127578094|NCT04612790|459088004|FG002|OLE Period (Up to 1 Year)|Other|0|||
127578095|NCT04612790|459088005|FG003|OLE Period (Up to 1 Year)|Other|1|||
127578096|NCT00408629|459088010|FG000|Overall Study|Adverse Event|13|||
127693496|NCT01757665|459505790|FG001|Overall Study|Withdrawal by Subject|0|||
127578097|NCT00408629|459088011|FG001|Overall Study|Adverse Event|27|||
127578098|NCT00408629|459088010|FG000|Overall Study|Withdrawal by Subject|8|||
127578099|NCT00408629|459088011|FG001|Overall Study|Withdrawal by Subject|4|||
127578100|NCT00408629|459088010|FG000|Overall Study|Lost to Follow-up|1|||
127578101|NCT00408629|459088011|FG001|Overall Study|Lost to Follow-up|1|||
127578102|NCT00408629|459088010|FG000|Overall Study|Lack of Efficacy|63|||
127578103|NCT00408629|459088011|FG001|Overall Study|Lack of Efficacy|73|||
128029898|NCT03382873|460735155|FG000|Overall Study|Visit not completed due to pandemic|16|||
127578104|NCT00408629|459088010|FG000|Overall Study|Protocol Violation|1|||
127578105|NCT00408629|459088011|FG001|Overall Study|Protocol Violation|5|||
127578106|NCT00408629|459088010|FG000|Overall Study|Miscellaneous|11|||
127578107|NCT00408629|459088011|FG001|Overall Study|Miscellaneous|15|||
127578108|NCT00191906|459088012|FG000|Study Period II|Adverse Event|0|||
127578109|NCT00191906|459088013|FG001|Study Period II|Adverse Event|1|||
127578110|NCT00191906|459088014|FG002|Study Period II|Adverse Event|0|||
127578111|NCT00191906|459088015|FG003|Study Period II|Adverse Event|0|||
127578112|NCT00191906|459088012|FG000|Study Period II|Withdrawal by Subject|0|||
127578113|NCT00191906|459088013|FG001|Study Period II|Withdrawal by Subject|3|||
127578114|NCT00191906|459088014|FG002|Study Period II|Withdrawal by Subject|0|||
127578115|NCT00191906|459088015|FG003|Study Period II|Withdrawal by Subject|0|||
127578116|NCT00191906|459088012|FG000|Study Period II|Parent/Caregiver Decision|0|||
127578117|NCT00191906|459088013|FG001|Study Period II|Parent/Caregiver Decision|1|||
127578118|NCT00191906|459088014|FG002|Study Period II|Parent/Caregiver Decision|0|||
127578119|NCT00191906|459088015|FG003|Study Period II|Parent/Caregiver Decision|0|||
127578120|NCT00191906|459088012|FG000|Study Period II|Entry Criteria Exclusion|0|||
127578121|NCT00191906|459088013|FG001|Study Period II|Entry Criteria Exclusion|0|||
127578122|NCT00191906|459088014|FG002|Study Period II|Entry Criteria Exclusion|1|||
127578123|NCT00191906|459088015|FG003|Study Period II|Entry Criteria Exclusion|0|||
127578124|NCT00191906|459088012|FG000|Study Period III|Adverse Event|1|||
127578125|NCT00191906|459088013|FG001|Study Period III|Adverse Event|0|||
127578126|NCT00191906|459088014|FG002|Study Period III|Adverse Event|0|||
127578127|NCT00191906|459088015|FG003|Study Period III|Adverse Event|0|||
127578128|NCT00191906|459088012|FG000|Study Period III|Lost to Follow-up|0|||
127578129|NCT00191906|459088013|FG001|Study Period III|Lost to Follow-up|1|||
127578130|NCT00191906|459088014|FG002|Study Period III|Lost to Follow-up|0|||
127578131|NCT00191906|459088015|FG003|Study Period III|Lost to Follow-up|0|||
127578132|NCT00191906|459088012|FG000|Study Period III|Parent/Caregiver Decision|1|||
127693497|NCT01757665|459505789|FG000|Overall Study|Lost to Follow-up|1|||
127693498|NCT01757665|459505790|FG001|Overall Study|Lost to Follow-up|1|||
127693499|NCT01757665|459505789|FG000|Overall Study|Not Implanted with Device|5|||
127693500|NCT01757665|459505790|FG001|Overall Study|Not Implanted with Device|1|||
127693501|NCT05816551|459505791|FG000|Overall Study|Withdrawal by Subject|0|||
127693502|NCT05816551|459505792|FG001|Overall Study|Withdrawal by Subject|1|||
127693503|NCT05816551|459505791|FG000|Overall Study|Withdrawn by Primary Investigator|3|||
127693504|NCT05816551|459505792|FG001|Overall Study|Withdrawn by Primary Investigator|0|||
127693505|NCT02651324|459505801|FG000|Overall Study|drug not administered, due dispensing issue|1|||
127693506|NCT02651324|459505802|FG001|Overall Study|drug not administered, due dispensing issue|0|||
127693507|NCT05461131|459505803|FG000|Overall Study|Lost to Follow-up|0|||
127693508|NCT05461131|459505804|FG001|Overall Study|Lost to Follow-up|2|||
127693509|NCT03101904|459505806|FG000|Wash Out (10 Days)|Adverse Event|1|||
127693510|NCT03101904|459505807|FG001|Wash Out (10 Days)|Adverse Event|0|||
127693511|NCT03101904|459505806|FG000|Wash Out (10 Days)|Lost to Follow-up|2|||
127693512|NCT03101904|459505807|FG001|Wash Out (10 Days)|Lost to Follow-up|0|||
127693513|NCT04538417|459505808|FG000|Overall Study|Withdrawal by Subject|2|||
127693514|NCT04549168|459505809|FG000|Randomization Phase|Adverse Event|0|||
127693515|NCT04549168|459505810|FG001|Randomization Phase|Adverse Event|0|||
127693516|NCT04549168|459505811|FG002|Randomization Phase|Adverse Event|1|||
127693517|NCT04549168|459505809|FG000|Randomization Phase|Other|0|||
127693518|NCT04549168|459505810|FG001|Randomization Phase|Other|2|||
127693519|NCT04549168|459505811|FG002|Randomization Phase|Other|0|||
127693520|NCT04549168|459505809|FG000|Randomization Phase|Withdrawal by Subject|0|||
127693521|NCT04549168|459505810|FG001|Randomization Phase|Withdrawal by Subject|2|||
127693522|NCT04549168|459505811|FG002|Randomization Phase|Withdrawal by Subject|1|||
127693523|NCT02662062|459505819|FG000|Overall Study|Withdrawal by Subject|1|||
127693524|NCT06311084|459505820|FG000|Overall Study|Lost to Follow-up|14|||
127693525|NCT03988634|459505821|FG000|Double-Blind|Adverse Event|4|||
127693526|NCT03988634|459505822|FG001|Double-Blind|Adverse Event|0|||
127693527|NCT03988634|459505823|FG002|Double-Blind|Adverse Event|0|||
127782835|NCT03716050|459831393|FG006|Overall Study|Protocol Violation|0|||
127578133|NCT00191906|459088013|FG001|Study Period III|Parent/Caregiver Decision|0|||
127578134|NCT00191906|459088014|FG002|Study Period III|Parent/Caregiver Decision|0|||
127578135|NCT00191906|459088015|FG003|Study Period III|Parent/Caregiver Decision|0|||
127578136|NCT00191906|459088012|FG000|Study Period III|Lack of Efficacy|3|||
127578137|NCT00191906|459088013|FG001|Study Period III|Lack of Efficacy|3|||
127578138|NCT00191906|459088014|FG002|Study Period III|Lack of Efficacy|0|||
127693528|NCT03988634|459505821|FG000|Double-Blind|Death|18|||
127693529|NCT03988634|459505822|FG001|Double-Blind|Death|26|||
127693530|NCT03988634|459505823|FG002|Double-Blind|Death|0|||
127782836|NCT03716050|459831394|FG007|Overall Study|Protocol Violation|2|||
127782837|NCT03123250|459831395|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
127782838|NCT01390272|459831396|FG000|Overall Study|Death|3|||
127782839|NCT01390272|459831397|FG001|Overall Study|Death|2|||
127782840|NCT01390272|459831396|FG000|Overall Study|Withdrawal by Subject|9|||
127782841|NCT01390272|459831397|FG001|Overall Study|Withdrawal by Subject|5|||
127782842|NCT01390272|459831396|FG000|Overall Study|Patient moved, no longer eligible|5|||
127782843|NCT01390272|459831397|FG001|Overall Study|Patient moved, no longer eligible|8|||
127782844|NCT02566577|459831398|FG000|Overall Study|Withdrawal by Subject|1|||
127782845|NCT02566577|459831399|FG001|Overall Study|Withdrawal by Subject|1|||
127782846|NCT02566577|459831398|FG000|Overall Study|Equipment failure|1|||
127578139|NCT00191906|459088015|FG003|Study Period III|Lack of Efficacy|0|||
127578140|NCT00573937|459088016|FG000|Overall Study|Study Terminated|0|||
127578141|NCT00573937|459088017|FG001|Overall Study|Study Terminated|1|||
127578142|NCT00333801|459088018|FG000|Overall Study|Moved to another state|5|||
127578143|NCT00333801|459088019|FG001|Overall Study|Moved to another state|3|||
127578144|NCT00333801|459088018|FG000|Overall Study|Lost to Follow-up|2|||
127578145|NCT00333801|459088019|FG001|Overall Study|Lost to Follow-up|0|||
127578146|NCT00333801|459088018|FG000|Overall Study|Incarcerated|1|||
127578147|NCT00333801|459088019|FG001|Overall Study|Incarcerated|2|||
127578148|NCT00333801|459088018|FG000|Overall Study|Withdrawal by Subject|0|||
127578149|NCT00333801|459088019|FG001|Overall Study|Withdrawal by Subject|1|||
127578150|NCT04171765|459088020|FG000|Overall Study|Adverse Event|2|||
127578151|NCT04171765|459088021|FG001|Overall Study|Adverse Event|0|||
127578152|NCT04171765|459088022|FG002|Overall Study|Adverse Event|1|||
127578153|NCT04171765|459088023|FG003|Overall Study|Adverse Event|0|||
127578154|NCT04171765|459088020|FG000|Overall Study|Lost to Follow-up|0|||
127578155|NCT04171765|459088021|FG001|Overall Study|Lost to Follow-up|2|||
127578156|NCT04171765|459088022|FG002|Overall Study|Lost to Follow-up|2|||
127578157|NCT04171765|459088023|FG003|Overall Study|Lost to Follow-up|2|||
127578158|NCT04171765|459088020|FG000|Overall Study|Week 58 visit missed|0|||
127578159|NCT04171765|459088021|FG001|Overall Study|Week 58 visit missed|0|||
127578160|NCT04171765|459088022|FG002|Overall Study|Week 58 visit missed|1|||
127578161|NCT04171765|459088023|FG003|Overall Study|Week 58 visit missed|0|||
127578162|NCT04171765|459088020|FG000|Overall Study|Study terminated by sponsor|2|||
127578163|NCT04171765|459088021|FG001|Overall Study|Study terminated by sponsor|0|||
127578164|NCT04171765|459088022|FG002|Overall Study|Study terminated by sponsor|0|||
127578165|NCT04171765|459088023|FG003|Overall Study|Study terminated by sponsor|0|||
127578166|NCT04171765|459088020|FG000|Overall Study|Withdrawal by Subject|1|||
127578167|NCT04171765|459088021|FG001|Overall Study|Withdrawal by Subject|0|||
127578168|NCT04171765|459088022|FG002|Overall Study|Withdrawal by Subject|0|||
127578169|NCT04171765|459088023|FG003|Overall Study|Withdrawal by Subject|3|||
127578170|NCT03633617|459088024|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
127578171|NCT03633617|459088025|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
127578172|NCT03633617|459088026|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
127578173|NCT03633617|459088027|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
127578174|NCT03633617|459088028|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
127578175|NCT03633617|459088029|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
127578176|NCT03633617|459088030|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
127578177|NCT03633617|459088031|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
127578178|NCT03633617|459088032|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
127578179|NCT03633617|459088033|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
127578180|NCT03633617|459088034|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
127578181|NCT03633617|459088024|FG000|Part A|Unconfirmed early termination visit|1|||
127578182|NCT03633617|459088025|FG001|Part A|Unconfirmed early termination visit|0|||
127578183|NCT03633617|459088026|FG002|Part A|Unconfirmed early termination visit|0|||
127578184|NCT03633617|459088027|FG003|Part A|Unconfirmed early termination visit|0|||
127578185|NCT03633617|459088028|FG004|Part A|Unconfirmed early termination visit|0|||
127578186|NCT03633617|459088029|FG005|Part A|Unconfirmed early termination visit|0|||
127578187|NCT03633617|459088030|FG006|Part A|Unconfirmed early termination visit|0|||
127782847|NCT02566577|459831399|FG001|Overall Study|Equipment failure|1|||
127782848|NCT02566577|459831398|FG000|Overall Study|Physical limitation|1|||
127782849|NCT02566577|459831399|FG001|Overall Study|Physical limitation|0|||
127578188|NCT03633617|459088031|FG007|Part A|Unconfirmed early termination visit|0|||
127578189|NCT03633617|459088032|FG008|Part A|Unconfirmed early termination visit|0|||
127578190|NCT03633617|459088033|FG009|Part A|Unconfirmed early termination visit|0|||
127578191|NCT03633617|459088034|FG010|Part A|Unconfirmed early termination visit|0|||
127578192|NCT03633617|459088024|FG000|Part A|Adverse Event|0|||
127578193|NCT03633617|459088025|FG001|Part A|Adverse Event|1|||
127782850|NCT00073528|459831408|FG000|Overall Study|Death|488|||
127782851|NCT00073528|459831409|FG001|Overall Study|Death|473|||
127782852|NCT00073528|459831408|FG000|Overall Study|Lost to Follow-up|52|||
127782853|NCT00073528|459831409|FG001|Overall Study|Lost to Follow-up|45|||
127578194|NCT03633617|459088026|FG002|Part A|Adverse Event|0|||
127578195|NCT03633617|459088027|FG003|Part A|Adverse Event|0|||
127578196|NCT03633617|459088028|FG004|Part A|Adverse Event|0|||
127578197|NCT03633617|459088029|FG005|Part A|Adverse Event|0|||
127578198|NCT03633617|459088030|FG006|Part A|Adverse Event|0|||
127578199|NCT03633617|459088031|FG007|Part A|Adverse Event|0|||
127578200|NCT03633617|459088032|FG008|Part A|Adverse Event|0|||
127578201|NCT03633617|459088033|FG009|Part A|Adverse Event|0|||
127578202|NCT03633617|459088034|FG010|Part A|Adverse Event|0|||
127578203|NCT03633617|459088024|FG000|Part A|Pregnancy|1|||
127578204|NCT03633617|459088025|FG001|Part A|Pregnancy|0|||
127578205|NCT03633617|459088026|FG002|Part A|Pregnancy|0|||
127578206|NCT03633617|459088027|FG003|Part A|Pregnancy|0|||
127578207|NCT03633617|459088028|FG004|Part A|Pregnancy|0|||
127578208|NCT03633617|459088029|FG005|Part A|Pregnancy|0|||
127578209|NCT03633617|459088030|FG006|Part A|Pregnancy|0|||
127578210|NCT03633617|459088031|FG007|Part A|Pregnancy|0|||
127578211|NCT03633617|459088032|FG008|Part A|Pregnancy|0|||
127578212|NCT03633617|459088033|FG009|Part A|Pregnancy|0|||
127578213|NCT03633617|459088034|FG010|Part A|Pregnancy|0|||
127578214|NCT03633617|459088024|FG000|Part A|Withdrawal by Subject|0|||
127578215|NCT03633617|459088025|FG001|Part A|Withdrawal by Subject|1|||
127578216|NCT03633617|459088026|FG002|Part A|Withdrawal by Subject|0|||
127578217|NCT03633617|459088027|FG003|Part A|Withdrawal by Subject|0|||
127578218|NCT03633617|459088028|FG004|Part A|Withdrawal by Subject|0|||
127578219|NCT03633617|459088029|FG005|Part A|Withdrawal by Subject|0|||
127578220|NCT03633617|459088030|FG006|Part A|Withdrawal by Subject|0|||
127578221|NCT03633617|459088031|FG007|Part A|Withdrawal by Subject|0|||
127578222|NCT03633617|459088032|FG008|Part A|Withdrawal by Subject|0|||
127578223|NCT03633617|459088033|FG009|Part A|Withdrawal by Subject|0|||
127578224|NCT03633617|459088034|FG010|Part A|Withdrawal by Subject|0|||
127578225|NCT03633617|459088024|FG000|Part B|Adverse Event|0|||
127578226|NCT03633617|459088025|FG001|Part B|Adverse Event|0|||
127578227|NCT03633617|459088026|FG002|Part B|Adverse Event|2|||
127578228|NCT03633617|459088027|FG003|Part B|Adverse Event|2|||
127578229|NCT03633617|459088028|FG004|Part B|Adverse Event|1|||
127578230|NCT03633617|459088029|FG005|Part B|Adverse Event|0|||
127578231|NCT03633617|459088030|FG006|Part B|Adverse Event|0|||
127578232|NCT03633617|459088031|FG007|Part B|Adverse Event|0|||
127578233|NCT03633617|459088032|FG008|Part B|Adverse Event|0|||
127578234|NCT03633617|459088033|FG009|Part B|Adverse Event|0|||
127578235|NCT03633617|459088034|FG010|Part B|Adverse Event|0|||
127578236|NCT03633617|459088024|FG000|Part B|Withdrawal by Subject|0|||
127578237|NCT03633617|459088025|FG001|Part B|Withdrawal by Subject|0|||
127578238|NCT03633617|459088026|FG002|Part B|Withdrawal by Subject|1|||
127578239|NCT03633617|459088027|FG003|Part B|Withdrawal by Subject|0|||
127578240|NCT03633617|459088028|FG004|Part B|Withdrawal by Subject|2|||
127578241|NCT03633617|459088029|FG005|Part B|Withdrawal by Subject|0|||
127578242|NCT03633617|459088030|FG006|Part B|Withdrawal by Subject|0|||
127578243|NCT03633617|459088031|FG007|Part B|Withdrawal by Subject|0|||
127578244|NCT03633617|459088032|FG008|Part B|Withdrawal by Subject|0|||
127578245|NCT03633617|459088033|FG009|Part B|Withdrawal by Subject|0|||
127578246|NCT03633617|459088034|FG010|Part B|Withdrawal by Subject|0|||
127782854|NCT00073528|459831408|FG000|Overall Study|Withdrawal by Subject|50|||
127782855|NCT00073528|459831409|FG001|Overall Study|Withdrawal by Subject|45|||
127782856|NCT00073528|459831408|FG000|Overall Study|Study terminated by Sponsor|10|||
127782857|NCT00073528|459831409|FG001|Overall Study|Study terminated by Sponsor|29|||
127782858|NCT00073528|459831408|FG000|Overall Study|Other|18|||
127782859|NCT00073528|459831409|FG001|Overall Study|Other|19|||
127782860|NCT00073528|459831408|FG000|Overall Study|Other|9|||
127782861|NCT00073528|459831409|FG001|Overall Study|Other|12|||
128029899|NCT03382873|460735156|FG001|Overall Study|Visit not completed due to pandemic|41|||
127578247|NCT03633617|459088024|FG000|Part B|Lost to Follow-up|0|||
127782862|NCT00073528|459831408|FG000|Overall Study|Protocol Violation|3|||
128029900|NCT03996395|460735159|FG000|Overall Study|Lost to Follow-up|4|||
128029901|NCT03996395|460735159|FG000|Overall Study|Withdrawal by Subject|1|||
127578248|NCT03633617|459088025|FG001|Part B|Lost to Follow-up|0|||
127578249|NCT03633617|459088026|FG002|Part B|Lost to Follow-up|0|||
127578250|NCT03633617|459088027|FG003|Part B|Lost to Follow-up|0|||
127578251|NCT03633617|459088028|FG004|Part B|Lost to Follow-up|1|||
127578252|NCT03633617|459088029|FG005|Part B|Lost to Follow-up|0|||
127578253|NCT03633617|459088030|FG006|Part B|Lost to Follow-up|0|||
127578254|NCT03633617|459088031|FG007|Part B|Lost to Follow-up|0|||
127578255|NCT03633617|459088032|FG008|Part B|Lost to Follow-up|0|||
127578256|NCT03633617|459088033|FG009|Part B|Lost to Follow-up|0|||
127578257|NCT03633617|459088034|FG010|Part B|Lost to Follow-up|0|||
127578258|NCT03633617|459088024|FG000|Part B|Physician Decision|0|||
127578259|NCT03633617|459088025|FG001|Part B|Physician Decision|0|||
127578260|NCT03633617|459088026|FG002|Part B|Physician Decision|0|||
127578261|NCT03633617|459088027|FG003|Part B|Physician Decision|0|||
127578262|NCT03633617|459088028|FG004|Part B|Physician Decision|1|||
127578263|NCT03633617|459088029|FG005|Part B|Physician Decision|0|||
127578264|NCT03633617|459088030|FG006|Part B|Physician Decision|0|||
127578265|NCT03633617|459088031|FG007|Part B|Physician Decision|0|||
127782863|NCT00073528|459831409|FG001|Overall Study|Protocol Violation|5|||
127782864|NCT03086057|459831410|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
127578266|NCT03633617|459088032|FG008|Part B|Physician Decision|0|||
127578267|NCT03633617|459088033|FG009|Part B|Physician Decision|0|||
127578268|NCT03633617|459088034|FG010|Part B|Physician Decision|0|||
127578269|NCT03633617|459088024|FG000|Part B|COVID-19 Restrictions|0|||
127578270|NCT03633617|459088025|FG001|Part B|COVID-19 Restrictions|0|||
127578271|NCT03633617|459088026|FG002|Part B|COVID-19 Restrictions|1|||
127578272|NCT03633617|459088027|FG003|Part B|COVID-19 Restrictions|0|||
127578273|NCT03633617|459088028|FG004|Part B|COVID-19 Restrictions|0|||
127578274|NCT03633617|459088029|FG005|Part B|COVID-19 Restrictions|0|||
127578275|NCT03633617|459088030|FG006|Part B|COVID-19 Restrictions|0|||
127578276|NCT03633617|459088031|FG007|Part B|COVID-19 Restrictions|0|||
127578277|NCT03633617|459088032|FG008|Part B|COVID-19 Restrictions|0|||
127578278|NCT03633617|459088033|FG009|Part B|COVID-19 Restrictions|0|||
127578279|NCT03633617|459088034|FG010|Part B|COVID-19 Restrictions|0|||
127578280|NCT03633617|459088024|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
127578281|NCT03633617|459088025|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
127578282|NCT03633617|459088026|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
127578283|NCT03633617|459088027|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
127578284|NCT03633617|459088028|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
127578285|NCT03633617|459088029|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
127578286|NCT03633617|459088030|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
127578287|NCT03633617|459088031|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
127578288|NCT03633617|459088032|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
127578289|NCT03633617|459088033|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
127578290|NCT03633617|459088034|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
127578291|NCT03633617|459088024|FG000|Part C (& Follow-up)|Adverse Event|0|||
127578292|NCT03633617|459088025|FG001|Part C (& Follow-up)|Adverse Event|0|||
127578293|NCT03633617|459088026|FG002|Part C (& Follow-up)|Adverse Event|0|||
127578294|NCT03633617|459088027|FG003|Part C (& Follow-up)|Adverse Event|0|||
127578295|NCT03633617|459088028|FG004|Part C (& Follow-up)|Adverse Event|0|||
127578296|NCT03633617|459088029|FG005|Part C (& Follow-up)|Adverse Event|1|||
127578297|NCT03633617|459088030|FG006|Part C (& Follow-up)|Adverse Event|0|||
127578298|NCT03633617|459088031|FG007|Part C (& Follow-up)|Adverse Event|1|||
127578299|NCT03633617|459088032|FG008|Part C (& Follow-up)|Adverse Event|0|||
127578300|NCT03633617|459088033|FG009|Part C (& Follow-up)|Adverse Event|0|||
127578301|NCT03633617|459088034|FG010|Part C (& Follow-up)|Adverse Event|0|||
127578302|NCT03633617|459088024|FG000|Part C (& Follow-up)|Pregnancy|0|||
127578303|NCT03633617|459088025|FG001|Part C (& Follow-up)|Pregnancy|0|||
127578304|NCT03633617|459088026|FG002|Part C (& Follow-up)|Pregnancy|0|||
127578305|NCT03633617|459088027|FG003|Part C (& Follow-up)|Pregnancy|0|||
127578306|NCT03633617|459088028|FG004|Part C (& Follow-up)|Pregnancy|0|||
127578307|NCT03633617|459088029|FG005|Part C (& Follow-up)|Pregnancy|0|||
127578308|NCT03633617|459088030|FG006|Part C (& Follow-up)|Pregnancy|0|||
127578309|NCT03633617|459088031|FG007|Part C (& Follow-up)|Pregnancy|0|||
127578310|NCT03633617|459088032|FG008|Part C (& Follow-up)|Pregnancy|0|||
127578311|NCT03633617|459088033|FG009|Part C (& Follow-up)|Pregnancy|1|||
127578312|NCT03633617|459088034|FG010|Part C (& Follow-up)|Pregnancy|0|||
127578313|NCT03633617|459088024|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
127578314|NCT03633617|459088025|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
127693531|NCT03988634|459505821|FG000|Double-Blind|Lost to Follow-up|6|||
127693532|NCT03988634|459505822|FG001|Double-Blind|Lost to Follow-up|7|||
127693533|NCT03988634|459505823|FG002|Double-Blind|Lost to Follow-up|0|||
127693534|NCT03988634|459505821|FG000|Double-Blind|Physician Decision|9|||
127693535|NCT03988634|459505822|FG001|Double-Blind|Physician Decision|5|||
127693536|NCT03988634|459505823|FG002|Double-Blind|Physician Decision|0|||
127693537|NCT03988634|459505821|FG000|Double-Blind|Subject decision|24|||
127693538|NCT03988634|459505822|FG001|Double-Blind|Subject decision|13|||
127693539|NCT03988634|459505823|FG002|Double-Blind|Subject decision|0|||
127693540|NCT03988634|459505821|FG000|Open-Label|Adverse Event|0|||
127693541|NCT03988634|459505822|FG001|Open-Label|Adverse Event|0|||
127693542|NCT03988634|459505823|FG002|Open-Label|Adverse Event|7|||
127693543|NCT03988634|459505821|FG000|Open-Label|Physician Decision|0|||
127693544|NCT03988634|459505822|FG001|Open-Label|Physician Decision|0|||
127693545|NCT03988634|459505823|FG002|Open-Label|Physician Decision|1|||
127578315|NCT03633617|459088026|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
127578316|NCT03633617|459088027|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
127578317|NCT03633617|459088028|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
127578318|NCT03633617|459088029|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
127578319|NCT03633617|459088030|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
127578320|NCT03633617|459088031|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
127693546|NCT03988634|459505821|FG000|Open-Label|Technical problems|0|||
127693547|NCT03988634|459505822|FG001|Open-Label|Technical problems|0|||
127693548|NCT03988634|459505823|FG002|Open-Label|Technical problems|1|||
128029902|NCT03996395|460735159|FG000|Overall Study|Study halted due to COVID-19 pandemic.|7|||
128029903|NCT03247673|460735162|FG000|Overall Study|Withdrawal by Subject|1|||
128029904|NCT03247673|460735163|FG001|Overall Study|Withdrawal by Subject|0|||
128029905|NCT03247673|460735164|FG002|Overall Study|Withdrawal by Subject|3|||
128029906|NCT03247673|460735162|FG000|Overall Study|Lost to Follow-up|0|||
127578321|NCT03633617|459088032|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
127578322|NCT03633617|459088033|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
127578323|NCT03633617|459088034|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
127578324|NCT03633617|459088024|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
127578325|NCT03633617|459088025|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
127578326|NCT03633617|459088026|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
127578327|NCT03633617|459088027|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
127578328|NCT03633617|459088028|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
127578329|NCT03633617|459088029|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
127578330|NCT03633617|459088030|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
127578331|NCT03633617|459088031|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
127578332|NCT03633617|459088032|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
127578333|NCT03633617|459088033|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
127578334|NCT03633617|459088034|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
127578335|NCT03633617|459088024|FG000|Part C (& Follow-up)|Physician Decision|0|||
127578336|NCT03633617|459088025|FG001|Part C (& Follow-up)|Physician Decision|0|||
127578337|NCT03633617|459088026|FG002|Part C (& Follow-up)|Physician Decision|0|||
127578338|NCT03633617|459088027|FG003|Part C (& Follow-up)|Physician Decision|0|||
127578339|NCT03633617|459088028|FG004|Part C (& Follow-up)|Physician Decision|0|||
127578340|NCT03633617|459088029|FG005|Part C (& Follow-up)|Physician Decision|0|||
127578341|NCT03633617|459088030|FG006|Part C (& Follow-up)|Physician Decision|0|||
127578342|NCT03633617|459088031|FG007|Part C (& Follow-up)|Physician Decision|1|||
127578343|NCT03633617|459088032|FG008|Part C (& Follow-up)|Physician Decision|0|||
127578344|NCT03633617|459088033|FG009|Part C (& Follow-up)|Physician Decision|0|||
127782865|NCT03086057|459831411|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
127782866|NCT03086057|459831412|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
127782867|NCT03086057|459831413|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
127782868|NCT03086057|459831410|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
127782869|NCT03086057|459831411|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
127782870|NCT03086057|459831412|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
127782871|NCT03086057|459831413|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
127782872|NCT03086057|459831410|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
127782873|NCT03086057|459831411|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
127782874|NCT03086057|459831412|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
127782875|NCT03086057|459831413|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
127782876|NCT03086057|459831410|FG000|Stage 1: PrEP Uptake|Death|1|||
127782877|NCT03086057|459831411|FG001|Stage 1: PrEP Uptake|Death|0|||
127782878|NCT03086057|459831412|FG002|Stage 1: PrEP Uptake|Death|0|||
127782879|NCT03086057|459831413|FG003|Stage 1: PrEP Uptake|Death|0|||
127782880|NCT03086057|459831410|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
127782881|NCT03086057|459831411|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
127782882|NCT03086057|459831412|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
127782883|NCT03086057|459831413|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
127782884|NCT03086057|459831410|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
127782885|NCT03086057|459831411|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
127782886|NCT03086057|459831412|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
127782887|NCT03086057|459831413|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
127782888|NCT03086057|459831410|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
127782889|NCT03086057|459831411|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
127782890|NCT03086057|459831412|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
127782891|NCT03086057|459831413|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
127782892|NCT04305275|459831416|FG000|Overall Study|Adverse Event|4|||
127782893|NCT04305275|459831417|FG001|Overall Study|Adverse Event|0|||
127782894|NCT04305275|459831416|FG000|Overall Study|Lost to Follow-up|1|||
127578345|NCT03633617|459088034|FG010|Part C (& Follow-up)|Physician Decision|1|||
127782895|NCT04305275|459831417|FG001|Overall Study|Lost to Follow-up|1|||
127782896|NCT04305275|459831416|FG000|Overall Study|Withdrawal by Participant|8|||
128029907|NCT03247673|460735163|FG001|Overall Study|Lost to Follow-up|0|||
128029908|NCT03247673|460735164|FG002|Overall Study|Lost to Follow-up|1|||
128029909|NCT02097225|460735165|FG000|Dose Level 4|Adverse Event|0|||
127578346|NCT03633617|459088024|FG000|Part C (& Follow-up)|COVID-19 related|0|||
127578347|NCT03633617|459088025|FG001|Part C (& Follow-up)|COVID-19 related|0|||
127578348|NCT03633617|459088026|FG002|Part C (& Follow-up)|COVID-19 related|0|||
127578349|NCT03633617|459088027|FG003|Part C (& Follow-up)|COVID-19 related|0|||
127578350|NCT03633617|459088028|FG004|Part C (& Follow-up)|COVID-19 related|0|||
127578351|NCT03633617|459088029|FG005|Part C (& Follow-up)|COVID-19 related|1|||
127782897|NCT04305275|459831417|FG001|Overall Study|Withdrawal by Participant|1|||
127782898|NCT01708291|459831428|FG000|Overall Study|fighting|2|||
127782899|NCT01708291|459831429|FG001|Overall Study|fighting|1|||
127782900|NCT01536951|459831430|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
127578352|NCT03633617|459088030|FG006|Part C (& Follow-up)|COVID-19 related|0|||
127578353|NCT03633617|459088031|FG007|Part C (& Follow-up)|COVID-19 related|0|||
127578354|NCT03633617|459088032|FG008|Part C (& Follow-up)|COVID-19 related|0|||
127578355|NCT03633617|459088033|FG009|Part C (& Follow-up)|COVID-19 related|0|||
127578356|NCT03633617|459088034|FG010|Part C (& Follow-up)|COVID-19 related|0|||
127578357|NCT03633617|459088024|FG000|Part C (& Follow-up)|Protocol Violation|0|||
127578358|NCT03633617|459088025|FG001|Part C (& Follow-up)|Protocol Violation|0|||
127578359|NCT03633617|459088026|FG002|Part C (& Follow-up)|Protocol Violation|0|||
127578360|NCT03633617|459088027|FG003|Part C (& Follow-up)|Protocol Violation|0|||
127881373|NCT02181842|460187394|FG000|Overall Study|Case Report Forms Uncollected|2|||
127881374|NCT01652872|460187395|FG000|Overall Study|Death|36|||
128029910|NCT02097225|460735166|FG001|Dose Level 4|Adverse Event|0|||
128029911|NCT02097225|460735167|FG002|Dose Level 4|Adverse Event|0|||
128029912|NCT02097225|460735168|FG003|Dose Level 4|Adverse Event|0|||
128029913|NCT02097225|460735169|FG004|Dose Level 4|Adverse Event|1|||
128029914|NCT02757963|460735171|FG000|Overall Study|Adverse Event|3|||
128029915|NCT02757963|460735171|FG000|Overall Study|Reached Stopping Criteria|1054|||
128029916|NCT02757963|460735171|FG000|Overall Study|Lost to Follow-up|5|||
128029917|NCT02757963|460735171|FG000|Overall Study|Physician Decision|1|||
128029918|NCT02757963|460735171|FG000|Overall Study|Withdrawal by Subject|34|||
128029919|NCT02971137|460735172|FG000|Overall Study|Lost to Follow-up|44|||
128029920|NCT02971137|460735173|FG001|Overall Study|Lost to Follow-up|56|||
128029921|NCT00911157|460735174|FG000|Overall Study|Adverse Event|4|||
128029922|NCT00911157|460735175|FG001|Overall Study|Adverse Event|1|||
128029923|NCT00911157|460735174|FG000|Overall Study|Withdrawal by Subject|1|||
128029924|NCT00911157|460735175|FG001|Overall Study|Withdrawal by Subject|1|||
128029925|NCT00911157|460735174|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
128029926|NCT00911157|460735175|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
128029927|NCT00911157|460735174|FG000|Overall Study|Need to treat for lung cancer|1|||
128029928|NCT00911157|460735175|FG001|Overall Study|Need to treat for lung cancer|0|||
128029929|NCT04650893|460735176|FG000|Overall Study|Lost to Follow-up|11|||
128029930|NCT04650893|460735177|FG001|Overall Study|Lost to Follow-up|10|||
128029931|NCT04650893|460735178|FG002|Overall Study|Lost to Follow-up|11|||
128029932|NCT05346640|460735184|FG000|Overall Study|Lack of Efficacy|2|||
128029933|NCT05346640|460735184|FG000|Overall Study|Lost to Follow-up|14|||
128029934|NCT05346640|460735184|FG000|Overall Study|Protocol Violation|4|||
128029935|NCT05346640|460735184|FG000|Overall Study|Withdrawal by Subject|2|||
128029936|NCT05346640|460735184|FG000|Overall Study|Physiological Complications|3|||
128029937|NCT05346640|460735184|FG000|Overall Study|Other Reason|3|||
128029938|NCT01251965|460737074|FG000|Overall Study|Participant/physician decision|1|||
128029939|NCT01251965|460737075|FG001|Overall Study|Participant/physician decision|2|||
128029940|NCT01251965|460737076|FG002|Overall Study|Participant/physician decision|0|||
128029941|NCT01251965|460737074|FG000|Overall Study|Death|0|||
128029942|NCT01251965|460737075|FG001|Overall Study|Death|0|||
128029943|NCT01251965|460737076|FG002|Overall Study|Death|11|||
128029944|NCT04616196|460737077|FG000|Overall Study|Progressive Disease|3|||
128029945|NCT04616196|460737078|FG001|Overall Study|Progressive Disease|0|||
128029946|NCT04616196|460737079|FG002|Overall Study|Progressive Disease|4|||
128029947|NCT04616196|460737080|FG003|Overall Study|Progressive Disease|1|||
128029948|NCT04616196|460737077|FG000|Overall Study|Death|2|||
128029949|NCT04616196|460737078|FG001|Overall Study|Death|4|||
128029950|NCT04616196|460737079|FG002|Overall Study|Death|1|||
128029951|NCT04616196|460737080|FG003|Overall Study|Death|0|||
128029952|NCT04616196|460737077|FG000|Overall Study|Withdrawal by Subject|0|||
128029953|NCT04616196|460737078|FG001|Overall Study|Withdrawal by Subject|2|||
128029954|NCT04616196|460737079|FG002|Overall Study|Withdrawal by Subject|0|||
128029955|NCT04616196|460737080|FG003|Overall Study|Withdrawal by Subject|0|||
128029956|NCT04616196|460737077|FG000|Overall Study|Lost to Follow-up|1|||
128029957|NCT04616196|460737078|FG001|Overall Study|Lost to Follow-up|0|||
128029958|NCT04616196|460737079|FG002|Overall Study|Lost to Follow-up|0|||
128029959|NCT04616196|460737080|FG003|Overall Study|Lost to Follow-up|0|||
128029960|NCT04616196|460737077|FG000|Overall Study|Sponsor request|2|||
128029961|NCT04616196|460737078|FG001|Overall Study|Sponsor request|1|||
128029962|NCT04616196|460737079|FG002|Overall Study|Sponsor request|1|||
128029963|NCT04616196|460737080|FG003|Overall Study|Sponsor request|2|||
128029964|NCT02410200|460737081|FG000|Overall Study|Adverse Event|2|||
128029965|NCT02801578|460737082|FG000|Overall Study|Adverse Event|2|||
128029966|NCT00668642|460737083|FG000|First Off-cycle|Cancer progression|1|||
128029967|NCT00668642|460737084|FG001|First Off-cycle|Cancer progression|0|||
128029968|NCT00668642|460737083|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
128029969|NCT00668642|460737084|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
128029970|NCT03682367|460737087|FG000|Overall Study|Protocol Violation|2|||
128029971|NCT03682367|460737088|FG001|Overall Study|Protocol Violation|1|||
128029972|NCT03682367|460737087|FG000|Overall Study|Closed Study Early|0|||
128029973|NCT03682367|460737088|FG001|Overall Study|Closed Study Early|3|||
128029974|NCT00770679|460737089|FG000|Overall Study|Lost to Follow-up|3|||
128029975|NCT00770679|460737089|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
128029976|NCT00129974|460737090|FG000|Overall Study|Other|1|||
127578361|NCT03633617|459088028|FG004|Part C (& Follow-up)|Protocol Violation|0|||
127578362|NCT03633617|459088029|FG005|Part C (& Follow-up)|Protocol Violation|0|||
127578363|NCT03633617|459088030|FG006|Part C (& Follow-up)|Protocol Violation|0|||
127578364|NCT03633617|459088031|FG007|Part C (& Follow-up)|Protocol Violation|0|||
127578365|NCT03633617|459088032|FG008|Part C (& Follow-up)|Protocol Violation|0|||
127578366|NCT03633617|459088033|FG009|Part C (& Follow-up)|Protocol Violation|3|||
127578367|NCT03633617|459088034|FG010|Part C (& Follow-up)|Protocol Violation|1|||
127578368|NCT03633617|459088024|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
127578369|NCT03633617|459088025|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
127578370|NCT03633617|459088026|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
127578371|NCT03633617|459088027|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
127578372|NCT03633617|459088028|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
127578373|NCT03633617|459088029|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
127578374|NCT03633617|459088030|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
127578375|NCT03633617|459088031|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
127578376|NCT03633617|459088032|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
127578377|NCT03633617|459088033|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
127578378|NCT03633617|459088034|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
127578379|NCT01050543|459088039|FG000|Overall Study|Withdrawal by Subject|0|||
127578380|NCT01050543|459088040|FG001|Overall Study|Withdrawal by Subject|2|||
127578381|NCT01050543|459088039|FG000|Overall Study|Protocol Violation|0|||
127578382|NCT01050543|459088040|FG001|Overall Study|Protocol Violation|1|||
127578383|NCT01050543|459088039|FG000|Overall Study|Administrative|4|||
127578384|NCT01050543|459088040|FG001|Overall Study|Administrative|1|||
127578385|NCT00570765|459088041|FG000|DB Phase|Withdrawal by Subject|1|||
127578386|NCT00570765|459088042|FG001|DB Phase|Withdrawal by Subject|0|||
127578387|NCT00570765|459088043|FG002|DB Phase|Withdrawal by Subject|0|||
127578388|NCT00570765|459088044|FG003|DB Phase|Withdrawal by Subject|0|||
127578389|NCT00570765|459088041|FG000|DB Phase|Protocol Violation|0|||
127578390|NCT00570765|459088042|FG001|DB Phase|Protocol Violation|1|||
127578391|NCT00570765|459088043|FG002|DB Phase|Protocol Violation|0|||
127578392|NCT00570765|459088044|FG003|DB Phase|Protocol Violation|0|||
127578393|NCT00570765|459088041|FG000|DB Phase|Adverse Event|3|||
127578394|NCT00570765|459088042|FG001|DB Phase|Adverse Event|6|||
127578395|NCT00570765|459088043|FG002|DB Phase|Adverse Event|0|||
127578396|NCT00570765|459088044|FG003|DB Phase|Adverse Event|0|||
127578397|NCT00570765|459088041|FG000|DB Phase|Did Not Receive Study Drug|0|||
127578398|NCT00570765|459088042|FG001|DB Phase|Did Not Receive Study Drug|0|||
127578399|NCT00570765|459088043|FG002|DB Phase|Did Not Receive Study Drug|1|||
127578400|NCT00570765|459088044|FG003|DB Phase|Did Not Receive Study Drug|0|||
127578401|NCT00570765|459088041|FG000|LTSE Phase|Withdrawal by Subject|0|||
127578402|NCT00570765|459088042|FG001|LTSE Phase|Withdrawal by Subject|0|||
127578403|NCT00570765|459088043|FG002|LTSE Phase|Withdrawal by Subject|0|||
127578404|NCT00570765|459088044|FG003|LTSE Phase|Withdrawal by Subject|1|||
127578405|NCT00570765|459088041|FG000|LTSE Phase|Adverse Event|0|||
127578406|NCT00570765|459088042|FG001|LTSE Phase|Adverse Event|0|||
127578407|NCT00570765|459088043|FG002|LTSE Phase|Adverse Event|0|||
127578408|NCT00570765|459088044|FG003|LTSE Phase|Adverse Event|7|||
127578409|NCT00570765|459088041|FG000|LTSE Phase|Physician Decision|0|||
127578410|NCT00570765|459088042|FG001|LTSE Phase|Physician Decision|0|||
127578411|NCT00570765|459088043|FG002|LTSE Phase|Physician Decision|0|||
127578412|NCT00570765|459088044|FG003|LTSE Phase|Physician Decision|4|||
127578413|NCT03711266|459088045|FG000|Overall Study|Lost to Follow-up|10|||
127578414|NCT01646073|459088046|FG000|Period A (12 Weeks)|Adverse Event|0|||
127578415|NCT01646073|459088047|FG001|Period A (12 Weeks)|Adverse Event|2|||
127578416|NCT01646073|459088046|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
127578417|NCT01646073|459088047|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
127578418|NCT01646073|459088046|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
127578419|NCT01646073|459088047|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
127578420|NCT01646073|459088046|FG000|Period A (12 Weeks)|Protocol Violation|0|||
127578421|NCT01646073|459088047|FG001|Period A (12 Weeks)|Protocol Violation|1|||
127578422|NCT01646073|459088046|FG000|Period A (12 Weeks)|Other|0|||
127578423|NCT01646073|459088047|FG001|Period A (12 Weeks)|Other|1|||
127578424|NCT01646073|459088046|FG000|Period B (12 Weeks)|Adverse Event|0|||
127578425|NCT01646073|459088047|FG001|Period B (12 Weeks)|Adverse Event|7|||
127578426|NCT01646073|459088046|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
127578427|NCT01646073|459088047|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
127578428|NCT01646073|459088046|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
127578429|NCT01646073|459088047|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
127578430|NCT00875979|459088049|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
127578431|NCT00875979|459088050|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
127693549|NCT04725240|459505824|FG000|Overall Study|Adverse Event|2|||
127693550|NCT02249949|459505825|FG000|Overall Study|Cancelled prior to treatment|2|||
127578432|NCT00875979|459088049|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
127578433|NCT00875979|459088050|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
127578434|NCT00875979|459088049|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
127578435|NCT00875979|459088050|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
127578436|NCT00875979|459088049|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
127578437|NCT00875979|459088050|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
127578438|NCT00875979|459088049|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
127578439|NCT00875979|459088050|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
127578440|NCT00875979|459088049|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
127578441|NCT00875979|459088050|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
127578442|NCT00875979|459088049|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
127578443|NCT00875979|459088050|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
127578444|NCT00875979|459088049|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
127578445|NCT00875979|459088050|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
127578446|NCT00875979|459088049|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
127578447|NCT00875979|459088050|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
127578448|NCT02456103|459088053|FG000|Overall Study|Study Closure|207|||
127578449|NCT02456103|459088053|FG000|Overall Study|Physician Decision|1|||
127578450|NCT02456103|459088053|FG000|Overall Study|Required prohibited medications|5|||
127578451|NCT02456103|459088053|FG000|Overall Study|Protocol Violation|1|||
127578452|NCT02456103|459088053|FG000|Overall Study|Adverse Event|5|||
127578453|NCT02456103|459088053|FG000|Overall Study|Abnormal Laboratory Value|2|||
127578454|NCT02456103|459088053|FG000|Overall Study|Lost to Follow-up|1|||
127578455|NCT02456103|459088053|FG000|Overall Study|Withdrawal by Subject|24|||
127578456|NCT02083081|459088054|FG000|Overall Study|Lost to Follow-up|31|||
127578457|NCT02083081|459088055|FG001|Overall Study|Lost to Follow-up|9|||
127578458|NCT02028871|459088058|FG000|Overall Study|Positive urine drug screen|1|||
127578459|NCT02028871|459088059|FG001|Overall Study|Positive urine drug screen|1|||
127578460|NCT02028871|459088058|FG000|Overall Study|Withdrawal by Subject|1|||
127578461|NCT02028871|459088059|FG001|Overall Study|Withdrawal by Subject|2|||
127578462|NCT02028871|459088058|FG000|Overall Study|IV placement difficulty|1|||
127578463|NCT02028871|459088059|FG001|Overall Study|IV placement difficulty|0|||
127578464|NCT02028871|459088058|FG000|Overall Study|Current Illness|1|||
127578465|NCT02028871|459088059|FG001|Overall Study|Current Illness|0|||
127578466|NCT01691898|459088060|FG000|Overall Study|Death|34|||
127578467|NCT01691898|459088061|FG001|Overall Study|Death|32|||
127578468|NCT01691898|459088062|FG002|Overall Study|Death|6|||
127578469|NCT01691898|459088063|FG003|Overall Study|Death|3|||
127578470|NCT01691898|459088064|FG004|Overall Study|Death|8|||
127578471|NCT01691898|459088065|FG005|Overall Study|Death|31|||
127578472|NCT01691898|459088060|FG000|Overall Study|Adverse Event|0|||
127578473|NCT01691898|459088061|FG001|Overall Study|Adverse Event|1|||
127578474|NCT01691898|459088062|FG002|Overall Study|Adverse Event|0|||
127578475|NCT01691898|459088063|FG003|Overall Study|Adverse Event|1|||
127578476|NCT01691898|459088064|FG004|Overall Study|Adverse Event|1|||
127578477|NCT01691898|459088065|FG005|Overall Study|Adverse Event|0|||
127578478|NCT01691898|459088060|FG000|Overall Study|Progression of Disease|1|||
127578479|NCT01691898|459088061|FG001|Overall Study|Progression of Disease|2|||
127578480|NCT01691898|459088062|FG002|Overall Study|Progression of Disease|1|||
127578481|NCT01691898|459088063|FG003|Overall Study|Progression of Disease|0|||
127578482|NCT01691898|459088064|FG004|Overall Study|Progression of Disease|0|||
127578483|NCT01691898|459088065|FG005|Overall Study|Progression of Disease|1|||
127578484|NCT01691898|459088060|FG000|Overall Study|Lost to Follow-up|3|||
127578485|NCT01691898|459088061|FG001|Overall Study|Lost to Follow-up|1|||
127578486|NCT01691898|459088062|FG002|Overall Study|Lost to Follow-up|0|||
127578487|NCT01691898|459088063|FG003|Overall Study|Lost to Follow-up|0|||
127578488|NCT01691898|459088064|FG004|Overall Study|Lost to Follow-up|1|||
127578489|NCT01691898|459088065|FG005|Overall Study|Lost to Follow-up|0|||
127578490|NCT01691898|459088060|FG000|Overall Study|Withdrawal by Subject|9|||
127578491|NCT01691898|459088061|FG001|Overall Study|Withdrawal by Subject|8|||
127578492|NCT01691898|459088062|FG002|Overall Study|Withdrawal by Subject|2|||
127578493|NCT01691898|459088063|FG003|Overall Study|Withdrawal by Subject|1|||
127782901|NCT01536951|459831431|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
127578494|NCT01691898|459088064|FG004|Overall Study|Withdrawal by Subject|3|||
127578495|NCT01691898|459088065|FG005|Overall Study|Withdrawal by Subject|3|||
127578496|NCT01691898|459088060|FG000|Overall Study|Non-Compliance|0|||
127578497|NCT01691898|459088061|FG001|Overall Study|Non-Compliance|0|||
128029977|NCT00414609|460737091|FG000|Core Study|Adverse Event|9|||
128029978|NCT00414609|460737092|FG001|Core Study|Adverse Event|11|||
128029979|NCT00414609|460737093|FG002|Core Study|Adverse Event|0|||
128029980|NCT00414609|460737091|FG000|Core Study|Abnormal laboratory values|0|||
128029981|NCT00414609|460737092|FG001|Core Study|Abnormal laboratory values|1|||
127578498|NCT01691898|459088062|FG002|Overall Study|Non-Compliance|0|||
127578499|NCT01691898|459088063|FG003|Overall Study|Non-Compliance|0|||
127578500|NCT01691898|459088064|FG004|Overall Study|Non-Compliance|1|||
127578501|NCT01691898|459088065|FG005|Overall Study|Non-Compliance|0|||
127578502|NCT01104155|459088067|FG000|Overall Study|Adverse Event|15|||
127782902|NCT01536951|459831432|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
128029982|NCT00414609|460737093|FG002|Core Study|Abnormal laboratory values|0|||
127578503|NCT01104155|459088068|FG001|Overall Study|Adverse Event|8|||
127578504|NCT01104155|459088067|FG000|Overall Study|Participant choice|6|||
127578505|NCT01104155|459088068|FG001|Overall Study|Participant choice|5|||
127578506|NCT01104155|459088067|FG000|Overall Study|Withdrawal of consent|1|||
127578507|NCT01104155|459088068|FG001|Overall Study|Withdrawal of consent|1|||
127578508|NCT01104155|459088067|FG000|Overall Study|Other|3|||
127578509|NCT01104155|459088068|FG001|Overall Study|Other|4|||
127578510|NCT01484132|459088074|FG000|Overall Study|Lost to Follow-up|8|||
127578511|NCT01484132|459088074|FG000|Overall Study|Difficulty with time commitment|2|||
127578512|NCT01484132|459088074|FG000|Overall Study|Ineligible|1|||
127578513|NCT01484132|459088074|FG000|Overall Study|No pre-treatment urine sample collected|1|||
127578514|NCT01484132|459088074|FG000|Overall Study|No post-treatment urine sample collected|10|||
127578515|NCT03799211|459088076|FG000|Overall Study|Lost to Follow-up|2|||
127578516|NCT03799211|459088077|FG001|Overall Study|Lost to Follow-up|13|||
127578517|NCT03799211|459088076|FG000|Overall Study|Withdrawal by Subject|2|||
127578518|NCT03799211|459088077|FG001|Overall Study|Withdrawal by Subject|0|||
127578519|NCT00764491|459088078|FG000|Overall Study|Lost to Follow-up|35|||
127578520|NCT00764491|459088079|FG001|Overall Study|Lost to Follow-up|17|||
127578521|NCT03139279|459088084|FG000|Overall Study|Physician Decision|2|||
127578522|NCT03139279|459088085|FG001|Overall Study|Physician Decision|0|||
127578523|NCT03139279|459088084|FG000|Overall Study|Protocol Violation|5|||
127578524|NCT03139279|459088085|FG001|Overall Study|Protocol Violation|4|||
127578525|NCT03139279|459088084|FG000|Overall Study|Withdrawal by Subject|0|||
127578526|NCT03139279|459088085|FG001|Overall Study|Withdrawal by Subject|2|||
127578527|NCT01460368|459088086|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
127578528|NCT01460368|459088087|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
127578529|NCT01460368|459088088|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
127578530|NCT01460368|459088089|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
127578531|NCT01460368|459088090|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
127578532|NCT01460368|459088091|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
127578533|NCT01460368|459088092|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
127578534|NCT01460368|459088086|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
127578535|NCT01460368|459088087|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
127578536|NCT01460368|459088088|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
127578537|NCT01460368|459088089|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
127578538|NCT01460368|459088090|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
127578539|NCT01460368|459088091|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
127578540|NCT01460368|459088092|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
127578541|NCT01460368|459088086|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
128029983|NCT00414609|460737091|FG000|Core Study|Abnormal test procedure results|1|||
128029984|NCT00414609|460737092|FG001|Core Study|Abnormal test procedure results|1|||
128029985|NCT00414609|460737093|FG002|Core Study|Abnormal test procedure results|0|||
128029986|NCT00414609|460737091|FG000|Core Study|Protocol deviation|0|||
128029987|NCT00414609|460737092|FG001|Core Study|Protocol deviation|1|||
128029988|NCT00414609|460737093|FG002|Core Study|Protocol deviation|0|||
128029989|NCT00414609|460737091|FG000|Core Study|Patient withdrew consent|10|||
128029990|NCT00414609|460737092|FG001|Core Study|Patient withdrew consent|11|||
128029991|NCT00414609|460737093|FG002|Core Study|Patient withdrew consent|0|||
128029992|NCT00414609|460737091|FG000|Core Study|Lost to Follow-up|7|||
128029993|NCT00414609|460737092|FG001|Core Study|Lost to Follow-up|4|||
128029994|NCT00414609|460737093|FG002|Core Study|Lost to Follow-up|0|||
128029995|NCT00414609|460737091|FG000|Core Study|Administrative problems|0|||
128029996|NCT00414609|460737092|FG001|Core Study|Administrative problems|2|||
128029997|NCT00414609|460737093|FG002|Core Study|Administrative problems|0|||
128029998|NCT00414609|460737091|FG000|Core Study|Death|7|||
128029999|NCT00414609|460737092|FG001|Core Study|Death|14|||
128030000|NCT00414609|460737093|FG002|Core Study|Death|0|||
128030001|NCT00414609|460737091|FG000|Extension Study|Adverse Event|0|||
128030002|NCT00414609|460737092|FG001|Extension Study|Adverse Event|0|||
128030003|NCT00414609|460737093|FG002|Extension Study|Adverse Event|14|||
127578542|NCT01460368|459088087|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
127578543|NCT01460368|459088088|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
127578544|NCT01460368|459088089|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
128030004|NCT00414609|460737091|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
128030005|NCT00414609|460737092|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
128030006|NCT00414609|460737093|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
128030007|NCT00414609|460737091|FG000|Extension Study|Withdrawal by Subject|0|||
128030008|NCT00414609|460737092|FG001|Extension Study|Withdrawal by Subject|0|||
128030009|NCT00414609|460737093|FG002|Extension Study|Withdrawal by Subject|13|||
128030010|NCT00414609|460737091|FG000|Extension Study|Lost to Follow-up|0|||
128030011|NCT00414609|460737092|FG001|Extension Study|Lost to Follow-up|0|||
128030012|NCT00414609|460737093|FG002|Extension Study|Lost to Follow-up|10|||
128030013|NCT00414609|460737091|FG000|Extension Study|Administrative problems|0|||
128030014|NCT00414609|460737092|FG001|Extension Study|Administrative problems|0|||
127881375|NCT01652872|460187396|FG001|Overall Study|Death|39|||
128030015|NCT00414609|460737093|FG002|Extension Study|Administrative problems|1|||
127881376|NCT01652872|460187395|FG000|Overall Study|Lost to Follow-up|28|||
127881377|NCT01652872|460187396|FG001|Overall Study|Lost to Follow-up|23|||
128030016|NCT00414609|460737091|FG000|Extension Study|Death|0|||
128030017|NCT00414609|460737092|FG001|Extension Study|Death|0|||
128030018|NCT00414609|460737093|FG002|Extension Study|Death|17|||
128030019|NCT00814983|460737098|FG000|Overall Study|Screen failure|1|||
128030020|NCT00814983|460737099|FG001|Overall Study|Screen failure|0|||
128030021|NCT00814983|460737098|FG000|Overall Study|Withdrawal by Subject|1|||
128030022|NCT00814983|460737099|FG001|Overall Study|Withdrawal by Subject|0|||
128030023|NCT00814983|460737098|FG000|Overall Study|Graft failure|1|||
128030024|NCT00814983|460737099|FG001|Overall Study|Graft failure|0|||
128030025|NCT03627468|460737100|FG000|Overall Study|Adverse Event|5|||
128030026|NCT03627468|460737101|FG001|Overall Study|Adverse Event|33|||
128030027|NCT03627468|460737100|FG000|Overall Study|Withdrawal by Subject|13|||
128030028|NCT03627468|460737101|FG001|Overall Study|Withdrawal by Subject|23|||
128030029|NCT03627468|460737100|FG000|Overall Study|Physician Decision|1|||
128030030|NCT03627468|460737101|FG001|Overall Study|Physician Decision|0|||
128030031|NCT03627468|460737100|FG000|Overall Study|Protocol Violation|0|||
128030032|NCT03627468|460737101|FG001|Overall Study|Protocol Violation|2|||
128030033|NCT03627468|460737100|FG000|Overall Study|Lost to Follow-up|10|||
128030034|NCT03627468|460737101|FG001|Overall Study|Lost to Follow-up|16|||
128030035|NCT03627468|460737100|FG000|Overall Study|Death|1|||
128030036|NCT03627468|460737101|FG001|Overall Study|Death|0|||
128030037|NCT03627468|460737100|FG000|Overall Study|Pregnancy|1|||
128030038|NCT03627468|460737101|FG001|Overall Study|Pregnancy|1|||
128030039|NCT03627468|460737100|FG000|Overall Study|Lack of Efficacy|0|||
128030040|NCT03627468|460737101|FG001|Overall Study|Lack of Efficacy|2|||
128030041|NCT03627468|460737100|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
128030042|NCT03627468|460737101|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
128030043|NCT00160563|460737102|FG000|Overall Study|Adverse Event|1|||
128030044|NCT00160563|460737103|FG001|Overall Study|Adverse Event|1|||
128030045|NCT00160563|460737104|FG002|Overall Study|Adverse Event|1|||
128030046|NCT00160563|460737102|FG000|Overall Study|Lost to Follow-up|1|||
128030047|NCT00160563|460737103|FG001|Overall Study|Lost to Follow-up|1|||
128030048|NCT00160563|460737104|FG002|Overall Study|Lost to Follow-up|2|||
128030049|NCT00160563|460737102|FG000|Overall Study|Protocol Violation|0|||
128030050|NCT00160563|460737103|FG001|Overall Study|Protocol Violation|0|||
128030051|NCT00160563|460737104|FG002|Overall Study|Protocol Violation|3|||
127578545|NCT01460368|459088090|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
127578546|NCT01460368|459088091|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
127578547|NCT01460368|459088092|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
127578548|NCT01460368|459088086|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
127578549|NCT01460368|459088087|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
127578550|NCT01460368|459088088|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
127578551|NCT01460368|459088089|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
127578552|NCT01460368|459088090|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
127578553|NCT01460368|459088091|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
127578554|NCT01460368|459088092|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
127578555|NCT01460368|459088086|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
127578556|NCT01460368|459088087|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
127578557|NCT01460368|459088088|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
127578558|NCT01460368|459088089|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
127578559|NCT01460368|459088090|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
127578560|NCT01460368|459088091|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
127578561|NCT01460368|459088092|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
127578562|NCT01565642|459088104|FG000|Overall Study|Withdrawal by Subject|2|||
127578563|NCT01565642|459088105|FG001|Overall Study|Withdrawal by Subject|1|||
127578564|NCT01898208|459088106|FG000|Overall Study|Positive blood culture|17|||
127578565|NCT01898208|459088107|FG001|Overall Study|Positive blood culture|23|||
127578566|NCT01898208|459088108|FG002|Overall Study|Positive blood culture|15|||
127578567|NCT01898208|459088106|FG000|Overall Study|Death/comfort care within 24 hours|10|||
127578568|NCT01898208|459088107|FG001|Overall Study|Death/comfort care within 24 hours|9|||
127578569|NCT01898208|459088108|FG002|Overall Study|Death/comfort care within 24 hours|8|||
127578570|NCT01898208|459088106|FG000|Overall Study|Negative Gram Stain|6|||
127578571|NCT01898208|459088107|FG001|Overall Study|Negative Gram Stain|9|||
127578572|NCT01898208|459088108|FG002|Overall Study|Negative Gram Stain|6|||
127578573|NCT01898208|459088106|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
128030052|NCT00160563|460737102|FG000|Overall Study|Withdrawal by Subject|1|||
128030053|NCT00160563|460737103|FG001|Overall Study|Withdrawal by Subject|2|||
128030054|NCT00160563|460737104|FG002|Overall Study|Withdrawal by Subject|3|||
128030055|NCT00160563|460737102|FG000|Overall Study|Other (listed in the study report)|48|||
128030056|NCT00160563|460737103|FG001|Overall Study|Other (listed in the study report)|40|||
128030057|NCT00160563|460737104|FG002|Overall Study|Other (listed in the study report)|81|||
128030058|NCT00160563|460737102|FG000|Overall Study|Missing reason|0|||
127578574|NCT01898208|459088107|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
127578575|NCT01898208|459088108|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
128030059|NCT00160563|460737103|FG001|Overall Study|Missing reason|1|||
128030060|NCT00160563|460737104|FG002|Overall Study|Missing reason|0|||
128030061|NCT04157738|460737105|FG000|Overall Study|Moved out of state|0|||
128030062|NCT04157738|460737106|FG001|Overall Study|Moved out of state|2|||
128030063|NCT04157738|460737105|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
128030064|NCT04157738|460737106|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
127578576|NCT01898208|459088106|FG000|Overall Study|System/Technical Error|1|||
127578577|NCT01898208|459088107|FG001|Overall Study|System/Technical Error|2|||
127578578|NCT01898208|459088108|FG002|Overall Study|System/Technical Error|3|||
127578579|NCT01898208|459088106|FG000|Overall Study|Lost to Follow-up|3|||
127578580|NCT01898208|459088107|FG001|Overall Study|Lost to Follow-up|1|||
127578581|NCT01898208|459088108|FG002|Overall Study|Lost to Follow-up|1|||
127578582|NCT01631812|459088109|FG000|Overall Study|Adverse Event|25|||
127578583|NCT01631812|459088109|FG000|Overall Study|Lack of Efficacy|5|||
127578584|NCT01631812|459088109|FG000|Overall Study|Withdrawal by Subject|4|||
127578585|NCT01631812|459088109|FG000|Overall Study|Physician Decision|3|||
127578586|NCT02435069|459088110|FG000|Dose Response - First Intervention|Adverse Event|0|||
127578587|NCT02435069|459088111|FG001|Dose Response - First Intervention|Adverse Event|1|||
127578588|NCT02435069|459088112|FG002|Dose Response - First Intervention|Adverse Event|1|||
127578589|NCT02435069|459088113|FG003|Dose Response - First Intervention|Adverse Event|0|||
127578590|NCT02435069|459088114|FG004|Dose Response - First Intervention|Adverse Event|0|||
127578591|NCT02435069|459088110|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
127578592|NCT02435069|459088111|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
127578593|NCT02435069|459088112|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
127578594|NCT02435069|459088113|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
127578595|NCT02435069|459088114|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
127578596|NCT02436681|459088115|FG000|Overall Study|Lost to Follow-up|10|||
127578597|NCT02436681|459088115|FG000|Overall Study|Withdrawal by Subject|2|||
127578598|NCT02436681|459088115|FG000|Overall Study|Death|2|||
127578599|NCT02030938|459088118|FG000|Overall Study|Lost to Follow-up|4|||
127578600|NCT02030938|459088118|FG000|Overall Study|Withdrawal by Subject|1|||
127578601|NCT03954132|459088120|FG000|Overall Study|Adverse Event|2|||
127578602|NCT03954132|459088121|FG001|Overall Study|Adverse Event|0|||
127578603|NCT03954132|459088120|FG000|Overall Study|Patient's wish|5|||
127578604|NCT03954132|459088121|FG001|Overall Study|Patient's wish|0|||
127578605|NCT03954132|459088120|FG000|Overall Study|Lost to Follow-up|10|||
127578606|NCT03954132|459088121|FG001|Overall Study|Lost to Follow-up|0|||
127578607|NCT03954132|459088120|FG000|Overall Study|Screening failure|0|||
127578608|NCT03954132|459088121|FG001|Overall Study|Screening failure|1|||
127578609|NCT03954132|459088120|FG000|Overall Study|No registration after Visit 1|5|||
127578610|NCT03954132|459088121|FG001|Overall Study|No registration after Visit 1|2|||
127578611|NCT03954132|459088120|FG000|Overall Study|Other reason than listed|2|||
127578612|NCT03954132|459088121|FG001|Overall Study|Other reason than listed|2|||
127578613|NCT03954132|459088120|FG000|Overall Study|Patient could not make visit due to vertebral fracture|1|||
127578614|NCT03954132|459088121|FG001|Overall Study|Patient could not make visit due to vertebral fracture|0|||
127578615|NCT03954132|459088120|FG000|Overall Study|False inclusion, violation of exclusion criteria|1|||
127578616|NCT03954132|459088121|FG001|Overall Study|False inclusion, violation of exclusion criteria|0|||
127578617|NCT02906332|459088129|FG000|Overall Study|Withdrawal by Subject|1|||
127578618|NCT02949700|459088130|FG000|Phase I|Withdrawal by Subject|1|||
127578619|NCT02949700|459088131|FG001|Phase I|Withdrawal by Subject|1|||
127578620|NCT02949700|459088132|FG002|Phase I|Withdrawal by Subject|0|||
127578621|NCT02949700|459088133|FG003|Phase I|Withdrawal by Subject|0|||
127578622|NCT02949700|459088130|FG000|Phase I|Protocol Violation|1|||
127578623|NCT02949700|459088131|FG001|Phase I|Protocol Violation|0|||
127578624|NCT02949700|459088132|FG002|Phase I|Protocol Violation|0|||
127578625|NCT02949700|459088133|FG003|Phase I|Protocol Violation|0|||
128030065|NCT00752219|460737110|FG000|Overall Study|Clinical failure|0|||
128030066|NCT00752219|460737111|FG001|Overall Study|Clinical failure|1|||
128030067|NCT00752219|460737110|FG000|Overall Study|Adverse Event|5|||
128030068|NCT00752219|460737111|FG001|Overall Study|Adverse Event|3|||
128030069|NCT00752219|460737110|FG000|Overall Study|Protocol deviation|1|||
128030070|NCT00752219|460737111|FG001|Overall Study|Protocol deviation|0|||
128030071|NCT00752219|460737110|FG000|Overall Study|Lost to Follow-up|1|||
128030072|NCT00752219|460737111|FG001|Overall Study|Lost to Follow-up|2|||
128030073|NCT00752219|460737110|FG000|Overall Study|Randomized but not treated|1|||
127578626|NCT02949700|459088130|FG000|Phase II|Withdrawal by Subject|0|||
128030074|NCT00752219|460737111|FG001|Overall Study|Randomized but not treated|0|||
128030075|NCT00752219|460737110|FG000|Overall Study|Other|3|||
128030076|NCT00752219|460737111|FG001|Overall Study|Other|0|||
127578627|NCT02949700|459088131|FG001|Phase II|Withdrawal by Subject|0|||
127578628|NCT02949700|459088132|FG002|Phase II|Withdrawal by Subject|0|||
127578629|NCT02949700|459088133|FG003|Phase II|Withdrawal by Subject|2|||
127578630|NCT02949700|459088130|FG000|Phase II|Protocol Violation|0|||
127578631|NCT02949700|459088131|FG001|Phase II|Protocol Violation|0|||
127578632|NCT02949700|459088132|FG002|Phase II|Protocol Violation|1|||
127578633|NCT02949700|459088133|FG003|Phase II|Protocol Violation|3|||
127578634|NCT02598960|459089691|FG000|Treatment Period|Disease Progression|4|||
127578635|NCT02598960|459089692|FG001|Treatment Period|Disease Progression|4|||
127578636|NCT02598960|459089693|FG002|Treatment Period|Disease Progression|4|||
127578637|NCT02598960|459089694|FG003|Treatment Period|Disease Progression|6|||
127578638|NCT02598960|459089695|FG004|Treatment Period|Disease Progression|8|||
127578639|NCT02598960|459089696|FG005|Treatment Period|Disease Progression|2|||
127578640|NCT02598960|459089697|FG006|Treatment Period|Disease Progression|2|||
127578641|NCT02598960|459089698|FG007|Treatment Period|Disease Progression|3|||
127578642|NCT02598960|459089699|FG008|Treatment Period|Disease Progression|7|||
127578643|NCT02598960|459089700|FG009|Treatment Period|Disease Progression|9|||
127578644|NCT02598960|459089701|FG010|Treatment Period|Disease Progression|7|||
127578645|NCT02598960|459089702|FG011|Treatment Period|Disease Progression|143|||
127578646|NCT02598960|459089703|FG012|Treatment Period|Disease Progression|23|||
127578647|NCT02598960|459089691|FG000|Treatment Period|Study drug toxicity|0|||
127578648|NCT02598960|459089692|FG001|Treatment Period|Study drug toxicity|0|||
127578649|NCT02598960|459089693|FG002|Treatment Period|Study drug toxicity|0|||
127578650|NCT02598960|459089694|FG003|Treatment Period|Study drug toxicity|0|||
127578651|NCT02598960|459089695|FG004|Treatment Period|Study drug toxicity|0|||
127578652|NCT02598960|459089696|FG005|Treatment Period|Study drug toxicity|0|||
127578653|NCT02598960|459089697|FG006|Treatment Period|Study drug toxicity|0|||
127578654|NCT02598960|459089698|FG007|Treatment Period|Study drug toxicity|0|||
127578655|NCT02598960|459089699|FG008|Treatment Period|Study drug toxicity|0|||
127578656|NCT02598960|459089700|FG009|Treatment Period|Study drug toxicity|1|||
127578657|NCT02598960|459089701|FG010|Treatment Period|Study drug toxicity|0|||
127578658|NCT02598960|459089702|FG011|Treatment Period|Study drug toxicity|3|||
127578659|NCT02598960|459089703|FG012|Treatment Period|Study drug toxicity|0|||
127578660|NCT02598960|459089691|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
127578661|NCT02598960|459089692|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
127578662|NCT02598960|459089693|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
127578663|NCT02598960|459089694|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
127578664|NCT02598960|459089695|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
127578665|NCT02598960|459089696|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
127578666|NCT02598960|459089697|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
127578667|NCT02598960|459089698|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
127578668|NCT02598960|459089699|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
127578669|NCT02598960|459089700|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
127578670|NCT02598960|459089701|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
127578671|NCT02598960|459089702|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
127578672|NCT02598960|459089703|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
127578673|NCT02598960|459089691|FG000|Treatment Period|participant request to discontinue|0|||
127578674|NCT02598960|459089692|FG001|Treatment Period|participant request to discontinue|1|||
127578675|NCT02598960|459089693|FG002|Treatment Period|participant request to discontinue|0|||
127578676|NCT02598960|459089694|FG003|Treatment Period|participant request to discontinue|0|||
127578677|NCT02598960|459089695|FG004|Treatment Period|participant request to discontinue|1|||
127578678|NCT02598960|459089696|FG005|Treatment Period|participant request to discontinue|0|||
127578679|NCT02598960|459089697|FG006|Treatment Period|participant request to discontinue|0|||
127578680|NCT02598960|459089698|FG007|Treatment Period|participant request to discontinue|0|||
127578681|NCT02598960|459089699|FG008|Treatment Period|participant request to discontinue|0|||
127578682|NCT02598960|459089700|FG009|Treatment Period|participant request to discontinue|0|||
127578683|NCT02598960|459089701|FG010|Treatment Period|participant request to discontinue|1|||
127578684|NCT02598960|459089702|FG011|Treatment Period|participant request to discontinue|4|||
127578685|NCT02598960|459089703|FG012|Treatment Period|participant request to discontinue|0|||
127578686|NCT02598960|459089691|FG000|Treatment Period|participant withdrew consent|0|||
127578687|NCT02598960|459089692|FG001|Treatment Period|participant withdrew consent|0|||
127578688|NCT02598960|459089693|FG002|Treatment Period|participant withdrew consent|0|||
127578689|NCT02598960|459089694|FG003|Treatment Period|participant withdrew consent|0|||
127578690|NCT02598960|459089695|FG004|Treatment Period|participant withdrew consent|0|||
127578691|NCT02598960|459089696|FG005|Treatment Period|participant withdrew consent|0|||
128030077|NCT01047540|460737115|FG000|Overall Study|Protocol Violation|1|||
128030078|NCT01047540|460737116|FG001|Overall Study|Protocol Violation|0|||
128030079|NCT01047540|460737117|FG002|Overall Study|Protocol Violation|0|||
128030080|NCT01047540|460737118|FG003|Overall Study|Protocol Violation|0|||
128030081|NCT01047540|460737119|FG004|Overall Study|Protocol Violation|0|||
128030082|NCT01047540|460737115|FG000|Overall Study|Lost to Follow-up|1|||
128030083|NCT01047540|460737116|FG001|Overall Study|Lost to Follow-up|0|||
128030084|NCT01047540|460737117|FG002|Overall Study|Lost to Follow-up|0|||
128030085|NCT01047540|460737118|FG003|Overall Study|Lost to Follow-up|0|||
127578692|NCT02598960|459089697|FG006|Treatment Period|participant withdrew consent|0|||
127578693|NCT02598960|459089698|FG007|Treatment Period|participant withdrew consent|0|||
127578694|NCT02598960|459089699|FG008|Treatment Period|participant withdrew consent|0|||
128030086|NCT01047540|460737119|FG004|Overall Study|Lost to Follow-up|0|||
128030087|NCT01047540|460737115|FG000|Overall Study|Withdrawal by Subject|1|||
127578695|NCT02598960|459089700|FG009|Treatment Period|participant withdrew consent|0|||
127578696|NCT02598960|459089701|FG010|Treatment Period|participant withdrew consent|0|||
127578697|NCT02598960|459089702|FG011|Treatment Period|participant withdrew consent|3|||
127578698|NCT02598960|459089703|FG012|Treatment Period|participant withdrew consent|0|||
127578699|NCT02598960|459089691|FG000|Treatment Period|No longer meets study criteria|0|||
127578700|NCT02598960|459089692|FG001|Treatment Period|No longer meets study criteria|0|||
127578701|NCT02598960|459089693|FG002|Treatment Period|No longer meets study criteria|0|||
127578702|NCT02598960|459089694|FG003|Treatment Period|No longer meets study criteria|0|||
127578703|NCT02598960|459089695|FG004|Treatment Period|No longer meets study criteria|0|||
127578704|NCT02598960|459089696|FG005|Treatment Period|No longer meets study criteria|0|||
127578705|NCT02598960|459089697|FG006|Treatment Period|No longer meets study criteria|0|||
127578706|NCT02598960|459089698|FG007|Treatment Period|No longer meets study criteria|0|||
127578707|NCT02598960|459089699|FG008|Treatment Period|No longer meets study criteria|0|||
127578708|NCT02598960|459089700|FG009|Treatment Period|No longer meets study criteria|0|||
127578709|NCT02598960|459089701|FG010|Treatment Period|No longer meets study criteria|0|||
127578710|NCT02598960|459089702|FG011|Treatment Period|No longer meets study criteria|1|||
127578711|NCT02598960|459089703|FG012|Treatment Period|No longer meets study criteria|0|||
127578712|NCT02598960|459089691|FG000|Treatment Period|Other Reasons|0|||
127578713|NCT02598960|459089692|FG001|Treatment Period|Other Reasons|0|||
127578714|NCT02598960|459089693|FG002|Treatment Period|Other Reasons|0|||
127578715|NCT02598960|459089694|FG003|Treatment Period|Other Reasons|0|||
127578716|NCT02598960|459089695|FG004|Treatment Period|Other Reasons|0|||
127578717|NCT02598960|459089696|FG005|Treatment Period|Other Reasons|0|||
127578718|NCT02598960|459089697|FG006|Treatment Period|Other Reasons|0|||
127578719|NCT02598960|459089698|FG007|Treatment Period|Other Reasons|0|||
127578720|NCT02598960|459089699|FG008|Treatment Period|Other Reasons|0|||
127578721|NCT02598960|459089700|FG009|Treatment Period|Other Reasons|0|||
127578722|NCT02598960|459089701|FG010|Treatment Period|Other Reasons|0|||
127578723|NCT02598960|459089702|FG011|Treatment Period|Other Reasons|0|||
127578724|NCT02598960|459089703|FG012|Treatment Period|Other Reasons|1|||
127578725|NCT02598960|459089691|FG000|Participants Entering Follow Up Period|Death|1|||
127578726|NCT02598960|459089692|FG001|Participants Entering Follow Up Period|Death|0|||
127578727|NCT02598960|459089693|FG002|Participants Entering Follow Up Period|Death|0|||
127578728|NCT02598960|459089694|FG003|Participants Entering Follow Up Period|Death|0|||
127578729|NCT02598960|459089695|FG004|Participants Entering Follow Up Period|Death|0|||
127578730|NCT02598960|459089696|FG005|Participants Entering Follow Up Period|Death|0|||
127578731|NCT02598960|459089697|FG006|Participants Entering Follow Up Period|Death|0|||
127578732|NCT02598960|459089698|FG007|Participants Entering Follow Up Period|Death|0|||
127578733|NCT02598960|459089699|FG008|Participants Entering Follow Up Period|Death|0|||
127578734|NCT02598960|459089700|FG009|Participants Entering Follow Up Period|Death|1|||
127578735|NCT02598960|459089701|FG010|Participants Entering Follow Up Period|Death|0|||
127578736|NCT02598960|459089702|FG011|Participants Entering Follow Up Period|Death|11|||
127578737|NCT02598960|459089703|FG012|Participants Entering Follow Up Period|Death|2|||
127578738|NCT02598960|459089691|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
127578739|NCT02598960|459089692|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
127578740|NCT02598960|459089693|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
127578741|NCT02598960|459089694|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
127578742|NCT02598960|459089695|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
127578743|NCT02598960|459089696|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
127578744|NCT02598960|459089697|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
127578745|NCT02598960|459089698|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
127578746|NCT02598960|459089699|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
127578747|NCT02598960|459089700|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
127578748|NCT02598960|459089701|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
127578749|NCT02598960|459089702|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
127578750|NCT02598960|459089703|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
127578751|NCT02598960|459089691|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
127578752|NCT02598960|459089692|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
127578753|NCT02598960|459089693|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
127578754|NCT02598960|459089694|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
127782903|NCT01536951|459831433|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
127782904|NCT01536951|459831434|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
127578755|NCT02598960|459089695|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
127578756|NCT02598960|459089696|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
127578757|NCT02598960|459089697|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
127578758|NCT02598960|459089698|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
127578759|NCT02598960|459089699|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
127578760|NCT02598960|459089700|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
127578761|NCT02598960|459089701|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
127578762|NCT02598960|459089702|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
127578763|NCT02598960|459089703|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
127578764|NCT02598960|459089691|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
127578765|NCT02598960|459089692|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
127578766|NCT02598960|459089693|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
127578767|NCT02598960|459089694|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
127578768|NCT02598960|459089695|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
127578769|NCT02598960|459089696|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
127578770|NCT02598960|459089697|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
127578771|NCT02598960|459089698|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
127578772|NCT02598960|459089699|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
127578773|NCT02598960|459089700|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
127578774|NCT02598960|459089701|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
127578775|NCT02598960|459089702|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
127578776|NCT02598960|459089703|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
127578777|NCT02598960|459089691|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
127578778|NCT02598960|459089692|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
127578779|NCT02598960|459089693|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
127578780|NCT02598960|459089694|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
127578781|NCT02598960|459089695|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
127578782|NCT02598960|459089696|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
127578783|NCT02598960|459089697|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
127578784|NCT02598960|459089698|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
127578785|NCT02598960|459089699|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
127578786|NCT02598960|459089700|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
127578787|NCT02598960|459089701|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
127578788|NCT02598960|459089702|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
127578789|NCT02598960|459089703|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
127578790|NCT01854658|459089706|FG000|Overall Study|Protocol Violation|6|||
127578791|NCT01854658|459089707|FG001|Overall Study|Protocol Violation|2|||
127578792|NCT01854658|459089708|FG002|Overall Study|Protocol Violation|2|||
127578793|NCT01854658|459089709|FG003|Overall Study|Protocol Violation|1|||
127578794|NCT01854658|459089706|FG000|Overall Study|Physician Decision|7|||
127578795|NCT01854658|459089707|FG001|Overall Study|Physician Decision|5|||
127578796|NCT01854658|459089708|FG002|Overall Study|Physician Decision|2|||
127578797|NCT01854658|459089709|FG003|Overall Study|Physician Decision|4|||
127578798|NCT01854658|459089706|FG000|Overall Study|Lost to Follow-up|8|||
127578799|NCT01854658|459089707|FG001|Overall Study|Lost to Follow-up|9|||
127578800|NCT01854658|459089708|FG002|Overall Study|Lost to Follow-up|8|||
127578801|NCT01854658|459089709|FG003|Overall Study|Lost to Follow-up|4|||
127578802|NCT01854658|459089706|FG000|Overall Study|Withdrawal by Subject|28|||
127578803|NCT01854658|459089707|FG001|Overall Study|Withdrawal by Subject|21|||
127578804|NCT01854658|459089708|FG002|Overall Study|Withdrawal by Subject|29|||
127578805|NCT01854658|459089709|FG003|Overall Study|Withdrawal by Subject|15|||
127578806|NCT01854658|459089706|FG000|Overall Study|Protocol-specified criteria|15|||
127578807|NCT01854658|459089707|FG001|Overall Study|Protocol-specified criteria|15|||
127578808|NCT01854658|459089708|FG002|Overall Study|Protocol-specified criteria|10|||
127578809|NCT01854658|459089709|FG003|Overall Study|Protocol-specified criteria|7|||
127578810|NCT01854658|459089706|FG000|Overall Study|Lack of Efficacy|3|||
127578811|NCT01854658|459089707|FG001|Overall Study|Lack of Efficacy|8|||
127578812|NCT01854658|459089708|FG002|Overall Study|Lack of Efficacy|4|||
127578813|NCT01854658|459089709|FG003|Overall Study|Lack of Efficacy|7|||
127578814|NCT01854658|459089706|FG000|Overall Study|Adverse Event|21|||
127578815|NCT01854658|459089707|FG001|Overall Study|Adverse Event|14|||
127578816|NCT01854658|459089708|FG002|Overall Study|Adverse Event|23|||
127578817|NCT01854658|459089709|FG003|Overall Study|Adverse Event|19|||
127578818|NCT01854658|459089706|FG000|Overall Study|Administrative reasons|5|||
127578819|NCT01854658|459089707|FG001|Overall Study|Administrative reasons|1|||
127578820|NCT01854658|459089708|FG002|Overall Study|Administrative reasons|2|||
127578821|NCT01854658|459089709|FG003|Overall Study|Administrative reasons|2|||
127578822|NCT01858376|459089710|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
127578823|NCT03894046|459089711|FG000|Overall Study|Protocol Violation|1|||
127578824|NCT03894046|459089712|FG001|Overall Study|Protocol Violation|0|||
127578825|NCT03894046|459089713|FG002|Overall Study|Protocol Violation|0|||
127578826|NCT03894046|459089711|FG000|Overall Study|Adverse Event|0|||
127578827|NCT03894046|459089712|FG001|Overall Study|Adverse Event|1|||
127578828|NCT03894046|459089713|FG002|Overall Study|Adverse Event|0|||
127578829|NCT03894046|459089711|FG000|Overall Study|Withdrawal by Subject|2|||
127578830|NCT03894046|459089712|FG001|Overall Study|Withdrawal by Subject|3|||
127578831|NCT03894046|459089713|FG002|Overall Study|Withdrawal by Subject|1|||
127578832|NCT03894046|459089711|FG000|Overall Study|Death|15|||
127578833|NCT03894046|459089712|FG001|Overall Study|Death|21|||
127578834|NCT03894046|459089713|FG002|Overall Study|Death|4|||
127578835|NCT03894046|459089711|FG000|Overall Study|No growth of ABC|2|||
127578836|NCT03894046|459089712|FG001|Overall Study|No growth of ABC|1|||
127578837|NCT03894046|459089713|FG002|Overall Study|No growth of ABC|0|||
127578838|NCT03894046|459089711|FG000|Overall Study|Physician Decision|1|||
127578839|NCT03894046|459089712|FG001|Overall Study|Physician Decision|1|||
127578840|NCT03894046|459089713|FG002|Overall Study|Physician Decision|1|||
127578841|NCT03894046|459089711|FG000|Overall Study|Prohibited concomitant medication|1|||
127578842|NCT03894046|459089712|FG001|Overall Study|Prohibited concomitant medication|0|||
127578843|NCT03894046|459089713|FG002|Overall Study|Prohibited concomitant medication|0|||
127578844|NCT03894046|459089711|FG000|Overall Study|Transferred to other arm/group|1|||
127578845|NCT03894046|459089712|FG001|Overall Study|Transferred to other arm/group|1|||
127578846|NCT03894046|459089713|FG002|Overall Study|Transferred to other arm/group|0|||
127578847|NCT02570074|459089720|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
127578848|NCT02570074|459089721|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
127578849|NCT02436304|459089722|FG000|Overall Study|Lost to Follow-up|0|||
127578850|NCT02436304|459089723|FG001|Overall Study|Lost to Follow-up|1|||
127578851|NCT02436304|459089724|FG002|Overall Study|Lost to Follow-up|0|||
127578852|NCT02436304|459089722|FG000|Overall Study|Withdrawal by Subject|0|||
127578853|NCT02436304|459089723|FG001|Overall Study|Withdrawal by Subject|1|||
127578854|NCT02436304|459089724|FG002|Overall Study|Withdrawal by Subject|0|||
127578855|NCT02436304|459089722|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
127578856|NCT02436304|459089723|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
127578857|NCT02436304|459089724|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
127578858|NCT00785928|459089725|FG000|Treatment Phase|Adverse Event|1|||
127578859|NCT00785928|459089726|FG001|Treatment Phase|Adverse Event|1|||
127578860|NCT00785928|459089727|FG002|Treatment Phase|Adverse Event|2|||
127578861|NCT00785928|459089728|FG003|Treatment Phase|Adverse Event|0|||
127578862|NCT00785928|459089729|FG004|Treatment Phase|Adverse Event|0|||
127578863|NCT00785928|459089730|FG005|Treatment Phase|Adverse Event|0|||
127578864|NCT00785928|459089731|FG006|Treatment Phase|Adverse Event|2|||
127578865|NCT00785928|459089725|FG000|Treatment Phase|Inadequate Response|0|||
127578866|NCT00785928|459089726|FG001|Treatment Phase|Inadequate Response|1|||
127578867|NCT00785928|459089727|FG002|Treatment Phase|Inadequate Response|0|||
127578868|NCT00785928|459089728|FG003|Treatment Phase|Inadequate Response|0|||
127578869|NCT00785928|459089729|FG004|Treatment Phase|Inadequate Response|0|||
127578870|NCT00785928|459089730|FG005|Treatment Phase|Inadequate Response|0|||
127578871|NCT00785928|459089731|FG006|Treatment Phase|Inadequate Response|0|||
127578872|NCT00785928|459089725|FG000|Treatment Phase|Lack of Efficacy|0|||
127578873|NCT00785928|459089726|FG001|Treatment Phase|Lack of Efficacy|1|||
127578874|NCT00785928|459089727|FG002|Treatment Phase|Lack of Efficacy|1|||
127578875|NCT00785928|459089728|FG003|Treatment Phase|Lack of Efficacy|0|||
127578876|NCT00785928|459089729|FG004|Treatment Phase|Lack of Efficacy|0|||
127578877|NCT00785928|459089730|FG005|Treatment Phase|Lack of Efficacy|0|||
127578878|NCT00785928|459089731|FG006|Treatment Phase|Lack of Efficacy|0|||
127578879|NCT00785928|459089725|FG000|Treatment Phase|Physician Decision|0|||
127578880|NCT00785928|459089726|FG001|Treatment Phase|Physician Decision|0|||
127578881|NCT00785928|459089727|FG002|Treatment Phase|Physician Decision|0|||
127578882|NCT00785928|459089728|FG003|Treatment Phase|Physician Decision|0|||
127578883|NCT00785928|459089729|FG004|Treatment Phase|Physician Decision|1|||
127578884|NCT00785928|459089730|FG005|Treatment Phase|Physician Decision|0|||
127578885|NCT00785928|459089731|FG006|Treatment Phase|Physician Decision|0|||
127578886|NCT00785928|459089725|FG000|Treatment Phase|Sponsor Decision|1|||
127578887|NCT00785928|459089726|FG001|Treatment Phase|Sponsor Decision|0|||
127578888|NCT00785928|459089727|FG002|Treatment Phase|Sponsor Decision|0|||
127578889|NCT00785928|459089728|FG003|Treatment Phase|Sponsor Decision|0|||
127578890|NCT00785928|459089729|FG004|Treatment Phase|Sponsor Decision|0|||
127578891|NCT00785928|459089730|FG005|Treatment Phase|Sponsor Decision|0|||
127578892|NCT00785928|459089731|FG006|Treatment Phase|Sponsor Decision|1|||
127578893|NCT00785928|459089725|FG000|Treatment Phase|Withdrawal by Subject|1|||
127578894|NCT00785928|459089726|FG001|Treatment Phase|Withdrawal by Subject|2|||
127578895|NCT00785928|459089727|FG002|Treatment Phase|Withdrawal by Subject|0|||
127782905|NCT01536951|459831435|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
127881378|NCT01652872|460187395|FG000|Overall Study|Decision by sponsor|5|||
127578896|NCT00785928|459089728|FG003|Treatment Phase|Withdrawal by Subject|0|||
127578897|NCT00785928|459089729|FG004|Treatment Phase|Withdrawal by Subject|1|||
127578898|NCT00785928|459089730|FG005|Treatment Phase|Withdrawal by Subject|0|||
127578899|NCT00785928|459089731|FG006|Treatment Phase|Withdrawal by Subject|0|||
127578900|NCT05021081|459089732|FG000|Phase 2|Subject enrolled in error|1|||
127578901|NCT05021081|459089733|FG001|Phase 2|Subject enrolled in error|1|||
127578902|NCT05021081|459089734|FG002|Phase 2|Subject enrolled in error|0|||
127578903|NCT00369122|459089735|FG000|Overall Study|Ineligible|10|||
127578904|NCT00369122|459089735|FG000|Overall Study|No protocol treatment|1|||
127578905|NCT00631696|459089738|FG000|Overall Study|Entered, not randomized to treatment|1|||
127578906|NCT00631696|459089739|FG001|Overall Study|Entered, not randomized to treatment|1|||
127578907|NCT00631696|459089738|FG000|Overall Study|Discontinued after database release date|1|||
127578908|NCT00631696|459089739|FG001|Overall Study|Discontinued after database release date|0|||
127578909|NCT00631696|459089738|FG000|Overall Study|Follow up after database release date|1|||
127578910|NCT00631696|459089739|FG001|Overall Study|Follow up after database release date|0|||
127578911|NCT00631696|459089738|FG000|Overall Study|Lost to Follow-up|7|||
127578912|NCT00631696|459089739|FG001|Overall Study|Lost to Follow-up|10|||
127578913|NCT00631696|459089738|FG000|Overall Study|Withdrawal by Subject|2|||
127578914|NCT00631696|459089739|FG001|Overall Study|Withdrawal by Subject|9|||
127578915|NCT00631696|459089738|FG000|Overall Study|Other|8|||
127578916|NCT00631696|459089739|FG001|Overall Study|Other|8|||
127578917|NCT00631696|459089738|FG000|Overall Study|Protocol Violation|9|||
127578918|NCT00631696|459089739|FG001|Overall Study|Protocol Violation|9|||
127578919|NCT00631696|459089738|FG000|Overall Study|Study terminated by sponsor|3|||
127578920|NCT00631696|459089739|FG001|Overall Study|Study terminated by sponsor|3|||
127578921|NCT00631696|459089738|FG000|Overall Study|Adverse Event|5|||
127578922|NCT00631696|459089739|FG001|Overall Study|Adverse Event|0|||
127578923|NCT00412542|459089742|FG000|Overall Study|Withdrawal by Subject|0|||
127578924|NCT00412542|459089743|FG001|Overall Study|Withdrawal by Subject|2|||
127578925|NCT00412542|459089742|FG000|Overall Study|Not Eligible|0|||
127578926|NCT00412542|459089743|FG001|Overall Study|Not Eligible|1|||
127578927|NCT03387683|459089746|FG000|Overall Study|In receipt of disallowed medication|1|||
127578928|NCT03387683|459089747|FG001|Overall Study|In receipt of disallowed medication|0|||
127578929|NCT03387683|459089746|FG000|Overall Study|Did not receive treatment|1|||
127578930|NCT03387683|459089747|FG001|Overall Study|Did not receive treatment|0|||
127578931|NCT01954342|459089748|FG000|Overall Study|Missing data from 13-16week study visit|0|||
127578932|NCT01954342|459089749|FG001|Overall Study|Missing data from 13-16week study visit|0|||
127578933|NCT01954342|459089750|FG002|Overall Study|Missing data from 13-16week study visit|0|||
127578934|NCT01954342|459089751|FG003|Overall Study|Missing data from 13-16week study visit|1|||
127578935|NCT01954342|459089748|FG000|Overall Study|Miscarriage|0|||
127578936|NCT01954342|459089749|FG001|Overall Study|Miscarriage|0|||
127578937|NCT01954342|459089750|FG002|Overall Study|Miscarriage|0|||
127578938|NCT01954342|459089751|FG003|Overall Study|Miscarriage|3|||
127578939|NCT01954342|459089748|FG000|Overall Study|Lost to Follow-up|0|||
127578940|NCT01954342|459089749|FG001|Overall Study|Lost to Follow-up|0|||
127578941|NCT01954342|459089750|FG002|Overall Study|Lost to Follow-up|0|||
127578942|NCT01954342|459089751|FG003|Overall Study|Lost to Follow-up|5|||
127578943|NCT01954342|459089748|FG000|Overall Study|Preterm delivery|0|||
127578944|NCT01954342|459089749|FG001|Overall Study|Preterm delivery|0|||
127578945|NCT01954342|459089750|FG002|Overall Study|Preterm delivery|0|||
127578946|NCT01954342|459089751|FG003|Overall Study|Preterm delivery|3|||
127578947|NCT01954342|459089748|FG000|Overall Study|Pre-eclampsia|0|||
127578948|NCT01954342|459089749|FG001|Overall Study|Pre-eclampsia|0|||
127578949|NCT01954342|459089750|FG002|Overall Study|Pre-eclampsia|0|||
127578950|NCT01954342|459089751|FG003|Overall Study|Pre-eclampsia|4|||
127578951|NCT01954342|459089748|FG000|Overall Study|Unreliable Data|0|||
127578952|NCT01954342|459089749|FG001|Overall Study|Unreliable Data|0|||
127578953|NCT01954342|459089750|FG002|Overall Study|Unreliable Data|0|||
127578954|NCT01954342|459089751|FG003|Overall Study|Unreliable Data|2|||
127578955|NCT00722423|459089752|FG000|Overall Study|Protocol Violation|0|||
127578956|NCT00722423|459089753|FG001|Overall Study|Protocol Violation|1|||
127578957|NCT01497275|459089754|FG000|Overall Study|Death|1|||
127578958|NCT01497275|459089754|FG000|Overall Study|Adverse Event|1|||
128030088|NCT01047540|460737116|FG001|Overall Study|Withdrawal by Subject|0|||
128030089|NCT01047540|460737117|FG002|Overall Study|Withdrawal by Subject|3|||
128030090|NCT01047540|460737118|FG003|Overall Study|Withdrawal by Subject|0|||
127578959|NCT01950169|459089755|FG000|Overall Study|Withdrawal by Subject|2|||
127578960|NCT01950169|459089756|FG001|Overall Study|Withdrawal by Subject|8|||
127578961|NCT01950169|459089757|FG002|Overall Study|Withdrawal by Subject|1|||
127578962|NCT01950169|459089755|FG000|Overall Study|Death|1|||
127578963|NCT01950169|459089756|FG001|Overall Study|Death|0|||
127578964|NCT01950169|459089757|FG002|Overall Study|Death|0|||
127578965|NCT05447897|459089760|FG000|Overall Study|Did not participate in survey|2|||
127578966|NCT04810481|459089764|FG000|Overall Study|Disqualified data sets|10|||
127578967|NCT04810481|459089765|FG001|Overall Study|Disqualified data sets|28|||
127578968|NCT01230710|459089774|FG000|Overall Study|Disease Progression|41|||
127693551|NCT02097420|459505826|FG000|Overall Study|Death|6|||
127693552|NCT02097420|459505826|FG000|Overall Study|Valve explanted|13|||
127693553|NCT02097420|459505826|FG000|Overall Study|Other Reason|1|||
127693554|NCT03161379|459505829|FG000|Overall Study|Withdrawal by Subject|4|||
127693555|NCT03161379|459505829|FG000|Overall Study|disease progression during chemotherapy|5|||
127693556|NCT03161379|459505829|FG000|Overall Study|no longer surgical candidate after chemotherapy|2|||
127693557|NCT03161379|459505829|FG000|Overall Study|not eligible to start study drug after chemotherapy|2|||
127693558|NCT03453619|459505834|FG000|Core Study (Part A)|Physician Decision|0|||
127578969|NCT01230710|459089774|FG000|Overall Study|Lost to Follow-up|3|||
127578970|NCT01230710|459089774|FG000|Overall Study|Death|4|||
127578971|NCT01230710|459089774|FG000|Overall Study|Withdrawal of Consent|1|||
127578972|NCT02808650|459089775|FG000|Overall Study|Death|0|||
127578973|NCT02808650|459089776|FG001|Overall Study|Death|0|||
127578974|NCT02808650|459089777|FG002|Overall Study|Death|0|||
127578975|NCT02808650|459089778|FG003|Overall Study|Death|0|||
127578976|NCT02808650|459089779|FG004|Overall Study|Death|1|||
127578977|NCT02808650|459089775|FG000|Overall Study|Lack of Efficacy|5|||
127578978|NCT02808650|459089776|FG001|Overall Study|Lack of Efficacy|5|||
127578979|NCT02808650|459089777|FG002|Overall Study|Lack of Efficacy|6|||
127578980|NCT02808650|459089778|FG003|Overall Study|Lack of Efficacy|5|||
127578981|NCT02808650|459089779|FG004|Overall Study|Lack of Efficacy|4|||
127578982|NCT02808650|459089775|FG000|Overall Study|Physician Decision|1|||
127578983|NCT02808650|459089776|FG001|Overall Study|Physician Decision|1|||
127578984|NCT02808650|459089777|FG002|Overall Study|Physician Decision|0|||
127578985|NCT02808650|459089778|FG003|Overall Study|Physician Decision|0|||
127578986|NCT02808650|459089779|FG004|Overall Study|Physician Decision|0|||
127578987|NCT02808650|459089775|FG000|Overall Study|Withdrawal by Subject|0|||
127578988|NCT02808650|459089776|FG001|Overall Study|Withdrawal by Subject|0|||
127578989|NCT02808650|459089777|FG002|Overall Study|Withdrawal by Subject|0|||
127578990|NCT02808650|459089778|FG003|Overall Study|Withdrawal by Subject|1|||
127578991|NCT02808650|459089779|FG004|Overall Study|Withdrawal by Subject|1|||
127578992|NCT02939079|459089780|FG000|Overall Study|Adverse Event|2|||
127578993|NCT02939079|459089781|FG001|Overall Study|Adverse Event|1|||
127578994|NCT02939079|459089780|FG000|Overall Study|Lost to Follow-up|0|||
127578995|NCT02939079|459089781|FG001|Overall Study|Lost to Follow-up|2|||
127578996|NCT02939079|459089780|FG000|Overall Study|Protocol Violation|1|||
127578997|NCT02939079|459089781|FG001|Overall Study|Protocol Violation|0|||
127578998|NCT02939079|459089780|FG000|Overall Study|Withdrawal by Subject|0|||
127578999|NCT02939079|459089781|FG001|Overall Study|Withdrawal by Subject|1|||
127579000|NCT02939079|459089780|FG000|Overall Study|relapse during the study|1|||
127579001|NCT02939079|459089781|FG001|Overall Study|relapse during the study|1|||
127579002|NCT04093414|459089782|FG000|3 Month Follow up|Physician Decision|0|||
127579003|NCT04093414|459089783|FG001|3 Month Follow up|Physician Decision|1|||
127579004|NCT04093414|459089782|FG000|6month Follow up|Physician Decision|1|||
127579005|NCT04093414|459089783|FG001|6month Follow up|Physician Decision|3|||
127579006|NCT04209348|459089784|FG000|Overall Study|Lost to Follow-up|1|||
127579007|NCT04209348|459089785|FG001|Overall Study|Lost to Follow-up|0|||
127579008|NCT02927262|459089788|FG000|Treatment Period (Up to 744 Days)|Withdrawal by Subject|3|||
127782906|NCT01536951|459831436|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
127782907|NCT01536951|459831437|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
127782908|NCT01536951|459831438|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
127782909|NCT01536951|459831430|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
127782910|NCT01536951|459831431|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
127782911|NCT01536951|459831432|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
127782912|NCT01536951|459831433|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
127782913|NCT01536951|459831434|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
127782914|NCT01536951|459831435|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
127782915|NCT01536951|459831436|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
127782916|NCT01536951|459831437|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
127782917|NCT01536951|459831438|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
127782918|NCT01843972|459831439|FG000|Overall Study|Withdrawal by Subject|0|||
127782919|NCT01843972|459831440|FG001|Overall Study|Withdrawal by Subject|0|||
127782920|NCT01843972|459831441|FG002|Overall Study|Withdrawal by Subject|0|||
127782921|NCT01843972|459831442|FG003|Overall Study|Withdrawal by Subject|0|||
127782922|NCT01843972|459831443|FG004|Overall Study|Withdrawal by Subject|1|||
127782923|NCT01843972|459831444|FG005|Overall Study|Withdrawal by Subject|0|||
127782924|NCT01843972|459831445|FG006|Overall Study|Withdrawal by Subject|0|||
127782925|NCT01843972|459831446|FG007|Overall Study|Withdrawal by Subject|0|||
127579009|NCT02927262|459089789|FG001|Treatment Period (Up to 744 Days)|Withdrawal by Subject|0|||
127782926|NCT01843972|459831447|FG008|Overall Study|Withdrawal by Subject|0|||
127782927|NCT01843972|459831448|FG009|Overall Study|Withdrawal by Subject|0|||
127782928|NCT00932425|459831449|FG000|Overall Study|Lost to Follow-up|0|||
127782929|NCT00932425|459831450|FG001|Overall Study|Lost to Follow-up|1|||
127782930|NCT00932425|459831449|FG000|Overall Study|Withdrawal by Subject|0|||
127782931|NCT00932425|459831450|FG001|Overall Study|Withdrawal by Subject|1|||
127579010|NCT02927262|459089788|FG000|Treatment Period (Up to 744 Days)|Death|1|||
127579011|NCT02927262|459089789|FG001|Treatment Period (Up to 744 Days)|Death|0|||
127579012|NCT02927262|459089788|FG000|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|1|||
127579013|NCT02927262|459089789|FG001|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|0|||
127579014|NCT02927262|459089788|FG000|Treatment Period (Up to 744 Days)|Physician Decision|1|||
127579015|NCT02927262|459089789|FG001|Treatment Period (Up to 744 Days)|Physician Decision|0|||
127579016|NCT02927262|459089788|FG000|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|0|||
127579017|NCT02927262|459089789|FG001|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|1|||
127579018|NCT02927262|459089788|FG000|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|0|||
127579019|NCT02927262|459089789|FG001|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|1|||
127579020|NCT02927262|459089788|FG000|Treatment Period (Up to 744 Days)|Randomized in error|1|||
127579021|NCT02927262|459089789|FG001|Treatment Period (Up to 744 Days)|Randomized in error|0|||
127579022|NCT02927262|459089788|FG000|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|1|||
127579023|NCT02927262|459089789|FG001|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|0|||
127579024|NCT02927262|459089788|FG000|Treatment Period (Up to 744 Days)|MRD positive|0|||
127579025|NCT02927262|459089789|FG001|Treatment Period (Up to 744 Days)|MRD positive|1|||
127579026|NCT02927262|459089788|FG000|Treatment Period (Up to 744 Days)|Disease Relapse|23|||
127579027|NCT02927262|459089789|FG001|Treatment Period (Up to 744 Days)|Disease Relapse|18|||
127579028|NCT02927262|459089788|FG000|Treatment Period (Up to 744 Days)|Adverse Event|7|||
127579029|NCT02927262|459089789|FG001|Treatment Period (Up to 744 Days)|Adverse Event|1|||
127579030|NCT02927262|459089788|FG000|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|1|||
127579031|NCT02927262|459089789|FG001|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|0|||
127579032|NCT02927262|459089788|FG000|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|0|||
127579033|NCT02927262|459089789|FG001|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|1|||
127579034|NCT02927262|459089788|FG000|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|0|||
127579035|NCT02927262|459089789|FG001|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|2|||
127579036|NCT02927262|459089788|FG000|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|2|||
128030091|NCT01047540|460737119|FG004|Overall Study|Withdrawal by Subject|1|||
128030092|NCT01047540|460737115|FG000|Overall Study|Pregnancy|1|||
128030093|NCT01047540|460737116|FG001|Overall Study|Pregnancy|0|||
128030094|NCT01047540|460737117|FG002|Overall Study|Pregnancy|0|||
128030095|NCT01047540|460737118|FG003|Overall Study|Pregnancy|0|||
128030096|NCT01047540|460737119|FG004|Overall Study|Pregnancy|0|||
128030097|NCT01047540|460737115|FG000|Overall Study|Adverse Event|1|||
128030098|NCT01047540|460737116|FG001|Overall Study|Adverse Event|0|||
128030099|NCT01047540|460737117|FG002|Overall Study|Adverse Event|0|||
128030100|NCT01047540|460737118|FG003|Overall Study|Adverse Event|0|||
128030101|NCT01047540|460737119|FG004|Overall Study|Adverse Event|0|||
128030102|NCT01437189|460737123|FG000|Overall Study|Adverse Event|3|||
128030103|NCT01437189|460737123|FG000|Overall Study|Lack of Efficacy|4|||
128030104|NCT01437189|460737123|FG000|Overall Study|Withdrawal by Subject|8|||
128030105|NCT00347269|460737124|FG000|Overall Study|Lost to Follow-up|74|||
127579037|NCT02927262|459089789|FG001|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|0|||
127579038|NCT02927262|459089788|FG000|Long Term Follow-up (Up to 1201 Days)|Death|23|||
127579039|NCT02927262|459089789|FG001|Long Term Follow-up (Up to 1201 Days)|Death|12|||
127579040|NCT00923936|459089790|FG000|Overall Study|progressive disease on study|2|||
127579041|NCT00923936|459089791|FG001|Overall Study|progressive disease on study|1|||
127579042|NCT00923936|459089790|FG000|Overall Study|Adverse Event|2|||
127579043|NCT00923936|459089791|FG001|Overall Study|Adverse Event|1|||
127579044|NCT00923936|459089790|FG000|Overall Study|Lost to follow up|2|||
127579045|NCT00923936|459089791|FG001|Overall Study|Lost to follow up|0|||
127579046|NCT00923936|459089790|FG000|Overall Study|Continuing in follow up period|2|||
127579047|NCT00923936|459089791|FG001|Overall Study|Continuing in follow up period|1|||
127579048|NCT01697358|459089792|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
127579049|NCT01697358|459089793|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
127579050|NCT01697358|459089792|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
127579051|NCT01697358|459089793|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
127579052|NCT01697358|459089792|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
127579053|NCT01697358|459089793|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
127579054|NCT01697358|459089792|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
127579055|NCT01697358|459089793|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
127579056|NCT01697358|459089792|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
127579057|NCT01697358|459089793|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
127579058|NCT01697358|459089792|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
127579059|NCT01697358|459089793|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
127579060|NCT01697358|459089792|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
127579061|NCT01697358|459089793|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
127579062|NCT01697358|459089792|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
127579063|NCT01697358|459089793|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
127881379|NCT01652872|460187396|FG001|Overall Study|Decision by sponsor|7|||
127881380|NCT01652872|460187395|FG000|Overall Study|Withdrawal by Subject|76|||
128030106|NCT00347269|460737125|FG001|Overall Study|Lost to Follow-up|65|||
128030107|NCT00347269|460737124|FG000|Overall Study|Withdrawal by Subject|18|||
128030108|NCT00347269|460737125|FG001|Overall Study|Withdrawal by Subject|38|||
128030109|NCT00347269|460737124|FG000|Overall Study|Death|2|||
128030110|NCT00347269|460737125|FG001|Overall Study|Death|3|||
128030111|NCT03654326|460737126|FG000|Overall Study|Withdrawal by Subject|5|||
128030112|NCT03654326|460737127|FG001|Overall Study|Withdrawal by Subject|3|||
127579064|NCT01697358|459089792|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
127579065|NCT01697358|459089793|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
127579066|NCT01697358|459089792|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
127579067|NCT01697358|459089793|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
127579068|NCT05394350|459089795|FG000|Overall Study|Death|2|||
127579069|NCT05394350|459089796|FG001|Overall Study|Death|2|||
127579070|NCT05394350|459089797|FG002|Overall Study|Death|4|||
127579071|NCT05394350|459089798|FG003|Overall Study|Death|0|||
127579072|NCT05394350|459089799|FG004|Overall Study|Death|1|||
127579073|NCT05394350|459089800|FG005|Overall Study|Death|0|||
127579074|NCT05394350|459089795|FG000|Overall Study|Study terminated by sponsor|1|||
127579075|NCT05394350|459089796|FG001|Overall Study|Study terminated by sponsor|1|||
127579076|NCT05394350|459089797|FG002|Overall Study|Study terminated by sponsor|7|||
127579077|NCT05394350|459089798|FG003|Overall Study|Study terminated by sponsor|3|||
127579078|NCT05394350|459089799|FG004|Overall Study|Study terminated by sponsor|2|||
127579079|NCT05394350|459089800|FG005|Overall Study|Study terminated by sponsor|4|||
127579080|NCT01336569|459089801|FG000|Overall Study|Lost to Follow-up|4|||
127579081|NCT02963935|459089804|FG000|Overall Study|Adverse Event|12|||
127579082|NCT02963935|459089805|FG001|Overall Study|Adverse Event|6|||
127579083|NCT02963935|459089804|FG000|Overall Study|Protocol Violation|2|||
127579084|NCT02963935|459089805|FG001|Overall Study|Protocol Violation|1|||
127579085|NCT02963935|459089804|FG000|Overall Study|Lack of Efficacy|0|||
127579086|NCT02963935|459089805|FG001|Overall Study|Lack of Efficacy|2|||
127579087|NCT02963935|459089804|FG000|Overall Study|Lost to Follow-up|1|||
127579088|NCT02963935|459089805|FG001|Overall Study|Lost to Follow-up|6|||
127579089|NCT02963935|459089804|FG000|Overall Study|Unclassified|13|||
127579090|NCT02963935|459089805|FG001|Overall Study|Unclassified|22|||
127579091|NCT02337738|459089806|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
127579092|NCT02337738|459089807|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
127579093|NCT02337738|459089808|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
127579094|NCT02337738|459089806|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
127579095|NCT02337738|459089807|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
127579096|NCT02337738|459089808|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
127579097|NCT02337738|459089806|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
127579098|NCT02337738|459089807|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
127579099|NCT02337738|459089808|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
127579100|NCT02337738|459089806|FG000|Overall Study|Voluntary Withdrawal|10|||
127579101|NCT02337738|459089807|FG001|Overall Study|Voluntary Withdrawal|5|||
127579102|NCT02337738|459089808|FG002|Overall Study|Voluntary Withdrawal|2|||
127579103|NCT02337738|459089806|FG000|Overall Study|Lack of Efficacy|2|||
127579104|NCT02337738|459089807|FG001|Overall Study|Lack of Efficacy|4|||
127579105|NCT02337738|459089808|FG002|Overall Study|Lack of Efficacy|0|||
127579106|NCT02337738|459089806|FG000|Overall Study|Investigator's Judgment|1|||
127579107|NCT02337738|459089807|FG001|Overall Study|Investigator's Judgment|1|||
127579108|NCT02337738|459089808|FG002|Overall Study|Investigator's Judgment|3|||
127579109|NCT00406354|459089809|FG000|All Randomized Patients|Protocol Violation|0|||
127579110|NCT00406354|459089810|FG001|All Randomized Patients|Protocol Violation|0|||
127579111|NCT00406354|459089811|FG002|All Randomized Patients|Protocol Violation|1|||
127579112|NCT00406354|459089809|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
127579113|NCT00406354|459089810|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
127579114|NCT00406354|459089811|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
127579115|NCT00406354|459089809|FG000|All Randomized and Treated Patients|Adverse Event|6|||
127579116|NCT00406354|459089810|FG001|All Randomized and Treated Patients|Adverse Event|2|||
127579117|NCT00406354|459089811|FG002|All Randomized and Treated Patients|Adverse Event|1|||
127579118|NCT00406354|459089809|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
127579119|NCT00406354|459089810|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
128030113|NCT03654326|460737126|FG000|Overall Study|Physician Decision|0|||
128030114|NCT03654326|460737127|FG001|Overall Study|Physician Decision|1|||
128030115|NCT03654326|460737126|FG000|Overall Study|Unable to adhere to study schedule|0|||
128030116|NCT03654326|460737127|FG001|Overall Study|Unable to adhere to study schedule|1|||
127579120|NCT00406354|459089811|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
127579121|NCT00406354|459089809|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
127579122|NCT00406354|459089810|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
127579123|NCT00406354|459089811|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
127579124|NCT00406354|459089809|FG000|All Randomized and Treated Patients|Physician Decision|0|||
127579125|NCT00406354|459089810|FG001|All Randomized and Treated Patients|Physician Decision|0|||
127579126|NCT00406354|459089811|FG002|All Randomized and Treated Patients|Physician Decision|1|||
127579127|NCT00747461|459089812|FG000|Overall Study|study terminated by sponsor|5|||
128030117|NCT03654326|460737126|FG000|Overall Study|Lost to Follow-up|1|||
128030118|NCT03654326|460737127|FG001|Overall Study|Lost to Follow-up|1|||
128030119|NCT04102514|460737128|FG000|Overall Study|Death|3|||
127579128|NCT00299182|459089825|FG000|Overall Study|Withdrawal by Subject|0|||
127579129|NCT00299182|459089826|FG001|Overall Study|Withdrawal by Subject|0|||
127579130|NCT00299182|459089827|FG002|Overall Study|Withdrawal by Subject|1|||
127579131|NCT00299182|459089828|FG003|Overall Study|Withdrawal by Subject|0|||
127579132|NCT00299182|459089829|FG004|Overall Study|Withdrawal by Subject|1|||
127579133|NCT00299182|459089830|FG005|Overall Study|Withdrawal by Subject|2|||
127579134|NCT00299182|459089831|FG006|Overall Study|Withdrawal by Subject|0|||
127579135|NCT00299182|459089825|FG000|Overall Study|Chemotherapy Changed|0|||
127579136|NCT00299182|459089826|FG001|Overall Study|Chemotherapy Changed|0|||
127579137|NCT00299182|459089827|FG002|Overall Study|Chemotherapy Changed|1|||
127579138|NCT00299182|459089828|FG003|Overall Study|Chemotherapy Changed|0|||
127579139|NCT00299182|459089829|FG004|Overall Study|Chemotherapy Changed|1|||
127579140|NCT00299182|459089830|FG005|Overall Study|Chemotherapy Changed|0|||
127579141|NCT00299182|459089831|FG006|Overall Study|Chemotherapy Changed|1|||
127579142|NCT00299182|459089825|FG000|Overall Study|Adverse Event|0|||
127579143|NCT00299182|459089826|FG001|Overall Study|Adverse Event|0|||
127579144|NCT00299182|459089827|FG002|Overall Study|Adverse Event|0|||
127579145|NCT00299182|459089828|FG003|Overall Study|Adverse Event|0|||
127579146|NCT00299182|459089829|FG004|Overall Study|Adverse Event|0|||
127579147|NCT00299182|459089830|FG005|Overall Study|Adverse Event|1|||
127579148|NCT00299182|459089831|FG006|Overall Study|Adverse Event|0|||
127579149|NCT00299182|459089825|FG000|Overall Study|Not Eligible|0|||
127579150|NCT00299182|459089826|FG001|Overall Study|Not Eligible|0|||
127579151|NCT00299182|459089827|FG002|Overall Study|Not Eligible|0|||
127579152|NCT00299182|459089828|FG003|Overall Study|Not Eligible|0|||
127579153|NCT00299182|459089829|FG004|Overall Study|Not Eligible|1|||
127579154|NCT00299182|459089830|FG005|Overall Study|Not Eligible|0|||
127579155|NCT00299182|459089831|FG006|Overall Study|Not Eligible|0|||
127579156|NCT00072176|459089838|FG000|Overall Study|Withdrawal by Subject|1|||
127579157|NCT00072176|459089839|FG001|Overall Study|Withdrawal by Subject|0|||
127579158|NCT00072176|459089838|FG000|Overall Study|Protocol Violation|0|||
127579159|NCT00072176|459089839|FG001|Overall Study|Protocol Violation|1|||
127579160|NCT04502979|459089842|FG000|Overall Study|Lost to Follow-up|1|||
127579161|NCT04502979|459089843|FG001|Overall Study|Lost to Follow-up|3|||
127579162|NCT04502979|459089842|FG000|Overall Study|Withdrawal by Subject|2|||
127579163|NCT04502979|459089843|FG001|Overall Study|Withdrawal by Subject|1|||
127579164|NCT01558739|459089846|FG000|Overall Study|Adverse Event|7|||
127579165|NCT01558739|459089846|FG000|Overall Study|Withdrawal by Subject|2|||
127579166|NCT01558739|459089846|FG000|Overall Study|Death|3|||
127579167|NCT01558739|459089846|FG000|Overall Study|Disease Progression|4|||
127579168|NCT01558739|459089846|FG000|Overall Study|Protocol Violation|1|||
127579169|NCT01067976|459089849|FG000|Overall Study|Study drug never administered|20|||
127579170|NCT01067976|459089849|FG000|Overall Study|Study prematurely discontinued|2|||
127579171|NCT00566111|459089850|FG000|Overall Study|Adverse Event|0|||
127579172|NCT00566111|459089851|FG001|Overall Study|Adverse Event|2|||
127579173|NCT01554397|459089852|FG000|Overall Study|Withdrawal by Subject|1|||
127579174|NCT01554397|459089853|FG001|Overall Study|Withdrawal by Subject|0|||
127579175|NCT01554397|459089852|FG000|Overall Study|Ineligible|7|||
127579176|NCT01554397|459089853|FG001|Overall Study|Ineligible|0|||
127579177|NCT00734474|459092468|FG000|Overall Study|Entry Criteria Not Met|0|||
127579178|NCT00734474|459092469|FG001|Overall Study|Entry Criteria Not Met|0|||
127579179|NCT00734474|459092470|FG002|Overall Study|Entry Criteria Not Met|5|||
127782932|NCT03805750|459831451|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
127782933|NCT03805750|459831452|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
127782934|NCT01177683|459831453|FG000|Study Treatment|Disease Progressions during treatment|2|||
127782935|NCT01177683|459831454|FG001|Study Treatment|Disease Progressions during treatment|0|||
127782936|NCT01177683|459831455|FG002|Study Treatment|Disease Progressions during treatment|3|||
127782937|NCT01177683|459831453|FG000|Study Treatment|Adverse Event|0|||
127782938|NCT01177683|459831454|FG001|Study Treatment|Adverse Event|1|||
127782939|NCT01177683|459831455|FG002|Study Treatment|Adverse Event|12|||
127782940|NCT01177683|459831453|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
127782941|NCT01177683|459831454|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
127782942|NCT01177683|459831455|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
127579180|NCT00734474|459092471|FG003|Overall Study|Entry Criteria Not Met|0|||
127579181|NCT00734474|459092472|FG004|Overall Study|Entry Criteria Not Met|3|||
127579182|NCT00734474|459092473|FG005|Overall Study|Entry Criteria Not Met|1|||
127579183|NCT00734474|459092474|FG006|Overall Study|Entry Criteria Not Met|0|||
127579184|NCT00734474|459092475|FG007|Overall Study|Entry Criteria Not Met|1|||
127579185|NCT00734474|459092476|FG008|Overall Study|Entry Criteria Not Met|1|||
127579186|NCT00734474|459092468|FG000|Overall Study|Lost to Follow-up|1|||
127579187|NCT00734474|459092469|FG001|Overall Study|Lost to Follow-up|0|||
127579188|NCT00734474|459092470|FG002|Overall Study|Lost to Follow-up|13|||
127579189|NCT00734474|459092471|FG003|Overall Study|Lost to Follow-up|0|||
127579190|NCT00734474|459092472|FG004|Overall Study|Lost to Follow-up|11|||
127579191|NCT00734474|459092473|FG005|Overall Study|Lost to Follow-up|1|||
127579192|NCT00734474|459092474|FG006|Overall Study|Lost to Follow-up|0|||
127579193|NCT00734474|459092475|FG007|Overall Study|Lost to Follow-up|9|||
127579194|NCT00734474|459092476|FG008|Overall Study|Lost to Follow-up|4|||
127579195|NCT00734474|459092468|FG000|Overall Study|Withdrawal by Subject|2|||
127579196|NCT00734474|459092469|FG001|Overall Study|Withdrawal by Subject|1|||
127579197|NCT00734474|459092470|FG002|Overall Study|Withdrawal by Subject|18|||
127579198|NCT00734474|459092471|FG003|Overall Study|Withdrawal by Subject|0|||
127579199|NCT00734474|459092472|FG004|Overall Study|Withdrawal by Subject|24|||
127579200|NCT00734474|459092473|FG005|Overall Study|Withdrawal by Subject|2|||
127579201|NCT00734474|459092474|FG006|Overall Study|Withdrawal by Subject|0|||
127579202|NCT00734474|459092475|FG007|Overall Study|Withdrawal by Subject|36|||
127579203|NCT00734474|459092476|FG008|Overall Study|Withdrawal by Subject|21|||
127579204|NCT00734474|459092468|FG000|Overall Study|Physician Decision|0|||
127579205|NCT00734474|459092469|FG001|Overall Study|Physician Decision|0|||
127579206|NCT00734474|459092470|FG002|Overall Study|Physician Decision|4|||
127579207|NCT00734474|459092471|FG003|Overall Study|Physician Decision|1|||
127579208|NCT00734474|459092472|FG004|Overall Study|Physician Decision|11|||
127579209|NCT00734474|459092473|FG005|Overall Study|Physician Decision|0|||
127579210|NCT00734474|459092474|FG006|Overall Study|Physician Decision|0|||
127579211|NCT00734474|459092475|FG007|Overall Study|Physician Decision|9|||
127579212|NCT00734474|459092476|FG008|Overall Study|Physician Decision|9|||
127579213|NCT00734474|459092468|FG000|Overall Study|Adverse Event|4|||
127579214|NCT00734474|459092469|FG001|Overall Study|Adverse Event|4|||
127579215|NCT00734474|459092470|FG002|Overall Study|Adverse Event|63|||
127579216|NCT00734474|459092471|FG003|Overall Study|Adverse Event|1|||
127579217|NCT00734474|459092472|FG004|Overall Study|Adverse Event|64|||
127579218|NCT00734474|459092473|FG005|Overall Study|Adverse Event|0|||
127579219|NCT00734474|459092474|FG006|Overall Study|Adverse Event|1|||
127579220|NCT00734474|459092475|FG007|Overall Study|Adverse Event|65|||
127579221|NCT00734474|459092476|FG008|Overall Study|Adverse Event|39|||
127579222|NCT00734474|459092468|FG000|Overall Study|Protocol Violation|0|||
127579223|NCT00734474|459092469|FG001|Overall Study|Protocol Violation|0|||
127579224|NCT00734474|459092470|FG002|Overall Study|Protocol Violation|4|||
127579225|NCT00734474|459092471|FG003|Overall Study|Protocol Violation|0|||
127579226|NCT00734474|459092472|FG004|Overall Study|Protocol Violation|3|||
127579227|NCT00734474|459092473|FG005|Overall Study|Protocol Violation|0|||
127579228|NCT00734474|459092474|FG006|Overall Study|Protocol Violation|0|||
127579229|NCT00734474|459092475|FG007|Overall Study|Protocol Violation|3|||
127579230|NCT00734474|459092476|FG008|Overall Study|Protocol Violation|1|||
127579231|NCT00734474|459092468|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
127579232|NCT00734474|459092469|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
127579233|NCT00734474|459092470|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
127579234|NCT00734474|459092471|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
127579235|NCT00734474|459092472|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
127579236|NCT00734474|459092473|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
127579237|NCT00734474|459092474|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
127579238|NCT00734474|459092475|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
127579239|NCT00734474|459092476|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
127579240|NCT00734474|459092468|FG000|Overall Study|Sponsor Decision|0|||
127579241|NCT00734474|459092469|FG001|Overall Study|Sponsor Decision|0|||
127579242|NCT00734474|459092470|FG002|Overall Study|Sponsor Decision|0|||
127579243|NCT00734474|459092471|FG003|Overall Study|Sponsor Decision|0|||
127693559|NCT03453619|459505835|FG001|Core Study (Part A)|Physician Decision|0|||
128030120|NCT04102514|460737129|FG001|Overall Study|Death|0|||
128030121|NCT04102514|460737130|FG002|Overall Study|Death|0|||
128030122|NCT04102514|460737131|FG003|Overall Study|Death|0|||
128030123|NCT04102514|460737128|FG000|Overall Study|Lost to Follow-up|0|||
128030124|NCT04102514|460737129|FG001|Overall Study|Lost to Follow-up|0|||
128030125|NCT04102514|460737130|FG002|Overall Study|Lost to Follow-up|3|||
128030126|NCT04102514|460737131|FG003|Overall Study|Lost to Follow-up|0|||
128030127|NCT04102514|460737128|FG000|Overall Study|Physician Decision|0|||
128030128|NCT04102514|460737129|FG001|Overall Study|Physician Decision|0|||
128030129|NCT04102514|460737130|FG002|Overall Study|Physician Decision|1|||
128030130|NCT04102514|460737131|FG003|Overall Study|Physician Decision|0|||
127579244|NCT00734474|459092472|FG004|Overall Study|Sponsor Decision|2|||
127579245|NCT00734474|459092473|FG005|Overall Study|Sponsor Decision|0|||
127579246|NCT00734474|459092474|FG006|Overall Study|Sponsor Decision|0|||
127579247|NCT00734474|459092475|FG007|Overall Study|Sponsor Decision|0|||
127579248|NCT00734474|459092476|FG008|Overall Study|Sponsor Decision|0|||
127579249|NCT00734474|459092468|FG000|Overall Study|Death|0|||
127579250|NCT00734474|459092469|FG001|Overall Study|Death|0|||
127579251|NCT00734474|459092470|FG002|Overall Study|Death|1|||
127579252|NCT00734474|459092471|FG003|Overall Study|Death|0|||
127579253|NCT00734474|459092472|FG004|Overall Study|Death|0|||
127579254|NCT00734474|459092473|FG005|Overall Study|Death|0|||
127579255|NCT00734474|459092474|FG006|Overall Study|Death|0|||
128030131|NCT04102514|460737128|FG000|Overall Study|Withdrawal by Subject|7|||
127579256|NCT00734474|459092475|FG007|Overall Study|Death|2|||
127579257|NCT00734474|459092476|FG008|Overall Study|Death|1|||
128030132|NCT04102514|460737129|FG001|Overall Study|Withdrawal by Subject|13|||
127579258|NCT00734474|459092468|FG000|Overall Study|Lack of Efficacy|0|||
127579259|NCT00734474|459092469|FG001|Overall Study|Lack of Efficacy|0|||
128030133|NCT04102514|460737130|FG002|Overall Study|Withdrawal by Subject|7|||
128030134|NCT04102514|460737131|FG003|Overall Study|Withdrawal by Subject|14|||
127579260|NCT00734474|459092470|FG002|Overall Study|Lack of Efficacy|4|||
127579261|NCT00734474|459092471|FG003|Overall Study|Lack of Efficacy|0|||
127579262|NCT00734474|459092472|FG004|Overall Study|Lack of Efficacy|0|||
127579263|NCT00734474|459092473|FG005|Overall Study|Lack of Efficacy|0|||
127579264|NCT00734474|459092474|FG006|Overall Study|Lack of Efficacy|0|||
127579265|NCT00734474|459092475|FG007|Overall Study|Lack of Efficacy|4|||
127579266|NCT00734474|459092476|FG008|Overall Study|Lack of Efficacy|6|||
127579267|NCT02497612|459092485|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
127579268|NCT02497612|459092486|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
127579269|NCT02497612|459092487|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
127579270|NCT02497612|459092488|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
127579271|NCT02497612|459092485|FG000|Overall Study|Participant's request|2|||
127579272|NCT02497612|459092486|FG001|Overall Study|Participant's request|3|||
127579273|NCT02497612|459092487|FG002|Overall Study|Participant's request|4|||
127579274|NCT02497612|459092488|FG003|Overall Study|Participant's request|1|||
127579275|NCT02497612|459092485|FG000|Overall Study|Investigator's judgement|1|||
127579276|NCT02497612|459092486|FG001|Overall Study|Investigator's judgement|0|||
127579277|NCT02497612|459092487|FG002|Overall Study|Investigator's judgement|0|||
127579278|NCT02497612|459092488|FG003|Overall Study|Investigator's judgement|2|||
127579279|NCT02497612|459092485|FG000|Overall Study|Adverse Event|3|||
127579280|NCT02497612|459092486|FG001|Overall Study|Adverse Event|1|||
127579281|NCT02497612|459092487|FG002|Overall Study|Adverse Event|4|||
127579282|NCT02497612|459092488|FG003|Overall Study|Adverse Event|1|||
127579283|NCT02497612|459092485|FG000|Overall Study|Lost to Follow-up|1|||
127579284|NCT02497612|459092486|FG001|Overall Study|Lost to Follow-up|1|||
127579285|NCT02497612|459092487|FG002|Overall Study|Lost to Follow-up|0|||
127579286|NCT02497612|459092488|FG003|Overall Study|Lost to Follow-up|1|||
127579287|NCT02497612|459092485|FG000|Overall Study|Other unspecified|1|||
127579288|NCT02497612|459092486|FG001|Overall Study|Other unspecified|1|||
127579289|NCT02497612|459092487|FG002|Overall Study|Other unspecified|2|||
127579290|NCT02497612|459092488|FG003|Overall Study|Other unspecified|0|||
127579291|NCT02497612|459092485|FG000|Overall Study|Not eligible|1|||
127579292|NCT02497612|459092486|FG001|Overall Study|Not eligible|0|||
127579293|NCT02497612|459092487|FG002|Overall Study|Not eligible|0|||
127579294|NCT02497612|459092488|FG003|Overall Study|Not eligible|1|||
127579295|NCT02651467|459092489|FG000|Overall Study|Withdrawal by Subject|0|||
127579296|NCT02651467|459092490|FG001|Overall Study|Withdrawal by Subject|0|||
127579297|NCT02651467|459092491|FG002|Overall Study|Withdrawal by Subject|2|||
127579298|NCT02651467|459092489|FG000|Overall Study|Other (Not specified)|1|||
127579299|NCT02651467|459092490|FG001|Overall Study|Other (Not specified)|0|||
127579300|NCT02651467|459092491|FG002|Overall Study|Other (Not specified)|2|||
127579301|NCT00004635|459092492|FG000|Period One|refused|2|||
127579302|NCT00004635|459092493|FG001|Period One|refused|1|||
127579303|NCT00004635|459092492|FG000|Period One|Withdrawal by Subject|1|||
127579304|NCT00004635|459092493|FG001|Period One|Withdrawal by Subject|1|||
127579305|NCT00004635|459092492|FG000|Period One|Protocol Violation|1|||
127579306|NCT00004635|459092493|FG001|Period One|Protocol Violation|0|||
127579307|NCT00004635|459092492|FG000|Period One|PSA did not go <5 ng/mL|1|||
127579308|NCT00004635|459092493|FG001|Period One|PSA did not go <5 ng/mL|0|||
127579309|NCT00004635|459092492|FG000|Period One|second malignancy|1|||
127579310|NCT00004635|459092493|FG001|Period One|second malignancy|0|||
127579311|NCT00004635|459092492|FG000|Period One|progressed|0|||
127579312|NCT00004635|459092493|FG001|Period One|progressed|2|||
127579313|NCT00004635|459092492|FG000|Period One|health problem|0|||
127579314|NCT00004635|459092493|FG001|Period One|health problem|1|||
127579315|NCT00004635|459092492|FG000|Period One|discrepancy in data entry|0|||
127579316|NCT00004635|459092493|FG001|Period One|discrepancy in data entry|1|||
127782943|NCT01177683|459831453|FG000|Study Treatment|Alternative therapy|0|||
127782944|NCT01177683|459831454|FG001|Study Treatment|Alternative therapy|0|||
127782945|NCT01177683|459831455|FG002|Study Treatment|Alternative therapy|4|||
127782946|NCT01177683|459831453|FG000|Study Treatment|Physician Decision|1|||
127782947|NCT01177683|459831454|FG001|Study Treatment|Physician Decision|0|||
128030135|NCT04102514|460737128|FG000|Overall Study|Moved to longterm care facility|6|||
128030136|NCT04102514|460737129|FG001|Overall Study|Moved to longterm care facility|0|||
127579317|NCT00004635|459092492|FG000|Period Two|progression|2|||
127579318|NCT00004635|459092493|FG001|Period Two|progression|3|||
127579319|NCT00004635|459092492|FG000|Period Two|Adverse Event|1|||
127782948|NCT01177683|459831455|FG002|Study Treatment|Physician Decision|1|||
128030137|NCT04102514|460737130|FG002|Overall Study|Moved to longterm care facility|4|||
127579320|NCT00004635|459092493|FG001|Period Two|Adverse Event|0|||
127579321|NCT00004635|459092492|FG000|Period Two|refused|0|||
127579322|NCT00004635|459092493|FG001|Period Two|refused|2|||
127579323|NCT00004635|459092492|FG000|Period Two|health problem|1|||
127579324|NCT00004635|459092493|FG001|Period Two|health problem|1|||
127579325|NCT00004635|459092492|FG000|Period Two|travel issues|0|||
127579326|NCT00004635|459092493|FG001|Period Two|travel issues|1|||
127579327|NCT00004635|459092492|FG000|Period Two|secondary malignancy|1|||
127782949|NCT01177683|459831453|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
127782950|NCT01177683|459831454|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
127782951|NCT01177683|459831455|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
127782952|NCT01177683|459831453|FG000|Study Treatment|Symptomatic Deterioration|0|||
127782953|NCT01177683|459831454|FG001|Study Treatment|Symptomatic Deterioration|0|||
127782954|NCT01177683|459831455|FG002|Study Treatment|Symptomatic Deterioration|1|||
127782955|NCT01177683|459831453|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
127782956|NCT01177683|459831454|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
127782957|NCT01177683|459831455|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
127782958|NCT01177683|459831453|FG000|Follow up|Patient lost to follow up|0|||
127782959|NCT01177683|459831454|FG001|Follow up|Patient lost to follow up|0|||
127782960|NCT01177683|459831455|FG002|Follow up|Patient lost to follow up|2|||
127782961|NCT01177683|459831453|FG000|Follow up|Death|2|||
127782962|NCT01177683|459831454|FG001|Follow up|Death|1|||
127782963|NCT01177683|459831455|FG002|Follow up|Death|7|||
127782964|NCT01177683|459831453|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
127782965|NCT01177683|459831454|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
127782966|NCT01177683|459831455|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
127782967|NCT03318978|459831461|FG000|Overall Study|Withdrawal by Subject|1|||
127782968|NCT02844816|459831462|FG000|Overall Study|No protocol treatment received|5|||
127782969|NCT02844816|459831463|FG001|Overall Study|No protocol treatment received|1|||
127782970|NCT02844816|459831462|FG000|Overall Study|Ineligible|22|||
127782971|NCT02844816|459831463|FG001|Overall Study|Ineligible|15|||
127782972|NCT02844816|459831462|FG000|Overall Study|Participant refusal|5|||
127782973|NCT02844816|459831463|FG001|Overall Study|Participant refusal|5|||
127782974|NCT02844816|459831462|FG000|Overall Study|Adverse Event|5|||
127782975|NCT02844816|459831463|FG001|Overall Study|Adverse Event|4|||
127782976|NCT02844816|459831462|FG000|Overall Study|Death|0|||
127782977|NCT02844816|459831463|FG001|Overall Study|Death|1|||
127782978|NCT02844816|459831462|FG000|Overall Study|Disease progression/recurrence|50|||
127782979|NCT02844816|459831463|FG001|Overall Study|Disease progression/recurrence|24|||
127782980|NCT02844816|459831462|FG000|Overall Study|Physician Decision|1|||
127782981|NCT02844816|459831463|FG001|Overall Study|Physician Decision|1|||
127782982|NCT01133379|459831464|FG000|Overall Study|Withdrawal by Subject|0|||
127782983|NCT01133379|459831465|FG001|Overall Study|Withdrawal by Subject|1|||
127782984|NCT01133379|459831466|FG002|Overall Study|Withdrawal by Subject|1|||
127782985|NCT01133379|459831464|FG000|Overall Study|Lost to Follow-up|1|||
127782986|NCT01133379|459831465|FG001|Overall Study|Lost to Follow-up|1|||
127782987|NCT01133379|459831466|FG002|Overall Study|Lost to Follow-up|1|||
127782988|NCT00591214|459831467|FG000|Overall Study|Physician Decision|7|||
127782989|NCT00591214|459831467|FG000|Overall Study|Withdrawal by Subject|1|||
127782990|NCT02142738|459832894|FG000|Overall Study|Adverse Event|13|||
127782991|NCT02142738|459832895|FG001|Overall Study|Adverse Event|9|||
127782992|NCT02142738|459832894|FG000|Overall Study|Death|92|||
127782993|NCT02142738|459832895|FG001|Overall Study|Death|112|||
127782994|NCT02142738|459832894|FG000|Overall Study|Lost to Follow-up|0|||
127782995|NCT02142738|459832895|FG001|Overall Study|Lost to Follow-up|3|||
127782996|NCT02142738|459832894|FG000|Overall Study|Withdrawal by Subject|6|||
127782997|NCT02142738|459832895|FG001|Overall Study|Withdrawal by Subject|7|||
127782998|NCT02142738|459832894|FG000|Overall Study|Follow up ended by sponsor|43|||
127782999|NCT02142738|459832895|FG001|Overall Study|Follow up ended by sponsor|20|||
127783000|NCT03688880|459832896|FG000|Overall Study|Withdrawal by Subject|0|||
127783001|NCT03688880|459832897|FG001|Overall Study|Withdrawal by Subject|2|||
127579328|NCT00004635|459092493|FG001|Period Two|secondary malignancy|1|||
127579329|NCT00004635|459092492|FG000|Period Two|Lost to Follow-up|1|||
127579330|NCT00004635|459092493|FG001|Period Two|Lost to Follow-up|0|||
127579331|NCT00004635|459092492|FG000|Period Two|discrepancy in data entry|0|||
127579332|NCT00004635|459092493|FG001|Period Two|discrepancy in data entry|1|||
127579333|NCT01890746|459092494|FG000|Overall Study|Death|39|||
127579334|NCT01890746|459092495|FG001|Overall Study|Death|30|||
127579335|NCT01890746|459092494|FG000|Overall Study|Adverse Event|1|||
127579336|NCT01890746|459092495|FG001|Overall Study|Adverse Event|0|||
127579337|NCT01890746|459092494|FG000|Overall Study|Lost to Follow-up|4|||
127579338|NCT01890746|459092495|FG001|Overall Study|Lost to Follow-up|1|||
127783002|NCT03688880|459832896|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
127783003|NCT03688880|459832897|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
127783004|NCT03688880|459832896|FG000|Overall Study|Lost to Follow-up|4|||
127783005|NCT03688880|459832897|FG001|Overall Study|Lost to Follow-up|7|||
127783006|NCT03688880|459832896|FG000|Overall Study|Adverse Event|0|||
127783007|NCT03688880|459832897|FG001|Overall Study|Adverse Event|2|||
127783008|NCT03688880|459832896|FG000|Overall Study|Device deficiencies|0|||
127783009|NCT03688880|459832897|FG001|Overall Study|Device deficiencies|2|||
127783010|NCT03688880|459832896|FG000|Overall Study|Other|10|||
127783011|NCT03688880|459832897|FG001|Overall Study|Other|16|||
127579339|NCT01890746|459092494|FG000|Overall Study|Physician Decision|3|||
127579340|NCT01890746|459092495|FG001|Overall Study|Physician Decision|2|||
127579341|NCT01890746|459092494|FG000|Overall Study|Withdrawal by Subject|5|||
127579342|NCT01890746|459092495|FG001|Overall Study|Withdrawal by Subject|8|||
127579343|NCT02642029|459092496|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
127579344|NCT02642029|459092497|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
127579345|NCT02642029|459092498|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
127579346|NCT02642029|459092499|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
127783012|NCT04490395|459832898|FG000|Overall Study|Lost to Follow-up|0|||
127783013|NCT04490395|459832899|FG001|Overall Study|Lost to Follow-up|1|||
127783014|NCT01942148|459832900|FG000|Overall Study|Adverse Event|4|||
127783015|NCT01942148|459832900|FG000|Overall Study|Lack of Efficacy|2|||
127783016|NCT01942148|459832900|FG000|Overall Study|Physician Decision|11|||
127783017|NCT01942148|459832900|FG000|Overall Study|Protocol Violation|1|||
127783018|NCT01942148|459832900|FG000|Overall Study|Withdrawal by Subject|8|||
127783019|NCT01942148|459832900|FG000|Overall Study|Use of the prohibition medicine|1|||
127783020|NCT00257725|459832902|FG000|Overall Study|Adverse Event|3|||
127783021|NCT01858532|459832903|FG000|Overall Study|Adverse Event|58|||
127783022|NCT01858532|459832904|FG001|Overall Study|Adverse Event|50|||
127783023|NCT01858532|459832905|FG002|Overall Study|Adverse Event|23|||
127783024|NCT01858532|459832906|FG003|Overall Study|Adverse Event|28|||
127783025|NCT01858532|459832903|FG000|Overall Study|Withdrew consent|71|||
127783026|NCT01858532|459832904|FG001|Overall Study|Withdrew consent|93|||
127783027|NCT01858532|459832905|FG002|Overall Study|Withdrew consent|46|||
127783028|NCT01858532|459832906|FG003|Overall Study|Withdrew consent|27|||
127579347|NCT02642029|459092500|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
127579348|NCT02642029|459092501|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
127579349|NCT02642029|459092496|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
127579350|NCT02642029|459092497|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
127579351|NCT02642029|459092498|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
127579352|NCT02642029|459092499|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
127579353|NCT02642029|459092500|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
127579354|NCT02642029|459092501|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
127783029|NCT01858532|459832903|FG000|Overall Study|Lost to Follow-up|17|||
127783030|NCT01858532|459832904|FG001|Overall Study|Lost to Follow-up|26|||
127783031|NCT01858532|459832905|FG002|Overall Study|Lost to Follow-up|11|||
127783032|NCT01858532|459832906|FG003|Overall Study|Lost to Follow-up|14|||
127579355|NCT02642029|459092496|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
127579356|NCT02642029|459092497|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
127579357|NCT02642029|459092498|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
127579358|NCT02642029|459092499|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
127579359|NCT02642029|459092500|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
127579360|NCT02642029|459092501|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
127579361|NCT02642029|459092496|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
127579362|NCT02642029|459092497|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
127579363|NCT02642029|459092498|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
127579364|NCT02642029|459092499|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
127579365|NCT02642029|459092500|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
127579366|NCT02642029|459092501|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
127579367|NCT02642029|459092496|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
127579368|NCT02642029|459092497|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
127579369|NCT02642029|459092498|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
127579370|NCT02642029|459092499|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
127579371|NCT02642029|459092500|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
127579372|NCT02642029|459092501|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
127579373|NCT02642029|459092496|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
127579374|NCT02642029|459092497|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
127579375|NCT02642029|459092498|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
127579376|NCT02642029|459092499|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
127579377|NCT02642029|459092500|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
127579378|NCT02642029|459092501|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
127579379|NCT00676338|459092503|FG000|Overall Study|Adverse Event|6|||
127579380|NCT00676338|459092504|FG001|Overall Study|Adverse Event|6|||
127579381|NCT00676338|459092505|FG002|Overall Study|Adverse Event|5|||
127579382|NCT00676338|459092506|FG003|Overall Study|Adverse Event|1|||
127579383|NCT00676338|459092503|FG000|Overall Study|Lost to Follow-up|4|||
127579384|NCT00676338|459092504|FG001|Overall Study|Lost to Follow-up|1|||
127579385|NCT00676338|459092505|FG002|Overall Study|Lost to Follow-up|3|||
127579386|NCT00676338|459092506|FG003|Overall Study|Lost to Follow-up|4|||
127783033|NCT01858532|459832903|FG000|Overall Study|Deterioration of medical status|3|||
127783034|NCT01858532|459832904|FG001|Overall Study|Deterioration of medical status|4|||
127783035|NCT01858532|459832905|FG002|Overall Study|Deterioration of medical status|3|||
127783036|NCT01858532|459832906|FG003|Overall Study|Deterioration of medical status|7|||
127881381|NCT01652872|460187396|FG001|Overall Study|Withdrawal by Subject|84|||
127579387|NCT00676338|459092503|FG000|Overall Study|Physician Decision|3|||
127579388|NCT00676338|459092504|FG001|Overall Study|Physician Decision|3|||
127579389|NCT00676338|459092505|FG002|Overall Study|Physician Decision|2|||
127579390|NCT00676338|459092506|FG003|Overall Study|Physician Decision|3|||
127579391|NCT00676338|459092503|FG000|Overall Study|Protocol Violation|5|||
127579392|NCT00676338|459092504|FG001|Overall Study|Protocol Violation|9|||
127579393|NCT00676338|459092505|FG002|Overall Study|Protocol Violation|2|||
127579394|NCT00676338|459092506|FG003|Overall Study|Protocol Violation|5|||
127579395|NCT00676338|459092503|FG000|Overall Study|Withdrawal by Subject|17|||
127579396|NCT00676338|459092504|FG001|Overall Study|Withdrawal by Subject|9|||
127579397|NCT00676338|459092505|FG002|Overall Study|Withdrawal by Subject|12|||
127579398|NCT00676338|459092506|FG003|Overall Study|Withdrawal by Subject|6|||
127579399|NCT00676338|459092503|FG000|Overall Study|Entry Criteria Not Met|0|||
127579400|NCT00676338|459092504|FG001|Overall Study|Entry Criteria Not Met|2|||
127579401|NCT00676338|459092505|FG002|Overall Study|Entry Criteria Not Met|1|||
127579402|NCT00676338|459092506|FG003|Overall Study|Entry Criteria Not Met|1|||
127579403|NCT00676338|459092503|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
127579404|NCT00676338|459092504|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
127579405|NCT00676338|459092505|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
127579406|NCT00676338|459092506|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
127579407|NCT02122458|459092507|FG000|Overall Study|Withdrawal by Subject|0|||
127579408|NCT02122458|459092508|FG001|Overall Study|Withdrawal by Subject|0|||
127579409|NCT02122458|459092509|FG002|Overall Study|Withdrawal by Subject|0|||
127579410|NCT02122458|459092510|FG003|Overall Study|Withdrawal by Subject|4|||
127579411|NCT02122458|459092511|FG004|Overall Study|Withdrawal by Subject|4|||
127579412|NCT02122458|459092512|FG005|Overall Study|Withdrawal by Subject|4|||
127579413|NCT02122458|459092513|FG006|Overall Study|Withdrawal by Subject|0|||
127579414|NCT02122458|459092507|FG000|Overall Study|Lost to Follow-up|1|||
127579415|NCT02122458|459092508|FG001|Overall Study|Lost to Follow-up|3|||
127579416|NCT02122458|459092509|FG002|Overall Study|Lost to Follow-up|0|||
127579417|NCT02122458|459092510|FG003|Overall Study|Lost to Follow-up|7|||
127579418|NCT02122458|459092511|FG004|Overall Study|Lost to Follow-up|5|||
127579419|NCT02122458|459092512|FG005|Overall Study|Lost to Follow-up|15|||
127579420|NCT02122458|459092513|FG006|Overall Study|Lost to Follow-up|1|||
127579421|NCT02122458|459092507|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
127693560|NCT03453619|459505836|FG002|Core Study (Part A)|Physician Decision|2|||
127693561|NCT03453619|459505837|FG003|Core Study (Part A)|Physician Decision|0|||
127693562|NCT03453619|459505834|FG000|Core Study (Part A)|Withdrawal by Subject|2|||
127693563|NCT03453619|459505835|FG001|Core Study (Part A)|Withdrawal by Subject|0|||
127693564|NCT03453619|459505836|FG002|Core Study (Part A)|Withdrawal by Subject|2|||
127693565|NCT03453619|459505837|FG003|Core Study (Part A)|Withdrawal by Subject|1|||
127693566|NCT03453619|459505834|FG000|Core Study (Part A)|Other|0|||
127693567|NCT03453619|459505835|FG001|Core Study (Part A)|Other|1|||
127693568|NCT03453619|459505836|FG002|Core Study (Part A)|Other|0|||
127693569|NCT03453619|459505837|FG003|Core Study (Part A)|Other|0|||
127693570|NCT03453619|459505834|FG000|Long-Term Extension (Part B)|Adverse Event|1|||
127693571|NCT03453619|459505835|FG001|Long-Term Extension (Part B)|Adverse Event|0|||
127693572|NCT03453619|459505836|FG002|Long-Term Extension (Part B)|Adverse Event|0|||
127693573|NCT03453619|459505837|FG003|Long-Term Extension (Part B)|Adverse Event|0|||
127693574|NCT03453619|459505834|FG000|Long-Term Extension (Part B)|Lost to Follow-up|1|||
127579422|NCT02122458|459092508|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
127579423|NCT02122458|459092509|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
127579424|NCT02122458|459092510|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
127579425|NCT02122458|459092511|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
127693575|NCT03453619|459505835|FG001|Long-Term Extension (Part B)|Lost to Follow-up|0|||
127693576|NCT03453619|459505836|FG002|Long-Term Extension (Part B)|Lost to Follow-up|0|||
127881382|NCT01216319|460187399|FG000|Overall Study|Lost to Follow-up|2|||
127579426|NCT02122458|459092512|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
127579427|NCT02122458|459092513|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
127579428|NCT02122458|459092507|FG000|Overall Study|Adverse Event|1|||
127579429|NCT02122458|459092508|FG001|Overall Study|Adverse Event|0|||
127579430|NCT02122458|459092509|FG002|Overall Study|Adverse Event|0|||
127579431|NCT02122458|459092510|FG003|Overall Study|Adverse Event|0|||
127579432|NCT02122458|459092511|FG004|Overall Study|Adverse Event|0|||
127579433|NCT02122458|459092512|FG005|Overall Study|Adverse Event|0|||
127579434|NCT02122458|459092513|FG006|Overall Study|Adverse Event|0|||
127579435|NCT02122458|459092507|FG000|Overall Study|Experimental Error|0|||
127579436|NCT02122458|459092508|FG001|Overall Study|Experimental Error|0|||
127579437|NCT02122458|459092509|FG002|Overall Study|Experimental Error|0|||
127579438|NCT02122458|459092510|FG003|Overall Study|Experimental Error|0|||
127579439|NCT02122458|459092511|FG004|Overall Study|Experimental Error|3|||
127579440|NCT02122458|459092512|FG005|Overall Study|Experimental Error|0|||
127579441|NCT02122458|459092513|FG006|Overall Study|Experimental Error|0|||
127579442|NCT02122458|459092507|FG000|Overall Study|Deployed or Moved|0|||
127579443|NCT02122458|459092508|FG001|Overall Study|Deployed or Moved|0|||
127579444|NCT02122458|459092509|FG002|Overall Study|Deployed or Moved|0|||
127579445|NCT02122458|459092510|FG003|Overall Study|Deployed or Moved|0|||
127579446|NCT02122458|459092511|FG004|Overall Study|Deployed or Moved|1|||
127579447|NCT02122458|459092512|FG005|Overall Study|Deployed or Moved|0|||
127579448|NCT02122458|459092513|FG006|Overall Study|Deployed or Moved|0|||
127579449|NCT02122458|459092507|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
127579450|NCT02122458|459092508|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
127579451|NCT02122458|459092509|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
127579452|NCT02122458|459092510|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
127579453|NCT02122458|459092511|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
127579454|NCT02122458|459092512|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
127579455|NCT02122458|459092513|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
127579456|NCT02122458|459092507|FG000|Overall Study|Noncompliance|0|||
127579457|NCT02122458|459092508|FG001|Overall Study|Noncompliance|1|||
127579458|NCT02122458|459092509|FG002|Overall Study|Noncompliance|0|||
127579459|NCT02122458|459092510|FG003|Overall Study|Noncompliance|0|||
127579460|NCT02122458|459092511|FG004|Overall Study|Noncompliance|0|||
127579461|NCT02122458|459092512|FG005|Overall Study|Noncompliance|0|||
127579462|NCT02122458|459092513|FG006|Overall Study|Noncompliance|0|||
127579463|NCT03161093|459092514|FG000|Overall Study|Protocol Violation|11|||
127579464|NCT03161093|459092515|FG001|Overall Study|Protocol Violation|14|||
127579465|NCT03161093|459092516|FG002|Overall Study|Protocol Violation|6|||
127693577|NCT03453619|459505837|FG003|Long-Term Extension (Part B)|Lost to Follow-up|1|||
127693578|NCT03453619|459505834|FG000|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
127693579|NCT03453619|459505835|FG001|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
127693580|NCT03453619|459505836|FG002|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
127693581|NCT03453619|459505837|FG003|Long-Term Extension (Part B)|Non-compliance with study drug|1|||
127693582|NCT03453619|459505834|FG000|Long-Term Extension (Part B)|Physician Decision|0|||
127693583|NCT03453619|459505835|FG001|Long-Term Extension (Part B)|Physician Decision|1|||
128030138|NCT04102514|460737131|FG003|Overall Study|Moved to longterm care facility|0|||
128030139|NCT00835549|460737132|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
128030140|NCT00835549|460737133|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
128030141|NCT00835042|460737134|FG000|First Intervention|Withdrawal by Subject|3|||
128030142|NCT00835042|460737135|FG001|First Intervention|Withdrawal by Subject|0|||
128030143|NCT00835042|460737134|FG000|First Intervention|Adverse Event|1|||
128030144|NCT00835042|460737135|FG001|First Intervention|Adverse Event|2|||
128030145|NCT00835042|460737134|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
128030146|NCT00835042|460737135|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
128030147|NCT00619918|460737136|FG000|Overall Study|Withdrawal by Subject|4|||
128030148|NCT00619918|460737137|FG001|Overall Study|Withdrawal by Subject|3|||
128030149|NCT00619918|460737136|FG000|Overall Study|Physician Decision|2|||
128030150|NCT00619918|460737137|FG001|Overall Study|Physician Decision|4|||
128030151|NCT00619918|460737136|FG000|Overall Study|Transfer to outside facility|3|||
128030152|NCT00619918|460737137|FG001|Overall Study|Transfer to outside facility|3|||
128030153|NCT00619918|460737136|FG000|Overall Study|Left before receiving first dose|7|||
128030154|NCT00619918|460737137|FG001|Overall Study|Left before receiving first dose|6|||
127579466|NCT03161093|459092517|FG003|Overall Study|Protocol Violation|13|||
127579467|NCT03161093|459092518|FG004|Overall Study|Protocol Violation|1|||
127579468|NCT03161093|459092519|FG005|Overall Study|Protocol Violation|0|||
127579469|NCT03161093|459092514|FG000|Overall Study|Adverse Event|5|||
127579470|NCT03161093|459092515|FG001|Overall Study|Adverse Event|21|||
127579471|NCT03161093|459092516|FG002|Overall Study|Adverse Event|16|||
127579472|NCT03161093|459092517|FG003|Overall Study|Adverse Event|35|||
127579473|NCT03161093|459092518|FG004|Overall Study|Adverse Event|2|||
127579474|NCT03161093|459092519|FG005|Overall Study|Adverse Event|1|||
127579475|NCT03161093|459092514|FG000|Overall Study|Lack of Efficacy|9|||
127579476|NCT03161093|459092515|FG001|Overall Study|Lack of Efficacy|13|||
128030155|NCT00619918|460737136|FG000|Overall Study|ICU admission|4|||
127579477|NCT03161093|459092516|FG002|Overall Study|Lack of Efficacy|9|||
127579478|NCT03161093|459092517|FG003|Overall Study|Lack of Efficacy|24|||
127579479|NCT03161093|459092518|FG004|Overall Study|Lack of Efficacy|4|||
127579480|NCT03161093|459092519|FG005|Overall Study|Lack of Efficacy|1|||
127579481|NCT03161093|459092514|FG000|Overall Study|Physician Decision|0|||
127579482|NCT03161093|459092515|FG001|Overall Study|Physician Decision|1|||
127579483|NCT03161093|459092516|FG002|Overall Study|Physician Decision|0|||
127579484|NCT03161093|459092517|FG003|Overall Study|Physician Decision|2|||
127579485|NCT03161093|459092518|FG004|Overall Study|Physician Decision|17|||
127579486|NCT03161093|459092519|FG005|Overall Study|Physician Decision|15|||
127579487|NCT03161093|459092514|FG000|Overall Study|Withdrawal by Subject|24|||
127579488|NCT03161093|459092515|FG001|Overall Study|Withdrawal by Subject|73|||
127579489|NCT03161093|459092516|FG002|Overall Study|Withdrawal by Subject|44|||
127579490|NCT03161093|459092517|FG003|Overall Study|Withdrawal by Subject|97|||
127579491|NCT03161093|459092518|FG004|Overall Study|Withdrawal by Subject|11|||
127579492|NCT03161093|459092519|FG005|Overall Study|Withdrawal by Subject|10|||
127579493|NCT03161093|459092514|FG000|Overall Study|Lost to Follow-up|3|||
127579494|NCT03161093|459092515|FG001|Overall Study|Lost to Follow-up|12|||
127579495|NCT03161093|459092516|FG002|Overall Study|Lost to Follow-up|4|||
127579496|NCT03161093|459092517|FG003|Overall Study|Lost to Follow-up|7|||
127579497|NCT03161093|459092518|FG004|Overall Study|Lost to Follow-up|8|||
127579498|NCT03161093|459092519|FG005|Overall Study|Lost to Follow-up|13|||
127579499|NCT03161093|459092514|FG000|Overall Study|Death|3|||
127579500|NCT03161093|459092515|FG001|Overall Study|Death|9|||
127579501|NCT03161093|459092516|FG002|Overall Study|Death|7|||
127579502|NCT03161093|459092517|FG003|Overall Study|Death|9|||
127579503|NCT03161093|459092518|FG004|Overall Study|Death|0|||
127579504|NCT03161093|459092519|FG005|Overall Study|Death|0|||
127579505|NCT03161093|459092514|FG000|Overall Study|Unknown - Not reported|0|||
127579506|NCT03161093|459092515|FG001|Overall Study|Unknown - Not reported|1|||
127579507|NCT03161093|459092516|FG002|Overall Study|Unknown - Not reported|0|||
127579508|NCT03161093|459092517|FG003|Overall Study|Unknown - Not reported|0|||
127579509|NCT03161093|459092518|FG004|Overall Study|Unknown - Not reported|0|||
127579510|NCT03161093|459092519|FG005|Overall Study|Unknown - Not reported|1|||
127579511|NCT02124161|459092520|FG000|Overall Study|Other unspecified|0|||
127579512|NCT02124161|459092521|FG001|Overall Study|Other unspecified|1|||
127579513|NCT02124161|459092520|FG000|Overall Study|Death|1|||
127579514|NCT02124161|459092521|FG001|Overall Study|Death|0|||
127579515|NCT02124161|459092520|FG000|Overall Study|Protocol Violation|2|||
127579516|NCT02124161|459092521|FG001|Overall Study|Protocol Violation|1|||
127579517|NCT02124161|459092520|FG000|Overall Study|Withdrawal by Subject|1|||
127579518|NCT02124161|459092521|FG001|Overall Study|Withdrawal by Subject|2|||
127579519|NCT02124161|459092520|FG000|Overall Study|Adverse Event|2|||
127579520|NCT02124161|459092521|FG001|Overall Study|Adverse Event|0|||
127579521|NCT02124161|459092520|FG000|Overall Study|Does not meet entrance criteria|2|||
127579522|NCT02124161|459092521|FG001|Overall Study|Does not meet entrance criteria|3|||
127579523|NCT02124161|459092520|FG000|Overall Study|No longer meets eligibility criteria|5|||
127579524|NCT02124161|459092521|FG001|Overall Study|No longer meets eligibility criteria|4|||
127579525|NCT02124161|459092520|FG000|Overall Study|Lost to Follow-up|3|||
127579526|NCT02124161|459092521|FG001|Overall Study|Lost to Follow-up|4|||
127579527|NCT02517866|459092522|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
127579528|NCT02517866|459092523|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
127579529|NCT02517866|459092524|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
127579530|NCT02517866|459092522|FG000|Overall Study|Significant Protocol Deviation|4|||
127579531|NCT02517866|459092523|FG001|Overall Study|Significant Protocol Deviation|1|||
127579532|NCT02517866|459092524|FG002|Overall Study|Significant Protocol Deviation|0|||
127579533|NCT02517866|459092522|FG000|Overall Study|Lost to Follow-up|1|||
127579534|NCT02517866|459092523|FG001|Overall Study|Lost to Follow-up|0|||
127579535|NCT02517866|459092524|FG002|Overall Study|Lost to Follow-up|0|||
127579536|NCT02517866|459092522|FG000|Overall Study|Voluntary Withdrawal|2|||
127579537|NCT02517866|459092523|FG001|Overall Study|Voluntary Withdrawal|2|||
127579538|NCT02517866|459092524|FG002|Overall Study|Voluntary Withdrawal|0|||
127579539|NCT02517866|459092522|FG000|Overall Study|Investigator Decision|2|||
127579540|NCT02517866|459092523|FG001|Overall Study|Investigator Decision|1|||
127579541|NCT02517866|459092524|FG002|Overall Study|Investigator Decision|0|||
127881383|NCT01216319|460187399|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
127881384|NCT04529096|460187400|FG000|Overall Study|Adverse Event|6|||
127579542|NCT02517866|459092522|FG000|Overall Study|Reason not specified|2|||
127579543|NCT02517866|459092523|FG001|Overall Study|Reason not specified|0|||
127579544|NCT02517866|459092524|FG002|Overall Study|Reason not specified|0|||
127579545|NCT01797731|459092525|FG000|Overall Study|Didn't have proper radiographs required|3|||
127579546|NCT01797731|459092526|FG001|Overall Study|Didn't have proper radiographs required|3|||
127579547|NCT00091442|459092528|FG000|Overall Study|Progressive Disease|220|||
127579548|NCT00091442|459092529|FG001|Overall Study|Progressive Disease|189|||
127579549|NCT00091442|459092528|FG000|Overall Study|Physician Decision|61|||
127579550|NCT00091442|459092529|FG001|Overall Study|Physician Decision|58|||
127579551|NCT00091442|459092528|FG000|Overall Study|Withdrawal by Subject|38|||
127579552|NCT00091442|459092529|FG001|Overall Study|Withdrawal by Subject|46|||
127579553|NCT00091442|459092528|FG000|Overall Study|Adverse Event|29|||
127579554|NCT00091442|459092529|FG001|Overall Study|Adverse Event|48|||
127579555|NCT00091442|459092528|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
127579556|NCT00091442|459092529|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
127579557|NCT00091442|459092528|FG000|Overall Study|Death|9|||
127579558|NCT00091442|459092529|FG001|Overall Study|Death|7|||
127579559|NCT00091442|459092528|FG000|Overall Study|Lost to Follow-up|1|||
127579560|NCT00091442|459092529|FG001|Overall Study|Lost to Follow-up|3|||
127881385|NCT04529096|460187401|FG001|Overall Study|Adverse Event|1|||
128030156|NCT00619918|460737137|FG001|Overall Study|ICU admission|6|||
128030157|NCT05524948|460737165|FG000|Overall Study|Withdrawal by Subject|1|||
128030158|NCT05524948|460737166|FG001|Overall Study|Withdrawal by Subject|0|||
128030159|NCT05524948|460737165|FG000|Overall Study|Participant did not receive call or showed up for final visit|1|||
128030160|NCT05524948|460737166|FG001|Overall Study|Participant did not receive call or showed up for final visit|1|||
128030161|NCT04661839|460737171|FG000|Overall Study|Not Treated|0|||
128030162|NCT04661839|460737172|FG001|Overall Study|Not Treated|0|||
128030163|NCT04661839|460737173|FG002|Overall Study|Not Treated|1|||
128030164|NCT04661839|460737174|FG003|Overall Study|Not Treated|0|||
128030165|NCT04661839|460737171|FG000|Overall Study|Lost to Follow-up|1|||
128030166|NCT04661839|460737172|FG001|Overall Study|Lost to Follow-up|0|||
128030167|NCT04661839|460737173|FG002|Overall Study|Lost to Follow-up|0|||
128030168|NCT04661839|460737174|FG003|Overall Study|Lost to Follow-up|1|||
128030169|NCT02758626|460737176|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
128030170|NCT02758626|460737177|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
128030171|NCT02758626|460737176|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
128030172|NCT02758626|460737177|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
128030173|NCT02758626|460737176|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
128030174|NCT02758626|460737177|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
128030175|NCT02758626|460737176|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
128030176|NCT02758626|460737177|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
128030177|NCT00855166|460737178|FG000|Overall Study|Adverse Event|0|||
128030178|NCT00855166|460737179|FG001|Overall Study|Adverse Event|2|||
128030179|NCT00855166|460737178|FG000|Overall Study|Death|0|||
128030180|NCT00855166|460737179|FG001|Overall Study|Death|1|||
128030181|NCT00855166|460737178|FG000|Overall Study|Withdrawal by Subject|1|||
128030182|NCT00855166|460737179|FG001|Overall Study|Withdrawal by Subject|4|||
128030183|NCT00855166|460737178|FG000|Overall Study|Poor/non-compliance|2|||
128030184|NCT00855166|460737179|FG001|Overall Study|Poor/non-compliance|0|||
128030185|NCT00855166|460737178|FG000|Overall Study|Administrative reasons by sponsor|1|||
128030186|NCT00855166|460737179|FG001|Overall Study|Administrative reasons by sponsor|0|||
128030187|NCT00855166|460737178|FG000|Overall Study|Subject no longer meets study criteria|1|||
128030188|NCT00855166|460737179|FG001|Overall Study|Subject no longer meets study criteria|1|||
128030189|NCT01848457|460737182|FG000|Overall Study|Death|1|||
128030190|NCT01848457|460737183|FG001|Overall Study|Death|0|||
128030191|NCT01848457|460737184|FG002|Overall Study|Death|0|||
128030192|NCT01848457|460737185|FG003|Overall Study|Death|0|||
128030193|NCT01272219|460737186|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
128030194|NCT01272219|460737187|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
128030195|NCT01272219|460737188|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
128030196|NCT01272219|460737189|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
128030197|NCT01272219|460737190|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
128030198|NCT01272219|460737191|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
128030199|NCT01272219|460737186|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
128030200|NCT01272219|460737187|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
128030201|NCT01272219|460737188|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
128030202|NCT01272219|460737189|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
128030203|NCT01272219|460737190|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
128030204|NCT01272219|460737191|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
128030205|NCT01272219|460737186|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
128030206|NCT01272219|460737187|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
128030207|NCT01272219|460737188|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
128030208|NCT01272219|460737189|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
128030209|NCT01272219|460737190|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
128030210|NCT01272219|460737191|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
128030211|NCT01272219|460737186|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
128030212|NCT01272219|460737187|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
128030213|NCT01272219|460737188|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
128030214|NCT01272219|460737189|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
128030215|NCT01272219|460737190|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
128030216|NCT01272219|460737191|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
128030217|NCT01272219|460737186|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
128030218|NCT01272219|460737187|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
128030219|NCT01272219|460737188|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
128030220|NCT01272219|460737189|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
128030221|NCT01272219|460737190|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
128030222|NCT01272219|460737191|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
128030223|NCT01272219|460737186|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
128030224|NCT01272219|460737187|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
127579561|NCT00091442|459092528|FG000|Overall Study|Other|2|||
127579562|NCT00091442|459092529|FG001|Overall Study|Other|6|||
127579563|NCT00629772|459092534|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
127579564|NCT00629772|459092535|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
127579565|NCT00629772|459092534|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
127579566|NCT00629772|459092535|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
127579567|NCT01393301|459092536|FG000|Overall Study|Lost to Follow-up|5|||
127579568|NCT01393301|459092537|FG001|Overall Study|Lost to Follow-up|3|||
127579569|NCT01393301|459092536|FG000|Overall Study|Withdrawal by Subject|2|||
127579570|NCT01393301|459092537|FG001|Overall Study|Withdrawal by Subject|0|||
127579571|NCT01393301|459092536|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
127579572|NCT01393301|459092537|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
127579573|NCT02758171|459092538|FG000|Wash-out|Withdrawal by Subject|1|||
127579574|NCT02758171|459092539|FG001|Wash-out|Withdrawal by Subject|0|||
127579575|NCT02758171|459092538|FG000|Wash-out|Other reason|1|||
127579576|NCT02758171|459092539|FG001|Wash-out|Other reason|0|||
127579577|NCT00853073|459092540|FG000|Overall Study|Withdrawal by Subject|3|||
127579578|NCT00853073|459092541|FG001|Overall Study|Withdrawal by Subject|2|||
127579579|NCT01999114|459092542|FG000|Overall Study|Adverse Event|8|||
127579580|NCT01999114|459092543|FG001|Overall Study|Adverse Event|7|||
127693584|NCT03453619|459505836|FG002|Long-Term Extension (Part B)|Physician Decision|0|||
127693585|NCT03453619|459505837|FG003|Long-Term Extension (Part B)|Physician Decision|0|||
127579581|NCT01999114|459092544|FG002|Overall Study|Adverse Event|2|||
127579582|NCT01999114|459092545|FG003|Overall Study|Adverse Event|2|||
127579583|NCT01999114|459092546|FG004|Overall Study|Adverse Event|1|||
127579584|NCT01999114|459092542|FG000|Overall Study|Withdrawal by Subject|0|||
128030225|NCT01272219|460737188|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
127579585|NCT01999114|459092543|FG001|Overall Study|Withdrawal by Subject|0|||
127579586|NCT01999114|459092544|FG002|Overall Study|Withdrawal by Subject|1|||
127579587|NCT01999114|459092545|FG003|Overall Study|Withdrawal by Subject|0|||
127579588|NCT01999114|459092546|FG004|Overall Study|Withdrawal by Subject|1|||
127579589|NCT01999114|459092542|FG000|Overall Study|Lost to Follow-up|0|||
127579590|NCT01999114|459092543|FG001|Overall Study|Lost to Follow-up|0|||
127579591|NCT01999114|459092544|FG002|Overall Study|Lost to Follow-up|1|||
127579592|NCT01999114|459092545|FG003|Overall Study|Lost to Follow-up|0|||
127579593|NCT01999114|459092546|FG004|Overall Study|Lost to Follow-up|0|||
127579594|NCT01999114|459092542|FG000|Overall Study|Administrative|0|||
127579595|NCT01999114|459092543|FG001|Overall Study|Administrative|0|||
127579596|NCT01999114|459092544|FG002|Overall Study|Administrative|1|||
127579597|NCT01999114|459092545|FG003|Overall Study|Administrative|1|||
127579598|NCT01999114|459092546|FG004|Overall Study|Administrative|2|||
127579599|NCT01309165|459092549|FG000|Overall Study|Lost to Follow-up|4|||
127579600|NCT01309165|459092550|FG001|Overall Study|Lost to Follow-up|3|||
127579601|NCT01309165|459092549|FG000|Overall Study|Return to work|1|||
127579602|NCT01309165|459092550|FG001|Overall Study|Return to work|2|||
127579603|NCT01309165|459092549|FG000|Overall Study|Left country|0|||
127579604|NCT01309165|459092550|FG001|Overall Study|Left country|1|||
127579605|NCT01309165|459092549|FG000|Overall Study|No transportation|0|||
127579606|NCT01309165|459092550|FG001|Overall Study|No transportation|1|||
127579607|NCT01309165|459092549|FG000|Overall Study|Admitted to hospital for second stroke|1|||
127579608|NCT01309165|459092550|FG001|Overall Study|Admitted to hospital for second stroke|0|||
127579609|NCT02410551|459092554|FG000|Overall Study|Adverse Event|1|||
127579610|NCT02410551|459092554|FG000|Overall Study|Withdrawal by Subject|1|||
127579611|NCT02410551|459092554|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
127579612|NCT01739309|459092555|FG000|Overall Study|Adverse Event|1|||
127579613|NCT01739309|459092555|FG000|Overall Study|Withdrawal by Subject|1|||
127579614|NCT01495975|459092556|FG000|Overall Study|Lost to Follow-up|1|||
127579615|NCT01495975|459092557|FG001|Overall Study|Lost to Follow-up|0|||
127579616|NCT01069627|459092558|FG000|Overall Study|Disease progression|7|||
127579617|NCT01069627|459092558|FG000|Overall Study|Adverse Event|12|||
127579618|NCT01069627|459092558|FG000|Overall Study|Protocol Violation|1|||
127579619|NCT00464269|459092559|FG000|Overall Study|Lack of Efficacy|1|||
127579620|NCT00464269|459092560|FG001|Overall Study|Lack of Efficacy|0|||
127579621|NCT00464269|459092561|FG002|Overall Study|Lack of Efficacy|0|||
127579622|NCT00464269|459092562|FG003|Overall Study|Lack of Efficacy|0|||
127579623|NCT00464269|459092559|FG000|Overall Study|Lost to Follow-up|0|||
127579624|NCT00464269|459092560|FG001|Overall Study|Lost to Follow-up|4|||
127579625|NCT00464269|459092561|FG002|Overall Study|Lost to Follow-up|0|||
127579626|NCT00464269|459092562|FG003|Overall Study|Lost to Follow-up|1|||
127579627|NCT00464269|459092559|FG000|Overall Study|Withdrawal by Subject|0|||
127579628|NCT00464269|459092560|FG001|Overall Study|Withdrawal by Subject|2|||
127579629|NCT00464269|459092561|FG002|Overall Study|Withdrawal by Subject|1|||
127579630|NCT00464269|459092562|FG003|Overall Study|Withdrawal by Subject|1|||
127579631|NCT00464269|459092559|FG000|Overall Study|Other reason|3|||
127579632|NCT00464269|459092560|FG001|Overall Study|Other reason|3|||
127579633|NCT00464269|459092561|FG002|Overall Study|Other reason|1|||
127579634|NCT00464269|459092562|FG003|Overall Study|Other reason|1|||
127579635|NCT00464269|459092559|FG000|Overall Study|AE, serious fatal|0|||
127579636|NCT00464269|459092560|FG001|Overall Study|AE, serious fatal|0|||
127579637|NCT00464269|459092561|FG002|Overall Study|AE, serious fatal|1|||
127579638|NCT00464269|459092562|FG003|Overall Study|AE, serious fatal|1|||
127579639|NCT00464269|459092559|FG000|Overall Study|SAE, non-fatal|0|||
127579640|NCT00464269|459092560|FG001|Overall Study|SAE, non-fatal|0|||
127579641|NCT00464269|459092561|FG002|Overall Study|SAE, non-fatal|0|||
127579642|NCT00464269|459092562|FG003|Overall Study|SAE, non-fatal|1|||
127579643|NCT00464269|459092559|FG000|Overall Study|AE, non-serious non-fatal|2|||
127579644|NCT00464269|459092560|FG001|Overall Study|AE, non-serious non-fatal|8|||
127579645|NCT00464269|459092561|FG002|Overall Study|AE, non-serious non-fatal|3|||
128030226|NCT01272219|460737189|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
128030227|NCT01272219|460737190|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
127579646|NCT00464269|459092562|FG003|Overall Study|AE, non-serious non-fatal|4|||
127579647|NCT00464269|459092559|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
127579648|NCT00464269|459092560|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
127579649|NCT00464269|459092561|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
127579650|NCT00464269|459092562|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
127579651|NCT05055128|459092563|FG000|Overall Study|Adverse Event|0|||
127579652|NCT05055128|459092564|FG001|Overall Study|Adverse Event|0|||
127579653|NCT05055128|459092565|FG002|Overall Study|Adverse Event|0|||
127579654|NCT05055128|459092566|FG003|Overall Study|Adverse Event|1|||
127579655|NCT05055128|459092567|FG004|Overall Study|Adverse Event|1|||
127579656|NCT05055128|459092563|FG000|Overall Study|Protocol Violation|0|||
127579657|NCT05055128|459092564|FG001|Overall Study|Protocol Violation|0|||
127579658|NCT05055128|459092565|FG002|Overall Study|Protocol Violation|0|||
127579659|NCT05055128|459092566|FG003|Overall Study|Protocol Violation|1|||
127579660|NCT05055128|459092567|FG004|Overall Study|Protocol Violation|0|||
127579661|NCT05055128|459092563|FG000|Overall Study|Withdrawal by Subject|5|||
127579662|NCT05055128|459092564|FG001|Overall Study|Withdrawal by Subject|2|||
127579663|NCT05055128|459092565|FG002|Overall Study|Withdrawal by Subject|2|||
127579664|NCT05055128|459092566|FG003|Overall Study|Withdrawal by Subject|4|||
127579665|NCT05055128|459092567|FG004|Overall Study|Withdrawal by Subject|2|||
127579666|NCT05055128|459092563|FG000|Overall Study|Randomized By Mistake|0|||
127579667|NCT05055128|459092564|FG001|Overall Study|Randomized By Mistake|1|||
127579668|NCT05055128|459092565|FG002|Overall Study|Randomized By Mistake|0|||
127579669|NCT05055128|459092566|FG003|Overall Study|Randomized By Mistake|0|||
127579670|NCT05055128|459092567|FG004|Overall Study|Randomized By Mistake|0|||
127579671|NCT05055128|459092563|FG000|Overall Study|Other|1|||
127579672|NCT05055128|459092564|FG001|Overall Study|Other|0|||
127579673|NCT05055128|459092565|FG002|Overall Study|Other|0|||
127579674|NCT05055128|459092566|FG003|Overall Study|Other|0|||
127579675|NCT05055128|459092567|FG004|Overall Study|Other|0|||
127579676|NCT01385371|459092568|FG000|Overall Study|Adverse Event|54|||
127579677|NCT01385371|459092569|FG001|Overall Study|Adverse Event|19|||
127579678|NCT01385371|459092568|FG000|Overall Study|Lost to Follow-up|16|||
127579679|NCT01385371|459092569|FG001|Overall Study|Lost to Follow-up|16|||
127579680|NCT01385371|459092568|FG000|Overall Study|Withdrawal by Subject|52|||
127579681|NCT01385371|459092569|FG001|Overall Study|Withdrawal by Subject|39|||
127579682|NCT01385371|459092568|FG000|Overall Study|Protocol Violation|25|||
127579683|NCT01385371|459092569|FG001|Overall Study|Protocol Violation|21|||
127579684|NCT01385371|459092568|FG000|Overall Study|Administrative|2|||
127579685|NCT01385371|459092569|FG001|Overall Study|Administrative|2|||
127579686|NCT02478372|459092570|FG000|Overall Study|Protocol Violation|12|||
127579687|NCT02478372|459092571|FG001|Overall Study|Protocol Violation|8|||
127579688|NCT02478372|459092570|FG000|Overall Study|Lost to Follow-up|1|||
127579689|NCT02478372|459092571|FG001|Overall Study|Lost to Follow-up|4|||
127579690|NCT02478372|459092570|FG000|Overall Study|Death|0|||
127579691|NCT02478372|459092571|FG001|Overall Study|Death|2|||
127579692|NCT02955797|459092574|FG000|Overall Study|Protocol Violation|1|||
127579693|NCT02955797|459092575|FG001|Overall Study|Protocol Violation|0|||
127579694|NCT02955797|459092576|FG002|Overall Study|Protocol Violation|0|||
127579695|NCT02955797|459092577|FG003|Overall Study|Protocol Violation|1|||
127579696|NCT02955797|459092574|FG000|Overall Study|Withdrawal by Subject|2|||
127579697|NCT02955797|459092575|FG001|Overall Study|Withdrawal by Subject|2|||
127579698|NCT02955797|459092576|FG002|Overall Study|Withdrawal by Subject|0|||
127579699|NCT02955797|459092577|FG003|Overall Study|Withdrawal by Subject|1|||
127579700|NCT02955797|459092574|FG000|Overall Study|Lost to Follow-up|0|||
127579701|NCT02955797|459092575|FG001|Overall Study|Lost to Follow-up|1|||
127579702|NCT02955797|459092576|FG002|Overall Study|Lost to Follow-up|0|||
127579703|NCT02955797|459092577|FG003|Overall Study|Lost to Follow-up|0|||
127579704|NCT02711345|459092579|FG000|Overall Study|Adverse Event|0|||
127579705|NCT02711345|459092580|FG001|Overall Study|Adverse Event|0|||
127579706|NCT02711345|459092581|FG002|Overall Study|Adverse Event|0|||
127579707|NCT02711345|459092582|FG003|Overall Study|Adverse Event|1|||
127579708|NCT02711345|459092583|FG004|Overall Study|Adverse Event|1|||
127579709|NCT02711345|459092584|FG005|Overall Study|Adverse Event|2|||
127579710|NCT02711345|459092585|FG006|Overall Study|Adverse Event|1|||
127579711|NCT02711345|459092586|FG007|Overall Study|Adverse Event|0|||
127579712|NCT02711345|459092587|FG008|Overall Study|Adverse Event|0|||
127579713|NCT02711345|459092588|FG009|Overall Study|Adverse Event|2|||
127579714|NCT02711345|459092579|FG000|Overall Study|Physician Decision|0|||
127579715|NCT02711345|459092580|FG001|Overall Study|Physician Decision|0|||
127579716|NCT02711345|459092581|FG002|Overall Study|Physician Decision|1|||
127579717|NCT02711345|459092582|FG003|Overall Study|Physician Decision|0|||
127579718|NCT02711345|459092583|FG004|Overall Study|Physician Decision|0|||
127579719|NCT02711345|459092584|FG005|Overall Study|Physician Decision|0|||
127579720|NCT02711345|459092585|FG006|Overall Study|Physician Decision|0|||
127579721|NCT02711345|459092586|FG007|Overall Study|Physician Decision|0|||
127579722|NCT02711345|459092587|FG008|Overall Study|Physician Decision|1|||
127579723|NCT02711345|459092588|FG009|Overall Study|Physician Decision|0|||
127579724|NCT02711345|459092579|FG000|Overall Study|Progressive disease|1|||
127579725|NCT02711345|459092580|FG001|Overall Study|Progressive disease|3|||
127579726|NCT02711345|459092581|FG002|Overall Study|Progressive disease|5|||
127693586|NCT05862870|459505838|FG000|Overall Study|Lost to Follow-up|3|||
127579727|NCT02711345|459092582|FG003|Overall Study|Progressive disease|3|||
127579728|NCT02711345|459092583|FG004|Overall Study|Progressive disease|7|||
127579729|NCT02711345|459092584|FG005|Overall Study|Progressive disease|2|||
127579730|NCT02711345|459092585|FG006|Overall Study|Progressive disease|8|||
127579731|NCT02711345|459092586|FG007|Overall Study|Progressive disease|4|||
127579732|NCT02711345|459092587|FG008|Overall Study|Progressive disease|5|||
127579733|NCT02711345|459092588|FG009|Overall Study|Progressive disease|6|||
127579734|NCT02711345|459092579|FG000|Overall Study|Subject/guardian decision|0|||
127579735|NCT02711345|459092580|FG001|Overall Study|Subject/guardian decision|0|||
127579736|NCT02711345|459092581|FG002|Overall Study|Subject/guardian decision|0|||
127579737|NCT02711345|459092582|FG003|Overall Study|Subject/guardian decision|0|||
127579738|NCT02711345|459092583|FG004|Overall Study|Subject/guardian decision|0|||
127579739|NCT02711345|459092584|FG005|Overall Study|Subject/guardian decision|2|||
127579740|NCT02711345|459092585|FG006|Overall Study|Subject/guardian decision|3|||
127579741|NCT02711345|459092586|FG007|Overall Study|Subject/guardian decision|1|||
127579742|NCT02711345|459092587|FG008|Overall Study|Subject/guardian decision|0|||
127579743|NCT02711345|459092588|FG009|Overall Study|Subject/guardian decision|4|||
127579744|NCT02711345|459092579|FG000|Overall Study|Death|1|||
127579745|NCT02711345|459092580|FG001|Overall Study|Death|0|||
127579746|NCT02711345|459092581|FG002|Overall Study|Death|0|||
127579747|NCT02711345|459092582|FG003|Overall Study|Death|0|||
127579748|NCT02711345|459092583|FG004|Overall Study|Death|0|||
127579749|NCT02711345|459092584|FG005|Overall Study|Death|0|||
127579750|NCT02711345|459092585|FG006|Overall Study|Death|0|||
127579751|NCT02711345|459092586|FG007|Overall Study|Death|1|||
127579752|NCT02711345|459092587|FG008|Overall Study|Death|0|||
127579753|NCT02711345|459092588|FG009|Overall Study|Death|0|||
127579754|NCT00961649|459092589|FG000|Overall Study|Adverse Event|4|||
127579755|NCT00961649|459092590|FG001|Overall Study|Adverse Event|0|||
127579756|NCT00961649|459092591|FG002|Overall Study|Adverse Event|0|||
127579757|NCT00961649|459092592|FG003|Overall Study|Adverse Event|2|||
127579758|NCT00961649|459092589|FG000|Overall Study|Inadequate control of IOP|0|||
127579759|NCT00961649|459092590|FG001|Overall Study|Inadequate control of IOP|0|||
127579760|NCT00961649|459092591|FG002|Overall Study|Inadequate control of IOP|0|||
127579761|NCT00961649|459092592|FG003|Overall Study|Inadequate control of IOP|1|||
127579762|NCT00961649|459092589|FG000|Overall Study|Patient has travel plans during holidays|0|||
127579763|NCT00961649|459092590|FG001|Overall Study|Patient has travel plans during holidays|0|||
127579764|NCT00961649|459092591|FG002|Overall Study|Patient has travel plans during holidays|1|||
127579765|NCT00961649|459092592|FG003|Overall Study|Patient has travel plans during holidays|0|||
127579766|NCT00961649|459092589|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
127579767|NCT00961649|459092590|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
127579768|NCT00961649|459092591|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
127579769|NCT00961649|459092592|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
127579770|NCT00961649|459092589|FG000|Overall Study|Study terminated by sponsor|4|||
127579771|NCT00961649|459092590|FG001|Overall Study|Study terminated by sponsor|4|||
127579772|NCT00961649|459092591|FG002|Overall Study|Study terminated by sponsor|4|||
127579773|NCT00961649|459092592|FG003|Overall Study|Study terminated by sponsor|1|||
127579774|NCT04043728|459092593|FG000|Overall Study|Lost to Follow-up|1|||
127579775|NCT04043728|459092594|FG001|Overall Study|Lost to Follow-up|2|||
127579776|NCT04043728|459092595|FG002|Overall Study|Lost to Follow-up|0|||
127579777|NCT01033851|459092596|FG000|Overall Study|Withdrawal by Subject|3|||
127579778|NCT01033851|459092597|FG001|Overall Study|Withdrawal by Subject|7|||
127579779|NCT02349542|459092598|FG000|Overall Study|Withdrawal by Subject|5|||
127579780|NCT01163266|459092601|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
127579781|NCT01163266|459092602|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
127579782|NCT01163266|459092603|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
127579783|NCT01163266|459092601|FG000|Overall Study|Lack of Efficacy|1|||
127579784|NCT01163266|459092602|FG001|Overall Study|Lack of Efficacy|3|||
127783037|NCT01858532|459832903|FG000|Overall Study|Investigator request|3|||
127783038|NCT01858532|459832904|FG001|Overall Study|Investigator request|4|||
127783039|NCT01858532|459832905|FG002|Overall Study|Investigator request|2|||
127783040|NCT01858532|459832906|FG003|Overall Study|Investigator request|6|||
127783041|NCT01858532|459832903|FG000|Overall Study|Other, not specified|29|||
127579785|NCT01163266|459092603|FG002|Overall Study|Lack of Efficacy|1|||
127579786|NCT01163266|459092601|FG000|Overall Study|Noncompliance with Study Drug|0|||
127579787|NCT01163266|459092602|FG001|Overall Study|Noncompliance with Study Drug|2|||
127579788|NCT01163266|459092603|FG002|Overall Study|Noncompliance with Study Drug|0|||
127579789|NCT01163266|459092601|FG000|Overall Study|Protocol Deviations|2|||
127783042|NCT01858532|459832904|FG001|Overall Study|Other, not specified|15|||
127783043|NCT01858532|459832905|FG002|Overall Study|Other, not specified|13|||
127783044|NCT01858532|459832906|FG003|Overall Study|Other, not specified|11|||
127783045|NCT00514514|459832907|FG000|Pre-phase|Death|10|||
127881386|NCT04529096|460187400|FG000|Overall Study|Lack of Efficacy|1|||
127783046|NCT00514514|459832908|FG001|Pre-phase|Death|0|||
127783047|NCT00514514|459832909|FG002|Pre-phase|Death|0|||
127783048|NCT00514514|459832907|FG000|Pre-phase|administrative problems|2|||
127881387|NCT04529096|460187401|FG001|Overall Study|Lack of Efficacy|0|||
127881388|NCT04529096|460187400|FG000|Overall Study|Lost to Follow-up|1|||
127881389|NCT04529096|460187401|FG001|Overall Study|Lost to Follow-up|1|||
128030228|NCT01272219|460737191|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
128030229|NCT01272219|460737186|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
127579790|NCT01163266|459092602|FG001|Overall Study|Protocol Deviations|2|||
127579791|NCT01163266|459092603|FG002|Overall Study|Protocol Deviations|5|||
127579792|NCT01163266|459092601|FG000|Overall Study|Withdrawal of Consent|5|||
127579793|NCT01163266|459092602|FG001|Overall Study|Withdrawal of Consent|7|||
127579794|NCT01163266|459092603|FG002|Overall Study|Withdrawal of Consent|3|||
127579795|NCT01163266|459092601|FG000|Overall Study|Lost to Follow-up|7|||
127881390|NCT04529096|460187400|FG000|Overall Study|Non-Compliance With Study Drug|0|||
127579796|NCT01163266|459092602|FG001|Overall Study|Lost to Follow-up|7|||
127579797|NCT01163266|459092603|FG002|Overall Study|Lost to Follow-up|10|||
127579798|NCT01163266|459092601|FG000|Overall Study|Other|1|||
127579799|NCT01163266|459092602|FG001|Overall Study|Other|1|||
127579800|NCT01163266|459092603|FG002|Overall Study|Other|2|||
127579801|NCT02919696|459092604|FG000|Overall Study|Adverse Event|1|||
127579802|NCT02919696|459092605|FG001|Overall Study|Adverse Event|2|||
127579803|NCT02919696|459092604|FG000|Overall Study|Withdrawal by Subject|2|||
127579804|NCT02919696|459092605|FG001|Overall Study|Withdrawal by Subject|1|||
127579805|NCT02919696|459092604|FG000|Overall Study|Sponsor Decision|1|||
127579806|NCT02919696|459092605|FG001|Overall Study|Sponsor Decision|1|||
127579807|NCT02919696|459092604|FG000|Overall Study|Never Treated|0|||
127579808|NCT02919696|459092605|FG001|Overall Study|Never Treated|1|||
127579809|NCT04308304|459092606|FG000|Overall Study|Withdrawal by Subject|4|||
127579810|NCT04308304|459092607|FG001|Overall Study|Withdrawal by Subject|0|||
127579811|NCT04308304|459092606|FG000|Overall Study|Protocol Violation|1|||
127579812|NCT04308304|459092607|FG001|Overall Study|Protocol Violation|0|||
127579813|NCT00945555|459092608|FG000|Overall Study|Referred to another hospital|5|||
127579814|NCT00945555|459092608|FG000|Overall Study|Worsening condition, intensive care unit|1|||
127579815|NCT00945555|459092608|FG000|Overall Study|Withdrawal by Subject|2|||
127579816|NCT00945555|459092608|FG000|Overall Study|Participant continued treatment at home|1|||
127579817|NCT00945555|459092608|FG000|Overall Study|Death|18|||
127579818|NCT00945555|459092608|FG000|Overall Study|Other|1|||
127579819|NCT01686828|459092610|FG000|Overall Study|Physician Decision|1|||
127579820|NCT01686828|459092611|FG001|Overall Study|Physician Decision|0|||
127579821|NCT01686828|459092612|FG002|Overall Study|Physician Decision|0|||
127579822|NCT01686828|459092613|FG003|Overall Study|Physician Decision|0|||
127579823|NCT01686828|459092610|FG000|Overall Study|New Job|0|||
127579824|NCT01686828|459092611|FG001|Overall Study|New Job|1|||
127579825|NCT01686828|459092612|FG002|Overall Study|New Job|0|||
127579826|NCT01686828|459092613|FG003|Overall Study|New Job|0|||
127579827|NCT01686828|459092610|FG000|Overall Study|Weight Loss|0|||
127579828|NCT01686828|459092611|FG001|Overall Study|Weight Loss|0|||
127579829|NCT01686828|459092612|FG002|Overall Study|Weight Loss|1|||
127579830|NCT01686828|459092613|FG003|Overall Study|Weight Loss|0|||
127579831|NCT01467583|459092614|FG000|Overall Study|Death|1|||
127579832|NCT01467583|459092615|FG001|Overall Study|Death|1|||
127579833|NCT01467583|459092616|FG002|Overall Study|Death|0|||
127579834|NCT01467583|459092614|FG000|Overall Study|Withdrawal by Subject|1|||
127579835|NCT01467583|459092615|FG001|Overall Study|Withdrawal by Subject|0|||
127579836|NCT01467583|459092616|FG002|Overall Study|Withdrawal by Subject|0|||
127579837|NCT01467583|459092614|FG000|Overall Study|Protocol Violation|0|||
127579838|NCT01467583|459092615|FG001|Overall Study|Protocol Violation|0|||
127579839|NCT01467583|459092616|FG002|Overall Study|Protocol Violation|2|||
127579840|NCT05274165|459092619|FG000|Overall Study|Withdrawal by Subject|3|||
127579841|NCT05274165|459092620|FG001|Overall Study|Withdrawal by Subject|3|||
127579842|NCT03360747|459092621|FG000|Overall Study|Voluntary Withdrawal|1|||
127579843|NCT02484690|459092622|FG000|Overall Study|Adverse Event|1|||
127579844|NCT02484690|459092623|FG001|Overall Study|Adverse Event|3|||
127579845|NCT02484690|459092624|FG002|Overall Study|Adverse Event|0|||
127579846|NCT02484690|459092625|FG003|Overall Study|Adverse Event|0|||
127579847|NCT02484690|459092626|FG004|Overall Study|Adverse Event|5|||
127579848|NCT02484690|459092622|FG000|Overall Study|Death|0|||
127579849|NCT02484690|459092623|FG001|Overall Study|Death|0|||
127783049|NCT00514514|459832908|FG001|Pre-phase|administrative problems|0|||
127783050|NCT00514514|459832909|FG002|Pre-phase|administrative problems|0|||
127783051|NCT00514514|459832907|FG000|Pre-phase|Protocol Violation|6|||
127783052|NCT00514514|459832908|FG001|Pre-phase|Protocol Violation|0|||
127783053|NCT00514514|459832909|FG002|Pre-phase|Protocol Violation|0|||
127783054|NCT00514514|459832907|FG000|Pre-phase|condition no longer requires study drug|7|||
127783055|NCT00514514|459832908|FG001|Pre-phase|condition no longer requires study drug|0|||
127783056|NCT00514514|459832909|FG002|Pre-phase|condition no longer requires study drug|0|||
128030230|NCT01272219|460737187|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
128030231|NCT01272219|460737188|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
127579850|NCT02484690|459092624|FG002|Overall Study|Death|0|||
127579851|NCT02484690|459092625|FG003|Overall Study|Death|0|||
127579852|NCT02484690|459092626|FG004|Overall Study|Death|1|||
127579853|NCT02484690|459092622|FG000|Overall Study|Withdrawal by Subject|1|||
127579854|NCT02484690|459092623|FG001|Overall Study|Withdrawal by Subject|3|||
127579855|NCT02484690|459092624|FG002|Overall Study|Withdrawal by Subject|1|||
127579856|NCT02484690|459092625|FG003|Overall Study|Withdrawal by Subject|2|||
127579857|NCT02484690|459092626|FG004|Overall Study|Withdrawal by Subject|0|||
127579858|NCT02484690|459092622|FG000|Overall Study|Physician Decision|2|||
127579859|NCT02484690|459092623|FG001|Overall Study|Physician Decision|0|||
127579860|NCT02484690|459092624|FG002|Overall Study|Physician Decision|1|||
127783057|NCT00514514|459832907|FG000|Pre-phase|abnormal test procedure results|15|||
127579861|NCT02484690|459092625|FG003|Overall Study|Physician Decision|0|||
127579862|NCT02484690|459092626|FG004|Overall Study|Physician Decision|0|||
127579863|NCT02484690|459092622|FG000|Overall Study|Lost to Follow-up|0|||
128030232|NCT01272219|460737189|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
127579864|NCT02484690|459092623|FG001|Overall Study|Lost to Follow-up|0|||
127579865|NCT02484690|459092624|FG002|Overall Study|Lost to Follow-up|1|||
127579866|NCT02484690|459092625|FG003|Overall Study|Lost to Follow-up|0|||
127579867|NCT02484690|459092626|FG004|Overall Study|Lost to Follow-up|0|||
127579868|NCT04916769|459092630|FG000|Period 1|Physician Decision|0|||
127579869|NCT04916769|459092631|FG001|Period 1|Physician Decision|0|||
127579870|NCT04916769|459092632|FG002|Period 1|Physician Decision|0|||
127579871|NCT04916769|459092633|FG003|Period 1|Physician Decision|0|||
127579872|NCT04916769|459092634|FG004|Period 1|Physician Decision|0|||
127579873|NCT04916769|459092635|FG005|Period 1|Physician Decision|1|||
127579874|NCT04916769|459092630|FG000|Period 2|Physician Decision|0|||
127579875|NCT04916769|459092631|FG001|Period 2|Physician Decision|1|||
127579876|NCT04916769|459092632|FG002|Period 2|Physician Decision|0|||
127579877|NCT04916769|459092633|FG003|Period 2|Physician Decision|0|||
127579878|NCT04916769|459092634|FG004|Period 2|Physician Decision|0|||
127579879|NCT04916769|459092635|FG005|Period 2|Physician Decision|0|||
127579880|NCT01386008|459092648|FG000|Overall Study|exited w/o incident /study discontinued|17|||
127579881|NCT01386008|459092648|FG000|Overall Study|Adverse Event|3|||
127579882|NCT03001882|459092649|FG000|Overall Study|Death|1|||
127579883|NCT03001882|459092650|FG001|Overall Study|Death|0|||
127579884|NCT03001882|459092651|FG002|Overall Study|Death|0|||
127579885|NCT03001882|459092652|FG003|Overall Study|Death|3|||
127579886|NCT03001882|459092649|FG000|Overall Study|Participant withdrew consent|0|||
127579887|NCT03001882|459092650|FG001|Overall Study|Participant withdrew consent|1|||
127579888|NCT03001882|459092651|FG002|Overall Study|Participant withdrew consent|0|||
127579889|NCT03001882|459092652|FG003|Overall Study|Participant withdrew consent|5|||
127579890|NCT03001882|459092649|FG000|Overall Study|Other reasons|1|||
127579891|NCT03001882|459092650|FG001|Overall Study|Other reasons|2|||
127579892|NCT03001882|459092651|FG002|Overall Study|Other reasons|0|||
127579893|NCT03001882|459092652|FG003|Overall Study|Other reasons|5|||
127579894|NCT03001882|459092649|FG000|Overall Study|Administrative reason by sponsor|0|||
127579895|NCT03001882|459092650|FG001|Overall Study|Administrative reason by sponsor|0|||
127579896|NCT03001882|459092651|FG002|Overall Study|Administrative reason by sponsor|0|||
127579897|NCT03001882|459092652|FG003|Overall Study|Administrative reason by sponsor|1|||
127579898|NCT03001882|459092649|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
127579899|NCT03001882|459092650|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
127579900|NCT03001882|459092651|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
127579901|NCT03001882|459092652|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
127579902|NCT03001882|459092649|FG000|Overall Study|Not reported|0|||
127579903|NCT03001882|459092650|FG001|Overall Study|Not reported|0|||
127579904|NCT03001882|459092651|FG002|Overall Study|Not reported|0|||
127579905|NCT03001882|459092652|FG003|Overall Study|Not reported|6|||
127579906|NCT03001882|459092649|FG000|Overall Study|Maximum clinical benefit|2|||
127579907|NCT03001882|459092650|FG001|Overall Study|Maximum clinical benefit|3|||
127579908|NCT03001882|459092651|FG002|Overall Study|Maximum clinical benefit|0|||
127579909|NCT03001882|459092652|FG003|Overall Study|Maximum clinical benefit|10|||
127579910|NCT03001882|459092649|FG000|Overall Study|AE unrelated to study drug|3|||
127579911|NCT03001882|459092650|FG001|Overall Study|AE unrelated to study drug|3|||
127579912|NCT03001882|459092651|FG002|Overall Study|AE unrelated to study drug|0|||
127579913|NCT03001882|459092652|FG003|Overall Study|AE unrelated to study drug|11|||
127579914|NCT03001882|459092649|FG000|Overall Study|Study Drug Toxicity|8|||
127579915|NCT03001882|459092650|FG001|Overall Study|Study Drug Toxicity|5|||
127579916|NCT03001882|459092651|FG002|Overall Study|Study Drug Toxicity|0|||
127579917|NCT03001882|459092652|FG003|Overall Study|Study Drug Toxicity|37|||
127579918|NCT03001882|459092649|FG000|Overall Study|Disease progression|16|||
127579919|NCT03001882|459092650|FG001|Overall Study|Disease progression|14|||
127579920|NCT03001882|459092651|FG002|Overall Study|Disease progression|1|||
127579921|NCT03001882|459092652|FG003|Overall Study|Disease progression|90|||
127579922|NCT00589290|459092653|FG000|Overall Study|Withdrawal by Subject|1|||
127579923|NCT01555983|459092654|FG000|Overall Study|Withdrawal by Subject|1|||
127579924|NCT01555983|459092655|FG001|Overall Study|Withdrawal by Subject|0|||
127579925|NCT01555983|459092656|FG002|Overall Study|Withdrawal by Subject|0|||
127579926|NCT01555983|459092657|FG003|Overall Study|Withdrawal by Subject|0|||
127579927|NCT01555983|459092658|FG004|Overall Study|Withdrawal by Subject|1|||
127579928|NCT01555983|459092659|FG005|Overall Study|Withdrawal by Subject|1|||
127579929|NCT00385762|459094169|FG000|Overall Study|Adverse Event|1|||
127579930|NCT00385762|459094169|FG000|Overall Study|Lost to Follow-up|1|||
127579931|NCT03270644|459094176|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
127693587|NCT00931710|459505848|FG000|Overall Study|Adverse Event|16|||
127693588|NCT00931710|459505849|FG001|Overall Study|Adverse Event|10|||
127693589|NCT00931710|459505848|FG000|Overall Study|Abnormal test procedure results|2|||
127693590|NCT00931710|459505849|FG001|Overall Study|Abnormal test procedure results|0|||
127693591|NCT00931710|459505848|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
127693592|NCT00931710|459505849|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
127693593|NCT00931710|459505848|FG000|Overall Study|Patient withdrew consent|4|||
127579932|NCT03270644|459094176|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
127579933|NCT00615108|459094177|FG000|Overall Study|Adverse Event|122|||
127579934|NCT00615108|459094177|FG000|Overall Study|Other|370|||
127579935|NCT00615108|459094177|FG000|Overall Study|Lost to Follow-up|15|||
127579936|NCT02024529|459094180|FG000|Overall Study|Withdrawal by Subject|11|||
127579937|NCT02024529|459094181|FG001|Overall Study|Withdrawal by Subject|21|||
127579938|NCT02024529|459094180|FG000|Overall Study|Lost to Follow-up|2|||
127579939|NCT02024529|459094181|FG001|Overall Study|Lost to Follow-up|4|||
127579940|NCT00354614|459094182|FG000|Overall Study|Lack of Efficacy|28|||
127579941|NCT01426438|459094183|FG000|Overall Study|Lost to Follow-up|1|||
127579942|NCT01426438|459094184|FG001|Overall Study|Lost to Follow-up|3|||
127579943|NCT01426438|459094183|FG000|Overall Study|Off study Treatment|9|||
127579944|NCT01426438|459094184|FG001|Overall Study|Off study Treatment|3|||
127579945|NCT01426438|459094183|FG000|Overall Study|Poor scan quality|3|||
127579946|NCT01426438|459094184|FG001|Overall Study|Poor scan quality|2|||
127579947|NCT01426438|459094183|FG000|Overall Study|Missed Scan|2|||
127579948|NCT01426438|459094184|FG001|Overall Study|Missed Scan|2|||
127579949|NCT01134731|459094185|FG000|Overall Study|Adverse Event|3|||
127579950|NCT01134731|459094186|FG001|Overall Study|Adverse Event|2|||
127579951|NCT01134731|459094187|FG002|Overall Study|Adverse Event|1|||
127579952|NCT01134731|459094185|FG000|Overall Study|Physician Decision|2|||
127579953|NCT01134731|459094186|FG001|Overall Study|Physician Decision|2|||
127579954|NCT01134731|459094187|FG002|Overall Study|Physician Decision|2|||
127579955|NCT01134731|459094185|FG000|Overall Study|Lack of Efficacy|0|||
127579956|NCT01134731|459094186|FG001|Overall Study|Lack of Efficacy|0|||
127579957|NCT01134731|459094187|FG002|Overall Study|Lack of Efficacy|1|||
127579958|NCT01134731|459094185|FG000|Overall Study|Withdrawal by Subject|3|||
127579959|NCT01134731|459094186|FG001|Overall Study|Withdrawal by Subject|3|||
127579960|NCT01134731|459094187|FG002|Overall Study|Withdrawal by Subject|1|||
127579961|NCT01134731|459094185|FG000|Overall Study|Lost to Follow-up|5|||
127579962|NCT01134731|459094186|FG001|Overall Study|Lost to Follow-up|4|||
127579963|NCT01134731|459094187|FG002|Overall Study|Lost to Follow-up|3|||
127579964|NCT01147640|459094188|FG000|Overall Study|Adverse Event|2|||
127579965|NCT01147640|459094189|FG001|Overall Study|Adverse Event|0|||
127579966|NCT01147640|459094188|FG000|Overall Study|Physician Decision|1|||
127579967|NCT01147640|459094189|FG001|Overall Study|Physician Decision|0|||
127579968|NCT01147640|459094188|FG000|Overall Study|Withdrawal by Subject|1|||
127579969|NCT01147640|459094189|FG001|Overall Study|Withdrawal by Subject|0|||
127579970|NCT01147640|459094188|FG000|Overall Study|Lost to Follow-up|0|||
127579971|NCT01147640|459094189|FG001|Overall Study|Lost to Follow-up|1|||
127579972|NCT01147640|459094188|FG000|Overall Study|Didn't meet eligibility criteria|1|||
127579973|NCT01147640|459094189|FG001|Overall Study|Didn't meet eligibility criteria|0|||
127579974|NCT05095454|459094191|FG000|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|0|||
127579975|NCT05095454|459094192|FG001|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|1|||
128030233|NCT01272219|460737190|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
128030234|NCT01272219|460737191|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
128030235|NCT01272219|460737186|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
128030236|NCT01272219|460737187|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
128030237|NCT01272219|460737188|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
128030238|NCT01272219|460737189|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
128030239|NCT01272219|460737190|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
128030240|NCT01272219|460737191|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
128030241|NCT01272219|460737186|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
128030242|NCT01272219|460737187|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
128030243|NCT01272219|460737188|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
128030244|NCT01272219|460737189|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
128030245|NCT01272219|460737190|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
128030246|NCT01272219|460737191|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
128030247|NCT01272219|460737186|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
128030248|NCT01272219|460737187|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
128030249|NCT01272219|460737188|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
128030250|NCT01272219|460737189|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
128030251|NCT01272219|460737190|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
128030252|NCT01272219|460737191|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
128030253|NCT01272219|460737186|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
128030254|NCT01272219|460737187|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
128030255|NCT01272219|460737188|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
128030256|NCT01272219|460737189|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
128030257|NCT01272219|460737190|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
127579976|NCT03342963|459094193|FG000|Overall Study|Adverse Event|1|||
127579977|NCT03342963|459094194|FG001|Overall Study|Adverse Event|2|||
127579978|NCT03342963|459094195|FG002|Overall Study|Adverse Event|0|||
128030258|NCT01272219|460737191|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
128030259|NCT01272219|460737186|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
128030260|NCT01272219|460737187|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
127579979|NCT03342963|459094196|FG003|Overall Study|Adverse Event|0|||
127579980|NCT03342963|459094193|FG000|Overall Study|Withdrawal by Subject|1|||
127579981|NCT03342963|459094194|FG001|Overall Study|Withdrawal by Subject|0|||
127579982|NCT03342963|459094195|FG002|Overall Study|Withdrawal by Subject|0|||
127579983|NCT03342963|459094196|FG003|Overall Study|Withdrawal by Subject|0|||
127579984|NCT03643575|459094197|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
127579985|NCT03643575|459094198|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
127579986|NCT03643575|459094199|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
127579987|NCT03643575|459094200|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
127579988|NCT03643575|459094201|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
127579989|NCT03643575|459094202|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
127579990|NCT03643575|459094197|FG000|Washout: 7 Days|Adverse Event|1|||
127579991|NCT03643575|459094198|FG001|Washout: 7 Days|Adverse Event|0|||
127579992|NCT03643575|459094199|FG002|Washout: 7 Days|Adverse Event|0|||
127579993|NCT03643575|459094200|FG003|Washout: 7 Days|Adverse Event|0|||
127579994|NCT03643575|459094201|FG004|Washout: 7 Days|Adverse Event|0|||
127579995|NCT03643575|459094202|FG005|Washout: 7 Days|Adverse Event|0|||
127579996|NCT03643575|459094197|FG000|Washout: 7 Days|Non compliance check in|0|||
127579997|NCT03643575|459094198|FG001|Washout: 7 Days|Non compliance check in|1|||
127579998|NCT03643575|459094199|FG002|Washout: 7 Days|Non compliance check in|0|||
127579999|NCT03643575|459094200|FG003|Washout: 7 Days|Non compliance check in|0|||
127580000|NCT03643575|459094201|FG004|Washout: 7 Days|Non compliance check in|0|||
127580001|NCT03643575|459094202|FG005|Washout: 7 Days|Non compliance check in|0|||
127580002|NCT01189604|459094203|FG000|Overall Study|Impossible to visit|0|||
127580003|NCT01189604|459094204|FG001|Overall Study|Impossible to visit|0|||
127580004|NCT01189604|459094205|FG002|Overall Study|Impossible to visit|0|||
127693594|NCT00931710|459505849|FG001|Overall Study|Patient withdrew consent|9|||
127693595|NCT00931710|459505848|FG000|Overall Study|Lost to Follow-up|6|||
127693596|NCT00931710|459505849|FG001|Overall Study|Lost to Follow-up|5|||
127693597|NCT00931710|459505848|FG000|Overall Study|Protocol deviation|1|||
127693598|NCT00931710|459505849|FG001|Overall Study|Protocol deviation|2|||
127693599|NCT04936035|459505850|FG000|Overall Study|Adverse Event|0|||
127693600|NCT04936035|459505851|FG001|Overall Study|Adverse Event|1|||
127693601|NCT04936035|459505852|FG002|Overall Study|Adverse Event|0|||
127693602|NCT04936035|459505853|FG003|Overall Study|Adverse Event|0|||
127693603|NCT04936035|459505854|FG004|Overall Study|Adverse Event|0|||
127693604|NCT04936035|459505850|FG000|Overall Study|Death|0|||
127693605|NCT04936035|459505851|FG001|Overall Study|Death|0|||
127693606|NCT04936035|459505852|FG002|Overall Study|Death|0|||
127693607|NCT04936035|459505853|FG003|Overall Study|Death|1|||
127693608|NCT04936035|459505854|FG004|Overall Study|Death|0|||
127693609|NCT04936035|459505850|FG000|Overall Study|Lost to Follow-up|0|||
127693610|NCT04936035|459505851|FG001|Overall Study|Lost to Follow-up|1|||
127693611|NCT04936035|459505852|FG002|Overall Study|Lost to Follow-up|1|||
127693612|NCT04936035|459505853|FG003|Overall Study|Lost to Follow-up|2|||
127693613|NCT04936035|459505854|FG004|Overall Study|Lost to Follow-up|1|||
127693614|NCT04936035|459505850|FG000|Overall Study|Physician Decision|0|||
127693615|NCT04936035|459505851|FG001|Overall Study|Physician Decision|1|||
127693616|NCT04936035|459505852|FG002|Overall Study|Physician Decision|0|||
127693617|NCT04936035|459505853|FG003|Overall Study|Physician Decision|0|||
127693618|NCT04936035|459505854|FG004|Overall Study|Physician Decision|0|||
127693619|NCT04936035|459505850|FG000|Overall Study|Protocol Deviation|0|||
127693620|NCT04936035|459505851|FG001|Overall Study|Protocol Deviation|0|||
127693621|NCT04936035|459505852|FG002|Overall Study|Protocol Deviation|1|||
127693622|NCT04936035|459505853|FG003|Overall Study|Protocol Deviation|0|||
127693623|NCT04936035|459505854|FG004|Overall Study|Protocol Deviation|0|||
127693624|NCT04936035|459505850|FG000|Overall Study|Subject Stopped Participation in the Study|5|||
127693625|NCT04936035|459505851|FG001|Overall Study|Subject Stopped Participation in the Study|5|||
127693626|NCT04936035|459505852|FG002|Overall Study|Subject Stopped Participation in the Study|1|||
127693627|NCT04936035|459505853|FG003|Overall Study|Subject Stopped Participation in the Study|2|||
127693628|NCT04936035|459505854|FG004|Overall Study|Subject Stopped Participation in the Study|3|||
127693629|NCT04936035|459505850|FG000|Overall Study|Reason Unknown|0|||
127693630|NCT04936035|459505851|FG001|Overall Study|Reason Unknown|0|||
127693631|NCT04936035|459505852|FG002|Overall Study|Reason Unknown|0|||
127693632|NCT04936035|459505853|FG003|Overall Study|Reason Unknown|0|||
127693633|NCT04936035|459505854|FG004|Overall Study|Reason Unknown|1|||
127693634|NCT04936035|459505850|FG000|Overall Study|Withdrawal by Subject|1|||
127693635|NCT04936035|459505851|FG001|Overall Study|Withdrawal by Subject|0|||
127693636|NCT04936035|459505852|FG002|Overall Study|Withdrawal by Subject|0|||
127693637|NCT04936035|459505853|FG003|Overall Study|Withdrawal by Subject|0|||
127693638|NCT04936035|459505854|FG004|Overall Study|Withdrawal by Subject|0|||
127693639|NCT04936035|459505850|FG000|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
127705206|NCT01928394|459551586|FG019|Treatment Period|Lost to Follow-up|0|||
127580005|NCT01189604|459094206|FG003|Overall Study|Impossible to visit|0|||
127580006|NCT01189604|459094207|FG004|Overall Study|Impossible to visit|0|||
127580007|NCT01189604|459094208|FG005|Overall Study|Impossible to visit|1|||
127580008|NCT01189604|459094209|FG006|Overall Study|Impossible to visit|0|||
127580009|NCT01189604|459094203|FG000|Overall Study|Adverse Event|0|||
127580010|NCT01189604|459094204|FG001|Overall Study|Adverse Event|1|||
127580011|NCT01189604|459094205|FG002|Overall Study|Adverse Event|0|||
127580012|NCT01189604|459094206|FG003|Overall Study|Adverse Event|0|||
127580013|NCT01189604|459094207|FG004|Overall Study|Adverse Event|2|||
127580014|NCT01189604|459094208|FG005|Overall Study|Adverse Event|0|||
127580015|NCT01189604|459094209|FG006|Overall Study|Adverse Event|1|||
127580016|NCT01189604|459094203|FG000|Overall Study|Withdrawal by Subject|1|||
127580017|NCT01189604|459094204|FG001|Overall Study|Withdrawal by Subject|0|||
127580018|NCT01189604|459094205|FG002|Overall Study|Withdrawal by Subject|0|||
127580019|NCT01189604|459094206|FG003|Overall Study|Withdrawal by Subject|0|||
127580020|NCT01189604|459094207|FG004|Overall Study|Withdrawal by Subject|0|||
127580021|NCT01189604|459094208|FG005|Overall Study|Withdrawal by Subject|0|||
127580022|NCT01189604|459094209|FG006|Overall Study|Withdrawal by Subject|0|||
127580023|NCT00986830|459094212|FG000|Overall Study|Death|1|||
127580024|NCT00986830|459094212|FG000|Overall Study|Lost to Follow-up|1|||
127580025|NCT00986830|459094212|FG000|Overall Study|Lack of Efficacy|1|||
127580026|NCT00986830|459094212|FG000|Overall Study|Unable to access sinus with device|5|||
127580027|NCT05085730|459094213|FG000|Overall Study|Withdrawal by Subject|4|||
127580028|NCT05085730|459094213|FG000|Overall Study|Physician Decision|1|||
127580029|NCT02038881|459094214|FG000|Overall Study|Withdrawal by Subject|0|||
127580030|NCT02038881|459094215|FG001|Overall Study|Withdrawal by Subject|0|||
127580031|NCT02038881|459094216|FG002|Overall Study|Withdrawal by Subject|1|||
127580032|NCT02038881|459094214|FG000|Overall Study|Lost to Follow-up|2|||
127580033|NCT02038881|459094215|FG001|Overall Study|Lost to Follow-up|0|||
127580034|NCT02038881|459094216|FG002|Overall Study|Lost to Follow-up|0|||
127580035|NCT02038881|459094214|FG000|Overall Study|incarcerated|1|||
127580036|NCT02038881|459094215|FG001|Overall Study|incarcerated|0|||
127580037|NCT02038881|459094216|FG002|Overall Study|incarcerated|0|||
127580038|NCT00333840|459094217|FG000|First-line Treatment Period|Adverse Event|38|||
127580039|NCT00333840|459094218|FG001|First-line Treatment Period|Adverse Event|37|||
127580040|NCT00333840|459094219|FG002|First-line Treatment Period|Adverse Event|0|||
127580041|NCT00333840|459094220|FG003|First-line Treatment Period|Adverse Event|0|||
127580042|NCT00333840|459094217|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
127580043|NCT00333840|459094218|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
127580044|NCT00333840|459094219|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
127580045|NCT00333840|459094220|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
127580046|NCT00333840|459094217|FG000|First-line Treatment Period|Abnormal procedure|2|||
127580047|NCT00333840|459094218|FG001|First-line Treatment Period|Abnormal procedure|0|||
127580048|NCT00333840|459094219|FG002|First-line Treatment Period|Abnormal procedure|0|||
127580049|NCT00333840|459094220|FG003|First-line Treatment Period|Abnormal procedure|0|||
128030261|NCT01272219|460737188|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
128030262|NCT01272219|460737189|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
127580050|NCT00333840|459094217|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
127580051|NCT00333840|459094218|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
127580052|NCT00333840|459094219|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
127580053|NCT00333840|459094220|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
127580054|NCT00333840|459094217|FG000|First-line Treatment Period|No longer required study drug|21|||
127580055|NCT00333840|459094218|FG001|First-line Treatment Period|No longer required study drug|8|||
127580056|NCT00333840|459094219|FG002|First-line Treatment Period|No longer required study drug|0|||
127580057|NCT00333840|459094220|FG003|First-line Treatment Period|No longer required study drug|0|||
127705207|NCT01928394|459551587|FG020|Treatment Period|Lost to Follow-up|0|||
128030263|NCT01272219|460737190|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
128030264|NCT01272219|460737191|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
128030265|NCT01272219|460737186|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
128030266|NCT01272219|460737187|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
128030267|NCT01272219|460737188|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
128030268|NCT01272219|460737189|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
128030269|NCT01272219|460737190|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
128030270|NCT01272219|460737191|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
128030271|NCT01272219|460737186|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
128030272|NCT01272219|460737187|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
128030273|NCT01272219|460737188|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
128030274|NCT01272219|460737189|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
128030275|NCT01272219|460737190|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
128030276|NCT01272219|460737191|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
127580058|NCT00333840|459094217|FG000|First-line Treatment Period|Protocol Violation|17|||
127580059|NCT00333840|459094218|FG001|First-line Treatment Period|Protocol Violation|17|||
127580060|NCT00333840|459094219|FG002|First-line Treatment Period|Protocol Violation|0|||
127580061|NCT00333840|459094220|FG003|First-line Treatment Period|Protocol Violation|0|||
127580062|NCT00333840|459094217|FG000|First-line Treatment Period|Subject withdrew consent|57|||
127580063|NCT00333840|459094218|FG001|First-line Treatment Period|Subject withdrew consent|77|||
127580064|NCT00333840|459094219|FG002|First-line Treatment Period|Subject withdrew consent|0|||
127580065|NCT00333840|459094220|FG003|First-line Treatment Period|Subject withdrew consent|0|||
127580066|NCT00333840|459094217|FG000|First-line Treatment Period|Lost to Follow-up|15|||
127580067|NCT00333840|459094218|FG001|First-line Treatment Period|Lost to Follow-up|6|||
127580068|NCT00333840|459094219|FG002|First-line Treatment Period|Lost to Follow-up|0|||
127580069|NCT00333840|459094220|FG003|First-line Treatment Period|Lost to Follow-up|0|||
127580070|NCT00333840|459094217|FG000|First-line Treatment Period|Administrative problems|12|||
127580071|NCT00333840|459094218|FG001|First-line Treatment Period|Administrative problems|6|||
127580072|NCT00333840|459094219|FG002|First-line Treatment Period|Administrative problems|0|||
127580073|NCT00333840|459094220|FG003|First-line Treatment Period|Administrative problems|0|||
127580074|NCT00333840|459094217|FG000|First-line Treatment Period|Death|19|||
127580075|NCT00333840|459094218|FG001|First-line Treatment Period|Death|2|||
127580076|NCT00333840|459094219|FG002|First-line Treatment Period|Death|0|||
127580077|NCT00333840|459094220|FG003|First-line Treatment Period|Death|0|||
127580078|NCT00333840|459094217|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
127580079|NCT00333840|459094218|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
127580080|NCT00333840|459094219|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
127580081|NCT00333840|459094220|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
127580082|NCT00333840|459094217|FG000|Second-line Treatment Period|Adverse Event|0|||
127580083|NCT00333840|459094218|FG001|Second-line Treatment Period|Adverse Event|0|||
127580084|NCT00333840|459094219|FG002|Second-line Treatment Period|Adverse Event|3|||
127580085|NCT00333840|459094220|FG003|Second-line Treatment Period|Adverse Event|34|||
127580086|NCT00333840|459094217|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
127580087|NCT00333840|459094218|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
127580088|NCT00333840|459094219|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
127580089|NCT00333840|459094220|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
127580090|NCT00333840|459094217|FG000|Second-line Treatment Period|Abnormal procedure|0|||
127580091|NCT00333840|459094218|FG001|Second-line Treatment Period|Abnormal procedure|0|||
127580092|NCT00333840|459094219|FG002|Second-line Treatment Period|Abnormal procedure|0|||
127580093|NCT00333840|459094220|FG003|Second-line Treatment Period|Abnormal procedure|1|||
127580094|NCT00333840|459094217|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
127580095|NCT00333840|459094218|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
127580096|NCT00333840|459094219|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
127580097|NCT00333840|459094220|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
127580098|NCT00333840|459094217|FG000|Second-line Treatment Period|No longer required study drug|0|||
127580099|NCT00333840|459094218|FG001|Second-line Treatment Period|No longer required study drug|0|||
127580100|NCT00333840|459094219|FG002|Second-line Treatment Period|No longer required study drug|1|||
127580101|NCT00333840|459094220|FG003|Second-line Treatment Period|No longer required study drug|14|||
127580102|NCT00333840|459094217|FG000|Second-line Treatment Period|Protocol Violation|0|||
127580103|NCT00333840|459094218|FG001|Second-line Treatment Period|Protocol Violation|0|||
127580104|NCT00333840|459094219|FG002|Second-line Treatment Period|Protocol Violation|1|||
127580105|NCT00333840|459094220|FG003|Second-line Treatment Period|Protocol Violation|10|||
127580106|NCT00333840|459094217|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
127580107|NCT00333840|459094218|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
127580108|NCT00333840|459094219|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
127580109|NCT00333840|459094220|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
127580110|NCT00333840|459094217|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
127580111|NCT00333840|459094218|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
127580112|NCT00333840|459094219|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
127580113|NCT00333840|459094220|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
127580114|NCT00333840|459094217|FG000|Second-line Treatment Period|Administrative problems|0|||
127580115|NCT00333840|459094218|FG001|Second-line Treatment Period|Administrative problems|0|||
127580116|NCT00333840|459094219|FG002|Second-line Treatment Period|Administrative problems|0|||
127580117|NCT00333840|459094220|FG003|Second-line Treatment Period|Administrative problems|7|||
127580118|NCT00333840|459094217|FG000|Second-line Treatment Period|Death|0|||
127580119|NCT00333840|459094218|FG001|Second-line Treatment Period|Death|0|||
127580120|NCT00333840|459094219|FG002|Second-line Treatment Period|Death|0|||
127580121|NCT00333840|459094220|FG003|Second-line Treatment Period|Death|9|||
127580122|NCT01453725|459094221|FG000|Overall Study|Adverse Event|3|||
127580123|NCT01453725|459094222|FG001|Overall Study|Adverse Event|3|||
127580124|NCT01453725|459094221|FG000|Overall Study|Lost to Follow-up|4|||
127580125|NCT01453725|459094222|FG001|Overall Study|Lost to Follow-up|0|||
127580126|NCT01453725|459094221|FG000|Overall Study|Non-compliance With Protocol|1|||
127580127|NCT01453725|459094222|FG001|Overall Study|Non-compliance With Protocol|2|||
127580128|NCT01453725|459094221|FG000|Overall Study|Protocol Violation|1|||
127580129|NCT01453725|459094222|FG001|Overall Study|Protocol Violation|0|||
127580130|NCT01453725|459094221|FG000|Overall Study|Withdrawal by Subject|2|||
127580131|NCT01453725|459094222|FG001|Overall Study|Withdrawal by Subject|3|||
127580132|NCT01453725|459094221|FG000|Overall Study|Pregnancy Wish|0|||
127580133|NCT01453725|459094222|FG001|Overall Study|Pregnancy Wish|2|||
127580134|NCT01453725|459094221|FG000|Overall Study|Pregnancy|1|||
127580135|NCT01453725|459094222|FG001|Overall Study|Pregnancy|0|||
127580136|NCT01453725|459094221|FG000|Overall Study|Physician Decision|1|||
127580137|NCT01453725|459094222|FG001|Overall Study|Physician Decision|1|||
127580138|NCT03719586|459094231|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
127783058|NCT00514514|459832908|FG001|Pre-phase|abnormal test procedure results|0|||
127783059|NCT00514514|459832909|FG002|Pre-phase|abnormal test procedure results|0|||
127783060|NCT00514514|459832907|FG000|Pre-phase|Lost to Follow-up|2|||
127783061|NCT00514514|459832908|FG001|Pre-phase|Lost to Follow-up|0|||
127783062|NCT00514514|459832909|FG002|Pre-phase|Lost to Follow-up|0|||
127783063|NCT00514514|459832907|FG000|Pre-phase|abnormal lab values|23|||
127783064|NCT00514514|459832908|FG001|Pre-phase|abnormal lab values|0|||
127783065|NCT00514514|459832909|FG002|Pre-phase|abnormal lab values|0|||
127783066|NCT00514514|459832907|FG000|Pre-phase|Lack of Efficacy|35|||
127783067|NCT00514514|459832908|FG001|Pre-phase|Lack of Efficacy|0|||
127783068|NCT00514514|459832909|FG002|Pre-phase|Lack of Efficacy|0|||
127783069|NCT00514514|459832907|FG000|Pre-phase|Adverse Event|137|||
127783070|NCT00514514|459832908|FG001|Pre-phase|Adverse Event|0|||
127783071|NCT00514514|459832909|FG002|Pre-phase|Adverse Event|0|||
127783072|NCT00514514|459832907|FG000|Pre-phase|Withdrawal by Subject|66|||
127783073|NCT00514514|459832908|FG001|Pre-phase|Withdrawal by Subject|0|||
127783074|NCT00514514|459832909|FG002|Pre-phase|Withdrawal by Subject|0|||
127783075|NCT00514514|459832907|FG000|Randomized - 9 Month|Death|3|||
127783076|NCT00514514|459832908|FG001|Randomized - 9 Month|Death|2|||
127783077|NCT00514514|459832909|FG002|Randomized - 9 Month|Death|2|||
127783078|NCT00514514|459832907|FG000|Randomized - 9 Month|Administrative problems|1|||
127783079|NCT00514514|459832908|FG001|Randomized - 9 Month|Administrative problems|1|||
127783080|NCT00514514|459832909|FG002|Randomized - 9 Month|Administrative problems|2|||
127783081|NCT00514514|459832907|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
127783082|NCT00514514|459832908|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
127783083|NCT00514514|459832909|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
127783084|NCT00514514|459832907|FG000|Randomized - 9 Month|Protocol Violation|1|||
127783085|NCT00514514|459832908|FG001|Randomized - 9 Month|Protocol Violation|1|||
127783086|NCT00514514|459832909|FG002|Randomized - 9 Month|Protocol Violation|0|||
127783087|NCT00514514|459832907|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
127783088|NCT00514514|459832908|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
127783089|NCT00514514|459832909|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
127783090|NCT00514514|459832907|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
127783091|NCT00514514|459832908|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
127783092|NCT00514514|459832909|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
127783093|NCT00514514|459832907|FG000|Randomized - 9 Month|Adverse Event|25|||
127783094|NCT00514514|459832908|FG001|Randomized - 9 Month|Adverse Event|44|||
127783095|NCT00514514|459832909|FG002|Randomized - 9 Month|Adverse Event|27|||
127783096|NCT00514514|459832907|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
127783097|NCT00514514|459832908|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
127783098|NCT00514514|459832909|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
127783099|NCT00514514|459832907|FG000|Extension - 4 Years|Lost to Follow-up|12|||
127783100|NCT00514514|459832908|FG001|Extension - 4 Years|Lost to Follow-up|10|||
127783101|NCT00514514|459832909|FG002|Extension - 4 Years|Lost to Follow-up|9|||
127783102|NCT00514514|459832907|FG000|Extension - 4 Years|Administrative problems|3|||
127783103|NCT00514514|459832908|FG001|Extension - 4 Years|Administrative problems|1|||
127783104|NCT00514514|459832909|FG002|Extension - 4 Years|Administrative problems|1|||
127783105|NCT00514514|459832907|FG000|Extension - 4 Years|Death|8|||
127783106|NCT00514514|459832908|FG001|Extension - 4 Years|Death|3|||
127783107|NCT00514514|459832909|FG002|Extension - 4 Years|Death|6|||
127783108|NCT00514514|459832907|FG000|Extension - 4 Years|Adverse Event|9|||
127783109|NCT00514514|459832908|FG001|Extension - 4 Years|Adverse Event|6|||
127783110|NCT00514514|459832909|FG002|Extension - 4 Years|Adverse Event|3|||
127783111|NCT03785925|459832911|FG000|Overall Study|Withdrawal by Subject|15|||
127783112|NCT03785925|459832911|FG000|Overall Study|Lost to Follow-up|1|||
127783113|NCT03794583|459832915|FG000|Overall Study|Death|8|||
127642549|NCT04124926|459313076|FG004|Maintenance Phase|Protocol Violation|0|||
127783114|NCT03794583|459832915|FG000|Overall Study|Study Terminated by Sponsor|24|||
127783115|NCT03794583|459832915|FG000|Overall Study|Withdrawal by Subject|9|||
127783116|NCT00003895|459832916|FG000|Overall Study|Adverse Event|4|||
127783117|NCT00003895|459832917|FG001|Overall Study|Adverse Event|0|||
127783118|NCT00003895|459832916|FG000|Overall Study|Lack of Efficacy|1|||
128030277|NCT01272219|460737186|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
128030278|NCT01272219|460737187|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
128030279|NCT01272219|460737188|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
128030280|NCT01272219|460737189|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
128030281|NCT01272219|460737190|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
128030282|NCT01272219|460737191|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
128030283|NCT01272219|460737186|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
128030284|NCT01272219|460737187|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
128030285|NCT01272219|460737188|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
128030286|NCT01272219|460737189|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
128030287|NCT01272219|460737190|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
128030288|NCT01272219|460737191|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
128030289|NCT03131479|460737192|FG000|Overall Study|Adverse Event|0|||
128030290|NCT03131479|460737193|FG001|Overall Study|Adverse Event|0|||
128030291|NCT03131479|460737194|FG002|Overall Study|Adverse Event|1|||
128030292|NCT03131479|460737195|FG003|Overall Study|Adverse Event|1|||
127580139|NCT03719586|459094232|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
127580140|NCT03719586|459094233|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
127580141|NCT03719586|459094234|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
127580142|NCT01332331|459094236|FG000|Overall Study|Lost to Follow-up|0|||
127580143|NCT01332331|459094237|FG001|Overall Study|Lost to Follow-up|1|||
127580144|NCT01332331|459094236|FG000|Overall Study|Adverse Event|1|||
127580145|NCT01332331|459094237|FG001|Overall Study|Adverse Event|1|||
127580146|NCT01332331|459094236|FG000|Overall Study|Physician Decision|1|||
128030293|NCT03131479|460737196|FG004|Overall Study|Adverse Event|0|||
128030294|NCT03131479|460737192|FG000|Overall Study|Subject/Guardian Decision|0|||
128030295|NCT03131479|460737193|FG001|Overall Study|Subject/Guardian Decision|0|||
128030296|NCT03131479|460737194|FG002|Overall Study|Subject/Guardian Decision|0|||
128030297|NCT03131479|460737195|FG003|Overall Study|Subject/Guardian Decision|1|||
128030298|NCT03131479|460737196|FG004|Overall Study|Subject/Guardian Decision|0|||
128030299|NCT04439903|460737199|FG000|Overall Study|Withdrawal by Subject|2|||
128030300|NCT04439903|460737199|FG000|Overall Study|Screen Failure|1|||
128030301|NCT02899754|460737200|FG000|Overall Study|Lost to Follow-up|7|||
128030302|NCT02899754|460737201|FG001|Overall Study|Lost to Follow-up|9|||
128030303|NCT04818229|460737204|FG000|Overall Study|The cohort was canceled due to COVID-19|20|||
128030304|NCT04818229|460737205|FG001|Overall Study|The cohort was canceled due to COVID-19|10|||
128030305|NCT04818229|460737206|FG002|Overall Study|The cohort was canceled due to COVID-19|10|||
128030306|NCT04818229|460737204|FG000|Overall Study|Adverse Event|3|||
128030307|NCT04818229|460737205|FG001|Overall Study|Adverse Event|1|||
128030308|NCT04818229|460737206|FG002|Overall Study|Adverse Event|1|||
128030309|NCT04818229|460737204|FG000|Overall Study|Withdrawal by Subject|0|||
128030310|NCT04818229|460737205|FG001|Overall Study|Withdrawal by Subject|0|||
128030311|NCT04818229|460737206|FG002|Overall Study|Withdrawal by Subject|2|||
128030312|NCT04818229|460737204|FG000|Overall Study|Lost to Follow-up|0|||
128030313|NCT04818229|460737205|FG001|Overall Study|Lost to Follow-up|0|||
128030314|NCT04818229|460737206|FG002|Overall Study|Lost to Follow-up|1|||
128030315|NCT04082364|460737207|FG000|Overall Study|Death|23|||
128030316|NCT04082364|460737208|FG001|Overall Study|Death|1|||
128030317|NCT04082364|460737209|FG002|Overall Study|Death|1|||
128030318|NCT04082364|460737210|FG003|Overall Study|Death|2|||
128030319|NCT04082364|460737211|FG004|Overall Study|Death|1|||
128030320|NCT04082364|460737207|FG000|Overall Study|Lost to Follow-up|1|||
128030321|NCT04082364|460737208|FG001|Overall Study|Lost to Follow-up|0|||
128030322|NCT04082364|460737209|FG002|Overall Study|Lost to Follow-up|0|||
128030323|NCT04082364|460737210|FG003|Overall Study|Lost to Follow-up|0|||
128030324|NCT04082364|460737211|FG004|Overall Study|Lost to Follow-up|1|||
128030325|NCT04082364|460737207|FG000|Overall Study|Physician Decision|1|||
127580147|NCT01332331|459094237|FG001|Overall Study|Physician Decision|0|||
127580148|NCT00178633|459094238|FG000|Overall Study|Lost to Follow-up|6|||
127580149|NCT00369707|459094239|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
127580150|NCT00369707|459094239|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
127580151|NCT00369707|459094239|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
127693640|NCT04936035|459505851|FG001|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
128030326|NCT04082364|460737208|FG001|Overall Study|Physician Decision|1|||
127693641|NCT04936035|459505852|FG002|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
128030327|NCT04082364|460737209|FG002|Overall Study|Physician Decision|0|||
128030328|NCT04082364|460737210|FG003|Overall Study|Physician Decision|2|||
128030329|NCT04082364|460737211|FG004|Overall Study|Physician Decision|1|||
128030330|NCT04082364|460737207|FG000|Overall Study|Withdrawal by Subject|1|||
128030331|NCT04082364|460737208|FG001|Overall Study|Withdrawal by Subject|1|||
128030332|NCT04082364|460737209|FG002|Overall Study|Withdrawal by Subject|0|||
128030333|NCT04082364|460737210|FG003|Overall Study|Withdrawal by Subject|0|||
128030334|NCT04082364|460737211|FG004|Overall Study|Withdrawal by Subject|1|||
127580152|NCT00369707|459094239|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
127580153|NCT00369707|459094239|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
127580154|NCT00369707|459094239|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
127580155|NCT00369707|459094239|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
127580156|NCT00369707|459094239|FG000|Follow up for 2 Years After Treatment|Death|1|||
127580157|NCT00369707|459094239|FG000|Follow up for 2 Years After Treatment|Other|2|||
127580158|NCT03605212|459094242|FG000|Treatment Period|Adverse Event|1|||
127580159|NCT03605212|459094243|FG001|Treatment Period|Adverse Event|0|||
127580160|NCT03605212|459094244|FG002|Treatment Period|Adverse Event|0|||
127580161|NCT03605212|459094245|FG003|Treatment Period|Adverse Event|0|||
127580162|NCT03605212|459094246|FG004|Treatment Period|Adverse Event|0|||
127580163|NCT03605212|459094242|FG000|Treatment Period|Physician Decision|0|||
127580164|NCT03605212|459094243|FG001|Treatment Period|Physician Decision|0|||
127580165|NCT03605212|459094244|FG002|Treatment Period|Physician Decision|0|||
127580166|NCT03605212|459094245|FG003|Treatment Period|Physician Decision|0|||
127580167|NCT03605212|459094246|FG004|Treatment Period|Physician Decision|1|||
127580168|NCT01756053|459094247|FG000|Period 1 (10 Days)|Protocol Violation|1|||
127580169|NCT01756053|459094248|FG001|Period 1 (10 Days)|Protocol Violation|1|||
127580170|NCT01756053|459094247|FG000|Period 2 (10 Days)|Protocol Violation|0|||
127580171|NCT01756053|459094248|FG001|Period 2 (10 Days)|Protocol Violation|2|||
127580172|NCT01254292|459094249|FG000|Comparative Phase|Adverse Event|25|||
127580173|NCT01254292|459094250|FG001|Comparative Phase|Adverse Event|25|||
127580174|NCT01254292|459094249|FG000|Comparative Phase|Lost to Follow-up|3|||
127580175|NCT01254292|459094250|FG001|Comparative Phase|Lost to Follow-up|21|||
127580176|NCT01254292|459094249|FG000|Comparative Phase|Pregnancy|2|||
127580177|NCT01254292|459094250|FG001|Comparative Phase|Pregnancy|6|||
127580178|NCT01254292|459094249|FG000|Comparative Phase|Withdrawal by Subject|20|||
127580179|NCT01254292|459094250|FG001|Comparative Phase|Withdrawal by Subject|21|||
127580180|NCT01254292|459094249|FG000|Comparative Phase|Protocol Violation|1|||
127580181|NCT01254292|459094250|FG001|Comparative Phase|Protocol Violation|2|||
127580182|NCT01254292|459094249|FG000|Comparative Phase|Wish for pregnancy|4|||
127580183|NCT01254292|459094250|FG001|Comparative Phase|Wish for pregnancy|6|||
127580184|NCT01254292|459094249|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
127580185|NCT01254292|459094250|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
127580186|NCT01254292|459094249|FG000|LCS12 Extension Phase|Adverse Event|9|||
127580187|NCT01254292|459094250|FG001|LCS12 Extension Phase|Adverse Event|0|||
127580188|NCT01254292|459094249|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
127580189|NCT01254292|459094250|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
127580190|NCT01254292|459094249|FG000|LCS12 Extension Phase|Other unknown|4|||
127580191|NCT01254292|459094250|FG001|LCS12 Extension Phase|Other unknown|0|||
127580192|NCT01254292|459094249|FG000|LCS12 Extension Phase|Pregnancy|2|||
127580193|NCT01254292|459094250|FG001|LCS12 Extension Phase|Pregnancy|0|||
127580194|NCT01254292|459094249|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
127580195|NCT01254292|459094250|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
127580196|NCT00285818|459094251|FG000|Overall Study|Withdrawal by Subject|3|||
127580197|NCT00285818|459094252|FG001|Overall Study|Withdrawal by Subject|2|||
127580198|NCT00285818|459094251|FG000|Overall Study|Lost to Follow-up|1|||
127580199|NCT00285818|459094252|FG001|Overall Study|Lost to Follow-up|0|||
127580200|NCT01986140|459094253|FG000|Overall Study|Withdrawal by Subject|31|||
127580201|NCT01986140|459094254|FG001|Overall Study|Withdrawal by Subject|25|||
127580202|NCT01986140|459094253|FG000|Overall Study|alternative treatment|1|||
127580203|NCT01986140|459094254|FG001|Overall Study|alternative treatment|1|||
127580204|NCT01986140|459094253|FG000|Overall Study|found not eligible|3|||
127580205|NCT01986140|459094254|FG001|Overall Study|found not eligible|0|||
127580206|NCT01986140|459094253|FG000|Overall Study|Adverse Event|0|||
127580207|NCT01986140|459094254|FG001|Overall Study|Adverse Event|1|||
127580208|NCT01986140|459094253|FG000|Overall Study|progression disease|0|||
127580209|NCT01986140|459094254|FG001|Overall Study|progression disease|1|||
127580210|NCT00471146|459094263|FG000|Overall Study|Adverse Event|32|||
127580211|NCT00471146|459094264|FG001|Overall Study|Adverse Event|33|||
127580212|NCT00471146|459094263|FG000|Overall Study|Withdrawal by Subject|14|||
127580213|NCT00471146|459094264|FG001|Overall Study|Withdrawal by Subject|11|||
127580214|NCT00471146|459094263|FG000|Overall Study|Death|11|||
127693642|NCT04936035|459505853|FG003|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|2|||
127693643|NCT04936035|459505854|FG004|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
127693644|NCT04936035|459505850|FG000|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
127693645|NCT04936035|459505851|FG001|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
127693646|NCT04936035|459505852|FG002|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
127783119|NCT00003895|459832917|FG001|Overall Study|Lack of Efficacy|1|||
127580215|NCT00471146|459094264|FG001|Overall Study|Death|12|||
127580216|NCT00471146|459094263|FG000|Overall Study|Lost to Follow-up|4|||
127580217|NCT00471146|459094264|FG001|Overall Study|Lost to Follow-up|2|||
127580218|NCT00471146|459094263|FG000|Overall Study|Protocol Violation|2|||
127881391|NCT04529096|460187401|FG001|Overall Study|Non-Compliance With Study Drug|1|||
127881392|NCT04529096|460187400|FG000|Overall Study|Physician Decision|1|||
127881393|NCT04529096|460187401|FG001|Overall Study|Physician Decision|3|||
127881394|NCT04529096|460187400|FG000|Overall Study|Withdrawal by Subject|5|||
127881395|NCT04529096|460187401|FG001|Overall Study|Withdrawal by Subject|0|||
127881396|NCT00929864|460187402|FG000|Overall Study|Death|1|||
127881397|NCT00929864|460187403|FG001|Overall Study|Death|1|||
127881398|NCT00929864|460187402|FG000|Overall Study|Adverse Event|11|||
127881399|NCT00929864|460187403|FG001|Overall Study|Adverse Event|30|||
127881400|NCT00929864|460187402|FG000|Overall Study|Lack of Efficacy|19|||
127881401|NCT00929864|460187403|FG001|Overall Study|Lack of Efficacy|16|||
127881402|NCT00929864|460187402|FG000|Overall Study|Lost to Follow-up|7|||
127881403|NCT00929864|460187403|FG001|Overall Study|Lost to Follow-up|12|||
127881404|NCT00929864|460187402|FG000|Overall Study|Withdrawal by Subject|20|||
127881405|NCT00929864|460187403|FG001|Overall Study|Withdrawal by Subject|9|||
127881406|NCT00929864|460187402|FG000|Overall Study|No longer met criteria|2|||
127881407|NCT00929864|460187403|FG001|Overall Study|No longer met criteria|1|||
127881408|NCT00929864|460187402|FG000|Overall Study|Poor or non-compliance|3|||
127881409|NCT00929864|460187403|FG001|Overall Study|Poor or non-compliance|3|||
127881410|NCT00929864|460187402|FG000|Overall Study|Pregnancy|0|||
127881411|NCT00929864|460187403|FG001|Overall Study|Pregnancy|3|||
127881412|NCT00929864|460187402|FG000|Overall Study|Administrative reason by Sponsor|1|||
127881413|NCT00929864|460187403|FG001|Overall Study|Administrative reason by Sponsor|1|||
127881414|NCT00929864|460187402|FG000|Overall Study|Non-specified|2|||
127881415|NCT00929864|460187403|FG001|Overall Study|Non-specified|7|||
127881416|NCT03454672|460187415|FG000|Overall Study|Adverse Event|1|||
127881417|NCT03454672|460187416|FG001|Overall Study|Adverse Event|1|||
127881418|NCT03454672|460187415|FG000|Overall Study|Lost to Follow-up|1|||
127881419|NCT03454672|460187416|FG001|Overall Study|Lost to Follow-up|3|||
127881420|NCT03454672|460187415|FG000|Overall Study|painful|1|||
127881421|NCT03454672|460187416|FG001|Overall Study|painful|2|||
127881422|NCT03454672|460187415|FG000|Overall Study|Non-compliance|2|||
127881423|NCT03454672|460187416|FG001|Overall Study|Non-compliance|4|||
127881424|NCT03454672|460187415|FG000|Overall Study|personal reasons|3|||
127881425|NCT03454672|460187416|FG001|Overall Study|personal reasons|2|||
127881426|NCT03454672|460187415|FG000|Overall Study|Withdrawal by Subject|1|||
127881427|NCT03454672|460187416|FG001|Overall Study|Withdrawal by Subject|0|||
127881428|NCT03985293|460187418|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
127881429|NCT03985293|460187419|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
127881430|NCT03985293|460187420|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
127881431|NCT03985293|460187421|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
127881432|NCT03985293|460187422|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
127881433|NCT03985293|460187423|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
127881434|NCT03985293|460187418|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
127881435|NCT03985293|460187419|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
127881436|NCT03985293|460187420|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
127881437|NCT03985293|460187421|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
127881438|NCT03985293|460187422|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
127881439|NCT03985293|460187423|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
127881440|NCT03985293|460187418|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
127881441|NCT03985293|460187419|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
127881442|NCT03985293|460187420|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
127881443|NCT03985293|460187421|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
127881444|NCT03985293|460187422|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
127881445|NCT03985293|460187423|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
127881446|NCT03985293|460187418|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
127881447|NCT03985293|460187419|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
127881448|NCT03985293|460187420|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
127881449|NCT03985293|460187421|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
127881450|NCT03985293|460187422|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
127580219|NCT00471146|459094264|FG001|Overall Study|Protocol Violation|2|||
127580220|NCT00471146|459094263|FG000|Overall Study|Objective progression or relapse|84|||
127881451|NCT03985293|460187423|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
127881452|NCT03985293|460187418|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
127881453|NCT03985293|460187419|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
127580221|NCT00471146|459094264|FG001|Overall Study|Objective progression or relapse|87|||
127580222|NCT00471146|459094263|FG000|Overall Study|Global deterioration of health status|12|||
127580223|NCT00471146|459094264|FG001|Overall Study|Global deterioration of health status|14|||
127881454|NCT03985293|460187420|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
127881455|NCT03985293|460187421|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
127881456|NCT03985293|460187422|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
127881457|NCT03985293|460187423|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
127881458|NCT03985293|460187418|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
127881459|NCT03985293|460187419|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
127881460|NCT03985293|460187420|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
127881461|NCT03985293|460187421|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
128030335|NCT04082364|460737207|FG000|Overall Study|Follow-up terminated by Sponsor|5|||
128030336|NCT04082364|460737208|FG001|Overall Study|Follow-up terminated by Sponsor|0|||
127580224|NCT00471146|459094263|FG000|Overall Study|Randomized but not treated|9|||
127580225|NCT00471146|459094264|FG001|Overall Study|Randomized but not treated|8|||
127580226|NCT00471146|459094263|FG000|Overall Study|Other|4|||
127580227|NCT00471146|459094264|FG001|Overall Study|Other|5|||
127580228|NCT02149875|459094265|FG000|Overall Study|Lost to Follow-up|3|||
127580229|NCT02149875|459094266|FG001|Overall Study|Lost to Follow-up|4|||
127881462|NCT03985293|460187422|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
127881463|NCT03985293|460187423|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
127881464|NCT03985293|460187418|FG000|FOLLOW-UP|Lost to Follow-up|0|||
127881465|NCT03985293|460187419|FG001|FOLLOW-UP|Lost to Follow-up|0|||
127881466|NCT03985293|460187420|FG002|FOLLOW-UP|Lost to Follow-up|1|||
127881467|NCT03985293|460187421|FG003|FOLLOW-UP|Lost to Follow-up|0|||
127881468|NCT03985293|460187422|FG004|FOLLOW-UP|Lost to Follow-up|0|||
127881469|NCT03985293|460187423|FG005|FOLLOW-UP|Lost to Follow-up|0|||
127881470|NCT00390572|460187424|FG000|Overall Study|Lost to Follow-up|8|||
127881471|NCT00390572|460187425|FG001|Overall Study|Lost to Follow-up|4|||
127881472|NCT00390572|460187424|FG000|Overall Study|health condition|0|||
127881473|NCT00390572|460187425|FG001|Overall Study|health condition|1|||
127881474|NCT01345058|460187432|FG000|Overall Study|Withdrawal by Subject|1|||
127881475|NCT01345058|460187433|FG001|Overall Study|Withdrawal by Subject|0|||
127881476|NCT01345058|460187432|FG000|Overall Study|Participant Reported Increase in Events|1|||
127881477|NCT01345058|460187433|FG001|Overall Study|Participant Reported Increase in Events|0|||
127881478|NCT01345058|460187432|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
127881479|NCT01345058|460187433|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
127881480|NCT01345058|460187432|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
127881481|NCT01345058|460187433|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
127881482|NCT01345058|460187432|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
127881483|NCT01345058|460187433|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
127881484|NCT01892020|460187440|FG000|Period 1|Adverse Event|1|||
127881485|NCT01892020|460187441|FG001|Period 1|Adverse Event|1|||
127881486|NCT01892020|460187440|FG000|Period 1|Protocol Violation|2|||
127881487|NCT01892020|460187441|FG001|Period 1|Protocol Violation|4|||
127881488|NCT01892020|460187440|FG000|Period 1|Unclassified|0|||
127881489|NCT01892020|460187441|FG001|Period 1|Unclassified|1|||
127881490|NCT01892020|460187440|FG000|Period 2|Protocol Violation|1|||
127881491|NCT01892020|460187441|FG001|Period 2|Protocol Violation|0|||
127881492|NCT03456726|460188773|FG000|Overall Study|Disease Progression|6|||
127881493|NCT03456726|460188774|FG001|Overall Study|Disease Progression|1|||
127881494|NCT03456726|460188773|FG000|Overall Study|Adverse Event|4|||
127881495|NCT03456726|460188774|FG001|Overall Study|Adverse Event|2|||
127881496|NCT03456726|460188773|FG000|Overall Study|Withdrawal by Subject|1|||
127881497|NCT03456726|460188774|FG001|Overall Study|Withdrawal by Subject|0|||
127881498|NCT03456726|460188773|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
127881499|NCT03456726|460188774|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
127881500|NCT04470622|460188775|FG000|Overall Study|Withdrawal by Subject|0|||
127881501|NCT04470622|460188776|FG001|Overall Study|Withdrawal by Subject|1|||
127881502|NCT04470622|460188775|FG000|Overall Study|Screen Failure|0|||
127881503|NCT04470622|460188776|FG001|Overall Study|Screen Failure|1|||
127881504|NCT04470622|460188775|FG000|Overall Study|Death|0|||
127881505|NCT04470622|460188776|FG001|Overall Study|Death|1|||
127881506|NCT00399490|460188777|FG000|Overall Study|Adverse Event|19|||
127881507|NCT00399490|460188777|FG000|Overall Study|Lack of Efficacy|31|||
127881508|NCT00399490|460188777|FG000|Overall Study|Lost to Follow-up|5|||
128030337|NCT04082364|460737209|FG002|Overall Study|Follow-up terminated by Sponsor|2|||
128030338|NCT04082364|460737210|FG003|Overall Study|Follow-up terminated by Sponsor|3|||
128030339|NCT04082364|460737211|FG004|Overall Study|Follow-up terminated by Sponsor|2|||
128030340|NCT04082364|460737207|FG000|Overall Study|Disease progression|0|||
128030341|NCT04082364|460737208|FG001|Overall Study|Disease progression|0|||
128030342|NCT04082364|460737209|FG002|Overall Study|Disease progression|0|||
127580230|NCT02149875|459094267|FG002|Overall Study|Lost to Follow-up|5|||
127580231|NCT02149875|459094265|FG000|Overall Study|Withdrawal by Subject|3|||
127580232|NCT02149875|459094266|FG001|Overall Study|Withdrawal by Subject|2|||
128030343|NCT04082364|460737210|FG003|Overall Study|Disease progression|1|||
127580233|NCT02149875|459094267|FG002|Overall Study|Withdrawal by Subject|2|||
127881509|NCT00399490|460188777|FG000|Overall Study|Withdrawal by Subject|18|||
127881510|NCT00399490|460188777|FG000|Overall Study|Other|25|||
128030344|NCT04082364|460737211|FG004|Overall Study|Disease progression|0|||
127580234|NCT02149875|459094265|FG000|Overall Study|Physician Decision|1|||
127580235|NCT02149875|459094266|FG001|Overall Study|Physician Decision|2|||
127580236|NCT02149875|459094267|FG002|Overall Study|Physician Decision|2|||
127881511|NCT02576054|460188778|FG000|Overall Study|Withdrawal by Subject|1|||
127881512|NCT01190098|460188779|FG000|Overall Study|Adverse Event|2|||
127881513|NCT01190098|460188780|FG001|Overall Study|Adverse Event|0|||
127881514|NCT01190098|460188779|FG000|Overall Study|Patient coomorbidity|0|||
127881515|NCT01190098|460188780|FG001|Overall Study|Patient coomorbidity|1|||
127580237|NCT01262573|459094268|FG000|Overall Study|Withdrawal by Subject|0|||
127580238|NCT01262573|459094269|FG001|Overall Study|Withdrawal by Subject|1|||
127580239|NCT03800173|459094276|FG000|Overall Study|Lost to Follow-up|0|||
127580240|NCT03800173|459094277|FG001|Overall Study|Lost to Follow-up|0|||
127580241|NCT03800173|459094278|FG002|Overall Study|Lost to Follow-up|0|||
127580242|NCT03800173|459094279|FG003|Overall Study|Lost to Follow-up|0|||
127580243|NCT03800173|459094280|FG004|Overall Study|Lost to Follow-up|1|||
127580244|NCT00936611|459094281|FG000|Overall Study|Progressive Disease|3|||
127580245|NCT00936611|459094281|FG000|Overall Study|New Systemic Therapy|22|||
127580246|NCT00936611|459094281|FG000|Overall Study|Lost to Follow-up|1|||
127580247|NCT00936611|459094281|FG000|Overall Study|Withdrawal by Subject|2|||
127580248|NCT00936611|459094281|FG000|Overall Study|Still on Follow-up|1|||
127580249|NCT00936611|459094281|FG000|Overall Study|Still on Active Therapy|7|||
127580250|NCT00936611|459094281|FG000|Overall Study|Ineligible for Study Drug|3|||
127580251|NCT02507973|459094282|FG000|Overall Study|Adverse Event|1|||
127580252|NCT01011738|459094284|FG000|Overall Study|Death|12|||
127580253|NCT01011738|459094285|FG001|Overall Study|Death|3|||
127580254|NCT01011738|459094286|FG002|Overall Study|Death|0|||
127580255|NCT01011738|459094284|FG000|Overall Study|Unknown reasons|312|||
127580256|NCT01011738|459094285|FG001|Overall Study|Unknown reasons|291|||
127580257|NCT01011738|459094286|FG002|Overall Study|Unknown reasons|17|||
127580258|NCT00543543|459094287|FG000|Base Study|Adverse Event|1|||
127580259|NCT00543543|459094288|FG001|Base Study|Adverse Event|11|||
127580260|NCT00543543|459094289|FG002|Base Study|Adverse Event|0|||
128030345|NCT03186378|460737212|FG000|Overall Study|Lost to Follow-up|1|||
128030346|NCT03186378|460737213|FG001|Overall Study|Lost to Follow-up|0|||
128030347|NCT02514746|460737214|FG000|Overall Study|Chronically Ill|1|||
128030348|NCT02514746|460737215|FG001|Overall Study|Chronically Ill|2|||
128030349|NCT02514746|460737214|FG000|Overall Study|Physician Decision|4|||
128030350|NCT02514746|460737215|FG001|Overall Study|Physician Decision|2|||
128030351|NCT02514746|460737214|FG000|Overall Study|Withdrawal by Subject|12|||
127580261|NCT00543543|459094290|FG003|Base Study|Adverse Event|5|||
127580262|NCT00543543|459094287|FG000|Base Study|Lost to Follow-up|12|||
127580263|NCT00543543|459094288|FG001|Base Study|Lost to Follow-up|749|||
127580264|NCT00543543|459094289|FG002|Base Study|Lost to Follow-up|9|||
127580265|NCT00543543|459094290|FG003|Base Study|Lost to Follow-up|701|||
127580266|NCT00543543|459094287|FG000|Base Study|Physician Decision|0|||
127580267|NCT00543543|459094288|FG001|Base Study|Physician Decision|4|||
127580268|NCT00543543|459094289|FG002|Base Study|Physician Decision|0|||
127580269|NCT00543543|459094290|FG003|Base Study|Physician Decision|7|||
127580270|NCT00543543|459094287|FG000|Base Study|Protocol Violation|0|||
127580271|NCT00543543|459094288|FG001|Base Study|Protocol Violation|6|||
127580272|NCT00543543|459094289|FG002|Base Study|Protocol Violation|0|||
127580273|NCT00543543|459094290|FG003|Base Study|Protocol Violation|6|||
127580274|NCT00543543|459094287|FG000|Base Study|Withdrawal by Subject|7|||
127580275|NCT00543543|459094288|FG001|Base Study|Withdrawal by Subject|482|||
127580276|NCT00543543|459094289|FG002|Base Study|Withdrawal by Subject|5|||
127580277|NCT00543543|459094290|FG003|Base Study|Withdrawal by Subject|503|||
127580278|NCT00543543|459094287|FG000|Extension Study|Adverse Event|0|||
127580279|NCT00543543|459094288|FG001|Extension Study|Adverse Event|0|||
127580280|NCT00543543|459094289|FG002|Extension Study|Adverse Event|0|||
127580281|NCT00543543|459094290|FG003|Extension Study|Adverse Event|5|||
127580282|NCT00543543|459094287|FG000|Extension Study|Lost to Follow-up|0|||
127580283|NCT00543543|459094288|FG001|Extension Study|Lost to Follow-up|0|||
127580284|NCT00543543|459094289|FG002|Extension Study|Lost to Follow-up|0|||
127580285|NCT00543543|459094290|FG003|Extension Study|Lost to Follow-up|77|||
127580286|NCT00543543|459094287|FG000|Extension Study|Physician Decision|0|||
127580287|NCT00543543|459094288|FG001|Extension Study|Physician Decision|0|||
127580288|NCT00543543|459094289|FG002|Extension Study|Physician Decision|0|||
128030352|NCT02514746|460737215|FG001|Overall Study|Withdrawal by Subject|10|||
128030353|NCT02514746|460737214|FG000|Overall Study|Other|5|||
127580289|NCT00543543|459094290|FG003|Extension Study|Physician Decision|7|||
127580290|NCT00543543|459094287|FG000|Extension Study|Pregnancy|0|||
127580291|NCT00543543|459094288|FG001|Extension Study|Pregnancy|0|||
127580292|NCT00543543|459094289|FG002|Extension Study|Pregnancy|0|||
127580293|NCT00543543|459094290|FG003|Extension Study|Pregnancy|6|||
127580294|NCT00543543|459094287|FG000|Extension Study|Protocol Violation|0|||
127580295|NCT00543543|459094288|FG001|Extension Study|Protocol Violation|0|||
127580296|NCT00543543|459094289|FG002|Extension Study|Protocol Violation|0|||
127580297|NCT00543543|459094290|FG003|Extension Study|Protocol Violation|11|||
127580298|NCT00543543|459094287|FG000|Extension Study|Withdrawal by Subject|0|||
128030354|NCT02514746|460737215|FG001|Overall Study|Other|1|||
127580299|NCT00543543|459094288|FG001|Extension Study|Withdrawal by Subject|0|||
127580300|NCT00543543|459094289|FG002|Extension Study|Withdrawal by Subject|0|||
127580301|NCT00543543|459094290|FG003|Extension Study|Withdrawal by Subject|120|||
127580302|NCT02586064|459094291|FG000|Overall Study|Other Obligations|6|||
127580303|NCT02586064|459094292|FG001|Overall Study|Other Obligations|6|||
127580304|NCT02586064|459094291|FG000|Overall Study|Other|3|||
127580305|NCT02586064|459094292|FG001|Overall Study|Other|7|||
128030355|NCT02181413|460737216|FG000|Overall Study|Withdrawal by Subject|45|||
127580306|NCT02586064|459094291|FG000|Overall Study|Never Started|3|||
127580307|NCT02586064|459094292|FG001|Overall Study|Never Started|3|||
127580308|NCT02586064|459094291|FG000|Overall Study|Lost Interest|1|||
127580309|NCT02586064|459094292|FG001|Overall Study|Lost Interest|4|||
127580310|NCT02586064|459094291|FG000|Overall Study|Miscellaneous Life Issues|0|||
127580311|NCT02586064|459094292|FG001|Overall Study|Miscellaneous Life Issues|5|||
127580312|NCT02586064|459094291|FG000|Overall Study|Infrequent Attendance|2|||
127580313|NCT02586064|459094292|FG001|Overall Study|Infrequent Attendance|1|||
127580314|NCT02586064|459094291|FG000|Overall Study|Timed Out|2|||
127580315|NCT02586064|459094292|FG001|Overall Study|Timed Out|0|||
127580316|NCT02586064|459094291|FG000|Overall Study|AUD relapse|0|||
127580317|NCT02586064|459094292|FG001|Overall Study|AUD relapse|2|||
127580318|NCT02586064|459094291|FG000|Overall Study|Legal Issue|1|||
127580319|NCT02586064|459094292|FG001|Overall Study|Legal Issue|0|||
127580320|NCT00484094|459094293|FG000|Overall Study|Discontinued|39|||
127580321|NCT00484094|459094293|FG000|Overall Study|Other|3|||
127580322|NCT00586625|459094294|FG000|Overall Study|Adverse Event|6|||
127580323|NCT00586625|459094295|FG001|Overall Study|Adverse Event|6|||
127580324|NCT00586625|459094294|FG000|Overall Study|Protocol Violation|3|||
127580325|NCT00586625|459094295|FG001|Overall Study|Protocol Violation|0|||
127580326|NCT00586625|459094294|FG000|Overall Study|Withdrawal by Subject|32|||
127580327|NCT00586625|459094295|FG001|Overall Study|Withdrawal by Subject|10|||
127580328|NCT00586625|459094294|FG000|Overall Study|Subject non-compliance|0|||
127580329|NCT00586625|459094295|FG001|Overall Study|Subject non-compliance|1|||
127580330|NCT00586625|459094294|FG000|Overall Study|Subject unable to return for visit|2|||
127580331|NCT00586625|459094295|FG001|Overall Study|Subject unable to return for visit|0|||
127580332|NCT00165984|459094296|FG000|Overall Study|Death|15|||
127580333|NCT03945266|459094297|FG000|Overall Study|Withdrawal by Subject|1|||
127580334|NCT03945266|459094298|FG001|Overall Study|Withdrawal by Subject|0|||
127580335|NCT03945266|459094297|FG000|Overall Study|Miscarriage|0|||
127580336|NCT03945266|459094298|FG001|Overall Study|Miscarriage|2|||
127580337|NCT03945266|459094297|FG000|Overall Study|Lost to Follow-up|1|||
127580338|NCT03945266|459094298|FG001|Overall Study|Lost to Follow-up|0|||
127580339|NCT03698331|459094300|FG000|Overall Study|Adverse Event|2|||
127580340|NCT03698331|459094301|FG001|Overall Study|Adverse Event|3|||
127580341|NCT03698331|459094300|FG000|Overall Study|Withdrawal by Subject|1|||
127580342|NCT03698331|459094301|FG001|Overall Study|Withdrawal by Subject|1|||
127580343|NCT03698331|459094300|FG000|Overall Study|Lost to Follow-up|0|||
127580344|NCT03698331|459094301|FG001|Overall Study|Lost to Follow-up|2|||
127580345|NCT03698331|459094300|FG000|Overall Study|Non-compliance with study drug|1|||
127580346|NCT03698331|459094301|FG001|Overall Study|Non-compliance with study drug|0|||
127580347|NCT02130024|459094302|FG000|Overall Study|Adverse Event|10|||
127580348|NCT02130024|459094303|FG001|Overall Study|Adverse Event|11|||
127580349|NCT02130024|459094302|FG000|Overall Study|Death|2|||
127580350|NCT02130024|459094303|FG001|Overall Study|Death|2|||
127580351|NCT02130024|459094302|FG000|Overall Study|Lost to Follow-up|1|||
127580352|NCT02130024|459094303|FG001|Overall Study|Lost to Follow-up|1|||
127580353|NCT02130024|459094302|FG000|Overall Study|Physician Decision|1|||
127580354|NCT02130024|459094303|FG001|Overall Study|Physician Decision|3|||
127580355|NCT02130024|459094302|FG000|Overall Study|Protocol Deviation|4|||
127580356|NCT02130024|459094303|FG001|Overall Study|Protocol Deviation|0|||
127580357|NCT02130024|459094302|FG000|Overall Study|Site Administration Problems|1|||
127580358|NCT02130024|459094303|FG001|Overall Study|Site Administration Problems|0|||
127580359|NCT02130024|459094302|FG000|Overall Study|Subject Withdrew Consent|6|||
127580360|NCT02130024|459094303|FG001|Overall Study|Subject Withdrew Consent|14|||
127580361|NCT04526509|459094304|FG000|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|40|||
127580362|NCT04526509|459094305|FG001|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
127580363|NCT04526509|459094306|FG002|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
127580364|NCT04526509|459094307|FG003|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
127580365|NCT04526509|459094308|FG004|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
127580366|NCT04526509|459094309|FG005|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
127580367|NCT04526509|459094310|FG006|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
127580368|NCT04526509|459094304|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|9|||
127580369|NCT04526509|459094305|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
127580370|NCT04526509|459094306|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
127580371|NCT04526509|459094307|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
127783120|NCT00003895|459832916|FG000|Overall Study|Patient Vacation|2|||
127783121|NCT00003895|459832917|FG001|Overall Study|Patient Vacation|0|||
127783122|NCT00003895|459832916|FG000|Overall Study|Withdrawal by Subject|0|||
127580372|NCT04526509|459094308|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
127783123|NCT00003895|459832917|FG001|Overall Study|Withdrawal by Subject|3|||
127783124|NCT00806195|459832920|FG000|Overall Study|Death|6|||
127881516|NCT01190098|460188779|FG000|Overall Study|Lack of transportation|1|||
127881517|NCT01190098|460188780|FG001|Overall Study|Lack of transportation|0|||
127881518|NCT01190098|460188779|FG000|Overall Study|Other|0|||
127881519|NCT01190098|460188780|FG001|Overall Study|Other|1|||
127881520|NCT02957682|460188781|FG000|Overall Study|Adverse Event|64|||
127881521|NCT02957682|460188782|FG001|Overall Study|Adverse Event|67|||
127881522|NCT02957682|460188781|FG000|Overall Study|Poor Compliance to Protocol|30|||
127881523|NCT02957682|460188782|FG001|Overall Study|Poor Compliance to Protocol|26|||
127881524|NCT02957682|460188781|FG000|Overall Study|Physician Decision|4|||
127881525|NCT02957682|460188782|FG001|Overall Study|Physician Decision|4|||
127881526|NCT02957682|460188781|FG000|Overall Study|Study Terminated by Sponsor|4|||
127881527|NCT02957682|460188782|FG001|Overall Study|Study Terminated by Sponsor|3|||
127881528|NCT02957682|460188781|FG000|Overall Study|Subject Moved|10|||
127881529|NCT02957682|460188782|FG001|Overall Study|Subject Moved|16|||
127881530|NCT02957682|460188781|FG000|Overall Study|Withdrawal by Subject|64|||
127881531|NCT02957682|460188782|FG001|Overall Study|Withdrawal by Subject|33|||
127881532|NCT02957682|460188781|FG000|Overall Study|Related to IMP Administration|3|||
127881533|NCT02957682|460188782|FG001|Overall Study|Related to IMP Administration|6|||
127881534|NCT02957682|460188781|FG000|Overall Study|Non-disclosed|16|||
127881535|NCT02957682|460188782|FG001|Overall Study|Non-disclosed|12|||
127881536|NCT02957682|460188781|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
127881537|NCT02957682|460188782|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
127881538|NCT02703454|460188790|FG000|Overall Study|Not treated|1|||
127881539|NCT02703454|460188791|FG001|Overall Study|Not treated|3|||
127881540|NCT02703454|460188790|FG000|Overall Study|Withdrawal by Subject|4|||
127580373|NCT04526509|459094309|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
127580374|NCT04526509|459094310|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
127580375|NCT04526509|459094304|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|1|||
127580376|NCT04526509|459094305|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
127580377|NCT04526509|459094306|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
127580378|NCT04526509|459094307|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
127580379|NCT04526509|459094308|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
127580380|NCT04526509|459094309|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
127580381|NCT04526509|459094310|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
127580382|NCT04526509|459094304|FG000|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|131|||
127580383|NCT04526509|459094305|FG001|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
127580384|NCT04526509|459094306|FG002|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
127580385|NCT04526509|459094307|FG003|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
127580386|NCT04526509|459094308|FG004|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
127580387|NCT04526509|459094309|FG005|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
127580388|NCT04526509|459094310|FG006|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
127580389|NCT04526509|459094304|FG000|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|97|||
127580390|NCT04526509|459094305|FG001|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
127580391|NCT04526509|459094306|FG002|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
127580392|NCT04526509|459094307|FG003|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
127580393|NCT04526509|459094308|FG004|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
127580394|NCT04526509|459094309|FG005|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
127642550|NCT04124926|459313072|FG000|Maintenance Phase|Lost to Follow-up|0|||
127783125|NCT00806195|459832921|FG001|Overall Study|Death|0|||
127783126|NCT00806195|459832922|FG002|Overall Study|Death|1|||
127783127|NCT00806195|459832923|FG003|Overall Study|Death|0|||
127783128|NCT00806195|459832920|FG000|Overall Study|Adverse Event|25|||
127783129|NCT00806195|459832921|FG001|Overall Study|Adverse Event|5|||
127783130|NCT00806195|459832922|FG002|Overall Study|Adverse Event|11|||
127783131|NCT00806195|459832923|FG003|Overall Study|Adverse Event|2|||
127783132|NCT00806195|459832920|FG000|Overall Study|Withdrawal by Subject|119|||
127783133|NCT00806195|459832921|FG001|Overall Study|Withdrawal by Subject|31|||
127783134|NCT00806195|459832922|FG002|Overall Study|Withdrawal by Subject|76|||
127881541|NCT02703454|460188791|FG001|Overall Study|Withdrawal by Subject|3|||
127881542|NCT02703454|460188790|FG000|Overall Study|Lost to Follow-up|1|||
127881543|NCT02703454|460188791|FG001|Overall Study|Lost to Follow-up|2|||
127881544|NCT02703454|460188790|FG000|Overall Study|Study discontinuation|5|||
127881545|NCT02703454|460188791|FG001|Overall Study|Study discontinuation|8|||
127580395|NCT04526509|459094310|FG006|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
127580396|NCT04526509|459094304|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|23|||
127580397|NCT04526509|459094305|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
127580398|NCT04526509|459094306|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
127580399|NCT04526509|459094307|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
127580400|NCT04526509|459094308|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
127580401|NCT04526509|459094309|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
127580402|NCT04526509|459094310|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
127580403|NCT04526509|459094304|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|6|||
127580404|NCT04526509|459094305|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
127580405|NCT04526509|459094306|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
127580406|NCT04526509|459094307|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
127580407|NCT04526509|459094308|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
127580408|NCT04526509|459094309|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
127580409|NCT04526509|459094310|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
127580410|NCT04526509|459094304|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|4|||
127580411|NCT04526509|459094305|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
127580412|NCT04526509|459094306|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
127580413|NCT04526509|459094307|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
127580414|NCT04526509|459094308|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
127580415|NCT04526509|459094309|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
127580416|NCT04526509|459094310|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
127580417|NCT04526509|459094304|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|3|||
127580418|NCT04526509|459094305|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
127580419|NCT04526509|459094306|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
127580420|NCT04526509|459094307|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
127580421|NCT04526509|459094308|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
127580422|NCT04526509|459094309|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
127580423|NCT04526509|459094310|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
127580424|NCT04526509|459094304|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|1|||
127580425|NCT04526509|459094305|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
127580426|NCT04526509|459094306|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
127580427|NCT04526509|459094307|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
127580428|NCT04526509|459094308|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
127580429|NCT04526509|459094309|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
127580430|NCT04526509|459094310|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
127580431|NCT04526509|459094304|FG000|Enrolled|Study Terminated by Sponsor|0|||
127580432|NCT04526509|459094305|FG001|Enrolled|Study Terminated by Sponsor|0|||
127580433|NCT04526509|459094306|FG002|Enrolled|Study Terminated by Sponsor|0|||
127580434|NCT04526509|459094307|FG003|Enrolled|Study Terminated by Sponsor|0|||
127580435|NCT04526509|459094308|FG004|Enrolled|Study Terminated by Sponsor|0|||
127580436|NCT04526509|459094309|FG005|Enrolled|Study Terminated by Sponsor|0|||
127580437|NCT04526509|459094310|FG006|Enrolled|Study Terminated by Sponsor|1|||
127580438|NCT04526509|459094304|FG000|Enrolled|Death prior to lymphodepletion|0|||
127580439|NCT04526509|459094305|FG001|Enrolled|Death prior to lymphodepletion|0|||
127580440|NCT04526509|459094306|FG002|Enrolled|Death prior to lymphodepletion|0|||
127580441|NCT04526509|459094307|FG003|Enrolled|Death prior to lymphodepletion|1|||
127580442|NCT04526509|459094308|FG004|Enrolled|Death prior to lymphodepletion|0|||
127580443|NCT04526509|459094309|FG005|Enrolled|Death prior to lymphodepletion|0|||
127580444|NCT04526509|459094310|FG006|Enrolled|Death prior to lymphodepletion|0|||
127580445|NCT04526509|459094304|FG000|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
127580446|NCT04526509|459094305|FG001|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
127580447|NCT04526509|459094306|FG002|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
127580448|NCT04526509|459094307|FG003|Enrolled|Did not meet Inclusion/Exclusion Criteria|1|||
127580449|NCT04526509|459094308|FG004|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
127580450|NCT04526509|459094309|FG005|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
127580451|NCT04526509|459094310|FG006|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
127580452|NCT04526509|459094304|FG000|Enrolled|Physician Decision|0|||
127580453|NCT04526509|459094305|FG001|Enrolled|Physician Decision|1|||
127580454|NCT04526509|459094306|FG002|Enrolled|Physician Decision|0|||
127580455|NCT04526509|459094307|FG003|Enrolled|Physician Decision|0|||
127580456|NCT04526509|459094308|FG004|Enrolled|Physician Decision|0|||
127580457|NCT04526509|459094309|FG005|Enrolled|Physician Decision|0|||
127580458|NCT04526509|459094310|FG006|Enrolled|Physician Decision|0|||
127580459|NCT04340193|459094312|FG000|Overall Study|Other reason|0|||
127580460|NCT04340193|459094313|FG001|Overall Study|Other reason|0|||
127580461|NCT04340193|459094314|FG002|Overall Study|Other reason|1|||
127783135|NCT00806195|459832923|FG003|Overall Study|Withdrawal by Subject|35|||
127783136|NCT00806195|459832920|FG000|Overall Study|Lost to Follow-up|217|||
127783137|NCT00806195|459832921|FG001|Overall Study|Lost to Follow-up|66|||
127783138|NCT00806195|459832922|FG002|Overall Study|Lost to Follow-up|90|||
127783139|NCT00806195|459832923|FG003|Overall Study|Lost to Follow-up|34|||
127783140|NCT00806195|459832920|FG000|Overall Study|Inappropriate Enrollment|0|||
127783141|NCT00806195|459832921|FG001|Overall Study|Inappropriate Enrollment|1|||
127783142|NCT00806195|459832922|FG002|Overall Study|Inappropriate Enrollment|0|||
127783143|NCT00806195|459832923|FG003|Overall Study|Inappropriate Enrollment|0|||
127783144|NCT00806195|459832920|FG000|Overall Study|Administrative Reason|113|||
127783145|NCT00806195|459832921|FG001|Overall Study|Administrative Reason|35|||
127783146|NCT00806195|459832922|FG002|Overall Study|Administrative Reason|66|||
127783147|NCT00806195|459832923|FG003|Overall Study|Administrative Reason|26|||
127783148|NCT00806195|459832920|FG000|Overall Study|Protocol Violation|34|||
127783149|NCT00806195|459832921|FG001|Overall Study|Protocol Violation|24|||
127783150|NCT00806195|459832922|FG002|Overall Study|Protocol Violation|26|||
127580462|NCT04340193|459094312|FG000|Overall Study|Disease recurrence|0|||
127580463|NCT04340193|459094313|FG001|Overall Study|Disease recurrence|1|||
127580464|NCT04340193|459094314|FG002|Overall Study|Disease recurrence|0|||
127580465|NCT04340193|459094312|FG000|Overall Study|Study drug toxicity|1|||
127580466|NCT04340193|459094313|FG001|Overall Study|Study drug toxicity|0|||
127580467|NCT04340193|459094314|FG002|Overall Study|Study drug toxicity|0|||
127580468|NCT04340193|459094312|FG000|Overall Study|Disease progression|1|||
127580469|NCT04340193|459094313|FG001|Overall Study|Disease progression|2|||
127580470|NCT04340193|459094314|FG002|Overall Study|Disease progression|3|||
127580471|NCT04340193|459094312|FG000|Overall Study|Administrative reasons by sponsor|0|||
127580472|NCT04340193|459094313|FG001|Overall Study|Administrative reasons by sponsor|1|||
127580473|NCT04340193|459094314|FG002|Overall Study|Administrative reasons by sponsor|0|||
127580474|NCT04340193|459094312|FG000|Overall Study|Adverse Event|1|||
127580475|NCT04340193|459094313|FG001|Overall Study|Adverse Event|1|||
127580476|NCT04340193|459094314|FG002|Overall Study|Adverse Event|0|||
127580477|NCT04449861|459094315|FG000|Overall Study|Withdrawal by Subject|4|||
127580478|NCT04449861|459094315|FG000|Overall Study|Lost to Follow-up|5|||
127580479|NCT04449861|459094315|FG000|Overall Study|Death|112|||
127580480|NCT00976677|459094316|FG000|Overall Study|Adverse Event|1|||
127580481|NCT00976677|459094317|FG001|Overall Study|Adverse Event|0|||
127580482|NCT00976677|459094316|FG000|Overall Study|Withdrawal by Subject|0|||
127580483|NCT00976677|459094317|FG001|Overall Study|Withdrawal by Subject|2|||
127580484|NCT00976677|459094316|FG000|Overall Study|Disease progression|1|||
127580485|NCT00976677|459094317|FG001|Overall Study|Disease progression|1|||
127580486|NCT00976677|459094316|FG000|Overall Study|Trial unblinded|2|||
127580487|NCT00976677|459094317|FG001|Overall Study|Trial unblinded|2|||
127580488|NCT00976677|459094316|FG000|Overall Study|Unknown/Missing|1|||
127580489|NCT00976677|459094317|FG001|Overall Study|Unknown/Missing|0|||
127580490|NCT03507400|459094318|FG000|Overall Study|discontinued|5|||
127580491|NCT03507400|459094319|FG001|Overall Study|discontinued|1|||
127580492|NCT03507400|459094318|FG000|Overall Study|Lost to Follow-up|8|||
127580493|NCT03507400|459094319|FG001|Overall Study|Lost to Follow-up|6|||
127580494|NCT03507400|459094318|FG000|Overall Study|Protocol Violation|0|||
127580495|NCT03507400|459094319|FG001|Overall Study|Protocol Violation|1|||
127580496|NCT00108433|459096065|FG000|Overall Study|Lack of Efficacy|1|||
127580497|NCT00108433|459096066|FG001|Overall Study|Lack of Efficacy|2|||
127580498|NCT00108433|459096065|FG000|Overall Study|Death|3|||
127580499|NCT00108433|459096066|FG001|Overall Study|Death|0|||
127580500|NCT00108433|459096065|FG000|Overall Study|Adverse Event|3|||
127580501|NCT00108433|459096066|FG001|Overall Study|Adverse Event|1|||
127580502|NCT00108433|459096065|FG000|Overall Study|Other|14|||
127580503|NCT00108433|459096066|FG001|Overall Study|Other|14|||
127580504|NCT04806503|459096070|FG000|Overall Study|Lost to Follow-up|0|||
127580505|NCT04806503|459096071|FG001|Overall Study|Lost to Follow-up|0|||
127580506|NCT04806503|459096072|FG002|Overall Study|Lost to Follow-up|1|||
127580507|NCT04806503|459096073|FG003|Overall Study|Lost to Follow-up|0|||
127580508|NCT04806503|459096074|FG004|Overall Study|Lost to Follow-up|0|||
127580509|NCT04806503|459096070|FG000|Overall Study|Withdrawal by Subject|1|||
127580510|NCT04806503|459096071|FG001|Overall Study|Withdrawal by Subject|0|||
127580511|NCT04806503|459096072|FG002|Overall Study|Withdrawal by Subject|1|||
127580512|NCT04806503|459096073|FG003|Overall Study|Withdrawal by Subject|1|||
127580513|NCT04806503|459096074|FG004|Overall Study|Withdrawal by Subject|1|||
127693647|NCT04936035|459505853|FG003|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
127693648|NCT04936035|459505854|FG004|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|1|||
127693649|NCT04936035|459505850|FG000|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
127693650|NCT04936035|459505851|FG001|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
127693651|NCT04936035|459505852|FG002|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
127693652|NCT04936035|459505853|FG003|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
127693653|NCT04936035|459505854|FG004|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|1|||
127693654|NCT05633407|459505855|FG000|Overall Study|Physician Decision|2|||
127693655|NCT05633407|459505856|FG001|Overall Study|Physician Decision|0|||
127693656|NCT05633407|459505855|FG000|Overall Study|Adverse Event|1|||
127693657|NCT05633407|459505856|FG001|Overall Study|Adverse Event|0|||
127783151|NCT00806195|459832923|FG003|Overall Study|Protocol Violation|9|||
127580514|NCT04806503|459096070|FG000|Overall Study|Adverse Event|1|||
127580515|NCT04806503|459096071|FG001|Overall Study|Adverse Event|1|||
127580516|NCT04806503|459096072|FG002|Overall Study|Adverse Event|0|||
127580517|NCT04806503|459096073|FG003|Overall Study|Adverse Event|1|||
127580518|NCT04806503|459096074|FG004|Overall Study|Adverse Event|0|||
127580519|NCT03589469|459096075|FG000|Overall Study|Withdrawal by Subject|8|||
127580520|NCT03589469|459096075|FG000|Overall Study|Physician Decision|20|||
127580521|NCT03589469|459096075|FG000|Overall Study|Death|97|||
127580522|NCT03589469|459096075|FG000|Overall Study|Lost to Follow-up|8|||
127783152|NCT02490475|459832924|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
127783153|NCT02490475|459832925|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
127783154|NCT02490475|459832926|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
128030356|NCT02181413|460737217|FG001|Overall Study|Withdrawal by Subject|61|||
128030357|NCT02181413|460737216|FG000|Overall Study|Reason Not Specified|2|||
128030358|NCT02181413|460737217|FG001|Overall Study|Reason Not Specified|5|||
128030359|NCT02181413|460737216|FG000|Overall Study|Lost to Follow-up|8|||
128030360|NCT02181413|460737217|FG001|Overall Study|Lost to Follow-up|7|||
128030361|NCT00050011|460737219|FG000|Overall Study|Adverse Event|41|||
128030362|NCT00050011|460737220|FG001|Overall Study|Adverse Event|46|||
128030363|NCT00050011|460737219|FG000|Overall Study|Abnormal laboratory value(s)|1|||
128030364|NCT00050011|460737220|FG001|Overall Study|Abnormal laboratory value(s)|1|||
128030365|NCT00050011|460737219|FG000|Overall Study|Abnormal test procedure results|0|||
128030366|NCT00050011|460737220|FG001|Overall Study|Abnormal test procedure results|1|||
128030367|NCT00050011|460737219|FG000|Overall Study|Lack of Efficacy|16|||
128030368|NCT00050011|460737220|FG001|Overall Study|Lack of Efficacy|21|||
128030369|NCT00050011|460737219|FG000|Overall Study|Participant condition no longer required|1|||
128030370|NCT00050011|460737220|FG001|Overall Study|Participant condition no longer required|0|||
128030371|NCT00050011|460737219|FG000|Overall Study|Protocol Violation|4|||
128030372|NCT00050011|460737220|FG001|Overall Study|Protocol Violation|10|||
128030373|NCT00050011|460737219|FG000|Overall Study|Withdrawal by Subject|34|||
128030374|NCT00050011|460737220|FG001|Overall Study|Withdrawal by Subject|26|||
128030375|NCT00050011|460737219|FG000|Overall Study|Lost to Follow-up|7|||
128030376|NCT00050011|460737220|FG001|Overall Study|Lost to Follow-up|9|||
128030377|NCT00050011|460737219|FG000|Overall Study|Administrative problems|10|||
128030378|NCT00050011|460737220|FG001|Overall Study|Administrative problems|6|||
128030379|NCT00050011|460737219|FG000|Overall Study|Death|7|||
128030380|NCT00050011|460737220|FG001|Overall Study|Death|4|||
128030381|NCT00050011|460737219|FG000|Overall Study|Unknown - Reason is missing|0|||
128030382|NCT00050011|460737220|FG001|Overall Study|Unknown - Reason is missing|2|||
128030383|NCT04806373|460737222|FG000|Overall Study|Withdrawal by Subject|1|||
128030384|NCT04806373|460737223|FG001|Overall Study|Withdrawal by Subject|1|||
128030385|NCT02061085|460737226|FG000|Overall Study|Adverse Event|8|||
128030386|NCT04903093|460737231|FG000|Overall Study|Withdrawal by Subject|0|||
128030387|NCT04903093|460737232|FG001|Overall Study|Withdrawal by Subject|0|||
128030388|NCT04903093|460737233|FG002|Overall Study|Withdrawal by Subject|0|||
128030389|NCT04903093|460737234|FG003|Overall Study|Withdrawal by Subject|1|||
128030390|NCT04903093|460737235|FG004|Overall Study|Withdrawal by Subject|0|||
128030391|NCT04903093|460737236|FG005|Overall Study|Withdrawal by Subject|0|||
128030392|NCT03973489|460737242|FG000|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
128030393|NCT03973489|460737243|FG001|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
128030394|NCT03973489|460737244|FG002|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
128030395|NCT03973489|460737245|FG003|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
128030396|NCT03973489|460737246|FG004|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
128030397|NCT03973489|460737247|FG005|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
128030398|NCT03973489|460737248|FG006|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
128030399|NCT03973489|460737249|FG007|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
128030400|NCT03973489|460737242|FG000|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
127580523|NCT03589469|459096075|FG000|Overall Study|Miscellaneous|1|||
127580524|NCT04195906|459096077|FG000|Part 1|Adverse Event|3|||
127580525|NCT04195906|459096078|FG001|Part 1|Adverse Event|7|||
127580526|NCT04195906|459096077|FG000|Part 1|Withdrawal by Subject|0|||
127580527|NCT04195906|459096078|FG001|Part 1|Withdrawal by Subject|1|||
127580528|NCT04195906|459096077|FG000|Part 2|Adverse Event|1|||
127580529|NCT04195906|459096078|FG001|Part 2|Adverse Event|1|||
127580530|NCT04195906|459096077|FG000|Part 2|Withdrawal by Subject|0|||
127580531|NCT04195906|459096078|FG001|Part 2|Withdrawal by Subject|3|||
127580532|NCT04195906|459096077|FG000|Part 2|Other|1|||
127580533|NCT04195906|459096078|FG001|Part 2|Other|3|||
127580534|NCT00371826|459096085|FG000|Core Phase (12 Months)|Adverse Event|15|||
127580535|NCT00371826|459096086|FG001|Core Phase (12 Months)|Adverse Event|4|||
127580536|NCT00371826|459096087|FG002|Core Phase (12 Months)|Adverse Event|9|||
127580537|NCT00371826|459096085|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
127580538|NCT00371826|459096086|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
127783155|NCT02490475|459832927|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
127783156|NCT02490475|459832924|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
127783157|NCT02490475|459832925|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
127783158|NCT02490475|459832926|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
127881546|NCT00791154|460188792|FG000|Overall Study|Noncompliance|0|||
127580539|NCT00371826|459096087|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
127580540|NCT00371826|459096085|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
128030401|NCT03973489|460737243|FG001|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
128030402|NCT03973489|460737244|FG002|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
128030403|NCT03973489|460737245|FG003|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
128030404|NCT03973489|460737246|FG004|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
127580541|NCT00371826|459096086|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
127580542|NCT00371826|459096087|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
127580543|NCT00371826|459096085|FG000|Core Phase (12 Months)|Protocol Violation|1|||
127580544|NCT00371826|459096086|FG001|Core Phase (12 Months)|Protocol Violation|0|||
127580545|NCT00371826|459096087|FG002|Core Phase (12 Months)|Protocol Violation|1|||
127580546|NCT00371826|459096085|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
127580547|NCT00371826|459096086|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
127580548|NCT00371826|459096087|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
127580549|NCT00371826|459096085|FG000|Core Phase (12 Months)|Administrative problems|1|||
127580550|NCT00371826|459096086|FG001|Core Phase (12 Months)|Administrative problems|0|||
127580551|NCT00371826|459096087|FG002|Core Phase (12 Months)|Administrative problems|8|||
127580552|NCT00371826|459096085|FG000|Core Phase (12 Months)|Graft Loss|0|||
127580553|NCT00371826|459096086|FG001|Core Phase (12 Months)|Graft Loss|1|||
127580554|NCT00371826|459096087|FG002|Core Phase (12 Months)|Graft Loss|0|||
127580555|NCT00371826|459096085|FG000|Extension Phase (24 Months)|Adverse Event|4|||
127580556|NCT00371826|459096086|FG001|Extension Phase (24 Months)|Adverse Event|5|||
127580557|NCT00371826|459096087|FG002|Extension Phase (24 Months)|Adverse Event|0|||
127580558|NCT00371826|459096085|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
127580559|NCT00371826|459096086|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
127580560|NCT00371826|459096087|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
127580561|NCT00371826|459096085|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
127580562|NCT00371826|459096086|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
127580563|NCT00371826|459096087|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
127580564|NCT00371826|459096085|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
127580565|NCT00371826|459096086|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
127580566|NCT00371826|459096087|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
127580567|NCT00371826|459096085|FG000|Extension Phase (24 Months)|Administrative problems|0|||
127580568|NCT00371826|459096086|FG001|Extension Phase (24 Months)|Administrative problems|0|||
127580569|NCT00371826|459096087|FG002|Extension Phase (24 Months)|Administrative problems|2|||
127580570|NCT00573183|459096088|FG000|Overall Study|Lost to Follow-up|52|||
127693658|NCT05633407|459505855|FG000|Overall Study|Withdrawal by Subject|1|||
127693659|NCT05633407|459505856|FG001|Overall Study|Withdrawal by Subject|0|||
127693660|NCT05633407|459505855|FG000|Overall Study|Other|1|||
127693661|NCT05633407|459505856|FG001|Overall Study|Other|1|||
127693662|NCT05179395|459505859|FG000|Overall Study|Lack of Efficacy|1|||
127693663|NCT05338086|459506968|FG000|Main Treatment Period (Day1 to Month 12)|Adverse Event|4|||
127693664|NCT05338086|459506969|FG001|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
127693665|NCT05338086|459506970|FG002|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
127693666|NCT05338086|459506971|FG003|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
127693667|NCT05338086|459506972|FG004|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
127693668|NCT05338086|459506968|FG000|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|1|||
127693669|NCT05338086|459506969|FG001|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|2|||
127693670|NCT05338086|459506970|FG002|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
127693671|NCT05338086|459506971|FG003|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
127693672|NCT05338086|459506972|FG004|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
127693673|NCT05338086|459506968|FG000|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
127693674|NCT05338086|459506969|FG001|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
127693675|NCT05338086|459506970|FG002|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
127693676|NCT05338086|459506971|FG003|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
127693677|NCT05338086|459506972|FG004|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
127693678|NCT05338086|459506968|FG000|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|1|||
127693679|NCT05338086|459506969|FG001|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
127693680|NCT05338086|459506970|FG002|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
127693681|NCT05338086|459506971|FG003|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
127693682|NCT05338086|459506972|FG004|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
127693683|NCT05338086|459506968|FG000|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
127693684|NCT05338086|459506969|FG001|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
127693685|NCT05338086|459506970|FG002|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
127693686|NCT05338086|459506971|FG003|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
127693687|NCT05338086|459506972|FG004|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
127693688|NCT05338086|459506968|FG000|Main Treatment Period (Day1 to Month 12)|other|23|||
127693689|NCT05338086|459506969|FG001|Main Treatment Period (Day1 to Month 12)|other|16|||
127693690|NCT05338086|459506970|FG002|Main Treatment Period (Day1 to Month 12)|other|0|||
127693691|NCT05338086|459506971|FG003|Main Treatment Period (Day1 to Month 12)|other|0|||
127580571|NCT00573183|459096089|FG001|Overall Study|Lost to Follow-up|50|||
127580572|NCT00573183|459096088|FG000|Overall Study|Withdrawal by Subject|8|||
127580573|NCT00573183|459096089|FG001|Overall Study|Withdrawal by Subject|2|||
127580574|NCT00573183|459096088|FG000|Overall Study|Death|0|||
127580575|NCT00573183|459096089|FG001|Overall Study|Death|1|||
127580576|NCT00573183|459096088|FG000|Overall Study|Adverse Event|2|||
127580577|NCT00573183|459096089|FG001|Overall Study|Adverse Event|0|||
127580578|NCT00573183|459096088|FG000|Overall Study|Incarceration|5|||
127580579|NCT00573183|459096089|FG001|Overall Study|Incarceration|8|||
127580580|NCT00573183|459096088|FG000|Overall Study|Other|5|||
127580581|NCT00573183|459096089|FG001|Overall Study|Other|2|||
127580582|NCT00428792|459096092|FG000|Overall Study|Lack of Efficacy|1|||
127580583|NCT00428792|459096093|FG001|Overall Study|Lack of Efficacy|3|||
127580584|NCT00428792|459096092|FG000|Overall Study|Lost to Follow-up|0|||
127580585|NCT00428792|459096093|FG001|Overall Study|Lost to Follow-up|1|||
127580586|NCT01926015|459096094|FG000|Overall Study|Withdrawal by parent/guardian|0|||
127580587|NCT01926015|459096095|FG001|Overall Study|Withdrawal by parent/guardian|1|||
127580588|NCT01926015|459096094|FG000|Overall Study|Randomized not treated|2|||
127580589|NCT01926015|459096095|FG001|Overall Study|Randomized not treated|0|||
127580590|NCT00639678|459096096|FG000|Overall Study|Withdrawal by Subject|3|||
127580591|NCT00639678|459096097|FG001|Overall Study|Withdrawal by Subject|0|||
127580592|NCT00639678|459096098|FG002|Overall Study|Withdrawal by Subject|4|||
127580593|NCT00639678|459096099|FG003|Overall Study|Withdrawal by Subject|0|||
127580594|NCT00639678|459096096|FG000|Overall Study|Lost to Follow-up|1|||
127580595|NCT00639678|459096097|FG001|Overall Study|Lost to Follow-up|0|||
127580596|NCT00639678|459096098|FG002|Overall Study|Lost to Follow-up|6|||
127580597|NCT00639678|459096099|FG003|Overall Study|Lost to Follow-up|0|||
127580598|NCT00639678|459096096|FG000|Overall Study|Adverse Event|0|||
127580599|NCT00639678|459096097|FG001|Overall Study|Adverse Event|1|||
127580600|NCT00639678|459096098|FG002|Overall Study|Adverse Event|0|||
127580601|NCT00639678|459096099|FG003|Overall Study|Adverse Event|0|||
127580602|NCT00639678|459096096|FG000|Overall Study|Lack of Compliance|0|||
127580603|NCT00639678|459096097|FG001|Overall Study|Lack of Compliance|0|||
127580604|NCT00639678|459096098|FG002|Overall Study|Lack of Compliance|1|||
127693692|NCT05338086|459506972|FG004|Main Treatment Period (Day1 to Month 12)|other|0|||
127693693|NCT05338086|459506968|FG000|Transition Period (M12 to M18)|Death|0|||
127693694|NCT05338086|459506969|FG001|Transition Period (M12 to M18)|Death|0|||
127693695|NCT05338086|459506970|FG002|Transition Period (M12 to M18)|Death|1|||
127693696|NCT05338086|459506971|FG003|Transition Period (M12 to M18)|Death|0|||
127693697|NCT05338086|459506972|FG004|Transition Period (M12 to M18)|Death|0|||
127693698|NCT05338086|459506968|FG000|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
127693699|NCT05338086|459506969|FG001|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
127693700|NCT05338086|459506970|FG002|Transition Period (M12 to M18)|Withdrawal by Subject|4|||
127693701|NCT05338086|459506971|FG003|Transition Period (M12 to M18)|Withdrawal by Subject|3|||
127693702|NCT05338086|459506972|FG004|Transition Period (M12 to M18)|Withdrawal by Subject|2|||
127693703|NCT05338086|459506968|FG000|Transition Period (M12 to M18)|Burden of study procedures|0|||
127693704|NCT05338086|459506969|FG001|Transition Period (M12 to M18)|Burden of study procedures|0|||
127693705|NCT05338086|459506970|FG002|Transition Period (M12 to M18)|Burden of study procedures|1|||
127693706|NCT05338086|459506971|FG003|Transition Period (M12 to M18)|Burden of study procedures|0|||
127693707|NCT05338086|459506972|FG004|Transition Period (M12 to M18)|Burden of study procedures|0|||
127693708|NCT05338086|459506968|FG000|Transition Period (M12 to M18)|Subject left the country|0|||
127693709|NCT05338086|459506969|FG001|Transition Period (M12 to M18)|Subject left the country|0|||
127693710|NCT05338086|459506970|FG002|Transition Period (M12 to M18)|Subject left the country|0|||
127693711|NCT05338086|459506971|FG003|Transition Period (M12 to M18)|Subject left the country|0|||
127693712|NCT05338086|459506972|FG004|Transition Period (M12 to M18)|Subject left the country|1|||
127693713|NCT03940703|459506973|FG000|Overall Study|Still under treatment|31|||
127693714|NCT03940703|459506974|FG001|Overall Study|Still under treatment|0|||
127693715|NCT04850807|459506982|FG000|Overall Study|Death|50|||
127693716|NCT04850807|459506983|FG001|Overall Study|Death|55|||
127693717|NCT04850807|459506982|FG000|Overall Study|Discharged|17|||
127693718|NCT04850807|459506983|FG001|Overall Study|Discharged|13|||
127693719|NCT04850807|459506982|FG000|Overall Study|Incomplete baseline data|3|||
127693720|NCT04850807|459506983|FG001|Overall Study|Incomplete baseline data|2|||
127693721|NCT02187003|459506984|FG000|Overall Study|Adverse Event|2|||
127693722|NCT02187003|459506985|FG001|Overall Study|Adverse Event|0|||
127693723|NCT02187003|459506984|FG000|Overall Study|Lost to Follow-up|14|||
127693724|NCT02187003|459506985|FG001|Overall Study|Lost to Follow-up|10|||
127693725|NCT02187003|459506984|FG000|Overall Study|Withdrawal by Subject|3|||
127693726|NCT02187003|459506985|FG001|Overall Study|Withdrawal by Subject|7|||
127693727|NCT02187003|459506984|FG000|Overall Study|Protocol Violation|2|||
127580605|NCT00639678|459096099|FG003|Overall Study|Lack of Compliance|0|||
127580606|NCT01364649|459096100|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
127693728|NCT02187003|459506985|FG001|Overall Study|Protocol Violation|4|||
127693729|NCT02187003|459506984|FG000|Overall Study|Other|5|||
127693730|NCT02187003|459506985|FG001|Overall Study|Other|5|||
127693731|NCT02187003|459506984|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
127580607|NCT01364649|459096101|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
127580608|NCT01364649|459096100|FG000|Overall Study|Lack of Efficacy|6|||
127580609|NCT01364649|459096101|FG001|Overall Study|Lack of Efficacy|0|||
127580610|NCT01364649|459096100|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
127580611|NCT01364649|459096101|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
127580612|NCT01364649|459096100|FG000|Overall Study|Protocol Deviations|4|||
127580613|NCT01364649|459096101|FG001|Overall Study|Protocol Deviations|8|||
127580614|NCT01364649|459096100|FG000|Overall Study|Withdrawal of Consent|9|||
127580615|NCT01364649|459096101|FG001|Overall Study|Withdrawal of Consent|7|||
127580616|NCT01364649|459096100|FG000|Overall Study|Lost to Follow-up|12|||
127580617|NCT01364649|459096101|FG001|Overall Study|Lost to Follow-up|13|||
127580618|NCT01364649|459096100|FG000|Overall Study|Other|4|||
127580619|NCT01364649|459096101|FG001|Overall Study|Other|1|||
127580620|NCT00902668|459096109|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
127580621|NCT01914757|459096110|FG000|Overall Study|Severe non-compliance to protocol|3|||
127580622|NCT01914757|459096111|FG001|Overall Study|Severe non-compliance to protocol|1|||
127580623|NCT01914757|459096112|FG002|Overall Study|Severe non-compliance to protocol|2|||
127580624|NCT01914757|459096110|FG000|Overall Study|Lost to Follow-up|5|||
127580625|NCT01914757|459096111|FG001|Overall Study|Lost to Follow-up|8|||
127580626|NCT01914757|459096112|FG002|Overall Study|Lost to Follow-up|6|||
127580627|NCT01914757|459096110|FG000|Overall Study|Withdrawal by Subject|15|||
127580628|NCT01914757|459096111|FG001|Overall Study|Withdrawal by Subject|27|||
127580629|NCT01914757|459096112|FG002|Overall Study|Withdrawal by Subject|19|||
127580630|NCT01914757|459096110|FG000|Overall Study|Death|2|||
127580631|NCT01914757|459096111|FG001|Overall Study|Death|2|||
127580632|NCT01914757|459096112|FG002|Overall Study|Death|1|||
127580633|NCT01914757|459096110|FG000|Overall Study|Adverse Event|4|||
127580634|NCT01914757|459096111|FG001|Overall Study|Adverse Event|3|||
127580635|NCT01914757|459096112|FG002|Overall Study|Adverse Event|4|||
127580636|NCT01914757|459096110|FG000|Overall Study|Study specific withdrawal criteria|0|||
127580637|NCT01914757|459096111|FG001|Overall Study|Study specific withdrawal criteria|1|||
127580638|NCT01914757|459096112|FG002|Overall Study|Study specific withdrawal criteria|0|||
127580639|NCT01914757|459096110|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
127580640|NCT01914757|459096111|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
127580641|NCT01914757|459096112|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
127580642|NCT01914757|459096110|FG000|Overall Study|Other reasons|5|||
127580643|NCT01914757|459096111|FG001|Overall Study|Other reasons|9|||
127580644|NCT01914757|459096112|FG002|Overall Study|Other reasons|4|||
127580645|NCT02833350|459096119|FG000|Overall Study|Adverse Event|0|||
127580646|NCT02833350|459096120|FG001|Overall Study|Adverse Event|3|||
127580647|NCT02833350|459096121|FG002|Overall Study|Adverse Event|4|||
127580648|NCT02833350|459096122|FG003|Overall Study|Adverse Event|4|||
127580649|NCT02833350|459096123|FG004|Overall Study|Adverse Event|1|||
127580650|NCT02833350|459096124|FG005|Overall Study|Adverse Event|0|||
127580651|NCT02833350|459096125|FG006|Overall Study|Adverse Event|1|||
127580652|NCT02833350|459096119|FG000|Overall Study|Death|0|||
127580653|NCT02833350|459096120|FG001|Overall Study|Death|0|||
127580654|NCT02833350|459096121|FG002|Overall Study|Death|1|||
127580655|NCT02833350|459096122|FG003|Overall Study|Death|0|||
127580656|NCT02833350|459096123|FG004|Overall Study|Death|0|||
127580657|NCT02833350|459096124|FG005|Overall Study|Death|0|||
127580658|NCT02833350|459096125|FG006|Overall Study|Death|0|||
127580659|NCT02833350|459096119|FG000|Overall Study|Lack of Efficacy|0|||
127580660|NCT02833350|459096120|FG001|Overall Study|Lack of Efficacy|2|||
127580661|NCT02833350|459096121|FG002|Overall Study|Lack of Efficacy|1|||
127580662|NCT02833350|459096122|FG003|Overall Study|Lack of Efficacy|4|||
127580663|NCT02833350|459096123|FG004|Overall Study|Lack of Efficacy|0|||
127693732|NCT02187003|459506985|FG001|Overall Study|Withdrawal by Parent/Guardian|5|||
127693733|NCT04593472|459506986|FG000|Overall Study|Death|31|||
127693734|NCT04593472|459506987|FG001|Overall Study|Death|27|||
127693735|NCT04593472|459506986|FG000|Overall Study|Withdrawal by Subject|12|||
127693736|NCT04593472|459506987|FG001|Overall Study|Withdrawal by Subject|12|||
127693737|NCT04593472|459506986|FG000|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|33|||
127693738|NCT04593472|459506987|FG001|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|22|||
127693739|NCT04593472|459506986|FG000|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|5|||
127693740|NCT04593472|459506987|FG001|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|4|||
127783159|NCT02490475|459832927|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
127783160|NCT02490475|459832924|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
127783161|NCT02490475|459832925|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
127783162|NCT02490475|459832926|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
127783163|NCT02490475|459832927|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
127580664|NCT02833350|459096124|FG005|Overall Study|Lack of Efficacy|1|||
127580665|NCT02833350|459096125|FG006|Overall Study|Lack of Efficacy|1|||
127580666|NCT02833350|459096119|FG000|Overall Study|Lost to Follow-up|0|||
127580667|NCT02833350|459096120|FG001|Overall Study|Lost to Follow-up|1|||
127580668|NCT02833350|459096121|FG002|Overall Study|Lost to Follow-up|0|||
127580669|NCT02833350|459096122|FG003|Overall Study|Lost to Follow-up|0|||
127580670|NCT02833350|459096123|FG004|Overall Study|Lost to Follow-up|0|||
127580671|NCT02833350|459096124|FG005|Overall Study|Lost to Follow-up|0|||
127580672|NCT02833350|459096125|FG006|Overall Study|Lost to Follow-up|1|||
127580673|NCT02833350|459096119|FG000|Overall Study|Withdrawal by Subject|3|||
127580674|NCT02833350|459096120|FG001|Overall Study|Withdrawal by Subject|3|||
127580675|NCT02833350|459096121|FG002|Overall Study|Withdrawal by Subject|2|||
127580676|NCT02833350|459096122|FG003|Overall Study|Withdrawal by Subject|0|||
127580677|NCT02833350|459096123|FG004|Overall Study|Withdrawal by Subject|2|||
127580678|NCT02833350|459096124|FG005|Overall Study|Withdrawal by Subject|0|||
127580679|NCT02833350|459096125|FG006|Overall Study|Withdrawal by Subject|2|||
127580680|NCT01500031|459096128|FG000|Overall Study|Death|1|||
127580681|NCT01500031|459096128|FG000|Overall Study|Withdrawal by Subject|4|||
127580682|NCT01856907|459096132|FG000|Overall Study|Pregnancy|0|||
127580683|NCT01856907|459096133|FG001|Overall Study|Pregnancy|1|||
127580684|NCT01856907|459096134|FG002|Overall Study|Pregnancy|0|||
127580685|NCT01856907|459096132|FG000|Overall Study|Pregnancy|0|||
127580686|NCT01856907|459096133|FG001|Overall Study|Pregnancy|1|||
127580687|NCT01856907|459096134|FG002|Overall Study|Pregnancy|0|||
127580688|NCT01856907|459096132|FG000|Overall Study|Withdrawal by Subject|0|||
127580689|NCT01856907|459096133|FG001|Overall Study|Withdrawal by Subject|1|||
127580690|NCT01856907|459096134|FG002|Overall Study|Withdrawal by Subject|0|||
127580691|NCT01604408|459096135|FG000|Treatment Period 1|Protocol Violation|0|||
127580692|NCT01604408|459096136|FG001|Treatment Period 1|Protocol Violation|1|||
127580693|NCT01604408|459096135|FG000|Treatment Period 2|Withdrawal by Subject|1|||
127580694|NCT01604408|459096136|FG001|Treatment Period 2|Withdrawal by Subject|1|||
127580695|NCT01604408|459096135|FG000|Treatment Period 2|Protocol Violation|1|||
127580696|NCT01604408|459096136|FG001|Treatment Period 2|Protocol Violation|0|||
127580697|NCT01604408|459096135|FG000|Treatment Period 2|Adverse Event|0|||
127580698|NCT01604408|459096136|FG001|Treatment Period 2|Adverse Event|1|||
127580699|NCT01604408|459096135|FG000|Treatment Period 3|Protocol Violation|1|||
127580700|NCT01604408|459096136|FG001|Treatment Period 3|Protocol Violation|1|||
127580701|NCT01604408|459096135|FG000|Treatment Period 3|Adverse Event|0|||
127580702|NCT01604408|459096136|FG001|Treatment Period 3|Adverse Event|3|||
127580703|NCT01604408|459096135|FG000|Treatment Period 3|Withdrawal by Subject|3|||
127580704|NCT01604408|459096136|FG001|Treatment Period 3|Withdrawal by Subject|1|||
127580705|NCT01604408|459096135|FG000|Treatment Period 3|Sponsor Decision|1|||
127580706|NCT01604408|459096136|FG001|Treatment Period 3|Sponsor Decision|0|||
127580707|NCT01604408|459096135|FG000|Treatment Period 4|Death|1|||
127580708|NCT01604408|459096136|FG001|Treatment Period 4|Death|0|||
127580709|NCT01604408|459096135|FG000|Treatment Period 4|Withdrawal by Subject|2|||
127580710|NCT01604408|459096136|FG001|Treatment Period 4|Withdrawal by Subject|1|||
127580711|NCT01604408|459096135|FG000|Treatment Period 4|Adverse Event|0|||
127580712|NCT01604408|459096136|FG001|Treatment Period 4|Adverse Event|1|||
127580713|NCT01604408|459096135|FG000|Treatment Period 5|Adverse Event|4|||
127580714|NCT01604408|459096136|FG001|Treatment Period 5|Adverse Event|0|||
127580715|NCT01604408|459096135|FG000|Treatment Period 6|Lost to Follow-up|0|||
127580716|NCT01604408|459096136|FG001|Treatment Period 6|Lost to Follow-up|1|||
127580717|NCT01604408|459096135|FG000|Treatment Period 6|Adverse Event|2|||
127783164|NCT02490475|459832924|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
127580718|NCT01604408|459096136|FG001|Treatment Period 6|Adverse Event|0|||
127783165|NCT02490475|459832925|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
127783166|NCT02490475|459832926|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
127783167|NCT02490475|459832927|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
127783168|NCT02490475|459832924|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
127783169|NCT02490475|459832925|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
127783170|NCT02490475|459832926|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
127783171|NCT02490475|459832927|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
127783172|NCT02490475|459832924|FG000|Period 2: Extension Phase|Refused Treatment|0|||
127580719|NCT01604408|459096135|FG000|Treatment Period 6|Sponsor decision|0|||
127580720|NCT01604408|459096136|FG001|Treatment Period 6|Sponsor decision|1|||
127783173|NCT02490475|459832925|FG001|Period 2: Extension Phase|Refused Treatment|0|||
127783174|NCT02490475|459832926|FG002|Period 2: Extension Phase|Refused Treatment|0|||
127783175|NCT02490475|459832927|FG003|Period 2: Extension Phase|Refused Treatment|1|||
127783176|NCT02490475|459832924|FG000|Period 2: Extension Phase|Adverse Event|0|||
127580721|NCT01604408|459096135|FG000|Observation Period|Adverse Event|1|||
127580722|NCT01604408|459096136|FG001|Observation Period|Adverse Event|1|||
127580723|NCT01604408|459096135|FG000|Observation Period|Withdrawal by Subject|0|||
127580724|NCT01604408|459096136|FG001|Observation Period|Withdrawal by Subject|2|||
127580725|NCT00917501|459096137|FG000|Overall Study|Lost to Follow-up|4|||
127580726|NCT00917501|459096138|FG001|Overall Study|Lost to Follow-up|1|||
127580727|NCT00917501|459096137|FG000|Overall Study|Withdrawal by Subject|3|||
127580728|NCT00917501|459096138|FG001|Overall Study|Withdrawal by Subject|1|||
127580729|NCT00917501|459096137|FG000|Overall Study|Lack of Efficacy|1|||
127580730|NCT00917501|459096138|FG001|Overall Study|Lack of Efficacy|2|||
128030405|NCT03973489|460737247|FG005|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
128030406|NCT03973489|460737248|FG006|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
128030407|NCT03973489|460737249|FG007|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
128030408|NCT03973489|460737242|FG000|Washout Period (at Least 3 Days)|Physician Decision|0|||
128030409|NCT03973489|460737243|FG001|Washout Period (at Least 3 Days)|Physician Decision|0|||
128030410|NCT03973489|460737244|FG002|Washout Period (at Least 3 Days)|Physician Decision|0|||
128030411|NCT03973489|460737245|FG003|Washout Period (at Least 3 Days)|Physician Decision|0|||
128030412|NCT03973489|460737246|FG004|Washout Period (at Least 3 Days)|Physician Decision|1|||
128030413|NCT03973489|460737247|FG005|Washout Period (at Least 3 Days)|Physician Decision|0|||
128030414|NCT03973489|460737248|FG006|Washout Period (at Least 3 Days)|Physician Decision|1|||
128030415|NCT03973489|460737249|FG007|Washout Period (at Least 3 Days)|Physician Decision|0|||
128030416|NCT03973489|460737242|FG000|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
128030417|NCT03973489|460737243|FG001|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
128030418|NCT03973489|460737244|FG002|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
128030419|NCT03973489|460737245|FG003|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
128030420|NCT03973489|460737246|FG004|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
128030421|NCT03973489|460737247|FG005|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
128030422|NCT03973489|460737248|FG006|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
128030423|NCT03973489|460737249|FG007|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
128030424|NCT03973489|460737242|FG000|Second Intervention (1 Day)|Adverse Event|0|||
128030425|NCT03973489|460737243|FG001|Second Intervention (1 Day)|Adverse Event|0|||
128030426|NCT03973489|460737244|FG002|Second Intervention (1 Day)|Adverse Event|0|||
128030427|NCT03973489|460737245|FG003|Second Intervention (1 Day)|Adverse Event|1|||
128030428|NCT03973489|460737246|FG004|Second Intervention (1 Day)|Adverse Event|0|||
128030429|NCT03973489|460737247|FG005|Second Intervention (1 Day)|Adverse Event|0|||
128030430|NCT03973489|460737248|FG006|Second Intervention (1 Day)|Adverse Event|0|||
128030431|NCT03973489|460737249|FG007|Second Intervention (1 Day)|Adverse Event|0|||
128030432|NCT03301415|460737250|FG000|Overall Study|Lost to Follow-up|2|||
128030433|NCT03301415|460737250|FG000|Overall Study|Unable to comply with visit schedule|2|||
128030434|NCT00392288|460737251|FG000|Overall Study|Adverse Event|17|||
128030435|NCT00392288|460737252|FG001|Overall Study|Adverse Event|7|||
128030436|NCT00392288|460737253|FG002|Overall Study|Adverse Event|8|||
128030437|NCT00392288|460737251|FG000|Overall Study|Lack of Efficacy|8|||
128030438|NCT00392288|460737252|FG001|Overall Study|Lack of Efficacy|5|||
128030439|NCT00392288|460737253|FG002|Overall Study|Lack of Efficacy|3|||
128030440|NCT00392288|460737251|FG000|Overall Study|Protocol Violation|1|||
128030441|NCT00392288|460737252|FG001|Overall Study|Protocol Violation|3|||
128030442|NCT00392288|460737253|FG002|Overall Study|Protocol Violation|1|||
128030443|NCT00392288|460737251|FG000|Overall Study|Lost to Follow-up|1|||
128030444|NCT00392288|460737252|FG001|Overall Study|Lost to Follow-up|1|||
128030445|NCT00392288|460737253|FG002|Overall Study|Lost to Follow-up|1|||
128030446|NCT00392288|460737251|FG000|Overall Study|Withdrawal by Subject|1|||
128030447|NCT00392288|460737252|FG001|Overall Study|Withdrawal by Subject|0|||
128030448|NCT00392288|460737253|FG002|Overall Study|Withdrawal by Subject|2|||
128030449|NCT00392288|460737251|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
128030450|NCT00392288|460737252|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
128030451|NCT00392288|460737253|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
128030452|NCT00392288|460737251|FG000|Overall Study|Other|3|||
128030453|NCT00392288|460737252|FG001|Overall Study|Other|4|||
128030454|NCT00392288|460737253|FG002|Overall Study|Other|1|||
128030455|NCT02544763|460737254|FG000|Overall Study|Adverse Event|8|||
128030456|NCT02544763|460737255|FG001|Overall Study|Adverse Event|8|||
128030457|NCT02544763|460737256|FG002|Overall Study|Adverse Event|0|||
128030458|NCT02544763|460737254|FG000|Overall Study|Withdrawn by parent/guardian|1|||
128030459|NCT02544763|460737255|FG001|Overall Study|Withdrawn by parent/guardian|1|||
128030460|NCT02544763|460737256|FG002|Overall Study|Withdrawn by parent/guardian|1|||
128030461|NCT02544763|460737254|FG000|Overall Study|Met withdrawal criteria|0|||
128030462|NCT02544763|460737255|FG001|Overall Study|Met withdrawal criteria|2|||
128030463|NCT02544763|460737256|FG002|Overall Study|Met withdrawal criteria|0|||
128030464|NCT02544763|460737254|FG000|Overall Study|Physician Decision|0|||
128030465|NCT02544763|460737255|FG001|Overall Study|Physician Decision|1|||
128030466|NCT02544763|460737256|FG002|Overall Study|Physician Decision|0|||
128030467|NCT02544763|460737254|FG000|Overall Study|Difficulties taking IMP|1|||
127580731|NCT00917501|459096137|FG000|Overall Study|trouble swollowing capsules|0|||
127580732|NCT00917501|459096138|FG001|Overall Study|trouble swollowing capsules|1|||
128030468|NCT02544763|460737255|FG001|Overall Study|Difficulties taking IMP|0|||
128030469|NCT02544763|460737256|FG002|Overall Study|Difficulties taking IMP|0|||
128030470|NCT02613507|460737272|FG000|Pre-Treamtent|Participant request to discontinue study treatment|0|||
128030471|NCT02613507|460737273|FG001|Pre-Treamtent|Participant request to discontinue study treatment|5|||
128030472|NCT02613507|460737272|FG000|Pre-Treamtent|Participant withdrew consent|0|||
128030473|NCT02613507|460737273|FG001|Pre-Treamtent|Participant withdrew consent|4|||
128030474|NCT02613507|460737272|FG000|Pre-Treamtent|Participant no longer meets study criteria|1|||
127580733|NCT04553679|459096139|FG000|Overall Study|Withdrawal by Subject|2|||
127580734|NCT04553679|459096140|FG001|Overall Study|Withdrawal by Subject|0|||
127580735|NCT04553679|459096139|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
127580736|NCT04553679|459096140|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
127580737|NCT03945214|459096141|FG000|Overall Study|Lost to Follow-up|3|||
127580738|NCT03945214|459096142|FG001|Overall Study|Lost to Follow-up|4|||
127580739|NCT03945214|459096143|FG002|Overall Study|Lost to Follow-up|7|||
127580740|NCT03945214|459096144|FG003|Overall Study|Lost to Follow-up|4|||
127580741|NCT00538291|459096151|FG000|Overall Study|Adverse Event|2|||
127580742|NCT00538291|459096151|FG000|Overall Study|Withdrawal by Subject|1|||
127580743|NCT00591344|459096152|FG000|Overall Study|Transportation issues|1|||
127580744|NCT00591344|459096153|FG001|Overall Study|Transportation issues|0|||
127580745|NCT00591344|459096152|FG000|Overall Study|Moved out of state|1|||
127580746|NCT00591344|459096153|FG001|Overall Study|Moved out of state|0|||
127580747|NCT00591344|459096152|FG000|Overall Study|Medical complications|1|||
127580748|NCT00591344|459096153|FG001|Overall Study|Medical complications|3|||
127580749|NCT00591344|459096152|FG000|Overall Study|Underwent DBS|2|||
127580750|NCT00591344|459096153|FG001|Overall Study|Underwent DBS|2|||
127580751|NCT00591344|459096152|FG000|Overall Study|Death|0|||
127580752|NCT00591344|459096153|FG001|Overall Study|Death|1|||
127580753|NCT00591344|459096152|FG000|Overall Study|Lost to Follow-up|0|||
127580754|NCT00591344|459096153|FG001|Overall Study|Lost to Follow-up|1|||
127580755|NCT00591344|459096152|FG000|Overall Study|Did not want to come off medication|0|||
127580756|NCT00591344|459096153|FG001|Overall Study|Did not want to come off medication|1|||
127580757|NCT01904058|459096157|FG000|Overall Study|Adverse Event|2|||
127580758|NCT01904058|459096158|FG001|Overall Study|Adverse Event|0|||
127580759|NCT01904058|459096159|FG002|Overall Study|Adverse Event|0|||
127580760|NCT01904058|459096160|FG003|Overall Study|Adverse Event|0|||
127580761|NCT01904058|459096157|FG000|Overall Study|Withdrawal by Subject|1|||
127580762|NCT01904058|459096158|FG001|Overall Study|Withdrawal by Subject|0|||
127580763|NCT01904058|459096159|FG002|Overall Study|Withdrawal by Subject|1|||
127580764|NCT01904058|459096160|FG003|Overall Study|Withdrawal by Subject|0|||
127580765|NCT01904058|459096157|FG000|Overall Study|Pregnancy|0|||
127580766|NCT01904058|459096158|FG001|Overall Study|Pregnancy|0|||
127580767|NCT01904058|459096159|FG002|Overall Study|Pregnancy|0|||
127580768|NCT01904058|459096160|FG003|Overall Study|Pregnancy|1|||
127580769|NCT03096483|459096161|FG000|Overall Study|Withdrawal by site|1|||
127580770|NCT04041375|459096166|FG000|Intervention Phase|Withdrawal by Subject|2|||
127580771|NCT04041375|459096167|FG001|Intervention Phase|Withdrawal by Subject|2|||
127580772|NCT04041375|459096166|FG000|Follow-up Phase|Death|2|||
127580773|NCT04041375|459096167|FG001|Follow-up Phase|Death|0|||
127580774|NCT04041375|459096166|FG000|Follow-up Phase|Lost to Follow-up|2|||
127580775|NCT04041375|459096167|FG001|Follow-up Phase|Lost to Follow-up|1|||
127580776|NCT04041375|459096166|FG000|Follow-up Phase|Too ill|3|||
127580777|NCT04041375|459096167|FG001|Follow-up Phase|Too ill|0|||
127580778|NCT04674644|459096173|FG000|Overall Study|with missing data|37|||
127580779|NCT03277690|459096177|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
127580780|NCT03277690|459096178|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
127580781|NCT03277690|459096177|FG000|Dose Titration and Maintenance|Physician Decision|1|||
127580782|NCT03277690|459096178|FG001|Dose Titration and Maintenance|Physician Decision|0|||
127580783|NCT03277690|459096177|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
127580784|NCT03277690|459096178|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
127580785|NCT03277690|459096177|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
127580786|NCT03277690|459096178|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
127580787|NCT03277690|459096177|FG000|Dose Titration and Maintenance|Adverse Event|15|||
127580788|NCT03277690|459096178|FG001|Dose Titration and Maintenance|Adverse Event|0|||
127580789|NCT03277690|459096177|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
127580790|NCT03277690|459096178|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
127580791|NCT03277690|459096177|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
127580792|NCT03277690|459096178|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
127580793|NCT00747812|459096179|FG000|Overall Study|Research Site Staff Relocation|5|||
127580794|NCT00747812|459096180|FG001|Overall Study|Research Site Staff Relocation|3|||
127783177|NCT02490475|459832925|FG001|Period 2: Extension Phase|Adverse Event|0|||
127783178|NCT02490475|459832926|FG002|Period 2: Extension Phase|Adverse Event|1|||
127580795|NCT01708161|459096181|FG000|Overall Study|Adverse Event|1|||
127580796|NCT01708161|459096182|FG001|Overall Study|Adverse Event|3|||
127783179|NCT02490475|459832927|FG003|Period 2: Extension Phase|Adverse Event|0|||
127783180|NCT00139776|459832928|FG000|Period I|Did not enter Period II|575|||
127580797|NCT01708161|459096183|FG002|Overall Study|Adverse Event|4|||
127580798|NCT01708161|459096184|FG003|Overall Study|Adverse Event|2|||
127580799|NCT01708161|459096185|FG004|Overall Study|Adverse Event|3|||
127783181|NCT00139776|459832929|FG001|Period I|Did not enter Period II|0|||
127580800|NCT01708161|459096186|FG005|Overall Study|Adverse Event|0|||
127580801|NCT01708161|459096181|FG000|Overall Study|Death|0|||
127580802|NCT01708161|459096182|FG001|Overall Study|Death|0|||
127580803|NCT01708161|459096183|FG002|Overall Study|Death|0|||
128030475|NCT02613507|460737273|FG001|Pre-Treamtent|Participant no longer meets study criteria|1|||
128030476|NCT02613507|460737272|FG000|Treatment|Not reported|3|||
128030477|NCT02613507|460737273|FG001|Treatment|Not reported|0|||
128030478|NCT02613507|460737272|FG000|Treatment|Other reasons|8|||
128030479|NCT02613507|460737273|FG001|Treatment|Other reasons|0|||
128030480|NCT02613507|460737272|FG000|Treatment|Participant no longer meets criteria|3|||
127580804|NCT01708161|459096184|FG003|Overall Study|Death|1|||
127580805|NCT01708161|459096185|FG004|Overall Study|Death|0|||
127580806|NCT01708161|459096186|FG005|Overall Study|Death|1|||
127580807|NCT01708161|459096181|FG000|Overall Study|Withdrawal by Subject|0|||
128030481|NCT02613507|460737273|FG001|Treatment|Participant no longer meets criteria|0|||
127580808|NCT01708161|459096182|FG001|Overall Study|Withdrawal by Subject|1|||
127580809|NCT01708161|459096183|FG002|Overall Study|Withdrawal by Subject|1|||
127580810|NCT01708161|459096184|FG003|Overall Study|Withdrawal by Subject|0|||
127580811|NCT01708161|459096185|FG004|Overall Study|Withdrawal by Subject|0|||
127580812|NCT01708161|459096186|FG005|Overall Study|Withdrawal by Subject|0|||
127580813|NCT01708161|459096181|FG000|Overall Study|Administrative problems|0|||
127580814|NCT01708161|459096182|FG001|Overall Study|Administrative problems|1|||
127580815|NCT01708161|459096183|FG002|Overall Study|Administrative problems|0|||
127580816|NCT01708161|459096184|FG003|Overall Study|Administrative problems|0|||
127580817|NCT01708161|459096185|FG004|Overall Study|Administrative problems|0|||
128030482|NCT02613507|460737272|FG000|Treatment|Maximum clinical benefit|5|||
127580818|NCT01708161|459096186|FG005|Overall Study|Administrative problems|0|||
127580819|NCT01708161|459096181|FG000|Overall Study|Disease progression|3|||
127580820|NCT01708161|459096182|FG001|Overall Study|Disease progression|5|||
128030483|NCT02613507|460737273|FG001|Treatment|Maximum clinical benefit|10|||
128030484|NCT02613507|460737272|FG000|Treatment|Lost to Follow-up|1|||
128030485|NCT02613507|460737273|FG001|Treatment|Lost to Follow-up|0|||
128030486|NCT02613507|460737272|FG000|Treatment|Participant withdrew consent|0|||
128030487|NCT02613507|460737273|FG001|Treatment|Participant withdrew consent|2|||
128030488|NCT02613507|460737272|FG000|Treatment|Participant request to discontinue study treatment|13|||
128030489|NCT02613507|460737273|FG001|Treatment|Participant request to discontinue study treatment|17|||
128030490|NCT02613507|460737272|FG000|Treatment|Adverse event unrelated to study drug|20|||
128030491|NCT02613507|460737273|FG001|Treatment|Adverse event unrelated to study drug|3|||
128030492|NCT02613507|460737272|FG000|Treatment|Death|2|||
128030493|NCT02613507|460737273|FG001|Treatment|Death|0|||
128030494|NCT02613507|460737272|FG000|Treatment|Study drug toxicity|19|||
128030495|NCT02613507|460737273|FG001|Treatment|Study drug toxicity|14|||
128030496|NCT02613507|460737272|FG000|Treatment|Disease progression|263|||
128030497|NCT02613507|460737273|FG001|Treatment|Disease progression|110|||
128030498|NCT03941093|460737274|FG000|Overall Study|Protocol Violation|0|||
128030499|NCT03941093|460737275|FG001|Overall Study|Protocol Violation|1|||
128030500|NCT03941093|460737274|FG000|Overall Study|Withdrawal by Subject|9|||
128030501|NCT03941093|460737275|FG001|Overall Study|Withdrawal by Subject|6|||
128030502|NCT04129398|460738644|FG000|Overall Study|Physician Decision|2|||
128030503|NCT00590317|460738649|FG000|Overall Study|Lack of Efficacy|1|||
128030504|NCT00590317|460738650|FG001|Overall Study|Lack of Efficacy|5|||
128030505|NCT02363283|460738651|FG000|Overall Study|Withdrawal by Subject|1|||
128030506|NCT02363283|460738651|FG000|Overall Study|Not eligible due to transaminitis|1|||
128030507|NCT00003907|460738658|FG000|Overall Study|Adverse Event|2|||
128030508|NCT00003907|460738659|FG001|Overall Study|Adverse Event|11|||
128030509|NCT00003907|460738658|FG000|Overall Study|Death|2|||
128030510|NCT00003907|460738659|FG001|Overall Study|Death|0|||
128030511|NCT00003907|460738658|FG000|Overall Study|Withdrawal by Subject|1|||
128030512|NCT00003907|460738659|FG001|Overall Study|Withdrawal by Subject|3|||
128030513|NCT00003907|460738658|FG000|Overall Study|Progressive disease|4|||
128030514|NCT00003907|460738659|FG001|Overall Study|Progressive disease|4|||
128030515|NCT00003907|460738658|FG000|Overall Study|Complicating disease|1|||
128030516|NCT00003907|460738659|FG001|Overall Study|Complicating disease|0|||
128030517|NCT00003907|460738658|FG000|Overall Study|Other|1|||
128030518|NCT00003907|460738659|FG001|Overall Study|Other|3|||
128030519|NCT00003907|460738658|FG000|Overall Study|ineligible or not treated|2|||
128030520|NCT00003907|460738659|FG001|Overall Study|ineligible or not treated|2|||
128030521|NCT01517178|460738660|FG000|Period 1|Adverse Event|1|||
128030522|NCT01517178|460738661|FG001|Period 1|Adverse Event|2|||
128030523|NCT01517178|460738660|FG000|Period 1|Lack of Efficacy|0|||
128030524|NCT01517178|460738661|FG001|Period 1|Lack of Efficacy|1|||
128030525|NCT01517178|460738660|FG000|Period 1|E.g. study termination|3|||
128030526|NCT01517178|460738661|FG001|Period 1|E.g. study termination|1|||
128030527|NCT01517178|460738660|FG000|Period 1|Withdrawal by Subject|0|||
128030528|NCT01517178|460738661|FG001|Period 1|Withdrawal by Subject|1|||
128030529|NCT01517178|460738660|FG000|Period 2|Adverse Event|1|||
128030530|NCT01517178|460738661|FG001|Period 2|Adverse Event|0|||
128030531|NCT01517178|460738660|FG000|Period 2|Withdrawal by Subject|3|||
128030532|NCT01517178|460738661|FG001|Period 2|Withdrawal by Subject|0|||
128030533|NCT01517178|460738660|FG000|Period 2|E.g. study termination|2|||
128030534|NCT01517178|460738661|FG001|Period 2|E.g. study termination|2|||
128030535|NCT01050218|460738668|FG000|Overall Study|Adverse Event|37|||
128030536|NCT01050218|460738668|FG000|Overall Study|Lack of Efficacy|8|||
127580821|NCT01708161|459096183|FG002|Overall Study|Disease progression|5|||
127580822|NCT01708161|459096184|FG003|Overall Study|Disease progression|13|||
127580823|NCT01708161|459096185|FG004|Overall Study|Disease progression|3|||
127580824|NCT01708161|459096186|FG005|Overall Study|Disease progression|0|||
127580825|NCT02019277|459096187|FG000|Overall Study|Withdrawal by Subject|3|||
127580826|NCT02019277|459096187|FG000|Overall Study|Death|7|||
127580827|NCT02019277|459096187|FG000|Overall Study|Did no Cooperate|1|||
127580828|NCT02019277|459096187|FG000|Overall Study|Adverse Event|1|||
127580829|NCT02633501|459096189|FG000|Overall Study|Adverse Event|0|||
127580830|NCT02633501|459096190|FG001|Overall Study|Adverse Event|0|||
127580831|NCT02633501|459096191|FG002|Overall Study|Adverse Event|1|||
127580832|NCT02633501|459096192|FG003|Overall Study|Adverse Event|0|||
127580833|NCT02633501|459096193|FG004|Overall Study|Adverse Event|1|||
127580834|NCT02633501|459096194|FG005|Overall Study|Adverse Event|1|||
127580835|NCT02633501|459096189|FG000|Overall Study|Withdrawal by Subject|2|||
127580836|NCT02633501|459096190|FG001|Overall Study|Withdrawal by Subject|1|||
127580837|NCT02633501|459096191|FG002|Overall Study|Withdrawal by Subject|2|||
127580838|NCT02633501|459096192|FG003|Overall Study|Withdrawal by Subject|2|||
127580839|NCT02633501|459096193|FG004|Overall Study|Withdrawal by Subject|1|||
127580840|NCT02633501|459096194|FG005|Overall Study|Withdrawal by Subject|3|||
127580841|NCT02633501|459096189|FG000|Overall Study|Various other reasons|0|||
127580842|NCT02633501|459096190|FG001|Overall Study|Various other reasons|2|||
127580843|NCT02633501|459096191|FG002|Overall Study|Various other reasons|4|||
127580844|NCT02633501|459096192|FG003|Overall Study|Various other reasons|1|||
127580845|NCT02633501|459096193|FG004|Overall Study|Various other reasons|7|||
127693741|NCT04593472|459506986|FG000|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|0|||
127693742|NCT04593472|459506987|FG001|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|2|||
127693743|NCT04593472|459506986|FG000|Overall Study|Lost to Follow-up|0|||
127693744|NCT04593472|459506987|FG001|Overall Study|Lost to Follow-up|2|||
127693745|NCT04593472|459506986|FG000|Overall Study|Still collecting 24-month assessment|17|||
127693746|NCT04593472|459506987|FG001|Overall Study|Still collecting 24-month assessment|10|||
127783182|NCT00139776|459832930|FG002|Period I|Did not enter Period II|0|||
127783183|NCT00139776|459832931|FG003|Period I|Did not enter Period II|0|||
127783184|NCT00139776|459832928|FG000|Period II|Not Randomized into Period III|0|||
127783185|NCT00139776|459832929|FG001|Period II|Not Randomized into Period III|322|||
127783186|NCT00139776|459832930|FG002|Period II|Not Randomized into Period III|0|||
127783187|NCT00139776|459832931|FG003|Period II|Not Randomized into Period III|0|||
127783188|NCT00139776|459832928|FG000|Period III|Adverse Event|0|||
127783189|NCT00139776|459832929|FG001|Period III|Adverse Event|0|||
127783190|NCT00139776|459832930|FG002|Period III|Adverse Event|22|||
127783191|NCT00139776|459832931|FG003|Period III|Adverse Event|23|||
127783192|NCT00139776|459832928|FG000|Period III|Other|0|||
127693747|NCT03896516|459506988|FG000|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|1|||
127693748|NCT03896516|459506989|FG001|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|0|||
127693749|NCT03896516|459506988|FG000|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
127693750|NCT03896516|459506989|FG001|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
127693751|NCT03896516|459506988|FG000|Washout Period|Physician Decision|3|||
127783193|NCT00139776|459832929|FG001|Period III|Other|0|||
127783194|NCT00139776|459832930|FG002|Period III|Other|23|||
127783195|NCT00139776|459832931|FG003|Period III|Other|34|||
127580846|NCT02633501|459096194|FG005|Overall Study|Various other reasons|11|||
127580847|NCT02633501|459096189|FG000|Overall Study|Lost to Follow-up|0|||
127580848|NCT02633501|459096190|FG001|Overall Study|Lost to Follow-up|0|||
127580849|NCT02633501|459096191|FG002|Overall Study|Lost to Follow-up|0|||
127693752|NCT03896516|459506989|FG001|Washout Period|Physician Decision|1|||
127783196|NCT00139776|459832928|FG000|Period III|Lack of Efficacy|0|||
127580850|NCT02633501|459096192|FG003|Overall Study|Lost to Follow-up|1|||
127580851|NCT02633501|459096193|FG004|Overall Study|Lost to Follow-up|2|||
127580852|NCT02633501|459096194|FG005|Overall Study|Lost to Follow-up|0|||
127580853|NCT02081183|459096196|FG000|Overall Study|Lost to Follow-up|0|||
127580854|NCT02081183|459096197|FG001|Overall Study|Lost to Follow-up|1|||
127580855|NCT02081183|459096196|FG000|Overall Study|Protocol Violation|1|||
127580856|NCT02081183|459096197|FG001|Overall Study|Protocol Violation|0|||
127580857|NCT02081183|459096196|FG000|Overall Study|Other|3|||
127580858|NCT02081183|459096197|FG001|Overall Study|Other|3|||
127580859|NCT00910273|459096202|FG000|Overall Study|Lack of Efficacy|6|||
127580860|NCT00910273|459096203|FG001|Overall Study|Lack of Efficacy|9|||
127580861|NCT00910273|459096202|FG000|Overall Study|Adverse Event|1|||
127580862|NCT00910273|459096203|FG001|Overall Study|Adverse Event|1|||
127580863|NCT00910273|459096202|FG000|Overall Study|Withdrawal by Subject|1|||
127580864|NCT00910273|459096203|FG001|Overall Study|Withdrawal by Subject|0|||
127580865|NCT00910273|459096202|FG000|Overall Study|Discontinuation of study by sponsor|8|||
127580866|NCT00910273|459096203|FG001|Overall Study|Discontinuation of study by sponsor|2|||
127580867|NCT00910273|459096202|FG000|Overall Study|Protocol Violation|1|||
127580868|NCT00910273|459096203|FG001|Overall Study|Protocol Violation|0|||
127580869|NCT00910273|459096202|FG000|Overall Study|Lost to Follow-up|1|||
127580870|NCT00910273|459096203|FG001|Overall Study|Lost to Follow-up|1|||
127580871|NCT00968864|459096204|FG000|Overall Study|Protocol exception/ not evaluable|1|||
127580872|NCT01346969|459096205|FG000|Overall Study|Withdrawal by Subject|0|||
127580873|NCT01346969|459096206|FG001|Overall Study|Withdrawal by Subject|0|||
127580874|NCT01346969|459096207|FG002|Overall Study|Withdrawal by Subject|1|||
127580875|NCT01346969|459096208|FG003|Overall Study|Withdrawal by Subject|0|||
127580876|NCT01346969|459096205|FG000|Overall Study|Lost to Follow-up|1|||
127580877|NCT01346969|459096206|FG001|Overall Study|Lost to Follow-up|0|||
127580878|NCT01346969|459096207|FG002|Overall Study|Lost to Follow-up|2|||
127580879|NCT01346969|459096208|FG003|Overall Study|Lost to Follow-up|0|||
127580880|NCT01346969|459096205|FG000|Overall Study|Physician Decision|0|||
127580881|NCT01346969|459096206|FG001|Overall Study|Physician Decision|0|||
127580882|NCT01346969|459096207|FG002|Overall Study|Physician Decision|0|||
127580883|NCT01346969|459096208|FG003|Overall Study|Physician Decision|1|||
127580884|NCT01346969|459096205|FG000|Overall Study|Randomized but not treated|1|||
127580885|NCT01346969|459096206|FG001|Overall Study|Randomized but not treated|0|||
127580886|NCT01346969|459096207|FG002|Overall Study|Randomized but not treated|0|||
127580887|NCT01346969|459096208|FG003|Overall Study|Randomized but not treated|0|||
127580888|NCT01414608|459096211|FG000|Overall Study|Ineligible|5|||
127580889|NCT01414608|459096212|FG001|Overall Study|Ineligible|2|||
127580890|NCT03553927|459096215|FG000|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
127580891|NCT03553927|459096216|FG001|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
127580892|NCT03553927|459096215|FG000|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|2|||
127580893|NCT03553927|459096216|FG001|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|0|||
127580894|NCT04176705|459096217|FG000|Overall Study|Withdrawal by Subject|4|||
127580895|NCT04176705|459096218|FG001|Overall Study|Withdrawal by Subject|4|||
127580896|NCT04176705|459096217|FG000|Overall Study|Death|1|||
127580897|NCT04176705|459096218|FG001|Overall Study|Death|1|||
127580898|NCT04176705|459096217|FG000|Overall Study|Lost to Follow-up|3|||
127580899|NCT04176705|459096218|FG001|Overall Study|Lost to Follow-up|3|||
127580900|NCT02423772|459096219|FG000|Overall Study|Lost to Follow-up|3|||
127580901|NCT02423772|459096220|FG001|Overall Study|Lost to Follow-up|3|||
127580902|NCT02423772|459096219|FG000|Overall Study|Did not begin intervention|2|||
127580903|NCT02423772|459096220|FG001|Overall Study|Did not begin intervention|5|||
127580904|NCT01193842|459096223|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
127580905|NCT01193842|459096224|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
127580906|NCT01193842|459096225|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
127580907|NCT01193842|459096226|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
127580908|NCT01193842|459096227|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
127580909|NCT01193842|459096223|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
127580910|NCT01193842|459096224|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
127580911|NCT01193842|459096225|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
127580912|NCT01193842|459096226|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
127580913|NCT01193842|459096227|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
127580914|NCT01193842|459096223|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
127580915|NCT01193842|459096224|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
127580916|NCT01193842|459096225|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
127580917|NCT01193842|459096226|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
127580918|NCT01193842|459096227|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
127693753|NCT03896516|459506988|FG000|Stage II (GLWL-01 or Placebo)|Physician Decision|0|||
127580919|NCT01193842|459096223|FG000|Phase II: Randomized Groups|Death|0|||
127580920|NCT01193842|459096224|FG001|Phase II: Randomized Groups|Death|0|||
127580921|NCT01193842|459096225|FG002|Phase II: Randomized Groups|Death|0|||
127580922|NCT01193842|459096226|FG003|Phase II: Randomized Groups|Death|1|||
127580923|NCT01193842|459096227|FG004|Phase II: Randomized Groups|Death|1|||
127580924|NCT01193842|459096223|FG000|Phase II: Randomized Groups|Adverse Event|0|||
127580925|NCT01193842|459096224|FG001|Phase II: Randomized Groups|Adverse Event|0|||
127580926|NCT01193842|459096225|FG002|Phase II: Randomized Groups|Adverse Event|0|||
127580927|NCT01193842|459096226|FG003|Phase II: Randomized Groups|Adverse Event|5|||
127580928|NCT01193842|459096227|FG004|Phase II: Randomized Groups|Adverse Event|3|||
127580929|NCT01193842|459096223|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
127580930|NCT01193842|459096224|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
127580931|NCT01193842|459096225|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
127580932|NCT01193842|459096226|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
127580933|NCT01193842|459096227|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
127580934|NCT01193842|459096223|FG000|Phase II: Randomized Groups|Ineligible|0|||
127580935|NCT01193842|459096224|FG001|Phase II: Randomized Groups|Ineligible|0|||
127580936|NCT01193842|459096225|FG002|Phase II: Randomized Groups|Ineligible|0|||
127580937|NCT01193842|459096226|FG003|Phase II: Randomized Groups|Ineligible|0|||
127580938|NCT01193842|459096227|FG004|Phase II: Randomized Groups|Ineligible|1|||
127580939|NCT01193842|459096223|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
127580940|NCT01193842|459096224|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
127580941|NCT01193842|459096225|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
127580942|NCT01193842|459096226|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
127580943|NCT01193842|459096227|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
127580944|NCT01759511|459096230|FG000|Overall Study|Adverse Event|4|||
127580945|NCT01759511|459096230|FG000|Overall Study|Death|2|||
127580946|NCT01759511|459096230|FG000|Overall Study|Lack of Efficacy|2|||
127580947|NCT01759511|459096230|FG000|Overall Study|Physician Decision|1|||
127580948|NCT01759511|459096230|FG000|Overall Study|Progressive Disease|5|||
127580949|NCT01759511|459096230|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
127580950|NCT01759511|459096230|FG000|Overall Study|Study Terminated by Sponsor|13|||
127580951|NCT01759511|459096230|FG000|Overall Study|Withdrawal by Subject|3|||
127580952|NCT03672643|459096231|FG000|Overall Study|Adverse Event|3|||
127580953|NCT03672643|459096231|FG000|Overall Study|Death|2|||
127580954|NCT03672643|459096231|FG000|Overall Study|Withdrawal by Subject|1|||
127580955|NCT03672643|459096231|FG000|Overall Study|Progressive disease|11|||
127580956|NCT03672643|459096231|FG000|Overall Study|Global deterioration of health status|1|||
127580957|NCT03672643|459096231|FG000|Overall Study|Refused further treatment|7|||
127580958|NCT03672643|459096231|FG000|Overall Study|Rolled over to a continuous study for Crizotinib treatment|16|||
127580959|NCT05736224|459096232|FG000|Overall Study|Excluded from analysis because processed biopsy sample was inadequate for analysis|1|||
127580960|NCT02557295|459096233|FG000|Overall Study|Withdrawal by Subject|9|||
127580961|NCT02557295|459096234|FG001|Overall Study|Withdrawal by Subject|2|||
127580962|NCT02557295|459096235|FG002|Overall Study|Withdrawal by Subject|4|||
127580963|NCT02557295|459096236|FG003|Overall Study|Withdrawal by Subject|0|||
127580964|NCT02557295|459096237|FG004|Overall Study|Withdrawal by Subject|0|||
127580965|NCT02557295|459096238|FG005|Overall Study|Withdrawal by Subject|0|||
127580966|NCT02557295|459096239|FG006|Overall Study|Withdrawal by Subject|15|||
127580967|NCT02557295|459096240|FG007|Overall Study|Withdrawal by Subject|1|||
127580968|NCT02557295|459096241|FG008|Overall Study|Withdrawal by Subject|3|||
127580969|NCT02557295|459096233|FG000|Overall Study|Disease Progression|0|||
127580970|NCT02557295|459096234|FG001|Overall Study|Disease Progression|0|||
127580971|NCT02557295|459096235|FG002|Overall Study|Disease Progression|0|||
127580972|NCT02557295|459096236|FG003|Overall Study|Disease Progression|0|||
127580973|NCT02557295|459096237|FG004|Overall Study|Disease Progression|0|||
127580974|NCT02557295|459096238|FG005|Overall Study|Disease Progression|0|||
127580975|NCT02557295|459096239|FG006|Overall Study|Disease Progression|1|||
127580976|NCT02557295|459096240|FG007|Overall Study|Disease Progression|0|||
127580977|NCT02557295|459096241|FG008|Overall Study|Disease Progression|0|||
127580978|NCT02557295|459096233|FG000|Overall Study|Lack of Efficacy|24|||
127580979|NCT02557295|459096234|FG001|Overall Study|Lack of Efficacy|1|||
127580980|NCT02557295|459096235|FG002|Overall Study|Lack of Efficacy|3|||
127580981|NCT02557295|459096236|FG003|Overall Study|Lack of Efficacy|0|||
127580982|NCT02557295|459096237|FG004|Overall Study|Lack of Efficacy|0|||
127580983|NCT02557295|459096238|FG005|Overall Study|Lack of Efficacy|0|||
127580984|NCT02557295|459096239|FG006|Overall Study|Lack of Efficacy|12|||
127580985|NCT02557295|459096240|FG007|Overall Study|Lack of Efficacy|1|||
127580986|NCT02557295|459096241|FG008|Overall Study|Lack of Efficacy|0|||
128030537|NCT01050218|460738668|FG000|Overall Study|Protocol Violation|3|||
128030538|NCT01050218|460738668|FG000|Overall Study|Withdrawal by Subject|18|||
127580987|NCT02557295|459096233|FG000|Overall Study|Adverse Event|16|||
127580988|NCT02557295|459096234|FG001|Overall Study|Adverse Event|2|||
127580989|NCT02557295|459096235|FG002|Overall Study|Adverse Event|3|||
127580990|NCT02557295|459096236|FG003|Overall Study|Adverse Event|0|||
127580991|NCT02557295|459096237|FG004|Overall Study|Adverse Event|0|||
127580992|NCT02557295|459096238|FG005|Overall Study|Adverse Event|0|||
127580993|NCT02557295|459096239|FG006|Overall Study|Adverse Event|2|||
128030539|NCT01050218|460738668|FG000|Overall Study|Discontinued by sponsor|18|||
127580994|NCT02557295|459096240|FG007|Overall Study|Adverse Event|1|||
127580995|NCT02557295|459096241|FG008|Overall Study|Adverse Event|1|||
127580996|NCT02557295|459096233|FG000|Overall Study|Lost to Follow-up|4|||
127580997|NCT02557295|459096234|FG001|Overall Study|Lost to Follow-up|0|||
127580998|NCT02557295|459096235|FG002|Overall Study|Lost to Follow-up|0|||
128030540|NCT01050218|460738668|FG000|Overall Study|Compliance|2|||
128030541|NCT01050218|460738668|FG000|Overall Study|Failed to return|7|||
127580999|NCT02557295|459096236|FG003|Overall Study|Lost to Follow-up|0|||
127581000|NCT02557295|459096237|FG004|Overall Study|Lost to Follow-up|0|||
127581001|NCT02557295|459096238|FG005|Overall Study|Lost to Follow-up|0|||
127581002|NCT02557295|459096239|FG006|Overall Study|Lost to Follow-up|9|||
127581003|NCT02557295|459096240|FG007|Overall Study|Lost to Follow-up|0|||
127581004|NCT02557295|459096241|FG008|Overall Study|Lost to Follow-up|0|||
127581005|NCT02557295|459096233|FG000|Overall Study|Study Close|54|||
127581006|NCT02557295|459096234|FG001|Overall Study|Study Close|3|||
127581007|NCT02557295|459096235|FG002|Overall Study|Study Close|5|||
127581008|NCT02557295|459096236|FG003|Overall Study|Study Close|3|||
127581009|NCT02557295|459096237|FG004|Overall Study|Study Close|0|||
127581010|NCT02557295|459096238|FG005|Overall Study|Study Close|0|||
127581011|NCT02557295|459096239|FG006|Overall Study|Study Close|37|||
127581012|NCT02557295|459096240|FG007|Overall Study|Study Close|3|||
127581013|NCT02557295|459096241|FG008|Overall Study|Study Close|19|||
127581014|NCT02557295|459096233|FG000|Overall Study|except for study close|4|||
127581015|NCT02557295|459096234|FG001|Overall Study|except for study close|0|||
127581016|NCT02557295|459096235|FG002|Overall Study|except for study close|0|||
127581017|NCT02557295|459096236|FG003|Overall Study|except for study close|0|||
127881547|NCT00791154|460188793|FG001|Overall Study|Noncompliance|1|||
127881548|NCT00791154|460188794|FG002|Overall Study|Noncompliance|0|||
127881549|NCT00791154|460188795|FG003|Overall Study|Noncompliance|0|||
127881550|NCT00791154|460188796|FG004|Overall Study|Noncompliance|1|||
127881551|NCT00791154|460188797|FG005|Overall Study|Noncompliance|1|||
127881552|NCT00791154|460188798|FG006|Overall Study|Noncompliance|1|||
127881553|NCT00791154|460188792|FG000|Overall Study|Adverse Event|0|||
127881554|NCT00791154|460188793|FG001|Overall Study|Adverse Event|0|||
127881555|NCT00791154|460188794|FG002|Overall Study|Adverse Event|0|||
127881556|NCT00791154|460188795|FG003|Overall Study|Adverse Event|0|||
127881557|NCT00791154|460188796|FG004|Overall Study|Adverse Event|2|||
127881558|NCT00791154|460188797|FG005|Overall Study|Adverse Event|0|||
127881559|NCT00791154|460188798|FG006|Overall Study|Adverse Event|1|||
127881560|NCT00791154|460188792|FG000|Overall Study|Full Consent withdrawn|1|||
127881561|NCT00791154|460188793|FG001|Overall Study|Full Consent withdrawn|3|||
127881562|NCT00791154|460188794|FG002|Overall Study|Full Consent withdrawn|0|||
127881563|NCT00791154|460188795|FG003|Overall Study|Full Consent withdrawn|0|||
127881564|NCT00791154|460188796|FG004|Overall Study|Full Consent withdrawn|1|||
127881565|NCT00791154|460188797|FG005|Overall Study|Full Consent withdrawn|3|||
127881566|NCT00791154|460188798|FG006|Overall Study|Full Consent withdrawn|1|||
128030542|NCT01050218|460738668|FG000|Overall Study|Serious Adverse Event|1|||
128030543|NCT01050218|460738668|FG000|Overall Study|Family emergency|1|||
128030544|NCT01149460|460738669|FG000|Overall Study|Withdrawal by Subject|0|||
128030545|NCT01149460|460738670|FG001|Overall Study|Withdrawal by Subject|2|||
128030546|NCT02272985|460738680|FG000|Overall Study|Withdrawal by Subject|1|||
128030547|NCT02272985|460738680|FG000|Overall Study|hip fracture|1|||
128030548|NCT02272985|460738680|FG000|Overall Study|kidney transplantation|1|||
128030549|NCT00266032|460738681|FG000|Treatment|Adverse Event|42|||
128030550|NCT00266032|460738682|FG001|Treatment|Adverse Event|26|||
128030551|NCT00266032|460738683|FG002|Treatment|Adverse Event|10|||
128030552|NCT00266032|460738681|FG000|Treatment|Lost to Follow-up|19|||
128030553|NCT00266032|460738682|FG001|Treatment|Lost to Follow-up|4|||
128030554|NCT00266032|460738683|FG002|Treatment|Lost to Follow-up|2|||
128030555|NCT00266032|460738681|FG000|Treatment|Pregnancy|3|||
128030556|NCT00266032|460738682|FG001|Treatment|Pregnancy|2|||
128030557|NCT00266032|460738683|FG002|Treatment|Pregnancy|2|||
128030558|NCT00266032|460738681|FG000|Treatment|Protocol Violation|6|||
128030559|NCT00266032|460738682|FG001|Treatment|Protocol Violation|14|||
128030560|NCT00266032|460738683|FG002|Treatment|Protocol Violation|13|||
128030561|NCT00266032|460738681|FG000|Treatment|Withdrawal by Subject|28|||
128030562|NCT00266032|460738682|FG001|Treatment|Withdrawal by Subject|13|||
128030563|NCT00266032|460738683|FG002|Treatment|Withdrawal by Subject|12|||
128030564|NCT00266032|460738681|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
128030565|NCT00266032|460738682|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
128030566|NCT00266032|460738683|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
128030567|NCT00266032|460738681|FG000|Open-label Safety Extension|Adverse Event|5|||
128030568|NCT00266032|460738682|FG001|Open-label Safety Extension|Adverse Event|0|||
128030569|NCT00266032|460738683|FG002|Open-label Safety Extension|Adverse Event|4|||
128030570|NCT00266032|460738681|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
127581018|NCT02557295|459096237|FG004|Overall Study|except for study close|0|||
127581019|NCT02557295|459096238|FG005|Overall Study|except for study close|0|||
127581020|NCT02557295|459096239|FG006|Overall Study|except for study close|5|||
127581021|NCT02557295|459096240|FG007|Overall Study|except for study close|1|||
127581022|NCT02557295|459096241|FG008|Overall Study|except for study close|0|||
127581023|NCT03673046|459097655|FG000|Overall Study|Adverse Event|1|||
127581024|NCT03673046|459097656|FG001|Overall Study|Adverse Event|1|||
127581025|NCT03673046|459097655|FG000|Overall Study|Withdrawal by Subject|8|||
127581026|NCT03673046|459097656|FG001|Overall Study|Withdrawal by Subject|2|||
127581027|NCT03817879|459097657|FG000|Overall Study|Drop out|5|||
127581028|NCT03817879|459097658|FG001|Overall Study|Drop out|12|||
127581029|NCT03817879|459097657|FG000|Overall Study|Withdrawal by Subject|0|||
127881567|NCT00791154|460188792|FG000|Overall Study|Lost to Follow-up|0|||
127881568|NCT00791154|460188793|FG001|Overall Study|Lost to Follow-up|0|||
128030571|NCT00266032|460738682|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
128030572|NCT00266032|460738683|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
128030573|NCT00266032|460738681|FG000|Open-label Safety Extension|Pregnancy|4|||
128030574|NCT00266032|460738682|FG001|Open-label Safety Extension|Pregnancy|1|||
128030575|NCT00266032|460738683|FG002|Open-label Safety Extension|Pregnancy|2|||
128030576|NCT00266032|460738681|FG000|Open-label Safety Extension|Protocol Violation|1|||
127581030|NCT03817879|459097658|FG001|Overall Study|Withdrawal by Subject|1|||
127783197|NCT00139776|459832929|FG001|Period III|Lack of Efficacy|0|||
128030577|NCT00266032|460738682|FG001|Open-label Safety Extension|Protocol Violation|3|||
128030578|NCT00266032|460738683|FG002|Open-label Safety Extension|Protocol Violation|2|||
128030579|NCT00266032|460738681|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
128030580|NCT00266032|460738682|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
128030581|NCT00266032|460738683|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
128030582|NCT00266032|460738681|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
127581031|NCT01896050|459097659|FG000|Overall Study|Adverse Event|37|||
127783198|NCT00139776|459832930|FG002|Period III|Lack of Efficacy|10|||
127783199|NCT00139776|459832931|FG003|Period III|Lack of Efficacy|24|||
127783200|NCT00139776|459832928|FG000|Period III|Lost to Follow-up|0|||
127783201|NCT00139776|459832929|FG001|Period III|Lost to Follow-up|0|||
127783202|NCT00139776|459832930|FG002|Period III|Lost to Follow-up|5|||
127783203|NCT00139776|459832931|FG003|Period III|Lost to Follow-up|4|||
127783204|NCT00139776|459832928|FG000|Period III|Withdrawal by Subject|0|||
127783205|NCT00139776|459832929|FG001|Period III|Withdrawal by Subject|0|||
127783206|NCT00139776|459832930|FG002|Period III|Withdrawal by Subject|16|||
127783207|NCT00139776|459832931|FG003|Period III|Withdrawal by Subject|21|||
127783208|NCT04912245|459832934|FG000|Overall Study|Withdrawal by Subject|21|||
127783209|NCT04912245|459832935|FG001|Overall Study|Withdrawal by Subject|4|||
127783210|NCT04912245|459832934|FG000|Overall Study|Lost to Follow-up|5|||
127783211|NCT04912245|459832935|FG001|Overall Study|Lost to Follow-up|11|||
127783212|NCT01134614|459832936|FG000|Overall Study|Still on treatment as of March 2013|21|||
127783213|NCT01134614|459832937|FG001|Overall Study|Still on treatment as of March 2013|13|||
127783214|NCT01134614|459832936|FG000|Overall Study|Progressive disease|60|||
127783215|NCT01134614|459832937|FG001|Overall Study|Progressive disease|54|||
127783216|NCT01134614|459832936|FG000|Overall Study|Adverse Event|26|||
127783217|NCT01134614|459832937|FG001|Overall Study|Adverse Event|39|||
127783218|NCT01134614|459832936|FG000|Overall Study|Death|5|||
127783219|NCT01134614|459832937|FG001|Overall Study|Death|8|||
127783220|NCT01134614|459832936|FG000|Overall Study|Withdrawal by Subject|3|||
127783221|NCT01134614|459832937|FG001|Overall Study|Withdrawal by Subject|2|||
127783222|NCT01134614|459832936|FG000|Overall Study|Alternative therapy|2|||
127783223|NCT01134614|459832937|FG001|Overall Study|Alternative therapy|0|||
127783224|NCT01134614|459832936|FG000|Overall Study|Complicating disease|2|||
127783225|NCT01134614|459832937|FG001|Overall Study|Complicating disease|1|||
127783226|NCT01134614|459832936|FG000|Overall Study|Physician's decision|0|||
127783227|NCT01134614|459832937|FG001|Overall Study|Physician's decision|1|||
127783228|NCT01134614|459832936|FG000|Overall Study|Never started treatment|4|||
127783229|NCT01134614|459832937|FG001|Overall Study|Never started treatment|1|||
127783230|NCT01134614|459832936|FG000|Overall Study|Pt received tx not allowed on study|0|||
127783231|NCT01134614|459832937|FG001|Overall Study|Pt received tx not allowed on study|1|||
127783232|NCT01134614|459832936|FG000|Overall Study|Symptomatic deterioration|0|||
127783233|NCT01134614|459832937|FG001|Overall Study|Symptomatic deterioration|1|||
127783234|NCT01134614|459832936|FG000|Overall Study|Patient in hospice care|0|||
127783235|NCT01134614|459832937|FG001|Overall Study|Patient in hospice care|1|||
127783236|NCT02752035|459832938|FG000|Safety Cohort: Approximately 5 Years|Miscellaneous|2|||
127783237|NCT02752035|459832939|FG001|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
127783238|NCT02752035|459832940|FG002|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
127783239|NCT02752035|459832941|FG003|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
127783240|NCT02752035|459832938|FG000|Safety Cohort: Approximately 5 Years|Disease relapse|5|||
127783241|NCT02752035|459832939|FG001|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
127783242|NCT02752035|459832940|FG002|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
127783243|NCT02752035|459832941|FG003|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
127783244|NCT02752035|459832938|FG000|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|1|||
127783245|NCT02752035|459832939|FG001|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
127783246|NCT02752035|459832940|FG002|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
127881569|NCT00791154|460188794|FG002|Overall Study|Lost to Follow-up|0|||
127881570|NCT00791154|460188795|FG003|Overall Study|Lost to Follow-up|1|||
127881571|NCT00791154|460188796|FG004|Overall Study|Lost to Follow-up|2|||
127581032|NCT01896050|459097660|FG001|Overall Study|Adverse Event|2|||
127581033|NCT01896050|459097659|FG000|Overall Study|Death|1|||
127783247|NCT02752035|459832941|FG003|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
127783248|NCT02752035|459832938|FG000|Safety Cohort: Approximately 5 Years|Lack of Efficacy|1|||
127783249|NCT02752035|459832939|FG001|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
127783250|NCT02752035|459832940|FG002|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
127581034|NCT01896050|459097660|FG001|Overall Study|Death|0|||
127581035|NCT00392015|459097661|FG000|Overall Study|Lost to Follow-up|2|||
127581036|NCT00392015|459097662|FG001|Overall Study|Lost to Follow-up|0|||
127581037|NCT00392015|459097663|FG002|Overall Study|Lost to Follow-up|2|||
127581038|NCT00392015|459097664|FG003|Overall Study|Lost to Follow-up|1|||
127581039|NCT00392015|459097665|FG004|Overall Study|Lost to Follow-up|1|||
127581040|NCT00392015|459097666|FG005|Overall Study|Lost to Follow-up|0|||
127581041|NCT00392015|459097661|FG000|Overall Study|Withdrawal by Subject|0|||
127581042|NCT00392015|459097662|FG001|Overall Study|Withdrawal by Subject|0|||
127581043|NCT00392015|459097663|FG002|Overall Study|Withdrawal by Subject|2|||
127581044|NCT00392015|459097664|FG003|Overall Study|Withdrawal by Subject|0|||
127581045|NCT00392015|459097665|FG004|Overall Study|Withdrawal by Subject|0|||
127581046|NCT00392015|459097666|FG005|Overall Study|Withdrawal by Subject|0|||
127581047|NCT00392015|459097661|FG000|Overall Study|Adverse Event|0|||
127581048|NCT00392015|459097662|FG001|Overall Study|Adverse Event|0|||
127581049|NCT00392015|459097663|FG002|Overall Study|Adverse Event|0|||
127581050|NCT00392015|459097664|FG003|Overall Study|Adverse Event|0|||
127581051|NCT00392015|459097665|FG004|Overall Study|Adverse Event|1|||
127581052|NCT00392015|459097666|FG005|Overall Study|Adverse Event|0|||
127581053|NCT00392015|459097661|FG000|Overall Study|Previous trial recipient|0|||
127581054|NCT00392015|459097662|FG001|Overall Study|Previous trial recipient|0|||
127581055|NCT00392015|459097663|FG002|Overall Study|Previous trial recipient|0|||
127581056|NCT00392015|459097664|FG003|Overall Study|Previous trial recipient|0|||
127581057|NCT00392015|459097665|FG004|Overall Study|Previous trial recipient|1|||
128030583|NCT00266032|460738682|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
128030584|NCT00266032|460738683|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
128030585|NCT01514357|460738684|FG000|Overall Study|Screen failure|2|||
128030586|NCT01514357|460738685|FG001|Overall Study|Screen failure|0|||
128030587|NCT01514357|460738684|FG000|Overall Study|Withdrawal by Subject|2|||
128030588|NCT01514357|460738685|FG001|Overall Study|Withdrawal by Subject|0|||
128030589|NCT04691115|460738688|FG000|Overall Study|Withdrawal by Subject|0|||
128030590|NCT04691115|460738689|FG001|Overall Study|Withdrawal by Subject|0|||
128030591|NCT04691115|460738690|FG002|Overall Study|Withdrawal by Subject|0|||
128030592|NCT04691115|460738691|FG003|Overall Study|Withdrawal by Subject|0|||
128030593|NCT04691115|460738692|FG004|Overall Study|Withdrawal by Subject|0|||
128030594|NCT04691115|460738693|FG005|Overall Study|Withdrawal by Subject|1|||
127581058|NCT00392015|459097666|FG005|Overall Study|Previous trial recipient|0|||
127581059|NCT03693300|459097667|FG000|Overall Study|Withdrawal by Subject|6|||
127581060|NCT03693300|459097668|FG001|Overall Study|Withdrawal by Subject|0|||
127581061|NCT03693300|459097667|FG000|Overall Study|Death|50|||
127783251|NCT02752035|459832941|FG003|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
127783252|NCT02752035|459832938|FG000|Safety Cohort: Approximately 5 Years|Death|5|||
127783253|NCT02752035|459832939|FG001|Safety Cohort: Approximately 5 Years|Death|0|||
127783254|NCT02752035|459832940|FG002|Safety Cohort: Approximately 5 Years|Death|0|||
127783255|NCT02752035|459832941|FG003|Safety Cohort: Approximately 5 Years|Death|0|||
127783256|NCT02752035|459832938|FG000|Safety Cohort: Approximately 5 Years|Adverse Event|1|||
127783257|NCT02752035|459832939|FG001|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
127783258|NCT02752035|459832940|FG002|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
127783259|NCT02752035|459832941|FG003|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
128030595|NCT04691115|460738694|FG006|Overall Study|Withdrawal by Subject|0|||
128030596|NCT04691115|460738695|FG007|Overall Study|Withdrawal by Subject|0|||
128030597|NCT04691115|460738696|FG008|Overall Study|Withdrawal by Subject|0|||
128030598|NCT04691115|460738697|FG009|Overall Study|Withdrawal by Subject|0|||
128030599|NCT04691115|460738698|FG010|Overall Study|Withdrawal by Subject|0|||
128030600|NCT04691115|460738699|FG011|Overall Study|Withdrawal by Subject|0|||
128030601|NCT04691115|460738700|FG012|Overall Study|Withdrawal by Subject|0|||
128030602|NCT04691115|460738701|FG013|Overall Study|Withdrawal by Subject|0|||
128030603|NCT02096354|460738706|FG000|Overall Study|Physician Decision|4|||
128030604|NCT02096354|460738707|FG001|Overall Study|Physician Decision|5|||
128030605|NCT02096354|460738708|FG002|Overall Study|Physician Decision|0|||
128030606|NCT02096354|460738706|FG000|Overall Study|Withdrawal by Subject|3|||
128030607|NCT02096354|460738707|FG001|Overall Study|Withdrawal by Subject|1|||
128030608|NCT02096354|460738708|FG002|Overall Study|Withdrawal by Subject|0|||
127581062|NCT03693300|459097668|FG001|Overall Study|Death|2|||
127581063|NCT03693300|459097667|FG000|Overall Study|Lost to Follow-up|2|||
127581064|NCT03693300|459097668|FG001|Overall Study|Lost to Follow-up|0|||
127581065|NCT02206048|459097669|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
127581066|NCT02925923|459097670|FG000|Overall Study|blood samples hemolyzed|0|||
127581067|NCT02925923|459097671|FG001|Overall Study|blood samples hemolyzed|2|||
127581068|NCT00866788|459097672|FG000|Overall Study|Adverse Event|0|||
127581069|NCT00866788|459097673|FG001|Overall Study|Adverse Event|2|||
127581070|NCT00866788|459097674|FG002|Overall Study|Adverse Event|0|||
127581071|NCT00866788|459097675|FG003|Overall Study|Adverse Event|1|||
127581072|NCT00866788|459097672|FG000|Overall Study|Lost to Follow-up|1|||
127783260|NCT02752035|459832938|FG000|Randomization: Approximately 3 Years|Miscellaneous|0|||
127581073|NCT00866788|459097673|FG001|Overall Study|Lost to Follow-up|1|||
127581074|NCT00866788|459097674|FG002|Overall Study|Lost to Follow-up|0|||
127581075|NCT00866788|459097675|FG003|Overall Study|Lost to Follow-up|2|||
127581076|NCT00866788|459097672|FG000|Overall Study|Withdrawal by Subject|2|||
127581077|NCT00866788|459097673|FG001|Overall Study|Withdrawal by Subject|1|||
127581078|NCT00866788|459097674|FG002|Overall Study|Withdrawal by Subject|0|||
127581079|NCT00866788|459097675|FG003|Overall Study|Withdrawal by Subject|1|||
127581080|NCT00866788|459097672|FG000|Overall Study|Pregnancy|0|||
127581081|NCT00866788|459097673|FG001|Overall Study|Pregnancy|1|||
127581082|NCT00866788|459097674|FG002|Overall Study|Pregnancy|0|||
127581083|NCT00866788|459097675|FG003|Overall Study|Pregnancy|0|||
127581084|NCT00866788|459097672|FG000|Overall Study|Disease progression|3|||
127581085|NCT00866788|459097673|FG001|Overall Study|Disease progression|1|||
127581086|NCT00866788|459097674|FG002|Overall Study|Disease progression|1|||
128030609|NCT02096354|460738706|FG000|Overall Study|Adverse Event|7|||
127581087|NCT00866788|459097675|FG003|Overall Study|Disease progression|0|||
127581088|NCT00866788|459097672|FG000|Overall Study|Physician Decision|0|||
127581089|NCT00866788|459097673|FG001|Overall Study|Physician Decision|0|||
127581090|NCT00866788|459097674|FG002|Overall Study|Physician Decision|1|||
128030610|NCT02096354|460738707|FG001|Overall Study|Adverse Event|4|||
128030611|NCT02096354|460738708|FG002|Overall Study|Adverse Event|0|||
128030612|NCT02096354|460738706|FG000|Overall Study|Ineligible|0|||
128030613|NCT02096354|460738707|FG001|Overall Study|Ineligible|0|||
128030614|NCT02096354|460738708|FG002|Overall Study|Ineligible|11|||
128030615|NCT03715829|460738709|FG000|Dose Ranging Period|Adverse Event|2|||
128030616|NCT03715829|460738710|FG001|Dose Ranging Period|Adverse Event|4|||
128030617|NCT03715829|460738711|FG002|Dose Ranging Period|Adverse Event|5|||
128030618|NCT03715829|460738712|FG003|Dose Ranging Period|Adverse Event|2|||
128030619|NCT03715829|460738713|FG004|Dose Ranging Period|Adverse Event|3|||
128030620|NCT03715829|460738714|FG005|Dose Ranging Period|Adverse Event|3|||
128030621|NCT03715829|460738715|FG006|Dose Ranging Period|Adverse Event|0|||
128030622|NCT03715829|460738716|FG007|Dose Ranging Period|Adverse Event|0|||
128030623|NCT03715829|460738717|FG008|Dose Ranging Period|Adverse Event|0|||
128030624|NCT03715829|460738718|FG009|Dose Ranging Period|Adverse Event|0|||
128030625|NCT03715829|460738719|FG010|Dose Ranging Period|Adverse Event|0|||
128030626|NCT03715829|460738709|FG000|Dose Ranging Period|Lack of Efficacy|0|||
128030627|NCT03715829|460738710|FG001|Dose Ranging Period|Lack of Efficacy|1|||
128030628|NCT03715829|460738711|FG002|Dose Ranging Period|Lack of Efficacy|0|||
128030629|NCT03715829|460738712|FG003|Dose Ranging Period|Lack of Efficacy|1|||
128030630|NCT03715829|460738713|FG004|Dose Ranging Period|Lack of Efficacy|0|||
128030631|NCT03715829|460738714|FG005|Dose Ranging Period|Lack of Efficacy|0|||
128030632|NCT03715829|460738715|FG006|Dose Ranging Period|Lack of Efficacy|0|||
128030633|NCT03715829|460738716|FG007|Dose Ranging Period|Lack of Efficacy|0|||
128030634|NCT03715829|460738717|FG008|Dose Ranging Period|Lack of Efficacy|0|||
128030635|NCT03715829|460738718|FG009|Dose Ranging Period|Lack of Efficacy|0|||
128030636|NCT03715829|460738719|FG010|Dose Ranging Period|Lack of Efficacy|0|||
128030637|NCT03715829|460738709|FG000|Dose Ranging Period|Lost to Follow-up|2|||
128030638|NCT03715829|460738710|FG001|Dose Ranging Period|Lost to Follow-up|0|||
128030639|NCT03715829|460738711|FG002|Dose Ranging Period|Lost to Follow-up|1|||
128030640|NCT03715829|460738712|FG003|Dose Ranging Period|Lost to Follow-up|1|||
128030641|NCT03715829|460738713|FG004|Dose Ranging Period|Lost to Follow-up|1|||
128030642|NCT03715829|460738714|FG005|Dose Ranging Period|Lost to Follow-up|2|||
128030643|NCT03715829|460738715|FG006|Dose Ranging Period|Lost to Follow-up|0|||
128030644|NCT03715829|460738716|FG007|Dose Ranging Period|Lost to Follow-up|0|||
128030645|NCT03715829|460738717|FG008|Dose Ranging Period|Lost to Follow-up|0|||
128030646|NCT03715829|460738718|FG009|Dose Ranging Period|Lost to Follow-up|0|||
128030647|NCT03715829|460738719|FG010|Dose Ranging Period|Lost to Follow-up|0|||
128030648|NCT03715829|460738709|FG000|Dose Ranging Period|Protocol Violation|0|||
128030649|NCT03715829|460738710|FG001|Dose Ranging Period|Protocol Violation|0|||
128030650|NCT03715829|460738711|FG002|Dose Ranging Period|Protocol Violation|0|||
128030651|NCT03715829|460738712|FG003|Dose Ranging Period|Protocol Violation|1|||
128030652|NCT03715829|460738713|FG004|Dose Ranging Period|Protocol Violation|0|||
127581091|NCT00866788|459097675|FG003|Overall Study|Physician Decision|1|||
127581092|NCT02742441|459097679|FG000|Overall Study|Lost to Follow-up|4|||
128030653|NCT03715829|460738714|FG005|Dose Ranging Period|Protocol Violation|0|||
128030654|NCT03715829|460738715|FG006|Dose Ranging Period|Protocol Violation|0|||
128030655|NCT03715829|460738716|FG007|Dose Ranging Period|Protocol Violation|0|||
128030656|NCT03715829|460738717|FG008|Dose Ranging Period|Protocol Violation|0|||
128030657|NCT03715829|460738718|FG009|Dose Ranging Period|Protocol Violation|0|||
128030658|NCT03715829|460738719|FG010|Dose Ranging Period|Protocol Violation|0|||
128030659|NCT03715829|460738709|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
128030660|NCT03715829|460738710|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
128030661|NCT03715829|460738711|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
127581093|NCT02742441|459097680|FG001|Overall Study|Lost to Follow-up|4|||
127581094|NCT02742441|459097679|FG000|Overall Study|Withdrawal by Subject|2|||
127581095|NCT02742441|459097680|FG001|Overall Study|Withdrawal by Subject|2|||
127581096|NCT02742441|459097679|FG000|Overall Study|Adverse Event|0|||
127581097|NCT02742441|459097680|FG001|Overall Study|Adverse Event|2|||
127581098|NCT02202837|459097683|FG000|Overall Study|Enbrel treatment discontinued|36|||
127581099|NCT02202837|459097684|FG001|Overall Study|Enbrel treatment discontinued|4|||
127581100|NCT02202837|459097683|FG000|Overall Study|Other|10|||
127581101|NCT02202837|459097684|FG001|Overall Study|Other|0|||
127581102|NCT02202837|459097683|FG000|Overall Study|Lost to Follow-up|7|||
127581103|NCT02202837|459097684|FG001|Overall Study|Lost to Follow-up|1|||
127581104|NCT02008318|459097685|FG000|Overall Study|Adverse Event|4|||
127581105|NCT02008318|459097686|FG001|Overall Study|Adverse Event|0|||
127581106|NCT02008318|459097685|FG000|Overall Study|Physician Decision|2|||
127581107|NCT02008318|459097686|FG001|Overall Study|Physician Decision|0|||
127581108|NCT02008318|459097685|FG000|Overall Study|Progressive Disease|2|||
127581109|NCT02008318|459097686|FG001|Overall Study|Progressive Disease|0|||
127581110|NCT02008318|459097685|FG000|Overall Study|Protocol Violation|1|||
127581111|NCT02008318|459097686|FG001|Overall Study|Protocol Violation|1|||
127581112|NCT02008318|459097685|FG000|Overall Study|Withdrawal by Subject|3|||
127581113|NCT02008318|459097686|FG001|Overall Study|Withdrawal by Subject|0|||
127581114|NCT00231842|459097687|FG000|Overall Study|Withdrawal by Subject|3|||
127581115|NCT00231842|459097687|FG000|Overall Study|Did not complete the last 3 cycle|8|||
127581116|NCT02422303|459097688|FG000|Overall Study|Lost to Follow-up|1|||
127581117|NCT02422303|459097689|FG001|Overall Study|Lost to Follow-up|1|||
127581118|NCT01788046|459097699|FG000|Overall Study|Withdrawal by Subject|12|||
127581119|NCT01788046|459097700|FG001|Overall Study|Withdrawal by Subject|12|||
127581120|NCT01788046|459097699|FG000|Overall Study|Lost to Follow-up|12|||
127581121|NCT01788046|459097700|FG001|Overall Study|Lost to Follow-up|19|||
127581122|NCT01788046|459097699|FG000|Overall Study|Death|7|||
127581123|NCT01788046|459097700|FG001|Overall Study|Death|5|||
127581124|NCT01788046|459097699|FG000|Overall Study|Protocol Specified Criteria|25|||
127581125|NCT01788046|459097700|FG001|Overall Study|Protocol Specified Criteria|1|||
127581126|NCT01031706|459097701|FG000|Overall Study|Adverse Event|1|||
127581127|NCT01031706|459097702|FG001|Overall Study|Adverse Event|0|||
127581128|NCT01031706|459097701|FG000|Overall Study|Withdrawal by Subject|1|||
127581129|NCT01031706|459097702|FG001|Overall Study|Withdrawal by Subject|1|||
127581130|NCT00850070|459097703|FG000|Overall Study|Lack of Efficacy|1|||
127581131|NCT00850070|459097704|FG001|Overall Study|Lack of Efficacy|1|||
127581132|NCT00850070|459097703|FG000|Overall Study|Adverse Event|2|||
127581133|NCT00850070|459097704|FG001|Overall Study|Adverse Event|0|||
127581134|NCT00074984|459097705|FG000|Overall Study|Death|1|||
127581135|NCT00074984|459097706|FG001|Overall Study|Death|2|||
127581136|NCT00074984|459097705|FG000|Overall Study|Withdrawal by Subject|2|||
127581137|NCT00074984|459097706|FG001|Overall Study|Withdrawal by Subject|3|||
127581138|NCT00074984|459097705|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
127581139|NCT00074984|459097706|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
127581140|NCT02046733|459097712|FG000|Overall Study|never initiated 'treatment visits'|6|||
127581141|NCT02046733|459097713|FG001|Overall Study|never initiated 'treatment visits'|0|||
127581142|NCT00199875|459097718|FG000|Overall Study|Withdrawal by Subject|0|||
127581143|NCT00199875|459097719|FG001|Overall Study|Withdrawal by Subject|0|||
127581144|NCT00199875|459097720|FG002|Overall Study|Withdrawal by Subject|0|||
127581145|NCT00199875|459097721|FG003|Overall Study|Withdrawal by Subject|0|||
127581146|NCT00199875|459097722|FG004|Overall Study|Withdrawal by Subject|1|||
127581147|NCT01024231|459097723|FG000|Overall Study|Other Reasons|1|||
127581148|NCT01024231|459097724|FG001|Overall Study|Other Reasons|2|||
127581149|NCT01024231|459097725|FG002|Overall Study|Other Reasons|0|||
127581150|NCT01024231|459097726|FG003|Overall Study|Other Reasons|0|||
127783261|NCT02752035|459832939|FG001|Randomization: Approximately 3 Years|Miscellaneous|7|||
127581151|NCT01024231|459097727|FG004|Overall Study|Other Reasons|2|||
127581152|NCT01024231|459097728|FG005|Overall Study|Other Reasons|0|||
127581153|NCT01024231|459097729|FG006|Overall Study|Other Reasons|1|||
127581154|NCT01024231|459097723|FG000|Overall Study|Maximum Clinical Benefit|1|||
127581155|NCT01024231|459097724|FG001|Overall Study|Maximum Clinical Benefit|2|||
127581156|NCT01024231|459097725|FG002|Overall Study|Maximum Clinical Benefit|0|||
127581157|NCT01024231|459097726|FG003|Overall Study|Maximum Clinical Benefit|1|||
127581158|NCT01024231|459097727|FG004|Overall Study|Maximum Clinical Benefit|1|||
127581159|NCT01024231|459097728|FG005|Overall Study|Maximum Clinical Benefit|0|||
127581160|NCT01024231|459097729|FG006|Overall Study|Maximum Clinical Benefit|0|||
127581161|NCT01024231|459097723|FG000|Overall Study|Disease Progression|3|||
127783262|NCT02752035|459832940|FG002|Randomization: Approximately 3 Years|Miscellaneous|4|||
127581162|NCT01024231|459097724|FG001|Overall Study|Disease Progression|1|||
127581163|NCT01024231|459097725|FG002|Overall Study|Disease Progression|3|||
127581164|NCT01024231|459097726|FG003|Overall Study|Disease Progression|0|||
127581165|NCT01024231|459097727|FG004|Overall Study|Disease Progression|4|||
127581166|NCT01024231|459097728|FG005|Overall Study|Disease Progression|11|||
127581167|NCT01024231|459097729|FG006|Overall Study|Disease Progression|6|||
127581168|NCT01024231|459097723|FG000|Overall Study|AE unrelated to Study Drug|0|||
127581169|NCT01024231|459097724|FG001|Overall Study|AE unrelated to Study Drug|1|||
127581170|NCT01024231|459097725|FG002|Overall Study|AE unrelated to Study Drug|0|||
127581171|NCT01024231|459097726|FG003|Overall Study|AE unrelated to Study Drug|0|||
127581172|NCT01024231|459097727|FG004|Overall Study|AE unrelated to Study Drug|0|||
127581173|NCT01024231|459097728|FG005|Overall Study|AE unrelated to Study Drug|0|||
127581174|NCT01024231|459097729|FG006|Overall Study|AE unrelated to Study Drug|0|||
127581175|NCT01024231|459097723|FG000|Overall Study|No longer meets criteria|0|||
127581176|NCT01024231|459097724|FG001|Overall Study|No longer meets criteria|0|||
127581177|NCT01024231|459097725|FG002|Overall Study|No longer meets criteria|0|||
127581178|NCT01024231|459097726|FG003|Overall Study|No longer meets criteria|0|||
127581179|NCT01024231|459097727|FG004|Overall Study|No longer meets criteria|1|||
127581180|NCT01024231|459097728|FG005|Overall Study|No longer meets criteria|0|||
127581181|NCT01024231|459097729|FG006|Overall Study|No longer meets criteria|1|||
127581182|NCT01024231|459097723|FG000|Overall Study|Study Drug Toxicity|1|||
127581183|NCT01024231|459097724|FG001|Overall Study|Study Drug Toxicity|6|||
127581184|NCT01024231|459097725|FG002|Overall Study|Study Drug Toxicity|6|||
127581185|NCT01024231|459097726|FG003|Overall Study|Study Drug Toxicity|4|||
127581186|NCT01024231|459097727|FG004|Overall Study|Study Drug Toxicity|2|||
127581187|NCT01024231|459097728|FG005|Overall Study|Study Drug Toxicity|0|||
127581188|NCT01024231|459097729|FG006|Overall Study|Study Drug Toxicity|7|||
127581189|NCT01024231|459097723|FG000|Overall Study|Death|6|||
127581190|NCT01024231|459097724|FG001|Overall Study|Death|2|||
127581191|NCT01024231|459097725|FG002|Overall Study|Death|1|||
127581192|NCT01024231|459097726|FG003|Overall Study|Death|0|||
127581193|NCT01024231|459097727|FG004|Overall Study|Death|4|||
127581194|NCT01024231|459097728|FG005|Overall Study|Death|3|||
127581195|NCT01024231|459097729|FG006|Overall Study|Death|5|||
127581196|NCT01024231|459097723|FG000|Overall Study|Lost to Follow-up|0|||
127581197|NCT01024231|459097724|FG001|Overall Study|Lost to Follow-up|0|||
127581198|NCT01024231|459097725|FG002|Overall Study|Lost to Follow-up|0|||
127581199|NCT01024231|459097726|FG003|Overall Study|Lost to Follow-up|0|||
127581200|NCT01024231|459097727|FG004|Overall Study|Lost to Follow-up|0|||
127581201|NCT01024231|459097728|FG005|Overall Study|Lost to Follow-up|0|||
127581202|NCT01024231|459097729|FG006|Overall Study|Lost to Follow-up|1|||
127581203|NCT01024231|459097723|FG000|Overall Study|Withdrew Consent|0|||
127581204|NCT01024231|459097724|FG001|Overall Study|Withdrew Consent|1|||
127581205|NCT01024231|459097725|FG002|Overall Study|Withdrew Consent|0|||
127581206|NCT01024231|459097726|FG003|Overall Study|Withdrew Consent|0|||
127581207|NCT01024231|459097727|FG004|Overall Study|Withdrew Consent|0|||
127581208|NCT01024231|459097728|FG005|Overall Study|Withdrew Consent|0|||
127581209|NCT01024231|459097729|FG006|Overall Study|Withdrew Consent|0|||
127581210|NCT01024231|459097723|FG000|Overall Study|Continuing on Treatment|0|||
127581211|NCT01024231|459097724|FG001|Overall Study|Continuing on Treatment|0|||
127581212|NCT01024231|459097725|FG002|Overall Study|Continuing on Treatment|0|||
127581213|NCT01024231|459097726|FG003|Overall Study|Continuing on Treatment|0|||
127581214|NCT01024231|459097727|FG004|Overall Study|Continuing on Treatment|3|||
127581215|NCT01024231|459097728|FG005|Overall Study|Continuing on Treatment|2|||
127581216|NCT01024231|459097729|FG006|Overall Study|Continuing on Treatment|0|||
127581217|NCT01013350|459097730|FG000|Overall Study|Lost to Follow-up|15|||
127581218|NCT01013350|459097731|FG001|Overall Study|Lost to Follow-up|95|||
127581219|NCT01013350|459097730|FG000|Overall Study|Adverse Event|0|||
127581220|NCT01013350|459097731|FG001|Overall Study|Adverse Event|1|||
127581221|NCT01013350|459097730|FG000|Overall Study|Physician Decision|4|||
127581222|NCT01013350|459097731|FG001|Overall Study|Physician Decision|20|||
127581223|NCT01013350|459097730|FG000|Overall Study|Withdrawal by Subject|15|||
127581224|NCT01013350|459097731|FG001|Overall Study|Withdrawal by Subject|38|||
127581225|NCT01013350|459097730|FG000|Overall Study|Death|3|||
127581226|NCT01013350|459097731|FG001|Overall Study|Death|5|||
127581227|NCT01013350|459097730|FG000|Overall Study|Participant entered interventional study|0|||
127581228|NCT01013350|459097731|FG001|Overall Study|Participant entered interventional study|8|||
127581229|NCT01013350|459097730|FG000|Overall Study|Other|1|||
127581230|NCT01013350|459097731|FG001|Overall Study|Other|25|||
127581231|NCT00395733|459097732|FG000|Period 2|Withdrawal by Subject|1|||
128030662|NCT03715829|460738712|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
128030663|NCT03715829|460738713|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
128030664|NCT03715829|460738714|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
128030665|NCT03715829|460738715|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
128030666|NCT03715829|460738716|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
128030667|NCT03715829|460738717|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
128030668|NCT03715829|460738718|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
127581232|NCT00395733|459097733|FG001|Period 2|Withdrawal by Subject|2|||
127581233|NCT00395733|459097732|FG000|Period 2|Protocol Violation|0|||
127581234|NCT00395733|459097733|FG001|Period 2|Protocol Violation|1|||
127581235|NCT00395733|459097732|FG000|Period 2|Adverse Event|0|||
127581236|NCT00395733|459097733|FG001|Period 2|Adverse Event|2|||
127581237|NCT00395733|459097732|FG000|Period 2|Technical problems|1|||
127581238|NCT00395733|459097733|FG001|Period 2|Technical problems|0|||
127581239|NCT01672736|459097735|FG000|Overall Study|Available drug expired on 31 May 16|3|||
127581240|NCT02853344|459097740|FG000|Overall Study|Lost to Follow-up|1|||
127581241|NCT02853344|459097741|FG001|Overall Study|Lost to Follow-up|1|||
128030669|NCT03715829|460738719|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
127581242|NCT02853344|459097740|FG000|Overall Study|Withdrawal by Subject|2|||
127581243|NCT02853344|459097741|FG001|Overall Study|Withdrawal by Subject|4|||
127581244|NCT02853344|459097740|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
127581245|NCT02853344|459097741|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
127581246|NCT02853344|459097740|FG000|Overall Study|Death|70|||
127581247|NCT02853344|459097741|FG001|Overall Study|Death|112|||
127581248|NCT02913612|459097742|FG000|Overall Study|Lost to Follow-up|6|||
127581249|NCT02913612|459097743|FG001|Overall Study|Lost to Follow-up|5|||
127581250|NCT02913612|459097744|FG002|Overall Study|Lost to Follow-up|2|||
127581251|NCT02913612|459097745|FG003|Overall Study|Lost to Follow-up|0|||
127581252|NCT02913612|459097742|FG000|Overall Study|Physician Decision|1|||
127581253|NCT02913612|459097743|FG001|Overall Study|Physician Decision|4|||
127581254|NCT02913612|459097744|FG002|Overall Study|Physician Decision|1|||
127581255|NCT02913612|459097745|FG003|Overall Study|Physician Decision|0|||
127581256|NCT02913612|459097742|FG000|Overall Study|Withdrawal by Subject|2|||
127581257|NCT02913612|459097743|FG001|Overall Study|Withdrawal by Subject|4|||
127581258|NCT02913612|459097744|FG002|Overall Study|Withdrawal by Subject|0|||
127581259|NCT02913612|459097745|FG003|Overall Study|Withdrawal by Subject|0|||
127581260|NCT02913612|459097742|FG000|Overall Study|Hemangioma resolved|1|||
127581261|NCT02913612|459097743|FG001|Overall Study|Hemangioma resolved|0|||
127581262|NCT02913612|459097744|FG002|Overall Study|Hemangioma resolved|0|||
127581263|NCT02913612|459097745|FG003|Overall Study|Hemangioma resolved|0|||
127581264|NCT02913612|459097742|FG000|Overall Study|Local IRB decision|1|||
127581265|NCT02913612|459097743|FG001|Overall Study|Local IRB decision|0|||
127581266|NCT02913612|459097744|FG002|Overall Study|Local IRB decision|0|||
127581267|NCT02913612|459097745|FG003|Overall Study|Local IRB decision|0|||
127581268|NCT02913612|459097742|FG000|Overall Study|Study drug non-compliance|1|||
127581269|NCT02913612|459097743|FG001|Overall Study|Study drug non-compliance|1|||
127581270|NCT02913612|459097744|FG002|Overall Study|Study drug non-compliance|0|||
127581271|NCT02913612|459097745|FG003|Overall Study|Study drug non-compliance|0|||
127581272|NCT02913612|459097742|FG000|Overall Study|Insurance issues|0|||
127581273|NCT02913612|459097743|FG001|Overall Study|Insurance issues|1|||
127581274|NCT02913612|459097744|FG002|Overall Study|Insurance issues|0|||
127581275|NCT02913612|459097745|FG003|Overall Study|Insurance issues|0|||
127581276|NCT02913612|459097742|FG000|Overall Study|Needed to treat second hemangioma|0|||
127581277|NCT02913612|459097743|FG001|Overall Study|Needed to treat second hemangioma|1|||
127581278|NCT02913612|459097744|FG002|Overall Study|Needed to treat second hemangioma|0|||
127581279|NCT02913612|459097745|FG003|Overall Study|Needed to treat second hemangioma|0|||
127581280|NCT02913612|459097742|FG000|Overall Study|Study completion criteria not met|0|||
127581281|NCT02913612|459097743|FG001|Overall Study|Study completion criteria not met|1|||
127581282|NCT02913612|459097744|FG002|Overall Study|Study completion criteria not met|0|||
127581283|NCT02913612|459097745|FG003|Overall Study|Study completion criteria not met|0|||
127581284|NCT02913612|459097742|FG000|Overall Study|Ineligible|0|||
127581285|NCT02913612|459097743|FG001|Overall Study|Ineligible|1|||
127581286|NCT02913612|459097744|FG002|Overall Study|Ineligible|0|||
127581287|NCT02913612|459097745|FG003|Overall Study|Ineligible|0|||
127581288|NCT01710046|459097746|FG000|Overall Study|Lost to Follow-up|1|||
127581289|NCT01710046|459097747|FG001|Overall Study|Lost to Follow-up|0|||
127581290|NCT03841448|459097748|FG000|Double-blind Treatment (DBT) Period|Death|1|||
127581291|NCT03841448|459097749|FG001|Double-blind Treatment (DBT) Period|Death|1|||
127581292|NCT03841448|459097750|FG002|Double-blind Treatment (DBT) Period|Death|0|||
127581293|NCT03841448|459097751|FG003|Double-blind Treatment (DBT) Period|Death|0|||
127581294|NCT03841448|459097748|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
127581295|NCT03841448|459097749|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
127581296|NCT03841448|459097750|FG002|Open-Label Extension (OLE) Period|Adverse Event|1|||
127581297|NCT03841448|459097751|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
127581298|NCT03841448|459097748|FG000|Open-Label Extension (OLE) Period|Death|0|||
127581299|NCT03841448|459097749|FG001|Open-Label Extension (OLE) Period|Death|0|||
127581300|NCT03841448|459097750|FG002|Open-Label Extension (OLE) Period|Death|0|||
127581301|NCT03841448|459097751|FG003|Open-Label Extension (OLE) Period|Death|1|||
127581302|NCT03841448|459097748|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
127581303|NCT03841448|459097749|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
127581304|NCT03841448|459097750|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
127581305|NCT03841448|459097751|FG003|Open-Label Extension (OLE) Period|Physician Decision|3|||
127581306|NCT03841448|459097748|FG000|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
127581307|NCT03841448|459097749|FG001|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
127581308|NCT03841448|459097750|FG002|Open-Label Extension (OLE) Period|Study termination by Sponsor|4|||
127581309|NCT03841448|459097751|FG003|Open-Label Extension (OLE) Period|Study termination by Sponsor|9|||
127581310|NCT03841448|459097748|FG000|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
127581311|NCT03841448|459097749|FG001|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
127581312|NCT03841448|459097750|FG002|Open-Label Extension (OLE) Period|Other Reason Not Specified|2|||
127581313|NCT03841448|459097751|FG003|Open-Label Extension (OLE) Period|Other Reason Not Specified|5|||
127881572|NCT00791154|460188797|FG005|Overall Study|Lost to Follow-up|0|||
127581314|NCT03896165|459097752|FG000|Overall Study|Withdrawal by Subject|2|||
127581315|NCT03181893|459097753|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
127581316|NCT03181893|459097754|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
127581317|NCT03181893|459097755|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
127581318|NCT03181893|459097756|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
127581319|NCT03181893|459097757|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
127581320|NCT03181893|459097758|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
127581321|NCT03181893|459097759|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
127581322|NCT03181893|459097760|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
127581323|NCT03181893|459097761|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
127581324|NCT03181893|459097762|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
127581325|NCT03181893|459097763|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
127581326|NCT03181893|459097753|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
127581327|NCT03181893|459097754|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
127581328|NCT03181893|459097755|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
127581329|NCT03181893|459097756|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
127581330|NCT03181893|459097757|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
127581331|NCT03181893|459097758|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
127581332|NCT03181893|459097759|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
127581333|NCT03181893|459097760|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
127581334|NCT03181893|459097761|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
127581335|NCT03181893|459097762|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
127581336|NCT03181893|459097763|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
127581337|NCT03181893|459097753|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
127581338|NCT03181893|459097754|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
127581339|NCT03181893|459097755|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
127581340|NCT03181893|459097756|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
127581341|NCT03181893|459097757|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
127581342|NCT03181893|459097758|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
127581343|NCT03181893|459097759|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
127581344|NCT03181893|459097760|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
127581345|NCT03181893|459097761|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
127581346|NCT03181893|459097762|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
127581347|NCT03181893|459097763|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
127581348|NCT03181893|459097753|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
127581349|NCT03181893|459097754|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
127581350|NCT03181893|459097755|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
127581351|NCT03181893|459097756|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
127581352|NCT03181893|459097757|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
127581353|NCT03181893|459097758|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
127693754|NCT03896516|459506989|FG001|Stage II (GLWL-01 or Placebo)|Physician Decision|1|||
127693755|NCT04703322|459506999|FG000|Overall Study|Ongoing|8|||
127693756|NCT04703322|459506999|FG000|Overall Study|Withdrawal by Subject|1|||
127693757|NCT03713086|459507000|FG000|Overall Study|Withdrawal by Subject|0|||
127693758|NCT03713086|459507001|FG001|Overall Study|Withdrawal by Subject|2|||
127693759|NCT03713086|459507002|FG002|Overall Study|Withdrawal by Subject|1|||
127693760|NCT03713086|459507003|FG003|Overall Study|Withdrawal by Subject|0|||
127693761|NCT03713086|459507000|FG000|Overall Study|Lost to Follow-up|0|||
127693762|NCT03713086|459507001|FG001|Overall Study|Lost to Follow-up|1|||
127693763|NCT03713086|459507002|FG002|Overall Study|Lost to Follow-up|0|||
127693764|NCT03713086|459507003|FG003|Overall Study|Lost to Follow-up|1|||
127693765|NCT00676715|459507010|FG000|Treatment Period (TP)|Adverse Event|0|||
127693766|NCT00676715|459507011|FG001|Treatment Period (TP)|Adverse Event|3|||
127693767|NCT00676715|459507012|FG002|Treatment Period (TP)|Adverse Event|2|||
127693768|NCT00676715|459507013|FG003|Treatment Period (TP)|Adverse Event|2|||
127693769|NCT00676715|459507010|FG000|Treatment Period (TP)|Death|0|||
127693770|NCT00676715|459507011|FG001|Treatment Period (TP)|Death|0|||
127693771|NCT00676715|459507012|FG002|Treatment Period (TP)|Death|1|||
127693772|NCT00676715|459507013|FG003|Treatment Period (TP)|Death|0|||
127693773|NCT00676715|459507010|FG000|Treatment Period (TP)|Failure to return|1|||
127693774|NCT00676715|459507011|FG001|Treatment Period (TP)|Failure to return|0|||
127693775|NCT00676715|459507012|FG002|Treatment Period (TP)|Failure to return|0|||
127693776|NCT00676715|459507013|FG003|Treatment Period (TP)|Failure to return|0|||
127693777|NCT00676715|459507010|FG000|Treatment Period (TP)|Violation of selection criteria at entry|0|||
127693778|NCT00676715|459507011|FG001|Treatment Period (TP)|Violation of selection criteria at entry|0|||
127693779|NCT00676715|459507012|FG002|Treatment Period (TP)|Violation of selection criteria at entry|1|||
127693780|NCT00676715|459507013|FG003|Treatment Period (TP)|Violation of selection criteria at entry|0|||
127783263|NCT02752035|459832941|FG003|Randomization: Approximately 3 Years|Miscellaneous|1|||
127783264|NCT02752035|459832938|FG000|Randomization: Approximately 3 Years|Disease Relapse|0|||
127783265|NCT02752035|459832939|FG001|Randomization: Approximately 3 Years|Disease Relapse|22|||
128030670|NCT03715829|460738709|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
128030671|NCT03715829|460738710|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
128030672|NCT03715829|460738711|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
128030673|NCT03715829|460738712|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
128030674|NCT03715829|460738713|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
128030675|NCT03715829|460738714|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
128030676|NCT03715829|460738715|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
128030677|NCT03715829|460738716|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
128030678|NCT03715829|460738717|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
128030679|NCT03715829|460738718|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
128030680|NCT03715829|460738719|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
128030681|NCT03715829|460738709|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
128030682|NCT03715829|460738710|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
128030683|NCT03715829|460738711|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
128030684|NCT03715829|460738712|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
128030685|NCT03715829|460738713|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
127581354|NCT03181893|459097759|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
127581355|NCT03181893|459097760|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
127581356|NCT03181893|459097761|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
127581357|NCT03181893|459097762|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
127581358|NCT03181893|459097763|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
127581359|NCT03181893|459097753|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
127581360|NCT03181893|459097754|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
127581361|NCT03181893|459097755|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
127581362|NCT03181893|459097756|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
127581363|NCT03181893|459097757|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
127581364|NCT03181893|459097758|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
127581365|NCT03181893|459097759|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
127581366|NCT03181893|459097760|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
127581367|NCT03181893|459097761|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
127581368|NCT03181893|459097762|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
127581369|NCT03181893|459097763|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
127581370|NCT04128371|459097764|FG000|Overall Study|Lack of Efficacy|1|||
127581371|NCT04815031|459097765|FG000|Overall Study|No adverse event information (missing information)|33|||
127581372|NCT00397215|459097775|FG000|Month 0 (Day 0)|Adverse Event|0|||
127581373|NCT00397215|459097776|FG001|Month 0 (Day 0)|Adverse Event|1|||
127581374|NCT00397215|459097777|FG002|Month 0 (Day 0)|Adverse Event|0|||
127581375|NCT00397215|459097778|FG003|Month 0 (Day 0)|Adverse Event|0|||
127581376|NCT00397215|459097775|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
127581377|NCT00397215|459097776|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
127581378|NCT00397215|459097777|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
127581379|NCT00397215|459097778|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
127581380|NCT00397215|459097775|FG000|Month 0 (Day 0)|Other|4|||
127581381|NCT00397215|459097776|FG001|Month 0 (Day 0)|Other|1|||
127581382|NCT00397215|459097777|FG002|Month 0 (Day 0)|Other|3|||
127581383|NCT00397215|459097778|FG003|Month 0 (Day 0)|Other|3|||
127581384|NCT00397215|459097775|FG000|Month 6 (Day 180)|Adverse Event|0|||
127581385|NCT00397215|459097776|FG001|Month 6 (Day 180)|Adverse Event|3|||
127581386|NCT00397215|459097777|FG002|Month 6 (Day 180)|Adverse Event|2|||
127581387|NCT00397215|459097778|FG003|Month 6 (Day 180)|Adverse Event|0|||
127581388|NCT00397215|459097775|FG000|Month 6 (Day 180)|Other|2|||
127581389|NCT00397215|459097776|FG001|Month 6 (Day 180)|Other|0|||
127581390|NCT00397215|459097777|FG002|Month 6 (Day 180)|Other|3|||
127581391|NCT00397215|459097778|FG003|Month 6 (Day 180)|Other|0|||
127581392|NCT02128932|459097779|FG000|Overall Study|Withdrawal by Subject|11|||
127581393|NCT02128932|459097780|FG001|Overall Study|Withdrawal by Subject|7|||
127581394|NCT02128932|459097781|FG002|Overall Study|Withdrawal by Subject|8|||
127581395|NCT02128932|459097779|FG000|Overall Study|Death|2|||
127693781|NCT00676715|459507010|FG000|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
127581396|NCT02128932|459097780|FG001|Overall Study|Death|0|||
127581397|NCT02128932|459097781|FG002|Overall Study|Death|2|||
127581398|NCT02128932|459097779|FG000|Overall Study|Lost to Follow-up|2|||
127581399|NCT02128932|459097780|FG001|Overall Study|Lost to Follow-up|1|||
127581400|NCT02128932|459097781|FG002|Overall Study|Lost to Follow-up|1|||
127581401|NCT02128932|459097779|FG000|Overall Study|No reason for withdrawal|12|||
127581402|NCT02128932|459097780|FG001|Overall Study|No reason for withdrawal|11|||
127581403|NCT02128932|459097781|FG002|Overall Study|No reason for withdrawal|7|||
127581404|NCT01361568|459097782|FG000|Overall Study|Adverse Event|0|||
127581405|NCT01361568|459097783|FG001|Overall Study|Adverse Event|0|||
127581406|NCT01361568|459097784|FG002|Overall Study|Adverse Event|0|||
127581407|NCT01361568|459097785|FG003|Overall Study|Adverse Event|0|||
127581408|NCT01361568|459097786|FG004|Overall Study|Adverse Event|1|||
127581409|NCT01361568|459097787|FG005|Overall Study|Adverse Event|0|||
127581410|NCT01361568|459097782|FG000|Overall Study|Physician Decision|0|||
127581411|NCT01361568|459097783|FG001|Overall Study|Physician Decision|0|||
127581412|NCT01361568|459097784|FG002|Overall Study|Physician Decision|0|||
127581413|NCT01361568|459097785|FG003|Overall Study|Physician Decision|0|||
127581414|NCT01361568|459097786|FG004|Overall Study|Physician Decision|0|||
127581415|NCT01361568|459097787|FG005|Overall Study|Physician Decision|1|||
127581416|NCT01361568|459097782|FG000|Overall Study|Withdrawal by Subject|2|||
127581417|NCT01361568|459097783|FG001|Overall Study|Withdrawal by Subject|1|||
127581418|NCT01361568|459097784|FG002|Overall Study|Withdrawal by Subject|0|||
127581419|NCT01361568|459097785|FG003|Overall Study|Withdrawal by Subject|0|||
127581420|NCT01361568|459097786|FG004|Overall Study|Withdrawal by Subject|0|||
127581421|NCT01361568|459097787|FG005|Overall Study|Withdrawal by Subject|1|||
127581422|NCT00657358|459097792|FG000|Overall Study|Lack of Efficacy|6|||
127581423|NCT02959983|459097793|FG000|Overall Study|Protocol Violation|0|||
127581424|NCT02959983|459097794|FG001|Overall Study|Protocol Violation|1|||
127581425|NCT02959983|459097793|FG000|Overall Study|Lack of Efficacy|0|||
127581426|NCT02959983|459097794|FG001|Overall Study|Lack of Efficacy|1|||
127581427|NCT02959983|459097793|FG000|Overall Study|Lost to Follow-up|12|||
127581428|NCT02959983|459097794|FG001|Overall Study|Lost to Follow-up|9|||
127581429|NCT02959983|459097793|FG000|Overall Study|Other|1|||
127581430|NCT02959983|459097794|FG001|Overall Study|Other|1|||
127581431|NCT02959983|459097793|FG000|Overall Study|Physician Decision|1|||
127581432|NCT02959983|459097794|FG001|Overall Study|Physician Decision|0|||
127581433|NCT02959983|459097793|FG000|Overall Study|Adverse Event|5|||
127581434|NCT02959983|459097794|FG001|Overall Study|Adverse Event|1|||
127581435|NCT02959983|459097793|FG000|Overall Study|Withdrawal by Subject|7|||
127581436|NCT02959983|459097794|FG001|Overall Study|Withdrawal by Subject|12|||
127581437|NCT02728596|459097795|FG000|Overall Study|Refusal unrelated to adverse event|3|||
127581438|NCT02728596|459097796|FG001|Overall Study|Refusal unrelated to adverse event|6|||
127581439|NCT02728596|459097797|FG002|Overall Study|Refusal unrelated to adverse event|7|||
127581440|NCT02728596|459097798|FG003|Overall Study|Refusal unrelated to adverse event|7|||
127581441|NCT02728596|459097795|FG000|Overall Study|Death|44|||
127581442|NCT02728596|459097796|FG001|Overall Study|Death|42|||
127581443|NCT02728596|459097797|FG002|Overall Study|Death|123|||
127581444|NCT02728596|459097798|FG003|Overall Study|Death|68|||
127581445|NCT01736124|459097804|FG000|Post-intervention Assessment|Death|2|||
127581446|NCT01736124|459097805|FG001|Post-intervention Assessment|Death|2|||
127581447|NCT01736124|459097804|FG000|Post-intervention Assessment|lost computer access|1|||
127581448|NCT01736124|459097805|FG001|Post-intervention Assessment|lost computer access|1|||
127581449|NCT01736124|459097804|FG000|Post-intervention Assessment|Moved away|3|||
127581450|NCT01736124|459097805|FG001|Post-intervention Assessment|Moved away|1|||
127581451|NCT01736124|459097804|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
127581452|NCT01736124|459097805|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
127581453|NCT01736124|459097804|FG000|Post-intervention Assessment|Illness|3|||
127581454|NCT01736124|459097805|FG001|Post-intervention Assessment|Illness|2|||
127581455|NCT01736124|459097804|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
127581456|NCT01736124|459097805|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
127581457|NCT01736124|459097804|FG000|Post-intervention Assessment|Temporarily away|3|||
127581458|NCT01736124|459097805|FG001|Post-intervention Assessment|Temporarily away|1|||
127581459|NCT01736124|459097804|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
127581460|NCT01736124|459097805|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
127581461|NCT01736124|459097804|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
127581462|NCT01736124|459097805|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
127581463|NCT01736124|459097804|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
127581464|NCT01736124|459097805|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
127581465|NCT01736124|459097804|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
127581466|NCT01736124|459097805|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
127581467|NCT01736124|459097804|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
127581468|NCT01736124|459097805|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
127581469|NCT01736124|459097804|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
127581470|NCT01736124|459097805|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
127693782|NCT00676715|459507011|FG001|Treatment Period (TP)|Refused treatment/did not cooperate|2|||
127693783|NCT00676715|459507012|FG002|Treatment Period (TP)|Refused treatment/did not cooperate|3|||
127693784|NCT00676715|459507013|FG003|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
127581471|NCT01736124|459097804|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
127581472|NCT01736124|459097805|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
127581473|NCT01736124|459097804|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
127581474|NCT01736124|459097805|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
127581475|NCT01736124|459097804|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
127581476|NCT01736124|459097805|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
127581477|NCT02180724|459099297|FG000|Overall Study|Death|26|||
127581478|NCT02180724|459099298|FG001|Overall Study|Death|1|||
127581479|NCT02180724|459099297|FG000|Overall Study|Lost to Follow-up|3|||
127581480|NCT02180724|459099298|FG001|Overall Study|Lost to Follow-up|1|||
127581481|NCT02180724|459099297|FG000|Overall Study|Withdrawal by Subject|4|||
127581482|NCT02180724|459099298|FG001|Overall Study|Withdrawal by Subject|2|||
127581483|NCT02180724|459099297|FG000|Overall Study|PI Decision|5|||
127581484|NCT02180724|459099298|FG001|Overall Study|PI Decision|2|||
127581485|NCT02180724|459099297|FG000|Overall Study|Study terminated by sponsor|54|||
127581486|NCT02180724|459099298|FG001|Overall Study|Study terminated by sponsor|8|||
127581487|NCT02281773|459099307|FG000|Overall Study|Adverse Event|6|||
127581488|NCT02281773|459099308|FG001|Overall Study|Adverse Event|1|||
127581489|NCT02281773|459099309|FG002|Overall Study|Adverse Event|4|||
127581490|NCT02281773|459099310|FG003|Overall Study|Adverse Event|8|||
127581491|NCT02281773|459099311|FG004|Overall Study|Adverse Event|9|||
127581492|NCT02281773|459099307|FG000|Overall Study|Protocol Violation|1|||
127581493|NCT02281773|459099308|FG001|Overall Study|Protocol Violation|0|||
127581494|NCT02281773|459099309|FG002|Overall Study|Protocol Violation|0|||
127581495|NCT02281773|459099310|FG003|Overall Study|Protocol Violation|2|||
127581496|NCT02281773|459099311|FG004|Overall Study|Protocol Violation|2|||
127581497|NCT02281773|459099307|FG000|Overall Study|Lost to Follow-up|2|||
127581498|NCT02281773|459099308|FG001|Overall Study|Lost to Follow-up|2|||
127581499|NCT02281773|459099309|FG002|Overall Study|Lost to Follow-up|6|||
127581500|NCT02281773|459099310|FG003|Overall Study|Lost to Follow-up|2|||
127581501|NCT02281773|459099311|FG004|Overall Study|Lost to Follow-up|10|||
127581502|NCT02281773|459099307|FG000|Overall Study|Withdrawal by Subject|2|||
127581503|NCT02281773|459099308|FG001|Overall Study|Withdrawal by Subject|8|||
127581504|NCT02281773|459099309|FG002|Overall Study|Withdrawal by Subject|6|||
127581505|NCT02281773|459099310|FG003|Overall Study|Withdrawal by Subject|6|||
127581506|NCT02281773|459099311|FG004|Overall Study|Withdrawal by Subject|8|||
127581507|NCT02281773|459099307|FG000|Overall Study|Other Reason|0|||
127581508|NCT02281773|459099308|FG001|Overall Study|Other Reason|4|||
127581509|NCT02281773|459099309|FG002|Overall Study|Other Reason|2|||
127581510|NCT02281773|459099310|FG003|Overall Study|Other Reason|3|||
127581511|NCT02281773|459099311|FG004|Overall Study|Other Reason|1|||
127581512|NCT02104752|459099312|FG000|Overall Study|Withdrawal by Subject|1|||
127581513|NCT02104752|459099313|FG001|Overall Study|Withdrawal by Subject|0|||
127581514|NCT02104752|459099312|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
127581515|NCT02104752|459099313|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
127581516|NCT05439941|459099314|FG000|Overall Study|Lack of Efficacy|8|||
127581517|NCT05439941|459099315|FG001|Overall Study|Lack of Efficacy|5|||
127581518|NCT05439941|459099316|FG002|Overall Study|Lack of Efficacy|3|||
127581519|NCT05439941|459099314|FG000|Overall Study|Treatment Failure|0|||
127581520|NCT05439941|459099315|FG001|Overall Study|Treatment Failure|1|||
127581521|NCT05439941|459099316|FG002|Overall Study|Treatment Failure|0|||
127581522|NCT05439941|459099314|FG000|Overall Study|Adverse Event|1|||
127581523|NCT05439941|459099315|FG001|Overall Study|Adverse Event|3|||
127581524|NCT05439941|459099316|FG002|Overall Study|Adverse Event|0|||
127581525|NCT05439941|459099314|FG000|Overall Study|Adverse Event - Parent Study|1|||
127581526|NCT05439941|459099315|FG001|Overall Study|Adverse Event - Parent Study|0|||
127581527|NCT05439941|459099316|FG002|Overall Study|Adverse Event - Parent Study|0|||
127581528|NCT05439941|459099314|FG000|Overall Study|Pregnancy|1|||
127581529|NCT05439941|459099315|FG001|Overall Study|Pregnancy|0|||
127581530|NCT05439941|459099316|FG002|Overall Study|Pregnancy|0|||
127581531|NCT05439941|459099314|FG000|Overall Study|Withdrawal by Subject|9|||
127581532|NCT05439941|459099315|FG001|Overall Study|Withdrawal by Subject|6|||
127581533|NCT05439941|459099316|FG002|Overall Study|Withdrawal by Subject|10|||
127581534|NCT05439941|459099314|FG000|Overall Study|Non-Compliance|1|||
127581535|NCT05439941|459099315|FG001|Overall Study|Non-Compliance|1|||
127581536|NCT05439941|459099316|FG002|Overall Study|Non-Compliance|1|||
127581537|NCT05439941|459099314|FG000|Overall Study|Lost to Follow-up|2|||
127581538|NCT05439941|459099315|FG001|Overall Study|Lost to Follow-up|2|||
127581539|NCT05439941|459099316|FG002|Overall Study|Lost to Follow-up|0|||
127581540|NCT05439941|459099314|FG000|Overall Study|Physician Decision|1|||
127581541|NCT05439941|459099315|FG001|Overall Study|Physician Decision|0|||
127581542|NCT05439941|459099316|FG002|Overall Study|Physician Decision|0|||
127581543|NCT05439941|459099314|FG000|Overall Study|Trial Termination by Sponsor|78|||
127581544|NCT05439941|459099315|FG001|Overall Study|Trial Termination by Sponsor|83|||
127581545|NCT05439941|459099316|FG002|Overall Study|Trial Termination by Sponsor|65|||
127581546|NCT05439941|459099314|FG000|Overall Study|Other than Reasons Listed|2|||
127581547|NCT05439941|459099315|FG001|Overall Study|Other than Reasons Listed|1|||
127581548|NCT05439941|459099316|FG002|Overall Study|Other than Reasons Listed|0|||
127581549|NCT02899299|459099317|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
128030686|NCT03715829|460738714|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
127581550|NCT02899299|459099318|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
127581551|NCT02899299|459099317|FG000|Pre-treatment|Participant withdrew consent|1|||
127581552|NCT02899299|459099318|FG001|Pre-treatment|Participant withdrew consent|11|||
127581553|NCT02899299|459099317|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
127581554|NCT02899299|459099318|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
127581555|NCT02899299|459099317|FG000|Pre-treatment|Not reported|0|||
127581556|NCT02899299|459099318|FG001|Pre-treatment|Not reported|1|||
127581557|NCT02899299|459099317|FG000|Treatment|Disease Progression|182|||
127581558|NCT02899299|459099318|FG001|Treatment|Disease Progression|43|||
127581559|NCT02899299|459099317|FG000|Treatment|Study Drug Toxicity|60|||
127581560|NCT02899299|459099318|FG001|Treatment|Study Drug Toxicity|24|||
127581561|NCT02899299|459099317|FG000|Treatment|Adverse Event unrelated to Study Drug|11|||
127581562|NCT02899299|459099318|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
127581563|NCT02899299|459099317|FG000|Treatment|Participant request to discontinue Study treatment|4|||
127581564|NCT02899299|459099318|FG001|Treatment|Participant request to discontinue Study treatment|10|||
127581565|NCT02899299|459099317|FG000|Treatment|Participant withdrew consent|6|||
127581566|NCT02899299|459099318|FG001|Treatment|Participant withdrew consent|3|||
127581567|NCT02899299|459099317|FG000|Treatment|Lost to Follow-up|0|||
127581568|NCT02899299|459099318|FG001|Treatment|Lost to Follow-up|2|||
127581569|NCT02899299|459099317|FG000|Treatment|Maximum Clinical Benefit|11|||
127581570|NCT02899299|459099318|FG001|Treatment|Maximum Clinical Benefit|2|||
127581571|NCT02899299|459099317|FG000|Treatment|Poor/Non-compliance|1|||
127581572|NCT02899299|459099318|FG001|Treatment|Poor/Non-compliance|0|||
127581573|NCT02899299|459099317|FG000|Treatment|Participant no longer meets Study criteria|4|||
127581574|NCT02899299|459099318|FG001|Treatment|Participant no longer meets Study criteria|0|||
127581575|NCT02899299|459099317|FG000|Treatment|Administrative reason by Sponsor|2|||
127581576|NCT02899299|459099318|FG001|Treatment|Administrative reason by Sponsor|0|||
127581577|NCT02899299|459099317|FG000|Treatment|Other reasons|12|||
127581578|NCT02899299|459099318|FG001|Treatment|Other reasons|2|||
127581579|NCT02899299|459099317|FG000|Treatment|Not reported|7|||
127581580|NCT02899299|459099318|FG001|Treatment|Not reported|0|||
127581581|NCT00313300|459099320|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
127581582|NCT00313300|459099321|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
127581583|NCT00313300|459099322|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
127581584|NCT00313300|459099323|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
127581585|NCT00313300|459099324|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
127581586|NCT00313300|459099320|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
127581587|NCT00313300|459099321|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
127581588|NCT00313300|459099322|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
127581589|NCT00313300|459099323|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
127581590|NCT00313300|459099324|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
127581591|NCT00313300|459099320|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
127581592|NCT00313300|459099321|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
127581593|NCT00313300|459099322|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
127581594|NCT00313300|459099323|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
127581595|NCT00313300|459099324|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
127581596|NCT00313300|459099320|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
127581597|NCT00313300|459099321|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
127581598|NCT00313300|459099322|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
127581599|NCT00313300|459099323|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
127581600|NCT00313300|459099324|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
127581601|NCT00313300|459099320|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
127581602|NCT00313300|459099321|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
127581603|NCT00313300|459099322|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
127581604|NCT00313300|459099323|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
127581605|NCT00313300|459099324|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
127581606|NCT00313300|459099320|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
127581607|NCT00313300|459099321|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
127581608|NCT00313300|459099322|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
127581609|NCT00313300|459099323|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
127581610|NCT00313300|459099324|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
127581611|NCT00313300|459099320|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
127581612|NCT00313300|459099321|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
127581613|NCT00313300|459099322|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
127581614|NCT00313300|459099323|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
127581615|NCT00313300|459099324|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
128030687|NCT03715829|460738715|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
128030688|NCT03715829|460738716|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
127581616|NCT00313300|459099320|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
127581617|NCT00313300|459099321|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
127581618|NCT00313300|459099322|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
127581619|NCT00313300|459099323|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
127581620|NCT00313300|459099324|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
127581621|NCT00313300|459099320|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
127581622|NCT00313300|459099321|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
127581623|NCT00313300|459099322|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
127581624|NCT00313300|459099323|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
127581625|NCT00313300|459099324|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
127581626|NCT00313300|459099320|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
127581627|NCT00313300|459099321|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
127581628|NCT00313300|459099322|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
127581629|NCT00313300|459099323|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
127581630|NCT00313300|459099324|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
127581631|NCT00313300|459099320|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
127581632|NCT00313300|459099321|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
127581633|NCT00313300|459099322|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
127581634|NCT00313300|459099323|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
127581635|NCT00313300|459099324|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
127581636|NCT00313300|459099320|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
127581637|NCT00313300|459099321|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
127581638|NCT00313300|459099322|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
127581639|NCT00313300|459099323|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
127581640|NCT00313300|459099324|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
127581641|NCT00313300|459099320|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
127581642|NCT00313300|459099321|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
127581643|NCT00313300|459099322|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
127581644|NCT00313300|459099323|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
127581645|NCT00313300|459099324|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
127581646|NCT00313300|459099320|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
127581647|NCT00313300|459099321|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
127581648|NCT00313300|459099322|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
127581649|NCT00313300|459099323|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
127581650|NCT00313300|459099324|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
127581651|NCT00313300|459099320|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
127581652|NCT00313300|459099321|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
127581653|NCT00313300|459099322|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
127581654|NCT00313300|459099323|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
127581655|NCT00313300|459099324|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
127581656|NCT00313300|459099320|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
127581657|NCT00313300|459099321|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
127581658|NCT00313300|459099322|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
127581659|NCT00313300|459099323|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
127581660|NCT00313300|459099324|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
127581661|NCT00313300|459099320|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
127581662|NCT00313300|459099321|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
127581663|NCT00313300|459099322|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
127581664|NCT00313300|459099323|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
127581665|NCT00313300|459099324|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
127581666|NCT00313300|459099320|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
127581667|NCT00313300|459099321|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
127581668|NCT00313300|459099322|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
127581669|NCT00313300|459099323|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
127581670|NCT00313300|459099324|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
127581671|NCT00313300|459099320|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
127581672|NCT00313300|459099321|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
127581673|NCT00313300|459099322|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
127581674|NCT00313300|459099323|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
127581675|NCT00313300|459099324|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
127581676|NCT00313300|459099320|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
127581677|NCT00313300|459099321|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
127581678|NCT00313300|459099322|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
127581679|NCT00313300|459099323|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
127581680|NCT00313300|459099324|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
127581681|NCT00313300|459099320|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
127581682|NCT00313300|459099321|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
127581683|NCT00313300|459099322|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
127581684|NCT00313300|459099323|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
127581685|NCT00313300|459099324|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
127581686|NCT02336373|459099325|FG000|Overall Study|Protocol closed early|4|||
127581687|NCT02336373|459099325|FG000|Overall Study|Physician Decision|14|||
127581688|NCT00850343|459099327|FG000|Overall Study|Withdrawal by Subject|11|||
127581689|NCT00850343|459099328|FG001|Overall Study|Withdrawal by Subject|0|||
127581690|NCT00850343|459099329|FG002|Overall Study|Withdrawal by Subject|3|||
127581691|NCT00850343|459099330|FG003|Overall Study|Withdrawal by Subject|2|||
127581692|NCT00850343|459099327|FG000|Overall Study|Adverse Event|15|||
127581693|NCT00850343|459099328|FG001|Overall Study|Adverse Event|2|||
127581694|NCT00850343|459099329|FG002|Overall Study|Adverse Event|6|||
127581695|NCT00850343|459099330|FG003|Overall Study|Adverse Event|6|||
127581696|NCT00850343|459099327|FG000|Overall Study|Pregnancy|0|||
127581697|NCT00850343|459099328|FG001|Overall Study|Pregnancy|0|||
127581698|NCT00850343|459099329|FG002|Overall Study|Pregnancy|0|||
127581699|NCT00850343|459099330|FG003|Overall Study|Pregnancy|1|||
127581700|NCT00850343|459099327|FG000|Overall Study|Lack of Efficacy|17|||
127581701|NCT00850343|459099328|FG001|Overall Study|Lack of Efficacy|0|||
127581702|NCT00850343|459099329|FG002|Overall Study|Lack of Efficacy|3|||
127581703|NCT00850343|459099330|FG003|Overall Study|Lack of Efficacy|2|||
127581704|NCT00850343|459099327|FG000|Overall Study|Non-compliance with Study Procedures|1|||
127581705|NCT00850343|459099328|FG001|Overall Study|Non-compliance with Study Procedures|0|||
127581706|NCT00850343|459099329|FG002|Overall Study|Non-compliance with Study Procedures|1|||
127581707|NCT00850343|459099330|FG003|Overall Study|Non-compliance with Study Procedures|1|||
127581708|NCT00850343|459099327|FG000|Overall Study|Physician Decision|2|||
127581709|NCT00850343|459099328|FG001|Overall Study|Physician Decision|1|||
127581710|NCT00850343|459099329|FG002|Overall Study|Physician Decision|1|||
127581711|NCT00850343|459099330|FG003|Overall Study|Physician Decision|1|||
127581712|NCT01626456|459099341|FG000|Overall Study|Withdrawal by Subject|21|||
127581713|NCT01626456|459099342|FG001|Overall Study|Withdrawal by Subject|46|||
127581714|NCT01626456|459099341|FG000|Overall Study|Adverse Event|2|||
127581715|NCT01626456|459099342|FG001|Overall Study|Adverse Event|27|||
127581716|NCT01626456|459099341|FG000|Overall Study|Lost to Follow-up|2|||
127581717|NCT01626456|459099342|FG001|Overall Study|Lost to Follow-up|27|||
127581718|NCT01626456|459099341|FG000|Overall Study|Lack of Efficacy|6|||
127581719|NCT01626456|459099342|FG001|Overall Study|Lack of Efficacy|7|||
127581720|NCT01626456|459099341|FG000|Overall Study|Physician Decision|1|||
127581721|NCT01626456|459099342|FG001|Overall Study|Physician Decision|4|||
127581722|NCT01626456|459099341|FG000|Overall Study|Protocol Violation|1|||
127581723|NCT01626456|459099342|FG001|Overall Study|Protocol Violation|1|||
127581724|NCT01626456|459099341|FG000|Overall Study|Site Closure|2|||
127581725|NCT01626456|459099342|FG001|Overall Study|Site Closure|3|||
127581726|NCT01626456|459099341|FG000|Overall Study|Incarceration|0|||
127581727|NCT01626456|459099342|FG001|Overall Study|Incarceration|2|||
127581728|NCT02468232|459099343|FG000|Core Part of Study|Adverse Event|0|||
127581729|NCT02468232|459099344|FG001|Core Part of Study|Adverse Event|1|||
127581730|NCT02468232|459099345|FG002|Core Part of Study|Adverse Event|0|||
128030689|NCT03715829|460738717|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
128030690|NCT03715829|460738718|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
128030691|NCT03715829|460738719|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
127581731|NCT02468232|459099346|FG003|Core Part of Study|Adverse Event|0|||
127581732|NCT02468232|459099343|FG000|Core Part of Study|Death|20|||
127581733|NCT02468232|459099344|FG001|Core Part of Study|Death|17|||
127581734|NCT02468232|459099345|FG002|Core Part of Study|Death|0|||
127581735|NCT02468232|459099346|FG003|Core Part of Study|Death|0|||
127581736|NCT02468232|459099343|FG000|Core Part of Study|Technical Problems|1|||
127581737|NCT02468232|459099344|FG001|Core Part of Study|Technical Problems|1|||
127581738|NCT02468232|459099345|FG002|Core Part of Study|Technical Problems|0|||
127581739|NCT02468232|459099346|FG003|Core Part of Study|Technical Problems|0|||
127581740|NCT02468232|459099343|FG000|OLE Part of Study|Adverse Event|0|||
127581741|NCT02468232|459099344|FG001|OLE Part of Study|Adverse Event|0|||
127581742|NCT02468232|459099345|FG002|OLE Part of Study|Adverse Event|4|||
127581743|NCT02468232|459099346|FG003|OLE Part of Study|Adverse Event|5|||
127581744|NCT02468232|459099343|FG000|OLE Part of Study|Death|0|||
127581745|NCT02468232|459099344|FG001|OLE Part of Study|Death|0|||
127581746|NCT02468232|459099345|FG002|OLE Part of Study|Death|4|||
127581747|NCT02468232|459099346|FG003|OLE Part of Study|Death|2|||
127581748|NCT02468232|459099343|FG000|OLE Part of Study|Physician Decision|0|||
127581749|NCT02468232|459099344|FG001|OLE Part of Study|Physician Decision|0|||
127581750|NCT02468232|459099345|FG002|OLE Part of Study|Physician Decision|4|||
127581751|NCT02468232|459099346|FG003|OLE Part of Study|Physician Decision|0|||
127581752|NCT02468232|459099343|FG000|OLE Part of Study|Subject/Guardian decision|0|||
127581753|NCT02468232|459099344|FG001|OLE Part of Study|Subject/Guardian decision|0|||
127581754|NCT02468232|459099345|FG002|OLE Part of Study|Subject/Guardian decision|2|||
127581755|NCT02468232|459099346|FG003|OLE Part of Study|Subject/Guardian decision|5|||
127581756|NCT00506662|459099347|FG000|Overall Study|Adverse Event|0|||
127581757|NCT00506662|459099348|FG001|Overall Study|Adverse Event|2|||
127581758|NCT00506662|459099347|FG000|Overall Study|Lack of Efficacy|1|||
127581759|NCT00506662|459099348|FG001|Overall Study|Lack of Efficacy|0|||
127581760|NCT00506662|459099347|FG000|Overall Study|Protocol Violation|2|||
127581761|NCT00506662|459099348|FG001|Overall Study|Protocol Violation|4|||
127581762|NCT00506662|459099347|FG000|Overall Study|Trial terminated|10|||
127581763|NCT00506662|459099348|FG001|Overall Study|Trial terminated|16|||
127581764|NCT00506662|459099347|FG000|Overall Study|Not recorded|4|||
127581765|NCT00506662|459099348|FG001|Overall Study|Not recorded|6|||
127581766|NCT00246753|459099349|FG000|Overall Study|Withdrawal by Subject|2|||
127581767|NCT00246753|459099349|FG000|Overall Study|Physician Decision|2|||
127581768|NCT00246753|459099349|FG000|Overall Study|Adverse Event|2|||
127581769|NCT00246753|459099349|FG000|Overall Study|Unacceptable toxicity|2|||
127581770|NCT02764333|459099353|FG000|Overall Study|Ineligible|1|||
127581771|NCT00617851|459099354|FG000|Overall Study|Death|0|||
127581772|NCT00617851|459099355|FG001|Overall Study|Death|0|||
127581773|NCT00617851|459099356|FG002|Overall Study|Death|0|||
127581774|NCT00617851|459099357|FG003|Overall Study|Death|1|||
127581775|NCT00617851|459099354|FG000|Overall Study|Withdrawal by Subject|14|||
127581776|NCT00617851|459099355|FG001|Overall Study|Withdrawal by Subject|7|||
127581777|NCT00617851|459099356|FG002|Overall Study|Withdrawal by Subject|12|||
127581778|NCT00617851|459099357|FG003|Overall Study|Withdrawal by Subject|4|||
127581779|NCT00617851|459099354|FG000|Overall Study|Lost to Follow-up|27|||
127581780|NCT00617851|459099355|FG001|Overall Study|Lost to Follow-up|29|||
127581781|NCT00617851|459099356|FG002|Overall Study|Lost to Follow-up|31|||
127581782|NCT00617851|459099357|FG003|Overall Study|Lost to Follow-up|19|||
127581783|NCT00617851|459099354|FG000|Overall Study|Inappropriate Enrollment|5|||
127581784|NCT00617851|459099355|FG001|Overall Study|Inappropriate Enrollment|4|||
127581785|NCT00617851|459099356|FG002|Overall Study|Inappropriate Enrollment|1|||
127581786|NCT00617851|459099357|FG003|Overall Study|Inappropriate Enrollment|1|||
127581787|NCT00617851|459099354|FG000|Overall Study|Unable to classify|1|||
127581788|NCT00617851|459099355|FG001|Overall Study|Unable to classify|0|||
127581789|NCT00617851|459099356|FG002|Overall Study|Unable to classify|1|||
127581790|NCT00617851|459099357|FG003|Overall Study|Unable to classify|0|||
127581791|NCT01200524|459099358|FG000|Overall Study|Withdrawal by Subject|1|||
127581792|NCT01200524|459099359|FG001|Overall Study|Withdrawal by Subject|1|||
127581793|NCT01200524|459099360|FG002|Overall Study|Withdrawal by Subject|3|||
127581794|NCT01200524|459099358|FG000|Overall Study|Adverse Event|1|||
127581795|NCT01200524|459099359|FG001|Overall Study|Adverse Event|0|||
127581796|NCT01200524|459099360|FG002|Overall Study|Adverse Event|0|||
127581797|NCT01200524|459099358|FG000|Overall Study|Non availability of study nurse|0|||
127581798|NCT01200524|459099359|FG001|Overall Study|Non availability of study nurse|0|||
127581799|NCT01200524|459099360|FG002|Overall Study|Non availability of study nurse|1|||
127581800|NCT01303861|459099363|FG000|Overall Study|Lost to Follow-up|34|||
127581801|NCT01303861|459099364|FG001|Overall Study|Lost to Follow-up|14|||
127581802|NCT01303861|459099365|FG002|Overall Study|Lost to Follow-up|27|||
127581803|NCT01303861|459099366|FG003|Overall Study|Lost to Follow-up|31|||
127581804|NCT01303861|459099363|FG000|Overall Study|Lack of Efficacy|3|||
127581805|NCT01303861|459099364|FG001|Overall Study|Lack of Efficacy|2|||
127581806|NCT01303861|459099365|FG002|Overall Study|Lack of Efficacy|1|||
127581807|NCT01303861|459099366|FG003|Overall Study|Lack of Efficacy|0|||
127581808|NCT01303861|459099363|FG000|Overall Study|Withdrawal by Subject|16|||
127581809|NCT01303861|459099364|FG001|Overall Study|Withdrawal by Subject|8|||
127581810|NCT01303861|459099365|FG002|Overall Study|Withdrawal by Subject|8|||
127581811|NCT01303861|459099366|FG003|Overall Study|Withdrawal by Subject|23|||
127581812|NCT01303861|459099363|FG000|Overall Study|Adverse Event|4|||
127581813|NCT01303861|459099364|FG001|Overall Study|Adverse Event|1|||
128030692|NCT03715829|460738709|FG000|Dose Ranging Period|Other|0|||
127581814|NCT01303861|459099365|FG002|Overall Study|Adverse Event|0|||
127581815|NCT01303861|459099366|FG003|Overall Study|Adverse Event|5|||
127581816|NCT01303861|459099363|FG000|Overall Study|Pregnancy|1|||
128030693|NCT03715829|460738710|FG001|Dose Ranging Period|Other|0|||
127581817|NCT01303861|459099364|FG001|Overall Study|Pregnancy|0|||
127581818|NCT01303861|459099365|FG002|Overall Study|Pregnancy|0|||
127581819|NCT01303861|459099366|FG003|Overall Study|Pregnancy|0|||
128030694|NCT03715829|460738711|FG002|Dose Ranging Period|Other|2|||
127581820|NCT02476201|459099378|FG000|Overall Study|Unable to program MPP|9|||
127581821|NCT02476201|459099378|FG000|Overall Study|Study echo not performed|5|||
127581822|NCT02476201|459099378|FG000|Overall Study|Adverse Event|4|||
127581823|NCT02476201|459099378|FG000|Overall Study|Death|2|||
127581824|NCT02476201|459099378|FG000|Overall Study|Lost to Follow-up|2|||
127581825|NCT02476201|459099378|FG000|Overall Study|MPP programmed to OFF|2|||
127581826|NCT02476201|459099378|FG000|Overall Study|Withdrawal by Subject|1|||
127581827|NCT02476201|459099378|FG000|Overall Study|Unsuccessful implant|1|||
127581828|NCT03626168|459099385|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
127581829|NCT03626168|459099386|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
127581830|NCT03626168|459099385|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
127581831|NCT03626168|459099386|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
127581832|NCT03626168|459099385|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
127581833|NCT03626168|459099386|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
127581834|NCT02248701|459099387|FG000|Overall Study|Withdrawal by Subject|2|||
127581835|NCT02248701|459099388|FG001|Overall Study|Withdrawal by Subject|1|||
127581836|NCT02248701|459099387|FG000|Overall Study|Physician Decision|0|||
127581837|NCT02248701|459099388|FG001|Overall Study|Physician Decision|1|||
127581838|NCT02248701|459099387|FG000|Overall Study|Adverse Event|1|||
127581839|NCT02248701|459099388|FG001|Overall Study|Adverse Event|0|||
127581840|NCT02248701|459099387|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
127581841|NCT02248701|459099388|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
127581842|NCT00808483|459099389|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
127581843|NCT00808483|459099390|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
127581844|NCT00808483|459099389|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
127581845|NCT00808483|459099390|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
127581846|NCT00808483|459099389|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
127581847|NCT00808483|459099390|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
127581848|NCT02357979|459099391|FG000|Overall Study|Lost to Follow-up|5|||
127581849|NCT02357979|459099392|FG001|Overall Study|Lost to Follow-up|5|||
127581850|NCT04289623|459099395|FG000|Wave 1 Emails|Email was not delivered|268|||
127581851|NCT04289623|459099396|FG001|Wave 1 Emails|Email was not delivered|257|||
127581852|NCT04289623|459099397|FG002|Wave 1 Emails|Email was not delivered|0|||
127581853|NCT04289623|459099398|FG003|Wave 1 Emails|Email was not delivered|0|||
127581854|NCT04289623|459099399|FG004|Wave 1 Emails|Email was not delivered|0|||
127581855|NCT04289623|459099400|FG005|Wave 1 Emails|Email was not delivered|0|||
127581856|NCT01772160|459099402|FG000|Overall Study|Death|3|||
127581857|NCT01772160|459099402|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
127581858|NCT01772160|459099402|FG000|Overall Study|Consent withdrawal|3|||
127581859|NCT01772160|459099402|FG000|Overall Study|Migrated / moved from the study area|4|||
127581860|NCT01772160|459099402|FG000|Overall Study|Lost to Follow-up|30|||
127581861|NCT01772160|459099402|FG000|Overall Study|Other|5|||
127581862|NCT01522248|459099403|FG000|Overall Study|Lost to Follow-up|1|||
127581863|NCT01522248|459099404|FG001|Overall Study|Lost to Follow-up|0|||
127581864|NCT00694707|459099405|FG000|Overall Study|Did Not Receive Treatment|0|||
127581865|NCT00694707|459099406|FG001|Overall Study|Did Not Receive Treatment|0|||
127581866|NCT00694707|459099407|FG002|Overall Study|Did Not Receive Treatment|1|||
127581867|NCT00694707|459099408|FG003|Overall Study|Did Not Receive Treatment|1|||
127581868|NCT00694707|459099409|FG004|Overall Study|Did Not Receive Treatment|1|||
127581869|NCT00694707|459099405|FG000|Overall Study|Adverse Event|22|||
127581870|NCT00694707|459099406|FG001|Overall Study|Adverse Event|14|||
127581871|NCT00694707|459099407|FG002|Overall Study|Adverse Event|8|||
127581872|NCT00694707|459099408|FG003|Overall Study|Adverse Event|12|||
127581873|NCT00694707|459099409|FG004|Overall Study|Adverse Event|13|||
127581874|NCT00694707|459099405|FG000|Overall Study|Insufficient Therapeutic Response|33|||
127581875|NCT00694707|459099406|FG001|Overall Study|Insufficient Therapeutic Response|18|||
127581876|NCT00694707|459099407|FG002|Overall Study|Insufficient Therapeutic Response|17|||
127581877|NCT00694707|459099408|FG003|Overall Study|Insufficient Therapeutic Response|15|||
127581878|NCT00694707|459099409|FG004|Overall Study|Insufficient Therapeutic Response|10|||
127581879|NCT00694707|459099405|FG000|Overall Study|Protocol Violation|1|||
127581880|NCT00694707|459099406|FG001|Overall Study|Protocol Violation|2|||
127581881|NCT00694707|459099407|FG002|Overall Study|Protocol Violation|1|||
127581882|NCT00694707|459099408|FG003|Overall Study|Protocol Violation|3|||
127581883|NCT00694707|459099409|FG004|Overall Study|Protocol Violation|1|||
127581884|NCT00694707|459099405|FG000|Overall Study|Withdrawal of Consent|14|||
127581885|NCT00694707|459099406|FG001|Overall Study|Withdrawal of Consent|18|||
127581886|NCT00694707|459099407|FG002|Overall Study|Withdrawal of Consent|22|||
127581887|NCT00694707|459099408|FG003|Overall Study|Withdrawal of Consent|16|||
127581888|NCT00694707|459099409|FG004|Overall Study|Withdrawal of Consent|15|||
127581889|NCT00694707|459099405|FG000|Overall Study|Lost to Follow-up|0|||
127581890|NCT00694707|459099406|FG001|Overall Study|Lost to Follow-up|1|||
127581891|NCT00694707|459099407|FG002|Overall Study|Lost to Follow-up|2|||
127581892|NCT00694707|459099408|FG003|Overall Study|Lost to Follow-up|0|||
127581893|NCT00694707|459099409|FG004|Overall Study|Lost to Follow-up|0|||
127581894|NCT00694707|459099405|FG000|Overall Study|Jeopardizing Parole Status|1|||
127581895|NCT00694707|459099406|FG001|Overall Study|Jeopardizing Parole Status|0|||
127581896|NCT00694707|459099407|FG002|Overall Study|Jeopardizing Parole Status|0|||
127581897|NCT00694707|459099408|FG003|Overall Study|Jeopardizing Parole Status|0|||
127581898|NCT00694707|459099409|FG004|Overall Study|Jeopardizing Parole Status|0|||
127581899|NCT00694707|459099405|FG000|Overall Study|Death in the Family|1|||
127581900|NCT00694707|459099406|FG001|Overall Study|Death in the Family|0|||
127581901|NCT00694707|459099407|FG002|Overall Study|Death in the Family|0|||
127581902|NCT00694707|459099408|FG003|Overall Study|Death in the Family|0|||
127581903|NCT00694707|459099409|FG004|Overall Study|Death in the Family|0|||
127581904|NCT00694707|459099405|FG000|Overall Study|Arrest by Police|0|||
127581905|NCT00694707|459099406|FG001|Overall Study|Arrest by Police|1|||
127581906|NCT00694707|459099407|FG002|Overall Study|Arrest by Police|0|||
127581907|NCT00694707|459099408|FG003|Overall Study|Arrest by Police|0|||
127581908|NCT00694707|459099409|FG004|Overall Study|Arrest by Police|0|||
127581909|NCT00694707|459099405|FG000|Overall Study|Administrative Reasons|0|||
127581910|NCT00694707|459099406|FG001|Overall Study|Administrative Reasons|1|||
127581911|NCT00694707|459099407|FG002|Overall Study|Administrative Reasons|0|||
127581912|NCT00694707|459099408|FG003|Overall Study|Administrative Reasons|2|||
127581913|NCT00694707|459099409|FG004|Overall Study|Administrative Reasons|0|||
127581914|NCT00694707|459099405|FG000|Overall Study|Notification of Past Head Injury|0|||
127581915|NCT00694707|459099406|FG001|Overall Study|Notification of Past Head Injury|0|||
127581916|NCT00694707|459099407|FG002|Overall Study|Notification of Past Head Injury|0|||
127581917|NCT00694707|459099408|FG003|Overall Study|Notification of Past Head Injury|1|||
127581918|NCT00694707|459099409|FG004|Overall Study|Notification of Past Head Injury|0|||
127581919|NCT01268150|459099417|FG000|Treatment Phase|Progression of disease|18|||
127581920|NCT01268150|459099417|FG000|Treatment Phase|Adverse Event|3|||
127581921|NCT01268150|459099417|FG000|Treatment Phase|Withdrawal by Subject|3|||
127581922|NCT01268150|459099417|FG000|Treatment Phase|Other|4|||
127581923|NCT01268150|459099417|FG000|Extension Phase|Adverse Event|3|||
127581924|NCT01268150|459099417|FG000|Extension Phase|Disease progression|18|||
127581925|NCT01268150|459099417|FG000|Extension Phase|Other|6|||
127581926|NCT03725852|459099418|FG000|Overall Study|Death|1|||
127581927|NCT03725852|459099419|FG001|Overall Study|Death|0|||
127581928|NCT03725852|459099418|FG000|Overall Study|Withdrawal by Subject|1|||
127581929|NCT03725852|459099419|FG001|Overall Study|Withdrawal by Subject|0|||
127581930|NCT03725852|459099418|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
127581931|NCT03725852|459099419|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
127581932|NCT04738734|459099421|FG000|Overall Study|Withdrawal by Subject|2|||
127581933|NCT04738734|459099422|FG001|Overall Study|Withdrawal by Subject|4|||
127581934|NCT04738734|459099421|FG000|Overall Study|Lost to Follow-up|5|||
127581935|NCT04738734|459099422|FG001|Overall Study|Lost to Follow-up|2|||
127581936|NCT04738734|459099421|FG000|Overall Study|Physician Decision|0|||
127581937|NCT04738734|459099422|FG001|Overall Study|Physician Decision|1|||
127581938|NCT04738734|459099421|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
127581939|NCT04738734|459099422|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
127581940|NCT02435147|459099425|FG000|Overall Study|non-evaluable DXA scan|11|||
127581941|NCT00973674|459099428|FG000|Overall Study|Protocol Violation|2|||
127581942|NCT00973674|459099429|FG001|Overall Study|Protocol Violation|0|||
127581943|NCT00116428|459099430|FG000|Overall Study|Withdrawal by Subject|2|||
127581944|NCT00116428|459099431|FG001|Overall Study|Withdrawal by Subject|5|||
127581945|NCT00116428|459099430|FG000|Overall Study|Did not meet inclusion criteria|1|||
127581946|NCT00116428|459099431|FG001|Overall Study|Did not meet inclusion criteria|0|||
127581947|NCT03452228|459099432|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
127581948|NCT03452228|459099433|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
127581949|NCT03452228|459099434|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
127581950|NCT03452228|459099432|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
127581951|NCT03452228|459099433|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
127581952|NCT03452228|459099434|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
127581953|NCT03452228|459099432|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
127581954|NCT03452228|459099433|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
127581955|NCT03452228|459099434|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
127581956|NCT03452228|459099432|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
127581957|NCT03452228|459099433|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
127581958|NCT03452228|459099434|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
127581959|NCT02713204|459099435|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
127581960|NCT02713204|459099436|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
127581961|NCT02713204|459099437|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
127581962|NCT02713204|459099438|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
127581963|NCT02713204|459099439|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
127581964|NCT02713204|459099440|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
127581965|NCT02713204|459099441|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
127581966|NCT02713204|459099442|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
127581967|NCT02713204|459099435|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
127581968|NCT02713204|459099436|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
127581969|NCT02713204|459099437|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
127581970|NCT02713204|459099438|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
127581971|NCT02713204|459099439|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
127581972|NCT02713204|459099440|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
127581973|NCT02713204|459099441|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
127581974|NCT02713204|459099442|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
128030695|NCT03715829|460738712|FG003|Dose Ranging Period|Other|0|||
128030696|NCT03715829|460738713|FG004|Dose Ranging Period|Other|0|||
128030697|NCT03715829|460738714|FG005|Dose Ranging Period|Other|3|||
128030698|NCT03715829|460738715|FG006|Dose Ranging Period|Other|0|||
128030699|NCT03715829|460738716|FG007|Dose Ranging Period|Other|0|||
128030700|NCT03715829|460738717|FG008|Dose Ranging Period|Other|0|||
128030701|NCT03715829|460738718|FG009|Dose Ranging Period|Other|0|||
128030702|NCT03715829|460738719|FG010|Dose Ranging Period|Other|0|||
128030703|NCT03715829|460738709|FG000|Extension Period|Adverse Event|0|||
128030704|NCT03715829|460738710|FG001|Extension Period|Adverse Event|0|||
128030705|NCT03715829|460738711|FG002|Extension Period|Adverse Event|0|||
128030706|NCT03715829|460738712|FG003|Extension Period|Adverse Event|0|||
128030707|NCT03715829|460738713|FG004|Extension Period|Adverse Event|0|||
128030708|NCT03715829|460738714|FG005|Extension Period|Adverse Event|0|||
128030709|NCT03715829|460738715|FG006|Extension Period|Adverse Event|3|||
128030710|NCT03715829|460738716|FG007|Extension Period|Adverse Event|1|||
128030711|NCT03715829|460738717|FG008|Extension Period|Adverse Event|6|||
128030712|NCT03715829|460738718|FG009|Extension Period|Adverse Event|0|||
128030713|NCT03715829|460738719|FG010|Extension Period|Adverse Event|0|||
128030714|NCT03715829|460738709|FG000|Extension Period|Lack of Efficacy|0|||
128030715|NCT03715829|460738710|FG001|Extension Period|Lack of Efficacy|0|||
128030716|NCT03715829|460738711|FG002|Extension Period|Lack of Efficacy|0|||
128030717|NCT03715829|460738712|FG003|Extension Period|Lack of Efficacy|0|||
128030718|NCT03715829|460738713|FG004|Extension Period|Lack of Efficacy|0|||
128030719|NCT03715829|460738714|FG005|Extension Period|Lack of Efficacy|0|||
128030720|NCT03715829|460738715|FG006|Extension Period|Lack of Efficacy|1|||
128030721|NCT03715829|460738716|FG007|Extension Period|Lack of Efficacy|9|||
128030722|NCT03715829|460738717|FG008|Extension Period|Lack of Efficacy|2|||
128030723|NCT03715829|460738718|FG009|Extension Period|Lack of Efficacy|0|||
128030724|NCT03715829|460738719|FG010|Extension Period|Lack of Efficacy|0|||
128030725|NCT03715829|460738709|FG000|Extension Period|Lost to Follow-up|0|||
128030726|NCT03715829|460738710|FG001|Extension Period|Lost to Follow-up|0|||
128030727|NCT03715829|460738711|FG002|Extension Period|Lost to Follow-up|0|||
128030728|NCT03715829|460738712|FG003|Extension Period|Lost to Follow-up|0|||
128030729|NCT03715829|460738713|FG004|Extension Period|Lost to Follow-up|0|||
128030730|NCT03715829|460738714|FG005|Extension Period|Lost to Follow-up|0|||
128030731|NCT03715829|460738715|FG006|Extension Period|Lost to Follow-up|0|||
128030732|NCT03715829|460738716|FG007|Extension Period|Lost to Follow-up|0|||
128030733|NCT03715829|460738717|FG008|Extension Period|Lost to Follow-up|2|||
128030734|NCT03715829|460738718|FG009|Extension Period|Lost to Follow-up|0|||
128030735|NCT03715829|460738719|FG010|Extension Period|Lost to Follow-up|0|||
128030736|NCT03715829|460738709|FG000|Extension Period|Protocol Violation|0|||
128030737|NCT03715829|460738710|FG001|Extension Period|Protocol Violation|0|||
128030738|NCT03715829|460738711|FG002|Extension Period|Protocol Violation|0|||
128030739|NCT03715829|460738712|FG003|Extension Period|Protocol Violation|0|||
128030740|NCT03715829|460738713|FG004|Extension Period|Protocol Violation|0|||
128030741|NCT03715829|460738714|FG005|Extension Period|Protocol Violation|0|||
128030742|NCT03715829|460738715|FG006|Extension Period|Protocol Violation|0|||
128030743|NCT03715829|460738716|FG007|Extension Period|Protocol Violation|0|||
128030744|NCT03715829|460738717|FG008|Extension Period|Protocol Violation|1|||
128030745|NCT03715829|460738718|FG009|Extension Period|Protocol Violation|0|||
128030746|NCT03715829|460738719|FG010|Extension Period|Protocol Violation|0|||
128030747|NCT03715829|460738709|FG000|Extension Period|Withdrawal by Subject|0|||
128030748|NCT03715829|460738710|FG001|Extension Period|Withdrawal by Subject|0|||
128030749|NCT03715829|460738711|FG002|Extension Period|Withdrawal by Subject|0|||
128030750|NCT03715829|460738712|FG003|Extension Period|Withdrawal by Subject|0|||
128030751|NCT03715829|460738713|FG004|Extension Period|Withdrawal by Subject|0|||
128030752|NCT03715829|460738714|FG005|Extension Period|Withdrawal by Subject|0|||
128030753|NCT03715829|460738715|FG006|Extension Period|Withdrawal by Subject|3|||
128030754|NCT03715829|460738716|FG007|Extension Period|Withdrawal by Subject|3|||
127581975|NCT02713204|459099435|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
127581976|NCT02713204|459099436|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
127581977|NCT02713204|459099437|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
127581978|NCT02713204|459099438|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
128030755|NCT03715829|460738717|FG008|Extension Period|Withdrawal by Subject|12|||
128030756|NCT03715829|460738718|FG009|Extension Period|Withdrawal by Subject|3|||
128030757|NCT03715829|460738719|FG010|Extension Period|Withdrawal by Subject|0|||
127581979|NCT02713204|459099439|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
127881573|NCT00791154|460188798|FG006|Overall Study|Lost to Follow-up|4|||
128030758|NCT03715829|460738709|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
128030759|NCT03715829|460738710|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
128030760|NCT03715829|460738711|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
128030761|NCT03715829|460738712|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
128030762|NCT03715829|460738713|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
128030763|NCT03715829|460738714|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
127581980|NCT02713204|459099440|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
127581981|NCT02713204|459099441|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
127581982|NCT02713204|459099442|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
127581983|NCT02713204|459099435|FG000|From Week 12 up to Week 36|Adverse Event|1|||
127581984|NCT02713204|459099436|FG001|From Week 12 up to Week 36|Adverse Event|0|||
127581985|NCT02713204|459099437|FG002|From Week 12 up to Week 36|Adverse Event|0|||
127581986|NCT02713204|459099438|FG003|From Week 12 up to Week 36|Adverse Event|1|||
127581987|NCT02713204|459099439|FG004|From Week 12 up to Week 36|Adverse Event|1|||
128030764|NCT03715829|460738715|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
127581988|NCT02713204|459099440|FG005|From Week 12 up to Week 36|Adverse Event|0|||
127581989|NCT02713204|459099441|FG006|From Week 12 up to Week 36|Adverse Event|2|||
127581990|NCT02713204|459099442|FG007|From Week 12 up to Week 36|Adverse Event|1|||
127581991|NCT02713204|459099435|FG000|From Week 12 up to Week 36|Death|0|||
127581992|NCT02713204|459099436|FG001|From Week 12 up to Week 36|Death|0|||
127581993|NCT02713204|459099437|FG002|From Week 12 up to Week 36|Death|0|||
127581994|NCT02713204|459099438|FG003|From Week 12 up to Week 36|Death|1|||
127581995|NCT02713204|459099439|FG004|From Week 12 up to Week 36|Death|0|||
127581996|NCT02713204|459099440|FG005|From Week 12 up to Week 36|Death|1|||
127581997|NCT02713204|459099441|FG006|From Week 12 up to Week 36|Death|0|||
127581998|NCT02713204|459099442|FG007|From Week 12 up to Week 36|Death|3|||
127581999|NCT02713204|459099435|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
127582000|NCT02713204|459099436|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
127582001|NCT02713204|459099437|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
127582002|NCT02713204|459099438|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
127582003|NCT02713204|459099439|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
127582004|NCT02713204|459099440|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
127582005|NCT02713204|459099441|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
127582006|NCT02713204|459099442|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
127582007|NCT02713204|459099435|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
127582008|NCT02713204|459099436|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
127582009|NCT02713204|459099437|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
127582010|NCT02713204|459099438|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
127582011|NCT02713204|459099439|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
127582012|NCT02713204|459099440|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
127582013|NCT02713204|459099441|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
127582014|NCT02713204|459099442|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
127582015|NCT00669396|459099443|FG000|Overall Study|Lost to Follow-up|10|||
127582016|NCT00669396|459099444|FG001|Overall Study|Lost to Follow-up|12|||
127582017|NCT04402060|459099445|FG000|Overall Study|Death|1|||
127582018|NCT04402060|459099446|FG001|Overall Study|Death|12|||
127582019|NCT04402060|459099447|FG002|Overall Study|Death|7|||
127582020|NCT04402060|459099445|FG000|Overall Study|Adverse Event|0|||
127582021|NCT04402060|459099446|FG001|Overall Study|Adverse Event|0|||
127582022|NCT04402060|459099447|FG002|Overall Study|Adverse Event|1|||
127582023|NCT04402060|459099445|FG000|Overall Study|Withdrawal by Subject|0|||
127582024|NCT04402060|459099446|FG001|Overall Study|Withdrawal by Subject|1|||
127582025|NCT04402060|459099447|FG002|Overall Study|Withdrawal by Subject|2|||
127582026|NCT04402060|459099445|FG000|Overall Study|Sponsor Request|0|||
127582027|NCT04402060|459099446|FG001|Overall Study|Sponsor Request|2|||
127582028|NCT04402060|459099447|FG002|Overall Study|Sponsor Request|0|||
127582029|NCT04402060|459099445|FG000|Overall Study|Physician Decision|0|||
127582030|NCT04402060|459099446|FG001|Overall Study|Physician Decision|0|||
127582031|NCT04402060|459099447|FG002|Overall Study|Physician Decision|1|||
127582032|NCT04402060|459099445|FG000|Overall Study|Other|0|||
127582033|NCT04402060|459099446|FG001|Overall Study|Other|1|||
127582034|NCT04402060|459099447|FG002|Overall Study|Other|0|||
127582035|NCT00331422|459099452|FG000|Overall Study|Did not receive entire study regimen|5|||
127582036|NCT02345226|459099453|FG000|Double-Blind Phase|Adverse Event|5|||
127582037|NCT02345226|459099454|FG001|Double-Blind Phase|Adverse Event|6|||
127582038|NCT02345226|459099453|FG000|Double-Blind Phase|Death|3|||
127582039|NCT02345226|459099454|FG001|Double-Blind Phase|Death|0|||
127582040|NCT02345226|459099453|FG000|Double-Blind Phase|Pregnancy|0|||
127582041|NCT02345226|459099454|FG001|Double-Blind Phase|Pregnancy|1|||
127582042|NCT02345226|459099453|FG000|Double-Blind Phase|Lack of Efficacy|1|||
127582043|NCT02345226|459099454|FG001|Double-Blind Phase|Lack of Efficacy|0|||
128030765|NCT03715829|460738716|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
127582044|NCT02345226|459099453|FG000|Double-Blind Phase|Investigator's Discretion|4|||
127582045|NCT02345226|459099454|FG001|Double-Blind Phase|Investigator's Discretion|3|||
127582046|NCT02345226|459099453|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
127582047|NCT02345226|459099454|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
127582048|NCT02345226|459099453|FG000|Double-Blind Phase|Withdrew Consent|41|||
127582049|NCT02345226|459099454|FG001|Double-Blind Phase|Withdrew Consent|39|||
127582050|NCT02345226|459099453|FG000|Double-Blind Phase|Lost to Follow-up|12|||
127582051|NCT02345226|459099454|FG001|Double-Blind Phase|Lost to Follow-up|16|||
127693785|NCT00676715|459507010|FG000|Treatment Period (TP)|Withdrew consent|3|||
127582052|NCT02345226|459099453|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
127582053|NCT02345226|459099454|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
127582054|NCT02345226|459099453|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
127582055|NCT02345226|459099454|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
127582056|NCT02282358|459099455|FG000|Overall Study|Nonevaluable|1|||
127582057|NCT03780543|459099456|FG000|Overall Study|Adverse Event|1|||
127582058|NCT03780543|459099457|FG001|Overall Study|Adverse Event|0|||
127783266|NCT02752035|459832940|FG002|Randomization: Approximately 3 Years|Disease Relapse|16|||
127783267|NCT02752035|459832941|FG003|Randomization: Approximately 3 Years|Disease Relapse|6|||
127783268|NCT02752035|459832938|FG000|Randomization: Approximately 3 Years|Physician Decision|0|||
127783269|NCT02752035|459832939|FG001|Randomization: Approximately 3 Years|Physician Decision|3|||
127783270|NCT02752035|459832940|FG002|Randomization: Approximately 3 Years|Physician Decision|1|||
127783271|NCT02752035|459832941|FG003|Randomization: Approximately 3 Years|Physician Decision|1|||
127783272|NCT02752035|459832938|FG000|Randomization: Approximately 3 Years|Withdrawal by Subject|0|||
127783273|NCT02752035|459832939|FG001|Randomization: Approximately 3 Years|Withdrawal by Subject|14|||
127783274|NCT02752035|459832940|FG002|Randomization: Approximately 3 Years|Withdrawal by Subject|7|||
127783275|NCT02752035|459832941|FG003|Randomization: Approximately 3 Years|Withdrawal by Subject|4|||
127783276|NCT02752035|459832938|FG000|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
127783277|NCT02752035|459832939|FG001|Randomization: Approximately 3 Years|Lack of Efficacy|4|||
127783278|NCT02752035|459832940|FG002|Randomization: Approximately 3 Years|Lack of Efficacy|14|||
127783279|NCT02752035|459832941|FG003|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
127783280|NCT02752035|459832938|FG000|Randomization: Approximately 3 Years|Death|0|||
127783281|NCT02752035|459832939|FG001|Randomization: Approximately 3 Years|Death|25|||
127783282|NCT02752035|459832940|FG002|Randomization: Approximately 3 Years|Death|13|||
127783283|NCT02752035|459832941|FG003|Randomization: Approximately 3 Years|Death|4|||
127783284|NCT02752035|459832938|FG000|Randomization: Approximately 3 Years|Adverse Event|0|||
127783285|NCT02752035|459832939|FG001|Randomization: Approximately 3 Years|Adverse Event|14|||
127783286|NCT02752035|459832940|FG002|Randomization: Approximately 3 Years|Adverse Event|2|||
127783287|NCT02752035|459832941|FG003|Randomization: Approximately 3 Years|Adverse Event|6|||
127783288|NCT02752035|459832938|FG000|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
127783289|NCT02752035|459832939|FG001|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
127783290|NCT02752035|459832940|FG002|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
127783291|NCT02752035|459832941|FG003|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
127582059|NCT03780543|459099458|FG002|Overall Study|Adverse Event|2|||
128030766|NCT03715829|460738717|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
128030767|NCT03715829|460738718|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
128030768|NCT03715829|460738719|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
128030769|NCT03715829|460738709|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
128030770|NCT03715829|460738710|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
128030771|NCT03715829|460738711|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
128030772|NCT03715829|460738712|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
128030773|NCT03715829|460738713|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
128030774|NCT03715829|460738714|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
128030775|NCT03715829|460738715|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
128030776|NCT03715829|460738716|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
128030777|NCT03715829|460738717|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
128030778|NCT03715829|460738718|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
128030779|NCT03715829|460738719|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
128030780|NCT03715829|460738709|FG000|Extension Period|Other|0|||
128030781|NCT03715829|460738710|FG001|Extension Period|Other|0|||
128030782|NCT03715829|460738711|FG002|Extension Period|Other|0|||
128030783|NCT03715829|460738712|FG003|Extension Period|Other|0|||
128030784|NCT03715829|460738713|FG004|Extension Period|Other|0|||
128030785|NCT03715829|460738714|FG005|Extension Period|Other|0|||
128030786|NCT03715829|460738715|FG006|Extension Period|Other|1|||
128030787|NCT03715829|460738716|FG007|Extension Period|Other|2|||
128030788|NCT03715829|460738717|FG008|Extension Period|Other|4|||
128030789|NCT03715829|460738718|FG009|Extension Period|Other|0|||
128030790|NCT03715829|460738719|FG010|Extension Period|Other|0|||
128030791|NCT03579719|460738720|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
128030792|NCT03253627|460738723|FG000|Overall Study|Lost to Follow-up|1|||
128030793|NCT03253627|460738724|FG001|Overall Study|Lost to Follow-up|2|||
128030794|NCT03253627|460738723|FG000|Overall Study|Withdrawal by Subject|0|||
128030795|NCT03253627|460738724|FG001|Overall Study|Withdrawal by Subject|2|||
128030796|NCT03253627|460738723|FG000|Overall Study|Inability to complete MRI|1|||
128030797|NCT03253627|460738724|FG001|Overall Study|Inability to complete MRI|0|||
128030798|NCT02940223|460738728|FG000|Overall Study|Failed Requirement|2|||
128030799|NCT02940223|460738729|FG001|Overall Study|Failed Requirement|0|||
128030800|NCT01813357|460738730|FG000|Overall Study|Lost to Follow-up|5|||
128030801|NCT01813357|460738731|FG001|Overall Study|Lost to Follow-up|6|||
128030802|NCT03773562|460738732|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
128030803|NCT03773562|460738732|FG000|Overall Study|Lost to Follow-up|10|||
128030804|NCT03773562|460738732|FG000|Overall Study|Withdrawal by Subject|1|||
128030805|NCT05810597|460738733|FG000|Period 1|Adverse Event|2|||
128030806|NCT05810597|460738734|FG001|Period 1|Adverse Event|0|||
128030807|NCT05810597|460738733|FG000|Period 1|Physician Decision|1|||
128030808|NCT05810597|460738734|FG001|Period 1|Physician Decision|0|||
128030809|NCT05021224|460738735|FG000|Overall Study|Did not complete all survey items|4|||
127582060|NCT03780543|459099456|FG000|Overall Study|Lost to Follow-up|2|||
127582061|NCT03780543|459099457|FG001|Overall Study|Lost to Follow-up|0|||
127582062|NCT03780543|459099458|FG002|Overall Study|Lost to Follow-up|1|||
127582063|NCT03780543|459099456|FG000|Overall Study|Study terminated by Sponsor|8|||
127582064|NCT03780543|459099457|FG001|Overall Study|Study terminated by Sponsor|7|||
127582065|NCT03780543|459099458|FG002|Overall Study|Study terminated by Sponsor|13|||
128030810|NCT05021224|460738736|FG001|Overall Study|Did not complete all survey items|1|||
128030811|NCT05021224|460738737|FG002|Overall Study|Did not complete all survey items|0|||
128030812|NCT05021224|460738738|FG003|Overall Study|Did not complete all survey items|2|||
128030813|NCT01111552|460738741|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
128030814|NCT01111552|460738742|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
128030815|NCT01111552|460738743|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
128030816|NCT01111552|460738744|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
128030817|NCT01111552|460738745|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
128030818|NCT01111552|460738741|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
128030819|NCT01111552|460738742|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
128030820|NCT01111552|460738743|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
128030821|NCT01111552|460738744|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
128030822|NCT01111552|460738745|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
128030823|NCT01111552|460738741|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
128030824|NCT01111552|460738742|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
128030825|NCT01111552|460738743|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
128030826|NCT01111552|460738744|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
128030827|NCT01111552|460738745|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
128030828|NCT01111552|460738741|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
128030829|NCT01111552|460738742|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
128030830|NCT01111552|460738743|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
127582066|NCT03780543|459099456|FG000|Overall Study|Withdrawal by Subject|1|||
127582067|NCT03780543|459099457|FG001|Overall Study|Withdrawal by Subject|8|||
127582068|NCT03780543|459099458|FG002|Overall Study|Withdrawal by Subject|1|||
127582069|NCT03780543|459099456|FG000|Overall Study|Noncompliance with study drug|1|||
127582070|NCT03780543|459099457|FG001|Overall Study|Noncompliance with study drug|0|||
127582071|NCT03780543|459099458|FG002|Overall Study|Noncompliance with study drug|0|||
127582072|NCT04032652|459099461|FG000|Overall Study|The study was terminated and the PI has|1|||
127582073|NCT04032652|459099462|FG001|Overall Study|The study was terminated and the PI has|1|||
127582074|NCT01863953|459101139|FG000|Overall Study|Adverse Event|0|||
127582075|NCT01863953|459101140|FG001|Overall Study|Adverse Event|0|||
127582076|NCT01863953|459101141|FG002|Overall Study|Adverse Event|1|||
127582077|NCT01824342|459101143|FG000|Overall Study|Withdrawal by Subject|0|||
127582078|NCT01824342|459101144|FG001|Overall Study|Withdrawal by Subject|3|||
127582079|NCT01824342|459101143|FG000|Overall Study|Adverse Event|1|||
127582080|NCT01824342|459101144|FG001|Overall Study|Adverse Event|1|||
127582081|NCT01824342|459101143|FG000|Overall Study|Disease Progression|1|||
127582082|NCT01824342|459101144|FG001|Overall Study|Disease Progression|1|||
127582083|NCT01824342|459101143|FG000|Overall Study|Physician Decision|5|||
127582084|NCT01824342|459101144|FG001|Overall Study|Physician Decision|0|||
127582085|NCT01824342|459101143|FG000|Overall Study|Death|2|||
127582086|NCT01824342|459101144|FG001|Overall Study|Death|0|||
127783292|NCT02752035|459832938|FG000|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
127783293|NCT02752035|459832939|FG001|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
127783294|NCT02752035|459832940|FG002|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
127783295|NCT02752035|459832941|FG003|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
127783296|NCT02752035|459832938|FG000|Long-term Follow-up: up to 3 Years|Death|5|||
127783297|NCT02752035|459832939|FG001|Long-term Follow-up: up to 3 Years|Death|26|||
127783298|NCT02752035|459832940|FG002|Long-term Follow-up: up to 3 Years|Death|30|||
127783299|NCT02752035|459832941|FG003|Long-term Follow-up: up to 3 Years|Death|10|||
127783300|NCT02752035|459832938|FG000|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
127783301|NCT02752035|459832939|FG001|Long-term Follow-up: up to 3 Years|Miscellaneous|3|||
127783302|NCT02752035|459832940|FG002|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
127783303|NCT02752035|459832941|FG003|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
127783304|NCT01519934|459832946|FG000|Overall Study|Lost to Follow-up|3|||
127783305|NCT01368536|459832949|FG000|Overall Study|Adverse Event|5|||
127783306|NCT01368536|459832950|FG001|Overall Study|Adverse Event|6|||
127783307|NCT01368536|459832951|FG002|Overall Study|Adverse Event|8|||
127783308|NCT01368536|459832949|FG000|Overall Study|Abnormal laboratory value(s)|0|||
127783309|NCT01368536|459832950|FG001|Overall Study|Abnormal laboratory value(s)|1|||
127783310|NCT01368536|459832951|FG002|Overall Study|Abnormal laboratory value(s)|2|||
127783311|NCT01368536|459832949|FG000|Overall Study|Abnormal test procedure result(s)|0|||
127783312|NCT01368536|459832950|FG001|Overall Study|Abnormal test procedure result(s)|0|||
127783313|NCT01368536|459832951|FG002|Overall Study|Abnormal test procedure result(s)|1|||
127783314|NCT01368536|459832949|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
127783315|NCT01368536|459832950|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
127783316|NCT01368536|459832951|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
127783317|NCT01368536|459832949|FG000|Overall Study|No longer required study medication|0|||
127783318|NCT01368536|459832950|FG001|Overall Study|No longer required study medication|0|||
127783319|NCT01368536|459832951|FG002|Overall Study|No longer required study medication|1|||
127783320|NCT01368536|459832949|FG000|Overall Study|Withdrawal by Subject|2|||
127783321|NCT01368536|459832950|FG001|Overall Study|Withdrawal by Subject|5|||
127783322|NCT01368536|459832951|FG002|Overall Study|Withdrawal by Subject|4|||
127783323|NCT01368536|459832949|FG000|Overall Study|Lost to Follow-up|3|||
127783324|NCT01368536|459832950|FG001|Overall Study|Lost to Follow-up|3|||
127783325|NCT01368536|459832951|FG002|Overall Study|Lost to Follow-up|5|||
127783326|NCT01368536|459832949|FG000|Overall Study|Administrative problems|34|||
127783327|NCT01368536|459832950|FG001|Overall Study|Administrative problems|39|||
127783328|NCT01368536|459832951|FG002|Overall Study|Administrative problems|35|||
127783329|NCT01368536|459832949|FG000|Overall Study|Protocol deviation|0|||
127783330|NCT01368536|459832950|FG001|Overall Study|Protocol deviation|3|||
127783331|NCT01368536|459832951|FG002|Overall Study|Protocol deviation|1|||
127783332|NCT03861936|459832952|FG000|Overall Study|Withdrawal by Subject|4|||
127783333|NCT03861936|459832953|FG001|Overall Study|Withdrawal by Subject|1|||
127783334|NCT03861936|459832954|FG002|Overall Study|Withdrawal by Subject|3|||
127783335|NCT03861936|459832952|FG000|Overall Study|Lost to Follow-up|5|||
127783336|NCT03861936|459832953|FG001|Overall Study|Lost to Follow-up|3|||
127783337|NCT03861936|459832954|FG002|Overall Study|Lost to Follow-up|3|||
127783338|NCT03861936|459832952|FG000|Overall Study|Physician Decision|0|||
127783339|NCT03861936|459832953|FG001|Overall Study|Physician Decision|1|||
128030831|NCT01111552|460738744|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
127582087|NCT01313858|459101145|FG000|Overall Study|Premature Treatment Termination|251|||
127582088|NCT01313858|459101146|FG001|Overall Study|Premature Treatment Termination|219|||
127582089|NCT01313858|459101147|FG002|Overall Study|Premature Treatment Termination|191|||
127582090|NCT01313858|459101145|FG000|Overall Study|Lost to Follow-up|35|||
127783340|NCT03861936|459832954|FG002|Overall Study|Physician Decision|0|||
127783341|NCT03861936|459832952|FG000|Overall Study|Protocol Deviation|0|||
127783342|NCT03861936|459832953|FG001|Overall Study|Protocol Deviation|0|||
127582091|NCT01313858|459101146|FG001|Overall Study|Lost to Follow-up|51|||
127582092|NCT01313858|459101147|FG002|Overall Study|Lost to Follow-up|47|||
127582093|NCT04015336|459101152|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
127582094|NCT01816074|459101157|FG000|Phase 1|Time commitment issues|0|||
127582095|NCT01816074|459101158|FG001|Phase 1|Time commitment issues|0|||
127582096|NCT01816074|459101159|FG002|Phase 1|Time commitment issues|1|||
127582097|NCT01816074|459101160|FG003|Phase 1|Time commitment issues|0|||
127582098|NCT01816074|459101157|FG000|Phase 2|Time commitment Issues|0|||
127582099|NCT01816074|459101158|FG001|Phase 2|Time commitment Issues|2|||
127582100|NCT01816074|459101159|FG002|Phase 2|Time commitment Issues|0|||
127582101|NCT01816074|459101160|FG003|Phase 2|Time commitment Issues|0|||
127582102|NCT01816074|459101157|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
127582103|NCT01816074|459101158|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
127582104|NCT01816074|459101159|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
127582105|NCT01816074|459101160|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
127582106|NCT01816074|459101157|FG000|Phase 2|Physician Decision|0|||
127582107|NCT01816074|459101158|FG001|Phase 2|Physician Decision|0|||
127582108|NCT01816074|459101159|FG002|Phase 2|Physician Decision|0|||
127582109|NCT01816074|459101160|FG003|Phase 2|Physician Decision|1|||
127582110|NCT01816074|459101157|FG000|Phase 2|Withdrawal by Subject|1|||
127582111|NCT01816074|459101158|FG001|Phase 2|Withdrawal by Subject|0|||
127582112|NCT01816074|459101159|FG002|Phase 2|Withdrawal by Subject|0|||
127582113|NCT01816074|459101160|FG003|Phase 2|Withdrawal by Subject|0|||
127582114|NCT03650556|459101161|FG000|Overall Study|Death|2|||
127783343|NCT03861936|459832954|FG002|Overall Study|Protocol Deviation|1|||
127783344|NCT03861936|459832952|FG000|Overall Study|Reason not Specified|5|||
128030832|NCT01111552|460738745|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
128030833|NCT01111552|460738741|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
128030834|NCT01111552|460738742|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
128030835|NCT01111552|460738743|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
128030836|NCT01111552|460738744|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
128030837|NCT01111552|460738745|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
128030838|NCT01111552|460738741|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
128030839|NCT01111552|460738742|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
128030840|NCT01111552|460738743|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
128030841|NCT01111552|460738744|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
128030842|NCT01111552|460738745|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
128030843|NCT01111552|460738741|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
128030844|NCT01111552|460738742|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
128030845|NCT01111552|460738743|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
128030846|NCT01111552|460738744|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
128030847|NCT01111552|460738745|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
128030848|NCT01111552|460738741|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
128030849|NCT01111552|460738742|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
128030850|NCT01111552|460738743|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
128030851|NCT01111552|460738744|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
128030852|NCT01111552|460738745|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
128030853|NCT01111552|460738741|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
128030854|NCT01111552|460738742|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
128030855|NCT01111552|460738743|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
128030856|NCT01111552|460738744|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
128030857|NCT01111552|460738745|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
128030858|NCT01111552|460738741|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
128030859|NCT01111552|460738742|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
128030860|NCT01111552|460738743|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
128030861|NCT01111552|460738744|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
128030862|NCT01111552|460738745|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
128030863|NCT01111552|460738741|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
128030864|NCT01111552|460738742|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
128030865|NCT01111552|460738743|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
128030866|NCT01111552|460738744|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
128030867|NCT01111552|460738745|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
127582115|NCT03650556|459101161|FG000|Overall Study|Withdrawal by Subject|20|||
127582116|NCT03650556|459101161|FG000|Overall Study|Physician Decision|2|||
127582117|NCT03650556|459101161|FG000|Overall Study|Lost to Follow-up|8|||
127582118|NCT03650556|459101161|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
127582119|NCT03650556|459101161|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
127582120|NCT00691301|459101162|FG000|Overall Study|Adverse Event|10|||
127582121|NCT00691301|459101162|FG000|Overall Study|Death|2|||
127582122|NCT00691301|459101162|FG000|Overall Study|Lack of Efficacy|32|||
127582123|NCT00691301|459101162|FG000|Overall Study|Withdrawal by Subject|4|||
127582124|NCT00691301|459101162|FG000|Overall Study|Concurrent illness|2|||
127582125|NCT00691301|459101162|FG000|Overall Study|other reason|3|||
127582126|NCT00691301|459101162|FG000|Overall Study|Did not initiate study treatment|1|||
127582127|NCT00463580|459101163|FG000|Overall Study|Lost to Follow-up|1|||
127582128|NCT00463580|459101164|FG001|Overall Study|Lost to Follow-up|0|||
127582129|NCT00463580|459101163|FG000|Overall Study|Schedule conflict|2|||
127582130|NCT00463580|459101164|FG001|Overall Study|Schedule conflict|0|||
127582131|NCT00463580|459101163|FG000|Overall Study|Medical/psychiatric complications|0|||
127582132|NCT00463580|459101164|FG001|Overall Study|Medical/psychiatric complications|2|||
127582133|NCT03917459|459101165|FG000|Overall Study|Adverse Event|1|||
127582134|NCT03917459|459101166|FG001|Overall Study|Adverse Event|0|||
127582135|NCT03917459|459101165|FG000|Overall Study|Withdrawal by Subject|0|||
127582136|NCT03917459|459101166|FG001|Overall Study|Withdrawal by Subject|1|||
127582137|NCT00491764|459101167|FG000|Overall Study|Adverse Event|1|||
127582138|NCT00491764|459101168|FG001|Overall Study|Adverse Event|2|||
127582139|NCT00491764|459101169|FG002|Overall Study|Adverse Event|4|||
127582140|NCT00491764|459101170|FG003|Overall Study|Adverse Event|4|||
127582141|NCT00491764|459101171|FG004|Overall Study|Adverse Event|0|||
127582142|NCT00491764|459101172|FG005|Overall Study|Adverse Event|1|||
127582143|NCT00491764|459101167|FG000|Overall Study|Lost to Follow-up|0|||
127582144|NCT00491764|459101168|FG001|Overall Study|Lost to Follow-up|1|||
127582145|NCT00491764|459101169|FG002|Overall Study|Lost to Follow-up|0|||
127582146|NCT00491764|459101170|FG003|Overall Study|Lost to Follow-up|1|||
127582147|NCT00491764|459101171|FG004|Overall Study|Lost to Follow-up|0|||
127582148|NCT00491764|459101172|FG005|Overall Study|Lost to Follow-up|3|||
127582149|NCT00491764|459101167|FG000|Overall Study|Withdrawal by Subject|2|||
127582150|NCT00491764|459101168|FG001|Overall Study|Withdrawal by Subject|3|||
127582151|NCT00491764|459101169|FG002|Overall Study|Withdrawal by Subject|1|||
127582152|NCT00491764|459101170|FG003|Overall Study|Withdrawal by Subject|2|||
127582153|NCT00491764|459101171|FG004|Overall Study|Withdrawal by Subject|2|||
127582154|NCT00491764|459101172|FG005|Overall Study|Withdrawal by Subject|4|||
127582155|NCT00491764|459101167|FG000|Overall Study|Non Compliance with the Protocol|1|||
127582156|NCT00491764|459101168|FG001|Overall Study|Non Compliance with the Protocol|0|||
127582157|NCT00491764|459101169|FG002|Overall Study|Non Compliance with the Protocol|0|||
127582158|NCT00491764|459101170|FG003|Overall Study|Non Compliance with the Protocol|0|||
127582159|NCT00491764|459101171|FG004|Overall Study|Non Compliance with the Protocol|0|||
127582160|NCT00491764|459101172|FG005|Overall Study|Non Compliance with the Protocol|0|||
127582161|NCT00491764|459101167|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
127582162|NCT00491764|459101168|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
127582163|NCT00491764|459101169|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
127582164|NCT00491764|459101170|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
127582165|NCT00491764|459101171|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
127582166|NCT00491764|459101172|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
127582167|NCT00491764|459101167|FG000|Overall Study|Administrative|1|||
127582168|NCT00491764|459101168|FG001|Overall Study|Administrative|0|||
127582169|NCT00491764|459101169|FG002|Overall Study|Administrative|2|||
127582170|NCT00491764|459101170|FG003|Overall Study|Administrative|1|||
127582171|NCT00491764|459101171|FG004|Overall Study|Administrative|0|||
127582172|NCT00491764|459101172|FG005|Overall Study|Administrative|0|||
127582173|NCT00697788|459101175|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
127582174|NCT00697788|459101176|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
127582175|NCT00697788|459101177|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
127582176|NCT00697788|459101178|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
127582177|NCT00697788|459101179|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
127582178|NCT00697788|459101180|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
127582179|NCT00697788|459101181|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
127582180|NCT00697788|459101182|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
127582181|NCT00697788|459101175|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
127582182|NCT00697788|459101176|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
127582183|NCT00697788|459101177|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
127582184|NCT00697788|459101178|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
127582185|NCT00697788|459101179|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
127582186|NCT00697788|459101180|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
127582187|NCT00697788|459101181|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
127582188|NCT00697788|459101182|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
127582189|NCT00075218|459101191|FG000|Double-Blind Treatment|Adverse Event|23|||
127582190|NCT00075218|459101192|FG001|Double-Blind Treatment|Adverse Event|4|||
127582191|NCT00075218|459101193|FG002|Double-Blind Treatment|Adverse Event|0|||
127582192|NCT00075218|459101191|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
127582193|NCT00075218|459101192|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
127582194|NCT00075218|459101193|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
127582195|NCT00075218|459101191|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
127582196|NCT00075218|459101192|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
127582197|NCT00075218|459101193|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
127582198|NCT00075218|459101191|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
127582199|NCT00075218|459101192|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
127582200|NCT00075218|459101193|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
127582201|NCT00075218|459101191|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
127582202|NCT00075218|459101192|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
127582203|NCT00075218|459101193|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
127582204|NCT00075218|459101191|FG000|Double-Blind Treatment|No study medication taken|2|||
127582205|NCT00075218|459101192|FG001|Double-Blind Treatment|No study medication taken|0|||
127582206|NCT00075218|459101193|FG002|Double-Blind Treatment|No study medication taken|0|||
127582207|NCT00075218|459101191|FG000|Open-Label Treatment|Lack of Efficacy|0|||
127582208|NCT00075218|459101192|FG001|Open-Label Treatment|Lack of Efficacy|0|||
127582209|NCT00075218|459101193|FG002|Open-Label Treatment|Lack of Efficacy|174|||
127582210|NCT00075218|459101191|FG000|Open-Label Treatment|Adverse Event|0|||
127582211|NCT00075218|459101192|FG001|Open-Label Treatment|Adverse Event|0|||
127582212|NCT00075218|459101193|FG002|Open-Label Treatment|Adverse Event|51|||
127582213|NCT00075218|459101191|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
127582214|NCT00075218|459101192|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
127582215|NCT00075218|459101193|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
127582216|NCT00075218|459101191|FG000|Open-Label Treatment|Decision of Sponsor|0|||
127582217|NCT00075218|459101192|FG001|Open-Label Treatment|Decision of Sponsor|0|||
127582218|NCT00075218|459101193|FG002|Open-Label Treatment|Decision of Sponsor|8|||
127582219|NCT00075218|459101191|FG000|Open-Label Treatment|Protocol Violation|0|||
127582220|NCT00075218|459101192|FG001|Open-Label Treatment|Protocol Violation|0|||
127582221|NCT00075218|459101193|FG002|Open-Label Treatment|Protocol Violation|1|||
127582222|NCT00075218|459101191|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
127582223|NCT00075218|459101192|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
127582224|NCT00075218|459101193|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
127582225|NCT03840174|459101196|FG000|Overall Study|Withdrawal by Subject|1|||
127582226|NCT03840174|459101197|FG001|Overall Study|Withdrawal by Subject|0|||
127582227|NCT03840174|459101198|FG002|Overall Study|Withdrawal by Subject|0|||
127582228|NCT03840174|459101199|FG003|Overall Study|Withdrawal by Subject|0|||
127582229|NCT00131508|459101202|FG000|Overall Study|Disease progression|0|||
127582230|NCT00131508|459101203|FG001|Overall Study|Disease progression|2|||
127582231|NCT00131508|459101202|FG000|Overall Study|Non-Compliance|2|||
127582232|NCT00131508|459101203|FG001|Overall Study|Non-Compliance|4|||
127582233|NCT00131508|459101202|FG000|Overall Study|Withdrawal by Subject|1|||
127582234|NCT00131508|459101203|FG001|Overall Study|Withdrawal by Subject|2|||
127582235|NCT00845858|459101205|FG000|Overall Study|Withdrawal by Subject|5|||
127582236|NCT00845858|459101206|FG001|Overall Study|Withdrawal by Subject|1|||
127582237|NCT00845858|459101207|FG002|Overall Study|Withdrawal by Subject|1|||
127582238|NCT00845858|459101205|FG000|Overall Study|Adverse Event|3|||
127582239|NCT00845858|459101206|FG001|Overall Study|Adverse Event|8|||
127582240|NCT00845858|459101207|FG002|Overall Study|Adverse Event|4|||
127582241|NCT00845858|459101205|FG000|Overall Study|Protocol Violation|0|||
127582242|NCT00845858|459101206|FG001|Overall Study|Protocol Violation|0|||
127582243|NCT00845858|459101207|FG002|Overall Study|Protocol Violation|1|||
127582244|NCT00845858|459101205|FG000|Overall Study|not eligible|0|||
127582245|NCT00845858|459101206|FG001|Overall Study|not eligible|3|||
127582246|NCT00845858|459101207|FG002|Overall Study|not eligible|2|||
127783345|NCT03861936|459832953|FG001|Overall Study|Reason not Specified|5|||
127783346|NCT03861936|459832954|FG002|Overall Study|Reason not Specified|3|||
127783347|NCT00359021|459832955|FG000|Overall Study|Adverse Event|26|||
127783348|NCT00359021|459832956|FG001|Overall Study|Adverse Event|8|||
127783349|NCT00359021|459832955|FG000|Overall Study|Subject Non-Compliant|1|||
127783350|NCT00359021|459832956|FG001|Overall Study|Subject Non-Compliant|2|||
127783351|NCT00359021|459832955|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
127783352|NCT00359021|459832956|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
128030868|NCT01111552|460738741|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
128030869|NCT01111552|460738742|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
128030870|NCT01111552|460738743|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
128030871|NCT01111552|460738744|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
128030872|NCT01111552|460738745|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
128030873|NCT01111552|460738741|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
127582247|NCT00880542|459101208|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
127582248|NCT00880542|459101208|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
127582249|NCT00880542|459101208|FG000|REP: Surgical Resection|progressive disease|1|||
127582250|NCT05047770|459101209|FG000|Overall Study|Withdrawal by Subject|15|||
127582251|NCT05047770|459101210|FG001|Overall Study|Withdrawal by Subject|10|||
127582252|NCT05047770|459101211|FG002|Overall Study|Withdrawal by Subject|6|||
127582253|NCT05047770|459101212|FG003|Overall Study|Withdrawal by Subject|12|||
127582254|NCT05047770|459101209|FG000|Overall Study|Lost to Follow-up|7|||
127582255|NCT05047770|459101210|FG001|Overall Study|Lost to Follow-up|5|||
127783353|NCT00359021|459832955|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
127783354|NCT00359021|459832956|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
127783355|NCT00359021|459832955|FG000|Overall Study|Withdrawal by Subject|2|||
127783356|NCT00359021|459832956|FG001|Overall Study|Withdrawal by Subject|9|||
127783357|NCT00359021|459832955|FG000|Overall Study|Lost to Follow-up|1|||
127783358|NCT00359021|459832956|FG001|Overall Study|Lost to Follow-up|0|||
127783359|NCT00359021|459832955|FG000|Overall Study|Other|4|||
127783360|NCT00359021|459832956|FG001|Overall Study|Other|1|||
127783361|NCT00359021|459832955|FG000|Overall Study|Pregnancy|1|||
127783362|NCT00359021|459832956|FG001|Overall Study|Pregnancy|0|||
127783363|NCT01236573|459832957|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
127783364|NCT01236573|459832958|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
127783365|NCT01236573|459832959|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
128030874|NCT01111552|460738742|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
127881574|NCT00791154|460188792|FG000|Overall Study|Death|5|||
127582256|NCT05047770|459101211|FG002|Overall Study|Lost to Follow-up|12|||
127582257|NCT05047770|459101212|FG003|Overall Study|Lost to Follow-up|13|||
127582258|NCT05047770|459101209|FG000|Overall Study|Other|1|||
127582259|NCT05047770|459101210|FG001|Overall Study|Other|0|||
127582260|NCT05047770|459101211|FG002|Overall Study|Other|1|||
127582261|NCT05047770|459101212|FG003|Overall Study|Other|0|||
127582262|NCT03758443|459101213|FG000|Induction Period|Adverse Event|2|||
127582263|NCT03758443|459101214|FG001|Induction Period|Adverse Event|4|||
127582264|NCT03758443|459101215|FG002|Induction Period|Adverse Event|2|||
127582265|NCT03758443|459101216|FG003|Induction Period|Adverse Event|3|||
127582266|NCT03758443|459101213|FG000|Induction Period|Physician Decision|1|||
127582267|NCT03758443|459101214|FG001|Induction Period|Physician Decision|1|||
127582268|NCT03758443|459101215|FG002|Induction Period|Physician Decision|3|||
127582269|NCT03758443|459101216|FG003|Induction Period|Physician Decision|0|||
127582270|NCT03758443|459101213|FG000|Induction Period|Protocol Violation|0|||
127582271|NCT03758443|459101214|FG001|Induction Period|Protocol Violation|0|||
127582272|NCT03758443|459101215|FG002|Induction Period|Protocol Violation|0|||
127582273|NCT03758443|459101216|FG003|Induction Period|Protocol Violation|1|||
127582274|NCT03758443|459101213|FG000|Induction Period|Withdrawal by Subject|3|||
127582275|NCT03758443|459101214|FG001|Induction Period|Withdrawal by Subject|2|||
127582276|NCT03758443|459101215|FG002|Induction Period|Withdrawal by Subject|2|||
127582277|NCT03758443|459101216|FG003|Induction Period|Withdrawal by Subject|4|||
127582278|NCT03758443|459101213|FG000|Extended Induction Period|Adverse Event|1|||
127582279|NCT03758443|459101214|FG001|Extended Induction Period|Adverse Event|1|||
127582280|NCT03758443|459101215|FG002|Extended Induction Period|Adverse Event|0|||
127881575|NCT00791154|460188793|FG001|Overall Study|Death|4|||
127881576|NCT00791154|460188794|FG002|Overall Study|Death|4|||
128030875|NCT01111552|460738743|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
128030876|NCT01111552|460738744|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
128030877|NCT01111552|460738745|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
128030878|NCT01111552|460738741|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
128030879|NCT01111552|460738742|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
128030880|NCT01111552|460738743|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
128030881|NCT01111552|460738744|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
128030882|NCT01111552|460738745|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
128030883|NCT01027351|460738746|FG000|Overall Study|Withdrawal by Subject|1|||
128030884|NCT01027351|460738747|FG001|Overall Study|Withdrawal by Subject|0|||
128030885|NCT01027351|460738748|FG002|Overall Study|Withdrawal by Subject|1|||
128030886|NCT01027351|460738749|FG003|Overall Study|Withdrawal by Subject|0|||
128030887|NCT01027351|460738750|FG004|Overall Study|Withdrawal by Subject|3|||
128030888|NCT01027351|460738751|FG005|Overall Study|Withdrawal by Subject|5|||
128030889|NCT01027351|460738746|FG000|Overall Study|Lost to Follow-up|1|||
128030890|NCT01027351|460738747|FG001|Overall Study|Lost to Follow-up|1|||
128030891|NCT01027351|460738748|FG002|Overall Study|Lost to Follow-up|0|||
128030892|NCT01027351|460738749|FG003|Overall Study|Lost to Follow-up|1|||
128030893|NCT01027351|460738750|FG004|Overall Study|Lost to Follow-up|6|||
128030894|NCT01027351|460738751|FG005|Overall Study|Lost to Follow-up|0|||
128030895|NCT01027351|460738746|FG000|Overall Study|Inappropriate enrollment|0|||
128030896|NCT01027351|460738747|FG001|Overall Study|Inappropriate enrollment|0|||
128030897|NCT01027351|460738748|FG002|Overall Study|Inappropriate enrollment|0|||
128030898|NCT01027351|460738749|FG003|Overall Study|Inappropriate enrollment|0|||
128030899|NCT01027351|460738750|FG004|Overall Study|Inappropriate enrollment|1|||
128030900|NCT01027351|460738751|FG005|Overall Study|Inappropriate enrollment|0|||
128030901|NCT01027351|460738746|FG000|Overall Study|Protocol Violation|1|||
128030902|NCT01027351|460738747|FG001|Overall Study|Protocol Violation|0|||
128030903|NCT01027351|460738748|FG002|Overall Study|Protocol Violation|0|||
128030904|NCT01027351|460738749|FG003|Overall Study|Protocol Violation|1|||
128030905|NCT01027351|460738750|FG004|Overall Study|Protocol Violation|1|||
128030906|NCT01027351|460738751|FG005|Overall Study|Protocol Violation|0|||
128030907|NCT04755231|460738752|FG000|Overall Study|Lost to Follow-up|5|||
128030908|NCT04755231|460738752|FG000|Overall Study|Withdrawal by Subject|5|||
128030909|NCT02184442|460738753|FG000|Overall Study|Death|61|||
128030910|NCT02184442|460738754|FG001|Overall Study|Death|65|||
127582281|NCT03758443|459101216|FG003|Extended Induction Period|Adverse Event|1|||
127582282|NCT03758443|459101213|FG000|Extended Induction Period|Lost to Follow-up|1|||
127582283|NCT03758443|459101214|FG001|Extended Induction Period|Lost to Follow-up|0|||
127582284|NCT03758443|459101215|FG002|Extended Induction Period|Lost to Follow-up|0|||
127582285|NCT03758443|459101216|FG003|Extended Induction Period|Lost to Follow-up|0|||
127582286|NCT03758443|459101213|FG000|Extended Induction Period|Physician Decision|2|||
127582287|NCT03758443|459101214|FG001|Extended Induction Period|Physician Decision|1|||
127582288|NCT03758443|459101215|FG002|Extended Induction Period|Physician Decision|2|||
127582289|NCT03758443|459101216|FG003|Extended Induction Period|Physician Decision|2|||
127881577|NCT00791154|460188795|FG003|Overall Study|Death|7|||
128030911|NCT02184442|460738753|FG000|Overall Study|Withdrawal by Subject|3|||
128030912|NCT02184442|460738754|FG001|Overall Study|Withdrawal by Subject|11|||
128030913|NCT01852214|460738755|FG000|Period 1|Adverse Event|1|||
127582290|NCT03758443|459101213|FG000|Extended Induction Period|Protocol Violation|0|||
127582291|NCT03758443|459101214|FG001|Extended Induction Period|Protocol Violation|0|||
127582292|NCT03758443|459101215|FG002|Extended Induction Period|Protocol Violation|0|||
127582293|NCT03758443|459101216|FG003|Extended Induction Period|Protocol Violation|1|||
127582294|NCT03758443|459101213|FG000|Extended Induction Period|Withdrawal by Subject|8|||
127582295|NCT03758443|459101214|FG001|Extended Induction Period|Withdrawal by Subject|1|||
127582296|NCT03758443|459101215|FG002|Extended Induction Period|Withdrawal by Subject|7|||
127582297|NCT03758443|459101216|FG003|Extended Induction Period|Withdrawal by Subject|3|||
127582298|NCT03758443|459101213|FG000|Extended Induction Period|Miscellaneous|1|||
127582299|NCT03758443|459101214|FG001|Extended Induction Period|Miscellaneous|0|||
127582300|NCT03758443|459101215|FG002|Extended Induction Period|Miscellaneous|0|||
127582301|NCT03758443|459101216|FG003|Extended Induction Period|Miscellaneous|0|||
127582302|NCT03758443|459101213|FG000|Maintenance Period|Adverse Event|1|||
127582303|NCT03758443|459101214|FG001|Maintenance Period|Adverse Event|2|||
127582304|NCT03758443|459101215|FG002|Maintenance Period|Adverse Event|0|||
127582305|NCT03758443|459101216|FG003|Maintenance Period|Adverse Event|0|||
127582306|NCT03758443|459101213|FG000|Maintenance Period|Lost to Follow-up|0|||
127582307|NCT03758443|459101214|FG001|Maintenance Period|Lost to Follow-up|0|||
127582308|NCT03758443|459101215|FG002|Maintenance Period|Lost to Follow-up|0|||
127582309|NCT03758443|459101216|FG003|Maintenance Period|Lost to Follow-up|1|||
127582310|NCT03758443|459101213|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
127582311|NCT03758443|459101214|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
127582312|NCT03758443|459101215|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
128030914|NCT01852214|460738756|FG001|Period 1|Adverse Event|2|||
127582313|NCT03758443|459101216|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
127582314|NCT03758443|459101213|FG000|Maintenance Period|Protocol Violation|0|||
127582315|NCT03758443|459101214|FG001|Maintenance Period|Protocol Violation|1|||
127582316|NCT03758443|459101215|FG002|Maintenance Period|Protocol Violation|0|||
127582317|NCT03758443|459101216|FG003|Maintenance Period|Protocol Violation|0|||
127582318|NCT03758443|459101213|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
127783366|NCT01236573|459832960|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
127783367|NCT01236573|459832961|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
127783368|NCT01236573|459832962|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
127783369|NCT01236573|459832963|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
127783370|NCT01236573|459832964|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
127881578|NCT00791154|460188796|FG004|Overall Study|Death|54|||
128030915|NCT01852214|460738755|FG000|Period 1|Withdrawal by Subject|0|||
128030916|NCT01852214|460738756|FG001|Period 1|Withdrawal by Subject|1|||
128030917|NCT01852214|460738755|FG000|Washout Period|Withdrawal by Subject|0|||
128030918|NCT01852214|460738756|FG001|Washout Period|Withdrawal by Subject|1|||
127582319|NCT03758443|459101214|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
127582320|NCT03758443|459101215|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
127582321|NCT03758443|459101216|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
127582322|NCT03758443|459101213|FG000|Maintenance Period|Withdrawal by Subject|1|||
127582323|NCT03758443|459101214|FG001|Maintenance Period|Withdrawal by Subject|0|||
127582324|NCT03758443|459101215|FG002|Maintenance Period|Withdrawal by Subject|1|||
127582325|NCT03758443|459101216|FG003|Maintenance Period|Withdrawal by Subject|1|||
127582326|NCT03758443|459101213|FG000|Maintenance Period|Miscellaneous|0|||
128030919|NCT00421408|460738757|FG000|Overall Study|Lost to Follow-up|30|||
128030920|NCT00421408|460738758|FG001|Overall Study|Lost to Follow-up|20|||
128030921|NCT00421408|460738757|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
128030922|NCT00421408|460738758|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
128030923|NCT04091438|460738759|FG000|Treatment Period 1 (1 Day)|Other|1|||
128030924|NCT04091438|460738760|FG001|Treatment Period 1 (1 Day)|Other|0|||
128030925|NCT04091438|460738759|FG000|Washout Period (1 Day)|Protocol deviation|0|||
128030926|NCT04091438|460738760|FG001|Washout Period (1 Day)|Protocol deviation|1|||
128030927|NCT04091438|460738759|FG000|Washout Period (1 Day)|Other|0|||
128030928|NCT04091438|460738760|FG001|Washout Period (1 Day)|Other|1|||
128030929|NCT04309500|460738766|FG000|Overall Study|Lost to Follow-up|1|||
128030930|NCT04309500|460738767|FG001|Overall Study|Lost to Follow-up|0|||
128030931|NCT04309500|460738768|FG002|Overall Study|Lost to Follow-up|0|||
128030932|NCT04309500|460738769|FG003|Overall Study|Lost to Follow-up|0|||
128030933|NCT02414841|460738770|FG000|Overall Study|Withdrawal by Subject|7|||
128030934|NCT02414841|460738771|FG001|Overall Study|Withdrawal by Subject|5|||
128030935|NCT02414841|460738770|FG000|Overall Study|Lost to Follow-up|13|||
128030936|NCT02414841|460738771|FG001|Overall Study|Lost to Follow-up|6|||
128030937|NCT02414841|460738770|FG000|Overall Study|Death|17|||
128030938|NCT02414841|460738771|FG001|Overall Study|Death|14|||
128030939|NCT02414841|460738770|FG000|Overall Study|Received a Kidney Transplant|13|||
128030940|NCT02414841|460738771|FG001|Overall Study|Received a Kidney Transplant|4|||
128030941|NCT02414841|460738770|FG000|Overall Study|Randomized But Not Treated|6|||
128030942|NCT02414841|460738771|FG001|Overall Study|Randomized But Not Treated|4|||
127881579|NCT00791154|460188797|FG005|Overall Study|Death|54|||
127881580|NCT00791154|460188798|FG006|Overall Study|Death|52|||
127881581|NCT00791154|460188792|FG000|Overall Study|Other event|0|||
127881582|NCT00791154|460188793|FG001|Overall Study|Other event|0|||
127881583|NCT00791154|460188794|FG002|Overall Study|Other event|2|||
127881584|NCT00791154|460188795|FG003|Overall Study|Other event|0|||
127881585|NCT00791154|460188796|FG004|Overall Study|Other event|2|||
127881586|NCT00791154|460188797|FG005|Overall Study|Other event|4|||
127881587|NCT00791154|460188798|FG006|Overall Study|Other event|2|||
127881588|NCT02284373|460188799|FG000|Overall Study|Withdrawal by Subject|0|||
127881589|NCT02284373|460188800|FG001|Overall Study|Withdrawal by Subject|1|||
127881590|NCT02284373|460188801|FG002|Overall Study|Withdrawal by Subject|0|||
127881591|NCT02284373|460188799|FG000|Overall Study|Other|0|||
127881592|NCT02284373|460188800|FG001|Overall Study|Other|1|||
127881593|NCT02284373|460188801|FG002|Overall Study|Other|0|||
127881594|NCT02284373|460188799|FG000|Overall Study|Lost to Follow-up|0|||
127881595|NCT02284373|460188800|FG001|Overall Study|Lost to Follow-up|1|||
127881596|NCT02284373|460188801|FG002|Overall Study|Lost to Follow-up|0|||
127881597|NCT02499406|460188802|FG000|Overall Study|missed 3 treatment sessions|4|||
127881598|NCT04651218|460188803|FG000|Overall Study|Withdrawal by Subject|0|||
127881599|NCT04651218|460188804|FG001|Overall Study|Withdrawal by Subject|2|||
127881600|NCT00414011|460188805|FG000|Overall Study|Physician Decision|3|||
127881601|NCT00414011|460188805|FG000|Overall Study|Withdrawal by Subject|2|||
127881602|NCT02476851|460188806|FG000|Overall Study|Protocol Violation|1|||
127881603|NCT02476851|460188807|FG001|Overall Study|Protocol Violation|1|||
127881604|NCT01399125|460188808|FG000|Overall Study|Adverse Event|32|||
127881605|NCT01399125|460188809|FG001|Overall Study|Adverse Event|30|||
127881606|NCT01399125|460188808|FG000|Overall Study|Abnormal Lab values|0|||
127881607|NCT01399125|460188809|FG001|Overall Study|Abnormal Lab values|1|||
127881608|NCT01399125|460188808|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
127881609|NCT01399125|460188809|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
127881610|NCT01399125|460188808|FG000|Overall Study|Withdrawal by Subject|5|||
127881611|NCT01399125|460188809|FG001|Overall Study|Withdrawal by Subject|8|||
127881612|NCT01399125|460188808|FG000|Overall Study|Lost to Follow-up|2|||
127881613|NCT01399125|460188809|FG001|Overall Study|Lost to Follow-up|3|||
127881614|NCT01399125|460188808|FG000|Overall Study|Administrative Problems|7|||
127881615|NCT01399125|460188809|FG001|Overall Study|Administrative Problems|11|||
127881616|NCT01399125|460188808|FG000|Overall Study|Death|0|||
127881617|NCT01399125|460188809|FG001|Overall Study|Death|1|||
127881618|NCT01399125|460188808|FG000|Overall Study|Protocol Deviation|5|||
127881619|NCT01399125|460188809|FG001|Overall Study|Protocol Deviation|2|||
127881620|NCT00647426|460188812|FG000|Overall Study|Withdrawal by Subject|2|||
127881621|NCT03578276|460188815|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
127881622|NCT03578276|460188816|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
127881623|NCT00981409|460188817|FG000|Overall Study|Adverse Event|4|||
127881624|NCT00981409|460188818|FG001|Overall Study|Adverse Event|0|||
127881625|NCT00981409|460188817|FG000|Overall Study|Protocol Violation|0|||
127881626|NCT00981409|460188818|FG001|Overall Study|Protocol Violation|1|||
127881627|NCT00981409|460188817|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
127881628|NCT00981409|460188818|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
127881629|NCT00078312|460188827|FG000|Overall Study|Adverse Event|43|||
127881630|NCT00078312|460188827|FG000|Overall Study|Lack of Efficacy|15|||
127881631|NCT00078312|460188827|FG000|Overall Study|Lost to Follow-up|41|||
127881632|NCT00078312|460188827|FG000|Overall Study|Physician Decision|9|||
127881633|NCT00078312|460188827|FG000|Overall Study|Protocol Violation|3|||
127881634|NCT00078312|460188827|FG000|Overall Study|Withdrawal by Subject|33|||
127881635|NCT00078312|460188827|FG000|Overall Study|Miscellaneous|33|||
127582327|NCT03758443|459101214|FG001|Maintenance Period|Miscellaneous|0|||
127582328|NCT03758443|459101215|FG002|Maintenance Period|Miscellaneous|1|||
127582329|NCT03758443|459101216|FG003|Maintenance Period|Miscellaneous|0|||
127582330|NCT01436396|459101217|FG000|Overall Study|Protocol Violation|7|||
127881636|NCT04840901|460188828|FG000|Overall Study|Lost to Follow-up|3|||
128030943|NCT03249558|460738772|FG000|Overall Study|Lost to Follow-up|2|||
127582331|NCT01436396|459101218|FG001|Overall Study|Protocol Violation|5|||
127582332|NCT01436396|459101217|FG000|Overall Study|Adverse Event|1|||
127582333|NCT01436396|459101218|FG001|Overall Study|Adverse Event|2|||
127582334|NCT01436396|459101217|FG000|Overall Study|Withdrawal by Subject|19|||
127881637|NCT04840901|460188829|FG001|Overall Study|Lost to Follow-up|1|||
127881638|NCT04840901|460188828|FG000|Overall Study|Moved|1|||
127881639|NCT04840901|460188829|FG001|Overall Study|Moved|0|||
127881640|NCT04840901|460188828|FG000|Overall Study|Unable to comply with study schedule|0|||
127881641|NCT04840901|460188829|FG001|Overall Study|Unable to comply with study schedule|1|||
127881642|NCT04840901|460188828|FG000|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|1|||
127881643|NCT04840901|460188829|FG001|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|0|||
127881644|NCT05354206|460188830|FG000|Overall Study|Withdrawal by Subject|1|||
127881645|NCT05354206|460188831|FG001|Overall Study|Withdrawal by Subject|0|||
127881646|NCT04285983|460188832|FG000|Overall Study|Protocol Violation|6|||
127881647|NCT04936334|460188833|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
127582335|NCT01436396|459101218|FG001|Overall Study|Withdrawal by Subject|29|||
127582336|NCT01436396|459101217|FG000|Overall Study|Serious adverse event|2|||
127582337|NCT01436396|459101218|FG001|Overall Study|Serious adverse event|3|||
127582338|NCT01436396|459101217|FG000|Overall Study|Lost to Follow-up|3|||
127582339|NCT01436396|459101218|FG001|Overall Study|Lost to Follow-up|3|||
127582340|NCT02191137|459101221|FG000|Treatment|Death|4|||
127582341|NCT02191137|459101221|FG000|Treatment|Withdrawal by Subject|3|||
127582342|NCT02191137|459101221|FG000|Treatment|Adverse Event|2|||
127582343|NCT02191137|459101221|FG000|Treatment|Other|1|||
127582344|NCT02191137|459101221|FG000|Follow-up|Lost to Follow-up|2|||
127582345|NCT02191137|459101221|FG000|Follow-up|Ongoing/unknown|2|||
127582346|NCT02191137|459101221|FG000|Follow-up|Adverse Event|1|||
127582347|NCT00071396|459101226|FG000|Overall Study|Withdrawal by Subject|1|||
127582348|NCT00071396|459101226|FG000|Overall Study|Physician Decision|2|||
127582349|NCT01297920|459101229|FG000|Overall Study|Adverse Event|42|||
127582350|NCT01297920|459101230|FG001|Overall Study|Adverse Event|10|||
127582351|NCT01297920|459101231|FG002|Overall Study|Adverse Event|38|||
127582352|NCT01297920|459101229|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
127582353|NCT01297920|459101230|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
127582354|NCT01297920|459101231|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
127582355|NCT01297920|459101229|FG000|Overall Study|Noncompliance|1|||
127582356|NCT01297920|459101230|FG001|Overall Study|Noncompliance|0|||
127582357|NCT01297920|459101231|FG002|Overall Study|Noncompliance|0|||
127582358|NCT01297920|459101229|FG000|Overall Study|Protocol Violation|1|||
127582359|NCT01297920|459101230|FG001|Overall Study|Protocol Violation|3|||
127582360|NCT01297920|459101231|FG002|Overall Study|Protocol Violation|0|||
127582361|NCT01297920|459101229|FG000|Overall Study|Inadequate Control of IOP|7|||
127582362|NCT01297920|459101230|FG001|Overall Study|Inadequate Control of IOP|9|||
127582363|NCT01297920|459101231|FG002|Overall Study|Inadequate Control of IOP|17|||
127582364|NCT01297920|459101229|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
127582365|NCT01297920|459101230|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
127582366|NCT01297920|459101231|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
127582367|NCT00474760|459101232|FG000|Overall Study|Death|0|||
127582368|NCT00474760|459101233|FG001|Overall Study|Death|0|||
127582369|NCT00474760|459101234|FG002|Overall Study|Death|0|||
127582370|NCT00474760|459101235|FG003|Overall Study|Death|0|||
127582371|NCT00474760|459101236|FG004|Overall Study|Death|2|||
127582372|NCT00474760|459101237|FG005|Overall Study|Death|0|||
127582373|NCT00474760|459101238|FG006|Overall Study|Death|0|||
127582374|NCT00474760|459101232|FG000|Overall Study|Adverse Event|0|||
127582375|NCT00474760|459101233|FG001|Overall Study|Adverse Event|0|||
127582376|NCT00474760|459101234|FG002|Overall Study|Adverse Event|0|||
127582377|NCT00474760|459101235|FG003|Overall Study|Adverse Event|0|||
127582378|NCT00474760|459101236|FG004|Overall Study|Adverse Event|1|||
127582379|NCT00474760|459101237|FG005|Overall Study|Adverse Event|7|||
127582380|NCT00474760|459101238|FG006|Overall Study|Adverse Event|0|||
127582381|NCT00474760|459101232|FG000|Overall Study|Laboratory abnormality|0|||
127582382|NCT00474760|459101233|FG001|Overall Study|Laboratory abnormality|0|||
127582383|NCT00474760|459101234|FG002|Overall Study|Laboratory abnormality|0|||
127582384|NCT00474760|459101235|FG003|Overall Study|Laboratory abnormality|0|||
127582385|NCT00474760|459101236|FG004|Overall Study|Laboratory abnormality|0|||
127582386|NCT00474760|459101237|FG005|Overall Study|Laboratory abnormality|1|||
127582387|NCT00474760|459101238|FG006|Overall Study|Laboratory abnormality|0|||
127582388|NCT00474760|459101232|FG000|Overall Study|Withdrawal by Subject|0|||
127582389|NCT00474760|459101233|FG001|Overall Study|Withdrawal by Subject|0|||
127582390|NCT00474760|459101234|FG002|Overall Study|Withdrawal by Subject|0|||
127582391|NCT00474760|459101235|FG003|Overall Study|Withdrawal by Subject|1|||
127582392|NCT00474760|459101236|FG004|Overall Study|Withdrawal by Subject|0|||
127582393|NCT00474760|459101237|FG005|Overall Study|Withdrawal by Subject|1|||
127582394|NCT00474760|459101238|FG006|Overall Study|Withdrawal by Subject|1|||
127582395|NCT00474760|459101232|FG000|Overall Study|Other|0|||
127582396|NCT00474760|459101233|FG001|Overall Study|Other|1|||
127582397|NCT00474760|459101234|FG002|Overall Study|Other|0|||
127582398|NCT00474760|459101235|FG003|Overall Study|Other|0|||
127582399|NCT00474760|459101236|FG004|Overall Study|Other|1|||
127582400|NCT00474760|459101237|FG005|Overall Study|Other|0|||
127582401|NCT00474760|459101238|FG006|Overall Study|Other|0|||
127582402|NCT00474760|459101232|FG000|Overall Study|Progressive disease|3|||
127582403|NCT00474760|459101233|FG001|Overall Study|Progressive disease|2|||
127582404|NCT00474760|459101234|FG002|Overall Study|Progressive disease|3|||
127582405|NCT00474760|459101235|FG003|Overall Study|Progressive disease|2|||
127582406|NCT00474760|459101236|FG004|Overall Study|Progressive disease|8|||
127582407|NCT00474760|459101237|FG005|Overall Study|Progressive disease|20|||
127582408|NCT00474760|459101238|FG006|Overall Study|Progressive disease|7|||
127582409|NCT00474760|459101232|FG000|Overall Study|Terminated by sponsor|0|||
127582410|NCT00474760|459101233|FG001|Overall Study|Terminated by sponsor|0|||
127582411|NCT00474760|459101234|FG002|Overall Study|Terminated by sponsor|0|||
127582412|NCT00474760|459101235|FG003|Overall Study|Terminated by sponsor|0|||
127582413|NCT00474760|459101236|FG004|Overall Study|Terminated by sponsor|0|||
127582414|NCT00474760|459101237|FG005|Overall Study|Terminated by sponsor|0|||
127582415|NCT00474760|459101238|FG006|Overall Study|Terminated by sponsor|2|||
127582416|NCT03386474|459101248|FG000|Overall Study|Death|1|||
127582417|NCT03386474|459101249|FG001|Overall Study|Death|0|||
127582418|NCT03386474|459101248|FG000|Overall Study|Adverse Event|0|||
127582419|NCT03386474|459101249|FG001|Overall Study|Adverse Event|1|||
127582420|NCT02155881|459101250|FG000|Overall Study|Withdrawal by Subject|0|||
127582421|NCT02155881|459101251|FG001|Overall Study|Withdrawal by Subject|2|||
127582422|NCT02155881|459101250|FG000|Overall Study|Inappropriately randomized|2|||
127582423|NCT02155881|459101251|FG001|Overall Study|Inappropriately randomized|2|||
127582424|NCT04357782|459101252|FG000|Overall Study|Discharged from hospital|1|||
127582425|NCT04357782|459101253|FG001|Overall Study|Discharged from hospital|0|||
127582426|NCT04357782|459101252|FG000|Overall Study|Death|0|||
127582427|NCT04357782|459101253|FG001|Overall Study|Death|2|||
127582428|NCT01786148|459101254|FG000|Overall Study|Lost to Follow-up|21|||
127582429|NCT01786148|459101255|FG001|Overall Study|Lost to Follow-up|13|||
127582430|NCT01786148|459101254|FG000|Overall Study|Death|0|||
127582431|NCT01786148|459101255|FG001|Overall Study|Death|1|||
127582432|NCT01786148|459101254|FG000|Overall Study|Withdrawal by Subject|0|||
127582433|NCT01786148|459101255|FG001|Overall Study|Withdrawal by Subject|7|||
127582434|NCT01786148|459101254|FG000|Overall Study|Incarceration|1|||
127582435|NCT01786148|459101255|FG001|Overall Study|Incarceration|1|||
127582436|NCT00066729|459101264|FG000|Overall Study|Lost to Follow-up|1|||
127582437|NCT00066729|459101264|FG000|Overall Study|Disease progression|1|||
127582438|NCT01811225|459101265|FG000|Treatment Period 1|Adverse Event|2|||
127582439|NCT01811225|459101266|FG001|Treatment Period 1|Adverse Event|3|||
127582440|NCT01811225|459101265|FG000|Treatment Period 1|Lost to Follow-up|12|||
127582441|NCT01811225|459101266|FG001|Treatment Period 1|Lost to Follow-up|8|||
127582442|NCT01811225|459101265|FG000|Treatment Period 1|transporation|1|||
127582443|NCT01811225|459101266|FG001|Treatment Period 1|transporation|0|||
127582444|NCT01811225|459101265|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
127582445|NCT01811225|459101266|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
127582446|NCT01811225|459101265|FG000|Treatment Period 2|Lost to Follow-up|1|||
127582447|NCT01811225|459101266|FG001|Treatment Period 2|Lost to Follow-up|2|||
127582448|NCT01811225|459101265|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
127582449|NCT01811225|459101266|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
127582450|NCT02158975|459101267|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
127582451|NCT03000569|459101268|FG000|Overall Study|Withdrawal by Subject|1|||
127582452|NCT03000569|459101269|FG001|Overall Study|Withdrawal by Subject|0|||
127582453|NCT04122534|459101270|FG000|Overall Study|Lost to Follow-up|4|||
127582454|NCT01254630|459101274|FG000|Overall Study|Adverse Event|36|||
127582455|NCT01254630|459101275|FG001|Overall Study|Adverse Event|15|||
127582456|NCT01254630|459101276|FG002|Overall Study|Adverse Event|40|||
127582457|NCT01254630|459101277|FG003|Overall Study|Adverse Event|8|||
127582458|NCT01254630|459101274|FG000|Overall Study|Death|461|||
127582459|NCT01254630|459101275|FG001|Overall Study|Death|151|||
127582460|NCT01254630|459101276|FG002|Overall Study|Death|478|||
127582461|NCT01254630|459101277|FG003|Overall Study|Death|139|||
127582462|NCT01254630|459101274|FG000|Overall Study|Lost to Follow-up|80|||
127582463|NCT01254630|459101275|FG001|Overall Study|Lost to Follow-up|26|||
127582464|NCT01254630|459101276|FG002|Overall Study|Lost to Follow-up|89|||
127582465|NCT01254630|459101277|FG003|Overall Study|Lost to Follow-up|32|||
127582466|NCT01254630|459101274|FG000|Overall Study|Physician Decision|24|||
127582467|NCT01254630|459101275|FG001|Overall Study|Physician Decision|8|||
127582468|NCT01254630|459101276|FG002|Overall Study|Physician Decision|16|||
127582469|NCT01254630|459101277|FG003|Overall Study|Physician Decision|7|||
127582470|NCT01254630|459101274|FG000|Overall Study|Withdrawal by Subject|201|||
127582471|NCT01254630|459101275|FG001|Overall Study|Withdrawal by Subject|94|||
127582472|NCT01254630|459101276|FG002|Overall Study|Withdrawal by Subject|188|||
127582473|NCT01254630|459101277|FG003|Overall Study|Withdrawal by Subject|89|||
127582474|NCT01254630|459101274|FG000|Overall Study|Study terminated by sponsor|0|||
127582475|NCT01254630|459101275|FG001|Overall Study|Study terminated by sponsor|994|||
127582476|NCT01254630|459101276|FG002|Overall Study|Study terminated by sponsor|0|||
127582477|NCT01254630|459101277|FG003|Overall Study|Study terminated by sponsor|1010|||
127582478|NCT01254630|459101274|FG000|Overall Study|Status not recorded|0|||
127582479|NCT01254630|459101275|FG001|Overall Study|Status not recorded|0|||
127582480|NCT01254630|459101276|FG002|Overall Study|Status not recorded|1|||
127582481|NCT01254630|459101277|FG003|Overall Study|Status not recorded|0|||
127582482|NCT02020577|459101278|FG000|Overall Study|Progressive disease|3|||
127582483|NCT02020577|459101279|FG001|Overall Study|Progressive disease|38|||
127582484|NCT02020577|459101278|FG000|Overall Study|Other AE or clinical progression|0|||
127582485|NCT02020577|459101279|FG001|Overall Study|Other AE or clinical progression|15|||
127582486|NCT02020577|459101278|FG000|Overall Study|Withdrawal by Subject|0|||
127881648|NCT00422058|460188834|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
127881649|NCT00422058|460188835|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
127881650|NCT00422058|460188836|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
127881651|NCT00422058|460188837|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
127582487|NCT02020577|459101279|FG001|Overall Study|Withdrawal by Subject|1|||
127881652|NCT00422058|460188838|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
127582488|NCT02020577|459101278|FG000|Overall Study|Other than stated above|0|||
127582489|NCT02020577|459101279|FG001|Overall Study|Other than stated above|1|||
127582490|NCT03113916|459101280|FG000|Overall Study|Withdrawal by Subject|9|||
127582491|NCT03113916|459101281|FG001|Overall Study|Withdrawal by Subject|7|||
127582492|NCT03113916|459101280|FG000|Overall Study|Pregnancy|1|||
127582493|NCT03113916|459101281|FG001|Overall Study|Pregnancy|3|||
127582494|NCT03113916|459101280|FG000|Overall Study|Lost to Follow-up|1|||
127582495|NCT03113916|459101281|FG001|Overall Study|Lost to Follow-up|2|||
127582496|NCT00241358|459101282|FG000|Overall Study|Determined to be not ineligible|0|||
127582497|NCT00241358|459101283|FG001|Overall Study|Determined to be not ineligible|1|||
127881653|NCT00422058|460188839|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
127881654|NCT00422058|460188834|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
127881655|NCT00422058|460188835|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
127881656|NCT00422058|460188836|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
127881657|NCT00422058|460188837|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
127881658|NCT00422058|460188838|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
127881659|NCT00422058|460188839|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
127881660|NCT00422058|460188834|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
127881661|NCT00422058|460188835|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
127881662|NCT00422058|460188836|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
127881663|NCT00422058|460188837|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
127881664|NCT00422058|460188838|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
127881665|NCT00422058|460188839|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
127881666|NCT00422058|460188834|FG000|Double-Blind, Week 0-20|Other|11|||
127881667|NCT00422058|460188835|FG001|Double-Blind, Week 0-20|Other|3|||
127881668|NCT00422058|460188836|FG002|Double-Blind, Week 0-20|Other|8|||
127881669|NCT00422058|460188837|FG003|Double-Blind, Week 0-20|Other|8|||
127881670|NCT00422058|460188838|FG004|Double-Blind, Week 0-20|Other|4|||
127881671|NCT00422058|460188839|FG005|Double-Blind, Week 0-20|Other|10|||
127881672|NCT00422058|460188834|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
127881673|NCT00422058|460188835|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
127881674|NCT00422058|460188836|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
127881675|NCT00422058|460188837|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
128030944|NCT03249558|460738773|FG001|Overall Study|Lost to Follow-up|1|||
127582498|NCT00241358|459101284|FG002|Overall Study|Determined to be not ineligible|1|||
127582499|NCT02663908|459101285|FG000|Overall Study|Withdrawal by Subject|8|||
127582500|NCT02663908|459101286|FG001|Overall Study|Withdrawal by Subject|5|||
127582501|NCT02663908|459101285|FG000|Overall Study|Lost to Follow-up|1|||
127582502|NCT02663908|459101286|FG001|Overall Study|Lost to Follow-up|5|||
127582503|NCT02663908|459101285|FG000|Overall Study|Adverse Event|13|||
127582504|NCT02663908|459101286|FG001|Overall Study|Adverse Event|11|||
127582505|NCT02663908|459101285|FG000|Overall Study|Protocol Violation|1|||
127582506|NCT02663908|459101286|FG001|Overall Study|Protocol Violation|2|||
127881676|NCT00422058|460188838|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
127881677|NCT00422058|460188839|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
128030945|NCT03249558|460738774|FG002|Overall Study|Lost to Follow-up|4|||
128030946|NCT03249558|460738772|FG000|Overall Study|Physician Decision|1|||
128030947|NCT03249558|460738773|FG001|Overall Study|Physician Decision|0|||
128030948|NCT03249558|460738774|FG002|Overall Study|Physician Decision|0|||
128030949|NCT03249558|460738772|FG000|Overall Study|Withdrawal by Subject|6|||
127582507|NCT02663908|459101285|FG000|Overall Study|Lack of therapeutic response|2|||
127582508|NCT02663908|459101286|FG001|Overall Study|Lack of therapeutic response|0|||
127881678|NCT00422058|460188834|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
127881679|NCT00422058|460188835|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
127881680|NCT00422058|460188836|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
127881681|NCT00422058|460188837|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
127881682|NCT00422058|460188838|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
128030950|NCT03249558|460738773|FG001|Overall Study|Withdrawal by Subject|5|||
127582509|NCT02663908|459101285|FG000|Overall Study|COVID-19|1|||
127582510|NCT02663908|459101286|FG001|Overall Study|COVID-19|0|||
127582511|NCT02663908|459101285|FG000|Overall Study|Site closed|1|||
127582512|NCT02663908|459101286|FG001|Overall Study|Site closed|0|||
127881683|NCT00422058|460188839|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
127881684|NCT00422058|460188834|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
128030951|NCT03249558|460738774|FG002|Overall Study|Withdrawal by Subject|7|||
128030952|NCT03249558|460738772|FG000|Overall Study|COVID-19 pandemic shutdown|1|||
127582513|NCT02663908|459101285|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
127881685|NCT00422058|460188835|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
127582514|NCT02663908|459101286|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
127582515|NCT02663908|459101285|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
127582516|NCT02663908|459101286|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
127582517|NCT02663908|459101285|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
127582518|NCT02663908|459101286|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
127582519|NCT02663908|459101285|FG000|Overall Study|Death|1|||
127582520|NCT02663908|459101286|FG001|Overall Study|Death|0|||
127582521|NCT02663908|459101285|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
127582522|NCT02663908|459101286|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
127582523|NCT02663908|459101285|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
127582524|NCT02663908|459101286|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
127582525|NCT03308786|459101287|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
127582526|NCT00761631|459101288|FG000|Overall Study|Parent/legal guardian request|8|||
127582527|NCT00761631|459101289|FG001|Overall Study|Parent/legal guardian request|3|||
127582528|NCT00761631|459101290|FG002|Overall Study|Parent/legal guardian request|8|||
127582529|NCT00761631|459101291|FG003|Overall Study|Parent/legal guardian request|0|||
127582530|NCT00761631|459101292|FG004|Overall Study|Parent/legal guardian request|5|||
127582531|NCT00761631|459101293|FG005|Overall Study|Parent/legal guardian request|0|||
127582532|NCT00761631|459101288|FG000|Overall Study|Lost to Follow-up|2|||
127582533|NCT00761631|459101289|FG001|Overall Study|Lost to Follow-up|4|||
127582534|NCT00761631|459101290|FG002|Overall Study|Lost to Follow-up|7|||
127582535|NCT00761631|459101291|FG003|Overall Study|Lost to Follow-up|1|||
127582536|NCT00761631|459101292|FG004|Overall Study|Lost to Follow-up|6|||
127582537|NCT00761631|459101293|FG005|Overall Study|Lost to Follow-up|1|||
127582538|NCT00761631|459101288|FG000|Overall Study|Protocol Violation|2|||
127582539|NCT00761631|459101289|FG001|Overall Study|Protocol Violation|0|||
127582540|NCT00761631|459101290|FG002|Overall Study|Protocol Violation|0|||
127582541|NCT00761631|459101291|FG003|Overall Study|Protocol Violation|1|||
127582542|NCT00761631|459101292|FG004|Overall Study|Protocol Violation|5|||
127582543|NCT00761631|459101293|FG005|Overall Study|Protocol Violation|1|||
127582544|NCT00761631|459101288|FG000|Overall Study|Randomized, not treated|1|||
127582545|NCT00761631|459101289|FG001|Overall Study|Randomized, not treated|0|||
127582546|NCT00761631|459101290|FG002|Overall Study|Randomized, not treated|0|||
127582547|NCT00761631|459101291|FG003|Overall Study|Randomized, not treated|0|||
127582548|NCT00761631|459101292|FG004|Overall Study|Randomized, not treated|0|||
127582549|NCT00761631|459101293|FG005|Overall Study|Randomized, not treated|0|||
127582550|NCT00761631|459101288|FG000|Overall Study|Failed to return|1|||
127582551|NCT00761631|459101289|FG001|Overall Study|Failed to return|0|||
127582552|NCT00761631|459101290|FG002|Overall Study|Failed to return|1|||
127582553|NCT00761631|459101291|FG003|Overall Study|Failed to return|1|||
127582554|NCT00761631|459101292|FG004|Overall Study|Failed to return|5|||
127582555|NCT00761631|459101293|FG005|Overall Study|Failed to return|2|||
127582556|NCT00761631|459101288|FG000|Overall Study|Physician Decision|1|||
127582557|NCT00761631|459101289|FG001|Overall Study|Physician Decision|0|||
127582558|NCT00761631|459101290|FG002|Overall Study|Physician Decision|0|||
127582559|NCT00761631|459101291|FG003|Overall Study|Physician Decision|0|||
127582560|NCT00761631|459101292|FG004|Overall Study|Physician Decision|0|||
127582561|NCT00761631|459101293|FG005|Overall Study|Physician Decision|0|||
127582562|NCT00761631|459101288|FG000|Overall Study|Other|0|||
127582563|NCT00761631|459101289|FG001|Overall Study|Other|0|||
127582564|NCT00761631|459101290|FG002|Overall Study|Other|0|||
127582565|NCT00761631|459101291|FG003|Overall Study|Other|0|||
127582566|NCT00761631|459101292|FG004|Overall Study|Other|1|||
127582567|NCT00761631|459101293|FG005|Overall Study|Other|1|||
127582568|NCT01402011|459101294|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
127582569|NCT01402011|459101295|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
127582570|NCT01402011|459101296|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
127582571|NCT01402011|459101294|FG000|Active Treatment Period|Withdrawal by Subject|1|||
127582572|NCT01402011|459101295|FG001|Active Treatment Period|Withdrawal by Subject|3|||
127582573|NCT01402011|459101296|FG002|Active Treatment Period|Withdrawal by Subject|0|||
127582574|NCT01402011|459101294|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
127582575|NCT01402011|459101295|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
127582576|NCT01402011|459101296|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
127582577|NCT01868503|459102697|FG000|Overall Study|Withdrawal by Subject|1|||
127582578|NCT01868503|459102697|FG000|Overall Study|Protocol Violation|1|||
127582579|NCT03080454|459102698|FG000|Baseline|Adverse Event|2|||
127582580|NCT03080454|459102698|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
127582581|NCT03080454|459102698|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
127582582|NCT00216476|459102699|FG000|Overall Study|Withdrawal by Subject|59|||
127582583|NCT00216476|459102700|FG001|Overall Study|Withdrawal by Subject|72|||
127582584|NCT00216476|459102701|FG002|Overall Study|Withdrawal by Subject|9|||
127582585|NCT00216476|459102699|FG000|Overall Study|Lost to Follow-up|10|||
127582586|NCT00216476|459102700|FG001|Overall Study|Lost to Follow-up|9|||
127582587|NCT00216476|459102701|FG002|Overall Study|Lost to Follow-up|1|||
127582588|NCT00216476|459102699|FG000|Overall Study|Adverse Event|6|||
127582589|NCT00216476|459102700|FG001|Overall Study|Adverse Event|10|||
127582590|NCT00216476|459102701|FG002|Overall Study|Adverse Event|1|||
127582591|NCT00216476|459102699|FG000|Overall Study|Lack of Efficacy|4|||
127582592|NCT00216476|459102700|FG001|Overall Study|Lack of Efficacy|3|||
127582593|NCT00216476|459102701|FG002|Overall Study|Lack of Efficacy|0|||
127582594|NCT00216476|459102699|FG000|Overall Study|Death|2|||
127582595|NCT00216476|459102700|FG001|Overall Study|Death|0|||
127582596|NCT00216476|459102701|FG002|Overall Study|Death|0|||
127582597|NCT00216476|459102699|FG000|Overall Study|Pregnancy|0|||
127582598|NCT00216476|459102700|FG001|Overall Study|Pregnancy|1|||
127582599|NCT00216476|459102701|FG002|Overall Study|Pregnancy|1|||
127582600|NCT00216476|459102699|FG000|Overall Study|Other|0|||
127582601|NCT00216476|459102700|FG001|Overall Study|Other|0|||
127582602|NCT00216476|459102701|FG002|Overall Study|Other|1|||
127582603|NCT00216476|459102699|FG000|Overall Study|Refuses Injection|11|||
127582604|NCT00216476|459102700|FG001|Overall Study|Refuses Injection|0|||
127582605|NCT00216476|459102701|FG002|Overall Study|Refuses Injection|0|||
127582606|NCT00216476|459102699|FG000|Overall Study|No Further Need for Treatment|3|||
127582607|NCT00216476|459102700|FG001|Overall Study|No Further Need for Treatment|4|||
127582608|NCT00216476|459102701|FG002|Overall Study|No Further Need for Treatment|1|||
127582609|NCT00216476|459102699|FG000|Overall Study|Non-compliance|0|||
127582610|NCT00216476|459102700|FG001|Overall Study|Non-compliance|4|||
127582611|NCT00216476|459102701|FG002|Overall Study|Non-compliance|1|||
127582612|NCT00216476|459102699|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
127582613|NCT00216476|459102700|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
127783371|NCT01236573|459832965|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
127582614|NCT00216476|459102701|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
127582615|NCT00216476|459102699|FG000|Overall Study|Administrative Reasons|1|||
127582616|NCT00216476|459102700|FG001|Overall Study|Administrative Reasons|1|||
127582617|NCT00216476|459102701|FG002|Overall Study|Administrative Reasons|0|||
127582618|NCT00216476|459102699|FG000|Overall Study|Protocol Deviation|5|||
127582619|NCT00216476|459102700|FG001|Overall Study|Protocol Deviation|1|||
127582620|NCT00216476|459102701|FG002|Overall Study|Protocol Deviation|0|||
127582621|NCT00216476|459102699|FG000|Overall Study|Patient Moved|2|||
127582622|NCT00216476|459102700|FG001|Overall Study|Patient Moved|2|||
127582623|NCT00216476|459102701|FG002|Overall Study|Patient Moved|0|||
127582624|NCT00696800|459102702|FG000|Overall Study|Adverse Event|16|||
127582625|NCT00696800|459102703|FG001|Overall Study|Adverse Event|3|||
127582626|NCT00696800|459102702|FG000|Overall Study|Insufficient compliance with medication|2|||
127582627|NCT00696800|459102703|FG001|Overall Study|Insufficient compliance with medication|1|||
127582628|NCT00696800|459102702|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
127582629|NCT00696800|459102703|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
127582630|NCT00696800|459102702|FG000|Overall Study|Insufficient ovarian response|4|||
127582631|NCT00696800|459102703|FG001|Overall Study|Insufficient ovarian response|1|||
127582632|NCT00696800|459102702|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
127582633|NCT00696800|459102703|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
127582634|NCT00696800|459102702|FG000|Overall Study|Too high ovarian response|6|||
127582635|NCT00696800|459102703|FG001|Overall Study|Too high ovarian response|1|||
127582636|NCT00696800|459102702|FG000|Overall Study|No/too few/bad quality oocytes|4|||
127582637|NCT00696800|459102703|FG001|Overall Study|No/too few/bad quality oocytes|3|||
127582638|NCT00696800|459102702|FG000|Overall Study|No/abnormal fertilization|11|||
127582639|NCT00696800|459102703|FG001|Overall Study|No/abnormal fertilization|13|||
127582640|NCT00696800|459102702|FG000|Overall Study|No/too few/bad quality embryos|24|||
127783372|NCT01236573|459832966|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
127783373|NCT01236573|459832967|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
127582641|NCT00696800|459102703|FG001|Overall Study|No/too few/bad quality embryos|18|||
127582642|NCT00696800|459102702|FG000|Overall Study|Other Reasons|5|||
127582643|NCT00696800|459102703|FG001|Overall Study|Other Reasons|3|||
127582644|NCT00696800|459102702|FG000|Overall Study|Not treated|1|||
127582645|NCT00696800|459102703|FG001|Overall Study|Not treated|2|||
127582646|NCT00287365|459102704|FG000|Overall Study|sample not acquired|13|||
127783374|NCT01236573|459832957|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
127582647|NCT02298023|459102707|FG000|Overall Study|Withdrawal by Subject|1|||
127783375|NCT01236573|459832958|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
127783376|NCT01236573|459832959|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
127783377|NCT01236573|459832960|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
127582648|NCT02298023|459102708|FG001|Overall Study|Withdrawal by Subject|0|||
127582649|NCT02298023|459102709|FG002|Overall Study|Withdrawal by Subject|0|||
127582650|NCT02840721|459102710|FG000|Treatment Period|Adverse Event|1|||
127582651|NCT02840721|459102710|FG000|Follow-Up|Lack of Efficacy|1|||
127582652|NCT02840721|459102710|FG000|Follow-Up|Withdrawal by Subject|4|||
127582653|NCT02840721|459102710|FG000|Follow-Up|Withdrawal of Consent|2|||
127582654|NCT01967173|459102711|FG000|Overall Study|Lost to Follow-up|5|||
127783378|NCT01236573|459832961|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
127582655|NCT01967173|459102712|FG001|Overall Study|Lost to Follow-up|3|||
127582656|NCT01967173|459102713|FG002|Overall Study|Lost to Follow-up|2|||
127582657|NCT01967173|459102714|FG003|Overall Study|Lost to Follow-up|4|||
127582658|NCT01967173|459102715|FG004|Overall Study|Lost to Follow-up|8|||
127582659|NCT01967173|459102716|FG005|Overall Study|Lost to Follow-up|12|||
127582660|NCT01967173|459102717|FG006|Overall Study|Lost to Follow-up|6|||
127582661|NCT01967173|459102718|FG007|Overall Study|Lost to Follow-up|8|||
127582662|NCT01967173|459102711|FG000|Overall Study|Physician Decision|2|||
127582663|NCT01967173|459102712|FG001|Overall Study|Physician Decision|0|||
127582664|NCT01967173|459102713|FG002|Overall Study|Physician Decision|2|||
127582665|NCT01967173|459102714|FG003|Overall Study|Physician Decision|1|||
127582666|NCT01967173|459102715|FG004|Overall Study|Physician Decision|1|||
127582667|NCT01967173|459102716|FG005|Overall Study|Physician Decision|1|||
127582668|NCT01967173|459102717|FG006|Overall Study|Physician Decision|1|||
127582669|NCT01967173|459102718|FG007|Overall Study|Physician Decision|0|||
127582670|NCT01967173|459102711|FG000|Overall Study|Lack of Efficacy|2|||
127582671|NCT01967173|459102712|FG001|Overall Study|Lack of Efficacy|0|||
127582672|NCT01967173|459102713|FG002|Overall Study|Lack of Efficacy|2|||
127582673|NCT01967173|459102714|FG003|Overall Study|Lack of Efficacy|2|||
127582674|NCT01967173|459102715|FG004|Overall Study|Lack of Efficacy|0|||
127582675|NCT01967173|459102716|FG005|Overall Study|Lack of Efficacy|1|||
127582676|NCT01967173|459102717|FG006|Overall Study|Lack of Efficacy|0|||
127582677|NCT01967173|459102718|FG007|Overall Study|Lack of Efficacy|2|||
127582678|NCT01967173|459102711|FG000|Overall Study|Pregnancy|0|||
127582679|NCT01967173|459102712|FG001|Overall Study|Pregnancy|0|||
127582680|NCT01967173|459102713|FG002|Overall Study|Pregnancy|0|||
127582681|NCT01967173|459102714|FG003|Overall Study|Pregnancy|0|||
127582682|NCT01967173|459102715|FG004|Overall Study|Pregnancy|0|||
127582683|NCT01967173|459102716|FG005|Overall Study|Pregnancy|0|||
127582684|NCT01967173|459102717|FG006|Overall Study|Pregnancy|1|||
127582685|NCT01967173|459102718|FG007|Overall Study|Pregnancy|1|||
127582686|NCT01967173|459102711|FG000|Overall Study|Adverse Event|0|||
127582687|NCT01967173|459102712|FG001|Overall Study|Adverse Event|0|||
127582688|NCT01967173|459102713|FG002|Overall Study|Adverse Event|0|||
127582689|NCT01967173|459102714|FG003|Overall Study|Adverse Event|0|||
127582690|NCT01967173|459102715|FG004|Overall Study|Adverse Event|0|||
127582691|NCT01967173|459102716|FG005|Overall Study|Adverse Event|0|||
127582692|NCT01967173|459102717|FG006|Overall Study|Adverse Event|0|||
127582693|NCT01967173|459102718|FG007|Overall Study|Adverse Event|1|||
127582694|NCT01967173|459102711|FG000|Overall Study|Withdrawal by Subject|15|||
127582695|NCT01967173|459102712|FG001|Overall Study|Withdrawal by Subject|14|||
127582696|NCT01967173|459102713|FG002|Overall Study|Withdrawal by Subject|10|||
127582697|NCT01967173|459102714|FG003|Overall Study|Withdrawal by Subject|7|||
127582698|NCT01967173|459102715|FG004|Overall Study|Withdrawal by Subject|8|||
127582699|NCT01967173|459102716|FG005|Overall Study|Withdrawal by Subject|9|||
127582700|NCT01967173|459102717|FG006|Overall Study|Withdrawal by Subject|10|||
127582701|NCT01967173|459102718|FG007|Overall Study|Withdrawal by Subject|12|||
127582702|NCT03307785|459102722|FG000|Part A: Up to 28.5 Months|Disease progression|2|||
127582703|NCT03307785|459102723|FG001|Part A: Up to 28.5 Months|Disease progression|0|||
127582704|NCT03307785|459102724|FG002|Part A: Up to 28.5 Months|Disease progression|0|||
127582705|NCT03307785|459102725|FG003|Part A: Up to 28.5 Months|Disease progression|0|||
127582706|NCT03307785|459102726|FG004|Part A: Up to 28.5 Months|Disease progression|0|||
127582707|NCT03307785|459102727|FG005|Part A: Up to 28.5 Months|Disease progression|0|||
127582708|NCT03307785|459102728|FG006|Part A: Up to 28.5 Months|Disease progression|0|||
127582709|NCT03307785|459102729|FG007|Part A: Up to 28.5 Months|Disease progression|0|||
127582710|NCT03307785|459102730|FG008|Part A: Up to 28.5 Months|Disease progression|0|||
127582711|NCT03307785|459102731|FG009|Part A: Up to 28.5 Months|Disease progression|0|||
127582712|NCT03307785|459102732|FG010|Part A: Up to 28.5 Months|Disease progression|0|||
127582713|NCT03307785|459102722|FG000|Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
127582714|NCT03307785|459102723|FG001|Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
127582715|NCT03307785|459102724|FG002|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
127582716|NCT03307785|459102725|FG003|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
127582717|NCT03307785|459102726|FG004|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
127582718|NCT03307785|459102727|FG005|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
127582719|NCT03307785|459102728|FG006|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
127582720|NCT03307785|459102729|FG007|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
127582721|NCT03307785|459102730|FG008|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
127582722|NCT03307785|459102731|FG009|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
127582723|NCT03307785|459102732|FG010|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
127582724|NCT03307785|459102722|FG000|Part A: Up to 28.5 Months|Death|4|||
127582725|NCT03307785|459102723|FG001|Part A: Up to 28.5 Months|Death|4|||
127582726|NCT03307785|459102724|FG002|Part A: Up to 28.5 Months|Death|0|||
127582727|NCT03307785|459102725|FG003|Part A: Up to 28.5 Months|Death|0|||
127582728|NCT03307785|459102726|FG004|Part A: Up to 28.5 Months|Death|0|||
127582729|NCT03307785|459102727|FG005|Part A: Up to 28.5 Months|Death|0|||
127582730|NCT03307785|459102728|FG006|Part A: Up to 28.5 Months|Death|0|||
127582731|NCT03307785|459102729|FG007|Part A: Up to 28.5 Months|Death|0|||
127582732|NCT03307785|459102730|FG008|Part A: Up to 28.5 Months|Death|0|||
127582733|NCT03307785|459102731|FG009|Part A: Up to 28.5 Months|Death|0|||
127582734|NCT03307785|459102732|FG010|Part A: Up to 28.5 Months|Death|0|||
127582735|NCT03307785|459102722|FG000|Part A: Up to 28.5 Months|Physician Decision|3|||
127582736|NCT03307785|459102723|FG001|Part A: Up to 28.5 Months|Physician Decision|1|||
127582737|NCT03307785|459102724|FG002|Part A: Up to 28.5 Months|Physician Decision|0|||
127582738|NCT03307785|459102725|FG003|Part A: Up to 28.5 Months|Physician Decision|0|||
127582739|NCT03307785|459102726|FG004|Part A: Up to 28.5 Months|Physician Decision|0|||
127582740|NCT03307785|459102727|FG005|Part A: Up to 28.5 Months|Physician Decision|0|||
127582741|NCT03307785|459102728|FG006|Part A: Up to 28.5 Months|Physician Decision|0|||
127582742|NCT03307785|459102729|FG007|Part A: Up to 28.5 Months|Physician Decision|0|||
127582743|NCT03307785|459102730|FG008|Part A: Up to 28.5 Months|Physician Decision|0|||
127582744|NCT03307785|459102731|FG009|Part A: Up to 28.5 Months|Physician Decision|0|||
127582745|NCT03307785|459102732|FG010|Part A: Up to 28.5 Months|Physician Decision|0|||
127582746|NCT03307785|459102722|FG000|Part B: Up to Approx. 66 Months|Disease progression|0|||
127582747|NCT03307785|459102723|FG001|Part B: Up to Approx. 66 Months|Disease progression|0|||
127582748|NCT03307785|459102724|FG002|Part B: Up to Approx. 66 Months|Disease progression|2|||
127582749|NCT03307785|459102725|FG003|Part B: Up to Approx. 66 Months|Disease progression|0|||
127582750|NCT03307785|459102726|FG004|Part B: Up to Approx. 66 Months|Disease progression|0|||
127582751|NCT03307785|459102727|FG005|Part B: Up to Approx. 66 Months|Disease progression|0|||
127582752|NCT03307785|459102728|FG006|Part B: Up to Approx. 66 Months|Disease progression|0|||
127693786|NCT00676715|459507011|FG001|Treatment Period (TP)|Withdrew consent|3|||
127693787|NCT00676715|459507012|FG002|Treatment Period (TP)|Withdrew consent|3|||
127582753|NCT03307785|459102729|FG007|Part B: Up to Approx. 66 Months|Disease progression|0|||
127582754|NCT03307785|459102730|FG008|Part B: Up to Approx. 66 Months|Disease progression|0|||
127582755|NCT03307785|459102731|FG009|Part B: Up to Approx. 66 Months|Disease progression|0|||
127582756|NCT03307785|459102732|FG010|Part B: Up to Approx. 66 Months|Disease progression|0|||
127582757|NCT03307785|459102722|FG000|Part B: Up to Approx. 66 Months|Death|0|||
127582758|NCT03307785|459102723|FG001|Part B: Up to Approx. 66 Months|Death|0|||
127582759|NCT03307785|459102724|FG002|Part B: Up to Approx. 66 Months|Death|7|||
127582760|NCT03307785|459102725|FG003|Part B: Up to Approx. 66 Months|Death|0|||
127582761|NCT03307785|459102726|FG004|Part B: Up to Approx. 66 Months|Death|0|||
127582762|NCT03307785|459102727|FG005|Part B: Up to Approx. 66 Months|Death|0|||
127582763|NCT03307785|459102728|FG006|Part B: Up to Approx. 66 Months|Death|0|||
127582764|NCT03307785|459102729|FG007|Part B: Up to Approx. 66 Months|Death|0|||
127582765|NCT03307785|459102730|FG008|Part B: Up to Approx. 66 Months|Death|0|||
127582766|NCT03307785|459102731|FG009|Part B: Up to Approx. 66 Months|Death|0|||
127582767|NCT03307785|459102732|FG010|Part B: Up to Approx. 66 Months|Death|0|||
127582768|NCT03307785|459102722|FG000|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
127582769|NCT03307785|459102723|FG001|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
127582770|NCT03307785|459102724|FG002|Part B: Up to Approx. 66 Months|Withdrawal by Subject|2|||
127582771|NCT03307785|459102725|FG003|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
127582772|NCT03307785|459102726|FG004|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
127582773|NCT03307785|459102727|FG005|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
127582774|NCT03307785|459102728|FG006|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
127582775|NCT03307785|459102729|FG007|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
127582776|NCT03307785|459102730|FG008|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
127582777|NCT03307785|459102731|FG009|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
127582778|NCT03307785|459102732|FG010|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
127582779|NCT03307785|459102722|FG000|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
127582780|NCT03307785|459102723|FG001|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
127582781|NCT03307785|459102724|FG002|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|2|||
127582782|NCT03307785|459102725|FG003|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
127582783|NCT03307785|459102726|FG004|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
127582784|NCT03307785|459102727|FG005|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
127582785|NCT03307785|459102728|FG006|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
127582786|NCT03307785|459102729|FG007|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
127582787|NCT03307785|459102730|FG008|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
127582788|NCT03307785|459102731|FG009|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
127582789|NCT03307785|459102732|FG010|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
127582790|NCT03307785|459102722|FG000|Part B: Up to Approx. 66 Months|Physician Decision|0|||
127582791|NCT03307785|459102723|FG001|Part B: Up to Approx. 66 Months|Physician Decision|0|||
127582792|NCT03307785|459102724|FG002|Part B: Up to Approx. 66 Months|Physician Decision|1|||
127582793|NCT03307785|459102725|FG003|Part B: Up to Approx. 66 Months|Physician Decision|0|||
127582794|NCT03307785|459102726|FG004|Part B: Up to Approx. 66 Months|Physician Decision|0|||
127582795|NCT03307785|459102727|FG005|Part B: Up to Approx. 66 Months|Physician Decision|0|||
127582796|NCT03307785|459102728|FG006|Part B: Up to Approx. 66 Months|Physician Decision|0|||
127582797|NCT03307785|459102729|FG007|Part B: Up to Approx. 66 Months|Physician Decision|0|||
127582798|NCT03307785|459102730|FG008|Part B: Up to Approx. 66 Months|Physician Decision|0|||
127582799|NCT03307785|459102731|FG009|Part B: Up to Approx. 66 Months|Physician Decision|0|||
127582800|NCT03307785|459102732|FG010|Part B: Up to Approx. 66 Months|Physician Decision|0|||
127582801|NCT03307785|459102722|FG000|Part C: Up to Approx. 60 Months|Physician Decision|0|||
127582802|NCT03307785|459102723|FG001|Part C: Up to Approx. 60 Months|Physician Decision|0|||
127582803|NCT03307785|459102724|FG002|Part C: Up to Approx. 60 Months|Physician Decision|0|||
127582804|NCT03307785|459102725|FG003|Part C: Up to Approx. 60 Months|Physician Decision|3|||
127582805|NCT03307785|459102726|FG004|Part C: Up to Approx. 60 Months|Physician Decision|1|||
127582806|NCT03307785|459102727|FG005|Part C: Up to Approx. 60 Months|Physician Decision|0|||
127582807|NCT03307785|459102728|FG006|Part C: Up to Approx. 60 Months|Physician Decision|0|||
127693788|NCT00676715|459507013|FG003|Treatment Period (TP)|Withdrew consent|3|||
127693789|NCT00676715|459507010|FG000|Treatment Period (TP)|Insufficient therapeutic response|1|||
127693790|NCT00676715|459507011|FG001|Treatment Period (TP)|Insufficient therapeutic response|1|||
127693791|NCT00676715|459507012|FG002|Treatment Period (TP)|Insufficient therapeutic response|2|||
127693792|NCT00676715|459507013|FG003|Treatment Period (TP)|Insufficient therapeutic response|1|||
127693793|NCT00676715|459507010|FG000|Treatment Period (TP)|Administrative|0|||
127693794|NCT00676715|459507011|FG001|Treatment Period (TP)|Administrative|0|||
127693795|NCT00676715|459507012|FG002|Treatment Period (TP)|Administrative|0|||
127693796|NCT00676715|459507013|FG003|Treatment Period (TP)|Administrative|1|||
127693797|NCT00676715|459507010|FG000|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
127693798|NCT00676715|459507011|FG001|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
127582808|NCT03307785|459102729|FG007|Part C: Up to Approx. 60 Months|Physician Decision|0|||
127582809|NCT03307785|459102730|FG008|Part C: Up to Approx. 60 Months|Physician Decision|0|||
127582810|NCT03307785|459102731|FG009|Part C: Up to Approx. 60 Months|Physician Decision|0|||
127582811|NCT03307785|459102732|FG010|Part C: Up to Approx. 60 Months|Physician Decision|0|||
127582812|NCT03307785|459102722|FG000|Part C: Up to Approx. 60 Months|Death|0|||
127582813|NCT03307785|459102723|FG001|Part C: Up to Approx. 60 Months|Death|0|||
127582814|NCT03307785|459102724|FG002|Part C: Up to Approx. 60 Months|Death|0|||
127582815|NCT03307785|459102725|FG003|Part C: Up to Approx. 60 Months|Death|2|||
127582816|NCT03307785|459102726|FG004|Part C: Up to Approx. 60 Months|Death|5|||
127582817|NCT03307785|459102727|FG005|Part C: Up to Approx. 60 Months|Death|0|||
127582818|NCT03307785|459102728|FG006|Part C: Up to Approx. 60 Months|Death|0|||
127582819|NCT03307785|459102729|FG007|Part C: Up to Approx. 60 Months|Death|0|||
127582820|NCT03307785|459102730|FG008|Part C: Up to Approx. 60 Months|Death|0|||
127582821|NCT03307785|459102731|FG009|Part C: Up to Approx. 60 Months|Death|0|||
127582822|NCT03307785|459102732|FG010|Part C: Up to Approx. 60 Months|Death|0|||
127582823|NCT03307785|459102722|FG000|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
127582824|NCT03307785|459102723|FG001|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
127582825|NCT03307785|459102724|FG002|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
127582826|NCT03307785|459102725|FG003|Part C: Up to Approx. 60 Months|Withdrawal by Subject|1|||
127582827|NCT03307785|459102726|FG004|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
127582828|NCT03307785|459102727|FG005|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
127582829|NCT03307785|459102728|FG006|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
127582830|NCT03307785|459102729|FG007|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
127582831|NCT03307785|459102730|FG008|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
127582832|NCT03307785|459102731|FG009|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
127582833|NCT03307785|459102732|FG010|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
127582834|NCT03307785|459102722|FG000|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
127582835|NCT03307785|459102723|FG001|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
127582836|NCT03307785|459102724|FG002|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
127582837|NCT03307785|459102725|FG003|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
127582838|NCT03307785|459102726|FG004|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|1|||
127582839|NCT03307785|459102727|FG005|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
127582840|NCT03307785|459102728|FG006|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
127582841|NCT03307785|459102729|FG007|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
127582842|NCT03307785|459102730|FG008|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
127582843|NCT03307785|459102731|FG009|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
127582844|NCT03307785|459102732|FG010|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
127582845|NCT03307785|459102722|FG000|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
127582846|NCT03307785|459102723|FG001|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
127582847|NCT03307785|459102724|FG002|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
127582848|NCT03307785|459102725|FG003|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
127582849|NCT03307785|459102726|FG004|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
127582850|NCT03307785|459102727|FG005|Part D: Up to Approx. 62.5 Months|Physician Decision|2|||
127582851|NCT03307785|459102728|FG006|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
127582852|NCT03307785|459102729|FG007|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
127582853|NCT03307785|459102730|FG008|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
127582854|NCT03307785|459102731|FG009|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
127582855|NCT03307785|459102732|FG010|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
127582856|NCT03307785|459102722|FG000|Part D: Up to Approx. 62.5 Months|Death|0|||
127582857|NCT03307785|459102723|FG001|Part D: Up to Approx. 62.5 Months|Death|0|||
127582858|NCT03307785|459102724|FG002|Part D: Up to Approx. 62.5 Months|Death|0|||
127582859|NCT03307785|459102725|FG003|Part D: Up to Approx. 62.5 Months|Death|0|||
127582860|NCT03307785|459102726|FG004|Part D: Up to Approx. 62.5 Months|Death|0|||
127582861|NCT03307785|459102727|FG005|Part D: Up to Approx. 62.5 Months|Death|1|||
127582862|NCT03307785|459102728|FG006|Part D: Up to Approx. 62.5 Months|Death|0|||
127582863|NCT03307785|459102729|FG007|Part D: Up to Approx. 62.5 Months|Death|0|||
127582864|NCT03307785|459102730|FG008|Part D: Up to Approx. 62.5 Months|Death|0|||
127582865|NCT03307785|459102731|FG009|Part D: Up to Approx. 62.5 Months|Death|0|||
127582866|NCT03307785|459102732|FG010|Part D: Up to Approx. 62.5 Months|Death|0|||
127582867|NCT03307785|459102722|FG000|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
127582868|NCT03307785|459102723|FG001|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
127582869|NCT03307785|459102724|FG002|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
127582870|NCT03307785|459102725|FG003|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
127783379|NCT01236573|459832962|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
127783380|NCT01236573|459832963|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
127582871|NCT03307785|459102726|FG004|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
127582872|NCT03307785|459102727|FG005|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|1|||
127783381|NCT01236573|459832964|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
127582873|NCT03307785|459102728|FG006|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
127582874|NCT03307785|459102729|FG007|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
127582875|NCT03307785|459102730|FG008|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
127582876|NCT03307785|459102731|FG009|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
127582877|NCT03307785|459102732|FG010|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
127582878|NCT03307785|459102722|FG000|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
127582879|NCT03307785|459102723|FG001|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
127582880|NCT03307785|459102724|FG002|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
127582881|NCT03307785|459102725|FG003|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
127582882|NCT03307785|459102726|FG004|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
127582883|NCT03307785|459102727|FG005|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|1|||
127582884|NCT03307785|459102728|FG006|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
127582885|NCT03307785|459102729|FG007|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
127582886|NCT03307785|459102730|FG008|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
127582887|NCT03307785|459102731|FG009|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
127582888|NCT03307785|459102732|FG010|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
127582889|NCT03307785|459102722|FG000|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
127582890|NCT03307785|459102723|FG001|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
127582891|NCT03307785|459102724|FG002|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
127582892|NCT03307785|459102725|FG003|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
127582893|NCT03307785|459102726|FG004|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
127582894|NCT03307785|459102727|FG005|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|1|||
127582895|NCT03307785|459102728|FG006|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
127582896|NCT03307785|459102729|FG007|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
127582897|NCT03307785|459102730|FG008|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
127582898|NCT03307785|459102731|FG009|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
127582899|NCT03307785|459102732|FG010|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
127582900|NCT03307785|459102722|FG000|Part E: Up to 4.4 Months|Death|0|||
127582901|NCT03307785|459102723|FG001|Part E: Up to 4.4 Months|Death|0|||
127582902|NCT03307785|459102724|FG002|Part E: Up to 4.4 Months|Death|0|||
127582903|NCT03307785|459102725|FG003|Part E: Up to 4.4 Months|Death|0|||
127582904|NCT03307785|459102726|FG004|Part E: Up to 4.4 Months|Death|0|||
127582905|NCT03307785|459102727|FG005|Part E: Up to 4.4 Months|Death|0|||
127582906|NCT03307785|459102728|FG006|Part E: Up to 4.4 Months|Death|1|||
127582907|NCT03307785|459102729|FG007|Part E: Up to 4.4 Months|Death|0|||
127582908|NCT03307785|459102730|FG008|Part E: Up to 4.4 Months|Death|0|||
127582909|NCT03307785|459102731|FG009|Part E: Up to 4.4 Months|Death|0|||
127582910|NCT03307785|459102732|FG010|Part E: Up to 4.4 Months|Death|0|||
127582911|NCT03307785|459102722|FG000|Part E: Up to 4.4 Months|Physician Decision|0|||
127582912|NCT03307785|459102723|FG001|Part E: Up to 4.4 Months|Physician Decision|0|||
127582913|NCT03307785|459102724|FG002|Part E: Up to 4.4 Months|Physician Decision|0|||
127582914|NCT03307785|459102725|FG003|Part E: Up to 4.4 Months|Physician Decision|0|||
127582915|NCT03307785|459102726|FG004|Part E: Up to 4.4 Months|Physician Decision|0|||
127582916|NCT03307785|459102727|FG005|Part E: Up to 4.4 Months|Physician Decision|0|||
127582917|NCT03307785|459102728|FG006|Part E: Up to 4.4 Months|Physician Decision|1|||
127582918|NCT03307785|459102729|FG007|Part E: Up to 4.4 Months|Physician Decision|0|||
127582919|NCT03307785|459102730|FG008|Part E: Up to 4.4 Months|Physician Decision|0|||
127582920|NCT03307785|459102731|FG009|Part E: Up to 4.4 Months|Physician Decision|0|||
127582921|NCT03307785|459102732|FG010|Part E: Up to 4.4 Months|Physician Decision|0|||
127582922|NCT03307785|459102722|FG000|Part F: Up to 3.5 Months|Physician Decision|0|||
127582923|NCT03307785|459102723|FG001|Part F: Up to 3.5 Months|Physician Decision|0|||
127582924|NCT03307785|459102724|FG002|Part F: Up to 3.5 Months|Physician Decision|0|||
127582925|NCT03307785|459102725|FG003|Part F: Up to 3.5 Months|Physician Decision|0|||
127582926|NCT03307785|459102726|FG004|Part F: Up to 3.5 Months|Physician Decision|0|||
127582927|NCT03307785|459102727|FG005|Part F: Up to 3.5 Months|Physician Decision|0|||
127582928|NCT03307785|459102728|FG006|Part F: Up to 3.5 Months|Physician Decision|0|||
127582929|NCT03307785|459102729|FG007|Part F: Up to 3.5 Months|Physician Decision|1|||
127582930|NCT03307785|459102730|FG008|Part F: Up to 3.5 Months|Physician Decision|0|||
127582931|NCT03307785|459102731|FG009|Part F: Up to 3.5 Months|Physician Decision|0|||
127582932|NCT03307785|459102732|FG010|Part F: Up to 3.5 Months|Physician Decision|0|||
127582933|NCT03021304|459102733|FG000|Overall Study|Lack of Efficacy|1|||
127582934|NCT00492531|459102735|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
127582935|NCT00492531|459102736|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
127582936|NCT00423514|459102738|FG000|Overall Study|Ineligible|1|||
127783382|NCT01236573|459832965|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
127582937|NCT00423514|459102739|FG001|Overall Study|Ineligible|0|||
127582938|NCT03685123|459102740|FG000|Weight Loss Phase|Withdrawal by Subject|1|||
127582939|NCT03685123|459102741|FG001|Weight Loss Phase|Withdrawal by Subject|0|||
127582940|NCT03685123|459102742|FG002|Weight Loss Phase|Withdrawal by Subject|0|||
127582941|NCT03685123|459102740|FG000|Weight Loss Phase|Did not obtain weight loss goal|3|||
127582942|NCT03685123|459102741|FG001|Weight Loss Phase|Did not obtain weight loss goal|0|||
127582943|NCT03685123|459102742|FG002|Weight Loss Phase|Did not obtain weight loss goal|0|||
127582944|NCT03685123|459102740|FG000|Weight Loss Phase|Lost to Follow-up|1|||
127582945|NCT03685123|459102741|FG001|Weight Loss Phase|Lost to Follow-up|0|||
127582946|NCT03685123|459102742|FG002|Weight Loss Phase|Lost to Follow-up|0|||
127582947|NCT03685123|459102740|FG000|Weight Loss Phase|PI removal due to subject lack of compliance|1|||
127582948|NCT03685123|459102741|FG001|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
127582949|NCT03685123|459102742|FG002|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
127582950|NCT03685123|459102740|FG000|Weight Maintenance Phase|Covid Pandemic|0|||
127582951|NCT03685123|459102741|FG001|Weight Maintenance Phase|Covid Pandemic|4|||
127582952|NCT03685123|459102742|FG002|Weight Maintenance Phase|Covid Pandemic|5|||
127582953|NCT03685123|459102740|FG000|Weight Maintenance Phase|Withdrawal by Subject|0|||
127582954|NCT03685123|459102741|FG001|Weight Maintenance Phase|Withdrawal by Subject|0|||
127582955|NCT03685123|459102742|FG002|Weight Maintenance Phase|Withdrawal by Subject|3|||
127582956|NCT00400764|459102743|FG000|Phase Ib|Adverse Event|1|||
127582957|NCT00400764|459102744|FG001|Phase Ib|Adverse Event|0|||
127582958|NCT00400764|459102745|FG002|Phase Ib|Adverse Event|0|||
127582959|NCT00400764|459102746|FG003|Phase Ib|Adverse Event|0|||
127582960|NCT00400764|459102747|FG004|Phase Ib|Adverse Event|0|||
127582961|NCT00400764|459102743|FG000|Phase Ib|Death|1|||
127582962|NCT00400764|459102744|FG001|Phase Ib|Death|0|||
127582963|NCT00400764|459102745|FG002|Phase Ib|Death|0|||
127582964|NCT00400764|459102746|FG003|Phase Ib|Death|0|||
127582965|NCT00400764|459102747|FG004|Phase Ib|Death|0|||
127582966|NCT00400764|459102743|FG000|Phase Ib|Disease Progression|4|||
127582967|NCT00400764|459102744|FG001|Phase Ib|Disease Progression|4|||
127582968|NCT00400764|459102745|FG002|Phase Ib|Disease Progression|0|||
127582969|NCT00400764|459102746|FG003|Phase Ib|Disease Progression|0|||
127582970|NCT00400764|459102747|FG004|Phase Ib|Disease Progression|0|||
127582971|NCT00400764|459102743|FG000|Phase II|Death|0|||
127582972|NCT00400764|459102744|FG001|Phase II|Death|0|||
127582973|NCT00400764|459102745|FG002|Phase II|Death|1|||
127582974|NCT00400764|459102746|FG003|Phase II|Death|2|||
127582975|NCT00400764|459102747|FG004|Phase II|Death|0|||
127582976|NCT00400764|459102743|FG000|Phase II|Lost to Follow-up|0|||
127582977|NCT00400764|459102744|FG001|Phase II|Lost to Follow-up|0|||
127582978|NCT00400764|459102745|FG002|Phase II|Lost to Follow-up|1|||
127582979|NCT00400764|459102746|FG003|Phase II|Lost to Follow-up|0|||
127582980|NCT00400764|459102747|FG004|Phase II|Lost to Follow-up|0|||
127582981|NCT00400764|459102743|FG000|Phase II|Physician Decision|0|||
127582982|NCT00400764|459102744|FG001|Phase II|Physician Decision|0|||
127582983|NCT00400764|459102745|FG002|Phase II|Physician Decision|1|||
127582984|NCT00400764|459102746|FG003|Phase II|Physician Decision|1|||
127582985|NCT00400764|459102747|FG004|Phase II|Physician Decision|0|||
127582986|NCT00400764|459102743|FG000|Phase II|Sponsor's decision to terminate|0|||
127582987|NCT00400764|459102744|FG001|Phase II|Sponsor's decision to terminate|0|||
127582988|NCT00400764|459102745|FG002|Phase II|Sponsor's decision to terminate|18|||
127582989|NCT00400764|459102746|FG003|Phase II|Sponsor's decision to terminate|22|||
127582990|NCT00400764|459102747|FG004|Phase II|Sponsor's decision to terminate|11|||
127582991|NCT00400764|459102743|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
127582992|NCT00400764|459102744|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
127582993|NCT00400764|459102745|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
127582994|NCT00400764|459102746|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
127582995|NCT00400764|459102747|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
127582996|NCT00400764|459102743|FG000|Phase II|Withdrawal by Subject|0|||
127582997|NCT00400764|459102744|FG001|Phase II|Withdrawal by Subject|0|||
127582998|NCT00400764|459102745|FG002|Phase II|Withdrawal by Subject|1|||
127582999|NCT00400764|459102746|FG003|Phase II|Withdrawal by Subject|1|||
127583000|NCT00400764|459102747|FG004|Phase II|Withdrawal by Subject|0|||
127583001|NCT02628938|459102748|FG000|Overall Study|Did not attend the follow up recall|2|||
127693799|NCT00676715|459507012|FG002|Treatment-free Period (TFP)|Withdrawal by Subject|4|||
127693800|NCT00676715|459507013|FG003|Treatment-free Period (TFP)|Withdrawal by Subject|5|||
127583002|NCT02628938|459102749|FG001|Overall Study|Did not attend the follow up recall|2|||
127583003|NCT02628938|459102750|FG002|Overall Study|Did not attend the follow up recall|1|||
127583004|NCT02628938|459102748|FG000|Overall Study|Failure to comply with the instructions|3|||
127693801|NCT00676715|459507010|FG000|Treatment-free Period (TFP)|Reason not provided|8|||
127693802|NCT00676715|459507011|FG001|Treatment-free Period (TFP)|Reason not provided|10|||
127693803|NCT00676715|459507012|FG002|Treatment-free Period (TFP)|Reason not provided|8|||
127693804|NCT00676715|459507013|FG003|Treatment-free Period (TFP)|Reason not provided|7|||
127693805|NCT00676715|459507010|FG000|Treatment-free Period (TFP)|Lost to Follow-up|2|||
127693806|NCT00676715|459507011|FG001|Treatment-free Period (TFP)|Lost to Follow-up|2|||
127693807|NCT00676715|459507012|FG002|Treatment-free Period (TFP)|Lost to Follow-up|6|||
127583005|NCT02628938|459102749|FG001|Overall Study|Failure to comply with the instructions|0|||
127583006|NCT02628938|459102750|FG002|Overall Study|Failure to comply with the instructions|3|||
127583007|NCT00843856|459102753|FG000|Overall Study|Lost to Follow-up|1|||
127583008|NCT00843856|459102754|FG001|Overall Study|Lost to Follow-up|2|||
127583009|NCT01893203|459102755|FG000|Overall Study|Withdrawal by Subject|1|||
127583010|NCT00621959|459102756|FG000|Overall Study|Adverse Event|4|||
127583011|NCT00621959|459102757|FG001|Overall Study|Adverse Event|2|||
127583012|NCT00621959|459102756|FG000|Overall Study|Lack of Efficacy|1|||
127583013|NCT00621959|459102757|FG001|Overall Study|Lack of Efficacy|1|||
127583014|NCT00621959|459102756|FG000|Overall Study|Lost to Follow-up|0|||
127583015|NCT00621959|459102757|FG001|Overall Study|Lost to Follow-up|2|||
127583016|NCT00621959|459102756|FG000|Overall Study|Withdrawal by Subject|1|||
127583017|NCT00621959|459102757|FG001|Overall Study|Withdrawal by Subject|1|||
127583018|NCT00621959|459102756|FG000|Overall Study|Other|1|||
127583019|NCT00621959|459102757|FG001|Overall Study|Other|3|||
127583020|NCT01758523|459102758|FG000|Overall Study|Adverse Event|2|||
127583021|NCT01758523|459102759|FG001|Overall Study|Adverse Event|1|||
127583022|NCT01758523|459102758|FG000|Overall Study|Lack of Efficacy|4|||
127583023|NCT01758523|459102759|FG001|Overall Study|Lack of Efficacy|2|||
127583024|NCT01758523|459102758|FG000|Overall Study|Lost to Follow-up|3|||
127583025|NCT01758523|459102759|FG001|Overall Study|Lost to Follow-up|4|||
127583026|NCT01758523|459102758|FG000|Overall Study|Withdrawal by Subject|12|||
127583027|NCT01758523|459102759|FG001|Overall Study|Withdrawal by Subject|7|||
127583028|NCT00590135|459102760|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
127583029|NCT04729621|459102761|FG000|Main Treatment Period (Week1 to Week 52)|Adverse Event|3|||
127583030|NCT04729621|459102762|FG001|Main Treatment Period (Week1 to Week 52)|Adverse Event|7|||
127583031|NCT04729621|459102763|FG002|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
127583032|NCT04729621|459102764|FG003|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
127583033|NCT04729621|459102765|FG004|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
127583034|NCT04729621|459102761|FG000|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|13|||
127583035|NCT04729621|459102762|FG001|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|12|||
127583036|NCT04729621|459102763|FG002|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
127583037|NCT04729621|459102764|FG003|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
127583038|NCT04729621|459102765|FG004|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
127583039|NCT04729621|459102761|FG000|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|2|||
127583040|NCT04729621|459102762|FG001|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|4|||
127583041|NCT04729621|459102763|FG002|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
127583042|NCT04729621|459102764|FG003|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
127583043|NCT04729621|459102765|FG004|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
127583044|NCT04729621|459102761|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
127583045|NCT04729621|459102762|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
127583046|NCT04729621|459102763|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|7|||
127583047|NCT04729621|459102764|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|2|||
127583048|NCT04729621|459102765|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
127583049|NCT04729621|459102761|FG000|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
127583050|NCT04729621|459102762|FG001|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
127583051|NCT04729621|459102763|FG002|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
127583052|NCT04729621|459102764|FG003|Transition Period (Week 52 to Week 78)|Lost to Follow-up|1|||
127583053|NCT04729621|459102765|FG004|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
127583054|NCT04729621|459102761|FG000|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
127583055|NCT04729621|459102762|FG001|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
127583056|NCT04729621|459102763|FG002|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
127583057|NCT04729621|459102764|FG003|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|2|||
127583058|NCT04729621|459102765|FG004|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
127583059|NCT03439657|459102766|FG000|Overall Study|Adverse Event|2|||
127583060|NCT03439657|459102767|FG001|Overall Study|Adverse Event|3|||
127583061|NCT03439657|459102766|FG000|Overall Study|Lost to Follow-up|1|||
127583062|NCT03439657|459102767|FG001|Overall Study|Lost to Follow-up|0|||
127583063|NCT03439657|459102766|FG000|Overall Study|Protocol Violation|1|||
127583064|NCT03439657|459102767|FG001|Overall Study|Protocol Violation|1|||
127583065|NCT03439657|459102766|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
127583066|NCT03439657|459102767|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
127583067|NCT00370071|459102771|FG000|Overall Study|Withdrawal by Subject|2|||
128030953|NCT03249558|460738773|FG001|Overall Study|COVID-19 pandemic shutdown|0|||
128030954|NCT03249558|460738774|FG002|Overall Study|COVID-19 pandemic shutdown|0|||
128030955|NCT03249558|460738772|FG000|Overall Study|Protocol Violation|1|||
128030956|NCT03249558|460738773|FG001|Overall Study|Protocol Violation|1|||
128030957|NCT03249558|460738774|FG002|Overall Study|Protocol Violation|2|||
128030958|NCT00561821|460738778|FG000|Overall Study|Not treated|0|||
128030959|NCT00561821|460738779|FG001|Overall Study|Not treated|0|||
128030960|NCT00561821|460738780|FG002|Overall Study|Not treated|1|||
127583068|NCT01999868|459102773|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
127583069|NCT01999868|459102774|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
127583070|NCT01999868|459102775|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
127583071|NCT01999868|459102773|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
127583072|NCT01999868|459102774|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
127583073|NCT01999868|459102775|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
127583074|NCT01999868|459102773|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
127583075|NCT01999868|459102774|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
127583076|NCT01999868|459102775|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
127583077|NCT01999868|459102773|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
127583078|NCT01999868|459102774|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
127583079|NCT01999868|459102775|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
127583080|NCT01999868|459102773|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
127583081|NCT01999868|459102774|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
127583082|NCT01999868|459102775|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
127583083|NCT01999868|459102773|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
127583084|NCT01999868|459102774|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
127583085|NCT01999868|459102775|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
127583086|NCT01999868|459102773|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
127583087|NCT01999868|459102774|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
127583088|NCT01999868|459102775|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
127583089|NCT01999868|459102773|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
127583090|NCT01999868|459102774|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
127583091|NCT01999868|459102775|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
127583092|NCT01999868|459102773|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
127583093|NCT01999868|459102774|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
127583094|NCT01999868|459102775|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
127583095|NCT01999868|459102773|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
127583096|NCT01999868|459102774|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
127583097|NCT01999868|459102775|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
127583098|NCT01999868|459102773|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
127583099|NCT01999868|459102774|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
127583100|NCT01999868|459102775|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
127583101|NCT01999868|459102773|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
127583102|NCT01999868|459102774|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
127583103|NCT01999868|459102775|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
127583104|NCT01999868|459102773|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
127583105|NCT01999868|459102774|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
127583106|NCT01999868|459102775|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
127583107|NCT01999868|459102773|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
127583108|NCT01999868|459102774|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
127583109|NCT01999868|459102775|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
127583110|NCT01999868|459102773|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
127583111|NCT01999868|459102774|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
127583112|NCT01999868|459102775|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
127583113|NCT00289016|459102780|FG000|Overall Study|Disease Progression|29|||
127583114|NCT00289016|459102780|FG000|Overall Study|Death|2|||
127583115|NCT00289016|459102780|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
127583116|NCT00289016|459102780|FG000|Overall Study|Withdrawal by Subject|2|||
127583117|NCT00289016|459102780|FG000|Overall Study|Adverse Event|1|||
127583118|NCT00289016|459102780|FG000|Overall Study|Other|1|||
127583119|NCT00319501|459102781|FG000|Double-blind Period|Withdrawal by Subject|0|||
127583120|NCT00319501|459102782|FG001|Double-blind Period|Withdrawal by Subject|3|||
127583121|NCT00319501|459102781|FG000|Double-blind Period|Sponsor Request|1|||
127583122|NCT00319501|459102782|FG001|Double-blind Period|Sponsor Request|0|||
127583123|NCT00319501|459102781|FG000|Double-blind Period|Did not receive treatment|42|||
127583124|NCT00319501|459102782|FG001|Double-blind Period|Did not receive treatment|29|||
127583125|NCT00319501|459102781|FG000|Open-label Period|Adverse Event|5|||
127583126|NCT00319501|459102782|FG001|Open-label Period|Adverse Event|0|||
127583127|NCT00319501|459102781|FG000|Open-label Period|Protocol Violation|6|||
127583128|NCT00319501|459102782|FG001|Open-label Period|Protocol Violation|0|||
127583129|NCT00319501|459102781|FG000|Open-label Period|Withdrawal by Subject|38|||
127583130|NCT00319501|459102782|FG001|Open-label Period|Withdrawal by Subject|0|||
127583131|NCT00319501|459102781|FG000|Open-label Period|Principal Investigator decision|6|||
127583132|NCT00319501|459102782|FG001|Open-label Period|Principal Investigator decision|0|||
127583133|NCT00319501|459102781|FG000|Open-label Period|Sponsor request|12|||
127583134|NCT00319501|459102782|FG001|Open-label Period|Sponsor request|0|||
127583135|NCT00319501|459102781|FG000|Open-label Period|Lost to Follow-up|5|||
127583136|NCT00319501|459102782|FG001|Open-label Period|Lost to Follow-up|0|||
127583137|NCT00319501|459102781|FG000|Open-label Period|Did not receive treatment|33|||
127583138|NCT00319501|459102782|FG001|Open-label Period|Did not receive treatment|0|||
127583139|NCT00319501|459102781|FG000|Open-label Period|Other|11|||
127583140|NCT00319501|459102782|FG001|Open-label Period|Other|0|||
127583141|NCT00319501|459102781|FG000|Open-label Extension Period|Adverse Event|2|||
127583142|NCT00319501|459102782|FG001|Open-label Extension Period|Adverse Event|0|||
127583143|NCT00319501|459102781|FG000|Open-label Extension Period|Did not receive treatment|18|||
127583144|NCT00319501|459102782|FG001|Open-label Extension Period|Did not receive treatment|0|||
127583145|NCT00319501|459102781|FG000|Open-label Extension Period|Other|1|||
127583146|NCT00319501|459102782|FG001|Open-label Extension Period|Other|0|||
127583147|NCT00319501|459102781|FG000|Open-label Extension Period|Principal investigator decision|2|||
127881686|NCT00422058|460188836|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
127881687|NCT00422058|460188837|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
127881688|NCT00422058|460188838|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
127881689|NCT00422058|460188839|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
127583148|NCT00319501|459102782|FG001|Open-label Extension Period|Principal investigator decision|0|||
127583149|NCT00319501|459102781|FG000|Open-label Extension Period|Sponsor request|26|||
127583150|NCT00319501|459102782|FG001|Open-label Extension Period|Sponsor request|0|||
127583151|NCT00319501|459102781|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
127583152|NCT00319501|459102782|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
127583153|NCT02764697|459102789|FG000|Overall Study|Lack of Efficacy|3|||
127583154|NCT00302107|459102790|FG000|Overall Study|Lost to Follow-up|6|||
127583155|NCT00302107|459102791|FG001|Overall Study|Lost to Follow-up|5|||
127783383|NCT01236573|459832966|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
127783384|NCT01236573|459832967|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
127783385|NCT01236573|459832957|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
127783386|NCT01236573|459832958|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
127783387|NCT01236573|459832959|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
127783388|NCT01236573|459832960|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
127783389|NCT01236573|459832961|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
127783390|NCT01236573|459832962|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
127783391|NCT01236573|459832963|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
127783392|NCT01236573|459832964|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
127783393|NCT01236573|459832965|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
127783394|NCT01236573|459832966|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
127783395|NCT01236573|459832967|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
127783396|NCT02161575|459832974|FG000|Overall Study|Protocol Violation|8|||
127783397|NCT02161575|459832974|FG000|Overall Study|Lack of Efficacy|1|||
127783398|NCT02161575|459832974|FG000|Overall Study|Adverse Event|2|||
127783399|NCT01835015|459832975|FG000|Overall Study|Adverse Event|0|||
127783400|NCT01835015|459832976|FG001|Overall Study|Adverse Event|0|||
127783401|NCT01835015|459832977|FG002|Overall Study|Adverse Event|1|||
127783402|NCT01835015|459832978|FG003|Overall Study|Adverse Event|0|||
127783403|NCT01835015|459832979|FG004|Overall Study|Adverse Event|0|||
127783404|NCT04109222|459832984|FG000|Overall Study|Adverse Event|1|||
127783405|NCT04109222|459832985|FG001|Overall Study|Adverse Event|0|||
127783406|NCT04109222|459832986|FG002|Overall Study|Adverse Event|0|||
127783407|NCT04569032|459832987|FG000|Overall Study|Death|10|||
127783408|NCT04569032|459832988|FG001|Overall Study|Death|13|||
127783409|NCT04569032|459832987|FG000|Overall Study|Withdrawal by Subject|2|||
127783410|NCT04569032|459832988|FG001|Overall Study|Withdrawal by Subject|0|||
127783411|NCT04569032|459832987|FG000|Overall Study|Lost to Follow-up|0|||
127783412|NCT04569032|459832988|FG001|Overall Study|Lost to Follow-up|1|||
127783413|NCT04569032|459832987|FG000|Overall Study|In long term follow up|22|||
127783414|NCT04569032|459832988|FG001|Overall Study|In long term follow up|34|||
127783415|NCT00701090|459832990|FG000|Overall Study|Adverse Event|11|||
127783416|NCT00701090|459832991|FG001|Overall Study|Adverse Event|2|||
127881690|NCT00422058|460188834|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
127881691|NCT00422058|460188835|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
127881692|NCT00422058|460188836|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
127881693|NCT00422058|460188837|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
127881694|NCT00422058|460188838|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
127583156|NCT00302107|459102790|FG000|Overall Study|Protocol Violation|1|||
127583157|NCT00302107|459102791|FG001|Overall Study|Protocol Violation|0|||
127583158|NCT00302107|459102790|FG000|Overall Study|Relocation|0|||
127783417|NCT00701090|459832990|FG000|Overall Study|Death|0|||
127783418|NCT00701090|459832991|FG001|Overall Study|Death|1|||
127783419|NCT00701090|459832990|FG000|Overall Study|Lack of Efficacy|5|||
127783420|NCT00701090|459832991|FG001|Overall Study|Lack of Efficacy|4|||
127583159|NCT00302107|459102791|FG001|Overall Study|Relocation|1|||
127583160|NCT00302107|459102790|FG000|Overall Study|Withdrawal by Subject|0|||
127583161|NCT00302107|459102791|FG001|Overall Study|Withdrawal by Subject|3|||
127583162|NCT00302107|459102790|FG000|Overall Study|Adverse Event|1|||
127583163|NCT00302107|459102791|FG001|Overall Study|Adverse Event|0|||
127583164|NCT01790932|459102792|FG000|Overall Study|Disease Progression|41|||
127583165|NCT01790932|459102792|FG000|Overall Study|Adverse Event|7|||
127583166|NCT01790932|459102792|FG000|Overall Study|Physician Decision|1|||
127583167|NCT01790932|459102792|FG000|Overall Study|Withdrawal by Subject|1|||
127583168|NCT04223973|459102793|FG000|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|5|||
127583169|NCT04223973|459102794|FG001|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|0|||
127583170|NCT04223973|459102793|FG000|Overall Study|Adverse Event|4|||
127583171|NCT04223973|459102794|FG001|Overall Study|Adverse Event|0|||
127583172|NCT04223973|459102793|FG000|Overall Study|patients reported product dysfunctions and decided to stop the study|3|||
127583173|NCT04223973|459102794|FG001|Overall Study|patients reported product dysfunctions and decided to stop the study|0|||
127583174|NCT04223973|459102793|FG000|Overall Study|Physician Decision|1|||
127583175|NCT04223973|459102794|FG001|Overall Study|Physician Decision|1|||
127583176|NCT04223973|459102793|FG000|Overall Study|Withdrawal by Subject|0|||
127583177|NCT04223973|459102794|FG001|Overall Study|Withdrawal by Subject|1|||
127583178|NCT01441180|459102800|FG000|Overall Study|Lost to Follow-up|1|||
128030961|NCT00561821|460738781|FG003|Overall Study|Not treated|0|||
128030962|NCT00561821|460738778|FG000|Overall Study|Withdrawal by Subject|0|||
128030963|NCT00561821|460738779|FG001|Overall Study|Withdrawal by Subject|1|||
128030964|NCT00561821|460738780|FG002|Overall Study|Withdrawal by Subject|0|||
128030965|NCT00561821|460738781|FG003|Overall Study|Withdrawal by Subject|2|||
127583179|NCT01441180|459102801|FG001|Overall Study|Lost to Follow-up|1|||
127583180|NCT01441180|459102802|FG002|Overall Study|Lost to Follow-up|1|||
127583181|NCT01441180|459102800|FG000|Overall Study|Discontinued|0|||
128030966|NCT00561821|460738778|FG000|Overall Study|Reasons not related to trial|2|||
128030967|NCT00561821|460738779|FG001|Overall Study|Reasons not related to trial|1|||
128030968|NCT00561821|460738780|FG002|Overall Study|Reasons not related to trial|0|||
128030969|NCT00561821|460738781|FG003|Overall Study|Reasons not related to trial|0|||
128030970|NCT00561821|460738778|FG000|Overall Study|Other (reason not specified)|1|||
128030971|NCT00561821|460738779|FG001|Overall Study|Other (reason not specified)|1|||
128030972|NCT00561821|460738780|FG002|Overall Study|Other (reason not specified)|0|||
128030973|NCT00561821|460738781|FG003|Overall Study|Other (reason not specified)|0|||
128030974|NCT00561821|460738778|FG000|Overall Study|Adverse Event|2|||
128030975|NCT00561821|460738779|FG001|Overall Study|Adverse Event|3|||
128030976|NCT00561821|460738780|FG002|Overall Study|Adverse Event|1|||
128030977|NCT00561821|460738781|FG003|Overall Study|Adverse Event|1|||
128030978|NCT05943990|460738782|FG000|Overall Study|Study Terminated by Sponsor|0|||
128030979|NCT05943990|460738783|FG001|Overall Study|Study Terminated by Sponsor|0|||
128030980|NCT05943990|460738784|FG002|Overall Study|Study Terminated by Sponsor|1|||
128030981|NCT02657356|460739746|FG000|Overall Study|Death|1|||
128030982|NCT02657356|460739747|FG001|Overall Study|Death|0|||
128030983|NCT02657356|460739746|FG000|Overall Study|Withdrawal by Subject|5|||
128030984|NCT02657356|460739747|FG001|Overall Study|Withdrawal by Subject|6|||
128030985|NCT02657356|460739746|FG000|Overall Study|Terminated by Sponsor|8|||
128030986|NCT02657356|460739747|FG001|Overall Study|Terminated by Sponsor|5|||
128030987|NCT02657356|460739746|FG000|Overall Study|Rolled over to EAP study|6|||
128030988|NCT02657356|460739747|FG001|Overall Study|Rolled over to EAP study|4|||
128030989|NCT03379870|460739748|FG000|Overall Study|Lost to Follow-up|1|||
128030990|NCT03379870|460739749|FG001|Overall Study|Lost to Follow-up|0|||
128030991|NCT03379870|460739748|FG000|Overall Study|Protocol Violation|1|||
128030992|NCT03379870|460739749|FG001|Overall Study|Protocol Violation|1|||
128030993|NCT01394185|460739750|FG000|Overall Study|Withdrawal by Subject|2|||
128030994|NCT01394185|460739751|FG001|Overall Study|Withdrawal by Subject|0|||
128030995|NCT01394185|460739752|FG002|Overall Study|Withdrawal by Subject|0|||
128030996|NCT01394185|460739753|FG003|Overall Study|Withdrawal by Subject|0|||
128030997|NCT01394185|460739754|FG004|Overall Study|Withdrawal by Subject|1|||
128030998|NCT01394185|460739755|FG005|Overall Study|Withdrawal by Subject|0|||
128030999|NCT01394185|460739750|FG000|Overall Study|Change in protocol|3|||
128031000|NCT01394185|460739751|FG001|Overall Study|Change in protocol|0|||
128031001|NCT01394185|460739752|FG002|Overall Study|Change in protocol|0|||
128031002|NCT01394185|460739753|FG003|Overall Study|Change in protocol|0|||
128031003|NCT01394185|460739754|FG004|Overall Study|Change in protocol|3|||
127583182|NCT01441180|459102801|FG001|Overall Study|Discontinued|0|||
127583183|NCT01441180|459102802|FG002|Overall Study|Discontinued|2|||
127783421|NCT00701090|459832990|FG000|Overall Study|Lost to Follow-up|9|||
128031004|NCT01394185|460739755|FG005|Overall Study|Change in protocol|0|||
128031005|NCT01394185|460739750|FG000|Overall Study|Protocol Violation|1|||
128031006|NCT01394185|460739751|FG001|Overall Study|Protocol Violation|0|||
128031007|NCT01394185|460739752|FG002|Overall Study|Protocol Violation|0|||
128031008|NCT01394185|460739753|FG003|Overall Study|Protocol Violation|1|||
128031009|NCT01394185|460739754|FG004|Overall Study|Protocol Violation|0|||
128031010|NCT01394185|460739755|FG005|Overall Study|Protocol Violation|1|||
128031011|NCT00267488|460739762|FG000|Overall Study|Sponsor Terminated Study|9|||
127881695|NCT00422058|460188839|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
127881696|NCT00422058|460188834|FG000|Open-Label Extension, Week 20-104|Other|13|||
127881697|NCT00422058|460188835|FG001|Open-Label Extension, Week 20-104|Other|14|||
127881698|NCT00422058|460188836|FG002|Open-Label Extension, Week 20-104|Other|6|||
127881699|NCT00422058|460188837|FG003|Open-Label Extension, Week 20-104|Other|13|||
127881700|NCT00422058|460188838|FG004|Open-Label Extension, Week 20-104|Other|16|||
127881701|NCT00422058|460188839|FG005|Open-Label Extension, Week 20-104|Other|18|||
127881702|NCT00110084|460188845|FG000|Overall Study|Adverse Event|9|||
127881703|NCT00110084|460188845|FG000|Overall Study|Death|1|||
127881704|NCT00110084|460188845|FG000|Overall Study|Patient Refusal|10|||
127881705|NCT00110084|460188845|FG000|Overall Study|Alternate Therapy|5|||
127881706|NCT00110084|460188845|FG000|Overall Study|Intercurrent Illness|1|||
127881707|NCT00110084|460188845|FG000|Overall Study|Other|2|||
127881708|NCT00103259|460188846|FG000|Overall Study|Death|3|||
127881709|NCT00103259|460188847|FG001|Overall Study|Death|2|||
127583184|NCT02569671|459102808|FG000|Overall Study|Lost to Follow-up|2|||
127583185|NCT02569671|459102809|FG001|Overall Study|Lost to Follow-up|1|||
127583186|NCT02569671|459102808|FG000|Overall Study|Withdrawal by Subject|1|||
127583187|NCT02569671|459102809|FG001|Overall Study|Withdrawal by Subject|3|||
127583188|NCT02612129|459102810|FG000|Single Dose Treatment Period|Screening Failure|1|||
127583189|NCT02612129|459102811|FG001|Single Dose Treatment Period|Screening Failure|0|||
127583190|NCT02612129|459102812|FG002|Single Dose Treatment Period|Screening Failure|0|||
127583191|NCT02612129|459102810|FG000|Continuous Treatment Period|Early Escape|0|||
127583192|NCT02612129|459102811|FG001|Continuous Treatment Period|Early Escape|2|||
127583193|NCT02612129|459102812|FG002|Continuous Treatment Period|Early Escape|0|||
127583194|NCT02612129|459102810|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
127583195|NCT02612129|459102811|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
127583196|NCT02612129|459102812|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
127583197|NCT02612129|459102810|FG000|Continuous Treatment Period|Safety Reasons|0|||
127583198|NCT02612129|459102811|FG001|Continuous Treatment Period|Safety Reasons|3|||
127583199|NCT02612129|459102812|FG002|Continuous Treatment Period|Safety Reasons|0|||
127583200|NCT02612129|459102810|FG000|Continuous Treatment Period|Death|0|||
127583201|NCT02612129|459102811|FG001|Continuous Treatment Period|Death|1|||
127583202|NCT02612129|459102812|FG002|Continuous Treatment Period|Death|0|||
127583203|NCT02612129|459102810|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
127583204|NCT02612129|459102811|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
127583205|NCT02612129|459102812|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
127583206|NCT03487549|459102813|FG000|Overall Study|Protocol Violation|0|||
127583207|NCT03487549|459102814|FG001|Overall Study|Protocol Violation|1|||
127583208|NCT03487549|459102813|FG000|Overall Study|Lost to Follow-up|2|||
127583209|NCT03487549|459102814|FG001|Overall Study|Lost to Follow-up|1|||
127583210|NCT03487549|459102813|FG000|Overall Study|Withdrawal by Subject|2|||
127583211|NCT03487549|459102814|FG001|Overall Study|Withdrawal by Subject|0|||
127583212|NCT06238362|459102815|FG000|Overall Study|Insufficient total sleep time|1|||
127583213|NCT06238362|459102816|FG001|Overall Study|Insufficient total sleep time|0|||
127583214|NCT06238362|459102815|FG000|Overall Study|Inadequate signal quality|1|||
127583215|NCT06238362|459102816|FG001|Overall Study|Inadequate signal quality|0|||
127783422|NCT00701090|459832991|FG001|Overall Study|Lost to Follow-up|9|||
127783423|NCT00701090|459832990|FG000|Overall Study|Physician Decision|3|||
127783424|NCT00701090|459832991|FG001|Overall Study|Physician Decision|4|||
127783425|NCT00701090|459832990|FG000|Overall Study|Protocol Violation|2|||
127783426|NCT00701090|459832991|FG001|Overall Study|Protocol Violation|3|||
127783427|NCT00701090|459832990|FG000|Overall Study|Withdrawal by Subject|11|||
127783428|NCT00701090|459832991|FG001|Overall Study|Withdrawal by Subject|16|||
127783429|NCT00701090|459832990|FG000|Overall Study|Other|7|||
127783430|NCT00701090|459832991|FG001|Overall Study|Other|12|||
127783431|NCT04534491|459832998|FG000|Overall Study|Not completed end-of-study interview|24|||
127783432|NCT04534491|459832998|FG000|Overall Study|Non-users|70|||
127783433|NCT04534491|459832998|FG000|Overall Study|Non-verifiable users|58|||
127783434|NCT00113074|459833000|FG000|Overall Study|Lost to Follow-up|10|||
127783435|NCT00113074|459833001|FG001|Overall Study|Lost to Follow-up|10|||
127783436|NCT00113074|459833002|FG002|Overall Study|Lost to Follow-up|14|||
127783437|NCT02114268|459833003|FG000|Overall Study|Lost to Follow-up|4|||
127783438|NCT02114268|459833004|FG001|Overall Study|Lost to Follow-up|1|||
127783439|NCT02114268|459833005|FG002|Overall Study|Lost to Follow-up|1|||
127783440|NCT02114268|459833006|FG003|Overall Study|Lost to Follow-up|0|||
127783441|NCT02114268|459833007|FG004|Overall Study|Lost to Follow-up|0|||
127783442|NCT02114268|459833008|FG005|Overall Study|Lost to Follow-up|2|||
127881710|NCT00103259|460188846|FG000|Overall Study|Withdrawal by Subject|2|||
127783443|NCT02114268|459833003|FG000|Overall Study|Withdrawal by Subject|1|||
127783444|NCT02114268|459833004|FG001|Overall Study|Withdrawal by Subject|0|||
127783445|NCT02114268|459833005|FG002|Overall Study|Withdrawal by Subject|0|||
127783446|NCT02114268|459833006|FG003|Overall Study|Withdrawal by Subject|0|||
127783447|NCT02114268|459833007|FG004|Overall Study|Withdrawal by Subject|0|||
127783448|NCT02114268|459833008|FG005|Overall Study|Withdrawal by Subject|1|||
127783449|NCT02114268|459833003|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
127583216|NCT05136690|459102817|FG000|Period 1|Withdrawal by Subject|0|||
127583217|NCT05136690|459102818|FG001|Period 1|Withdrawal by Subject|1|||
127583218|NCT05136690|459102817|FG000|Period 2|Lost to Follow-up|0|||
127583219|NCT05136690|459102818|FG001|Period 2|Lost to Follow-up|3|||
127583220|NCT05136690|459102817|FG000|Period 2|Withdrawal by Subject|0|||
127583221|NCT05136690|459102818|FG001|Period 2|Withdrawal by Subject|1|||
127583222|NCT00531934|459105093|FG000|Overall Study|Adverse Event|4|||
127583223|NCT00531934|459105094|FG001|Overall Study|Adverse Event|8|||
127583224|NCT00531934|459105093|FG000|Overall Study|Progression|52|||
127583225|NCT00531934|459105094|FG001|Overall Study|Progression|42|||
127583226|NCT00531934|459105093|FG000|Overall Study|Death|7|||
127583227|NCT00531934|459105094|FG001|Overall Study|Death|10|||
127583228|NCT00531934|459105093|FG000|Overall Study|Withdrawal by Subject|1|||
127583229|NCT00531934|459105094|FG001|Overall Study|Withdrawal by Subject|1|||
127783450|NCT02114268|459833004|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
127783451|NCT02114268|459833005|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
127783452|NCT02114268|459833006|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
127783453|NCT02114268|459833007|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
127783454|NCT02114268|459833008|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
127783455|NCT03962738|459833009|FG000|Overall Study|Protocol Deviation|3|||
127783456|NCT03962738|459833010|FG001|Overall Study|Protocol Deviation|0|||
127783457|NCT03962738|459833011|FG002|Overall Study|Protocol Deviation|1|||
127783458|NCT03962738|459833012|FG003|Overall Study|Protocol Deviation|1|||
127783459|NCT03962738|459833009|FG000|Overall Study|Withdrawal by Subject|4|||
127783460|NCT03962738|459833010|FG001|Overall Study|Withdrawal by Subject|0|||
127783461|NCT03962738|459833011|FG002|Overall Study|Withdrawal by Subject|0|||
127783462|NCT03962738|459833012|FG003|Overall Study|Withdrawal by Subject|0|||
127783463|NCT03962738|459833009|FG000|Overall Study|Lost to Follow-up|0|||
127783464|NCT03962738|459833010|FG001|Overall Study|Lost to Follow-up|0|||
127783465|NCT03962738|459833011|FG002|Overall Study|Lost to Follow-up|1|||
127783466|NCT03962738|459833012|FG003|Overall Study|Lost to Follow-up|0|||
127783467|NCT00509067|459833013|FG000|Overall Study|Lost to Follow-up|1|||
127783468|NCT00509067|459833014|FG001|Overall Study|Lost to Follow-up|1|||
127783469|NCT00509067|459833013|FG000|Overall Study|Adverse Event|3|||
127783470|NCT00509067|459833014|FG001|Overall Study|Adverse Event|1|||
127783471|NCT00509067|459833013|FG000|Overall Study|Protocol Violation|0|||
127783472|NCT00509067|459833014|FG001|Overall Study|Protocol Violation|3|||
127783473|NCT00131469|459833015|FG000|Overall Study|Withdrawal by Subject|3|||
127783474|NCT00131469|459833016|FG001|Overall Study|Withdrawal by Subject|4|||
127783475|NCT00131469|459833015|FG000|Overall Study|Protocol Violation|3|||
127783476|NCT00131469|459833016|FG001|Overall Study|Protocol Violation|1|||
127783477|NCT00131469|459833015|FG000|Overall Study|Death|0|||
127783478|NCT00131469|459833016|FG001|Overall Study|Death|1|||
127783479|NCT00131469|459833015|FG000|Overall Study|Lost to Follow-up|0|||
127783480|NCT00131469|459833016|FG001|Overall Study|Lost to Follow-up|1|||
127783481|NCT00131469|459833015|FG000|Overall Study|scan not analyzable|3|||
127583230|NCT00531934|459105093|FG000|Overall Study|Other|2|||
127783482|NCT00131469|459833016|FG001|Overall Study|scan not analyzable|6|||
127783483|NCT03654976|459833020|FG000|Overall Study|Withdrawal by Subject|12|||
127783484|NCT03654976|459833021|FG001|Overall Study|Withdrawal by Subject|11|||
127783485|NCT03654976|459833020|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
127783486|NCT03654976|459833021|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
127783487|NCT03654976|459833020|FG000|Overall Study|Adverse Event|5|||
127783488|NCT03654976|459833021|FG001|Overall Study|Adverse Event|0|||
127583231|NCT00531934|459105094|FG001|Overall Study|Other|2|||
127783489|NCT03654976|459833020|FG000|Overall Study|Lost to Follow-up|2|||
127583232|NCT01543698|459105099|FG000|Phase 1b|Disease progression|2|||
127583233|NCT01543698|459105100|FG001|Phase 1b|Disease progression|4|||
127783490|NCT03654976|459833021|FG001|Overall Study|Lost to Follow-up|0|||
127783491|NCT03654976|459833020|FG000|Overall Study|Lack of Efficacy|0|||
127583234|NCT01543698|459105101|FG002|Phase 1b|Disease progression|3|||
127583235|NCT01543698|459105102|FG003|Phase 1b|Disease progression|2|||
127583236|NCT01543698|459105103|FG004|Phase 1b|Disease progression|10|||
127583237|NCT01543698|459105104|FG005|Phase 1b|Disease progression|6|||
127583238|NCT01543698|459105105|FG006|Phase 1b|Disease progression|5|||
127583239|NCT01543698|459105106|FG007|Phase 1b|Disease progression|3|||
127583240|NCT01543698|459105107|FG008|Phase 1b|Disease progression|4|||
127583241|NCT01543698|459105108|FG009|Phase 1b|Disease progression|5|||
127583242|NCT01543698|459105109|FG010|Phase 1b|Disease progression|1|||
127583243|NCT01543698|459105110|FG011|Phase 1b|Disease progression|0|||
127583244|NCT01543698|459105111|FG012|Phase 1b|Disease progression|0|||
127583245|NCT01543698|459105112|FG013|Phase 1b|Disease progression|0|||
127583246|NCT01543698|459105113|FG014|Phase 1b|Disease progression|0|||
127583247|NCT01543698|459105099|FG000|Phase 1b|Death|0|||
127583248|NCT01543698|459105100|FG001|Phase 1b|Death|0|||
127583249|NCT01543698|459105101|FG002|Phase 1b|Death|1|||
127783492|NCT03654976|459833021|FG001|Overall Study|Lack of Efficacy|1|||
127783493|NCT00117598|459833022|FG000|Prior to Treatment Cross Over|Death|40|||
127783494|NCT00117598|459833023|FG001|Prior to Treatment Cross Over|Death|41|||
127783495|NCT00117598|459833024|FG002|Prior to Treatment Cross Over|Death|37|||
127783496|NCT00117598|459833025|FG003|Prior to Treatment Cross Over|Death|0|||
127783497|NCT00117598|459833026|FG004|Prior to Treatment Cross Over|Death|0|||
127783498|NCT00117598|459833022|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
127881711|NCT00103259|460188847|FG001|Overall Study|Withdrawal by Subject|3|||
127881712|NCT00103259|460188846|FG000|Overall Study|alternative therapy|1|||
127783499|NCT00117598|459833023|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
127881713|NCT00103259|460188847|FG001|Overall Study|alternative therapy|0|||
127881714|NCT00103259|460188846|FG000|Overall Study|other (reasons were not specified)|2|||
127881715|NCT00103259|460188847|FG001|Overall Study|other (reasons were not specified)|1|||
127881716|NCT00103259|460188846|FG000|Overall Study|ineligible/no protocol therapy|4|||
127881717|NCT00103259|460188847|FG001|Overall Study|ineligible/no protocol therapy|6|||
127881718|NCT02866695|460188852|FG000|Overall Study|Adverse Event|1|||
127881719|NCT02866695|460188852|FG000|Overall Study|Lost to Follow-up|1|||
127881720|NCT03224234|460188853|FG000|Main Study|Lost to Follow-up|5|||
127881721|NCT03224234|460188854|FG001|Main Study|Lost to Follow-up|5|||
127881722|NCT05016765|460188855|FG000|Overall Study|Lost to Follow-up|4|||
127881723|NCT01346501|460188859|FG000|Overall Study|Initiated Other Biological Agents|3|||
127881724|NCT01346501|460188860|FG001|Overall Study|Initiated Other Biological Agents|1|||
127881725|NCT01346501|460188859|FG000|Overall Study|Other|8|||
127881726|NCT01346501|460188860|FG001|Overall Study|Other|12|||
127881727|NCT04101721|460188861|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
127881728|NCT04101721|460188862|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
127881729|NCT04101721|460188861|FG000|Overall Study|Death|0|||
127881730|NCT04101721|460188862|FG001|Overall Study|Death|1|||
127881731|NCT04101721|460188861|FG000|Overall Study|Lost to Follow-up|0|||
127881732|NCT04101721|460188862|FG001|Overall Study|Lost to Follow-up|3|||
127881733|NCT02564952|460188863|FG000|Overall Study|Adverse Event|6|||
127881734|NCT02564952|460188863|FG000|Overall Study|Lost to Follow-up|1|||
128031012|NCT00267488|460739762|FG000|Overall Study|Protocol Violation|1|||
128031013|NCT00267488|460739762|FG000|Overall Study|Other (Disease Progression)|1|||
128031014|NCT01557569|460739763|FG000|Overall Study|Adverse Event|2|||
128031015|NCT01557569|460739764|FG001|Overall Study|Adverse Event|0|||
128031016|NCT01557569|460739763|FG000|Overall Study|high blood pressure|0|||
128031017|NCT01557569|460739764|FG001|Overall Study|high blood pressure|1|||
128031018|NCT01557569|460739763|FG000|Overall Study|Withdrawal by Subject|3|||
128031019|NCT01557569|460739764|FG001|Overall Study|Withdrawal by Subject|5|||
128031020|NCT01557569|460739763|FG000|Overall Study|noncompliance with rules of residential|0|||
128031021|NCT01557569|460739764|FG001|Overall Study|noncompliance with rules of residential|1|||
128031022|NCT01817777|460739767|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
128031023|NCT01817777|460739768|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
128031024|NCT01817777|460739769|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
128031025|NCT01817777|460739767|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
128031026|NCT01817777|460739768|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
128031027|NCT01817777|460739769|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
128031028|NCT01817777|460739767|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
128031029|NCT01817777|460739768|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
128031030|NCT01817777|460739769|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
128031031|NCT01817777|460739767|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
128031032|NCT01817777|460739768|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
128031033|NCT01817777|460739769|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
127583250|NCT01543698|459105102|FG003|Phase 1b|Death|1|||
128031034|NCT01817777|460739767|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
128031035|NCT01817777|460739768|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
127583251|NCT01543698|459105103|FG004|Phase 1b|Death|0|||
127583252|NCT01543698|459105104|FG005|Phase 1b|Death|0|||
127583253|NCT01543698|459105105|FG006|Phase 1b|Death|0|||
127783500|NCT00117598|459833024|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
127693808|NCT00676715|459507013|FG003|Treatment-free Period (TFP)|Lost to Follow-up|2|||
127693809|NCT00676715|459507010|FG000|Treatment-free Period (TFP)|Adverse Event|0|||
127693810|NCT00676715|459507011|FG001|Treatment-free Period (TFP)|Adverse Event|0|||
127693811|NCT00676715|459507012|FG002|Treatment-free Period (TFP)|Adverse Event|1|||
127693812|NCT00676715|459507013|FG003|Treatment-free Period (TFP)|Adverse Event|0|||
127693813|NCT00676715|459507010|FG000|Treatment-free Period (TFP)|Death|1|||
127693814|NCT00676715|459507011|FG001|Treatment-free Period (TFP)|Death|1|||
127693815|NCT00676715|459507012|FG002|Treatment-free Period (TFP)|Death|1|||
127693816|NCT00676715|459507013|FG003|Treatment-free Period (TFP)|Death|0|||
127693817|NCT00676715|459507010|FG000|Open Label Extension (OLE)|Reason not provided|3|||
127693818|NCT00676715|459507011|FG001|Open Label Extension (OLE)|Reason not provided|4|||
127693819|NCT00676715|459507012|FG002|Open Label Extension (OLE)|Reason not provided|1|||
127693820|NCT00676715|459507013|FG003|Open Label Extension (OLE)|Reason not provided|4|||
127693821|NCT00676715|459507010|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
127693822|NCT00676715|459507011|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
127693823|NCT00676715|459507012|FG002|Open Label Extension (OLE)|Lost to Follow-up|1|||
128031036|NCT01817777|460739769|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
128031037|NCT00557440|460739770|FG000|Treatment Period 1|Adverse Event|0|||
128031038|NCT00557440|460739771|FG001|Treatment Period 1|Adverse Event|0|||
128031039|NCT00557440|460739772|FG002|Treatment Period 1|Adverse Event|1|||
128031040|NCT03524157|460739773|FG000|Overall Study|cytology not readable|0|||
128031041|NCT03524157|460739774|FG001|Overall Study|cytology not readable|0|||
128031042|NCT03524157|460739775|FG002|Overall Study|cytology not readable|1|||
128031043|NCT01592747|460739776|FG000|Overall Study|Loss of Therapeutic Response|107|||
128031044|NCT01592747|460739777|FG001|Overall Study|Loss of Therapeutic Response|108|||
128031045|NCT01592747|460739778|FG002|Overall Study|Loss of Therapeutic Response|100|||
128031046|NCT01592747|460739776|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
128031047|NCT01592747|460739777|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
128031048|NCT01592747|460739778|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
128031049|NCT01592747|460739776|FG000|Overall Study|Adverse Event|1|||
128031050|NCT01592747|460739777|FG001|Overall Study|Adverse Event|0|||
128031051|NCT01592747|460739778|FG002|Overall Study|Adverse Event|0|||
128031052|NCT01592747|460739776|FG000|Overall Study|Protocol Violation|4|||
128031053|NCT01592747|460739777|FG001|Overall Study|Protocol Violation|0|||
128031054|NCT01592747|460739778|FG002|Overall Study|Protocol Violation|4|||
128031055|NCT01592747|460739776|FG000|Overall Study|Lack of Efficacy|0|||
128031056|NCT01592747|460739777|FG001|Overall Study|Lack of Efficacy|1|||
128031057|NCT01592747|460739778|FG002|Overall Study|Lack of Efficacy|0|||
128031058|NCT01592747|460739776|FG000|Overall Study|Withdrawal by Subject|2|||
128031059|NCT01592747|460739777|FG001|Overall Study|Withdrawal by Subject|0|||
128031060|NCT01592747|460739778|FG002|Overall Study|Withdrawal by Subject|2|||
128031061|NCT01592747|460739776|FG000|Overall Study|Lost to Follow-up|1|||
128031062|NCT01592747|460739777|FG001|Overall Study|Lost to Follow-up|0|||
128031063|NCT01592747|460739778|FG002|Overall Study|Lost to Follow-up|1|||
128031064|NCT01592747|460739776|FG000|Overall Study|Other Reasons|1|||
128031065|NCT01592747|460739777|FG001|Overall Study|Other Reasons|1|||
128031066|NCT01592747|460739778|FG002|Overall Study|Other Reasons|0|||
128031067|NCT02951819|460739781|FG000|Overall Study|Death|9|||
128031068|NCT02951819|460739782|FG001|Overall Study|Death|7|||
128031069|NCT02951819|460739781|FG000|Overall Study|Withdrawal by Subject|3|||
128031070|NCT02951819|460739782|FG001|Overall Study|Withdrawal by Subject|0|||
128031071|NCT02951819|460739781|FG000|Overall Study|Adverse Event|1|||
128031072|NCT02951819|460739782|FG001|Overall Study|Adverse Event|0|||
128031073|NCT02951819|460739781|FG000|Overall Study|Lack of Efficacy|4|||
128031074|NCT02951819|460739782|FG001|Overall Study|Lack of Efficacy|0|||
128031075|NCT02951819|460739781|FG000|Overall Study|Lost to Follow-up|1|||
128031076|NCT02951819|460739782|FG001|Overall Study|Lost to Follow-up|0|||
128031077|NCT02951819|460739781|FG000|Overall Study|Progressive Disease|1|||
128031078|NCT02951819|460739782|FG001|Overall Study|Progressive Disease|0|||
128031079|NCT02951819|460739781|FG000|Overall Study|Other|9|||
128031080|NCT02951819|460739782|FG001|Overall Study|Other|0|||
128031081|NCT01922895|460739787|FG000|Overall Study|Death|0|||
128031082|NCT01922895|460739788|FG001|Overall Study|Death|1|||
128031083|NCT01922895|460739787|FG000|Overall Study|Withdrawal by Subject|1|||
127693824|NCT00676715|459507013|FG003|Open Label Extension (OLE)|Lost to Follow-up|1|||
127693825|NCT00676715|459507010|FG000|Open Label Extension (OLE)|Withdrawal by Subject|2|||
127693826|NCT00676715|459507011|FG001|Open Label Extension (OLE)|Withdrawal by Subject|4|||
127693827|NCT00676715|459507012|FG002|Open Label Extension (OLE)|Withdrawal by Subject|3|||
128031084|NCT01922895|460739788|FG001|Overall Study|Withdrawal by Subject|2|||
128031085|NCT01922895|460739787|FG000|Overall Study|Lost to Follow-up|5|||
128031086|NCT01922895|460739788|FG001|Overall Study|Lost to Follow-up|11|||
128031087|NCT01916226|460739789|FG000|Overall Study|Adverse Event|1|||
128031088|NCT01916226|460739790|FG001|Overall Study|Adverse Event|0|||
128031089|NCT01916226|460739791|FG002|Overall Study|Adverse Event|1|||
128031090|NCT01916226|460739792|FG003|Overall Study|Adverse Event|1|||
127783501|NCT00117598|459833025|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
127783502|NCT00117598|459833026|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
127783503|NCT00117598|459833022|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
127783504|NCT00117598|459833023|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
127783505|NCT00117598|459833024|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
127783506|NCT00117598|459833025|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
127783507|NCT00117598|459833026|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
127783508|NCT00117598|459833022|FG000|Prior to Treatment Cross Over|Other|15|||
127783509|NCT00117598|459833023|FG001|Prior to Treatment Cross Over|Other|9|||
127783510|NCT00117598|459833024|FG002|Prior to Treatment Cross Over|Other|9|||
128031091|NCT01916226|460739789|FG000|Overall Study|Lack of Efficacy|0|||
128031092|NCT01916226|460739790|FG001|Overall Study|Lack of Efficacy|0|||
128031093|NCT01916226|460739791|FG002|Overall Study|Lack of Efficacy|2|||
128031094|NCT01916226|460739792|FG003|Overall Study|Lack of Efficacy|1|||
128031095|NCT01916226|460739789|FG000|Overall Study|Protocol Violation|0|||
128031096|NCT01916226|460739790|FG001|Overall Study|Protocol Violation|1|||
128031097|NCT01916226|460739791|FG002|Overall Study|Protocol Violation|0|||
128031098|NCT01916226|460739792|FG003|Overall Study|Protocol Violation|1|||
128031099|NCT01916226|460739789|FG000|Overall Study|Physician Decision|0|||
128031100|NCT01916226|460739790|FG001|Overall Study|Physician Decision|0|||
128031101|NCT01916226|460739791|FG002|Overall Study|Physician Decision|0|||
128031102|NCT01916226|460739792|FG003|Overall Study|Physician Decision|1|||
128031103|NCT03163667|460739793|FG000|Overall Study|Death|15|||
128031104|NCT03163667|460739794|FG001|Overall Study|Death|27|||
128031105|NCT03163667|460739793|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
128031106|NCT03163667|460739794|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
128031107|NCT01422382|460739800|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
127881735|NCT02564952|460188863|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
127881736|NCT02564952|460188863|FG000|Overall Study|Withdrawal by Subject|1|||
127881737|NCT02564952|460188863|FG000|Overall Study|Low Efficacy|1|||
128031108|NCT02412436|460739801|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
128031109|NCT02412436|460739801|FG000|Overall Study|Lost to Follow-up|6|||
128031110|NCT02412436|460739801|FG000|Overall Study|Unable to get to clinic|3|||
128031111|NCT02412436|460739801|FG000|Overall Study|Death|1|||
128031112|NCT02412436|460739801|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
128031113|NCT04090749|460739802|FG000|Open Label Pilot|Lost to Follow-up|1|||
128031114|NCT04090749|460739803|FG001|Open Label Pilot|Lost to Follow-up|0|||
128031115|NCT04090749|460739804|FG002|Open Label Pilot|Lost to Follow-up|0|||
128031116|NCT04090749|460739802|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
128031117|NCT04090749|460739803|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
128031118|NCT04090749|460739804|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
128031119|NCT04090749|460739802|FG000|Pilot Trial|Lost to Follow-up|0|||
128031120|NCT04090749|460739803|FG001|Pilot Trial|Lost to Follow-up|1|||
128031121|NCT04090749|460739804|FG002|Pilot Trial|Lost to Follow-up|1|||
128031122|NCT02528305|460739805|FG000|Overall Study|Withdrawal by Subject|1|||
128031123|NCT02528305|460739805|FG000|Overall Study|Adverse Event|1|||
128031124|NCT02528305|460739805|FG000|Overall Study|Physician Decision|1|||
128031125|NCT02691494|460739806|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
128031126|NCT02691494|460739807|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
128031127|NCT02691494|460739808|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
128031128|NCT02691494|460739806|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
128031129|NCT02691494|460739807|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
128031130|NCT02691494|460739808|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
128031131|NCT02691494|460739806|FG000|Post-Treatment Follow-Up Period|Other|2|||
128031132|NCT02691494|460739807|FG001|Post-Treatment Follow-Up Period|Other|1|||
128031133|NCT02691494|460739808|FG002|Post-Treatment Follow-Up Period|Other|1|||
128031134|NCT02691494|460739806|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
128031135|NCT02691494|460739807|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
128031136|NCT02691494|460739808|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
128031137|NCT02691494|460739806|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
127783511|NCT00117598|459833025|FG003|Prior to Treatment Cross Over|Other|0|||
128031138|NCT02691494|460739807|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
128031139|NCT02691494|460739808|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
128031140|NCT00787800|460739809|FG000|Overall Study|Withdrawal by Subject|3|||
128031141|NCT00787800|460739810|FG001|Overall Study|Withdrawal by Subject|5|||
128031142|NCT00787800|460739809|FG000|Overall Study|Death|0|||
128031143|NCT00787800|460739810|FG001|Overall Study|Death|2|||
128031144|NCT00913835|460739813|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
128031145|NCT00913835|460739814|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
128031146|NCT00913835|460739813|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
127783512|NCT00117598|459833026|FG004|Prior to Treatment Cross Over|Other|0|||
127783513|NCT00117598|459833022|FG000|After Treament Cross Over|Death|0|||
128031147|NCT00913835|460739814|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
128031148|NCT00913835|460739813|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
128031149|NCT00913835|460739814|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
128031150|NCT00913835|460739813|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
128031151|NCT00913835|460739814|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
128031152|NCT00913835|460739813|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
128031153|NCT00913835|460739814|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
128031154|NCT00637156|460739815|FG000|Overall Study|Withdrawal by Subject|0|||
128031155|NCT00637156|460739816|FG001|Overall Study|Withdrawal by Subject|7|||
128031156|NCT00637156|460739815|FG000|Overall Study|Death|0|||
128031157|NCT00637156|460739816|FG001|Overall Study|Death|1|||
128031158|NCT00637156|460739815|FG000|Overall Study|Lost to Follow-up|10|||
128031159|NCT00637156|460739816|FG001|Overall Study|Lost to Follow-up|16|||
127693828|NCT00676715|459507013|FG003|Open Label Extension (OLE)|Withdrawal by Subject|3|||
127783514|NCT00117598|459833023|FG001|After Treament Cross Over|Death|0|||
127583254|NCT01543698|459105106|FG007|Phase 1b|Death|0|||
127583255|NCT01543698|459105107|FG008|Phase 1b|Death|0|||
127583256|NCT01543698|459105108|FG009|Phase 1b|Death|0|||
127583257|NCT01543698|459105109|FG010|Phase 1b|Death|1|||
127583258|NCT01543698|459105110|FG011|Phase 1b|Death|0|||
127583259|NCT01543698|459105111|FG012|Phase 1b|Death|0|||
127583260|NCT01543698|459105112|FG013|Phase 1b|Death|0|||
127583261|NCT01543698|459105113|FG014|Phase 1b|Death|0|||
127583262|NCT01543698|459105099|FG000|Phase 1b|Withdrawal by Subject|0|||
127583263|NCT01543698|459105100|FG001|Phase 1b|Withdrawal by Subject|1|||
127693829|NCT00676715|459507010|FG000|Open Label Extension (OLE)|Adverse Event|0|||
127693830|NCT00676715|459507011|FG001|Open Label Extension (OLE)|Adverse Event|3|||
127693831|NCT00676715|459507012|FG002|Open Label Extension (OLE)|Adverse Event|1|||
127693832|NCT00676715|459507013|FG003|Open Label Extension (OLE)|Adverse Event|0|||
127693833|NCT00676715|459507010|FG000|Open Label Extension (OLE)|Death|2|||
127693834|NCT00676715|459507011|FG001|Open Label Extension (OLE)|Death|0|||
127693835|NCT00676715|459507012|FG002|Open Label Extension (OLE)|Death|2|||
127693836|NCT00676715|459507013|FG003|Open Label Extension (OLE)|Death|2|||
127693837|NCT01820260|459507014|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
127693838|NCT01820260|459507015|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
127693839|NCT01820260|459507016|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
127693840|NCT01820260|459507017|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
127693841|NCT01820260|459507018|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
127693842|NCT01820260|459507019|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
127693843|NCT01820260|459507020|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
127693844|NCT01820260|459507021|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
127693845|NCT01820260|459507022|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
127693846|NCT01820260|459507023|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
127693847|NCT01820260|459507024|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
127693848|NCT01820260|459507025|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
127693849|NCT01820260|459507026|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
127693850|NCT01820260|459507027|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
127693851|NCT01820260|459507014|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
127693852|NCT01820260|459507015|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
127693853|NCT01820260|459507016|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
127693854|NCT01820260|459507017|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
127693855|NCT01820260|459507018|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
127693856|NCT01820260|459507019|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
127693857|NCT01820260|459507020|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
127693858|NCT01820260|459507021|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
127693859|NCT01820260|459507022|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
127693860|NCT01820260|459507023|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
127693861|NCT01820260|459507024|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
127693862|NCT01820260|459507025|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
127693863|NCT01820260|459507026|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
127693864|NCT01820260|459507027|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
127693865|NCT04831281|459507029|FG000|Overall Study|Adverse Event|1|||
127693866|NCT04831281|459507030|FG001|Overall Study|Adverse Event|0|||
127693867|NCT04831281|459507031|FG002|Overall Study|Adverse Event|3|||
127693868|NCT04831281|459507029|FG000|Overall Study|Withdrawal by Subject|0|||
127693869|NCT04831281|459507030|FG001|Overall Study|Withdrawal by Subject|1|||
127693870|NCT04831281|459507031|FG002|Overall Study|Withdrawal by Subject|2|||
127693871|NCT04831281|459507029|FG000|Overall Study|Undetermined|1|||
127693872|NCT04831281|459507030|FG001|Overall Study|Undetermined|1|||
127693873|NCT04831281|459507031|FG002|Overall Study|Undetermined|0|||
127693874|NCT02728076|459507032|FG000|Overall Study|Physician Decision|4|||
127693875|NCT05054374|459507033|FG000|Overall Study|Withdrawal by Subject|1|||
127693876|NCT05054374|459507034|FG001|Overall Study|Withdrawal by Subject|0|||
127693877|NCT05054374|459507035|FG002|Overall Study|Withdrawal by Subject|0|||
127693878|NCT05054374|459507036|FG003|Overall Study|Withdrawal by Subject|0|||
127693879|NCT05054374|459507033|FG000|Overall Study|Progressive Disease|5|||
127693880|NCT05054374|459507034|FG001|Overall Study|Progressive Disease|0|||
127693881|NCT05054374|459507035|FG002|Overall Study|Progressive Disease|0|||
127693882|NCT05054374|459507036|FG003|Overall Study|Progressive Disease|0|||
127693883|NCT04089371|459507037|FG000|Overall Study|Withdrawal by Subject|0|||
127693884|NCT04089371|459507038|FG001|Overall Study|Withdrawal by Subject|1|||
127693885|NCT04089371|459507037|FG000|Overall Study|Study terminated early|0|||
127693886|NCT04089371|459507038|FG001|Overall Study|Study terminated early|9|||
127693887|NCT02307565|459507040|FG000|Overall Study|Adverse Event|3|||
127693888|NCT02307565|459507041|FG001|Overall Study|Adverse Event|2|||
127693889|NCT02307565|459507040|FG000|Overall Study|Withdrawal by Subject|2|||
127693890|NCT02307565|459507041|FG001|Overall Study|Withdrawal by Subject|2|||
127583264|NCT01543698|459105101|FG002|Phase 1b|Withdrawal by Subject|0|||
127583265|NCT01543698|459105102|FG003|Phase 1b|Withdrawal by Subject|1|||
127583266|NCT01543698|459105103|FG004|Phase 1b|Withdrawal by Subject|0|||
127583267|NCT01543698|459105104|FG005|Phase 1b|Withdrawal by Subject|0|||
127583268|NCT01543698|459105105|FG006|Phase 1b|Withdrawal by Subject|1|||
127583269|NCT01543698|459105106|FG007|Phase 1b|Withdrawal by Subject|0|||
127583270|NCT01543698|459105107|FG008|Phase 1b|Withdrawal by Subject|0|||
127583271|NCT01543698|459105108|FG009|Phase 1b|Withdrawal by Subject|0|||
127583272|NCT01543698|459105109|FG010|Phase 1b|Withdrawal by Subject|0|||
127583273|NCT01543698|459105110|FG011|Phase 1b|Withdrawal by Subject|0|||
127583274|NCT01543698|459105111|FG012|Phase 1b|Withdrawal by Subject|0|||
127783515|NCT00117598|459833024|FG002|After Treament Cross Over|Death|0|||
127583275|NCT01543698|459105112|FG013|Phase 1b|Withdrawal by Subject|0|||
127583276|NCT01543698|459105113|FG014|Phase 1b|Withdrawal by Subject|0|||
127583277|NCT01543698|459105099|FG000|Phase 1b|Adverse Event|1|||
127583278|NCT01543698|459105100|FG001|Phase 1b|Adverse Event|0|||
127583279|NCT01543698|459105101|FG002|Phase 1b|Adverse Event|0|||
127583280|NCT01543698|459105102|FG003|Phase 1b|Adverse Event|1|||
127583281|NCT01543698|459105103|FG004|Phase 1b|Adverse Event|2|||
127583282|NCT01543698|459105104|FG005|Phase 1b|Adverse Event|2|||
127583283|NCT01543698|459105105|FG006|Phase 1b|Adverse Event|0|||
127583284|NCT01543698|459105106|FG007|Phase 1b|Adverse Event|0|||
127583285|NCT01543698|459105107|FG008|Phase 1b|Adverse Event|1|||
127583286|NCT01543698|459105108|FG009|Phase 1b|Adverse Event|1|||
127583287|NCT01543698|459105109|FG010|Phase 1b|Adverse Event|2|||
127583288|NCT01543698|459105110|FG011|Phase 1b|Adverse Event|0|||
127583289|NCT01543698|459105111|FG012|Phase 1b|Adverse Event|0|||
127583290|NCT01543698|459105112|FG013|Phase 1b|Adverse Event|0|||
127583291|NCT01543698|459105113|FG014|Phase 1b|Adverse Event|0|||
127583292|NCT01543698|459105099|FG000|Phase 1b|Administrative problems|1|||
127583293|NCT01543698|459105100|FG001|Phase 1b|Administrative problems|0|||
127583294|NCT01543698|459105101|FG002|Phase 1b|Administrative problems|0|||
127583295|NCT01543698|459105102|FG003|Phase 1b|Administrative problems|0|||
127583296|NCT01543698|459105103|FG004|Phase 1b|Administrative problems|1|||
127583297|NCT01543698|459105104|FG005|Phase 1b|Administrative problems|0|||
127583298|NCT01543698|459105105|FG006|Phase 1b|Administrative problems|0|||
127583299|NCT01543698|459105106|FG007|Phase 1b|Administrative problems|1|||
127583300|NCT01543698|459105107|FG008|Phase 1b|Administrative problems|0|||
127583301|NCT01543698|459105108|FG009|Phase 1b|Administrative problems|0|||
127583302|NCT01543698|459105109|FG010|Phase 1b|Administrative problems|2|||
127583303|NCT01543698|459105110|FG011|Phase 1b|Administrative problems|0|||
127583304|NCT01543698|459105111|FG012|Phase 1b|Administrative problems|0|||
127583305|NCT01543698|459105112|FG013|Phase 1b|Administrative problems|0|||
127583306|NCT01543698|459105113|FG014|Phase 1b|Administrative problems|0|||
127583307|NCT01543698|459105099|FG000|Phase 1b|Protocol Violation|2|||
127583308|NCT01543698|459105100|FG001|Phase 1b|Protocol Violation|0|||
127583309|NCT01543698|459105101|FG002|Phase 1b|Protocol Violation|0|||
127583310|NCT01543698|459105102|FG003|Phase 1b|Protocol Violation|0|||
127783516|NCT00117598|459833025|FG003|After Treament Cross Over|Death|1|||
127783517|NCT00117598|459833026|FG004|After Treament Cross Over|Death|2|||
127583311|NCT01543698|459105103|FG004|Phase 1b|Protocol Violation|0|||
127583312|NCT01543698|459105104|FG005|Phase 1b|Protocol Violation|0|||
127583313|NCT01543698|459105105|FG006|Phase 1b|Protocol Violation|0|||
127583314|NCT01543698|459105106|FG007|Phase 1b|Protocol Violation|0|||
128031160|NCT00461812|460739817|FG000|Overall Study|study terminated|10|||
128031161|NCT01308788|460739818|FG000|2-year Treatment|medication change by treating physician|4|||
127583315|NCT01543698|459105107|FG008|Phase 1b|Protocol Violation|0|||
127583316|NCT01543698|459105108|FG009|Phase 1b|Protocol Violation|0|||
127583317|NCT01543698|459105109|FG010|Phase 1b|Protocol Violation|0|||
127583318|NCT01543698|459105110|FG011|Phase 1b|Protocol Violation|0|||
127583319|NCT01543698|459105111|FG012|Phase 1b|Protocol Violation|0|||
127583320|NCT01543698|459105112|FG013|Phase 1b|Protocol Violation|0|||
127583321|NCT01543698|459105113|FG014|Phase 1b|Protocol Violation|0|||
127583322|NCT01543698|459105099|FG000|Phase 2|Protocol Violation|0|||
127583323|NCT01543698|459105100|FG001|Phase 2|Protocol Violation|0|||
127583324|NCT01543698|459105101|FG002|Phase 2|Protocol Violation|0|||
127583325|NCT01543698|459105102|FG003|Phase 2|Protocol Violation|0|||
127583326|NCT01543698|459105103|FG004|Phase 2|Protocol Violation|0|||
127583327|NCT01543698|459105104|FG005|Phase 2|Protocol Violation|0|||
127583328|NCT01543698|459105105|FG006|Phase 2|Protocol Violation|0|||
127583329|NCT01543698|459105106|FG007|Phase 2|Protocol Violation|0|||
127583330|NCT01543698|459105107|FG008|Phase 2|Protocol Violation|0|||
127583331|NCT01543698|459105108|FG009|Phase 2|Protocol Violation|0|||
127783518|NCT00117598|459833022|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
127583332|NCT01543698|459105109|FG010|Phase 2|Protocol Violation|0|||
127583333|NCT01543698|459105110|FG011|Phase 2|Protocol Violation|0|||
127583334|NCT01543698|459105111|FG012|Phase 2|Protocol Violation|1|||
127583335|NCT01543698|459105112|FG013|Phase 2|Protocol Violation|0|||
128031162|NCT01308788|460739819|FG001|2-year Treatment|medication change by treating physician|11|||
127583336|NCT01543698|459105113|FG014|Phase 2|Protocol Violation|0|||
127583337|NCT01543698|459105099|FG000|Phase 2|Disease progression|0|||
127583338|NCT01543698|459105100|FG001|Phase 2|Disease progression|0|||
127583339|NCT01543698|459105101|FG002|Phase 2|Disease progression|0|||
127583340|NCT01543698|459105102|FG003|Phase 2|Disease progression|0|||
127583341|NCT01543698|459105103|FG004|Phase 2|Disease progression|0|||
127583342|NCT01543698|459105104|FG005|Phase 2|Disease progression|0|||
127583343|NCT01543698|459105105|FG006|Phase 2|Disease progression|0|||
127583344|NCT01543698|459105106|FG007|Phase 2|Disease progression|0|||
127583345|NCT01543698|459105107|FG008|Phase 2|Disease progression|0|||
127583346|NCT01543698|459105108|FG009|Phase 2|Disease progression|0|||
127583347|NCT01543698|459105109|FG010|Phase 2|Disease progression|0|||
127783519|NCT00117598|459833023|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
127583348|NCT01543698|459105110|FG011|Phase 2|Disease progression|10|||
127583349|NCT01543698|459105111|FG012|Phase 2|Disease progression|21|||
127583350|NCT01543698|459105112|FG013|Phase 2|Disease progression|30|||
127583351|NCT01543698|459105113|FG014|Phase 2|Disease progression|25|||
127583352|NCT01543698|459105099|FG000|Phase 2|Death|0|||
127583353|NCT01543698|459105100|FG001|Phase 2|Death|0|||
127583354|NCT01543698|459105101|FG002|Phase 2|Death|0|||
127583355|NCT01543698|459105102|FG003|Phase 2|Death|0|||
127583356|NCT01543698|459105103|FG004|Phase 2|Death|0|||
127583357|NCT01543698|459105104|FG005|Phase 2|Death|0|||
127583358|NCT01543698|459105105|FG006|Phase 2|Death|0|||
127583359|NCT01543698|459105106|FG007|Phase 2|Death|0|||
127583360|NCT01543698|459105107|FG008|Phase 2|Death|0|||
128031163|NCT03193437|460739820|FG000|Overall Study|Adverse Event|4|||
128031164|NCT03193437|460739820|FG000|Overall Study|Withdrawal by Subject|2|||
128031165|NCT03193437|460739820|FG000|Overall Study|Disease Progression|2|||
128031166|NCT05487378|460739821|FG000|1st Intervention (1week)|Withdrawal by Subject|2|||
128031167|NCT05487378|460739822|FG001|1st Intervention (1week)|Withdrawal by Subject|0|||
128031168|NCT05487378|460739821|FG000|2nd Intervention (1 Week)|Withdrawal by Subject|0|||
128031169|NCT05487378|460739822|FG001|2nd Intervention (1 Week)|Withdrawal by Subject|1|||
128031170|NCT00964678|460739835|FG000|Overall Study|Physician Decision|4|||
128031171|NCT03359395|460739838|FG000|First Intervention A / B|Withdrawal by Subject|1|||
128031172|NCT03359395|460739839|FG001|First Intervention A / B|Withdrawal by Subject|0|||
128031173|NCT03359395|460739838|FG000|First Intervention A / B|Lost to Follow-up|2|||
128031174|NCT03359395|460739839|FG001|First Intervention A / B|Lost to Follow-up|3|||
128031175|NCT03359395|460739838|FG000|Second Intervention B/A|Exclusion criteria|0|||
128031176|NCT03359395|460739839|FG001|Second Intervention B/A|Exclusion criteria|1|||
128031177|NCT03359395|460739838|FG000|Second Intervention B/A|Lost to Follow-up|3|||
128031178|NCT03359395|460739839|FG001|Second Intervention B/A|Lost to Follow-up|2|||
128031179|NCT03164356|460739840|FG000|Overall Study|Lost to Follow-up|1|||
128031180|NCT03164356|460739841|FG001|Overall Study|Lost to Follow-up|1|||
128031181|NCT03164356|460739842|FG002|Overall Study|Lost to Follow-up|2|||
128031182|NCT03164356|460739843|FG003|Overall Study|Lost to Follow-up|1|||
128031183|NCT03164356|460739840|FG000|Overall Study|Physician Decision|0|||
128031184|NCT03164356|460739841|FG001|Overall Study|Physician Decision|0|||
128031185|NCT03164356|460739842|FG002|Overall Study|Physician Decision|3|||
128031186|NCT03164356|460739843|FG003|Overall Study|Physician Decision|0|||
128031187|NCT03164356|460739840|FG000|Overall Study|Protocol Violation|2|||
128031188|NCT03164356|460739841|FG001|Overall Study|Protocol Violation|1|||
128031189|NCT03164356|460739842|FG002|Overall Study|Protocol Violation|0|||
128031190|NCT03164356|460739843|FG003|Overall Study|Protocol Violation|0|||
128031191|NCT03164356|460739840|FG000|Overall Study|Withdrawal by Subject|1|||
128031192|NCT03164356|460739841|FG001|Overall Study|Withdrawal by Subject|0|||
128031193|NCT03164356|460739842|FG002|Overall Study|Withdrawal by Subject|0|||
128031194|NCT03164356|460739843|FG003|Overall Study|Withdrawal by Subject|0|||
128031195|NCT03164356|460739840|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
128031196|NCT03164356|460739841|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
128031197|NCT03164356|460739842|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
128031198|NCT03164356|460739843|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
128031199|NCT03164356|460739840|FG000|Overall Study|Subject Incarcerated|0|||
128031200|NCT03164356|460739841|FG001|Overall Study|Subject Incarcerated|1|||
128031201|NCT03164356|460739842|FG002|Overall Study|Subject Incarcerated|0|||
128031202|NCT03164356|460739843|FG003|Overall Study|Subject Incarcerated|0|||
128031203|NCT03164356|460739840|FG000|Overall Study|Prosthetist unable to participate|0|||
128031204|NCT03164356|460739841|FG001|Overall Study|Prosthetist unable to participate|2|||
128031205|NCT03164356|460739842|FG002|Overall Study|Prosthetist unable to participate|1|||
128031206|NCT03164356|460739843|FG003|Overall Study|Prosthetist unable to participate|0|||
128031207|NCT03443401|460741060|FG000|Overall Study|Lost to Follow-up|13|||
128031208|NCT03443401|460741060|FG000|Overall Study|Influential outlier|1|||
128031209|NCT02904265|460741061|FG000|Overall Study|Physician Decision|1|||
128031210|NCT02904265|460741062|FG001|Overall Study|Physician Decision|2|||
128031211|NCT02254460|460741063|FG000|Overall Study|Adverse Event|1|||
128031212|NCT02254460|460741064|FG001|Overall Study|Adverse Event|0|||
128031213|NCT00137449|460741065|FG000|Overall Study|Disease Progression|8|||
128031214|NCT00137449|460741066|FG001|Overall Study|Disease Progression|13|||
128031215|NCT00137449|460741065|FG000|Overall Study|Death|4|||
128031216|NCT00137449|460741066|FG001|Overall Study|Death|3|||
127583361|NCT01543698|459105108|FG009|Phase 2|Death|0|||
128031217|NCT00137449|460741065|FG000|Overall Study|Adverse Event|3|||
128031218|NCT00137449|460741066|FG001|Overall Study|Adverse Event|1|||
128031219|NCT00137449|460741065|FG000|Overall Study|Withdrawal by Subject|1|||
128031220|NCT00137449|460741066|FG001|Overall Study|Withdrawal by Subject|1|||
128031221|NCT01356940|460741067|FG000|First Intervention (28 Days)|Adverse Event|1|||
128031222|NCT01356940|460741068|FG001|First Intervention (28 Days)|Adverse Event|0|||
128031223|NCT01356940|460741067|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
128031224|NCT01356940|460741068|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
127583362|NCT01543698|459105109|FG010|Phase 2|Death|0|||
127583363|NCT01543698|459105110|FG011|Phase 2|Death|0|||
127583364|NCT01543698|459105111|FG012|Phase 2|Death|1|||
127583365|NCT01543698|459105112|FG013|Phase 2|Death|1|||
127583366|NCT01543698|459105113|FG014|Phase 2|Death|1|||
128031225|NCT02489279|460741069|FG000|Overall Study|Lost to Follow-up|12|||
128031226|NCT02489279|460741070|FG001|Overall Study|Lost to Follow-up|10|||
128031227|NCT00505687|460741073|FG000|Overall Study|Important protocol violation|2|||
128031228|NCT00505687|460741073|FG000|Overall Study|Lack of Efficacy|15|||
128031229|NCT00505687|460741073|FG000|Overall Study|Adverse Event|48|||
128031230|NCT00505687|460741073|FG000|Overall Study|Subject withdrew consent|15|||
128031231|NCT00505687|460741073|FG000|Overall Study|Lost to Follow-up|1|||
128031232|NCT00505687|460741073|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
128031233|NCT00505687|460741073|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
128031234|NCT00505687|460741073|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
128031235|NCT00505687|460741073|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
128031236|NCT00505687|460741073|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
128031237|NCT00505687|460741073|FG000|Overall Study|Other: Disease Progression|1|||
128031238|NCT00505687|460741073|FG000|Overall Study|Other: As Per Sponsor|8|||
128031239|NCT00831389|460741074|FG000|Overall Study|Withdrawal by Subject|0|||
128031240|NCT00831389|460741075|FG001|Overall Study|Withdrawal by Subject|1|||
128031241|NCT00278161|460741077|FG000|Overall Study|Death|11|||
128031242|NCT00443456|460741078|FG000|Overall Study|Adverse Event|16|||
128031243|NCT00443456|460741078|FG000|Overall Study|Move|1|||
128031244|NCT00443456|460741078|FG000|Overall Study|Withdrawal by Subject|1|||
128031245|NCT02157610|460741079|FG000|Overall Study|Death|4|||
128031246|NCT02157610|460741080|FG001|Overall Study|Death|4|||
128031247|NCT00124657|460741081|FG000|Overall Study|Toxicity|0|||
128031248|NCT00124657|460741082|FG001|Overall Study|Toxicity|0|||
128031249|NCT00124657|460741083|FG002|Overall Study|Toxicity|1|||
128031250|NCT00124657|460741081|FG000|Overall Study|Non-compliance|1|||
128031251|NCT00124657|460741082|FG001|Overall Study|Non-compliance|0|||
128031252|NCT00124657|460741083|FG002|Overall Study|Non-compliance|4|||
128031253|NCT00124657|460741081|FG000|Overall Study|Progressive disease|14|||
128031254|NCT00124657|460741082|FG001|Overall Study|Progressive disease|5|||
128031255|NCT00124657|460741083|FG002|Overall Study|Progressive disease|27|||
128031256|NCT00124657|460741081|FG000|Overall Study|Intercurrent illness|1|||
128031257|NCT00124657|460741082|FG001|Overall Study|Intercurrent illness|0|||
128031258|NCT00124657|460741083|FG002|Overall Study|Intercurrent illness|0|||
128031259|NCT01935947|460741084|FG000|Overall Study|Adverse Event|0|||
128031260|NCT01935947|460741085|FG001|Overall Study|Adverse Event|2|||
128031261|NCT01935947|460741086|FG002|Overall Study|Adverse Event|0|||
128031262|NCT01935947|460741084|FG000|Overall Study|Diease Progression|2|||
128031263|NCT01935947|460741085|FG001|Overall Study|Diease Progression|2|||
128031264|NCT01935947|460741086|FG002|Overall Study|Diease Progression|2|||
128031265|NCT01935947|460741084|FG000|Overall Study|Death|1|||
128031266|NCT01935947|460741085|FG001|Overall Study|Death|0|||
128031267|NCT01935947|460741086|FG002|Overall Study|Death|0|||
128031268|NCT04507763|460741087|FG000|Overall Study|Participants did not meet entrance criteria|201|||
128031269|NCT01378195|460741088|FG000|Overall Study|Lost to Follow-up|29|||
128031270|NCT01378195|460741089|FG001|Overall Study|Lost to Follow-up|18|||
128031271|NCT00425555|460741090|FG000|Overall Study|Withdrawal by Subject|11|||
128031272|NCT00425555|460741091|FG001|Overall Study|Withdrawal by Subject|8|||
128031273|NCT00425555|460741090|FG000|Overall Study|Lost to Follow-up|0|||
128031274|NCT00425555|460741091|FG001|Overall Study|Lost to Follow-up|1|||
128031275|NCT00425555|460741090|FG000|Overall Study|Administrative problems|3|||
128031276|NCT00425555|460741091|FG001|Overall Study|Administrative problems|0|||
128031277|NCT00425555|460741090|FG000|Overall Study|Death|1|||
128031278|NCT00425555|460741091|FG001|Overall Study|Death|2|||
128031279|NCT00425555|460741090|FG000|Overall Study|New cancer therapy|2|||
128031280|NCT00425555|460741091|FG001|Overall Study|New cancer therapy|1|||
128031281|NCT00425555|460741090|FG000|Overall Study|Disease progression|36|||
128031282|NCT00425555|460741091|FG001|Overall Study|Disease progression|33|||
128031283|NCT00425555|460741090|FG000|Overall Study|Adverse Event|25|||
128031284|NCT00425555|460741091|FG001|Overall Study|Adverse Event|15|||
127583367|NCT01543698|459105099|FG000|Phase 2|Administrative problems|0|||
127783520|NCT00117598|459833024|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
127783521|NCT00117598|459833025|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
127783522|NCT00117598|459833026|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
127783523|NCT00117598|459833022|FG000|After Treament Cross Over|Other|0|||
127783524|NCT00117598|459833023|FG001|After Treament Cross Over|Other|0|||
127783525|NCT00117598|459833024|FG002|After Treament Cross Over|Other|0|||
127783526|NCT00117598|459833025|FG003|After Treament Cross Over|Other|1|||
127783527|NCT00117598|459833026|FG004|After Treament Cross Over|Other|2|||
127783528|NCT03098836|459833027|FG000|Overall Study|Adverse Event|1|||
127783529|NCT03098836|459833028|FG001|Overall Study|Adverse Event|3|||
127783530|NCT03098836|459833027|FG000|Overall Study|Lack of Efficacy|30|||
127783531|NCT03098836|459833028|FG001|Overall Study|Lack of Efficacy|15|||
128031285|NCT00425555|460741090|FG000|Overall Study|Protocol Violation|1|||
128031286|NCT00425555|460741091|FG001|Overall Study|Protocol Violation|0|||
128031287|NCT02853136|460741092|FG000|Wash-out|Adverse Event|0|||
127783532|NCT03098836|459833027|FG000|Overall Study|Physician Decision|2|||
128031288|NCT02853136|460741093|FG001|Wash-out|Adverse Event|0|||
128031289|NCT02853136|460741094|FG002|Wash-out|Adverse Event|0|||
128031290|NCT02853136|460741095|FG003|Wash-out|Adverse Event|1|||
127583368|NCT01543698|459105100|FG001|Phase 2|Administrative problems|0|||
127583369|NCT01543698|459105101|FG002|Phase 2|Administrative problems|0|||
127583370|NCT01543698|459105102|FG003|Phase 2|Administrative problems|0|||
127583371|NCT01543698|459105103|FG004|Phase 2|Administrative problems|0|||
127783533|NCT03098836|459833028|FG001|Overall Study|Physician Decision|1|||
127783534|NCT03098836|459833027|FG000|Overall Study|Withdrawal by Subject|3|||
127783535|NCT03098836|459833028|FG001|Overall Study|Withdrawal by Subject|2|||
127783536|NCT04688775|459833031|FG000|Placebo-controlled Period|Randomized, not treated|1|||
127783537|NCT04688775|459833032|FG001|Placebo-controlled Period|Randomized, not treated|1|||
127783538|NCT04688775|459833033|FG002|Placebo-controlled Period|Randomized, not treated|0|||
127783539|NCT04688775|459833034|FG003|Placebo-controlled Period|Randomized, not treated|0|||
127783540|NCT04688775|459833031|FG000|Placebo-controlled Period|Adverse Event|2|||
127783541|NCT04688775|459833032|FG001|Placebo-controlled Period|Adverse Event|0|||
127783542|NCT04688775|459833033|FG002|Placebo-controlled Period|Adverse Event|0|||
127783543|NCT04688775|459833034|FG003|Placebo-controlled Period|Adverse Event|0|||
127783544|NCT04688775|459833031|FG000|Placebo-controlled Period|Lack of Efficacy|1|||
127783545|NCT04688775|459833032|FG001|Placebo-controlled Period|Lack of Efficacy|2|||
127783546|NCT04688775|459833033|FG002|Placebo-controlled Period|Lack of Efficacy|0|||
127783547|NCT04688775|459833034|FG003|Placebo-controlled Period|Lack of Efficacy|0|||
127783548|NCT04688775|459833031|FG000|Placebo-controlled Period|Protocol Violation|0|||
127783549|NCT04688775|459833032|FG001|Placebo-controlled Period|Protocol Violation|1|||
127783550|NCT04688775|459833033|FG002|Placebo-controlled Period|Protocol Violation|0|||
127783551|NCT04688775|459833034|FG003|Placebo-controlled Period|Protocol Violation|0|||
127783552|NCT04688775|459833031|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
127783553|NCT04688775|459833032|FG001|Placebo-controlled Period|Withdrawal by Subject|6|||
127783554|NCT04688775|459833033|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
127783555|NCT04688775|459833034|FG003|Placebo-controlled Period|Withdrawal by Subject|0|||
127783556|NCT04688775|459833031|FG000|Placebo-controlled Period|Other reasons|0|||
127783557|NCT04688775|459833032|FG001|Placebo-controlled Period|Other reasons|1|||
127783558|NCT04688775|459833033|FG002|Placebo-controlled Period|Other reasons|0|||
127783559|NCT04688775|459833034|FG003|Placebo-controlled Period|Other reasons|0|||
127783560|NCT04688775|459833031|FG000|Delayed Start Period|Adverse Event|0|||
127783561|NCT04688775|459833032|FG001|Delayed Start Period|Adverse Event|0|||
127783562|NCT04688775|459833033|FG002|Delayed Start Period|Adverse Event|1|||
127783563|NCT04688775|459833034|FG003|Delayed Start Period|Adverse Event|0|||
127783564|NCT04688775|459833031|FG000|Delayed Start Period|Lack of Efficacy|0|||
127783565|NCT04688775|459833032|FG001|Delayed Start Period|Lack of Efficacy|0|||
127783566|NCT04688775|459833033|FG002|Delayed Start Period|Lack of Efficacy|0|||
127783567|NCT04688775|459833034|FG003|Delayed Start Period|Lack of Efficacy|3|||
127783568|NCT04688775|459833031|FG000|Delayed Start Period|Withdrawal by Subject|0|||
127783569|NCT04688775|459833032|FG001|Delayed Start Period|Withdrawal by Subject|0|||
127783570|NCT04688775|459833033|FG002|Delayed Start Period|Withdrawal by Subject|2|||
127783571|NCT04688775|459833034|FG003|Delayed Start Period|Withdrawal by Subject|4|||
127783572|NCT04688775|459833031|FG000|Delayed Start Period|Lost to Follow-up|0|||
127783573|NCT04688775|459833032|FG001|Delayed Start Period|Lost to Follow-up|0|||
127783574|NCT04688775|459833033|FG002|Delayed Start Period|Lost to Follow-up|2|||
127783575|NCT04688775|459833034|FG003|Delayed Start Period|Lost to Follow-up|1|||
127783576|NCT04688775|459833031|FG000|Delayed Start Period|other reasons|0|||
127783577|NCT04688775|459833032|FG001|Delayed Start Period|other reasons|0|||
127783578|NCT04688775|459833033|FG002|Delayed Start Period|other reasons|1|||
127783579|NCT04688775|459833034|FG003|Delayed Start Period|other reasons|0|||
127783580|NCT01770912|459833035|FG000|Overall Study|Lost to Follow-up|2|||
127783581|NCT01770912|459833036|FG001|Overall Study|Lost to Follow-up|0|||
127783582|NCT01817751|459833041|FG000|Overall Study|Physician Decision|1|||
127783583|NCT00382018|459833042|FG000|Overall Study|Progression|0|||
127783584|NCT00382018|459833043|FG001|Overall Study|Progression|136|||
127783585|NCT00382018|459833044|FG002|Overall Study|Progression|51|||
127783586|NCT00382018|459833045|FG003|Overall Study|Progression|43|||
127583372|NCT01543698|459105104|FG005|Phase 2|Administrative problems|0|||
127583373|NCT01543698|459105105|FG006|Phase 2|Administrative problems|0|||
127783587|NCT00382018|459833042|FG000|Overall Study|Death|0|||
127783588|NCT00382018|459833043|FG001|Overall Study|Death|9|||
127783589|NCT00382018|459833044|FG002|Overall Study|Death|7|||
127783590|NCT00382018|459833045|FG003|Overall Study|Death|11|||
127783591|NCT00382018|459833042|FG000|Overall Study|Withdrawal by Subject|0|||
127783592|NCT00382018|459833043|FG001|Overall Study|Withdrawal by Subject|4|||
127783593|NCT00382018|459833044|FG002|Overall Study|Withdrawal by Subject|3|||
127783594|NCT00382018|459833045|FG003|Overall Study|Withdrawal by Subject|4|||
127783595|NCT00382018|459833042|FG000|Overall Study|Other, not protocol specified|0|||
127783596|NCT00382018|459833043|FG001|Overall Study|Other, not protocol specified|16|||
127783597|NCT00382018|459833044|FG002|Overall Study|Other, not protocol specified|3|||
127783598|NCT00382018|459833045|FG003|Overall Study|Other, not protocol specified|1|||
127783599|NCT00789880|459833046|FG000|Overall Study|Adverse Event|0|||
127783600|NCT00789880|459833047|FG001|Overall Study|Adverse Event|0|||
127583374|NCT01543698|459105106|FG007|Phase 2|Administrative problems|0|||
128031291|NCT00841815|460741096|FG000|Washout|Withdrawal by Subject|0|||
128031292|NCT00841815|460741097|FG001|Washout|Withdrawal by Subject|1|||
128031293|NCT00867334|460741098|FG000|Overall Study|Withdrawal by Subject|0|||
128031294|NCT00867334|460741099|FG001|Overall Study|Withdrawal by Subject|1|||
128031295|NCT00867334|460741098|FG000|Overall Study|Withdrawal by Subject|1|||
128031296|NCT00867334|460741099|FG001|Overall Study|Withdrawal by Subject|0|||
128031297|NCT00867334|460741098|FG000|Overall Study|Withdrawal by Subject|1|||
128031298|NCT00867334|460741099|FG001|Overall Study|Withdrawal by Subject|0|||
128031299|NCT01148771|460741100|FG000|Washout Period|Withdrawal by Subject|0|||
128031300|NCT01148771|460741101|FG001|Washout Period|Withdrawal by Subject|1|||
128031301|NCT03787615|460741102|FG000|Overall Study|Withdrawal by Subject|2|||
128031302|NCT03787615|460741102|FG000|Overall Study|Lost to Follow-up|2|||
128031303|NCT05418426|460741103|FG000|Overall Study|Adverse Event|0|||
128031304|NCT05418426|460741104|FG001|Overall Study|Adverse Event|1|||
128031305|NCT05418426|460741105|FG002|Overall Study|Adverse Event|0|||
128031306|NCT05418426|460741103|FG000|Overall Study|Withdrawal by Subject|0|||
128031307|NCT05418426|460741104|FG001|Overall Study|Withdrawal by Subject|1|||
128031308|NCT05418426|460741105|FG002|Overall Study|Withdrawal by Subject|0|||
127583375|NCT01543698|459105107|FG008|Phase 2|Administrative problems|0|||
127583376|NCT01543698|459105108|FG009|Phase 2|Administrative problems|0|||
127583377|NCT01543698|459105109|FG010|Phase 2|Administrative problems|0|||
127583378|NCT01543698|459105110|FG011|Phase 2|Administrative problems|0|||
127583379|NCT01543698|459105111|FG012|Phase 2|Administrative problems|0|||
127583380|NCT01543698|459105112|FG013|Phase 2|Administrative problems|3|||
127583381|NCT01543698|459105113|FG014|Phase 2|Administrative problems|1|||
127583382|NCT01543698|459105099|FG000|Phase 2|Withdrawal by Subject|0|||
127583383|NCT01543698|459105100|FG001|Phase 2|Withdrawal by Subject|0|||
127583384|NCT01543698|459105101|FG002|Phase 2|Withdrawal by Subject|0|||
127583385|NCT01543698|459105102|FG003|Phase 2|Withdrawal by Subject|0|||
127583386|NCT01543698|459105103|FG004|Phase 2|Withdrawal by Subject|0|||
127583387|NCT01543698|459105104|FG005|Phase 2|Withdrawal by Subject|0|||
127583388|NCT01543698|459105105|FG006|Phase 2|Withdrawal by Subject|0|||
127583389|NCT01543698|459105106|FG007|Phase 2|Withdrawal by Subject|0|||
127583390|NCT01543698|459105107|FG008|Phase 2|Withdrawal by Subject|0|||
127583391|NCT01543698|459105108|FG009|Phase 2|Withdrawal by Subject|0|||
127583392|NCT01543698|459105109|FG010|Phase 2|Withdrawal by Subject|0|||
127583393|NCT01543698|459105110|FG011|Phase 2|Withdrawal by Subject|0|||
127583394|NCT01543698|459105111|FG012|Phase 2|Withdrawal by Subject|0|||
127583395|NCT01543698|459105112|FG013|Phase 2|Withdrawal by Subject|3|||
127583396|NCT01543698|459105113|FG014|Phase 2|Withdrawal by Subject|1|||
127583397|NCT01543698|459105099|FG000|Phase 2|Adverse Event|0|||
127583398|NCT01543698|459105100|FG001|Phase 2|Adverse Event|0|||
127583399|NCT01543698|459105101|FG002|Phase 2|Adverse Event|0|||
127583400|NCT01543698|459105102|FG003|Phase 2|Adverse Event|0|||
127583401|NCT01543698|459105103|FG004|Phase 2|Adverse Event|0|||
127583402|NCT01543698|459105104|FG005|Phase 2|Adverse Event|0|||
127583403|NCT01543698|459105105|FG006|Phase 2|Adverse Event|0|||
127583404|NCT01543698|459105106|FG007|Phase 2|Adverse Event|0|||
127583405|NCT01543698|459105107|FG008|Phase 2|Adverse Event|0|||
127583406|NCT01543698|459105108|FG009|Phase 2|Adverse Event|0|||
127583407|NCT01543698|459105109|FG010|Phase 2|Adverse Event|0|||
127583408|NCT01543698|459105110|FG011|Phase 2|Adverse Event|1|||
127583409|NCT01543698|459105111|FG012|Phase 2|Adverse Event|3|||
127583410|NCT01543698|459105112|FG013|Phase 2|Adverse Event|5|||
127583411|NCT01543698|459105113|FG014|Phase 2|Adverse Event|14|||
128031309|NCT05418426|460741103|FG000|Overall Study|Protocol Violation|0|||
128031310|NCT05418426|460741104|FG001|Overall Study|Protocol Violation|0|||
128031311|NCT05418426|460741105|FG002|Overall Study|Protocol Violation|1|||
128031312|NCT01674062|460741106|FG000|Overall Study|Insufficient Therapeutic Response|56|||
128031313|NCT01674062|460741107|FG001|Overall Study|Insufficient Therapeutic Response|26|||
128031314|NCT01674062|460741106|FG000|Overall Study|Other|8|||
128031315|NCT01674062|460741107|FG001|Overall Study|Other|1|||
128031316|NCT01674062|460741106|FG000|Overall Study|Adverse Event|1|||
128031317|NCT01674062|460741107|FG001|Overall Study|Adverse Event|1|||
128031318|NCT01674062|460741106|FG000|Overall Study|Death|0|||
128031319|NCT01674062|460741107|FG001|Overall Study|Death|1|||
128031320|NCT01674062|460741106|FG000|Overall Study|Programming Error|1|||
128031321|NCT01674062|460741107|FG001|Overall Study|Programming Error|0|||
127583412|NCT00150709|459105114|FG000|Overall Study|Protocol Violation|7|||
128031322|NCT04620668|460741108|FG000|Overall Study|Withdrawal by Subject|2|||
127583413|NCT00150709|459105115|FG001|Overall Study|Protocol Violation|8|||
127583414|NCT00150709|459105116|FG002|Overall Study|Protocol Violation|3|||
127583415|NCT00150709|459105117|FG003|Overall Study|Protocol Violation|1|||
127583416|NCT00150709|459105114|FG000|Overall Study|Adverse Event|8|||
127583417|NCT00150709|459105115|FG001|Overall Study|Adverse Event|2|||
127583418|NCT00150709|459105116|FG002|Overall Study|Adverse Event|2|||
127583419|NCT00150709|459105117|FG003|Overall Study|Adverse Event|3|||
127583420|NCT00150709|459105114|FG000|Overall Study|Lack of Efficacy|6|||
127583421|NCT00150709|459105115|FG001|Overall Study|Lack of Efficacy|11|||
128031323|NCT04620668|460741109|FG001|Overall Study|Withdrawal by Subject|0|||
128031324|NCT04620668|460741108|FG000|Overall Study|Ineligible despite claims at outset of the study|1|||
127881738|NCT02564952|460188863|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
127881739|NCT00756652|460188864|FG000|Original Phase|Withdrawal by Subject|864|||
127881740|NCT00756652|460188865|FG001|Original Phase|Withdrawal by Subject|23|||
127881741|NCT00756652|460188864|FG000|Original Phase|Lost to Follow-up|601|||
127881742|NCT00756652|460188865|FG001|Original Phase|Lost to Follow-up|0|||
127881743|NCT00756652|460188864|FG000|Original Phase|Other Discontinuation|797|||
127881744|NCT00756652|460188865|FG001|Original Phase|Other Discontinuation|5|||
127881745|NCT00756652|460188864|FG000|Original Phase|Participant Noncompliance|18622|||
127881746|NCT00756652|460188865|FG001|Original Phase|Participant Noncompliance|424|||
127881747|NCT00756652|460188864|FG000|Original Phase|Unknown Discontinuation Reason|2|||
127881748|NCT00756652|460188865|FG001|Original Phase|Unknown Discontinuation Reason|0|||
127881749|NCT00756652|460188864|FG000|Original Phase|Participants without data|3259|||
127881750|NCT00756652|460188865|FG001|Original Phase|Participants without data|466|||
127881751|NCT00756652|460188864|FG000|Original Phase|Death|168|||
128031325|NCT04620668|460741109|FG001|Overall Study|Ineligible despite claims at outset of the study|0|||
128031326|NCT04620668|460741108|FG000|Overall Study|Removed before analysis: missing data|2|||
128031327|NCT04620668|460741109|FG001|Overall Study|Removed before analysis: missing data|0|||
128031328|NCT04620668|460741108|FG000|Overall Study|Removed before analysis: failed multiple quality check questions|1|||
128031329|NCT04620668|460741109|FG001|Overall Study|Removed before analysis: failed multiple quality check questions|2|||
128031330|NCT04620668|460741108|FG000|Overall Study|Removed before analysis: statistical outlier|1|||
128031331|NCT04620668|460741109|FG001|Overall Study|Removed before analysis: statistical outlier|2|||
128031332|NCT03647137|460741113|FG000|Overall Study|Scan Limitation|2|||
128031333|NCT03647137|460741114|FG001|Overall Study|Scan Limitation|1|||
128031334|NCT03647137|460741115|FG002|Overall Study|Scan Limitation|1|||
128031335|NCT03647137|460741116|FG003|Overall Study|Scan Limitation|2|||
128031336|NCT01443026|460741120|FG000|Overall Study|Physician Decision|1|||
128031337|NCT01443026|460741121|FG001|Overall Study|Physician Decision|0|||
128031338|NCT01443026|460741120|FG000|Overall Study|Death|0|||
128031339|NCT01443026|460741121|FG001|Overall Study|Death|1|||
128031340|NCT01443026|460741120|FG000|Overall Study|Withdrawal by Subject|0|||
128031341|NCT01443026|460741121|FG001|Overall Study|Withdrawal by Subject|3|||
128031342|NCT01443026|460741120|FG000|Overall Study|Lost to Follow-up|2|||
128031343|NCT01443026|460741121|FG001|Overall Study|Lost to Follow-up|1|||
128031344|NCT00581919|460741122|FG000|Overall Study|Adverse Event|8|||
128031345|NCT00581919|460741122|FG000|Overall Study|Death|1|||
128031346|NCT00581919|460741122|FG000|Overall Study|Disease Progression|10|||
128031347|NCT00581919|460741122|FG000|Overall Study|Physician Decision|1|||
128031348|NCT00581919|460741122|FG000|Overall Study|Other Complicating Disease|1|||
128031349|NCT00581919|460741122|FG000|Overall Study|Started Non-Protocol Therapy|2|||
128031350|NCT00581919|460741122|FG000|Overall Study|Withdrawal by Subject|1|||
128031351|NCT02655601|460741123|FG000|Overall Study|Adverse Event|0|||
128031352|NCT02655601|460741124|FG001|Overall Study|Adverse Event|0|||
128031353|NCT02655601|460741125|FG002|Overall Study|Adverse Event|0|||
128031354|NCT02655601|460741126|FG003|Overall Study|Adverse Event|1|||
128031355|NCT02655601|460741127|FG004|Overall Study|Adverse Event|1|||
128031356|NCT02655601|460741128|FG005|Overall Study|Adverse Event|0|||
128031357|NCT02655601|460741123|FG000|Overall Study|Physician Decision|0|||
128031358|NCT02655601|460741124|FG001|Overall Study|Physician Decision|0|||
128031359|NCT02655601|460741125|FG002|Overall Study|Physician Decision|0|||
128031360|NCT02655601|460741126|FG003|Overall Study|Physician Decision|0|||
127583422|NCT00150709|459105116|FG002|Overall Study|Lack of Efficacy|9|||
127583423|NCT00150709|459105117|FG003|Overall Study|Lack of Efficacy|0|||
127583424|NCT00150709|459105114|FG000|Overall Study|Withdrawal by Subject|7|||
127583425|NCT00150709|459105115|FG001|Overall Study|Withdrawal by Subject|10|||
127583426|NCT00150709|459105116|FG002|Overall Study|Withdrawal by Subject|5|||
127583427|NCT00150709|459105117|FG003|Overall Study|Withdrawal by Subject|0|||
127583428|NCT00150709|459105114|FG000|Overall Study|Lost to Follow-up|3|||
127583429|NCT00150709|459105115|FG001|Overall Study|Lost to Follow-up|2|||
127583430|NCT00150709|459105116|FG002|Overall Study|Lost to Follow-up|0|||
127583431|NCT00150709|459105117|FG003|Overall Study|Lost to Follow-up|0|||
127583432|NCT00150709|459105114|FG000|Overall Study|Sponsor decision|0|||
127583433|NCT00150709|459105115|FG001|Overall Study|Sponsor decision|0|||
127583434|NCT00150709|459105116|FG002|Overall Study|Sponsor decision|0|||
127583435|NCT00150709|459105117|FG003|Overall Study|Sponsor decision|1|||
127583436|NCT00150709|459105114|FG000|Overall Study|Site/Investigator discontinued the study|5|||
127583437|NCT00150709|459105115|FG001|Overall Study|Site/Investigator discontinued the study|5|||
127583438|NCT00150709|459105116|FG002|Overall Study|Site/Investigator discontinued the study|2|||
127583439|NCT00150709|459105117|FG003|Overall Study|Site/Investigator discontinued the study|0|||
127881752|NCT00756652|460188865|FG001|Original Phase|Death|1|||
127881753|NCT00756652|460188864|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
127881754|NCT00756652|460188865|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
128031361|NCT02655601|460741127|FG004|Overall Study|Physician Decision|1|||
128031362|NCT02655601|460741128|FG005|Overall Study|Physician Decision|1|||
128031363|NCT02655601|460741123|FG000|Overall Study|Withdrawal by Subject|0|||
128031364|NCT02655601|460741124|FG001|Overall Study|Withdrawal by Subject|0|||
128031365|NCT02655601|460741125|FG002|Overall Study|Withdrawal by Subject|0|||
128031366|NCT02655601|460741126|FG003|Overall Study|Withdrawal by Subject|0|||
128031367|NCT02655601|460741127|FG004|Overall Study|Withdrawal by Subject|4|||
128031368|NCT02655601|460741128|FG005|Overall Study|Withdrawal by Subject|8|||
128031369|NCT02655601|460741123|FG000|Overall Study|Treatment delayed too long per protocol due to adverse events|1|||
128031370|NCT02655601|460741124|FG001|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
128031371|NCT02655601|460741125|FG002|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
128031372|NCT02655601|460741126|FG003|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
127783601|NCT00789880|459833048|FG002|Overall Study|Adverse Event|0|||
128031373|NCT02655601|460741127|FG004|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
128031374|NCT02655601|460741128|FG005|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
128031375|NCT03829683|460741133|FG000|Overall Study|Lost to Follow-up|1|||
128031376|NCT03829683|460741134|FG001|Overall Study|Lost to Follow-up|0|||
128031377|NCT03829683|460741133|FG000|Overall Study|Physician Decision|3|||
128031378|NCT03829683|460741134|FG001|Overall Study|Physician Decision|1|||
128031379|NCT03829683|460741133|FG000|Overall Study|Withdrawal by Subject|0|||
128031380|NCT03829683|460741134|FG001|Overall Study|Withdrawal by Subject|1|||
128031381|NCT03829683|460741133|FG000|Overall Study|Discharge from hospital|1|||
128031382|NCT03829683|460741134|FG001|Overall Study|Discharge from hospital|0|||
128031383|NCT02796651|460741139|FG000|Overall Study|Adverse Event|6|||
128031384|NCT02796651|460741139|FG000|Overall Study|Lost to Follow-up|1|||
128031385|NCT02796651|460741139|FG000|Overall Study|Withdrawal by Subject|4|||
128031386|NCT02796651|460741139|FG000|Overall Study|Protocol Violation|4|||
128031387|NCT02796651|460741139|FG000|Overall Study|Lack of Efficacy|1|||
128031388|NCT02796651|460741139|FG000|Overall Study|Other|10|||
128031389|NCT05430919|460741143|FG000|Overall Study|Protocol Violation|0|||
128031390|NCT05430919|460741144|FG001|Overall Study|Protocol Violation|0|||
128031391|NCT05430919|460741145|FG002|Overall Study|Protocol Violation|1|||
128031392|NCT05430919|460741146|FG003|Overall Study|Protocol Violation|0|||
128031393|NCT05430919|460741143|FG000|Overall Study|Lost to Follow-up|0|||
128031394|NCT05430919|460741144|FG001|Overall Study|Lost to Follow-up|1|||
128031395|NCT05430919|460741145|FG002|Overall Study|Lost to Follow-up|0|||
128031396|NCT05430919|460741146|FG003|Overall Study|Lost to Follow-up|0|||
128031397|NCT05430919|460741143|FG000|Overall Study|Withdrawal by Subject|3|||
128031398|NCT05430919|460741144|FG001|Overall Study|Withdrawal by Subject|0|||
128031399|NCT05430919|460741145|FG002|Overall Study|Withdrawal by Subject|0|||
128031400|NCT05430919|460741146|FG003|Overall Study|Withdrawal by Subject|1|||
128031401|NCT05014919|460741147|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
128031402|NCT05014919|460741148|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
128031403|NCT05014919|460741149|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
128031404|NCT05014919|460741147|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
128031405|NCT05014919|460741148|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
128031406|NCT05014919|460741149|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
128031407|NCT05014919|460741147|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
128031408|NCT05014919|460741148|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
127783602|NCT00789880|459833049|FG003|Overall Study|Adverse Event|0|||
127783603|NCT00789880|459833050|FG004|Overall Study|Adverse Event|1|||
127783604|NCT00789880|459833051|FG005|Overall Study|Adverse Event|0|||
127783605|NCT00789880|459833046|FG000|Overall Study|Protocol Violation|0|||
127783606|NCT00789880|459833047|FG001|Overall Study|Protocol Violation|1|||
127783607|NCT00789880|459833048|FG002|Overall Study|Protocol Violation|0|||
127783608|NCT00789880|459833049|FG003|Overall Study|Protocol Violation|1|||
127783609|NCT00789880|459833050|FG004|Overall Study|Protocol Violation|0|||
127783610|NCT00789880|459833051|FG005|Overall Study|Protocol Violation|0|||
127783611|NCT00789880|459833046|FG000|Overall Study|Withdrawal by Subject|1|||
128031409|NCT05014919|460741149|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
128031410|NCT05014919|460741147|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
128031411|NCT05014919|460741148|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
128031412|NCT05014919|460741149|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
128031413|NCT05014919|460741147|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
128031414|NCT05014919|460741148|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
128031415|NCT05014919|460741149|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
128031416|NCT05014919|460741147|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
128031417|NCT05014919|460741148|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
128031418|NCT05014919|460741149|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
128031419|NCT05014919|460741147|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
128031420|NCT05014919|460741148|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
128031421|NCT05014919|460741149|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
127783612|NCT00789880|459833047|FG001|Overall Study|Withdrawal by Subject|0|||
127783613|NCT00789880|459833048|FG002|Overall Study|Withdrawal by Subject|0|||
127783614|NCT00789880|459833049|FG003|Overall Study|Withdrawal by Subject|0|||
128031422|NCT05014919|460741147|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
128031423|NCT05014919|460741148|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
128031424|NCT05014919|460741149|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
128031425|NCT00680914|460741150|FG000|Overall Study|Consent withdrawal|6|||
128031426|NCT00680914|460741151|FG001|Overall Study|Consent withdrawal|3|||
128031427|NCT00680914|460741150|FG000|Overall Study|Lost to Follow-up|4|||
128031428|NCT00680914|460741151|FG001|Overall Study|Lost to Follow-up|0|||
128031429|NCT00680914|460741150|FG000|Overall Study|serious adverse event (SAE)|0|||
128031430|NCT00680914|460741151|FG001|Overall Study|serious adverse event (SAE)|1|||
128031431|NCT02971163|460741154|FG000|Overall Study|Lost to Follow-up|4|||
128031432|NCT02971163|460741155|FG001|Overall Study|Lost to Follow-up|2|||
128031433|NCT00539500|460741156|FG000|Overall Study|Disease Progression|1|||
128031434|NCT00539500|460741156|FG000|Overall Study|Lost to Follow-up|2|||
128031435|NCT01491919|460741157|FG000|Overall Study|Insufficient PK sampling|1|||
128031436|NCT01491919|460741158|FG001|Overall Study|Insufficient PK sampling|2|||
128031437|NCT01491919|460741159|FG002|Overall Study|Insufficient PK sampling|1|||
128031438|NCT02871219|460741160|FG000|Overall Study|Adverse Event|15|||
128031439|NCT02871219|460741160|FG000|Overall Study|Death|3|||
128031440|NCT02871219|460741160|FG000|Overall Study|Progression|3|||
128031441|NCT02871219|460741160|FG000|Overall Study|Infections|7|||
128031442|NCT02871219|460741160|FG000|Overall Study|Infusion Related|4|||
128031443|NCT05375929|460741166|FG000|Main Study: Treatment Phase (12 Weeks)|Adverse Event|1|||
128031444|NCT05375929|460741167|FG001|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
128031445|NCT05375929|460741168|FG002|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
128031446|NCT05375929|460741169|FG003|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
128031447|NCT05375929|460741166|FG000|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
128031448|NCT05375929|460741167|FG001|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
128031449|NCT05375929|460741168|FG002|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
128031450|NCT05375929|460741169|FG003|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
127783615|NCT00789880|459833050|FG004|Overall Study|Withdrawal by Subject|2|||
127783616|NCT00789880|459833051|FG005|Overall Study|Withdrawal by Subject|0|||
127783617|NCT01977820|459833055|FG000|Overall Study|Sponsor terminated the study|1|||
127783618|NCT01977820|459833056|FG001|Overall Study|Sponsor terminated the study|1|||
127783619|NCT02568475|459833057|FG000|Overall Study|Lost to Follow-up|40|||
127783620|NCT02568475|459833058|FG001|Overall Study|Lost to Follow-up|39|||
127783621|NCT02568475|459833057|FG000|Overall Study|Withdrawal by Subject|2|||
127783622|NCT02568475|459833058|FG001|Overall Study|Withdrawal by Subject|0|||
127783623|NCT02568475|459833057|FG000|Overall Study|Discharged home|4|||
127783624|NCT02568475|459833058|FG001|Overall Study|Discharged home|4|||
127783625|NCT02568475|459833057|FG000|Overall Study|Short-term: Discharge location unknown|4|||
127783626|NCT02568475|459833058|FG001|Overall Study|Short-term: Discharge location unknown|0|||
127783627|NCT02568475|459833057|FG000|Overall Study|Transferred to another facility|1|||
127783628|NCT02568475|459833058|FG001|Overall Study|Transferred to another facility|0|||
127783629|NCT00493220|459833059|FG000|Third Intervention|Withdrawal by Subject|1|||
127783630|NCT00493220|459833060|FG001|Third Intervention|Withdrawal by Subject|0|||
127783631|NCT00493220|459833061|FG002|Third Intervention|Withdrawal by Subject|0|||
128031451|NCT05375929|460741166|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|6|||
128031452|NCT05375929|460741167|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|5|||
128031453|NCT05375929|460741168|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
128031454|NCT05375929|460741169|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
128031455|NCT05375929|460741166|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
128031456|NCT05375929|460741167|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|1|||
128031457|NCT05375929|460741168|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
128031458|NCT05375929|460741169|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
128031459|NCT05375929|460741166|FG000|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|1|||
128031460|NCT05375929|460741167|FG001|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
128031461|NCT05375929|460741168|FG002|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
128031462|NCT05375929|460741169|FG003|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
128031463|NCT05375929|460741166|FG000|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
128031464|NCT05375929|460741167|FG001|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|1|||
128031465|NCT05375929|460741168|FG002|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
128031466|NCT05375929|460741169|FG003|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
128031467|NCT05375929|460741166|FG000|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
127783632|NCT00493220|459833062|FG003|Third Intervention|Withdrawal by Subject|0|||
127783633|NCT00493220|459833063|FG004|Third Intervention|Withdrawal by Subject|0|||
127783634|NCT00493220|459833064|FG005|Third Intervention|Withdrawal by Subject|0|||
127783635|NCT02625233|459833065|FG000|Overall Study|Adverse Event|2|||
127783636|NCT02625233|459833066|FG001|Overall Study|Adverse Event|0|||
127783637|NCT01704287|459834403|FG000|Initial Treatment Period|Death|139|||
127783638|NCT01704287|459834404|FG001|Initial Treatment Period|Death|129|||
127783639|NCT01704287|459834405|FG002|Initial Treatment Period|Death|71|||
127783640|NCT01704287|459834406|FG003|Initial Treatment Period|Death|0|||
127783641|NCT01704287|459834407|FG004|Initial Treatment Period|Death|0|||
127783642|NCT01704287|459834403|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
127783643|NCT01704287|459834404|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
127783644|NCT01704287|459834405|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
127783645|NCT01704287|459834406|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
127783646|NCT01704287|459834407|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
127783647|NCT01704287|459834403|FG000|Initial Treatment Period|Lost to Follow-up|5|||
127783648|NCT01704287|459834404|FG001|Initial Treatment Period|Lost to Follow-up|3|||
127783649|NCT01704287|459834405|FG002|Initial Treatment Period|Lost to Follow-up|0|||
127783650|NCT01704287|459834406|FG003|Initial Treatment Period|Lost to Follow-up|0|||
127783651|NCT01704287|459834407|FG004|Initial Treatment Period|Lost to Follow-up|0|||
127783652|NCT01704287|459834403|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
127783653|NCT01704287|459834404|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
127783654|NCT01704287|459834405|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
127783655|NCT01704287|459834406|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
127783656|NCT01704287|459834407|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
127783657|NCT01704287|459834403|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
127783658|NCT01704287|459834404|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
127783659|NCT01704287|459834405|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
127783660|NCT01704287|459834406|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
127783661|NCT01704287|459834407|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
127783662|NCT01704287|459834403|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
127783663|NCT01704287|459834404|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
127783664|NCT01704287|459834405|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
127783665|NCT01704287|459834406|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
127783666|NCT01704287|459834407|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
127783667|NCT01704287|459834403|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
127783668|NCT01704287|459834404|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
127783669|NCT01704287|459834405|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
127783670|NCT01704287|459834406|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
127783671|NCT01704287|459834407|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
127783672|NCT04024228|459834408|FG000|Overall Study|Adverse Event|1|||
127783673|NCT04024228|459834409|FG001|Overall Study|Adverse Event|0|||
127783674|NCT04024228|459834408|FG000|Overall Study|Protocol Deviation|0|||
127783675|NCT04024228|459834409|FG001|Overall Study|Protocol Deviation|2|||
127783676|NCT04024228|459834408|FG000|Overall Study|Withdrawal by Subject|3|||
127783677|NCT04024228|459834409|FG001|Overall Study|Withdrawal by Subject|4|||
127783678|NCT00938717|459834410|FG000|Overall Study|Adverse Event|10|||
127783679|NCT00938717|459834411|FG001|Overall Study|Adverse Event|41|||
127783680|NCT00938717|459834410|FG000|Overall Study|Protocol Violation|11|||
127783681|NCT00938717|459834411|FG001|Overall Study|Protocol Violation|8|||
127783682|NCT00938717|459834410|FG000|Overall Study|Withdrawal by Subject|26|||
127783683|NCT00938717|459834411|FG001|Overall Study|Withdrawal by Subject|24|||
127783684|NCT00938717|459834410|FG000|Overall Study|Lost to Follow-up|13|||
127783685|NCT00938717|459834411|FG001|Overall Study|Lost to Follow-up|18|||
127783686|NCT00938717|459834410|FG000|Overall Study|Lack of Efficacy|33|||
127783687|NCT00938717|459834411|FG001|Overall Study|Lack of Efficacy|15|||
127783688|NCT00938717|459834410|FG000|Overall Study|Other reason|5|||
127783689|NCT00938717|459834411|FG001|Overall Study|Other reason|2|||
127783690|NCT01462435|459834414|FG000|Overall Study|Lack of Efficacy|1|||
127783691|NCT01462435|459834415|FG001|Overall Study|Lack of Efficacy|0|||
127783692|NCT01462435|459834416|FG002|Overall Study|Lack of Efficacy|0|||
127783693|NCT01462435|459834417|FG003|Overall Study|Lack of Efficacy|3|||
127783694|NCT01462435|459834414|FG000|Overall Study|Physician Decision|0|||
127783695|NCT01462435|459834415|FG001|Overall Study|Physician Decision|0|||
127783696|NCT01462435|459834416|FG002|Overall Study|Physician Decision|1|||
127783697|NCT01462435|459834417|FG003|Overall Study|Physician Decision|0|||
127783698|NCT01462435|459834414|FG000|Overall Study|Withdrawal by Subject|0|||
127783699|NCT01462435|459834415|FG001|Overall Study|Withdrawal by Subject|0|||
127783700|NCT01462435|459834416|FG002|Overall Study|Withdrawal by Subject|0|||
127783701|NCT01462435|459834417|FG003|Overall Study|Withdrawal by Subject|1|||
127783702|NCT01462435|459834414|FG000|Overall Study|Lost to Follow-up|0|||
127783703|NCT01462435|459834415|FG001|Overall Study|Lost to Follow-up|0|||
127783704|NCT01462435|459834416|FG002|Overall Study|Lost to Follow-up|0|||
127783705|NCT01462435|459834417|FG003|Overall Study|Lost to Follow-up|1|||
127783706|NCT05092919|459834418|FG000|Overall Study|Lost to Follow-up|7|||
127783707|NCT05092919|459834418|FG000|Overall Study|Withdrawal by Subject|2|||
127783708|NCT02248259|459834420|FG000|Treatment Period 1|Adverse Event|0|||
128031468|NCT05375929|460741167|FG001|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
128031469|NCT05375929|460741168|FG002|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
128031470|NCT05375929|460741169|FG003|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|1|||
128031471|NCT05375929|460741166|FG000|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
128031472|NCT05375929|460741167|FG001|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
128031473|NCT05375929|460741168|FG002|Substudy: Treatment Phase (1 Year)|Physician Decision|4|||
128031474|NCT05375929|460741169|FG003|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
128031475|NCT05375929|460741166|FG000|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
128031476|NCT05375929|460741167|FG001|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
128031477|NCT05375929|460741168|FG002|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|1|||
128031478|NCT05375929|460741169|FG003|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
128031479|NCT05375929|460741166|FG000|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
128031480|NCT05375929|460741167|FG001|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
128031481|NCT05375929|460741168|FG002|Substudy: Treatment Phase (1 Year)|Adverse Event|2|||
128031482|NCT05375929|460741169|FG003|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
128031483|NCT00773461|460741174|FG000|Overall Study|Adverse Event|1|||
128031484|NCT00773461|460741175|FG001|Overall Study|Adverse Event|3|||
128031485|NCT00773461|460741174|FG000|Overall Study|Withdrawal by Subject|4|||
128031486|NCT00773461|460741175|FG001|Overall Study|Withdrawal by Subject|1|||
128031487|NCT00322218|460741178|FG000|Overall Study|Death|3|||
127583440|NCT00150709|459105114|FG000|Overall Study|Decision of parent(s)|1|||
127583441|NCT00150709|459105115|FG001|Overall Study|Decision of parent(s)|2|||
127583442|NCT00150709|459105116|FG002|Overall Study|Decision of parent(s)|0|||
127583443|NCT00150709|459105117|FG003|Overall Study|Decision of parent(s)|0|||
127583444|NCT00150709|459105114|FG000|Overall Study|Decision of parent(s) and investigator|3|||
127583445|NCT00150709|459105115|FG001|Overall Study|Decision of parent(s) and investigator|0|||
127583446|NCT00150709|459105116|FG002|Overall Study|Decision of parent(s) and investigator|0|||
127583447|NCT00150709|459105117|FG003|Overall Study|Decision of parent(s) and investigator|0|||
127583448|NCT00150709|459105114|FG000|Overall Study|Loss/ incompleteness of efficacy|12|||
127583449|NCT00150709|459105115|FG001|Overall Study|Loss/ incompleteness of efficacy|12|||
127583450|NCT00150709|459105116|FG002|Overall Study|Loss/ incompleteness of efficacy|2|||
127583451|NCT00150709|459105117|FG003|Overall Study|Loss/ incompleteness of efficacy|2|||
127583452|NCT00150709|459105114|FG000|Overall Study|Investigator decision|1|||
127583453|NCT00150709|459105115|FG001|Overall Study|Investigator decision|0|||
127583454|NCT00150709|459105116|FG002|Overall Study|Investigator decision|0|||
127583455|NCT00150709|459105117|FG003|Overall Study|Investigator decision|1|||
127583456|NCT00150709|459105114|FG000|Overall Study|Subject relocated|2|||
127583457|NCT00150709|459105115|FG001|Overall Study|Subject relocated|2|||
127583458|NCT00150709|459105116|FG002|Overall Study|Subject relocated|1|||
127583459|NCT00150709|459105117|FG003|Overall Study|Subject relocated|0|||
127583460|NCT00150709|459105114|FG000|Overall Study|Subject continues Keppra through prescriptions|0|||
127583461|NCT00150709|459105115|FG001|Overall Study|Subject continues Keppra through prescriptions|4|||
127783709|NCT02248259|459834421|FG001|Treatment Period 1|Adverse Event|0|||
127783710|NCT02248259|459834422|FG002|Treatment Period 1|Adverse Event|1|||
127783711|NCT02248259|459834423|FG003|Treatment Period 1|Adverse Event|0|||
127783712|NCT02573870|459834424|FG000|Overall Study|Adverse Event|0|||
127783713|NCT02573870|459834425|FG001|Overall Study|Adverse Event|2|||
127783714|NCT02573870|459834424|FG000|Overall Study|Lack of Efficacy|0|||
127783715|NCT02573870|459834425|FG001|Overall Study|Lack of Efficacy|1|||
127783716|NCT02573870|459834424|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
127783717|NCT02573870|459834425|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
127783718|NCT02573870|459834424|FG000|Overall Study|Lost to Follow-up|0|||
127783719|NCT02573870|459834425|FG001|Overall Study|Lost to Follow-up|1|||
127783720|NCT02573870|459834424|FG000|Overall Study|Other: Fail to Meet Visit|0|||
127783721|NCT02573870|459834425|FG001|Overall Study|Other: Fail to Meet Visit|2|||
127783722|NCT01848288|459834432|FG000|Overall Study|Death|1|||
127783723|NCT01848288|459834432|FG000|Overall Study|Protocol Violation|1|||
127783724|NCT01848288|459834432|FG000|Overall Study|Withdrawal by Subject|1|||
127783725|NCT01007032|459834434|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
127783726|NCT01007032|459834435|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
127783727|NCT01007032|459834436|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
127783728|NCT01007032|459834437|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
127783729|NCT01007032|459834434|FG000|Overall Study|Withdrawal by Subject|0|||
127783730|NCT01007032|459834435|FG001|Overall Study|Withdrawal by Subject|0|||
127783731|NCT01007032|459834436|FG002|Overall Study|Withdrawal by Subject|0|||
127783732|NCT01007032|459834437|FG003|Overall Study|Withdrawal by Subject|1|||
127783733|NCT00677820|459834438|FG000|Overall Study|Lost to Follow-up|1|||
127783734|NCT00677820|459834439|FG001|Overall Study|Lost to Follow-up|0|||
127881755|NCT00756652|460188864|FG000|Re-Op Phase|Withdrawal by Subject|62|||
128031488|NCT00322218|460741179|FG001|Overall Study|Death|6|||
128031489|NCT00908141|460741187|FG000|Overall Study|Withdrawal by Subject|0|||
128031490|NCT00908141|460741188|FG001|Overall Study|Withdrawal by Subject|1|||
128031491|NCT02520154|460741189|FG000|Overall Study|Death|1|||
128031492|NCT02520154|460741189|FG000|Overall Study|Withdrawal by Subject|2|||
127881756|NCT00756652|460188865|FG001|Re-Op Phase|Withdrawal by Subject|0|||
127881757|NCT00756652|460188864|FG000|Re-Op Phase|Death|6|||
127881758|NCT00756652|460188865|FG001|Re-Op Phase|Death|0|||
127881759|NCT00756652|460188864|FG000|Re-Op Phase|Lost to Follow-up|340|||
127881760|NCT00756652|460188865|FG001|Re-Op Phase|Lost to Follow-up|0|||
127881761|NCT00756652|460188864|FG000|Re-Op Phase|Site Closed|2454|||
127881762|NCT00756652|460188865|FG001|Re-Op Phase|Site Closed|0|||
127881763|NCT00756652|460188864|FG000|Re-Op Phase|Withdrawn after explant|14|||
127881764|NCT00756652|460188865|FG001|Re-Op Phase|Withdrawn after explant|0|||
127881765|NCT02610842|460188866|FG000|Overall Study|Lost to Follow-up|5|||
127881766|NCT00038467|460188867|FG000|Overall Study|Adverse Event|170|||
127881767|NCT00038467|460188868|FG001|Overall Study|Adverse Event|145|||
127881768|NCT00038467|460188867|FG000|Overall Study|Withdrawal by Subject|150|||
127881769|NCT00038467|460188868|FG001|Overall Study|Withdrawal by Subject|107|||
127881770|NCT00038467|460188867|FG000|Overall Study|Protocol Violation|19|||
127881771|NCT00038467|460188868|FG001|Overall Study|Protocol Violation|22|||
127881772|NCT00038467|460188867|FG000|Overall Study|Death|22|||
127881773|NCT00038467|460188868|FG001|Overall Study|Death|16|||
127881774|NCT00038467|460188867|FG000|Overall Study|Lost to Follow-up|15|||
127881775|NCT00038467|460188868|FG001|Overall Study|Lost to Follow-up|10|||
127881776|NCT00038467|460188867|FG000|Overall Study|Recurrence|109|||
127881777|NCT00038467|460188868|FG001|Overall Study|Recurrence|179|||
127881778|NCT00038467|460188867|FG000|Overall Study|Randomized, but not treated|31|||
127881779|NCT00038467|460188868|FG001|Overall Study|Randomized, but not treated|35|||
127881780|NCT00038467|460188867|FG000|Overall Study|Other|26|||
127881781|NCT00038467|460188868|FG001|Overall Study|Other|28|||
127881782|NCT01988493|460188869|FG000|Overall Study|Randomized but not treated|0|||
127881783|NCT01988493|460188870|FG001|Overall Study|Randomized but not treated|0|||
127881784|NCT01988493|460188871|FG002|Overall Study|Randomized but not treated|0|||
127881785|NCT01988493|460188872|FG003|Overall Study|Randomized but not treated|0|||
127881786|NCT01988493|460188873|FG004|Overall Study|Randomized but not treated|1|||
127881787|NCT00627458|460188874|FG000|Overall Study|Migrated from study area|1|||
127881788|NCT00627458|460188875|FG001|Overall Study|Migrated from study area|0|||
127881789|NCT00627458|460188876|FG002|Overall Study|Migrated from study area|1|||
127881790|NCT00627458|460188874|FG000|Overall Study|Withdrawal by Subject|2|||
127881791|NCT00627458|460188875|FG001|Overall Study|Withdrawal by Subject|6|||
127881792|NCT00627458|460188876|FG002|Overall Study|Withdrawal by Subject|5|||
127881793|NCT00627458|460188874|FG000|Overall Study|Lost to Follow-up|1|||
127881794|NCT00627458|460188875|FG001|Overall Study|Lost to Follow-up|1|||
127881795|NCT00627458|460188876|FG002|Overall Study|Lost to Follow-up|0|||
127881796|NCT02617446|460188880|FG000|Overall Study|Withdrawal by Subject|0|||
127881797|NCT02617446|460188881|FG001|Overall Study|Withdrawal by Subject|2|||
127881798|NCT02617446|460188882|FG002|Overall Study|Withdrawal by Subject|0|||
127881799|NCT02617446|460188880|FG000|Overall Study|Adverse Event|1|||
127881800|NCT02617446|460188881|FG001|Overall Study|Adverse Event|0|||
127881801|NCT02617446|460188882|FG002|Overall Study|Adverse Event|5|||
127881802|NCT02617446|460188880|FG000|Overall Study|Lost to Follow-up|3|||
127881803|NCT02617446|460188881|FG001|Overall Study|Lost to Follow-up|0|||
127881804|NCT02617446|460188882|FG002|Overall Study|Lost to Follow-up|0|||
127881805|NCT02617446|460188880|FG000|Overall Study|Death|0|||
127881806|NCT02617446|460188881|FG001|Overall Study|Death|0|||
127881807|NCT02617446|460188882|FG002|Overall Study|Death|2|||
127881808|NCT00530088|460188883|FG000|Overall Study|Disease Progression|4|||
127881809|NCT00530088|460188883|FG000|Overall Study|Physician Decision|4|||
127881810|NCT00530088|460188883|FG000|Overall Study|Other Not Specified|2|||
127881811|NCT00902278|460188884|FG000|Overall Study|Physician Decision|1|||
127881812|NCT00902278|460188885|FG001|Overall Study|Physician Decision|0|||
127881813|NCT00902278|460188886|FG002|Overall Study|Physician Decision|2|||
127881814|NCT00902278|460188887|FG003|Overall Study|Physician Decision|0|||
127881815|NCT00902278|460188888|FG004|Overall Study|Physician Decision|1|||
127881816|NCT00902278|460188884|FG000|Overall Study|Lost to Follow-up|3|||
127881817|NCT00902278|460188885|FG001|Overall Study|Lost to Follow-up|2|||
128031493|NCT02520154|460741189|FG000|Overall Study|Physician Decision|2|||
128031494|NCT00980044|460742785|FG000|Overall Study|Withdrawal by Subject|5|||
128031495|NCT00980044|460742786|FG001|Overall Study|Withdrawal by Subject|7|||
128031496|NCT00980044|460742787|FG002|Overall Study|Withdrawal by Subject|3|||
128031497|NCT00980044|460742785|FG000|Overall Study|Protocol Violation|0|||
127881818|NCT00902278|460188886|FG002|Overall Study|Lost to Follow-up|3|||
127881819|NCT00902278|460188887|FG003|Overall Study|Lost to Follow-up|0|||
127881820|NCT00902278|460188888|FG004|Overall Study|Lost to Follow-up|1|||
127881821|NCT04822701|460188895|FG000|Overall Study|Not treated|2|||
127881822|NCT04822701|460188896|FG001|Overall Study|Not treated|0|||
127881823|NCT04822701|460188895|FG000|Overall Study|Lost to Follow-up|1|||
127881824|NCT04822701|460188896|FG001|Overall Study|Lost to Follow-up|0|||
127881825|NCT04822701|460188895|FG000|Overall Study|Withdrawal by Subject|1|||
127881826|NCT04822701|460188896|FG001|Overall Study|Withdrawal by Subject|0|||
127881827|NCT00858234|460190691|FG000|Overall Study|Adverse Event|6|||
127881828|NCT00858234|460190691|FG000|Overall Study|Progressive disease|2|||
127881829|NCT00858234|460190691|FG000|Overall Study|Status unknown|1|||
127881830|NCT01678924|460190692|FG000|Overall Study|Adverse Event|1|||
127881831|NCT01678924|460190693|FG001|Overall Study|Adverse Event|1|||
128031498|NCT00980044|460742786|FG001|Overall Study|Protocol Violation|0|||
128031499|NCT00980044|460742787|FG002|Overall Study|Protocol Violation|2|||
128031500|NCT00500331|460742791|FG000|Overall Study|Adverse Event|0|||
128031501|NCT00500331|460742792|FG001|Overall Study|Adverse Event|2|||
128031502|NCT00500331|460742793|FG002|Overall Study|Adverse Event|0|||
128031503|NCT00500331|460742794|FG003|Overall Study|Adverse Event|1|||
128031504|NCT00500331|460742795|FG004|Overall Study|Adverse Event|2|||
128031505|NCT00500331|460742796|FG005|Overall Study|Adverse Event|2|||
128031506|NCT00500331|460742797|FG006|Overall Study|Adverse Event|0|||
128031507|NCT00500331|460742791|FG000|Overall Study|Lost to Follow-up|1|||
128031508|NCT00500331|460742792|FG001|Overall Study|Lost to Follow-up|1|||
128031509|NCT00500331|460742793|FG002|Overall Study|Lost to Follow-up|1|||
128031510|NCT00500331|460742794|FG003|Overall Study|Lost to Follow-up|2|||
127583462|NCT00150709|459105116|FG002|Overall Study|Subject continues Keppra through prescriptions|0|||
127583463|NCT00150709|459105117|FG003|Overall Study|Subject continues Keppra through prescriptions|0|||
127583464|NCT00150709|459105114|FG000|Overall Study|Convenience|0|||
127583465|NCT00150709|459105115|FG001|Overall Study|Convenience|1|||
127583466|NCT00150709|459105116|FG002|Overall Study|Convenience|0|||
127583467|NCT00150709|459105117|FG003|Overall Study|Convenience|0|||
127583468|NCT00150709|459105114|FG000|Overall Study|Subject entered new drug study|0|||
127583469|NCT00150709|459105115|FG001|Overall Study|Subject entered new drug study|1|||
127583470|NCT00150709|459105116|FG002|Overall Study|Subject entered new drug study|0|||
127583471|NCT00150709|459105117|FG003|Overall Study|Subject entered new drug study|0|||
127583472|NCT00150709|459105114|FG000|Overall Study|Subject to undergo surgery for seizures|0|||
127583473|NCT00150709|459105115|FG001|Overall Study|Subject to undergo surgery for seizures|1|||
127583474|NCT00150709|459105116|FG002|Overall Study|Subject to undergo surgery for seizures|0|||
127583475|NCT00150709|459105117|FG003|Overall Study|Subject to undergo surgery for seizures|0|||
127583476|NCT00150709|459105114|FG000|Overall Study|Lack of ease of swallowing|0|||
127583477|NCT00150709|459105115|FG001|Overall Study|Lack of ease of swallowing|1|||
127583478|NCT00150709|459105116|FG002|Overall Study|Lack of ease of swallowing|0|||
127583479|NCT00150709|459105117|FG003|Overall Study|Lack of ease of swallowing|0|||
127583480|NCT02975336|459105118|FG000|DBPC (52 Weeks)|Adverse Event|16|||
127583481|NCT02975336|459105119|FG001|DBPC (52 Weeks)|Adverse Event|17|||
127583482|NCT02975336|459105120|FG002|DBPC (52 Weeks)|Adverse Event|13|||
127583483|NCT02975336|459105121|FG003|DBPC (52 Weeks)|Adverse Event|18|||
127583484|NCT02975336|459105122|FG004|DBPC (52 Weeks)|Adverse Event|0|||
127583485|NCT02975336|459105123|FG005|DBPC (52 Weeks)|Adverse Event|0|||
127583486|NCT02975336|459105124|FG006|DBPC (52 Weeks)|Adverse Event|0|||
127583487|NCT02975336|459105125|FG007|DBPC (52 Weeks)|Adverse Event|0|||
127583488|NCT02975336|459105118|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
127583489|NCT02975336|459105119|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
127583490|NCT02975336|459105120|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
127583491|NCT02975336|459105121|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
127583492|NCT02975336|459105122|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
127583493|NCT02975336|459105123|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
127583494|NCT02975336|459105124|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
127583495|NCT02975336|459105125|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
127583496|NCT02975336|459105118|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
127583497|NCT02975336|459105119|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
127583498|NCT02975336|459105120|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
127583499|NCT02975336|459105121|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
127583500|NCT02975336|459105122|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
127583501|NCT02975336|459105123|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
127583502|NCT02975336|459105124|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
127583503|NCT02975336|459105125|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
127583504|NCT02975336|459105118|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
127583505|NCT02975336|459105119|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
127583506|NCT02975336|459105120|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
127583507|NCT02975336|459105121|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
127583508|NCT02975336|459105122|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
127583509|NCT02975336|459105123|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
127583510|NCT02975336|459105124|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
127583511|NCT02975336|459105125|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
127583512|NCT02975336|459105118|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
127881832|NCT01678924|460190694|FG002|Overall Study|Adverse Event|0|||
127583513|NCT02975336|459105119|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
127881833|NCT01678924|460190695|FG003|Overall Study|Adverse Event|1|||
127583514|NCT02975336|459105120|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
127583515|NCT02975336|459105121|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
128031511|NCT00500331|460742795|FG004|Overall Study|Lost to Follow-up|1|||
128031512|NCT00500331|460742796|FG005|Overall Study|Lost to Follow-up|0|||
128031513|NCT00500331|460742797|FG006|Overall Study|Lost to Follow-up|0|||
128031514|NCT00500331|460742791|FG000|Overall Study|Protocol Violation|3|||
128031515|NCT00500331|460742792|FG001|Overall Study|Protocol Violation|1|||
128031516|NCT00500331|460742793|FG002|Overall Study|Protocol Violation|1|||
127583516|NCT02975336|459105122|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
127583517|NCT02975336|459105123|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
127583518|NCT02975336|459105124|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
127583519|NCT02975336|459105125|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
127583520|NCT02975336|459105118|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
127583521|NCT02975336|459105119|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
127583522|NCT02975336|459105120|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
127583523|NCT02975336|459105121|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
127583524|NCT02975336|459105122|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
127583525|NCT02975336|459105123|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
127583526|NCT02975336|459105124|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
127583527|NCT02975336|459105125|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
128031517|NCT00500331|460742794|FG003|Overall Study|Protocol Violation|0|||
128031518|NCT00500331|460742795|FG004|Overall Study|Protocol Violation|1|||
128031519|NCT00500331|460742796|FG005|Overall Study|Protocol Violation|1|||
128031520|NCT00500331|460742797|FG006|Overall Study|Protocol Violation|1|||
128031521|NCT00500331|460742791|FG000|Overall Study|Withdrawal by Subject|4|||
128031522|NCT00500331|460742792|FG001|Overall Study|Withdrawal by Subject|0|||
128031523|NCT00500331|460742793|FG002|Overall Study|Withdrawal by Subject|1|||
128031524|NCT00500331|460742794|FG003|Overall Study|Withdrawal by Subject|5|||
128031525|NCT00500331|460742795|FG004|Overall Study|Withdrawal by Subject|0|||
128031526|NCT00500331|460742796|FG005|Overall Study|Withdrawal by Subject|1|||
128031527|NCT00500331|460742797|FG006|Overall Study|Withdrawal by Subject|1|||
128031528|NCT00500331|460742791|FG000|Overall Study|Lack of Efficacy|3|||
128031529|NCT00500331|460742792|FG001|Overall Study|Lack of Efficacy|1|||
128031530|NCT00500331|460742793|FG002|Overall Study|Lack of Efficacy|0|||
128031531|NCT00500331|460742794|FG003|Overall Study|Lack of Efficacy|0|||
128031532|NCT00500331|460742795|FG004|Overall Study|Lack of Efficacy|0|||
128031533|NCT00500331|460742796|FG005|Overall Study|Lack of Efficacy|0|||
128031534|NCT00500331|460742797|FG006|Overall Study|Lack of Efficacy|0|||
128031535|NCT00500331|460742791|FG000|Overall Study|Liver function test abnormality|0|||
128031536|NCT00500331|460742792|FG001|Overall Study|Liver function test abnormality|0|||
128031537|NCT00500331|460742793|FG002|Overall Study|Liver function test abnormality|1|||
128031538|NCT00500331|460742794|FG003|Overall Study|Liver function test abnormality|0|||
128031539|NCT00500331|460742795|FG004|Overall Study|Liver function test abnormality|0|||
128031540|NCT00500331|460742796|FG005|Overall Study|Liver function test abnormality|0|||
128031541|NCT00500331|460742797|FG006|Overall Study|Liver function test abnormality|0|||
128031542|NCT00500331|460742791|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
128031543|NCT00500331|460742792|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
128031544|NCT00500331|460742793|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
128031545|NCT00500331|460742794|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
128031546|NCT00500331|460742795|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
127583528|NCT02975336|459105118|FG000|LTE (104 Weeks)|Adverse Event|0|||
127583529|NCT02975336|459105119|FG001|LTE (104 Weeks)|Adverse Event|0|||
127583530|NCT02975336|459105120|FG002|LTE (104 Weeks)|Adverse Event|0|||
127583531|NCT02975336|459105121|FG003|LTE (104 Weeks)|Adverse Event|0|||
127583532|NCT02975336|459105122|FG004|LTE (104 Weeks)|Adverse Event|7|||
127583533|NCT02975336|459105123|FG005|LTE (104 Weeks)|Adverse Event|4|||
127583534|NCT02975336|459105124|FG006|LTE (104 Weeks)|Adverse Event|2|||
127583535|NCT02975336|459105125|FG007|LTE (104 Weeks)|Adverse Event|0|||
127583536|NCT02975336|459105118|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
127583537|NCT02975336|459105119|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
127583538|NCT02975336|459105120|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
127583539|NCT02975336|459105121|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
127583540|NCT02975336|459105122|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
127583541|NCT02975336|459105123|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
127583542|NCT02975336|459105124|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
127583543|NCT02975336|459105125|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
128031547|NCT00500331|460742796|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
128031548|NCT00500331|460742797|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
128031549|NCT00500331|460742791|FG000|Overall Study|Didn't return for continuation of study|1|||
127583544|NCT02975336|459105118|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
127583545|NCT02975336|459105119|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
127583546|NCT02975336|459105120|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
127783735|NCT01101438|459834443|FG000|Overall Study|Withdrawal by Subject|8|||
127783736|NCT01101438|459834444|FG001|Overall Study|Withdrawal by Subject|9|||
128031550|NCT00500331|460742792|FG001|Overall Study|Didn't return for continuation of study|0|||
128031551|NCT00500331|460742793|FG002|Overall Study|Didn't return for continuation of study|0|||
128031552|NCT00500331|460742794|FG003|Overall Study|Didn't return for continuation of study|0|||
128031553|NCT00500331|460742795|FG004|Overall Study|Didn't return for continuation of study|0|||
128031554|NCT00500331|460742796|FG005|Overall Study|Didn't return for continuation of study|0|||
128031555|NCT00500331|460742797|FG006|Overall Study|Didn't return for continuation of study|0|||
128031556|NCT00500331|460742791|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
127583547|NCT02975336|459105121|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
127583548|NCT02975336|459105122|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
127583549|NCT02975336|459105123|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
127583550|NCT02975336|459105124|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
128031557|NCT00500331|460742792|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
128031558|NCT00500331|460742793|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
128031559|NCT00500331|460742794|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
128031560|NCT00500331|460742795|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
128031561|NCT00500331|460742796|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
128031562|NCT00500331|460742797|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
128031563|NCT00500331|460742791|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
127583551|NCT02975336|459105125|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
127583552|NCT02975336|459105118|FG000|LTE (104 Weeks)|Other|0|||
127583553|NCT02975336|459105119|FG001|LTE (104 Weeks)|Other|0|||
127583554|NCT02975336|459105120|FG002|LTE (104 Weeks)|Other|0|||
127583555|NCT02975336|459105121|FG003|LTE (104 Weeks)|Other|0|||
127583556|NCT02975336|459105122|FG004|LTE (104 Weeks)|Other|55|||
127583557|NCT02975336|459105123|FG005|LTE (104 Weeks)|Other|63|||
127583558|NCT02975336|459105124|FG006|LTE (104 Weeks)|Other|76|||
127693891|NCT03385629|459507047|FG000|Follow-up Well Child Visit 2|Lost to Follow-up|214|||
127693892|NCT03385629|459507048|FG001|Follow-up Well Child Visit 2|Lost to Follow-up|160|||
127693893|NCT03385629|459507047|FG000|Follow-up Well Child Visit 2|Withdrawal by Subject|6|||
127693894|NCT03385629|459507048|FG001|Follow-up Well Child Visit 2|Withdrawal by Subject|3|||
127783737|NCT00290290|459834467|FG000|Overall Study|Death|3|||
127693895|NCT03385629|459507047|FG000|Follow-up Well Child Visit 3|Lost to Follow-up|266|||
127693896|NCT03385629|459507048|FG001|Follow-up Well Child Visit 3|Lost to Follow-up|186|||
127693897|NCT02913872|459507053|FG000|Overall Study|Withdrawal by Subject|1|||
127693898|NCT00220740|459507057|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
127783738|NCT00290290|459834468|FG001|Overall Study|Death|4|||
127783739|NCT00290290|459834467|FG000|Overall Study|Withdrawal by Subject|2|||
127783740|NCT00290290|459834468|FG001|Overall Study|Withdrawal by Subject|2|||
127783741|NCT00290290|459834467|FG000|Overall Study|Underwent clean surgical procedure|13|||
127783742|NCT00290290|459834468|FG001|Overall Study|Underwent clean surgical procedure|12|||
127783743|NCT03023059|459834472|FG000|Overall Study|Withdrawal by Subject|5|||
127783744|NCT00596947|459834477|FG000|Overall Study|study halted due to low enrollment|5|||
127783745|NCT00596947|459834478|FG001|Overall Study|study halted due to low enrollment|3|||
127783746|NCT00596947|459834477|FG000|Overall Study|Lost to Follow-up|1|||
127783747|NCT00596947|459834478|FG001|Overall Study|Lost to Follow-up|0|||
127783748|NCT00496730|459834479|FG000|Overall Study|Lost to Follow-up|4|||
127783749|NCT00496730|459834480|FG001|Overall Study|Lost to Follow-up|3|||
127783750|NCT00496730|459834479|FG000|Overall Study|Withdrawal by Subject|2|||
127783751|NCT00496730|459834480|FG001|Overall Study|Withdrawal by Subject|2|||
127783752|NCT00574288|459834481|FG000|Overall Study|Adverse Event|2|||
127783753|NCT00574288|459834482|FG001|Overall Study|Adverse Event|0|||
127783754|NCT00574288|459834483|FG002|Overall Study|Adverse Event|0|||
128031564|NCT00500331|460742792|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
128031565|NCT00500331|460742793|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
128031566|NCT00500331|460742794|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
128031567|NCT00500331|460742795|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
128031568|NCT00500331|460742796|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
128031569|NCT00500331|460742797|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
128031570|NCT00500331|460742791|FG000|Overall Study|Participant was randomized by mistake|1|||
128031571|NCT00500331|460742792|FG001|Overall Study|Participant was randomized by mistake|0|||
128031572|NCT00500331|460742793|FG002|Overall Study|Participant was randomized by mistake|0|||
128031573|NCT00500331|460742794|FG003|Overall Study|Participant was randomized by mistake|0|||
128031574|NCT00500331|460742795|FG004|Overall Study|Participant was randomized by mistake|0|||
128031575|NCT00500331|460742796|FG005|Overall Study|Participant was randomized by mistake|0|||
128031576|NCT00500331|460742797|FG006|Overall Study|Participant was randomized by mistake|0|||
128031577|NCT00500331|460742791|FG000|Overall Study|Diabetologist nurse in the study|0|||
128031578|NCT00500331|460742792|FG001|Overall Study|Diabetologist nurse in the study|0|||
128031579|NCT00500331|460742793|FG002|Overall Study|Diabetologist nurse in the study|1|||
128031580|NCT00500331|460742794|FG003|Overall Study|Diabetologist nurse in the study|0|||
128031581|NCT00500331|460742795|FG004|Overall Study|Diabetologist nurse in the study|0|||
128031582|NCT00500331|460742796|FG005|Overall Study|Diabetologist nurse in the study|0|||
128031583|NCT00500331|460742797|FG006|Overall Study|Diabetologist nurse in the study|0|||
128031584|NCT00500331|460742791|FG000|Overall Study|State ban of biological samples export|0|||
128031585|NCT00500331|460742792|FG001|Overall Study|State ban of biological samples export|0|||
128031586|NCT00500331|460742793|FG002|Overall Study|State ban of biological samples export|0|||
128031587|NCT00500331|460742794|FG003|Overall Study|State ban of biological samples export|1|||
128031588|NCT00500331|460742795|FG004|Overall Study|State ban of biological samples export|0|||
128031589|NCT00500331|460742796|FG005|Overall Study|State ban of biological samples export|0|||
128031590|NCT00500331|460742797|FG006|Overall Study|State ban of biological samples export|0|||
128031591|NCT00500331|460742791|FG000|Overall Study|Protocol violated|0|||
128031592|NCT00500331|460742792|FG001|Overall Study|Protocol violated|0|||
128031593|NCT00500331|460742793|FG002|Overall Study|Protocol violated|0|||
128031594|NCT00500331|460742794|FG003|Overall Study|Protocol violated|1|||
128031595|NCT00500331|460742795|FG004|Overall Study|Protocol violated|0|||
127583559|NCT02975336|459105125|FG007|LTE (104 Weeks)|Other|72|||
127783755|NCT00574288|459834484|FG003|Overall Study|Adverse Event|0|||
127783756|NCT00574288|459834485|FG004|Overall Study|Adverse Event|1|||
127783757|NCT00574288|459834486|FG005|Overall Study|Adverse Event|0|||
127583560|NCT01823146|459105126|FG000|Overall Study|Withdrawal by Subject|0|||
127583561|NCT01823146|459105127|FG001|Overall Study|Withdrawal by Subject|1|||
127583562|NCT01823146|459105126|FG000|Overall Study|Lost to Follow-up|2|||
127583563|NCT01823146|459105127|FG001|Overall Study|Lost to Follow-up|1|||
127583564|NCT02110238|459105128|FG000|12 Week Pivotal Phase|Adverse Event|3|||
127583565|NCT02110238|459105129|FG001|12 Week Pivotal Phase|Adverse Event|0|||
127583566|NCT02110238|459105128|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
127583567|NCT02110238|459105129|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
127583568|NCT02110238|459105128|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
127583569|NCT02110238|459105129|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
127583570|NCT02110238|459105128|FG000|12 Week Pivotal Phase|Physician Decision|0|||
127583571|NCT02110238|459105129|FG001|12 Week Pivotal Phase|Physician Decision|2|||
127583572|NCT02110238|459105128|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
127583573|NCT02110238|459105129|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
127783758|NCT00574288|459834487|FG006|Overall Study|Adverse Event|0|||
127783759|NCT00574288|459834481|FG000|Overall Study|Death|0|||
127783760|NCT00574288|459834482|FG001|Overall Study|Death|0|||
127783761|NCT00574288|459834483|FG002|Overall Study|Death|0|||
127783762|NCT00574288|459834484|FG003|Overall Study|Death|0|||
127783763|NCT00574288|459834485|FG004|Overall Study|Death|0|||
127783764|NCT00574288|459834486|FG005|Overall Study|Death|25|||
127583574|NCT02110238|459105128|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
127583575|NCT02110238|459105129|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
127583576|NCT02110238|459105128|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
127583577|NCT02110238|459105129|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
127583578|NCT02110238|459105128|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
127583579|NCT02110238|459105129|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
127583580|NCT02110238|459105128|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
127583581|NCT02110238|459105129|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
127583582|NCT02110238|459105128|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
127583583|NCT02110238|459105129|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
127583584|NCT02110238|459105128|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
127583585|NCT02110238|459105129|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
127583586|NCT01419626|459105136|FG000|Overall Study|Protocol Violation|3|||
127583587|NCT01419626|459105137|FG001|Overall Study|Protocol Violation|2|||
127583588|NCT01419626|459105138|FG002|Overall Study|Protocol Violation|2|||
127583589|NCT01419626|459105136|FG000|Overall Study|Withdrawal by Subject|1|||
127583590|NCT01419626|459105137|FG001|Overall Study|Withdrawal by Subject|0|||
127583591|NCT01419626|459105138|FG002|Overall Study|Withdrawal by Subject|0|||
127583592|NCT01419626|459105136|FG000|Overall Study|Lost to Follow-up|0|||
127583593|NCT01419626|459105137|FG001|Overall Study|Lost to Follow-up|1|||
127583594|NCT01419626|459105138|FG002|Overall Study|Lost to Follow-up|1|||
127583595|NCT01365052|459105139|FG000|Overall Study|Adverse Event|4|||
127583596|NCT01365052|459105140|FG001|Overall Study|Adverse Event|4|||
127583597|NCT01146912|459105141|FG000|Overall Study|Already received influenza vaccination|817|||
127583598|NCT01146912|459105142|FG001|Overall Study|Already received influenza vaccination|822|||
127583599|NCT01146912|459105143|FG002|Overall Study|Already received influenza vaccination|13|||
127583600|NCT01146912|459105144|FG003|Overall Study|Already received influenza vaccination|15|||
127583601|NCT01146912|459105145|FG004|Overall Study|Already received influenza vaccination|41|||
127583602|NCT01146912|459105146|FG005|Overall Study|Already received influenza vaccination|61|||
127583603|NCT01146912|459105147|FG006|Overall Study|Already received influenza vaccination|56|||
127583604|NCT01146912|459105148|FG007|Overall Study|Already received influenza vaccination|0|||
127583605|NCT01146912|459105141|FG000|Overall Study|< 14 weeks gestational age|0|||
127583606|NCT01146912|459105142|FG001|Overall Study|< 14 weeks gestational age|0|||
127583607|NCT01146912|459105143|FG002|Overall Study|< 14 weeks gestational age|3|||
127583608|NCT01146912|459105144|FG003|Overall Study|< 14 weeks gestational age|2|||
127583609|NCT01146912|459105145|FG004|Overall Study|< 14 weeks gestational age|0|||
127583610|NCT01146912|459105146|FG005|Overall Study|< 14 weeks gestational age|0|||
127583611|NCT01146912|459105147|FG006|Overall Study|< 14 weeks gestational age|0|||
127583612|NCT01146912|459105148|FG007|Overall Study|< 14 weeks gestational age|0|||
127583613|NCT01146912|459105141|FG000|Overall Study|Duplicate patient|0|||
127583614|NCT01146912|459105142|FG001|Overall Study|Duplicate patient|0|||
127583615|NCT01146912|459105143|FG002|Overall Study|Duplicate patient|1|||
127783765|NCT00574288|459834487|FG006|Overall Study|Death|21|||
127783766|NCT00574288|459834481|FG000|Overall Study|Lost to Follow-up|0|||
127783767|NCT00574288|459834482|FG001|Overall Study|Lost to Follow-up|0|||
127783768|NCT00574288|459834483|FG002|Overall Study|Lost to Follow-up|0|||
127783769|NCT00574288|459834484|FG003|Overall Study|Lost to Follow-up|0|||
127783770|NCT00574288|459834485|FG004|Overall Study|Lost to Follow-up|0|||
127783771|NCT00574288|459834486|FG005|Overall Study|Lost to Follow-up|1|||
127783772|NCT00574288|459834487|FG006|Overall Study|Lost to Follow-up|2|||
127783773|NCT00574288|459834481|FG000|Overall Study|Study Terminated By Sponsor|0|||
127583616|NCT01146912|459105144|FG003|Overall Study|Duplicate patient|0|||
127583617|NCT01146912|459105145|FG004|Overall Study|Duplicate patient|0|||
127583618|NCT01146912|459105146|FG005|Overall Study|Duplicate patient|0|||
127783774|NCT00574288|459834482|FG001|Overall Study|Study Terminated By Sponsor|0|||
127583619|NCT01146912|459105147|FG006|Overall Study|Duplicate patient|0|||
127783775|NCT00574288|459834483|FG002|Overall Study|Study Terminated By Sponsor|0|||
127783776|NCT00574288|459834484|FG003|Overall Study|Study Terminated By Sponsor|0|||
127783777|NCT00574288|459834485|FG004|Overall Study|Study Terminated By Sponsor|0|||
127783778|NCT00574288|459834486|FG005|Overall Study|Study Terminated By Sponsor|0|||
127583620|NCT01146912|459105148|FG007|Overall Study|Duplicate patient|0|||
127583621|NCT01145625|459105149|FG000|Overall Study|Lost to Follow-up|8|||
127583622|NCT01145625|459105150|FG001|Overall Study|Lost to Follow-up|9|||
127583623|NCT01145625|459105149|FG000|Overall Study|Adverse Event|6|||
127583624|NCT01145625|459105150|FG001|Overall Study|Adverse Event|4|||
127583625|NCT01145625|459105149|FG000|Overall Study|Protocol Violation|3|||
127783779|NCT00574288|459834487|FG006|Overall Study|Study Terminated By Sponsor|5|||
127783780|NCT00574288|459834481|FG000|Overall Study|Progressive Disease|17|||
127783781|NCT00574288|459834482|FG001|Overall Study|Progressive Disease|2|||
127783782|NCT00574288|459834483|FG002|Overall Study|Progressive Disease|3|||
127783783|NCT00574288|459834484|FG003|Overall Study|Progressive Disease|2|||
127783784|NCT00574288|459834485|FG004|Overall Study|Progressive Disease|1|||
127583626|NCT01145625|459105150|FG001|Overall Study|Protocol Violation|1|||
127583627|NCT01145625|459105149|FG000|Overall Study|Withdrawal by Subject|7|||
127583628|NCT01145625|459105150|FG001|Overall Study|Withdrawal by Subject|16|||
127583629|NCT01145625|459105149|FG000|Overall Study|Pregnancy|0|||
127583630|NCT01145625|459105150|FG001|Overall Study|Pregnancy|1|||
127583631|NCT02202980|459105153|FG000|Overall Study|Lack of Efficacy|1|||
127583632|NCT02202980|459105154|FG001|Overall Study|Lack of Efficacy|0|||
127583633|NCT02202980|459105155|FG002|Overall Study|Lack of Efficacy|7|||
127583634|NCT02202980|459105156|FG003|Overall Study|Lack of Efficacy|0|||
127583635|NCT02202980|459105157|FG004|Overall Study|Lack of Efficacy|3|||
127583636|NCT02202980|459105158|FG005|Overall Study|Lack of Efficacy|1|||
127583637|NCT02202980|459105159|FG006|Overall Study|Lack of Efficacy|11|||
127583638|NCT02202980|459105160|FG007|Overall Study|Lack of Efficacy|2|||
127583639|NCT02202980|459105161|FG008|Overall Study|Lack of Efficacy|2|||
127583640|NCT02202980|459105162|FG009|Overall Study|Lack of Efficacy|0|||
127583641|NCT02202980|459105163|FG010|Overall Study|Lack of Efficacy|0|||
127583642|NCT02202980|459105164|FG011|Overall Study|Lack of Efficacy|3|||
127583643|NCT02202980|459105165|FG012|Overall Study|Lack of Efficacy|10|||
127583644|NCT02202980|459105166|FG013|Overall Study|Lack of Efficacy|0|||
127583645|NCT02202980|459105153|FG000|Overall Study|Protocol Violation|0|||
127583646|NCT02202980|459105154|FG001|Overall Study|Protocol Violation|0|||
127583647|NCT02202980|459105155|FG002|Overall Study|Protocol Violation|0|||
127583648|NCT02202980|459105156|FG003|Overall Study|Protocol Violation|3|||
127583649|NCT02202980|459105157|FG004|Overall Study|Protocol Violation|3|||
127583650|NCT02202980|459105158|FG005|Overall Study|Protocol Violation|0|||
127583651|NCT02202980|459105159|FG006|Overall Study|Protocol Violation|0|||
127583652|NCT02202980|459105160|FG007|Overall Study|Protocol Violation|0|||
127583653|NCT02202980|459105161|FG008|Overall Study|Protocol Violation|0|||
127583654|NCT02202980|459105162|FG009|Overall Study|Protocol Violation|0|||
127583655|NCT02202980|459105163|FG010|Overall Study|Protocol Violation|0|||
127783785|NCT00574288|459834486|FG005|Overall Study|Progressive Disease|0|||
127783786|NCT00574288|459834487|FG006|Overall Study|Progressive Disease|0|||
127783787|NCT00574288|459834481|FG000|Overall Study|Other|1|||
127783788|NCT00574288|459834482|FG001|Overall Study|Other|1|||
127783789|NCT00574288|459834483|FG002|Overall Study|Other|0|||
127783790|NCT00574288|459834484|FG003|Overall Study|Other|0|||
127783791|NCT00574288|459834485|FG004|Overall Study|Other|0|||
127783792|NCT00574288|459834486|FG005|Overall Study|Other|0|||
127783793|NCT00574288|459834487|FG006|Overall Study|Other|0|||
127783794|NCT02361944|459834488|FG000|Overall Study|surgery cancellation|0|||
127783795|NCT02361944|459834489|FG001|Overall Study|surgery cancellation|1|||
127783796|NCT02811549|459834490|FG000|Overall Study|Lost to Follow-up|1|||
127783797|NCT02811549|459834490|FG000|Overall Study|Withdrawal by Subject|3|||
127783798|NCT02811549|459834490|FG000|Overall Study|Subject screen failed|4|||
127783799|NCT02811549|459834490|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
127783800|NCT03472924|459834492|FG000|Overall Study|Adverse Event|1|||
127783801|NCT03472924|459834493|FG001|Overall Study|Adverse Event|0|||
127783802|NCT00427349|459834495|FG000|Overall Study|Lack of Efficacy|23|||
127783803|NCT00427349|459834495|FG000|Overall Study|Adverse Event|14|||
127783804|NCT00427349|459834495|FG000|Overall Study|Death|1|||
127783805|NCT00427349|459834495|FG000|Overall Study|Withdrawal by Subject|3|||
127783806|NCT00427349|459834495|FG000|Overall Study|Alternative therapy|1|||
127583656|NCT02202980|459105164|FG011|Overall Study|Protocol Violation|0|||
127583657|NCT02202980|459105165|FG012|Overall Study|Protocol Violation|0|||
127583658|NCT02202980|459105166|FG013|Overall Study|Protocol Violation|0|||
127583659|NCT02202980|459105153|FG000|Overall Study|Lost to Follow-up|0|||
127583660|NCT02202980|459105154|FG001|Overall Study|Lost to Follow-up|1|||
127583661|NCT02202980|459105155|FG002|Overall Study|Lost to Follow-up|1|||
127583662|NCT02202980|459105156|FG003|Overall Study|Lost to Follow-up|1|||
127583663|NCT02202980|459105157|FG004|Overall Study|Lost to Follow-up|0|||
127583664|NCT02202980|459105158|FG005|Overall Study|Lost to Follow-up|0|||
127583665|NCT02202980|459105159|FG006|Overall Study|Lost to Follow-up|0|||
127583666|NCT02202980|459105160|FG007|Overall Study|Lost to Follow-up|1|||
127783807|NCT00427349|459834495|FG000|Overall Study|Other|2|||
128031596|NCT00500331|460742796|FG005|Overall Study|Protocol violated|0|||
127583667|NCT02202980|459105161|FG008|Overall Study|Lost to Follow-up|1|||
127583668|NCT02202980|459105162|FG009|Overall Study|Lost to Follow-up|0|||
127783808|NCT00427349|459834495|FG000|Overall Study|Ineligible|1|||
127783809|NCT00427349|459834495|FG000|Overall Study|Never started therapy|1|||
127583669|NCT02202980|459105163|FG010|Overall Study|Lost to Follow-up|0|||
127583670|NCT02202980|459105164|FG011|Overall Study|Lost to Follow-up|0|||
127583671|NCT02202980|459105165|FG012|Overall Study|Lost to Follow-up|1|||
127583672|NCT02202980|459105166|FG013|Overall Study|Lost to Follow-up|0|||
128031597|NCT00500331|460742797|FG006|Overall Study|Protocol violated|0|||
128031598|NCT00833703|460742798|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
128031599|NCT00833703|460742799|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
128031600|NCT05538728|460742800|FG000|Overall Study|Withdrawal by Subject|1|||
128031601|NCT05538728|460742801|FG001|Overall Study|Withdrawal by Subject|1|||
128031602|NCT01904279|460742802|FG000|Overall Study|Lack of Efficacy|2|||
128031603|NCT01904279|460742803|FG001|Overall Study|Lack of Efficacy|3|||
128031604|NCT01904279|460742802|FG000|Overall Study|Withdrawal by Subject|1|||
128031605|NCT01904279|460742803|FG001|Overall Study|Withdrawal by Subject|0|||
128031606|NCT00959049|460742806|FG000|Overall Study|Adverse Event|1|||
128031607|NCT00959049|460742807|FG001|Overall Study|Adverse Event|0|||
128031608|NCT00959049|460742808|FG002|Overall Study|Adverse Event|0|||
128031609|NCT00959049|460742809|FG003|Overall Study|Adverse Event|0|||
128031610|NCT00959049|460742810|FG004|Overall Study|Adverse Event|0|||
128031611|NCT00959049|460742811|FG005|Overall Study|Adverse Event|0|||
128031612|NCT00959049|460742806|FG000|Overall Study|Lost to Follow-up|17|||
128031613|NCT00959049|460742807|FG001|Overall Study|Lost to Follow-up|5|||
128031614|NCT00959049|460742808|FG002|Overall Study|Lost to Follow-up|1|||
128031615|NCT00959049|460742809|FG003|Overall Study|Lost to Follow-up|10|||
128031616|NCT00959049|460742810|FG004|Overall Study|Lost to Follow-up|9|||
128031617|NCT00959049|460742811|FG005|Overall Study|Lost to Follow-up|1|||
128031618|NCT00959049|460742806|FG000|Overall Study|Contraindicated medication|0|||
128031619|NCT00959049|460742807|FG001|Overall Study|Contraindicated medication|0|||
128031620|NCT00959049|460742808|FG002|Overall Study|Contraindicated medication|0|||
128031621|NCT00959049|460742809|FG003|Overall Study|Contraindicated medication|1|||
128031622|NCT00959049|460742810|FG004|Overall Study|Contraindicated medication|0|||
128031623|NCT00959049|460742811|FG005|Overall Study|Contraindicated medication|0|||
128031624|NCT00959049|460742806|FG000|Overall Study|Withdrawal by Subject|0|||
128031625|NCT00959049|460742807|FG001|Overall Study|Withdrawal by Subject|2|||
128031626|NCT00959049|460742808|FG002|Overall Study|Withdrawal by Subject|0|||
128031627|NCT00959049|460742809|FG003|Overall Study|Withdrawal by Subject|0|||
128031628|NCT00959049|460742810|FG004|Overall Study|Withdrawal by Subject|0|||
128031629|NCT00959049|460742811|FG005|Overall Study|Withdrawal by Subject|0|||
128031630|NCT02263547|460742812|FG000|Overall Study|Adverse Event|1|||
128031631|NCT02263547|460742812|FG000|Overall Study|Lost to Follow-up|2|||
127583673|NCT02202980|459105153|FG000|Overall Study|Withdrew Consent|0|||
127583674|NCT02202980|459105154|FG001|Overall Study|Withdrew Consent|1|||
127583675|NCT02202980|459105155|FG002|Overall Study|Withdrew Consent|2|||
127583676|NCT02202980|459105156|FG003|Overall Study|Withdrew Consent|0|||
127583677|NCT02202980|459105157|FG004|Overall Study|Withdrew Consent|0|||
127583678|NCT02202980|459105158|FG005|Overall Study|Withdrew Consent|0|||
127583679|NCT02202980|459105159|FG006|Overall Study|Withdrew Consent|0|||
127783810|NCT05082376|459834497|FG000|Overall Study|Lost to Follow-up|2|||
128031632|NCT00095576|460742813|FG000|Overall Study|Adverse Event|5|||
127583680|NCT02202980|459105160|FG007|Overall Study|Withdrew Consent|0|||
127583681|NCT02202980|459105161|FG008|Overall Study|Withdrew Consent|1|||
127583682|NCT02202980|459105162|FG009|Overall Study|Withdrew Consent|0|||
127583683|NCT02202980|459105163|FG010|Overall Study|Withdrew Consent|0|||
127583684|NCT02202980|459105164|FG011|Overall Study|Withdrew Consent|0|||
127583685|NCT02202980|459105165|FG012|Overall Study|Withdrew Consent|0|||
127583686|NCT02202980|459105166|FG013|Overall Study|Withdrew Consent|0|||
128031633|NCT00095576|460742814|FG001|Overall Study|Adverse Event|3|||
128031634|NCT00095576|460742813|FG000|Overall Study|Lost to Follow-up|233|||
128031635|NCT00095576|460742814|FG001|Overall Study|Lost to Follow-up|229|||
128031636|NCT00095576|460742813|FG000|Overall Study|Protocol Violation|1|||
128031637|NCT00095576|460742814|FG001|Overall Study|Protocol Violation|0|||
128031638|NCT00095576|460742813|FG000|Overall Study|Withdrawal by Subject|34|||
127583687|NCT05224141|459105171|FG000|Overall Study|Ongoing|75|||
127583688|NCT05224141|459105172|FG001|Overall Study|Ongoing|88|||
127583689|NCT05224141|459105171|FG000|Overall Study|Withdrawal by Subject|2|||
127583690|NCT05224141|459105172|FG001|Overall Study|Withdrawal by Subject|4|||
127583691|NCT05224141|459105171|FG000|Overall Study|Death|153|||
127583692|NCT05224141|459105172|FG001|Overall Study|Death|138|||
127583693|NCT03469934|459105175|FG000|Overall Study|Withdrawal by Subject|0|||
127583694|NCT03469934|459105176|FG001|Overall Study|Withdrawal by Subject|1|||
127583695|NCT04889222|459105180|FG000|Overall Study|Did not meet eligibility criteria|8|||
127583696|NCT04889222|459105180|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
127583697|NCT04889222|459105180|FG000|Overall Study|Did not proceed due to time constraints|5|||
127583698|NCT01609231|459105181|FG000|Overall Study|Adverse Event|1|||
127583699|NCT01609231|459105182|FG001|Overall Study|Adverse Event|3|||
127583700|NCT01609231|459105181|FG000|Overall Study|Physician Decision|1|||
127583701|NCT01609231|459105182|FG001|Overall Study|Physician Decision|0|||
127583702|NCT01609231|459105181|FG000|Overall Study|Withdrawal by Subject|1|||
127583703|NCT01609231|459105182|FG001|Overall Study|Withdrawal by Subject|0|||
127583704|NCT01180647|459105183|FG000|Overall Study|Lost to Follow-up|5|||
127583705|NCT01180647|459105184|FG001|Overall Study|Lost to Follow-up|6|||
127583706|NCT02639546|459105191|FG000|Overall Study|Death|2|||
127583707|NCT02639546|459105192|FG001|Overall Study|Death|2|||
127583708|NCT02639546|459105193|FG002|Overall Study|Death|1|||
127583709|NCT02639546|459105194|FG003|Overall Study|Death|2|||
127583710|NCT02639546|459105195|FG004|Overall Study|Death|2|||
127583711|NCT02639546|459105196|FG005|Overall Study|Death|2|||
127583712|NCT02639546|459105197|FG006|Overall Study|Death|0|||
127583713|NCT02639546|459105198|FG007|Overall Study|Death|0|||
127583714|NCT02639546|459105191|FG000|Overall Study|Lost to Follow-up|0|||
127583715|NCT02639546|459105192|FG001|Overall Study|Lost to Follow-up|0|||
127583716|NCT02639546|459105193|FG002|Overall Study|Lost to Follow-up|1|||
127583717|NCT02639546|459105194|FG003|Overall Study|Lost to Follow-up|0|||
127583718|NCT02639546|459105195|FG004|Overall Study|Lost to Follow-up|1|||
127583719|NCT02639546|459105196|FG005|Overall Study|Lost to Follow-up|1|||
127583720|NCT02639546|459105197|FG006|Overall Study|Lost to Follow-up|0|||
127583721|NCT02639546|459105198|FG007|Overall Study|Lost to Follow-up|1|||
127583722|NCT02639546|459105191|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
127583723|NCT02639546|459105192|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
127583724|NCT02639546|459105193|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
127583725|NCT02639546|459105194|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
127583726|NCT02639546|459105195|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
127583727|NCT02639546|459105196|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
127583728|NCT02639546|459105197|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
127583729|NCT02639546|459105198|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
127583730|NCT02639546|459105191|FG000|Overall Study|Study Terminated By Sponsor|0|||
127583731|NCT02639546|459105192|FG001|Overall Study|Study Terminated By Sponsor|2|||
127583732|NCT02639546|459105193|FG002|Overall Study|Study Terminated By Sponsor|3|||
127583733|NCT02639546|459105194|FG003|Overall Study|Study Terminated By Sponsor|4|||
127583734|NCT02639546|459105195|FG004|Overall Study|Study Terminated By Sponsor|4|||
127583735|NCT02639546|459105196|FG005|Overall Study|Study Terminated By Sponsor|3|||
127583736|NCT02639546|459105197|FG006|Overall Study|Study Terminated By Sponsor|3|||
127583737|NCT02639546|459105198|FG007|Overall Study|Study Terminated By Sponsor|9|||
127583738|NCT02639546|459105191|FG000|Overall Study|Withdrawal by Subject|2|||
127583739|NCT02639546|459105192|FG001|Overall Study|Withdrawal by Subject|2|||
127583740|NCT02639546|459105193|FG002|Overall Study|Withdrawal by Subject|1|||
127583741|NCT02639546|459105194|FG003|Overall Study|Withdrawal by Subject|0|||
127583742|NCT02639546|459105195|FG004|Overall Study|Withdrawal by Subject|0|||
127583743|NCT02639546|459105196|FG005|Overall Study|Withdrawal by Subject|1|||
127583744|NCT02639546|459105197|FG006|Overall Study|Withdrawal by Subject|2|||
127583745|NCT02639546|459105198|FG007|Overall Study|Withdrawal by Subject|1|||
127583746|NCT00113087|459105200|FG000|Overall Study|Death or Transplant|14|||
127583747|NCT00113087|459105201|FG001|Overall Study|Death or Transplant|16|||
127583748|NCT00113087|459105200|FG000|Overall Study|Family or MD withdrew subject|10|||
127583749|NCT00113087|459105201|FG001|Overall Study|Family or MD withdrew subject|5|||
127583750|NCT00386607|459105202|FG000|Core|Adverse Event|40|||
127583751|NCT00386607|459105203|FG001|Core|Adverse Event|0|||
127583752|NCT00386607|459105202|FG000|Core|Abnormal laboratory value(s)|3|||
127583753|NCT00386607|459105203|FG001|Core|Abnormal laboratory value(s)|0|||
127583754|NCT00386607|459105202|FG000|Core|Unsatisfactory therapeutic effect|23|||
127583755|NCT00386607|459105203|FG001|Core|Unsatisfactory therapeutic effect|0|||
127583756|NCT00386607|459105202|FG000|Core|Condition no longer requires study drug|4|||
127583757|NCT00386607|459105203|FG001|Core|Condition no longer requires study drug|0|||
127583758|NCT00386607|459105202|FG000|Core|Patient withdrew consent|15|||
127583759|NCT00386607|459105203|FG001|Core|Patient withdrew consent|0|||
127583760|NCT00386607|459105202|FG000|Core|Lost to Follow-up|23|||
127583761|NCT00386607|459105203|FG001|Core|Lost to Follow-up|0|||
127583762|NCT00386607|459105202|FG000|Core|Administrative problems|1|||
127583763|NCT00386607|459105203|FG001|Core|Administrative problems|0|||
127583764|NCT00386607|459105202|FG000|Core|Protocol Deviation|6|||
127583765|NCT00386607|459105203|FG001|Core|Protocol Deviation|0|||
127583766|NCT00386607|459105202|FG000|Extension|Adverse Event|0|||
127583767|NCT00386607|459105203|FG001|Extension|Adverse Event|6|||
127583768|NCT00386607|459105202|FG000|Extension|Abnormal laboratory value(s)|0|||
127583769|NCT00386607|459105203|FG001|Extension|Abnormal laboratory value(s)|1|||
127583770|NCT00386607|459105202|FG000|Extension|Administrative problems|0|||
127583771|NCT00386607|459105203|FG001|Extension|Administrative problems|1|||
127583772|NCT00386607|459105202|FG000|Extension|Lost to Follow-up|0|||
127583773|NCT00386607|459105203|FG001|Extension|Lost to Follow-up|3|||
127583774|NCT00386607|459105202|FG000|Extension|Patient withdrew consent|0|||
127583775|NCT00386607|459105203|FG001|Extension|Patient withdrew consent|5|||
127583776|NCT00386607|459105202|FG000|Extension|Unsatisfactory therapeutic effect|0|||
127583777|NCT00386607|459105203|FG001|Extension|Unsatisfactory therapeutic effect|1|||
127583778|NCT04251273|459105204|FG000|Overall Study|Lost to Follow-up|331|||
127583779|NCT04251273|459105205|FG001|Overall Study|Lost to Follow-up|290|||
127583780|NCT00810693|459105206|FG000|Treatment Period|Adverse Event|8|||
127583781|NCT00810693|459105207|FG001|Treatment Period|Adverse Event|1|||
127583782|NCT00810693|459105208|FG002|Treatment Period|Adverse Event|7|||
127583783|NCT00810693|459105206|FG000|Treatment Period|Death|0|||
127583784|NCT00810693|459105207|FG001|Treatment Period|Death|1|||
127583785|NCT00810693|459105208|FG002|Treatment Period|Death|2|||
127583786|NCT00810693|459105206|FG000|Treatment Period|Lack of Efficacy|0|||
127583787|NCT00810693|459105207|FG001|Treatment Period|Lack of Efficacy|0|||
127583788|NCT00810693|459105208|FG002|Treatment Period|Lack of Efficacy|1|||
127583789|NCT00810693|459105206|FG000|Treatment Period|Lost to Follow-up|1|||
127583790|NCT00810693|459105207|FG001|Treatment Period|Lost to Follow-up|0|||
127583791|NCT00810693|459105208|FG002|Treatment Period|Lost to Follow-up|0|||
127583792|NCT00810693|459105206|FG000|Treatment Period|Non-compliance|1|||
127583793|NCT00810693|459105207|FG001|Treatment Period|Non-compliance|0|||
127583794|NCT00810693|459105208|FG002|Treatment Period|Non-compliance|0|||
127583795|NCT00810693|459105206|FG000|Treatment Period|Protocol Violation|1|||
128031639|NCT00095576|460742814|FG001|Overall Study|Withdrawal by Subject|47|||
128031640|NCT00095576|460742813|FG000|Overall Study|Option to switch to a rollover study|1097|||
128031641|NCT00095576|460742814|FG001|Overall Study|Option to switch to a rollover study|1099|||
128031642|NCT00095576|460742813|FG000|Overall Study|Site terminated|75|||
128031643|NCT00095576|460742814|FG001|Overall Study|Site terminated|67|||
128031644|NCT00095576|460742813|FG000|Overall Study|Subject moved|30|||
128031645|NCT00095576|460742814|FG001|Overall Study|Subject moved|36|||
128031646|NCT01344356|460742815|FG000|Overall Study|Physician Decision|0|||
128031647|NCT01344356|460742816|FG001|Overall Study|Physician Decision|3|||
128031648|NCT01344356|460742815|FG000|Overall Study|Lost to Follow-up|0|||
128031649|NCT01344356|460742816|FG001|Overall Study|Lost to Follow-up|6|||
128031650|NCT02014467|460742819|FG000|Overall Study|Adverse Event|4|||
128031651|NCT02014467|460742820|FG001|Overall Study|Adverse Event|0|||
128031652|NCT02014467|460742819|FG000|Overall Study|Protocol Violation|3|||
128031653|NCT02014467|460742820|FG001|Overall Study|Protocol Violation|0|||
128031654|NCT02014467|460742819|FG000|Overall Study|Physician Decision|2|||
128031655|NCT02014467|460742820|FG001|Overall Study|Physician Decision|3|||
128031656|NCT02014467|460742819|FG000|Overall Study|Withdrawal by Subject|16|||
128031657|NCT02014467|460742820|FG001|Overall Study|Withdrawal by Subject|4|||
128031658|NCT00480532|460742823|FG000|Overall Study|Withdrawal by Subject|2|||
128031659|NCT00480532|460742824|FG001|Overall Study|Withdrawal by Subject|4|||
128031660|NCT00480532|460742825|FG002|Overall Study|Withdrawal by Subject|3|||
128031661|NCT00480532|460742826|FG003|Overall Study|Withdrawal by Subject|1|||
128031662|NCT00480532|460742823|FG000|Overall Study|Protocol Violation|0|||
128031663|NCT00480532|460742824|FG001|Overall Study|Protocol Violation|0|||
128031664|NCT00480532|460742825|FG002|Overall Study|Protocol Violation|1|||
128031665|NCT00480532|460742826|FG003|Overall Study|Protocol Violation|0|||
128031666|NCT03242434|460742827|FG000|Overall Study|Death|0|||
128031667|NCT03242434|460742828|FG001|Overall Study|Death|2|||
128031668|NCT03427619|460742829|FG000|Overall Study|Physician Decision|3|||
128031669|NCT03427619|460742829|FG000|Overall Study|Withdrawal by Subject|4|||
128031670|NCT03427619|460742829|FG000|Overall Study|Lost to Follow-up|5|||
128031671|NCT03427619|460742829|FG000|Overall Study|Administrative|4|||
128031672|NCT03427619|460742829|FG000|Overall Study|Other|2|||
127583796|NCT00810693|459105207|FG001|Treatment Period|Protocol Violation|2|||
127583797|NCT00810693|459105208|FG002|Treatment Period|Protocol Violation|2|||
127583798|NCT00810693|459105206|FG000|Treatment Period|Withdrawal by Subject|6|||
127583799|NCT00810693|459105207|FG001|Treatment Period|Withdrawal by Subject|2|||
127583800|NCT00810693|459105208|FG002|Treatment Period|Withdrawal by Subject|3|||
127583801|NCT00810693|459105206|FG000|Treatment Period|Not treated|0|||
127583802|NCT00810693|459105207|FG001|Treatment Period|Not treated|1|||
127583803|NCT00810693|459105208|FG002|Treatment Period|Not treated|1|||
127583804|NCT00810693|459105206|FG000|Follow-up Period (FUP)|Adverse Event|3|||
127583805|NCT00810693|459105207|FG001|Follow-up Period (FUP)|Adverse Event|1|||
127583806|NCT00810693|459105208|FG002|Follow-up Period (FUP)|Adverse Event|1|||
127583807|NCT00810693|459105206|FG000|Follow-up Period (FUP)|Death|2|||
127583808|NCT00810693|459105207|FG001|Follow-up Period (FUP)|Death|0|||
127783811|NCT04425720|459834505|FG000|Overall Study|Withdrawal by Subject|0|||
127783812|NCT04425720|459834506|FG001|Overall Study|Withdrawal by Subject|20|||
127783813|NCT00290186|459834507|FG000|Overall Study|Adverse Event|1|||
127783814|NCT00290186|459834508|FG001|Overall Study|Adverse Event|1|||
127783815|NCT00290186|459834507|FG000|Overall Study|Lost to Follow-up|3|||
127783816|NCT00290186|459834508|FG001|Overall Study|Lost to Follow-up|2|||
127783817|NCT00290186|459834507|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
127783818|NCT00290186|459834508|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
127783819|NCT00290186|459834507|FG000|Overall Study|Withdrawal by Subject|0|||
127881834|NCT01678924|460190692|FG000|Overall Study|Lack of Efficacy|7|||
127583809|NCT00810693|459105208|FG002|Follow-up Period (FUP)|Death|1|||
127583810|NCT00810693|459105206|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
127583811|NCT00810693|459105207|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
127583812|NCT00810693|459105208|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
127583813|NCT00810693|459105206|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
127583814|NCT00810693|459105207|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
128031673|NCT03427619|460742829|FG000|Overall Study|Unknown or Missing Completion Status|48|||
128031674|NCT05763381|460742830|FG000|Overall Study|Lost to Follow-up|2|||
127881835|NCT01678924|460190693|FG001|Overall Study|Lack of Efficacy|2|||
128031675|NCT05763381|460742831|FG001|Overall Study|Lost to Follow-up|3|||
128031676|NCT05763381|460742830|FG000|Overall Study|Withdrawal by Subject|1|||
128031677|NCT05763381|460742831|FG001|Overall Study|Withdrawal by Subject|2|||
128031678|NCT03464461|460742833|FG000|Overall Study|exclusionary medication given ,|1|||
128031679|NCT03464461|460742834|FG001|Overall Study|exclusionary medication given ,|2|||
127783820|NCT00290186|459834508|FG001|Overall Study|Withdrawal by Subject|1|||
127783821|NCT00445224|459834509|FG000|Specific Exercises|Withdrawal by Subject|3|||
127783822|NCT00445224|459834510|FG001|Specific Exercises|Withdrawal by Subject|3|||
127783823|NCT00445224|459834509|FG000|Specific Exercises|Withdrawal by Subject|1|||
127783824|NCT00445224|459834510|FG001|Specific Exercises|Withdrawal by Subject|0|||
127783825|NCT04085523|459834515|FG000|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
127783826|NCT04085523|459834516|FG001|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
127783827|NCT04085523|459834517|FG002|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
127783828|NCT04085523|459834518|FG003|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
127783829|NCT04085523|459834519|FG004|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
127783830|NCT04085523|459834520|FG005|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|2|||
128031680|NCT03464461|460742835|FG002|Overall Study|exclusionary medication given ,|0|||
128031681|NCT03464461|460742833|FG000|Overall Study|Physician Decision|0|||
128031682|NCT03464461|460742834|FG001|Overall Study|Physician Decision|1|||
128031683|NCT03464461|460742835|FG002|Overall Study|Physician Decision|0|||
128031684|NCT03685149|460742837|FG000|First Intervention (4 Weeks)|Adverse Event|0|||
128031685|NCT03685149|460742838|FG001|First Intervention (4 Weeks)|Adverse Event|2|||
128031686|NCT03685149|460742837|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
128031687|NCT03685149|460742838|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
128031688|NCT03685149|460742837|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
128031689|NCT03685149|460742838|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
128031690|NCT04876391|460742839|FG000|Overall Study|Withdrawal by Subject|1|||
128031691|NCT04876391|460742840|FG001|Overall Study|Withdrawal by Subject|10|||
128031692|NCT04876391|460742839|FG000|Overall Study|Lost to Follow-up|2|||
128031693|NCT04876391|460742840|FG001|Overall Study|Lost to Follow-up|4|||
128031694|NCT04876391|460742839|FG000|Overall Study|Lack of Efficacy|0|||
128031695|NCT04876391|460742840|FG001|Overall Study|Lack of Efficacy|2|||
128031696|NCT04876391|460742839|FG000|Overall Study|Adverse Event|3|||
128031697|NCT04876391|460742840|FG001|Overall Study|Adverse Event|1|||
128031698|NCT04876391|460742839|FG000|Overall Study|Patient non-compliance|0|||
128031699|NCT04876391|460742840|FG001|Overall Study|Patient non-compliance|1|||
128031700|NCT04876391|460742839|FG000|Overall Study|Personal reasons|0|||
128031701|NCT04876391|460742840|FG001|Overall Study|Personal reasons|1|||
128031702|NCT04876391|460742839|FG000|Overall Study|Withdrawn as per protocol|2|||
128031703|NCT04876391|460742840|FG001|Overall Study|Withdrawn as per protocol|2|||
128031704|NCT00209131|460742844|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
128031705|NCT00209131|460742845|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
128031706|NCT05360784|460742846|FG000|Overall Study|Discontinued|25|||
128031707|NCT05360784|460742847|FG001|Overall Study|Discontinued|11|||
128031708|NCT05142306|460742848|FG000|Overall Study|Withdrawal by Subject|0|||
127583815|NCT00810693|459105208|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
127583816|NCT00810693|459105206|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
127583817|NCT00810693|459105207|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
127583818|NCT00810693|459105208|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
127583819|NCT03212690|459105209|FG000|Overall Study|Protocol Violation|1|||
127583820|NCT02846324|459105210|FG000|Overall Study|Other|1|||
127583821|NCT02846324|459105211|FG001|Overall Study|Other|0|||
127583822|NCT02846324|459105212|FG002|Overall Study|Other|0|||
127583823|NCT02846324|459105213|FG003|Overall Study|Other|0|||
127783831|NCT01877915|459834523|FG000|Overall Study|Lost to Follow-up|10|||
127783832|NCT01877915|459834524|FG001|Overall Study|Lost to Follow-up|9|||
127783833|NCT01877915|459834523|FG000|Overall Study|Withdrawal by Subject|42|||
127783834|NCT01877915|459834524|FG001|Overall Study|Withdrawal by Subject|55|||
127783835|NCT01877915|459834523|FG000|Overall Study|Other|2|||
127783836|NCT01877915|459834524|FG001|Overall Study|Other|4|||
127783837|NCT03520959|459834525|FG000|Overall Study|Study terminated by Sponsor|0|||
127783838|NCT03520959|459834526|FG001|Overall Study|Study terminated by Sponsor|1|||
127783839|NCT01449461|459834527|FG000|Overall Study|Adverse Event|0|||
127783840|NCT01449461|459834528|FG001|Overall Study|Adverse Event|3|||
127783841|NCT01449461|459834529|FG002|Overall Study|Adverse Event|2|||
127881836|NCT01678924|460190694|FG002|Overall Study|Lack of Efficacy|0|||
127881837|NCT01678924|460190695|FG003|Overall Study|Lack of Efficacy|5|||
127881838|NCT01678924|460190692|FG000|Overall Study|Lost to Follow-up|0|||
127881839|NCT01678924|460190693|FG001|Overall Study|Lost to Follow-up|4|||
127881840|NCT01678924|460190694|FG002|Overall Study|Lost to Follow-up|0|||
127881841|NCT01678924|460190695|FG003|Overall Study|Lost to Follow-up|2|||
127881842|NCT01678924|460190692|FG000|Overall Study|Personal Reasons|2|||
127881843|NCT01678924|460190693|FG001|Overall Study|Personal Reasons|2|||
127881844|NCT01678924|460190694|FG002|Overall Study|Personal Reasons|2|||
127881845|NCT01678924|460190695|FG003|Overall Study|Personal Reasons|7|||
127881846|NCT01678924|460190692|FG000|Overall Study|Withdrawal by Subject|0|||
127881847|NCT01678924|460190693|FG001|Overall Study|Withdrawal by Subject|3|||
127881848|NCT01678924|460190694|FG002|Overall Study|Withdrawal by Subject|0|||
127881849|NCT01678924|460190695|FG003|Overall Study|Withdrawal by Subject|2|||
127881850|NCT01678924|460190692|FG000|Overall Study|Unable to attend scheduled visits|0|||
127881851|NCT01678924|460190693|FG001|Overall Study|Unable to attend scheduled visits|0|||
127881852|NCT01678924|460190694|FG002|Overall Study|Unable to attend scheduled visits|0|||
127583824|NCT02846324|459105210|FG000|Overall Study|Withdrawal by Subject|1|||
127583825|NCT02846324|459105211|FG001|Overall Study|Withdrawal by Subject|0|||
127583826|NCT02846324|459105212|FG002|Overall Study|Withdrawal by Subject|4|||
127583827|NCT02846324|459105213|FG003|Overall Study|Withdrawal by Subject|0|||
127583828|NCT01927627|459105216|FG000|Overall Study|Adverse Event|3|||
127583829|NCT01927627|459105216|FG000|Overall Study|Lack of Efficacy|1|||
127783842|NCT01449461|459834530|FG003|Overall Study|Adverse Event|3|||
127783843|NCT01449461|459834531|FG004|Overall Study|Adverse Event|4|||
127783844|NCT01449461|459834532|FG005|Overall Study|Adverse Event|4|||
127783845|NCT01449461|459834527|FG000|Overall Study|Death|0|||
127881853|NCT01678924|460190695|FG003|Overall Study|Unable to attend scheduled visits|1|||
127881854|NCT00640614|460190699|FG000|Overall Study|Lost to Follow-up|1|||
127881855|NCT00640614|460190700|FG001|Overall Study|Lost to Follow-up|0|||
127881856|NCT00529802|460190701|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
127583830|NCT01927627|459105216|FG000|Overall Study|Financial Concerns|1|||
127881857|NCT00529802|460190701|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
127783846|NCT01449461|459834528|FG001|Overall Study|Death|2|||
127583831|NCT00467857|459105220|FG000|Overall Study|Adverse Event|1|||
127583832|NCT00467857|459105221|FG001|Overall Study|Adverse Event|0|||
127783847|NCT01449461|459834529|FG002|Overall Study|Death|0|||
127783848|NCT01449461|459834530|FG003|Overall Study|Death|0|||
127783849|NCT01449461|459834531|FG004|Overall Study|Death|7|||
127783850|NCT01449461|459834532|FG005|Overall Study|Death|1|||
127783851|NCT01449461|459834527|FG000|Overall Study|Physician Decision|0|||
127783852|NCT01449461|459834528|FG001|Overall Study|Physician Decision|1|||
127783853|NCT01449461|459834529|FG002|Overall Study|Physician Decision|0|||
127783854|NCT01449461|459834530|FG003|Overall Study|Physician Decision|4|||
127783855|NCT01449461|459834531|FG004|Overall Study|Physician Decision|1|||
127783856|NCT01449461|459834532|FG005|Overall Study|Physician Decision|0|||
127783857|NCT01449461|459834527|FG000|Overall Study|Documented Progressive Disease|4|||
127783858|NCT01449461|459834528|FG001|Overall Study|Documented Progressive Disease|7|||
127783859|NCT01449461|459834529|FG002|Overall Study|Documented Progressive Disease|14|||
127783860|NCT01449461|459834530|FG003|Overall Study|Documented Progressive Disease|15|||
127783861|NCT01449461|459834531|FG004|Overall Study|Documented Progressive Disease|24|||
127783862|NCT01449461|459834532|FG005|Overall Study|Documented Progressive Disease|5|||
127783863|NCT01449461|459834527|FG000|Overall Study|Clinical Progressive Disease|2|||
127783864|NCT01449461|459834528|FG001|Overall Study|Clinical Progressive Disease|2|||
127783865|NCT01449461|459834529|FG002|Overall Study|Clinical Progressive Disease|0|||
127783866|NCT01449461|459834530|FG003|Overall Study|Clinical Progressive Disease|3|||
127783867|NCT01449461|459834531|FG004|Overall Study|Clinical Progressive Disease|4|||
127783868|NCT01449461|459834532|FG005|Overall Study|Clinical Progressive Disease|2|||
127583833|NCT00467857|459105220|FG000|Overall Study|Withdrew consent|2|||
127583834|NCT00467857|459105221|FG001|Overall Study|Withdrew consent|0|||
127583835|NCT00467857|459105220|FG000|Overall Study|Death|0|||
127583836|NCT00467857|459105221|FG001|Overall Study|Death|1|||
127583837|NCT00467857|459105220|FG000|Overall Study|Discharged from court service|0|||
127583838|NCT00467857|459105221|FG001|Overall Study|Discharged from court service|1|||
127583839|NCT00467857|459105220|FG000|Overall Study|Emergency care required|0|||
127583840|NCT00467857|459105221|FG001|Overall Study|Emergency care required|1|||
127583841|NCT00467857|459105220|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
127583842|NCT00467857|459105221|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
127583843|NCT00467857|459105220|FG000|Overall Study|Discontinuation reason missing|0|||
127583844|NCT00467857|459105221|FG001|Overall Study|Discontinuation reason missing|3|||
127583845|NCT03576495|459105226|FG000|Period 1 (0 Months)|Lost to Follow-up|51|||
127583846|NCT03576495|459105227|FG001|Period 1 (0 Months)|Lost to Follow-up|40|||
127583847|NCT04203797|459105229|FG000|Overall Study|Adverse Event|1|||
127783869|NCT01449461|459834527|FG000|Overall Study|Protocol Violation|0|||
127783870|NCT01449461|459834528|FG001|Overall Study|Protocol Violation|0|||
128031709|NCT05142306|460742849|FG001|Overall Study|Withdrawal by Subject|0|||
128031710|NCT05142306|460742850|FG002|Overall Study|Withdrawal by Subject|1|||
128031711|NCT02251041|460742851|FG000|Overall Study|Did not receive intervention|15|||
128031712|NCT02251041|460742852|FG001|Overall Study|Did not receive intervention|4|||
128031713|NCT04079920|460742853|FG000|Overall Study|Adverse event, not related to study drug|2|||
128031714|NCT04079920|460742853|FG000|Overall Study|Adverse event related to study drug|10|||
128031715|NCT04079920|460742853|FG000|Overall Study|Death|2|||
128031716|NCT04079920|460742853|FG000|Overall Study|Lost to Follow-up|22|||
128031717|NCT04079920|460742853|FG000|Overall Study|Physician Decision|1|||
128031718|NCT04079920|460742853|FG000|Overall Study|Withdrawal by Subject|11|||
127583848|NCT04203797|459105230|FG001|Overall Study|Adverse Event|0|||
127583849|NCT04203797|459105229|FG000|Overall Study|Did not complete End of Study follow-up|1|||
127583850|NCT04203797|459105230|FG001|Overall Study|Did not complete End of Study follow-up|0|||
127583851|NCT03208127|459105231|FG000|Overall Study|Death|1|||
127583852|NCT00579098|459105232|FG000|Overall Study|Lost to Follow-up|2|||
127583853|NCT00579098|459105233|FG001|Overall Study|Lost to Follow-up|0|||
127583854|NCT00579098|459105232|FG000|Overall Study|Adverse Event|2|||
127583855|NCT00579098|459105233|FG001|Overall Study|Adverse Event|3|||
127583856|NCT00579098|459105232|FG000|Overall Study|Withdrawal by Subject|2|||
127583857|NCT00579098|459105233|FG001|Overall Study|Withdrawal by Subject|3|||
127583858|NCT00579098|459105232|FG000|Overall Study|AF returned after ablation|3|||
127583859|NCT00579098|459105233|FG001|Overall Study|AF returned after ablation|2|||
127783871|NCT01449461|459834529|FG002|Overall Study|Protocol Violation|0|||
127783872|NCT01449461|459834530|FG003|Overall Study|Protocol Violation|1|||
127783873|NCT01449461|459834531|FG004|Overall Study|Protocol Violation|0|||
128031719|NCT04918771|460742854|FG000|Overall Study|Withdrawal by Subject|4|||
127583860|NCT02121522|459105238|FG000|Overall Study|Adverse Event|1|||
127583861|NCT00516074|459105240|FG000|Overall Study|Adverse Event|0|||
127583862|NCT00516074|459105241|FG001|Overall Study|Adverse Event|1|||
127583863|NCT00516074|459105240|FG000|Overall Study|Subject Decision|4|||
127583864|NCT00516074|459105241|FG001|Overall Study|Subject Decision|2|||
127583865|NCT00516074|459105240|FG000|Overall Study|Loss of Glucose Control|2|||
127783874|NCT01449461|459834532|FG005|Overall Study|Protocol Violation|0|||
128031720|NCT04918771|460742855|FG001|Overall Study|Withdrawal by Subject|5|||
127783875|NCT01449461|459834527|FG000|Overall Study|Site Terminated by Sponsor|0|||
128031721|NCT04918771|460742854|FG000|Overall Study|Incorrect inclusion ineligible patient|3|||
128031722|NCT04918771|460742855|FG001|Overall Study|Incorrect inclusion ineligible patient|4|||
128031723|NCT01299961|460742862|FG000|Overall Study|Adverse Event|3|||
128031724|NCT01299961|460742862|FG000|Overall Study|Lack of Efficacy|2|||
128031725|NCT01299961|460742862|FG000|Overall Study|Lost to Follow-up|1|||
127583866|NCT00516074|459105241|FG001|Overall Study|Loss of Glucose Control|0|||
127583867|NCT00338104|459105242|FG000|Overall Study|Protocol Violation|2|||
127583868|NCT00338104|459105243|FG001|Overall Study|Protocol Violation|1|||
127583869|NCT00338104|459105244|FG002|Overall Study|Protocol Violation|3|||
127583870|NCT00633750|459105246|FG000|Overall Study|Adverse Event|2|||
127583871|NCT00633750|459105246|FG000|Overall Study|Withdrawal by Subject|3|||
127583872|NCT02215096|459105249|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
127583873|NCT02215096|459105250|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
127583874|NCT02215096|459105251|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
127583875|NCT02215096|459105252|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
127583876|NCT02215096|459105253|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
128031726|NCT02904096|460742863|FG000|Overall Study|Adverse Event|1|||
128031727|NCT02904096|460742864|FG001|Overall Study|Adverse Event|0|||
128031728|NCT02904096|460742863|FG000|Overall Study|Withdrawal by Subject|4|||
128031729|NCT02904096|460742864|FG001|Overall Study|Withdrawal by Subject|3|||
127583877|NCT02215096|459105249|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
127583878|NCT02215096|459105250|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
127583879|NCT02215096|459105251|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
127583880|NCT02215096|459105252|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
127583881|NCT02215096|459105253|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
127583882|NCT02215096|459105249|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
127583883|NCT02215096|459105250|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
128031730|NCT02904096|460742863|FG000|Overall Study|Lost to Follow-up|10|||
127583884|NCT02215096|459105251|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
127583885|NCT02215096|459105252|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
127583886|NCT02215096|459105253|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
127583887|NCT02215096|459105249|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
127583888|NCT02215096|459105250|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
127583889|NCT02215096|459105251|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
127583890|NCT02215096|459105252|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
127583891|NCT02215096|459105253|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
127583892|NCT03666624|459105258|FG000|Overall Study|participant grieving over recent death of parent|1|||
127583893|NCT03666624|459105259|FG001|Overall Study|participant grieving over recent death of parent|0|||
127583894|NCT00569270|459105260|FG000|Period: First Intervention|Protocol Violation|0|||
127583895|NCT00569270|459105261|FG001|Period: First Intervention|Protocol Violation|1|||
127583896|NCT03822182|459105262|FG000|Overall Study|Protocol Violation|0|||
127583897|NCT03822182|459105263|FG001|Overall Study|Protocol Violation|1|||
127583898|NCT03822182|459105264|FG002|Overall Study|Protocol Violation|1|||
127583899|NCT00810355|459105265|FG000|Overall Study|Lost to Follow-up|13|||
127583900|NCT00810355|459105266|FG001|Overall Study|Lost to Follow-up|17|||
127583901|NCT00810355|459105267|FG002|Overall Study|Lost to Follow-up|11|||
127583902|NCT00810355|459105265|FG000|Overall Study|Withdrawal by Subject|1|||
127583903|NCT00810355|459105266|FG001|Overall Study|Withdrawal by Subject|0|||
127583904|NCT00810355|459105267|FG002|Overall Study|Withdrawal by Subject|0|||
127583905|NCT00003487|459105268|FG000|Overall Study|Not evaluable|2|||
127583906|NCT03855228|459105270|FG000|Overall Study|Adverse Event|2|||
128031731|NCT02904096|460742864|FG001|Overall Study|Lost to Follow-up|17|||
128031732|NCT02904096|460742863|FG000|Overall Study|Non-compliant|3|||
128031733|NCT02904096|460742864|FG001|Overall Study|Non-compliant|1|||
128031734|NCT02904096|460742863|FG000|Overall Study|Sponsor instructed|1|||
128031735|NCT02904096|460742864|FG001|Overall Study|Sponsor instructed|0|||
128031736|NCT05305651|460742865|FG000|Overall Study|Death|1|||
127583907|NCT03855228|459105271|FG001|Overall Study|Adverse Event|4|||
127583908|NCT03855228|459105272|FG002|Overall Study|Adverse Event|4|||
127693899|NCT00220740|459507058|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
127693900|NCT00220740|459507057|FG000|Efficacy Period|Adverse Event|1|||
127693901|NCT00220740|459507058|FG001|Efficacy Period|Adverse Event|1|||
127693902|NCT00220740|459507057|FG000|Efficacy Period|Withdrawal by Subject|1|||
128031737|NCT05305651|460742865|FG000|Overall Study|Withdrawal by Subject|4|||
128031738|NCT05305651|460742865|FG000|Overall Study|Lost to Follow-up|4|||
127583909|NCT03855228|459105273|FG003|Overall Study|Adverse Event|8|||
128031739|NCT00526799|460742866|FG000|Overall Study|Withdrawal by Subject|1|||
127583910|NCT03855228|459105270|FG000|Overall Study|Treatment Failure|1|||
128031740|NCT00526799|460742867|FG001|Overall Study|Withdrawal by Subject|0|||
127583911|NCT03855228|459105271|FG001|Overall Study|Treatment Failure|2|||
127583912|NCT03855228|459105272|FG002|Overall Study|Treatment Failure|1|||
127583913|NCT03855228|459105273|FG003|Overall Study|Treatment Failure|8|||
127583914|NCT03855228|459105270|FG000|Overall Study|Lost to Follow-up|0|||
127583915|NCT03855228|459105271|FG001|Overall Study|Lost to Follow-up|0|||
127583916|NCT03855228|459105272|FG002|Overall Study|Lost to Follow-up|0|||
127583917|NCT03855228|459105273|FG003|Overall Study|Lost to Follow-up|1|||
127583918|NCT03855228|459105270|FG000|Overall Study|Protocol Violation|0|||
127583919|NCT03855228|459105271|FG001|Overall Study|Protocol Violation|1|||
127583920|NCT03855228|459105272|FG002|Overall Study|Protocol Violation|2|||
127583921|NCT03855228|459105273|FG003|Overall Study|Protocol Violation|1|||
127583922|NCT03855228|459105270|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
127583923|NCT03855228|459105271|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
127583924|NCT03855228|459105272|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
127583925|NCT03855228|459105273|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
127583926|NCT01757535|459105276|FG000|Overall Study|Disease Relapse|151|||
127583927|NCT01757535|459105277|FG001|Overall Study|Disease Relapse|181|||
127583928|NCT01757535|459105276|FG000|Overall Study|Other Reasons|28|||
127583929|NCT01757535|459105277|FG001|Overall Study|Other Reasons|27|||
127583930|NCT01757535|459105276|FG000|Overall Study|Adverse Event|31|||
127583931|NCT01757535|459105277|FG001|Overall Study|Adverse Event|11|||
127583932|NCT01757535|459105276|FG000|Overall Study|Withdrew Consent|19|||
127583933|NCT01757535|459105277|FG001|Overall Study|Withdrew Consent|13|||
127583934|NCT01757535|459105276|FG000|Overall Study|Physician Decision|7|||
127583935|NCT01757535|459105277|FG001|Overall Study|Physician Decision|0|||
127583936|NCT01757535|459105276|FG000|Overall Study|Death|2|||
127583937|NCT01757535|459105277|FG001|Overall Study|Death|2|||
127583938|NCT05147428|459105280|FG000|Overall Study|Removed prior to mailing|289|||
128031741|NCT00526799|460742866|FG000|Overall Study|Intercurrent Complicating Disease|0|||
128031742|NCT00526799|460742867|FG001|Overall Study|Intercurrent Complicating Disease|1|||
127583939|NCT05147428|459105281|FG001|Overall Study|Removed prior to mailing|306|||
127583940|NCT05147428|459105282|FG002|Overall Study|Removed prior to mailing|270|||
127583941|NCT05147428|459105280|FG000|Overall Study|Died or disenrolled during blackout period|239|||
127583942|NCT05147428|459105281|FG001|Overall Study|Died or disenrolled during blackout period|278|||
127583943|NCT05147428|459105282|FG002|Overall Study|Died or disenrolled during blackout period|273|||
127583944|NCT00217620|459106876|FG000|Overall Study|Adverse Event|2|||
127583945|NCT00217620|459106876|FG000|Overall Study|Progression|31|||
127583946|NCT00217620|459106876|FG000|Overall Study|Not Protocol Specified|4|||
127583947|NCT00217620|459106876|FG000|Overall Study|Ineligible|13|||
127583948|NCT00217620|459106876|FG000|Overall Study|Never received treatment|1|||
127583949|NCT00825682|459106882|FG000|Overall Study|personal reasons/ inconvenience|13|||
127583950|NCT00825682|459106883|FG001|Overall Study|personal reasons/ inconvenience|5|||
127583951|NCT01550289|459106884|FG000|Overall Study|Protocol Violation|1|||
127583952|NCT01550289|459106885|FG001|Overall Study|Protocol Violation|0|||
127583953|NCT01550289|459106884|FG000|Overall Study|Lost to Follow-up|1|||
127583954|NCT01550289|459106885|FG001|Overall Study|Lost to Follow-up|1|||
127583955|NCT01550289|459106884|FG000|Overall Study|Withdrawal by Subject|11|||
127583956|NCT01550289|459106885|FG001|Overall Study|Withdrawal by Subject|3|||
127583957|NCT01897454|459106886|FG000|Overall Study|Withdrawal by Subject|1|||
127583958|NCT01392443|459106893|FG000|Overall Study|Disease progression|30|||
127583959|NCT01392443|459106893|FG000|Overall Study|Adverse Event|24|||
127583960|NCT01392443|459106893|FG000|Overall Study|Death|7|||
127583961|NCT01392443|459106893|FG000|Overall Study|Withdrawal by Subject|5|||
127583962|NCT01392443|459106893|FG000|Overall Study|Lost to Follow-up|1|||
127583963|NCT01392443|459106893|FG000|Overall Study|Protocol Violation|1|||
127583964|NCT01977794|459106894|FG000|Overall Study|Adverse Event|2|||
127583965|NCT01977794|459106895|FG001|Overall Study|Adverse Event|2|||
127583966|NCT01977794|459106894|FG000|Overall Study|Lost to Follow-up|2|||
127583967|NCT01977794|459106895|FG001|Overall Study|Lost to Follow-up|1|||
127583968|NCT01977794|459106894|FG000|Overall Study|Protocol Violation|1|||
127583969|NCT01977794|459106895|FG001|Overall Study|Protocol Violation|0|||
127583970|NCT01977794|459106894|FG000|Overall Study|Death|1|||
127583971|NCT01977794|459106895|FG001|Overall Study|Death|1|||
127583972|NCT01977794|459106894|FG000|Overall Study|Withdrew consent|2|||
127583973|NCT01977794|459106895|FG001|Overall Study|Withdrew consent|1|||
127583974|NCT01977794|459106894|FG000|Overall Study|Other|0|||
127583975|NCT01977794|459106895|FG001|Overall Study|Other|1|||
127583976|NCT00533897|459106900|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
127583977|NCT00533897|459106901|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
127583978|NCT00533897|459106902|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
127583979|NCT00533897|459106903|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
127583980|NCT00533897|459106904|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
127583981|NCT00533897|459106905|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
127583982|NCT00533897|459106906|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
127583983|NCT00533897|459106907|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
127583984|NCT00533897|459106900|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
127583985|NCT00533897|459106901|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
127583986|NCT00533897|459106902|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
127583987|NCT00533897|459106903|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
127583988|NCT00533897|459106904|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
127583989|NCT00533897|459106905|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
127583990|NCT00533897|459106906|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
127583991|NCT00533897|459106907|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
127583992|NCT00533897|459106900|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
127583993|NCT00533897|459106901|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
127583994|NCT00533897|459106902|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
127583995|NCT00533897|459106903|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
127583996|NCT00533897|459106904|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
127583997|NCT00533897|459106905|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
127583998|NCT00533897|459106906|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
127583999|NCT00533897|459106907|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
127584000|NCT00533897|459106900|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
127584001|NCT00533897|459106901|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
127584002|NCT00533897|459106902|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
127584003|NCT00533897|459106903|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
127584004|NCT00533897|459106904|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
127584005|NCT00533897|459106905|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
127584006|NCT00533897|459106906|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
127584007|NCT00533897|459106907|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
127584008|NCT00533897|459106900|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
127584009|NCT00533897|459106901|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
127584010|NCT00533897|459106902|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
127584011|NCT00533897|459106903|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
127584012|NCT00533897|459106904|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
127584013|NCT00533897|459106905|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
127584014|NCT00533897|459106906|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
127584015|NCT00533897|459106907|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
127584016|NCT00533897|459106900|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
127584017|NCT00533897|459106901|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
127584018|NCT00533897|459106902|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
127584019|NCT00533897|459106903|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
127584020|NCT00533897|459106904|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
127584021|NCT00533897|459106905|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
127584022|NCT00533897|459106906|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
127584023|NCT00533897|459106907|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
127584024|NCT00533897|459106900|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
127584025|NCT00533897|459106901|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
127584026|NCT00533897|459106902|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
127584027|NCT00533897|459106903|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
127584028|NCT00533897|459106904|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
127693903|NCT00220740|459507058|FG001|Efficacy Period|Withdrawal by Subject|0|||
128031743|NCT04003389|460742868|FG000|Overall Study|Adverse Event|27|||
128031744|NCT04003389|460742869|FG001|Overall Study|Adverse Event|34|||
128031745|NCT04003389|460742870|FG002|Overall Study|Adverse Event|28|||
128031746|NCT04003389|460742868|FG000|Overall Study|Lost to Follow-up|39|||
128031747|NCT04003389|460742869|FG001|Overall Study|Lost to Follow-up|30|||
128031748|NCT04003389|460742870|FG002|Overall Study|Lost to Follow-up|33|||
128031749|NCT04003389|460742868|FG000|Overall Study|Protocol Violation|1|||
128031750|NCT04003389|460742869|FG001|Overall Study|Protocol Violation|6|||
128031751|NCT04003389|460742870|FG002|Overall Study|Protocol Violation|5|||
128031752|NCT04003389|460742868|FG000|Overall Study|Withdrawal by Subject|119|||
128031753|NCT04003389|460742869|FG001|Overall Study|Withdrawal by Subject|79|||
127584029|NCT00533897|459106905|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
127584030|NCT00533897|459106906|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
127584031|NCT00533897|459106907|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
127584032|NCT00533897|459106900|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
127584033|NCT00533897|459106901|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
127584034|NCT00533897|459106902|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
127584035|NCT00533897|459106903|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
127584036|NCT00533897|459106904|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
127584037|NCT00533897|459106905|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
127584038|NCT00533897|459106906|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
127693904|NCT00220740|459507057|FG000|Efficacy Period|Protocol Violation|1|||
127693905|NCT00220740|459507058|FG001|Efficacy Period|Protocol Violation|0|||
127693906|NCT00220740|459507057|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
128031754|NCT04003389|460742870|FG002|Overall Study|Withdrawal by Subject|85|||
127881858|NCT00529802|460190701|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
127881859|NCT00529802|460190701|FG000|Evaluable for Primary Endpoint|Death|1|||
127881860|NCT00529802|460190701|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
127881861|NCT00529802|460190701|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
127584039|NCT00533897|459106907|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
127584040|NCT00533897|459106900|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
127584041|NCT00533897|459106901|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
127881862|NCT00529802|460190701|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
127881863|NCT01336608|460190702|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
127881864|NCT01336608|460190703|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
127881865|NCT01336608|460190704|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
127881866|NCT01336608|460190705|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
127881867|NCT01336608|460190702|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
127881868|NCT01336608|460190703|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
127881869|NCT01336608|460190704|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
127881870|NCT01336608|460190705|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
127881871|NCT01336608|460190702|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
127881872|NCT01336608|460190703|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
127881873|NCT01336608|460190704|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
127881874|NCT01336608|460190705|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
127881875|NCT01336608|460190702|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
127881876|NCT01336608|460190703|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
127881877|NCT01336608|460190704|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
127881878|NCT01336608|460190705|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
128031755|NCT04003389|460742868|FG000|Overall Study|Miscellaneous|14|||
128031756|NCT04003389|460742869|FG001|Overall Study|Miscellaneous|11|||
128031757|NCT04003389|460742870|FG002|Overall Study|Miscellaneous|14|||
128031758|NCT04003389|460742868|FG000|Overall Study|Participant did not receive study drug|1|||
128031759|NCT04003389|460742869|FG001|Overall Study|Participant did not receive study drug|0|||
128031760|NCT04003389|460742870|FG002|Overall Study|Participant did not receive study drug|0|||
128031761|NCT02298946|460742873|FG000|Overall Study|Did not receive treatment|2|||
128031762|NCT02298946|460742874|FG001|Overall Study|Did not receive treatment|0|||
128031763|NCT02298946|460742873|FG000|Overall Study|Unevaluable|2|||
128031764|NCT02298946|460742874|FG001|Overall Study|Unevaluable|1|||
128031765|NCT04629196|460742878|FG000|Overall Study|Subject discontinued study drug|1|||
128031766|NCT04629196|460742879|FG001|Overall Study|Subject discontinued study drug|0|||
128031767|NCT04629196|460742878|FG000|Overall Study|Subject study drug dosing increased|1|||
128031768|NCT04629196|460742879|FG001|Overall Study|Subject study drug dosing increased|1|||
128031769|NCT04629196|460742878|FG000|Overall Study|Withdrawal by Subject|1|||
128031770|NCT04629196|460742879|FG001|Overall Study|Withdrawal by Subject|2|||
128031771|NCT01450631|460742883|FG000|Overall Study|Lost to Follow-up|2|||
128031772|NCT01450631|460742884|FG001|Overall Study|Lost to Follow-up|4|||
128031773|NCT01450631|460742883|FG000|Overall Study|Withdrawal by Subject|1|||
128031774|NCT01450631|460742884|FG001|Overall Study|Withdrawal by Subject|0|||
128031775|NCT00835354|460742885|FG000|First Intervention|Adverse Event|0|||
128031776|NCT00835354|460742886|FG001|First Intervention|Adverse Event|1|||
128031777|NCT03204812|460742887|FG000|Overall Study|Adverse Event|3|||
128031778|NCT01385995|460742889|FG000|Period 1, 2 Months|Physician Decision|1|||
128031779|NCT01385995|460742890|FG001|Period 1, 2 Months|Physician Decision|0|||
128031780|NCT00112385|460742891|FG000|Overall Study|Lost to Follow-up|1|||
128031781|NCT00112385|460742892|FG001|Overall Study|Lost to Follow-up|0|||
128031782|NCT00112385|460742891|FG000|Overall Study|Withdrawal by Subject|0|||
128031783|NCT00112385|460742892|FG001|Overall Study|Withdrawal by Subject|1|||
128031784|NCT03648372|460742900|FG000|Overall Study|Withdrawal by Subject|2|||
128031785|NCT03648372|460742901|FG001|Overall Study|Withdrawal by Subject|0|||
128031786|NCT03648372|460742902|FG002|Overall Study|Withdrawal by Subject|0|||
128031787|NCT03648372|460742903|FG003|Overall Study|Withdrawal by Subject|0|||
128031788|NCT03648372|460742904|FG004|Overall Study|Withdrawal by Subject|0|||
128031789|NCT03648372|460742905|FG005|Overall Study|Withdrawal by Subject|1|||
127584042|NCT00533897|459106902|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
127584043|NCT00533897|459106903|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
127881879|NCT01336608|460190702|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
127881880|NCT01336608|460190703|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
128031790|NCT03648372|460742906|FG006|Overall Study|Withdrawal by Subject|2|||
128031791|NCT03648372|460742907|FG007|Overall Study|Withdrawal by Subject|0|||
128031792|NCT03648372|460742908|FG008|Overall Study|Withdrawal by Subject|0|||
128031793|NCT03648372|460742909|FG009|Overall Study|Withdrawal by Subject|0|||
128031794|NCT03648372|460742910|FG010|Overall Study|Withdrawal by Subject|2|||
128031795|NCT03648372|460742911|FG011|Overall Study|Withdrawal by Subject|0|||
128031796|NCT03648372|460742912|FG012|Overall Study|Withdrawal by Subject|2|||
127584044|NCT00533897|459106904|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
127584045|NCT00533897|459106905|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
127584046|NCT00533897|459106906|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
127584047|NCT00533897|459106907|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
127584048|NCT00533897|459106900|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
127584049|NCT00533897|459106901|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
127584050|NCT00533897|459106902|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
127881881|NCT01336608|460190704|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
127881882|NCT01336608|460190705|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
127881883|NCT01336608|460190702|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
127881884|NCT01336608|460190703|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
127584051|NCT00533897|459106903|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
127584052|NCT00533897|459106904|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
127584053|NCT00533897|459106905|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
127584054|NCT00533897|459106906|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
127584055|NCT00533897|459106907|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
127584056|NCT00533897|459106900|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
127584057|NCT00533897|459106901|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
127584058|NCT00533897|459106902|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
127584059|NCT00533897|459106903|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
127584060|NCT00533897|459106904|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
127584061|NCT00533897|459106905|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
127584062|NCT00533897|459106906|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
127584063|NCT00533897|459106907|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
127584064|NCT00533897|459106900|FG000|Long Term Extension (LTE)|Death|0|||
127584065|NCT00533897|459106901|FG001|Long Term Extension (LTE)|Death|0|||
127584066|NCT00533897|459106902|FG002|Long Term Extension (LTE)|Death|0|||
127584067|NCT00533897|459106903|FG003|Long Term Extension (LTE)|Death|0|||
127584068|NCT00533897|459106904|FG004|Long Term Extension (LTE)|Death|0|||
127584069|NCT00533897|459106905|FG005|Long Term Extension (LTE)|Death|0|||
127584070|NCT00533897|459106906|FG006|Long Term Extension (LTE)|Death|1|||
127584071|NCT00533897|459106907|FG007|Long Term Extension (LTE)|Death|3|||
127881885|NCT01336608|460190704|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
127881886|NCT01336608|460190705|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
127881887|NCT01336608|460190702|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
127881888|NCT01336608|460190703|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
127584072|NCT00533897|459106900|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
127584073|NCT00533897|459106901|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
127584074|NCT00533897|459106902|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
127584075|NCT00533897|459106903|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
127584076|NCT00533897|459106904|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
127584077|NCT00533897|459106905|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
127584078|NCT00533897|459106906|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
127584079|NCT00533897|459106907|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
127584080|NCT00533897|459106900|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
127584081|NCT00533897|459106901|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
127584082|NCT00533897|459106902|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
127584083|NCT00533897|459106903|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
127584084|NCT00533897|459106904|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
127584085|NCT00533897|459106905|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
127584086|NCT00533897|459106906|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
128031797|NCT03648372|460742913|FG013|Overall Study|Withdrawal by Subject|0|||
128031798|NCT03648372|460742914|FG014|Overall Study|Withdrawal by Subject|0|||
128031799|NCT03648372|460742915|FG015|Overall Study|Withdrawal by Subject|0|||
128031800|NCT03648372|460742916|FG016|Overall Study|Withdrawal by Subject|1|||
128031801|NCT03648372|460742917|FG017|Overall Study|Withdrawal by Subject|0|||
127584087|NCT00533897|459106907|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
127584088|NCT00533897|459106900|FG000|Long Term Extension (LTE)|Adverse Event|0|||
127584089|NCT00533897|459106901|FG001|Long Term Extension (LTE)|Adverse Event|0|||
127584090|NCT00533897|459106902|FG002|Long Term Extension (LTE)|Adverse Event|0|||
127584091|NCT00533897|459106903|FG003|Long Term Extension (LTE)|Adverse Event|0|||
127584092|NCT00533897|459106904|FG004|Long Term Extension (LTE)|Adverse Event|0|||
127584093|NCT00533897|459106905|FG005|Long Term Extension (LTE)|Adverse Event|0|||
127584094|NCT00533897|459106906|FG006|Long Term Extension (LTE)|Adverse Event|2|||
127584095|NCT00533897|459106907|FG007|Long Term Extension (LTE)|Adverse Event|5|||
127584096|NCT00533897|459106900|FG000|Long Term Extension (LTE)|Pregnancy|0|||
128031802|NCT03648372|460742918|FG018|Overall Study|Withdrawal by Subject|0|||
128031803|NCT03648372|460742919|FG019|Overall Study|Withdrawal by Subject|0|||
128031804|NCT03648372|460742920|FG020|Overall Study|Withdrawal by Subject|0|||
128031805|NCT03648372|460742900|FG000|Overall Study|Progressive Disease|2|||
128031806|NCT03648372|460742901|FG001|Overall Study|Progressive Disease|3|||
128031807|NCT03648372|460742902|FG002|Overall Study|Progressive Disease|4|||
127584097|NCT00533897|459106901|FG001|Long Term Extension (LTE)|Pregnancy|0|||
127584098|NCT00533897|459106902|FG002|Long Term Extension (LTE)|Pregnancy|0|||
128031808|NCT03648372|460742903|FG003|Overall Study|Progressive Disease|3|||
127584099|NCT00533897|459106903|FG003|Long Term Extension (LTE)|Pregnancy|0|||
127584100|NCT00533897|459106904|FG004|Long Term Extension (LTE)|Pregnancy|0|||
127584101|NCT00533897|459106905|FG005|Long Term Extension (LTE)|Pregnancy|0|||
127584102|NCT00533897|459106906|FG006|Long Term Extension (LTE)|Pregnancy|0|||
127584103|NCT00533897|459106907|FG007|Long Term Extension (LTE)|Pregnancy|2|||
128031809|NCT03648372|460742904|FG004|Overall Study|Progressive Disease|2|||
128031810|NCT03648372|460742905|FG005|Overall Study|Progressive Disease|2|||
128031811|NCT03648372|460742906|FG006|Overall Study|Progressive Disease|3|||
127584104|NCT00533897|459106900|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
127584105|NCT00533897|459106901|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
127584106|NCT00533897|459106902|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
127584107|NCT00533897|459106903|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
128031812|NCT03648372|460742907|FG007|Overall Study|Progressive Disease|3|||
128031813|NCT03648372|460742908|FG008|Overall Study|Progressive Disease|5|||
128031814|NCT03648372|460742909|FG009|Overall Study|Progressive Disease|5|||
128031815|NCT03648372|460742910|FG010|Overall Study|Progressive Disease|2|||
128031816|NCT03648372|460742911|FG011|Overall Study|Progressive Disease|3|||
128031817|NCT03648372|460742912|FG012|Overall Study|Progressive Disease|3|||
128031818|NCT03648372|460742913|FG013|Overall Study|Progressive Disease|3|||
128031819|NCT03648372|460742914|FG014|Overall Study|Progressive Disease|6|||
128031820|NCT03648372|460742915|FG015|Overall Study|Progressive Disease|0|||
128031821|NCT03648372|460742916|FG016|Overall Study|Progressive Disease|0|||
128031822|NCT03648372|460742917|FG017|Overall Study|Progressive Disease|0|||
128031823|NCT03648372|460742918|FG018|Overall Study|Progressive Disease|0|||
128031824|NCT03648372|460742919|FG019|Overall Study|Progressive Disease|0|||
128031825|NCT03648372|460742920|FG020|Overall Study|Progressive Disease|0|||
128031826|NCT03648372|460742900|FG000|Overall Study|Other|0|||
128031827|NCT03648372|460742901|FG001|Overall Study|Other|0|||
128031828|NCT03648372|460742902|FG002|Overall Study|Other|0|||
128031829|NCT03648372|460742903|FG003|Overall Study|Other|0|||
128031830|NCT03648372|460742904|FG004|Overall Study|Other|1|||
128031831|NCT03648372|460742905|FG005|Overall Study|Other|0|||
128031832|NCT03648372|460742906|FG006|Overall Study|Other|0|||
128031833|NCT03648372|460742907|FG007|Overall Study|Other|0|||
128031834|NCT03648372|460742908|FG008|Overall Study|Other|0|||
128031835|NCT03648372|460742909|FG009|Overall Study|Other|0|||
128031836|NCT03648372|460742910|FG010|Overall Study|Other|1|||
128031837|NCT03648372|460742911|FG011|Overall Study|Other|2|||
128031838|NCT03648372|460742912|FG012|Overall Study|Other|1|||
128031839|NCT03648372|460742913|FG013|Overall Study|Other|3|||
128031840|NCT03648372|460742914|FG014|Overall Study|Other|0|||
128031841|NCT03648372|460742915|FG015|Overall Study|Other|5|||
128031842|NCT03648372|460742916|FG016|Overall Study|Other|1|||
128031843|NCT03648372|460742917|FG017|Overall Study|Other|5|||
128031844|NCT03648372|460742918|FG018|Overall Study|Other|0|||
128031845|NCT03648372|460742919|FG019|Overall Study|Other|1|||
128031846|NCT03648372|460742920|FG020|Overall Study|Other|0|||
128031847|NCT03648372|460742900|FG000|Overall Study|Lost to Follow-up|0|||
128031848|NCT03648372|460742901|FG001|Overall Study|Lost to Follow-up|0|||
128031849|NCT03648372|460742902|FG002|Overall Study|Lost to Follow-up|0|||
128031850|NCT03648372|460742903|FG003|Overall Study|Lost to Follow-up|0|||
128031851|NCT03648372|460742904|FG004|Overall Study|Lost to Follow-up|0|||
128031852|NCT03648372|460742905|FG005|Overall Study|Lost to Follow-up|0|||
128031853|NCT03648372|460742906|FG006|Overall Study|Lost to Follow-up|0|||
128031854|NCT03648372|460742907|FG007|Overall Study|Lost to Follow-up|0|||
128031855|NCT03648372|460742908|FG008|Overall Study|Lost to Follow-up|0|||
128031856|NCT03648372|460742909|FG009|Overall Study|Lost to Follow-up|0|||
128031857|NCT03648372|460742910|FG010|Overall Study|Lost to Follow-up|0|||
128031858|NCT03648372|460742911|FG011|Overall Study|Lost to Follow-up|0|||
128031859|NCT03648372|460742912|FG012|Overall Study|Lost to Follow-up|0|||
128031860|NCT03648372|460742913|FG013|Overall Study|Lost to Follow-up|1|||
128031861|NCT03648372|460742914|FG014|Overall Study|Lost to Follow-up|0|||
128031862|NCT03648372|460742915|FG015|Overall Study|Lost to Follow-up|1|||
128031863|NCT03648372|460742916|FG016|Overall Study|Lost to Follow-up|0|||
128031864|NCT03648372|460742917|FG017|Overall Study|Lost to Follow-up|1|||
128031865|NCT03648372|460742918|FG018|Overall Study|Lost to Follow-up|0|||
128031866|NCT03648372|460742919|FG019|Overall Study|Lost to Follow-up|0|||
128031867|NCT03648372|460742920|FG020|Overall Study|Lost to Follow-up|0|||
128031868|NCT03648372|460742900|FG000|Overall Study|Start of a New Systemic Treatment|0|||
127584108|NCT00533897|459106904|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
127584109|NCT00533897|459106905|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
128031869|NCT03648372|460742901|FG001|Overall Study|Start of a New Systemic Treatment|0|||
128031870|NCT03648372|460742902|FG002|Overall Study|Start of a New Systemic Treatment|0|||
128031871|NCT03648372|460742903|FG003|Overall Study|Start of a New Systemic Treatment|0|||
128031872|NCT03648372|460742904|FG004|Overall Study|Start of a New Systemic Treatment|0|||
128031873|NCT03648372|460742905|FG005|Overall Study|Start of a New Systemic Treatment|0|||
128031874|NCT03648372|460742906|FG006|Overall Study|Start of a New Systemic Treatment|0|||
128031875|NCT03648372|460742907|FG007|Overall Study|Start of a New Systemic Treatment|2|||
128031876|NCT03648372|460742908|FG008|Overall Study|Start of a New Systemic Treatment|0|||
128031877|NCT03648372|460742909|FG009|Overall Study|Start of a New Systemic Treatment|0|||
128031878|NCT03648372|460742910|FG010|Overall Study|Start of a New Systemic Treatment|1|||
128031879|NCT03648372|460742911|FG011|Overall Study|Start of a New Systemic Treatment|0|||
128031880|NCT03648372|460742912|FG012|Overall Study|Start of a New Systemic Treatment|0|||
128031881|NCT03648372|460742913|FG013|Overall Study|Start of a New Systemic Treatment|0|||
128031882|NCT03648372|460742914|FG014|Overall Study|Start of a New Systemic Treatment|0|||
128031883|NCT03648372|460742915|FG015|Overall Study|Start of a New Systemic Treatment|0|||
128031884|NCT03648372|460742916|FG016|Overall Study|Start of a New Systemic Treatment|0|||
127584110|NCT00533897|459106906|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
127584111|NCT00533897|459106907|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
127584112|NCT00533897|459106900|FG000|Long Term Extension (LTE)|Other|0|||
127584113|NCT00533897|459106901|FG001|Long Term Extension (LTE)|Other|0|||
127584114|NCT00533897|459106902|FG002|Long Term Extension (LTE)|Other|0|||
127584115|NCT00533897|459106903|FG003|Long Term Extension (LTE)|Other|0|||
127584116|NCT00533897|459106904|FG004|Long Term Extension (LTE)|Other|0|||
127584117|NCT00533897|459106905|FG005|Long Term Extension (LTE)|Other|0|||
127584118|NCT00533897|459106906|FG006|Long Term Extension (LTE)|Other|1|||
127584119|NCT00533897|459106907|FG007|Long Term Extension (LTE)|Other|6|||
127584120|NCT03228433|459106908|FG000|Overall Study|Lost to Follow-up|1|||
127584121|NCT03228433|459106909|FG001|Overall Study|Lost to Follow-up|0|||
127584122|NCT03228433|459106910|FG002|Overall Study|Lost to Follow-up|0|||
127584123|NCT03228433|459106911|FG003|Overall Study|Lost to Follow-up|0|||
127584124|NCT03228433|459106912|FG004|Overall Study|Lost to Follow-up|0|||
127584125|NCT03228433|459106913|FG005|Overall Study|Lost to Follow-up|0|||
127584126|NCT03228433|459106908|FG000|Overall Study|Positive alcohol test|0|||
127584127|NCT03228433|459106909|FG001|Overall Study|Positive alcohol test|0|||
127693907|NCT00220740|459507058|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
127693908|NCT03941860|459507061|FG000|Overall Study|Withdrawal by Subject|0|||
127584128|NCT03228433|459106910|FG002|Overall Study|Positive alcohol test|0|||
127584129|NCT03228433|459106911|FG003|Overall Study|Positive alcohol test|1|||
127693909|NCT03941860|459507062|FG001|Overall Study|Withdrawal by Subject|1|||
127693910|NCT03361748|459507066|FG000|Overall Study|Death|77|||
127693911|NCT03361748|459507066|FG000|Overall Study|Lost to Follow-up|4|||
127693912|NCT03361748|459507066|FG000|Overall Study|Withdrawal by Subject|20|||
127693913|NCT02814838|459507069|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
127693914|NCT02814838|459507070|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
127693915|NCT02814838|459507069|FG000|Overall Study|Consent withdrawal|1|||
127693916|NCT02814838|459507070|FG001|Overall Study|Consent withdrawal|1|||
127693917|NCT01361711|459507072|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
127693918|NCT01361711|459507072|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
127693919|NCT01361711|459507072|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
127693920|NCT01361711|459507072|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
127693921|NCT01361711|459507072|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
127693922|NCT01361711|459507072|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
127693923|NCT01361711|459507072|FG000|Completed Week 18 of Treatment|Other|9|||
127693924|NCT01361711|459507072|FG000|10 Year Follow-up|Still in follow-up|22|||
127693925|NCT01361711|459507072|FG000|10 Year Follow-up|Death|7|||
127693926|NCT01361711|459507072|FG000|10 Year Follow-up|Developed new cancer|1|||
127693927|NCT01361711|459507072|FG000|10 Year Follow-up|Lost to Follow-up|2|||
127693928|NCT01361711|459507072|FG000|10 Year Follow-up|New treatment started|6|||
127783876|NCT01449461|459834528|FG001|Overall Study|Site Terminated by Sponsor|1|||
127584130|NCT03228433|459106912|FG004|Overall Study|Positive alcohol test|0|||
127584131|NCT03228433|459106913|FG005|Overall Study|Positive alcohol test|0|||
127584132|NCT01030536|459106914|FG000|Overall Study|Withdrawal by Subject|0|||
127584133|NCT01030536|459106915|FG001|Overall Study|Withdrawal by Subject|0|||
127584134|NCT01030536|459106916|FG002|Overall Study|Withdrawal by Subject|1|||
127584135|NCT01030536|459106917|FG003|Overall Study|Withdrawal by Subject|0|||
127584136|NCT01030536|459106918|FG004|Overall Study|Withdrawal by Subject|0|||
127584137|NCT01030536|459106914|FG000|Overall Study|undefined|1|||
127584138|NCT01030536|459106915|FG001|Overall Study|undefined|0|||
127584139|NCT01030536|459106916|FG002|Overall Study|undefined|1|||
127584140|NCT01030536|459106917|FG003|Overall Study|undefined|1|||
127584141|NCT01030536|459106918|FG004|Overall Study|undefined|0|||
127584142|NCT01030536|459106914|FG000|Overall Study|Adverse Event|0|||
127584143|NCT01030536|459106915|FG001|Overall Study|Adverse Event|3|||
127584144|NCT01030536|459106916|FG002|Overall Study|Adverse Event|1|||
127584145|NCT01030536|459106917|FG003|Overall Study|Adverse Event|0|||
127584146|NCT01030536|459106918|FG004|Overall Study|Adverse Event|1|||
127584147|NCT01030536|459106914|FG000|Overall Study|Progressive disease|6|||
127584148|NCT01030536|459106915|FG001|Overall Study|Progressive disease|2|||
127584149|NCT01030536|459106916|FG002|Overall Study|Progressive disease|3|||
127584150|NCT01030536|459106917|FG003|Overall Study|Progressive disease|2|||
127584151|NCT01030536|459106918|FG004|Overall Study|Progressive disease|0|||
127584152|NCT01030536|459106914|FG000|Overall Study|Death|0|||
127584153|NCT01030536|459106915|FG001|Overall Study|Death|1|||
127584154|NCT01030536|459106916|FG002|Overall Study|Death|0|||
127584155|NCT01030536|459106917|FG003|Overall Study|Death|0|||
127584156|NCT01030536|459106918|FG004|Overall Study|Death|0|||
127584157|NCT01781975|459106933|FG000|Overall Study|Death|1|||
127584158|NCT01781975|459106934|FG001|Overall Study|Death|0|||
127584159|NCT01781975|459106933|FG000|Overall Study|Withdrawal by Subject|1|||
127584160|NCT01781975|459106934|FG001|Overall Study|Withdrawal by Subject|1|||
127584161|NCT02404220|459106936|FG000|Overall Study|Adverse Event|0|||
127584162|NCT02404220|459106937|FG001|Overall Study|Adverse Event|0|||
127584163|NCT02404220|459106938|FG002|Overall Study|Adverse Event|1|||
127584164|NCT02404220|459106939|FG003|Overall Study|Adverse Event|0|||
127584165|NCT02404220|459106936|FG000|Overall Study|Death|5|||
127584166|NCT02404220|459106937|FG001|Overall Study|Death|5|||
127584167|NCT02404220|459106938|FG002|Overall Study|Death|3|||
127584168|NCT02404220|459106939|FG003|Overall Study|Death|8|||
127584169|NCT02404220|459106936|FG000|Overall Study|Progressive Disease|0|||
127584170|NCT02404220|459106937|FG001|Overall Study|Progressive Disease|0|||
127584171|NCT02404220|459106938|FG002|Overall Study|Progressive Disease|1|||
127584172|NCT02404220|459106939|FG003|Overall Study|Progressive Disease|1|||
127584173|NCT02404220|459106936|FG000|Overall Study|Study Terminated by Sponsor|0|||
127584174|NCT02404220|459106937|FG001|Overall Study|Study Terminated by Sponsor|0|||
127584175|NCT02404220|459106938|FG002|Overall Study|Study Terminated by Sponsor|2|||
127584176|NCT02404220|459106939|FG003|Overall Study|Study Terminated by Sponsor|1|||
127584177|NCT02404220|459106936|FG000|Overall Study|Withdrawal by Subject|0|||
127584178|NCT02404220|459106937|FG001|Overall Study|Withdrawal by Subject|1|||
127584179|NCT02404220|459106938|FG002|Overall Study|Withdrawal by Subject|0|||
127584180|NCT02404220|459106939|FG003|Overall Study|Withdrawal by Subject|0|||
127584181|NCT02404220|459106936|FG000|Overall Study|Enrolled but Never Treated|0|||
127584182|NCT02404220|459106937|FG001|Overall Study|Enrolled but Never Treated|2|||
127584183|NCT02404220|459106938|FG002|Overall Study|Enrolled but Never Treated|0|||
127584184|NCT02404220|459106939|FG003|Overall Study|Enrolled but Never Treated|0|||
127584185|NCT01622231|459106940|FG000|Overall Study|Physician Decision|1|||
127584186|NCT01622231|459106940|FG000|Overall Study|Withdrawal by Subject|1|||
127584187|NCT02589405|459106942|FG000|Overall Study|Adverse Event|3|||
127584188|NCT02589405|459106942|FG000|Overall Study|Withdrawal by Subject|1|||
127584189|NCT02905149|459106943|FG000|Overall Study|Lost to Follow-up|2|||
127693929|NCT01361711|459507072|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
127693930|NCT01361711|459507072|FG000|10 Year Follow-up|Progressive Disease|1|||
127693931|NCT02596126|459507073|FG000|Overall Study|Lost to Follow-up|12|||
127693932|NCT02596126|459507074|FG001|Overall Study|Lost to Follow-up|21|||
127693933|NCT02596126|459507073|FG000|Overall Study|Protocol Violation|7|||
127693934|NCT02596126|459507074|FG001|Overall Study|Protocol Violation|9|||
127693935|NCT03396588|459507075|FG000|Overall Study|Physician Decision|2|||
127693936|NCT03396588|459507076|FG001|Overall Study|Physician Decision|3|||
127693937|NCT00812461|459507077|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
127584190|NCT02905149|459106944|FG001|Overall Study|Lost to Follow-up|0|||
127584191|NCT02329080|459106945|FG000|Overall Study|Adverse Event|1|||
127584192|NCT02329080|459106945|FG000|Overall Study|Death|4|||
127584193|NCT02329080|459106945|FG000|Overall Study|Lack of Efficacy|22|||
127584194|NCT02329080|459106945|FG000|Overall Study|Lost to Follow-up|1|||
127584195|NCT02329080|459106945|FG000|Overall Study|Physician Decision|2|||
128031885|NCT03648372|460742917|FG017|Overall Study|Start of a New Systemic Treatment|0|||
128031886|NCT03648372|460742918|FG018|Overall Study|Start of a New Systemic Treatment|0|||
128031887|NCT03648372|460742919|FG019|Overall Study|Start of a New Systemic Treatment|0|||
128031888|NCT03648372|460742920|FG020|Overall Study|Start of a New Systemic Treatment|0|||
128031889|NCT04280783|460744178|FG000|Overall Study|Family issues unrelated to the study.|1|||
128031890|NCT04280783|460744179|FG001|Overall Study|Family issues unrelated to the study.|0|||
128031891|NCT04280783|460744178|FG000|Overall Study|Withdrawal by Subject|0|||
128031892|NCT04280783|460744179|FG001|Overall Study|Withdrawal by Subject|1|||
128031893|NCT05654181|460744180|FG000|Overall Study|Adverse Event|1|||
128031894|NCT05654181|460744181|FG001|Overall Study|Adverse Event|0|||
128031895|NCT05654181|460744182|FG002|Overall Study|Adverse Event|0|||
128031896|NCT05654181|460744183|FG003|Overall Study|Adverse Event|0|||
128031897|NCT05654181|460744184|FG004|Overall Study|Adverse Event|0|||
128031898|NCT05654181|460744185|FG005|Overall Study|Adverse Event|0|||
128031899|NCT05654181|460744186|FG006|Overall Study|Adverse Event|0|||
128031900|NCT05654181|460744187|FG007|Overall Study|Adverse Event|1|||
128031901|NCT05654181|460744188|FG008|Overall Study|Adverse Event|0|||
128031902|NCT05654181|460744189|FG009|Overall Study|Adverse Event|0|||
128031903|NCT05654181|460744180|FG000|Overall Study|Withdrawal by Subject|0|||
128031904|NCT05654181|460744181|FG001|Overall Study|Withdrawal by Subject|0|||
128031905|NCT05654181|460744182|FG002|Overall Study|Withdrawal by Subject|0|||
128031906|NCT05654181|460744183|FG003|Overall Study|Withdrawal by Subject|0|||
128031907|NCT05654181|460744184|FG004|Overall Study|Withdrawal by Subject|0|||
128031908|NCT05654181|460744185|FG005|Overall Study|Withdrawal by Subject|0|||
128031909|NCT05654181|460744186|FG006|Overall Study|Withdrawal by Subject|0|||
128031910|NCT05654181|460744187|FG007|Overall Study|Withdrawal by Subject|1|||
128031911|NCT05654181|460744188|FG008|Overall Study|Withdrawal by Subject|0|||
128031912|NCT05654181|460744189|FG009|Overall Study|Withdrawal by Subject|0|||
128031913|NCT05654181|460744180|FG000|Overall Study|Other|0|||
128031914|NCT05654181|460744181|FG001|Overall Study|Other|0|||
128031915|NCT05654181|460744182|FG002|Overall Study|Other|0|||
128031916|NCT05654181|460744183|FG003|Overall Study|Other|0|||
128031917|NCT05654181|460744184|FG004|Overall Study|Other|1|||
128031918|NCT05654181|460744185|FG005|Overall Study|Other|1|||
128031919|NCT05654181|460744186|FG006|Overall Study|Other|0|||
128031920|NCT05654181|460744187|FG007|Overall Study|Other|0|||
128031921|NCT05654181|460744188|FG008|Overall Study|Other|0|||
128031922|NCT05654181|460744189|FG009|Overall Study|Other|0|||
128031923|NCT04101331|460744190|FG000|Overall Study|Adverse Event|9|||
128031924|NCT04101331|460744190|FG000|Overall Study|Disease progression|82|||
128031925|NCT04101331|460744190|FG000|Overall Study|Withdrawal by Subject|1|||
128031926|NCT04101331|460744190|FG000|Overall Study|Investigator decision|6|||
128031927|NCT04101331|460744190|FG000|Overall Study|Death|6|||
128031928|NCT04101331|460744190|FG000|Overall Study|Allogenic transplant|1|||
128031929|NCT04110145|460744192|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
128031930|NCT04110145|460744193|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
127584196|NCT02329080|459106945|FG000|Overall Study|Partial response|4|||
127584197|NCT02329080|459106945|FG000|Overall Study|Complete response|4|||
127584198|NCT03082261|459106954|FG000|Overall Study|Death|4|||
127584199|NCT03082261|459106954|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
127584200|NCT03082261|459106954|FG000|Overall Study|Insurance denial|1|||
128031931|NCT04110145|460744194|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
128031932|NCT04110145|460744195|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
128031933|NCT04110145|460744196|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
128031934|NCT02254291|460744197|FG000|Overall Study|Withdrawal by Subject|0|||
128031935|NCT02254291|460744198|FG001|Overall Study|Withdrawal by Subject|3|||
128031936|NCT02254291|460744199|FG002|Overall Study|Withdrawal by Subject|1|||
128031937|NCT02254291|460744197|FG000|Overall Study|Missing follow-up information|0|||
127584201|NCT03082261|459106954|FG000|Overall Study|Peripheral lead added|1|||
128031938|NCT02254291|460744198|FG001|Overall Study|Missing follow-up information|0|||
128031939|NCT02254291|460744199|FG002|Overall Study|Missing follow-up information|1|||
128031940|NCT00488293|460744209|FG000|Overall Study|Lost to Follow-up|28|||
128031941|NCT00488293|460744210|FG001|Overall Study|Lost to Follow-up|25|||
128031942|NCT00488293|460744209|FG000|Overall Study|Withdrawal by Subject|5|||
128031943|NCT00488293|460744210|FG001|Overall Study|Withdrawal by Subject|3|||
128031944|NCT00488293|460744209|FG000|Overall Study|Death|2|||
127584202|NCT03082261|459106954|FG000|Overall Study|Withdrawal by Subject|40|||
127584203|NCT03082261|459106954|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
128031945|NCT00488293|460744210|FG001|Overall Study|Death|1|||
128031946|NCT00488293|460744209|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
127584204|NCT03082261|459106954|FG000|Overall Study|Subject implanted with device other than study device|1|||
127584205|NCT03082261|459106954|FG000|Overall Study|Lost to Follow-up|14|||
127584206|NCT03082261|459106954|FG000|Overall Study|Subject moved to a different state|1|||
127584207|NCT03082261|459106954|FG000|Overall Study|Subject non-compliance|2|||
127584208|NCT03082261|459106954|FG000|Overall Study|Subject participation terminated by investigator|9|||
127584209|NCT03082261|459106954|FG000|Overall Study|Subject participation terminated by sponsor|4|||
127584210|NCT03082261|459106954|FG000|Overall Study|System explant|19|||
127584211|NCT03082261|459106954|FG000|Overall Study|Unable to place lead(s)|2|||
127584212|NCT03082261|459106954|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
127584213|NCT01032174|459106959|FG000|Overall Study|Adverse Event|0|||
127584214|NCT01032174|459106960|FG001|Overall Study|Adverse Event|1|||
128031947|NCT00488293|460744210|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
128031948|NCT03436732|460744211|FG000|Overall Study|Not treated-enrolled in different study|1|||
128031949|NCT03436732|460744212|FG001|Overall Study|Not treated-enrolled in different study|0|||
128031950|NCT03436732|460744211|FG000|Overall Study|Off study after cycle 1|1|||
128031951|NCT03436732|460744212|FG001|Overall Study|Off study after cycle 1|0|||
128031952|NCT03436732|460744211|FG000|Overall Study|Adverse Event|2|||
128031953|NCT03436732|460744212|FG001|Overall Study|Adverse Event|0|||
128031954|NCT03436732|460744211|FG000|Overall Study|Death|0|||
128031955|NCT03436732|460744212|FG001|Overall Study|Death|1|||
128031956|NCT03345550|460744213|FG000|Overall Study|Withdrawal by Subject|1|||
128031957|NCT03345550|460744214|FG001|Overall Study|Withdrawal by Subject|0|||
128031958|NCT03345550|460744213|FG000|Overall Study|Lost to Follow-up|4|||
128031959|NCT03345550|460744214|FG001|Overall Study|Lost to Follow-up|5|||
128031960|NCT00567502|460744215|FG000|Overall Study|Lost to Follow-up|91|||
128031961|NCT00567502|460744216|FG001|Overall Study|Lost to Follow-up|14|||
128031962|NCT00567502|460744217|FG002|Overall Study|Lost to Follow-up|351|||
128031963|NCT00567502|460744218|FG003|Overall Study|Lost to Follow-up|2|||
128031964|NCT00567502|460744215|FG000|Overall Study|Death|65|||
128031965|NCT00567502|460744216|FG001|Overall Study|Death|16|||
128031966|NCT00567502|460744217|FG002|Overall Study|Death|360|||
128031967|NCT00567502|460744218|FG003|Overall Study|Death|5|||
127584215|NCT00702689|459106961|FG000|Overall Study|Withdrawal by Subject|4|||
127584216|NCT00702689|459106961|FG000|Overall Study|Recurrent malignancy|1|||
127584217|NCT00702689|459106961|FG000|Overall Study|Adverse Event|1|||
127584218|NCT01281137|459106964|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
127584219|NCT01281137|459106965|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
127584220|NCT01281137|459106964|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
127584221|NCT01281137|459106965|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
127642551|NCT04124926|459313073|FG001|Maintenance Phase|Lost to Follow-up|0|||
127783877|NCT01449461|459834529|FG002|Overall Study|Site Terminated by Sponsor|2|||
127783878|NCT01449461|459834530|FG003|Overall Study|Site Terminated by Sponsor|3|||
127783879|NCT01449461|459834531|FG004|Overall Study|Site Terminated by Sponsor|4|||
127783880|NCT01449461|459834532|FG005|Overall Study|Site Terminated by Sponsor|1|||
127783881|NCT01449461|459834527|FG000|Overall Study|Withdrawal by Subject|0|||
127783882|NCT01449461|459834528|FG001|Overall Study|Withdrawal by Subject|1|||
127783883|NCT01449461|459834529|FG002|Overall Study|Withdrawal by Subject|0|||
127783884|NCT01449461|459834530|FG003|Overall Study|Withdrawal by Subject|0|||
127783885|NCT01449461|459834531|FG004|Overall Study|Withdrawal by Subject|2|||
127783886|NCT01449461|459834532|FG005|Overall Study|Withdrawal by Subject|1|||
127783887|NCT01449461|459834527|FG000|Overall Study|Reason not Specified|0|||
127783888|NCT01449461|459834528|FG001|Overall Study|Reason not Specified|1|||
127783889|NCT01449461|459834529|FG002|Overall Study|Reason not Specified|0|||
127783890|NCT01449461|459834530|FG003|Overall Study|Reason not Specified|3|||
127783891|NCT01449461|459834531|FG004|Overall Study|Reason not Specified|2|||
127783892|NCT01449461|459834532|FG005|Overall Study|Reason not Specified|1|||
127783893|NCT01357577|459834533|FG000|Overall Study|Lost to Follow-up|20|||
127783894|NCT01357577|459834534|FG001|Overall Study|Lost to Follow-up|16|||
127783895|NCT01357577|459834533|FG000|Overall Study|Withdrawal by Subject|16|||
127783896|NCT01357577|459834534|FG001|Overall Study|Withdrawal by Subject|8|||
127783897|NCT01357577|459834533|FG000|Overall Study|look at data in database?|1|||
127783898|NCT01357577|459834534|FG001|Overall Study|look at data in database?|2|||
127783899|NCT03697720|459835613|FG000|Overall Study|Lost to Follow-up|7|||
127783900|NCT03496012|459835618|FG000|Overall Study|Withdrawal by Subject|2|||
127783901|NCT03496012|459835619|FG001|Overall Study|Withdrawal by Subject|0|||
127783902|NCT03496012|459835620|FG002|Overall Study|Withdrawal by Subject|2|||
127783903|NCT03496012|459835618|FG000|Overall Study|Adverse Event|0|||
127783904|NCT03496012|459835619|FG001|Overall Study|Adverse Event|0|||
127783905|NCT03496012|459835620|FG002|Overall Study|Adverse Event|1|||
127783906|NCT03496012|459835618|FG000|Overall Study|Reason Not Specified|2|||
127783907|NCT03496012|459835619|FG001|Overall Study|Reason Not Specified|0|||
127783908|NCT03496012|459835620|FG002|Overall Study|Reason Not Specified|1|||
127783909|NCT01439282|459835621|FG000|Overall Study|Adverse Event|5|||
127783910|NCT01439282|459835622|FG001|Overall Study|Adverse Event|0|||
128031968|NCT00567502|460744215|FG000|Overall Study|Other|64|||
127584222|NCT01281137|459106964|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
127584223|NCT01281137|459106965|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
127584224|NCT01281137|459106964|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
127584225|NCT01281137|459106965|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
127584226|NCT01281137|459106964|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
127584227|NCT01281137|459106965|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
127584228|NCT02761733|459106968|FG000|Overall Study|Death|3|||
127584229|NCT02761733|459106969|FG001|Overall Study|Death|5|||
127584230|NCT02761733|459106970|FG002|Overall Study|Death|1|||
127584231|NCT02761733|459106971|FG003|Overall Study|Death|1|||
127584232|NCT02761733|459106968|FG000|Overall Study|Lost to Follow-up|6|||
127584233|NCT02761733|459106969|FG001|Overall Study|Lost to Follow-up|7|||
127584234|NCT02761733|459106970|FG002|Overall Study|Lost to Follow-up|0|||
127584235|NCT02761733|459106971|FG003|Overall Study|Lost to Follow-up|3|||
127584236|NCT02761733|459106968|FG000|Overall Study|Physician Decision|4|||
127584237|NCT02761733|459106969|FG001|Overall Study|Physician Decision|0|||
127584238|NCT02761733|459106970|FG002|Overall Study|Physician Decision|0|||
127584239|NCT02761733|459106971|FG003|Overall Study|Physician Decision|0|||
127584240|NCT02761733|459106968|FG000|Overall Study|Withdrawal by Subject|2|||
127584241|NCT02761733|459106969|FG001|Overall Study|Withdrawal by Subject|0|||
127584242|NCT02761733|459106970|FG002|Overall Study|Withdrawal by Subject|0|||
127584243|NCT02761733|459106971|FG003|Overall Study|Withdrawal by Subject|0|||
127584244|NCT02761733|459106968|FG000|Overall Study|Discharged from Study Site|10|||
127584245|NCT02761733|459106969|FG001|Overall Study|Discharged from Study Site|9|||
127584246|NCT02761733|459106970|FG002|Overall Study|Discharged from Study Site|25|||
127584247|NCT02761733|459106971|FG003|Overall Study|Discharged from Study Site|11|||
127584248|NCT02761733|459106968|FG000|Overall Study|Cognitive Impairment|5|||
127584249|NCT02761733|459106969|FG001|Overall Study|Cognitive Impairment|0|||
127584250|NCT02761733|459106970|FG002|Overall Study|Cognitive Impairment|1|||
127584251|NCT02761733|459106971|FG003|Overall Study|Cognitive Impairment|0|||
127584252|NCT01986907|459106974|FG000|Overall Study|Adverse Event|11|||
127584253|NCT01986907|459106974|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
127584254|NCT01986907|459106974|FG000|Overall Study|Protocol Violation|4|||
127584255|NCT01986907|459106974|FG000|Overall Study|Withdrawal by Subject|76|||
127584256|NCT01986907|459106974|FG000|Overall Study|Lost to Follow-up|38|||
127584257|NCT01986907|459106974|FG000|Overall Study|Death|9|||
127584258|NCT04295772|459106978|FG000|Overall Study|Protocol Violation|1|||
127584259|NCT04295772|459106979|FG001|Overall Study|Protocol Violation|0|||
127584260|NCT04295772|459106978|FG000|Overall Study|Ongoing for safety monitoring|14|||
127584261|NCT04295772|459106979|FG001|Overall Study|Ongoing for safety monitoring|1|||
127584262|NCT04295772|459106978|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
127584263|NCT04295772|459106979|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
127584264|NCT00447005|459106991|FG000|Overall Study|Adverse Event|1|||
127584265|NCT00447005|459106991|FG000|Overall Study|Lack of Efficacy|11|||
127584266|NCT01484275|459106992|FG000|Overall Study|Study terminated by sponsor|28|||
127584267|NCT01484275|459106993|FG001|Overall Study|Study terminated by sponsor|32|||
127584268|NCT01484275|459106992|FG000|Overall Study|Other|10|||
127584269|NCT01484275|459106993|FG001|Overall Study|Other|0|||
127584270|NCT01484275|459106992|FG000|Overall Study|Death|3|||
127584271|NCT01484275|459106993|FG001|Overall Study|Death|4|||
127584272|NCT01484275|459106992|FG000|Overall Study|Withdrawal by Subject|1|||
127584273|NCT01484275|459106993|FG001|Overall Study|Withdrawal by Subject|5|||
127584274|NCT01484275|459106992|FG000|Overall Study|Lost to Follow-up|1|||
127584275|NCT01484275|459106993|FG001|Overall Study|Lost to Follow-up|1|||
127584276|NCT04154930|459106996|FG000|Overall Study|Withdrawal by Subject|15|||
127584277|NCT04154930|459106997|FG001|Overall Study|Withdrawal by Subject|6|||
127584278|NCT04154930|459106996|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
127584279|NCT04154930|459106997|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
127584280|NCT04154930|459106996|FG000|Overall Study|Lost to Follow-up|14|||
127584281|NCT04154930|459106997|FG001|Overall Study|Lost to Follow-up|6|||
127584282|NCT04154930|459106996|FG000|Overall Study|Other|6|||
127584283|NCT04154930|459106997|FG001|Overall Study|Other|0|||
127584284|NCT02130297|459107000|FG000|Overall Study|Lost to Follow-up|4|||
127584285|NCT00806351|459107009|FG000|Overall Study|Death|5|||
127584286|NCT00806351|459107010|FG001|Overall Study|Death|4|||
127584287|NCT00913380|459107011|FG000|Clinical Outcomes|Lost to Follow-up|6|||
127584288|NCT00913380|459107012|FG001|Clinical Outcomes|Lost to Follow-up|6|||
127584289|NCT00508755|459107018|FG000|Overall Study|Withdrawal by Subject|1|||
127584290|NCT02004522|459107024|FG000|Overall Study|Adverse Event|55|||
127584291|NCT02004522|459107025|FG001|Overall Study|Adverse Event|6|||
127584292|NCT02004522|459107024|FG000|Overall Study|Withdrawal by Subject|13|||
127584293|NCT02004522|459107025|FG001|Overall Study|Withdrawal by Subject|7|||
127584294|NCT02004522|459107024|FG000|Overall Study|Death|12|||
128031969|NCT00567502|460744216|FG001|Overall Study|Other|2|||
128031970|NCT00567502|460744217|FG002|Overall Study|Other|134|||
128031971|NCT00567502|460744218|FG003|Overall Study|Other|6|||
128031972|NCT00567502|460744215|FG000|Overall Study|Participant request|12|||
128031973|NCT00567502|460744216|FG001|Overall Study|Participant request|1|||
128031974|NCT00567502|460744217|FG002|Overall Study|Participant request|33|||
128031975|NCT00567502|460744218|FG003|Overall Study|Participant request|1|||
128031976|NCT00567502|460744215|FG000|Overall Study|Sponsor request|9|||
128031977|NCT00567502|460744216|FG001|Overall Study|Sponsor request|0|||
128031978|NCT00567502|460744217|FG002|Overall Study|Sponsor request|30|||
128031979|NCT00567502|460744218|FG003|Overall Study|Sponsor request|1|||
128031980|NCT00567502|460744215|FG000|Overall Study|Never Initiated Treatment|0|||
128031981|NCT00567502|460744216|FG001|Overall Study|Never Initiated Treatment|0|||
128031982|NCT00567502|460744217|FG002|Overall Study|Never Initiated Treatment|0|||
128031983|NCT00567502|460744218|FG003|Overall Study|Never Initiated Treatment|72|||
128031984|NCT00337168|460744219|FG000|Overall Study|Death|5|||
128031985|NCT00337168|460744219|FG000|Overall Study|Not protocol specified|2|||
128031986|NCT00337168|460744219|FG000|Overall Study|Did not start therapy|1|||
128031987|NCT03283241|460744220|FG000|Overall Study|Adverse Event|4|||
128031988|NCT03283241|460744221|FG001|Overall Study|Adverse Event|1|||
128031989|NCT03283241|460744220|FG000|Overall Study|Withdrawal by Subject|0|||
128031990|NCT03283241|460744221|FG001|Overall Study|Withdrawal by Subject|1|||
128031991|NCT03283241|460744220|FG000|Overall Study|Subject relocated to Finland|0|||
128031992|NCT03283241|460744221|FG001|Overall Study|Subject relocated to Finland|1|||
128031993|NCT00666263|460744224|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
127881889|NCT01336608|460190704|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
127881890|NCT01336608|460190705|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
127881891|NCT01336608|460190702|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
127881892|NCT01336608|460190703|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
127881893|NCT01336608|460190704|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
128031994|NCT00666263|460744225|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
127584295|NCT02004522|459107025|FG001|Overall Study|Death|3|||
127584296|NCT02004522|459107024|FG000|Overall Study|Physician Decision|3|||
127584297|NCT02004522|459107025|FG001|Overall Study|Physician Decision|4|||
127584298|NCT02004522|459107024|FG000|Overall Study|Protocol Violation|1|||
127584299|NCT02004522|459107025|FG001|Overall Study|Protocol Violation|0|||
127584300|NCT02004522|459107024|FG000|Overall Study|Other is reason listed by PI|4|||
127584301|NCT02004522|459107025|FG001|Overall Study|Other is reason listed by PI|1|||
127584302|NCT02004522|459107024|FG000|Overall Study|Never Dosed|2|||
127584303|NCT02004522|459107025|FG001|Overall Study|Never Dosed|4|||
127584304|NCT02004522|459107024|FG000|Overall Study|Disease Progression|35|||
127584305|NCT02004522|459107025|FG001|Overall Study|Disease Progression|31|||
127584306|NCT02004522|459107024|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
127584307|NCT02004522|459107025|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
127584308|NCT01787331|459107026|FG000|Overall Study|Physician Decision|1|||
127584309|NCT01787331|459107026|FG000|Overall Study|Withdrawal by Subject|1|||
127584310|NCT00667875|459107029|FG000|Overall Study|Adverse Event|0|||
127584311|NCT00667875|459107030|FG001|Overall Study|Adverse Event|2|||
127584312|NCT00667875|459107031|FG002|Overall Study|Adverse Event|6|||
127584313|NCT00667875|459107029|FG000|Overall Study|Withdrawal by Subject|10|||
127584314|NCT00667875|459107030|FG001|Overall Study|Withdrawal by Subject|9|||
127881894|NCT01336608|460190705|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
127584315|NCT00667875|459107031|FG002|Overall Study|Withdrawal by Subject|7|||
127584316|NCT00450255|459107032|FG000|Overall Study|Prior RFA ablation of liver|1|||
127584317|NCT01696071|459107033|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
127881895|NCT01336608|460190702|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
127881896|NCT01336608|460190703|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
128031995|NCT00666263|460744224|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
127584318|NCT01696071|459107034|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
127584319|NCT00437983|459107035|FG000|Overall Study|Adverse Event|6|||
127584320|NCT00437983|459107036|FG001|Overall Study|Adverse Event|6|||
128031996|NCT00666263|460744225|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
128031997|NCT00666263|460744224|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
128031998|NCT00666263|460744225|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
127584321|NCT00437983|459107035|FG000|Overall Study|Protocol Violation|2|||
127584322|NCT00437983|459107036|FG001|Overall Study|Protocol Violation|1|||
127584323|NCT00437983|459107035|FG000|Overall Study|Withdrawal by Subject|5|||
127584324|NCT00437983|459107036|FG001|Overall Study|Withdrawal by Subject|6|||
128031999|NCT00586157|460744226|FG000|First Intervention|Worsening behavior|1|||
128032000|NCT00586157|460744227|FG001|First Intervention|Worsening behavior|0|||
128032001|NCT00586157|460744226|FG000|Second Intervention|Withdrawal by Subject|1|||
127584325|NCT00678080|459107037|FG000|Overall Study|Physician Decision|2|||
127584326|NCT00678080|459107038|FG001|Overall Study|Physician Decision|0|||
127584327|NCT00678080|459107037|FG000|Overall Study|Lost to Follow-up|1|||
127584328|NCT00678080|459107038|FG001|Overall Study|Lost to Follow-up|0|||
127584329|NCT00678080|459107037|FG000|Overall Study|Withdrawal by Subject|0|||
127584330|NCT00678080|459107038|FG001|Overall Study|Withdrawal by Subject|1|||
127584331|NCT03730012|459107039|FG000|Overall Study|Adverse Event|0|||
127584332|NCT03730012|459107040|FG001|Overall Study|Adverse Event|1|||
127584333|NCT03730012|459107039|FG000|Overall Study|Lack of Efficacy|1|||
127584334|NCT03730012|459107040|FG001|Overall Study|Lack of Efficacy|5|||
127584335|NCT03730012|459107039|FG000|Overall Study|Withdrawal by Subject|0|||
127584336|NCT03730012|459107040|FG001|Overall Study|Withdrawal by Subject|1|||
127584337|NCT03730012|459107039|FG000|Overall Study|Miscellaneous|2|||
127584338|NCT03730012|459107040|FG001|Overall Study|Miscellaneous|1|||
127584339|NCT03320057|459108431|FG000|Overall Study|Lost to Follow-up|4|||
127693938|NCT00812461|459507078|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
127584340|NCT03320057|459108432|FG001|Overall Study|Lost to Follow-up|17|||
127584341|NCT03320057|459108431|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
127584342|NCT03320057|459108432|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
127584343|NCT01367002|459108433|FG000|Overall Study|Withdrawal by Subject|1|||
127584344|NCT01367002|459108434|FG001|Overall Study|Withdrawal by Subject|0|||
127584345|NCT01367002|459108433|FG000|Overall Study|Physician Decision|0|||
127584346|NCT01367002|459108434|FG001|Overall Study|Physician Decision|2|||
127584347|NCT00717093|459108438|FG000|Overall Study|Adverse Event|19|||
127584348|NCT00717093|459108439|FG001|Overall Study|Adverse Event|9|||
127584349|NCT00717093|459108438|FG000|Overall Study|Lack of Efficacy|3|||
127584350|NCT00717093|459108439|FG001|Overall Study|Lack of Efficacy|13|||
127584351|NCT00717093|459108438|FG000|Overall Study|Lost to Follow-up|9|||
127584352|NCT00717093|459108439|FG001|Overall Study|Lost to Follow-up|6|||
127584353|NCT00717093|459108438|FG000|Overall Study|Withdrawal by Subject|12|||
127584354|NCT00717093|459108439|FG001|Overall Study|Withdrawal by Subject|19|||
127584355|NCT00717093|459108438|FG000|Overall Study|Other|0|||
127584356|NCT00717093|459108439|FG001|Overall Study|Other|1|||
127584357|NCT00717093|459108438|FG000|Overall Study|Randomized but not treated|1|||
127584358|NCT00717093|459108439|FG001|Overall Study|Randomized but not treated|0|||
127584359|NCT01516437|459108440|FG000|Overall Study|Reason not specified|0|||
127584360|NCT01516437|459108441|FG001|Overall Study|Reason not specified|0|||
127584361|NCT01516437|459108442|FG002|Overall Study|Reason not specified|1|||
127584362|NCT01516437|459108443|FG003|Overall Study|Reason not specified|1|||
127693939|NCT00812461|459507077|FG000|All Treated Patients|Adverse Event|8|||
128032002|NCT00586157|460744227|FG001|Second Intervention|Withdrawal by Subject|0|||
128032003|NCT00586157|460744226|FG000|Second Intervention|Worsening behavior|1|||
128032004|NCT00586157|460744227|FG001|Second Intervention|Worsening behavior|0|||
128032005|NCT00586157|460744226|FG000|Second Intervention|Adverse Event|0|||
128032006|NCT00586157|460744227|FG001|Second Intervention|Adverse Event|1|||
128032007|NCT01225952|460744229|FG000|Overall Study|Lost to Follow-up|1|||
128032008|NCT01225952|460744230|FG001|Overall Study|Lost to Follow-up|0|||
128032009|NCT01225952|460744231|FG002|Overall Study|Lost to Follow-up|0|||
128032010|NCT01225952|460744229|FG000|Overall Study|Study Eye Explanted|0|||
128032011|NCT01225952|460744230|FG001|Overall Study|Study Eye Explanted|0|||
128032012|NCT01225952|460744231|FG002|Overall Study|Study Eye Explanted|1|||
128032013|NCT01225952|460744229|FG000|Overall Study|Withdrawal by Subject|4|||
128032014|NCT01225952|460744230|FG001|Overall Study|Withdrawal by Subject|4|||
128032015|NCT01225952|460744231|FG002|Overall Study|Withdrawal by Subject|5|||
128032016|NCT01225952|460744229|FG000|Overall Study|Surgical complications|1|||
128032017|NCT01225952|460744230|FG001|Overall Study|Surgical complications|0|||
128032018|NCT01225952|460744231|FG002|Overall Study|Surgical complications|0|||
128032019|NCT02378480|460744232|FG000|Overall Study|Physician Decision|1|||
128032020|NCT02378480|460744233|FG001|Overall Study|Physician Decision|1|||
128032021|NCT02378480|460744232|FG000|Overall Study|Death|1|||
128032022|NCT02378480|460744233|FG001|Overall Study|Death|2|||
128032023|NCT02378480|460744232|FG000|Overall Study|Randomized, but Not Treated|6|||
127584363|NCT00316719|459108446|FG000|Overall Study|Adverse Event|0|||
127584364|NCT00316719|459108447|FG001|Overall Study|Adverse Event|6|||
127584365|NCT00316719|459108446|FG000|Overall Study|Consent withdrawn|2|||
127584366|NCT00316719|459108447|FG001|Overall Study|Consent withdrawn|0|||
127584367|NCT02468674|459108452|FG000|Overall Study|Adverse Event|0|||
127584368|NCT02468674|459108453|FG001|Overall Study|Adverse Event|0|||
127584369|NCT02468674|459108454|FG002|Overall Study|Adverse Event|0|||
127584370|NCT02468674|459108455|FG003|Overall Study|Adverse Event|1|||
127584371|NCT02468674|459108456|FG004|Overall Study|Adverse Event|0|||
127584372|NCT02468674|459108457|FG005|Overall Study|Adverse Event|1|||
127584373|NCT02468674|459108458|FG006|Overall Study|Adverse Event|0|||
127584374|NCT02468674|459108459|FG007|Overall Study|Adverse Event|0|||
128032024|NCT02378480|460744233|FG001|Overall Study|Randomized, but Not Treated|4|||
128032025|NCT02378480|460744232|FG000|Overall Study|Adverse Event|0|||
128032026|NCT02378480|460744233|FG001|Overall Study|Adverse Event|1|||
128032027|NCT02378480|460744232|FG000|Overall Study|Missed EOT/PTE Visit|1|||
128032028|NCT02378480|460744233|FG001|Overall Study|Missed EOT/PTE Visit|2|||
128032029|NCT02378480|460744232|FG000|Overall Study|Withdrawal by Subject|9|||
128032030|NCT02378480|460744233|FG001|Overall Study|Withdrawal by Subject|4|||
128032031|NCT02378480|460744232|FG000|Overall Study|Lost to Follow-up|10|||
128032032|NCT02378480|460744233|FG001|Overall Study|Lost to Follow-up|18|||
128032033|NCT01230060|460744237|FG000|Overall Study|Withdrawal by Subject|1|||
128032034|NCT01217892|460744239|FG000|Overall Study|Adverse Event|1|||
127584375|NCT02468674|459108460|FG008|Overall Study|Adverse Event|0|||
127584376|NCT02468674|459108452|FG000|Overall Study|Lost to Follow-up|1|||
127584377|NCT02468674|459108453|FG001|Overall Study|Lost to Follow-up|0|||
127584378|NCT02468674|459108454|FG002|Overall Study|Lost to Follow-up|0|||
127584379|NCT02468674|459108455|FG003|Overall Study|Lost to Follow-up|0|||
127584380|NCT02468674|459108456|FG004|Overall Study|Lost to Follow-up|0|||
127584381|NCT02468674|459108457|FG005|Overall Study|Lost to Follow-up|0|||
127584382|NCT02468674|459108458|FG006|Overall Study|Lost to Follow-up|0|||
127584383|NCT02468674|459108459|FG007|Overall Study|Lost to Follow-up|1|||
127584384|NCT02468674|459108460|FG008|Overall Study|Lost to Follow-up|1|||
127584385|NCT02468674|459108452|FG000|Overall Study|Physician Decision|0|||
127584386|NCT02468674|459108453|FG001|Overall Study|Physician Decision|0|||
127584387|NCT02468674|459108454|FG002|Overall Study|Physician Decision|0|||
127584388|NCT02468674|459108455|FG003|Overall Study|Physician Decision|0|||
127584389|NCT02468674|459108456|FG004|Overall Study|Physician Decision|0|||
127584390|NCT02468674|459108457|FG005|Overall Study|Physician Decision|0|||
127584391|NCT02468674|459108458|FG006|Overall Study|Physician Decision|1|||
127584392|NCT02468674|459108459|FG007|Overall Study|Physician Decision|0|||
127584393|NCT02468674|459108460|FG008|Overall Study|Physician Decision|0|||
127584394|NCT02468674|459108452|FG000|Overall Study|Patient/Guardian Decision|0|||
127584395|NCT02468674|459108453|FG001|Overall Study|Patient/Guardian Decision|0|||
127584396|NCT02468674|459108454|FG002|Overall Study|Patient/Guardian Decision|0|||
127584397|NCT02468674|459108455|FG003|Overall Study|Patient/Guardian Decision|0|||
127584398|NCT02468674|459108456|FG004|Overall Study|Patient/Guardian Decision|1|||
127584399|NCT02468674|459108457|FG005|Overall Study|Patient/Guardian Decision|0|||
127584400|NCT02468674|459108458|FG006|Overall Study|Patient/Guardian Decision|0|||
127584401|NCT02468674|459108459|FG007|Overall Study|Patient/Guardian Decision|2|||
127584402|NCT02468674|459108460|FG008|Overall Study|Patient/Guardian Decision|1|||
127584403|NCT02468674|459108452|FG000|Overall Study|Protocol Deviation|0|||
127584404|NCT02468674|459108453|FG001|Overall Study|Protocol Deviation|0|||
127584405|NCT02468674|459108454|FG002|Overall Study|Protocol Deviation|0|||
127584406|NCT02468674|459108455|FG003|Overall Study|Protocol Deviation|0|||
127584407|NCT02468674|459108456|FG004|Overall Study|Protocol Deviation|0|||
127584408|NCT02468674|459108457|FG005|Overall Study|Protocol Deviation|0|||
127584409|NCT02468674|459108458|FG006|Overall Study|Protocol Deviation|0|||
128032035|NCT01217892|460744240|FG001|Overall Study|Adverse Event|1|||
128032036|NCT01217892|460744241|FG002|Overall Study|Adverse Event|1|||
128032037|NCT01217892|460744242|FG003|Overall Study|Adverse Event|0|||
128032038|NCT01217892|460744239|FG000|Overall Study|Withdrawal by Subject|0|||
128032039|NCT01217892|460744240|FG001|Overall Study|Withdrawal by Subject|2|||
127584410|NCT02468674|459108459|FG007|Overall Study|Protocol Deviation|1|||
127584411|NCT02468674|459108460|FG008|Overall Study|Protocol Deviation|1|||
127584412|NCT01644565|459108461|FG000|Overall Study|Undisclosed Medical History|1|||
127584413|NCT01644565|459108462|FG001|Overall Study|Undisclosed Medical History|0|||
127584414|NCT01644565|459108463|FG002|Overall Study|Undisclosed Medical History|0|||
128032040|NCT01217892|460744241|FG002|Overall Study|Withdrawal by Subject|1|||
127584415|NCT01644565|459108464|FG003|Overall Study|Undisclosed Medical History|0|||
127584416|NCT01644565|459108465|FG004|Overall Study|Undisclosed Medical History|0|||
127584417|NCT01644565|459108466|FG005|Overall Study|Undisclosed Medical History|0|||
127584418|NCT01644565|459108467|FG006|Overall Study|Undisclosed Medical History|0|||
127584419|NCT01644565|459108468|FG007|Overall Study|Undisclosed Medical History|0|||
127584420|NCT01644565|459108469|FG008|Overall Study|Undisclosed Medical History|0|||
127584421|NCT01644565|459108461|FG000|Overall Study|Lost to Follow-up|0|||
127584422|NCT01644565|459108462|FG001|Overall Study|Lost to Follow-up|0|||
127584423|NCT01644565|459108463|FG002|Overall Study|Lost to Follow-up|0|||
128032041|NCT01217892|460744242|FG003|Overall Study|Withdrawal by Subject|0|||
128032042|NCT01217892|460744239|FG000|Overall Study|Lab value|1|||
128032043|NCT01217892|460744240|FG001|Overall Study|Lab value|0|||
127584424|NCT01644565|459108464|FG003|Overall Study|Lost to Follow-up|1|||
127584425|NCT01644565|459108465|FG004|Overall Study|Lost to Follow-up|0|||
127584426|NCT01644565|459108466|FG005|Overall Study|Lost to Follow-up|0|||
127584427|NCT01644565|459108467|FG006|Overall Study|Lost to Follow-up|0|||
127584428|NCT01644565|459108468|FG007|Overall Study|Lost to Follow-up|2|||
127584429|NCT01644565|459108469|FG008|Overall Study|Lost to Follow-up|0|||
127584430|NCT01644565|459108461|FG000|Overall Study|Family emergency|0|||
127584431|NCT01644565|459108462|FG001|Overall Study|Family emergency|0|||
127584432|NCT01644565|459108463|FG002|Overall Study|Family emergency|0|||
128032044|NCT01217892|460744241|FG002|Overall Study|Lab value|1|||
128032045|NCT01217892|460744242|FG003|Overall Study|Lab value|0|||
128032046|NCT01217892|460744239|FG000|Overall Study|Subject no longer meets study criteria|5|||
127584433|NCT01644565|459108464|FG003|Overall Study|Family emergency|0|||
127584434|NCT01644565|459108465|FG004|Overall Study|Family emergency|1|||
127584435|NCT01644565|459108466|FG005|Overall Study|Family emergency|0|||
127584436|NCT01644565|459108467|FG006|Overall Study|Family emergency|0|||
127584437|NCT01644565|459108468|FG007|Overall Study|Family emergency|0|||
127584438|NCT01644565|459108469|FG008|Overall Study|Family emergency|0|||
127584439|NCT01644565|459108461|FG000|Overall Study|Relocation|0|||
127584440|NCT01644565|459108462|FG001|Overall Study|Relocation|0|||
127584441|NCT01644565|459108463|FG002|Overall Study|Relocation|0|||
127584442|NCT01644565|459108464|FG003|Overall Study|Relocation|0|||
127584443|NCT01644565|459108465|FG004|Overall Study|Relocation|0|||
127584444|NCT01644565|459108466|FG005|Overall Study|Relocation|0|||
127584445|NCT01644565|459108467|FG006|Overall Study|Relocation|0|||
127584446|NCT01644565|459108468|FG007|Overall Study|Relocation|0|||
127584447|NCT01644565|459108469|FG008|Overall Study|Relocation|1|||
127584448|NCT00094172|459108473|FG000|Overall Study|Adverse Event|0|||
127584449|NCT00094172|459108474|FG001|Overall Study|Adverse Event|1|||
127584450|NCT00094172|459108473|FG000|Overall Study|Lost to Follow-up|2|||
127584451|NCT00094172|459108474|FG001|Overall Study|Lost to Follow-up|0|||
127584452|NCT00094172|459108473|FG000|Overall Study|Protocol Violation|0|||
127584453|NCT00094172|459108474|FG001|Overall Study|Protocol Violation|1|||
127584454|NCT00094172|459108473|FG000|Overall Study|Withdrawal by Subject|10|||
127584455|NCT00094172|459108474|FG001|Overall Study|Withdrawal by Subject|5|||
127584456|NCT00094172|459108473|FG000|Overall Study|Primary endpoint met.|1|||
127584457|NCT00094172|459108474|FG001|Overall Study|Primary endpoint met.|0|||
127584458|NCT00094172|459108473|FG000|Overall Study|Started other MS therapy due to disease|1|||
127584459|NCT00094172|459108474|FG001|Overall Study|Started other MS therapy due to disease|0|||
127584460|NCT03689530|459108477|FG000|Overall Study|Withdrawal by Subject|53|||
127584461|NCT03689530|459108478|FG001|Overall Study|Withdrawal by Subject|16|||
127584462|NCT00713323|459108479|FG000|Overall Study|Adverse Event|75|||
127584463|NCT00713323|459108479|FG000|Overall Study|Withdrawal by Subject|15|||
127584464|NCT00713323|459108479|FG000|Overall Study|Lost to Follow-up|11|||
127584465|NCT00713323|459108479|FG000|Overall Study|Lack of Efficacy|36|||
127584466|NCT00713323|459108479|FG000|Overall Study|Low creatine clearance at screening|1|||
127584467|NCT00713323|459108479|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
127584468|NCT00713323|459108479|FG000|Overall Study|Surgery cured allodynic pain|1|||
127584469|NCT00713323|459108479|FG000|Overall Study|Pain free|1|||
127584470|NCT00713323|459108479|FG000|Overall Study|Non-compliance|1|||
127584471|NCT00713323|459108479|FG000|Overall Study|Pain resolved|1|||
127584472|NCT00713323|459108479|FG000|Overall Study|Subject travelling to USA|1|||
127584473|NCT00713323|459108479|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
127584474|NCT00713323|459108479|FG000|Overall Study|Treatment that may interact with Sativex|1|||
127584475|NCT00827502|459108481|FG000|Overall Study|randomized but not treated|11|||
127584476|NCT00827502|459108481|FG000|Overall Study|Adverse Event|1|||
127584477|NCT00827502|459108481|FG000|Overall Study|Lost to Follow-up|4|||
127584478|NCT00827502|459108481|FG000|Overall Study|Withdrawal by Subject|5|||
127584479|NCT02478632|459108482|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
127584480|NCT02478632|459108483|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
127584481|NCT02478632|459108482|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
127584482|NCT02478632|459108483|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
127584483|NCT02478632|459108482|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
127584484|NCT02478632|459108483|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
127584485|NCT04622306|459108484|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
128032047|NCT01217892|460744240|FG001|Overall Study|Subject no longer meets study criteria|2|||
128032048|NCT01217892|460744241|FG002|Overall Study|Subject no longer meets study criteria|4|||
128032049|NCT01217892|460744242|FG003|Overall Study|Subject no longer meets study criteria|8|||
128032050|NCT01217892|460744239|FG000|Overall Study|Incorrect enrollment|0|||
128032051|NCT01217892|460744240|FG001|Overall Study|Incorrect enrollment|1|||
127584486|NCT04622306|459108485|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
128032052|NCT01217892|460744241|FG002|Overall Study|Incorrect enrollment|1|||
127584487|NCT04622306|459108486|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
127584488|NCT04622306|459108487|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
128032053|NCT01217892|460744242|FG003|Overall Study|Incorrect enrollment|0|||
127584489|NCT04622306|459108488|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
127584490|NCT04622306|459108489|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
127584491|NCT04622306|459108484|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
127584492|NCT04622306|459108485|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
127584493|NCT04622306|459108486|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
128032054|NCT01217892|460744239|FG000|Overall Study|Poor/Non-Compliance|0|||
128032055|NCT01217892|460744240|FG001|Overall Study|Poor/Non-Compliance|0|||
127584494|NCT04622306|459108487|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
128032056|NCT01217892|460744241|FG002|Overall Study|Poor/Non-Compliance|1|||
128032057|NCT01217892|460744242|FG003|Overall Study|Poor/Non-Compliance|0|||
128032058|NCT01052779|460744244|FG000|Overall Study|Adverse Event|1|||
128032059|NCT01052779|460744245|FG001|Overall Study|Adverse Event|4|||
128032060|NCT01052779|460744244|FG000|Overall Study|Withdrawal by Subject|1|||
128032061|NCT01052779|460744245|FG001|Overall Study|Withdrawal by Subject|2|||
128032062|NCT01052779|460744244|FG000|Overall Study|Other-Protocol Violation|1|||
128032063|NCT01052779|460744245|FG001|Overall Study|Other-Protocol Violation|1|||
128032064|NCT01052779|460744244|FG000|Overall Study|Other-Surgery|0|||
128032065|NCT01052779|460744245|FG001|Overall Study|Other-Surgery|2|||
128032066|NCT01052779|460744244|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
128032067|NCT01052779|460744245|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
128032068|NCT03802916|460744246|FG000|Overall Study|Adverse Event|0|||
128032069|NCT03802916|460744247|FG001|Overall Study|Adverse Event|1|||
128032070|NCT03802916|460744246|FG000|Overall Study|Withdrawal by Subject|0|||
128032071|NCT03802916|460744247|FG001|Overall Study|Withdrawal by Subject|1|||
128032072|NCT03663582|460744248|FG000|Overall Study|Physician Decision|1|||
128032073|NCT01285102|460744249|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
128032074|NCT03729609|460744265|FG000|Overall Study|Protocol Violation|1|||
127584495|NCT04622306|459108488|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
127584496|NCT04622306|459108489|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
127584497|NCT00864721|459108490|FG000|Overall Study|Patient request|11|||
127584498|NCT00864721|459108490|FG000|Overall Study|Hospitalized|1|||
127584499|NCT00864721|459108490|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
127584500|NCT00864721|459108490|FG000|Overall Study|Adverse Event|21|||
127584501|NCT00736944|459108491|FG000|Induction|Death|1|||
127584502|NCT00736944|459108491|FG000|Definitive Treatment|Physician Decision|1|||
127584503|NCT05350410|459108492|FG000|Overall Study|Withdrawal by Subject|1|||
127584504|NCT01601132|459108493|FG000|Overall Study|Patient withdrew consent|1|||
127584505|NCT01601132|459108493|FG000|Overall Study|Protocol deviation|1|||
127584506|NCT00142935|459108494|FG000|Overall Study|Other reason|1|||
127584507|NCT00142935|459108495|FG001|Overall Study|Other reason|1|||
127584508|NCT00142935|459108496|FG002|Overall Study|Other reason|1|||
127584509|NCT00142935|459108494|FG000|Overall Study|Lost to Follow-up|2|||
127584510|NCT00142935|459108495|FG001|Overall Study|Lost to Follow-up|5|||
127584511|NCT00142935|459108496|FG002|Overall Study|Lost to Follow-up|5|||
127584512|NCT00142935|459108494|FG000|Overall Study|Death|0|||
127584513|NCT00142935|459108495|FG001|Overall Study|Death|2|||
127584514|NCT00142935|459108496|FG002|Overall Study|Death|1|||
127584515|NCT01330030|459108503|FG000|Overall Study|Lost to Follow-up|16|||
127584516|NCT01330030|459108504|FG001|Overall Study|Lost to Follow-up|17|||
127584517|NCT02980783|459108505|FG000|Overall Study|Lost to Follow-up|1|||
127584518|NCT02130570|459108506|FG000|Overall Study|Death|3|||
127584519|NCT02130570|459108507|FG001|Overall Study|Death|5|||
127584520|NCT02130570|459108506|FG000|Overall Study|Withdrawal by Subject|6|||
127584521|NCT02130570|459108507|FG001|Overall Study|Withdrawal by Subject|3|||
127584522|NCT02130570|459108506|FG000|Overall Study|Part of practice that discontinued study|0|||
127584523|NCT02130570|459108507|FG001|Overall Study|Part of practice that discontinued study|5|||
127584524|NCT01696695|459108508|FG000|Overall Study|Disease progression|373|||
127584525|NCT01696695|459108508|FG000|Overall Study|Death|29|||
127584526|NCT01696695|459108508|FG000|Overall Study|Adverse Event|74|||
128032075|NCT00605189|460744271|FG000|Overall Study|Adverse Event|1|||
128032076|NCT00605189|460744272|FG001|Overall Study|Adverse Event|0|||
128032077|NCT00605189|460744273|FG002|Overall Study|Adverse Event|0|||
128032078|NCT00605189|460744271|FG000|Overall Study|Other|2|||
127584527|NCT01696695|459108508|FG000|Overall Study|Withdrawal by Subject|92|||
127584528|NCT01696695|459108508|FG000|Overall Study|Lost to Follow-up|48|||
127584529|NCT01696695|459108508|FG000|Overall Study|Other|74|||
127584530|NCT01696695|459108508|FG000|Overall Study|Major Protocol Violation|192|||
127584531|NCT02805972|459108516|FG000|Washout Period|Lost to Follow-up|3|||
127584532|NCT02805972|459108517|FG001|Washout Period|Lost to Follow-up|0|||
128032079|NCT00605189|460744272|FG001|Overall Study|Other|2|||
128032080|NCT00605189|460744273|FG002|Overall Study|Other|0|||
128032081|NCT02697448|460744274|FG000|Overall Study|Protocol Violation|2|||
127584533|NCT02716805|459108518|FG000|Overall Study|Progressive disease|2|||
127584534|NCT02716805|459108519|FG001|Overall Study|Progressive disease|0|||
127584535|NCT02716805|459108520|FG002|Overall Study|Progressive disease|0|||
127584536|NCT02716805|459108521|FG003|Overall Study|Progressive disease|0|||
127584537|NCT00932126|459108522|FG000|Overall Study|Adverse Event|0|||
127584538|NCT00932126|459108523|FG001|Overall Study|Adverse Event|0|||
128032082|NCT02697448|460744275|FG001|Overall Study|Protocol Violation|4|||
128032083|NCT02697448|460744274|FG000|Overall Study|Clinical concerns during ablation|1|||
127584539|NCT00932126|459108524|FG002|Overall Study|Adverse Event|0|||
127584540|NCT00932126|459108525|FG003|Overall Study|Adverse Event|0|||
127584541|NCT00932126|459108526|FG004|Overall Study|Adverse Event|0|||
128032084|NCT02697448|460744275|FG001|Overall Study|Clinical concerns during ablation|1|||
128032085|NCT02697448|460744274|FG000|Overall Study|No data collected|2|||
128032086|NCT02697448|460744275|FG001|Overall Study|No data collected|0|||
127584542|NCT00932126|459108527|FG005|Overall Study|Adverse Event|0|||
127584543|NCT00932126|459108528|FG006|Overall Study|Adverse Event|1|||
127584544|NCT00932126|459108529|FG007|Overall Study|Adverse Event|2|||
127584545|NCT00932126|459108522|FG000|Overall Study|Protocol Violation|0|||
127584546|NCT00932126|459108523|FG001|Overall Study|Protocol Violation|0|||
127584547|NCT00932126|459108524|FG002|Overall Study|Protocol Violation|0|||
127584548|NCT00932126|459108525|FG003|Overall Study|Protocol Violation|0|||
127584549|NCT00932126|459108526|FG004|Overall Study|Protocol Violation|1|||
127584550|NCT00932126|459108527|FG005|Overall Study|Protocol Violation|0|||
127584551|NCT00932126|459108528|FG006|Overall Study|Protocol Violation|0|||
127584552|NCT00932126|459108529|FG007|Overall Study|Protocol Violation|0|||
127584553|NCT00932126|459108522|FG000|Overall Study|Withdrawal by Subject|0|||
127584554|NCT00932126|459108523|FG001|Overall Study|Withdrawal by Subject|0|||
127584555|NCT00932126|459108524|FG002|Overall Study|Withdrawal by Subject|1|||
127584556|NCT00932126|459108525|FG003|Overall Study|Withdrawal by Subject|0|||
127584557|NCT00932126|459108526|FG004|Overall Study|Withdrawal by Subject|0|||
127584558|NCT00932126|459108527|FG005|Overall Study|Withdrawal by Subject|0|||
127584559|NCT00932126|459108528|FG006|Overall Study|Withdrawal by Subject|0|||
127584560|NCT00932126|459108529|FG007|Overall Study|Withdrawal by Subject|1|||
127584561|NCT00932126|459108522|FG000|Overall Study|Objective progression or relapse|3|||
127584562|NCT00932126|459108523|FG001|Overall Study|Objective progression or relapse|3|||
127584563|NCT00932126|459108524|FG002|Overall Study|Objective progression or relapse|2|||
127584564|NCT00932126|459108525|FG003|Overall Study|Objective progression or relapse|3|||
127584565|NCT00932126|459108526|FG004|Overall Study|Objective progression or relapse|3|||
127584566|NCT00932126|459108527|FG005|Overall Study|Objective progression or relapse|3|||
127584567|NCT00932126|459108528|FG006|Overall Study|Objective progression or relapse|3|||
127584568|NCT00932126|459108529|FG007|Overall Study|Objective progression or relapse|5|||
127584569|NCT00932126|459108522|FG000|Overall Study|Other|0|||
127584570|NCT00932126|459108523|FG001|Overall Study|Other|0|||
127584571|NCT00932126|459108524|FG002|Overall Study|Other|0|||
127584572|NCT00932126|459108525|FG003|Overall Study|Other|0|||
127584573|NCT00932126|459108526|FG004|Overall Study|Other|1|||
127584574|NCT00932126|459108527|FG005|Overall Study|Other|0|||
127584575|NCT00932126|459108528|FG006|Overall Study|Other|1|||
127584576|NCT00932126|459108529|FG007|Overall Study|Other|2|||
127584577|NCT00239590|459108530|FG000|Randomized|Lost to Follow-up|0|||
127584578|NCT00239590|459108531|FG001|Randomized|Lost to Follow-up|1|||
127584579|NCT00239590|459108530|FG000|Randomized|Withdrawal by Subject|0|||
127584580|NCT00239590|459108531|FG001|Randomized|Withdrawal by Subject|1|||
127584581|NCT00239590|459108530|FG000|Completed Study Protocol|Adverse Event|1|||
127584582|NCT00239590|459108531|FG001|Completed Study Protocol|Adverse Event|1|||
127584583|NCT00239590|459108530|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
127584584|NCT00239590|459108531|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
127584585|NCT02362269|459108534|FG000|Overall Study|Moved|1|||
127584586|NCT02362269|459108535|FG001|Overall Study|Moved|0|||
127584587|NCT02362269|459108534|FG000|Overall Study|Lost to Follow-up|0|||
127584588|NCT02362269|459108535|FG001|Overall Study|Lost to Follow-up|6|||
127693940|NCT00812461|459507078|FG001|All Treated Patients|Adverse Event|15|||
127693941|NCT00812461|459507077|FG000|All Treated Patients|Lack of Efficacy|13|||
127693942|NCT00812461|459507078|FG001|All Treated Patients|Lack of Efficacy|7|||
127693943|NCT00812461|459507077|FG000|All Treated Patients|Non-compliance|6|||
127693944|NCT00812461|459507078|FG001|All Treated Patients|Non-compliance|9|||
127693945|NCT00812461|459507077|FG000|All Treated Patients|Protocol Violation|36|||
127693946|NCT00812461|459507078|FG001|All Treated Patients|Protocol Violation|27|||
127693947|NCT00812461|459507077|FG000|All Treated Patients|Withdrawal by Subject|45|||
127693948|NCT00812461|459507078|FG001|All Treated Patients|Withdrawal by Subject|54|||
127693949|NCT00812461|459507077|FG000|All Treated Patients|Lost to Follow-up|11|||
127693950|NCT00812461|459507078|FG001|All Treated Patients|Lost to Follow-up|14|||
127693951|NCT00812461|459507077|FG000|All Treated Patients|Other Reason|13|||
127693952|NCT00812461|459507078|FG001|All Treated Patients|Other Reason|21|||
127693953|NCT02471638|459507082|FG000|Overall Study|Early Term Withdrawal|10|||
127693954|NCT04178733|459508600|FG000|Overall Study|Investigator Decision|0|||
127693955|NCT04178733|459508601|FG001|Overall Study|Investigator Decision|0|||
127693956|NCT04178733|459508602|FG002|Overall Study|Investigator Decision|0|||
127693957|NCT04178733|459508603|FG003|Overall Study|Investigator Decision|1|||
127693958|NCT04178733|459508604|FG004|Overall Study|Investigator Decision|2|||
127693959|NCT04833777|459508610|FG000|Overall Study|Lost to Follow-up|1|||
127693960|NCT04833777|459508611|FG001|Overall Study|Lost to Follow-up|0|||
127693961|NCT02287311|459508612|FG000|Cohort 1: Dose Level 1|Death|2|||
127693962|NCT02287311|459508613|FG001|Cohort 1: Dose Level 1|Death|0|||
127693963|NCT02287311|459508614|FG002|Cohort 1: Dose Level 1|Death|0|||
127584589|NCT01903031|459108536|FG000|Overall Study|Not Able to Attend Clinic|1|||
127584590|NCT01903031|459108537|FG001|Overall Study|Not Able to Attend Clinic|1|||
127584591|NCT01903031|459108538|FG002|Overall Study|Not Able to Attend Clinic|0|||
127584592|NCT01903031|459108536|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
127584593|NCT01903031|459108537|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
127693964|NCT02287311|459508615|FG003|Cohort 1: Dose Level 1|Death|3|||
127584594|NCT01903031|459108538|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
127584595|NCT01903031|459108536|FG000|Overall Study|Adverse Event|0|||
127584596|NCT01903031|459108537|FG001|Overall Study|Adverse Event|1|||
127584597|NCT01903031|459108538|FG002|Overall Study|Adverse Event|0|||
127584598|NCT01903031|459108536|FG000|Overall Study|Withdrawal by Subject|0|||
127584599|NCT01903031|459108537|FG001|Overall Study|Withdrawal by Subject|1|||
127584600|NCT01903031|459108538|FG002|Overall Study|Withdrawal by Subject|1|||
127584601|NCT01903031|459108536|FG000|Overall Study|Protocol Violation|0|||
127584602|NCT01903031|459108537|FG001|Overall Study|Protocol Violation|0|||
127584603|NCT01903031|459108538|FG002|Overall Study|Protocol Violation|2|||
127584604|NCT01903031|459108536|FG000|Overall Study|Lost to Follow-up|0|||
127584605|NCT01903031|459108537|FG001|Overall Study|Lost to Follow-up|0|||
127584606|NCT01903031|459108538|FG002|Overall Study|Lost to Follow-up|1|||
127584607|NCT01903031|459108536|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
127584608|NCT01903031|459108537|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
127584609|NCT01903031|459108538|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
127584610|NCT03540030|459108539|FG000|Overall Study|Withdrawal by Subject|2|||
127584611|NCT03540030|459108540|FG001|Overall Study|Withdrawal by Subject|1|||
127584612|NCT03540030|459108539|FG000|Overall Study|screen fail|7|||
127584613|NCT03540030|459108540|FG001|Overall Study|screen fail|1|||
127584614|NCT03540030|459108539|FG000|Overall Study|never had surgery after signing consent|9|||
127584615|NCT03540030|459108540|FG001|Overall Study|never had surgery after signing consent|1|||
127584616|NCT00347360|459108550|FG000|Overall Study|Adverse Event|1|||
127584617|NCT00347360|459108551|FG001|Overall Study|Adverse Event|2|||
127584618|NCT00347360|459108552|FG002|Overall Study|Adverse Event|0|||
127584619|NCT00347360|459108553|FG003|Overall Study|Adverse Event|4|||
127584620|NCT00347360|459108554|FG004|Overall Study|Adverse Event|1|||
127584621|NCT00347360|459108555|FG005|Overall Study|Adverse Event|2|||
127693965|NCT02287311|459508616|FG004|Cohort 1: Dose Level 1|Death|0|||
127584622|NCT00347360|459108556|FG006|Overall Study|Adverse Event|2|||
127584623|NCT00347360|459108557|FG007|Overall Study|Adverse Event|0|||
127693966|NCT02287311|459508617|FG005|Cohort 1: Dose Level 1|Death|0|||
127693967|NCT02287311|459508618|FG006|Cohort 1: Dose Level 1|Death|1|||
127693968|NCT02287311|459508619|FG007|Cohort 1: Dose Level 1|Death|0|||
127693969|NCT02287311|459508620|FG008|Cohort 1: Dose Level 1|Death|0|||
127693970|NCT02287311|459508612|FG000|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
127693971|NCT02287311|459508613|FG001|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
127693972|NCT02287311|459508614|FG002|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
127693973|NCT02287311|459508615|FG003|Cohort 1: Dose Level 1|Lost to Follow-up|2|||
127693974|NCT02287311|459508616|FG004|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
127693975|NCT02287311|459508617|FG005|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
127693976|NCT02287311|459508618|FG006|Cohort 1: Dose Level 1|Lost to Follow-up|1|||
127693977|NCT02287311|459508619|FG007|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
127693978|NCT02287311|459508620|FG008|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
127693979|NCT02287311|459508612|FG000|Cohort 1: Dose Level 1|Physician Decision|1|||
127693980|NCT02287311|459508613|FG001|Cohort 1: Dose Level 1|Physician Decision|0|||
127693981|NCT02287311|459508614|FG002|Cohort 1: Dose Level 1|Physician Decision|0|||
127693982|NCT02287311|459508615|FG003|Cohort 1: Dose Level 1|Physician Decision|0|||
127693983|NCT02287311|459508616|FG004|Cohort 1: Dose Level 1|Physician Decision|0|||
127693984|NCT02287311|459508617|FG005|Cohort 1: Dose Level 1|Physician Decision|0|||
127693985|NCT02287311|459508618|FG006|Cohort 1: Dose Level 1|Physician Decision|0|||
127693986|NCT02287311|459508619|FG007|Cohort 1: Dose Level 1|Physician Decision|0|||
127693987|NCT02287311|459508620|FG008|Cohort 1: Dose Level 1|Physician Decision|0|||
127693988|NCT02287311|459508612|FG000|Cohort 2: Dose Level 2|Death|0|||
127693989|NCT02287311|459508613|FG001|Cohort 2: Dose Level 2|Death|2|||
127693990|NCT02287311|459508614|FG002|Cohort 2: Dose Level 2|Death|0|||
127693991|NCT02287311|459508615|FG003|Cohort 2: Dose Level 2|Death|0|||
127693992|NCT02287311|459508616|FG004|Cohort 2: Dose Level 2|Death|2|||
127693993|NCT02287311|459508617|FG005|Cohort 2: Dose Level 2|Death|0|||
127693994|NCT02287311|459508618|FG006|Cohort 2: Dose Level 2|Death|0|||
127693995|NCT02287311|459508619|FG007|Cohort 2: Dose Level 2|Death|2|||
127693996|NCT02287311|459508620|FG008|Cohort 2: Dose Level 2|Death|0|||
127693997|NCT02287311|459508612|FG000|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
127693998|NCT02287311|459508613|FG001|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
127584624|NCT00347360|459108558|FG008|Overall Study|Adverse Event|2|||
127584625|NCT00347360|459108559|FG009|Overall Study|Adverse Event|3|||
127584626|NCT00347360|459108560|FG010|Overall Study|Adverse Event|3|||
127584627|NCT00347360|459108561|FG011|Overall Study|Adverse Event|1|||
127584628|NCT00347360|459108562|FG012|Overall Study|Adverse Event|3|||
127584629|NCT00347360|459108563|FG013|Overall Study|Adverse Event|2|||
127584630|NCT00347360|459108564|FG014|Overall Study|Adverse Event|2|||
127584631|NCT00347360|459108550|FG000|Overall Study|Lost to Follow-up|0|||
127693999|NCT02287311|459508614|FG002|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
127694000|NCT02287311|459508615|FG003|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
127694001|NCT02287311|459508616|FG004|Cohort 2: Dose Level 2|Lost to Follow-up|1|||
127694002|NCT02287311|459508617|FG005|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
127694003|NCT02287311|459508618|FG006|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
128032087|NCT05473715|460744276|FG000|Overall Study|Trial terminate|2|||
127584632|NCT00347360|459108551|FG001|Overall Study|Lost to Follow-up|0|||
127584633|NCT00347360|459108552|FG002|Overall Study|Lost to Follow-up|0|||
127584634|NCT00347360|459108553|FG003|Overall Study|Lost to Follow-up|2|||
127584635|NCT00347360|459108554|FG004|Overall Study|Lost to Follow-up|1|||
127584636|NCT00347360|459108555|FG005|Overall Study|Lost to Follow-up|1|||
127584637|NCT00347360|459108556|FG006|Overall Study|Lost to Follow-up|0|||
127584638|NCT00347360|459108557|FG007|Overall Study|Lost to Follow-up|1|||
127584639|NCT00347360|459108558|FG008|Overall Study|Lost to Follow-up|1|||
127584640|NCT00347360|459108559|FG009|Overall Study|Lost to Follow-up|2|||
127584641|NCT00347360|459108560|FG010|Overall Study|Lost to Follow-up|0|||
127584642|NCT00347360|459108561|FG011|Overall Study|Lost to Follow-up|0|||
127584643|NCT00347360|459108562|FG012|Overall Study|Lost to Follow-up|1|||
127584644|NCT00347360|459108563|FG013|Overall Study|Lost to Follow-up|0|||
127584645|NCT00347360|459108564|FG014|Overall Study|Lost to Follow-up|0|||
127584646|NCT00347360|459108550|FG000|Overall Study|Protocol Violation|2|||
127584647|NCT00347360|459108551|FG001|Overall Study|Protocol Violation|3|||
127584648|NCT00347360|459108552|FG002|Overall Study|Protocol Violation|1|||
127584649|NCT00347360|459108553|FG003|Overall Study|Protocol Violation|2|||
127584650|NCT00347360|459108554|FG004|Overall Study|Protocol Violation|1|||
127584651|NCT00347360|459108555|FG005|Overall Study|Protocol Violation|2|||
127584652|NCT00347360|459108556|FG006|Overall Study|Protocol Violation|0|||
127584653|NCT00347360|459108557|FG007|Overall Study|Protocol Violation|0|||
127783911|NCT01439282|459835621|FG000|Overall Study|Withdrawal by Subject|2|||
127783912|NCT01439282|459835622|FG001|Overall Study|Withdrawal by Subject|0|||
127783913|NCT01439282|459835621|FG000|Overall Study|Other|1|||
127783914|NCT01439282|459835622|FG001|Overall Study|Other|1|||
127783915|NCT01502709|459835625|FG000|Overall Study|Lost to Follow-up|4|||
127783916|NCT01502709|459835626|FG001|Overall Study|Lost to Follow-up|0|||
127783917|NCT04096274|459835627|FG000|Phase I|Lost to Follow-up|5|||
127783918|NCT04096274|459835628|FG001|Phase I|Lost to Follow-up|5|||
127783919|NCT04096274|459835627|FG000|Phase II|Lost to Follow-up|11|||
127584654|NCT00347360|459108558|FG008|Overall Study|Protocol Violation|1|||
127584655|NCT00347360|459108559|FG009|Overall Study|Protocol Violation|2|||
127783920|NCT04096274|459835628|FG001|Phase II|Lost to Follow-up|11|||
127783921|NCT00937937|459835629|FG000|Overall Study|Adverse Event|6|||
127783922|NCT00937937|459835629|FG000|Overall Study|Withdrawal by Subject|2|||
127783923|NCT00937937|459835629|FG000|Overall Study|Progression/relapse|61|||
127783924|NCT00937937|459835629|FG000|Overall Study|Death|1|||
127783925|NCT00937937|459835629|FG000|Overall Study|Other|2|||
127783926|NCT02807480|459835631|FG000|Overall Study|Withdrawal by Subject|14|||
127783927|NCT02807480|459835632|FG001|Overall Study|Withdrawal by Subject|10|||
127783928|NCT02163187|459835633|FG000|Overall Study|Device removed|1|||
127783929|NCT02163187|459835634|FG001|Overall Study|Device removed|0|||
127783930|NCT02163187|459835633|FG000|Overall Study|Progressive disease|1|||
127783931|NCT02163187|459835634|FG001|Overall Study|Progressive disease|0|||
127783932|NCT02369848|459835635|FG000|Overall Study|Death|1|||
127783933|NCT02369848|459835635|FG000|Overall Study|Withdrawal by Subject|2|||
127783934|NCT02369848|459835635|FG000|Overall Study|Lost to Follow-up|1|||
127783935|NCT03281668|459835637|FG000|Overall Study|Physician Decision|1|||
127783936|NCT03281668|459835637|FG000|Overall Study|scheduling conflict, family circumstance|2|||
127783937|NCT03281668|459835637|FG000|Overall Study|Withdrawal by Subject|4|||
127783938|NCT03281668|459835637|FG000|Overall Study|Lost to Follow-up|1|||
127783939|NCT01543152|459835638|FG000|Overall Study|Withdrawal by Subject|0|||
127783940|NCT01543152|459835639|FG001|Overall Study|Withdrawal by Subject|2|||
127783941|NCT01543152|459835640|FG002|Overall Study|Withdrawal by Subject|0|||
127783942|NCT01543152|459835641|FG003|Overall Study|Withdrawal by Subject|0|||
127584656|NCT00347360|459108560|FG010|Overall Study|Protocol Violation|0|||
127584657|NCT00347360|459108561|FG011|Overall Study|Protocol Violation|0|||
127584658|NCT00347360|459108562|FG012|Overall Study|Protocol Violation|0|||
127584659|NCT00347360|459108563|FG013|Overall Study|Protocol Violation|1|||
127584660|NCT00347360|459108564|FG014|Overall Study|Protocol Violation|0|||
128032088|NCT05473715|460744277|FG001|Overall Study|Trial terminate|1|||
128032089|NCT02919618|460744281|FG000|Overall Study|Death|1|||
128032090|NCT02592863|460744282|FG000|Overall Study|Withdrawal by Subject|2|||
128032091|NCT02592863|460744283|FG001|Overall Study|Withdrawal by Subject|2|||
128032092|NCT02592863|460744282|FG000|Overall Study|Lost to Follow-up|1|||
127584661|NCT00347360|459108550|FG000|Overall Study|Withdrawal by Subject|0|||
127584662|NCT00347360|459108551|FG001|Overall Study|Withdrawal by Subject|1|||
127584663|NCT00347360|459108552|FG002|Overall Study|Withdrawal by Subject|2|||
127584664|NCT00347360|459108553|FG003|Overall Study|Withdrawal by Subject|4|||
127783943|NCT01543152|459835642|FG004|Overall Study|Withdrawal by Subject|0|||
127783944|NCT02932410|459835643|FG000|Overall Study|Death|7|||
127783945|NCT02932410|459835644|FG001|Overall Study|Death|6|||
127783946|NCT02932410|459835645|FG002|Overall Study|Death|0|||
127584665|NCT00347360|459108554|FG004|Overall Study|Withdrawal by Subject|1|||
127584666|NCT00347360|459108555|FG005|Overall Study|Withdrawal by Subject|2|||
127584667|NCT00347360|459108556|FG006|Overall Study|Withdrawal by Subject|1|||
127783947|NCT02932410|459835646|FG003|Overall Study|Death|0|||
128032093|NCT02592863|460744283|FG001|Overall Study|Lost to Follow-up|1|||
128032094|NCT02743221|460744284|FG000|Overall Study|Progressive disease|29|||
128032095|NCT02743221|460744285|FG001|Overall Study|Progressive disease|38|||
128032096|NCT02743221|460744284|FG000|Overall Study|Adverse Event|17|||
128032097|NCT02743221|460744285|FG001|Overall Study|Adverse Event|14|||
128032098|NCT02743221|460744284|FG000|Overall Study|non medical reason|8|||
128032099|NCT02743221|460744285|FG001|Overall Study|non medical reason|2|||
128032100|NCT02743221|460744284|FG000|Overall Study|Physician Decision|2|||
128032101|NCT02743221|460744285|FG001|Overall Study|Physician Decision|5|||
128032102|NCT02743221|460744284|FG000|Overall Study|Patient not eligible, not treated|0|||
128032103|NCT02743221|460744285|FG001|Overall Study|Patient not eligible, not treated|1|||
128032104|NCT03411044|460744287|FG000|Overall Study|Death|30|||
128032105|NCT03411044|460744287|FG000|Overall Study|Withdrawal by Subject|48|||
128032106|NCT03411044|460744287|FG000|Overall Study|Lost to Follow-up|78|||
128032107|NCT03411044|460744287|FG000|Overall Study|Adverse Event|30|||
128032108|NCT03411044|460744287|FG000|Overall Study|Missing status|4|||
128032109|NCT02609503|460744288|FG000|Overall Study|Adverse Event|1|||
128032110|NCT02609503|460744288|FG000|Overall Study|Death|1|||
128032111|NCT02609503|460744288|FG000|Overall Study|Withdrawal by Subject|1|||
128032112|NCT02609503|460744288|FG000|Overall Study|Disease progression|1|||
128032113|NCT01969409|460744289|FG000|Overall Study|Death|2|||
128032114|NCT01969409|460744290|FG001|Overall Study|Death|2|||
128032115|NCT01969409|460744289|FG000|Overall Study|Transplant|1|||
128032116|NCT01969409|460744290|FG001|Overall Study|Transplant|1|||
128032117|NCT01969409|460744289|FG000|Overall Study|Withdrawal by Subject|0|||
128032118|NCT01969409|460744290|FG001|Overall Study|Withdrawal by Subject|1|||
128032119|NCT02226653|460744291|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
128032120|NCT02226653|460744292|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
128032121|NCT02226653|460744291|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
128032122|NCT02226653|460744292|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
128032123|NCT03078868|460744294|FG000|Overall Study|Physician Decision|3|||
128032124|NCT00437073|460744297|FG000|Overall Study|Sponsor Terminated Study|1|||
127584668|NCT00347360|459108557|FG007|Overall Study|Withdrawal by Subject|1|||
127584669|NCT00347360|459108558|FG008|Overall Study|Withdrawal by Subject|1|||
127584670|NCT00347360|459108559|FG009|Overall Study|Withdrawal by Subject|1|||
127584671|NCT00347360|459108560|FG010|Overall Study|Withdrawal by Subject|0|||
127584672|NCT00347360|459108561|FG011|Overall Study|Withdrawal by Subject|3|||
127584673|NCT00347360|459108562|FG012|Overall Study|Withdrawal by Subject|4|||
127584674|NCT00347360|459108563|FG013|Overall Study|Withdrawal by Subject|2|||
127584675|NCT00347360|459108564|FG014|Overall Study|Withdrawal by Subject|1|||
127584676|NCT00347360|459108550|FG000|Overall Study|Lack of Efficacy|1|||
127584677|NCT00347360|459108551|FG001|Overall Study|Lack of Efficacy|1|||
127584678|NCT00347360|459108552|FG002|Overall Study|Lack of Efficacy|3|||
127584679|NCT00347360|459108553|FG003|Overall Study|Lack of Efficacy|1|||
127584680|NCT00347360|459108554|FG004|Overall Study|Lack of Efficacy|0|||
127584681|NCT00347360|459108555|FG005|Overall Study|Lack of Efficacy|1|||
127584682|NCT00347360|459108556|FG006|Overall Study|Lack of Efficacy|0|||
127584683|NCT00347360|459108557|FG007|Overall Study|Lack of Efficacy|1|||
127584684|NCT00347360|459108558|FG008|Overall Study|Lack of Efficacy|1|||
127584685|NCT00347360|459108559|FG009|Overall Study|Lack of Efficacy|0|||
127584686|NCT00347360|459108560|FG010|Overall Study|Lack of Efficacy|0|||
127584687|NCT00347360|459108561|FG011|Overall Study|Lack of Efficacy|0|||
127584688|NCT00347360|459108562|FG012|Overall Study|Lack of Efficacy|0|||
127584689|NCT00347360|459108563|FG013|Overall Study|Lack of Efficacy|0|||
127584690|NCT00347360|459108564|FG014|Overall Study|Lack of Efficacy|0|||
127584691|NCT00347360|459108550|FG000|Overall Study|Reason not listed/blank|1|||
127584692|NCT00347360|459108551|FG001|Overall Study|Reason not listed/blank|0|||
127783948|NCT02932410|459835643|FG000|Overall Study|Lost to Follow-up|1|||
127783949|NCT02932410|459835644|FG001|Overall Study|Lost to Follow-up|2|||
127783950|NCT02932410|459835645|FG002|Overall Study|Lost to Follow-up|0|||
127783951|NCT02932410|459835646|FG003|Overall Study|Lost to Follow-up|0|||
127783952|NCT02932410|459835643|FG000|Overall Study|Parent/Subjects decision|6|||
127783953|NCT02932410|459835644|FG001|Overall Study|Parent/Subjects decision|6|||
127783954|NCT02932410|459835645|FG002|Overall Study|Parent/Subjects decision|1|||
127783955|NCT02932410|459835646|FG003|Overall Study|Parent/Subjects decision|0|||
127783956|NCT02932410|459835643|FG000|Overall Study|Physician Decision|0|||
127783957|NCT02932410|459835644|FG001|Overall Study|Physician Decision|1|||
127783958|NCT02932410|459835645|FG002|Overall Study|Physician Decision|0|||
127783959|NCT02932410|459835646|FG003|Overall Study|Physician Decision|0|||
127783960|NCT00762892|459835652|FG000|Overall Study|Lost to Follow-up|2|||
127783961|NCT00762892|459835653|FG001|Overall Study|Lost to Follow-up|5|||
128032125|NCT00437073|460744298|FG001|Overall Study|Sponsor Terminated Study|0|||
128032126|NCT00437073|460744297|FG000|Overall Study|Physician Decision|0|||
128032127|NCT00437073|460744298|FG001|Overall Study|Physician Decision|1|||
128032128|NCT04221438|460744301|FG000|Overall Study|Adverse Event|1|||
128032129|NCT04221438|460744301|FG000|Overall Study|No surgery within required timeframe due to Covid diagnosis|1|||
128032130|NCT03514134|460746100|FG000|Overall Study|Lost to Follow-up|0|||
128032131|NCT03514134|460746101|FG001|Overall Study|Lost to Follow-up|1|||
128032132|NCT02471144|460746102|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
128032133|NCT02471144|460746103|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
127881897|NCT01336608|460190704|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
127881898|NCT01336608|460190705|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
127881899|NCT01336608|460190702|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
127881900|NCT01336608|460190703|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
127881901|NCT01336608|460190704|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
127881902|NCT01336608|460190705|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
127881903|NCT01336608|460190702|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
127881904|NCT01336608|460190703|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
127881905|NCT01336608|460190704|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
127881906|NCT01336608|460190705|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
127881907|NCT01336608|460190702|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
127881908|NCT01336608|460190703|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
127881909|NCT01336608|460190704|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
127881910|NCT01336608|460190705|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
127881911|NCT01336608|460190702|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
127881912|NCT01336608|460190703|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
127881913|NCT01336608|460190704|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
127881914|NCT01336608|460190705|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
127881915|NCT00080288|460190706|FG000|Overall Study|Adverse Event|7|||
127881916|NCT00080288|460190707|FG001|Overall Study|Adverse Event|4|||
127881917|NCT00080288|460190706|FG000|Overall Study|Lost to Follow-up|3|||
127881918|NCT00080288|460190707|FG001|Overall Study|Lost to Follow-up|5|||
127881919|NCT00080288|460190706|FG000|Overall Study|Physician Decision|6|||
127881920|NCT00080288|460190707|FG001|Overall Study|Physician Decision|2|||
127881921|NCT00080288|460190706|FG000|Overall Study|Withdrawal by Subject|3|||
127881922|NCT00080288|460190707|FG001|Overall Study|Withdrawal by Subject|16|||
127881923|NCT00080288|460190706|FG000|Overall Study|Miscellaneous|11|||
127881924|NCT00080288|460190707|FG001|Overall Study|Miscellaneous|11|||
127881925|NCT03044431|460190708|FG000|Overall Study|Lost to Follow-up|59|||
127881926|NCT02328547|460190709|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
127881927|NCT02328547|460190710|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
127881928|NCT02328547|460190709|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
127881929|NCT02328547|460190710|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
127881930|NCT00344305|460190714|FG000|Overall Study|Lost to Follow-up|2|||
127881931|NCT00344305|460190715|FG001|Overall Study|Lost to Follow-up|0|||
127881932|NCT00344305|460190714|FG000|Overall Study|Participant was not contacted in window|0|||
127881933|NCT00344305|460190715|FG001|Overall Study|Participant was not contacted in window|1|||
127881934|NCT01726335|460190722|FG000|Overall Study|Lost to Follow-up|2|||
127881935|NCT01726335|460190722|FG000|Overall Study|Withdrawal by Subject|15|||
127881936|NCT01726335|460190722|FG000|Overall Study|Adverse Event|4|||
127881937|NCT01726335|460190722|FG000|Overall Study|Lost to Follow-up|2|||
127881938|NCT01726335|460190722|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
127881939|NCT01796860|460190727|FG000|Overall Study|Withdrawal by Subject|3|||
127881940|NCT02626182|460190729|FG000|Overall Study|Adverse Event|2|||
127881941|NCT02626182|460190730|FG001|Overall Study|Adverse Event|0|||
127881942|NCT01508325|460190731|FG000|Overall Study|Withdrawal by Subject|8|||
127881943|NCT01508325|460190732|FG001|Overall Study|Withdrawal by Subject|9|||
127881944|NCT01508325|460190731|FG000|Overall Study|Protocol Violation|0|||
127881945|NCT01508325|460190732|FG001|Overall Study|Protocol Violation|3|||
127881946|NCT01508325|460190731|FG000|Overall Study|Physician Decision|2|||
127881947|NCT01508325|460190732|FG001|Overall Study|Physician Decision|1|||
127881948|NCT01508325|460190731|FG000|Overall Study|Adverse Event|1|||
127881949|NCT01508325|460190732|FG001|Overall Study|Adverse Event|0|||
127881950|NCT01508325|460190731|FG000|Overall Study|Lost to Follow-up|5|||
127881951|NCT01508325|460190732|FG001|Overall Study|Lost to Follow-up|6|||
127881952|NCT01508325|460190731|FG000|Overall Study|Other|2|||
127881953|NCT01508325|460190732|FG001|Overall Study|Other|2|||
127881954|NCT03543046|460190738|FG000|Overall Study|Adverse Event|1|||
127881955|NCT03543046|460190739|FG001|Overall Study|Adverse Event|1|||
127881956|NCT03543046|460190738|FG000|Overall Study|Physician Decision|1|||
127881957|NCT03543046|460190739|FG001|Overall Study|Physician Decision|1|||
128032134|NCT02471144|460746104|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
128032135|NCT02471144|460746105|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
127881958|NCT03543046|460190738|FG000|Overall Study|Protocol Violation|1|||
127881959|NCT03543046|460190739|FG001|Overall Study|Protocol Violation|0|||
127881960|NCT03869684|460190740|FG000|Overall Study|Adverse Event|0|||
127881961|NCT03869684|460190741|FG001|Overall Study|Adverse Event|3|||
127881962|NCT03869684|460190742|FG002|Overall Study|Adverse Event|1|||
127881963|NCT03869684|460190740|FG000|Overall Study|Withdrawal by Subject|1|||
127881964|NCT03869684|460190741|FG001|Overall Study|Withdrawal by Subject|0|||
127881965|NCT03869684|460190742|FG002|Overall Study|Withdrawal by Subject|0|||
127881966|NCT03869684|460190740|FG000|Overall Study|Lost to Follow-up|1|||
127881967|NCT03869684|460190741|FG001|Overall Study|Lost to Follow-up|0|||
127783962|NCT00762892|459835652|FG000|Overall Study|Withdrawal by Subject|0|||
127783963|NCT00762892|459835653|FG001|Overall Study|Withdrawal by Subject|1|||
127783964|NCT00762892|459835652|FG000|Overall Study|Death|1|||
127783965|NCT00762892|459835653|FG001|Overall Study|Death|0|||
127783966|NCT00762892|459835652|FG000|Overall Study|Pregnancy|1|||
127783967|NCT00762892|459835653|FG001|Overall Study|Pregnancy|0|||
127783968|NCT00762892|459835652|FG000|Overall Study|Incarceration|1|||
127783969|NCT00762892|459835653|FG001|Overall Study|Incarceration|0|||
127783970|NCT01841749|459835654|FG000|Overall Study|Protocol Violation|1|||
127783971|NCT00549939|459835658|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
127783972|NCT00549939|459835659|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
127584693|NCT00347360|459108552|FG002|Overall Study|Reason not listed/blank|0|||
127584694|NCT00347360|459108553|FG003|Overall Study|Reason not listed/blank|0|||
127584695|NCT00347360|459108554|FG004|Overall Study|Reason not listed/blank|0|||
127584696|NCT00347360|459108555|FG005|Overall Study|Reason not listed/blank|0|||
127584697|NCT00347360|459108556|FG006|Overall Study|Reason not listed/blank|1|||
127584698|NCT00347360|459108557|FG007|Overall Study|Reason not listed/blank|0|||
127584699|NCT00347360|459108558|FG008|Overall Study|Reason not listed/blank|0|||
127783973|NCT00549939|459835660|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
127783974|NCT00549939|459835658|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
127783975|NCT00549939|459835659|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
127783976|NCT00549939|459835660|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
127783977|NCT00549939|459835658|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
127783978|NCT00549939|459835659|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
127783979|NCT00549939|459835660|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
127783980|NCT00549939|459835658|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
127783981|NCT00549939|459835659|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
127783982|NCT00549939|459835660|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
127783983|NCT00549939|459835658|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
127783984|NCT00549939|459835659|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
127783985|NCT00549939|459835660|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
127783986|NCT00549939|459835658|FG000|40-week Open Label Treatment Period|Other|0|||
127783987|NCT00549939|459835659|FG001|40-week Open Label Treatment Period|Other|1|||
127783988|NCT00549939|459835660|FG002|40-week Open Label Treatment Period|Other|4|||
127783989|NCT03677596|459835661|FG000|Overall Study|Adverse Event|0|||
127783990|NCT03677596|459835662|FG001|Overall Study|Adverse Event|1|||
127783991|NCT03677596|459835661|FG000|Overall Study|Death|10|||
127783992|NCT03677596|459835662|FG001|Overall Study|Death|6|||
127783993|NCT03677596|459835661|FG000|Overall Study|Lost to Follow-up|0|||
127783994|NCT03677596|459835662|FG001|Overall Study|Lost to Follow-up|1|||
127783995|NCT03677596|459835661|FG000|Overall Study|Progressive Disease|8|||
127783996|NCT03677596|459835662|FG001|Overall Study|Progressive Disease|8|||
127783997|NCT03677596|459835661|FG000|Overall Study|Withdrawal by Subject|3|||
127783998|NCT03677596|459835662|FG001|Overall Study|Withdrawal by Subject|0|||
127783999|NCT03677596|459835661|FG000|Overall Study|Disease Relapse|2|||
127784000|NCT03677596|459835662|FG001|Overall Study|Disease Relapse|2|||
127784001|NCT03677596|459835661|FG000|Overall Study|Other|0|||
127784002|NCT03677596|459835662|FG001|Overall Study|Other|1|||
127784003|NCT05197049|459835665|FG000|Overall Study|Death|0|||
127784004|NCT05197049|459835666|FG001|Overall Study|Death|1|||
127784005|NCT05197049|459835667|FG002|Overall Study|Death|0|||
127784006|NCT05197049|459835665|FG000|Overall Study|Lost to Follow-up|3|||
127784007|NCT05197049|459835666|FG001|Overall Study|Lost to Follow-up|1|||
127784008|NCT05197049|459835667|FG002|Overall Study|Lost to Follow-up|0|||
127784009|NCT05197049|459835665|FG000|Overall Study|Withdrawal by Subject|15|||
127784010|NCT05197049|459835666|FG001|Overall Study|Withdrawal by Subject|3|||
127784011|NCT05197049|459835667|FG002|Overall Study|Withdrawal by Subject|1|||
127784012|NCT05197049|459835665|FG000|Overall Study|GCP non-compliance|1|||
127784013|NCT05197049|459835666|FG001|Overall Study|GCP non-compliance|2|||
127784014|NCT05197049|459835667|FG002|Overall Study|GCP non-compliance|0|||
127784015|NCT01161043|459835670|FG000|Overall Study|Withdrawal by Subject|3|||
128032136|NCT02471144|460746106|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
127584700|NCT00347360|459108559|FG009|Overall Study|Reason not listed/blank|0|||
127584701|NCT00347360|459108560|FG010|Overall Study|Reason not listed/blank|0|||
127784016|NCT02164929|459835677|FG000|Overall Study|Converted to open procedure|1|||
127784017|NCT02164929|459835678|FG001|Overall Study|Converted to open procedure|0|||
127784018|NCT02164929|459835679|FG002|Overall Study|Converted to open procedure|0|||
127784019|NCT02164929|459835680|FG003|Overall Study|Converted to open procedure|2|||
128032137|NCT02471144|460746107|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
128032138|NCT02471144|460746108|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
127784020|NCT02164929|459835677|FG000|Overall Study|Failed regional block|0|||
127784021|NCT02164929|459835678|FG001|Overall Study|Failed regional block|0|||
127784022|NCT02164929|459835679|FG002|Overall Study|Failed regional block|1|||
127584702|NCT00347360|459108561|FG011|Overall Study|Reason not listed/blank|0|||
127584703|NCT00347360|459108562|FG012|Overall Study|Reason not listed/blank|0|||
128032139|NCT02471144|460746109|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
128032140|NCT02471144|460746110|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
128032141|NCT02471144|460746111|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
128032142|NCT02471144|460746112|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
128032143|NCT02471144|460746102|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
128032144|NCT02471144|460746103|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
128032145|NCT02471144|460746104|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
128032146|NCT02471144|460746105|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
128032147|NCT02471144|460746106|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
128032148|NCT02471144|460746107|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
128032149|NCT02471144|460746108|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
127584704|NCT00347360|459108563|FG013|Overall Study|Reason not listed/blank|1|||
127584705|NCT00347360|459108564|FG014|Overall Study|Reason not listed/blank|0|||
128032150|NCT02471144|460746109|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
128032151|NCT02471144|460746110|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
128032152|NCT02471144|460746111|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
127584706|NCT00347360|459108550|FG000|Overall Study|Per sponsors instruction|0|||
127584707|NCT00347360|459108551|FG001|Overall Study|Per sponsors instruction|1|||
127584708|NCT00347360|459108552|FG002|Overall Study|Per sponsors instruction|0|||
127584709|NCT00347360|459108553|FG003|Overall Study|Per sponsors instruction|0|||
127584710|NCT00347360|459108554|FG004|Overall Study|Per sponsors instruction|0|||
127584711|NCT00347360|459108555|FG005|Overall Study|Per sponsors instruction|0|||
127584712|NCT00347360|459108556|FG006|Overall Study|Per sponsors instruction|0|||
127584713|NCT00347360|459108557|FG007|Overall Study|Per sponsors instruction|0|||
127584714|NCT00347360|459108558|FG008|Overall Study|Per sponsors instruction|0|||
127881968|NCT03869684|460190742|FG002|Overall Study|Lost to Follow-up|0|||
127881969|NCT03869684|460190740|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
127881970|NCT03869684|460190741|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
127881971|NCT03869684|460190742|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
127881972|NCT01227954|460190747|FG000|Overall Study|Protocol Violation|6|||
127881973|NCT01227954|460190747|FG000|Overall Study|No protocol treatment|7|||
127881974|NCT02787785|460190750|FG000|Overall Study|Death|3|||
127881975|NCT02787785|460190751|FG001|Overall Study|Death|4|||
127881976|NCT02787785|460190750|FG000|Overall Study|Lost to Follow-up|1|||
127881977|NCT02787785|460190751|FG001|Overall Study|Lost to Follow-up|1|||
127881978|NCT02787785|460190750|FG000|Overall Study|Withdrawal by Subject|0|||
127881979|NCT02787785|460190751|FG001|Overall Study|Withdrawal by Subject|5|||
127881980|NCT04736576|460190754|FG000|Overall Study|Progressive disease|3|||
127881981|NCT04736576|460190755|FG001|Overall Study|Progressive disease|1|||
127881982|NCT04736576|460190754|FG000|Overall Study|Death|1|||
127881983|NCT04736576|460190755|FG001|Overall Study|Death|0|||
127881984|NCT01850108|460190756|FG000|Overall Study|Lost to Follow-up|4|||
127881985|NCT01850108|460190756|FG000|Overall Study|Not eligible|1|||
127881986|NCT01850108|460190756|FG000|Overall Study|Failed engraftment|2|||
127881987|NCT01850108|460190756|FG000|Overall Study|Physician Decision|1|||
127881988|NCT04330482|460190761|FG000|Overall Study|Lost to Follow-up|2|||
127881989|NCT04330482|460190762|FG001|Overall Study|Lost to Follow-up|1|||
127881990|NCT04330482|460190761|FG000|Overall Study|Withdrawal by Subject|0|||
127881991|NCT04330482|460190762|FG001|Overall Study|Withdrawal by Subject|3|||
127881992|NCT05144477|460190764|FG000|Overall Study|Withdrawal by Subject|1|||
127881993|NCT05144477|460190765|FG001|Overall Study|Withdrawal by Subject|1|||
127881994|NCT03273712|460190766|FG000|Overall Study|Death|5|||
127881995|NCT03273712|460190766|FG000|Overall Study|Adverse Event|1|||
127881996|NCT03273712|460190766|FG000|Overall Study|Disease Progression|1|||
127881997|NCT04333199|460190767|FG000|Evaluated Patients|Lost to Follow-up|0|||
127881998|NCT04333199|460190768|FG001|Evaluated Patients|Lost to Follow-up|1|||
128032153|NCT02471144|460746112|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
128032154|NCT02471144|460746102|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
128032155|NCT02471144|460746103|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
128032156|NCT02471144|460746104|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
127584715|NCT00347360|459108559|FG009|Overall Study|Per sponsors instruction|0|||
127881999|NCT04333199|460190769|FG002|Evaluated Patients|Lost to Follow-up|2|||
127584716|NCT00347360|459108560|FG010|Overall Study|Per sponsors instruction|0|||
127584717|NCT00347360|459108561|FG011|Overall Study|Per sponsors instruction|0|||
127584718|NCT00347360|459108562|FG012|Overall Study|Per sponsors instruction|0|||
127882000|NCT02268045|460190780|FG000|Overall Study|Death|4|||
127882001|NCT02268045|460190781|FG001|Overall Study|Death|4|||
127882002|NCT02268045|460190780|FG000|Overall Study|Disease Progression|2|||
127882003|NCT02268045|460190781|FG001|Overall Study|Disease Progression|1|||
128032157|NCT02471144|460746105|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
128032158|NCT02471144|460746106|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
127584719|NCT00347360|459108563|FG013|Overall Study|Per sponsors instruction|0|||
127584720|NCT00347360|459108564|FG014|Overall Study|Per sponsors instruction|0|||
127584721|NCT00347360|459108550|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
127882004|NCT02268045|460190780|FG000|Overall Study|Adverse Event|7|||
127882005|NCT02268045|460190781|FG001|Overall Study|Adverse Event|7|||
127784023|NCT02164929|459835680|FG003|Overall Study|Failed regional block|0|||
127784024|NCT00971178|459835681|FG000|Overall Study|Lost to Follow-up|2|||
127784025|NCT00971178|459835682|FG001|Overall Study|Lost to Follow-up|2|||
127784026|NCT00971178|459835683|FG002|Overall Study|Lost to Follow-up|2|||
127784027|NCT00424749|459835685|FG000|Overall Study|Withdrawal by Subject|1|||
127784028|NCT02577406|459835686|FG000|Randomized Period|Death|1|||
127784029|NCT02577406|459835687|FG001|Randomized Period|Death|0|||
127784030|NCT02577406|459835686|FG000|Randomized Period|Other reasons|0|||
127784031|NCT02577406|459835687|FG001|Randomized Period|Other reasons|20|||
127784032|NCT02577406|459835686|FG000|Treatment Period|Death|38|||
127784033|NCT02577406|459835687|FG001|Treatment Period|Death|23|||
127784034|NCT02577406|459835686|FG000|Treatment Period|Adverse Event|17|||
127784035|NCT02577406|459835687|FG001|Treatment Period|Adverse Event|12|||
127784036|NCT02577406|459835686|FG000|Treatment Period|Progressive Disease|53|||
127784037|NCT02577406|459835687|FG001|Treatment Period|Progressive Disease|37|||
127784038|NCT02577406|459835686|FG000|Treatment Period|Withdrawal by Subject|10|||
127784039|NCT02577406|459835687|FG001|Treatment Period|Withdrawal by Subject|24|||
127584722|NCT00347360|459108551|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
127584723|NCT00347360|459108552|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
127584724|NCT00347360|459108553|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
127584725|NCT00347360|459108554|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
127584726|NCT00347360|459108555|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
127584727|NCT00347360|459108556|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
127584728|NCT00347360|459108557|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
127584729|NCT00347360|459108558|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
127584730|NCT00347360|459108559|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
127584731|NCT00347360|459108560|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
127584732|NCT00347360|459108561|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
127584733|NCT00347360|459108562|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
127584734|NCT00347360|459108563|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
127584735|NCT00347360|459108564|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
127584736|NCT00347360|459108550|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
127584737|NCT00347360|459108551|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
127584738|NCT00347360|459108552|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
127584739|NCT00347360|459108553|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
127584740|NCT00347360|459108554|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
127584741|NCT00347360|459108555|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
127584742|NCT00347360|459108556|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
127584743|NCT00347360|459108557|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
127584744|NCT00347360|459108558|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
127584745|NCT00347360|459108559|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
127584746|NCT00347360|459108560|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
127584747|NCT00347360|459108561|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
127584748|NCT00347360|459108562|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
127584749|NCT00347360|459108563|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
127584750|NCT00347360|459108564|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
127584751|NCT00347360|459108550|FG000|Overall Study|Abnormal lab values|0|||
127584752|NCT00347360|459108551|FG001|Overall Study|Abnormal lab values|0|||
127584753|NCT00347360|459108552|FG002|Overall Study|Abnormal lab values|0|||
127584754|NCT00347360|459108553|FG003|Overall Study|Abnormal lab values|0|||
127584755|NCT00347360|459108554|FG004|Overall Study|Abnormal lab values|0|||
127584756|NCT00347360|459108555|FG005|Overall Study|Abnormal lab values|0|||
127584757|NCT00347360|459108556|FG006|Overall Study|Abnormal lab values|1|||
127584758|NCT00347360|459108557|FG007|Overall Study|Abnormal lab values|0|||
127584759|NCT00347360|459108558|FG008|Overall Study|Abnormal lab values|0|||
127584760|NCT00347360|459108559|FG009|Overall Study|Abnormal lab values|0|||
127584761|NCT00347360|459108560|FG010|Overall Study|Abnormal lab values|0|||
127584762|NCT00347360|459108561|FG011|Overall Study|Abnormal lab values|0|||
127584763|NCT00347360|459108562|FG012|Overall Study|Abnormal lab values|0|||
127584764|NCT00347360|459108563|FG013|Overall Study|Abnormal lab values|0|||
127584765|NCT00347360|459108564|FG014|Overall Study|Abnormal lab values|0|||
127584766|NCT00347360|459108550|FG000|Overall Study|PI recommended early withdrawal|0|||
127584767|NCT00347360|459108551|FG001|Overall Study|PI recommended early withdrawal|0|||
127784040|NCT02577406|459835686|FG000|Treatment Period|Lost to Follow-up|0|||
127784041|NCT02577406|459835687|FG001|Treatment Period|Lost to Follow-up|1|||
127784042|NCT02577406|459835686|FG000|Treatment Period|Transition to commercially available treatment|1|||
127784043|NCT02577406|459835687|FG001|Treatment Period|Transition to commercially available treatment|1|||
127784044|NCT02577406|459835686|FG000|Treatment Period|Physician Decision|1|||
127584768|NCT00347360|459108552|FG002|Overall Study|PI recommended early withdrawal|0|||
127584769|NCT00347360|459108553|FG003|Overall Study|PI recommended early withdrawal|0|||
127584770|NCT00347360|459108554|FG004|Overall Study|PI recommended early withdrawal|0|||
127784045|NCT02577406|459835687|FG001|Treatment Period|Physician Decision|0|||
128032159|NCT02471144|460746107|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
128032160|NCT02471144|460746108|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
128032161|NCT02471144|460746109|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
128032162|NCT02471144|460746110|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
127584771|NCT00347360|459108555|FG005|Overall Study|PI recommended early withdrawal|0|||
127584772|NCT00347360|459108556|FG006|Overall Study|PI recommended early withdrawal|0|||
127584773|NCT00347360|459108557|FG007|Overall Study|PI recommended early withdrawal|0|||
127584774|NCT00347360|459108558|FG008|Overall Study|PI recommended early withdrawal|0|||
127584775|NCT00347360|459108559|FG009|Overall Study|PI recommended early withdrawal|1|||
127584776|NCT00347360|459108560|FG010|Overall Study|PI recommended early withdrawal|0|||
127584777|NCT00347360|459108561|FG011|Overall Study|PI recommended early withdrawal|0|||
127584778|NCT00347360|459108562|FG012|Overall Study|PI recommended early withdrawal|0|||
127584779|NCT00347360|459108563|FG013|Overall Study|PI recommended early withdrawal|0|||
127584780|NCT00347360|459108564|FG014|Overall Study|PI recommended early withdrawal|0|||
127584781|NCT00347360|459108550|FG000|Overall Study|Did not meet criteria before ABPM|0|||
127584782|NCT00347360|459108551|FG001|Overall Study|Did not meet criteria before ABPM|0|||
127584783|NCT00347360|459108552|FG002|Overall Study|Did not meet criteria before ABPM|0|||
127584784|NCT00347360|459108553|FG003|Overall Study|Did not meet criteria before ABPM|0|||
127584785|NCT00347360|459108554|FG004|Overall Study|Did not meet criteria before ABPM|0|||
127584786|NCT00347360|459108555|FG005|Overall Study|Did not meet criteria before ABPM|0|||
127784046|NCT02577406|459835686|FG000|Treatment Period|Disease Relapse|28|||
127784047|NCT02577406|459835687|FG001|Treatment Period|Disease Relapse|1|||
127784048|NCT02577406|459835686|FG000|Treatment Period|Protocol Violation|0|||
127784049|NCT02577406|459835687|FG001|Treatment Period|Protocol Violation|1|||
127784050|NCT02577406|459835686|FG000|Treatment Period|Other Reasons|3|||
127784051|NCT02577406|459835687|FG001|Treatment Period|Other Reasons|39|||
127784052|NCT02577406|459835686|FG000|Treatment Period|Hematopoietic Stem Cell Transplantation|6|||
127784053|NCT02577406|459835687|FG001|Treatment Period|Hematopoietic Stem Cell Transplantation|2|||
127784054|NCT02138617|459835688|FG000|Overall Study|Death|1|||
127784055|NCT02138617|459835689|FG001|Overall Study|Death|2|||
127784056|NCT02138617|459835690|FG002|Overall Study|Death|2|||
127784057|NCT02138617|459835688|FG000|Overall Study|Adverse Event|8|||
127784058|NCT02138617|459835689|FG001|Overall Study|Adverse Event|5|||
127784059|NCT02138617|459835690|FG002|Overall Study|Adverse Event|2|||
127784060|NCT02138617|459835688|FG000|Overall Study|Disease Progression|20|||
127784061|NCT02138617|459835689|FG001|Overall Study|Disease Progression|13|||
127784062|NCT02138617|459835690|FG002|Overall Study|Disease Progression|4|||
127784063|NCT02138617|459835688|FG000|Overall Study|Withdrawal by Subject|7|||
127784064|NCT02138617|459835689|FG001|Overall Study|Withdrawal by Subject|10|||
127784065|NCT02138617|459835690|FG002|Overall Study|Withdrawal by Subject|2|||
127784066|NCT02138617|459835688|FG000|Overall Study|other complicating disease|0|||
127784067|NCT02138617|459835689|FG001|Overall Study|other complicating disease|2|||
127784068|NCT02138617|459835690|FG002|Overall Study|other complicating disease|0|||
127784069|NCT02138617|459835688|FG000|Overall Study|Protocol Violation|1|||
127784070|NCT02138617|459835689|FG001|Overall Study|Protocol Violation|0|||
127784071|NCT02138617|459835690|FG002|Overall Study|Protocol Violation|0|||
127784072|NCT02138617|459835688|FG000|Overall Study|Physician Decision|7|||
127784073|NCT02138617|459835689|FG001|Overall Study|Physician Decision|6|||
127784074|NCT02138617|459835690|FG002|Overall Study|Physician Decision|0|||
127784075|NCT02138617|459835688|FG000|Overall Study|financial reason|0|||
127784076|NCT02138617|459835689|FG001|Overall Study|financial reason|1|||
127784077|NCT02138617|459835690|FG002|Overall Study|financial reason|0|||
127784078|NCT02138617|459835688|FG000|Overall Study|other therapy|3|||
127784079|NCT02138617|459835689|FG001|Overall Study|other therapy|4|||
127784080|NCT02138617|459835690|FG002|Overall Study|other therapy|0|||
127784081|NCT04033445|459835691|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|2|||
127784082|NCT04033445|459835692|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|1|||
127784083|NCT04033445|459835693|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
127784084|NCT04033445|459835694|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
127784085|NCT04033445|459835695|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
127784086|NCT04033445|459835696|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|9|||
127784087|NCT04033445|459835697|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|7|||
127584787|NCT00347360|459108556|FG006|Overall Study|Did not meet criteria before ABPM|0|||
127584788|NCT00347360|459108557|FG007|Overall Study|Did not meet criteria before ABPM|0|||
127784088|NCT04033445|459835698|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
127784089|NCT04033445|459835699|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
127784090|NCT04033445|459835700|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
127784091|NCT04033445|459835701|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
127784092|NCT04033445|459835702|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
127784093|NCT04033445|459835703|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
127784094|NCT04033445|459835704|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
128032163|NCT02471144|460746111|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
127584789|NCT00347360|459108558|FG008|Overall Study|Did not meet criteria before ABPM|0|||
128032164|NCT02471144|460746112|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
128032165|NCT02471144|460746102|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
128032166|NCT02471144|460746103|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
128032167|NCT02471144|460746104|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
128032168|NCT02471144|460746105|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
128032169|NCT02471144|460746106|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
128032170|NCT02471144|460746107|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
128032171|NCT02471144|460746108|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
128032172|NCT02471144|460746109|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
128032173|NCT02471144|460746110|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
128032174|NCT02471144|460746111|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
128032175|NCT02471144|460746112|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
127694004|NCT02287311|459508619|FG007|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
127694005|NCT02287311|459508620|FG008|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
127694006|NCT02287311|459508612|FG000|Cohort 2: Dose Level 2|Refused follow-up|0|||
127694007|NCT02287311|459508613|FG001|Cohort 2: Dose Level 2|Refused follow-up|1|||
127694008|NCT02287311|459508614|FG002|Cohort 2: Dose Level 2|Refused follow-up|0|||
127694009|NCT02287311|459508615|FG003|Cohort 2: Dose Level 2|Refused follow-up|0|||
127694010|NCT02287311|459508616|FG004|Cohort 2: Dose Level 2|Refused follow-up|0|||
127694011|NCT02287311|459508617|FG005|Cohort 2: Dose Level 2|Refused follow-up|0|||
127694012|NCT02287311|459508618|FG006|Cohort 2: Dose Level 2|Refused follow-up|0|||
127694013|NCT02287311|459508619|FG007|Cohort 2: Dose Level 2|Refused follow-up|0|||
127694014|NCT02287311|459508620|FG008|Cohort 2: Dose Level 2|Refused follow-up|0|||
127694015|NCT02287311|459508612|FG000|Cohort 3: Dose Level 3|Death|0|||
127694016|NCT02287311|459508613|FG001|Cohort 3: Dose Level 3|Death|0|||
127694017|NCT02287311|459508614|FG002|Cohort 3: Dose Level 3|Death|4|||
127694018|NCT02287311|459508615|FG003|Cohort 3: Dose Level 3|Death|0|||
127694019|NCT02287311|459508616|FG004|Cohort 3: Dose Level 3|Death|0|||
127694020|NCT02287311|459508617|FG005|Cohort 3: Dose Level 3|Death|4|||
127694021|NCT02287311|459508618|FG006|Cohort 3: Dose Level 3|Death|0|||
127694022|NCT02287311|459508619|FG007|Cohort 3: Dose Level 3|Death|0|||
127694023|NCT02287311|459508620|FG008|Cohort 3: Dose Level 3|Death|2|||
127694024|NCT02287311|459508612|FG000|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
127694025|NCT02287311|459508613|FG001|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
127694026|NCT02287311|459508614|FG002|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
127694027|NCT02287311|459508615|FG003|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
127694028|NCT02287311|459508616|FG004|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
127694029|NCT02287311|459508617|FG005|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
127694030|NCT02287311|459508618|FG006|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
127694031|NCT02287311|459508619|FG007|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
127694032|NCT02287311|459508620|FG008|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
127694033|NCT02287311|459508612|FG000|Cohort 3: Dose Level 3|On long-term follow-up|0|||
127694034|NCT02287311|459508613|FG001|Cohort 3: Dose Level 3|On long-term follow-up|0|||
127694035|NCT02287311|459508614|FG002|Cohort 3: Dose Level 3|On long-term follow-up|0|||
127694036|NCT02287311|459508615|FG003|Cohort 3: Dose Level 3|On long-term follow-up|0|||
127694037|NCT02287311|459508616|FG004|Cohort 3: Dose Level 3|On long-term follow-up|0|||
127694038|NCT02287311|459508617|FG005|Cohort 3: Dose Level 3|On long-term follow-up|1|||
127694039|NCT02287311|459508618|FG006|Cohort 3: Dose Level 3|On long-term follow-up|0|||
127694040|NCT02287311|459508619|FG007|Cohort 3: Dose Level 3|On long-term follow-up|0|||
127694041|NCT02287311|459508620|FG008|Cohort 3: Dose Level 3|On long-term follow-up|1|||
127694042|NCT03648840|459508621|FG000|First IV Infusion Session|Adverse Event|0|||
127694043|NCT03648840|459508622|FG001|First IV Infusion Session|Adverse Event|2|||
127694044|NCT03648840|459508621|FG000|Session 1 to Session 2 Interval|Pandemic|0|||
127694045|NCT03648840|459508622|FG001|Session 1 to Session 2 Interval|Pandemic|1|||
128032176|NCT02471144|460746102|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
128032177|NCT02471144|460746103|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
128032178|NCT02471144|460746104|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
128032179|NCT02471144|460746105|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
127694046|NCT03648840|459508621|FG000|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|8|||
127694047|NCT03648840|459508622|FG001|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|11|||
127694048|NCT03648840|459508621|FG000|Session 2 to Imaging Interval|MRI exclusion (left handed)|3|||
127694049|NCT03648840|459508622|FG001|Session 2 to Imaging Interval|MRI exclusion (left handed)|5|||
127694050|NCT05418296|459508623|FG000|Overall Study|Withdrawal by Subject|4|||
127694051|NCT05418296|459508624|FG001|Overall Study|Withdrawal by Subject|1|||
127784095|NCT04033445|459835691|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
127694052|NCT05382936|459508625|FG000|Overall Study|Progressive Disease|3|||
127694053|NCT05382936|459508626|FG001|Overall Study|Progressive Disease|5|||
127694054|NCT05382936|459508627|FG002|Overall Study|Progressive Disease|2|||
127694055|NCT05382936|459508628|FG003|Overall Study|Progressive Disease|5|||
127694056|NCT05382936|459508625|FG000|Overall Study|Adverse Event|0|||
127694057|NCT05382936|459508626|FG001|Overall Study|Adverse Event|1|||
127584790|NCT00347360|459108559|FG009|Overall Study|Did not meet criteria before ABPM|0|||
127584791|NCT00347360|459108560|FG010|Overall Study|Did not meet criteria before ABPM|1|||
128032180|NCT02471144|460746106|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
128032181|NCT02471144|460746107|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
128032182|NCT02471144|460746108|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
128032183|NCT02471144|460746109|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
128032184|NCT02471144|460746110|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
128032185|NCT02471144|460746111|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
128032186|NCT02471144|460746112|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
127584792|NCT00347360|459108561|FG011|Overall Study|Did not meet criteria before ABPM|0|||
127584793|NCT00347360|459108562|FG012|Overall Study|Did not meet criteria before ABPM|0|||
127584794|NCT00347360|459108563|FG013|Overall Study|Did not meet criteria before ABPM|0|||
127584795|NCT00347360|459108564|FG014|Overall Study|Did not meet criteria before ABPM|0|||
127584796|NCT00347360|459108550|FG000|Overall Study|Randomized in error|0|||
127584797|NCT00347360|459108551|FG001|Overall Study|Randomized in error|0|||
127584798|NCT00347360|459108552|FG002|Overall Study|Randomized in error|0|||
127584799|NCT00347360|459108553|FG003|Overall Study|Randomized in error|0|||
127584800|NCT00347360|459108554|FG004|Overall Study|Randomized in error|0|||
127584801|NCT00347360|459108555|FG005|Overall Study|Randomized in error|0|||
127584802|NCT00347360|459108556|FG006|Overall Study|Randomized in error|0|||
127584803|NCT00347360|459108557|FG007|Overall Study|Randomized in error|0|||
127584804|NCT00347360|459108558|FG008|Overall Study|Randomized in error|0|||
127584805|NCT00347360|459108559|FG009|Overall Study|Randomized in error|0|||
127584806|NCT00347360|459108560|FG010|Overall Study|Randomized in error|0|||
127584807|NCT00347360|459108561|FG011|Overall Study|Randomized in error|1|||
127584808|NCT00347360|459108562|FG012|Overall Study|Randomized in error|0|||
127584809|NCT00347360|459108563|FG013|Overall Study|Randomized in error|0|||
127584810|NCT00347360|459108564|FG014|Overall Study|Randomized in error|0|||
127584811|NCT00347360|459108550|FG000|Overall Study|Failed inclusion criteria #4|0|||
127584812|NCT00347360|459108551|FG001|Overall Study|Failed inclusion criteria #4|0|||
127584813|NCT00347360|459108552|FG002|Overall Study|Failed inclusion criteria #4|0|||
127584814|NCT00347360|459108553|FG003|Overall Study|Failed inclusion criteria #4|0|||
127584815|NCT00347360|459108554|FG004|Overall Study|Failed inclusion criteria #4|0|||
127584816|NCT00347360|459108555|FG005|Overall Study|Failed inclusion criteria #4|0|||
127584817|NCT00347360|459108556|FG006|Overall Study|Failed inclusion criteria #4|0|||
127584818|NCT00347360|459108557|FG007|Overall Study|Failed inclusion criteria #4|0|||
127584819|NCT00347360|459108558|FG008|Overall Study|Failed inclusion criteria #4|0|||
127584820|NCT00347360|459108559|FG009|Overall Study|Failed inclusion criteria #4|0|||
127584821|NCT00347360|459108560|FG010|Overall Study|Failed inclusion criteria #4|0|||
127584822|NCT00347360|459108561|FG011|Overall Study|Failed inclusion criteria #4|1|||
127584823|NCT00347360|459108562|FG012|Overall Study|Failed inclusion criteria #4|0|||
127584824|NCT00347360|459108563|FG013|Overall Study|Failed inclusion criteria #4|0|||
127584825|NCT00347360|459108564|FG014|Overall Study|Failed inclusion criteria #4|0|||
127584826|NCT00347360|459108550|FG000|Overall Study|Prolonged duration between visits|0|||
127584827|NCT00347360|459108551|FG001|Overall Study|Prolonged duration between visits|0|||
127694058|NCT05382936|459508627|FG002|Overall Study|Adverse Event|1|||
127694059|NCT05382936|459508628|FG003|Overall Study|Adverse Event|0|||
127694060|NCT05382936|459508625|FG000|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
127694061|NCT05382936|459508626|FG001|Overall Study|Deteriorated Performance Status. Unlikely Benefit|1|||
127694062|NCT05382936|459508627|FG002|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
127694063|NCT05382936|459508628|FG003|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
127694064|NCT05382936|459508625|FG000|Overall Study|Withdrawal by Subject|0|||
127694065|NCT05382936|459508626|FG001|Overall Study|Withdrawal by Subject|0|||
127694066|NCT05382936|459508627|FG002|Overall Study|Withdrawal by Subject|1|||
127694067|NCT05382936|459508628|FG003|Overall Study|Withdrawal by Subject|1|||
127694068|NCT04630262|459508633|FG000|Overall Study|Intraoperative Screen Failure|5|||
127694069|NCT04630262|459508633|FG000|Overall Study|Study terminated prematurely|71|||
128032187|NCT02471144|460746102|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
127584828|NCT00347360|459108552|FG002|Overall Study|Prolonged duration between visits|0|||
127694070|NCT04630262|459508633|FG000|Overall Study|Withdrawal by Subject|2|||
127694071|NCT04630262|459508633|FG000|Overall Study|Physician Decision|2|||
127694072|NCT01195831|459508635|FG000|Overall Study|Lost to Follow-up|2|||
127694073|NCT01195831|459508636|FG001|Overall Study|Lost to Follow-up|4|||
127694074|NCT01195831|459508635|FG000|Overall Study|Withdrawal by Subject|2|||
128032188|NCT02471144|460746103|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
128032189|NCT02471144|460746104|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
127584829|NCT00347360|459108553|FG003|Overall Study|Prolonged duration between visits|0|||
127584830|NCT00347360|459108554|FG004|Overall Study|Prolonged duration between visits|0|||
127694075|NCT01195831|459508636|FG001|Overall Study|Withdrawal by Subject|2|||
127584831|NCT00347360|459108555|FG005|Overall Study|Prolonged duration between visits|0|||
127694076|NCT01195831|459508635|FG000|Overall Study|Adverse Event|4|||
127694077|NCT01195831|459508636|FG001|Overall Study|Adverse Event|2|||
127584832|NCT00347360|459108556|FG006|Overall Study|Prolonged duration between visits|0|||
127584833|NCT00347360|459108557|FG007|Overall Study|Prolonged duration between visits|0|||
127584834|NCT00347360|459108558|FG008|Overall Study|Prolonged duration between visits|0|||
127584835|NCT00347360|459108559|FG009|Overall Study|Prolonged duration between visits|0|||
127584836|NCT00347360|459108560|FG010|Overall Study|Prolonged duration between visits|0|||
127584837|NCT00347360|459108561|FG011|Overall Study|Prolonged duration between visits|0|||
127584838|NCT00347360|459108562|FG012|Overall Study|Prolonged duration between visits|1|||
128032190|NCT02471144|460746105|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
128032191|NCT02471144|460746106|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
128032192|NCT02471144|460746107|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
128032193|NCT02471144|460746108|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
128032194|NCT02471144|460746109|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
128032195|NCT02471144|460746110|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
128032196|NCT02471144|460746111|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
128032197|NCT02471144|460746112|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
128032198|NCT02471144|460746102|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
128032199|NCT02471144|460746103|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
128032200|NCT02471144|460746104|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
128032201|NCT02471144|460746105|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
128032202|NCT02471144|460746106|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
128032203|NCT02471144|460746107|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
128032204|NCT02471144|460746108|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
128032205|NCT02471144|460746109|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
128032206|NCT02471144|460746110|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
128032207|NCT02471144|460746111|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
128032208|NCT02471144|460746112|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
128032209|NCT02471144|460746102|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
128032210|NCT02471144|460746103|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
128032211|NCT02471144|460746104|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
128032212|NCT02471144|460746105|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
128032213|NCT02471144|460746106|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
128032214|NCT02471144|460746107|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
128032215|NCT02471144|460746108|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
128032216|NCT02471144|460746109|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
128032217|NCT02471144|460746110|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
128032218|NCT02471144|460746111|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
128032219|NCT02471144|460746112|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
127584839|NCT00347360|459108563|FG013|Overall Study|Prolonged duration between visits|0|||
127584840|NCT00347360|459108564|FG014|Overall Study|Prolonged duration between visits|0|||
127584841|NCT00347360|459108550|FG000|Overall Study|Subject left town, ran out of study drug|0|||
127584842|NCT00347360|459108551|FG001|Overall Study|Subject left town, ran out of study drug|0|||
127584843|NCT00347360|459108552|FG002|Overall Study|Subject left town, ran out of study drug|0|||
127584844|NCT00347360|459108553|FG003|Overall Study|Subject left town, ran out of study drug|0|||
127584845|NCT00347360|459108554|FG004|Overall Study|Subject left town, ran out of study drug|0|||
127584846|NCT00347360|459108555|FG005|Overall Study|Subject left town, ran out of study drug|0|||
127584847|NCT00347360|459108556|FG006|Overall Study|Subject left town, ran out of study drug|0|||
127584848|NCT00347360|459108557|FG007|Overall Study|Subject left town, ran out of study drug|0|||
127584849|NCT00347360|459108558|FG008|Overall Study|Subject left town, ran out of study drug|0|||
127584850|NCT00347360|459108559|FG009|Overall Study|Subject left town, ran out of study drug|0|||
127584851|NCT00347360|459108560|FG010|Overall Study|Subject left town, ran out of study drug|0|||
127584852|NCT00347360|459108561|FG011|Overall Study|Subject left town, ran out of study drug|0|||
127584853|NCT00347360|459108562|FG012|Overall Study|Subject left town, ran out of study drug|0|||
127584854|NCT00347360|459108563|FG013|Overall Study|Subject left town, ran out of study drug|1|||
127584855|NCT00347360|459108564|FG014|Overall Study|Subject left town, ran out of study drug|0|||
127584856|NCT00347360|459108550|FG000|Overall Study|Subject refuse to sign updated consent|0|||
127584857|NCT00347360|459108551|FG001|Overall Study|Subject refuse to sign updated consent|0|||
127584858|NCT00347360|459108552|FG002|Overall Study|Subject refuse to sign updated consent|0|||
127584859|NCT00347360|459108553|FG003|Overall Study|Subject refuse to sign updated consent|0|||
127584860|NCT00347360|459108554|FG004|Overall Study|Subject refuse to sign updated consent|0|||
128032220|NCT02471144|460746102|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
128032221|NCT02471144|460746103|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
127584861|NCT00347360|459108555|FG005|Overall Study|Subject refuse to sign updated consent|0|||
127584862|NCT00347360|459108556|FG006|Overall Study|Subject refuse to sign updated consent|0|||
127584863|NCT00347360|459108557|FG007|Overall Study|Subject refuse to sign updated consent|0|||
127584864|NCT00347360|459108558|FG008|Overall Study|Subject refuse to sign updated consent|0|||
127584865|NCT00347360|459108559|FG009|Overall Study|Subject refuse to sign updated consent|0|||
128032222|NCT02471144|460746104|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
128032223|NCT02471144|460746105|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
128032224|NCT02471144|460746106|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
128032225|NCT02471144|460746107|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
128032226|NCT02471144|460746108|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
127584866|NCT00347360|459108560|FG010|Overall Study|Subject refuse to sign updated consent|0|||
127584867|NCT00347360|459108561|FG011|Overall Study|Subject refuse to sign updated consent|0|||
127584868|NCT00347360|459108562|FG012|Overall Study|Subject refuse to sign updated consent|0|||
127784096|NCT04033445|459835692|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
127784097|NCT04033445|459835693|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
127784098|NCT04033445|459835694|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
127784099|NCT04033445|459835695|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
127784100|NCT04033445|459835696|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
127784101|NCT04033445|459835697|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
127784102|NCT04033445|459835698|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
127784103|NCT04033445|459835699|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
127784104|NCT04033445|459835700|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
127784105|NCT04033445|459835701|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
127784106|NCT04033445|459835702|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
127784107|NCT04033445|459835703|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
127784108|NCT04033445|459835704|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
127784109|NCT04033445|459835691|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
127882006|NCT02268045|460190780|FG000|Overall Study|Withdrawal by Subject|2|||
127882007|NCT02268045|460190781|FG001|Overall Study|Withdrawal by Subject|6|||
127882008|NCT02268045|460190780|FG000|Overall Study|Physician Decision|0|||
128032227|NCT02471144|460746109|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
127584869|NCT00347360|459108563|FG013|Overall Study|Subject refuse to sign updated consent|0|||
127584870|NCT00347360|459108564|FG014|Overall Study|Subject refuse to sign updated consent|1|||
127584871|NCT00347360|459108550|FG000|Overall Study|Visits conflicted with new job|0|||
127584872|NCT00347360|459108551|FG001|Overall Study|Visits conflicted with new job|0|||
127584873|NCT00347360|459108552|FG002|Overall Study|Visits conflicted with new job|0|||
127584874|NCT00347360|459108553|FG003|Overall Study|Visits conflicted with new job|0|||
127584875|NCT00347360|459108554|FG004|Overall Study|Visits conflicted with new job|0|||
127584876|NCT00347360|459108555|FG005|Overall Study|Visits conflicted with new job|0|||
127584877|NCT00347360|459108556|FG006|Overall Study|Visits conflicted with new job|1|||
127584878|NCT00347360|459108557|FG007|Overall Study|Visits conflicted with new job|0|||
127584879|NCT00347360|459108558|FG008|Overall Study|Visits conflicted with new job|0|||
127584880|NCT00347360|459108559|FG009|Overall Study|Visits conflicted with new job|0|||
127584881|NCT00347360|459108560|FG010|Overall Study|Visits conflicted with new job|0|||
127584882|NCT00347360|459108561|FG011|Overall Study|Visits conflicted with new job|0|||
127584883|NCT00347360|459108562|FG012|Overall Study|Visits conflicted with new job|0|||
127584884|NCT00347360|459108563|FG013|Overall Study|Visits conflicted with new job|0|||
127584885|NCT00347360|459108564|FG014|Overall Study|Visits conflicted with new job|0|||
127584886|NCT02187744|459108570|FG000|Study|Participant refused further follow-up|1|||
127584887|NCT02187744|459108571|FG001|Study|Participant refused further follow-up|0|||
127584888|NCT02187744|459108570|FG000|Study|Other|2|||
127584889|NCT02187744|459108571|FG001|Study|Other|1|||
127584890|NCT02187744|459108570|FG000|Study|Lost to Follow-up|0|||
127584891|NCT02187744|459108571|FG001|Study|Lost to Follow-up|2|||
127584892|NCT02187744|459108570|FG000|Study|Related adverse event, not serious|0|||
127584893|NCT02187744|459108571|FG001|Study|Related adverse event, not serious|2|||
127584894|NCT02187744|459108570|FG000|Study|Death|1|||
127584895|NCT02187744|459108571|FG001|Study|Death|0|||
127584896|NCT02187744|459108570|FG000|Study|Related adverse event, serious non-fatal|0|||
127584897|NCT02187744|459108571|FG001|Study|Related adverse event, serious non-fatal|1|||
127584898|NCT02187744|459108570|FG000|Treatment|Death|1|||
127584899|NCT02187744|459108571|FG001|Treatment|Death|0|||
127584900|NCT02187744|459108570|FG000|Treatment|Related adverse event, serious non-fatal|0|||
127584901|NCT02187744|459108571|FG001|Treatment|Related adverse event, serious non-fatal|1|||
127584902|NCT02187744|459108570|FG000|Treatment|Related adverse event, not serious|0|||
127584903|NCT02187744|459108571|FG001|Treatment|Related adverse event, not serious|2|||
127584904|NCT02187744|459108570|FG000|Treatment|Lost to Follow-up|0|||
127584905|NCT02187744|459108571|FG001|Treatment|Lost to Follow-up|1|||
127584906|NCT02187744|459108570|FG000|Treatment|Other|2|||
127584907|NCT02187744|459108571|FG001|Treatment|Other|0|||
127584908|NCT02187744|459108570|FG000|Treatment|Participant refused continued treatment|1|||
127584909|NCT02187744|459108571|FG001|Treatment|Participant refused continued treatment|1|||
128032228|NCT02471144|460746110|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
127584910|NCT01187433|459108572|FG000|Overall Study|Protocol Violation|6|||
127584911|NCT01187433|459108573|FG001|Overall Study|Protocol Violation|2|||
127584912|NCT01187433|459108572|FG000|Overall Study|Withdrawal by Subject|5|||
127584913|NCT01187433|459108573|FG001|Overall Study|Withdrawal by Subject|2|||
127694078|NCT01195831|459508635|FG000|Overall Study|Protocol Violation|0|||
127694079|NCT01195831|459508636|FG001|Overall Study|Protocol Violation|2|||
127584914|NCT00672646|459108577|FG000|Overall Study|Lost to Follow-up|0|||
127584915|NCT00672646|459108578|FG001|Overall Study|Lost to Follow-up|1|||
127584916|NCT00672646|459108579|FG002|Overall Study|Lost to Follow-up|2|||
127584917|NCT00672646|459108577|FG000|Overall Study|Withdrawal by Subject|0|||
127584918|NCT00672646|459108578|FG001|Overall Study|Withdrawal by Subject|0|||
127584919|NCT00672646|459108579|FG002|Overall Study|Withdrawal by Subject|1|||
127584920|NCT00142298|459108582|FG000|Overall Study|Adverse Event|10|||
127584921|NCT00142298|459108583|FG001|Overall Study|Adverse Event|10|||
127584922|NCT00142298|459108584|FG002|Overall Study|Adverse Event|1|||
127584923|NCT00142298|459108585|FG003|Overall Study|Adverse Event|5|||
127584924|NCT00142298|459108586|FG004|Overall Study|Adverse Event|2|||
127584925|NCT00142298|459108587|FG005|Overall Study|Adverse Event|2|||
127584926|NCT00142298|459108588|FG006|Overall Study|Adverse Event|0|||
127584927|NCT00142298|459108589|FG007|Overall Study|Adverse Event|0|||
127584928|NCT00142298|459108590|FG008|Overall Study|Adverse Event|0|||
127584929|NCT00142298|459108591|FG009|Overall Study|Adverse Event|0|||
127584930|NCT00142298|459108582|FG000|Overall Study|Clinical disease progression|1|||
127584931|NCT00142298|459108583|FG001|Overall Study|Clinical disease progression|0|||
127584932|NCT00142298|459108584|FG002|Overall Study|Clinical disease progression|0|||
127584933|NCT00142298|459108585|FG003|Overall Study|Clinical disease progression|0|||
127584934|NCT00142298|459108586|FG004|Overall Study|Clinical disease progression|0|||
127584935|NCT00142298|459108587|FG005|Overall Study|Clinical disease progression|0|||
127584936|NCT00142298|459108588|FG006|Overall Study|Clinical disease progression|0|||
127584937|NCT00142298|459108589|FG007|Overall Study|Clinical disease progression|0|||
127584938|NCT00142298|459108590|FG008|Overall Study|Clinical disease progression|0|||
127584939|NCT00142298|459108591|FG009|Overall Study|Clinical disease progression|0|||
127584940|NCT00142298|459108582|FG000|Overall Study|Death|1|||
127584941|NCT00142298|459108583|FG001|Overall Study|Death|1|||
127584942|NCT00142298|459108584|FG002|Overall Study|Death|1|||
127694080|NCT01857934|459508637|FG000|Overall Study|Relapse or progression|2|||
127694081|NCT01857934|459508637|FG000|Overall Study|Unacceptable toxicity|3|||
127694082|NCT01857934|459508637|FG000|Overall Study|Unwillingness or inability to comply|2|||
127694083|NCT01857934|459508637|FG000|Overall Study|Physician Decision|3|||
127694084|NCT04638998|459508642|FG000|Overall Study|Withdrawal by Subject|1|||
127694085|NCT04638998|459508643|FG001|Overall Study|Withdrawal by Subject|3|||
127694086|NCT03692676|459508644|FG000|Overall Study|exclude patients with prior use|4424|||
127694087|NCT03692676|459508645|FG001|Overall Study|exclude patients with prior use|24726|||
127694088|NCT03692676|459508646|FG002|Overall Study|exclude patients with prior use|0|||
127694089|NCT03692676|459508647|FG003|Overall Study|exclude patients with prior use|0|||
127694090|NCT03692676|459508644|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
127784110|NCT04033445|459835692|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
128032229|NCT02471144|460746111|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
128032230|NCT02471144|460746112|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
128032231|NCT02471144|460746102|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
128032232|NCT02471144|460746103|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
128032233|NCT02471144|460746104|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
128032234|NCT02471144|460746105|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
128032235|NCT02471144|460746106|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
128032236|NCT02471144|460746107|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
128032237|NCT02471144|460746108|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
128032238|NCT02471144|460746109|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
128032239|NCT02471144|460746110|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
128032240|NCT02471144|460746111|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
128032241|NCT02471144|460746112|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
128032242|NCT02471144|460746102|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
128032243|NCT02471144|460746103|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
128032244|NCT02471144|460746104|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
128032245|NCT02471144|460746105|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
128032246|NCT02471144|460746106|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
128032247|NCT02471144|460746107|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
128032248|NCT02471144|460746108|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
128032249|NCT02471144|460746109|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
128032250|NCT02471144|460746110|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
128032251|NCT02471144|460746111|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
128032252|NCT02471144|460746112|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
127584943|NCT00142298|459108585|FG003|Overall Study|Death|0|||
127584944|NCT00142298|459108586|FG004|Overall Study|Death|0|||
127584945|NCT00142298|459108587|FG005|Overall Study|Death|6|||
127584946|NCT00142298|459108588|FG006|Overall Study|Death|0|||
127584947|NCT00142298|459108589|FG007|Overall Study|Death|0|||
127584948|NCT00142298|459108590|FG008|Overall Study|Death|0|||
127584949|NCT00142298|459108591|FG009|Overall Study|Death|0|||
127584950|NCT00142298|459108582|FG000|Overall Study|Lack of Efficacy|44|||
127584951|NCT00142298|459108583|FG001|Overall Study|Lack of Efficacy|62|||
127584952|NCT00142298|459108584|FG002|Overall Study|Lack of Efficacy|9|||
127584953|NCT00142298|459108585|FG003|Overall Study|Lack of Efficacy|12|||
127584954|NCT00142298|459108586|FG004|Overall Study|Lack of Efficacy|1|||
127584955|NCT00142298|459108587|FG005|Overall Study|Lack of Efficacy|0|||
127784111|NCT04033445|459835693|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
127784112|NCT04033445|459835694|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
127784113|NCT04033445|459835695|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
127784114|NCT04033445|459835696|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
127784115|NCT04033445|459835697|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
127784116|NCT04033445|459835698|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
127784117|NCT04033445|459835699|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
127784118|NCT04033445|459835700|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
127784119|NCT04033445|459835701|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
127784120|NCT04033445|459835702|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
127784121|NCT04033445|459835703|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
127784122|NCT04033445|459835704|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
127784123|NCT04033445|459835691|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
127784124|NCT04033445|459835692|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
127784125|NCT04033445|459835693|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
127784126|NCT04033445|459835694|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
127784127|NCT04033445|459835695|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
127784128|NCT04033445|459835696|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|2|||
127784129|NCT04033445|459835697|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|1|||
127784130|NCT04033445|459835698|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
127784131|NCT04033445|459835699|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
127784132|NCT04033445|459835700|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
127784133|NCT04033445|459835701|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
127784134|NCT04033445|459835702|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
127784135|NCT04033445|459835703|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
127784136|NCT04033445|459835704|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
127784137|NCT04033445|459835691|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
127784138|NCT04033445|459835692|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
127784139|NCT04033445|459835693|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
127784140|NCT04033445|459835694|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
127784141|NCT04033445|459835695|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
127784142|NCT04033445|459835696|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
127784143|NCT04033445|459835697|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|1|||
127784144|NCT04033445|459835698|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
127784145|NCT04033445|459835699|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
127784146|NCT04033445|459835700|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
127784147|NCT04033445|459835701|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
127584956|NCT00142298|459108588|FG006|Overall Study|Lack of Efficacy|0|||
127584957|NCT00142298|459108589|FG007|Overall Study|Lack of Efficacy|1|||
127784148|NCT04033445|459835702|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
127784149|NCT04033445|459835703|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
127784150|NCT04033445|459835704|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
127784151|NCT04033445|459835691|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
127784152|NCT04033445|459835692|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
127784153|NCT04033445|459835693|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
127784154|NCT04033445|459835694|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
127784155|NCT04033445|459835695|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
127784156|NCT04033445|459835696|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|12|||
127784157|NCT04033445|459835697|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|6|||
127584958|NCT00142298|459108590|FG008|Overall Study|Lack of Efficacy|0|||
127584959|NCT00142298|459108591|FG009|Overall Study|Lack of Efficacy|0|||
127584960|NCT00142298|459108582|FG000|Overall Study|Non-compliance|15|||
127584961|NCT00142298|459108583|FG001|Overall Study|Non-compliance|13|||
127584962|NCT00142298|459108584|FG002|Overall Study|Non-compliance|0|||
127584963|NCT00142298|459108585|FG003|Overall Study|Non-compliance|6|||
127584964|NCT00142298|459108586|FG004|Overall Study|Non-compliance|1|||
127584965|NCT00142298|459108587|FG005|Overall Study|Non-compliance|0|||
127584966|NCT00142298|459108588|FG006|Overall Study|Non-compliance|0|||
127584967|NCT00142298|459108589|FG007|Overall Study|Non-compliance|3|||
127784158|NCT04033445|459835698|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
127784159|NCT04033445|459835699|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
127584968|NCT00142298|459108590|FG008|Overall Study|Non-compliance|3|||
127584969|NCT00142298|459108591|FG009|Overall Study|Non-compliance|0|||
127584970|NCT00142298|459108582|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
127584971|NCT00142298|459108583|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
127584972|NCT00142298|459108584|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
127584973|NCT00142298|459108585|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
127584974|NCT00142298|459108586|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
127584975|NCT00142298|459108587|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
127584976|NCT00142298|459108588|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
127584977|NCT00142298|459108589|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
127694091|NCT03692676|459508645|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
127694092|NCT03692676|459508646|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
127882009|NCT02268045|460190781|FG001|Overall Study|Physician Decision|1|||
128032253|NCT02471144|460746102|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
128032254|NCT02471144|460746103|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
128032255|NCT02471144|460746104|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
128032256|NCT02471144|460746105|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
128032257|NCT02471144|460746106|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
128032258|NCT02471144|460746107|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
128032259|NCT02471144|460746108|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
128032260|NCT02471144|460746109|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
128032261|NCT02471144|460746110|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
128032262|NCT02471144|460746111|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
128032263|NCT02471144|460746112|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
128032264|NCT02471144|460746102|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
128032265|NCT02471144|460746103|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
128032266|NCT02471144|460746104|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
128032267|NCT02471144|460746105|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
128032268|NCT02471144|460746106|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
128032269|NCT02471144|460746107|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
128032270|NCT02471144|460746108|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
128032271|NCT02471144|460746109|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
128032272|NCT02471144|460746110|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
128032273|NCT02471144|460746111|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
128032274|NCT02471144|460746112|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
128032275|NCT02471144|460746102|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
128032276|NCT02471144|460746103|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
128032277|NCT02471144|460746104|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
128032278|NCT02471144|460746105|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
128032279|NCT02471144|460746106|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
128032280|NCT02471144|460746107|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
128032281|NCT02471144|460746108|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
128032282|NCT02471144|460746109|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
128032283|NCT02471144|460746110|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
128032284|NCT02471144|460746111|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
128032285|NCT02471144|460746112|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
128032286|NCT00003645|460746113|FG000|Overall Study|Death|4|||
128032287|NCT00003645|460746114|FG001|Overall Study|Death|1|||
128032288|NCT00003645|460746113|FG000|Overall Study|Lost to Follow-up|7|||
128032289|NCT00003645|460746114|FG001|Overall Study|Lost to Follow-up|8|||
128032290|NCT00003645|460746113|FG000|Overall Study|Withdrawal by Subject|1|||
128032291|NCT00003645|460746114|FG001|Overall Study|Withdrawal by Subject|3|||
128032292|NCT03768336|460746117|FG000|Overall Study|Lost to Follow-up|3|||
128032293|NCT03768336|460746118|FG001|Overall Study|Lost to Follow-up|2|||
128032294|NCT03768336|460746117|FG000|Overall Study|Became Ineligible|2|||
128032295|NCT03768336|460746118|FG001|Overall Study|Became Ineligible|0|||
128032296|NCT03768336|460746117|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
128032297|NCT03768336|460746118|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
128032298|NCT03768336|460746117|FG000|Overall Study|Missed final survey (post-treatment|0|||
128032299|NCT03768336|460746118|FG001|Overall Study|Missed final survey (post-treatment|1|||
128032300|NCT03977155|460746119|FG000|Overall Study|Adverse Event|3|||
128032301|NCT03977155|460746120|FG001|Overall Study|Adverse Event|0|||
128032302|NCT03977155|460746121|FG002|Overall Study|Adverse Event|0|||
128032303|NCT03977155|460746119|FG000|Overall Study|Lost to Follow-up|0|||
128032304|NCT03977155|460746120|FG001|Overall Study|Lost to Follow-up|1|||
128032305|NCT03977155|460746121|FG002|Overall Study|Lost to Follow-up|0|||
128032306|NCT03977155|460746119|FG000|Overall Study|Withdrawal by Subject|1|||
128032307|NCT03977155|460746120|FG001|Overall Study|Withdrawal by Subject|1|||
128032308|NCT03977155|460746121|FG002|Overall Study|Withdrawal by Subject|2|||
128032309|NCT03977155|460746119|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
128032310|NCT03977155|460746120|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
128032311|NCT03977155|460746121|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
128032312|NCT03502681|460746124|FG000|Overall Study|Adverse Event|1|||
128032313|NCT03502681|460746125|FG001|Overall Study|Adverse Event|1|||
128032314|NCT03502681|460746124|FG000|Overall Study|Disease Progression|2|||
127584978|NCT00142298|459108590|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
127584979|NCT00142298|459108591|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
127584980|NCT00142298|459108582|FG000|Overall Study|Pregnancy|4|||
127584981|NCT00142298|459108583|FG001|Overall Study|Pregnancy|4|||
127584982|NCT00142298|459108584|FG002|Overall Study|Pregnancy|2|||
127584983|NCT00142298|459108585|FG003|Overall Study|Pregnancy|3|||
127584984|NCT00142298|459108586|FG004|Overall Study|Pregnancy|0|||
127584985|NCT00142298|459108587|FG005|Overall Study|Pregnancy|0|||
127584986|NCT00142298|459108588|FG006|Overall Study|Pregnancy|0|||
127584987|NCT00142298|459108589|FG007|Overall Study|Pregnancy|0|||
127584988|NCT00142298|459108590|FG008|Overall Study|Pregnancy|1|||
127584989|NCT00142298|459108591|FG009|Overall Study|Pregnancy|0|||
127584990|NCT00142298|459108582|FG000|Overall Study|Virologic breakthrough|19|||
127584991|NCT00142298|459108583|FG001|Overall Study|Virologic breakthrough|23|||
127584992|NCT00142298|459108584|FG002|Overall Study|Virologic breakthrough|9|||
127584993|NCT00142298|459108585|FG003|Overall Study|Virologic breakthrough|7|||
127584994|NCT00142298|459108586|FG004|Overall Study|Virologic breakthrough|2|||
127584995|NCT00142298|459108587|FG005|Overall Study|Virologic breakthrough|3|||
127584996|NCT00142298|459108588|FG006|Overall Study|Virologic breakthrough|3|||
127584997|NCT00142298|459108589|FG007|Overall Study|Virologic breakthrough|0|||
127584998|NCT00142298|459108590|FG008|Overall Study|Virologic breakthrough|0|||
127584999|NCT00142298|459108591|FG009|Overall Study|Virologic breakthrough|0|||
127585000|NCT00142298|459108582|FG000|Overall Study|Other- not specified|0|||
127585001|NCT00142298|459108583|FG001|Overall Study|Other- not specified|3|||
127585002|NCT00142298|459108584|FG002|Overall Study|Other- not specified|0|||
127585003|NCT00142298|459108585|FG003|Overall Study|Other- not specified|1|||
127585004|NCT00142298|459108586|FG004|Overall Study|Other- not specified|0|||
127585005|NCT00142298|459108587|FG005|Overall Study|Other- not specified|0|||
127585006|NCT00142298|459108588|FG006|Overall Study|Other- not specified|0|||
127585007|NCT00142298|459108589|FG007|Overall Study|Other- not specified|0|||
127585008|NCT00142298|459108590|FG008|Overall Study|Other- not specified|0|||
127585009|NCT00142298|459108591|FG009|Overall Study|Other- not specified|0|||
127585010|NCT00142298|459108582|FG000|Overall Study|Lost to Follow-up|0|||
127585011|NCT00142298|459108583|FG001|Overall Study|Lost to Follow-up|0|||
127585012|NCT00142298|459108584|FG002|Overall Study|Lost to Follow-up|0|||
127585013|NCT00142298|459108585|FG003|Overall Study|Lost to Follow-up|0|||
127585014|NCT00142298|459108586|FG004|Overall Study|Lost to Follow-up|0|||
127585015|NCT00142298|459108587|FG005|Overall Study|Lost to Follow-up|0|||
127585016|NCT00142298|459108588|FG006|Overall Study|Lost to Follow-up|2|||
127585017|NCT00142298|459108589|FG007|Overall Study|Lost to Follow-up|0|||
127585018|NCT00142298|459108590|FG008|Overall Study|Lost to Follow-up|0|||
127585019|NCT00142298|459108591|FG009|Overall Study|Lost to Follow-up|0|||
127585020|NCT00142298|459108582|FG000|Overall Study|Treatment Failure|0|||
127585021|NCT00142298|459108583|FG001|Overall Study|Treatment Failure|0|||
127585022|NCT00142298|459108584|FG002|Overall Study|Treatment Failure|0|||
127585023|NCT00142298|459108585|FG003|Overall Study|Treatment Failure|0|||
127694093|NCT03692676|459508647|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
127694094|NCT03692676|459508644|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
127694095|NCT03692676|459508645|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
128032315|NCT03502681|460746125|FG001|Overall Study|Disease Progression|1|||
128032316|NCT06790303|460746126|FG000|Overall Study|Study Terminated by sponsor|4|||
128032317|NCT06790303|460746126|FG000|Overall Study|Death|4|||
128032318|NCT01905540|460746131|FG000|Period 3|Other|1|||
128032319|NCT01905540|460746132|FG001|Period 3|Other|0|||
128032320|NCT01905540|460746133|FG002|Period 3|Other|1|||
128032321|NCT01905540|460746134|FG003|Period 3|Other|1|||
128032322|NCT02367885|460746135|FG000|Overall Study|Lost to Follow-up|1|||
128032323|NCT02367885|460746136|FG001|Overall Study|Lost to Follow-up|0|||
128032324|NCT02367885|460746137|FG002|Overall Study|Lost to Follow-up|0|||
128032325|NCT02367885|460746135|FG000|Overall Study|Withdrawal by Subject|1|||
128032326|NCT02367885|460746136|FG001|Overall Study|Withdrawal by Subject|0|||
128032327|NCT02367885|460746137|FG002|Overall Study|Withdrawal by Subject|0|||
127585024|NCT00142298|459108586|FG004|Overall Study|Treatment Failure|0|||
127585025|NCT00142298|459108587|FG005|Overall Study|Treatment Failure|2|||
127585026|NCT00142298|459108588|FG006|Overall Study|Treatment Failure|2|||
127585027|NCT00142298|459108589|FG007|Overall Study|Treatment Failure|0|||
127585028|NCT00142298|459108590|FG008|Overall Study|Treatment Failure|0|||
127585029|NCT00142298|459108591|FG009|Overall Study|Treatment Failure|0|||
127585030|NCT00300274|459108592|FG000|Overall Study|Withdrawal by Subject|12|||
127585031|NCT00300274|459108593|FG001|Overall Study|Withdrawal by Subject|3|||
127585032|NCT00300274|459108594|FG002|Overall Study|Withdrawal by Subject|14|||
127585033|NCT00300274|459108592|FG000|Overall Study|Lost to Follow-up|3|||
128032328|NCT01602484|460746138|FG000|Overall Study|Airway issues unrelated to study|0|||
128032329|NCT01602484|460746139|FG001|Overall Study|Airway issues unrelated to study|1|||
128032330|NCT02743962|460746142|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
128032331|NCT02743962|460746143|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
128032332|NCT02327169|460746147|FG000|Overall Study|Progressive Disease|1|||
128032333|NCT02327169|460746148|FG001|Overall Study|Progressive Disease|3|||
128032334|NCT02327169|460746149|FG002|Overall Study|Progressive Disease|4|||
128032335|NCT02327169|460746150|FG003|Overall Study|Progressive Disease|3|||
128032336|NCT02327169|460746151|FG004|Overall Study|Progressive Disease|4|||
128032337|NCT02327169|460746152|FG005|Overall Study|Progressive Disease|3|||
128032338|NCT02327169|460746153|FG006|Overall Study|Progressive Disease|3|||
128032339|NCT02327169|460746154|FG007|Overall Study|Progressive Disease|3|||
128032340|NCT02327169|460746155|FG008|Overall Study|Progressive Disease|4|||
128032341|NCT02327169|460746156|FG009|Overall Study|Progressive Disease|4|||
128032342|NCT02327169|460746157|FG010|Overall Study|Progressive Disease|4|||
128032343|NCT02327169|460746158|FG011|Overall Study|Progressive Disease|3|||
128032344|NCT02327169|460746159|FG012|Overall Study|Progressive Disease|1|||
128032345|NCT02327169|460746160|FG013|Overall Study|Progressive Disease|3|||
127585034|NCT00300274|459108593|FG001|Overall Study|Lost to Follow-up|4|||
127585035|NCT00300274|459108594|FG002|Overall Study|Lost to Follow-up|5|||
127585036|NCT00300274|459108592|FG000|Overall Study|Death|31|||
127585037|NCT00300274|459108593|FG001|Overall Study|Death|20|||
127585038|NCT00300274|459108594|FG002|Overall Study|Death|25|||
127585039|NCT00300274|459108592|FG000|Overall Study|Re-transplant|0|||
127585040|NCT00300274|459108593|FG001|Overall Study|Re-transplant|0|||
127585041|NCT00300274|459108594|FG002|Overall Study|Re-transplant|1|||
127585042|NCT00242216|459108595|FG000|Overall Study|Lost to Follow-up|12|||
127585043|NCT00242216|459108596|FG001|Overall Study|Lost to Follow-up|17|||
127585044|NCT00242216|459108595|FG000|Overall Study|Death|4|||
127585045|NCT00242216|459108596|FG001|Overall Study|Death|2|||
127585046|NCT00242216|459108595|FG000|Overall Study|Lack of Efficacy|1|||
127585047|NCT00242216|459108596|FG001|Overall Study|Lack of Efficacy|2|||
127585048|NCT00242216|459108595|FG000|Overall Study|no medicaiton dispensed|1|||
127585049|NCT00242216|459108596|FG001|Overall Study|no medicaiton dispensed|1|||
127585050|NCT04439201|459108597|FG000|Overall Study|Ineligible|2|||
127585051|NCT04439201|459108597|FG000|Overall Study|Never start protocol therapy|1|||
127585052|NCT04439201|459108597|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
127585053|NCT04439201|459108597|FG000|Overall Study|Mutation status not confirmed|4|||
127585054|NCT04439201|459108597|FG000|Overall Study|Adverse Event|1|||
127585055|NCT04439201|459108597|FG000|Overall Study|Death|7|||
127585056|NCT04439201|459108597|FG000|Overall Study|Withdrawal by Subject|2|||
127585057|NCT04439201|459108597|FG000|Overall Study|Disease progression|20|||
127585058|NCT04439201|459108597|FG000|Overall Study|Alternative therapy|1|||
127585059|NCT04439201|459108597|FG000|Overall Study|Physician Decision|1|||
127585060|NCT04680052|459110182|FG000|Overall Study|Ongoing|244|||
127585061|NCT04680052|459110183|FG001|Overall Study|Ongoing|229|||
127585062|NCT04680052|459110184|FG002|Overall Study|Ongoing|39|||
127585063|NCT04680052|459110185|FG003|Overall Study|Ongoing|46|||
127694096|NCT03692676|459508646|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
127694097|NCT03692676|459508647|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
127694098|NCT03692676|459508644|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
127694099|NCT03692676|459508645|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
127694100|NCT03692676|459508646|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
127694101|NCT03692676|459508647|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
127694102|NCT03692676|459508644|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
127694103|NCT03692676|459508645|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
127694104|NCT03692676|459508646|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
127705208|NCT01928394|459551588|FG021|Treatment Period|Lost to Follow-up|0|||
127705209|NCT01928394|459551589|FG022|Treatment Period|Lost to Follow-up|1|||
127705210|NCT01928394|459551567|FG000|Treatment Period|Death|0|||
127705211|NCT01928394|459551568|FG001|Treatment Period|Death|0|||
128032346|NCT02327169|460746161|FG014|Overall Study|Progressive Disease|3|||
128032347|NCT02327169|460746147|FG000|Overall Study|Adverse Event|2|||
127585064|NCT04680052|459110182|FG000|Overall Study|Death|15|||
127585065|NCT04680052|459110183|FG001|Overall Study|Death|22|||
127585066|NCT04680052|459110184|FG002|Overall Study|Death|7|||
127585067|NCT04680052|459110185|FG003|Overall Study|Death|1|||
127585068|NCT04680052|459110182|FG000|Overall Study|Lost to Follow-up|3|||
127585069|NCT04680052|459110183|FG001|Overall Study|Lost to Follow-up|2|||
127585070|NCT04680052|459110184|FG002|Overall Study|Lost to Follow-up|0|||
127585071|NCT04680052|459110185|FG003|Overall Study|Lost to Follow-up|1|||
127784160|NCT04033445|459835700|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
127784161|NCT04033445|459835701|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
127784162|NCT04033445|459835702|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
128032348|NCT02327169|460746148|FG001|Overall Study|Adverse Event|0|||
128032349|NCT02327169|460746149|FG002|Overall Study|Adverse Event|1|||
128032350|NCT02327169|460746150|FG003|Overall Study|Adverse Event|0|||
128032351|NCT02327169|460746151|FG004|Overall Study|Adverse Event|1|||
127784163|NCT04033445|459835703|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
127784164|NCT04033445|459835704|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
127585072|NCT04680052|459110182|FG000|Overall Study|Withdrawal by Subject|11|||
127585073|NCT04680052|459110183|FG001|Overall Study|Withdrawal by Subject|19|||
127784165|NCT04033445|459835691|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
127784166|NCT04033445|459835692|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
127784167|NCT04033445|459835693|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
127784168|NCT04033445|459835694|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
127784169|NCT04033445|459835695|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
127784170|NCT04033445|459835696|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
127784171|NCT04033445|459835697|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
127784172|NCT04033445|459835698|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
127784173|NCT04033445|459835699|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
127784174|NCT04033445|459835700|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
127784175|NCT04033445|459835701|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
127784176|NCT04033445|459835702|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
127784177|NCT04033445|459835703|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
128032352|NCT02327169|460746152|FG005|Overall Study|Adverse Event|0|||
128032353|NCT02327169|460746153|FG006|Overall Study|Adverse Event|0|||
128032354|NCT02327169|460746154|FG007|Overall Study|Adverse Event|0|||
127585074|NCT04680052|459110184|FG002|Overall Study|Withdrawal by Subject|7|||
127585075|NCT04680052|459110185|FG003|Overall Study|Withdrawal by Subject|5|||
127585076|NCT04680052|459110182|FG000|Overall Study|Missing|0|||
127585077|NCT04680052|459110183|FG001|Overall Study|Missing|1|||
127585078|NCT04680052|459110184|FG002|Overall Study|Missing|0|||
127585079|NCT04680052|459110185|FG003|Overall Study|Missing|0|||
127585080|NCT04680052|459110182|FG000|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
127585081|NCT04680052|459110183|FG001|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|1|||
127585082|NCT04680052|459110184|FG002|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
127585083|NCT04680052|459110185|FG003|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
127585084|NCT04680052|459110182|FG000|Overall Study|Physician Decision|0|||
127585085|NCT04680052|459110183|FG001|Overall Study|Physician Decision|1|||
127585086|NCT04680052|459110184|FG002|Overall Study|Physician Decision|0|||
127585087|NCT04680052|459110185|FG003|Overall Study|Physician Decision|0|||
127585088|NCT06956170|459110186|FG000|Overall Study|Death|2|||
127585089|NCT06956170|459110187|FG001|Overall Study|Death|1|||
127585090|NCT06956170|459110186|FG000|Overall Study|Withdrawal by Subject|1|||
127585091|NCT06956170|459110187|FG001|Overall Study|Withdrawal by Subject|0|||
127585092|NCT06956170|459110186|FG000|Overall Study|Ongoing|7|||
127585093|NCT06956170|459110187|FG001|Overall Study|Ongoing|10|||
127585094|NCT02400333|459110188|FG000|Overall Study|Withdrawal by Subject|0|||
127585095|NCT02400333|459110189|FG001|Overall Study|Withdrawal by Subject|1|||
127585096|NCT02400333|459110190|FG002|Overall Study|Withdrawal by Subject|0|||
127585097|NCT02400333|459110191|FG003|Overall Study|Withdrawal by Subject|1|||
127585098|NCT02400333|459110188|FG000|Overall Study|Protocol Violation|1|||
127585099|NCT02400333|459110189|FG001|Overall Study|Protocol Violation|0|||
127585100|NCT02400333|459110190|FG002|Overall Study|Protocol Violation|2|||
127585101|NCT02400333|459110191|FG003|Overall Study|Protocol Violation|1|||
127585102|NCT02280304|459110197|FG000|Overall Study|Lost to Follow-up|7|||
127585103|NCT02280304|459110198|FG001|Overall Study|Lost to Follow-up|8|||
127585104|NCT00934089|459110202|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
127585105|NCT00934089|459110203|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
127585106|NCT00934089|459110202|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
127585107|NCT00934089|459110203|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
127585108|NCT00003473|459110204|FG000|Overall Study|Three patients were not evaluable.|3|||
127585109|NCT01546207|459110210|FG000|Overall Study|Death|1|||
127882010|NCT02268045|460190780|FG000|Overall Study|Protocol Violation|1|||
127585110|NCT02555683|459110211|FG000|Overall Study|Physician Decision|1|||
127585111|NCT02555683|459110212|FG001|Overall Study|Physician Decision|0|||
127585112|NCT02555683|459110213|FG002|Overall Study|Physician Decision|2|||
127585113|NCT02555683|459110211|FG000|Overall Study|Lost to Follow-up|2|||
127585114|NCT02555683|459110212|FG001|Overall Study|Lost to Follow-up|1|||
127585115|NCT02555683|459110213|FG002|Overall Study|Lost to Follow-up|2|||
127585116|NCT02555683|459110211|FG000|Overall Study|Technical Problems|1|||
127585117|NCT02555683|459110212|FG001|Overall Study|Technical Problems|1|||
128032355|NCT02327169|460746155|FG008|Overall Study|Adverse Event|0|||
128032356|NCT02327169|460746156|FG009|Overall Study|Adverse Event|2|||
127585118|NCT02555683|459110213|FG002|Overall Study|Technical Problems|0|||
127585119|NCT02555683|459110211|FG000|Overall Study|Protocol deviation|0|||
127585120|NCT02555683|459110212|FG001|Overall Study|Protocol deviation|1|||
127585121|NCT02555683|459110213|FG002|Overall Study|Protocol deviation|0|||
127585122|NCT02555683|459110211|FG000|Overall Study|Lack of Efficacy|2|||
127585123|NCT02555683|459110212|FG001|Overall Study|Lack of Efficacy|0|||
127585124|NCT02555683|459110213|FG002|Overall Study|Lack of Efficacy|0|||
127585125|NCT02555683|459110211|FG000|Overall Study|Death|0|||
127585126|NCT02555683|459110212|FG001|Overall Study|Death|1|||
128032357|NCT02327169|460746157|FG010|Overall Study|Adverse Event|0|||
127585127|NCT02555683|459110213|FG002|Overall Study|Death|2|||
127585128|NCT02555683|459110211|FG000|Overall Study|Adverse Event|1|||
127585129|NCT02555683|459110212|FG001|Overall Study|Adverse Event|0|||
127585130|NCT02555683|459110213|FG002|Overall Study|Adverse Event|1|||
127585131|NCT02555683|459110211|FG000|Overall Study|Subject/guardian decision|12|||
127585132|NCT02555683|459110212|FG001|Overall Study|Subject/guardian decision|12|||
127585133|NCT02555683|459110213|FG002|Overall Study|Subject/guardian decision|22|||
127585134|NCT02555683|459110211|FG000|Overall Study|Death post Treatment/safety period|0|||
127585135|NCT02555683|459110212|FG001|Overall Study|Death post Treatment/safety period|1|||
127585136|NCT02555683|459110213|FG002|Overall Study|Death post Treatment/safety period|0|||
127585137|NCT05074667|459110214|FG000|Overall Study|Death|1|||
127585138|NCT05074667|459110214|FG000|Overall Study|Withdrawal by Subject|4|||
127694105|NCT03692676|459508647|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
128032358|NCT02327169|460746158|FG011|Overall Study|Adverse Event|3|||
128032359|NCT02327169|460746159|FG012|Overall Study|Adverse Event|0|||
128032360|NCT02327169|460746160|FG013|Overall Study|Adverse Event|2|||
128032361|NCT02327169|460746161|FG014|Overall Study|Adverse Event|1|||
128032362|NCT02327169|460746147|FG000|Overall Study|Symptomatic Deterioration|0|||
128032363|NCT02327169|460746148|FG001|Overall Study|Symptomatic Deterioration|0|||
127585139|NCT05074667|459110214|FG000|Overall Study|Lost to Follow-up|10|||
127585140|NCT01947582|459110219|FG000|Overall Study|Withdrawal by Subject|1|||
127585141|NCT01826604|459110220|FG000|Overall Study|Lost to Follow-up|8|||
127585142|NCT01826604|459110221|FG001|Overall Study|Lost to Follow-up|9|||
127705212|NCT01928394|459551569|FG002|Treatment Period|Death|0|||
128032364|NCT02327169|460746149|FG002|Overall Study|Symptomatic Deterioration|1|||
128032365|NCT02327169|460746150|FG003|Overall Study|Symptomatic Deterioration|0|||
128032366|NCT02327169|460746151|FG004|Overall Study|Symptomatic Deterioration|1|||
128032367|NCT02327169|460746152|FG005|Overall Study|Symptomatic Deterioration|1|||
128032368|NCT02327169|460746153|FG006|Overall Study|Symptomatic Deterioration|0|||
128032369|NCT02327169|460746154|FG007|Overall Study|Symptomatic Deterioration|0|||
128032370|NCT02327169|460746155|FG008|Overall Study|Symptomatic Deterioration|2|||
128032371|NCT02327169|460746156|FG009|Overall Study|Symptomatic Deterioration|1|||
128032372|NCT02327169|460746157|FG010|Overall Study|Symptomatic Deterioration|0|||
128032373|NCT02327169|460746158|FG011|Overall Study|Symptomatic Deterioration|0|||
128032374|NCT02327169|460746159|FG012|Overall Study|Symptomatic Deterioration|0|||
128032375|NCT02327169|460746160|FG013|Overall Study|Symptomatic Deterioration|2|||
128032376|NCT02327169|460746161|FG014|Overall Study|Symptomatic Deterioration|1|||
128032377|NCT02327169|460746147|FG000|Overall Study|Reason Not Specified|0|||
128032378|NCT02327169|460746148|FG001|Overall Study|Reason Not Specified|0|||
128032379|NCT02327169|460746149|FG002|Overall Study|Reason Not Specified|1|||
128032380|NCT02327169|460746150|FG003|Overall Study|Reason Not Specified|0|||
128032381|NCT02327169|460746151|FG004|Overall Study|Reason Not Specified|0|||
128032382|NCT02327169|460746152|FG005|Overall Study|Reason Not Specified|0|||
128032383|NCT02327169|460746153|FG006|Overall Study|Reason Not Specified|0|||
128032384|NCT02327169|460746154|FG007|Overall Study|Reason Not Specified|0|||
128032385|NCT02327169|460746155|FG008|Overall Study|Reason Not Specified|0|||
128032386|NCT02327169|460746156|FG009|Overall Study|Reason Not Specified|1|||
128032387|NCT02327169|460746157|FG010|Overall Study|Reason Not Specified|2|||
128032388|NCT02327169|460746158|FG011|Overall Study|Reason Not Specified|1|||
127694106|NCT03692676|459508644|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
127585143|NCT00491075|459110222|FG000|Overall Study|Withdrawal by Subject|1|||
127585144|NCT00491075|459110222|FG000|Overall Study|Physician Decision|1|||
128032389|NCT02327169|460746159|FG012|Overall Study|Reason Not Specified|0|||
128032390|NCT02327169|460746160|FG013|Overall Study|Reason Not Specified|0|||
128032391|NCT02327169|460746161|FG014|Overall Study|Reason Not Specified|2|||
128032392|NCT02327169|460746147|FG000|Overall Study|Withdrawal by Subject|1|||
128032393|NCT02327169|460746148|FG001|Overall Study|Withdrawal by Subject|0|||
128032394|NCT02327169|460746149|FG002|Overall Study|Withdrawal by Subject|0|||
128032395|NCT02327169|460746150|FG003|Overall Study|Withdrawal by Subject|0|||
128032396|NCT02327169|460746151|FG004|Overall Study|Withdrawal by Subject|1|||
128032397|NCT02327169|460746152|FG005|Overall Study|Withdrawal by Subject|0|||
128032398|NCT02327169|460746153|FG006|Overall Study|Withdrawal by Subject|0|||
128032399|NCT02327169|460746154|FG007|Overall Study|Withdrawal by Subject|1|||
128032400|NCT02327169|460746155|FG008|Overall Study|Withdrawal by Subject|0|||
128032401|NCT02327169|460746156|FG009|Overall Study|Withdrawal by Subject|0|||
128032402|NCT02327169|460746157|FG010|Overall Study|Withdrawal by Subject|0|||
128032403|NCT02327169|460746158|FG011|Overall Study|Withdrawal by Subject|0|||
128032404|NCT02327169|460746159|FG012|Overall Study|Withdrawal by Subject|0|||
128032405|NCT02327169|460746160|FG013|Overall Study|Withdrawal by Subject|0|||
128032406|NCT02327169|460746161|FG014|Overall Study|Withdrawal by Subject|3|||
128032407|NCT02327169|460746147|FG000|Overall Study|Lost to Follow-up|0|||
128032408|NCT02327169|460746148|FG001|Overall Study|Lost to Follow-up|0|||
128032409|NCT02327169|460746149|FG002|Overall Study|Lost to Follow-up|0|||
128032410|NCT02327169|460746150|FG003|Overall Study|Lost to Follow-up|0|||
128032411|NCT02327169|460746151|FG004|Overall Study|Lost to Follow-up|1|||
128032412|NCT02327169|460746152|FG005|Overall Study|Lost to Follow-up|0|||
128032413|NCT02327169|460746153|FG006|Overall Study|Lost to Follow-up|0|||
128032414|NCT02327169|460746154|FG007|Overall Study|Lost to Follow-up|0|||
128032415|NCT02327169|460746155|FG008|Overall Study|Lost to Follow-up|0|||
128032416|NCT02327169|460746156|FG009|Overall Study|Lost to Follow-up|0|||
128032417|NCT02327169|460746157|FG010|Overall Study|Lost to Follow-up|0|||
128032418|NCT02327169|460746158|FG011|Overall Study|Lost to Follow-up|0|||
128032419|NCT02327169|460746159|FG012|Overall Study|Lost to Follow-up|0|||
128032420|NCT02327169|460746160|FG013|Overall Study|Lost to Follow-up|0|||
128032421|NCT02327169|460746161|FG014|Overall Study|Lost to Follow-up|0|||
128032422|NCT01381679|460746166|FG000|Overall Study|Adverse Event|3|||
128032423|NCT01381679|460746166|FG000|Overall Study|Lost to Follow-up|885|||
128032424|NCT04023487|460746167|FG000|Overall Study|Lost to Follow-up|5|||
128032425|NCT04023487|460746168|FG001|Overall Study|Lost to Follow-up|4|||
128032426|NCT04023487|460746167|FG000|Overall Study|Pregnancy|1|||
128032427|NCT04023487|460746168|FG001|Overall Study|Pregnancy|2|||
128032428|NCT04023487|460746167|FG000|Overall Study|Withdrawal by Subject|4|||
128032429|NCT04023487|460746168|FG001|Overall Study|Withdrawal by Subject|5|||
128032430|NCT04023487|460746167|FG000|Overall Study|Partially completed testing|8|||
128032431|NCT04023487|460746168|FG001|Overall Study|Partially completed testing|4|||
128032432|NCT04770285|460746171|FG000|Overall Study|Non-Compliance With Study Treatment|3|||
128032433|NCT04770285|460746172|FG001|Overall Study|Non-Compliance With Study Treatment|3|||
128032434|NCT04770285|460746171|FG000|Overall Study|Lack of Efficacy|0|||
128032435|NCT04770285|460746172|FG001|Overall Study|Lack of Efficacy|1|||
128032436|NCT04770285|460746171|FG000|Overall Study|Lost to Follow-up|11|||
128032437|NCT04770285|460746172|FG001|Overall Study|Lost to Follow-up|8|||
128032438|NCT04770285|460746171|FG000|Overall Study|Protocol Deviation|6|||
128032439|NCT04770285|460746172|FG001|Overall Study|Protocol Deviation|6|||
128032440|NCT04770285|460746171|FG000|Overall Study|Technical Problem|0|||
128032441|NCT04770285|460746172|FG001|Overall Study|Technical Problem|1|||
128032442|NCT04770285|460746171|FG000|Overall Study|Withdrawal by Subject|9|||
128032443|NCT04770285|460746172|FG001|Overall Study|Withdrawal by Subject|8|||
128032444|NCT04770285|460746171|FG000|Overall Study|Reason Not Specified|0|||
128032445|NCT04770285|460746172|FG001|Overall Study|Reason Not Specified|1|||
128032446|NCT03766399|460746173|FG000|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
128032447|NCT03766399|460746174|FG001|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
128032448|NCT03766399|460746175|FG002|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
128032449|NCT03766399|460746176|FG003|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
128032450|NCT03766399|460746177|FG004|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
128032451|NCT03766399|460746178|FG005|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
128032452|NCT03766399|460746179|FG006|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
128032453|NCT03766399|460746180|FG007|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
128032454|NCT03766399|460746181|FG008|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
128032455|NCT03766399|460746182|FG009|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
128032456|NCT03766399|460746183|FG010|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
128032457|NCT03766399|460746184|FG011|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
128032458|NCT03766399|460746185|FG012|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
128032459|NCT03766399|460746186|FG013|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|1|||
128032460|NCT03766399|460746187|FG014|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
128032461|NCT03766399|460746188|FG015|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
127882011|NCT02268045|460190781|FG001|Overall Study|Protocol Violation|1|||
127585145|NCT01603355|459110223|FG000|Overall Study|Lack of Efficacy|2|||
127585146|NCT03019185|459110230|FG000|Overall Study|Lost to Follow-up|3|||
127585147|NCT03019185|459110231|FG001|Overall Study|Lost to Follow-up|0|||
127585148|NCT03019185|459110232|FG002|Overall Study|Lost to Follow-up|2|||
127585149|NCT03019185|459110230|FG000|Overall Study|Withdrawal by Subject|1|||
127585150|NCT03019185|459110231|FG001|Overall Study|Withdrawal by Subject|1|||
127585151|NCT03019185|459110232|FG002|Overall Study|Withdrawal by Subject|0|||
127585152|NCT03019185|459110230|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
127585153|NCT03019185|459110231|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
127585154|NCT03019185|459110232|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
127585155|NCT03019185|459110230|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
127585156|NCT03019185|459110231|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
127585157|NCT03019185|459110232|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
127585158|NCT03355365|459110235|FG000|Year 1, First Intervention|Withdrawal by Subject|1|||
127585159|NCT03355365|459110236|FG001|Year 1, First Intervention|Withdrawal by Subject|0|||
127585160|NCT03355365|459110235|FG000|Year 1, First Intervention|Protocol Violation|1|||
127585161|NCT03355365|459110236|FG001|Year 1, First Intervention|Protocol Violation|0|||
127585162|NCT03355365|459110235|FG000|Year 1, First Intervention|pandemic travel limitation|1|||
127585163|NCT03355365|459110236|FG001|Year 1, First Intervention|pandemic travel limitation|0|||
127585164|NCT03355365|459110235|FG000|Year 2, Crossover Intervention|pandemic travel limitation|1|||
127585165|NCT03355365|459110236|FG001|Year 2, Crossover Intervention|pandemic travel limitation|0|||
127585166|NCT03355365|459110235|FG000|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|1|||
127585167|NCT03355365|459110236|FG001|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|0|||
127585168|NCT03355365|459110235|FG000|Year 2, Crossover Intervention|severe COVID|0|||
127585169|NCT03355365|459110236|FG001|Year 2, Crossover Intervention|severe COVID|1|||
127585170|NCT03355365|459110235|FG000|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|0|||
127585171|NCT03355365|459110236|FG001|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|1|||
127585172|NCT01705730|459110237|FG000|Overall Study|Lack of Efficacy|1|||
127585173|NCT01705730|459110237|FG000|Overall Study|Adverse Event|3|||
127585174|NCT01705730|459110237|FG000|Overall Study|Lost to Follow-up|1|||
127585175|NCT01705730|459110237|FG000|Overall Study|Reason not Specified|4|||
127784178|NCT04033445|459835704|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
127784179|NCT04033445|459835691|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
127784180|NCT04033445|459835692|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
127784181|NCT04033445|459835693|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
127784182|NCT04033445|459835694|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
127784183|NCT04033445|459835695|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
127784184|NCT04033445|459835696|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
127784185|NCT04033445|459835697|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
127784186|NCT04033445|459835698|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
128032462|NCT03766399|460746189|FG016|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
128032463|NCT03766399|460746190|FG017|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
128032464|NCT02014376|460746191|FG000|Overall Study|Adverse Event|1|||
128032465|NCT02014376|460746192|FG001|Overall Study|Adverse Event|1|||
128032466|NCT02014376|460746193|FG002|Overall Study|Adverse Event|0|||
128032467|NCT02014376|460746191|FG000|Overall Study|Lost to Follow-up|2|||
128032468|NCT02014376|460746192|FG001|Overall Study|Lost to Follow-up|0|||
128032469|NCT02014376|460746193|FG002|Overall Study|Lost to Follow-up|0|||
128032470|NCT01435356|460746199|FG000|Overall Study|Adverse Event|2|||
128032471|NCT01435356|460746200|FG001|Overall Study|Adverse Event|0|||
128032472|NCT01435356|460746199|FG000|Overall Study|Disease progression/recurrence|17|||
128032473|NCT01435356|460746200|FG001|Overall Study|Disease progression/recurrence|10|||
128032474|NCT01435356|460746199|FG000|Overall Study|Protocol Violation|0|||
128032475|NCT01435356|460746200|FG001|Overall Study|Protocol Violation|1|||
128032476|NCT01435356|460746199|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
128032477|NCT01435356|460746200|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
128032478|NCT01435356|460746199|FG000|Overall Study|Withdrawal by Subject|1|||
128032479|NCT01435356|460746200|FG001|Overall Study|Withdrawal by Subject|1|||
128032480|NCT01435356|460746199|FG000|Overall Study|Facial palsy|1|||
128032481|NCT01435356|460746200|FG001|Overall Study|Facial palsy|0|||
128032482|NCT01435356|460746199|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
128032483|NCT01435356|460746200|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
128032484|NCT01435356|460746199|FG000|Overall Study|Physician Decision|1|||
128032485|NCT01435356|460746200|FG001|Overall Study|Physician Decision|0|||
128032486|NCT01435356|460746199|FG000|Overall Study|Patient decision|3|||
128032487|NCT01435356|460746200|FG001|Overall Study|Patient decision|0|||
128032488|NCT01435356|460746199|FG000|Overall Study|Patient moved to another city|1|||
127585176|NCT01773733|459110238|FG000|Overall Study|Adverse Event|3286|||
127585177|NCT01773733|459110239|FG001|Overall Study|Adverse Event|540|||
127585178|NCT01773733|459110238|FG000|Overall Study|Pregnancy|28|||
128032489|NCT01435356|460746200|FG001|Overall Study|Patient moved to another city|1|||
128032490|NCT04875533|460746201|FG000|Overall Study|Adverse Event|6|||
128032491|NCT04875533|460746202|FG001|Overall Study|Adverse Event|4|||
128032492|NCT04875533|460746201|FG000|Overall Study|Protocol Violation|4|||
128032493|NCT04875533|460746202|FG001|Overall Study|Protocol Violation|0|||
128032494|NCT04875533|460746201|FG000|Overall Study|Withdrawal by Subject|8|||
128032495|NCT04875533|460746202|FG001|Overall Study|Withdrawal by Subject|5|||
128032496|NCT04875533|460746201|FG000|Overall Study|No longer meets eligibility criteria|1|||
128032497|NCT04875533|460746202|FG001|Overall Study|No longer meets eligibility criteria|0|||
128032498|NCT04875533|460746201|FG000|Overall Study|Other|0|||
128032499|NCT04875533|460746202|FG001|Overall Study|Other|2|||
128032500|NCT02657343|460746203|FG000|Overall Study|Death|0|||
128032501|NCT02657343|460746204|FG001|Overall Study|Death|2|||
128032502|NCT02657343|460746205|FG002|Overall Study|Death|0|||
128032503|NCT02657343|460746206|FG003|Overall Study|Death|0|||
128032504|NCT02657343|460746207|FG004|Overall Study|Death|0|||
128032505|NCT02657343|460746208|FG005|Overall Study|Death|0|||
128032506|NCT02657343|460746203|FG000|Overall Study|Patient went to hospice|1|||
128032507|NCT02657343|460746204|FG001|Overall Study|Patient went to hospice|0|||
128032508|NCT02657343|460746205|FG002|Overall Study|Patient went to hospice|0|||
128032509|NCT02657343|460746206|FG003|Overall Study|Patient went to hospice|0|||
128032510|NCT02657343|460746207|FG004|Overall Study|Patient went to hospice|0|||
128032511|NCT02657343|460746208|FG005|Overall Study|Patient went to hospice|0|||
128032512|NCT02657343|460746203|FG000|Overall Study|Withdrawal by Subject|0|||
128032513|NCT02657343|460746204|FG001|Overall Study|Withdrawal by Subject|0|||
128032514|NCT02657343|460746205|FG002|Overall Study|Withdrawal by Subject|0|||
128032515|NCT02657343|460746206|FG003|Overall Study|Withdrawal by Subject|0|||
128032516|NCT02657343|460746207|FG004|Overall Study|Withdrawal by Subject|1|||
128032517|NCT02657343|460746208|FG005|Overall Study|Withdrawal by Subject|0|||
128032518|NCT02011542|460746210|FG000|Overall Study|Physician Decision|1|||
128032519|NCT00982280|460746214|FG000|Observation Period|Not eligible to be dosed|19|||
128032520|NCT00982280|460746214|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
127585179|NCT01773733|459110239|FG001|Overall Study|Pregnancy|0|||
127585180|NCT01773733|459110238|FG000|Overall Study|Other different categories of not compl|55415|||
127585181|NCT01773733|459110239|FG001|Overall Study|Other different categories of not compl|7781|||
127585182|NCT00705289|459110240|FG000|Overall Study|Subject or treating physician's choice|131|||
127585183|NCT02601027|459110242|FG000|Registration to Surgery|Withdrawal by Subject|20|||
127585184|NCT02601027|459110243|FG001|Registration to Surgery|Withdrawal by Subject|10|||
127585185|NCT02609828|459110244|FG000|Overall Study|Adverse Event|8|||
127585186|NCT02609828|459110245|FG001|Overall Study|Adverse Event|1|||
127585187|NCT02609828|459110246|FG002|Overall Study|Adverse Event|0|||
127585188|NCT02609828|459110247|FG003|Overall Study|Adverse Event|6|||
127585189|NCT02609828|459110244|FG000|Overall Study|Death|15|||
127585190|NCT02609828|459110245|FG001|Overall Study|Death|1|||
127585191|NCT02609828|459110246|FG002|Overall Study|Death|1|||
127585192|NCT02609828|459110247|FG003|Overall Study|Death|19|||
127585193|NCT02609828|459110244|FG000|Overall Study|Insufficient clinical response|2|||
127585194|NCT02609828|459110245|FG001|Overall Study|Insufficient clinical response|1|||
128032521|NCT00982280|460746214|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
128032522|NCT00982280|460746214|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
128032523|NCT00982280|460746214|FG000|Maintenance Period|Adverse Event|1|||
128032524|NCT01979185|460746215|FG000|Period 2|Other|0|||
128032525|NCT01979185|460746216|FG001|Period 2|Other|1|||
128032526|NCT00980798|460746217|FG000|Overall Study|Adverse Event|7|||
128032527|NCT00980798|460746218|FG001|Overall Study|Adverse Event|36|||
128032528|NCT00980798|460746217|FG000|Overall Study|Lack of Efficacy|16|||
128032529|NCT00980798|460746218|FG001|Overall Study|Lack of Efficacy|5|||
128032530|NCT00980798|460746217|FG000|Overall Study|Lost to Follow-up|0|||
128032531|NCT00980798|460746218|FG001|Overall Study|Lost to Follow-up|1|||
128032532|NCT00980798|460746217|FG000|Overall Study|Physician Decision|2|||
128032533|NCT00980798|460746218|FG001|Overall Study|Physician Decision|1|||
128032534|NCT00980798|460746217|FG000|Overall Study|Withdrawal by Subject|8|||
128032535|NCT00980798|460746218|FG001|Overall Study|Withdrawal by Subject|11|||
128032536|NCT00980798|460746217|FG000|Overall Study|Other|0|||
128032537|NCT00980798|460746218|FG001|Overall Study|Other|1|||
128032538|NCT04724837|460746219|FG000|Overall Study|Other|4|||
127585195|NCT02609828|459110246|FG002|Overall Study|Insufficient clinical response|0|||
127585196|NCT02609828|459110247|FG003|Overall Study|Insufficient clinical response|0|||
128032539|NCT04724837|460746220|FG001|Overall Study|Other|16|||
128032540|NCT04724837|460746221|FG002|Overall Study|Other|0|||
128032541|NCT04724837|460746219|FG000|Overall Study|Withdrawal by Subject|2|||
128032542|NCT04724837|460746220|FG001|Overall Study|Withdrawal by Subject|9|||
128032543|NCT04724837|460746221|FG002|Overall Study|Withdrawal by Subject|9|||
128032544|NCT04724837|460746219|FG000|Overall Study|Adverse Event|2|||
128032545|NCT04724837|460746220|FG001|Overall Study|Adverse Event|7|||
127585197|NCT02609828|459110244|FG000|Overall Study|Lost to Follow-up|0|||
127585198|NCT02609828|459110245|FG001|Overall Study|Lost to Follow-up|0|||
127585199|NCT02609828|459110246|FG002|Overall Study|Lost to Follow-up|0|||
127585200|NCT02609828|459110247|FG003|Overall Study|Lost to Follow-up|1|||
127585201|NCT02609828|459110244|FG000|Overall Study|Protocol Violation|2|||
127585202|NCT02609828|459110245|FG001|Overall Study|Protocol Violation|0|||
127585203|NCT02609828|459110246|FG002|Overall Study|Protocol Violation|0|||
127585204|NCT02609828|459110247|FG003|Overall Study|Protocol Violation|1|||
127585205|NCT02609828|459110244|FG000|Overall Study|Withdrawal by Subject|12|||
127585206|NCT02609828|459110245|FG001|Overall Study|Withdrawal by Subject|1|||
127585207|NCT02609828|459110246|FG002|Overall Study|Withdrawal by Subject|0|||
127585208|NCT02609828|459110247|FG003|Overall Study|Withdrawal by Subject|10|||
127585209|NCT02609828|459110244|FG000|Overall Study|Other|3|||
127585210|NCT02609828|459110245|FG001|Overall Study|Other|0|||
127585211|NCT02609828|459110246|FG002|Overall Study|Other|0|||
127585212|NCT02609828|459110247|FG003|Overall Study|Other|6|||
127585213|NCT02609828|459110244|FG000|Overall Study|Randomized but not treated|1|||
127585214|NCT02609828|459110245|FG001|Overall Study|Randomized but not treated|0|||
127585215|NCT02609828|459110246|FG002|Overall Study|Randomized but not treated|0|||
127585216|NCT02609828|459110247|FG003|Overall Study|Randomized but not treated|0|||
127585217|NCT04891978|459110248|FG000|Baseline|Protocol Violation|2|||
127585218|NCT04891978|459110249|FG001|Baseline|Protocol Violation|1|||
127585219|NCT04891978|459110250|FG002|Baseline|Protocol Violation|0|||
127585220|NCT04891978|459110248|FG000|Baseline|Missing AIRQ|1|||
127585221|NCT04891978|459110249|FG001|Baseline|Missing AIRQ|0|||
127585222|NCT04891978|459110250|FG002|Baseline|Missing AIRQ|0|||
127585223|NCT04891978|459110248|FG000|Baseline|Did not attend a baseline visit|0|||
127585224|NCT04891978|459110249|FG001|Baseline|Did not attend a baseline visit|0|||
127585225|NCT04891978|459110250|FG002|Baseline|Did not attend a baseline visit|9|||
127585226|NCT00413244|459110253|FG000|Overall Study|Withdrawal by Subject|10|||
127585227|NCT00413244|459110254|FG001|Overall Study|Withdrawal by Subject|1|||
127585228|NCT02264639|459110255|FG000|Overall Study|Death (after completing single-dose phase)|1|||
127585229|NCT02264639|459110256|FG001|Overall Study|Death (after completing single-dose phase)|0|||
127585230|NCT02264639|459110257|FG002|Overall Study|Death (after completing single-dose phase)|0|||
127585231|NCT02264639|459110258|FG003|Overall Study|Death (after completing single-dose phase)|0|||
127585232|NCT02264639|459110259|FG004|Overall Study|Death (after completing single-dose phase)|0|||
127585233|NCT02264639|459110255|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
127585234|NCT02264639|459110256|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
127585235|NCT02264639|459110257|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
127585236|NCT02264639|459110258|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
127585237|NCT02264639|459110259|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
127585238|NCT02264639|459110255|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
127585239|NCT02264639|459110256|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
127585240|NCT02264639|459110257|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
127585241|NCT02264639|459110258|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
127585242|NCT02264639|459110259|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
127585243|NCT02264639|459110255|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
127585244|NCT02264639|459110256|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
127585245|NCT02264639|459110257|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
127585246|NCT02264639|459110258|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
127585247|NCT02264639|459110259|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
127585248|NCT01416272|459110260|FG000|Overall Study|Unacceptable distance visual acuity|2|||
127585249|NCT01416272|459110260|FG000|Overall Study|Lost to Follow-up|1|||
127585250|NCT01416272|459110260|FG000|Overall Study|Study related complaints|1|||
127585251|NCT04545060|459110261|FG000|Overall Study|Adverse Event|0|||
127585252|NCT04545060|459110262|FG001|Overall Study|Adverse Event|1|||
127585253|NCT04545060|459110261|FG000|Overall Study|Death|0|||
127585254|NCT04545060|459110262|FG001|Overall Study|Death|5|||
127585255|NCT04545060|459110261|FG000|Overall Study|Lost to Follow-up|10|||
127585256|NCT04545060|459110262|FG001|Overall Study|Lost to Follow-up|13|||
127585257|NCT04545060|459110261|FG000|Overall Study|Physician Decision|3|||
127585258|NCT04545060|459110262|FG001|Overall Study|Physician Decision|0|||
127585259|NCT04545060|459110261|FG000|Overall Study|Withdrawal by Subject|17|||
127585260|NCT04545060|459110262|FG001|Overall Study|Withdrawal by Subject|22|||
127585261|NCT00619177|459110265|FG000|Overall Study|Adverse Event|18|||
127585262|NCT00619177|459110265|FG000|Overall Study|Lost to Follow-up|2|||
127585263|NCT00619177|459110265|FG000|Overall Study|Lack of Efficacy|1|||
127585264|NCT00619177|459110265|FG000|Overall Study|Missing termination information|481|||
127585265|NCT00619177|459110265|FG000|Overall Study|Not specified reasons|6|||
127585266|NCT02319837|459110266|FG000|Study Treatment Phase|Centrally confirmed radiographic progression|26|||
127585267|NCT02319837|459110267|FG001|Study Treatment Phase|Centrally confirmed radiographic progression|66|||
127585268|NCT02319837|459110268|FG002|Study Treatment Phase|Centrally confirmed radiographic progression|37|||
127784187|NCT04033445|459835699|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
127585269|NCT02319837|459110266|FG000|Study Treatment Phase|PSA progression notification from sponsor|2|||
127585270|NCT02319837|459110267|FG001|Study Treatment Phase|PSA progression notification from sponsor|20|||
127585271|NCT02319837|459110268|FG002|Study Treatment Phase|PSA progression notification from sponsor|5|||
127585272|NCT02319837|459110266|FG000|Study Treatment Phase|Adverse Event|73|||
127585273|NCT02319837|459110267|FG001|Study Treatment Phase|Adverse Event|36|||
127585274|NCT02319837|459110268|FG002|Study Treatment Phase|Adverse Event|63|||
127585275|NCT02319837|459110266|FG000|Study Treatment Phase|Development of castration resistance|0|||
127585276|NCT02319837|459110267|FG001|Study Treatment Phase|Development of castration resistance|2|||
127585277|NCT02319837|459110268|FG002|Study Treatment Phase|Development of castration resistance|0|||
127585278|NCT02319837|459110266|FG000|Study Treatment Phase|Withdrawal by Subject|26|||
127585279|NCT02319837|459110267|FG001|Study Treatment Phase|Withdrawal by Subject|32|||
127585280|NCT02319837|459110268|FG002|Study Treatment Phase|Withdrawal by Subject|25|||
127585281|NCT02319837|459110266|FG000|Study Treatment Phase|Protocol Violation|2|||
127585282|NCT02319837|459110267|FG001|Study Treatment Phase|Protocol Violation|2|||
127585283|NCT02319837|459110268|FG002|Study Treatment Phase|Protocol Violation|1|||
127585284|NCT02319837|459110266|FG000|Study Treatment Phase|Lost to Follow-up|0|||
127585285|NCT02319837|459110267|FG001|Study Treatment Phase|Lost to Follow-up|1|||
127585286|NCT02319837|459110268|FG002|Study Treatment Phase|Lost to Follow-up|0|||
127585287|NCT02319837|459110266|FG000|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|17|||
127585288|NCT02319837|459110267|FG001|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|41|||
127585289|NCT02319837|459110268|FG002|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|26|||
127585290|NCT02319837|459110266|FG000|Study Treatment Phase|Other|0|||
127585291|NCT02319837|459110267|FG001|Study Treatment Phase|Other|1|||
127585292|NCT02319837|459110268|FG002|Study Treatment Phase|Other|0|||
127585293|NCT02319837|459110266|FG000|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|207|||
127585294|NCT02319837|459110267|FG001|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|153|||
127585295|NCT02319837|459110268|FG002|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|197|||
127585296|NCT02319837|459110266|FG000|Study Treatment Phase|Participants did not receive treatment.|2|||
127585297|NCT02319837|459110267|FG001|Study Treatment Phase|Participants did not receive treatment.|4|||
127585298|NCT02319837|459110268|FG002|Study Treatment Phase|Participants did not receive treatment.|1|||
127585299|NCT02319837|459110266|FG000|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|67|||
127585300|NCT02319837|459110267|FG001|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|104|||
127585301|NCT02319837|459110268|FG002|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|62|||
127585302|NCT02319837|459110266|FG000|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|5|||
127585303|NCT02319837|459110267|FG001|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|8|||
127585304|NCT02319837|459110268|FG002|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|12|||
127585305|NCT02319837|459110266|FG000|Long-Term Follow-Up Phase|Withdrawal by Subject|40|||
127784188|NCT04033445|459835700|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
127784189|NCT04033445|459835701|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
127784190|NCT04033445|459835702|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
127784191|NCT04033445|459835703|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
127784192|NCT04033445|459835704|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
127784193|NCT04033445|459835691|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
127784194|NCT04033445|459835692|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
127784195|NCT04033445|459835693|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
127784196|NCT04033445|459835694|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
127784197|NCT04033445|459835695|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
127784198|NCT04033445|459835696|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
127784199|NCT04033445|459835697|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
127784200|NCT04033445|459835698|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|4|||
127784201|NCT04033445|459835699|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|6|||
127784202|NCT04033445|459835700|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
127784203|NCT04033445|459835701|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
127784204|NCT04033445|459835702|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
127784205|NCT04033445|459835703|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
127784206|NCT04033445|459835704|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
127784207|NCT04033445|459835691|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
127784208|NCT04033445|459835692|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
127784209|NCT04033445|459835693|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
127784210|NCT04033445|459835694|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
127784211|NCT04033445|459835695|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
128032546|NCT04724837|460746221|FG002|Overall Study|Adverse Event|4|||
128032547|NCT04724837|460746219|FG000|Overall Study|Lost to Follow-up|0|||
128032548|NCT04724837|460746220|FG001|Overall Study|Lost to Follow-up|1|||
128032549|NCT04724837|460746221|FG002|Overall Study|Lost to Follow-up|3|||
128032550|NCT04724837|460746219|FG000|Overall Study|Physician Decision|1|||
128032551|NCT04724837|460746220|FG001|Overall Study|Physician Decision|2|||
128032552|NCT04724837|460746221|FG002|Overall Study|Physician Decision|0|||
128032553|NCT04724837|460746219|FG000|Overall Study|Death|0|||
128032554|NCT04724837|460746220|FG001|Overall Study|Death|0|||
128032555|NCT04724837|460746221|FG002|Overall Study|Death|1|||
128032556|NCT04724837|460746219|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
128032557|NCT04724837|460746220|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
128032558|NCT04724837|460746221|FG002|Overall Study|Failure to Meet Randomization Criteria|3|||
128032559|NCT04724837|460746219|FG000|Overall Study|Study Terminated by Sponsor|0|||
128032560|NCT04724837|460746220|FG001|Overall Study|Study Terminated by Sponsor|1|||
128032561|NCT04724837|460746221|FG002|Overall Study|Study Terminated by Sponsor|0|||
128032562|NCT00522379|460746222|FG000|Overall Study|Adverse Event|12|||
128032563|NCT00522379|460746223|FG001|Overall Study|Adverse Event|15|||
128032564|NCT00522379|460746224|FG002|Overall Study|Adverse Event|12|||
128032565|NCT00522379|460746225|FG003|Overall Study|Adverse Event|5|||
128032566|NCT00522379|460746226|FG004|Overall Study|Adverse Event|17|||
128032567|NCT00522379|460746222|FG000|Overall Study|Lack of Efficacy|3|||
128032568|NCT00522379|460746223|FG001|Overall Study|Lack of Efficacy|0|||
128032569|NCT00522379|460746224|FG002|Overall Study|Lack of Efficacy|2|||
128032570|NCT00522379|460746225|FG003|Overall Study|Lack of Efficacy|2|||
128032571|NCT00522379|460746226|FG004|Overall Study|Lack of Efficacy|7|||
128032572|NCT00522379|460746222|FG000|Overall Study|Withdrawal by Subject|2|||
128032573|NCT00522379|460746223|FG001|Overall Study|Withdrawal by Subject|3|||
128032574|NCT00522379|460746224|FG002|Overall Study|Withdrawal by Subject|1|||
128032575|NCT00522379|460746225|FG003|Overall Study|Withdrawal by Subject|2|||
128032576|NCT00522379|460746226|FG004|Overall Study|Withdrawal by Subject|0|||
128032577|NCT00522379|460746222|FG000|Overall Study|Protocol Violation|1|||
128032578|NCT00522379|460746223|FG001|Overall Study|Protocol Violation|1|||
128032579|NCT00522379|460746224|FG002|Overall Study|Protocol Violation|2|||
128032580|NCT00522379|460746225|FG003|Overall Study|Protocol Violation|0|||
128032581|NCT00522379|460746226|FG004|Overall Study|Protocol Violation|0|||
128032582|NCT00522379|460746222|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
128032583|NCT00522379|460746223|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
128032584|NCT00522379|460746224|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
128032585|NCT00522379|460746225|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
128032586|NCT00522379|460746226|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
128032587|NCT00522379|460746222|FG000|Overall Study|Lost to Follow-up|1|||
128032588|NCT00522379|460746223|FG001|Overall Study|Lost to Follow-up|0|||
127882012|NCT01766310|460190782|FG000|Overall Study|Lost to Follow-up|1|||
127882013|NCT01766310|460190783|FG001|Overall Study|Lost to Follow-up|3|||
128032589|NCT00522379|460746224|FG002|Overall Study|Lost to Follow-up|4|||
128032590|NCT00522379|460746225|FG003|Overall Study|Lost to Follow-up|2|||
128032591|NCT00522379|460746226|FG004|Overall Study|Lost to Follow-up|2|||
128032592|NCT00522379|460746222|FG000|Overall Study|Randomization error|0|||
127694107|NCT03692676|459508645|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
128032593|NCT00522379|460746223|FG001|Overall Study|Randomization error|0|||
128032594|NCT00522379|460746224|FG002|Overall Study|Randomization error|0|||
128032595|NCT00522379|460746225|FG003|Overall Study|Randomization error|0|||
128032596|NCT00522379|460746226|FG004|Overall Study|Randomization error|1|||
128032597|NCT00522379|460746222|FG000|Overall Study|Dispensing error|1|||
128032598|NCT00522379|460746223|FG001|Overall Study|Dispensing error|0|||
128032599|NCT00522379|460746224|FG002|Overall Study|Dispensing error|0|||
128032600|NCT00522379|460746225|FG003|Overall Study|Dispensing error|1|||
128032601|NCT00522379|460746226|FG004|Overall Study|Dispensing error|0|||
128032602|NCT00522379|460746222|FG000|Overall Study|Subject Moved|1|||
128032603|NCT00522379|460746223|FG001|Overall Study|Subject Moved|1|||
128032604|NCT00522379|460746224|FG002|Overall Study|Subject Moved|0|||
128032605|NCT00522379|460746225|FG003|Overall Study|Subject Moved|0|||
128032606|NCT00522379|460746226|FG004|Overall Study|Subject Moved|0|||
128032607|NCT00522379|460746222|FG000|Overall Study|Sponsor Request|0|||
128032608|NCT00522379|460746223|FG001|Overall Study|Sponsor Request|1|||
128032609|NCT00522379|460746224|FG002|Overall Study|Sponsor Request|0|||
128032610|NCT00522379|460746225|FG003|Overall Study|Sponsor Request|0|||
128032611|NCT00522379|460746226|FG004|Overall Study|Sponsor Request|0|||
128032612|NCT00522379|460746222|FG000|Overall Study|Family Problem|0|||
128032613|NCT00522379|460746223|FG001|Overall Study|Family Problem|0|||
128032614|NCT00522379|460746224|FG002|Overall Study|Family Problem|1|||
128032615|NCT00522379|460746225|FG003|Overall Study|Family Problem|0|||
128032616|NCT00522379|460746226|FG004|Overall Study|Family Problem|0|||
128032617|NCT00522379|460746222|FG000|Overall Study|Site Closed|0|||
128032618|NCT00522379|460746223|FG001|Overall Study|Site Closed|0|||
128032619|NCT00522379|460746224|FG002|Overall Study|Site Closed|0|||
128032620|NCT00522379|460746225|FG003|Overall Study|Site Closed|1|||
128032621|NCT00522379|460746226|FG004|Overall Study|Site Closed|0|||
128032622|NCT00522379|460746222|FG000|Overall Study|Subject Withdrawal|0|||
128032623|NCT00522379|460746223|FG001|Overall Study|Subject Withdrawal|0|||
128032624|NCT00522379|460746224|FG002|Overall Study|Subject Withdrawal|0|||
127585306|NCT02319837|459110267|FG001|Long-Term Follow-Up Phase|Withdrawal by Subject|36|||
127585307|NCT02319837|459110268|FG002|Long-Term Follow-Up Phase|Withdrawal by Subject|38|||
127585308|NCT02319837|459110266|FG000|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
127585309|NCT02319837|459110267|FG001|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
127585310|NCT02319837|459110268|FG002|Long-Term Follow-Up Phase|Lost to Follow-up|4|||
127585311|NCT02319837|459110266|FG000|Long-Term Follow-Up Phase|Death|33|||
127585312|NCT02319837|459110267|FG001|Long-Term Follow-Up Phase|Death|54|||
127585313|NCT02319837|459110268|FG002|Long-Term Follow-Up Phase|Death|42|||
127585314|NCT00753766|459110269|FG000|Overall Study|Physician Decision|1|||
127585315|NCT00753766|459110270|FG001|Overall Study|Physician Decision|0|||
127585316|NCT00839852|459110275|FG000|Overall Study|Adverse Event|10|||
127585317|NCT00839852|459110275|FG000|Overall Study|Insufficient Therapeutic Response|3|||
127585318|NCT00839852|459110275|FG000|Overall Study|Protocol Violation|9|||
127585319|NCT00839852|459110275|FG000|Overall Study|Withdrawal of Consent|16|||
127585320|NCT00839852|459110275|FG000|Overall Study|Lost to Follow-up|7|||
127585321|NCT00839852|459110275|FG000|Overall Study|Lack of Compliance While in Jail|1|||
127585322|NCT00839852|459110275|FG000|Overall Study|Pregnancy|1|||
127585323|NCT04545554|459110276|FG000|Overall Study|Withdrawal by Subject|0|||
127585324|NCT04545554|459110277|FG001|Overall Study|Withdrawal by Subject|0|||
127585325|NCT04545554|459110278|FG002|Overall Study|Withdrawal by Subject|0|||
127585326|NCT04545554|459110279|FG003|Overall Study|Withdrawal by Subject|1|||
127585327|NCT04545554|459110280|FG004|Overall Study|Withdrawal by Subject|0|||
127585328|NCT04545554|459110281|FG005|Overall Study|Withdrawal by Subject|0|||
127585329|NCT00494299|459110282|FG000|Overall Study|Adverse Event|93|||
127585330|NCT00494299|459110283|FG001|Overall Study|Adverse Event|13|||
127585331|NCT00494299|459110282|FG000|Overall Study|Lost to Follow-up|1|||
127585332|NCT00494299|459110283|FG001|Overall Study|Lost to Follow-up|0|||
127585333|NCT00494299|459110282|FG000|Overall Study|Physician Decision|0|||
127585334|NCT00494299|459110283|FG001|Overall Study|Physician Decision|2|||
127585335|NCT00494299|459110282|FG000|Overall Study|Protocol Violation|1|||
127585336|NCT00494299|459110283|FG001|Overall Study|Protocol Violation|2|||
127585337|NCT00494299|459110282|FG000|Overall Study|Withdrawal by Subject|8|||
127585338|NCT00494299|459110283|FG001|Overall Study|Withdrawal by Subject|3|||
127585339|NCT00494299|459110282|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
127585340|NCT00494299|459110283|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
127585341|NCT00494299|459110282|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
127585342|NCT00494299|459110283|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
127585343|NCT00494299|459110282|FG000|Overall Study|Site Closed by Sponsor|6|||
127585344|NCT00494299|459110283|FG001|Overall Study|Site Closed by Sponsor|0|||
127585345|NCT00494299|459110282|FG000|Overall Study|Protocol Driven Decision Point|11|||
127585346|NCT00494299|459110283|FG001|Overall Study|Protocol Driven Decision Point|22|||
127585347|NCT01206166|459110287|FG000|Overall Study|No evaluable data|2|||
127585348|NCT01206166|459110288|FG001|Overall Study|No evaluable data|3|||
127585349|NCT00066365|459110289|FG000|Overall Study|Adverse Event|1|||
127585350|NCT00066365|459110290|FG001|Overall Study|Adverse Event|0|||
127585351|NCT00066365|459110289|FG000|Overall Study|Lack of Efficacy|15|||
127585352|NCT00066365|459110290|FG001|Overall Study|Lack of Efficacy|12|||
127585353|NCT00066365|459110289|FG000|Overall Study|Physician Decision|1|||
127585354|NCT00066365|459110290|FG001|Overall Study|Physician Decision|0|||
127585355|NCT00066365|459110289|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
127585356|NCT00066365|459110290|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
127585357|NCT00066365|459110289|FG000|Overall Study|Ineligible|4|||
127585358|NCT00066365|459110290|FG001|Overall Study|Ineligible|2|||
128032625|NCT00522379|460746225|FG003|Overall Study|Subject Withdrawal|1|||
128032626|NCT00522379|460746226|FG004|Overall Study|Subject Withdrawal|0|||
128032627|NCT00967499|460746231|FG000|Overall Study|Adverse Event|0|||
128032628|NCT00967499|460746232|FG001|Overall Study|Adverse Event|1|||
128032629|NCT00967499|460746231|FG000|Overall Study|Protocol Violation|1|||
128032630|NCT00967499|460746232|FG001|Overall Study|Protocol Violation|0|||
128032631|NCT00967499|460746231|FG000|Overall Study|Sponsor Decision|1|||
128032632|NCT00967499|460746232|FG001|Overall Study|Sponsor Decision|0|||
128032633|NCT00967499|460746231|FG000|Overall Study|Randomized but not treated|63|||
128032634|NCT00967499|460746232|FG001|Overall Study|Randomized but not treated|59|||
128032635|NCT04562090|460746234|FG000|Overall Study|Withdrawal by Subject|3|||
128032636|NCT04562090|460746235|FG001|Overall Study|Withdrawal by Subject|4|||
128032637|NCT04562090|460746234|FG000|Overall Study|Protocol Violation|2|||
127585359|NCT02635776|459110294|FG000|Overall Study|Physician Decision|1|||
127585360|NCT02635776|459110295|FG001|Overall Study|Physician Decision|0|||
127585361|NCT02635776|459110294|FG000|Overall Study|Adverse Event|51|||
127585362|NCT02635776|459110295|FG001|Overall Study|Adverse Event|3|||
127585363|NCT02635776|459110294|FG000|Overall Study|Withdrawal by Subject|41|||
128032638|NCT04562090|460746235|FG001|Overall Study|Protocol Violation|0|||
127585364|NCT02635776|459110295|FG001|Overall Study|Withdrawal by Subject|7|||
127585365|NCT02635776|459110294|FG000|Overall Study|Lost to Follow-up|4|||
127585366|NCT02635776|459110295|FG001|Overall Study|Lost to Follow-up|0|||
127585367|NCT02635776|459110294|FG000|Overall Study|Other reasons|5|||
127585368|NCT02635776|459110295|FG001|Overall Study|Other reasons|1|||
127585369|NCT03608254|459110296|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
127585370|NCT03608254|459110296|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
127585371|NCT00660673|459110297|FG000|Overall Study|Adverse Event|84|||
127585372|NCT00660673|459110297|FG000|Overall Study|Lack of Efficacy|7|||
127585373|NCT00660673|459110297|FG000|Overall Study|Withdrawal by Subject|22|||
127585374|NCT00660673|459110297|FG000|Overall Study|Administrative|2|||
127585375|NCT00660673|459110297|FG000|Overall Study|Protocol Violation|2|||
127585376|NCT02058693|459110304|FG000|Phase 1|Withdrawal by Subject|3|||
127585377|NCT02058693|459110305|FG001|Phase 1|Withdrawal by Subject|2|||
127585378|NCT02058693|459110304|FG000|Phase 1|Adverse Event|0|||
127585379|NCT02058693|459110305|FG001|Phase 1|Adverse Event|1|||
127585380|NCT02058693|459110304|FG000|Phase 1|Lack of Efficacy|1|||
127585381|NCT02058693|459110305|FG001|Phase 1|Lack of Efficacy|0|||
127585382|NCT02058693|459110304|FG000|Phase 1|Physician Decision|1|||
127585383|NCT02058693|459110305|FG001|Phase 1|Physician Decision|1|||
127585384|NCT02058693|459110304|FG000|Phase 2|Withdrawal by Subject|0|||
127585385|NCT02058693|459110305|FG001|Phase 2|Withdrawal by Subject|2|||
127585386|NCT00722800|459110306|FG000|Overall Study|Withdrawal by Subject|1|||
127585387|NCT00722800|459110307|FG001|Overall Study|Withdrawal by Subject|0|||
127585388|NCT00722800|459110306|FG000|Overall Study|Physician Decision|1|||
127585389|NCT00722800|459110307|FG001|Overall Study|Physician Decision|0|||
127585390|NCT01449539|459110308|FG000|Overall Study|Withdrawal by Subject|3|||
127585391|NCT01449539|459110308|FG000|Overall Study|Toxicity not study related|1|||
127585392|NCT01972568|459110309|FG000|Overall Study|Other events|3|||
127585393|NCT01972568|459110310|FG001|Overall Study|Other events|0|||
127585394|NCT01972568|459110311|FG002|Overall Study|Other events|0|||
127585395|NCT01972568|459110309|FG000|Overall Study|Lack of Efficacy|0|||
127585396|NCT01972568|459110310|FG001|Overall Study|Lack of Efficacy|1|||
127585397|NCT01972568|459110311|FG002|Overall Study|Lack of Efficacy|2|||
127585398|NCT01972568|459110309|FG000|Overall Study|Protocol Violation|1|||
127784212|NCT04033445|459835696|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
127784213|NCT04033445|459835697|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
127784214|NCT04033445|459835698|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|1|||
127784215|NCT04033445|459835699|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|3|||
127784216|NCT04033445|459835700|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
127784217|NCT04033445|459835701|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
127784218|NCT04033445|459835702|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
127784219|NCT04033445|459835703|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
127784220|NCT04033445|459835704|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
127784221|NCT04033445|459835691|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
127784222|NCT04033445|459835692|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
127784223|NCT04033445|459835693|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
127784224|NCT04033445|459835694|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
127784225|NCT04033445|459835695|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
128032639|NCT04562090|460746234|FG000|Overall Study|Lack of Efficacy|0|||
127585399|NCT01972568|459110310|FG001|Overall Study|Protocol Violation|2|||
127585400|NCT01972568|459110311|FG002|Overall Study|Protocol Violation|2|||
127585401|NCT01972568|459110309|FG000|Overall Study|Withdrawal by Subject|6|||
127585402|NCT01972568|459110310|FG001|Overall Study|Withdrawal by Subject|3|||
127585403|NCT01972568|459110311|FG002|Overall Study|Withdrawal by Subject|7|||
127585404|NCT01972568|459110309|FG000|Overall Study|Lost to Follow-up|1|||
127585405|NCT01972568|459110310|FG001|Overall Study|Lost to Follow-up|0|||
127585406|NCT01972568|459110311|FG002|Overall Study|Lost to Follow-up|0|||
127585407|NCT01972568|459110309|FG000|Overall Study|Adverse Event|5|||
127585408|NCT01972568|459110310|FG001|Overall Study|Adverse Event|6|||
127585409|NCT01972568|459110311|FG002|Overall Study|Adverse Event|5|||
127585410|NCT02572401|459110312|FG000|Overall Study|Lost to Follow-up|5|||
127585411|NCT02572401|459110313|FG001|Overall Study|Lost to Follow-up|8|||
127585412|NCT02572401|459110314|FG002|Overall Study|Lost to Follow-up|9|||
127585413|NCT02572401|459110315|FG003|Overall Study|Lost to Follow-up|9|||
127585414|NCT02572401|459110312|FG000|Overall Study|Death|0|||
127585415|NCT02572401|459110313|FG001|Overall Study|Death|0|||
127585416|NCT02572401|459110314|FG002|Overall Study|Death|0|||
127585417|NCT02572401|459110315|FG003|Overall Study|Death|1|||
127585418|NCT00306189|459110316|FG000|Overall Study|Physician Decision|0|||
127585419|NCT00306189|459110317|FG001|Overall Study|Physician Decision|0|||
127585420|NCT00306189|459110318|FG002|Overall Study|Physician Decision|0|||
127585421|NCT00306189|459110319|FG003|Overall Study|Physician Decision|1|||
128032640|NCT04562090|460746235|FG001|Overall Study|Lack of Efficacy|1|||
128032641|NCT04562090|460746234|FG000|Overall Study|Adverse Event|1|||
127585422|NCT00306189|459110316|FG000|Overall Study|Adverse Event|3|||
127585423|NCT00306189|459110317|FG001|Overall Study|Adverse Event|3|||
127585424|NCT00306189|459110318|FG002|Overall Study|Adverse Event|2|||
127585425|NCT00306189|459110319|FG003|Overall Study|Adverse Event|2|||
127585426|NCT00306189|459110316|FG000|Overall Study|Withdrawal by Subject|4|||
127585427|NCT00306189|459110317|FG001|Overall Study|Withdrawal by Subject|2|||
127585428|NCT00306189|459110318|FG002|Overall Study|Withdrawal by Subject|8|||
127585429|NCT00306189|459110319|FG003|Overall Study|Withdrawal by Subject|1|||
127585430|NCT00306189|459110316|FG000|Overall Study|Ineligibility determined|1|||
127585431|NCT00306189|459110317|FG001|Overall Study|Ineligibility determined|1|||
127585432|NCT00306189|459110318|FG002|Overall Study|Ineligibility determined|1|||
127585433|NCT00306189|459110319|FG003|Overall Study|Ineligibility determined|1|||
127585434|NCT00306189|459110316|FG000|Overall Study|Other|1|||
127585435|NCT00306189|459110317|FG001|Overall Study|Other|0|||
127585436|NCT00306189|459110318|FG002|Overall Study|Other|0|||
127585437|NCT00306189|459110319|FG003|Overall Study|Other|0|||
127585438|NCT00945893|459110320|FG000|Overall Study|Lost to Follow-up|2|||
127585439|NCT00945893|459110321|FG001|Overall Study|Lost to Follow-up|8|||
127585440|NCT00945893|459110320|FG000|Overall Study|Withdrawal of consent|1|||
127585441|NCT00945893|459110321|FG001|Overall Study|Withdrawal of consent|2|||
127585442|NCT00283400|459111949|FG000|Overall Study|Withdrawal by Subject|1|||
127585443|NCT00283400|459111950|FG001|Overall Study|Withdrawal by Subject|1|||
127585444|NCT00283400|459111951|FG002|Overall Study|Withdrawal by Subject|0|||
127585445|NCT00283400|459111952|FG003|Overall Study|Withdrawal by Subject|0|||
127585446|NCT00283400|459111949|FG000|Overall Study|Death|1|||
127585447|NCT00283400|459111950|FG001|Overall Study|Death|0|||
127585448|NCT00283400|459111951|FG002|Overall Study|Death|1|||
127585449|NCT00283400|459111952|FG003|Overall Study|Death|0|||
127585450|NCT01034631|459111954|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
127585451|NCT01034631|459111955|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
127585452|NCT01034631|459111956|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
127585453|NCT01034631|459111954|FG000|Phase II|Not Evaluable per protocol|0|||
127585454|NCT01034631|459111955|FG001|Phase II|Not Evaluable per protocol|0|||
127585455|NCT01034631|459111956|FG002|Phase II|Not Evaluable per protocol|2|||
127585456|NCT01034631|459111954|FG000|Phase II|Determined Ineligible per protocol|0|||
127585457|NCT01034631|459111955|FG001|Phase II|Determined Ineligible per protocol|1|||
127585458|NCT01034631|459111956|FG002|Phase II|Determined Ineligible per protocol|0|||
127585459|NCT01560403|459111957|FG000|Overall Study|Lost to Follow-up|0|||
127585460|NCT01560403|459111958|FG001|Overall Study|Lost to Follow-up|1|||
127585461|NCT01890473|459111959|FG000|Overall Study|Lost to Follow-up|1|||
127585462|NCT01890473|459111960|FG001|Overall Study|Lost to Follow-up|0|||
127585463|NCT01890473|459111959|FG000|Overall Study|Poor/non-compliance|1|||
127585464|NCT01890473|459111960|FG001|Overall Study|Poor/non-compliance|0|||
127585465|NCT03166735|459111961|FG000|Overall Study|Not Treated|1|||
127585466|NCT03166735|459111962|FG001|Overall Study|Not Treated|0|||
127585467|NCT03166735|459111963|FG002|Overall Study|Not Treated|0|||
127585468|NCT03166735|459111964|FG003|Overall Study|Not Treated|0|||
127585469|NCT03166735|459111965|FG004|Overall Study|Not Treated|0|||
127585470|NCT03166735|459111961|FG000|Overall Study|follow-up not completed as planned|0|||
127585471|NCT03166735|459111962|FG001|Overall Study|follow-up not completed as planned|1|||
127585472|NCT03166735|459111963|FG002|Overall Study|follow-up not completed as planned|1|||
127585473|NCT03166735|459111964|FG003|Overall Study|follow-up not completed as planned|0|||
127585474|NCT03166735|459111965|FG004|Overall Study|follow-up not completed as planned|1|||
127585475|NCT03166735|459111961|FG000|Overall Study|Withdrawal by Subject|0|||
127585476|NCT03166735|459111962|FG001|Overall Study|Withdrawal by Subject|0|||
127585477|NCT03166735|459111963|FG002|Overall Study|Withdrawal by Subject|1|||
127585478|NCT03166735|459111964|FG003|Overall Study|Withdrawal by Subject|1|||
127585479|NCT03166735|459111965|FG004|Overall Study|Withdrawal by Subject|2|||
127585480|NCT03166735|459111961|FG000|Overall Study|Lost to Follow-up|0|||
127585481|NCT03166735|459111962|FG001|Overall Study|Lost to Follow-up|2|||
127585482|NCT03166735|459111963|FG002|Overall Study|Lost to Follow-up|1|||
127585483|NCT03166735|459111964|FG003|Overall Study|Lost to Follow-up|0|||
127585484|NCT03166735|459111965|FG004|Overall Study|Lost to Follow-up|1|||
128032642|NCT04562090|460746235|FG001|Overall Study|Adverse Event|4|||
128032643|NCT04562090|460746234|FG000|Overall Study|Miscellaneous|0|||
128032644|NCT04562090|460746235|FG001|Overall Study|Miscellaneous|3|||
127585485|NCT03372096|459111969|FG000|Overall Study|Study Closed|8|||
127585486|NCT00040365|459111970|FG000|Overall Study|Death|1|||
127585487|NCT00040365|459111970|FG000|Overall Study|Progressive disease|7|||
127585488|NCT00040365|459111970|FG000|Overall Study|Lost to Follow-up|3|||
127585489|NCT00541931|459111971|FG000|Overall Study|Adverse Event|1|||
128032645|NCT03633058|460746236|FG000|Overall Study|Adverse Event|0|||
128032646|NCT03633058|460746237|FG001|Overall Study|Adverse Event|0|||
127585490|NCT00541931|459111972|FG001|Overall Study|Adverse Event|0|||
127585491|NCT00541931|459111971|FG000|Overall Study|Lost to Follow-up|3|||
127585492|NCT00541931|459111972|FG001|Overall Study|Lost to Follow-up|3|||
127585493|NCT00541931|459111971|FG000|Overall Study|Withdrawal by Subject|1|||
127585494|NCT00541931|459111972|FG001|Overall Study|Withdrawal by Subject|0|||
127585495|NCT00541931|459111971|FG000|Overall Study|Transportation Issue|0|||
128032647|NCT03633058|460746238|FG002|Overall Study|Adverse Event|1|||
128032648|NCT03633058|460746239|FG003|Overall Study|Adverse Event|0|||
127585496|NCT00541931|459111972|FG001|Overall Study|Transportation Issue|1|||
127585497|NCT00680017|459111973|FG000|Overall Study|Adverse Event|13|||
127585498|NCT00680017|459111974|FG001|Overall Study|Adverse Event|7|||
127585499|NCT00680017|459111973|FG000|Overall Study|Withdrawal by Subject|2|||
127585500|NCT00680017|459111974|FG001|Overall Study|Withdrawal by Subject|5|||
127585501|NCT00680017|459111973|FG000|Overall Study|Lost to Follow-up|2|||
127585502|NCT00680017|459111974|FG001|Overall Study|Lost to Follow-up|0|||
127585503|NCT01086033|459111976|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
127585504|NCT01086033|459111976|FG000|Overall Study|Lost to Follow-up|86|||
127585505|NCT01086033|459111976|FG000|Overall Study|Adverse Event|42|||
127585506|NCT01086033|459111976|FG000|Overall Study|Withdrawal by Subject|41|||
127585507|NCT01086033|459111976|FG000|Overall Study|Other|14|||
127585508|NCT01086033|459111976|FG000|Overall Study|Other|13|||
127585509|NCT01086033|459111976|FG000|Overall Study|AE and Withdrew Consent|5|||
127585510|NCT01086033|459111976|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
127585511|NCT01086033|459111976|FG000|Overall Study|Withdrew consent and Other Reason|4|||
127585512|NCT01086033|459111976|FG000|Overall Study|AE and Lack of Efficacy|4|||
127585513|NCT01086033|459111976|FG000|Overall Study|Death|1|||
127585514|NCT01086033|459111976|FG000|Overall Study|AE and Lost to Follow-up|1|||
127585515|NCT01086033|459111976|FG000|Overall Study|AE and Other Reason|1|||
127585516|NCT01086033|459111976|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
127585517|NCT05154578|459111977|FG000|Overall Study|Withdrawal by Subject|2|||
127585518|NCT05154578|459111978|FG001|Overall Study|Withdrawal by Subject|3|||
127585519|NCT05154578|459111979|FG002|Overall Study|Withdrawal by Subject|2|||
127585520|NCT05154578|459111980|FG003|Overall Study|Withdrawal by Subject|4|||
127585521|NCT05154578|459111981|FG004|Overall Study|Withdrawal by Subject|0|||
127585522|NCT05154578|459111977|FG000|Overall Study|Lost to Follow-up|0|||
127585523|NCT05154578|459111978|FG001|Overall Study|Lost to Follow-up|1|||
127585524|NCT05154578|459111979|FG002|Overall Study|Lost to Follow-up|0|||
127585525|NCT05154578|459111980|FG003|Overall Study|Lost to Follow-up|3|||
127585526|NCT05154578|459111981|FG004|Overall Study|Lost to Follow-up|0|||
127585527|NCT05154578|459111977|FG000|Overall Study|Adverse Event|0|||
127585528|NCT05154578|459111978|FG001|Overall Study|Adverse Event|0|||
127585529|NCT05154578|459111979|FG002|Overall Study|Adverse Event|0|||
127585530|NCT05154578|459111980|FG003|Overall Study|Adverse Event|1|||
127585531|NCT05154578|459111981|FG004|Overall Study|Adverse Event|0|||
127585532|NCT05154578|459111977|FG000|Overall Study|Relocated to another province|0|||
127585533|NCT05154578|459111978|FG001|Overall Study|Relocated to another province|0|||
127585534|NCT05154578|459111979|FG002|Overall Study|Relocated to another province|1|||
127585535|NCT05154578|459111980|FG003|Overall Study|Relocated to another province|0|||
127585536|NCT05154578|459111981|FG004|Overall Study|Relocated to another province|1|||
127585537|NCT05154578|459111977|FG000|Overall Study|Baby loss|0|||
127585538|NCT05154578|459111978|FG001|Overall Study|Baby loss|1|||
127585539|NCT05154578|459111979|FG002|Overall Study|Baby loss|0|||
127585540|NCT05154578|459111980|FG003|Overall Study|Baby loss|0|||
127585541|NCT05154578|459111981|FG004|Overall Study|Baby loss|0|||
127585542|NCT04572633|459111982|FG000|Overall Study|Participant in active follow-up at 30 days|47|||
127585543|NCT02924571|459111983|FG000|Overall Study|Lost to Follow-up|1|||
127585544|NCT02924571|459111984|FG001|Overall Study|Lost to Follow-up|1|||
127585545|NCT02924571|459111985|FG002|Overall Study|Lost to Follow-up|0|||
127585546|NCT00434954|459111986|FG000|Overall Study|Adverse Event|17|||
127585547|NCT00434954|459111987|FG001|Overall Study|Adverse Event|2|||
127585548|NCT00434954|459111986|FG000|Overall Study|Entry criteria not met|14|||
127585549|NCT00434954|459111987|FG001|Overall Study|Entry criteria not met|16|||
127585550|NCT00434954|459111986|FG000|Overall Study|Lost to Follow-up|0|||
127585551|NCT00434954|459111987|FG001|Overall Study|Lost to Follow-up|1|||
127585552|NCT00434954|459111986|FG000|Overall Study|Physician Decision|6|||
127585553|NCT00434954|459111987|FG001|Overall Study|Physician Decision|3|||
127585554|NCT00434954|459111986|FG000|Overall Study|Protocol Violation|36|||
127585555|NCT00434954|459111987|FG001|Overall Study|Protocol Violation|27|||
127585556|NCT00434954|459111986|FG000|Overall Study|Sponsor decision|1|||
127585557|NCT00434954|459111987|FG001|Overall Study|Sponsor decision|0|||
127585558|NCT00434954|459111986|FG000|Overall Study|Subject decision|8|||
127585559|NCT00434954|459111987|FG001|Overall Study|Subject decision|22|||
127585560|NCT00894166|459111988|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
127585561|NCT00894166|459111989|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
127585562|NCT00894166|459111990|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
127585563|NCT00894166|459111991|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
127585564|NCT00894166|459111992|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
127585565|NCT00894166|459111993|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
127585566|NCT00894166|459111994|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
127585567|NCT00894166|459111995|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
127585568|NCT00894166|459111988|FG000|Overall Study|Death|0|||
127585569|NCT00894166|459111989|FG001|Overall Study|Death|0|||
127585570|NCT00894166|459111990|FG002|Overall Study|Death|0|||
127585571|NCT00894166|459111991|FG003|Overall Study|Death|1|||
127585572|NCT00894166|459111992|FG004|Overall Study|Death|0|||
128032649|NCT03312543|460746240|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
128032650|NCT03312543|460746241|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
128032651|NCT03312543|460746240|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
128032652|NCT03312543|460746241|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
127585573|NCT00894166|459111993|FG005|Overall Study|Death|0|||
127585574|NCT00894166|459111994|FG006|Overall Study|Death|0|||
127585575|NCT00894166|459111995|FG007|Overall Study|Death|0|||
127585576|NCT03750955|459112003|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
127585577|NCT03750955|459112004|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
127585578|NCT03750955|459112003|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
127585579|NCT03750955|459112004|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
127585580|NCT01180985|459112007|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
127585581|NCT01180985|459112008|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
128032653|NCT03312543|460746240|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
128032654|NCT03312543|460746241|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
127585582|NCT03345914|459112011|FG000|Overall Study|Transition to another study at week 16|80|||
127585583|NCT03345914|459112012|FG001|Overall Study|Transition to another study at week 16|86|||
127585584|NCT03345914|459112013|FG002|Overall Study|Transition to another study at week 16|78|||
127585585|NCT03345914|459112011|FG000|Overall Study|Transition to OLE during follow-up|37|||
127585586|NCT03345914|459112012|FG001|Overall Study|Transition to OLE during follow-up|33|||
127585587|NCT03345914|459112013|FG002|Overall Study|Transition to OLE during follow-up|39|||
127585588|NCT03345914|459112011|FG000|Overall Study|Physician Decision|0|||
127585589|NCT03345914|459112012|FG001|Overall Study|Physician Decision|1|||
127585590|NCT03345914|459112013|FG002|Overall Study|Physician Decision|1|||
127585591|NCT03345914|459112011|FG000|Overall Study|Withdrawal by Subject|5|||
127585592|NCT03345914|459112012|FG001|Overall Study|Withdrawal by Subject|1|||
127585593|NCT03345914|459112013|FG002|Overall Study|Withdrawal by Subject|2|||
127585594|NCT03345914|459112011|FG000|Overall Study|Other|1|||
127585595|NCT03345914|459112012|FG001|Overall Study|Other|1|||
127585596|NCT03345914|459112013|FG002|Overall Study|Other|1|||
127585597|NCT03345914|459112011|FG000|Overall Study|Ongoing|0|||
127585598|NCT03345914|459112012|FG001|Overall Study|Ongoing|0|||
127585599|NCT03345914|459112013|FG002|Overall Study|Ongoing|1|||
127585600|NCT01952145|459112018|FG000|Overall Study|Protocol Violation|2|||
127585601|NCT01952145|459112019|FG001|Overall Study|Protocol Violation|1|||
127585602|NCT01952145|459112018|FG000|Overall Study|Death|0|||
127585603|NCT01952145|459112019|FG001|Overall Study|Death|1|||
127585604|NCT01952145|459112018|FG000|Overall Study|Adverse Event|9|||
127585605|NCT01952145|459112019|FG001|Overall Study|Adverse Event|0|||
127585606|NCT01952145|459112018|FG000|Overall Study|Withdrawal Criteria|16|||
127585607|NCT01952145|459112019|FG001|Overall Study|Withdrawal Criteria|11|||
127585608|NCT01952145|459112018|FG000|Overall Study|Unclassified|1|||
127585609|NCT01952145|459112019|FG001|Overall Study|Unclassified|1|||
127585610|NCT03758066|459112020|FG000|Overall Study|Lost to Follow-up|14|||
127585611|NCT04138810|459112024|FG000|Overall Study|Withdrawal by Subject|0|||
127585612|NCT04138810|459112025|FG001|Overall Study|Withdrawal by Subject|1|||
127585613|NCT04138810|459112024|FG000|Overall Study|Subject cancelled surgery|1|||
127585614|NCT04138810|459112025|FG001|Overall Study|Subject cancelled surgery|0|||
127585615|NCT00762385|459112028|FG000|First Intervention|Lens Issue|1|||
127585616|NCT00762385|459112029|FG001|First Intervention|Lens Issue|1|||
127585617|NCT00762385|459112028|FG000|First Intervention|Lost to Follow-up|0|||
127585618|NCT00762385|459112029|FG001|First Intervention|Lost to Follow-up|2|||
127585619|NCT00762385|459112028|FG000|First Intervention|Ineligible|1|||
127585620|NCT00762385|459112029|FG001|First Intervention|Ineligible|0|||
127585621|NCT00762385|459112028|FG000|First Intervention|Protocol Violation|0|||
127585622|NCT00762385|459112029|FG001|First Intervention|Protocol Violation|1|||
127585623|NCT00762385|459112028|FG000|Second Intervention|Protocol Violation|3|||
127585624|NCT00762385|459112029|FG001|Second Intervention|Protocol Violation|3|||
127585625|NCT01540838|459112030|FG000|Overall Study|Open nasogastric tube|9|||
127585626|NCT01540838|459112031|FG001|Overall Study|Open nasogastric tube|7|||
127585627|NCT01540838|459112030|FG000|Overall Study|Treatment doses missing|8|||
127585628|NCT01540838|459112031|FG001|Overall Study|Treatment doses missing|12|||
127585629|NCT01540838|459112030|FG000|Overall Study|Additional antibiotic treatment|1|||
127585630|NCT01540838|459112031|FG001|Overall Study|Additional antibiotic treatment|2|||
127585631|NCT01540838|459112030|FG000|Overall Study|Died before treatment initiation|1|||
127585632|NCT01540838|459112031|FG001|Overall Study|Died before treatment initiation|1|||
128032655|NCT03312543|460746240|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
128032656|NCT03312543|460746241|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
127585633|NCT01540838|459112030|FG000|Overall Study|Not BM. Other treatment|3|||
127585634|NCT01540838|459112031|FG001|Overall Study|Not BM. Other treatment|1|||
127585635|NCT03641339|459112034|FG000|Overall Study|Physician Decision|1|||
127585636|NCT03641339|459112035|FG001|Overall Study|Physician Decision|0|||
128032657|NCT03312543|460746240|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
128032658|NCT03312543|460746241|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
128032659|NCT03312543|460746240|FG000|Regression (Week 12 to Week 24)|Death|0|||
128032660|NCT03312543|460746241|FG001|Regression (Week 12 to Week 24)|Death|1|||
127585637|NCT03641339|459112036|FG002|Overall Study|Physician Decision|0|||
127585638|NCT03641339|459112037|FG003|Overall Study|Physician Decision|0|||
127585639|NCT03641339|459112038|FG004|Overall Study|Physician Decision|0|||
127585640|NCT03641339|459112039|FG005|Overall Study|Physician Decision|0|||
127585641|NCT03641339|459112034|FG000|Overall Study|Withdrawal by Subject|0|||
127585642|NCT03641339|459112035|FG001|Overall Study|Withdrawal by Subject|2|||
127585643|NCT03641339|459112036|FG002|Overall Study|Withdrawal by Subject|0|||
127585644|NCT03641339|459112037|FG003|Overall Study|Withdrawal by Subject|2|||
127585645|NCT03641339|459112038|FG004|Overall Study|Withdrawal by Subject|0|||
127585646|NCT03641339|459112039|FG005|Overall Study|Withdrawal by Subject|1|||
127585647|NCT00493025|459112040|FG000|Overall Study|Physician Decision|19|||
127585648|NCT03173313|459112042|FG000|Overall Study|Lost to Follow-up|2|||
127585649|NCT03173313|459112043|FG001|Overall Study|Lost to Follow-up|3|||
127585650|NCT03173313|459112042|FG000|Overall Study|Withdrawal by Subject|0|||
127585651|NCT03173313|459112043|FG001|Overall Study|Withdrawal by Subject|1|||
127585652|NCT03173313|459112042|FG000|Overall Study|Death|5|||
127585653|NCT03173313|459112043|FG001|Overall Study|Death|0|||
127585654|NCT03173313|459112042|FG000|Overall Study|Physician Decision|1|||
127585655|NCT03173313|459112043|FG001|Overall Study|Physician Decision|0|||
127585656|NCT03173313|459112042|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
127585657|NCT03173313|459112043|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
127585658|NCT03173313|459112042|FG000|Overall Study|Bone Fracture|1|||
127585659|NCT03173313|459112043|FG001|Overall Study|Bone Fracture|0|||
127585660|NCT01876420|459112044|FG000|Overall Study|Missed 30 day visit|1|||
127585661|NCT03863197|459112045|FG000|Overall Study|Lost to Follow-up|2|||
127585662|NCT03863197|459112046|FG001|Overall Study|Lost to Follow-up|3|||
127585663|NCT03863197|459112045|FG000|Overall Study|Withdrawal by Subject|4|||
127585664|NCT03863197|459112046|FG001|Overall Study|Withdrawal by Subject|0|||
127585665|NCT03863197|459112045|FG000|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|2|||
127585666|NCT03863197|459112046|FG001|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|0|||
127585667|NCT05338216|459112047|FG000|Overall Study|Withdrawal by Subject|1|||
127585668|NCT05338216|459112048|FG001|Overall Study|Withdrawal by Subject|1|||
127585669|NCT01065597|459112052|FG000|Overall Study|Adverse Event|1|||
127585670|NCT00446251|459112053|FG000|Overall Study|On-study Transplants|2|||
127585671|NCT00446251|459112053|FG000|Overall Study|Rituximab Infusion Reaction|2|||
127585672|NCT00446251|459112053|FG000|Overall Study|Lost to Follow-up|1|||
127585673|NCT01042678|459112054|FG000|Overall Study|Physician Decision|1|||
128032661|NCT03034044|460746242|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
127585674|NCT01042678|459112055|FG001|Overall Study|Physician Decision|0|||
127585675|NCT01042678|459112056|FG002|Overall Study|Physician Decision|0|||
127585676|NCT01042678|459112057|FG003|Overall Study|Physician Decision|0|||
127585677|NCT01042678|459112058|FG004|Overall Study|Physician Decision|0|||
128032662|NCT05535972|460746243|FG000|Overall Study|Withdrawal by Subject|31|||
128032663|NCT05535972|460746243|FG000|Overall Study|Lost to Follow-up|5|||
127585678|NCT01042678|459112059|FG005|Overall Study|Physician Decision|0|||
127585679|NCT00788073|459112065|FG000|STX209 Then Placebo|Adverse Event|1|||
127585680|NCT00788073|459112066|FG001|STX209 Then Placebo|Adverse Event|0|||
127585681|NCT00788073|459112065|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
127585682|NCT00788073|459112066|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
127585683|NCT00788073|459112065|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
127585684|NCT00788073|459112066|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
127585685|NCT00788073|459112065|FG000|STX209 Then Placebo|unable to return due to travel|0|||
127585686|NCT00788073|459112066|FG001|STX209 Then Placebo|unable to return due to travel|1|||
127585687|NCT00788073|459112065|FG000|Placebo Then STX209|Adverse Event|2|||
127585688|NCT00788073|459112066|FG001|Placebo Then STX209|Adverse Event|0|||
127585689|NCT00788073|459112065|FG000|Placebo Then STX209|Protocol Violation|0|||
127585690|NCT00788073|459112066|FG001|Placebo Then STX209|Protocol Violation|1|||
127585691|NCT05213481|459112068|FG000|Overall Study|Adverse Event|3|||
127784226|NCT04033445|459835696|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
127784227|NCT04033445|459835697|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
127784228|NCT04033445|459835698|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
128032664|NCT05535972|460746243|FG000|Overall Study|Adverse Event|6|||
127585692|NCT05213481|459112068|FG000|Overall Study|Lost to Follow-up|1|||
127585693|NCT00415168|459112069|FG000|Overall Study|Death|26|||
127585694|NCT00415168|459112069|FG000|Overall Study|Lost to Follow-up|3|||
127585695|NCT00415168|459112069|FG000|Overall Study|Physician Decision|13|||
127585696|NCT00415168|459112069|FG000|Overall Study|Sponsor Decision|4|||
127585697|NCT00415168|459112069|FG000|Overall Study|Withdrawal by Subject|6|||
127585698|NCT02925117|459112074|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
127585699|NCT02925117|459112075|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
127585700|NCT02925117|459112076|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
128032665|NCT05535972|460746243|FG000|Overall Study|Protocol Deviation|2|||
128032666|NCT02402647|460746246|FG000|Overall Study|Lost to Follow-up|13|||
127585701|NCT02925117|459112077|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
127585702|NCT02925117|459112078|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
127585703|NCT02925117|459112079|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
127585704|NCT02925117|459112080|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
127585705|NCT02925117|459112081|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
127585706|NCT02925117|459112082|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
127585707|NCT02925117|459112083|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
127585708|NCT02925117|459112084|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
127585709|NCT02925117|459112085|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
127585710|NCT02925117|459112074|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
127585711|NCT02925117|459112075|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
127585712|NCT02925117|459112076|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
127585713|NCT02925117|459112077|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
127585714|NCT02925117|459112078|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
127585715|NCT02925117|459112079|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
127585716|NCT02925117|459112080|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
127585717|NCT02925117|459112081|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
127585718|NCT02925117|459112082|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
127585719|NCT02925117|459112083|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
127585720|NCT02925117|459112084|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
127585721|NCT02925117|459112085|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
127585722|NCT02925117|459112074|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
127585723|NCT02925117|459112075|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
127585724|NCT02925117|459112076|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
127585725|NCT02925117|459112077|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
127585726|NCT02925117|459112078|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
127585727|NCT02925117|459112079|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
127585728|NCT02925117|459112080|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
127585729|NCT02925117|459112081|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
127585730|NCT02925117|459112082|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
127585731|NCT02925117|459112083|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
127585732|NCT02925117|459112084|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
127585733|NCT02925117|459112085|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
127585734|NCT02925117|459112074|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
127585735|NCT02925117|459112075|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
127585736|NCT02925117|459112076|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
127585737|NCT02925117|459112077|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
127585738|NCT02925117|459112078|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
127585739|NCT02925117|459112079|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
127585740|NCT02925117|459112080|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
127585741|NCT02925117|459112081|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
127585742|NCT02925117|459112082|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
127585743|NCT02925117|459112083|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
127585744|NCT02925117|459112084|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
127585745|NCT02925117|459112085|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
127585746|NCT02925117|459112074|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
127585747|NCT02925117|459112075|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
127585748|NCT02925117|459112076|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
127585749|NCT02925117|459112077|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
127585750|NCT02925117|459112078|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
127585751|NCT02925117|459112079|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
127585752|NCT02925117|459112080|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
127585753|NCT02925117|459112081|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
127585754|NCT02925117|459112082|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
127585755|NCT02925117|459112083|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
127585756|NCT02925117|459112084|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
127585757|NCT02925117|459112085|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
127585758|NCT02925117|459112074|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
127585759|NCT02925117|459112075|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
127585760|NCT02925117|459112076|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
127585761|NCT02925117|459112077|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
127585762|NCT02925117|459112078|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
127694108|NCT03692676|459508646|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
127694109|NCT03692676|459508647|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
128032667|NCT02402647|460746247|FG001|Overall Study|Lost to Follow-up|7|||
128032668|NCT02402647|460746246|FG000|Overall Study|Protocol Violation|1|||
127585763|NCT02925117|459112079|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
127585764|NCT02925117|459112080|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
127585765|NCT02925117|459112081|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
127585766|NCT02925117|459112082|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
127585767|NCT02925117|459112083|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
127585768|NCT02925117|459112084|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
127585769|NCT02925117|459112085|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
127585770|NCT02925117|459112074|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
127585771|NCT02925117|459112075|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
127585772|NCT02925117|459112076|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
127585773|NCT02925117|459112077|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
127585774|NCT02925117|459112078|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
127585775|NCT02925117|459112079|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
127585776|NCT02925117|459112080|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
127585777|NCT02925117|459112081|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
127585778|NCT02925117|459112082|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
127585779|NCT02925117|459112083|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
127585780|NCT02925117|459112084|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
127585781|NCT02925117|459112085|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
127585782|NCT02925117|459112074|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
127585783|NCT02925117|459112075|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
127585784|NCT02925117|459112076|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
127585785|NCT02925117|459112077|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
127585786|NCT02925117|459112078|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
127585787|NCT02925117|459112079|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
127585788|NCT02925117|459112080|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
127585789|NCT02925117|459112081|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
127585790|NCT02925117|459112082|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
127585791|NCT02925117|459112083|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
127585792|NCT02925117|459112084|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
127585793|NCT02925117|459112085|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
127585794|NCT02059408|459112090|FG000|Overall Study|Did not get tested|0|||
127585795|NCT02059408|459112091|FG001|Overall Study|Did not get tested|330|||
127585796|NCT02059408|459112092|FG002|Overall Study|Did not get tested|358|||
127585797|NCT01681472|459112094|FG000|Overall Study|Adverse Event|0|||
127585798|NCT01681472|459112095|FG001|Overall Study|Adverse Event|1|||
127585799|NCT01681472|459112096|FG002|Overall Study|Adverse Event|0|||
127585800|NCT01681472|459112097|FG003|Overall Study|Adverse Event|0|||
127585801|NCT03128047|459112107|FG000|Overall Study|Withdrawal by Subject|1|||
127585802|NCT04805541|459114013|FG000|Overall Study|Unable to be retinally photographed with good quality.|35|||
127585803|NCT00129272|459114024|FG000|Overall Study|Lost to Follow-up|12|||
127585804|NCT00129272|459114025|FG001|Overall Study|Lost to Follow-up|11|||
127585805|NCT00129272|459114024|FG000|Overall Study|Withdrawal by Subject|5|||
127585806|NCT00129272|459114025|FG001|Overall Study|Withdrawal by Subject|11|||
127585807|NCT01786668|459114026|FG000|Overall Study|Adverse Event|0|||
127585808|NCT01786668|459114027|FG001|Overall Study|Adverse Event|1|||
127585809|NCT01786668|459114028|FG002|Overall Study|Adverse Event|1|||
127585810|NCT01786668|459114029|FG003|Overall Study|Adverse Event|2|||
127585811|NCT01786668|459114026|FG000|Overall Study|Withdrawal by Subject|0|||
127585812|NCT01786668|459114027|FG001|Overall Study|Withdrawal by Subject|0|||
128032669|NCT02402647|460746247|FG001|Overall Study|Protocol Violation|1|||
127585813|NCT01786668|459114028|FG002|Overall Study|Withdrawal by Subject|3|||
127585814|NCT01786668|459114029|FG003|Overall Study|Withdrawal by Subject|1|||
127585815|NCT01786668|459114026|FG000|Overall Study|Pregnancy|0|||
127585816|NCT01786668|459114027|FG001|Overall Study|Pregnancy|0|||
127585817|NCT01786668|459114028|FG002|Overall Study|Pregnancy|0|||
127585818|NCT01786668|459114029|FG003|Overall Study|Pregnancy|1|||
127585819|NCT01786668|459114026|FG000|Overall Study|Lost to Follow-up|1|||
127585820|NCT01786668|459114027|FG001|Overall Study|Lost to Follow-up|0|||
127585821|NCT01786668|459114028|FG002|Overall Study|Lost to Follow-up|1|||
127585822|NCT01786668|459114029|FG003|Overall Study|Lost to Follow-up|0|||
127585823|NCT03570697|459114030|FG000|Overall Study|Lost to Follow-up|0|||
127585824|NCT03570697|459114031|FG001|Overall Study|Lost to Follow-up|1|||
127585825|NCT03570697|459114030|FG000|Overall Study|Death|2|||
127585826|NCT03570697|459114031|FG001|Overall Study|Death|0|||
127585827|NCT03570697|459114030|FG000|Overall Study|Withdrawal by Subject|4|||
127585828|NCT03570697|459114031|FG001|Overall Study|Withdrawal by Subject|2|||
127585829|NCT01849783|459114032|FG000|Overall Study|Adverse Event|5|||
127585830|NCT01849783|459114032|FG000|Overall Study|Death|2|||
127585831|NCT01849783|459114032|FG000|Overall Study|Physician Decision|1|||
127585832|NCT01849783|459114032|FG000|Overall Study|Withdrawal by Subject|1|||
128032670|NCT02402647|460746246|FG000|Overall Study|scheduled and timed out|2|||
128032671|NCT02402647|460746247|FG001|Overall Study|scheduled and timed out|1|||
128032672|NCT02402647|460746246|FG000|Overall Study|medical illness|2|||
128032673|NCT02402647|460746247|FG001|Overall Study|medical illness|4|||
127585833|NCT01849783|459114032|FG000|Overall Study|Unable to comply|2|||
127585834|NCT01849783|459114032|FG000|Overall Study|Disease progression|11|||
127585835|NCT01776840|459114033|FG000|Overall Study|Lost to Follow-up|12|||
127585836|NCT01776840|459114034|FG001|Overall Study|Lost to Follow-up|7|||
127585837|NCT01776840|459114033|FG000|Overall Study|Withdrawal by Subject|32|||
127585838|NCT01776840|459114034|FG001|Overall Study|Withdrawal by Subject|48|||
127585839|NCT01776840|459114033|FG000|Overall Study|Sponsor decision|89|||
127585840|NCT01776840|459114034|FG001|Overall Study|Sponsor decision|87|||
127585841|NCT03948581|459114036|FG000|Overall Study|Lost to Follow-up|0|||
127585842|NCT03948581|459114037|FG001|Overall Study|Lost to Follow-up|1|||
128032674|NCT02402647|460746246|FG000|Overall Study|Moved|2|||
128032675|NCT02402647|460746247|FG001|Overall Study|Moved|0|||
127585843|NCT03068455|459114038|FG000|Pre-treatment Period|Disease progression|0|||
127585844|NCT03068455|459114039|FG001|Pre-treatment Period|Disease progression|1|||
127585845|NCT03068455|459114038|FG000|Pre-treatment Period|Participant withdrew consent|1|||
127585846|NCT03068455|459114039|FG001|Pre-treatment Period|Participant withdrew consent|1|||
127585847|NCT03068455|459114038|FG000|Pre-treatment Period|Poor/non-compliance|0|||
127585848|NCT03068455|459114039|FG001|Pre-treatment Period|Poor/non-compliance|1|||
127585849|NCT03068455|459114038|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
127585850|NCT03068455|459114039|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
127585851|NCT03068455|459114038|FG000|Pre-treatment Period|Not reported|2|||
127585852|NCT03068455|459114039|FG001|Pre-treatment Period|Not reported|1|||
127585853|NCT03068455|459114038|FG000|Treatment Period|Disease progression|166|||
127585854|NCT03068455|459114039|FG001|Treatment Period|Disease progression|208|||
127585855|NCT03068455|459114038|FG000|Treatment Period|Study drug toxicity|317|||
127585856|NCT03068455|459114039|FG001|Treatment Period|Study drug toxicity|104|||
127585857|NCT03068455|459114038|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
127585858|NCT03068455|459114039|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
127585859|NCT03068455|459114038|FG000|Treatment Period|Participant request to stop therapy|33|||
127585860|NCT03068455|459114039|FG001|Treatment Period|Participant request to stop therapy|20|||
127585861|NCT03068455|459114038|FG000|Treatment Period|Participant withdrew consent|5|||
127585862|NCT03068455|459114039|FG001|Treatment Period|Participant withdrew consent|10|||
127585863|NCT03068455|459114038|FG000|Treatment Period|Poor/non-compliance|3|||
127585864|NCT03068455|459114039|FG001|Treatment Period|Poor/non-compliance|0|||
127585865|NCT03068455|459114038|FG000|Treatment Period|Participant no longer meets study criteria|1|||
127585866|NCT03068455|459114039|FG001|Treatment Period|Participant no longer meets study criteria|3|||
127585867|NCT03068455|459114038|FG000|Treatment Period|Other reasons|12|||
127585868|NCT03068455|459114039|FG001|Treatment Period|Other reasons|4|||
127585869|NCT04515394|459114040|FG000|Overall Study|Participant did not receive treatment|1|||
127585870|NCT01058655|459114041|FG000|Overall Study|Withdrawal by Subject|1|||
127585871|NCT01058655|459114042|FG001|Overall Study|Withdrawal by Subject|0|||
127585872|NCT01058655|459114043|FG002|Overall Study|Withdrawal by Subject|3|||
127585873|NCT01058655|459114044|FG003|Overall Study|Withdrawal by Subject|4|||
127585874|NCT01058655|459114041|FG000|Overall Study|Prolonged Treatment Delay|0|||
127585875|NCT01058655|459114042|FG001|Overall Study|Prolonged Treatment Delay|0|||
127585876|NCT01058655|459114043|FG002|Overall Study|Prolonged Treatment Delay|0|||
127585877|NCT01058655|459114044|FG003|Overall Study|Prolonged Treatment Delay|2|||
127585878|NCT01058655|459114041|FG000|Overall Study|Symptomatic Deterioration|0|||
127585879|NCT01058655|459114042|FG001|Overall Study|Symptomatic Deterioration|0|||
127585880|NCT01058655|459114043|FG002|Overall Study|Symptomatic Deterioration|0|||
127585881|NCT01058655|459114044|FG003|Overall Study|Symptomatic Deterioration|1|||
127585882|NCT01058655|459114041|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
127585883|NCT01058655|459114042|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
127585884|NCT01058655|459114043|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
127585885|NCT01058655|459114044|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
127585886|NCT01058655|459114041|FG000|Overall Study|Death|0|||
127585887|NCT01058655|459114042|FG001|Overall Study|Death|1|||
127585888|NCT01058655|459114043|FG002|Overall Study|Death|1|||
127585889|NCT01058655|459114044|FG003|Overall Study|Death|0|||
127585890|NCT01058655|459114041|FG000|Overall Study|Disease Progression|1|||
127585891|NCT01058655|459114042|FG001|Overall Study|Disease Progression|2|||
127585892|NCT01058655|459114043|FG002|Overall Study|Disease Progression|4|||
127585893|NCT01058655|459114044|FG003|Overall Study|Disease Progression|24|||
127585894|NCT01058655|459114041|FG000|Overall Study|Other|0|||
127585895|NCT01058655|459114042|FG001|Overall Study|Other|0|||
127585896|NCT01058655|459114043|FG002|Overall Study|Other|0|||
127585897|NCT01058655|459114044|FG003|Overall Study|Other|4|||
127585898|NCT04472429|459114048|FG000|Randomized Period|Ongoing|90|||
127585899|NCT04472429|459114049|FG001|Randomized Period|Ongoing|40|||
127585900|NCT04472429|459114050|FG002|Randomized Period|Ongoing|0|||
127585901|NCT04472429|459114048|FG000|Randomized Period|Death|52|||
127585902|NCT04472429|459114049|FG001|Randomized Period|Death|37|||
127585903|NCT04472429|459114050|FG002|Randomized Period|Death|0|||
127585904|NCT04472429|459114048|FG000|Randomized Period|Lost to Follow-up|4|||
127585905|NCT04472429|459114049|FG001|Randomized Period|Lost to Follow-up|0|||
127585906|NCT04472429|459114050|FG002|Randomized Period|Lost to Follow-up|0|||
127585907|NCT04472429|459114048|FG000|Randomized Period|Physician Decision|1|||
127585908|NCT04472429|459114049|FG001|Randomized Period|Physician Decision|2|||
127585909|NCT04472429|459114050|FG002|Randomized Period|Physician Decision|0|||
127585910|NCT04472429|459114048|FG000|Randomized Period|Withdrawal by Subject|6|||
127585911|NCT04472429|459114049|FG001|Randomized Period|Withdrawal by Subject|5|||
127694110|NCT03692676|459508644|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
128032676|NCT02402647|460746246|FG000|Overall Study|loved one illness|1|||
127585912|NCT04472429|459114050|FG002|Randomized Period|Withdrawal by Subject|0|||
127585913|NCT04472429|459114048|FG000|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
127585914|NCT04472429|459114049|FG001|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|1|||
127705213|NCT01928394|459551570|FG003|Treatment Period|Death|0|||
127585915|NCT04472429|459114050|FG002|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
127585916|NCT04472429|459114048|FG000|Randomized Period|New Diagnosis of Lymphoma|1|||
127585917|NCT04472429|459114049|FG001|Randomized Period|New Diagnosis of Lymphoma|0|||
127585918|NCT04472429|459114050|FG002|Randomized Period|New Diagnosis of Lymphoma|0|||
127585919|NCT04472429|459114048|FG000|Open-label Monotherapy Period|Ongoing|0|||
127585920|NCT04472429|459114049|FG001|Open-label Monotherapy Period|Ongoing|0|||
127585921|NCT04472429|459114050|FG002|Open-label Monotherapy Period|Ongoing|32|||
127585922|NCT04472429|459114048|FG000|Open-label Monotherapy Period|Death|0|||
127585923|NCT04472429|459114049|FG001|Open-label Monotherapy Period|Death|0|||
127585924|NCT04472429|459114050|FG002|Open-label Monotherapy Period|Death|35|||
127585925|NCT04472429|459114048|FG000|Open-label Monotherapy Period|Lost to Follow-up|0|||
127585926|NCT04472429|459114049|FG001|Open-label Monotherapy Period|Lost to Follow-up|0|||
127585927|NCT04472429|459114050|FG002|Open-label Monotherapy Period|Lost to Follow-up|2|||
127585928|NCT01313312|459114053|FG000|Overall Study|Adverse Event|5|||
127585929|NCT01313312|459114053|FG000|Overall Study|Withdrawal by Subject|18|||
127585930|NCT01313312|459114053|FG000|Overall Study|Lack of Efficacy|3|||
127585931|NCT01313312|459114053|FG000|Overall Study|Investigator Decision|1|||
127585932|NCT01313312|459114053|FG000|Overall Study|Observational Phase|1|||
127585933|NCT01313312|459114053|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
127585934|NCT01313312|459114053|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
127585935|NCT00892047|459114054|FG000|Overall Study|Adverse Event|2|||
127585936|NCT00892047|459114055|FG001|Overall Study|Adverse Event|2|||
127585937|NCT00892047|459114054|FG000|Overall Study|subject burden|2|||
127585938|NCT00892047|459114055|FG001|Overall Study|subject burden|3|||
127585939|NCT00892047|459114054|FG000|Overall Study|Lack of Efficacy|0|||
127585940|NCT00892047|459114055|FG001|Overall Study|Lack of Efficacy|2|||
127585941|NCT05306977|459114056|FG000|Overall Study|Withdrawal by Subject|1|||
127585942|NCT01387789|459114062|FG000|Overall Study|Adverse Event|5|||
127585943|NCT01387789|459114062|FG000|Overall Study|Lack of Efficacy|2|||
127585944|NCT01387789|459114062|FG000|Overall Study|Lost to Follow-up|1|||
127585945|NCT00181155|459114063|FG000|Overall Study|Physician Decision|1|||
127585946|NCT00181155|459114064|FG001|Overall Study|Physician Decision|0|||
127585947|NCT00181155|459114063|FG000|Overall Study|Withdrawal by Subject|1|||
127585948|NCT00181155|459114064|FG001|Overall Study|Withdrawal by Subject|0|||
127585949|NCT01788228|459114065|FG000|Overall Study|Migrated/moved from study area|1|||
127585950|NCT01788228|459114066|FG001|Overall Study|Migrated/moved from study area|0|||
127585951|NCT01548287|459114072|FG000|Screening|No reason provided|0|||
127585952|NCT01548287|459114073|FG001|Screening|No reason provided|0|||
127585953|NCT01548287|459114074|FG002|Screening|No reason provided|0|||
127585954|NCT01548287|459114075|FG003|Screening|No reason provided|0|||
127585955|NCT01548287|459114076|FG004|Screening|No reason provided|9|||
127585956|NCT01548287|459114072|FG000|Screening|Did not meet eligibility criteria|0|||
127585957|NCT01548287|459114073|FG001|Screening|Did not meet eligibility criteria|0|||
127585958|NCT01548287|459114074|FG002|Screening|Did not meet eligibility criteria|0|||
127585959|NCT01548287|459114075|FG003|Screening|Did not meet eligibility criteria|0|||
127585960|NCT01548287|459114076|FG004|Screening|Did not meet eligibility criteria|74|||
127585961|NCT01548287|459114072|FG000|Randomized Period|Did not meet inclusion criteria|0|||
127585962|NCT01548287|459114073|FG001|Randomized Period|Did not meet inclusion criteria|0|||
127585963|NCT01548287|459114074|FG002|Randomized Period|Did not meet inclusion criteria|2|||
127585964|NCT01548287|459114075|FG003|Randomized Period|Did not meet inclusion criteria|0|||
127585965|NCT01548287|459114076|FG004|Randomized Period|Did not meet inclusion criteria|0|||
127585966|NCT01548287|459114072|FG000|Randomized Period|Adverse Event|0|||
127585967|NCT01548287|459114073|FG001|Randomized Period|Adverse Event|2|||
127585968|NCT01548287|459114074|FG002|Randomized Period|Adverse Event|5|||
127585969|NCT01548287|459114075|FG003|Randomized Period|Adverse Event|0|||
127585970|NCT01548287|459114076|FG004|Randomized Period|Adverse Event|0|||
127585971|NCT02993757|459114077|FG000|Overall Study|Non compliance with the protocol|155|||
127585972|NCT02993757|459114078|FG001|Overall Study|Non compliance with the protocol|170|||
127585973|NCT02993757|459114077|FG000|Overall Study|Lost to Follow-up|1|||
127585974|NCT02993757|459114078|FG001|Overall Study|Lost to Follow-up|0|||
127585975|NCT02993757|459114077|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
127585976|NCT02993757|459114078|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
127585977|NCT02762578|459114079|FG000|Overall Study|Adverse Event|1|||
127585978|NCT02762578|459114080|FG001|Overall Study|Adverse Event|6|||
127585979|NCT02762578|459114079|FG000|Overall Study|Protocol Violation|4|||
127585980|NCT02762578|459114080|FG001|Overall Study|Protocol Violation|2|||
127585981|NCT02762578|459114079|FG000|Overall Study|Withdrawal by Subject|4|||
127585982|NCT02762578|459114080|FG001|Overall Study|Withdrawal by Subject|2|||
127585983|NCT02762578|459114079|FG000|Overall Study|Unclassified|6|||
127585984|NCT02762578|459114080|FG001|Overall Study|Unclassified|0|||
127585985|NCT00259610|459114083|FG000|Overall Study|Withdrawal by Subject|33|||
127585986|NCT00259610|459114084|FG001|Overall Study|Withdrawal by Subject|25|||
127585987|NCT00259610|459114085|FG002|Overall Study|Withdrawal by Subject|29|||
127585988|NCT00259610|459114086|FG003|Overall Study|Withdrawal by Subject|19|||
127585989|NCT00259610|459114083|FG000|Overall Study|Lost to Follow-up|19|||
127585990|NCT00259610|459114084|FG001|Overall Study|Lost to Follow-up|8|||
127585991|NCT00259610|459114085|FG002|Overall Study|Lost to Follow-up|18|||
127585992|NCT00259610|459114086|FG003|Overall Study|Lost to Follow-up|15|||
127585993|NCT00259610|459114083|FG000|Overall Study|Physician Decision|6|||
127585994|NCT00259610|459114084|FG001|Overall Study|Physician Decision|4|||
127585995|NCT00259610|459114085|FG002|Overall Study|Physician Decision|7|||
127585996|NCT00259610|459114086|FG003|Overall Study|Physician Decision|2|||
127585997|NCT00259610|459114083|FG000|Overall Study|Death|1|||
127585998|NCT00259610|459114084|FG001|Overall Study|Death|1|||
127585999|NCT00259610|459114085|FG002|Overall Study|Death|2|||
127586000|NCT00259610|459114086|FG003|Overall Study|Death|0|||
127586001|NCT00259610|459114083|FG000|Overall Study|non medical reason|6|||
127586002|NCT00259610|459114084|FG001|Overall Study|non medical reason|2|||
127586003|NCT00259610|459114085|FG002|Overall Study|non medical reason|10|||
127586004|NCT00259610|459114086|FG003|Overall Study|non medical reason|3|||
127586005|NCT00259610|459114083|FG000|Overall Study|Adverse Event|3|||
127586006|NCT00259610|459114084|FG001|Overall Study|Adverse Event|4|||
127586007|NCT00259610|459114085|FG002|Overall Study|Adverse Event|5|||
127586008|NCT00259610|459114086|FG003|Overall Study|Adverse Event|2|||
127586009|NCT00259610|459114083|FG000|Overall Study|Serious Adverse Event|8|||
127586010|NCT00259610|459114084|FG001|Overall Study|Serious Adverse Event|2|||
127586011|NCT00259610|459114085|FG002|Overall Study|Serious Adverse Event|2|||
127586012|NCT00259610|459114086|FG003|Overall Study|Serious Adverse Event|2|||
127586013|NCT00957580|459114089|FG000|Overall Study|Ongoing at data cut-off|0|||
127586014|NCT00957580|459114090|FG001|Overall Study|Ongoing at data cut-off|1|||
127586015|NCT00957580|459114091|FG002|Overall Study|Ongoing at data cut-off|0|||
127586016|NCT00957580|459114089|FG000|Overall Study|Enrolled but not treated|0|||
127586017|NCT00957580|459114090|FG001|Overall Study|Enrolled but not treated|1|||
127586018|NCT00957580|459114091|FG002|Overall Study|Enrolled but not treated|0|||
127586019|NCT01090492|459114092|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
127586020|NCT01090492|459114093|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
127586021|NCT01090492|459114094|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
127586022|NCT01090492|459114095|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
127586023|NCT01090492|459114096|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
127586024|NCT01090492|459114097|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
127586025|NCT01090492|459114098|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
127586026|NCT01090492|459114099|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
127586027|NCT01090492|459114092|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
127586028|NCT01090492|459114093|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
127586029|NCT01090492|459114094|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
127586030|NCT01090492|459114095|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
127586031|NCT01090492|459114096|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
127586032|NCT01090492|459114097|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
127586033|NCT01090492|459114098|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
127586034|NCT01090492|459114099|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
127586035|NCT01090492|459114092|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
127586036|NCT01090492|459114093|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
127586037|NCT01090492|459114094|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
127586038|NCT01090492|459114095|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
127586039|NCT01090492|459114096|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
127586040|NCT01090492|459114097|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
127586041|NCT01090492|459114098|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
127586042|NCT01090492|459114099|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
127586043|NCT01090492|459114092|FG000|First Intervention Period (4 Weeks)|Other|0|||
127586044|NCT01090492|459114093|FG001|First Intervention Period (4 Weeks)|Other|0|||
127586045|NCT01090492|459114094|FG002|First Intervention Period (4 Weeks)|Other|1|||
127586046|NCT01090492|459114095|FG003|First Intervention Period (4 Weeks)|Other|1|||
127586047|NCT01090492|459114096|FG004|First Intervention Period (4 Weeks)|Other|2|||
127586048|NCT01090492|459114097|FG005|First Intervention Period (4 Weeks)|Other|0|||
127586049|NCT01090492|459114098|FG006|First Intervention Period (4 Weeks)|Other|0|||
127586050|NCT01090492|459114099|FG007|First Intervention Period (4 Weeks)|Other|0|||
127586051|NCT01090492|459114092|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
127586052|NCT01090492|459114093|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
127586053|NCT01090492|459114094|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
127586054|NCT01090492|459114095|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
127586055|NCT01090492|459114096|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
127586056|NCT01090492|459114097|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
127586057|NCT01090492|459114098|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
127586058|NCT01090492|459114099|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
127586059|NCT01090492|459114092|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
127694111|NCT03692676|459508645|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
127586060|NCT01090492|459114093|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
127586061|NCT01090492|459114094|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
127586062|NCT01090492|459114095|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
127586063|NCT01090492|459114096|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
127586064|NCT01090492|459114097|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
127586065|NCT01090492|459114098|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
127586066|NCT01090492|459114099|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
127586067|NCT01090492|459114092|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
127586068|NCT01090492|459114093|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
127586069|NCT01090492|459114094|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
127586070|NCT01090492|459114095|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
127586071|NCT01090492|459114096|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
127586072|NCT01090492|459114097|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
127586073|NCT01090492|459114098|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
127586074|NCT01090492|459114099|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
127586075|NCT01090492|459114092|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
127586076|NCT01090492|459114093|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
127586077|NCT01090492|459114094|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
127586078|NCT01090492|459114095|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
127586079|NCT01090492|459114096|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
127586080|NCT01090492|459114097|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
127586081|NCT01090492|459114098|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
127586082|NCT01090492|459114099|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
127586083|NCT01090492|459114092|FG000|Second Intervention Period (4 Weeks)|Other|0|||
127586084|NCT01090492|459114093|FG001|Second Intervention Period (4 Weeks)|Other|1|||
127586085|NCT01090492|459114094|FG002|Second Intervention Period (4 Weeks)|Other|1|||
127586086|NCT01090492|459114095|FG003|Second Intervention Period (4 Weeks)|Other|0|||
127586087|NCT01090492|459114096|FG004|Second Intervention Period (4 Weeks)|Other|0|||
127586088|NCT01090492|459114097|FG005|Second Intervention Period (4 Weeks)|Other|0|||
127586089|NCT01090492|459114098|FG006|Second Intervention Period (4 Weeks)|Other|0|||
127586090|NCT01090492|459114099|FG007|Second Intervention Period (4 Weeks)|Other|0|||
127586091|NCT01090492|459114092|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
127586092|NCT01090492|459114093|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
127586093|NCT01090492|459114094|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
127586094|NCT01090492|459114095|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
127586095|NCT01090492|459114096|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
127586096|NCT01090492|459114097|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
127586097|NCT01090492|459114098|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
127586098|NCT01090492|459114099|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
127586099|NCT01090492|459114092|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
127586100|NCT01090492|459114093|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
127586101|NCT01090492|459114094|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
127586102|NCT01090492|459114095|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
127586103|NCT01090492|459114096|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
127586104|NCT01090492|459114097|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
127586105|NCT01090492|459114098|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
127586106|NCT01090492|459114099|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
127586107|NCT03113071|459114100|FG000|Overall Study|Withdrawal by Subject|1|||
127586108|NCT03113071|459114101|FG001|Overall Study|Withdrawal by Subject|0|||
127586109|NCT01611155|459114102|FG000|Overall Study|Adverse Event|1|||
127586110|NCT01611155|459114103|FG001|Overall Study|Adverse Event|1|||
127586111|NCT01611155|459114102|FG000|Overall Study|Refused further treatment|6|||
127586112|NCT01611155|459114103|FG001|Overall Study|Refused further treatment|4|||
127586113|NCT01611155|459114102|FG000|Overall Study|Disease progression|1|||
127586114|NCT01611155|459114103|FG001|Overall Study|Disease progression|0|||
127586115|NCT01611155|459114102|FG000|Overall Study|Withdrawal by Subject|1|||
127586116|NCT01611155|459114103|FG001|Overall Study|Withdrawal by Subject|0|||
127586117|NCT01611155|459114102|FG000|Overall Study|Alternative treatment|0|||
127586118|NCT01611155|459114103|FG001|Overall Study|Alternative treatment|1|||
127586119|NCT01611155|459114102|FG000|Overall Study|Ineligible patient|0|||
127586120|NCT01611155|459114103|FG001|Overall Study|Ineligible patient|1|||
127586121|NCT01602120|459114104|FG000|Overall Study|Adverse Event|3|||
127586122|NCT01602120|459114105|FG001|Overall Study|Adverse Event|6|||
127586123|NCT01602120|459114106|FG002|Overall Study|Adverse Event|0|||
127586124|NCT01602120|459114107|FG003|Overall Study|Adverse Event|2|||
127586125|NCT01602120|459114104|FG000|Overall Study|Death|0|||
127586126|NCT01602120|459114105|FG001|Overall Study|Death|4|||
127784229|NCT04033445|459835699|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|1|||
127882014|NCT01154673|460190784|FG000|Overall Study|Lost to Follow-up|1|||
127586127|NCT01602120|459114106|FG002|Overall Study|Death|0|||
127586128|NCT01602120|459114107|FG003|Overall Study|Death|0|||
127586129|NCT01602120|459114104|FG000|Overall Study|Lost to Follow-up|0|||
127784230|NCT04033445|459835700|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
127784231|NCT04033445|459835701|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
127784232|NCT04033445|459835702|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
127784233|NCT04033445|459835703|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
127586130|NCT01602120|459114105|FG001|Overall Study|Lost to Follow-up|1|||
127586131|NCT01602120|459114106|FG002|Overall Study|Lost to Follow-up|0|||
127586132|NCT01602120|459114107|FG003|Overall Study|Lost to Follow-up|1|||
127586133|NCT01602120|459114104|FG000|Overall Study|Protocol Violation|1|||
127586134|NCT01602120|459114105|FG001|Overall Study|Protocol Violation|1|||
127586135|NCT01602120|459114106|FG002|Overall Study|Protocol Violation|0|||
127586136|NCT01602120|459114107|FG003|Overall Study|Protocol Violation|0|||
127586137|NCT01602120|459114104|FG000|Overall Study|Non-compliance|0|||
127586138|NCT01602120|459114105|FG001|Overall Study|Non-compliance|3|||
127586139|NCT01602120|459114106|FG002|Overall Study|Non-compliance|0|||
127586140|NCT01602120|459114107|FG003|Overall Study|Non-compliance|1|||
127586141|NCT01602120|459114104|FG000|Overall Study|Withdrawal by Subject|8|||
127586142|NCT01602120|459114105|FG001|Overall Study|Withdrawal by Subject|17|||
127586143|NCT01602120|459114106|FG002|Overall Study|Withdrawal by Subject|0|||
127586144|NCT01602120|459114107|FG003|Overall Study|Withdrawal by Subject|3|||
127586145|NCT01602120|459114104|FG000|Overall Study|Study Terminated by Sponsor|12|||
127784234|NCT04033445|459835704|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
127784235|NCT04033445|459835691|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
127784236|NCT04033445|459835692|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
127784237|NCT04033445|459835693|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
127784238|NCT04033445|459835694|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|1|||
127784239|NCT04033445|459835695|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
127784240|NCT04033445|459835696|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
127784241|NCT04033445|459835697|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
127784242|NCT04033445|459835698|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
127784243|NCT04033445|459835699|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
127784244|NCT04033445|459835700|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
127784245|NCT04033445|459835701|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
127784246|NCT04033445|459835702|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
127784247|NCT04033445|459835703|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
127784248|NCT04033445|459835704|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
127784249|NCT04033445|459835691|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
127882015|NCT01154673|460190785|FG001|Overall Study|Lost to Follow-up|0|||
127586146|NCT01602120|459114105|FG001|Overall Study|Study Terminated by Sponsor|24|||
127586147|NCT01602120|459114106|FG002|Overall Study|Study Terminated by Sponsor|17|||
127586148|NCT01602120|459114107|FG003|Overall Study|Study Terminated by Sponsor|44|||
127586149|NCT01602120|459114104|FG000|Overall Study|Physician Decision|2|||
127586150|NCT01602120|459114105|FG001|Overall Study|Physician Decision|3|||
127586151|NCT01602120|459114106|FG002|Overall Study|Physician Decision|0|||
127586152|NCT01602120|459114107|FG003|Overall Study|Physician Decision|0|||
127586153|NCT01602120|459114104|FG000|Overall Study|Unspecified Reason|3|||
127586154|NCT01602120|459114105|FG001|Overall Study|Unspecified Reason|1|||
127586155|NCT01602120|459114106|FG002|Overall Study|Unspecified Reason|0|||
127586156|NCT01602120|459114107|FG003|Overall Study|Unspecified Reason|2|||
127586157|NCT00868608|459114114|FG000|Overall Study|Withdrawal by Subject|3|||
127586158|NCT00868608|459114115|FG001|Overall Study|Withdrawal by Subject|1|||
127586159|NCT00868608|459114116|FG002|Overall Study|Withdrawal by Subject|0|||
127586160|NCT00868608|459114114|FG000|Overall Study|Lost to Follow-up|3|||
127586161|NCT00868608|459114115|FG001|Overall Study|Lost to Follow-up|0|||
127586162|NCT00868608|459114116|FG002|Overall Study|Lost to Follow-up|1|||
127586163|NCT00868608|459114114|FG000|Overall Study|Death|16|||
127586164|NCT00868608|459114115|FG001|Overall Study|Death|2|||
127586165|NCT00868608|459114116|FG002|Overall Study|Death|4|||
127586166|NCT00868608|459114114|FG000|Overall Study|Other - Unspecified|1|||
128032677|NCT02402647|460746247|FG001|Overall Study|loved one illness|0|||
128032678|NCT02402647|460746246|FG000|Overall Study|deceased preexisting condition|2|||
128032679|NCT02402647|460746247|FG001|Overall Study|deceased preexisting condition|0|||
128032680|NCT02402647|460746246|FG000|Overall Study|Other|2|||
128032681|NCT02402647|460746247|FG001|Overall Study|Other|1|||
127586167|NCT00868608|459114115|FG001|Overall Study|Other - Unspecified|0|||
127586168|NCT00868608|459114116|FG002|Overall Study|Other - Unspecified|0|||
127586169|NCT01999179|459114120|FG000|Overall Study|Adverse Event|1|||
127586170|NCT01999179|459114120|FG000|Overall Study|Lost to Follow-up|1|||
127586171|NCT01999179|459114120|FG000|Overall Study|Change in Therapy|3|||
127586172|NCT01999179|459114120|FG000|Overall Study|New catheter|2|||
127586173|NCT02564796|459114124|FG000|Overall Study|Physician Decision|2|||
127586174|NCT02564796|459114125|FG001|Overall Study|Physician Decision|2|||
127586175|NCT00453063|459114126|FG000|Overall Study|Adverse Event|1|||
127586176|NCT00453063|459114127|FG001|Overall Study|Adverse Event|2|||
128032682|NCT04197583|460746248|FG000|Overall Study|Study Stent Replacement|34|||
127586177|NCT00453063|459114126|FG000|Overall Study|Withdrawal by Subject|1|||
127586178|NCT00453063|459114127|FG001|Overall Study|Withdrawal by Subject|1|||
127586179|NCT00453063|459114126|FG000|Overall Study|Protocol Violation|1|||
127586180|NCT00453063|459114127|FG001|Overall Study|Protocol Violation|0|||
127586181|NCT00289783|459114130|FG000|Primary Phase|Adverse Event|10|||
127586182|NCT00289783|459114131|FG001|Primary Phase|Adverse Event|1|||
127586183|NCT00289783|459114130|FG000|Primary Phase|Protocol Violation|27|||
127586184|NCT00289783|459114131|FG001|Primary Phase|Protocol Violation|6|||
127586185|NCT00289783|459114130|FG000|Primary Phase|Withdrawal by Subject|93|||
127586186|NCT00289783|459114131|FG001|Primary Phase|Withdrawal by Subject|40|||
127586187|NCT00289783|459114130|FG000|Primary Phase|Lost to Follow-up|60|||
127586188|NCT00289783|459114131|FG001|Primary Phase|Lost to Follow-up|14|||
127586189|NCT00289783|459114130|FG000|Primary Phase|Migration from the study area|26|||
127586190|NCT00289783|459114131|FG001|Primary Phase|Migration from the study area|10|||
127586191|NCT00289783|459114130|FG000|Primary Phase|Other|32|||
127586192|NCT00289783|459114131|FG001|Primary Phase|Other|12|||
127586193|NCT00289783|459114130|FG000|Fourth Dose Phase|Adverse Event|1|||
127586194|NCT00289783|459114131|FG001|Fourth Dose Phase|Adverse Event|0|||
127586195|NCT00289783|459114130|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
127586196|NCT00289783|459114131|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
127784250|NCT04033445|459835692|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
127784251|NCT04033445|459835693|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
127784252|NCT04033445|459835694|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
127784253|NCT04033445|459835695|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
127784254|NCT04033445|459835696|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
127784255|NCT04033445|459835697|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
127784256|NCT04033445|459835698|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|3|||
127784257|NCT04033445|459835699|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|2|||
127784258|NCT04033445|459835700|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
127784259|NCT04033445|459835701|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
127784260|NCT04033445|459835702|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
127784261|NCT04033445|459835703|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
127784262|NCT04033445|459835704|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
127784263|NCT04033445|459835691|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
127784264|NCT04033445|459835692|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
127784265|NCT04033445|459835693|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
127784266|NCT04033445|459835694|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
127784267|NCT04033445|459835695|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
127784268|NCT04033445|459835696|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
127784269|NCT04033445|459835697|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
127784270|NCT04033445|459835698|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|1|||
127784271|NCT04033445|459835699|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
127784272|NCT04033445|459835700|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
127784273|NCT04033445|459835701|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
127784274|NCT04033445|459835702|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
127784275|NCT04033445|459835703|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
127784276|NCT04033445|459835704|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
127784277|NCT04033445|459835691|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
127784278|NCT04033445|459835692|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
127784279|NCT04033445|459835693|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
127784280|NCT04033445|459835694|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
127784281|NCT04033445|459835695|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
127784282|NCT04033445|459835696|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
128032683|NCT04197583|460746249|FG001|Overall Study|Study Stent Replacement|8|||
128032684|NCT04197583|460746248|FG000|Overall Study|Lost to Follow-up|14|||
128032685|NCT04197583|460746249|FG001|Overall Study|Lost to Follow-up|3|||
128032686|NCT04197583|460746248|FG000|Overall Study|Death|3|||
127586197|NCT00289783|459114130|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
127586198|NCT00289783|459114131|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
127586199|NCT00289783|459114130|FG000|Fourth Dose Phase|Migration from the study area|1|||
127586200|NCT00289783|459114131|FG001|Fourth Dose Phase|Migration from the study area|1|||
127586201|NCT00289783|459114130|FG000|Fourth Dose Phase|Other|22|||
127586202|NCT00289783|459114131|FG001|Fourth Dose Phase|Other|10|||
127586203|NCT00566995|459114132|FG000|Overall Study|Toxicity|4|||
127586204|NCT00566995|459114132|FG000|Overall Study|Withdrew consent|3|||
127586205|NCT03128411|459114135|FG000|Treatment Phase|Adverse Event|21|||
127586206|NCT03128411|459114135|FG000|Treatment Phase|Physician Decision|1|||
127586207|NCT03128411|459114135|FG000|Treatment Phase|Other|2|||
127586208|NCT03128411|459114135|FG000|Long Term Follow-up Phase|Death|2|||
127586209|NCT00594659|459114143|FG000|Overall Study|Lost to Follow-up|13|||
127586210|NCT00594659|459114144|FG001|Overall Study|Lost to Follow-up|9|||
128032687|NCT04197583|460746249|FG001|Overall Study|Death|0|||
128032688|NCT04197583|460746248|FG000|Overall Study|Physician Decision|1|||
128032689|NCT04197583|460746249|FG001|Overall Study|Physician Decision|0|||
128032690|NCT04197583|460746248|FG000|Overall Study|Withdrawal by Subject|1|||
128032691|NCT04197583|460746249|FG001|Overall Study|Withdrawal by Subject|1|||
128032692|NCT04197583|460746248|FG000|Overall Study|Discontinued. Patient had disseminated metastatic condition|0|||
128032693|NCT04197583|460746249|FG001|Overall Study|Discontinued. Patient had disseminated metastatic condition|1|||
128032694|NCT04197583|460746248|FG000|Overall Study|Screen Failure|0|||
128032695|NCT04197583|460746249|FG001|Overall Study|Screen Failure|20|||
128032696|NCT04134936|460746251|FG000|Overall Study|Adverse Event|3|||
128032697|NCT04134936|460746252|FG001|Overall Study|Adverse Event|2|||
128032698|NCT04134936|460746251|FG000|Overall Study|Withdrawal by Subject|2|||
128032699|NCT04134936|460746252|FG001|Overall Study|Withdrawal by Subject|3|||
128032700|NCT04134936|460746251|FG000|Overall Study|Physician Decision|0|||
128032701|NCT04134936|460746252|FG001|Overall Study|Physician Decision|1|||
128032702|NCT04134936|460746251|FG000|Overall Study|Progressive disease, joined another trial|1|||
128032703|NCT04134936|460746252|FG001|Overall Study|Progressive disease, joined another trial|0|||
128032704|NCT04134936|460746251|FG000|Overall Study|Progressive disease|1|||
128032705|NCT04134936|460746252|FG001|Overall Study|Progressive disease|0|||
128032706|NCT00323622|460746255|FG000|Overall Study|Other|30|||
128032707|NCT00323622|460746256|FG001|Overall Study|Other|91|||
128032708|NCT00323622|460746257|FG002|Overall Study|Other|4|||
128032709|NCT00323622|460746258|FG003|Overall Study|Other|12|||
128032710|NCT00323622|460746259|FG004|Overall Study|Other|32|||
128032711|NCT00323622|460746260|FG005|Overall Study|Other|74|||
128032712|NCT00323622|460746261|FG006|Overall Study|Other|5|||
128032713|NCT00323622|460746262|FG007|Overall Study|Other|13|||
128032714|NCT00323622|460746255|FG000|Overall Study|Death|1|||
128032715|NCT00323622|460746256|FG001|Overall Study|Death|1|||
128032716|NCT00323622|460746257|FG002|Overall Study|Death|0|||
128032717|NCT00323622|460746258|FG003|Overall Study|Death|0|||
128032718|NCT00323622|460746259|FG004|Overall Study|Death|7|||
128032719|NCT00323622|460746260|FG005|Overall Study|Death|0|||
128032720|NCT00323622|460746261|FG006|Overall Study|Death|0|||
128032721|NCT00323622|460746262|FG007|Overall Study|Death|2|||
128032722|NCT02420717|460746263|FG000|Overall Study|Did not receive all study medication|2|||
128032723|NCT02420717|460746264|FG001|Overall Study|Did not receive all study medication|0|||
128032724|NCT02420717|460746265|FG002|Overall Study|Did not receive all study medication|0|||
128032725|NCT04191135|460746282|FG000|Induction Treatment|Not Treated|2|||
128032726|NCT04191135|460746283|FG001|Induction Treatment|Not Treated|0|||
128032727|NCT04191135|460746284|FG002|Induction Treatment|Not Treated|0|||
128032728|NCT04191135|460746282|FG000|Induction Treatment|Ongoing to Blinded Treatment Period|271|||
128032729|NCT04191135|460746283|FG001|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
128032730|NCT04191135|460746284|FG002|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
128032731|NCT04191135|460746282|FG000|Induction Treatment|Adverse Event|25|||
128032732|NCT04191135|460746283|FG001|Induction Treatment|Adverse Event|0|||
127586211|NCT00594659|459114145|FG002|Overall Study|Lost to Follow-up|7|||
127586212|NCT00228384|459114146|FG000|Overall Study|Death|9|||
127586213|NCT00228384|459114147|FG001|Overall Study|Death|3|||
127586214|NCT00228384|459114146|FG000|Overall Study|Lost to Follow-up|6|||
127586215|NCT00228384|459114147|FG001|Overall Study|Lost to Follow-up|10|||
127586216|NCT00228384|459114146|FG000|Overall Study|Surgical Intervention (bypass)|5|||
127586217|NCT00228384|459114147|FG001|Overall Study|Surgical Intervention (bypass)|5|||
127586218|NCT00228384|459114146|FG000|Overall Study|Withdrawal by Subject|9|||
127586219|NCT00228384|459114147|FG001|Overall Study|Withdrawal by Subject|10|||
127586220|NCT00228384|459114146|FG000|Overall Study|Physician Decision|0|||
127586221|NCT00228384|459114147|FG001|Overall Study|Physician Decision|1|||
127586222|NCT01785069|459114153|FG000|Overall Study|Implanted with nonstudy device|1|||
127784283|NCT04033445|459835697|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
127784284|NCT04033445|459835698|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|1|||
127784285|NCT04033445|459835699|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
127784286|NCT04033445|459835700|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
127784287|NCT04033445|459835701|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
128032733|NCT04191135|460746284|FG002|Induction Treatment|Adverse Event|0|||
128032734|NCT04191135|460746282|FG000|Induction Treatment|Clinical Progression|8|||
128032735|NCT04191135|460746283|FG001|Induction Treatment|Clinical Progression|0|||
128032736|NCT04191135|460746284|FG002|Induction Treatment|Clinical Progression|0|||
128032737|NCT04191135|460746282|FG000|Induction Treatment|Excluded Medication|1|||
128032738|NCT04191135|460746283|FG001|Induction Treatment|Excluded Medication|0|||
128032739|NCT04191135|460746284|FG002|Induction Treatment|Excluded Medication|0|||
128032740|NCT04191135|460746282|FG000|Induction Treatment|Failure to Meet Continuation Criteria|2|||
128032741|NCT04191135|460746283|FG001|Induction Treatment|Failure to Meet Continuation Criteria|0|||
128032742|NCT04191135|460746284|FG002|Induction Treatment|Failure to Meet Continuation Criteria|0|||
128032743|NCT04191135|460746282|FG000|Induction Treatment|Failure to Meet Randomization Criteria|2|||
128032744|NCT04191135|460746283|FG001|Induction Treatment|Failure to Meet Randomization Criteria|0|||
127784288|NCT04033445|459835702|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
127784289|NCT04033445|459835703|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
128032745|NCT04191135|460746284|FG002|Induction Treatment|Failure to Meet Randomization Criteria|0|||
127586223|NCT01785069|459114154|FG001|Overall Study|Implanted with nonstudy device|2|||
127586224|NCT01785069|459114155|FG002|Overall Study|Implanted with nonstudy device|1|||
127586225|NCT01785069|459114156|FG003|Overall Study|Implanted with nonstudy device|0|||
127586226|NCT01785069|459114153|FG000|Overall Study|Death|0|||
127586227|NCT01785069|459114154|FG001|Overall Study|Death|0|||
127586228|NCT01785069|459114155|FG002|Overall Study|Death|2|||
127586229|NCT01785069|459114156|FG003|Overall Study|Death|0|||
127586230|NCT01785069|459114153|FG000|Overall Study|Subject choice|2|||
127586231|NCT01785069|459114154|FG001|Overall Study|Subject choice|2|||
127586232|NCT01785069|459114155|FG002|Overall Study|Subject choice|0|||
127586233|NCT01785069|459114156|FG003|Overall Study|Subject choice|1|||
127586234|NCT01785069|459114153|FG000|Overall Study|Lost to Follow-up|1|||
127586235|NCT01785069|459114154|FG001|Overall Study|Lost to Follow-up|2|||
127586236|NCT01785069|459114155|FG002|Overall Study|Lost to Follow-up|4|||
127586237|NCT01785069|459114156|FG003|Overall Study|Lost to Follow-up|1|||
127586238|NCT01785069|459114153|FG000|Overall Study|Reason not Specified|1|||
127586239|NCT01785069|459114154|FG001|Overall Study|Reason not Specified|2|||
127586240|NCT01785069|459114155|FG002|Overall Study|Reason not Specified|1|||
127586241|NCT01785069|459114156|FG003|Overall Study|Reason not Specified|4|||
127586242|NCT01785069|459114153|FG000|Overall Study|Not evaluable|7|||
127586243|NCT01785069|459114154|FG001|Overall Study|Not evaluable|4|||
127586244|NCT01785069|459114155|FG002|Overall Study|Not evaluable|5|||
128032746|NCT04191135|460746282|FG000|Induction Treatment|Physician Decision|2|||
128032747|NCT04191135|460746283|FG001|Induction Treatment|Physician Decision|0|||
128032748|NCT04191135|460746284|FG002|Induction Treatment|Physician Decision|0|||
127586245|NCT01785069|459114156|FG003|Overall Study|Not evaluable|8|||
127586246|NCT00660699|459114158|FG000|Overall Study|Withdrawal by Subject|2|||
127586247|NCT05358444|459114171|FG000|Overall Study|Withdrawal by Subject|0|||
127586248|NCT05358444|459114172|FG001|Overall Study|Withdrawal by Subject|1|||
127586249|NCT05358444|459114171|FG000|Overall Study|Lost to Follow-up|0|||
127586250|NCT05358444|459114172|FG001|Overall Study|Lost to Follow-up|3|||
127586251|NCT02900976|459114175|FG000|Overall Study|Adverse Event|0|||
127586252|NCT02900976|459114176|FG001|Overall Study|Adverse Event|1|||
127586253|NCT02900976|459114175|FG000|Overall Study|Physician Decision|0|||
127586254|NCT02900976|459114176|FG001|Overall Study|Physician Decision|2|||
127586255|NCT02900976|459114175|FG000|Overall Study|Progressive disease|0|||
127586256|NCT02900976|459114176|FG001|Overall Study|Progressive disease|6|||
127586257|NCT04997304|459114177|FG000|Overall Study|Lost to Follow-up|11|||
127586258|NCT04997304|459114177|FG000|Overall Study|Death|1|||
127586259|NCT04997304|459114177|FG000|Overall Study|Withdrawal by Subject|14|||
127586260|NCT01752985|459114178|FG000|Treatment Period|Subject request to discontinue treatment|1|||
127586261|NCT01752985|459114179|FG001|Treatment Period|Subject request to discontinue treatment|0|||
127586262|NCT01752985|459114180|FG002|Treatment Period|Subject request to discontinue treatment|1|||
127586263|NCT01752985|459114178|FG000|Treatment Period|Subject no longer meets study criteria|0|||
128032749|NCT04191135|460746282|FG000|Induction Treatment|Progressive Disease|135|||
128032750|NCT04191135|460746283|FG001|Induction Treatment|Progressive Disease|0|||
128032751|NCT04191135|460746284|FG002|Induction Treatment|Progressive Disease|0|||
128032752|NCT04191135|460746282|FG000|Induction Treatment|Protocol Violation|10|||
128032753|NCT04191135|460746283|FG001|Induction Treatment|Protocol Violation|0|||
128032754|NCT04191135|460746284|FG002|Induction Treatment|Protocol Violation|0|||
128032755|NCT04191135|460746282|FG000|Induction Treatment|Withdrawal by Subject|4|||
128032756|NCT04191135|460746283|FG001|Induction Treatment|Withdrawal by Subject|0|||
128032757|NCT04191135|460746284|FG002|Induction Treatment|Withdrawal by Subject|0|||
128032758|NCT04191135|460746282|FG000|Randomized Treatment|Death|0|||
128032759|NCT04191135|460746283|FG001|Randomized Treatment|Death|50|||
128032760|NCT04191135|460746284|FG002|Randomized Treatment|Death|54|||
128032761|NCT04191135|460746282|FG000|Randomized Treatment|Lost to Follow-up|0|||
128032762|NCT04191135|460746283|FG001|Randomized Treatment|Lost to Follow-up|0|||
128032763|NCT04191135|460746284|FG002|Randomized Treatment|Lost to Follow-up|1|||
128032764|NCT04191135|460746282|FG000|Randomized Treatment|Withdrawal by Subject|0|||
128032765|NCT04191135|460746283|FG001|Randomized Treatment|Withdrawal by Subject|2|||
127586264|NCT01752985|459114179|FG001|Treatment Period|Subject no longer meets study criteria|1|||
127586265|NCT01752985|459114180|FG002|Treatment Period|Subject no longer meets study criteria|1|||
127586266|NCT01752985|459114178|FG000|Treatment Period|Adverse Event|2|||
127586267|NCT01752985|459114179|FG001|Treatment Period|Adverse Event|1|||
127586268|NCT01752985|459114180|FG002|Treatment Period|Adverse Event|2|||
128032766|NCT04191135|460746284|FG002|Randomized Treatment|Withdrawal by Subject|0|||
128032767|NCT04191135|460746282|FG000|Randomized Treatment|Ongoing in Trial|0|||
128032768|NCT04191135|460746283|FG001|Randomized Treatment|Ongoing in Trial|83|||
128032769|NCT04191135|460746284|FG002|Randomized Treatment|Ongoing in Trial|81|||
127586269|NCT01752985|459114178|FG000|Treatment Period|Withdrawal by Subject|1|||
127586270|NCT01752985|459114179|FG001|Treatment Period|Withdrawal by Subject|1|||
127586271|NCT01752985|459114180|FG002|Treatment Period|Withdrawal by Subject|0|||
128032770|NCT01444781|460747789|FG000|Overall Study|Lost to Follow-up|0|||
128032771|NCT01444781|460747790|FG001|Overall Study|Lost to Follow-up|3|||
128032772|NCT01444781|460747791|FG002|Overall Study|Lost to Follow-up|1|||
128032773|NCT01444781|460747789|FG000|Overall Study|Withdrawal by Subject|3|||
128032774|NCT01444781|460747790|FG001|Overall Study|Withdrawal by Subject|1|||
128032775|NCT01444781|460747791|FG002|Overall Study|Withdrawal by Subject|2|||
128032776|NCT03033784|460747795|FG000|Overall Study|Anxiety related to MRI scanner|0|||
128032777|NCT03033784|460747796|FG001|Overall Study|Anxiety related to MRI scanner|1|||
128032778|NCT03033784|460747797|FG002|Overall Study|Anxiety related to MRI scanner|0|||
128032779|NCT03033784|460747798|FG003|Overall Study|Anxiety related to MRI scanner|0|||
128032780|NCT03033784|460747799|FG004|Overall Study|Anxiety related to MRI scanner|0|||
128032781|NCT03033784|460747800|FG005|Overall Study|Anxiety related to MRI scanner|0|||
128032782|NCT03033784|460747801|FG006|Overall Study|Anxiety related to MRI scanner|0|||
128032783|NCT03033784|460747802|FG007|Overall Study|Anxiety related to MRI scanner|0|||
128032784|NCT03033784|460747803|FG008|Overall Study|Anxiety related to MRI scanner|0|||
128032785|NCT03033784|460747804|FG009|Overall Study|Anxiety related to MRI scanner|0|||
128032786|NCT03033784|460747805|FG010|Overall Study|Anxiety related to MRI scanner|0|||
128032787|NCT03033784|460747806|FG011|Overall Study|Anxiety related to MRI scanner|0|||
128032788|NCT03033784|460747807|FG012|Overall Study|Anxiety related to MRI scanner|0|||
128032789|NCT03033784|460747795|FG000|Overall Study|Withdrawal by Subject|0|||
127586272|NCT01752985|459114178|FG000|Treatment Period|Lost to Follow-up|0|||
127586273|NCT01752985|459114179|FG001|Treatment Period|Lost to Follow-up|0|||
127586274|NCT01752985|459114180|FG002|Treatment Period|Lost to Follow-up|1|||
127586275|NCT06934993|459114181|FG000|Overall Study|Withdrawal by Subject|29|||
127586276|NCT06934993|459114181|FG000|Overall Study|elevated postoperative creatinine level|11|||
127586277|NCT06934993|459114181|FG000|Overall Study|Death|3|||
127586278|NCT01995825|459115519|FG000|Overall Study|Withdrawal by Subject|1|||
127586279|NCT01995825|459115520|FG001|Overall Study|Withdrawal by Subject|0|||
127586280|NCT01385566|459115521|FG000|Overall Study|Lost to Follow-up|1|||
127586281|NCT01385566|459115522|FG001|Overall Study|Lost to Follow-up|0|||
127586282|NCT01385566|459115523|FG002|Overall Study|Lost to Follow-up|0|||
127586283|NCT01385566|459115524|FG003|Overall Study|Lost to Follow-up|0|||
127586284|NCT01385566|459115525|FG004|Overall Study|Lost to Follow-up|0|||
127586285|NCT01385566|459115526|FG005|Overall Study|Lost to Follow-up|0|||
127586286|NCT01385566|459115521|FG000|Overall Study|Withdrawal by Subject|0|||
127586287|NCT01385566|459115522|FG001|Overall Study|Withdrawal by Subject|0|||
127586288|NCT01385566|459115523|FG002|Overall Study|Withdrawal by Subject|0|||
127586289|NCT01385566|459115524|FG003|Overall Study|Withdrawal by Subject|1|||
127586290|NCT01385566|459115525|FG004|Overall Study|Withdrawal by Subject|0|||
127586291|NCT01385566|459115526|FG005|Overall Study|Withdrawal by Subject|0|||
127586292|NCT00403234|459115529|FG000|Overall Study|Withdrawal by Subject|0|||
127586293|NCT00403234|459115530|FG001|Overall Study|Withdrawal by Subject|1|||
127586294|NCT00403234|459115531|FG002|Overall Study|Withdrawal by Subject|0|||
127586295|NCT00403234|459115532|FG003|Overall Study|Withdrawal by Subject|0|||
127586296|NCT00403234|459115529|FG000|Overall Study|Adverse Event|1|||
127586297|NCT00403234|459115530|FG001|Overall Study|Adverse Event|0|||
127586298|NCT00403234|459115531|FG002|Overall Study|Adverse Event|1|||
127586299|NCT00403234|459115532|FG003|Overall Study|Adverse Event|0|||
127586300|NCT04092582|459115533|FG000|Overall Study|Death|1|||
127586301|NCT04092582|459115534|FG001|Overall Study|Death|1|||
127586302|NCT04092582|459115533|FG000|Overall Study|Withdrawal by Subject|4|||
127586303|NCT04092582|459115534|FG001|Overall Study|Withdrawal by Subject|1|||
127586304|NCT04092582|459115533|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
127586305|NCT04092582|459115534|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
127586306|NCT00560105|459115541|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
127586307|NCT00560105|459115542|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
127798474|NCT01789970|459885613|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
128032790|NCT03033784|460747796|FG001|Overall Study|Withdrawal by Subject|0|||
128032791|NCT03033784|460747797|FG002|Overall Study|Withdrawal by Subject|0|||
128032792|NCT03033784|460747798|FG003|Overall Study|Withdrawal by Subject|0|||
128032793|NCT03033784|460747799|FG004|Overall Study|Withdrawal by Subject|0|||
128032794|NCT03033784|460747800|FG005|Overall Study|Withdrawal by Subject|0|||
128032795|NCT03033784|460747801|FG006|Overall Study|Withdrawal by Subject|0|||
128032796|NCT03033784|460747802|FG007|Overall Study|Withdrawal by Subject|0|||
128032797|NCT03033784|460747803|FG008|Overall Study|Withdrawal by Subject|0|||
128032798|NCT03033784|460747804|FG009|Overall Study|Withdrawal by Subject|0|||
128032799|NCT03033784|460747805|FG010|Overall Study|Withdrawal by Subject|0|||
128032800|NCT03033784|460747806|FG011|Overall Study|Withdrawal by Subject|0|||
128032801|NCT03033784|460747807|FG012|Overall Study|Withdrawal by Subject|2|||
128032802|NCT02374255|460747809|FG000|Overall Study|Withdrawal by Subject|2|||
128032803|NCT02374255|460747810|FG001|Overall Study|Withdrawal by Subject|0|||
128032804|NCT02374255|460747811|FG002|Overall Study|Withdrawal by Subject|0|||
128032805|NCT02374255|460747812|FG003|Overall Study|Withdrawal by Subject|0|||
128032806|NCT03332056|460747813|FG000|Overall Study|Incomplete questionnaires|8|||
128032807|NCT03332056|460747814|FG001|Overall Study|Incomplete questionnaires|9|||
128032808|NCT03332056|460747813|FG000|Overall Study|Passed stone prior to surgery date|1|||
128032809|NCT03332056|460747814|FG001|Overall Study|Passed stone prior to surgery date|0|||
128032810|NCT03332056|460747813|FG000|Overall Study|Did not require a ureteral stent|0|||
128032811|NCT03332056|460747814|FG001|Overall Study|Did not require a ureteral stent|1|||
128032812|NCT02093520|460747815|FG000|Overall Study|Not treated|6|||
128032813|NCT02093520|460747816|FG001|Overall Study|Not treated|22|||
128032814|NCT03014089|460747817|FG000|Overall Study|Withdrawal by Subject|0|||
128032815|NCT03014089|460747818|FG001|Overall Study|Withdrawal by Subject|1|||
128032816|NCT03014089|460747819|FG002|Overall Study|Withdrawal by Subject|1|||
128032817|NCT03014089|460747820|FG003|Overall Study|Withdrawal by Subject|1|||
128032818|NCT03014089|460747817|FG000|Overall Study|Lost to Follow-up|1|||
128032819|NCT03014089|460747818|FG001|Overall Study|Lost to Follow-up|0|||
128032820|NCT03014089|460747819|FG002|Overall Study|Lost to Follow-up|0|||
128032821|NCT03014089|460747820|FG003|Overall Study|Lost to Follow-up|0|||
128032822|NCT03014089|460747817|FG000|Overall Study|Adverse Event|1|||
128032823|NCT03014089|460747818|FG001|Overall Study|Adverse Event|0|||
128032824|NCT03014089|460747819|FG002|Overall Study|Adverse Event|1|||
128032825|NCT03014089|460747820|FG003|Overall Study|Adverse Event|0|||
127586308|NCT02025621|459115550|FG000|Overall Study|Withdrawal by Subject|1|||
127586309|NCT02025621|459115551|FG001|Overall Study|Withdrawal by Subject|0|||
127586310|NCT02025621|459115550|FG000|Overall Study|Death|0|||
127586311|NCT02025621|459115551|FG001|Overall Study|Death|1|||
127586312|NCT02025621|459115550|FG000|Overall Study|No longer eligible|10|||
127586313|NCT02025621|459115551|FG001|Overall Study|No longer eligible|15|||
127586314|NCT02025621|459115550|FG000|Overall Study|Surgery initiated before infusion|3|||
127586315|NCT02025621|459115551|FG001|Overall Study|Surgery initiated before infusion|3|||
127586316|NCT00739674|459115552|FG000|Overall Study|Screening failures|19|||
127586317|NCT00739674|459115553|FG001|Overall Study|Screening failures|17|||
127586318|NCT00739674|459115552|FG000|Overall Study|Site 212 removal|19|||
127694112|NCT03692676|459508646|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
127694113|NCT03692676|459508647|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
127694114|NCT03692676|459508644|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
127694115|NCT03692676|459508645|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
127694116|NCT03692676|459508646|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
127694117|NCT03692676|459508647|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
127694118|NCT03692676|459508644|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
127694119|NCT03692676|459508645|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
127694120|NCT03692676|459508646|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
127694121|NCT03692676|459508647|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
127694122|NCT03692676|459508644|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
127694123|NCT03692676|459508645|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
127694124|NCT03692676|459508646|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
127694125|NCT03692676|459508647|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
127694126|NCT03692676|459508644|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
127694127|NCT03692676|459508645|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
128032826|NCT00321932|460747821|FG000|Overall Study|Death|3|||
128032827|NCT00321932|460747822|FG001|Overall Study|Death|6|||
128032828|NCT00321932|460747821|FG000|Overall Study|Withdrawal by Subject|3|||
128032829|NCT00321932|460747822|FG001|Overall Study|Withdrawal by Subject|6|||
128032830|NCT00321932|460747821|FG000|Overall Study|Early relapse|2|||
128032831|NCT00321932|460747822|FG001|Overall Study|Early relapse|8|||
128032832|NCT00321932|460747821|FG000|Overall Study|Missing data|2|||
128032833|NCT00321932|460747822|FG001|Overall Study|Missing data|1|||
127586319|NCT00739674|459115553|FG001|Overall Study|Site 212 removal|13|||
127586320|NCT00739674|459115552|FG000|Overall Study|No follow-up data|33|||
127586321|NCT00739674|459115553|FG001|Overall Study|No follow-up data|18|||
127586322|NCT00739674|459115552|FG000|Overall Study|Dietician consultation >30 days|1|||
127586323|NCT00739674|459115553|FG001|Overall Study|Dietician consultation >30 days|9|||
127586324|NCT00739674|459115552|FG000|Overall Study|Adverse Event|22|||
127586325|NCT00739674|459115553|FG001|Overall Study|Adverse Event|13|||
127586326|NCT00739674|459115552|FG000|Overall Study|Death|1|||
127586327|NCT00739674|459115553|FG001|Overall Study|Death|0|||
127586328|NCT00739674|459115552|FG000|Overall Study|Lack of Efficacy|1|||
127586329|NCT00739674|459115553|FG001|Overall Study|Lack of Efficacy|0|||
127586330|NCT00739674|459115552|FG000|Overall Study|Lost to Follow-up|52|||
128032834|NCT03360344|460747826|FG000|Overall Study|Withdrawal by Subject|0|||
128032835|NCT03360344|460747827|FG001|Overall Study|Withdrawal by Subject|1|||
128032836|NCT03360344|460747828|FG002|Overall Study|Withdrawal by Subject|1|||
128032837|NCT03257657|460747834|FG000|Overall Study|Lost to Follow-up|0|||
128032838|NCT03257657|460747835|FG001|Overall Study|Lost to Follow-up|3|||
128032839|NCT03257657|460747834|FG000|Overall Study|Withdrawn|0|||
127586331|NCT00739674|459115553|FG001|Overall Study|Lost to Follow-up|30|||
127586332|NCT00739674|459115552|FG000|Overall Study|Protocol Violation|5|||
127694128|NCT03692676|459508646|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
127694129|NCT03692676|459508647|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
127694130|NCT03692676|459508644|FG000|Overall Study|Other|0|||
127694131|NCT03692676|459508645|FG001|Overall Study|Other|805|||
127694132|NCT03692676|459508646|FG002|Overall Study|Other|758|||
127694133|NCT03692676|459508647|FG003|Overall Study|Other|277|||
127694134|NCT03692676|459508644|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
127694135|NCT03692676|459508645|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
127694136|NCT03692676|459508646|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
127694137|NCT03692676|459508647|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
127694138|NCT05374837|459508650|FG000|Overall Study|Lost to Follow-up|17|||
127694139|NCT05374837|459508651|FG001|Overall Study|Lost to Follow-up|18|||
127694140|NCT05406921|459508657|FG000|Overall Study|Withdrawal by Subject|25|||
127694141|NCT05406921|459508658|FG001|Overall Study|Withdrawal by Subject|0|||
127694142|NCT05406921|459508659|FG002|Overall Study|Withdrawal by Subject|25|||
127694143|NCT05406921|459508657|FG000|Overall Study|Protocol Violation|0|||
127694144|NCT05406921|459508658|FG001|Overall Study|Protocol Violation|12|||
127694145|NCT05406921|459508659|FG002|Overall Study|Protocol Violation|0|||
127694146|NCT02312960|459508669|FG000|Overall Study|Death|24|||
127694147|NCT02312960|459508670|FG001|Overall Study|Death|32|||
127694148|NCT02312960|459508671|FG002|Overall Study|Death|25|||
127694149|NCT02312960|459508672|FG003|Overall Study|Death|11|||
127694150|NCT02312960|459508673|FG004|Overall Study|Death|5|||
127694151|NCT02312960|459508674|FG005|Overall Study|Death|5|||
127694152|NCT02312960|459508675|FG006|Overall Study|Death|8|||
127694153|NCT02312960|459508676|FG007|Overall Study|Death|5|||
127694154|NCT02312960|459508677|FG008|Overall Study|Death|7|||
127694155|NCT02312960|459508678|FG009|Overall Study|Death|3|||
127694156|NCT02312960|459508679|FG010|Overall Study|Death|3|||
127694157|NCT02312960|459508680|FG011|Overall Study|Death|1|||
127694158|NCT02312960|459508681|FG012|Overall Study|Death|25|||
127694159|NCT02312960|459508682|FG013|Overall Study|Death|19|||
127694160|NCT02312960|459508669|FG000|Overall Study|Missing|0|||
127694161|NCT02312960|459508670|FG001|Overall Study|Missing|0|||
127694162|NCT02312960|459508671|FG002|Overall Study|Missing|2|||
127694163|NCT02312960|459508672|FG003|Overall Study|Missing|0|||
127694164|NCT02312960|459508673|FG004|Overall Study|Missing|0|||
127694165|NCT02312960|459508674|FG005|Overall Study|Missing|0|||
127694166|NCT02312960|459508675|FG006|Overall Study|Missing|0|||
127694167|NCT02312960|459508676|FG007|Overall Study|Missing|0|||
127694168|NCT02312960|459508677|FG008|Overall Study|Missing|0|||
127694169|NCT02312960|459508678|FG009|Overall Study|Missing|0|||
127694170|NCT02312960|459508679|FG010|Overall Study|Missing|0|||
127694171|NCT02312960|459508680|FG011|Overall Study|Missing|0|||
127694172|NCT02312960|459508681|FG012|Overall Study|Missing|0|||
127694173|NCT02312960|459508682|FG013|Overall Study|Missing|0|||
127694174|NCT02312960|459508669|FG000|Overall Study|Lost to Follow-up|0|||
127694175|NCT02312960|459508670|FG001|Overall Study|Lost to Follow-up|0|||
127694176|NCT02312960|459508671|FG002|Overall Study|Lost to Follow-up|1|||
127694177|NCT02312960|459508672|FG003|Overall Study|Lost to Follow-up|0|||
128032840|NCT03257657|460747835|FG001|Overall Study|Withdrawn|1|||
127694178|NCT02312960|459508673|FG004|Overall Study|Lost to Follow-up|0|||
127694179|NCT02312960|459508674|FG005|Overall Study|Lost to Follow-up|0|||
127694180|NCT02312960|459508675|FG006|Overall Study|Lost to Follow-up|1|||
127694181|NCT02312960|459508676|FG007|Overall Study|Lost to Follow-up|1|||
128032841|NCT03257657|460747834|FG000|Overall Study|Noted not eligible right after enrolled|0|||
127586333|NCT00739674|459115553|FG001|Overall Study|Protocol Violation|5|||
127586334|NCT00739674|459115552|FG000|Overall Study|Withdrawal by Subject|9|||
127586335|NCT00739674|459115553|FG001|Overall Study|Withdrawal by Subject|9|||
127694182|NCT02312960|459508677|FG008|Overall Study|Lost to Follow-up|0|||
127586336|NCT00739674|459115552|FG000|Overall Study|Reason missing|2|||
127586337|NCT00739674|459115553|FG001|Overall Study|Reason missing|0|||
127586338|NCT00739674|459115552|FG000|Overall Study|Clinic closed|6|||
127586339|NCT00739674|459115553|FG001|Overall Study|Clinic closed|4|||
127586340|NCT00739674|459115552|FG000|Overall Study|Patient moved|3|||
127586341|NCT00739674|459115553|FG001|Overall Study|Patient moved|2|||
127586342|NCT00739674|459115552|FG000|Overall Study|Non compliant|4|||
127586343|NCT00739674|459115553|FG001|Overall Study|Non compliant|0|||
127586344|NCT00739674|459115552|FG000|Overall Study|Unable to attend visit|3|||
127586345|NCT00739674|459115553|FG001|Overall Study|Unable to attend visit|1|||
127586346|NCT00739674|459115552|FG000|Overall Study|Home monitoring off meds|1|||
127586347|NCT00739674|459115553|FG001|Overall Study|Home monitoring off meds|0|||
127586348|NCT00739674|459115552|FG000|Overall Study|Erectile dysfunction|0|||
127586349|NCT00739674|459115553|FG001|Overall Study|Erectile dysfunction|1|||
127586350|NCT01594281|459115554|FG000|Interventional Core Phase|Protocol Deviation|1|||
127586351|NCT01594281|459115555|FG001|Interventional Core Phase|Protocol Deviation|0|||
127586352|NCT01594281|459115556|FG002|Interventional Core Phase|Protocol Deviation|0|||
127586353|NCT01594281|459115554|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
127586354|NCT01594281|459115555|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
127586355|NCT01594281|459115556|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
127586356|NCT01594281|459115554|FG000|Interventional Core Phase|Death|1|||
127586357|NCT01594281|459115555|FG001|Interventional Core Phase|Death|1|||
127586358|NCT01594281|459115556|FG002|Interventional Core Phase|Death|2|||
127586359|NCT01594281|459115554|FG000|Interventional Core Phase|Lost to Follow-up|1|||
127586360|NCT01594281|459115555|FG001|Interventional Core Phase|Lost to Follow-up|4|||
127586361|NCT01594281|459115556|FG002|Interventional Core Phase|Lost to Follow-up|1|||
127586362|NCT01594281|459115554|FG000|Interventional Core Phase|Adverse Event|4|||
127586363|NCT01594281|459115555|FG001|Interventional Core Phase|Adverse Event|4|||
127586364|NCT01594281|459115556|FG002|Interventional Core Phase|Adverse Event|4|||
127586365|NCT01594281|459115554|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
127586366|NCT01594281|459115555|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
127586367|NCT01594281|459115556|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
127586368|NCT01594281|459115554|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
127586369|NCT01594281|459115555|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
127586370|NCT01594281|459115556|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
127586371|NCT01594281|459115554|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
127586372|NCT01594281|459115555|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
127586373|NCT01594281|459115556|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
127586374|NCT01871532|459115561|FG000|Overall Study|Withdrawal by Subject|1|||
127586375|NCT01871532|459115562|FG001|Overall Study|Withdrawal by Subject|2|||
127586376|NCT02195583|459115564|FG000|Overall Study|Lost to Follow-up|1|||
127586377|NCT02195583|459115564|FG000|Overall Study|Withdrawal by Subject|4|||
127586378|NCT02195583|459115564|FG000|Overall Study|Adverse Event|2|||
127586379|NCT02195583|459115564|FG000|Overall Study|Other Reason|2|||
127586380|NCT01709513|459115565|FG000|Overall Study|Randomized but not treated|0|||
127586381|NCT01709513|459115566|FG001|Overall Study|Randomized but not treated|1|||
127586382|NCT01709513|459115567|FG002|Overall Study|Randomized but not treated|0|||
127586383|NCT01709513|459115565|FG000|Overall Study|Adverse Event|16|||
127586384|NCT01709513|459115566|FG001|Overall Study|Adverse Event|31|||
127586385|NCT01709513|459115567|FG002|Overall Study|Adverse Event|23|||
127586386|NCT01709513|459115565|FG000|Overall Study|Poor compliance to protocol|2|||
127586387|NCT01709513|459115566|FG001|Overall Study|Poor compliance to protocol|0|||
127586388|NCT01709513|459115567|FG002|Overall Study|Poor compliance to protocol|0|||
127586389|NCT01709513|459115565|FG000|Overall Study|Other|3|||
127586390|NCT01709513|459115566|FG001|Overall Study|Other|11|||
127586391|NCT01709513|459115567|FG002|Overall Study|Other|7|||
127586392|NCT04218695|459115568|FG000|Overall Study|Adverse Event|1|||
127586393|NCT04218695|459115569|FG001|Overall Study|Adverse Event|0|||
127586394|NCT00983437|459115570|FG000|Overall Study|Adverse Event|9|||
127586395|NCT00983437|459115570|FG000|Overall Study|Lack of Efficacy|1|||
127586396|NCT00983437|459115570|FG000|Overall Study|Withdrawal by Subject|8|||
127586397|NCT00983437|459115570|FG000|Overall Study|Noncompliance to Study Procedures|1|||
127586398|NCT00983437|459115570|FG000|Overall Study|Lost to Follow-up|2|||
127784290|NCT04033445|459835704|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
127586399|NCT00983437|459115570|FG000|Overall Study|Other Reason|26|||
127586400|NCT01543958|459115571|FG000|Overall Study|Loss to follow-up|3|||
127586401|NCT01543958|459115571|FG000|Overall Study|ART initiation|1|||
127586402|NCT04019288|459115572|FG000|Overall Study|Death|1|||
127586403|NCT04019288|459115573|FG001|Overall Study|Death|0|||
127586404|NCT04019288|459115574|FG002|Overall Study|Death|0|||
127586405|NCT01945281|459115576|FG000|Overall Study|Adverse Event|1|||
127586406|NCT01945281|459115577|FG001|Overall Study|Adverse Event|0|||
127586407|NCT01945281|459115576|FG000|Overall Study|Death|3|||
127586408|NCT01945281|459115577|FG001|Overall Study|Death|3|||
127586409|NCT01945281|459115576|FG000|Overall Study|Physician Decision|1|||
127586410|NCT01945281|459115577|FG001|Overall Study|Physician Decision|1|||
127586411|NCT01945281|459115576|FG000|Overall Study|Technical Problems|1|||
127586412|NCT01945281|459115577|FG001|Overall Study|Technical Problems|0|||
127586413|NCT04401423|459115578|FG000|Overall Study|Withdrawal by Subject|3|||
127586414|NCT04401423|459115579|FG001|Overall Study|Withdrawal by Subject|1|||
127586415|NCT04401423|459115578|FG000|Overall Study|Physician Decision|2|||
127586416|NCT04401423|459115579|FG001|Overall Study|Physician Decision|1|||
127586417|NCT01020981|459115582|FG000|Overall Study|Did not return mailed survey|74|||
127586418|NCT01020981|459115583|FG001|Overall Study|Did not return mailed survey|58|||
127586419|NCT01020981|459115582|FG000|Overall Study|Survey returned undeliverable|8|||
127586420|NCT01020981|459115583|FG001|Overall Study|Survey returned undeliverable|32|||
127586421|NCT01020981|459115582|FG000|Overall Study|Participant declined to complete survey|2|||
127586422|NCT01020981|459115583|FG001|Overall Study|Participant declined to complete survey|0|||
127586423|NCT00799383|459115586|FG000|Overall Study|Protocol Violation|1|||
127586424|NCT00799383|459115587|FG001|Overall Study|Protocol Violation|1|||
127586425|NCT00799383|459115586|FG000|Overall Study|Adverse Event|0|||
127586426|NCT00799383|459115587|FG001|Overall Study|Adverse Event|1|||
127586427|NCT00799383|459115586|FG000|Overall Study|Lost to Follow-up|1|||
127586428|NCT00799383|459115587|FG001|Overall Study|Lost to Follow-up|2|||
127586429|NCT00799383|459115586|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
127586430|NCT00799383|459115587|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
127586431|NCT00799383|459115586|FG000|Overall Study|Withdrawal by Subject|0|||
127586432|NCT00799383|459115587|FG001|Overall Study|Withdrawal by Subject|1|||
127586433|NCT00726986|459115588|FG000|Induction Phase|Adverse Event|4|||
127586434|NCT00726986|459115588|FG000|Induction Phase|Withdrawal by Subject|2|||
127586435|NCT00726986|459115588|FG000|Induction Phase|Death|2|||
127586436|NCT00726986|459115588|FG000|Induction Phase|Lack of Efficacy|5|||
127586437|NCT00726986|459115588|FG000|Induction Phase|Secondary Disease|2|||
127784291|NCT04033445|459835691|FG000|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
127784292|NCT04033445|459835692|FG001|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
127784293|NCT04033445|459835693|FG002|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
127784294|NCT04033445|459835694|FG003|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
127784295|NCT04033445|459835695|FG004|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
127784296|NCT04033445|459835696|FG005|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
127784297|NCT04033445|459835697|FG006|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
127784298|NCT04033445|459835698|FG007|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
127784299|NCT04033445|459835699|FG008|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
127784300|NCT04033445|459835700|FG009|Maintenance Study (Week 0 to Week 44)|Adverse Event|12|||
127784301|NCT04033445|459835701|FG010|Maintenance Study (Week 0 to Week 44)|Adverse Event|9|||
127784302|NCT04033445|459835702|FG011|Maintenance Study (Week 0 to Week 44)|Adverse Event|10|||
127784303|NCT04033445|459835703|FG012|Maintenance Study (Week 0 to Week 44)|Adverse Event|11|||
127784304|NCT04033445|459835704|FG013|Maintenance Study (Week 0 to Week 44)|Adverse Event|5|||
127784305|NCT04033445|459835691|FG000|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
127784306|NCT04033445|459835692|FG001|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
127784307|NCT04033445|459835693|FG002|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
127784308|NCT04033445|459835694|FG003|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
127784309|NCT04033445|459835695|FG004|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
127784310|NCT04033445|459835696|FG005|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
127784311|NCT04033445|459835697|FG006|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
127784312|NCT04033445|459835698|FG007|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
127784313|NCT04033445|459835699|FG008|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
127784314|NCT04033445|459835700|FG009|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|6|||
127784315|NCT04033445|459835701|FG010|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
127784316|NCT04033445|459835702|FG011|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|1|||
127784317|NCT04033445|459835703|FG012|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|5|||
127784318|NCT04033445|459835704|FG013|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
127784319|NCT04033445|459835691|FG000|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
127784320|NCT04033445|459835692|FG001|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
127784321|NCT04033445|459835693|FG002|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
127784322|NCT04033445|459835694|FG003|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
127784323|NCT04033445|459835695|FG004|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
127784324|NCT04033445|459835696|FG005|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
127784325|NCT04033445|459835697|FG006|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
127784326|NCT04033445|459835698|FG007|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
127784327|NCT04033445|459835699|FG008|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
128032842|NCT03257657|460747835|FG001|Overall Study|Noted not eligible right after enrolled|1|||
127586438|NCT00726986|459115588|FG000|Maintenance Phase|Adverse Event|1|||
127586439|NCT00726986|459115588|FG000|Maintenance Phase|Lack of Efficacy|2|||
127586440|NCT00612040|459115597|FG000|Overall Study|Adverse Event|0|||
127586441|NCT00612040|459115598|FG001|Overall Study|Adverse Event|2|||
127586442|NCT00612040|459115599|FG002|Overall Study|Adverse Event|1|||
127586443|NCT00612040|459115597|FG000|Overall Study|Protocol Violation|1|||
127586444|NCT00612040|459115598|FG001|Overall Study|Protocol Violation|2|||
127586445|NCT00612040|459115599|FG002|Overall Study|Protocol Violation|1|||
127586446|NCT00612040|459115597|FG000|Overall Study|Lack of Efficacy|2|||
127586447|NCT00612040|459115598|FG001|Overall Study|Lack of Efficacy|1|||
127586448|NCT00612040|459115599|FG002|Overall Study|Lack of Efficacy|0|||
127586449|NCT00612040|459115597|FG000|Overall Study|Unclassified|2|||
127586450|NCT00612040|459115598|FG001|Overall Study|Unclassified|2|||
127586451|NCT00612040|459115599|FG002|Overall Study|Unclassified|5|||
127586452|NCT00885846|459115601|FG000|Overall Study|Withdrawal by Subject|2|||
127586453|NCT00885846|459115602|FG001|Overall Study|Withdrawal by Subject|5|||
127586454|NCT00885846|459115603|FG002|Overall Study|Withdrawal by Subject|2|||
127586455|NCT03330288|459115617|FG000|Overall Study|Other reason|1|||
127586456|NCT03330288|459115618|FG001|Overall Study|Other reason|1|||
127586457|NCT03330288|459115617|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
127586458|NCT03330288|459115618|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
127586459|NCT03330288|459115617|FG000|Overall Study|Adverse Event|1|||
127586460|NCT03330288|459115618|FG001|Overall Study|Adverse Event|0|||
127586461|NCT03330288|459115617|FG000|Overall Study|Withdrawal by Subject|1|||
127586462|NCT03330288|459115618|FG001|Overall Study|Withdrawal by Subject|0|||
127586463|NCT03330288|459115617|FG000|Overall Study|Lost to Follow-up|26|||
127586464|NCT03330288|459115618|FG001|Overall Study|Lost to Follow-up|7|||
127586465|NCT01719783|459115622|FG000|Dose 2|Physician Decision|1|||
127586466|NCT01719783|459115623|FG001|Dose 2|Physician Decision|0|||
127586467|NCT01254331|459115625|FG000|Initial Phase|Adverse Event|3|||
127586468|NCT01254331|459115625|FG000|Initial Phase|Withdrawal by Subject|1|||
127586469|NCT01254331|459115625|FG000|Initial Phase|Pregnancy|1|||
127586470|NCT01254331|459115625|FG000|Extension Phase|Lack of Efficacy|1|||
127586471|NCT01254331|459115625|FG000|Extension Phase|Lost to Follow-up|3|||
127586472|NCT01612858|459115626|FG000|Overall Study|Withdrawal by Subject|5|||
127586473|NCT01612858|459115627|FG001|Overall Study|Withdrawal by Subject|1|||
127586474|NCT01768286|459115630|FG000|Overall Study|Randomized But Not Treated|0|||
127586475|NCT01768286|459115631|FG001|Overall Study|Randomized But Not Treated|0|||
127586476|NCT01768286|459115632|FG002|Overall Study|Randomized But Not Treated|1|||
127586477|NCT01768286|459115633|FG003|Overall Study|Randomized But Not Treated|0|||
127586478|NCT01768286|459115630|FG000|Overall Study|Lack of Efficacy|7|||
127586479|NCT01768286|459115631|FG001|Overall Study|Lack of Efficacy|4|||
127586480|NCT01768286|459115632|FG002|Overall Study|Lack of Efficacy|0|||
127586481|NCT01768286|459115633|FG003|Overall Study|Lack of Efficacy|1|||
127586482|NCT01768286|459115630|FG000|Overall Study|Withdrew Consent|0|||
127586483|NCT01768286|459115631|FG001|Overall Study|Withdrew Consent|0|||
127586484|NCT01768286|459115632|FG002|Overall Study|Withdrew Consent|1|||
127586485|NCT01768286|459115633|FG003|Overall Study|Withdrew Consent|0|||
127586486|NCT02699593|459115635|FG000|Period 1|Unsatisfactory Visual Response|0|||
127586487|NCT02699593|459115636|FG001|Period 1|Unsatisfactory Visual Response|1|||
127586488|NCT02699593|459115635|FG000|Period 1|Torn Contact Len|4|||
127586489|NCT02699593|459115636|FG001|Period 1|Torn Contact Len|3|||
127586490|NCT02699593|459115635|FG000|Period 1|Protocol Violation|0|||
127586491|NCT02699593|459115636|FG001|Period 1|Protocol Violation|1|||
127586492|NCT02699593|459115635|FG000|Period 1|Withdrawal by Subject|0|||
127586493|NCT02699593|459115636|FG001|Period 1|Withdrawal by Subject|1|||
127586494|NCT02699593|459115635|FG000|Period 1|Adverse Event|1|||
127586495|NCT02699593|459115636|FG001|Period 1|Adverse Event|1|||
127586496|NCT02699593|459115635|FG000|Period 2|Adverse Event|1|||
127586497|NCT02699593|459115636|FG001|Period 2|Adverse Event|1|||
127586498|NCT02699593|459115635|FG000|Period 2|Lost Contact Lens|0|||
127586499|NCT02699593|459115636|FG001|Period 2|Lost Contact Lens|1|||
127586500|NCT02699593|459115635|FG000|Period 2|Torn Contact Lens|1|||
127586501|NCT02699593|459115636|FG001|Period 2|Torn Contact Lens|0|||
127586502|NCT03344796|459115637|FG000|Overall Study|Lost to Follow-up|0|||
127586503|NCT03344796|459115638|FG001|Overall Study|Lost to Follow-up|0|||
127586504|NCT03344796|459115639|FG002|Overall Study|Lost to Follow-up|0|||
127586505|NCT03344796|459115640|FG003|Overall Study|Lost to Follow-up|0|||
127586506|NCT03344796|459115641|FG004|Overall Study|Lost to Follow-up|0|||
127586507|NCT03344796|459115642|FG005|Overall Study|Lost to Follow-up|2|||
127586508|NCT03298867|459115645|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
127586509|NCT03298867|459115646|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
127586510|NCT03298867|459115645|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
127586511|NCT03298867|459115646|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
127586512|NCT03298867|459115645|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
127586513|NCT03298867|459115646|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
127586514|NCT03298867|459115645|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
127586515|NCT03298867|459115646|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
127586516|NCT03298867|459115645|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
127586517|NCT03298867|459115646|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
127694183|NCT02312960|459508678|FG009|Overall Study|Lost to Follow-up|1|||
128032843|NCT01992757|460747853|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
128032844|NCT00688740|460747854|FG000|Overall Study|Adverse Event|45|||
128032845|NCT00688740|460747855|FG001|Overall Study|Adverse Event|8|||
128032846|NCT00688740|460747854|FG000|Overall Study|Death|2|||
128032847|NCT00688740|460747855|FG001|Overall Study|Death|2|||
128032848|NCT00688740|460747854|FG000|Overall Study|Lost to Follow-up|0|||
128032849|NCT00688740|460747855|FG001|Overall Study|Lost to Follow-up|1|||
128032850|NCT00688740|460747854|FG000|Overall Study|Consent Withdrawn|17|||
128032851|NCT00688740|460747855|FG001|Overall Study|Consent Withdrawn|17|||
128032852|NCT00688740|460747854|FG000|Overall Study|Breast Cancer Relapse|1|||
128032853|NCT00688740|460747855|FG001|Overall Study|Breast Cancer Relapse|4|||
128032854|NCT00688740|460747854|FG000|Overall Study|Violation of Inclusion Criteria|1|||
128032855|NCT00688740|460747855|FG001|Overall Study|Violation of Inclusion Criteria|3|||
128032856|NCT00856557|460747858|FG000|Overall Study|No patients with contextual flags|12|||
128032857|NCT00856557|460747859|FG001|Overall Study|No patients with contextual flags|16|||
128032858|NCT01432444|460747860|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
128032859|NCT01432444|460747861|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
128032860|NCT01432444|460747862|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
128032861|NCT01432444|460747860|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
128032862|NCT01432444|460747861|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
128032863|NCT01432444|460747862|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
128032864|NCT01432444|460747860|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
128032865|NCT01432444|460747861|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
128032866|NCT01432444|460747862|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
128032867|NCT01432444|460747860|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
128032868|NCT01432444|460747861|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
128032869|NCT01432444|460747862|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
128032870|NCT01432444|460747860|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
128032871|NCT01432444|460747861|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
128032872|NCT01432444|460747862|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
128032873|NCT01432444|460747860|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
128032874|NCT01432444|460747861|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
128032875|NCT01432444|460747862|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
128032876|NCT01432444|460747860|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
128032877|NCT01432444|460747861|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
128032878|NCT01432444|460747862|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
128032879|NCT01432444|460747860|FG000|Treatment Phase|Lost to Follow-up|0|||
128032880|NCT01432444|460747861|FG001|Treatment Phase|Lost to Follow-up|33|||
128032881|NCT01432444|460747862|FG002|Treatment Phase|Lost to Follow-up|0|||
128032882|NCT01432444|460747860|FG000|Treatment Phase|Adverse Event|0|||
128032883|NCT01432444|460747861|FG001|Treatment Phase|Adverse Event|37|||
128032884|NCT01432444|460747862|FG002|Treatment Phase|Adverse Event|0|||
128032885|NCT01432444|460747860|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
128032886|NCT01432444|460747861|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
128032887|NCT01432444|460747862|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
128032888|NCT01432444|460747860|FG000|Treatment Phase|Physician Decision|0|||
128032889|NCT01432444|460747861|FG001|Treatment Phase|Physician Decision|5|||
128032890|NCT01432444|460747862|FG002|Treatment Phase|Physician Decision|0|||
128032891|NCT01432444|460747860|FG000|Treatment Phase|Withdrawal by Subject|0|||
128032892|NCT01432444|460747861|FG001|Treatment Phase|Withdrawal by Subject|41|||
128032893|NCT01432444|460747862|FG002|Treatment Phase|Withdrawal by Subject|0|||
128032894|NCT01432444|460747860|FG000|Treatment Phase|Protocol Deviation|0|||
128032895|NCT01432444|460747861|FG001|Treatment Phase|Protocol Deviation|3|||
128032896|NCT01432444|460747862|FG002|Treatment Phase|Protocol Deviation|0|||
128032897|NCT01432444|460747860|FG000|Treatment Phase|Lack of Efficacy|0|||
128032898|NCT01432444|460747861|FG001|Treatment Phase|Lack of Efficacy|10|||
128032899|NCT01432444|460747862|FG002|Treatment Phase|Lack of Efficacy|0|||
128032900|NCT01432444|460747860|FG000|Extension Phase|Lost to Follow-up|0|||
128032901|NCT01432444|460747861|FG001|Extension Phase|Lost to Follow-up|0|||
128032902|NCT01432444|460747862|FG002|Extension Phase|Lost to Follow-up|17|||
128032903|NCT01432444|460747860|FG000|Extension Phase|Adverse Event|0|||
128032904|NCT01432444|460747861|FG001|Extension Phase|Adverse Event|0|||
128032905|NCT01432444|460747862|FG002|Extension Phase|Adverse Event|10|||
128032906|NCT01432444|460747860|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
128032907|NCT01432444|460747861|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
128032908|NCT01432444|460747862|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
128032909|NCT01432444|460747860|FG000|Extension Phase|Met Withdrawal Criteria|0|||
128032910|NCT01432444|460747861|FG001|Extension Phase|Met Withdrawal Criteria|0|||
128032911|NCT01432444|460747862|FG002|Extension Phase|Met Withdrawal Criteria|144|||
128032912|NCT01432444|460747860|FG000|Extension Phase|Physician Decision|0|||
128032913|NCT01432444|460747861|FG001|Extension Phase|Physician Decision|0|||
128032914|NCT01432444|460747862|FG002|Extension Phase|Physician Decision|1|||
128032915|NCT01432444|460747860|FG000|Extension Phase|Withdrawal by Subject|0|||
128032916|NCT01432444|460747861|FG001|Extension Phase|Withdrawal by Subject|0|||
128032917|NCT01432444|460747862|FG002|Extension Phase|Withdrawal by Subject|13|||
128032918|NCT03673176|460747863|FG000|Overall Study|Death prior to intervention|1|||
128032919|NCT03673176|460747863|FG000|Overall Study|Death following intervention|3|||
128032920|NCT03673176|460747863|FG000|Overall Study|Withdrawal by Subject|1|||
128032921|NCT02301897|460747864|FG000|Treatment Course 1|Non-Compliance|0|||
128032922|NCT02301897|460747865|FG001|Treatment Course 1|Non-Compliance|0|||
128032923|NCT02301897|460747866|FG002|Treatment Course 1|Non-Compliance|1|||
128032924|NCT02301897|460747864|FG000|Treatment Course 1|Adverse Event|1|||
128032925|NCT02301897|460747865|FG001|Treatment Course 1|Adverse Event|1|||
128032926|NCT02301897|460747866|FG002|Treatment Course 1|Adverse Event|0|||
128032927|NCT02301897|460747864|FG000|Treatment Course 1|Lost to Follow-up|1|||
128032928|NCT02301897|460747865|FG001|Treatment Course 1|Lost to Follow-up|2|||
128032929|NCT02301897|460747866|FG002|Treatment Course 1|Lost to Follow-up|1|||
128032930|NCT02301897|460747864|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
128032931|NCT02301897|460747865|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
128032932|NCT02301897|460747866|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
128032933|NCT02301897|460747864|FG000|Treatment Course 1|Withdrawal by Subject|0|||
128032934|NCT02301897|460747865|FG001|Treatment Course 1|Withdrawal by Subject|0|||
128032935|NCT02301897|460747866|FG002|Treatment Course 1|Withdrawal by Subject|2|||
128032936|NCT02301897|460747864|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
128032937|NCT02301897|460747865|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
128032938|NCT02301897|460747866|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
127586518|NCT03298867|459115645|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
127586519|NCT03298867|459115646|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
127586520|NCT03298867|459115645|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
127586521|NCT03298867|459115646|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
127586522|NCT03298867|459115645|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
127586523|NCT03298867|459115646|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
127586524|NCT03298867|459115645|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
127586525|NCT03298867|459115646|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
127586526|NCT01453361|459115647|FG000|Overall Study|Disease Progression|6|||
127586527|NCT01453361|459115647|FG000|Overall Study|Screen-Failures|10|||
127586528|NCT04560998|459115648|FG000|Overall Study|Withdrawal by Subject|18|||
127586529|NCT04560998|459115649|FG001|Overall Study|Withdrawal by Subject|12|||
127586530|NCT04560998|459115648|FG000|Overall Study|Lost to Follow-up|8|||
127586531|NCT04560998|459115649|FG001|Overall Study|Lost to Follow-up|5|||
127586532|NCT04560998|459115648|FG000|Overall Study|Physician Decision|4|||
127586533|NCT04560998|459115649|FG001|Overall Study|Physician Decision|0|||
127586534|NCT04678661|459117370|FG000|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|17|||
127586535|NCT04678661|459117371|FG001|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|0|||
127586536|NCT04678661|459117370|FG000|Overall Study|Protocol Violation|2|||
127586537|NCT04678661|459117371|FG001|Overall Study|Protocol Violation|0|||
127586538|NCT04678661|459117370|FG000|Overall Study|Withdrawal by Subject|1|||
127586539|NCT04678661|459117371|FG001|Overall Study|Withdrawal by Subject|0|||
127586540|NCT04678661|459117370|FG000|Overall Study|Lost to Follow-up|2|||
127586541|NCT04678661|459117371|FG001|Overall Study|Lost to Follow-up|0|||
127586542|NCT04678661|459117370|FG000|Overall Study|Death|2|||
127586543|NCT04678661|459117371|FG001|Overall Study|Death|0|||
127586544|NCT01397890|459117372|FG000|Overall Study|Withdrawal by Subject|7|||
127586545|NCT01397890|459117373|FG001|Overall Study|Withdrawal by Subject|11|||
128032939|NCT02301897|460747864|FG000|Treatment Course 2|Lost to Follow-up|0|||
128032940|NCT02301897|460747865|FG001|Treatment Course 2|Lost to Follow-up|2|||
127586546|NCT01397890|459117372|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
128032941|NCT02301897|460747866|FG002|Treatment Course 2|Lost to Follow-up|0|||
128032942|NCT02301897|460747864|FG000|Treatment Course 2|Pregnancy|0|||
127586547|NCT01397890|459117373|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
127586548|NCT01397890|459117372|FG000|Overall Study|Death|2|||
127784328|NCT04033445|459835700|FG009|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
128032943|NCT02301897|460747865|FG001|Treatment Course 2|Pregnancy|1|||
128032944|NCT02301897|460747866|FG002|Treatment Course 2|Pregnancy|1|||
128032945|NCT02301897|460747864|FG000|Treatment Course 2|Withdrawal by Subject|0|||
127784329|NCT04033445|459835701|FG010|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
127784330|NCT04033445|459835702|FG011|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
127784331|NCT04033445|459835703|FG012|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
127784332|NCT04033445|459835704|FG013|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
127784333|NCT04033445|459835691|FG000|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
127784334|NCT04033445|459835692|FG001|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
127784335|NCT04033445|459835693|FG002|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
127784336|NCT04033445|459835694|FG003|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
127784337|NCT04033445|459835695|FG004|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
127784338|NCT04033445|459835696|FG005|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
127784339|NCT04033445|459835697|FG006|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
127586549|NCT01397890|459117373|FG001|Overall Study|Death|3|||
127784340|NCT04033445|459835698|FG007|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
127784341|NCT04033445|459835699|FG008|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
127784342|NCT04033445|459835700|FG009|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
127784343|NCT04033445|459835701|FG010|Maintenance Study (Week 0 to Week 44)|Physician Decision|4|||
127784344|NCT04033445|459835702|FG011|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
127784345|NCT04033445|459835703|FG012|Maintenance Study (Week 0 to Week 44)|Physician Decision|2|||
127784346|NCT04033445|459835704|FG013|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
127784347|NCT04033445|459835691|FG000|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
127784348|NCT04033445|459835692|FG001|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
127784349|NCT04033445|459835693|FG002|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
127784350|NCT04033445|459835694|FG003|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
127784351|NCT04033445|459835695|FG004|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
127784352|NCT04033445|459835696|FG005|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
127784353|NCT04033445|459835697|FG006|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
127784354|NCT04033445|459835698|FG007|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
127784355|NCT04033445|459835699|FG008|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
127784356|NCT04033445|459835700|FG009|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|8|||
127784357|NCT04033445|459835701|FG010|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|4|||
127784358|NCT04033445|459835702|FG011|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|7|||
127784359|NCT04033445|459835703|FG012|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|6|||
127784360|NCT04033445|459835704|FG013|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|5|||
127784361|NCT04033445|459835691|FG000|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
127784362|NCT04033445|459835692|FG001|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
127784363|NCT04033445|459835693|FG002|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
127784364|NCT04033445|459835694|FG003|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
127784365|NCT04033445|459835695|FG004|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
127784366|NCT04033445|459835696|FG005|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
127784367|NCT04033445|459835697|FG006|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
127784368|NCT04033445|459835698|FG007|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
127784369|NCT04033445|459835699|FG008|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
127784370|NCT04033445|459835700|FG009|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
127784371|NCT04033445|459835701|FG010|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
127784372|NCT04033445|459835702|FG011|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
127784373|NCT04033445|459835703|FG012|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
127784374|NCT04033445|459835704|FG013|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|1|||
127586550|NCT01397890|459117372|FG000|Overall Study|Lost to Follow-up|1|||
127586551|NCT01397890|459117373|FG001|Overall Study|Lost to Follow-up|4|||
127586552|NCT01397890|459117372|FG000|Overall Study|Condition under Investigation Worsened|1|||
127586553|NCT01397890|459117373|FG001|Overall Study|Condition under Investigation Worsened|3|||
127586554|NCT01397890|459117372|FG000|Overall Study|Adverse Event|1|||
127586555|NCT01397890|459117373|FG001|Overall Study|Adverse Event|2|||
127586556|NCT01397890|459117372|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
127586557|NCT01397890|459117373|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
127586558|NCT01397890|459117372|FG000|Overall Study|Others|2|||
127586559|NCT01397890|459117373|FG001|Overall Study|Others|1|||
127586560|NCT00002651|459117374|FG000|Induction|Adverse Event|44|||
127586561|NCT00002651|459117375|FG001|Induction|Adverse Event|0|||
127586562|NCT00002651|459117376|FG002|Induction|Adverse Event|0|||
127586563|NCT00002651|459117374|FG000|Induction|Refusal unrelated to adverse event|50|||
127586564|NCT00002651|459117375|FG001|Induction|Refusal unrelated to adverse event|0|||
127586565|NCT00002651|459117376|FG002|Induction|Refusal unrelated to adverse event|0|||
127586566|NCT00002651|459117374|FG000|Induction|Progression/relapse|274|||
127586567|NCT00002651|459117375|FG001|Induction|Progression/relapse|0|||
127586568|NCT00002651|459117376|FG002|Induction|Progression/relapse|0|||
127586569|NCT00002651|459117374|FG000|Induction|Death|62|||
127586570|NCT00002651|459117375|FG001|Induction|Death|0|||
127586571|NCT00002651|459117376|FG002|Induction|Death|0|||
127586572|NCT00002651|459117374|FG000|Induction|Other|823|||
127586573|NCT00002651|459117375|FG001|Induction|Other|0|||
127586574|NCT00002651|459117376|FG002|Induction|Other|0|||
127586575|NCT00002651|459117374|FG000|Induction|not eligible|90|||
127586576|NCT00002651|459117375|FG001|Induction|not eligible|0|||
127586577|NCT00002651|459117376|FG002|Induction|not eligible|0|||
127784375|NCT04033445|459835691|FG000|Maintenance Study (Week 0 to Week 44)|Other|0|||
127784376|NCT04033445|459835692|FG001|Maintenance Study (Week 0 to Week 44)|Other|0|||
127784377|NCT04033445|459835693|FG002|Maintenance Study (Week 0 to Week 44)|Other|0|||
127784378|NCT04033445|459835694|FG003|Maintenance Study (Week 0 to Week 44)|Other|0|||
127784379|NCT04033445|459835695|FG004|Maintenance Study (Week 0 to Week 44)|Other|0|||
127784380|NCT04033445|459835696|FG005|Maintenance Study (Week 0 to Week 44)|Other|0|||
127784381|NCT04033445|459835697|FG006|Maintenance Study (Week 0 to Week 44)|Other|0|||
127784382|NCT04033445|459835698|FG007|Maintenance Study (Week 0 to Week 44)|Other|0|||
127784383|NCT04033445|459835699|FG008|Maintenance Study (Week 0 to Week 44)|Other|0|||
127784384|NCT04033445|459835700|FG009|Maintenance Study (Week 0 to Week 44)|Other|1|||
127784385|NCT04033445|459835701|FG010|Maintenance Study (Week 0 to Week 44)|Other|1|||
127784386|NCT04033445|459835702|FG011|Maintenance Study (Week 0 to Week 44)|Other|2|||
127784387|NCT04033445|459835703|FG012|Maintenance Study (Week 0 to Week 44)|Other|2|||
127784388|NCT04033445|459835704|FG013|Maintenance Study (Week 0 to Week 44)|Other|2|||
127784389|NCT04033445|459835691|FG000|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
127784390|NCT04033445|459835692|FG001|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
127784391|NCT04033445|459835693|FG002|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
127784392|NCT04033445|459835694|FG003|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
127784393|NCT04033445|459835695|FG004|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
127784394|NCT04033445|459835696|FG005|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
127784395|NCT04033445|459835697|FG006|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
127784396|NCT04033445|459835698|FG007|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
127784397|NCT04033445|459835699|FG008|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
127784398|NCT04033445|459835700|FG009|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
127784399|NCT04033445|459835701|FG010|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
127784400|NCT04033445|459835702|FG011|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
127784401|NCT04033445|459835703|FG012|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
127784402|NCT04033445|459835704|FG013|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
127784403|NCT04754802|459835710|FG000|Overall Study|Lost to Follow-up|0|||
127784404|NCT04754802|459835711|FG001|Overall Study|Lost to Follow-up|2|||
127784405|NCT04754802|459835710|FG000|Overall Study|Withdrawal by Subject|2|||
127784406|NCT04754802|459835711|FG001|Overall Study|Withdrawal by Subject|0|||
127784407|NCT04451161|459835712|FG000|Overall Study|Lost to Follow-up|28|||
127784408|NCT04451161|459835713|FG001|Overall Study|Lost to Follow-up|37|||
127784409|NCT04451161|459835714|FG002|Overall Study|Lost to Follow-up|22|||
127784410|NCT04451161|459835715|FG003|Overall Study|Lost to Follow-up|13|||
127784411|NCT04451161|459835716|FG004|Overall Study|Lost to Follow-up|11|||
127784412|NCT04451161|459835717|FG005|Overall Study|Lost to Follow-up|14|||
127784413|NCT04451161|459835712|FG000|Overall Study|Withdrawal by Subject|3|||
127784414|NCT04451161|459835713|FG001|Overall Study|Withdrawal by Subject|0|||
127784415|NCT04451161|459835714|FG002|Overall Study|Withdrawal by Subject|0|||
127784416|NCT04451161|459835715|FG003|Overall Study|Withdrawal by Subject|0|||
127784417|NCT04451161|459835716|FG004|Overall Study|Withdrawal by Subject|2|||
127784418|NCT04451161|459835717|FG005|Overall Study|Withdrawal by Subject|4|||
127784419|NCT05525689|459835718|FG000|Overall Study|Lost to Follow-up|1|||
127784420|NCT05525689|459835719|FG001|Overall Study|Lost to Follow-up|0|||
127784421|NCT01671111|459835720|FG000|Overall Study|Adverse Event|2|||
127784422|NCT01671111|459835720|FG000|Overall Study|Lack of Efficacy|1|||
127784423|NCT01671111|459835720|FG000|Overall Study|Withdrawal by Subject|2|||
128032946|NCT02301897|460747865|FG001|Treatment Course 2|Withdrawal by Subject|2|||
128032947|NCT02301897|460747866|FG002|Treatment Course 2|Withdrawal by Subject|0|||
128032948|NCT02301897|460747864|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
128032949|NCT02301897|460747865|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
128032950|NCT02301897|460747866|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
127586578|NCT00002651|459117374|FG000|Consolidation and Randomization|Adverse Event|0|||
127586579|NCT00002651|459117375|FG001|Consolidation and Randomization|Adverse Event|36|||
127586580|NCT00002651|459117376|FG002|Consolidation and Randomization|Adverse Event|14|||
127586581|NCT00002651|459117374|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
127784424|NCT01671111|459835720|FG000|Overall Study|Physician Decision|1|||
127784425|NCT01671111|459835720|FG000|Overall Study|Other|24|||
127784426|NCT03680911|459835721|FG000|At Home Treatment|Study Termination|3|||
127784427|NCT03680911|459835722|FG001|At Home Treatment|Study Termination|0|||
127586582|NCT00002651|459117375|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
127586583|NCT00002651|459117376|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
127586584|NCT00002651|459117374|FG000|Consolidation and Randomization|Progression/relapse|0|||
127586585|NCT00002651|459117375|FG001|Consolidation and Randomization|Progression/relapse|295|||
127586586|NCT00002651|459117376|FG002|Consolidation and Randomization|Progression/relapse|298|||
127586587|NCT00002651|459117374|FG000|Consolidation and Randomization|Death|0|||
127586588|NCT00002651|459117375|FG001|Consolidation and Randomization|Death|38|||
127586589|NCT00002651|459117376|FG002|Consolidation and Randomization|Death|48|||
127586590|NCT00002651|459117374|FG000|Consolidation and Randomization|Other|0|||
127586591|NCT00002651|459117375|FG001|Consolidation and Randomization|Other|314|||
127586592|NCT00002651|459117376|FG002|Consolidation and Randomization|Other|313|||
127586593|NCT00002651|459117374|FG000|Consolidation and Randomization|not eligible|0|||
127586594|NCT00002651|459117375|FG001|Consolidation and Randomization|not eligible|102|||
127586595|NCT00002651|459117376|FG002|Consolidation and Randomization|not eligible|112|||
127586596|NCT03741062|459117379|FG000|Overall Study|Protocol Violation|1|||
127586597|NCT03741062|459117380|FG001|Overall Study|Protocol Violation|0|||
127586598|NCT02763462|459117384|FG000|Overall Study|Protocol Violation|6|||
127586599|NCT03417219|459117385|FG000|Overall Study|Lost to Follow-up|0|||
127586600|NCT03417219|459117386|FG001|Overall Study|Lost to Follow-up|3|||
127586601|NCT00261807|459117387|FG000|Overall Study|Lost to Follow-up|2|||
127586602|NCT00261807|459117387|FG000|Overall Study|Adverse Event|2|||
127586603|NCT00261807|459117387|FG000|Overall Study|Death|1|||
127586604|NCT00261807|459117387|FG000|Overall Study|Protocol Violation|2|||
127586605|NCT02100514|459117390|FG000|Treatment Period|Adverse Event|0|||
127586606|NCT02100514|459117391|FG001|Treatment Period|Adverse Event|5|||
127586607|NCT02100514|459117392|FG002|Treatment Period|Adverse Event|0|||
127586608|NCT02100514|459117393|FG003|Treatment Period|Adverse Event|0|||
127586609|NCT02100514|459117394|FG004|Treatment Period|Adverse Event|0|||
127586610|NCT02100514|459117390|FG000|Treatment Period|Death|2|||
127586611|NCT02100514|459117391|FG001|Treatment Period|Death|2|||
127586612|NCT02100514|459117392|FG002|Treatment Period|Death|0|||
127586613|NCT02100514|459117393|FG003|Treatment Period|Death|0|||
127586614|NCT02100514|459117394|FG004|Treatment Period|Death|0|||
127586615|NCT02100514|459117390|FG000|Treatment Period|Lost to Follow-up|5|||
127586616|NCT02100514|459117391|FG001|Treatment Period|Lost to Follow-up|17|||
127586617|NCT02100514|459117392|FG002|Treatment Period|Lost to Follow-up|0|||
127586618|NCT02100514|459117393|FG003|Treatment Period|Lost to Follow-up|0|||
127586619|NCT02100514|459117394|FG004|Treatment Period|Lost to Follow-up|0|||
127586620|NCT02100514|459117390|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
127586621|NCT02100514|459117391|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
127586622|NCT02100514|459117392|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
127586623|NCT02100514|459117393|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
127586624|NCT02100514|459117394|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
127586625|NCT02100514|459117390|FG000|Treatment Period|Protocol Violation|1|||
127586626|NCT02100514|459117391|FG001|Treatment Period|Protocol Violation|1|||
127586627|NCT02100514|459117392|FG002|Treatment Period|Protocol Violation|0|||
127586628|NCT02100514|459117393|FG003|Treatment Period|Protocol Violation|0|||
127586629|NCT02100514|459117394|FG004|Treatment Period|Protocol Violation|0|||
127586630|NCT02100514|459117390|FG000|Treatment Period|Withdrawal by Subject|12|||
127586631|NCT02100514|459117391|FG001|Treatment Period|Withdrawal by Subject|37|||
127586632|NCT02100514|459117392|FG002|Treatment Period|Withdrawal by Subject|0|||
127586633|NCT02100514|459117393|FG003|Treatment Period|Withdrawal by Subject|0|||
127586634|NCT02100514|459117394|FG004|Treatment Period|Withdrawal by Subject|0|||
127586635|NCT02100514|459117390|FG000|Treatment Period|Other|9|||
127586636|NCT02100514|459117391|FG001|Treatment Period|Other|11|||
127586637|NCT02100514|459117392|FG002|Treatment Period|Other|0|||
127586638|NCT02100514|459117393|FG003|Treatment Period|Other|0|||
127586639|NCT02100514|459117394|FG004|Treatment Period|Other|0|||
127586640|NCT02100514|459117390|FG000|Extension Period|Withdrew consent|0|||
127784428|NCT03680911|459835721|FG000|At Home Treatment|Lost to Follow-up|0|||
127784429|NCT03680911|459835722|FG001|At Home Treatment|Lost to Follow-up|1|||
127586641|NCT02100514|459117391|FG001|Extension Period|Withdrew consent|0|||
127586642|NCT02100514|459117392|FG002|Extension Period|Withdrew consent|2|||
127586643|NCT02100514|459117393|FG003|Extension Period|Withdrew consent|0|||
127586644|NCT02100514|459117394|FG004|Extension Period|Withdrew consent|0|||
127586645|NCT02021331|459117395|FG000|Overall Study|Adverse Event|0|||
127586646|NCT02021331|459117396|FG001|Overall Study|Adverse Event|2|||
127586647|NCT00762229|459117397|FG000|Overall Study|Lost to Follow-up|1|||
127586648|NCT00762229|459117398|FG001|Overall Study|Lost to Follow-up|1|||
127586649|NCT00762229|459117397|FG000|Overall Study|did not recveive intervention|0|||
127586650|NCT00762229|459117398|FG001|Overall Study|did not recveive intervention|1|||
127586651|NCT00319553|459117401|FG000|Overall Study|Protocol Violation|1|||
127586652|NCT00319553|459117402|FG001|Overall Study|Protocol Violation|2|||
127586653|NCT00319553|459117401|FG000|Overall Study|Lost to Follow-up|2|||
127586654|NCT00319553|459117402|FG001|Overall Study|Lost to Follow-up|1|||
127586655|NCT00319553|459117401|FG000|Overall Study|Withdrawal by Subject|1|||
127586656|NCT00319553|459117402|FG001|Overall Study|Withdrawal by Subject|1|||
128032951|NCT02439957|460747867|FG000|Overall Study|Study Terminated|3|||
128032952|NCT02439957|460747868|FG001|Overall Study|Study Terminated|3|||
128032953|NCT00478257|460747869|FG000|Overall Study|Withdrawal by Subject|8|||
128032954|NCT00478257|460747870|FG001|Overall Study|Withdrawal by Subject|3|||
128032955|NCT03931330|460747871|FG000|Overall Study|Physician Decision|1|||
128032956|NCT03412929|460747872|FG000|Overall Study|Protocol Violation|3|||
128032957|NCT03895372|460747877|FG000|Investigational Treatment Period|Adverse Event|1|||
128032958|NCT03895372|460747878|FG001|Investigational Treatment Period|Adverse Event|0|||
128032959|NCT03895372|460747879|FG002|Investigational Treatment Period|Adverse Event|0|||
128032960|NCT03895372|460747880|FG003|Investigational Treatment Period|Adverse Event|0|||
128032961|NCT03895372|460747881|FG004|Investigational Treatment Period|Adverse Event|0|||
128032962|NCT03895372|460747882|FG005|Investigational Treatment Period|Adverse Event|0|||
128032963|NCT03895372|460747883|FG006|Investigational Treatment Period|Adverse Event|4|||
128032964|NCT03895372|460747884|FG007|Investigational Treatment Period|Adverse Event|3|||
128032965|NCT03895372|460747877|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
128032966|NCT03895372|460747878|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
128032967|NCT03895372|460747879|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
128032968|NCT03895372|460747880|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
128032969|NCT03895372|460747881|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
128032970|NCT03895372|460747882|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
128032971|NCT03895372|460747883|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
128032972|NCT03895372|460747884|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
128032973|NCT03895372|460747877|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
128032974|NCT03895372|460747878|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
127586657|NCT01896102|459117405|FG000|Overall Study|Death|1|||
127586658|NCT01896102|459117405|FG000|Overall Study|Participant to receive allogenic transplant|2|||
127586659|NCT00444912|459117408|FG000|Overall Study|Death|1|||
127586660|NCT00444912|459117409|FG001|Overall Study|Death|2|||
127586661|NCT00444912|459117408|FG000|Overall Study|Lost to Follow-up|1|||
127586662|NCT00444912|459117409|FG001|Overall Study|Lost to Follow-up|0|||
127586663|NCT00444912|459117408|FG000|Overall Study|Participant Failed Mobilization|1|||
127586664|NCT00444912|459117409|FG001|Overall Study|Participant Failed Mobilization|0|||
127586665|NCT01281865|459117410|FG000|Overall Study|Adverse Event|1|||
127586666|NCT01281865|459117411|FG001|Overall Study|Adverse Event|1|||
127586667|NCT01281865|459117410|FG000|Overall Study|Withdrawal by Subject|1|||
127586668|NCT01281865|459117411|FG001|Overall Study|Withdrawal by Subject|0|||
127586669|NCT01281865|459117410|FG000|Overall Study|Lack of Efficacy|1|||
127586670|NCT01281865|459117411|FG001|Overall Study|Lack of Efficacy|0|||
127586671|NCT02747875|459117412|FG000|Overall Study|Physician Decision|1|||
127586672|NCT02747875|459117413|FG001|Overall Study|Physician Decision|0|||
127586673|NCT02747875|459117412|FG000|Overall Study|Adverse Event|0|||
127586674|NCT02747875|459117413|FG001|Overall Study|Adverse Event|1|||
127586675|NCT03478657|459117414|FG000|Overall Study|Withdrawal by Subject|0|||
127586676|NCT03478657|459117415|FG001|Overall Study|Withdrawal by Subject|1|||
127586677|NCT02590003|459117416|FG000|Overall Study|Death|1|||
127586678|NCT02590003|459117417|FG001|Overall Study|Death|2|||
127586679|NCT01702805|459117419|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
127586680|NCT01702805|459117420|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
127586681|NCT01702805|459117419|FG000|Overall Study|Incomplete Follow-up|18|||
127586682|NCT01702805|459117420|FG001|Overall Study|Incomplete Follow-up|15|||
127586683|NCT01702805|459117419|FG000|Overall Study|Vital Status Assessment Only|40|||
127586684|NCT01702805|459117420|FG001|Overall Study|Vital Status Assessment Only|39|||
127784430|NCT03680911|459835721|FG000|At Home Treatment|Withdrawal by Subject|0|||
127784431|NCT03680911|459835722|FG001|At Home Treatment|Withdrawal by Subject|2|||
127784432|NCT03680911|459835721|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
127784433|NCT03680911|459835722|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
128032975|NCT03895372|460747879|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
128032976|NCT03895372|460747880|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
128032977|NCT03895372|460747881|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
128032978|NCT03895372|460747882|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
128032979|NCT03895372|460747883|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
128032980|NCT03895372|460747884|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
128032981|NCT03895372|460747877|FG000|Investigational Treatment Period|Other|0|||
128032982|NCT03895372|460747878|FG001|Investigational Treatment Period|Other|0|||
128032983|NCT03895372|460747879|FG002|Investigational Treatment Period|Other|0|||
128032984|NCT03895372|460747880|FG003|Investigational Treatment Period|Other|0|||
128032985|NCT03895372|460747881|FG004|Investigational Treatment Period|Other|0|||
128032986|NCT03895372|460747882|FG005|Investigational Treatment Period|Other|1|||
127586685|NCT01702805|459117419|FG000|Overall Study|Lost to Follow-up|5|||
127586686|NCT01702805|459117420|FG001|Overall Study|Lost to Follow-up|5|||
127586687|NCT04457336|459117423|FG000|Period 2: Part A|Withdrawal by Subject|0|||
127586688|NCT04457336|459117424|FG001|Period 2: Part A|Withdrawal by Subject|1|||
127586689|NCT04457336|459117425|FG002|Period 2: Part A|Withdrawal by Subject|1|||
127586690|NCT04457336|459117426|FG003|Period 2: Part A|Withdrawal by Subject|1|||
127586691|NCT04457336|459117427|FG004|Period 2: Part A|Withdrawal by Subject|0|||
127586692|NCT04457336|459117428|FG005|Period 2: Part A|Withdrawal by Subject|0|||
127586693|NCT04457336|459117429|FG006|Period 2: Part A|Withdrawal by Subject|0|||
127586694|NCT04457336|459117430|FG007|Period 2: Part A|Withdrawal by Subject|0|||
127586695|NCT04457336|459117423|FG000|Period 2: Part A|Adverse Event|0|||
127586696|NCT04457336|459117424|FG001|Period 2: Part A|Adverse Event|0|||
127586697|NCT04457336|459117425|FG002|Period 2: Part A|Adverse Event|1|||
127586698|NCT04457336|459117426|FG003|Period 2: Part A|Adverse Event|1|||
127586699|NCT04457336|459117427|FG004|Period 2: Part A|Adverse Event|0|||
127586700|NCT04457336|459117428|FG005|Period 2: Part A|Adverse Event|0|||
127586701|NCT04457336|459117429|FG006|Period 2: Part A|Adverse Event|0|||
127586702|NCT04457336|459117430|FG007|Period 2: Part A|Adverse Event|0|||
127586703|NCT04457336|459117423|FG000|Period 2: Part A|Study Terminated|0|||
127586704|NCT04457336|459117424|FG001|Period 2: Part A|Study Terminated|0|||
127586705|NCT04457336|459117425|FG002|Period 2: Part A|Study Terminated|1|||
127586706|NCT04457336|459117426|FG003|Period 2: Part A|Study Terminated|0|||
127586707|NCT04457336|459117427|FG004|Period 2: Part A|Study Terminated|0|||
127586708|NCT04457336|459117428|FG005|Period 2: Part A|Study Terminated|0|||
127586709|NCT04457336|459117429|FG006|Period 2: Part A|Study Terminated|0|||
127586710|NCT04457336|459117430|FG007|Period 2: Part A|Study Terminated|0|||
127586711|NCT04457336|459117423|FG000|Period 2: Part A|Protocol Violation|0|||
127586712|NCT04457336|459117424|FG001|Period 2: Part A|Protocol Violation|1|||
127586713|NCT04457336|459117425|FG002|Period 2: Part A|Protocol Violation|0|||
127586714|NCT04457336|459117426|FG003|Period 2: Part A|Protocol Violation|0|||
127586715|NCT04457336|459117427|FG004|Period 2: Part A|Protocol Violation|0|||
127586716|NCT04457336|459117428|FG005|Period 2: Part A|Protocol Violation|0|||
127586717|NCT04457336|459117429|FG006|Period 2: Part A|Protocol Violation|0|||
127586718|NCT04457336|459117430|FG007|Period 2: Part A|Protocol Violation|0|||
127586719|NCT04457336|459117423|FG000|Period 2: Part A|Lost to Follow-up|0|||
127586720|NCT04457336|459117424|FG001|Period 2: Part A|Lost to Follow-up|1|||
127586721|NCT04457336|459117425|FG002|Period 2: Part A|Lost to Follow-up|0|||
127586722|NCT04457336|459117426|FG003|Period 2: Part A|Lost to Follow-up|0|||
127586723|NCT04457336|459117427|FG004|Period 2: Part A|Lost to Follow-up|0|||
127586724|NCT04457336|459117428|FG005|Period 2: Part A|Lost to Follow-up|0|||
127586725|NCT04457336|459117429|FG006|Period 2: Part A|Lost to Follow-up|0|||
127586726|NCT04457336|459117430|FG007|Period 2: Part A|Lost to Follow-up|0|||
127586727|NCT04457336|459117423|FG000|Period 2: Part A|Other|0|||
127586728|NCT04457336|459117424|FG001|Period 2: Part A|Other|1|||
127586729|NCT04457336|459117425|FG002|Period 2: Part A|Other|0|||
127586730|NCT04457336|459117426|FG003|Period 2: Part A|Other|0|||
127586731|NCT04457336|459117427|FG004|Period 2: Part A|Other|0|||
127586732|NCT04457336|459117428|FG005|Period 2: Part A|Other|0|||
127586733|NCT04457336|459117429|FG006|Period 2: Part A|Other|0|||
127586734|NCT04457336|459117430|FG007|Period 2: Part A|Other|0|||
127586735|NCT04457336|459117423|FG000|Period 2: Part A|Physician Decision|0|||
127586736|NCT04457336|459117424|FG001|Period 2: Part A|Physician Decision|0|||
127586737|NCT04457336|459117425|FG002|Period 2: Part A|Physician Decision|0|||
127586738|NCT04457336|459117426|FG003|Period 2: Part A|Physician Decision|1|||
127586739|NCT04457336|459117427|FG004|Period 2: Part A|Physician Decision|0|||
128032987|NCT03895372|460747883|FG006|Investigational Treatment Period|Other|0|||
128032988|NCT03895372|460747884|FG007|Investigational Treatment Period|Other|2|||
127586740|NCT04457336|459117428|FG005|Period 2: Part A|Physician Decision|0|||
127586741|NCT04457336|459117429|FG006|Period 2: Part A|Physician Decision|0|||
127586742|NCT04457336|459117430|FG007|Period 2: Part A|Physician Decision|0|||
127586743|NCT04457336|459117423|FG000|Period 3: Part B|Study Terminated|0|||
127586744|NCT04457336|459117424|FG001|Period 3: Part B|Study Terminated|0|||
127586745|NCT04457336|459117425|FG002|Period 3: Part B|Study Terminated|0|||
127586746|NCT04457336|459117426|FG003|Period 3: Part B|Study Terminated|0|||
127586747|NCT04457336|459117427|FG004|Period 3: Part B|Study Terminated|1|||
127586748|NCT04457336|459117428|FG005|Period 3: Part B|Study Terminated|10|||
128032989|NCT03895372|460747877|FG000|Investigational Treatment Period|Protocol Violation|0|||
128032990|NCT03895372|460747878|FG001|Investigational Treatment Period|Protocol Violation|0|||
128032991|NCT03895372|460747879|FG002|Investigational Treatment Period|Protocol Violation|0|||
128032992|NCT03895372|460747880|FG003|Investigational Treatment Period|Protocol Violation|1|||
128032993|NCT03895372|460747881|FG004|Investigational Treatment Period|Protocol Violation|0|||
128032994|NCT03895372|460747882|FG005|Investigational Treatment Period|Protocol Violation|0|||
128032995|NCT03895372|460747883|FG006|Investigational Treatment Period|Protocol Violation|0|||
128032996|NCT03895372|460747884|FG007|Investigational Treatment Period|Protocol Violation|0|||
128032997|NCT03895372|460747877|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
128032998|NCT03895372|460747878|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
128032999|NCT03895372|460747879|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
128033000|NCT03895372|460747880|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
128033001|NCT03895372|460747881|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
128033002|NCT03895372|460747882|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
128033003|NCT03895372|460747883|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
127586749|NCT04457336|459117429|FG006|Period 3: Part B|Study Terminated|13|||
127586750|NCT04457336|459117430|FG007|Period 3: Part B|Study Terminated|0|||
127586751|NCT04457336|459117423|FG000|Period 3: Part B|Withdrawal by Subject|0|||
127586752|NCT04457336|459117424|FG001|Period 3: Part B|Withdrawal by Subject|0|||
127586753|NCT04457336|459117425|FG002|Period 3: Part B|Withdrawal by Subject|0|||
127586754|NCT04457336|459117426|FG003|Period 3: Part B|Withdrawal by Subject|0|||
127586755|NCT04457336|459117427|FG004|Period 3: Part B|Withdrawal by Subject|0|||
127586756|NCT04457336|459117428|FG005|Period 3: Part B|Withdrawal by Subject|1|||
127586757|NCT04457336|459117429|FG006|Period 3: Part B|Withdrawal by Subject|2|||
127586758|NCT04457336|459117430|FG007|Period 3: Part B|Withdrawal by Subject|0|||
127586759|NCT04457336|459117423|FG000|Period 4: Part C|Study Terminated|0|||
127586760|NCT04457336|459117424|FG001|Period 4: Part C|Study Terminated|0|||
127586761|NCT04457336|459117425|FG002|Period 4: Part C|Study Terminated|0|||
128033004|NCT03895372|460747884|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
128033005|NCT03895372|460747877|FG000|Extension Treatment Period|Adverse Event|0|||
128033006|NCT03895372|460747878|FG001|Extension Treatment Period|Adverse Event|1|||
128033007|NCT03895372|460747879|FG002|Extension Treatment Period|Adverse Event|0|||
128033008|NCT03895372|460747880|FG003|Extension Treatment Period|Adverse Event|1|||
128033009|NCT03895372|460747881|FG004|Extension Treatment Period|Adverse Event|0|||
128033010|NCT03895372|460747882|FG005|Extension Treatment Period|Adverse Event|0|||
128033011|NCT03895372|460747883|FG006|Extension Treatment Period|Adverse Event|3|||
128033012|NCT03895372|460747884|FG007|Extension Treatment Period|Adverse Event|3|||
128033013|NCT03895372|460747877|FG000|Extension Treatment Period|Other|1|||
128033014|NCT03895372|460747878|FG001|Extension Treatment Period|Other|3|||
128033015|NCT03895372|460747879|FG002|Extension Treatment Period|Other|0|||
128033016|NCT03895372|460747880|FG003|Extension Treatment Period|Other|0|||
128033017|NCT03895372|460747881|FG004|Extension Treatment Period|Other|1|||
128033018|NCT03895372|460747882|FG005|Extension Treatment Period|Other|0|||
128033019|NCT03895372|460747883|FG006|Extension Treatment Period|Other|0|||
128033020|NCT03895372|460747884|FG007|Extension Treatment Period|Other|2|||
128033021|NCT03895372|460747877|FG000|Extension Treatment Period|Pregnancy|0|||
128033022|NCT03895372|460747878|FG001|Extension Treatment Period|Pregnancy|0|||
127586762|NCT04457336|459117426|FG003|Period 4: Part C|Study Terminated|0|||
127586763|NCT04457336|459117427|FG004|Period 4: Part C|Study Terminated|0|||
127586764|NCT04457336|459117428|FG005|Period 4: Part C|Study Terminated|0|||
127586765|NCT04457336|459117429|FG006|Period 4: Part C|Study Terminated|0|||
127586766|NCT04457336|459117430|FG007|Period 4: Part C|Study Terminated|30|||
127586767|NCT04457336|459117423|FG000|Period 4: Part C|Adverse Event|0|||
127586768|NCT04457336|459117424|FG001|Period 4: Part C|Adverse Event|0|||
127586769|NCT04457336|459117425|FG002|Period 4: Part C|Adverse Event|0|||
127586770|NCT04457336|459117426|FG003|Period 4: Part C|Adverse Event|0|||
127586771|NCT04457336|459117427|FG004|Period 4: Part C|Adverse Event|0|||
127586772|NCT04457336|459117428|FG005|Period 4: Part C|Adverse Event|0|||
127586773|NCT04457336|459117429|FG006|Period 4: Part C|Adverse Event|0|||
127586774|NCT04457336|459117430|FG007|Period 4: Part C|Adverse Event|2|||
127586775|NCT04457336|459117423|FG000|Period 4: Part C|Site Terminated|0|||
127586776|NCT04457336|459117424|FG001|Period 4: Part C|Site Terminated|0|||
127586777|NCT04457336|459117425|FG002|Period 4: Part C|Site Terminated|0|||
127586778|NCT04457336|459117426|FG003|Period 4: Part C|Site Terminated|0|||
127586779|NCT04457336|459117427|FG004|Period 4: Part C|Site Terminated|0|||
127586780|NCT04457336|459117428|FG005|Period 4: Part C|Site Terminated|0|||
127586781|NCT04457336|459117429|FG006|Period 4: Part C|Site Terminated|0|||
127586782|NCT04457336|459117430|FG007|Period 4: Part C|Site Terminated|1|||
127586783|NCT04457336|459117423|FG000|Period 4: Part C|Other|0|||
127586784|NCT04457336|459117424|FG001|Period 4: Part C|Other|0|||
127586785|NCT04457336|459117425|FG002|Period 4: Part C|Other|0|||
127586786|NCT04457336|459117426|FG003|Period 4: Part C|Other|0|||
127586787|NCT04457336|459117427|FG004|Period 4: Part C|Other|0|||
127586788|NCT04457336|459117428|FG005|Period 4: Part C|Other|0|||
127586789|NCT04457336|459117429|FG006|Period 4: Part C|Other|0|||
127586790|NCT04457336|459117430|FG007|Period 4: Part C|Other|2|||
127586791|NCT04457336|459117423|FG000|Period 4: Part C|Withdrawal by Subject|0|||
127586792|NCT04457336|459117424|FG001|Period 4: Part C|Withdrawal by Subject|0|||
127586793|NCT04457336|459117425|FG002|Period 4: Part C|Withdrawal by Subject|0|||
127586794|NCT04457336|459117426|FG003|Period 4: Part C|Withdrawal by Subject|0|||
127586795|NCT04457336|459117427|FG004|Period 4: Part C|Withdrawal by Subject|0|||
127586796|NCT04457336|459117428|FG005|Period 4: Part C|Withdrawal by Subject|0|||
127586797|NCT04457336|459117429|FG006|Period 4: Part C|Withdrawal by Subject|0|||
128033023|NCT03895372|460747879|FG002|Extension Treatment Period|Pregnancy|0|||
128033024|NCT03895372|460747880|FG003|Extension Treatment Period|Pregnancy|0|||
128033025|NCT03895372|460747881|FG004|Extension Treatment Period|Pregnancy|1|||
128033026|NCT03895372|460747882|FG005|Extension Treatment Period|Pregnancy|0|||
128033027|NCT03895372|460747883|FG006|Extension Treatment Period|Pregnancy|0|||
128033028|NCT03895372|460747884|FG007|Extension Treatment Period|Pregnancy|0|||
128033029|NCT03895372|460747877|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
127586798|NCT04457336|459117430|FG007|Period 4: Part C|Withdrawal by Subject|3|||
127586799|NCT02693119|459117433|FG000|Open-Label Period|Withdrawal by Subject|0|||
128033030|NCT03895372|460747878|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
127586800|NCT02693119|459117434|FG001|Open-Label Period|Withdrawal by Subject|1|||
127586801|NCT01350492|459117435|FG000|Intervention|Lost to Follow-up|2|||
127586802|NCT01350492|459117436|FG001|Intervention|Lost to Follow-up|5|||
127586803|NCT01350492|459117435|FG000|Intervention|Withdrawal by Subject|3|||
127586804|NCT01350492|459117436|FG001|Intervention|Withdrawal by Subject|1|||
127586805|NCT01350492|459117435|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
127586806|NCT01350492|459117436|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
127586807|NCT01350492|459117435|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
128033031|NCT03895372|460747879|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
128033032|NCT03895372|460747880|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
127586808|NCT01350492|459117436|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
128033033|NCT03895372|460747881|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
128033034|NCT03895372|460747882|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
128033035|NCT03895372|460747883|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
128033036|NCT03895372|460747884|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
128033037|NCT01472185|460747889|FG000|Overall Study|Randomized but Not Treated|0|||
128033038|NCT01472185|460747890|FG001|Overall Study|Randomized but Not Treated|1|||
128033039|NCT01472185|460747889|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
128033040|NCT01472185|460747890|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
128033041|NCT01472185|460747889|FG000|Overall Study|Hyperglycemia|5|||
128033042|NCT01472185|460747890|FG001|Overall Study|Hyperglycemia|2|||
127586809|NCT04203498|459117437|FG000|Overall Study|Decision by the investigator, GW, or authority|0|||
127586810|NCT04203498|459117438|FG001|Overall Study|Decision by the investigator, GW, or authority|1|||
127586811|NCT04203498|459117437|FG000|Overall Study|Withdrawal of patient consent|7|||
127586812|NCT04203498|459117438|FG001|Overall Study|Withdrawal of patient consent|2|||
127586813|NCT04203498|459117437|FG000|Overall Study|Adverse Event|4|||
127586814|NCT04203498|459117438|FG001|Overall Study|Adverse Event|1|||
127586815|NCT04203498|459117437|FG000|Overall Study|Drug not dispensed due to endpoint error|1|||
127586816|NCT04203498|459117438|FG001|Overall Study|Drug not dispensed due to endpoint error|0|||
127586817|NCT04203498|459117437|FG000|Overall Study|Did not receive IMP|2|||
127586818|NCT04203498|459117438|FG001|Overall Study|Did not receive IMP|0|||
127586819|NCT00939640|459117439|FG000|Overall Study|Physician Decision|1|||
127586820|NCT01235689|459117444|FG000|Overall Study|Adverse Event|12|||
127586821|NCT01235689|459117445|FG001|Overall Study|Adverse Event|16|||
127586822|NCT01235689|459117444|FG000|Overall Study|Lack of Efficacy|12|||
127586823|NCT01235689|459117445|FG001|Overall Study|Lack of Efficacy|5|||
127586824|NCT01235689|459117444|FG000|Overall Study|Withdrawal by Subject|3|||
128033043|NCT01472185|460747889|FG000|Overall Study|Investigator's Discretion|3|||
128033044|NCT01472185|460747890|FG001|Overall Study|Investigator's Discretion|1|||
127586825|NCT01235689|459117445|FG001|Overall Study|Withdrawal by Subject|4|||
127586826|NCT01235689|459117444|FG000|Overall Study|Lost to Follow-up|1|||
127586827|NCT01235689|459117445|FG001|Overall Study|Lost to Follow-up|2|||
127586828|NCT01235689|459117444|FG000|Overall Study|Miscellaneous|1|||
127586829|NCT01235689|459117445|FG001|Overall Study|Miscellaneous|5|||
127586830|NCT01443078|459117446|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
128033045|NCT01472185|460747889|FG000|Overall Study|Lost to Follow-up|4|||
128033046|NCT01472185|460747890|FG001|Overall Study|Lost to Follow-up|1|||
128033047|NCT01472185|460747889|FG000|Overall Study|Protocol Violation|5|||
127586831|NCT01443078|459117446|FG000|Overall Study|Withdrawal by Subject|1|||
127586832|NCT01443078|459117446|FG000|Overall Study|Patient had brain mets|1|||
127586833|NCT02106975|459117453|FG000|Overall Study|Death|25|||
127586834|NCT02106975|459117454|FG001|Overall Study|Death|39|||
127586835|NCT00005044|459117455|FG000|Overall Study|Protocol Violation|37|||
127586836|NCT00005044|459117456|FG001|Overall Study|Protocol Violation|46|||
127586837|NCT00005044|459117455|FG000|Overall Study|Withdrawal by Subject|1|||
127586838|NCT00005044|459117456|FG001|Overall Study|Withdrawal by Subject|5|||
127586839|NCT00005044|459117455|FG000|Overall Study|No protocol treatment|0|||
127586840|NCT00005044|459117456|FG001|Overall Study|No protocol treatment|1|||
127586841|NCT03988088|459117457|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
127586842|NCT03988088|459117458|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
127784434|NCT00898443|459835727|FG000|Overall Study|Withdrawal by Subject|1|||
127784435|NCT00898443|459835728|FG001|Overall Study|Withdrawal by Subject|0|||
127784436|NCT04695392|459835729|FG000|Overall Study|Withdrawn by parent/guardian|0|||
127784437|NCT04695392|459835730|FG001|Overall Study|Withdrawn by parent/guardian|1|||
127586843|NCT03988088|459117459|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
127586844|NCT03988088|459117460|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
127586845|NCT03988088|459117457|FG000|Open-Label Addendum|Lost to Follow-up|0|||
127586846|NCT03988088|459117458|FG001|Open-Label Addendum|Lost to Follow-up|0|||
127784438|NCT04695392|459835729|FG000|Overall Study|Withdrawn by physician|0|||
127586847|NCT03988088|459117459|FG002|Open-Label Addendum|Lost to Follow-up|1|||
127586848|NCT03988088|459117460|FG003|Open-Label Addendum|Lost to Follow-up|0|||
127586849|NCT04431453|459117461|FG000|Overall Study|Withdrew Consent|0|||
127586850|NCT04431453|459117462|FG001|Overall Study|Withdrew Consent|1|||
127586851|NCT04431453|459117463|FG002|Overall Study|Withdrew Consent|0|||
127586852|NCT04431453|459117464|FG003|Overall Study|Withdrew Consent|2|||
127586853|NCT04431453|459117465|FG004|Overall Study|Withdrew Consent|0|||
127586854|NCT04431453|459117466|FG005|Overall Study|Withdrew Consent|0|||
127586855|NCT04431453|459117467|FG006|Overall Study|Withdrew Consent|0|||
127586856|NCT04431453|459117468|FG007|Overall Study|Withdrew Consent|0|||
127586857|NCT04431453|459117461|FG000|Overall Study|Death|1|||
127586858|NCT04431453|459117462|FG001|Overall Study|Death|0|||
127586859|NCT04431453|459117463|FG002|Overall Study|Death|0|||
127586860|NCT04431453|459117464|FG003|Overall Study|Death|0|||
127586861|NCT04431453|459117465|FG004|Overall Study|Death|0|||
127586862|NCT04431453|459117466|FG005|Overall Study|Death|0|||
127586863|NCT04431453|459117467|FG006|Overall Study|Death|0|||
127586864|NCT04431453|459117468|FG007|Overall Study|Death|1|||
127586865|NCT04431453|459117461|FG000|Overall Study|Lost to Follow-up|0|||
127586866|NCT04431453|459117462|FG001|Overall Study|Lost to Follow-up|0|||
127586867|NCT04431453|459117463|FG002|Overall Study|Lost to Follow-up|1|||
127586868|NCT04431453|459117464|FG003|Overall Study|Lost to Follow-up|1|||
127586869|NCT04431453|459117465|FG004|Overall Study|Lost to Follow-up|0|||
128033048|NCT01472185|460747890|FG001|Overall Study|Protocol Violation|1|||
128033049|NCT01472185|460747889|FG000|Overall Study|Subject Noncompliance|8|||
128033050|NCT01472185|460747890|FG001|Overall Study|Subject Noncompliance|15|||
128033051|NCT01472185|460747889|FG000|Overall Study|Subject Withdrew Consent|6|||
128033052|NCT01472185|460747890|FG001|Overall Study|Subject Withdrew Consent|3|||
128033053|NCT01051661|460747897|FG000|Overall Study|Adverse Event|1|||
128033054|NCT01051661|460747898|FG001|Overall Study|Adverse Event|1|||
128033055|NCT01051661|460747899|FG002|Overall Study|Adverse Event|1|||
128033056|NCT01051661|460747900|FG003|Overall Study|Adverse Event|1|||
128033057|NCT01051661|460747901|FG004|Overall Study|Adverse Event|0|||
128033058|NCT01051661|460747902|FG005|Overall Study|Adverse Event|0|||
128033059|NCT01051661|460747897|FG000|Overall Study|Lost to Follow-up|13|||
128033060|NCT01051661|460747898|FG001|Overall Study|Lost to Follow-up|22|||
128033061|NCT01051661|460747899|FG002|Overall Study|Lost to Follow-up|15|||
128033062|NCT01051661|460747900|FG003|Overall Study|Lost to Follow-up|17|||
128033063|NCT01051661|460747901|FG004|Overall Study|Lost to Follow-up|10|||
128033064|NCT01051661|460747902|FG005|Overall Study|Lost to Follow-up|24|||
128033065|NCT01051661|460747897|FG000|Overall Study|Migrated/moved from study area|1|||
128033066|NCT01051661|460747898|FG001|Overall Study|Migrated/moved from study area|6|||
128033067|NCT01051661|460747899|FG002|Overall Study|Migrated/moved from study area|6|||
128033068|NCT01051661|460747900|FG003|Overall Study|Migrated/moved from study area|8|||
128033069|NCT01051661|460747901|FG004|Overall Study|Migrated/moved from study area|7|||
128033070|NCT01051661|460747902|FG005|Overall Study|Migrated/moved from study area|3|||
128033071|NCT01051661|460747897|FG000|Overall Study|Refused blood sampling|0|||
128033072|NCT01051661|460747898|FG001|Overall Study|Refused blood sampling|0|||
128033073|NCT01051661|460747899|FG002|Overall Study|Refused blood sampling|0|||
128033074|NCT01051661|460747900|FG003|Overall Study|Refused blood sampling|0|||
128033075|NCT01051661|460747901|FG004|Overall Study|Refused blood sampling|0|||
128033076|NCT01051661|460747902|FG005|Overall Study|Refused blood sampling|1|||
128033077|NCT01051661|460747897|FG000|Overall Study|Data not reliable|1|||
128033078|NCT01051661|460747898|FG001|Overall Study|Data not reliable|0|||
128033079|NCT01051661|460747899|FG002|Overall Study|Data not reliable|0|||
128033080|NCT01051661|460747900|FG003|Overall Study|Data not reliable|0|||
128033081|NCT01051661|460747901|FG004|Overall Study|Data not reliable|0|||
128033082|NCT01051661|460747902|FG005|Overall Study|Data not reliable|1|||
128033083|NCT01051661|460747897|FG000|Overall Study|Unable to attend visit(s)|2|||
127586870|NCT04431453|459117466|FG005|Overall Study|Lost to Follow-up|0|||
127586871|NCT04431453|459117467|FG006|Overall Study|Lost to Follow-up|0|||
127586872|NCT04431453|459117468|FG007|Overall Study|Lost to Follow-up|0|||
127586873|NCT04431453|459117461|FG000|Overall Study|Enrolled but Never Treated|0|||
127586874|NCT04431453|459117462|FG001|Overall Study|Enrolled but Never Treated|0|||
127586875|NCT04431453|459117463|FG002|Overall Study|Enrolled but Never Treated|0|||
127586876|NCT04431453|459117464|FG003|Overall Study|Enrolled but Never Treated|0|||
127586877|NCT04431453|459117465|FG004|Overall Study|Enrolled but Never Treated|1|||
127586878|NCT04431453|459117466|FG005|Overall Study|Enrolled but Never Treated|0|||
127586879|NCT04431453|459117467|FG006|Overall Study|Enrolled but Never Treated|0|||
127586880|NCT04431453|459117468|FG007|Overall Study|Enrolled but Never Treated|0|||
127586881|NCT03546062|459117469|FG000|Overall Study|Adverse Event|6|||
127586882|NCT03546062|459117470|FG001|Overall Study|Adverse Event|5|||
127586883|NCT03546062|459117471|FG002|Overall Study|Adverse Event|8|||
127586884|NCT02083965|459117473|FG000|Treatment Period|Other|1|||
127586885|NCT02083965|459117474|FG001|Treatment Period|Other|0|||
127586886|NCT04502433|459117476|FG000|Overall Study|Death|2|||
127586887|NCT04502433|459117477|FG001|Overall Study|Death|4|||
127586888|NCT04502433|459117476|FG000|Overall Study|Lost to Follow-up|1|||
127586889|NCT04502433|459117477|FG001|Overall Study|Lost to Follow-up|0|||
127586890|NCT04502433|459117476|FG000|Overall Study|Physician Decision|0|||
127586891|NCT04502433|459117477|FG001|Overall Study|Physician Decision|1|||
127586892|NCT02935842|459117478|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
127586893|NCT02935842|459117479|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
127586894|NCT02935842|459117480|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
127586895|NCT02935842|459117481|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
127586896|NCT02935842|459117478|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
127882016|NCT01154673|460190784|FG000|Overall Study|moved out of province|1|||
128033084|NCT01051661|460747898|FG001|Overall Study|Unable to attend visit(s)|4|||
128033085|NCT01051661|460747899|FG002|Overall Study|Unable to attend visit(s)|2|||
128033086|NCT01051661|460747900|FG003|Overall Study|Unable to attend visit(s)|1|||
127586897|NCT02935842|459117479|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
127586898|NCT02935842|459117480|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
128033087|NCT01051661|460747901|FG004|Overall Study|Unable to attend visit(s)|3|||
128033088|NCT01051661|460747902|FG005|Overall Study|Unable to attend visit(s)|2|||
128033089|NCT01051661|460747897|FG000|Overall Study|Consent not received from both parents|0|||
128033090|NCT01051661|460747898|FG001|Overall Study|Consent not received from both parents|0|||
127586899|NCT02935842|459117481|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
127586900|NCT02935842|459117478|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
127586901|NCT02935842|459117479|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
127586902|NCT02935842|459117480|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
127586903|NCT02935842|459117481|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
127586904|NCT02935842|459117478|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
127586905|NCT02935842|459117479|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
127586906|NCT02935842|459117480|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
128033091|NCT01051661|460747899|FG002|Overall Study|Consent not received from both parents|0|||
128033092|NCT01051661|460747900|FG003|Overall Study|Consent not received from both parents|0|||
128033093|NCT01051661|460747901|FG004|Overall Study|Consent not received from both parents|0|||
128033094|NCT01051661|460747902|FG005|Overall Study|Consent not received from both parents|1|||
128033095|NCT01051661|460747897|FG000|Overall Study|Failure to comply with protocol|0|||
128033096|NCT01051661|460747898|FG001|Overall Study|Failure to comply with protocol|0|||
128033097|NCT01051661|460747899|FG002|Overall Study|Failure to comply with protocol|2|||
128033098|NCT01051661|460747900|FG003|Overall Study|Failure to comply with protocol|0|||
128033099|NCT01051661|460747901|FG004|Overall Study|Failure to comply with protocol|0|||
128033100|NCT01051661|460747902|FG005|Overall Study|Failure to comply with protocol|0|||
128033101|NCT01051661|460747897|FG000|Overall Study|Subject lost legal representation|0|||
128033102|NCT01051661|460747898|FG001|Overall Study|Subject lost legal representation|0|||
128033103|NCT01051661|460747899|FG002|Overall Study|Subject lost legal representation|0|||
128033104|NCT01051661|460747900|FG003|Overall Study|Subject lost legal representation|0|||
128033105|NCT01051661|460747901|FG004|Overall Study|Subject lost legal representation|1|||
128033106|NCT01051661|460747902|FG005|Overall Study|Subject lost legal representation|0|||
128033107|NCT01051661|460747897|FG000|Overall Study|Protocol Violation|0|||
128033108|NCT01051661|460747898|FG001|Overall Study|Protocol Violation|0|||
128033109|NCT01051661|460747899|FG002|Overall Study|Protocol Violation|0|||
128033110|NCT01051661|460747900|FG003|Overall Study|Protocol Violation|1|||
128033111|NCT01051661|460747901|FG004|Overall Study|Protocol Violation|2|||
128033112|NCT01051661|460747902|FG005|Overall Study|Protocol Violation|1|||
128033113|NCT01051661|460747897|FG000|Overall Study|Withdrawal by Subject|16|||
128033114|NCT01051661|460747898|FG001|Overall Study|Withdrawal by Subject|30|||
128033115|NCT01051661|460747899|FG002|Overall Study|Withdrawal by Subject|13|||
128033116|NCT01051661|460747900|FG003|Overall Study|Withdrawal by Subject|28|||
128033117|NCT01051661|460747901|FG004|Overall Study|Withdrawal by Subject|12|||
128033118|NCT01051661|460747902|FG005|Overall Study|Withdrawal by Subject|34|||
127784439|NCT04695392|459835730|FG001|Overall Study|Withdrawn by physician|1|||
127784440|NCT04702737|459835737|FG000|Overall Study|Decision by Sponsor|1|||
127784441|NCT04702737|459835737|FG000|Overall Study|Withdrawal of Consent from Study|3|||
127784442|NCT04702737|459835737|FG000|Overall Study|Lost to Follow-up|1|||
127784443|NCT04702737|459835737|FG000|Overall Study|Death|35|||
128033119|NCT04642079|460747903|FG000|Overall Study|Lost to Follow-up|2|||
127586907|NCT02935842|459117481|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
127586908|NCT02935842|459117478|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
127586909|NCT02935842|459117479|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
127586910|NCT02935842|459117480|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
127586911|NCT02935842|459117481|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
127586912|NCT00911547|459117482|FG000|Overall Study|Adverse Event|8|||
127586913|NCT00911547|459117483|FG001|Overall Study|Adverse Event|27|||
127586914|NCT00911547|459117484|FG002|Overall Study|Adverse Event|11|||
127586915|NCT00911547|459117485|FG003|Overall Study|Adverse Event|6|||
127586916|NCT00911547|459117482|FG000|Overall Study|Lost to Follow-up|0|||
127586917|NCT00911547|459117483|FG001|Overall Study|Lost to Follow-up|0|||
127586918|NCT00911547|459117484|FG002|Overall Study|Lost to Follow-up|2|||
127586919|NCT00911547|459117485|FG003|Overall Study|Lost to Follow-up|1|||
127586920|NCT00911547|459117482|FG000|Overall Study|Protocol Violation|0|||
127586921|NCT00911547|459117483|FG001|Overall Study|Protocol Violation|5|||
127586922|NCT00911547|459117484|FG002|Overall Study|Protocol Violation|5|||
127586923|NCT00911547|459117485|FG003|Overall Study|Protocol Violation|1|||
127586924|NCT00911547|459117482|FG000|Overall Study|Withdrawal by Subject|3|||
127586925|NCT00911547|459117483|FG001|Overall Study|Withdrawal by Subject|10|||
127586926|NCT00911547|459117484|FG002|Overall Study|Withdrawal by Subject|4|||
127586927|NCT00911547|459117485|FG003|Overall Study|Withdrawal by Subject|8|||
128033120|NCT04642079|460747904|FG001|Overall Study|Lost to Follow-up|5|||
128033121|NCT04642079|460747905|FG002|Overall Study|Lost to Follow-up|2|||
128033122|NCT04642079|460747906|FG003|Overall Study|Lost to Follow-up|0|||
128033123|NCT04642079|460747903|FG000|Overall Study|Withdrawal by Subject|0|||
128033124|NCT04642079|460747904|FG001|Overall Study|Withdrawal by Subject|4|||
127784444|NCT00698997|459835738|FG000|Overall Study|Lost to Follow-up|3|||
127586928|NCT01201785|459117486|FG000|Overall Study|Lost to Follow-up|16|||
127586929|NCT04545385|459117489|FG000|Overall Study|Withdrawal by Subject|2|||
127586930|NCT04545385|459117490|FG001|Overall Study|Withdrawal by Subject|0|||
127586931|NCT04545385|459117489|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
127784445|NCT00698997|459835739|FG001|Overall Study|Lost to Follow-up|0|||
127586932|NCT04545385|459117490|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
127586933|NCT04545385|459117489|FG000|Overall Study|Study termination|10|||
127586934|NCT04545385|459117490|FG001|Overall Study|Study termination|10|||
127586935|NCT04545385|459117489|FG000|Overall Study|Sponsor decision|2|||
127586936|NCT04545385|459117490|FG001|Overall Study|Sponsor decision|2|||
127586937|NCT04545385|459117489|FG000|Overall Study|Other than specified|1|||
127586938|NCT04545385|459117490|FG001|Overall Study|Other than specified|0|||
127586939|NCT00915278|459117491|FG000|Overall Study|Death|1|||
127586940|NCT00915278|459117492|FG001|Overall Study|Death|0|||
127586941|NCT00915278|459117493|FG002|Overall Study|Death|0|||
127586942|NCT00915278|459117494|FG003|Overall Study|Death|0|||
127586943|NCT00915278|459117495|FG004|Overall Study|Death|0|||
127586944|NCT00915278|459117496|FG005|Overall Study|Death|0|||
127586945|NCT00915278|459117491|FG000|Overall Study|Lost to Follow-up|0|||
127586946|NCT00915278|459117492|FG001|Overall Study|Lost to Follow-up|1|||
127586947|NCT00915278|459117493|FG002|Overall Study|Lost to Follow-up|0|||
127586948|NCT00915278|459117494|FG003|Overall Study|Lost to Follow-up|0|||
127586949|NCT00915278|459117495|FG004|Overall Study|Lost to Follow-up|0|||
127586950|NCT00915278|459117496|FG005|Overall Study|Lost to Follow-up|0|||
127586951|NCT00915278|459117491|FG000|Overall Study|Withdrawal by Subject|0|||
127586952|NCT00915278|459117492|FG001|Overall Study|Withdrawal by Subject|1|||
127586953|NCT00915278|459117493|FG002|Overall Study|Withdrawal by Subject|0|||
127586954|NCT00915278|459117494|FG003|Overall Study|Withdrawal by Subject|0|||
127586955|NCT00915278|459117495|FG004|Overall Study|Withdrawal by Subject|1|||
127586956|NCT00915278|459117496|FG005|Overall Study|Withdrawal by Subject|4|||
127586957|NCT00915278|459117491|FG000|Overall Study|Adverse Event|4|||
127586958|NCT00915278|459117492|FG001|Overall Study|Adverse Event|1|||
127586959|NCT00915278|459117493|FG002|Overall Study|Adverse Event|0|||
127586960|NCT00915278|459117494|FG003|Overall Study|Adverse Event|0|||
127586961|NCT00915278|459117495|FG004|Overall Study|Adverse Event|0|||
127586962|NCT00915278|459117496|FG005|Overall Study|Adverse Event|0|||
127586963|NCT00915278|459117491|FG000|Overall Study|Progressive disease/clinical progression|0|||
127586964|NCT00915278|459117492|FG001|Overall Study|Progressive disease/clinical progression|0|||
127586965|NCT00915278|459117493|FG002|Overall Study|Progressive disease/clinical progression|0|||
127586966|NCT00915278|459117494|FG003|Overall Study|Progressive disease/clinical progression|3|||
127586967|NCT00915278|459117495|FG004|Overall Study|Progressive disease/clinical progression|1|||
127586968|NCT00915278|459117496|FG005|Overall Study|Progressive disease/clinical progression|2|||
127586969|NCT00915278|459117491|FG000|Overall Study|Infusion related AEs|0|||
127586970|NCT00915278|459117492|FG001|Overall Study|Infusion related AEs|0|||
127586971|NCT00915278|459117493|FG002|Overall Study|Infusion related AEs|0|||
127586972|NCT00915278|459117494|FG003|Overall Study|Infusion related AEs|0|||
127586973|NCT00915278|459117495|FG004|Overall Study|Infusion related AEs|0|||
127586974|NCT00915278|459117496|FG005|Overall Study|Infusion related AEs|2|||
127586975|NCT00915278|459117491|FG000|Overall Study|Admission to hospice|0|||
127586976|NCT00915278|459117492|FG001|Overall Study|Admission to hospice|0|||
127586977|NCT00915278|459117493|FG002|Overall Study|Admission to hospice|1|||
127586978|NCT00915278|459117494|FG003|Overall Study|Admission to hospice|0|||
127586979|NCT00915278|459117495|FG004|Overall Study|Admission to hospice|0|||
127586980|NCT00915278|459117496|FG005|Overall Study|Admission to hospice|0|||
127586981|NCT00939770|459117499|FG000|Overall Study|Adverse Event|1|||
127586982|NCT00939770|459117500|FG001|Overall Study|Adverse Event|1|||
127586983|NCT00939770|459117501|FG002|Overall Study|Adverse Event|0|||
127586984|NCT00939770|459117502|FG003|Overall Study|Adverse Event|0|||
127586985|NCT00939770|459117503|FG004|Overall Study|Adverse Event|6|||
127586986|NCT00939770|459117504|FG005|Overall Study|Adverse Event|2|||
127586987|NCT00939770|459117505|FG006|Overall Study|Adverse Event|1|||
127586988|NCT00939770|459117506|FG007|Overall Study|Adverse Event|1|||
127586989|NCT00939770|459117499|FG000|Overall Study|Lack of Efficacy|4|||
127586990|NCT00939770|459117500|FG001|Overall Study|Lack of Efficacy|6|||
127586991|NCT00939770|459117501|FG002|Overall Study|Lack of Efficacy|13|||
127586992|NCT00939770|459117502|FG003|Overall Study|Lack of Efficacy|9|||
127586993|NCT00939770|459117503|FG004|Overall Study|Lack of Efficacy|16|||
127586994|NCT00939770|459117504|FG005|Overall Study|Lack of Efficacy|8|||
127586995|NCT00939770|459117505|FG006|Overall Study|Lack of Efficacy|11|||
127586996|NCT00939770|459117506|FG007|Overall Study|Lack of Efficacy|1|||
127586997|NCT00939770|459117499|FG000|Overall Study|Lost to Follow-up|0|||
127586998|NCT00939770|459117500|FG001|Overall Study|Lost to Follow-up|0|||
127586999|NCT00939770|459117501|FG002|Overall Study|Lost to Follow-up|0|||
127587000|NCT00939770|459117502|FG003|Overall Study|Lost to Follow-up|0|||
127587001|NCT00939770|459117503|FG004|Overall Study|Lost to Follow-up|1|||
127587002|NCT00939770|459117504|FG005|Overall Study|Lost to Follow-up|0|||
127587003|NCT00939770|459117505|FG006|Overall Study|Lost to Follow-up|0|||
127587004|NCT00939770|459117506|FG007|Overall Study|Lost to Follow-up|0|||
127587005|NCT00939770|459117499|FG000|Overall Study|Physician Decision|0|||
127587006|NCT00939770|459117500|FG001|Overall Study|Physician Decision|0|||
127882017|NCT01154673|460190785|FG001|Overall Study|moved out of province|0|||
127587007|NCT00939770|459117501|FG002|Overall Study|Physician Decision|2|||
127587008|NCT00939770|459117502|FG003|Overall Study|Physician Decision|0|||
128033125|NCT04642079|460747905|FG002|Overall Study|Withdrawal by Subject|1|||
128033126|NCT04642079|460747906|FG003|Overall Study|Withdrawal by Subject|2|||
128033127|NCT04642079|460747903|FG000|Overall Study|Other|0|||
128033128|NCT04642079|460747904|FG001|Overall Study|Other|0|||
127587009|NCT00939770|459117503|FG004|Overall Study|Physician Decision|7|||
127587010|NCT00939770|459117504|FG005|Overall Study|Physician Decision|1|||
127587011|NCT00939770|459117505|FG006|Overall Study|Physician Decision|0|||
127587012|NCT00939770|459117506|FG007|Overall Study|Physician Decision|6|||
127587013|NCT00939770|459117499|FG000|Overall Study|Protocol Violation|0|||
127587014|NCT00939770|459117500|FG001|Overall Study|Protocol Violation|0|||
127784446|NCT00698997|459835738|FG000|Overall Study|Withdrawal by Subject|7|||
127784447|NCT00698997|459835739|FG001|Overall Study|Withdrawal by Subject|27|||
127784448|NCT01436084|459835742|FG000|Overall Study|Disease Progression|2|||
127784449|NCT01436084|459835742|FG000|Overall Study|Withdrawal by Subject|1|||
127784450|NCT01436084|459835742|FG000|Overall Study|Early Closure of Study|1|||
127784451|NCT04814823|459835744|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
127784452|NCT00943579|459835749|FG000|Overall Study|Adverse Event|4|||
127784453|NCT00943579|459835750|FG001|Overall Study|Adverse Event|3|||
127784454|NCT00943579|459835749|FG000|Overall Study|Lack of Efficacy|2|||
127784455|NCT00943579|459835750|FG001|Overall Study|Lack of Efficacy|2|||
127784456|NCT02322125|459836960|FG000|Overall Study|Withdrawal by Subject|2|||
127784457|NCT00449670|459836962|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
127784458|NCT00449670|459836963|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
127784459|NCT00449670|459836962|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
127784460|NCT00449670|459836963|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
127784461|NCT00449670|459836962|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
127784462|NCT00449670|459836963|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
127784463|NCT00449670|459836962|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
128033129|NCT04642079|460747905|FG002|Overall Study|Other|0|||
128033130|NCT04642079|460747906|FG003|Overall Study|Other|1|||
127784464|NCT00449670|459836963|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
127784465|NCT00449670|459836962|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
128033131|NCT04642079|460747903|FG000|Overall Study|No longer met eligibility criteria|1|||
128033132|NCT04642079|460747904|FG001|Overall Study|No longer met eligibility criteria|0|||
128033133|NCT04642079|460747905|FG002|Overall Study|No longer met eligibility criteria|1|||
128033134|NCT04642079|460747906|FG003|Overall Study|No longer met eligibility criteria|1|||
128033135|NCT00635050|460747911|FG000|Overall Study|Withdrawal by Subject|1|||
128033136|NCT03038620|460747912|FG000|Overall Study|Lost to Follow-up|18|||
128033137|NCT03038620|460747913|FG001|Overall Study|Lost to Follow-up|23|||
128033138|NCT03038620|460747912|FG000|Overall Study|Withdrawal by Subject|0|||
128033139|NCT03038620|460747913|FG001|Overall Study|Withdrawal by Subject|15|||
128033140|NCT03038620|460747912|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
128033141|NCT03038620|460747913|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
128033142|NCT00759395|460747915|FG000|Overall Study|Adverse Event|1|||
128033143|NCT00759395|460747916|FG001|Overall Study|Adverse Event|0|||
128033144|NCT00759395|460747915|FG000|Overall Study|Withdrawal by Subject|1|||
127784466|NCT00449670|459836963|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
127784467|NCT00449670|459836962|FG000|Booster Phase (Study no.109873)|Other|0|||
127784468|NCT00449670|459836963|FG001|Booster Phase (Study no.109873)|Other|2|||
127784469|NCT04183790|459836964|FG000|Overall Study|Participants did not rollover to Part B|12|||
127784470|NCT04183790|459836965|FG001|Overall Study|Participants did not rollover to Part B|0|||
127784471|NCT04183790|459836964|FG000|Overall Study|Withdrawal of consent (not due to AE)|6|||
127784472|NCT04183790|459836965|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
127784473|NCT04183790|459836964|FG000|Overall Study|Commercial drug is available for participant|6|||
127784474|NCT04183790|459836965|FG001|Overall Study|Commercial drug is available for participant|0|||
127784475|NCT04183790|459836964|FG000|Overall Study|Adverse Event|1|||
127784476|NCT04183790|459836965|FG001|Overall Study|Adverse Event|0|||
127784477|NCT04183790|459836964|FG000|Overall Study|Not enrolled in 107 study|0|||
127784478|NCT04183790|459836965|FG001|Overall Study|Not enrolled in 107 study|2|||
128033145|NCT00759395|460747916|FG001|Overall Study|Withdrawal by Subject|0|||
128033146|NCT00759395|460747915|FG000|Overall Study|Lack of Efficacy|0|||
128033147|NCT00759395|460747916|FG001|Overall Study|Lack of Efficacy|2|||
127587015|NCT00939770|459117501|FG002|Overall Study|Protocol Violation|0|||
127587016|NCT00939770|459117502|FG003|Overall Study|Protocol Violation|0|||
127587017|NCT00939770|459117503|FG004|Overall Study|Protocol Violation|1|||
127587018|NCT00939770|459117504|FG005|Overall Study|Protocol Violation|0|||
128033148|NCT00086515|460747921|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
128033149|NCT00086515|460747922|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
127587019|NCT00939770|459117505|FG006|Overall Study|Protocol Violation|0|||
127587020|NCT00939770|459117506|FG007|Overall Study|Protocol Violation|0|||
127587021|NCT00939770|459117499|FG000|Overall Study|Withdrawal by Subject|0|||
128033150|NCT00086515|460747921|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
127587022|NCT00939770|459117500|FG001|Overall Study|Withdrawal by Subject|1|||
127587023|NCT00939770|459117501|FG002|Overall Study|Withdrawal by Subject|5|||
127587024|NCT00939770|459117502|FG003|Overall Study|Withdrawal by Subject|2|||
127587025|NCT00939770|459117503|FG004|Overall Study|Withdrawal by Subject|6|||
127587026|NCT00939770|459117504|FG005|Overall Study|Withdrawal by Subject|0|||
127587027|NCT00939770|459117505|FG006|Overall Study|Withdrawal by Subject|2|||
127587028|NCT00939770|459117506|FG007|Overall Study|Withdrawal by Subject|2|||
127587029|NCT01817530|459117511|FG000|Overall Study|Exclusionary Medication Received|0|||
127587030|NCT01817530|459117512|FG001|Overall Study|Exclusionary Medication Received|0|||
127587031|NCT01817530|459117513|FG002|Overall Study|Exclusionary Medication Received|0|||
127694184|NCT02312960|459508679|FG010|Overall Study|Lost to Follow-up|0|||
127587032|NCT01817530|459117514|FG003|Overall Study|Exclusionary Medication Received|0|||
127587033|NCT01817530|459117515|FG004|Overall Study|Exclusionary Medication Received|1|||
127587034|NCT01817530|459117516|FG005|Overall Study|Exclusionary Medication Received|0|||
127587035|NCT01817530|459117517|FG006|Overall Study|Exclusionary Medication Received|0|||
127587036|NCT01817530|459117518|FG007|Overall Study|Exclusionary Medication Received|0|||
127587037|NCT01817530|459117511|FG000|Overall Study|Adverse Event|6|||
127587038|NCT01817530|459117512|FG001|Overall Study|Adverse Event|3|||
127784479|NCT01251653|459836966|FG000|Overall Study|Progressive Disease|1|||
127784480|NCT01251653|459836967|FG001|Overall Study|Progressive Disease|7|||
127784481|NCT01251653|459836968|FG002|Overall Study|Progressive Disease|16|||
127784482|NCT01251653|459836969|FG003|Overall Study|Progressive Disease|4|||
127784483|NCT01251653|459836970|FG004|Overall Study|Progressive Disease|0|||
127784484|NCT01251653|459836971|FG005|Overall Study|Progressive Disease|17|||
127784485|NCT01251653|459836972|FG006|Overall Study|Progressive Disease|14|||
127784486|NCT01251653|459836973|FG007|Overall Study|Progressive Disease|7|||
127784487|NCT01251653|459836974|FG008|Overall Study|Progressive Disease|5|||
127784488|NCT01251653|459836966|FG000|Overall Study|Dose-limiting toxicity|0|||
127784489|NCT01251653|459836967|FG001|Overall Study|Dose-limiting toxicity|1|||
127784490|NCT01251653|459836968|FG002|Overall Study|Dose-limiting toxicity|1|||
127784491|NCT01251653|459836969|FG003|Overall Study|Dose-limiting toxicity|1|||
127784492|NCT01251653|459836970|FG004|Overall Study|Dose-limiting toxicity|0|||
127784493|NCT01251653|459836971|FG005|Overall Study|Dose-limiting toxicity|0|||
127784494|NCT01251653|459836972|FG006|Overall Study|Dose-limiting toxicity|2|||
127784495|NCT01251653|459836973|FG007|Overall Study|Dose-limiting toxicity|0|||
127784496|NCT01251653|459836974|FG008|Overall Study|Dose-limiting toxicity|0|||
127784497|NCT01251653|459836966|FG000|Overall Study|Adverse Event|1|||
127784498|NCT01251653|459836967|FG001|Overall Study|Adverse Event|0|||
127784499|NCT01251653|459836968|FG002|Overall Study|Adverse Event|2|||
127784500|NCT01251653|459836969|FG003|Overall Study|Adverse Event|1|||
127784501|NCT01251653|459836970|FG004|Overall Study|Adverse Event|1|||
127784502|NCT01251653|459836971|FG005|Overall Study|Adverse Event|0|||
127784503|NCT01251653|459836972|FG006|Overall Study|Adverse Event|2|||
127784504|NCT01251653|459836973|FG007|Overall Study|Adverse Event|2|||
127784505|NCT01251653|459836974|FG008|Overall Study|Adverse Event|1|||
127784506|NCT01251653|459836966|FG000|Overall Study|Withdrawal by Subject|1|||
127784507|NCT01251653|459836967|FG001|Overall Study|Withdrawal by Subject|0|||
128033151|NCT00086515|460747922|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
128033152|NCT00086515|460747921|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
128033153|NCT00086515|460747922|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
128033154|NCT00086515|460747921|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
128033155|NCT00086515|460747922|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
128033156|NCT00086515|460747921|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
128033157|NCT00086515|460747922|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
128033158|NCT00086515|460747921|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
128033159|NCT00086515|460747922|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
128033160|NCT00086515|460747921|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
128033161|NCT00086515|460747922|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
128033162|NCT00086515|460747921|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
128033163|NCT00086515|460747922|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
128033164|NCT00086515|460747921|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
128033165|NCT00086515|460747922|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
128033166|NCT00086515|460747921|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
128033167|NCT00086515|460747922|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
128033168|NCT00086515|460747921|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
128033169|NCT00086515|460747922|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
128033170|NCT00086515|460747921|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
128033171|NCT00086515|460747922|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
128033172|NCT00086515|460747921|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
128033173|NCT00086515|460747922|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
128033174|NCT00086515|460747921|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
128033175|NCT00086515|460747922|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
128033176|NCT00086515|460747921|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
128033177|NCT00086515|460747922|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
128033178|NCT00086515|460747921|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
128033179|NCT00086515|460747922|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
128033180|NCT00086515|460747921|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
128033181|NCT00086515|460747922|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
128033182|NCT00086515|460747921|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
128033183|NCT00086515|460747922|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
127587039|NCT01817530|459117513|FG002|Overall Study|Adverse Event|2|||
127784508|NCT01251653|459836968|FG002|Overall Study|Withdrawal by Subject|1|||
127784509|NCT01251653|459836969|FG003|Overall Study|Withdrawal by Subject|0|||
128033184|NCT00086515|460747921|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
128033185|NCT00086515|460747922|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
128033186|NCT00086515|460747921|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
128033187|NCT00086515|460747922|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
128033188|NCT00086515|460747921|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
128033189|NCT00086515|460747922|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
128033190|NCT00086515|460747921|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
128033191|NCT00086515|460747922|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
128033192|NCT00086515|460747921|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
128033193|NCT00086515|460747922|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
128033194|NCT00086515|460747921|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
128033195|NCT00086515|460747922|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
127587040|NCT01817530|459117514|FG003|Overall Study|Adverse Event|5|||
127587041|NCT01817530|459117515|FG004|Overall Study|Adverse Event|0|||
127587042|NCT01817530|459117516|FG005|Overall Study|Adverse Event|10|||
127587043|NCT01817530|459117517|FG006|Overall Study|Adverse Event|5|||
127587044|NCT01817530|459117518|FG007|Overall Study|Adverse Event|8|||
127587045|NCT01817530|459117511|FG000|Overall Study|Subject Noncompliant|3|||
127587046|NCT01817530|459117512|FG001|Overall Study|Subject Noncompliant|1|||
127587047|NCT01817530|459117513|FG002|Overall Study|Subject Noncompliant|0|||
127587048|NCT01817530|459117514|FG003|Overall Study|Subject Noncompliant|4|||
127587049|NCT01817530|459117515|FG004|Overall Study|Subject Noncompliant|0|||
127587050|NCT01817530|459117516|FG005|Overall Study|Subject Noncompliant|1|||
127587051|NCT01817530|459117517|FG006|Overall Study|Subject Noncompliant|1|||
127587052|NCT01817530|459117518|FG007|Overall Study|Subject Noncompliant|1|||
127587053|NCT01817530|459117511|FG000|Overall Study|Lack of Efficacy|1|||
127587054|NCT01817530|459117512|FG001|Overall Study|Lack of Efficacy|0|||
127587055|NCT01817530|459117513|FG002|Overall Study|Lack of Efficacy|0|||
127587056|NCT01817530|459117514|FG003|Overall Study|Lack of Efficacy|0|||
127587057|NCT01817530|459117515|FG004|Overall Study|Lack of Efficacy|0|||
127587058|NCT01817530|459117516|FG005|Overall Study|Lack of Efficacy|1|||
127587059|NCT01817530|459117517|FG006|Overall Study|Lack of Efficacy|0|||
127587060|NCT01817530|459117518|FG007|Overall Study|Lack of Efficacy|1|||
127587061|NCT01817530|459117511|FG000|Overall Study|Pregnancy|0|||
127587062|NCT01817530|459117512|FG001|Overall Study|Pregnancy|0|||
127587063|NCT01817530|459117513|FG002|Overall Study|Pregnancy|0|||
127587064|NCT01817530|459117514|FG003|Overall Study|Pregnancy|0|||
127587065|NCT01817530|459117515|FG004|Overall Study|Pregnancy|0|||
127587066|NCT01817530|459117516|FG005|Overall Study|Pregnancy|1|||
127587067|NCT01817530|459117517|FG006|Overall Study|Pregnancy|0|||
127587068|NCT01817530|459117518|FG007|Overall Study|Pregnancy|0|||
127587069|NCT01817530|459117511|FG000|Overall Study|Other|0|||
127587070|NCT01817530|459117512|FG001|Overall Study|Other|1|||
127587071|NCT01817530|459117513|FG002|Overall Study|Other|0|||
127587072|NCT01817530|459117514|FG003|Overall Study|Other|0|||
127587073|NCT01817530|459117515|FG004|Overall Study|Other|1|||
127587074|NCT01817530|459117516|FG005|Overall Study|Other|0|||
127587075|NCT01817530|459117517|FG006|Overall Study|Other|5|||
127587076|NCT01817530|459117518|FG007|Overall Study|Other|0|||
127587077|NCT01817530|459117511|FG000|Overall Study|Surgery or Invasive Intervention|1|||
127587078|NCT01817530|459117512|FG001|Overall Study|Surgery or Invasive Intervention|0|||
127587079|NCT01817530|459117513|FG002|Overall Study|Surgery or Invasive Intervention|0|||
127587080|NCT01817530|459117514|FG003|Overall Study|Surgery or Invasive Intervention|0|||
127587081|NCT01817530|459117515|FG004|Overall Study|Surgery or Invasive Intervention|1|||
127587082|NCT01817530|459117516|FG005|Overall Study|Surgery or Invasive Intervention|1|||
127587083|NCT01817530|459117517|FG006|Overall Study|Surgery or Invasive Intervention|1|||
127587084|NCT01817530|459117518|FG007|Overall Study|Surgery or Invasive Intervention|0|||
128033196|NCT00086515|460747921|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
128033197|NCT00086515|460747922|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
128033198|NCT00086515|460747921|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
128033199|NCT00086515|460747922|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
128033200|NCT00086515|460747921|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
128033201|NCT00086515|460747922|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
128033202|NCT00086515|460747921|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
128033203|NCT00086515|460747922|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
128033204|NCT00086515|460747921|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
127587085|NCT01817530|459117511|FG000|Overall Study|Consent Withdrawn by Subject|3|||
127587086|NCT01817530|459117512|FG001|Overall Study|Consent Withdrawn by Subject|4|||
127587087|NCT01817530|459117513|FG002|Overall Study|Consent Withdrawn by Subject|7|||
127587088|NCT01817530|459117514|FG003|Overall Study|Consent Withdrawn by Subject|3|||
127587089|NCT01817530|459117515|FG004|Overall Study|Consent Withdrawn by Subject|5|||
127587090|NCT01817530|459117516|FG005|Overall Study|Consent Withdrawn by Subject|3|||
127587091|NCT01817530|459117517|FG006|Overall Study|Consent Withdrawn by Subject|3|||
127587092|NCT01817530|459117518|FG007|Overall Study|Consent Withdrawn by Subject|10|||
127587093|NCT01817530|459117511|FG000|Overall Study|Lost to Follow-up|1|||
127587094|NCT01817530|459117512|FG001|Overall Study|Lost to Follow-up|4|||
127587095|NCT01817530|459117513|FG002|Overall Study|Lost to Follow-up|2|||
127587096|NCT01817530|459117514|FG003|Overall Study|Lost to Follow-up|1|||
127587097|NCT01817530|459117515|FG004|Overall Study|Lost to Follow-up|3|||
127587098|NCT01817530|459117516|FG005|Overall Study|Lost to Follow-up|2|||
128033205|NCT00086515|460747922|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
127587099|NCT01817530|459117517|FG006|Overall Study|Lost to Follow-up|8|||
127587100|NCT01817530|459117518|FG007|Overall Study|Lost to Follow-up|4|||
127587101|NCT01798004|459119052|FG000|Overall Study|Death|2|||
127587102|NCT01798004|459119052|FG000|Overall Study|Lack of Efficacy|8|||
127587103|NCT01798004|459119052|FG000|Overall Study|Physician Decision|25|||
127587104|NCT01798004|459119052|FG000|Overall Study|Withdrawal by Subject|4|||
127587105|NCT01798004|459119052|FG000|Overall Study|Ineligible|4|||
127587106|NCT01798004|459119052|FG000|Overall Study|Patient/parent refusal|7|||
127587107|NCT01798004|459119052|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
127587108|NCT01798004|459119052|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
127587109|NCT03281577|459119058|FG000|Overall Study|Adverse Event|0|||
127587110|NCT03281577|459119059|FG001|Overall Study|Adverse Event|0|||
127587111|NCT03281577|459119060|FG002|Overall Study|Adverse Event|0|||
128033206|NCT00086515|460747921|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
128033207|NCT00086515|460747922|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
128033208|NCT00086515|460747921|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
128033209|NCT00086515|460747922|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
128033210|NCT00049543|460747923|FG000|Overall Study|still on treatment|2|||
128033211|NCT00049543|460747924|FG001|Overall Study|still on treatment|9|||
128033212|NCT02106832|460747925|FG000|Overall Study|Adverse Event|1|||
128033213|NCT02106832|460747926|FG001|Overall Study|Adverse Event|2|||
128033214|NCT02106832|460747927|FG002|Overall Study|Adverse Event|3|||
128033215|NCT02106832|460747928|FG003|Overall Study|Adverse Event|0|||
128033216|NCT02106832|460747925|FG000|Overall Study|Death|4|||
128033217|NCT02106832|460747926|FG001|Overall Study|Death|4|||
128033218|NCT02106832|460747927|FG002|Overall Study|Death|1|||
128033219|NCT02106832|460747928|FG003|Overall Study|Death|4|||
128033220|NCT02106832|460747925|FG000|Overall Study|Deterioration of general conditions|0|||
128033221|NCT02106832|460747926|FG001|Overall Study|Deterioration of general conditions|0|||
128033222|NCT02106832|460747927|FG002|Overall Study|Deterioration of general conditions|1|||
128033223|NCT02106832|460747928|FG003|Overall Study|Deterioration of general conditions|0|||
128033224|NCT02106832|460747925|FG000|Overall Study|Lost to Follow-up|0|||
128033225|NCT02106832|460747926|FG001|Overall Study|Lost to Follow-up|1|||
128033226|NCT02106832|460747927|FG002|Overall Study|Lost to Follow-up|1|||
128033227|NCT02106832|460747928|FG003|Overall Study|Lost to Follow-up|3|||
128033228|NCT02106832|460747925|FG000|Overall Study|Physician Decision|1|||
128033229|NCT02106832|460747926|FG001|Overall Study|Physician Decision|0|||
128033230|NCT02106832|460747927|FG002|Overall Study|Physician Decision|0|||
128033231|NCT02106832|460747928|FG003|Overall Study|Physician Decision|0|||
128033232|NCT02106832|460747925|FG000|Overall Study|Protocol Violation|0|||
128033233|NCT02106832|460747926|FG001|Overall Study|Protocol Violation|0|||
128033234|NCT02106832|460747927|FG002|Overall Study|Protocol Violation|0|||
128033235|NCT02106832|460747928|FG003|Overall Study|Protocol Violation|1|||
128033236|NCT02106832|460747925|FG000|Overall Study|Withdrawal by Subject|17|||
128033237|NCT02106832|460747926|FG001|Overall Study|Withdrawal by Subject|17|||
128033238|NCT02106832|460747927|FG002|Overall Study|Withdrawal by Subject|10|||
128033239|NCT02106832|460747928|FG003|Overall Study|Withdrawal by Subject|7|||
128033240|NCT02106832|460747925|FG000|Overall Study|Technical problems|0|||
128033241|NCT02106832|460747926|FG001|Overall Study|Technical problems|1|||
128033242|NCT02106832|460747927|FG002|Overall Study|Technical problems|0|||
128033243|NCT02106832|460747928|FG003|Overall Study|Technical problems|0|||
128033244|NCT03485157|460747929|FG000|Double Blind Phase|Lost to Follow-up|4|||
128033245|NCT03485157|460747930|FG001|Double Blind Phase|Lost to Follow-up|4|||
128033246|NCT03485157|460747929|FG000|Double Blind Phase|Adverse Event|2|||
128033247|NCT03485157|460747930|FG001|Double Blind Phase|Adverse Event|1|||
127587112|NCT03281577|459119061|FG003|Overall Study|Adverse Event|1|||
127587113|NCT03281577|459119058|FG000|Overall Study|Withdrawal by Subject|1|||
127587114|NCT03281577|459119059|FG001|Overall Study|Withdrawal by Subject|0|||
127587115|NCT03281577|459119060|FG002|Overall Study|Withdrawal by Subject|0|||
127694185|NCT02312960|459508680|FG011|Overall Study|Lost to Follow-up|0|||
127694186|NCT02312960|459508681|FG012|Overall Study|Lost to Follow-up|1|||
127694187|NCT02312960|459508682|FG013|Overall Study|Lost to Follow-up|0|||
127694188|NCT02312960|459508669|FG000|Overall Study|Withdrawal by Subject|1|||
127694189|NCT02312960|459508670|FG001|Overall Study|Withdrawal by Subject|2|||
127694190|NCT02312960|459508671|FG002|Overall Study|Withdrawal by Subject|0|||
127694191|NCT02312960|459508672|FG003|Overall Study|Withdrawal by Subject|0|||
127694192|NCT02312960|459508673|FG004|Overall Study|Withdrawal by Subject|1|||
127694193|NCT02312960|459508674|FG005|Overall Study|Withdrawal by Subject|0|||
127694194|NCT02312960|459508675|FG006|Overall Study|Withdrawal by Subject|1|||
127587116|NCT03281577|459119061|FG003|Overall Study|Withdrawal by Subject|0|||
127587117|NCT02323113|459119062|FG000|Overall Study|Adverse Event|3|||
127587118|NCT02323113|459119063|FG001|Overall Study|Adverse Event|3|||
127587119|NCT02323113|459119064|FG002|Overall Study|Adverse Event|2|||
127587120|NCT02323113|459119065|FG003|Overall Study|Adverse Event|5|||
127587121|NCT02323113|459119066|FG004|Overall Study|Adverse Event|8|||
127587122|NCT02323113|459119067|FG005|Overall Study|Adverse Event|3|||
127587123|NCT02323113|459119068|FG006|Overall Study|Adverse Event|6|||
127587124|NCT02323113|459119069|FG007|Overall Study|Adverse Event|0|||
127587125|NCT02323113|459119062|FG000|Overall Study|Progressive Disease|0|||
127587126|NCT02323113|459119063|FG001|Overall Study|Progressive Disease|1|||
127587127|NCT02323113|459119064|FG002|Overall Study|Progressive Disease|1|||
127587128|NCT02323113|459119065|FG003|Overall Study|Progressive Disease|0|||
127587129|NCT02323113|459119066|FG004|Overall Study|Progressive Disease|0|||
127587130|NCT02323113|459119067|FG005|Overall Study|Progressive Disease|3|||
127587131|NCT02323113|459119068|FG006|Overall Study|Progressive Disease|0|||
127587132|NCT02323113|459119069|FG007|Overall Study|Progressive Disease|0|||
127587133|NCT02323113|459119062|FG000|Overall Study|Symptomatic Deterioration|0|||
127587134|NCT02323113|459119063|FG001|Overall Study|Symptomatic Deterioration|0|||
127587135|NCT02323113|459119064|FG002|Overall Study|Symptomatic Deterioration|1|||
127587136|NCT02323113|459119065|FG003|Overall Study|Symptomatic Deterioration|0|||
127587137|NCT02323113|459119066|FG004|Overall Study|Symptomatic Deterioration|1|||
127587138|NCT02323113|459119067|FG005|Overall Study|Symptomatic Deterioration|0|||
127587139|NCT02323113|459119068|FG006|Overall Study|Symptomatic Deterioration|0|||
127587140|NCT02323113|459119069|FG007|Overall Study|Symptomatic Deterioration|0|||
127587141|NCT02323113|459119062|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
127587142|NCT02323113|459119063|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
127587143|NCT02323113|459119064|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
127587144|NCT02323113|459119065|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
127587145|NCT02323113|459119066|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
128033248|NCT03485157|460747929|FG000|Double Blind Phase|Withdrawal by Subject|6|||
128033249|NCT03485157|460747930|FG001|Double Blind Phase|Withdrawal by Subject|9|||
128033250|NCT03485157|460747929|FG000|Double Blind Phase|Removal by PI|3|||
128033251|NCT03485157|460747930|FG001|Double Blind Phase|Removal by PI|7|||
128033252|NCT03485157|460747929|FG000|Open Label Phase|Lost to Follow-up|1|||
128033253|NCT03485157|460747930|FG001|Open Label Phase|Lost to Follow-up|2|||
128033254|NCT03485157|460747929|FG000|Open Label Phase|Adverse Event|0|||
128033255|NCT03485157|460747930|FG001|Open Label Phase|Adverse Event|1|||
128033256|NCT03485157|460747929|FG000|Open Label Phase|Withdrawal by Subject|1|||
128033257|NCT03485157|460747930|FG001|Open Label Phase|Withdrawal by Subject|2|||
128033258|NCT03485157|460747929|FG000|Open Label Phase|Removal by PI|2|||
128033259|NCT03485157|460747930|FG001|Open Label Phase|Removal by PI|0|||
128033260|NCT00265122|460747931|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
128033261|NCT00265122|460747932|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
128033262|NCT00265122|460747933|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
128033263|NCT00265122|460747934|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
128033264|NCT00265122|460747935|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
128033265|NCT00265122|460747936|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
128033266|NCT00265122|460747931|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
128033267|NCT00265122|460747932|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
128033268|NCT00265122|460747933|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
128033269|NCT00265122|460747934|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
127587146|NCT02323113|459119067|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
127587147|NCT02323113|459119068|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
127587148|NCT02323113|459119069|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
127587149|NCT02323113|459119062|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
127587150|NCT02323113|459119063|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
127587151|NCT02323113|459119064|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
127587152|NCT02323113|459119065|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
127587153|NCT02323113|459119066|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
127587154|NCT02323113|459119067|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
127587155|NCT02323113|459119068|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
127784510|NCT01251653|459836970|FG004|Overall Study|Withdrawal by Subject|1|||
127784511|NCT01251653|459836971|FG005|Overall Study|Withdrawal by Subject|1|||
127784512|NCT01251653|459836972|FG006|Overall Study|Withdrawal by Subject|0|||
128033270|NCT00265122|460747935|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
128033271|NCT00265122|460747936|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
128033272|NCT00265122|460747931|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
127587156|NCT02323113|459119069|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
127587157|NCT00443261|459119070|FG000|Overall Study|Death|1|||
127587158|NCT01663532|459119071|FG000|Overall Study|Lost to Follow-up|9|||
127587159|NCT01663532|459119072|FG001|Overall Study|Lost to Follow-up|10|||
127587160|NCT01663532|459119071|FG000|Overall Study|Adverse Event|7|||
127587161|NCT01663532|459119072|FG001|Overall Study|Adverse Event|13|||
127587162|NCT01663532|459119071|FG000|Overall Study|Met Withdrawal Criteria|7|||
127587163|NCT01663532|459119072|FG001|Overall Study|Met Withdrawal Criteria|6|||
127587164|NCT01663532|459119071|FG000|Overall Study|Physician Decision|1|||
127587165|NCT01663532|459119072|FG001|Overall Study|Physician Decision|1|||
127587166|NCT01663532|459119071|FG000|Overall Study|Withdrawal by Subject|35|||
127587167|NCT01663532|459119072|FG001|Overall Study|Withdrawal by Subject|17|||
127587168|NCT01663532|459119071|FG000|Overall Study|Lack of Efficacy|15|||
127587169|NCT01663532|459119072|FG001|Overall Study|Lack of Efficacy|60|||
127587170|NCT01433991|459119078|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
127587171|NCT01433991|459119079|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
127587172|NCT01433991|459119080|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
127587173|NCT01433991|459119081|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
127587174|NCT01433991|459119078|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
127587175|NCT01433991|459119079|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
127587176|NCT01433991|459119080|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
127587177|NCT01433991|459119081|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
127587178|NCT01433991|459119078|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
127587179|NCT01433991|459119079|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
127587180|NCT01433991|459119080|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
127587181|NCT01433991|459119081|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
127587182|NCT01433991|459119078|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
127587183|NCT01433991|459119079|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
127587184|NCT01433991|459119080|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
127587185|NCT01433991|459119081|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
127587186|NCT01433991|459119078|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
127587187|NCT01433991|459119079|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
127587188|NCT01433991|459119080|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
127587189|NCT01433991|459119081|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
127587190|NCT01433991|459119078|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
127587191|NCT01433991|459119079|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
127587192|NCT01433991|459119080|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
127587193|NCT01433991|459119081|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
127587194|NCT01433991|459119078|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
127587195|NCT01433991|459119079|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
127587196|NCT01433991|459119080|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
127587197|NCT01433991|459119081|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
127587198|NCT03539081|459119083|FG000|Overall Study|Withdrawal by Subject|2|||
127587199|NCT03539081|459119084|FG001|Overall Study|Withdrawal by Subject|3|||
127587200|NCT03539081|459119085|FG002|Overall Study|Withdrawal by Subject|0|||
127587201|NCT03539081|459119083|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
127587202|NCT03539081|459119084|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
127587203|NCT03539081|459119085|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
127587204|NCT01673867|459119089|FG000|Randomization|Adverse event unrelated to study drug|1|||
127587205|NCT01673867|459119090|FG001|Randomization|Adverse event unrelated to study drug|0|||
127587206|NCT01673867|459119089|FG000|Randomization|Participant request to discontinue study treatment|0|||
127587207|NCT01673867|459119090|FG001|Randomization|Participant request to discontinue study treatment|4|||
127587208|NCT01673867|459119089|FG000|Randomization|Withdrawal by participant|0|||
127587209|NCT01673867|459119090|FG001|Randomization|Withdrawal by participant|12|||
127587210|NCT01673867|459119089|FG000|Randomization|Lost to Follow-up|0|||
127587211|NCT01673867|459119090|FG001|Randomization|Lost to Follow-up|1|||
127587212|NCT01673867|459119089|FG000|Randomization|Participant no longer meets study criteria|4|||
127587213|NCT01673867|459119090|FG001|Randomization|Participant no longer meets study criteria|5|||
127587214|NCT01673867|459119089|FG000|Treatment|Disease Progression|208|||
127587215|NCT01673867|459119090|FG001|Treatment|Disease Progression|178|||
127587216|NCT01673867|459119089|FG000|Treatment|Study Drug Toxicity|23|||
127587217|NCT01673867|459119090|FG001|Treatment|Study Drug Toxicity|43|||
127587218|NCT01673867|459119089|FG000|Treatment|Death|2|||
127587219|NCT01673867|459119090|FG001|Treatment|Death|3|||
127587220|NCT01673867|459119089|FG000|Treatment|Adverse event unrelated to study drug|23|||
127587221|NCT01673867|459119090|FG001|Treatment|Adverse event unrelated to study drug|10|||
127587222|NCT01673867|459119089|FG000|Treatment|Participant request to discontinue study treatment|7|||
127587223|NCT01673867|459119090|FG001|Treatment|Participant request to discontinue study treatment|17|||
127587224|NCT01673867|459119089|FG000|Treatment|Withdrawal by participant|5|||
127587225|NCT01673867|459119090|FG001|Treatment|Withdrawal by participant|5|||
127587226|NCT01673867|459119089|FG000|Treatment|Maximum clinical benefit|1|||
127587227|NCT01673867|459119090|FG001|Treatment|Maximum clinical benefit|10|||
127587228|NCT01673867|459119089|FG000|Treatment|Participant no longer meets study criteria|2|||
127587229|NCT01673867|459119090|FG001|Treatment|Participant no longer meets study criteria|0|||
127587230|NCT01673867|459119089|FG000|Treatment|Administrative reason by sponsor|3|||
127587231|NCT01673867|459119090|FG001|Treatment|Administrative reason by sponsor|0|||
127587232|NCT01673867|459119089|FG000|Treatment|Other reason|11|||
127587233|NCT01673867|459119090|FG001|Treatment|Other reason|2|||
127587234|NCT02550106|459119093|FG000|Overall Study|Adverse Event|1|||
127587235|NCT02550106|459119093|FG000|Overall Study|Lack of Efficacy|3|||
127587236|NCT02550106|459119093|FG000|Overall Study|Protocol Violation|6|||
127784513|NCT01251653|459836973|FG007|Overall Study|Withdrawal by Subject|1|||
127784514|NCT01251653|459836974|FG008|Overall Study|Withdrawal by Subject|0|||
127784515|NCT01251653|459836966|FG000|Overall Study|Other reason not mentioned above|0|||
127784516|NCT01251653|459836967|FG001|Overall Study|Other reason not mentioned above|0|||
127784517|NCT01251653|459836968|FG002|Overall Study|Other reason not mentioned above|0|||
127784518|NCT01251653|459836969|FG003|Overall Study|Other reason not mentioned above|0|||
127784519|NCT01251653|459836970|FG004|Overall Study|Other reason not mentioned above|0|||
127784520|NCT01251653|459836971|FG005|Overall Study|Other reason not mentioned above|0|||
127784521|NCT01251653|459836972|FG006|Overall Study|Other reason not mentioned above|0|||
127784522|NCT01251653|459836973|FG007|Overall Study|Other reason not mentioned above|2|||
127784523|NCT01251653|459836974|FG008|Overall Study|Other reason not mentioned above|0|||
127784524|NCT02232802|459836976|FG000|Period 1|Sponsor request|1|||
128033273|NCT00265122|460747932|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
128033274|NCT00265122|460747933|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
128033275|NCT00265122|460747934|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
128033276|NCT00265122|460747935|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
128033277|NCT00265122|460747936|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
128033278|NCT00265122|460747931|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
128033279|NCT00265122|460747932|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
128033280|NCT00265122|460747933|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
128033281|NCT00265122|460747934|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
128033282|NCT00265122|460747935|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
128033283|NCT00265122|460747936|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
128033284|NCT00265122|460747931|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
128033285|NCT00265122|460747932|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
128033286|NCT00265122|460747933|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
128033287|NCT00265122|460747934|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
128033288|NCT00265122|460747935|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
128033289|NCT00265122|460747936|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
128033290|NCT00265122|460747931|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
128033291|NCT00265122|460747932|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
128033292|NCT00265122|460747933|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
127587237|NCT02550106|459119093|FG000|Overall Study|Withdrawal by Subject|2|||
127587238|NCT00354744|459119094|FG000|Overall Study|Adverse Event|2|||
127587239|NCT00354744|459119094|FG000|Overall Study|Death|2|||
127587240|NCT00354744|459119094|FG000|Overall Study|Lack of Efficacy|11|||
127587241|NCT00354744|459119094|FG000|Overall Study|Lost to Follow-up|2|||
127587242|NCT00354744|459119094|FG000|Overall Study|Physician Decision|11|||
127784525|NCT02232802|459836977|FG001|Period 1|Sponsor request|0|||
127784526|NCT02232802|459836976|FG000|Period 1|Adverse Event|1|||
127784527|NCT02232802|459836977|FG001|Period 1|Adverse Event|1|||
127784528|NCT00885703|459836982|FG000|Overall Study|Death|9|||
128033293|NCT00265122|460747934|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
128033294|NCT00265122|460747935|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
128033295|NCT00265122|460747936|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
128033296|NCT05205616|460747937|FG000|Overall Study|Lost to Follow-up|4|||
127587243|NCT00354744|459119094|FG000|Overall Study|Withdrawal by Subject|14|||
127587244|NCT01193530|459119095|FG000|Overall Study|Withdrawal by Subject|2|||
127587245|NCT01193530|459119096|FG001|Overall Study|Withdrawal by Subject|2|||
128033297|NCT05205616|460747938|FG001|Overall Study|Lost to Follow-up|4|||
128033298|NCT03620981|460747948|FG000|Overall Study|Adverse Event|14|||
128033299|NCT03620981|460747949|FG001|Overall Study|Adverse Event|38|||
127587246|NCT01193530|459119095|FG000|Overall Study|Began Contraindicated Therapy|1|||
127587247|NCT01193530|459119096|FG001|Overall Study|Began Contraindicated Therapy|0|||
127587248|NCT01193530|459119095|FG000|Overall Study|Lost Light Box|0|||
127587249|NCT01193530|459119096|FG001|Overall Study|Lost Light Box|1|||
127784529|NCT00885703|459836983|FG001|Overall Study|Death|7|||
127784530|NCT00885703|459836984|FG002|Overall Study|Death|8|||
127784531|NCT00885703|459836985|FG003|Overall Study|Death|7|||
127587250|NCT01193530|459119095|FG000|Overall Study|Returned home - out of state|0|||
127587251|NCT01193530|459119096|FG001|Overall Study|Returned home - out of state|1|||
127587252|NCT01193530|459119095|FG000|Overall Study|Non-Compliance|0|||
127587253|NCT01193530|459119096|FG001|Overall Study|Non-Compliance|1|||
127784532|NCT00885703|459836986|FG004|Overall Study|Death|7|||
127784533|NCT00885703|459836987|FG005|Overall Study|Death|8|||
127784534|NCT00885703|459836988|FG006|Overall Study|Death|4|||
127784535|NCT00885703|459836982|FG000|Overall Study|Lost to Follow-up|0|||
128033300|NCT03620981|460747950|FG002|Overall Study|Adverse Event|25|||
128033301|NCT03620981|460747948|FG000|Overall Study|Lack of Efficacy|2|||
128033302|NCT03620981|460747949|FG001|Overall Study|Lack of Efficacy|1|||
128033303|NCT03620981|460747950|FG002|Overall Study|Lack of Efficacy|1|||
128033304|NCT03620981|460747948|FG000|Overall Study|Physician Decision|7|||
128033305|NCT03620981|460747949|FG001|Overall Study|Physician Decision|4|||
128033306|NCT03620981|460747950|FG002|Overall Study|Physician Decision|4|||
128033307|NCT03620981|460747948|FG000|Overall Study|Protocol Violation|1|||
128033308|NCT03620981|460747949|FG001|Overall Study|Protocol Violation|2|||
128033309|NCT03620981|460747950|FG002|Overall Study|Protocol Violation|1|||
128033310|NCT03620981|460747948|FG000|Overall Study|Withdrawal by Legal Representative|2|||
128033311|NCT03620981|460747949|FG001|Overall Study|Withdrawal by Legal Representative|1|||
128033312|NCT03620981|460747950|FG002|Overall Study|Withdrawal by Legal Representative|1|||
128033313|NCT03620981|460747948|FG000|Overall Study|Withdrawal by Care Giver|2|||
128033314|NCT03620981|460747949|FG001|Overall Study|Withdrawal by Care Giver|0|||
128033315|NCT03620981|460747950|FG002|Overall Study|Withdrawal by Care Giver|1|||
128033316|NCT03620981|460747948|FG000|Overall Study|Non-compliance with Study Drug|1|||
128033317|NCT03620981|460747949|FG001|Overall Study|Non-compliance with Study Drug|1|||
128033318|NCT03620981|460747950|FG002|Overall Study|Non-compliance with Study Drug|0|||
128033319|NCT02607722|460747951|FG000|Overall Study|No data reliability|1|||
128033320|NCT02607722|460747951|FG000|Overall Study|no patient visit|18|||
128033321|NCT02607722|460747951|FG000|Overall Study|missing info in CRF|13|||
128033322|NCT02607722|460747951|FG000|Overall Study|Withdrawal by Subject|616|||
128033323|NCT02607722|460747951|FG000|Overall Study|Lost to Follow-up|312|||
128033324|NCT02607722|460747951|FG000|Overall Study|Improved|22|||
128033325|NCT02607722|460747951|FG000|Overall Study|Lack of Efficacy|316|||
128033326|NCT02607722|460747951|FG000|Overall Study|Adverse Event|2553|||
128033327|NCT02607722|460747951|FG000|Overall Study|Not treated|1|||
127784536|NCT00885703|459836983|FG001|Overall Study|Lost to Follow-up|0|||
127784537|NCT00885703|459836984|FG002|Overall Study|Lost to Follow-up|1|||
127784538|NCT00885703|459836985|FG003|Overall Study|Lost to Follow-up|0|||
127784539|NCT00885703|459836986|FG004|Overall Study|Lost to Follow-up|0|||
127784540|NCT00885703|459836987|FG005|Overall Study|Lost to Follow-up|1|||
127784541|NCT00885703|459836988|FG006|Overall Study|Lost to Follow-up|0|||
127784542|NCT00885703|459836982|FG000|Overall Study|Withdrawal by Subject|0|||
127784543|NCT00885703|459836983|FG001|Overall Study|Withdrawal by Subject|0|||
127784544|NCT00885703|459836984|FG002|Overall Study|Withdrawal by Subject|0|||
127784545|NCT00885703|459836985|FG003|Overall Study|Withdrawal by Subject|1|||
127784546|NCT00885703|459836986|FG004|Overall Study|Withdrawal by Subject|3|||
127784547|NCT00885703|459836987|FG005|Overall Study|Withdrawal by Subject|1|||
127784548|NCT00885703|459836988|FG006|Overall Study|Withdrawal by Subject|1|||
127784549|NCT00885703|459836982|FG000|Overall Study|Ineligible (no CM)|1|||
127784550|NCT00885703|459836983|FG001|Overall Study|Ineligible (no CM)|3|||
127784551|NCT00885703|459836984|FG002|Overall Study|Ineligible (no CM)|2|||
127784552|NCT00885703|459836985|FG003|Overall Study|Ineligible (no CM)|1|||
127784553|NCT00885703|459836986|FG004|Overall Study|Ineligible (no CM)|2|||
128033328|NCT02607722|460747951|FG000|Overall Study|No CRF collected|138|||
128033329|NCT02607722|460747951|FG000|Overall Study|without CRF|4225|||
128033330|NCT02607722|460747951|FG000|Overall Study|Physician Decision|367|||
127587254|NCT00926328|459119099|FG000|Overall Study|Lost to Follow-up|12|||
128033331|NCT03238196|460747952|FG000|Overall Study|Adverse Event|3|||
127784554|NCT00885703|459836987|FG005|Overall Study|Ineligible (no CM)|3|||
127784555|NCT00885703|459836988|FG006|Overall Study|Ineligible (no CM)|1|||
127784556|NCT01183143|459836989|FG000|Overall Study|Protocol Violation|115|||
127784557|NCT01183143|459836989|FG000|Overall Study|Withdrawal by Subject|19|||
127784558|NCT01183143|459836989|FG000|Overall Study|Subject Questionnaires not returned|5|||
127784559|NCT01183143|459836989|FG000|Overall Study|Subjects enrolled, but not treated|11|||
127784560|NCT01490450|459836991|FG000|Period 1|Lack of Efficacy|2|||
128033332|NCT03238196|460747953|FG001|Overall Study|Adverse Event|0|||
128033333|NCT03238196|460747954|FG002|Overall Study|Adverse Event|2|||
128033334|NCT03238196|460747955|FG003|Overall Study|Adverse Event|2|||
128033335|NCT03238196|460747952|FG000|Overall Study|Withdrawal by Subject|4|||
128033336|NCT03238196|460747953|FG001|Overall Study|Withdrawal by Subject|1|||
128033337|NCT03238196|460747954|FG002|Overall Study|Withdrawal by Subject|1|||
128033338|NCT03238196|460747955|FG003|Overall Study|Withdrawal by Subject|0|||
128033339|NCT03238196|460747952|FG000|Overall Study|Disease progression|14|||
128033340|NCT03238196|460747953|FG001|Overall Study|Disease progression|2|||
128033341|NCT03238196|460747954|FG002|Overall Study|Disease progression|3|||
127784561|NCT01490450|459836992|FG001|Period 1|Lack of Efficacy|0|||
127784562|NCT01490450|459836993|FG002|Period 1|Lack of Efficacy|3|||
127587255|NCT00926328|459119100|FG001|Overall Study|Lost to Follow-up|14|||
127587256|NCT00289133|459119101|FG000|Overall Study|Non-study device implanted|12|||
127587257|NCT00289133|459119102|FG001|Overall Study|Non-study device implanted|0|||
127587258|NCT00289133|459119101|FG000|Overall Study|Protocol Violation|32|||
127587259|NCT00289133|459119102|FG001|Overall Study|Protocol Violation|38|||
127587260|NCT00289133|459119101|FG000|Overall Study|Withdrawal by Subject|9|||
127587261|NCT00289133|459119102|FG001|Overall Study|Withdrawal by Subject|10|||
128033342|NCT03238196|460747955|FG003|Overall Study|Disease progression|2|||
128033343|NCT03238196|460747952|FG000|Overall Study|Still on treatment|1|||
127587262|NCT00289133|459119101|FG000|Overall Study|Death|5|||
127587263|NCT00289133|459119102|FG001|Overall Study|Death|10|||
127587264|NCT00289133|459119101|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
127587265|NCT00289133|459119102|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
127587266|NCT00289133|459119101|FG000|Overall Study|Physician Decision|41|||
127587267|NCT00289133|459119102|FG001|Overall Study|Physician Decision|45|||
127587268|NCT00289133|459119101|FG000|Overall Study|Revision|8|||
127587269|NCT00289133|459119102|FG001|Overall Study|Revision|6|||
127587270|NCT00289133|459119101|FG000|Overall Study|Lost to Follow-up|92|||
127587271|NCT00289133|459119102|FG001|Overall Study|Lost to Follow-up|115|||
127587272|NCT01513343|459119105|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
127587273|NCT01513343|459119106|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
127587274|NCT01513343|459119105|FG000|Post Data Collection|Dropped/withdrew from study|7|||
127587275|NCT01513343|459119106|FG001|Post Data Collection|Dropped/withdrew from study|1|||
127587276|NCT01513343|459119105|FG000|Post Data Collection|Lost to Follow-up|10|||
127587277|NCT01513343|459119106|FG001|Post Data Collection|Lost to Follow-up|23|||
127587278|NCT01513343|459119105|FG000|6-month Follow-up|Lost to Follow-up|28|||
127587279|NCT01513343|459119106|FG001|6-month Follow-up|Lost to Follow-up|17|||
127587280|NCT01513343|459119105|FG000|12-month Follow-up|Lost to Follow-up|10|||
127587281|NCT01513343|459119106|FG001|12-month Follow-up|Lost to Follow-up|3|||
127587282|NCT02165215|459119110|FG000|Induction Phase|Adverse Event|1|||
127587283|NCT02165215|459119111|FG001|Induction Phase|Adverse Event|0|||
127587284|NCT02165215|459119112|FG002|Induction Phase|Adverse Event|0|||
127587285|NCT02165215|459119110|FG000|Induction Phase|Withdrawal by Subject|10|||
127587286|NCT02165215|459119111|FG001|Induction Phase|Withdrawal by Subject|0|||
127587287|NCT02165215|459119112|FG002|Induction Phase|Withdrawal by Subject|0|||
127587288|NCT02165215|459119110|FG000|Induction Phase|Protocol Violation|1|||
127587289|NCT02165215|459119111|FG001|Induction Phase|Protocol Violation|0|||
127587290|NCT02165215|459119112|FG002|Induction Phase|Protocol Violation|0|||
127587291|NCT02165215|459119110|FG000|Induction Phase|Physician Decision|1|||
127587292|NCT02165215|459119111|FG001|Induction Phase|Physician Decision|0|||
127587293|NCT02165215|459119112|FG002|Induction Phase|Physician Decision|0|||
127587294|NCT02165215|459119110|FG000|Induction Phase|Lack of Efficacy|2|||
127587295|NCT02165215|459119111|FG001|Induction Phase|Lack of Efficacy|0|||
127587296|NCT02165215|459119112|FG002|Induction Phase|Lack of Efficacy|0|||
127587297|NCT02165215|459119110|FG000|Induction Phase|Non-Compliance|2|||
127587298|NCT02165215|459119111|FG001|Induction Phase|Non-Compliance|0|||
127587299|NCT02165215|459119112|FG002|Induction Phase|Non-Compliance|0|||
127587300|NCT02165215|459119110|FG000|Induction Phase|Lost to Follow-up|6|||
127587301|NCT02165215|459119111|FG001|Induction Phase|Lost to Follow-up|0|||
127587302|NCT02165215|459119112|FG002|Induction Phase|Lost to Follow-up|0|||
127587303|NCT02165215|459119110|FG000|Maintenance Phase|Withdrawal by Subject|0|||
127587304|NCT02165215|459119111|FG001|Maintenance Phase|Withdrawal by Subject|7|||
127587305|NCT02165215|459119112|FG002|Maintenance Phase|Withdrawal by Subject|3|||
127587306|NCT02165215|459119110|FG000|Maintenance Phase|Multiple reasons|0|||
127587307|NCT02165215|459119111|FG001|Maintenance Phase|Multiple reasons|2|||
127587308|NCT02165215|459119112|FG002|Maintenance Phase|Multiple reasons|1|||
127587309|NCT02165215|459119110|FG000|Maintenance Phase|Lost to Follow-up|0|||
127587310|NCT02165215|459119111|FG001|Maintenance Phase|Lost to Follow-up|2|||
127587311|NCT02165215|459119112|FG002|Maintenance Phase|Lost to Follow-up|0|||
127587312|NCT02165215|459119110|FG000|Maintenance Phase|Adverse Event|0|||
127587313|NCT02165215|459119111|FG001|Maintenance Phase|Adverse Event|1|||
127587314|NCT02165215|459119112|FG002|Maintenance Phase|Adverse Event|1|||
128033344|NCT03238196|460747953|FG001|Overall Study|Still on treatment|0|||
128033345|NCT03238196|460747954|FG002|Overall Study|Still on treatment|0|||
128033346|NCT03238196|460747955|FG003|Overall Study|Still on treatment|0|||
128033347|NCT04938427|460747956|FG000|Overall Study|Adverse Event|5|||
128033348|NCT04938427|460747957|FG001|Overall Study|Adverse Event|19|||
127587315|NCT00064337|459119113|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
127587316|NCT00064337|459119113|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
127587317|NCT00064337|459119113|FG000|PBSCC or Induction/PBSCC|Progression|3|||
127587318|NCT00064337|459119113|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
127587319|NCT00064337|459119113|FG000|PBSCC or Induction/PBSCC|Death|2|||
127587320|NCT00064337|459119113|FG000|Transplant|Adverse Event|9|||
127587321|NCT00064337|459119113|FG000|Transplant|Not protocol-specified|5|||
127587322|NCT00064337|459119113|FG000|Transplant|Death|3|||
128033349|NCT04938427|460747956|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
128033350|NCT04938427|460747957|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
127587323|NCT00064337|459119113|FG000|Transplant|Patient Refusal|2|||
127587324|NCT00064337|459119113|FG000|Transplant|Progression|2|||
127587325|NCT00064337|459119113|FG000|Maintenance|Adverse Event|3|||
127587326|NCT00064337|459119113|FG000|Maintenance|Progression|2|||
127587327|NCT00064337|459119113|FG000|Maintenance|On treatment at time of analysis|2|||
127587328|NCT00064337|459119113|FG000|Maintenance|Not protocol-specified|2|||
127587329|NCT00064337|459119113|FG000|Maintenance|Death|1|||
127587330|NCT02279420|459119114|FG000|Overall Study|Lost to Follow-up|23|||
127587331|NCT05096221|459119117|FG000|Part 2|Physician Decision|0|||
127587332|NCT05096221|459119118|FG001|Part 2|Physician Decision|1|||
127587333|NCT03094169|459119120|FG000|Overall Study|Lack of Efficacy|0|||
127587334|NCT03094169|459119121|FG001|Overall Study|Lack of Efficacy|0|||
127587335|NCT03094169|459119122|FG002|Overall Study|Lack of Efficacy|0|||
127587336|NCT03094169|459119123|FG003|Overall Study|Lack of Efficacy|0|||
127587337|NCT03094169|459119124|FG004|Overall Study|Lack of Efficacy|0|||
127587338|NCT03094169|459119125|FG005|Overall Study|Lack of Efficacy|0|||
127587339|NCT03094169|459119126|FG006|Overall Study|Lack of Efficacy|0|||
127587340|NCT03094169|459119127|FG007|Overall Study|Lack of Efficacy|21|||
127587341|NCT03094169|459119120|FG000|Overall Study|Adverse Event|0|||
127587342|NCT03094169|459119121|FG001|Overall Study|Adverse Event|0|||
127587343|NCT03094169|459119122|FG002|Overall Study|Adverse Event|0|||
127587344|NCT03094169|459119123|FG003|Overall Study|Adverse Event|0|||
127587345|NCT03094169|459119124|FG004|Overall Study|Adverse Event|0|||
127587346|NCT03094169|459119125|FG005|Overall Study|Adverse Event|0|||
127587347|NCT03094169|459119126|FG006|Overall Study|Adverse Event|0|||
127587348|NCT03094169|459119127|FG007|Overall Study|Adverse Event|2|||
127587349|NCT03094169|459119120|FG000|Overall Study|Withdrawal by Subject|0|||
127587350|NCT03094169|459119121|FG001|Overall Study|Withdrawal by Subject|0|||
127587351|NCT03094169|459119122|FG002|Overall Study|Withdrawal by Subject|0|||
127587352|NCT03094169|459119123|FG003|Overall Study|Withdrawal by Subject|0|||
127587353|NCT03094169|459119124|FG004|Overall Study|Withdrawal by Subject|0|||
127587354|NCT03094169|459119125|FG005|Overall Study|Withdrawal by Subject|0|||
127587355|NCT03094169|459119126|FG006|Overall Study|Withdrawal by Subject|1|||
127587356|NCT03094169|459119127|FG007|Overall Study|Withdrawal by Subject|1|||
127587357|NCT03094169|459119120|FG000|Overall Study|Trial Termination|0|||
127587358|NCT03094169|459119121|FG001|Overall Study|Trial Termination|0|||
127587359|NCT03094169|459119122|FG002|Overall Study|Trial Termination|0|||
127587360|NCT03094169|459119123|FG003|Overall Study|Trial Termination|0|||
127587361|NCT03094169|459119124|FG004|Overall Study|Trial Termination|0|||
127587362|NCT03094169|459119125|FG005|Overall Study|Trial Termination|0|||
127587363|NCT03094169|459119126|FG006|Overall Study|Trial Termination|0|||
127587364|NCT03094169|459119127|FG007|Overall Study|Trial Termination|1|||
127587365|NCT04645953|459119128|FG000|Overall Study|Lost to Follow-up|2|||
127587366|NCT04645953|459119129|FG001|Overall Study|Lost to Follow-up|1|||
127587367|NCT04645953|459119130|FG002|Overall Study|Lost to Follow-up|1|||
127587368|NCT04645953|459119128|FG000|Overall Study|Withdrawal by Subject|0|||
127587369|NCT04645953|459119129|FG001|Overall Study|Withdrawal by Subject|1|||
127587370|NCT04645953|459119130|FG002|Overall Study|Withdrawal by Subject|0|||
127587371|NCT04645953|459119128|FG000|Overall Study|Physician Decision|0|||
127587372|NCT04645953|459119129|FG001|Overall Study|Physician Decision|1|||
127587373|NCT04645953|459119130|FG002|Overall Study|Physician Decision|0|||
127587374|NCT04645953|459119128|FG000|Overall Study|Discontinued Prior to Dosing|0|||
127587375|NCT04645953|459119129|FG001|Overall Study|Discontinued Prior to Dosing|0|||
127587376|NCT04645953|459119130|FG002|Overall Study|Discontinued Prior to Dosing|2|||
127587377|NCT04613375|459119131|FG000|Overall Study|Death|198|||
127587378|NCT04613375|459119131|FG000|Overall Study|Withdrawal by Subject|3|||
127587379|NCT01921387|459119132|FG000|Overall Study|Adverse Event|1|||
127587380|NCT01706146|459119134|FG000|Overall Study|Withdrawal by Subject|1|||
127587381|NCT01706146|459119134|FG000|Overall Study|Adverse Event|3|||
127587382|NCT01706146|459119134|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
127587383|NCT00675948|459119135|FG000|Overall Study|Adverse Event|23|||
127587384|NCT00675948|459119136|FG001|Overall Study|Adverse Event|1|||
128033351|NCT04938427|460747956|FG000|Overall Study|Withdrawal by Subject|1|||
127587385|NCT00675948|459119135|FG000|Overall Study|Lack of Efficacy|3|||
127587386|NCT00675948|459119136|FG001|Overall Study|Lack of Efficacy|0|||
128033352|NCT04938427|460747957|FG001|Overall Study|Withdrawal by Subject|0|||
128033353|NCT04938427|460747956|FG000|Overall Study|Reason Not Specified|2|||
128033354|NCT04938427|460747957|FG001|Overall Study|Reason Not Specified|1|||
127587387|NCT00675948|459119135|FG000|Overall Study|Withdrawal by Subject|7|||
128033355|NCT00936936|460749469|FG000|Overall Study|Adverse Event|7|||
128033356|NCT00936936|460749470|FG001|Overall Study|Adverse Event|1|||
128033357|NCT00936936|460749469|FG000|Overall Study|Disease Progression|2|||
128033358|NCT00936936|460749470|FG001|Overall Study|Disease Progression|2|||
127587388|NCT00675948|459119136|FG001|Overall Study|Withdrawal by Subject|0|||
127587389|NCT00675948|459119135|FG000|Overall Study|Lost to Follow-up|2|||
127587390|NCT00675948|459119136|FG001|Overall Study|Lost to Follow-up|0|||
127784563|NCT01490450|459836994|FG003|Period 1|Lack of Efficacy|0|||
127587391|NCT00675948|459119135|FG000|Overall Study|Protocol Violation|1|||
127587392|NCT00675948|459119136|FG001|Overall Study|Protocol Violation|0|||
128033359|NCT00936936|460749469|FG000|Overall Study|Unrelated|3|||
128033360|NCT00936936|460749470|FG001|Overall Study|Unrelated|1|||
128033361|NCT01373281|460749471|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
128033362|NCT01373281|460749472|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
128033363|NCT01373281|460749471|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
128033364|NCT01373281|460749472|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
128033365|NCT01373281|460749471|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
128033366|NCT01373281|460749472|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
128033367|NCT01373281|460749471|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
128033368|NCT01373281|460749472|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
128033369|NCT01373281|460749471|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
128033370|NCT01373281|460749472|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
128033371|NCT01373281|460749471|FG000|Surveillance Expansion Period|Protocol Violation|9|||
128033372|NCT01373281|460749472|FG001|Surveillance Expansion Period|Protocol Violation|1|||
128033373|NCT01373281|460749471|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
128033374|NCT01373281|460749472|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
128033375|NCT01373281|460749471|FG000|Surveillance Expansion Period|Serious adverse event|3|||
128033376|NCT01373281|460749472|FG001|Surveillance Expansion Period|Serious adverse event|4|||
128033377|NCT00851084|460749473|FG000|Overall Study|Randomized but not treated|1|||
128033378|NCT00851084|460749474|FG001|Overall Study|Randomized but not treated|0|||
128033379|NCT00851084|460749473|FG000|Overall Study|Adverse Event|26|||
128033380|NCT00851084|460749474|FG001|Overall Study|Adverse Event|36|||
128033381|NCT00851084|460749473|FG000|Overall Study|Disease progression|52|||
128033382|NCT00851084|460749474|FG001|Overall Study|Disease progression|47|||
128033383|NCT00851084|460749473|FG000|Overall Study|Poor compliance to protocol|1|||
128033384|NCT00851084|460749474|FG001|Overall Study|Poor compliance to protocol|1|||
128033385|NCT00851084|460749473|FG000|Overall Study|Physician Decision|13|||
128033386|NCT00851084|460749474|FG001|Overall Study|Physician Decision|14|||
128033387|NCT00851084|460749473|FG000|Overall Study|Consent withdrawn|0|||
128033388|NCT00851084|460749474|FG001|Overall Study|Consent withdrawn|2|||
128033389|NCT00851084|460749473|FG000|Overall Study|Withdrawal by Subject|11|||
128033390|NCT00851084|460749474|FG001|Overall Study|Withdrawal by Subject|12|||
128033391|NCT00851084|460749473|FG000|Overall Study|Metastatic surgery|6|||
128033392|NCT00851084|460749474|FG001|Overall Study|Metastatic surgery|6|||
128033393|NCT00851084|460749473|FG000|Overall Study|Other|7|||
128033394|NCT00851084|460749474|FG001|Overall Study|Other|1|||
127587393|NCT00675948|459119135|FG000|Overall Study|Pain under control|1|||
127587394|NCT00675948|459119136|FG001|Overall Study|Pain under control|0|||
127587395|NCT00675948|459119135|FG000|Overall Study|Sponsor decision|0|||
127587396|NCT00675948|459119136|FG001|Overall Study|Sponsor decision|1|||
127587397|NCT00675948|459119135|FG000|Overall Study|Patient died|1|||
127587398|NCT00675948|459119136|FG001|Overall Study|Patient died|0|||
127587399|NCT00675948|459119135|FG000|Overall Study|Patient unable to comply with diaries|1|||
127587400|NCT00675948|459119136|FG001|Overall Study|Patient unable to comply with diaries|0|||
127587401|NCT00675948|459119135|FG000|Overall Study|Patient feels unable to take medication|0|||
127587402|NCT00675948|459119136|FG001|Overall Study|Patient feels unable to take medication|1|||
127587403|NCT02582983|459119137|FG000|Overall Study|Death|3|||
127587404|NCT02582983|459119137|FG000|Overall Study|Withdrawal by Subject|2|||
127587405|NCT02582983|459119137|FG000|Overall Study|Adverse Event|1|||
127587406|NCT02527161|459119138|FG000|Overall Study|Failed MRI|52|||
127587407|NCT02527161|459119138|FG000|Overall Study|Withdrawal by Subject|19|||
127587408|NCT02527161|459119138|FG000|Overall Study|Delay in or unfit for surgery|16|||
127587409|NCT02527161|459119138|FG000|Overall Study|MRI contraindication|6|||
127587410|NCT02527161|459119138|FG000|Overall Study|Consent violation|4|||
127587411|NCT02527161|459119138|FG000|Overall Study|Only Recruited to Part A|27|||
127587412|NCT02527161|459119138|FG000|Overall Study|Physician Decision|1|||
127587413|NCT02527161|459119138|FG000|Overall Study|Adverse Event|1|||
127587414|NCT02527161|459119138|FG000|Overall Study|Lost to Follow-up|6|||
127587415|NCT05209360|459119139|FG000|Overall Study|Withdrawal by Subject|0|||
127587416|NCT05209360|459119140|FG001|Overall Study|Withdrawal by Subject|0|||
127587417|NCT05209360|459119141|FG002|Overall Study|Withdrawal by Subject|1|||
127587418|NCT05209360|459119142|FG003|Overall Study|Withdrawal by Subject|0|||
128033395|NCT00734032|460749475|FG000|Overall Study|Adverse Event|0|||
127587419|NCT05209360|459119143|FG004|Overall Study|Withdrawal by Subject|0|||
127587420|NCT05209360|459119144|FG005|Overall Study|Withdrawal by Subject|0|||
127587421|NCT00724932|459119145|FG000|Overall Study|Lost to Follow-up|1|||
127587422|NCT00724932|459119146|FG001|Overall Study|Lost to Follow-up|0|||
127587423|NCT00724932|459119145|FG000|Overall Study|Not treated|4|||
127587424|NCT00724932|459119146|FG001|Overall Study|Not treated|3|||
127587425|NCT01081678|459119149|FG000|Overall Study|Ineligibility Determined|0|||
127587426|NCT01081678|459119150|FG001|Overall Study|Ineligibility Determined|0|||
127587427|NCT01081678|459119151|FG002|Overall Study|Ineligibility Determined|1|||
127784564|NCT01490450|459836991|FG000|Period 1|Adverse Event|0|||
127784565|NCT01490450|459836992|FG001|Period 1|Adverse Event|0|||
128033396|NCT00734032|460749476|FG001|Overall Study|Adverse Event|1|||
128033397|NCT00734032|460749477|FG002|Overall Study|Adverse Event|0|||
127587428|NCT01081678|459119152|FG003|Overall Study|Ineligibility Determined|1|||
127587429|NCT01081678|459119149|FG000|Overall Study|Noncompliance|3|||
127587430|NCT01081678|459119150|FG001|Overall Study|Noncompliance|4|||
127587431|NCT01081678|459119151|FG002|Overall Study|Noncompliance|5|||
127587432|NCT01081678|459119152|FG003|Overall Study|Noncompliance|2|||
127587433|NCT01081678|459119149|FG000|Overall Study|Adverse Event|2|||
127587434|NCT01081678|459119150|FG001|Overall Study|Adverse Event|1|||
127587435|NCT01081678|459119151|FG002|Overall Study|Adverse Event|2|||
127587436|NCT01081678|459119152|FG003|Overall Study|Adverse Event|2|||
127587437|NCT01081678|459119149|FG000|Overall Study|Withdrawal by Subject|15|||
127587438|NCT01081678|459119150|FG001|Overall Study|Withdrawal by Subject|7|||
127587439|NCT01081678|459119151|FG002|Overall Study|Withdrawal by Subject|17|||
127587440|NCT01081678|459119152|FG003|Overall Study|Withdrawal by Subject|14|||
127587441|NCT01081678|459119149|FG000|Overall Study|Administrative Decision|1|||
127587442|NCT01081678|459119150|FG001|Overall Study|Administrative Decision|0|||
127587443|NCT01081678|459119151|FG002|Overall Study|Administrative Decision|0|||
127587444|NCT01081678|459119152|FG003|Overall Study|Administrative Decision|1|||
127587445|NCT01081678|459119149|FG000|Overall Study|Lost to Follow-up|4|||
127587446|NCT01081678|459119150|FG001|Overall Study|Lost to Follow-up|1|||
127587447|NCT01081678|459119151|FG002|Overall Study|Lost to Follow-up|4|||
127587448|NCT01081678|459119152|FG003|Overall Study|Lost to Follow-up|3|||
127587449|NCT01081678|459119149|FG000|Overall Study|Death|2|||
127587450|NCT01081678|459119150|FG001|Overall Study|Death|2|||
127587451|NCT01081678|459119151|FG002|Overall Study|Death|2|||
127587452|NCT01081678|459119152|FG003|Overall Study|Death|6|||
127587453|NCT01081678|459119149|FG000|Overall Study|Other|0|||
127587454|NCT01081678|459119150|FG001|Overall Study|Other|1|||
127587455|NCT01081678|459119151|FG002|Overall Study|Other|0|||
127587456|NCT01081678|459119152|FG003|Overall Study|Other|0|||
127587457|NCT01007812|459119155|FG000|Period 1, One Week|Lost to Follow-up|0|||
127587458|NCT01007812|459119156|FG001|Period 1, One Week|Lost to Follow-up|1|||
127587459|NCT01007812|459119155|FG000|Period 1, One Week|Discomfort|1|||
127587460|NCT01007812|459119156|FG001|Period 1, One Week|Discomfort|0|||
127587461|NCT01091974|459119157|FG000|Overall Study|Did not start intervention|3|||
127784566|NCT01490450|459836993|FG002|Period 1|Adverse Event|0|||
127784567|NCT01490450|459836994|FG003|Period 1|Adverse Event|5|||
127784568|NCT01490450|459836991|FG000|Period 1|Request to discontinue treatment|1|||
127784569|NCT01490450|459836992|FG001|Period 1|Request to discontinue treatment|0|||
127784570|NCT01490450|459836993|FG002|Period 1|Request to discontinue treatment|0|||
127784571|NCT01490450|459836994|FG003|Period 1|Request to discontinue treatment|0|||
127784572|NCT01490450|459836991|FG000|Period 1|Withdrawal by Subject|0|||
127784573|NCT01490450|459836992|FG001|Period 1|Withdrawal by Subject|0|||
127784574|NCT01490450|459836993|FG002|Period 1|Withdrawal by Subject|0|||
127882018|NCT00646282|460190786|FG000|Overall Study|Protocol terminated|4|||
127587462|NCT01091974|459119158|FG001|Overall Study|Did not start intervention|1|||
127587463|NCT01091974|459119159|FG002|Overall Study|Did not start intervention|3|||
127587464|NCT01091974|459119160|FG003|Overall Study|Did not start intervention|1|||
127587465|NCT01091974|459119157|FG000|Overall Study|resumed sleep medication|0|||
127587466|NCT01091974|459119158|FG001|Overall Study|resumed sleep medication|0|||
127587467|NCT01091974|459119159|FG002|Overall Study|resumed sleep medication|1|||
127587468|NCT01091974|459119160|FG003|Overall Study|resumed sleep medication|2|||
127587469|NCT01091974|459119157|FG000|Overall Study|Withdrawal by Subject|1|||
127587470|NCT01091974|459119158|FG001|Overall Study|Withdrawal by Subject|3|||
127587471|NCT01091974|459119159|FG002|Overall Study|Withdrawal by Subject|2|||
127587472|NCT01091974|459119160|FG003|Overall Study|Withdrawal by Subject|2|||
127587473|NCT01091974|459119157|FG000|Overall Study|side-effects|1|||
127587474|NCT01091974|459119158|FG001|Overall Study|side-effects|1|||
127587475|NCT01091974|459119159|FG002|Overall Study|side-effects|0|||
127587476|NCT01091974|459119160|FG003|Overall Study|side-effects|2|||
127587477|NCT02499783|459119161|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
127587478|NCT02499783|459119162|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
127587479|NCT02499783|459119163|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
127587480|NCT02499783|459119161|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
127587481|NCT02499783|459119162|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
127587482|NCT02499783|459119163|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
127587483|NCT02499783|459119161|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
127705214|NCT01928394|459551571|FG004|Treatment Period|Death|0|||
127705215|NCT01928394|459551572|FG005|Treatment Period|Death|0|||
127705216|NCT01928394|459551573|FG006|Treatment Period|Death|0|||
127705217|NCT01928394|459551574|FG007|Treatment Period|Death|0|||
127705218|NCT01928394|459551575|FG008|Treatment Period|Death|0|||
127705219|NCT01928394|459551576|FG009|Treatment Period|Death|0|||
127705220|NCT01928394|459551577|FG010|Treatment Period|Death|0|||
127705221|NCT01928394|459551578|FG011|Treatment Period|Death|0|||
127705222|NCT01928394|459551579|FG012|Treatment Period|Death|0|||
127705223|NCT01928394|459551580|FG013|Treatment Period|Death|1|||
127705224|NCT01928394|459551581|FG014|Treatment Period|Death|2|||
127705225|NCT01928394|459551582|FG015|Treatment Period|Death|0|||
127587484|NCT02499783|459119162|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
127587485|NCT02499783|459119163|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
127587486|NCT02499783|459119161|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
127587487|NCT02499783|459119162|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
127587488|NCT02499783|459119163|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
127587489|NCT02499783|459119161|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
127587490|NCT02499783|459119162|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
127587491|NCT02499783|459119163|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
127587492|NCT02499783|459119161|FG000|DB Period: Weeks 0-8|Other|1|||
127587493|NCT02499783|459119162|FG001|DB Period: Weeks 0-8|Other|1|||
127587494|NCT02499783|459119163|FG002|DB Period: Weeks 0-8|Other|0|||
127587495|NCT02499783|459119161|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
127587496|NCT02499783|459119162|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
127587497|NCT02499783|459119163|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
127587498|NCT02499783|459119161|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
127587499|NCT02499783|459119162|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
127587500|NCT02499783|459119163|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
127587501|NCT02499783|459119161|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
127587502|NCT02499783|459119162|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
127784575|NCT01490450|459836994|FG003|Period 1|Withdrawal by Subject|3|||
127784576|NCT01490450|459836991|FG000|Period 1|No longer met study criteria|0|||
127784577|NCT01490450|459836992|FG001|Period 1|No longer met study criteria|1|||
127784578|NCT01490450|459836993|FG002|Period 1|No longer met study criteria|1|||
127784579|NCT01490450|459836994|FG003|Period 1|No longer met study criteria|0|||
127784580|NCT01490450|459836991|FG000|Period 2|Lack of Efficacy|0|||
127784581|NCT01490450|459836992|FG001|Period 2|Lack of Efficacy|0|||
127784582|NCT01490450|459836993|FG002|Period 2|Lack of Efficacy|0|||
127784583|NCT01490450|459836994|FG003|Period 2|Lack of Efficacy|1|||
127784584|NCT01490450|459836991|FG000|Period 2|Adverse Event|1|||
127784585|NCT01490450|459836992|FG001|Period 2|Adverse Event|1|||
127784586|NCT01490450|459836993|FG002|Period 2|Adverse Event|0|||
127784587|NCT01490450|459836994|FG003|Period 2|Adverse Event|1|||
127784588|NCT01490450|459836991|FG000|Period 2|Withdrawal by Subject|1|||
127784589|NCT01490450|459836992|FG001|Period 2|Withdrawal by Subject|0|||
127784590|NCT01490450|459836993|FG002|Period 2|Withdrawal by Subject|0|||
127784591|NCT01490450|459836994|FG003|Period 2|Withdrawal by Subject|0|||
127784592|NCT01490450|459836991|FG000|Period 2|Lost to Follow-up|0|||
127784593|NCT01490450|459836992|FG001|Period 2|Lost to Follow-up|0|||
127784594|NCT01490450|459836993|FG002|Period 2|Lost to Follow-up|0|||
127784595|NCT01490450|459836994|FG003|Period 2|Lost to Follow-up|2|||
127784596|NCT03197493|459836995|FG000|Overall Study|Withdrawal by Subject|5|||
127784597|NCT02865018|459836997|FG000|Overall Study|Withdrawal by Subject|1|||
127784598|NCT05500274|459837003|FG000|Overall Study|Not able to complete the session and follow-up visits.|7|||
127784599|NCT05500274|459837004|FG001|Overall Study|Not able to complete the session and follow-up visits.|15|||
127784600|NCT05500274|459837003|FG000|Overall Study|Lost to Follow-up|76|||
127784601|NCT05500274|459837004|FG001|Overall Study|Lost to Follow-up|51|||
127784602|NCT05807464|459837005|FG000|Overall Study|Adverse Event|1|||
127784603|NCT01555151|459837006|FG000|Overall Study|Withdrawal by Subject|6|||
127784604|NCT01555151|459837007|FG001|Overall Study|Withdrawal by Subject|2|||
127784605|NCT01555151|459837008|FG002|Overall Study|Withdrawal by Subject|0|||
127784606|NCT01555151|459837009|FG003|Overall Study|Withdrawal by Subject|2|||
127784607|NCT01555151|459837006|FG000|Overall Study|Administrative|3|||
127784608|NCT01555151|459837007|FG001|Overall Study|Administrative|1|||
127784609|NCT01555151|459837008|FG002|Overall Study|Administrative|2|||
127784610|NCT01555151|459837009|FG003|Overall Study|Administrative|0|||
127784611|NCT01555151|459837006|FG000|Overall Study|Protocol Violation|3|||
127784612|NCT01555151|459837007|FG001|Overall Study|Protocol Violation|3|||
127784613|NCT01555151|459837008|FG002|Overall Study|Protocol Violation|3|||
127784614|NCT01555151|459837009|FG003|Overall Study|Protocol Violation|5|||
127784615|NCT01555151|459837006|FG000|Overall Study|Adverse Event|1|||
127882019|NCT00646282|460190787|FG001|Overall Study|Protocol terminated|4|||
127587503|NCT02499783|459119163|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
127784616|NCT01555151|459837007|FG001|Overall Study|Adverse Event|2|||
127784617|NCT01555151|459837008|FG002|Overall Study|Adverse Event|1|||
127784618|NCT01555151|459837009|FG003|Overall Study|Adverse Event|2|||
127882020|NCT01556490|460190788|FG000|Randomized Patients Summary|Protocol Violation|22|||
127882021|NCT01556490|460190789|FG001|Randomized Patients Summary|Protocol Violation|23|||
127587504|NCT02499783|459119161|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
127587505|NCT02499783|459119162|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
127587506|NCT02499783|459119163|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
127784619|NCT01555151|459837006|FG000|Overall Study|Lost to Follow-up|0|||
127784620|NCT01555151|459837007|FG001|Overall Study|Lost to Follow-up|0|||
127784621|NCT01555151|459837008|FG002|Overall Study|Lost to Follow-up|0|||
127784622|NCT01555151|459837009|FG003|Overall Study|Lost to Follow-up|1|||
127784623|NCT03596866|459837010|FG000|Overall Study|Site terminated by Sponsor|64|||
127784624|NCT03596866|459837011|FG001|Overall Study|Site terminated by Sponsor|65|||
127784625|NCT03596866|459837010|FG000|Overall Study|Death|37|||
127587507|NCT01866293|459119164|FG000|Overall Study|Adverse Event|2|||
127587508|NCT00555971|459119166|FG000|Overall Study|Adverse Event|1|||
127587509|NCT00555971|459119167|FG001|Overall Study|Adverse Event|1|||
127587510|NCT00518284|459119168|FG000|Overall Study|Adverse Event|0|||
127587511|NCT00518284|459119169|FG001|Overall Study|Adverse Event|1|||
127587512|NCT00518284|459119170|FG002|Overall Study|Adverse Event|0|||
127587513|NCT00518284|459119171|FG003|Overall Study|Adverse Event|0|||
127587514|NCT00518284|459119168|FG000|Overall Study|Study Termination|0|||
127587515|NCT00518284|459119169|FG001|Overall Study|Study Termination|2|||
127587516|NCT00518284|459119170|FG002|Overall Study|Study Termination|1|||
127587517|NCT00518284|459119171|FG003|Overall Study|Study Termination|2|||
127587518|NCT02571777|459119172|FG000|Overall Study|Subject/guardian decision|34|||
127587519|NCT02571777|459119173|FG001|Overall Study|Subject/guardian decision|26|||
128033398|NCT00734032|460749478|FG003|Overall Study|Adverse Event|0|||
128033399|NCT00133705|460749481|FG000|Overall Study|Withdrawal by Subject|2|||
128033400|NCT00133705|460749482|FG001|Overall Study|Withdrawal by Subject|3|||
128033401|NCT04992273|460749486|FG000|Overall Study|Lost to Follow-up|0|||
127587520|NCT02571777|459119174|FG002|Overall Study|Subject/guardian decision|26|||
127587521|NCT02571777|459119175|FG003|Overall Study|Subject/guardian decision|25|||
127587522|NCT02571777|459119176|FG004|Overall Study|Subject/guardian decision|27|||
127587523|NCT02571777|459119172|FG000|Overall Study|Protocol Deviation|2|||
127587524|NCT02571777|459119173|FG001|Overall Study|Protocol Deviation|3|||
127587525|NCT02571777|459119174|FG002|Overall Study|Protocol Deviation|4|||
127587526|NCT02571777|459119175|FG003|Overall Study|Protocol Deviation|8|||
127587527|NCT02571777|459119176|FG004|Overall Study|Protocol Deviation|4|||
127587528|NCT02571777|459119172|FG000|Overall Study|Death|1|||
127587529|NCT02571777|459119173|FG001|Overall Study|Death|1|||
128033402|NCT04992273|460749487|FG001|Overall Study|Lost to Follow-up|1|||
128033403|NCT03440411|460749488|FG000|Overall Study|Adverse Event|0|||
128033404|NCT03440411|460749489|FG001|Overall Study|Adverse Event|0|||
128033405|NCT03440411|460749490|FG002|Overall Study|Adverse Event|1|||
128033406|NCT03440411|460749491|FG003|Overall Study|Adverse Event|0|||
128033407|NCT03440411|460749488|FG000|Overall Study|PD|2|||
127587530|NCT02571777|459119174|FG002|Overall Study|Death|4|||
127587531|NCT02571777|459119175|FG003|Overall Study|Death|0|||
128033408|NCT03440411|460749489|FG001|Overall Study|PD|1|||
128033409|NCT03440411|460749490|FG002|Overall Study|PD|1|||
128033410|NCT03440411|460749491|FG003|Overall Study|PD|1|||
128033411|NCT03440411|460749488|FG000|Overall Study|Withdrawal by Subject|1|||
128033412|NCT03440411|460749489|FG001|Overall Study|Withdrawal by Subject|0|||
128033413|NCT03440411|460749490|FG002|Overall Study|Withdrawal by Subject|0|||
128033414|NCT03440411|460749491|FG003|Overall Study|Withdrawal by Subject|0|||
128033415|NCT03440411|460749488|FG000|Overall Study|Closed study by sponsor|0|||
128033416|NCT03440411|460749489|FG001|Overall Study|Closed study by sponsor|0|||
128033417|NCT03440411|460749490|FG002|Overall Study|Closed study by sponsor|0|||
128033418|NCT03440411|460749491|FG003|Overall Study|Closed study by sponsor|1|||
128033419|NCT03847519|460749496|FG000|Overall Study|Death|5|||
128033420|NCT03847519|460749497|FG001|Overall Study|Death|8|||
128033421|NCT03847519|460749498|FG002|Overall Study|Death|1|||
128033422|NCT03847519|460749496|FG000|Overall Study|Lost to Follow-up|1|||
128033423|NCT03847519|460749497|FG001|Overall Study|Lost to Follow-up|2|||
128033424|NCT03847519|460749498|FG002|Overall Study|Lost to Follow-up|0|||
128033425|NCT03847519|460749496|FG000|Overall Study|Study Terminated by Sponsor|0|||
128033426|NCT03847519|460749497|FG001|Overall Study|Study Terminated by Sponsor|3|||
128033427|NCT03847519|460749498|FG002|Overall Study|Study Terminated by Sponsor|2|||
128033428|NCT03528902|460749503|FG000|Overall Study|Adverse Event|1|||
128033429|NCT03528902|460749504|FG001|Overall Study|Adverse Event|0|||
127587532|NCT02571777|459119176|FG004|Overall Study|Death|0|||
127587533|NCT02571777|459119172|FG000|Overall Study|Lost to Follow-up|1|||
128033430|NCT00645658|460749505|FG000|Overall Study|Withdrawal by Subject|1|||
128033431|NCT00645658|460749506|FG001|Overall Study|Withdrawal by Subject|0|||
128033432|NCT00645658|460749505|FG000|Overall Study|Did not complete all assesments|0|||
128033433|NCT00645658|460749506|FG001|Overall Study|Did not complete all assesments|2|||
128033434|NCT03605693|460749507|FG000|Overall Study|Lost to Follow-up|4|||
128033435|NCT03605693|460749508|FG001|Overall Study|Lost to Follow-up|0|||
128033436|NCT03605693|460749507|FG000|Overall Study|Physician Decision|1|||
127587534|NCT02571777|459119173|FG001|Overall Study|Lost to Follow-up|1|||
127587535|NCT02571777|459119174|FG002|Overall Study|Lost to Follow-up|2|||
127587536|NCT02571777|459119175|FG003|Overall Study|Lost to Follow-up|0|||
127587537|NCT02571777|459119176|FG004|Overall Study|Lost to Follow-up|1|||
127587538|NCT02571777|459119172|FG000|Overall Study|Physician Decision|1|||
127587539|NCT02571777|459119173|FG001|Overall Study|Physician Decision|7|||
127587540|NCT02571777|459119174|FG002|Overall Study|Physician Decision|5|||
127587541|NCT02571777|459119175|FG003|Overall Study|Physician Decision|2|||
128033437|NCT03605693|460749508|FG001|Overall Study|Physician Decision|0|||
128033438|NCT03093415|460749509|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
128033439|NCT03093415|460749510|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
128033440|NCT03093415|460749511|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
127587542|NCT02571777|459119176|FG004|Overall Study|Physician Decision|4|||
127587543|NCT02571777|459119172|FG000|Overall Study|Pregnancy|0|||
127587544|NCT02571777|459119173|FG001|Overall Study|Pregnancy|0|||
127587545|NCT02571777|459119174|FG002|Overall Study|Pregnancy|0|||
127587546|NCT02571777|459119175|FG003|Overall Study|Pregnancy|2|||
127587547|NCT02571777|459119176|FG004|Overall Study|Pregnancy|0|||
127587548|NCT00801632|459119177|FG000|Overall Study|Re-transplant|1|||
127587549|NCT02369016|459119178|FG000|Overall Study|AE associated with clinical disease progression|2|||
127587550|NCT02369016|459119179|FG001|Overall Study|AE associated with clinical disease progression|1|||
127587551|NCT02369016|459119178|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
127587552|NCT02369016|459119179|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
127587553|NCT02369016|459119178|FG000|Overall Study|Progressive disease - clinical progression|1|||
127587554|NCT02369016|459119179|FG001|Overall Study|Progressive disease - clinical progression|4|||
127587555|NCT02369016|459119178|FG000|Overall Study|withdrawal by patient|4|||
127587556|NCT02369016|459119179|FG001|Overall Study|withdrawal by patient|0|||
127587557|NCT02369016|459119178|FG000|Overall Study|Progressive disease - radiological progression|6|||
127587558|NCT02369016|459119179|FG001|Overall Study|Progressive disease - radiological progression|2|||
127587559|NCT01702961|459119180|FG000|Overall Study|Additional treatment|3|||
127587560|NCT01702961|459119180|FG000|Overall Study|Progressive disease|5|||
127587561|NCT01702961|459119180|FG000|Overall Study|Relapse|20|||
127587562|NCT01702961|459119180|FG000|Overall Study|Death|6|||
127587563|NCT01702961|459119180|FG000|Overall Study|Lost to Follow-up|2|||
127587564|NCT01702961|459119180|FG000|Overall Study|Ongoing|11|||
127587565|NCT02229383|459119181|FG000|Overall Study|Adverse Event|7|||
127587566|NCT02229383|459119182|FG001|Overall Study|Adverse Event|4|||
127587567|NCT02229383|459119181|FG000|Overall Study|Death|0|||
127587568|NCT02229383|459119182|FG001|Overall Study|Death|1|||
127587569|NCT02229383|459119181|FG000|Overall Study|Lost to Follow-up|5|||
127587570|NCT02229383|459119182|FG001|Overall Study|Lost to Follow-up|3|||
127587571|NCT02229383|459119181|FG000|Overall Study|Withdrawal by Subject|4|||
127587572|NCT02229383|459119182|FG001|Overall Study|Withdrawal by Subject|6|||
127587573|NCT02229383|459119181|FG000|Overall Study|Did not receive treatment|1|||
127587574|NCT02229383|459119182|FG001|Overall Study|Did not receive treatment|0|||
127587575|NCT02229383|459119181|FG000|Overall Study|Other|3|||
127587576|NCT02229383|459119182|FG001|Overall Study|Other|8|||
127587577|NCT00674362|459119183|FG000|Double Blind|Adverse Event|6|||
127587578|NCT00674362|459119184|FG001|Double Blind|Adverse Event|6|||
127587579|NCT00674362|459119183|FG000|Double Blind|Lack of Efficacy|2|||
127587580|NCT00674362|459119184|FG001|Double Blind|Lack of Efficacy|6|||
127587581|NCT00674362|459119183|FG000|Double Blind|Loss of efficacy|0|||
127587582|NCT00674362|459119184|FG001|Double Blind|Loss of efficacy|1|||
127587583|NCT00674362|459119183|FG000|Double Blind|Withdrawal by Subject|4|||
127587584|NCT00674362|459119184|FG001|Double Blind|Withdrawal by Subject|3|||
127587585|NCT00674362|459119183|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
127587586|NCT00674362|459119184|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
127587587|NCT00674362|459119183|FG000|Double Blind|Other: Surgery|0|||
127587588|NCT00674362|459119184|FG001|Double Blind|Other: Surgery|1|||
127587589|NCT00674362|459119183|FG000|Open Label|Adverse Event|1|||
127587590|NCT00674362|459119184|FG001|Open Label|Adverse Event|0|||
127587591|NCT00674362|459119183|FG000|Open Label|Other: Subject moved to extension study|1|||
127587592|NCT00674362|459119184|FG001|Open Label|Other: Subject moved to extension study|0|||
127587593|NCT01201850|459119186|FG000|Overall Study|Tumor progression|4|||
127587594|NCT00191139|459119187|FG000|Overall Study|Adverse Event|2|||
127587595|NCT00191139|459119188|FG001|Overall Study|Adverse Event|6|||
127587596|NCT00191139|459119187|FG000|Overall Study|Death|2|||
127587597|NCT00191139|459119188|FG001|Overall Study|Death|0|||
127587598|NCT00191139|459119187|FG000|Overall Study|Withdrawal by Subject|0|||
127587599|NCT00191139|459119188|FG001|Overall Study|Withdrawal by Subject|3|||
127587600|NCT00191139|459119187|FG000|Overall Study|Disease Progression|0|||
127587601|NCT00191139|459119188|FG001|Overall Study|Disease Progression|1|||
127587602|NCT00191139|459119187|FG000|Overall Study|Other|1|||
127587603|NCT00191139|459119188|FG001|Overall Study|Other|2|||
127587604|NCT03846804|459119189|FG000|Overall Study|Refused blood draw|1|||
127587605|NCT03846804|459119189|FG000|Overall Study|Protocol Violation|1|||
127587606|NCT00404235|459119190|FG000|Overall Study|Withdrawal by Subject|1|||
127587607|NCT00404235|459119191|FG001|Overall Study|Withdrawal by Subject|2|||
127587608|NCT00345839|459119192|FG000|Overall Study|Withdrawal by Subject|91|||
127587609|NCT00345839|459119193|FG001|Overall Study|Withdrawal by Subject|98|||
127587610|NCT00345839|459119192|FG000|Overall Study|Lost to Follow-up|58|||
127587611|NCT00345839|459119193|FG001|Overall Study|Lost to Follow-up|61|||
127587612|NCT00743483|459119196|FG000|Baseline Period|Physician Decision|1|||
127587613|NCT00743483|459119196|FG000|Treatment Period|Adverse Event|1|||
127587614|NCT01466153|459119197|FG000|Overall Study|Disease Progression|2|||
127587615|NCT01466153|459119198|FG001|Overall Study|Disease Progression|2|||
127587616|NCT01466153|459119199|FG002|Overall Study|Disease Progression|0|||
127587617|NCT01466153|459119197|FG000|Overall Study|Adverse Event|14|||
127587618|NCT01466153|459119198|FG001|Overall Study|Adverse Event|13|||
127587619|NCT01466153|459119199|FG002|Overall Study|Adverse Event|17|||
127587620|NCT01466153|459119197|FG000|Overall Study|Withdrawal of Consent|2|||
127587621|NCT01466153|459119198|FG001|Overall Study|Withdrawal of Consent|0|||
127587622|NCT01466153|459119199|FG002|Overall Study|Withdrawal of Consent|0|||
127587623|NCT01466153|459119197|FG000|Overall Study|Investigator Discretion|3|||
127587624|NCT01466153|459119198|FG001|Overall Study|Investigator Discretion|2|||
127587625|NCT01466153|459119199|FG002|Overall Study|Investigator Discretion|2|||
127587626|NCT01466153|459119197|FG000|Overall Study|Randomized-Not Treated|2|||
127587627|NCT01466153|459119198|FG001|Overall Study|Randomized-Not Treated|3|||
127587628|NCT01466153|459119199|FG002|Overall Study|Randomized-Not Treated|4|||
127587629|NCT01466153|459119197|FG000|Overall Study|Other-Unspecified|6|||
127587630|NCT01466153|459119198|FG001|Overall Study|Other-Unspecified|4|||
127587631|NCT01466153|459119199|FG002|Overall Study|Other-Unspecified|2|||
127587632|NCT01153347|459120941|FG000|Overall Study|Withdrawal by Subject|7|||
127587633|NCT01153347|459120942|FG001|Overall Study|Withdrawal by Subject|7|||
127587634|NCT01153347|459120943|FG002|Overall Study|Withdrawal by Subject|7|||
127587635|NCT01153347|459120944|FG003|Overall Study|Withdrawal by Subject|7|||
127587636|NCT01153347|459120941|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
127587637|NCT01153347|459120942|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
127587638|NCT01153347|459120943|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
127587639|NCT01153347|459120944|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
127587640|NCT01153347|459120941|FG000|Overall Study|Adverse Event|3|||
127587641|NCT01153347|459120942|FG001|Overall Study|Adverse Event|9|||
127587642|NCT01153347|459120943|FG002|Overall Study|Adverse Event|21|||
127587643|NCT01153347|459120944|FG003|Overall Study|Adverse Event|7|||
127587644|NCT01153347|459120941|FG000|Overall Study|Severe non-compliance to protocol|6|||
127587645|NCT01153347|459120942|FG001|Overall Study|Severe non-compliance to protocol|7|||
127587646|NCT01153347|459120943|FG002|Overall Study|Severe non-compliance to protocol|4|||
127587647|NCT01153347|459120944|FG003|Overall Study|Severe non-compliance to protocol|3|||
127587648|NCT01153347|459120941|FG000|Overall Study|Condition under investigation worsened|1|||
127587649|NCT01153347|459120942|FG001|Overall Study|Condition under investigation worsened|1|||
127587650|NCT01153347|459120943|FG002|Overall Study|Condition under investigation worsened|0|||
127587651|NCT01153347|459120944|FG003|Overall Study|Condition under investigation worsened|0|||
127587652|NCT01153347|459120941|FG000|Overall Study|Lack of Efficacy|2|||
127587653|NCT01153347|459120942|FG001|Overall Study|Lack of Efficacy|2|||
127587654|NCT01153347|459120943|FG002|Overall Study|Lack of Efficacy|0|||
127587655|NCT01153347|459120944|FG003|Overall Study|Lack of Efficacy|4|||
127587656|NCT01153347|459120941|FG000|Overall Study|Study-specific withdrawal criteria|4|||
127587657|NCT01153347|459120942|FG001|Overall Study|Study-specific withdrawal criteria|3|||
127587658|NCT01153347|459120943|FG002|Overall Study|Study-specific withdrawal criteria|1|||
127587659|NCT01153347|459120944|FG003|Overall Study|Study-specific withdrawal criteria|2|||
127587660|NCT01153347|459120941|FG000|Overall Study|Lost to Follow-up|4|||
127587661|NCT01153347|459120942|FG001|Overall Study|Lost to Follow-up|9|||
127587662|NCT01153347|459120943|FG002|Overall Study|Lost to Follow-up|11|||
127587663|NCT01153347|459120944|FG003|Overall Study|Lost to Follow-up|8|||
127587664|NCT01153347|459120941|FG000|Overall Study|Other|5|||
127587665|NCT01153347|459120942|FG001|Overall Study|Other|5|||
127587666|NCT01153347|459120943|FG002|Overall Study|Other|4|||
127587667|NCT01153347|459120944|FG003|Overall Study|Other|0|||
127587668|NCT01153347|459120941|FG000|Overall Study|Death|1|||
127587669|NCT01153347|459120942|FG001|Overall Study|Death|0|||
127587670|NCT01153347|459120943|FG002|Overall Study|Death|0|||
127587671|NCT01153347|459120944|FG003|Overall Study|Death|0|||
127587672|NCT00297830|459120945|FG000|6 Month Visit|Death|1|||
127587673|NCT00297830|459120946|FG001|6 Month Visit|Death|0|||
127587674|NCT00297830|459120947|FG002|6 Month Visit|Death|2|||
127587675|NCT00297830|459120945|FG000|6 Month Visit|Withdrawal by Subject|2|||
127587676|NCT00297830|459120946|FG001|6 Month Visit|Withdrawal by Subject|1|||
127587677|NCT00297830|459120947|FG002|6 Month Visit|Withdrawal by Subject|1|||
127587678|NCT00297830|459120945|FG000|6 Month Visit|Adverse Event|0|||
127587679|NCT00297830|459120946|FG001|6 Month Visit|Adverse Event|1|||
127587680|NCT00297830|459120947|FG002|6 Month Visit|Adverse Event|0|||
127587681|NCT00297830|459120945|FG000|12 Month Visit|Lost to Follow-up|1|||
127587682|NCT00297830|459120946|FG001|12 Month Visit|Lost to Follow-up|0|||
127587683|NCT00297830|459120947|FG002|12 Month Visit|Lost to Follow-up|0|||
127587684|NCT00297830|459120945|FG000|12 Month Visit|Adverse Event|0|||
127587685|NCT00297830|459120946|FG001|12 Month Visit|Adverse Event|3|||
127587686|NCT00297830|459120947|FG002|12 Month Visit|Adverse Event|0|||
127587687|NCT00297830|459120945|FG000|12 Month Visit|Withdrawal by Subject|0|||
127587688|NCT00297830|459120946|FG001|12 Month Visit|Withdrawal by Subject|3|||
127587689|NCT00297830|459120947|FG002|12 Month Visit|Withdrawal by Subject|0|||
127587690|NCT01751178|459120950|FG000|Overall Study|Adverse Event|2|||
127587691|NCT01751178|459120951|FG001|Overall Study|Adverse Event|0|||
127587692|NCT01751178|459120952|FG002|Overall Study|Adverse Event|0|||
127587693|NCT01751178|459120950|FG000|Overall Study|Other Reason (unknown)|1|||
127705226|NCT01928394|459551583|FG016|Treatment Period|Death|0|||
127587694|NCT01751178|459120951|FG001|Overall Study|Other Reason (unknown)|0|||
127587695|NCT01751178|459120952|FG002|Overall Study|Other Reason (unknown)|2|||
127587696|NCT03095612|459120962|FG000|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
127587697|NCT03095612|459120963|FG001|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|4|||
127587698|NCT03095612|459120964|FG002|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
127587699|NCT03095612|459120965|FG003|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
127587700|NCT03095612|459120966|FG004|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
127587701|NCT03095612|459120967|FG005|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
127587702|NCT03095612|459120968|FG006|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
127587703|NCT04447794|459120971|FG000|Overall Study|Lost to Follow-up|2|||
127587704|NCT04447794|459120972|FG001|Overall Study|Lost to Follow-up|3|||
127587705|NCT04447794|459120973|FG002|Overall Study|Lost to Follow-up|8|||
127587706|NCT04447794|459120971|FG000|Overall Study|Withdrawal by Subject|1|||
127587707|NCT04447794|459120972|FG001|Overall Study|Withdrawal by Subject|1|||
127587708|NCT04447794|459120973|FG002|Overall Study|Withdrawal by Subject|0|||
127587709|NCT00621582|459120974|FG000|Overall Study|Adverse Event|7|||
127587710|NCT00621582|459120974|FG000|Overall Study|Protocol Violation|57|||
127587711|NCT00621582|459120974|FG000|Overall Study|Lost to Follow-up|24|||
127587712|NCT00621582|459120974|FG000|Overall Study|issues not identified by investigators|18|||
127587713|NCT01387932|459120976|FG000|Randomized and Treated|Physician Decision|3|||
127587714|NCT01387932|459120977|FG001|Randomized and Treated|Physician Decision|2|||
127587715|NCT01387932|459120976|FG000|Randomized and Treated|Withdrawal by Subject|4|||
127587716|NCT01387932|459120977|FG001|Randomized and Treated|Withdrawal by Subject|2|||
127587717|NCT01387932|459120976|FG000|Survival Follow-up|Liver Transplant|24|||
127587718|NCT01387932|459120977|FG001|Survival Follow-up|Liver Transplant|28|||
127587719|NCT01387932|459120976|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
127587720|NCT01387932|459120977|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
127587721|NCT01387932|459120976|FG000|Survival Follow-up|Withdrawal by Subject|2|||
127587722|NCT01387932|459120977|FG001|Survival Follow-up|Withdrawal by Subject|4|||
127587723|NCT01387932|459120976|FG000|Survival Follow-up|Lost to Follow-up|6|||
127587724|NCT01387932|459120977|FG001|Survival Follow-up|Lost to Follow-up|5|||
127587725|NCT02571075|459120978|FG000|Overall Study|Lost to Follow-up|20|||
127587726|NCT02571075|459120979|FG001|Overall Study|Lost to Follow-up|24|||
127587727|NCT00963937|459120984|FG000|Overall Study|Protocol Violation|1|||
127587728|NCT00963937|459120985|FG001|Overall Study|Protocol Violation|1|||
127587729|NCT00963937|459120986|FG002|Overall Study|Protocol Violation|0|||
127587730|NCT00963937|459120984|FG000|Overall Study|Physician Decision|18|||
127587731|NCT00963937|459120985|FG001|Overall Study|Physician Decision|10|||
127587732|NCT00963937|459120986|FG002|Overall Study|Physician Decision|4|||
127587733|NCT00205881|459120987|FG000|Overall Study|Withdrawal by Subject|16|||
127587734|NCT00389597|459120994|FG000|Overall Study|Lost to Follow-up|8|||
127587735|NCT00389597|459120995|FG001|Overall Study|Lost to Follow-up|6|||
127587736|NCT00389597|459120996|FG002|Overall Study|Lost to Follow-up|4|||
127587737|NCT00389597|459120997|FG003|Overall Study|Lost to Follow-up|6|||
127587738|NCT00781274|459120998|FG000|Overall Study|Withdrawal by Subject|2|||
127587739|NCT02021773|459120999|FG000|Overall Study|Adverse Event|1|||
127587740|NCT02021773|459121000|FG001|Overall Study|Adverse Event|4|||
127587741|NCT02021773|459121001|FG002|Overall Study|Adverse Event|3|||
127587742|NCT02021773|459120999|FG000|Overall Study|Lack of Efficacy|2|||
127587743|NCT02021773|459121000|FG001|Overall Study|Lack of Efficacy|2|||
127587744|NCT02021773|459121001|FG002|Overall Study|Lack of Efficacy|2|||
127587745|NCT02021773|459120999|FG000|Overall Study|Protocol Violation|2|||
127587746|NCT02021773|459121000|FG001|Overall Study|Protocol Violation|3|||
127587747|NCT02021773|459121001|FG002|Overall Study|Protocol Violation|1|||
127587748|NCT02021773|459120999|FG000|Overall Study|Withdrawal by Subject|3|||
127587749|NCT02021773|459121000|FG001|Overall Study|Withdrawal by Subject|4|||
127587750|NCT02021773|459121001|FG002|Overall Study|Withdrawal by Subject|5|||
127587751|NCT02021773|459120999|FG000|Overall Study|Lost to Follow-up|1|||
127587752|NCT02021773|459121000|FG001|Overall Study|Lost to Follow-up|3|||
127587753|NCT02021773|459121001|FG002|Overall Study|Lost to Follow-up|0|||
127882022|NCT01556490|460190788|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
127587754|NCT02021773|459120999|FG000|Overall Study|Reason not specified|3|||
127587755|NCT02021773|459121000|FG001|Overall Study|Reason not specified|0|||
127587756|NCT02021773|459121001|FG002|Overall Study|Reason not specified|0|||
127587757|NCT01534962|459121002|FG000|Overall Study|Randomized but did not start treatment|2|||
127587758|NCT01534962|459121003|FG001|Overall Study|Randomized but did not start treatment|0|||
127587759|NCT01534962|459121004|FG002|Overall Study|Randomized but did not start treatment|0|||
127587760|NCT01534962|459121005|FG003|Overall Study|Randomized but did not start treatment|1|||
127587761|NCT01534962|459121002|FG000|Overall Study|Discontinued at AF recurrence|35|||
127587762|NCT01534962|459121003|FG001|Overall Study|Discontinued at AF recurrence|26|||
127587763|NCT01534962|459121004|FG002|Overall Study|Discontinued at AF recurrence|24|||
127587764|NCT01534962|459121005|FG003|Overall Study|Discontinued at AF recurrence|31|||
127587765|NCT02243696|459121006|FG000|Overall Study|Death|282|||
127587766|NCT02243696|459121006|FG000|Overall Study|Withdrawal by Subject|79|||
127587767|NCT02243696|459121006|FG000|Overall Study|Lost to Follow-up|57|||
127587768|NCT02243696|459121006|FG000|Overall Study|Subject No Longer has Study System|42|||
127587769|NCT02243696|459121006|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
127587770|NCT02243696|459121006|FG000|Overall Study|Study Terminated for EP PASSION|961|||
127587771|NCT00087607|459121007|FG000|Overall Study|Adverse Event|14|||
127587772|NCT00087607|459121008|FG001|Overall Study|Adverse Event|24|||
127587773|NCT00087607|459121007|FG000|Overall Study|Death|0|||
127587774|NCT00087607|459121008|FG001|Overall Study|Death|1|||
127587775|NCT00087607|459121007|FG000|Overall Study|Insufficient Therapeutic Response|53|||
127587776|NCT00087607|459121008|FG001|Overall Study|Insufficient Therapeutic Response|42|||
127587777|NCT00087607|459121007|FG000|Overall Study|Failure to return|21|||
127587778|NCT00087607|459121008|FG001|Overall Study|Failure to return|17|||
127587779|NCT00087607|459121007|FG000|Overall Study|Withdrew Consent|12|||
127587780|NCT00087607|459121008|FG001|Overall Study|Withdrew Consent|16|||
127587781|NCT00087607|459121007|FG000|Overall Study|Administrative|12|||
127587782|NCT00087607|459121008|FG001|Overall Study|Administrative|12|||
127587783|NCT00087607|459121007|FG000|Overall Study|Refused Treatment|5|||
127587784|NCT00087607|459121008|FG001|Overall Study|Refused Treatment|7|||
127587785|NCT00087607|459121007|FG000|Overall Study|Other Protocol Violation|5|||
127587786|NCT00087607|459121008|FG001|Overall Study|Other Protocol Violation|2|||
127587787|NCT00087607|459121007|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
127587788|NCT00087607|459121008|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
127587789|NCT00190671|459121009|FG000|Overall Study|Satisfactory Response|4|||
127587790|NCT00190671|459121010|FG001|Overall Study|Satisfactory Response|7|||
127587791|NCT00190671|459121009|FG000|Overall Study|Lack of Efficacy|19|||
127587792|NCT00190671|459121010|FG001|Overall Study|Lack of Efficacy|24|||
127587793|NCT00190671|459121009|FG000|Overall Study|Death from Study Disease|1|||
127587794|NCT00190671|459121010|FG001|Overall Study|Death from Study Disease|1|||
127587795|NCT00190671|459121009|FG000|Overall Study|Adverse Event|3|||
127587796|NCT00190671|459121010|FG001|Overall Study|Adverse Event|2|||
127587797|NCT00190671|459121009|FG000|Overall Study|Clinical Relapse|0|||
127587798|NCT00190671|459121010|FG001|Overall Study|Clinical Relapse|1|||
127587799|NCT00190671|459121009|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
127587800|NCT00190671|459121010|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
127587801|NCT00190671|459121009|FG000|Overall Study|Death from Other Causes|0|||
127587802|NCT00190671|459121010|FG001|Overall Study|Death from Other Causes|2|||
127587803|NCT00190671|459121009|FG000|Overall Study|Protocol Violation|0|||
127587804|NCT00190671|459121010|FG001|Overall Study|Protocol Violation|1|||
127587805|NCT00190671|459121009|FG000|Overall Study|Withdrawal by Subject|0|||
127587806|NCT00190671|459121010|FG001|Overall Study|Withdrawal by Subject|2|||
127587807|NCT00191269|459121011|FG000|Overall Study|Protocol Violation|0|||
127587808|NCT00191269|459121012|FG001|Overall Study|Protocol Violation|2|||
127587809|NCT00191269|459121011|FG000|Overall Study|Adverse Event|1|||
127587810|NCT00191269|459121012|FG001|Overall Study|Adverse Event|4|||
127587811|NCT00191269|459121011|FG000|Overall Study|Progression of Disease|4|||
127587812|NCT00191269|459121012|FG001|Overall Study|Progression of Disease|42|||
127587813|NCT00191269|459121011|FG000|Overall Study|Lack of Efficacy|1|||
128033441|NCT03093415|460749509|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
128033442|NCT03093415|460749510|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
128033443|NCT03093415|460749511|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
128033444|NCT03093415|460749509|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
128033445|NCT03093415|460749510|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
128033446|NCT03093415|460749511|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
128033447|NCT03093415|460749509|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
128033448|NCT03093415|460749510|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
128033449|NCT03093415|460749511|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
128033450|NCT03093415|460749509|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
128033451|NCT03093415|460749510|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
128033452|NCT03093415|460749511|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
128033453|NCT03093415|460749509|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
128033454|NCT03093415|460749510|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
128033455|NCT03093415|460749511|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
128033456|NCT03093415|460749509|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
128033457|NCT03093415|460749510|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
128033458|NCT03093415|460749511|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
128033459|NCT03093415|460749509|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
128033460|NCT03093415|460749510|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
128033461|NCT03093415|460749511|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
128033462|NCT03093415|460749509|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
127587814|NCT00191269|459121012|FG001|Overall Study|Lack of Efficacy|5|||
127587815|NCT00191269|459121011|FG000|Overall Study|Withdrawal by Subject|0|||
127587816|NCT00191269|459121012|FG001|Overall Study|Withdrawal by Subject|1|||
127587817|NCT00191269|459121011|FG000|Overall Study|Pathologic Aggrevation|0|||
127587818|NCT00191269|459121012|FG001|Overall Study|Pathologic Aggrevation|1|||
127587819|NCT00191269|459121011|FG000|Overall Study|Physician Decision|0|||
127587820|NCT00191269|459121012|FG001|Overall Study|Physician Decision|3|||
127587821|NCT02151110|459121016|FG000|Overall Study|Withdrawal by Subject|0|||
127587822|NCT02151110|459121017|FG001|Overall Study|Withdrawal by Subject|0|||
127587823|NCT02151110|459121018|FG002|Overall Study|Withdrawal by Subject|0|||
127587824|NCT02151110|459121019|FG003|Overall Study|Withdrawal by Subject|0|||
127587825|NCT02151110|459121020|FG004|Overall Study|Withdrawal by Subject|0|||
128033463|NCT03093415|460749510|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
128033464|NCT03093415|460749511|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
128033465|NCT03093415|460749509|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
128033466|NCT03093415|460749510|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
128033467|NCT03093415|460749511|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
128033468|NCT03093415|460749509|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
128033469|NCT03093415|460749510|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
128033470|NCT03093415|460749511|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
128033471|NCT00023595|460749516|FG000|5 Year Follow up|Lost to Follow-up|2|||
128033472|NCT00023595|460749517|FG001|5 Year Follow up|Lost to Follow-up|2|||
128033473|NCT00023595|460749518|FG002|5 Year Follow up|Lost to Follow-up|1|||
128033474|NCT00023595|460749519|FG003|5 Year Follow up|Lost to Follow-up|7|||
128033475|NCT00023595|460749520|FG004|5 Year Follow up|Lost to Follow-up|3|||
128033476|NCT00023595|460749516|FG000|10 Year Follow up|Lost to Follow-up|12|||
127587826|NCT02151110|459121021|FG005|Overall Study|Withdrawal by Subject|0|||
127587827|NCT02151110|459121022|FG006|Overall Study|Withdrawal by Subject|0|||
128033477|NCT00023595|460749517|FG001|10 Year Follow up|Lost to Follow-up|10|||
128033478|NCT00023595|460749518|FG002|10 Year Follow up|Lost to Follow-up|3|||
127587828|NCT02151110|459121023|FG007|Overall Study|Withdrawal by Subject|1|||
127694195|NCT02312960|459508676|FG007|Overall Study|Withdrawal by Subject|2|||
127694196|NCT02312960|459508677|FG008|Overall Study|Withdrawal by Subject|2|||
127694197|NCT02312960|459508678|FG009|Overall Study|Withdrawal by Subject|3|||
127694198|NCT02312960|459508679|FG010|Overall Study|Withdrawal by Subject|0|||
127694199|NCT02312960|459508680|FG011|Overall Study|Withdrawal by Subject|0|||
127694200|NCT02312960|459508681|FG012|Overall Study|Withdrawal by Subject|2|||
128033479|NCT00023595|460749519|FG003|10 Year Follow up|Lost to Follow-up|0|||
128033480|NCT00023595|460749520|FG004|10 Year Follow up|Lost to Follow-up|0|||
128033481|NCT05889468|460749521|FG000|Overall Study|Lost to Follow-up|9|||
128033482|NCT05889468|460749522|FG001|Overall Study|Lost to Follow-up|2|||
128033483|NCT05889468|460749521|FG000|Overall Study|Withdrawal by Subject|2|||
128033484|NCT05889468|460749522|FG001|Overall Study|Withdrawal by Subject|2|||
128033485|NCT01309230|460749523|FG000|Overall Study|Withdrawal by Subject|0|||
128033486|NCT01309230|460749524|FG001|Overall Study|Withdrawal by Subject|2|||
128033487|NCT01309230|460749523|FG000|Overall Study|Observation arm closed|0|||
128033488|NCT01309230|460749524|FG001|Overall Study|Observation arm closed|2|||
128033489|NCT03900650|460749529|FG000|Overall Study|Withdrawal by Subject|1|||
128033490|NCT03900650|460749530|FG001|Overall Study|Withdrawal by Subject|1|||
128033491|NCT03900650|460749531|FG002|Overall Study|Withdrawal by Subject|0|||
128033492|NCT03900650|460749532|FG003|Overall Study|Withdrawal by Subject|0|||
128033493|NCT03900650|460749529|FG000|Overall Study|Withdrawn by staff|1|||
128033494|NCT03900650|460749530|FG001|Overall Study|Withdrawn by staff|0|||
128033495|NCT03900650|460749531|FG002|Overall Study|Withdrawn by staff|0|||
128033496|NCT03900650|460749532|FG003|Overall Study|Withdrawn by staff|0|||
128033497|NCT00427700|460749533|FG000|Overall Study|Lost to Follow-up|2|||
128033498|NCT00427700|460749534|FG001|Overall Study|Lost to Follow-up|5|||
128033499|NCT00427700|460749533|FG000|Overall Study|no induction of menses|1|||
128033500|NCT00427700|460749534|FG001|Overall Study|no induction of menses|4|||
128033501|NCT00427700|460749533|FG000|Overall Study|Pregnancy|0|||
128033502|NCT00427700|460749534|FG001|Overall Study|Pregnancy|2|||
128033503|NCT04581395|460749535|FG000|Overall Study|Protocol Violation|4|||
128033504|NCT04581395|460749536|FG001|Overall Study|Protocol Violation|3|||
128033505|NCT04581395|460749537|FG002|Overall Study|Protocol Violation|2|||
128033506|NCT04581395|460749535|FG000|Overall Study|Physician Decision|0|||
128033507|NCT04581395|460749536|FG001|Overall Study|Physician Decision|1|||
128033508|NCT04581395|460749537|FG002|Overall Study|Physician Decision|0|||
128033509|NCT00815633|460749538|FG000|Overall Study|study terminated|1|||
128033510|NCT00721110|460749539|FG000|Overall Study|Ultram use|1|||
128033511|NCT00721110|460749540|FG001|Overall Study|Ultram use|0|||
128033512|NCT00721110|460749541|FG002|Overall Study|Ultram use|0|||
128033513|NCT00721110|460749542|FG003|Overall Study|Ultram use|0|||
128033514|NCT00721110|460749539|FG000|Overall Study|vertical incision|0|||
128033515|NCT00721110|460749540|FG001|Overall Study|vertical incision|0|||
128033516|NCT00721110|460749541|FG002|Overall Study|vertical incision|1|||
128033517|NCT00721110|460749542|FG003|Overall Study|vertical incision|0|||
128033518|NCT01554904|460749543|FG000|Overall Study|Withdrawal by Subject|3|||
128033519|NCT01554904|460749543|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
128033520|NCT01605097|460749544|FG000|Overall Study|Protocol Violation|1|||
128033521|NCT02038647|460749545|FG000|Overall Study|Progressive Disease|50|||
128033522|NCT02038647|460749546|FG001|Overall Study|Progressive Disease|59|||
128033523|NCT02038647|460749545|FG000|Overall Study|Adverse Event|18|||
128033524|NCT02038647|460749546|FG001|Overall Study|Adverse Event|10|||
128033525|NCT02038647|460749545|FG000|Overall Study|Symptomatic Deterioration|7|||
128033526|NCT02038647|460749546|FG001|Overall Study|Symptomatic Deterioration|7|||
128033527|NCT02038647|460749545|FG000|Overall Study|Withdrawal by Subject|5|||
128033528|NCT02038647|460749546|FG001|Overall Study|Withdrawal by Subject|2|||
128033529|NCT02038647|460749545|FG000|Overall Study|Not Reported|0|||
128033530|NCT02038647|460749546|FG001|Overall Study|Not Reported|1|||
128033531|NCT02038647|460749545|FG000|Overall Study|Ongoing at Datacut|9|||
128033532|NCT02038647|460749546|FG001|Overall Study|Ongoing at Datacut|10|||
128033533|NCT02757430|460749547|FG000|Overall Study|Physician Decision|6|||
128033534|NCT02757430|460749547|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
128033535|NCT02757430|460749547|FG000|Overall Study|No informed consent|1|||
128033536|NCT02757430|460749547|FG000|Overall Study|No procedure performed|2|||
128033537|NCT02082977|460749548|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
128033538|NCT02082977|460749549|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
128033539|NCT02082977|460749550|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
128033540|NCT02082977|460749551|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
128033541|NCT02082977|460749552|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
128033542|NCT02082977|460749553|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
128033543|NCT02082977|460749554|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
128033544|NCT02082977|460749555|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
128033545|NCT02082977|460749556|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
128033546|NCT02082977|460749557|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
128033547|NCT02082977|460749548|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
128033548|NCT02082977|460749549|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
127694201|NCT02312960|459508682|FG013|Overall Study|Withdrawal by Subject|0|||
128033549|NCT02082977|460749550|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
127587829|NCT02151110|459121016|FG000|Overall Study|Lost to Follow-up|0|||
127587830|NCT02151110|459121017|FG001|Overall Study|Lost to Follow-up|0|||
127587831|NCT02151110|459121018|FG002|Overall Study|Lost to Follow-up|0|||
127587832|NCT02151110|459121019|FG003|Overall Study|Lost to Follow-up|0|||
127587833|NCT02151110|459121020|FG004|Overall Study|Lost to Follow-up|0|||
127587834|NCT02151110|459121021|FG005|Overall Study|Lost to Follow-up|0|||
127587835|NCT02151110|459121022|FG006|Overall Study|Lost to Follow-up|0|||
127587836|NCT02151110|459121023|FG007|Overall Study|Lost to Follow-up|2|||
127587837|NCT02015754|459121024|FG000|Overall Study|Disease progression|5|||
127587838|NCT02015754|459121024|FG000|Overall Study|Change in treatment modality|5|||
127587839|NCT02015754|459121024|FG000|Overall Study|Lost to Follow-up|1|||
128033550|NCT02082977|460749551|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
128033551|NCT02082977|460749552|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
128033552|NCT02082977|460749553|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
128033553|NCT02082977|460749554|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
127587840|NCT04528732|459121031|FG000|Overall Study|Death|1|||
127587841|NCT04528732|459121032|FG001|Overall Study|Death|0|||
127587842|NCT04528732|459121033|FG002|Overall Study|Death|1|||
127587843|NCT04528732|459121031|FG000|Overall Study|Lost to Follow-up|0|||
127587844|NCT04528732|459121032|FG001|Overall Study|Lost to Follow-up|1|||
127587845|NCT04528732|459121033|FG002|Overall Study|Lost to Follow-up|2|||
127587846|NCT05399641|459121034|FG000|Overall Study|Adverse Event|0|||
127587847|NCT05399641|459121035|FG001|Overall Study|Adverse Event|1|||
127587848|NCT05399641|459121036|FG002|Overall Study|Adverse Event|1|||
127587849|NCT05399641|459121034|FG000|Overall Study|Lost to Follow-up|1|||
127587850|NCT05399641|459121035|FG001|Overall Study|Lost to Follow-up|2|||
127587851|NCT05399641|459121036|FG002|Overall Study|Lost to Follow-up|2|||
127587852|NCT05399641|459121034|FG000|Overall Study|Physician Decision|1|||
127587853|NCT05399641|459121035|FG001|Overall Study|Physician Decision|3|||
127587854|NCT05399641|459121036|FG002|Overall Study|Physician Decision|3|||
127587855|NCT05399641|459121034|FG000|Overall Study|Withdrawal by Subject|4|||
127587856|NCT05399641|459121035|FG001|Overall Study|Withdrawal by Subject|11|||
127587857|NCT05399641|459121036|FG002|Overall Study|Withdrawal by Subject|7|||
127587858|NCT05399641|459121034|FG000|Overall Study|Reason not defined|3|||
127587859|NCT05399641|459121035|FG001|Overall Study|Reason not defined|5|||
127587860|NCT05399641|459121036|FG002|Overall Study|Reason not defined|6|||
127587861|NCT02094677|459121037|FG000|Overall Study|Screening|3|||
127587862|NCT02094677|459121038|FG001|Overall Study|Screening|1|||
127587863|NCT01300650|459121039|FG000|Overall Study|Adverse Event|1|||
127587864|NCT00668707|459121048|FG000|Overall Study|Cancer Recurrence|58|||
127587865|NCT00668707|459121049|FG001|Overall Study|Cancer Recurrence|58|||
127587866|NCT00668707|459121048|FG000|Overall Study|Withdrawal by Subject|117|||
127587867|NCT00668707|459121049|FG001|Overall Study|Withdrawal by Subject|100|||
127587868|NCT00668707|459121048|FG000|Overall Study|Lost to Follow-up|3|||
127587869|NCT00668707|459121049|FG001|Overall Study|Lost to Follow-up|6|||
127587870|NCT00668707|459121048|FG000|Overall Study|Protocol Violation|10|||
128033554|NCT02082977|460749555|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
128033555|NCT02082977|460749556|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
127587871|NCT00668707|459121049|FG001|Overall Study|Protocol Violation|12|||
127587872|NCT00668707|459121048|FG000|Overall Study|Death|11|||
127587873|NCT00668707|459121049|FG001|Overall Study|Death|4|||
127587874|NCT00923156|459121050|FG000|Overall Study|Adverse Event|0|||
127587875|NCT00923156|459121051|FG001|Overall Study|Adverse Event|2|||
127587876|NCT00923156|459121052|FG002|Overall Study|Adverse Event|1|||
127587877|NCT00923156|459121050|FG000|Overall Study|Abnormal laboratory values|0|||
127587878|NCT00923156|459121051|FG001|Overall Study|Abnormal laboratory values|0|||
127587879|NCT00923156|459121052|FG002|Overall Study|Abnormal laboratory values|1|||
127587880|NCT00923156|459121050|FG000|Overall Study|Withdrawal by Subject|0|||
127587881|NCT00923156|459121051|FG001|Overall Study|Withdrawal by Subject|1|||
127587882|NCT00923156|459121052|FG002|Overall Study|Withdrawal by Subject|0|||
127587883|NCT00923156|459121050|FG000|Overall Study|Death|0|||
127587884|NCT00923156|459121051|FG001|Overall Study|Death|1|||
127587885|NCT00923156|459121052|FG002|Overall Study|Death|0|||
127587886|NCT00923156|459121050|FG000|Overall Study|Lack of Efficacy|0|||
127587887|NCT00923156|459121051|FG001|Overall Study|Lack of Efficacy|0|||
127587888|NCT00923156|459121052|FG002|Overall Study|Lack of Efficacy|1|||
127587889|NCT03137537|459121054|FG000|Overall Study|Adverse Event|0|||
127587890|NCT03137537|459121055|FG001|Overall Study|Adverse Event|1|||
127587891|NCT04066023|459121056|FG000|Overall Study|Adverse Event|0|||
127587892|NCT04066023|459121057|FG001|Overall Study|Adverse Event|0|||
127587893|NCT04066023|459121058|FG002|Overall Study|Adverse Event|1|||
127587894|NCT04066023|459121056|FG000|Overall Study|Sponsor decision|3|||
127587895|NCT04066023|459121057|FG001|Overall Study|Sponsor decision|6|||
127587896|NCT04066023|459121058|FG002|Overall Study|Sponsor decision|2|||
127587897|NCT04066023|459121056|FG000|Overall Study|Physician Decision|0|||
128033556|NCT02082977|460749557|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
127587898|NCT04066023|459121057|FG001|Overall Study|Physician Decision|0|||
127587899|NCT04066023|459121058|FG002|Overall Study|Physician Decision|1|||
127587900|NCT04066023|459121056|FG000|Overall Study|Lost to Follow-up|0|||
127587901|NCT04066023|459121057|FG001|Overall Study|Lost to Follow-up|1|||
127587902|NCT04066023|459121058|FG002|Overall Study|Lost to Follow-up|1|||
127587903|NCT04066023|459121056|FG000|Overall Study|Noncompliance|0|||
127587904|NCT04066023|459121057|FG001|Overall Study|Noncompliance|1|||
127587905|NCT04066023|459121058|FG002|Overall Study|Noncompliance|1|||
127587906|NCT03386448|459121059|FG000|Overall Study|Adverse Event|0|||
127587907|NCT03386448|459121060|FG001|Overall Study|Adverse Event|2|||
127587908|NCT03338010|459121063|FG000|Overall Study|Withdrawal by Subject|14|||
127587909|NCT03338010|459121064|FG001|Overall Study|Withdrawal by Subject|8|||
127587910|NCT03338010|459121063|FG000|Overall Study|Lost to Follow-up|4|||
127587911|NCT03338010|459121064|FG001|Overall Study|Lost to Follow-up|2|||
127587912|NCT03338010|459121063|FG000|Overall Study|Adverse Event|3|||
127587913|NCT03338010|459121064|FG001|Overall Study|Adverse Event|2|||
127587914|NCT03338010|459121063|FG000|Overall Study|Physician Decision|2|||
127587915|NCT03338010|459121064|FG001|Overall Study|Physician Decision|2|||
127587916|NCT03338010|459121063|FG000|Overall Study|Non-Compliance with Study Drug|0|||
127587917|NCT03338010|459121064|FG001|Overall Study|Non-Compliance with Study Drug|3|||
127587918|NCT03338010|459121063|FG000|Overall Study|Protocol Violation|0|||
127587919|NCT03338010|459121064|FG001|Overall Study|Protocol Violation|1|||
127587920|NCT01146665|459121065|FG000|Overall Study|Withdrawal by Subject|10|||
127587921|NCT01146665|459121066|FG001|Overall Study|Withdrawal by Subject|16|||
127587922|NCT02465515|459121067|FG000|Overall Study|Investigator site closed|4|||
127587923|NCT02465515|459121068|FG001|Overall Study|Investigator site closed|5|||
127587924|NCT02465515|459121067|FG000|Overall Study|Withdrawal by Subject|74|||
127587925|NCT02465515|459121068|FG001|Overall Study|Withdrawal by Subject|43|||
127587926|NCT02465515|459121067|FG000|Overall Study|Physician Decision|8|||
127587927|NCT02465515|459121068|FG001|Overall Study|Physician Decision|12|||
127587928|NCT02465515|459121067|FG000|Overall Study|Lost to Follow-up|68|||
127587929|NCT02465515|459121068|FG001|Overall Study|Lost to Follow-up|51|||
127587930|NCT00293033|459121069|FG000|Open-label Titration Period|Adverse Event|10|||
127587931|NCT00293033|459121069|FG000|Open-label Titration Period|Death|3|||
127587932|NCT00293033|459121069|FG000|Open-label Titration Period|Lack of Efficacy|5|||
127587933|NCT00293033|459121069|FG000|Open-label Titration Period|Protocol Violation|2|||
127587934|NCT00293033|459121069|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
127587935|NCT00293033|459121069|FG000|Open-label Titration Period|Noncompliance and other|27|||
127587936|NCT00293033|459121069|FG000|Double-blind Treatment Period|Adverse Event|3|||
127587937|NCT00293033|459121069|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
127587938|NCT00293033|459121069|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
127587939|NCT00293033|459121069|FG000|Double-blind Treatment Period|Noncompliance|4|||
127587940|NCT00816595|459121070|FG000|Overall Study|Withdrawal by Subject|2|||
127587941|NCT00816595|459121071|FG001|Overall Study|Withdrawal by Subject|0|||
127587942|NCT03583697|459121072|FG000|Overall Study|Withdrawal by Subject|0|||
127587943|NCT03583697|459121073|FG001|Overall Study|Withdrawal by Subject|0|||
127587944|NCT03583697|459121074|FG002|Overall Study|Withdrawal by Subject|1|||
127587945|NCT03583697|459121072|FG000|Overall Study|AE of sudden infant death syndrome, not related|0|||
127587946|NCT03583697|459121073|FG001|Overall Study|AE of sudden infant death syndrome, not related|1|||
127587947|NCT03583697|459121074|FG002|Overall Study|AE of sudden infant death syndrome, not related|0|||
127587948|NCT00679432|459121077|FG000|Overall Study|Adverse Event|5|||
127587949|NCT00679432|459121078|FG001|Overall Study|Adverse Event|6|||
128033557|NCT02082977|460749548|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
128033558|NCT02082977|460749549|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
128033559|NCT02082977|460749550|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
128033560|NCT02082977|460749551|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
128033561|NCT02082977|460749552|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
128033562|NCT02082977|460749553|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
128033563|NCT02082977|460749554|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
128033564|NCT02082977|460749555|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
128033565|NCT02082977|460749556|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
128033566|NCT02082977|460749557|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
128033567|NCT02082977|460749548|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
128033568|NCT02082977|460749549|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
128033569|NCT02082977|460749550|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
128033570|NCT02082977|460749551|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
128033571|NCT02082977|460749552|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
128033572|NCT02082977|460749553|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
128033573|NCT02082977|460749554|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
128033574|NCT02082977|460749555|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
128033575|NCT02082977|460749556|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
128033576|NCT02082977|460749557|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
128033577|NCT02082977|460749548|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
128033578|NCT02082977|460749549|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
128033579|NCT02082977|460749550|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
128033580|NCT02082977|460749551|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
128033581|NCT02082977|460749552|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
127587950|NCT00679432|459121079|FG002|Overall Study|Adverse Event|10|||
127587951|NCT00679432|459121080|FG003|Overall Study|Adverse Event|7|||
127587952|NCT00679432|459121077|FG000|Overall Study|Protocol Violation|1|||
127587953|NCT00679432|459121078|FG001|Overall Study|Protocol Violation|1|||
127587954|NCT00679432|459121079|FG002|Overall Study|Protocol Violation|2|||
127587955|NCT00679432|459121080|FG003|Overall Study|Protocol Violation|1|||
127587956|NCT00679432|459121077|FG000|Overall Study|Withdrawal by Subject|8|||
127587957|NCT00679432|459121078|FG001|Overall Study|Withdrawal by Subject|11|||
127587958|NCT00679432|459121079|FG002|Overall Study|Withdrawal by Subject|10|||
127587959|NCT00679432|459121080|FG003|Overall Study|Withdrawal by Subject|9|||
127694202|NCT05458011|459508683|FG000|DB Period (12 Weeks)|Adverse Event|2|||
127587960|NCT00679432|459121077|FG000|Overall Study|Lost to Follow-up|1|||
127587961|NCT00679432|459121078|FG001|Overall Study|Lost to Follow-up|5|||
127587962|NCT00679432|459121079|FG002|Overall Study|Lost to Follow-up|4|||
127587963|NCT00679432|459121080|FG003|Overall Study|Lost to Follow-up|2|||
127587964|NCT00679432|459121077|FG000|Overall Study|Physician Decision|3|||
127587965|NCT00679432|459121078|FG001|Overall Study|Physician Decision|2|||
127587966|NCT00679432|459121079|FG002|Overall Study|Physician Decision|2|||
127587967|NCT00679432|459121080|FG003|Overall Study|Physician Decision|2|||
127587968|NCT00679432|459121077|FG000|Overall Study|Sponsor decision|1|||
127587969|NCT00679432|459121078|FG001|Overall Study|Sponsor decision|0|||
127587970|NCT00679432|459121079|FG002|Overall Study|Sponsor decision|0|||
127587971|NCT00679432|459121080|FG003|Overall Study|Sponsor decision|0|||
127587972|NCT00679432|459121077|FG000|Overall Study|Lack of Efficacy|13|||
127587973|NCT00679432|459121078|FG001|Overall Study|Lack of Efficacy|9|||
127587974|NCT00679432|459121079|FG002|Overall Study|Lack of Efficacy|14|||
127587975|NCT00679432|459121080|FG003|Overall Study|Lack of Efficacy|8|||
127587976|NCT00679432|459121077|FG000|Overall Study|Infectious colitis, normal histology|5|||
127587977|NCT00679432|459121078|FG001|Overall Study|Infectious colitis, normal histology|4|||
127587978|NCT00679432|459121079|FG002|Overall Study|Infectious colitis, normal histology|8|||
127587979|NCT00679432|459121080|FG003|Overall Study|Infectious colitis, normal histology|3|||
127587980|NCT00679432|459121077|FG000|Overall Study|Randomization error, return to prior Rx|0|||
127694203|NCT05458011|459508684|FG001|DB Period (12 Weeks)|Adverse Event|1|||
128033582|NCT02082977|460749553|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
128033583|NCT02082977|460749554|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
128033584|NCT02082977|460749555|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
128033585|NCT02082977|460749556|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
128033586|NCT02082977|460749557|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
128033587|NCT00663260|460749569|FG000|Overall Study|Lack of Efficacy|2|||
127587981|NCT00679432|459121078|FG001|Overall Study|Randomization error, return to prior Rx|0|||
128033588|NCT00663260|460749570|FG001|Overall Study|Lack of Efficacy|0|||
128033589|NCT00663260|460749571|FG002|Overall Study|Lack of Efficacy|0|||
128033590|NCT00663260|460749569|FG000|Overall Study|Adverse Event|12|||
128033591|NCT00663260|460749570|FG001|Overall Study|Adverse Event|7|||
128033592|NCT00663260|460749571|FG002|Overall Study|Adverse Event|6|||
128033593|NCT00663260|460749569|FG000|Overall Study|Withdrawal by Subject|3|||
127587982|NCT00679432|459121079|FG002|Overall Study|Randomization error, return to prior Rx|3|||
127587983|NCT00679432|459121080|FG003|Overall Study|Randomization error, return to prior Rx|0|||
127694204|NCT05458011|459508685|FG002|DB Period (12 Weeks)|Adverse Event|1|||
127694205|NCT05458011|459508683|FG000|DB Period (12 Weeks)|Withdrawal by Subject|4|||
127694206|NCT05458011|459508684|FG001|DB Period (12 Weeks)|Withdrawal by Subject|1|||
127694207|NCT05458011|459508685|FG002|DB Period (12 Weeks)|Withdrawal by Subject|1|||
127784626|NCT03596866|459837011|FG001|Overall Study|Death|24|||
127784627|NCT03596866|459837010|FG000|Overall Study|Withdrawal by Subject|4|||
127784628|NCT03596866|459837011|FG001|Overall Study|Withdrawal by Subject|6|||
127784629|NCT03596866|459837010|FG000|Overall Study|Missing|0|||
127784630|NCT03596866|459837011|FG001|Overall Study|Missing|6|||
127694208|NCT05458011|459508683|FG000|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
127784631|NCT03596866|459837010|FG000|Overall Study|Lost to Follow-up|2|||
127784632|NCT03596866|459837011|FG001|Overall Study|Lost to Follow-up|3|||
127784633|NCT03596866|459837010|FG000|Overall Study|Protocol Violation|1|||
127694209|NCT05458011|459508684|FG001|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
127694210|NCT05458011|459508685|FG002|DB Period (12 Weeks)|Non-compliance with trial drug|1|||
127694211|NCT05458011|459508683|FG000|DB Period (12 Weeks)|Protocol deviation|0|||
127694212|NCT05458011|459508684|FG001|DB Period (12 Weeks)|Protocol deviation|2|||
127694213|NCT05458011|459508685|FG002|DB Period (12 Weeks)|Protocol deviation|2|||
127694214|NCT05458011|459508683|FG000|OL Period (12 Weeks)|Adverse Event|1|||
127694215|NCT05458011|459508684|FG001|OL Period (12 Weeks)|Adverse Event|2|||
127694216|NCT05458011|459508685|FG002|OL Period (12 Weeks)|Adverse Event|1|||
127694217|NCT05458011|459508683|FG000|OL Period (12 Weeks)|Withdrawal by Subject|0|||
127694218|NCT05458011|459508684|FG001|OL Period (12 Weeks)|Withdrawal by Subject|3|||
127694219|NCT05458011|459508685|FG002|OL Period (12 Weeks)|Withdrawal by Subject|0|||
127694220|NCT02900924|459508705|FG000|Overall Study|Death|52|||
127694221|NCT02900924|459508705|FG000|Overall Study|Lost to Follow-up|4|||
127694222|NCT02900924|459508705|FG000|Overall Study|Withdrawal by Subject|20|||
127694223|NCT02900924|459508705|FG000|Overall Study|Missed Visit|33|||
127694224|NCT02365766|459508725|FG000|Overall Study|Withdrawal by Subject|0|||
127694225|NCT02365766|459508726|FG001|Overall Study|Withdrawal by Subject|0|||
127694226|NCT02365766|459508727|FG002|Overall Study|Withdrawal by Subject|1|||
127694227|NCT02365766|459508725|FG000|Overall Study|Eligibility Criteria Not Met|0|||
127694228|NCT02365766|459508726|FG001|Overall Study|Eligibility Criteria Not Met|0|||
127694229|NCT02365766|459508727|FG002|Overall Study|Eligibility Criteria Not Met|1|||
127694230|NCT05956002|459508729|FG000|Treatment Period 3|Adverse Event|0|||
127694231|NCT05956002|459508730|FG001|Treatment Period 3|Adverse Event|0|||
127694232|NCT05956002|459508731|FG002|Treatment Period 3|Adverse Event|1|||
127694233|NCT05956002|459508732|FG003|Treatment Period 3|Adverse Event|0|||
127694234|NCT03978871|459508734|FG000|Overall Study|Lost to Follow-up|11|||
127694235|NCT03978871|459508735|FG001|Overall Study|Lost to Follow-up|12|||
127694236|NCT04072822|459508736|FG000|Treatment|Adverse Event|9|||
127694237|NCT04072822|459508737|FG001|Treatment|Adverse Event|5|||
127694238|NCT04072822|459508736|FG000|Treatment|Met Stopping Criteria|13|||
127694239|NCT04072822|459508737|FG001|Treatment|Met Stopping Criteria|24|||
127694240|NCT04072822|459508736|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
127694241|NCT04072822|459508737|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
127784634|NCT03596866|459837011|FG001|Overall Study|Protocol Violation|0|||
127784635|NCT03596866|459837010|FG000|Overall Study|Reason Not Specified|14|||
128033594|NCT00663260|460749570|FG001|Overall Study|Withdrawal by Subject|1|||
128033595|NCT00663260|460749571|FG002|Overall Study|Withdrawal by Subject|6|||
128033596|NCT00663260|460749569|FG000|Overall Study|Death|1|||
128033597|NCT00663260|460749570|FG001|Overall Study|Death|0|||
128033598|NCT00663260|460749571|FG002|Overall Study|Death|1|||
128033599|NCT00663260|460749569|FG000|Overall Study|Lost to Follow-up|0|||
128033600|NCT00663260|460749570|FG001|Overall Study|Lost to Follow-up|1|||
128033601|NCT00663260|460749571|FG002|Overall Study|Lost to Follow-up|0|||
128033602|NCT00663260|460749569|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
128033603|NCT00663260|460749570|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
128033604|NCT00663260|460749571|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
128033605|NCT02231580|460749574|FG000|Overall Study|Adverse Event|5|||
128033606|NCT02231580|460749575|FG001|Overall Study|Adverse Event|0|||
128033607|NCT05852340|460749578|FG000|Period 5|Not completing the meal|0|||
128033608|NCT05852340|460749579|FG001|Period 5|Not completing the meal|1|||
128033609|NCT05852340|460749580|FG002|Period 5|Not completing the meal|0|||
127694242|NCT04072822|459508736|FG000|Treatment|Withdrawal by Subject|0|||
127694243|NCT04072822|459508737|FG001|Treatment|Withdrawal by Subject|2|||
127694244|NCT04072822|459508736|FG000|Treatment|Death|0|||
127694245|NCT04072822|459508737|FG001|Treatment|Death|2|||
127694246|NCT04072822|459508736|FG000|Treatment|Lost to Follow-up|11|||
127694247|NCT04072822|459508737|FG001|Treatment|Lost to Follow-up|3|||
127694248|NCT04072822|459508736|FG000|Treatment|Physician Decision|1|||
127694249|NCT04072822|459508737|FG001|Treatment|Physician Decision|0|||
127694250|NCT04072822|459508736|FG000|Treatment|Other|7|||
127694251|NCT04072822|459508737|FG001|Treatment|Other|9|||
127694252|NCT04072822|459508736|FG000|Follow-up|Withdrawal by Subject|1|||
127694253|NCT04072822|459508737|FG001|Follow-up|Withdrawal by Subject|0|||
127694254|NCT04072822|459508736|FG000|Follow-up|Lost to Follow-up|5|||
127694255|NCT04072822|459508737|FG001|Follow-up|Lost to Follow-up|4|||
127694256|NCT04391894|459508739|FG000|Overall Study|Adverse Event|1|||
127694257|NCT04391894|459508740|FG001|Overall Study|Adverse Event|1|||
127694258|NCT04391894|459508741|FG002|Overall Study|Adverse Event|1|||
127694259|NCT04391894|459508742|FG003|Overall Study|Adverse Event|1|||
128033610|NCT05852340|460749581|FG003|Period 5|Not completing the meal|0|||
128033611|NCT05852340|460749578|FG000|Period 5|Adverse Event|0|||
128033612|NCT05852340|460749579|FG001|Period 5|Adverse Event|0|||
128033613|NCT05852340|460749580|FG002|Period 5|Adverse Event|0|||
128033614|NCT05852340|460749581|FG003|Period 5|Adverse Event|1|||
128033615|NCT05852470|460749582|FG000|Overall Study|Withdrawal by Subject|0|||
128033616|NCT05852470|460749583|FG001|Overall Study|Withdrawal by Subject|1|||
128033617|NCT01903863|460749584|FG000|Overall Study|Physician Decision|2|||
128033618|NCT01903863|460749585|FG001|Overall Study|Physician Decision|0|||
128033619|NCT03537508|460749590|FG000|Overall Study|Adverse Event|2|||
128033620|NCT03537508|460749591|FG001|Overall Study|Adverse Event|1|||
128033621|NCT03537508|460749590|FG000|Overall Study|Protocol Violation|65|||
128033622|NCT03537508|460749591|FG001|Overall Study|Protocol Violation|48|||
128033623|NCT03537508|460749590|FG000|Overall Study|Lost to Follow-up|86|||
128033624|NCT03537508|460749591|FG001|Overall Study|Lost to Follow-up|60|||
128033625|NCT03537508|460749590|FG000|Overall Study|Withdrawal by parent/guardian|263|||
128033626|NCT03537508|460749591|FG001|Overall Study|Withdrawal by parent/guardian|149|||
128033627|NCT01972659|460749592|FG000|Overall Study|Protocol Violation|2|||
128033628|NCT01972659|460749593|FG001|Overall Study|Protocol Violation|2|||
128033629|NCT01972659|460749592|FG000|Overall Study|problems realted to acceleromyograph|2|||
128033630|NCT01972659|460749593|FG001|Overall Study|problems realted to acceleromyograph|1|||
128033631|NCT04144517|460749597|FG000|Overall Study|Physician Decision|0|||
128033632|NCT04144517|460749598|FG001|Overall Study|Physician Decision|1|||
128033633|NCT04144517|460749597|FG000|Overall Study|Other|2|||
128033634|NCT04144517|460749598|FG001|Overall Study|Other|2|||
128033635|NCT04144517|460749597|FG000|Overall Study|Death|6|||
128033636|NCT04144517|460749598|FG001|Overall Study|Death|3|||
128033637|NCT00835367|460749604|FG000|Washout|Adverse Event|2|||
128033638|NCT00835367|460749605|FG001|Washout|Adverse Event|0|||
128033639|NCT00835367|460749604|FG000|Washout|Withdrawal by Subject|1|||
128033640|NCT00835367|460749605|FG001|Washout|Withdrawal by Subject|0|||
128033641|NCT00835367|460749604|FG000|Second Intervention|Adverse Event|1|||
128033642|NCT00835367|460749605|FG001|Second Intervention|Adverse Event|1|||
128033643|NCT01397253|460751598|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
128033644|NCT01397253|460751599|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
128033645|NCT01892189|460751600|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
128033646|NCT01892189|460751601|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
128033647|NCT01892189|460751602|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
128033648|NCT01892189|460751603|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
128033649|NCT01892189|460751604|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
128033650|NCT01892189|460751605|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
128033651|NCT01892189|460751606|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
128033652|NCT01892189|460751607|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
128033653|NCT01892189|460751608|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
128033654|NCT01892189|460751600|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
128033655|NCT01892189|460751601|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
128033656|NCT01892189|460751602|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
128033657|NCT01892189|460751603|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
128033658|NCT01892189|460751604|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
128033659|NCT01892189|460751605|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
128033660|NCT01892189|460751606|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
128033661|NCT01892189|460751607|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
128033662|NCT01892189|460751608|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
128033663|NCT01892189|460751600|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
128033664|NCT01892189|460751601|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
128033665|NCT01892189|460751602|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
128033666|NCT01892189|460751603|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
127694260|NCT04391894|459508743|FG004|Overall Study|Adverse Event|1|||
127694261|NCT04391894|459508739|FG000|Overall Study|Lost to Follow-up|1|||
127694262|NCT04391894|459508740|FG001|Overall Study|Lost to Follow-up|0|||
127694263|NCT04391894|459508741|FG002|Overall Study|Lost to Follow-up|0|||
127694264|NCT04391894|459508742|FG003|Overall Study|Lost to Follow-up|0|||
127694265|NCT04391894|459508743|FG004|Overall Study|Lost to Follow-up|0|||
127694266|NCT04391894|459508739|FG000|Overall Study|Protocol Violation|0|||
127694267|NCT04391894|459508740|FG001|Overall Study|Protocol Violation|0|||
127694268|NCT04391894|459508741|FG002|Overall Study|Protocol Violation|0|||
127694269|NCT04391894|459508742|FG003|Overall Study|Protocol Violation|1|||
127694270|NCT04391894|459508743|FG004|Overall Study|Protocol Violation|0|||
127694271|NCT04391894|459508739|FG000|Overall Study|Withdrawal by Subject|2|||
127694272|NCT04391894|459508740|FG001|Overall Study|Withdrawal by Subject|0|||
127694273|NCT04391894|459508741|FG002|Overall Study|Withdrawal by Subject|3|||
127694274|NCT04391894|459508742|FG003|Overall Study|Withdrawal by Subject|0|||
127694275|NCT04391894|459508743|FG004|Overall Study|Withdrawal by Subject|1|||
127694276|NCT04391894|459508739|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
127694277|NCT04391894|459508740|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
127694278|NCT04391894|459508741|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
127694279|NCT04391894|459508742|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
127694280|NCT04391894|459508743|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
127694281|NCT02323321|459508744|FG000|Overall Study|Re-Transplant|1|||
128033667|NCT01892189|460751604|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
127694282|NCT02323321|459508744|FG000|Overall Study|Death|12|||
127694283|NCT00446225|459508745|FG000|Overall Study|Protocol Violation|1|||
127694284|NCT00446225|459508746|FG001|Overall Study|Protocol Violation|0|||
127694285|NCT04450342|459508747|FG000|Overall Study|Adverse Event|1|||
127694286|NCT04450342|459508748|FG001|Overall Study|Adverse Event|1|||
127694287|NCT04450342|459508749|FG002|Overall Study|Adverse Event|0|||
127694288|NCT04450342|459508747|FG000|Overall Study|Device not used|1|||
127694289|NCT04450342|459508748|FG001|Overall Study|Device not used|0|||
127694290|NCT04450342|459508749|FG002|Overall Study|Device not used|0|||
127694291|NCT04450342|459508747|FG000|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|1|||
127694292|NCT04450342|459508748|FG001|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
127694293|NCT04450342|459508749|FG002|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
127694294|NCT04450342|459508747|FG000|Overall Study|Physician Decision|1|||
127694295|NCT04450342|459508748|FG001|Overall Study|Physician Decision|0|||
127694296|NCT04450342|459508749|FG002|Overall Study|Physician Decision|1|||
127694297|NCT04450342|459508747|FG000|Overall Study|Protocol Deviation|0|||
127694298|NCT04450342|459508748|FG001|Overall Study|Protocol Deviation|1|||
127694299|NCT04450342|459508749|FG002|Overall Study|Protocol Deviation|0|||
127694300|NCT04450342|459508747|FG000|Overall Study|Reoperation|1|||
127694301|NCT04450342|459508748|FG001|Overall Study|Reoperation|1|||
127694302|NCT04450342|459508749|FG002|Overall Study|Reoperation|0|||
127694303|NCT04450342|459508747|FG000|Overall Study|Screen Failures|0|||
127694304|NCT04450342|459508748|FG001|Overall Study|Screen Failures|0|||
127694305|NCT04450342|459508749|FG002|Overall Study|Screen Failures|2|||
127694306|NCT04450342|459508747|FG000|Overall Study|Site Terminated by Sponsor|1|||
128033668|NCT01892189|460751605|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
128033669|NCT01892189|460751606|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
128033670|NCT01892189|460751607|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
128033671|NCT01892189|460751608|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
128033672|NCT03322566|460751616|FG000|Overall Study|Death|34|||
128033673|NCT03322566|460751617|FG001|Overall Study|Death|35|||
128033674|NCT03322566|460751618|FG002|Overall Study|Death|23|||
128033675|NCT03322566|460751616|FG000|Overall Study|Physician Decision|6|||
128033676|NCT03322566|460751617|FG001|Overall Study|Physician Decision|7|||
128033677|NCT03322566|460751618|FG002|Overall Study|Physician Decision|2|||
128033678|NCT03322566|460751616|FG000|Overall Study|Withdrawal by Subject|4|||
128033679|NCT03322566|460751617|FG001|Overall Study|Withdrawal by Subject|3|||
128033680|NCT03322566|460751618|FG002|Overall Study|Withdrawal by Subject|6|||
127694307|NCT04450342|459508748|FG001|Overall Study|Site Terminated by Sponsor|1|||
128033681|NCT03322566|460751616|FG000|Overall Study|Lost to Follow-up|0|||
128033682|NCT03322566|460751617|FG001|Overall Study|Lost to Follow-up|0|||
128033683|NCT03322566|460751618|FG002|Overall Study|Lost to Follow-up|1|||
128033684|NCT03322566|460751616|FG000|Overall Study|Study terminated by sponsor|1|||
128033685|NCT03322566|460751617|FG001|Overall Study|Study terminated by sponsor|0|||
128033686|NCT03322566|460751618|FG002|Overall Study|Study terminated by sponsor|1|||
128033687|NCT02314923|460751619|FG000|Overall Study|Death|0|||
128033688|NCT02314923|460751620|FG001|Overall Study|Death|0|||
128033689|NCT02314923|460751621|FG002|Overall Study|Death|0|||
128033690|NCT02314923|460751622|FG003|Overall Study|Death|1|||
128033691|NCT02314923|460751623|FG004|Overall Study|Death|0|||
127694308|NCT04450342|459508749|FG002|Overall Study|Site Terminated by Sponsor|1|||
127694309|NCT04450342|459508747|FG000|Overall Study|Study Terminated by Sponsor|31|||
127694310|NCT04450342|459508748|FG001|Overall Study|Study Terminated by Sponsor|29|||
127694311|NCT04450342|459508749|FG002|Overall Study|Study Terminated by Sponsor|6|||
128033692|NCT02314923|460751624|FG005|Overall Study|Death|0|||
127587984|NCT02339584|459121087|FG000|Overall Study|Adverse Event|11|||
127587985|NCT02339584|459121088|FG001|Overall Study|Adverse Event|7|||
127587986|NCT02339584|459121087|FG000|Overall Study|Lack of Efficacy|0|||
127587987|NCT02339584|459121088|FG001|Overall Study|Lack of Efficacy|1|||
127587988|NCT02339584|459121087|FG000|Overall Study|Physician Decision|1|||
127587989|NCT02339584|459121088|FG001|Overall Study|Physician Decision|2|||
127587990|NCT02339584|459121087|FG000|Overall Study|Protocol Violation|1|||
127587991|NCT02339584|459121088|FG001|Overall Study|Protocol Violation|1|||
127587992|NCT02339584|459121087|FG000|Overall Study|Withdrawal by Subject|2|||
127587993|NCT02339584|459121088|FG001|Overall Study|Withdrawal by Subject|4|||
127587994|NCT01084083|459121091|FG000|Overall Study|Adverse Event|5|||
127587995|NCT01084083|459121091|FG000|Overall Study|Death|1|||
127587996|NCT01084083|459121091|FG000|Overall Study|Withdrawal by Subject|2|||
127587997|NCT01084083|459121091|FG000|Overall Study|Complicating disease|1|||
127587998|NCT01084083|459121091|FG000|Overall Study|Other|2|||
127587999|NCT01084083|459121091|FG000|Overall Study|Never started assigned therapy|1|||
127588000|NCT00873912|459121093|FG000|Overall Study|Withdrawal by Subject|1|||
127588001|NCT00873912|459121094|FG001|Overall Study|Withdrawal by Subject|0|||
127588002|NCT00873912|459121093|FG000|Overall Study|Lost to Follow-up|2|||
127588003|NCT00873912|459121094|FG001|Overall Study|Lost to Follow-up|0|||
127588004|NCT01088997|459121095|FG000|Overall Study|Physician Decision|1|||
127588005|NCT01088997|459121096|FG001|Overall Study|Physician Decision|1|||
127588006|NCT01088997|459121095|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
127588007|NCT01088997|459121096|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
127588008|NCT01088997|459121095|FG000|Overall Study|Excluded prior to receiving drug|1|||
127588009|NCT01088997|459121096|FG001|Overall Study|Excluded prior to receiving drug|1|||
127588010|NCT05695209|459121100|FG000|3-months|Withdrawal by Subject|2|||
127588011|NCT05695209|459121101|FG001|3-months|Withdrawal by Subject|0|||
127588012|NCT05695209|459121100|FG000|3-months|Unable to contact for 3-month data collection|0|||
127588013|NCT05695209|459121101|FG001|3-months|Unable to contact for 3-month data collection|1|||
127588014|NCT05695209|459121100|FG000|6-months|Lost to Follow-up|1|||
127588015|NCT05695209|459121101|FG001|6-months|Lost to Follow-up|1|||
127588016|NCT03749447|459122838|FG000|Overall Study|Adverse Event|11|||
127588017|NCT03749447|459122839|FG001|Overall Study|Adverse Event|3|||
127588018|NCT03749447|459122838|FG000|Overall Study|Death|1|||
127588019|NCT03749447|459122839|FG001|Overall Study|Death|1|||
127588020|NCT03749447|459122838|FG000|Overall Study|Lost to Follow-up|2|||
127588021|NCT03749447|459122839|FG001|Overall Study|Lost to Follow-up|2|||
127588022|NCT03749447|459122838|FG000|Overall Study|Reason Not Specified|0|||
127588023|NCT03749447|459122839|FG001|Overall Study|Reason Not Specified|3|||
127588024|NCT03749447|459122838|FG000|Overall Study|Physician Decision|4|||
127588025|NCT03749447|459122839|FG001|Overall Study|Physician Decision|3|||
127588026|NCT03749447|459122838|FG000|Overall Study|Protocol-Specified Withdrawal Criteria Met|1|||
127588027|NCT03749447|459122839|FG001|Overall Study|Protocol-Specified Withdrawal Criteria Met|3|||
127588028|NCT03749447|459122838|FG000|Overall Study|Study Terminated By Sponsor|112|||
127588029|NCT03749447|459122839|FG001|Overall Study|Study Terminated By Sponsor|105|||
127588030|NCT03749447|459122838|FG000|Overall Study|Withdrawal by Subject|12|||
127588031|NCT03749447|459122839|FG001|Overall Study|Withdrawal by Subject|6|||
127588032|NCT03749447|459122838|FG000|Overall Study|Non-compliance With Study Drug|0|||
127588033|NCT03749447|459122839|FG001|Overall Study|Non-compliance With Study Drug|1|||
127588034|NCT05996718|459122840|FG000|Overall Study|Lost to Follow-up|3|||
127588035|NCT01218113|459122841|FG000|Overall Study|Withdrawal by Subject|1|||
127694312|NCT04450342|459508747|FG000|Overall Study|Withdrawal by Subject|0|||
127588036|NCT01218113|459122842|FG001|Overall Study|Withdrawal by Subject|0|||
127588037|NCT01218113|459122843|FG002|Overall Study|Withdrawal by Subject|1|||
127588038|NCT01218113|459122841|FG000|Overall Study|Lost to Follow-up|4|||
127588039|NCT01218113|459122842|FG001|Overall Study|Lost to Follow-up|1|||
127588040|NCT01218113|459122843|FG002|Overall Study|Lost to Follow-up|4|||
127694313|NCT04450342|459508748|FG001|Overall Study|Withdrawal by Subject|1|||
127588041|NCT01218113|459122841|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
127588042|NCT01218113|459122842|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
127588043|NCT01218113|459122843|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
127588044|NCT01713686|459122844|FG000|Overall Study|Lost to Follow-up|9|||
127588045|NCT01713686|459122844|FG000|Overall Study|Withdrawal by Subject|6|||
127588046|NCT04840615|459122845|FG000|Overall Study|None of the participants completed all 4 cycles.|0|||
127694314|NCT04450342|459508749|FG002|Overall Study|Withdrawal by Subject|2|||
127784636|NCT03596866|459837011|FG001|Overall Study|Reason Not Specified|13|||
127784637|NCT00262522|459837016|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
127784638|NCT00262522|459837017|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
127784639|NCT00262522|459837018|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
127784640|NCT00262522|459837019|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
127784641|NCT00262522|459837016|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
127784642|NCT00262522|459837017|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
127784643|NCT00262522|459837018|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
127784644|NCT00262522|459837019|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
127784645|NCT00262522|459837016|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
127784646|NCT00262522|459837017|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
127784647|NCT00262522|459837018|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
127588047|NCT04840615|459122846|FG001|Overall Study|None of the participants completed all 4 cycles.|2|||
127588048|NCT04840615|459122847|FG002|Overall Study|None of the participants completed all 4 cycles.|0|||
127588049|NCT00967668|459122848|FG000|Overall Study|Withdrawal by Subject|13|||
127588050|NCT00967668|459122849|FG001|Overall Study|Withdrawal by Subject|8|||
127588051|NCT00967668|459122850|FG002|Overall Study|Withdrawal by Subject|8|||
127588052|NCT00967668|459122848|FG000|Overall Study|Death|0|||
127588053|NCT00967668|459122849|FG001|Overall Study|Death|2|||
127588054|NCT00967668|459122850|FG002|Overall Study|Death|4|||
127588055|NCT00967668|459122848|FG000|Overall Study|Removed due to behavior|1|||
127588056|NCT00967668|459122849|FG001|Overall Study|Removed due to behavior|1|||
127588057|NCT00967668|459122850|FG002|Overall Study|Removed due to behavior|2|||
127588058|NCT00967668|459122848|FG000|Overall Study|Refused Year 2|11|||
127588059|NCT00967668|459122849|FG001|Overall Study|Refused Year 2|6|||
127588060|NCT00967668|459122850|FG002|Overall Study|Refused Year 2|4|||
127588061|NCT00967668|459122848|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
127588062|NCT00967668|459122849|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
127588063|NCT00967668|459122850|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
127588064|NCT00967668|459122848|FG000|Overall Study|Lost to Follow-up|15|||
127588065|NCT00967668|459122849|FG001|Overall Study|Lost to Follow-up|9|||
127588066|NCT00967668|459122850|FG002|Overall Study|Lost to Follow-up|16|||
127588067|NCT00967668|459122848|FG000|Overall Study|Refused 12-mo assessment|3|||
127588068|NCT00967668|459122849|FG001|Overall Study|Refused 12-mo assessment|1|||
127588069|NCT00967668|459122850|FG002|Overall Study|Refused 12-mo assessment|9|||
127588070|NCT00967668|459122848|FG000|Overall Study|Pregnancy|1|||
127588071|NCT00967668|459122849|FG001|Overall Study|Pregnancy|0|||
127588072|NCT00967668|459122850|FG002|Overall Study|Pregnancy|0|||
127588073|NCT00115739|459122852|FG000|Overall Study|Lost to Follow-up|3|||
127588074|NCT00709761|459122855|FG000|Overall Study|Withdrawal by Subject|8|||
127588075|NCT00709761|459122855|FG000|Overall Study|study closed/terminated|17|||
127588076|NCT00709761|459122855|FG000|Overall Study|Lost to Follow-up|2|||
127588077|NCT01606800|459122856|FG000|Overall Study|Adverse Event|3|||
127588078|NCT01606800|459122857|FG001|Overall Study|Adverse Event|1|||
127588079|NCT01606800|459122856|FG000|Overall Study|Participant withdrew consent|0|||
127588080|NCT01606800|459122857|FG001|Overall Study|Participant withdrew consent|1|||
127588081|NCT01606800|459122856|FG000|Overall Study|Missing completion status|2|||
127588082|NCT01606800|459122857|FG001|Overall Study|Missing completion status|0|||
127588083|NCT03311724|459122858|FG000|Overall Study|Physician Decision|0|||
127588084|NCT03311724|459122859|FG001|Overall Study|Physician Decision|0|||
127588085|NCT03311724|459122860|FG002|Overall Study|Physician Decision|0|||
127588086|NCT03311724|459122861|FG003|Overall Study|Physician Decision|1|||
127588087|NCT03311724|459122858|FG000|Overall Study|Protocol Violation|1|||
127588088|NCT03311724|459122859|FG001|Overall Study|Protocol Violation|0|||
127588089|NCT03311724|459122860|FG002|Overall Study|Protocol Violation|1|||
127588090|NCT03311724|459122861|FG003|Overall Study|Protocol Violation|0|||
127588091|NCT03311724|459122858|FG000|Overall Study|Withdrawal by Subject|1|||
127588092|NCT03311724|459122859|FG001|Overall Study|Withdrawal by Subject|1|||
127588093|NCT03311724|459122860|FG002|Overall Study|Withdrawal by Subject|0|||
127588094|NCT03311724|459122861|FG003|Overall Study|Withdrawal by Subject|0|||
127588095|NCT03311724|459122858|FG000|Overall Study|Lost to Follow-up|1|||
127588096|NCT03311724|459122859|FG001|Overall Study|Lost to Follow-up|0|||
127588097|NCT03311724|459122860|FG002|Overall Study|Lost to Follow-up|0|||
127784648|NCT00262522|459837019|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
127784649|NCT00262522|459837016|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
127887318|NCT01298596|460210579|FG001|Overall Study|Withdrawal by Subject|1|||
128033693|NCT02314923|460751625|FG006|Overall Study|Death|0|||
128033694|NCT02314923|460751626|FG007|Overall Study|Death|0|||
127588098|NCT03311724|459122861|FG003|Overall Study|Lost to Follow-up|0|||
127588099|NCT03311724|459122858|FG000|Overall Study|Sponsor Decision|0|||
127588100|NCT03311724|459122859|FG001|Overall Study|Sponsor Decision|0|||
127588101|NCT03311724|459122860|FG002|Overall Study|Sponsor Decision|1|||
127588102|NCT03311724|459122861|FG003|Overall Study|Sponsor Decision|0|||
127588103|NCT00844831|459122868|FG000|Overall Study|Withdrawal by Subject|4|||
127588104|NCT00844831|459122868|FG000|Overall Study|Adverse Event|1|||
127588105|NCT00844831|459122868|FG000|Overall Study|Physician Decision|1|||
127784650|NCT00262522|459837017|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
127694315|NCT01057433|459508754|FG000|Overall Study|Adverse Event|1|||
127694316|NCT05268302|459508755|FG000|Overall Study|Death|0|||
127694317|NCT05268302|459508756|FG001|Overall Study|Death|1|||
127694332|NCT02811679|459508759|FG000|Overall Study|Adverse Event|1|||
127694333|NCT02811679|459508759|FG000|Overall Study|Lack of Efficacy|6|||
127694334|NCT02811679|459508759|FG000|Overall Study|Early study closure due to slow accrual|3|||
127694335|NCT05319860|459508761|FG000|Overall Study|Death|1|||
127694336|NCT05319860|459508762|FG001|Overall Study|Death|1|||
127694337|NCT05319860|459508761|FG000|Overall Study|Lost to Follow-up|3|||
127694338|NCT05319860|459508762|FG001|Overall Study|Lost to Follow-up|1|||
127694339|NCT05319860|459508761|FG000|Overall Study|Withdrawal by Subject|1|||
127694340|NCT05319860|459508762|FG001|Overall Study|Withdrawal by Subject|7|||
127694341|NCT04314895|459508763|FG000|Overall Study|Lost to Follow-up|1|||
127694342|NCT04314895|459508763|FG000|Overall Study|Death|10|||
127694343|NCT04314895|459508763|FG000|Overall Study|Physician Decision|2|||
127694344|NCT04402489|459510699|FG000|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
127694345|NCT04402489|459510700|FG001|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|1|||
127694346|NCT04402489|459510701|FG002|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
127694347|NCT04402489|459510702|FG003|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
127694348|NCT04402489|459510703|FG004|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
127694349|NCT04402489|459510699|FG000|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|1|||
127694350|NCT04402489|459510700|FG001|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
127694351|NCT04402489|459510701|FG002|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
127694352|NCT04402489|459510702|FG003|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
127694353|NCT04402489|459510703|FG004|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
127694354|NCT04402489|459510699|FG000|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|3|||
127694355|NCT04402489|459510700|FG001|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
127694356|NCT04402489|459510701|FG002|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
127694357|NCT04402489|459510702|FG003|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
127882023|NCT01556490|460190789|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
128033695|NCT02314923|460751627|FG008|Overall Study|Death|0|||
128033696|NCT02314923|460751628|FG009|Overall Study|Death|0|||
128033697|NCT02314923|460751619|FG000|Overall Study|Lost to Follow-up|2|||
128033698|NCT02314923|460751620|FG001|Overall Study|Lost to Follow-up|3|||
128033699|NCT02314923|460751621|FG002|Overall Study|Lost to Follow-up|1|||
128033700|NCT02314923|460751622|FG003|Overall Study|Lost to Follow-up|0|||
128033701|NCT02314923|460751623|FG004|Overall Study|Lost to Follow-up|0|||
128033702|NCT02314923|460751624|FG005|Overall Study|Lost to Follow-up|0|||
128033703|NCT02314923|460751625|FG006|Overall Study|Lost to Follow-up|3|||
128033704|NCT02314923|460751626|FG007|Overall Study|Lost to Follow-up|4|||
128033705|NCT02314923|460751627|FG008|Overall Study|Lost to Follow-up|2|||
128033706|NCT02314923|460751628|FG009|Overall Study|Lost to Follow-up|0|||
128033707|NCT02314923|460751619|FG000|Overall Study|Withdrawal by Subject|0|||
128033708|NCT02314923|460751620|FG001|Overall Study|Withdrawal by Subject|0|||
128033709|NCT02314923|460751621|FG002|Overall Study|Withdrawal by Subject|1|||
128033710|NCT02314923|460751622|FG003|Overall Study|Withdrawal by Subject|0|||
128033711|NCT02314923|460751623|FG004|Overall Study|Withdrawal by Subject|1|||
128033712|NCT02314923|460751624|FG005|Overall Study|Withdrawal by Subject|0|||
128033713|NCT02314923|460751625|FG006|Overall Study|Withdrawal by Subject|1|||
128033714|NCT02314923|460751626|FG007|Overall Study|Withdrawal by Subject|0|||
128033715|NCT02314923|460751627|FG008|Overall Study|Withdrawal by Subject|0|||
128033716|NCT02314923|460751628|FG009|Overall Study|Withdrawal by Subject|0|||
128033717|NCT02314923|460751619|FG000|Overall Study|Physician Decision|0|||
128033718|NCT02314923|460751620|FG001|Overall Study|Physician Decision|1|||
128033719|NCT02314923|460751621|FG002|Overall Study|Physician Decision|0|||
128033720|NCT02314923|460751622|FG003|Overall Study|Physician Decision|0|||
128033721|NCT02314923|460751623|FG004|Overall Study|Physician Decision|0|||
128033722|NCT02314923|460751624|FG005|Overall Study|Physician Decision|0|||
128033723|NCT02314923|460751625|FG006|Overall Study|Physician Decision|0|||
128033724|NCT02314923|460751626|FG007|Overall Study|Physician Decision|0|||
128033725|NCT02314923|460751627|FG008|Overall Study|Physician Decision|0|||
128033726|NCT02314923|460751628|FG009|Overall Study|Physician Decision|0|||
128033727|NCT02314923|460751619|FG000|Overall Study|Participant unavailable|0|||
128033728|NCT02314923|460751620|FG001|Overall Study|Participant unavailable|0|||
128033729|NCT02314923|460751621|FG002|Overall Study|Participant unavailable|0|||
128033730|NCT02314923|460751622|FG003|Overall Study|Participant unavailable|0|||
128033731|NCT02314923|460751623|FG004|Overall Study|Participant unavailable|0|||
128033732|NCT02314923|460751624|FG005|Overall Study|Participant unavailable|1|||
128033733|NCT02314923|460751625|FG006|Overall Study|Participant unavailable|0|||
128033734|NCT02314923|460751626|FG007|Overall Study|Participant unavailable|0|||
128033735|NCT02314923|460751627|FG008|Overall Study|Participant unavailable|0|||
128033736|NCT02314923|460751628|FG009|Overall Study|Participant unavailable|0|||
128033737|NCT02314923|460751619|FG000|Overall Study|Screen failure|0|||
128033738|NCT02314923|460751620|FG001|Overall Study|Screen failure|0|||
128033739|NCT02314923|460751621|FG002|Overall Study|Screen failure|0|||
127588106|NCT03305575|459122879|FG000|Overall Study|Physician Decision|1|||
127588107|NCT03305575|459122880|FG001|Overall Study|Physician Decision|0|||
127588108|NCT03486223|459122889|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
127588109|NCT03486223|459122890|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
127588110|NCT01819831|459122891|FG000|Overall Study|Withdrawal by Subject|1|||
127588111|NCT01749137|459122892|FG000|Overall Study|Adverse Event|4|||
127588112|NCT01749137|459122893|FG001|Overall Study|Adverse Event|4|||
127588113|NCT01749137|459122892|FG000|Overall Study|Lost to Follow-up|2|||
127588114|NCT01749137|459122893|FG001|Overall Study|Lost to Follow-up|3|||
127588115|NCT01749137|459122892|FG000|Overall Study|Physician Decision|1|||
127588116|NCT01749137|459122893|FG001|Overall Study|Physician Decision|0|||
127588117|NCT01749137|459122892|FG000|Overall Study|Withdrawal by Subject|8|||
127588118|NCT01749137|459122893|FG001|Overall Study|Withdrawal by Subject|4|||
127588119|NCT03130257|459122909|FG000|Overall Study|Withdrawal by Subject|1|||
127588120|NCT03130257|459122910|FG001|Overall Study|Withdrawal by Subject|0|||
127588121|NCT03130257|459122911|FG002|Overall Study|Withdrawal by Subject|2|||
127588122|NCT01847274|459122912|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
127588123|NCT01847274|459122913|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
127588124|NCT01847274|459122914|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
127588125|NCT01847274|459122915|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
127588126|NCT01847274|459122916|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
127588127|NCT01847274|459122917|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
127588128|NCT01847274|459122918|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
127588129|NCT01847274|459122919|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
127588130|NCT01847274|459122920|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
127588131|NCT01847274|459122921|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
127588132|NCT01847274|459122922|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
127588133|NCT01847274|459122912|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
127588134|NCT01847274|459122913|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
127588135|NCT01847274|459122914|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
127588136|NCT01847274|459122915|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
127588137|NCT01847274|459122916|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
127588138|NCT01847274|459122917|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
127588139|NCT01847274|459122918|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
127588140|NCT01847274|459122919|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
127588141|NCT01847274|459122920|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
127588142|NCT01847274|459122921|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
127588143|NCT01847274|459122922|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
127588144|NCT01847274|459122912|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
127588145|NCT01847274|459122913|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
127588146|NCT01847274|459122914|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
127588147|NCT01847274|459122915|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
127588148|NCT01847274|459122916|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
127588149|NCT01847274|459122917|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
127588150|NCT01847274|459122918|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
127588151|NCT01847274|459122919|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
127588152|NCT01847274|459122920|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
127588153|NCT01847274|459122921|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
127588154|NCT01847274|459122922|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
127588155|NCT01847274|459122912|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
127588156|NCT01847274|459122913|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
127588157|NCT01847274|459122914|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
127588158|NCT01847274|459122915|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
127588159|NCT01847274|459122916|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
127588160|NCT01847274|459122917|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
127588161|NCT01847274|459122918|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
127588162|NCT01847274|459122919|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
127588163|NCT01847274|459122920|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
127588164|NCT01847274|459122921|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
127588165|NCT01847274|459122922|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
127588166|NCT01847274|459122912|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
127588167|NCT01847274|459122913|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
127588168|NCT01847274|459122914|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
127588169|NCT01847274|459122915|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
127588170|NCT01847274|459122916|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
127588171|NCT01847274|459122917|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
127588172|NCT01847274|459122918|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
127588173|NCT01847274|459122919|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
127588174|NCT01847274|459122920|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
127588175|NCT01847274|459122921|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
127694358|NCT04402489|459510703|FG004|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
127705227|NCT01928394|459551584|FG017|Treatment Period|Death|0|||
128033740|NCT02314923|460751622|FG003|Overall Study|Screen failure|0|||
128033741|NCT02314923|460751623|FG004|Overall Study|Screen failure|0|||
128033742|NCT02314923|460751624|FG005|Overall Study|Screen failure|0|||
128033743|NCT02314923|460751625|FG006|Overall Study|Screen failure|1|||
128033744|NCT02314923|460751626|FG007|Overall Study|Screen failure|0|||
128033745|NCT02314923|460751627|FG008|Overall Study|Screen failure|0|||
128033746|NCT02314923|460751628|FG009|Overall Study|Screen failure|0|||
128033747|NCT02314923|460751619|FG000|Overall Study|Participant relocation|1|||
128033748|NCT02314923|460751620|FG001|Overall Study|Participant relocation|0|||
128033749|NCT02314923|460751621|FG002|Overall Study|Participant relocation|0|||
128033750|NCT02314923|460751622|FG003|Overall Study|Participant relocation|0|||
127588176|NCT01847274|459122922|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
127588177|NCT01847274|459122912|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
127588178|NCT01847274|459122913|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
127588179|NCT01847274|459122914|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
127588180|NCT01847274|459122915|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
127588181|NCT01847274|459122916|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
127588182|NCT01847274|459122917|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
127588183|NCT01847274|459122918|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
127588184|NCT01847274|459122919|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
127588185|NCT01847274|459122920|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
127588186|NCT01847274|459122921|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
127588187|NCT01847274|459122922|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
127588188|NCT01847274|459122912|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
128033751|NCT02314923|460751623|FG004|Overall Study|Participant relocation|0|||
128033752|NCT02314923|460751624|FG005|Overall Study|Participant relocation|0|||
128033753|NCT02314923|460751625|FG006|Overall Study|Participant relocation|0|||
128033754|NCT02314923|460751626|FG007|Overall Study|Participant relocation|1|||
128033755|NCT02314923|460751627|FG008|Overall Study|Participant relocation|0|||
127588189|NCT01847274|459122913|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
127588190|NCT01847274|459122914|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
127588191|NCT01847274|459122915|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
127588192|NCT01847274|459122916|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
127588193|NCT01847274|459122917|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
127588194|NCT01847274|459122918|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
127588195|NCT01847274|459122919|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
127588196|NCT01847274|459122920|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
127588197|NCT01847274|459122921|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
127588198|NCT01847274|459122922|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
127588199|NCT01847274|459122912|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
127588200|NCT01847274|459122913|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
127588201|NCT01847274|459122914|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
127588202|NCT01847274|459122915|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
127588203|NCT01847274|459122916|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
127588204|NCT01847274|459122917|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
127588205|NCT01847274|459122918|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
127588206|NCT01847274|459122919|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
127588207|NCT01847274|459122920|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
127588208|NCT01847274|459122921|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
127588209|NCT01847274|459122922|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
127588210|NCT01847274|459122912|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
127588211|NCT01847274|459122913|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
127588212|NCT01847274|459122914|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
127588213|NCT01847274|459122915|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
127588214|NCT01847274|459122916|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
127588215|NCT01847274|459122917|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
127588216|NCT01847274|459122918|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
127588217|NCT01847274|459122919|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
127588218|NCT01847274|459122920|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
127588219|NCT01847274|459122921|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
127588220|NCT01847274|459122922|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
127588221|NCT01847274|459122912|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
127588222|NCT01847274|459122913|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
127588223|NCT01847274|459122914|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
127588224|NCT01847274|459122915|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
127705228|NCT01928394|459551585|FG018|Treatment Period|Death|0|||
128033756|NCT02314923|460751628|FG009|Overall Study|Participant relocation|0|||
128033757|NCT00725985|460751629|FG000|ITP- Treatment Disposition|Adverse Event|20|||
127588225|NCT01847274|459122916|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
127588226|NCT01847274|459122917|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
127588227|NCT01847274|459122918|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
127588228|NCT01847274|459122919|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
127588229|NCT01847274|459122920|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
127588230|NCT01847274|459122921|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
127588231|NCT01847274|459122922|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
127588232|NCT01847274|459122912|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
127588233|NCT01847274|459122913|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
127588234|NCT01847274|459122914|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
127588235|NCT01847274|459122915|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
127588236|NCT01847274|459122916|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
127588237|NCT01847274|459122917|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
127588238|NCT01847274|459122918|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
127588239|NCT01847274|459122919|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
127588240|NCT01847274|459122920|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
127588241|NCT01847274|459122921|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
127588242|NCT01847274|459122922|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
127588243|NCT01847274|459122912|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
127588244|NCT01847274|459122913|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
127588245|NCT01847274|459122914|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
127588246|NCT01847274|459122915|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
127588247|NCT01847274|459122916|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
127588248|NCT01847274|459122917|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
127588249|NCT01847274|459122918|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
127588250|NCT01847274|459122919|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
127588251|NCT01847274|459122920|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
127588252|NCT01847274|459122921|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
127588253|NCT01847274|459122922|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
127588254|NCT01847274|459122912|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
127588255|NCT01847274|459122913|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
127588256|NCT01847274|459122914|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
127588257|NCT01847274|459122915|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
127588258|NCT01847274|459122916|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
127588259|NCT01847274|459122917|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
127588260|NCT01847274|459122918|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
127588261|NCT01847274|459122919|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
127588262|NCT01847274|459122920|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
127588263|NCT01847274|459122921|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
127588264|NCT01847274|459122922|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
127588265|NCT01847274|459122912|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
127588266|NCT01847274|459122913|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
127588267|NCT01847274|459122914|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
127588268|NCT01847274|459122915|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
127588269|NCT01847274|459122916|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
127588270|NCT01847274|459122917|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
127588271|NCT01847274|459122918|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
127588272|NCT01847274|459122919|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
127588273|NCT01847274|459122920|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
127588274|NCT01847274|459122921|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
127588275|NCT01847274|459122922|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
127588276|NCT01847274|459122912|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
127588277|NCT01847274|459122913|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
127705229|NCT01928394|459551586|FG019|Treatment Period|Death|0|||
128033758|NCT00725985|460751630|FG001|ITP- Treatment Disposition|Adverse Event|10|||
128033759|NCT00725985|460751631|FG002|ITP- Treatment Disposition|Adverse Event|5|||
128033760|NCT00725985|460751632|FG003|ITP- Treatment Disposition|Adverse Event|0|||
128033761|NCT00725985|460751633|FG004|ITP- Treatment Disposition|Adverse Event|0|||
128033762|NCT00725985|460751634|FG005|ITP- Treatment Disposition|Adverse Event|0|||
128033763|NCT00725985|460751635|FG006|ITP- Treatment Disposition|Adverse Event|0|||
128033764|NCT00725985|460751636|FG007|ITP- Treatment Disposition|Adverse Event|0|||
128033765|NCT00725985|460751637|FG008|ITP- Treatment Disposition|Adverse Event|0|||
128033766|NCT00725985|460751638|FG009|ITP- Treatment Disposition|Adverse Event|0|||
127705230|NCT01928394|459551587|FG020|Treatment Period|Death|0|||
128033767|NCT00725985|460751639|FG010|ITP- Treatment Disposition|Adverse Event|0|||
128033768|NCT00725985|460751640|FG011|ITP- Treatment Disposition|Adverse Event|0|||
128033769|NCT00725985|460751629|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
128033770|NCT00725985|460751630|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
128033771|NCT00725985|460751631|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
128033772|NCT00725985|460751632|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
128033773|NCT00725985|460751633|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
128033774|NCT00725985|460751634|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
128033775|NCT00725985|460751635|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
128033776|NCT00725985|460751636|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
128033777|NCT00725985|460751637|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
128033778|NCT00725985|460751638|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
128033779|NCT00725985|460751639|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
128033780|NCT00725985|460751640|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
128033781|NCT00725985|460751629|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
128033782|NCT00725985|460751630|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
128033783|NCT00725985|460751631|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
128033784|NCT00725985|460751632|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
128033785|NCT00725985|460751633|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
128033786|NCT00725985|460751634|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
128033787|NCT00725985|460751635|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
128033788|NCT00725985|460751636|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
128033789|NCT00725985|460751637|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
128033790|NCT00725985|460751638|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
128033791|NCT00725985|460751639|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
128033792|NCT00725985|460751640|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
128033793|NCT00725985|460751629|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
128033794|NCT00725985|460751630|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
128033795|NCT00725985|460751631|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
128033796|NCT00725985|460751632|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
128033797|NCT00725985|460751633|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
128033798|NCT00725985|460751634|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
128033799|NCT00725985|460751635|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
128033800|NCT00725985|460751636|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
128033801|NCT00725985|460751637|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
128033802|NCT00725985|460751638|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
128033803|NCT00725985|460751639|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
128033804|NCT00725985|460751640|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
128033805|NCT00725985|460751629|FG000|ITP- Treatment Disposition|Other|50|||
128033806|NCT00725985|460751630|FG001|ITP- Treatment Disposition|Other|38|||
128033807|NCT00725985|460751631|FG002|ITP- Treatment Disposition|Other|24|||
128033808|NCT00725985|460751632|FG003|ITP- Treatment Disposition|Other|0|||
128033809|NCT00725985|460751633|FG004|ITP- Treatment Disposition|Other|0|||
128033810|NCT00725985|460751634|FG005|ITP- Treatment Disposition|Other|0|||
128033811|NCT00725985|460751635|FG006|ITP- Treatment Disposition|Other|0|||
128033812|NCT00725985|460751636|FG007|ITP- Treatment Disposition|Other|0|||
127588278|NCT01847274|459122914|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
127588279|NCT01847274|459122915|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
127588280|NCT01847274|459122916|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
127588281|NCT01847274|459122917|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
127588282|NCT01847274|459122918|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
127588283|NCT01847274|459122919|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
127588284|NCT01847274|459122920|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
127588285|NCT01847274|459122921|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
127588286|NCT01847274|459122922|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
127588287|NCT01847274|459122912|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
127588288|NCT01847274|459122913|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
127588289|NCT01847274|459122914|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
127588290|NCT01847274|459122915|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
127588291|NCT01847274|459122916|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
127588292|NCT01847274|459122917|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
127588293|NCT01847274|459122918|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
127588294|NCT01847274|459122919|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
128033813|NCT00725985|460751637|FG008|ITP- Treatment Disposition|Other|0|||
128033814|NCT00725985|460751638|FG009|ITP- Treatment Disposition|Other|0|||
128033815|NCT00725985|460751639|FG010|ITP- Treatment Disposition|Other|0|||
127588295|NCT01847274|459122920|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
127588296|NCT01847274|459122921|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
127588297|NCT01847274|459122922|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
127588298|NCT00288054|459122923|FG000|Overall Study|Protocol Violation|2|||
127588299|NCT00288054|459122923|FG000|Overall Study|Lack of Efficacy|16|||
127588300|NCT00288054|459122923|FG000|Overall Study|Adverse Event|3|||
127588301|NCT00288054|459122923|FG000|Overall Study|Withdrawal by Subject|1|||
127588302|NCT00288054|459122923|FG000|Overall Study|Not protocol specified|2|||
127588303|NCT00289991|459122924|FG000|Overall Study|Death|35|||
127588304|NCT00289991|459122925|FG001|Overall Study|Death|38|||
127588305|NCT00289991|459122924|FG000|Overall Study|Adverse Event|15|||
127588306|NCT00289991|459122925|FG001|Overall Study|Adverse Event|13|||
127588307|NCT00289991|459122924|FG000|Overall Study|Failure of prophylaxis|1|||
127588308|NCT00289991|459122925|FG001|Overall Study|Failure of prophylaxis|1|||
127588309|NCT00289991|459122924|FG000|Overall Study|Fungal breakthrough infection|0|||
127588310|NCT00289991|459122925|FG001|Overall Study|Fungal breakthrough infection|1|||
127588311|NCT00289991|459122924|FG000|Overall Study|Lost to Follow-up|0|||
127588312|NCT00289991|459122925|FG001|Overall Study|Lost to Follow-up|1|||
127588313|NCT00289991|459122924|FG000|Overall Study|Withdrawal by Subject|2|||
127588314|NCT00289991|459122925|FG001|Overall Study|Withdrawal by Subject|12|||
127588315|NCT00289991|459122924|FG000|Overall Study|Other|5|||
127588316|NCT00289991|459122925|FG001|Overall Study|Other|14|||
127588317|NCT01606007|459122932|FG000|Overall Study|Reason 'Other' in the protocol|0|||
127588318|NCT01606007|459122933|FG001|Overall Study|Reason 'Other' in the protocol|1|||
127588319|NCT01606007|459122934|FG002|Overall Study|Reason 'Other' in the protocol|1|||
127588320|NCT01606007|459122932|FG000|Overall Study|Pregnancy|0|||
127588321|NCT01606007|459122933|FG001|Overall Study|Pregnancy|1|||
127588322|NCT01606007|459122934|FG002|Overall Study|Pregnancy|1|||
127588323|NCT01606007|459122932|FG000|Overall Study|Withdrawal by Subject|8|||
127588324|NCT01606007|459122933|FG001|Overall Study|Withdrawal by Subject|6|||
127588325|NCT01606007|459122934|FG002|Overall Study|Withdrawal by Subject|1|||
127588326|NCT01606007|459122932|FG000|Overall Study|Adverse Event|0|||
127588327|NCT01606007|459122933|FG001|Overall Study|Adverse Event|1|||
127588328|NCT01606007|459122934|FG002|Overall Study|Adverse Event|1|||
127588329|NCT01606007|459122932|FG000|Overall Study|discontinue study treatment|0|||
127588330|NCT01606007|459122933|FG001|Overall Study|discontinue study treatment|2|||
127588331|NCT01606007|459122934|FG002|Overall Study|discontinue study treatment|1|||
127588332|NCT01606007|459122932|FG000|Overall Study|Lost to Follow-up|6|||
127588333|NCT01606007|459122933|FG001|Overall Study|Lost to Follow-up|8|||
127588334|NCT01606007|459122934|FG002|Overall Study|Lost to Follow-up|5|||
127588335|NCT01606007|459122932|FG000|Overall Study|Poor/Non-compliance|1|||
127588336|NCT01606007|459122933|FG001|Overall Study|Poor/Non-compliance|0|||
127588337|NCT01606007|459122934|FG002|Overall Study|Poor/Non-compliance|0|||
127588338|NCT03733470|459122939|FG000|Overall Study|PI Decision|1|||
127588339|NCT03733470|459122940|FG001|Overall Study|PI Decision|1|||
127588340|NCT01010061|459122941|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
127588341|NCT01010061|459122942|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
127588342|NCT01010061|459122941|FG000|Overall Study|Disease Progression|2|||
127588343|NCT01010061|459122942|FG001|Overall Study|Disease Progression|8|||
127588344|NCT01010061|459122941|FG000|Overall Study|Withdrew Consent|5|||
127588345|NCT01010061|459122942|FG001|Overall Study|Withdrew Consent|1|||
127588346|NCT01010061|459122941|FG000|Overall Study|Death|3|||
127588347|NCT01010061|459122942|FG001|Overall Study|Death|6|||
127588348|NCT01010061|459122941|FG000|Overall Study|Administrative/Other|0|||
127588349|NCT01010061|459122942|FG001|Overall Study|Administrative/Other|1|||
127588350|NCT01010061|459122941|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
127588351|NCT01010061|459122942|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
127588352|NCT01010061|459122941|FG000|Overall Study|Insufficient Therapeutic Response|1|||
127588353|NCT01010061|459122942|FG001|Overall Study|Insufficient Therapeutic Response|5|||
127588354|NCT01010061|459122941|FG000|Overall Study|Violation of Selection Criteria|0|||
127588355|NCT01010061|459122942|FG001|Overall Study|Violation of Selection Criteria|1|||
127588356|NCT01010061|459122941|FG000|Overall Study|Did Not Receive Treatment|2|||
127588357|NCT01010061|459122942|FG001|Overall Study|Did Not Receive Treatment|2|||
127588358|NCT03470441|459122943|FG000|Overall Study|Death|0|||
127588359|NCT03470441|459122944|FG001|Overall Study|Death|1|||
127588360|NCT03470441|459122945|FG002|Overall Study|Death|1|||
127588361|NCT03470441|459122946|FG003|Overall Study|Death|0|||
127882024|NCT01289990|460190793|FG000|Overall Study|Death|0|||
127588362|NCT03470441|459122943|FG000|Overall Study|Adverse Event|0|||
127588363|NCT03470441|459122944|FG001|Overall Study|Adverse Event|0|||
127588364|NCT03470441|459122945|FG002|Overall Study|Adverse Event|0|||
127588365|NCT03470441|459122946|FG003|Overall Study|Adverse Event|1|||
127588366|NCT03470441|459122943|FG000|Overall Study|Withdrawal by Subject|1|||
127588367|NCT03470441|459122944|FG001|Overall Study|Withdrawal by Subject|4|||
127588368|NCT03470441|459122945|FG002|Overall Study|Withdrawal by Subject|1|||
127588369|NCT03470441|459122946|FG003|Overall Study|Withdrawal by Subject|3|||
127588370|NCT02217878|459122950|FG000|Overall Study|required morphine due to chest pain|1|||
127882025|NCT01289990|460190794|FG001|Overall Study|Death|0|||
127588371|NCT02217878|459122951|FG001|Overall Study|required morphine due to chest pain|2|||
127588372|NCT02217878|459122950|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
127588373|NCT02217878|459122951|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
127588374|NCT00282984|459122957|FG000|Overall Study|Death|2|||
127588375|NCT00282984|459122958|FG001|Overall Study|Death|5|||
127588376|NCT00282984|459122957|FG000|Overall Study|Adverse Event|8|||
127588377|NCT00282984|459122958|FG001|Overall Study|Adverse Event|5|||
127588378|NCT00282984|459122957|FG000|Overall Study|Lack of Efficacy|0|||
127588379|NCT00282984|459122958|FG001|Overall Study|Lack of Efficacy|2|||
127588380|NCT00282984|459122957|FG000|Overall Study|Lost to Follow-up|14|||
127588381|NCT00282984|459122958|FG001|Overall Study|Lost to Follow-up|10|||
127588382|NCT00282984|459122957|FG000|Overall Study|Withdrawal by Participant|22|||
127588383|NCT00282984|459122958|FG001|Overall Study|Withdrawal by Participant|34|||
127588384|NCT00282984|459122957|FG000|Overall Study|Participant stopped study medication|2|||
127588385|NCT00282984|459122958|FG001|Overall Study|Participant stopped study medication|2|||
127588386|NCT00282984|459122957|FG000|Overall Study|Participant only allowed phone follow-up|0|||
127588387|NCT00282984|459122958|FG001|Overall Study|Participant only allowed phone follow-up|1|||
127588388|NCT00282984|459122957|FG000|Overall Study|Participant used antipsychosis meds|0|||
127588389|NCT00282984|459122958|FG001|Overall Study|Participant used antipsychosis meds|1|||
127588390|NCT00282984|459122957|FG000|Overall Study|lack of motivation|1|||
127588391|NCT00282984|459122958|FG001|Overall Study|lack of motivation|0|||
127588392|NCT00282984|459122957|FG000|Overall Study|in prison|0|||
127588393|NCT00282984|459122958|FG001|Overall Study|in prison|1|||
127588394|NCT00282984|459122957|FG000|Overall Study|Protocol Violation|2|||
127588395|NCT00282984|459122958|FG001|Overall Study|Protocol Violation|0|||
127588396|NCT01128842|459122963|FG000|Overall Study|Adverse Event|1|||
127588397|NCT01128842|459122963|FG000|Overall Study|Disease Progression|6|||
127588398|NCT03408483|459122964|FG000|Overall Study|Physician Decision|3|||
127588399|NCT03408483|459122965|FG001|Overall Study|Physician Decision|3|||
127588400|NCT03408483|459122964|FG000|Overall Study|Lost to Follow-up|3|||
127588401|NCT03408483|459122965|FG001|Overall Study|Lost to Follow-up|0|||
127588402|NCT00114530|459122967|FG000|Overall Study|Death|3|||
127588403|NCT00114530|459122968|FG001|Overall Study|Death|11|||
127588404|NCT00114530|459122967|FG000|Overall Study|Lost to Follow-up|1|||
127588405|NCT00114530|459122968|FG001|Overall Study|Lost to Follow-up|1|||
127588406|NCT00114530|459122967|FG000|Overall Study|Physician Decision|1|||
127588407|NCT00114530|459122968|FG001|Overall Study|Physician Decision|1|||
127588408|NCT00114530|459122967|FG000|Overall Study|Withdrawal by Subject|2|||
127588409|NCT00114530|459122968|FG001|Overall Study|Withdrawal by Subject|6|||
127588410|NCT00114530|459122967|FG000|Overall Study|Breast Cancer|1|||
127588411|NCT00114530|459122968|FG001|Overall Study|Breast Cancer|0|||
127588412|NCT00114530|459122967|FG000|Overall Study|Subject decision after endpoint failure|0|||
127588413|NCT00114530|459122968|FG001|Overall Study|Subject decision after endpoint failure|1|||
127588414|NCT00114530|459122967|FG000|Overall Study|Ineligible|1|||
127588415|NCT00114530|459122968|FG001|Overall Study|Ineligible|0|||
127588416|NCT00365508|459122969|FG000|Overall Study|Lost to Follow-up|139|||
127588417|NCT00365508|459122970|FG001|Overall Study|Lost to Follow-up|154|||
127588418|NCT00751933|459122973|FG000|Overall Study|Withdrawal by Subject|0|||
128033816|NCT00725985|460751640|FG011|ITP- Treatment Disposition|Other|0|||
128033817|NCT00725985|460751629|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
127588419|NCT00751933|459122974|FG001|Overall Study|Withdrawal by Subject|1|||
127588420|NCT00751933|459122975|FG002|Overall Study|Withdrawal by Subject|0|||
127588421|NCT00751933|459122976|FG003|Overall Study|Withdrawal by Subject|0|||
127588422|NCT00751933|459122973|FG000|Overall Study|Physician Decision|0|||
127588423|NCT00751933|459122974|FG001|Overall Study|Physician Decision|0|||
127588424|NCT00751933|459122975|FG002|Overall Study|Physician Decision|1|||
127588425|NCT00751933|459122976|FG003|Overall Study|Physician Decision|1|||
127588426|NCT02538029|459122978|FG000|Overall Study|unable to complete cognitive assessments|1|||
127588427|NCT02538029|459122979|FG001|Overall Study|unable to complete cognitive assessments|0|||
127588428|NCT02538029|459122980|FG002|Overall Study|unable to complete cognitive assessments|1|||
127588429|NCT05248867|459122982|FG000|Double-blind Period|Lost to Follow-up|0|||
127588430|NCT05248867|459122983|FG001|Double-blind Period|Lost to Follow-up|3|||
127588431|NCT05248867|459122984|FG002|Double-blind Period|Lost to Follow-up|0|||
127588432|NCT05248867|459122985|FG003|Double-blind Period|Lost to Follow-up|0|||
127588433|NCT05248867|459122986|FG004|Double-blind Period|Lost to Follow-up|0|||
127588434|NCT05248867|459122987|FG005|Double-blind Period|Lost to Follow-up|0|||
127588435|NCT05248867|459122982|FG000|Double-blind Period|Withdrawal by Subject|5|||
127588436|NCT05248867|459122983|FG001|Double-blind Period|Withdrawal by Subject|14|||
127588437|NCT05248867|459122984|FG002|Double-blind Period|Withdrawal by Subject|0|||
127588438|NCT05248867|459122985|FG003|Double-blind Period|Withdrawal by Subject|0|||
127588439|NCT05248867|459122986|FG004|Double-blind Period|Withdrawal by Subject|0|||
127588440|NCT05248867|459122987|FG005|Double-blind Period|Withdrawal by Subject|0|||
127588441|NCT05248867|459122982|FG000|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
127588442|NCT05248867|459122983|FG001|Double-blind Period|Withdrawal by Subject due to Adverse Event|3|||
127588443|NCT05248867|459122984|FG002|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
127588444|NCT05248867|459122985|FG003|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
127588445|NCT05248867|459122986|FG004|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
127588446|NCT05248867|459122987|FG005|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
127588447|NCT05248867|459122982|FG000|Double-blind Period|Other, not specified|3|||
127588448|NCT05248867|459122983|FG001|Double-blind Period|Other, not specified|8|||
127588449|NCT05248867|459122984|FG002|Double-blind Period|Other, not specified|0|||
127588450|NCT05248867|459122985|FG003|Double-blind Period|Other, not specified|0|||
127588451|NCT05248867|459122986|FG004|Double-blind Period|Other, not specified|0|||
127588452|NCT05248867|459122987|FG005|Double-blind Period|Other, not specified|0|||
127588453|NCT05248867|459122982|FG000|Open-label Period|Withdrawal by Subject|0|||
127588454|NCT05248867|459122983|FG001|Open-label Period|Withdrawal by Subject|0|||
127588455|NCT05248867|459122984|FG002|Open-label Period|Withdrawal by Subject|3|||
127588456|NCT05248867|459122985|FG003|Open-label Period|Withdrawal by Subject|1|||
127588457|NCT05248867|459122986|FG004|Open-label Period|Withdrawal by Subject|7|||
127588458|NCT05248867|459122987|FG005|Open-label Period|Withdrawal by Subject|9|||
127588459|NCT05248867|459122982|FG000|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
127588460|NCT05248867|459122983|FG001|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
127588461|NCT05248867|459122984|FG002|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
127588462|NCT05248867|459122985|FG003|Open-label Period|Withdrawal by Subject due to Adverse Event|1|||
127588463|NCT05248867|459122986|FG004|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
127588464|NCT05248867|459122987|FG005|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
127588465|NCT05248867|459122982|FG000|Open-label Period|Lost to Follow-up|0|||
127588466|NCT05248867|459122983|FG001|Open-label Period|Lost to Follow-up|0|||
127588467|NCT05248867|459122984|FG002|Open-label Period|Lost to Follow-up|0|||
127588468|NCT05248867|459122985|FG003|Open-label Period|Lost to Follow-up|0|||
127588469|NCT05248867|459122986|FG004|Open-label Period|Lost to Follow-up|5|||
127588470|NCT05248867|459122987|FG005|Open-label Period|Lost to Follow-up|2|||
127588471|NCT05248867|459122982|FG000|Open-label Period|COVID-19 Infection|0|||
127588472|NCT05248867|459122983|FG001|Open-label Period|COVID-19 Infection|0|||
127588473|NCT05248867|459122984|FG002|Open-label Period|COVID-19 Infection|0|||
127588474|NCT05248867|459122985|FG003|Open-label Period|COVID-19 Infection|0|||
127588475|NCT05248867|459122986|FG004|Open-label Period|COVID-19 Infection|1|||
127588476|NCT05248867|459122987|FG005|Open-label Period|COVID-19 Infection|0|||
127588477|NCT05248867|459122982|FG000|Open-label Period|Other, not specified|0|||
127588478|NCT05248867|459122983|FG001|Open-label Period|Other, not specified|0|||
127588479|NCT05248867|459122984|FG002|Open-label Period|Other, not specified|0|||
127588480|NCT05248867|459122985|FG003|Open-label Period|Other, not specified|0|||
127588481|NCT05248867|459122986|FG004|Open-label Period|Other, not specified|4|||
127588482|NCT05248867|459122987|FG005|Open-label Period|Other, not specified|0|||
127588483|NCT01064310|459122988|FG000|Period 1|Adverse Event|7|||
127588484|NCT01064310|459122989|FG001|Period 1|Adverse Event|10|||
127588485|NCT01064310|459122990|FG002|Period 1|Adverse Event|0|||
127588486|NCT01064310|459122988|FG000|Period 1|Physician Decision|1|||
127588487|NCT01064310|459122989|FG001|Period 1|Physician Decision|0|||
127588488|NCT01064310|459122990|FG002|Period 1|Physician Decision|0|||
127588489|NCT01064310|459122988|FG000|Period 1|Withdrawal by Subject|2|||
127588490|NCT01064310|459122989|FG001|Period 1|Withdrawal by Subject|2|||
127588491|NCT01064310|459122990|FG002|Period 1|Withdrawal by Subject|0|||
127588492|NCT01064310|459122988|FG000|Period 1|Lack of Efficacy|3|||
127588493|NCT01064310|459122989|FG001|Period 1|Lack of Efficacy|5|||
127588494|NCT01064310|459122990|FG002|Period 1|Lack of Efficacy|0|||
127588495|NCT01064310|459122988|FG000|Period 1|Entered Open-label Period|1|||
127588496|NCT01064310|459122989|FG001|Period 1|Entered Open-label Period|1|||
127588497|NCT01064310|459122990|FG002|Period 1|Entered Open-label Period|0|||
127588498|NCT01064310|459122988|FG000|Period 2|Adverse Event|2|||
127588499|NCT01064310|459122989|FG001|Period 2|Adverse Event|1|||
127588500|NCT01064310|459122990|FG002|Period 2|Adverse Event|0|||
127588501|NCT01064310|459122988|FG000|Period 2|Physician Decision|0|||
127588502|NCT01064310|459122989|FG001|Period 2|Physician Decision|1|||
127588503|NCT01064310|459122990|FG002|Period 2|Physician Decision|0|||
127588504|NCT01064310|459122988|FG000|Period 2|Entered Open-label Period|1|||
127588505|NCT01064310|459122989|FG001|Period 2|Entered Open-label Period|0|||
127588506|NCT01064310|459122990|FG002|Period 2|Entered Open-label Period|0|||
127588507|NCT01064310|459122988|FG000|Period 2|Lack of Efficacy|1|||
127588508|NCT01064310|459122989|FG001|Period 2|Lack of Efficacy|4|||
127588509|NCT01064310|459122990|FG002|Period 2|Lack of Efficacy|0|||
127588510|NCT01064310|459122988|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
127588511|NCT01064310|459122989|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
127588512|NCT01064310|459122990|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
127588513|NCT01064310|459122988|FG000|Open Label Pazopinib|Adverse Event|0|||
127588514|NCT01064310|459122989|FG001|Open Label Pazopinib|Adverse Event|0|||
127588515|NCT01064310|459122990|FG002|Open Label Pazopinib|Adverse Event|12|||
127588516|NCT01064310|459122988|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
127588517|NCT01064310|459122989|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
127588518|NCT01064310|459122990|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
127588519|NCT01064310|459122988|FG000|Open Label Pazopinib|Physician Decision|0|||
127588520|NCT01064310|459122989|FG001|Open Label Pazopinib|Physician Decision|0|||
127588521|NCT01064310|459122990|FG002|Open Label Pazopinib|Physician Decision|20|||
127588522|NCT01980940|459122991|FG000|Overall Study|Protocol Violation|0|||
127588523|NCT01980940|459122992|FG001|Overall Study|Protocol Violation|0|||
127588524|NCT01980940|459122993|FG002|Overall Study|Protocol Violation|0|||
127588525|NCT01980940|459122994|FG003|Overall Study|Protocol Violation|0|||
127588526|NCT01980940|459122995|FG004|Overall Study|Protocol Violation|0|||
127588527|NCT01980940|459122996|FG005|Overall Study|Protocol Violation|2|||
127588528|NCT01980940|459122997|FG006|Overall Study|Protocol Violation|0|||
127588529|NCT01980940|459122998|FG007|Overall Study|Protocol Violation|0|||
127588530|NCT00688753|459124598|FG000|Overall Study|Disease progression|55|||
127588531|NCT00688753|459124598|FG000|Overall Study|Missing|1|||
127588532|NCT00688753|459124598|FG000|Overall Study|Death|9|||
127588533|NCT00688753|459124598|FG000|Overall Study|Withdrawal by Subject|3|||
127588534|NCT00688753|459124598|FG000|Overall Study|Adverse Event|20|||
127588535|NCT00688753|459124598|FG000|Overall Study|Protocol Violation|1|||
127588536|NCT00688753|459124598|FG000|Overall Study|Lost to Follow-up|3|||
127588537|NCT03187197|459124599|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
127588538|NCT03187197|459124600|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
127588539|NCT03187197|459124601|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
127588540|NCT03187197|459124599|FG000|Overall Study|Withdrawal by Subject|8|||
127588541|NCT03187197|459124600|FG001|Overall Study|Withdrawal by Subject|63|||
127588542|NCT03187197|459124601|FG002|Overall Study|Withdrawal by Subject|4|||
127588543|NCT03187197|459124599|FG000|Overall Study|Lost to Follow-up|1|||
127588544|NCT03187197|459124600|FG001|Overall Study|Lost to Follow-up|60|||
127588545|NCT03187197|459124601|FG002|Overall Study|Lost to Follow-up|7|||
127588546|NCT03187197|459124599|FG000|Overall Study|Adverse Event|6|||
127588547|NCT03187197|459124600|FG001|Overall Study|Adverse Event|29|||
127588548|NCT03187197|459124601|FG002|Overall Study|Adverse Event|0|||
127588549|NCT03187197|459124599|FG000|Overall Study|Death|0|||
127588550|NCT03187197|459124600|FG001|Overall Study|Death|11|||
127588551|NCT03187197|459124601|FG002|Overall Study|Death|0|||
127588552|NCT03187197|459124599|FG000|Overall Study|Administrative problem|1|||
127588553|NCT03187197|459124600|FG001|Overall Study|Administrative problem|1|||
127588554|NCT03187197|459124601|FG002|Overall Study|Administrative problem|0|||
127588555|NCT03187197|459124599|FG000|Overall Study|Reason not listed|2|||
127588556|NCT03187197|459124600|FG001|Overall Study|Reason not listed|54|||
127588557|NCT03187197|459124601|FG002|Overall Study|Reason not listed|1|||
127588558|NCT03187197|459124599|FG000|Overall Study|Missing|1|||
127588559|NCT03187197|459124600|FG001|Overall Study|Missing|32|||
127588560|NCT03187197|459124601|FG002|Overall Study|Missing|3|||
127588561|NCT03187197|459124599|FG000|Overall Study|Status missing|2|||
127588562|NCT03187197|459124600|FG001|Overall Study|Status missing|33|||
127588563|NCT03187197|459124601|FG002|Overall Study|Status missing|3|||
127588564|NCT03187197|459124599|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
127588565|NCT03187197|459124600|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
127588566|NCT03187197|459124601|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
127588567|NCT00259649|459124602|FG000|Overall Study|Lost to Follow-up|7|||
127588568|NCT00259649|459124602|FG000|Overall Study|irregular menses|3|||
127588569|NCT02200211|459124605|FG000|Overall Study|Lost to Follow-up|7|||
127588570|NCT02200211|459124606|FG001|Overall Study|Lost to Follow-up|7|||
127588571|NCT02200211|459124607|FG002|Overall Study|Lost to Follow-up|1|||
127588572|NCT02200211|459124608|FG003|Overall Study|Lost to Follow-up|2|||
127588573|NCT02200211|459124605|FG000|Overall Study|Withdrawal by Subject|1|||
127588574|NCT02200211|459124606|FG001|Overall Study|Withdrawal by Subject|0|||
127588575|NCT02200211|459124607|FG002|Overall Study|Withdrawal by Subject|0|||
127588576|NCT02200211|459124608|FG003|Overall Study|Withdrawal by Subject|0|||
127588577|NCT01918774|459124609|FG000|Overall Study|Lost prior to first CBTw session|4|||
127588578|NCT01918774|459124609|FG000|Overall Study|Lost to Follow-up|1|||
127588579|NCT00717197|459124616|FG000|Overall Study|Unable to purchase study drug|5|||
127588580|NCT00717197|459124616|FG000|Overall Study|Tumor Progression|1|||
127588581|NCT00717197|459124616|FG000|Overall Study|Physician Decision|1|||
127694359|NCT04402489|459510699|FG000|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
127694360|NCT04402489|459510700|FG001|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
127694361|NCT04402489|459510701|FG002|26 Weeks Double-Blind Extension (DBE)|Adverse Event|1|||
127694362|NCT04402489|459510702|FG003|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
127694363|NCT04402489|459510703|FG004|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
127588582|NCT00982137|459124617|FG000|Overall Study|Lost to Follow-up|0|||
127588583|NCT00982137|459124618|FG001|Overall Study|Lost to Follow-up|0|||
127588584|NCT00982137|459124619|FG002|Overall Study|Lost to Follow-up|0|||
127588585|NCT00982137|459124620|FG003|Overall Study|Lost to Follow-up|1|||
127588586|NCT00982137|459124617|FG000|Overall Study|Withdrawal by Subject|0|||
127588587|NCT00982137|459124618|FG001|Overall Study|Withdrawal by Subject|1|||
127588588|NCT00982137|459124619|FG002|Overall Study|Withdrawal by Subject|0|||
127588589|NCT00982137|459124620|FG003|Overall Study|Withdrawal by Subject|0|||
127588590|NCT00787891|459124624|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
127588591|NCT00787891|459124625|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
127588592|NCT00787891|459124624|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
127588593|NCT00787891|459124625|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
128033818|NCT00725985|460751630|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
128033819|NCT00725985|460751631|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
127588594|NCT00787891|459124624|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
127588595|NCT00787891|459124625|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
127588596|NCT00787891|459124624|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
127588597|NCT00787891|459124625|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
127588598|NCT00787891|459124624|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
127588599|NCT00787891|459124625|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
127588600|NCT00787891|459124624|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
127588601|NCT00787891|459124625|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
127882026|NCT01289990|460190795|FG002|Overall Study|Death|0|||
127882027|NCT01289990|460190796|FG003|Overall Study|Death|1|||
128033820|NCT00725985|460751632|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
128033821|NCT00725985|460751633|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
127588602|NCT00787891|459124624|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
127588603|NCT00787891|459124625|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
127588604|NCT00787891|459124624|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
127588605|NCT00787891|459124625|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
127588606|NCT00787891|459124624|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
127588607|NCT00787891|459124625|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
127588608|NCT00787891|459124624|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
127588609|NCT00787891|459124625|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
127588610|NCT02980601|459124628|FG000|Overall Study|Lost to Follow-up|2|||
127588611|NCT02980601|459124629|FG001|Overall Study|Lost to Follow-up|2|||
127588612|NCT02980601|459124628|FG000|Overall Study|Death|0|||
127588613|NCT02980601|459124629|FG001|Overall Study|Death|1|||
127588614|NCT02980601|459124628|FG000|Overall Study|Graft loss|1|||
127588615|NCT02980601|459124629|FG001|Overall Study|Graft loss|0|||
127588616|NCT02980601|459124628|FG000|Overall Study|Failed to sign consent|2|||
127588617|NCT02980601|459124629|FG001|Overall Study|Failed to sign consent|0|||
127588618|NCT01575769|459124630|FG000|Overall Study|Adverse Event|1|||
127588619|NCT01575769|459124630|FG000|Overall Study|Study terminated by sponsor|40|||
127588620|NCT00674700|459124633|FG000|Year 1|Adverse Event|17|||
127588621|NCT00674700|459124634|FG001|Year 1|Adverse Event|20|||
127588622|NCT00674700|459124635|FG002|Year 1|Adverse Event|5|||
127588623|NCT00674700|459124633|FG000|Year 1|Withdrawal by Subject|7|||
127588624|NCT00674700|459124634|FG001|Year 1|Withdrawal by Subject|7|||
127588625|NCT00674700|459124635|FG002|Year 1|Withdrawal by Subject|6|||
127588626|NCT00674700|459124633|FG000|Year 1|Any other reason not above-mentioned|7|||
127588627|NCT00674700|459124634|FG001|Year 1|Any other reason not above-mentioned|7|||
127588628|NCT00674700|459124635|FG002|Year 1|Any other reason not above-mentioned|6|||
128033822|NCT00725985|460751634|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
128033823|NCT00725985|460751635|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
128033824|NCT00725985|460751636|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
127588629|NCT00674700|459124633|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
127588630|NCT00674700|459124634|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
127588631|NCT00674700|459124635|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
127588632|NCT00674700|459124633|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
127588633|NCT00674700|459124634|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
127588634|NCT00674700|459124635|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
127588635|NCT00674700|459124633|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
128033825|NCT00725985|460751637|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
128033826|NCT00725985|460751638|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
128033827|NCT00725985|460751639|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
128033828|NCT00725985|460751640|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
128033829|NCT00725985|460751629|FG000|OLMP (Up to 96 Weeks)|Death|0|||
128033830|NCT00725985|460751630|FG001|OLMP (Up to 96 Weeks)|Death|0|||
128033831|NCT00725985|460751631|FG002|OLMP (Up to 96 Weeks)|Death|0|||
127588636|NCT00674700|459124634|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
127588637|NCT00674700|459124635|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
127588638|NCT00395304|459124636|FG000|Treatment Period 1|Withdrawal by Subject|0|||
127588639|NCT00395304|459124637|FG001|Treatment Period 1|Withdrawal by Subject|3|||
127588640|NCT00395304|459124638|FG002|Treatment Period 1|Withdrawal by Subject|0|||
128033832|NCT00725985|460751632|FG003|OLMP (Up to 96 Weeks)|Death|0|||
128033833|NCT00725985|460751633|FG004|OLMP (Up to 96 Weeks)|Death|1|||
127588641|NCT00395304|459124639|FG003|Treatment Period 1|Withdrawal by Subject|2|||
127588642|NCT00395304|459124640|FG004|Treatment Period 1|Withdrawal by Subject|1|||
127588643|NCT00395304|459124641|FG005|Treatment Period 1|Withdrawal by Subject|1|||
127588644|NCT00395304|459124636|FG000|Treatment Period 1|Lost to Follow-up|1|||
127588645|NCT00395304|459124637|FG001|Treatment Period 1|Lost to Follow-up|0|||
127588646|NCT00395304|459124638|FG002|Treatment Period 1|Lost to Follow-up|0|||
127588647|NCT00395304|459124639|FG003|Treatment Period 1|Lost to Follow-up|1|||
127588648|NCT00395304|459124640|FG004|Treatment Period 1|Lost to Follow-up|0|||
127588649|NCT00395304|459124641|FG005|Treatment Period 1|Lost to Follow-up|1|||
127588650|NCT00395304|459124636|FG000|Treatment Period 1|Physician Decision|0|||
127588651|NCT00395304|459124637|FG001|Treatment Period 1|Physician Decision|1|||
127588652|NCT00395304|459124638|FG002|Treatment Period 1|Physician Decision|0|||
127588653|NCT00395304|459124639|FG003|Treatment Period 1|Physician Decision|0|||
127588654|NCT00395304|459124640|FG004|Treatment Period 1|Physician Decision|0|||
127588655|NCT00395304|459124641|FG005|Treatment Period 1|Physician Decision|0|||
127588656|NCT00395304|459124636|FG000|Treatment Period 2|Withdrawal by Subject|0|||
127588657|NCT00395304|459124637|FG001|Treatment Period 2|Withdrawal by Subject|0|||
127588658|NCT00395304|459124638|FG002|Treatment Period 2|Withdrawal by Subject|0|||
127588659|NCT00395304|459124639|FG003|Treatment Period 2|Withdrawal by Subject|1|||
127588660|NCT00395304|459124640|FG004|Treatment Period 2|Withdrawal by Subject|0|||
127588661|NCT00395304|459124641|FG005|Treatment Period 2|Withdrawal by Subject|2|||
127588662|NCT00395304|459124636|FG000|Treatment Period 2|Lost to Follow-up|0|||
127588663|NCT00395304|459124637|FG001|Treatment Period 2|Lost to Follow-up|3|||
127588664|NCT00395304|459124638|FG002|Treatment Period 2|Lost to Follow-up|0|||
127588665|NCT00395304|459124639|FG003|Treatment Period 2|Lost to Follow-up|0|||
127588666|NCT00395304|459124640|FG004|Treatment Period 2|Lost to Follow-up|0|||
127588667|NCT00395304|459124641|FG005|Treatment Period 2|Lost to Follow-up|0|||
127588668|NCT00395304|459124636|FG000|Treatment Period 2|Physician Decision|0|||
127588669|NCT00395304|459124637|FG001|Treatment Period 2|Physician Decision|0|||
127588670|NCT00395304|459124638|FG002|Treatment Period 2|Physician Decision|1|||
127588671|NCT00395304|459124639|FG003|Treatment Period 2|Physician Decision|0|||
127588672|NCT00395304|459124640|FG004|Treatment Period 2|Physician Decision|0|||
127588673|NCT00395304|459124641|FG005|Treatment Period 2|Physician Decision|0|||
127588674|NCT00395304|459124636|FG000|Treatment Period 2|Other|0|||
127588675|NCT00395304|459124637|FG001|Treatment Period 2|Other|1|||
127588676|NCT00395304|459124638|FG002|Treatment Period 2|Other|0|||
127588677|NCT00395304|459124639|FG003|Treatment Period 2|Other|0|||
127588678|NCT00395304|459124640|FG004|Treatment Period 2|Other|0|||
127588679|NCT00395304|459124641|FG005|Treatment Period 2|Other|0|||
127588680|NCT00395304|459124636|FG000|Treatment Period 3|Withdrawal by Subject|0|||
127588681|NCT00395304|459124637|FG001|Treatment Period 3|Withdrawal by Subject|0|||
127588682|NCT00395304|459124638|FG002|Treatment Period 3|Withdrawal by Subject|0|||
127588683|NCT00395304|459124639|FG003|Treatment Period 3|Withdrawal by Subject|1|||
127588684|NCT00395304|459124640|FG004|Treatment Period 3|Withdrawal by Subject|0|||
127588685|NCT00395304|459124641|FG005|Treatment Period 3|Withdrawal by Subject|1|||
127588686|NCT00395304|459124636|FG000|Treatment Period 3|Lost to Follow-up|1|||
127588687|NCT00395304|459124637|FG001|Treatment Period 3|Lost to Follow-up|1|||
127588688|NCT00395304|459124638|FG002|Treatment Period 3|Lost to Follow-up|0|||
127588689|NCT00395304|459124639|FG003|Treatment Period 3|Lost to Follow-up|0|||
127588690|NCT00395304|459124640|FG004|Treatment Period 3|Lost to Follow-up|0|||
127588691|NCT00395304|459124641|FG005|Treatment Period 3|Lost to Follow-up|0|||
127588692|NCT00395304|459124636|FG000|Treatment Period 3|Physician Decision|0|||
127588693|NCT00395304|459124637|FG001|Treatment Period 3|Physician Decision|1|||
127588694|NCT00395304|459124638|FG002|Treatment Period 3|Physician Decision|0|||
127588695|NCT00395304|459124639|FG003|Treatment Period 3|Physician Decision|0|||
127588696|NCT00395304|459124640|FG004|Treatment Period 3|Physician Decision|0|||
127588697|NCT00395304|459124641|FG005|Treatment Period 3|Physician Decision|0|||
128033834|NCT00725985|460751634|FG005|OLMP (Up to 96 Weeks)|Death|0|||
127588698|NCT00395304|459124636|FG000|Treatment Period 3|Other|0|||
128033835|NCT00725985|460751635|FG006|OLMP (Up to 96 Weeks)|Death|0|||
128033836|NCT00725985|460751636|FG007|OLMP (Up to 96 Weeks)|Death|0|||
128033837|NCT00725985|460751637|FG008|OLMP (Up to 96 Weeks)|Death|0|||
128033838|NCT00725985|460751638|FG009|OLMP (Up to 96 Weeks)|Death|0|||
127588699|NCT00395304|459124637|FG001|Treatment Period 3|Other|0|||
127588700|NCT00395304|459124638|FG002|Treatment Period 3|Other|0|||
127588701|NCT00395304|459124639|FG003|Treatment Period 3|Other|1|||
127588702|NCT00395304|459124640|FG004|Treatment Period 3|Other|0|||
127588703|NCT00395304|459124641|FG005|Treatment Period 3|Other|0|||
127588704|NCT03797014|459124643|FG000|Overall Study|Withdrawal by Subject|1|||
127588705|NCT03797014|459124643|FG000|Overall Study|Lost to Follow-up|1|||
127588706|NCT03797014|459124643|FG000|Overall Study|Protocol Violation|1|||
127588707|NCT01970397|459124644|FG000|Overall Study|Adverse Event|0|||
127588708|NCT01970397|459124645|FG001|Overall Study|Adverse Event|1|||
127588709|NCT01970397|459124644|FG000|Overall Study|Lost to Follow-up|0|||
128033839|NCT00725985|460751639|FG010|OLMP (Up to 96 Weeks)|Death|0|||
128033840|NCT00725985|460751640|FG011|OLMP (Up to 96 Weeks)|Death|0|||
127588710|NCT01970397|459124645|FG001|Overall Study|Lost to Follow-up|1|||
127588711|NCT01970397|459124644|FG000|Overall Study|Personal Reasons|1|||
127588712|NCT01970397|459124645|FG001|Overall Study|Personal Reasons|2|||
127588713|NCT01970397|459124644|FG000|Overall Study|Protocol Violation|1|||
127588714|NCT01970397|459124645|FG001|Overall Study|Protocol Violation|1|||
127588715|NCT01389817|459124648|FG000|Overall Study|Physician Decision|1|||
127588716|NCT01389817|459124649|FG001|Overall Study|Physician Decision|0|||
127588717|NCT01389817|459124648|FG000|Overall Study|Lost to Follow-up|1|||
127588718|NCT01389817|459124649|FG001|Overall Study|Lost to Follow-up|0|||
127588719|NCT01389817|459124648|FG000|Overall Study|Withdrawal by Subject|2|||
127588720|NCT01389817|459124649|FG001|Overall Study|Withdrawal by Subject|0|||
127588721|NCT02871297|459124652|FG000|Overall Study|Adverse Event|34|||
127588722|NCT02871297|459124652|FG000|Overall Study|Lack of Efficacy|10|||
127588723|NCT02871297|459124652|FG000|Overall Study|Non-compliance with study drug|15|||
127588724|NCT02871297|459124652|FG000|Overall Study|Protocol Violation|3|||
127588725|NCT02871297|459124652|FG000|Overall Study|Withdrawal by Subject|20|||
127588726|NCT02871297|459124652|FG000|Overall Study|Lost to Follow-up|13|||
127588727|NCT02871297|459124652|FG000|Overall Study|Rolled over to 13546A|2|||
127588728|NCT02871297|459124652|FG000|Overall Study|Other than specified|39|||
127588729|NCT02587234|459124655|FG000|Overall Study|Withdrawal by Subject|1|||
127588730|NCT02587234|459124656|FG001|Overall Study|Withdrawal by Subject|1|||
127588731|NCT02587234|459124655|FG000|Overall Study|Lost to Follow-up|0|||
127588732|NCT02587234|459124656|FG001|Overall Study|Lost to Follow-up|2|||
127588733|NCT03068130|459124657|FG000|Overall Study|Adverse Event|19|||
127588734|NCT03068130|459124657|FG000|Overall Study|Death|14|||
127588735|NCT03068130|459124657|FG000|Overall Study|Lost to Follow-up|4|||
127588736|NCT03068130|459124657|FG000|Overall Study|Withdrawal by Subject|26|||
127588737|NCT03068130|459124657|FG000|Overall Study|Administrative Reasons|3|||
127588738|NCT03068130|459124657|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
127588739|NCT03068130|459124657|FG000|Overall Study|Study terminated by sponsor|194|||
127588740|NCT02835820|459124662|FG000|Overall Study|Baseline Screen Failure|0|||
127588741|NCT02835820|459124663|FG001|Overall Study|Baseline Screen Failure|3|||
127588742|NCT03039283|459124666|FG000|Overall Study|Protocol Violation|2|||
127588743|NCT01867424|459124667|FG000|Overall Study|Patient noncompliance|2|||
127588744|NCT01867424|459124668|FG001|Overall Study|Patient noncompliance|1|||
127588745|NCT01056653|459124669|FG000|Overall Study|Lost to Follow-up|0|||
127588746|NCT01056653|459124670|FG001|Overall Study|Lost to Follow-up|0|||
127588747|NCT01056653|459124671|FG002|Overall Study|Lost to Follow-up|2|||
127588748|NCT05386680|459124672|FG000|Overall Study|Guardian decision|2|||
127588749|NCT03727230|459124673|FG000|Overall Study|Lost to Follow-up|12|||
127588750|NCT04377620|459124675|FG000|Overall Study|Death|42|||
127588751|NCT04377620|459124676|FG001|Overall Study|Death|48|||
127588752|NCT04377620|459124677|FG002|Overall Study|Death|36|||
127588753|NCT04377620|459124675|FG000|Overall Study|Withdrawal by Subject|0|||
127588754|NCT04377620|459124676|FG001|Overall Study|Withdrawal by Subject|2|||
127588755|NCT04377620|459124677|FG002|Overall Study|Withdrawal by Subject|0|||
127588756|NCT03768414|459124678|FG000|Overall Study|Adverse Event or side effects|72|||
127588757|NCT03768414|459124679|FG001|Overall Study|Adverse Event or side effects|28|||
127588758|NCT03768414|459124678|FG000|Overall Study|Refusal unrelated to adverse event|33|||
127588759|NCT03768414|459124679|FG001|Overall Study|Refusal unrelated to adverse event|33|||
127588760|NCT03768414|459124678|FG000|Overall Study|Progression/relapse|132|||
127588761|NCT03768414|459124679|FG001|Overall Study|Progression/relapse|60|||
127588762|NCT03768414|459124678|FG000|Overall Study|Death|9|||
127588763|NCT03768414|459124679|FG001|Overall Study|Death|6|||
127588764|NCT03768414|459124678|FG000|Overall Study|Other - not protocol specified|45|||
127588765|NCT03768414|459124679|FG001|Overall Study|Other - not protocol specified|18|||
127588766|NCT03768414|459124678|FG000|Overall Study|Reason under review|3|||
127588767|NCT03768414|459124679|FG001|Overall Study|Reason under review|2|||
127588768|NCT03851705|459124680|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
127588769|NCT03851705|459124681|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
127588770|NCT03851705|459124682|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
127588771|NCT03851705|459124683|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
127588772|NCT03851705|459124680|FG000|Part 1: Double-Blind Period|Other reason|1|||
127588773|NCT03851705|459124681|FG001|Part 1: Double-Blind Period|Other reason|0|||
127588774|NCT03851705|459124682|FG002|Part 1: Double-Blind Period|Other reason|0|||
127588775|NCT03851705|459124683|FG003|Part 1: Double-Blind Period|Other reason|0|||
127588776|NCT03851705|459124680|FG000|Part 2: Open-Label Period|Other reason|0|||
127588777|NCT03851705|459124681|FG001|Part 2: Open-Label Period|Other reason|0|||
127588778|NCT03851705|459124682|FG002|Part 2: Open-Label Period|Other reason|0|||
127588779|NCT03851705|459124683|FG003|Part 2: Open-Label Period|Other reason|1|||
127588780|NCT03851705|459124680|FG000|Part 2: Open-Label Period|Death|0|||
127588781|NCT03851705|459124681|FG001|Part 2: Open-Label Period|Death|0|||
127588782|NCT03851705|459124682|FG002|Part 2: Open-Label Period|Death|3|||
127588783|NCT03851705|459124683|FG003|Part 2: Open-Label Period|Death|0|||
127588784|NCT03851705|459124680|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
127588785|NCT03851705|459124681|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
127588786|NCT03851705|459124682|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
127588787|NCT03851705|459124683|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
127588788|NCT02197520|459124690|FG000|Period 1|Withdrawal by Subject|1|||
127588789|NCT02197520|459124691|FG001|Period 1|Withdrawal by Subject|0|||
127588790|NCT02197520|459124690|FG000|Period 2|Adverse Event|0|||
127588791|NCT02197520|459124691|FG001|Period 2|Adverse Event|2|||
127588792|NCT02197520|459124690|FG000|Period 2|Withdrawal by Subject|1|||
127588793|NCT02197520|459124691|FG001|Period 2|Withdrawal by Subject|0|||
127588794|NCT01306942|459124692|FG000|Phase I|Adverse Event|2|||
127588795|NCT01306942|459124693|FG001|Phase I|Adverse Event|2|||
127588796|NCT01306942|459124694|FG002|Phase I|Adverse Event|0|||
127588797|NCT01306942|459124695|FG003|Phase I|Adverse Event|0|||
127588798|NCT01306942|459124692|FG000|Phase I|Physician Decision|3|||
127588799|NCT01306942|459124693|FG001|Phase I|Physician Decision|1|||
127588800|NCT01306942|459124694|FG002|Phase I|Physician Decision|0|||
127588801|NCT01306942|459124695|FG003|Phase I|Physician Decision|0|||
127588802|NCT01306942|459124692|FG000|Phase II|Adverse Event|0|||
127588803|NCT01306942|459124693|FG001|Phase II|Adverse Event|0|||
127588804|NCT01306942|459124694|FG002|Phase II|Adverse Event|0|||
127588805|NCT01306942|459124695|FG003|Phase II|Adverse Event|6|||
127588806|NCT01306942|459124692|FG000|Phase II|Physician Decision|2|||
127588807|NCT01306942|459124693|FG001|Phase II|Physician Decision|0|||
127588808|NCT01306942|459124694|FG002|Phase II|Physician Decision|0|||
127588809|NCT01306942|459124695|FG003|Phase II|Physician Decision|5|||
127588810|NCT01306942|459124692|FG000|Phase II|Withdrawal by Subject|0|||
127588811|NCT01306942|459124693|FG001|Phase II|Withdrawal by Subject|0|||
127588812|NCT01306942|459124694|FG002|Phase II|Withdrawal by Subject|0|||
127588813|NCT01306942|459124695|FG003|Phase II|Withdrawal by Subject|2|||
127588814|NCT01306942|459124692|FG000|Phase II|Death|0|||
127588815|NCT01306942|459124693|FG001|Phase II|Death|0|||
127588816|NCT01306942|459124694|FG002|Phase II|Death|0|||
127588817|NCT01306942|459124695|FG003|Phase II|Death|1|||
127588818|NCT01306942|459124692|FG000|Phase II|Not finished treatment|0|||
127588819|NCT01306942|459124693|FG001|Phase II|Not finished treatment|0|||
127588820|NCT01306942|459124694|FG002|Phase II|Not finished treatment|0|||
127588821|NCT01306942|459124695|FG003|Phase II|Not finished treatment|1|||
127588822|NCT01306942|459124692|FG000|Phase II|Protocol Violation|0|||
127588823|NCT01306942|459124693|FG001|Phase II|Protocol Violation|0|||
127588824|NCT01306942|459124694|FG002|Phase II|Protocol Violation|0|||
127588825|NCT01306942|459124695|FG003|Phase II|Protocol Violation|1|||
127588826|NCT00369824|459124702|FG000|Overall Study|Adverse Event|0|||
127588827|NCT00369824|459124703|FG001|Overall Study|Adverse Event|2|||
127588828|NCT00369824|459124704|FG002|Overall Study|Adverse Event|0|||
127588829|NCT00369824|459124705|FG003|Overall Study|Adverse Event|0|||
127588830|NCT00369824|459124706|FG004|Overall Study|Adverse Event|1|||
127588831|NCT00369824|459124707|FG005|Overall Study|Adverse Event|0|||
127588832|NCT00369824|459124702|FG000|Overall Study|Protocol Violation|0|||
127588833|NCT00369824|459124703|FG001|Overall Study|Protocol Violation|1|||
127588834|NCT00369824|459124704|FG002|Overall Study|Protocol Violation|0|||
127588835|NCT00369824|459124705|FG003|Overall Study|Protocol Violation|1|||
127588836|NCT00369824|459124706|FG004|Overall Study|Protocol Violation|1|||
127588837|NCT00369824|459124707|FG005|Overall Study|Protocol Violation|0|||
127588838|NCT00369824|459124702|FG000|Overall Study|Withdrawal by Subject|9|||
127588839|NCT00369824|459124703|FG001|Overall Study|Withdrawal by Subject|5|||
127588840|NCT00369824|459124704|FG002|Overall Study|Withdrawal by Subject|5|||
127588841|NCT00369824|459124705|FG003|Overall Study|Withdrawal by Subject|4|||
127588842|NCT00369824|459124706|FG004|Overall Study|Withdrawal by Subject|6|||
127588843|NCT00369824|459124707|FG005|Overall Study|Withdrawal by Subject|2|||
127588844|NCT00369824|459124702|FG000|Overall Study|Lost to Follow-up|6|||
127588845|NCT00369824|459124703|FG001|Overall Study|Lost to Follow-up|11|||
127588846|NCT00369824|459124704|FG002|Overall Study|Lost to Follow-up|7|||
127588847|NCT00369824|459124705|FG003|Overall Study|Lost to Follow-up|8|||
127588848|NCT00369824|459124706|FG004|Overall Study|Lost to Follow-up|9|||
127588849|NCT00369824|459124707|FG005|Overall Study|Lost to Follow-up|6|||
127588850|NCT00369824|459124702|FG000|Overall Study|Other|0|||
127588851|NCT00369824|459124703|FG001|Overall Study|Other|0|||
127588852|NCT00369824|459124704|FG002|Overall Study|Other|0|||
127588853|NCT00369824|459124705|FG003|Overall Study|Other|2|||
127588854|NCT00369824|459124706|FG004|Overall Study|Other|1|||
127588855|NCT00369824|459124707|FG005|Overall Study|Other|3|||
127588856|NCT00334958|459124708|FG000|Overall Study|Medication Noncompliance|0|||
127588857|NCT00334958|459124709|FG001|Overall Study|Medication Noncompliance|3|||
127588858|NCT00334958|459124708|FG000|Overall Study|Protocol Violation|2|||
127588859|NCT00334958|459124709|FG001|Overall Study|Protocol Violation|2|||
127588860|NCT00334958|459124708|FG000|Overall Study|Request of the investigator or sponsor|0|||
127588861|NCT00334958|459124709|FG001|Overall Study|Request of the investigator or sponsor|1|||
127588862|NCT00334958|459124708|FG000|Overall Study|Withdrawal by Subject|7|||
127588863|NCT00334958|459124709|FG001|Overall Study|Withdrawal by Subject|4|||
127588864|NCT00334958|459124708|FG000|Overall Study|Adverse Event|27|||
127588865|NCT00334958|459124709|FG001|Overall Study|Adverse Event|12|||
127588866|NCT00334958|459124708|FG000|Overall Study|Other|1|||
127588867|NCT00334958|459124709|FG001|Overall Study|Other|2|||
127588868|NCT03385564|459124710|FG000|Overall Study|Adverse Event|0|||
127588869|NCT03385564|459124711|FG001|Overall Study|Adverse Event|0|||
127588870|NCT03385564|459124712|FG002|Overall Study|Adverse Event|3|||
127588871|NCT03385564|459124713|FG003|Overall Study|Adverse Event|3|||
127588872|NCT03385564|459124710|FG000|Overall Study|Other than listed|0|||
127588873|NCT03385564|459124711|FG001|Overall Study|Other than listed|0|||
127588874|NCT03385564|459124712|FG002|Overall Study|Other than listed|0|||
127588875|NCT03385564|459124713|FG003|Overall Study|Other than listed|5|||
127588876|NCT03385564|459124710|FG000|Overall Study|Withdrawal by Subject|0|||
127588877|NCT03385564|459124711|FG001|Overall Study|Withdrawal by Subject|1|||
127588878|NCT03385564|459124712|FG002|Overall Study|Withdrawal by Subject|1|||
128033841|NCT00725985|460751629|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
127588879|NCT03385564|459124713|FG003|Overall Study|Withdrawal by Subject|0|||
127588880|NCT03385564|459124710|FG000|Overall Study|Lack of Efficacy|0|||
127588881|NCT03385564|459124711|FG001|Overall Study|Lack of Efficacy|0|||
127588882|NCT03385564|459124712|FG002|Overall Study|Lack of Efficacy|0|||
127588883|NCT03385564|459124713|FG003|Overall Study|Lack of Efficacy|1|||
128033842|NCT00725985|460751630|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
128033843|NCT00725985|460751631|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
128033844|NCT00725985|460751632|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
128033845|NCT00725985|460751633|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
128033846|NCT00725985|460751634|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
128033847|NCT00725985|460751635|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
128033848|NCT00725985|460751636|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
128033849|NCT00725985|460751637|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
128033850|NCT00725985|460751638|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
128033851|NCT00725985|460751639|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
128033852|NCT00725985|460751640|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
128033853|NCT00725985|460751629|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
128033854|NCT00725985|460751630|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
128033855|NCT00725985|460751631|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
128033856|NCT00725985|460751632|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
128033857|NCT00725985|460751633|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
128033858|NCT00725985|460751634|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
128033859|NCT00725985|460751635|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
128033860|NCT00725985|460751636|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
128033861|NCT00725985|460751637|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
128033862|NCT00725985|460751638|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
128033863|NCT00725985|460751639|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
128033864|NCT00725985|460751640|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
128033865|NCT00725985|460751629|FG000|OLMP (Up to 96 Weeks)|Other|0|||
127588884|NCT03385564|459124710|FG000|Overall Study|Death|0|||
127588885|NCT03385564|459124711|FG001|Overall Study|Death|0|||
127588886|NCT03385564|459124712|FG002|Overall Study|Death|1|||
127588887|NCT03385564|459124713|FG003|Overall Study|Death|0|||
127588888|NCT00622401|459124714|FG000|Overall Study|Disease progression prior to treatment|3|||
127588889|NCT00622401|459124715|FG001|Overall Study|Disease progression prior to treatment|2|||
127588890|NCT00622401|459124716|FG002|Overall Study|Disease progression prior to treatment|0|||
127588891|NCT00478231|459124723|FG000|Overall Study|Death|7|||
127588892|NCT00478231|459124723|FG000|Overall Study|Lack of Efficacy|47|||
127588893|NCT00478231|459124723|FG000|Overall Study|Lost to Follow-up|7|||
127588894|NCT00478231|459124723|FG000|Overall Study|Withdrawal by Subject|6|||
127588895|NCT00478231|459124723|FG000|Overall Study|Other|9|||
127588896|NCT00478231|459124723|FG000|Overall Study|Adverse Event|5|||
127588897|NCT00478231|459124723|FG000|Overall Study|Randomized, not treated|3|||
127588898|NCT00824720|459124724|FG000|Overall Study|failed plug insertion|3|||
127588899|NCT00824720|459124725|FG001|Overall Study|failed plug insertion|1|||
127588900|NCT00824720|459124726|FG002|Overall Study|failed plug insertion|0|||
127588901|NCT00824720|459124724|FG000|Overall Study|Protocol Violation|0|||
127588902|NCT00824720|459124725|FG001|Overall Study|Protocol Violation|0|||
127588903|NCT00824720|459124726|FG002|Overall Study|Protocol Violation|1|||
127588904|NCT00873015|459124727|FG000|Overall Study|Withdrawal by Subject|0|||
127588905|NCT00873015|459124728|FG001|Overall Study|Withdrawal by Subject|1|||
127588906|NCT00873015|459124729|FG002|Overall Study|Withdrawal by Subject|0|||
128033866|NCT00725985|460751630|FG001|OLMP (Up to 96 Weeks)|Other|0|||
128033867|NCT00725985|460751631|FG002|OLMP (Up to 96 Weeks)|Other|0|||
128033868|NCT00725985|460751632|FG003|OLMP (Up to 96 Weeks)|Other|15|||
128033869|NCT00725985|460751633|FG004|OLMP (Up to 96 Weeks)|Other|20|||
128033870|NCT00725985|460751634|FG005|OLMP (Up to 96 Weeks)|Other|44|||
128033871|NCT00725985|460751635|FG006|OLMP (Up to 96 Weeks)|Other|0|||
128033872|NCT00725985|460751636|FG007|OLMP (Up to 96 Weeks)|Other|0|||
127588907|NCT00873015|459124730|FG003|Overall Study|Withdrawal by Subject|0|||
127588908|NCT01382212|459124731|FG000|Overall Study|Kidney transplant|1|||
127588909|NCT01382212|459124731|FG000|Overall Study|Withdrew consent|1|||
127588910|NCT01273597|459124732|FG000|Overall Study|Adverse Event|5|||
127588911|NCT01273597|459124732|FG000|Overall Study|Underwent Kidney Transplantation|2|||
127588912|NCT01273597|459124732|FG000|Overall Study|Reason Not Reported|1|||
127588913|NCT03329573|459124733|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
127588914|NCT03329573|459124734|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
127588915|NCT03329573|459124735|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
128033873|NCT00725985|460751637|FG008|OLMP (Up to 96 Weeks)|Other|0|||
128033874|NCT00725985|460751638|FG009|OLMP (Up to 96 Weeks)|Other|0|||
128033875|NCT00725985|460751639|FG010|OLMP (Up to 96 Weeks)|Other|0|||
128033876|NCT00725985|460751640|FG011|OLMP (Up to 96 Weeks)|Other|0|||
128033877|NCT00725985|460751629|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
128033878|NCT00725985|460751630|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
128033879|NCT00725985|460751631|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
128033880|NCT00725985|460751632|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
128033881|NCT00725985|460751633|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
128033882|NCT00725985|460751634|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
128033883|NCT00725985|460751635|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
128033884|NCT00725985|460751636|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
128033885|NCT00725985|460751637|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
128033886|NCT00725985|460751638|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
128033887|NCT00725985|460751639|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
128033888|NCT00725985|460751640|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
128033889|NCT00725985|460751629|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
128033890|NCT00725985|460751630|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
128033891|NCT00725985|460751631|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
128033892|NCT00725985|460751632|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
128033893|NCT00725985|460751633|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
128033894|NCT00725985|460751634|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
128033895|NCT00725985|460751635|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
128033896|NCT00725985|460751636|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
128033897|NCT00725985|460751637|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
128033898|NCT00725985|460751638|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
128033899|NCT00725985|460751639|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
128033900|NCT00725985|460751640|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
128033901|NCT00725985|460751629|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
128033902|NCT00725985|460751630|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
128033903|NCT00725985|460751631|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
128033904|NCT00725985|460751632|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
128033905|NCT00725985|460751633|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
128033906|NCT00725985|460751634|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
128033907|NCT00725985|460751635|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
128033908|NCT00725985|460751636|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
127705231|NCT01928394|459551588|FG021|Treatment Period|Death|0|||
128033909|NCT00725985|460751637|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
128033910|NCT00725985|460751638|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
128033911|NCT00725985|460751639|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
128033912|NCT00725985|460751640|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
128033913|NCT00725985|460751629|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
128033914|NCT00725985|460751630|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
128033915|NCT00725985|460751631|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
127588916|NCT03329573|459124736|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
127588917|NCT03329573|459124733|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
127588918|NCT03329573|459124734|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
127588919|NCT03329573|459124735|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
127588920|NCT03329573|459124736|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
127588921|NCT03329573|459124733|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
127588922|NCT03329573|459124734|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
127588923|NCT03329573|459124735|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
127588924|NCT03329573|459124736|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
127588925|NCT03329573|459124733|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
127588926|NCT03329573|459124734|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
127588927|NCT03329573|459124735|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
127588928|NCT03329573|459124736|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
127588929|NCT02777333|459124739|FG000|Overall Study|Withdrawal by Subject|0|||
127588930|NCT02777333|459124740|FG001|Overall Study|Withdrawal by Subject|1|||
127588931|NCT02777333|459124739|FG000|Overall Study|Lost to Follow-up|0|||
127588932|NCT02777333|459124740|FG001|Overall Study|Lost to Follow-up|1|||
127588933|NCT00837811|459124741|FG000|Overall Study|Adverse Event|4|||
127588934|NCT00837811|459124742|FG001|Overall Study|Adverse Event|6|||
127588935|NCT00837811|459124743|FG002|Overall Study|Adverse Event|0|||
128033916|NCT00725985|460751632|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
128033917|NCT00725985|460751633|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
128033918|NCT00725985|460751634|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
128033919|NCT00725985|460751635|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
128033920|NCT00725985|460751636|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
127588936|NCT00837811|459124741|FG000|Overall Study|Death|1|||
128033921|NCT00725985|460751637|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
128033922|NCT00725985|460751638|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
128033923|NCT00725985|460751639|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
128033924|NCT00725985|460751640|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
128033925|NCT02546323|460751641|FG000|Overall Study|Withdrawal by Subject|36|||
128033926|NCT02546323|460751642|FG001|Overall Study|Withdrawal by Subject|33|||
128033927|NCT02546323|460751641|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
128033928|NCT02546323|460751642|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
128033929|NCT02546323|460751641|FG000|Overall Study|Adverse Event|17|||
128033930|NCT02546323|460751642|FG001|Overall Study|Adverse Event|11|||
128033931|NCT02546323|460751641|FG000|Overall Study|Patient Specific Reasons|1|||
128033932|NCT02546323|460751642|FG001|Overall Study|Patient Specific Reasons|2|||
128033933|NCT02546323|460751641|FG000|Overall Study|Lost to Follow-up|2|||
128033934|NCT02546323|460751642|FG001|Overall Study|Lost to Follow-up|3|||
128033935|NCT02546323|460751641|FG000|Overall Study|Non-compliance with Study Drug|2|||
128033936|NCT02546323|460751642|FG001|Overall Study|Non-compliance with Study Drug|2|||
128033937|NCT02546323|460751641|FG000|Overall Study|Met Withdrawal Criteria|2|||
128033938|NCT02546323|460751642|FG001|Overall Study|Met Withdrawal Criteria|14|||
128033939|NCT04476784|460751643|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
128033940|NCT04476784|460751644|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
128033941|NCT00863304|460751645|FG000|Overall Study|Adverse Event|10|||
128033942|NCT00863304|460751646|FG001|Overall Study|Adverse Event|4|||
128033943|NCT00863304|460751647|FG002|Overall Study|Adverse Event|14|||
128033944|NCT00863304|460751648|FG003|Overall Study|Adverse Event|16|||
128033945|NCT00863304|460751645|FG000|Overall Study|Lost to Follow-up|1|||
128033946|NCT00863304|460751646|FG001|Overall Study|Lost to Follow-up|5|||
128033947|NCT00863304|460751647|FG002|Overall Study|Lost to Follow-up|4|||
128033948|NCT00863304|460751648|FG003|Overall Study|Lost to Follow-up|2|||
128033949|NCT00863304|460751645|FG000|Overall Study|Lack of Efficacy|57|||
128033950|NCT00863304|460751646|FG001|Overall Study|Lack of Efficacy|26|||
127588937|NCT00837811|459124742|FG001|Overall Study|Death|1|||
127588938|NCT00837811|459124743|FG002|Overall Study|Death|0|||
127588939|NCT00837811|459124741|FG000|Overall Study|Lack of Efficacy|0|||
127588940|NCT00837811|459124742|FG001|Overall Study|Lack of Efficacy|11|||
128033951|NCT00863304|460751647|FG002|Overall Study|Lack of Efficacy|30|||
127588941|NCT00837811|459124743|FG002|Overall Study|Lack of Efficacy|0|||
128033952|NCT00863304|460751648|FG003|Overall Study|Lack of Efficacy|28|||
127694364|NCT04402489|459510699|FG000|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
127882028|NCT01289990|460190797|FG004|Overall Study|Death|2|||
128033953|NCT00863304|460751645|FG000|Overall Study|Withdrawal by Subject|19|||
128033954|NCT00863304|460751646|FG001|Overall Study|Withdrawal by Subject|14|||
128033955|NCT00863304|460751647|FG002|Overall Study|Withdrawal by Subject|20|||
128033956|NCT00863304|460751648|FG003|Overall Study|Withdrawal by Subject|18|||
128033957|NCT00863304|460751645|FG000|Overall Study|Other|1|||
128033958|NCT00863304|460751646|FG001|Overall Study|Other|0|||
128033959|NCT00863304|460751647|FG002|Overall Study|Other|0|||
128033960|NCT00863304|460751648|FG003|Overall Study|Other|1|||
128033961|NCT00863304|460751645|FG000|Overall Study|Protocol Violation|2|||
128033962|NCT00863304|460751646|FG001|Overall Study|Protocol Violation|6|||
128033963|NCT00863304|460751647|FG002|Overall Study|Protocol Violation|2|||
128033964|NCT00863304|460751648|FG003|Overall Study|Protocol Violation|0|||
127588942|NCT00837811|459124741|FG000|Overall Study|Lost to Follow-up|1|||
127588943|NCT00837811|459124742|FG001|Overall Study|Lost to Follow-up|3|||
127588944|NCT00837811|459124743|FG002|Overall Study|Lost to Follow-up|0|||
127588945|NCT00837811|459124741|FG000|Overall Study|Physician Decision|0|||
127588946|NCT00837811|459124742|FG001|Overall Study|Physician Decision|2|||
127588947|NCT00837811|459124743|FG002|Overall Study|Physician Decision|1|||
127588948|NCT00837811|459124741|FG000|Overall Study|Withdrawal by Subject|1|||
127588949|NCT00837811|459124742|FG001|Overall Study|Withdrawal by Subject|9|||
127588950|NCT00837811|459124743|FG002|Overall Study|Withdrawal by Subject|0|||
127588951|NCT00837811|459124741|FG000|Overall Study|Sponsor Decision|0|||
127588952|NCT00837811|459124742|FG001|Overall Study|Sponsor Decision|2|||
127588953|NCT00837811|459124743|FG002|Overall Study|Sponsor Decision|0|||
127588954|NCT04731363|459124746|FG000|Overall Study|Could not obtain samples|0|||
127588955|NCT04731363|459124747|FG001|Overall Study|Could not obtain samples|1|||
127588956|NCT04731363|459124748|FG002|Overall Study|Could not obtain samples|0|||
127588957|NCT04731363|459124749|FG003|Overall Study|Could not obtain samples|0|||
127588958|NCT04731363|459124746|FG000|Overall Study|Physician Decision|0|||
127588959|NCT04731363|459124747|FG001|Overall Study|Physician Decision|1|||
127588960|NCT04731363|459124748|FG002|Overall Study|Physician Decision|0|||
127588961|NCT04731363|459124749|FG003|Overall Study|Physician Decision|0|||
127588962|NCT02513394|459124750|FG000|Overall Study|Withdrawal by Subject|11|||
127588963|NCT02513394|459124751|FG001|Overall Study|Withdrawal by Subject|23|||
127588964|NCT02513394|459124750|FG000|Overall Study|Ineligible|1|||
127588965|NCT02513394|459124751|FG001|Overall Study|Ineligible|0|||
127588966|NCT04292743|459124752|FG000|Overall Study|Physician Decision|1|||
127588967|NCT04292743|459124753|FG001|Overall Study|Physician Decision|3|||
127588968|NCT04292743|459124754|FG002|Overall Study|Physician Decision|0|||
127588969|NCT04292743|459124755|FG003|Overall Study|Physician Decision|0|||
127588970|NCT04292743|459124752|FG000|Overall Study|Withdrawal by Subject|0|||
127588971|NCT04292743|459124753|FG001|Overall Study|Withdrawal by Subject|5|||
127588972|NCT04292743|459124754|FG002|Overall Study|Withdrawal by Subject|0|||
127588973|NCT04292743|459124755|FG003|Overall Study|Withdrawal by Subject|0|||
127588974|NCT04292743|459124752|FG000|Overall Study|Death|0|||
127588975|NCT04292743|459124753|FG001|Overall Study|Death|1|||
127588976|NCT04292743|459124754|FG002|Overall Study|Death|0|||
127588977|NCT04292743|459124755|FG003|Overall Study|Death|0|||
127588978|NCT04292743|459124752|FG000|Overall Study|Progression of Disease|2|||
127588979|NCT04292743|459124753|FG001|Overall Study|Progression of Disease|5|||
127588980|NCT04292743|459124754|FG002|Overall Study|Progression of Disease|0|||
127588981|NCT04292743|459124755|FG003|Overall Study|Progression of Disease|0|||
127588982|NCT04292743|459124752|FG000|Overall Study|No Treatment per protocol|0|||
127588983|NCT04292743|459124753|FG001|Overall Study|No Treatment per protocol|2|||
127588984|NCT04292743|459124754|FG002|Overall Study|No Treatment per protocol|0|||
127588985|NCT04292743|459124755|FG003|Overall Study|No Treatment per protocol|0|||
127588986|NCT05766423|459124756|FG000|Overall Study|Withdrawal by Subject|1|||
127588987|NCT05766423|459124757|FG001|Overall Study|Withdrawal by Subject|0|||
127588988|NCT05766423|459124756|FG000|Overall Study|Consented, not scheduled|3|||
127588989|NCT05766423|459124757|FG001|Overall Study|Consented, not scheduled|5|||
127588990|NCT02385045|459126590|FG000|Overall Study|Endoscopy could not be completed|4|||
127588991|NCT00042289|459126591|FG000|Overall Study|Lost to Follow-up|3|||
127588992|NCT00042289|459126592|FG001|Overall Study|Lost to Follow-up|0|||
127588993|NCT00042289|459126593|FG002|Overall Study|Lost to Follow-up|0|||
127588994|NCT00042289|459126594|FG003|Overall Study|Lost to Follow-up|1|||
127588995|NCT00042289|459126595|FG004|Overall Study|Lost to Follow-up|3|||
127588996|NCT00042289|459126596|FG005|Overall Study|Lost to Follow-up|3|||
127588997|NCT00042289|459126597|FG006|Overall Study|Lost to Follow-up|6|||
127588998|NCT00042289|459126598|FG007|Overall Study|Lost to Follow-up|1|||
127588999|NCT00042289|459126599|FG008|Overall Study|Lost to Follow-up|1|||
127589000|NCT00042289|459126600|FG009|Overall Study|Lost to Follow-up|0|||
127589001|NCT00042289|459126601|FG010|Overall Study|Lost to Follow-up|0|||
127589002|NCT00042289|459126602|FG011|Overall Study|Lost to Follow-up|0|||
128033965|NCT00863304|460751645|FG000|Overall Study|Randomized, but not Treated|3|||
128033966|NCT00863304|460751646|FG001|Overall Study|Randomized, but not Treated|1|||
128033967|NCT00863304|460751647|FG002|Overall Study|Randomized, but not Treated|4|||
127589003|NCT00042289|459126603|FG012|Overall Study|Lost to Follow-up|0|||
127589004|NCT00042289|459126604|FG013|Overall Study|Lost to Follow-up|0|||
127589005|NCT00042289|459126605|FG014|Overall Study|Lost to Follow-up|0|||
127589006|NCT00042289|459126606|FG015|Overall Study|Lost to Follow-up|1|||
127589007|NCT00042289|459126607|FG016|Overall Study|Lost to Follow-up|1|||
127589008|NCT00042289|459126608|FG017|Overall Study|Lost to Follow-up|0|||
127705232|NCT01928394|459551589|FG022|Treatment Period|Death|0|||
127589009|NCT00042289|459126609|FG018|Overall Study|Lost to Follow-up|3|||
128033968|NCT00863304|460751648|FG003|Overall Study|Randomized, but not Treated|1|||
128033969|NCT00863304|460751645|FG000|Overall Study|Entered extension study|101|||
127589010|NCT00042289|459126610|FG019|Overall Study|Lost to Follow-up|2|||
127589011|NCT00042289|459126611|FG020|Overall Study|Lost to Follow-up|0|||
127589012|NCT00042289|459126612|FG021|Overall Study|Lost to Follow-up|0|||
127589013|NCT00042289|459126613|FG022|Overall Study|Lost to Follow-up|0|||
127589014|NCT00042289|459126614|FG023|Overall Study|Lost to Follow-up|0|||
127589015|NCT00042289|459126615|FG024|Overall Study|Lost to Follow-up|0|||
127589016|NCT00042289|459126616|FG025|Overall Study|Lost to Follow-up|0|||
127589017|NCT00042289|459126617|FG026|Overall Study|Lost to Follow-up|2|||
127589018|NCT00042289|459126618|FG027|Overall Study|Lost to Follow-up|2|||
127589019|NCT00042289|459126619|FG028|Overall Study|Lost to Follow-up|2|||
127589020|NCT00042289|459126620|FG029|Overall Study|Lost to Follow-up|0|||
127589021|NCT00042289|459126621|FG030|Overall Study|Lost to Follow-up|0|||
127589022|NCT00042289|459126622|FG031|Overall Study|Lost to Follow-up|2|||
127589023|NCT00042289|459126623|FG032|Overall Study|Lost to Follow-up|1|||
127589024|NCT00042289|459126624|FG033|Overall Study|Lost to Follow-up|1|||
127589025|NCT00042289|459126625|FG034|Overall Study|Lost to Follow-up|1|||
127589026|NCT00042289|459126626|FG035|Overall Study|Lost to Follow-up|2|||
127589027|NCT00042289|459126627|FG036|Overall Study|Lost to Follow-up|1|||
127589028|NCT00042289|459126628|FG037|Overall Study|Lost to Follow-up|1|||
127589029|NCT00042289|459126629|FG038|Overall Study|Lost to Follow-up|0|||
127589030|NCT00042289|459126630|FG039|Overall Study|Lost to Follow-up|5|||
127589031|NCT00042289|459126631|FG040|Overall Study|Lost to Follow-up|0|||
127589032|NCT00042289|459126632|FG041|Overall Study|Lost to Follow-up|2|||
127589033|NCT00042289|459126633|FG042|Overall Study|Lost to Follow-up|2|||
127589034|NCT00042289|459126634|FG043|Overall Study|Lost to Follow-up|0|||
127589035|NCT00042289|459126635|FG044|Overall Study|Lost to Follow-up|0|||
127589036|NCT00042289|459126636|FG045|Overall Study|Lost to Follow-up|1|||
127589037|NCT00042289|459126637|FG046|Overall Study|Lost to Follow-up|0|||
127589038|NCT00042289|459126591|FG000|Overall Study|Other reason|0|||
127589039|NCT00042289|459126592|FG001|Overall Study|Other reason|0|||
127589040|NCT00042289|459126593|FG002|Overall Study|Other reason|0|||
127589041|NCT00042289|459126594|FG003|Overall Study|Other reason|2|||
127589042|NCT00042289|459126595|FG004|Overall Study|Other reason|0|||
127589043|NCT00042289|459126596|FG005|Overall Study|Other reason|0|||
127589044|NCT00042289|459126597|FG006|Overall Study|Other reason|0|||
127589045|NCT00042289|459126598|FG007|Overall Study|Other reason|0|||
127589046|NCT00042289|459126599|FG008|Overall Study|Other reason|0|||
127589047|NCT00042289|459126600|FG009|Overall Study|Other reason|0|||
127589048|NCT00042289|459126601|FG010|Overall Study|Other reason|0|||
127589049|NCT00042289|459126602|FG011|Overall Study|Other reason|0|||
127589050|NCT00042289|459126603|FG012|Overall Study|Other reason|0|||
127589051|NCT00042289|459126604|FG013|Overall Study|Other reason|0|||
127589052|NCT00042289|459126605|FG014|Overall Study|Other reason|0|||
127589053|NCT00042289|459126606|FG015|Overall Study|Other reason|0|||
127589054|NCT00042289|459126607|FG016|Overall Study|Other reason|0|||
127589055|NCT00042289|459126608|FG017|Overall Study|Other reason|0|||
127589056|NCT00042289|459126609|FG018|Overall Study|Other reason|1|||
127589057|NCT00042289|459126610|FG019|Overall Study|Other reason|0|||
127589058|NCT00042289|459126611|FG020|Overall Study|Other reason|0|||
127589059|NCT00042289|459126612|FG021|Overall Study|Other reason|0|||
127589060|NCT00042289|459126613|FG022|Overall Study|Other reason|0|||
127589061|NCT00042289|459126614|FG023|Overall Study|Other reason|1|||
127589062|NCT00042289|459126615|FG024|Overall Study|Other reason|0|||
127589063|NCT00042289|459126616|FG025|Overall Study|Other reason|0|||
128033970|NCT00863304|460751646|FG001|Overall Study|Entered extension study|129|||
128033971|NCT00863304|460751647|FG002|Overall Study|Entered extension study|113|||
128033972|NCT00863304|460751648|FG003|Overall Study|Entered extension study|125|||
128033973|NCT01055028|460751649|FG000|Screening|Screen Failure|1|||
128033974|NCT01055028|460751650|FG001|Screening|Screen Failure|1|||
128033975|NCT01055028|460751649|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
128033976|NCT01055028|460751650|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
128033977|NCT01055028|460751649|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
128033978|NCT01055028|460751650|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
128033979|NCT01055028|460751649|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
128033980|NCT01055028|460751650|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
128033981|NCT06582732|460751651|FG000|Initial Study Period|Adverse Event|0|||
128033982|NCT06582732|460751652|FG001|Initial Study Period|Adverse Event|0|||
128033983|NCT06582732|460751653|FG002|Initial Study Period|Adverse Event|0|||
128033984|NCT06582732|460751654|FG003|Initial Study Period|Adverse Event|2|||
128033985|NCT06582732|460751655|FG004|Initial Study Period|Adverse Event|0|||
128033986|NCT06582732|460751656|FG005|Initial Study Period|Adverse Event|0|||
127589064|NCT00042289|459126617|FG026|Overall Study|Other reason|1|||
127589065|NCT00042289|459126618|FG027|Overall Study|Other reason|0|||
127589066|NCT00042289|459126619|FG028|Overall Study|Other reason|3|||
127589067|NCT00042289|459126620|FG029|Overall Study|Other reason|0|||
127589068|NCT00042289|459126621|FG030|Overall Study|Other reason|0|||
127589069|NCT00042289|459126622|FG031|Overall Study|Other reason|1|||
127589070|NCT00042289|459126623|FG032|Overall Study|Other reason|0|||
127589071|NCT00042289|459126624|FG033|Overall Study|Other reason|1|||
128033987|NCT06582732|460751657|FG006|Initial Study Period|Adverse Event|0|||
127589072|NCT00042289|459126625|FG034|Overall Study|Other reason|0|||
127589073|NCT00042289|459126626|FG035|Overall Study|Other reason|2|||
127589074|NCT00042289|459126627|FG036|Overall Study|Other reason|0|||
127589075|NCT00042289|459126628|FG037|Overall Study|Other reason|0|||
127589076|NCT00042289|459126629|FG038|Overall Study|Other reason|0|||
127589077|NCT00042289|459126630|FG039|Overall Study|Other reason|0|||
127589078|NCT00042289|459126631|FG040|Overall Study|Other reason|0|||
127589079|NCT00042289|459126632|FG041|Overall Study|Other reason|0|||
127589080|NCT00042289|459126633|FG042|Overall Study|Other reason|0|||
127589081|NCT00042289|459126634|FG043|Overall Study|Other reason|1|||
127589082|NCT00042289|459126635|FG044|Overall Study|Other reason|0|||
127589083|NCT00042289|459126636|FG045|Overall Study|Other reason|0|||
127589084|NCT00042289|459126637|FG046|Overall Study|Other reason|0|||
127589085|NCT00042289|459126591|FG000|Overall Study|Severe debilitation, unable to continue|0|||
127589086|NCT00042289|459126592|FG001|Overall Study|Severe debilitation, unable to continue|0|||
127589087|NCT00042289|459126593|FG002|Overall Study|Severe debilitation, unable to continue|0|||
127589088|NCT00042289|459126594|FG003|Overall Study|Severe debilitation, unable to continue|0|||
127589089|NCT00042289|459126595|FG004|Overall Study|Severe debilitation, unable to continue|0|||
127589090|NCT00042289|459126596|FG005|Overall Study|Severe debilitation, unable to continue|0|||
127589091|NCT00042289|459126597|FG006|Overall Study|Severe debilitation, unable to continue|0|||
127589092|NCT00042289|459126598|FG007|Overall Study|Severe debilitation, unable to continue|0|||
127589093|NCT00042289|459126599|FG008|Overall Study|Severe debilitation, unable to continue|0|||
127589094|NCT00042289|459126600|FG009|Overall Study|Severe debilitation, unable to continue|0|||
127589095|NCT00042289|459126601|FG010|Overall Study|Severe debilitation, unable to continue|0|||
127589096|NCT00042289|459126602|FG011|Overall Study|Severe debilitation, unable to continue|0|||
127589097|NCT00042289|459126603|FG012|Overall Study|Severe debilitation, unable to continue|0|||
127589098|NCT00042289|459126604|FG013|Overall Study|Severe debilitation, unable to continue|0|||
127589099|NCT00042289|459126605|FG014|Overall Study|Severe debilitation, unable to continue|0|||
127589100|NCT00042289|459126606|FG015|Overall Study|Severe debilitation, unable to continue|0|||
127589101|NCT00042289|459126607|FG016|Overall Study|Severe debilitation, unable to continue|0|||
127589102|NCT00042289|459126608|FG017|Overall Study|Severe debilitation, unable to continue|0|||
127589103|NCT00042289|459126609|FG018|Overall Study|Severe debilitation, unable to continue|0|||
127589104|NCT00042289|459126610|FG019|Overall Study|Severe debilitation, unable to continue|0|||
127589105|NCT00042289|459126611|FG020|Overall Study|Severe debilitation, unable to continue|0|||
127589106|NCT00042289|459126612|FG021|Overall Study|Severe debilitation, unable to continue|1|||
127589107|NCT00042289|459126613|FG022|Overall Study|Severe debilitation, unable to continue|0|||
127589108|NCT00042289|459126614|FG023|Overall Study|Severe debilitation, unable to continue|1|||
127589109|NCT00042289|459126615|FG024|Overall Study|Severe debilitation, unable to continue|0|||
127589110|NCT00042289|459126616|FG025|Overall Study|Severe debilitation, unable to continue|0|||
127589111|NCT00042289|459126617|FG026|Overall Study|Severe debilitation, unable to continue|0|||
127589112|NCT00042289|459126618|FG027|Overall Study|Severe debilitation, unable to continue|1|||
127589113|NCT00042289|459126619|FG028|Overall Study|Severe debilitation, unable to continue|0|||
127589114|NCT00042289|459126620|FG029|Overall Study|Severe debilitation, unable to continue|0|||
127589115|NCT00042289|459126621|FG030|Overall Study|Severe debilitation, unable to continue|0|||
127589116|NCT00042289|459126622|FG031|Overall Study|Severe debilitation, unable to continue|1|||
127589117|NCT00042289|459126623|FG032|Overall Study|Severe debilitation, unable to continue|1|||
127589118|NCT00042289|459126624|FG033|Overall Study|Severe debilitation, unable to continue|0|||
127589119|NCT00042289|459126625|FG034|Overall Study|Severe debilitation, unable to continue|0|||
127589120|NCT00042289|459126626|FG035|Overall Study|Severe debilitation, unable to continue|0|||
127589121|NCT00042289|459126627|FG036|Overall Study|Severe debilitation, unable to continue|0|||
127589122|NCT00042289|459126628|FG037|Overall Study|Severe debilitation, unable to continue|0|||
127589123|NCT00042289|459126629|FG038|Overall Study|Severe debilitation, unable to continue|0|||
127589124|NCT00042289|459126630|FG039|Overall Study|Severe debilitation, unable to continue|0|||
127589125|NCT00042289|459126631|FG040|Overall Study|Severe debilitation, unable to continue|0|||
127589126|NCT00042289|459126632|FG041|Overall Study|Severe debilitation, unable to continue|0|||
127589127|NCT00042289|459126633|FG042|Overall Study|Severe debilitation, unable to continue|0|||
127589128|NCT00042289|459126634|FG043|Overall Study|Severe debilitation, unable to continue|0|||
127589129|NCT00042289|459126635|FG044|Overall Study|Severe debilitation, unable to continue|0|||
127589130|NCT00042289|459126636|FG045|Overall Study|Severe debilitation, unable to continue|0|||
127589131|NCT00042289|459126637|FG046|Overall Study|Severe debilitation, unable to continue|0|||
127589132|NCT00042289|459126591|FG000|Overall Study|Site closed|0|||
127589133|NCT00042289|459126592|FG001|Overall Study|Site closed|0|||
127589134|NCT00042289|459126593|FG002|Overall Study|Site closed|0|||
127589135|NCT00042289|459126594|FG003|Overall Study|Site closed|0|||
127589136|NCT00042289|459126595|FG004|Overall Study|Site closed|0|||
127589137|NCT00042289|459126596|FG005|Overall Study|Site closed|0|||
127589138|NCT00042289|459126597|FG006|Overall Study|Site closed|0|||
127589139|NCT00042289|459126598|FG007|Overall Study|Site closed|0|||
127589140|NCT00042289|459126599|FG008|Overall Study|Site closed|0|||
127589141|NCT00042289|459126600|FG009|Overall Study|Site closed|0|||
127589142|NCT00042289|459126601|FG010|Overall Study|Site closed|0|||
127882029|NCT01289990|460190798|FG005|Overall Study|Death|1|||
127589143|NCT00042289|459126602|FG011|Overall Study|Site closed|0|||
127589144|NCT00042289|459126603|FG012|Overall Study|Site closed|0|||
127589145|NCT00042289|459126604|FG013|Overall Study|Site closed|0|||
127589146|NCT00042289|459126605|FG014|Overall Study|Site closed|0|||
127589147|NCT00042289|459126606|FG015|Overall Study|Site closed|0|||
127589148|NCT00042289|459126607|FG016|Overall Study|Site closed|0|||
127589149|NCT00042289|459126608|FG017|Overall Study|Site closed|0|||
127589150|NCT00042289|459126609|FG018|Overall Study|Site closed|0|||
127589151|NCT00042289|459126610|FG019|Overall Study|Site closed|0|||
127589152|NCT00042289|459126611|FG020|Overall Study|Site closed|0|||
127589153|NCT00042289|459126612|FG021|Overall Study|Site closed|0|||
127589154|NCT00042289|459126613|FG022|Overall Study|Site closed|0|||
127589155|NCT00042289|459126614|FG023|Overall Study|Site closed|0|||
127589156|NCT00042289|459126615|FG024|Overall Study|Site closed|0|||
127589157|NCT00042289|459126616|FG025|Overall Study|Site closed|0|||
127589158|NCT00042289|459126617|FG026|Overall Study|Site closed|0|||
127589159|NCT00042289|459126618|FG027|Overall Study|Site closed|0|||
127589160|NCT00042289|459126619|FG028|Overall Study|Site closed|0|||
127589161|NCT00042289|459126620|FG029|Overall Study|Site closed|0|||
127589162|NCT00042289|459126621|FG030|Overall Study|Site closed|0|||
127589163|NCT00042289|459126622|FG031|Overall Study|Site closed|3|||
127589164|NCT00042289|459126623|FG032|Overall Study|Site closed|0|||
127589165|NCT00042289|459126624|FG033|Overall Study|Site closed|0|||
127589166|NCT00042289|459126625|FG034|Overall Study|Site closed|0|||
127589167|NCT00042289|459126626|FG035|Overall Study|Site closed|0|||
127589168|NCT00042289|459126627|FG036|Overall Study|Site closed|1|||
127589169|NCT00042289|459126628|FG037|Overall Study|Site closed|0|||
127589170|NCT00042289|459126629|FG038|Overall Study|Site closed|0|||
127589171|NCT00042289|459126630|FG039|Overall Study|Site closed|0|||
127589172|NCT00042289|459126631|FG040|Overall Study|Site closed|0|||
127589173|NCT00042289|459126632|FG041|Overall Study|Site closed|0|||
127589174|NCT00042289|459126633|FG042|Overall Study|Site closed|1|||
127589175|NCT00042289|459126634|FG043|Overall Study|Site closed|0|||
127589176|NCT00042289|459126635|FG044|Overall Study|Site closed|0|||
127589177|NCT00042289|459126636|FG045|Overall Study|Site closed|0|||
127589178|NCT00042289|459126637|FG046|Overall Study|Site closed|0|||
127589179|NCT00042289|459126591|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
127589180|NCT00042289|459126592|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
127589181|NCT00042289|459126593|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
127589182|NCT00042289|459126594|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
127589183|NCT00042289|459126595|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
127589184|NCT00042289|459126596|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
127589185|NCT00042289|459126597|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
127589186|NCT00042289|459126598|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
127589187|NCT00042289|459126599|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
127589188|NCT00042289|459126600|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
127589189|NCT00042289|459126601|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
127589190|NCT00042289|459126602|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
127589191|NCT00042289|459126603|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
127589192|NCT00042289|459126604|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
127589193|NCT00042289|459126605|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
127589194|NCT00042289|459126606|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
127589195|NCT00042289|459126607|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
127589196|NCT00042289|459126608|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
127589197|NCT00042289|459126609|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
127589198|NCT00042289|459126610|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
127589199|NCT00042289|459126611|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
127589200|NCT00042289|459126612|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
127589201|NCT00042289|459126613|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
127589202|NCT00042289|459126614|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
127589203|NCT00042289|459126615|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
127589204|NCT00042289|459126616|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
127589205|NCT00042289|459126617|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
127694365|NCT04402489|459510700|FG001|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
127882030|NCT01289990|460190799|FG006|Overall Study|Death|0|||
127589206|NCT00042289|459126618|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
127589207|NCT00042289|459126619|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
127589208|NCT00042289|459126620|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
127589209|NCT00042289|459126621|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
127589210|NCT00042289|459126622|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
127589211|NCT00042289|459126623|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
127589212|NCT00042289|459126624|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
127589213|NCT00042289|459126625|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
127589214|NCT00042289|459126626|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
127589215|NCT00042289|459126627|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
127589216|NCT00042289|459126628|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
127589217|NCT00042289|459126629|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
127589218|NCT00042289|459126630|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
127589219|NCT00042289|459126631|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
127589220|NCT00042289|459126632|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
127589221|NCT00042289|459126633|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
127589222|NCT00042289|459126634|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
127589223|NCT00042289|459126635|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
127589224|NCT00042289|459126636|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
127589225|NCT00042289|459126637|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
127589226|NCT00042289|459126591|FG000|Overall Study|Protocol Violation|0|||
127589227|NCT00042289|459126592|FG001|Overall Study|Protocol Violation|0|||
127589228|NCT00042289|459126593|FG002|Overall Study|Protocol Violation|0|||
127589229|NCT00042289|459126594|FG003|Overall Study|Protocol Violation|0|||
127589230|NCT00042289|459126595|FG004|Overall Study|Protocol Violation|0|||
127589231|NCT00042289|459126596|FG005|Overall Study|Protocol Violation|1|||
127589232|NCT00042289|459126597|FG006|Overall Study|Protocol Violation|0|||
127589233|NCT00042289|459126598|FG007|Overall Study|Protocol Violation|1|||
127589234|NCT00042289|459126599|FG008|Overall Study|Protocol Violation|0|||
127589235|NCT00042289|459126600|FG009|Overall Study|Protocol Violation|0|||
127589236|NCT00042289|459126601|FG010|Overall Study|Protocol Violation|0|||
127589237|NCT00042289|459126602|FG011|Overall Study|Protocol Violation|0|||
127589238|NCT00042289|459126603|FG012|Overall Study|Protocol Violation|0|||
127589239|NCT00042289|459126604|FG013|Overall Study|Protocol Violation|0|||
127589240|NCT00042289|459126605|FG014|Overall Study|Protocol Violation|0|||
127589241|NCT00042289|459126606|FG015|Overall Study|Protocol Violation|0|||
127589242|NCT00042289|459126607|FG016|Overall Study|Protocol Violation|0|||
127589243|NCT00042289|459126608|FG017|Overall Study|Protocol Violation|0|||
127589244|NCT00042289|459126609|FG018|Overall Study|Protocol Violation|0|||
127589245|NCT00042289|459126610|FG019|Overall Study|Protocol Violation|0|||
127589246|NCT00042289|459126611|FG020|Overall Study|Protocol Violation|0|||
127589247|NCT00042289|459126612|FG021|Overall Study|Protocol Violation|0|||
127589248|NCT00042289|459126613|FG022|Overall Study|Protocol Violation|0|||
127589249|NCT00042289|459126614|FG023|Overall Study|Protocol Violation|1|||
127589250|NCT00042289|459126615|FG024|Overall Study|Protocol Violation|1|||
127589251|NCT00042289|459126616|FG025|Overall Study|Protocol Violation|0|||
127589252|NCT00042289|459126617|FG026|Overall Study|Protocol Violation|2|||
127589253|NCT00042289|459126618|FG027|Overall Study|Protocol Violation|0|||
127589254|NCT00042289|459126619|FG028|Overall Study|Protocol Violation|0|||
127589255|NCT00042289|459126620|FG029|Overall Study|Protocol Violation|0|||
127589256|NCT00042289|459126621|FG030|Overall Study|Protocol Violation|1|||
127589257|NCT00042289|459126622|FG031|Overall Study|Protocol Violation|0|||
127589258|NCT00042289|459126623|FG032|Overall Study|Protocol Violation|0|||
127589259|NCT00042289|459126624|FG033|Overall Study|Protocol Violation|0|||
128033988|NCT06582732|460751651|FG000|Initial Study Period|Death|1|||
128033989|NCT06582732|460751652|FG001|Initial Study Period|Death|0|||
128033990|NCT06582732|460751653|FG002|Initial Study Period|Death|0|||
128033991|NCT06582732|460751654|FG003|Initial Study Period|Death|0|||
128033992|NCT06582732|460751655|FG004|Initial Study Period|Death|1|||
128033993|NCT06582732|460751656|FG005|Initial Study Period|Death|0|||
128033994|NCT06582732|460751657|FG006|Initial Study Period|Death|0|||
128033995|NCT06582732|460751651|FG000|Initial Study Period|Lost to Follow-up|0|||
128033996|NCT06582732|460751652|FG001|Initial Study Period|Lost to Follow-up|0|||
128033997|NCT06582732|460751653|FG002|Initial Study Period|Lost to Follow-up|2|||
128033998|NCT06582732|460751654|FG003|Initial Study Period|Lost to Follow-up|0|||
128033999|NCT06582732|460751655|FG004|Initial Study Period|Lost to Follow-up|0|||
128034000|NCT06582732|460751656|FG005|Initial Study Period|Lost to Follow-up|0|||
128034001|NCT06582732|460751657|FG006|Initial Study Period|Lost to Follow-up|0|||
128034002|NCT06582732|460751651|FG000|Initial Study Period|Withdrawal by Subject|0|||
128034003|NCT06582732|460751652|FG001|Initial Study Period|Withdrawal by Subject|1|||
128034004|NCT06582732|460751653|FG002|Initial Study Period|Withdrawal by Subject|0|||
128034005|NCT06582732|460751654|FG003|Initial Study Period|Withdrawal by Subject|1|||
127589260|NCT00042289|459126625|FG034|Overall Study|Protocol Violation|0|||
127589261|NCT00042289|459126626|FG035|Overall Study|Protocol Violation|0|||
127589262|NCT00042289|459126627|FG036|Overall Study|Protocol Violation|0|||
127589263|NCT00042289|459126628|FG037|Overall Study|Protocol Violation|0|||
127694366|NCT04402489|459510701|FG002|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
127882031|NCT01289990|460190800|FG007|Overall Study|Death|0|||
128034006|NCT06582732|460751655|FG004|Initial Study Period|Withdrawal by Subject|3|||
128034007|NCT06582732|460751656|FG005|Initial Study Period|Withdrawal by Subject|1|||
127589264|NCT00042289|459126629|FG038|Overall Study|Protocol Violation|0|||
127589265|NCT00042289|459126630|FG039|Overall Study|Protocol Violation|0|||
127589266|NCT00042289|459126631|FG040|Overall Study|Protocol Violation|0|||
127589267|NCT00042289|459126632|FG041|Overall Study|Protocol Violation|1|||
127589268|NCT00042289|459126633|FG042|Overall Study|Protocol Violation|1|||
127589269|NCT00042289|459126634|FG043|Overall Study|Protocol Violation|1|||
127589270|NCT00042289|459126635|FG044|Overall Study|Protocol Violation|0|||
127589271|NCT00042289|459126636|FG045|Overall Study|Protocol Violation|0|||
127589272|NCT00042289|459126637|FG046|Overall Study|Protocol Violation|0|||
127589273|NCT00042289|459126591|FG000|Overall Study|Withdrawal by Subject|4|||
127589274|NCT00042289|459126592|FG001|Overall Study|Withdrawal by Subject|1|||
127589275|NCT00042289|459126593|FG002|Overall Study|Withdrawal by Subject|0|||
127589276|NCT00042289|459126594|FG003|Overall Study|Withdrawal by Subject|2|||
127589277|NCT00042289|459126595|FG004|Overall Study|Withdrawal by Subject|0|||
127589278|NCT00042289|459126596|FG005|Overall Study|Withdrawal by Subject|2|||
127589279|NCT00042289|459126597|FG006|Overall Study|Withdrawal by Subject|0|||
127589280|NCT00042289|459126598|FG007|Overall Study|Withdrawal by Subject|0|||
127589281|NCT00042289|459126599|FG008|Overall Study|Withdrawal by Subject|0|||
127589282|NCT00042289|459126600|FG009|Overall Study|Withdrawal by Subject|1|||
127589283|NCT00042289|459126601|FG010|Overall Study|Withdrawal by Subject|0|||
127589284|NCT00042289|459126602|FG011|Overall Study|Withdrawal by Subject|0|||
127589285|NCT00042289|459126603|FG012|Overall Study|Withdrawal by Subject|2|||
127589286|NCT00042289|459126604|FG013|Overall Study|Withdrawal by Subject|0|||
127589287|NCT00042289|459126605|FG014|Overall Study|Withdrawal by Subject|0|||
127589288|NCT00042289|459126606|FG015|Overall Study|Withdrawal by Subject|0|||
127589289|NCT00042289|459126607|FG016|Overall Study|Withdrawal by Subject|0|||
127589290|NCT00042289|459126608|FG017|Overall Study|Withdrawal by Subject|0|||
127589291|NCT00042289|459126609|FG018|Overall Study|Withdrawal by Subject|0|||
127589292|NCT00042289|459126610|FG019|Overall Study|Withdrawal by Subject|0|||
127589293|NCT00042289|459126611|FG020|Overall Study|Withdrawal by Subject|0|||
127589294|NCT00042289|459126612|FG021|Overall Study|Withdrawal by Subject|1|||
127589295|NCT00042289|459126613|FG022|Overall Study|Withdrawal by Subject|1|||
127589296|NCT00042289|459126614|FG023|Overall Study|Withdrawal by Subject|1|||
127589297|NCT00042289|459126615|FG024|Overall Study|Withdrawal by Subject|0|||
127589298|NCT00042289|459126616|FG025|Overall Study|Withdrawal by Subject|0|||
127589299|NCT00042289|459126617|FG026|Overall Study|Withdrawal by Subject|1|||
127589300|NCT00042289|459126618|FG027|Overall Study|Withdrawal by Subject|0|||
127589301|NCT00042289|459126619|FG028|Overall Study|Withdrawal by Subject|2|||
127589302|NCT00042289|459126620|FG029|Overall Study|Withdrawal by Subject|0|||
127589303|NCT00042289|459126621|FG030|Overall Study|Withdrawal by Subject|0|||
127589304|NCT00042289|459126622|FG031|Overall Study|Withdrawal by Subject|1|||
127589305|NCT00042289|459126623|FG032|Overall Study|Withdrawal by Subject|2|||
127589306|NCT00042289|459126624|FG033|Overall Study|Withdrawal by Subject|1|||
127589307|NCT00042289|459126625|FG034|Overall Study|Withdrawal by Subject|0|||
127589308|NCT00042289|459126626|FG035|Overall Study|Withdrawal by Subject|0|||
127589309|NCT00042289|459126627|FG036|Overall Study|Withdrawal by Subject|0|||
127589310|NCT00042289|459126628|FG037|Overall Study|Withdrawal by Subject|1|||
127589311|NCT00042289|459126629|FG038|Overall Study|Withdrawal by Subject|0|||
127589312|NCT00042289|459126630|FG039|Overall Study|Withdrawal by Subject|0|||
127589313|NCT00042289|459126631|FG040|Overall Study|Withdrawal by Subject|0|||
127589314|NCT00042289|459126632|FG041|Overall Study|Withdrawal by Subject|0|||
127589315|NCT00042289|459126633|FG042|Overall Study|Withdrawal by Subject|1|||
127589316|NCT00042289|459126634|FG043|Overall Study|Withdrawal by Subject|0|||
127589317|NCT00042289|459126635|FG044|Overall Study|Withdrawal by Subject|0|||
127589318|NCT00042289|459126636|FG045|Overall Study|Withdrawal by Subject|0|||
127589319|NCT00042289|459126637|FG046|Overall Study|Withdrawal by Subject|0|||
127589320|NCT01687998|459126638|FG000|Overall Study|Withdrawal by Subject|49|||
127589321|NCT01687998|459126639|FG001|Overall Study|Withdrawal by Subject|51|||
127589322|NCT01687998|459126638|FG000|Overall Study|Known to be Alive at Study End|54|||
127589323|NCT01687998|459126639|FG001|Overall Study|Known to be Alive at Study End|62|||
127589324|NCT01687998|459126638|FG000|Overall Study|Lost to Follow-up|9|||
127589325|NCT01687998|459126639|FG001|Overall Study|Lost to Follow-up|7|||
127589326|NCT00745823|459126640|FG000|Overall Study|Adverse Event|5|||
127589327|NCT00745823|459126641|FG001|Overall Study|Adverse Event|3|||
127589328|NCT00745823|459126640|FG000|Overall Study|Lack of Efficacy|20|||
127589329|NCT00745823|459126641|FG001|Overall Study|Lack of Efficacy|6|||
127589330|NCT00745823|459126640|FG000|Overall Study|Lost to Follow-up|10|||
127589331|NCT00745823|459126641|FG001|Overall Study|Lost to Follow-up|11|||
127589332|NCT00745823|459126640|FG000|Overall Study|Physician Decision|10|||
127784651|NCT00262522|459837018|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
127784652|NCT00262522|459837019|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
127589333|NCT00745823|459126641|FG001|Overall Study|Physician Decision|5|||
127589334|NCT00745823|459126640|FG000|Overall Study|Pregnancy|0|||
127589335|NCT00745823|459126641|FG001|Overall Study|Pregnancy|4|||
127784653|NCT00262522|459837016|FG000|Study Start Through 8 Weeks|Death|1|||
127589336|NCT00745823|459126640|FG000|Overall Study|Withdrawal by Subject|14|||
127589337|NCT00745823|459126641|FG001|Overall Study|Withdrawal by Subject|8|||
127589338|NCT00745823|459126640|FG000|Overall Study|Study Terminated by Sponsor|326|||
127589339|NCT00745823|459126641|FG001|Overall Study|Study Terminated by Sponsor|349|||
127589340|NCT00612690|459126642|FG000|Overall Study|Lost to Follow-up|72|||
127784654|NCT00262522|459837017|FG001|Study Start Through 8 Weeks|Death|0|||
127589341|NCT00612690|459126643|FG001|Overall Study|Lost to Follow-up|98|||
127589342|NCT00612690|459126642|FG000|Overall Study|Withdrawal by Subject|32|||
127589343|NCT00612690|459126643|FG001|Overall Study|Withdrawal by Subject|20|||
127589344|NCT00612690|459126642|FG000|Overall Study|Withdrawal by Site|11|||
127589345|NCT00612690|459126643|FG001|Overall Study|Withdrawal by Site|0|||
127589346|NCT02955602|459126644|FG000|Overall Study|Adverse Event|0|||
127589347|NCT02955602|459126645|FG001|Overall Study|Adverse Event|3|||
127589348|NCT02955602|459126646|FG002|Overall Study|Adverse Event|0|||
127589349|NCT02955602|459126644|FG000|Overall Study|Withdrawal of informed consent|1|||
127589350|NCT02955602|459126645|FG001|Overall Study|Withdrawal of informed consent|3|||
127589351|NCT02955602|459126646|FG002|Overall Study|Withdrawal of informed consent|2|||
127589352|NCT02955602|459126644|FG000|Overall Study|Lost to Follow-up|0|||
127589353|NCT02955602|459126645|FG001|Overall Study|Lost to Follow-up|0|||
127589354|NCT02955602|459126646|FG002|Overall Study|Lost to Follow-up|1|||
127589355|NCT02955602|459126644|FG000|Overall Study|Other|0|||
127589356|NCT02955602|459126645|FG001|Overall Study|Other|1|||
127589357|NCT02955602|459126646|FG002|Overall Study|Other|3|||
127589358|NCT03156543|459126647|FG000|Overall Study|Withdrawal by Subject|1|||
127589359|NCT03156543|459126648|FG001|Overall Study|Withdrawal by Subject|0|||
127589360|NCT01434667|459126652|FG000|Overall Study|Lost to Follow-up|5|||
127589361|NCT01434667|459126653|FG001|Overall Study|Lost to Follow-up|10|||
127589362|NCT02966028|459126654|FG000|Overall Study|Adverse Event|7|||
127589363|NCT02966028|459126655|FG001|Overall Study|Adverse Event|13|||
127589364|NCT02966028|459126656|FG002|Overall Study|Adverse Event|10|||
127589365|NCT02966028|459126654|FG000|Overall Study|Physician Decision|1|||
127589366|NCT02966028|459126655|FG001|Overall Study|Physician Decision|0|||
127589367|NCT02966028|459126656|FG002|Overall Study|Physician Decision|2|||
127589368|NCT02966028|459126654|FG000|Overall Study|Withdrawal by Subject|7|||
127589369|NCT02966028|459126655|FG001|Overall Study|Withdrawal by Subject|5|||
127589370|NCT02966028|459126656|FG002|Overall Study|Withdrawal by Subject|5|||
127589371|NCT02966028|459126654|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
127589372|NCT02966028|459126655|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
127589373|NCT02966028|459126656|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
127589374|NCT04115839|459126657|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
127589375|NCT04115839|459126658|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
127589376|NCT04115839|459126659|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
127589377|NCT04115839|459126660|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
127589378|NCT04115839|459126661|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
127589379|NCT04115839|459126662|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
127589380|NCT04115839|459126663|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
127589381|NCT04115839|459126657|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
127589382|NCT04115839|459126658|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
127589383|NCT04115839|459126659|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
127589384|NCT04115839|459126660|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
127589385|NCT04115839|459126661|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
127589386|NCT04115839|459126662|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
127589387|NCT04115839|459126663|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
127589388|NCT04115839|459126657|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
127589389|NCT04115839|459126658|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
127589390|NCT04115839|459126659|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
127589391|NCT04115839|459126660|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
127589392|NCT04115839|459126661|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
127589393|NCT04115839|459126662|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
127589394|NCT04115839|459126663|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
127589395|NCT04115839|459126657|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
127589396|NCT04115839|459126658|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
127589397|NCT04115839|459126659|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
127589398|NCT04115839|459126660|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
128034008|NCT06582732|460751657|FG006|Initial Study Period|Withdrawal by Subject|2|||
127589399|NCT04115839|459126661|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
127589400|NCT04115839|459126662|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
128034009|NCT06582732|460751651|FG000|Initial Study Period|Moved Away|0|||
128034010|NCT06582732|460751652|FG001|Initial Study Period|Moved Away|0|||
128034011|NCT06582732|460751653|FG002|Initial Study Period|Moved Away|0|||
127589401|NCT04115839|459126663|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
127589402|NCT04115839|459126657|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
127589403|NCT04115839|459126658|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
127589404|NCT04115839|459126659|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
127589405|NCT04115839|459126660|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
127589406|NCT04115839|459126661|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
127784655|NCT00262522|459837018|FG002|Study Start Through 8 Weeks|Death|0|||
127784656|NCT00262522|459837019|FG003|Study Start Through 8 Weeks|Death|0|||
127784657|NCT00262522|459837016|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
127589407|NCT04115839|459126662|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
127589408|NCT04115839|459126663|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
127589409|NCT04115839|459126657|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
127589410|NCT04115839|459126658|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
127589411|NCT04115839|459126659|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
127589412|NCT04115839|459126660|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
127589413|NCT04115839|459126661|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
127589414|NCT04115839|459126662|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
127589415|NCT04115839|459126663|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
127589416|NCT02034110|459126664|FG000|Overall Study|Physician Decision|0|||
127589417|NCT02034110|459126665|FG001|Overall Study|Physician Decision|0|||
127589418|NCT02034110|459126666|FG002|Overall Study|Physician Decision|0|||
127589419|NCT02034110|459126667|FG003|Overall Study|Physician Decision|0|||
127589420|NCT02034110|459126668|FG004|Overall Study|Physician Decision|2|||
127589421|NCT02034110|459126669|FG005|Overall Study|Physician Decision|0|||
127589422|NCT02034110|459126670|FG006|Overall Study|Physician Decision|1|||
127589423|NCT02034110|459126671|FG007|Overall Study|Physician Decision|0|||
127589424|NCT02034110|459126664|FG000|Overall Study|Lost to Follow-up|1|||
127589425|NCT02034110|459126665|FG001|Overall Study|Lost to Follow-up|0|||
127589426|NCT02034110|459126666|FG002|Overall Study|Lost to Follow-up|0|||
127589427|NCT02034110|459126667|FG003|Overall Study|Lost to Follow-up|0|||
127589428|NCT02034110|459126668|FG004|Overall Study|Lost to Follow-up|1|||
128034012|NCT06582732|460751654|FG003|Initial Study Period|Moved Away|0|||
128034013|NCT06582732|460751655|FG004|Initial Study Period|Moved Away|1|||
128034014|NCT06582732|460751656|FG005|Initial Study Period|Moved Away|0|||
128034015|NCT06582732|460751657|FG006|Initial Study Period|Moved Away|0|||
128034016|NCT02507934|460751658|FG000|Overall Study|Lost to Follow-up|2|||
128034017|NCT02507934|460751659|FG001|Overall Study|Lost to Follow-up|0|||
128034018|NCT02507934|460751658|FG000|Overall Study|Withdrawal by Subject|2|||
128034019|NCT02507934|460751659|FG001|Overall Study|Withdrawal by Subject|0|||
128034020|NCT05030766|460751660|FG000|Phase 1 Participants|Lost to Follow-up|12|||
128034021|NCT05030766|460751661|FG001|Phase 1 Participants|Lost to Follow-up|22|||
128034022|NCT05030766|460751662|FG002|Phase 1 Participants|Lost to Follow-up|0|||
128034023|NCT05030766|460751663|FG003|Phase 1 Participants|Lost to Follow-up|0|||
128034024|NCT05030766|460751660|FG000|Phase 1 Participants|Did not attend sessions after being randomized|16|||
128034025|NCT05030766|460751661|FG001|Phase 1 Participants|Did not attend sessions after being randomized|9|||
128034026|NCT05030766|460751662|FG002|Phase 1 Participants|Did not attend sessions after being randomized|0|||
128034027|NCT05030766|460751663|FG003|Phase 1 Participants|Did not attend sessions after being randomized|0|||
128034028|NCT05030766|460751660|FG000|Phase 2 Participants|Lost to Follow-up|0|||
128034029|NCT05030766|460751661|FG001|Phase 2 Participants|Lost to Follow-up|0|||
128034030|NCT05030766|460751662|FG002|Phase 2 Participants|Lost to Follow-up|6|||
128034031|NCT05030766|460751663|FG003|Phase 2 Participants|Lost to Follow-up|2|||
128034032|NCT03559530|460751670|FG000|Overall Study|non-location of medical records|44|||
128034033|NCT03559530|460751671|FG001|Overall Study|non-location of medical records|0|||
128034034|NCT03559530|460751670|FG000|Overall Study|culture results not considered for treat|29|||
128034035|NCT03559530|460751671|FG001|Overall Study|culture results not considered for treat|0|||
128034036|NCT03559530|460751670|FG000|Overall Study|duplicate cases|8|||
128034037|NCT03559530|460751671|FG001|Overall Study|duplicate cases|0|||
128034038|NCT03559530|460751670|FG000|Overall Study|other species of Acinetobacte|7|||
128034039|NCT03559530|460751671|FG001|Overall Study|other species of Acinetobacte|0|||
128034040|NCT03559530|460751670|FG000|Overall Study|contamination / colonization|3|||
128034041|NCT03559530|460751671|FG001|Overall Study|contamination / colonization|0|||
128034042|NCT03331354|460751672|FG000|Overall Study|Withdrawal by Subject|1|||
128034043|NCT03331354|460751673|FG001|Overall Study|Withdrawal by Subject|3|||
128034044|NCT03331354|460751672|FG000|Overall Study|Lost to Follow-up|3|||
128034045|NCT03331354|460751673|FG001|Overall Study|Lost to Follow-up|3|||
128034046|NCT03331354|460751672|FG000|Overall Study|Found employment before initiated active intervention|0|||
128034047|NCT03331354|460751673|FG001|Overall Study|Found employment before initiated active intervention|4|||
128034048|NCT01362790|460751676|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
128034049|NCT01362790|460751677|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
128034050|NCT01362790|460751678|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
128034051|NCT01362790|460751679|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
128034052|NCT01362790|460751680|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
128034053|NCT01362790|460751681|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
127589429|NCT02034110|459126669|FG005|Overall Study|Lost to Follow-up|0|||
127589430|NCT02034110|459126670|FG006|Overall Study|Lost to Follow-up|1|||
127589431|NCT02034110|459126671|FG007|Overall Study|Lost to Follow-up|0|||
127589432|NCT02034110|459126664|FG000|Overall Study|Withdrawal by Subject|5|||
127589433|NCT02034110|459126665|FG001|Overall Study|Withdrawal by Subject|7|||
127589434|NCT02034110|459126666|FG002|Overall Study|Withdrawal by Subject|0|||
127589435|NCT02034110|459126667|FG003|Overall Study|Withdrawal by Subject|3|||
127589436|NCT02034110|459126668|FG004|Overall Study|Withdrawal by Subject|7|||
127589437|NCT02034110|459126669|FG005|Overall Study|Withdrawal by Subject|0|||
127589438|NCT02034110|459126670|FG006|Overall Study|Withdrawal by Subject|3|||
127589439|NCT02034110|459126671|FG007|Overall Study|Withdrawal by Subject|1|||
127589440|NCT02034110|459126664|FG000|Overall Study|Study closed by sponsor|6|||
127589441|NCT02034110|459126665|FG001|Overall Study|Study closed by sponsor|2|||
127589442|NCT02034110|459126666|FG002|Overall Study|Study closed by sponsor|0|||
127589443|NCT02034110|459126667|FG003|Overall Study|Study closed by sponsor|6|||
127589444|NCT02034110|459126668|FG004|Overall Study|Study closed by sponsor|7|||
127589445|NCT02034110|459126669|FG005|Overall Study|Study closed by sponsor|0|||
127589446|NCT02034110|459126670|FG006|Overall Study|Study closed by sponsor|42|||
127589447|NCT02034110|459126671|FG007|Overall Study|Study closed by sponsor|0|||
127694367|NCT04402489|459510702|FG003|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|1|||
127694368|NCT04402489|459510703|FG004|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
127694369|NCT04402489|459510699|FG000|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
127694370|NCT04402489|459510700|FG001|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|1|||
127882032|NCT01289990|460190801|FG008|Overall Study|Death|0|||
127589448|NCT00621985|459126672|FG000|Dexamethasone Admission|Adverse Event|1|||
127882033|NCT01289990|460190802|FG009|Overall Study|Death|0|||
127882034|NCT01289990|460190803|FG010|Overall Study|Death|0|||
127589449|NCT01877265|459126676|FG000|Treatment Period 1|Sponsor Decision|0|||
127589450|NCT01877265|459126677|FG001|Treatment Period 1|Sponsor Decision|0|||
127589451|NCT01877265|459126678|FG002|Treatment Period 1|Sponsor Decision|1|||
127589452|NCT01877265|459126679|FG003|Treatment Period 1|Sponsor Decision|0|||
127589453|NCT01877265|459126680|FG004|Treatment Period 1|Sponsor Decision|0|||
127589454|NCT01877265|459126681|FG005|Treatment Period 1|Sponsor Decision|0|||
127589455|NCT01877265|459126676|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
127589456|NCT01877265|459126677|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
127589457|NCT01877265|459126678|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
127589458|NCT01877265|459126679|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
127589459|NCT01877265|459126680|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
127589460|NCT01877265|459126681|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
127589461|NCT01877265|459126676|FG000|Treatment Period 3|Lost to Follow-up|1|||
127589462|NCT01877265|459126677|FG001|Treatment Period 3|Lost to Follow-up|0|||
127589463|NCT01877265|459126678|FG002|Treatment Period 3|Lost to Follow-up|0|||
127589464|NCT01877265|459126679|FG003|Treatment Period 3|Lost to Follow-up|0|||
127589465|NCT01877265|459126680|FG004|Treatment Period 3|Lost to Follow-up|0|||
127589466|NCT01877265|459126681|FG005|Treatment Period 3|Lost to Follow-up|0|||
127589467|NCT00691015|459126682|FG000|Overall Study|Refused further treatment|1|||
127589468|NCT04160195|459126685|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
127589469|NCT04160195|459126686|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
127882035|NCT01289990|460190804|FG011|Overall Study|Death|1|||
127882036|NCT01289990|460190805|FG012|Overall Study|Death|0|||
127882037|NCT01289990|460190793|FG000|Overall Study|Lost to Follow-up|3|||
127882038|NCT01289990|460190794|FG001|Overall Study|Lost to Follow-up|2|||
127882039|NCT01289990|460190795|FG002|Overall Study|Lost to Follow-up|5|||
127882040|NCT01289990|460190796|FG003|Overall Study|Lost to Follow-up|5|||
127882041|NCT01289990|460190797|FG004|Overall Study|Lost to Follow-up|3|||
127882042|NCT01289990|460190798|FG005|Overall Study|Lost to Follow-up|4|||
127882043|NCT01289990|460190799|FG006|Overall Study|Lost to Follow-up|2|||
127882044|NCT01289990|460190800|FG007|Overall Study|Lost to Follow-up|2|||
127882045|NCT01289990|460190801|FG008|Overall Study|Lost to Follow-up|1|||
127882046|NCT01289990|460190802|FG009|Overall Study|Lost to Follow-up|4|||
127882047|NCT01289990|460190803|FG010|Overall Study|Lost to Follow-up|2|||
127882048|NCT01289990|460190804|FG011|Overall Study|Lost to Follow-up|1|||
127882049|NCT01289990|460190805|FG012|Overall Study|Lost to Follow-up|2|||
127882050|NCT01289990|460190793|FG000|Overall Study|Withdrawal by Subject|15|||
128034054|NCT01362790|460751682|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
128034055|NCT01362790|460751676|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
128034056|NCT01362790|460751677|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
128034057|NCT01362790|460751678|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
128034058|NCT01362790|460751679|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
128034059|NCT01362790|460751680|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
128034060|NCT01362790|460751681|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
128034061|NCT01362790|460751682|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
128034062|NCT01362790|460751676|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
128034063|NCT01362790|460751677|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
128034064|NCT01362790|460751678|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
128034065|NCT01362790|460751679|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
128034066|NCT01362790|460751680|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
127882051|NCT01289990|460190794|FG001|Overall Study|Withdrawal by Subject|14|||
127882052|NCT01289990|460190795|FG002|Overall Study|Withdrawal by Subject|12|||
128034067|NCT01362790|460751681|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
128034068|NCT01362790|460751682|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
127589470|NCT00684593|459126687|FG000|Overall Study|Adverse Event|0|||
127589471|NCT00684593|459126688|FG001|Overall Study|Adverse Event|2|||
127589472|NCT03535844|459126689|FG000|Overall Study|Withdrawal by Subject|0|||
127589473|NCT03535844|459126690|FG001|Overall Study|Withdrawal by Subject|1|||
127589474|NCT00160693|459126692|FG000|Overall Study|Adverse Event|97|||
127589475|NCT00160693|459126692|FG000|Overall Study|Lack of Efficacy|30|||
127589476|NCT00160693|459126692|FG000|Overall Study|Protocol Violation|24|||
127589477|NCT00160693|459126692|FG000|Overall Study|Lost to Follow-up|15|||
127589478|NCT00160693|459126692|FG000|Overall Study|Withdrawal by Subject|54|||
127589479|NCT00160693|459126692|FG000|Overall Study|Study terminated by sponsor|15|||
127589480|NCT02193867|459126697|FG000|Overall Study|Death|2|||
127589481|NCT02193867|459126697|FG000|Overall Study|Sponsor Study Termination|2|||
127589482|NCT03600818|459126698|FG000|Overall Study|Adverse Event|4|||
127589483|NCT03600818|459126699|FG001|Overall Study|Adverse Event|7|||
127589484|NCT03600818|459126698|FG000|Overall Study|Lack of Efficacy|9|||
127589485|NCT03600818|459126699|FG001|Overall Study|Lack of Efficacy|4|||
127589486|NCT03600818|459126698|FG000|Overall Study|Withdrawal by Subject|4|||
127589487|NCT03600818|459126699|FG001|Overall Study|Withdrawal by Subject|3|||
127589488|NCT03600818|459126698|FG000|Overall Study|Other-unspecified|5|||
127589489|NCT03600818|459126699|FG001|Overall Study|Other-unspecified|3|||
127589490|NCT03600818|459126698|FG000|Overall Study|Randomized and not treated|0|||
127589491|NCT03600818|459126699|FG001|Overall Study|Randomized and not treated|1|||
127589492|NCT02059395|459126701|FG000|Overall Study|Lost to Follow-up|2|||
127589493|NCT02059395|459126702|FG001|Overall Study|Lost to Follow-up|4|||
127589494|NCT01488370|459126705|FG000|Overall Study|Protocol Violation|0|||
127589495|NCT01488370|459126706|FG001|Overall Study|Protocol Violation|1|||
127589496|NCT01488370|459126707|FG002|Overall Study|Protocol Violation|1|||
127589497|NCT04189081|459126709|FG000|Overall Study|Lost to Follow-up|1|||
127589498|NCT04189081|459126710|FG001|Overall Study|Lost to Follow-up|0|||
127589499|NCT04189081|459126711|FG002|Overall Study|Lost to Follow-up|0|||
127589500|NCT04189081|459126709|FG000|Overall Study|Withdrawal by Subject|0|||
127589501|NCT04189081|459126710|FG001|Overall Study|Withdrawal by Subject|0|||
127589502|NCT04189081|459126711|FG002|Overall Study|Withdrawal by Subject|1|||
127589503|NCT02228460|459126715|FG000|Overall Study|Adverse Event|1|||
127589504|NCT02228460|459126715|FG000|Overall Study|Lost to Follow-up|1|||
127589505|NCT01243892|459126716|FG000|Overall Study|Did not meet eligibility criteria|2|||
127589506|NCT01243892|459126717|FG001|Overall Study|Did not meet eligibility criteria|0|||
127589507|NCT03706079|459126721|FG000|Predecessor Study|Death|0|||
127589508|NCT03706079|459126722|FG001|Predecessor Study|Death|2|||
127589509|NCT03706079|459126723|FG002|Predecessor Study|Death|0|||
127589510|NCT03706079|459126724|FG003|Predecessor Study|Death|1|||
127589511|NCT03706079|459126725|FG004|Predecessor Study|Death|0|||
127589512|NCT03706079|459126726|FG005|Predecessor Study|Death|0|||
127589513|NCT03706079|459126721|FG000|Predecessor Study|Lost to Follow-up|5|||
127589514|NCT03706079|459126722|FG001|Predecessor Study|Lost to Follow-up|2|||
127589515|NCT03706079|459126723|FG002|Predecessor Study|Lost to Follow-up|0|||
127589516|NCT03706079|459126724|FG003|Predecessor Study|Lost to Follow-up|0|||
127589517|NCT03706079|459126725|FG004|Predecessor Study|Lost to Follow-up|1|||
127589518|NCT03706079|459126726|FG005|Predecessor Study|Lost to Follow-up|0|||
127589519|NCT03706079|459126721|FG000|Predecessor Study|Withdrawal by Subject|8|||
127589520|NCT03706079|459126722|FG001|Predecessor Study|Withdrawal by Subject|15|||
127589521|NCT03706079|459126723|FG002|Predecessor Study|Withdrawal by Subject|0|||
127589522|NCT03706079|459126724|FG003|Predecessor Study|Withdrawal by Subject|5|||
127589523|NCT03706079|459126725|FG004|Predecessor Study|Withdrawal by Subject|2|||
127589524|NCT03706079|459126726|FG005|Predecessor Study|Withdrawal by Subject|0|||
127589525|NCT03706079|459126721|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
127589526|NCT03706079|459126722|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
127589527|NCT03706079|459126723|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
127589528|NCT03706079|459126724|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
127589529|NCT03706079|459126725|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
127589530|NCT03706079|459126726|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
127589531|NCT03706079|459126721|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
127694371|NCT04402489|459510701|FG002|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|2|||
127589532|NCT03706079|459126722|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
127589533|NCT03706079|459126723|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
127589534|NCT03706079|459126724|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
127589535|NCT03706079|459126725|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
127589536|NCT03706079|459126726|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
127589537|NCT03706079|459126721|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
127589538|NCT03706079|459126722|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
127589539|NCT03706079|459126723|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
127589540|NCT03706079|459126724|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
127589541|NCT03706079|459126725|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
127589542|NCT03706079|459126726|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
127589543|NCT03706079|459126721|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
127589544|NCT03706079|459126722|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
127589545|NCT03706079|459126723|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
127589546|NCT03706079|459126724|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
127589547|NCT03706079|459126725|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
127589548|NCT03706079|459126726|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
127589549|NCT03706079|459126721|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
127589550|NCT03706079|459126722|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
127589551|NCT03706079|459126723|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
127589552|NCT03706079|459126724|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
127589553|NCT03706079|459126725|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
127589554|NCT03706079|459126726|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
127589555|NCT03706079|459126721|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
127589556|NCT03706079|459126722|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
127589557|NCT03706079|459126723|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
127589558|NCT03706079|459126724|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
127589559|NCT03706079|459126725|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
127589560|NCT03706079|459126726|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
127589561|NCT03706079|459126721|FG000|Long Term Extension (DESTINATION)|Death|8|||
127589562|NCT03706079|459126722|FG001|Long Term Extension (DESTINATION)|Death|2|||
127589563|NCT03706079|459126723|FG002|Long Term Extension (DESTINATION)|Death|2|||
127589564|NCT03706079|459126724|FG003|Long Term Extension (DESTINATION)|Death|1|||
127589565|NCT03706079|459126725|FG004|Long Term Extension (DESTINATION)|Death|0|||
127589566|NCT03706079|459126726|FG005|Long Term Extension (DESTINATION)|Death|0|||
127589567|NCT00968513|459126727|FG000|Overall Study|Death|4|||
127589568|NCT00968513|459126728|FG001|Overall Study|Death|10|||
128034069|NCT01362790|460751676|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
128034070|NCT01362790|460751677|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
128034071|NCT01362790|460751678|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
128034072|NCT01362790|460751679|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
128034073|NCT01362790|460751680|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
128034074|NCT01362790|460751681|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
127589569|NCT00968513|459126729|FG002|Overall Study|Death|15|||
127589570|NCT05379231|459126730|FG000|Home Visit|Withdrawal by Subject|2|||
127784658|NCT00262522|459837017|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
127784659|NCT00262522|459837018|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
128034075|NCT01362790|460751682|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
128034076|NCT01362790|460751676|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
128034077|NCT01362790|460751677|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
128034078|NCT01362790|460751678|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
128034079|NCT01362790|460751679|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
128034080|NCT01362790|460751680|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
128034081|NCT01362790|460751681|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
128034082|NCT01362790|460751682|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
128034083|NCT01362790|460751676|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
128034084|NCT01362790|460751677|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
128034085|NCT01362790|460751678|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
128034086|NCT01362790|460751679|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
128034087|NCT01362790|460751680|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
128034088|NCT01362790|460751681|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
128034089|NCT01362790|460751682|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
128034090|NCT01362790|460751676|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
128034091|NCT01362790|460751677|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
128034092|NCT01362790|460751678|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
128034093|NCT01362790|460751679|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
128034094|NCT01362790|460751680|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
128034095|NCT01362790|460751681|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
128034096|NCT01362790|460751682|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
128034097|NCT01362790|460751676|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
128034098|NCT01362790|460751677|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
127589571|NCT05379231|459126730|FG000|In-lab Visit|Withdrawal by Subject|2|||
127589572|NCT01203098|459126737|FG000|Overall Study|Adverse Event|3|||
127589573|NCT01203098|459126738|FG001|Overall Study|Adverse Event|1|||
127589574|NCT01203098|459126739|FG002|Overall Study|Adverse Event|7|||
128034099|NCT01362790|460751678|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
128034100|NCT01362790|460751679|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
128034101|NCT01362790|460751680|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
127589575|NCT01203098|459126737|FG000|Overall Study|Lost to Follow-up|0|||
127589576|NCT01203098|459126738|FG001|Overall Study|Lost to Follow-up|0|||
127589577|NCT01203098|459126739|FG002|Overall Study|Lost to Follow-up|1|||
127589578|NCT01203098|459126737|FG000|Overall Study|Physician Decision|2|||
127589579|NCT01203098|459126738|FG001|Overall Study|Physician Decision|2|||
127589580|NCT01203098|459126739|FG002|Overall Study|Physician Decision|0|||
127589581|NCT01203098|459126737|FG000|Overall Study|Withdrawal by Subject|1|||
127589582|NCT01203098|459126738|FG001|Overall Study|Withdrawal by Subject|1|||
127589583|NCT01203098|459126739|FG002|Overall Study|Withdrawal by Subject|3|||
127589584|NCT00730405|459126742|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
127589585|NCT00730405|459126743|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
127589586|NCT00730405|459126744|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
127589587|NCT00730405|459126745|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
127589588|NCT00730405|459126746|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
127589589|NCT00730405|459126742|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
127589590|NCT00730405|459126743|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
127589591|NCT00730405|459126744|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
127589592|NCT00730405|459126745|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
127589593|NCT00730405|459126746|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
127589594|NCT00730405|459126742|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
127589595|NCT00730405|459126743|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
127589596|NCT00730405|459126744|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
127589597|NCT00730405|459126745|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
127589598|NCT00730405|459126746|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
127589599|NCT00730405|459126742|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
127589600|NCT00730405|459126743|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
127589601|NCT00730405|459126744|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
127589602|NCT00730405|459126745|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
127589603|NCT00730405|459126746|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
127589604|NCT00730405|459126742|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
127589605|NCT00730405|459126743|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
127589606|NCT00730405|459126744|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
127589607|NCT00730405|459126745|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
127589608|NCT00730405|459126746|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
127589609|NCT00730405|459126742|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
127589610|NCT00730405|459126743|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
127589611|NCT00730405|459126744|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
127589612|NCT00730405|459126745|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
127589613|NCT00730405|459126746|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
127589614|NCT00730405|459126742|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
127589615|NCT00730405|459126743|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
127589616|NCT00730405|459126744|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
127589617|NCT00730405|459126745|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
127589618|NCT00730405|459126746|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
127589619|NCT00730405|459126742|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
127589620|NCT00730405|459126743|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
127589621|NCT00730405|459126744|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
127589622|NCT00730405|459126745|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
127589623|NCT00730405|459126746|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
127589624|NCT00730405|459126742|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
127589625|NCT00730405|459126743|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
127589626|NCT00730405|459126744|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
127589627|NCT00730405|459126745|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
127589628|NCT00730405|459126746|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
127589629|NCT00730405|459126742|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
127589630|NCT00730405|459126743|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
127589631|NCT00730405|459126744|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
127589632|NCT00730405|459126745|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
127589633|NCT00730405|459126746|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
127589634|NCT00730405|459126742|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
127589635|NCT00730405|459126743|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
127589636|NCT00730405|459126744|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
127589637|NCT00730405|459126745|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
127589638|NCT00730405|459126746|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
127589639|NCT00730405|459126742|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
127589640|NCT00730405|459126743|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
127589641|NCT00730405|459126744|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
127589642|NCT00730405|459126745|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
127589643|NCT00730405|459126746|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
127589644|NCT00730405|459126742|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
127589645|NCT00730405|459126743|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
127589646|NCT00730405|459126744|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
127589647|NCT00730405|459126745|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
127589648|NCT00730405|459126746|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
127589649|NCT00730405|459126742|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
127589650|NCT00730405|459126743|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
127589651|NCT00730405|459126744|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
127589652|NCT00730405|459126745|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
127589653|NCT00730405|459126746|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
127589654|NCT00730405|459126742|FG000|Overall Study-Treatment Phase|Change of location|0|||
127589655|NCT00730405|459126743|FG001|Overall Study-Treatment Phase|Change of location|0|||
127589656|NCT00730405|459126744|FG002|Overall Study-Treatment Phase|Change of location|0|||
127589657|NCT00730405|459126745|FG003|Overall Study-Treatment Phase|Change of location|1|||
127589658|NCT00730405|459126746|FG004|Overall Study-Treatment Phase|Change of location|0|||
127589659|NCT00730405|459126742|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
127589660|NCT00730405|459126743|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
127589661|NCT00730405|459126744|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
127589662|NCT00730405|459126745|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
127589663|NCT00730405|459126746|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
127589664|NCT00730405|459126742|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
127589665|NCT00730405|459126743|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
127589666|NCT00730405|459126744|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
127589667|NCT00730405|459126745|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
127589668|NCT00730405|459126746|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
127589669|NCT00730405|459126742|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
127589670|NCT00730405|459126743|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
127589671|NCT00730405|459126744|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
127589672|NCT00730405|459126745|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
127589673|NCT00730405|459126746|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
127589674|NCT00730405|459126742|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
127589675|NCT00730405|459126743|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
127589676|NCT00730405|459126744|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
127589677|NCT00730405|459126745|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
127589678|NCT00730405|459126746|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
127589679|NCT00730405|459126742|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
127589680|NCT00730405|459126743|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
127589681|NCT00730405|459126744|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
127589682|NCT00730405|459126745|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
127589683|NCT00730405|459126746|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
127589684|NCT00730405|459126742|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
127589685|NCT00730405|459126743|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
127589686|NCT00730405|459126744|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
127589687|NCT00730405|459126745|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
127589688|NCT00730405|459126746|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
127589689|NCT00730405|459126742|FG000|Overall Study-follow-up Phase|Death|0|||
127589690|NCT00730405|459126743|FG001|Overall Study-follow-up Phase|Death|1|||
127589691|NCT00730405|459126744|FG002|Overall Study-follow-up Phase|Death|0|||
127589692|NCT00730405|459126745|FG003|Overall Study-follow-up Phase|Death|1|||
127589693|NCT00730405|459126746|FG004|Overall Study-follow-up Phase|Death|0|||
127589694|NCT00730405|459126742|FG000|Overall Study-follow-up Phase|Change of location|1|||
127589695|NCT00730405|459126743|FG001|Overall Study-follow-up Phase|Change of location|1|||
127589696|NCT00730405|459126744|FG002|Overall Study-follow-up Phase|Change of location|0|||
127589697|NCT00730405|459126745|FG003|Overall Study-follow-up Phase|Change of location|1|||
127589698|NCT00730405|459126746|FG004|Overall Study-follow-up Phase|Change of location|0|||
127589699|NCT00730405|459126742|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
127589700|NCT00730405|459126743|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
127589701|NCT00730405|459126744|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
127589702|NCT00730405|459126745|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
127589703|NCT00730405|459126746|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
127589704|NCT00730405|459126742|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
127589705|NCT00730405|459126743|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
127589706|NCT00730405|459126744|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
127589707|NCT00730405|459126745|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
127589708|NCT00730405|459126746|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
127589709|NCT00730405|459126742|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
127589710|NCT00730405|459126743|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
127589711|NCT00730405|459126744|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
127589712|NCT00730405|459126745|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
127589713|NCT00730405|459126746|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
127589714|NCT00730405|459126742|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
127589715|NCT00730405|459126743|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
127589716|NCT00730405|459126744|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
127589717|NCT00730405|459126745|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
127589718|NCT00730405|459126746|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
127589719|NCT00730405|459126742|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
127589720|NCT00730405|459126743|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
127589721|NCT00730405|459126744|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
127589722|NCT00730405|459126745|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
127589723|NCT00730405|459126746|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
127589724|NCT00730405|459126742|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
127589725|NCT00730405|459126743|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
127589726|NCT00730405|459126744|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
127589727|NCT00730405|459126745|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
127589728|NCT00730405|459126746|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
127589729|NCT00730405|459126742|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
127589730|NCT00730405|459126743|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
127589731|NCT00730405|459126744|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
127589732|NCT00730405|459126745|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
127589733|NCT00730405|459126746|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
127589734|NCT00730405|459126742|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
127589735|NCT00730405|459126743|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
127589736|NCT00730405|459126744|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
127589737|NCT00730405|459126745|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
127589738|NCT00730405|459126746|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
127589739|NCT00730405|459126742|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
127589740|NCT00730405|459126743|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
127589741|NCT00730405|459126744|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
127589742|NCT00730405|459126745|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
127589743|NCT00730405|459126746|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
127589744|NCT00730405|459126742|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
127589745|NCT00730405|459126743|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
127589746|NCT00730405|459126744|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
127589747|NCT00730405|459126745|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
127589748|NCT00730405|459126746|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
127589749|NCT00730405|459126742|FG000|Overall Study-follow-up Phase|Missing|0|||
127589750|NCT00730405|459126743|FG001|Overall Study-follow-up Phase|Missing|0|||
127589751|NCT00730405|459126744|FG002|Overall Study-follow-up Phase|Missing|2|||
127589752|NCT00730405|459126745|FG003|Overall Study-follow-up Phase|Missing|0|||
127589753|NCT00730405|459126746|FG004|Overall Study-follow-up Phase|Missing|0|||
127589754|NCT00730405|459126742|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
127589755|NCT00730405|459126743|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
127589756|NCT00730405|459126744|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
127589757|NCT00730405|459126745|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
127589758|NCT00730405|459126746|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
127784660|NCT00262522|459837019|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
127784661|NCT00262522|459837016|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
127784662|NCT00262522|459837017|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
127784663|NCT00262522|459837018|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
127784664|NCT00262522|459837019|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
127784665|NCT00262522|459837016|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
127784666|NCT00262522|459837017|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
127784667|NCT00262522|459837018|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
127784668|NCT00262522|459837019|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
127784669|NCT00262522|459837016|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
127784670|NCT00262522|459837017|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
127589759|NCT00730405|459126742|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
127589760|NCT00730405|459126743|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
127589761|NCT00730405|459126744|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
127589762|NCT00730405|459126745|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
127589763|NCT00730405|459126746|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
127589764|NCT00730405|459126742|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
127589765|NCT00730405|459126743|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
127589766|NCT00730405|459126744|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
127589767|NCT00730405|459126745|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
127589768|NCT00730405|459126746|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
127694372|NCT04402489|459510702|FG003|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
127694373|NCT04402489|459510703|FG004|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
127694374|NCT05063994|459510718|FG000|Cortef Run-In|Withdrawal of Consent|1|||
127694375|NCT05063994|459510719|FG001|Cortef Run-In|Withdrawal of Consent|0|||
127589769|NCT00730405|459126742|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
127589770|NCT00730405|459126743|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
127589771|NCT00730405|459126744|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
127589772|NCT00730405|459126745|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
127589773|NCT00730405|459126746|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
127589774|NCT00730405|459126742|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
127589775|NCT00730405|459126743|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
127589776|NCT00730405|459126744|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
127589777|NCT00730405|459126745|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
127589778|NCT00730405|459126746|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
127589779|NCT00730405|459126742|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
127589780|NCT00730405|459126743|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
127589781|NCT00730405|459126744|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
127589782|NCT00730405|459126745|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
127589783|NCT00730405|459126746|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
127589784|NCT01496807|459126750|FG000|Overall Study|Progressive Disease|21|||
127589785|NCT01496807|459126750|FG000|Overall Study|Participant preference/toxicity|8|||
127589786|NCT01496807|459126750|FG000|Overall Study|Change in diagnosis|1|||
127589787|NCT02591290|459126754|FG000|Overall Study|Withdrawal by Subject|2|||
127589788|NCT00913497|459126755|FG000|Overall Study|Adverse Event|1|||
127589789|NCT00913497|459126755|FG000|Overall Study|Withdrawal by Subject|2|||
127589790|NCT02002091|459126756|FG000|Screening|Lost to Follow-up|10|||
127589791|NCT02002091|459126757|FG001|Screening|Lost to Follow-up|12|||
127589792|NCT02002091|459126756|FG000|Screening|Death|3|||
127589793|NCT02002091|459126757|FG001|Screening|Death|2|||
127589794|NCT01390649|459126758|FG000|Overall Study|Physician Decision|1|||
127589795|NCT03087643|459126760|FG000|Overall Study|Withdrawal by Subject|2|||
127589796|NCT03087643|459126761|FG001|Overall Study|Withdrawal by Subject|4|||
127589797|NCT03087643|459126760|FG000|Overall Study|Death|2|||
127589798|NCT03087643|459126761|FG001|Overall Study|Death|2|||
127589799|NCT02083783|459126765|FG000|Overall Study|Withdrawal by Subject|1|||
127589800|NCT02083783|459126766|FG001|Overall Study|Withdrawal by Subject|0|||
127589801|NCT01546883|459126769|FG000|Overall Study|Withdrawal by Subject|3|||
127589802|NCT01546883|459126769|FG000|Overall Study|Adverse Event|4|||
127589803|NCT01546883|459126769|FG000|Overall Study|Lost to Follow-up|2|||
127589804|NCT01546883|459126769|FG000|Overall Study|early closure of study|2|||
127589805|NCT01546883|459126769|FG000|Overall Study|other unrelated illness|1|||
127589806|NCT02256631|459126773|FG000|Overall Study|Lost to Follow-up|1|||
127694376|NCT05063994|459510720|FG002|Cortef Run-In|Withdrawal of Consent|0|||
127694377|NCT05063994|459510718|FG000|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|1|||
127694378|NCT05063994|459510719|FG001|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
127694379|NCT05063994|459510720|FG002|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
127694380|NCT05063994|459510718|FG000|Treatment|Physician Decision|0|||
127589807|NCT02256631|459126774|FG001|Overall Study|Lost to Follow-up|1|||
127589808|NCT02256631|459126775|FG002|Overall Study|Lost to Follow-up|0|||
127694381|NCT05063994|459510719|FG001|Treatment|Physician Decision|0|||
127694382|NCT05063994|459510720|FG002|Treatment|Physician Decision|1|||
127694383|NCT05063994|459510718|FG000|Treatment|Withdrawal by Subject|0|||
127694384|NCT05063994|459510719|FG001|Treatment|Withdrawal by Subject|0|||
127694385|NCT05063994|459510720|FG002|Treatment|Withdrawal by Subject|1|||
127589809|NCT02256631|459126776|FG003|Overall Study|Lost to Follow-up|2|||
127589810|NCT02256631|459126777|FG004|Overall Study|Lost to Follow-up|0|||
127589811|NCT02256631|459126778|FG005|Overall Study|Lost to Follow-up|4|||
127589812|NCT02256631|459126779|FG006|Overall Study|Lost to Follow-up|1|||
127589813|NCT02256631|459126773|FG000|Overall Study|Withdrawal by Subject|0|||
127589814|NCT02256631|459126774|FG001|Overall Study|Withdrawal by Subject|0|||
127589815|NCT02256631|459126775|FG002|Overall Study|Withdrawal by Subject|0|||
127589816|NCT02256631|459126776|FG003|Overall Study|Withdrawal by Subject|1|||
127589817|NCT02256631|459126777|FG004|Overall Study|Withdrawal by Subject|1|||
127589818|NCT02256631|459126778|FG005|Overall Study|Withdrawal by Subject|0|||
127589819|NCT02256631|459126779|FG006|Overall Study|Withdrawal by Subject|1|||
128034102|NCT01362790|460751681|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
128034103|NCT01362790|460751682|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
128034104|NCT01362790|460751676|FG000|Pilot Phase & Phase 2|Death on study|0|||
128034105|NCT01362790|460751677|FG001|Pilot Phase & Phase 2|Death on study|0|||
128034106|NCT01362790|460751678|FG002|Pilot Phase & Phase 2|Death on study|0|||
128034107|NCT01362790|460751679|FG003|Pilot Phase & Phase 2|Death on study|1|||
127589820|NCT02256631|459126773|FG000|Overall Study|Unable to get to clinic|0|||
127589821|NCT02256631|459126774|FG001|Overall Study|Unable to get to clinic|2|||
127589822|NCT02256631|459126775|FG002|Overall Study|Unable to get to clinic|0|||
127589823|NCT02256631|459126776|FG003|Overall Study|Unable to get to clinic|1|||
127589824|NCT02256631|459126777|FG004|Overall Study|Unable to get to clinic|0|||
127589825|NCT02256631|459126778|FG005|Overall Study|Unable to get to clinic|1|||
127589826|NCT02256631|459126779|FG006|Overall Study|Unable to get to clinic|2|||
127589827|NCT00457301|459126780|FG000|Overall Study|Withdrawal by Subject|3|||
127589828|NCT00457301|459126781|FG001|Overall Study|Withdrawal by Subject|3|||
127589829|NCT00457301|459126780|FG000|Overall Study|Censored out of the study|15|||
127589830|NCT00457301|459126781|FG001|Overall Study|Censored out of the study|14|||
127589831|NCT00457301|459126780|FG000|Overall Study|Death|5|||
127589832|NCT00457301|459126781|FG001|Overall Study|Death|7|||
127589833|NCT00001880|459126783|FG000|Overall Study|Death|14|||
127589834|NCT02657369|459126784|FG000|Overall Study|Death|27|||
127589835|NCT02657369|459126784|FG000|Overall Study|Study terminated by sponsor|7|||
127589836|NCT00361569|459126785|FG000|Overall Study|Protocol Violation|3|||
127589837|NCT00361569|459126786|FG001|Overall Study|Protocol Violation|2|||
127589838|NCT00361569|459126787|FG002|Overall Study|Protocol Violation|4|||
127589839|NCT00361569|459126788|FG003|Overall Study|Protocol Violation|2|||
127589840|NCT00361569|459126785|FG000|Overall Study|Withdrawal by Subject|2|||
127589841|NCT00361569|459126786|FG001|Overall Study|Withdrawal by Subject|1|||
127589842|NCT00361569|459126787|FG002|Overall Study|Withdrawal by Subject|9|||
127589843|NCT00361569|459126788|FG003|Overall Study|Withdrawal by Subject|14|||
127589844|NCT00361569|459126785|FG000|Overall Study|Adverse Event|3|||
127589845|NCT00361569|459126786|FG001|Overall Study|Adverse Event|5|||
127589846|NCT00361569|459126787|FG002|Overall Study|Adverse Event|2|||
127589847|NCT00361569|459126788|FG003|Overall Study|Adverse Event|2|||
127589848|NCT00361569|459126785|FG000|Overall Study|Lost to Follow-up|2|||
127589849|NCT00361569|459126786|FG001|Overall Study|Lost to Follow-up|3|||
127589850|NCT00361569|459126787|FG002|Overall Study|Lost to Follow-up|3|||
127589851|NCT00361569|459126788|FG003|Overall Study|Lost to Follow-up|2|||
127589852|NCT00361569|459126785|FG000|Overall Study|Not specified by investigator|2|||
127589853|NCT00361569|459126786|FG001|Overall Study|Not specified by investigator|0|||
127589854|NCT00361569|459126787|FG002|Overall Study|Not specified by investigator|0|||
127589855|NCT00361569|459126788|FG003|Overall Study|Not specified by investigator|1|||
127589856|NCT04094883|459126789|FG000|Overall Study|Withdrawal by Subject|1|||
127589857|NCT01063868|459126790|FG000|Overall Study|Adverse Event|9|||
127589858|NCT01063868|459126791|FG001|Overall Study|Adverse Event|7|||
127589859|NCT01063868|459126790|FG000|Overall Study|Withdrawal by Subject|3|||
127589860|NCT01063868|459126791|FG001|Overall Study|Withdrawal by Subject|1|||
127589861|NCT01063868|459126790|FG000|Overall Study|Study Terminated By Sponsor|23|||
127589862|NCT01063868|459126791|FG001|Overall Study|Study Terminated By Sponsor|4|||
127589863|NCT03307967|459126794|FG000|Overall Study|Lost to Follow-up|4|||
127589864|NCT02578316|459126795|FG000|Extension Phase|Progression of disease|6|||
127589865|NCT05372419|459126796|FG000|Overall Study|Protocol Deviation|1|||
127589866|NCT05372419|459126796|FG000|Overall Study|Withdrawal by Subject|5|||
127589867|NCT05372419|459126796|FG000|Overall Study|Lost to Follow-up|7|||
127589868|NCT04362072|459126800|FG000|Treatment|Adverse Event|1|||
127694386|NCT05063994|459510718|FG000|Treatment|Withdrawal of Consent|0|||
128034108|NCT01362790|460751680|FG004|Pilot Phase & Phase 2|Death on study|0|||
127589869|NCT04362072|459126800|FG000|Treatment|Death|9|||
127694387|NCT05063994|459510719|FG001|Treatment|Withdrawal of Consent|0|||
128034109|NCT01362790|460751681|FG005|Pilot Phase & Phase 2|Death on study|0|||
127589870|NCT04362072|459126800|FG000|Treatment|Physician Decision|2|||
127589871|NCT04362072|459126800|FG000|Treatment|Progressive disease|27|||
127589872|NCT04362072|459126800|FG000|Treatment|Withdrawal by Subject|4|||
127589873|NCT04362072|459126800|FG000|Treatment|Global deterioration of health status|1|||
127589874|NCT04362072|459126800|FG000|Treatment|Switched to commercial Lorlatinib|13|||
127589875|NCT04362072|459126800|FG000|Treatment|Entered Lorlatinib continuation Study|11|||
127589876|NCT04362072|459126800|FG000|Treatment|Other|3|||
127589877|NCT04362072|459126800|FG000|Follow up|Death|2|||
127589878|NCT04362072|459126800|FG000|Follow up|Other|2|||
127589879|NCT01133522|459126801|FG000|Overall Study|Withdrawal by Subject|0|||
127589880|NCT01133522|459126802|FG001|Overall Study|Withdrawal by Subject|1|||
127589881|NCT01133522|459126803|FG002|Overall Study|Withdrawal by Subject|0|||
127694388|NCT05063994|459510720|FG002|Treatment|Withdrawal of Consent|1|||
127589882|NCT01133522|459126804|FG003|Overall Study|Withdrawal by Subject|1|||
127589883|NCT01133522|459126805|FG004|Overall Study|Withdrawal by Subject|0|||
127589884|NCT01133522|459126806|FG005|Overall Study|Withdrawal by Subject|0|||
127589885|NCT01133522|459126807|FG006|Overall Study|Withdrawal by Subject|0|||
127589886|NCT01133522|459126808|FG007|Overall Study|Withdrawal by Subject|0|||
127589887|NCT01133522|459126809|FG008|Overall Study|Withdrawal by Subject|0|||
127589888|NCT01133522|459126810|FG009|Overall Study|Withdrawal by Subject|0|||
127589889|NCT01133522|459126801|FG000|Overall Study|Physician Decision|0|||
127589890|NCT01133522|459126802|FG001|Overall Study|Physician Decision|0|||
127589891|NCT01133522|459126803|FG002|Overall Study|Physician Decision|0|||
127589892|NCT01133522|459126804|FG003|Overall Study|Physician Decision|0|||
127589893|NCT01133522|459126805|FG004|Overall Study|Physician Decision|1|||
127589894|NCT01133522|459126806|FG005|Overall Study|Physician Decision|0|||
127589895|NCT01133522|459126807|FG006|Overall Study|Physician Decision|0|||
127589896|NCT01133522|459126808|FG007|Overall Study|Physician Decision|0|||
127589897|NCT01133522|459126809|FG008|Overall Study|Physician Decision|0|||
127589898|NCT01133522|459126810|FG009|Overall Study|Physician Decision|0|||
127589899|NCT00381485|459128909|FG000|Open-Label Run-In Period|Adverse Event|9|||
127589900|NCT00381485|459128910|FG001|Open-Label Run-In Period|Adverse Event|0|||
127589901|NCT00381485|459128911|FG002|Open-Label Run-In Period|Adverse Event|0|||
127589902|NCT00381485|459128912|FG003|Open-Label Run-In Period|Adverse Event|0|||
127589903|NCT00381485|459128909|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
127589904|NCT00381485|459128910|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
127589905|NCT00381485|459128911|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
127589906|NCT00381485|459128912|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
127589907|NCT00381485|459128909|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
127694389|NCT01180634|459510722|FG000|Overall Study|Adverse Event|4|||
127589908|NCT00381485|459128910|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
127589909|NCT00381485|459128911|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
127589910|NCT00381485|459128912|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
127589911|NCT00381485|459128909|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
127589912|NCT00381485|459128910|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
127589913|NCT00381485|459128911|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
127589914|NCT00381485|459128912|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
127589915|NCT00381485|459128909|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
127589916|NCT00381485|459128910|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
128034110|NCT01362790|460751682|FG006|Pilot Phase & Phase 2|Death on study|0|||
128034111|NCT01362790|460751676|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
128034112|NCT01362790|460751677|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
128034113|NCT01362790|460751678|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
128034114|NCT01362790|460751679|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
128034115|NCT01362790|460751680|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
128034116|NCT01362790|460751681|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
128034117|NCT01362790|460751682|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
128034118|NCT01362790|460751676|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
128034119|NCT01362790|460751677|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
128034120|NCT01362790|460751678|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
128034121|NCT01362790|460751679|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
128034122|NCT01362790|460751680|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
128034123|NCT01362790|460751681|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
128034124|NCT01362790|460751682|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
128034125|NCT01362790|460751676|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
127589917|NCT00381485|459128911|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
127589918|NCT00381485|459128912|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
127694390|NCT01180634|459510723|FG001|Overall Study|Adverse Event|1|||
127589919|NCT00381485|459128909|FG000|Open-Label Run-In Period|Treatment failure|1|||
127589920|NCT00381485|459128910|FG001|Open-Label Run-In Period|Treatment failure|0|||
127589921|NCT00381485|459128911|FG002|Open-Label Run-In Period|Treatment failure|0|||
128034126|NCT01362790|460751677|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
128034127|NCT01362790|460751678|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
128034128|NCT01362790|460751679|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
128034129|NCT01362790|460751680|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
128034130|NCT01362790|460751681|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
128034131|NCT01362790|460751682|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
128034132|NCT02457065|460751683|FG000|Overall Study|Lost to Follow-up|9|||
127694391|NCT01180634|459510722|FG000|Overall Study|Miscellaneous|2|||
127589922|NCT00381485|459128912|FG003|Open-Label Run-In Period|Treatment failure|0|||
127589923|NCT00381485|459128909|FG000|Double-Blind Treatment Period|Adverse Event|0|||
127589924|NCT00381485|459128910|FG001|Double-Blind Treatment Period|Adverse Event|2|||
127694392|NCT01180634|459510723|FG001|Overall Study|Miscellaneous|0|||
128034133|NCT02457065|460751684|FG001|Overall Study|Lost to Follow-up|11|||
128034134|NCT01506726|460751691|FG000|Overall Study|Adverse Event|1|||
128034135|NCT01506726|460751692|FG001|Overall Study|Adverse Event|2|||
128034136|NCT04347538|460751696|FG000|Overall Study|Lost to Follow-up|4|||
128034137|NCT04347538|460751697|FG001|Overall Study|Lost to Follow-up|5|||
127589925|NCT00381485|459128911|FG002|Double-Blind Treatment Period|Adverse Event|2|||
127589926|NCT00381485|459128912|FG003|Double-Blind Treatment Period|Adverse Event|5|||
128034138|NCT04347538|460751698|FG002|Overall Study|Lost to Follow-up|7|||
128034139|NCT02135133|460751699|FG000|Overall Study|Adverse Event|10|||
128034140|NCT02135133|460751699|FG000|Overall Study|regulatory mandate|5|||
128034141|NCT05081843|460751700|FG000|Overall Study|Lost to Follow-up|135|||
128034142|NCT05081843|460751701|FG001|Overall Study|Lost to Follow-up|145|||
128034143|NCT02303821|460751702|FG000|Overall Study|Withdrawal by Subject|0|||
128034144|NCT02303821|460751703|FG001|Overall Study|Withdrawal by Subject|0|||
128034145|NCT02303821|460751704|FG002|Overall Study|Withdrawal by Subject|0|||
128034146|NCT02303821|460751705|FG003|Overall Study|Withdrawal by Subject|0|||
128034147|NCT02303821|460751706|FG004|Overall Study|Withdrawal by Subject|0|||
127589927|NCT00381485|459128909|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
127589928|NCT00381485|459128910|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
127589929|NCT00381485|459128911|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
127589930|NCT00381485|459128912|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
127589931|NCT00381485|459128909|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
127589932|NCT00381485|459128910|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
127589933|NCT00381485|459128911|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
127589934|NCT00381485|459128912|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
127589935|NCT00381485|459128909|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
127589936|NCT00381485|459128910|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
127589937|NCT00381485|459128911|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
127589938|NCT00381485|459128912|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
127589939|NCT00381485|459128909|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
127589940|NCT00381485|459128910|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
127589941|NCT00381485|459128911|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
127589942|NCT00381485|459128912|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
127589943|NCT00381485|459128909|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
127589944|NCT00381485|459128910|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
127589945|NCT00381485|459128911|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
127589946|NCT00381485|459128912|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
127589947|NCT00381485|459128909|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
127589948|NCT00381485|459128910|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
127589949|NCT00381485|459128911|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
127589950|NCT00381485|459128912|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
127589951|NCT00381485|459128909|FG000|Double-Blind Treatment Period|Administrative|0|||
127589952|NCT00381485|459128910|FG001|Double-Blind Treatment Period|Administrative|1|||
127589953|NCT00381485|459128911|FG002|Double-Blind Treatment Period|Administrative|0|||
127589954|NCT00381485|459128912|FG003|Double-Blind Treatment Period|Administrative|1|||
128034148|NCT02303821|460751707|FG005|Overall Study|Withdrawal by Subject|0|||
128034149|NCT02303821|460751708|FG006|Overall Study|Withdrawal by Subject|0|||
128034150|NCT02303821|460751709|FG007|Overall Study|Withdrawal by Subject|2|||
128034151|NCT02303821|460751702|FG000|Overall Study|Death|0|||
127589955|NCT01235351|459128913|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
127589956|NCT01235351|459128914|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
127589957|NCT01898806|459128918|FG000|Overall Study|Withdrawal by Subject|2|||
127589958|NCT01898806|459128918|FG000|Overall Study|Physician Decision|1|||
127589959|NCT00126191|459128919|FG000|Overall Study|Physician Decision|0|||
127589960|NCT00126191|459128920|FG001|Overall Study|Physician Decision|1|||
127589961|NCT00126191|459128919|FG000|Overall Study|Death|0|||
127589962|NCT00126191|459128920|FG001|Overall Study|Death|1|||
127589963|NCT01648101|459128921|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
127589964|NCT01648101|459128922|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
127589965|NCT01648101|459128923|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
127589966|NCT01648101|459128921|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
127589967|NCT01648101|459128922|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
128034152|NCT02303821|460751703|FG001|Overall Study|Death|2|||
128034153|NCT02303821|460751704|FG002|Overall Study|Death|0|||
128034154|NCT02303821|460751705|FG003|Overall Study|Death|0|||
128034155|NCT02303821|460751706|FG004|Overall Study|Death|0|||
127589968|NCT01648101|459128923|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
128034156|NCT02303821|460751707|FG005|Overall Study|Death|3|||
127589969|NCT01648101|459128921|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
127589970|NCT01648101|459128922|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
127589971|NCT01648101|459128923|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
127589972|NCT01648101|459128921|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
127589973|NCT01648101|459128922|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
127589974|NCT01648101|459128923|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
127589975|NCT01648101|459128921|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
127589976|NCT01648101|459128922|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
127589977|NCT01648101|459128923|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
127589978|NCT01648101|459128921|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
127589979|NCT01648101|459128922|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
127589980|NCT01648101|459128923|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
127589981|NCT01648101|459128921|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
127589982|NCT01648101|459128922|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
127589983|NCT01648101|459128923|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
127589984|NCT01648101|459128921|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
127589985|NCT01648101|459128922|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
127589986|NCT01648101|459128923|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
127589987|NCT01648101|459128921|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
127589988|NCT01648101|459128922|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
127589989|NCT01648101|459128923|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
127589990|NCT01648101|459128921|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
127589991|NCT01648101|459128922|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
127589992|NCT01648101|459128923|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
128034157|NCT02303821|460751708|FG006|Overall Study|Death|41|||
128034158|NCT02303821|460751709|FG007|Overall Study|Death|29|||
128034159|NCT02303821|460751702|FG000|Overall Study|Lost to Follow-up|0|||
128034160|NCT02303821|460751703|FG001|Overall Study|Lost to Follow-up|0|||
127589993|NCT01648101|459128921|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
127589994|NCT01648101|459128922|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
127589995|NCT01648101|459128923|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
127589996|NCT03003390|459128924|FG000|Overall Study|Physician Decision|2|||
127589997|NCT03003390|459128925|FG001|Overall Study|Physician Decision|0|||
127589998|NCT03003390|459128924|FG000|Overall Study|Parent refused intervention|2|||
127589999|NCT03003390|459128925|FG001|Overall Study|Parent refused intervention|0|||
127590000|NCT00307294|459128941|FG000|Overall Study|Withdrawal by Subject|1|||
127590001|NCT01581931|459128946|FG000|Washout|Adverse Event|0|||
127590002|NCT01581931|459128947|FG001|Washout|Adverse Event|1|||
127590003|NCT02954237|459128948|FG000|Overall Study|Withdrawal by Subject|25|||
127590004|NCT02954237|459128948|FG000|Overall Study|Missed visit|16|||
127590005|NCT02954237|459128948|FG000|Overall Study|Death|2|||
127590006|NCT00590720|459128956|FG000|Overall Study|Lost to Follow-up|1|||
127590007|NCT00590720|459128957|FG001|Overall Study|Lost to Follow-up|0|||
127590008|NCT00590720|459128956|FG000|Overall Study|Withdrawal by Subject|0|||
127590009|NCT00590720|459128957|FG001|Overall Study|Withdrawal by Subject|1|||
127590010|NCT01001377|459128958|FG000|Overall Study|Ineligibility determined|2|||
127590011|NCT01001377|459128959|FG001|Overall Study|Ineligibility determined|0|||
127590012|NCT01001377|459128958|FG000|Overall Study|Withdrawal by Subject|19|||
127590013|NCT01001377|459128959|FG001|Overall Study|Withdrawal by Subject|20|||
127590014|NCT01001377|459128958|FG000|Overall Study|Lost to Follow-up|14|||
127590015|NCT01001377|459128959|FG001|Overall Study|Lost to Follow-up|17|||
127590016|NCT01001377|459128958|FG000|Overall Study|Death|391|||
127590017|NCT01001377|459128959|FG001|Overall Study|Death|384|||
127590018|NCT03616600|459128960|FG000|Overall Study|Withdrawal by Subject|1|||
127590019|NCT03616600|459128961|FG001|Overall Study|Withdrawal by Subject|0|||
127590020|NCT01651039|459128962|FG000|Overall Study|Non-evaluables|5|||
127590021|NCT01651039|459128962|FG000|Overall Study|Physician Decision|2|||
127590022|NCT01651039|459128962|FG000|Overall Study|Withdrawal by Subject|1|||
127590023|NCT01651039|459128962|FG000|Overall Study|Progressive Disease|22|||
127590024|NCT04930965|459128965|FG000|Overall Study|Lost to Follow-up|7|||
127590025|NCT04930965|459128966|FG001|Overall Study|Lost to Follow-up|5|||
127590026|NCT00134082|459128967|FG000|Overall Study|Adverse Event|2|||
127590027|NCT00134082|459128967|FG000|Overall Study|Death|1|||
127590028|NCT02849678|459128968|FG000|Overall Study|Protocol Violation|3|||
127590029|NCT02849678|459128969|FG001|Overall Study|Protocol Violation|6|||
128034161|NCT02303821|460751704|FG002|Overall Study|Lost to Follow-up|0|||
127590030|NCT01471171|459128970|FG000|Treatment Period 1|Adverse Event|4|||
127590031|NCT01471171|459128971|FG001|Treatment Period 1|Adverse Event|1|||
128034162|NCT02303821|460751705|FG003|Overall Study|Lost to Follow-up|0|||
127590032|NCT01471171|459128970|FG000|Treatment Period 2|Adverse Event|1|||
127590033|NCT01471171|459128971|FG001|Treatment Period 2|Adverse Event|0|||
127590034|NCT03478930|459128972|FG000|Overall Study|Adverse Event|0|||
127590035|NCT03478930|459128973|FG001|Overall Study|Adverse Event|1|||
127590036|NCT03478930|459128972|FG000|Overall Study|Lack of Efficacy|3|||
127590037|NCT03478930|459128973|FG001|Overall Study|Lack of Efficacy|3|||
127590038|NCT03478930|459128972|FG000|Overall Study|Withdrawal by Subject|6|||
127590039|NCT03478930|459128973|FG001|Overall Study|Withdrawal by Subject|5|||
127590040|NCT00705484|459128976|FG000|Overall Study|Adverse Event|28|||
127590041|NCT00705484|459128977|FG001|Overall Study|Adverse Event|27|||
127590042|NCT00705484|459128976|FG000|Overall Study|Lost to Follow-up|169|||
127590043|NCT00705484|459128977|FG001|Overall Study|Lost to Follow-up|250|||
127590044|NCT00705484|459128976|FG000|Overall Study|Withdrawal by Subject|96|||
127590045|NCT00705484|459128977|FG001|Overall Study|Withdrawal by Subject|72|||
127590046|NCT00705484|459128976|FG000|Overall Study|Administrative|89|||
127590047|NCT00705484|459128977|FG001|Overall Study|Administrative|59|||
127590048|NCT03982368|459128982|FG000|Overall Study|Adverse Event|6|||
127590049|NCT03982368|459128983|FG001|Overall Study|Adverse Event|4|||
127590050|NCT03982368|459128984|FG002|Overall Study|Adverse Event|3|||
127590051|NCT03982368|459128982|FG000|Overall Study|Lost to Follow-up|2|||
127590052|NCT03982368|459128983|FG001|Overall Study|Lost to Follow-up|1|||
127590053|NCT03982368|459128984|FG002|Overall Study|Lost to Follow-up|0|||
127590054|NCT03982368|459128982|FG000|Overall Study|Withdrawal by Subject|1|||
127590055|NCT03982368|459128983|FG001|Overall Study|Withdrawal by Subject|2|||
127590056|NCT03982368|459128984|FG002|Overall Study|Withdrawal by Subject|0|||
127590057|NCT03982368|459128982|FG000|Overall Study|unknow|4|||
127590058|NCT03982368|459128983|FG001|Overall Study|unknow|0|||
127590059|NCT03982368|459128984|FG002|Overall Study|unknow|2|||
127590060|NCT00329238|459128985|FG000|Overall Study|Adverse Event|147|||
127590061|NCT00329238|459128986|FG001|Overall Study|Adverse Event|129|||
127590062|NCT00329238|459128985|FG000|Overall Study|Protocol Violation|23|||
127590063|NCT00329238|459128986|FG001|Overall Study|Protocol Violation|34|||
127590064|NCT00329238|459128985|FG000|Overall Study|Lost to Follow-up|2|||
127590065|NCT00329238|459128986|FG001|Overall Study|Lost to Follow-up|6|||
127590066|NCT00329238|459128985|FG000|Overall Study|Withdrawal by Subject|64|||
127590067|NCT00329238|459128986|FG001|Overall Study|Withdrawal by Subject|58|||
127590068|NCT00329238|459128985|FG000|Overall Study|Other reason (not specified)|40|||
127590069|NCT00329238|459128986|FG001|Overall Study|Other reason (not specified)|54|||
127590070|NCT05393895|459128989|FG000|Overall Study|Adverse Event|2|||
127590071|NCT05393895|459128990|FG001|Overall Study|Adverse Event|3|||
127590072|NCT05393895|459128989|FG000|Overall Study|Lost to Follow-up|4|||
127590073|NCT05393895|459128990|FG001|Overall Study|Lost to Follow-up|3|||
127590074|NCT05393895|459128989|FG000|Overall Study|Protocol Violation|1|||
127590075|NCT05393895|459128990|FG001|Overall Study|Protocol Violation|0|||
127590076|NCT05393895|459128989|FG000|Overall Study|Withdrawal by Subject|1|||
127590077|NCT05393895|459128990|FG001|Overall Study|Withdrawal by Subject|4|||
127590078|NCT05537883|459128993|FG000|Overall Study|revisional surgery|4|||
127590079|NCT05537883|459128994|FG001|Overall Study|revisional surgery|2|||
127590080|NCT05537883|459128993|FG000|Overall Study|surgeries were cancelled|0|||
127590081|NCT05537883|459128994|FG001|Overall Study|surgeries were cancelled|2|||
127590082|NCT05537883|459128993|FG000|Overall Study|not being compliant with the Seamless MD app|31|||
127590083|NCT05537883|459128994|FG001|Overall Study|not being compliant with the Seamless MD app|30|||
127590084|NCT01302834|459128995|FG000|Overall Study|Protocol Violation|17|||
127590085|NCT01302834|459128996|FG001|Overall Study|Protocol Violation|23|||
127590086|NCT01302834|459128995|FG000|Overall Study|HIV positive|1|||
127590087|NCT01302834|459128996|FG001|Overall Study|HIV positive|3|||
127590088|NCT01328431|459128997|FG000|Baseline|Protocol Violation|0|||
127590089|NCT01328431|459128998|FG001|Baseline|Protocol Violation|2|||
127590090|NCT01328431|459128997|FG000|1 Month (1M)|Lost to Follow-up|55|||
127590091|NCT01328431|459128998|FG001|1 Month (1M)|Lost to Follow-up|58|||
127590092|NCT01328431|459128997|FG000|3 Month (3M)|Death|2|||
127590093|NCT01328431|459128998|FG001|3 Month (3M)|Death|2|||
127590094|NCT01328431|459128997|FG000|3 Month (3M)|Lost to Follow-up|75|||
127590095|NCT01328431|459128998|FG001|3 Month (3M)|Lost to Follow-up|70|||
127590096|NCT01328431|459128997|FG000|12 Month (12M)|Death|2|||
127590097|NCT01328431|459128998|FG001|12 Month (12M)|Death|6|||
127590098|NCT01328431|459128997|FG000|12 Month (12M)|Lost to Follow-up|82|||
127590099|NCT01328431|459128998|FG001|12 Month (12M)|Lost to Follow-up|91|||
127590100|NCT02296320|459129003|FG000|Overall Study|Withdrawal by Subject|4|||
127590101|NCT02296320|459129004|FG001|Overall Study|Withdrawal by Subject|0|||
127590102|NCT02296320|459129005|FG002|Overall Study|Withdrawal by Subject|2|||
127590103|NCT02296320|459129003|FG000|Overall Study|Death|24|||
127590104|NCT02296320|459129004|FG001|Overall Study|Death|3|||
127590105|NCT02296320|459129005|FG002|Overall Study|Death|27|||
127590106|NCT02296320|459129003|FG000|Overall Study|Lost to Follow-up|5|||
127590107|NCT02296320|459129004|FG001|Overall Study|Lost to Follow-up|2|||
127590108|NCT02296320|459129005|FG002|Overall Study|Lost to Follow-up|7|||
127590109|NCT02296320|459129003|FG000|Overall Study|Not treated|2|||
127590110|NCT02296320|459129004|FG001|Overall Study|Not treated|0|||
127590111|NCT02296320|459129005|FG002|Overall Study|Not treated|0|||
127590112|NCT02296320|459129003|FG000|Overall Study|Not - specified|0|||
127590113|NCT02296320|459129004|FG001|Overall Study|Not - specified|0|||
127590114|NCT02296320|459129005|FG002|Overall Study|Not - specified|1|||
127590115|NCT03310021|459129009|FG000|Overall Study|Withdrawal by Subject|0|||
127590116|NCT03310021|459129010|FG001|Overall Study|Withdrawal by Subject|0|||
127590117|NCT03310021|459129011|FG002|Overall Study|Withdrawal by Subject|0|||
127590118|NCT03310021|459129012|FG003|Overall Study|Withdrawal by Subject|0|||
127590119|NCT03310021|459129013|FG004|Overall Study|Withdrawal by Subject|0|||
127590120|NCT03310021|459129014|FG005|Overall Study|Withdrawal by Subject|0|||
127590121|NCT03310021|459129015|FG006|Overall Study|Withdrawal by Subject|1|||
127590122|NCT03310021|459129016|FG007|Overall Study|Withdrawal by Subject|0|||
127590123|NCT03310021|459129017|FG008|Overall Study|Withdrawal by Subject|0|||
127590124|NCT03310021|459129018|FG009|Overall Study|Withdrawal by Subject|0|||
127590125|NCT03310021|459129019|FG010|Overall Study|Withdrawal by Subject|0|||
127590126|NCT03310021|459129020|FG011|Overall Study|Withdrawal by Subject|0|||
127590127|NCT03310021|459129021|FG012|Overall Study|Withdrawal by Subject|0|||
127590128|NCT03310021|459129022|FG013|Overall Study|Withdrawal by Subject|0|||
127590129|NCT03310021|459129023|FG014|Overall Study|Withdrawal by Subject|0|||
127590130|NCT03310021|459129024|FG015|Overall Study|Withdrawal by Subject|0|||
127590131|NCT03310021|459129025|FG016|Overall Study|Withdrawal by Subject|0|||
127590132|NCT03310021|459129026|FG017|Overall Study|Withdrawal by Subject|0|||
127590133|NCT03310021|459129027|FG018|Overall Study|Withdrawal by Subject|0|||
127590134|NCT03310021|459129028|FG019|Overall Study|Withdrawal by Subject|0|||
127590135|NCT03310021|459129009|FG000|Overall Study|Lost to Follow-up|0|||
127590136|NCT03310021|459129010|FG001|Overall Study|Lost to Follow-up|0|||
127590137|NCT03310021|459129011|FG002|Overall Study|Lost to Follow-up|0|||
127590138|NCT03310021|459129012|FG003|Overall Study|Lost to Follow-up|0|||
127590139|NCT03310021|459129013|FG004|Overall Study|Lost to Follow-up|0|||
127590140|NCT03310021|459129014|FG005|Overall Study|Lost to Follow-up|0|||
127590141|NCT03310021|459129015|FG006|Overall Study|Lost to Follow-up|0|||
127590142|NCT03310021|459129016|FG007|Overall Study|Lost to Follow-up|0|||
127590143|NCT03310021|459129017|FG008|Overall Study|Lost to Follow-up|0|||
127590144|NCT03310021|459129018|FG009|Overall Study|Lost to Follow-up|0|||
127590145|NCT03310021|459129019|FG010|Overall Study|Lost to Follow-up|1|||
127590146|NCT03310021|459129020|FG011|Overall Study|Lost to Follow-up|0|||
127590147|NCT03310021|459129021|FG012|Overall Study|Lost to Follow-up|0|||
127590148|NCT03310021|459129022|FG013|Overall Study|Lost to Follow-up|0|||
127590149|NCT03310021|459129023|FG014|Overall Study|Lost to Follow-up|0|||
127590150|NCT03310021|459129024|FG015|Overall Study|Lost to Follow-up|0|||
127590151|NCT03310021|459129025|FG016|Overall Study|Lost to Follow-up|0|||
127590152|NCT03310021|459129026|FG017|Overall Study|Lost to Follow-up|0|||
127590153|NCT03310021|459129027|FG018|Overall Study|Lost to Follow-up|0|||
127590154|NCT03310021|459129028|FG019|Overall Study|Lost to Follow-up|0|||
127590155|NCT01427972|459129029|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
127590156|NCT01427972|459129030|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
127590157|NCT01427972|459129031|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
127590158|NCT01427972|459129032|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
127590159|NCT01427972|459129033|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
127590160|NCT01427972|459129034|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
127590161|NCT01427972|459129035|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
127590162|NCT01427972|459129036|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
127590163|NCT01427972|459129037|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
127590164|NCT01427972|459129038|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
127590165|NCT01427972|459129039|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
127590166|NCT01427972|459129040|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
127590167|NCT01427972|459129029|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
127590168|NCT01427972|459129030|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
127590169|NCT01427972|459129031|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
127590170|NCT01427972|459129032|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
127590171|NCT01427972|459129033|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
127590172|NCT01427972|459129034|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
127590173|NCT01427972|459129035|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
127590174|NCT01427972|459129036|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
127590175|NCT01427972|459129037|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
127590176|NCT01427972|459129038|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
127590177|NCT01427972|459129039|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
127590178|NCT01427972|459129040|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
127590179|NCT01427972|459129029|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
127882053|NCT01289990|460190796|FG003|Overall Study|Withdrawal by Subject|13|||
127882054|NCT01289990|460190797|FG004|Overall Study|Withdrawal by Subject|8|||
127882055|NCT01289990|460190798|FG005|Overall Study|Withdrawal by Subject|7|||
127590180|NCT01427972|459129030|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
127590181|NCT01427972|459129031|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
127590182|NCT01427972|459129032|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
127590183|NCT01427972|459129033|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
127590184|NCT01427972|459129034|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
127590185|NCT01427972|459129035|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
127590186|NCT01427972|459129036|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
127590187|NCT01427972|459129037|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
127590188|NCT01427972|459129038|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
127590189|NCT01427972|459129039|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
127590190|NCT01427972|459129040|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
127590191|NCT00530946|459129041|FG000|Overall Study|Adverse Event|1|||
127590192|NCT00530946|459129042|FG001|Overall Study|Adverse Event|2|||
127590193|NCT00530946|459129043|FG002|Overall Study|Adverse Event|1|||
127590194|NCT00530946|459129044|FG003|Overall Study|Adverse Event|1|||
127590195|NCT00530946|459129041|FG000|Overall Study|Protocol Violation|0|||
127590196|NCT00530946|459129042|FG001|Overall Study|Protocol Violation|0|||
127590197|NCT00530946|459129043|FG002|Overall Study|Protocol Violation|0|||
127590198|NCT00530946|459129044|FG003|Overall Study|Protocol Violation|1|||
127590199|NCT00530946|459129041|FG000|Overall Study|Noncompliance|1|||
127590200|NCT00530946|459129042|FG001|Overall Study|Noncompliance|0|||
127590201|NCT00530946|459129043|FG002|Overall Study|Noncompliance|0|||
127590202|NCT00530946|459129044|FG003|Overall Study|Noncompliance|0|||
127590203|NCT00622284|459129045|FG000|Overall Study|Lack of Efficacy|45|||
127590204|NCT00622284|459129046|FG001|Overall Study|Lack of Efficacy|15|||
127590205|NCT00622284|459129045|FG000|Overall Study|Adverse Event|61|||
127590206|NCT00622284|459129046|FG001|Overall Study|Adverse Event|90|||
127590207|NCT00622284|459129045|FG000|Overall Study|Protocol Violation|12|||
127590208|NCT00622284|459129046|FG001|Overall Study|Protocol Violation|5|||
127590209|NCT00622284|459129045|FG000|Overall Study|Lost to Follow-up|11|||
127590210|NCT00622284|459129046|FG001|Overall Study|Lost to Follow-up|13|||
127590211|NCT00622284|459129045|FG000|Overall Study|Withdrawal by Subject|27|||
127590212|NCT00622284|459129046|FG001|Overall Study|Withdrawal by Subject|24|||
127590213|NCT00622284|459129045|FG000|Overall Study|Other reason (not specified)|33|||
127590214|NCT00622284|459129046|FG001|Overall Study|Other reason (not specified)|24|||
127590215|NCT00880009|459129051|FG000|Overall Study|Study terminated by sponsor|14|||
127590216|NCT00880009|459129051|FG000|Overall Study|Withdrawal by Subject|1|||
127590217|NCT00880009|459129051|FG000|Overall Study|Protocol Violation|1|||
127590218|NCT03322631|459129054|FG000|Overall Study|Withdrawal by Subject|0|||
127590219|NCT03322631|459129055|FG001|Overall Study|Withdrawal by Subject|1|||
127590220|NCT03322631|459129056|FG002|Overall Study|Withdrawal by Subject|0|||
127590221|NCT03322631|459129057|FG003|Overall Study|Withdrawal by Subject|0|||
127590222|NCT03322631|459129054|FG000|Overall Study|Adverse Event|0|||
127590223|NCT03322631|459129055|FG001|Overall Study|Adverse Event|0|||
127590224|NCT03322631|459129056|FG002|Overall Study|Adverse Event|1|||
127590225|NCT03322631|459129057|FG003|Overall Study|Adverse Event|0|||
127590226|NCT02378961|459129059|FG000|Overall Study|Lack of Efficacy|4|||
127590227|NCT02378961|459129060|FG001|Overall Study|Lack of Efficacy|2|||
127590228|NCT02378961|459129061|FG002|Overall Study|Lack of Efficacy|0|||
127590229|NCT02378961|459129062|FG003|Overall Study|Lack of Efficacy|1|||
127590230|NCT02378961|459129059|FG000|Overall Study|Death|0|||
128034163|NCT02303821|460751706|FG004|Overall Study|Lost to Follow-up|0|||
128034164|NCT02303821|460751707|FG005|Overall Study|Lost to Follow-up|0|||
127590231|NCT02378961|459129060|FG001|Overall Study|Death|0|||
127590232|NCT02378961|459129061|FG002|Overall Study|Death|1|||
127590233|NCT02378961|459129062|FG003|Overall Study|Death|0|||
127590234|NCT02412618|459129063|FG000|Overall Study|Withdrawal by Subject|1|||
127590235|NCT02412618|459129064|FG001|Overall Study|Withdrawal by Subject|1|||
127590236|NCT02412618|459129063|FG000|Overall Study|Expulsion|1|||
127590237|NCT02412618|459129064|FG001|Overall Study|Expulsion|1|||
127590238|NCT01253408|459129065|FG000|Overall Study|Adverse Event|0|||
127590239|NCT01253408|459129066|FG001|Overall Study|Adverse Event|1|||
128034165|NCT02303821|460751708|FG006|Overall Study|Lost to Follow-up|1|||
127590240|NCT01253408|459129067|FG002|Overall Study|Adverse Event|0|||
127590241|NCT01217801|459129068|FG000|Period 1|Protocol Violation|1|||
127590242|NCT01217801|459129069|FG001|Period 1|Protocol Violation|1|||
127590243|NCT01217801|459129068|FG000|Period 1|Withdrawal by Subject|0|||
127590244|NCT01217801|459129069|FG001|Period 1|Withdrawal by Subject|1|||
127590245|NCT03035409|459129071|FG000|Overall Study|Adverse Event|5|||
127590246|NCT03035409|459129071|FG000|Overall Study|Death|2|||
127590247|NCT03035409|459129071|FG000|Overall Study|Withdrawal by Subject|2|||
127590248|NCT03035409|459129071|FG000|Overall Study|Non compliance|4|||
127590249|NCT03035409|459129071|FG000|Overall Study|Patient was jittery|1|||
127590250|NCT03035409|459129071|FG000|Overall Study|Did not like Questionnaire|1|||
127590251|NCT03035409|459129071|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
127590252|NCT03035409|459129071|FG000|Overall Study|Did not like taking drugs|1|||
127590253|NCT01552694|459129076|FG000|Overall Study|Lost to Follow-up|0|||
127590254|NCT01552694|459129077|FG001|Overall Study|Lost to Follow-up|1|||
128034166|NCT02303821|460751709|FG007|Overall Study|Lost to Follow-up|0|||
127590255|NCT01552694|459129076|FG000|Overall Study|Protocol Violation|0|||
127590256|NCT01552694|459129077|FG001|Overall Study|Protocol Violation|1|||
128034167|NCT02303821|460751702|FG000|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
128034168|NCT02303821|460751703|FG001|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
128034169|NCT02303821|460751704|FG002|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
128034170|NCT02303821|460751705|FG003|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
128034171|NCT02303821|460751706|FG004|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
127694393|NCT01180634|459510722|FG000|Overall Study|Withdrawal by Subject|4|||
127694394|NCT01180634|459510723|FG001|Overall Study|Withdrawal by Subject|0|||
127694395|NCT03692611|459510724|FG000|Overall Study|Found to be ineligible postrandomization|3|||
127694396|NCT03692611|459510725|FG001|Overall Study|Found to be ineligible postrandomization|0|||
127694397|NCT04419168|459510726|FG000|Overall Study|Protocol Violation|1|||
127694398|NCT04419168|459510727|FG001|Overall Study|Protocol Violation|1|||
127694399|NCT04419168|459510726|FG000|Overall Study|Lost to Follow-up|7|||
127694400|NCT04419168|459510727|FG001|Overall Study|Lost to Follow-up|7|||
127694401|NCT04419168|459510726|FG000|Overall Study|Missed 6-month Visit|48|||
127694402|NCT04419168|459510727|FG001|Overall Study|Missed 6-month Visit|45|||
127694403|NCT04490915|459510728|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
127694404|NCT04490915|459510729|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
127590257|NCT03724032|459129078|FG000|Overall Study|Physician Decision|1|||
127590258|NCT03724032|459129079|FG001|Overall Study|Physician Decision|0|||
127590259|NCT03724032|459129080|FG002|Overall Study|Physician Decision|0|||
127590260|NCT03724032|459129078|FG000|Overall Study|Protocol Violation|2|||
127590261|NCT03724032|459129079|FG001|Overall Study|Protocol Violation|2|||
127590262|NCT03724032|459129080|FG002|Overall Study|Protocol Violation|1|||
127694405|NCT04490915|459510728|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
127694406|NCT04490915|459510729|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
127694407|NCT04490915|459510728|FG000|DB Treatment Period (24 Weeks)|Adverse Event|0|||
127694408|NCT04490915|459510729|FG001|DB Treatment Period (24 Weeks)|Adverse Event|1|||
127694409|NCT04490915|459510728|FG000|OL Treatment Period (6 Months)|Withdrawal by Subject|1|||
128034172|NCT02303821|460751707|FG005|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
128034173|NCT02303821|460751708|FG006|Overall Study|Withdrawal prior to Carfilzomib dosing|1|||
128034174|NCT02303821|460751709|FG007|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
128034175|NCT02303821|460751702|FG000|Overall Study|Decision by sponsor|0|||
128034176|NCT02303821|460751703|FG001|Overall Study|Decision by sponsor|0|||
128034177|NCT02303821|460751704|FG002|Overall Study|Decision by sponsor|0|||
128034178|NCT02303821|460751705|FG003|Overall Study|Decision by sponsor|0|||
127590263|NCT02639065|459129084|FG000|Study Treatment|Disease Progression|13|||
127694410|NCT04490915|459510729|FG001|OL Treatment Period (6 Months)|Withdrawal by Subject|0|||
128034179|NCT02303821|460751706|FG004|Overall Study|Decision by sponsor|0|||
127694411|NCT04490915|459510728|FG000|OL Treatment Period (6 Months)|Lost to Follow-up|0|||
127694412|NCT04490915|459510729|FG001|OL Treatment Period (6 Months)|Lost to Follow-up|1|||
127590264|NCT02639065|459129084|FG000|Study Treatment|Adverse Event|9|||
127590265|NCT02639065|459129084|FG000|Study Treatment|Withdrawal by Subject|1|||
127590266|NCT02639065|459129084|FG000|Follow up|Subject refused to follow up|1|||
127590267|NCT02639065|459129084|FG000|Follow up|Symptomatic Deterioration|2|||
128034180|NCT02303821|460751707|FG005|Overall Study|Decision by sponsor|1|||
128034181|NCT02303821|460751708|FG006|Overall Study|Decision by sponsor|0|||
128034182|NCT02303821|460751709|FG007|Overall Study|Decision by sponsor|0|||
128034183|NCT02303821|460751702|FG000|Overall Study|Protocol-specified criteria|0|||
128034184|NCT02303821|460751703|FG001|Overall Study|Protocol-specified criteria|1|||
128034185|NCT02303821|460751704|FG002|Overall Study|Protocol-specified criteria|0|||
128034186|NCT02303821|460751705|FG003|Overall Study|Protocol-specified criteria|0|||
128034187|NCT02303821|460751706|FG004|Overall Study|Protocol-specified criteria|0|||
127590268|NCT02639065|459129084|FG000|Follow up|Death|2|||
127590269|NCT02639065|459129084|FG000|Follow up|Study Terminated|1|||
127590270|NCT02639065|459129084|FG000|Follow up|Disease Progression|3|||
127590271|NCT00481078|459129085|FG000|Overall Study|Progression of disease|11|||
127590272|NCT00481078|459129086|FG001|Overall Study|Progression of disease|11|||
127590273|NCT00481078|459129085|FG000|Overall Study|Adverse Event|15|||
127590274|NCT00481078|459129086|FG001|Overall Study|Adverse Event|3|||
127590275|NCT00481078|459129085|FG000|Overall Study|Death|5|||
127590276|NCT00481078|459129086|FG001|Overall Study|Death|3|||
127590277|NCT00481078|459129085|FG000|Overall Study|Intercurrent illness|1|||
127694413|NCT04490915|459510728|FG000|OL Treatment Period (6 Months)|Adverse Event|0|||
127784671|NCT00262522|459837018|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
127590278|NCT00481078|459129086|FG001|Overall Study|Intercurrent illness|0|||
127590279|NCT00481078|459129085|FG000|Overall Study|Withdrawal by Subject|7|||
128034188|NCT02303821|460751707|FG005|Overall Study|Protocol-specified criteria|1|||
128034189|NCT02303821|460751708|FG006|Overall Study|Protocol-specified criteria|0|||
127590280|NCT00481078|459129086|FG001|Overall Study|Withdrawal by Subject|1|||
127590281|NCT00481078|459129085|FG000|Overall Study|Information not available|1|||
127694414|NCT04490915|459510729|FG001|OL Treatment Period (6 Months)|Adverse Event|1|||
127590282|NCT00481078|459129086|FG001|Overall Study|Information not available|0|||
127590283|NCT00481078|459129085|FG000|Overall Study|Received other treatment|2|||
127590284|NCT00481078|459129086|FG001|Overall Study|Received other treatment|1|||
127590285|NCT00481078|459129085|FG000|Overall Study|Brain metastasis|0|||
127590286|NCT00481078|459129086|FG001|Overall Study|Brain metastasis|1|||
127590287|NCT01558271|459129087|FG000|Overall Study|Adverse Event|6|||
127590288|NCT01558271|459129088|FG001|Overall Study|Adverse Event|3|||
127590289|NCT01558271|459129089|FG002|Overall Study|Adverse Event|4|||
127590290|NCT01558271|459129087|FG000|Overall Study|Lost to Follow-up|1|||
127590291|NCT01558271|459129088|FG001|Overall Study|Lost to Follow-up|0|||
127590292|NCT01558271|459129089|FG002|Overall Study|Lost to Follow-up|0|||
127590293|NCT01558271|459129087|FG000|Overall Study|Protocol Violation|1|||
127590294|NCT01558271|459129088|FG001|Overall Study|Protocol Violation|0|||
127590295|NCT01558271|459129089|FG002|Overall Study|Protocol Violation|0|||
127590296|NCT01558271|459129087|FG000|Overall Study|Withdrawal by Subject|10|||
127590297|NCT01558271|459129088|FG001|Overall Study|Withdrawal by Subject|6|||
127590298|NCT01558271|459129089|FG002|Overall Study|Withdrawal by Subject|12|||
127590299|NCT01558271|459129087|FG000|Overall Study|Physician Decision|0|||
127590300|NCT01558271|459129088|FG001|Overall Study|Physician Decision|2|||
127590301|NCT01558271|459129089|FG002|Overall Study|Physician Decision|1|||
127590302|NCT01845831|459129090|FG000|Inpatient Phase|Withdrawal by Subject|1|||
127590303|NCT01845831|459129091|FG001|Inpatient Phase|Withdrawal by Subject|1|||
127590304|NCT01845831|459129092|FG002|Inpatient Phase|Withdrawal by Subject|0|||
127590305|NCT01845831|459129093|FG003|Inpatient Phase|Withdrawal by Subject|0|||
127590306|NCT01845831|459129094|FG004|Inpatient Phase|Withdrawal by Subject|0|||
127590307|NCT02610725|459129095|FG000|Overall Study|Lost to Follow-up|197|||
127590308|NCT02610725|459129095|FG000|Overall Study|self-reported contraindication|9|||
127590309|NCT00826943|459129096|FG000|Overall Study|Withdrawal by Subject|0|||
127590310|NCT00826943|459129097|FG001|Overall Study|Withdrawal by Subject|0|||
127590311|NCT00826943|459129098|FG002|Overall Study|Withdrawal by Subject|0|||
127590312|NCT00826943|459129099|FG003|Overall Study|Withdrawal by Subject|0|||
127590313|NCT00826943|459129100|FG004|Overall Study|Withdrawal by Subject|1|||
127590314|NCT00826943|459129101|FG005|Overall Study|Withdrawal by Subject|0|||
127590315|NCT01348165|459129102|FG000|Overall Study|Adverse Event|0|||
127590316|NCT01348165|459129103|FG001|Overall Study|Adverse Event|0|||
127590317|NCT01348165|459129104|FG002|Overall Study|Adverse Event|0|||
127590318|NCT01348165|459129105|FG003|Overall Study|Adverse Event|0|||
127590319|NCT01348165|459129106|FG004|Overall Study|Adverse Event|0|||
127590320|NCT01348165|459129107|FG005|Overall Study|Adverse Event|0|||
127590321|NCT01348165|459129108|FG006|Overall Study|Adverse Event|1|||
127590322|NCT01594762|459129109|FG000|Overall Study|Withdrawal by Subject|1|||
127590323|NCT01594762|459129110|FG001|Overall Study|Withdrawal by Subject|0|||
127590324|NCT01594762|459129109|FG000|Overall Study|Lost to Follow-up|10|||
127590325|NCT01594762|459129110|FG001|Overall Study|Lost to Follow-up|10|||
127590326|NCT05570500|459129113|FG000|Overall Study|Lost to Follow-up|7|||
127590327|NCT05570500|459129114|FG001|Overall Study|Lost to Follow-up|5|||
127590328|NCT04706091|459129115|FG000|Treatment 2|Withdrawal by Subject|1|||
127590329|NCT04706091|459129116|FG001|Treatment 2|Withdrawal by Subject|0|||
127590330|NCT02612727|459129117|FG000|Overall Study|Parent request|4|||
127590331|NCT02612727|459129118|FG001|Overall Study|Parent request|1|||
127590332|NCT02612727|459129117|FG000|Overall Study|Needed treatment incompatible with PT|1|||
127590333|NCT02612727|459129118|FG001|Overall Study|Needed treatment incompatible with PT|1|||
127590334|NCT02612727|459129117|FG000|Overall Study|Direct hyperbilirubinemia|0|||
127590335|NCT02612727|459129118|FG001|Overall Study|Direct hyperbilirubinemia|2|||
127590336|NCT01446289|459129119|FG000|Overall Study|Withdrawal by Subject|1|||
127590337|NCT01446289|459129120|FG001|Overall Study|Withdrawal by Subject|0|||
127590338|NCT01446289|459129121|FG002|Overall Study|Withdrawal by Subject|1|||
127590339|NCT01446289|459129122|FG003|Overall Study|Withdrawal by Subject|0|||
127590340|NCT02302807|459129123|FG000|Overall Study|Withdrawal by Subject|28|||
127590341|NCT02302807|459129124|FG001|Overall Study|Withdrawal by Subject|11|||
127590342|NCT02302807|459129123|FG000|Overall Study|Lost to Follow-up|4|||
127882056|NCT01289990|460190799|FG006|Overall Study|Withdrawal by Subject|13|||
128034190|NCT02303821|460751709|FG007|Overall Study|Protocol-specified criteria|0|||
128034191|NCT04507269|460751720|FG000|Overall Study|Withdrawal by Subject|1|||
128034192|NCT04507269|460751721|FG001|Overall Study|Withdrawal by Subject|1|||
128034193|NCT04507269|460751722|FG002|Overall Study|Withdrawal by Subject|0|||
127590343|NCT02302807|459129124|FG001|Overall Study|Lost to Follow-up|6|||
127590344|NCT02302807|459129123|FG000|Overall Study|Death|397|||
127590345|NCT02302807|459129124|FG001|Overall Study|Death|385|||
127590346|NCT02302807|459129123|FG000|Overall Study|Study Terminated By Sponsor|35|||
127590347|NCT02302807|459129124|FG001|Overall Study|Study Terminated By Sponsor|64|||
127590348|NCT02302807|459129123|FG000|Overall Study|Physician Decision|0|||
127590349|NCT02302807|459129124|FG001|Overall Study|Physician Decision|1|||
127590350|NCT05243641|459129125|FG000|Overall Study|Adverse Event|3|||
127590351|NCT05243641|459129126|FG001|Overall Study|Adverse Event|0|||
127882057|NCT01289990|460190800|FG007|Overall Study|Withdrawal by Subject|9|||
127590352|NCT05243641|459129127|FG002|Overall Study|Adverse Event|0|||
128034194|NCT04507269|460751723|FG003|Overall Study|Withdrawal by Subject|0|||
127590353|NCT05243641|459129128|FG003|Overall Study|Adverse Event|1|||
127590354|NCT05243641|459129129|FG004|Overall Study|Adverse Event|0|||
127590355|NCT05243641|459129130|FG005|Overall Study|Adverse Event|0|||
127590356|NCT05243641|459129125|FG000|Overall Study|Disease progression|4|||
127590357|NCT05243641|459129126|FG001|Overall Study|Disease progression|0|||
127590358|NCT05243641|459129127|FG002|Overall Study|Disease progression|0|||
127590359|NCT05243641|459129128|FG003|Overall Study|Disease progression|2|||
127590360|NCT05243641|459129129|FG004|Overall Study|Disease progression|0|||
127590361|NCT05243641|459129130|FG005|Overall Study|Disease progression|0|||
127590362|NCT04518306|459129131|FG000|Double-Blind Period|Run in failure|0|||
127590363|NCT04518306|459129132|FG001|Double-Blind Period|Run in failure|0|||
127590364|NCT04518306|459129133|FG002|Double-Blind Period|Run in failure|1|||
127590365|NCT04518306|459129131|FG000|Double-Blind Period|Adverse Event|0|||
127590366|NCT04518306|459129132|FG001|Double-Blind Period|Adverse Event|2|||
127590367|NCT04518306|459129133|FG002|Double-Blind Period|Adverse Event|2|||
127590368|NCT04518306|459129131|FG000|Double-Blind Period|Lost to Follow-up|1|||
127590369|NCT04518306|459129132|FG001|Double-Blind Period|Lost to Follow-up|2|||
127590370|NCT04518306|459129133|FG002|Double-Blind Period|Lost to Follow-up|2|||
127590371|NCT04518306|459129131|FG000|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
127590372|NCT04518306|459129132|FG001|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
127590373|NCT04518306|459129133|FG002|Double-Blind Period|Participant moved to open-label extension (OLE) study|8|||
127590374|NCT04518306|459129131|FG000|Double-Blind Period|Other|0|||
127590375|NCT04518306|459129132|FG001|Double-Blind Period|Other|2|||
127590376|NCT04518306|459129133|FG002|Double-Blind Period|Other|0|||
127590377|NCT04518306|459129131|FG000|Double-Blind Period|Missing|0|||
127590378|NCT04518306|459129132|FG001|Double-Blind Period|Missing|1|||
127590379|NCT04518306|459129133|FG002|Double-Blind Period|Missing|0|||
127590380|NCT03904043|459129134|FG000|Overall Study|Adverse Event|1|||
127590381|NCT03904043|459129135|FG001|Overall Study|Adverse Event|1|||
127590382|NCT03904043|459129134|FG000|Overall Study|Withdrawal by Subject|1|||
127590383|NCT03904043|459129135|FG001|Overall Study|Withdrawal by Subject|0|||
127590384|NCT03904043|459129134|FG000|Overall Study|Non-compliance|1|||
127590385|NCT03904043|459129135|FG001|Overall Study|Non-compliance|0|||
127590386|NCT03904043|459129134|FG000|Overall Study|Did not start treatment|1|||
127590387|NCT03904043|459129135|FG001|Overall Study|Did not start treatment|0|||
127590388|NCT01664533|459130799|FG000|Overall Study|Death|42|||
127590389|NCT01664533|459130799|FG000|Overall Study|Lost to Follow-up|3|||
127590390|NCT01664533|459130799|FG000|Overall Study|Study termination|9|||
127590391|NCT01664533|459130799|FG000|Overall Study|Protocol Violation|3|||
127590392|NCT00290888|459130800|FG000|Overall Study|Physician Decision|3|||
127590393|NCT00290888|459130801|FG001|Overall Study|Physician Decision|1|||
127590394|NCT03000439|459130802|FG000|Open Label Part 1|Adverse Event|6|||
127590395|NCT03000439|459130803|FG001|Open Label Part 1|Adverse Event|0|||
127590396|NCT03000439|459130804|FG002|Open Label Part 1|Adverse Event|0|||
127590397|NCT03000439|459130805|FG003|Open Label Part 1|Adverse Event|0|||
127590398|NCT03000439|459130802|FG000|Open Label Part 1|Other|2|||
127590399|NCT03000439|459130803|FG001|Open Label Part 1|Other|0|||
127590400|NCT03000439|459130804|FG002|Open Label Part 1|Other|0|||
127590401|NCT03000439|459130805|FG003|Open Label Part 1|Other|0|||
127590402|NCT03000439|459130802|FG000|Open Label Part 1|Insufficient clinical response|16|||
127590403|NCT03000439|459130803|FG001|Open Label Part 1|Insufficient clinical response|0|||
127590404|NCT03000439|459130804|FG002|Open Label Part 1|Insufficient clinical response|0|||
127590405|NCT03000439|459130805|FG003|Open Label Part 1|Insufficient clinical response|0|||
127590406|NCT03000439|459130802|FG000|Open Label Part 2|Other|0|||
127694415|NCT04490915|459510728|FG000|OL Treatment Period (6 Months)|Ongoing in the Study|34|||
127694416|NCT04490915|459510729|FG001|OL Treatment Period (6 Months)|Ongoing in the Study|58|||
127694417|NCT05009251|459510730|FG000|Overall Study|Protocol Violation|100|||
127882058|NCT01289990|460190801|FG008|Overall Study|Withdrawal by Subject|12|||
127882059|NCT01289990|460190802|FG009|Overall Study|Withdrawal by Subject|13|||
128034195|NCT04507269|460751724|FG004|Overall Study|Withdrawal by Subject|0|||
128034196|NCT04507269|460751725|FG005|Overall Study|Withdrawal by Subject|0|||
128034197|NCT04507269|460751720|FG000|Overall Study|Lost to Follow-up|0|||
127590407|NCT03000439|459130803|FG001|Open Label Part 2|Other|5|||
127590408|NCT03000439|459130804|FG002|Open Label Part 2|Other|0|||
127590409|NCT03000439|459130805|FG003|Open Label Part 2|Other|0|||
127590410|NCT03000439|459130802|FG000|Open Label Part 2|Insufficient clinical response|0|||
127694418|NCT05009251|459510731|FG001|Overall Study|Protocol Violation|105|||
128034198|NCT04507269|460751721|FG001|Overall Study|Lost to Follow-up|0|||
127590411|NCT03000439|459130803|FG001|Open Label Part 2|Insufficient clinical response|12|||
127590412|NCT03000439|459130804|FG002|Open Label Part 2|Insufficient clinical response|0|||
127590413|NCT03000439|459130805|FG003|Open Label Part 2|Insufficient clinical response|0|||
127590414|NCT03000439|459130802|FG000|Double Blind Phase|Adverse Event|0|||
127590415|NCT03000439|459130803|FG001|Double Blind Phase|Adverse Event|0|||
127590416|NCT03000439|459130804|FG002|Double Blind Phase|Adverse Event|2|||
127590417|NCT03000439|459130805|FG003|Double Blind Phase|Adverse Event|1|||
127590418|NCT03000439|459130802|FG000|Double Blind Phase|Withdrawal by parent/guardian|0|||
127590419|NCT03000439|459130803|FG001|Double Blind Phase|Withdrawal by parent/guardian|0|||
127694419|NCT05009251|459510732|FG002|Overall Study|Protocol Violation|119|||
127694420|NCT05009251|459510733|FG003|Overall Study|Protocol Violation|120|||
127694421|NCT05009251|459510734|FG004|Overall Study|Protocol Violation|119|||
127694422|NCT05009251|459510730|FG000|Overall Study|Death|25|||
127694423|NCT05009251|459510731|FG001|Overall Study|Death|22|||
127590420|NCT03000439|459130804|FG002|Double Blind Phase|Withdrawal by parent/guardian|2|||
127590421|NCT03000439|459130805|FG003|Double Blind Phase|Withdrawal by parent/guardian|0|||
127590422|NCT03000439|459130802|FG000|Double Blind Phase|Other|0|||
127590423|NCT03000439|459130803|FG001|Double Blind Phase|Other|0|||
127590424|NCT03000439|459130804|FG002|Double Blind Phase|Other|10|||
127590425|NCT03000439|459130805|FG003|Double Blind Phase|Other|11|||
127590426|NCT03000439|459130802|FG000|Double Blind Phase|Insufficient clinical response|0|||
127590427|NCT03000439|459130803|FG001|Double Blind Phase|Insufficient clinical response|0|||
127590428|NCT03000439|459130804|FG002|Double Blind Phase|Insufficient clinical response|0|||
127590429|NCT03000439|459130805|FG003|Double Blind Phase|Insufficient clinical response|2|||
127590430|NCT00592384|459130806|FG000|Overall Study|Withdrawal by Subject|5|||
127590431|NCT00592384|459130807|FG001|Overall Study|Withdrawal by Subject|6|||
127694424|NCT05009251|459510732|FG002|Overall Study|Death|24|||
127694425|NCT05009251|459510733|FG003|Overall Study|Death|19|||
127694426|NCT05009251|459510734|FG004|Overall Study|Death|15|||
127590432|NCT02151591|459130808|FG000|Overall Study|Lost to Follow-up|6|||
127590433|NCT02151591|459130809|FG001|Overall Study|Lost to Follow-up|3|||
127590434|NCT04932096|459130813|FG000|Overall Study|Withdrawal by Subject|1|||
127590435|NCT04932096|459130814|FG001|Overall Study|Withdrawal by Subject|1|||
127590436|NCT04932096|459130813|FG000|Overall Study|Partial completion (did not complete primary outcome survey)|0|||
127590437|NCT04932096|459130814|FG001|Overall Study|Partial completion (did not complete primary outcome survey)|1|||
127590438|NCT00964860|459130816|FG000|Overall Study|Withdrawal by Subject|0|||
127590439|NCT00964860|459130817|FG001|Overall Study|Withdrawal by Subject|1|||
127590440|NCT03716024|459130818|FG000|Overall Study|Randomized, not Treated|7|||
127590441|NCT03716024|459130819|FG001|Overall Study|Randomized, not Treated|8|||
127590442|NCT03716024|459130818|FG000|Overall Study|Adverse Event|1|||
127694427|NCT03786783|459510737|FG000|Overall Study|Death|1|||
127694428|NCT03786783|459510737|FG000|Overall Study|Physician Decision|6|||
127590443|NCT03716024|459130819|FG001|Overall Study|Adverse Event|2|||
127590444|NCT03716024|459130818|FG000|Overall Study|Treatment Failure|1|||
127590445|NCT03716024|459130819|FG001|Overall Study|Treatment Failure|0|||
127590446|NCT03716024|459130818|FG000|Overall Study|Lost to Follow-up|2|||
127590447|NCT03716024|459130819|FG001|Overall Study|Lost to Follow-up|6|||
127590448|NCT03716024|459130818|FG000|Overall Study|Withdrawal by Subject|0|||
127590449|NCT03716024|459130819|FG001|Overall Study|Withdrawal by Subject|1|||
127590450|NCT03716024|459130818|FG000|Overall Study|Missing Reason|0|||
127590451|NCT03716024|459130819|FG001|Overall Study|Missing Reason|1|||
127590452|NCT00867568|459130820|FG000|Overall Study|Lack of Efficacy|10|||
127590453|NCT00867568|459130820|FG000|Overall Study|Adverse Event|4|||
127590454|NCT00867568|459130820|FG000|Overall Study|Withdrawal by Subject|1|||
127590455|NCT04343261|459130821|FG000|Overall Study|Adverse Event|1|||
127590456|NCT04343261|459130821|FG000|Overall Study|received inadequate amount of antibodies|7|||
127590457|NCT05275400|459130829|FG000|Treatment Period|Adverse Event|7|||
127590458|NCT05275400|459130830|FG001|Treatment Period|Adverse Event|1|||
127590459|NCT05275400|459130829|FG000|Treatment Period|Assigned Treatment by Mistake|6|||
127590460|NCT05275400|459130830|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
127590461|NCT05275400|459130829|FG000|Treatment Period|Death|5|||
127694429|NCT03786783|459510737|FG000|Overall Study|Withdrawal by Subject|2|||
127694430|NCT03786783|459510737|FG000|Overall Study|Disease Progression|7|||
127694431|NCT03786783|459510737|FG000|Overall Study|Patient/Parent Refusal|4|||
127590462|NCT05275400|459130830|FG001|Treatment Period|Death|2|||
127590463|NCT05275400|459130829|FG000|Treatment Period|Protocol Violation|1|||
127590464|NCT05275400|459130830|FG001|Treatment Period|Protocol Violation|0|||
127590465|NCT05275400|459130829|FG000|Treatment Period|Physician Decision|5|||
127590466|NCT05275400|459130830|FG001|Treatment Period|Physician Decision|4|||
127590467|NCT05275400|459130829|FG000|Treatment Period|Non-Compliance with Study Drug|5|||
127590468|NCT05275400|459130830|FG001|Treatment Period|Non-Compliance with Study Drug|1|||
127694432|NCT00616967|459510738|FG000|Overall Study|Withdrawal by Subject|0|||
127590469|NCT05275400|459130829|FG000|Treatment Period|Withdrawal by Subject|30|||
127590470|NCT05275400|459130830|FG001|Treatment Period|Withdrawal by Subject|12|||
127590471|NCT05275400|459130829|FG000|Treatment Period|Lost to Follow-up|1|||
127590472|NCT05275400|459130830|FG001|Treatment Period|Lost to Follow-up|5|||
127590473|NCT05275400|459130829|FG000|Treatment Period|Lack of Efficacy|1|||
127590474|NCT05275400|459130830|FG001|Treatment Period|Lack of Efficacy|0|||
127590475|NCT05275400|459130829|FG000|Treatment Period|Sponsor Decision|1|||
127590476|NCT05275400|459130830|FG001|Treatment Period|Sponsor Decision|0|||
127590477|NCT05275400|459130829|FG000|Follow-Up Period|Death|2|||
127590478|NCT05275400|459130830|FG001|Follow-Up Period|Death|0|||
127590479|NCT05275400|459130829|FG000|Follow-Up Period|Protocol Violation|1|||
127590480|NCT05275400|459130830|FG001|Follow-Up Period|Protocol Violation|0|||
127590481|NCT05275400|459130829|FG000|Follow-Up Period|Withdrawal by Subject|3|||
127590482|NCT05275400|459130830|FG001|Follow-Up Period|Withdrawal by Subject|0|||
127590483|NCT02585960|459130831|FG000|PK/Safety Assessment Period|Physician Decision|0|||
127590484|NCT02585960|459130832|FG001|PK/Safety Assessment Period|Physician Decision|1|||
127590485|NCT02585960|459130833|FG002|PK/Safety Assessment Period|Physician Decision|0|||
127590486|NCT02585960|459130831|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
127590487|NCT02585960|459130832|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
127590488|NCT02585960|459130833|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
127590489|NCT02585960|459130831|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
127590490|NCT02585960|459130832|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
127590491|NCT02585960|459130833|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
127590492|NCT02585960|459130831|FG000|PK/Safety Assessment Period|Other|4|||
127590493|NCT02585960|459130832|FG001|PK/Safety Assessment Period|Other|4|||
127590494|NCT02585960|459130833|FG002|PK/Safety Assessment Period|Other|0|||
127590495|NCT02585960|459130831|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
127590496|NCT02585960|459130832|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
127590497|NCT02585960|459130833|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
127590498|NCT02585960|459130831|FG000|PK/Safety Assessment Period|Screen Failure|0|||
127590499|NCT02585960|459130832|FG001|PK/Safety Assessment Period|Screen Failure|0|||
127590500|NCT02585960|459130833|FG002|PK/Safety Assessment Period|Screen Failure|1|||
127590501|NCT02585960|459130831|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
127590502|NCT02585960|459130832|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
127590503|NCT02585960|459130833|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
127590504|NCT02585960|459130831|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
127590505|NCT02585960|459130832|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
127590506|NCT02585960|459130833|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
127590507|NCT03639935|459130834|FG000|Overall Study|Death|3|||
127590508|NCT03639935|459130834|FG000|Overall Study|Adverse Event|1|||
127590509|NCT06333613|459130835|FG000|Overall Study|Doesn't Like Wearing Contacts|1|||
127590510|NCT03648541|459130837|FG000|Re-induction Period Only|Withdrawal by Subject|1|||
127590511|NCT03648541|459130838|FG001|Re-induction Period Only|Withdrawal by Subject|0|||
127590512|NCT03648541|459130837|FG000|Re-induction Period Only|Lack of Efficacy|7|||
127590513|NCT03648541|459130838|FG001|Re-induction Period Only|Lack of Efficacy|0|||
127590514|NCT03648541|459130837|FG000|Maintenance Period Only|Missing|0|||
127590515|NCT03648541|459130838|FG001|Maintenance Period Only|Missing|1|||
127590516|NCT03648541|459130837|FG000|Maintenance Period Only|Other not listed below|0|||
127590517|NCT03648541|459130838|FG001|Maintenance Period Only|Other not listed below|4|||
127590518|NCT03648541|459130837|FG000|Maintenance Period Only|Withdrawal by Subject|0|||
127590519|NCT03648541|459130838|FG001|Maintenance Period Only|Withdrawal by Subject|3|||
127590520|NCT03648541|459130837|FG000|Maintenance Period Only|Protocol Violation|0|||
127590521|NCT03648541|459130838|FG001|Maintenance Period Only|Protocol Violation|1|||
127590522|NCT03648541|459130837|FG000|Maintenance Period Only|Lack of Efficacy|0|||
127590523|NCT03648541|459130838|FG001|Maintenance Period Only|Lack of Efficacy|18|||
127590524|NCT03648541|459130837|FG000|Maintenance Period Only|Adverse Event|0|||
127590525|NCT03648541|459130838|FG001|Maintenance Period Only|Adverse Event|4|||
127590526|NCT03648541|459130837|FG000|Maintenance Period Only|Stopped maintenance treatment due to study stop|0|||
127590527|NCT03648541|459130838|FG001|Maintenance Period Only|Stopped maintenance treatment due to study stop|3|||
127590528|NCT04623216|459130841|FG000|Overall Study|Death|5|||
127590529|NCT04623216|459130842|FG001|Overall Study|Death|2|||
127590530|NCT04623216|459130843|FG002|Overall Study|Death|0|||
127590531|NCT04623216|459130844|FG003|Overall Study|Death|0|||
127590532|NCT04623216|459130841|FG000|Overall Study|Terminated by Sponsor|3|||
127590533|NCT04623216|459130842|FG001|Overall Study|Terminated by Sponsor|2|||
127590534|NCT04623216|459130843|FG002|Overall Study|Terminated by Sponsor|2|||
127694433|NCT00616967|459510739|FG001|Overall Study|Withdrawal by Subject|0|||
127694434|NCT00616967|459510740|FG002|Overall Study|Withdrawal by Subject|1|||
127590535|NCT04623216|459130844|FG003|Overall Study|Terminated by Sponsor|0|||
127590536|NCT04623216|459130841|FG000|Overall Study|Physician Decision|1|||
127590537|NCT04623216|459130842|FG001|Overall Study|Physician Decision|0|||
127590538|NCT04623216|459130843|FG002|Overall Study|Physician Decision|0|||
127590539|NCT04623216|459130844|FG003|Overall Study|Physician Decision|0|||
127590540|NCT00044083|459130845|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
127590541|NCT00044083|459130846|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
127590542|NCT00044083|459130845|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
127590543|NCT00044083|459130846|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
127590544|NCT00044083|459130845|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
127590545|NCT00044083|459130846|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
127590546|NCT00044083|459130845|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
127590547|NCT00044083|459130846|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
127590548|NCT00044083|459130845|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
127590549|NCT00044083|459130846|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
127590550|NCT00044083|459130845|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
127590551|NCT00044083|459130846|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
127590552|NCT00044083|459130845|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
127590553|NCT00044083|459130846|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
127590554|NCT00044083|459130845|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
127590555|NCT00044083|459130846|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
127590556|NCT00044083|459130845|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
127590557|NCT00044083|459130846|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
127590558|NCT00044083|459130845|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
127590559|NCT00044083|459130846|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
127590560|NCT01619423|459130847|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
127590561|NCT01619423|459130848|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
127590562|NCT01619423|459130849|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
127590563|NCT01619423|459130850|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
127590564|NCT02340975|459130853|FG000|Overall Study|Death|6|||
127590565|NCT02340975|459130854|FG001|Overall Study|Death|23|||
127590566|NCT02340975|459130855|FG002|Overall Study|Death|21|||
127590567|NCT02340975|459130856|FG003|Overall Study|Death|7|||
127590568|NCT02340975|459130857|FG004|Overall Study|Death|21|||
127590569|NCT02340975|459130858|FG005|Overall Study|Death|13|||
127590570|NCT02340975|459130853|FG000|Overall Study|Lost to Follow-up|0|||
127590571|NCT02340975|459130854|FG001|Overall Study|Lost to Follow-up|0|||
127590572|NCT02340975|459130855|FG002|Overall Study|Lost to Follow-up|0|||
127590573|NCT02340975|459130856|FG003|Overall Study|Lost to Follow-up|0|||
127590574|NCT02340975|459130857|FG004|Overall Study|Lost to Follow-up|2|||
127590575|NCT02340975|459130858|FG005|Overall Study|Lost to Follow-up|0|||
127590576|NCT02340975|459130853|FG000|Overall Study|Withdrawal by Subject|0|||
127590577|NCT02340975|459130854|FG001|Overall Study|Withdrawal by Subject|0|||
127590578|NCT02340975|459130855|FG002|Overall Study|Withdrawal by Subject|3|||
127590579|NCT02340975|459130856|FG003|Overall Study|Withdrawal by Subject|3|||
127590580|NCT02340975|459130857|FG004|Overall Study|Withdrawal by Subject|2|||
127590581|NCT02340975|459130858|FG005|Overall Study|Withdrawal by Subject|0|||
127590582|NCT02340975|459130853|FG000|Overall Study|Other|0|||
127590583|NCT02340975|459130854|FG001|Overall Study|Other|4|||
127590584|NCT02340975|459130855|FG002|Overall Study|Other|0|||
127590585|NCT02340975|459130856|FG003|Overall Study|Other|2|||
127590586|NCT02340975|459130857|FG004|Overall Study|Other|0|||
127590587|NCT02340975|459130858|FG005|Overall Study|Other|6|||
127590588|NCT00119106|459130867|FG000|Overall Study|HIV infected at baseline|179|||
127590589|NCT00119106|459130868|FG001|Overall Study|HIV infected at baseline|178|||
127590590|NCT03066804|459130869|FG000|Overall Study|Physician Decision|0|||
127590591|NCT03066804|459130870|FG001|Overall Study|Physician Decision|4|||
127590592|NCT03066804|459130869|FG000|Overall Study|Death|23|||
127590593|NCT03066804|459130870|FG001|Overall Study|Death|17|||
127590594|NCT03066804|459130869|FG000|Overall Study|Withdrawal by Subject|19|||
127590595|NCT03066804|459130870|FG001|Overall Study|Withdrawal by Subject|25|||
127590596|NCT03066804|459130869|FG000|Overall Study|Lost to Follow-up|2|||
127590597|NCT03066804|459130870|FG001|Overall Study|Lost to Follow-up|0|||
127590598|NCT03066804|459130869|FG000|Overall Study|Adverse Event|2|||
127590599|NCT03066804|459130870|FG001|Overall Study|Adverse Event|3|||
127590600|NCT03066804|459130869|FG000|Overall Study|Technical problems|5|||
127590601|NCT03066804|459130870|FG001|Overall Study|Technical problems|1|||
127590602|NCT01874054|459130874|FG000|Overall Study|Withdrawal by Subject|3|||
127590603|NCT01874054|459130874|FG000|Overall Study|Study Termination by Sponsor|42|||
127590604|NCT01874054|459130874|FG000|Overall Study|Lost to Follow-up|5|||
127590605|NCT01874054|459130874|FG000|Overall Study|Death|5|||
127590606|NCT00702923|459130875|FG000|Overall Study|Adverse Event|1|||
127590607|NCT03953820|459130881|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
127590608|NCT03953820|459130882|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
127590609|NCT03953820|459130883|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
127590610|NCT03953820|459130881|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
127590611|NCT03953820|459130882|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
127694435|NCT02910583|459510741|FG000|Overall Study|Death|7|||
127590612|NCT03953820|459130883|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
127590613|NCT00291577|459130888|FG000|Overall Study|Adverse Event|1|||
127590614|NCT00291577|459130888|FG000|Overall Study|Other|4|||
127590615|NCT00291577|459130888|FG000|Overall Study|Withdrawal by Subject|2|||
127590616|NCT00291577|459130888|FG000|Overall Study|Lack of Efficacy|14|||
127590617|NCT04967443|459130891|FG000|Open Label Treatment|Death|1|||
127590618|NCT04967443|459130892|FG001|Open Label Treatment|Death|0|||
127590619|NCT04967443|459130893|FG002|Open Label Treatment|Death|0|||
127590620|NCT04967443|459130894|FG003|Open Label Treatment|Death|0|||
127590621|NCT04967443|459130895|FG004|Open Label Treatment|Death|0|||
127590622|NCT04967443|459130896|FG005|Open Label Treatment|Death|0|||
127590623|NCT04967443|459130897|FG006|Open Label Treatment|Death|0|||
127590624|NCT04967443|459130898|FG007|Open Label Treatment|Death|0|||
127590625|NCT04967443|459130891|FG000|Open Label Treatment|Lost to Follow-up|0|||
127590626|NCT04967443|459130892|FG001|Open Label Treatment|Lost to Follow-up|0|||
127590627|NCT04967443|459130893|FG002|Open Label Treatment|Lost to Follow-up|1|||
127590628|NCT04967443|459130894|FG003|Open Label Treatment|Lost to Follow-up|0|||
127590629|NCT04967443|459130895|FG004|Open Label Treatment|Lost to Follow-up|0|||
127590630|NCT04967443|459130896|FG005|Open Label Treatment|Lost to Follow-up|0|||
127590631|NCT04967443|459130897|FG006|Open Label Treatment|Lost to Follow-up|0|||
127590632|NCT04967443|459130898|FG007|Open Label Treatment|Lost to Follow-up|0|||
127590633|NCT04967443|459130891|FG000|Open Label Treatment|Withdrawal by Subject|0|||
127590634|NCT04967443|459130892|FG001|Open Label Treatment|Withdrawal by Subject|1|||
127590635|NCT04967443|459130893|FG002|Open Label Treatment|Withdrawal by Subject|0|||
127590636|NCT04967443|459130894|FG003|Open Label Treatment|Withdrawal by Subject|1|||
127590637|NCT04967443|459130895|FG004|Open Label Treatment|Withdrawal by Subject|0|||
127590638|NCT04967443|459130896|FG005|Open Label Treatment|Withdrawal by Subject|1|||
127590639|NCT04967443|459130897|FG006|Open Label Treatment|Withdrawal by Subject|2|||
127590640|NCT04967443|459130898|FG007|Open Label Treatment|Withdrawal by Subject|3|||
127590641|NCT04967443|459130891|FG000|Follow-Up|Death|1|||
127590642|NCT04967443|459130892|FG001|Follow-Up|Death|0|||
127590643|NCT04967443|459130893|FG002|Follow-Up|Death|0|||
127590644|NCT04967443|459130894|FG003|Follow-Up|Death|0|||
127590645|NCT04967443|459130895|FG004|Follow-Up|Death|0|||
127590646|NCT04967443|459130896|FG005|Follow-Up|Death|0|||
127590647|NCT04967443|459130897|FG006|Follow-Up|Death|0|||
127590648|NCT04967443|459130898|FG007|Follow-Up|Death|0|||
127590649|NCT04967443|459130891|FG000|Follow-Up|Lost to Follow-up|0|||
127590650|NCT04967443|459130892|FG001|Follow-Up|Lost to Follow-up|0|||
127590651|NCT04967443|459130893|FG002|Follow-Up|Lost to Follow-up|1|||
127590652|NCT04967443|459130894|FG003|Follow-Up|Lost to Follow-up|1|||
127590653|NCT04967443|459130895|FG004|Follow-Up|Lost to Follow-up|0|||
127590654|NCT04967443|459130896|FG005|Follow-Up|Lost to Follow-up|0|||
127590655|NCT04967443|459130897|FG006|Follow-Up|Lost to Follow-up|0|||
127590656|NCT04967443|459130898|FG007|Follow-Up|Lost to Follow-up|0|||
127590657|NCT04967443|459130891|FG000|Follow-Up|Withdrawal by Subject|0|||
127590658|NCT04967443|459130892|FG001|Follow-Up|Withdrawal by Subject|1|||
127590659|NCT04967443|459130893|FG002|Follow-Up|Withdrawal by Subject|0|||
127590660|NCT04967443|459130894|FG003|Follow-Up|Withdrawal by Subject|1|||
127590661|NCT04967443|459130895|FG004|Follow-Up|Withdrawal by Subject|0|||
127590662|NCT04967443|459130896|FG005|Follow-Up|Withdrawal by Subject|1|||
127590663|NCT04967443|459130897|FG006|Follow-Up|Withdrawal by Subject|2|||
127590664|NCT04967443|459130898|FG007|Follow-Up|Withdrawal by Subject|3|||
127590665|NCT02405780|459130900|FG000|Period I|Adverse Event|8|||
127590666|NCT02405780|459130901|FG001|Period I|Adverse Event|0|||
127590667|NCT02405780|459130902|FG002|Period I|Adverse Event|3|||
127590668|NCT02405780|459130903|FG003|Period I|Adverse Event|7|||
127590669|NCT02405780|459130900|FG000|Period I|Medical reasons|1|||
127590670|NCT02405780|459130901|FG001|Period I|Medical reasons|1|||
127590671|NCT02405780|459130902|FG002|Period I|Medical reasons|0|||
127590672|NCT02405780|459130903|FG003|Period I|Medical reasons|1|||
127784672|NCT00262522|459837019|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
127590673|NCT02405780|459130900|FG000|Period I|Screening Failure|1|||
127590674|NCT02405780|459130901|FG001|Period I|Screening Failure|0|||
127590675|NCT02405780|459130902|FG002|Period I|Screening Failure|1|||
127590676|NCT02405780|459130903|FG003|Period I|Screening Failure|0|||
127590677|NCT02405780|459130900|FG000|Period I|Withdrawal by Subject|9|||
127590678|NCT02405780|459130901|FG001|Period I|Withdrawal by Subject|1|||
127590679|NCT02405780|459130902|FG002|Period I|Withdrawal by Subject|3|||
127590680|NCT02405780|459130903|FG003|Period I|Withdrawal by Subject|4|||
127590681|NCT02405780|459130900|FG000|Period I|Non-compliance with study procedures|8|||
127590682|NCT02405780|459130901|FG001|Period I|Non-compliance with study procedures|6|||
127590683|NCT02405780|459130902|FG002|Period I|Non-compliance with study procedures|8|||
127590684|NCT02405780|459130903|FG003|Period I|Non-compliance with study procedures|11|||
127590685|NCT02405780|459130900|FG000|Period II|Adverse Event|3|||
127784673|NCT00262522|459837016|FG000|Study Start Through 48 Weeks|Death|2|||
127590686|NCT02405780|459130901|FG001|Period II|Adverse Event|5|||
127590687|NCT02405780|459130902|FG002|Period II|Adverse Event|4|||
127590688|NCT02405780|459130903|FG003|Period II|Adverse Event|11|||
127590689|NCT02405780|459130900|FG000|Period II|Medical reason|0|||
127590690|NCT02405780|459130901|FG001|Period II|Medical reason|1|||
127590691|NCT02405780|459130902|FG002|Period II|Medical reason|0|||
127590692|NCT02405780|459130903|FG003|Period II|Medical reason|0|||
127590693|NCT02405780|459130900|FG000|Period II|Pregnancy|0|||
127590694|NCT02405780|459130901|FG001|Period II|Pregnancy|0|||
127590695|NCT02405780|459130902|FG002|Period II|Pregnancy|1|||
127590696|NCT02405780|459130903|FG003|Period II|Pregnancy|0|||
127590697|NCT02405780|459130900|FG000|Period II|Withdrawal by Subject|7|||
127590698|NCT02405780|459130901|FG001|Period II|Withdrawal by Subject|4|||
127590699|NCT02405780|459130902|FG002|Period II|Withdrawal by Subject|0|||
127590700|NCT02405780|459130903|FG003|Period II|Withdrawal by Subject|3|||
127590701|NCT02405780|459130900|FG000|Period II|Non-compliance with study procedures|5|||
127590702|NCT02405780|459130901|FG001|Period II|Non-compliance with study procedures|2|||
127590703|NCT02405780|459130902|FG002|Period II|Non-compliance with study procedures|7|||
127590704|NCT02405780|459130903|FG003|Period II|Non-compliance with study procedures|4|||
127590705|NCT01654536|459130904|FG000|Overall Study|Lost to Follow-up|5|||
127590706|NCT01654536|459130905|FG001|Overall Study|Lost to Follow-up|5|||
127590707|NCT01654536|459130904|FG000|Overall Study|Physician Decision|12|||
127590708|NCT01654536|459130905|FG001|Overall Study|Physician Decision|8|||
127590709|NCT01654536|459130904|FG000|Overall Study|Withdrawal by Subject|27|||
127590710|NCT01654536|459130905|FG001|Overall Study|Withdrawal by Subject|25|||
127590711|NCT04502693|459130908|FG000|Overall Study|Adverse Event|7|||
127590712|NCT04502693|459130909|FG001|Overall Study|Adverse Event|6|||
127590713|NCT04502693|459130910|FG002|Overall Study|Adverse Event|11|||
127590714|NCT04502693|459130911|FG003|Overall Study|Adverse Event|1|||
127590715|NCT04502693|459130908|FG000|Overall Study|Lost to Follow-up|32|||
127590716|NCT04502693|459130909|FG001|Overall Study|Lost to Follow-up|36|||
127590717|NCT04502693|459130910|FG002|Overall Study|Lost to Follow-up|69|||
127590718|NCT04502693|459130911|FG003|Overall Study|Lost to Follow-up|4|||
127590719|NCT04502693|459130908|FG000|Overall Study|Protocol Violation|8|||
127590720|NCT04502693|459130909|FG001|Overall Study|Protocol Violation|8|||
127590721|NCT04502693|459130910|FG002|Overall Study|Protocol Violation|16|||
127590722|NCT04502693|459130911|FG003|Overall Study|Protocol Violation|1|||
127590723|NCT04502693|459130908|FG000|Overall Study|Withdrawal by Subject|46|||
127590724|NCT04502693|459130909|FG001|Overall Study|Withdrawal by Subject|38|||
127590725|NCT04502693|459130910|FG002|Overall Study|Withdrawal by Subject|54|||
127590726|NCT04502693|459130911|FG003|Overall Study|Withdrawal by Subject|7|||
127590727|NCT04502693|459130908|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|6|||
127590728|NCT04502693|459130909|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
127590729|NCT04502693|459130910|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|9|||
127590730|NCT04502693|459130911|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
127590731|NCT04502693|459130908|FG000|Overall Study|Other|1|||
127590732|NCT04502693|459130909|FG001|Overall Study|Other|0|||
127590733|NCT04502693|459130910|FG002|Overall Study|Other|1|||
127590734|NCT04502693|459130911|FG003|Overall Study|Other|1|||
127590735|NCT00602797|459130913|FG000|Overall Study|Adverse Event|1|||
127590736|NCT03943147|459130916|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
127590737|NCT03943147|459130917|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
127590738|NCT03943147|459130916|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
127590739|NCT03943147|459130917|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
127590740|NCT03943147|459130916|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
127590741|NCT03943147|459130917|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
127590742|NCT03943147|459130916|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
127590743|NCT03943147|459130917|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
127590744|NCT03943147|459130916|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
127590745|NCT03943147|459130917|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
127590746|NCT03943147|459130916|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
127590747|NCT03943147|459130917|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
127590748|NCT01318993|459130918|FG000|Overall Study|Adverse Event|53|||
127590749|NCT01318993|459130918|FG000|Overall Study|Lack of Efficacy|121|||
127590750|NCT01318993|459130918|FG000|Overall Study|Protocol Violation|3|||
127590751|NCT01318993|459130918|FG000|Overall Study|Protocol based stopping criteria|6|||
127590752|NCT01318993|459130918|FG000|Overall Study|Study closed or terminated|174|||
127590753|NCT01318993|459130918|FG000|Overall Study|Lost to Follow-up|4|||
127590754|NCT01318993|459130918|FG000|Overall Study|Physician Decision|13|||
127590755|NCT01318993|459130918|FG000|Overall Study|Withdrawal by Subject|24|||
127590756|NCT00629707|459130919|FG000|Overall Study|Withdrawal by Subject|0|||
127590757|NCT00629707|459130920|FG001|Overall Study|Withdrawal by Subject|1|||
127590758|NCT00629707|459130919|FG000|Overall Study|Physician Decision|0|||
127590759|NCT00629707|459130920|FG001|Overall Study|Physician Decision|1|||
127590760|NCT03736447|459130923|FG000|Overall Study|Adverse Event|5|||
127590761|NCT03736447|459130924|FG001|Overall Study|Adverse Event|1|||
127590762|NCT03736447|459130923|FG000|Overall Study|Withdrawal by Subject|5|||
127590763|NCT03736447|459130924|FG001|Overall Study|Withdrawal by Subject|1|||
127590764|NCT03736447|459130923|FG000|Overall Study|Lost to Follow-up|1|||
127590765|NCT03736447|459130924|FG001|Overall Study|Lost to Follow-up|0|||
127590766|NCT03736447|459130923|FG000|Overall Study|Physician Decision|1|||
127590767|NCT03736447|459130924|FG001|Overall Study|Physician Decision|0|||
127694436|NCT02910583|459510742|FG001|Overall Study|Death|3|||
127590768|NCT03736447|459130923|FG000|Overall Study|Continued commitment to study treatment|3|||
127694437|NCT02910583|459510741|FG000|Overall Study|Lost to Follow-up|1|||
127590769|NCT03736447|459130924|FG001|Overall Study|Continued commitment to study treatment|0|||
127590770|NCT03736447|459130923|FG000|Overall Study|Taste aversion to study product|0|||
127590771|NCT03736447|459130924|FG001|Overall Study|Taste aversion to study product|1|||
127590772|NCT02619175|459130925|FG000|Overall Study|Withdrawal by Subject|1|||
127590773|NCT02619175|459130926|FG001|Overall Study|Withdrawal by Subject|0|||
127590774|NCT02619175|459130925|FG000|Overall Study|foot pain|1|||
127590775|NCT02619175|459130926|FG001|Overall Study|foot pain|0|||
127590776|NCT00074152|459130927|FG000|Overall Study|Death|21|||
127590777|NCT00074152|459130928|FG001|Overall Study|Death|9|||
127590778|NCT00074152|459130927|FG000|Overall Study|Lack of Efficacy|34|||
127590779|NCT00074152|459130928|FG001|Overall Study|Lack of Efficacy|24|||
127590780|NCT03547583|459130930|FG000|Overall Study|Adverse Event|16|||
127590781|NCT03547583|459130931|FG001|Overall Study|Adverse Event|11|||
127590782|NCT03547583|459130932|FG002|Overall Study|Adverse Event|10|||
127590783|NCT03547583|459130930|FG000|Overall Study|Death|11|||
127590784|NCT03547583|459130931|FG001|Overall Study|Death|7|||
127590785|NCT03547583|459130932|FG002|Overall Study|Death|4|||
127590786|NCT03547583|459130930|FG000|Overall Study|Lost to Follow-up|1|||
127590787|NCT03547583|459130931|FG001|Overall Study|Lost to Follow-up|0|||
127590788|NCT03547583|459130932|FG002|Overall Study|Lost to Follow-up|0|||
127590789|NCT03547583|459130930|FG000|Overall Study|Non-compliance with study drug|0|||
127590790|NCT03547583|459130931|FG001|Overall Study|Non-compliance with study drug|0|||
127590791|NCT03547583|459130932|FG002|Overall Study|Non-compliance with study drug|1|||
127590792|NCT03547583|459130930|FG000|Overall Study|Physician Decision|1|||
127590793|NCT03547583|459130931|FG001|Overall Study|Physician Decision|0|||
127590794|NCT03547583|459130932|FG002|Overall Study|Physician Decision|3|||
127590795|NCT03547583|459130930|FG000|Overall Study|Protocol Violation|2|||
127590796|NCT03547583|459130931|FG001|Overall Study|Protocol Violation|1|||
127590797|NCT03547583|459130932|FG002|Overall Study|Protocol Violation|1|||
127590798|NCT03547583|459130930|FG000|Overall Study|Withdrawal by Subject|12|||
127590799|NCT03547583|459130931|FG001|Overall Study|Withdrawal by Subject|19|||
127590800|NCT03547583|459130932|FG002|Overall Study|Withdrawal by Subject|10|||
127590801|NCT03547583|459130930|FG000|Overall Study|Other|2|||
127590802|NCT03547583|459130931|FG001|Overall Study|Other|2|||
127590803|NCT03547583|459130932|FG002|Overall Study|Other|3|||
127590804|NCT00382252|459130933|FG000|Overall Study|Death|4|||
127590805|NCT00382252|459130933|FG000|Overall Study|Protocol Violation|8|||
127590806|NCT00382252|459130933|FG000|Overall Study|Not treated by RFA|1|||
127590807|NCT02166905|459130936|FG000|Overall Study|Withdrawal by Subject|1|||
127590808|NCT02166905|459130937|FG001|Overall Study|Withdrawal by Subject|0|||
127590809|NCT02166905|459130938|FG002|Overall Study|Withdrawal by Subject|0|||
127590810|NCT02166905|459130939|FG003|Overall Study|Withdrawal by Subject|0|||
127694438|NCT02910583|459510742|FG001|Overall Study|Lost to Follow-up|0|||
127590811|NCT02617628|459130940|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
127590812|NCT02617628|459130941|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
127590813|NCT03278873|459130945|FG000|Overall Study|Withdrawal by Subject|0|||
127590814|NCT03278873|459130946|FG001|Overall Study|Withdrawal by Subject|1|||
127590815|NCT03278873|459130947|FG002|Overall Study|Withdrawal by Subject|0|||
127590816|NCT03278873|459130948|FG003|Overall Study|Withdrawal by Subject|0|||
127590817|NCT03278873|459130945|FG000|Overall Study|Sponsor's decision|0|||
127590818|NCT03278873|459130946|FG001|Overall Study|Sponsor's decision|1|||
127590819|NCT03278873|459130947|FG002|Overall Study|Sponsor's decision|0|||
127590820|NCT03278873|459130948|FG003|Overall Study|Sponsor's decision|0|||
127590821|NCT03278873|459130945|FG000|Overall Study|Early Termination|2|||
127590822|NCT03278873|459130946|FG001|Overall Study|Early Termination|6|||
127590823|NCT03278873|459130947|FG002|Overall Study|Early Termination|0|||
127590824|NCT03278873|459130948|FG003|Overall Study|Early Termination|4|||
127590825|NCT03278873|459130945|FG000|Overall Study|Lost to Follow-up|0|||
127590826|NCT03278873|459130946|FG001|Overall Study|Lost to Follow-up|0|||
127694439|NCT02910583|459510741|FG000|Overall Study|Withdrawal by Subject|12|||
127694440|NCT02910583|459510742|FG001|Overall Study|Withdrawal by Subject|8|||
127590827|NCT03278873|459130947|FG002|Overall Study|Lost to Follow-up|2|||
127590828|NCT03278873|459130948|FG003|Overall Study|Lost to Follow-up|0|||
127590829|NCT03278873|459130945|FG000|Overall Study|The patient decided to withdraw via email|1|||
127694441|NCT02910583|459510741|FG000|Overall Study|Other, Not Specified|6|||
127590830|NCT03278873|459130946|FG001|Overall Study|The patient decided to withdraw via email|0|||
127590831|NCT03278873|459130947|FG002|Overall Study|The patient decided to withdraw via email|0|||
127590832|NCT03278873|459130948|FG003|Overall Study|The patient decided to withdraw via email|0|||
127590833|NCT03278873|459130945|FG000|Overall Study|The patient was unresponsive to contact|0|||
127590834|NCT03278873|459130946|FG001|Overall Study|The patient was unresponsive to contact|0|||
127590835|NCT03278873|459130947|FG002|Overall Study|The patient was unresponsive to contact|0|||
127694442|NCT02910583|459510742|FG001|Overall Study|Other, Not Specified|3|||
127590836|NCT03278873|459130948|FG003|Overall Study|The patient was unresponsive to contact|4|||
127590837|NCT03278873|459130945|FG000|Overall Study|The patient wished to participate no longer|0|||
127590838|NCT03278873|459130946|FG001|Overall Study|The patient wished to participate no longer|1|||
127590839|NCT03278873|459130947|FG002|Overall Study|The patient wished to participate no longer|0|||
127590840|NCT03278873|459130948|FG003|Overall Study|The patient wished to participate no longer|0|||
127590841|NCT03278873|459130945|FG000|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
127590842|NCT03278873|459130946|FG001|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
127590843|NCT03278873|459130947|FG002|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|1|||
127590844|NCT03278873|459130948|FG003|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
127590845|NCT02801331|459130949|FG000|Overall Study|Transferred to another hospital|8|||
127590846|NCT02801331|459130950|FG001|Overall Study|Transferred to another hospital|7|||
127590847|NCT02801331|459130949|FG000|Overall Study|Withdrawal by Subject|0|||
127590848|NCT02801331|459130950|FG001|Overall Study|Withdrawal by Subject|4|||
127590849|NCT02801331|459130949|FG000|Overall Study|Subsequently met exclusion/withdrawal criteria|3|||
127590850|NCT02801331|459130950|FG001|Overall Study|Subsequently met exclusion/withdrawal criteria|5|||
127590855|NCT04698187|459130961|FG000|Overall Study|Withdrawal by Subject|7|||
127590856|NCT04698187|459130961|FG000|Overall Study|Death|21|||
127590857|NCT04698187|459130961|FG000|Overall Study|Sponsor Decision|15|||
127590858|NCT04698187|459130961|FG000|Overall Study|In-transit Disease|1|||
127590859|NCT02469298|459132780|FG000|Overall Study|Protocol Violation|0|||
127590860|NCT02469298|459132781|FG001|Overall Study|Protocol Violation|1|||
127590861|NCT02469298|459132782|FG002|Overall Study|Protocol Violation|1|||
127590862|NCT02469298|459132783|FG003|Overall Study|Protocol Violation|0|||
127590863|NCT02469298|459132780|FG000|Overall Study|Lost to Follow-up|1|||
127590864|NCT02469298|459132781|FG001|Overall Study|Lost to Follow-up|0|||
127590865|NCT02469298|459132782|FG002|Overall Study|Lost to Follow-up|1|||
127590866|NCT02469298|459132783|FG003|Overall Study|Lost to Follow-up|0|||
127590867|NCT02469298|459132780|FG000|Overall Study|Physician Decision|0|||
127590868|NCT02469298|459132781|FG001|Overall Study|Physician Decision|0|||
127590869|NCT02469298|459132782|FG002|Overall Study|Physician Decision|0|||
127590870|NCT02469298|459132783|FG003|Overall Study|Physician Decision|1|||
127590871|NCT02469298|459132780|FG000|Overall Study|Withdrawal by Subject|0|||
127590872|NCT02469298|459132781|FG001|Overall Study|Withdrawal by Subject|0|||
127590873|NCT02469298|459132782|FG002|Overall Study|Withdrawal by Subject|0|||
127590874|NCT02469298|459132783|FG003|Overall Study|Withdrawal by Subject|1|||
127590875|NCT02370160|459132787|FG000|Overall Study|Death|3|||
127590876|NCT02370160|459132788|FG001|Overall Study|Death|4|||
127590877|NCT02370160|459132789|FG002|Overall Study|Death|1|||
127590878|NCT04487730|459132790|FG000|Overall Study|Withdrawal by Subject|3|||
127590879|NCT04487730|459132791|FG001|Overall Study|Withdrawal by Subject|1|||
127590880|NCT04487730|459132790|FG000|Overall Study|Lost to Follow-up|0|||
127590881|NCT04487730|459132791|FG001|Overall Study|Lost to Follow-up|1|||
127590882|NCT04487730|459132790|FG000|Overall Study|Physician Decision|0|||
127590883|NCT04487730|459132791|FG001|Overall Study|Physician Decision|1|||
127590884|NCT03291808|459132796|FG000|Overall Study|Lost to Follow-up|6|||
127590885|NCT03291808|459132796|FG000|Overall Study|Research burden|4|||
127590886|NCT01892293|459132799|FG000|Overall Study|Apheresed but not treated|4|||
127590887|NCT03602482|459132800|FG000|Overall Study|Withdrawal by Subject|6|||
127590888|NCT03602482|459132801|FG001|Overall Study|Withdrawal by Subject|7|||
127590889|NCT03602482|459132802|FG002|Overall Study|Withdrawal by Subject|0|||
127590890|NCT03602482|459132803|FG003|Overall Study|Withdrawal by Subject|0|||
127590891|NCT02397278|459132804|FG000|Overall Study|Withdrawal by Subject|0|||
127590892|NCT02397278|459132805|FG001|Overall Study|Withdrawal by Subject|2|||
127590893|NCT02397278|459132804|FG000|Overall Study|Deemed ineligible following surgery|1|||
127590894|NCT02397278|459132805|FG001|Overall Study|Deemed ineligible following surgery|1|||
127694443|NCT01331005|459510744|FG000|Overall Study|Lost to Follow-up|2|||
127694444|NCT01331005|459510745|FG001|Overall Study|Lost to Follow-up|1|||
127694445|NCT01331005|459510744|FG000|Overall Study|Withdrawal by Subject|2|||
127590895|NCT01397084|459132810|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
127694446|NCT01331005|459510745|FG001|Overall Study|Withdrawal by Subject|3|||
127694447|NCT05059262|459510746|FG000|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|3|||
127590896|NCT01397084|459132810|FG000|Overall Study|Protocol Violation|2|||
127590897|NCT01397084|459132810|FG000|Overall Study|Adverse Event|2|||
127590898|NCT01397084|459132810|FG000|Overall Study|Withdrawal by Subject|1|||
127590899|NCT01397084|459132810|FG000|Overall Study|Lost to Follow-up|1|||
127590900|NCT01397084|459132810|FG000|Overall Study|Used other proton pump inhibitor|1|||
127694448|NCT05059262|459510747|FG001|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|0|||
127590901|NCT00618072|459132816|FG000|Overall Study|Lost to Follow-up|2|||
127590902|NCT00618072|459132817|FG001|Overall Study|Lost to Follow-up|0|||
127590903|NCT00618072|459132818|FG002|Overall Study|Lost to Follow-up|3|||
127590904|NCT00618072|459132816|FG000|Overall Study|Physician Decision|0|||
127590905|NCT00618072|459132817|FG001|Overall Study|Physician Decision|1|||
127590906|NCT00618072|459132818|FG002|Overall Study|Physician Decision|1|||
127590907|NCT03292588|459132819|FG000|Overall Study|Death|1|||
127590908|NCT03292588|459132820|FG001|Overall Study|Death|0|||
127590909|NCT03292588|459132819|FG000|Overall Study|Lost to Follow-up|12|||
127590910|NCT03292588|459132820|FG001|Overall Study|Lost to Follow-up|16|||
127590911|NCT03292588|459132819|FG000|Overall Study|Physician Decision|0|||
127590912|NCT03292588|459132820|FG001|Overall Study|Physician Decision|1|||
127590913|NCT03292588|459132819|FG000|Overall Study|Withdrawal by Subject|4|||
127590914|NCT03292588|459132820|FG001|Overall Study|Withdrawal by Subject|4|||
127590915|NCT03292588|459132819|FG000|Overall Study|Move out of town|1|||
127590916|NCT03292588|459132820|FG001|Overall Study|Move out of town|0|||
127694449|NCT05059262|459510746|FG000|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
127694450|NCT05059262|459510747|FG001|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
127590917|NCT03292588|459132819|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
127590918|NCT03292588|459132820|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
127590919|NCT00062374|459132821|FG000|Overall Study|Not treated|12|||
127590920|NCT03633695|459132824|FG000|Overall Study|Lost to Follow-up|4|||
127590921|NCT03633695|459132825|FG001|Overall Study|Lost to Follow-up|5|||
127590922|NCT03633695|459132824|FG000|Overall Study|Discontinued|8|||
127590923|NCT03633695|459132825|FG001|Overall Study|Discontinued|4|||
127590924|NCT02380677|459132833|FG000|Overall Study|Adverse Event|0|||
127590925|NCT02380677|459132834|FG001|Overall Study|Adverse Event|0|||
127590926|NCT02380677|459132835|FG002|Overall Study|Adverse Event|0|||
127590927|NCT02380677|459132836|FG003|Overall Study|Adverse Event|1|||
127590928|NCT02380677|459132837|FG004|Overall Study|Adverse Event|1|||
127590929|NCT02380677|459132838|FG005|Overall Study|Adverse Event|4|||
127694451|NCT05059262|459510746|FG000|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
127694452|NCT05059262|459510747|FG001|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
127694453|NCT05059262|459510746|FG000|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|0|||
127694454|NCT05059262|459510747|FG001|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|1|||
127694455|NCT05059262|459510746|FG000|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|1|||
127694456|NCT05059262|459510747|FG001|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|0|||
127694457|NCT05059262|459510746|FG000|Part 2: Open Label (Weeks 25 - EoS)|Death|1|||
127694458|NCT05059262|459510747|FG001|Part 2: Open Label (Weeks 25 - EoS)|Death|0|||
127694459|NCT05059262|459510746|FG000|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|0|||
127694460|NCT05059262|459510747|FG001|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|1|||
127694461|NCT05059262|459510746|FG000|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|0|||
127694462|NCT05059262|459510747|FG001|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|2|||
127694463|NCT05059262|459510746|FG000|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|73|||
127694464|NCT05059262|459510747|FG001|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|32|||
127694465|NCT02029443|459510759|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
127694466|NCT02029443|459510760|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
127694467|NCT02029443|459510761|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
127694468|NCT02029443|459510762|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
127694469|NCT02029443|459510763|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
127694470|NCT02029443|459510759|FG000|Overall Study|Death|13|||
127694471|NCT02029443|459510760|FG001|Overall Study|Death|2|||
127694472|NCT02029443|459510761|FG002|Overall Study|Death|2|||
127694473|NCT02029443|459510762|FG003|Overall Study|Death|11|||
127694474|NCT02029443|459510763|FG004|Overall Study|Death|2|||
127694475|NCT02029443|459510759|FG000|Overall Study|Lost to Follow-up|1|||
127694476|NCT02029443|459510760|FG001|Overall Study|Lost to Follow-up|0|||
127694477|NCT02029443|459510761|FG002|Overall Study|Lost to Follow-up|1|||
127694478|NCT02029443|459510762|FG003|Overall Study|Lost to Follow-up|1|||
127694479|NCT02029443|459510763|FG004|Overall Study|Lost to Follow-up|0|||
127694480|NCT02029443|459510759|FG000|Overall Study|Started other anti-cancer therapy|17|||
127590930|NCT02380677|459132839|FG006|Overall Study|Adverse Event|2|||
127590931|NCT02380677|459132840|FG007|Overall Study|Adverse Event|2|||
127590932|NCT02380677|459132841|FG008|Overall Study|Adverse Event|2|||
127590933|NCT02380677|459132842|FG009|Overall Study|Adverse Event|1|||
127590934|NCT02380677|459132843|FG010|Overall Study|Adverse Event|2|||
127590935|NCT02380677|459132844|FG011|Overall Study|Adverse Event|1|||
127590936|NCT02380677|459132833|FG000|Overall Study|Physician Decision|1|||
127590937|NCT02380677|459132834|FG001|Overall Study|Physician Decision|0|||
127590938|NCT02380677|459132835|FG002|Overall Study|Physician Decision|1|||
127590939|NCT02380677|459132836|FG003|Overall Study|Physician Decision|1|||
127590940|NCT02380677|459132837|FG004|Overall Study|Physician Decision|0|||
127590941|NCT02380677|459132838|FG005|Overall Study|Physician Decision|0|||
127590942|NCT02380677|459132839|FG006|Overall Study|Physician Decision|0|||
127590943|NCT02380677|459132840|FG007|Overall Study|Physician Decision|0|||
127590944|NCT02380677|459132841|FG008|Overall Study|Physician Decision|0|||
127590945|NCT02380677|459132842|FG009|Overall Study|Physician Decision|0|||
127590946|NCT02380677|459132843|FG010|Overall Study|Physician Decision|0|||
127590947|NCT02380677|459132844|FG011|Overall Study|Physician Decision|0|||
127590948|NCT02380677|459132833|FG000|Overall Study|Lack of Efficacy|0|||
127590949|NCT02380677|459132834|FG001|Overall Study|Lack of Efficacy|1|||
127590950|NCT02380677|459132835|FG002|Overall Study|Lack of Efficacy|2|||
127590951|NCT02380677|459132836|FG003|Overall Study|Lack of Efficacy|0|||
127590952|NCT02380677|459132837|FG004|Overall Study|Lack of Efficacy|4|||
127590953|NCT02380677|459132838|FG005|Overall Study|Lack of Efficacy|1|||
127590954|NCT02380677|459132839|FG006|Overall Study|Lack of Efficacy|1|||
127590955|NCT02380677|459132840|FG007|Overall Study|Lack of Efficacy|2|||
127590956|NCT02380677|459132841|FG008|Overall Study|Lack of Efficacy|2|||
127590957|NCT02380677|459132842|FG009|Overall Study|Lack of Efficacy|0|||
127694481|NCT02029443|459510760|FG001|Overall Study|Started other anti-cancer therapy|4|||
127694482|NCT02029443|459510761|FG002|Overall Study|Started other anti-cancer therapy|7|||
127694483|NCT02029443|459510762|FG003|Overall Study|Started other anti-cancer therapy|9|||
127694484|NCT02029443|459510763|FG004|Overall Study|Started other anti-cancer therapy|3|||
127590958|NCT02380677|459132843|FG010|Overall Study|Lack of Efficacy|2|||
127590959|NCT02380677|459132844|FG011|Overall Study|Lack of Efficacy|1|||
127590960|NCT02380677|459132833|FG000|Overall Study|Withdrawal by Subject|0|||
127590961|NCT02380677|459132834|FG001|Overall Study|Withdrawal by Subject|0|||
127590962|NCT02380677|459132835|FG002|Overall Study|Withdrawal by Subject|0|||
127590963|NCT02380677|459132836|FG003|Overall Study|Withdrawal by Subject|0|||
127590964|NCT02380677|459132837|FG004|Overall Study|Withdrawal by Subject|0|||
127590965|NCT02380677|459132838|FG005|Overall Study|Withdrawal by Subject|0|||
127590966|NCT02380677|459132839|FG006|Overall Study|Withdrawal by Subject|0|||
127590967|NCT02380677|459132840|FG007|Overall Study|Withdrawal by Subject|0|||
127694485|NCT02029443|459510759|FG000|Overall Study|Withdrawal by Subject|3|||
127694486|NCT02029443|459510760|FG001|Overall Study|Withdrawal by Subject|1|||
127694487|NCT02029443|459510761|FG002|Overall Study|Withdrawal by Subject|1|||
127694488|NCT02029443|459510762|FG003|Overall Study|Withdrawal by Subject|1|||
127590968|NCT02380677|459132841|FG008|Overall Study|Withdrawal by Subject|0|||
127590969|NCT02380677|459132842|FG009|Overall Study|Withdrawal by Subject|1|||
127590970|NCT02380677|459132843|FG010|Overall Study|Withdrawal by Subject|0|||
127590971|NCT02380677|459132844|FG011|Overall Study|Withdrawal by Subject|3|||
127590972|NCT02380677|459132833|FG000|Overall Study|Other|0|||
127590973|NCT02380677|459132834|FG001|Overall Study|Other|0|||
127590974|NCT02380677|459132835|FG002|Overall Study|Other|0|||
127590975|NCT02380677|459132836|FG003|Overall Study|Other|1|||
127590976|NCT02380677|459132837|FG004|Overall Study|Other|1|||
127590977|NCT02380677|459132838|FG005|Overall Study|Other|1|||
127590978|NCT02380677|459132839|FG006|Overall Study|Other|0|||
127590979|NCT02380677|459132840|FG007|Overall Study|Other|0|||
127590980|NCT02380677|459132841|FG008|Overall Study|Other|0|||
127590981|NCT02380677|459132842|FG009|Overall Study|Other|0|||
127590982|NCT02380677|459132843|FG010|Overall Study|Other|0|||
127590983|NCT02380677|459132844|FG011|Overall Study|Other|0|||
127590984|NCT02170298|459132846|FG000|Overall Study|Withdrawal by Subject|0|||
127590985|NCT02170298|459132847|FG001|Overall Study|Withdrawal by Subject|1|||
127590986|NCT02170298|459132846|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
127590987|NCT02170298|459132847|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
127590988|NCT01976338|459132848|FG000|Overall Study|Physician Decision|0|||
127590989|NCT01976338|459132849|FG001|Overall Study|Physician Decision|1|||
127590990|NCT01976338|459132848|FG000|Overall Study|Lost to Follow-up|3|||
127590991|NCT01976338|459132849|FG001|Overall Study|Lost to Follow-up|0|||
127590992|NCT01976338|459132848|FG000|Overall Study|Withdrawal by Subject|5|||
127590993|NCT01976338|459132849|FG001|Overall Study|Withdrawal by Subject|2|||
127590994|NCT01976338|459132848|FG000|Overall Study|Adverse Event|5|||
127590995|NCT01976338|459132849|FG001|Overall Study|Adverse Event|1|||
127590996|NCT00777608|459132850|FG000|Overall Study|Lost to Follow-up|1|||
127590997|NCT00777608|459132851|FG001|Overall Study|Lost to Follow-up|1|||
127590998|NCT00777608|459132850|FG000|Overall Study|Withdrawal by Subject|1|||
127590999|NCT00777608|459132851|FG001|Overall Study|Withdrawal by Subject|3|||
127591000|NCT00777608|459132850|FG000|Overall Study|Protocol Violation|1|||
127591001|NCT00777608|459132851|FG001|Overall Study|Protocol Violation|0|||
127591002|NCT00777608|459132850|FG000|Overall Study|Investigator Decision|1|||
127591003|NCT00777608|459132851|FG001|Overall Study|Investigator Decision|2|||
127591004|NCT02853604|459132852|FG000|Overall Study|Withdrawal by Subject|12|||
127591005|NCT02853604|459132853|FG001|Overall Study|Withdrawal by Subject|35|||
127591006|NCT02853604|459132852|FG000|Overall Study|Lost to Follow-up|4|||
127591007|NCT02853604|459132853|FG001|Overall Study|Lost to Follow-up|8|||
127591008|NCT02853604|459132852|FG000|Overall Study|Death|1|||
127591009|NCT02853604|459132853|FG001|Overall Study|Death|5|||
127591010|NCT02853604|459132852|FG000|Overall Study|Miscellaneous|11|||
127591011|NCT02853604|459132853|FG001|Overall Study|Miscellaneous|2|||
127591012|NCT02853604|459132852|FG000|Overall Study|Progressive Disease|0|||
127591013|NCT02853604|459132853|FG001|Overall Study|Progressive Disease|2|||
127591014|NCT04213079|459132854|FG000|Overall Study|Lost to Follow-up|0|||
127591015|NCT04213079|459132855|FG001|Overall Study|Lost to Follow-up|2|||
127591016|NCT03766581|459132857|FG000|Randomization|Other reasons|2|||
127591017|NCT03766581|459132858|FG001|Randomization|Other reasons|1|||
127591018|NCT03766581|459132859|FG002|Randomization|Other reasons|0|||
127694489|NCT02029443|459510763|FG004|Overall Study|Withdrawal by Subject|0|||
127694490|NCT02029443|459510759|FG000|Overall Study|Other|6|||
127694491|NCT02029443|459510760|FG001|Overall Study|Other|6|||
127694492|NCT02029443|459510761|FG002|Overall Study|Other|4|||
127694493|NCT02029443|459510762|FG003|Overall Study|Other|2|||
127591019|NCT03766581|459132860|FG003|Randomization|Other reasons|1|||
127591020|NCT03766581|459132861|FG004|Randomization|Other reasons|0|||
127591021|NCT03766581|459132862|FG005|Randomization|Other reasons|0|||
127591022|NCT03766581|459132863|FG006|Randomization|Other reasons|0|||
127591023|NCT03766581|459132864|FG007|Randomization|Other reasons|0|||
127591024|NCT03766581|459132857|FG000|Randomization|Participant no longer meets study criteria|5|||
127694494|NCT02029443|459510763|FG004|Overall Study|Other|0|||
127694495|NCT03393975|459510767|FG000|Urgent Treatment Period|Physician Decision|0|||
127591025|NCT03766581|459132858|FG001|Randomization|Participant no longer meets study criteria|3|||
127591026|NCT03766581|459132859|FG002|Randomization|Participant no longer meets study criteria|4|||
127591027|NCT03766581|459132860|FG003|Randomization|Participant no longer meets study criteria|0|||
127591028|NCT03766581|459132861|FG004|Randomization|Participant no longer meets study criteria|2|||
127694496|NCT03393975|459510768|FG001|Urgent Treatment Period|Physician Decision|0|||
127591029|NCT03766581|459132862|FG005|Randomization|Participant no longer meets study criteria|3|||
127591030|NCT03766581|459132863|FG006|Randomization|Participant no longer meets study criteria|0|||
127591031|NCT03766581|459132864|FG007|Randomization|Participant no longer meets study criteria|1|||
127591032|NCT03766581|459132857|FG000|Randomization|Participant request to discontinue study treatment|1|||
127591033|NCT03766581|459132858|FG001|Randomization|Participant request to discontinue study treatment|0|||
127591034|NCT03766581|459132859|FG002|Randomization|Participant request to discontinue study treatment|0|||
127591035|NCT03766581|459132860|FG003|Randomization|Participant request to discontinue study treatment|0|||
127591036|NCT03766581|459132861|FG004|Randomization|Participant request to discontinue study treatment|1|||
127591037|NCT03766581|459132862|FG005|Randomization|Participant request to discontinue study treatment|2|||
127591038|NCT03766581|459132863|FG006|Randomization|Participant request to discontinue study treatment|0|||
127591039|NCT03766581|459132864|FG007|Randomization|Participant request to discontinue study treatment|0|||
127591040|NCT03766581|459132857|FG000|Randomization|Participant withdrew consent|1|||
127591041|NCT03766581|459132858|FG001|Randomization|Participant withdrew consent|0|||
127591042|NCT03766581|459132859|FG002|Randomization|Participant withdrew consent|1|||
127591043|NCT03766581|459132860|FG003|Randomization|Participant withdrew consent|2|||
127591044|NCT03766581|459132861|FG004|Randomization|Participant withdrew consent|1|||
127591045|NCT03766581|459132862|FG005|Randomization|Participant withdrew consent|1|||
127591046|NCT03766581|459132863|FG006|Randomization|Participant withdrew consent|0|||
127591047|NCT03766581|459132864|FG007|Randomization|Participant withdrew consent|0|||
127591048|NCT03766581|459132857|FG000|Treatment|Adverse Event|82|||
127591049|NCT03766581|459132858|FG001|Treatment|Adverse Event|44|||
127591050|NCT03766581|459132859|FG002|Treatment|Adverse Event|47|||
127591051|NCT03766581|459132860|FG003|Treatment|Adverse Event|46|||
127591052|NCT03766581|459132861|FG004|Treatment|Adverse Event|50|||
127591053|NCT03766581|459132862|FG005|Treatment|Adverse Event|77|||
127591054|NCT03766581|459132863|FG006|Treatment|Adverse Event|5|||
127591055|NCT03766581|459132864|FG007|Treatment|Adverse Event|2|||
127591056|NCT03766581|459132857|FG000|Treatment|Participant request to discontinue treatment|34|||
127591057|NCT03766581|459132858|FG001|Treatment|Participant request to discontinue treatment|6|||
127591058|NCT03766581|459132859|FG002|Treatment|Participant request to discontinue treatment|10|||
127591059|NCT03766581|459132860|FG003|Treatment|Participant request to discontinue treatment|10|||
127591060|NCT03766581|459132861|FG004|Treatment|Participant request to discontinue treatment|14|||
127591061|NCT03766581|459132862|FG005|Treatment|Participant request to discontinue treatment|15|||
127591062|NCT03766581|459132863|FG006|Treatment|Participant request to discontinue treatment|0|||
127591063|NCT03766581|459132864|FG007|Treatment|Participant request to discontinue treatment|1|||
127591064|NCT03766581|459132857|FG000|Treatment|Participant withdrew consent|11|||
127591065|NCT03766581|459132858|FG001|Treatment|Participant withdrew consent|4|||
127591066|NCT03766581|459132859|FG002|Treatment|Participant withdrew consent|5|||
127591067|NCT03766581|459132860|FG003|Treatment|Participant withdrew consent|5|||
127591068|NCT03766581|459132861|FG004|Treatment|Participant withdrew consent|4|||
127591069|NCT03766581|459132862|FG005|Treatment|Participant withdrew consent|4|||
127591070|NCT03766581|459132863|FG006|Treatment|Participant withdrew consent|0|||
127591071|NCT03766581|459132864|FG007|Treatment|Participant withdrew consent|0|||
127591072|NCT03766581|459132857|FG000|Treatment|Death|1|||
127591073|NCT03766581|459132858|FG001|Treatment|Death|0|||
127591074|NCT03766581|459132859|FG002|Treatment|Death|0|||
127591075|NCT03766581|459132860|FG003|Treatment|Death|0|||
127591076|NCT03766581|459132861|FG004|Treatment|Death|0|||
127591077|NCT03766581|459132862|FG005|Treatment|Death|0|||
127591078|NCT03766581|459132863|FG006|Treatment|Death|0|||
127591079|NCT03766581|459132864|FG007|Treatment|Death|0|||
127591080|NCT03766581|459132857|FG000|Treatment|Lost to Follow-up|1|||
127591081|NCT03766581|459132858|FG001|Treatment|Lost to Follow-up|0|||
127591082|NCT03766581|459132859|FG002|Treatment|Lost to Follow-up|0|||
127591083|NCT03766581|459132860|FG003|Treatment|Lost to Follow-up|1|||
127591084|NCT03766581|459132861|FG004|Treatment|Lost to Follow-up|0|||
127591085|NCT03766581|459132862|FG005|Treatment|Lost to Follow-up|0|||
127591086|NCT03766581|459132863|FG006|Treatment|Lost to Follow-up|0|||
127591087|NCT03766581|459132864|FG007|Treatment|Lost to Follow-up|0|||
127882060|NCT01289990|460190803|FG010|Overall Study|Withdrawal by Subject|11|||
127882061|NCT01289990|460190804|FG011|Overall Study|Withdrawal by Subject|13|||
127882062|NCT01289990|460190805|FG012|Overall Study|Withdrawal by Subject|16|||
127591088|NCT03766581|459132857|FG000|Treatment|Poor/Non compliance|2|||
127591089|NCT03766581|459132858|FG001|Treatment|Poor/Non compliance|2|||
127591090|NCT03766581|459132859|FG002|Treatment|Poor/Non compliance|1|||
127591091|NCT03766581|459132860|FG003|Treatment|Poor/Non compliance|1|||
127591092|NCT03766581|459132861|FG004|Treatment|Poor/Non compliance|1|||
127591093|NCT03766581|459132862|FG005|Treatment|Poor/Non compliance|1|||
127591094|NCT03766581|459132863|FG006|Treatment|Poor/Non compliance|0|||
127591095|NCT03766581|459132864|FG007|Treatment|Poor/Non compliance|0|||
127591096|NCT03766581|459132857|FG000|Treatment|Participant no longer meets study criteria|9|||
127591097|NCT03766581|459132858|FG001|Treatment|Participant no longer meets study criteria|1|||
127591098|NCT03766581|459132859|FG002|Treatment|Participant no longer meets study criteria|5|||
127591099|NCT03766581|459132860|FG003|Treatment|Participant no longer meets study criteria|4|||
127882063|NCT01289990|460190793|FG000|Overall Study|discontinued in preceding trial|18|||
127591100|NCT03766581|459132861|FG004|Treatment|Participant no longer meets study criteria|4|||
127591101|NCT03766581|459132862|FG005|Treatment|Participant no longer meets study criteria|4|||
127591102|NCT03766581|459132863|FG006|Treatment|Participant no longer meets study criteria|2|||
127591103|NCT03766581|459132864|FG007|Treatment|Participant no longer meets study criteria|0|||
127591104|NCT03766581|459132857|FG000|Treatment|Other reasons|13|||
127591105|NCT03766581|459132858|FG001|Treatment|Other reasons|8|||
127591106|NCT03766581|459132859|FG002|Treatment|Other reasons|3|||
127591107|NCT03766581|459132860|FG003|Treatment|Other reasons|7|||
127591108|NCT03766581|459132861|FG004|Treatment|Other reasons|3|||
127591109|NCT03766581|459132862|FG005|Treatment|Other reasons|3|||
127591110|NCT03766581|459132863|FG006|Treatment|Other reasons|0|||
127591111|NCT03766581|459132864|FG007|Treatment|Other reasons|0|||
127591112|NCT02732119|459132865|FG000|Phase I|Adverse Event|1|||
127591113|NCT02732119|459132866|FG001|Phase I|Adverse Event|3|||
127591114|NCT02732119|459132867|FG002|Phase I|Adverse Event|1|||
127591115|NCT02732119|459132868|FG003|Phase I|Adverse Event|0|||
127591116|NCT02732119|459132869|FG004|Phase I|Adverse Event|0|||
127591117|NCT02732119|459132865|FG000|Phase I|Progressive disease|7|||
127591118|NCT02732119|459132866|FG001|Phase I|Progressive disease|3|||
127591119|NCT02732119|459132867|FG002|Phase I|Progressive disease|2|||
127591120|NCT02732119|459132868|FG003|Phase I|Progressive disease|0|||
127591121|NCT02732119|459132869|FG004|Phase I|Progressive disease|0|||
127591122|NCT02732119|459132865|FG000|Phase I|Protocol deviation|0|||
127591123|NCT02732119|459132866|FG001|Phase I|Protocol deviation|1|||
127591124|NCT02732119|459132867|FG002|Phase I|Protocol deviation|0|||
127591125|NCT02732119|459132868|FG003|Phase I|Protocol deviation|0|||
127591126|NCT02732119|459132869|FG004|Phase I|Protocol deviation|0|||
127591127|NCT02732119|459132865|FG000|Phase I|Physician Decision|0|||
127591128|NCT02732119|459132866|FG001|Phase I|Physician Decision|3|||
127591129|NCT02732119|459132867|FG002|Phase I|Physician Decision|4|||
127591130|NCT02732119|459132868|FG003|Phase I|Physician Decision|0|||
127591131|NCT02732119|459132869|FG004|Phase I|Physician Decision|0|||
127591132|NCT02732119|459132865|FG000|Phase II|Adverse Event|0|||
127591133|NCT02732119|459132866|FG001|Phase II|Adverse Event|0|||
127591134|NCT02732119|459132867|FG002|Phase II|Adverse Event|0|||
127591135|NCT02732119|459132868|FG003|Phase II|Adverse Event|3|||
127591136|NCT02732119|459132869|FG004|Phase II|Adverse Event|3|||
127591137|NCT02732119|459132865|FG000|Phase II|Death|0|||
127591138|NCT02732119|459132866|FG001|Phase II|Death|0|||
127591139|NCT02732119|459132867|FG002|Phase II|Death|0|||
127591140|NCT02732119|459132868|FG003|Phase II|Death|1|||
127591141|NCT02732119|459132869|FG004|Phase II|Death|0|||
127591142|NCT02732119|459132865|FG000|Phase II|Progressive dissease|0|||
127591143|NCT02732119|459132866|FG001|Phase II|Progressive dissease|0|||
127591144|NCT02732119|459132867|FG002|Phase II|Progressive dissease|0|||
127591145|NCT02732119|459132868|FG003|Phase II|Progressive dissease|30|||
127591146|NCT02732119|459132869|FG004|Phase II|Progressive dissease|23|||
127591147|NCT02732119|459132865|FG000|Phase II|Study terminated by sponsor|0|||
127591148|NCT02732119|459132866|FG001|Phase II|Study terminated by sponsor|0|||
127591149|NCT02732119|459132867|FG002|Phase II|Study terminated by sponsor|0|||
127591150|NCT02732119|459132868|FG003|Phase II|Study terminated by sponsor|2|||
127591151|NCT02732119|459132869|FG004|Phase II|Study terminated by sponsor|2|||
127591152|NCT02732119|459132865|FG000|Phase II|Other|0|||
127591153|NCT02732119|459132866|FG001|Phase II|Other|0|||
127591154|NCT02732119|459132867|FG002|Phase II|Other|0|||
127591155|NCT02732119|459132868|FG003|Phase II|Other|2|||
127591156|NCT02732119|459132869|FG004|Phase II|Other|0|||
127591157|NCT02732119|459132865|FG000|Phase II|Physician Decision|0|||
127591158|NCT02732119|459132866|FG001|Phase II|Physician Decision|0|||
127591159|NCT02732119|459132867|FG002|Phase II|Physician Decision|0|||
127591160|NCT02732119|459132868|FG003|Phase II|Physician Decision|8|||
127591161|NCT02732119|459132869|FG004|Phase II|Physician Decision|5|||
127591162|NCT02099708|459132879|FG000|Overall Study|Data Not Available|30|||
127591163|NCT02099708|459132879|FG000|Overall Study|Lost to Follow-up|141|||
127591164|NCT02099708|459132879|FG000|Overall Study|Other|29|||
127591165|NCT05466682|459132883|FG000|Overall Study|Withdrawal by Subject|0|||
127591166|NCT05466682|459132884|FG001|Overall Study|Withdrawal by Subject|2|||
127591167|NCT05466682|459132883|FG000|Overall Study|Lost to Follow-up|2|||
127591168|NCT05466682|459132884|FG001|Overall Study|Lost to Follow-up|1|||
127591169|NCT01697566|459132885|FG000|Overall Study|Withdrawal by Subject|0|||
127591170|NCT01697566|459132886|FG001|Overall Study|Withdrawal by Subject|0|||
127591171|NCT01697566|459132887|FG002|Overall Study|Withdrawal by Subject|1|||
127591172|NCT01697566|459132888|FG003|Overall Study|Withdrawal by Subject|1|||
127591173|NCT01697566|459132885|FG000|Overall Study|Final biopsy not obtained|0|||
127591174|NCT01697566|459132886|FG001|Overall Study|Final biopsy not obtained|0|||
127591175|NCT01697566|459132887|FG002|Overall Study|Final biopsy not obtained|1|||
127591176|NCT01697566|459132888|FG003|Overall Study|Final biopsy not obtained|0|||
127591177|NCT01930123|459132889|FG000|Overall Study|Adverse Event|1|||
127591178|NCT01930123|459132890|FG001|Overall Study|Adverse Event|0|||
127591179|NCT01930123|459132889|FG000|Overall Study|Physician Decision|21|||
127591180|NCT01930123|459132890|FG001|Overall Study|Physician Decision|8|||
127591181|NCT01930123|459132889|FG000|Overall Study|Withdrawal by Subject|1|||
127591182|NCT01930123|459132890|FG001|Overall Study|Withdrawal by Subject|0|||
127591183|NCT01447433|459132893|FG000|Overall Study|Lost to Follow-up|0|||
127591184|NCT01447433|459132894|FG001|Overall Study|Lost to Follow-up|2|||
127591185|NCT01447433|459132893|FG000|Overall Study|Withdrawal by Subject|3|||
127591186|NCT01447433|459132894|FG001|Overall Study|Withdrawal by Subject|3|||
127591187|NCT01447433|459132893|FG000|Overall Study|Protocol Violation|1|||
127591188|NCT01447433|459132894|FG001|Overall Study|Protocol Violation|1|||
127591189|NCT00036270|459132895|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
127591190|NCT00036270|459132896|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
127591191|NCT00036270|459132895|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
127591192|NCT00036270|459132896|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
127591193|NCT00036270|459132895|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
127591194|NCT00036270|459132896|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
127591195|NCT00036270|459132895|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
127591196|NCT00036270|459132896|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
127591197|NCT00036270|459132895|FG000|Study Treatment to 5 Year Report|Other|277|||
127591198|NCT00036270|459132896|FG001|Study Treatment to 5 Year Report|Other|288|||
127591199|NCT00036270|459132895|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
127591200|NCT00036270|459132896|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
127591201|NCT00036270|459132895|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
127591202|NCT00036270|459132896|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
127591203|NCT00036270|459132895|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
127591204|NCT00036270|459132896|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
127591205|NCT00036270|459132895|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
127591206|NCT00036270|459132896|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
127591207|NCT00036270|459132895|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
127591208|NCT00036270|459132896|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
127591209|NCT00036270|459132895|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
127591210|NCT00036270|459132896|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
127591211|NCT01964430|459132897|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
127591212|NCT01964430|459132898|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
127591213|NCT01964430|459132897|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
127591214|NCT01964430|459132898|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
127591215|NCT01964430|459132897|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
127591216|NCT01964430|459132898|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
127591217|NCT01964430|459132897|FG000|Treatment Period|Adverse Event|71|||
127591218|NCT01964430|459132898|FG001|Treatment Period|Adverse Event|37|||
127591219|NCT01964430|459132897|FG000|Treatment Period|Withdrawal by Subject|36|||
127591220|NCT01964430|459132898|FG001|Treatment Period|Withdrawal by Subject|27|||
127591221|NCT01964430|459132897|FG000|Treatment Period|Death|1|||
127591222|NCT01964430|459132898|FG001|Treatment Period|Death|3|||
127591223|NCT01964430|459132897|FG000|Treatment Period|Protocol Deviation|0|||
127591224|NCT01964430|459132898|FG001|Treatment Period|Protocol Deviation|1|||
127591225|NCT01964430|459132897|FG000|Treatment Period|Physician Decision|5|||
127591226|NCT01964430|459132898|FG001|Treatment Period|Physician Decision|4|||
127591227|NCT01964430|459132897|FG000|Treatment Period|Disease Relapse|28|||
127591228|NCT01964430|459132898|FG001|Treatment Period|Disease Relapse|38|||
127591229|NCT01964430|459132897|FG000|Treatment Period|Other reasons|1|||
127591230|NCT01964430|459132898|FG001|Treatment Period|Other reasons|3|||
127591231|NCT02516163|459132899|FG000|Overall Study|Withdrawal by Subject|1|||
127591232|NCT02516163|459132899|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
127591233|NCT02516163|459132899|FG000|Overall Study|Unfit/delay in surgery|3|||
127591234|NCT02516163|459132899|FG000|Overall Study|Use of incorrect measurement technique|5|||
127591235|NCT02516163|459132899|FG000|Overall Study|Data not recorded|2|||
127591236|NCT02516163|459132899|FG000|Overall Study|MRI contraindication exclusion|6|||
127591237|NCT02801396|459132900|FG000|Period 1|Withdrawal by Subject|0|||
127591238|NCT02801396|459132901|FG001|Period 1|Withdrawal by Subject|0|||
127784674|NCT00262522|459837017|FG001|Study Start Through 48 Weeks|Death|0|||
127784675|NCT00262522|459837018|FG002|Study Start Through 48 Weeks|Death|1|||
127591239|NCT02801396|459132902|FG002|Period 1|Withdrawal by Subject|0|||
127591240|NCT02801396|459132903|FG003|Period 1|Withdrawal by Subject|0|||
127591241|NCT02801396|459132904|FG004|Period 1|Withdrawal by Subject|1|||
127591242|NCT02801396|459132905|FG005|Period 1|Withdrawal by Subject|0|||
127591243|NCT01658072|459132908|FG000|Overall Study|Protocol Violation|4|||
127591244|NCT01658072|459132909|FG001|Overall Study|Protocol Violation|2|||
127591245|NCT00799422|459132916|FG000|First Week of Wear|Lost to Follow-up|0|||
127591246|NCT00799422|459132917|FG001|First Week of Wear|Lost to Follow-up|0|||
127591247|NCT00799422|459132918|FG002|First Week of Wear|Lost to Follow-up|1|||
127591248|NCT00799422|459132919|FG003|First Week of Wear|Lost to Follow-up|0|||
127591249|NCT00799422|459132920|FG004|First Week of Wear|Lost to Follow-up|0|||
127591250|NCT00799422|459132921|FG005|First Week of Wear|Lost to Follow-up|0|||
127591251|NCT00799422|459132916|FG000|First Week of Wear|Adverse Event|0|||
127591252|NCT00799422|459132917|FG001|First Week of Wear|Adverse Event|0|||
127591253|NCT00799422|459132918|FG002|First Week of Wear|Adverse Event|0|||
127591254|NCT00799422|459132919|FG003|First Week of Wear|Adverse Event|1|||
127591255|NCT00799422|459132920|FG004|First Week of Wear|Adverse Event|0|||
127591256|NCT00799422|459132921|FG005|First Week of Wear|Adverse Event|0|||
127591257|NCT01587001|459132928|FG000|Overall Study|Lost to Follow-up|2|||
127591258|NCT01587001|459132929|FG001|Overall Study|Lost to Follow-up|0|||
127591259|NCT01587001|459132928|FG000|Overall Study|Insufficient samples to complete testing|4|||
127591260|NCT01587001|459132929|FG001|Overall Study|Insufficient samples to complete testing|1|||
127591261|NCT02756013|459132930|FG000|Overall Study|Adverse Event|1|||
127591262|NCT02756013|459132930|FG000|Overall Study|Hypersensitivity|1|||
127591263|NCT03334539|459132931|FG000|Overall Study|Adverse Event|3|||
127591264|NCT03334539|459132932|FG001|Overall Study|Adverse Event|5|||
127591265|NCT03334539|459132933|FG002|Overall Study|Adverse Event|0|||
127591266|NCT03334539|459132931|FG000|Overall Study|Withdrawal by Subject|0|||
127591267|NCT03334539|459132932|FG001|Overall Study|Withdrawal by Subject|1|||
127591268|NCT03334539|459132933|FG002|Overall Study|Withdrawal by Subject|1|||
127591269|NCT03334539|459132931|FG000|Overall Study|Administrative Reasons|1|||
127591270|NCT03334539|459132932|FG001|Overall Study|Administrative Reasons|0|||
127591271|NCT03334539|459132933|FG002|Overall Study|Administrative Reasons|0|||
127591272|NCT03334539|459132931|FG000|Overall Study|Hypertension Not Controlled|0|||
127591273|NCT03334539|459132932|FG001|Overall Study|Hypertension Not Controlled|1|||
127591274|NCT03334539|459132933|FG002|Overall Study|Hypertension Not Controlled|0|||
127591275|NCT03706456|459132934|FG000|Overall Study|Adverse Event|1|||
127591276|NCT03706456|459132934|FG000|Overall Study|Lack of Efficacy|2|||
127591277|NCT02784431|459132935|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
127591278|NCT02784431|459132935|FG000|Overall Study|Early Study Termination|19|||
127591279|NCT03302234|459132938|FG000|Overall Study|Death|191|||
127591280|NCT03302234|459132939|FG001|Overall Study|Death|192|||
127591281|NCT03302234|459132938|FG000|Overall Study|Withdrawal by Subject|2|||
127591282|NCT03302234|459132939|FG001|Overall Study|Withdrawal by Subject|2|||
127591283|NCT03302234|459132938|FG000|Overall Study|Sponsor Decision|90|||
127591284|NCT03302234|459132939|FG001|Overall Study|Sponsor Decision|89|||
127591285|NCT03302234|459132938|FG000|Overall Study|Laryngeal carcinoma|0|||
127591286|NCT03302234|459132939|FG001|Overall Study|Laryngeal carcinoma|1|||
127591287|NCT03302234|459132938|FG000|Overall Study|Not Reported|1|||
127591288|NCT03302234|459132939|FG001|Overall Study|Not Reported|0|||
127591289|NCT02795832|459132940|FG000|Overall Study|Adverse Event|0|||
127591290|NCT02795832|459132941|FG001|Overall Study|Adverse Event|0|||
127591291|NCT02795832|459132942|FG002|Overall Study|Adverse Event|0|||
127591292|NCT02795832|459132943|FG003|Overall Study|Adverse Event|0|||
127591293|NCT02795832|459132944|FG004|Overall Study|Adverse Event|0|||
127591294|NCT02795832|459132945|FG005|Overall Study|Adverse Event|3|||
127591295|NCT04523220|459132946|FG000|Main Treatment Period|Physician Decision|1|||
127591296|NCT04523220|459132947|FG001|Main Treatment Period|Physician Decision|1|||
127591297|NCT04523220|459132948|FG002|Main Treatment Period|Physician Decision|0|||
127591298|NCT04523220|459132946|FG000|Main Treatment Period|Other|5|||
127591299|NCT04523220|459132947|FG001|Main Treatment Period|Other|2|||
127591300|NCT04523220|459132948|FG002|Main Treatment Period|Other|4|||
127591301|NCT04523220|459132946|FG000|Main Treatment Period|Subject Decision|5|||
127591302|NCT04523220|459132947|FG001|Main Treatment Period|Subject Decision|7|||
127591303|NCT04523220|459132948|FG002|Main Treatment Period|Subject Decision|3|||
127591304|NCT04523220|459132946|FG000|Main Treatment Period|Death|5|||
127591305|NCT04523220|459132947|FG001|Main Treatment Period|Death|11|||
127591306|NCT04523220|459132948|FG002|Main Treatment Period|Death|4|||
127591307|NCT04523220|459132946|FG000|Main Treatment Period|Adverse Event|11|||
127591308|NCT04523220|459132947|FG001|Main Treatment Period|Adverse Event|9|||
127591309|NCT04523220|459132948|FG002|Main Treatment Period|Adverse Event|9|||
127591310|NCT04523220|459132946|FG000|Main Treatment Period|Withdrawal by Subject|3|||
127591311|NCT04523220|459132947|FG001|Main Treatment Period|Withdrawal by Subject|3|||
127591312|NCT04523220|459132948|FG002|Main Treatment Period|Withdrawal by Subject|4|||
127591313|NCT04523220|459132946|FG000|Main Treatment Period|Study drug never adminstered|10|||
127591314|NCT04523220|459132947|FG001|Main Treatment Period|Study drug never adminstered|3|||
127591315|NCT04523220|459132948|FG002|Main Treatment Period|Study drug never adminstered|5|||
127591316|NCT04523220|459132946|FG000|Extension Treatment Period|Physician Decision|1|||
127591317|NCT04523220|459132947|FG001|Extension Treatment Period|Physician Decision|0|||
127591318|NCT04523220|459132948|FG002|Extension Treatment Period|Physician Decision|3|||
127591319|NCT04523220|459132946|FG000|Extension Treatment Period|Other|2|||
127591320|NCT04523220|459132947|FG001|Extension Treatment Period|Other|6|||
127591321|NCT04523220|459132948|FG002|Extension Treatment Period|Other|6|||
127591322|NCT04523220|459132946|FG000|Extension Treatment Period|Subject Decision|5|||
127591323|NCT04523220|459132947|FG001|Extension Treatment Period|Subject Decision|2|||
127591324|NCT04523220|459132948|FG002|Extension Treatment Period|Subject Decision|4|||
127591325|NCT04523220|459132946|FG000|Extension Treatment Period|Death|6|||
127591326|NCT04523220|459132947|FG001|Extension Treatment Period|Death|4|||
127591327|NCT04523220|459132948|FG002|Extension Treatment Period|Death|7|||
127591328|NCT04523220|459132946|FG000|Extension Treatment Period|Adverse Event|6|||
127591329|NCT04523220|459132947|FG001|Extension Treatment Period|Adverse Event|7|||
127591330|NCT04523220|459132948|FG002|Extension Treatment Period|Adverse Event|9|||
127591331|NCT04523220|459132946|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
127591332|NCT04523220|459132947|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
127591333|NCT04523220|459132948|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
127591334|NCT04523220|459132946|FG000|Extension Treatment Period|Study drug never administered|0|||
127591335|NCT04523220|459132947|FG001|Extension Treatment Period|Study drug never administered|1|||
127591336|NCT04523220|459132948|FG002|Extension Treatment Period|Study drug never administered|0|||
127591337|NCT00221403|459132949|FG000|Overall Study|Protocol Violation|1|||
127591338|NCT00221403|459132950|FG001|Overall Study|Protocol Violation|0|||
127591339|NCT00221403|459132951|FG002|Overall Study|Protocol Violation|0|||
127591340|NCT00221403|459132949|FG000|Overall Study|Physician Decision|1|||
127591341|NCT00221403|459132950|FG001|Overall Study|Physician Decision|0|||
127591342|NCT00221403|459132951|FG002|Overall Study|Physician Decision|0|||
127591343|NCT00221403|459132949|FG000|Overall Study|Withdrawal by Subject|0|||
127591344|NCT00221403|459132950|FG001|Overall Study|Withdrawal by Subject|3|||
127591345|NCT00221403|459132951|FG002|Overall Study|Withdrawal by Subject|0|||
127591346|NCT00221403|459132949|FG000|Overall Study|Lack of Efficacy|0|||
127591347|NCT00221403|459132950|FG001|Overall Study|Lack of Efficacy|1|||
127591348|NCT00221403|459132951|FG002|Overall Study|Lack of Efficacy|0|||
127591349|NCT00221403|459132949|FG000|Overall Study|Adverse Event|0|||
127591350|NCT00221403|459132950|FG001|Overall Study|Adverse Event|1|||
127591351|NCT00221403|459132951|FG002|Overall Study|Adverse Event|0|||
127591352|NCT02010775|459132952|FG000|Overall Study|Adverse Event|0|||
127591353|NCT02010775|459132953|FG001|Overall Study|Adverse Event|0|||
127591354|NCT02010775|459132954|FG002|Overall Study|Adverse Event|0|||
127591355|NCT02010775|459132955|FG003|Overall Study|Adverse Event|0|||
127591356|NCT02010775|459132956|FG004|Overall Study|Adverse Event|1|||
127591357|NCT02010775|459132952|FG000|Overall Study|Pregnancy|0|||
127591358|NCT02010775|459132953|FG001|Overall Study|Pregnancy|0|||
127591359|NCT02010775|459132954|FG002|Overall Study|Pregnancy|2|||
127591360|NCT02010775|459132955|FG003|Overall Study|Pregnancy|0|||
127591361|NCT02010775|459132956|FG004|Overall Study|Pregnancy|0|||
127591362|NCT02010775|459132952|FG000|Overall Study|Lost to Follow-up|2|||
127591363|NCT02010775|459132953|FG001|Overall Study|Lost to Follow-up|0|||
127591364|NCT02010775|459132954|FG002|Overall Study|Lost to Follow-up|0|||
127591365|NCT02010775|459132955|FG003|Overall Study|Lost to Follow-up|1|||
127591366|NCT02010775|459132956|FG004|Overall Study|Lost to Follow-up|1|||
127591367|NCT02010775|459132952|FG000|Overall Study|Personal Reasons|3|||
127591368|NCT02010775|459132953|FG001|Overall Study|Personal Reasons|3|||
127591369|NCT02010775|459132954|FG002|Overall Study|Personal Reasons|1|||
127591370|NCT02010775|459132955|FG003|Overall Study|Personal Reasons|2|||
127591371|NCT02010775|459132956|FG004|Overall Study|Personal Reasons|4|||
127591372|NCT00256750|459132959|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
127591373|NCT00256750|459132960|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
127591374|NCT00256750|459132961|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
127591375|NCT00256750|459132959|FG000|Transplanted Pre-Treatment|Other|2|||
127591376|NCT00256750|459132960|FG001|Transplanted Pre-Treatment|Other|0|||
127591377|NCT00256750|459132961|FG002|Transplanted Pre-Treatment|Other|0|||
127591378|NCT00256750|459132959|FG000|Transplanted Pre-Treatment|Death|1|||
127591379|NCT00256750|459132960|FG001|Transplanted Pre-Treatment|Death|0|||
127591380|NCT00256750|459132961|FG002|Transplanted Pre-Treatment|Death|0|||
127591381|NCT00256750|459132959|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
127591382|NCT00256750|459132960|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
127591383|NCT00256750|459132961|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
127591384|NCT00256750|459132959|FG000|Post-Transplant Treated (12 Months)|Death|3|||
127591385|NCT00256750|459132960|FG001|Post-Transplant Treated (12 Months)|Death|2|||
127591386|NCT00256750|459132961|FG002|Post-Transplant Treated (12 Months)|Death|4|||
127591387|NCT00256750|459132959|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
127591388|NCT00256750|459132960|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
127591389|NCT00256750|459132961|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
127694497|NCT03393975|459510769|FG002|Urgent Treatment Period|Physician Decision|0|||
127694498|NCT03393975|459510770|FG003|Urgent Treatment Period|Physician Decision|1|||
127882064|NCT01289990|460190794|FG001|Overall Study|discontinued in preceding trial|20|||
127882065|NCT01289990|460190795|FG002|Overall Study|discontinued in preceding trial|41|||
127591390|NCT00256750|459132959|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
127591391|NCT00256750|459132960|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
127591392|NCT00256750|459132961|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
127591393|NCT00256750|459132959|FG000|Post-Transplant Treated (12 Months)|Other|5|||
127591394|NCT00256750|459132960|FG001|Post-Transplant Treated (12 Months)|Other|4|||
127591395|NCT00256750|459132961|FG002|Post-Transplant Treated (12 Months)|Other|2|||
127591396|NCT00256750|459132959|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
127591397|NCT00256750|459132960|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
127591398|NCT00256750|459132961|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
127591399|NCT00256750|459132959|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
127591400|NCT00256750|459132960|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
127591401|NCT00256750|459132961|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
127591402|NCT00256750|459132959|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
127591403|NCT00256750|459132960|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
127591404|NCT00256750|459132961|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
127591405|NCT00256750|459132959|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
127591406|NCT00256750|459132960|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
127591407|NCT00256750|459132961|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
127591408|NCT00256750|459132959|FG000|Post-Transplant Treated (24 Months)|Death|3|||
127591409|NCT00256750|459132960|FG001|Post-Transplant Treated (24 Months)|Death|0|||
127591410|NCT00256750|459132961|FG002|Post-Transplant Treated (24 Months)|Death|0|||
127591411|NCT00256750|459132959|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
127591412|NCT00256750|459132960|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
127591413|NCT00256750|459132961|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
127591414|NCT00256750|459132959|FG000|Post-Transplant Treated (24 Months)|Other|2|||
127591415|NCT00256750|459132960|FG001|Post-Transplant Treated (24 Months)|Other|0|||
127591416|NCT00256750|459132961|FG002|Post-Transplant Treated (24 Months)|Other|1|||
127591417|NCT00256750|459132959|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
127591418|NCT00256750|459132960|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
127591419|NCT00256750|459132961|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
127591420|NCT00256750|459132959|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
127591421|NCT00256750|459132960|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
127591422|NCT00256750|459132961|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
127591423|NCT00256750|459132959|FG000|Post-Transplant Treated (36 Months)|Death|0|||
127591424|NCT00256750|459132960|FG001|Post-Transplant Treated (36 Months)|Death|2|||
127591425|NCT00256750|459132961|FG002|Post-Transplant Treated (36 Months)|Death|1|||
127591426|NCT00256750|459132959|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
127591427|NCT00256750|459132960|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
127591428|NCT00256750|459132961|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
127591429|NCT00256750|459132959|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
127591430|NCT00256750|459132960|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
127591431|NCT00256750|459132961|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
127591432|NCT00256750|459132959|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
127591433|NCT00256750|459132960|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
127591434|NCT00256750|459132961|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
127591435|NCT00256750|459132959|FG000|Post-Transplant Treated (36 Months)|Other|0|||
127591436|NCT00256750|459132960|FG001|Post-Transplant Treated (36 Months)|Other|1|||
127591437|NCT00256750|459132961|FG002|Post-Transplant Treated (36 Months)|Other|1|||
127591438|NCT00256750|459132959|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
127591439|NCT00256750|459132960|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
127591440|NCT00256750|459132961|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
127591441|NCT00256750|459132959|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
127591442|NCT00256750|459132960|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
127591443|NCT00256750|459132961|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
127591444|NCT00256750|459132959|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
127591445|NCT00256750|459132960|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
127591446|NCT00256750|459132961|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
127591447|NCT00256750|459132959|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
127591448|NCT00256750|459132960|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
127591449|NCT00256750|459132961|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
127591450|NCT00256750|459132959|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
127591451|NCT00256750|459132960|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
127591452|NCT00256750|459132961|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
127591453|NCT00256750|459132959|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
127591454|NCT00256750|459132960|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
127591455|NCT00256750|459132961|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
127591456|NCT00256750|459132959|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
127591457|NCT00256750|459132960|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
127591458|NCT00256750|459132961|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
127591459|NCT00256750|459132959|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
127591460|NCT00256750|459132960|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
127591461|NCT00256750|459132961|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
127591462|NCT00256750|459132959|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
127591463|NCT00256750|459132960|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
127591464|NCT00256750|459132961|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
127591465|NCT02030041|459132962|FG000|Overall Study|Withdrawal by Subject|2|||
127591466|NCT02030041|459132963|FG001|Overall Study|Withdrawal by Subject|2|||
127694499|NCT03393975|459510767|FG000|Prophylaxis Period 1|Reason not Specified|0|||
127694500|NCT03393975|459510768|FG001|Prophylaxis Period 1|Reason not Specified|1|||
127694501|NCT03393975|459510769|FG002|Prophylaxis Period 1|Reason not Specified|0|||
127591467|NCT02030041|459132964|FG002|Overall Study|Withdrawal by Subject|1|||
127591468|NCT01197560|459132965|FG000|Overall Study|Adverse Event|6|||
127591469|NCT01197560|459132966|FG001|Overall Study|Adverse Event|8|||
127591470|NCT01197560|459132965|FG000|Overall Study|Death|3|||
127591471|NCT01197560|459132966|FG001|Overall Study|Death|5|||
127694502|NCT03393975|459510770|FG003|Prophylaxis Period 1|Reason not Specified|0|||
127694503|NCT03393975|459510767|FG000|Prophylaxis Period 2|Reason not Specified|0|||
127694504|NCT03393975|459510768|FG001|Prophylaxis Period 2|Reason not Specified|1|||
127694505|NCT03393975|459510769|FG002|Prophylaxis Period 2|Reason not Specified|0|||
127694506|NCT03393975|459510770|FG003|Prophylaxis Period 2|Reason not Specified|0|||
127694507|NCT02549339|459510777|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
127694508|NCT02549339|459510778|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
127784676|NCT00262522|459837019|FG003|Study Start Through 48 Weeks|Death|0|||
127591472|NCT01197560|459132965|FG000|Overall Study|Withdrawal by Subject|1|||
127591473|NCT01197560|459132966|FG001|Overall Study|Withdrawal by Subject|1|||
127591474|NCT01197560|459132965|FG000|Overall Study|Disease progression|40|||
127591475|NCT01197560|459132966|FG001|Overall Study|Disease progression|35|||
127591476|NCT01197560|459132965|FG000|Overall Study|Miscellaneous|4|||
127591477|NCT01197560|459132966|FG001|Overall Study|Miscellaneous|3|||
127591478|NCT01197560|459132965|FG000|Overall Study|Missing|0|||
127591479|NCT01197560|459132966|FG001|Overall Study|Missing|1|||
127591480|NCT05201703|459132967|FG000|Overall Study|Did not understand how to boost medication despite counseling; did not boost|0|||
127591481|NCT05201703|459132968|FG001|Overall Study|Did not understand how to boost medication despite counseling; did not boost|1|||
127694509|NCT02549339|459510777|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
127694510|NCT02549339|459510778|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
127591482|NCT05201703|459132967|FG000|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|0|||
127591483|NCT05201703|459132968|FG001|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|1|||
127591484|NCT00558558|459132972|FG000|Overall Study|Unable to swallow|1|||
127591485|NCT00558558|459132972|FG000|Overall Study|Withdrawal by Subject|1|||
127591486|NCT00558558|459132972|FG000|Overall Study|Lack of Efficacy|4|||
127591487|NCT01473836|459134473|FG000|Overall Study|Adverse Event|4|||
127591488|NCT01473836|459134473|FG000|Overall Study|Lack of Efficacy|1|||
127591489|NCT01473836|459134473|FG000|Overall Study|Does not meet entrance criteria|1|||
127591490|NCT03364023|459134474|FG000|Overall Study|Lost to Follow-up|3|||
127591491|NCT03364023|459134474|FG000|Overall Study|Death|14|||
127591492|NCT00105469|459134489|FG000|Overall Study|Adverse Event|9|||
127591493|NCT00105469|459134490|FG001|Overall Study|Adverse Event|8|||
127591494|NCT00105469|459134489|FG000|Overall Study|Protocol Violation|4|||
127591495|NCT00105469|459134490|FG001|Overall Study|Protocol Violation|0|||
127591496|NCT00105469|459134489|FG000|Overall Study|Withdrawal by Subject|2|||
127591497|NCT00105469|459134490|FG001|Overall Study|Withdrawal by Subject|3|||
127591498|NCT00105469|459134489|FG000|Overall Study|Lost to Follow-up|1|||
127591499|NCT00105469|459134490|FG001|Overall Study|Lost to Follow-up|0|||
127591500|NCT00105469|459134489|FG000|Overall Study|Lack of Efficacy|2|||
127591501|NCT00105469|459134490|FG001|Overall Study|Lack of Efficacy|0|||
127591502|NCT00105469|459134489|FG000|Overall Study|Other Reason|4|||
127591503|NCT00105469|459134490|FG001|Overall Study|Other Reason|0|||
127591504|NCT02820753|459134492|FG000|2 Month|Withdrawal by Subject|3|||
127591505|NCT02820753|459134493|FG001|2 Month|Withdrawal by Subject|3|||
127591506|NCT02820753|459134492|FG000|2 Month|Lost to Follow-up|24|||
127591507|NCT02820753|459134493|FG001|2 Month|Lost to Follow-up|26|||
127591508|NCT02820753|459134492|FG000|2 Month|Stopped per NIH Hold|51|||
127591509|NCT02820753|459134493|FG001|2 Month|Stopped per NIH Hold|13|||
127591510|NCT02820753|459134492|FG000|6 Month|Withdrawal by Subject|2|||
127591511|NCT02820753|459134493|FG001|6 Month|Withdrawal by Subject|2|||
127591512|NCT02820753|459134492|FG000|6 Month|Lost to Follow-up|20|||
127591513|NCT02820753|459134493|FG001|6 Month|Lost to Follow-up|27|||
127591514|NCT02820753|459134492|FG000|6 Month|Stopped per NIH Hold|81|||
127591515|NCT02820753|459134493|FG001|6 Month|Stopped per NIH Hold|81|||
127591516|NCT02820753|459134492|FG000|6 Month|Death|0|||
127591517|NCT02820753|459134493|FG001|6 Month|Death|1|||
127591518|NCT02161731|459134497|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
127591519|NCT02161731|459134498|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
127591520|NCT02161731|459134497|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
127591521|NCT02161731|459134498|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
127591522|NCT01408485|459134499|FG000|Overall Study|Withdrawal by Subject|21|||
127591523|NCT00617773|459134500|FG000|Overall Study|Physician Decision|1|||
127591524|NCT00617773|459134500|FG000|Overall Study|Lack of compliance with the protocol|1|||
127591525|NCT00617773|459134500|FG000|Overall Study|Withdrawal by Subject|1|||
127591526|NCT00617773|459134500|FG000|Overall Study|Death|1|||
127591527|NCT00617773|459134500|FG000|Overall Study|Progressive disease|19|||
127591528|NCT00617773|459134500|FG000|Overall Study|Protocol Violation|1|||
127591529|NCT05035550|459134509|FG000|Overall Study|Withdrawal by Subject|3|||
127591530|NCT05035550|459134510|FG001|Overall Study|Withdrawal by Subject|0|||
127591531|NCT01751867|459134511|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
127591532|NCT01751867|459134512|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
127591533|NCT01751867|459134511|FG000|Overall Study|Diease Progression|4|||
127591534|NCT01751867|459134512|FG001|Overall Study|Diease Progression|18|||
127591535|NCT01751867|459134511|FG000|Overall Study|Adverse Event|8|||
127591536|NCT01751867|459134512|FG001|Overall Study|Adverse Event|15|||
127591537|NCT01751867|459134511|FG000|Overall Study|Poor Compliance|0|||
127591538|NCT01751867|459134512|FG001|Overall Study|Poor Compliance|5|||
127591539|NCT01751867|459134511|FG000|Overall Study|Withdrawal by Subject|3|||
127591540|NCT01751867|459134512|FG001|Overall Study|Withdrawal by Subject|1|||
127591541|NCT01751867|459134511|FG000|Overall Study|Physician Decision|4|||
127591542|NCT01751867|459134512|FG001|Overall Study|Physician Decision|7|||
127591543|NCT01751867|459134511|FG000|Overall Study|Protocol Violation|0|||
127591544|NCT01751867|459134512|FG001|Overall Study|Protocol Violation|2|||
127591545|NCT01751867|459134511|FG000|Overall Study|Death|0|||
127591546|NCT01751867|459134512|FG001|Overall Study|Death|5|||
127591547|NCT01751867|459134511|FG000|Overall Study|Other|11|||
127591548|NCT01751867|459134512|FG001|Overall Study|Other|37|||
127591549|NCT01751867|459134511|FG000|Overall Study|Randomized but not treated.|2|||
127591550|NCT01751867|459134512|FG001|Overall Study|Randomized but not treated.|1|||
127591551|NCT01806545|459134513|FG000|Overall Study|Adverse Event|2|||
127591552|NCT01806545|459134514|FG001|Overall Study|Adverse Event|3|||
127591553|NCT01806545|459134513|FG000|Overall Study|Lost to Follow-up|1|||
127591554|NCT01806545|459134514|FG001|Overall Study|Lost to Follow-up|0|||
127591555|NCT01806545|459134513|FG000|Overall Study|Withdrawal by Subject|3|||
127591556|NCT01806545|459134514|FG001|Overall Study|Withdrawal by Subject|2|||
127591557|NCT00840450|459134521|FG000|Overall Study|Adverse Event|1|||
127591558|NCT00840450|459134521|FG000|Overall Study|Lack of Efficacy|2|||
127591559|NCT00617123|459134522|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
127591560|NCT00617123|459134523|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
127591561|NCT00617123|459134522|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
127591562|NCT00617123|459134523|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
127591563|NCT00617123|459134522|FG000|Referral Screening Period|Adverse Event|0|||
127591564|NCT00617123|459134523|FG001|Referral Screening Period|Adverse Event|1|||
127591565|NCT00617123|459134522|FG000|Study Treatment Period|Withdrawal by Subject|8|||
127591566|NCT00617123|459134523|FG001|Study Treatment Period|Withdrawal by Subject|12|||
127591567|NCT00617123|459134522|FG000|Study Treatment Period|Adverse Event|7|||
127591568|NCT00617123|459134523|FG001|Study Treatment Period|Adverse Event|3|||
127591569|NCT00617123|459134522|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
127591570|NCT00617123|459134523|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
127591571|NCT00617123|459134522|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
127591572|NCT00617123|459134523|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
127591573|NCT00133952|459134525|FG000|Overall Study|Adverse Event|1|||
127591574|NCT00133952|459134526|FG001|Overall Study|Adverse Event|2|||
127591575|NCT00133952|459134525|FG000|Overall Study|Death|3|||
127591576|NCT00133952|459134526|FG001|Overall Study|Death|2|||
127591577|NCT00133952|459134525|FG000|Overall Study|Lost to Follow-up|9|||
127591578|NCT00133952|459134526|FG001|Overall Study|Lost to Follow-up|14|||
127591579|NCT00133952|459134525|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
127591580|NCT00133952|459134526|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
127591581|NCT00133952|459134525|FG000|Overall Study|Protocol Violation|1|||
127591582|NCT00133952|459134526|FG001|Overall Study|Protocol Violation|1|||
127591583|NCT00133952|459134525|FG000|Overall Study|Withdrawal by Subject|20|||
127591584|NCT00133952|459134526|FG001|Overall Study|Withdrawal by Subject|4|||
127591585|NCT00133952|459134525|FG000|Overall Study|Physician Decision|4|||
127591586|NCT00133952|459134526|FG001|Overall Study|Physician Decision|3|||
127591587|NCT00133952|459134525|FG000|Overall Study|Sponsor Decision|0|||
127591588|NCT00133952|459134526|FG001|Overall Study|Sponsor Decision|1|||
127591589|NCT00520936|459134528|FG000|Overall Study|Physician Decision|0|||
127591590|NCT00520936|459134529|FG001|Overall Study|Physician Decision|2|||
127591591|NCT00520936|459134530|FG002|Overall Study|Physician Decision|1|||
127591592|NCT00520936|459134531|FG003|Overall Study|Physician Decision|0|||
127591593|NCT00520936|459134532|FG004|Overall Study|Physician Decision|0|||
127591594|NCT00520936|459134533|FG005|Overall Study|Physician Decision|0|||
127591595|NCT00520936|459134534|FG006|Overall Study|Physician Decision|0|||
127591596|NCT00520936|459134535|FG007|Overall Study|Physician Decision|0|||
127591597|NCT00520936|459134528|FG000|Overall Study|Withdrawal by Subject|0|||
127591598|NCT00520936|459134529|FG001|Overall Study|Withdrawal by Subject|0|||
127591599|NCT00520936|459134530|FG002|Overall Study|Withdrawal by Subject|0|||
127591600|NCT00520936|459134531|FG003|Overall Study|Withdrawal by Subject|0|||
127591601|NCT00520936|459134532|FG004|Overall Study|Withdrawal by Subject|0|||
127591602|NCT00520936|459134533|FG005|Overall Study|Withdrawal by Subject|0|||
127591603|NCT00520936|459134534|FG006|Overall Study|Withdrawal by Subject|0|||
127591604|NCT00520936|459134535|FG007|Overall Study|Withdrawal by Subject|1|||
127591605|NCT00520936|459134528|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
127591606|NCT00520936|459134529|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
127591607|NCT00520936|459134530|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
127591608|NCT00520936|459134531|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
127591609|NCT00520936|459134532|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
127591610|NCT00520936|459134533|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
127591611|NCT00520936|459134534|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
127591612|NCT00520936|459134535|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
127591613|NCT00520936|459134528|FG000|Overall Study|Death|0|||
127591614|NCT00520936|459134529|FG001|Overall Study|Death|0|||
127591615|NCT00520936|459134530|FG002|Overall Study|Death|0|||
127591616|NCT00520936|459134531|FG003|Overall Study|Death|0|||
127591617|NCT00520936|459134532|FG004|Overall Study|Death|0|||
127591618|NCT00520936|459134533|FG005|Overall Study|Death|0|||
127591619|NCT00520936|459134534|FG006|Overall Study|Death|1|||
127591620|NCT00520936|459134535|FG007|Overall Study|Death|0|||
127591621|NCT00520936|459134528|FG000|Overall Study|Protocol Violation|0|||
127591622|NCT00520936|459134529|FG001|Overall Study|Protocol Violation|1|||
127591623|NCT00520936|459134530|FG002|Overall Study|Protocol Violation|1|||
127591624|NCT00520936|459134531|FG003|Overall Study|Protocol Violation|0|||
127591625|NCT00520936|459134532|FG004|Overall Study|Protocol Violation|1|||
127591626|NCT00520936|459134533|FG005|Overall Study|Protocol Violation|0|||
127591627|NCT00520936|459134534|FG006|Overall Study|Protocol Violation|1|||
127591628|NCT00520936|459134535|FG007|Overall Study|Protocol Violation|0|||
127591629|NCT00003479|459134537|FG000|Overall Study|Not evaluable|3|||
127694511|NCT02549339|459510777|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
127694512|NCT02549339|459510778|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
127694513|NCT02549339|459510777|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
127591630|NCT02128113|459134538|FG000|Overall Study|Withdrawal by Subject|3|||
127591631|NCT02128113|459134539|FG001|Overall Study|Withdrawal by Subject|1|||
127591632|NCT02128113|459134540|FG002|Overall Study|Withdrawal by Subject|0|||
127591633|NCT02128113|459134538|FG000|Overall Study|Protocol Violation|0|||
127591634|NCT02128113|459134539|FG001|Overall Study|Protocol Violation|1|||
127591635|NCT02128113|459134540|FG002|Overall Study|Protocol Violation|0|||
127591636|NCT02128113|459134538|FG000|Overall Study|Surgery cancelled|0|||
127591637|NCT02128113|459134539|FG001|Overall Study|Surgery cancelled|1|||
127591638|NCT02128113|459134540|FG002|Overall Study|Surgery cancelled|0|||
127591639|NCT02128113|459134538|FG000|Overall Study|Adverse Event|0|||
127591640|NCT02128113|459134539|FG001|Overall Study|Adverse Event|0|||
127591641|NCT02128113|459134540|FG002|Overall Study|Adverse Event|1|||
127591642|NCT01061177|459134541|FG000|Overall Study|Adverse Event|117|||
127591643|NCT01061177|459134541|FG000|Overall Study|Withdrawal by Subject|27|||
127591644|NCT01061177|459134541|FG000|Overall Study|Disease progression|17|||
127591645|NCT01061177|459134541|FG000|Overall Study|Protocol Violation|11|||
127591646|NCT01061177|459134541|FG000|Overall Study|Lost to Follow-up|9|||
127591647|NCT01061177|459134541|FG000|Overall Study|New cancer therapy|9|||
127591648|NCT01061177|459134541|FG000|Overall Study|Abnormal laboratory values|6|||
127591649|NCT01061177|459134541|FG000|Overall Study|Abnormal test procedure results|4|||
127591650|NCT01061177|459134541|FG000|Overall Study|Administratie problems|4|||
127591651|NCT01061177|459134541|FG000|Overall Study|Death|4|||
127591652|NCT00299104|459134542|FG000|Treatment Period|Adverse Event|14|||
127591653|NCT00299104|459134543|FG001|Treatment Period|Adverse Event|9|||
127591654|NCT00299104|459134544|FG002|Treatment Period|Adverse Event|7|||
127591655|NCT00299104|459134542|FG000|Treatment Period|Death|1|||
127591656|NCT00299104|459134543|FG001|Treatment Period|Death|1|||
127591657|NCT00299104|459134544|FG002|Treatment Period|Death|1|||
127591658|NCT00299104|459134542|FG000|Treatment Period|Insufficient therapeutic response|34|||
127591659|NCT00299104|459134543|FG001|Treatment Period|Insufficient therapeutic response|13|||
127591660|NCT00299104|459134544|FG002|Treatment Period|Insufficient therapeutic response|8|||
127591661|NCT00299104|459134542|FG000|Treatment Period|Failure to return|9|||
127591662|NCT00299104|459134543|FG001|Treatment Period|Failure to return|8|||
127591663|NCT00299104|459134544|FG002|Treatment Period|Failure to return|8|||
127591664|NCT00299104|459134542|FG000|Treatment Period|Violation of selection criteria|1|||
127591665|NCT00299104|459134543|FG001|Treatment Period|Violation of selection criteria|2|||
127591666|NCT00299104|459134544|FG002|Treatment Period|Violation of selection criteria|0|||
127591667|NCT00299104|459134542|FG000|Treatment Period|Protocol Violation|1|||
127591668|NCT00299104|459134543|FG001|Treatment Period|Protocol Violation|1|||
127591669|NCT00299104|459134544|FG002|Treatment Period|Protocol Violation|0|||
127591670|NCT00299104|459134542|FG000|Treatment Period|Refused treatment|9|||
127591671|NCT00299104|459134543|FG001|Treatment Period|Refused treatment|2|||
127591672|NCT00299104|459134544|FG002|Treatment Period|Refused treatment|2|||
127591673|NCT00299104|459134542|FG000|Treatment Period|Withdrew consent|14|||
127591674|NCT00299104|459134543|FG001|Treatment Period|Withdrew consent|19|||
127591675|NCT00299104|459134544|FG002|Treatment Period|Withdrew consent|9|||
127694514|NCT02549339|459510778|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
127591676|NCT00299104|459134542|FG000|Treatment Period|Administrative reasons|106|||
127591677|NCT00299104|459134543|FG001|Treatment Period|Administrative reasons|120|||
127591678|NCT00299104|459134544|FG002|Treatment Period|Administrative reasons|137|||
127591679|NCT00299104|459134542|FG000|Safety Follow-Up (SFU) Period|Death|3|||
127591680|NCT00299104|459134543|FG001|Safety Follow-Up (SFU) Period|Death|2|||
127591681|NCT00299104|459134544|FG002|Safety Follow-Up (SFU) Period|Death|1|||
127591682|NCT00299104|459134542|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
127591683|NCT00299104|459134543|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
127591684|NCT00299104|459134544|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
127591685|NCT00299104|459134542|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
127591686|NCT00299104|459134543|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
127591687|NCT00299104|459134544|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
127591688|NCT00299104|459134542|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
127591689|NCT00299104|459134543|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
127591690|NCT00299104|459134544|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
127591691|NCT00299104|459134542|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
127591692|NCT00299104|459134543|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
127591693|NCT00299104|459134544|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
127591694|NCT00299104|459134542|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
127591695|NCT00299104|459134543|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
127591696|NCT00299104|459134544|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
127591697|NCT00299104|459134542|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
127591698|NCT00299104|459134543|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
127591699|NCT00299104|459134544|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
127591700|NCT00299104|459134542|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
127591701|NCT00299104|459134543|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
127591702|NCT00299104|459134544|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
127591703|NCT00587054|459134554|FG000|Overall Study|Patient not treated|9|||
127591704|NCT02197247|459134559|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
127591705|NCT02197247|459134559|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
127591706|NCT02197247|459134559|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
127591707|NCT02197247|459134559|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
127591708|NCT02197247|459134559|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
127591709|NCT02197247|459134559|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
127591710|NCT02197247|459134559|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
127591711|NCT02197247|459134559|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
127591712|NCT01854710|459134566|FG000|Overall Study|Withdrawal by Subject|2|||
127887319|NCT01298596|460210578|FG000|Overall Study|Death|5|||
127694515|NCT02549339|459510777|FG000|12-month Follow-up|Lack of Efficacy|0|||
127591713|NCT01854710|459134567|FG001|Overall Study|Withdrawal by Subject|1|||
127591714|NCT01854710|459134568|FG002|Overall Study|Withdrawal by Subject|0|||
127591715|NCT01854710|459134569|FG003|Overall Study|Withdrawal by Subject|0|||
127591716|NCT01854710|459134570|FG004|Overall Study|Withdrawal by Subject|0|||
127591717|NCT01854710|459134571|FG005|Overall Study|Withdrawal by Subject|0|||
127591718|NCT01854710|459134566|FG000|Overall Study|CRI procedural error|2|||
127591719|NCT01854710|459134567|FG001|Overall Study|CRI procedural error|2|||
127591720|NCT01854710|459134568|FG002|Overall Study|CRI procedural error|2|||
127591721|NCT01854710|459134569|FG003|Overall Study|CRI procedural error|2|||
127591722|NCT01854710|459134570|FG004|Overall Study|CRI procedural error|2|||
127591723|NCT01854710|459134571|FG005|Overall Study|CRI procedural error|2|||
127591724|NCT00370032|459134574|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
127591725|NCT00370032|459134575|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
127591726|NCT00370032|459134574|FG000|Washout Period|Withdrawal by Subject|0|||
127591727|NCT00370032|459134575|FG001|Washout Period|Withdrawal by Subject|1|||
127591728|NCT00370032|459134574|FG000|Washout Period|Lost to Follow-up|0|||
127591729|NCT00370032|459134575|FG001|Washout Period|Lost to Follow-up|1|||
127591730|NCT00370032|459134574|FG000|Washout Period|Adverse Event|1|||
127591731|NCT00370032|459134575|FG001|Washout Period|Adverse Event|0|||
127591732|NCT00370032|459134574|FG000|Follow-up Period|Withdrawal by Subject|1|||
127591733|NCT00370032|459134575|FG001|Follow-up Period|Withdrawal by Subject|0|||
127591734|NCT01578187|459134576|FG000|Usability Phase|Withdrawal by Subject|1|||
127591735|NCT03208244|459134577|FG000|Overall Study|Death|1|||
127591736|NCT01709162|459134578|FG000|Overall Study|Disease progression|3|||
127591737|NCT01709162|459134579|FG001|Overall Study|Disease progression|3|||
127591738|NCT01709162|459134578|FG000|Overall Study|Study drug toxicity|2|||
127591739|NCT01709162|459134579|FG001|Overall Study|Study drug toxicity|0|||
127591740|NCT01709162|459134578|FG000|Overall Study|Administrative reason by sponsor|0|||
127591741|NCT01709162|459134579|FG001|Overall Study|Administrative reason by sponsor|1|||
127591742|NCT01709162|459134578|FG000|Overall Study|Other|1|||
127591743|NCT01709162|459134579|FG001|Overall Study|Other|0|||
127591744|NCT01709162|459134578|FG000|Overall Study|Withdrawal by Subject|0|||
127591745|NCT01709162|459134579|FG001|Overall Study|Withdrawal by Subject|1|||
127591746|NCT03845985|459134581|FG000|Overall Study|Lost to Follow-up|2|||
127591747|NCT03845985|459134582|FG001|Overall Study|Lost to Follow-up|1|||
127591748|NCT03845985|459134581|FG000|Overall Study|Physician Decision|1|||
127591749|NCT03845985|459134582|FG001|Overall Study|Physician Decision|0|||
127591750|NCT03845985|459134581|FG000|Overall Study|Withdrawal by Subject|4|||
127591751|NCT03845985|459134582|FG001|Overall Study|Withdrawal by Subject|1|||
127591752|NCT00968201|459134586|FG000|Base Study - (Period II)|Adverse Event|8|||
127591753|NCT00968201|459134587|FG001|Base Study - (Period II)|Adverse Event|0|||
127591754|NCT00968201|459134588|FG002|Base Study - (Period II)|Adverse Event|16|||
127591755|NCT00968201|459134586|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
127591756|NCT00968201|459134587|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
127591757|NCT00968201|459134588|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
127591758|NCT00968201|459134586|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
127591759|NCT00968201|459134587|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
127591760|NCT00968201|459134588|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
127591761|NCT00968201|459134586|FG000|Base Study - (Period II)|Protocol Violation|12|||
127591762|NCT00968201|459134587|FG001|Base Study - (Period II)|Protocol Violation|0|||
127591763|NCT00968201|459134588|FG002|Base Study - (Period II)|Protocol Violation|12|||
127591764|NCT00968201|459134586|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
127591765|NCT00968201|459134587|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
127784677|NCT00262522|459837016|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
127784678|NCT00262522|459837017|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
127784679|NCT00262522|459837018|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
127784680|NCT00262522|459837019|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
127784681|NCT00262522|459837016|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
127784682|NCT00262522|459837017|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
127784683|NCT00262522|459837018|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
127784684|NCT00262522|459837019|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
127784685|NCT00262522|459837016|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
127784686|NCT00262522|459837017|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
127784687|NCT00262522|459837018|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
127784688|NCT00262522|459837019|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
127591766|NCT00968201|459134588|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
127591767|NCT00968201|459134586|FG000|Base Study - (Period II)|Site Error|0|||
127591768|NCT00968201|459134587|FG001|Base Study - (Period II)|Site Error|0|||
127591769|NCT00968201|459134588|FG002|Base Study - (Period II)|Site Error|1|||
127591770|NCT00968201|459134586|FG000|Extension Study - (Period III)|Adverse Event|0|||
127591771|NCT00968201|459134587|FG001|Extension Study - (Period III)|Adverse Event|5|||
127591772|NCT00968201|459134588|FG002|Extension Study - (Period III)|Adverse Event|22|||
127591773|NCT00968201|459134586|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
128034199|NCT04507269|460751722|FG002|Overall Study|Lost to Follow-up|0|||
128034200|NCT04507269|460751723|FG003|Overall Study|Lost to Follow-up|0|||
128034201|NCT04507269|460751724|FG004|Overall Study|Lost to Follow-up|1|||
128034202|NCT04507269|460751725|FG005|Overall Study|Lost to Follow-up|0|||
128034203|NCT00071032|460751729|FG000|Overall Study|Lost to Follow-up|1|||
127591774|NCT00968201|459134587|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
127591775|NCT00968201|459134588|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
127591776|NCT00968201|459134586|FG000|Extension Study - (Period III)|Protocol Violation|0|||
127591777|NCT00968201|459134587|FG001|Extension Study - (Period III)|Protocol Violation|17|||
127591778|NCT00968201|459134588|FG002|Extension Study - (Period III)|Protocol Violation|14|||
127591779|NCT00968201|459134586|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
127591780|NCT00968201|459134587|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
127591781|NCT00968201|459134588|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
127591782|NCT00968201|459134586|FG000|Extension Study - (Period III)|Patient Relocated|0|||
127591783|NCT00968201|459134587|FG001|Extension Study - (Period III)|Patient Relocated|1|||
127591784|NCT00968201|459134588|FG002|Extension Study - (Period III)|Patient Relocated|1|||
127591785|NCT00968201|459134586|FG000|Extension Study - (Period III)|Noncompliance|0|||
127591786|NCT00968201|459134587|FG001|Extension Study - (Period III)|Noncompliance|0|||
127591787|NCT00968201|459134588|FG002|Extension Study - (Period III)|Noncompliance|3|||
127591788|NCT00968201|459134586|FG000|Extension Study - (Period III)|Other|0|||
127591789|NCT00968201|459134587|FG001|Extension Study - (Period III)|Other|0|||
127591790|NCT00968201|459134588|FG002|Extension Study - (Period III)|Other|2|||
127591791|NCT00968201|459134586|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
127591792|NCT00968201|459134587|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
127591793|NCT00968201|459134588|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
127591794|NCT04974697|459134589|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
127591795|NCT04974697|459134589|FG000|Overall Study|Lens discomfort|1|||
127591796|NCT00571948|459134591|FG000|Overall Study|Lost to Follow-up|2|||
127591797|NCT00571948|459134592|FG001|Overall Study|Lost to Follow-up|0|||
127591798|NCT00571948|459134591|FG000|Overall Study|Withdrawal by Subject|1|||
127591799|NCT00571948|459134592|FG001|Overall Study|Withdrawal by Subject|2|||
127591800|NCT00571948|459134591|FG000|Overall Study|Protocol Violation|3|||
127591801|NCT00571948|459134592|FG001|Overall Study|Protocol Violation|3|||
127591802|NCT00571948|459134591|FG000|Overall Study|infant refused study meal|3|||
127591803|NCT00571948|459134592|FG001|Overall Study|infant refused study meal|4|||
127591804|NCT00571948|459134591|FG000|Overall Study|Parent were afraid of blood colection|2|||
127591805|NCT00571948|459134592|FG001|Overall Study|Parent were afraid of blood colection|5|||
127591806|NCT04112784|459134593|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
127591807|NCT04112784|459134593|FG000|Overall Study|Screen Failures|4|||
127591808|NCT02006719|459134594|FG000|Overall Study|Withdrawal by Subject|10|||
127591809|NCT02006719|459134595|FG001|Overall Study|Withdrawal by Subject|2|||
127591810|NCT02006719|459134594|FG000|Overall Study|Lost to Follow-up|5|||
127591811|NCT02006719|459134595|FG001|Overall Study|Lost to Follow-up|1|||
127591812|NCT02006719|459134594|FG000|Overall Study|Protocol Violation|2|||
127591813|NCT02006719|459134595|FG001|Overall Study|Protocol Violation|0|||
127591814|NCT02006719|459134594|FG000|Overall Study|Adverse Event|1|||
127591815|NCT02006719|459134595|FG001|Overall Study|Adverse Event|1|||
127591816|NCT02006719|459134594|FG000|Overall Study|Other/Unknown|0|||
127591817|NCT02006719|459134595|FG001|Overall Study|Other/Unknown|1|||
127591818|NCT00393029|459134596|FG000|Overall Study|Not treated|0|||
127591819|NCT00393029|459134597|FG001|Overall Study|Not treated|1|||
127591820|NCT04659161|459134598|FG000|Overall Study|Adverse Event|10|||
127591821|NCT04659161|459134599|FG001|Overall Study|Adverse Event|6|||
127591822|NCT04659161|459134598|FG000|Overall Study|Withdrawal by Subject|13|||
127591823|NCT04659161|459134599|FG001|Overall Study|Withdrawal by Subject|12|||
127591824|NCT04659161|459134598|FG000|Overall Study|Other|9|||
127591825|NCT04659161|459134599|FG001|Overall Study|Other|8|||
127591826|NCT01929343|459134600|FG000|Overall Study|Physician Decision|0|||
127591827|NCT01929343|459134601|FG001|Overall Study|Physician Decision|2|||
127591828|NCT01929343|459134602|FG002|Overall Study|Physician Decision|0|||
127591829|NCT01929343|459134600|FG000|Overall Study|Withdrawal by Subject|1|||
127591830|NCT01929343|459134601|FG001|Overall Study|Withdrawal by Subject|0|||
128034204|NCT00071032|460751730|FG001|Overall Study|Lost to Follow-up|1|||
127591831|NCT01929343|459134602|FG002|Overall Study|Withdrawal by Subject|0|||
127591832|NCT02197130|459134605|FG000|Overall Study|Adverse Event|13|||
127591833|NCT02197130|459134606|FG001|Overall Study|Adverse Event|4|||
127591834|NCT02197130|459134607|FG002|Overall Study|Adverse Event|23|||
127591835|NCT02197130|459134605|FG000|Overall Study|Death|0|||
127591836|NCT02197130|459134606|FG001|Overall Study|Death|1|||
127591837|NCT02197130|459134607|FG002|Overall Study|Death|0|||
127591838|NCT02197130|459134605|FG000|Overall Study|Lost to Follow-up|2|||
127591839|NCT02197130|459134606|FG001|Overall Study|Lost to Follow-up|0|||
127591840|NCT02197130|459134607|FG002|Overall Study|Lost to Follow-up|1|||
127591841|NCT02197130|459134605|FG000|Overall Study|Does not meet entrance criteria|0|||
127591842|NCT02197130|459134606|FG001|Overall Study|Does not meet entrance criteria|0|||
128034205|NCT00071032|460751729|FG000|Overall Study|Withdrawal by Subject|8|||
127591843|NCT02197130|459134607|FG002|Overall Study|Does not meet entrance criteria|1|||
127591844|NCT02197130|459134605|FG000|Overall Study|Withdrawal by Subject|0|||
127591845|NCT02197130|459134606|FG001|Overall Study|Withdrawal by Subject|3|||
127591846|NCT02197130|459134607|FG002|Overall Study|Withdrawal by Subject|4|||
127591847|NCT02197130|459134605|FG000|Overall Study|Other|1|||
127591848|NCT02197130|459134606|FG001|Overall Study|Other|0|||
127591849|NCT02197130|459134607|FG002|Overall Study|Other|3|||
127591850|NCT00211510|459134610|FG000|Overall Study|Physician Decision|3|||
127591851|NCT00211510|459134611|FG001|Overall Study|Physician Decision|1|||
127591852|NCT00211510|459134610|FG000|Overall Study|Withdrawal by Subject|3|||
127591853|NCT00211510|459134611|FG001|Overall Study|Withdrawal by Subject|1|||
127591854|NCT01737697|459134614|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
127591855|NCT01737697|459134615|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
127591856|NCT01737697|459134616|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
127591857|NCT01737697|459134617|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
127591858|NCT01737697|459134618|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
127591859|NCT01737697|459134619|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
127591860|NCT01737697|459134620|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
127591861|NCT01737697|459134621|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
127591862|NCT01737697|459134622|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
127591863|NCT01737697|459134623|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
127591864|NCT01737697|459134624|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
127591865|NCT01737697|459134625|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
127591866|NCT01737697|459134626|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
127591867|NCT01737697|459134627|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
127591868|NCT01737697|459134628|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
127591869|NCT01737697|459134614|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
127591870|NCT01737697|459134615|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
127591871|NCT01737697|459134616|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
127591872|NCT01737697|459134617|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
127591873|NCT01737697|459134618|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
127591874|NCT01737697|459134619|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
127591875|NCT01737697|459134620|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
127591876|NCT01737697|459134621|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
127591877|NCT01737697|459134622|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
127591878|NCT01737697|459134623|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
127591879|NCT01737697|459134624|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
127591880|NCT01737697|459134625|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
127591881|NCT01737697|459134626|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
127591882|NCT01737697|459134627|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
127591883|NCT01737697|459134628|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
127591884|NCT01737697|459134614|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
127591885|NCT01737697|459134615|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
127591886|NCT01737697|459134616|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
127591887|NCT01737697|459134617|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
127591888|NCT01737697|459134618|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
127591889|NCT01737697|459134619|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
127591890|NCT01737697|459134620|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
127591891|NCT01737697|459134621|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
127591892|NCT01737697|459134622|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
127591893|NCT01737697|459134623|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
127591894|NCT01737697|459134624|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
127591895|NCT01737697|459134625|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
127591896|NCT01737697|459134626|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
127591897|NCT01737697|459134627|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
127591898|NCT01737697|459134628|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
127591899|NCT01737697|459134614|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
127591900|NCT01737697|459134615|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
127591901|NCT01737697|459134616|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
127591902|NCT01737697|459134617|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
127591903|NCT01737697|459134618|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
127591904|NCT01737697|459134619|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
127591905|NCT01737697|459134620|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
127784689|NCT00262522|459837016|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
127591906|NCT01737697|459134621|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
127591907|NCT01737697|459134622|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
127591908|NCT01737697|459134623|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
127784690|NCT00262522|459837017|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
127591909|NCT01737697|459134624|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
127591910|NCT01737697|459134625|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
127591911|NCT01737697|459134626|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
127591912|NCT01737697|459134627|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
127591913|NCT01737697|459134628|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
127591914|NCT01737697|459134614|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
127591915|NCT01737697|459134615|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
127591916|NCT01737697|459134616|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
127591917|NCT01737697|459134617|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
127591918|NCT01737697|459134618|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
127591919|NCT01737697|459134619|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
127591920|NCT01737697|459134620|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
127591921|NCT01737697|459134621|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
127591922|NCT01737697|459134622|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
127591923|NCT01737697|459134623|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
127591924|NCT01737697|459134624|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
127591925|NCT01737697|459134625|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
127591926|NCT01737697|459134626|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
127591927|NCT01737697|459134627|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
127591928|NCT01737697|459134628|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
127591929|NCT01737697|459134614|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
127591930|NCT01737697|459134615|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
127591931|NCT01737697|459134616|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
127591932|NCT01737697|459134617|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
127591933|NCT01737697|459134618|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
127591934|NCT01737697|459134619|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
127591935|NCT01737697|459134620|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
127591936|NCT01737697|459134621|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
127591937|NCT01737697|459134622|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
127591938|NCT01737697|459134623|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
127591939|NCT01737697|459134624|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
127591940|NCT01737697|459134625|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
127591941|NCT01737697|459134626|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
127591942|NCT01737697|459134627|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
127591943|NCT01737697|459134628|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
127591944|NCT01737697|459134614|FG000|Subacute Phase|Adverse Event|0|||
127591945|NCT01737697|459134615|FG001|Subacute Phase|Adverse Event|0|||
127591946|NCT01737697|459134616|FG002|Subacute Phase|Adverse Event|0|||
127591947|NCT01737697|459134617|FG003|Subacute Phase|Adverse Event|0|||
127591948|NCT01737697|459134618|FG004|Subacute Phase|Adverse Event|0|||
127591949|NCT01737697|459134619|FG005|Subacute Phase|Adverse Event|1|||
127591950|NCT01737697|459134620|FG006|Subacute Phase|Adverse Event|1|||
127591951|NCT01737697|459134621|FG007|Subacute Phase|Adverse Event|1|||
127591952|NCT01737697|459134622|FG008|Subacute Phase|Adverse Event|1|||
127591953|NCT01737697|459134623|FG009|Subacute Phase|Adverse Event|1|||
127591954|NCT01737697|459134624|FG010|Subacute Phase|Adverse Event|4|||
127591955|NCT01737697|459134625|FG011|Subacute Phase|Adverse Event|1|||
127591956|NCT01737697|459134626|FG012|Subacute Phase|Adverse Event|1|||
127591957|NCT01737697|459134627|FG013|Subacute Phase|Adverse Event|0|||
127591958|NCT01737697|459134628|FG014|Subacute Phase|Adverse Event|0|||
127591959|NCT01737697|459134614|FG000|Subacute Phase|Withdrawal by Subject|0|||
127591960|NCT01737697|459134615|FG001|Subacute Phase|Withdrawal by Subject|0|||
127591961|NCT01737697|459134616|FG002|Subacute Phase|Withdrawal by Subject|0|||
127591962|NCT01737697|459134617|FG003|Subacute Phase|Withdrawal by Subject|0|||
127591963|NCT01737697|459134618|FG004|Subacute Phase|Withdrawal by Subject|0|||
127591964|NCT01737697|459134619|FG005|Subacute Phase|Withdrawal by Subject|1|||
127591965|NCT01737697|459134620|FG006|Subacute Phase|Withdrawal by Subject|0|||
128034206|NCT00071032|460751730|FG001|Overall Study|Withdrawal by Subject|6|||
127591966|NCT01737697|459134621|FG007|Subacute Phase|Withdrawal by Subject|2|||
127591967|NCT01737697|459134622|FG008|Subacute Phase|Withdrawal by Subject|0|||
127591968|NCT01737697|459134623|FG009|Subacute Phase|Withdrawal by Subject|1|||
127591969|NCT01737697|459134624|FG010|Subacute Phase|Withdrawal by Subject|0|||
127591970|NCT01737697|459134625|FG011|Subacute Phase|Withdrawal by Subject|1|||
128034207|NCT00071032|460751729|FG000|Overall Study|Missing Primary Outcome|0|||
128034208|NCT00071032|460751730|FG001|Overall Study|Missing Primary Outcome|1|||
128034209|NCT06071104|460751731|FG000|Overall Study|Non-ocular and non-device related adverse event|1|||
127591971|NCT01737697|459134626|FG012|Subacute Phase|Withdrawal by Subject|1|||
127591972|NCT01737697|459134627|FG013|Subacute Phase|Withdrawal by Subject|1|||
127591973|NCT01737697|459134628|FG014|Subacute Phase|Withdrawal by Subject|0|||
127591974|NCT01737697|459134614|FG000|Subacute Phase|Lost to Follow-up|0|||
128034210|NCT03518060|460751732|FG000|Overall Study|Death|1|||
127591975|NCT01737697|459134615|FG001|Subacute Phase|Lost to Follow-up|0|||
127591976|NCT01737697|459134616|FG002|Subacute Phase|Lost to Follow-up|0|||
127591977|NCT01737697|459134617|FG003|Subacute Phase|Lost to Follow-up|0|||
127591978|NCT01737697|459134618|FG004|Subacute Phase|Lost to Follow-up|0|||
127591979|NCT01737697|459134619|FG005|Subacute Phase|Lost to Follow-up|0|||
127591980|NCT01737697|459134620|FG006|Subacute Phase|Lost to Follow-up|0|||
127591981|NCT01737697|459134621|FG007|Subacute Phase|Lost to Follow-up|0|||
127591982|NCT01737697|459134622|FG008|Subacute Phase|Lost to Follow-up|0|||
127591983|NCT01737697|459134623|FG009|Subacute Phase|Lost to Follow-up|0|||
127591984|NCT01737697|459134624|FG010|Subacute Phase|Lost to Follow-up|0|||
127591985|NCT01737697|459134625|FG011|Subacute Phase|Lost to Follow-up|0|||
127591986|NCT01737697|459134626|FG012|Subacute Phase|Lost to Follow-up|0|||
127591987|NCT01737697|459134627|FG013|Subacute Phase|Lost to Follow-up|0|||
127591988|NCT01737697|459134628|FG014|Subacute Phase|Lost to Follow-up|1|||
127591989|NCT01737697|459134614|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
127591990|NCT01737697|459134615|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
127591991|NCT01737697|459134616|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
127591992|NCT01737697|459134617|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
127591993|NCT01737697|459134618|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
127591994|NCT01737697|459134619|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
127591995|NCT01737697|459134620|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
127591996|NCT01737697|459134621|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
127591997|NCT01737697|459134622|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
127591998|NCT01737697|459134623|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
127591999|NCT01737697|459134624|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
127592000|NCT01737697|459134625|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
127592001|NCT01737697|459134626|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
127592002|NCT01737697|459134627|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
127592003|NCT01737697|459134628|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
127592004|NCT01737697|459134614|FG000|Subacute Phase|Protocol Violation|0|||
127592005|NCT01737697|459134615|FG001|Subacute Phase|Protocol Violation|0|||
127592006|NCT01737697|459134616|FG002|Subacute Phase|Protocol Violation|0|||
127592007|NCT01737697|459134617|FG003|Subacute Phase|Protocol Violation|0|||
127592008|NCT01737697|459134618|FG004|Subacute Phase|Protocol Violation|0|||
127592009|NCT01737697|459134619|FG005|Subacute Phase|Protocol Violation|1|||
127592010|NCT01737697|459134620|FG006|Subacute Phase|Protocol Violation|0|||
127592011|NCT01737697|459134621|FG007|Subacute Phase|Protocol Violation|0|||
127592012|NCT01737697|459134622|FG008|Subacute Phase|Protocol Violation|0|||
127592013|NCT01737697|459134623|FG009|Subacute Phase|Protocol Violation|0|||
127592014|NCT01737697|459134624|FG010|Subacute Phase|Protocol Violation|1|||
127592015|NCT01737697|459134625|FG011|Subacute Phase|Protocol Violation|0|||
127592016|NCT01737697|459134626|FG012|Subacute Phase|Protocol Violation|0|||
127592017|NCT01737697|459134627|FG013|Subacute Phase|Protocol Violation|0|||
127592018|NCT01737697|459134628|FG014|Subacute Phase|Protocol Violation|0|||
127592019|NCT01737697|459134614|FG000|Subacute Phase|Physician Decision|0|||
127592020|NCT01737697|459134615|FG001|Subacute Phase|Physician Decision|0|||
127592021|NCT01737697|459134616|FG002|Subacute Phase|Physician Decision|0|||
128034211|NCT03518060|460751732|FG000|Overall Study|Poor adherence|1|||
128034212|NCT03518060|460751732|FG000|Overall Study|Withdrawal of informed consent|2|||
128034213|NCT03518060|460751732|FG000|Overall Study|Interaction with comedication or comorbidities|4|||
128034214|NCT03518060|460751732|FG000|Overall Study|Physician Decision|7|||
128034215|NCT03518060|460751732|FG000|Overall Study|Adverse drug reactions|23|||
128034216|NCT03518060|460751732|FG000|Overall Study|Withdrawal by Subject|25|||
128034217|NCT03518060|460751732|FG000|Overall Study|Lost to Follow-up|13|||
128034218|NCT04116489|460751738|FG000|Overall Study|Participant left facility and was no longer eligible|4|||
128034219|NCT04116489|460751738|FG000|Overall Study|Withdrawal by Subject|1|||
128034220|NCT03734536|460751739|FG000|Overall Study|Withdrew Consent|1|||
127592022|NCT01737697|459134617|FG003|Subacute Phase|Physician Decision|0|||
127592023|NCT01737697|459134618|FG004|Subacute Phase|Physician Decision|0|||
127592024|NCT01737697|459134619|FG005|Subacute Phase|Physician Decision|0|||
127592025|NCT01737697|459134620|FG006|Subacute Phase|Physician Decision|0|||
127592026|NCT01737697|459134621|FG007|Subacute Phase|Physician Decision|0|||
127592027|NCT01737697|459134622|FG008|Subacute Phase|Physician Decision|1|||
127592028|NCT01737697|459134623|FG009|Subacute Phase|Physician Decision|0|||
127592029|NCT01737697|459134624|FG010|Subacute Phase|Physician Decision|0|||
127592030|NCT01737697|459134625|FG011|Subacute Phase|Physician Decision|0|||
127592031|NCT01737697|459134626|FG012|Subacute Phase|Physician Decision|0|||
127592032|NCT01737697|459134627|FG013|Subacute Phase|Physician Decision|0|||
128034221|NCT03734536|460751740|FG001|Overall Study|Withdrew Consent|5|||
128034222|NCT03734536|460751739|FG000|Overall Study|Lost to Follow-up|10|||
128034223|NCT03734536|460751740|FG001|Overall Study|Lost to Follow-up|7|||
127592033|NCT01737697|459134628|FG014|Subacute Phase|Physician Decision|0|||
127592034|NCT01737697|459134614|FG000|Subacute Phase|Death|0|||
127592035|NCT01737697|459134615|FG001|Subacute Phase|Death|0|||
127592036|NCT01737697|459134616|FG002|Subacute Phase|Death|0|||
127592037|NCT01737697|459134617|FG003|Subacute Phase|Death|0|||
127592038|NCT01737697|459134618|FG004|Subacute Phase|Death|0|||
127592039|NCT01737697|459134619|FG005|Subacute Phase|Death|0|||
127592040|NCT01737697|459134620|FG006|Subacute Phase|Death|0|||
127592041|NCT01737697|459134621|FG007|Subacute Phase|Death|0|||
127592042|NCT01737697|459134622|FG008|Subacute Phase|Death|0|||
127592043|NCT01737697|459134623|FG009|Subacute Phase|Death|0|||
127592044|NCT01737697|459134624|FG010|Subacute Phase|Death|1|||
128034224|NCT04727151|460751741|FG000|Overall Study|Death|0|||
128034225|NCT04727151|460751742|FG001|Overall Study|Death|0|||
128034226|NCT04727151|460751743|FG002|Overall Study|Death|0|||
128034227|NCT04727151|460751744|FG003|Overall Study|Death|0|||
128034228|NCT04727151|460751745|FG004|Overall Study|Death|3|||
128034229|NCT04727151|460751741|FG000|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
128034230|NCT04727151|460751742|FG001|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
128034231|NCT04727151|460751743|FG002|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
128034232|NCT04727151|460751744|FG003|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
128034233|NCT04727151|460751745|FG004|Overall Study|failed to meet pre-treatment inclusion criteria|2|||
128034234|NCT01969058|460751746|FG000|Overall Study|Withdrawal by Subject|2|||
128034235|NCT01969058|460751747|FG001|Overall Study|Withdrawal by Subject|0|||
128034236|NCT01969058|460751746|FG000|Overall Study|Adverse Event|1|||
128034237|NCT01969058|460751747|FG001|Overall Study|Adverse Event|0|||
128034238|NCT01346592|460751749|FG000|Overall Study|Lost to Follow-up|62|||
128034239|NCT01346592|460751750|FG001|Overall Study|Lost to Follow-up|29|||
128034240|NCT01346592|460751751|FG002|Overall Study|Lost to Follow-up|29|||
128034241|NCT01346592|460751749|FG000|Overall Study|Protocol Violation|2|||
128034242|NCT01346592|460751750|FG001|Overall Study|Protocol Violation|1|||
128034243|NCT01346592|460751751|FG002|Overall Study|Protocol Violation|0|||
128034244|NCT01346592|460751749|FG000|Overall Study|Death|1|||
128034245|NCT01346592|460751750|FG001|Overall Study|Death|3|||
128034246|NCT01346592|460751751|FG002|Overall Study|Death|4|||
128034247|NCT01346592|460751749|FG000|Overall Study|Adverse Event|0|||
128034248|NCT01346592|460751750|FG001|Overall Study|Adverse Event|1|||
127592045|NCT01737697|459134625|FG011|Subacute Phase|Death|0|||
127592046|NCT01737697|459134626|FG012|Subacute Phase|Death|0|||
127592047|NCT01737697|459134627|FG013|Subacute Phase|Death|0|||
127592048|NCT01737697|459134628|FG014|Subacute Phase|Death|0|||
127592049|NCT03338998|459134632|FG000|Treatment Period|Withdrawal by Subject|1|||
127592050|NCT03338998|459134633|FG001|Treatment Period|Withdrawal by Subject|1|||
127592051|NCT03338998|459134632|FG000|Treatment Period|Adverse Event|0|||
127592052|NCT03338998|459134633|FG001|Treatment Period|Adverse Event|2|||
127592053|NCT03338998|459134632|FG000|Treatment Period|Protocol deviation|1|||
127592054|NCT03338998|459134633|FG001|Treatment Period|Protocol deviation|0|||
127592055|NCT03338998|459134632|FG000|Treatment Period|Physician Decision|2|||
127592056|NCT03338998|459134633|FG001|Treatment Period|Physician Decision|0|||
127592057|NCT03338998|459134632|FG000|Treatment Period|Subject failed swallow test|4|||
127592058|NCT03338998|459134633|FG001|Treatment Period|Subject failed swallow test|0|||
127592059|NCT03338998|459134632|FG000|Safety Follow-Up Period|Adverse Event|0|||
127592060|NCT03338998|459134633|FG001|Safety Follow-Up Period|Adverse Event|1|||
127592061|NCT03338998|459134632|FG000|Safety Follow-Up Period|Protocol deviation|1|||
127592062|NCT03338998|459134633|FG001|Safety Follow-Up Period|Protocol deviation|0|||
127592063|NCT03338998|459134632|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
127592064|NCT03338998|459134633|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
127592065|NCT03288129|459134635|FG000|Overall Study|Adverse Event|10|||
127592066|NCT03288129|459134635|FG000|Overall Study|Lost to Follow-up|3|||
127592067|NCT03288129|459134635|FG000|Overall Study|Withdrawal by Subject|3|||
127592068|NCT03288129|459134635|FG000|Overall Study|Withdrawal of consent/assent|1|||
127592069|NCT03288129|459134635|FG000|Overall Study|Other|5|||
127642552|NCT04124926|459313074|FG002|Maintenance Phase|Lost to Follow-up|7|||
127642553|NCT04124926|459313075|FG003|Maintenance Phase|Lost to Follow-up|8|||
127642554|NCT04124926|459313076|FG004|Maintenance Phase|Lost to Follow-up|9|||
127642555|NCT04124926|459313072|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
127642556|NCT04124926|459313073|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
127642557|NCT04124926|459313074|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
127642558|NCT04124926|459313075|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
127784691|NCT00262522|459837018|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
127784692|NCT00262522|459837019|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
127784693|NCT00262522|459837016|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
127784694|NCT00262522|459837017|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
127784695|NCT00262522|459837018|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
128034249|NCT01346592|460751751|FG002|Overall Study|Adverse Event|0|||
127642559|NCT04124926|459313076|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
127642560|NCT04124926|459313072|FG000|Maintenance Phase|Pregnancy|0|||
127642561|NCT04124926|459313073|FG001|Maintenance Phase|Pregnancy|0|||
127642562|NCT04124926|459313074|FG002|Maintenance Phase|Pregnancy|0|||
127642563|NCT04124926|459313075|FG003|Maintenance Phase|Pregnancy|1|||
127642564|NCT04124926|459313076|FG004|Maintenance Phase|Pregnancy|0|||
127642565|NCT04124926|459313072|FG000|Maintenance Phase|Lack of Efficacy|0|||
127642566|NCT04124926|459313073|FG001|Maintenance Phase|Lack of Efficacy|0|||
127642567|NCT04124926|459313074|FG002|Maintenance Phase|Lack of Efficacy|0|||
127642568|NCT04124926|459313075|FG003|Maintenance Phase|Lack of Efficacy|0|||
127642569|NCT04124926|459313076|FG004|Maintenance Phase|Lack of Efficacy|1|||
128034250|NCT01346592|460751749|FG000|Overall Study|Withdrawal by Subject|77|||
128034251|NCT01346592|460751750|FG001|Overall Study|Withdrawal by Subject|51|||
128034252|NCT01346592|460751751|FG002|Overall Study|Withdrawal by Subject|38|||
127592070|NCT05255068|459136624|FG000|Overall Study|Lost to Follow-up|0|||
127592071|NCT05255068|459136625|FG001|Overall Study|Lost to Follow-up|1|||
127592072|NCT00540514|459136628|FG000|Overall Study|Still on treatment|3|||
127592073|NCT00540514|459136629|FG001|Overall Study|Still on treatment|0|||
127592074|NCT00540514|459136628|FG000|Overall Study|Unacceptable Toxicity|61|||
127592075|NCT00540514|459136629|FG001|Overall Study|Unacceptable Toxicity|62|||
127592076|NCT00540514|459136628|FG000|Overall Study|Adverse Event|20|||
127592077|NCT00540514|459136629|FG001|Overall Study|Adverse Event|24|||
127592078|NCT00540514|459136628|FG000|Overall Study|Physician Decision|86|||
127592079|NCT00540514|459136629|FG001|Overall Study|Physician Decision|99|||
127592080|NCT00540514|459136628|FG000|Overall Study|Protocol Deviation|3|||
127592081|NCT00540514|459136629|FG001|Overall Study|Protocol Deviation|4|||
127592082|NCT00540514|459136628|FG000|Overall Study|Lost to Follow-up|1|||
127592083|NCT00540514|459136629|FG001|Overall Study|Lost to Follow-up|1|||
127592084|NCT00540514|459136628|FG000|Overall Study|Withdrawal by Subject|65|||
127592085|NCT00540514|459136629|FG001|Overall Study|Withdrawal by Subject|67|||
127592086|NCT00540514|459136628|FG000|Overall Study|Excluded prior to treatment|7|||
127592087|NCT00540514|459136629|FG001|Overall Study|Excluded prior to treatment|7|||
127592088|NCT00540514|459136628|FG000|Overall Study|Paclitaxel not available|0|||
127592089|NCT00540514|459136629|FG001|Overall Study|Paclitaxel not available|2|||
127592090|NCT02501473|459136630|FG000|Overall Study|Study Terminated|2|||
127592091|NCT02501473|459136631|FG001|Overall Study|Study Terminated|3|||
127592092|NCT02501473|459136632|FG002|Overall Study|Study Terminated|7|||
127592093|NCT02501473|459136633|FG003|Overall Study|Study Terminated|9|||
127592094|NCT02501473|459136634|FG004|Overall Study|Study Terminated|2|||
127592095|NCT02501473|459136635|FG005|Overall Study|Study Terminated|10|||
127592096|NCT02501473|459136636|FG006|Overall Study|Study Terminated|1|||
127592097|NCT02501473|459136637|FG007|Overall Study|Study Terminated|0|||
127592098|NCT02501473|459136630|FG000|Overall Study|Withdrawal by Subject|0|||
127592099|NCT02501473|459136631|FG001|Overall Study|Withdrawal by Subject|0|||
127592100|NCT02501473|459136632|FG002|Overall Study|Withdrawal by Subject|3|||
127592101|NCT02501473|459136633|FG003|Overall Study|Withdrawal by Subject|3|||
127592102|NCT02501473|459136634|FG004|Overall Study|Withdrawal by Subject|2|||
127592103|NCT02501473|459136635|FG005|Overall Study|Withdrawal by Subject|2|||
127592104|NCT02501473|459136636|FG006|Overall Study|Withdrawal by Subject|0|||
127592105|NCT02501473|459136637|FG007|Overall Study|Withdrawal by Subject|0|||
127592106|NCT02501473|459136630|FG000|Overall Study|Death|0|||
127592107|NCT02501473|459136631|FG001|Overall Study|Death|0|||
127592108|NCT02501473|459136632|FG002|Overall Study|Death|1|||
127592109|NCT02501473|459136633|FG003|Overall Study|Death|1|||
127592110|NCT02501473|459136634|FG004|Overall Study|Death|0|||
127592111|NCT02501473|459136635|FG005|Overall Study|Death|1|||
127592112|NCT02501473|459136636|FG006|Overall Study|Death|0|||
127592113|NCT02501473|459136637|FG007|Overall Study|Death|0|||
127592114|NCT02501473|459136630|FG000|Overall Study|Lost to Follow-up|1|||
127592115|NCT02501473|459136631|FG001|Overall Study|Lost to Follow-up|0|||
127592116|NCT02501473|459136632|FG002|Overall Study|Lost to Follow-up|1|||
127592117|NCT02501473|459136633|FG003|Overall Study|Lost to Follow-up|0|||
127592118|NCT02501473|459136634|FG004|Overall Study|Lost to Follow-up|0|||
127592119|NCT02501473|459136635|FG005|Overall Study|Lost to Follow-up|1|||
127592120|NCT02501473|459136636|FG006|Overall Study|Lost to Follow-up|0|||
127592121|NCT02501473|459136637|FG007|Overall Study|Lost to Follow-up|0|||
127592122|NCT02501473|459136630|FG000|Overall Study|Reason not specified|0|||
127592123|NCT02501473|459136631|FG001|Overall Study|Reason not specified|0|||
127592124|NCT02501473|459136632|FG002|Overall Study|Reason not specified|1|||
127592125|NCT02501473|459136633|FG003|Overall Study|Reason not specified|1|||
127784696|NCT00262522|459837019|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
127592126|NCT02501473|459136634|FG004|Overall Study|Reason not specified|0|||
127592127|NCT02501473|459136635|FG005|Overall Study|Reason not specified|0|||
127592128|NCT02501473|459136636|FG006|Overall Study|Reason not specified|0|||
127592129|NCT02501473|459136637|FG007|Overall Study|Reason not specified|0|||
127592130|NCT00907777|459136638|FG000|Overall Study|Withdrawal by Subject|0|||
127592131|NCT00907777|459136639|FG001|Overall Study|Withdrawal by Subject|1|||
127592132|NCT00599924|459136642|FG000|Overall Study|Lack of Efficacy|3|||
127592133|NCT00599924|459136643|FG001|Overall Study|Lack of Efficacy|5|||
127592134|NCT00599924|459136644|FG002|Overall Study|Lack of Efficacy|1|||
127592135|NCT00599924|459136645|FG003|Overall Study|Lack of Efficacy|2|||
127592136|NCT00599924|459136646|FG004|Overall Study|Lack of Efficacy|3|||
127592137|NCT00599924|459136647|FG005|Overall Study|Lack of Efficacy|2|||
127592138|NCT00599924|459136648|FG006|Overall Study|Lack of Efficacy|0|||
127592139|NCT00599924|459136642|FG000|Overall Study|Adverse Event|0|||
127592140|NCT00599924|459136643|FG001|Overall Study|Adverse Event|0|||
127592141|NCT00599924|459136644|FG002|Overall Study|Adverse Event|0|||
127592142|NCT00599924|459136645|FG003|Overall Study|Adverse Event|2|||
127592143|NCT00599924|459136646|FG004|Overall Study|Adverse Event|0|||
127784697|NCT00262522|459837016|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
127592144|NCT00599924|459136647|FG005|Overall Study|Adverse Event|0|||
127592145|NCT00599924|459136648|FG006|Overall Study|Adverse Event|2|||
127592146|NCT00599924|459136642|FG000|Overall Study|Death|0|||
127592147|NCT00599924|459136643|FG001|Overall Study|Death|0|||
127592148|NCT00599924|459136644|FG002|Overall Study|Death|0|||
127592149|NCT00599924|459136645|FG003|Overall Study|Death|2|||
127592150|NCT00599924|459136646|FG004|Overall Study|Death|0|||
127592151|NCT00599924|459136647|FG005|Overall Study|Death|2|||
127592152|NCT00599924|459136648|FG006|Overall Study|Death|1|||
127592153|NCT00599924|459136642|FG000|Overall Study|Protocol Violation|0|||
127592154|NCT00599924|459136643|FG001|Overall Study|Protocol Violation|0|||
127592155|NCT00599924|459136644|FG002|Overall Study|Protocol Violation|0|||
127592156|NCT00599924|459136645|FG003|Overall Study|Protocol Violation|1|||
127592157|NCT00599924|459136646|FG004|Overall Study|Protocol Violation|0|||
127592158|NCT00599924|459136647|FG005|Overall Study|Protocol Violation|0|||
127592159|NCT00599924|459136648|FG006|Overall Study|Protocol Violation|0|||
127592160|NCT00599924|459136642|FG000|Overall Study|Withdrawal by Subject|0|||
127592161|NCT00599924|459136643|FG001|Overall Study|Withdrawal by Subject|0|||
127592162|NCT00599924|459136644|FG002|Overall Study|Withdrawal by Subject|1|||
127592163|NCT00599924|459136645|FG003|Overall Study|Withdrawal by Subject|0|||
127592164|NCT00599924|459136646|FG004|Overall Study|Withdrawal by Subject|1|||
127592165|NCT00599924|459136647|FG005|Overall Study|Withdrawal by Subject|0|||
127592166|NCT00599924|459136648|FG006|Overall Study|Withdrawal by Subject|0|||
127592167|NCT00599924|459136642|FG000|Overall Study|Other|0|||
127592168|NCT00599924|459136643|FG001|Overall Study|Other|0|||
127592169|NCT00599924|459136644|FG002|Overall Study|Other|0|||
127592170|NCT00599924|459136645|FG003|Overall Study|Other|1|||
127592171|NCT00599924|459136646|FG004|Overall Study|Other|2|||
127592172|NCT00599924|459136647|FG005|Overall Study|Other|0|||
127592173|NCT00599924|459136648|FG006|Overall Study|Other|2|||
127592174|NCT02601469|459136649|FG000|Overall Study|Enrolled in Error|1|||
127592175|NCT02601469|459136650|FG001|Overall Study|Enrolled in Error|0|||
127592176|NCT01806298|459136651|FG000|Overall Study|Adverse Event|3|||
127592177|NCT01806298|459136651|FG000|Overall Study|Protocol Non-compliance|1|||
127592178|NCT01806298|459136651|FG000|Overall Study|Withdrawal by Subject|1|||
127592179|NCT01806298|459136651|FG000|Overall Study|Other|5|||
127592180|NCT03808545|459136652|FG000|Overall Study|Withdrawal by Subject|1|||
127592181|NCT03808545|459136653|FG001|Overall Study|Withdrawal by Subject|1|||
127592182|NCT00980057|459136658|FG000|Overall Study|Death|13|||
127592183|NCT00980057|459136659|FG001|Overall Study|Death|3|||
127592184|NCT00980057|459136658|FG000|Overall Study|Adverse Event|0|||
127592185|NCT00980057|459136659|FG001|Overall Study|Adverse Event|1|||
127592186|NCT00980057|459136658|FG000|Overall Study|Physician Decision|4|||
127592187|NCT00980057|459136659|FG001|Overall Study|Physician Decision|0|||
127592188|NCT00980057|459136658|FG000|Overall Study|Lost to Follow-up|1|||
127592189|NCT00980057|459136659|FG001|Overall Study|Lost to Follow-up|0|||
127592190|NCT00980057|459136658|FG000|Overall Study|Withdrawal by Subject|1|||
127592191|NCT00980057|459136659|FG001|Overall Study|Withdrawal by Subject|1|||
127592192|NCT04980040|459136660|FG000|Overall Study|Violated the Inclusion Criteria|260|||
127592193|NCT04980040|459136660|FG000|Overall Study|Violated the Administration & Dosage|225|||
127592194|NCT04980040|459136660|FG000|Overall Study|Lost to Safety-Follow-up|4|||
127592195|NCT04980040|459136660|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
127592196|NCT01315678|459136661|FG000|Overall Study|Withdrawal by Subject|7|||
127592197|NCT01315678|459136662|FG001|Overall Study|Withdrawal by Subject|3|||
127592198|NCT01315678|459136661|FG000|Overall Study|Adverse Event|3|||
127592199|NCT01315678|459136662|FG001|Overall Study|Adverse Event|1|||
127592200|NCT01315678|459136661|FG000|Overall Study|Lost to Follow-up|1|||
127592201|NCT01315678|459136662|FG001|Overall Study|Lost to Follow-up|0|||
127784698|NCT00262522|459837017|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
127784699|NCT00262522|459837018|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
127784700|NCT00262522|459837019|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
127784701|NCT00262522|459837016|FG000|Study Start Through 96 Weeks|Death|2|||
127784702|NCT00262522|459837017|FG001|Study Start Through 96 Weeks|Death|0|||
127784703|NCT00262522|459837018|FG002|Study Start Through 96 Weeks|Death|2|||
127784704|NCT00262522|459837019|FG003|Study Start Through 96 Weeks|Death|0|||
127882066|NCT01289990|460190796|FG003|Overall Study|discontinued in preceding trial|17|||
127592202|NCT01315678|459136661|FG000|Overall Study|similar reason to those listed above|3|||
127592203|NCT01315678|459136662|FG001|Overall Study|similar reason to those listed above|2|||
127592204|NCT00573469|459136663|FG000|Overall Study|Adverse Event|1|||
127592205|NCT00573469|459136664|FG001|Overall Study|Adverse Event|1|||
127592206|NCT00573469|459136665|FG002|Overall Study|Adverse Event|1|||
127592207|NCT00573469|459136663|FG000|Overall Study|Withdrawal by Subject|0|||
127592208|NCT00573469|459136664|FG001|Overall Study|Withdrawal by Subject|2|||
127592209|NCT00573469|459136665|FG002|Overall Study|Withdrawal by Subject|0|||
127592210|NCT00573469|459136663|FG000|Overall Study|Other|5|||
127592211|NCT00573469|459136664|FG001|Overall Study|Other|1|||
127592212|NCT00573469|459136665|FG002|Overall Study|Other|3|||
127784705|NCT00262522|459837016|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
127592213|NCT01532414|459136666|FG000|Overall Study|Lost to Follow-up|3|||
127592214|NCT01532414|459136667|FG001|Overall Study|Lost to Follow-up|0|||
127592215|NCT01532414|459136668|FG002|Overall Study|Lost to Follow-up|1|||
127592216|NCT01532414|459136666|FG000|Overall Study|Withdrawal by Subject|3|||
127592217|NCT01532414|459136667|FG001|Overall Study|Withdrawal by Subject|0|||
127592218|NCT01532414|459136668|FG002|Overall Study|Withdrawal by Subject|0|||
127592219|NCT01532414|459136666|FG000|Overall Study|No V6 semen sample|0|||
127592220|NCT01532414|459136667|FG001|Overall Study|No V6 semen sample|1|||
127592221|NCT01532414|459136668|FG002|Overall Study|No V6 semen sample|0|||
127592222|NCT01532414|459136666|FG000|Overall Study|Adverse Event|0|||
127592223|NCT01532414|459136667|FG001|Overall Study|Adverse Event|1|||
127592224|NCT01532414|459136668|FG002|Overall Study|Adverse Event|1|||
127592225|NCT01532414|459136666|FG000|Overall Study|Unable to complete 24 hour PK|0|||
127592226|NCT01532414|459136667|FG001|Overall Study|Unable to complete 24 hour PK|0|||
127592227|NCT01532414|459136668|FG002|Overall Study|Unable to complete 24 hour PK|1|||
127592228|NCT01532414|459136666|FG000|Overall Study|Withdrawn by sponsor|1|||
127592229|NCT01532414|459136667|FG001|Overall Study|Withdrawn by sponsor|0|||
127592230|NCT01532414|459136668|FG002|Overall Study|Withdrawn by sponsor|0|||
127592231|NCT00187486|459136669|FG000|Overall Study|Protocol Violation|1|||
127592232|NCT01508650|459136673|FG000|Overall Study|Lost to Follow-up|0|||
127592233|NCT01508650|459136674|FG001|Overall Study|Lost to Follow-up|3|||
127592234|NCT02064894|459136675|FG000|Overall Study|Withdrawal by Subject|43|||
127592235|NCT02064894|459136676|FG001|Overall Study|Withdrawal by Subject|102|||
127592236|NCT02064894|459136677|FG002|Overall Study|Withdrawal by Subject|115|||
127592237|NCT01396148|459136678|FG000|Overall Study|Patient Decision|1|||
127592238|NCT00884312|459136681|FG000|Overall Study|Non-fatal Progressive Disease|0|||
127592239|NCT00884312|459136682|FG001|Overall Study|Non-fatal Progressive Disease|8|||
127592240|NCT00884312|459136681|FG000|Overall Study|Fatal Progressive Disease|0|||
127592241|NCT00884312|459136682|FG001|Overall Study|Fatal Progressive Disease|1|||
127592242|NCT00884312|459136681|FG000|Overall Study|Non-fatal Adverse Event|1|||
127592243|NCT00884312|459136682|FG001|Overall Study|Non-fatal Adverse Event|0|||
127592244|NCT00884312|459136681|FG000|Overall Study|Fatal Adverse Event|1|||
127592245|NCT00884312|459136682|FG001|Overall Study|Fatal Adverse Event|4|||
127592246|NCT00884312|459136681|FG000|Overall Study|Withdrawal by Subject|0|||
127592247|NCT00884312|459136682|FG001|Overall Study|Withdrawal by Subject|6|||
127592248|NCT00884312|459136681|FG000|Overall Study|Physician Decision|0|||
127592249|NCT00884312|459136682|FG001|Overall Study|Physician Decision|1|||
127592250|NCT00884312|459136681|FG000|Overall Study|Other|0|||
127592251|NCT00884312|459136682|FG001|Overall Study|Other|4|||
127592252|NCT00884312|459136681|FG000|Overall Study|Did Not Receive Study Drug|0|||
127592253|NCT00884312|459136682|FG001|Overall Study|Did Not Receive Study Drug|1|||
127592254|NCT00224042|459136683|FG000|Overall Study|Adverse Event|2|||
127592255|NCT00224042|459136684|FG001|Overall Study|Adverse Event|1|||
127592256|NCT00224042|459136683|FG000|Overall Study|Protocol Violation|0|||
127592257|NCT00224042|459136684|FG001|Overall Study|Protocol Violation|1|||
127592258|NCT00224042|459136683|FG000|Overall Study|Physician Decision|0|||
127592259|NCT00224042|459136684|FG001|Overall Study|Physician Decision|1|||
127592260|NCT00224042|459136683|FG000|Overall Study|Did not meet lab incusion criteria|2|||
127592261|NCT00224042|459136684|FG001|Overall Study|Did not meet lab incusion criteria|3|||
127592262|NCT00224042|459136683|FG000|Overall Study|Other|2|||
127592263|NCT00224042|459136684|FG001|Overall Study|Other|0|||
127592264|NCT03052725|459136685|FG000|Overall Study|Adverse Event|2|||
127592265|NCT03052725|459136686|FG001|Overall Study|Adverse Event|0|||
127592266|NCT03052725|459136685|FG000|Overall Study|Withdrawal by Subject|3|||
127592267|NCT03052725|459136686|FG001|Overall Study|Withdrawal by Subject|4|||
127592268|NCT03052725|459136685|FG000|Overall Study|Pregnancy|0|||
127592269|NCT03052725|459136686|FG001|Overall Study|Pregnancy|1|||
127592270|NCT03052725|459136685|FG000|Overall Study|Site closure|0|||
127592271|NCT03052725|459136686|FG001|Overall Study|Site closure|1|||
127592272|NCT03052725|459136685|FG000|Overall Study|Study terminated by sponsor|143|||
127592273|NCT03052725|459136686|FG001|Overall Study|Study terminated by sponsor|144|||
127592274|NCT00847379|459136693|FG000|Overall Study|Study terminated by Sponsor|59|||
127592275|NCT00847379|459136694|FG001|Overall Study|Study terminated by Sponsor|57|||
127592276|NCT00847379|459136695|FG002|Overall Study|Study terminated by Sponsor|57|||
127592277|NCT02969369|459136696|FG000|Study|Adverse Event|1|||
127592278|NCT02969369|459136697|FG001|Study|Adverse Event|6|||
127592279|NCT02969369|459136696|FG000|Study|Lack of Efficacy|0|||
127592280|NCT02969369|459136697|FG001|Study|Lack of Efficacy|1|||
127592281|NCT02969369|459136696|FG000|Study|Lost to Follow-up|0|||
127592282|NCT02969369|459136697|FG001|Study|Lost to Follow-up|1|||
127592283|NCT02969369|459136696|FG000|Study|Withdrawal by Subject|3|||
127592284|NCT02969369|459136697|FG001|Study|Withdrawal by Subject|5|||
127592285|NCT02969369|459136696|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
127592286|NCT02969369|459136697|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
127592287|NCT02969369|459136696|FG000|Double-blind Period|Adverse Event|1|||
127592288|NCT02969369|459136697|FG001|Double-blind Period|Adverse Event|5|||
127592289|NCT02969369|459136696|FG000|Double-blind Period|Lost to Follow-up|0|||
127592290|NCT02969369|459136697|FG001|Double-blind Period|Lost to Follow-up|1|||
127592291|NCT02969369|459136696|FG000|Double-blind Period|Withdrawal by Subject|2|||
127694516|NCT02549339|459510778|FG001|12-month Follow-up|Lack of Efficacy|2|||
127694517|NCT02549339|459510777|FG000|12-month Follow-up|Withdrawal by Subject|8|||
127592292|NCT02969369|459136697|FG001|Double-blind Period|Withdrawal by Subject|3|||
127592293|NCT02969369|459136696|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
127592294|NCT02969369|459136697|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
127694518|NCT02549339|459510778|FG001|12-month Follow-up|Withdrawal by Subject|3|||
127694519|NCT02549339|459510777|FG000|12-month Follow-up|Lost to Follow-up|1|||
127694520|NCT02549339|459510778|FG001|12-month Follow-up|Lost to Follow-up|3|||
127694521|NCT02549339|459510777|FG000|12-month Follow-up|Other|0|||
127694522|NCT02549339|459510778|FG001|12-month Follow-up|Other|3|||
127694523|NCT03016169|459510779|FG000|Overall Study|Lost to Follow-up|4|||
127694524|NCT03016169|459510779|FG000|Overall Study|Death|54|||
127694525|NCT03016169|459510779|FG000|Overall Study|Device Explant|11|||
127694526|NCT03016169|459510779|FG000|Overall Study|Withdrawal by Subject|19|||
127694527|NCT03016169|459510779|FG000|Overall Study|Other Reasons|1|||
127694528|NCT02724878|459510780|FG000|Overall Study|Still on Active Therapy|15|||
127694529|NCT02724878|459510780|FG000|Overall Study|Disease Progression|31|||
127694530|NCT02724878|459510780|FG000|Overall Study|Toxicity|5|||
127694531|NCT02724878|459510780|FG000|Overall Study|Death|1|||
127694532|NCT02724878|459510780|FG000|Overall Study|Withdrawal by Subject|4|||
127694533|NCT02724878|459510780|FG000|Overall Study|Lost to Follow-up|2|||
127694534|NCT02724878|459510780|FG000|Overall Study|Protocol Violation|1|||
127694535|NCT02724878|459510780|FG000|Overall Study|Ineligible for Study Drug|5|||
127694536|NCT02724878|459510780|FG000|Overall Study|not started|1|||
127694537|NCT04838262|459510782|FG000|Overall Study|Withdrawal by Subject|9|||
127694538|NCT04838262|459510783|FG001|Overall Study|Withdrawal by Subject|4|||
127694539|NCT03175029|459510786|FG000|Overall Study|Withdrawal by Subject|2|||
127694540|NCT03175029|459510787|FG001|Overall Study|Withdrawal by Subject|1|||
127694541|NCT03175029|459510786|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
127694542|NCT03175029|459510787|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
127694543|NCT05524233|459510788|FG000|Overall Study|Lost to Follow-up|2|||
127694544|NCT05524233|459510788|FG000|Overall Study|Adverse Event|2|||
127694545|NCT05524233|459510788|FG000|Overall Study|Withdrawal by Subject|1|||
127694546|NCT02506959|459510789|FG000|Overall Study|Physician Decision|2|||
127694547|NCT02506959|459510790|FG001|Overall Study|Physician Decision|1|||
127694548|NCT04382898|459510792|FG000|Part 1: Dose Titration|Withdrawal by Subject|1|||
127694549|NCT04382898|459510793|FG001|Part 1: Dose Titration|Withdrawal by Subject|0|||
127592295|NCT02969369|459136696|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
127592296|NCT02969369|459136697|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
127592297|NCT02969369|459136696|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
127592298|NCT02969369|459136697|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
127592299|NCT02969369|459136696|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
127592300|NCT02969369|459136697|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
127592301|NCT00521014|459136698|FG000|Overall Study|Inevaluable, not treated|1|||
127592302|NCT02794883|459136699|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
127592303|NCT02794883|459136700|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
127592304|NCT02794883|459136701|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
127592305|NCT02794883|459136699|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
127592306|NCT02794883|459136700|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
127592307|NCT02794883|459136701|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
127592308|NCT02794883|459136699|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
127694550|NCT04382898|459510794|FG002|Part 1: Dose Titration|Withdrawal by Subject|0|||
127694551|NCT04382898|459510795|FG003|Part 1: Dose Titration|Withdrawal by Subject|0|||
127694552|NCT04382898|459510796|FG004|Part 1: Dose Titration|Withdrawal by Subject|0|||
127784706|NCT00262522|459837017|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
127694553|NCT04382898|459510792|FG000|Part 1: Dose Titration|Death|6|||
127694554|NCT04382898|459510793|FG001|Part 1: Dose Titration|Death|0|||
127694555|NCT04382898|459510794|FG002|Part 1: Dose Titration|Death|0|||
127694556|NCT04382898|459510795|FG003|Part 1: Dose Titration|Death|0|||
127694557|NCT04382898|459510796|FG004|Part 1: Dose Titration|Death|0|||
127694558|NCT04382898|459510792|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
127694559|NCT04382898|459510793|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
127694560|NCT04382898|459510794|FG002|Part 2: Dose Expansion|Withdrawal by Subject|1|||
127694561|NCT04382898|459510795|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
127694562|NCT04382898|459510796|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
127694563|NCT04382898|459510792|FG000|Part 2: Dose Expansion|Lost to Follow-up|0|||
127694564|NCT04382898|459510793|FG001|Part 2: Dose Expansion|Lost to Follow-up|0|||
127694565|NCT04382898|459510794|FG002|Part 2: Dose Expansion|Lost to Follow-up|1|||
127694566|NCT04382898|459510795|FG003|Part 2: Dose Expansion|Lost to Follow-up|0|||
127694567|NCT04382898|459510796|FG004|Part 2: Dose Expansion|Lost to Follow-up|0|||
127694568|NCT04382898|459510792|FG000|Part 2: Dose Expansion|Death|0|||
127694569|NCT04382898|459510793|FG001|Part 2: Dose Expansion|Death|17|||
127694570|NCT04382898|459510794|FG002|Part 2: Dose Expansion|Death|13|||
127694571|NCT04382898|459510795|FG003|Part 2: Dose Expansion|Death|1|||
127694572|NCT04382898|459510796|FG004|Part 2: Dose Expansion|Death|0|||
127694573|NCT04382898|459510792|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
127694574|NCT04382898|459510793|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
127694575|NCT04382898|459510794|FG002|Part 2: Dose Expansion|Progressive Disease|1|||
127694576|NCT04382898|459510795|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
127694577|NCT04382898|459510796|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
127694578|NCT04382898|459510792|FG000|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
127694579|NCT04382898|459510793|FG001|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
127694580|NCT04382898|459510794|FG002|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
127694581|NCT04382898|459510795|FG003|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
127694582|NCT04382898|459510796|FG004|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
127694583|NCT04382898|459510792|FG000|Part 2: Dose Expansion|Other|0|||
127694584|NCT04382898|459510793|FG001|Part 2: Dose Expansion|Other|0|||
127694585|NCT04382898|459510794|FG002|Part 2: Dose Expansion|Other|1|||
127694586|NCT04382898|459510795|FG003|Part 2: Dose Expansion|Other|0|||
127694587|NCT04382898|459510796|FG004|Part 2: Dose Expansion|Other|0|||
127694588|NCT05229120|459510797|FG000|Overall Study|Withdrawal by Subject|8|||
127694589|NCT03932682|459510800|FG000|Overall Study|Death|1|||
127694590|NCT03932682|459510801|FG001|Overall Study|Death|2|||
127694591|NCT03932682|459510800|FG000|Overall Study|Withdrawal by Subject|37|||
127694592|NCT03932682|459510801|FG001|Overall Study|Withdrawal by Subject|45|||
127694593|NCT03932682|459510800|FG000|Overall Study|Lost to Follow-up|19|||
127694594|NCT03932682|459510801|FG001|Overall Study|Lost to Follow-up|25|||
127694595|NCT03932682|459510800|FG000|Overall Study|Protocol Violation|0|||
127694596|NCT03932682|459510801|FG001|Overall Study|Protocol Violation|2|||
127694597|NCT03932682|459510800|FG000|Overall Study|Other|9|||
127694598|NCT03932682|459510801|FG001|Overall Study|Other|23|||
127694599|NCT01566695|459510802|FG000|Overall Study|Lack of Efficacy|1|||
127694600|NCT01566695|459510803|FG001|Overall Study|Lack of Efficacy|0|||
127694601|NCT01566695|459510802|FG000|Overall Study|Adverse Event|3|||
127694602|NCT01566695|459510803|FG001|Overall Study|Adverse Event|0|||
127694603|NCT01566695|459510802|FG000|Overall Study|Death|79|||
127694604|NCT01566695|459510803|FG001|Overall Study|Death|86|||
127694605|NCT01566695|459510802|FG000|Overall Study|Withdrawal by Subject|13|||
127694606|NCT01566695|459510803|FG001|Overall Study|Withdrawal by Subject|12|||
127694607|NCT01566695|459510802|FG000|Overall Study|Lost to Follow-up|0|||
127694608|NCT01566695|459510803|FG001|Overall Study|Lost to Follow-up|3|||
127694609|NCT01566695|459510802|FG000|Overall Study|Other reasons|11|||
127694610|NCT01566695|459510803|FG001|Overall Study|Other reasons|8|||
127694611|NCT03763708|459510804|FG000|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|4|||
127694612|NCT03763708|459510805|FG001|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
127694613|NCT03763708|459510806|FG002|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
127694614|NCT03763708|459510807|FG003|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
127694615|NCT03763708|459510808|FG004|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
127694616|NCT03763708|459510809|FG005|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
127694617|NCT03763708|459510810|FG006|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
127694618|NCT03763708|459510811|FG007|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
127694619|NCT03763708|459510812|FG008|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
127694620|NCT03763708|459510804|FG000|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
127694621|NCT03763708|459510805|FG001|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
127694622|NCT03763708|459510806|FG002|Cohort 3: Cycling Evolve|Withdrawal by Subject|1|||
127882067|NCT01289990|460190797|FG004|Overall Study|discontinued in preceding trial|11|||
128034253|NCT01346592|460751749|FG000|Overall Study|Inappropriate enrollment|3|||
128034254|NCT01346592|460751750|FG001|Overall Study|Inappropriate enrollment|1|||
128034255|NCT01346592|460751751|FG002|Overall Study|Inappropriate enrollment|1|||
127694623|NCT03763708|459510807|FG003|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
127694624|NCT03763708|459510808|FG004|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
127694625|NCT03763708|459510809|FG005|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
127694626|NCT03763708|459510810|FG006|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
127694627|NCT03763708|459510811|FG007|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
127694628|NCT03763708|459510812|FG008|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
127694629|NCT03763708|459510804|FG000|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
127694630|NCT03763708|459510805|FG001|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
127592309|NCT02794883|459136700|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
127592310|NCT02794883|459136701|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
127592311|NCT02794883|459136699|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
127592312|NCT02794883|459136700|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
127592313|NCT02794883|459136701|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
127592314|NCT02794883|459136699|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
127592315|NCT02794883|459136700|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
127592316|NCT02794883|459136701|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
127592317|NCT02794883|459136699|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
127592318|NCT02794883|459136700|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
127592319|NCT02794883|459136701|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
127592320|NCT02794883|459136699|FG000|Follow-up Period (up to 2 Years)|Death|12|||
127592321|NCT02794883|459136700|FG001|Follow-up Period (up to 2 Years)|Death|10|||
127592322|NCT02794883|459136701|FG002|Follow-up Period (up to 2 Years)|Death|10|||
127592323|NCT00003499|459136702|FG000|Overall Study|Not evaluable|8|||
127592324|NCT02864498|459136703|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
127592325|NCT02864498|459136704|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
127592326|NCT02864498|459136705|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
127592327|NCT02864498|459136703|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
127592328|NCT02864498|459136704|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
127592329|NCT02864498|459136705|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
127592330|NCT02864498|459136703|FG000|Overall Study|Investigator Discretion|0|||
127592331|NCT02864498|459136704|FG001|Overall Study|Investigator Discretion|2|||
127592332|NCT02864498|459136705|FG002|Overall Study|Investigator Discretion|1|||
127592333|NCT02864498|459136703|FG000|Overall Study|Lost to Follow-up|8|||
127592334|NCT02864498|459136704|FG001|Overall Study|Lost to Follow-up|6|||
127592335|NCT02864498|459136705|FG002|Overall Study|Lost to Follow-up|3|||
127592336|NCT02864498|459136703|FG000|Overall Study|Lack of Efficacy|5|||
127592337|NCT02864498|459136704|FG001|Overall Study|Lack of Efficacy|3|||
127592338|NCT02864498|459136705|FG002|Overall Study|Lack of Efficacy|3|||
127592339|NCT02864498|459136703|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
127592340|NCT02864498|459136704|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
127592341|NCT02864498|459136705|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
127592342|NCT02864498|459136703|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
127592343|NCT02864498|459136704|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
127592344|NCT02864498|459136705|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
127592345|NCT02864498|459136703|FG000|Overall Study|Subject moved out of the country.|0|||
127592346|NCT02864498|459136704|FG001|Overall Study|Subject moved out of the country.|0|||
127592347|NCT02864498|459136705|FG002|Overall Study|Subject moved out of the country.|1|||
127592348|NCT00851747|459136709|FG000|Overall Study|Physician Decision|6|||
127592349|NCT00851747|459136710|FG001|Overall Study|Physician Decision|6|||
127592350|NCT00851747|459136711|FG002|Overall Study|Physician Decision|6|||
127592351|NCT00601458|459136712|FG000|Overall Study|Dosing Error|1|||
127592352|NCT00601458|459136713|FG001|Overall Study|Dosing Error|0|||
127592353|NCT00601458|459136714|FG002|Overall Study|Dosing Error|0|||
127592354|NCT00601458|459136712|FG000|Overall Study|Incomplete Data|0|||
127592355|NCT00601458|459136713|FG001|Overall Study|Incomplete Data|2|||
127592356|NCT00601458|459136714|FG002|Overall Study|Incomplete Data|0|||
127592357|NCT00601458|459136712|FG000|Overall Study|Protocol Violation|3|||
127592358|NCT00601458|459136713|FG001|Overall Study|Protocol Violation|2|||
127592359|NCT00601458|459136714|FG002|Overall Study|Protocol Violation|1|||
127592360|NCT00601458|459136712|FG000|Overall Study|Early Termination|0|||
127592361|NCT00601458|459136713|FG001|Overall Study|Early Termination|1|||
127592362|NCT00601458|459136714|FG002|Overall Study|Early Termination|1|||
127592363|NCT01844518|459136716|FG000|Overall Study|Adverse Event|7|||
127592364|NCT01844518|459136717|FG001|Overall Study|Adverse Event|1|||
127592365|NCT01844518|459136716|FG000|Overall Study|Lack of Efficacy|17|||
127592366|NCT01844518|459136717|FG001|Overall Study|Lack of Efficacy|5|||
127592367|NCT01844518|459136716|FG000|Overall Study|Participant's request to discontinue|4|||
127592368|NCT01844518|459136717|FG001|Overall Study|Participant's request to discontinue|1|||
127592369|NCT01844518|459136716|FG000|Overall Study|Poor/Non-compliance|1|||
127592370|NCT01844518|459136717|FG001|Overall Study|Poor/Non-compliance|0|||
128034256|NCT01346592|460751749|FG000|Overall Study|Administrative reason|1|||
127592371|NCT01844518|459136716|FG000|Overall Study|No Longer Met Study Criteria|2|||
127592372|NCT01844518|459136717|FG001|Overall Study|No Longer Met Study Criteria|0|||
127592373|NCT01844518|459136716|FG000|Overall Study|Withdrawal by Subject|9|||
127592374|NCT01844518|459136717|FG001|Overall Study|Withdrawal by Subject|0|||
127592375|NCT01844518|459136716|FG000|Overall Study|Pregnancy|1|||
127592376|NCT01844518|459136717|FG001|Overall Study|Pregnancy|0|||
127592377|NCT04584645|459136719|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
128034257|NCT01346592|460751750|FG001|Overall Study|Administrative reason|0|||
127887320|NCT01298596|460210579|FG001|Overall Study|Death|3|||
127592378|NCT04584645|459136720|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
127592379|NCT00390468|459136721|FG000|Overall Study|Protocol Violation|2|||
127592380|NCT00390468|459136721|FG000|Overall Study|Lack of Efficacy|1|||
127592381|NCT03129100|459136722|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
127592382|NCT03129100|459136723|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
127592383|NCT03129100|459136724|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
127592384|NCT03129100|459136725|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
127592385|NCT03129100|459136726|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
127592386|NCT03129100|459136727|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
127592387|NCT03129100|459136728|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
127592388|NCT03129100|459136729|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
127592389|NCT03129100|459136730|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
127592390|NCT03129100|459136731|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
127592391|NCT03129100|459136732|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
127592392|NCT03129100|459136733|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
127592393|NCT03129100|459136734|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
127592394|NCT03129100|459136735|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
127592395|NCT03129100|459136736|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
127592396|NCT03129100|459136737|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
127592397|NCT03129100|459136738|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
127592398|NCT03129100|459136739|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
127592399|NCT03129100|459136740|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
127592400|NCT03129100|459136741|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
127592401|NCT03129100|459136742|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
127592402|NCT03129100|459136743|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
127592403|NCT03129100|459136744|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
127592404|NCT03129100|459136745|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
127592405|NCT03129100|459136746|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
127592406|NCT03129100|459136747|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
127592407|NCT03129100|459136722|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
127592408|NCT03129100|459136723|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
127592409|NCT03129100|459136724|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
127592410|NCT03129100|459136725|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
127592411|NCT03129100|459136726|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
127592412|NCT03129100|459136727|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
127592413|NCT03129100|459136728|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
127592414|NCT03129100|459136729|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
127592415|NCT03129100|459136730|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
127592416|NCT03129100|459136731|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
127592417|NCT03129100|459136732|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
127592418|NCT03129100|459136733|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
127592419|NCT03129100|459136734|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
127592420|NCT03129100|459136735|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
127592421|NCT03129100|459136736|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
127592422|NCT03129100|459136737|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
127592423|NCT03129100|459136738|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
127592424|NCT03129100|459136739|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
127592425|NCT03129100|459136740|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
127592426|NCT03129100|459136741|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
127592427|NCT03129100|459136742|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
127592428|NCT03129100|459136743|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
127592429|NCT03129100|459136744|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
127592430|NCT03129100|459136745|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
127592431|NCT03129100|459136746|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
127592432|NCT03129100|459136747|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
127592433|NCT03129100|459136722|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
127592434|NCT03129100|459136723|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
127592435|NCT03129100|459136724|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
127592436|NCT03129100|459136725|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
127592437|NCT03129100|459136726|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
127592438|NCT03129100|459136727|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
127592439|NCT03129100|459136728|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
127592440|NCT03129100|459136729|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
127592441|NCT03129100|459136730|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
127592442|NCT03129100|459136731|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
127887321|NCT01298596|460210578|FG000|Overall Study|Lost to Follow-up|6|||
127592443|NCT03129100|459136732|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
127592444|NCT03129100|459136733|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
127592445|NCT03129100|459136734|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
127592446|NCT03129100|459136735|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
127592447|NCT03129100|459136736|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
127592448|NCT03129100|459136737|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
127592449|NCT03129100|459136738|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
127592450|NCT03129100|459136739|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
127592451|NCT03129100|459136740|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
127592452|NCT03129100|459136741|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
127592453|NCT03129100|459136742|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
127592454|NCT03129100|459136743|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
127592455|NCT03129100|459136744|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
127592456|NCT03129100|459136745|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
127592457|NCT03129100|459136746|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
127592458|NCT03129100|459136747|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
127592459|NCT03129100|459136722|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
127592460|NCT03129100|459136723|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
127592461|NCT03129100|459136724|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
127592462|NCT03129100|459136725|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
127592463|NCT03129100|459136726|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
127592464|NCT03129100|459136727|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
127592465|NCT03129100|459136728|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
128034258|NCT01346592|460751751|FG002|Overall Study|Administrative reason|0|||
128034259|NCT01346592|460751749|FG000|Overall Study|Unable to Classify|7|||
127592466|NCT03129100|459136729|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
127592467|NCT03129100|459136730|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
127592468|NCT03129100|459136731|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
127592469|NCT03129100|459136732|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
127592470|NCT03129100|459136733|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
127592471|NCT03129100|459136734|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
127592472|NCT03129100|459136735|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
127592473|NCT03129100|459136736|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
127592474|NCT03129100|459136737|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
127592475|NCT03129100|459136738|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
127592476|NCT03129100|459136739|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
127592477|NCT03129100|459136740|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
127592478|NCT03129100|459136741|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
127592479|NCT03129100|459136742|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
127592480|NCT03129100|459136743|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
127592481|NCT03129100|459136744|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
127592482|NCT03129100|459136745|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
127592483|NCT03129100|459136746|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
127592484|NCT03129100|459136747|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
127592485|NCT03129100|459136722|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
127592486|NCT03129100|459136723|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
127592487|NCT03129100|459136724|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
127592488|NCT03129100|459136725|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
127592489|NCT03129100|459136726|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
127592490|NCT03129100|459136727|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
127592491|NCT03129100|459136728|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
127592492|NCT03129100|459136729|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
127592493|NCT03129100|459136730|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
127592494|NCT03129100|459136731|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
127592495|NCT03129100|459136732|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
127592496|NCT03129100|459136733|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
127592497|NCT03129100|459136734|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
127592498|NCT03129100|459136735|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
127592499|NCT03129100|459136736|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
127592500|NCT03129100|459136737|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
127592501|NCT03129100|459136738|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
127592502|NCT03129100|459136739|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
127592503|NCT03129100|459136740|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
127592504|NCT03129100|459136741|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
127592505|NCT03129100|459136742|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
127592506|NCT03129100|459136743|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
127592507|NCT03129100|459136744|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
127592508|NCT03129100|459136745|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
127592509|NCT03129100|459136746|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
127592510|NCT03129100|459136747|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
127592511|NCT03129100|459136722|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
127592512|NCT03129100|459136723|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
127592513|NCT03129100|459136724|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
127592514|NCT03129100|459136725|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
127592515|NCT03129100|459136726|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
127592516|NCT03129100|459136727|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
127592517|NCT03129100|459136728|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
127592518|NCT03129100|459136729|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
127592519|NCT03129100|459136730|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
127592520|NCT03129100|459136731|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
127592521|NCT03129100|459136732|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
127592522|NCT03129100|459136733|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
127592523|NCT03129100|459136734|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
127592524|NCT03129100|459136735|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
127592525|NCT03129100|459136736|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
127592526|NCT03129100|459136737|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
127592527|NCT03129100|459136738|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
127592528|NCT03129100|459136739|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
127592529|NCT03129100|459136740|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
127592530|NCT03129100|459136741|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
127592531|NCT03129100|459136742|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
127592532|NCT03129100|459136743|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
127592533|NCT03129100|459136744|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
127592534|NCT03129100|459136745|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
127592535|NCT03129100|459136746|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
127592536|NCT03129100|459136747|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
127592537|NCT03129100|459136722|FG000|Period2 Extension Period (Group A and B)|Death|0|||
127592538|NCT03129100|459136723|FG001|Period2 Extension Period (Group A and B)|Death|0|||
127592539|NCT03129100|459136724|FG002|Period2 Extension Period (Group A and B)|Death|1|||
127592540|NCT03129100|459136725|FG003|Period2 Extension Period (Group A and B)|Death|0|||
127592541|NCT03129100|459136726|FG004|Period2 Extension Period (Group A and B)|Death|0|||
127592542|NCT03129100|459136727|FG005|Period2 Extension Period (Group A and B)|Death|0|||
127592543|NCT03129100|459136728|FG006|Period2 Extension Period (Group A and B)|Death|0|||
127592544|NCT03129100|459136729|FG007|Period2 Extension Period (Group A and B)|Death|0|||
127592545|NCT03129100|459136730|FG008|Period2 Extension Period (Group A and B)|Death|0|||
127592546|NCT03129100|459136731|FG009|Period2 Extension Period (Group A and B)|Death|0|||
127592547|NCT03129100|459136732|FG010|Period2 Extension Period (Group A and B)|Death|0|||
127592548|NCT03129100|459136733|FG011|Period2 Extension Period (Group A and B)|Death|0|||
127592549|NCT03129100|459136734|FG012|Period2 Extension Period (Group A and B)|Death|0|||
127592550|NCT03129100|459136735|FG013|Period2 Extension Period (Group A and B)|Death|0|||
127592551|NCT03129100|459136736|FG014|Period2 Extension Period (Group A and B)|Death|0|||
127592552|NCT03129100|459136737|FG015|Period2 Extension Period (Group A and B)|Death|0|||
127592553|NCT03129100|459136738|FG016|Period2 Extension Period (Group A and B)|Death|0|||
127592554|NCT03129100|459136739|FG017|Period2 Extension Period (Group A and B)|Death|0|||
127592555|NCT03129100|459136740|FG018|Period2 Extension Period (Group A and B)|Death|0|||
127592556|NCT03129100|459136741|FG019|Period2 Extension Period (Group A and B)|Death|0|||
127592557|NCT03129100|459136742|FG020|Period2 Extension Period (Group A and B)|Death|0|||
127592558|NCT03129100|459136743|FG021|Period2 Extension Period (Group A and B)|Death|0|||
127592559|NCT03129100|459136744|FG022|Period2 Extension Period (Group A and B)|Death|0|||
127592560|NCT03129100|459136745|FG023|Period2 Extension Period (Group A and B)|Death|0|||
127592561|NCT03129100|459136746|FG024|Period2 Extension Period (Group A and B)|Death|0|||
127592562|NCT03129100|459136747|FG025|Period2 Extension Period (Group A and B)|Death|0|||
127592563|NCT03129100|459136722|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
127592564|NCT03129100|459136723|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
127592565|NCT03129100|459136724|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
127592566|NCT03129100|459136725|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
127592567|NCT03129100|459136726|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
127592568|NCT03129100|459136727|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
127592569|NCT03129100|459136728|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
127592570|NCT03129100|459136729|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
127592571|NCT03129100|459136730|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
127592572|NCT03129100|459136731|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
127592573|NCT03129100|459136732|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
127592574|NCT03129100|459136733|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
127694631|NCT03763708|459510806|FG002|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
127694632|NCT03763708|459510807|FG003|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|2|||
127592575|NCT03129100|459136734|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
127592576|NCT03129100|459136735|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
127694633|NCT03763708|459510808|FG004|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
127694634|NCT03763708|459510809|FG005|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
127694635|NCT03763708|459510810|FG006|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
127592577|NCT03129100|459136736|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
127694636|NCT03763708|459510811|FG007|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
127694637|NCT03763708|459510812|FG008|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
127694638|NCT03763708|459510804|FG000|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
127694639|NCT03763708|459510805|FG001|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
127694640|NCT03763708|459510806|FG002|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
127694641|NCT03763708|459510807|FG003|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
127694642|NCT03763708|459510808|FG004|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|2|||
127694643|NCT03763708|459510809|FG005|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
127694644|NCT03763708|459510810|FG006|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
127694645|NCT03763708|459510811|FG007|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
127694646|NCT03763708|459510812|FG008|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
127694647|NCT03763708|459510804|FG000|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
127694648|NCT03763708|459510805|FG001|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
127694649|NCT03763708|459510806|FG002|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
127694650|NCT03763708|459510807|FG003|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
127694651|NCT03763708|459510808|FG004|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
127694652|NCT03763708|459510809|FG005|Cohort 6: DTM-LE SCS|Withdrawal by Subject|2|||
127694653|NCT03763708|459510810|FG006|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
127694654|NCT03763708|459510811|FG007|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
127694655|NCT03763708|459510812|FG008|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
127694656|NCT03763708|459510804|FG000|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
127694657|NCT03763708|459510805|FG001|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
127694658|NCT03763708|459510806|FG002|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
127694659|NCT03763708|459510807|FG003|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
127694660|NCT03763708|459510808|FG004|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
127694661|NCT03763708|459510809|FG005|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
127592578|NCT03129100|459136737|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
127592579|NCT03129100|459136738|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
127592580|NCT03129100|459136739|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
127592581|NCT03129100|459136740|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
127592582|NCT03129100|459136741|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
127592583|NCT03129100|459136742|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
127592584|NCT03129100|459136743|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
127592585|NCT03129100|459136744|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
127592586|NCT03129100|459136745|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
127592587|NCT03129100|459136746|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
127592588|NCT03129100|459136747|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
127592589|NCT03129100|459136722|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
127592590|NCT03129100|459136723|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
127592591|NCT03129100|459136724|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
127592592|NCT03129100|459136725|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
127592593|NCT03129100|459136726|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
127592594|NCT03129100|459136727|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
127592595|NCT03129100|459136728|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
127592596|NCT03129100|459136729|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
127592597|NCT03129100|459136730|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
127592598|NCT03129100|459136731|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
127592599|NCT03129100|459136732|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
127592600|NCT03129100|459136733|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
127592601|NCT03129100|459136734|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
127592602|NCT03129100|459136735|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
127592603|NCT03129100|459136736|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
127592604|NCT03129100|459136737|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
127592605|NCT03129100|459136738|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
127592606|NCT03129100|459136739|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
127592607|NCT03129100|459136740|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
127592608|NCT03129100|459136741|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
127592609|NCT03129100|459136742|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
127592610|NCT03129100|459136743|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
127592611|NCT03129100|459136744|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
127694662|NCT03763708|459510810|FG006|Cohort 7: Super Cycle|Withdrawal by Subject|9|||
127694663|NCT03763708|459510811|FG007|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
127694664|NCT03763708|459510812|FG008|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
127887322|NCT01298596|460210579|FG001|Overall Study|Lost to Follow-up|14|||
128034260|NCT01346592|460751750|FG001|Overall Study|Unable to Classify|3|||
127592612|NCT03129100|459136745|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
127592613|NCT03129100|459136746|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
127592614|NCT03129100|459136747|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
127592615|NCT03129100|459136722|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
127592616|NCT03129100|459136723|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
127592617|NCT03129100|459136724|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
127592618|NCT03129100|459136725|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
127592619|NCT03129100|459136726|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
127592620|NCT03129100|459136727|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
127592621|NCT03129100|459136728|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
127592622|NCT03129100|459136729|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
127592623|NCT03129100|459136730|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
127592624|NCT03129100|459136731|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
127592625|NCT03129100|459136732|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
127592626|NCT03129100|459136733|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
127592627|NCT03129100|459136734|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
127592628|NCT03129100|459136735|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
127592629|NCT03129100|459136736|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
127592630|NCT03129100|459136737|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
127592631|NCT03129100|459136738|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
127592632|NCT03129100|459136739|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
127592633|NCT03129100|459136740|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
127592634|NCT03129100|459136741|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
127592635|NCT03129100|459136742|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
127592636|NCT03129100|459136743|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
127592637|NCT03129100|459136744|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
127592638|NCT03129100|459136745|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
127592639|NCT03129100|459136746|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
127592640|NCT03129100|459136747|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
127592641|NCT03129100|459136722|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
127592642|NCT03129100|459136723|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
127592643|NCT03129100|459136724|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
127592644|NCT03129100|459136725|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
127592645|NCT03129100|459136726|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
127592646|NCT03129100|459136727|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
127592647|NCT03129100|459136728|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
127592648|NCT03129100|459136729|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
127592649|NCT03129100|459136730|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
127592650|NCT03129100|459136731|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
127592651|NCT03129100|459136732|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
127592652|NCT03129100|459136733|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
127592653|NCT03129100|459136734|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
127592654|NCT03129100|459136735|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
127592655|NCT03129100|459136736|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
127592656|NCT03129100|459136737|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
127592657|NCT03129100|459136738|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
127592658|NCT03129100|459136739|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
127592659|NCT03129100|459136740|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
127592660|NCT03129100|459136741|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
127592661|NCT03129100|459136742|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
127592662|NCT03129100|459136743|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
127592663|NCT03129100|459136744|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
127592664|NCT03129100|459136745|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
127592665|NCT03129100|459136746|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
127592666|NCT03129100|459136747|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
127592667|NCT03129100|459136722|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
127592668|NCT03129100|459136723|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
127592669|NCT03129100|459136724|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
127592670|NCT03129100|459136725|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
127592671|NCT03129100|459136726|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
127592672|NCT03129100|459136727|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
127592673|NCT03129100|459136728|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
127592674|NCT03129100|459136729|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
127592675|NCT03129100|459136730|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
127592676|NCT03129100|459136731|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
127592677|NCT03129100|459136732|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
127592678|NCT03129100|459136733|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
127592679|NCT03129100|459136734|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
127592680|NCT03129100|459136735|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
127592681|NCT03129100|459136736|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
127592682|NCT03129100|459136737|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
127592683|NCT03129100|459136738|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
127592684|NCT03129100|459136739|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
127592685|NCT03129100|459136740|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
127592686|NCT03129100|459136741|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
127592687|NCT03129100|459136742|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
127592688|NCT03129100|459136743|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
127592689|NCT03129100|459136744|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
127592690|NCT03129100|459136745|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
127592691|NCT03129100|459136746|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
127592692|NCT03129100|459136747|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
127592693|NCT03129100|459136722|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
127592694|NCT03129100|459136723|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
127592695|NCT03129100|459136724|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
127592696|NCT03129100|459136725|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
127592697|NCT03129100|459136726|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
127592698|NCT03129100|459136727|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
127592699|NCT03129100|459136728|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
127592700|NCT03129100|459136729|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
127592701|NCT03129100|459136730|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
127592702|NCT03129100|459136731|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
127592703|NCT03129100|459136732|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
127592704|NCT03129100|459136733|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
127592705|NCT03129100|459136734|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
127592706|NCT03129100|459136735|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
127592707|NCT03129100|459136736|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
127592708|NCT03129100|459136737|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
127592709|NCT03129100|459136738|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
127592710|NCT03129100|459136739|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
127592711|NCT03129100|459136740|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
127592712|NCT03129100|459136741|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
127592713|NCT03129100|459136742|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
127592714|NCT03129100|459136743|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
127592715|NCT03129100|459136744|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
127592716|NCT03129100|459136745|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
127592717|NCT03129100|459136746|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
127592718|NCT03129100|459136747|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
127592719|NCT03129100|459136722|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
127592720|NCT03129100|459136723|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
127592721|NCT03129100|459136724|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
127592722|NCT03129100|459136725|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
127592723|NCT03129100|459136726|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
127592724|NCT03129100|459136727|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
127592725|NCT03129100|459136728|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
127592726|NCT03129100|459136729|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
127592727|NCT03129100|459136730|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
127592728|NCT03129100|459136731|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
127592729|NCT03129100|459136732|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
127592730|NCT03129100|459136733|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
127592731|NCT03129100|459136734|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
127592732|NCT03129100|459136735|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
127592733|NCT03129100|459136736|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
127592734|NCT03129100|459136737|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
127592735|NCT03129100|459136738|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
127784707|NCT00262522|459837018|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
127784708|NCT00262522|459837019|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
127784709|NCT00262522|459837016|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
127784710|NCT00262522|459837017|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
127784711|NCT00262522|459837018|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
127784712|NCT00262522|459837019|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
127784713|NCT03159091|459837020|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
127784714|NCT03159091|459837021|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
127784715|NCT03159091|459837020|FG000|Overall Study|Patient has taken no dose of study drug|0|||
127784716|NCT03159091|459837021|FG001|Overall Study|Patient has taken no dose of study drug|1|||
127784717|NCT03740165|459837022|FG000|Overall Study|Death|232|||
127784718|NCT03740165|459837023|FG001|Overall Study|Death|242|||
127784719|NCT03740165|459837024|FG002|Overall Study|Death|229|||
127784720|NCT03740165|459837022|FG000|Overall Study|Lost to Follow-up|0|||
127784721|NCT03740165|459837023|FG001|Overall Study|Lost to Follow-up|0|||
127784722|NCT03740165|459837024|FG002|Overall Study|Lost to Follow-up|1|||
127784723|NCT03740165|459837022|FG000|Overall Study|Withdrawal by Subject|7|||
127784724|NCT03740165|459837023|FG001|Overall Study|Withdrawal by Subject|4|||
128034261|NCT01346592|460751751|FG002|Overall Study|Unable to Classify|6|||
128034262|NCT02679274|460751752|FG000|Overall Study|Withdrawal by Subject|1|||
127592736|NCT03129100|459136739|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
127592737|NCT03129100|459136740|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
127592738|NCT03129100|459136741|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
127592739|NCT03129100|459136742|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
127592740|NCT03129100|459136743|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
127592741|NCT03129100|459136744|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
127592742|NCT03129100|459136745|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
127592743|NCT03129100|459136746|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
127592744|NCT03129100|459136747|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
127592745|NCT03129100|459136722|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
127592746|NCT03129100|459136723|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
127592747|NCT03129100|459136724|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
127592748|NCT03129100|459136725|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
127592749|NCT03129100|459136726|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
127592750|NCT03129100|459136727|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
127592751|NCT03129100|459136728|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
127592752|NCT03129100|459136729|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
127592753|NCT03129100|459136730|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
127592754|NCT03129100|459136731|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
127592755|NCT03129100|459136732|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
127592756|NCT03129100|459136733|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
127592757|NCT03129100|459136734|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
127592758|NCT03129100|459136735|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
127592759|NCT03129100|459136736|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
127592760|NCT03129100|459136737|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
127592761|NCT03129100|459136738|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
127592762|NCT03129100|459136739|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
127592763|NCT03129100|459136740|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
127592764|NCT03129100|459136741|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
127592765|NCT03129100|459136742|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
127592766|NCT03129100|459136743|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
127592767|NCT03129100|459136744|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
127592768|NCT03129100|459136745|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
127592769|NCT03129100|459136746|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
127592770|NCT03129100|459136747|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
127592771|NCT03129100|459136722|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
127592772|NCT03129100|459136723|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
127592773|NCT03129100|459136724|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
127592774|NCT03129100|459136725|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
127592775|NCT03129100|459136726|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
127592776|NCT03129100|459136727|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
128034263|NCT02679274|460751753|FG001|Overall Study|Withdrawal by Subject|0|||
128034264|NCT04976855|460751757|FG000|Part I|Withdrawal by Subject|0|||
128034265|NCT04976855|460751758|FG001|Part I|Withdrawal by Subject|1|||
128034266|NCT04976855|460751759|FG002|Part I|Withdrawal by Subject|0|||
128034267|NCT04976855|460751760|FG003|Part I|Withdrawal by Subject|0|||
127592777|NCT03129100|459136728|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
127592778|NCT03129100|459136729|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
127592779|NCT03129100|459136730|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
127592780|NCT03129100|459136731|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
127592781|NCT03129100|459136732|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
127592782|NCT03129100|459136733|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
127592783|NCT03129100|459136734|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
127592784|NCT03129100|459136735|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
127592785|NCT03129100|459136736|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
127592786|NCT03129100|459136737|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
127592787|NCT03129100|459136738|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
127592788|NCT03129100|459136739|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
127592789|NCT03129100|459136740|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
127592790|NCT03129100|459136741|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
127592791|NCT03129100|459136742|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
127592792|NCT03129100|459136743|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
127592793|NCT03129100|459136744|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
127592794|NCT03129100|459136745|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
127592795|NCT03129100|459136746|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
127592796|NCT03129100|459136747|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
127592797|NCT03129100|459136722|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
127592798|NCT03129100|459136723|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
127592799|NCT03129100|459136724|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
127592800|NCT03129100|459136725|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
127592801|NCT03129100|459136726|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
127592802|NCT03129100|459136727|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
127592803|NCT03129100|459136728|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
127784725|NCT03740165|459837024|FG002|Overall Study|Withdrawal by Subject|3|||
127784726|NCT03740165|459837022|FG000|Overall Study|Ongoing in Study|216|||
127784727|NCT03740165|459837023|FG001|Overall Study|Ongoing in Study|212|||
127784728|NCT03740165|459837024|FG002|Overall Study|Ongoing in Study|221|||
127784729|NCT02044133|459837025|FG000|Overall Study|Lost to Follow-up|1|||
127784730|NCT02044133|459837026|FG001|Overall Study|Lost to Follow-up|1|||
127592804|NCT03129100|459136729|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
127592805|NCT03129100|459136730|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
127592806|NCT03129100|459136731|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
127592807|NCT03129100|459136732|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
127592808|NCT03129100|459136733|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
127592809|NCT03129100|459136734|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
127592810|NCT03129100|459136735|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
127592811|NCT03129100|459136736|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
127592812|NCT03129100|459136737|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
127592813|NCT03129100|459136738|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
127592814|NCT03129100|459136739|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
127592815|NCT03129100|459136740|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
127592816|NCT03129100|459136741|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
127592817|NCT03129100|459136742|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
127592818|NCT03129100|459136743|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
127592819|NCT03129100|459136744|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
127592820|NCT03129100|459136745|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
127592821|NCT03129100|459136746|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
127592822|NCT03129100|459136747|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
127592823|NCT03129100|459136722|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
127592824|NCT03129100|459136723|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
127592825|NCT03129100|459136724|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
127592826|NCT03129100|459136725|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
127592827|NCT03129100|459136726|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
127592828|NCT03129100|459136727|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
127592829|NCT03129100|459136728|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
127592830|NCT03129100|459136729|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
127592831|NCT03129100|459136730|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
127592832|NCT03129100|459136731|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
127592833|NCT03129100|459136732|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
127592834|NCT03129100|459136733|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
127784731|NCT02044133|459837025|FG000|Overall Study|Death|1|||
127694665|NCT03763708|459510804|FG000|Cohort 7: Super Cycle|Adverse Event|0|||
127694666|NCT03763708|459510805|FG001|Cohort 7: Super Cycle|Adverse Event|0|||
127694667|NCT03763708|459510806|FG002|Cohort 7: Super Cycle|Adverse Event|0|||
127694668|NCT03763708|459510807|FG003|Cohort 7: Super Cycle|Adverse Event|0|||
127694669|NCT03763708|459510808|FG004|Cohort 7: Super Cycle|Adverse Event|0|||
127694670|NCT03763708|459510809|FG005|Cohort 7: Super Cycle|Adverse Event|0|||
127694671|NCT03763708|459510810|FG006|Cohort 7: Super Cycle|Adverse Event|1|||
127694672|NCT03763708|459510811|FG007|Cohort 7: Super Cycle|Adverse Event|0|||
127694673|NCT03763708|459510812|FG008|Cohort 7: Super Cycle|Adverse Event|0|||
127694674|NCT03763708|459510804|FG000|Cohort 7: Super Cycle|Screen Failure|0|||
127694675|NCT03763708|459510805|FG001|Cohort 7: Super Cycle|Screen Failure|0|||
127694676|NCT03763708|459510806|FG002|Cohort 7: Super Cycle|Screen Failure|0|||
127694677|NCT03763708|459510807|FG003|Cohort 7: Super Cycle|Screen Failure|0|||
127694678|NCT03763708|459510808|FG004|Cohort 7: Super Cycle|Screen Failure|0|||
127694679|NCT03763708|459510809|FG005|Cohort 7: Super Cycle|Screen Failure|0|||
127694680|NCT03763708|459510810|FG006|Cohort 7: Super Cycle|Screen Failure|1|||
127694681|NCT03763708|459510811|FG007|Cohort 7: Super Cycle|Screen Failure|0|||
127694682|NCT03763708|459510812|FG008|Cohort 7: Super Cycle|Screen Failure|0|||
127694683|NCT03763708|459510804|FG000|Cohort 9: DPN Flow|Screen Failure|0|||
127694684|NCT03763708|459510805|FG001|Cohort 9: DPN Flow|Screen Failure|0|||
127694685|NCT03763708|459510806|FG002|Cohort 9: DPN Flow|Screen Failure|0|||
127694686|NCT03763708|459510807|FG003|Cohort 9: DPN Flow|Screen Failure|0|||
127694687|NCT03763708|459510808|FG004|Cohort 9: DPN Flow|Screen Failure|0|||
127694688|NCT03763708|459510809|FG005|Cohort 9: DPN Flow|Screen Failure|0|||
127694689|NCT03763708|459510810|FG006|Cohort 9: DPN Flow|Screen Failure|0|||
127694690|NCT03763708|459510811|FG007|Cohort 9: DPN Flow|Screen Failure|0|||
127694691|NCT03763708|459510812|FG008|Cohort 9: DPN Flow|Screen Failure|1|||
127694692|NCT05470400|459510813|FG000|Overall Study|Lost to Follow-up|0|||
127694693|NCT05470400|459510814|FG001|Overall Study|Lost to Follow-up|0|||
127694694|NCT05470400|459510815|FG002|Overall Study|Lost to Follow-up|0|||
127694695|NCT05470400|459510816|FG003|Overall Study|Lost to Follow-up|0|||
127592835|NCT03129100|459136734|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
127592836|NCT03129100|459136735|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
127592837|NCT03129100|459136736|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
127592838|NCT03129100|459136737|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
127592839|NCT03129100|459136738|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
127592840|NCT03129100|459136739|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
127592841|NCT03129100|459136740|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
127592842|NCT03129100|459136741|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
127592843|NCT03129100|459136742|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
127592844|NCT03129100|459136743|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
127592845|NCT03129100|459136744|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
127592846|NCT03129100|459136745|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
127592847|NCT03129100|459136746|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
127592848|NCT03129100|459136747|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
127592849|NCT03129100|459136722|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
127592850|NCT03129100|459136723|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
127592851|NCT03129100|459136724|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
127592852|NCT03129100|459136725|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
127592853|NCT03129100|459136726|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
127592854|NCT03129100|459136727|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
127592855|NCT03129100|459136728|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
127592856|NCT03129100|459136729|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
127592857|NCT03129100|459136730|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
127592858|NCT03129100|459136731|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
127592859|NCT03129100|459136732|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
127694696|NCT05470400|459510817|FG004|Overall Study|Lost to Follow-up|0|||
127694697|NCT05470400|459510818|FG005|Overall Study|Lost to Follow-up|0|||
127694698|NCT05470400|459510819|FG006|Overall Study|Lost to Follow-up|0|||
127694699|NCT05470400|459510820|FG007|Overall Study|Lost to Follow-up|1|||
127694700|NCT05470400|459510813|FG000|Overall Study|Withdrawal by Subject|1|||
127694701|NCT05470400|459510814|FG001|Overall Study|Withdrawal by Subject|0|||
127694702|NCT05470400|459510815|FG002|Overall Study|Withdrawal by Subject|0|||
127694703|NCT05470400|459510816|FG003|Overall Study|Withdrawal by Subject|0|||
127694704|NCT05470400|459510817|FG004|Overall Study|Withdrawal by Subject|0|||
127784732|NCT02044133|459837026|FG001|Overall Study|Death|0|||
127784733|NCT02044133|459837025|FG000|Overall Study|Release|3|||
127784734|NCT02044133|459837026|FG001|Overall Study|Release|4|||
127784735|NCT02044133|459837025|FG000|Overall Study|Transfer|1|||
127784736|NCT02044133|459837026|FG001|Overall Study|Transfer|0|||
127784737|NCT02044133|459837025|FG000|Overall Study|refusal of blood sampling|0|||
127784738|NCT02044133|459837026|FG001|Overall Study|refusal of blood sampling|1|||
127784739|NCT05318937|459837027|FG000|Overall Study|Non-Compliance with Study Drug|1|||
127784740|NCT05318937|459837028|FG001|Overall Study|Non-Compliance with Study Drug|0|||
128034268|NCT04976855|460751761|FG004|Part I|Withdrawal by Subject|0|||
127592860|NCT03129100|459136733|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
127592861|NCT03129100|459136734|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
127592862|NCT03129100|459136735|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
127592863|NCT03129100|459136736|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
127592864|NCT03129100|459136737|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
127592865|NCT03129100|459136738|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
127592866|NCT03129100|459136739|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
127592867|NCT03129100|459136740|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
127592868|NCT03129100|459136741|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
127592869|NCT03129100|459136742|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
127592870|NCT03129100|459136743|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
127592871|NCT03129100|459136744|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
127592872|NCT03129100|459136745|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
127592873|NCT03129100|459136746|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
127592874|NCT03129100|459136747|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
127592875|NCT03129100|459136722|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
127592876|NCT03129100|459136723|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
127592877|NCT03129100|459136724|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
127592878|NCT03129100|459136725|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
127592879|NCT03129100|459136726|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
127592880|NCT03129100|459136727|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
127592881|NCT03129100|459136728|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
127592882|NCT03129100|459136729|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
127592883|NCT03129100|459136730|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
127592884|NCT03129100|459136731|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
127592885|NCT03129100|459136732|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
127592886|NCT03129100|459136733|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
127592887|NCT03129100|459136734|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
127592888|NCT03129100|459136735|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
127592889|NCT03129100|459136736|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
127592890|NCT03129100|459136737|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
127592891|NCT03129100|459136738|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
127592892|NCT03129100|459136739|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
127592893|NCT03129100|459136740|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
127592894|NCT03129100|459136741|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
127592895|NCT03129100|459136742|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
127592896|NCT03129100|459136743|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
127592897|NCT03129100|459136744|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
127592898|NCT03129100|459136745|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
127592899|NCT03129100|459136746|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
127592900|NCT03129100|459136747|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
127592901|NCT03129100|459136722|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
127592902|NCT03129100|459136723|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
127592903|NCT03129100|459136724|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
127592904|NCT03129100|459136725|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
127592905|NCT03129100|459136726|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
127592906|NCT03129100|459136727|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
127592907|NCT03129100|459136728|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
127592908|NCT03129100|459136729|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
127592909|NCT03129100|459136730|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
127592910|NCT03129100|459136731|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
127592911|NCT03129100|459136732|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
127592912|NCT03129100|459136733|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
127592913|NCT03129100|459136734|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
127784741|NCT05318937|459837027|FG000|Overall Study|Lost to Follow-up|0|||
127784742|NCT05318937|459837028|FG001|Overall Study|Lost to Follow-up|1|||
127784743|NCT05318937|459837027|FG000|Overall Study|Withdrawal by Subject|0|||
127784744|NCT05318937|459837028|FG001|Overall Study|Withdrawal by Subject|2|||
127784745|NCT05318937|459837027|FG000|Overall Study|Protocol Violation|0|||
127784746|NCT05318937|459837028|FG001|Overall Study|Protocol Violation|1|||
127784747|NCT05678257|459837034|FG000|Overall Study|Withdrawal by Subject|2|||
127784748|NCT05678257|459837035|FG001|Overall Study|Withdrawal by Subject|0|||
127784749|NCT05678257|459837036|FG002|Overall Study|Withdrawal by Subject|5|||
127784750|NCT05678257|459837034|FG000|Overall Study|Physician Decision|1|||
127784751|NCT05678257|459837035|FG001|Overall Study|Physician Decision|0|||
127784752|NCT05678257|459837036|FG002|Overall Study|Physician Decision|1|||
127784753|NCT05678257|459837034|FG000|Overall Study|Adverse Event|1|||
127784754|NCT05678257|459837035|FG001|Overall Study|Adverse Event|3|||
127784755|NCT05678257|459837036|FG002|Overall Study|Adverse Event|1|||
127784756|NCT05678257|459837034|FG000|Overall Study|Progressive disease|11|||
127784757|NCT05678257|459837035|FG001|Overall Study|Progressive disease|18|||
127784758|NCT05678257|459837036|FG002|Overall Study|Progressive disease|7|||
128034269|NCT04976855|460751762|FG005|Part I|Withdrawal by Subject|0|||
128034270|NCT04976855|460751763|FG006|Part I|Withdrawal by Subject|0|||
128034271|NCT04976855|460751757|FG000|Part II|Adverse Event|0|||
128034272|NCT04976855|460751758|FG001|Part II|Adverse Event|0|||
127592914|NCT03129100|459136735|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
127592915|NCT03129100|459136736|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
127592916|NCT03129100|459136737|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
127592917|NCT03129100|459136738|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
127592918|NCT03129100|459136739|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
127592919|NCT03129100|459136740|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
127592920|NCT03129100|459136741|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
127592921|NCT03129100|459136742|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
127592922|NCT03129100|459136743|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
127592923|NCT03129100|459136744|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
127592924|NCT03129100|459136745|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
127592925|NCT03129100|459136746|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
127592926|NCT03129100|459136747|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
127592927|NCT03129100|459136722|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
127592928|NCT03129100|459136723|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
127592929|NCT03129100|459136724|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
127592930|NCT03129100|459136725|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
127592931|NCT03129100|459136726|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
127592932|NCT03129100|459136727|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
127592933|NCT03129100|459136728|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
127592934|NCT03129100|459136729|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
127592935|NCT03129100|459136730|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
127592936|NCT03129100|459136731|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
127592937|NCT03129100|459136732|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
127592938|NCT03129100|459136733|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
127592939|NCT03129100|459136734|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
127592940|NCT03129100|459136735|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
127592941|NCT03129100|459136736|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
127592942|NCT03129100|459136737|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
127592943|NCT03129100|459136738|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
127592944|NCT03129100|459136739|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
127592945|NCT03129100|459136740|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
127592946|NCT03129100|459136741|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
127592947|NCT03129100|459136742|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
127592948|NCT03129100|459136743|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
127592949|NCT03129100|459136744|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
127592950|NCT03129100|459136745|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
127592951|NCT03129100|459136746|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
127592952|NCT03129100|459136747|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
127592953|NCT03129100|459136722|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
127592954|NCT03129100|459136723|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
127592955|NCT03129100|459136724|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
127592956|NCT03129100|459136725|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
127592957|NCT03129100|459136726|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
127592958|NCT03129100|459136727|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
127592959|NCT03129100|459136728|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
127592960|NCT03129100|459136729|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
127592961|NCT03129100|459136730|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
127592962|NCT03129100|459136731|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
127592963|NCT03129100|459136732|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
127592964|NCT03129100|459136733|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
127592965|NCT03129100|459136734|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
127592966|NCT03129100|459136735|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
127592967|NCT03129100|459136736|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
127592968|NCT03129100|459136737|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
128034273|NCT04976855|460751759|FG002|Part II|Adverse Event|0|||
128034274|NCT04976855|460751760|FG003|Part II|Adverse Event|1|||
128034275|NCT04976855|460751761|FG004|Part II|Adverse Event|0|||
128034276|NCT04976855|460751762|FG005|Part II|Adverse Event|0|||
128034277|NCT04976855|460751763|FG006|Part II|Adverse Event|0|||
127592969|NCT03129100|459136738|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
127592970|NCT03129100|459136739|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
127592971|NCT03129100|459136740|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
127694705|NCT05470400|459510818|FG005|Overall Study|Withdrawal by Subject|1|||
127694706|NCT05470400|459510819|FG006|Overall Study|Withdrawal by Subject|0|||
128034278|NCT04976855|460751757|FG000|Part II|Withdrawal by Subject|0|||
127592972|NCT03129100|459136741|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
127592973|NCT03129100|459136742|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
128034279|NCT04976855|460751758|FG001|Part II|Withdrawal by Subject|0|||
128034280|NCT04976855|460751759|FG002|Part II|Withdrawal by Subject|0|||
127592974|NCT03129100|459136743|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
127592975|NCT03129100|459136744|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
127592976|NCT03129100|459136745|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
127592977|NCT03129100|459136746|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
127592978|NCT03129100|459136747|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
127592979|NCT03129100|459136722|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
127592980|NCT03129100|459136723|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
127592981|NCT03129100|459136724|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
127592982|NCT03129100|459136725|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
127592983|NCT03129100|459136726|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
127592984|NCT03129100|459136727|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
127592985|NCT03129100|459136728|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
127592986|NCT03129100|459136729|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
127592987|NCT03129100|459136730|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
127592988|NCT03129100|459136731|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
127592989|NCT03129100|459136732|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
127592990|NCT03129100|459136733|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
127592991|NCT03129100|459136734|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
127592992|NCT03129100|459136735|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
127592993|NCT03129100|459136736|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
127592994|NCT03129100|459136737|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
127592995|NCT03129100|459136738|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
127592996|NCT03129100|459136739|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
127592997|NCT03129100|459136740|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
127592998|NCT03129100|459136741|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
127592999|NCT03129100|459136742|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
127593000|NCT03129100|459136743|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
127593001|NCT03129100|459136744|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
127593002|NCT03129100|459136745|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
127593003|NCT03129100|459136746|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
127593004|NCT03129100|459136747|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
127593005|NCT03129100|459136722|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
127593006|NCT03129100|459136723|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
127593007|NCT03129100|459136724|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
127593008|NCT03129100|459136725|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
127593009|NCT03129100|459136726|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
127593010|NCT03129100|459136727|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
127593011|NCT03129100|459136728|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
127593012|NCT03129100|459136729|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
127593013|NCT03129100|459136730|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
127593014|NCT03129100|459136731|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
127593015|NCT03129100|459136732|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
127593016|NCT03129100|459136733|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
127593017|NCT03129100|459136734|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
127593018|NCT03129100|459136735|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
127593019|NCT03129100|459136736|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
127593020|NCT03129100|459136737|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
127593021|NCT03129100|459136738|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
127593022|NCT03129100|459136739|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
127593023|NCT03129100|459136740|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
127593024|NCT03129100|459136741|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
127593025|NCT03129100|459136742|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
127593026|NCT03129100|459136743|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
127593027|NCT03129100|459136744|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
127593028|NCT03129100|459136745|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
127593029|NCT03129100|459136746|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
127593030|NCT03129100|459136747|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
127784759|NCT05678257|459837034|FG000|Overall Study|No longer clinically benefitting|2|||
127784760|NCT05678257|459837035|FG001|Overall Study|No longer clinically benefitting|1|||
127784761|NCT05678257|459837036|FG002|Overall Study|No longer clinically benefitting|0|||
127784762|NCT05678257|459837034|FG000|Overall Study|Sponsor decision|5|||
127784763|NCT05678257|459837035|FG001|Overall Study|Sponsor decision|9|||
127593031|NCT03129100|459136722|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
127593032|NCT03129100|459136723|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
127784764|NCT05678257|459837036|FG002|Overall Study|Sponsor decision|8|||
127784765|NCT05678257|459837034|FG000|Overall Study|Protocol Violation|0|||
128034281|NCT04976855|460751760|FG003|Part II|Withdrawal by Subject|0|||
128034282|NCT04976855|460751761|FG004|Part II|Withdrawal by Subject|1|||
128034283|NCT04976855|460751762|FG005|Part II|Withdrawal by Subject|0|||
128034284|NCT04976855|460751763|FG006|Part II|Withdrawal by Subject|0|||
128034285|NCT04976855|460751757|FG000|Part II|Lost to Follow-up|0|||
128034286|NCT04976855|460751758|FG001|Part II|Lost to Follow-up|0|||
128034287|NCT04976855|460751759|FG002|Part II|Lost to Follow-up|0|||
128034288|NCT04976855|460751760|FG003|Part II|Lost to Follow-up|0|||
127593033|NCT03129100|459136724|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
127593034|NCT03129100|459136725|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
127593035|NCT03129100|459136726|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
127593036|NCT03129100|459136727|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
127593037|NCT03129100|459136728|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
127593038|NCT03129100|459136729|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
127593039|NCT03129100|459136730|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
127593040|NCT03129100|459136731|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
127593041|NCT03129100|459136732|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
127593042|NCT03129100|459136733|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
127593043|NCT03129100|459136734|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
127593044|NCT03129100|459136735|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
127593045|NCT03129100|459136736|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
127593046|NCT03129100|459136737|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
127593047|NCT03129100|459136738|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
127593048|NCT03129100|459136739|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
127593049|NCT03129100|459136740|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
127593050|NCT03129100|459136741|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
127593051|NCT03129100|459136742|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
127593052|NCT03129100|459136743|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
127593053|NCT03129100|459136744|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
127593054|NCT03129100|459136745|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
127593055|NCT03129100|459136746|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
127593056|NCT03129100|459136747|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
127593057|NCT03129100|459136722|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
127593058|NCT03129100|459136723|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
127593059|NCT03129100|459136724|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
127593060|NCT03129100|459136725|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
127593061|NCT03129100|459136726|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
127593062|NCT03129100|459136727|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
127593063|NCT03129100|459136728|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
127593064|NCT03129100|459136729|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
127593065|NCT03129100|459136730|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
127593066|NCT03129100|459136731|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
127593067|NCT03129100|459136732|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
127593068|NCT03129100|459136733|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
127593069|NCT03129100|459136734|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
127593070|NCT03129100|459136735|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
127593071|NCT03129100|459136736|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
127593072|NCT03129100|459136737|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
127593073|NCT03129100|459136738|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
127593074|NCT03129100|459136739|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
127593075|NCT03129100|459136740|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
127593076|NCT03129100|459136741|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
127593077|NCT03129100|459136742|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
127593078|NCT03129100|459136743|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
127593079|NCT03129100|459136744|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
127593080|NCT03129100|459136745|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
127593081|NCT03129100|459136746|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
127593082|NCT03129100|459136747|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
127593083|NCT03129100|459136722|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
127593084|NCT03129100|459136723|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
127593085|NCT03129100|459136724|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
127593086|NCT03129100|459136725|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
127593087|NCT03129100|459136726|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
127593088|NCT03129100|459136727|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
127593089|NCT03129100|459136728|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
128034289|NCT04976855|460751761|FG004|Part II|Lost to Follow-up|0|||
128034290|NCT04976855|460751762|FG005|Part II|Lost to Follow-up|1|||
128034291|NCT04976855|460751763|FG006|Part II|Lost to Follow-up|0|||
128034292|NCT02038036|460751765|FG000|Core Study|Adverse Event|7|||
127593090|NCT03129100|459136729|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
127593091|NCT03129100|459136730|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
127593092|NCT03129100|459136731|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
127593093|NCT03129100|459136732|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
127593094|NCT03129100|459136733|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
127593095|NCT03129100|459136734|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
127593096|NCT03129100|459136735|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
127593097|NCT03129100|459136736|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
127593098|NCT03129100|459136737|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
127593099|NCT03129100|459136738|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
127593100|NCT03129100|459136739|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
127593101|NCT03129100|459136740|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
127593102|NCT03129100|459136741|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
127593103|NCT03129100|459136742|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
127593104|NCT03129100|459136743|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
127593105|NCT03129100|459136744|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
127593106|NCT03129100|459136745|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
127593107|NCT03129100|459136746|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
127593108|NCT03129100|459136747|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
127593109|NCT03708328|459136754|FG000|Overall Study|Death|3|||
127593110|NCT03708328|459136755|FG001|Overall Study|Death|3|||
127593111|NCT03708328|459136756|FG002|Overall Study|Death|4|||
127593112|NCT03708328|459136757|FG003|Overall Study|Death|2|||
127593113|NCT03708328|459136758|FG004|Overall Study|Death|2|||
127593114|NCT03708328|459136759|FG005|Overall Study|Death|13|||
127593115|NCT03708328|459136760|FG006|Overall Study|Death|26|||
127593116|NCT03708328|459136761|FG007|Overall Study|Death|18|||
127593117|NCT03708328|459136762|FG008|Overall Study|Death|13|||
127593118|NCT03708328|459136763|FG009|Overall Study|Death|8|||
127593119|NCT03708328|459136754|FG000|Overall Study|Lost to Follow-up|0|||
127593120|NCT03708328|459136755|FG001|Overall Study|Lost to Follow-up|1|||
127593121|NCT03708328|459136756|FG002|Overall Study|Lost to Follow-up|0|||
127593122|NCT03708328|459136757|FG003|Overall Study|Lost to Follow-up|1|||
127593123|NCT03708328|459136758|FG004|Overall Study|Lost to Follow-up|0|||
127593124|NCT03708328|459136759|FG005|Overall Study|Lost to Follow-up|3|||
127593125|NCT03708328|459136760|FG006|Overall Study|Lost to Follow-up|3|||
127593126|NCT03708328|459136761|FG007|Overall Study|Lost to Follow-up|0|||
127593127|NCT03708328|459136762|FG008|Overall Study|Lost to Follow-up|0|||
127593128|NCT03708328|459136763|FG009|Overall Study|Lost to Follow-up|1|||
127593129|NCT03708328|459136754|FG000|Overall Study|Physician Decision|0|||
127593130|NCT03708328|459136755|FG001|Overall Study|Physician Decision|0|||
127593131|NCT03708328|459136756|FG002|Overall Study|Physician Decision|0|||
127593132|NCT03708328|459136757|FG003|Overall Study|Physician Decision|0|||
127593133|NCT03708328|459136758|FG004|Overall Study|Physician Decision|0|||
127593134|NCT03708328|459136759|FG005|Overall Study|Physician Decision|1|||
127593135|NCT03708328|459136760|FG006|Overall Study|Physician Decision|0|||
127593136|NCT03708328|459136761|FG007|Overall Study|Physician Decision|0|||
127593137|NCT03708328|459136762|FG008|Overall Study|Physician Decision|0|||
127593138|NCT03708328|459136763|FG009|Overall Study|Physician Decision|0|||
127593139|NCT03708328|459136754|FG000|Overall Study|Withdrawal by Subject|0|||
127593140|NCT03708328|459136755|FG001|Overall Study|Withdrawal by Subject|0|||
127593141|NCT03708328|459136756|FG002|Overall Study|Withdrawal by Subject|0|||
127593142|NCT03708328|459136757|FG003|Overall Study|Withdrawal by Subject|0|||
127593143|NCT03708328|459136758|FG004|Overall Study|Withdrawal by Subject|1|||
127593144|NCT03708328|459136759|FG005|Overall Study|Withdrawal by Subject|0|||
127593145|NCT03708328|459136760|FG006|Overall Study|Withdrawal by Subject|2|||
127593146|NCT03708328|459136761|FG007|Overall Study|Withdrawal by Subject|4|||
127593147|NCT03708328|459136762|FG008|Overall Study|Withdrawal by Subject|1|||
127593148|NCT03708328|459136763|FG009|Overall Study|Withdrawal by Subject|5|||
127593149|NCT03708328|459136754|FG000|Overall Study|Study Closed Locally|0|||
127882068|NCT01289990|460190798|FG005|Overall Study|discontinued in preceding trial|12|||
127593150|NCT03708328|459136755|FG001|Overall Study|Study Closed Locally|0|||
127593151|NCT03708328|459136756|FG002|Overall Study|Study Closed Locally|0|||
127593152|NCT03708328|459136757|FG003|Overall Study|Study Closed Locally|0|||
127593153|NCT03708328|459136758|FG004|Overall Study|Study Closed Locally|0|||
127593154|NCT03708328|459136759|FG005|Overall Study|Study Closed Locally|0|||
127593155|NCT03708328|459136760|FG006|Overall Study|Study Closed Locally|0|||
127593156|NCT03708328|459136761|FG007|Overall Study|Study Closed Locally|1|||
127593157|NCT03708328|459136762|FG008|Overall Study|Study Closed Locally|0|||
127593158|NCT03708328|459136763|FG009|Overall Study|Study Closed Locally|0|||
127593159|NCT03708328|459136754|FG000|Overall Study|Study Ended By Sponsor|0|||
127593160|NCT03708328|459136755|FG001|Overall Study|Study Ended By Sponsor|0|||
127593161|NCT03708328|459136756|FG002|Overall Study|Study Ended By Sponsor|0|||
127593162|NCT03708328|459136757|FG003|Overall Study|Study Ended By Sponsor|0|||
127593163|NCT03708328|459136758|FG004|Overall Study|Study Ended By Sponsor|0|||
127593164|NCT03708328|459136759|FG005|Overall Study|Study Ended By Sponsor|1|||
127593165|NCT03708328|459136760|FG006|Overall Study|Study Ended By Sponsor|0|||
127593166|NCT03708328|459136761|FG007|Overall Study|Study Ended By Sponsor|1|||
127593167|NCT03708328|459136762|FG008|Overall Study|Study Ended By Sponsor|0|||
127593168|NCT03708328|459136763|FG009|Overall Study|Study Ended By Sponsor|0|||
127593169|NCT03708328|459136754|FG000|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
127593170|NCT03708328|459136755|FG001|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
127593171|NCT03708328|459136756|FG002|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
127593172|NCT03708328|459136757|FG003|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
127593173|NCT03708328|459136758|FG004|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
127593174|NCT03708328|459136759|FG005|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
127593175|NCT03708328|459136760|FG006|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
127593176|NCT03708328|459136761|FG007|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
127593177|NCT03708328|459136762|FG008|Overall Study|Participant Was Alive, Did Not Return to Hospital|1|||
127593178|NCT03708328|459136763|FG009|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
127593179|NCT02605824|459136764|FG000|Overall Study|Physician Decision|1|||
127593180|NCT02605824|459136765|FG001|Overall Study|Physician Decision|0|||
127593181|NCT03715530|459136767|FG000|Overall Study|Lost to Follow-up|3|||
127593182|NCT03715530|459136768|FG001|Overall Study|Lost to Follow-up|1|||
127593183|NCT03715530|459136769|FG002|Overall Study|Lost to Follow-up|2|||
127593184|NCT01962896|459136773|FG000|Overall Study|Lack of Efficacy|4|||
127593185|NCT03648983|459136774|FG000|Overall Study|Study was terminated due to PI departure|95|||
127593186|NCT01269463|459136775|FG000|First Intervention|Withdrawal by Subject|1|||
127593187|NCT01269463|459136776|FG001|First Intervention|Withdrawal by Subject|0|||
127593188|NCT01269463|459136775|FG000|First Intervention|Adverse Event|1|||
127593189|NCT01269463|459136776|FG001|First Intervention|Adverse Event|0|||
127593190|NCT01269463|459136775|FG000|First Intervention|Lack of Efficacy|0|||
127593191|NCT01269463|459136776|FG001|First Intervention|Lack of Efficacy|1|||
127593192|NCT01269463|459136775|FG000|First Intervention|Physician Decision|0|||
127593193|NCT01269463|459136776|FG001|First Intervention|Physician Decision|1|||
127593194|NCT04404361|459136780|FG000|Overall Study|Death|12|||
127593195|NCT04404361|459136781|FG001|Overall Study|Death|12|||
127593196|NCT04404361|459136780|FG000|Overall Study|Withdrawal by Subject|13|||
127593197|NCT04404361|459136781|FG001|Overall Study|Withdrawal by Subject|5|||
127593198|NCT04404361|459136780|FG000|Overall Study|Lost to Follow-up|6|||
127593199|NCT04404361|459136781|FG001|Overall Study|Lost to Follow-up|3|||
127593200|NCT04404361|459136780|FG000|Overall Study|patient hospitalized and was nonverbal at the end of the study|0|||
127593201|NCT04404361|459136781|FG001|Overall Study|patient hospitalized and was nonverbal at the end of the study|1|||
127593202|NCT02862171|459136782|FG000|Overall Study|Death|1|||
127593203|NCT02862171|459136782|FG000|Overall Study|Lost to Follow-up|13|||
127593204|NCT02862171|459136782|FG000|Overall Study|Withdrawal by Subject|57|||
127593205|NCT02862171|459136782|FG000|Overall Study|Non-compliance|4|||
127593206|NCT02862171|459136782|FG000|Overall Study|HIV-1 seroconversion|18|||
127593207|NCT02549937|459136784|FG000|Overall Study|Death|0|||
127593208|NCT02549937|459136785|FG001|Overall Study|Death|1|||
127593209|NCT02549937|459136786|FG002|Overall Study|Death|0|||
127593210|NCT02549937|459136787|FG003|Overall Study|Death|1|||
127593211|NCT02549937|459136788|FG004|Overall Study|Death|0|||
127593212|NCT02549937|459136789|FG005|Overall Study|Death|8|||
127593213|NCT02549937|459136790|FG006|Overall Study|Death|0|||
127593214|NCT02549937|459136791|FG007|Overall Study|Death|0|||
127593215|NCT02549937|459136792|FG008|Overall Study|Death|19|||
127593216|NCT02549937|459136784|FG000|Overall Study|No follow up required|3|||
127593217|NCT02549937|459136785|FG001|Overall Study|No follow up required|6|||
127593218|NCT02549937|459136786|FG002|Overall Study|No follow up required|3|||
127593219|NCT02549937|459136787|FG003|Overall Study|No follow up required|8|||
127593220|NCT02549937|459136788|FG004|Overall Study|No follow up required|12|||
127593221|NCT02549937|459136789|FG005|Overall Study|No follow up required|21|||
127593222|NCT02549937|459136790|FG006|Overall Study|No follow up required|9|||
127593223|NCT02549937|459136791|FG007|Overall Study|No follow up required|11|||
127593224|NCT02549937|459136792|FG008|Overall Study|No follow up required|0|||
127593225|NCT02549937|459136784|FG000|Overall Study|Other|0|||
127593226|NCT02549937|459136785|FG001|Overall Study|Other|0|||
127593227|NCT02549937|459136786|FG002|Overall Study|Other|0|||
127593228|NCT02549937|459136787|FG003|Overall Study|Other|0|||
127593229|NCT02549937|459136788|FG004|Overall Study|Other|1|||
127593230|NCT02549937|459136789|FG005|Overall Study|Other|0|||
127593231|NCT02549937|459136790|FG006|Overall Study|Other|3|||
127593232|NCT02549937|459136791|FG007|Overall Study|Other|2|||
127593233|NCT02549937|459136792|FG008|Overall Study|Other|3|||
127593234|NCT02549937|459136784|FG000|Overall Study|Lost to Follow-up|0|||
127593235|NCT02549937|459136785|FG001|Overall Study|Lost to Follow-up|0|||
127593236|NCT02549937|459136786|FG002|Overall Study|Lost to Follow-up|0|||
127593237|NCT02549937|459136787|FG003|Overall Study|Lost to Follow-up|0|||
127593238|NCT02549937|459136788|FG004|Overall Study|Lost to Follow-up|0|||
127593239|NCT02549937|459136789|FG005|Overall Study|Lost to Follow-up|0|||
127593240|NCT02549937|459136790|FG006|Overall Study|Lost to Follow-up|0|||
127593241|NCT02549937|459136791|FG007|Overall Study|Lost to Follow-up|0|||
127593242|NCT02549937|459136792|FG008|Overall Study|Lost to Follow-up|3|||
127593243|NCT02549937|459136784|FG000|Overall Study|Withdrawal by Subject|0|||
127593244|NCT02549937|459136785|FG001|Overall Study|Withdrawal by Subject|0|||
127593245|NCT02549937|459136786|FG002|Overall Study|Withdrawal by Subject|0|||
127593246|NCT02549937|459136787|FG003|Overall Study|Withdrawal by Subject|0|||
127593247|NCT02549937|459136788|FG004|Overall Study|Withdrawal by Subject|0|||
127593248|NCT02549937|459136789|FG005|Overall Study|Withdrawal by Subject|1|||
127593249|NCT02549937|459136790|FG006|Overall Study|Withdrawal by Subject|4|||
127593250|NCT02549937|459136791|FG007|Overall Study|Withdrawal by Subject|3|||
127593251|NCT02549937|459136792|FG008|Overall Study|Withdrawal by Subject|2|||
127593252|NCT02549937|459136784|FG000|Overall Study|Sponsor Decision|0|||
127593253|NCT02549937|459136785|FG001|Overall Study|Sponsor Decision|0|||
127593254|NCT02549937|459136786|FG002|Overall Study|Sponsor Decision|0|||
127593255|NCT02549937|459136787|FG003|Overall Study|Sponsor Decision|0|||
127593256|NCT02549937|459136788|FG004|Overall Study|Sponsor Decision|0|||
127593257|NCT02549937|459136789|FG005|Overall Study|Sponsor Decision|0|||
128034293|NCT02038036|460751766|FG001|Core Study|Adverse Event|7|||
128034294|NCT02038036|460751765|FG000|Core Study|Death|1|||
128034295|NCT02038036|460751766|FG001|Core Study|Death|1|||
128034296|NCT02038036|460751765|FG000|Core Study|Disease progression|2|||
127593258|NCT02549937|459136790|FG006|Overall Study|Sponsor Decision|0|||
127593259|NCT02549937|459136791|FG007|Overall Study|Sponsor Decision|0|||
127694707|NCT05470400|459510820|FG007|Overall Study|Withdrawal by Subject|2|||
127694708|NCT01809691|459510823|FG000|Overall Study|Currently on Treatment|192|||
127694709|NCT01809691|459510824|FG001|Overall Study|Currently on Treatment|100|||
127694710|NCT01809691|459510823|FG000|Overall Study|No Protocol Treatment|10|||
127694711|NCT01809691|459510824|FG001|Overall Study|No Protocol Treatment|11|||
127694712|NCT01809691|459510823|FG000|Overall Study|Adverse Event|80|||
127694713|NCT01809691|459510824|FG001|Overall Study|Adverse Event|21|||
127694714|NCT01809691|459510823|FG000|Overall Study|Disease Progression|226|||
127694715|NCT01809691|459510824|FG001|Overall Study|Disease Progression|372|||
127694716|NCT01809691|459510823|FG000|Overall Study|Death|26|||
127694717|NCT01809691|459510824|FG001|Overall Study|Death|13|||
127694718|NCT01809691|459510823|FG000|Overall Study|Participant Refusal|70|||
127694719|NCT01809691|459510824|FG001|Overall Study|Participant Refusal|72|||
127694720|NCT01809691|459510823|FG000|Overall Study|Other, Not Specified|34|||
127694721|NCT01809691|459510824|FG001|Overall Study|Other, Not Specified|52|||
127694722|NCT02281955|459510829|FG000|Overall Study|Death|1|||
127694723|NCT03892616|459510835|FG000|Washout Period 2|Met discontinuation criterion|0|||
127694724|NCT03892616|459510836|FG001|Washout Period 2|Met discontinuation criterion|0|||
127694725|NCT03892616|459510837|FG002|Washout Period 2|Met discontinuation criterion|0|||
127694726|NCT03892616|459510838|FG003|Washout Period 2|Met discontinuation criterion|0|||
127694727|NCT03892616|459510839|FG004|Washout Period 2|Met discontinuation criterion|0|||
127694728|NCT03892616|459510840|FG005|Washout Period 2|Met discontinuation criterion|0|||
127694729|NCT03892616|459510841|FG006|Washout Period 2|Met discontinuation criterion|0|||
127694730|NCT03892616|459510842|FG007|Washout Period 2|Met discontinuation criterion|0|||
127694731|NCT03892616|459510843|FG008|Washout Period 2|Met discontinuation criterion|1|||
127694732|NCT03892616|459510844|FG009|Washout Period 2|Met discontinuation criterion|0|||
127694733|NCT03892616|459510845|FG010|Washout Period 2|Met discontinuation criterion|0|||
127694734|NCT03892616|459510846|FG011|Washout Period 2|Met discontinuation criterion|0|||
127694735|NCT00378105|459510847|FG000|Overall Study|Adverse Event|3|||
127694736|NCT00378105|459510848|FG001|Overall Study|Adverse Event|1|||
127694737|NCT00378105|459510847|FG000|Overall Study|Withdrawal by Subject|3|||
127694738|NCT00378105|459510848|FG001|Overall Study|Withdrawal by Subject|3|||
127694739|NCT00378105|459510847|FG000|Overall Study|Death|1|||
127694740|NCT00378105|459510848|FG001|Overall Study|Death|0|||
127694741|NCT00378105|459510847|FG000|Overall Study|Going to transplant|7|||
127694742|NCT00378105|459510848|FG001|Overall Study|Going to transplant|8|||
127694743|NCT00378105|459510847|FG000|Overall Study|Progressive disease|3|||
127694744|NCT00378105|459510848|FG001|Overall Study|Progressive disease|3|||
127694745|NCT00378105|459510847|FG000|Overall Study|remain on study|3|||
127694746|NCT00378105|459510848|FG001|Overall Study|remain on study|11|||
127694747|NCT00378105|459510847|FG000|Overall Study|Physician Decision|0|||
127694748|NCT00378105|459510848|FG001|Overall Study|Physician Decision|2|||
127694749|NCT00378105|459510847|FG000|Overall Study|Going non-protocol therapy|0|||
127694750|NCT00378105|459510848|FG001|Overall Study|Going non-protocol therapy|1|||
127694751|NCT00378105|459510847|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
127694752|NCT00378105|459510848|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
127593260|NCT02549937|459136792|FG008|Overall Study|Sponsor Decision|6|||
127694753|NCT05192200|459510849|FG000|Treatment Period|Other|1|||
127694754|NCT05192200|459510849|FG000|Treatment Period|Lack of Efficacy|1|||
127694755|NCT05192200|459510849|FG000|Treatment Period|Withdrawal by Subject|1|||
127694756|NCT05192200|459510849|FG000|Follow-up|Withdrawal by Subject|1|||
127694757|NCT04533347|459510852|FG000|Overall Study|Adverse Event|1|||
127694758|NCT04533347|459510853|FG001|Overall Study|Adverse Event|2|||
127694759|NCT04533347|459510852|FG000|Overall Study|Lost to Follow-up|2|||
127694760|NCT04533347|459510853|FG001|Overall Study|Lost to Follow-up|0|||
127593261|NCT03930797|459136793|FG000|Overall Study|Lost to Follow-up|3|||
127593262|NCT03930797|459136794|FG001|Overall Study|Lost to Follow-up|10|||
127593263|NCT00662012|459136795|FG000|Overall Study|Lost to Follow-up|85|||
127593264|NCT00662012|459136795|FG000|Overall Study|Death|1|||
127593265|NCT00662012|459136795|FG000|Overall Study|Withdrawal by Subject|1|||
127593266|NCT02144012|459136798|FG000|Overall Study|Adverse Event|1|||
127593267|NCT02144012|459136799|FG001|Overall Study|Adverse Event|0|||
127593268|NCT02144012|459136798|FG000|Overall Study|Death|1|||
127593269|NCT02144012|459136799|FG001|Overall Study|Death|0|||
127593270|NCT02144012|459136798|FG000|Overall Study|Withdrawal by Subject|11|||
127593271|NCT02144012|459136799|FG001|Overall Study|Withdrawal by Subject|3|||
127593272|NCT02144012|459136798|FG000|Overall Study|Study Terminated by Sponsor|18|||
127593273|NCT02144012|459136799|FG001|Overall Study|Study Terminated by Sponsor|12|||
127593274|NCT02144012|459136798|FG000|Overall Study|Other|3|||
127593275|NCT02144012|459136799|FG001|Overall Study|Other|0|||
127593276|NCT01949506|459136800|FG000|Overall Study|Physician Decision|1|||
127593277|NCT02915016|459136801|FG000|Overall Study|Lost to Follow-up|4|||
127593278|NCT02915016|459136802|FG001|Overall Study|Lost to Follow-up|2|||
127593279|NCT02915016|459136803|FG002|Overall Study|Lost to Follow-up|5|||
127593280|NCT02915016|459136804|FG003|Overall Study|Lost to Follow-up|3|||
127593281|NCT02915016|459136805|FG004|Overall Study|Lost to Follow-up|5|||
127593282|NCT02915016|459136806|FG005|Overall Study|Lost to Follow-up|2|||
127593283|NCT02915016|459136807|FG006|Overall Study|Lost to Follow-up|8|||
127784766|NCT05678257|459837035|FG001|Overall Study|Protocol Violation|0|||
127784767|NCT05678257|459837036|FG002|Overall Study|Protocol Violation|1|||
127784768|NCT05678257|459837034|FG000|Overall Study|Patient non-compliance|0|||
127784769|NCT05678257|459837035|FG001|Overall Study|Patient non-compliance|0|||
127784770|NCT05678257|459837036|FG002|Overall Study|Patient non-compliance|3|||
127784771|NCT05314517|459837037|FG000|Double-blind Period|Adverse Event|4|||
127784772|NCT05314517|459837038|FG001|Double-blind Period|Adverse Event|0|||
127784773|NCT05314517|459837039|FG002|Double-blind Period|Adverse Event|0|||
127784774|NCT05314517|459837040|FG003|Double-blind Period|Adverse Event|0|||
127784775|NCT05314517|459837037|FG000|Double-blind Period|Noncompliance|0|||
127784776|NCT05314517|459837038|FG001|Double-blind Period|Noncompliance|1|||
127593284|NCT02915016|459136808|FG007|Overall Study|Lost to Follow-up|2|||
127593285|NCT02915016|459136801|FG000|Overall Study|Physician Decision|0|||
127593286|NCT02915016|459136802|FG001|Overall Study|Physician Decision|0|||
127593287|NCT02915016|459136803|FG002|Overall Study|Physician Decision|1|||
127593288|NCT02915016|459136804|FG003|Overall Study|Physician Decision|0|||
127593289|NCT02915016|459136805|FG004|Overall Study|Physician Decision|0|||
127593290|NCT02915016|459136806|FG005|Overall Study|Physician Decision|1|||
127784777|NCT05314517|459837039|FG002|Double-blind Period|Noncompliance|0|||
127784778|NCT05314517|459837040|FG003|Double-blind Period|Noncompliance|0|||
127784779|NCT05314517|459837037|FG000|Double-blind Period|Randomized, not treated|1|||
127784780|NCT05314517|459837038|FG001|Double-blind Period|Randomized, not treated|0|||
127784781|NCT05314517|459837039|FG002|Double-blind Period|Randomized, not treated|0|||
127784782|NCT05314517|459837040|FG003|Double-blind Period|Randomized, not treated|0|||
127784783|NCT05314517|459837037|FG000|Open-label Extension|Adverse Event|0|||
127784784|NCT05314517|459837038|FG001|Open-label Extension|Adverse Event|0|||
127784785|NCT05314517|459837039|FG002|Open-label Extension|Adverse Event|1|||
127784786|NCT05314517|459837040|FG003|Open-label Extension|Adverse Event|2|||
127784787|NCT05314517|459837037|FG000|Open-label Extension|Investigator decision|0|||
127784788|NCT05314517|459837038|FG001|Open-label Extension|Investigator decision|0|||
127784789|NCT05314517|459837039|FG002|Open-label Extension|Investigator decision|1|||
127784790|NCT05314517|459837040|FG003|Open-label Extension|Investigator decision|0|||
127784791|NCT05314517|459837037|FG000|Open-label Extension|Lost to Follow-up|0|||
127784792|NCT05314517|459837038|FG001|Open-label Extension|Lost to Follow-up|0|||
127784793|NCT05314517|459837039|FG002|Open-label Extension|Lost to Follow-up|0|||
127784794|NCT05314517|459837040|FG003|Open-label Extension|Lost to Follow-up|1|||
127784795|NCT05314517|459837037|FG000|Open-label Extension|Withdrawal by Subject|0|||
127784796|NCT05314517|459837038|FG001|Open-label Extension|Withdrawal by Subject|0|||
127784797|NCT05314517|459837039|FG002|Open-label Extension|Withdrawal by Subject|1|||
127784798|NCT05314517|459837040|FG003|Open-label Extension|Withdrawal by Subject|2|||
127784799|NCT05314517|459837037|FG000|Open-label Extension|Use of prohibited medication|0|||
127784800|NCT05314517|459837038|FG001|Open-label Extension|Use of prohibited medication|0|||
127593291|NCT02915016|459136807|FG006|Overall Study|Physician Decision|2|||
127593292|NCT02915016|459136808|FG007|Overall Study|Physician Decision|0|||
127784801|NCT05314517|459837039|FG002|Open-label Extension|Use of prohibited medication|1|||
127784802|NCT05314517|459837040|FG003|Open-label Extension|Use of prohibited medication|0|||
127784803|NCT05314517|459837037|FG000|Open-label Extension|Sponsor decision to terminate study|0|||
127784804|NCT05314517|459837038|FG001|Open-label Extension|Sponsor decision to terminate study|0|||
127784805|NCT05314517|459837039|FG002|Open-label Extension|Sponsor decision to terminate study|13|||
127784806|NCT05314517|459837040|FG003|Open-label Extension|Sponsor decision to terminate study|15|||
127784807|NCT04969276|459837041|FG000|Overall Study|Protocol Deviation|0|||
127593293|NCT02915016|459136801|FG000|Overall Study|Withdrawal by Subject|2|||
127593294|NCT02915016|459136802|FG001|Overall Study|Withdrawal by Subject|0|||
127593295|NCT02915016|459136803|FG002|Overall Study|Withdrawal by Subject|1|||
127593296|NCT02915016|459136804|FG003|Overall Study|Withdrawal by Subject|0|||
127593297|NCT02915016|459136805|FG004|Overall Study|Withdrawal by Subject|1|||
127784808|NCT04969276|459837042|FG001|Overall Study|Protocol Deviation|1|||
127784809|NCT04969276|459837043|FG002|Overall Study|Protocol Deviation|0|||
127784810|NCT04969276|459837041|FG000|Overall Study|Withdrawal by Subject|1|||
127784811|NCT04969276|459837042|FG001|Overall Study|Withdrawal by Subject|10|||
127784812|NCT04969276|459837043|FG002|Overall Study|Withdrawal by Subject|0|||
127784813|NCT04969276|459837041|FG000|Overall Study|Lost to Follow-up|0|||
127784814|NCT04969276|459837042|FG001|Overall Study|Lost to Follow-up|1|||
127784815|NCT04969276|459837043|FG002|Overall Study|Lost to Follow-up|0|||
127784816|NCT04655144|459837047|FG000|Overall Study|Consumed THC|1|||
127784817|NCT04655144|459837048|FG001|Overall Study|Consumed THC|0|||
127784818|NCT04655144|459837047|FG000|Overall Study|Unilateral embolization|0|||
127784819|NCT04655144|459837048|FG001|Overall Study|Unilateral embolization|1|||
127784820|NCT04490018|459837049|FG000|Overall Study|Protocol Violation|0|||
127784821|NCT04490018|459837050|FG001|Overall Study|Protocol Violation|2|||
127784822|NCT04490018|459837051|FG002|Overall Study|Protocol Violation|1|||
127784823|NCT04490018|459837049|FG000|Overall Study|Lost to Follow-up|2|||
127784824|NCT04490018|459837050|FG001|Overall Study|Lost to Follow-up|2|||
127784825|NCT04490018|459837051|FG002|Overall Study|Lost to Follow-up|0|||
127784826|NCT04490018|459837049|FG000|Overall Study|Withdrawal by Subject|2|||
127784827|NCT04490018|459837050|FG001|Overall Study|Withdrawal by Subject|1|||
127784828|NCT04490018|459837051|FG002|Overall Study|Withdrawal by Subject|0|||
127784829|NCT04490018|459837049|FG000|Overall Study|Withdrawal by parent/guardian|2|||
127784830|NCT04490018|459837050|FG001|Overall Study|Withdrawal by parent/guardian|3|||
127784831|NCT04490018|459837051|FG002|Overall Study|Withdrawal by parent/guardian|0|||
127784832|NCT00282295|459837053|FG000|Overall Study|Adverse Event|0|||
127784833|NCT00282295|459837054|FG001|Overall Study|Adverse Event|1|||
127784834|NCT00282295|459837055|FG002|Overall Study|Adverse Event|0|||
127784835|NCT00282295|459837053|FG000|Overall Study|Serious Adverse Events|0|||
127784836|NCT00282295|459837054|FG001|Overall Study|Serious Adverse Events|0|||
127784837|NCT00282295|459837055|FG002|Overall Study|Serious Adverse Events|1|||
127784838|NCT00282295|459837053|FG000|Overall Study|Protocol Violation|0|||
127784839|NCT00282295|459837054|FG001|Overall Study|Protocol Violation|2|||
127784840|NCT00282295|459837055|FG002|Overall Study|Protocol Violation|1|||
127784841|NCT00282295|459837053|FG000|Overall Study|Withdrawal by Subject|2|||
127784842|NCT00282295|459837054|FG001|Overall Study|Withdrawal by Subject|6|||
127784843|NCT00282295|459837055|FG002|Overall Study|Withdrawal by Subject|4|||
127784844|NCT00282295|459837053|FG000|Overall Study|Lost to Follow-up|1|||
127784845|NCT00282295|459837054|FG001|Overall Study|Lost to Follow-up|7|||
127784846|NCT00282295|459837055|FG002|Overall Study|Lost to Follow-up|2|||
127784847|NCT00282295|459837053|FG000|Overall Study|Other|0|||
127784848|NCT00282295|459837054|FG001|Overall Study|Other|1|||
127784849|NCT00282295|459837055|FG002|Overall Study|Other|0|||
127784850|NCT03337542|459837056|FG000|Overall Study|Withdrew Consent|17|||
127784851|NCT03337542|459837056|FG000|Overall Study|Allergic Adverse Event|1|||
127784852|NCT03337542|459837056|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
127784853|NCT03337542|459837056|FG000|Overall Study|Lost to Follow-up|1|||
127784854|NCT03337542|459837056|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
127784855|NCT00121108|459837057|FG000|Overall Study|Lost to Follow-up|10|||
127784856|NCT00121108|459837058|FG001|Overall Study|Lost to Follow-up|22|||
127784857|NCT00121108|459837057|FG000|Overall Study|Withdrawal by Subject|106|||
127784858|NCT00121108|459837058|FG001|Overall Study|Withdrawal by Subject|195|||
127784859|NCT00121108|459837057|FG000|Overall Study|Death|5|||
127784860|NCT00121108|459837058|FG001|Overall Study|Death|8|||
127784861|NCT01380379|459837059|FG000|Overall Study|Pregnancy|1|||
128034297|NCT02038036|460751766|FG001|Core Study|Disease progression|2|||
128034298|NCT02038036|460751765|FG000|Core Study|Lost to Follow-up|0|||
128034299|NCT02038036|460751766|FG001|Core Study|Lost to Follow-up|1|||
128034300|NCT02038036|460751765|FG000|Core Study|Physician Decision|2|||
128034301|NCT02038036|460751766|FG001|Core Study|Physician Decision|1|||
127593298|NCT02915016|459136806|FG005|Overall Study|Withdrawal by Subject|3|||
127593299|NCT02915016|459136807|FG006|Overall Study|Withdrawal by Subject|1|||
127593300|NCT02915016|459136808|FG007|Overall Study|Withdrawal by Subject|1|||
127593301|NCT02915016|459136801|FG000|Overall Study|Elected not to continue|0|||
127593302|NCT02915016|459136802|FG001|Overall Study|Elected not to continue|0|||
127593303|NCT02915016|459136803|FG002|Overall Study|Elected not to continue|0|||
127593304|NCT02915016|459136804|FG003|Overall Study|Elected not to continue|1|||
127593305|NCT02915016|459136805|FG004|Overall Study|Elected not to continue|0|||
127593306|NCT02915016|459136806|FG005|Overall Study|Elected not to continue|0|||
127593307|NCT02915016|459136807|FG006|Overall Study|Elected not to continue|1|||
127593308|NCT02915016|459136808|FG007|Overall Study|Elected not to continue|0|||
127784862|NCT03977974|459837062|FG000|Period 2|Adverse Event|0|||
127784863|NCT03977974|459837063|FG001|Period 2|Adverse Event|0|||
127784864|NCT03977974|459837064|FG002|Period 2|Adverse Event|0|||
128034302|NCT02038036|460751765|FG000|Core Study|Subject/guardian decision|0|||
127593309|NCT02915016|459136801|FG000|Overall Study|HIV infection|1|||
127593310|NCT02915016|459136802|FG001|Overall Study|HIV infection|1|||
127784865|NCT03977974|459837065|FG003|Period 2|Adverse Event|0|||
127784866|NCT03977974|459837066|FG004|Period 2|Adverse Event|1|||
127784867|NCT03977974|459837067|FG005|Period 2|Adverse Event|0|||
127784868|NCT03977974|459837068|FG006|Period 2|Adverse Event|0|||
127784869|NCT03977974|459837069|FG007|Period 2|Adverse Event|0|||
127784870|NCT03977974|459837070|FG008|Period 2|Adverse Event|0|||
127784871|NCT03977974|459837071|FG009|Period 2|Adverse Event|0|||
127784872|NCT03977974|459837072|FG010|Period 2|Adverse Event|0|||
127784873|NCT03977974|459837073|FG011|Period 2|Adverse Event|0|||
127784874|NCT03977974|459837074|FG012|Period 2|Adverse Event|0|||
127784875|NCT01524198|459838255|FG000|Overall Study|Protocol Violation|8|||
128034303|NCT02038036|460751766|FG001|Core Study|Subject/guardian decision|1|||
128034304|NCT02038036|460751765|FG000|Core Study|Withdrawal by Subject|3|||
128034305|NCT02038036|460751766|FG001|Core Study|Withdrawal by Subject|1|||
128034306|NCT02038036|460751765|FG000|Crossover Period|Withdrawal by Subject|0|||
128034307|NCT02038036|460751766|FG001|Crossover Period|Withdrawal by Subject|3|||
128034308|NCT02038036|460751765|FG000|Crossover Period|Adverse Event|0|||
128034309|NCT02038036|460751766|FG001|Crossover Period|Adverse Event|9|||
128034310|NCT02038036|460751765|FG000|Crossover Period|Death|0|||
128034311|NCT02038036|460751766|FG001|Crossover Period|Death|2|||
127593311|NCT02915016|459136803|FG002|Overall Study|HIV infection|1|||
128034312|NCT02038036|460751765|FG000|Crossover Period|Disease progression|0|||
128034313|NCT02038036|460751766|FG001|Crossover Period|Disease progression|3|||
128034314|NCT02038036|460751765|FG000|Crossover Period|Lost to Follow-up|0|||
128034315|NCT02038036|460751766|FG001|Crossover Period|Lost to Follow-up|1|||
127593312|NCT02915016|459136804|FG003|Overall Study|HIV infection|0|||
127593313|NCT02915016|459136805|FG004|Overall Study|HIV infection|1|||
127593314|NCT02915016|459136806|FG005|Overall Study|HIV infection|0|||
127593315|NCT02915016|459136807|FG006|Overall Study|HIV infection|0|||
127593316|NCT02915016|459136808|FG007|Overall Study|HIV infection|0|||
127593317|NCT02915016|459136801|FG000|Overall Study|Participant unable to adhere|0|||
127593318|NCT02915016|459136802|FG001|Overall Study|Participant unable to adhere|0|||
127593319|NCT02915016|459136803|FG002|Overall Study|Participant unable to adhere|0|||
127593320|NCT02915016|459136804|FG003|Overall Study|Participant unable to adhere|0|||
127593321|NCT02915016|459136805|FG004|Overall Study|Participant unable to adhere|0|||
127593322|NCT02915016|459136806|FG005|Overall Study|Participant unable to adhere|0|||
127593323|NCT02915016|459136807|FG006|Overall Study|Participant unable to adhere|0|||
127593324|NCT02915016|459136808|FG007|Overall Study|Participant unable to adhere|1|||
127593325|NCT05425745|459136823|FG000|Overall Study|Withdrawal of Consent|3|||
127593326|NCT05425745|459136824|FG001|Overall Study|Withdrawal of Consent|3|||
127593327|NCT05425745|459136823|FG000|Overall Study|Death|2|||
127593328|NCT05425745|459136824|FG001|Overall Study|Death|3|||
127593329|NCT05425745|459136823|FG000|Overall Study|Lost to Follow-up|1|||
127593330|NCT05425745|459136824|FG001|Overall Study|Lost to Follow-up|2|||
127593331|NCT05425745|459136823|FG000|Overall Study|Adverse Event|0|||
127593332|NCT05425745|459136824|FG001|Overall Study|Adverse Event|1|||
127593333|NCT05425745|459136823|FG000|Overall Study|Did not return for end of study visit|0|||
127593334|NCT05425745|459136824|FG001|Overall Study|Did not return for end of study visit|1|||
127593335|NCT05425745|459136823|FG000|Overall Study|End of study visit completed by phone|1|||
127593336|NCT05425745|459136824|FG001|Overall Study|End of study visit completed by phone|0|||
127593337|NCT05425745|459136823|FG000|Overall Study|Subject decision|1|||
127593338|NCT05425745|459136824|FG001|Overall Study|Subject decision|0|||
127593339|NCT02891850|459138240|FG000|Overall Study|Adverse Event|3|||
127593340|NCT02891850|459138241|FG001|Overall Study|Adverse Event|0|||
127784876|NCT01524198|459838256|FG001|Overall Study|Protocol Violation|6|||
128034316|NCT02038036|460751765|FG000|Crossover Period|Physician Decision|0|||
128034317|NCT02038036|460751766|FG001|Crossover Period|Physician Decision|2|||
127593341|NCT02891850|459138240|FG000|Overall Study|Death|0|||
128034318|NCT00791648|460753136|FG000|Overall Study|Physician Decision|0|||
128034319|NCT00791648|460753137|FG001|Overall Study|Physician Decision|1|||
127593342|NCT02891850|459138241|FG001|Overall Study|Death|4|||
127593343|NCT02891850|459138240|FG000|Overall Study|Physician Decision|1|||
128034320|NCT00791648|460753136|FG000|Overall Study|Withdrawal by Subject|0|||
127593344|NCT02891850|459138241|FG001|Overall Study|Physician Decision|0|||
127593345|NCT02891850|459138240|FG000|Overall Study|Pregnancy|1|||
127593346|NCT02891850|459138241|FG001|Overall Study|Pregnancy|0|||
127593347|NCT02891850|459138240|FG000|Overall Study|Withdrawal by Subject|2|||
127784877|NCT01524198|459838255|FG000|Overall Study|Withdrawal by Subject|15|||
127784878|NCT01524198|459838256|FG001|Overall Study|Withdrawal by Subject|10|||
128034321|NCT00791648|460753137|FG001|Overall Study|Withdrawal by Subject|1|||
128034322|NCT04976777|460753138|FG000|Overall Study|COVID-19 Infection|1|||
128034323|NCT04976777|460753139|FG001|Overall Study|COVID-19 Infection|0|||
128034324|NCT00462826|460753140|FG000|Overall Study|Ineligible - second primary|1|||
128034325|NCT00462826|460753140|FG000|Overall Study|Ineligible - wrong cell type|1|||
128034326|NCT00462826|460753140|FG000|Overall Study|Ineligible - wrong primary|2|||
128034327|NCT00462826|460753140|FG000|Overall Study|Never treated|1|||
128034328|NCT02278003|460753141|FG000|Overall Study|Withdrawal by Subject|11|||
128034329|NCT02278003|460753142|FG001|Overall Study|Withdrawal by Subject|0|||
128034330|NCT02278003|460753141|FG000|Overall Study|Not Treated|1|||
128034331|NCT02278003|460753142|FG001|Overall Study|Not Treated|0|||
128034332|NCT02278003|460753141|FG000|Overall Study|Recognition task improperly completed|7|||
127593348|NCT02891850|459138241|FG001|Overall Study|Withdrawal by Subject|3|||
127593349|NCT02674529|459138242|FG000|Overall Study|Lost to Follow-up|1|||
127593350|NCT02674529|459138243|FG001|Overall Study|Lost to Follow-up|2|||
127593351|NCT02674529|459138242|FG000|Overall Study|Withdrawal by Subject|2|||
127593352|NCT02674529|459138243|FG001|Overall Study|Withdrawal by Subject|1|||
127593353|NCT02674529|459138242|FG000|Overall Study|Physician Decision|0|||
127593354|NCT02674529|459138243|FG001|Overall Study|Physician Decision|1|||
127593355|NCT02674529|459138242|FG000|Overall Study|Protocol Violation|0|||
127593356|NCT02674529|459138243|FG001|Overall Study|Protocol Violation|1|||
127593357|NCT00331682|459138244|FG000|Overall Study|Adverse Event|1|||
127593358|NCT00004978|459138245|FG000|Overall Study|Death|107|||
127593359|NCT00004978|459138246|FG001|Overall Study|Death|116|||
127593360|NCT00004978|459138245|FG000|Overall Study|Lost to Follow-up|101|||
127593361|NCT00004978|459138246|FG001|Overall Study|Lost to Follow-up|108|||
127593362|NCT00004978|459138245|FG000|Overall Study|Withdrawal by Subject|17|||
127593363|NCT00004978|459138246|FG001|Overall Study|Withdrawal by Subject|26|||
127593364|NCT00004978|459138245|FG000|Overall Study|site closure - not in analysis cohort|19|||
127593365|NCT00004978|459138246|FG001|Overall Study|site closure - not in analysis cohort|20|||
127593366|NCT03761277|459138247|FG000|Enrollment to Implant|Screen Failure|17|||
127593367|NCT03761277|459138247|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
127593368|NCT03761277|459138247|FG000|Enrollment to Implant|Physician Decision|2|||
127593369|NCT03761277|459138247|FG000|Enrollment to Implant|Site Closure|3|||
127593370|NCT03761277|459138247|FG000|Enrollment to Implant|Sponsor Request|2|||
128034333|NCT02278003|460753142|FG001|Overall Study|Recognition task improperly completed|0|||
128034334|NCT00939185|460753147|FG000|Overall Study|Adverse Event|3|||
128034335|NCT00939185|460753147|FG000|Overall Study|Lack of Efficacy|1|||
128034336|NCT00939185|460753147|FG000|Overall Study|Lost to Follow-up|6|||
128034337|NCT00939185|460753147|FG000|Overall Study|Other|3|||
128034338|NCT00939185|460753147|FG000|Overall Study|Withdrawal by Subject|2|||
128034339|NCT00939185|460753147|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
128034340|NCT00363298|460753148|FG000|First Study Week|Lack of Efficacy|6|||
128034341|NCT00363298|460753149|FG001|First Study Week|Lack of Efficacy|5|||
128034342|NCT00363298|460753148|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
128034343|NCT00363298|460753149|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
127593371|NCT03761277|459138247|FG000|Post-Implant to 6 Months|Adverse Event|2|||
128034344|NCT00836706|460753150|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
128034345|NCT00836706|460753151|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
128034346|NCT02332928|460753160|FG000|Overall Study|Withdrawal by Subject|0|||
128034347|NCT02332928|460753161|FG001|Overall Study|Withdrawal by Subject|2|||
128034348|NCT02332928|460753160|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
128034349|NCT02332928|460753161|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
128034350|NCT04484857|460753162|FG000|Overall Study|Adverse Event|2|||
128034351|NCT04484857|460753162|FG000|Overall Study|Death|10|||
128034352|NCT04484857|460753162|FG000|Overall Study|Withdrawal by Subject|3|||
128034353|NCT04484857|460753162|FG000|Overall Study|Transferred/Relocation|5|||
128034354|NCT04484857|460753162|FG000|Overall Study|Kidney Transplant|7|||
128034355|NCT04484857|460753162|FG000|Overall Study|Other than specified|4|||
128034356|NCT04484857|460753162|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
128034357|NCT02390076|460753163|FG000|Overall Study|Lost to Follow-up|2|||
128034358|NCT02390076|460753164|FG001|Overall Study|Lost to Follow-up|1|||
128034359|NCT02390076|460753165|FG002|Overall Study|Lost to Follow-up|4|||
128034360|NCT01358734|460753166|FG000|Overall Study|Adverse Event|4|||
128034361|NCT01358734|460753167|FG001|Overall Study|Adverse Event|7|||
128034362|NCT01358734|460753168|FG002|Overall Study|Adverse Event|3|||
128034363|NCT01358734|460753166|FG000|Overall Study|Lack of Efficacy|0|||
128034364|NCT01358734|460753167|FG001|Overall Study|Lack of Efficacy|1|||
128034365|NCT01358734|460753168|FG002|Overall Study|Lack of Efficacy|3|||
128034366|NCT01358734|460753166|FG000|Overall Study|Withdrawal by Subject|1|||
128034367|NCT01358734|460753167|FG001|Overall Study|Withdrawal by Subject|6|||
127784879|NCT04419610|459838257|FG000|Overall Study|Withdrawal by Subject|3|||
127784880|NCT04419610|459838258|FG001|Overall Study|Withdrawal by Subject|1|||
127784881|NCT04419610|459838257|FG000|Overall Study|Adverse Event|1|||
127784882|NCT04419610|459838258|FG001|Overall Study|Adverse Event|0|||
127784883|NCT04419610|459838257|FG000|Overall Study|discharged early|1|||
127784884|NCT04419610|459838258|FG001|Overall Study|discharged early|1|||
127784885|NCT00054704|459838263|FG000|Overall Study|Lack of Efficacy|2|||
127784886|NCT00054704|459838264|FG001|Overall Study|Lack of Efficacy|3|||
127784887|NCT00054704|459838263|FG000|Overall Study|Adverse Event|3|||
127784888|NCT00054704|459838264|FG001|Overall Study|Adverse Event|1|||
128034368|NCT01358734|460753168|FG002|Overall Study|Withdrawal by Subject|3|||
128034369|NCT01358734|460753166|FG000|Overall Study|Death|3|||
127593372|NCT03761277|459138247|FG000|Post-Implant to 6 Months|Death|1|||
127593373|NCT03761277|459138247|FG000|Post-Implant to 6 Months|Site Closure|2|||
127593374|NCT03761277|459138247|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
127593375|NCT03761277|459138247|FG000|6 Months to 12 Months|Physician Decision|2|||
127593376|NCT03761277|459138247|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
127593377|NCT03555591|459138248|FG000|Overall Study|Protocol Violation|77|||
128034370|NCT01358734|460753167|FG001|Overall Study|Death|7|||
127593378|NCT00578812|459138249|FG000|Overall Study|Not treated|6|||
127593379|NCT00578812|459138250|FG001|Overall Study|Not treated|7|||
127593380|NCT01029795|459138256|FG000|Overall Study|Entry Criteria Not Met|2|||
127593381|NCT01029795|459138257|FG001|Overall Study|Entry Criteria Not Met|1|||
127593382|NCT01029795|459138256|FG000|Overall Study|Physician Decision|2|||
127593383|NCT01029795|459138257|FG001|Overall Study|Physician Decision|1|||
127593384|NCT01029795|459138256|FG000|Overall Study|Sponsor Decision|11|||
127593385|NCT01029795|459138257|FG001|Overall Study|Sponsor Decision|17|||
127593386|NCT01029795|459138256|FG000|Overall Study|Withdrawal by Subject|1|||
127593387|NCT01029795|459138257|FG001|Overall Study|Withdrawal by Subject|3|||
127593388|NCT03217175|459138260|FG000|Overall Study|Physician Decision|4|||
127593389|NCT03217175|459138261|FG001|Overall Study|Physician Decision|1|||
127593390|NCT00429273|459138265|FG000|Overall Study|Lost to Follow-up|1|||
127593391|NCT00429273|459138266|FG001|Overall Study|Lost to Follow-up|2|||
127593392|NCT00429273|459138267|FG002|Overall Study|Lost to Follow-up|2|||
127593393|NCT00429273|459138265|FG000|Overall Study|Physician Decision|6|||
127593394|NCT00429273|459138266|FG001|Overall Study|Physician Decision|5|||
127593395|NCT00429273|459138267|FG002|Overall Study|Physician Decision|5|||
127593396|NCT00429273|459138265|FG000|Overall Study|Adverse Event|1|||
127593397|NCT00429273|459138266|FG001|Overall Study|Adverse Event|1|||
127593398|NCT00429273|459138267|FG002|Overall Study|Adverse Event|2|||
127593399|NCT01438957|459138268|FG000|Overall Study|Physician Decision|1|||
127593400|NCT01438957|459138269|FG001|Overall Study|Physician Decision|1|||
127593401|NCT01438957|459138270|FG002|Overall Study|Physician Decision|0|||
127593402|NCT01438957|459138271|FG003|Overall Study|Physician Decision|1|||
127593403|NCT01438957|459138272|FG004|Overall Study|Physician Decision|0|||
127593404|NCT02548650|459138277|FG000|Triple Therapy|Adverse Event|1|||
127593405|NCT02548650|459138278|FG001|Triple Therapy|Adverse Event|0|||
127593406|NCT02548650|459138277|FG000|Triple Therapy|Withdrawal by Subject|0|||
127593407|NCT02548650|459138278|FG001|Triple Therapy|Withdrawal by Subject|4|||
127593408|NCT02548650|459138277|FG000|Double Therapy|Adverse Event|1|||
127593409|NCT02548650|459138278|FG001|Double Therapy|Adverse Event|1|||
127593410|NCT02548650|459138277|FG000|Double Therapy|Withdrawal by Subject|0|||
127593411|NCT02548650|459138278|FG001|Double Therapy|Withdrawal by Subject|1|||
127593412|NCT01539538|459138279|FG000|Overall Study|Adverse Event|13|||
127784889|NCT00054704|459838263|FG000|Overall Study|Lost to Follow-up|0|||
127784890|NCT00054704|459838264|FG001|Overall Study|Lost to Follow-up|1|||
127784891|NCT00362414|459838265|FG000|Overall Study|Death|2|||
127784892|NCT00362414|459838265|FG000|Overall Study|Adverse Event|1|||
127784893|NCT02053168|459838266|FG000|Overall Study|Withdrawal by Subject|1|||
127784894|NCT02053168|459838266|FG000|Overall Study|Physician Decision|1|||
127784895|NCT02053168|459838266|FG000|Overall Study|Lost to Follow-up|1|||
127784896|NCT00636675|459838267|FG000|Overall Study|Lost to Follow-up|121|||
127784897|NCT00636675|459838268|FG001|Overall Study|Lost to Follow-up|31|||
127784898|NCT00636675|459838267|FG000|Overall Study|Withdrawal by Subject|19|||
127784899|NCT00636675|459838268|FG001|Overall Study|Withdrawal by Subject|10|||
127784900|NCT04053868|459838269|FG000|Overall Study|Withdrawal by Subject|1|||
127784901|NCT04053868|459838270|FG001|Overall Study|Withdrawal by Subject|0|||
127784902|NCT00833053|459838271|FG000|Overall Study|Adverse Event|4|||
127784903|NCT00833053|459838272|FG001|Overall Study|Adverse Event|0|||
127784904|NCT00833053|459838271|FG000|Overall Study|Treatment Failure|3|||
127784905|NCT00833053|459838272|FG001|Overall Study|Treatment Failure|1|||
127784906|NCT00833053|459838271|FG000|Overall Study|Withdrawal by Subject|0|||
127784907|NCT00833053|459838272|FG001|Overall Study|Withdrawal by Subject|1|||
127784908|NCT00833053|459838271|FG000|Overall Study|Protocol Violation|2|||
127784909|NCT00833053|459838272|FG001|Overall Study|Protocol Violation|1|||
127784910|NCT02187471|459838274|FG000|Overall Study|Protocol Violation|4|||
127784911|NCT02187471|459838275|FG001|Overall Study|Protocol Violation|5|||
127784912|NCT02187471|459838276|FG002|Overall Study|Protocol Violation|4|||
127784913|NCT02187471|459838277|FG003|Overall Study|Protocol Violation|4|||
127784914|NCT02187471|459838274|FG000|Overall Study|Missing|0|||
127784915|NCT02187471|459838275|FG001|Overall Study|Missing|0|||
127593413|NCT01539538|459138280|FG001|Overall Study|Adverse Event|18|||
127593414|NCT01539538|459138279|FG000|Overall Study|Lack of Efficacy|13|||
127593415|NCT01539538|459138280|FG001|Overall Study|Lack of Efficacy|16|||
128034371|NCT01358734|460753168|FG002|Overall Study|Death|2|||
127593416|NCT01539538|459138279|FG000|Overall Study|Withdrawal by Subject|2|||
127593417|NCT01539538|459138280|FG001|Overall Study|Withdrawal by Subject|3|||
127593418|NCT01539538|459138279|FG000|Overall Study|PCA no longer required or PCA problem|3|||
127593419|NCT01539538|459138280|FG001|Overall Study|PCA no longer required or PCA problem|7|||
127593420|NCT01909674|459138281|FG000|Overall Study|Withdrawal by Subject|5|||
127593421|NCT01909674|459138282|FG001|Overall Study|Withdrawal by Subject|2|||
127784916|NCT02187471|459838276|FG002|Overall Study|Missing|0|||
127784917|NCT02187471|459838277|FG003|Overall Study|Missing|1|||
127784918|NCT02187471|459838274|FG000|Overall Study|Lack of Efficacy|18|||
127784919|NCT02187471|459838275|FG001|Overall Study|Lack of Efficacy|9|||
127784920|NCT02187471|459838276|FG002|Overall Study|Lack of Efficacy|13|||
127593422|NCT04390191|459138283|FG000|Overall Study|Withdrawal by Subject|1|||
127593423|NCT04390191|459138284|FG001|Overall Study|Withdrawal by Subject|0|||
127593424|NCT03978832|459138285|FG000|Overall Study|Adverse Event|1|||
127593425|NCT03978832|459138285|FG000|Overall Study|Lost to Follow-up|1|||
127593426|NCT03978832|459138285|FG000|Overall Study|Withdrawal by Subject|6|||
127593427|NCT03978832|459138285|FG000|Overall Study|Physician Decision|2|||
127593428|NCT03978832|459138285|FG000|Overall Study|did not pass screening criteria|44|||
127593429|NCT01727297|459138290|FG000|Overall Study|Death|13|||
127593430|NCT01727297|459138291|FG001|Overall Study|Death|0|||
127593431|NCT01727297|459138290|FG000|Overall Study|Protocol Violation|1|||
127593432|NCT01727297|459138291|FG001|Overall Study|Protocol Violation|10|||
127593433|NCT01727297|459138290|FG000|Overall Study|Adverse Event|3|||
127593434|NCT01727297|459138291|FG001|Overall Study|Adverse Event|1|||
127593435|NCT01727297|459138290|FG000|Overall Study|Lost to Follow-up|11|||
127593436|NCT01727297|459138291|FG001|Overall Study|Lost to Follow-up|0|||
127593437|NCT01727297|459138290|FG000|Overall Study|Withdrawal by Subject|26|||
127593438|NCT01727297|459138291|FG001|Overall Study|Withdrawal by Subject|27|||
127593439|NCT01727297|459138290|FG000|Overall Study|Physician Decision|19|||
127593440|NCT01727297|459138291|FG001|Overall Study|Physician Decision|5|||
127593441|NCT01727297|459138290|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
127593442|NCT01727297|459138291|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
127593443|NCT02042183|459138292|FG000|Overall Study|Physician Decision|7|||
127593444|NCT02042183|459138293|FG001|Overall Study|Physician Decision|2|||
127593445|NCT02042183|459138292|FG000|Overall Study|Lack of Efficacy|4|||
127593446|NCT02042183|459138293|FG001|Overall Study|Lack of Efficacy|3|||
127593447|NCT02042183|459138292|FG000|Overall Study|Non-compliance with Study Drug|2|||
127593448|NCT02042183|459138293|FG001|Overall Study|Non-compliance with Study Drug|3|||
127593449|NCT02042183|459138292|FG000|Overall Study|Adverse Event|17|||
127593450|NCT02042183|459138293|FG001|Overall Study|Adverse Event|6|||
127593451|NCT02042183|459138292|FG000|Overall Study|Other|3|||
127593452|NCT02042183|459138293|FG001|Overall Study|Other|3|||
127593453|NCT02042183|459138292|FG000|Overall Study|Withdrawal by Subject|21|||
127593454|NCT02042183|459138293|FG001|Overall Study|Withdrawal by Subject|16|||
127593455|NCT02042183|459138292|FG000|Overall Study|Site Terminated by Sponsor|2|||
127593456|NCT02042183|459138293|FG001|Overall Study|Site Terminated by Sponsor|1|||
127593457|NCT02042183|459138292|FG000|Overall Study|Lost to Follow-up|9|||
127784921|NCT02187471|459838277|FG003|Overall Study|Lack of Efficacy|11|||
127784922|NCT02187471|459838274|FG000|Overall Study|Adverse Event|24|||
127784923|NCT02187471|459838275|FG001|Overall Study|Adverse Event|34|||
127784924|NCT02187471|459838276|FG002|Overall Study|Adverse Event|44|||
127784925|NCT02187471|459838277|FG003|Overall Study|Adverse Event|36|||
127784926|NCT02187471|459838274|FG000|Overall Study|Withdrawal by Subject|23|||
127784927|NCT02187471|459838275|FG001|Overall Study|Withdrawal by Subject|29|||
127784928|NCT02187471|459838276|FG002|Overall Study|Withdrawal by Subject|22|||
127784929|NCT02187471|459838277|FG003|Overall Study|Withdrawal by Subject|24|||
127784930|NCT02187471|459838274|FG000|Overall Study|Other|7|||
127784931|NCT02187471|459838275|FG001|Overall Study|Other|5|||
127784932|NCT02187471|459838276|FG002|Overall Study|Other|3|||
127784933|NCT02187471|459838277|FG003|Overall Study|Other|4|||
127784934|NCT02236520|459838278|FG000|Overall Study|Physician Decision|0|||
127784935|NCT02236520|459838279|FG001|Overall Study|Physician Decision|5|||
127784936|NCT02236520|459838280|FG002|Overall Study|Physician Decision|0|||
127784937|NCT02236520|459838281|FG003|Overall Study|Physician Decision|0|||
127784938|NCT02236520|459838278|FG000|Overall Study|Withdrawal by Subject|1|||
127784939|NCT02236520|459838279|FG001|Overall Study|Withdrawal by Subject|0|||
127784940|NCT02236520|459838280|FG002|Overall Study|Withdrawal by Subject|0|||
127784941|NCT02236520|459838281|FG003|Overall Study|Withdrawal by Subject|1|||
127784942|NCT02236520|459838278|FG000|Overall Study|Pregnancy|1|||
127784943|NCT02236520|459838279|FG001|Overall Study|Pregnancy|0|||
127784944|NCT02236520|459838280|FG002|Overall Study|Pregnancy|0|||
127784945|NCT02236520|459838281|FG003|Overall Study|Pregnancy|0|||
127784946|NCT01785160|459838282|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
127784947|NCT01785160|459838282|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
127784948|NCT00957528|459838283|FG000|Overall Study|Protocol Violation|0|||
127784949|NCT00957528|459838284|FG001|Overall Study|Protocol Violation|1|||
127593458|NCT02042183|459138293|FG001|Overall Study|Lost to Follow-up|2|||
127593459|NCT02244606|459138294|FG000|Overall Study|Adverse Event|0|||
127593460|NCT02244606|459138295|FG001|Overall Study|Adverse Event|1|||
127593461|NCT02244606|459138296|FG002|Overall Study|Adverse Event|1|||
127593462|NCT02244606|459138297|FG003|Overall Study|Adverse Event|0|||
127593463|NCT02244606|459138294|FG000|Overall Study|Lost to Follow-up|2|||
127593464|NCT02244606|459138295|FG001|Overall Study|Lost to Follow-up|2|||
127593465|NCT02244606|459138296|FG002|Overall Study|Lost to Follow-up|1|||
127593466|NCT02244606|459138297|FG003|Overall Study|Lost to Follow-up|0|||
127784950|NCT00957528|459838285|FG002|Overall Study|Protocol Violation|0|||
127593467|NCT02244606|459138294|FG000|Overall Study|Protocol Violation|0|||
127784951|NCT00957528|459838283|FG000|Overall Study|Withdrawal by Subject|0|||
127784952|NCT00957528|459838284|FG001|Overall Study|Withdrawal by Subject|0|||
127593468|NCT02244606|459138295|FG001|Overall Study|Protocol Violation|0|||
127593469|NCT02244606|459138296|FG002|Overall Study|Protocol Violation|0|||
127593470|NCT02244606|459138297|FG003|Overall Study|Protocol Violation|1|||
127593471|NCT02244606|459138294|FG000|Overall Study|Withdrawal by Subject|1|||
127593472|NCT02244606|459138295|FG001|Overall Study|Withdrawal by Subject|1|||
127593473|NCT02244606|459138296|FG002|Overall Study|Withdrawal by Subject|0|||
127593474|NCT02244606|459138297|FG003|Overall Study|Withdrawal by Subject|0|||
127593475|NCT02244606|459138294|FG000|Overall Study|Did Not Complete Study for Reason Other:|0|||
127593476|NCT02244606|459138295|FG001|Overall Study|Did Not Complete Study for Reason Other:|1|||
127593477|NCT02244606|459138296|FG002|Overall Study|Did Not Complete Study for Reason Other:|1|||
127593478|NCT02244606|459138297|FG003|Overall Study|Did Not Complete Study for Reason Other:|0|||
127593479|NCT00378378|459138300|FG000|Overall Study|Withdrawal by Subject|0|||
127593480|NCT00378378|459138301|FG001|Overall Study|Withdrawal by Subject|1|||
127593481|NCT00378378|459138302|FG002|Overall Study|Withdrawal by Subject|0|||
127593482|NCT00378378|459138300|FG000|Overall Study|Treatment Failure|0|||
127593483|NCT00378378|459138301|FG001|Overall Study|Treatment Failure|0|||
127593484|NCT00378378|459138302|FG002|Overall Study|Treatment Failure|1|||
127593485|NCT00378378|459138300|FG000|Overall Study|Non-compliance with protocol|0|||
127882069|NCT01289990|460190799|FG006|Overall Study|discontinued in preceding trial|18|||
127593486|NCT00378378|459138301|FG001|Overall Study|Non-compliance with protocol|0|||
127593487|NCT00378378|459138302|FG002|Overall Study|Non-compliance with protocol|1|||
127593488|NCT00407797|459138303|FG000|Overall Study|Lost to Follow-up|2|||
127593489|NCT00407797|459138303|FG000|Overall Study|Adverse Event|6|||
127593490|NCT00407797|459138303|FG000|Overall Study|Other|7|||
127593491|NCT00407797|459138303|FG000|Overall Study|Withdrawal by Subject|3|||
127593492|NCT01812174|459138304|FG000|Overall Study|Death|1|||
127593493|NCT01812174|459138305|FG001|Overall Study|Death|0|||
127593494|NCT01812174|459138304|FG000|Overall Study|Protocol Violation|2|||
127593495|NCT01812174|459138305|FG001|Overall Study|Protocol Violation|0|||
127593496|NCT00553644|459138306|FG000|Overall Study|Adverse Event|17|||
127593497|NCT00553644|459138306|FG000|Overall Study|Withdrawal by Subject|4|||
127593498|NCT00553644|459138306|FG000|Overall Study|Physician Decision|1|||
127593499|NCT00553644|459138306|FG000|Overall Study|Alternative therapy|6|||
127593500|NCT03782792|459138307|FG000|Overall Study|Patient left the country|0|||
127593501|NCT03782792|459138308|FG001|Overall Study|Patient left the country|1|||
127593502|NCT03782792|459138307|FG000|Overall Study|Withdrawal by Subject|1|||
127593503|NCT03782792|459138308|FG001|Overall Study|Withdrawal by Subject|2|||
127593504|NCT02321800|459138310|FG000|Overall Study|Withdrawal by Subject|3|||
127593505|NCT02321800|459138311|FG001|Overall Study|Withdrawal by Subject|3|||
127593506|NCT02321800|459138310|FG000|Overall Study|Death|1|||
127593507|NCT02321800|459138311|FG001|Overall Study|Death|0|||
127593508|NCT02321800|459138310|FG000|Overall Study|Protocol Violation|1|||
127593509|NCT02321800|459138311|FG001|Overall Study|Protocol Violation|0|||
127593510|NCT02321800|459138310|FG000|Overall Study|Lost to Follow-up|10|||
127593511|NCT02321800|459138311|FG001|Overall Study|Lost to Follow-up|4|||
127593512|NCT02321800|459138310|FG000|Overall Study|Adverse Event|2|||
127593513|NCT02321800|459138311|FG001|Overall Study|Adverse Event|3|||
127593514|NCT02321800|459138310|FG000|Overall Study|Other, Miscellaneous|3|||
127593515|NCT02321800|459138311|FG001|Overall Study|Other, Miscellaneous|1|||
127593516|NCT03132220|459138312|FG000|Overall Study|Lost to Follow-up|17|||
127593517|NCT03132220|459138313|FG001|Overall Study|Lost to Follow-up|8|||
127593518|NCT03132220|459138312|FG000|Overall Study|Withdrawal by Subject|1|||
127593519|NCT03132220|459138313|FG001|Overall Study|Withdrawal by Subject|4|||
127593520|NCT01051323|459138314|FG000|Overall Study|Discontinuation of treatment|103|||
127593521|NCT01051323|459138314|FG000|Overall Study|Transplantation|28|||
127593522|NCT01051323|459138314|FG000|Overall Study|Dialysis dependency|22|||
127593523|NCT01051323|459138314|FG000|Overall Study|Withdrawal by Subject|13|||
127593524|NCT01051323|459138314|FG000|Overall Study|Lost to Follow-up|31|||
127593525|NCT01051323|459138314|FG000|Overall Study|Death|129|||
127593526|NCT01051323|459138314|FG000|Overall Study|Hospitalization|28|||
127593527|NCT01051323|459138314|FG000|Overall Study|Other|148|||
127593528|NCT01051323|459138314|FG000|Overall Study|Missing|37|||
127593529|NCT01537393|459138315|FG000|Overall Study|Exclude prior to study|32|||
127593530|NCT01537393|459138316|FG001|Overall Study|Exclude prior to study|44|||
127593531|NCT01537393|459138315|FG000|Overall Study|Death|20|||
127593532|NCT01537393|459138316|FG001|Overall Study|Death|32|||
127593533|NCT01537393|459138315|FG000|Overall Study|Withdrawal by Subject|18|||
127593534|NCT01537393|459138316|FG001|Overall Study|Withdrawal by Subject|17|||
127593535|NCT01537393|459138315|FG000|Overall Study|Lost to Follow-up|53|||
127593536|NCT01537393|459138316|FG001|Overall Study|Lost to Follow-up|48|||
127593537|NCT01537393|459138315|FG000|Overall Study|Failure - Regrafted|28|||
127593538|NCT01537393|459138316|FG001|Overall Study|Failure - Regrafted|43|||
127593539|NCT01537393|459138315|FG000|Overall Study|Failure - Not regrafted|2|||
127593540|NCT01537393|459138316|FG001|Overall Study|Failure - Not regrafted|6|||
127593541|NCT01537393|459138315|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
127593542|NCT01537393|459138316|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
127593543|NCT01233258|459138323|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
128034372|NCT01358734|460753166|FG000|Overall Study|Progressive Disease|5|||
128034373|NCT01358734|460753167|FG001|Overall Study|Progressive Disease|13|||
128034374|NCT01358734|460753168|FG002|Overall Study|Progressive Disease|16|||
127593544|NCT01233258|459138324|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
127593545|NCT01233258|459138325|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
127593546|NCT01233258|459138326|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
127593547|NCT01233258|459138327|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
127593548|NCT01233258|459138328|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
127593549|NCT01233258|459138323|FG000|First Intervention (6 Months)|Protocol Violation|0|||
127593550|NCT01233258|459138324|FG001|First Intervention (6 Months)|Protocol Violation|0|||
127593551|NCT01233258|459138325|FG002|First Intervention (6 Months)|Protocol Violation|1|||
127593552|NCT01233258|459138326|FG003|First Intervention (6 Months)|Protocol Violation|0|||
127593553|NCT01233258|459138327|FG004|First Intervention (6 Months)|Protocol Violation|0|||
127593554|NCT01233258|459138328|FG005|First Intervention (6 Months)|Protocol Violation|0|||
127593555|NCT01233258|459138323|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
127593556|NCT01233258|459138324|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
127593557|NCT01233258|459138325|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
127593558|NCT01233258|459138326|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
127593559|NCT01233258|459138327|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
127593560|NCT01233258|459138328|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
127593561|NCT01637272|459138330|FG000|Overall Study|Adverse Event|6|||
127593562|NCT01637272|459138330|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
127593563|NCT01637272|459138330|FG000|Overall Study|Withdrawal by Subject|3|||
127593564|NCT01637272|459138330|FG000|Overall Study|Lost to Follow-up|2|||
127593565|NCT01637272|459138330|FG000|Overall Study|completed core, did not enter ext. phase|4|||
127593566|NCT01637272|459138330|FG000|Overall Study|Administrative problems|1|||
127593567|NCT01637272|459138330|FG000|Overall Study|Protocol Violation|2|||
127593568|NCT01496612|459138331|FG000|1st Intervention|Adverse Event|1|||
127593569|NCT01496612|459138332|FG001|1st Intervention|Adverse Event|0|||
127593570|NCT01496612|459138331|FG000|1st Intervention|Withdrawal by Subject|1|||
127593571|NCT01496612|459138332|FG001|1st Intervention|Withdrawal by Subject|0|||
127593572|NCT02695329|459138338|FG000|Overall Study|Adverse Event|1|||
127593573|NCT02695329|459138339|FG001|Overall Study|Adverse Event|0|||
127593574|NCT02695329|459138338|FG000|Overall Study|Poor X-ray quality for measurement|4|||
127593575|NCT02695329|459138339|FG001|Overall Study|Poor X-ray quality for measurement|5|||
127593576|NCT01866930|459138341|FG000|Treatment Period|Other|1|||
127593577|NCT01866930|459138342|FG001|Treatment Period|Other|0|||
127593578|NCT01866930|459138341|FG000|Treatment Period|Death|0|||
127593579|NCT01866930|459138342|FG001|Treatment Period|Death|2|||
127593580|NCT01866930|459138341|FG000|Treatment Period|Poor/non compliance|0|||
127593581|NCT01866930|459138342|FG001|Treatment Period|Poor/non compliance|2|||
127593582|NCT01866930|459138341|FG000|Treatment Period|No longer meets study criteria|0|||
127593583|NCT01866930|459138342|FG001|Treatment Period|No longer meets study criteria|1|||
127593584|NCT01866930|459138341|FG000|Treatment Period|Withdrawal by Subject|2|||
127593585|NCT01866930|459138342|FG001|Treatment Period|Withdrawal by Subject|8|||
127593586|NCT01866930|459138341|FG000|Treatment Period|Lack of Efficacy|1|||
127593587|NCT01866930|459138342|FG001|Treatment Period|Lack of Efficacy|9|||
127593588|NCT01866930|459138341|FG000|Treatment Period|Adverse Event|4|||
127593589|NCT01866930|459138342|FG001|Treatment Period|Adverse Event|12|||
127593590|NCT01866930|459138341|FG000|Treatment Period|Lost to Follow-up|1|||
127593591|NCT01866930|459138342|FG001|Treatment Period|Lost to Follow-up|1|||
127593592|NCT01866930|459138341|FG000|Follow-up Period|Lost to Follow-up|1|||
127593593|NCT01866930|459138342|FG001|Follow-up Period|Lost to Follow-up|1|||
127593594|NCT01866930|459138341|FG000|Follow-up Period|Other|1|||
127593595|NCT01866930|459138342|FG001|Follow-up Period|Other|5|||
127593596|NCT01866930|459138341|FG000|Follow-up Period|No longer required per protocol|1|||
127593597|NCT01866930|459138342|FG001|Follow-up Period|No longer required per protocol|0|||
127593598|NCT01866930|459138341|FG000|Follow-up Period|Withdrawal by Subject|3|||
127593599|NCT01866930|459138342|FG001|Follow-up Period|Withdrawal by Subject|3|||
127593600|NCT00279305|459138343|FG000|Overall Study|Pregnancy|1|||
127593601|NCT00279305|459138344|FG001|Overall Study|Pregnancy|0|||
127593602|NCT00279305|459138343|FG000|Overall Study|Withdrawal by Subject|2|||
127593603|NCT00279305|459138344|FG001|Overall Study|Withdrawal by Subject|0|||
127593604|NCT00279305|459138343|FG000|Overall Study|Dificulting establishing IV|1|||
127593605|NCT00279305|459138344|FG001|Overall Study|Dificulting establishing IV|0|||
127593606|NCT00279305|459138343|FG000|Overall Study|FDA Safety Alert|4|||
127694761|NCT04533347|459510852|FG000|Overall Study|Withdrawal by Subject|1|||
127694762|NCT04533347|459510853|FG001|Overall Study|Withdrawal by Subject|0|||
127593607|NCT00279305|459138344|FG001|Overall Study|FDA Safety Alert|1|||
127593608|NCT00317356|459138347|FG000|Overall Study|Adverse Event|0|||
127593609|NCT00317356|459138348|FG001|Overall Study|Adverse Event|0|||
127593610|NCT00317356|459138349|FG002|Overall Study|Adverse Event|1|||
127593611|NCT00317356|459138350|FG003|Overall Study|Adverse Event|0|||
127593612|NCT00317356|459138347|FG000|Overall Study|Lack of Efficacy|1|||
127593613|NCT00317356|459138348|FG001|Overall Study|Lack of Efficacy|1|||
127593614|NCT00317356|459138349|FG002|Overall Study|Lack of Efficacy|0|||
127694763|NCT03907397|459510854|FG000|Overall Study|Lost to Follow-up|0|||
127694764|NCT03907397|459510855|FG001|Overall Study|Lost to Follow-up|1|||
127694765|NCT03907397|459510854|FG000|Overall Study|Physician Decision|2|||
127694766|NCT03907397|459510855|FG001|Overall Study|Physician Decision|1|||
127694767|NCT03907397|459510854|FG000|Overall Study|Withdrawal by Subject|5|||
127694768|NCT03907397|459510855|FG001|Overall Study|Withdrawal by Subject|4|||
127694769|NCT03907397|459510854|FG000|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|1|||
127694770|NCT03907397|459510855|FG001|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|0|||
127694771|NCT04083235|459512804|FG000|Overall Study|Death|252|||
127694772|NCT04083235|459512805|FG001|Overall Study|Death|277|||
127694773|NCT04083235|459512804|FG000|Overall Study|Withdrawal by Subject|13|||
127694774|NCT04083235|459512805|FG001|Overall Study|Withdrawal by Subject|17|||
127694775|NCT04083235|459512804|FG000|Overall Study|Lost to Follow-up|1|||
127694776|NCT04083235|459512805|FG001|Overall Study|Lost to Follow-up|1|||
127694777|NCT04083235|459512804|FG000|Overall Study|Does not meet entry criteria|1|||
127694778|NCT04083235|459512805|FG001|Overall Study|Does not meet entry criteria|0|||
127694779|NCT04083235|459512804|FG000|Overall Study|Did not receive treatment|13|||
127694780|NCT04083235|459512805|FG001|Overall Study|Did not receive treatment|8|||
127694781|NCT04083235|459512804|FG000|Overall Study|Ongoing at the time of DCO|44|||
127784953|NCT00957528|459838285|FG002|Overall Study|Withdrawal by Subject|1|||
127784954|NCT02234479|459838290|FG000|Overall Study|Withdrawal by Subject|1|||
127784955|NCT02234479|459838291|FG001|Overall Study|Withdrawal by Subject|3|||
127784956|NCT02318667|459838292|FG000|Overall Study|Adverse Event|1|||
127784957|NCT02318667|459838292|FG000|Overall Study|Lack of Efficacy|6|||
127784958|NCT02318667|459838292|FG000|Overall Study|Protocol Violation|2|||
127784959|NCT02289742|459838293|FG000|First Wear Period|Adverse event prior to treatment|0|||
127784960|NCT02289742|459838294|FG001|First Wear Period|Adverse event prior to treatment|1|||
127784961|NCT02289742|459838295|FG002|First Wear Period|Adverse event prior to treatment|0|||
127784962|NCT02289742|459838296|FG003|First Wear Period|Adverse event prior to treatment|0|||
127784963|NCT02289742|459838293|FG000|First Wear Period|Adverse Event|0|||
127784964|NCT02289742|459838294|FG001|First Wear Period|Adverse Event|0|||
127784965|NCT02289742|459838295|FG002|First Wear Period|Adverse Event|1|||
127784966|NCT02289742|459838296|FG003|First Wear Period|Adverse Event|0|||
127784967|NCT02289742|459838293|FG000|First Wear Period|Other prior to treatment|0|||
127784968|NCT02289742|459838294|FG001|First Wear Period|Other prior to treatment|0|||
127784969|NCT02289742|459838295|FG002|First Wear Period|Other prior to treatment|0|||
127784970|NCT02289742|459838296|FG003|First Wear Period|Other prior to treatment|1|||
127784971|NCT02289742|459838293|FG000|Third Wear Period|Adverse Event|0|||
127784972|NCT02289742|459838294|FG001|Third Wear Period|Adverse Event|1|||
127784973|NCT02289742|459838295|FG002|Third Wear Period|Adverse Event|0|||
127784974|NCT02289742|459838296|FG003|Third Wear Period|Adverse Event|0|||
127784975|NCT02289742|459838293|FG000|Third Wear Period|Reason not given|0|||
127784976|NCT02289742|459838294|FG001|Third Wear Period|Reason not given|0|||
127882070|NCT01289990|460190800|FG007|Overall Study|discontinued in preceding trial|8|||
127593615|NCT00317356|459138350|FG003|Overall Study|Lack of Efficacy|3|||
127593616|NCT00317356|459138347|FG000|Overall Study|Physician Decision|0|||
127593617|NCT00317356|459138348|FG001|Overall Study|Physician Decision|1|||
127593618|NCT00317356|459138349|FG002|Overall Study|Physician Decision|0|||
127593619|NCT00317356|459138350|FG003|Overall Study|Physician Decision|0|||
127593620|NCT00621153|459138357|FG000|Overall Study|Safety Reason|8|||
127593621|NCT00621153|459138358|FG001|Overall Study|Safety Reason|7|||
127593622|NCT00621153|459138357|FG000|Overall Study|Adverse Event|3|||
127593623|NCT00621153|459138358|FG001|Overall Study|Adverse Event|2|||
127593624|NCT00621153|459138357|FG000|Overall Study|Lost to Follow-up|5|||
127593625|NCT00621153|459138358|FG001|Overall Study|Lost to Follow-up|1|||
127593626|NCT00621153|459138357|FG000|Overall Study|Withdrawal by Subject|4|||
127593627|NCT00621153|459138358|FG001|Overall Study|Withdrawal by Subject|5|||
127593628|NCT00753415|459138359|FG000|Part A|Disease progression|1|||
127593629|NCT00753415|459138360|FG001|Part A|Disease progression|0|||
127593630|NCT00753415|459138361|FG002|Part A|Disease progression|1|||
127593631|NCT00753415|459138362|FG003|Part A|Disease progression|2|||
127593632|NCT00753415|459138363|FG004|Part A|Disease progression|0|||
127593633|NCT00753415|459138364|FG005|Part A|Disease progression|0|||
127593634|NCT00753415|459138365|FG006|Part A|Disease progression|0|||
127593635|NCT00753415|459138366|FG007|Part A|Disease progression|0|||
127784977|NCT02289742|459838295|FG002|Third Wear Period|Reason not given|0|||
127784978|NCT02289742|459838296|FG003|Third Wear Period|Reason not given|1|||
127784979|NCT01365039|459838297|FG000|Overall Study|Study related symptoms and complaints|1|||
127882071|NCT01289990|460190801|FG008|Overall Study|discontinued in preceding trial|17|||
127593636|NCT00753415|459138367|FG008|Part A|Disease progression|0|||
127593637|NCT00753415|459138368|FG009|Part A|Disease progression|0|||
127593638|NCT00753415|459138359|FG000|Part A|Withdrawal by Subject|0|||
127593639|NCT00753415|459138360|FG001|Part A|Withdrawal by Subject|0|||
127593640|NCT00753415|459138361|FG002|Part A|Withdrawal by Subject|1|||
127694782|NCT04083235|459512805|FG001|Overall Study|Ongoing at the time of DCO|7|||
127694783|NCT03958955|459512806|FG000|Overall Study|Adverse Event|1|||
127694784|NCT02927769|459512808|FG000|Induction Phase|Study drug toxicity|1|||
127593641|NCT00753415|459138362|FG003|Part A|Withdrawal by Subject|0|||
127593642|NCT00753415|459138363|FG004|Part A|Withdrawal by Subject|0|||
127593643|NCT00753415|459138364|FG005|Part A|Withdrawal by Subject|0|||
127593644|NCT00753415|459138365|FG006|Part A|Withdrawal by Subject|0|||
127593645|NCT00753415|459138366|FG007|Part A|Withdrawal by Subject|0|||
127593646|NCT00753415|459138367|FG008|Part A|Withdrawal by Subject|0|||
127593647|NCT00753415|459138368|FG009|Part A|Withdrawal by Subject|0|||
127593648|NCT00753415|459138359|FG000|Part B|Lost to Follow-up|0|||
127593649|NCT00753415|459138360|FG001|Part B|Lost to Follow-up|0|||
127593650|NCT00753415|459138361|FG002|Part B|Lost to Follow-up|0|||
127593651|NCT00753415|459138362|FG003|Part B|Lost to Follow-up|0|||
127593652|NCT00753415|459138363|FG004|Part B|Lost to Follow-up|0|||
127593653|NCT00753415|459138364|FG005|Part B|Lost to Follow-up|0|||
127593654|NCT00753415|459138365|FG006|Part B|Lost to Follow-up|0|||
127593655|NCT00753415|459138366|FG007|Part B|Lost to Follow-up|1|||
127593656|NCT00753415|459138367|FG008|Part B|Lost to Follow-up|1|||
127593657|NCT00753415|459138368|FG009|Part B|Lost to Follow-up|0|||
127593658|NCT00753415|459138359|FG000|Part B|Disease progression|0|||
127593659|NCT00753415|459138360|FG001|Part B|Disease progression|0|||
127593660|NCT00753415|459138361|FG002|Part B|Disease progression|0|||
127593661|NCT00753415|459138362|FG003|Part B|Disease progression|0|||
127593662|NCT00753415|459138363|FG004|Part B|Disease progression|0|||
127593663|NCT00753415|459138364|FG005|Part B|Disease progression|0|||
127593664|NCT00753415|459138365|FG006|Part B|Disease progression|0|||
127593665|NCT00753415|459138366|FG007|Part B|Disease progression|0|||
127593666|NCT00753415|459138367|FG008|Part B|Disease progression|2|||
127593667|NCT00753415|459138368|FG009|Part B|Disease progression|1|||
127593668|NCT04212650|459138369|FG000|Overall Study|Withdrawal by Subject|1|||
127593669|NCT04212650|459138370|FG001|Overall Study|Withdrawal by Subject|0|||
127593670|NCT00630396|459140300|FG000|Overall Study|Death|4|||
127593671|NCT00630396|459140300|FG000|Overall Study|Lost to Follow-up|3|||
127593672|NCT00790023|459140304|FG000|Overall Study|Adverse Event|2|||
127593673|NCT00790023|459140305|FG001|Overall Study|Adverse Event|1|||
127593674|NCT00790023|459140306|FG002|Overall Study|Adverse Event|4|||
127593675|NCT00790023|459140304|FG000|Overall Study|Protocol Violation|2|||
127593676|NCT00790023|459140305|FG001|Overall Study|Protocol Violation|4|||
127593677|NCT00790023|459140306|FG002|Overall Study|Protocol Violation|2|||
127593678|NCT00790023|459140304|FG000|Overall Study|Withdrawal by Subject|2|||
127593679|NCT00790023|459140305|FG001|Overall Study|Withdrawal by Subject|0|||
127593680|NCT00790023|459140306|FG002|Overall Study|Withdrawal by Subject|6|||
127593681|NCT00790023|459140304|FG000|Overall Study|Lost to Follow-up|0|||
127593682|NCT00790023|459140305|FG001|Overall Study|Lost to Follow-up|0|||
127593683|NCT00790023|459140306|FG002|Overall Study|Lost to Follow-up|1|||
127593684|NCT00790023|459140304|FG000|Overall Study|Other|5|||
127593685|NCT00790023|459140305|FG001|Overall Study|Other|5|||
127593686|NCT00790023|459140306|FG002|Overall Study|Other|8|||
127593687|NCT01338792|459140307|FG000|Overall Study|Adverse Event|2|||
127593688|NCT01338792|459140307|FG000|Overall Study|Death|1|||
127593689|NCT01338792|459140307|FG000|Overall Study|Withdrawal by Subject|1|||
127593690|NCT02468414|459140308|FG000|Overall Study|Early Study Termination by Sponsor|1|||
127593691|NCT02468414|459140309|FG001|Overall Study|Early Study Termination by Sponsor|0|||
127694785|NCT02927769|459512809|FG001|Induction Phase|Study drug toxicity|1|||
127694786|NCT02927769|459512808|FG000|Induction Phase|Disease progression|0|||
127694787|NCT02927769|459512809|FG001|Induction Phase|Disease progression|1|||
127694788|NCT02927769|459512808|FG000|Intensification Phase|Study drug toxicity|1|||
127694789|NCT02927769|459512809|FG001|Intensification Phase|Study drug toxicity|0|||
127694790|NCT02807636|459512812|FG000|Overall Study|Lost to Follow-up|10|||
127694791|NCT02807636|459512813|FG001|Overall Study|Lost to Follow-up|13|||
127694792|NCT02807636|459512814|FG002|Overall Study|Lost to Follow-up|6|||
127694793|NCT02807636|459512812|FG000|Overall Study|Protocol Deviation|1|||
127694794|NCT02807636|459512813|FG001|Overall Study|Protocol Deviation|0|||
127694795|NCT02807636|459512814|FG002|Overall Study|Protocol Deviation|0|||
127694796|NCT02807636|459512812|FG000|Overall Study|Symptomatic Deterioration|0|||
127694797|NCT02807636|459512813|FG001|Overall Study|Symptomatic Deterioration|1|||
127694798|NCT02807636|459512814|FG002|Overall Study|Symptomatic Deterioration|0|||
127694799|NCT02807636|459512812|FG000|Overall Study|Withdrawal by Subject|39|||
127694800|NCT02807636|459512813|FG001|Overall Study|Withdrawal by Subject|28|||
127694801|NCT02807636|459512814|FG002|Overall Study|Withdrawal by Subject|24|||
127694802|NCT02807636|459512812|FG000|Overall Study|Death|303|||
127694803|NCT02807636|459512813|FG001|Overall Study|Death|332|||
127694804|NCT02807636|459512814|FG002|Overall Study|Death|272|||
127694805|NCT02807636|459512812|FG000|Overall Study|Study Terminated By Sponsor|47|||
127694806|NCT02807636|459512813|FG001|Overall Study|Study Terminated By Sponsor|76|||
127593692|NCT02468414|459140308|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
127694807|NCT02807636|459512814|FG002|Overall Study|Study Terminated By Sponsor|60|||
127694808|NCT02807636|459512812|FG000|Overall Study|Physician Decision|0|||
127593693|NCT02468414|459140309|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
127593694|NCT02468414|459140308|FG000|Overall Study|Screen Failure|1|||
127593695|NCT02468414|459140309|FG001|Overall Study|Screen Failure|0|||
127694809|NCT02807636|459512813|FG001|Overall Study|Physician Decision|1|||
127694810|NCT02807636|459512814|FG002|Overall Study|Physician Decision|0|||
127694811|NCT05082909|459512815|FG000|Overall Study|Protocol Violation|0|||
127694812|NCT05082909|459512816|FG001|Overall Study|Protocol Violation|0|||
127694813|NCT05082909|459512817|FG002|Overall Study|Protocol Violation|1|||
127694814|NCT05082909|459512818|FG003|Overall Study|Protocol Violation|0|||
127694815|NCT05082909|459512819|FG004|Overall Study|Protocol Violation|0|||
127694816|NCT05082909|459512820|FG005|Overall Study|Protocol Violation|0|||
127694817|NCT04088630|459512821|FG000|Overall Study|Lost to Follow-up|3|||
127694818|NCT04088630|459512822|FG001|Overall Study|Lost to Follow-up|2|||
127694819|NCT04088630|459512823|FG002|Overall Study|Lost to Follow-up|6|||
127694820|NCT04088630|459512821|FG000|Overall Study|Death|3|||
127694821|NCT04088630|459512822|FG001|Overall Study|Death|1|||
127694822|NCT04088630|459512823|FG002|Overall Study|Death|1|||
127694823|NCT04088630|459512821|FG000|Overall Study|Physician Decision|0|||
127694824|NCT04088630|459512822|FG001|Overall Study|Physician Decision|1|||
127694825|NCT04088630|459512823|FG002|Overall Study|Physician Decision|1|||
127694826|NCT03315754|459512826|FG000|Overall Study|COVID-19 complications leading to death|1|||
127694827|NCT03315754|459512826|FG000|Overall Study|insurance coverage issue|1|||
127694828|NCT02954341|459512827|FG000|Overall Study|Attempted Implant unsuccessful|5|||
127694829|NCT02954341|459512827|FG000|Overall Study|Death|90|||
127694830|NCT02954341|459512827|FG000|Overall Study|Withdrawal by Subject|4|||
127694831|NCT02954341|459512827|FG000|Overall Study|Physician Decision|13|||
127694832|NCT02954341|459512827|FG000|Overall Study|Not Implanted due to COVID restrictions|1|||
127694833|NCT02954341|459512827|FG000|Overall Study|Not implanted due to physician's decision|1|||
127694834|NCT02954341|459512827|FG000|Overall Study|Withdrawn Prior Implant Attempt|17|||
127694835|NCT05227209|459512831|FG000|Overall Study|Adverse Event|11|||
127694836|NCT05227209|459512831|FG000|Overall Study|Lost to Follow-up|1|||
127694837|NCT05227209|459512831|FG000|Overall Study|Withdrawal by Subject|7|||
127694838|NCT05227209|459512831|FG000|Overall Study|Other Early Termination Reason (Not Listed on CRF)|36|||
127694839|NCT04245501|459512836|FG000|Overall Study|Adverse Event|2|||
127694840|NCT04245501|459512837|FG001|Overall Study|Adverse Event|0|||
127694841|NCT04245501|459512836|FG000|Overall Study|ineligible participant unknowingly enrolled|0|||
127694842|NCT04245501|459512837|FG001|Overall Study|ineligible participant unknowingly enrolled|1|||
127784980|NCT01365039|459838298|FG001|Overall Study|Study related symptoms and complaints|0|||
127784981|NCT00253643|459838303|FG000|Overall Study|Withdrawal by Subject|0|||
127784982|NCT00253643|459838304|FG001|Overall Study|Withdrawal by Subject|0|||
127784983|NCT00253643|459838305|FG002|Overall Study|Withdrawal by Subject|1|||
127784984|NCT00253643|459838306|FG003|Overall Study|Withdrawal by Subject|1|||
127784985|NCT00253643|459838303|FG000|Overall Study|Non-Compliance|0|||
127784986|NCT00253643|459838304|FG001|Overall Study|Non-Compliance|0|||
127784987|NCT00253643|459838305|FG002|Overall Study|Non-Compliance|0|||
127784988|NCT00253643|459838306|FG003|Overall Study|Non-Compliance|2|||
127784989|NCT00383084|459838307|FG000|Overall Study|Withdrawal by Subject|12|||
127784990|NCT00383084|459838308|FG001|Overall Study|Withdrawal by Subject|10|||
127784991|NCT02636582|459838309|FG000|Overall Study|Surgical Pathology|1|||
127784992|NCT02636582|459838310|FG001|Overall Study|Surgical Pathology|0|||
127784993|NCT01263483|459838311|FG000|Overall Study|Adverse Event|4|||
127784994|NCT01263483|459838312|FG001|Overall Study|Adverse Event|0|||
127784995|NCT01263483|459838313|FG002|Overall Study|Adverse Event|3|||
127784996|NCT01263483|459838311|FG000|Overall Study|Withdrawal by Subject|1|||
127784997|NCT01263483|459838312|FG001|Overall Study|Withdrawal by Subject|0|||
127784998|NCT01263483|459838313|FG002|Overall Study|Withdrawal by Subject|0|||
127784999|NCT01263483|459838311|FG000|Overall Study|Lack of Efficacy|2|||
127785000|NCT01263483|459838312|FG001|Overall Study|Lack of Efficacy|0|||
127785001|NCT01263483|459838313|FG002|Overall Study|Lack of Efficacy|0|||
127785002|NCT01263483|459838311|FG000|Overall Study|Protocol Violation|0|||
127785003|NCT01263483|459838312|FG001|Overall Study|Protocol Violation|1|||
127785004|NCT01263483|459838313|FG002|Overall Study|Protocol Violation|1|||
127785005|NCT01263483|459838311|FG000|Overall Study|Participant Unavailability|0|||
127694843|NCT01426425|459512838|FG000|Overall Study|Exited prior to EP study|22|||
127694844|NCT01426425|459512838|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
127694845|NCT01426425|459512838|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
127785006|NCT01263483|459838312|FG001|Overall Study|Participant Unavailability|1|||
127785007|NCT01263483|459838313|FG002|Overall Study|Participant Unavailability|1|||
127785008|NCT00326209|459838314|FG000|Overall Study|Adverse Event|28|||
127785009|NCT00326209|459838314|FG000|Overall Study|Withdrawal by Subject|22|||
127785010|NCT00326209|459838314|FG000|Overall Study|Lack of Efficacy|31|||
127694846|NCT03281291|459512844|FG000|Overall Study|Serious Adverse Event And/Or pIMD|2|||
127694847|NCT03281291|459512845|FG001|Overall Study|Serious Adverse Event And/Or pIMD|1|||
127694848|NCT03281291|459512846|FG002|Overall Study|Serious Adverse Event And/Or pIMD|0|||
127694849|NCT03281291|459512847|FG003|Overall Study|Serious Adverse Event And/Or pIMD|4|||
127694850|NCT03281291|459512848|FG004|Overall Study|Serious Adverse Event And/Or pIMD|1|||
127694851|NCT03281291|459512844|FG000|Overall Study|Protocol Deviation|2|||
127694852|NCT03281291|459512845|FG001|Overall Study|Protocol Deviation|0|||
127694853|NCT03281291|459512846|FG002|Overall Study|Protocol Deviation|1|||
127785011|NCT00326209|459838314|FG000|Overall Study|Lost to Follow-up|18|||
127785012|NCT00326209|459838314|FG000|Overall Study|Participant non-compliant|6|||
128034375|NCT01358734|460753166|FG000|Overall Study|Non-compliance with study drug|0|||
128034376|NCT01358734|460753167|FG001|Overall Study|Non-compliance with study drug|0|||
128034377|NCT01358734|460753168|FG002|Overall Study|Non-compliance with study drug|1|||
128034378|NCT01358734|460753166|FG000|Overall Study|Other|2|||
128034379|NCT01358734|460753167|FG001|Overall Study|Other|5|||
128034380|NCT01358734|460753168|FG002|Overall Study|Other|4|||
128034381|NCT01358734|460753166|FG000|Overall Study|Protocol Violation|0|||
128034382|NCT01358734|460753167|FG001|Overall Study|Protocol Violation|0|||
128034383|NCT01358734|460753168|FG002|Overall Study|Protocol Violation|2|||
128034384|NCT01822925|460753169|FG000|Overall Study|Adverse Event|1|||
128034385|NCT01822925|460753170|FG001|Overall Study|Adverse Event|1|||
128034386|NCT01822925|460753171|FG002|Overall Study|Adverse Event|1|||
128034387|NCT01822925|460753172|FG003|Overall Study|Adverse Event|1|||
128034388|NCT01822925|460753169|FG000|Overall Study|Lost to Follow-up|0|||
128034389|NCT01822925|460753170|FG001|Overall Study|Lost to Follow-up|1|||
128034390|NCT01822925|460753171|FG002|Overall Study|Lost to Follow-up|0|||
128034391|NCT01822925|460753172|FG003|Overall Study|Lost to Follow-up|0|||
128034392|NCT01822925|460753169|FG000|Overall Study|Protocol Violation|1|||
128034393|NCT01822925|460753170|FG001|Overall Study|Protocol Violation|0|||
128034394|NCT01822925|460753171|FG002|Overall Study|Protocol Violation|0|||
128034395|NCT01822925|460753172|FG003|Overall Study|Protocol Violation|1|||
128034396|NCT01822925|460753169|FG000|Overall Study|Withdrawal by Subject|2|||
128034397|NCT01822925|460753170|FG001|Overall Study|Withdrawal by Subject|0|||
128034398|NCT01822925|460753171|FG002|Overall Study|Withdrawal by Subject|2|||
128034399|NCT01822925|460753172|FG003|Overall Study|Withdrawal by Subject|2|||
128034400|NCT01822925|460753169|FG000|Overall Study|Taking prohibited medication|2|||
128034401|NCT01822925|460753170|FG001|Overall Study|Taking prohibited medication|0|||
128034402|NCT01822925|460753171|FG002|Overall Study|Taking prohibited medication|0|||
128034403|NCT01822925|460753172|FG003|Overall Study|Taking prohibited medication|1|||
128034404|NCT04617860|460753177|FG000|Overall Study|Adverse Event|0|||
128034405|NCT04617860|460753178|FG001|Overall Study|Adverse Event|2|||
128034406|NCT04617860|460753179|FG002|Overall Study|Adverse Event|2|||
128034407|NCT04617860|460753177|FG000|Overall Study|Withdrawal by Subject|0|||
128034408|NCT04617860|460753178|FG001|Overall Study|Withdrawal by Subject|0|||
128034409|NCT04617860|460753179|FG002|Overall Study|Withdrawal by Subject|2|||
128034410|NCT04617860|460753177|FG000|Overall Study|Physician Decision|0|||
128034411|NCT04617860|460753178|FG001|Overall Study|Physician Decision|1|||
128034412|NCT04617860|460753179|FG002|Overall Study|Physician Decision|0|||
128034413|NCT04617860|460753177|FG000|Overall Study|Sponsor Decision|0|||
128034414|NCT04617860|460753178|FG001|Overall Study|Sponsor Decision|3|||
128034415|NCT04617860|460753179|FG002|Overall Study|Sponsor Decision|1|||
128034416|NCT04617860|460753177|FG000|Overall Study|Termination of Study by Sponsor|8|||
128034417|NCT04617860|460753178|FG001|Overall Study|Termination of Study by Sponsor|4|||
128034418|NCT04617860|460753179|FG002|Overall Study|Termination of Study by Sponsor|13|||
128034419|NCT01182350|460753180|FG000|Overall Study|Adverse Event|5|||
128034420|NCT01182350|460753181|FG001|Overall Study|Adverse Event|0|||
128034421|NCT01182350|460753182|FG002|Overall Study|Adverse Event|0|||
127593696|NCT01652703|459140310|FG000|Overall Study|Withdrawal by Subject|0|||
127593697|NCT01652703|459140311|FG001|Overall Study|Withdrawal by Subject|1|||
127593698|NCT01652703|459140312|FG002|Overall Study|Withdrawal by Subject|3|||
127593699|NCT01652703|459140313|FG003|Overall Study|Withdrawal by Subject|1|||
127593700|NCT01652703|459140314|FG004|Overall Study|Withdrawal by Subject|0|||
127593701|NCT01652703|459140315|FG005|Overall Study|Withdrawal by Subject|1|||
127593702|NCT01652703|459140310|FG000|Overall Study|Other|0|||
127593703|NCT01652703|459140311|FG001|Overall Study|Other|0|||
127593704|NCT01652703|459140312|FG002|Overall Study|Other|0|||
128034422|NCT01182350|460753183|FG003|Overall Study|Adverse Event|0|||
128034423|NCT01182350|460753184|FG004|Overall Study|Adverse Event|0|||
128034424|NCT01182350|460753180|FG000|Overall Study|Disease Progression|15|||
128034425|NCT01182350|460753181|FG001|Overall Study|Disease Progression|12|||
128034426|NCT01182350|460753182|FG002|Overall Study|Disease Progression|0|||
128034427|NCT01182350|460753183|FG003|Overall Study|Disease Progression|1|||
128034428|NCT01182350|460753184|FG004|Overall Study|Disease Progression|0|||
128034429|NCT01182350|460753180|FG000|Overall Study|Death|0|||
128034430|NCT01182350|460753181|FG001|Overall Study|Death|1|||
128034431|NCT01182350|460753182|FG002|Overall Study|Death|1|||
128034432|NCT01182350|460753183|FG003|Overall Study|Death|0|||
128034433|NCT01182350|460753184|FG004|Overall Study|Death|0|||
128034434|NCT01182350|460753180|FG000|Overall Study|Withdrawal by Subject|3|||
128034435|NCT01182350|460753181|FG001|Overall Study|Withdrawal by Subject|1|||
128034436|NCT01182350|460753182|FG002|Overall Study|Withdrawal by Subject|0|||
128034437|NCT01182350|460753183|FG003|Overall Study|Withdrawal by Subject|1|||
128034438|NCT01182350|460753184|FG004|Overall Study|Withdrawal by Subject|0|||
128034439|NCT01182350|460753180|FG000|Overall Study|Alternative Therapy|2|||
128034440|NCT01182350|460753181|FG001|Overall Study|Alternative Therapy|0|||
128034441|NCT01182350|460753182|FG002|Overall Study|Alternative Therapy|1|||
128034442|NCT01182350|460753183|FG003|Overall Study|Alternative Therapy|0|||
128034443|NCT01182350|460753184|FG004|Overall Study|Alternative Therapy|0|||
128034444|NCT01182350|460753180|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
128034445|NCT01182350|460753181|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
127785013|NCT00326209|459838314|FG000|Overall Study|Sponsor closed study|173|||
127785014|NCT00326209|459838314|FG000|Overall Study|Prohibited medication use|1|||
127785015|NCT00326209|459838314|FG000|Overall Study|Violation of entry criteria|1|||
127785016|NCT00326209|459838314|FG000|Overall Study|Withdrawn in error|1|||
127785017|NCT00326209|459838314|FG000|Overall Study|Pregnancy|1|||
127785018|NCT00714285|459838315|FG000|Overall Study|Lost to Follow-up|0|||
127785019|NCT00714285|459838316|FG001|Overall Study|Lost to Follow-up|2|||
127785020|NCT00714285|459838317|FG002|Overall Study|Lost to Follow-up|0|||
127785021|NCT00714285|459838318|FG003|Overall Study|Lost to Follow-up|1|||
127785022|NCT00714285|459838315|FG000|Overall Study|Migrated/moved from study area|0|||
127785023|NCT00714285|459838316|FG001|Overall Study|Migrated/moved from study area|1|||
127785024|NCT00714285|459838317|FG002|Overall Study|Migrated/moved from study area|0|||
127785025|NCT00714285|459838318|FG003|Overall Study|Migrated/moved from study area|0|||
127785026|NCT01372384|459838319|FG000|Overall Study|Progression of disease|3|||
127785027|NCT01131676|459838324|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
127785028|NCT01131676|459838325|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
127785029|NCT01131676|459838326|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
127785030|NCT01131676|459838324|FG000|Discontinuation From Treatment|Not treated|4|||
127785031|NCT01131676|459838325|FG001|Discontinuation From Treatment|Not treated|2|||
127785032|NCT01131676|459838326|FG002|Discontinuation From Treatment|Not treated|2|||
127785033|NCT01131676|459838324|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
127785034|NCT01131676|459838325|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
127785035|NCT01131676|459838326|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
127785036|NCT01131676|459838324|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
127785037|NCT01131676|459838325|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
127785038|NCT01131676|459838326|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
127785039|NCT01131676|459838324|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
127785040|NCT01131676|459838325|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
127785041|NCT01131676|459838326|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
127785042|NCT01131676|459838324|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
127785043|NCT01131676|459838325|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
127785044|NCT01131676|459838326|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
127785045|NCT01131676|459838324|FG000|Discontinuation From Treatment|Other than those specified|162|||
127785046|NCT01131676|459838325|FG001|Discontinuation From Treatment|Other than those specified|142|||
127785047|NCT01131676|459838326|FG002|Discontinuation From Treatment|Other than those specified|125|||
127785048|NCT01131676|459838324|FG000|Discontinuation From Treatment|Adverse Event|303|||
127785049|NCT01131676|459838325|FG001|Discontinuation From Treatment|Adverse Event|267|||
127785050|NCT01131676|459838326|FG002|Discontinuation From Treatment|Adverse Event|273|||
127785051|NCT01131676|459838324|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
127785052|NCT01131676|459838325|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
127785053|NCT01131676|459838326|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
127785054|NCT01131676|459838324|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
127785055|NCT01131676|459838325|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
127785056|NCT01131676|459838326|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
127785057|NCT01131676|459838324|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
127785058|NCT01131676|459838325|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
127785059|NCT01131676|459838326|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
127785060|NCT01131676|459838324|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
127785061|NCT01131676|459838325|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
127785062|NCT01131676|459838326|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
127785063|NCT01131676|459838324|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
127785064|NCT01131676|459838325|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
127593705|NCT01652703|459140313|FG003|Overall Study|Other|1|||
127593706|NCT01652703|459140314|FG004|Overall Study|Other|1|||
127593707|NCT01652703|459140315|FG005|Overall Study|Other|1|||
127593708|NCT02155608|459140319|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
127593709|NCT02155608|459140320|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
127593710|NCT02155608|459140319|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
127593711|NCT02155608|459140320|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
127593712|NCT00903695|459140321|FG000|Overall Study|medical exclusion after 1st testing|1|||
127785065|NCT01131676|459838326|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
127593713|NCT00903695|459140322|FG001|Overall Study|medical exclusion after 1st testing|0|||
127593714|NCT00903695|459140321|FG000|Overall Study|lung cancer|1|||
127593715|NCT00903695|459140322|FG001|Overall Study|lung cancer|0|||
127593716|NCT00543140|459140324|FG000|Overall Study|Lost to Follow-up|33|||
128034446|NCT01182350|460753182|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
128034447|NCT01182350|460753183|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
127593717|NCT00543140|459140324|FG000|Overall Study|Withdrawal by Subject|13|||
127593718|NCT00543140|459140324|FG000|Overall Study|Protocol Violation|10|||
127593719|NCT00543140|459140324|FG000|Overall Study|Insufficient weight loss|10|||
127593720|NCT00543140|459140324|FG000|Overall Study|SAE leading to explant of SAGB|3|||
127593721|NCT00543140|459140324|FG000|Overall Study|Death|1|||
127593722|NCT00543140|459140324|FG000|Overall Study|Subject moved|1|||
127593723|NCT00543140|459140324|FG000|Overall Study|Conversion to different procedure|1|||
127593724|NCT04532164|459140327|FG000|Overall Study|Adverse Event|1|||
127593725|NCT04532164|459140327|FG000|Overall Study|Protocol Violation|5|||
127593726|NCT04532164|459140327|FG000|Overall Study|Lost to Follow-up|1|||
127593727|NCT04532164|459140327|FG000|Overall Study|Found to be Ineligible|3|||
127593728|NCT04532164|459140327|FG000|Overall Study|Withdrawal by Subject|14|||
127593729|NCT02599129|459140328|FG000|Overall Study|Lack of Efficacy|2|||
127593730|NCT02599129|459140329|FG001|Overall Study|Lack of Efficacy|2|||
127593731|NCT02599129|459140328|FG000|Overall Study|Lost to Follow-up|1|||
127593732|NCT02599129|459140329|FG001|Overall Study|Lost to Follow-up|0|||
127593733|NCT02599129|459140328|FG000|Overall Study|Withdrawal by Subject|2|||
127593734|NCT02599129|459140329|FG001|Overall Study|Withdrawal by Subject|1|||
127593735|NCT00727025|459140333|FG000|Overall Study|Physician Decision|23|||
127593736|NCT02269241|459140334|FG000|Overall Study|Lost to Follow-up|269|||
127593737|NCT02269241|459140334|FG000|Overall Study|Withdrawal by Subject|155|||
127593738|NCT02269241|459140334|FG000|Overall Study|Protocol Violation|1|||
127593739|NCT02269241|459140334|FG000|Overall Study|Physician Decision|7|||
127593740|NCT02269241|459140334|FG000|Overall Study|Pregnancy|15|||
128034448|NCT01182350|460753184|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
128034449|NCT01182350|460753180|FG000|Overall Study|Unevaluable for Biopsy|0|||
128034450|NCT01182350|460753181|FG001|Overall Study|Unevaluable for Biopsy|0|||
127593741|NCT02269241|459140334|FG000|Overall Study|Wish for pregnancy|5|||
127593742|NCT02269241|459140334|FG000|Overall Study|Development of an exclusion criteria|16|||
127593743|NCT02269241|459140334|FG000|Overall Study|Adverse Event|113|||
127593744|NCT02269241|459140334|FG000|Overall Study|At the specific request of the sponsor|20|||
127593745|NCT02269241|459140334|FG000|Overall Study|Several reasons not classified|53|||
128034451|NCT01182350|460753182|FG002|Overall Study|Unevaluable for Biopsy|0|||
127593746|NCT02269241|459140334|FG000|Overall Study|Screening failures|546|||
127593747|NCT02270957|459140335|FG000|Overall Study|Lack of Efficacy|2|||
127593748|NCT02270957|459140336|FG001|Overall Study|Lack of Efficacy|4|||
127593749|NCT02270957|459140335|FG000|Overall Study|Adverse Event|2|||
127593750|NCT02270957|459140336|FG001|Overall Study|Adverse Event|0|||
127593751|NCT00166114|459140342|FG000|Overall Study|Protocol Violation|2|||
127593752|NCT00166114|459140343|FG001|Overall Study|Protocol Violation|1|||
127593753|NCT00166114|459140342|FG000|Overall Study|Withdrawal by Subject|10|||
127593754|NCT00166114|459140343|FG001|Overall Study|Withdrawal by Subject|4|||
127593755|NCT00166114|459140342|FG000|Overall Study|Adverse Event|2|||
127593756|NCT00166114|459140343|FG001|Overall Study|Adverse Event|1|||
127593757|NCT00545168|459140350|FG000|Overall Study|Lost to Follow-up|5|||
127593758|NCT00545168|459140351|FG001|Overall Study|Lost to Follow-up|5|||
127593759|NCT00545168|459140352|FG002|Overall Study|Lost to Follow-up|5|||
127593760|NCT00545168|459140350|FG000|Overall Study|Withdrawal by Subject|9|||
127593761|NCT00545168|459140351|FG001|Overall Study|Withdrawal by Subject|0|||
127593762|NCT00545168|459140352|FG002|Overall Study|Withdrawal by Subject|13|||
127593763|NCT00545168|459140350|FG000|Overall Study|Protocol Violation|1|||
127593764|NCT00545168|459140351|FG001|Overall Study|Protocol Violation|0|||
127593765|NCT00545168|459140352|FG002|Overall Study|Protocol Violation|1|||
127593766|NCT00545168|459140350|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
127593767|NCT00545168|459140351|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
127593768|NCT00545168|459140352|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
127593769|NCT01218204|459140353|FG000|Part B Washout|Adverse Event|0|||
127593770|NCT01218204|459140354|FG001|Part B Washout|Adverse Event|1|||
127593771|NCT01218204|459140355|FG002|Part B Washout|Adverse Event|0|||
127593772|NCT01218204|459140356|FG003|Part B Washout|Adverse Event|0|||
127593773|NCT01218204|459140353|FG000|Part B Washout|Lost to Follow-up|0|||
127593774|NCT01218204|459140354|FG001|Part B Washout|Lost to Follow-up|2|||
127593775|NCT01218204|459140355|FG002|Part B Washout|Lost to Follow-up|0|||
127593776|NCT01218204|459140356|FG003|Part B Washout|Lost to Follow-up|0|||
127593777|NCT01218204|459140353|FG000|Part B Washout|Physician Decision|0|||
127593778|NCT01218204|459140354|FG001|Part B Washout|Physician Decision|14|||
127593779|NCT01218204|459140355|FG002|Part B Washout|Physician Decision|0|||
127694854|NCT03281291|459512847|FG003|Overall Study|Protocol Deviation|2|||
127593780|NCT01218204|459140356|FG003|Part B Washout|Physician Decision|0|||
127593781|NCT01218204|459140353|FG000|Part B Washout|Withdrawal by Subject|0|||
127593782|NCT01218204|459140354|FG001|Part B Washout|Withdrawal by Subject|14|||
127593783|NCT01218204|459140355|FG002|Part B Washout|Withdrawal by Subject|0|||
127593784|NCT01218204|459140356|FG003|Part B Washout|Withdrawal by Subject|0|||
127593785|NCT01218204|459140353|FG000|Part B Washout|Reached defined stopping criteria|0|||
127593786|NCT01218204|459140354|FG001|Part B Washout|Reached defined stopping criteria|2|||
128034452|NCT01182350|460753183|FG003|Overall Study|Unevaluable for Biopsy|0|||
128034453|NCT01182350|460753184|FG004|Overall Study|Unevaluable for Biopsy|3|||
127593787|NCT01218204|459140355|FG002|Part B Washout|Reached defined stopping criteria|0|||
127785066|NCT01131676|459838324|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
127785067|NCT01131676|459838325|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
127785068|NCT01131676|459838326|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
127785069|NCT02576444|459838327|FG000|Overall Study|Death|1|||
127785070|NCT02576444|459838328|FG001|Overall Study|Death|1|||
127785071|NCT02576444|459838329|FG002|Overall Study|Death|0|||
127785072|NCT02576444|459838330|FG003|Overall Study|Death|0|||
127785073|NCT02576444|459838327|FG000|Overall Study|Withdrawal by Subject|0|||
127785074|NCT02576444|459838328|FG001|Overall Study|Withdrawal by Subject|0|||
127785075|NCT02576444|459838329|FG002|Overall Study|Withdrawal by Subject|2|||
127785076|NCT02576444|459838330|FG003|Overall Study|Withdrawal by Subject|0|||
127785077|NCT02576444|459838327|FG000|Overall Study|Adverse Event|0|||
127785078|NCT02576444|459838328|FG001|Overall Study|Adverse Event|0|||
127785079|NCT02576444|459838329|FG002|Overall Study|Adverse Event|1|||
127785080|NCT02576444|459838330|FG003|Overall Study|Adverse Event|0|||
127785081|NCT02576444|459838327|FG000|Overall Study|Physician Decision|0|||
127785082|NCT02576444|459838328|FG001|Overall Study|Physician Decision|0|||
127785083|NCT02576444|459838329|FG002|Overall Study|Physician Decision|1|||
127785084|NCT02576444|459838330|FG003|Overall Study|Physician Decision|0|||
127785085|NCT00829179|459838334|FG000|Overall Study|Withdrawal by Subject|1|||
127785086|NCT03000179|459838335|FG000|Overall Study|Lost to Follow-up|2|||
127785087|NCT02343159|459838336|FG000|Overall Study|Early Study Termination|16|||
127785088|NCT02343159|459838337|FG001|Overall Study|Early Study Termination|19|||
127785089|NCT02343159|459838338|FG002|Overall Study|Early Study Termination|23|||
127785090|NCT02343159|459838336|FG000|Overall Study|Physician Decision|2|||
127785091|NCT02343159|459838337|FG001|Overall Study|Physician Decision|0|||
127785092|NCT02343159|459838338|FG002|Overall Study|Physician Decision|1|||
127785093|NCT02343159|459838336|FG000|Overall Study|Withdrawal by Subject|3|||
127785094|NCT02343159|459838337|FG001|Overall Study|Withdrawal by Subject|0|||
127785095|NCT02343159|459838338|FG002|Overall Study|Withdrawal by Subject|2|||
127785096|NCT02343159|459838336|FG000|Overall Study|Lost to Follow-up|0|||
127785097|NCT02343159|459838337|FG001|Overall Study|Lost to Follow-up|2|||
127785098|NCT02343159|459838338|FG002|Overall Study|Lost to Follow-up|2|||
127785099|NCT02343159|459838336|FG000|Overall Study|Adverse Event|4|||
127785100|NCT02343159|459838337|FG001|Overall Study|Adverse Event|4|||
127785101|NCT02343159|459838338|FG002|Overall Study|Adverse Event|2|||
127785102|NCT02343159|459838336|FG000|Overall Study|Sponsor Decision|0|||
127785103|NCT02343159|459838337|FG001|Overall Study|Sponsor Decision|1|||
127785104|NCT02343159|459838338|FG002|Overall Study|Sponsor Decision|0|||
127785105|NCT02343159|459838336|FG000|Overall Study|Enrollment Error|1|||
127785106|NCT02343159|459838337|FG001|Overall Study|Enrollment Error|0|||
127785107|NCT02343159|459838338|FG002|Overall Study|Enrollment Error|0|||
127785108|NCT01075412|459838344|FG000|Overall Study|Withdrawal by Subject|0|||
127785109|NCT01075412|459838345|FG001|Overall Study|Withdrawal by Subject|1|||
127785110|NCT00865904|459838348|FG000|Overall Study|Randomized but not Treated|2|||
127785111|NCT00865904|459838349|FG001|Overall Study|Randomized but not Treated|0|||
127785112|NCT00865904|459838350|FG002|Overall Study|Randomized but not Treated|0|||
127785113|NCT00865904|459838351|FG003|Overall Study|Randomized but not Treated|1|||
127785114|NCT00865904|459838352|FG004|Overall Study|Randomized but not Treated|1|||
127593788|NCT01218204|459140356|FG003|Part B Washout|Reached defined stopping criteria|0|||
127593789|NCT01218204|459140353|FG000|Part B Washout|Did not meet continuation criteria|0|||
127593790|NCT01218204|459140354|FG001|Part B Washout|Did not meet continuation criteria|112|||
127593791|NCT01218204|459140355|FG002|Part B Washout|Did not meet continuation criteria|0|||
127593792|NCT01218204|459140356|FG003|Part B Washout|Did not meet continuation criteria|0|||
127593793|NCT01218204|459140353|FG000|Part B Run-in|Adverse Event|0|||
127593794|NCT01218204|459140354|FG001|Part B Run-in|Adverse Event|0|||
127593795|NCT01218204|459140355|FG002|Part B Run-in|Adverse Event|1|||
127593796|NCT01218204|459140356|FG003|Part B Run-in|Adverse Event|0|||
127593797|NCT01218204|459140353|FG000|Part B Run-in|Protocol Violation|0|||
127593798|NCT01218204|459140354|FG001|Part B Run-in|Protocol Violation|0|||
127593799|NCT01218204|459140355|FG002|Part B Run-in|Protocol Violation|2|||
127593800|NCT01218204|459140356|FG003|Part B Run-in|Protocol Violation|0|||
127593801|NCT01218204|459140353|FG000|Part B Run-in|Withdrawal by Subject|0|||
127785115|NCT03625687|459838353|FG000|Overall Study|Death|1|||
127785116|NCT00711425|459838358|FG000|Overall Study|Protocol Violation|1|||
127785117|NCT00711425|459838358|FG000|Overall Study|Death|2|||
127785118|NCT00711425|459838358|FG000|Overall Study|Lost to Follow-up|1|||
127785119|NCT04607148|459838359|FG000|Overall Study|Withdrawal by Subject|0|||
127785120|NCT04607148|459838360|FG001|Overall Study|Withdrawal by Subject|4|||
128034454|NCT03898180|460753185|FG000|Overall Study|Death|178|||
127593802|NCT01218204|459140354|FG001|Part B Run-in|Withdrawal by Subject|0|||
127593803|NCT01218204|459140355|FG002|Part B Run-in|Withdrawal by Subject|3|||
127785121|NCT04607148|459838361|FG002|Overall Study|Withdrawal by Subject|2|||
127785122|NCT04607148|459838362|FG003|Overall Study|Withdrawal by Subject|8|||
127694855|NCT03281291|459512848|FG004|Overall Study|Protocol Deviation|1|||
127694856|NCT03281291|459512844|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
127694857|NCT03281291|459512845|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
127694858|NCT03281291|459512846|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
127694859|NCT03281291|459512847|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
127694860|NCT03281291|459512848|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
127694861|NCT03281291|459512844|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
127694862|NCT03281291|459512845|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
127694863|NCT03281291|459512846|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
127694864|NCT03281291|459512847|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
127694865|NCT03281291|459512848|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
127694866|NCT03281291|459512844|FG000|Overall Study|Lost to Follow-up|10|||
127694867|NCT03281291|459512845|FG001|Overall Study|Lost to Follow-up|10|||
127694868|NCT03281291|459512846|FG002|Overall Study|Lost to Follow-up|4|||
127694869|NCT03281291|459512847|FG003|Overall Study|Lost to Follow-up|6|||
127694870|NCT03281291|459512848|FG004|Overall Study|Lost to Follow-up|10|||
127694871|NCT03281291|459512844|FG000|Overall Study|Other|0|||
127694872|NCT03281291|459512845|FG001|Overall Study|Other|2|||
127694873|NCT03281291|459512846|FG002|Overall Study|Other|0|||
127694874|NCT03281291|459512847|FG003|Overall Study|Other|2|||
127694875|NCT03281291|459512848|FG004|Overall Study|Other|1|||
127694876|NCT00512070|459512851|FG000|Phase I - Olanzapine Only|Lost to Follow-up|4|||
127694877|NCT00512070|459512852|FG001|Phase I - Olanzapine Only|Lost to Follow-up|0|||
127694878|NCT00512070|459512853|FG002|Phase I - Olanzapine Only|Lost to Follow-up|0|||
127694879|NCT00512070|459512851|FG000|Phase II - Randomization to Melatonin|Data unable to be collected|0|||
127694880|NCT00512070|459512852|FG001|Phase II - Randomization to Melatonin|Data unable to be collected|2|||
127694881|NCT00512070|459512853|FG002|Phase II - Randomization to Melatonin|Data unable to be collected|1|||
127694882|NCT00961571|459512854|FG000|Overall Study|Physician Decision|39|||
127694883|NCT02530671|459512860|FG000|Overall Study|Lost to Follow-up|2|||
127694884|NCT02530671|459512861|FG001|Overall Study|Lost to Follow-up|0|||
127694885|NCT02530671|459512860|FG000|Overall Study|Withdrawal by Subject|1|||
127694886|NCT02530671|459512861|FG001|Overall Study|Withdrawal by Subject|0|||
127694887|NCT04390048|459512867|FG000|Overall Study|Withdrawal by Subject|1|||
127694888|NCT04390048|459512868|FG001|Overall Study|Withdrawal by Subject|3|||
127694889|NCT01415154|459512869|FG000|Overall Study|Lack of Efficacy|4|||
127694890|NCT01415154|459512870|FG001|Overall Study|Lack of Efficacy|5|||
127694891|NCT01415154|459512869|FG000|Overall Study|Withdrawal by Subject|7|||
127694892|NCT01415154|459512870|FG001|Overall Study|Withdrawal by Subject|8|||
127694893|NCT01415154|459512869|FG000|Overall Study|Lost to Follow-up|1|||
127694894|NCT01415154|459512870|FG001|Overall Study|Lost to Follow-up|4|||
127694895|NCT01415154|459512869|FG000|Overall Study|Protocol Violation|0|||
127694896|NCT01415154|459512870|FG001|Overall Study|Protocol Violation|1|||
127694897|NCT01415154|459512869|FG000|Overall Study|Satisfactory Response|0|||
127694898|NCT01415154|459512870|FG001|Overall Study|Satisfactory Response|1|||
127785123|NCT04607148|459838359|FG000|Overall Study|Study Terminated by Sponsor|14|||
127785124|NCT04607148|459838360|FG001|Overall Study|Study Terminated by Sponsor|59|||
127785125|NCT04607148|459838361|FG002|Overall Study|Study Terminated by Sponsor|9|||
127785126|NCT04607148|459838362|FG003|Overall Study|Study Terminated by Sponsor|39|||
127785127|NCT04607148|459838359|FG000|Overall Study|Sponsor Decision|0|||
127785128|NCT04607148|459838360|FG001|Overall Study|Sponsor Decision|0|||
127785129|NCT04607148|459838361|FG002|Overall Study|Sponsor Decision|1|||
127785130|NCT04607148|459838362|FG003|Overall Study|Sponsor Decision|0|||
127785131|NCT04607148|459838359|FG000|Overall Study|Non-Compliance With Study Drug|0|||
127785132|NCT04607148|459838360|FG001|Overall Study|Non-Compliance With Study Drug|1|||
127785133|NCT04607148|459838361|FG002|Overall Study|Non-Compliance With Study Drug|0|||
127785134|NCT04607148|459838362|FG003|Overall Study|Non-Compliance With Study Drug|0|||
127785135|NCT04607148|459838359|FG000|Overall Study|Lost to Follow-up|0|||
127785136|NCT04607148|459838360|FG001|Overall Study|Lost to Follow-up|2|||
128034455|NCT03898180|460753186|FG001|Overall Study|Death|173|||
128034456|NCT03898180|460753185|FG000|Overall Study|Physician Decision|1|||
128034457|NCT03898180|460753186|FG001|Overall Study|Physician Decision|0|||
127785137|NCT04607148|459838361|FG002|Overall Study|Lost to Follow-up|0|||
127785138|NCT04607148|459838362|FG003|Overall Study|Lost to Follow-up|0|||
127785139|NCT04607148|459838359|FG000|Overall Study|Death|0|||
127785140|NCT04607148|459838360|FG001|Overall Study|Death|3|||
127785141|NCT04607148|459838361|FG002|Overall Study|Death|0|||
127785142|NCT04607148|459838362|FG003|Overall Study|Death|1|||
127694899|NCT01415154|459512869|FG000|Overall Study|Adverse Event|1|||
127694900|NCT01415154|459512870|FG001|Overall Study|Adverse Event|1|||
127694901|NCT03126019|459512871|FG000|Overall Study|Death|5|||
127694902|NCT03126019|459512872|FG001|Overall Study|Death|27|||
127694903|NCT03126019|459512871|FG000|Overall Study|Lost to Follow-up|2|||
127785143|NCT04607148|459838359|FG000|Overall Study|Adverse Event|0|||
127785144|NCT04607148|459838360|FG001|Overall Study|Adverse Event|1|||
128034458|NCT03898180|460753185|FG000|Overall Study|Sponsor Decision|3|||
127593804|NCT01218204|459140356|FG003|Part B Run-in|Withdrawal by Subject|0|||
127593805|NCT01218204|459140353|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
127593806|NCT01218204|459140354|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
127593807|NCT01218204|459140355|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
127593808|NCT01218204|459140356|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
127593809|NCT01218204|459140353|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
127593810|NCT01218204|459140354|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
127593811|NCT01218204|459140355|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
127785145|NCT04607148|459838361|FG002|Overall Study|Adverse Event|0|||
127785146|NCT04607148|459838362|FG003|Overall Study|Adverse Event|0|||
127785147|NCT00916149|459838363|FG000|Overall Study|Lost to Follow-up|3|||
127785148|NCT00916149|459838364|FG001|Overall Study|Lost to Follow-up|2|||
127785149|NCT00916149|459838365|FG002|Overall Study|Lost to Follow-up|0|||
127785150|NCT00916149|459838363|FG000|Overall Study|Unable to place scalp EEG leads|1|||
127785151|NCT00916149|459838364|FG001|Overall Study|Unable to place scalp EEG leads|0|||
127785152|NCT00916149|459838365|FG002|Overall Study|Unable to place scalp EEG leads|0|||
127785153|NCT00589420|459838366|FG000|Overall Study|screen failure|1|||
127785154|NCT00912028|459838367|FG000|Overall Study|Lost to Follow-up|2|||
127785155|NCT00912028|459838368|FG001|Overall Study|Lost to Follow-up|3|||
127785156|NCT00912028|459838369|FG002|Overall Study|Lost to Follow-up|0|||
127785157|NCT00912028|459838370|FG003|Overall Study|Lost to Follow-up|1|||
127785158|NCT00912028|459838371|FG004|Overall Study|Lost to Follow-up|3|||
127785159|NCT00912028|459838367|FG000|Overall Study|Withdrawal by Subject|3|||
127785160|NCT00912028|459838368|FG001|Overall Study|Withdrawal by Subject|0|||
127785161|NCT00912028|459838369|FG002|Overall Study|Withdrawal by Subject|0|||
127785162|NCT00912028|459838370|FG003|Overall Study|Withdrawal by Subject|0|||
127785163|NCT00912028|459838371|FG004|Overall Study|Withdrawal by Subject|0|||
127785164|NCT01940471|459838372|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
127785165|NCT01940471|459838373|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
127785166|NCT01940471|459838374|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
127785167|NCT01940471|459838375|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
127785168|NCT01940471|459838372|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
127785169|NCT01940471|459838373|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
127785170|NCT01940471|459838374|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
127785171|NCT01940471|459838375|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
127785172|NCT01940471|459838372|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
127785173|NCT01940471|459838373|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
127785174|NCT01940471|459838374|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
127785175|NCT01940471|459838375|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
127785176|NCT01940471|459838372|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
127785177|NCT01940471|459838373|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
127785178|NCT01940471|459838374|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
127785179|NCT01940471|459838375|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
127785180|NCT01940471|459838372|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
127785181|NCT01940471|459838373|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
127785182|NCT01940471|459838374|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
127785183|NCT01940471|459838375|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
127785184|NCT01940471|459838372|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
127785185|NCT01940471|459838373|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
127785186|NCT01940471|459838374|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
127785187|NCT01940471|459838375|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
127785188|NCT01940471|459838372|FG000|Period 1: Double-blind Phase|Death|2|||
127785189|NCT01940471|459838373|FG001|Period 1: Double-blind Phase|Death|1|||
127785190|NCT01940471|459838374|FG002|Period 1: Double-blind Phase|Death|0|||
127785191|NCT01940471|459838375|FG003|Period 1: Double-blind Phase|Death|0|||
127785192|NCT01940471|459838372|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
127785193|NCT01940471|459838373|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
127785194|NCT01940471|459838374|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
127785195|NCT01940471|459838375|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
127785196|NCT01940471|459838372|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
127785197|NCT01940471|459838373|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
127785198|NCT01940471|459838374|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
127785199|NCT01940471|459838375|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
127785200|NCT01940471|459838372|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
127785201|NCT01940471|459838373|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
127593812|NCT01218204|459140356|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
127593813|NCT00127660|459140357|FG000|Overall Study|Protocol Violation|3|||
127593814|NCT00127660|459140358|FG001|Overall Study|Protocol Violation|3|||
127882072|NCT01289990|460190802|FG009|Overall Study|discontinued in preceding trial|21|||
127882073|NCT01289990|460190803|FG010|Overall Study|discontinued in preceding trial|17|||
127882074|NCT01289990|460190804|FG011|Overall Study|discontinued in preceding trial|17|||
127882075|NCT01289990|460190805|FG012|Overall Study|discontinued in preceding trial|24|||
127882076|NCT01289990|460190793|FG000|Overall Study|did not continue in extension|41|||
127882077|NCT01289990|460190794|FG001|Overall Study|did not continue in extension|45|||
127882078|NCT01289990|460190795|FG002|Overall Study|did not continue in extension|51|||
127882079|NCT01289990|460190796|FG003|Overall Study|did not continue in extension|51|||
127882080|NCT01289990|460190797|FG004|Overall Study|did not continue in extension|48|||
127882081|NCT01289990|460190798|FG005|Overall Study|did not continue in extension|50|||
127882082|NCT01289990|460190799|FG006|Overall Study|did not continue in extension|54|||
127882083|NCT01289990|460190800|FG007|Overall Study|did not continue in extension|36|||
127882084|NCT01289990|460190801|FG008|Overall Study|did not continue in extension|44|||
127882085|NCT01289990|460190802|FG009|Overall Study|did not continue in extension|48|||
127882086|NCT01289990|460190803|FG010|Overall Study|did not continue in extension|45|||
127882087|NCT01289990|460190804|FG011|Overall Study|did not continue in extension|34|||
127882088|NCT01289990|460190805|FG012|Overall Study|did not continue in extension|56|||
127882089|NCT01289990|460190793|FG000|Overall Study|Not treated|0|||
127882090|NCT01289990|460190794|FG001|Overall Study|Not treated|0|||
127882091|NCT01289990|460190795|FG002|Overall Study|Not treated|0|||
127882092|NCT01289990|460190796|FG003|Overall Study|Not treated|0|||
127882093|NCT01289990|460190797|FG004|Overall Study|Not treated|0|||
127882094|NCT01289990|460190798|FG005|Overall Study|Not treated|0|||
127882095|NCT01289990|460190799|FG006|Overall Study|Not treated|1|||
127882096|NCT01289990|460190800|FG007|Overall Study|Not treated|0|||
127882097|NCT01289990|460190801|FG008|Overall Study|Not treated|1|||
127882098|NCT01289990|460190802|FG009|Overall Study|Not treated|0|||
127882099|NCT01289990|460190803|FG010|Overall Study|Not treated|1|||
127882100|NCT01289990|460190804|FG011|Overall Study|Not treated|2|||
127882101|NCT01289990|460190805|FG012|Overall Study|Not treated|0|||
127882102|NCT00683904|460190806|FG000|Dose Level 1|Disease progression|2|||
127882103|NCT00683904|460190807|FG001|Dose Level 1|Disease progression|0|||
127882104|NCT00683904|460190806|FG000|Dose Level 1|Adverse Event|1|||
127882105|NCT00683904|460190807|FG001|Dose Level 1|Adverse Event|0|||
127882106|NCT00683904|460190806|FG000|Dose Level 2|Adverse Event|0|||
127882107|NCT00683904|460190807|FG001|Dose Level 2|Adverse Event|2|||
127882108|NCT01488071|460190808|FG000|Overall Study|Adverse Event|15|||
127882109|NCT01488071|460190809|FG001|Overall Study|Adverse Event|23|||
127882110|NCT01488071|460190808|FG000|Overall Study|Lack of Efficacy|11|||
127882111|NCT01488071|460190809|FG001|Overall Study|Lack of Efficacy|17|||
127882112|NCT01488071|460190808|FG000|Overall Study|Non-compliance with study drug|2|||
127882113|NCT01488071|460190809|FG001|Overall Study|Non-compliance with study drug|0|||
127882114|NCT01488071|460190808|FG000|Overall Study|Protocol Violation|5|||
127882115|NCT01488071|460190809|FG001|Overall Study|Protocol Violation|7|||
127593815|NCT00127660|459140359|FG002|Overall Study|Protocol Violation|5|||
127593816|NCT00127660|459140360|FG003|Overall Study|Protocol Violation|0|||
127593817|NCT01987505|459140361|FG000|Overall Study|Other|9|||
127593818|NCT01987505|459140361|FG000|Overall Study|Withdrawal by Subject|2|||
127593819|NCT01987505|459140361|FG000|Overall Study|Other Reason|2|||
127593820|NCT01987505|459140361|FG000|Overall Study|Lost to Follow-up|15|||
127593821|NCT01987505|459140361|FG000|Overall Study|Investigator Decision|2|||
127593822|NCT01987505|459140361|FG000|Overall Study|Death|4|||
127593823|NCT00489541|459140362|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
127593824|NCT00489541|459140363|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
127593825|NCT00489541|459140362|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
127593826|NCT00489541|459140363|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
127593827|NCT00489541|459140362|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
127593828|NCT00489541|459140363|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
127593829|NCT00489541|459140362|FG000|12-Month Clinical Follow-up|Death|3|||
127593830|NCT00489541|459140363|FG001|12-Month Clinical Follow-up|Death|2|||
127593831|NCT00489541|459140362|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
127593832|NCT00489541|459140363|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
127882116|NCT01488071|460190808|FG000|Overall Study|Withdrawal of Consent|14|||
127882117|NCT01488071|460190809|FG001|Overall Study|Withdrawal of Consent|12|||
127593833|NCT00489541|459140362|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
127593834|NCT00489541|459140363|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
127882118|NCT01488071|460190808|FG000|Overall Study|Lost to Follow-up|1|||
127882119|NCT01488071|460190809|FG001|Overall Study|Lost to Follow-up|0|||
127593835|NCT05131646|459140364|FG000|Overall Study|Withdrawal by Subject|1|||
127593836|NCT05131646|459140365|FG001|Overall Study|Withdrawal by Subject|0|||
127882120|NCT01488071|460190808|FG000|Overall Study|Administrative or Other Reason(s)|5|||
127882121|NCT01488071|460190809|FG001|Overall Study|Administrative or Other Reason(s)|4|||
127882122|NCT02587325|460190810|FG000|16-Week Dose-finding Safety Part|Adverse Event|1|||
127882123|NCT02587325|460190811|FG001|16-Week Dose-finding Safety Part|Adverse Event|0|||
127882124|NCT02587325|460190812|FG002|16-Week Dose-finding Safety Part|Adverse Event|0|||
127882125|NCT02587325|460190813|FG003|16-Week Dose-finding Safety Part|Adverse Event|0|||
127694904|NCT03126019|459512872|FG001|Overall Study|Lost to Follow-up|4|||
127694905|NCT03126019|459512871|FG000|Overall Study|Withdrawal by Subject|1|||
127694906|NCT03126019|459512872|FG001|Overall Study|Withdrawal by Subject|9|||
127694907|NCT03126019|459512871|FG000|Overall Study|Physician Decision|1|||
127694908|NCT03126019|459512872|FG001|Overall Study|Physician Decision|0|||
127694909|NCT03126019|459512871|FG000|Overall Study|Transitioned to Rollover Study|0|||
127694910|NCT03126019|459512872|FG001|Overall Study|Transitioned to Rollover Study|11|||
127694911|NCT03126019|459512871|FG000|Overall Study|Did Not Return to Site for Care|0|||
127694912|NCT03126019|459512872|FG001|Overall Study|Did Not Return to Site for Care|1|||
127694913|NCT03126019|459512871|FG000|Overall Study|Site Closed|0|||
127694914|NCT03126019|459512872|FG001|Overall Study|Site Closed|1|||
127694915|NCT04556656|459512875|FG000|Overall Study|Withdrawal by Subject|14|||
127694916|NCT04556656|459512876|FG001|Overall Study|Withdrawal by Subject|12|||
127694917|NCT04556656|459512875|FG000|Overall Study|Physician Decision|1|||
127694918|NCT04556656|459512876|FG001|Overall Study|Physician Decision|0|||
127694919|NCT04556656|459512875|FG000|Overall Study|Adverse Event|4|||
127694920|NCT04556656|459512876|FG001|Overall Study|Adverse Event|7|||
127694921|NCT04556656|459512875|FG000|Overall Study|Death|4|||
127694922|NCT04556656|459512876|FG001|Overall Study|Death|0|||
127694923|NCT04556656|459512875|FG000|Overall Study|Lost to Follow-up|3|||
127694924|NCT04556656|459512876|FG001|Overall Study|Lost to Follow-up|2|||
127694925|NCT04556656|459512875|FG000|Overall Study|Not further specified|2|||
127694926|NCT04556656|459512876|FG001|Overall Study|Not further specified|1|||
127694927|NCT03138512|459512886|FG000|Randomization|Participants withdrew consent|0|||
127694928|NCT03138512|459512887|FG001|Randomization|Participants withdrew consent|1|||
127694929|NCT03138512|459512888|FG002|Randomization|Participants withdrew consent|1|||
127694930|NCT03138512|459512889|FG003|Randomization|Participants withdrew consent|0|||
128034459|NCT03898180|460753186|FG001|Overall Study|Sponsor Decision|0|||
128034460|NCT03898180|460753185|FG000|Overall Study|Lost to Follow-up|1|||
127694931|NCT03138512|459512890|FG004|Randomization|Participants withdrew consent|0|||
127694932|NCT03138512|459512886|FG000|Randomization|Participant no longer meets study criteria|0|||
127694933|NCT03138512|459512887|FG001|Randomization|Participant no longer meets study criteria|3|||
127694934|NCT03138512|459512888|FG002|Randomization|Participant no longer meets study criteria|1|||
127694935|NCT03138512|459512889|FG003|Randomization|Participant no longer meets study criteria|1|||
127694936|NCT03138512|459512890|FG004|Randomization|Participant no longer meets study criteria|3|||
127694937|NCT03138512|459512886|FG000|Randomization|Other reasons|1|||
127694938|NCT03138512|459512887|FG001|Randomization|Other reasons|0|||
127694939|NCT03138512|459512888|FG002|Randomization|Other reasons|0|||
127694940|NCT03138512|459512889|FG003|Randomization|Other reasons|0|||
127694941|NCT03138512|459512890|FG004|Randomization|Other reasons|0|||
127694942|NCT03138512|459512886|FG000|Treatment Part A|Disease recurrence|10|||
127785202|NCT01940471|459838374|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
127785203|NCT01940471|459838375|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
127785204|NCT01940471|459838372|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
127785205|NCT01940471|459838373|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
127785206|NCT01940471|459838374|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
127785207|NCT01940471|459838375|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
127785208|NCT01940471|459838372|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
127785209|NCT01940471|459838373|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
127785210|NCT01940471|459838374|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
127785211|NCT01940471|459838375|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
127785212|NCT01940471|459838372|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
127785213|NCT01940471|459838373|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
127785214|NCT01940471|459838374|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
127785215|NCT01940471|459838375|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
127785216|NCT01940471|459838372|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
128034461|NCT03898180|460753186|FG001|Overall Study|Lost to Follow-up|0|||
128034462|NCT03898180|460753185|FG000|Overall Study|Withdrawal by Subject|5|||
128034463|NCT03898180|460753186|FG001|Overall Study|Withdrawal by Subject|4|||
127694943|NCT03138512|459512887|FG001|Treatment Part A|Disease recurrence|20|||
127694944|NCT03138512|459512888|FG002|Treatment Part A|Disease recurrence|0|||
127694945|NCT03138512|459512889|FG003|Treatment Part A|Disease recurrence|0|||
127694946|NCT03138512|459512890|FG004|Treatment Part A|Disease recurrence|0|||
127694947|NCT03138512|459512886|FG000|Treatment Part A|Study Drug Toxicity|132|||
127694948|NCT03138512|459512887|FG001|Treatment Part A|Study Drug Toxicity|5|||
127694949|NCT03138512|459512888|FG002|Treatment Part A|Study Drug Toxicity|0|||
128034464|NCT01646827|460753187|FG000|Overall Study|Lost to Follow-up|0|||
128034465|NCT01646827|460753188|FG001|Overall Study|Lost to Follow-up|3|||
127694950|NCT03138512|459512889|FG003|Treatment Part A|Study Drug Toxicity|0|||
127694951|NCT03138512|459512890|FG004|Treatment Part A|Study Drug Toxicity|0|||
127694952|NCT03138512|459512886|FG000|Treatment Part A|Death|1|||
127694953|NCT03138512|459512887|FG001|Treatment Part A|Death|0|||
127694954|NCT03138512|459512888|FG002|Treatment Part A|Death|0|||
127694955|NCT03138512|459512889|FG003|Treatment Part A|Death|0|||
127694956|NCT03138512|459512890|FG004|Treatment Part A|Death|0|||
127593837|NCT05131646|459140366|FG002|Overall Study|Withdrawal by Subject|0|||
127593838|NCT03266107|459140367|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
127593839|NCT03266107|459140367|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
127593840|NCT03266107|459140367|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
127593841|NCT03266107|459140367|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
127593842|NCT01191801|459140372|FG000|Overall Study|Death|36|||
127593843|NCT01191801|459140373|FG001|Overall Study|Death|12|||
127593844|NCT01191801|459140372|FG000|Overall Study|Lack of Efficacy|176|||
127593845|NCT01191801|459140373|FG001|Overall Study|Lack of Efficacy|258|||
127593846|NCT01191801|459140372|FG000|Overall Study|Adverse Event|9|||
127593847|NCT01191801|459140373|FG001|Overall Study|Adverse Event|8|||
127593848|NCT01191801|459140372|FG000|Overall Study|Protocol Violation|2|||
127593849|NCT01191801|459140373|FG001|Overall Study|Protocol Violation|4|||
127593850|NCT01191801|459140372|FG000|Overall Study|Physician Decision|47|||
127593851|NCT01191801|459140373|FG001|Overall Study|Physician Decision|24|||
127593852|NCT01191801|459140372|FG000|Overall Study|Withdrawal by Subject|1|||
127593853|NCT01191801|459140373|FG001|Overall Study|Withdrawal by Subject|4|||
127593854|NCT01191801|459140372|FG000|Overall Study|Not Provided|45|||
127593855|NCT01191801|459140373|FG001|Overall Study|Not Provided|27|||
127593856|NCT05147350|459140381|FG000|Overall Study|Death|2|||
127785217|NCT01940471|459838373|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
127785218|NCT01940471|459838374|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
127785219|NCT01940471|459838375|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
127785220|NCT01940471|459838372|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
127785221|NCT01940471|459838373|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
127785222|NCT01940471|459838374|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
127785223|NCT01940471|459838375|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
127785224|NCT01940471|459838372|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
127785225|NCT01940471|459838373|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
127785226|NCT01940471|459838374|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
127785227|NCT01940471|459838375|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
127785228|NCT01940471|459838372|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
127785229|NCT01940471|459838373|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
127785230|NCT01940471|459838374|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
127785231|NCT01940471|459838375|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
127785232|NCT01940471|459838372|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
127785233|NCT01940471|459838373|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
127785234|NCT01940471|459838374|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
127785235|NCT01940471|459838375|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
127785236|NCT01940471|459838372|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
127785237|NCT01940471|459838373|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
127785238|NCT01940471|459838374|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
127785239|NCT01940471|459838375|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
127785240|NCT01940471|459838372|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
127785241|NCT01940471|459838373|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
127785242|NCT01940471|459838374|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
127785243|NCT01940471|459838375|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
127785244|NCT01940471|459838372|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
127785245|NCT01940471|459838373|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
127785246|NCT01940471|459838374|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
127785247|NCT01940471|459838375|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
127785248|NCT01846624|459838380|FG000|Overall Study|Died during induction, no midostaurin|1|||
127785249|NCT03574753|459838381|FG000|Overall Study|Adverse Event|3|||
127785250|NCT03574753|459838381|FG000|Overall Study|Progression/relapse|19|||
127785251|NCT03574753|459838381|FG000|Overall Study|Death|1|||
127785252|NCT01744665|459838384|FG000|Monitoring Phase|Adverse Event|4|||
127785253|NCT01744665|459838384|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
127593857|NCT05147350|459140382|FG001|Overall Study|Death|3|||
127593858|NCT05147350|459140383|FG002|Overall Study|Death|3|||
127593859|NCT05147350|459140384|FG003|Overall Study|Death|2|||
127593860|NCT05147350|459140385|FG004|Overall Study|Death|2|||
127593861|NCT05147350|459140386|FG005|Overall Study|Death|1|||
127593862|NCT05147350|459140387|FG006|Overall Study|Death|1|||
127593863|NCT05147350|459140388|FG007|Overall Study|Death|3|||
127593864|NCT05147350|459140381|FG000|Overall Study|Sponsor Decision to Terminate Study|0|||
127593865|NCT05147350|459140382|FG001|Overall Study|Sponsor Decision to Terminate Study|0|||
127593866|NCT05147350|459140383|FG002|Overall Study|Sponsor Decision to Terminate Study|1|||
127593867|NCT05147350|459140384|FG003|Overall Study|Sponsor Decision to Terminate Study|0|||
127593868|NCT05147350|459140385|FG004|Overall Study|Sponsor Decision to Terminate Study|4|||
127593869|NCT05147350|459140386|FG005|Overall Study|Sponsor Decision to Terminate Study|0|||
127593870|NCT05147350|459140387|FG006|Overall Study|Sponsor Decision to Terminate Study|0|||
127593871|NCT05147350|459140388|FG007|Overall Study|Sponsor Decision to Terminate Study|1|||
127593872|NCT05147350|459140381|FG000|Overall Study|Withdrawal by Subject|0|||
127593873|NCT05147350|459140382|FG001|Overall Study|Withdrawal by Subject|0|||
127593874|NCT05147350|459140383|FG002|Overall Study|Withdrawal by Subject|3|||
127593875|NCT05147350|459140384|FG003|Overall Study|Withdrawal by Subject|1|||
127593876|NCT05147350|459140385|FG004|Overall Study|Withdrawal by Subject|1|||
127593877|NCT05147350|459140386|FG005|Overall Study|Withdrawal by Subject|0|||
127593878|NCT05147350|459140387|FG006|Overall Study|Withdrawal by Subject|1|||
127593879|NCT05147350|459140388|FG007|Overall Study|Withdrawal by Subject|0|||
127593880|NCT05147350|459140381|FG000|Overall Study|Other Reasons|0|||
127593881|NCT05147350|459140382|FG001|Overall Study|Other Reasons|0|||
127593882|NCT05147350|459140383|FG002|Overall Study|Other Reasons|2|||
127593883|NCT05147350|459140384|FG003|Overall Study|Other Reasons|0|||
127593884|NCT05147350|459140385|FG004|Overall Study|Other Reasons|0|||
127593885|NCT05147350|459140386|FG005|Overall Study|Other Reasons|2|||
127593886|NCT05147350|459140387|FG006|Overall Study|Other Reasons|1|||
127593887|NCT05147350|459140388|FG007|Overall Study|Other Reasons|1|||
127593888|NCT01192516|459140393|FG000|Overall Study|Lost to Follow-up|7|||
127593889|NCT01192516|459140394|FG001|Overall Study|Lost to Follow-up|10|||
127593890|NCT01192516|459140395|FG002|Overall Study|Lost to Follow-up|7|||
127593891|NCT01192516|459140393|FG000|Overall Study|Withdrawal by Subject|4|||
127593892|NCT01192516|459140394|FG001|Overall Study|Withdrawal by Subject|4|||
127593893|NCT01192516|459140395|FG002|Overall Study|Withdrawal by Subject|1|||
127593894|NCT01192516|459140393|FG000|Overall Study|started new treatment|5|||
127593895|NCT01192516|459140394|FG001|Overall Study|started new treatment|1|||
127593896|NCT01192516|459140395|FG002|Overall Study|started new treatment|0|||
127593897|NCT01192516|459140393|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
127593898|NCT01192516|459140394|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
127593899|NCT01192516|459140395|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
127593900|NCT01256008|459140396|FG000|Overall Study|Lost to Follow-up|6|||
127593901|NCT01256008|459140397|FG001|Overall Study|Lost to Follow-up|4|||
127593902|NCT01256008|459140398|FG002|Overall Study|Lost to Follow-up|11|||
127593903|NCT01256008|459140396|FG000|Overall Study|Withdrawal by Subject|2|||
127593904|NCT01256008|459140397|FG001|Overall Study|Withdrawal by Subject|3|||
127593905|NCT01256008|459140398|FG002|Overall Study|Withdrawal by Subject|10|||
127593906|NCT05228132|459140401|FG000|Overall Study|Investigation Early Termination by Sponsor|2|||
127593907|NCT05228132|459140401|FG000|Overall Study|Adverse Event|3|||
127593908|NCT05228132|459140401|FG000|Overall Study|Lost to Follow-up|1|||
127593909|NCT05228132|459140401|FG000|Overall Study|Arteriovenous-fistula mature|1|||
127593910|NCT01336764|459140402|FG000|Overall Study|Withdrawal by Subject|5|||
127593911|NCT01336764|459140403|FG001|Overall Study|Withdrawal by Subject|5|||
127593912|NCT00730132|459140404|FG000|Overall Study|Protocol Violation|154|||
127593913|NCT00730132|459140404|FG000|Overall Study|Death|1|||
127593914|NCT01626391|459140405|FG000|Overall Study|Physician Decision|1|||
127593915|NCT01626391|459140406|FG001|Overall Study|Physician Decision|0|||
127593916|NCT01626391|459140405|FG000|Overall Study|Withdrawal by Subject|1|||
127785254|NCT01744665|459838384|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
127785255|NCT01744665|459838384|FG000|Monitoring Phase|Withdrawal by Subject|5|||
127785256|NCT01744665|459838384|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
127785257|NCT01744665|459838384|FG000|Consolidation Phase|Adverse Event|2|||
127785258|NCT01744665|459838384|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
127785259|NCT01744665|459838384|FG000|Consolidation Phase|Withdrawal by Subject|4|||
127785260|NCT01744665|459838384|FG000|Consolidation Phase|Administrative problems|9|||
127785261|NCT01744665|459838384|FG000|Re-initiation Phase|Administrative problems|10|||
127785262|NCT01744665|459838384|FG000|Re-initiation Phase|Adverse Event|1|||
127785263|NCT01744665|459838384|FG000|Re-initiation Phase|No longer required treatment|1|||
127785264|NCT01744665|459838384|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
127785265|NCT03184077|459838386|FG000|Overall Study|Lost to Follow-up|21|||
127785266|NCT03184077|459838387|FG001|Overall Study|Lost to Follow-up|21|||
127785267|NCT03462719|459838388|FG000|Overall Study|Withdrawal by Subject|4|||
127785268|NCT03462719|459838389|FG001|Overall Study|Withdrawal by Subject|3|||
127785269|NCT03462719|459838388|FG000|Overall Study|Ongoing|87|||
127785270|NCT03462719|459838389|FG001|Overall Study|Ongoing|72|||
127785271|NCT02046096|459838390|FG000|Overall Study|Death|28|||
127785272|NCT02046096|459838391|FG001|Overall Study|Death|45|||
127785273|NCT02046096|459838390|FG000|Overall Study|Lost to Follow-up|9|||
127785274|NCT02046096|459838391|FG001|Overall Study|Lost to Follow-up|20|||
127785275|NCT02046096|459838390|FG000|Overall Study|Withdrawal by Subject|5|||
127785276|NCT02046096|459838391|FG001|Overall Study|Withdrawal by Subject|17|||
127785277|NCT02046096|459838390|FG000|Overall Study|Other endpoint|2|||
127785278|NCT02046096|459838391|FG001|Overall Study|Other endpoint|19|||
127785279|NCT01401842|459838395|FG000|Overall Study|Withdrawal by Subject|3|||
127785280|NCT01401842|459838396|FG001|Overall Study|Withdrawal by Subject|2|||
127785281|NCT01401842|459838395|FG000|Overall Study|academic reason|4|||
127785282|NCT01401842|459838396|FG001|Overall Study|academic reason|1|||
127694957|NCT03138512|459512886|FG000|Treatment Part A|Adverse event unrelated to study drug|9|||
127694958|NCT03138512|459512887|FG001|Treatment Part A|Adverse event unrelated to study drug|4|||
127694959|NCT03138512|459512888|FG002|Treatment Part A|Adverse event unrelated to study drug|0|||
127694960|NCT03138512|459512889|FG003|Treatment Part A|Adverse event unrelated to study drug|0|||
127694961|NCT03138512|459512890|FG004|Treatment Part A|Adverse event unrelated to study drug|0|||
127694962|NCT03138512|459512886|FG000|Treatment Part A|Participant request to discontinue treatment|9|||
127694963|NCT03138512|459512887|FG001|Treatment Part A|Participant request to discontinue treatment|4|||
127694964|NCT03138512|459512888|FG002|Treatment Part A|Participant request to discontinue treatment|0|||
127694965|NCT03138512|459512889|FG003|Treatment Part A|Participant request to discontinue treatment|0|||
127694966|NCT03138512|459512890|FG004|Treatment Part A|Participant request to discontinue treatment|0|||
127694967|NCT03138512|459512886|FG000|Treatment Part A|Participant withdrew consent|2|||
127694968|NCT03138512|459512887|FG001|Treatment Part A|Participant withdrew consent|4|||
127694969|NCT03138512|459512888|FG002|Treatment Part A|Participant withdrew consent|0|||
127694970|NCT03138512|459512889|FG003|Treatment Part A|Participant withdrew consent|0|||
127694971|NCT03138512|459512890|FG004|Treatment Part A|Participant withdrew consent|0|||
127694972|NCT03138512|459512886|FG000|Treatment Part A|Lost to Follow-up|0|||
127694973|NCT03138512|459512887|FG001|Treatment Part A|Lost to Follow-up|1|||
127694974|NCT03138512|459512888|FG002|Treatment Part A|Lost to Follow-up|0|||
127694975|NCT03138512|459512889|FG003|Treatment Part A|Lost to Follow-up|0|||
127694976|NCT03138512|459512890|FG004|Treatment Part A|Lost to Follow-up|0|||
127694977|NCT03138512|459512886|FG000|Treatment Part A|Poor/non-compliance|1|||
127694978|NCT03138512|459512887|FG001|Treatment Part A|Poor/non-compliance|0|||
127694979|NCT03138512|459512888|FG002|Treatment Part A|Poor/non-compliance|0|||
127694980|NCT03138512|459512889|FG003|Treatment Part A|Poor/non-compliance|0|||
127694981|NCT03138512|459512890|FG004|Treatment Part A|Poor/non-compliance|0|||
127694982|NCT03138512|459512886|FG000|Treatment Part A|Pregnancy|0|||
127694983|NCT03138512|459512887|FG001|Treatment Part A|Pregnancy|1|||
127694984|NCT03138512|459512888|FG002|Treatment Part A|Pregnancy|0|||
127694985|NCT03138512|459512889|FG003|Treatment Part A|Pregnancy|0|||
127785283|NCT01401842|459838395|FG000|Overall Study|changed companies|20|||
127785284|NCT01401842|459838396|FG001|Overall Study|changed companies|34|||
127785285|NCT01401842|459838395|FG000|Overall Study|discharged from US Army|3|||
127785286|NCT01401842|459838396|FG001|Overall Study|discharged from US Army|4|||
127785287|NCT01401842|459838395|FG000|Overall Study|invalid follow-up strength data|1|||
127785288|NCT01401842|459838396|FG001|Overall Study|invalid follow-up strength data|4|||
127785289|NCT01401842|459838395|FG000|Overall Study|on profile|9|||
127785290|NCT01401842|459838396|FG001|Overall Study|on profile|5|||
127785291|NCT01401842|459838395|FG000|Overall Study|other/unknown|28|||
127785292|NCT01401842|459838396|FG001|Overall Study|other/unknown|17|||
127785293|NCT06156215|459838403|FG000|Overall Study|Withdrawal by Subject|2|||
127785294|NCT06156215|459838404|FG001|Overall Study|Withdrawal by Subject|4|||
127785295|NCT06156215|459838405|FG002|Overall Study|Withdrawal by Subject|4|||
127785296|NCT06156215|459838406|FG003|Overall Study|Withdrawal by Subject|0|||
127785297|NCT06156215|459838407|FG004|Overall Study|Withdrawal by Subject|2|||
127785298|NCT06156215|459838408|FG005|Overall Study|Withdrawal by Subject|2|||
127785299|NCT06156215|459838403|FG000|Overall Study|Left ED without completing study|9|||
127785300|NCT06156215|459838404|FG001|Overall Study|Left ED without completing study|3|||
127785301|NCT06156215|459838405|FG002|Overall Study|Left ED without completing study|9|||
127785302|NCT06156215|459838406|FG003|Overall Study|Left ED without completing study|0|||
127785303|NCT06156215|459838407|FG004|Overall Study|Left ED without completing study|8|||
127785304|NCT06156215|459838408|FG005|Overall Study|Left ED without completing study|16|||
127785305|NCT06156215|459838403|FG000|Overall Study|Physician Decision|1|||
127785306|NCT06156215|459838404|FG001|Overall Study|Physician Decision|0|||
127785307|NCT06156215|459838405|FG002|Overall Study|Physician Decision|0|||
127785308|NCT06156215|459838406|FG003|Overall Study|Physician Decision|0|||
127785309|NCT06156215|459838407|FG004|Overall Study|Physician Decision|0|||
127785310|NCT06156215|459838408|FG005|Overall Study|Physician Decision|0|||
127785311|NCT06156215|459838403|FG000|Overall Study|Became or found ineligible|2|||
127785312|NCT06156215|459838404|FG001|Overall Study|Became or found ineligible|0|||
127785313|NCT06156215|459838405|FG002|Overall Study|Became or found ineligible|2|||
127785314|NCT06156215|459838406|FG003|Overall Study|Became or found ineligible|0|||
127785315|NCT06156215|459838407|FG004|Overall Study|Became or found ineligible|1|||
127785316|NCT06156215|459838408|FG005|Overall Study|Became or found ineligible|2|||
127785317|NCT00766038|459839617|FG000|Overall Study|Lost to Follow-up|15|||
127785318|NCT00766038|459839618|FG001|Overall Study|Lost to Follow-up|14|||
127785319|NCT00847145|459839619|FG000|Overall Study|AE or Death|0|||
127785320|NCT00847145|459839620|FG001|Overall Study|AE or Death|1|||
127785321|NCT00847145|459839621|FG002|Overall Study|AE or Death|1|||
127882126|NCT02587325|460190814|FG004|16-Week Dose-finding Safety Part|Adverse Event|0|||
127694986|NCT03138512|459512890|FG004|Treatment Part A|Pregnancy|0|||
127785322|NCT00847145|459839622|FG003|Overall Study|AE or Death|0|||
127785323|NCT00847145|459839623|FG004|Overall Study|AE or Death|0|||
127785324|NCT00847145|459839624|FG005|Overall Study|AE or Death|0|||
127785325|NCT00847145|459839625|FG006|Overall Study|AE or Death|0|||
127785326|NCT00847145|459839626|FG007|Overall Study|AE or Death|0|||
127785327|NCT00847145|459839619|FG000|Overall Study|Withdrawal by Subject|3|||
127785328|NCT00847145|459839620|FG001|Overall Study|Withdrawal by Subject|4|||
127785329|NCT00847145|459839621|FG002|Overall Study|Withdrawal by Subject|6|||
127785330|NCT00847145|459839622|FG003|Overall Study|Withdrawal by Subject|1|||
127785331|NCT00847145|459839623|FG004|Overall Study|Withdrawal by Subject|0|||
127882127|NCT02587325|460190810|FG000|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
127882128|NCT02587325|460190811|FG001|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
127882129|NCT02587325|460190812|FG002|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
127882130|NCT02587325|460190813|FG003|16-Week Dose-finding Safety Part|COVID-19 risk|1|||
127882131|NCT02587325|460190814|FG004|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
127882132|NCT02587325|460190810|FG000|32-Week Optional Extension Part|Adverse Event|0|||
127882133|NCT02587325|460190811|FG001|32-Week Optional Extension Part|Adverse Event|0|||
127882134|NCT02587325|460190812|FG002|32-Week Optional Extension Part|Adverse Event|1|||
127882135|NCT02587325|460190813|FG003|32-Week Optional Extension Part|Adverse Event|0|||
127882136|NCT02587325|460190814|FG004|32-Week Optional Extension Part|Adverse Event|0|||
127882137|NCT02587325|460190810|FG000|32-Week Optional Extension Part|Lost to Follow-up|0|||
127882138|NCT02587325|460190811|FG001|32-Week Optional Extension Part|Lost to Follow-up|0|||
127882139|NCT02587325|460190812|FG002|32-Week Optional Extension Part|Lost to Follow-up|1|||
127882140|NCT02587325|460190813|FG003|32-Week Optional Extension Part|Lost to Follow-up|0|||
127882141|NCT02587325|460190814|FG004|32-Week Optional Extension Part|Lost to Follow-up|1|||
127882142|NCT01831596|460190815|FG000|Overall Study|Other|8|||
127882143|NCT02524665|460190819|FG000|Overall Study|Lost to Follow-up|1|||
127882144|NCT02602080|460190820|FG000|Overall Study|Protocol Violation|6|||
127882145|NCT02602080|460190821|FG001|Overall Study|Protocol Violation|1|||
127882146|NCT02602080|460190822|FG002|Overall Study|Protocol Violation|3|||
127882147|NCT04355767|460190828|FG000|Overall Study|Withdrawal by Subject|2|||
127882148|NCT04355767|460190829|FG001|Overall Study|Withdrawal by Subject|2|||
127882149|NCT04355767|460190828|FG000|Overall Study|Death|5|||
127882150|NCT04355767|460190829|FG001|Overall Study|Death|1|||
127882151|NCT01999322|460190830|FG000|Overall Study|Adverse Event|1|||
127882152|NCT01999322|460190831|FG001|Overall Study|Adverse Event|0|||
127882153|NCT02200614|460190832|FG000|Double Blind Treatment|Adverse Event|86|||
127882154|NCT02200614|460190833|FG001|Double Blind Treatment|Adverse Event|48|||
127882155|NCT02200614|460190832|FG000|Double Blind Treatment|Confirmed metastasis|120|||
127882156|NCT02200614|460190833|FG001|Double Blind Treatment|Confirmed metastasis|140|||
127882157|NCT02200614|460190832|FG000|Double Blind Treatment|Judgment of the investigator|59|||
127882158|NCT02200614|460190833|FG001|Double Blind Treatment|Judgment of the investigator|99|||
127882159|NCT02200614|460190832|FG000|Double Blind Treatment|Metastasis by local reading|1|||
127882160|NCT02200614|460190833|FG001|Double Blind Treatment|Metastasis by local reading|3|||
127882161|NCT02200614|460190832|FG000|Double Blind Treatment|Other reason|6|||
127593917|NCT01626391|459140406|FG001|Overall Study|Withdrawal by Subject|0|||
127593918|NCT05229406|459140409|FG000|Overall Study|Withdrawal by Subject|1|||
127593919|NCT05229406|459140410|FG001|Overall Study|Withdrawal by Subject|2|||
127785332|NCT00847145|459839624|FG005|Overall Study|Withdrawal by Subject|0|||
127785333|NCT00847145|459839625|FG006|Overall Study|Withdrawal by Subject|1|||
127785334|NCT00847145|459839626|FG007|Overall Study|Withdrawal by Subject|1|||
127785335|NCT00847145|459839619|FG000|Overall Study|Lost to Follow-up|3|||
127785336|NCT00847145|459839620|FG001|Overall Study|Lost to Follow-up|1|||
127785337|NCT00847145|459839621|FG002|Overall Study|Lost to Follow-up|1|||
127785338|NCT00847145|459839622|FG003|Overall Study|Lost to Follow-up|0|||
127785339|NCT00847145|459839623|FG004|Overall Study|Lost to Follow-up|4|||
127785340|NCT00847145|459839624|FG005|Overall Study|Lost to Follow-up|4|||
127785341|NCT00847145|459839625|FG006|Overall Study|Lost to Follow-up|8|||
127785342|NCT00847145|459839626|FG007|Overall Study|Lost to Follow-up|2|||
127785343|NCT00847145|459839619|FG000|Overall Study|Inappropriate enrollment|0|||
127785344|NCT00847145|459839620|FG001|Overall Study|Inappropriate enrollment|0|||
127785345|NCT00847145|459839621|FG002|Overall Study|Inappropriate enrollment|0|||
127785346|NCT00847145|459839622|FG003|Overall Study|Inappropriate enrollment|0|||
127593920|NCT01032837|459140411|FG000|Overall Study|Adverse event/internal illness|0|||
127593921|NCT01032837|459140412|FG001|Overall Study|Adverse event/internal illness|1|||
127593922|NCT01032837|459140413|FG002|Overall Study|Adverse event/internal illness|0|||
127593923|NCT01032837|459140414|FG003|Overall Study|Adverse event/internal illness|1|||
127593924|NCT01032837|459140411|FG000|Overall Study|Withdrew consent|0|||
127593925|NCT01032837|459140412|FG001|Overall Study|Withdrew consent|2|||
127785347|NCT00847145|459839623|FG004|Overall Study|Inappropriate enrollment|1|||
127785348|NCT00847145|459839624|FG005|Overall Study|Inappropriate enrollment|0|||
127882162|NCT02200614|460190833|FG001|Double Blind Treatment|Other reason|2|||
127882163|NCT02200614|460190832|FG000|Double Blind Treatment|Personal reason|77|||
127882164|NCT02200614|460190833|FG001|Double Blind Treatment|Personal reason|85|||
127882165|NCT02200614|460190832|FG000|Double Blind Treatment|Protocol deviation|14|||
127882166|NCT02200614|460190833|FG001|Double Blind Treatment|Protocol deviation|7|||
127882167|NCT02200614|460190832|FG000|Double Blind Treatment|Not treated|1|||
127882168|NCT02200614|460190833|FG001|Double Blind Treatment|Not treated|0|||
127593926|NCT01032837|459140413|FG002|Overall Study|Withdrew consent|0|||
127785349|NCT00847145|459839625|FG006|Overall Study|Inappropriate enrollment|0|||
127882169|NCT02200614|460190832|FG000|Open Label|Adverse Event|41|||
127882170|NCT02200614|460190833|FG001|Open Label|Adverse Event|11|||
127882171|NCT02200614|460190832|FG000|Open Label|Confirmed metastasis|1|||
127882172|NCT02200614|460190833|FG001|Open Label|Confirmed metastasis|0|||
127882173|NCT02200614|460190832|FG000|Open Label|Judgment of the investigator|29|||
127882174|NCT02200614|460190833|FG001|Open Label|Judgment of the investigator|2|||
127882175|NCT02200614|460190832|FG000|Open Label|Metastasis by local reading|138|||
127882176|NCT02200614|460190833|FG001|Open Label|Metastasis by local reading|27|||
127882177|NCT02200614|460190832|FG000|Open Label|Other reason|22|||
127882178|NCT02200614|460190833|FG001|Open Label|Other reason|4|||
127593927|NCT01032837|459140414|FG003|Overall Study|Withdrew consent|1|||
127593928|NCT01032837|459140411|FG000|Overall Study|Failed to return|0|||
127593929|NCT01032837|459140412|FG001|Overall Study|Failed to return|0|||
127593930|NCT01032837|459140413|FG002|Overall Study|Failed to return|1|||
127593931|NCT01032837|459140414|FG003|Overall Study|Failed to return|0|||
127785350|NCT00847145|459839626|FG007|Overall Study|Inappropriate enrollment|0|||
127785351|NCT00847145|459839619|FG000|Overall Study|Protocol Violation|0|||
127785352|NCT00847145|459839620|FG001|Overall Study|Protocol Violation|0|||
127785353|NCT00847145|459839621|FG002|Overall Study|Protocol Violation|3|||
127785354|NCT00847145|459839622|FG003|Overall Study|Protocol Violation|0|||
127785355|NCT00847145|459839623|FG004|Overall Study|Protocol Violation|1|||
127785356|NCT00847145|459839624|FG005|Overall Study|Protocol Violation|0|||
127785357|NCT00847145|459839625|FG006|Overall Study|Protocol Violation|0|||
127785358|NCT00847145|459839626|FG007|Overall Study|Protocol Violation|1|||
127785359|NCT02833974|459839627|FG000|Overall Study|Lost to Follow-up|1|||
127785360|NCT02833974|459839628|FG001|Overall Study|Lost to Follow-up|0|||
127785361|NCT02833974|459839627|FG000|Overall Study|Adverse Event|0|||
127785362|NCT02833974|459839628|FG001|Overall Study|Adverse Event|3|||
127785363|NCT00307151|459839630|FG000|Overall Study|Death|4|||
127785364|NCT00307151|459839631|FG001|Overall Study|Death|3|||
127785365|NCT00307151|459839632|FG002|Overall Study|Death|10|||
127785366|NCT00307151|459839633|FG003|Overall Study|Death|3|||
127882179|NCT02200614|460190832|FG000|Open Label|Personal reason|60|||
127882180|NCT02200614|460190833|FG001|Open Label|Personal reason|8|||
127882181|NCT02200614|460190832|FG000|Open Label|Protocol deviation|3|||
127882182|NCT02200614|460190833|FG001|Open Label|Protocol deviation|2|||
127882183|NCT02200614|460190832|FG000|Open Label|Missing|2|||
127882184|NCT02200614|460190833|FG001|Open Label|Missing|2|||
127882185|NCT03302299|460192702|FG000|Overall Study|Protocol Violation|1|||
127882186|NCT04318535|460192703|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
127882187|NCT04318535|460192704|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
127882188|NCT04318535|460192705|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
127882189|NCT01901146|460192706|FG000|Neoadjuvant Phase|Death|1|||
127882190|NCT01901146|460192707|FG001|Neoadjuvant Phase|Death|2|||
127882191|NCT01901146|460192708|FG002|Neoadjuvant Phase|Death|0|||
128034466|NCT01646827|460753187|FG000|Overall Study|Physician Decision|1|||
128034467|NCT01646827|460753188|FG001|Overall Study|Physician Decision|2|||
128034468|NCT01646827|460753187|FG000|Overall Study|Withdrawal by Subject|1|||
128034469|NCT01646827|460753188|FG001|Overall Study|Withdrawal by Subject|0|||
128034470|NCT00928668|460753189|FG000|Overall Study|Adverse Event|1|||
128034471|NCT00928668|460753190|FG001|Overall Study|Adverse Event|0|||
127882192|NCT01901146|460192709|FG003|Neoadjuvant Phase|Death|0|||
128034472|NCT00928668|460753191|FG002|Overall Study|Adverse Event|0|||
128034473|NCT00928668|460753192|FG003|Overall Study|Adverse Event|0|||
127785367|NCT00307151|459839630|FG000|Overall Study|Severe debilitation, unable to continue|1|||
127785368|NCT00307151|459839631|FG001|Overall Study|Severe debilitation, unable to continue|0|||
127785369|NCT00307151|459839632|FG002|Overall Study|Severe debilitation, unable to continue|0|||
127785370|NCT00307151|459839633|FG003|Overall Study|Severe debilitation, unable to continue|0|||
127785371|NCT00307151|459839630|FG000|Overall Study|Subject unable to get to clinic|1|||
127785372|NCT00307151|459839631|FG001|Overall Study|Subject unable to get to clinic|0|||
127785373|NCT00307151|459839632|FG002|Overall Study|Subject unable to get to clinic|6|||
127785374|NCT00307151|459839633|FG003|Overall Study|Subject unable to get to clinic|2|||
127785375|NCT00307151|459839630|FG000|Overall Study|Withdrew consent|0|||
127785376|NCT00307151|459839631|FG001|Overall Study|Withdrew consent|1|||
127785377|NCT00307151|459839632|FG002|Overall Study|Withdrew consent|1|||
127882193|NCT01901146|460192710|FG004|Neoadjuvant Phase|Death|0|||
127882194|NCT01901146|460192706|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
127882195|NCT01901146|460192707|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
127785378|NCT00307151|459839633|FG003|Overall Study|Withdrew consent|3|||
128034474|NCT00928668|460753193|FG004|Overall Study|Adverse Event|0|||
128034475|NCT00928668|460753189|FG000|Overall Study|Protocol Violation|0|||
128034476|NCT00928668|460753190|FG001|Overall Study|Protocol Violation|0|||
127593932|NCT01032837|459140411|FG000|Overall Study|Refused treatment|0|||
127785379|NCT00307151|459839630|FG000|Overall Study|Not willing to adhere to study reqs|2|||
127785380|NCT00307151|459839631|FG001|Overall Study|Not willing to adhere to study reqs|0|||
127882196|NCT01901146|460192708|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
127694987|NCT03138512|459512886|FG000|Treatment Part A|Other reasons|11|||
127694988|NCT03138512|459512887|FG001|Treatment Part A|Other reasons|8|||
127694989|NCT03138512|459512888|FG002|Treatment Part A|Other reasons|0|||
127694990|NCT03138512|459512889|FG003|Treatment Part A|Other reasons|0|||
127694991|NCT03138512|459512890|FG004|Treatment Part A|Other reasons|0|||
127694992|NCT03138512|459512886|FG000|Treatment Part B|Disease recurrence|0|||
127694993|NCT03138512|459512887|FG001|Treatment Part B|Disease recurrence|0|||
127694994|NCT03138512|459512888|FG002|Treatment Part B|Disease recurrence|6|||
127694995|NCT03138512|459512889|FG003|Treatment Part B|Disease recurrence|12|||
127694996|NCT03138512|459512890|FG004|Treatment Part B|Disease recurrence|10|||
127694997|NCT03138512|459512886|FG000|Treatment Part B|Study drug toxicity|0|||
127694998|NCT03138512|459512887|FG001|Treatment Part B|Study drug toxicity|0|||
127694999|NCT03138512|459512888|FG002|Treatment Part B|Study drug toxicity|63|||
127695000|NCT03138512|459512889|FG003|Treatment Part B|Study drug toxicity|3|||
127695001|NCT03138512|459512890|FG004|Treatment Part B|Study drug toxicity|45|||
127695002|NCT03138512|459512886|FG000|Treatment Part B|Death|0|||
127695003|NCT03138512|459512887|FG001|Treatment Part B|Death|0|||
127695004|NCT03138512|459512888|FG002|Treatment Part B|Death|1|||
127695005|NCT03138512|459512889|FG003|Treatment Part B|Death|0|||
127695006|NCT03138512|459512890|FG004|Treatment Part B|Death|0|||
127695007|NCT03138512|459512886|FG000|Treatment Part B|Adverse event unrelated to study drug|0|||
127695008|NCT03138512|459512887|FG001|Treatment Part B|Adverse event unrelated to study drug|0|||
127695009|NCT03138512|459512888|FG002|Treatment Part B|Adverse event unrelated to study drug|5|||
127695010|NCT03138512|459512889|FG003|Treatment Part B|Adverse event unrelated to study drug|2|||
127695011|NCT03138512|459512890|FG004|Treatment Part B|Adverse event unrelated to study drug|12|||
127695012|NCT03138512|459512886|FG000|Treatment Part B|Participants request to discontinue study treatment|0|||
127695013|NCT03138512|459512887|FG001|Treatment Part B|Participants request to discontinue study treatment|0|||
127695014|NCT03138512|459512888|FG002|Treatment Part B|Participants request to discontinue study treatment|6|||
127695015|NCT03138512|459512889|FG003|Treatment Part B|Participants request to discontinue study treatment|4|||
127695016|NCT03138512|459512890|FG004|Treatment Part B|Participants request to discontinue study treatment|6|||
127695017|NCT03138512|459512886|FG000|Treatment Part B|Participant withdrew consent|0|||
127695018|NCT03138512|459512887|FG001|Treatment Part B|Participant withdrew consent|0|||
127695019|NCT03138512|459512888|FG002|Treatment Part B|Participant withdrew consent|1|||
127695020|NCT03138512|459512889|FG003|Treatment Part B|Participant withdrew consent|1|||
127695021|NCT03138512|459512890|FG004|Treatment Part B|Participant withdrew consent|2|||
127695022|NCT03138512|459512886|FG000|Treatment Part B|Lost to Follow-up|0|||
127695023|NCT03138512|459512887|FG001|Treatment Part B|Lost to Follow-up|0|||
127695024|NCT03138512|459512888|FG002|Treatment Part B|Lost to Follow-up|0|||
127695025|NCT03138512|459512889|FG003|Treatment Part B|Lost to Follow-up|1|||
127695026|NCT03138512|459512890|FG004|Treatment Part B|Lost to Follow-up|0|||
127695027|NCT03138512|459512886|FG000|Treatment Part B|Poor/non-compliance|0|||
127695028|NCT03138512|459512887|FG001|Treatment Part B|Poor/non-compliance|0|||
127695029|NCT03138512|459512888|FG002|Treatment Part B|Poor/non-compliance|1|||
127695030|NCT03138512|459512889|FG003|Treatment Part B|Poor/non-compliance|1|||
127695031|NCT03138512|459512890|FG004|Treatment Part B|Poor/non-compliance|1|||
127695032|NCT03138512|459512886|FG000|Treatment Part B|Other reasons|0|||
127695033|NCT03138512|459512887|FG001|Treatment Part B|Other reasons|0|||
127695034|NCT03138512|459512888|FG002|Treatment Part B|Other reasons|3|||
127695035|NCT03138512|459512889|FG003|Treatment Part B|Other reasons|1|||
127695036|NCT03138512|459512890|FG004|Treatment Part B|Other reasons|5|||
127695037|NCT05323084|459512892|FG000|Period 2 - Washout|Lost to Follow-up|0|||
127695038|NCT05323084|459512893|FG001|Period 2 - Washout|Lost to Follow-up|1|||
127695039|NCT04382404|459512894|FG000|Overall Study|Adverse Event|1|||
127695040|NCT04382404|459512894|FG000|Overall Study|Lost to Follow-up|2|||
127695057|NCT05687916|459512899|FG000|Overall Study|Adverse Event|1|||
127695058|NCT05687916|459512900|FG001|Overall Study|Adverse Event|2|||
127695059|NCT05687916|459512901|FG002|Overall Study|Adverse Event|0|||
127593933|NCT01032837|459140412|FG001|Overall Study|Refused treatment|0|||
127593934|NCT01032837|459140413|FG002|Overall Study|Refused treatment|0|||
127593935|NCT01032837|459140414|FG003|Overall Study|Refused treatment|1|||
127593936|NCT00843024|459140415|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
127593937|NCT00843024|459140416|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
127593938|NCT00843024|459140417|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
127593939|NCT00843024|459140418|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
127593940|NCT00843024|459140419|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
127593941|NCT00843024|459140420|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
127593942|NCT00843024|459140415|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
127593943|NCT00843024|459140416|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
127593944|NCT00843024|459140417|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
127593945|NCT00843024|459140418|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
127593946|NCT00843024|459140419|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
127593947|NCT00843024|459140420|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
127593948|NCT00843024|459140415|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
127593949|NCT00843024|459140416|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
127593950|NCT00843024|459140417|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
127593951|NCT00843024|459140418|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
127593952|NCT00843024|459140419|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
127593953|NCT00843024|459140420|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
127593954|NCT00843024|459140415|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
127593955|NCT00843024|459140416|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
127593956|NCT00843024|459140417|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
127593957|NCT00843024|459140418|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
127593958|NCT00843024|459140419|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
127593959|NCT00843024|459140420|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
127593960|NCT00843024|459140415|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
127695060|NCT05687916|459512899|FG000|Overall Study|Withdrawal by Subject|1|||
127695061|NCT05687916|459512900|FG001|Overall Study|Withdrawal by Subject|0|||
127695062|NCT05687916|459512901|FG002|Overall Study|Withdrawal by Subject|1|||
127695063|NCT05687916|459512899|FG000|Overall Study|Protocol Violation|0|||
127695064|NCT05687916|459512900|FG001|Overall Study|Protocol Violation|2|||
127695065|NCT05687916|459512901|FG002|Overall Study|Protocol Violation|1|||
127695066|NCT05687916|459512899|FG000|Overall Study|Reason not Specified|1|||
127593961|NCT00843024|459140416|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
127593962|NCT00843024|459140417|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
127593963|NCT00843024|459140418|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
127695067|NCT05687916|459512900|FG001|Overall Study|Reason not Specified|0|||
127695068|NCT05687916|459512901|FG002|Overall Study|Reason not Specified|0|||
127695069|NCT03332017|459512902|FG000|Overall Study|Lost to Follow-up|1|||
127695070|NCT03332017|459512903|FG001|Overall Study|Lost to Follow-up|2|||
127695071|NCT03332017|459512902|FG000|Overall Study|Death|17|||
127695072|NCT03332017|459512903|FG001|Overall Study|Death|16|||
127695073|NCT03332017|459512902|FG000|Overall Study|Withdrawal by Subject|6|||
127695074|NCT03332017|459512903|FG001|Overall Study|Withdrawal by Subject|14|||
127695075|NCT03332017|459512902|FG000|Overall Study|Other|1|||
127695076|NCT03332017|459512903|FG001|Overall Study|Other|3|||
127695077|NCT03332017|459512902|FG000|Overall Study|Remained in Study (Ongoing)|47|||
127695078|NCT03332017|459512903|FG001|Overall Study|Remained in Study (Ongoing)|110|||
127695079|NCT01261312|459512904|FG000|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|27|||
127695080|NCT01261312|459512905|FG001|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|26|||
127695081|NCT01261312|459512906|FG002|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|9|||
127695082|NCT01261312|459512907|FG003|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
127695083|NCT01261312|459512908|FG004|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
127695084|NCT01261312|459512909|FG005|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
127695085|NCT01261312|459512910|FG006|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
127695086|NCT01261312|459512911|FG007|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
127695087|NCT01261312|459512912|FG008|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
127695088|NCT01261312|459512913|FG009|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
127695089|NCT01261312|459512914|FG010|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
127695090|NCT01261312|459512915|FG011|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
127695091|NCT01261312|459512916|FG012|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
127695092|NCT01261312|459512904|FG000|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
127695093|NCT01261312|459512905|FG001|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
127695094|NCT01261312|459512906|FG002|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
127882197|NCT01901146|460192709|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
127882198|NCT01901146|460192710|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
128034477|NCT00928668|460753191|FG002|Overall Study|Protocol Violation|0|||
128034478|NCT00928668|460753192|FG003|Overall Study|Protocol Violation|0|||
127785381|NCT00307151|459839632|FG002|Overall Study|Not willing to adhere to study reqs|2|||
127785382|NCT00307151|459839633|FG003|Overall Study|Not willing to adhere to study reqs|2|||
127785383|NCT00307151|459839630|FG000|Overall Study|Clinic unable to contact subject|3|||
127785384|NCT00307151|459839631|FG001|Overall Study|Clinic unable to contact subject|3|||
127785385|NCT00307151|459839632|FG002|Overall Study|Clinic unable to contact subject|1|||
127785386|NCT00307151|459839633|FG003|Overall Study|Clinic unable to contact subject|1|||
127785387|NCT00516048|459839637|FG000|Overall Study|Death|0|||
127785388|NCT00516048|459839638|FG001|Overall Study|Death|0|||
127785389|NCT00516048|459839639|FG002|Overall Study|Death|1|||
127785390|NCT00516048|459839637|FG000|Overall Study|Subject Decision|0|||
127785391|NCT00516048|459839638|FG001|Overall Study|Subject Decision|2|||
127785392|NCT00516048|459839639|FG002|Overall Study|Subject Decision|0|||
127785393|NCT00096785|459839640|FG000|Overall Study|Lost to Follow-up|1|||
127785394|NCT00096785|459839641|FG001|Overall Study|Lost to Follow-up|0|||
127785395|NCT00096785|459839640|FG000|Overall Study|Withdrawal by Subject|0|||
127785396|NCT00096785|459839641|FG001|Overall Study|Withdrawal by Subject|1|||
127785397|NCT00096785|459839640|FG000|Overall Study|Relocated|1|||
127785398|NCT00096785|459839641|FG001|Overall Study|Relocated|0|||
127785399|NCT02081534|459839645|FG000|Overall Study|Adverse Event|5|||
127785400|NCT02081534|459839646|FG001|Overall Study|Adverse Event|4|||
127785401|NCT02081534|459839647|FG002|Overall Study|Adverse Event|3|||
127785402|NCT02081534|459839648|FG003|Overall Study|Adverse Event|10|||
127785403|NCT02081534|459839649|FG004|Overall Study|Adverse Event|2|||
127785404|NCT02081534|459839650|FG005|Overall Study|Adverse Event|8|||
127785405|NCT02081534|459839651|FG006|Overall Study|Adverse Event|2|||
127785406|NCT02081534|459839645|FG000|Overall Study|Withdrawal by Subject|0|||
127785407|NCT02081534|459839646|FG001|Overall Study|Withdrawal by Subject|1|||
127785408|NCT02081534|459839647|FG002|Overall Study|Withdrawal by Subject|1|||
127785409|NCT02081534|459839648|FG003|Overall Study|Withdrawal by Subject|1|||
127785410|NCT02081534|459839649|FG004|Overall Study|Withdrawal by Subject|1|||
127785411|NCT02081534|459839650|FG005|Overall Study|Withdrawal by Subject|0|||
127785412|NCT02081534|459839651|FG006|Overall Study|Withdrawal by Subject|1|||
127785413|NCT02081534|459839645|FG000|Overall Study|Protocol Violation|0|||
127785414|NCT02081534|459839646|FG001|Overall Study|Protocol Violation|3|||
127785415|NCT02081534|459839647|FG002|Overall Study|Protocol Violation|0|||
127785416|NCT02081534|459839648|FG003|Overall Study|Protocol Violation|0|||
127785417|NCT02081534|459839649|FG004|Overall Study|Protocol Violation|0|||
127785418|NCT02081534|459839650|FG005|Overall Study|Protocol Violation|0|||
127785419|NCT02081534|459839651|FG006|Overall Study|Protocol Violation|1|||
127785420|NCT02081534|459839645|FG000|Overall Study|Lost to Follow-up|0|||
127785421|NCT02081534|459839646|FG001|Overall Study|Lost to Follow-up|0|||
127785422|NCT02081534|459839647|FG002|Overall Study|Lost to Follow-up|0|||
127785423|NCT02081534|459839648|FG003|Overall Study|Lost to Follow-up|2|||
127785424|NCT02081534|459839649|FG004|Overall Study|Lost to Follow-up|1|||
127785425|NCT02081534|459839650|FG005|Overall Study|Lost to Follow-up|1|||
127785426|NCT02081534|459839651|FG006|Overall Study|Lost to Follow-up|0|||
127785427|NCT00003535|459839652|FG000|Overall Study|Not evaluable|5|||
127785428|NCT02181816|459839653|FG000|Overall Study|Case Report Forms Uncollected|38|||
127785429|NCT02181816|459839653|FG000|Overall Study|Protocol Deviation|21|||
127785430|NCT03807349|459839656|FG000|Overall Study|Early Study Termination|9|||
127785431|NCT00294060|459839657|FG000|Overall Study|Death|225|||
127785432|NCT00294060|459839657|FG000|Overall Study|Other|59|||
127785433|NCT00294060|459839657|FG000|Overall Study|Lost to Follow-up|55|||
127785434|NCT00294060|459839657|FG000|Overall Study|Withdrawal by Subject|11|||
127785435|NCT00294060|459839657|FG000|Overall Study|Physician Decision|797|||
127785436|NCT00294060|459839657|FG000|Overall Study|Medical condition|3|||
127785437|NCT00294060|459839657|FG000|Overall Study|Device explanted/not replaced|23|||
127785438|NCT01360554|459839658|FG000|Overall Study|Death|359|||
127785439|NCT01360554|459839659|FG001|Overall Study|Death|371|||
127785440|NCT01360554|459839658|FG000|Overall Study|Lost to Follow-up|4|||
127785441|NCT01360554|459839659|FG001|Overall Study|Lost to Follow-up|4|||
127785442|NCT01360554|459839658|FG000|Overall Study|Withdrawal by Subject|23|||
127785443|NCT01360554|459839659|FG001|Overall Study|Withdrawal by Subject|24|||
127785444|NCT01360554|459839658|FG000|Overall Study|Study terminated by sponsor|49|||
128034479|NCT00928668|460753193|FG004|Overall Study|Protocol Violation|1|||
127785445|NCT01360554|459839659|FG001|Overall Study|Study terminated by sponsor|37|||
127785446|NCT01360554|459839658|FG000|Overall Study|Other, not specified|1|||
127882199|NCT01901146|460192706|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
128034480|NCT00928668|460753189|FG000|Overall Study|Withdrawal by Subject|0|||
128034481|NCT00928668|460753190|FG001|Overall Study|Withdrawal by Subject|1|||
127785447|NCT01360554|459839659|FG001|Overall Study|Other, not specified|0|||
127785448|NCT01360554|459839658|FG000|Overall Study|Randomized but not treated.|3|||
127785449|NCT01360554|459839659|FG001|Overall Study|Randomized but not treated.|3|||
127785450|NCT00187096|459839661|FG000|Overall Study|unacceptable toxicity|0|||
127785451|NCT00187096|459839662|FG001|Overall Study|unacceptable toxicity|0|||
127785452|NCT00187096|459839663|FG002|Overall Study|unacceptable toxicity|1|||
128034482|NCT00928668|460753191|FG002|Overall Study|Withdrawal by Subject|1|||
128034483|NCT00928668|460753192|FG003|Overall Study|Withdrawal by Subject|0|||
128034484|NCT00928668|460753193|FG004|Overall Study|Withdrawal by Subject|0|||
127695095|NCT01261312|459512907|FG003|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
127695096|NCT01261312|459512908|FG004|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
127695097|NCT01261312|459512909|FG005|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
127695098|NCT01261312|459512910|FG006|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
127695099|NCT01261312|459512911|FG007|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
127695100|NCT01261312|459512912|FG008|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
127695101|NCT01261312|459512913|FG009|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
127695102|NCT01261312|459512914|FG010|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
127695103|NCT01261312|459512915|FG011|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
127695104|NCT01261312|459512916|FG012|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
127695105|NCT01261312|459512904|FG000|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|3|||
127695106|NCT01261312|459512905|FG001|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|2|||
127695107|NCT01261312|459512906|FG002|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
127695108|NCT01261312|459512907|FG003|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
127695109|NCT01261312|459512908|FG004|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
128034485|NCT00928668|460753189|FG000|Overall Study|Other reasons not listed above|0|||
128034486|NCT00928668|460753190|FG001|Overall Study|Other reasons not listed above|0|||
128034487|NCT00928668|460753191|FG002|Overall Study|Other reasons not listed above|0|||
128034488|NCT00928668|460753192|FG003|Overall Study|Other reasons not listed above|1|||
128034489|NCT00928668|460753193|FG004|Overall Study|Other reasons not listed above|0|||
128034490|NCT01767987|460753197|FG000|Overall Study|Physician Decision|4|||
128034491|NCT01767987|460753198|FG001|Overall Study|Physician Decision|1|||
128034492|NCT03232567|460753199|FG000|Overall Study|Withdrawal by Subject|0|||
128034493|NCT03232567|460753200|FG001|Overall Study|Withdrawal by Subject|1|||
128034494|NCT03232567|460753201|FG002|Overall Study|Withdrawal by Subject|0|||
128034495|NCT03232567|460753202|FG003|Overall Study|Withdrawal by Subject|0|||
128034496|NCT05837481|460753203|FG000|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|0|||
128034497|NCT05837481|460753204|FG001|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|1|||
128034498|NCT03038087|460753210|FG000|Overall Study|lost data|1|||
128034499|NCT00654355|460753211|FG000|Overall Study|Lost to Follow-up|2|||
128034500|NCT00654355|460753212|FG001|Overall Study|Lost to Follow-up|2|||
128034501|NCT05805150|460753219|FG000|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|0|||
128034502|NCT05805150|460753220|FG001|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|1|||
128034503|NCT02284893|460753221|FG000|26 Week (Short Term)|Adverse Event|1|||
128034504|NCT02284893|460753222|FG001|26 Week (Short Term)|Adverse Event|9|||
128034505|NCT02284893|460753221|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
128034506|NCT02284893|460753222|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
128034507|NCT02284893|460753221|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
128034508|NCT02284893|460753222|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
128034509|NCT02284893|460753221|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
128034510|NCT02284893|460753222|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
128034511|NCT02284893|460753221|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
128034512|NCT02284893|460753222|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
128034513|NCT02284893|460753221|FG000|26 Week (Short Term)|Other|1|||
128034514|NCT02284893|460753222|FG001|26 Week (Short Term)|Other|1|||
128034515|NCT02284893|460753221|FG000|52 Week (Long Term)|Adverse Event|3|||
128034516|NCT02284893|460753222|FG001|52 Week (Long Term)|Adverse Event|1|||
128034517|NCT02284893|460753221|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
128034518|NCT02284893|460753222|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
128034519|NCT02284893|460753221|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
128034520|NCT02284893|460753222|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
128034521|NCT02284893|460753221|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
128034522|NCT02284893|460753222|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
128034523|NCT02284893|460753221|FG000|52 Week (Long Term)|Non-Compliance|2|||
128034524|NCT02284893|460753222|FG001|52 Week (Long Term)|Non-Compliance|3|||
128034525|NCT00105066|460753227|FG000|Overall Study|Adverse Event|2|||
128034526|NCT00105066|460753228|FG001|Overall Study|Adverse Event|5|||
128034527|NCT04716894|460753255|FG000|Period 2: Itraconazole Alone|Not treated: positive alcohol test|1|||
128034528|NCT04716894|460753255|FG000|Period 2: Itraconazole Alone|COVID-19 related reason|1|||
128034529|NCT02259231|460753262|FG000|Overall Study|Adverse Event|1|||
128034530|NCT02259231|460753263|FG001|Overall Study|Adverse Event|1|||
128034531|NCT02259231|460753264|FG002|Overall Study|Adverse Event|2|||
127695110|NCT01261312|459512909|FG005|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
127882200|NCT01901146|460192707|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
127882201|NCT01901146|460192708|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
128034532|NCT02259231|460753265|FG003|Overall Study|Adverse Event|0|||
128034533|NCT02259231|460753266|FG004|Overall Study|Adverse Event|0|||
128034534|NCT02259231|460753267|FG005|Overall Study|Adverse Event|0|||
128034535|NCT02259231|460753268|FG006|Overall Study|Adverse Event|0|||
128034536|NCT02259231|460753262|FG000|Overall Study|Progressive Disease|4|||
128034537|NCT02259231|460753263|FG001|Overall Study|Progressive Disease|5|||
128034538|NCT02259231|460753264|FG002|Overall Study|Progressive Disease|4|||
128034539|NCT02259231|460753265|FG003|Overall Study|Progressive Disease|5|||
128034540|NCT02259231|460753266|FG004|Overall Study|Progressive Disease|4|||
128034541|NCT02259231|460753267|FG005|Overall Study|Progressive Disease|5|||
128034542|NCT02259231|460753268|FG006|Overall Study|Progressive Disease|4|||
128034543|NCT02259231|460753262|FG000|Overall Study|Sponsor termination of study|1|||
128034544|NCT02259231|460753263|FG001|Overall Study|Sponsor termination of study|0|||
128034545|NCT02259231|460753264|FG002|Overall Study|Sponsor termination of study|0|||
128034546|NCT02259231|460753265|FG003|Overall Study|Sponsor termination of study|1|||
128034547|NCT02259231|460753266|FG004|Overall Study|Sponsor termination of study|2|||
128034548|NCT02259231|460753267|FG005|Overall Study|Sponsor termination of study|1|||
128034549|NCT02259231|460753268|FG006|Overall Study|Sponsor termination of study|1|||
128034550|NCT00847730|460753272|FG000|Overall Study|Multiple interruptions in therapy|8|||
128034551|NCT02496000|460753275|FG000|Overall Study|Withdrawal by Subject|1|||
128034552|NCT02496000|460753276|FG001|Overall Study|Withdrawal by Subject|2|||
128034553|NCT02496000|460753277|FG002|Overall Study|Withdrawal by Subject|0|||
128034554|NCT02496000|460753275|FG000|Overall Study|Lost to Follow-up|1|||
128034555|NCT02496000|460753276|FG001|Overall Study|Lost to Follow-up|0|||
128034556|NCT02496000|460753277|FG002|Overall Study|Lost to Follow-up|1|||
128034557|NCT02496000|460753275|FG000|Overall Study|Protocol Violation|0|||
128034558|NCT02496000|460753276|FG001|Overall Study|Protocol Violation|0|||
128034559|NCT02496000|460753277|FG002|Overall Study|Protocol Violation|1|||
128034560|NCT02496000|460753275|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
128034561|NCT02496000|460753276|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
128034562|NCT02496000|460753277|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
128034563|NCT02496000|460753275|FG000|Overall Study|undetermined|0|||
128034564|NCT02496000|460753276|FG001|Overall Study|undetermined|1|||
128034565|NCT02496000|460753277|FG002|Overall Study|undetermined|0|||
128034566|NCT02255656|460753278|FG000|Overall Study|Adverse Event|11|||
128034567|NCT02255656|460753278|FG000|Overall Study|Poor compliance to protocol|3|||
128034568|NCT02255656|460753278|FG000|Overall Study|Lost to Follow-up|30|||
128034569|NCT02255656|460753278|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
128034570|NCT02255656|460753278|FG000|Overall Study|Other|126|||
128034571|NCT01877278|460753279|FG000|Overall Study|Lost to Follow-up|3|||
128034572|NCT01877278|460753280|FG001|Overall Study|Lost to Follow-up|3|||
128034573|NCT02757768|460753284|FG000|Overall Study|Randomized Never Received Study Drug|3|||
128034574|NCT02757768|460753285|FG001|Overall Study|Randomized Never Received Study Drug|4|||
128034575|NCT02757768|460753284|FG000|Overall Study|Adverse Event|5|||
128034576|NCT02757768|460753285|FG001|Overall Study|Adverse Event|3|||
128034577|NCT02757768|460753284|FG000|Overall Study|Lack of Efficacy|2|||
128034578|NCT02757768|460753285|FG001|Overall Study|Lack of Efficacy|1|||
128034579|NCT02757768|460753284|FG000|Overall Study|Lost to Follow-up|1|||
128034580|NCT02757768|460753285|FG001|Overall Study|Lost to Follow-up|0|||
128034581|NCT02757768|460753284|FG000|Overall Study|Protocol Deviation|2|||
128034582|NCT02757768|460753285|FG001|Overall Study|Protocol Deviation|9|||
128034583|NCT02757768|460753284|FG000|Overall Study|Withdrawal by Subject|16|||
128034584|NCT02757768|460753285|FG001|Overall Study|Withdrawal by Subject|9|||
128034585|NCT02757768|460753284|FG000|Overall Study|Miscellaneous|4|||
128034586|NCT02757768|460753285|FG001|Overall Study|Miscellaneous|2|||
128034587|NCT02495883|460753286|FG000|Overall Study|Excessive head motion|1|||
128034588|NCT02495883|460753287|FG001|Overall Study|Excessive head motion|0|||
128034589|NCT02776735|460753288|FG000|Overall Study|Adverse Event|0|||
128034590|NCT02776735|460753289|FG001|Overall Study|Adverse Event|0|||
128034591|NCT02776735|460753290|FG002|Overall Study|Adverse Event|0|||
128034592|NCT02776735|460753291|FG003|Overall Study|Adverse Event|1|||
128034593|NCT02776735|460753292|FG004|Overall Study|Adverse Event|0|||
128034594|NCT02776735|460753293|FG005|Overall Study|Adverse Event|1|||
128034595|NCT02776735|460753288|FG000|Overall Study|Lost to Follow-up|0|||
128034596|NCT02776735|460753289|FG001|Overall Study|Lost to Follow-up|0|||
128034597|NCT02776735|460753290|FG002|Overall Study|Lost to Follow-up|0|||
128034598|NCT02776735|460753291|FG003|Overall Study|Lost to Follow-up|1|||
128034599|NCT02776735|460753292|FG004|Overall Study|Lost to Follow-up|0|||
128034600|NCT02776735|460753293|FG005|Overall Study|Lost to Follow-up|0|||
128034601|NCT02776735|460753288|FG000|Overall Study|Withdrawal by parent/guardian|0|||
128034602|NCT02776735|460753289|FG001|Overall Study|Withdrawal by parent/guardian|0|||
128034603|NCT02776735|460753290|FG002|Overall Study|Withdrawal by parent/guardian|2|||
128034604|NCT02776735|460753291|FG003|Overall Study|Withdrawal by parent/guardian|2|||
128034605|NCT02776735|460753292|FG004|Overall Study|Withdrawal by parent/guardian|0|||
128034606|NCT02776735|460753293|FG005|Overall Study|Withdrawal by parent/guardian|0|||
128034607|NCT02776735|460753288|FG000|Overall Study|Withdrawal by Subject|1|||
128034608|NCT02776735|460753289|FG001|Overall Study|Withdrawal by Subject|0|||
127785453|NCT02113436|459839664|FG000|Period 1: 8 Weeks|Adverse Event|1|||
127785454|NCT02113436|459839665|FG001|Period 1: 8 Weeks|Adverse Event|0|||
127785455|NCT02113436|459839666|FG002|Period 1: 8 Weeks|Adverse Event|0|||
127785456|NCT02113436|459839667|FG003|Period 1: 8 Weeks|Adverse Event|0|||
127785457|NCT02113436|459839664|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
127785458|NCT02113436|459839665|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
127785459|NCT02113436|459839666|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
127785460|NCT02113436|459839667|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
127785461|NCT02113436|459839664|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
127785462|NCT02113436|459839665|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
127785463|NCT02113436|459839666|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
127785464|NCT02113436|459839667|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
127785465|NCT02113436|459839664|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
127785466|NCT02113436|459839665|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
127785467|NCT02113436|459839666|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
127785468|NCT02113436|459839667|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
127785469|NCT02113436|459839664|FG000|Period 2: 16 Weeks|Adverse Event|0|||
127785470|NCT02113436|459839665|FG001|Period 2: 16 Weeks|Adverse Event|0|||
127785471|NCT02113436|459839666|FG002|Period 2: 16 Weeks|Adverse Event|4|||
127785472|NCT02113436|459839667|FG003|Period 2: 16 Weeks|Adverse Event|5|||
127785473|NCT02113436|459839664|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
127785474|NCT02113436|459839665|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
127785475|NCT02113436|459839666|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
127785476|NCT02113436|459839667|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
127785477|NCT02113436|459839664|FG000|Period 2: 16 Weeks|Physician Decision|0|||
127785478|NCT02113436|459839665|FG001|Period 2: 16 Weeks|Physician Decision|0|||
127785479|NCT02113436|459839666|FG002|Period 2: 16 Weeks|Physician Decision|2|||
127785480|NCT02113436|459839667|FG003|Period 2: 16 Weeks|Physician Decision|0|||
127785481|NCT02113436|459839664|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
127785482|NCT02113436|459839665|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
127785483|NCT02113436|459839666|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
127785484|NCT02113436|459839667|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
127785485|NCT02159729|459839668|FG000|Overall Study|Adverse Event|0|||
127785486|NCT02159729|459839669|FG001|Overall Study|Adverse Event|1|||
127785487|NCT02159729|459839668|FG000|Overall Study|Subject's Request|13|||
127785488|NCT02159729|459839669|FG001|Overall Study|Subject's Request|10|||
127785489|NCT02159729|459839668|FG000|Overall Study|Lost to Follow-up|24|||
127785490|NCT02159729|459839669|FG001|Overall Study|Lost to Follow-up|9|||
127785491|NCT02159729|459839668|FG000|Overall Study|Non compliance|2|||
127785492|NCT02159729|459839669|FG001|Overall Study|Non compliance|0|||
127785493|NCT02159729|459839668|FG000|Overall Study|Other Unspecified|3|||
127785494|NCT02159729|459839669|FG001|Overall Study|Other Unspecified|1|||
127785495|NCT01816061|459839672|FG000|Overall Study|Lost to Follow-up|13|||
127785496|NCT01816061|459839673|FG001|Overall Study|Lost to Follow-up|24|||
127785497|NCT01961349|459839674|FG000|Overall Study|Withdrawal by Subject|1|||
127785498|NCT01961349|459839675|FG001|Overall Study|Withdrawal by Subject|4|||
127785499|NCT01961349|459839676|FG002|Overall Study|Withdrawal by Subject|0|||
127785500|NCT01961349|459839674|FG000|Overall Study|Adverse Event|0|||
127785501|NCT01961349|459839675|FG001|Overall Study|Adverse Event|0|||
127785502|NCT01961349|459839676|FG002|Overall Study|Adverse Event|1|||
127785503|NCT01961349|459839674|FG000|Overall Study|registration error, personal reason etc|2|||
127785504|NCT01961349|459839675|FG001|Overall Study|registration error, personal reason etc|2|||
127785505|NCT01961349|459839676|FG002|Overall Study|registration error, personal reason etc|1|||
127785506|NCT01299376|459839677|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
127785507|NCT01299376|459839678|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
127785508|NCT01299376|459839677|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
127785509|NCT01299376|459839678|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
127785510|NCT01299376|459839677|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
127785511|NCT01299376|459839678|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
127785512|NCT01299376|459839677|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
127785513|NCT01299376|459839678|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
127785514|NCT01299376|459839677|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
127785515|NCT01299376|459839678|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
127785516|NCT01299376|459839677|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
127785517|NCT01299376|459839678|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
127785518|NCT01299376|459839677|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
127593964|NCT00843024|459140419|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
127785519|NCT01299376|459839678|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
127785520|NCT01299376|459839677|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
127785521|NCT01299376|459839678|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
127785522|NCT01299376|459839677|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
127785523|NCT01299376|459839678|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
127882202|NCT01901146|460192709|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
127593965|NCT00843024|459140420|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
127593966|NCT00843024|459140415|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
127593967|NCT00843024|459140416|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
127593968|NCT00843024|459140417|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
127593969|NCT00843024|459140418|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
127593970|NCT00843024|459140419|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
127785524|NCT01299376|459839677|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
127785525|NCT01299376|459839678|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
127785526|NCT01299376|459839677|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
127593971|NCT00843024|459140420|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
127593972|NCT00843024|459140415|FG000|Single-blind Placebo Run-In Phase|Other|0|||
127593973|NCT00843024|459140416|FG001|Single-blind Placebo Run-In Phase|Other|1|||
127593974|NCT00843024|459140417|FG002|Single-blind Placebo Run-In Phase|Other|0|||
127593975|NCT00843024|459140418|FG003|Single-blind Placebo Run-In Phase|Other|0|||
127593976|NCT00843024|459140419|FG004|Single-blind Placebo Run-In Phase|Other|0|||
127593977|NCT00843024|459140420|FG005|Single-blind Placebo Run-In Phase|Other|0|||
127593978|NCT00843024|459140415|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
127593979|NCT00843024|459140416|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
127593980|NCT00843024|459140417|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
127593981|NCT00843024|459140418|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
127593982|NCT00843024|459140419|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
127593983|NCT00843024|459140420|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
127593984|NCT00843024|459140415|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
127593985|NCT00843024|459140416|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
127593986|NCT00843024|459140417|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
127593987|NCT00843024|459140418|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
127785527|NCT01299376|459839678|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
127785528|NCT04315181|459839679|FG000|Overall Study|Non-responsive to drug conditions.|1|||
127785529|NCT05879107|459839682|FG000|Overall Study|Withdrawal by participant, not due to an adverse event|5|||
127785530|NCT05879107|459839683|FG001|Overall Study|Withdrawal by participant, not due to an adverse event|7|||
127785531|NCT05879107|459839682|FG000|Overall Study|Migrated / moved from the study area|1|||
127785532|NCT05879107|459839683|FG001|Overall Study|Migrated / moved from the study area|1|||
127785533|NCT05879107|459839682|FG000|Overall Study|Lost to Follow-up|8|||
127785534|NCT05879107|459839683|FG001|Overall Study|Lost to Follow-up|13|||
127785535|NCT05879107|459839682|FG000|Overall Study|Death|0|||
127785536|NCT05879107|459839683|FG001|Overall Study|Death|2|||
127785537|NCT05879107|459839682|FG000|Overall Study|Other|0|||
127785538|NCT05879107|459839683|FG001|Overall Study|Other|3|||
127785539|NCT00843518|459839684|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
127785540|NCT00843518|459839685|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
127785541|NCT00843518|459839684|FG000|Period 2 (Double-blind Treatment)|Death|0|||
127785542|NCT00843518|459839685|FG001|Period 2 (Double-blind Treatment)|Death|1|||
127785543|NCT00843518|459839684|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
127785544|NCT00843518|459839685|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
127785545|NCT00843518|459839684|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
127785546|NCT00843518|459839685|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
127785547|NCT00843518|459839684|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
127785548|NCT00843518|459839685|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
127785549|NCT00843518|459839684|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
127785550|NCT00843518|459839685|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
127785551|NCT00843518|459839684|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
127785552|NCT00843518|459839685|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
127785553|NCT00827606|459839686|FG000|Overall Study|Protocol Violation|4|||
127785554|NCT00827606|459839687|FG001|Overall Study|Protocol Violation|3|||
127785555|NCT00827606|459839686|FG000|Overall Study|Lost to Follow-up|3|||
127785556|NCT00827606|459839687|FG001|Overall Study|Lost to Follow-up|1|||
127785557|NCT00827606|459839686|FG000|Overall Study|Withdrawal by Subject|7|||
128034609|NCT02776735|460753290|FG002|Overall Study|Withdrawal by Subject|0|||
128034610|NCT02776735|460753291|FG003|Overall Study|Withdrawal by Subject|0|||
128034611|NCT02776735|460753292|FG004|Overall Study|Withdrawal by Subject|0|||
128034612|NCT02776735|460753293|FG005|Overall Study|Withdrawal by Subject|1|||
128034613|NCT02776735|460753288|FG000|Overall Study|Other|0|||
127593988|NCT00843024|459140419|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
127785558|NCT00827606|459839687|FG001|Overall Study|Withdrawal by Subject|6|||
127785559|NCT00827606|459839686|FG000|Overall Study|Pregnancy|0|||
127785560|NCT00827606|459839687|FG001|Overall Study|Pregnancy|1|||
127785561|NCT00827606|459839686|FG000|Overall Study|Other|5|||
127785562|NCT00827606|459839687|FG001|Overall Study|Other|13|||
127785563|NCT00827606|459839686|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
127785564|NCT00827606|459839687|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
127593989|NCT00843024|459140420|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
127785565|NCT00827606|459839686|FG000|Overall Study|Adverse Event|4|||
127785566|NCT00827606|459839687|FG001|Overall Study|Adverse Event|2|||
127785567|NCT04037748|459839694|FG000|Treatment Period 1|Withdrawal by Subject|3|||
127785568|NCT04037748|459839695|FG001|Treatment Period 1|Withdrawal by Subject|0|||
127785569|NCT04037748|459839694|FG000|Treatment Period 1|Adverse Event|1|||
127785570|NCT04037748|459839695|FG001|Treatment Period 1|Adverse Event|1|||
127785571|NCT04037748|459839694|FG000|Treatment Period 1|Protocol Violation|4|||
127785572|NCT04037748|459839695|FG001|Treatment Period 1|Protocol Violation|5|||
127785573|NCT04037748|459839694|FG000|Treatment Period 2|Adverse Event|0|||
128034614|NCT02776735|460753289|FG001|Overall Study|Other|0|||
128034615|NCT02776735|460753290|FG002|Overall Study|Other|3|||
128034616|NCT02776735|460753291|FG003|Overall Study|Other|0|||
128034617|NCT02776735|460753292|FG004|Overall Study|Other|0|||
128034618|NCT02776735|460753293|FG005|Overall Study|Other|0|||
128034619|NCT04123704|460754941|FG000|Overall Study|Disease progression|2|||
128034620|NCT03440385|460754942|FG000|Overall Study|Other Reason|4|||
128034621|NCT03440385|460754943|FG001|Overall Study|Other Reason|1|||
128034622|NCT03440385|460754942|FG000|Overall Study|Site Closed|1|||
128034623|NCT03440385|460754943|FG001|Overall Study|Site Closed|0|||
128034624|NCT03440385|460754942|FG000|Overall Study|Lost to Follow-up|2|||
128034625|NCT03440385|460754943|FG001|Overall Study|Lost to Follow-up|0|||
128034626|NCT03440385|460754942|FG000|Overall Study|Withdrawal by Subject|12|||
128034627|NCT03440385|460754943|FG001|Overall Study|Withdrawal by Subject|6|||
128034628|NCT03440385|460754942|FG000|Overall Study|Lack of Efficacy|9|||
128034629|NCT03440385|460754943|FG001|Overall Study|Lack of Efficacy|2|||
128034630|NCT03440385|460754942|FG000|Overall Study|Adverse Event|15|||
128034631|NCT03440385|460754943|FG001|Overall Study|Adverse Event|11|||
128034632|NCT03552029|460754944|FG000|Overall Study|Death|3|||
128034633|NCT03552029|460754945|FG001|Overall Study|Death|0|||
128034634|NCT03552029|460754944|FG000|Overall Study|Adverse Event|1|||
128034635|NCT03552029|460754945|FG001|Overall Study|Adverse Event|0|||
128034636|NCT03552029|460754944|FG000|Overall Study|Lack of Efficacy|0|||
128034637|NCT03552029|460754945|FG001|Overall Study|Lack of Efficacy|2|||
128034638|NCT03552029|460754944|FG000|Overall Study|Physician Decision|0|||
128034639|NCT03552029|460754945|FG001|Overall Study|Physician Decision|1|||
128034640|NCT03552029|460754944|FG000|Overall Study|Study terminated by Sponsor|0|||
128034641|NCT03552029|460754945|FG001|Overall Study|Study terminated by Sponsor|1|||
128034642|NCT03552029|460754944|FG000|Overall Study|Other|0|||
128034643|NCT03552029|460754945|FG001|Overall Study|Other|2|||
128034644|NCT03468998|460754951|FG000|Overall Study|Withdrawal by Subject|1|||
128034645|NCT03468998|460754952|FG001|Overall Study|Withdrawal by Subject|1|||
128034646|NCT03468998|460754953|FG002|Overall Study|Withdrawal by Subject|0|||
128034647|NCT03468998|460754954|FG003|Overall Study|Withdrawal by Subject|4|||
128034648|NCT03468998|460754955|FG004|Overall Study|Withdrawal by Subject|1|||
128034649|NCT03468998|460754956|FG005|Overall Study|Withdrawal by Subject|0|||
128034650|NCT02989857|460754959|FG000|Randomization Phase|Not Treated|3|||
128034651|NCT02989857|460754960|FG001|Randomization Phase|Not Treated|2|||
128034652|NCT02989857|460754961|FG002|Randomization Phase|Not Treated|0|||
128034653|NCT00633126|460754964|FG000|Overall Study|Did not receive full dose|1|||
128034654|NCT02538614|460754967|FG000|Overall Study|Progressive Disease|2|||
128034655|NCT01425814|460754972|FG000|Period 1|Stability criteria not fulfilled|0|||
128034656|NCT01425814|460754973|FG001|Period 1|Stability criteria not fulfilled|1|||
128034657|NCT01425814|460754974|FG002|Period 1|Stability criteria not fulfilled|0|||
128034658|NCT01425814|460754975|FG003|Period 1|Stability criteria not fulfilled|0|||
128034659|NCT01425814|460754976|FG004|Period 1|Stability criteria not fulfilled|0|||
128034660|NCT01425814|460754977|FG005|Period 1|Stability criteria not fulfilled|0|||
128034661|NCT01425814|460754972|FG000|Period 2|Stability criteria not fulfilled|0|||
128034662|NCT01425814|460754973|FG001|Period 2|Stability criteria not fulfilled|1|||
128034663|NCT01425814|460754974|FG002|Period 2|Stability criteria not fulfilled|0|||
128034664|NCT01425814|460754975|FG003|Period 2|Stability criteria not fulfilled|0|||
128034665|NCT01425814|460754976|FG004|Period 2|Stability criteria not fulfilled|0|||
128034666|NCT01425814|460754977|FG005|Period 2|Stability criteria not fulfilled|0|||
128034667|NCT01425814|460754972|FG000|Period 3|Adverse Event|0|||
128034668|NCT01425814|460754973|FG001|Period 3|Adverse Event|0|||
127785574|NCT04037748|459839695|FG001|Treatment Period 2|Adverse Event|1|||
128034669|NCT01425814|460754974|FG002|Period 3|Adverse Event|0|||
127785575|NCT04037748|459839694|FG000|Treatment Period 2|Protocol Violation|2|||
127785576|NCT04037748|459839695|FG001|Treatment Period 2|Protocol Violation|0|||
127882203|NCT01901146|460192710|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
128034670|NCT01425814|460754975|FG003|Period 3|Adverse Event|0|||
128034671|NCT01425814|460754976|FG004|Period 3|Adverse Event|0|||
128034672|NCT01425814|460754977|FG005|Period 3|Adverse Event|1|||
128034673|NCT01425814|460754972|FG000|Period 4|Adverse Event|1|||
128034674|NCT01425814|460754973|FG001|Period 4|Adverse Event|0|||
128034675|NCT01425814|460754974|FG002|Period 4|Adverse Event|1|||
128034676|NCT01425814|460754975|FG003|Period 4|Adverse Event|0|||
128034677|NCT01425814|460754976|FG004|Period 4|Adverse Event|0|||
128034678|NCT01425814|460754977|FG005|Period 4|Adverse Event|0|||
128034679|NCT01425814|460754972|FG000|Period 5|Stability criteria not fulfilled|0|||
128034680|NCT01425814|460754973|FG001|Period 5|Stability criteria not fulfilled|0|||
127882204|NCT01901146|460192706|FG000|Neoadjuvant Phase|Physician Decision|1|||
127882205|NCT01901146|460192707|FG001|Neoadjuvant Phase|Physician Decision|2|||
127882206|NCT01901146|460192708|FG002|Neoadjuvant Phase|Physician Decision|0|||
127882207|NCT01901146|460192709|FG003|Neoadjuvant Phase|Physician Decision|0|||
127882208|NCT01901146|460192710|FG004|Neoadjuvant Phase|Physician Decision|0|||
127882209|NCT01901146|460192706|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
127882210|NCT01901146|460192707|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
127882211|NCT01901146|460192708|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
127882212|NCT01901146|460192709|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
127882213|NCT01901146|460192710|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
127882214|NCT01901146|460192706|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
127882215|NCT01901146|460192707|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
127882216|NCT01901146|460192708|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
127882217|NCT01901146|460192709|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
128034681|NCT01425814|460754974|FG002|Period 5|Stability criteria not fulfilled|1|||
128034682|NCT01425814|460754975|FG003|Period 5|Stability criteria not fulfilled|0|||
127593990|NCT00843024|459140415|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
127593991|NCT00843024|459140416|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
127593992|NCT00843024|459140417|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
127593993|NCT00843024|459140418|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
127593994|NCT00843024|459140419|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
127593995|NCT00843024|459140420|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
127593996|NCT00843024|459140415|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
127593997|NCT00843024|459140416|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
127593998|NCT00843024|459140417|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
127593999|NCT00843024|459140418|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
127594000|NCT00843024|459140419|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
127594001|NCT00843024|459140420|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
127594002|NCT00843024|459140415|FG000|Double-blind Treatment Phase|Physician Decision|0|||
127594003|NCT00843024|459140416|FG001|Double-blind Treatment Phase|Physician Decision|0|||
127594004|NCT00843024|459140417|FG002|Double-blind Treatment Phase|Physician Decision|0|||
127594005|NCT00843024|459140418|FG003|Double-blind Treatment Phase|Physician Decision|3|||
127594006|NCT00843024|459140419|FG004|Double-blind Treatment Phase|Physician Decision|1|||
127594007|NCT00843024|459140420|FG005|Double-blind Treatment Phase|Physician Decision|1|||
127594008|NCT00843024|459140415|FG000|Double-blind Treatment Phase|Adverse Event|0|||
127594009|NCT00843024|459140416|FG001|Double-blind Treatment Phase|Adverse Event|0|||
127594010|NCT00843024|459140417|FG002|Double-blind Treatment Phase|Adverse Event|0|||
127594011|NCT00843024|459140418|FG003|Double-blind Treatment Phase|Adverse Event|0|||
127594012|NCT00843024|459140419|FG004|Double-blind Treatment Phase|Adverse Event|1|||
127594013|NCT00843024|459140420|FG005|Double-blind Treatment Phase|Adverse Event|1|||
127594014|NCT00843024|459140415|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
127594015|NCT00843024|459140416|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
127594016|NCT00843024|459140417|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
127594017|NCT00843024|459140418|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
127594018|NCT00843024|459140419|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
127594019|NCT00843024|459140420|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
127594020|NCT02439138|459140422|FG000|Overall Study|Adverse Event|1|||
127594021|NCT02439138|459140422|FG000|Overall Study|PI decision to terminate the study|2|||
127882218|NCT01901146|460192710|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
127882219|NCT01901146|460192706|FG000|Adjuvant Phase|Other|0|||
127882220|NCT01901146|460192707|FG001|Adjuvant Phase|Other|0|||
127882221|NCT01901146|460192708|FG002|Adjuvant Phase|Other|1|||
128034683|NCT01425814|460754976|FG004|Period 5|Stability criteria not fulfilled|0|||
128034684|NCT01425814|460754977|FG005|Period 5|Stability criteria not fulfilled|1|||
127882222|NCT01901146|460192709|FG003|Adjuvant Phase|Other|0|||
128034685|NCT00565747|460754979|FG000|Overall Study|No embryo transfer|67|||
128034686|NCT00565747|460754980|FG001|Overall Study|No embryo transfer|73|||
128034687|NCT02684461|460754983|FG000|Overall Study|Adverse Event|1|||
128034688|NCT02684461|460754984|FG001|Overall Study|Adverse Event|0|||
128034689|NCT02684461|460754985|FG002|Overall Study|Adverse Event|0|||
128034690|NCT02684461|460754983|FG000|Overall Study|Lack of Efficacy|1|||
128034691|NCT02684461|460754984|FG001|Overall Study|Lack of Efficacy|2|||
127882223|NCT01901146|460192710|FG004|Adjuvant Phase|Other|0|||
127882224|NCT01901146|460192706|FG000|Adjuvant Phase|Death|0|||
128034692|NCT02684461|460754985|FG002|Overall Study|Lack of Efficacy|0|||
128034693|NCT02138825|460754986|FG000|Main Study Treatment|Adverse Event|11|||
128034694|NCT02138825|460754987|FG001|Main Study Treatment|Adverse Event|3|||
127594022|NCT00006237|459140427|FG000|Overall Study|Adverse Event|39|||
128034695|NCT02138825|460754986|FG000|Main Study Treatment|Death|1|||
127594023|NCT00006237|459140428|FG001|Overall Study|Adverse Event|29|||
127594024|NCT00006237|459140427|FG000|Overall Study|Death|1|||
127594025|NCT00006237|459140428|FG001|Overall Study|Death|0|||
128034696|NCT02138825|460754987|FG001|Main Study Treatment|Death|2|||
127594026|NCT00006237|459140427|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
127594027|NCT00006237|459140428|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
127594028|NCT00006237|459140427|FG000|Overall Study|Progression/relapse|54|||
127594029|NCT00006237|459140428|FG001|Overall Study|Progression/relapse|2|||
127594030|NCT00006237|459140427|FG000|Overall Study|Not eligible|9|||
127594031|NCT00006237|459140428|FG001|Overall Study|Not eligible|20|||
127594032|NCT00006237|459140427|FG000|Overall Study|Withdrawal by Subject|0|||
127594033|NCT00006237|459140428|FG001|Overall Study|Withdrawal by Subject|1|||
127594034|NCT00006237|459140427|FG000|Overall Study|Not protocol specified|14|||
127594035|NCT00006237|459140428|FG001|Overall Study|Not protocol specified|5|||
127594036|NCT01846416|459140431|FG000|Treatment Phase|Death|2|||
127594037|NCT01846416|459140432|FG001|Treatment Phase|Death|9|||
127594038|NCT01846416|459140433|FG002|Treatment Phase|Death|1|||
127594039|NCT01846416|459140431|FG000|Treatment Phase|Withdrawal by Subject|2|||
127594040|NCT01846416|459140432|FG001|Treatment Phase|Withdrawal by Subject|4|||
127594041|NCT01846416|459140433|FG002|Treatment Phase|Withdrawal by Subject|2|||
127594042|NCT01846416|459140431|FG000|Treatment Phase|Other|1|||
127594043|NCT01846416|459140432|FG001|Treatment Phase|Other|5|||
127594044|NCT01846416|459140433|FG002|Treatment Phase|Other|1|||
127594045|NCT01846416|459140431|FG000|Treatment Phase|Physician Decision|1|||
127594046|NCT01846416|459140432|FG001|Treatment Phase|Physician Decision|2|||
127594047|NCT01846416|459140433|FG002|Treatment Phase|Physician Decision|0|||
127594048|NCT01846416|459140431|FG000|Treatment Phase|Adverse Event|3|||
127594049|NCT01846416|459140432|FG001|Treatment Phase|Adverse Event|4|||
127594050|NCT01846416|459140433|FG002|Treatment Phase|Adverse Event|0|||
127594051|NCT01846416|459140431|FG000|Treatment Phase|Non-compliance|0|||
127594052|NCT01846416|459140432|FG001|Treatment Phase|Non-compliance|2|||
127594053|NCT01846416|459140433|FG002|Treatment Phase|Non-compliance|0|||
127594054|NCT01846416|459140431|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
127594055|NCT01846416|459140432|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
127594056|NCT01846416|459140433|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
127594057|NCT01846416|459140431|FG000|Treatment Phase|Progressive Disease|21|||
127594058|NCT01846416|459140432|FG001|Treatment Phase|Progressive Disease|63|||
127594059|NCT01846416|459140433|FG002|Treatment Phase|Progressive Disease|9|||
127785577|NCT04544475|459839700|FG000|Overall Study|Withdrawal by Subject|1|||
127785578|NCT04544475|459839701|FG001|Overall Study|Withdrawal by Subject|3|||
127594060|NCT01846416|459140431|FG000|Survival Follow-up|Death|21|||
127594061|NCT01846416|459140432|FG001|Survival Follow-up|Death|62|||
127594062|NCT01846416|459140433|FG002|Survival Follow-up|Death|9|||
127785579|NCT01378858|459839702|FG000|Overall Study|Withdrawal by Subject|4|||
127785580|NCT01378858|459839703|FG001|Overall Study|Withdrawal by Subject|4|||
127785581|NCT00942175|459839704|FG000|Overall Study|Adverse Event|2|||
127785582|NCT00942175|459839705|FG001|Overall Study|Adverse Event|1|||
127785583|NCT00942175|459839706|FG002|Overall Study|Adverse Event|0|||
127785584|NCT00942175|459839707|FG003|Overall Study|Adverse Event|0|||
127785585|NCT00942175|459839704|FG000|Overall Study|Protocol Violation|0|||
127785586|NCT00942175|459839705|FG001|Overall Study|Protocol Violation|1|||
127785587|NCT00942175|459839706|FG002|Overall Study|Protocol Violation|2|||
127785588|NCT00942175|459839707|FG003|Overall Study|Protocol Violation|0|||
127785589|NCT00942175|459839704|FG000|Overall Study|Pregnancy|0|||
127785590|NCT00942175|459839705|FG001|Overall Study|Pregnancy|0|||
127785591|NCT00942175|459839706|FG002|Overall Study|Pregnancy|0|||
127785592|NCT00942175|459839707|FG003|Overall Study|Pregnancy|1|||
127785593|NCT00942175|459839704|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
127785594|NCT00942175|459839705|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
127785595|NCT00942175|459839706|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
127785596|NCT00942175|459839707|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
127785597|NCT00942175|459839704|FG000|Overall Study|Low Platelet Count|0|||
127785598|NCT00942175|459839705|FG001|Overall Study|Low Platelet Count|2|||
127785599|NCT00942175|459839706|FG002|Overall Study|Low Platelet Count|0|||
127785600|NCT00942175|459839707|FG003|Overall Study|Low Platelet Count|0|||
127785601|NCT02664272|459839708|FG000|Overall Study|Fluoroscopic images not made available|2|||
128034697|NCT02138825|460754986|FG000|Main Study Treatment|Protocol Violation|2|||
127594063|NCT01846416|459140431|FG000|Survival Follow-up|Lost to Follow-up|0|||
127594064|NCT01846416|459140432|FG001|Survival Follow-up|Lost to Follow-up|2|||
127594065|NCT01846416|459140433|FG002|Survival Follow-up|Lost to Follow-up|2|||
127594066|NCT01846416|459140431|FG000|Survival Follow-up|Withdrawal by Subject|2|||
127594067|NCT01846416|459140432|FG001|Survival Follow-up|Withdrawal by Subject|7|||
127594068|NCT01846416|459140433|FG002|Survival Follow-up|Withdrawal by Subject|0|||
127785602|NCT03073980|459839709|FG000|Overall Study|Lost to Follow-up|10|||
127785603|NCT03073980|459839710|FG001|Overall Study|Lost to Follow-up|2|||
127785604|NCT03073980|459839711|FG002|Overall Study|Lost to Follow-up|9|||
127785605|NCT03073980|459839709|FG000|Overall Study|No post-procedure data|0|||
127785606|NCT03073980|459839710|FG001|Overall Study|No post-procedure data|0|||
127785607|NCT03073980|459839711|FG002|Overall Study|No post-procedure data|2|||
127785608|NCT00501007|459839712|FG000|Overall Study|Inclusion criteria not met.|29|||
127594069|NCT01846416|459140431|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
127594070|NCT01846416|459140432|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
127882225|NCT01901146|460192707|FG001|Adjuvant Phase|Death|0|||
127882226|NCT01901146|460192708|FG002|Adjuvant Phase|Death|0|||
127882227|NCT01901146|460192709|FG003|Adjuvant Phase|Death|0|||
127882228|NCT01901146|460192710|FG004|Adjuvant Phase|Death|3|||
127882229|NCT01901146|460192706|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
127882230|NCT01901146|460192707|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
127882231|NCT01901146|460192708|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
127882232|NCT01901146|460192709|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
127882233|NCT01901146|460192710|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
127882234|NCT01901146|460192706|FG000|Adjuvant Phase|Physician Decision|0|||
127882235|NCT01901146|460192707|FG001|Adjuvant Phase|Physician Decision|0|||
127882236|NCT01901146|460192708|FG002|Adjuvant Phase|Physician Decision|9|||
127882237|NCT01901146|460192709|FG003|Adjuvant Phase|Physician Decision|2|||
127882238|NCT01901146|460192710|FG004|Adjuvant Phase|Physician Decision|4|||
127882239|NCT01901146|460192706|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
127882240|NCT01901146|460192707|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
127882241|NCT01901146|460192708|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
127882242|NCT01901146|460192709|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
127882243|NCT01901146|460192710|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
127882244|NCT02996448|460192713|FG000|Overall Study|Study terminated due to adverse effects|3|||
127882245|NCT00606801|460192714|FG000|Intervention|Protocol Violation|3|||
127882246|NCT00606801|460192715|FG001|Intervention|Protocol Violation|3|||
127882247|NCT00303316|460192718|FG000|Overall Study|Protocol Violation|1|||
127882248|NCT00303316|460192719|FG001|Overall Study|Protocol Violation|0|||
127882249|NCT00303316|460192718|FG000|Overall Study|Lost to Follow-up|0|||
128034698|NCT02138825|460754987|FG001|Main Study Treatment|Protocol Violation|2|||
128034699|NCT02138825|460754986|FG000|Main Study Treatment|Sponsor decision|12|||
127594071|NCT01846416|459140433|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
127594072|NCT01846416|459140431|FG000|Survival Follow-up|Other|3|||
127594073|NCT01846416|459140432|FG001|Survival Follow-up|Other|1|||
127594074|NCT01846416|459140433|FG002|Survival Follow-up|Other|1|||
127594075|NCT02837783|459140436|FG000|Overall Study|Adverse Event|1|||
127594076|NCT02837783|459140437|FG001|Overall Study|Adverse Event|0|||
127594077|NCT02837783|459140436|FG000|Overall Study|Other, Not Specified|1|||
127594078|NCT02837783|459140437|FG001|Overall Study|Other, Not Specified|2|||
127695111|NCT01261312|459512910|FG006|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
127695112|NCT01261312|459512911|FG007|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
127695113|NCT01261312|459512912|FG008|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
127695114|NCT01261312|459512913|FG009|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
127695115|NCT01261312|459512914|FG010|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
127695116|NCT01261312|459512915|FG011|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
127695117|NCT01261312|459512916|FG012|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
127695118|NCT01261312|459512904|FG000|Dose Escalation Phase (Day 0- Week 170)|Death|5|||
127695119|NCT01261312|459512905|FG001|Dose Escalation Phase (Day 0- Week 170)|Death|4|||
127695120|NCT01261312|459512906|FG002|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
127695121|NCT01261312|459512907|FG003|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
127695122|NCT01261312|459512908|FG004|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
127695123|NCT01261312|459512909|FG005|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
127695124|NCT01261312|459512910|FG006|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
127695125|NCT01261312|459512911|FG007|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
127695126|NCT01261312|459512912|FG008|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
127695127|NCT01261312|459512913|FG009|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
127695128|NCT01261312|459512914|FG010|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
127695129|NCT01261312|459512915|FG011|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
127695130|NCT01261312|459512916|FG012|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
127695131|NCT01261312|459512904|FG000|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|4|||
127695132|NCT01261312|459512905|FG001|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|1|||
127695133|NCT01261312|459512906|FG002|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|3|||
127695134|NCT01261312|459512907|FG003|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
127695135|NCT01261312|459512908|FG004|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
127695136|NCT01261312|459512909|FG005|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
127695137|NCT01261312|459512910|FG006|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
127882250|NCT00303316|460192719|FG001|Overall Study|Lost to Follow-up|1|||
127882251|NCT00303316|460192718|FG000|Overall Study|Withdrawal by Subject|1|||
127882252|NCT00303316|460192719|FG001|Overall Study|Withdrawal by Subject|2|||
127882253|NCT01586624|460192720|FG000|Overall Study|Adverse Event|3|||
127882254|NCT01586624|460192721|FG001|Overall Study|Adverse Event|0|||
127882255|NCT01586624|460192722|FG002|Overall Study|Adverse Event|2|||
127594079|NCT01487200|459140438|FG000|Overall Study|Withdrawal by Subject|0|||
127594080|NCT01487200|459140439|FG001|Overall Study|Withdrawal by Subject|1|||
127594081|NCT01487200|459140440|FG002|Overall Study|Withdrawal by Subject|0|||
127695138|NCT01261312|459512911|FG007|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
127695139|NCT01261312|459512912|FG008|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
127695140|NCT01261312|459512913|FG009|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
127695141|NCT01261312|459512914|FG010|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
127695142|NCT01261312|459512915|FG011|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
127695143|NCT01261312|459512916|FG012|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
127695144|NCT01261312|459512904|FG000|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
127695145|NCT01261312|459512905|FG001|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
127695146|NCT01261312|459512906|FG002|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
127695147|NCT01261312|459512907|FG003|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
127695148|NCT01261312|459512908|FG004|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
127695149|NCT01261312|459512909|FG005|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
127695150|NCT01261312|459512910|FG006|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
127695151|NCT01261312|459512911|FG007|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
127695152|NCT01261312|459512912|FG008|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
127695153|NCT01261312|459512913|FG009|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
127695154|NCT01261312|459512914|FG010|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
127695155|NCT01261312|459512915|FG011|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
127695156|NCT01261312|459512916|FG012|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
127695157|NCT01261312|459512904|FG000|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|3|||
127695158|NCT01261312|459512905|FG001|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
127695159|NCT01261312|459512906|FG002|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|2|||
127695160|NCT01261312|459512907|FG003|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
127695161|NCT01261312|459512908|FG004|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
127695162|NCT01261312|459512909|FG005|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
127695163|NCT01261312|459512910|FG006|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
127695164|NCT01261312|459512911|FG007|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
127695165|NCT01261312|459512912|FG008|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
127695166|NCT01261312|459512913|FG009|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
127695167|NCT01261312|459512914|FG010|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
127695168|NCT01261312|459512915|FG011|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
127695169|NCT01261312|459512916|FG012|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
127695170|NCT01261312|459512904|FG000|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
127695171|NCT01261312|459512905|FG001|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
127695172|NCT01261312|459512906|FG002|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
127695173|NCT01261312|459512907|FG003|DE Phase: r/r AML (Week 75-242)|Progressive Disease|14|||
127695174|NCT01261312|459512908|FG004|DE Phase: r/r AML (Week 75-242)|Progressive Disease|16|||
127695175|NCT01261312|459512909|FG005|DE Phase: r/r AML (Week 75-242)|Progressive Disease|24|||
127695176|NCT01261312|459512910|FG006|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
127695177|NCT01261312|459512911|FG007|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
127695178|NCT01261312|459512912|FG008|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
127695179|NCT01261312|459512913|FG009|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
127695180|NCT01261312|459512914|FG010|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
127695181|NCT01261312|459512915|FG011|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
127695182|NCT01261312|459512916|FG012|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
127695183|NCT01261312|459512904|FG000|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
127695184|NCT01261312|459512905|FG001|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
127695185|NCT01261312|459512906|FG002|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
127695186|NCT01261312|459512907|FG003|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
127695187|NCT01261312|459512908|FG004|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
127695188|NCT01261312|459512909|FG005|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
127695189|NCT01261312|459512910|FG006|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
127695190|NCT01261312|459512911|FG007|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
127695191|NCT01261312|459512912|FG008|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
127695192|NCT01261312|459512913|FG009|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
127695193|NCT01261312|459512914|FG010|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
127695194|NCT01261312|459512915|FG011|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
127785609|NCT00501007|459839713|FG001|Overall Study|Inclusion criteria not met.|25|||
127785610|NCT00545064|459839714|FG000|Overall Study|Lost to Follow-up|3|||
127785611|NCT00545064|459839714|FG000|Overall Study|Withdrawal by Subject|2|||
127785612|NCT00545064|459839714|FG000|Overall Study|did not complete course of treatment|1|||
127785613|NCT00545064|459839714|FG000|Overall Study|cancel all appointments, no rebooking|1|||
127785614|NCT00545064|459839714|FG000|Overall Study|inclement weather|1|||
127785615|NCT00258674|459839717|FG000|Overall Study|Death|32|||
127785616|NCT00258674|459839718|FG001|Overall Study|Death|53|||
127695195|NCT01261312|459512916|FG012|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
127695196|NCT01261312|459512904|FG000|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
127695197|NCT01261312|459512905|FG001|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
127695198|NCT01261312|459512906|FG002|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
127695199|NCT01261312|459512907|FG003|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
127695200|NCT01261312|459512908|FG004|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|1|||
127695201|NCT01261312|459512909|FG005|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|2|||
127695202|NCT01261312|459512910|FG006|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
127695203|NCT01261312|459512911|FG007|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
127695204|NCT01261312|459512912|FG008|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
127695205|NCT01261312|459512913|FG009|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
127695206|NCT01261312|459512914|FG010|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
127695207|NCT01261312|459512915|FG011|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
127695208|NCT01261312|459512916|FG012|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
127695209|NCT01261312|459512904|FG000|DE Phase: r/r AML (Week 75-242)|Death|0|||
127695210|NCT01261312|459512905|FG001|DE Phase: r/r AML (Week 75-242)|Death|0|||
127695211|NCT01261312|459512906|FG002|DE Phase: r/r AML (Week 75-242)|Death|0|||
127695212|NCT01261312|459512907|FG003|DE Phase: r/r AML (Week 75-242)|Death|4|||
127695213|NCT01261312|459512908|FG004|DE Phase: r/r AML (Week 75-242)|Death|3|||
127695214|NCT01261312|459512909|FG005|DE Phase: r/r AML (Week 75-242)|Death|10|||
127695215|NCT01261312|459512910|FG006|DE Phase: r/r AML (Week 75-242)|Death|0|||
127695216|NCT01261312|459512911|FG007|DE Phase: r/r AML (Week 75-242)|Death|0|||
127695217|NCT01261312|459512912|FG008|DE Phase: r/r AML (Week 75-242)|Death|0|||
127695218|NCT01261312|459512913|FG009|DE Phase: r/r AML (Week 75-242)|Death|0|||
127695219|NCT01261312|459512914|FG010|DE Phase: r/r AML (Week 75-242)|Death|0|||
127695220|NCT01261312|459512915|FG011|DE Phase: r/r AML (Week 75-242)|Death|0|||
127695221|NCT01261312|459512916|FG012|DE Phase: r/r AML (Week 75-242)|Death|0|||
127695222|NCT01261312|459512904|FG000|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
127695223|NCT01261312|459512905|FG001|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
127785617|NCT00258674|459839719|FG002|Overall Study|Death|34|||
127785618|NCT03715153|459839720|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
127785619|NCT03715153|459839721|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
127695224|NCT01261312|459512906|FG002|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
127695225|NCT01261312|459512907|FG003|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
127695226|NCT01261312|459512908|FG004|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
127695227|NCT01261312|459512909|FG005|DE Phase: r/r AML (Week 75-242)|Investigator Decision|6|||
127695228|NCT01261312|459512910|FG006|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
128034700|NCT02138825|460754987|FG001|Main Study Treatment|Sponsor decision|18|||
128034701|NCT02138825|460754986|FG000|Main Study Treatment|Study terminated by sponsor|10|||
128034702|NCT02138825|460754987|FG001|Main Study Treatment|Study terminated by sponsor|9|||
128034703|NCT02138825|460754986|FG000|Main Study Treatment|Withdrawal by Subject|3|||
127594082|NCT01487200|459140441|FG003|Overall Study|Withdrawal by Subject|0|||
127594083|NCT02207244|459140442|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
127594084|NCT02207244|459140443|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
127594085|NCT02207244|459140444|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
127594086|NCT02207244|459140445|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
127594087|NCT02207244|459140446|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
127594088|NCT02207244|459140447|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
127594089|NCT02207244|459140448|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
127594090|NCT02207244|459140449|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
127594091|NCT02207244|459140450|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
127594092|NCT02207244|459140451|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
127594093|NCT02207244|459140452|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
127594094|NCT02207244|459140442|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
127594095|NCT02207244|459140443|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
127594096|NCT02207244|459140444|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
127594097|NCT02207244|459140445|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
127594098|NCT02207244|459140446|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
127594099|NCT02207244|459140447|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
127594100|NCT02207244|459140448|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
127594101|NCT02207244|459140449|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
127594102|NCT02207244|459140450|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
127594103|NCT02207244|459140451|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
127594104|NCT02207244|459140452|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
127594105|NCT02207244|459140442|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
127594106|NCT02207244|459140443|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
127594107|NCT02207244|459140444|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
127594108|NCT02207244|459140445|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
127594109|NCT02207244|459140446|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
127594110|NCT02207244|459140447|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
127594111|NCT02207244|459140448|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
127594112|NCT02207244|459140449|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
127594113|NCT02207244|459140450|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
127594114|NCT02207244|459140451|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
127594115|NCT02207244|459140452|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
127594116|NCT02207244|459140442|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
127594117|NCT02207244|459140443|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
127594118|NCT02207244|459140444|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
127785620|NCT03715153|459839720|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
127785621|NCT03715153|459839721|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
127785622|NCT03715153|459839720|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
127785623|NCT03715153|459839721|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
127785624|NCT03715153|459839720|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
127785625|NCT03715153|459839721|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
127785626|NCT03715153|459839720|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
127785627|NCT03715153|459839721|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
127594119|NCT02207244|459140445|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
127594120|NCT02207244|459140446|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
128034704|NCT02138825|460754987|FG001|Main Study Treatment|Withdrawal by Subject|1|||
128034705|NCT02138825|460754986|FG000|Main Study Treatment|Medical decision|1|||
128034706|NCT02138825|460754987|FG001|Main Study Treatment|Medical decision|0|||
127594121|NCT02207244|459140447|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
127594122|NCT02207244|459140448|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
127594123|NCT02207244|459140449|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
127594124|NCT02207244|459140450|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
127594125|NCT02207244|459140451|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
127594126|NCT02207244|459140452|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
127594127|NCT02207244|459140442|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
127594128|NCT02207244|459140443|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
127785628|NCT03715153|459839720|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
127785629|NCT03715153|459839721|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
128034707|NCT02138825|460754986|FG000|Long-term Extension|Study termination by sponsor|32|||
128034708|NCT02138825|460754987|FG001|Long-term Extension|Study termination by sponsor|38|||
127594129|NCT02207244|459140444|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
127594130|NCT02207244|459140445|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
127594131|NCT02207244|459140446|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
127594132|NCT02207244|459140447|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
127594133|NCT02207244|459140448|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
127594134|NCT02207244|459140449|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
127594135|NCT02207244|459140450|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
127594136|NCT02207244|459140451|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
127594137|NCT02207244|459140452|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
127594138|NCT02207244|459140442|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
127594139|NCT02207244|459140443|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
127594140|NCT02207244|459140444|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
127594141|NCT02207244|459140445|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
127594142|NCT02207244|459140446|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
127594143|NCT02207244|459140447|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
127594144|NCT02207244|459140448|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
127594145|NCT02207244|459140449|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
127594146|NCT02207244|459140450|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
127594147|NCT02207244|459140451|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
127594148|NCT02207244|459140452|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
127594149|NCT02207244|459140442|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
127594150|NCT02207244|459140443|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
127594151|NCT02207244|459140444|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
127594152|NCT02207244|459140445|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
127594153|NCT02207244|459140446|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
127594154|NCT02207244|459140447|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
127594155|NCT02207244|459140448|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
127594156|NCT02207244|459140449|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
127594157|NCT02207244|459140450|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
127594158|NCT02207244|459140451|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
127594159|NCT02207244|459140452|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
127594160|NCT02207244|459140442|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
127594161|NCT02207244|459140443|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
127594162|NCT02207244|459140444|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
127594163|NCT02207244|459140445|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
127594164|NCT02207244|459140446|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
127594165|NCT02207244|459140447|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
127594166|NCT02207244|459140448|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
127594167|NCT02207244|459140449|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
127594168|NCT02207244|459140450|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
127594169|NCT02207244|459140451|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
127594170|NCT02207244|459140452|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
127594171|NCT02207244|459140442|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
127594172|NCT02207244|459140443|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
127594173|NCT02207244|459140444|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
127594174|NCT02207244|459140445|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
127594175|NCT02207244|459140446|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
127594176|NCT02207244|459140447|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
127594177|NCT02207244|459140448|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
127594178|NCT02207244|459140449|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
127594179|NCT02207244|459140450|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
127594180|NCT02207244|459140451|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
127594181|NCT02207244|459140452|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
127594182|NCT02207244|459140442|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
127594183|NCT02207244|459140443|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
127594184|NCT02207244|459140444|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
127594185|NCT02207244|459140445|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
127594186|NCT02207244|459140446|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
127594187|NCT02207244|459140447|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
127594188|NCT02207244|459140448|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
127594189|NCT02207244|459140449|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
127594190|NCT02207244|459140450|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
127594191|NCT02207244|459140451|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
127594192|NCT02207244|459140452|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
127594193|NCT02207244|459140442|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
127594194|NCT02207244|459140443|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
127594195|NCT02207244|459140444|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
127594196|NCT02207244|459140445|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
127594197|NCT02207244|459140446|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
127594198|NCT02207244|459140447|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
127594199|NCT02207244|459140448|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
127594200|NCT02207244|459140449|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
127594201|NCT02207244|459140450|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
127594202|NCT02207244|459140451|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
127695229|NCT01261312|459512911|FG007|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
127695230|NCT01261312|459512912|FG008|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
127785630|NCT01358760|459839726|FG000|Overall Study|Adverse Event|3|||
127785631|NCT01358760|459839727|FG001|Overall Study|Adverse Event|4|||
127785632|NCT01358760|459839728|FG002|Overall Study|Adverse Event|3|||
127785633|NCT01358760|459839726|FG000|Overall Study|Lost to Follow-up|1|||
127785634|NCT01358760|459839727|FG001|Overall Study|Lost to Follow-up|1|||
127785635|NCT01358760|459839728|FG002|Overall Study|Lost to Follow-up|3|||
127785636|NCT01358760|459839726|FG000|Overall Study|Withdrawal by Subject|5|||
127785637|NCT01358760|459839727|FG001|Overall Study|Withdrawal by Subject|3|||
127785638|NCT01358760|459839728|FG002|Overall Study|Withdrawal by Subject|2|||
127785639|NCT01358760|459839726|FG000|Overall Study|Physician Decision|1|||
127785640|NCT01358760|459839727|FG001|Overall Study|Physician Decision|0|||
127785641|NCT01358760|459839728|FG002|Overall Study|Physician Decision|1|||
127785642|NCT01358760|459839726|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
127785643|NCT01358760|459839727|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
127785644|NCT01358760|459839728|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
127785645|NCT00597753|459839731|FG000|Overall Study|Adverse Event|6|||
127785646|NCT00597753|459839732|FG001|Overall Study|Adverse Event|2|||
127785647|NCT00597753|459839731|FG000|Overall Study|Death|55|||
127785648|NCT00597753|459839732|FG001|Overall Study|Death|29|||
127785649|NCT00597753|459839731|FG000|Overall Study|Lack of Efficacy|2|||
127785650|NCT00597753|459839732|FG001|Overall Study|Lack of Efficacy|0|||
127785651|NCT00597753|459839731|FG000|Overall Study|Lost to Follow-up|10|||
127785652|NCT00597753|459839732|FG001|Overall Study|Lost to Follow-up|3|||
127785653|NCT00597753|459839731|FG000|Overall Study|Physician Decision|5|||
127785654|NCT00597753|459839732|FG001|Overall Study|Physician Decision|1|||
127785655|NCT00597753|459839731|FG000|Overall Study|Pregnancy|1|||
127785656|NCT00597753|459839732|FG001|Overall Study|Pregnancy|0|||
127785657|NCT00597753|459839731|FG000|Overall Study|Withdrawal by Subject|35|||
127785658|NCT00597753|459839732|FG001|Overall Study|Withdrawal by Subject|12|||
127785659|NCT00597753|459839731|FG000|Overall Study|Discontinued Dialysis|0|||
127785660|NCT00597753|459839732|FG001|Overall Study|Discontinued Dialysis|1|||
127785661|NCT00597753|459839731|FG000|Overall Study|Never dosed|2|||
127785662|NCT00597753|459839732|FG001|Overall Study|Never dosed|0|||
127695231|NCT01261312|459512913|FG009|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
127695232|NCT01261312|459512914|FG010|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
127695233|NCT01261312|459512915|FG011|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
127695234|NCT01261312|459512916|FG012|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
127695235|NCT01261312|459512904|FG000|DE Phase: r/r AML (Week 75-242)|HCT|0|||
127695236|NCT01261312|459512905|FG001|DE Phase: r/r AML (Week 75-242)|HCT|0|||
127695237|NCT01261312|459512906|FG002|DE Phase: r/r AML (Week 75-242)|HCT|0|||
127695238|NCT01261312|459512907|FG003|DE Phase: r/r AML (Week 75-242)|HCT|5|||
127695239|NCT01261312|459512908|FG004|DE Phase: r/r AML (Week 75-242)|HCT|3|||
127695240|NCT01261312|459512909|FG005|DE Phase: r/r AML (Week 75-242)|HCT|9|||
127695241|NCT01261312|459512910|FG006|DE Phase: r/r AML (Week 75-242)|HCT|0|||
127695242|NCT01261312|459512911|FG007|DE Phase: r/r AML (Week 75-242)|HCT|0|||
127695243|NCT01261312|459512912|FG008|DE Phase: r/r AML (Week 75-242)|HCT|0|||
127695244|NCT01261312|459512913|FG009|DE Phase: r/r AML (Week 75-242)|HCT|0|||
127695245|NCT01261312|459512914|FG010|DE Phase: r/r AML (Week 75-242)|HCT|0|||
127695246|NCT01261312|459512915|FG011|DE Phase: r/r AML (Week 75-242)|HCT|0|||
127695247|NCT01261312|459512916|FG012|DE Phase: r/r AML (Week 75-242)|HCT|0|||
127695248|NCT01261312|459512904|FG000|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
127695249|NCT01261312|459512905|FG001|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
127695250|NCT01261312|459512906|FG002|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
127695251|NCT01261312|459512907|FG003|DE Phase: r/r AML (Week 75-242)|Reason not Specified|1|||
127785663|NCT00597753|459839731|FG000|Overall Study|Noncompliance|2|||
127785664|NCT00597753|459839732|FG001|Overall Study|Noncompliance|1|||
127785665|NCT00597753|459839731|FG000|Overall Study|Relocation|17|||
127785666|NCT00597753|459839732|FG001|Overall Study|Relocation|6|||
127785667|NCT00597753|459839731|FG000|Overall Study|Renal transplant|10|||
127785668|NCT00597753|459839732|FG001|Overall Study|Renal transplant|3|||
127785669|NCT00597753|459839731|FG000|Overall Study|Site closed by sponsor|19|||
127785670|NCT00597753|459839732|FG001|Overall Study|Site closed by sponsor|7|||
127594203|NCT02207244|459140452|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
127785671|NCT00597753|459839731|FG000|Overall Study|Site elected to close|2|||
127785672|NCT00597753|459839732|FG001|Overall Study|Site elected to close|4|||
127785673|NCT03451851|459839733|FG000|PCP: Week 0 -16|Adverse Event|1|||
127785674|NCT03451851|459839734|FG001|PCP: Week 0 -16|Adverse Event|0|||
127785675|NCT03451851|459839735|FG002|PCP: Week 0 -16|Adverse Event|0|||
127785676|NCT03451851|459839736|FG003|PCP: Week 0 -16|Adverse Event|0|||
127785677|NCT03451851|459839737|FG004|PCP: Week 0 -16|Adverse Event|0|||
127785678|NCT03451851|459839738|FG005|PCP: Week 0 -16|Adverse Event|0|||
127785679|NCT03451851|459839739|FG006|PCP: Week 0 -16|Adverse Event|1|||
127785680|NCT03451851|459839740|FG007|PCP: Week 0 -16|Adverse Event|0|||
127785681|NCT03451851|459839733|FG000|PCP: Week 0 -16|Withdrawal by Subject|0|||
127785682|NCT03451851|459839734|FG001|PCP: Week 0 -16|Withdrawal by Subject|0|||
127785683|NCT03451851|459839735|FG002|PCP: Week 0 -16|Withdrawal by Subject|1|||
127785684|NCT03451851|459839736|FG003|PCP: Week 0 -16|Withdrawal by Subject|0|||
127785685|NCT03451851|459839737|FG004|PCP: Week 0 -16|Withdrawal by Subject|0|||
127785686|NCT03451851|459839738|FG005|PCP: Week 0 -16|Withdrawal by Subject|0|||
127785687|NCT03451851|459839739|FG006|PCP: Week 0 -16|Withdrawal by Subject|0|||
127785688|NCT03451851|459839740|FG007|PCP: Week 0 -16|Withdrawal by Subject|0|||
127785689|NCT03451851|459839733|FG000|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
127785690|NCT03451851|459839734|FG001|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
127785691|NCT03451851|459839735|FG002|PCP: Week 0 -16|Withdrawal by Parent/Guardian|2|||
127785692|NCT03451851|459839736|FG003|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
127785693|NCT03451851|459839737|FG004|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
127785694|NCT03451851|459839738|FG005|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
127785695|NCT03451851|459839739|FG006|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
127785696|NCT03451851|459839740|FG007|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
127785697|NCT03451851|459839733|FG000|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
127785698|NCT03451851|459839734|FG001|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
127785699|NCT03451851|459839735|FG002|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
127785700|NCT03451851|459839736|FG003|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
127785701|NCT03451851|459839737|FG004|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|3|||
127594204|NCT02207244|459140442|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
127785702|NCT03451851|459839738|FG005|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|1|||
127785703|NCT03451851|459839739|FG006|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
127785704|NCT03451851|459839740|FG007|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
127785705|NCT03451851|459839733|FG000|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
127785706|NCT03451851|459839734|FG001|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
127785707|NCT03451851|459839735|FG002|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
127785708|NCT03451851|459839736|FG003|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
127785709|NCT03451851|459839737|FG004|Withdrawal and Retreament: Week 16-52|Other Unspecified|1|||
127785710|NCT03451851|459839738|FG005|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
127785711|NCT03451851|459839739|FG006|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
127785712|NCT03451851|459839740|FG007|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
127785713|NCT03451851|459839733|FG000|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
127785714|NCT03451851|459839734|FG001|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
127785715|NCT03451851|459839735|FG002|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
127785716|NCT03451851|459839736|FG003|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
127785717|NCT03451851|459839737|FG004|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|2|||
127785718|NCT03451851|459839738|FG005|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
128034709|NCT02138825|460754986|FG000|Safety Follow-up|Adverse Event|4|||
128034710|NCT02138825|460754987|FG001|Safety Follow-up|Adverse Event|3|||
128034711|NCT02138825|460754986|FG000|Safety Follow-up|Death|11|||
128034712|NCT02138825|460754987|FG001|Safety Follow-up|Death|5|||
128034713|NCT02138825|460754986|FG000|Safety Follow-up|Withdrawal by Subject|5|||
128034714|NCT02138825|460754987|FG001|Safety Follow-up|Withdrawal by Subject|3|||
127594205|NCT02207244|459140443|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
127594206|NCT02207244|459140444|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
127594207|NCT02207244|459140445|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
127594208|NCT02207244|459140446|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
127594209|NCT02207244|459140447|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
127594210|NCT02207244|459140448|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
127594211|NCT02207244|459140449|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
128034715|NCT02138825|460754986|FG000|Safety Follow-up|clinic worsening|1|||
128034716|NCT02138825|460754987|FG001|Safety Follow-up|clinic worsening|0|||
128034717|NCT02138825|460754986|FG000|Safety Follow-up|withdrawal by PI|1|||
127594212|NCT02207244|459140450|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
127594213|NCT02207244|459140451|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
127594214|NCT02207244|459140452|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
127594215|NCT02207244|459140442|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
127594216|NCT02207244|459140443|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
127594217|NCT02207244|459140444|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
127594218|NCT02207244|459140445|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
127594219|NCT02207244|459140446|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
127594220|NCT02207244|459140447|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
127594221|NCT02207244|459140448|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
127594222|NCT02207244|459140449|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
127594223|NCT02207244|459140450|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
127594224|NCT02207244|459140451|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
127594225|NCT02207244|459140452|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
127785719|NCT03451851|459839739|FG006|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
127785720|NCT03451851|459839740|FG007|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
127785721|NCT05885737|459839741|FG000|DB Period|Adverse Event|4|||
127785722|NCT05885737|459839742|FG001|DB Period|Adverse Event|4|||
127785723|NCT05885737|459839741|FG000|DB Period|Lost to Follow-up|0|||
127785724|NCT05885737|459839742|FG001|DB Period|Lost to Follow-up|1|||
127785725|NCT05885737|459839741|FG000|DB Period|Physician Decision|2|||
127785726|NCT05885737|459839742|FG001|DB Period|Physician Decision|0|||
127785727|NCT05885737|459839741|FG000|DB Period|Withdrawal by Subject|12|||
127785728|NCT05885737|459839742|FG001|DB Period|Withdrawal by Subject|6|||
127785729|NCT05885737|459839741|FG000|DB Period|Other: Unspecified|2|||
127785730|NCT05885737|459839742|FG001|DB Period|Other: Unspecified|2|||
127785731|NCT05885737|459839741|FG000|OLE Period|Adverse Event|3|||
127785732|NCT05885737|459839742|FG001|OLE Period|Adverse Event|2|||
127785733|NCT05885737|459839741|FG000|OLE Period|Physician Decision|1|||
127785734|NCT05885737|459839742|FG001|OLE Period|Physician Decision|0|||
127785735|NCT05885737|459839741|FG000|OLE Period|Withdrawal by Subject|5|||
127785736|NCT05885737|459839742|FG001|OLE Period|Withdrawal by Subject|5|||
127785737|NCT05885737|459839741|FG000|OLE Period|Other: Unspecified|2|||
127785738|NCT05885737|459839742|FG001|OLE Period|Other: Unspecified|1|||
127785739|NCT00736255|459841552|FG000|Overall Study|Adverse Event|1|||
127785740|NCT00736255|459841553|FG001|Overall Study|Adverse Event|0|||
127785741|NCT00736255|459841552|FG000|Overall Study|Physician Decision|1|||
127785742|NCT00736255|459841553|FG001|Overall Study|Physician Decision|0|||
127785743|NCT00736255|459841552|FG000|Overall Study|Non-compliance|1|||
127785744|NCT00736255|459841553|FG001|Overall Study|Non-compliance|1|||
127785745|NCT02966509|459841557|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
127785746|NCT02966509|459841558|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
127785747|NCT02966509|459841557|FG000|Baseline Satisfaction Survey|Death|0|||
127785748|NCT02966509|459841558|FG001|Baseline Satisfaction Survey|Death|1|||
127785749|NCT02966509|459841557|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
127785750|NCT02966509|459841558|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
127785751|NCT02966509|459841557|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
127785752|NCT02966509|459841558|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
127785753|NCT02966509|459841557|FG000|6 Month Satisfaction Decision Survey|Death|22|||
127785754|NCT02966509|459841558|FG001|6 Month Satisfaction Decision Survey|Death|25|||
127785755|NCT02966509|459841557|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
127785756|NCT02966509|459841558|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
127785757|NCT02966509|459841557|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
127785758|NCT02966509|459841558|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
127785759|NCT02966509|459841557|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
127785760|NCT02966509|459841558|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
127785761|NCT02966509|459841557|FG000|6 Month Satisfaction Survey|Death|36|||
127785762|NCT02966509|459841558|FG001|6 Month Satisfaction Survey|Death|33|||
127785763|NCT02966509|459841557|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
127785764|NCT02966509|459841558|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
127785765|NCT02966509|459841557|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
127785766|NCT02966509|459841558|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
127594226|NCT02207244|459140442|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
127594227|NCT02207244|459140443|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
127785767|NCT02966509|459841557|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
127785768|NCT02966509|459841558|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
127785769|NCT02966509|459841557|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
127785770|NCT02966509|459841558|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
127594228|NCT02207244|459140444|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
127785771|NCT02966509|459841557|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
127785772|NCT02966509|459841558|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
127785773|NCT00404820|459841559|FG000|Overall Study|Adverse Event|4|||
127785774|NCT00404820|459841560|FG001|Overall Study|Adverse Event|16|||
127785775|NCT00404820|459841559|FG000|Overall Study|Withdrawal by Subject|5|||
127785776|NCT00404820|459841560|FG001|Overall Study|Withdrawal by Subject|3|||
127785777|NCT00404820|459841559|FG000|Overall Study|Lost to Follow-up|7|||
127594229|NCT02207244|459140445|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
127594230|NCT02207244|459140446|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
127594231|NCT02207244|459140447|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
127594232|NCT02207244|459140448|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
127594233|NCT02207244|459140449|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
127594234|NCT02207244|459140450|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
127594235|NCT02207244|459140451|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
127594236|NCT02207244|459140452|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
127785778|NCT00404820|459841560|FG001|Overall Study|Lost to Follow-up|3|||
127785779|NCT00404820|459841559|FG000|Overall Study|Administrative problems|2|||
127785780|NCT00404820|459841560|FG001|Overall Study|Administrative problems|0|||
127785781|NCT00404820|459841559|FG000|Overall Study|Death|1|||
127785782|NCT00404820|459841560|FG001|Overall Study|Death|0|||
127785783|NCT00404820|459841559|FG000|Overall Study|Other|0|||
127785784|NCT00404820|459841560|FG001|Overall Study|Other|2|||
127785785|NCT01469182|459841565|FG000|Overall Study|Adverse Event|21|||
127785786|NCT01469182|459841566|FG001|Overall Study|Adverse Event|3|||
127785787|NCT01469182|459841565|FG000|Overall Study|Lost to Follow-up|3|||
127785788|NCT01469182|459841566|FG001|Overall Study|Lost to Follow-up|0|||
127785789|NCT01469182|459841565|FG000|Overall Study|Withdrawal by Subject|4|||
127785790|NCT01469182|459841566|FG001|Overall Study|Withdrawal by Subject|1|||
127785791|NCT01469182|459841565|FG000|Overall Study|Protocol Violation|4|||
127785792|NCT01469182|459841566|FG001|Overall Study|Protocol Violation|2|||
127785793|NCT01469182|459841565|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
127785794|NCT01469182|459841566|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
127785795|NCT02687542|459841569|FG000|Overall Study|Medication error without associated AEs|0|||
127785796|NCT02687542|459841570|FG001|Overall Study|Medication error without associated AEs|0|||
127785797|NCT02687542|459841571|FG002|Overall Study|Medication error without associated AEs|0|||
127785798|NCT02687542|459841572|FG003|Overall Study|Medication error without associated AEs|0|||
127785799|NCT02687542|459841573|FG004|Overall Study|Medication error without associated AEs|1|||
127785800|NCT02687542|459841569|FG000|Overall Study|Lost to Follow-up|0|||
127785801|NCT02687542|459841570|FG001|Overall Study|Lost to Follow-up|0|||
127785802|NCT02687542|459841571|FG002|Overall Study|Lost to Follow-up|0|||
127785803|NCT02687542|459841572|FG003|Overall Study|Lost to Follow-up|0|||
127785804|NCT02687542|459841573|FG004|Overall Study|Lost to Follow-up|1|||
127785805|NCT02687542|459841569|FG000|Overall Study|Protocol Violation|0|||
127785806|NCT02687542|459841570|FG001|Overall Study|Protocol Violation|1|||
127785807|NCT02687542|459841571|FG002|Overall Study|Protocol Violation|0|||
127785808|NCT02687542|459841572|FG003|Overall Study|Protocol Violation|0|||
127785809|NCT02687542|459841573|FG004|Overall Study|Protocol Violation|0|||
127785810|NCT02687542|459841569|FG000|Overall Study|Other|5|||
127785811|NCT02687542|459841570|FG001|Overall Study|Other|9|||
127785812|NCT02687542|459841571|FG002|Overall Study|Other|10|||
127785813|NCT02687542|459841572|FG003|Overall Study|Other|6|||
127785814|NCT02687542|459841573|FG004|Overall Study|Other|5|||
127785815|NCT02687542|459841569|FG000|Overall Study|Adverse Event|3|||
127785816|NCT02687542|459841570|FG001|Overall Study|Adverse Event|1|||
127785817|NCT02687542|459841571|FG002|Overall Study|Adverse Event|3|||
128034718|NCT02138825|460754987|FG001|Safety Follow-up|withdrawal by PI|0|||
128034719|NCT02138825|460754986|FG000|Safety Follow-up|logistical difficulties|0|||
128034720|NCT02138825|460754987|FG001|Safety Follow-up|logistical difficulties|1|||
128034721|NCT02138825|460754986|FG000|Safety Follow-up|progressive disease|0|||
128034722|NCT02138825|460754987|FG001|Safety Follow-up|progressive disease|2|||
128034723|NCT02138825|460754986|FG000|Safety Follow-up|too unwell to attend the visit|0|||
128034724|NCT02138825|460754987|FG001|Safety Follow-up|too unwell to attend the visit|1|||
128034725|NCT02138825|460754986|FG000|Safety Follow-up|treatment unblinded|0|||
128034726|NCT02138825|460754987|FG001|Safety Follow-up|treatment unblinded|1|||
128034727|NCT02138825|460754986|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
128034728|NCT02138825|460754987|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
128034729|NCT03243084|460754996|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
128034730|NCT03243084|460754997|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
128034731|NCT02300233|460754998|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
128034732|NCT02300233|460754999|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
128034733|NCT02300233|460755000|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
128034734|NCT02300233|460754998|FG000|Overall Study|Withdrawal by Subject|1|||
128034735|NCT02300233|460754999|FG001|Overall Study|Withdrawal by Subject|0|||
128034736|NCT02300233|460755000|FG002|Overall Study|Withdrawal by Subject|3|||
128034737|NCT02300233|460754998|FG000|Overall Study|Investigator Judgement|0|||
128034738|NCT02300233|460754999|FG001|Overall Study|Investigator Judgement|0|||
128034739|NCT02300233|460755000|FG002|Overall Study|Investigator Judgement|1|||
127785818|NCT02687542|459841572|FG003|Overall Study|Adverse Event|2|||
127785819|NCT02687542|459841573|FG004|Overall Study|Adverse Event|9|||
127785820|NCT02687542|459841569|FG000|Overall Study|Withdrawal by Subject|0|||
127785821|NCT02687542|459841570|FG001|Overall Study|Withdrawal by Subject|1|||
127785822|NCT02687542|459841571|FG002|Overall Study|Withdrawal by Subject|1|||
127594237|NCT02207244|459140442|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
127594238|NCT02207244|459140443|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
127594239|NCT02207244|459140444|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
127594240|NCT02207244|459140445|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
127594241|NCT02207244|459140446|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
127594242|NCT02207244|459140447|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
127594243|NCT02207244|459140448|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
127594244|NCT02207244|459140449|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
127594245|NCT02207244|459140450|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
127594246|NCT02207244|459140451|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
127594247|NCT02207244|459140452|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
127594248|NCT02207244|459140442|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
127594249|NCT02207244|459140443|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
127594250|NCT02207244|459140444|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
127594251|NCT02207244|459140445|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
127594252|NCT02207244|459140446|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
127594253|NCT02207244|459140447|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
127594254|NCT02207244|459140448|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
127594255|NCT02207244|459140449|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
127594256|NCT02207244|459140450|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
127594257|NCT02207244|459140451|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
127594258|NCT02207244|459140452|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
127594259|NCT02207244|459140442|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
127594260|NCT02207244|459140443|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
127594261|NCT02207244|459140444|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
127594262|NCT02207244|459140445|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
127594263|NCT02207244|459140446|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
127594264|NCT02207244|459140447|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
127594265|NCT02207244|459140448|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
127594266|NCT02207244|459140449|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
127594267|NCT02207244|459140450|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
127594268|NCT02207244|459140451|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
127594269|NCT02207244|459140452|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
127594270|NCT02207244|459140442|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
127594271|NCT02207244|459140443|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
127594272|NCT02207244|459140444|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
127594273|NCT02207244|459140445|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
127594274|NCT02207244|459140446|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
127594275|NCT02207244|459140447|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
127594276|NCT02207244|459140448|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
127594277|NCT02207244|459140449|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
127594278|NCT02207244|459140450|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
127594279|NCT02207244|459140451|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
127594280|NCT02207244|459140452|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
127594281|NCT02207244|459140442|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
127594282|NCT02207244|459140443|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
127594283|NCT02207244|459140444|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
127594284|NCT02207244|459140445|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
127594285|NCT02207244|459140446|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
127594286|NCT02207244|459140447|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
127594287|NCT02207244|459140448|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
127594288|NCT02207244|459140449|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
127594289|NCT02207244|459140450|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
127594290|NCT02207244|459140451|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
127594291|NCT02207244|459140452|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
127594292|NCT02207244|459140442|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
127594293|NCT02207244|459140443|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
127594294|NCT02207244|459140444|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
127594295|NCT02207244|459140445|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
127594296|NCT02207244|459140446|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
127594297|NCT02207244|459140447|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
127594298|NCT02207244|459140448|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
127594299|NCT02207244|459140449|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
127594300|NCT02207244|459140450|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
127594301|NCT02207244|459140451|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
127594302|NCT02207244|459140452|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
127594303|NCT02207244|459140442|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
127594304|NCT02207244|459140443|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
127594305|NCT02207244|459140444|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
127594306|NCT02207244|459140445|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
127594307|NCT02207244|459140446|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
127594308|NCT02207244|459140447|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
127594309|NCT02207244|459140448|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
127594310|NCT02207244|459140449|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
127594311|NCT02207244|459140450|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
127594312|NCT02207244|459140451|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
127594313|NCT02207244|459140452|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
127594314|NCT02207244|459140442|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
127594315|NCT02207244|459140443|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
127594316|NCT02207244|459140444|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
127594317|NCT02207244|459140445|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
127594318|NCT02207244|459140446|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
127594319|NCT02207244|459140447|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
127594320|NCT02207244|459140448|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
127594321|NCT02207244|459140449|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
127594322|NCT02207244|459140450|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
127594323|NCT02207244|459140451|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
127594324|NCT02207244|459140452|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
127594325|NCT02207244|459140442|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
127594326|NCT02207244|459140443|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
127594327|NCT02207244|459140444|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
127594328|NCT02207244|459140445|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
127594329|NCT02207244|459140446|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
127594330|NCT02207244|459140447|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
127594331|NCT02207244|459140448|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
127594332|NCT02207244|459140449|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
127594333|NCT02207244|459140450|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
127594334|NCT02207244|459140451|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
127594335|NCT02207244|459140452|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
127594336|NCT02207244|459140442|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
127594337|NCT02207244|459140443|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
127594338|NCT02207244|459140444|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
127594339|NCT02207244|459140445|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
127594340|NCT02207244|459140446|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
127594341|NCT02207244|459140447|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
127594342|NCT02207244|459140448|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
127594343|NCT02207244|459140449|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
127594344|NCT02207244|459140450|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
127594345|NCT02207244|459140451|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
127594346|NCT02207244|459140452|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
127594347|NCT02207244|459140442|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
127594348|NCT02207244|459140443|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
127594349|NCT02207244|459140444|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
127594350|NCT02207244|459140445|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
127695252|NCT01261312|459512908|FG004|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
127695253|NCT01261312|459512909|FG005|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
127695254|NCT01261312|459512910|FG006|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
127695255|NCT01261312|459512911|FG007|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
127695256|NCT01261312|459512912|FG008|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
127695257|NCT01261312|459512913|FG009|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
127695258|NCT01261312|459512914|FG010|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
127695259|NCT01261312|459512915|FG011|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
127695260|NCT01261312|459512916|FG012|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
127695261|NCT01261312|459512904|FG000|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
127785823|NCT02687542|459841572|FG003|Overall Study|Withdrawal by Subject|2|||
128034740|NCT02300233|460754998|FG000|Overall Study|Reason Not Specified|0|||
128034741|NCT02300233|460754999|FG001|Overall Study|Reason Not Specified|0|||
128034742|NCT02300233|460755000|FG002|Overall Study|Reason Not Specified|5|||
128034743|NCT04380142|460755003|FG000|LD/CD Stabilization Period|Adverse Event|3|||
127594351|NCT02207244|459140446|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
127594352|NCT02207244|459140447|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
127594353|NCT02207244|459140448|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
127594354|NCT02207244|459140449|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
127594355|NCT02207244|459140450|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
127594356|NCT02207244|459140451|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
127594357|NCT02207244|459140452|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
127594358|NCT02207244|459140442|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
127594359|NCT02207244|459140443|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
127594360|NCT02207244|459140444|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
127594361|NCT02207244|459140445|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
127594362|NCT02207244|459140446|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
127594363|NCT02207244|459140447|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
127594364|NCT02207244|459140448|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
127594365|NCT02207244|459140449|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
127594366|NCT02207244|459140450|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
127594367|NCT02207244|459140451|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
127785824|NCT02687542|459841573|FG004|Overall Study|Withdrawal by Subject|4|||
127785825|NCT01838616|459841574|FG000|Titration Period|Adverse Event|18|||
127785826|NCT01838616|459841575|FG001|Titration Period|Adverse Event|48|||
127785827|NCT01838616|459841574|FG000|Titration Period|Lack of Efficacy|5|||
127785828|NCT01838616|459841575|FG001|Titration Period|Lack of Efficacy|12|||
127785829|NCT01838616|459841574|FG000|Titration Period|Withdrawal by Subject|5|||
127785830|NCT01838616|459841575|FG001|Titration Period|Withdrawal by Subject|5|||
127785831|NCT01838616|459841574|FG000|Titration Period|Technical problems|1|||
127785832|NCT01838616|459841575|FG001|Titration Period|Technical problems|0|||
127785833|NCT01838616|459841574|FG000|Titration Period|Other|1|||
127785834|NCT01838616|459841575|FG001|Titration Period|Other|0|||
127785835|NCT01838616|459841574|FG000|Titration Period|Protocol Violation|0|||
127785836|NCT01838616|459841575|FG001|Titration Period|Protocol Violation|1|||
127785837|NCT01838616|459841574|FG000|Continuation Period|Lack of Efficacy|3|||
127785838|NCT01838616|459841575|FG001|Continuation Period|Lack of Efficacy|5|||
127785839|NCT01838616|459841574|FG000|Continuation Period|Adverse Event|8|||
127594368|NCT02207244|459140452|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
127594369|NCT02207244|459140442|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
127594370|NCT02207244|459140443|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
127594371|NCT02207244|459140444|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
127594372|NCT02207244|459140445|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
127594373|NCT02207244|459140446|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
127594374|NCT02207244|459140447|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
127594375|NCT02207244|459140448|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
127594376|NCT02207244|459140449|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
127594377|NCT02207244|459140450|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
127594378|NCT02207244|459140451|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
127594379|NCT02207244|459140452|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
127594380|NCT02207244|459140442|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
127594381|NCT02207244|459140443|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
127594382|NCT02207244|459140444|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
127594383|NCT02207244|459140445|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
127594384|NCT02207244|459140446|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
127594385|NCT02207244|459140447|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
127594386|NCT02207244|459140448|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
127594387|NCT02207244|459140449|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
127594388|NCT02207244|459140450|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
127594389|NCT02207244|459140451|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
127594390|NCT02207244|459140452|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
127594391|NCT02207244|459140442|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
127594392|NCT02207244|459140443|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
127594393|NCT02207244|459140444|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
127594394|NCT02207244|459140445|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
127594395|NCT02207244|459140446|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
127594396|NCT02207244|459140447|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
127594397|NCT02207244|459140448|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
127594398|NCT02207244|459140449|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
127785840|NCT01838616|459841575|FG001|Continuation Period|Adverse Event|4|||
127785841|NCT01838616|459841574|FG000|Continuation Period|Protocol Violation|2|||
127785842|NCT01838616|459841575|FG001|Continuation Period|Protocol Violation|0|||
127785843|NCT01838616|459841574|FG000|Continuation Period|Lost to Follow-up|1|||
128034744|NCT04380142|460755004|FG001|LD/CD Stabilization Period|Adverse Event|0|||
128034745|NCT04380142|460755005|FG002|LD/CD Stabilization Period|Adverse Event|0|||
127594399|NCT02207244|459140450|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
127594400|NCT02207244|459140451|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
127594401|NCT02207244|459140452|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
127594402|NCT02216591|459140453|FG000|Overall Study|Lost to Follow-up|0|||
127594403|NCT02216591|459140454|FG001|Overall Study|Lost to Follow-up|1|||
127594404|NCT00039130|459140455|FG000|Overall Study|Adverse Event|11|||
127594405|NCT00039130|459140455|FG000|Overall Study|Death|9|||
127594406|NCT00039130|459140455|FG000|Overall Study|Withdrawal by Subject|3|||
127594407|NCT00039130|459140455|FG000|Overall Study|Progression|2|||
127594408|NCT00039130|459140455|FG000|Overall Study|Subsequent treatment|2|||
127594409|NCT00039130|459140455|FG000|Overall Study|Physician Decision|3|||
127594410|NCT03919799|459140461|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
127594411|NCT03919799|459140462|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
127594412|NCT03919799|459140463|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
127594413|NCT03919799|459140464|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
127594414|NCT03919799|459140465|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
127594415|NCT03919799|459140461|FG000|DB Period (28 Weeks)|Adverse Event|1|||
127594416|NCT03919799|459140462|FG001|DB Period (28 Weeks)|Adverse Event|1|||
127594417|NCT03919799|459140463|FG002|DB Period (28 Weeks)|Adverse Event|1|||
127594418|NCT03919799|459140464|FG003|DB Period (28 Weeks)|Adverse Event|0|||
127594419|NCT03919799|459140465|FG004|DB Period (28 Weeks)|Adverse Event|0|||
127594420|NCT03919799|459140461|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
127594421|NCT03919799|459140462|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
127594422|NCT03919799|459140463|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
127594423|NCT03919799|459140464|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
127594424|NCT03919799|459140465|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
127594425|NCT03919799|459140461|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
127594426|NCT03919799|459140462|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
127594427|NCT03919799|459140463|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
127594428|NCT03919799|459140464|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
127594429|NCT03919799|459140465|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
127594430|NCT03919799|459140461|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
127594431|NCT03919799|459140462|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
127594432|NCT03919799|459140463|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
127594433|NCT03919799|459140464|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
127594434|NCT03919799|459140465|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
127594435|NCT05475236|459140467|FG000|Overall Study|Withdrawal by Subject|0|||
127594436|NCT05475236|459140468|FG001|Overall Study|Withdrawal by Subject|1|||
127594437|NCT04419714|459140470|FG000|Overall Study|Technical Fault|5|||
127594438|NCT04419714|459140470|FG000|Overall Study|Protocol Deviation|2|||
127594439|NCT04419714|459140470|FG000|Overall Study|Withdrawal by Subject|1|||
127594440|NCT04023526|459141948|FG000|Overall Study|Ongoing treatment at data cutoff|5|||
127594441|NCT04023526|459141949|FG001|Overall Study|Ongoing treatment at data cutoff|9|||
127594442|NCT04023526|459141948|FG000|Overall Study|Randomized but did not receive assigned treatment|0|||
127594443|NCT04023526|459141949|FG001|Overall Study|Randomized but did not receive assigned treatment|1|||
127594444|NCT00638378|459141954|FG000|Overall Study|Death|2|||
127594445|NCT00638378|459141954|FG000|Overall Study|Adverse Event|1|||
127594446|NCT00638378|459141954|FG000|Overall Study|Disease progression|15|||
127594447|NCT00638378|459141954|FG000|Overall Study|Physician Decision|4|||
127594448|NCT01411774|459141970|FG000|Overall Study|Withdrawal by Subject|0|||
127594449|NCT01411774|459141971|FG001|Overall Study|Withdrawal by Subject|3|||
127594450|NCT00056316|459141974|FG000|Overall Study|Withdrawal by Subject|2|||
127594451|NCT00056316|459141975|FG001|Overall Study|Withdrawal by Subject|2|||
127594452|NCT00056316|459141974|FG000|Overall Study|Death/NH placement of pt|1|||
127594453|NCT00056316|459141975|FG001|Overall Study|Death/NH placement of pt|1|||
127594454|NCT02990910|459141977|FG000|Overall Study|Lack of Efficacy|6|||
127594455|NCT02990910|459141978|FG001|Overall Study|Lack of Efficacy|10|||
127594456|NCT00309387|459141985|FG000|Overall Study|Death|72|||
127594457|NCT00309387|459141986|FG001|Overall Study|Death|73|||
127695262|NCT01261312|459512905|FG001|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
128034746|NCT04380142|460755003|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
128034747|NCT04380142|460755004|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
128034748|NCT04380142|460755005|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
128034749|NCT04380142|460755003|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
128034750|NCT04380142|460755004|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
128034751|NCT04380142|460755005|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
128034752|NCT04380142|460755003|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
128034753|NCT04380142|460755004|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
127594458|NCT00309387|459141985|FG000|Overall Study|Lost to Follow-up|70|||
127594459|NCT00309387|459141986|FG001|Overall Study|Lost to Follow-up|86|||
127695263|NCT01261312|459512906|FG002|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
127695264|NCT01261312|459512907|FG003|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
128034754|NCT04380142|460755005|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
128034755|NCT04380142|460755003|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
128034756|NCT04380142|460755004|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
128034757|NCT04380142|460755005|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
128034758|NCT04380142|460755003|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
128034759|NCT04380142|460755004|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
128034760|NCT04380142|460755005|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
128034761|NCT04380142|460755003|FG000|Double-Blind Treatment Period|Adverse Event|0|||
128034762|NCT04380142|460755004|FG001|Double-Blind Treatment Period|Adverse Event|1|||
128034763|NCT04380142|460755005|FG002|Double-Blind Treatment Period|Adverse Event|14|||
128034764|NCT04380142|460755003|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
128034765|NCT04380142|460755004|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
128034766|NCT04380142|460755005|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
128034767|NCT04380142|460755003|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
128034768|NCT04380142|460755004|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
128034769|NCT04380142|460755005|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
128034770|NCT04380142|460755003|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
128034771|NCT04380142|460755004|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
128034772|NCT04380142|460755005|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
128034773|NCT04380142|460755003|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
128034774|NCT04380142|460755004|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
128034775|NCT04380142|460755005|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
128034776|NCT04380142|460755003|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
128034777|NCT04380142|460755004|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
128034778|NCT04380142|460755005|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
128034779|NCT03773484|460755010|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
128034780|NCT01889251|460755011|FG000|Overall Study|Adverse Event|1|||
128034781|NCT01889251|460755012|FG001|Overall Study|Adverse Event|0|||
127785844|NCT01838616|459841575|FG001|Continuation Period|Lost to Follow-up|0|||
127785845|NCT01838616|459841574|FG000|Continuation Period|Withdrawal by Subject|0|||
127785846|NCT01838616|459841575|FG001|Continuation Period|Withdrawal by Subject|4|||
127785847|NCT01838616|459841574|FG000|Continuation Period|Technical problems|0|||
127785848|NCT01838616|459841575|FG001|Continuation Period|Technical problems|1|||
127785849|NCT01838616|459841574|FG000|Pick-up Arm|Lack of Efficacy|4|||
127785850|NCT01838616|459841575|FG001|Pick-up Arm|Lack of Efficacy|0|||
127785851|NCT01838616|459841574|FG000|Pick-up Arm|Adverse Event|9|||
127785852|NCT01838616|459841575|FG001|Pick-up Arm|Adverse Event|0|||
127785853|NCT01838616|459841574|FG000|Pick-up Arm|Withdrawal by Subject|1|||
127785854|NCT01838616|459841575|FG001|Pick-up Arm|Withdrawal by Subject|0|||
127785855|NCT01838616|459841574|FG000|Pick-up Arm|Technical problems|1|||
127785856|NCT01838616|459841575|FG001|Pick-up Arm|Technical problems|0|||
127785857|NCT01566773|459841576|FG000|Overall Study|Protocol specified criteria|4|||
127785858|NCT01566773|459841576|FG000|Overall Study|Protocol Violation|4|||
127785859|NCT01566773|459841576|FG000|Overall Study|Withdrawal by Subject|9|||
127785860|NCT01566773|459841576|FG000|Overall Study|Administrative reason|1|||
127785861|NCT01566773|459841576|FG000|Overall Study|Adverse Event|10|||
127785862|NCT01566773|459841576|FG000|Overall Study|Physician Decision|2|||
127785863|NCT01033734|459841577|FG000|Overall Study|Withdrawal by Subject|1|||
128034782|NCT01344226|460755018|FG000|Overall Study|Protocol Violation|2|||
128034783|NCT01344226|460755018|FG000|Overall Study|Withdrawal by Subject|3|||
127785864|NCT00111800|459841578|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
127785865|NCT00111800|459841579|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
127785866|NCT00111800|459841580|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
127785867|NCT00111800|459841581|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
127785868|NCT00111800|459841582|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
127594460|NCT02483520|459141987|FG000|Overall Study|Lost to Follow-up|3|||
127594461|NCT02483520|459141988|FG001|Overall Study|Lost to Follow-up|4|||
127594462|NCT02483520|459141987|FG000|Overall Study|Withdrawal by Subject|4|||
127594463|NCT02483520|459141988|FG001|Overall Study|Withdrawal by Subject|14|||
127594464|NCT02483520|459141987|FG000|Overall Study|Hospitalized|2|||
127594465|NCT02483520|459141988|FG001|Overall Study|Hospitalized|3|||
127594466|NCT02483520|459141987|FG000|Overall Study|Moved to LTC|2|||
127594467|NCT02483520|459141988|FG001|Overall Study|Moved to LTC|3|||
127594468|NCT03902574|459141998|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
127594469|NCT03902574|459141999|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
127594470|NCT03902574|459142000|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
127594471|NCT04492618|459142002|FG000|Overall Study|Withdrawal by Subject|1|||
127594472|NCT03489720|459142003|FG000|Overall Study|Withdrawal by Subject|2|||
127594473|NCT03489720|459142004|FG001|Overall Study|Withdrawal by Subject|0|||
127594474|NCT02495168|459142007|FG000|Overall Study|Other than Specified|18|||
128034784|NCT01344226|460755018|FG000|Overall Study|Lack of Efficacy|3|||
128034785|NCT03211416|460755020|FG000|Overall Study|Adverse Event|7|||
128034786|NCT03211416|460755020|FG000|Overall Study|Lack of Efficacy|2|||
128034787|NCT03211416|460755020|FG000|Overall Study|Physician Decision|1|||
128034788|NCT02302222|460755022|FG000|Overall Study|Physician Decision|0|||
128034789|NCT02302222|460755023|FG001|Overall Study|Physician Decision|4|||
128034790|NCT02302222|460755022|FG000|Overall Study|Lost to Follow-up|1|||
128034791|NCT02302222|460755023|FG001|Overall Study|Lost to Follow-up|0|||
128034792|NCT02302222|460755022|FG000|Overall Study|Treatment discontinued before day 5|0|||
128034793|NCT02302222|460755023|FG001|Overall Study|Treatment discontinued before day 5|1|||
128034794|NCT02302222|460755022|FG000|Overall Study|Withdrawn prior to any treatment|0|||
128034795|NCT02302222|460755023|FG001|Overall Study|Withdrawn prior to any treatment|1|||
128034796|NCT03781570|460755029|FG000|Overall Study|Technical Issues (equipment failure)|31|||
128034797|NCT03781570|460755029|FG000|Overall Study|Withdrawal by Subject|7|||
128034798|NCT03781570|460755029|FG000|Overall Study|Physical Constraints|11|||
128034799|NCT01107496|460755030|FG000|Overall Study|Adverse Event|1|||
128034800|NCT01107496|460755031|FG001|Overall Study|Adverse Event|0|||
128034801|NCT01107496|460755030|FG000|Overall Study|Lack of Efficacy|1|||
128034802|NCT01107496|460755031|FG001|Overall Study|Lack of Efficacy|0|||
128034803|NCT01107496|460755030|FG000|Overall Study|Protocol Violation|0|||
128034804|NCT01107496|460755031|FG001|Overall Study|Protocol Violation|1|||
128034805|NCT01107496|460755030|FG000|Overall Study|Lost to Follow-up|0|||
128034806|NCT01107496|460755031|FG001|Overall Study|Lost to Follow-up|1|||
128034807|NCT03709472|460755032|FG000|4 Month Assessment (Post Treatment)|Lost to Follow-up|8|||
128034808|NCT03709472|460755033|FG001|4 Month Assessment (Post Treatment)|Lost to Follow-up|30|||
128034809|NCT03709472|460755032|FG000|Assessment (12-month Post Baseline)|Lost to Follow-up|12|||
128034810|NCT03709472|460755033|FG001|Assessment (12-month Post Baseline)|Lost to Follow-up|46|||
128034811|NCT03559556|460755034|FG000|Overall Study|Withdrawal by Subject|1|||
128034812|NCT05318287|460755040|FG000|Overall Study|Lost to Follow-up|8|||
128034813|NCT05185453|460755041|FG000|Overall Study|Lost to Follow-up|13|||
128034814|NCT05185453|460755042|FG001|Overall Study|Lost to Follow-up|3|||
128034815|NCT02457793|460755046|FG000|Overall Study|Reason not specified|0|||
128034816|NCT02457793|460755047|FG001|Overall Study|Reason not specified|0|||
128034817|NCT02457793|460755048|FG002|Overall Study|Reason not specified|0|||
128034818|NCT02457793|460755049|FG003|Overall Study|Reason not specified|1|||
128034819|NCT02457793|460755050|FG004|Overall Study|Reason not specified|1|||
128034820|NCT02457793|460755051|FG005|Overall Study|Reason not specified|1|||
128034821|NCT02457793|460755046|FG000|Overall Study|Withdrawal by Subject|0|||
128034822|NCT02457793|460755047|FG001|Overall Study|Withdrawal by Subject|4|||
128034823|NCT02457793|460755048|FG002|Overall Study|Withdrawal by Subject|2|||
128034824|NCT02457793|460755049|FG003|Overall Study|Withdrawal by Subject|2|||
127594475|NCT02495168|459142008|FG001|Overall Study|Other than Specified|22|||
128034825|NCT02457793|460755050|FG004|Overall Study|Withdrawal by Subject|2|||
128034826|NCT02457793|460755051|FG005|Overall Study|Withdrawal by Subject|2|||
128034827|NCT02457793|460755046|FG000|Overall Study|Adverse Event|0|||
128034828|NCT02457793|460755047|FG001|Overall Study|Adverse Event|0|||
128034829|NCT02457793|460755048|FG002|Overall Study|Adverse Event|0|||
127594476|NCT02495168|459142009|FG002|Overall Study|Other than Specified|5|||
127594477|NCT02495168|459142007|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
128034830|NCT02457793|460755049|FG003|Overall Study|Adverse Event|1|||
128034831|NCT02457793|460755050|FG004|Overall Study|Adverse Event|0|||
128034832|NCT02457793|460755051|FG005|Overall Study|Adverse Event|0|||
128034833|NCT02457793|460755046|FG000|Overall Study|Physician Decision|1|||
128034834|NCT02457793|460755047|FG001|Overall Study|Physician Decision|0|||
128034835|NCT02457793|460755048|FG002|Overall Study|Physician Decision|1|||
128034836|NCT02457793|460755049|FG003|Overall Study|Physician Decision|1|||
128034837|NCT02457793|460755050|FG004|Overall Study|Physician Decision|1|||
128034838|NCT02457793|460755051|FG005|Overall Study|Physician Decision|3|||
128034839|NCT00835172|460755069|FG000|Washout|Protocol Violation|0|||
128034840|NCT00835172|460755070|FG001|Washout|Protocol Violation|1|||
128034841|NCT04890509|460755071|FG000|Overall Study|Death|4|||
128034842|NCT04890509|460755072|FG001|Overall Study|Death|4|||
128034843|NCT03274466|460755073|FG000|Overall Study|Withdrawal by Subject|7|||
128034844|NCT03274466|460755074|FG001|Overall Study|Withdrawal by Subject|3|||
128034845|NCT03274466|460755073|FG000|Overall Study|Protocol Specified Withdrawal|5|||
128034846|NCT03274466|460755074|FG001|Overall Study|Protocol Specified Withdrawal|11|||
128034847|NCT03274466|460755073|FG000|Overall Study|Lost to Follow-up|5|||
128034848|NCT03274466|460755074|FG001|Overall Study|Lost to Follow-up|7|||
128034849|NCT03274466|460755073|FG000|Overall Study|Subject Non-compliance|0|||
128034850|NCT03274466|460755074|FG001|Overall Study|Subject Non-compliance|1|||
128034851|NCT03274466|460755073|FG000|Overall Study|Adverse Event|3|||
128034852|NCT03274466|460755074|FG001|Overall Study|Adverse Event|3|||
128034853|NCT03274466|460755073|FG000|Overall Study|Physician Decision|0|||
128034854|NCT03274466|460755074|FG001|Overall Study|Physician Decision|1|||
128034855|NCT03274466|460755073|FG000|Overall Study|Protocol Violation|3|||
128034856|NCT03274466|460755074|FG001|Overall Study|Protocol Violation|3|||
128034857|NCT00618787|460755077|FG000|Overall Study|Adverse Event|0|||
128034858|NCT00618787|460755078|FG001|Overall Study|Adverse Event|1|||
128034859|NCT00618787|460755077|FG000|Overall Study|Withdrawal by Subject|2|||
128034860|NCT00618787|460755078|FG001|Overall Study|Withdrawal by Subject|1|||
128034861|NCT00618787|460755077|FG000|Overall Study|Lost to Follow-up|1|||
128034862|NCT00618787|460755078|FG001|Overall Study|Lost to Follow-up|0|||
128034863|NCT01107886|460755079|FG000|Overall Study|Lost to Follow-up|15|||
128034864|NCT01107886|460755080|FG001|Overall Study|Lost to Follow-up|13|||
128034865|NCT01107886|460755079|FG000|Overall Study|Withdrawal by Subject|180|||
128034866|NCT01107886|460755080|FG001|Overall Study|Withdrawal by Subject|196|||
128034867|NCT01107886|460755079|FG000|Overall Study|Administrative withdrawal of consent|7|||
128034868|NCT01107886|460755080|FG001|Overall Study|Administrative withdrawal of consent|5|||
128034869|NCT01649869|460755085|FG000|Overall Study|Family member illness|1|||
128034870|NCT01649869|460755086|FG001|Overall Study|Family member illness|0|||
128034871|NCT01649869|460755085|FG000|Overall Study|Required treatment outside protocol|1|||
128034872|NCT01649869|460755086|FG001|Overall Study|Required treatment outside protocol|0|||
128034873|NCT01649869|460755085|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
128034874|NCT01649869|460755086|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
128034875|NCT02333799|460757747|FG000|Treatment Period|Withdrawal by Subject|1|||
128034876|NCT02333799|460757747|FG000|Treatment Period|Death|6|||
128034877|NCT02333799|460757747|FG000|6 Month Follow Up Period|Physician Decision|1|||
128034878|NCT02333799|460757747|FG000|6 Month Follow Up Period|Death|1|||
128034879|NCT02333799|460757747|FG000|7 to 24 Month Follow Up Period|Lost to Follow-up|1|||
128034880|NCT02333799|460757747|FG000|7 to 24 Month Follow Up Period|Physician Decision|1|||
128034881|NCT01657370|460757751|FG000|Overall Study|Withdrawal by Subject|0|||
128034882|NCT01657370|460757752|FG001|Overall Study|Withdrawal by Subject|0|||
128034883|NCT01657370|460757753|FG002|Overall Study|Withdrawal by Subject|1|||
128034884|NCT01657370|460757754|FG003|Overall Study|Withdrawal by Subject|0|||
128034885|NCT01657370|460757755|FG004|Overall Study|Withdrawal by Subject|0|||
128034886|NCT01657370|460757756|FG005|Overall Study|Withdrawal by Subject|1|||
128034887|NCT01657370|460757751|FG000|Overall Study|Physician Decision|2|||
128034888|NCT01657370|460757752|FG001|Overall Study|Physician Decision|3|||
128034889|NCT01657370|460757753|FG002|Overall Study|Physician Decision|1|||
128034890|NCT01657370|460757754|FG003|Overall Study|Physician Decision|2|||
128034891|NCT01657370|460757755|FG004|Overall Study|Physician Decision|5|||
128034892|NCT01657370|460757756|FG005|Overall Study|Physician Decision|0|||
128034893|NCT01657370|460757751|FG000|Overall Study|Lack of Qualifying Event|1|||
128034894|NCT01657370|460757752|FG001|Overall Study|Lack of Qualifying Event|0|||
127594478|NCT02495168|459142008|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
127594479|NCT02495168|459142009|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
128034895|NCT01657370|460757753|FG002|Overall Study|Lack of Qualifying Event|3|||
128034896|NCT01657370|460757754|FG003|Overall Study|Lack of Qualifying Event|2|||
128034897|NCT01657370|460757755|FG004|Overall Study|Lack of Qualifying Event|1|||
128034898|NCT01657370|460757756|FG005|Overall Study|Lack of Qualifying Event|2|||
128034899|NCT01657370|460757751|FG000|Overall Study|Adverse Event|0|||
128034900|NCT01657370|460757752|FG001|Overall Study|Adverse Event|0|||
128034901|NCT01657370|460757753|FG002|Overall Study|Adverse Event|0|||
128034902|NCT01657370|460757754|FG003|Overall Study|Adverse Event|0|||
128034903|NCT01657370|460757755|FG004|Overall Study|Adverse Event|1|||
128034904|NCT01657370|460757756|FG005|Overall Study|Adverse Event|0|||
128034905|NCT01657370|460757751|FG000|Overall Study|Protocol Violation|1|||
128034906|NCT01657370|460757752|FG001|Overall Study|Protocol Violation|1|||
128034907|NCT01657370|460757753|FG002|Overall Study|Protocol Violation|1|||
128034908|NCT01657370|460757754|FG003|Overall Study|Protocol Violation|1|||
127785869|NCT00111800|459841583|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
127785870|NCT00111800|459841578|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
127785871|NCT00111800|459841579|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
127785872|NCT00111800|459841580|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
127785873|NCT00111800|459841581|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
127785874|NCT00111800|459841582|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
127785875|NCT00111800|459841583|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
127785876|NCT00111800|459841578|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
127785877|NCT00111800|459841579|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
127785878|NCT00111800|459841580|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
127785879|NCT00111800|459841581|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
127785880|NCT00111800|459841582|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
127785881|NCT00111800|459841583|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
127785882|NCT00111800|459841578|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
127785883|NCT00111800|459841579|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
127785884|NCT00111800|459841580|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
127785885|NCT00111800|459841581|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
127785886|NCT00111800|459841582|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
127785887|NCT00111800|459841583|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
127785888|NCT00111800|459841578|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
127785889|NCT00111800|459841579|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
127785890|NCT00111800|459841580|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
127785891|NCT00111800|459841581|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
127785892|NCT00111800|459841582|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
127785893|NCT00111800|459841583|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
127785894|NCT00111800|459841578|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
127785895|NCT00111800|459841579|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
127785896|NCT00111800|459841580|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
127785897|NCT00111800|459841581|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
127785898|NCT00111800|459841582|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
127785899|NCT00111800|459841583|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
127785900|NCT00111800|459841578|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
127785901|NCT00111800|459841579|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
127785902|NCT00111800|459841580|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
127785903|NCT00111800|459841581|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
128034909|NCT01657370|460757755|FG004|Overall Study|Protocol Violation|0|||
128034910|NCT01657370|460757756|FG005|Overall Study|Protocol Violation|0|||
128034911|NCT01657370|460757751|FG000|Overall Study|Lost to Follow-up|2|||
128034912|NCT01657370|460757752|FG001|Overall Study|Lost to Follow-up|0|||
128034913|NCT01657370|460757753|FG002|Overall Study|Lost to Follow-up|1|||
127695265|NCT01261312|459512908|FG004|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
127695266|NCT01261312|459512909|FG005|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
127695267|NCT01261312|459512910|FG006|DE Phase: TN AML (Week 85-283)|Progressive Disease|9|||
127695268|NCT01261312|459512911|FG007|DE Phase: TN AML (Week 85-283)|Progressive Disease|11|||
127695269|NCT01261312|459512912|FG008|DE Phase: TN AML (Week 85-283)|Progressive Disease|17|||
127695270|NCT01261312|459512913|FG009|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
127695271|NCT01261312|459512914|FG010|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
127695272|NCT01261312|459512915|FG011|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
127695273|NCT01261312|459512916|FG012|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
127695274|NCT01261312|459512904|FG000|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
127695275|NCT01261312|459512905|FG001|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
127695276|NCT01261312|459512906|FG002|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
127695277|NCT01261312|459512907|FG003|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
127695278|NCT01261312|459512908|FG004|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
127695279|NCT01261312|459512909|FG005|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
127695280|NCT01261312|459512910|FG006|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
127695281|NCT01261312|459512911|FG007|DE Phase: TN AML (Week 85-283)|Adverse Event|1|||
127695282|NCT01261312|459512912|FG008|DE Phase: TN AML (Week 85-283)|Adverse Event|2|||
127695283|NCT01261312|459512913|FG009|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
127695284|NCT01261312|459512914|FG010|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
127695285|NCT01261312|459512915|FG011|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
127695286|NCT01261312|459512916|FG012|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
127695287|NCT01261312|459512904|FG000|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
127695288|NCT01261312|459512905|FG001|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
127695289|NCT01261312|459512906|FG002|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
127785904|NCT00111800|459841582|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
128034914|NCT01657370|460757754|FG003|Overall Study|Lost to Follow-up|0|||
128034915|NCT01657370|460757755|FG004|Overall Study|Lost to Follow-up|0|||
128034916|NCT01657370|460757756|FG005|Overall Study|Lost to Follow-up|1|||
128034917|NCT01168596|460757765|FG000|Overall Study|Withdrawal by Subject|3|||
128034918|NCT01168596|460757766|FG001|Overall Study|Withdrawal by Subject|1|||
128034919|NCT00876447|460757767|FG000|Overall Study|Other miscellaneous reasons|3|||
127594480|NCT02495168|459142007|FG000|Overall Study|Physician Decision|1|||
127594481|NCT02495168|459142008|FG001|Overall Study|Physician Decision|1|||
127785905|NCT00111800|459841583|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
127785906|NCT00111800|459841578|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
127785907|NCT00111800|459841579|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
127785908|NCT00111800|459841580|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
127785909|NCT00111800|459841581|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
127785910|NCT00111800|459841582|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
127785911|NCT00111800|459841583|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
127785912|NCT00111800|459841578|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
127785913|NCT00111800|459841579|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
127785914|NCT00111800|459841580|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
127785915|NCT00111800|459841581|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
127785916|NCT00111800|459841582|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
127785917|NCT00111800|459841583|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
127785918|NCT00111800|459841578|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
127785919|NCT00111800|459841579|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
127785920|NCT00111800|459841580|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
127785921|NCT00111800|459841581|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
127785922|NCT00111800|459841582|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
127785923|NCT00111800|459841583|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
127785924|NCT00111800|459841578|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
127785925|NCT00111800|459841579|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
127785926|NCT00111800|459841580|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
127785927|NCT00111800|459841581|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
127785928|NCT00111800|459841582|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
127785929|NCT00111800|459841583|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
127785930|NCT00111800|459841578|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
127785931|NCT00111800|459841579|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
127785932|NCT00111800|459841580|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
127785933|NCT00111800|459841581|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
127785934|NCT00111800|459841582|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
127785935|NCT00111800|459841583|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
127785936|NCT00111800|459841578|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
127785937|NCT00111800|459841579|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
127785938|NCT00111800|459841580|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
127785939|NCT00111800|459841581|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
127785940|NCT00111800|459841582|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
127785941|NCT00111800|459841583|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
127785942|NCT00111800|459841578|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
127785943|NCT00111800|459841579|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
127785944|NCT00111800|459841580|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
127785945|NCT00111800|459841581|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
127785946|NCT00111800|459841582|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
127785947|NCT00111800|459841583|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
127785948|NCT00111800|459841578|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
127785949|NCT00111800|459841579|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
127785950|NCT00111800|459841580|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
127785951|NCT00111800|459841581|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
127785952|NCT00111800|459841582|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
127785953|NCT00111800|459841583|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
127785954|NCT00111800|459841578|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
127785955|NCT00111800|459841579|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
128034920|NCT00876447|460757768|FG001|Overall Study|Other miscellaneous reasons|8|||
128034921|NCT00876447|460757767|FG000|Overall Study|Site closure|19|||
128034922|NCT00876447|460757768|FG001|Overall Study|Site closure|14|||
128034923|NCT00876447|460757767|FG000|Overall Study|Protocol Violation|9|||
128034924|NCT00876447|460757768|FG001|Overall Study|Protocol Violation|3|||
127594482|NCT02495168|459142009|FG002|Overall Study|Physician Decision|0|||
127785956|NCT00111800|459841580|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
127785957|NCT00111800|459841581|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
127882256|NCT01586624|460192723|FG003|Overall Study|Adverse Event|1|||
127882257|NCT01586624|460192724|FG004|Overall Study|Adverse Event|3|||
127882258|NCT01586624|460192725|FG005|Overall Study|Adverse Event|3|||
127882259|NCT01586624|460192726|FG006|Overall Study|Adverse Event|2|||
127882260|NCT01586624|460192727|FG007|Overall Study|Adverse Event|3|||
127882261|NCT01586624|460192720|FG000|Overall Study|Physician Decision|0|||
127882262|NCT01586624|460192721|FG001|Overall Study|Physician Decision|1|||
127882263|NCT01586624|460192722|FG002|Overall Study|Physician Decision|1|||
127882264|NCT01586624|460192723|FG003|Overall Study|Physician Decision|0|||
127882265|NCT01586624|460192724|FG004|Overall Study|Physician Decision|2|||
127882266|NCT01586624|460192725|FG005|Overall Study|Physician Decision|0|||
127882267|NCT01586624|460192726|FG006|Overall Study|Physician Decision|1|||
127882268|NCT01586624|460192727|FG007|Overall Study|Physician Decision|1|||
127882269|NCT01586624|460192720|FG000|Overall Study|Withdrawal by Subject|0|||
127882270|NCT01586624|460192721|FG001|Overall Study|Withdrawal by Subject|0|||
127882271|NCT01586624|460192722|FG002|Overall Study|Withdrawal by Subject|0|||
127785958|NCT00111800|459841582|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
127785959|NCT00111800|459841583|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
127785960|NCT00111800|459841578|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
127785961|NCT00111800|459841579|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
127785962|NCT00111800|459841580|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
127785963|NCT00111800|459841581|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
127785964|NCT00111800|459841582|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
127882272|NCT01586624|460192723|FG003|Overall Study|Withdrawal by Subject|1|||
127882273|NCT01586624|460192724|FG004|Overall Study|Withdrawal by Subject|0|||
127882274|NCT01586624|460192725|FG005|Overall Study|Withdrawal by Subject|0|||
127882275|NCT01586624|460192726|FG006|Overall Study|Withdrawal by Subject|0|||
127785965|NCT00111800|459841583|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
127785966|NCT00111800|459841578|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
127785967|NCT00111800|459841579|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
127785968|NCT00111800|459841580|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
128034925|NCT00876447|460757767|FG000|Overall Study|Personal reasons|30|||
128034926|NCT00876447|460757768|FG001|Overall Study|Personal reasons|28|||
128034927|NCT00876447|460757767|FG000|Overall Study|Lost to Follow-up|6|||
128034928|NCT00876447|460757768|FG001|Overall Study|Lost to Follow-up|15|||
128034929|NCT00876447|460757767|FG000|Overall Study|Pregnancy|4|||
128034930|NCT00876447|460757768|FG001|Overall Study|Pregnancy|2|||
128034931|NCT00876447|460757767|FG000|Overall Study|Lack of Efficacy|5|||
128034932|NCT00876447|460757768|FG001|Overall Study|Lack of Efficacy|3|||
128034933|NCT00876447|460757767|FG000|Overall Study|Adverse Event|4|||
128034934|NCT00876447|460757768|FG001|Overall Study|Adverse Event|8|||
128034935|NCT02297516|460757771|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
128034936|NCT02297516|460757772|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
127594483|NCT02495168|459142007|FG000|Overall Study|Lost to Follow-up|10|||
127785969|NCT00111800|459841581|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
127785970|NCT00111800|459841582|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
127785971|NCT00111800|459841583|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
127785972|NCT00111800|459841578|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
127785973|NCT00111800|459841579|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
127785974|NCT00111800|459841580|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
127785975|NCT00111800|459841581|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
127882276|NCT01586624|460192727|FG007|Overall Study|Withdrawal by Subject|0|||
127594484|NCT02495168|459142008|FG001|Overall Study|Lost to Follow-up|6|||
127594485|NCT02495168|459142009|FG002|Overall Study|Lost to Follow-up|1|||
127594486|NCT02495168|459142007|FG000|Overall Study|Withdrawal by Subject|1|||
127594487|NCT02495168|459142008|FG001|Overall Study|Withdrawal by Subject|4|||
127594488|NCT02495168|459142009|FG002|Overall Study|Withdrawal by Subject|2|||
127594489|NCT02495168|459142007|FG000|Overall Study|Protocol Violation|0|||
127594490|NCT02495168|459142008|FG001|Overall Study|Protocol Violation|10|||
127594491|NCT02495168|459142009|FG002|Overall Study|Protocol Violation|1|||
127594492|NCT02495168|459142007|FG000|Overall Study|Adverse Event|4|||
127594493|NCT02495168|459142008|FG001|Overall Study|Adverse Event|8|||
127594494|NCT02495168|459142009|FG002|Overall Study|Adverse Event|3|||
127594495|NCT02495168|459142007|FG000|Overall Study|Lack of Efficacy|0|||
127594496|NCT02495168|459142008|FG001|Overall Study|Lack of Efficacy|0|||
127594497|NCT02495168|459142009|FG002|Overall Study|Lack of Efficacy|3|||
127594498|NCT00814164|459142012|FG000|Overall Study|Progression|7|||
127594499|NCT00814164|459142012|FG000|Overall Study|not stated|7|||
127594500|NCT00814164|459142012|FG000|Overall Study|Death|5|||
127594501|NCT01169493|459142021|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
127594502|NCT01169493|459142022|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
127594503|NCT01169493|459142023|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
127594504|NCT01169493|459142024|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
127594505|NCT01169493|459142025|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
127594506|NCT01169493|459142026|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
127594507|NCT01169493|459142021|FG000|Period 3 (6 Months)|Adverse Event|0|||
127594508|NCT01169493|459142022|FG001|Period 3 (6 Months)|Adverse Event|1|||
127594509|NCT01169493|459142023|FG002|Period 3 (6 Months)|Adverse Event|0|||
127594510|NCT01169493|459142024|FG003|Period 3 (6 Months)|Adverse Event|0|||
127594511|NCT01169493|459142025|FG004|Period 3 (6 Months)|Adverse Event|0|||
127594512|NCT01169493|459142026|FG005|Period 3 (6 Months)|Adverse Event|0|||
127594513|NCT01169493|459142021|FG000|Period 3 (6 Months)|Physician Decision|0|||
127882277|NCT01586624|460192720|FG000|Overall Study|Evidence of disease progression|1|||
127882278|NCT01586624|460192721|FG001|Overall Study|Evidence of disease progression|3|||
127882279|NCT01586624|460192722|FG002|Overall Study|Evidence of disease progression|2|||
127594514|NCT01169493|459142022|FG001|Period 3 (6 Months)|Physician Decision|1|||
127594515|NCT01169493|459142023|FG002|Period 3 (6 Months)|Physician Decision|1|||
127594516|NCT01169493|459142024|FG003|Period 3 (6 Months)|Physician Decision|0|||
127594517|NCT01169493|459142025|FG004|Period 3 (6 Months)|Physician Decision|0|||
127594518|NCT01169493|459142026|FG005|Period 3 (6 Months)|Physician Decision|0|||
127882280|NCT01586624|460192723|FG003|Overall Study|Evidence of disease progression|5|||
127882281|NCT01586624|460192724|FG004|Overall Study|Evidence of disease progression|3|||
127882282|NCT01586624|460192725|FG005|Overall Study|Evidence of disease progression|5|||
128034937|NCT02297516|460757771|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
128034938|NCT02297516|460757772|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
127594519|NCT00420927|459142030|FG000|Period 1|Adverse Event|19|||
127594520|NCT00420927|459142031|FG001|Period 1|Adverse Event|15|||
127594521|NCT00420927|459142032|FG002|Period 1|Adverse Event|0|||
127594522|NCT00420927|459142033|FG003|Period 1|Adverse Event|0|||
127594523|NCT00420927|459142034|FG004|Period 1|Adverse Event|0|||
127594524|NCT00420927|459142035|FG005|Period 1|Adverse Event|0|||
127594525|NCT00420927|459142036|FG006|Period 1|Adverse Event|0|||
127594526|NCT00420927|459142030|FG000|Period 1|Withdrawal by Subject|7|||
127594527|NCT00420927|459142031|FG001|Period 1|Withdrawal by Subject|12|||
127594528|NCT00420927|459142032|FG002|Period 1|Withdrawal by Subject|0|||
127594529|NCT00420927|459142033|FG003|Period 1|Withdrawal by Subject|0|||
127785976|NCT00111800|459841582|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
127785977|NCT00111800|459841583|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
127785978|NCT00111800|459841578|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
127785979|NCT00111800|459841579|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
127785980|NCT00111800|459841580|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
127785981|NCT00111800|459841581|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
127785982|NCT00111800|459841582|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
127785983|NCT00111800|459841583|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
127785984|NCT00111800|459841578|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
127785985|NCT00111800|459841579|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
127785986|NCT00111800|459841580|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
127785987|NCT00111800|459841581|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
127785988|NCT00111800|459841582|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
127785989|NCT00111800|459841583|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
127785990|NCT00111800|459841578|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
127785991|NCT00111800|459841579|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
127785992|NCT00111800|459841580|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
127785993|NCT00111800|459841581|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
127785994|NCT00111800|459841582|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
127785995|NCT00111800|459841583|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
127785996|NCT00111800|459841578|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
127785997|NCT00111800|459841579|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
127785998|NCT00111800|459841580|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
127785999|NCT00111800|459841581|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
127786000|NCT00111800|459841582|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
127786001|NCT00111800|459841583|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
127786002|NCT00111800|459841578|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
127786003|NCT00111800|459841579|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
127786004|NCT00111800|459841580|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
127786005|NCT00111800|459841581|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
127786006|NCT00111800|459841582|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
127786007|NCT00111800|459841583|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
127786008|NCT00111800|459841578|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
127786009|NCT00111800|459841579|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
127786010|NCT00111800|459841580|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
127786011|NCT00111800|459841581|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
127786012|NCT00111800|459841582|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
127786013|NCT00111800|459841583|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
127786014|NCT00111800|459841578|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
127786015|NCT00111800|459841579|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
127786016|NCT00111800|459841580|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
127786017|NCT00111800|459841581|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
127786018|NCT00111800|459841582|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
127786019|NCT00111800|459841583|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
127786020|NCT01549275|459841584|FG000|Overall Study|Lost to Follow-up|1|||
127786021|NCT01549275|459841585|FG001|Overall Study|Lost to Follow-up|0|||
127786022|NCT01111851|459841588|FG000|Overall Study|All planned PET scans were not obtained.|2|||
127786023|NCT01111851|459841589|FG001|Overall Study|All planned PET scans were not obtained.|0|||
127786024|NCT01471015|459841591|FG000|Overall Study|Death|0|||
127786025|NCT01471015|459841592|FG001|Overall Study|Death|1|||
127786026|NCT01471015|459841593|FG002|Overall Study|Death|1|||
127786027|NCT01843842|459841594|FG000|Overall Study|Do not meet inclusion criteria|1|||
127786028|NCT01843842|459841595|FG001|Overall Study|Do not meet inclusion criteria|1|||
127786029|NCT02953340|459841596|FG000|Overall Study|Death|0|||
127786030|NCT02953340|459841597|FG001|Overall Study|Death|1|||
127786031|NCT02953340|459841596|FG000|Overall Study|Investigator Decision|3|||
127786032|NCT02953340|459841597|FG001|Overall Study|Investigator Decision|3|||
127594530|NCT00420927|459142034|FG004|Period 1|Withdrawal by Subject|0|||
127594531|NCT00420927|459142035|FG005|Period 1|Withdrawal by Subject|0|||
127594532|NCT00420927|459142036|FG006|Period 1|Withdrawal by Subject|0|||
128034939|NCT02297516|460757771|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
128034940|NCT02297516|460757772|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
127594533|NCT00420927|459142030|FG000|Period 1|Lost to Follow-up|8|||
127594534|NCT00420927|459142031|FG001|Period 1|Lost to Follow-up|6|||
127594535|NCT00420927|459142032|FG002|Period 1|Lost to Follow-up|0|||
128034941|NCT00366457|460757776|FG000|Overall Study|never began study therapy|2|||
128034942|NCT00189423|460757781|FG000|Overall Study|Death|746|||
128034943|NCT00189423|460757782|FG001|Overall Study|Death|747|||
128034944|NCT00189423|460757781|FG000|Overall Study|Withdrawal by Subject|9|||
128034945|NCT00189423|460757782|FG001|Overall Study|Withdrawal by Subject|9|||
128034946|NCT00189423|460757781|FG000|Overall Study|Lost to Follow-up|10|||
128034947|NCT00189423|460757782|FG001|Overall Study|Lost to Follow-up|10|||
128034948|NCT04622592|460757783|FG000|Overall Study|Death|0|||
128034949|NCT04622592|460757784|FG001|Overall Study|Death|0|||
128034950|NCT04622592|460757785|FG002|Overall Study|Death|1|||
128034951|NCT04622592|460757786|FG003|Overall Study|Death|0|||
128034952|NCT04622592|460757787|FG004|Overall Study|Death|0|||
128034953|NCT04622592|460757788|FG005|Overall Study|Death|0|||
128034954|NCT04622592|460757789|FG006|Overall Study|Death|0|||
128034955|NCT04622592|460757790|FG007|Overall Study|Death|1|||
128034956|NCT04622592|460757783|FG000|Overall Study|Lost to Follow-up|0|||
128034957|NCT04622592|460757784|FG001|Overall Study|Lost to Follow-up|0|||
128034958|NCT04622592|460757785|FG002|Overall Study|Lost to Follow-up|0|||
128034959|NCT04622592|460757786|FG003|Overall Study|Lost to Follow-up|3|||
128034960|NCT04622592|460757787|FG004|Overall Study|Lost to Follow-up|1|||
128034961|NCT04622592|460757788|FG005|Overall Study|Lost to Follow-up|0|||
128034962|NCT04622592|460757789|FG006|Overall Study|Lost to Follow-up|2|||
128034963|NCT04622592|460757790|FG007|Overall Study|Lost to Follow-up|2|||
128034964|NCT04622592|460757783|FG000|Overall Study|Physician Decision|0|||
128034965|NCT04622592|460757784|FG001|Overall Study|Physician Decision|0|||
127594536|NCT00420927|459142033|FG003|Period 1|Lost to Follow-up|0|||
127594537|NCT00420927|459142034|FG004|Period 1|Lost to Follow-up|0|||
127594538|NCT00420927|459142035|FG005|Period 1|Lost to Follow-up|0|||
127594539|NCT00420927|459142036|FG006|Period 1|Lost to Follow-up|0|||
127695290|NCT01261312|459512907|FG003|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
127695291|NCT01261312|459512908|FG004|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
127695292|NCT01261312|459512909|FG005|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
127695293|NCT01261312|459512910|FG006|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
127695294|NCT01261312|459512911|FG007|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
127695295|NCT01261312|459512912|FG008|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
127695296|NCT01261312|459512913|FG009|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
127695297|NCT01261312|459512914|FG010|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
127695298|NCT01261312|459512915|FG011|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
127695299|NCT01261312|459512916|FG012|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
127695300|NCT01261312|459512904|FG000|DE Phase: TN AML (Week 85-283)|Death|0|||
127695301|NCT01261312|459512905|FG001|DE Phase: TN AML (Week 85-283)|Death|0|||
127695302|NCT01261312|459512906|FG002|DE Phase: TN AML (Week 85-283)|Death|0|||
127695303|NCT01261312|459512907|FG003|DE Phase: TN AML (Week 85-283)|Death|0|||
127695304|NCT01261312|459512908|FG004|DE Phase: TN AML (Week 85-283)|Death|0|||
127695305|NCT01261312|459512909|FG005|DE Phase: TN AML (Week 85-283)|Death|0|||
127695306|NCT01261312|459512910|FG006|DE Phase: TN AML (Week 85-283)|Death|4|||
127695307|NCT01261312|459512911|FG007|DE Phase: TN AML (Week 85-283)|Death|7|||
127695308|NCT01261312|459512912|FG008|DE Phase: TN AML (Week 85-283)|Death|11|||
127695309|NCT01261312|459512913|FG009|DE Phase: TN AML (Week 85-283)|Death|0|||
127695310|NCT01261312|459512914|FG010|DE Phase: TN AML (Week 85-283)|Death|0|||
127695311|NCT01261312|459512915|FG011|DE Phase: TN AML (Week 85-283)|Death|0|||
127695312|NCT01261312|459512916|FG012|DE Phase: TN AML (Week 85-283)|Death|0|||
127695313|NCT01261312|459512904|FG000|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
127695314|NCT01261312|459512905|FG001|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
127695315|NCT01261312|459512906|FG002|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
127695316|NCT01261312|459512907|FG003|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
127695317|NCT01261312|459512908|FG004|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
127695318|NCT01261312|459512909|FG005|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
128034966|NCT04622592|460757785|FG002|Overall Study|Physician Decision|0|||
128034967|NCT04622592|460757786|FG003|Overall Study|Physician Decision|0|||
128034968|NCT04622592|460757787|FG004|Overall Study|Physician Decision|1|||
128034969|NCT04622592|460757788|FG005|Overall Study|Physician Decision|0|||
128034970|NCT04622592|460757789|FG006|Overall Study|Physician Decision|0|||
128034971|NCT04622592|460757790|FG007|Overall Study|Physician Decision|0|||
128034972|NCT04622592|460757783|FG000|Overall Study|Withdrawal by Subject|1|||
127594540|NCT00420927|459142030|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
127594541|NCT00420927|459142031|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
127594542|NCT00420927|459142032|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
127695319|NCT01261312|459512910|FG006|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
128034973|NCT04622592|460757784|FG001|Overall Study|Withdrawal by Subject|0|||
128034974|NCT04622592|460757785|FG002|Overall Study|Withdrawal by Subject|2|||
127786033|NCT02953340|459841596|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
127594543|NCT00420927|459142033|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
127594544|NCT00420927|459142034|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
127594545|NCT00420927|459142035|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
127594546|NCT00420927|459142036|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
127594547|NCT00420927|459142030|FG000|Period 1|Death|2|||
127594548|NCT00420927|459142031|FG001|Period 1|Death|0|||
127594549|NCT00420927|459142032|FG002|Period 1|Death|0|||
127594550|NCT00420927|459142033|FG003|Period 1|Death|0|||
127594551|NCT00420927|459142034|FG004|Period 1|Death|0|||
127594552|NCT00420927|459142035|FG005|Period 1|Death|0|||
127594553|NCT00420927|459142036|FG006|Period 1|Death|0|||
127594554|NCT00420927|459142030|FG000|Period 1|Subject moved/relocated|0|||
127594555|NCT00420927|459142031|FG001|Period 1|Subject moved/relocated|2|||
127594556|NCT00420927|459142032|FG002|Period 1|Subject moved/relocated|0|||
127594557|NCT00420927|459142033|FG003|Period 1|Subject moved/relocated|0|||
127594558|NCT00420927|459142034|FG004|Period 1|Subject moved/relocated|0|||
127594559|NCT00420927|459142035|FG005|Period 1|Subject moved/relocated|0|||
127594560|NCT00420927|459142036|FG006|Period 1|Subject moved/relocated|0|||
127594561|NCT00420927|459142030|FG000|Period 1|Noncompliant with study drug|1|||
127594562|NCT00420927|459142031|FG001|Period 1|Noncompliant with study drug|1|||
127594563|NCT00420927|459142032|FG002|Period 1|Noncompliant with study drug|0|||
127594564|NCT00420927|459142033|FG003|Period 1|Noncompliant with study drug|0|||
127594565|NCT00420927|459142034|FG004|Period 1|Noncompliant with study drug|0|||
127594566|NCT00420927|459142035|FG005|Period 1|Noncompliant with study drug|0|||
127594567|NCT00420927|459142036|FG006|Period 1|Noncompliant with study drug|0|||
127594568|NCT00420927|459142030|FG000|Period 1|Randomization error|1|||
127594569|NCT00420927|459142031|FG001|Period 1|Randomization error|0|||
127594570|NCT00420927|459142032|FG002|Period 1|Randomization error|0|||
127594571|NCT00420927|459142033|FG003|Period 1|Randomization error|0|||
127594572|NCT00420927|459142034|FG004|Period 1|Randomization error|0|||
127594573|NCT00420927|459142035|FG005|Period 1|Randomization error|0|||
127594574|NCT00420927|459142036|FG006|Period 1|Randomization error|0|||
127594575|NCT00420927|459142030|FG000|Period 1|Suspected tuberculosis/positive test|1|||
127594576|NCT00420927|459142031|FG001|Period 1|Suspected tuberculosis/positive test|1|||
127594577|NCT00420927|459142032|FG002|Period 1|Suspected tuberculosis/positive test|0|||
127594578|NCT00420927|459142033|FG003|Period 1|Suspected tuberculosis/positive test|0|||
127594579|NCT00420927|459142034|FG004|Period 1|Suspected tuberculosis/positive test|0|||
127594580|NCT00420927|459142035|FG005|Period 1|Suspected tuberculosis/positive test|0|||
127594581|NCT00420927|459142036|FG006|Period 1|Suspected tuberculosis/positive test|0|||
127594582|NCT00420927|459142030|FG000|Period 1|Study site closure|0|||
127594583|NCT00420927|459142031|FG001|Period 1|Study site closure|1|||
127594584|NCT00420927|459142032|FG002|Period 1|Study site closure|0|||
127594585|NCT00420927|459142033|FG003|Period 1|Study site closure|0|||
127594586|NCT00420927|459142034|FG004|Period 1|Study site closure|0|||
127594587|NCT00420927|459142035|FG005|Period 1|Study site closure|0|||
127594588|NCT00420927|459142036|FG006|Period 1|Study site closure|0|||
127594589|NCT00420927|459142030|FG000|Period 1|Subject received new diagnosis|0|||
127594590|NCT00420927|459142031|FG001|Period 1|Subject received new diagnosis|2|||
127594591|NCT00420927|459142032|FG002|Period 1|Subject received new diagnosis|0|||
127594592|NCT00420927|459142033|FG003|Period 1|Subject received new diagnosis|0|||
127786034|NCT02953340|459841597|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
127594593|NCT00420927|459142034|FG004|Period 1|Subject received new diagnosis|0|||
127594594|NCT00420927|459142035|FG005|Period 1|Subject received new diagnosis|0|||
127594595|NCT00420927|459142036|FG006|Period 1|Subject received new diagnosis|0|||
127786035|NCT02953340|459841596|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
127786036|NCT02953340|459841597|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
127594596|NCT00420927|459142030|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
127594597|NCT00420927|459142031|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
127594598|NCT00420927|459142032|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
127594599|NCT00420927|459142033|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
127594600|NCT00420927|459142034|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
127594601|NCT00420927|459142035|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
127594602|NCT00420927|459142036|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
127594603|NCT00420927|459142030|FG000|Period 1|Failed to meet entry criteria|8|||
127594604|NCT00420927|459142031|FG001|Period 1|Failed to meet entry criteria|7|||
127594605|NCT00420927|459142032|FG002|Period 1|Failed to meet entry criteria|0|||
127594606|NCT00420927|459142033|FG003|Period 1|Failed to meet entry criteria|0|||
127594607|NCT00420927|459142034|FG004|Period 1|Failed to meet entry criteria|0|||
127594608|NCT00420927|459142035|FG005|Period 1|Failed to meet entry criteria|0|||
127594609|NCT00420927|459142036|FG006|Period 1|Failed to meet entry criteria|0|||
127594610|NCT00420927|459142030|FG000|Period 1|Took prohibited medication|1|||
127594611|NCT00420927|459142031|FG001|Period 1|Took prohibited medication|3|||
127594612|NCT00420927|459142032|FG002|Period 1|Took prohibited medication|0|||
127594613|NCT00420927|459142033|FG003|Period 1|Took prohibited medication|0|||
127594614|NCT00420927|459142034|FG004|Period 1|Took prohibited medication|0|||
127786037|NCT02953340|459841596|FG000|Overall Study|Withdrawal by Subject|9|||
127882283|NCT01586624|460192726|FG006|Overall Study|Evidence of disease progression|4|||
127882284|NCT01586624|460192727|FG007|Overall Study|Evidence of disease progression|6|||
127882285|NCT01586624|460192720|FG000|Overall Study|Screen failure (no treatment received)|0|||
127882286|NCT01586624|460192721|FG001|Overall Study|Screen failure (no treatment received)|0|||
127594615|NCT00420927|459142035|FG005|Period 1|Took prohibited medication|0|||
128034975|NCT04622592|460757786|FG003|Overall Study|Withdrawal by Subject|0|||
127594616|NCT00420927|459142036|FG006|Period 1|Took prohibited medication|0|||
127594617|NCT00420927|459142030|FG000|Period 2|Adverse Event|0|||
127594618|NCT00420927|459142031|FG001|Period 2|Adverse Event|0|||
127594619|NCT00420927|459142032|FG002|Period 2|Adverse Event|7|||
127594620|NCT00420927|459142033|FG003|Period 2|Adverse Event|3|||
127594621|NCT00420927|459142034|FG004|Period 2|Adverse Event|17|||
127594622|NCT00420927|459142035|FG005|Period 2|Adverse Event|6|||
127594623|NCT00420927|459142036|FG006|Period 2|Adverse Event|20|||
127594624|NCT00420927|459142030|FG000|Period 2|Withdrawal by Subject|0|||
127594625|NCT00420927|459142031|FG001|Period 2|Withdrawal by Subject|0|||
127594626|NCT00420927|459142032|FG002|Period 2|Withdrawal by Subject|1|||
127594627|NCT00420927|459142033|FG003|Period 2|Withdrawal by Subject|3|||
127594628|NCT00420927|459142034|FG004|Period 2|Withdrawal by Subject|11|||
127594629|NCT00420927|459142035|FG005|Period 2|Withdrawal by Subject|2|||
127594630|NCT00420927|459142036|FG006|Period 2|Withdrawal by Subject|12|||
127594631|NCT00420927|459142030|FG000|Period 2|Lost to Follow-up|0|||
127594632|NCT00420927|459142031|FG001|Period 2|Lost to Follow-up|0|||
127594633|NCT00420927|459142032|FG002|Period 2|Lost to Follow-up|2|||
127594634|NCT00420927|459142033|FG003|Period 2|Lost to Follow-up|2|||
127594635|NCT00420927|459142034|FG004|Period 2|Lost to Follow-up|6|||
127594636|NCT00420927|459142035|FG005|Period 2|Lost to Follow-up|3|||
127594637|NCT00420927|459142036|FG006|Period 2|Lost to Follow-up|9|||
127594638|NCT00420927|459142030|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
127594639|NCT00420927|459142031|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
127594640|NCT00420927|459142032|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
127594641|NCT00420927|459142033|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
127594642|NCT00420927|459142034|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
127594643|NCT00420927|459142035|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
127594644|NCT00420927|459142036|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
127594645|NCT00420927|459142030|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
127594646|NCT00420927|459142031|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
127594647|NCT00420927|459142032|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
127594648|NCT00420927|459142033|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
127594649|NCT00420927|459142034|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
127594650|NCT00420927|459142035|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
127594651|NCT00420927|459142036|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
127594652|NCT00420927|459142030|FG000|Period 2|Subject unable to find transportation|0|||
127594653|NCT00420927|459142031|FG001|Period 2|Subject unable to find transportation|0|||
127882287|NCT01586624|460192722|FG002|Overall Study|Screen failure (no treatment received)|0|||
127882288|NCT01586624|460192723|FG003|Overall Study|Screen failure (no treatment received)|0|||
128034976|NCT04622592|460757787|FG004|Overall Study|Withdrawal by Subject|0|||
128034977|NCT04622592|460757788|FG005|Overall Study|Withdrawal by Subject|0|||
128034978|NCT04622592|460757789|FG006|Overall Study|Withdrawal by Subject|1|||
128034979|NCT04622592|460757790|FG007|Overall Study|Withdrawal by Subject|4|||
128034980|NCT04622592|460757783|FG000|Overall Study|Other than specified above|0|||
128034981|NCT04622592|460757784|FG001|Overall Study|Other than specified above|0|||
128034982|NCT04622592|460757785|FG002|Overall Study|Other than specified above|1|||
128034983|NCT04622592|460757786|FG003|Overall Study|Other than specified above|0|||
128034984|NCT04622592|460757787|FG004|Overall Study|Other than specified above|0|||
128034985|NCT04622592|460757788|FG005|Overall Study|Other than specified above|0|||
128034986|NCT04622592|460757789|FG006|Overall Study|Other than specified above|0|||
128034987|NCT04622592|460757790|FG007|Overall Study|Other than specified above|0|||
128034988|NCT00183248|460757795|FG000|Overall Study|Lost to Follow-up|0|||
128034989|NCT00183248|460757796|FG001|Overall Study|Lost to Follow-up|1|||
127594654|NCT00420927|459142032|FG002|Period 2|Subject unable to find transportation|0|||
128034990|NCT00183248|460757795|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
128034991|NCT00183248|460757796|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
128034992|NCT03309202|460757797|FG000|Overall Study|Lost to Follow-up|1|||
128034993|NCT03309202|460757798|FG001|Overall Study|Lost to Follow-up|0|||
128034994|NCT03309202|460757799|FG002|Overall Study|Lost to Follow-up|0|||
127594655|NCT00420927|459142033|FG003|Period 2|Subject unable to find transportation|0|||
127594656|NCT00420927|459142034|FG004|Period 2|Subject unable to find transportation|0|||
127594657|NCT00420927|459142035|FG005|Period 2|Subject unable to find transportation|0|||
127594658|NCT00420927|459142036|FG006|Period 2|Subject unable to find transportation|1|||
127594659|NCT00420927|459142030|FG000|Period 2|Physician Decision|0|||
127594660|NCT00420927|459142031|FG001|Period 2|Physician Decision|0|||
127594661|NCT00420927|459142032|FG002|Period 2|Physician Decision|0|||
127594662|NCT00420927|459142033|FG003|Period 2|Physician Decision|0|||
128034995|NCT03309202|460757800|FG003|Overall Study|Lost to Follow-up|0|||
128034996|NCT00415636|460757801|FG000|Overall Study|Symptomatic deterioration|1|||
128034997|NCT00415636|460757802|FG001|Overall Study|Symptomatic deterioration|0|||
128034998|NCT00415636|460757803|FG002|Overall Study|Symptomatic deterioration|1|||
127594663|NCT00420927|459142034|FG004|Period 2|Physician Decision|1|||
127594664|NCT00420927|459142035|FG005|Period 2|Physician Decision|1|||
127594665|NCT00420927|459142036|FG006|Period 2|Physician Decision|0|||
127594666|NCT00420927|459142030|FG000|Period 2|Sponsor decision|0|||
127594667|NCT00420927|459142031|FG001|Period 2|Sponsor decision|0|||
127594668|NCT00420927|459142032|FG002|Period 2|Sponsor decision|1|||
127594669|NCT00420927|459142033|FG003|Period 2|Sponsor decision|0|||
127594670|NCT00420927|459142034|FG004|Period 2|Sponsor decision|0|||
127594671|NCT00420927|459142035|FG005|Period 2|Sponsor decision|0|||
127594672|NCT00420927|459142036|FG006|Period 2|Sponsor decision|1|||
127594673|NCT00420927|459142030|FG000|Period 2|Randomization error|0|||
127594674|NCT00420927|459142031|FG001|Period 2|Randomization error|0|||
127594675|NCT00420927|459142032|FG002|Period 2|Randomization error|0|||
127594676|NCT00420927|459142033|FG003|Period 2|Randomization error|0|||
127594677|NCT00420927|459142034|FG004|Period 2|Randomization error|1|||
127594678|NCT00420927|459142035|FG005|Period 2|Randomization error|1|||
127594679|NCT00420927|459142036|FG006|Period 2|Randomization error|0|||
127594680|NCT00420927|459142030|FG000|Period 2|Noncompliant with study drug|0|||
127594681|NCT00420927|459142031|FG001|Period 2|Noncompliant with study drug|0|||
127594682|NCT00420927|459142032|FG002|Period 2|Noncompliant with study drug|0|||
127594683|NCT00420927|459142033|FG003|Period 2|Noncompliant with study drug|1|||
127594684|NCT00420927|459142034|FG004|Period 2|Noncompliant with study drug|0|||
127594685|NCT00420927|459142035|FG005|Period 2|Noncompliant with study drug|0|||
127594686|NCT00420927|459142036|FG006|Period 2|Noncompliant with study drug|2|||
127594687|NCT00420927|459142030|FG000|Period 2|Methotrexate intolerance|0|||
127594688|NCT00420927|459142031|FG001|Period 2|Methotrexate intolerance|0|||
127594689|NCT00420927|459142032|FG002|Period 2|Methotrexate intolerance|0|||
127594690|NCT00420927|459142033|FG003|Period 2|Methotrexate intolerance|0|||
127594691|NCT00420927|459142034|FG004|Period 2|Methotrexate intolerance|0|||
127594692|NCT00420927|459142035|FG005|Period 2|Methotrexate intolerance|0|||
127594693|NCT00420927|459142036|FG006|Period 2|Methotrexate intolerance|1|||
127594694|NCT00420927|459142030|FG000|Period 2|Took prohibited medication|0|||
127594695|NCT00420927|459142031|FG001|Period 2|Took prohibited medication|0|||
127594696|NCT00420927|459142032|FG002|Period 2|Took prohibited medication|0|||
127594697|NCT00420927|459142033|FG003|Period 2|Took prohibited medication|0|||
127594698|NCT00420927|459142034|FG004|Period 2|Took prohibited medication|1|||
127594699|NCT00420927|459142035|FG005|Period 2|Took prohibited medication|0|||
127594700|NCT00420927|459142036|FG006|Period 2|Took prohibited medication|0|||
127594701|NCT02246660|459142037|FG000|Overall Study|Withdrawal by Subject|0|||
127594702|NCT02246660|459142038|FG001|Overall Study|Withdrawal by Subject|1|||
127594703|NCT02246660|459142039|FG002|Overall Study|Withdrawal by Subject|0|||
127594704|NCT02246660|459142037|FG000|Overall Study|Death|0|||
127594705|NCT02246660|459142038|FG001|Overall Study|Death|0|||
127594706|NCT02246660|459142039|FG002|Overall Study|Death|1|||
127594707|NCT03018704|459142040|FG000|Overall Study|Lost to Follow-up|1|||
127594708|NCT03018704|459142041|FG001|Overall Study|Lost to Follow-up|1|||
127594709|NCT00320411|459142042|FG000|Overall Study|No investigational product admin.|4|||
127594710|NCT02557646|459142046|FG000|Overall Study|Adverse Event|40|||
127594711|NCT02557646|459142046|FG000|Overall Study|Death|1|||
127594712|NCT02557646|459142046|FG000|Overall Study|Lack of Efficacy|186|||
127594713|NCT02557646|459142046|FG000|Overall Study|Withdrawal by Subject|18|||
127594714|NCT02557646|459142046|FG000|Overall Study|Lost to Follow-up|17|||
127594715|NCT02557646|459142046|FG000|Overall Study|Other|14|||
127594716|NCT00518986|459142047|FG000|Overall Study|Adverse Event|12|||
127594717|NCT00518986|459142048|FG001|Overall Study|Adverse Event|7|||
127594718|NCT00518986|459142047|FG000|Overall Study|Lack of Efficacy|0|||
127594719|NCT00518986|459142048|FG001|Overall Study|Lack of Efficacy|2|||
127594720|NCT00518986|459142047|FG000|Overall Study|Lost to Follow-up|3|||
127594721|NCT00518986|459142048|FG001|Overall Study|Lost to Follow-up|2|||
127594722|NCT00518986|459142047|FG000|Overall Study|Physician Decision|0|||
127594723|NCT00518986|459142048|FG001|Overall Study|Physician Decision|3|||
127695320|NCT01261312|459512911|FG007|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
128034999|NCT00415636|460757804|FG003|Overall Study|Symptomatic deterioration|2|||
128035000|NCT00415636|460757805|FG004|Overall Study|Symptomatic deterioration|0|||
127594724|NCT00518986|459142047|FG000|Overall Study|Protocol Violation|5|||
127594725|NCT00518986|459142048|FG001|Overall Study|Protocol Violation|7|||
127594726|NCT00518986|459142047|FG000|Overall Study|Withdrawal by Subject|4|||
127594727|NCT00518986|459142048|FG001|Overall Study|Withdrawal by Subject|4|||
127594728|NCT00518986|459142047|FG000|Overall Study|Non-Specific|2|||
127594729|NCT00518986|459142048|FG001|Overall Study|Non-Specific|1|||
127594730|NCT04448171|459142049|FG000|Overall Study|Procedure Cancelled|1|||
127594731|NCT04448171|459142050|FG001|Overall Study|Procedure Cancelled|0|||
127594732|NCT04448171|459142049|FG000|Overall Study|Protocol Violation|1|||
127594733|NCT04448171|459142050|FG001|Overall Study|Protocol Violation|0|||
127594734|NCT00660309|459142053|FG000|Overall Study|Adverse Event|2|||
127786038|NCT02953340|459841597|FG001|Overall Study|Withdrawal by Subject|9|||
127786039|NCT02953340|459841596|FG000|Overall Study|Sponsor decision|0|||
127786040|NCT02953340|459841597|FG001|Overall Study|Sponsor decision|2|||
127786041|NCT02953340|459841596|FG000|Overall Study|Lost to Follow-up|3|||
127882289|NCT01586624|460192724|FG004|Overall Study|Screen failure (no treatment received)|0|||
127882290|NCT01586624|460192725|FG005|Overall Study|Screen failure (no treatment received)|0|||
127882291|NCT01586624|460192726|FG006|Overall Study|Screen failure (no treatment received)|1|||
127882292|NCT01586624|460192727|FG007|Overall Study|Screen failure (no treatment received)|0|||
127882293|NCT01160198|460192730|FG000|Overall Study|Withdrawal by Subject|2|||
127882294|NCT01160198|460192731|FG001|Overall Study|Withdrawal by Subject|1|||
127882295|NCT01160198|460192732|FG002|Overall Study|Withdrawal by Subject|0|||
127882296|NCT01160198|460192730|FG000|Overall Study|Adverse Event|0|||
127882297|NCT01160198|460192731|FG001|Overall Study|Adverse Event|1|||
127882298|NCT01160198|460192732|FG002|Overall Study|Adverse Event|0|||
127882299|NCT01160198|460192730|FG000|Overall Study|Lost to Follow-up|0|||
127882300|NCT01160198|460192731|FG001|Overall Study|Lost to Follow-up|1|||
127882301|NCT01160198|460192732|FG002|Overall Study|Lost to Follow-up|0|||
127882302|NCT01160198|460192730|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
127882303|NCT01160198|460192731|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
127882304|NCT01160198|460192732|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
127882305|NCT02016755|460192735|FG000|Overall Study|Major amputation of index limb|2|||
127882306|NCT02016755|460192735|FG000|Overall Study|Adverse Event|2|||
127882307|NCT02016755|460192735|FG000|Overall Study|Physician Decision|1|||
127882308|NCT02016755|460192735|FG000|Overall Study|Death|2|||
127882309|NCT01396161|460192739|FG000|Overall Study|Withdrawal by Subject|0|||
127882310|NCT01396161|460192740|FG001|Overall Study|Withdrawal by Subject|0|||
127786042|NCT02953340|459841597|FG001|Overall Study|Lost to Follow-up|2|||
127786043|NCT02953340|459841596|FG000|Overall Study|Reason not specified|2|||
127786044|NCT02953340|459841597|FG001|Overall Study|Reason not specified|2|||
127786045|NCT01376778|459841598|FG000|Overall Study|Lost to Follow-up|3|||
127786046|NCT01376778|459841599|FG001|Overall Study|Lost to Follow-up|2|||
127786047|NCT00928889|459841600|FG000|Overall Study|Lost to Follow-up|3|||
127786048|NCT00928889|459841601|FG001|Overall Study|Lost to Follow-up|1|||
127786049|NCT00928889|459841600|FG000|Overall Study|Protocol Violation|0|||
127786050|NCT00928889|459841601|FG001|Overall Study|Protocol Violation|1|||
127786051|NCT00928889|459841600|FG000|Overall Study|Adverse Event|1|||
127786052|NCT00928889|459841601|FG001|Overall Study|Adverse Event|0|||
127786053|NCT00928889|459841600|FG000|Overall Study|Other|1|||
127786054|NCT00928889|459841601|FG001|Overall Study|Other|0|||
127786055|NCT04712110|459841602|FG000|Overall Study|Lost to Follow-up|0|||
127786056|NCT04712110|459841603|FG001|Overall Study|Lost to Follow-up|1|||
127786057|NCT04712110|459841602|FG000|Overall Study|Withdrawal by Subject|0|||
127786058|NCT04712110|459841603|FG001|Overall Study|Withdrawal by Subject|4|||
127786059|NCT04712110|459841602|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
127786060|NCT04712110|459841603|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
127786061|NCT01517893|459841604|FG000|Overall Study|Withdrawal by Subject|3|||
127882311|NCT01396161|460192741|FG002|Overall Study|Withdrawal by Subject|0|||
127882312|NCT01396161|460192742|FG003|Overall Study|Withdrawal by Subject|0|||
128035001|NCT00415636|460757806|FG005|Overall Study|Symptomatic deterioration|1|||
128035002|NCT00415636|460757801|FG000|Overall Study|Adverse Event|0|||
128035003|NCT00415636|460757802|FG001|Overall Study|Adverse Event|0|||
128035004|NCT00415636|460757803|FG002|Overall Study|Adverse Event|0|||
128035005|NCT00415636|460757804|FG003|Overall Study|Adverse Event|1|||
128035006|NCT00415636|460757805|FG004|Overall Study|Adverse Event|1|||
128035007|NCT00415636|460757806|FG005|Overall Study|Adverse Event|0|||
128035008|NCT00415636|460757801|FG000|Overall Study|Withdrawal by Subject|0|||
128035009|NCT00415636|460757802|FG001|Overall Study|Withdrawal by Subject|0|||
128035010|NCT00415636|460757803|FG002|Overall Study|Withdrawal by Subject|0|||
128035011|NCT00415636|460757804|FG003|Overall Study|Withdrawal by Subject|0|||
128035012|NCT00415636|460757805|FG004|Overall Study|Withdrawal by Subject|1|||
128035013|NCT00415636|460757806|FG005|Overall Study|Withdrawal by Subject|0|||
128035014|NCT00415636|460757801|FG000|Overall Study|Disease progression|0|||
128035015|NCT00415636|460757802|FG001|Overall Study|Disease progression|0|||
128035016|NCT00415636|460757803|FG002|Overall Study|Disease progression|0|||
128035017|NCT00415636|460757804|FG003|Overall Study|Disease progression|3|||
128035018|NCT00415636|460757805|FG004|Overall Study|Disease progression|0|||
128035019|NCT00415636|460757806|FG005|Overall Study|Disease progression|1|||
127786062|NCT01517893|459841605|FG001|Overall Study|Withdrawal by Subject|0|||
127786063|NCT01309659|459841606|FG000|Overall Study|Protocol Violation|0|||
128035020|NCT04734210|460757807|FG000|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
128035021|NCT04734210|460757808|FG001|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
128035022|NCT04734210|460757809|FG002|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|0|||
128035023|NCT04734210|460757807|FG000|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|1|||
127786064|NCT01309659|459841607|FG001|Overall Study|Protocol Violation|1|||
127786065|NCT03462576|459841608|FG000|Overall Study|Protocol Violation|5|||
127786066|NCT03462576|459841609|FG001|Overall Study|Protocol Violation|11|||
127594735|NCT00660309|459142054|FG001|Overall Study|Adverse Event|0|||
127594736|NCT00660309|459142053|FG000|Overall Study|Withdrawal by Subject|0|||
127594737|NCT00660309|459142054|FG001|Overall Study|Withdrawal by Subject|3|||
127594738|NCT02573311|459142055|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
127594739|NCT02573311|459142056|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
127594740|NCT02573311|459142055|FG000|Disposition for Part 2|Physician Decision|25|||
127594741|NCT02573311|459142056|FG001|Disposition for Part 2|Physician Decision|7|||
127594742|NCT02573311|459142055|FG000|Disposition for Part 2|Adverse Event|36|||
127594743|NCT02573311|459142056|FG001|Disposition for Part 2|Adverse Event|5|||
127594744|NCT02573311|459142055|FG000|Disposition for Part 2|Lost to Follow-up|76|||
127594745|NCT02573311|459142056|FG001|Disposition for Part 2|Lost to Follow-up|7|||
127594746|NCT02573311|459142055|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
127594747|NCT02573311|459142056|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
127594748|NCT02573311|459142055|FG000|Disposition for Part 2|Investigator decision|0|||
127594749|NCT02573311|459142056|FG001|Disposition for Part 2|Investigator decision|1|||
127594750|NCT02573311|459142055|FG000|Disposition for Part 2|Other than specified above|13|||
127594751|NCT02573311|459142056|FG001|Disposition for Part 2|Other than specified above|3|||
127594752|NCT04171531|459142058|FG000|Overall Study|Lost to Follow-up|4|||
127594753|NCT04171531|459142059|FG001|Overall Study|Lost to Follow-up|5|||
127594754|NCT04171531|459142058|FG000|Overall Study|Consent only through 6 months|1|||
127594755|NCT04171531|459142059|FG001|Overall Study|Consent only through 6 months|1|||
127594756|NCT04171531|459142058|FG000|Overall Study|Insurance did not cover procedure|0|||
127594757|NCT04171531|459142059|FG001|Overall Study|Insurance did not cover procedure|1|||
127594758|NCT04171531|459142058|FG000|Overall Study|Physician Decision|0|||
127594759|NCT04171531|459142059|FG001|Overall Study|Physician Decision|3|||
127786067|NCT03462576|459841610|FG002|Overall Study|Protocol Violation|7|||
127786068|NCT03462576|459841608|FG000|Overall Study|Device Malfunction|0|||
127786069|NCT03462576|459841609|FG001|Overall Study|Device Malfunction|0|||
127786070|NCT03462576|459841610|FG002|Overall Study|Device Malfunction|1|||
127786071|NCT02285777|459841614|FG000|Overall Study|Withdrawal by Subject|1|||
127786072|NCT02285777|459841615|FG001|Overall Study|Withdrawal by Subject|1|||
127786073|NCT02285777|459841614|FG000|Overall Study|Lost to Follow-up|4|||
127786074|NCT02285777|459841615|FG001|Overall Study|Lost to Follow-up|2|||
127786075|NCT00271596|459841621|FG000|Overall Study|Protocol Violation|1|||
127786076|NCT00271596|459841622|FG001|Overall Study|Protocol Violation|0|||
127786077|NCT00271596|459841621|FG000|Overall Study|Withdrawal by Subject|0|||
127786078|NCT00271596|459841622|FG001|Overall Study|Withdrawal by Subject|1|||
127786079|NCT01431274|459841626|FG000|Overall Study|Adverse Event|51|||
127786080|NCT01431274|459841627|FG001|Overall Study|Adverse Event|37|||
127786081|NCT01431274|459841628|FG002|Overall Study|Adverse Event|43|||
127786082|NCT01431274|459841629|FG003|Overall Study|Adverse Event|30|||
127786083|NCT01431274|459841630|FG004|Overall Study|Adverse Event|37|||
127786084|NCT01431274|459841626|FG000|Overall Study|Consent withdrawn not due to AE|29|||
127786085|NCT01431274|459841627|FG001|Overall Study|Consent withdrawn not due to AE|20|||
127786086|NCT01431274|459841628|FG002|Overall Study|Consent withdrawn not due to AE|17|||
127786087|NCT01431274|459841629|FG003|Overall Study|Consent withdrawn not due to AE|20|||
127786088|NCT01431274|459841630|FG004|Overall Study|Consent withdrawn not due to AE|11|||
127786089|NCT01431274|459841626|FG000|Overall Study|Non compliant with protocol|5|||
127786090|NCT01431274|459841627|FG001|Overall Study|Non compliant with protocol|8|||
127786091|NCT01431274|459841628|FG002|Overall Study|Non compliant with protocol|4|||
127786092|NCT01431274|459841629|FG003|Overall Study|Non compliant with protocol|4|||
127786093|NCT01431274|459841630|FG004|Overall Study|Non compliant with protocol|4|||
127786094|NCT01431274|459841626|FG000|Overall Study|Lost to Follow-up|6|||
127786095|NCT01431274|459841627|FG001|Overall Study|Lost to Follow-up|7|||
127786096|NCT01431274|459841628|FG002|Overall Study|Lost to Follow-up|1|||
127786097|NCT01431274|459841629|FG003|Overall Study|Lost to Follow-up|4|||
127786098|NCT01431274|459841630|FG004|Overall Study|Lost to Follow-up|0|||
127786099|NCT01431274|459841626|FG000|Overall Study|Other reason not stated above|6|||
127594760|NCT04171531|459142058|FG000|Overall Study|Withdrawal by Subject|1|||
127594761|NCT04171531|459142059|FG001|Overall Study|Withdrawal by Subject|5|||
127594762|NCT05683249|459142060|FG000|Overall Study|Adverse Event|3|||
127594763|NCT05683249|459142061|FG001|Overall Study|Adverse Event|1|||
127786100|NCT01431274|459841627|FG001|Overall Study|Other reason not stated above|5|||
127594764|NCT05683249|459142060|FG000|Overall Study|Lack of Efficacy|0|||
127786101|NCT01431274|459841628|FG002|Overall Study|Other reason not stated above|7|||
127786102|NCT01431274|459841629|FG003|Overall Study|Other reason not stated above|2|||
127786103|NCT01431274|459841630|FG004|Overall Study|Other reason not stated above|4|||
127786104|NCT01069172|459841631|FG000|Overall Study|Withdrawal by Subject|1|||
127786105|NCT01069172|459841632|FG001|Overall Study|Withdrawal by Subject|0|||
127786106|NCT03901079|459841633|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
127786107|NCT02973087|459841634|FG000|Overall Study|Withdrawal by Subject|2|||
127594765|NCT05683249|459142061|FG001|Overall Study|Lack of Efficacy|2|||
127594766|NCT05683249|459142060|FG000|Overall Study|Lost to Follow-up|6|||
127594767|NCT05683249|459142061|FG001|Overall Study|Lost to Follow-up|5|||
127594768|NCT05683249|459142060|FG000|Overall Study|Non-compliance with Study Drug|2|||
127594769|NCT05683249|459142061|FG001|Overall Study|Non-compliance with Study Drug|0|||
127594770|NCT05683249|459142060|FG000|Overall Study|Protocol Violation|6|||
127594771|NCT05683249|459142061|FG001|Overall Study|Protocol Violation|3|||
127594772|NCT05683249|459142060|FG000|Overall Study|Withdrawal by Subject|9|||
127594773|NCT05683249|459142061|FG001|Overall Study|Withdrawal by Subject|8|||
127594774|NCT05683249|459142060|FG000|Overall Study|Other|0|||
127594775|NCT05683249|459142061|FG001|Overall Study|Other|2|||
127594776|NCT03366337|459142065|FG000|Overall Study|Lost to Follow-up|1|||
127594777|NCT03366337|459142066|FG001|Overall Study|Lost to Follow-up|0|||
127594778|NCT03366337|459142067|FG002|Overall Study|Lost to Follow-up|1|||
127594779|NCT03366337|459142068|FG003|Overall Study|Lost to Follow-up|0|||
127594780|NCT03366337|459142065|FG000|Overall Study|Withdrawal by Subject|2|||
127594781|NCT03366337|459142066|FG001|Overall Study|Withdrawal by Subject|0|||
127594782|NCT03366337|459142067|FG002|Overall Study|Withdrawal by Subject|1|||
127594783|NCT03366337|459142068|FG003|Overall Study|Withdrawal by Subject|1|||
127594784|NCT05288062|459142070|FG000|Overall Study|Ineligible|0|||
127594785|NCT05288062|459142071|FG001|Overall Study|Ineligible|0|||
127594786|NCT05288062|459142072|FG002|Overall Study|Ineligible|1|||
127594787|NCT05288062|459142073|FG003|Overall Study|Ineligible|0|||
127594788|NCT05288062|459142070|FG000|Overall Study|Withdrawal by Subject|0|||
127594789|NCT05288062|459142071|FG001|Overall Study|Withdrawal by Subject|0|||
127594790|NCT05288062|459142072|FG002|Overall Study|Withdrawal by Subject|1|||
127594791|NCT05288062|459142073|FG003|Overall Study|Withdrawal by Subject|0|||
127594792|NCT00459953|459142074|FG000|Overall Study|not analyzed-household member in study|1|||
127594793|NCT00459953|459142075|FG001|Overall Study|not analyzed-household member in study|1|||
127594794|NCT01049308|459142076|FG000|Pill Counts|Withdrawal by Subject|83|||
127594795|NCT03926169|459142081|FG000|Period A|Adverse Event|2|||
127594796|NCT03926169|459142082|FG001|Period A|Adverse Event|2|||
127594797|NCT03926169|459142083|FG002|Period A|Adverse Event|1|||
127594798|NCT03926169|459142081|FG000|Period A|Withdrawal by Subject|2|||
127594799|NCT03926169|459142082|FG001|Period A|Withdrawal by Subject|2|||
127594800|NCT03926169|459142083|FG002|Period A|Withdrawal by Subject|2|||
127594801|NCT03926169|459142081|FG000|Period A|Lost to Follow-up|3|||
127594802|NCT03926169|459142082|FG001|Period A|Lost to Follow-up|1|||
127594803|NCT03926169|459142083|FG002|Period A|Lost to Follow-up|0|||
127594804|NCT03926169|459142081|FG000|Period A|Lack of Efficacy|0|||
127594805|NCT03926169|459142082|FG001|Period A|Lack of Efficacy|2|||
127594806|NCT03926169|459142083|FG002|Period A|Lack of Efficacy|2|||
127594807|NCT03926169|459142081|FG000|Period A|COVID-19 Infection|0|||
127594808|NCT03926169|459142082|FG001|Period A|COVID-19 Infection|1|||
127594809|NCT03926169|459142083|FG002|Period A|COVID-19 Infection|0|||
127594810|NCT03926169|459142081|FG000|Period A|COVID-19 Logistical Restrictions|0|||
127594811|NCT03926169|459142082|FG001|Period A|COVID-19 Logistical Restrictions|2|||
127594812|NCT03926169|459142083|FG002|Period A|COVID-19 Logistical Restrictions|1|||
127594813|NCT03926169|459142081|FG000|Period A|Other, Not Specified|1|||
127594814|NCT03926169|459142082|FG001|Period A|Other, Not Specified|0|||
127594815|NCT03926169|459142083|FG002|Period A|Other, Not Specified|0|||
127594816|NCT03926169|459142081|FG000|Period B|Adverse Event|3|||
127594817|NCT03926169|459142082|FG001|Period B|Adverse Event|1|||
127594818|NCT03926169|459142083|FG002|Period B|Adverse Event|1|||
127594819|NCT03926169|459142081|FG000|Period B|Withdrawal by Subject|1|||
127594820|NCT03926169|459142082|FG001|Period B|Withdrawal by Subject|3|||
127594821|NCT03926169|459142083|FG002|Period B|Withdrawal by Subject|0|||
127594822|NCT03926169|459142081|FG000|Period B|Lack of Efficacy|3|||
127594823|NCT03926169|459142082|FG001|Period B|Lack of Efficacy|1|||
127594824|NCT03926169|459142083|FG002|Period B|Lack of Efficacy|1|||
127594825|NCT03926169|459142081|FG000|Period B|Lost to Follow-up|1|||
127594826|NCT03926169|459142082|FG001|Period B|Lost to Follow-up|1|||
127594827|NCT03926169|459142083|FG002|Period B|Lost to Follow-up|4|||
127594828|NCT03926169|459142081|FG000|Period B|Other, Not Specified|62|||
127594829|NCT03926169|459142082|FG001|Period B|Other, Not Specified|57|||
127594830|NCT03926169|459142083|FG002|Period B|Other, Not Specified|65|||
127594831|NCT02615145|459142085|FG000|Overall Study|Did Not Start Treatment|0|||
127594832|NCT02615145|459142086|FG001|Overall Study|Did Not Start Treatment|0|||
127594833|NCT02615145|459142087|FG002|Overall Study|Did Not Start Treatment|1|||
127594834|NCT02615145|459142088|FG003|Overall Study|Did Not Start Treatment|1|||
127594835|NCT02615145|459142085|FG000|Overall Study|Failure to Return|20|||
127594836|NCT02615145|459142086|FG001|Overall Study|Failure to Return|10|||
127594837|NCT02615145|459142087|FG002|Overall Study|Failure to Return|7|||
127594838|NCT02615145|459142088|FG003|Overall Study|Failure to Return|0|||
127695321|NCT01261312|459512912|FG008|DE Phase: TN AML (Week 85-283)|Investigator Decision|9|||
127695322|NCT01261312|459512913|FG009|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
127695323|NCT01261312|459512914|FG010|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
127695324|NCT01261312|459512915|FG011|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
127695325|NCT01261312|459512916|FG012|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
127695326|NCT01261312|459512904|FG000|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
127695327|NCT01261312|459512905|FG001|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
127695328|NCT01261312|459512906|FG002|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
127695329|NCT01261312|459512907|FG003|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
127786108|NCT02973087|459841635|FG001|Overall Study|Withdrawal by Subject|1|||
127786109|NCT02973087|459841634|FG000|Overall Study|Adverse Event|1|||
127786110|NCT02973087|459841635|FG001|Overall Study|Adverse Event|0|||
127786111|NCT02973087|459841634|FG000|Overall Study|other|1|||
127594839|NCT02615145|459142085|FG000|Overall Study|Death|2|||
127594840|NCT02615145|459142086|FG001|Overall Study|Death|3|||
127594841|NCT02615145|459142087|FG002|Overall Study|Death|0|||
127594842|NCT02615145|459142088|FG003|Overall Study|Death|0|||
127594843|NCT02615145|459142085|FG000|Overall Study|Other, Not Specified|5|||
127594844|NCT02615145|459142086|FG001|Overall Study|Other, Not Specified|2|||
127594845|NCT02615145|459142087|FG002|Overall Study|Other, Not Specified|0|||
127594846|NCT02615145|459142088|FG003|Overall Study|Other, Not Specified|0|||
127594847|NCT03727347|459142089|FG000|Overall Study|Withdrawal by Subject|2|||
127594848|NCT03727347|459142089|FG000|Overall Study|Lost to Follow-up|1|||
127594849|NCT03200860|459142090|FG000|Overall Study|Withdrawal by Subject|1|||
127594850|NCT03200860|459142091|FG001|Overall Study|Withdrawal by Subject|0|||
127594851|NCT01744197|459142093|FG000|Overall Study|Received 1 patch|2|||
127594852|NCT01744197|459142094|FG001|Overall Study|Received 1 patch|1|||
127594853|NCT01744197|459142093|FG000|Overall Study|No patch received|2|||
127594854|NCT01744197|459142094|FG001|Overall Study|No patch received|2|||
127594855|NCT02324569|459143645|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
127594856|NCT02324569|459143646|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
127594857|NCT02324569|459143645|FG000|Overall Study|Voluntary Withdrawal|3|||
127594858|NCT02324569|459143646|FG001|Overall Study|Voluntary Withdrawal|6|||
127594859|NCT02324569|459143645|FG000|Overall Study|Lack of Efficacy|2|||
127594860|NCT02324569|459143646|FG001|Overall Study|Lack of Efficacy|3|||
127594861|NCT02324569|459143645|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
127695330|NCT01261312|459512908|FG004|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
127786112|NCT02973087|459841635|FG001|Overall Study|other|1|||
127786113|NCT01506960|459841636|FG000|Overall Study|Did not meet angiographic criteria|47|||
128035024|NCT04734210|460757808|FG001|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
128035025|NCT04734210|460757809|FG002|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
128035026|NCT04734210|460757807|FG000|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|1|||
128035027|NCT04734210|460757808|FG001|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
128035028|NCT04734210|460757809|FG002|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
128035029|NCT04734210|460757807|FG000|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
128035030|NCT04734210|460757808|FG001|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
128035031|NCT04734210|460757809|FG002|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|1|||
128035032|NCT05201807|460757813|FG000|Overall Study|Adverse Event|1|||
128035033|NCT05201807|460757813|FG000|Overall Study|COVID-19 Related|1|||
128035034|NCT01209767|460757814|FG000|Overall Study|Withdrawal by Subject|1|||
128035035|NCT01209767|460757814|FG000|Overall Study|Lost to Follow-up|3|||
128035036|NCT01702298|460757815|FG000|Overall Study|Withdrawal by Subject|1|||
128035037|NCT01029535|460757817|FG000|Overall Study|Lost to Follow-up|24|||
128035038|NCT01029535|460757817|FG000|Overall Study|Protocol Violation|2|||
128035039|NCT01029535|460757817|FG000|Overall Study|Participant Withdrew Consent|2|||
128035040|NCT01029535|460757817|FG000|Overall Study|Adverse Event|1|||
128035041|NCT01029535|460757817|FG000|Overall Study|Use of Another Treatment|1|||
128035042|NCT01029535|460757817|FG000|Overall Study|Death|1|||
128035043|NCT00573768|460757818|FG000|Overall Study|Adverse Event|1|||
128035044|NCT00573768|460757819|FG001|Overall Study|Adverse Event|1|||
128035045|NCT00573768|460757820|FG002|Overall Study|Adverse Event|2|||
128035046|NCT00573768|460757818|FG000|Overall Study|Protocol Violation|1|||
128035047|NCT00573768|460757819|FG001|Overall Study|Protocol Violation|0|||
128035048|NCT00573768|460757820|FG002|Overall Study|Protocol Violation|1|||
128035049|NCT00573768|460757818|FG000|Overall Study|Withdrawal by Subject|0|||
128035050|NCT00573768|460757819|FG001|Overall Study|Withdrawal by Subject|1|||
128035051|NCT00573768|460757820|FG002|Overall Study|Withdrawal by Subject|0|||
128035052|NCT00573768|460757818|FG000|Overall Study|Lost to Follow-up|0|||
128035053|NCT00573768|460757819|FG001|Overall Study|Lost to Follow-up|0|||
128035054|NCT00573768|460757820|FG002|Overall Study|Lost to Follow-up|1|||
128035055|NCT00904371|460757821|FG000|Overall Study|Adverse Event|2|||
128035056|NCT00904371|460757821|FG000|Overall Study|Lost to Follow-up|4|||
128035057|NCT00904371|460757821|FG000|Overall Study|Discontinued at target blood pressure|2|||
128035058|NCT00904371|460757821|FG000|Overall Study|Continued with Tritace|1|||
128035059|NCT00583219|460757824|FG000|Phase 2|Withdrawal by Subject|1|||
128035060|NCT02090764|460757825|FG000|Overall Study|Adverse Event|1|||
128035061|NCT02090764|460757826|FG001|Overall Study|Adverse Event|3|||
128035062|NCT02090764|460757825|FG000|Overall Study|Lack of Efficacy|0|||
128035063|NCT02090764|460757826|FG001|Overall Study|Lack of Efficacy|13|||
128035064|NCT02090764|460757825|FG000|Overall Study|Withdrawal by Subject|2|||
128035065|NCT02090764|460757826|FG001|Overall Study|Withdrawal by Subject|1|||
128035066|NCT02090764|460757825|FG000|Overall Study|Intercurrent illness and other|1|||
128035067|NCT02090764|460757826|FG001|Overall Study|Intercurrent illness and other|1|||
128035068|NCT02090764|460757825|FG000|Overall Study|Lost to Follow-up|2|||
128035069|NCT02090764|460757826|FG001|Overall Study|Lost to Follow-up|2|||
128035070|NCT00833690|460757829|FG000|Overall Study|Withdrawal by Subject|1|||
128035071|NCT00833690|460757830|FG001|Overall Study|Withdrawal by Subject|0|||
128035072|NCT00833690|460757831|FG002|Overall Study|Withdrawal by Subject|0|||
128035073|NCT00833690|460757829|FG000|Overall Study|Discontinued study drug|3|||
128035074|NCT00833690|460757830|FG001|Overall Study|Discontinued study drug|2|||
128035075|NCT00833690|460757831|FG002|Overall Study|Discontinued study drug|0|||
128035076|NCT05448950|460757832|FG000|Overall Study|Death|2|||
128035077|NCT05448950|460757832|FG000|Overall Study|Withdrawal by Subject|1|||
128035078|NCT05448950|460757832|FG000|Overall Study|AVG abandoned|4|||
128035079|NCT02836249|460757833|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
128035080|NCT02836249|460757834|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
128035081|NCT02836249|460757835|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
128035082|NCT02836249|460757836|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
128035083|NCT02836249|460757833|FG000|Double-Blind Treatment Phase|Pregnancy|3|||
128035084|NCT02836249|460757834|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
128035085|NCT02836249|460757835|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
128035086|NCT02836249|460757836|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
128035087|NCT02836249|460757833|FG000|Double-Blind Treatment Phase|Withdrew Consent|5|||
128035088|NCT02836249|460757834|FG001|Double-Blind Treatment Phase|Withdrew Consent|2|||
128035089|NCT02836249|460757835|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
128035090|NCT02836249|460757836|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
127786114|NCT00450723|459841638|FG000|Overall Study|Physician Decision|5|||
127786115|NCT00932360|459841639|FG000|Washout (One Week)|Withdrawal by Subject|0|||
127695331|NCT01261312|459512909|FG005|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
127695332|NCT01261312|459512910|FG006|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
127695333|NCT01261312|459512911|FG007|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|1|||
127695334|NCT01261312|459512912|FG008|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
127695335|NCT01261312|459512913|FG009|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
127695336|NCT01261312|459512914|FG010|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
127695337|NCT01261312|459512915|FG011|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
127695338|NCT01261312|459512916|FG012|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
127695339|NCT01261312|459512904|FG000|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
127695340|NCT01261312|459512905|FG001|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
128035091|NCT02836249|460757833|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
128035092|NCT02836249|460757834|FG001|Double-Blind Treatment Phase|Lost to Follow-up|1|||
128035093|NCT02836249|460757835|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
128035094|NCT02836249|460757836|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
128035095|NCT02836249|460757833|FG000|Double-Blind Treatment Phase|Investigator's discretion|0|||
128035096|NCT02836249|460757834|FG001|Double-Blind Treatment Phase|Investigator's discretion|1|||
128035097|NCT02836249|460757835|FG002|Double-Blind Treatment Phase|Investigator's discretion|0|||
128035098|NCT02836249|460757836|FG003|Double-Blind Treatment Phase|Investigator's discretion|0|||
128035099|NCT02836249|460757833|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
128035100|NCT02836249|460757834|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
128035101|NCT02836249|460757835|FG002|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
128035102|NCT02836249|460757836|FG003|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
128035103|NCT02836249|460757833|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
128035104|NCT02836249|460757834|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
128035105|NCT02836249|460757835|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|6|||
128035106|NCT02836249|460757836|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
128035107|NCT02836249|460757833|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
128035108|NCT02836249|460757834|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
128035109|NCT02836249|460757835|FG002|Open-Label TAF Treatment Phase|Withdrew consent|4|||
128035110|NCT02836249|460757836|FG003|Open-Label TAF Treatment Phase|Withdrew consent|3|||
128035111|NCT02836249|460757833|FG000|Open-Label TAF Treatment Phase|Death|0|||
128035112|NCT02836249|460757834|FG001|Open-Label TAF Treatment Phase|Death|0|||
128035113|NCT02836249|460757835|FG002|Open-Label TAF Treatment Phase|Death|1|||
128035114|NCT02836249|460757836|FG003|Open-Label TAF Treatment Phase|Death|0|||
128035115|NCT02836249|460757833|FG000|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
128035116|NCT02836249|460757834|FG001|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
128035117|NCT02836249|460757835|FG002|Open-Label TAF Treatment Phase|Lack of Efficacy|1|||
128035118|NCT02836249|460757836|FG003|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
128035119|NCT02836249|460757833|FG000|Open-Label TAF Treatment Phase|Pregnancy|0|||
128035120|NCT02836249|460757834|FG001|Open-Label TAF Treatment Phase|Pregnancy|0|||
128035121|NCT02836249|460757835|FG002|Open-Label TAF Treatment Phase|Pregnancy|1|||
128035122|NCT02836249|460757836|FG003|Open-Label TAF Treatment Phase|Pregnancy|0|||
128035123|NCT04752566|460757837|FG000|Overall Study|Protocol Violation|0|||
128035124|NCT04752566|460757838|FG001|Overall Study|Protocol Violation|1|||
128035125|NCT04752566|460757837|FG000|Overall Study|Death|1|||
127594862|NCT02324569|459143646|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
127594863|NCT02324569|459143645|FG000|Overall Study|Inconvenient Schedule|2|||
127594864|NCT02324569|459143646|FG001|Overall Study|Inconvenient Schedule|0|||
127594865|NCT01943292|459143653|FG000|Overall Study|Withdrawal by Subject|1|||
127594866|NCT01943292|459143654|FG001|Overall Study|Withdrawal by Subject|0|||
127594867|NCT01943292|459143655|FG002|Overall Study|Withdrawal by Subject|0|||
127594868|NCT00911820|459143656|FG000|Overall Study|RECIST progression|12|||
127594869|NCT00911820|459143657|FG001|Overall Study|RECIST progression|8|||
127594870|NCT00911820|459143656|FG000|Overall Study|Adverse Event|8|||
127594871|NCT00911820|459143657|FG001|Overall Study|Adverse Event|8|||
127594872|NCT00911820|459143656|FG000|Overall Study|Clinical Progression|7|||
127594873|NCT00911820|459143657|FG001|Overall Study|Clinical Progression|5|||
127594874|NCT00911820|459143656|FG000|Overall Study|Physician Decision|5|||
127594875|NCT00911820|459143657|FG001|Overall Study|Physician Decision|9|||
127594876|NCT00911820|459143656|FG000|Overall Study|Decline in Performance Status|4|||
127594877|NCT00911820|459143657|FG001|Overall Study|Decline in Performance Status|2|||
127594878|NCT00911820|459143656|FG000|Overall Study|Withdrawal by Subject|3|||
127594879|NCT00911820|459143657|FG001|Overall Study|Withdrawal by Subject|4|||
127594880|NCT00911820|459143656|FG000|Overall Study|Death|1|||
127594881|NCT00911820|459143657|FG001|Overall Study|Death|2|||
127594882|NCT00911820|459143656|FG000|Overall Study|Pursue surgery|1|||
127594883|NCT00911820|459143657|FG001|Overall Study|Pursue surgery|1|||
127594884|NCT00911820|459143656|FG000|Overall Study|Pursue Radiation|1|||
127594885|NCT00911820|459143657|FG001|Overall Study|Pursue Radiation|0|||
127594886|NCT00911820|459143656|FG000|Overall Study|Still on Therapy|2|||
127594887|NCT00911820|459143657|FG001|Overall Study|Still on Therapy|2|||
127594888|NCT00911820|459143656|FG000|Overall Study|Pathology Not Confirmed|1|||
127594889|NCT00911820|459143657|FG001|Overall Study|Pathology Not Confirmed|0|||
127594890|NCT00911820|459143656|FG000|Overall Study|Withdraw before Receive Treatment|0|||
127594891|NCT00911820|459143657|FG001|Overall Study|Withdraw before Receive Treatment|2|||
127594892|NCT01852110|459143658|FG000|Overall Study|Adverse Event|12|||
127594893|NCT01852110|459143659|FG001|Overall Study|Adverse Event|5|||
127594894|NCT01852110|459143660|FG002|Overall Study|Adverse Event|0|||
127594895|NCT01852110|459143661|FG003|Overall Study|Adverse Event|0|||
127594896|NCT01852110|459143662|FG004|Overall Study|Adverse Event|0|||
127594897|NCT01852110|459143663|FG005|Overall Study|Adverse Event|0|||
127594898|NCT01852110|459143658|FG000|Overall Study|Lost to Follow-up|1|||
127594899|NCT01852110|459143659|FG001|Overall Study|Lost to Follow-up|3|||
127594900|NCT01852110|459143660|FG002|Overall Study|Lost to Follow-up|0|||
127594901|NCT01852110|459143661|FG003|Overall Study|Lost to Follow-up|0|||
127594902|NCT01852110|459143662|FG004|Overall Study|Lost to Follow-up|0|||
127594903|NCT01852110|459143663|FG005|Overall Study|Lost to Follow-up|0|||
127594904|NCT01852110|459143658|FG000|Overall Study|Non-compliance with Study Drug|2|||
127594905|NCT01852110|459143659|FG001|Overall Study|Non-compliance with Study Drug|1|||
127594906|NCT01852110|459143660|FG002|Overall Study|Non-compliance with Study Drug|0|||
127594907|NCT01852110|459143661|FG003|Overall Study|Non-compliance with Study Drug|0|||
127594908|NCT01852110|459143662|FG004|Overall Study|Non-compliance with Study Drug|0|||
127594909|NCT01852110|459143663|FG005|Overall Study|Non-compliance with Study Drug|0|||
127594910|NCT01852110|459143658|FG000|Overall Study|Physician Decision|1|||
127594911|NCT01852110|459143659|FG001|Overall Study|Physician Decision|0|||
127594912|NCT01852110|459143660|FG002|Overall Study|Physician Decision|0|||
127594913|NCT01852110|459143661|FG003|Overall Study|Physician Decision|0|||
127594914|NCT01852110|459143662|FG004|Overall Study|Physician Decision|0|||
127594915|NCT01852110|459143663|FG005|Overall Study|Physician Decision|0|||
127594916|NCT01852110|459143658|FG000|Overall Study|Protocol Violation|0|||
127786116|NCT00932360|459841640|FG001|Washout (One Week)|Withdrawal by Subject|0|||
127786117|NCT00932360|459841641|FG002|Washout (One Week)|Withdrawal by Subject|0|||
127786118|NCT00932360|459841642|FG003|Washout (One Week)|Withdrawal by Subject|0|||
127594917|NCT01852110|459143659|FG001|Overall Study|Protocol Violation|1|||
127594918|NCT01852110|459143660|FG002|Overall Study|Protocol Violation|0|||
127594919|NCT01852110|459143661|FG003|Overall Study|Protocol Violation|0|||
127594920|NCT01852110|459143662|FG004|Overall Study|Protocol Violation|0|||
127594921|NCT01852110|459143663|FG005|Overall Study|Protocol Violation|0|||
127594922|NCT01852110|459143658|FG000|Overall Study|Study Terminated by Sponsor|30|||
127594923|NCT01852110|459143659|FG001|Overall Study|Study Terminated by Sponsor|32|||
127594924|NCT01852110|459143660|FG002|Overall Study|Study Terminated by Sponsor|0|||
127594925|NCT01852110|459143661|FG003|Overall Study|Study Terminated by Sponsor|0|||
127594926|NCT01852110|459143662|FG004|Overall Study|Study Terminated by Sponsor|0|||
127594927|NCT01852110|459143663|FG005|Overall Study|Study Terminated by Sponsor|0|||
127594928|NCT01852110|459143658|FG000|Overall Study|Withdrawal by Subject|4|||
127594929|NCT01852110|459143659|FG001|Overall Study|Withdrawal by Subject|4|||
127594930|NCT01852110|459143660|FG002|Overall Study|Withdrawal by Subject|0|||
127786119|NCT00932360|459841643|FG004|Washout (One Week)|Withdrawal by Subject|2|||
127594931|NCT01852110|459143661|FG003|Overall Study|Withdrawal by Subject|0|||
127594932|NCT01852110|459143662|FG004|Overall Study|Withdrawal by Subject|0|||
127594933|NCT01852110|459143663|FG005|Overall Study|Withdrawal by Subject|0|||
127594934|NCT02101060|459143669|FG000|Overall Study|Adverse Event|1|||
127594935|NCT02101060|459143670|FG001|Overall Study|Adverse Event|0|||
127594936|NCT02101060|459143669|FG000|Overall Study|Withdrawal by Subject|1|||
127594937|NCT02101060|459143670|FG001|Overall Study|Withdrawal by Subject|1|||
127594938|NCT02101060|459143669|FG000|Overall Study|Lost to Follow-up|3|||
127594939|NCT02101060|459143670|FG001|Overall Study|Lost to Follow-up|3|||
127594940|NCT03462082|459143671|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
127594941|NCT03462082|459143672|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
127594942|NCT03462082|459143673|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
127594943|NCT03462082|459143674|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
127594944|NCT03462082|459143675|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
127594945|NCT03462082|459143676|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
127594946|NCT03462082|459143677|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
127594947|NCT03462082|459143678|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
127594948|NCT03454997|459143684|FG000|Overall Study|Staff Coach - Left Oranization|1|||
127594949|NCT03454997|459143685|FG001|Overall Study|Staff Coach - Left Oranization|1|||
127594950|NCT03454997|459143684|FG000|Overall Study|Staff Coach - Withdrawal by Site|0|||
127594951|NCT03454997|459143685|FG001|Overall Study|Staff Coach - Withdrawal by Site|2|||
127594952|NCT03454997|459143684|FG000|Overall Study|Staff Coach - Withdrawal by subject|0|||
127594953|NCT03454997|459143685|FG001|Overall Study|Staff Coach - Withdrawal by subject|1|||
127594954|NCT03454997|459143684|FG000|Overall Study|Staff Coach - Lost to follow-up|0|||
127594955|NCT03454997|459143685|FG001|Overall Study|Staff Coach - Lost to follow-up|1|||
127594956|NCT03454997|459143684|FG000|Overall Study|Client with SMI - Lost to follow-up|2|||
127594957|NCT03454997|459143685|FG001|Overall Study|Client with SMI - Lost to follow-up|1|||
127594958|NCT03454997|459143684|FG000|Overall Study|Client with SMI - Left organization|0|||
127594959|NCT03454997|459143685|FG001|Overall Study|Client with SMI - Left organization|1|||
127594960|NCT03454997|459143684|FG000|Overall Study|Client with SMI - Withdrawal by site|0|||
127594961|NCT03454997|459143685|FG001|Overall Study|Client with SMI - Withdrawal by site|11|||
127594962|NCT00299975|459143690|FG000|Overall Study|Adverse Event|1|||
127594963|NCT00299975|459143691|FG001|Overall Study|Adverse Event|0|||
127594964|NCT00299975|459143692|FG002|Overall Study|Adverse Event|2|||
127594965|NCT00299975|459143690|FG000|Overall Study|Pregnancy|0|||
127594966|NCT00299975|459143691|FG001|Overall Study|Pregnancy|0|||
127594967|NCT00299975|459143692|FG002|Overall Study|Pregnancy|1|||
127594968|NCT00299975|459143690|FG000|Overall Study|Lack of Efficacy|1|||
127594969|NCT00299975|459143691|FG001|Overall Study|Lack of Efficacy|0|||
127594970|NCT00299975|459143692|FG002|Overall Study|Lack of Efficacy|1|||
127594971|NCT00299975|459143690|FG000|Overall Study|Lost to Follow-up|1|||
127594972|NCT00299975|459143691|FG001|Overall Study|Lost to Follow-up|0|||
127594973|NCT00299975|459143692|FG002|Overall Study|Lost to Follow-up|0|||
127594974|NCT00299975|459143690|FG000|Overall Study|Withdrawal by Subject|0|||
127594975|NCT00299975|459143691|FG001|Overall Study|Withdrawal by Subject|1|||
127594976|NCT00299975|459143692|FG002|Overall Study|Withdrawal by Subject|3|||
127594977|NCT00299975|459143690|FG000|Overall Study|Physician Decision|0|||
127594978|NCT00299975|459143691|FG001|Overall Study|Physician Decision|0|||
127594979|NCT00299975|459143692|FG002|Overall Study|Physician Decision|1|||
127594980|NCT00982878|459143693|FG000|Overall Study|Physician Decision|1|||
127594981|NCT02627144|459143696|FG000|Overall Study|Serious adverse event|32|||
127594982|NCT02627144|459143696|FG000|Overall Study|Cancer progression|171|||
127594983|NCT02627144|459143696|FG000|Overall Study|Death from cancer|20|||
127594984|NCT02627144|459143696|FG000|Overall Study|Death from other cause|8|||
127594985|NCT02627144|459143696|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
127594986|NCT02627144|459143696|FG000|Overall Study|Administrative reasons|65|||
127594987|NCT02627144|459143696|FG000|Overall Study|Lost to Follow-up|8|||
127594988|NCT02627144|459143696|FG000|Overall Study|Enrolled, not treated|6|||
127594989|NCT02627144|459143696|FG000|Overall Study|Other|17|||
127594990|NCT01906008|459143701|FG000|Overall Study|Lost to Follow-up|2|||
127594991|NCT01906008|459143702|FG001|Overall Study|Lost to Follow-up|0|||
127594992|NCT01906008|459143701|FG000|Overall Study|Oxaliplatin toxicity|2|||
127594993|NCT01906008|459143702|FG001|Overall Study|Oxaliplatin toxicity|0|||
127594994|NCT01906008|459143701|FG000|Overall Study|Protocol Violation|0|||
127594995|NCT01906008|459143702|FG001|Overall Study|Protocol Violation|1|||
127594996|NCT01906008|459143701|FG000|Overall Study|Withdrawal by Subject|1|||
127695341|NCT01261312|459512906|FG002|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
127594997|NCT01906008|459143702|FG001|Overall Study|Withdrawal by Subject|5|||
127594998|NCT01906008|459143701|FG000|Overall Study|Did not start study med|3|||
127594999|NCT01906008|459143702|FG001|Overall Study|Did not start study med|4|||
127595000|NCT01906008|459143701|FG000|Overall Study|Oxaliplatin stops|10|||
128035126|NCT04752566|460757838|FG001|Overall Study|Death|0|||
127595001|NCT01906008|459143702|FG001|Overall Study|Oxaliplatin stops|8|||
127595002|NCT01906008|459143701|FG000|Overall Study|Hospice|1|||
127595003|NCT01906008|459143702|FG001|Overall Study|Hospice|0|||
128035127|NCT04752566|460757837|FG000|Overall Study|Adverse Event|1|||
128035128|NCT04752566|460757838|FG001|Overall Study|Adverse Event|0|||
128035129|NCT04752566|460757837|FG000|Overall Study|Withdrawal by Subject|2|||
128035130|NCT04752566|460757838|FG001|Overall Study|Withdrawal by Subject|0|||
127595004|NCT01906008|459143701|FG000|Overall Study|Physician Decision|3|||
127595005|NCT01906008|459143702|FG001|Overall Study|Physician Decision|3|||
127595006|NCT01906008|459143701|FG000|Overall Study|Lack of compliance of study med|5|||
127595007|NCT01906008|459143702|FG001|Overall Study|Lack of compliance of study med|3|||
127595008|NCT01906008|459143701|FG000|Overall Study|Adverse Event|0|||
127595009|NCT01906008|459143702|FG001|Overall Study|Adverse Event|3|||
127595010|NCT02220205|459143705|FG000|Overall Study|Withdrawal by Subject|1|||
127595011|NCT02220205|459143706|FG001|Overall Study|Withdrawal by Subject|0|||
127595012|NCT01465997|459143707|FG000|Overall Study|Adverse Event|12|||
127595013|NCT01465997|459143708|FG001|Overall Study|Adverse Event|22|||
127595014|NCT01465997|459143707|FG000|Overall Study|Lack of Efficacy|13|||
127595015|NCT01465997|459143708|FG001|Overall Study|Lack of Efficacy|1|||
127595016|NCT01465997|459143707|FG000|Overall Study|Protocol Violation|1|||
127595017|NCT01465997|459143708|FG001|Overall Study|Protocol Violation|4|||
127595018|NCT01465997|459143707|FG000|Overall Study|Lost to Follow-up|6|||
127595019|NCT01465997|459143708|FG001|Overall Study|Lost to Follow-up|9|||
127595020|NCT01465997|459143707|FG000|Overall Study|Withdrawal by Subject|32|||
127595021|NCT01465997|459143708|FG001|Overall Study|Withdrawal by Subject|35|||
127595022|NCT01465997|459143707|FG000|Overall Study|investigator's decision|1|||
127595023|NCT01465997|459143708|FG001|Overall Study|investigator's decision|1|||
127595024|NCT01465997|459143707|FG000|Overall Study|Death|0|||
127595025|NCT01465997|459143708|FG001|Overall Study|Death|1|||
127595026|NCT01465997|459143707|FG000|Overall Study|sponsor's decision|1|||
127595027|NCT01465997|459143708|FG001|Overall Study|sponsor's decision|1|||
127595028|NCT01465997|459143707|FG000|Overall Study|subject withdrew consent|1|||
127595029|NCT01465997|459143708|FG001|Overall Study|subject withdrew consent|0|||
127595030|NCT01465997|459143707|FG000|Overall Study|local lab unblinded site|1|||
127595031|NCT01465997|459143708|FG001|Overall Study|local lab unblinded site|0|||
127595032|NCT01465997|459143707|FG000|Overall Study|withdrew before follow-up|0|||
127595033|NCT01465997|459143708|FG001|Overall Study|withdrew before follow-up|13|||
127595034|NCT01465997|459143707|FG000|Overall Study|decision by site staff|0|||
127595035|NCT01465997|459143708|FG001|Overall Study|decision by site staff|1|||
127595036|NCT01465997|459143707|FG000|Overall Study|subject left participation SP0993|0|||
127595037|NCT01465997|459143708|FG001|Overall Study|subject left participation SP0993|1|||
127595038|NCT00642460|459143709|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
127595039|NCT00642460|459143710|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
127595040|NCT00642460|459143711|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
127595041|NCT00642460|459143712|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
127595042|NCT00642460|459143713|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
127595043|NCT00642460|459143714|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
127595044|NCT00642460|459143709|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
127595045|NCT00642460|459143710|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
127595046|NCT00642460|459143711|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
127595047|NCT00642460|459143712|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
127595048|NCT00642460|459143713|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
127595049|NCT00642460|459143714|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
127595050|NCT00642460|459143709|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
127595051|NCT00642460|459143710|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
127595052|NCT00642460|459143711|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
127595053|NCT00642460|459143712|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
127595054|NCT00642460|459143713|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
127595055|NCT00642460|459143714|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
127595056|NCT00642460|459143709|FG000|Part II: Open-Label Up to Week 92|Death|0|||
127595057|NCT00642460|459143710|FG001|Part II: Open-Label Up to Week 92|Death|1|||
127595058|NCT00642460|459143711|FG002|Part II: Open-Label Up to Week 92|Death|0|||
127595059|NCT00642460|459143712|FG003|Part II: Open-Label Up to Week 92|Death|2|||
127595060|NCT00642460|459143713|FG004|Part II: Open-Label Up to Week 92|Death|0|||
127595061|NCT00642460|459143714|FG005|Part II: Open-Label Up to Week 92|Death|0|||
127595062|NCT00642460|459143709|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
127595063|NCT00642460|459143710|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
127595064|NCT00642460|459143711|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
127595065|NCT00642460|459143712|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
127595066|NCT00642460|459143713|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
127595067|NCT00642460|459143714|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
127595068|NCT00642460|459143709|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
127595069|NCT00642460|459143710|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
127595070|NCT00642460|459143711|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
127595071|NCT00642460|459143712|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
127695342|NCT01261312|459512907|FG003|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
127595072|NCT00642460|459143713|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
127595073|NCT00642460|459143714|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
127695343|NCT01261312|459512908|FG004|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
127595074|NCT00642460|459143709|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
127595075|NCT00642460|459143710|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
127595076|NCT00642460|459143711|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
127595077|NCT00642460|459143712|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
127595078|NCT00642460|459143713|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
127595079|NCT00642460|459143714|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
127595080|NCT00642460|459143709|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
127595081|NCT00642460|459143710|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
127595082|NCT00642460|459143711|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
127786120|NCT00932360|459841644|FG005|Washout (One Week)|Withdrawal by Subject|0|||
127786121|NCT04143009|459841645|FG000|Pilot Trial|Lost to Follow-up|0|||
127786122|NCT04143009|459841646|FG001|Pilot Trial|Lost to Follow-up|1|||
127786123|NCT04143009|459841647|FG002|Pilot Trial|Lost to Follow-up|1|||
127786124|NCT05003622|459841648|FG000|Overall Study|Progressive disease|2|||
127786125|NCT05003622|459841648|FG000|Overall Study|Withdrawal by Subject|1|||
127786126|NCT01045798|459841656|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
127786127|NCT01045798|459841657|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
127786128|NCT01045798|459841656|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
127786129|NCT01045798|459841657|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
127786130|NCT01045798|459841656|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
127786131|NCT01045798|459841657|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
127786132|NCT01045798|459841656|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
127786133|NCT01045798|459841657|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
127786134|NCT05321069|459841660|FG000|Overall Study|Adverse Event|52|||
127786135|NCT05321069|459841661|FG001|Overall Study|Adverse Event|52|||
127786136|NCT05321069|459841662|FG002|Overall Study|Adverse Event|64|||
127786137|NCT05321069|459841660|FG000|Overall Study|Protocol Violation|1|||
127786138|NCT05321069|459841661|FG001|Overall Study|Protocol Violation|1|||
127786139|NCT05321069|459841662|FG002|Overall Study|Protocol Violation|0|||
127786140|NCT05321069|459841660|FG000|Overall Study|Withdrawal by Subject|23|||
127786141|NCT05321069|459841661|FG001|Overall Study|Withdrawal by Subject|18|||
127786142|NCT05321069|459841662|FG002|Overall Study|Withdrawal by Subject|12|||
127786143|NCT05321069|459841660|FG000|Overall Study|Lost to Follow-up|1|||
127786144|NCT05321069|459841661|FG001|Overall Study|Lost to Follow-up|0|||
127786145|NCT05321069|459841662|FG002|Overall Study|Lost to Follow-up|1|||
127786146|NCT05321069|459841660|FG000|Overall Study|No reason stated by the participants|23|||
127786147|NCT05321069|459841661|FG001|Overall Study|No reason stated by the participants|22|||
127786148|NCT05321069|459841662|FG002|Overall Study|No reason stated by the participants|16|||
127786149|NCT05321069|459841660|FG000|Overall Study|Lack of Efficacy|1|||
127786150|NCT05321069|459841661|FG001|Overall Study|Lack of Efficacy|1|||
127786151|NCT05321069|459841662|FG002|Overall Study|Lack of Efficacy|0|||
127786152|NCT00687440|459841665|FG000|Overall Study|Adverse Event|3|||
127786153|NCT00687440|459841665|FG000|Overall Study|Lost to Follow-up|3|||
127786154|NCT00687440|459841665|FG000|Overall Study|Lack of Efficacy|2|||
127786155|NCT00687440|459841665|FG000|Overall Study|Death|2|||
127786156|NCT00687440|459841665|FG000|Overall Study|Other|1|||
127786157|NCT00687440|459841665|FG000|Overall Study|Missing|1|||
127786158|NCT05264740|459841670|FG000|Baseline|Withdrawal by Subject|0|||
127786159|NCT05264740|459841671|FG001|Baseline|Withdrawal by Subject|1|||
127786160|NCT05264740|459841670|FG000|Follow Up 1|Lost to Follow-up|1|||
127786161|NCT05264740|459841671|FG001|Follow Up 1|Lost to Follow-up|1|||
127786162|NCT05264740|459841670|FG000|Follow Up 1|Withdrawal by Subject|0|||
127786163|NCT05264740|459841671|FG001|Follow Up 1|Withdrawal by Subject|1|||
127786164|NCT05264740|459841670|FG000|Follow Up 2|Lost to Follow-up|1|||
127786165|NCT05264740|459841671|FG001|Follow Up 2|Lost to Follow-up|4|||
127786166|NCT05264740|459841670|FG000|Follow Up 3|Lost to Follow-up|7|||
127786167|NCT05264740|459841671|FG001|Follow Up 3|Lost to Follow-up|4|||
127786168|NCT01538628|459841672|FG000|Overall Study|Withdrawal by Subject|1|||
127786169|NCT01538628|459841673|FG001|Overall Study|Withdrawal by Subject|1|||
127786170|NCT01538628|459841672|FG000|Overall Study|Lost to Follow-up|0|||
127786171|NCT01538628|459841673|FG001|Overall Study|Lost to Follow-up|1|||
127786172|NCT01717287|459842813|FG000|Overall Study|Lost to Follow-up|0|||
127786173|NCT01717287|459842814|FG001|Overall Study|Lost to Follow-up|2|||
127786174|NCT01717287|459842813|FG000|Overall Study|Protocol Violation|0|||
127786175|NCT01717287|459842814|FG001|Overall Study|Protocol Violation|1|||
127786176|NCT02535715|459842815|FG000|Overall Study|Withdrawal by Subject|0|||
127786177|NCT02535715|459842816|FG001|Overall Study|Withdrawal by Subject|0|||
127786178|NCT02535715|459842817|FG002|Overall Study|Withdrawal by Subject|1|||
127786179|NCT00909181|459842818|FG000|Overall Study|Lost to Follow-up|39|||
127786180|NCT00909181|459842819|FG001|Overall Study|Lost to Follow-up|18|||
127786181|NCT00909181|459842820|FG002|Overall Study|Lost to Follow-up|33|||
127786182|NCT02349048|459842822|FG000|Overall Study|Withdrawal by Subject|4|||
127786183|NCT02349048|459842823|FG001|Overall Study|Withdrawal by Subject|0|||
127786184|NCT02349048|459842822|FG000|Overall Study|Lost to Follow-up|1|||
127786185|NCT02349048|459842823|FG001|Overall Study|Lost to Follow-up|0|||
127786186|NCT00094770|459842826|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
128035131|NCT04752566|460757837|FG000|Overall Study|Physician Decision|1|||
128035132|NCT04752566|460757838|FG001|Overall Study|Physician Decision|1|||
128035133|NCT02958865|460757839|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
128035134|NCT02958865|460757840|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
128035135|NCT02958865|460757841|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
128035136|NCT02958865|460757842|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
128035137|NCT02958865|460757843|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
128035138|NCT02958865|460757844|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
128035139|NCT02958865|460757845|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
128035140|NCT02958865|460757846|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
128035141|NCT02958865|460757847|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
128035142|NCT02958865|460757848|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
128035143|NCT02958865|460757849|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
128035144|NCT02958865|460757850|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
128035145|NCT02958865|460757851|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
128035146|NCT02958865|460757852|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
128035147|NCT02958865|460757853|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
128035148|NCT02958865|460757854|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
128035149|NCT02958865|460757839|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
128035150|NCT02958865|460757840|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
128035151|NCT02958865|460757841|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
128035152|NCT02958865|460757842|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
128035153|NCT02958865|460757843|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
128035154|NCT02958865|460757844|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
128035155|NCT02958865|460757845|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
128035156|NCT02958865|460757846|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
128035157|NCT02958865|460757847|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
128035158|NCT02958865|460757848|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
128035159|NCT02958865|460757849|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
128035160|NCT02958865|460757850|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
128035161|NCT02958865|460757851|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
128035162|NCT02958865|460757852|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
128035163|NCT02958865|460757853|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
128035164|NCT02958865|460757854|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
128035165|NCT02958865|460757839|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
128035166|NCT02958865|460757840|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
128035167|NCT02958865|460757841|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
128035168|NCT02958865|460757842|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
128035169|NCT02958865|460757843|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
128035170|NCT02958865|460757844|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
128035171|NCT02958865|460757845|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
128035172|NCT02958865|460757846|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
128035173|NCT02958865|460757847|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
128035174|NCT02958865|460757848|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
128035175|NCT02958865|460757849|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
128035176|NCT02958865|460757850|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
128035177|NCT02958865|460757851|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
128035178|NCT02958865|460757852|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
128035179|NCT02958865|460757853|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
128035180|NCT02958865|460757854|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
128035181|NCT02958865|460757839|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
128035182|NCT02958865|460757840|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
128035183|NCT02958865|460757841|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
128035184|NCT02958865|460757842|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
128035185|NCT02958865|460757843|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
128035186|NCT02958865|460757844|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
128035187|NCT02958865|460757845|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
128035188|NCT02958865|460757846|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
128035189|NCT02958865|460757847|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
128035190|NCT02958865|460757848|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
127595083|NCT00642460|459143712|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
127595084|NCT00642460|459143713|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
128035191|NCT02958865|460757849|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
128035192|NCT02958865|460757850|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
128035193|NCT02958865|460757851|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
128035194|NCT02958865|460757852|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
128035195|NCT02958865|460757853|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
128035196|NCT02958865|460757854|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
127595085|NCT00642460|459143714|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
127595086|NCT00642460|459143709|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
127595087|NCT00642460|459143710|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
127595088|NCT00642460|459143711|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
127595089|NCT00642460|459143712|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
127595090|NCT00642460|459143713|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
127595091|NCT00642460|459143714|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
127595092|NCT00642460|459143709|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
127595093|NCT00642460|459143710|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
127595094|NCT00642460|459143711|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
127595095|NCT00642460|459143712|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
127882313|NCT01396161|460192743|FG004|Overall Study|Withdrawal by Subject|1|||
127882314|NCT01396161|460192744|FG005|Overall Study|Withdrawal by Subject|0|||
127882315|NCT01396161|460192745|FG006|Overall Study|Withdrawal by Subject|0|||
127882316|NCT01396161|460192739|FG000|Overall Study|Other|0|||
127882317|NCT01396161|460192740|FG001|Overall Study|Other|0|||
127882318|NCT01396161|460192741|FG002|Overall Study|Other|0|||
127882319|NCT01396161|460192742|FG003|Overall Study|Other|0|||
127882320|NCT01396161|460192743|FG004|Overall Study|Other|0|||
127882321|NCT01396161|460192744|FG005|Overall Study|Other|0|||
127882322|NCT01396161|460192745|FG006|Overall Study|Other|1|||
127882323|NCT00306852|460192750|FG000|Overall Study|Death|14|||
127882324|NCT00306852|460192751|FG001|Overall Study|Death|14|||
127882325|NCT00306852|460192750|FG000|Overall Study|Lost to Follow-up|15|||
127882326|NCT00306852|460192751|FG001|Overall Study|Lost to Follow-up|24|||
127882327|NCT03343054|460192753|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
127882328|NCT03343054|460192754|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
127882329|NCT03343054|460192755|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
127882330|NCT03343054|460192753|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
127882331|NCT03343054|460192754|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
127882332|NCT03343054|460192755|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
127882333|NCT03343054|460192753|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
127882334|NCT03343054|460192754|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
127882335|NCT03343054|460192755|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
127882336|NCT03343054|460192753|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
127882337|NCT03343054|460192754|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
127882338|NCT03343054|460192755|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
127882339|NCT01467570|460192756|FG000|Overall Study|Lost to Follow-up|8|||
127882340|NCT01467570|460192757|FG001|Overall Study|Lost to Follow-up|9|||
127882341|NCT02766088|460192760|FG000|Overall Study|Sponsor study termination|498|||
127882342|NCT02766088|460192760|FG000|Overall Study|Migrated/moved from the study area|1|||
127882343|NCT02766088|460192760|FG000|Overall Study|Lost to Follow-up|5|||
128035197|NCT02958865|460757839|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
128035198|NCT02958865|460757840|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
128035199|NCT02958865|460757841|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
128035200|NCT02958865|460757842|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
128035201|NCT02958865|460757843|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
128035202|NCT02958865|460757844|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
128035203|NCT02958865|460757845|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
128035204|NCT02958865|460757846|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
128035205|NCT02958865|460757847|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
128035206|NCT02958865|460757848|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
128035207|NCT02958865|460757849|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
128035208|NCT02958865|460757850|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
128035209|NCT02958865|460757851|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
128035210|NCT02958865|460757852|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
128035211|NCT02958865|460757853|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
128035212|NCT02958865|460757854|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
128035213|NCT02958865|460757839|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
128035214|NCT02958865|460757840|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
128035215|NCT02958865|460757841|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
128035216|NCT02958865|460757842|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
128035217|NCT02958865|460757843|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
128035218|NCT02958865|460757844|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
128035219|NCT02958865|460757845|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
128035220|NCT02958865|460757846|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
128035221|NCT02958865|460757847|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
128035222|NCT02958865|460757848|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
128035223|NCT02958865|460757849|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
128035224|NCT02958865|460757850|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
128035225|NCT02958865|460757851|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
128035226|NCT02958865|460757852|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
128035227|NCT02958865|460757853|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
128035228|NCT02958865|460757854|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
128035229|NCT02958865|460757839|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
128035230|NCT02958865|460757840|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
128035231|NCT02958865|460757841|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
128035232|NCT02958865|460757842|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
128035233|NCT02958865|460757843|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
128035234|NCT02958865|460757844|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
128035235|NCT02958865|460757845|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
128035236|NCT02958865|460757846|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
128035237|NCT02958865|460757847|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
128035238|NCT02958865|460757848|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
128035239|NCT02958865|460757849|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
128035240|NCT02958865|460757850|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
127595096|NCT00642460|459143713|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
127595097|NCT00642460|459143714|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
127595098|NCT00642460|459143709|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
127595099|NCT00642460|459143710|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
127595100|NCT00642460|459143711|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
127595101|NCT00642460|459143712|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
127595102|NCT00642460|459143713|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
127595103|NCT00642460|459143714|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
127595104|NCT00642460|459143709|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
127595105|NCT00642460|459143710|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
127595106|NCT00642460|459143711|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
127595107|NCT00642460|459143712|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
127595108|NCT00642460|459143713|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
127595109|NCT00642460|459143714|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
127595110|NCT00642460|459143709|FG000|Part III: Open-Label Up to Week 260|Other|0|||
127595111|NCT00642460|459143710|FG001|Part III: Open-Label Up to Week 260|Other|0|||
127595112|NCT00642460|459143711|FG002|Part III: Open-Label Up to Week 260|Other|0|||
127595113|NCT00642460|459143712|FG003|Part III: Open-Label Up to Week 260|Other|0|||
127595114|NCT00642460|459143713|FG004|Part III: Open-Label Up to Week 260|Other|2|||
127595115|NCT00642460|459143714|FG005|Part III: Open-Label Up to Week 260|Other|2|||
127595116|NCT00642460|459143709|FG000|Part III: Open-Label Up to Week 260|Death|0|||
127595117|NCT00642460|459143710|FG001|Part III: Open-Label Up to Week 260|Death|0|||
127595118|NCT00642460|459143711|FG002|Part III: Open-Label Up to Week 260|Death|0|||
127595119|NCT00642460|459143712|FG003|Part III: Open-Label Up to Week 260|Death|0|||
127595120|NCT00642460|459143713|FG004|Part III: Open-Label Up to Week 260|Death|0|||
127595121|NCT00642460|459143714|FG005|Part III: Open-Label Up to Week 260|Death|3|||
127595122|NCT00642460|459143709|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
127595123|NCT00642460|459143710|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
127595124|NCT00642460|459143711|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
127595125|NCT00642460|459143712|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
127595126|NCT00642460|459143713|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
127595127|NCT00642460|459143714|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
127595128|NCT00642460|459143709|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
127595129|NCT00642460|459143710|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
127595130|NCT00642460|459143711|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
127595131|NCT00642460|459143712|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
127595132|NCT00642460|459143713|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
127595133|NCT00642460|459143714|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
127595134|NCT02088047|459143717|FG000|Overall Study|Withdrawal by Subject|1|||
127595135|NCT02088047|459143718|FG001|Overall Study|Withdrawal by Subject|0|||
127595136|NCT04605484|459143721|FG000|Overall Study|Lost to Follow-up|0|||
127595137|NCT04605484|459143722|FG001|Overall Study|Lost to Follow-up|1|||
127595138|NCT04605484|459143723|FG002|Overall Study|Lost to Follow-up|1|||
127695344|NCT01261312|459512909|FG005|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
127695345|NCT01261312|459512910|FG006|DE Phase: TN AML (Week 85-283)|Reason not Specified|5|||
127695346|NCT01261312|459512911|FG007|DE Phase: TN AML (Week 85-283)|Reason not Specified|1|||
128035241|NCT02958865|460757851|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
128035242|NCT02958865|460757852|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
128035243|NCT02958865|460757853|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
128035244|NCT02958865|460757854|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
128035245|NCT02958865|460757839|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
128035246|NCT02958865|460757840|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
128035247|NCT02958865|460757841|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
128035248|NCT02958865|460757842|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
128035249|NCT02958865|460757843|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
128035250|NCT02958865|460757844|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
128035251|NCT02958865|460757845|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
128035252|NCT02958865|460757846|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
128035253|NCT02958865|460757847|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
128035254|NCT02958865|460757848|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
128035255|NCT02958865|460757849|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
128035256|NCT02958865|460757850|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
128035257|NCT02958865|460757851|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
128035258|NCT02958865|460757852|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
128035259|NCT02958865|460757853|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
128035260|NCT02958865|460757854|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
128035261|NCT02958865|460757839|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
128035262|NCT02958865|460757840|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
128035263|NCT02958865|460757841|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
128035264|NCT02958865|460757842|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
128035265|NCT02958865|460757843|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
128035266|NCT02958865|460757844|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
128035267|NCT02958865|460757845|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
128035268|NCT02958865|460757846|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
128035269|NCT02958865|460757847|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
128035270|NCT02958865|460757848|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
128035271|NCT02958865|460757849|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
127595139|NCT04605484|459143721|FG000|Overall Study|Other|0|||
127595140|NCT04605484|459143722|FG001|Overall Study|Other|1|||
127595141|NCT04605484|459143723|FG002|Overall Study|Other|0|||
127595142|NCT04862585|459143726|FG000|Overall Study|two subjects withdrew due to perceived side effects of premedications|2|||
127595143|NCT04862585|459143727|FG001|Overall Study|two subjects withdrew due to perceived side effects of premedications|0|||
127595144|NCT04862585|459143726|FG000|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|2|||
128035272|NCT02958865|460757850|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
128035273|NCT02958865|460757851|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
128035274|NCT02958865|460757852|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
128035275|NCT02958865|460757853|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
128035276|NCT02958865|460757854|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
128035277|NCT02958865|460757839|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
128035278|NCT02958865|460757840|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
128035279|NCT02958865|460757841|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
128035280|NCT02958865|460757842|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
128035281|NCT02958865|460757843|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
128035282|NCT02958865|460757844|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
128035283|NCT02958865|460757845|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
128035284|NCT02958865|460757846|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
128035285|NCT02958865|460757847|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
128035286|NCT02958865|460757848|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
128035287|NCT02958865|460757849|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
127595145|NCT04862585|459143727|FG001|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|3|||
128035288|NCT02958865|460757850|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
128035289|NCT02958865|460757851|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
128035290|NCT02958865|460757852|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
128035291|NCT02958865|460757853|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
128035292|NCT02958865|460757854|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
127595146|NCT04862585|459143726|FG000|Overall Study|one subject discontinued paclitaxel due to toxicity|0|||
127786187|NCT00094770|459842827|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
127786188|NCT00094770|459842826|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
127786189|NCT00094770|459842827|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
127786190|NCT00094770|459842826|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
127786191|NCT00094770|459842827|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
128035293|NCT02958865|460757839|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
128035294|NCT02958865|460757840|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
128035295|NCT02958865|460757841|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
128035296|NCT02958865|460757842|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
127786192|NCT00094770|459842826|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
127786193|NCT00094770|459842827|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
127786194|NCT00094770|459842826|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
127786195|NCT00094770|459842827|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
127786196|NCT00094770|459842826|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
127786197|NCT00094770|459842827|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
127786198|NCT00094770|459842826|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
127786199|NCT00094770|459842827|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
127786200|NCT00094770|459842826|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
127786201|NCT00094770|459842827|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
127786202|NCT00094770|459842826|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
127786203|NCT00094770|459842827|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
127786204|NCT00094770|459842826|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
127786205|NCT00094770|459842827|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
127786206|NCT00094770|459842826|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
127786207|NCT00094770|459842827|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
127786208|NCT00094770|459842826|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
127786209|NCT00094770|459842827|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
127786210|NCT00094770|459842826|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
127786211|NCT00094770|459842827|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
127786212|NCT00094770|459842826|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
127786213|NCT00094770|459842827|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
127786214|NCT00094770|459842826|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
127786215|NCT00094770|459842827|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
127786216|NCT00094770|459842826|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
127786217|NCT00094770|459842827|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
127786218|NCT00094770|459842826|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
127786219|NCT00094770|459842827|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
127786220|NCT00094770|459842826|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
127786221|NCT00094770|459842827|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
127786222|NCT00914927|459842829|FG000|Overall Study|Adverse Event|0|||
127786223|NCT00914927|459842830|FG001|Overall Study|Adverse Event|0|||
127786224|NCT00914927|459842831|FG002|Overall Study|Adverse Event|0|||
127786225|NCT00914927|459842832|FG003|Overall Study|Adverse Event|0|||
127786226|NCT00914927|459842833|FG004|Overall Study|Adverse Event|1|||
127786227|NCT00914927|459842834|FG005|Overall Study|Adverse Event|0|||
127786228|NCT00914927|459842835|FG006|Overall Study|Adverse Event|0|||
127786229|NCT00914927|459842829|FG000|Overall Study|Withdrawal by Subject|0|||
127786230|NCT00914927|459842830|FG001|Overall Study|Withdrawal by Subject|1|||
127786231|NCT00914927|459842831|FG002|Overall Study|Withdrawal by Subject|0|||
127786232|NCT00914927|459842832|FG003|Overall Study|Withdrawal by Subject|1|||
127786233|NCT00914927|459842833|FG004|Overall Study|Withdrawal by Subject|0|||
127786234|NCT00914927|459842834|FG005|Overall Study|Withdrawal by Subject|0|||
127786235|NCT00914927|459842835|FG006|Overall Study|Withdrawal by Subject|0|||
127786236|NCT00914927|459842829|FG000|Overall Study|Lost to Follow-up|0|||
127786237|NCT00914927|459842830|FG001|Overall Study|Lost to Follow-up|0|||
127786238|NCT00914927|459842831|FG002|Overall Study|Lost to Follow-up|0|||
127786239|NCT00914927|459842832|FG003|Overall Study|Lost to Follow-up|1|||
127786240|NCT00914927|459842833|FG004|Overall Study|Lost to Follow-up|0|||
127786241|NCT00914927|459842834|FG005|Overall Study|Lost to Follow-up|0|||
127786242|NCT00914927|459842835|FG006|Overall Study|Lost to Follow-up|0|||
127786243|NCT00914927|459842829|FG000|Overall Study|Administrative/Other|2|||
127786244|NCT00914927|459842830|FG001|Overall Study|Administrative/Other|1|||
127786245|NCT00914927|459842831|FG002|Overall Study|Administrative/Other|0|||
127786246|NCT00914927|459842832|FG003|Overall Study|Administrative/Other|0|||
127786247|NCT00914927|459842833|FG004|Overall Study|Administrative/Other|1|||
127786248|NCT00914927|459842834|FG005|Overall Study|Administrative/Other|0|||
127786249|NCT00914927|459842835|FG006|Overall Study|Administrative/Other|0|||
127786250|NCT04773106|459842836|FG000|Overall Study|Withdrawal by Subject|3|||
127786251|NCT04773106|459842836|FG000|Overall Study|Death|1|||
127786252|NCT01349465|459842837|FG000|Overall Study|Adverse Event|1|||
127786253|NCT01349465|459842838|FG001|Overall Study|Adverse Event|0|||
127786254|NCT01349465|459842837|FG000|Overall Study|Death|3|||
127786255|NCT01349465|459842838|FG001|Overall Study|Death|0|||
127786256|NCT01349465|459842837|FG000|Overall Study|Lost to Follow-up|10|||
127786257|NCT01349465|459842838|FG001|Overall Study|Lost to Follow-up|1|||
127786258|NCT01349465|459842837|FG000|Overall Study|Withdrawal by Subject|4|||
127786259|NCT01349465|459842838|FG001|Overall Study|Withdrawal by Subject|2|||
127786260|NCT01349465|459842837|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
127786261|NCT01349465|459842838|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
127786262|NCT01648790|459842841|FG000|Treatment 3|Withdrawal by Subject|0|||
127786263|NCT01648790|459842842|FG001|Treatment 3|Withdrawal by Subject|0|||
127786264|NCT01648790|459842843|FG002|Treatment 3|Withdrawal by Subject|0|||
127786265|NCT01648790|459842844|FG003|Treatment 3|Withdrawal by Subject|1|||
127786266|NCT01648790|459842845|FG004|Treatment 3|Withdrawal by Subject|0|||
127595147|NCT04862585|459143727|FG001|Overall Study|one subject discontinued paclitaxel due to toxicity|1|||
127595148|NCT04862585|459143726|FG000|Overall Study|one withdrew without providing a reason|0|||
127595149|NCT04862585|459143727|FG001|Overall Study|one withdrew without providing a reason|1|||
127595150|NCT00496470|459143728|FG000|Overall Study|Adverse Event|8|||
127595151|NCT00496470|459143729|FG001|Overall Study|Adverse Event|10|||
127595152|NCT00496470|459143728|FG000|Overall Study|Withdrawal by Subject|5|||
127595153|NCT00496470|459143729|FG001|Overall Study|Withdrawal by Subject|12|||
127595154|NCT00496470|459143728|FG000|Overall Study|Incorrectly enrolled|13|||
127595155|NCT00496470|459143729|FG001|Overall Study|Incorrectly enrolled|5|||
127595156|NCT00496470|459143728|FG000|Overall Study|Other reason|0|||
127595157|NCT00496470|459143729|FG001|Overall Study|Other reason|2|||
127595158|NCT01217814|459143730|FG000|Overall Study|Adverse Event|1|||
127595159|NCT01217814|459143731|FG001|Overall Study|Adverse Event|1|||
127595160|NCT01217814|459143732|FG002|Overall Study|Adverse Event|0|||
127595161|NCT01217814|459143730|FG000|Overall Study|Lack of Efficacy|0|||
127595162|NCT01217814|459143731|FG001|Overall Study|Lack of Efficacy|0|||
127595163|NCT01217814|459143732|FG002|Overall Study|Lack of Efficacy|1|||
127595164|NCT01370356|459143733|FG000|Overall Study|Death|1|||
127595165|NCT01370356|459143734|FG001|Overall Study|Death|0|||
127595166|NCT01370356|459143733|FG000|Overall Study|Lack of Efficacy|6|||
127595167|NCT01370356|459143734|FG001|Overall Study|Lack of Efficacy|28|||
127595168|NCT01370356|459143733|FG000|Overall Study|Lost to Follow-up|76|||
127595169|NCT01370356|459143734|FG001|Overall Study|Lost to Follow-up|81|||
127595170|NCT01370356|459143733|FG000|Overall Study|Withdrawal by Subject|54|||
127595171|NCT01370356|459143734|FG001|Overall Study|Withdrawal by Subject|59|||
127786267|NCT02969187|459842846|FG000|Overall Study|Physician Decision|12|||
127786268|NCT02969187|459842847|FG001|Overall Study|Physician Decision|13|||
127786269|NCT01486927|459842848|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
127786270|NCT01486927|459842848|FG000|Overall Study|Physician Decision|1|||
127786271|NCT01486927|459842848|FG000|Overall Study|50 Exposure days not reached|2|||
127786272|NCT01486927|459842848|FG000|Overall Study|Withdrawal by Subject|8|||
127786273|NCT01486927|459842848|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
127786274|NCT00365456|459842849|FG000|Trial Period I (12 Months)|Adverse Event|84|||
127786275|NCT00365456|459842850|FG001|Trial Period I (12 Months)|Adverse Event|0|||
127786276|NCT00365456|459842849|FG000|Trial Period I (12 Months)|Non-compliance|3|||
127786277|NCT00365456|459842850|FG001|Trial Period I (12 Months)|Non-compliance|0|||
127786278|NCT00365456|459842849|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
127786279|NCT00365456|459842850|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
127786280|NCT00365456|459842849|FG000|Trial Period I (12 Months)|Other|11|||
127786281|NCT00365456|459842850|FG001|Trial Period I (12 Months)|Other|0|||
127786282|NCT00365456|459842849|FG000|Trial Period II (12 Months)|Adverse Event|0|||
127786283|NCT00365456|459842850|FG001|Trial Period II (12 Months)|Adverse Event|6|||
127786284|NCT00365456|459842849|FG000|Trial Period II (12 Months)|Non-compliance|0|||
127786285|NCT00365456|459842850|FG001|Trial Period II (12 Months)|Non-compliance|2|||
127786286|NCT00365456|459842849|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
127786287|NCT00365456|459842850|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
127786288|NCT00365456|459842849|FG000|Trial Period II (12 Months)|Other|0|||
127786289|NCT00365456|459842850|FG001|Trial Period II (12 Months)|Other|1|||
127786290|NCT00365456|459842849|FG000|Trial Period III (12 Months)|Adverse Event|13|||
127786291|NCT00365456|459842850|FG001|Trial Period III (12 Months)|Adverse Event|3|||
127786292|NCT00365456|459842849|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
127786293|NCT00365456|459842850|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
127786294|NCT00365456|459842849|FG000|Trial Period III (12 Months)|Other|1|||
127786295|NCT00365456|459842850|FG001|Trial Period III (12 Months)|Other|1|||
127786296|NCT03668600|459842851|FG000|Overall Study|Study Terminated by the Sponsor|157|||
127786297|NCT03668600|459842851|FG000|Overall Study|Protocol Violation|1|||
127595172|NCT01370356|459143733|FG000|Overall Study|Reason not specified|39|||
127595173|NCT01370356|459143734|FG001|Overall Study|Reason not specified|43|||
127595174|NCT01370356|459143733|FG000|Overall Study|Protocol Violation|3|||
127595175|NCT01370356|459143734|FG001|Overall Study|Protocol Violation|3|||
127595176|NCT01370356|459143733|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
127595177|NCT01370356|459143734|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
127595178|NCT01370356|459143733|FG000|Overall Study|AE Not Related to Study Drug|1|||
127595179|NCT01370356|459143734|FG001|Overall Study|AE Not Related to Study Drug|4|||
127786298|NCT03668600|459842851|FG000|Overall Study|Pregnancy|1|||
127786299|NCT03668600|459842851|FG000|Overall Study|Lost to Follow-up|7|||
127595180|NCT00040664|459143735|FG000|Overall Study|Adverse Event|12|||
127595181|NCT00040664|459143736|FG001|Overall Study|Adverse Event|3|||
127595182|NCT00040664|459143737|FG002|Overall Study|Adverse Event|2|||
127786300|NCT03668600|459842851|FG000|Overall Study|Withdrawal by Subject|56|||
127786301|NCT03668600|459842851|FG000|Overall Study|Lack of Efficacy|7|||
127786302|NCT03668600|459842851|FG000|Overall Study|Adverse Event|1|||
127786303|NCT01476475|459842853|FG000|Overall Study|Adverse Event|6|||
127786304|NCT01476475|459842854|FG001|Overall Study|Adverse Event|0|||
127786305|NCT01476475|459842853|FG000|Overall Study|Poor compliance to protocol|1|||
127882344|NCT02766088|460192760|FG000|Overall Study|Other|1|||
127595183|NCT00040664|459143738|FG003|Overall Study|Adverse Event|7|||
127595184|NCT00040664|459143735|FG000|Overall Study|Lack of Efficacy|9|||
127595185|NCT00040664|459143736|FG001|Overall Study|Lack of Efficacy|2|||
127595186|NCT00040664|459143737|FG002|Overall Study|Lack of Efficacy|3|||
127595187|NCT00040664|459143738|FG003|Overall Study|Lack of Efficacy|4|||
127595188|NCT00040664|459143735|FG000|Overall Study|Insufficient CD4 response|1|||
127595189|NCT00040664|459143736|FG001|Overall Study|Insufficient CD4 response|0|||
127695347|NCT01261312|459512912|FG008|DE Phase: TN AML (Week 85-283)|Reason not Specified|6|||
127695348|NCT01261312|459512913|FG009|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
127882345|NCT02766088|460192760|FG000|Overall Study|Death|1|||
127882346|NCT01222715|460192761|FG000|Overall Study|Adverse Event|0|||
127882347|NCT01222715|460192762|FG001|Overall Study|Adverse Event|4|||
127882348|NCT01222715|460192761|FG000|Overall Study|Death|0|||
127882349|NCT01222715|460192762|FG001|Overall Study|Death|1|||
127882350|NCT01222715|460192761|FG000|Overall Study|Lack of Efficacy|22|||
127882351|NCT01222715|460192762|FG001|Overall Study|Lack of Efficacy|14|||
127882352|NCT01222715|460192761|FG000|Overall Study|Physician Decision|12|||
127882353|NCT01222715|460192762|FG001|Overall Study|Physician Decision|2|||
127882354|NCT01222715|460192761|FG000|Overall Study|Refusal of further protocol therapy|0|||
127595190|NCT00040664|459143737|FG002|Overall Study|Insufficient CD4 response|1|||
127695349|NCT01261312|459512914|FG010|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
127695350|NCT01261312|459512915|FG011|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
127695351|NCT01261312|459512916|FG012|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
127695352|NCT01261312|459512904|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
127695353|NCT01261312|459512905|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
127695354|NCT01261312|459512906|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
127695355|NCT01261312|459512907|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
127695356|NCT01261312|459512908|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
127695357|NCT01261312|459512909|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
127695358|NCT01261312|459512910|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
127695359|NCT01261312|459512911|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
127695360|NCT01261312|459512912|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
127882355|NCT01222715|460192762|FG001|Overall Study|Refusal of further protocol therapy|4|||
127882356|NCT01222715|460192761|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
128035297|NCT02958865|460757843|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
128035298|NCT02958865|460757844|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
128035299|NCT02958865|460757845|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
127595191|NCT00040664|459143738|FG003|Overall Study|Insufficient CD4 response|0|||
127595192|NCT00040664|459143735|FG000|Overall Study|Lost to Follow-up|4|||
127595193|NCT00040664|459143736|FG001|Overall Study|Lost to Follow-up|2|||
127595194|NCT00040664|459143737|FG002|Overall Study|Lost to Follow-up|0|||
127595195|NCT00040664|459143738|FG003|Overall Study|Lost to Follow-up|2|||
127595196|NCT00040664|459143735|FG000|Overall Study|Protocol Violation|2|||
127595197|NCT00040664|459143736|FG001|Overall Study|Protocol Violation|1|||
127595198|NCT00040664|459143737|FG002|Overall Study|Protocol Violation|0|||
127595199|NCT00040664|459143738|FG003|Overall Study|Protocol Violation|1|||
127595200|NCT00040664|459143735|FG000|Overall Study|Withdrawal by Subject|7|||
127595201|NCT00040664|459143736|FG001|Overall Study|Withdrawal by Subject|0|||
127595202|NCT00040664|459143737|FG002|Overall Study|Withdrawal by Subject|3|||
127595203|NCT00040664|459143738|FG003|Overall Study|Withdrawal by Subject|4|||
127595204|NCT00040664|459143735|FG000|Overall Study|Pregnancy|3|||
127595205|NCT00040664|459143736|FG001|Overall Study|Pregnancy|0|||
127595206|NCT00040664|459143737|FG002|Overall Study|Pregnancy|0|||
127595207|NCT00040664|459143738|FG003|Overall Study|Pregnancy|3|||
127595208|NCT00040664|459143735|FG000|Overall Study|Medication adherence/compliance problems|8|||
127595209|NCT00040664|459143736|FG001|Overall Study|Medication adherence/compliance problems|2|||
127595210|NCT00040664|459143737|FG002|Overall Study|Medication adherence/compliance problems|1|||
127595211|NCT00040664|459143738|FG003|Overall Study|Medication adherence/compliance problems|5|||
127595212|NCT00040664|459143735|FG000|Overall Study|Poor taste|2|||
127595213|NCT00040664|459143736|FG001|Overall Study|Poor taste|0|||
127595214|NCT00040664|459143737|FG002|Overall Study|Poor taste|2|||
127595215|NCT00040664|459143738|FG003|Overall Study|Poor taste|0|||
127595216|NCT00040664|459143735|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
127595217|NCT00040664|459143736|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
127595218|NCT00040664|459143737|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
127595219|NCT00040664|459143738|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
127595220|NCT00040664|459143735|FG000|Overall Study|Change of formulation|2|||
127595221|NCT00040664|459143736|FG001|Overall Study|Change of formulation|2|||
127595222|NCT00040664|459143737|FG002|Overall Study|Change of formulation|0|||
127595223|NCT00040664|459143738|FG003|Overall Study|Change of formulation|0|||
127595224|NCT00040664|459143735|FG000|Overall Study|Non-viability of oral suspension|1|||
127595225|NCT00040664|459143736|FG001|Overall Study|Non-viability of oral suspension|0|||
127595226|NCT00040664|459143737|FG002|Overall Study|Non-viability of oral suspension|1|||
127786306|NCT01476475|459842854|FG001|Overall Study|Poor compliance to protocol|1|||
127786307|NCT01476475|459842853|FG000|Overall Study|Other reasons|4|||
127786308|NCT01476475|459842854|FG001|Overall Study|Other reasons|2|||
127786309|NCT01278745|459842855|FG000|Overall Study|Death|2|||
127786310|NCT01278745|459842856|FG001|Overall Study|Death|5|||
127786311|NCT01278745|459842857|FG002|Overall Study|Death|7|||
127786312|NCT01278745|459842858|FG003|Overall Study|Death|0|||
127786313|NCT01278745|459842855|FG000|Overall Study|Physician Decision|1|||
127786314|NCT01278745|459842856|FG001|Overall Study|Physician Decision|0|||
127786315|NCT01278745|459842857|FG002|Overall Study|Physician Decision|0|||
127786316|NCT01278745|459842858|FG003|Overall Study|Physician Decision|9|||
127786317|NCT01278745|459842855|FG000|Overall Study|Withdrawal by Subject|1|||
127786318|NCT01278745|459842856|FG001|Overall Study|Withdrawal by Subject|1|||
127786319|NCT01278745|459842857|FG002|Overall Study|Withdrawal by Subject|5|||
127786320|NCT01278745|459842858|FG003|Overall Study|Withdrawal by Subject|1|||
127786321|NCT01278745|459842855|FG000|Overall Study|Sponsor Decision|1|||
127786322|NCT01278745|459842856|FG001|Overall Study|Sponsor Decision|0|||
127786323|NCT01278745|459842857|FG002|Overall Study|Sponsor Decision|62|||
127786324|NCT01278745|459842858|FG003|Overall Study|Sponsor Decision|6|||
127786325|NCT01278745|459842855|FG000|Overall Study|Ineligible|0|||
127786326|NCT01278745|459842856|FG001|Overall Study|Ineligible|0|||
127786327|NCT01278745|459842857|FG002|Overall Study|Ineligible|42|||
127786328|NCT01278745|459842858|FG003|Overall Study|Ineligible|61|||
127786329|NCT01278745|459842855|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
127786330|NCT01278745|459842856|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
127786331|NCT01278745|459842857|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
127786332|NCT01278745|459842858|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
127786333|NCT01265615|459842859|FG000|Overall Study|Protocol Violation|2|||
127786334|NCT01265615|459842860|FG001|Overall Study|Protocol Violation|2|||
127786335|NCT01265615|459842861|FG002|Overall Study|Protocol Violation|4|||
127786336|NCT01265615|459842862|FG003|Overall Study|Protocol Violation|3|||
127786337|NCT00454857|459842867|FG000|Overall Study|Withdrawal by Subject|15|||
127786338|NCT00454857|459842867|FG000|Overall Study|Lost to Follow-up|16|||
127786339|NCT00454857|459842867|FG000|Overall Study|Noncompliance|6|||
127786340|NCT00454857|459842867|FG000|Overall Study|Death|5|||
127786341|NCT00454857|459842867|FG000|Overall Study|Other|11|||
127786342|NCT00454857|459842867|FG000|Overall Study|Reason unknown|1|||
127786343|NCT02375724|459842875|FG000|Overall Study|Lack of Efficacy|1|||
127786344|NCT02375724|459842876|FG001|Overall Study|Lack of Efficacy|1|||
127786345|NCT02375724|459842875|FG000|Overall Study|Withdrawal by Subject|1|||
127786346|NCT02375724|459842876|FG001|Overall Study|Withdrawal by Subject|1|||
127786347|NCT02375724|459842875|FG000|Overall Study|Lost to Follow-up|1|||
127786348|NCT02375724|459842876|FG001|Overall Study|Lost to Follow-up|0|||
127786349|NCT02375724|459842875|FG000|Overall Study|Protocol Violation|1|||
127786350|NCT02375724|459842876|FG001|Overall Study|Protocol Violation|0|||
127786351|NCT02375724|459842875|FG000|Overall Study|Adverse Event|2|||
127786352|NCT02375724|459842876|FG001|Overall Study|Adverse Event|4|||
127786353|NCT01197521|459842879|FG000|Overall Study|Not reported|24|||
127786354|NCT01197521|459842880|FG001|Overall Study|Not reported|25|||
127786355|NCT01197521|459842881|FG002|Overall Study|Not reported|21|||
127786356|NCT01197521|459842879|FG000|Overall Study|Enrolment in long term extension|42|||
127786357|NCT01197521|459842880|FG001|Overall Study|Enrolment in long term extension|36|||
127786358|NCT01197521|459842881|FG002|Overall Study|Enrolment in long term extension|87|||
127595227|NCT00040664|459143738|FG003|Overall Study|Non-viability of oral suspension|0|||
127595228|NCT00729651|459143739|FG000|Overall Study|Withdrawal by Subject|5|||
127595229|NCT00729651|459143740|FG001|Overall Study|Withdrawal by Subject|6|||
127595230|NCT00729651|459143739|FG000|Overall Study|Lost to Follow-up|5|||
127595231|NCT00729651|459143740|FG001|Overall Study|Lost to Follow-up|4|||
127595232|NCT00729651|459143739|FG000|Overall Study|Protocol Violation|0|||
127595233|NCT00729651|459143740|FG001|Overall Study|Protocol Violation|1|||
127595234|NCT00729651|459143739|FG000|Overall Study|Adverse Event|7|||
127595235|NCT00729651|459143740|FG001|Overall Study|Adverse Event|3|||
127595236|NCT00729651|459143739|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
127595237|NCT00729651|459143740|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
127595238|NCT00729651|459143739|FG000|Overall Study|Subject's private reason|2|||
127786359|NCT01197521|459842879|FG000|Overall Study|Severe non-compliance to protocol|1|||
127786360|NCT01197521|459842880|FG001|Overall Study|Severe non-compliance to protocol|3|||
127786361|NCT01197521|459842881|FG002|Overall Study|Severe non-compliance to protocol|3|||
127786362|NCT01197521|459842879|FG000|Overall Study|Lack of therapeutic response|2|||
127786363|NCT01197521|459842880|FG001|Overall Study|Lack of therapeutic response|3|||
127786364|NCT01197521|459842881|FG002|Overall Study|Lack of therapeutic response|4|||
127786365|NCT01197521|459842879|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
127786366|NCT01197521|459842880|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
127786367|NCT01197521|459842881|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
127786368|NCT01197521|459842879|FG000|Overall Study|Lost to Follow-up|3|||
127595239|NCT00729651|459143740|FG001|Overall Study|Subject's private reason|0|||
127595240|NCT02925494|459143741|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
127786369|NCT01197521|459842880|FG001|Overall Study|Lost to Follow-up|2|||
127786370|NCT01197521|459842881|FG002|Overall Study|Lost to Follow-up|2|||
127786371|NCT01197521|459842879|FG000|Overall Study|Adverse Event|25|||
127786372|NCT01197521|459842880|FG001|Overall Study|Adverse Event|28|||
127786373|NCT01197521|459842881|FG002|Overall Study|Adverse Event|24|||
127786374|NCT03962101|459842882|FG000|Overall Study|Adverse Event|1|||
127786375|NCT03962101|459842882|FG000|Overall Study|Physician Decision|2|||
127786376|NCT03962101|459842882|FG000|Overall Study|Not related to medical events|1|||
127786377|NCT04206605|459842888|FG000|Overall Study|Adverse Event|0|||
127786378|NCT04206605|459842889|FG001|Overall Study|Adverse Event|1|||
127786379|NCT04206605|459842888|FG000|Overall Study|Withdrawal by Subject|1|||
127786380|NCT04206605|459842889|FG001|Overall Study|Withdrawal by Subject|0|||
127786381|NCT00078325|459842892|FG000|Overall Study|Adverse Event|15|||
127786382|NCT00078325|459842893|FG001|Overall Study|Adverse Event|10|||
127786383|NCT00078325|459842894|FG002|Overall Study|Adverse Event|5|||
127786384|NCT00078325|459842892|FG000|Overall Study|Protocol Violation|2|||
127786385|NCT00078325|459842893|FG001|Overall Study|Protocol Violation|2|||
127786386|NCT00078325|459842894|FG002|Overall Study|Protocol Violation|0|||
127786387|NCT00078325|459842892|FG000|Overall Study|Withdrawal by Subject|1|||
127595241|NCT02925494|459143742|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
127595242|NCT02925494|459143743|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
127595243|NCT02925494|459143744|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
127595244|NCT02925494|459143741|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
127595245|NCT02925494|459143742|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
127595246|NCT02925494|459143743|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
127595247|NCT02925494|459143744|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
127595248|NCT02925494|459143741|FG000|Post-Treatment Follow-Up Period|Other|1|||
127595249|NCT02925494|459143742|FG001|Post-Treatment Follow-Up Period|Other|4|||
127595250|NCT02925494|459143743|FG002|Post-Treatment Follow-Up Period|Other|3|||
127595251|NCT02925494|459143744|FG003|Post-Treatment Follow-Up Period|Other|6|||
127595252|NCT02925494|459143741|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
127595253|NCT02925494|459143742|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
127595254|NCT02925494|459143743|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
127595255|NCT02925494|459143744|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
127595256|NCT02925494|459143741|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
127595257|NCT02925494|459143742|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
127595258|NCT02925494|459143743|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
127595259|NCT02925494|459143744|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
127595260|NCT02925494|459143741|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
127595261|NCT02925494|459143742|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
127595262|NCT02925494|459143743|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
127595263|NCT02925494|459143744|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
127595264|NCT02925494|459143741|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
127595265|NCT02925494|459143742|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
127595266|NCT02925494|459143743|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
127595267|NCT02925494|459143744|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
127595268|NCT06149247|459143749|FG000|Overall Study|Adverse Event|0|||
127595269|NCT06149247|459143750|FG001|Overall Study|Adverse Event|1|||
127595270|NCT05182125|459143751|FG000|Overall Study|Withdrawal by Subject|0|||
127595271|NCT05182125|459143752|FG001|Overall Study|Withdrawal by Subject|0|||
127595272|NCT05182125|459143753|FG002|Overall Study|Withdrawal by Subject|0|||
127595273|NCT05182125|459143754|FG003|Overall Study|Withdrawal by Subject|0|||
127595274|NCT05182125|459143755|FG004|Overall Study|Withdrawal by Subject|2|||
127595275|NCT05182125|459143756|FG005|Overall Study|Withdrawal by Subject|0|||
127595276|NCT05182125|459143751|FG000|Overall Study|Participant unable to adhere Visit Schedule|0|||
127595277|NCT05182125|459143752|FG001|Overall Study|Participant unable to adhere Visit Schedule|0|||
127595278|NCT05182125|459143753|FG002|Overall Study|Participant unable to adhere Visit Schedule|0|||
127595279|NCT05182125|459143754|FG003|Overall Study|Participant unable to adhere Visit Schedule|1|||
127595280|NCT05182125|459143755|FG004|Overall Study|Participant unable to adhere Visit Schedule|0|||
127786388|NCT00078325|459842893|FG001|Overall Study|Withdrawal by Subject|5|||
127595281|NCT05182125|459143756|FG005|Overall Study|Participant unable to adhere Visit Schedule|0|||
127595282|NCT05182125|459143751|FG000|Overall Study|Death|0|||
127595283|NCT05182125|459143752|FG001|Overall Study|Death|0|||
127595284|NCT05182125|459143753|FG002|Overall Study|Death|0|||
127595285|NCT05182125|459143754|FG003|Overall Study|Death|0|||
127595286|NCT05182125|459143755|FG004|Overall Study|Death|1|||
127595287|NCT05182125|459143756|FG005|Overall Study|Death|0|||
127786389|NCT00078325|459842894|FG002|Overall Study|Withdrawal by Subject|3|||
127786390|NCT00078325|459842892|FG000|Overall Study|Lost to Follow-up|0|||
127786391|NCT00078325|459842893|FG001|Overall Study|Lost to Follow-up|1|||
127786392|NCT00078325|459842894|FG002|Overall Study|Lost to Follow-up|1|||
127595288|NCT05182125|459143751|FG000|Overall Study|Health Contact Follow-up|5|||
127595289|NCT05182125|459143752|FG001|Overall Study|Health Contact Follow-up|5|||
127786393|NCT00078325|459842892|FG000|Overall Study|Physician Decision|2|||
127695361|NCT01261312|459512913|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
127695362|NCT01261312|459512914|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
127695363|NCT01261312|459512915|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|9|||
127695364|NCT01261312|459512916|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|2|||
127695365|NCT01261312|459512904|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
127695366|NCT01261312|459512905|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
127695367|NCT01261312|459512906|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
127695368|NCT01261312|459512907|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
127695369|NCT01261312|459512908|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
127695370|NCT01261312|459512909|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
127695371|NCT01261312|459512910|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
127695372|NCT01261312|459512911|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
127695373|NCT01261312|459512912|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
127695374|NCT01261312|459512913|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|2|||
127695375|NCT01261312|459512914|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
127695376|NCT01261312|459512915|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
127695377|NCT01261312|459512916|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
127695378|NCT01261312|459512904|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
127695379|NCT01261312|459512905|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
127695380|NCT01261312|459512906|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
127695381|NCT01261312|459512907|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
127695382|NCT01261312|459512908|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
127695383|NCT01261312|459512909|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
127695384|NCT01261312|459512910|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
127695385|NCT01261312|459512911|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
127695386|NCT01261312|459512912|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
127695387|NCT01261312|459512913|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|4|||
127695388|NCT01261312|459512914|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|5|||
127695389|NCT01261312|459512915|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
127695390|NCT01261312|459512916|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
127695391|NCT01261312|459512904|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
127695392|NCT01261312|459512905|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
127695393|NCT01261312|459512906|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
127786394|NCT00078325|459842893|FG001|Overall Study|Physician Decision|0|||
127786395|NCT00078325|459842894|FG002|Overall Study|Physician Decision|1|||
127786396|NCT00078325|459842892|FG000|Overall Study|Miscellaneous|1|||
127786397|NCT00078325|459842893|FG001|Overall Study|Miscellaneous|1|||
127786398|NCT00078325|459842894|FG002|Overall Study|Miscellaneous|1|||
127786399|NCT00578136|459842895|FG000|Overall Study|Not given intervention|1|||
127786400|NCT00578136|459842896|FG001|Overall Study|Not given intervention|1|||
127786401|NCT02047253|459842897|FG000|Overall Study|Lost to Follow-up|8|||
127786402|NCT01987960|459842899|FG000|Period 1|Adverse Event|24|||
127786403|NCT01987960|459842900|FG001|Period 1|Adverse Event|0|||
127786404|NCT01987960|459842901|FG002|Period 1|Adverse Event|0|||
127786405|NCT01987960|459842902|FG003|Period 1|Adverse Event|0|||
127786406|NCT01987960|459842899|FG000|Period 1|Lack of Efficacy|4|||
127786407|NCT01987960|459842900|FG001|Period 1|Lack of Efficacy|0|||
127786408|NCT01987960|459842901|FG002|Period 1|Lack of Efficacy|0|||
127786409|NCT01987960|459842902|FG003|Period 1|Lack of Efficacy|0|||
127786410|NCT01987960|459842899|FG000|Period 1|Non-compliance with IMP|6|||
127786411|NCT01987960|459842900|FG001|Period 1|Non-compliance with IMP|0|||
127786412|NCT01987960|459842901|FG002|Period 1|Non-compliance with IMP|0|||
127786413|NCT01987960|459842902|FG003|Period 1|Non-compliance with IMP|0|||
127786414|NCT01987960|459842899|FG000|Period 1|Protocol Violation|12|||
127786415|NCT01987960|459842900|FG001|Period 1|Protocol Violation|0|||
127786416|NCT01987960|459842901|FG002|Period 1|Protocol Violation|0|||
127786417|NCT01987960|459842902|FG003|Period 1|Protocol Violation|0|||
127786418|NCT01987960|459842899|FG000|Period 1|Withdrawal by Subject|21|||
127786419|NCT01987960|459842900|FG001|Period 1|Withdrawal by Subject|0|||
128035300|NCT02958865|460757846|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
127786420|NCT01987960|459842901|FG002|Period 1|Withdrawal by Subject|0|||
127786421|NCT01987960|459842902|FG003|Period 1|Withdrawal by Subject|0|||
127786422|NCT01987960|459842899|FG000|Period 1|Lost to Follow-up|40|||
127786423|NCT01987960|459842900|FG001|Period 1|Lost to Follow-up|0|||
127786424|NCT01987960|459842901|FG002|Period 1|Lost to Follow-up|0|||
127786425|NCT01987960|459842902|FG003|Period 1|Lost to Follow-up|0|||
127786426|NCT01987960|459842899|FG000|Period 1|administrative or other reason|75|||
127786427|NCT01987960|459842900|FG001|Period 1|administrative or other reason|0|||
127786428|NCT01987960|459842901|FG002|Period 1|administrative or other reason|0|||
127786429|NCT01987960|459842902|FG003|Period 1|administrative or other reason|0|||
127786430|NCT01987960|459842899|FG000|Period 1|Withdrawal of consent before treatment|4|||
127786431|NCT01987960|459842900|FG001|Period 1|Withdrawal of consent before treatment|0|||
128035301|NCT02958865|460757847|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
127786432|NCT01987960|459842901|FG002|Period 1|Withdrawal of consent before treatment|0|||
127786433|NCT01987960|459842902|FG003|Period 1|Withdrawal of consent before treatment|0|||
127786434|NCT01987960|459842899|FG000|Period 2|Adverse Event|0|||
127786435|NCT01987960|459842900|FG001|Period 2|Adverse Event|0|||
127786436|NCT01987960|459842901|FG002|Period 2|Adverse Event|1|||
127786437|NCT01987960|459842902|FG003|Period 2|Adverse Event|0|||
127786438|NCT01987960|459842899|FG000|Period 2|Withdrawal by Subject|0|||
127786439|NCT01987960|459842900|FG001|Period 2|Withdrawal by Subject|0|||
127786440|NCT01987960|459842901|FG002|Period 2|Withdrawal by Subject|1|||
127786441|NCT01987960|459842902|FG003|Period 2|Withdrawal by Subject|0|||
127786442|NCT01987960|459842899|FG000|Period 2|Administrative or other reason|0|||
127786443|NCT01987960|459842900|FG001|Period 2|Administrative or other reason|5|||
127786444|NCT01987960|459842901|FG002|Period 2|Administrative or other reason|7|||
127786445|NCT01987960|459842902|FG003|Period 2|Administrative or other reason|0|||
127786446|NCT01987960|459842899|FG000|Period 3|Adverse Event|0|||
127786447|NCT01987960|459842900|FG001|Period 3|Adverse Event|0|||
127786448|NCT01987960|459842901|FG002|Period 3|Adverse Event|0|||
127786449|NCT01987960|459842902|FG003|Period 3|Adverse Event|7|||
127786450|NCT01987960|459842899|FG000|Period 3|Non-compliance with IMP|0|||
127786451|NCT01987960|459842900|FG001|Period 3|Non-compliance with IMP|0|||
127786452|NCT01987960|459842901|FG002|Period 3|Non-compliance with IMP|0|||
127786453|NCT01987960|459842902|FG003|Period 3|Non-compliance with IMP|1|||
127786454|NCT01987960|459842899|FG000|Period 3|Protocol Violation|0|||
127786455|NCT01987960|459842900|FG001|Period 3|Protocol Violation|0|||
127786456|NCT01987960|459842901|FG002|Period 3|Protocol Violation|0|||
127786457|NCT01987960|459842902|FG003|Period 3|Protocol Violation|6|||
127786458|NCT01987960|459842899|FG000|Period 3|Withdrawal by Subject|0|||
127786459|NCT01987960|459842900|FG001|Period 3|Withdrawal by Subject|0|||
127786460|NCT01987960|459842901|FG002|Period 3|Withdrawal by Subject|0|||
127786461|NCT01987960|459842902|FG003|Period 3|Withdrawal by Subject|9|||
127786462|NCT01987960|459842899|FG000|Period 3|Lost to Follow-up|0|||
127786463|NCT01987960|459842900|FG001|Period 3|Lost to Follow-up|0|||
127786464|NCT01987960|459842901|FG002|Period 3|Lost to Follow-up|0|||
127786465|NCT01987960|459842902|FG003|Period 3|Lost to Follow-up|5|||
127786466|NCT01987960|459842899|FG000|Period 3|Administrative or other reason|0|||
127786467|NCT01987960|459842900|FG001|Period 3|Administrative or other reason|0|||
127786468|NCT01987960|459842901|FG002|Period 3|Administrative or other reason|0|||
127786469|NCT01987960|459842902|FG003|Period 3|Administrative or other reason|43|||
127786470|NCT01924182|459842907|FG000|Overall Study|Withdrawal by Subject|1|||
127786471|NCT01924182|459842908|FG001|Overall Study|Withdrawal by Subject|0|||
127786472|NCT00993265|459842910|FG000|Overall Study|Adverse Event|1|||
127786473|NCT00993265|459842911|FG001|Overall Study|Adverse Event|0|||
127786474|NCT00993265|459842910|FG000|Overall Study|Changed dose of concomitant drug|2|||
127786475|NCT00993265|459842911|FG001|Overall Study|Changed dose of concomitant drug|0|||
127786476|NCT00993265|459842910|FG000|Overall Study|Non-compliant with study medication|1|||
127786477|NCT00993265|459842911|FG001|Overall Study|Non-compliant with study medication|0|||
127786478|NCT01357655|459842913|FG000|Overall Study|Administrative Reason by Sponsor|45|||
127786479|NCT01357655|459842914|FG001|Overall Study|Administrative Reason by Sponsor|0|||
127786480|NCT01357655|459842913|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
127786481|NCT01357655|459842914|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
127786482|NCT01357655|459842913|FG000|Overall Study|Disease Progression|1|||
127786483|NCT01357655|459842914|FG001|Overall Study|Disease Progression|0|||
127786484|NCT01357655|459842913|FG000|Overall Study|Lost to Follow-up|2|||
127786485|NCT01357655|459842914|FG001|Overall Study|Lost to Follow-up|0|||
127786486|NCT01357655|459842913|FG000|Overall Study|Maximum Clinical Benefit|2|||
127786487|NCT01357655|459842914|FG001|Overall Study|Maximum Clinical Benefit|0|||
127786488|NCT01357655|459842913|FG000|Overall Study|Reason Unspecified|1|||
127786489|NCT01357655|459842914|FG001|Overall Study|Reason Unspecified|0|||
127786490|NCT01357655|459842913|FG000|Overall Study|Study Drug Toxicity|11|||
127786491|NCT01357655|459842914|FG001|Overall Study|Study Drug Toxicity|0|||
127786492|NCT01357655|459842913|FG000|Overall Study|Subject Withdrew Consent|1|||
127786493|NCT01357655|459842914|FG001|Overall Study|Subject Withdrew Consent|0|||
127786494|NCT00609986|459842915|FG000|Overall Study|Did not receive transplant or treatment|8|||
127786495|NCT00609986|459842916|FG001|Overall Study|Did not receive transplant or treatment|3|||
127786496|NCT04722042|459842918|FG000|Overall Study|Withdrawal by Subject|2|||
127786497|NCT04722042|459842919|FG001|Overall Study|Withdrawal by Subject|1|||
127786498|NCT04722042|459842920|FG002|Overall Study|Withdrawal by Subject|0|||
127786499|NCT02090413|459842921|FG000|Overall Study|Adverse Event|11|||
127786500|NCT02090413|459842922|FG001|Overall Study|Adverse Event|15|||
127882357|NCT01222715|460192762|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
127786501|NCT02090413|459842923|FG002|Overall Study|Adverse Event|20|||
127786502|NCT02090413|459842921|FG000|Overall Study|Flushing event|2|||
127786503|NCT02090413|459842922|FG001|Overall Study|Flushing event|0|||
127786504|NCT02090413|459842923|FG002|Overall Study|Flushing event|1|||
127786505|NCT02090413|459842921|FG000|Overall Study|Withdrawal by Subject|2|||
127786506|NCT02090413|459842922|FG001|Overall Study|Withdrawal by Subject|2|||
127786507|NCT02090413|459842923|FG002|Overall Study|Withdrawal by Subject|2|||
127595290|NCT05182125|459143753|FG002|Overall Study|Health Contact Follow-up|2|||
127595291|NCT05182125|459143754|FG003|Overall Study|Health Contact Follow-up|9|||
127595292|NCT05182125|459143755|FG004|Overall Study|Health Contact Follow-up|7|||
127595293|NCT05182125|459143756|FG005|Overall Study|Health Contact Follow-up|2|||
127595294|NCT01218243|459143757|FG000|Overall Study|Lack of Efficacy|1|||
127595295|NCT01218243|459143758|FG001|Overall Study|Lack of Efficacy|1|||
127595296|NCT01218243|459143757|FG000|Overall Study|Lost to Follow-up|3|||
127595297|NCT01218243|459143758|FG001|Overall Study|Lost to Follow-up|3|||
127595298|NCT01218243|459143757|FG000|Overall Study|Protocol Violation|5|||
127595299|NCT01218243|459143758|FG001|Overall Study|Protocol Violation|10|||
127595300|NCT01950741|459143767|FG000|Overall Study|Lost to Follow-up|1|||
127595301|NCT01950741|459143767|FG000|Overall Study|Death|1|||
127595302|NCT01950741|459143767|FG000|Overall Study|Withdrawal by Subject|1|||
127595303|NCT02521870|459143768|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
127595304|NCT02521870|459143769|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
127595305|NCT02521870|459143770|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
127595306|NCT02521870|459143771|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
127595307|NCT02521870|459143772|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
127595308|NCT02521870|459143773|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
127595309|NCT02521870|459143774|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
127595310|NCT02521870|459143775|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
127595311|NCT02521870|459143776|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
127595312|NCT02521870|459143777|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
127595313|NCT02521870|459143778|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
127595314|NCT02521870|459143779|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
127595315|NCT02521870|459143768|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
127595316|NCT02521870|459143769|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
127595317|NCT02521870|459143770|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
127595318|NCT02521870|459143771|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
127595319|NCT02521870|459143772|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
127595320|NCT02521870|459143773|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
127595321|NCT02521870|459143774|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
127595322|NCT02521870|459143775|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
127595323|NCT02521870|459143776|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
127595324|NCT02521870|459143777|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
127595325|NCT02521870|459143778|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
127595326|NCT02521870|459143779|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
127595327|NCT02521870|459143768|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
127595328|NCT02521870|459143769|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
127595329|NCT02521870|459143770|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
127595330|NCT02521870|459143771|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
127595331|NCT02521870|459143772|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
127595332|NCT02521870|459143773|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
127595333|NCT02521870|459143774|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
127595334|NCT02521870|459143775|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
127595335|NCT02521870|459143776|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
127595336|NCT02521870|459143777|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
127595337|NCT02521870|459143778|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
127595338|NCT02521870|459143779|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
127595339|NCT02521870|459143768|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
127595340|NCT02521870|459143769|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
127595341|NCT02521870|459143770|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
127595342|NCT02521870|459143771|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
127595343|NCT02521870|459143772|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
127595344|NCT02521870|459143773|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
127595345|NCT02521870|459143774|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
127595346|NCT02521870|459143775|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
127595347|NCT02521870|459143776|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
127595348|NCT02521870|459143777|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
127595349|NCT02521870|459143778|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
127595350|NCT02521870|459143779|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
127595351|NCT02521870|459143768|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
127595352|NCT02521870|459143769|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
127595353|NCT02521870|459143770|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
127595354|NCT02521870|459143771|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
127595355|NCT02521870|459143772|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
127595356|NCT02521870|459143773|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
127595357|NCT02521870|459143774|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
127595358|NCT02521870|459143775|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
127595359|NCT02521870|459143776|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
127595360|NCT02521870|459143777|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
127595361|NCT02521870|459143778|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
127595362|NCT02521870|459143779|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
127695394|NCT01261312|459512907|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
127695395|NCT01261312|459512908|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
127695396|NCT01261312|459512909|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
127695397|NCT01261312|459512910|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
127695398|NCT01261312|459512911|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
127695399|NCT01261312|459512912|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
127695400|NCT01261312|459512913|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
127695401|NCT01261312|459512914|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|4|||
127695402|NCT01261312|459512915|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|1|||
127695403|NCT01261312|459512916|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
127695404|NCT01261312|459512904|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
127695405|NCT01261312|459512905|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
127695406|NCT01261312|459512906|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
127695407|NCT01261312|459512907|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
127695408|NCT01261312|459512908|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
127695409|NCT01261312|459512909|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
127695410|NCT01261312|459512910|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
127695411|NCT01261312|459512911|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
127695412|NCT01261312|459512912|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
127695413|NCT01261312|459512913|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
127695414|NCT01261312|459512914|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|6|||
127695415|NCT01261312|459512915|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|3|||
127786508|NCT02090413|459842921|FG000|Overall Study|Investigator Decision|1|||
127786509|NCT02090413|459842922|FG001|Overall Study|Investigator Decision|1|||
127786510|NCT02090413|459842923|FG002|Overall Study|Investigator Decision|0|||
127786511|NCT02090413|459842921|FG000|Overall Study|Other|2|||
127786512|NCT02090413|459842922|FG001|Overall Study|Other|1|||
127786513|NCT02090413|459842923|FG002|Overall Study|Other|0|||
127786514|NCT02090413|459842921|FG000|Overall Study|Lost to Follow-up|1|||
127786515|NCT02090413|459842922|FG001|Overall Study|Lost to Follow-up|1|||
127786516|NCT02090413|459842923|FG002|Overall Study|Lost to Follow-up|0|||
127786517|NCT02321930|459842929|FG000|Overall Study|Lost to Follow-up|1|||
127786518|NCT01293968|459842930|FG000|Overall Study|non-cooperation|3|||
127786519|NCT01293968|459842931|FG001|Overall Study|non-cooperation|3|||
127786520|NCT01484977|459842932|FG000|Overall Study|Adverse Event|8|||
127786521|NCT01484977|459842932|FG000|Overall Study|Lack of Efficacy|4|||
127786522|NCT01484977|459842932|FG000|Overall Study|Protocol Violation|6|||
127786523|NCT01484977|459842932|FG000|Overall Study|Lost to Follow-up|1|||
127786524|NCT01484977|459842932|FG000|Overall Study|Withdrawal by Subject|4|||
127786525|NCT01484977|459842932|FG000|Overall Study|Subject Protocol Non-compliant|1|||
127786526|NCT01484977|459842932|FG000|Overall Study|Moving Overseas|1|||
127786527|NCT01484977|459842932|FG000|Overall Study|Low White Blood Cell Count|1|||
127786528|NCT01484977|459842932|FG000|Overall Study|Lack of Compliance|1|||
127786529|NCT00853749|459842933|FG000|Overall Study|Lost to Follow-up|0|||
127786530|NCT00853749|459842934|FG001|Overall Study|Lost to Follow-up|1|||
127786531|NCT04857996|459842935|FG000|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|4|||
127786532|NCT04857996|459842936|FG001|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|5|||
127786533|NCT04857996|459842935|FG000|Overall Study|Lost to Follow-up|1|||
127786534|NCT04857996|459842936|FG001|Overall Study|Lost to Follow-up|3|||
127786535|NCT04857996|459842935|FG000|Overall Study|Site Closure|1|||
127786536|NCT04857996|459842936|FG001|Overall Study|Site Closure|0|||
127786537|NCT04857996|459842935|FG000|Overall Study|Withdrawal by Subject|1|||
127786538|NCT04857996|459842936|FG001|Overall Study|Withdrawal by Subject|0|||
127786539|NCT02269787|459842937|FG000|Overall Study|Lost to Follow-up|20|||
127786540|NCT02269787|459842938|FG001|Overall Study|Lost to Follow-up|6|||
127786541|NCT02269787|459842937|FG000|Overall Study|Death|2|||
127786542|NCT02269787|459842938|FG001|Overall Study|Death|3|||
127695416|NCT01261312|459512916|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
127786543|NCT02269787|459842937|FG000|Overall Study|Incapacitated|0|||
127786544|NCT02269787|459842938|FG001|Overall Study|Incapacitated|1|||
127786545|NCT00798135|459842939|FG000|Overall Study|Disease progression, relapse|11|||
127786546|NCT00798135|459842939|FG000|Overall Study|Disease progression, refractory|1|||
127786547|NCT00798135|459842939|FG000|Overall Study|Physician Decision|1|||
127786548|NCT02228720|459842940|FG000|Open Label - Day 30|Lost to Follow-up|1|||
127786549|NCT01392677|459842943|FG000|Overall Study|Adverse Event|3|||
127786550|NCT01392677|459842944|FG001|Overall Study|Adverse Event|1|||
127786551|NCT01392677|459842943|FG000|Overall Study|Withdrawal by Subject|0|||
127786552|NCT01392677|459842944|FG001|Overall Study|Withdrawal by Subject|2|||
127786553|NCT01392677|459842943|FG000|Overall Study|Incorrect enrollment|2|||
127695417|NCT01261312|459512904|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
127695418|NCT01261312|459512905|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
127695419|NCT01261312|459512906|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
127695420|NCT01261312|459512907|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
127695421|NCT01261312|459512908|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
127695422|NCT01261312|459512909|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
127695423|NCT01261312|459512910|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
127695424|NCT01261312|459512911|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
127695425|NCT01261312|459512912|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
127695426|NCT01261312|459512913|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|3|||
127695427|NCT01261312|459512914|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|1|||
127695428|NCT01261312|459512915|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|6|||
127695429|NCT01261312|459512916|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|4|||
127695430|NCT01261312|459512904|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
127695431|NCT01261312|459512905|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
127786554|NCT01392677|459842944|FG001|Overall Study|Incorrect enrollment|3|||
127786555|NCT01392677|459842943|FG000|Overall Study|Other reason|3|||
127786556|NCT01392677|459842944|FG001|Overall Study|Other reason|2|||
127786557|NCT03996876|459842945|FG000|Overall Study|Incomplete Data|2|||
127786558|NCT03996876|459842946|FG001|Overall Study|Incomplete Data|4|||
127786559|NCT03080883|459842949|FG000|Overall Study|Withdrawal by Subject|11|||
127786560|NCT03080883|459842950|FG001|Overall Study|Withdrawal by Subject|15|||
127786561|NCT03080883|459842949|FG000|Overall Study|Adverse Event|22|||
127786562|NCT03080883|459842950|FG001|Overall Study|Adverse Event|22|||
127786563|NCT03080883|459842949|FG000|Overall Study|Alternative Therapy|0|||
127786564|NCT03080883|459842950|FG001|Overall Study|Alternative Therapy|3|||
127786565|NCT03080883|459842949|FG000|Overall Study|Other Complicating Disease|9|||
127786566|NCT03080883|459842950|FG001|Overall Study|Other Complicating Disease|5|||
127786567|NCT03080883|459842949|FG000|Overall Study|Death|21|||
127786568|NCT03080883|459842950|FG001|Overall Study|Death|16|||
127786569|NCT03080883|459842949|FG000|Overall Study|Physician Decision|2|||
127786570|NCT03080883|459842950|FG001|Overall Study|Physician Decision|2|||
127786571|NCT03080883|459842949|FG000|Overall Study|Disease Progression|2|||
127786572|NCT03080883|459842950|FG001|Overall Study|Disease Progression|8|||
127786573|NCT03080883|459842949|FG000|Overall Study|Lost to Follow-up|1|||
127786574|NCT03080883|459842950|FG001|Overall Study|Lost to Follow-up|1|||
127798475|NCT01789970|459885614|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
127798476|NCT01789970|459885615|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
127798477|NCT01789970|459885613|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
127798478|NCT01789970|459885614|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
127798479|NCT01789970|459885615|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
127798480|NCT01789970|459885613|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
127798481|NCT01789970|459885614|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
127798482|NCT01789970|459885615|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
127798483|NCT01789970|459885613|FG000|Open-label Titration Period|Pregnancy|2|||
127798484|NCT01789970|459885614|FG001|Open-label Titration Period|Pregnancy|0|||
127798485|NCT01789970|459885615|FG002|Open-label Titration Period|Pregnancy|0|||
127798486|NCT01789970|459885613|FG000|Open-label Titration Period|Other|76|||
127798487|NCT01789970|459885614|FG001|Open-label Titration Period|Other|0|||
127798488|NCT01789970|459885615|FG002|Open-label Titration Period|Other|0|||
127798489|NCT01789970|459885613|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
127798490|NCT01789970|459885614|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
127798491|NCT01789970|459885615|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
127798492|NCT01789970|459885613|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
127798493|NCT01789970|459885614|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
127798494|NCT01789970|459885615|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
127695432|NCT01261312|459512906|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
127798495|NCT01789970|459885613|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
127798496|NCT01789970|459885614|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
127798497|NCT01789970|459885615|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
127798498|NCT01789970|459885613|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
127798499|NCT01789970|459885614|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
127798500|NCT01789970|459885615|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
127798501|NCT01789970|459885613|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
127798502|NCT01789970|459885614|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
127798503|NCT01789970|459885615|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
127798504|NCT01789970|459885613|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
127798505|NCT01789970|459885614|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
127595363|NCT02521870|459143768|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
127595364|NCT02521870|459143769|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
127595365|NCT02521870|459143770|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
127595366|NCT02521870|459143771|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
127595367|NCT02521870|459143772|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
127595368|NCT02521870|459143773|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
127595369|NCT02521870|459143774|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
127595370|NCT02521870|459143775|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
127595371|NCT02521870|459143776|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
127595372|NCT02521870|459143777|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
127595373|NCT02521870|459143778|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
127595374|NCT02521870|459143779|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
127595375|NCT02521870|459143768|FG000|Phase 2: Dose Expansion|Death|0|||
127595376|NCT02521870|459143769|FG001|Phase 2: Dose Expansion|Death|0|||
127595377|NCT02521870|459143770|FG002|Phase 2: Dose Expansion|Death|0|||
127595378|NCT02521870|459143771|FG003|Phase 2: Dose Expansion|Death|0|||
127595379|NCT02521870|459143772|FG004|Phase 2: Dose Expansion|Death|1|||
127595380|NCT02521870|459143773|FG005|Phase 2: Dose Expansion|Death|1|||
127595381|NCT02521870|459143774|FG006|Phase 2: Dose Expansion|Death|3|||
127595382|NCT02521870|459143775|FG007|Phase 2: Dose Expansion|Death|1|||
127595383|NCT02521870|459143776|FG008|Phase 2: Dose Expansion|Death|1|||
127595384|NCT02521870|459143777|FG009|Phase 2: Dose Expansion|Death|5|||
127595385|NCT02521870|459143778|FG010|Phase 2: Dose Expansion|Death|2|||
127595386|NCT02521870|459143779|FG011|Phase 2: Dose Expansion|Death|2|||
127595387|NCT02521870|459143768|FG000|Phase 2: Dose Expansion|Other|0|||
127595388|NCT02521870|459143769|FG001|Phase 2: Dose Expansion|Other|0|||
127595389|NCT02521870|459143770|FG002|Phase 2: Dose Expansion|Other|0|||
127595390|NCT02521870|459143771|FG003|Phase 2: Dose Expansion|Other|0|||
127595391|NCT02521870|459143772|FG004|Phase 2: Dose Expansion|Other|10|||
127595392|NCT02521870|459143773|FG005|Phase 2: Dose Expansion|Other|3|||
127595393|NCT02521870|459143774|FG006|Phase 2: Dose Expansion|Other|2|||
127595394|NCT02521870|459143775|FG007|Phase 2: Dose Expansion|Other|0|||
127595395|NCT02521870|459143776|FG008|Phase 2: Dose Expansion|Other|10|||
127595396|NCT02521870|459143777|FG009|Phase 2: Dose Expansion|Other|5|||
127595397|NCT02521870|459143778|FG010|Phase 2: Dose Expansion|Other|1|||
127595398|NCT02521870|459143779|FG011|Phase 2: Dose Expansion|Other|7|||
127595399|NCT02521870|459143768|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
127595400|NCT02521870|459143769|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
127595401|NCT02521870|459143770|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
127595402|NCT02521870|459143771|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
127595403|NCT02521870|459143772|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
127595404|NCT02521870|459143773|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
127595405|NCT02521870|459143774|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
127595406|NCT02521870|459143775|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
127595407|NCT02521870|459143776|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
127595408|NCT02521870|459143777|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
127595409|NCT02521870|459143778|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
127595410|NCT02521870|459143779|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
127595411|NCT02521870|459143768|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
127595412|NCT02521870|459143769|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
127595413|NCT02521870|459143770|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
127595414|NCT02521870|459143771|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
127595415|NCT02521870|459143772|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
127595416|NCT02521870|459143773|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
127595417|NCT02521870|459143774|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
127595418|NCT02521870|459143775|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
127595419|NCT02521870|459143776|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
127595420|NCT02521870|459143777|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
127595421|NCT02521870|459143778|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
127595422|NCT02521870|459143779|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
127595423|NCT00519831|459143780|FG000|Overall Study|Adverse Event|3|||
127595424|NCT02854631|459143781|FG000|Overall Study|Adverse Event|1|||
127882358|NCT01222715|460192761|FG000|Overall Study|Ineligible|0|||
127882359|NCT01222715|460192762|FG001|Overall Study|Ineligible|1|||
127882360|NCT01222715|460192761|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
127882361|NCT01222715|460192762|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
127882362|NCT03555890|460192771|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
127595425|NCT02854631|459143782|FG001|Overall Study|Adverse Event|2|||
127595426|NCT02854631|459143781|FG000|Overall Study|Withdrew Consent|3|||
127595427|NCT02854631|459143782|FG001|Overall Study|Withdrew Consent|2|||
127595428|NCT02854631|459143781|FG000|Overall Study|Investigator's Discretion|2|||
127595429|NCT02854631|459143782|FG001|Overall Study|Investigator's Discretion|0|||
127595430|NCT02854631|459143781|FG000|Overall Study|Death|12|||
127595431|NCT02854631|459143782|FG001|Overall Study|Death|8|||
127595432|NCT02854631|459143781|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
127595433|NCT02854631|459143782|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
127595434|NCT02854631|459143781|FG000|Overall Study|Protocol Violation|0|||
127595435|NCT02854631|459143782|FG001|Overall Study|Protocol Violation|1|||
127595436|NCT02854631|459143781|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
127595437|NCT02854631|459143782|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
127595438|NCT02854631|459143781|FG000|Overall Study|Lost to Follow-up|4|||
127595439|NCT02854631|459143782|FG001|Overall Study|Lost to Follow-up|2|||
127882363|NCT03555890|460192772|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
127882364|NCT03555890|460192773|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
127595440|NCT00844896|459143783|FG000|Overall Study|Lost to Follow-up|12|||
127595441|NCT00844896|459143784|FG001|Overall Study|Lost to Follow-up|16|||
127595442|NCT00844896|459143783|FG000|Overall Study|Parents did not have time to complete|0|||
127595443|NCT00844896|459143784|FG001|Overall Study|Parents did not have time to complete|1|||
127695433|NCT01261312|459512907|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
127695434|NCT01261312|459512908|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
127695435|NCT01261312|459512909|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
127695436|NCT01261312|459512910|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
127695437|NCT01261312|459512911|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
127695438|NCT01261312|459512912|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
127695439|NCT01261312|459512913|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
127695440|NCT01261312|459512914|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
127695441|NCT01261312|459512915|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
127695442|NCT01261312|459512916|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|1|||
127695443|NCT04401800|459512926|FG000|Overall Study|Death|17|||
127695444|NCT04401800|459512926|FG000|Overall Study|Lost to Follow-up|5|||
127695445|NCT04401800|459512926|FG000|Overall Study|Withdrawal by Subject|4|||
127695446|NCT02783300|459512933|FG000|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
127695447|NCT02783300|459512934|FG001|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
127695448|NCT02783300|459512935|FG002|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
127695449|NCT02783300|459512936|FG003|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
127695450|NCT02783300|459512937|FG004|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
127695451|NCT02783300|459512938|FG005|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
127695452|NCT02783300|459512939|FG006|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|1|||
127695453|NCT02783300|459512940|FG007|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
127695454|NCT02783300|459512941|FG008|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
127695455|NCT02783300|459512942|FG009|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
127695456|NCT02783300|459512943|FG010|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
127695457|NCT02783300|459512944|FG011|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
127695458|NCT02783300|459512945|FG012|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
127695459|NCT02783300|459512946|FG013|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
127695460|NCT02783300|459512947|FG014|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
127695461|NCT02783300|459512948|FG015|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
127695462|NCT02783300|459512949|FG016|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
127695463|NCT02783300|459512950|FG017|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
127695464|NCT02783300|459512951|FG018|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
127695465|NCT02783300|459512952|FG019|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
127695466|NCT02783300|459512953|FG020|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
127695467|NCT02783300|459512954|FG021|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
127695468|NCT02783300|459512955|FG022|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
127695469|NCT02783300|459512956|FG023|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
127695470|NCT02783300|459512957|FG024|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
127695471|NCT02783300|459512958|FG025|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
127695472|NCT02783300|459512959|FG026|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
127695473|NCT02783300|459512933|FG000|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
127695474|NCT02783300|459512934|FG001|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
127695475|NCT02783300|459512935|FG002|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
127695476|NCT02783300|459512936|FG003|Part 1- Dose Escalation Phase|Lost to Follow-up|1|||
127695477|NCT02783300|459512937|FG004|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
127695478|NCT02783300|459512938|FG005|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
127695479|NCT02783300|459512939|FG006|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
127695480|NCT02783300|459512940|FG007|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
127695481|NCT02783300|459512941|FG008|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
127695482|NCT02783300|459512942|FG009|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
127695483|NCT02783300|459512943|FG010|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
127695484|NCT02783300|459512944|FG011|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
127595444|NCT02233647|459143788|FG000|Overall Study|Adverse Event|1|||
127595445|NCT04342897|459143789|FG000|Overall Study|Death|7|||
127595446|NCT04342897|459143790|FG001|Overall Study|Death|4|||
127595447|NCT04342897|459143789|FG000|Overall Study|Lost to Follow-up|6|||
127595448|NCT04342897|459143790|FG001|Overall Study|Lost to Follow-up|6|||
127595449|NCT04342897|459143789|FG000|Overall Study|Withdrawal by Subject|1|||
127595450|NCT04342897|459143790|FG001|Overall Study|Withdrawal by Subject|2|||
127595451|NCT02634320|459143792|FG000|Overall Study|Adverse Event|2|||
127595452|NCT02634320|459143792|FG000|Overall Study|Lost to Follow-up|3|||
127595453|NCT02634320|459143792|FG000|Overall Study|Moved out of area|2|||
127595454|NCT02634320|459143792|FG000|Overall Study|Out of window for study visits|1|||
127595455|NCT02634320|459143792|FG000|Overall Study|Protocol Violation|1|||
127595456|NCT02634320|459143792|FG000|Overall Study|Withdrawal by Subject|5|||
127595457|NCT02634320|459143792|FG000|Overall Study|Lack of Efficacy|2|||
127595458|NCT04656691|459143799|FG000|Overall Study|Adverse Event|1|||
127595459|NCT03199274|459143800|FG000|Overall Study|Withdrawal by Subject|4|||
127595460|NCT03199274|459143801|FG001|Overall Study|Withdrawal by Subject|0|||
127595461|NCT03199274|459143800|FG000|Overall Study|Lost to Follow-up|0|||
127595462|NCT03199274|459143801|FG001|Overall Study|Lost to Follow-up|1|||
127595463|NCT03199274|459143800|FG000|Overall Study|Deemed screen fail because he had no arteries to access during flow study|0|||
127595464|NCT03199274|459143801|FG001|Overall Study|Deemed screen fail because he had no arteries to access during flow study|1|||
127595465|NCT05980182|459143807|FG000|Overall Study|Lost to Follow-up|10|||
127595466|NCT00410046|459145512|FG000|Overall Study|Adverse Event|3|||
127595467|NCT00410046|459145512|FG000|Overall Study|Withdrawal by Subject|1|||
127595468|NCT00410046|459145512|FG000|Overall Study|Lost to Follow-up|1|||
127595469|NCT03098550|459145513|FG000|Overall Study|Disease Progression|30|||
127595470|NCT03098550|459145514|FG001|Overall Study|Disease Progression|19|||
127595471|NCT03098550|459145515|FG002|Overall Study|Disease Progression|41|||
127595472|NCT03098550|459145513|FG000|Overall Study|Study Drug Toxicity|2|||
127595473|NCT03098550|459145514|FG001|Overall Study|Study Drug Toxicity|1|||
127595474|NCT03098550|459145515|FG002|Overall Study|Study Drug Toxicity|0|||
127595475|NCT03098550|459145513|FG000|Overall Study|Death|1|||
127595476|NCT03098550|459145514|FG001|Overall Study|Death|0|||
127595477|NCT03098550|459145515|FG002|Overall Study|Death|0|||
127595478|NCT03098550|459145513|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
127595479|NCT03098550|459145514|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
127595480|NCT03098550|459145515|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
127595481|NCT03098550|459145513|FG000|Overall Study|Administrative reason by sponsor|0|||
127595482|NCT03098550|459145514|FG001|Overall Study|Administrative reason by sponsor|0|||
127595483|NCT03098550|459145515|FG002|Overall Study|Administrative reason by sponsor|1|||
127595484|NCT03098550|459145513|FG000|Overall Study|Other reasons|2|||
127595485|NCT03098550|459145514|FG001|Overall Study|Other reasons|0|||
127595486|NCT03098550|459145515|FG002|Overall Study|Other reasons|0|||
127595487|NCT00482612|459145526|FG000|In-treatment Period|No study medication administered|0|||
127595488|NCT00482612|459145527|FG001|In-treatment Period|No study medication administered|0|||
127595489|NCT00482612|459145528|FG002|In-treatment Period|No study medication administered|1|||
127595490|NCT00482612|459145529|FG003|In-treatment Period|No study medication administered|0|||
127595491|NCT00482612|459145526|FG000|Follow-up Period|Other|4|||
127595492|NCT00482612|459145527|FG001|Follow-up Period|Other|2|||
127595493|NCT00482612|459145528|FG002|Follow-up Period|Other|1|||
127595494|NCT00482612|459145529|FG003|Follow-up Period|Other|2|||
127595495|NCT00482612|459145526|FG000|Follow-up Period|Lack of compliance|0|||
127595496|NCT00482612|459145527|FG001|Follow-up Period|Lack of compliance|0|||
127595497|NCT00482612|459145528|FG002|Follow-up Period|Lack of compliance|1|||
127595498|NCT00482612|459145529|FG003|Follow-up Period|Lack of compliance|0|||
127595499|NCT00482612|459145526|FG000|Follow-up Period|Lost to Follow-up|0|||
127595500|NCT00482612|459145527|FG001|Follow-up Period|Lost to Follow-up|4|||
127595501|NCT00482612|459145528|FG002|Follow-up Period|Lost to Follow-up|2|||
127595502|NCT00482612|459145529|FG003|Follow-up Period|Lost to Follow-up|1|||
127595503|NCT00482612|459145526|FG000|Follow-up Period|Adverse Event|4|||
127595504|NCT00482612|459145527|FG001|Follow-up Period|Adverse Event|7|||
127595505|NCT00482612|459145528|FG002|Follow-up Period|Adverse Event|9|||
127595506|NCT00482612|459145529|FG003|Follow-up Period|Adverse Event|0|||
127695485|NCT02783300|459512945|FG012|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
127695486|NCT02783300|459512946|FG013|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
127695487|NCT02783300|459512947|FG014|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
127695488|NCT02783300|459512948|FG015|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
127695489|NCT02783300|459512949|FG016|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
127595507|NCT00482612|459145526|FG000|Follow-up Period|Lack of Efficacy|2|||
127595508|NCT00482612|459145527|FG001|Follow-up Period|Lack of Efficacy|0|||
127595509|NCT00482612|459145528|FG002|Follow-up Period|Lack of Efficacy|1|||
127595510|NCT00482612|459145529|FG003|Follow-up Period|Lack of Efficacy|0|||
127595511|NCT00482612|459145526|FG000|Follow-up Period|Withdrawal by Subject|3|||
127595512|NCT00482612|459145527|FG001|Follow-up Period|Withdrawal by Subject|5|||
127595513|NCT00482612|459145528|FG002|Follow-up Period|Withdrawal by Subject|7|||
127695490|NCT02783300|459512950|FG017|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
127595514|NCT00482612|459145529|FG003|Follow-up Period|Withdrawal by Subject|2|||
127595515|NCT00482612|459145526|FG000|Follow-up Period|Reasons not related to trial|1|||
127595516|NCT00482612|459145527|FG001|Follow-up Period|Reasons not related to trial|0|||
127595517|NCT00482612|459145528|FG002|Follow-up Period|Reasons not related to trial|1|||
127595518|NCT00482612|459145529|FG003|Follow-up Period|Reasons not related to trial|3|||
127595519|NCT01366521|459145530|FG000|Overall Study|Adverse Event|1|||
127595520|NCT01366521|459145531|FG001|Overall Study|Adverse Event|0|||
127595521|NCT01366521|459145532|FG002|Overall Study|Adverse Event|0|||
127595522|NCT01366521|459145533|FG003|Overall Study|Adverse Event|0|||
127595523|NCT01366521|459145530|FG000|Overall Study|Protocol Violation|0|||
127595524|NCT01366521|459145531|FG001|Overall Study|Protocol Violation|0|||
127595525|NCT01366521|459145532|FG002|Overall Study|Protocol Violation|1|||
127595526|NCT01366521|459145533|FG003|Overall Study|Protocol Violation|0|||
127595527|NCT01366521|459145530|FG000|Overall Study|Physician Decision|0|||
127595528|NCT01366521|459145531|FG001|Overall Study|Physician Decision|0|||
127595529|NCT01366521|459145532|FG002|Overall Study|Physician Decision|1|||
127595530|NCT01366521|459145533|FG003|Overall Study|Physician Decision|0|||
127595531|NCT01366521|459145530|FG000|Overall Study|Withdrawal by Subject|0|||
127595532|NCT01366521|459145531|FG001|Overall Study|Withdrawal by Subject|1|||
127595533|NCT01366521|459145532|FG002|Overall Study|Withdrawal by Subject|0|||
127595534|NCT01366521|459145533|FG003|Overall Study|Withdrawal by Subject|0|||
127595535|NCT00684307|459145534|FG000|Overall Study|Adverse Event|11|||
127595536|NCT00684307|459145535|FG001|Overall Study|Adverse Event|6|||
127595537|NCT00684307|459145536|FG002|Overall Study|Adverse Event|15|||
127595538|NCT00684307|459145537|FG003|Overall Study|Adverse Event|16|||
127595539|NCT00684307|459145538|FG004|Overall Study|Adverse Event|8|||
127595540|NCT00684307|459145534|FG000|Overall Study|Development of increasing Liver Function|0|||
127595541|NCT00684307|459145535|FG001|Overall Study|Development of increasing Liver Function|2|||
127595542|NCT00684307|459145536|FG002|Overall Study|Development of increasing Liver Function|0|||
127595543|NCT00684307|459145537|FG003|Overall Study|Development of increasing Liver Function|1|||
127595544|NCT00684307|459145538|FG004|Overall Study|Development of increasing Liver Function|0|||
127595545|NCT00684307|459145534|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
127595546|NCT00684307|459145535|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
127595547|NCT00684307|459145536|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
127595548|NCT00684307|459145537|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
127595549|NCT00684307|459145538|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
127595550|NCT00684307|459145534|FG000|Overall Study|Incorrect enrolment or randomization|4|||
127595551|NCT00684307|459145535|FG001|Overall Study|Incorrect enrolment or randomization|0|||
127595552|NCT00684307|459145536|FG002|Overall Study|Incorrect enrolment or randomization|0|||
127595553|NCT00684307|459145537|FG003|Overall Study|Incorrect enrolment or randomization|0|||
127595554|NCT00684307|459145538|FG004|Overall Study|Incorrect enrolment or randomization|0|||
127595555|NCT00684307|459145534|FG000|Overall Study|Interupted IP for more than 7 days|0|||
127595556|NCT00684307|459145535|FG001|Overall Study|Interupted IP for more than 7 days|4|||
127595557|NCT00684307|459145536|FG002|Overall Study|Interupted IP for more than 7 days|1|||
127595558|NCT00684307|459145537|FG003|Overall Study|Interupted IP for more than 7 days|3|||
127595559|NCT00684307|459145538|FG004|Overall Study|Interupted IP for more than 7 days|3|||
127595560|NCT00684307|459145534|FG000|Overall Study|Severe non compliance to protocol|1|||
127595561|NCT00684307|459145535|FG001|Overall Study|Severe non compliance to protocol|0|||
127595562|NCT00684307|459145536|FG002|Overall Study|Severe non compliance to protocol|0|||
127595563|NCT00684307|459145537|FG003|Overall Study|Severe non compliance to protocol|1|||
127595564|NCT00684307|459145538|FG004|Overall Study|Severe non compliance to protocol|2|||
127595565|NCT00684307|459145534|FG000|Overall Study|Participant not willing to continue|7|||
127595566|NCT00684307|459145535|FG001|Overall Study|Participant not willing to continue|10|||
127595567|NCT00684307|459145536|FG002|Overall Study|Participant not willing to continue|11|||
127595568|NCT00684307|459145537|FG003|Overall Study|Participant not willing to continue|5|||
127595569|NCT00684307|459145538|FG004|Overall Study|Participant not willing to continue|8|||
127595570|NCT00684307|459145534|FG000|Overall Study|Criteria from the CSR|0|||
127595571|NCT00684307|459145535|FG001|Overall Study|Criteria from the CSR|0|||
127595572|NCT00684307|459145536|FG002|Overall Study|Criteria from the CSR|1|||
127595573|NCT00684307|459145537|FG003|Overall Study|Criteria from the CSR|3|||
127595574|NCT00684307|459145538|FG004|Overall Study|Criteria from the CSR|3|||
127595575|NCT00759031|459145539|FG000|First Intervention (1 Day)|Physician Decision|1|||
127595576|NCT00759031|459145540|FG001|First Intervention (1 Day)|Physician Decision|0|||
127595577|NCT00759031|459145539|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
127595578|NCT00759031|459145540|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
127595579|NCT00759031|459145539|FG000|First Intervention (1 Day)|Screening failure|1|||
127595580|NCT00759031|459145540|FG001|First Intervention (1 Day)|Screening failure|0|||
127595581|NCT01599234|459145543|FG000|Overall Study|Adverse Event|9|||
127595582|NCT01599234|459145544|FG001|Overall Study|Adverse Event|5|||
127595583|NCT01599234|459145543|FG000|Overall Study|Withdrawal by Subject|2|||
127595584|NCT01599234|459145544|FG001|Overall Study|Withdrawal by Subject|1|||
127595585|NCT01599234|459145543|FG000|Overall Study|Lost to Follow-up|1|||
127695491|NCT02783300|459512951|FG018|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
127786575|NCT04360551|459844311|FG000|Overall Study|Withdrawal by Subject|1|||
127786576|NCT04360551|459844312|FG001|Overall Study|Withdrawal by Subject|0|||
127786577|NCT00388973|459844317|FG000|Overall Study|Adverse Event|16|||
127786578|NCT00388973|459844318|FG001|Overall Study|Adverse Event|6|||
127786579|NCT00388973|459844317|FG000|Overall Study|Lack of Efficacy|1|||
127786580|NCT00388973|459844318|FG001|Overall Study|Lack of Efficacy|12|||
127786581|NCT00388973|459844317|FG000|Overall Study|Protocol Violation|3|||
127786582|NCT00388973|459844318|FG001|Overall Study|Protocol Violation|0|||
127786583|NCT00388973|459844317|FG000|Overall Study|Withdrawal by Subject|14|||
127786584|NCT00388973|459844318|FG001|Overall Study|Withdrawal by Subject|17|||
127786585|NCT00388973|459844317|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
127786586|NCT00388973|459844318|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
127882365|NCT03555890|460192774|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
127882366|NCT03372369|460192775|FG000|Qualification Period|Withdrawal by Subject|16|||
127595586|NCT01599234|459145544|FG001|Overall Study|Lost to Follow-up|2|||
127595587|NCT01599234|459145543|FG000|Overall Study|Lack of Efficacy|2|||
127595588|NCT01599234|459145544|FG001|Overall Study|Lack of Efficacy|4|||
127595589|NCT01599234|459145543|FG000|Overall Study|Unable to operate spray|1|||
127595590|NCT01599234|459145544|FG001|Overall Study|Unable to operate spray|0|||
127595591|NCT01599234|459145543|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
127595592|NCT01599234|459145544|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
127595593|NCT01599234|459145543|FG000|Overall Study|Death|1|||
127595594|NCT01599234|459145544|FG001|Overall Study|Death|0|||
127595595|NCT01599234|459145543|FG000|Overall Study|Patient would not stop driving|1|||
127595596|NCT01599234|459145544|FG001|Overall Study|Patient would not stop driving|0|||
127595597|NCT01599234|459145543|FG000|Overall Study|Contra-indication discovered|0|||
127595598|NCT01599234|459145544|FG001|Overall Study|Contra-indication discovered|1|||
127595599|NCT01599234|459145543|FG000|Overall Study|Pregnancy|0|||
127595600|NCT01599234|459145544|FG001|Overall Study|Pregnancy|1|||
127595601|NCT02899988|459145546|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
127595602|NCT02899988|459145547|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
127595603|NCT02899988|459145548|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
127595604|NCT02899988|459145549|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
127595605|NCT02899988|459145550|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
127595606|NCT02899988|459145551|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
127595607|NCT02899988|459145552|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
127595608|NCT02899988|459145553|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
127595609|NCT02899988|459145554|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
127595610|NCT02899988|459145555|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
127595611|NCT02899988|459145556|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
127595612|NCT02899988|459145546|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
127595613|NCT02899988|459145547|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
127595614|NCT02899988|459145548|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
127595615|NCT02899988|459145549|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
127595616|NCT02899988|459145550|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
127595617|NCT02899988|459145551|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
127595618|NCT02899988|459145552|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
127595619|NCT02899988|459145553|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
127595620|NCT02899988|459145554|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
127595621|NCT02899988|459145555|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
127595622|NCT02899988|459145556|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
127595623|NCT02899988|459145546|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
127595624|NCT02899988|459145547|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
127595625|NCT02899988|459145548|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
127595626|NCT02899988|459145549|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
127595627|NCT02899988|459145550|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
127595628|NCT02899988|459145551|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
127595629|NCT02899988|459145552|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
127595630|NCT02899988|459145553|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
127595631|NCT02899988|459145554|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
127595632|NCT02899988|459145555|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
127595633|NCT02899988|459145556|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
127595634|NCT02899988|459145546|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
127595635|NCT02899988|459145547|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
127595636|NCT02899988|459145548|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
127595637|NCT02899988|459145549|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
127595638|NCT02899988|459145550|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
127595639|NCT02899988|459145551|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
127786587|NCT00388973|459844317|FG000|Overall Study|Did not complete 61 days of treatment|5|||
127786588|NCT00388973|459844318|FG001|Overall Study|Did not complete 61 days of treatment|4|||
127786589|NCT00388973|459844317|FG000|Overall Study|Left region|0|||
127786590|NCT00388973|459844318|FG001|Overall Study|Left region|1|||
127786591|NCT00388973|459844317|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
127786592|NCT00388973|459844318|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
127786593|NCT04179734|459844336|FG000|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|4|||
127786594|NCT04179734|459844337|FG001|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|3|||
127786595|NCT04179734|459844336|FG000|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|0|||
127786596|NCT04179734|459844337|FG001|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|2|||
127786597|NCT01761292|459844339|FG000|Part 1|Adverse Event|1|||
127786598|NCT01761292|459844339|FG000|Part 1|not receiving treatment in Part 1|1|||
127786599|NCT01761292|459844339|FG000|Extension 1|Withdrawal by Subject|1|||
127786600|NCT00840086|459844340|FG000|Overall Study|Adverse Event|1|||
127786601|NCT00840086|459844340|FG000|Overall Study|Protocol Violation|2|||
127786602|NCT00840086|459844340|FG000|Overall Study|Lost to Follow-up|1|||
127786603|NCT03332498|459844341|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
127786604|NCT03332498|459844342|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
127786605|NCT03332498|459844343|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
127786606|NCT04036708|459844344|FG000|Overall Study|Lost to Follow-up|14|||
127786607|NCT04036708|459844345|FG001|Overall Study|Lost to Follow-up|4|||
127786608|NCT04036708|459844346|FG002|Overall Study|Lost to Follow-up|14|||
127786609|NCT04036708|459844347|FG003|Overall Study|Lost to Follow-up|4|||
127786610|NCT01444742|459844350|FG000|Overall Study|Death|1|||
127786611|NCT03370120|459844353|FG000|Overall Study|Adverse event, non-fatal|24|||
127786612|NCT03370120|459844353|FG000|Overall Study|Withdrawal by Subject|6|||
127786613|NCT03370120|459844353|FG000|Overall Study|Lost to Follow-up|1|||
127786614|NCT03370120|459844353|FG000|Overall Study|Lack of Efficacy|37|||
127786615|NCT03370120|459844353|FG000|Overall Study|Per sponsor's instructions|1|||
127786616|NCT03370120|459844353|FG000|Overall Study|Study was terminated by parent company UCB|2|||
127786617|NCT03370120|459844353|FG000|Overall Study|The study was ended by the promoter|3|||
127786618|NCT03370120|459844353|FG000|Overall Study|Discontinuation of drug development|3|||
127786619|NCT03370120|459844353|FG000|Overall Study|End of project|2|||
127786620|NCT03370120|459844353|FG000|Overall Study|Premature study closure|2|||
127786621|NCT03370120|459844353|FG000|Overall Study|Premature program termination|1|||
127786622|NCT03370120|459844353|FG000|Overall Study|Premature study termination|7|||
127786623|NCT03370120|459844353|FG000|Overall Study|Trial terminated by sponsor|2|||
127786624|NCT03370120|459844353|FG000|Overall Study|Trial discontinued by sponsor|2|||
127786625|NCT03370120|459844353|FG000|Overall Study|Study ended|15|||
127786626|NCT03370120|459844353|FG000|Overall Study|Clinical trial has been cancelled|1|||
127786627|NCT03370120|459844353|FG000|Overall Study|End of study per sponsor decision|2|||
127786628|NCT03370120|459844353|FG000|Overall Study|Promoter's decision|2|||
127786629|NCT03370120|459844353|FG000|Overall Study|The trial has been suspended|3|||
127786630|NCT03370120|459844353|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
127786631|NCT03370120|459844353|FG000|Overall Study|Early termination by order of sponsor|2|||
127786632|NCT03370120|459844353|FG000|Overall Study|Discontinuation of the study|5|||
127786633|NCT03370120|459844353|FG000|Overall Study|End of clinical trial discontinuation|1|||
127786634|NCT03370120|459844353|FG000|Overall Study|Because the clinical trial ended halfway|4|||
127786635|NCT03370120|459844353|FG000|Overall Study|Development discontinued|5|||
127786636|NCT03370120|459844353|FG000|Overall Study|Padsenovil program closed|3|||
127882367|NCT03372369|460192776|FG001|Qualification Period|Withdrawal by Subject|13|||
128035302|NCT02958865|460757848|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
128035303|NCT02958865|460757849|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
127595640|NCT02899988|459145552|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
127595641|NCT02899988|459145553|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
127595642|NCT02899988|459145554|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
127595643|NCT02899988|459145555|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
127595644|NCT02899988|459145556|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
127595645|NCT02899988|459145546|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
127595646|NCT02899988|459145547|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
127595647|NCT02899988|459145548|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
127595648|NCT02899988|459145549|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
127595649|NCT02899988|459145550|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
127595650|NCT02899988|459145551|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
127595651|NCT02899988|459145552|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
127595652|NCT02899988|459145553|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
128035304|NCT02958865|460757850|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
128035305|NCT02958865|460757851|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
128035306|NCT02958865|460757852|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
128035307|NCT02958865|460757853|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
127595653|NCT02899988|459145554|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
127595654|NCT02899988|459145555|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
127595655|NCT02899988|459145556|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
127882368|NCT03372369|460192775|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
128035308|NCT02958865|460757854|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
127595656|NCT02899988|459145546|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
127595657|NCT02899988|459145547|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
127595658|NCT02899988|459145548|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
127595659|NCT02899988|459145549|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
127595660|NCT02899988|459145550|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
127595661|NCT02899988|459145551|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
127595662|NCT02899988|459145552|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
127595663|NCT02899988|459145553|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
127595664|NCT02899988|459145554|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
127595665|NCT02899988|459145555|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
127595666|NCT02899988|459145556|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
127595667|NCT01401283|459145557|FG000|Overall Study|surgery cancelled|5|||
127595668|NCT01401283|459145558|FG001|Overall Study|surgery cancelled|8|||
127595669|NCT01401283|459145557|FG000|Overall Study|preoperative arrhythmia|5|||
127595670|NCT01401283|459145558|FG001|Overall Study|preoperative arrhythmia|0|||
127595671|NCT01401283|459145557|FG000|Overall Study|no central venous access|0|||
127595672|NCT01401283|459145558|FG001|Overall Study|no central venous access|1|||
127595673|NCT01401283|459145557|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
127595674|NCT01401283|459145558|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
127595675|NCT02433483|459145559|FG000|Overall Study|Unacceptable toxicity|1|||
127595676|NCT02433483|459145559|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
127595677|NCT04271605|459145563|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
127595678|NCT02485301|459145564|FG000|Overall Study|Serious Adverse Events|2|||
127595679|NCT02485301|459145565|FG001|Overall Study|Serious Adverse Events|1|||
127595680|NCT02485301|459145564|FG000|Overall Study|Protocol Violation|0|||
127786637|NCT03370120|459844353|FG000|Overall Study|End of project|2|||
127786638|NCT03370120|459844353|FG000|Overall Study|Termination of project|1|||
127786639|NCT03370120|459844353|FG000|Overall Study|The study was interrupted by sponsor|4|||
127786640|NCT03370120|459844353|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
127786641|NCT03370120|459844353|FG000|Overall Study|End of sponsor decision|1|||
127786642|NCT03370120|459844353|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
127786643|NCT03370120|459844353|FG000|Overall Study|Early termination of studies|5|||
127786644|NCT03370120|459844353|FG000|Overall Study|This study is ended early|1|||
127786645|NCT03370120|459844353|FG000|Overall Study|End of padsevonil program|2|||
127786646|NCT03370120|459844353|FG000|Overall Study|Decision of sponsor|6|||
127786647|NCT03370120|459844353|FG000|Overall Study|Asked by the sponsor|3|||
127786648|NCT03370120|459844353|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
127786649|NCT03370120|459844353|FG000|Overall Study|PI decision poor compliance from participant|1|||
127786650|NCT03370120|459844353|FG000|Overall Study|Promoter ended the study|3|||
127786651|NCT03370120|459844353|FG000|Overall Study|Premature study close by sponsor's decision|4|||
127786652|NCT03370120|459844353|FG000|Overall Study|Study terminated by sponsor|33|||
127786653|NCT03370120|459844353|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
127786654|NCT03370120|459844353|FG000|Overall Study|Sponsor decision to terminate study|63|||
127786655|NCT03370120|459844353|FG000|Overall Study|Program closure|3|||
127786656|NCT03370120|459844353|FG000|Overall Study|Study ended prematurely|1|||
127786657|NCT03370120|459844353|FG000|Overall Study|Study stopped by sponsor|2|||
127786658|NCT03370120|459844353|FG000|Overall Study|Program termination|55|||
127786659|NCT03370120|459844353|FG000|Overall Study|Sponsor decision|62|||
127786660|NCT03370120|459844353|FG000|Overall Study|Sponsor study closure|10|||
127786661|NCT04206020|459844355|FG000|Overall Study|Adverse Event|1|||
127786662|NCT04206020|459844356|FG001|Overall Study|Adverse Event|4|||
127786663|NCT04206020|459844355|FG000|Overall Study|Protocol Violation|2|||
127786664|NCT04206020|459844356|FG001|Overall Study|Protocol Violation|0|||
127786665|NCT04206020|459844355|FG000|Overall Study|Withdrawal by Subject|2|||
127786666|NCT04206020|459844356|FG001|Overall Study|Withdrawal by Subject|0|||
127786667|NCT04206020|459844355|FG000|Overall Study|Lost to Follow-up|2|||
127786668|NCT04206020|459844356|FG001|Overall Study|Lost to Follow-up|0|||
127786669|NCT04206020|459844355|FG000|Overall Study|Pregnancy|0|||
127786670|NCT04206020|459844356|FG001|Overall Study|Pregnancy|1|||
127786671|NCT04206020|459844355|FG000|Overall Study|Unable to attend visits|1|||
127786672|NCT04206020|459844356|FG001|Overall Study|Unable to attend visits|2|||
127882369|NCT03372369|460192776|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
127882370|NCT03372369|460192775|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
127595681|NCT02485301|459145565|FG001|Overall Study|Protocol Violation|1|||
127595682|NCT02485301|459145564|FG000|Overall Study|Withdrawal by Subject|6|||
127595683|NCT02485301|459145565|FG001|Overall Study|Withdrawal by Subject|7|||
127786673|NCT02700412|459844357|FG000|Overall Study|Adverse Event|6|||
127786674|NCT02700412|459844357|FG000|Overall Study|Death|1|||
127786675|NCT02700412|459844357|FG000|Overall Study|Lack of Efficacy|19|||
127786676|NCT02700412|459844357|FG000|Overall Study|Protocol Violation|5|||
127786677|NCT02700412|459844357|FG000|Overall Study|Withdrawal by Subject|2|||
127786678|NCT00632099|459844358|FG000|Overall Study|Lost to Follow-up|3|||
127786679|NCT00632099|459844359|FG001|Overall Study|Lost to Follow-up|3|||
127786680|NCT03374189|459844360|FG000|Overall Study|Lost to Follow-up|1|||
127786681|NCT03374189|459844361|FG001|Overall Study|Lost to Follow-up|0|||
127786682|NCT00552175|459844364|FG000|Overall Study|Lack of Efficacy|2|||
127786683|NCT00552175|459844365|FG001|Overall Study|Lack of Efficacy|0|||
127786684|NCT00552175|459844366|FG002|Overall Study|Lack of Efficacy|1|||
127786685|NCT00552175|459844364|FG000|Overall Study|Adverse Event|9|||
127786686|NCT00552175|459844365|FG001|Overall Study|Adverse Event|9|||
127786687|NCT00552175|459844366|FG002|Overall Study|Adverse Event|10|||
127786688|NCT00552175|459844364|FG000|Overall Study|Withdrawal by Subject|2|||
127786689|NCT00552175|459844365|FG001|Overall Study|Withdrawal by Subject|2|||
127786690|NCT00552175|459844366|FG002|Overall Study|Withdrawal by Subject|1|||
127786691|NCT00552175|459844364|FG000|Overall Study|Lost to Follow-up|0|||
127786692|NCT00552175|459844365|FG001|Overall Study|Lost to Follow-up|0|||
127786693|NCT00552175|459844366|FG002|Overall Study|Lost to Follow-up|1|||
127786694|NCT00552175|459844364|FG000|Overall Study|Entry Criteria Not Met|1|||
127786695|NCT00552175|459844365|FG001|Overall Study|Entry Criteria Not Met|1|||
127786696|NCT00552175|459844366|FG002|Overall Study|Entry Criteria Not Met|0|||
127786697|NCT00552175|459844364|FG000|Overall Study|Reason Not Specified|3|||
127786698|NCT00552175|459844365|FG001|Overall Study|Reason Not Specified|1|||
127786699|NCT00552175|459844366|FG002|Overall Study|Reason Not Specified|1|||
127786700|NCT01543828|459844368|FG000|Treatment 2|Lost to Follow-up|1|||
127786701|NCT01543828|459844369|FG001|Treatment 2|Lost to Follow-up|0|||
127786702|NCT03975920|459844370|FG000|Overall Study|Lost to Follow-up|1|||
127786703|NCT03975920|459844371|FG001|Overall Study|Lost to Follow-up|2|||
127786704|NCT03975920|459844370|FG000|Overall Study|Protocol Violation|1|||
127786705|NCT03975920|459844371|FG001|Overall Study|Protocol Violation|1|||
127786706|NCT03975920|459844370|FG000|Overall Study|Did not complete survey|2|||
127786707|NCT03975920|459844371|FG001|Overall Study|Did not complete survey|1|||
127786708|NCT02285998|459844372|FG000|Overall Study|Adverse Event|9|||
127786709|NCT02285998|459844373|FG001|Overall Study|Adverse Event|8|||
127786710|NCT02285998|459844372|FG000|Overall Study|Physician Decision|1|||
127786711|NCT02285998|459844373|FG001|Overall Study|Physician Decision|2|||
127786712|NCT02285998|459844372|FG000|Overall Study|Lost to Follow-up|176|||
127786713|NCT02285998|459844373|FG001|Overall Study|Lost to Follow-up|172|||
127786714|NCT02285998|459844372|FG000|Overall Study|Withdrawal by Subject|53|||
127786715|NCT02285998|459844373|FG001|Overall Study|Withdrawal by Subject|61|||
127786716|NCT02285998|459844372|FG000|Overall Study|Other Reasons|7|||
127786717|NCT02285998|459844373|FG001|Overall Study|Other Reasons|10|||
127786718|NCT01820364|459844376|FG000|Part I: LGX818|Death|1|||
127786719|NCT01820364|459844377|FG001|Part I: LGX818|Death|0|||
127786720|NCT01820364|459844376|FG000|Part I: LGX818|Administrative Problems|3|||
127786721|NCT01820364|459844377|FG001|Part I: LGX818|Administrative Problems|0|||
127786722|NCT01820364|459844376|FG000|Part I: LGX818|Adverse Event|6|||
127786723|NCT01820364|459844377|FG001|Part I: LGX818|Adverse Event|0|||
127786724|NCT01820364|459844376|FG000|Part I: LGX818|Disease Progression|4|||
127786725|NCT01820364|459844377|FG001|Part I: LGX818|Disease Progression|0|||
127786726|NCT01820364|459844376|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
127786727|NCT01820364|459844377|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
127786728|NCT03451084|459844380|FG000|Overall Study|Withdrawal by Subject|2|||
127786729|NCT03451084|459844381|FG001|Overall Study|Withdrawal by Subject|1|||
127786730|NCT03451084|459844382|FG002|Overall Study|Withdrawal by Subject|2|||
127786731|NCT03451084|459844383|FG003|Overall Study|Withdrawal by Subject|1|||
127786732|NCT03451084|459844380|FG000|Overall Study|Disease recurrence|0|||
127786733|NCT03451084|459844381|FG001|Overall Study|Disease recurrence|2|||
127786734|NCT03451084|459844382|FG002|Overall Study|Disease recurrence|0|||
127786735|NCT03451084|459844383|FG003|Overall Study|Disease recurrence|0|||
127595684|NCT02485301|459145564|FG000|Overall Study|Migrated/moved from study area|10|||
127595685|NCT02485301|459145565|FG001|Overall Study|Migrated/moved from study area|19|||
127595686|NCT02485301|459145564|FG000|Overall Study|Lost to Follow-up|17|||
127595687|NCT02485301|459145565|FG001|Overall Study|Lost to Follow-up|17|||
127595688|NCT02485301|459145564|FG000|Overall Study|Other|3|||
127595689|NCT02485301|459145565|FG001|Overall Study|Other|4|||
127595690|NCT01059825|459145566|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
127786736|NCT03451084|459844380|FG000|Overall Study|Lack of Efficacy|0|||
127595691|NCT01059825|459145567|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
127786737|NCT03451084|459844381|FG001|Overall Study|Lack of Efficacy|3|||
127786738|NCT03451084|459844382|FG002|Overall Study|Lack of Efficacy|0|||
127786739|NCT03451084|459844383|FG003|Overall Study|Lack of Efficacy|1|||
127786740|NCT03451084|459844380|FG000|Overall Study|Death|1|||
127786741|NCT03451084|459844381|FG001|Overall Study|Death|0|||
127786742|NCT03451084|459844382|FG002|Overall Study|Death|2|||
127786743|NCT03451084|459844383|FG003|Overall Study|Death|0|||
127786744|NCT03451084|459844380|FG000|Overall Study|Physician Decision|0|||
127786745|NCT03451084|459844381|FG001|Overall Study|Physician Decision|0|||
127786746|NCT03451084|459844382|FG002|Overall Study|Physician Decision|2|||
127786747|NCT03451084|459844383|FG003|Overall Study|Physician Decision|2|||
127786748|NCT03451084|459844380|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
127786749|NCT03451084|459844381|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
127786750|NCT03451084|459844382|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
127786751|NCT03451084|459844383|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
127786752|NCT04995055|459844389|FG000|Period 1|COVID-19 Related|1|||
127786753|NCT04995055|459844390|FG001|Period 1|COVID-19 Related|0|||
127786754|NCT04995055|459844389|FG000|Period 1|Withdrawal by Subject|0|||
127786755|NCT04995055|459844390|FG001|Period 1|Withdrawal by Subject|1|||
127786756|NCT04995055|459844389|FG000|Period 1|Subject discontinued due to timing|4|||
127786757|NCT04995055|459844390|FG001|Period 1|Subject discontinued due to timing|4|||
127786758|NCT03418129|459844393|FG000|Overall Study|Lost to Follow-up|11|||
127786759|NCT03418129|459844394|FG001|Overall Study|Lost to Follow-up|20|||
127786760|NCT03418129|459844395|FG002|Overall Study|Lost to Follow-up|15|||
127786761|NCT03418129|459844393|FG000|Overall Study|Withdrawal by Subject|3|||
127786762|NCT03418129|459844394|FG001|Overall Study|Withdrawal by Subject|6|||
127786763|NCT03418129|459844395|FG002|Overall Study|Withdrawal by Subject|4|||
127786764|NCT01066585|459844403|FG000|Overall Study|Protocol Violation|1|||
127786765|NCT01066585|459844404|FG001|Overall Study|Protocol Violation|0|||
127786766|NCT01066585|459844403|FG000|Overall Study|Withdrawal by Subject|0|||
127786767|NCT01066585|459844404|FG001|Overall Study|Withdrawal by Subject|3|||
127786768|NCT00884273|459844407|FG000|Overall Study|Adverse Event|0|||
127786769|NCT00884273|459844408|FG001|Overall Study|Adverse Event|2|||
127786770|NCT00884273|459844407|FG000|Overall Study|Protocol Violation|1|||
127786771|NCT00884273|459844408|FG001|Overall Study|Protocol Violation|3|||
127786772|NCT00884273|459844407|FG000|Overall Study|Practical reasons|1|||
127786773|NCT00884273|459844408|FG001|Overall Study|Practical reasons|0|||
127786774|NCT04126083|459844411|FG000|Overall Study|Withdrawal by Subject|1|||
127786775|NCT03710486|459844415|FG000|Overall Study|Lost to Follow-up (at least 12 months)|13|||
127786776|NCT03710486|459844416|FG001|Overall Study|Lost to Follow-up (at least 12 months)|10|||
127786777|NCT03710486|459844415|FG000|Overall Study|Missing|0|||
127786778|NCT03710486|459844416|FG001|Overall Study|Missing|2|||
127786779|NCT01279850|459844421|FG000|Overall Study|Protocol Violation|50|||
127786780|NCT01279850|459844421|FG000|Overall Study|No Drug Administration Information|7|||
127786781|NCT01279850|459844421|FG000|Overall Study|No Visit After Treatment|34|||
127786782|NCT01131520|459844422|FG000|Overall Study|Computer problem|1|||
127786783|NCT01131520|459844423|FG001|Overall Study|Computer problem|0|||
127786784|NCT01131520|459844422|FG000|Overall Study|Counselor not available|0|||
127786785|NCT01131520|459844423|FG001|Overall Study|Counselor not available|3|||
127786786|NCT01131520|459844422|FG000|Overall Study|Subject changed history after enrollment|0|||
127786787|NCT01131520|459844423|FG001|Overall Study|Subject changed history after enrollment|1|||
127786788|NCT01147744|459844424|FG000|Overall Study|Protocol Violation|1|||
127786789|NCT01147744|459844425|FG001|Overall Study|Protocol Violation|0|||
127786790|NCT01147744|459844426|FG002|Overall Study|Protocol Violation|1|||
127786791|NCT01147744|459844427|FG003|Overall Study|Protocol Violation|0|||
127786792|NCT01147744|459844428|FG004|Overall Study|Protocol Violation|1|||
127786793|NCT01147744|459844429|FG005|Overall Study|Protocol Violation|3|||
127786794|NCT01147744|459844430|FG006|Overall Study|Protocol Violation|1|||
127786795|NCT01147744|459844424|FG000|Overall Study|Physician Decision|0|||
127786796|NCT01147744|459844425|FG001|Overall Study|Physician Decision|1|||
127786797|NCT01147744|459844426|FG002|Overall Study|Physician Decision|1|||
127786798|NCT01147744|459844427|FG003|Overall Study|Physician Decision|0|||
127786799|NCT01147744|459844428|FG004|Overall Study|Physician Decision|0|||
127786800|NCT01147744|459844429|FG005|Overall Study|Physician Decision|0|||
127786801|NCT01147744|459844430|FG006|Overall Study|Physician Decision|1|||
127786802|NCT01147744|459844424|FG000|Overall Study|Lack of Efficacy|11|||
127786803|NCT01147744|459844425|FG001|Overall Study|Lack of Efficacy|11|||
127786804|NCT01147744|459844426|FG002|Overall Study|Lack of Efficacy|9|||
127786805|NCT01147744|459844427|FG003|Overall Study|Lack of Efficacy|11|||
127786806|NCT01147744|459844428|FG004|Overall Study|Lack of Efficacy|13|||
127786807|NCT01147744|459844429|FG005|Overall Study|Lack of Efficacy|8|||
127786808|NCT01147744|459844430|FG006|Overall Study|Lack of Efficacy|7|||
127786809|NCT01147744|459844424|FG000|Overall Study|Adverse Event|1|||
127882371|NCT03372369|460192776|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
127882372|NCT02239601|460192777|FG000|Overall Study|Withdrawal by Subject|3|||
127882373|NCT02239601|460192778|FG001|Overall Study|Withdrawal by Subject|4|||
127882374|NCT02239601|460192777|FG000|Overall Study|Protocol Violation|4|||
127786810|NCT01147744|459844425|FG001|Overall Study|Adverse Event|2|||
127786811|NCT01147744|459844426|FG002|Overall Study|Adverse Event|3|||
127786812|NCT01147744|459844427|FG003|Overall Study|Adverse Event|0|||
127786813|NCT01147744|459844428|FG004|Overall Study|Adverse Event|2|||
127786814|NCT01147744|459844429|FG005|Overall Study|Adverse Event|1|||
127786815|NCT01147744|459844430|FG006|Overall Study|Adverse Event|2|||
127786816|NCT01147744|459844424|FG000|Overall Study|Withdrawal by Subject|8|||
127786817|NCT01147744|459844425|FG001|Overall Study|Withdrawal by Subject|4|||
127786818|NCT01147744|459844426|FG002|Overall Study|Withdrawal by Subject|2|||
127786819|NCT01147744|459844427|FG003|Overall Study|Withdrawal by Subject|2|||
127786820|NCT01147744|459844428|FG004|Overall Study|Withdrawal by Subject|2|||
127882375|NCT02239601|460192778|FG001|Overall Study|Protocol Violation|2|||
127786821|NCT01147744|459844429|FG005|Overall Study|Withdrawal by Subject|5|||
127786822|NCT01147744|459844430|FG006|Overall Study|Withdrawal by Subject|2|||
127786823|NCT01147744|459844424|FG000|Overall Study|Lost to Follow-up|0|||
127786824|NCT01147744|459844425|FG001|Overall Study|Lost to Follow-up|1|||
127786825|NCT01147744|459844426|FG002|Overall Study|Lost to Follow-up|0|||
127786826|NCT01147744|459844427|FG003|Overall Study|Lost to Follow-up|0|||
127786827|NCT01147744|459844428|FG004|Overall Study|Lost to Follow-up|0|||
127786828|NCT01147744|459844429|FG005|Overall Study|Lost to Follow-up|0|||
127786829|NCT01147744|459844430|FG006|Overall Study|Lost to Follow-up|0|||
127786830|NCT01147744|459844424|FG000|Overall Study|Sponsor decision to amend protocol|7|||
127786831|NCT01147744|459844425|FG001|Overall Study|Sponsor decision to amend protocol|4|||
127786832|NCT01147744|459844426|FG002|Overall Study|Sponsor decision to amend protocol|2|||
127786833|NCT01147744|459844427|FG003|Overall Study|Sponsor decision to amend protocol|5|||
127786834|NCT01147744|459844428|FG004|Overall Study|Sponsor decision to amend protocol|7|||
127786835|NCT01147744|459844429|FG005|Overall Study|Sponsor decision to amend protocol|2|||
127786836|NCT01147744|459844430|FG006|Overall Study|Sponsor decision to amend protocol|6|||
127786837|NCT01147744|459844424|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
127786838|NCT01147744|459844425|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
127786839|NCT01147744|459844426|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
127786840|NCT01147744|459844427|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
127786841|NCT01147744|459844428|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
127786842|NCT01147744|459844429|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
127786843|NCT01147744|459844430|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
127786844|NCT02536313|459844435|FG000|Overall Study|Lack of Efficacy|0|||
127595692|NCT01059825|459145568|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
127595693|NCT01059825|459145569|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
127595694|NCT01059825|459145570|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
127786845|NCT02536313|459844436|FG001|Overall Study|Lack of Efficacy|1|||
127786846|NCT02437864|459844442|FG000|Overall Study|Protocol Violation|4|||
127786847|NCT02437864|459844443|FG001|Overall Study|Protocol Violation|0|||
127786848|NCT01892163|459844444|FG000|Overall Study|Death|1|||
127786849|NCT01892163|459844445|FG001|Overall Study|Death|1|||
127786850|NCT01892163|459844444|FG000|Overall Study|Lost to Follow-up|1|||
127595695|NCT01059825|459145571|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
127595696|NCT01059825|459145572|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
127595697|NCT01059825|459145566|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
127786851|NCT01892163|459844445|FG001|Overall Study|Lost to Follow-up|0|||
127786852|NCT03302975|459844446|FG000|Overall Study|Lost to Follow-up|4|||
127786853|NCT00807742|459844448|FG000|Overall Study|Death|9|||
127786854|NCT00807742|459844449|FG001|Overall Study|Death|2|||
127786855|NCT00807742|459844448|FG000|Overall Study|Withdrawal by Subject|2|||
127786856|NCT00807742|459844449|FG001|Overall Study|Withdrawal by Subject|1|||
127786857|NCT00807742|459844448|FG000|Overall Study|Lost to Follow-up|35|||
127786858|NCT00807742|459844449|FG001|Overall Study|Lost to Follow-up|51|||
127786859|NCT00492752|459844450|FG000|Double Blind Treatment|Death|13|||
127786860|NCT00492752|459844451|FG001|Double Blind Treatment|Death|0|||
127786861|NCT00492752|459844452|FG002|Double Blind Treatment|Death|2|||
127786862|NCT00492752|459844453|FG003|Double Blind Treatment|Death|0|||
127786863|NCT00492752|459844450|FG000|Double Blind Treatment|Adverse Event|1|||
127786864|NCT00492752|459844451|FG001|Double Blind Treatment|Adverse Event|0|||
127786865|NCT00492752|459844452|FG002|Double Blind Treatment|Adverse Event|0|||
127786866|NCT00492752|459844453|FG003|Double Blind Treatment|Adverse Event|0|||
127786867|NCT00492752|459844450|FG000|Double Blind Treatment|Protocol Violation|0|||
127786868|NCT00492752|459844451|FG001|Double Blind Treatment|Protocol Violation|0|||
127786869|NCT00492752|459844452|FG002|Double Blind Treatment|Protocol Violation|1|||
127786870|NCT00492752|459844453|FG003|Double Blind Treatment|Protocol Violation|0|||
127786871|NCT00492752|459844450|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
127595698|NCT01059825|459145567|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
127595699|NCT01059825|459145568|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
127786872|NCT00492752|459844451|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
127595700|NCT01059825|459145569|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
127595701|NCT01059825|459145570|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
127786873|NCT00492752|459844452|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
127786874|NCT00492752|459844453|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
127786875|NCT00492752|459844450|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
127786876|NCT00492752|459844451|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
127786877|NCT00492752|459844452|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
127786878|NCT00492752|459844453|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
127786879|NCT00492752|459844450|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
127786880|NCT00492752|459844451|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
127786881|NCT00492752|459844452|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
127786882|NCT00492752|459844453|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
127786883|NCT00492752|459844450|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
127786884|NCT00492752|459844451|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
127786885|NCT00492752|459844452|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
127786886|NCT00492752|459844453|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
127595702|NCT01059825|459145571|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
127595703|NCT01059825|459145572|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
127786887|NCT00492752|459844450|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
127786888|NCT00492752|459844451|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
127786889|NCT00492752|459844452|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
127786890|NCT00492752|459844453|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
127786891|NCT00492752|459844450|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
127786892|NCT00492752|459844451|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
127786893|NCT00492752|459844452|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
127786894|NCT00492752|459844453|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
127786895|NCT00492752|459844450|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
127786896|NCT00492752|459844451|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
127786897|NCT00492752|459844452|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
127786898|NCT00492752|459844453|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
127786899|NCT00492752|459844450|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
127786900|NCT00492752|459844451|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
127786901|NCT00492752|459844452|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
127786902|NCT00492752|459844453|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
127786903|NCT00219284|459844454|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
127786904|NCT00219284|459844455|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
127786905|NCT00219284|459844454|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
127786906|NCT00219284|459844455|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
127786907|NCT00219284|459844454|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
127786908|NCT00219284|459844455|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
127786909|NCT00219284|459844454|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
127786910|NCT00219284|459844455|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
127786911|NCT00219284|459844454|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
127786912|NCT00219284|459844455|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
127786913|NCT00219284|459844454|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
127786914|NCT00219284|459844455|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
127786915|NCT00219284|459844454|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
127786916|NCT00219284|459844455|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
127786917|NCT00219284|459844454|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
127786918|NCT00219284|459844455|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
127786919|NCT00219284|459844454|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
127786920|NCT00219284|459844455|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
127786921|NCT02258451|459844456|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
127786922|NCT02258451|459844457|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
127786923|NCT02258451|459844456|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
127786924|NCT02258451|459844457|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
127786925|NCT02258451|459844456|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
127786926|NCT02258451|459844457|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
127786927|NCT02258451|459844456|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
127786928|NCT02258451|459844457|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
127786929|NCT02258451|459844456|FG000|Overall Study|Discontinuation all treatment due to death|4|||
127786930|NCT02258451|459844457|FG001|Overall Study|Discontinuation all treatment due to death|3|||
127786931|NCT02258451|459844456|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
127786932|NCT02258451|459844457|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
127786933|NCT02258451|459844456|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
127882376|NCT04682639|460192779|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
127882377|NCT04682639|460192780|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
127595704|NCT01059825|459145566|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
127595705|NCT01059825|459145567|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
127595706|NCT01059825|459145568|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
127595707|NCT01059825|459145569|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
127595708|NCT01059825|459145570|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
127595709|NCT01059825|459145571|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
127595710|NCT01059825|459145572|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
127786934|NCT02258451|459844457|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
127786935|NCT02258451|459844456|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
127786936|NCT02258451|459844457|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
127786937|NCT02258451|459844456|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
127786938|NCT02258451|459844457|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
127786939|NCT02258451|459844456|FG000|Overall Study|Other reason|1|||
127786940|NCT02258451|459844457|FG001|Overall Study|Other reason|1|||
127786941|NCT02258451|459844456|FG000|Overall Study|Never treated|2|||
127786942|NCT02258451|459844457|FG001|Overall Study|Never treated|3|||
127786943|NCT05419128|459844462|FG000|Overall Study|Withdrawal by Subject|1|||
127786944|NCT05419128|459844463|FG001|Overall Study|Withdrawal by Subject|1|||
127786945|NCT05419128|459844464|FG002|Overall Study|Withdrawal by Subject|0|||
127786946|NCT05419128|459844465|FG003|Overall Study|Withdrawal by Subject|1|||
127786947|NCT05419128|459844466|FG004|Overall Study|Withdrawal by Subject|1|||
127786948|NCT05419128|459844467|FG005|Overall Study|Withdrawal by Subject|0|||
127786949|NCT05419128|459844462|FG000|Overall Study|Lost to Follow-up|0|||
127786950|NCT05419128|459844463|FG001|Overall Study|Lost to Follow-up|0|||
127786951|NCT05419128|459844464|FG002|Overall Study|Lost to Follow-up|1|||
127786952|NCT05419128|459844465|FG003|Overall Study|Lost to Follow-up|0|||
127786953|NCT05419128|459844466|FG004|Overall Study|Lost to Follow-up|0|||
127786954|NCT05419128|459844467|FG005|Overall Study|Lost to Follow-up|1|||
127786955|NCT03834519|459844468|FG000|Overall Study|Lost to Follow-up|2|||
127786956|NCT03834519|459844469|FG001|Overall Study|Lost to Follow-up|1|||
127786957|NCT03834519|459844468|FG000|Overall Study|Withdrawal by Subject|5|||
127786958|NCT03834519|459844469|FG001|Overall Study|Withdrawal by Subject|8|||
127786959|NCT03834519|459844468|FG000|Overall Study|Death|368|||
127786960|NCT03834519|459844469|FG001|Overall Study|Death|174|||
127786961|NCT03834519|459844468|FG000|Overall Study|Physician Decision|5|||
127786962|NCT03834519|459844469|FG001|Overall Study|Physician Decision|1|||
127786963|NCT03834519|459844468|FG000|Overall Study|Sponsor decision|149|||
127786964|NCT03834519|459844469|FG001|Overall Study|Sponsor decision|80|||
127786965|NCT00517751|459844470|FG000|Overall Study|Death|3|||
127786966|NCT00517751|459844470|FG000|Overall Study|Withdrawal by Subject|37|||
127786967|NCT00517751|459844470|FG000|Overall Study|Lost to Follow-up|4|||
127786968|NCT00517751|459844470|FG000|Overall Study|patient not over due|6|||
127786969|NCT00517751|459844470|FG000|Overall Study|Patient not due for visit|76|||
127786970|NCT00517751|459844470|FG000|Overall Study|Missing|3|||
127786971|NCT00346073|459846033|FG000|Overall Study|Serious Adverse Event|2|||
128035309|NCT02958865|460757839|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
128035310|NCT02958865|460757840|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
128035311|NCT02958865|460757841|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
128035312|NCT02958865|460757842|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
128035313|NCT02958865|460757843|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
127595711|NCT01059825|459145566|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
127595712|NCT01059825|459145567|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
127882378|NCT04682639|460192781|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
127882379|NCT04682639|460192782|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
127882380|NCT04682639|460192783|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
127882381|NCT04682639|460192779|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
127882382|NCT04682639|460192780|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
127595713|NCT01059825|459145568|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
127595714|NCT01059825|459145569|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
127595715|NCT01059825|459145570|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
127595716|NCT01059825|459145571|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
127595717|NCT01059825|459145572|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
127786972|NCT00346073|459846034|FG001|Overall Study|Serious Adverse Event|0|||
127786973|NCT00346073|459846033|FG000|Overall Study|Lost to Follow-up|39|||
127786974|NCT00346073|459846034|FG001|Overall Study|Lost to Follow-up|24|||
127786975|NCT03703882|459846039|FG000|Overall Study|Adverse Event|1|||
127882383|NCT04682639|460192781|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
127882384|NCT04682639|460192782|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
127595718|NCT01059825|459145566|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
127595719|NCT01059825|459145567|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
127786976|NCT03703882|459846040|FG001|Overall Study|Adverse Event|0|||
127786977|NCT03703882|459846039|FG000|Overall Study|Lost to Follow-up|0|||
127786978|NCT03703882|459846040|FG001|Overall Study|Lost to Follow-up|2|||
127786979|NCT03703882|459846039|FG000|Overall Study|Non-compliance with study drug|0|||
127786980|NCT03703882|459846040|FG001|Overall Study|Non-compliance with study drug|1|||
127786981|NCT03703882|459846039|FG000|Overall Study|Physician Decision|0|||
127786982|NCT03703882|459846040|FG001|Overall Study|Physician Decision|1|||
127786983|NCT03703882|459846039|FG000|Overall Study|Progressive disease|1|||
127786984|NCT03703882|459846040|FG001|Overall Study|Progressive disease|0|||
127786985|NCT03703882|459846039|FG000|Overall Study|Withdrawal by parent/guardian|1|||
127882385|NCT04682639|460192783|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
128035314|NCT02958865|460757844|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
128035315|NCT02958865|460757845|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
128035316|NCT02958865|460757846|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
128035317|NCT02958865|460757847|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
127595720|NCT01059825|459145568|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
127595721|NCT01059825|459145569|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
127595722|NCT01059825|459145570|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
127595723|NCT01059825|459145571|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
127595724|NCT01059825|459145572|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
127595725|NCT01059825|459145566|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
127595726|NCT01059825|459145567|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
127595727|NCT01059825|459145568|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
127595728|NCT01059825|459145569|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
127595729|NCT01059825|459145570|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
127595730|NCT01059825|459145571|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
127595731|NCT01059825|459145572|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
127595732|NCT01059825|459145566|FG000|Treatment Period|Lost to Follow-up|2|||
127595733|NCT01059825|459145567|FG001|Treatment Period|Lost to Follow-up|1|||
127595734|NCT01059825|459145568|FG002|Treatment Period|Lost to Follow-up|0|||
127595735|NCT01059825|459145569|FG003|Treatment Period|Lost to Follow-up|1|||
127595736|NCT01059825|459145570|FG004|Treatment Period|Lost to Follow-up|2|||
127595737|NCT01059825|459145571|FG005|Treatment Period|Lost to Follow-up|0|||
127595738|NCT01059825|459145572|FG006|Treatment Period|Lost to Follow-up|0|||
127695492|NCT02783300|459512952|FG019|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
127695493|NCT02783300|459512953|FG020|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
127695494|NCT02783300|459512954|FG021|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
127695495|NCT02783300|459512955|FG022|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
127695496|NCT02783300|459512956|FG023|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
127695497|NCT02783300|459512957|FG024|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
127695498|NCT02783300|459512958|FG025|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
127695499|NCT02783300|459512959|FG026|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
127695500|NCT02783300|459512933|FG000|Part 1- Dose Escalation Phase|Other reasons|0|||
127695501|NCT02783300|459512934|FG001|Part 1- Dose Escalation Phase|Other reasons|0|||
127695502|NCT02783300|459512935|FG002|Part 1- Dose Escalation Phase|Other reasons|0|||
127695503|NCT02783300|459512936|FG003|Part 1- Dose Escalation Phase|Other reasons|0|||
127695504|NCT02783300|459512937|FG004|Part 1- Dose Escalation Phase|Other reasons|0|||
127695505|NCT02783300|459512938|FG005|Part 1- Dose Escalation Phase|Other reasons|0|||
127695506|NCT02783300|459512939|FG006|Part 1- Dose Escalation Phase|Other reasons|0|||
127695507|NCT02783300|459512940|FG007|Part 1- Dose Escalation Phase|Other reasons|0|||
127695508|NCT02783300|459512941|FG008|Part 1- Dose Escalation Phase|Other reasons|0|||
127695509|NCT02783300|459512942|FG009|Part 1- Dose Escalation Phase|Other reasons|0|||
127695510|NCT02783300|459512943|FG010|Part 1- Dose Escalation Phase|Other reasons|0|||
127695511|NCT02783300|459512944|FG011|Part 1- Dose Escalation Phase|Other reasons|0|||
127695512|NCT02783300|459512945|FG012|Part 1- Dose Escalation Phase|Other reasons|2|||
127695513|NCT02783300|459512946|FG013|Part 1- Dose Escalation Phase|Other reasons|0|||
127695514|NCT02783300|459512947|FG014|Part 1- Dose Escalation Phase|Other reasons|0|||
127695515|NCT02783300|459512948|FG015|Part 1- Dose Escalation Phase|Other reasons|0|||
127695516|NCT02783300|459512949|FG016|Part 1- Dose Escalation Phase|Other reasons|0|||
127695517|NCT02783300|459512950|FG017|Part 1- Dose Escalation Phase|Other reasons|0|||
127695518|NCT02783300|459512951|FG018|Part 1- Dose Escalation Phase|Other reasons|0|||
127695519|NCT02783300|459512952|FG019|Part 1- Dose Escalation Phase|Other reasons|0|||
127695520|NCT02783300|459512953|FG020|Part 1- Dose Escalation Phase|Other reasons|0|||
127695521|NCT02783300|459512954|FG021|Part 1- Dose Escalation Phase|Other reasons|0|||
127695522|NCT02783300|459512955|FG022|Part 1- Dose Escalation Phase|Other reasons|0|||
127695523|NCT02783300|459512956|FG023|Part 1- Dose Escalation Phase|Other reasons|0|||
127695524|NCT02783300|459512957|FG024|Part 1- Dose Escalation Phase|Other reasons|0|||
127695525|NCT02783300|459512958|FG025|Part 1- Dose Escalation Phase|Other reasons|0|||
127695526|NCT02783300|459512959|FG026|Part 1- Dose Escalation Phase|Other reasons|0|||
127695527|NCT02783300|459512933|FG000|Part 1- Dose Escalation Phase|Investigator discretion|0|||
127695528|NCT02783300|459512934|FG001|Part 1- Dose Escalation Phase|Investigator discretion|0|||
127695529|NCT02783300|459512935|FG002|Part 1- Dose Escalation Phase|Investigator discretion|0|||
127695530|NCT02783300|459512936|FG003|Part 1- Dose Escalation Phase|Investigator discretion|0|||
127695531|NCT02783300|459512937|FG004|Part 1- Dose Escalation Phase|Investigator discretion|0|||
127695532|NCT02783300|459512938|FG005|Part 1- Dose Escalation Phase|Investigator discretion|0|||
127695533|NCT02783300|459512939|FG006|Part 1- Dose Escalation Phase|Investigator discretion|4|||
127695534|NCT02783300|459512940|FG007|Part 1- Dose Escalation Phase|Investigator discretion|0|||
127695535|NCT02783300|459512941|FG008|Part 1- Dose Escalation Phase|Investigator discretion|0|||
127695536|NCT02783300|459512942|FG009|Part 1- Dose Escalation Phase|Investigator discretion|0|||
127786986|NCT03703882|459846040|FG001|Overall Study|Withdrawal by parent/guardian|0|||
127786987|NCT03703882|459846039|FG000|Overall Study|Starting another treatment|0|||
127786988|NCT03703882|459846040|FG001|Overall Study|Starting another treatment|1|||
127786989|NCT03703882|459846039|FG000|Overall Study|noncompliance with study procedures|0|||
127786990|NCT03703882|459846040|FG001|Overall Study|noncompliance with study procedures|1|||
127786991|NCT01617460|459846041|FG000|Overall Study|Adverse Event|10|||
127786992|NCT01617460|459846041|FG000|Overall Study|Physician Decision|16|||
127786993|NCT01617460|459846041|FG000|Overall Study|Protocol Violation|5|||
128035318|NCT02958865|460757848|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
128035319|NCT02958865|460757849|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
128035320|NCT02958865|460757850|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
128035321|NCT02958865|460757851|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
128035322|NCT02958865|460757852|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
128035323|NCT02958865|460757853|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
128035324|NCT02958865|460757854|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
128035325|NCT02958865|460757839|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
128035326|NCT02958865|460757840|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
128035327|NCT02958865|460757841|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
128035328|NCT02958865|460757842|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
128035329|NCT02958865|460757843|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
128035330|NCT02958865|460757844|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
128035331|NCT02958865|460757845|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
128035332|NCT02958865|460757846|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
128035333|NCT02958865|460757847|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
128035334|NCT02958865|460757848|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
128035335|NCT02958865|460757849|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
128035336|NCT02958865|460757850|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
128035337|NCT02958865|460757851|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
128035338|NCT02958865|460757852|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
128035339|NCT02958865|460757853|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
128035340|NCT02958865|460757854|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
128035341|NCT02958865|460757839|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
128035342|NCT02958865|460757840|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
128035343|NCT02958865|460757841|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
128035344|NCT02958865|460757842|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
128035345|NCT02958865|460757843|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
128035346|NCT02958865|460757844|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
128035347|NCT02958865|460757845|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
128035348|NCT02958865|460757846|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
128035349|NCT02958865|460757847|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
128035350|NCT02958865|460757848|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
128035351|NCT02958865|460757849|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
128035352|NCT02958865|460757850|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
128035353|NCT02958865|460757851|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
128035354|NCT02958865|460757852|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
128035355|NCT02958865|460757853|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
128035356|NCT02958865|460757854|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
128035357|NCT02958865|460757839|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
128035358|NCT02958865|460757840|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
128035359|NCT02958865|460757841|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
128035360|NCT02958865|460757842|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
128035361|NCT02958865|460757843|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
128035362|NCT02958865|460757844|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
128035363|NCT02958865|460757845|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
127595739|NCT01059825|459145566|FG000|Treatment Period|Withdrawal by Subject|3|||
127595740|NCT01059825|459145567|FG001|Treatment Period|Withdrawal by Subject|0|||
127595741|NCT01059825|459145568|FG002|Treatment Period|Withdrawal by Subject|1|||
127595742|NCT01059825|459145569|FG003|Treatment Period|Withdrawal by Subject|5|||
127786994|NCT01617460|459846041|FG000|Overall Study|Withdrawal by Subject|9|||
128035364|NCT02958865|460757846|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
128035365|NCT02958865|460757847|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
128035366|NCT02958865|460757848|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
127595743|NCT01059825|459145570|FG004|Treatment Period|Withdrawal by Subject|4|||
127595744|NCT01059825|459145571|FG005|Treatment Period|Withdrawal by Subject|1|||
127786995|NCT00075023|459846045|FG000|Pilot Study|Physician Decision|1|||
127786996|NCT00075023|459846046|FG001|Pilot Study|Physician Decision|2|||
127786997|NCT00075023|459846045|FG000|Pilot Study|Withdrawal by Subject|1|||
127786998|NCT00075023|459846046|FG001|Pilot Study|Withdrawal by Subject|0|||
128035367|NCT02958865|460757849|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
128035368|NCT02958865|460757850|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
127595745|NCT01059825|459145572|FG006|Treatment Period|Withdrawal by Subject|0|||
127595746|NCT01059825|459145566|FG000|Treatment Period|Other reason not specified|1|||
127595747|NCT01059825|459145567|FG001|Treatment Period|Other reason not specified|2|||
127595748|NCT01059825|459145568|FG002|Treatment Period|Other reason not specified|1|||
127595749|NCT01059825|459145569|FG003|Treatment Period|Other reason not specified|2|||
127595750|NCT01059825|459145570|FG004|Treatment Period|Other reason not specified|0|||
127595751|NCT01059825|459145571|FG005|Treatment Period|Other reason not specified|0|||
127595752|NCT01059825|459145572|FG006|Treatment Period|Other reason not specified|0|||
127595753|NCT01059825|459145566|FG000|Treatment Period|Protocol Violation|0|||
127595754|NCT01059825|459145567|FG001|Treatment Period|Protocol Violation|0|||
127595755|NCT01059825|459145568|FG002|Treatment Period|Protocol Violation|1|||
127595756|NCT01059825|459145569|FG003|Treatment Period|Protocol Violation|1|||
127595757|NCT01059825|459145570|FG004|Treatment Period|Protocol Violation|1|||
127595758|NCT01059825|459145571|FG005|Treatment Period|Protocol Violation|1|||
127595759|NCT01059825|459145572|FG006|Treatment Period|Protocol Violation|0|||
127595760|NCT01059825|459145566|FG000|Treatment Period|Adverse event related to study drug|1|||
127595761|NCT01059825|459145567|FG001|Treatment Period|Adverse event related to study drug|0|||
127595762|NCT01059825|459145568|FG002|Treatment Period|Adverse event related to study drug|1|||
127595763|NCT01059825|459145569|FG003|Treatment Period|Adverse event related to study drug|1|||
127595764|NCT01059825|459145570|FG004|Treatment Period|Adverse event related to study drug|0|||
127595765|NCT01059825|459145571|FG005|Treatment Period|Adverse event related to study drug|0|||
127595766|NCT01059825|459145572|FG006|Treatment Period|Adverse event related to study drug|0|||
127595767|NCT01059825|459145566|FG000|Treatment Period|Insufficient clinical response|3|||
127595768|NCT01059825|459145567|FG001|Treatment Period|Insufficient clinical response|0|||
127595769|NCT01059825|459145568|FG002|Treatment Period|Insufficient clinical response|0|||
127595770|NCT01059825|459145569|FG003|Treatment Period|Insufficient clinical response|0|||
127595771|NCT01059825|459145570|FG004|Treatment Period|Insufficient clinical response|0|||
127595772|NCT01059825|459145571|FG005|Treatment Period|Insufficient clinical response|0|||
127595773|NCT01059825|459145572|FG006|Treatment Period|Insufficient clinical response|0|||
127595774|NCT01059825|459145566|FG000|Treatment Period|Adverse event not related to study drug|0|||
127595775|NCT01059825|459145567|FG001|Treatment Period|Adverse event not related to study drug|1|||
127595776|NCT01059825|459145568|FG002|Treatment Period|Adverse event not related to study drug|2|||
127595777|NCT01059825|459145569|FG003|Treatment Period|Adverse event not related to study drug|1|||
127595778|NCT01059825|459145570|FG004|Treatment Period|Adverse event not related to study drug|1|||
127595779|NCT01059825|459145571|FG005|Treatment Period|Adverse event not related to study drug|1|||
127595780|NCT01059825|459145572|FG006|Treatment Period|Adverse event not related to study drug|0|||
127595781|NCT00743340|459145573|FG000|Overall Study|Study medication non-compliance|1|||
127595782|NCT00743340|459145573|FG000|Overall Study|Lost to Follow-up|1|||
127595783|NCT00743340|459145573|FG000|Overall Study|Withdrawal from the Study|5|||
127595784|NCT00743340|459145573|FG000|Overall Study|Protocol Violation|1|||
127595785|NCT00743340|459145573|FG000|Overall Study|Virologic failure|8|||
127595786|NCT00743340|459145573|FG000|Overall Study|Pregnancy|1|||
127595787|NCT00743340|459145573|FG000|Overall Study|Rolled over to other Gilead Study|23|||
127595788|NCT00743340|459145573|FG000|Overall Study|Participant Relocated|1|||
127595789|NCT01425281|459145574|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
127595790|NCT01425281|459145575|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
127595791|NCT01425281|459145574|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
127595792|NCT01425281|459145575|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
127595793|NCT01425281|459145574|FG000|At 180-day Clinical Follow-up|Death|0|||
127595794|NCT01425281|459145575|FG001|At 180-day Clinical Follow-up|Death|1|||
127595795|NCT01425281|459145574|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
127595796|NCT01425281|459145575|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
127595797|NCT01425281|459145574|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
127595798|NCT01425281|459145575|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
127595799|NCT01425281|459145574|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
127595800|NCT01425281|459145575|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
127595801|NCT01425281|459145574|FG000|At 2-year Clinical Follow-up|Death|2|||
127595802|NCT01425281|459145575|FG001|At 2-year Clinical Follow-up|Death|0|||
127595803|NCT01425281|459145574|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
127595804|NCT01425281|459145575|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
127595805|NCT01425281|459145574|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
127595806|NCT01425281|459145575|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
127595807|NCT01425281|459145574|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
127595808|NCT01425281|459145575|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
127595809|NCT01425281|459145574|FG000|At 3-year Clinical Follow-up|Death|2|||
127595810|NCT01425281|459145575|FG001|At 3-year Clinical Follow-up|Death|3|||
127595811|NCT01425281|459145574|FG000|At 4-year Clinical Follow-up|Death|7|||
127695537|NCT02783300|459512943|FG010|Part 1- Dose Escalation Phase|Investigator discretion|0|||
127695538|NCT02783300|459512944|FG011|Part 1- Dose Escalation Phase|Investigator discretion|0|||
127786999|NCT03670953|459846047|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
127787000|NCT03670953|459846048|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
127595812|NCT01425281|459145575|FG001|At 4-year Clinical Follow-up|Death|3|||
127595813|NCT01425281|459145574|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
127787001|NCT03670953|459846049|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
127787002|NCT03670953|459846050|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
127787003|NCT03670953|459846047|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
127787004|NCT03670953|459846048|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
127787005|NCT03670953|459846049|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
127787006|NCT03670953|459846050|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
127787007|NCT03670953|459846047|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
127787008|NCT03670953|459846048|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
127787009|NCT03670953|459846049|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
127787010|NCT03670953|459846050|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
127787011|NCT03670953|459846047|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
127787012|NCT03670953|459846048|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
127787013|NCT03670953|459846049|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
127787014|NCT03670953|459846050|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
127787015|NCT03670953|459846047|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
127595814|NCT01425281|459145575|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
127595815|NCT01425281|459145574|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
127595816|NCT01425281|459145575|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
127595817|NCT01425281|459145574|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
127595818|NCT01425281|459145575|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
127595819|NCT01425281|459145574|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
127595820|NCT01425281|459145575|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
127595821|NCT01425281|459145574|FG000|At 5-year Clinical Follow-up|Death|2|||
127595822|NCT01425281|459145575|FG001|At 5-year Clinical Follow-up|Death|0|||
127595823|NCT01425281|459145574|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
127595824|NCT01425281|459145575|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
127595825|NCT01425281|459145574|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
127595826|NCT01425281|459145575|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
127595827|NCT01425281|459145574|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
127595828|NCT01425281|459145575|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
127595829|NCT01402492|459145577|FG000|Overall Study|Withdrawal by Subject|17|||
127595830|NCT01402492|459145578|FG001|Overall Study|Withdrawal by Subject|11|||
127595831|NCT01402492|459145579|FG002|Overall Study|Withdrawal by Subject|11|||
127595832|NCT01402492|459145577|FG000|Overall Study|Adverse Event|2|||
127595833|NCT01402492|459145578|FG001|Overall Study|Adverse Event|3|||
127595834|NCT01402492|459145579|FG002|Overall Study|Adverse Event|4|||
127595835|NCT01402492|459145577|FG000|Overall Study|Physician Decision|0|||
127595836|NCT01402492|459145578|FG001|Overall Study|Physician Decision|3|||
127595837|NCT01402492|459145579|FG002|Overall Study|Physician Decision|0|||
127595838|NCT01402492|459145577|FG000|Overall Study|Incarcerated (N=3)|2|||
127595839|NCT01402492|459145578|FG001|Overall Study|Incarcerated (N=3)|0|||
127595840|NCT01402492|459145579|FG002|Overall Study|Incarcerated (N=3)|1|||
127595841|NCT03167411|459145580|FG000|Overall Study|Adverse Event|0|||
127595842|NCT03167411|459145581|FG001|Overall Study|Adverse Event|1|||
127595843|NCT02651922|459145582|FG000|Overall Study|due to exclusion criteria|2|||
127595844|NCT00171730|459145583|FG000|Overall Study|Adverse Event|3|||
127787016|NCT03670953|459846048|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
127787017|NCT03670953|459846049|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
127787018|NCT03670953|459846050|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
127787019|NCT03670953|459846047|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
127787020|NCT03670953|459846048|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
127787021|NCT03670953|459846049|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
127787022|NCT03670953|459846050|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
127787023|NCT03670953|459846047|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
127787024|NCT03670953|459846048|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
127787025|NCT03670953|459846049|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
127787026|NCT03670953|459846050|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
127787027|NCT03670953|459846047|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
127787028|NCT03670953|459846048|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
127787029|NCT03670953|459846049|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
127595845|NCT00171730|459145583|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
127595846|NCT00171730|459145583|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
127595847|NCT00171730|459145583|FG000|Overall Study|Withdrawal by Subject|3|||
127595848|NCT02266225|459145584|FG000|Overall Study|Lost to Follow-up|2|||
127595849|NCT02266225|459145584|FG000|Overall Study|Death|1|||
127595850|NCT02266225|459145584|FG000|Overall Study|Withdrawal by Subject|13|||
127595851|NCT01835587|459145587|FG000|Overall Study|Disease Recurrence or Relapse|0|||
127882386|NCT04682639|460192779|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
127882387|NCT04682639|460192780|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
127882388|NCT04682639|460192781|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
127882389|NCT04682639|460192782|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
127882390|NCT04682639|460192783|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
127882391|NCT04682639|460192779|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
127882392|NCT04682639|460192780|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
127882393|NCT04682639|460192781|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
127882394|NCT04682639|460192782|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
127882395|NCT04682639|460192783|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
127882396|NCT04682639|460192779|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
127882397|NCT04682639|460192780|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
127882398|NCT04682639|460192781|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
127882399|NCT04682639|460192782|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
127882400|NCT04682639|460192783|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
127882401|NCT04682639|460192779|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
127882402|NCT04682639|460192780|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
127882403|NCT04682639|460192781|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
127882404|NCT04682639|460192782|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
127882405|NCT04682639|460192783|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
127882406|NCT04682639|460192779|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
127882407|NCT04682639|460192780|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
127882408|NCT04682639|460192781|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
127882409|NCT04682639|460192782|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
127882410|NCT04682639|460192783|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
127882411|NCT04682639|460192779|FG000|OLE Period (28 Weeks)|Other|1|||
127882412|NCT04682639|460192780|FG001|OLE Period (28 Weeks)|Other|2|||
127882413|NCT04682639|460192781|FG002|OLE Period (28 Weeks)|Other|0|||
127882414|NCT04682639|460192782|FG003|OLE Period (28 Weeks)|Other|0|||
127882415|NCT04682639|460192783|FG004|OLE Period (28 Weeks)|Other|1|||
127882416|NCT04682639|460192779|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
127882417|NCT04682639|460192780|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
127882418|NCT04682639|460192781|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
127882419|NCT04682639|460192782|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
127882420|NCT04682639|460192783|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
127882421|NCT04682639|460192779|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
127787030|NCT03670953|459846050|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
127787031|NCT03670953|459846047|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
127595852|NCT01835587|459145588|FG001|Overall Study|Disease Recurrence or Relapse|3|||
127595853|NCT01835587|459145589|FG002|Overall Study|Disease Recurrence or Relapse|0|||
127595854|NCT01835587|459145590|FG003|Overall Study|Disease Recurrence or Relapse|3|||
127595855|NCT01835587|459145587|FG000|Overall Study|Withdrawal by Subject|2|||
127595856|NCT01835587|459145588|FG001|Overall Study|Withdrawal by Subject|0|||
127595857|NCT01835587|459145589|FG002|Overall Study|Withdrawal by Subject|0|||
127595858|NCT01835587|459145590|FG003|Overall Study|Withdrawal by Subject|3|||
127595859|NCT01835587|459145587|FG000|Overall Study|Adverse Event|0|||
127595860|NCT01835587|459145588|FG001|Overall Study|Adverse Event|0|||
127595861|NCT01835587|459145589|FG002|Overall Study|Adverse Event|2|||
127595862|NCT01835587|459145590|FG003|Overall Study|Adverse Event|2|||
127595863|NCT01835587|459145587|FG000|Overall Study|Death|0|||
127595864|NCT01835587|459145588|FG001|Overall Study|Death|0|||
127595865|NCT01835587|459145589|FG002|Overall Study|Death|0|||
127595866|NCT01835587|459145590|FG003|Overall Study|Death|1|||
127595867|NCT01835587|459145587|FG000|Overall Study|Miscellaneous|0|||
127595868|NCT01835587|459145588|FG001|Overall Study|Miscellaneous|1|||
127595869|NCT01835587|459145589|FG002|Overall Study|Miscellaneous|0|||
127595870|NCT01835587|459145590|FG003|Overall Study|Miscellaneous|0|||
127595871|NCT00357968|459145591|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
127595872|NCT00357968|459145592|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
127595873|NCT00357968|459145591|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
127595874|NCT00357968|459145592|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
127595875|NCT00600483|459145593|FG000|Overall Study|Lost to Follow-up|26|||
127595876|NCT00600483|459145594|FG001|Overall Study|Lost to Follow-up|47|||
127595877|NCT00600483|459145593|FG000|Overall Study|Randomized but not treated|10|||
127595878|NCT00600483|459145594|FG001|Overall Study|Randomized but not treated|0|||
127595879|NCT02846779|459145609|FG000|Overall Study|Lost Enrollment|83|||
127595880|NCT02846779|459145610|FG001|Overall Study|Lost Enrollment|82|||
127595881|NCT02846779|459145611|FG002|Overall Study|Lost Enrollment|86|||
127595882|NCT02846779|459145609|FG000|Overall Study|Less than 31 days of follow-up|56|||
127595883|NCT02846779|459145610|FG001|Overall Study|Less than 31 days of follow-up|45|||
127595884|NCT02846779|459145611|FG002|Overall Study|Less than 31 days of follow-up|52|||
127595885|NCT01325584|459145616|FG000|Overall Study|Death|1|||
127595886|NCT00887978|459145617|FG000|Overall Study|Adverse Event|18|||
127595887|NCT00887978|459145618|FG001|Overall Study|Adverse Event|5|||
127787032|NCT03670953|459846048|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
127787033|NCT03670953|459846049|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
127787034|NCT03670953|459846050|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
127787035|NCT03670953|459846047|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
127787036|NCT03670953|459846048|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
127787037|NCT03670953|459846049|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
127787038|NCT03670953|459846050|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
127787039|NCT03670953|459846047|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
127787040|NCT03670953|459846048|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
127787041|NCT03670953|459846049|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
127882422|NCT04682639|460192780|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
127595888|NCT00887978|459145617|FG000|Overall Study|Clinical Worsening|4|||
127595889|NCT00887978|459145618|FG001|Overall Study|Clinical Worsening|4|||
127595890|NCT00887978|459145617|FG000|Overall Study|Death|2|||
127595891|NCT00887978|459145618|FG001|Overall Study|Death|3|||
127595892|NCT00887978|459145617|FG000|Overall Study|Withdrawal by Subject|1|||
127595893|NCT00887978|459145618|FG001|Overall Study|Withdrawal by Subject|2|||
127595894|NCT00887978|459145617|FG000|Overall Study|Lost to Follow-up|0|||
127595895|NCT00887978|459145618|FG001|Overall Study|Lost to Follow-up|1|||
127595896|NCT04102020|459145619|FG000|Overall Study|Adverse Event|1|||
127595897|NCT04102020|459145620|FG001|Overall Study|Adverse Event|0|||
127595898|NCT04102020|459145621|FG002|Overall Study|Adverse Event|0|||
127595899|NCT04102020|459145622|FG003|Overall Study|Adverse Event|1|||
127595900|NCT04102020|459145623|FG004|Overall Study|Adverse Event|0|||
127595901|NCT04102020|459145619|FG000|Overall Study|Withdrawal by Subject|0|||
127595902|NCT04102020|459145620|FG001|Overall Study|Withdrawal by Subject|1|||
127595903|NCT04102020|459145621|FG002|Overall Study|Withdrawal by Subject|1|||
127595904|NCT04102020|459145622|FG003|Overall Study|Withdrawal by Subject|1|||
127595905|NCT04102020|459145623|FG004|Overall Study|Withdrawal by Subject|1|||
127595906|NCT04102020|459145619|FG000|Overall Study|Death|1|||
127595907|NCT04102020|459145620|FG001|Overall Study|Death|4|||
127595908|NCT04102020|459145621|FG002|Overall Study|Death|1|||
127595909|NCT04102020|459145622|FG003|Overall Study|Death|1|||
127595910|NCT04102020|459145623|FG004|Overall Study|Death|0|||
127595911|NCT04102020|459145619|FG000|Overall Study|Physician Decision|1|||
127595912|NCT04102020|459145620|FG001|Overall Study|Physician Decision|2|||
127595913|NCT04102020|459145621|FG002|Overall Study|Physician Decision|2|||
127595914|NCT04102020|459145622|FG003|Overall Study|Physician Decision|0|||
127595915|NCT04102020|459145623|FG004|Overall Study|Physician Decision|1|||
127595916|NCT04102020|459145619|FG000|Overall Study|COVID-19 Infection|1|||
127595917|NCT04102020|459145620|FG001|Overall Study|COVID-19 Infection|0|||
127595918|NCT04102020|459145621|FG002|Overall Study|COVID-19 Infection|0|||
127595919|NCT04102020|459145622|FG003|Overall Study|COVID-19 Infection|0|||
127595920|NCT04102020|459145623|FG004|Overall Study|COVID-19 Infection|0|||
127595921|NCT04102020|459145619|FG000|Overall Study|Not disclosed|5|||
127595922|NCT04102020|459145620|FG001|Overall Study|Not disclosed|3|||
127882423|NCT04682639|460192781|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
127595923|NCT04102020|459145621|FG002|Overall Study|Not disclosed|8|||
127595924|NCT04102020|459145622|FG003|Overall Study|Not disclosed|0|||
127595925|NCT04102020|459145623|FG004|Overall Study|Not disclosed|1|||
127595926|NCT04102020|459145619|FG000|Overall Study|MIssing|1|||
127595927|NCT04102020|459145620|FG001|Overall Study|MIssing|0|||
127595928|NCT04102020|459145621|FG002|Overall Study|MIssing|1|||
127595929|NCT04102020|459145622|FG003|Overall Study|MIssing|1|||
127595930|NCT04102020|459145623|FG004|Overall Study|MIssing|1|||
127595931|NCT04102020|459145619|FG000|Overall Study|Continuing in ongoing study|13|||
127595932|NCT04102020|459145620|FG001|Overall Study|Continuing in ongoing study|13|||
127787042|NCT03670953|459846050|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
127787043|NCT03670953|459846047|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
127787044|NCT03670953|459846048|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
127787045|NCT03670953|459846049|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
127787046|NCT03670953|459846050|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
127787047|NCT03670953|459846047|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
127787048|NCT03670953|459846048|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
127787049|NCT03670953|459846049|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
127787050|NCT03670953|459846050|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
127787051|NCT03670953|459846047|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
127787052|NCT03670953|459846048|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
127787053|NCT03670953|459846049|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
127787054|NCT03670953|459846050|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
127787055|NCT03670953|459846047|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
127787056|NCT03670953|459846048|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
127787057|NCT03670953|459846049|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
127787058|NCT03670953|459846050|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
127787059|NCT03670953|459846047|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
127787060|NCT03670953|459846048|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
127595933|NCT04102020|459145621|FG002|Overall Study|Continuing in ongoing study|7|||
127595934|NCT04102020|459145622|FG003|Overall Study|Continuing in ongoing study|26|||
127595935|NCT04102020|459145623|FG004|Overall Study|Continuing in ongoing study|12|||
127595936|NCT04600921|459145632|FG000|Overall Study|Withdrawal by Subject|3|||
127595937|NCT04600921|459145633|FG001|Overall Study|Withdrawal by Subject|5|||
127595938|NCT04600921|459145632|FG000|Overall Study|Death|0|||
127595939|NCT04600921|459145633|FG001|Overall Study|Death|1|||
127595940|NCT02239978|459147360|FG000|Overall Study|Withdrawal by Subject|2|||
127595941|NCT02239978|459147361|FG001|Overall Study|Withdrawal by Subject|0|||
127595942|NCT00996216|459147367|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
127595943|NCT00996216|459147367|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
127595944|NCT00996216|459147367|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
127595945|NCT00793403|459147370|FG000|Overall Study|Other|73|||
127595946|NCT00842712|459147371|FG000|Safety Run-in Part|Adverse Event|0|||
127595947|NCT00842712|459147372|FG001|Safety Run-in Part|Adverse Event|1|||
127595948|NCT00842712|459147373|FG002|Safety Run-in Part|Adverse Event|0|||
127595949|NCT00842712|459147374|FG003|Safety Run-in Part|Adverse Event|0|||
127595950|NCT00842712|459147375|FG004|Safety Run-in Part|Adverse Event|0|||
127595951|NCT00842712|459147376|FG005|Safety Run-in Part|Adverse Event|0|||
127595952|NCT00842712|459147377|FG006|Safety Run-in Part|Adverse Event|0|||
127595953|NCT00842712|459147371|FG000|Safety Run-in Part|Progressive disease|3|||
127595954|NCT00842712|459147372|FG001|Safety Run-in Part|Progressive disease|1|||
127595955|NCT00842712|459147373|FG002|Safety Run-in Part|Progressive disease|0|||
127595956|NCT00842712|459147374|FG003|Safety Run-in Part|Progressive disease|1|||
127595957|NCT00842712|459147375|FG004|Safety Run-in Part|Progressive disease|0|||
127595958|NCT00842712|459147376|FG005|Safety Run-in Part|Progressive disease|0|||
127595959|NCT00842712|459147377|FG006|Safety Run-in Part|Progressive disease|0|||
127595960|NCT00842712|459147371|FG000|Randomized Part|Randomized but not treated|0|||
127595961|NCT00842712|459147372|FG001|Randomized Part|Randomized but not treated|0|||
127595962|NCT00842712|459147373|FG002|Randomized Part|Randomized but not treated|0|||
127595963|NCT00842712|459147374|FG003|Randomized Part|Randomized but not treated|0|||
127595964|NCT00842712|459147375|FG004|Randomized Part|Randomized but not treated|0|||
127595965|NCT00842712|459147376|FG005|Randomized Part|Randomized but not treated|1|||
127595966|NCT00842712|459147377|FG006|Randomized Part|Randomized but not treated|4|||
127595967|NCT00842712|459147371|FG000|Randomized Part|Ongoing at cut-off date|0|||
127595968|NCT00842712|459147372|FG001|Randomized Part|Ongoing at cut-off date|0|||
127595969|NCT00842712|459147373|FG002|Randomized Part|Ongoing at cut-off date|0|||
127595970|NCT00842712|459147374|FG003|Randomized Part|Ongoing at cut-off date|0|||
127595971|NCT00842712|459147375|FG004|Randomized Part|Ongoing at cut-off date|0|||
127787061|NCT03670953|459846049|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
127595972|NCT00842712|459147376|FG005|Randomized Part|Ongoing at cut-off date|0|||
127787062|NCT03670953|459846050|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
127787063|NCT03670953|459846047|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
127595973|NCT00842712|459147377|FG006|Randomized Part|Ongoing at cut-off date|2|||
127595974|NCT01384760|459147380|FG000|Overall Study|Lost to Follow-up|0|||
127595975|NCT01384760|459147381|FG001|Overall Study|Lost to Follow-up|6|||
127595976|NCT01384760|459147380|FG000|Overall Study|Protocol Violation|16|||
127595977|NCT01384760|459147381|FG001|Overall Study|Protocol Violation|0|||
127595978|NCT00963547|459147382|FG000|Overall Study|Adverse Event|0|||
127595979|NCT00963547|459147383|FG001|Overall Study|Adverse Event|1|||
127595980|NCT00963547|459147384|FG002|Overall Study|Adverse Event|0|||
127595981|NCT00963547|459147385|FG003|Overall Study|Adverse Event|1|||
127787064|NCT03670953|459846048|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
127787065|NCT03670953|459846049|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
127787066|NCT03670953|459846050|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
127787067|NCT03670953|459846047|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
127787068|NCT03670953|459846048|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
127787069|NCT03670953|459846049|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
127787070|NCT03670953|459846050|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
127787071|NCT02603120|459846051|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
127787072|NCT02603120|459846052|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
127787073|NCT02603120|459846051|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
127787074|NCT02603120|459846052|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
127787075|NCT02603120|459846051|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
127787076|NCT02603120|459846052|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
127787077|NCT02603120|459846051|FG000|Double-Blind Treatment Phase|Death|2|||
127787078|NCT02603120|459846052|FG001|Double-Blind Treatment Phase|Death|0|||
127787079|NCT02603120|459846051|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
127787080|NCT02603120|459846052|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
127787081|NCT02603120|459846051|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
127787082|NCT02603120|459846052|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
127882424|NCT04682639|460192782|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
127882425|NCT04682639|460192783|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
127882426|NCT04682639|460192779|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
127882427|NCT04682639|460192780|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
127882428|NCT04682639|460192781|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
127882429|NCT04682639|460192782|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
127882430|NCT04682639|460192783|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
127882431|NCT04682639|460192779|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
127882432|NCT04682639|460192780|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
127595982|NCT00963547|459147386|FG004|Overall Study|Adverse Event|0|||
127595983|NCT00963547|459147387|FG005|Overall Study|Adverse Event|0|||
127595984|NCT00963547|459147388|FG006|Overall Study|Adverse Event|0|||
127595985|NCT00963547|459147382|FG000|Overall Study|Physician Decision|1|||
127595986|NCT00963547|459147383|FG001|Overall Study|Physician Decision|1|||
127595987|NCT00963547|459147384|FG002|Overall Study|Physician Decision|0|||
127595988|NCT00963547|459147385|FG003|Overall Study|Physician Decision|0|||
127595989|NCT00963547|459147386|FG004|Overall Study|Physician Decision|0|||
127595990|NCT00963547|459147387|FG005|Overall Study|Physician Decision|0|||
127595991|NCT00963547|459147388|FG006|Overall Study|Physician Decision|0|||
127595992|NCT00963547|459147382|FG000|Overall Study|Progressive Disease|3|||
127595993|NCT00963547|459147383|FG001|Overall Study|Progressive Disease|8|||
127595994|NCT00963547|459147384|FG002|Overall Study|Progressive Disease|9|||
127595995|NCT00963547|459147385|FG003|Overall Study|Progressive Disease|5|||
127595996|NCT00963547|459147386|FG004|Overall Study|Progressive Disease|0|||
127595997|NCT00963547|459147387|FG005|Overall Study|Progressive Disease|0|||
127595998|NCT00963547|459147388|FG006|Overall Study|Progressive Disease|0|||
127595999|NCT00963547|459147382|FG000|Overall Study|Withdrawal by Subject|0|||
127596000|NCT00963547|459147383|FG001|Overall Study|Withdrawal by Subject|0|||
127596001|NCT00963547|459147384|FG002|Overall Study|Withdrawal by Subject|3|||
127596002|NCT00963547|459147385|FG003|Overall Study|Withdrawal by Subject|0|||
127596003|NCT00963547|459147386|FG004|Overall Study|Withdrawal by Subject|0|||
127882433|NCT04682639|460192781|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
127596004|NCT00963547|459147387|FG005|Overall Study|Withdrawal by Subject|0|||
127596005|NCT00963547|459147388|FG006|Overall Study|Withdrawal by Subject|0|||
127787083|NCT02603120|459846051|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
127882434|NCT04682639|460192782|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
127882435|NCT04682639|460192783|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
127882436|NCT00883740|460192784|FG000|First Intervention|Lost to Follow-up|1|||
127596006|NCT00963547|459147382|FG000|Overall Study|Reason Unknown|0|||
127596007|NCT00963547|459147383|FG001|Overall Study|Reason Unknown|1|||
127596008|NCT00963547|459147384|FG002|Overall Study|Reason Unknown|0|||
127596009|NCT00963547|459147385|FG003|Overall Study|Reason Unknown|0|||
127596010|NCT00963547|459147386|FG004|Overall Study|Reason Unknown|0|||
127596011|NCT00963547|459147387|FG005|Overall Study|Reason Unknown|0|||
127596012|NCT00963547|459147388|FG006|Overall Study|Reason Unknown|0|||
127596013|NCT00660023|459147391|FG000|Overall Study|Adverse Event|2|||
127596014|NCT00660023|459147391|FG000|Overall Study|Death|8|||
127596015|NCT00660023|459147391|FG000|Overall Study|Blood Transfusion|5|||
127596016|NCT00660023|459147391|FG000|Overall Study|Renal Transplantation|3|||
127596017|NCT00660023|459147391|FG000|Overall Study|Withdrawal by Subject|1|||
127596018|NCT00660023|459147391|FG000|Overall Study|Missed Pregnancy Test|1|||
127596019|NCT00660023|459147391|FG000|Overall Study|Other Screening Failure|9|||
127596020|NCT02430311|459147392|FG000|Part A|Adverse Event|0|||
127596021|NCT02430311|459147393|FG001|Part A|Adverse Event|1|||
127596022|NCT02430311|459147392|FG000|Part A|Withdrawal by Subject|1|||
127596023|NCT02430311|459147393|FG001|Part A|Withdrawal by Subject|0|||
127596024|NCT02430311|459147392|FG000|Part B|Meet study-specific withdrawal criteria|6|||
127787084|NCT02603120|459846052|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
127787085|NCT02603120|459846051|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
127596025|NCT02430311|459147393|FG001|Part B|Meet study-specific withdrawal criteria|6|||
127596026|NCT02430311|459147392|FG000|Part B|Withdrawal by Subject|2|||
127596027|NCT02430311|459147393|FG001|Part B|Withdrawal by Subject|2|||
127596028|NCT02430311|459147392|FG000|Part B|Adverse Event|1|||
127596029|NCT02430311|459147393|FG001|Part B|Adverse Event|0|||
127596030|NCT02430311|459147392|FG000|Part B|Death|1|||
127596031|NCT02430311|459147393|FG001|Part B|Death|0|||
127596032|NCT04180488|459147394|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
127787086|NCT02603120|459846052|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
127787087|NCT02603120|459846051|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
127787088|NCT02603120|459846052|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
127787089|NCT02603120|459846051|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
127596033|NCT04180488|459147395|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
127596034|NCT04180488|459147396|FG002|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
127596035|NCT04180488|459147397|FG003|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
127596036|NCT04180488|459147398|FG004|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
127596037|NCT04180488|459147399|FG005|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
127596038|NCT04180488|459147394|FG000|Overall Study|Withdrawal by Subject|8|||
127596039|NCT04180488|459147395|FG001|Overall Study|Withdrawal by Subject|4|||
127596040|NCT04180488|459147396|FG002|Overall Study|Withdrawal by Subject|5|||
127596041|NCT04180488|459147397|FG003|Overall Study|Withdrawal by Subject|2|||
127596042|NCT04180488|459147398|FG004|Overall Study|Withdrawal by Subject|8|||
127596043|NCT04180488|459147399|FG005|Overall Study|Withdrawal by Subject|6|||
127596044|NCT04180488|459147394|FG000|Overall Study|Adverse Event|3|||
127596045|NCT04180488|459147395|FG001|Overall Study|Adverse Event|2|||
127596046|NCT04180488|459147396|FG002|Overall Study|Adverse Event|0|||
127596047|NCT04180488|459147397|FG003|Overall Study|Adverse Event|0|||
127596048|NCT04180488|459147398|FG004|Overall Study|Adverse Event|0|||
127596049|NCT04180488|459147399|FG005|Overall Study|Adverse Event|0|||
127596050|NCT04180488|459147394|FG000|Overall Study|Poor compliance to protocol|0|||
127596051|NCT04180488|459147395|FG001|Overall Study|Poor compliance to protocol|0|||
127596052|NCT04180488|459147396|FG002|Overall Study|Poor compliance to protocol|1|||
127596053|NCT04180488|459147397|FG003|Overall Study|Poor compliance to protocol|0|||
127596054|NCT04180488|459147398|FG004|Overall Study|Poor compliance to protocol|0|||
127596055|NCT04180488|459147399|FG005|Overall Study|Poor compliance to protocol|0|||
127596056|NCT03506815|459147400|FG000|Overall Study|Adverse Event|8|||
127596057|NCT03506815|459147401|FG001|Overall Study|Adverse Event|0|||
127596058|NCT03506815|459147400|FG000|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|5|||
127596059|NCT03506815|459147401|FG001|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|0|||
127596060|NCT03506815|459147400|FG000|Overall Study|Protocol Violation|1|||
127596061|NCT03506815|459147401|FG001|Overall Study|Protocol Violation|0|||
127596062|NCT03506815|459147400|FG000|Overall Study|Elective Surgery|1|||
127596063|NCT03506815|459147401|FG001|Overall Study|Elective Surgery|0|||
127596064|NCT04160091|459147404|FG000|Overall Study|Terminated by Sponsor|7|||
127596065|NCT04160091|459147405|FG001|Overall Study|Terminated by Sponsor|3|||
127596066|NCT04160091|459147406|FG002|Overall Study|Terminated by Sponsor|5|||
127596067|NCT04160091|459147407|FG003|Overall Study|Terminated by Sponsor|2|||
127596068|NCT04160091|459147404|FG000|Overall Study|Noncompliance|0|||
127596069|NCT04160091|459147405|FG001|Overall Study|Noncompliance|0|||
127596070|NCT04160091|459147406|FG002|Overall Study|Noncompliance|0|||
127596071|NCT04160091|459147407|FG003|Overall Study|Noncompliance|1|||
127596072|NCT04160091|459147404|FG000|Overall Study|Withdrawal by Subject|0|||
127596073|NCT04160091|459147405|FG001|Overall Study|Withdrawal by Subject|0|||
127596074|NCT04160091|459147406|FG002|Overall Study|Withdrawal by Subject|0|||
127596075|NCT04160091|459147407|FG003|Overall Study|Withdrawal by Subject|1|||
127596076|NCT00381095|459147413|FG000|Overall Study|Death|3|||
127596077|NCT00381095|459147414|FG001|Overall Study|Death|4|||
127596078|NCT00381095|459147413|FG000|Overall Study|Lack of Efficacy|2|||
127596079|NCT00381095|459147414|FG001|Overall Study|Lack of Efficacy|4|||
127596080|NCT00381095|459147413|FG000|Overall Study|Other|2|||
127596081|NCT00381095|459147414|FG001|Overall Study|Other|2|||
127596082|NCT00381095|459147413|FG000|Overall Study|Protocol Violation|1|||
127596083|NCT00381095|459147414|FG001|Overall Study|Protocol Violation|1|||
127596084|NCT00381095|459147413|FG000|Overall Study|Withdrawal by Subject|3|||
127596085|NCT00381095|459147414|FG001|Overall Study|Withdrawal by Subject|3|||
127596086|NCT00381095|459147413|FG000|Overall Study|Adverse Event|2|||
127596087|NCT00381095|459147414|FG001|Overall Study|Adverse Event|7|||
127596088|NCT01104493|459147415|FG000|Overall Study|Lost to Follow-up|0|||
127596089|NCT01104493|459147416|FG001|Overall Study|Lost to Follow-up|2|||
127596090|NCT01342796|459147417|FG000|Overall Study|Withdrawal by Subject|2|||
127596091|NCT01342796|459147418|FG001|Overall Study|Withdrawal by Subject|0|||
127596092|NCT01342796|459147417|FG000|Overall Study|Lost to Follow-up|0|||
127596093|NCT01342796|459147418|FG001|Overall Study|Lost to Follow-up|3|||
127596094|NCT01342796|459147417|FG000|Overall Study|Inappropriate enrollment|1|||
127596095|NCT01342796|459147418|FG001|Overall Study|Inappropriate enrollment|0|||
127596096|NCT03342690|459147427|FG000|Overall Study|Missing Information|9|||
127596097|NCT03342690|459147427|FG000|Overall Study|Protocol Violation|16|||
127596098|NCT00549302|459147430|FG000|Double-Blind|Death|2|||
127596099|NCT00549302|459147431|FG001|Double-Blind|Death|9|||
127596100|NCT00549302|459147432|FG002|Double-Blind|Death|0|||
127596101|NCT00549302|459147430|FG000|Double-Blind|Adverse Event|3|||
127596102|NCT00549302|459147431|FG001|Double-Blind|Adverse Event|16|||
127596103|NCT00549302|459147432|FG002|Double-Blind|Adverse Event|0|||
127596104|NCT00549302|459147430|FG000|Double-Blind|Withdrawal by Subject|3|||
127596105|NCT00549302|459147431|FG001|Double-Blind|Withdrawal by Subject|8|||
127596106|NCT00549302|459147432|FG002|Double-Blind|Withdrawal by Subject|0|||
127596107|NCT00549302|459147430|FG000|Double-Blind|Investigator Decision|1|||
127596108|NCT00549302|459147431|FG001|Double-Blind|Investigator Decision|5|||
127596109|NCT00549302|459147432|FG002|Double-Blind|Investigator Decision|0|||
127596110|NCT00549302|459147430|FG000|Double-Blind|Sponsor Decision|0|||
127596111|NCT00549302|459147431|FG001|Double-Blind|Sponsor Decision|1|||
127596112|NCT00549302|459147432|FG002|Double-Blind|Sponsor Decision|0|||
127596113|NCT00549302|459147430|FG000|Double-Blind|Lost to Follow-up|1|||
127596114|NCT00549302|459147431|FG001|Double-Blind|Lost to Follow-up|2|||
127596115|NCT00549302|459147432|FG002|Double-Blind|Lost to Follow-up|0|||
127596116|NCT00549302|459147430|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
127596117|NCT00549302|459147431|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
127596118|NCT00549302|459147432|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
127596119|NCT00549302|459147430|FG000|Double-Blind|New condition or starts new therapy|0|||
127596120|NCT00549302|459147431|FG001|Double-Blind|New condition or starts new therapy|2|||
127596121|NCT00549302|459147432|FG002|Double-Blind|New condition or starts new therapy|0|||
127596122|NCT00549302|459147430|FG000|Open-Label|Adverse Event|0|||
127596123|NCT00549302|459147431|FG001|Open-Label|Adverse Event|0|||
127596124|NCT00549302|459147432|FG002|Open-Label|Adverse Event|11|||
127596125|NCT00549302|459147430|FG000|Open-Label|Death|0|||
127596126|NCT00549302|459147431|FG001|Open-Label|Death|0|||
127596127|NCT00549302|459147432|FG002|Open-Label|Death|40|||
127596128|NCT00549302|459147430|FG000|Open-Label|Investigator Decision|0|||
127596129|NCT00549302|459147431|FG001|Open-Label|Investigator Decision|0|||
127596130|NCT00549302|459147432|FG002|Open-Label|Investigator Decision|5|||
127596131|NCT00549302|459147430|FG000|Open-Label|Lost to Follow-up|0|||
127596132|NCT00549302|459147431|FG001|Open-Label|Lost to Follow-up|0|||
127596133|NCT00549302|459147432|FG002|Open-Label|Lost to Follow-up|2|||
127596134|NCT00549302|459147430|FG000|Open-Label|Other|0|||
127596135|NCT00549302|459147431|FG001|Open-Label|Other|0|||
127596136|NCT00549302|459147432|FG002|Open-Label|Other|3|||
127596137|NCT00549302|459147430|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
127596138|NCT00549302|459147431|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
127596139|NCT00549302|459147432|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
127596140|NCT00549302|459147430|FG000|Open-Label|Withdrawal by Subject|0|||
127596141|NCT00549302|459147431|FG001|Open-Label|Withdrawal by Subject|0|||
127596142|NCT00549302|459147432|FG002|Open-Label|Withdrawal by Subject|6|||
127596143|NCT03585504|459147433|FG000|Overall Study|Lost to Follow-up|26|||
127596144|NCT03585504|459147434|FG001|Overall Study|Lost to Follow-up|29|||
127596145|NCT01414114|459147435|FG000|Overall Study|Adverse Event|2|||
128035369|NCT02958865|460757851|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
128035370|NCT02958865|460757852|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
128035371|NCT02958865|460757853|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
127596146|NCT01414114|459147435|FG000|Overall Study|Withdrawal by Subject|1|||
127596147|NCT01414114|459147435|FG000|Overall Study|Other|2|||
127596148|NCT00105482|459147436|FG000|Overall Study|Adverse Event|1|||
127596149|NCT00105482|459147437|FG001|Overall Study|Adverse Event|1|||
127596150|NCT00105482|459147436|FG000|Overall Study|Lost to Follow-up|26|||
127596151|NCT00105482|459147437|FG001|Overall Study|Lost to Follow-up|17|||
127596152|NCT00105482|459147436|FG000|Overall Study|Withdrawal by Subject|0|||
127596153|NCT00105482|459147437|FG001|Overall Study|Withdrawal by Subject|1|||
127596154|NCT00105482|459147436|FG000|Overall Study|Lost Interest|29|||
127596155|NCT00105482|459147437|FG001|Overall Study|Lost Interest|32|||
128035372|NCT02958865|460757854|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
128035373|NCT02958865|460757839|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
127596156|NCT00105482|459147436|FG000|Overall Study|Scheduling Conflict|2|||
127596157|NCT00105482|459147437|FG001|Overall Study|Scheduling Conflict|3|||
127596158|NCT00105482|459147436|FG000|Overall Study|Withdrawn by PI|1|||
127596159|NCT00105482|459147437|FG001|Overall Study|Withdrawn by PI|1|||
127596160|NCT05620563|459147438|FG000|Overall Study|Adverse Event|3|||
127596161|NCT05620563|459147439|FG001|Overall Study|Adverse Event|1|||
127596162|NCT05620563|459147438|FG000|Overall Study|Lost to Follow-up|0|||
127596163|NCT05620563|459147439|FG001|Overall Study|Lost to Follow-up|2|||
127596164|NCT05620563|459147438|FG000|Overall Study|Protocol Deviation|1|||
127596165|NCT05620563|459147439|FG001|Overall Study|Protocol Deviation|2|||
127596166|NCT05620563|459147438|FG000|Overall Study|Withdrawal by Subject|3|||
128035374|NCT02958865|460757840|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
128035375|NCT02958865|460757841|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
128035376|NCT02958865|460757842|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
128035377|NCT02958865|460757843|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
127596167|NCT05620563|459147439|FG001|Overall Study|Withdrawal by Subject|3|||
127596168|NCT05620563|459147438|FG000|Overall Study|Physician Decision|0|||
127596169|NCT05620563|459147439|FG001|Overall Study|Physician Decision|1|||
127596170|NCT00085631|459147445|FG000|Overall Study|Missing Data|4|||
127596171|NCT00085631|459147446|FG001|Overall Study|Missing Data|11|||
127596172|NCT00085631|459147447|FG002|Overall Study|Missing Data|7|||
127596173|NCT00411645|459147448|FG000|Overall Study|Consent Withdrawn|13|||
127596174|NCT00411645|459147449|FG001|Overall Study|Consent Withdrawn|22|||
127596175|NCT00411645|459147448|FG000|Overall Study|Death|56|||
127596176|NCT00411645|459147449|FG001|Overall Study|Death|135|||
127596177|NCT00411645|459147448|FG000|Overall Study|Investigator/Sponsor Decision|10|||
127596178|NCT00411645|459147449|FG001|Overall Study|Investigator/Sponsor Decision|7|||
127596179|NCT00411645|459147448|FG000|Overall Study|Lost to Follow-up|2|||
127596180|NCT00411645|459147449|FG001|Overall Study|Lost to Follow-up|0|||
127596181|NCT04626297|459147452|FG000|Overall Study|Adverse Event|5|||
127596182|NCT04626297|459147453|FG001|Overall Study|Adverse Event|3|||
127596183|NCT04626297|459147452|FG000|Overall Study|Lost to Follow-up|7|||
127596184|NCT04626297|459147453|FG001|Overall Study|Lost to Follow-up|3|||
127596185|NCT04626297|459147452|FG000|Overall Study|Protocol Violation|5|||
127596186|NCT04626297|459147453|FG001|Overall Study|Protocol Violation|1|||
127596187|NCT04626297|459147452|FG000|Overall Study|Withdrawal by Subject|20|||
127596188|NCT04626297|459147453|FG001|Overall Study|Withdrawal by Subject|6|||
127596189|NCT04626297|459147452|FG000|Overall Study|Sponsor decision|2|||
127596190|NCT04626297|459147453|FG001|Overall Study|Sponsor decision|1|||
127596191|NCT05048784|459147460|FG000|Period 1|Adverse Event|3|||
127596192|NCT05048784|459147461|FG001|Period 1|Adverse Event|1|||
127596193|NCT05048784|459147462|FG002|Period 1|Adverse Event|0|||
127596194|NCT05048784|459147463|FG003|Period 1|Adverse Event|0|||
127596195|NCT05048784|459147460|FG000|Period 2|Lost to Follow-up|0|||
127596196|NCT05048784|459147461|FG001|Period 2|Lost to Follow-up|1|||
127596197|NCT05048784|459147462|FG002|Period 2|Lost to Follow-up|0|||
127596198|NCT05048784|459147463|FG003|Period 2|Lost to Follow-up|0|||
127596199|NCT03521934|459147464|FG000|Overall Study|Death|65|||
127596200|NCT03521934|459147465|FG001|Overall Study|Death|73|||
127596201|NCT03521934|459147464|FG000|Overall Study|Withdrawal by Subject|18|||
127596202|NCT03521934|459147465|FG001|Overall Study|Withdrawal by Subject|23|||
127596203|NCT03521934|459147464|FG000|Overall Study|Site Terminated by Sponsor|39|||
127596204|NCT03521934|459147465|FG001|Overall Study|Site Terminated by Sponsor|35|||
127596205|NCT03521934|459147464|FG000|Overall Study|Study Terminated by Sponsor|483|||
127596206|NCT03521934|459147465|FG001|Overall Study|Study Terminated by Sponsor|477|||
127596207|NCT03521934|459147464|FG000|Overall Study|Reason not Specified|3|||
127596208|NCT03521934|459147465|FG001|Overall Study|Reason not Specified|6|||
127596209|NCT03020160|459147468|FG000|Overall Study|Withdrawal by Subject|1|||
127596210|NCT03020160|459147469|FG001|Overall Study|Withdrawal by Subject|0|||
127596211|NCT01513473|459147470|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
127596212|NCT01513473|459147471|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
127596213|NCT01513473|459147470|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
127596214|NCT01513473|459147471|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
127596215|NCT01513473|459147470|FG000|Main Trial (26 Weeks)|Unclassified|0|||
127596216|NCT01513473|459147471|FG001|Main Trial (26 Weeks)|Unclassified|2|||
127596217|NCT01513473|459147470|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
127596218|NCT01513473|459147471|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
127596219|NCT01513473|459147470|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
127596220|NCT01513473|459147471|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
127596221|NCT00284050|459147472|FG000|Overall Study|Adverse Event|1|||
127596222|NCT00284050|459147473|FG001|Overall Study|Adverse Event|1|||
127596223|NCT00284050|459147474|FG002|Overall Study|Adverse Event|1|||
128035378|NCT02958865|460757844|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
128035379|NCT02958865|460757845|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
127596224|NCT00284050|459147472|FG000|Overall Study|Lack of Efficacy|0|||
127596225|NCT00284050|459147473|FG001|Overall Study|Lack of Efficacy|1|||
127596226|NCT00284050|459147474|FG002|Overall Study|Lack of Efficacy|3|||
127596227|NCT00284050|459147472|FG000|Overall Study|Protocol Violation|0|||
127596228|NCT00284050|459147473|FG001|Overall Study|Protocol Violation|1|||
127596229|NCT00284050|459147474|FG002|Overall Study|Protocol Violation|2|||
127596230|NCT00284050|459147472|FG000|Overall Study|Withdrawal by Subject|2|||
127596231|NCT00284050|459147473|FG001|Overall Study|Withdrawal by Subject|2|||
127596232|NCT00284050|459147474|FG002|Overall Study|Withdrawal by Subject|2|||
127596233|NCT00284050|459147472|FG000|Overall Study|Lost to Follow-up|1|||
127596234|NCT00284050|459147473|FG001|Overall Study|Lost to Follow-up|0|||
127596235|NCT00284050|459147474|FG002|Overall Study|Lost to Follow-up|1|||
127596236|NCT00284050|459147472|FG000|Overall Study|Death|1|||
128035380|NCT02958865|460757846|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
128035381|NCT02958865|460757847|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
128035382|NCT02958865|460757848|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
128035383|NCT02958865|460757849|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
127596237|NCT00284050|459147473|FG001|Overall Study|Death|0|||
127596238|NCT00284050|459147474|FG002|Overall Study|Death|0|||
127596239|NCT02547649|459147477|FG000|Overall Study|Lost to Follow-up|3|||
127596240|NCT02547649|459147478|FG001|Overall Study|Lost to Follow-up|1|||
127596241|NCT02547649|459147479|FG002|Overall Study|Lost to Follow-up|1|||
127596242|NCT02547649|459147477|FG000|Overall Study|Not vaccinated|0|||
127596243|NCT02547649|459147478|FG001|Overall Study|Not vaccinated|0|||
127596244|NCT02547649|459147479|FG002|Overall Study|Not vaccinated|1|||
127596245|NCT02547649|459147477|FG000|Overall Study|Withdrawal by Subject|0|||
127596246|NCT02547649|459147478|FG001|Overall Study|Withdrawal by Subject|4|||
127596247|NCT02547649|459147479|FG002|Overall Study|Withdrawal by Subject|2|||
127596248|NCT01750242|459147482|FG000|Overall Study|Unreadable Images|3|||
127596249|NCT01484197|459147485|FG000|Treatment Period 1|Adverse Event|1|||
127596250|NCT01484197|459147486|FG001|Treatment Period 1|Adverse Event|0|||
127596251|NCT01484197|459147487|FG002|Treatment Period 1|Adverse Event|0|||
127596252|NCT01484197|459147488|FG003|Treatment Period 1|Adverse Event|0|||
127596253|NCT01484197|459147485|FG000|Treatment Period 2|Subject withdrew consent|0|||
127596254|NCT01484197|459147486|FG001|Treatment Period 2|Subject withdrew consent|0|||
127596255|NCT01484197|459147487|FG002|Treatment Period 2|Subject withdrew consent|0|||
127596256|NCT01484197|459147488|FG003|Treatment Period 2|Subject withdrew consent|1|||
127596257|NCT02706691|459147499|FG000|Overall Study|Adverse Event|1|||
127596258|NCT05025241|459147505|FG000|Screening|Failed Screening|5|||
127596259|NCT05025241|459147505|FG000|Treatment and Follow Up|Adverse Event|3|||
127596260|NCT01053221|459147506|FG000|Overall Study|The study was closed prematurely|5|||
127596261|NCT01053221|459147507|FG001|Overall Study|The study was closed prematurely|9|||
127596262|NCT00211809|459147510|FG000|Overall Study|Lack of Efficacy|1|||
127596263|NCT00211809|459147510|FG000|Overall Study|Lost to Follow-up|2|||
127596264|NCT00211809|459147510|FG000|Overall Study|Pregnancy|1|||
127596265|NCT00211809|459147510|FG000|Overall Study|side effects|2|||
127596266|NCT04294472|459147511|FG000|Overall Study|Adverse Event|0|||
127596267|NCT04294472|459147512|FG001|Overall Study|Adverse Event|1|||
127596268|NCT04294472|459147513|FG002|Overall Study|Adverse Event|1|||
127596269|NCT04294472|459147511|FG000|Overall Study|Randomized but not treated|0|||
127596270|NCT04294472|459147512|FG001|Overall Study|Randomized but not treated|1|||
127596271|NCT04294472|459147513|FG002|Overall Study|Randomized but not treated|1|||
127596272|NCT01756898|459147517|FG000|Overall Study|Adverse Event|7|||
127596273|NCT01756898|459147518|FG001|Overall Study|Adverse Event|1|||
127596274|NCT01756898|459147519|FG002|Overall Study|Adverse Event|0|||
127596275|NCT01756898|459147520|FG003|Overall Study|Adverse Event|0|||
127596276|NCT01756898|459147517|FG000|Overall Study|Lack of Efficacy|4|||
127596277|NCT01756898|459147518|FG001|Overall Study|Lack of Efficacy|7|||
127596278|NCT01756898|459147519|FG002|Overall Study|Lack of Efficacy|6|||
127596279|NCT01756898|459147520|FG003|Overall Study|Lack of Efficacy|6|||
127596280|NCT01756898|459147517|FG000|Overall Study|Lost to Follow-up|2|||
127596281|NCT01756898|459147518|FG001|Overall Study|Lost to Follow-up|4|||
127596282|NCT01756898|459147519|FG002|Overall Study|Lost to Follow-up|2|||
127596283|NCT01756898|459147520|FG003|Overall Study|Lost to Follow-up|3|||
127596284|NCT01756898|459147517|FG000|Overall Study|Protocol Violation|1|||
127596285|NCT01756898|459147518|FG001|Overall Study|Protocol Violation|2|||
127596286|NCT01756898|459147519|FG002|Overall Study|Protocol Violation|2|||
127596287|NCT01756898|459147520|FG003|Overall Study|Protocol Violation|1|||
127596288|NCT01756898|459147517|FG000|Overall Study|Withdrew Consent|5|||
127596289|NCT01756898|459147518|FG001|Overall Study|Withdrew Consent|3|||
127596290|NCT01756898|459147519|FG002|Overall Study|Withdrew Consent|5|||
127596291|NCT01756898|459147520|FG003|Overall Study|Withdrew Consent|6|||
127596292|NCT01756898|459147517|FG000|Overall Study|Other|0|||
127596293|NCT01756898|459147518|FG001|Overall Study|Other|2|||
127596294|NCT01756898|459147519|FG002|Overall Study|Other|2|||
127596295|NCT01756898|459147520|FG003|Overall Study|Other|0|||
127596296|NCT00496054|459147521|FG000|Overall Study|Adverse Event|1|||
127596297|NCT00496054|459147521|FG000|Overall Study|Lost to Follow-up|7|||
127596298|NCT00471328|459147524|FG000|Core Phase|Adverse Event|18|||
127882437|NCT00883740|460192785|FG001|First Intervention|Lost to Follow-up|0|||
127596299|NCT00471328|459147525|FG001|Core Phase|Adverse Event|6|||
127596300|NCT00471328|459147524|FG000|Core Phase|Death|8|||
127596301|NCT00471328|459147525|FG001|Core Phase|Death|4|||
127596302|NCT00471328|459147524|FG000|Core Phase|Withdrawal by Subject|2|||
127596303|NCT00471328|459147525|FG001|Core Phase|Withdrawal by Subject|2|||
127596304|NCT00471328|459147524|FG000|Core Phase|Abnormal laboratory value|1|||
127596305|NCT00471328|459147525|FG001|Core Phase|Abnormal laboratory value|0|||
127596306|NCT00471328|459147524|FG000|Core Phase|Disease Progression|78|||
127596307|NCT00471328|459147525|FG001|Core Phase|Disease Progression|53|||
127596308|NCT00471328|459147524|FG000|Core Phase|Administrative Problem|0|||
127596309|NCT00471328|459147525|FG001|Core Phase|Administrative Problem|1|||
127882438|NCT00883740|460192784|FG000|First Intervention|No longer willing to participate|2|||
127596310|NCT00471328|459147524|FG000|Core Phase|Protocol Deviation|0|||
128035384|NCT02958865|460757850|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
128035385|NCT02958865|460757851|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
128035386|NCT02958865|460757852|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
128035387|NCT02958865|460757853|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
128035388|NCT02958865|460757854|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
128035389|NCT02958865|460757839|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
128035390|NCT02958865|460757840|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
128035391|NCT02958865|460757841|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
128035392|NCT02958865|460757842|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
128035393|NCT02958865|460757843|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
128035394|NCT02958865|460757844|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
128035395|NCT02958865|460757845|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
128035396|NCT02958865|460757846|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
128035397|NCT02958865|460757847|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
128035398|NCT02958865|460757848|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
128035399|NCT02958865|460757849|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
128035400|NCT02958865|460757850|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
128035401|NCT02958865|460757851|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
128035402|NCT02958865|460757852|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
128035403|NCT02958865|460757853|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
128035404|NCT02958865|460757854|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
128035405|NCT02661815|460757855|FG000|Overall Study|Withdrawal by Subject|1|||
128035406|NCT02661815|460757856|FG001|Overall Study|Withdrawal by Subject|0|||
128035407|NCT02661815|460757857|FG002|Overall Study|Withdrawal by Subject|0|||
128035408|NCT02661815|460757858|FG003|Overall Study|Withdrawal by Subject|0|||
128035409|NCT01153516|460757859|FG000|Overall Study|Both subjects refused surgery|2|||
128035410|NCT01153516|460757860|FG001|Overall Study|Both subjects refused surgery|0|||
128035411|NCT01728246|460757871|FG000|Overall Study|Participant needed rescue medication|1|||
128035412|NCT01728246|460757872|FG001|Overall Study|Participant needed rescue medication|5|||
128035413|NCT01728246|460757871|FG000|Overall Study|Protocol Violation|1|||
128035414|NCT01728246|460757872|FG001|Overall Study|Protocol Violation|0|||
127596311|NCT00471328|459147525|FG001|Core Phase|Protocol Deviation|1|||
127596312|NCT00471328|459147524|FG000|Extension Phase|Adverse Event|3|||
127596313|NCT00471328|459147525|FG001|Extension Phase|Adverse Event|12|||
127596314|NCT00471328|459147524|FG000|Extension Phase|Withdrawal by Subject|0|||
127596315|NCT00471328|459147525|FG001|Extension Phase|Withdrawal by Subject|2|||
127596316|NCT00471328|459147524|FG000|Extension Phase|Death|1|||
127596317|NCT00471328|459147525|FG001|Extension Phase|Death|7|||
127596318|NCT00471328|459147524|FG000|Extension Phase|Protocol Deviation|3|||
127596319|NCT00471328|459147525|FG001|Extension Phase|Protocol Deviation|1|||
127596320|NCT00471328|459147524|FG000|Extension Phase|Treatment duration as per protocol|0|||
127596321|NCT00471328|459147525|FG001|Extension Phase|Treatment duration as per protocol|1|||
127596322|NCT00471328|459147524|FG000|Extension Phase|Disease Progression|32|||
127596323|NCT00471328|459147525|FG001|Extension Phase|Disease Progression|44|||
127596324|NCT00471328|459147524|FG000|Extension Phase|New cancer Therapy|1|||
127596325|NCT00471328|459147525|FG001|Extension Phase|New cancer Therapy|0|||
127596326|NCT00471328|459147524|FG000|Extension Phase|Administrative Problem|1|||
127596327|NCT00471328|459147525|FG001|Extension Phase|Administrative Problem|0|||
127596328|NCT04051008|459147526|FG000|Overall Study|Withdrawal by Subject|2|||
127596329|NCT04051008|459147527|FG001|Overall Study|Withdrawal by Subject|0|||
127596330|NCT04051008|459147528|FG002|Overall Study|Withdrawal by Subject|1|||
127596331|NCT02132130|459147531|FG000|Overall Study|Lost to Follow-up|0|||
127596332|NCT02132130|459147532|FG001|Overall Study|Lost to Follow-up|2|||
127596333|NCT02132130|459147533|FG002|Overall Study|Lost to Follow-up|0|||
127596334|NCT02132130|459147534|FG003|Overall Study|Lost to Follow-up|0|||
127596335|NCT02132130|459147531|FG000|Overall Study|Withdrawal by Subject|0|||
127596336|NCT02132130|459147532|FG001|Overall Study|Withdrawal by Subject|0|||
127596337|NCT02132130|459147533|FG002|Overall Study|Withdrawal by Subject|0|||
127596338|NCT02132130|459147534|FG003|Overall Study|Withdrawal by Subject|1|||
127596339|NCT00838578|459147535|FG000|Overall Study|Protocol Violation|2|||
127596340|NCT01482884|459147538|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
127596341|NCT01482884|459147539|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
127596342|NCT01482884|459147538|FG000|Overall Study|Protocol Violation|1|||
127596343|NCT01482884|459147539|FG001|Overall Study|Protocol Violation|0|||
128035415|NCT01728246|460757871|FG000|Overall Study|Withdrawal by Subject|2|||
128035416|NCT01728246|460757872|FG001|Overall Study|Withdrawal by Subject|3|||
128035417|NCT01728246|460757871|FG000|Overall Study|Lost to Follow-up|23|||
128035418|NCT01728246|460757872|FG001|Overall Study|Lost to Follow-up|22|||
128035419|NCT01728246|460757871|FG000|Overall Study|Lack of Efficacy|1|||
128035420|NCT01728246|460757872|FG001|Overall Study|Lack of Efficacy|1|||
127596344|NCT01482884|459147538|FG000|Overall Study|Lost to Follow-up|2|||
127596345|NCT01482884|459147539|FG001|Overall Study|Lost to Follow-up|2|||
127596346|NCT01482884|459147538|FG000|Overall Study|Lack of Efficacy|0|||
127787090|NCT02603120|459846052|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
127787091|NCT02603120|459846051|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
127787092|NCT02603120|459846052|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
127596347|NCT01482884|459147539|FG001|Overall Study|Lack of Efficacy|1|||
127596348|NCT01482884|459147538|FG000|Overall Study|Adverse Event|2|||
127596349|NCT01482884|459147539|FG001|Overall Study|Adverse Event|1|||
127596350|NCT01482884|459147538|FG000|Overall Study|Withdrawal by Subject|8|||
127596351|NCT01482884|459147539|FG001|Overall Study|Withdrawal by Subject|13|||
127596352|NCT00580606|459147540|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
127596353|NCT00580606|459147541|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
127596354|NCT00580606|459147540|FG000|Open Label (OL)|Withdrawal by Subject|4|||
127596355|NCT00580606|459147541|FG001|Open Label (OL)|Withdrawal by Subject|6|||
127596356|NCT00580606|459147540|FG000|Open Label (OL)|Dosing Symptoms|0|||
127596357|NCT00580606|459147541|FG001|Open Label (OL)|Dosing Symptoms|1|||
127596358|NCT00580606|459147540|FG000|Open Label (OL)|Lost to Follow-up|0|||
127596359|NCT00580606|459147541|FG001|Open Label (OL)|Lost to Follow-up|1|||
127596360|NCT00580606|459147540|FG000|Open Label (OL)|Pregnancy|0|||
127596361|NCT00580606|459147541|FG001|Open Label (OL)|Pregnancy|1|||
127596362|NCT00580606|459147540|FG000|Open Label (OL)|Non-compliance|2|||
127596363|NCT00580606|459147541|FG001|Open Label (OL)|Non-compliance|0|||
127596364|NCT00580606|459147540|FG000|Open Label (OL)|Physician Decision|1|||
127596365|NCT00580606|459147541|FG001|Open Label (OL)|Physician Decision|1|||
127787093|NCT02603120|459846051|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
127787094|NCT02603120|459846052|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
127787095|NCT02603120|459846051|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
127787096|NCT02603120|459846052|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
127787097|NCT02603120|459846051|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
127787098|NCT02603120|459846052|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
127787099|NCT00176605|459846055|FG000|Overall Study|Withdrawal by Subject|2|||
127787100|NCT01321710|459846056|FG000|Overall Study|Lost to Follow-up|4|||
127787101|NCT01321710|459846057|FG001|Overall Study|Lost to Follow-up|5|||
127787102|NCT01321710|459846058|FG002|Overall Study|Lost to Follow-up|0|||
127787103|NCT01227187|459846059|FG000|Overall Study|Physician Decision|0|||
127787104|NCT01227187|459846060|FG001|Overall Study|Physician Decision|0|||
127787105|NCT01227187|459846061|FG002|Overall Study|Physician Decision|0|||
127596366|NCT00580606|459147540|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
127596367|NCT00580606|459147541|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
127596368|NCT00439244|459147544|FG000|Overall Study|Adverse Event|5|||
127596369|NCT00439244|459147545|FG001|Overall Study|Adverse Event|2|||
127596370|NCT00439244|459147546|FG002|Overall Study|Adverse Event|3|||
127596371|NCT00439244|459147544|FG000|Overall Study|Withdrawal by Subject|3|||
127596372|NCT00439244|459147545|FG001|Overall Study|Withdrawal by Subject|1|||
127596373|NCT00439244|459147546|FG002|Overall Study|Withdrawal by Subject|2|||
127596374|NCT00439244|459147544|FG000|Overall Study|Lost to Follow-up|2|||
127596375|NCT00439244|459147545|FG001|Overall Study|Lost to Follow-up|1|||
127596376|NCT00439244|459147546|FG002|Overall Study|Lost to Follow-up|2|||
127596377|NCT00439244|459147544|FG000|Overall Study|Death|0|||
127596378|NCT00439244|459147545|FG001|Overall Study|Death|1|||
127596379|NCT00439244|459147546|FG002|Overall Study|Death|0|||
127596380|NCT00439244|459147544|FG000|Overall Study|Protocol Violation|0|||
127596381|NCT00439244|459147545|FG001|Overall Study|Protocol Violation|1|||
127596382|NCT00439244|459147546|FG002|Overall Study|Protocol Violation|0|||
127596383|NCT00439244|459147544|FG000|Overall Study|Administrative problems|1|||
127596384|NCT00439244|459147545|FG001|Overall Study|Administrative problems|0|||
127596385|NCT00439244|459147546|FG002|Overall Study|Administrative problems|0|||
127596386|NCT03655691|459147547|FG000|Overall Study|Adverse Event|0|||
127596387|NCT03655691|459147548|FG001|Overall Study|Adverse Event|0|||
127596388|NCT03655691|459147549|FG002|Overall Study|Adverse Event|1|||
127596389|NCT03655691|459147547|FG000|Overall Study|Lost to Follow-up|1|||
127596390|NCT03655691|459147548|FG001|Overall Study|Lost to Follow-up|1|||
127596391|NCT03655691|459147549|FG002|Overall Study|Lost to Follow-up|2|||
127596392|NCT03655691|459147547|FG000|Overall Study|Protocol Violation|0|||
127596393|NCT03655691|459147548|FG001|Overall Study|Protocol Violation|1|||
127596394|NCT03655691|459147549|FG002|Overall Study|Protocol Violation|0|||
127596395|NCT03655691|459147547|FG000|Overall Study|Withdrawal by Subject|1|||
127596396|NCT03655691|459147548|FG001|Overall Study|Withdrawal by Subject|1|||
127596397|NCT03655691|459147549|FG002|Overall Study|Withdrawal by Subject|0|||
127596398|NCT05353985|459147550|FG000|Overall Study|Adverse Event|5|||
127596399|NCT05353985|459147551|FG001|Overall Study|Adverse Event|7|||
127596400|NCT05353985|459147550|FG000|Overall Study|Lost to Follow-up|1|||
127787106|NCT01227187|459846062|FG003|Overall Study|Physician Decision|1|||
127787107|NCT02463409|459846063|FG000|Overall Study|Withdrawal by Subject|1|||
127787108|NCT02463409|459846063|FG000|Overall Study|Screen failure|1|||
127787109|NCT03577730|459846065|FG000|Overall Study|Physician Decision|3|||
127787110|NCT03577730|459846066|FG001|Overall Study|Physician Decision|1|||
127787111|NCT03577730|459846065|FG000|Overall Study|Did not receive allocated intervention|1|||
127596401|NCT05353985|459147551|FG001|Overall Study|Lost to Follow-up|1|||
127596402|NCT05353985|459147550|FG000|Overall Study|Protocol Violation|1|||
127596403|NCT05353985|459147551|FG001|Overall Study|Protocol Violation|0|||
127596404|NCT05353985|459147550|FG000|Overall Study|Withdrawal by Subject|13|||
127596405|NCT05353985|459147551|FG001|Overall Study|Withdrawal by Subject|17|||
127596406|NCT05353985|459147550|FG000|Overall Study|Reason Not Specified|1|||
127596407|NCT05353985|459147551|FG001|Overall Study|Reason Not Specified|0|||
127596408|NCT05353985|459147550|FG000|Overall Study|Randomized in Error & Not Treated|0|||
127596409|NCT05353985|459147551|FG001|Overall Study|Randomized in Error & Not Treated|1|||
127596410|NCT02041286|459149337|FG000|Overall Study|Adverse Event|1|||
127787112|NCT03577730|459846066|FG001|Overall Study|Did not receive allocated intervention|0|||
127787113|NCT01911442|459846067|FG000|Overall Study|Adverse Event|2|||
127787114|NCT01911442|459846068|FG001|Overall Study|Adverse Event|2|||
127787115|NCT01911442|459846069|FG002|Overall Study|Adverse Event|4|||
127787116|NCT01911442|459846067|FG000|Overall Study|Lack of Efficacy|1|||
127787117|NCT01911442|459846068|FG001|Overall Study|Lack of Efficacy|1|||
127787118|NCT01911442|459846069|FG002|Overall Study|Lack of Efficacy|1|||
127787119|NCT01911442|459846067|FG000|Overall Study|Lost to Follow-up|2|||
127787120|NCT01911442|459846068|FG001|Overall Study|Lost to Follow-up|0|||
127787121|NCT01911442|459846069|FG002|Overall Study|Lost to Follow-up|1|||
127596411|NCT01349790|459149340|FG000|Overall Study|Investigator Judgement|3|||
127596412|NCT01349790|459149340|FG000|Overall Study|Death|2|||
127596413|NCT01349790|459149340|FG000|Overall Study|Withdrawal by Patient|2|||
127596414|NCT01349790|459149340|FG000|Overall Study|Adverse Event|1|||
127596415|NCT01349790|459149340|FG000|Overall Study|Lost to Follow-up|1|||
127596416|NCT02085785|459149343|FG000|Overall Study|Withdrawal by Subject|2|||
127596417|NCT02085785|459149344|FG001|Overall Study|Withdrawal by Subject|1|||
127596418|NCT02085785|459149343|FG000|Overall Study|Lost to Follow-up|0|||
127596419|NCT02085785|459149344|FG001|Overall Study|Lost to Follow-up|1|||
127596420|NCT00779467|459149345|FG000|Overall Study|Lack of Efficacy|11|||
127596421|NCT00779467|459149346|FG001|Overall Study|Lack of Efficacy|2|||
127596422|NCT00779467|459149347|FG002|Overall Study|Lack of Efficacy|6|||
127596423|NCT00779467|459149348|FG003|Overall Study|Lack of Efficacy|11|||
127596424|NCT00779467|459149345|FG000|Overall Study|failed inclusion criteria|3|||
127596425|NCT00779467|459149346|FG001|Overall Study|failed inclusion criteria|3|||
127596426|NCT00779467|459149347|FG002|Overall Study|failed inclusion criteria|1|||
127596427|NCT00779467|459149348|FG003|Overall Study|failed inclusion criteria|2|||
127596428|NCT00779467|459149345|FG000|Overall Study|missing data|1|||
127596429|NCT00779467|459149346|FG001|Overall Study|missing data|0|||
127596430|NCT00779467|459149347|FG002|Overall Study|missing data|1|||
127596431|NCT00779467|459149348|FG003|Overall Study|missing data|4|||
127596432|NCT00779467|459149345|FG000|Overall Study|technical issue|0|||
127596433|NCT00779467|459149346|FG001|Overall Study|technical issue|0|||
127787122|NCT01911442|459846067|FG000|Overall Study|Withdrawal by Subject|1|||
127787123|NCT01911442|459846068|FG001|Overall Study|Withdrawal by Subject|0|||
127787124|NCT01911442|459846069|FG002|Overall Study|Withdrawal by Subject|6|||
127787125|NCT01911442|459846067|FG000|Overall Study|Mother's Work Schedule|0|||
127787126|NCT01911442|459846068|FG001|Overall Study|Mother's Work Schedule|1|||
127787127|NCT01911442|459846069|FG002|Overall Study|Mother's Work Schedule|0|||
127787128|NCT00122681|459846073|FG000|Overall Study|Adverse Event|20|||
127787129|NCT00122681|459846074|FG001|Overall Study|Adverse Event|16|||
127787130|NCT00122681|459846073|FG000|Overall Study|Lost to Follow-up|1080|||
127787131|NCT00122681|459846074|FG001|Overall Study|Lost to Follow-up|1097|||
127787132|NCT00122681|459846073|FG000|Overall Study|Protocol Violation|7|||
127787133|NCT00122681|459846074|FG001|Overall Study|Protocol Violation|10|||
127787134|NCT00122681|459846073|FG000|Overall Study|Withdrawal by Subject|257|||
127787135|NCT00122681|459846074|FG001|Overall Study|Withdrawal by Subject|251|||
127787136|NCT00122681|459846073|FG000|Overall Study|Personal reasons|150|||
127787137|NCT00122681|459846074|FG001|Overall Study|Personal reasons|147|||
127787138|NCT02819635|459846075|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
127596434|NCT00779467|459149347|FG002|Overall Study|technical issue|2|||
127787139|NCT02819635|459846076|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
127787140|NCT02819635|459846077|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
127596435|NCT00779467|459149348|FG003|Overall Study|technical issue|1|||
127596436|NCT00779467|459149345|FG000|Overall Study|unavailable research staff|0|||
128035421|NCT01728246|460757871|FG000|Overall Study|Adverse Event|8|||
127596437|NCT00779467|459149346|FG001|Overall Study|unavailable research staff|0|||
127596438|NCT00779467|459149347|FG002|Overall Study|unavailable research staff|0|||
127596439|NCT00779467|459149348|FG003|Overall Study|unavailable research staff|1|||
127596440|NCT02692703|459149349|FG000|Overall Study|Lost to Follow-up|1|||
127596441|NCT02692703|459149349|FG000|Overall Study|Other|1|||
127596442|NCT04118166|459149350|FG000|Overall Study|Adverse Event|1|||
127596443|NCT00885105|459149351|FG000|Overall Study|Withdrawal by Subject|0|||
127596444|NCT00885105|459149352|FG001|Overall Study|Withdrawal by Subject|8|||
127787141|NCT02819635|459846078|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
127787142|NCT02819635|459846079|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
127596445|NCT00885105|459149351|FG000|Overall Study|Adverse Event|1|||
127596446|NCT00885105|459149352|FG001|Overall Study|Adverse Event|0|||
127596447|NCT00885105|459149351|FG000|Overall Study|Protocol Violation|0|||
127596448|NCT00885105|459149352|FG001|Overall Study|Protocol Violation|2|||
127596449|NCT02708121|459149353|FG000|Overall Study|Withdrawn by Study Team|1|||
127596450|NCT02708121|459149354|FG001|Overall Study|Withdrawn by Study Team|1|||
127596451|NCT02708121|459149353|FG000|Overall Study|Withdrawal by Subject|0|||
127596452|NCT02708121|459149354|FG001|Overall Study|Withdrawal by Subject|4|||
127596453|NCT01833520|459149357|FG000|Overall Study|Lack of Efficacy|3|||
127596454|NCT01833520|459149358|FG001|Overall Study|Lack of Efficacy|3|||
127596455|NCT01833520|459149359|FG002|Overall Study|Lack of Efficacy|8|||
127596456|NCT01833520|459149360|FG003|Overall Study|Lack of Efficacy|3|||
127596457|NCT02743520|459149361|FG000|Overall Study|Withdrawal by Subject|1|||
127596458|NCT01749514|459149362|FG000|Overall Study|Lost to Follow-up|0|||
127596459|NCT01749514|459149363|FG001|Overall Study|Lost to Follow-up|0|||
127596460|NCT01749514|459149364|FG002|Overall Study|Lost to Follow-up|0|||
127596461|NCT01749514|459149365|FG003|Overall Study|Lost to Follow-up|0|||
127596462|NCT01749514|459149366|FG004|Overall Study|Lost to Follow-up|0|||
127596463|NCT01749514|459149367|FG005|Overall Study|Lost to Follow-up|0|||
127596464|NCT01749514|459149368|FG006|Overall Study|Lost to Follow-up|0|||
127596465|NCT01749514|459149369|FG007|Overall Study|Lost to Follow-up|1|||
127596466|NCT01749514|459149362|FG000|Overall Study|Withdrawal by Subject|0|||
127596467|NCT01749514|459149363|FG001|Overall Study|Withdrawal by Subject|0|||
127596468|NCT01749514|459149364|FG002|Overall Study|Withdrawal by Subject|0|||
127596469|NCT01749514|459149365|FG003|Overall Study|Withdrawal by Subject|0|||
127596470|NCT01749514|459149366|FG004|Overall Study|Withdrawal by Subject|0|||
127596471|NCT01749514|459149367|FG005|Overall Study|Withdrawal by Subject|1|||
127596472|NCT01749514|459149368|FG006|Overall Study|Withdrawal by Subject|0|||
127596473|NCT01749514|459149369|FG007|Overall Study|Withdrawal by Subject|1|||
127596474|NCT01749514|459149362|FG000|Overall Study|Not Reported|0|||
127596475|NCT01749514|459149363|FG001|Overall Study|Not Reported|0|||
127596476|NCT01749514|459149364|FG002|Overall Study|Not Reported|0|||
127596477|NCT01749514|459149365|FG003|Overall Study|Not Reported|0|||
127596478|NCT01749514|459149366|FG004|Overall Study|Not Reported|0|||
127596479|NCT01749514|459149367|FG005|Overall Study|Not Reported|0|||
127596480|NCT01749514|459149368|FG006|Overall Study|Not Reported|0|||
127596481|NCT01749514|459149369|FG007|Overall Study|Not Reported|5|||
127596482|NCT00938639|459149371|FG000|Overall Study|Moved away from study area|0|||
127596483|NCT00938639|459149372|FG001|Overall Study|Moved away from study area|1|||
127596484|NCT00938639|459149371|FG000|Overall Study|Lost to Follow-up|1|||
127596485|NCT00938639|459149372|FG001|Overall Study|Lost to Follow-up|2|||
127596486|NCT00938639|459149371|FG000|Overall Study|Family issues|1|||
127596487|NCT00938639|459149372|FG001|Overall Study|Family issues|1|||
127596488|NCT00938639|459149371|FG000|Overall Study|Participant noncompliance|1|||
127596489|NCT00938639|459149372|FG001|Overall Study|Participant noncompliance|0|||
127596490|NCT02509156|459149375|FG000|Randomized Phase|Death|1|||
127596491|NCT02509156|459149376|FG001|Randomized Phase|Death|0|||
127596492|NCT02509156|459149375|FG000|Randomized Phase|Withdrawal by Subject|1|||
127596493|NCT02509156|459149376|FG001|Randomized Phase|Withdrawal by Subject|1|||
127596494|NCT04326231|459149377|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
127596495|NCT00006903|459149380|FG000|Overall Study|Still receiving treatment|0|||
127596496|NCT00006903|459149381|FG001|Overall Study|Still receiving treatment|0|||
127596497|NCT00006903|459149382|FG002|Overall Study|Still receiving treatment|1|||
127596498|NCT00006903|459149380|FG000|Overall Study|Refused further treatment|0|||
127596499|NCT00006903|459149381|FG001|Overall Study|Refused further treatment|2|||
127596500|NCT00006903|459149382|FG002|Overall Study|Refused further treatment|1|||
127596501|NCT00006903|459149380|FG000|Overall Study|Adverse Event|0|||
127596502|NCT00006903|459149381|FG001|Overall Study|Adverse Event|0|||
127596503|NCT00006903|459149382|FG002|Overall Study|Adverse Event|1|||
127596504|NCT00006903|459149380|FG000|Overall Study|Death|0|||
127596505|NCT00006903|459149381|FG001|Overall Study|Death|1|||
127596506|NCT00006903|459149382|FG002|Overall Study|Death|0|||
127596507|NCT00006903|459149380|FG000|Overall Study|Patient never treated|0|||
127596508|NCT00006903|459149381|FG001|Overall Study|Patient never treated|0|||
127596509|NCT00006903|459149382|FG002|Overall Study|Patient never treated|1|||
127596510|NCT00006903|459149380|FG000|Overall Study|Ineligible|10|||
127596511|NCT00006903|459149381|FG001|Overall Study|Ineligible|1|||
127596512|NCT00006903|459149382|FG002|Overall Study|Ineligible|2|||
127695539|NCT02783300|459512945|FG012|Part 1- Dose Escalation Phase|Investigator discretion|3|||
127596513|NCT01678911|459149383|FG000|Second Intervention|Lost to Follow-up|2|||
127596514|NCT01678911|459149384|FG001|Second Intervention|Lost to Follow-up|0|||
127596515|NCT01980992|459149385|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
127596516|NCT01980992|459149386|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
128035422|NCT01728246|460757872|FG001|Overall Study|Adverse Event|5|||
127596517|NCT01980992|459149385|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
127596518|NCT01980992|459149386|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
127596519|NCT01980992|459149385|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
127596520|NCT01980992|459149386|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
128035423|NCT01983111|460757873|FG000|Overall Study|Withdrawal by Subject|8|||
128035424|NCT01983111|460757874|FG001|Overall Study|Withdrawal by Subject|6|||
128035425|NCT01983111|460757873|FG000|Overall Study|Adverse Event|4|||
128035426|NCT01983111|460757874|FG001|Overall Study|Adverse Event|0|||
128035427|NCT01983111|460757873|FG000|Overall Study|Protocol Violation|0|||
128035428|NCT01983111|460757874|FG001|Overall Study|Protocol Violation|1|||
128035429|NCT00855335|460757875|FG000|Overall Study|Lost to Follow-up|0|||
128035430|NCT00855335|460757876|FG001|Overall Study|Lost to Follow-up|0|||
128035431|NCT00855335|460757877|FG002|Overall Study|Lost to Follow-up|3|||
128035432|NCT00855335|460757878|FG003|Overall Study|Lost to Follow-up|1|||
128035433|NCT00855335|460757879|FG004|Overall Study|Lost to Follow-up|0|||
128035434|NCT00855335|460757875|FG000|Overall Study|Withdrawal by Subject|0|||
128035435|NCT00855335|460757876|FG001|Overall Study|Withdrawal by Subject|0|||
128035436|NCT00855335|460757877|FG002|Overall Study|Withdrawal by Subject|0|||
128035437|NCT00855335|460757878|FG003|Overall Study|Withdrawal by Subject|1|||
128035438|NCT00855335|460757879|FG004|Overall Study|Withdrawal by Subject|0|||
128035439|NCT00855335|460757875|FG000|Overall Study|Adverse Event|2|||
128035440|NCT00855335|460757876|FG001|Overall Study|Adverse Event|0|||
128035441|NCT00855335|460757877|FG002|Overall Study|Adverse Event|0|||
128035442|NCT00855335|460757878|FG003|Overall Study|Adverse Event|0|||
128035443|NCT00855335|460757879|FG004|Overall Study|Adverse Event|0|||
128035444|NCT00855335|460757875|FG000|Overall Study|Physician Decision|1|||
128035445|NCT00855335|460757876|FG001|Overall Study|Physician Decision|1|||
128035446|NCT00855335|460757877|FG002|Overall Study|Physician Decision|0|||
128035447|NCT00855335|460757878|FG003|Overall Study|Physician Decision|0|||
128035448|NCT00855335|460757879|FG004|Overall Study|Physician Decision|0|||
128035449|NCT00855335|460757875|FG000|Overall Study|Other|2|||
128035450|NCT00855335|460757876|FG001|Overall Study|Other|1|||
128035451|NCT00855335|460757877|FG002|Overall Study|Other|2|||
128035452|NCT00855335|460757878|FG003|Overall Study|Other|5|||
128035453|NCT00855335|460757879|FG004|Overall Study|Other|1|||
128035454|NCT03502200|460757880|FG000|Overall Study|Adverse Event|1|||
128035455|NCT03502200|460757881|FG001|Overall Study|Adverse Event|0|||
128035456|NCT03502200|460757880|FG000|Overall Study|Lost to Follow-up|36|||
128035457|NCT03502200|460757881|FG001|Overall Study|Lost to Follow-up|38|||
128035458|NCT03502200|460757880|FG000|Overall Study|Study Team Decision|1|||
128035459|NCT03502200|460757881|FG001|Overall Study|Study Team Decision|1|||
128035460|NCT03502200|460757880|FG000|Overall Study|Withdrawal by Subject|5|||
127596521|NCT01980992|459149385|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
127596522|NCT01980992|459149386|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
127596523|NCT01980992|459149385|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
127596524|NCT01980992|459149386|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
127596525|NCT01980992|459149385|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
127596526|NCT01980992|459149386|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
127596527|NCT01366209|459149389|FG000|Overall Study|Adverse Event|6|||
128035461|NCT03502200|460757881|FG001|Overall Study|Withdrawal by Subject|7|||
128035462|NCT03502200|460757880|FG000|Overall Study|Death|0|||
128035463|NCT03502200|460757881|FG001|Overall Study|Death|2|||
128035464|NCT02706392|460757883|FG000|Overall Study|Death|1|||
128035465|NCT02706392|460757884|FG001|Overall Study|Death|0|||
128035466|NCT02706392|460757885|FG002|Overall Study|Death|2|||
128035467|NCT02706392|460757886|FG003|Overall Study|Death|2|||
128035468|NCT02706392|460757887|FG004|Overall Study|Death|5|||
128035469|NCT02706392|460757888|FG005|Overall Study|Death|2|||
127596528|NCT01366209|459149390|FG001|Overall Study|Adverse Event|7|||
127596529|NCT01366209|459149389|FG000|Overall Study|Withdrawal by Subject|4|||
127596530|NCT01366209|459149390|FG001|Overall Study|Withdrawal by Subject|4|||
127596531|NCT01366209|459149389|FG000|Overall Study|Death|12|||
127596532|NCT01366209|459149390|FG001|Overall Study|Death|19|||
127596533|NCT01366209|459149389|FG000|Overall Study|Lung transplantation|6|||
127596534|NCT01366209|459149390|FG001|Overall Study|Lung transplantation|1|||
127596535|NCT01366209|459149389|FG000|Overall Study|Lost to Follow-up|2|||
127596536|NCT01366209|459149390|FG001|Overall Study|Lost to Follow-up|1|||
127596537|NCT01366209|459149389|FG000|Overall Study|Physician Decision|1|||
127596538|NCT01366209|459149390|FG001|Overall Study|Physician Decision|0|||
127596539|NCT01366209|459149389|FG000|Overall Study|Sponsors decision|0|||
127596540|NCT01366209|459149390|FG001|Overall Study|Sponsors decision|1|||
127596541|NCT01366209|459149389|FG000|Overall Study|Withdrew consent|4|||
127596542|NCT01366209|459149390|FG001|Overall Study|Withdrew consent|3|||
127596543|NCT02670837|459149391|FG000|Overall Study|Death|2|||
127596544|NCT02670837|459149392|FG001|Overall Study|Death|0|||
127596545|NCT02670837|459149393|FG002|Overall Study|Death|0|||
127596546|NCT00582166|459149394|FG000|Overall Study|Death|1|||
127596547|NCT00582166|459149394|FG000|Overall Study|Ineligible pathology|1|||
127596548|NCT02532972|459149395|FG000|Overall Study|Withdrawal by Subject|1|||
127596549|NCT01606436|459149396|FG000|Overall Study|Withdrawal by Subject|0|||
127596550|NCT01606436|459149397|FG001|Overall Study|Withdrawal by Subject|0|||
127596551|NCT01606436|459149398|FG002|Overall Study|Withdrawal by Subject|1|||
127596552|NCT01606436|459149399|FG003|Overall Study|Withdrawal by Subject|1|||
127596553|NCT01606436|459149400|FG004|Overall Study|Withdrawal by Subject|1|||
127596554|NCT01606436|459149401|FG005|Overall Study|Withdrawal by Subject|0|||
127596555|NCT01606436|459149396|FG000|Overall Study|Adverse Event|0|||
127596556|NCT01606436|459149397|FG001|Overall Study|Adverse Event|0|||
127596557|NCT01606436|459149398|FG002|Overall Study|Adverse Event|1|||
127596558|NCT01606436|459149399|FG003|Overall Study|Adverse Event|0|||
127596559|NCT01606436|459149400|FG004|Overall Study|Adverse Event|0|||
127596560|NCT01606436|459149401|FG005|Overall Study|Adverse Event|0|||
127596561|NCT01606436|459149396|FG000|Overall Study|Sponsor Decision|0|||
127596562|NCT01606436|459149397|FG001|Overall Study|Sponsor Decision|0|||
127596563|NCT01606436|459149398|FG002|Overall Study|Sponsor Decision|0|||
127596564|NCT01606436|459149399|FG003|Overall Study|Sponsor Decision|1|||
127596565|NCT01606436|459149400|FG004|Overall Study|Sponsor Decision|0|||
127596566|NCT01606436|459149401|FG005|Overall Study|Sponsor Decision|0|||
127596567|NCT02859454|459149402|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
127596568|NCT01025752|459149403|FG000|Overall Study|Lost to Follow-up|7|||
127596569|NCT01025752|459149404|FG001|Overall Study|Lost to Follow-up|10|||
127596570|NCT01025752|459149403|FG000|Overall Study|Physician Decision|1|||
127596571|NCT01025752|459149404|FG001|Overall Study|Physician Decision|3|||
127596572|NCT01417234|459149407|FG000|Overall Study|Subject non-compliant|3|||
127596573|NCT00023764|459149408|FG000|Overall Study|Other|1|||
127596574|NCT00023764|459149408|FG000|Overall Study|Adverse Event|4|||
127596575|NCT00023764|459149408|FG000|Overall Study|Withdrawal by Subject|1|||
127596576|NCT00023764|459149408|FG000|Overall Study|Progression of disease|6|||
127596577|NCT00023764|459149408|FG000|Overall Study|patient received other treatment|1|||
127596578|NCT00023764|459149408|FG000|Overall Study|delay in obtaining staging images|1|||
127596579|NCT02603419|459149413|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
127596580|NCT02603419|459149414|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
127596581|NCT02603419|459149415|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
127596582|NCT02603419|459149416|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
127596583|NCT02603419|459149417|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
127596584|NCT02603419|459149418|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
127596585|NCT02603419|459149413|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
127787143|NCT02819635|459846080|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
127787144|NCT02819635|459846081|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
127787145|NCT02819635|459846082|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
128035470|NCT01968980|460757891|FG000|Overall Study|Death|0|||
127596586|NCT02603419|459149414|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
127596587|NCT02603419|459149415|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
127596588|NCT02603419|459149416|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
127596589|NCT02603419|459149417|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
127596590|NCT02603419|459149418|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
127596591|NCT02603419|459149413|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
127596592|NCT02603419|459149414|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
127596593|NCT02603419|459149415|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
127596594|NCT02603419|459149416|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
127596595|NCT02603419|459149417|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
127596596|NCT02603419|459149418|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
127596597|NCT02603419|459149413|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
127596598|NCT02603419|459149414|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
127596599|NCT02603419|459149415|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
127596600|NCT02603419|459149416|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
127596601|NCT02603419|459149417|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
127596602|NCT02603419|459149418|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
127596603|NCT02603419|459149413|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
127596604|NCT02603419|459149414|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
128035471|NCT01968980|460757892|FG001|Overall Study|Death|1|||
128035472|NCT01968980|460757891|FG000|Overall Study|Adverse Event|1|||
128035473|NCT01968980|460757892|FG001|Overall Study|Adverse Event|3|||
128035474|NCT01968980|460757891|FG000|Overall Study|Does not meet entry criteria|1|||
127596605|NCT02603419|459149415|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
127596606|NCT02603419|459149416|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
127596607|NCT02603419|459149417|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
127596608|NCT02603419|459149418|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
127596609|NCT02603419|459149413|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
127596610|NCT02603419|459149414|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
127787146|NCT02819635|459846083|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
127787147|NCT02819635|459846084|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
127787148|NCT02819635|459846085|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
127787149|NCT02819635|459846086|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
127787150|NCT02819635|459846075|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
127787151|NCT02819635|459846076|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
127787152|NCT02819635|459846077|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
127787153|NCT02819635|459846078|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
127787154|NCT02819635|459846079|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
127787155|NCT02819635|459846080|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
127787156|NCT02819635|459846081|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
127596611|NCT02603419|459149415|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
127596612|NCT02603419|459149416|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
127596613|NCT02603419|459149417|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
127596614|NCT02603419|459149418|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
127596615|NCT02603419|459149413|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
127596616|NCT02603419|459149414|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
127596617|NCT02603419|459149415|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
127596618|NCT02603419|459149416|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
127596619|NCT02603419|459149417|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
127596620|NCT02603419|459149418|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
127596621|NCT02603419|459149413|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
127596622|NCT02603419|459149414|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
127596623|NCT02603419|459149415|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
127596624|NCT02603419|459149416|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
127596625|NCT02603419|459149417|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
127596626|NCT02603419|459149418|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
127596627|NCT02603419|459149413|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
127596628|NCT02603419|459149414|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
127787157|NCT02819635|459846082|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
127787158|NCT02819635|459846083|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
127787159|NCT02819635|459846084|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
127787160|NCT02819635|459846085|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
128035475|NCT01968980|460757892|FG001|Overall Study|Does not meet entry criteria|3|||
128035476|NCT01968980|460757891|FG000|Overall Study|Withdrawal by Subject|13|||
128035477|NCT01968980|460757892|FG001|Overall Study|Withdrawal by Subject|5|||
128035478|NCT01968980|460757891|FG000|Overall Study|Other unspecified|1|||
128035479|NCT01968980|460757892|FG001|Overall Study|Other unspecified|2|||
128035480|NCT00787150|460757893|FG000|Overall Study|Adverse Event|4|||
128035481|NCT00787150|460757894|FG001|Overall Study|Adverse Event|4|||
128035482|NCT00787150|460757895|FG002|Overall Study|Adverse Event|4|||
128035483|NCT00787150|460757893|FG000|Overall Study|Physician Decision|1|||
128035484|NCT00787150|460757894|FG001|Overall Study|Physician Decision|2|||
128035485|NCT00787150|460757895|FG002|Overall Study|Physician Decision|1|||
128035486|NCT00787150|460757893|FG000|Overall Study|Withdrawal by Subject|2|||
128035487|NCT00787150|460757894|FG001|Overall Study|Withdrawal by Subject|1|||
128035488|NCT00787150|460757895|FG002|Overall Study|Withdrawal by Subject|0|||
128035489|NCT00787150|460757893|FG000|Overall Study|Dosing incorrect study durg|2|||
128035490|NCT00787150|460757894|FG001|Overall Study|Dosing incorrect study durg|0|||
128035491|NCT00787150|460757895|FG002|Overall Study|Dosing incorrect study durg|0|||
127596629|NCT02603419|459149415|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
127787161|NCT02819635|459846086|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
127787162|NCT02819635|459846075|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
127787163|NCT02819635|459846076|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
127596630|NCT02603419|459149416|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
127596631|NCT02603419|459149417|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
127596632|NCT02603419|459149418|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
127596633|NCT02603419|459149413|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
127596634|NCT02603419|459149414|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
127596635|NCT02603419|459149415|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
127596636|NCT02603419|459149416|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
127596637|NCT02603419|459149417|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
127596638|NCT02603419|459149418|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
127596639|NCT02850965|459149419|FG000|Overall Study|Other than listed|3|||
127596640|NCT02850965|459149420|FG001|Overall Study|Other than listed|4|||
127596641|NCT02850965|459149419|FG000|Overall Study|Protocol Violation|0|||
127596642|NCT02850965|459149420|FG001|Overall Study|Protocol Violation|2|||
127596643|NCT02850965|459149419|FG000|Overall Study|Lost to Follow-up|5|||
127596644|NCT02850965|459149420|FG001|Overall Study|Lost to Follow-up|3|||
127596645|NCT02850965|459149419|FG000|Overall Study|Lack of Efficacy|4|||
127596646|NCT02850965|459149420|FG001|Overall Study|Lack of Efficacy|8|||
127596647|NCT02850965|459149419|FG000|Overall Study|Adverse Event|3|||
127596648|NCT02850965|459149420|FG001|Overall Study|Adverse Event|2|||
127596649|NCT02850965|459149419|FG000|Overall Study|Withdrawal by Subject|3|||
127596650|NCT02850965|459149420|FG001|Overall Study|Withdrawal by Subject|4|||
127596651|NCT02850965|459149419|FG000|Overall Study|Physician Decision|0|||
127596652|NCT02850965|459149420|FG001|Overall Study|Physician Decision|1|||
127596653|NCT02850965|459149419|FG000|Overall Study|Randomized but not treated|0|||
127596654|NCT02850965|459149420|FG001|Overall Study|Randomized but not treated|1|||
127596655|NCT02289417|459149421|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
127596656|NCT02289417|459149422|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
127596657|NCT02289417|459149423|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
127596658|NCT02289417|459149424|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
127596659|NCT02289417|459149425|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
127596660|NCT02289417|459149426|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
127596661|NCT02289417|459149427|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
127596662|NCT02289417|459149428|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
127596663|NCT02289417|459149429|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
127596664|NCT02289417|459149421|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
127596665|NCT02289417|459149422|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
127596666|NCT02289417|459149423|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
127596667|NCT02289417|459149424|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
127596668|NCT02289417|459149425|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
127596669|NCT02289417|459149426|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
127596670|NCT02289417|459149427|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
127596671|NCT02289417|459149428|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
127787164|NCT02819635|459846077|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
127787165|NCT02819635|459846078|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
127787166|NCT02819635|459846079|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
127787167|NCT02819635|459846080|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
127787168|NCT02819635|459846081|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
127787169|NCT02819635|459846082|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
127787170|NCT02819635|459846083|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
127787171|NCT02819635|459846084|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
127787172|NCT02819635|459846085|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
127787173|NCT02819635|459846086|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
127787174|NCT02819635|459846075|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
127787175|NCT02819635|459846076|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
127787176|NCT02819635|459846077|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
127787177|NCT02819635|459846078|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
127787178|NCT02819635|459846079|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
127596672|NCT02289417|459149429|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
127596673|NCT02289417|459149421|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
127596674|NCT02289417|459149422|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
127596675|NCT02289417|459149423|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
127596676|NCT02289417|459149424|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
127596677|NCT02289417|459149425|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
127596678|NCT02289417|459149426|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
127787179|NCT02819635|459846080|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
127787180|NCT02819635|459846081|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
127787181|NCT02819635|459846082|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
127787182|NCT02819635|459846083|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
127787183|NCT02819635|459846084|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
127787184|NCT02819635|459846085|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
127787185|NCT02819635|459846086|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
127787186|NCT02819635|459846075|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
127787187|NCT02819635|459846076|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
127787188|NCT02819635|459846077|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
127787189|NCT02819635|459846078|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
127787190|NCT02819635|459846079|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
127787191|NCT02819635|459846080|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
127787192|NCT02819635|459846081|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
127787193|NCT02819635|459846082|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
127787194|NCT02819635|459846083|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
127787195|NCT02819635|459846084|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
127787196|NCT02819635|459846085|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
127787197|NCT02819635|459846086|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
127787198|NCT02819635|459846075|FG000|Substudy 2, Part 2|Adverse Event|0|||
127787199|NCT02819635|459846076|FG001|Substudy 2, Part 2|Adverse Event|0|||
127787200|NCT02819635|459846077|FG002|Substudy 2, Part 2|Adverse Event|0|||
127787201|NCT02819635|459846078|FG003|Substudy 2, Part 2|Adverse Event|0|||
127787202|NCT02819635|459846079|FG004|Substudy 2, Part 2|Adverse Event|0|||
127787203|NCT02819635|459846080|FG005|Substudy 2, Part 2|Adverse Event|4|||
127787204|NCT02819635|459846081|FG006|Substudy 2, Part 2|Adverse Event|0|||
127787205|NCT02819635|459846082|FG007|Substudy 2, Part 2|Adverse Event|0|||
127787206|NCT02819635|459846083|FG008|Substudy 2, Part 2|Adverse Event|0|||
127787207|NCT02819635|459846084|FG009|Substudy 2, Part 2|Adverse Event|0|||
127596679|NCT02289417|459149427|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
127596680|NCT02289417|459149428|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
127596681|NCT02289417|459149429|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
127596682|NCT02289417|459149421|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
127596683|NCT02289417|459149422|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
127596684|NCT02289417|459149423|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
127596685|NCT02289417|459149424|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
127596686|NCT02289417|459149425|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
127596687|NCT02289417|459149426|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
127596688|NCT02289417|459149427|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
127596689|NCT02289417|459149428|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
127596690|NCT02289417|459149429|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
127596691|NCT02289417|459149421|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
127596692|NCT02289417|459149422|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
127596693|NCT02289417|459149423|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
127596694|NCT02289417|459149424|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
127596695|NCT02289417|459149425|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
127596696|NCT02289417|459149426|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
127596697|NCT02289417|459149427|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
127596698|NCT02289417|459149428|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
127596699|NCT02289417|459149429|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
127596700|NCT02289417|459149421|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
127596701|NCT02289417|459149422|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
127596702|NCT02289417|459149423|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
127596703|NCT02289417|459149424|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
127596704|NCT02289417|459149425|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
127596705|NCT02289417|459149426|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
127596706|NCT02289417|459149427|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
127787208|NCT02819635|459846085|FG010|Substudy 2, Part 2|Adverse Event|0|||
128035492|NCT01849276|460757900|FG000|Followed for Survival for 5 Years|Death|1|||
128035493|NCT01849276|460757900|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
128035494|NCT00879398|460757903|FG000|Overall Study|Visit Stop|399|||
128035495|NCT00879398|460757903|FG000|Overall Study|Lack of Efficacy|64|||
127596707|NCT02289417|459149428|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
127596708|NCT02289417|459149429|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
127596709|NCT02289417|459149421|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
127596710|NCT02289417|459149422|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
127695540|NCT02783300|459512946|FG013|Part 1- Dose Escalation Phase|Investigator discretion|0|||
127695541|NCT02783300|459512947|FG014|Part 1- Dose Escalation Phase|Investigator discretion|0|||
127695542|NCT02783300|459512948|FG015|Part 1- Dose Escalation Phase|Investigator discretion|0|||
127695543|NCT02783300|459512949|FG016|Part 1- Dose Escalation Phase|Investigator discretion|0|||
127695544|NCT02783300|459512950|FG017|Part 1- Dose Escalation Phase|Investigator discretion|0|||
127695545|NCT02783300|459512951|FG018|Part 1- Dose Escalation Phase|Investigator discretion|0|||
127695546|NCT02783300|459512952|FG019|Part 1- Dose Escalation Phase|Investigator discretion|0|||
127695547|NCT02783300|459512953|FG020|Part 1- Dose Escalation Phase|Investigator discretion|0|||
127695548|NCT02783300|459512954|FG021|Part 1- Dose Escalation Phase|Investigator discretion|0|||
127695549|NCT02783300|459512955|FG022|Part 1- Dose Escalation Phase|Investigator discretion|0|||
127695550|NCT02783300|459512956|FG023|Part 1- Dose Escalation Phase|Investigator discretion|0|||
127695551|NCT02783300|459512957|FG024|Part 1- Dose Escalation Phase|Investigator discretion|0|||
127695552|NCT02783300|459512958|FG025|Part 1- Dose Escalation Phase|Investigator discretion|0|||
127695553|NCT02783300|459512959|FG026|Part 1- Dose Escalation Phase|Investigator discretion|0|||
127695554|NCT02783300|459512933|FG000|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
127695555|NCT02783300|459512934|FG001|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
127695556|NCT02783300|459512935|FG002|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
127695557|NCT02783300|459512936|FG003|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
127695558|NCT02783300|459512937|FG004|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
127695559|NCT02783300|459512938|FG005|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
127695560|NCT02783300|459512939|FG006|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
127695561|NCT02783300|459512940|FG007|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
127695562|NCT02783300|459512941|FG008|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
127695563|NCT02783300|459512942|FG009|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
127695564|NCT02783300|459512943|FG010|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
127695565|NCT02783300|459512944|FG011|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
127695566|NCT02783300|459512945|FG012|Part 1- Dose Escalation Phase|Withdrawal by Subject|2|||
127695567|NCT02783300|459512946|FG013|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
127695568|NCT02783300|459512947|FG014|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
127695569|NCT02783300|459512948|FG015|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
127695570|NCT02783300|459512949|FG016|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
127695571|NCT02783300|459512950|FG017|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
127695572|NCT02783300|459512951|FG018|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
128035496|NCT00879398|460757903|FG000|Overall Study|Adverse Event|41|||
128035497|NCT00879398|460757903|FG000|Overall Study|Other Reasons|171|||
128035498|NCT01380080|460757905|FG000|Overall Study|Death|36|||
128035499|NCT01380080|460757906|FG001|Overall Study|Death|44|||
128035500|NCT01380080|460757905|FG000|Overall Study|Site is closing|28|||
128035501|NCT01380080|460757906|FG001|Overall Study|Site is closing|31|||
128035502|NCT01380080|460757905|FG000|Overall Study|Not able to get to clinic|7|||
128035503|NCT01380080|460757906|FG001|Overall Study|Not able to get to clinic|1|||
128035504|NCT01380080|460757905|FG000|Overall Study|Not willing to adhere to requirements|6|||
128035505|NCT01380080|460757906|FG001|Overall Study|Not willing to adhere to requirements|2|||
128035506|NCT01380080|460757905|FG000|Overall Study|Withdrawal by Subject|5|||
128035507|NCT01380080|460757906|FG001|Overall Study|Withdrawal by Subject|2|||
128035508|NCT01380080|460757905|FG000|Overall Study|Lost to Follow-up|3|||
128035509|NCT01380080|460757906|FG001|Overall Study|Lost to Follow-up|3|||
128035510|NCT01722669|460757911|FG000|Overall Study|Withdrawal by Subject|0|||
128035511|NCT01722669|460757912|FG001|Overall Study|Withdrawal by Subject|0|||
128035512|NCT01722669|460757913|FG002|Overall Study|Withdrawal by Subject|0|||
128035513|NCT01722669|460757914|FG003|Overall Study|Withdrawal by Subject|0|||
127695573|NCT02783300|459512952|FG019|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
127695574|NCT02783300|459512953|FG020|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
127695575|NCT02783300|459512954|FG021|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
127695576|NCT02783300|459512955|FG022|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
127695577|NCT02783300|459512956|FG023|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
127695578|NCT02783300|459512957|FG024|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
127695579|NCT02783300|459512958|FG025|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
127695580|NCT02783300|459512959|FG026|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
127695581|NCT02783300|459512933|FG000|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
127695582|NCT02783300|459512934|FG001|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
127695583|NCT02783300|459512935|FG002|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
127695584|NCT02783300|459512936|FG003|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
127695585|NCT02783300|459512937|FG004|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
127695586|NCT02783300|459512938|FG005|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
127695587|NCT02783300|459512939|FG006|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
127695588|NCT02783300|459512940|FG007|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
127695589|NCT02783300|459512941|FG008|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
127695590|NCT02783300|459512942|FG009|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
127695591|NCT02783300|459512943|FG010|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
127695592|NCT02783300|459512944|FG011|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
127695593|NCT02783300|459512945|FG012|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
127695594|NCT02783300|459512946|FG013|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
127787209|NCT02819635|459846086|FG011|Substudy 2, Part 2|Adverse Event|0|||
127787210|NCT02819635|459846075|FG000|Substudy 2, Part 2|Withdrew consent|0|||
127695595|NCT02783300|459512947|FG014|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
127695596|NCT02783300|459512948|FG015|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
127695597|NCT02783300|459512949|FG016|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
127695598|NCT02783300|459512950|FG017|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
127695599|NCT02783300|459512951|FG018|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
127695600|NCT02783300|459512952|FG019|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
127695601|NCT02783300|459512953|FG020|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
127695602|NCT02783300|459512954|FG021|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
127695603|NCT02783300|459512955|FG022|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
127787211|NCT02819635|459846076|FG001|Substudy 2, Part 2|Withdrew consent|0|||
127787212|NCT02819635|459846077|FG002|Substudy 2, Part 2|Withdrew consent|0|||
127787213|NCT02819635|459846078|FG003|Substudy 2, Part 2|Withdrew consent|0|||
127787214|NCT02819635|459846079|FG004|Substudy 2, Part 2|Withdrew consent|0|||
127787215|NCT02819635|459846080|FG005|Substudy 2, Part 2|Withdrew consent|3|||
127787216|NCT02819635|459846081|FG006|Substudy 2, Part 2|Withdrew consent|1|||
127787217|NCT02819635|459846082|FG007|Substudy 2, Part 2|Withdrew consent|0|||
127787218|NCT02819635|459846083|FG008|Substudy 2, Part 2|Withdrew consent|0|||
127787219|NCT02819635|459846084|FG009|Substudy 2, Part 2|Withdrew consent|0|||
127787220|NCT02819635|459846085|FG010|Substudy 2, Part 2|Withdrew consent|0|||
127787221|NCT02819635|459846086|FG011|Substudy 2, Part 2|Withdrew consent|0|||
127787222|NCT02819635|459846075|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
127787223|NCT02819635|459846076|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
127787224|NCT02819635|459846077|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
127787225|NCT02819635|459846078|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
127787226|NCT02819635|459846079|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
127787227|NCT02819635|459846080|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
127787228|NCT02819635|459846081|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
127787229|NCT02819635|459846082|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
127787230|NCT02819635|459846083|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
127787231|NCT02819635|459846084|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
127787232|NCT02819635|459846085|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
127787233|NCT02819635|459846086|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
127695604|NCT02783300|459512956|FG023|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
127695605|NCT02783300|459512957|FG024|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
127695606|NCT02783300|459512958|FG025|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
127695607|NCT02783300|459512959|FG026|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
127695608|NCT02783300|459512933|FG000|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
127787234|NCT02819635|459846075|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
127787235|NCT02819635|459846076|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
127787236|NCT02819635|459846077|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
127787237|NCT02819635|459846078|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
127787238|NCT02819635|459846079|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
127596711|NCT02289417|459149423|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
127596712|NCT02289417|459149424|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
127596713|NCT02289417|459149425|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
127596714|NCT02289417|459149426|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
127596715|NCT02289417|459149427|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
127596716|NCT02289417|459149428|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
127596717|NCT02289417|459149429|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
127882439|NCT00883740|460192785|FG001|First Intervention|No longer willing to participate|0|||
127882440|NCT00883740|460192784|FG000|First Intervention|Protocol Violation|3|||
127596718|NCT02289417|459149421|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
127596719|NCT02289417|459149422|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
127596720|NCT02289417|459149423|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
127596721|NCT02289417|459149424|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
127596722|NCT02289417|459149425|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
127596723|NCT02289417|459149426|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
127596724|NCT02289417|459149427|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
127596725|NCT02289417|459149428|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
127596726|NCT02289417|459149429|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
127596727|NCT02289417|459149421|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
127596728|NCT02289417|459149422|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
127596729|NCT02289417|459149423|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
127596730|NCT02289417|459149424|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
127596731|NCT02289417|459149425|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
127596732|NCT02289417|459149426|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
127596733|NCT02289417|459149427|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
127596734|NCT02289417|459149428|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
127596735|NCT02289417|459149429|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
127596736|NCT02289417|459149421|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
127596737|NCT02289417|459149422|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
127596738|NCT02289417|459149423|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
127596739|NCT02289417|459149424|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
127596740|NCT02289417|459149425|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
127596741|NCT02289417|459149426|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
127596742|NCT02289417|459149427|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
127596743|NCT02289417|459149428|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
127596744|NCT02289417|459149429|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
127596745|NCT02289417|459149421|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
127596746|NCT02289417|459149422|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
127596747|NCT02289417|459149423|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
127596748|NCT02289417|459149424|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
127596749|NCT02289417|459149425|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
127596750|NCT02289417|459149426|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
127596751|NCT02289417|459149427|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
127596752|NCT02289417|459149428|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
127596753|NCT02289417|459149429|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
127596754|NCT02289417|459149421|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
127596755|NCT02289417|459149422|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
127596756|NCT02289417|459149423|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
127596757|NCT02289417|459149424|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
127596758|NCT02289417|459149425|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
127596759|NCT02289417|459149426|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
127596760|NCT02289417|459149427|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
127596761|NCT02289417|459149428|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
127596762|NCT02289417|459149429|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
127596763|NCT02289417|459149421|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
127596764|NCT02289417|459149422|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
127596765|NCT02289417|459149423|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
127596766|NCT02289417|459149424|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
127596767|NCT02289417|459149425|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
127596768|NCT02289417|459149426|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
127596769|NCT02289417|459149427|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
127596770|NCT02289417|459149428|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
127596771|NCT02289417|459149429|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
127596772|NCT02289417|459149421|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
127596773|NCT02289417|459149422|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
127596774|NCT02289417|459149423|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
127882441|NCT00883740|460192785|FG001|First Intervention|Protocol Violation|6|||
127882442|NCT00883740|460192784|FG000|First Intervention|Adverse Event|1|||
127596775|NCT02289417|459149424|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
127596776|NCT02289417|459149425|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
127596777|NCT02289417|459149426|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
127596778|NCT02289417|459149427|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
127596779|NCT02289417|459149428|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
127596780|NCT02289417|459149429|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
127596781|NCT04786990|459149430|FG000|Overall Study|Withdrawal by Subject|1|||
127596782|NCT04786990|459149430|FG000|Overall Study|Adverse Event|1|||
127596783|NCT04786990|459149430|FG000|Overall Study|Lost to Follow-up|1|||
127596784|NCT04786990|459149430|FG000|Overall Study|Noncompliance|1|||
127596785|NCT04786990|459149430|FG000|Overall Study|Unable to complete site visits|1|||
127596786|NCT04786990|459149430|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
127596787|NCT01782222|459149431|FG000|Overall Study|Adverse Event|4|||
127596788|NCT01782222|459149432|FG001|Overall Study|Adverse Event|5|||
127596789|NCT01782222|459149433|FG002|Overall Study|Adverse Event|3|||
127596790|NCT01782222|459149431|FG000|Overall Study|Lack of Efficacy|2|||
127596791|NCT01782222|459149432|FG001|Overall Study|Lack of Efficacy|1|||
127596792|NCT01782222|459149433|FG002|Overall Study|Lack of Efficacy|0|||
127596793|NCT01782222|459149431|FG000|Overall Study|Protocol Violation|1|||
127596794|NCT01782222|459149432|FG001|Overall Study|Protocol Violation|0|||
127596795|NCT01782222|459149433|FG002|Overall Study|Protocol Violation|0|||
127596796|NCT01782222|459149431|FG000|Overall Study|Withdrawal by Subject|1|||
127596797|NCT01782222|459149432|FG001|Overall Study|Withdrawal by Subject|4|||
127596798|NCT01782222|459149433|FG002|Overall Study|Withdrawal by Subject|1|||
127596799|NCT01782222|459149431|FG000|Overall Study|Moved to other state|0|||
127596800|NCT01782222|459149432|FG001|Overall Study|Moved to other state|1|||
127596801|NCT01782222|459149433|FG002|Overall Study|Moved to other state|0|||
127596802|NCT01500694|459149437|FG000|Overall Study|Adverse Event|4|||
127596803|NCT01500694|459149438|FG001|Overall Study|Adverse Event|3|||
127596804|NCT01500694|459149437|FG000|Overall Study|Protocol Violation|0|||
127596805|NCT01500694|459149438|FG001|Overall Study|Protocol Violation|1|||
127596806|NCT01500694|459149437|FG000|Overall Study|Withdrawal by Subject|23|||
127596807|NCT01500694|459149438|FG001|Overall Study|Withdrawal by Subject|14|||
127596808|NCT01500694|459149437|FG000|Overall Study|Lost to Follow-up|2|||
127596809|NCT01500694|459149438|FG001|Overall Study|Lost to Follow-up|3|||
127596810|NCT01500694|459149437|FG000|Overall Study|Lack of Efficacy|14|||
127596811|NCT01500694|459149438|FG001|Overall Study|Lack of Efficacy|5|||
127596812|NCT01500694|459149437|FG000|Overall Study|Other|9|||
127596813|NCT01500694|459149438|FG001|Overall Study|Other|3|||
127596814|NCT00833794|459149439|FG000|Open-label Phase|Adverse Event|225|||
127596815|NCT00833794|459149440|FG001|Open-label Phase|Adverse Event|0|||
127596816|NCT00833794|459149439|FG000|Open-label Phase|Lack of Efficacy|28|||
127596817|NCT00833794|459149440|FG001|Open-label Phase|Lack of Efficacy|0|||
127596818|NCT00833794|459149439|FG000|Open-label Phase|Withdrawal by Subject|48|||
127596819|NCT00833794|459149440|FG001|Open-label Phase|Withdrawal by Subject|0|||
127596820|NCT00833794|459149439|FG000|Open-label Phase|Physician Decision|20|||
127596821|NCT00833794|459149440|FG001|Open-label Phase|Physician Decision|0|||
127596822|NCT00833794|459149439|FG000|Open-label Phase|Administrative reason|1|||
127596823|NCT00833794|459149440|FG001|Open-label Phase|Administrative reason|0|||
127596824|NCT00833794|459149439|FG000|Open-label Phase|Protocol Violation|47|||
127596825|NCT00833794|459149440|FG001|Open-label Phase|Protocol Violation|0|||
127596826|NCT00833794|459149439|FG000|Open-label Phase|Did not complete wash-out period|12|||
127596827|NCT00833794|459149440|FG001|Open-label Phase|Did not complete wash-out period|0|||
127596828|NCT00833794|459149439|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
127596829|NCT00833794|459149440|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
127596830|NCT00833794|459149439|FG000|Double-blind Phase|Adverse Event|44|||
127596831|NCT00833794|459149440|FG001|Double-blind Phase|Adverse Event|11|||
127596832|NCT00833794|459149439|FG000|Double-blind Phase|Lack of Efficacy|34|||
127596833|NCT00833794|459149440|FG001|Double-blind Phase|Lack of Efficacy|22|||
127596834|NCT00833794|459149439|FG000|Double-blind Phase|Withdrawal by Subject|23|||
127596835|NCT00833794|459149440|FG001|Double-blind Phase|Withdrawal by Subject|6|||
127596836|NCT00833794|459149439|FG000|Double-blind Phase|Physician Decision|4|||
127596837|NCT00833794|459149440|FG001|Double-blind Phase|Physician Decision|7|||
127596838|NCT00833794|459149439|FG000|Double-blind Phase|Administrative reason|1|||
127596839|NCT00833794|459149440|FG001|Double-blind Phase|Administrative reason|3|||
127596840|NCT02007109|459149443|FG000|Overall Study|Diary not returned or excluded|102|||
127596841|NCT02007109|459149443|FG000|Overall Study|Excluded - Age<7yo|9|||
127596842|NCT03572062|459149444|FG000|Overall Study|Adverse Event|0|||
127596843|NCT03572062|459149445|FG001|Overall Study|Adverse Event|0|||
127596844|NCT03572062|459149446|FG002|Overall Study|Adverse Event|0|||
127596845|NCT03572062|459149447|FG003|Overall Study|Adverse Event|0|||
127596846|NCT03572062|459149448|FG004|Overall Study|Adverse Event|0|||
127596847|NCT03572062|459149449|FG005|Overall Study|Adverse Event|0|||
127596848|NCT03572062|459149450|FG006|Overall Study|Adverse Event|0|||
127596849|NCT03572062|459149451|FG007|Overall Study|Adverse Event|0|||
127596850|NCT03572062|459149452|FG008|Overall Study|Adverse Event|1|||
127596851|NCT03572062|459149453|FG009|Overall Study|Adverse Event|3|||
127787239|NCT02819635|459846080|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
127787240|NCT02819635|459846081|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
127787241|NCT02819635|459846082|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
127787242|NCT02819635|459846083|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
127787243|NCT02819635|459846084|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
127787244|NCT02819635|459846085|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
127787245|NCT02819635|459846086|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
127787246|NCT02819635|459846075|FG000|Substudy 2, Part 2|Other, not specified|0|||
127787247|NCT02819635|459846076|FG001|Substudy 2, Part 2|Other, not specified|0|||
127787248|NCT02819635|459846077|FG002|Substudy 2, Part 2|Other, not specified|0|||
128035514|NCT01722669|460757915|FG004|Overall Study|Withdrawal by Subject|0|||
128035515|NCT01722669|460757916|FG005|Overall Study|Withdrawal by Subject|2|||
128035516|NCT00643279|460757928|FG000|Overall Study|Death|13|||
128035517|NCT00643279|460757929|FG001|Overall Study|Death|11|||
128035518|NCT00643279|460757928|FG000|Overall Study|Withdrawal by Subject|3|||
127596852|NCT03572062|459149444|FG000|Overall Study|Death|0|||
127596853|NCT03572062|459149445|FG001|Overall Study|Death|0|||
127596854|NCT03572062|459149446|FG002|Overall Study|Death|0|||
127596855|NCT03572062|459149447|FG003|Overall Study|Death|0|||
127596856|NCT03572062|459149448|FG004|Overall Study|Death|0|||
127596857|NCT03572062|459149449|FG005|Overall Study|Death|1|||
127787249|NCT02819635|459846078|FG003|Substudy 2, Part 2|Other, not specified|0|||
127787250|NCT02819635|459846079|FG004|Substudy 2, Part 2|Other, not specified|0|||
127787251|NCT02819635|459846080|FG005|Substudy 2, Part 2|Other, not specified|4|||
127787252|NCT02819635|459846081|FG006|Substudy 2, Part 2|Other, not specified|8|||
127787253|NCT02819635|459846082|FG007|Substudy 2, Part 2|Other, not specified|0|||
127787254|NCT02819635|459846083|FG008|Substudy 2, Part 2|Other, not specified|0|||
127787255|NCT02819635|459846084|FG009|Substudy 2, Part 2|Other, not specified|0|||
127787256|NCT02819635|459846085|FG010|Substudy 2, Part 2|Other, not specified|0|||
127787257|NCT02819635|459846086|FG011|Substudy 2, Part 2|Other, not specified|0|||
127787258|NCT02819635|459846075|FG000|Substudy 3|Adverse Event|0|||
127787259|NCT02819635|459846076|FG001|Substudy 3|Adverse Event|0|||
127787260|NCT02819635|459846077|FG002|Substudy 3|Adverse Event|0|||
127787261|NCT02819635|459846078|FG003|Substudy 3|Adverse Event|0|||
127787262|NCT02819635|459846079|FG004|Substudy 3|Adverse Event|0|||
127787263|NCT02819635|459846080|FG005|Substudy 3|Adverse Event|0|||
127787264|NCT02819635|459846081|FG006|Substudy 3|Adverse Event|0|||
127787265|NCT02819635|459846082|FG007|Substudy 3|Adverse Event|0|||
127787266|NCT02819635|459846083|FG008|Substudy 3|Adverse Event|32|||
127787267|NCT02819635|459846084|FG009|Substudy 3|Adverse Event|3|||
127787268|NCT02819635|459846085|FG010|Substudy 3|Adverse Event|12|||
127787269|NCT02819635|459846086|FG011|Substudy 3|Adverse Event|18|||
127787270|NCT02819635|459846075|FG000|Substudy 3|Withdrew consent|0|||
127787271|NCT02819635|459846076|FG001|Substudy 3|Withdrew consent|0|||
127787272|NCT02819635|459846077|FG002|Substudy 3|Withdrew consent|0|||
127787273|NCT02819635|459846078|FG003|Substudy 3|Withdrew consent|0|||
127787274|NCT02819635|459846079|FG004|Substudy 3|Withdrew consent|0|||
127787275|NCT02819635|459846080|FG005|Substudy 3|Withdrew consent|0|||
127787276|NCT02819635|459846081|FG006|Substudy 3|Withdrew consent|0|||
127787277|NCT02819635|459846082|FG007|Substudy 3|Withdrew consent|0|||
127787278|NCT02819635|459846083|FG008|Substudy 3|Withdrew consent|11|||
127787279|NCT02819635|459846084|FG009|Substudy 3|Withdrew consent|1|||
127787280|NCT02819635|459846085|FG010|Substudy 3|Withdrew consent|4|||
127787281|NCT02819635|459846086|FG011|Substudy 3|Withdrew consent|9|||
127787282|NCT02819635|459846075|FG000|Substudy 3|Lost to Follow-up|0|||
127787283|NCT02819635|459846076|FG001|Substudy 3|Lost to Follow-up|0|||
127787284|NCT02819635|459846077|FG002|Substudy 3|Lost to Follow-up|0|||
128035519|NCT00643279|460757929|FG001|Overall Study|Withdrawal by Subject|0|||
128035520|NCT00643279|460757928|FG000|Overall Study|Lost to Follow-up|0|||
128035521|NCT00643279|460757929|FG001|Overall Study|Lost to Follow-up|1|||
128035522|NCT00643279|460757928|FG000|Overall Study|Physician Decision|0|||
128035523|NCT00643279|460757929|FG001|Overall Study|Physician Decision|1|||
128035524|NCT05715827|460757930|FG000|Overall Study|Physician Decision|0|||
128035525|NCT05715827|460757931|FG001|Overall Study|Physician Decision|1|||
128035526|NCT05715827|460757930|FG000|Overall Study|console communication error|0|||
128035527|NCT05715827|460757931|FG001|Overall Study|console communication error|1|||
128035528|NCT03814044|460757932|FG000|Overall Study|Protocol deviation|1|||
128035529|NCT05929326|460757933|FG000|Overall Study|unqualified sample|2|||
128035530|NCT05929326|460757934|FG001|Overall Study|unqualified sample|3|||
128035531|NCT05929326|460757935|FG002|Overall Study|unqualified sample|7|||
128035532|NCT03557502|460757944|FG000|Protocol 2|Withdrawal by Subject|1|||
128035533|NCT03557502|460757945|FG001|Protocol 2|Withdrawal by Subject|1|||
128035534|NCT03557502|460757944|FG000|Protocol 2|Met exclusion criteria at Post timepoint|1|||
128035535|NCT03557502|460757945|FG001|Protocol 2|Met exclusion criteria at Post timepoint|1|||
128035536|NCT03021486|460759322|FG000|Overall Study|Withdrawal by Subject|1|||
128035537|NCT03021486|460759323|FG001|Overall Study|Withdrawal by Subject|1|||
127596858|NCT03572062|459149450|FG006|Overall Study|Death|0|||
127787285|NCT02819635|459846078|FG003|Substudy 3|Lost to Follow-up|0|||
127596859|NCT03572062|459149451|FG007|Overall Study|Death|0|||
127596860|NCT03572062|459149452|FG008|Overall Study|Death|0|||
127596861|NCT03572062|459149453|FG009|Overall Study|Death|0|||
127596862|NCT03572062|459149444|FG000|Overall Study|Lost to Follow-up|0|||
127596863|NCT03572062|459149445|FG001|Overall Study|Lost to Follow-up|0|||
127596864|NCT03572062|459149446|FG002|Overall Study|Lost to Follow-up|0|||
127596865|NCT03572062|459149447|FG003|Overall Study|Lost to Follow-up|0|||
127596866|NCT03572062|459149448|FG004|Overall Study|Lost to Follow-up|0|||
127596867|NCT03572062|459149449|FG005|Overall Study|Lost to Follow-up|1|||
127596868|NCT03572062|459149450|FG006|Overall Study|Lost to Follow-up|1|||
127596869|NCT03572062|459149451|FG007|Overall Study|Lost to Follow-up|0|||
127596870|NCT03572062|459149452|FG008|Overall Study|Lost to Follow-up|0|||
127596871|NCT03572062|459149453|FG009|Overall Study|Lost to Follow-up|0|||
127596872|NCT03572062|459149444|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
127596873|NCT03572062|459149445|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
127596874|NCT03572062|459149446|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
127596875|NCT03572062|459149447|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
127596876|NCT03572062|459149448|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
127596877|NCT03572062|459149449|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
127596878|NCT03572062|459149450|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
127596879|NCT03572062|459149451|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
127596880|NCT03572062|459149452|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
127596881|NCT03572062|459149453|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
127596882|NCT03572062|459149444|FG000|Overall Study|Study Terminated By Sponsor|0|||
127596883|NCT03572062|459149445|FG001|Overall Study|Study Terminated By Sponsor|0|||
127596884|NCT03572062|459149446|FG002|Overall Study|Study Terminated By Sponsor|0|||
127596885|NCT03572062|459149447|FG003|Overall Study|Study Terminated By Sponsor|0|||
127596886|NCT03572062|459149448|FG004|Overall Study|Study Terminated By Sponsor|0|||
127596887|NCT03572062|459149449|FG005|Overall Study|Study Terminated By Sponsor|0|||
127596888|NCT03572062|459149450|FG006|Overall Study|Study Terminated By Sponsor|0|||
127596889|NCT03572062|459149451|FG007|Overall Study|Study Terminated By Sponsor|0|||
127596890|NCT03572062|459149452|FG008|Overall Study|Study Terminated By Sponsor|29|||
127596891|NCT03572062|459149453|FG009|Overall Study|Study Terminated By Sponsor|27|||
127596892|NCT03572062|459149444|FG000|Overall Study|Physician Decision|0|||
127596893|NCT03572062|459149445|FG001|Overall Study|Physician Decision|0|||
127596894|NCT03572062|459149446|FG002|Overall Study|Physician Decision|0|||
127596895|NCT03572062|459149447|FG003|Overall Study|Physician Decision|0|||
127596896|NCT03572062|459149448|FG004|Overall Study|Physician Decision|0|||
127596897|NCT03572062|459149449|FG005|Overall Study|Physician Decision|0|||
127596898|NCT03572062|459149450|FG006|Overall Study|Physician Decision|0|||
127596899|NCT03572062|459149451|FG007|Overall Study|Physician Decision|0|||
127596900|NCT03572062|459149452|FG008|Overall Study|Physician Decision|1|||
127596901|NCT03572062|459149453|FG009|Overall Study|Physician Decision|0|||
127596902|NCT03572062|459149444|FG000|Overall Study|Withdrawal by Subject|0|||
127596903|NCT03572062|459149445|FG001|Overall Study|Withdrawal by Subject|0|||
127596904|NCT03572062|459149446|FG002|Overall Study|Withdrawal by Subject|0|||
127596905|NCT03572062|459149447|FG003|Overall Study|Withdrawal by Subject|0|||
127787286|NCT02819635|459846079|FG004|Substudy 3|Lost to Follow-up|0|||
127787287|NCT02819635|459846080|FG005|Substudy 3|Lost to Follow-up|0|||
128035538|NCT03021486|460759324|FG002|Overall Study|Withdrawal by Subject|3|||
128035539|NCT03021486|460759322|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
128035540|NCT03021486|460759323|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
128035541|NCT03021486|460759324|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
128035542|NCT04887831|460759325|FG000|Overall Study|Death|26|||
128035543|NCT04887831|460759326|FG001|Overall Study|Death|26|||
128035544|NCT04887831|460759325|FG000|Overall Study|Lost to Follow-up|0|||
128035545|NCT04887831|460759326|FG001|Overall Study|Lost to Follow-up|1|||
128035546|NCT04887831|460759325|FG000|Overall Study|Withdrawal by Subject|2|||
128035547|NCT04887831|460759326|FG001|Overall Study|Withdrawal by Subject|1|||
128035548|NCT04887831|460759325|FG000|Overall Study|Study Terminated by Sponsor|18|||
128035549|NCT04887831|460759326|FG001|Overall Study|Study Terminated by Sponsor|17|||
128035550|NCT04887831|460759325|FG000|Overall Study|Other|1|||
128035551|NCT04887831|460759326|FG001|Overall Study|Other|0|||
127596906|NCT03572062|459149448|FG004|Overall Study|Withdrawal by Subject|0|||
127596907|NCT03572062|459149449|FG005|Overall Study|Withdrawal by Subject|0|||
127596908|NCT03572062|459149450|FG006|Overall Study|Withdrawal by Subject|0|||
127596909|NCT03572062|459149451|FG007|Overall Study|Withdrawal by Subject|0|||
127596910|NCT03572062|459149452|FG008|Overall Study|Withdrawal by Subject|0|||
127596911|NCT03572062|459149453|FG009|Overall Study|Withdrawal by Subject|1|||
128035552|NCT00730327|460759327|FG000|Overall Study|Lost to Follow-up|14|||
127596912|NCT03572062|459149444|FG000|Overall Study|Randomized But Not Treated|0|||
127596913|NCT03572062|459149445|FG001|Overall Study|Randomized But Not Treated|0|||
127596914|NCT03572062|459149446|FG002|Overall Study|Randomized But Not Treated|0|||
128035553|NCT00730327|460759328|FG001|Overall Study|Lost to Follow-up|16|||
128035554|NCT00730327|460759327|FG000|Overall Study|Adverse Event|8|||
127596915|NCT03572062|459149447|FG003|Overall Study|Randomized But Not Treated|0|||
128035555|NCT00730327|460759328|FG001|Overall Study|Adverse Event|1|||
128035556|NCT00730327|460759327|FG000|Overall Study|Withdrawal by Subject|3|||
128035557|NCT00730327|460759328|FG001|Overall Study|Withdrawal by Subject|13|||
128035558|NCT00730327|460759327|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
128035559|NCT00730327|460759328|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
128035560|NCT02552225|460759329|FG000|Overall Study|Withdrawal by Subject|1|||
128035561|NCT02552225|460759330|FG001|Overall Study|Withdrawal by Subject|0|||
128035562|NCT01497197|460759331|FG000|Overall Study|Lost to Follow-up|1|||
128035563|NCT01497197|460759332|FG001|Overall Study|Lost to Follow-up|0|||
128035564|NCT01497197|460759331|FG000|Overall Study|Protocol Violation|0|||
128035565|NCT01497197|460759332|FG001|Overall Study|Protocol Violation|2|||
128035566|NCT01497197|460759331|FG000|Overall Study|Withdrawal by Subject|2|||
128035567|NCT01497197|460759332|FG001|Overall Study|Withdrawal by Subject|1|||
128035568|NCT01497197|460759331|FG000|Overall Study|Excessive/lack of response to treatment|1|||
128035569|NCT01497197|460759332|FG001|Overall Study|Excessive/lack of response to treatment|0|||
128035570|NCT01497197|460759331|FG000|Overall Study|Risk of OHSS|1|||
128035571|NCT01497197|460759332|FG001|Overall Study|Risk of OHSS|0|||
128035572|NCT01497197|460759331|FG000|Overall Study|No oocytes retrieved|3|||
128035573|NCT01497197|460759332|FG001|Overall Study|No oocytes retrieved|2|||
128035574|NCT01497197|460759331|FG000|Overall Study|No fertilisation|6|||
128035575|NCT01497197|460759332|FG001|Overall Study|No fertilisation|5|||
128035576|NCT01497197|460759331|FG000|Overall Study|Intention to freeze all embryos|0|||
128035577|NCT01497197|460759332|FG001|Overall Study|Intention to freeze all embryos|1|||
128035578|NCT01497197|460759331|FG000|Overall Study|All embryos discarded|0|||
128035579|NCT01497197|460759332|FG001|Overall Study|All embryos discarded|3|||
128035580|NCT01497197|460759331|FG000|Overall Study|Other|3|||
128035581|NCT01497197|460759332|FG001|Overall Study|Other|1|||
128035582|NCT04507204|460759335|FG000|Overall Study|Adverse Event|8|||
128035583|NCT04507204|460759336|FG001|Overall Study|Adverse Event|13|||
128035584|NCT04507204|460759335|FG000|Overall Study|Death|0|||
128035585|NCT04507204|460759336|FG001|Overall Study|Death|1|||
128035586|NCT04507204|460759335|FG000|Overall Study|Lost to Follow-up|15|||
128035587|NCT04507204|460759336|FG001|Overall Study|Lost to Follow-up|14|||
128035588|NCT04507204|460759335|FG000|Overall Study|Poor Compliance with Protocol|2|||
128035589|NCT04507204|460759336|FG001|Overall Study|Poor Compliance with Protocol|4|||
128035590|NCT04507204|460759335|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
128035591|NCT04507204|460759336|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
128035592|NCT04507204|460759335|FG000|Overall Study|Withdrawal of Patient Consent|21|||
128035593|NCT04507204|460759336|FG001|Overall Study|Withdrawal of Patient Consent|13|||
128035594|NCT01206517|460759341|FG000|Overall Study|Withdrawal by Subject|0|||
128035595|NCT01206517|460759342|FG001|Overall Study|Withdrawal by Subject|0|||
128035596|NCT01206517|460759343|FG002|Overall Study|Withdrawal by Subject|2|||
128035597|NCT01206517|460759344|FG003|Overall Study|Withdrawal by Subject|0|||
128035598|NCT01206517|460759345|FG004|Overall Study|Withdrawal by Subject|1|||
128035599|NCT01206517|460759346|FG005|Overall Study|Withdrawal by Subject|0|||
128035600|NCT03493958|460759347|FG000|Overall Study|Withdrawal by Subject|6|||
128035601|NCT03493958|460759347|FG000|Overall Study|Lost to Follow-up|7|||
128035602|NCT03493958|460759347|FG000|Overall Study|Did not complete all required study procedures|2|||
128035603|NCT04047446|460759348|FG000|Overall Study|Physician Decision|1|||
128035604|NCT04047446|460759349|FG001|Overall Study|Physician Decision|0|||
128035605|NCT02367456|460759350|FG000|Overall Study|Death|8|||
128035606|NCT02367456|460759351|FG001|Overall Study|Death|24|||
127596916|NCT03572062|459149448|FG004|Overall Study|Randomized But Not Treated|1|||
127596917|NCT03572062|459149449|FG005|Overall Study|Randomized But Not Treated|2|||
127596918|NCT03572062|459149450|FG006|Overall Study|Randomized But Not Treated|0|||
127596919|NCT03572062|459149451|FG007|Overall Study|Randomized But Not Treated|1|||
128035607|NCT02367456|460759352|FG002|Overall Study|Death|17|||
128035608|NCT02367456|460759350|FG000|Overall Study|Lost to Follow-up|1|||
128035609|NCT02367456|460759351|FG001|Overall Study|Lost to Follow-up|3|||
127596920|NCT03572062|459149452|FG008|Overall Study|Randomized But Not Treated|0|||
127596921|NCT03572062|459149453|FG009|Overall Study|Randomized But Not Treated|0|||
128035610|NCT02367456|460759352|FG002|Overall Study|Lost to Follow-up|1|||
128035611|NCT02367456|460759350|FG000|Overall Study|Other reason|3|||
128035612|NCT02367456|460759351|FG001|Overall Study|Other reason|3|||
128035613|NCT02367456|460759352|FG002|Overall Study|Other reason|9|||
128035614|NCT02367456|460759350|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
128035615|NCT02367456|460759351|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
128035616|NCT02367456|460759352|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
127596922|NCT01605877|459149454|FG000|Overall Study|Withdrawal by Subject|1|||
128035617|NCT01198587|460759358|FG000|Overall Study|Lost to Follow-up|8|||
128035618|NCT01198587|460759359|FG001|Overall Study|Lost to Follow-up|0|||
128035619|NCT01198587|460759360|FG002|Overall Study|Lost to Follow-up|9|||
128035620|NCT01198587|460759361|FG003|Overall Study|Lost to Follow-up|0|||
128035621|NCT02095106|460759364|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
127596923|NCT00458211|459149455|FG000|Overall Study|Lack of Efficacy|12|||
127596924|NCT00458211|459149455|FG000|Overall Study|Withdrawal by Subject|2|||
127596925|NCT00458211|459149455|FG000|Overall Study|Protocol Violation|2|||
127596926|NCT01918085|459149458|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
127596927|NCT01918085|459149459|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
127596928|NCT03310775|459149471|FG000|Overall Study|Lost to Follow-up|2|||
127596929|NCT03310775|459149472|FG001|Overall Study|Lost to Follow-up|3|||
127596930|NCT03310775|459149471|FG000|Overall Study|aggravation of depression|0|||
127596931|NCT03310775|459149472|FG001|Overall Study|aggravation of depression|1|||
127596932|NCT00679302|459149477|FG000|Overall Study|Lost to Follow-up|8|||
127596933|NCT00679302|459149478|FG001|Overall Study|Lost to Follow-up|4|||
127596934|NCT00646776|459149479|FG000|Overall Study|Adverse Event|1|||
127596935|NCT00646776|459149480|FG001|Overall Study|Adverse Event|9|||
127596936|NCT00646776|459149479|FG000|Overall Study|Investigator discretion|0|||
127596937|NCT00646776|459149480|FG001|Overall Study|Investigator discretion|4|||
127596938|NCT00126568|459149481|FG000|Overall Study|Death|2|||
127596939|NCT03031678|459149483|FG000|Overall Study|Study closed prior to completion|1|||
127596940|NCT01753856|459149484|FG000|Overall Study|Adverse Event|1|||
127596941|NCT01753856|459149485|FG001|Overall Study|Adverse Event|0|||
127596942|NCT01753856|459149484|FG000|Overall Study|Withdrawal by Subject|0|||
127596943|NCT01753856|459149485|FG001|Overall Study|Withdrawal by Subject|2|||
127596944|NCT01753856|459149484|FG000|Overall Study|Sponsor Decision|2|||
127596945|NCT01753856|459149485|FG001|Overall Study|Sponsor Decision|0|||
127596946|NCT00434330|459149490|FG000|Overall Study|Adverse Event|0|||
127596947|NCT00434330|459149491|FG001|Overall Study|Adverse Event|0|||
127596948|NCT00434330|459149492|FG002|Overall Study|Adverse Event|1|||
127596949|NCT00434330|459149493|FG003|Overall Study|Adverse Event|0|||
127596950|NCT00434330|459149494|FG004|Overall Study|Adverse Event|0|||
127596951|NCT00434330|459149495|FG005|Overall Study|Adverse Event|0|||
127596952|NCT00434330|459149490|FG000|Overall Study|Death|1|||
127596953|NCT00434330|459149491|FG001|Overall Study|Death|0|||
127596954|NCT00434330|459149492|FG002|Overall Study|Death|0|||
127596955|NCT00434330|459149493|FG003|Overall Study|Death|0|||
127596956|NCT00434330|459149494|FG004|Overall Study|Death|1|||
127596957|NCT00434330|459149495|FG005|Overall Study|Death|1|||
127596958|NCT00434330|459149490|FG000|Overall Study|Withdrawal by Subject|0|||
127596959|NCT00434330|459149491|FG001|Overall Study|Withdrawal by Subject|0|||
127596960|NCT00434330|459149492|FG002|Overall Study|Withdrawal by Subject|1|||
127596961|NCT00434330|459149493|FG003|Overall Study|Withdrawal by Subject|1|||
127596962|NCT00434330|459149494|FG004|Overall Study|Withdrawal by Subject|0|||
127596963|NCT00434330|459149495|FG005|Overall Study|Withdrawal by Subject|0|||
127596964|NCT00434330|459149490|FG000|Overall Study|Renal transplant|0|||
127596965|NCT00434330|459149491|FG001|Overall Study|Renal transplant|0|||
127596966|NCT00434330|459149492|FG002|Overall Study|Renal transplant|0|||
127596967|NCT00434330|459149493|FG003|Overall Study|Renal transplant|1|||
127596968|NCT00434330|459149494|FG004|Overall Study|Renal transplant|0|||
127596969|NCT00434330|459149495|FG005|Overall Study|Renal transplant|0|||
128035622|NCT02095106|460759365|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
128035623|NCT00553254|460759368|FG000|Overall Study|Death|3|||
128035624|NCT00553254|460759369|FG001|Overall Study|Death|6|||
128035625|NCT00553254|460759370|FG002|Overall Study|Death|25|||
128035626|NCT00553254|460759368|FG000|Overall Study|Lost to Follow-up|0|||
127596970|NCT00434330|459149490|FG000|Overall Study|Subject Not Compliant With Study|0|||
127596971|NCT00434330|459149491|FG001|Overall Study|Subject Not Compliant With Study|0|||
127596972|NCT00434330|459149492|FG002|Overall Study|Subject Not Compliant With Study|1|||
127596973|NCT00434330|459149493|FG003|Overall Study|Subject Not Compliant With Study|0|||
127596974|NCT00434330|459149494|FG004|Overall Study|Subject Not Compliant With Study|0|||
127596975|NCT00434330|459149495|FG005|Overall Study|Subject Not Compliant With Study|0|||
127596976|NCT04847557|459149496|FG000|Overall Study|Adverse Event|1|||
127596977|NCT04847557|459149497|FG001|Overall Study|Adverse Event|0|||
127596978|NCT04847557|459149496|FG000|Overall Study|Death|19|||
127596979|NCT04847557|459149497|FG001|Overall Study|Death|15|||
127596980|NCT04847557|459149496|FG000|Overall Study|Lost to Follow-up|3|||
127596981|NCT04847557|459149497|FG001|Overall Study|Lost to Follow-up|6|||
127596982|NCT04847557|459149496|FG000|Overall Study|Physician Decision|1|||
127596983|NCT04847557|459149497|FG001|Overall Study|Physician Decision|0|||
127596984|NCT04847557|459149496|FG000|Overall Study|Protocol Violation|0|||
127596985|NCT04847557|459149497|FG001|Overall Study|Protocol Violation|1|||
127596986|NCT04847557|459149496|FG000|Overall Study|Withdrawal by Subject|8|||
128035627|NCT00553254|460759369|FG001|Overall Study|Lost to Follow-up|0|||
128035628|NCT00553254|460759370|FG002|Overall Study|Lost to Follow-up|2|||
127596987|NCT04847557|459149497|FG001|Overall Study|Withdrawal by Subject|14|||
127596988|NCT02310568|459151887|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
127596989|NCT02310568|459151888|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
127596990|NCT02310568|459151889|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
127596991|NCT02310568|459151890|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
127596992|NCT02310568|459151891|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
127596993|NCT02310568|459151887|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
128035629|NCT00553254|460759368|FG000|Overall Study|Withdrawal by Subject|2|||
128035630|NCT00553254|460759369|FG001|Overall Study|Withdrawal by Subject|0|||
127596994|NCT02310568|459151888|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
127596995|NCT02310568|459151889|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
127596996|NCT02310568|459151890|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
127596997|NCT02310568|459151891|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
127596998|NCT02310568|459151887|FG000|Stage 1 ( 4 Weeks)|Other|1|||
127596999|NCT02310568|459151888|FG001|Stage 1 ( 4 Weeks)|Other|1|||
127597000|NCT02310568|459151889|FG002|Stage 1 ( 4 Weeks)|Other|0|||
127597001|NCT02310568|459151890|FG003|Stage 1 ( 4 Weeks)|Other|0|||
127597002|NCT02310568|459151891|FG004|Stage 1 ( 4 Weeks)|Other|0|||
127597003|NCT02310568|459151887|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
127597004|NCT02310568|459151888|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
127597005|NCT02310568|459151889|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
127597006|NCT02310568|459151890|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
127597007|NCT02310568|459151891|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
127597008|NCT02310568|459151887|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
127597009|NCT02310568|459151888|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
127597010|NCT02310568|459151889|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
127597011|NCT02310568|459151890|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
127597012|NCT02310568|459151891|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
127597013|NCT02310568|459151887|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
127597014|NCT02310568|459151888|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
127597015|NCT02310568|459151889|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
127597016|NCT02310568|459151890|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
127597017|NCT02310568|459151891|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
127597018|NCT02310568|459151887|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
127597019|NCT02310568|459151888|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
127597020|NCT02310568|459151889|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
127597021|NCT02310568|459151890|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
127597022|NCT02310568|459151891|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
127597023|NCT02310568|459151887|FG000|Stage 2 (4 Weeks)|Other|0|||
127597024|NCT02310568|459151888|FG001|Stage 2 (4 Weeks)|Other|1|||
127597025|NCT02310568|459151889|FG002|Stage 2 (4 Weeks)|Other|1|||
127597026|NCT02310568|459151890|FG003|Stage 2 (4 Weeks)|Other|0|||
127597027|NCT02310568|459151891|FG004|Stage 2 (4 Weeks)|Other|0|||
127597028|NCT02310568|459151887|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
127597029|NCT02310568|459151888|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
127597030|NCT02310568|459151889|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
127597031|NCT02310568|459151890|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
127597032|NCT02310568|459151891|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
127597033|NCT02310568|459151887|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
127597034|NCT02310568|459151888|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
127597035|NCT02310568|459151889|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
127597036|NCT02310568|459151890|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
127787288|NCT02819635|459846081|FG006|Substudy 3|Lost to Follow-up|0|||
127787289|NCT02819635|459846082|FG007|Substudy 3|Lost to Follow-up|0|||
127787290|NCT02819635|459846083|FG008|Substudy 3|Lost to Follow-up|1|||
127787291|NCT02819635|459846084|FG009|Substudy 3|Lost to Follow-up|0|||
127787292|NCT02819635|459846085|FG010|Substudy 3|Lost to Follow-up|1|||
127787293|NCT02819635|459846086|FG011|Substudy 3|Lost to Follow-up|1|||
127787294|NCT02819635|459846075|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
127787295|NCT02819635|459846076|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
127787296|NCT02819635|459846077|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
127787297|NCT02819635|459846078|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
127787298|NCT02819635|459846079|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
127787299|NCT02819635|459846080|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
127787300|NCT02819635|459846081|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
127787301|NCT02819635|459846082|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
127787302|NCT02819635|459846083|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
127597037|NCT02310568|459151891|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
127787303|NCT02819635|459846084|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
127787304|NCT02819635|459846085|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
127597038|NCT02310568|459151887|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
127597039|NCT02310568|459151888|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
127597040|NCT02310568|459151889|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
127597041|NCT02310568|459151890|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
127597042|NCT02310568|459151891|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
127597043|NCT02989194|459151901|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
127597044|NCT02989194|459151902|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
127597045|NCT02989194|459151903|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
127597046|NCT02989194|459151901|FG000|Overall Study|Lost to Follow-up|0|||
127597047|NCT02989194|459151902|FG001|Overall Study|Lost to Follow-up|1|||
127597048|NCT02989194|459151903|FG002|Overall Study|Lost to Follow-up|0|||
127597049|NCT02989194|459151901|FG000|Overall Study|Withdrawal by Subject|0|||
127597050|NCT02989194|459151902|FG001|Overall Study|Withdrawal by Subject|1|||
127787305|NCT02819635|459846086|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
127597051|NCT02989194|459151903|FG002|Overall Study|Withdrawal by Subject|0|||
127597052|NCT01549860|459151904|FG000|Overall Study|Withdrawal by Subject|1|||
127597053|NCT01549860|459151905|FG001|Overall Study|Withdrawal by Subject|0|||
127597054|NCT01549860|459151904|FG000|Overall Study|Physician Decision|1|||
127597055|NCT01549860|459151905|FG001|Overall Study|Physician Decision|1|||
127597056|NCT01224431|459151908|FG000|Overall Study|not randomized|0|||
127597057|NCT01224431|459151909|FG001|Overall Study|not randomized|4|||
127597058|NCT01224431|459151908|FG000|Overall Study|no video record|0|||
127597059|NCT01224431|459151909|FG001|Overall Study|no video record|1|||
127597060|NCT01327885|459151914|FG000|Overall Study|Disease progression-according to RECIST|173|||
127597061|NCT01327885|459151915|FG001|Overall Study|Disease progression-according to RECIST|165|||
127597062|NCT01327885|459151914|FG000|Overall Study|Clinical progression|24|||
127597063|NCT01327885|459151915|FG001|Overall Study|Clinical progression|27|||
127597064|NCT01327885|459151914|FG000|Overall Study|Adverse Event|14|||
127597065|NCT01327885|459151915|FG001|Overall Study|Adverse Event|10|||
127597066|NCT01327885|459151914|FG000|Overall Study|Subject choice|5|||
127597067|NCT01327885|459151915|FG001|Overall Study|Subject choice|10|||
127597068|NCT01327885|459151914|FG000|Overall Study|Other|8|||
127597069|NCT01327885|459151915|FG001|Overall Study|Other|6|||
127597070|NCT01327885|459151914|FG000|Overall Study|Withdrawal of consent from study|3|||
127597071|NCT01327885|459151915|FG001|Overall Study|Withdrawal of consent from study|4|||
127597072|NCT01327885|459151914|FG000|Overall Study|Not treated|1|||
127597073|NCT01327885|459151915|FG001|Overall Study|Not treated|1|||
127597074|NCT01327885|459151914|FG000|Overall Study|Administrative decision|0|||
127597075|NCT01327885|459151915|FG001|Overall Study|Administrative decision|1|||
127597076|NCT03824912|459151918|FG000|Overall Study|Lost to Follow-up|18|||
127597077|NCT03824912|459151919|FG001|Overall Study|Lost to Follow-up|15|||
127597078|NCT03824912|459151920|FG002|Overall Study|Lost to Follow-up|8|||
127597079|NCT03824912|459151918|FG000|Overall Study|Negative Baseline Culture Result|118|||
127597080|NCT03824912|459151919|FG001|Overall Study|Negative Baseline Culture Result|112|||
127597081|NCT03824912|459151920|FG002|Overall Study|Negative Baseline Culture Result|57|||
127597082|NCT03824912|459151918|FG000|Overall Study|Non-Compliance with Study Drug|0|||
127597083|NCT03824912|459151919|FG001|Overall Study|Non-Compliance with Study Drug|0|||
127597084|NCT03824912|459151920|FG002|Overall Study|Non-Compliance with Study Drug|1|||
127787306|NCT02819635|459846075|FG000|Substudy 3|Other, not specified|0|||
127787307|NCT02819635|459846076|FG001|Substudy 3|Other, not specified|0|||
127787308|NCT02819635|459846077|FG002|Substudy 3|Other, not specified|0|||
127787309|NCT02819635|459846078|FG003|Substudy 3|Other, not specified|0|||
127787310|NCT02819635|459846079|FG004|Substudy 3|Other, not specified|0|||
127787311|NCT02819635|459846080|FG005|Substudy 3|Other, not specified|0|||
127787312|NCT02819635|459846081|FG006|Substudy 3|Other, not specified|0|||
127597085|NCT03824912|459151918|FG000|Overall Study|Protocol Violation|1|||
127597086|NCT03824912|459151919|FG001|Overall Study|Protocol Violation|4|||
127597087|NCT03824912|459151920|FG002|Overall Study|Protocol Violation|1|||
127597088|NCT03824912|459151918|FG000|Overall Study|Withdrawal by Subject|3|||
127597089|NCT03824912|459151919|FG001|Overall Study|Withdrawal by Subject|2|||
127597090|NCT03824912|459151920|FG002|Overall Study|Withdrawal by Subject|1|||
127597091|NCT03824912|459151918|FG000|Overall Study|Participation in another study|0|||
127787313|NCT02819635|459846082|FG007|Substudy 3|Other, not specified|0|||
128035631|NCT00553254|460759370|FG002|Overall Study|Withdrawal by Subject|2|||
128035632|NCT00553254|460759368|FG000|Overall Study|Study terminated by Sponsor|0|||
128035633|NCT00553254|460759369|FG001|Overall Study|Study terminated by Sponsor|0|||
128035634|NCT00553254|460759370|FG002|Overall Study|Study terminated by Sponsor|1|||
128035635|NCT00553254|460759368|FG000|Overall Study|Other|1|||
128035636|NCT00553254|460759369|FG001|Overall Study|Other|0|||
128035637|NCT00553254|460759370|FG002|Overall Study|Other|13|||
128035638|NCT00754572|460759378|FG000|Overall Study|Adverse Event|19|||
128035639|NCT00754572|460759378|FG000|Overall Study|Other|39|||
128035640|NCT00754572|460759378|FG000|Overall Study|Protocol Violation|3|||
128035641|NCT00754572|460759378|FG000|Overall Study|Withdrawal by Subject|3|||
128035642|NCT00754572|460759378|FG000|Overall Study|Lack of Efficacy|2|||
128035643|NCT00754572|460759378|FG000|Overall Study|Death|1|||
128035644|NCT00754572|460759378|FG000|Overall Study|Administrative Reason|3|||
128035645|NCT00754572|460759378|FG000|Overall Study|Lost to Follow-up|1|||
128035646|NCT03746015|460759381|FG000|Overall Study|Withdrawal of Consent|1|||
128035647|NCT03746015|460759382|FG001|Overall Study|Withdrawal of Consent|0|||
128035648|NCT03746015|460759383|FG002|Overall Study|Withdrawal of Consent|0|||
128035649|NCT05134649|460759384|FG000|Overall Study|Lost to Follow-up|12|||
128035650|NCT05134649|460759384|FG000|Overall Study|Withdrawal by Subject|14|||
128035651|NCT05134649|460759384|FG000|Overall Study|Pregnancy|1|||
128035652|NCT05134649|460759384|FG000|Overall Study|Other, not specified|3|||
128035653|NCT01559935|460759385|FG000|Car Phase|Toxicity|4|||
128035654|NCT01559935|460759385|FG000|Car Phase|Death|1|||
128035655|NCT01559935|460759385|FG000|Car Phase|Lack of Efficacy|2|||
128035656|NCT01559935|460759385|FG000|Car Phase|Lost to Follow-up|1|||
128035657|NCT01559935|460759385|FG000|Car Phase|Physician Decision|1|||
128035658|NCT01559935|460759385|FG000|Car Phase|Withdrawal by Subject|2|||
128035659|NCT01559935|460759385|FG000|Car Phase|Per protocol|1|||
128035660|NCT01559935|460759385|FG000|Car Phase|Insurance|1|||
128035661|NCT01559935|460759385|FG000|Car Phase|non-compliance|1|||
128035662|NCT01559935|460759385|FG000|BiRD Phase|Toxicity|1|||
128035663|NCT01559935|460759385|FG000|BiRD Phase|Lack of Efficacy|1|||
128035664|NCT01559935|460759385|FG000|BiRD Phase|Withdrawal by Subject|2|||
128035665|NCT01559935|460759385|FG000|Maintenance Phase|Remains on study|28|||
128035666|NCT01559935|460759385|FG000|Maintenance Phase|Toxicity|1|||
128035667|NCT01559935|460759385|FG000|Maintenance Phase|Lack of Efficacy|18|||
128035668|NCT01559935|460759385|FG000|Maintenance Phase|Withdrawal by Subject|5|||
128035669|NCT01559935|460759385|FG000|Maintenance Phase|Non-compliance|2|||
128035670|NCT01038323|460759391|FG000|Overall Study|Withdrawal by Subject|3|||
128035671|NCT01038323|460759392|FG001|Overall Study|Withdrawal by Subject|2|||
128035672|NCT01038323|460759393|FG002|Overall Study|Withdrawal by Subject|4|||
128035673|NCT01143402|460759394|FG000|Overall Study|Rapid clinical decline|1|||
128035674|NCT01143402|460759395|FG001|Overall Study|Rapid clinical decline|1|||
128035675|NCT01143402|460759396|FG002|Overall Study|Rapid clinical decline|0|||
128035676|NCT01143402|460759394|FG000|Overall Study|Not Treated|0|||
128035677|NCT01143402|460759395|FG001|Overall Study|Not Treated|0|||
128035678|NCT01143402|460759396|FG002|Overall Study|Not Treated|1|||
128035679|NCT02526290|460759397|FG000|Overall Study|Adverse Event|3|||
128035680|NCT02526290|460759397|FG000|Overall Study|Withdrawal by Subject|4|||
128035681|NCT02526290|460759397|FG000|Overall Study|Physician Decision|1|||
128035682|NCT00619866|460759401|FG000|Weeks 1 - 12|Adverse Event|0|||
128035683|NCT00619866|460759402|FG001|Weeks 1 - 12|Adverse Event|1|||
128035684|NCT00619866|460759403|FG002|Weeks 1 - 12|Adverse Event|2|||
128035685|NCT00619866|460759404|FG003|Weeks 1 - 12|Adverse Event|0|||
128035686|NCT00619866|460759405|FG004|Weeks 1 - 12|Adverse Event|0|||
128035687|NCT00619866|460759401|FG000|Weeks 1 - 12|Non-compliance|0|||
128035688|NCT00619866|460759402|FG001|Weeks 1 - 12|Non-compliance|0|||
128035689|NCT00619866|460759403|FG002|Weeks 1 - 12|Non-compliance|1|||
128035690|NCT00619866|460759404|FG003|Weeks 1 - 12|Non-compliance|0|||
128035691|NCT00619866|460759405|FG004|Weeks 1 - 12|Non-compliance|0|||
128035692|NCT00619866|460759401|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
127597092|NCT03824912|459151919|FG001|Overall Study|Participation in another study|1|||
128035693|NCT00619866|460759402|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
127787314|NCT02819635|459846083|FG008|Substudy 3|Other, not specified|202|||
128035694|NCT00619866|460759403|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
128035695|NCT00619866|460759404|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
128035696|NCT00619866|460759405|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
128035697|NCT00619866|460759401|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
128035698|NCT00619866|460759402|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
128035699|NCT00619866|460759403|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
128035700|NCT00619866|460759404|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
128035701|NCT00619866|460759405|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
128035702|NCT00619866|460759401|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
128035703|NCT00619866|460759402|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
128035704|NCT00619866|460759403|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
128035705|NCT00619866|460759404|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
128035706|NCT00619866|460759405|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
128035707|NCT00619866|460759401|FG000|Weeks 1 - 12|Sponsor Decision|0|||
128035708|NCT00619866|460759402|FG001|Weeks 1 - 12|Sponsor Decision|1|||
128035709|NCT00619866|460759403|FG002|Weeks 1 - 12|Sponsor Decision|0|||
128035710|NCT00619866|460759404|FG003|Weeks 1 - 12|Sponsor Decision|0|||
128035711|NCT00619866|460759405|FG004|Weeks 1 - 12|Sponsor Decision|0|||
128035712|NCT00619866|460759401|FG000|Weeks 13 - 24|Adverse Event|0|||
128035713|NCT00619866|460759402|FG001|Weeks 13 - 24|Adverse Event|0|||
128035714|NCT00619866|460759403|FG002|Weeks 13 - 24|Adverse Event|2|||
128035715|NCT00619866|460759404|FG003|Weeks 13 - 24|Adverse Event|1|||
128035716|NCT00619866|460759405|FG004|Weeks 13 - 24|Adverse Event|0|||
128035717|NCT00619866|460759401|FG000|Weeks 13 - 24|Protocol Deviation|0|||
128035718|NCT00619866|460759402|FG001|Weeks 13 - 24|Protocol Deviation|0|||
128035719|NCT00619866|460759403|FG002|Weeks 13 - 24|Protocol Deviation|0|||
128035720|NCT00619866|460759404|FG003|Weeks 13 - 24|Protocol Deviation|1|||
128035721|NCT00619866|460759405|FG004|Weeks 13 - 24|Protocol Deviation|0|||
128035722|NCT00619866|460759401|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
128035723|NCT00619866|460759402|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
128035724|NCT00619866|460759403|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
128035725|NCT00619866|460759404|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
128035726|NCT00619866|460759405|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
128035727|NCT00619866|460759401|FG000|Weeks 13 - 24|Non-compliance|0|||
128035728|NCT00619866|460759402|FG001|Weeks 13 - 24|Non-compliance|1|||
128035729|NCT00619866|460759403|FG002|Weeks 13 - 24|Non-compliance|1|||
128035730|NCT00619866|460759404|FG003|Weeks 13 - 24|Non-compliance|0|||
128035731|NCT00619866|460759405|FG004|Weeks 13 - 24|Non-compliance|0|||
128035732|NCT00619866|460759401|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
128035733|NCT00619866|460759402|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
128035734|NCT00619866|460759403|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
128035735|NCT00619866|460759404|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
128035736|NCT00619866|460759405|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
128035737|NCT02589938|460759412|FG000|Overall Study|Withdrawal by Subject|11|||
128035738|NCT02589938|460759413|FG001|Overall Study|Withdrawal by Subject|5|||
128035739|NCT02589938|460759414|FG002|Overall Study|Withdrawal by Subject|6|||
128035740|NCT02589938|460759412|FG000|Overall Study|Lost to Follow-up|3|||
128035741|NCT02589938|460759413|FG001|Overall Study|Lost to Follow-up|3|||
128035742|NCT02589938|460759414|FG002|Overall Study|Lost to Follow-up|3|||
128035743|NCT02589938|460759412|FG000|Overall Study|Death|1|||
128035744|NCT02589938|460759413|FG001|Overall Study|Death|0|||
128035745|NCT02589938|460759414|FG002|Overall Study|Death|1|||
128035746|NCT02589938|460759412|FG000|Overall Study|Protocol Violation|6|||
128035747|NCT02589938|460759413|FG001|Overall Study|Protocol Violation|2|||
128035748|NCT02589938|460759414|FG002|Overall Study|Protocol Violation|3|||
128035749|NCT02589938|460759412|FG000|Overall Study|Physician Decision|1|||
128035750|NCT02589938|460759413|FG001|Overall Study|Physician Decision|0|||
128035751|NCT02589938|460759414|FG002|Overall Study|Physician Decision|0|||
128035752|NCT02589938|460759412|FG000|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|2|||
128035753|NCT02589938|460759413|FG001|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|3|||
128035754|NCT02589938|460759414|FG002|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|4|||
128035755|NCT02521285|460759415|FG000|Overall Study|Lost to Follow-up|1|||
128035756|NCT02521285|460759416|FG001|Overall Study|Lost to Follow-up|1|||
128035757|NCT02521285|460759415|FG000|Overall Study|Withdrawal by Subject|1|||
128035758|NCT02521285|460759416|FG001|Overall Study|Withdrawal by Subject|1|||
128035759|NCT02521285|460759415|FG000|Overall Study|Adverse Event|0|||
128035760|NCT02521285|460759416|FG001|Overall Study|Adverse Event|1|||
128035761|NCT01121757|460759419|FG000|First Drug|Death|1|||
128035762|NCT01121757|460759420|FG001|First Drug|Death|0|||
128035763|NCT01121757|460759419|FG000|First Drug|Disease Progression|0|||
128035764|NCT01121757|460759420|FG001|First Drug|Disease Progression|2|||
128035765|NCT01121757|460759419|FG000|Combination|Physician Decision|0|||
128035766|NCT01121757|460759420|FG001|Combination|Physician Decision|1|||
128035767|NCT01121757|460759419|FG000|Combination|Disease Progression|2|||
128035768|NCT01121757|460759420|FG001|Combination|Disease Progression|0|||
128035769|NCT04251533|460759421|FG000|Overall Study|Progressive disease|33|||
128035770|NCT04251533|460759422|FG001|Overall Study|Progressive disease|29|||
128035771|NCT04251533|460759423|FG002|Overall Study|Progressive disease|22|||
128035772|NCT04251533|460759421|FG000|Overall Study|Death|5|||
128035773|NCT04251533|460759422|FG001|Overall Study|Death|1|||
128035774|NCT04251533|460759423|FG002|Overall Study|Death|3|||
128035775|NCT04251533|460759421|FG000|Overall Study|Physician Decision|3|||
128035776|NCT04251533|460759422|FG001|Overall Study|Physician Decision|2|||
128035777|NCT04251533|460759423|FG002|Overall Study|Physician Decision|4|||
127787315|NCT02819635|459846084|FG009|Substudy 3|Other, not specified|5|||
128035778|NCT04251533|460759421|FG000|Overall Study|Participant decision|1|||
128035779|NCT04251533|460759422|FG001|Overall Study|Participant decision|3|||
128035780|NCT04251533|460759423|FG002|Overall Study|Participant decision|1|||
128035781|NCT04251533|460759421|FG000|Overall Study|Adverse Event|2|||
128035782|NCT04251533|460759422|FG001|Overall Study|Adverse Event|1|||
128035783|NCT04251533|460759423|FG002|Overall Study|Adverse Event|1|||
128035784|NCT00210132|460759428|FG000|Overall Study|Protocol Violation|1|||
128035785|NCT00210132|460759429|FG001|Overall Study|Protocol Violation|4|||
127882443|NCT00883740|460192785|FG001|First Intervention|Adverse Event|2|||
127597093|NCT03824912|459151920|FG002|Overall Study|Participation in another study|0|||
127597094|NCT02511184|459151921|FG000|Overall Study|Death|1|||
127597095|NCT02511184|459151922|FG001|Overall Study|Death|0|||
127597096|NCT02511184|459151921|FG000|Overall Study|Lost to Follow-up|0|||
127597097|NCT02511184|459151922|FG001|Overall Study|Lost to Follow-up|1|||
127597098|NCT02511184|459151921|FG000|Overall Study|Study terminated by sponsor|1|||
127597099|NCT02511184|459151922|FG001|Overall Study|Study terminated by sponsor|5|||
127597100|NCT02511184|459151921|FG000|Overall Study|Withdrawal by Subject|0|||
127695609|NCT02783300|459512934|FG001|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
127597101|NCT02511184|459151922|FG001|Overall Study|Withdrawal by Subject|1|||
127597102|NCT01963403|459151927|FG000|Overall Study|Lost to Follow-up|2|||
127597103|NCT01963403|459151928|FG001|Overall Study|Lost to Follow-up|3|||
127597104|NCT01963403|459151927|FG000|Overall Study|Implant removal|0|||
127597105|NCT01963403|459151928|FG001|Overall Study|Implant removal|1|||
127597106|NCT03519932|459151935|FG000|First Intervention|Adverse Event|1|||
127597107|NCT03519932|459151936|FG001|First Intervention|Adverse Event|3|||
127597108|NCT02254486|459151937|FG000|Overall Study|Adverse Event|1|||
127597109|NCT02254486|459151938|FG001|Overall Study|Adverse Event|1|||
127597110|NCT02254486|459151937|FG000|Overall Study|Lack of Efficacy|1|||
127597111|NCT02254486|459151938|FG001|Overall Study|Lack of Efficacy|0|||
127597112|NCT02254486|459151937|FG000|Overall Study|Lost to Follow-up|2|||
127597113|NCT02254486|459151938|FG001|Overall Study|Lost to Follow-up|4|||
127597114|NCT02254486|459151937|FG000|Overall Study|Protocol Violation|1|||
127597115|NCT02254486|459151938|FG001|Overall Study|Protocol Violation|2|||
127597116|NCT02254486|459151937|FG000|Overall Study|Withdrawal by Subject|17|||
127597117|NCT02254486|459151938|FG001|Overall Study|Withdrawal by Subject|15|||
127597118|NCT02254486|459151937|FG000|Overall Study|GFR<60mL/min|16|||
127597119|NCT02254486|459151938|FG001|Overall Study|GFR<60mL/min|21|||
127597120|NCT02254486|459151937|FG000|Overall Study|Various|12|||
127597121|NCT02254486|459151938|FG001|Overall Study|Various|12|||
127597122|NCT01350414|459151939|FG000|Overall Study|Lost to Follow-up|13|||
127597123|NCT01350414|459151939|FG000|Overall Study|Withdrawal by Subject|4|||
127597124|NCT01350414|459151939|FG000|Overall Study|Physician Decision|2|||
127597125|NCT04016285|459151940|FG000|Overall Study|Did not progress to surgery|2|||
127597126|NCT04016285|459151941|FG001|Overall Study|Did not progress to surgery|5|||
127597127|NCT04016285|459151940|FG000|Overall Study|Failed to collect outcome data|5|||
127597128|NCT04016285|459151941|FG001|Overall Study|Failed to collect outcome data|3|||
127597129|NCT02573350|459151944|FG000|Overall Study|Lost to Follow-up|2|||
127597130|NCT02573350|459151945|FG001|Overall Study|Lost to Follow-up|1|||
127597131|NCT02573350|459151944|FG000|Overall Study|Adverse Event|3|||
127597132|NCT02573350|459151945|FG001|Overall Study|Adverse Event|4|||
127597133|NCT02573350|459151944|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
127597134|NCT02573350|459151945|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
127597135|NCT02573350|459151944|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
127597136|NCT02573350|459151945|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
127597137|NCT02573350|459151944|FG000|Overall Study|Subject withdrew consent to participate|6|||
127597138|NCT02573350|459151945|FG001|Overall Study|Subject withdrew consent to participate|1|||
127597139|NCT02573350|459151944|FG000|Overall Study|Protocol Deviation|1|||
127597140|NCT02573350|459151945|FG001|Overall Study|Protocol Deviation|1|||
127597141|NCT01979016|459151946|FG000|Overall Study|Withdrawal by Subject|2|||
127597142|NCT01979016|459151947|FG001|Overall Study|Withdrawal by Subject|0|||
127597143|NCT01979016|459151946|FG000|Overall Study|Adverse Event|0|||
127597144|NCT01979016|459151947|FG001|Overall Study|Adverse Event|1|||
127597145|NCT04983264|459151948|FG000|Part B: Multiple Dose Period|Physician Decision|0|||
127597146|NCT04983264|459151949|FG001|Part B: Multiple Dose Period|Physician Decision|1|||
127597147|NCT04983264|459151950|FG002|Part B: Multiple Dose Period|Physician Decision|0|||
127597148|NCT04983264|459151948|FG000|Part C: Extended Treatment Period|Physician Decision|0|||
127695610|NCT02783300|459512935|FG002|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
127695611|NCT02783300|459512936|FG003|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
127695612|NCT02783300|459512937|FG004|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
127695613|NCT02783300|459512938|FG005|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
127695614|NCT02783300|459512939|FG006|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
127695615|NCT02783300|459512940|FG007|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
127695616|NCT02783300|459512941|FG008|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
127695617|NCT02783300|459512942|FG009|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
127695618|NCT02783300|459512943|FG010|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
127695619|NCT02783300|459512944|FG011|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
127882444|NCT00883740|460192784|FG000|Second Intervention|Protocol Violation|1|||
127597149|NCT04983264|459151949|FG001|Part C: Extended Treatment Period|Physician Decision|0|||
127597150|NCT04983264|459151950|FG002|Part C: Extended Treatment Period|Physician Decision|1|||
127597151|NCT02551731|459151955|FG000|Overall Study|Withdrawal by Subject|2|||
127597152|NCT03765918|459151964|FG000|Overall Study|Death|109|||
127597153|NCT03765918|459151965|FG001|Overall Study|Death|127|||
127597154|NCT03765918|459151964|FG000|Overall Study|Lost to Follow-up|2|||
127597155|NCT03765918|459151965|FG001|Overall Study|Lost to Follow-up|3|||
127597156|NCT03765918|459151964|FG000|Overall Study|Withdrawal by Subject|12|||
127597157|NCT03765918|459151965|FG001|Overall Study|Withdrawal by Subject|16|||
127597158|NCT03765918|459151964|FG000|Overall Study|Participants Ongoing|240|||
127597159|NCT03765918|459151965|FG001|Overall Study|Participants Ongoing|205|||
127597160|NCT04202965|459151966|FG000|Overall Study|Adverse Event|3|||
127597161|NCT04202965|459151966|FG000|Overall Study|Did not meet inclusion criteria|1|||
127597162|NCT00356369|459151967|FG000|Active Phase|Withdrawal by Subject|2|||
127597163|NCT00356369|459151968|FG001|Active Phase|Withdrawal by Subject|1|||
127597164|NCT02117648|459151971|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
127597165|NCT02117648|459151971|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
127597166|NCT02117648|459151971|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
127597167|NCT02117648|459151971|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
127597168|NCT02117648|459151971|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
127597169|NCT02117648|459151971|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
127597170|NCT02117648|459151971|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
127597171|NCT02117648|459151971|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
127597172|NCT02117648|459151971|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
127597173|NCT02117648|459151971|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
127597174|NCT02117648|459151971|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
127597175|NCT01985867|459151972|FG000|Overall Study|Lost to Follow-up|3|||
127597176|NCT01985867|459151973|FG001|Overall Study|Lost to Follow-up|4|||
127597177|NCT01985867|459151972|FG000|Overall Study|Adverse Event|3|||
127597178|NCT01985867|459151973|FG001|Overall Study|Adverse Event|2|||
127597179|NCT01985867|459151972|FG000|Overall Study|Lack of Efficacy|1|||
127597180|NCT01985867|459151973|FG001|Overall Study|Lack of Efficacy|0|||
127597181|NCT00553514|459151976|FG000|Overall Study|Protocol deviation|0|||
127597182|NCT00553514|459151977|FG001|Overall Study|Protocol deviation|0|||
127597183|NCT00553514|459151978|FG002|Overall Study|Protocol deviation|0|||
127597184|NCT00553514|459151979|FG003|Overall Study|Protocol deviation|1|||
127597185|NCT00553514|459151980|FG004|Overall Study|Protocol deviation|0|||
127597186|NCT00553514|459151976|FG000|Overall Study|Lack of ovarian response|4|||
127597187|NCT00553514|459151977|FG001|Overall Study|Lack of ovarian response|5|||
127597188|NCT00553514|459151978|FG002|Overall Study|Lack of ovarian response|5|||
127597189|NCT00553514|459151979|FG003|Overall Study|Lack of ovarian response|5|||
127597190|NCT00553514|459151980|FG004|Overall Study|Lack of ovarian response|6|||
127597191|NCT00553514|459151976|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
127597192|NCT00553514|459151977|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
127597193|NCT00553514|459151978|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
127597194|NCT00553514|459151979|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
127597195|NCT00553514|459151980|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
127597196|NCT00553514|459151976|FG000|Overall Study|Risk of multiple pregnancy|0|||
127597197|NCT00553514|459151977|FG001|Overall Study|Risk of multiple pregnancy|2|||
127597198|NCT00553514|459151978|FG002|Overall Study|Risk of multiple pregnancy|0|||
127597199|NCT00553514|459151979|FG003|Overall Study|Risk of multiple pregnancy|1|||
127597200|NCT00553514|459151980|FG004|Overall Study|Risk of multiple pregnancy|0|||
127597201|NCT00553514|459151976|FG000|Overall Study|Other|1|||
127597202|NCT00553514|459151977|FG001|Overall Study|Other|1|||
127597203|NCT00553514|459151978|FG002|Overall Study|Other|0|||
127597204|NCT00553514|459151979|FG003|Overall Study|Other|0|||
127597205|NCT00553514|459151980|FG004|Overall Study|Other|1|||
127597206|NCT01442675|459151985|FG000|Overall Study|Protocol Violation|6|||
127597207|NCT01442675|459151985|FG000|Overall Study|Lost to Follow-up|2|||
127597208|NCT01442675|459151985|FG000|Overall Study|Withdrawal by Subject|4|||
127597209|NCT01919723|459151986|FG000|Overall Study|Blood Samples Hemolyzed|2|||
127597210|NCT01919723|459151987|FG001|Overall Study|Blood Samples Hemolyzed|2|||
127695620|NCT02783300|459512945|FG012|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
127597211|NCT00752232|459151988|FG000|Overall Study|Protocol Violation|0|||
127597212|NCT00752232|459151989|FG001|Overall Study|Protocol Violation|0|||
127597213|NCT00752232|459151990|FG002|Overall Study|Protocol Violation|0|||
127597214|NCT00752232|459151991|FG003|Overall Study|Protocol Violation|0|||
127597215|NCT00752232|459151992|FG004|Overall Study|Protocol Violation|0|||
127597216|NCT00752232|459151993|FG005|Overall Study|Protocol Violation|1|||
127597217|NCT00752232|459151994|FG006|Overall Study|Protocol Violation|0|||
127597218|NCT00752232|459151988|FG000|Overall Study|Caregiver request|2|||
127597219|NCT00752232|459151989|FG001|Overall Study|Caregiver request|0|||
127597220|NCT00752232|459151990|FG002|Overall Study|Caregiver request|0|||
127597221|NCT00752232|459151991|FG003|Overall Study|Caregiver request|0|||
127597222|NCT00752232|459151992|FG004|Overall Study|Caregiver request|1|||
127597223|NCT00752232|459151993|FG005|Overall Study|Caregiver request|0|||
127597224|NCT00752232|459151994|FG006|Overall Study|Caregiver request|0|||
127597225|NCT00752232|459151988|FG000|Overall Study|Investigator request|0|||
127597226|NCT00752232|459151989|FG001|Overall Study|Investigator request|0|||
127597227|NCT00752232|459151990|FG002|Overall Study|Investigator request|0|||
127597228|NCT00752232|459151991|FG003|Overall Study|Investigator request|0|||
127597229|NCT00752232|459151992|FG004|Overall Study|Investigator request|1|||
127597230|NCT00752232|459151993|FG005|Overall Study|Investigator request|0|||
127597231|NCT00752232|459151994|FG006|Overall Study|Investigator request|0|||
127597232|NCT00752232|459151988|FG000|Overall Study|Subject request|0|||
127597233|NCT00752232|459151989|FG001|Overall Study|Subject request|0|||
127597234|NCT00752232|459151990|FG002|Overall Study|Subject request|1|||
127597235|NCT00752232|459151991|FG003|Overall Study|Subject request|0|||
127597236|NCT00752232|459151992|FG004|Overall Study|Subject request|0|||
127597237|NCT00752232|459151993|FG005|Overall Study|Subject request|0|||
127597238|NCT00752232|459151994|FG006|Overall Study|Subject request|0|||
127597239|NCT00752232|459151988|FG000|Overall Study|Group home admission|0|||
127597240|NCT00752232|459151989|FG001|Overall Study|Group home admission|0|||
127597241|NCT00752232|459151990|FG002|Overall Study|Group home admission|0|||
127597242|NCT00752232|459151991|FG003|Overall Study|Group home admission|1|||
127597243|NCT00752232|459151992|FG004|Overall Study|Group home admission|0|||
127597244|NCT00752232|459151993|FG005|Overall Study|Group home admission|0|||
127597245|NCT00752232|459151994|FG006|Overall Study|Group home admission|0|||
127597246|NCT00752232|459151988|FG000|Overall Study|Caregiver could not attend the subject|0|||
127597247|NCT00752232|459151989|FG001|Overall Study|Caregiver could not attend the subject|0|||
127597248|NCT00752232|459151990|FG002|Overall Study|Caregiver could not attend the subject|0|||
127597249|NCT00752232|459151991|FG003|Overall Study|Caregiver could not attend the subject|0|||
127597250|NCT00752232|459151992|FG004|Overall Study|Caregiver could not attend the subject|1|||
127597251|NCT00752232|459151993|FG005|Overall Study|Caregiver could not attend the subject|0|||
127597252|NCT00752232|459151994|FG006|Overall Study|Caregiver could not attend the subject|0|||
127597253|NCT04502589|459151995|FG000|Overall Study|Physician Decision|1|||
127597254|NCT04502589|459151996|FG001|Overall Study|Physician Decision|0|||
127597255|NCT00555321|459151997|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
127597256|NCT00555321|459151998|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
127597257|NCT00555321|459151999|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
127597258|NCT00555321|459152000|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
127597259|NCT00555321|459152001|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
127597260|NCT00555321|459151997|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
127597261|NCT00555321|459151998|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
127597262|NCT00555321|459151999|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
127597263|NCT00555321|459152000|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
127597264|NCT00555321|459152001|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
127597265|NCT00555321|459151997|FG000|Treatment Phase up to 12-months|Death|2|||
127597266|NCT00555321|459151998|FG001|Treatment Phase up to 12-months|Death|1|||
127597267|NCT00555321|459151999|FG002|Treatment Phase up to 12-months|Death|4|||
127597268|NCT00555321|459152000|FG003|Treatment Phase up to 12-months|Death|0|||
127597269|NCT00555321|459152001|FG004|Treatment Phase up to 12-months|Death|0|||
127597270|NCT00555321|459151997|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
127597271|NCT00555321|459151998|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
127597272|NCT00555321|459151999|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
127597273|NCT00555321|459152000|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
127597274|NCT00555321|459152001|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
127597275|NCT00555321|459151997|FG000|Treatment Phase up to 12-months|Other Reason|1|||
127597276|NCT00555321|459151998|FG001|Treatment Phase up to 12-months|Other Reason|3|||
127597277|NCT00555321|459151999|FG002|Treatment Phase up to 12-months|Other Reason|2|||
127597278|NCT00555321|459152000|FG003|Treatment Phase up to 12-months|Other Reason|0|||
127597279|NCT00555321|459152001|FG004|Treatment Phase up to 12-months|Other Reason|0|||
127597280|NCT00555321|459151997|FG000|Treatment Phase up to 12-months|Never treated|2|||
127597281|NCT00555321|459151998|FG001|Treatment Phase up to 12-months|Never treated|3|||
127597282|NCT00555321|459151999|FG002|Treatment Phase up to 12-months|Never treated|1|||
127597283|NCT00555321|459152000|FG003|Treatment Phase up to 12-months|Never treated|0|||
127597284|NCT00555321|459152001|FG004|Treatment Phase up to 12-months|Never treated|4|||
127695621|NCT02783300|459512946|FG013|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
127597285|NCT00555321|459151997|FG000|Long-term Extension Phase|Adverse Event|2|||
127597286|NCT00555321|459151998|FG001|Long-term Extension Phase|Adverse Event|5|||
127597287|NCT00555321|459151999|FG002|Long-term Extension Phase|Adverse Event|2|||
127597288|NCT00555321|459152000|FG003|Long-term Extension Phase|Adverse Event|1|||
127597289|NCT00555321|459152001|FG004|Long-term Extension Phase|Adverse Event|0|||
127597290|NCT00555321|459151997|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
127597291|NCT00555321|459151998|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
127597292|NCT00555321|459151999|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
127597293|NCT00555321|459152000|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
127695622|NCT02783300|459512947|FG014|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
127597294|NCT00555321|459152001|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
127597295|NCT00555321|459151997|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
127597296|NCT00555321|459151998|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
127597297|NCT00555321|459151999|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
127597298|NCT00555321|459152000|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
127597299|NCT00555321|459152001|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
127597300|NCT00555321|459151997|FG000|Long-term Extension Phase|Death|2|||
127597301|NCT00555321|459151998|FG001|Long-term Extension Phase|Death|0|||
127597302|NCT00555321|459151999|FG002|Long-term Extension Phase|Death|0|||
127597303|NCT00555321|459152000|FG003|Long-term Extension Phase|Death|3|||
127597304|NCT00555321|459152001|FG004|Long-term Extension Phase|Death|0|||
127597305|NCT00555321|459151997|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
127597306|NCT00555321|459151998|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
127597307|NCT00555321|459151999|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
127597308|NCT00555321|459152000|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
127597309|NCT00555321|459152001|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
127597310|NCT00555321|459151997|FG000|Long-term Extension Phase|Other Reason|1|||
127597311|NCT00555321|459151998|FG001|Long-term Extension Phase|Other Reason|0|||
127597312|NCT00555321|459151999|FG002|Long-term Extension Phase|Other Reason|2|||
127597313|NCT00555321|459152000|FG003|Long-term Extension Phase|Other Reason|0|||
127597314|NCT00555321|459152001|FG004|Long-term Extension Phase|Other Reason|0|||
127597315|NCT00160251|459152002|FG000|Prior to Amendment 2|Adverse Event|2|||
127597316|NCT00160251|459152003|FG001|Prior to Amendment 2|Adverse Event|1|||
127597317|NCT00160251|459152004|FG002|Prior to Amendment 2|Adverse Event|3|||
127597318|NCT00160251|459152005|FG003|Prior to Amendment 2|Adverse Event|1|||
127597319|NCT00160251|459152006|FG004|Prior to Amendment 2|Adverse Event|1|||
127597320|NCT00160251|459152007|FG005|Prior to Amendment 2|Adverse Event|1|||
127597321|NCT00160251|459152008|FG006|Prior to Amendment 2|Adverse Event|1|||
127597322|NCT00160251|459152009|FG007|Prior to Amendment 2|Adverse Event|0|||
127597323|NCT00160251|459152002|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
127597324|NCT00160251|459152003|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
127597325|NCT00160251|459152004|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
127597326|NCT00160251|459152005|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
127597327|NCT00160251|459152006|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
127597328|NCT00160251|459152007|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
127597329|NCT00160251|459152008|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
127597330|NCT00160251|459152009|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
127597331|NCT00160251|459152002|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
127597332|NCT00160251|459152003|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
127597333|NCT00160251|459152004|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
127597334|NCT00160251|459152005|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
127597335|NCT00160251|459152006|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
127597336|NCT00160251|459152007|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
127597337|NCT00160251|459152008|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
127597338|NCT00160251|459152009|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
127597339|NCT00160251|459152002|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
127597340|NCT00160251|459152003|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
127597341|NCT00160251|459152004|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
127597342|NCT00160251|459152005|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
127597343|NCT00160251|459152006|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
127597344|NCT00160251|459152007|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
127597345|NCT00160251|459152008|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
127597346|NCT00160251|459152009|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
127597347|NCT00160251|459152002|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
127597348|NCT00160251|459152003|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
127787316|NCT02819635|459846085|FG010|Substudy 3|Other, not specified|89|||
127597349|NCT00160251|459152004|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
127597350|NCT00160251|459152005|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
127597351|NCT00160251|459152006|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
127597352|NCT00160251|459152007|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
127597353|NCT00160251|459152008|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
127597354|NCT00160251|459152009|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
127597355|NCT00160251|459152002|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
127597356|NCT00160251|459152003|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
127597357|NCT00160251|459152004|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
127597358|NCT00160251|459152005|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
127787317|NCT02819635|459846086|FG011|Substudy 3|Other, not specified|39|||
127787318|NCT03179891|459846087|FG000|First Intervention|Withdrawal by Subject|1|||
127787319|NCT03179891|459846088|FG001|First Intervention|Withdrawal by Subject|1|||
127597359|NCT00160251|459152006|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
127597360|NCT00160251|459152007|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
127597361|NCT00160251|459152008|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
127597362|NCT00160251|459152009|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
127597363|NCT00160251|459152002|FG000|Post-amendment 2|Adverse Event|0|||
128035786|NCT03636022|460759433|FG000|Overall Study|Withdrawal by Subject|1|||
128035787|NCT03636022|460759434|FG001|Overall Study|Withdrawal by Subject|3|||
128035788|NCT03189719|460759435|FG000|Overall Study|Death|325|||
128035789|NCT03189719|460759436|FG001|Overall Study|Death|361|||
128035790|NCT03189719|460759435|FG000|Overall Study|Physician Decision|1|||
128035791|NCT03189719|460759436|FG001|Overall Study|Physician Decision|0|||
128035792|NCT03189719|460759435|FG000|Overall Study|Sponsor Decision|40|||
128035793|NCT03189719|460759436|FG001|Overall Study|Sponsor Decision|12|||
128035794|NCT03189719|460759435|FG000|Overall Study|Withdrawal by Subject|7|||
128035795|NCT03189719|460759436|FG001|Overall Study|Withdrawal by Subject|3|||
128035796|NCT03448393|460759437|FG000|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
128035797|NCT03448393|460759438|FG001|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
128035798|NCT03448393|460759439|FG002|Dose Escalation|Not Treated - participant did not receive cell infusion.|1|||
128035799|NCT03448393|460759440|FG003|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
128035800|NCT03448393|460759441|FG004|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
128035801|NCT03448393|460759442|FG005|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
128035802|NCT03448393|460759443|FG006|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
128035803|NCT03448393|460759444|FG007|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
128035804|NCT03448393|460759445|FG008|Dose Escalation|Not Treated - participant did not receive cell infusion.|8|||
128035805|NCT03448393|460759437|FG000|Dose Expansion|Not treated - screen failure|0|||
128035806|NCT03448393|460759438|FG001|Dose Expansion|Not treated - screen failure|0|||
128035807|NCT03448393|460759439|FG002|Dose Expansion|Not treated - screen failure|0|||
128035808|NCT03448393|460759440|FG003|Dose Expansion|Not treated - screen failure|0|||
128035809|NCT03448393|460759441|FG004|Dose Expansion|Not treated - screen failure|0|||
128035810|NCT03448393|460759442|FG005|Dose Expansion|Not treated - screen failure|0|||
128035811|NCT03448393|460759443|FG006|Dose Expansion|Not treated - screen failure|0|||
128035812|NCT03448393|460759444|FG007|Dose Expansion|Not treated - screen failure|0|||
128035813|NCT03448393|460759445|FG008|Dose Expansion|Not treated - screen failure|7|||
128035814|NCT03012880|460759446|FG000|Overall Study|Withdrawal by Subject|1|||
128035815|NCT03012880|460759447|FG001|Overall Study|Withdrawal by Subject|0|||
128035816|NCT03012880|460759446|FG000|Overall Study|Ineligible|1|||
128035817|NCT03012880|460759447|FG001|Overall Study|Ineligible|0|||
128035818|NCT01587196|460759448|FG000|Overall Study|Lost to Follow-up|50|||
128035819|NCT01587196|460759448|FG000|Overall Study|Withdrawal by Subject|4|||
128035820|NCT02769481|460759449|FG000|Overall Study|Protocol Violation|1|||
128035821|NCT02769481|460759450|FG001|Overall Study|Protocol Violation|0|||
128035822|NCT02769481|460759449|FG000|Overall Study|Adverse Event|3|||
128035823|NCT02769481|460759450|FG001|Overall Study|Adverse Event|6|||
128035824|NCT02769481|460759449|FG000|Overall Study|Entry Criteria Not Met|1|||
128035825|NCT02769481|460759450|FG001|Overall Study|Entry Criteria Not Met|2|||
128035826|NCT02769481|460759449|FG000|Overall Study|Withdrawal by Subject|14|||
128035827|NCT02769481|460759450|FG001|Overall Study|Withdrawal by Subject|16|||
128035828|NCT02769481|460759449|FG000|Overall Study|Lost to Follow-up|9|||
128035829|NCT02769481|460759450|FG001|Overall Study|Lost to Follow-up|9|||
128035830|NCT02769481|460759449|FG000|Overall Study|Physician Decision|0|||
128035831|NCT02769481|460759450|FG001|Overall Study|Physician Decision|1|||
128035832|NCT02769481|460759449|FG000|Overall Study|Terminated by Sponsor|1|||
128035833|NCT02769481|460759450|FG001|Overall Study|Terminated by Sponsor|0|||
128035834|NCT02769481|460759449|FG000|Overall Study|Death|0|||
128035835|NCT02769481|460759450|FG001|Overall Study|Death|1|||
128035836|NCT02769481|460759449|FG000|Overall Study|Undefined|4|||
128035837|NCT02769481|460759450|FG001|Overall Study|Undefined|1|||
128035838|NCT03510715|460759451|FG000|Overall Study|Adverse Event|1|||
128035839|NCT03510715|460759452|FG001|Overall Study|Adverse Event|0|||
128035840|NCT04795531|460760849|FG000|Overall Study|Withdrawal by Subject|4|||
128035841|NCT04795531|460760850|FG001|Overall Study|Withdrawal by Subject|4|||
128035842|NCT04795531|460760849|FG000|Overall Study|Lost to Follow-up|0|||
128035843|NCT04795531|460760850|FG001|Overall Study|Lost to Follow-up|1|||
128035844|NCT04795531|460760849|FG000|Overall Study|Physician Decision|0|||
128035845|NCT04795531|460760850|FG001|Overall Study|Physician Decision|2|||
128035846|NCT04795531|460760849|FG000|Overall Study|Death|2|||
128035847|NCT04795531|460760850|FG001|Overall Study|Death|1|||
128035848|NCT04043286|460760851|FG000|Overall Study|Withdrawal by Subject|2|||
128035849|NCT04043286|460760852|FG001|Overall Study|Withdrawal by Subject|2|||
128035850|NCT01323192|460760853|FG000|Overall Study|Adverse Event|6|||
128035851|NCT01323192|460760854|FG001|Overall Study|Adverse Event|1|||
128035852|NCT01323192|460760853|FG000|Overall Study|Withdrawal by Subject|3|||
128035853|NCT01323192|460760854|FG001|Overall Study|Withdrawal by Subject|1|||
128035854|NCT01323192|460760853|FG000|Overall Study|Noncompliance with study medication|0|||
128035855|NCT01323192|460760854|FG001|Overall Study|Noncompliance with study medication|3|||
128035856|NCT01323192|460760853|FG000|Overall Study|Nonmedical reasons|0|||
128035857|NCT01323192|460760854|FG001|Overall Study|Nonmedical reasons|1|||
128035858|NCT02296476|460760855|FG000|Overall Study|Disease Progression|6|||
127597364|NCT00160251|459152003|FG001|Post-amendment 2|Adverse Event|0|||
127597365|NCT00160251|459152004|FG002|Post-amendment 2|Adverse Event|0|||
127597366|NCT00160251|459152005|FG003|Post-amendment 2|Adverse Event|0|||
127597367|NCT00160251|459152006|FG004|Post-amendment 2|Adverse Event|0|||
127597368|NCT00160251|459152007|FG005|Post-amendment 2|Adverse Event|0|||
127597369|NCT00160251|459152008|FG006|Post-amendment 2|Adverse Event|0|||
127597370|NCT00160251|459152009|FG007|Post-amendment 2|Adverse Event|20|||
127597371|NCT00160251|459152002|FG000|Post-amendment 2|Lack of Efficacy|0|||
127597372|NCT00160251|459152003|FG001|Post-amendment 2|Lack of Efficacy|0|||
127597373|NCT00160251|459152004|FG002|Post-amendment 2|Lack of Efficacy|0|||
127597374|NCT00160251|459152005|FG003|Post-amendment 2|Lack of Efficacy|0|||
127597375|NCT00160251|459152006|FG004|Post-amendment 2|Lack of Efficacy|0|||
127597376|NCT00160251|459152007|FG005|Post-amendment 2|Lack of Efficacy|0|||
127597377|NCT00160251|459152008|FG006|Post-amendment 2|Lack of Efficacy|0|||
127597378|NCT00160251|459152009|FG007|Post-amendment 2|Lack of Efficacy|24|||
127597379|NCT00160251|459152002|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
127597380|NCT00160251|459152003|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
127597381|NCT00160251|459152004|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
127695623|NCT02783300|459512948|FG015|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
127695624|NCT02783300|459512949|FG016|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
127695625|NCT02783300|459512950|FG017|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
127695626|NCT02783300|459512951|FG018|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
128035859|NCT02296476|460760856|FG001|Overall Study|Disease Progression|4|||
128035860|NCT02296476|460760857|FG002|Overall Study|Disease Progression|2|||
128035861|NCT00442702|460760858|FG000|Titration Period|Adverse Event|2|||
128035862|NCT00442702|460760859|FG001|Titration Period|Adverse Event|0|||
128035863|NCT00442702|460760858|FG000|Titration Period|Death|3|||
127695627|NCT02783300|459512952|FG019|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|2|||
127695628|NCT02783300|459512953|FG020|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
127695629|NCT02783300|459512954|FG021|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
128035864|NCT00442702|460760859|FG001|Titration Period|Death|2|||
128035865|NCT00442702|460760858|FG000|Titration Period|Insufficient Therapeutic Response|1|||
128035866|NCT00442702|460760859|FG001|Titration Period|Insufficient Therapeutic Response|0|||
128035867|NCT00442702|460760858|FG000|Titration Period|Refused Treatment|4|||
128035868|NCT00442702|460760859|FG001|Titration Period|Refused Treatment|1|||
128035869|NCT00442702|460760858|FG000|Titration Period|Failure to return|1|||
128035870|NCT00442702|460760859|FG001|Titration Period|Failure to return|0|||
128035871|NCT00442702|460760858|FG000|Titration Period|Hospitalized in another hospital|1|||
128035872|NCT00442702|460760859|FG001|Titration Period|Hospitalized in another hospital|0|||
128035873|NCT00442702|460760858|FG000|Evaluation Period|Adverse Event|1|||
128035874|NCT00442702|460760859|FG001|Evaluation Period|Adverse Event|0|||
127597382|NCT00160251|459152005|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
127695630|NCT02783300|459512955|FG022|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
127695631|NCT02783300|459512956|FG023|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
127695632|NCT02783300|459512957|FG024|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
127695633|NCT02783300|459512958|FG025|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
127695634|NCT02783300|459512959|FG026|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
127695635|NCT02783300|459512933|FG000|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
127695636|NCT02783300|459512934|FG001|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
128035875|NCT00442702|460760858|FG000|Evaluation Period|Death|1|||
128035876|NCT00442702|460760859|FG001|Evaluation Period|Death|1|||
128035877|NCT00442702|460760858|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
127597383|NCT00160251|459152006|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
127597384|NCT00160251|459152007|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
127597385|NCT00160251|459152008|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
127597386|NCT00160251|459152009|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
127597387|NCT03334448|459152015|FG000|Washout|Personal Reason|0|||
127597388|NCT03334448|459152016|FG001|Washout|Personal Reason|1|||
127597389|NCT03334448|459152017|FG002|Washout|Personal Reason|0|||
127597390|NCT03334448|459152018|FG003|Washout|Personal Reason|0|||
127597391|NCT03334448|459152015|FG000|Washout|Protocol Violation|0|||
127597392|NCT03334448|459152016|FG001|Washout|Protocol Violation|0|||
127597393|NCT03334448|459152017|FG002|Washout|Protocol Violation|0|||
127597394|NCT03334448|459152018|FG003|Washout|Protocol Violation|1|||
127597395|NCT01683383|459152020|FG000|Overall Study|Infant was not transported|1|||
127597396|NCT01683383|459152021|FG001|Overall Study|Infant was not transported|0|||
127597397|NCT00855920|459152022|FG000|Overall Study|Protocol Violation|0|||
127597398|NCT00855920|459152023|FG001|Overall Study|Protocol Violation|0|||
127597399|NCT00855920|459152024|FG002|Overall Study|Protocol Violation|2|||
127597400|NCT00855920|459152022|FG000|Overall Study|Adverse Event|2|||
127597401|NCT00855920|459152023|FG001|Overall Study|Adverse Event|1|||
127597402|NCT00855920|459152024|FG002|Overall Study|Adverse Event|1|||
127597403|NCT00855920|459152022|FG000|Overall Study|Lack of Efficacy|2|||
127597404|NCT00855920|459152023|FG001|Overall Study|Lack of Efficacy|2|||
127597405|NCT00855920|459152024|FG002|Overall Study|Lack of Efficacy|2|||
127597406|NCT00855920|459152022|FG000|Overall Study|Withdrawal by Subject|2|||
127597407|NCT00855920|459152023|FG001|Overall Study|Withdrawal by Subject|3|||
127597408|NCT00855920|459152024|FG002|Overall Study|Withdrawal by Subject|2|||
127597409|NCT00855920|459152022|FG000|Overall Study|Lost to Follow-up|1|||
127597410|NCT00855920|459152023|FG001|Overall Study|Lost to Follow-up|0|||
127597411|NCT00855920|459152024|FG002|Overall Study|Lost to Follow-up|2|||
127597412|NCT00855920|459152022|FG000|Overall Study|Death|0|||
127597413|NCT00855920|459152023|FG001|Overall Study|Death|1|||
127597414|NCT00855920|459152024|FG002|Overall Study|Death|0|||
127597415|NCT00855920|459152022|FG000|Overall Study|Decision by the sponsor|0|||
127597416|NCT00855920|459152023|FG001|Overall Study|Decision by the sponsor|1|||
127597417|NCT00855920|459152024|FG002|Overall Study|Decision by the sponsor|1|||
127597418|NCT00855920|459152022|FG000|Overall Study|Other than specified above|1|||
127597419|NCT00855920|459152023|FG001|Overall Study|Other than specified above|1|||
127597420|NCT00855920|459152024|FG002|Overall Study|Other than specified above|1|||
127597421|NCT00996307|459152025|FG000|Overall Study|Adverse Event|0|||
127597422|NCT00996307|459152026|FG001|Overall Study|Adverse Event|1|||
127597423|NCT00996307|459152027|FG002|Overall Study|Adverse Event|0|||
127597424|NCT00996307|459152028|FG003|Overall Study|Adverse Event|0|||
127597425|NCT00996307|459152025|FG000|Overall Study|Withdrawal by Subject|3|||
127597426|NCT00996307|459152026|FG001|Overall Study|Withdrawal by Subject|2|||
127597427|NCT00996307|459152027|FG002|Overall Study|Withdrawal by Subject|5|||
127695637|NCT02783300|459512935|FG002|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
127597428|NCT00996307|459152028|FG003|Overall Study|Withdrawal by Subject|5|||
127597429|NCT00996307|459152025|FG000|Overall Study|Lost to Follow-up|13|||
127597430|NCT00996307|459152026|FG001|Overall Study|Lost to Follow-up|13|||
127597431|NCT00996307|459152027|FG002|Overall Study|Lost to Follow-up|7|||
127597432|NCT00996307|459152028|FG003|Overall Study|Lost to Follow-up|15|||
127597433|NCT00996307|459152025|FG000|Overall Study|Administrative reason|0|||
127597434|NCT00996307|459152026|FG001|Overall Study|Administrative reason|1|||
127597435|NCT00996307|459152027|FG002|Overall Study|Administrative reason|0|||
127597436|NCT00996307|459152028|FG003|Overall Study|Administrative reason|0|||
127597437|NCT00996307|459152025|FG000|Overall Study|Unable to classify|4|||
127597438|NCT00996307|459152026|FG001|Overall Study|Unable to classify|0|||
127597439|NCT00996307|459152027|FG002|Overall Study|Unable to classify|2|||
127597440|NCT00996307|459152028|FG003|Overall Study|Unable to classify|1|||
127597441|NCT02496611|459152031|FG000|Overall Study|Lost to Follow-up|2|||
127597442|NCT02496611|459152032|FG001|Overall Study|Lost to Follow-up|1|||
127597443|NCT02496611|459152031|FG000|Overall Study|Withdrawal by Subject|5|||
127597444|NCT02496611|459152032|FG001|Overall Study|Withdrawal by Subject|2|||
127597445|NCT02788357|459152036|FG000|Overall Study|Lost to Follow-up|3|||
127597446|NCT02788357|459152037|FG001|Overall Study|Lost to Follow-up|0|||
127597447|NCT01365910|459152038|FG000|Overall Study|Withdrawal by Subject|7|||
127597448|NCT01365910|459152038|FG000|Overall Study|disease progression|18|||
127597449|NCT01365910|459152038|FG000|Overall Study|Adverse Event|3|||
128035878|NCT00442702|460760859|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
127597450|NCT01365910|459152038|FG000|Overall Study|other complicating disease|1|||
127597451|NCT01365910|459152038|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
127597452|NCT00371137|459152039|FG000|Overall Study|Adverse Event|20|||
127597453|NCT00371137|459152040|FG001|Overall Study|Adverse Event|35|||
127597454|NCT00371137|459152041|FG002|Overall Study|Adverse Event|42|||
127597455|NCT00371137|459152039|FG000|Overall Study|Withdrawal by Subject|11|||
127597456|NCT00371137|459152040|FG001|Overall Study|Withdrawal by Subject|10|||
127597457|NCT00371137|459152041|FG002|Overall Study|Withdrawal by Subject|15|||
127597458|NCT00371137|459152039|FG000|Overall Study|Lost to Follow-up|6|||
127597459|NCT00371137|459152040|FG001|Overall Study|Lost to Follow-up|3|||
127597460|NCT00371137|459152041|FG002|Overall Study|Lost to Follow-up|5|||
127597461|NCT00371137|459152039|FG000|Overall Study|Lack of Efficacy|30|||
127597462|NCT00371137|459152040|FG001|Overall Study|Lack of Efficacy|12|||
127597463|NCT00371137|459152041|FG002|Overall Study|Lack of Efficacy|13|||
127597464|NCT00371137|459152039|FG000|Overall Study|Sponsor Decision|2|||
127597465|NCT00371137|459152040|FG001|Overall Study|Sponsor Decision|1|||
127597466|NCT00371137|459152041|FG002|Overall Study|Sponsor Decision|2|||
127597467|NCT00371137|459152039|FG000|Overall Study|Physician Decision|1|||
127597468|NCT00371137|459152040|FG001|Overall Study|Physician Decision|1|||
127597469|NCT00371137|459152041|FG002|Overall Study|Physician Decision|1|||
127597470|NCT00371137|459152039|FG000|Overall Study|Protocol Violation|2|||
127597471|NCT00371137|459152040|FG001|Overall Study|Protocol Violation|1|||
127597472|NCT00371137|459152041|FG002|Overall Study|Protocol Violation|1|||
127597473|NCT00536198|459152042|FG000|Overall Study|Lost to Follow-up|15|||
127597474|NCT00536198|459152043|FG001|Overall Study|Lost to Follow-up|14|||
127597475|NCT00536198|459152042|FG000|Overall Study|Withdrawal by Subject|16|||
127597476|NCT00536198|459152043|FG001|Overall Study|Withdrawal by Subject|12|||
127597477|NCT00536198|459152042|FG000|Overall Study|Adverse Event|2|||
127597478|NCT00536198|459152043|FG001|Overall Study|Adverse Event|2|||
127597479|NCT00536198|459152042|FG000|Overall Study|Rescue|3|||
127597480|NCT00536198|459152043|FG001|Overall Study|Rescue|9|||
127597481|NCT00536198|459152042|FG000|Overall Study|Pregnancy|1|||
127597482|NCT00536198|459152043|FG001|Overall Study|Pregnancy|1|||
127597483|NCT00536198|459152042|FG000|Overall Study|Protocol Violation|0|||
127597484|NCT00536198|459152043|FG001|Overall Study|Protocol Violation|1|||
127597485|NCT02013791|459152044|FG000|Period 1|Lost to Follow-up|0|||
127597486|NCT02013791|459152045|FG001|Period 1|Lost to Follow-up|0|||
127597487|NCT02013791|459152046|FG002|Period 1|Lost to Follow-up|0|||
127597488|NCT02013791|459152047|FG003|Period 1|Lost to Follow-up|1|||
127597489|NCT02013791|459152048|FG004|Period 1|Lost to Follow-up|0|||
127597490|NCT02013791|459152049|FG005|Period 1|Lost to Follow-up|0|||
127597491|NCT02013791|459152050|FG006|Period 1|Lost to Follow-up|1|||
127597492|NCT02013791|459152051|FG007|Period 1|Lost to Follow-up|1|||
127597493|NCT02013791|459152052|FG008|Period 1|Lost to Follow-up|0|||
127597494|NCT02013791|459152044|FG000|Period 1|Other Miscellaneous Reasons|0|||
127597495|NCT02013791|459152045|FG001|Period 1|Other Miscellaneous Reasons|2|||
127597496|NCT02013791|459152046|FG002|Period 1|Other Miscellaneous Reasons|0|||
127597497|NCT02013791|459152047|FG003|Period 1|Other Miscellaneous Reasons|0|||
127597498|NCT02013791|459152048|FG004|Period 1|Other Miscellaneous Reasons|0|||
127597499|NCT02013791|459152049|FG005|Period 1|Other Miscellaneous Reasons|0|||
127597500|NCT02013791|459152050|FG006|Period 1|Other Miscellaneous Reasons|0|||
127597501|NCT02013791|459152051|FG007|Period 1|Other Miscellaneous Reasons|0|||
127597502|NCT02013791|459152052|FG008|Period 1|Other Miscellaneous Reasons|0|||
127597503|NCT03798483|459152053|FG000|Overall Study|Lost to Follow-up|2|||
127597504|NCT01858389|459152057|FG000|Overall Study|Death|1|||
127597505|NCT01858389|459152058|FG001|Overall Study|Death|3|||
127597506|NCT01858389|459152057|FG000|Overall Study|Study terminated by sponsor|0|||
127597507|NCT01858389|459152058|FG001|Overall Study|Study terminated by sponsor|2|||
127597508|NCT01858389|459152057|FG000|Overall Study|Withdrawal by Subject|0|||
127597509|NCT01858389|459152058|FG001|Overall Study|Withdrawal by Subject|1|||
127597510|NCT01858389|459152057|FG000|Overall Study|Progressive disease|10|||
127597511|NCT01858389|459152058|FG001|Overall Study|Progressive disease|11|||
127597512|NCT01858389|459152057|FG000|Overall Study|Other|2|||
127597513|NCT01858389|459152058|FG001|Overall Study|Other|4|||
127597514|NCT01858389|459152057|FG000|Overall Study|Adverse Event|3|||
127597515|NCT01858389|459152058|FG001|Overall Study|Adverse Event|1|||
127597516|NCT01858389|459152057|FG000|Overall Study|Did not receive treatment|0|||
127597517|NCT01858389|459152058|FG001|Overall Study|Did not receive treatment|3|||
127597518|NCT01691781|459152059|FG000|Overall Study|Withdrawal by Subject|4|||
127597519|NCT01691781|459152060|FG001|Overall Study|Withdrawal by Subject|3|||
127597520|NCT01691781|459152059|FG000|Overall Study|Physician Decision|1|||
127597521|NCT01691781|459152060|FG001|Overall Study|Physician Decision|1|||
127597522|NCT01691781|459152059|FG000|Overall Study|Protocol Violation|2|||
127597523|NCT01691781|459152060|FG001|Overall Study|Protocol Violation|2|||
127597524|NCT01691781|459152059|FG000|Overall Study|Adverse Event|0|||
127597525|NCT01691781|459152060|FG001|Overall Study|Adverse Event|1|||
127597526|NCT00687323|459152061|FG000|Overall Study|Death|25|||
127597527|NCT00687323|459152061|FG000|Overall Study|Withdrawal by Subject|1|||
127597528|NCT00687323|459152061|FG000|Overall Study|Excluded from efficacy evaluations|6|||
127597529|NCT00687323|459152061|FG000|Overall Study|Screen failure|148|||
127597530|NCT00598832|459152064|FG000|Overall Study|Lack of Efficacy|3|||
127597531|NCT00598832|459152065|FG001|Overall Study|Lack of Efficacy|7|||
127597532|NCT00598832|459152064|FG000|Overall Study|Adverse Event|6|||
127597533|NCT00598832|459152065|FG001|Overall Study|Adverse Event|2|||
127597534|NCT00598832|459152064|FG000|Overall Study|Withdrawal by Subject|25|||
127597535|NCT00598832|459152065|FG001|Overall Study|Withdrawal by Subject|36|||
127597536|NCT00598832|459152064|FG000|Overall Study|Protocol Violation|0|||
127597537|NCT00598832|459152065|FG001|Overall Study|Protocol Violation|2|||
127597538|NCT00598832|459152064|FG000|Overall Study|Lost to Follow-up|24|||
127597539|NCT00598832|459152065|FG001|Overall Study|Lost to Follow-up|29|||
127597540|NCT00598832|459152064|FG000|Overall Study|Pregnancy|2|||
127597541|NCT00598832|459152065|FG001|Overall Study|Pregnancy|2|||
127597542|NCT00598832|459152064|FG000|Overall Study|Physician Decision|1|||
127597543|NCT00598832|459152065|FG001|Overall Study|Physician Decision|4|||
127597544|NCT00598832|459152064|FG000|Overall Study|Non compliance|1|||
127597545|NCT00598832|459152065|FG001|Overall Study|Non compliance|0|||
127597546|NCT02760069|459152066|FG000|Overall Study|Withdrawal by Subject|0|||
127597547|NCT02760069|459152067|FG001|Overall Study|Withdrawal by Subject|1|||
127597548|NCT02760069|459152068|FG002|Overall Study|Withdrawal by Subject|1|||
127597549|NCT03064451|459152074|FG000|Overall Study|Lost to Follow-up|1|||
127597550|NCT03064451|459152074|FG000|Overall Study|Mapping Failure|4|||
127597551|NCT03064451|459152074|FG000|Overall Study|Exited prior to procedure|8|||
127597552|NCT03064451|459152074|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
127597553|NCT05109442|459152077|FG000|Overall Study|Withdrawal by Subject|0|||
127597554|NCT05109442|459152078|FG001|Overall Study|Withdrawal by Subject|0|||
127597555|NCT05109442|459152079|FG002|Overall Study|Withdrawal by Subject|1|||
127597556|NCT05109442|459152080|FG003|Overall Study|Withdrawal by Subject|0|||
127597557|NCT05109442|459152081|FG004|Overall Study|Withdrawal by Subject|0|||
127597558|NCT05109442|459152082|FG005|Overall Study|Withdrawal by Subject|0|||
127597559|NCT05109442|459152077|FG000|Overall Study|Adverse Event|0|||
127597560|NCT05109442|459152078|FG001|Overall Study|Adverse Event|1|||
127597561|NCT05109442|459152079|FG002|Overall Study|Adverse Event|5|||
127597562|NCT05109442|459152080|FG003|Overall Study|Adverse Event|0|||
127597563|NCT05109442|459152081|FG004|Overall Study|Adverse Event|0|||
127597564|NCT05109442|459152082|FG005|Overall Study|Adverse Event|2|||
127597565|NCT05109442|459152077|FG000|Overall Study|Death|0|||
127597566|NCT05109442|459152078|FG001|Overall Study|Death|0|||
127787320|NCT03179891|459846087|FG000|First Intervention|Unspecified reason|1|||
127787321|NCT03179891|459846088|FG001|First Intervention|Unspecified reason|0|||
127787322|NCT03179891|459846087|FG000|First Intervention|Protocol Violation|0|||
127787323|NCT03179891|459846088|FG001|First Intervention|Protocol Violation|1|||
127787324|NCT04416555|459846090|FG000|Overall Study|Withdrawal by Subject|0|||
127787325|NCT04416555|459846091|FG001|Overall Study|Withdrawal by Subject|3|||
127597567|NCT05109442|459152079|FG002|Overall Study|Death|4|||
127597568|NCT05109442|459152080|FG003|Overall Study|Death|0|||
127597569|NCT05109442|459152081|FG004|Overall Study|Death|0|||
127787326|NCT02004262|459846102|FG000|Overall Study|Death|67|||
127597570|NCT05109442|459152082|FG005|Overall Study|Death|1|||
127597571|NCT05109442|459152077|FG000|Overall Study|Physician Decision|1|||
127597572|NCT05109442|459152078|FG001|Overall Study|Physician Decision|0|||
127597573|NCT05109442|459152079|FG002|Overall Study|Physician Decision|1|||
127597574|NCT05109442|459152080|FG003|Overall Study|Physician Decision|0|||
127597575|NCT05109442|459152081|FG004|Overall Study|Physician Decision|0|||
127597576|NCT05109442|459152082|FG005|Overall Study|Physician Decision|2|||
127597577|NCT05109442|459152077|FG000|Overall Study|Other than listed|0|||
127597578|NCT05109442|459152078|FG001|Overall Study|Other than listed|0|||
127597579|NCT05109442|459152079|FG002|Overall Study|Other than listed|9|||
127597580|NCT05109442|459152080|FG003|Overall Study|Other than listed|2|||
127597581|NCT05109442|459152081|FG004|Overall Study|Other than listed|0|||
127597582|NCT05109442|459152082|FG005|Overall Study|Other than listed|8|||
127597583|NCT05109442|459152077|FG000|Overall Study|Lack of Efficacy|3|||
127597584|NCT05109442|459152078|FG001|Overall Study|Lack of Efficacy|5|||
127597585|NCT05109442|459152079|FG002|Overall Study|Lack of Efficacy|29|||
127597586|NCT05109442|459152080|FG003|Overall Study|Lack of Efficacy|10|||
127597587|NCT05109442|459152081|FG004|Overall Study|Lack of Efficacy|11|||
127597588|NCT05109442|459152082|FG005|Overall Study|Lack of Efficacy|17|||
127695638|NCT02783300|459512936|FG003|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
127695639|NCT02783300|459512937|FG004|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
127695640|NCT02783300|459512938|FG005|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
127695641|NCT02783300|459512939|FG006|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
127695642|NCT02783300|459512940|FG007|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
127695643|NCT02783300|459512941|FG008|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
127695644|NCT02783300|459512942|FG009|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
127695645|NCT02783300|459512943|FG010|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
127695646|NCT02783300|459512944|FG011|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
127695647|NCT02783300|459512945|FG012|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
127695648|NCT02783300|459512946|FG013|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
127695649|NCT02783300|459512947|FG014|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
127695650|NCT02783300|459512948|FG015|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
127695651|NCT02783300|459512949|FG016|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
127695652|NCT02783300|459512950|FG017|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
127695653|NCT02783300|459512951|FG018|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
127695654|NCT02783300|459512952|FG019|Part 2- Disease-specific Expansion Phase|Other reasons|3|||
127882445|NCT00883740|460192785|FG001|Second Intervention|Protocol Violation|0|||
127597591|NCT04853225|459152085|FG000|Overall Study|Withdrawal by Subject|81|||
127597592|NCT04853225|459152086|FG001|Overall Study|Withdrawal by Subject|4|||
127597593|NCT04853225|459152087|FG002|Overall Study|Withdrawal by Subject|1|||
127597594|NCT04853225|459152085|FG000|Overall Study|Physician Decision|12|||
127597595|NCT04853225|459152086|FG001|Overall Study|Physician Decision|4|||
127597596|NCT04853225|459152087|FG002|Overall Study|Physician Decision|1|||
127597597|NCT04853225|459152085|FG000|Overall Study|Lost to Follow-up|50|||
127597598|NCT04853225|459152086|FG001|Overall Study|Lost to Follow-up|0|||
127597599|NCT04853225|459152087|FG002|Overall Study|Lost to Follow-up|0|||
127597600|NCT04853225|459152085|FG000|Overall Study|Other|102|||
127597601|NCT04853225|459152086|FG001|Overall Study|Other|11|||
127597602|NCT04853225|459152087|FG002|Overall Study|Other|5|||
127597603|NCT04853225|459152085|FG000|Overall Study|Not included in the Full Population due to Investigator discretion|1|||
127597604|NCT04853225|459152086|FG001|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
127597605|NCT04853225|459152087|FG002|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
127597606|NCT04853225|459152085|FG000|Overall Study|Not included in the Full Population due to withdrew consent|1|||
127597607|NCT04853225|459152086|FG001|Overall Study|Not included in the Full Population due to withdrew consent|0|||
127597608|NCT04853225|459152087|FG002|Overall Study|Not included in the Full Population due to withdrew consent|0|||
127597609|NCT02700815|459153632|FG000|Overall Study|Adverse Event|0|||
127597610|NCT02700815|459153633|FG001|Overall Study|Adverse Event|6|||
127597611|NCT02700815|459153634|FG002|Overall Study|Adverse Event|2|||
127597612|NCT02700815|459153635|FG003|Overall Study|Adverse Event|3|||
127597613|NCT02700815|459153632|FG000|Overall Study|Lack of Efficacy|0|||
127597614|NCT02700815|459153633|FG001|Overall Study|Lack of Efficacy|0|||
127597615|NCT02700815|459153634|FG002|Overall Study|Lack of Efficacy|1|||
127597616|NCT02700815|459153635|FG003|Overall Study|Lack of Efficacy|2|||
127597617|NCT02700815|459153632|FG000|Overall Study|Lost to Follow-up|1|||
127597618|NCT02700815|459153633|FG001|Overall Study|Lost to Follow-up|0|||
127597619|NCT02700815|459153634|FG002|Overall Study|Lost to Follow-up|0|||
127597620|NCT02700815|459153635|FG003|Overall Study|Lost to Follow-up|1|||
127597621|NCT02700815|459153632|FG000|Overall Study|Refusal to continue medication|0|||
127597622|NCT02700815|459153633|FG001|Overall Study|Refusal to continue medication|1|||
127597623|NCT02700815|459153634|FG002|Overall Study|Refusal to continue medication|0|||
127597624|NCT02700815|459153635|FG003|Overall Study|Refusal to continue medication|1|||
127597625|NCT02700815|459153632|FG000|Overall Study|Withdrawal by Subject|0|||
127597626|NCT02700815|459153633|FG001|Overall Study|Withdrawal by Subject|0|||
127597627|NCT02700815|459153634|FG002|Overall Study|Withdrawal by Subject|1|||
127597628|NCT02700815|459153635|FG003|Overall Study|Withdrawal by Subject|0|||
127597629|NCT02154490|459153638|FG000|Overall Study|No tissue submitted|23|||
127597630|NCT02154490|459153638|FG000|Overall Study|No biomarker results|167|||
127597631|NCT02154490|459153638|FG000|Overall Study|Not assigned to a sub-study|270|||
127597632|NCT02154490|459153638|FG000|Overall Study|Did not register to a sub-study|749|||
127597633|NCT02961751|459153647|FG000|Overall Study|Lost to Follow-up|11|||
127597634|NCT02961751|459153647|FG000|Overall Study|Physician Decision|2|||
127597635|NCT02961751|459153647|FG000|Overall Study|Not Eligible at Enrollment|1|||
127597636|NCT02961751|459153647|FG000|Overall Study|Protocol Violation|1|||
127597637|NCT02373202|459153648|FG000|Overall Study|Adverse Event|2|||
127597638|NCT02373202|459153649|FG001|Overall Study|Adverse Event|5|||
127597639|NCT02373202|459153650|FG002|Overall Study|Adverse Event|2|||
127597640|NCT02373202|459153651|FG003|Overall Study|Adverse Event|1|||
127597641|NCT02373202|459153648|FG000|Overall Study|Lack of Efficacy|0|||
127597642|NCT02373202|459153649|FG001|Overall Study|Lack of Efficacy|0|||
128035879|NCT00442702|460760858|FG000|Evaluation Period|Refused treatment|1|||
127597643|NCT02373202|459153650|FG002|Overall Study|Lack of Efficacy|1|||
128035880|NCT00442702|460760859|FG001|Evaluation Period|Refused treatment|1|||
127597644|NCT02373202|459153651|FG003|Overall Study|Lack of Efficacy|0|||
127597645|NCT02373202|459153648|FG000|Overall Study|Other|0|||
127597646|NCT02373202|459153649|FG001|Overall Study|Other|1|||
127597647|NCT02373202|459153650|FG002|Overall Study|Other|0|||
127597648|NCT02373202|459153651|FG003|Overall Study|Other|0|||
127597649|NCT00720434|459153655|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
127597650|NCT00720434|459153656|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
127597651|NCT00720434|459153657|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
127597652|NCT00720434|459153658|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
127597653|NCT00720434|459153655|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
127597654|NCT00720434|459153656|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
127597655|NCT00720434|459153657|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
127597656|NCT00720434|459153658|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
127597657|NCT00720434|459153655|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
127597658|NCT00720434|459153656|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
127597659|NCT00720434|459153657|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
127597660|NCT00720434|459153658|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
127597661|NCT00720434|459153655|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
128035881|NCT00442702|460760858|FG000|Evaluation Period|Renal transplant|0|||
127695655|NCT02783300|459512953|FG020|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
128035882|NCT00442702|460760859|FG001|Evaluation Period|Renal transplant|1|||
128035883|NCT00442702|460760858|FG000|Evaluation Period|Failure to return|1|||
128035884|NCT00442702|460760859|FG001|Evaluation Period|Failure to return|0|||
128035885|NCT00442702|460760858|FG000|Evaluation Period|Site closure|0|||
128035886|NCT00442702|460760859|FG001|Evaluation Period|Site closure|1|||
128035887|NCT03122184|460760864|FG000|Overall Study|Lost to Follow-up|4|||
128035888|NCT03122184|460760865|FG001|Overall Study|Lost to Follow-up|6|||
128035889|NCT03122184|460760864|FG000|Overall Study|Withdrawal by Subject|3|||
128035890|NCT03122184|460760865|FG001|Overall Study|Withdrawal by Subject|0|||
128035891|NCT03122184|460760864|FG000|Overall Study|Terminated due to cognitive problem|1|||
128035892|NCT03122184|460760865|FG001|Overall Study|Terminated due to cognitive problem|0|||
128035893|NCT02835690|460760866|FG000|Overall Study|Death|12|||
128035894|NCT02835690|460760867|FG001|Overall Study|Death|11|||
128035895|NCT02835690|460760868|FG002|Overall Study|Death|13|||
128035896|NCT02835690|460760866|FG000|Overall Study|Transferred to Extension Study|2|||
128035897|NCT02835690|460760867|FG001|Overall Study|Transferred to Extension Study|2|||
128035898|NCT02835690|460760868|FG002|Overall Study|Transferred to Extension Study|1|||
128035899|NCT02835690|460760866|FG000|Overall Study|Did Not Continue on Extension Study|0|||
128035900|NCT02835690|460760867|FG001|Overall Study|Did Not Continue on Extension Study|0|||
128035901|NCT02835690|460760868|FG002|Overall Study|Did Not Continue on Extension Study|1|||
128035902|NCT02835690|460760866|FG000|Overall Study|Not Treated|0|||
128035903|NCT02835690|460760867|FG001|Overall Study|Not Treated|2|||
128035904|NCT02835690|460760868|FG002|Overall Study|Not Treated|0|||
128035905|NCT03674281|460760869|FG000|Overall Study|screen failure|2|||
128035906|NCT03674281|460760870|FG001|Overall Study|screen failure|0|||
128035907|NCT03674281|460760871|FG002|Overall Study|screen failure|0|||
128035908|NCT03674281|460760869|FG000|Overall Study|Withdrawal by Subject|1|||
128035909|NCT03674281|460760870|FG001|Overall Study|Withdrawal by Subject|3|||
128035910|NCT03674281|460760871|FG002|Overall Study|Withdrawal by Subject|3|||
128035911|NCT00710593|460760872|FG000|Overall Study|Incarceration|1|||
128035912|NCT00710593|460760873|FG001|Overall Study|Incarceration|0|||
128035913|NCT00710593|460760872|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
128035914|NCT00710593|460760873|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
128035915|NCT00710593|460760872|FG000|Overall Study|Lost to Follow-up|3|||
128035916|NCT00710593|460760873|FG001|Overall Study|Lost to Follow-up|1|||
128035917|NCT00710593|460760872|FG000|Overall Study|Moved out of area|1|||
128035918|NCT00710593|460760873|FG001|Overall Study|Moved out of area|0|||
128035919|NCT00710593|460760872|FG000|Overall Study|Failure to adhere or complete study eval|1|||
128035920|NCT00710593|460760873|FG001|Overall Study|Failure to adhere or complete study eval|1|||
128035921|NCT00710593|460760872|FG000|Overall Study|Protocol Violation|1|||
128035922|NCT00710593|460760873|FG001|Overall Study|Protocol Violation|1|||
128035923|NCT00710593|460760872|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
128035924|NCT00710593|460760873|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
128035925|NCT02986074|460760877|FG000|First Trial Period|Adverse Event|1|||
128035926|NCT02986074|460760878|FG001|First Trial Period|Adverse Event|0|||
128035927|NCT02986074|460760879|FG002|First Trial Period|Adverse Event|0|||
128035928|NCT02986074|460760880|FG003|First Trial Period|Adverse Event|0|||
128035929|NCT02986074|460760877|FG000|Follow up Period|system explant|0|||
128035930|NCT02986074|460760878|FG001|Follow up Period|system explant|0|||
128035931|NCT02986074|460760879|FG002|Follow up Period|system explant|1|||
128035932|NCT02986074|460760880|FG003|Follow up Period|system explant|2|||
128035933|NCT02986074|460760877|FG000|Follow up Period|Physician Decision|0|||
128035934|NCT02986074|460760878|FG001|Follow up Period|Physician Decision|0|||
128035935|NCT02986074|460760879|FG002|Follow up Period|Physician Decision|0|||
128035936|NCT02986074|460760880|FG003|Follow up Period|Physician Decision|1|||
128035937|NCT01263119|460760881|FG000|Period 1|Protocol Violation|2|||
128035938|NCT01263119|460760881|FG000|Period 2|Adverse Event|2|||
128035939|NCT03580044|460760882|FG000|Overall Study|Death|2|||
128035940|NCT03580044|460760883|FG001|Overall Study|Death|1|||
127695656|NCT02783300|459512954|FG021|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
127695657|NCT02783300|459512955|FG022|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
127787327|NCT02004262|459846103|FG001|Overall Study|Death|64|||
128035941|NCT03580044|460760882|FG000|Overall Study|Withdrawal by Subject|1|||
128035942|NCT03580044|460760883|FG001|Overall Study|Withdrawal by Subject|1|||
128035943|NCT01664624|460760884|FG000|Overall Study|Adverse Event|0|||
128035944|NCT01664624|460760885|FG001|Overall Study|Adverse Event|1|||
128035945|NCT01664624|460760886|FG002|Overall Study|Adverse Event|0|||
128035946|NCT01664624|460760887|FG003|Overall Study|Adverse Event|0|||
128035947|NCT04067011|460760891|FG000|Overall Study|Not Treated|8|||
128035948|NCT04067011|460760892|FG001|Overall Study|Not Treated|7|||
128035949|NCT04067011|460760893|FG002|Overall Study|Not Treated|5|||
128035950|NCT04067011|460760891|FG000|Overall Study|Adverse Event|2|||
128035951|NCT04067011|460760892|FG001|Overall Study|Adverse Event|1|||
128035952|NCT04067011|460760893|FG002|Overall Study|Adverse Event|0|||
128035953|NCT04067011|460760891|FG000|Overall Study|Withdrawal by Subject|6|||
128035954|NCT04067011|460760892|FG001|Overall Study|Withdrawal by Subject|2|||
127695658|NCT02783300|459512956|FG023|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
127695659|NCT02783300|459512957|FG024|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
127695660|NCT02783300|459512958|FG025|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
127695661|NCT02783300|459512959|FG026|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
127695662|NCT02783300|459512933|FG000|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
127695663|NCT02783300|459512934|FG001|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
127695664|NCT02783300|459512935|FG002|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
127695665|NCT02783300|459512936|FG003|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
127695666|NCT02783300|459512937|FG004|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
127695667|NCT02783300|459512938|FG005|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
127597662|NCT00720434|459153656|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
127597663|NCT00720434|459153657|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
127597664|NCT00720434|459153658|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
127597665|NCT00720434|459153655|FG000|Open-Label Period (Week 5-72)|Other|4|||
127597666|NCT00720434|459153656|FG001|Open-Label Period (Week 5-72)|Other|3|||
127597667|NCT00720434|459153657|FG002|Open-Label Period (Week 5-72)|Other|3|||
127597668|NCT00720434|459153658|FG003|Open-Label Period (Week 5-72)|Other|2|||
127597669|NCT03138889|459153669|FG000|Overall Study|Withdrawal by Subject|5|||
127597670|NCT03138889|459153670|FG001|Overall Study|Withdrawal by Subject|5|||
127597671|NCT03138889|459153671|FG002|Overall Study|Withdrawal by Subject|0|||
127597672|NCT03138889|459153672|FG003|Overall Study|Withdrawal by Subject|2|||
127597673|NCT03138889|459153673|FG004|Overall Study|Withdrawal by Subject|1|||
127597674|NCT03138889|459153674|FG005|Overall Study|Withdrawal by Subject|3|||
127597675|NCT03138889|459153675|FG006|Overall Study|Withdrawal by Subject|0|||
127597676|NCT03138889|459153676|FG007|Overall Study|Withdrawal by Subject|1|||
127597677|NCT02289690|459153679|FG000|Overall Study|Adverse Event Related to Progression|0|||
127597678|NCT02289690|459153680|FG001|Overall Study|Adverse Event Related to Progression|1|||
127597679|NCT02289690|459153681|FG002|Overall Study|Adverse Event Related to Progression|1|||
127597680|NCT02289690|459153682|FG003|Overall Study|Adverse Event Related to Progression|0|||
127597681|NCT02289690|459153683|FG004|Overall Study|Adverse Event Related to Progression|1|||
127597682|NCT02289690|459153684|FG005|Overall Study|Adverse Event Related to Progression|0|||
127597683|NCT02289690|459153685|FG006|Overall Study|Adverse Event Related to Progression|1|||
127597684|NCT02289690|459153686|FG007|Overall Study|Adverse Event Related to Progression|0|||
127597685|NCT02289690|459153687|FG008|Overall Study|Adverse Event Related to Progression|0|||
127597686|NCT02289690|459153688|FG009|Overall Study|Adverse Event Related to Progression|0|||
127597687|NCT02289690|459153679|FG000|Overall Study|Withdrawal by Subject|1|||
127597688|NCT02289690|459153680|FG001|Overall Study|Withdrawal by Subject|0|||
127597689|NCT02289690|459153681|FG002|Overall Study|Withdrawal by Subject|0|||
127597690|NCT02289690|459153682|FG003|Overall Study|Withdrawal by Subject|0|||
127597691|NCT02289690|459153683|FG004|Overall Study|Withdrawal by Subject|1|||
127597692|NCT02289690|459153684|FG005|Overall Study|Withdrawal by Subject|1|||
127597693|NCT02289690|459153685|FG006|Overall Study|Withdrawal by Subject|0|||
127597694|NCT02289690|459153686|FG007|Overall Study|Withdrawal by Subject|0|||
127597695|NCT02289690|459153687|FG008|Overall Study|Withdrawal by Subject|4|||
127597696|NCT02289690|459153688|FG009|Overall Study|Withdrawal by Subject|2|||
127597697|NCT02289690|459153679|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
127597698|NCT02289690|459153680|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
127597699|NCT02289690|459153681|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
127597700|NCT02289690|459153682|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
127597701|NCT02289690|459153683|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
127597702|NCT02289690|459153684|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
127597703|NCT02289690|459153685|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
127597704|NCT02289690|459153686|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
127597705|NCT02289690|459153687|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
127597706|NCT02289690|459153688|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
127597707|NCT02289690|459153679|FG000|Overall Study|Lost to Follow-up|0|||
127695668|NCT02783300|459512939|FG006|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
127695669|NCT02783300|459512940|FG007|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
127695670|NCT02783300|459512941|FG008|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
128035955|NCT04067011|460760893|FG002|Overall Study|Withdrawal by Subject|1|||
127597708|NCT02289690|459153680|FG001|Overall Study|Lost to Follow-up|0|||
127597709|NCT02289690|459153681|FG002|Overall Study|Lost to Follow-up|0|||
127597710|NCT02289690|459153682|FG003|Overall Study|Lost to Follow-up|0|||
127597711|NCT02289690|459153683|FG004|Overall Study|Lost to Follow-up|0|||
127597712|NCT02289690|459153684|FG005|Overall Study|Lost to Follow-up|0|||
127597713|NCT02289690|459153685|FG006|Overall Study|Lost to Follow-up|0|||
127597714|NCT02289690|459153686|FG007|Overall Study|Lost to Follow-up|1|||
127787328|NCT02004262|459846104|FG002|Overall Study|Death|66|||
127597715|NCT02289690|459153687|FG008|Overall Study|Lost to Follow-up|0|||
127597716|NCT02289690|459153688|FG009|Overall Study|Lost to Follow-up|2|||
127597717|NCT02289690|459153679|FG000|Overall Study|Death|0|||
127597718|NCT02289690|459153680|FG001|Overall Study|Death|0|||
127597719|NCT02289690|459153681|FG002|Overall Study|Death|0|||
127597720|NCT02289690|459153682|FG003|Overall Study|Death|0|||
127597721|NCT02289690|459153683|FG004|Overall Study|Death|0|||
127597722|NCT02289690|459153684|FG005|Overall Study|Death|0|||
127597723|NCT02289690|459153685|FG006|Overall Study|Death|0|||
127787329|NCT02004262|459846105|FG003|Overall Study|Death|28|||
127787330|NCT02004262|459846106|FG004|Overall Study|Death|29|||
127787331|NCT02004262|459846107|FG005|Overall Study|Death|22|||
127787332|NCT02004262|459846102|FG000|Overall Study|Withdrawal by Subject|1|||
127787333|NCT02004262|459846103|FG001|Overall Study|Withdrawal by Subject|0|||
127787334|NCT02004262|459846104|FG002|Overall Study|Withdrawal by Subject|4|||
127787335|NCT02004262|459846105|FG003|Overall Study|Withdrawal by Subject|0|||
127787336|NCT02004262|459846106|FG004|Overall Study|Withdrawal by Subject|1|||
127787337|NCT02004262|459846107|FG005|Overall Study|Withdrawal by Subject|3|||
127597724|NCT02289690|459153686|FG007|Overall Study|Death|49|||
127597725|NCT02289690|459153687|FG008|Overall Study|Death|45|||
127597726|NCT02289690|459153688|FG009|Overall Study|Death|41|||
127597727|NCT02289690|459153679|FG000|Overall Study|Sponsor Discontinued Study|0|||
127597728|NCT02289690|459153680|FG001|Overall Study|Sponsor Discontinued Study|0|||
127597729|NCT02289690|459153681|FG002|Overall Study|Sponsor Discontinued Study|0|||
127597730|NCT02289690|459153682|FG003|Overall Study|Sponsor Discontinued Study|0|||
127597731|NCT02289690|459153683|FG004|Overall Study|Sponsor Discontinued Study|0|||
127597732|NCT02289690|459153684|FG005|Overall Study|Sponsor Discontinued Study|0|||
127597733|NCT02289690|459153685|FG006|Overall Study|Sponsor Discontinued Study|0|||
127597734|NCT02289690|459153686|FG007|Overall Study|Sponsor Discontinued Study|9|||
127597735|NCT02289690|459153687|FG008|Overall Study|Sponsor Discontinued Study|7|||
127597736|NCT02289690|459153688|FG009|Overall Study|Sponsor Discontinued Study|15|||
127597737|NCT02289690|459153679|FG000|Overall Study|Other|0|||
127597738|NCT02289690|459153680|FG001|Overall Study|Other|0|||
127597739|NCT02289690|459153681|FG002|Overall Study|Other|0|||
127695671|NCT02783300|459512942|FG009|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
127695672|NCT02783300|459512943|FG010|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
127695673|NCT02783300|459512944|FG011|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
127695674|NCT02783300|459512945|FG012|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
127695675|NCT02783300|459512946|FG013|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
127695676|NCT02783300|459512947|FG014|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
127695677|NCT02783300|459512948|FG015|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
127695678|NCT02783300|459512949|FG016|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
127695679|NCT02783300|459512950|FG017|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
127695680|NCT02783300|459512951|FG018|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
127695681|NCT02783300|459512952|FG019|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
127695682|NCT02783300|459512953|FG020|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
127695683|NCT02783300|459512954|FG021|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
127695684|NCT02783300|459512955|FG022|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
127695685|NCT02783300|459512956|FG023|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
127695686|NCT02783300|459512957|FG024|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
127695687|NCT02783300|459512958|FG025|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
127695688|NCT02783300|459512959|FG026|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
127695689|NCT02783300|459512933|FG000|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
127695690|NCT02783300|459512934|FG001|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
127695691|NCT02783300|459512935|FG002|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
127695692|NCT02783300|459512936|FG003|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
127695693|NCT02783300|459512937|FG004|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
127695694|NCT02783300|459512938|FG005|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
127695695|NCT02783300|459512939|FG006|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
127695696|NCT02783300|459512940|FG007|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
127695697|NCT02783300|459512941|FG008|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
127695698|NCT02783300|459512942|FG009|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
127695699|NCT02783300|459512943|FG010|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
127695700|NCT02783300|459512944|FG011|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
127787338|NCT02004262|459846102|FG000|Overall Study|Lost to Follow-up|1|||
127787339|NCT02004262|459846103|FG001|Overall Study|Lost to Follow-up|1|||
127787340|NCT02004262|459846104|FG002|Overall Study|Lost to Follow-up|0|||
127787341|NCT02004262|459846105|FG003|Overall Study|Lost to Follow-up|0|||
127597740|NCT02289690|459153682|FG003|Overall Study|Other|1|||
127597741|NCT02289690|459153683|FG004|Overall Study|Other|1|||
127597742|NCT02289690|459153684|FG005|Overall Study|Other|0|||
127597743|NCT02289690|459153685|FG006|Overall Study|Other|1|||
127597744|NCT02289690|459153686|FG007|Overall Study|Other|2|||
127597745|NCT02289690|459153687|FG008|Overall Study|Other|3|||
127597746|NCT02289690|459153688|FG009|Overall Study|Other|1|||
128035956|NCT04067011|460760891|FG000|Overall Study|Lost to Follow-up|0|||
128035957|NCT04067011|460760892|FG001|Overall Study|Lost to Follow-up|0|||
128035958|NCT04067011|460760893|FG002|Overall Study|Lost to Follow-up|1|||
128035959|NCT04067011|460760891|FG000|Overall Study|Physician Decision|1|||
128035960|NCT04067011|460760892|FG001|Overall Study|Physician Decision|1|||
128035961|NCT04067011|460760893|FG002|Overall Study|Physician Decision|0|||
128035962|NCT04067011|460760891|FG000|Overall Study|Other Reasons|2|||
127597747|NCT04166435|459153695|FG000|Overall Study|2 patients ineligible for response|2|||
127597748|NCT02407704|459153708|FG000|Overall Study|Lost to Follow-up|0|||
127597749|NCT02407704|459153709|FG001|Overall Study|Lost to Follow-up|0|||
127597750|NCT02407704|459153710|FG002|Overall Study|Lost to Follow-up|0|||
127597751|NCT02407704|459153711|FG003|Overall Study|Lost to Follow-up|2|||
127597752|NCT02407704|459153708|FG000|Overall Study|Protocol Violation|0|||
127597753|NCT02407704|459153709|FG001|Overall Study|Protocol Violation|0|||
127597754|NCT02407704|459153710|FG002|Overall Study|Protocol Violation|0|||
127597755|NCT02407704|459153711|FG003|Overall Study|Protocol Violation|1|||
127597756|NCT02407704|459153708|FG000|Overall Study|Withdrawal by Subject|0|||
127597757|NCT02407704|459153709|FG001|Overall Study|Withdrawal by Subject|0|||
127597758|NCT02407704|459153710|FG002|Overall Study|Withdrawal by Subject|1|||
127597759|NCT02407704|459153711|FG003|Overall Study|Withdrawal by Subject|0|||
127597760|NCT03944954|459153712|FG000|Overall Study|Withdrawal by Subject|22|||
127597761|NCT03944954|459153713|FG001|Overall Study|Withdrawal by Subject|4|||
127597762|NCT03944954|459153712|FG000|Overall Study|Lost to Follow-up|18|||
127597763|NCT03944954|459153713|FG001|Overall Study|Lost to Follow-up|0|||
127597764|NCT03944954|459153712|FG000|Overall Study|Failed Medical Screening|7|||
127597765|NCT03944954|459153713|FG001|Overall Study|Failed Medical Screening|0|||
127597766|NCT02730455|459153716|FG000|Overall Study|Death|5|||
127597767|NCT02730455|459153717|FG001|Overall Study|Death|6|||
127597768|NCT02730455|459153718|FG002|Overall Study|Death|4|||
127597769|NCT02730455|459153716|FG000|Overall Study|Consent withdrawn|2|||
127597770|NCT02730455|459153717|FG001|Overall Study|Consent withdrawn|4|||
127597771|NCT02730455|459153718|FG002|Overall Study|Consent withdrawn|1|||
127597772|NCT02730455|459153716|FG000|Overall Study|Lost to Follow-up|3|||
127597773|NCT02730455|459153717|FG001|Overall Study|Lost to Follow-up|1|||
127597774|NCT02730455|459153718|FG002|Overall Study|Lost to Follow-up|4|||
127597775|NCT02730455|459153716|FG000|Overall Study|Other|1|||
127597776|NCT02730455|459153717|FG001|Overall Study|Other|1|||
127597777|NCT02730455|459153718|FG002|Overall Study|Other|2|||
127597778|NCT02730455|459153716|FG000|Overall Study|Other|2|||
127597779|NCT02730455|459153717|FG001|Overall Study|Other|2|||
127597780|NCT02730455|459153718|FG002|Overall Study|Other|0|||
127597781|NCT02268084|459153725|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
128035963|NCT04067011|460760892|FG001|Overall Study|Other Reasons|0|||
128035964|NCT04067011|460760893|FG002|Overall Study|Other Reasons|1|||
128035965|NCT04067011|460760891|FG000|Overall Study|Missing|0|||
128035966|NCT04067011|460760892|FG001|Overall Study|Missing|2|||
128035967|NCT04067011|460760893|FG002|Overall Study|Missing|0|||
128035968|NCT05209386|460760894|FG000|Overall Study|Withdrawal by Subject|8|||
128035969|NCT05209386|460760894|FG000|Overall Study|Period of sEEG implant insufficient to collect complete behavioral task|24|||
128035970|NCT04462471|460760895|FG000|Overall Study|Adverse Event|0|||
128035971|NCT04462471|460760896|FG001|Overall Study|Adverse Event|1|||
128035972|NCT04462471|460760897|FG002|Overall Study|Adverse Event|0|||
128035973|NCT04462471|460760898|FG003|Overall Study|Adverse Event|0|||
128035974|NCT04462471|460760895|FG000|Overall Study|Disease progression|1|||
128035975|NCT04462471|460760896|FG001|Overall Study|Disease progression|0|||
128035976|NCT04462471|460760897|FG002|Overall Study|Disease progression|0|||
128035977|NCT04462471|460760898|FG003|Overall Study|Disease progression|0|||
128035978|NCT05901636|460760902|FG000|Overall Study|Lost to Follow-up|0|||
128035979|NCT05901636|460760903|FG001|Overall Study|Lost to Follow-up|1|||
128035980|NCT05901636|460760904|FG002|Overall Study|Lost to Follow-up|0|||
128035981|NCT05901636|460760905|FG003|Overall Study|Lost to Follow-up|1|||
128035982|NCT05901636|460760906|FG004|Overall Study|Lost to Follow-up|1|||
128035983|NCT05901636|460760907|FG005|Overall Study|Lost to Follow-up|3|||
127597782|NCT02268084|459153726|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
127597783|NCT02268084|459153725|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
127597784|NCT02268084|459153726|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
127597785|NCT05227027|459153727|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
127597786|NCT05227027|459153728|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
127597787|NCT02725710|459153730|FG000|Overall Study|Lost to Follow-up|1|||
127597788|NCT02725710|459153731|FG001|Overall Study|Lost to Follow-up|0|||
128035984|NCT05901636|460760908|FG006|Overall Study|Lost to Follow-up|1|||
128035985|NCT05901636|460760902|FG000|Overall Study|Non- Compliance With Study Schedule|0|||
128035986|NCT05901636|460760903|FG001|Overall Study|Non- Compliance With Study Schedule|0|||
128035987|NCT05901636|460760904|FG002|Overall Study|Non- Compliance With Study Schedule|2|||
128035988|NCT05901636|460760905|FG003|Overall Study|Non- Compliance With Study Schedule|1|||
127597789|NCT00640601|459153736|FG000|Overall Study|Adverse Event|43|||
127787342|NCT02004262|459846106|FG004|Overall Study|Lost to Follow-up|0|||
127787343|NCT02004262|459846107|FG005|Overall Study|Lost to Follow-up|0|||
127787344|NCT02004262|459846102|FG000|Overall Study|Study Terminated by Sponsor|4|||
127787345|NCT02004262|459846103|FG001|Overall Study|Study Terminated by Sponsor|3|||
127787346|NCT02004262|459846104|FG002|Overall Study|Study Terminated by Sponsor|2|||
127787347|NCT02004262|459846105|FG003|Overall Study|Study Terminated by Sponsor|1|||
127787348|NCT02004262|459846106|FG004|Overall Study|Study Terminated by Sponsor|1|||
127787349|NCT02004262|459846107|FG005|Overall Study|Study Terminated by Sponsor|5|||
127787350|NCT01923285|459846108|FG000|Overall Study|Withdrawal by Subject|7|||
127787351|NCT01923285|459846109|FG001|Overall Study|Withdrawal by Subject|6|||
127787352|NCT03200366|459846113|FG000|Patient Navigation Intervention Given|Death|0|||
127597790|NCT00640601|459153736|FG000|Overall Study|Withdrawal by Subject|20|||
127597791|NCT00640601|459153736|FG000|Overall Study|Protocol Violation|6|||
127597792|NCT00640601|459153736|FG000|Overall Study|Lack of Efficacy|16|||
127597793|NCT00640601|459153736|FG000|Overall Study|Lost to Follow-up|9|||
127597794|NCT00640601|459153736|FG000|Overall Study|Physician Decision|8|||
127597795|NCT00640601|459153736|FG000|Overall Study|treatment naive, combination therapy|10|||
127597796|NCT01666782|459153739|FG000|Overall Study|Received 2 doses of vaccine|0|||
127597797|NCT01666782|459153740|FG001|Overall Study|Received 2 doses of vaccine|1|||
127597798|NCT01666782|459153739|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
127597799|NCT01666782|459153740|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
127597800|NCT03681405|459153741|FG000|Overall Study|Found to be ineligible after randomized|1|||
127597801|NCT03681405|459153742|FG001|Overall Study|Found to be ineligible after randomized|0|||
127597802|NCT03978520|459153754|FG000|Overall Study|Adverse Event|2|||
127597803|NCT03978520|459153755|FG001|Overall Study|Adverse Event|5|||
127597804|NCT03978520|459153756|FG002|Overall Study|Adverse Event|3|||
127597805|NCT03978520|459153757|FG003|Overall Study|Adverse Event|5|||
127597806|NCT03978520|459153758|FG004|Overall Study|Adverse Event|6|||
127597807|NCT03978520|459153754|FG000|Overall Study|Withdrawal by Subject|10|||
127597808|NCT03978520|459153755|FG001|Overall Study|Withdrawal by Subject|4|||
127597809|NCT03978520|459153756|FG002|Overall Study|Withdrawal by Subject|5|||
127597810|NCT03978520|459153757|FG003|Overall Study|Withdrawal by Subject|6|||
127597811|NCT03978520|459153758|FG004|Overall Study|Withdrawal by Subject|5|||
127597812|NCT03978520|459153754|FG000|Overall Study|Lost to Follow-up|2|||
127597813|NCT03978520|459153755|FG001|Overall Study|Lost to Follow-up|2|||
127597814|NCT03978520|459153756|FG002|Overall Study|Lost to Follow-up|2|||
127597815|NCT03978520|459153757|FG003|Overall Study|Lost to Follow-up|0|||
127597816|NCT03978520|459153758|FG004|Overall Study|Lost to Follow-up|1|||
127597817|NCT03978520|459153754|FG000|Overall Study|COVID-19 infection|0|||
127597818|NCT03978520|459153755|FG001|Overall Study|COVID-19 infection|1|||
127597819|NCT03978520|459153756|FG002|Overall Study|COVID-19 infection|0|||
127597820|NCT03978520|459153757|FG003|Overall Study|COVID-19 infection|0|||
127597821|NCT03978520|459153758|FG004|Overall Study|COVID-19 infection|0|||
127597822|NCT03978520|459153754|FG000|Overall Study|Other, not specified|9|||
127597823|NCT03978520|459153755|FG001|Overall Study|Other, not specified|4|||
127597824|NCT03978520|459153756|FG002|Overall Study|Other, not specified|1|||
127597825|NCT03978520|459153757|FG003|Overall Study|Other, not specified|1|||
127597826|NCT03978520|459153758|FG004|Overall Study|Other, not specified|2|||
127597827|NCT03978520|459153754|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
127597828|NCT03978520|459153755|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
127597829|NCT03978520|459153756|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
127597830|NCT03978520|459153757|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
127597831|NCT03978520|459153758|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
127597832|NCT01927367|459153761|FG000|Overall Study|Withdrawal by Subject|7|||
127597833|NCT01927367|459153762|FG001|Overall Study|Withdrawal by Subject|4|||
127597834|NCT01927367|459153761|FG000|Overall Study|No baseline data|0|||
127597835|NCT01927367|459153762|FG001|Overall Study|No baseline data|1|||
127597836|NCT02547454|459153763|FG000|Overall Study|Due to hemodialysis|53|||
127597837|NCT02547454|459153763|FG000|Overall Study|Due to transplantation|1|||
127597838|NCT02547454|459153763|FG000|Overall Study|Due to no further need to treat|4|||
127597839|NCT02547454|459153763|FG000|Overall Study|Death|38|||
127597840|NCT02547454|459153763|FG000|Overall Study|Lost to Follow-up|26|||
127597841|NCT02547454|459153763|FG000|Overall Study|Other|39|||
127597842|NCT02547454|459153763|FG000|Overall Study|No data|11|||
127787353|NCT03200366|459846114|FG001|Patient Navigation Intervention Given|Death|2|||
127597843|NCT03694821|459153764|FG000|Overall Study|Study terminated|4|||
127787354|NCT03200366|459846115|FG002|Patient Navigation Intervention Given|Death|0|||
127787355|NCT03200366|459846113|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
127787356|NCT03200366|459846114|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
127597844|NCT03694821|459153765|FG001|Overall Study|Study terminated|8|||
127597845|NCT03694821|459153766|FG002|Overall Study|Study terminated|4|||
127597846|NCT00203996|459153767|FG000|Overall Study|Lost to Follow-up|0|||
127597847|NCT00203996|459153768|FG001|Overall Study|Lost to Follow-up|0|||
127597848|NCT00203996|459153769|FG002|Overall Study|Lost to Follow-up|0|||
128035989|NCT05901636|460760906|FG004|Overall Study|Non- Compliance With Study Schedule|0|||
128035990|NCT05901636|460760907|FG005|Overall Study|Non- Compliance With Study Schedule|0|||
128035991|NCT05901636|460760908|FG006|Overall Study|Non- Compliance With Study Schedule|2|||
128035992|NCT05901636|460760902|FG000|Overall Study|Withdrawal by Subject|1|||
128035993|NCT05901636|460760903|FG001|Overall Study|Withdrawal by Subject|1|||
128035994|NCT05901636|460760904|FG002|Overall Study|Withdrawal by Subject|0|||
128035995|NCT05901636|460760905|FG003|Overall Study|Withdrawal by Subject|0|||
128035996|NCT05901636|460760906|FG004|Overall Study|Withdrawal by Subject|1|||
128035997|NCT05901636|460760907|FG005|Overall Study|Withdrawal by Subject|1|||
128035998|NCT05901636|460760908|FG006|Overall Study|Withdrawal by Subject|0|||
128035999|NCT05901636|460760902|FG000|Overall Study|Other|0|||
128036000|NCT05901636|460760903|FG001|Overall Study|Other|0|||
128036001|NCT05901636|460760904|FG002|Overall Study|Other|1|||
128036002|NCT05901636|460760905|FG003|Overall Study|Other|1|||
128036003|NCT05901636|460760906|FG004|Overall Study|Other|0|||
128036004|NCT05901636|460760907|FG005|Overall Study|Other|0|||
128036005|NCT05901636|460760908|FG006|Overall Study|Other|0|||
128036006|NCT04583618|460760909|FG000|Overall Study|Adverse Event|0|||
128036007|NCT04583618|460760910|FG001|Overall Study|Adverse Event|0|||
128036008|NCT04583618|460760911|FG002|Overall Study|Adverse Event|1|||
128036009|NCT04583618|460760912|FG003|Overall Study|Adverse Event|0|||
128036010|NCT04583618|460760913|FG004|Overall Study|Adverse Event|0|||
128036011|NCT04583618|460760909|FG000|Overall Study|Protocol deviation|1|||
128036012|NCT04583618|460760910|FG001|Overall Study|Protocol deviation|1|||
128036013|NCT04583618|460760911|FG002|Overall Study|Protocol deviation|1|||
128036014|NCT04583618|460760912|FG003|Overall Study|Protocol deviation|0|||
128036015|NCT04583618|460760913|FG004|Overall Study|Protocol deviation|0|||
128036016|NCT04583618|460760909|FG000|Overall Study|Withdrawal by Subject|2|||
128036017|NCT04583618|460760910|FG001|Overall Study|Withdrawal by Subject|1|||
128036018|NCT04583618|460760911|FG002|Overall Study|Withdrawal by Subject|3|||
128036019|NCT04583618|460760912|FG003|Overall Study|Withdrawal by Subject|1|||
128036020|NCT04583618|460760913|FG004|Overall Study|Withdrawal by Subject|1|||
128036021|NCT04583618|460760909|FG000|Overall Study|Lost to Follow-up|0|||
128036022|NCT04583618|460760910|FG001|Overall Study|Lost to Follow-up|1|||
128036023|NCT04583618|460760911|FG002|Overall Study|Lost to Follow-up|3|||
128036024|NCT04583618|460760912|FG003|Overall Study|Lost to Follow-up|1|||
128036025|NCT04583618|460760913|FG004|Overall Study|Lost to Follow-up|1|||
128036026|NCT02711202|460760914|FG000|Overall Study|Adverse Event|3|||
128036027|NCT02711202|460760915|FG001|Overall Study|Adverse Event|0|||
128036028|NCT02711202|460760914|FG000|Overall Study|graft loss|1|||
128036029|NCT02711202|460760915|FG001|Overall Study|graft loss|0|||
128036030|NCT00432965|460760916|FG000|Overall Study|Lost to Follow-up|22|||
128036031|NCT00432965|460760917|FG001|Overall Study|Lost to Follow-up|19|||
128036032|NCT00432965|460760916|FG000|Overall Study|Withdrawal by Subject|13|||
128036033|NCT00432965|460760917|FG001|Overall Study|Withdrawal by Subject|13|||
128036034|NCT00432965|460760916|FG000|Overall Study|Physician Decision|14|||
128036035|NCT00432965|460760917|FG001|Overall Study|Physician Decision|13|||
128036036|NCT00432965|460760916|FG000|Overall Study|Lack of Efficacy|8|||
128036037|NCT00432965|460760917|FG001|Overall Study|Lack of Efficacy|13|||
128036038|NCT00432965|460760916|FG000|Overall Study|Non-compliance|7|||
128036039|NCT00432965|460760917|FG001|Overall Study|Non-compliance|0|||
128036040|NCT00432965|460760916|FG000|Overall Study|Adverse Event|22|||
128036041|NCT00432965|460760917|FG001|Overall Study|Adverse Event|19|||
128036042|NCT00432965|460760916|FG000|Overall Study|Death|3|||
128036043|NCT00432965|460760917|FG001|Overall Study|Death|4|||
128036044|NCT00432965|460760916|FG000|Overall Study|Exclusionary Methods|1|||
128036045|NCT00432965|460760917|FG001|Overall Study|Exclusionary Methods|2|||
128036046|NCT00432965|460760916|FG000|Overall Study|Incomplete Data|4|||
128036047|NCT00432965|460760917|FG001|Overall Study|Incomplete Data|3|||
128036048|NCT03330847|460760922|FG000|Overall Study|Patients ongoing study|62|||
128036049|NCT03330847|460760923|FG001|Overall Study|Patients ongoing study|65|||
128036050|NCT03330847|460760924|FG002|Overall Study|Patients ongoing study|15|||
128036051|NCT01355627|460760925|FG000|Overall Study|Request By the Patient to Discontinue|5|||
128036052|NCT01355627|460760926|FG001|Overall Study|Request By the Patient to Discontinue|7|||
127695701|NCT02783300|459512945|FG012|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
127695702|NCT02783300|459512946|FG013|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
127695703|NCT02783300|459512947|FG014|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|3|||
127695704|NCT02783300|459512948|FG015|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
127695705|NCT02783300|459512949|FG016|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
128036053|NCT01355627|460760925|FG000|Overall Study|Lost to Follow-up|8|||
128036054|NCT01355627|460760926|FG001|Overall Study|Lost to Follow-up|7|||
128036055|NCT01355627|460760925|FG000|Overall Study|Fatal Adverse Event|19|||
128036056|NCT01355627|460760926|FG001|Overall Study|Fatal Adverse Event|23|||
128036057|NCT01355627|460760925|FG000|Overall Study|Other|1|||
128036058|NCT01355627|460760926|FG001|Overall Study|Other|1|||
128036059|NCT02293551|460760929|FG000|Part A and B Period 2|Withdrawal by Subject|0|||
128036060|NCT02293551|460760930|FG001|Part A and B Period 2|Withdrawal by Subject|0|||
128036061|NCT02293551|460760931|FG002|Part A and B Period 2|Withdrawal by Subject|0|||
127882446|NCT00883740|460192784|FG000|Second Intervention|No longer willing to participate|0|||
127882447|NCT00883740|460192785|FG001|Second Intervention|No longer willing to participate|1|||
127882448|NCT01392170|460192786|FG000|Overall Study|Withdrawal by Subject|1|||
127882449|NCT01392170|460192786|FG000|Overall Study|Ineligible|1|||
127882450|NCT02748616|460192788|FG000|Overall Study|Lost to Follow-up|1|||
127882451|NCT02748616|460192788|FG000|Overall Study|Withdrawal by Subject|2|||
127882452|NCT02748616|460192788|FG000|Overall Study|Physician Decision|2|||
127882453|NCT02748616|460192788|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
127882454|NCT01296152|460192789|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
127882455|NCT01414062|460192794|FG000|Overall Study|Lost to Follow-up|3|||
127882456|NCT01414062|460192795|FG001|Overall Study|Lost to Follow-up|2|||
127882457|NCT01414062|460192794|FG000|Overall Study|Left Country|1|||
127882458|NCT01414062|460192795|FG001|Overall Study|Left Country|1|||
127882459|NCT01414062|460192794|FG000|Overall Study|Family Disapproval|1|||
127882460|NCT01414062|460192795|FG001|Overall Study|Family Disapproval|0|||
127882461|NCT01414062|460192794|FG000|Overall Study|Withdrawal by Subject|0|||
127787357|NCT03200366|459846115|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
127787358|NCT03200366|459846113|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
127787359|NCT03200366|459846114|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
127787360|NCT03200366|459846115|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
127787361|NCT03200366|459846113|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
127787362|NCT03200366|459846114|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
127882462|NCT01414062|460192795|FG001|Overall Study|Withdrawal by Subject|1|||
127597849|NCT00203996|459153770|FG003|Overall Study|Lost to Follow-up|1|||
127597850|NCT00203996|459153771|FG004|Overall Study|Lost to Follow-up|0|||
127597851|NCT00203996|459153772|FG005|Overall Study|Lost to Follow-up|0|||
127597852|NCT00203996|459153773|FG006|Overall Study|Lost to Follow-up|0|||
127597853|NCT00203996|459153774|FG007|Overall Study|Lost to Follow-up|0|||
127597854|NCT00203996|459153775|FG008|Overall Study|Lost to Follow-up|0|||
127597855|NCT00203996|459153776|FG009|Overall Study|Lost to Follow-up|0|||
127597856|NCT00203996|459153767|FG000|Overall Study|Protocol Violation|0|||
127597857|NCT00203996|459153768|FG001|Overall Study|Protocol Violation|0|||
127597858|NCT00203996|459153769|FG002|Overall Study|Protocol Violation|0|||
127597859|NCT00203996|459153770|FG003|Overall Study|Protocol Violation|6|||
127597860|NCT00203996|459153771|FG004|Overall Study|Protocol Violation|1|||
127597861|NCT00203996|459153772|FG005|Overall Study|Protocol Violation|0|||
127597862|NCT00203996|459153773|FG006|Overall Study|Protocol Violation|0|||
127597863|NCT00203996|459153774|FG007|Overall Study|Protocol Violation|0|||
127597864|NCT00203996|459153775|FG008|Overall Study|Protocol Violation|0|||
127597865|NCT00203996|459153776|FG009|Overall Study|Protocol Violation|0|||
127597866|NCT00203996|459153767|FG000|Overall Study|Physician Decision|0|||
127597867|NCT00203996|459153768|FG001|Overall Study|Physician Decision|0|||
127597868|NCT00203996|459153769|FG002|Overall Study|Physician Decision|0|||
127597869|NCT00203996|459153770|FG003|Overall Study|Physician Decision|2|||
127597870|NCT00203996|459153771|FG004|Overall Study|Physician Decision|0|||
127597871|NCT00203996|459153772|FG005|Overall Study|Physician Decision|0|||
127597872|NCT00203996|459153773|FG006|Overall Study|Physician Decision|0|||
127597873|NCT00203996|459153774|FG007|Overall Study|Physician Decision|0|||
127597874|NCT00203996|459153775|FG008|Overall Study|Physician Decision|0|||
127597875|NCT00203996|459153776|FG009|Overall Study|Physician Decision|1|||
127597876|NCT00203996|459153767|FG000|Overall Study|CPAP machine malfunction|0|||
127597877|NCT00203996|459153768|FG001|Overall Study|CPAP machine malfunction|0|||
127597878|NCT00203996|459153769|FG002|Overall Study|CPAP machine malfunction|0|||
127597879|NCT00203996|459153770|FG003|Overall Study|CPAP machine malfunction|1|||
127597880|NCT00203996|459153771|FG004|Overall Study|CPAP machine malfunction|0|||
127597881|NCT00203996|459153772|FG005|Overall Study|CPAP machine malfunction|0|||
127597882|NCT00203996|459153773|FG006|Overall Study|CPAP machine malfunction|0|||
127597883|NCT00203996|459153774|FG007|Overall Study|CPAP machine malfunction|0|||
127597884|NCT00203996|459153775|FG008|Overall Study|CPAP machine malfunction|0|||
127597885|NCT00203996|459153776|FG009|Overall Study|CPAP machine malfunction|0|||
127597886|NCT00203996|459153767|FG000|Overall Study|Scheduling issue|0|||
127597887|NCT00203996|459153768|FG001|Overall Study|Scheduling issue|0|||
127597888|NCT00203996|459153769|FG002|Overall Study|Scheduling issue|0|||
127597889|NCT00203996|459153770|FG003|Overall Study|Scheduling issue|0|||
127597890|NCT00203996|459153771|FG004|Overall Study|Scheduling issue|0|||
127597891|NCT00203996|459153772|FG005|Overall Study|Scheduling issue|0|||
127882463|NCT04057118|460192798|FG000|Overall Study|Adverse Event|1|||
127882464|NCT04057118|460192799|FG001|Overall Study|Adverse Event|0|||
127597892|NCT00203996|459153773|FG006|Overall Study|Scheduling issue|0|||
127882465|NCT04057118|460192800|FG002|Overall Study|Adverse Event|1|||
127882466|NCT04057118|460192801|FG003|Overall Study|Adverse Event|1|||
127882467|NCT04057118|460192798|FG000|Overall Study|Physician Decision|0|||
127597893|NCT00203996|459153774|FG007|Overall Study|Scheduling issue|2|||
127597894|NCT00203996|459153775|FG008|Overall Study|Scheduling issue|0|||
127597895|NCT00203996|459153776|FG009|Overall Study|Scheduling issue|0|||
127597896|NCT03918447|459153777|FG000|Overall Study|Death|1|||
127597897|NCT03918447|459153778|FG001|Overall Study|Death|0|||
127597898|NCT03918447|459153777|FG000|Overall Study|Lost to Follow-up|13|||
127597899|NCT03918447|459153778|FG001|Overall Study|Lost to Follow-up|6|||
127597900|NCT03918447|459153777|FG000|Overall Study|Withdrawal by Subject|19|||
127597901|NCT03918447|459153778|FG001|Overall Study|Withdrawal by Subject|17|||
127597902|NCT03918447|459153777|FG000|Overall Study|Study Terminated by Sponsor|195|||
127597903|NCT03918447|459153778|FG001|Overall Study|Study Terminated by Sponsor|197|||
127597904|NCT03918447|459153777|FG000|Overall Study|Reason not Specified|0|||
127597905|NCT03918447|459153778|FG001|Overall Study|Reason not Specified|1|||
127597906|NCT03278613|459153779|FG000|Overall Study|Lost to Follow-up|3|||
127597907|NCT03278613|459153780|FG001|Overall Study|Lost to Follow-up|1|||
127597908|NCT01405456|459153781|FG000|Overall Study|Lost to Follow-up|2|||
127597909|NCT01405456|459153782|FG001|Overall Study|Lost to Follow-up|1|||
127597910|NCT01405456|459153781|FG000|Overall Study|Physician Decision|1|||
127597911|NCT01405456|459153782|FG001|Overall Study|Physician Decision|0|||
127597912|NCT00850564|459153783|FG000|Overall Study|Withdrawal by Subject|2|||
127597913|NCT05355805|459153784|FG000|Overall Study|Lost to Follow-up|6|||
127597914|NCT05355805|459153785|FG001|Overall Study|Lost to Follow-up|11|||
127597915|NCT05355805|459153786|FG002|Overall Study|Lost to Follow-up|10|||
127597916|NCT05355805|459153787|FG003|Overall Study|Lost to Follow-up|6|||
127597917|NCT05355805|459153784|FG000|Overall Study|Decision by Sponsor|0|||
127597918|NCT05355805|459153785|FG001|Overall Study|Decision by Sponsor|0|||
127597919|NCT05355805|459153786|FG002|Overall Study|Decision by Sponsor|1|||
127597920|NCT05355805|459153787|FG003|Overall Study|Decision by Sponsor|0|||
127597921|NCT05355805|459153784|FG000|Overall Study|Withdrawal by Subject|7|||
127597922|NCT05355805|459153785|FG001|Overall Study|Withdrawal by Subject|14|||
127597923|NCT05355805|459153786|FG002|Overall Study|Withdrawal by Subject|15|||
127597924|NCT05355805|459153787|FG003|Overall Study|Withdrawal by Subject|13|||
127597925|NCT01937559|459153788|FG000|Overall Study|Physician Decision|3|||
127597926|NCT01937559|459153789|FG001|Overall Study|Physician Decision|3|||
127597927|NCT01937559|459153790|FG002|Overall Study|Physician Decision|0|||
127597928|NCT01937559|459153788|FG000|Overall Study|Withdrawal by Subject|6|||
127597929|NCT01937559|459153789|FG001|Overall Study|Withdrawal by Subject|4|||
127597930|NCT01937559|459153790|FG002|Overall Study|Withdrawal by Subject|0|||
127597931|NCT01937559|459153788|FG000|Overall Study|screen fail|2|||
127597932|NCT01937559|459153789|FG001|Overall Study|screen fail|4|||
127597933|NCT01937559|459153790|FG002|Overall Study|screen fail|0|||
127597934|NCT02167893|459153791|FG000|Overall Study|Investigator transferred|85|||
127597935|NCT02167893|459153791|FG000|Overall Study|Investigator health reasons|10|||
127597936|NCT02167893|459153791|FG000|Overall Study|Case report forms not collected|68|||
127597937|NCT04818840|459153792|FG000|Overall Study|Lost to Follow-up|0|||
127597938|NCT04818840|459153793|FG001|Overall Study|Lost to Follow-up|5|||
127597939|NCT04818840|459153792|FG000|Overall Study|Physician Decision|1|||
127597940|NCT04818840|459153793|FG001|Overall Study|Physician Decision|0|||
127597941|NCT04818840|459153792|FG000|Overall Study|Site Terminated by Sponsor|0|||
127597942|NCT04818840|459153793|FG001|Overall Study|Site Terminated by Sponsor|3|||
127597943|NCT04818840|459153792|FG000|Overall Study|Study Terminated by Sponsor|43|||
127597944|NCT04818840|459153793|FG001|Overall Study|Study Terminated by Sponsor|7|||
127597945|NCT04818840|459153792|FG000|Overall Study|Withdrawal by Subject|0|||
127597946|NCT04818840|459153793|FG001|Overall Study|Withdrawal by Subject|1|||
127597947|NCT00524368|459155554|FG000|Overall Study|Adverse Event|10|||
127597948|NCT00524368|459155555|FG001|Overall Study|Adverse Event|12|||
127597949|NCT00524368|459155554|FG000|Overall Study|Lost to Follow-up|9|||
127597950|NCT00524368|459155555|FG001|Overall Study|Lost to Follow-up|13|||
127597951|NCT00524368|459155554|FG000|Overall Study|Withdrawal by Subject|4|||
127597952|NCT00524368|459155555|FG001|Overall Study|Withdrawal by Subject|5|||
127597953|NCT00524368|459155554|FG000|Overall Study|Non-compliant|8|||
127597954|NCT00524368|459155555|FG001|Overall Study|Non-compliant|9|||
127882468|NCT04057118|460192799|FG001|Overall Study|Physician Decision|0|||
127882469|NCT04057118|460192800|FG002|Overall Study|Physician Decision|1|||
127882470|NCT04057118|460192801|FG003|Overall Study|Physician Decision|1|||
127882471|NCT04057118|460192798|FG000|Overall Study|Withdrawal by Subject|2|||
127597955|NCT00524368|459155554|FG000|Overall Study|Reached a Virologic Endpoint|3|||
127597956|NCT00524368|459155555|FG001|Overall Study|Reached a Virologic Endpoint|2|||
127597957|NCT00524368|459155554|FG000|Overall Study|Sponsor's Decision|2|||
127597958|NCT00524368|459155555|FG001|Overall Study|Sponsor's Decision|0|||
127597959|NCT00524368|459155554|FG000|Overall Study|Ineligible to Continue the study|2|||
127597960|NCT00524368|459155555|FG001|Overall Study|Ineligible to Continue the study|5|||
127597961|NCT00524368|459155554|FG000|Overall Study|Other|3|||
127597962|NCT00524368|459155555|FG001|Overall Study|Other|2|||
127597963|NCT00793598|459155556|FG000|Overall Study|Patient Request|0|||
127597964|NCT00793598|459155557|FG001|Overall Study|Patient Request|1|||
127597965|NCT00793598|459155558|FG002|Overall Study|Patient Request|0|||
127597966|NCT00793598|459155559|FG003|Overall Study|Patient Request|0|||
127597967|NCT00793598|459155560|FG004|Overall Study|Patient Request|0|||
127597968|NCT00793598|459155561|FG005|Overall Study|Patient Request|0|||
127597969|NCT00793598|459155562|FG006|Overall Study|Patient Request|0|||
127882472|NCT04057118|460192799|FG001|Overall Study|Withdrawal by Subject|2|||
127597970|NCT00793598|459155563|FG007|Overall Study|Patient Request|0|||
127597971|NCT00793598|459155556|FG000|Overall Study|Protocol Violation|0|||
127597972|NCT00793598|459155557|FG001|Overall Study|Protocol Violation|0|||
127597973|NCT00793598|459155558|FG002|Overall Study|Protocol Violation|0|||
127597974|NCT00793598|459155559|FG003|Overall Study|Protocol Violation|0|||
127597975|NCT00793598|459155560|FG004|Overall Study|Protocol Violation|0|||
127597976|NCT00793598|459155561|FG005|Overall Study|Protocol Violation|0|||
127597977|NCT00793598|459155562|FG006|Overall Study|Protocol Violation|0|||
127597978|NCT00793598|459155563|FG007|Overall Study|Protocol Violation|1|||
127597979|NCT00793598|459155556|FG000|Overall Study|Subject not dosed|0|||
127597980|NCT00793598|459155557|FG001|Overall Study|Subject not dosed|0|||
127597981|NCT00793598|459155558|FG002|Overall Study|Subject not dosed|0|||
127597982|NCT00793598|459155559|FG003|Overall Study|Subject not dosed|0|||
127597983|NCT00793598|459155560|FG004|Overall Study|Subject not dosed|0|||
127597984|NCT00793598|459155561|FG005|Overall Study|Subject not dosed|1|||
127597985|NCT00793598|459155562|FG006|Overall Study|Subject not dosed|0|||
127597986|NCT00793598|459155563|FG007|Overall Study|Subject not dosed|0|||
127597987|NCT00531232|459155564|FG000|Overall Study|Investigator decision|0|||
127597988|NCT00531232|459155565|FG001|Overall Study|Investigator decision|0|||
127597989|NCT00531232|459155566|FG002|Overall Study|Investigator decision|4|||
127597990|NCT00531232|459155564|FG000|Overall Study|Participants refused further treatment|0|||
127597991|NCT00531232|459155565|FG001|Overall Study|Participants refused further treatment|1|||
127597992|NCT00531232|459155566|FG002|Overall Study|Participants refused further treatment|2|||
127597993|NCT00531232|459155564|FG000|Overall Study|Adverse events (AEs)|1|||
127597994|NCT00531232|459155565|FG001|Overall Study|Adverse events (AEs)|2|||
127787363|NCT03200366|459846115|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
127787364|NCT03200366|459846113|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
127787365|NCT03200366|459846114|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
127787366|NCT03200366|459846115|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
127787367|NCT03200366|459846113|FG000|6 Month Post-Baseline Interview|Death|1|||
127787368|NCT03200366|459846114|FG001|6 Month Post-Baseline Interview|Death|1|||
127597995|NCT00531232|459155566|FG002|Overall Study|Adverse events (AEs)|2|||
127597996|NCT00531232|459155564|FG000|Overall Study|Treatment failure|1|||
127597997|NCT00531232|459155565|FG001|Overall Study|Treatment failure|3|||
127597998|NCT00531232|459155566|FG002|Overall Study|Treatment failure|7|||
127597999|NCT00531232|459155564|FG000|Overall Study|Disease recurrence|0|||
127598000|NCT00531232|459155565|FG001|Overall Study|Disease recurrence|0|||
127598001|NCT00531232|459155566|FG002|Overall Study|Disease recurrence|1|||
127598002|NCT00531232|459155564|FG000|Overall Study|Deceased|2|||
127598003|NCT00531232|459155565|FG001|Overall Study|Deceased|2|||
127598004|NCT00531232|459155566|FG002|Overall Study|Deceased|2|||
127598005|NCT00531232|459155564|FG000|Overall Study|Withdrawal by Subject|0|||
127598006|NCT00531232|459155565|FG001|Overall Study|Withdrawal by Subject|1|||
127598007|NCT00531232|459155566|FG002|Overall Study|Withdrawal by Subject|2|||
127598008|NCT00531232|459155564|FG000|Overall Study|Other|0|||
127598009|NCT00531232|459155565|FG001|Overall Study|Other|0|||
127598010|NCT00531232|459155566|FG002|Overall Study|Other|5|||
127598011|NCT03909295|459155571|FG000|Overall Study|Adverse Event|2|||
127598012|NCT03909295|459155571|FG000|Overall Study|Study terminated by sponsor|50|||
127598013|NCT01411228|459155572|FG000|Overall Study|Lost to Follow-up|0|||
127598014|NCT01411228|459155573|FG001|Overall Study|Lost to Follow-up|0|||
127598015|NCT01411228|459155574|FG002|Overall Study|Lost to Follow-up|1|||
127598016|NCT01411228|459155572|FG000|Overall Study|Withdrawal by Subject|1|||
127598017|NCT01411228|459155573|FG001|Overall Study|Withdrawal by Subject|0|||
127598018|NCT01411228|459155574|FG002|Overall Study|Withdrawal by Subject|0|||
127598019|NCT01752907|459155580|FG000|Overall Study|Withdrawal by Subject|4|||
127598020|NCT01752907|459155581|FG001|Overall Study|Withdrawal by Subject|10|||
127598021|NCT01752907|459155580|FG000|Overall Study|Lost to Follow-up|2|||
127598022|NCT01752907|459155581|FG001|Overall Study|Lost to Follow-up|1|||
127598023|NCT01752907|459155580|FG000|Overall Study|Decision by Sponsor|6|||
127598024|NCT01752907|459155581|FG001|Overall Study|Decision by Sponsor|9|||
127598025|NCT02670083|459155585|FG000|Overall Study|Adverse Event|16|||
127598026|NCT02670083|459155586|FG001|Overall Study|Adverse Event|13|||
127598027|NCT02670083|459155585|FG000|Overall Study|Death|4|||
127598028|NCT02670083|459155586|FG001|Overall Study|Death|6|||
127598029|NCT02670083|459155585|FG000|Overall Study|Lost to Follow-up|2|||
127787369|NCT03200366|459846115|FG002|6 Month Post-Baseline Interview|Death|1|||
127787370|NCT03200366|459846113|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
127598030|NCT02670083|459155586|FG001|Overall Study|Lost to Follow-up|2|||
127598031|NCT02670083|459155585|FG000|Overall Study|Multiple Reasons|9|||
127598032|NCT02670083|459155586|FG001|Overall Study|Multiple Reasons|9|||
127598033|NCT02670083|459155585|FG000|Overall Study|Physician Decision|0|||
127598034|NCT02670083|459155586|FG001|Overall Study|Physician Decision|2|||
127598035|NCT02670083|459155585|FG000|Overall Study|Study Terminated By Sponsor|257|||
127598036|NCT02670083|459155586|FG001|Overall Study|Study Terminated By Sponsor|254|||
127598037|NCT02670083|459155585|FG000|Overall Study|Symptomatic Deterioration|0|||
127598038|NCT02670083|459155586|FG001|Overall Study|Symptomatic Deterioration|2|||
127598039|NCT02670083|459155585|FG000|Overall Study|Withdrawal by Subject|32|||
127598040|NCT02670083|459155586|FG001|Overall Study|Withdrawal by Subject|31|||
127598041|NCT02670083|459155585|FG000|Overall Study|Non-Compliance With Study Drug|1|||
127598042|NCT02670083|459155586|FG001|Overall Study|Non-Compliance With Study Drug|0|||
127598043|NCT00464087|459155589|FG000|Overall Study|No PCI per inclusion criteria|0|||
127598044|NCT00464087|459155590|FG001|Overall Study|No PCI per inclusion criteria|0|||
127598045|NCT00464087|459155591|FG002|Overall Study|No PCI per inclusion criteria|29|||
127598046|NCT00609492|459155592|FG000|Overall Study|Withdrawal by Subject|0|||
127598047|NCT00609492|459155593|FG001|Overall Study|Withdrawal by Subject|2|||
127598048|NCT00609492|459155594|FG002|Overall Study|Withdrawal by Subject|3|||
127598049|NCT00609492|459155592|FG000|Overall Study|Lost to Follow-up|1|||
127598050|NCT00609492|459155593|FG001|Overall Study|Lost to Follow-up|1|||
127598051|NCT00609492|459155594|FG002|Overall Study|Lost to Follow-up|4|||
127598052|NCT02057406|459155595|FG000|Overall Study|Physician Decision|0|||
127598053|NCT02057406|459155596|FG001|Overall Study|Physician Decision|0|||
127598054|NCT02057406|459155597|FG002|Overall Study|Physician Decision|2|||
127598055|NCT02057406|459155595|FG000|Overall Study|Withdrawal by Subject|0|||
127598056|NCT02057406|459155596|FG001|Overall Study|Withdrawal by Subject|2|||
127598057|NCT02057406|459155597|FG002|Overall Study|Withdrawal by Subject|0|||
127598058|NCT02057406|459155595|FG000|Overall Study|Lost to Follow-up|0|||
127598059|NCT02057406|459155596|FG001|Overall Study|Lost to Follow-up|0|||
127598060|NCT02057406|459155597|FG002|Overall Study|Lost to Follow-up|1|||
127598061|NCT02057406|459155595|FG000|Overall Study|Death|1|||
127598062|NCT02057406|459155596|FG001|Overall Study|Death|0|||
127598063|NCT02057406|459155597|FG002|Overall Study|Death|0|||
127598064|NCT02057406|459155595|FG000|Overall Study|Protocol Violation|0|||
127598065|NCT02057406|459155596|FG001|Overall Study|Protocol Violation|1|||
127598066|NCT02057406|459155597|FG002|Overall Study|Protocol Violation|0|||
127598067|NCT02057406|459155595|FG000|Overall Study|Patient transportation issues|0|||
127598068|NCT02057406|459155596|FG001|Overall Study|Patient transportation issues|0|||
127598069|NCT02057406|459155597|FG002|Overall Study|Patient transportation issues|1|||
127598070|NCT03654651|459155598|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
127598071|NCT03654651|459155599|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
127598072|NCT01702454|459155602|FG000|Overall Study|Consent withdrawal|0|||
127598073|NCT01702454|459155603|FG001|Overall Study|Consent withdrawal|1|||
127598074|NCT01702454|459155602|FG000|Overall Study|Migrated/moved from study area|0|||
127598075|NCT01702454|459155603|FG001|Overall Study|Migrated/moved from study area|1|||
127598076|NCT01702454|459155602|FG000|Overall Study|Lost to Follow-up|3|||
127598077|NCT01702454|459155603|FG001|Overall Study|Lost to Follow-up|6|||
127598078|NCT03510884|459155608|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
127598079|NCT03510884|459155609|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
127598080|NCT03510884|459155610|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
127598081|NCT03510884|459155611|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
127598082|NCT03510884|459155608|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
127598083|NCT03510884|459155609|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
127598084|NCT03510884|459155610|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
127598085|NCT03510884|459155611|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
127598086|NCT03510884|459155608|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
127598087|NCT03510884|459155609|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
127598088|NCT03510884|459155610|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
127598089|NCT03510884|459155611|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
127598090|NCT03510884|459155608|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
127598091|NCT03510884|459155609|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
127598092|NCT03510884|459155610|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
127598093|NCT03510884|459155611|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
127598094|NCT03510884|459155608|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
127598095|NCT03510884|459155609|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
127598096|NCT03510884|459155610|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
127598097|NCT03510884|459155611|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
127598098|NCT03510884|459155608|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
127598099|NCT03510884|459155609|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
127598100|NCT03510884|459155610|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
127598101|NCT03510884|459155611|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
127598102|NCT03510884|459155608|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
127598103|NCT03510884|459155609|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
127695706|NCT02783300|459512950|FG017|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
127695707|NCT02783300|459512951|FG018|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|7|||
127598104|NCT03510884|459155610|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
127882473|NCT04057118|460192800|FG002|Overall Study|Withdrawal by Subject|0|||
127882474|NCT04057118|460192801|FG003|Overall Study|Withdrawal by Subject|2|||
127695708|NCT02783300|459512952|FG019|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
127695709|NCT02783300|459512953|FG020|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
127695710|NCT02783300|459512954|FG021|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
127695711|NCT02783300|459512955|FG022|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
127695712|NCT02783300|459512956|FG023|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
127695713|NCT02783300|459512957|FG024|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
127695714|NCT02783300|459512958|FG025|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
127695715|NCT02783300|459512959|FG026|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
127695716|NCT02783300|459512933|FG000|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
127695717|NCT02783300|459512934|FG001|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
127695718|NCT02783300|459512935|FG002|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
127695719|NCT02783300|459512936|FG003|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
127695720|NCT02783300|459512937|FG004|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
127695721|NCT02783300|459512938|FG005|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
127695722|NCT02783300|459512939|FG006|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
127695723|NCT02783300|459512940|FG007|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
127787371|NCT03200366|459846114|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
127787372|NCT03200366|459846115|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
127787373|NCT03200366|459846113|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
127787374|NCT03200366|459846114|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
127787375|NCT03200366|459846115|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
127787376|NCT03200366|459846113|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
127787377|NCT03200366|459846114|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
127787378|NCT03200366|459846115|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
127787379|NCT03200366|459846113|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
127787380|NCT03200366|459846114|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
127882475|NCT04057118|460192798|FG000|Overall Study|Not Specific|0|||
127882476|NCT04057118|460192799|FG001|Overall Study|Not Specific|0|||
127598105|NCT03510884|459155611|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
127598106|NCT03510884|459155608|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
127598107|NCT03510884|459155609|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
127598108|NCT03510884|459155610|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
127598109|NCT03510884|459155611|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
127598110|NCT03510884|459155608|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
127598111|NCT03510884|459155609|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
127598112|NCT03510884|459155610|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
127598113|NCT03510884|459155611|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
127598114|NCT03510884|459155608|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
127598115|NCT03510884|459155609|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
127598116|NCT03510884|459155610|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
127598117|NCT03510884|459155611|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
127598118|NCT00856284|459155612|FG000|Overall Study|Hyperglycemic rescue|231|||
127598119|NCT00856284|459155613|FG001|Overall Study|Hyperglycemic rescue|201|||
127598120|NCT00856284|459155614|FG002|Overall Study|Hyperglycemic rescue|235|||
127598121|NCT00856284|459155612|FG000|Overall Study|Adverse Event|60|||
127598122|NCT00856284|459155613|FG001|Overall Study|Adverse Event|74|||
127598123|NCT00856284|459155614|FG002|Overall Study|Adverse Event|82|||
127598124|NCT00856284|459155612|FG000|Overall Study|Major protocol deviation|24|||
127598125|NCT00856284|459155613|FG001|Overall Study|Major protocol deviation|16|||
127598126|NCT00856284|459155614|FG002|Overall Study|Major protocol deviation|15|||
127598127|NCT00856284|459155612|FG000|Overall Study|Lost to Follow-up|20|||
127598128|NCT00856284|459155613|FG001|Overall Study|Lost to Follow-up|22|||
127598129|NCT00856284|459155614|FG002|Overall Study|Lost to Follow-up|28|||
127598130|NCT00856284|459155612|FG000|Overall Study|Voluntary withdrawal|48|||
127598131|NCT00856284|459155613|FG001|Overall Study|Voluntary withdrawal|52|||
127598132|NCT00856284|459155614|FG002|Overall Study|Voluntary withdrawal|62|||
127598133|NCT00856284|459155612|FG000|Overall Study|Pregnancy|1|||
127598134|NCT00856284|459155613|FG001|Overall Study|Pregnancy|2|||
127598135|NCT00856284|459155614|FG002|Overall Study|Pregnancy|0|||
127598136|NCT00856284|459155612|FG000|Overall Study|Investigator discretion|9|||
127598137|NCT00856284|459155613|FG001|Overall Study|Investigator discretion|8|||
127598138|NCT00856284|459155614|FG002|Overall Study|Investigator discretion|10|||
127598139|NCT00856284|459155612|FG000|Overall Study|Other|15|||
127598140|NCT00856284|459155613|FG001|Overall Study|Other|17|||
127598141|NCT00856284|459155614|FG002|Overall Study|Other|14|||
127598142|NCT00856284|459155612|FG000|Overall Study|Randomized in error|0|||
127598143|NCT00856284|459155613|FG001|Overall Study|Randomized in error|0|||
127598144|NCT00856284|459155614|FG002|Overall Study|Randomized in error|1|||
127598145|NCT02904512|459155617|FG000|Overall Study|Withdrawal by Subject|1|||
127598146|NCT02904512|459155618|FG001|Overall Study|Withdrawal by Subject|0|||
127598147|NCT02904512|459155617|FG000|Overall Study|Transferred to ICU|1|||
127598148|NCT02904512|459155618|FG001|Overall Study|Transferred to ICU|0|||
127598149|NCT02904512|459155617|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
128036062|NCT02293551|460760932|FG003|Part A and B Period 2|Withdrawal by Subject|0|||
128036063|NCT02293551|460760933|FG004|Part A and B Period 2|Withdrawal by Subject|0|||
128036064|NCT02293551|460760934|FG005|Part A and B Period 2|Withdrawal by Subject|1|||
128036065|NCT02293551|460760929|FG000|Part A and B Period 3|Withdrawal by Subject|0|||
128036066|NCT02293551|460760930|FG001|Part A and B Period 3|Withdrawal by Subject|0|||
128036067|NCT02293551|460760931|FG002|Part A and B Period 3|Withdrawal by Subject|0|||
127598150|NCT02904512|459155618|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
127598151|NCT00267046|459155623|FG000|Overall Study|Disease progression|4|||
127695724|NCT02783300|459512941|FG008|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
127695725|NCT02783300|459512942|FG009|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
127695726|NCT02783300|459512943|FG010|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
127695727|NCT02783300|459512944|FG011|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
127695728|NCT02783300|459512945|FG012|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
127695729|NCT02783300|459512946|FG013|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
127695730|NCT02783300|459512947|FG014|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
127695731|NCT02783300|459512948|FG015|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
128036068|NCT02293551|460760932|FG003|Part A and B Period 3|Withdrawal by Subject|2|||
128036069|NCT02293551|460760933|FG004|Part A and B Period 3|Withdrawal by Subject|0|||
128036070|NCT02293551|460760934|FG005|Part A and B Period 3|Withdrawal by Subject|1|||
128036071|NCT02293551|460760929|FG000|Part A and Part B Period 4|Withdrawal by Subject|0|||
127598152|NCT00267046|459155624|FG001|Overall Study|Disease progression|2|||
127598153|NCT00267046|459155623|FG000|Overall Study|Chemotoxicity|2|||
127598154|NCT00267046|459155624|FG001|Overall Study|Chemotoxicity|0|||
127598155|NCT00267046|459155623|FG000|Overall Study|Open-label palifermin|2|||
127598156|NCT00267046|459155624|FG001|Overall Study|Open-label palifermin|7|||
127598157|NCT00267046|459155623|FG000|Overall Study|Surgery|3|||
128036072|NCT02293551|460760930|FG001|Part A and Part B Period 4|Withdrawal by Subject|0|||
128036073|NCT02293551|460760931|FG002|Part A and Part B Period 4|Withdrawal by Subject|0|||
127598158|NCT00267046|459155624|FG001|Overall Study|Surgery|1|||
127598159|NCT00267046|459155623|FG000|Overall Study|Withdrawal by Subject|1|||
127598160|NCT00267046|459155624|FG001|Overall Study|Withdrawal by Subject|0|||
127598161|NCT00267046|459155623|FG000|Overall Study|Radiation|0|||
127598162|NCT00267046|459155624|FG001|Overall Study|Radiation|1|||
127598163|NCT00460408|459155625|FG000|Overall Study|Adverse Event|1|||
127598164|NCT00460408|459155626|FG001|Overall Study|Adverse Event|0|||
127598165|NCT00460408|459155627|FG002|Overall Study|Adverse Event|0|||
127598166|NCT00460408|459155628|FG003|Overall Study|Adverse Event|0|||
127598167|NCT00460408|459155625|FG000|Overall Study|Death|7|||
127598168|NCT00460408|459155626|FG001|Overall Study|Death|0|||
127598169|NCT00460408|459155627|FG002|Overall Study|Death|0|||
128036074|NCT02293551|460760932|FG003|Part A and Part B Period 4|Withdrawal by Subject|2|||
128036075|NCT02293551|460760933|FG004|Part A and Part B Period 4|Withdrawal by Subject|0|||
128036076|NCT02293551|460760934|FG005|Part A and Part B Period 4|Withdrawal by Subject|1|||
128036077|NCT04532749|460760935|FG000|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|1|||
128036078|NCT04532749|460760936|FG001|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|6|||
128036079|NCT04532749|460760935|FG000|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|2|||
128036080|NCT04532749|460760936|FG001|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|5|||
128036081|NCT04532749|460760935|FG000|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|2|||
128036082|NCT04532749|460760936|FG001|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|0|||
128036083|NCT04532749|460760935|FG000|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|0|||
128036084|NCT04532749|460760936|FG001|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|1|||
128036085|NCT04532749|460760935|FG000|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|0|||
128036086|NCT04532749|460760936|FG001|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|1|||
128036087|NCT04532749|460760935|FG000|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|0|||
127598170|NCT00460408|459155628|FG003|Overall Study|Death|0|||
128036088|NCT04532749|460760936|FG001|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|1|||
128036089|NCT04532749|460760935|FG000|DB Treatment Phase (Day 1 to Day 43)|Other|1|||
128036090|NCT04532749|460760936|FG001|DB Treatment Phase (Day 1 to Day 43)|Other|2|||
128036091|NCT04532749|460760935|FG000|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|0|||
128036092|NCT04532749|460760936|FG001|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|3|||
128036093|NCT04532749|460760935|FG000|Follow-up Phase (Day 44 to Day 57)|Adverse Event|0|||
128036094|NCT04532749|460760936|FG001|Follow-up Phase (Day 44 to Day 57)|Adverse Event|1|||
128036095|NCT04532749|460760935|FG000|Follow-up Phase (Day 44 to Day 57)|Other|1|||
128036096|NCT04532749|460760936|FG001|Follow-up Phase (Day 44 to Day 57)|Other|2|||
128036097|NCT00642759|460760937|FG000|Overall Study|Protocol Violation|1|||
128036098|NCT03612570|460760944|FG000|Overall Study|Lost to Follow-up|1|||
128036099|NCT04756531|460760945|FG000|Overall Study|Adverse Event|0|||
128036100|NCT04756531|460760946|FG001|Overall Study|Adverse Event|0|||
128036101|NCT04756531|460760947|FG002|Overall Study|Adverse Event|0|||
128036102|NCT04756531|460760948|FG003|Overall Study|Adverse Event|0|||
128036103|NCT04756531|460760949|FG004|Overall Study|Adverse Event|1|||
128036104|NCT04756531|460760950|FG005|Overall Study|Adverse Event|0|||
128036105|NCT04756531|460760951|FG006|Overall Study|Adverse Event|0|||
128036106|NCT04756531|460760952|FG007|Overall Study|Adverse Event|0|||
128036107|NCT04756531|460760953|FG008|Overall Study|Adverse Event|0|||
128036108|NCT04756531|460760954|FG009|Overall Study|Adverse Event|0|||
128036109|NCT04756531|460760955|FG010|Overall Study|Adverse Event|0|||
128036110|NCT04756531|460760956|FG011|Overall Study|Adverse Event|0|||
128036111|NCT04756531|460760957|FG012|Overall Study|Adverse Event|0|||
127598171|NCT00460408|459155625|FG000|Overall Study|Lost to Follow-up|11|||
127598172|NCT00460408|459155626|FG001|Overall Study|Lost to Follow-up|0|||
127598173|NCT00460408|459155627|FG002|Overall Study|Lost to Follow-up|1|||
127598174|NCT00460408|459155628|FG003|Overall Study|Lost to Follow-up|0|||
127598175|NCT00460408|459155625|FG000|Overall Study|Withdrawal by Subject|31|||
127598176|NCT00460408|459155626|FG001|Overall Study|Withdrawal by Subject|0|||
127598177|NCT00460408|459155627|FG002|Overall Study|Withdrawal by Subject|0|||
127598178|NCT00460408|459155628|FG003|Overall Study|Withdrawal by Subject|0|||
127598179|NCT00460408|459155625|FG000|Overall Study|Insufficient clinical response|5|||
127598180|NCT00460408|459155626|FG001|Overall Study|Insufficient clinical response|1|||
127598181|NCT00460408|459155627|FG002|Overall Study|Insufficient clinical response|5|||
127598182|NCT00460408|459155628|FG003|Overall Study|Insufficient clinical response|0|||
127598183|NCT00460408|459155625|FG000|Overall Study|Other|12|||
127598184|NCT00460408|459155626|FG001|Overall Study|Other|2|||
127598185|NCT00460408|459155627|FG002|Overall Study|Other|0|||
127598186|NCT00460408|459155628|FG003|Overall Study|Other|0|||
127598187|NCT00865124|459155629|FG000|Overall Study|Physician Decision|2|||
127598188|NCT00865124|459155630|FG001|Overall Study|Physician Decision|1|||
127598189|NCT00865124|459155631|FG002|Overall Study|Physician Decision|0|||
127598190|NCT00865124|459155629|FG000|Overall Study|Withdrawn consent|2|||
127598191|NCT00865124|459155630|FG001|Overall Study|Withdrawn consent|0|||
127598192|NCT00865124|459155631|FG002|Overall Study|Withdrawn consent|0|||
127598193|NCT03247530|459155637|FG000|Overall Study|Withdrawal by caregiver|19|||
127598194|NCT03247530|459155638|FG001|Overall Study|Withdrawal by caregiver|8|||
127598195|NCT03247530|459155639|FG002|Overall Study|Withdrawal by caregiver|10|||
127598196|NCT03247530|459155637|FG000|Overall Study|Lost to Follow-up|3|||
127598197|NCT03247530|459155638|FG001|Overall Study|Lost to Follow-up|9|||
127598198|NCT03247530|459155639|FG002|Overall Study|Lost to Follow-up|6|||
127598199|NCT03247530|459155637|FG000|Overall Study|Adverse Event|2|||
127598200|NCT03247530|459155638|FG001|Overall Study|Adverse Event|5|||
127598201|NCT03247530|459155639|FG002|Overall Study|Adverse Event|2|||
127598202|NCT03247530|459155637|FG000|Overall Study|Failure to follow procedure|1|||
127598203|NCT03247530|459155638|FG001|Overall Study|Failure to follow procedure|1|||
127598204|NCT03247530|459155639|FG002|Overall Study|Failure to follow procedure|1|||
127598205|NCT03247530|459155637|FG000|Overall Study|Withdrawal by Subject|1|||
127598206|NCT03247530|459155638|FG001|Overall Study|Withdrawal by Subject|1|||
127598207|NCT03247530|459155639|FG002|Overall Study|Withdrawal by Subject|0|||
127598208|NCT03247530|459155637|FG000|Overall Study|Study medication misuse|0|||
127598209|NCT03247530|459155638|FG001|Overall Study|Study medication misuse|1|||
127598210|NCT03247530|459155639|FG002|Overall Study|Study medication misuse|0|||
127598211|NCT03247530|459155637|FG000|Overall Study|Other, multiple categories|1|||
127598212|NCT03247530|459155638|FG001|Overall Study|Other, multiple categories|3|||
127598213|NCT03247530|459155639|FG002|Overall Study|Other, multiple categories|1|||
127598214|NCT01442493|459155641|FG000|Overall Study|withdrawn from study|3|||
127598215|NCT01442493|459155642|FG001|Overall Study|withdrawn from study|2|||
127598216|NCT01986985|459155643|FG000|Overall Study|Withdrawal by Subject|4|||
127598217|NCT01986985|459155643|FG000|Overall Study|Scan not completed due to malfunction|3|||
127598218|NCT03042533|459155644|FG000|Overall Study|MD left program|1|||
127598219|NCT03042533|459155645|FG001|Overall Study|MD left program|4|||
127598220|NCT03042533|459155646|FG002|Overall Study|MD left program|1|||
127598221|NCT02288559|459155648|FG000|Overall Study|Adverse Event|1|||
127598222|NCT02288559|459155649|FG001|Overall Study|Adverse Event|1|||
127598223|NCT02288559|459155650|FG002|Overall Study|Adverse Event|5|||
127598224|NCT02288559|459155651|FG003|Overall Study|Adverse Event|0|||
127598225|NCT02288559|459155648|FG000|Overall Study|Death|0|||
127598226|NCT02288559|459155649|FG001|Overall Study|Death|0|||
127598227|NCT02288559|459155650|FG002|Overall Study|Death|1|||
127598228|NCT02288559|459155651|FG003|Overall Study|Death|0|||
127598229|NCT02288559|459155648|FG000|Overall Study|Lost to Follow-up|0|||
127598230|NCT02288559|459155649|FG001|Overall Study|Lost to Follow-up|0|||
127598231|NCT02288559|459155650|FG002|Overall Study|Lost to Follow-up|0|||
127598232|NCT02288559|459155651|FG003|Overall Study|Lost to Follow-up|1|||
127598233|NCT02288559|459155648|FG000|Overall Study|Withdrawal by Subject|0|||
127598234|NCT02288559|459155649|FG001|Overall Study|Withdrawal by Subject|0|||
127598235|NCT02288559|459155650|FG002|Overall Study|Withdrawal by Subject|2|||
127598236|NCT02288559|459155651|FG003|Overall Study|Withdrawal by Subject|1|||
127598237|NCT02288559|459155648|FG000|Overall Study|Reason Not Specified|0|||
127598238|NCT02288559|459155649|FG001|Overall Study|Reason Not Specified|0|||
127598239|NCT02288559|459155650|FG002|Overall Study|Reason Not Specified|3|||
127598240|NCT02288559|459155651|FG003|Overall Study|Reason Not Specified|0|||
127598241|NCT01111149|459155652|FG000|Overall Study|Protocol Violation|1|||
127598242|NCT01111149|459155653|FG001|Overall Study|Protocol Violation|1|||
127598243|NCT01111149|459155654|FG002|Overall Study|Protocol Violation|2|||
127598244|NCT01111149|459155652|FG000|Overall Study|Withdrawal by Subject|1|||
127598245|NCT01111149|459155653|FG001|Overall Study|Withdrawal by Subject|0|||
127598246|NCT01111149|459155654|FG002|Overall Study|Withdrawal by Subject|2|||
127598247|NCT00759954|459155655|FG000|Overall Study|Personal reason|1|||
127598248|NCT00759954|459155656|FG001|Overall Study|Personal reason|0|||
127598249|NCT00759954|459155655|FG000|Overall Study|Adverse Event|1|||
127598250|NCT00759954|459155656|FG001|Overall Study|Adverse Event|2|||
127787381|NCT03200366|459846115|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
127787382|NCT03200366|459846113|FG000|9 Month Post-Baseline Interview|Death|1|||
127787383|NCT03200366|459846114|FG001|9 Month Post-Baseline Interview|Death|1|||
127787384|NCT03200366|459846115|FG002|9 Month Post-Baseline Interview|Death|1|||
127787385|NCT03200366|459846113|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
127787386|NCT03200366|459846114|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
127787387|NCT03200366|459846115|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
127787388|NCT03200366|459846113|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
127787389|NCT03200366|459846114|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
127787390|NCT03200366|459846115|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
127787391|NCT03200366|459846113|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
127787392|NCT03200366|459846114|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
127787393|NCT03200366|459846115|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
127787394|NCT02018822|459846116|FG000|Overall Study|filling replaced by crown|0|||
127787395|NCT02018822|459846117|FG001|Overall Study|filling replaced by crown|1|||
127787396|NCT02018822|459846118|FG002|Overall Study|filling replaced by crown|0|||
127787397|NCT02018822|459846116|FG000|Overall Study|Physician Decision|0|||
127787398|NCT02018822|459846117|FG001|Overall Study|Physician Decision|1|||
127787399|NCT02018822|459846118|FG002|Overall Study|Physician Decision|1|||
127787400|NCT02018822|459846116|FG000|Overall Study|Lost to Follow-up|6|||
127787401|NCT02018822|459846117|FG001|Overall Study|Lost to Follow-up|6|||
127787402|NCT02018822|459846118|FG002|Overall Study|Lost to Follow-up|5|||
127787403|NCT03201458|459846119|FG000|Overall Study|No longer eligible|2|||
127787404|NCT03201458|459846120|FG001|Overall Study|No longer eligible|5|||
127787405|NCT03201458|459846119|FG000|Overall Study|Health event before starting|1|||
127787406|NCT03201458|459846120|FG001|Overall Study|Health event before starting|0|||
127787407|NCT03201458|459846119|FG000|Overall Study|Physician Decision|1|||
127787408|NCT03201458|459846120|FG001|Overall Study|Physician Decision|0|||
127787409|NCT00715026|459846123|FG000|Overall Study|Withdrawal by Subject|5|||
127787410|NCT00715026|459846123|FG000|Overall Study|Lost to Follow-up|3|||
127787411|NCT00715026|459846123|FG000|Overall Study|Protocol Violation|1|||
128036112|NCT04756531|460760958|FG013|Overall Study|Adverse Event|0|||
128036113|NCT04756531|460760959|FG014|Overall Study|Adverse Event|0|||
128036114|NCT04756531|460760960|FG015|Overall Study|Adverse Event|0|||
128036115|NCT04756531|460760961|FG016|Overall Study|Adverse Event|0|||
128036116|NCT04756531|460760962|FG017|Overall Study|Adverse Event|0|||
128036117|NCT04756531|460760945|FG000|Overall Study|Withdrawal by Subject|0|||
128036118|NCT04756531|460760946|FG001|Overall Study|Withdrawal by Subject|0|||
128036119|NCT04756531|460760947|FG002|Overall Study|Withdrawal by Subject|0|||
128036120|NCT04756531|460760948|FG003|Overall Study|Withdrawal by Subject|0|||
128036121|NCT04756531|460760949|FG004|Overall Study|Withdrawal by Subject|0|||
128036122|NCT04756531|460760950|FG005|Overall Study|Withdrawal by Subject|0|||
128036123|NCT04756531|460760951|FG006|Overall Study|Withdrawal by Subject|1|||
128036124|NCT04756531|460760952|FG007|Overall Study|Withdrawal by Subject|0|||
128036125|NCT04756531|460760953|FG008|Overall Study|Withdrawal by Subject|0|||
128036126|NCT04756531|460760954|FG009|Overall Study|Withdrawal by Subject|0|||
128036127|NCT04756531|460760955|FG010|Overall Study|Withdrawal by Subject|0|||
128036128|NCT04756531|460760956|FG011|Overall Study|Withdrawal by Subject|0|||
128036129|NCT04756531|460760957|FG012|Overall Study|Withdrawal by Subject|0|||
128036130|NCT04756531|460760958|FG013|Overall Study|Withdrawal by Subject|0|||
128036131|NCT04756531|460760959|FG014|Overall Study|Withdrawal by Subject|0|||
128036132|NCT04756531|460760960|FG015|Overall Study|Withdrawal by Subject|0|||
128036133|NCT04756531|460760961|FG016|Overall Study|Withdrawal by Subject|0|||
128036134|NCT04756531|460760962|FG017|Overall Study|Withdrawal by Subject|0|||
128036135|NCT04569084|460760963|FG000|Overall Study|Adverse Event|10|||
128036136|NCT04569084|460760964|FG001|Overall Study|Adverse Event|14|||
128036137|NCT04569084|460760963|FG000|Overall Study|Death|2|||
128036138|NCT04569084|460760964|FG001|Overall Study|Death|3|||
128036139|NCT04569084|460760963|FG000|Overall Study|Lost to Follow-up|1|||
128036140|NCT04569084|460760964|FG001|Overall Study|Lost to Follow-up|1|||
128036141|NCT04569084|460760963|FG000|Overall Study|Physician Decision|3|||
128036142|NCT04569084|460760964|FG001|Overall Study|Physician Decision|3|||
128036143|NCT04569084|460760963|FG000|Overall Study|Protocol Violation|2|||
128036144|NCT04569084|460760964|FG001|Overall Study|Protocol Violation|1|||
128036145|NCT04569084|460760963|FG000|Overall Study|Withdrawal by Subject|20|||
128036146|NCT04569084|460760964|FG001|Overall Study|Withdrawal by Subject|21|||
128036147|NCT04569084|460760963|FG000|Overall Study|Study terminated by sponsor|26|||
128036148|NCT04569084|460760964|FG001|Overall Study|Study terminated by sponsor|23|||
128036149|NCT04569084|460760963|FG000|Overall Study|Other|3|||
128036150|NCT04569084|460760964|FG001|Overall Study|Other|5|||
128036151|NCT01346176|460760965|FG000|Recruited|Protocol Violation|1|||
127598251|NCT02320149|459155658|FG000|Overall Study|Adverse Event|3|||
127787412|NCT00715026|459846123|FG000|Overall Study|Surgery done on non-study consented hip|1|||
127787413|NCT00750737|459846124|FG000|Overall Study|Withdrawal by Subject|3|||
127787414|NCT00750737|459846125|FG001|Overall Study|Withdrawal by Subject|3|||
128036152|NCT01346176|460760966|FG001|Recruited|Protocol Violation|0|||
128036153|NCT01346176|460760967|FG002|Recruited|Protocol Violation|0|||
127882477|NCT04057118|460192800|FG002|Overall Study|Not Specific|1|||
127882478|NCT04057118|460192801|FG003|Overall Study|Not Specific|1|||
127882479|NCT00190684|460192802|FG000|Overall Study|Adverse Event|86|||
127882480|NCT00190684|460192802|FG000|Overall Study|Satisfactory response|80|||
127882481|NCT00190684|460192802|FG000|Overall Study|Lack of efficacy|204|||
127882482|NCT00190684|460192802|FG000|Overall Study|Lost to Follow-up|232|||
127882483|NCT00190684|460192802|FG000|Overall Study|Patient moved|60|||
127882484|NCT00190684|460192802|FG000|Overall Study|Patient Decision|432|||
127882485|NCT00190684|460192802|FG000|Overall Study|Clinical relapse|67|||
127882486|NCT00190684|460192802|FG000|Overall Study|Sponsor's decision|17|||
127882487|NCT00190684|460192802|FG000|Overall Study|Physician Decision|84|||
127882488|NCT00190684|460192802|FG000|Overall Study|Protocol Violation|123|||
127882489|NCT00190684|460192802|FG000|Overall Study|Study Period III Completed|103|||
127882490|NCT00190684|460192802|FG000|Overall Study|Study Period V Completed|1|||
127882491|NCT00829439|460192808|FG000|Overall Study|Adverse Event|0|||
127882492|NCT00829439|460192809|FG001|Overall Study|Adverse Event|0|||
127882493|NCT00829439|460192810|FG002|Overall Study|Adverse Event|1|||
127882494|NCT00829439|460192811|FG003|Overall Study|Adverse Event|0|||
127882495|NCT01155284|460192812|FG000|Overall Study|Withdrawal by Subject|4|||
127882496|NCT01155284|460192813|FG001|Overall Study|Withdrawal by Subject|3|||
127882497|NCT01155284|460192812|FG000|Overall Study|Lost to Follow-up|1|||
127882498|NCT01155284|460192813|FG001|Overall Study|Lost to Follow-up|2|||
127882499|NCT01155284|460192812|FG000|Overall Study|Physician Decision|1|||
127882500|NCT01155284|460192813|FG001|Overall Study|Physician Decision|0|||
127882501|NCT01155284|460192812|FG000|Overall Study|Adverse Event|1|||
127882502|NCT01155284|460192813|FG001|Overall Study|Adverse Event|0|||
127882503|NCT04529499|460192824|FG000|Overall Study|Withdrawal by Subject|9|||
127882504|NCT04529499|460192825|FG001|Overall Study|Withdrawal by Subject|11|||
127882505|NCT04529499|460192824|FG000|Overall Study|Physician Decision|1|||
127882506|NCT04529499|460192825|FG001|Overall Study|Physician Decision|2|||
127882507|NCT04529499|460192824|FG000|Overall Study|Adverse Event|4|||
127882508|NCT04529499|460192825|FG001|Overall Study|Adverse Event|4|||
127882509|NCT04529499|460192824|FG000|Overall Study|Death|14|||
127882510|NCT04529499|460192825|FG001|Overall Study|Death|11|||
127882511|NCT04529499|460192824|FG000|Overall Study|Lost to Follow-up|1|||
127882512|NCT04529499|460192825|FG001|Overall Study|Lost to Follow-up|1|||
127882513|NCT04529499|460192824|FG000|Overall Study|Others|7|||
127598252|NCT02320149|459155659|FG001|Overall Study|Adverse Event|7|||
127598253|NCT02320149|459155658|FG000|Overall Study|Withdrawal of Consent|28|||
127598254|NCT02320149|459155659|FG001|Overall Study|Withdrawal of Consent|32|||
127598255|NCT02320149|459155658|FG000|Overall Study|Lost to Follow-up|21|||
127598256|NCT02320149|459155659|FG001|Overall Study|Lost to Follow-up|34|||
127598257|NCT02320149|459155658|FG000|Overall Study|Protocol Violation|2|||
127598258|NCT02320149|459155659|FG001|Overall Study|Protocol Violation|1|||
127598259|NCT02320149|459155658|FG000|Overall Study|Noncompliance with Study Treatment|7|||
127598260|NCT02320149|459155659|FG001|Overall Study|Noncompliance with Study Treatment|2|||
127598261|NCT02320149|459155658|FG000|Overall Study|Lack of Efficacy|0|||
127598262|NCT02320149|459155659|FG001|Overall Study|Lack of Efficacy|1|||
127598263|NCT02320149|459155658|FG000|Overall Study|Other Miscellaneous Reasons|2|||
127598264|NCT02320149|459155659|FG001|Overall Study|Other Miscellaneous Reasons|3|||
127598265|NCT01741701|459155663|FG000|Overall Study|Adverse Event|5|||
127598266|NCT01741701|459155664|FG001|Overall Study|Adverse Event|1|||
127598267|NCT01741701|459155663|FG000|Overall Study|Withdrawal by Subject|0|||
127598268|NCT01741701|459155664|FG001|Overall Study|Withdrawal by Subject|1|||
127598269|NCT03033394|459155665|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
127695732|NCT02783300|459512949|FG016|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
127598270|NCT03033394|459155665|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
127882514|NCT04529499|460192825|FG001|Overall Study|Others|11|||
127882515|NCT00758706|460192826|FG000|Overall Study|Adverse Event|4|||
127598271|NCT03033394|459155665|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
127882516|NCT00758706|460192827|FG001|Overall Study|Adverse Event|4|||
127598272|NCT03033394|459155665|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
127882517|NCT01494649|460192828|FG000|Overall Study|Lost to Follow-up|0|||
127882518|NCT01494649|460192829|FG001|Overall Study|Lost to Follow-up|1|||
127882519|NCT03467971|460192830|FG000|Treatment Period 2|Withdrawal by Subject|0|||
127882520|NCT03467971|460192831|FG001|Treatment Period 2|Withdrawal by Subject|1|||
127882521|NCT01174368|460192834|FG000|Overall Study|Withdrawal by Subject|1|||
128036154|NCT01346176|460760965|FG000|Completed Advance Directive|Death|3|||
127598273|NCT03033394|459155665|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
127598274|NCT02036294|459155666|FG000|Overall Study|Death|7|||
127598275|NCT02036294|459155667|FG001|Overall Study|Death|8|||
127598276|NCT02036294|459155666|FG000|Overall Study|Withdrawal by Subject|2|||
127598277|NCT02036294|459155667|FG001|Overall Study|Withdrawal by Subject|3|||
127598278|NCT00137046|459155675|FG000|Overall Study|Death|2|||
127598279|NCT00137046|459155676|FG001|Overall Study|Death|1|||
127598280|NCT00137046|459155675|FG000|Overall Study|Adverse Event|16|||
127598281|NCT00137046|459155676|FG001|Overall Study|Adverse Event|5|||
127598282|NCT00137046|459155675|FG000|Overall Study|Laboratory Abnormality|2|||
127598283|NCT00137046|459155676|FG001|Overall Study|Laboratory Abnormality|0|||
127598284|NCT00137046|459155675|FG000|Overall Study|Lack of Efficacy|13|||
127598285|NCT00137046|459155676|FG001|Overall Study|Lack of Efficacy|1|||
127598286|NCT00137046|459155675|FG000|Overall Study|Lost to Follow-up|8|||
127598287|NCT00137046|459155676|FG001|Overall Study|Lost to Follow-up|24|||
127598288|NCT00137046|459155675|FG000|Overall Study|Other|23|||
127598289|NCT00137046|459155676|FG001|Overall Study|Other|19|||
127598290|NCT00137046|459155675|FG000|Overall Study|Withdrawal by Subject|33|||
127598291|NCT00137046|459155676|FG001|Overall Study|Withdrawal by Subject|42|||
127598292|NCT00137046|459155675|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
127598293|NCT00137046|459155676|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
127598294|NCT00137046|459155675|FG000|Overall Study|Withdrew prior to study treatment|1|||
127598295|NCT00137046|459155676|FG001|Overall Study|Withdrew prior to study treatment|1|||
127598296|NCT01648205|459155681|FG000|Placebo|Pregnancy|1|||
127598297|NCT01648205|459155681|FG000|Placebo|Withdrawal by Subject|1|||
127598298|NCT01648205|459155681|FG000|Placebo|Protocol Violation|2|||
127598299|NCT01648205|459155681|FG000|Ranolazine|Death|1|||
127598300|NCT01648205|459155681|FG000|Ranolazine|Withdrawal by Subject|1|||
127598301|NCT01648205|459155681|FG000|Ranolazine|Protocol Violation|3|||
127598302|NCT02142959|459155685|FG000|Overall Study|Adverse Event|1|||
127598303|NCT02142959|459155686|FG001|Overall Study|Adverse Event|0|||
127598304|NCT02142959|459155687|FG002|Overall Study|Adverse Event|0|||
127598305|NCT02142959|459155685|FG000|Overall Study|Death|0|||
127598306|NCT02142959|459155686|FG001|Overall Study|Death|1|||
127598307|NCT02142959|459155687|FG002|Overall Study|Death|0|||
127598308|NCT02142959|459155685|FG000|Overall Study|Withdrawal by Subject|3|||
127598309|NCT02142959|459155686|FG001|Overall Study|Withdrawal by Subject|1|||
127598310|NCT02142959|459155687|FG002|Overall Study|Withdrawal by Subject|3|||
127598311|NCT02142959|459155685|FG000|Overall Study|Administrative Reasons|1|||
127598312|NCT02142959|459155686|FG001|Overall Study|Administrative Reasons|0|||
127598313|NCT02142959|459155687|FG002|Overall Study|Administrative Reasons|1|||
127598314|NCT02142959|459155685|FG000|Overall Study|Missing|0|||
127598315|NCT02142959|459155686|FG001|Overall Study|Missing|1|||
127598316|NCT02142959|459155687|FG002|Overall Study|Missing|0|||
127598317|NCT02142959|459155685|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
127598318|NCT02142959|459155686|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
127598319|NCT02142959|459155687|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
127598320|NCT02142959|459155685|FG000|Overall Study|Patient didn't complete end of study visit|0|||
127598321|NCT02142959|459155686|FG001|Overall Study|Patient didn't complete end of study visit|0|||
127598322|NCT02142959|459155687|FG002|Overall Study|Patient didn't complete end of study visit|1|||
127598323|NCT03547687|459155688|FG000|Overall Study|Withdrawal by Subject|1|||
127598324|NCT03547687|459155688|FG000|Overall Study|Death|1|||
127598325|NCT03667924|459155689|FG000|Baseline Completed|Lost to Follow-up|0|||
127598326|NCT03667924|459155690|FG001|Baseline Completed|Lost to Follow-up|2|||
127598327|NCT03667924|459155691|FG002|Baseline Completed|Lost to Follow-up|0|||
127598328|NCT03667924|459155689|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
127598329|NCT03667924|459155690|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
127598330|NCT03667924|459155691|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
127598331|NCT03667924|459155689|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
128036155|NCT01346176|460760966|FG001|Completed Advance Directive|Death|2|||
128036156|NCT01346176|460760967|FG002|Completed Advance Directive|Death|2|||
128036157|NCT01346176|460760965|FG000|Completed Advance Directive|Became Ineligible|3|||
128036158|NCT01346176|460760966|FG001|Completed Advance Directive|Became Ineligible|0|||
127598332|NCT03667924|459155690|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
127598333|NCT03667924|459155691|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
127598334|NCT03667924|459155689|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
127598335|NCT03667924|459155690|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
127598336|NCT03667924|459155691|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
127598337|NCT03667924|459155689|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
128036159|NCT01346176|460760967|FG002|Completed Advance Directive|Became Ineligible|1|||
127598338|NCT03667924|459155690|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
127598339|NCT03667924|459155691|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
127642570|NCT04124926|459313072|FG000|Maintenance Phase|Withdrawal of Consent|0|||
127882522|NCT04449354|460192835|FG000|Overall Study|Withdrawal by Subject|1|||
127882523|NCT05789420|460192836|FG000|Screening and Safety Assessments|Completed Alternate Status|1|||
127882524|NCT05789420|460192836|FG000|Randomization to Product Assessments|Failed alcohol breath test and urine test on day -1|1|||
127882525|NCT01220128|460192837|FG000|Overall Study|Progressive disease|0|||
127882526|NCT01220128|460192838|FG001|Overall Study|Progressive disease|0|||
127882527|NCT01220128|460192839|FG002|Overall Study|Progressive disease|2|||
127882528|NCT01220128|460192840|FG003|Overall Study|Progressive disease|0|||
127882529|NCT01220128|460192841|FG004|Overall Study|Progressive disease|0|||
128036160|NCT01346176|460760965|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
128036161|NCT01346176|460760966|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
128036162|NCT01346176|460760967|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
128036163|NCT01346176|460760965|FG000|Completed Satisfaction Survey|Death|3|||
128036164|NCT01346176|460760966|FG001|Completed Satisfaction Survey|Death|0|||
128036165|NCT01346176|460760967|FG002|Completed Satisfaction Survey|Death|2|||
128036166|NCT01346176|460760965|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
128036167|NCT01346176|460760966|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
128036168|NCT01346176|460760967|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
128036169|NCT01994876|460760968|FG000|Test Period 1|Withdrawal by Subject|0|||
128036170|NCT01994876|460760969|FG001|Test Period 1|Withdrawal by Subject|1|||
128036171|NCT01994876|460760968|FG000|Test Period 1|Adverse Event|0|||
128036172|NCT01994876|460760969|FG001|Test Period 1|Adverse Event|1|||
128036173|NCT01994876|460760968|FG000|Test Period 2|Adverse Event|1|||
128036174|NCT01994876|460760969|FG001|Test Period 2|Adverse Event|0|||
128036175|NCT01994876|460760968|FG000|Test Period 2|Protocol Violation|0|||
128036176|NCT01994876|460760969|FG001|Test Period 2|Protocol Violation|1|||
128036177|NCT01400412|460760970|FG000|Overall Study|Lost to Follow-up|4|||
128036178|NCT01400412|460760971|FG001|Overall Study|Lost to Follow-up|7|||
128036179|NCT01400412|460760970|FG000|Overall Study|Withdrawal by Subject|3|||
128036180|NCT01400412|460760971|FG001|Overall Study|Withdrawal by Subject|4|||
128036181|NCT01400412|460760970|FG000|Overall Study|Unable to complete|3|||
128036182|NCT01400412|460760971|FG001|Overall Study|Unable to complete|3|||
128036183|NCT01400412|460760970|FG000|Overall Study|Never started study treatment|0|||
128036184|NCT01400412|460760971|FG001|Overall Study|Never started study treatment|3|||
128036185|NCT04490278|460762120|FG000|Overall Study|Lost to Follow-up|6|||
128036186|NCT02829996|460762121|FG000|Overall Study|Withdrawal by Subject|1|||
128036187|NCT02829996|460762122|FG001|Overall Study|Withdrawal by Subject|0|||
128036188|NCT02829996|460762123|FG002|Overall Study|Withdrawal by Subject|0|||
128036189|NCT02829996|460762124|FG003|Overall Study|Withdrawal by Subject|0|||
128036190|NCT02829996|460762125|FG004|Overall Study|Withdrawal by Subject|0|||
128036191|NCT01441960|460762126|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
128036192|NCT01441960|460762127|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
128036193|NCT01441960|460762126|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
128036194|NCT01441960|460762127|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
128036195|NCT01441960|460762126|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
127598340|NCT03667924|459155689|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
127598341|NCT03667924|459155690|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
127598342|NCT03667924|459155691|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
127598343|NCT03667924|459155689|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
127598344|NCT03667924|459155690|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
127598345|NCT03667924|459155691|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
127598346|NCT04557371|459155701|FG000|Overall Study|Covid-19-related|0|||
127598347|NCT04557371|459155702|FG001|Overall Study|Covid-19-related|1|||
127598348|NCT04557371|459155703|FG002|Overall Study|Covid-19-related|0|||
127598349|NCT04557371|459155701|FG000|Overall Study|Withdrawal by Subject|0|||
127598350|NCT04557371|459155702|FG001|Overall Study|Withdrawal by Subject|1|||
127598351|NCT04557371|459155703|FG002|Overall Study|Withdrawal by Subject|0|||
127598352|NCT04557371|459155701|FG000|Overall Study|Adverse Event|1|||
127598353|NCT04557371|459155702|FG001|Overall Study|Adverse Event|0|||
127882530|NCT01220128|460192842|FG005|Overall Study|Progressive disease|0|||
128036196|NCT01441960|460762127|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
128036197|NCT00069641|460762132|FG000|Overall Study|Death|1|||
128036198|NCT00069641|460762133|FG001|Overall Study|Death|0|||
128036199|NCT00069641|460762134|FG002|Overall Study|Death|1|||
128036200|NCT03186638|460762135|FG000|Overall Study|Withdrawal by Subject|4|||
128036201|NCT03186638|460762136|FG001|Overall Study|Withdrawal by Subject|4|||
128036202|NCT03186638|460762135|FG000|Overall Study|Withdrawn due to medical problem|3|||
128036203|NCT03186638|460762136|FG001|Overall Study|Withdrawn due to medical problem|2|||
128036204|NCT03186638|460762135|FG000|Overall Study|Lost to Follow-up|1|||
128036205|NCT03186638|460762136|FG001|Overall Study|Lost to Follow-up|0|||
127598354|NCT04557371|459155703|FG002|Overall Study|Adverse Event|0|||
127598355|NCT00897104|459155706|FG000|Overall Study|Lost to Follow-up|12|||
127598356|NCT00897104|459155707|FG001|Overall Study|Lost to Follow-up|17|||
127598357|NCT00897104|459155708|FG002|Overall Study|Lost to Follow-up|2|||
127598358|NCT00897104|459155706|FG000|Overall Study|Pregnancy|0|||
127598359|NCT00897104|459155707|FG001|Overall Study|Pregnancy|1|||
127598360|NCT00897104|459155708|FG002|Overall Study|Pregnancy|0|||
127598361|NCT00897104|459155706|FG000|Overall Study|Protocol Violation|0|||
127598362|NCT00897104|459155707|FG001|Overall Study|Protocol Violation|1|||
127598363|NCT00897104|459155708|FG002|Overall Study|Protocol Violation|0|||
127598364|NCT00897104|459155706|FG000|Overall Study|Withdrawal by Subject|23|||
127598365|NCT00897104|459155707|FG001|Overall Study|Withdrawal by Subject|27|||
127598366|NCT00897104|459155708|FG002|Overall Study|Withdrawal by Subject|3|||
127598367|NCT00897104|459155706|FG000|Overall Study|Abnormal Prestudy Labs|2|||
127598368|NCT00897104|459155707|FG001|Overall Study|Abnormal Prestudy Labs|0|||
127598369|NCT00897104|459155708|FG002|Overall Study|Abnormal Prestudy Labs|0|||
127598370|NCT00897104|459155706|FG000|Overall Study|Abnormal Baseline ECG|2|||
127598371|NCT00897104|459155707|FG001|Overall Study|Abnormal Baseline ECG|2|||
127598372|NCT00897104|459155708|FG002|Overall Study|Abnormal Baseline ECG|0|||
127598373|NCT00897104|459155706|FG000|Overall Study|Need for Concom. Med.|0|||
127598374|NCT00897104|459155707|FG001|Overall Study|Need for Concom. Med.|1|||
127598375|NCT00897104|459155708|FG002|Overall Study|Need for Concom. Med.|1|||
127598376|NCT00897104|459155706|FG000|Overall Study|Lack of Migraine Attack|20|||
127598377|NCT00897104|459155707|FG001|Overall Study|Lack of Migraine Attack|22|||
127598378|NCT00897104|459155708|FG002|Overall Study|Lack of Migraine Attack|1|||
127598379|NCT00897104|459155706|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
127598380|NCT00897104|459155707|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
127598381|NCT00897104|459155708|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
127598382|NCT00897104|459155706|FG000|Overall Study|Other|3|||
127598383|NCT00897104|459155707|FG001|Overall Study|Other|0|||
127598384|NCT00897104|459155708|FG002|Overall Study|Other|0|||
127598385|NCT00897104|459155706|FG000|Overall Study|Protocol Violation|1|||
127598386|NCT00897104|459155707|FG001|Overall Study|Protocol Violation|0|||
127598387|NCT00897104|459155708|FG002|Overall Study|Protocol Violation|0|||
127598388|NCT00897104|459155706|FG000|Overall Study|Withdrawal by Subject|0|||
127598389|NCT00897104|459155707|FG001|Overall Study|Withdrawal by Subject|0|||
127598390|NCT00897104|459155708|FG002|Overall Study|Withdrawal by Subject|1|||
127598391|NCT01059799|459155711|FG000|Overall Study|Adverse Event|2|||
127598392|NCT01059799|459155712|FG001|Overall Study|Adverse Event|3|||
127598393|NCT01059799|459155711|FG000|Overall Study|Lack of Efficacy|1|||
127598394|NCT01059799|459155712|FG001|Overall Study|Lack of Efficacy|0|||
127598395|NCT01059799|459155711|FG000|Overall Study|Protocol Violation|3|||
127598396|NCT01059799|459155712|FG001|Overall Study|Protocol Violation|2|||
127598397|NCT01059799|459155711|FG000|Overall Study|Withdrawal criteria|13|||
127598398|NCT01059799|459155712|FG001|Overall Study|Withdrawal criteria|2|||
127598399|NCT01059799|459155711|FG000|Overall Study|Other|12|||
127598400|NCT01059799|459155712|FG001|Overall Study|Other|3|||
127598401|NCT00750204|459155713|FG000|Overall Study|study halted prematurely|1|||
127598402|NCT00750204|459155714|FG001|Overall Study|study halted prematurely|1|||
127598403|NCT00477971|459155715|FG000|Overall Study|Disease progression|6|||
127598404|NCT00477971|459155716|FG001|Overall Study|Disease progression|0|||
127598405|NCT00477971|459155715|FG000|Overall Study|Withdrawal by Subject|3|||
127598406|NCT00477971|459155716|FG001|Overall Study|Withdrawal by Subject|1|||
127598407|NCT00477971|459155715|FG000|Overall Study|Adverse Event|3|||
128036206|NCT04573972|460762141|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
128036207|NCT04573972|460762142|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
128036208|NCT01517984|460762143|FG000|Overall Study|Lost to Follow-up|0|||
127598408|NCT00477971|459155716|FG001|Overall Study|Adverse Event|0|||
127598409|NCT00477971|459155715|FG000|Overall Study|Death|2|||
127695733|NCT02783300|459512950|FG017|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
127598410|NCT00477971|459155716|FG001|Overall Study|Death|4|||
127598411|NCT00477971|459155715|FG000|Overall Study|Alternative treatment|3|||
127598412|NCT00477971|459155716|FG001|Overall Study|Alternative treatment|1|||
127598413|NCT03700671|459155717|FG000|Overall Study|Lack of Efficacy|1|||
127598414|NCT03700671|459155718|FG001|Overall Study|Lack of Efficacy|2|||
127598415|NCT01774968|459155719|FG000|Overall Study|Adverse Event|4|||
127598416|NCT01774968|459155720|FG001|Overall Study|Adverse Event|4|||
128036209|NCT01517984|460762144|FG001|Overall Study|Lost to Follow-up|1|||
127598417|NCT01774968|459155719|FG000|Overall Study|Death|0|||
127598418|NCT01774968|459155720|FG001|Overall Study|Death|1|||
127598419|NCT01774968|459155719|FG000|Overall Study|Lost to Follow-up|1|||
128036210|NCT01517984|460762145|FG002|Overall Study|Lost to Follow-up|0|||
128036211|NCT01517984|460762146|FG003|Overall Study|Lost to Follow-up|0|||
128036212|NCT01517984|460762143|FG000|Overall Study|Withdrawal by Subject|1|||
127787415|NCT04707157|459846126|FG000|Overall Study|Adverse Event|12|||
127787416|NCT04707157|459846127|FG001|Overall Study|Adverse Event|3|||
127787417|NCT04707157|459846126|FG000|Overall Study|Lost to Follow-up|2|||
127787418|NCT04707157|459846127|FG001|Overall Study|Lost to Follow-up|0|||
127787419|NCT04707157|459846126|FG000|Overall Study|Sponsor's decision|1|||
127787420|NCT04707157|459846127|FG001|Overall Study|Sponsor's decision|0|||
127787421|NCT04707157|459846126|FG000|Overall Study|Physician Decision|8|||
127787422|NCT04707157|459846127|FG001|Overall Study|Physician Decision|5|||
127787423|NCT04707157|459846126|FG000|Overall Study|Protocol Deviation|1|||
127787424|NCT04707157|459846127|FG001|Overall Study|Protocol Deviation|0|||
127787425|NCT04707157|459846126|FG000|Overall Study|Withdrawal by Subject|1|||
127787426|NCT04707157|459846127|FG001|Overall Study|Withdrawal by Subject|1|||
127787427|NCT01389752|459846130|FG000|Study Period 1|Sponsor decision|0|||
127787428|NCT01389752|459846131|FG001|Study Period 1|Sponsor decision|2|||
127787429|NCT01389752|459846130|FG000|Study Period 2|Sponsor decision|1|||
127787430|NCT01389752|459846131|FG001|Study Period 2|Sponsor decision|0|||
127787431|NCT04251910|459846137|FG000|Overall Study|Covid 19 lockdown|0|||
128036213|NCT01517984|460762144|FG001|Overall Study|Withdrawal by Subject|8|||
128036214|NCT01517984|460762145|FG002|Overall Study|Withdrawal by Subject|4|||
128036215|NCT01517984|460762146|FG003|Overall Study|Withdrawal by Subject|1|||
128036216|NCT01517984|460762143|FG000|Overall Study|Screen Failure|4|||
128036217|NCT01517984|460762144|FG001|Overall Study|Screen Failure|0|||
128036218|NCT01517984|460762145|FG002|Overall Study|Screen Failure|0|||
128036219|NCT01517984|460762146|FG003|Overall Study|Screen Failure|0|||
128036220|NCT01517984|460762143|FG000|Overall Study|Ineligible for randomization|0|||
128036221|NCT01517984|460762144|FG001|Overall Study|Ineligible for randomization|14|||
128036222|NCT01517984|460762145|FG002|Overall Study|Ineligible for randomization|0|||
128036223|NCT01517984|460762146|FG003|Overall Study|Ineligible for randomization|0|||
127598420|NCT01774968|459155720|FG001|Overall Study|Lost to Follow-up|3|||
127598421|NCT01774968|459155719|FG000|Overall Study|Physician Decision|5|||
127598422|NCT01774968|459155720|FG001|Overall Study|Physician Decision|1|||
127598423|NCT01774968|459155719|FG000|Overall Study|Protocol Violation|14|||
127598424|NCT01774968|459155720|FG001|Overall Study|Protocol Violation|13|||
127598425|NCT01774968|459155719|FG000|Overall Study|Sponsor Decision|0|||
127598426|NCT01774968|459155720|FG001|Overall Study|Sponsor Decision|2|||
127598427|NCT01774968|459155719|FG000|Overall Study|Withdrawal by Subject|6|||
127598428|NCT01774968|459155720|FG001|Overall Study|Withdrawal by Subject|11|||
127598429|NCT02345850|459157404|FG000|Overall Study|Not transplanted|10|||
127598430|NCT02345850|459157405|FG001|Overall Study|Not transplanted|5|||
127598431|NCT02345850|459157406|FG002|Overall Study|Not transplanted|4|||
127598432|NCT02345850|459157404|FG000|Overall Study|Lost to Follow-up|2|||
127598433|NCT02345850|459157405|FG001|Overall Study|Lost to Follow-up|3|||
127598434|NCT02345850|459157406|FG002|Overall Study|Lost to Follow-up|2|||
127598435|NCT02345850|459157404|FG000|Overall Study|Withdrawal by Subject|1|||
127598436|NCT02345850|459157405|FG001|Overall Study|Withdrawal by Subject|0|||
127598437|NCT02345850|459157406|FG002|Overall Study|Withdrawal by Subject|0|||
127598438|NCT01991067|459157414|FG000|Overall Study|Lost to Follow-up|6|||
127598439|NCT01991067|459157415|FG001|Overall Study|Lost to Follow-up|5|||
127598440|NCT02141282|459157418|FG000|Overall Study|Adverse event, not related to progression|8|||
127598441|NCT02141282|459157419|FG001|Overall Study|Adverse event, not related to progression|1|||
127598442|NCT02141282|459157420|FG002|Overall Study|Adverse event, not related to progression|3|||
127598443|NCT02141282|459157421|FG003|Overall Study|Adverse event, not related to progression|1|||
127598444|NCT02141282|459157418|FG000|Overall Study|Adverse event, related to progression|1|||
127598445|NCT02141282|459157419|FG001|Overall Study|Adverse event, related to progression|0|||
127598446|NCT02141282|459157420|FG002|Overall Study|Adverse event, related to progression|2|||
127787432|NCT04251910|459846138|FG001|Overall Study|Covid 19 lockdown|5|||
127598447|NCT02141282|459157421|FG003|Overall Study|Adverse event, related to progression|0|||
127598448|NCT02141282|459157418|FG000|Overall Study|COVID-19 infection|1|||
127787433|NCT04251910|459846139|FG002|Overall Study|Covid 19 lockdown|0|||
127787434|NCT04251910|459846140|FG003|Overall Study|Covid 19 lockdown|4|||
127787435|NCT04251910|459846141|FG004|Overall Study|Covid 19 lockdown|0|||
127882531|NCT01220128|460192843|FG006|Overall Study|Progressive disease|0|||
127598449|NCT02141282|459157419|FG001|Overall Study|COVID-19 infection|0|||
127598450|NCT02141282|459157420|FG002|Overall Study|COVID-19 infection|0|||
127598451|NCT02141282|459157421|FG003|Overall Study|COVID-19 infection|0|||
127598452|NCT02141282|459157418|FG000|Overall Study|Lost to Follow-up|0|||
127787436|NCT04251910|459846142|FG005|Overall Study|Covid 19 lockdown|0|||
127787437|NCT04251910|459846137|FG000|Overall Study|Assisted living facility was closed|0|||
128036224|NCT05067335|460762147|FG000|Double-blind Period: Day 1 - Month 6|Adverse Event|1|||
128036225|NCT05067335|460762148|FG001|Double-blind Period: Day 1 - Month 6|Adverse Event|2|||
127787438|NCT04251910|459846138|FG001|Overall Study|Assisted living facility was closed|0|||
127598453|NCT02141282|459157419|FG001|Overall Study|Lost to Follow-up|0|||
127598454|NCT02141282|459157420|FG002|Overall Study|Lost to Follow-up|4|||
127598455|NCT02141282|459157421|FG003|Overall Study|Lost to Follow-up|2|||
127598456|NCT02141282|459157418|FG000|Overall Study|Other, not specified|14|||
127598457|NCT02141282|459157419|FG001|Overall Study|Other, not specified|11|||
127598458|NCT02141282|459157420|FG002|Overall Study|Other, not specified|23|||
127598459|NCT02141282|459157421|FG003|Overall Study|Other, not specified|9|||
127598460|NCT02141282|459157418|FG000|Overall Study|Progressive disease, Richter's|4|||
127598461|NCT02141282|459157419|FG001|Overall Study|Progressive disease, Richter's|1|||
127598462|NCT02141282|459157420|FG002|Overall Study|Progressive disease, Richter's|1|||
127598463|NCT02141282|459157421|FG003|Overall Study|Progressive disease, Richter's|1|||
127598464|NCT02141282|459157418|FG000|Overall Study|Progressive disease per protocol|12|||
127598465|NCT02141282|459157419|FG001|Overall Study|Progressive disease per protocol|7|||
127598466|NCT02141282|459157420|FG002|Overall Study|Progressive disease per protocol|9|||
127598467|NCT02141282|459157421|FG003|Overall Study|Progressive disease per protocol|2|||
127598468|NCT02141282|459157418|FG000|Overall Study|Stem cell transplant|1|||
127598469|NCT02141282|459157419|FG001|Overall Study|Stem cell transplant|0|||
127598470|NCT02141282|459157420|FG002|Overall Study|Stem cell transplant|1|||
127598471|NCT02141282|459157421|FG003|Overall Study|Stem cell transplant|0|||
127598472|NCT02141282|459157418|FG000|Overall Study|Study terminated by Sponsor|0|||
127598473|NCT02141282|459157419|FG001|Overall Study|Study terminated by Sponsor|1|||
127598474|NCT02141282|459157420|FG002|Overall Study|Study terminated by Sponsor|0|||
127598475|NCT02141282|459157421|FG003|Overall Study|Study terminated by Sponsor|0|||
127598476|NCT02141282|459157418|FG000|Overall Study|Subject non-compliance|0|||
127598477|NCT02141282|459157419|FG001|Overall Study|Subject non-compliance|0|||
127598478|NCT02141282|459157420|FG002|Overall Study|Subject non-compliance|1|||
127598479|NCT02141282|459157421|FG003|Overall Study|Subject non-compliance|0|||
127598480|NCT02141282|459157418|FG000|Overall Study|Withdrew consent|2|||
127598481|NCT02141282|459157419|FG001|Overall Study|Withdrew consent|0|||
127598482|NCT02141282|459157420|FG002|Overall Study|Withdrew consent|4|||
127598483|NCT02141282|459157421|FG003|Overall Study|Withdrew consent|0|||
127598484|NCT02425046|459157422|FG000|Overall Study|Lost to Follow-up|52|||
127598485|NCT02425046|459157423|FG001|Overall Study|Lost to Follow-up|50|||
127598486|NCT02425046|459157424|FG002|Overall Study|Lost to Follow-up|56|||
127598487|NCT02425046|459157422|FG000|Overall Study|Withdrawal by Subject|16|||
127598488|NCT02425046|459157423|FG001|Overall Study|Withdrawal by Subject|12|||
127598489|NCT02425046|459157424|FG002|Overall Study|Withdrawal by Subject|0|||
127598490|NCT02692716|459157425|FG000|Overall Study|Lost to Follow-up|2|||
127598491|NCT02692716|459157426|FG001|Overall Study|Lost to Follow-up|5|||
127598492|NCT02692716|459157425|FG000|Overall Study|Withdrawal by Subject|3|||
127598493|NCT02692716|459157426|FG001|Overall Study|Withdrawal by Subject|1|||
127598494|NCT02782780|459157427|FG000|Overall Study|dropped out after randomization.|7|||
127598495|NCT02782780|459157428|FG001|Overall Study|dropped out after randomization.|5|||
127598496|NCT02782780|459157427|FG000|Overall Study|Protocol Violation|0|||
127598497|NCT02782780|459157428|FG001|Overall Study|Protocol Violation|2|||
127598498|NCT03562481|459157429|FG000|First Intervention|Lost to Follow-up|1|||
127598499|NCT03562481|459157430|FG001|First Intervention|Lost to Follow-up|0|||
127598500|NCT01413191|459157431|FG000|Overall Study|Lost to Follow-up|5|||
127598501|NCT01413191|459157431|FG000|Overall Study|Disease Progression|5|||
127598502|NCT01413191|459157431|FG000|Overall Study|Death|1|||
127598503|NCT01124422|459157433|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
127598504|NCT01124422|459157434|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
127598505|NCT01124422|459157435|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
127598506|NCT01124422|459157433|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
127598507|NCT01124422|459157434|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
127598508|NCT01124422|459157435|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
127598509|NCT01124422|459157433|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
127598510|NCT01124422|459157434|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
127598511|NCT01124422|459157435|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
127598512|NCT01124422|459157433|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
127598513|NCT01124422|459157434|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
127598514|NCT01124422|459157435|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
127598515|NCT01124422|459157433|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
127598516|NCT01124422|459157434|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
127598517|NCT01124422|459157435|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
127598518|NCT01124422|459157433|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
127695734|NCT02783300|459512951|FG018|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
127695735|NCT02783300|459512952|FG019|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
127695736|NCT02783300|459512953|FG020|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
127695737|NCT02783300|459512954|FG021|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
127695738|NCT02783300|459512955|FG022|Part 2- Disease-specific Expansion Phase|Investigator discretion|2|||
127695739|NCT02783300|459512956|FG023|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
128036226|NCT05067335|460762149|FG002|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
128036227|NCT05067335|460762150|FG003|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
128036228|NCT05067335|460762147|FG000|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
128036229|NCT05067335|460762148|FG001|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
128036230|NCT05067335|460762149|FG002|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
128036231|NCT05067335|460762150|FG003|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
127787439|NCT04251910|459846139|FG002|Overall Study|Assisted living facility was closed|0|||
127787440|NCT04251910|459846140|FG003|Overall Study|Assisted living facility was closed|0|||
127787441|NCT04251910|459846141|FG004|Overall Study|Assisted living facility was closed|1|||
128036232|NCT05067335|460762147|FG000|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|6|||
128036233|NCT05067335|460762148|FG001|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|10|||
128036234|NCT05067335|460762149|FG002|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
128036235|NCT05067335|460762150|FG003|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
128036236|NCT05067335|460762147|FG000|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|1|||
128036237|NCT05067335|460762148|FG001|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
128036238|NCT05067335|460762149|FG002|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
128036239|NCT05067335|460762150|FG003|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
128036240|NCT05067335|460762147|FG000|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
128036241|NCT05067335|460762148|FG001|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|1|||
128036242|NCT05067335|460762149|FG002|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
128036243|NCT05067335|460762150|FG003|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
128036244|NCT05067335|460762147|FG000|Open-label Period: Month 7 - 12|Adverse Event|0|||
128036245|NCT05067335|460762148|FG001|Open-label Period: Month 7 - 12|Adverse Event|0|||
128036246|NCT05067335|460762149|FG002|Open-label Period: Month 7 - 12|Adverse Event|3|||
128036247|NCT05067335|460762150|FG003|Open-label Period: Month 7 - 12|Adverse Event|2|||
128036248|NCT05067335|460762147|FG000|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
127787442|NCT04251910|459846142|FG005|Overall Study|Assisted living facility was closed|0|||
127787443|NCT00804570|459846145|FG000|Overall Study|Adverse Event|14|||
127787444|NCT00804570|459846146|FG001|Overall Study|Adverse Event|7|||
127787445|NCT00804570|459846145|FG000|Overall Study|Lack of Efficacy|0|||
127787446|NCT00804570|459846146|FG001|Overall Study|Lack of Efficacy|1|||
127787447|NCT00804570|459846145|FG000|Overall Study|Lost to Follow-up|18|||
127787448|NCT00804570|459846146|FG001|Overall Study|Lost to Follow-up|21|||
127787449|NCT00804570|459846145|FG000|Overall Study|Entry criteria not met|5|||
127787450|NCT00804570|459846146|FG001|Overall Study|Entry criteria not met|5|||
128036249|NCT05067335|460762148|FG001|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
127787451|NCT00804570|459846145|FG000|Overall Study|Protocol Violation|12|||
127787452|NCT00804570|459846146|FG001|Overall Study|Protocol Violation|16|||
127598519|NCT01124422|459157434|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
127598520|NCT01124422|459157435|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
127598521|NCT01124422|459157433|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
127598522|NCT01124422|459157434|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
127598523|NCT01124422|459157435|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
127598524|NCT01124422|459157433|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
127598525|NCT01124422|459157434|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
127598526|NCT01124422|459157435|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
127598527|NCT01124422|459157433|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
127598528|NCT01124422|459157434|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
127598529|NCT01124422|459157435|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
127598530|NCT01124422|459157433|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
127598531|NCT01124422|459157434|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
127598532|NCT01124422|459157435|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
127598533|NCT03454893|459157440|FG000|Overall Study|Study Terminated by the Sponsor|5|||
127598534|NCT03454893|459157440|FG000|Overall Study|Did not pass screening|4|||
127598535|NCT04876274|459157441|FG000|Overall Study|Lost to Follow-up|9|||
127598536|NCT04876274|459157442|FG001|Overall Study|Lost to Follow-up|12|||
127598537|NCT02051608|459157443|FG000|Part 1: Double Blind Treatment|Death|3|||
127598538|NCT02051608|459157444|FG001|Part 1: Double Blind Treatment|Death|3|||
127598539|NCT02051608|459157445|FG002|Part 1: Double Blind Treatment|Death|0|||
127598540|NCT02051608|459157446|FG003|Part 1: Double Blind Treatment|Death|0|||
127598541|NCT02051608|459157443|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
127598542|NCT02051608|459157444|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
127598543|NCT02051608|459157445|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
127598544|NCT02051608|459157446|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
127598545|NCT02051608|459157443|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
127598546|NCT02051608|459157444|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
127598547|NCT02051608|459157445|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
127598548|NCT02051608|459157446|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
127598549|NCT02051608|459157443|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
127598550|NCT02051608|459157444|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
127598551|NCT02051608|459157445|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
127598552|NCT02051608|459157446|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
127598553|NCT02051608|459157443|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
127598554|NCT02051608|459157444|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
127598555|NCT02051608|459157445|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
127598556|NCT02051608|459157446|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
127598557|NCT02051608|459157443|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
127598558|NCT02051608|459157444|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
127598559|NCT02051608|459157445|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
127598560|NCT02051608|459157446|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
127598561|NCT02051608|459157443|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
127598562|NCT02051608|459157444|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
127598563|NCT02051608|459157445|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
127598564|NCT02051608|459157446|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
127598565|NCT02051608|459157443|FG000|Part 1: Double Blind Treatment|Other|6|||
127598566|NCT02051608|459157444|FG001|Part 1: Double Blind Treatment|Other|3|||
127598567|NCT02051608|459157445|FG002|Part 1: Double Blind Treatment|Other|0|||
127598568|NCT02051608|459157446|FG003|Part 1: Double Blind Treatment|Other|0|||
127598569|NCT02051608|459157443|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
127598570|NCT02051608|459157444|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
127598571|NCT02051608|459157445|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
127598572|NCT02051608|459157446|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
127598573|NCT02051608|459157443|FG000|Part 2: Open-label Extension|Adverse Event|0|||
127598574|NCT02051608|459157444|FG001|Part 2: Open-label Extension|Adverse Event|0|||
127598575|NCT02051608|459157445|FG002|Part 2: Open-label Extension|Adverse Event|6|||
127695740|NCT02783300|459512957|FG024|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
127598576|NCT02051608|459157446|FG003|Part 2: Open-label Extension|Adverse Event|8|||
127695741|NCT02783300|459512958|FG025|Part 2- Disease-specific Expansion Phase|Investigator discretion|4|||
127695742|NCT02783300|459512959|FG026|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
127695743|NCT02783300|459512933|FG000|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
127695744|NCT02783300|459512934|FG001|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
127598577|NCT02051608|459157443|FG000|Part 2: Open-label Extension|Death|0|||
127598578|NCT02051608|459157444|FG001|Part 2: Open-label Extension|Death|0|||
127598579|NCT02051608|459157445|FG002|Part 2: Open-label Extension|Death|7|||
127598580|NCT02051608|459157446|FG003|Part 2: Open-label Extension|Death|4|||
127598581|NCT02051608|459157443|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
128036250|NCT05067335|460762149|FG002|Open-label Period: Month 7 - 12|Lost to Follow-up|1|||
127695745|NCT02783300|459512935|FG002|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
127695746|NCT02783300|459512936|FG003|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
127695747|NCT02783300|459512937|FG004|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
127695748|NCT02783300|459512938|FG005|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
127695749|NCT02783300|459512939|FG006|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
127695750|NCT02783300|459512940|FG007|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
127695751|NCT02783300|459512941|FG008|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
127695752|NCT02783300|459512942|FG009|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
127695753|NCT02783300|459512943|FG010|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
127787453|NCT00804570|459846145|FG000|Overall Study|Physician Decision|1|||
127787454|NCT00804570|459846146|FG001|Overall Study|Physician Decision|2|||
127787455|NCT00804570|459846145|FG000|Overall Study|Sponsor decision|1|||
127787456|NCT00804570|459846146|FG001|Overall Study|Sponsor decision|4|||
127787457|NCT00804570|459846145|FG000|Overall Study|Withdrawal by Subject|21|||
127787458|NCT00804570|459846146|FG001|Overall Study|Withdrawal by Subject|38|||
127787459|NCT00290342|459846147|FG000|Overall Study|Other|0|||
127787460|NCT00290342|459846148|FG001|Overall Study|Other|1|||
127787461|NCT00290342|459846147|FG000|Overall Study|Withdrawal by Subject|6|||
127787462|NCT00290342|459846148|FG001|Overall Study|Withdrawal by Subject|4|||
127787463|NCT00290342|459846147|FG000|Overall Study|Lost to Follow-up|1|||
127787464|NCT00290342|459846148|FG001|Overall Study|Lost to Follow-up|0|||
127787465|NCT01056510|459846151|FG000|Overall Study|Dropout Before Start of Treatment|1|||
127787466|NCT01056510|459846152|FG001|Overall Study|Dropout Before Start of Treatment|1|||
127787467|NCT01056510|459846151|FG000|Overall Study|Withdrawal by Subject|4|||
127787468|NCT01056510|459846152|FG001|Overall Study|Withdrawal by Subject|2|||
127787469|NCT01056510|459846151|FG000|Overall Study|Death|29|||
127787470|NCT01056510|459846152|FG001|Overall Study|Death|34|||
127787471|NCT01056510|459846151|FG000|Overall Study|Noncompliance|1|||
127787472|NCT01056510|459846152|FG001|Overall Study|Noncompliance|3|||
127787473|NCT01056510|459846151|FG000|Overall Study|Physician Decision|4|||
127787474|NCT01056510|459846152|FG001|Overall Study|Physician Decision|5|||
127787475|NCT01056510|459846151|FG000|Overall Study|Lost to Follow-up|5|||
127787476|NCT01056510|459846152|FG001|Overall Study|Lost to Follow-up|6|||
128036251|NCT05067335|460762150|FG003|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
128036252|NCT05067335|460762147|FG000|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
128036253|NCT05067335|460762148|FG001|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
128036254|NCT05067335|460762149|FG002|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
128036255|NCT05067335|460762150|FG003|Open-label Period: Month 7 - 12|Withdrawal by Subject|3|||
128036256|NCT05067335|460762147|FG000|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
128036257|NCT05067335|460762148|FG001|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
128036258|NCT05067335|460762149|FG002|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|1|||
128036259|NCT05067335|460762150|FG003|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
128036260|NCT05067335|460762147|FG000|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
128036261|NCT05067335|460762148|FG001|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
128036262|NCT05067335|460762149|FG002|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|1|||
128036263|NCT05067335|460762150|FG003|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
128036264|NCT00261833|460762151|FG000|Overall Study|Death|1|||
128036265|NCT00261833|460762152|FG001|Overall Study|Death|3|||
127695754|NCT02783300|459512944|FG011|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
127787477|NCT01056510|459846151|FG000|Overall Study|Other|10|||
127787478|NCT01056510|459846152|FG001|Overall Study|Other|12|||
127787479|NCT01056510|459846151|FG000|Overall Study|Missing|0|||
127787480|NCT01056510|459846152|FG001|Overall Study|Missing|1|||
127787481|NCT00243386|459846153|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
127787482|NCT00243386|459846154|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
127787483|NCT00243386|459846155|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
127598582|NCT02051608|459157444|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
127598583|NCT02051608|459157445|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
127598584|NCT02051608|459157446|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
127598585|NCT02051608|459157443|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
127598586|NCT02051608|459157444|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
127598587|NCT02051608|459157445|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
127598588|NCT02051608|459157446|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
127598589|NCT02051608|459157443|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
127598590|NCT02051608|459157444|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
127598591|NCT02051608|459157445|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
127598592|NCT02051608|459157446|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
127598593|NCT02051608|459157443|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
127787484|NCT00243386|459846153|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
127787485|NCT00243386|459846154|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
127787486|NCT00243386|459846155|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
127787487|NCT00243386|459846153|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
127787488|NCT00243386|459846154|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
127787489|NCT00243386|459846155|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
127787490|NCT00243386|459846153|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
127787491|NCT00243386|459846154|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
127787492|NCT00243386|459846155|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
127787493|NCT00243386|459846153|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
127787494|NCT00243386|459846154|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
127787495|NCT00243386|459846155|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
127787496|NCT00243386|459846153|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
127787497|NCT00243386|459846154|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
127787498|NCT00243386|459846155|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
127787499|NCT00243386|459846153|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
127787500|NCT00243386|459846154|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
127787501|NCT00243386|459846155|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
127787502|NCT00243386|459846153|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
127787503|NCT00243386|459846154|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
127787504|NCT00243386|459846155|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
127787505|NCT00133991|459846156|FG000|Overall Study|Death|4|||
127787506|NCT03002155|459846157|FG000|Overall Study|Lost to Follow-up|1|||
127787507|NCT03002155|459846158|FG001|Overall Study|Lost to Follow-up|2|||
127787508|NCT03002155|459846157|FG000|Overall Study|Withdrawal by Subject|1|||
127787509|NCT03002155|459846158|FG001|Overall Study|Withdrawal by Subject|0|||
127787510|NCT03002155|459846157|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
127787511|NCT03002155|459846158|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
127787512|NCT00545298|459846159|FG000|Overall Study|Issues with Standard of Care|2|||
127598594|NCT02051608|459157444|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
127598595|NCT02051608|459157445|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
127598596|NCT02051608|459157446|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
127787513|NCT00545298|459846160|FG001|Overall Study|Issues with Standard of Care|0|||
127787514|NCT00545298|459846161|FG002|Overall Study|Issues with Standard of Care|1|||
127598597|NCT02051608|459157443|FG000|Part 2: Open-label Extension|Physician Decision|0|||
127598598|NCT02051608|459157444|FG001|Part 2: Open-label Extension|Physician Decision|0|||
127598599|NCT02051608|459157445|FG002|Part 2: Open-label Extension|Physician Decision|8|||
127598600|NCT02051608|459157446|FG003|Part 2: Open-label Extension|Physician Decision|5|||
127598601|NCT02051608|459157443|FG000|Part 2: Open-label Extension|Other|0|||
127598602|NCT02051608|459157444|FG001|Part 2: Open-label Extension|Other|0|||
127598603|NCT02051608|459157445|FG002|Part 2: Open-label Extension|Other|9|||
127598604|NCT02051608|459157446|FG003|Part 2: Open-label Extension|Other|9|||
127598605|NCT01948050|459157451|FG000|Overall Study|Withdrawal by Subject|0|||
127598606|NCT01948050|459157452|FG001|Overall Study|Withdrawal by Subject|1|||
127598607|NCT03303079|459157453|FG000|Overall Study|Adverse Event|0|||
127598608|NCT03303079|459157454|FG001|Overall Study|Adverse Event|1|||
127598609|NCT03303079|459157455|FG002|Overall Study|Adverse Event|3|||
127598610|NCT03303079|459157453|FG000|Overall Study|Protocol Violation|5|||
127598611|NCT03303079|459157454|FG001|Overall Study|Protocol Violation|4|||
127598612|NCT03303079|459157455|FG002|Overall Study|Protocol Violation|7|||
127598613|NCT03303079|459157453|FG000|Overall Study|Withdrawal by Subject|2|||
127598614|NCT03303079|459157454|FG001|Overall Study|Withdrawal by Subject|4|||
127598615|NCT03303079|459157455|FG002|Overall Study|Withdrawal by Subject|2|||
127598616|NCT03303079|459157453|FG000|Overall Study|Other than specified|0|||
127598617|NCT03303079|459157454|FG001|Overall Study|Other than specified|2|||
127598618|NCT03303079|459157455|FG002|Overall Study|Other than specified|0|||
127695755|NCT02783300|459512945|FG012|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
127695756|NCT02783300|459512946|FG013|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
127695757|NCT02783300|459512947|FG014|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
127695758|NCT02783300|459512948|FG015|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
127695759|NCT02783300|459512949|FG016|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
127695760|NCT02783300|459512950|FG017|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
127695761|NCT02783300|459512951|FG018|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
127695762|NCT02783300|459512952|FG019|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
127695763|NCT02783300|459512953|FG020|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
127695764|NCT02783300|459512954|FG021|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
127695765|NCT02783300|459512955|FG022|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
127695766|NCT02783300|459512956|FG023|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
127695767|NCT02783300|459512957|FG024|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
127695768|NCT02783300|459512958|FG025|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
127695769|NCT02783300|459512959|FG026|Part 3- Dose Determination Phase|Withdrawal by Subject|1|||
127695770|NCT02783300|459512933|FG000|Part 3- Dose Determination Phase|Investigator discretion|0|||
127695771|NCT02783300|459512934|FG001|Part 3- Dose Determination Phase|Investigator discretion|0|||
127695772|NCT02783300|459512935|FG002|Part 3- Dose Determination Phase|Investigator discretion|0|||
127695773|NCT02783300|459512936|FG003|Part 3- Dose Determination Phase|Investigator discretion|0|||
127695774|NCT02783300|459512937|FG004|Part 3- Dose Determination Phase|Investigator discretion|0|||
127695775|NCT02783300|459512938|FG005|Part 3- Dose Determination Phase|Investigator discretion|0|||
127695776|NCT02783300|459512939|FG006|Part 3- Dose Determination Phase|Investigator discretion|0|||
127695777|NCT02783300|459512940|FG007|Part 3- Dose Determination Phase|Investigator discretion|0|||
127695778|NCT02783300|459512941|FG008|Part 3- Dose Determination Phase|Investigator discretion|0|||
127695779|NCT02783300|459512942|FG009|Part 3- Dose Determination Phase|Investigator discretion|0|||
127695780|NCT02783300|459512943|FG010|Part 3- Dose Determination Phase|Investigator discretion|0|||
127695781|NCT02783300|459512944|FG011|Part 3- Dose Determination Phase|Investigator discretion|0|||
127695782|NCT02783300|459512945|FG012|Part 3- Dose Determination Phase|Investigator discretion|0|||
127695783|NCT02783300|459512946|FG013|Part 3- Dose Determination Phase|Investigator discretion|0|||
127695784|NCT02783300|459512947|FG014|Part 3- Dose Determination Phase|Investigator discretion|0|||
127695785|NCT02783300|459512948|FG015|Part 3- Dose Determination Phase|Investigator discretion|0|||
127695786|NCT02783300|459512949|FG016|Part 3- Dose Determination Phase|Investigator discretion|0|||
127695787|NCT02783300|459512950|FG017|Part 3- Dose Determination Phase|Investigator discretion|0|||
127695788|NCT02783300|459512951|FG018|Part 3- Dose Determination Phase|Investigator discretion|0|||
127787515|NCT00978029|459846162|FG000|Overall Study|Adverse Event|1|||
127787516|NCT00978029|459846163|FG001|Overall Study|Adverse Event|2|||
127787517|NCT00978029|459846164|FG002|Overall Study|Adverse Event|5|||
127787518|NCT00978029|459846162|FG000|Overall Study|Withdrawal by Subject|0|||
127787519|NCT00978029|459846163|FG001|Overall Study|Withdrawal by Subject|0|||
127598619|NCT02005445|459157456|FG000|Overall Study|Dual study enrollment|0|||
127598620|NCT02005445|459157457|FG001|Overall Study|Dual study enrollment|1|||
127882532|NCT01220128|460192837|FG000|Overall Study|Sponsor study termination|0|||
127598621|NCT01156311|459157458|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
127598622|NCT01156311|459157459|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
127598623|NCT01156311|459157460|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
127598624|NCT01156311|459157461|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
127598625|NCT01156311|459157458|FG000|2-Month Monotherapy Period|Physician Decision|0|||
127598626|NCT01156311|459157459|FG001|2-Month Monotherapy Period|Physician Decision|1|||
128036266|NCT00261833|460762151|FG000|Overall Study|Adverse Event|1|||
128036267|NCT00261833|460762152|FG001|Overall Study|Adverse Event|4|||
128036268|NCT00261833|460762151|FG000|Overall Study|Withdrawal by Subject|5|||
128036269|NCT00261833|460762152|FG001|Overall Study|Withdrawal by Subject|7|||
128036270|NCT00261833|460762151|FG000|Overall Study|Protocol Violation|0|||
128036271|NCT00261833|460762152|FG001|Overall Study|Protocol Violation|1|||
128036272|NCT00261833|460762151|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
128036273|NCT00261833|460762152|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
127598627|NCT01156311|459157460|FG002|2-Month Monotherapy Period|Physician Decision|0|||
127598628|NCT01156311|459157461|FG003|2-Month Monotherapy Period|Physician Decision|0|||
127598629|NCT01156311|459157458|FG000|2-Month Monotherapy Period|Other|1|||
127598630|NCT01156311|459157459|FG001|2-Month Monotherapy Period|Other|0|||
127598631|NCT01156311|459157460|FG002|2-Month Monotherapy Period|Other|0|||
127598632|NCT01156311|459157461|FG003|2-Month Monotherapy Period|Other|0|||
127598633|NCT01156311|459157458|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
127598634|NCT01156311|459157459|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
127598635|NCT01156311|459157460|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
127598636|NCT01156311|459157461|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
127598637|NCT01156311|459157458|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
127598638|NCT01156311|459157459|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
127598639|NCT01156311|459157460|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
127598640|NCT01156311|459157461|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
127598641|NCT01156311|459157458|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
127598642|NCT01156311|459157459|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
127598643|NCT01156311|459157460|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
127598644|NCT01156311|459157461|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
127598645|NCT01156311|459157458|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
127598646|NCT01156311|459157459|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
127598647|NCT01156311|459157460|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
127598648|NCT01156311|459157461|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
127598649|NCT01156311|459157458|FG000|6-month Add-on Therapy Period|Other|0|||
127598650|NCT01156311|459157459|FG001|6-month Add-on Therapy Period|Other|0|||
127598651|NCT01156311|459157460|FG002|6-month Add-on Therapy Period|Other|1|||
127598652|NCT01156311|459157461|FG003|6-month Add-on Therapy Period|Other|2|||
127598653|NCT01830972|459157476|FG000|Part II|Withdrawal by Subject|2|||
127598654|NCT01830972|459157477|FG001|Part II|Withdrawal by Subject|2|||
127598655|NCT01830972|459157476|FG000|Part III|Withdrawal by Subject|1|||
127598656|NCT01830972|459157477|FG001|Part III|Withdrawal by Subject|0|||
127598657|NCT01830972|459157476|FG000|Part III|Noncompliance|1|||
127598658|NCT01830972|459157477|FG001|Part III|Noncompliance|0|||
127598659|NCT01830972|459157476|FG000|Part IV|Withdrawal by Subject|2|||
127598660|NCT01830972|459157477|FG001|Part IV|Withdrawal by Subject|1|||
127598661|NCT01830972|459157476|FG000|Part IV|Non-Compliance|1|||
127598662|NCT01830972|459157477|FG001|Part IV|Non-Compliance|0|||
127598663|NCT01574326|459157478|FG000|Overall Study|Randomized but not treated|0|||
127695789|NCT02783300|459512952|FG019|Part 3- Dose Determination Phase|Investigator discretion|0|||
127695790|NCT02783300|459512953|FG020|Part 3- Dose Determination Phase|Investigator discretion|0|||
127695791|NCT02783300|459512954|FG021|Part 3- Dose Determination Phase|Investigator discretion|0|||
127695792|NCT02783300|459512955|FG022|Part 3- Dose Determination Phase|Investigator discretion|0|||
127695793|NCT02783300|459512956|FG023|Part 3- Dose Determination Phase|Investigator discretion|0|||
127695794|NCT02783300|459512957|FG024|Part 3- Dose Determination Phase|Investigator discretion|0|||
127695795|NCT02783300|459512958|FG025|Part 3- Dose Determination Phase|Investigator discretion|0|||
127695796|NCT02783300|459512959|FG026|Part 3- Dose Determination Phase|Investigator discretion|3|||
127695797|NCT03535272|459512960|FG000|Overall Study|Lost to Follow-up|71|||
127695798|NCT03535272|459512961|FG001|Overall Study|Lost to Follow-up|73|||
127695799|NCT04831216|459512968|FG000|Overall Study|Lost to Follow-up|32|||
127695800|NCT03930342|459512972|FG000|Overall Study|Lost to Follow-up|70|||
127695801|NCT03930342|459512973|FG001|Overall Study|Lost to Follow-up|77|||
127882533|NCT01220128|460192838|FG001|Overall Study|Sponsor study termination|1|||
128036274|NCT00261833|460762151|FG000|Overall Study|Lung transplantation|1|||
128036275|NCT00261833|460762152|FG001|Overall Study|Lung transplantation|1|||
128036276|NCT00261833|460762151|FG000|Overall Study|Missing reason|1|||
127598664|NCT01574326|459157479|FG001|Overall Study|Randomized but not treated|1|||
127598665|NCT01574326|459157478|FG000|Overall Study|Withdrawal by Participant|2|||
127598666|NCT01574326|459157479|FG001|Overall Study|Withdrawal by Participant|4|||
127598667|NCT01574326|459157478|FG000|Overall Study|Physician Decision|5|||
127598668|NCT01574326|459157479|FG001|Overall Study|Physician Decision|3|||
127598669|NCT01574326|459157478|FG000|Overall Study|Adverse Event|1|||
127598670|NCT01574326|459157479|FG001|Overall Study|Adverse Event|3|||
127598671|NCT01574326|459157478|FG000|Overall Study|Other: Mainly kidney transplant|8|||
127598672|NCT01574326|459157479|FG001|Overall Study|Other: Mainly kidney transplant|8|||
127598673|NCT04997161|459157480|FG000|Overall Study|Study terminated by sponsor|3|||
127598674|NCT04044716|459157481|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
127598675|NCT04044716|459157482|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
127598676|NCT04044716|459157483|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
127598677|NCT04044716|459157481|FG000|Overall Study|Lost to Follow-up|2|||
127598678|NCT04044716|459157482|FG001|Overall Study|Lost to Follow-up|3|||
127598679|NCT04044716|459157483|FG002|Overall Study|Lost to Follow-up|0|||
127598680|NCT01018186|459157484|FG000|2-week Run-in Period|Protocol Violation|1|||
127598681|NCT01018186|459157485|FG001|2-week Run-in Period|Protocol Violation|0|||
127598682|NCT01018186|459157486|FG002|2-week Run-in Period|Protocol Violation|0|||
127598683|NCT01018186|459157487|FG003|2-week Run-in Period|Protocol Violation|0|||
127598684|NCT01018186|459157484|FG000|2-week Run-in Period|Lost to Follow-up|2|||
127598685|NCT01018186|459157485|FG001|2-week Run-in Period|Lost to Follow-up|0|||
127598686|NCT01018186|459157486|FG002|2-week Run-in Period|Lost to Follow-up|0|||
127598687|NCT01018186|459157487|FG003|2-week Run-in Period|Lost to Follow-up|0|||
127598688|NCT01018186|459157484|FG000|2-week Run-in Period|Physician Decision|3|||
127598689|NCT01018186|459157485|FG001|2-week Run-in Period|Physician Decision|0|||
127598690|NCT01018186|459157486|FG002|2-week Run-in Period|Physician Decision|0|||
127598691|NCT01018186|459157487|FG003|2-week Run-in Period|Physician Decision|0|||
127598692|NCT01018186|459157484|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
127598693|NCT01018186|459157485|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
127598694|NCT01018186|459157486|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
127598695|NCT01018186|459157487|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
127598696|NCT01018186|459157484|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
127598697|NCT01018186|459157485|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
127598698|NCT01018186|459157486|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
127598699|NCT01018186|459157487|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
127598700|NCT01018186|459157484|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
127598701|NCT01018186|459157485|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
127598702|NCT01018186|459157486|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
127598703|NCT01018186|459157487|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
127598704|NCT01018186|459157484|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
127598705|NCT01018186|459157485|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
127598706|NCT01018186|459157486|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
127598707|NCT01018186|459157487|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
127598708|NCT01018186|459157484|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
127598709|NCT01018186|459157485|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
127598710|NCT01018186|459157486|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
127598711|NCT01018186|459157487|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
127598712|NCT01018186|459157484|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
127598713|NCT01018186|459157485|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
127598714|NCT01018186|459157486|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
127598715|NCT01018186|459157487|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
127598716|NCT01018186|459157484|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
127598717|NCT01018186|459157485|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
127598718|NCT01018186|459157486|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
127598719|NCT01018186|459157487|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
127598720|NCT01018186|459157484|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
127598721|NCT01018186|459157485|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
127598722|NCT01018186|459157486|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
127598723|NCT01018186|459157487|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
127598724|NCT01018186|459157484|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
127598725|NCT01018186|459157485|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
127598726|NCT01018186|459157486|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
127598727|NCT01018186|459157487|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
127598728|NCT03049280|459157488|FG000|Overall Study|Physician Decision|1|||
127598729|NCT03552198|459157489|FG000|Overall Study|Lost to Follow-up|42|||
127598730|NCT03552198|459157490|FG001|Overall Study|Lost to Follow-up|48|||
127598731|NCT03552198|459157491|FG002|Overall Study|Lost to Follow-up|15|||
127598732|NCT03552198|459157492|FG003|Overall Study|Lost to Follow-up|19|||
127598733|NCT03552198|459157489|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
127598734|NCT03552198|459157490|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
127598735|NCT03552198|459157491|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
127598736|NCT03552198|459157492|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
127598737|NCT03552198|459157489|FG000|Overall Study|Did not receive air alerts|1|||
127598738|NCT03552198|459157490|FG001|Overall Study|Did not receive air alerts|0|||
127598739|NCT03552198|459157491|FG002|Overall Study|Did not receive air alerts|0|||
127598740|NCT03552198|459157492|FG003|Overall Study|Did not receive air alerts|1|||
127598741|NCT03235154|459157493|FG000|Overall Study|Withdrawal by Subject|1|||
127598742|NCT03235154|459157493|FG000|Overall Study|Adverse Event|1|||
127598743|NCT03235154|459157493|FG000|Overall Study|Lost to Follow-up|2|||
127598744|NCT02326025|459157494|FG000|Overall Study|Adverse Event|3|||
127598745|NCT02326025|459157495|FG001|Overall Study|Adverse Event|0|||
127598746|NCT02326025|459157494|FG000|Overall Study|Physician Decision|1|||
127598747|NCT02326025|459157495|FG001|Overall Study|Physician Decision|2|||
127598748|NCT02326025|459157494|FG000|Overall Study|Physician and Participant Decision|1|||
127598749|NCT02326025|459157495|FG001|Overall Study|Physician and Participant Decision|0|||
127598750|NCT02326025|459157494|FG000|Overall Study|Withdrawal by Subject|0|||
127598751|NCT02326025|459157495|FG001|Overall Study|Withdrawal by Subject|2|||
127598752|NCT02326025|459157494|FG000|Overall Study|Protocol Violation|0|||
127598753|NCT02326025|459157495|FG001|Overall Study|Protocol Violation|1|||
127598754|NCT00001723|459157496|FG000|Overall Study|Lack of Efficacy|6|||
128036277|NCT00261833|460762152|FG001|Overall Study|Missing reason|0|||
127598755|NCT00001723|459157497|FG001|Overall Study|Lack of Efficacy|7|||
127598756|NCT00001723|459157496|FG000|Overall Study|Lack of family interest|4|||
127598757|NCT00001723|459157497|FG001|Overall Study|Lack of family interest|5|||
127598758|NCT00001723|459157496|FG000|Overall Study|Lost to Follow-up|2|||
127598759|NCT00001723|459157497|FG001|Overall Study|Lost to Follow-up|2|||
127598760|NCT00001723|459157496|FG000|Overall Study|medication intolerance|1|||
127598761|NCT00001723|459157497|FG001|Overall Study|medication intolerance|2|||
127598762|NCT02643082|459157498|FG000|Period 1|Adverse Event|1|||
127598763|NCT02643082|459157499|FG001|Period 1|Adverse Event|0|||
127598764|NCT01324999|459157500|FG000|Overall Study|Adverse Event|3|||
127598765|NCT01324999|459157500|FG000|Overall Study|Withdrawal by Subject|2|||
127598766|NCT00276744|459157501|FG000|PART A|Reason unknown|98|||
127598767|NCT01714635|459157507|FG000|Overall Study|Discontinued|1|||
127598768|NCT01714635|459157508|FG001|Overall Study|Discontinued|0|||
127598769|NCT01714635|459157509|FG002|Overall Study|Discontinued|2|||
127598770|NCT01714635|459157507|FG000|Overall Study|Missed 6-month exam|1|||
127598771|NCT01714635|459157508|FG001|Overall Study|Missed 6-month exam|0|||
127598772|NCT01714635|459157509|FG002|Overall Study|Missed 6-month exam|0|||
127598773|NCT00230607|459157510|FG000|Overall Study|Other|3|||
127598774|NCT02860169|459157511|FG000|Part A|Withdrawal by Subject|1|||
127598775|NCT02860169|459157511|FG000|Part A|Other (Screening failure)|6|||
127598776|NCT02860169|459157511|FG000|Part A|Other (Survey not completed)|3|||
127598777|NCT02860169|459157511|FG000|Part A|Other (did not completed consent)|1|||
127598778|NCT02860169|459157511|FG000|Part B|Other (Screening failure)|10|||
127598779|NCT02860169|459157511|FG000|Part B|Withdrawal by Subject|1|||
127598780|NCT02860169|459157511|FG000|Part C|Other (Screening failure)|1|||
127598781|NCT02743871|459157512|FG000|Overall Study|Lost to Follow-up|0|||
127598782|NCT02743871|459157513|FG001|Overall Study|Lost to Follow-up|0|||
127598783|NCT02743871|459157514|FG002|Overall Study|Lost to Follow-up|0|||
127598784|NCT02743871|459157515|FG003|Overall Study|Lost to Follow-up|1|||
127598785|NCT02743871|459157516|FG004|Overall Study|Lost to Follow-up|0|||
127598786|NCT02743871|459157517|FG005|Overall Study|Lost to Follow-up|0|||
127598787|NCT02743871|459157518|FG006|Overall Study|Lost to Follow-up|1|||
127598788|NCT02743871|459157519|FG007|Overall Study|Lost to Follow-up|0|||
127598789|NCT02743871|459157520|FG008|Overall Study|Lost to Follow-up|0|||
127598790|NCT02743871|459157521|FG009|Overall Study|Lost to Follow-up|0|||
127598791|NCT02743871|459157522|FG010|Overall Study|Lost to Follow-up|0|||
127598792|NCT02743871|459157523|FG011|Overall Study|Lost to Follow-up|2|||
127598793|NCT02743871|459157524|FG012|Overall Study|Lost to Follow-up|0|||
127598794|NCT02743871|459157525|FG013|Overall Study|Lost to Follow-up|0|||
127598795|NCT02743871|459157512|FG000|Overall Study|Withdrawal by Subject|0|||
127598796|NCT02743871|459157513|FG001|Overall Study|Withdrawal by Subject|0|||
127598797|NCT02743871|459157514|FG002|Overall Study|Withdrawal by Subject|0|||
127598798|NCT02743871|459157515|FG003|Overall Study|Withdrawal by Subject|0|||
127598799|NCT02743871|459157516|FG004|Overall Study|Withdrawal by Subject|0|||
127598800|NCT02743871|459157517|FG005|Overall Study|Withdrawal by Subject|0|||
127598801|NCT02743871|459157518|FG006|Overall Study|Withdrawal by Subject|0|||
127598802|NCT02743871|459157519|FG007|Overall Study|Withdrawal by Subject|0|||
127598803|NCT02743871|459157520|FG008|Overall Study|Withdrawal by Subject|0|||
127598804|NCT02743871|459157521|FG009|Overall Study|Withdrawal by Subject|0|||
127598805|NCT02743871|459157522|FG010|Overall Study|Withdrawal by Subject|1|||
127598806|NCT02743871|459157523|FG011|Overall Study|Withdrawal by Subject|0|||
127598807|NCT02743871|459157524|FG012|Overall Study|Withdrawal by Subject|12|||
127598808|NCT02743871|459157525|FG013|Overall Study|Withdrawal by Subject|6|||
127787520|NCT00978029|459846164|FG002|Overall Study|Withdrawal by Subject|1|||
127787521|NCT00978029|459846162|FG000|Overall Study|Protocol Violation|0|||
127787522|NCT00978029|459846163|FG001|Overall Study|Protocol Violation|1|||
127787523|NCT00978029|459846164|FG002|Overall Study|Protocol Violation|0|||
127787524|NCT01793142|459846168|FG000|Overall Study|Randomized not treated|7|||
128036278|NCT00261833|460762151|FG000|Overall Study|Not interested in being participant|0|||
127598809|NCT02743871|459157512|FG000|Overall Study|Adverse Event|1|||
127598810|NCT02743871|459157513|FG001|Overall Study|Adverse Event|0|||
127598811|NCT02743871|459157514|FG002|Overall Study|Adverse Event|0|||
127598812|NCT02743871|459157515|FG003|Overall Study|Adverse Event|0|||
127598813|NCT02743871|459157516|FG004|Overall Study|Adverse Event|0|||
127598814|NCT02743871|459157517|FG005|Overall Study|Adverse Event|0|||
127598815|NCT02743871|459157518|FG006|Overall Study|Adverse Event|0|||
127598816|NCT02743871|459157519|FG007|Overall Study|Adverse Event|0|||
127598817|NCT02743871|459157520|FG008|Overall Study|Adverse Event|0|||
127598818|NCT02743871|459157521|FG009|Overall Study|Adverse Event|0|||
127598819|NCT02743871|459157522|FG010|Overall Study|Adverse Event|0|||
127598820|NCT02743871|459157523|FG011|Overall Study|Adverse Event|0|||
127598821|NCT02743871|459157524|FG012|Overall Study|Adverse Event|0|||
127598822|NCT02743871|459157525|FG013|Overall Study|Adverse Event|0|||
127598823|NCT02743871|459157512|FG000|Overall Study|Other|0|||
127598824|NCT02743871|459157513|FG001|Overall Study|Other|0|||
127598825|NCT02743871|459157514|FG002|Overall Study|Other|0|||
127598826|NCT02743871|459157515|FG003|Overall Study|Other|0|||
127598827|NCT02743871|459157516|FG004|Overall Study|Other|0|||
127598828|NCT02743871|459157517|FG005|Overall Study|Other|0|||
127598829|NCT02743871|459157518|FG006|Overall Study|Other|0|||
127598830|NCT02743871|459157519|FG007|Overall Study|Other|0|||
127598831|NCT02743871|459157520|FG008|Overall Study|Other|0|||
127598832|NCT02743871|459157521|FG009|Overall Study|Other|0|||
127598833|NCT02743871|459157522|FG010|Overall Study|Other|0|||
127598834|NCT02743871|459157523|FG011|Overall Study|Other|1|||
127598835|NCT02743871|459157524|FG012|Overall Study|Other|1|||
127598836|NCT02743871|459157525|FG013|Overall Study|Other|1|||
127598837|NCT02743871|459157512|FG000|Overall Study|Protocol Violation|0|||
127598838|NCT02743871|459157513|FG001|Overall Study|Protocol Violation|0|||
127598839|NCT02743871|459157514|FG002|Overall Study|Protocol Violation|0|||
127598840|NCT02743871|459157515|FG003|Overall Study|Protocol Violation|0|||
127598841|NCT02743871|459157516|FG004|Overall Study|Protocol Violation|0|||
127598842|NCT02743871|459157517|FG005|Overall Study|Protocol Violation|0|||
127598843|NCT02743871|459157518|FG006|Overall Study|Protocol Violation|0|||
127598844|NCT02743871|459157519|FG007|Overall Study|Protocol Violation|0|||
127598845|NCT02743871|459157520|FG008|Overall Study|Protocol Violation|0|||
127598846|NCT02743871|459157521|FG009|Overall Study|Protocol Violation|0|||
127598847|NCT02743871|459157522|FG010|Overall Study|Protocol Violation|0|||
127598848|NCT02743871|459157523|FG011|Overall Study|Protocol Violation|0|||
127598849|NCT02743871|459157524|FG012|Overall Study|Protocol Violation|2|||
127598850|NCT02743871|459157525|FG013|Overall Study|Protocol Violation|0|||
127598851|NCT02848651|459157530|FG000|Overall Study|Death|85|||
127598852|NCT02848651|459157530|FG000|Overall Study|Lost to Follow-up|1|||
127598853|NCT02848651|459157530|FG000|Overall Study|Non-Compliance|1|||
127598854|NCT02848651|459157530|FG000|Overall Study|Symptomatic Deterioration|1|||
127598855|NCT02848651|459157530|FG000|Overall Study|Physician Decision|4|||
127598856|NCT02848651|459157530|FG000|Overall Study|Withdrawal by Subject|14|||
127598857|NCT00662363|459157533|FG000|Overall Study|Withdrawal by Subject|6|||
127598858|NCT00662363|459157534|FG001|Overall Study|Withdrawal by Subject|5|||
127598859|NCT00662363|459157533|FG000|Overall Study|Adverse Event|0|||
127598860|NCT00662363|459157534|FG001|Overall Study|Adverse Event|3|||
127598861|NCT00662363|459157533|FG000|Overall Study|Discharged early from rehab|4|||
127598862|NCT00662363|459157534|FG001|Overall Study|Discharged early from rehab|1|||
127598863|NCT00662363|459157533|FG000|Overall Study|Protocol Violation|1|||
127598864|NCT00662363|459157534|FG001|Overall Study|Protocol Violation|1|||
127598865|NCT01428453|459157535|FG000|Overall Study|Adverse Event|2|||
127598866|NCT01428453|459157536|FG001|Overall Study|Adverse Event|7|||
127598867|NCT01428453|459157535|FG000|Overall Study|Protocol Violation|1|||
127598868|NCT01428453|459157536|FG001|Overall Study|Protocol Violation|0|||
127598869|NCT01428453|459157535|FG000|Overall Study|Lost to Follow-up|0|||
127598870|NCT01428453|459157536|FG001|Overall Study|Lost to Follow-up|1|||
127598871|NCT01428453|459157535|FG000|Overall Study|Withdrawal by Subject|3|||
127598872|NCT01428453|459157536|FG001|Overall Study|Withdrawal by Subject|1|||
127787525|NCT01553188|459846169|FG000|Overall Study|Patient choice|1|||
127598873|NCT03789318|459157541|FG000|Overall Study|Adverse Event|0|||
127598874|NCT03789318|459157542|FG001|Overall Study|Adverse Event|0|||
127598875|NCT03789318|459157543|FG002|Overall Study|Adverse Event|1|||
127598876|NCT03789318|459157544|FG003|Overall Study|Adverse Event|1|||
127598877|NCT03789318|459157545|FG004|Overall Study|Adverse Event|0|||
127598878|NCT03789318|459157541|FG000|Overall Study|Lost to Follow-up|0|||
127598879|NCT03789318|459157542|FG001|Overall Study|Lost to Follow-up|0|||
127598880|NCT03789318|459157543|FG002|Overall Study|Lost to Follow-up|1|||
127598881|NCT03789318|459157544|FG003|Overall Study|Lost to Follow-up|0|||
127598882|NCT03789318|459157545|FG004|Overall Study|Lost to Follow-up|0|||
127598883|NCT03789318|459157541|FG000|Overall Study|Withdrawal by Subject|0|||
127598884|NCT03789318|459157542|FG001|Overall Study|Withdrawal by Subject|0|||
127598885|NCT03789318|459157543|FG002|Overall Study|Withdrawal by Subject|1|||
127598886|NCT03789318|459157544|FG003|Overall Study|Withdrawal by Subject|0|||
127598887|NCT03789318|459157545|FG004|Overall Study|Withdrawal by Subject|0|||
127787526|NCT01553188|459846170|FG001|Overall Study|Patient choice|0|||
127787527|NCT01553188|459846171|FG002|Overall Study|Patient choice|0|||
127598888|NCT01317160|459157546|FG000|Overall Study|Incorrect inclusion|1|||
127598889|NCT01317160|459157547|FG001|Overall Study|Incorrect inclusion|1|||
127598890|NCT01317160|459157546|FG000|Overall Study|Lost to Follow-up|3|||
127598891|NCT01317160|459157547|FG001|Overall Study|Lost to Follow-up|3|||
127598892|NCT01317160|459157546|FG000|Overall Study|Withdrawal by Subject|0|||
127598893|NCT01317160|459157547|FG001|Overall Study|Withdrawal by Subject|2|||
127598894|NCT04203238|459159437|FG000|Overall Study|Withdrawal by Subject|1|||
127598895|NCT04203238|459159438|FG001|Overall Study|Withdrawal by Subject|1|||
127598896|NCT04203238|459159437|FG000|Overall Study|Covid-19|3|||
127598897|NCT04203238|459159438|FG001|Overall Study|Covid-19|0|||
127598898|NCT01955733|459159439|FG000|Period 1|Lost to Follow-up|1|||
127598899|NCT01955733|459159440|FG001|Period 1|Lost to Follow-up|0|||
127598900|NCT01955733|459159441|FG002|Period 1|Lost to Follow-up|0|||
127598901|NCT01955733|459159439|FG000|Period 2|Adverse Event|1|||
127598902|NCT01955733|459159440|FG001|Period 2|Adverse Event|0|||
127598903|NCT01955733|459159441|FG002|Period 2|Adverse Event|0|||
127598904|NCT01955733|459159439|FG000|Period 2|Physician Decision|0|||
127598905|NCT01955733|459159440|FG001|Period 2|Physician Decision|0|||
127598906|NCT01955733|459159441|FG002|Period 2|Physician Decision|1|||
127598907|NCT01955733|459159439|FG000|Period 2|Withdrawal by Subject|1|||
127598908|NCT01955733|459159440|FG001|Period 2|Withdrawal by Subject|3|||
127598909|NCT01955733|459159441|FG002|Period 2|Withdrawal by Subject|2|||
127598910|NCT01955733|459159439|FG000|Period 2|Study terminated by sponsor|8|||
127598911|NCT01955733|459159440|FG001|Period 2|Study terminated by sponsor|14|||
127598912|NCT01955733|459159441|FG002|Period 2|Study terminated by sponsor|16|||
127598913|NCT01955733|459159439|FG000|Period 2|Lost to Follow-up|2|||
127598914|NCT01955733|459159440|FG001|Period 2|Lost to Follow-up|0|||
127598915|NCT01955733|459159441|FG002|Period 2|Lost to Follow-up|0|||
127598916|NCT01955733|459159439|FG000|Period 2|Other not defined above|0|||
127598917|NCT01955733|459159440|FG001|Period 2|Other not defined above|2|||
127598918|NCT01955733|459159441|FG002|Period 2|Other not defined above|2|||
127598919|NCT00733408|459159442|FG000|Overall Study|Adverse Event|4|||
127598920|NCT02762266|459159443|FG000|Overall Study|Physician Decision|2|||
127598921|NCT02762266|459159444|FG001|Overall Study|Physician Decision|0|||
127598922|NCT01438424|459159445|FG000|Overall Study|Continuing treatment|29|||
127598923|NCT01438424|459159445|FG000|Overall Study|Minimal virologic response|95|||
127598924|NCT01438424|459159445|FG000|Overall Study|Not identified|55|||
127598925|NCT01438424|459159445|FG000|Overall Study|Withdrawal by Subject|104|||
127598926|NCT01438424|459159445|FG000|Overall Study|Progression of chronic hepatitis B|22|||
127598927|NCT01438424|459159445|FG000|Overall Study|Death|22|||
127598928|NCT01438424|459159445|FG000|Overall Study|Adverse Event|17|||
127598929|NCT01438424|459159445|FG000|Overall Study|Lost to Follow-up|17|||
127598930|NCT01438424|459159445|FG000|Overall Study|Abnormal laboratory test result|14|||
127598931|NCT01438424|459159445|FG000|Overall Study|Need for drug prohibited by protocol|14|||
127598932|NCT01438424|459159445|FG000|Overall Study|Pregnancy|7|||
127598933|NCT01438424|459159445|FG000|Overall Study|No longer met inclusion criteria|1|||
127598934|NCT01438424|459159445|FG000|Overall Study|Participant noncompliance|20|||
127598935|NCT03312933|459159446|FG000|Overall Study|Protocol Violation|15|||
127598936|NCT03312933|459159446|FG000|Overall Study|Lost to Follow-up|36|||
127598937|NCT03312933|459159446|FG000|Overall Study|Withdrawal by Subject|3|||
127598938|NCT00224055|459159452|FG000|Overall Study|Adverse Event|9|||
127598939|NCT00224055|459159453|FG001|Overall Study|Adverse Event|3|||
127598940|NCT00224055|459159452|FG000|Overall Study|Lost to Follow-up|1|||
127598941|NCT00224055|459159453|FG001|Overall Study|Lost to Follow-up|2|||
127598942|NCT00224055|459159452|FG000|Overall Study|Protocol Violation|1|||
127598943|NCT00224055|459159453|FG001|Overall Study|Protocol Violation|1|||
127598944|NCT00224055|459159452|FG000|Overall Study|Inclusion Violation|3|||
127598945|NCT00224055|459159453|FG001|Overall Study|Inclusion Violation|6|||
127787528|NCT01553188|459846172|FG003|Overall Study|Patient choice|0|||
127787529|NCT01553188|459846169|FG000|Overall Study|Intercurrent illness and adverse event|0|||
127787530|NCT01553188|459846170|FG001|Overall Study|Intercurrent illness and adverse event|1|||
127598946|NCT00224055|459159452|FG000|Overall Study|Withdrawal by Subject|0|||
127598947|NCT00224055|459159453|FG001|Overall Study|Withdrawal by Subject|2|||
127598948|NCT00224055|459159452|FG000|Overall Study|Other|1|||
127598949|NCT00224055|459159453|FG001|Overall Study|Other|0|||
127598950|NCT04317066|459159454|FG000|Overall Study|Sponsor decision|5|||
127598951|NCT04317066|459159454|FG000|Overall Study|Death|2|||
127598952|NCT00848081|459159457|FG000|Overall Study|Adverse Event|6|||
127598953|NCT00848081|459159458|FG001|Overall Study|Adverse Event|7|||
127598954|NCT00848081|459159457|FG000|Overall Study|Protocol Violation|8|||
127598955|NCT00848081|459159458|FG001|Overall Study|Protocol Violation|5|||
127598956|NCT00848081|459159457|FG000|Overall Study|Lost to Follow-up|1|||
127598957|NCT00848081|459159458|FG001|Overall Study|Lost to Follow-up|0|||
127598958|NCT00848081|459159457|FG000|Overall Study|Physician Decision|0|||
127598959|NCT00848081|459159458|FG001|Overall Study|Physician Decision|3|||
127598960|NCT00848081|459159457|FG000|Overall Study|Withdrawal by Subject|5|||
127598961|NCT00848081|459159458|FG001|Overall Study|Withdrawal by Subject|3|||
127598962|NCT02064868|459159459|FG000|Overall Study|Lost to Follow-up|14|||
127598963|NCT02064868|459159460|FG001|Overall Study|Lost to Follow-up|8|||
127598964|NCT02064868|459159459|FG000|Overall Study|Physician Decision|1|||
127598965|NCT02064868|459159460|FG001|Overall Study|Physician Decision|0|||
127598966|NCT02064868|459159459|FG000|Overall Study|Withdrawal by Subject|14|||
127598967|NCT02064868|459159460|FG001|Overall Study|Withdrawal by Subject|3|||
127598968|NCT02064868|459159459|FG000|Overall Study|Technical Problems or Missing|5|||
127598969|NCT02064868|459159460|FG001|Overall Study|Technical Problems or Missing|2|||
127598970|NCT02014597|459159461|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
127598971|NCT02014597|459159462|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
127598972|NCT00754624|459159466|FG000|Overall Study|Adverse Event|16|||
127598973|NCT00754624|459159466|FG000|Overall Study|Death|1|||
127598974|NCT00754624|459159466|FG000|Overall Study|Physician Decision|8|||
127598975|NCT00754624|459159466|FG000|Overall Study|Protocol Violation|1|||
127598976|NCT00754624|459159466|FG000|Overall Study|Withdrawal by Subject|28|||
127598977|NCT00754624|459159466|FG000|Overall Study|Various|12|||
127598978|NCT00754624|459159466|FG000|Overall Study|Lost to Follow-up|3|||
127598979|NCT00418314|459159467|FG000|Overall Study|Withdrawal by Subject|1|||
127598980|NCT00418314|459159468|FG001|Overall Study|Withdrawal by Subject|2|||
127598981|NCT00931762|459159469|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
127598982|NCT00931762|459159469|FG000|Overall Study|Administrative Problems|5|||
127598983|NCT00931762|459159469|FG000|Overall Study|Death|1|||
127598984|NCT00931762|459159469|FG000|Overall Study|Disease Progression|3|||
127598985|NCT00931762|459159469|FG000|Overall Study|Adverse Event (s)|11|||
127598986|NCT00931762|459159469|FG000|Overall Study|Subject withdrew consent|13|||
127598987|NCT02664441|459159476|FG000|Randomization|Withdrawal by Subject|0|||
127598988|NCT02664441|459159477|FG001|Randomization|Withdrawal by Subject|1|||
127598989|NCT02664441|459159476|FG000|36-week Randomized Trial|Adverse Event|2|||
127598990|NCT02664441|459159477|FG001|36-week Randomized Trial|Adverse Event|0|||
127598991|NCT02664441|459159476|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
127598992|NCT02664441|459159477|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
127598993|NCT02664441|459159476|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
127598994|NCT02664441|459159477|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
127598995|NCT02664441|459159476|FG000|18-week Open Label Extension|Adverse Event|1|||
127598996|NCT02664441|459159477|FG001|18-week Open Label Extension|Adverse Event|0|||
127598997|NCT02664441|459159476|FG000|18-week Open Label Extension|Physician Decision|1|||
127598998|NCT02664441|459159477|FG001|18-week Open Label Extension|Physician Decision|0|||
127598999|NCT02664441|459159476|FG000|18-week Open Label Extension|Death|1|||
127599000|NCT02664441|459159477|FG001|18-week Open Label Extension|Death|0|||
127599001|NCT02664441|459159476|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
127599002|NCT02664441|459159477|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
127599003|NCT01529346|459159478|FG000|Overall Study|Lost to Follow-up|2|||
127599004|NCT01529346|459159479|FG001|Overall Study|Lost to Follow-up|0|||
127599005|NCT01529346|459159480|FG002|Overall Study|Lost to Follow-up|1|||
127599006|NCT01529346|459159481|FG003|Overall Study|Lost to Follow-up|0|||
127599007|NCT01529346|459159482|FG004|Overall Study|Lost to Follow-up|0|||
127599008|NCT01529346|459159478|FG000|Overall Study|Other|0|||
127599009|NCT01529346|459159479|FG001|Overall Study|Other|1|||
127599010|NCT01529346|459159480|FG002|Overall Study|Other|1|||
127599011|NCT01529346|459159481|FG003|Overall Study|Other|0|||
127599012|NCT01529346|459159482|FG004|Overall Study|Other|0|||
127599013|NCT00589914|459159485|FG000|Overall Study|Adverse Event|19|||
127599014|NCT00589914|459159486|FG001|Overall Study|Adverse Event|10|||
127599015|NCT00589914|459159485|FG000|Overall Study|Death|2|||
127599016|NCT00589914|459159486|FG001|Overall Study|Death|0|||
127599017|NCT00589914|459159485|FG000|Overall Study|Lack of Efficacy|40|||
127599018|NCT00589914|459159486|FG001|Overall Study|Lack of Efficacy|43|||
127599019|NCT00589914|459159485|FG000|Overall Study|Lost to Follow-up|11|||
127599020|NCT00589914|459159486|FG001|Overall Study|Lost to Follow-up|18|||
127599021|NCT00589914|459159485|FG000|Overall Study|Pregnancy|1|||
127599022|NCT00589914|459159486|FG001|Overall Study|Pregnancy|0|||
127599023|NCT00589914|459159485|FG000|Overall Study|Withdrawal by Subject|55|||
127599024|NCT00589914|459159486|FG001|Overall Study|Withdrawal by Subject|49|||
127599025|NCT00589914|459159485|FG000|Overall Study|Other|22|||
127599026|NCT00589914|459159486|FG001|Overall Study|Other|17|||
127599027|NCT01402544|459159492|FG000|Overall Study|Withdrawal by Subject|6|||
127599028|NCT01314443|459159493|FG000|Overall Study|Withdrawal by Subject|2|||
127599029|NCT01314443|459159494|FG001|Overall Study|Withdrawal by Subject|1|||
127599030|NCT01314443|459159495|FG002|Overall Study|Withdrawal by Subject|1|||
127599031|NCT01314443|459159496|FG003|Overall Study|Withdrawal by Subject|1|||
127599032|NCT01314443|459159493|FG000|Overall Study|Protocol Violation|2|||
127599033|NCT01314443|459159494|FG001|Overall Study|Protocol Violation|2|||
127599034|NCT01314443|459159495|FG002|Overall Study|Protocol Violation|1|||
127599035|NCT01314443|459159496|FG003|Overall Study|Protocol Violation|1|||
127599036|NCT00449540|459159498|FG000|Pretreatment Phase|No migraine experienced|66|||
127599037|NCT00449540|459159499|FG001|Pretreatment Phase|No migraine experienced|0|||
127599038|NCT00449540|459159500|FG002|Pretreatment Phase|No migraine experienced|0|||
127599039|NCT00449540|459159498|FG000|Treatment Phase|did not experience or treat migraine|0|||
127599040|NCT00449540|459159499|FG001|Treatment Phase|did not experience or treat migraine|20|||
127599041|NCT00449540|459159500|FG002|Treatment Phase|did not experience or treat migraine|17|||
127599042|NCT02709785|459159501|FG000|Overall Study|Withdrawal by Subject|1|||
127599043|NCT02709785|459159502|FG001|Overall Study|Withdrawal by Subject|2|||
127599044|NCT02709785|459159503|FG002|Overall Study|Withdrawal by Subject|1|||
127599045|NCT00010374|459159504|FG000|Overall Study|False positive phrenic nerve test|1|||
127599046|NCT01961323|459159505|FG000|Overall Study|Withdrawal by Subject|7|||
127599047|NCT01961323|459159505|FG000|Overall Study|Lost to Follow-up|8|||
127599048|NCT01961323|459159505|FG000|Overall Study|screen failure|34|||
127599049|NCT02875860|459159508|FG000|Overall Study|Withdrawal by Subject|0|||
127599050|NCT02875860|459159509|FG001|Overall Study|Withdrawal by Subject|1|||
127599051|NCT00372112|459159514|FG000|Overall Study|Adverse Event|0|||
127599052|NCT00372112|459159515|FG001|Overall Study|Adverse Event|1|||
127599053|NCT00372112|459159516|FG002|Overall Study|Adverse Event|1|||
127599054|NCT00372112|459159517|FG003|Overall Study|Adverse Event|1|||
127599055|NCT00372112|459159514|FG000|Overall Study|Withdrawal by Subject|0|||
127599056|NCT00372112|459159515|FG001|Overall Study|Withdrawal by Subject|0|||
127599057|NCT00372112|459159516|FG002|Overall Study|Withdrawal by Subject|2|||
127599058|NCT00372112|459159517|FG003|Overall Study|Withdrawal by Subject|1|||
127599059|NCT00372112|459159514|FG000|Overall Study|Exacerbation|0|||
127599060|NCT00372112|459159515|FG001|Overall Study|Exacerbation|0|||
127599061|NCT00372112|459159516|FG002|Overall Study|Exacerbation|0|||
127599062|NCT00372112|459159517|FG003|Overall Study|Exacerbation|1|||
127599063|NCT00372112|459159514|FG000|Overall Study|PR >240 at Visit 3|0|||
127599064|NCT00372112|459159515|FG001|Overall Study|PR >240 at Visit 3|0|||
127599065|NCT00372112|459159516|FG002|Overall Study|PR >240 at Visit 3|0|||
127599066|NCT00372112|459159517|FG003|Overall Study|PR >240 at Visit 3|1|||
127599067|NCT00372112|459159514|FG000|Overall Study|Hepatitis B|1|||
127599068|NCT00372112|459159515|FG001|Overall Study|Hepatitis B|0|||
127599069|NCT00372112|459159516|FG002|Overall Study|Hepatitis B|0|||
127599070|NCT00372112|459159517|FG003|Overall Study|Hepatitis B|0|||
127599071|NCT00372112|459159514|FG000|Overall Study|Other-protocol violation|0|||
127599072|NCT00372112|459159515|FG001|Overall Study|Other-protocol violation|0|||
127599073|NCT00372112|459159516|FG002|Overall Study|Other-protocol violation|1|||
127599074|NCT00372112|459159517|FG003|Overall Study|Other-protocol violation|0|||
127599075|NCT04649060|459159518|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
127599076|NCT04649060|459159519|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
127599077|NCT04649060|459159518|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
127599078|NCT04649060|459159519|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
127599079|NCT04649060|459159518|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
127599080|NCT04649060|459159519|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
127599081|NCT04649060|459159518|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
127599082|NCT04649060|459159519|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
127599083|NCT04649060|459159518|FG000|Arm A/Arm B Treatment|Patient Request|1|||
127599084|NCT04649060|459159519|FG001|Arm A/Arm B Treatment|Patient Request|0|||
127599085|NCT04649060|459159518|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
127599086|NCT04649060|459159519|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
127599087|NCT04649060|459159518|FG000|Arm A/Arm B Treatment|Other|1|||
127599088|NCT04649060|459159519|FG001|Arm A/Arm B Treatment|Other|0|||
127599089|NCT04649060|459159518|FG000|Crossover (Arm B)|Adverse Event|0|||
127599090|NCT04649060|459159519|FG001|Crossover (Arm B)|Adverse Event|1|||
127599091|NCT04649060|459159518|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
127599092|NCT04649060|459159519|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
127599093|NCT02205814|459159521|FG000|Overall Study|Lost to Follow-up|0|||
127599094|NCT02205814|459159522|FG001|Overall Study|Lost to Follow-up|0|||
127599095|NCT02205814|459159523|FG002|Overall Study|Lost to Follow-up|0|||
127599096|NCT02205814|459159524|FG003|Overall Study|Lost to Follow-up|1|||
127599097|NCT02205814|459159521|FG000|Overall Study|Lack of Efficacy|1|||
127599098|NCT02205814|459159522|FG001|Overall Study|Lack of Efficacy|0|||
127599099|NCT02205814|459159523|FG002|Overall Study|Lack of Efficacy|1|||
127599100|NCT02205814|459159524|FG003|Overall Study|Lack of Efficacy|1|||
127599101|NCT02205814|459159521|FG000|Overall Study|Physician Decision|0|||
127599102|NCT02205814|459159522|FG001|Overall Study|Physician Decision|0|||
127599103|NCT02205814|459159523|FG002|Overall Study|Physician Decision|1|||
127599104|NCT02205814|459159524|FG003|Overall Study|Physician Decision|0|||
127599105|NCT02205814|459159521|FG000|Overall Study|Protocol Violation|1|||
127599106|NCT02205814|459159522|FG001|Overall Study|Protocol Violation|0|||
127599107|NCT02205814|459159523|FG002|Overall Study|Protocol Violation|0|||
127695802|NCT05021640|459514718|FG000|Overall Study|Lost to Follow-up|0|||
127695803|NCT05021640|459514719|FG001|Overall Study|Lost to Follow-up|0|||
127695804|NCT05021640|459514720|FG002|Overall Study|Lost to Follow-up|0|||
127695805|NCT05021640|459514721|FG003|Overall Study|Lost to Follow-up|0|||
127695806|NCT05021640|459514722|FG004|Overall Study|Lost to Follow-up|1|||
127695807|NCT04737772|459514723|FG000|Phase 2 Study|Lost to Follow-up|15|||
127695808|NCT04737772|459514724|FG001|Phase 2 Study|Lost to Follow-up|15|||
127695809|NCT04737772|459514723|FG000|Phase 2 Study|Withdrawal by Subject|0|||
127599108|NCT02205814|459159524|FG003|Overall Study|Protocol Violation|1|||
127599109|NCT02205814|459159521|FG000|Overall Study|Withdrawal by Subject|0|||
127599110|NCT02205814|459159522|FG001|Overall Study|Withdrawal by Subject|1|||
127599111|NCT02205814|459159523|FG002|Overall Study|Withdrawal by Subject|2|||
127599112|NCT02205814|459159524|FG003|Overall Study|Withdrawal by Subject|1|||
127599113|NCT02205814|459159521|FG000|Overall Study|not compliant with study procedures|0|||
127599114|NCT02205814|459159522|FG001|Overall Study|not compliant with study procedures|0|||
127599115|NCT02205814|459159523|FG002|Overall Study|not compliant with study procedures|1|||
127599116|NCT02205814|459159524|FG003|Overall Study|not compliant with study procedures|0|||
127599117|NCT01426373|459159525|FG000|Overall Study|Adverse Event|6|||
127599118|NCT01426373|459159525|FG000|Overall Study|Lost to Follow-up|14|||
127599119|NCT01426373|459159525|FG000|Overall Study|Participant Convenience|10|||
127599120|NCT01426373|459159525|FG000|Overall Study|Miscellaneous Reasons|4|||
127599121|NCT04952402|459159526|FG000|Overall Study|Lost to Follow-up|1|||
127599122|NCT04952402|459159527|FG001|Overall Study|Lost to Follow-up|3|||
127599123|NCT04952402|459159526|FG000|Overall Study|Lack Of Venous Access|0|||
127599124|NCT04952402|459159527|FG001|Overall Study|Lack Of Venous Access|1|||
127599125|NCT00726661|459159528|FG000|Overall Study|Lost to Follow-up|36|||
127599126|NCT00726661|459159529|FG001|Overall Study|Lost to Follow-up|11|||
127599127|NCT00726661|459159528|FG000|Overall Study|Withdrawal by Subject|17|||
127599128|NCT00726661|459159529|FG001|Overall Study|Withdrawal by Subject|13|||
127599129|NCT00726661|459159528|FG000|Overall Study|Trial terminated by sponsor|214|||
127599130|NCT00726661|459159529|FG001|Overall Study|Trial terminated by sponsor|187|||
127599131|NCT00726661|459159528|FG000|Overall Study|Death|475|||
127599132|NCT00726661|459159529|FG001|Overall Study|Death|159|||
127599133|NCT00726661|459159528|FG000|Overall Study|Physician Decision|25|||
127599134|NCT00726661|459159529|FG001|Overall Study|Physician Decision|13|||
127599135|NCT00726661|459159528|FG000|Overall Study|Other|47|||
127599136|NCT00726661|459159529|FG001|Overall Study|Other|35|||
127599137|NCT01285310|459159530|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
127599138|NCT01285310|459159531|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
127599139|NCT01285310|459159532|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
127599140|NCT01285310|459159533|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
127599141|NCT01285310|459159534|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
127599142|NCT01285310|459159530|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
127599143|NCT01285310|459159531|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
127599144|NCT01285310|459159532|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
127599145|NCT01285310|459159533|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
127599146|NCT01285310|459159534|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
127599147|NCT01285310|459159530|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
127599148|NCT01285310|459159531|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
127599149|NCT01285310|459159532|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
127599150|NCT01285310|459159533|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
127599151|NCT01285310|459159534|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
127599152|NCT01285310|459159530|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
127599153|NCT01285310|459159531|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
127599154|NCT01285310|459159532|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
127599155|NCT01285310|459159533|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
127599156|NCT01285310|459159534|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
127599157|NCT01285310|459159530|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
127599158|NCT01285310|459159531|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
127599159|NCT01285310|459159532|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
127599160|NCT01285310|459159533|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
127599161|NCT01285310|459159534|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
127599162|NCT01285310|459159530|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
127599163|NCT01285310|459159531|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
127599164|NCT01285310|459159532|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
127599165|NCT01285310|459159533|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
127599166|NCT01285310|459159534|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
127599167|NCT01285310|459159530|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
127599168|NCT01285310|459159531|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
127599169|NCT01285310|459159532|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
127599170|NCT01285310|459159533|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
127599171|NCT01285310|459159534|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
127599172|NCT01285310|459159530|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
127599173|NCT01285310|459159531|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
127599174|NCT01285310|459159532|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
127599175|NCT01285310|459159533|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
127599176|NCT01285310|459159534|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
127599177|NCT01285310|459159530|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
127695810|NCT04737772|459514724|FG001|Phase 2 Study|Withdrawal by Subject|1|||
127599178|NCT01285310|459159531|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
127599179|NCT01285310|459159532|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
127599180|NCT01285310|459159533|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
127599181|NCT01285310|459159534|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
127599182|NCT01285310|459159530|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
127599183|NCT01285310|459159531|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
127599184|NCT01285310|459159532|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
127599185|NCT01285310|459159533|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
127599186|NCT01285310|459159534|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
127599187|NCT01285310|459159530|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
127599188|NCT01285310|459159531|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
127599189|NCT01285310|459159532|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
127599190|NCT01285310|459159533|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
127599191|NCT01285310|459159534|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
127599192|NCT01285310|459159530|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
127599193|NCT01285310|459159531|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
127599194|NCT01285310|459159532|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
127599195|NCT01285310|459159533|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
127599196|NCT01285310|459159534|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
127599197|NCT00005937|459159557|FG000|Overall Study|Lack of Efficacy|5|||
127599198|NCT01574612|459159558|FG000|Overall Study|Adverse Event|3|||
127599199|NCT01574612|459159558|FG000|Overall Study|non compliant with drug|2|||
127599200|NCT01574612|459159558|FG000|Overall Study|Withdrawal by Subject|1|||
127599201|NCT01574612|459159558|FG000|Overall Study|Lost to Follow-up|2|||
127599202|NCT01957644|459159561|FG000|Overall Study|Adverse Event|4|||
127599203|NCT01957644|459159562|FG001|Overall Study|Adverse Event|2|||
127599204|NCT01957644|459159563|FG002|Overall Study|Adverse Event|0|||
127599205|NCT01957644|459159564|FG003|Overall Study|Adverse Event|0|||
127599206|NCT01957644|459159565|FG004|Overall Study|Adverse Event|1|||
127599207|NCT01957644|459159561|FG000|Overall Study|Progressive disease / relapse|0|||
127599208|NCT01957644|459159562|FG001|Overall Study|Progressive disease / relapse|1|||
127599209|NCT01957644|459159563|FG002|Overall Study|Progressive disease / relapse|0|||
127599210|NCT01957644|459159564|FG003|Overall Study|Progressive disease / relapse|1|||
127599211|NCT01957644|459159565|FG004|Overall Study|Progressive disease / relapse|0|||
127599212|NCT01957644|459159561|FG000|Overall Study|Other reason|1|||
127599213|NCT01957644|459159562|FG001|Overall Study|Other reason|2|||
127599214|NCT01957644|459159563|FG002|Overall Study|Other reason|1|||
127599215|NCT01957644|459159564|FG003|Overall Study|Other reason|1|||
127599216|NCT01957644|459159565|FG004|Overall Study|Other reason|0|||
127599217|NCT01957644|459159561|FG000|Overall Study|Withdrawal by Subject|1|||
127599218|NCT01957644|459159562|FG001|Overall Study|Withdrawal by Subject|0|||
127599219|NCT01957644|459159563|FG002|Overall Study|Withdrawal by Subject|0|||
127599220|NCT01957644|459159564|FG003|Overall Study|Withdrawal by Subject|0|||
127599221|NCT01957644|459159565|FG004|Overall Study|Withdrawal by Subject|0|||
127599222|NCT01957644|459159561|FG000|Overall Study|Protocol Violation|0|||
127599223|NCT01957644|459159562|FG001|Overall Study|Protocol Violation|1|||
127599224|NCT01957644|459159563|FG002|Overall Study|Protocol Violation|0|||
127599225|NCT01957644|459159564|FG003|Overall Study|Protocol Violation|0|||
127599226|NCT01957644|459159565|FG004|Overall Study|Protocol Violation|0|||
127599227|NCT00927784|459159569|FG000|Overall Study|Death|1|||
127599228|NCT00927784|459159570|FG001|Overall Study|Death|0|||
127599229|NCT00927784|459159569|FG000|Overall Study|Withdrawal by Subject|1|||
127599230|NCT00927784|459159570|FG001|Overall Study|Withdrawal by Subject|0|||
127599231|NCT02170051|459159571|FG000|Overall Study|Withdrawal by Subject|10|||
127599232|NCT02170051|459159572|FG001|Overall Study|Withdrawal by Subject|10|||
127599233|NCT02170051|459159571|FG000|Overall Study|Lost to Follow-up|1|||
127599234|NCT02170051|459159572|FG001|Overall Study|Lost to Follow-up|3|||
127599235|NCT01867021|459159573|FG000|Overall Study|Adverse Event|0|||
127599236|NCT01867021|459159574|FG001|Overall Study|Adverse Event|1|||
127599237|NCT01867021|459159573|FG000|Overall Study|Not Eligible|0|||
127599238|NCT01867021|459159574|FG001|Overall Study|Not Eligible|1|||
127599239|NCT01867021|459159573|FG000|Overall Study|Death|1|||
127599240|NCT01867021|459159574|FG001|Overall Study|Death|0|||
127599241|NCT01867021|459159573|FG000|Overall Study|Lost to Follow-up|0|||
127599242|NCT01867021|459159574|FG001|Overall Study|Lost to Follow-up|2|||
127599243|NCT01867021|459159573|FG000|Overall Study|Withdrawal by Subject|1|||
127599244|NCT01867021|459159574|FG001|Overall Study|Withdrawal by Subject|6|||
127599245|NCT00881712|459159575|FG000|Overall Study|Death|1|||
127599246|NCT00881712|459159576|FG001|Overall Study|Death|0|||
127599247|NCT00881712|459159577|FG002|Overall Study|Death|0|||
127599248|NCT00881712|459159575|FG000|Overall Study|Withdrawal by Subject|1|||
127599249|NCT00881712|459159576|FG001|Overall Study|Withdrawal by Subject|0|||
127599250|NCT00881712|459159577|FG002|Overall Study|Withdrawal by Subject|0|||
127599251|NCT03060629|459159580|FG000|Overall Study|Death|4|||
127599252|NCT03060629|459159581|FG001|Overall Study|Death|5|||
127695811|NCT04737772|459514723|FG000|Phase 2 Study|Did not take any coaching calls|4|||
127695812|NCT04737772|459514724|FG001|Phase 2 Study|Did not take any coaching calls|0|||
127695813|NCT04737772|459514723|FG000|Pilot Phase 1 of Study|Withdrawal by Subject|0|||
127695814|NCT04737772|459514724|FG001|Pilot Phase 1 of Study|Withdrawal by Subject|1|||
127695815|NCT04737772|459514723|FG000|Pilot Phase 1 of Study|Randomized but ineligible|0|||
127695816|NCT04737772|459514724|FG001|Pilot Phase 1 of Study|Randomized but ineligible|1|||
127695817|NCT05691309|459514726|FG000|Overall Study|vancomycin discontinued by clinical team|2|||
127695818|NCT05691309|459514726|FG000|Overall Study|vancomycin levels not evaluable|2|||
127695819|NCT01804816|459514727|FG000|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3|||
127695820|NCT01804816|459514727|FG000|Acupuncture (Second 5 Weeks)|Physician Decision|1|||
127695821|NCT04421378|459514733|FG000|Overall Study|Adverse Event|2|||
127695822|NCT04421378|459514734|FG001|Overall Study|Adverse Event|7|||
127695823|NCT04421378|459514735|FG002|Overall Study|Adverse Event|0|||
127695824|NCT04421378|459514736|FG003|Overall Study|Adverse Event|1|||
127695825|NCT04421378|459514737|FG004|Overall Study|Adverse Event|0|||
127695826|NCT04421378|459514733|FG000|Overall Study|Physician Decision|1|||
127695827|NCT04421378|459514734|FG001|Overall Study|Physician Decision|2|||
127695828|NCT04421378|459514735|FG002|Overall Study|Physician Decision|0|||
127695829|NCT04421378|459514736|FG003|Overall Study|Physician Decision|0|||
127695830|NCT04421378|459514737|FG004|Overall Study|Physician Decision|0|||
127695831|NCT04421378|459514733|FG000|Overall Study|Progressive Disease|16|||
127695832|NCT04421378|459514734|FG001|Overall Study|Progressive Disease|4|||
127695833|NCT04421378|459514735|FG002|Overall Study|Progressive Disease|18|||
127695834|NCT04421378|459514736|FG003|Overall Study|Progressive Disease|11|||
127695835|NCT04421378|459514737|FG004|Overall Study|Progressive Disease|3|||
127695836|NCT04421378|459514733|FG000|Overall Study|Study Terminated by Sponsor|0|||
127695837|NCT04421378|459514734|FG001|Overall Study|Study Terminated by Sponsor|1|||
127695838|NCT04421378|459514735|FG002|Overall Study|Study Terminated by Sponsor|1|||
127695839|NCT04421378|459514736|FG003|Overall Study|Study Terminated by Sponsor|0|||
127695840|NCT04421378|459514737|FG004|Overall Study|Study Terminated by Sponsor|0|||
127695841|NCT04421378|459514733|FG000|Overall Study|Withdrawal by Subject|3|||
127695842|NCT04421378|459514734|FG001|Overall Study|Withdrawal by Subject|1|||
127695843|NCT04421378|459514735|FG002|Overall Study|Withdrawal by Subject|0|||
127695844|NCT04421378|459514736|FG003|Overall Study|Withdrawal by Subject|2|||
127695845|NCT04421378|459514737|FG004|Overall Study|Withdrawal by Subject|0|||
127695846|NCT04421378|459514733|FG000|Overall Study|Other|1|||
127695847|NCT04421378|459514734|FG001|Overall Study|Other|0|||
127695848|NCT04421378|459514735|FG002|Overall Study|Other|0|||
127695849|NCT04421378|459514736|FG003|Overall Study|Other|0|||
127695850|NCT04421378|459514737|FG004|Overall Study|Other|0|||
127695851|NCT04263311|459514738|FG000|Overall Study|Lost to Follow-up|1|||
127695852|NCT04263311|459514739|FG001|Overall Study|Lost to Follow-up|2|||
127695853|NCT04263311|459514740|FG002|Overall Study|Lost to Follow-up|0|||
127695854|NCT04263311|459514738|FG000|Overall Study|Health Issues|1|||
127695855|NCT04263311|459514739|FG001|Overall Study|Health Issues|0|||
127695856|NCT04263311|459514740|FG002|Overall Study|Health Issues|0|||
127695857|NCT04263311|459514738|FG000|Overall Study|Left the country|1|||
127695858|NCT04263311|459514739|FG001|Overall Study|Left the country|0|||
127695859|NCT04263311|459514740|FG002|Overall Study|Left the country|0|||
127695860|NCT04263311|459514738|FG000|Overall Study|Unable to maintain time commitment|1|||
127695861|NCT04263311|459514739|FG001|Overall Study|Unable to maintain time commitment|0|||
127695862|NCT04263311|459514740|FG002|Overall Study|Unable to maintain time commitment|0|||
127695863|NCT04263311|459514738|FG000|Overall Study|No longer interested|1|||
127695864|NCT04263311|459514739|FG001|Overall Study|No longer interested|0|||
127695865|NCT04263311|459514740|FG002|Overall Study|No longer interested|0|||
127695866|NCT04263311|459514738|FG000|Overall Study|Ineligible post consent|0|||
127695867|NCT04263311|459514739|FG001|Overall Study|Ineligible post consent|0|||
127695868|NCT04263311|459514740|FG002|Overall Study|Ineligible post consent|5|||
128036279|NCT00261833|460762152|FG001|Overall Study|Not interested in being participant|1|||
128036280|NCT00622726|460762153|FG000|March, 2008 to August, 2010|Death|5|||
128036281|NCT00622726|460762154|FG001|March, 2008 to August, 2010|Death|2|||
128036282|NCT00622726|460762153|FG000|August, 2010 to April, 2013|Death|1|||
127695869|NCT02592330|459514741|FG000|Overall Study|Withdrawal by Subject|1|||
127695870|NCT02592330|459514742|FG001|Overall Study|Withdrawal by Subject|0|||
127695871|NCT02592330|459514741|FG000|Overall Study|Failed Biopsy|1|||
127787531|NCT01553188|459846171|FG002|Overall Study|Intercurrent illness and adverse event|2|||
127787532|NCT01553188|459846172|FG003|Overall Study|Intercurrent illness and adverse event|0|||
127787533|NCT04744207|459846176|FG000|Treatment|Withdrawal by Subject|2|||
127787534|NCT04744207|459846177|FG001|Treatment|Withdrawal by Subject|0|||
127695872|NCT02592330|459514742|FG001|Overall Study|Failed Biopsy|0|||
127695873|NCT03090152|459514743|FG000|Overall Study|Withdrawal by Subject|0|||
127695874|NCT03090152|459514744|FG001|Overall Study|Withdrawal by Subject|2|||
127695875|NCT03090152|459514745|FG002|Overall Study|Withdrawal by Subject|1|||
127695876|NCT03090152|459514743|FG000|Overall Study|Surgery Canceled|1|||
127695877|NCT03090152|459514744|FG001|Overall Study|Surgery Canceled|0|||
127695878|NCT03090152|459514745|FG002|Overall Study|Surgery Canceled|0|||
128036283|NCT00622726|460762154|FG001|August, 2010 to April, 2013|Death|5|||
127787535|NCT04744207|459846176|FG000|Treatment|Adverse Event|1|||
127787536|NCT04744207|459846177|FG001|Treatment|Adverse Event|2|||
127787537|NCT04066491|459846178|FG000|Overall Study|Randomized, not treated|0|||
127787538|NCT04066491|459846179|FG001|Overall Study|Randomized, not treated|0|||
127787539|NCT04066491|459846180|FG002|Overall Study|Randomized, not treated|2|||
127787540|NCT04506086|459846181|FG000|Overall Study|Withdrawal by Subject|2|||
127787541|NCT00495820|459846184|FG000|Overall Study|Adverse Event|1|||
127599253|NCT03060629|459159580|FG000|Overall Study|Withdrawal by Subject|50|||
127599254|NCT03060629|459159581|FG001|Overall Study|Withdrawal by Subject|35|||
127599255|NCT03060629|459159580|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
127599256|NCT03060629|459159581|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
127599257|NCT03060629|459159580|FG000|Overall Study|Participant Relocate|15|||
127599258|NCT03060629|459159581|FG001|Overall Study|Participant Relocate|15|||
127599259|NCT03060629|459159580|FG000|Overall Study|Unable to Contact Participant|34|||
127599260|NCT03060629|459159581|FG001|Overall Study|Unable to Contact Participant|23|||
127599261|NCT03060629|459159580|FG000|Overall Study|Investigator Decision|7|||
127599262|NCT03060629|459159581|FG001|Overall Study|Investigator Decision|7|||
127599263|NCT03060629|459159580|FG000|Overall Study|Study Terminated by Sponsor|1100|||
127599264|NCT03060629|459159581|FG001|Overall Study|Study Terminated by Sponsor|1123|||
127599265|NCT03060629|459159580|FG000|Overall Study|Other|4|||
127599266|NCT03060629|459159581|FG001|Overall Study|Other|4|||
127599267|NCT02505867|459159582|FG000|Overall Study|Lack of Efficacy|6|||
127599268|NCT02505867|459159583|FG001|Overall Study|Lack of Efficacy|6|||
127599269|NCT01862874|459159584|FG000|Overall Study|Randomized not treated|1|||
127599270|NCT01862874|459159585|FG001|Overall Study|Randomized not treated|0|||
127599271|NCT01862874|459159584|FG000|Overall Study|Adverse Event|0|||
127599272|NCT01862874|459159585|FG001|Overall Study|Adverse Event|3|||
127599273|NCT01862874|459159584|FG000|Overall Study|Lost to Follow-up|26|||
127599274|NCT01862874|459159585|FG001|Overall Study|Lost to Follow-up|29|||
127599275|NCT01862874|459159584|FG000|Overall Study|Physician Decision|5|||
127599276|NCT01862874|459159585|FG001|Overall Study|Physician Decision|3|||
127599277|NCT01862874|459159584|FG000|Overall Study|Withdrawn by parent/guardian|1|||
127599278|NCT01862874|459159585|FG001|Overall Study|Withdrawn by parent/guardian|1|||
127599279|NCT01862874|459159584|FG000|Overall Study|Withdrawal by Subject|46|||
127599280|NCT01862874|459159585|FG001|Overall Study|Withdrawal by Subject|40|||
127599281|NCT01862874|459159584|FG000|Overall Study|Death|0|||
127599282|NCT01862874|459159585|FG001|Overall Study|Death|1|||
127599283|NCT01244425|459159586|FG000|Overall Study|Withdrawal by Subject|2|||
127599284|NCT01244425|459159587|FG001|Overall Study|Withdrawal by Subject|2|||
127599285|NCT01244425|459159586|FG000|Overall Study|Adverse Event|1|||
127599286|NCT01244425|459159587|FG001|Overall Study|Adverse Event|1|||
127599287|NCT02744391|459159588|FG000|Overall Study|Lost to Follow-up|9|||
127599288|NCT02744391|459159588|FG000|Overall Study|Physician Decision|2|||
127599289|NCT02744391|459159588|FG000|Overall Study|Withdrawal by Subject|3|||
127599290|NCT01996709|459159589|FG000|Overall Study|Withdrawal by Subject|1|||
127599291|NCT01996709|459159590|FG001|Overall Study|Withdrawal by Subject|0|||
127599292|NCT01996709|459159589|FG000|Overall Study|Lost to Follow-up|3|||
127599293|NCT01996709|459159590|FG001|Overall Study|Lost to Follow-up|0|||
127599294|NCT01996709|459159589|FG000|Overall Study|Subject Non-Compliant|1|||
127599295|NCT01996709|459159590|FG001|Overall Study|Subject Non-Compliant|0|||
127599296|NCT01996709|459159589|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
127599297|NCT01996709|459159590|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
127599298|NCT02480114|459159595|FG000|Overall Study|Not completing surveys|3|||
127599299|NCT02480114|459159596|FG001|Overall Study|Not completing surveys|2|||
127599300|NCT02480114|459159595|FG000|Overall Study|Withdrawal by Subject|2|||
127599301|NCT02480114|459159596|FG001|Overall Study|Withdrawal by Subject|4|||
127599302|NCT02480114|459159595|FG000|Overall Study|Disease progression|3|||
127599303|NCT02480114|459159596|FG001|Overall Study|Disease progression|0|||
127599304|NCT02480114|459159595|FG000|Overall Study|Improper completion of survey|1|||
127599305|NCT02480114|459159596|FG001|Overall Study|Improper completion of survey|1|||
127599306|NCT02480114|459159595|FG000|Overall Study|Not eligible|0|||
127599307|NCT02480114|459159596|FG001|Overall Study|Not eligible|1|||
127599308|NCT01535053|459159597|FG000|Overall Study|Ineligible|1|||
127599309|NCT01535053|459159598|FG001|Overall Study|Ineligible|2|||
127599310|NCT00512707|459159599|FG000|Overall Study|Lost to Follow-up|5|||
127599311|NCT00512707|459159600|FG001|Overall Study|Lost to Follow-up|11|||
127599312|NCT00512707|459159599|FG000|Overall Study|Developed skin irritation|2|||
127599313|NCT00512707|459159600|FG001|Overall Study|Developed skin irritation|1|||
127599314|NCT00512707|459159599|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
127599315|NCT00512707|459159600|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
127599316|NCT00512707|459159599|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
127599317|NCT00512707|459159600|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
127599318|NCT01134783|459161288|FG000|Overall Study|Pregnancy|16|||
127599319|NCT01134783|459161289|FG001|Overall Study|Pregnancy|8|||
127599320|NCT01134783|459161288|FG000|Overall Study|Withdrawal by Subject|15|||
127787542|NCT00495820|459846185|FG001|Overall Study|Adverse Event|1|||
127787543|NCT00820950|459846186|FG000|Overall Study|Scheduling Conflict|0|||
127695879|NCT03090152|459514743|FG000|Overall Study|Epidural catheter could not be placed|0|||
127695880|NCT03090152|459514744|FG001|Overall Study|Epidural catheter could not be placed|2|||
127695881|NCT03090152|459514745|FG002|Overall Study|Epidural catheter could not be placed|0|||
127695882|NCT04673929|459514746|FG000|Overall Study|Death|73|||
127695883|NCT04673929|459514746|FG000|Overall Study|Did not reach the 2 year follow up point (observational study)|43|||
127695884|NCT04024813|459514747|FG000|Overall Study|Study terminated by Sponsor|1|||
127695885|NCT05034952|459514748|FG000|Overall Study|Adverse Event|1|||
127695886|NCT05034952|459514749|FG001|Overall Study|Adverse Event|0|||
127695887|NCT05034952|459514750|FG002|Overall Study|Adverse Event|0|||
127695888|NCT05034952|459514751|FG003|Overall Study|Adverse Event|0|||
127695889|NCT05034952|459514748|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
127695890|NCT05034952|459514749|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
127695891|NCT05034952|459514750|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
127695892|NCT05034952|459514751|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
127599321|NCT01134783|459161289|FG001|Overall Study|Withdrawal by Subject|9|||
127599322|NCT01134783|459161288|FG000|Overall Study|Lost to Follow-up|5|||
127599323|NCT01134783|459161289|FG001|Overall Study|Lost to Follow-up|20|||
127599324|NCT04221009|459161290|FG000|Overall Study|Withdrawal by Subject|4|||
127599325|NCT04232124|459161291|FG000|Overall Study|Lost to Follow-up|3|||
127599326|NCT01404325|459161292|FG000|Overall Study|Lost to Follow-up|1|||
127599327|NCT01404325|459161293|FG001|Overall Study|Lost to Follow-up|0|||
127599328|NCT01404325|459161292|FG000|Overall Study|Death|2|||
127599329|NCT01404325|459161293|FG001|Overall Study|Death|0|||
127599330|NCT01404325|459161292|FG000|Overall Study|Graft loss/Retransplantation|1|||
127599331|NCT01404325|459161293|FG001|Overall Study|Graft loss/Retransplantation|0|||
127599332|NCT01404325|459161292|FG000|Overall Study|non-specified reason|0|||
127599333|NCT01404325|459161293|FG001|Overall Study|non-specified reason|2|||
127599334|NCT01499667|459161294|FG000|Overall Study|administrative problems|4|||
127599335|NCT01499667|459161295|FG001|Overall Study|administrative problems|5|||
127599336|NCT01499667|459161296|FG002|Overall Study|administrative problems|5|||
127599337|NCT01499667|459161294|FG000|Overall Study|Protocol Violation|1|||
127599338|NCT01499667|459161295|FG001|Overall Study|Protocol Violation|3|||
127599339|NCT01499667|459161296|FG002|Overall Study|Protocol Violation|2|||
127599340|NCT01499667|459161294|FG000|Overall Study|Adverse Event|0|||
127599341|NCT01499667|459161295|FG001|Overall Study|Adverse Event|2|||
127599342|NCT01499667|459161296|FG002|Overall Study|Adverse Event|2|||
127599343|NCT01499667|459161294|FG000|Overall Study|Withdrawal by Subject|2|||
127599344|NCT01499667|459161295|FG001|Overall Study|Withdrawal by Subject|1|||
127599345|NCT01499667|459161296|FG002|Overall Study|Withdrawal by Subject|1|||
127599346|NCT01499667|459161294|FG000|Overall Study|Lack of Efficacy|2|||
127599347|NCT01499667|459161295|FG001|Overall Study|Lack of Efficacy|0|||
127599348|NCT01499667|459161296|FG002|Overall Study|Lack of Efficacy|0|||
127599349|NCT01034462|459161300|FG000|Overall Study|Adverse Event|7|||
127599350|NCT01034462|459161301|FG001|Overall Study|Adverse Event|17|||
127599351|NCT01034462|459161300|FG000|Overall Study|Lack of Efficacy|4|||
127599352|NCT01034462|459161301|FG001|Overall Study|Lack of Efficacy|4|||
127599353|NCT01034462|459161300|FG000|Overall Study|Protocol Violation|10|||
127599354|NCT01034462|459161301|FG001|Overall Study|Protocol Violation|7|||
127599355|NCT01034462|459161300|FG000|Overall Study|Withdrawal by Subject|9|||
127599356|NCT01034462|459161301|FG001|Overall Study|Withdrawal by Subject|8|||
127695893|NCT05034952|459514748|FG000|Overall Study|Lost to Follow-up|1|||
127695894|NCT05034952|459514749|FG001|Overall Study|Lost to Follow-up|4|||
127695895|NCT05034952|459514750|FG002|Overall Study|Lost to Follow-up|3|||
127695896|NCT05034952|459514751|FG003|Overall Study|Lost to Follow-up|3|||
127787544|NCT00820950|459846187|FG001|Overall Study|Scheduling Conflict|0|||
127787545|NCT00820950|459846188|FG002|Overall Study|Scheduling Conflict|0|||
127787546|NCT00820950|459846189|FG003|Overall Study|Scheduling Conflict|0|||
127787547|NCT00820950|459846190|FG004|Overall Study|Scheduling Conflict|0|||
127599357|NCT01034462|459161300|FG000|Overall Study|Lost to Follow-up|14|||
127599358|NCT01034462|459161301|FG001|Overall Study|Lost to Follow-up|16|||
127599359|NCT01034462|459161300|FG000|Overall Study|Other reasons|1|||
127599360|NCT01034462|459161301|FG001|Overall Study|Other reasons|2|||
127599361|NCT01594125|459161302|FG000|Overall Study|Withdrawal by Subject|1|||
127599362|NCT01594125|459161303|FG001|Overall Study|Withdrawal by Subject|0|||
127599363|NCT01594125|459161304|FG002|Overall Study|Withdrawal by Subject|0|||
127599364|NCT01594125|459161305|FG003|Overall Study|Withdrawal by Subject|1|||
127599365|NCT01594125|459161306|FG004|Overall Study|Withdrawal by Subject|0|||
127599366|NCT01594125|459161302|FG000|Overall Study|Progressive Disease|3|||
127599367|NCT01594125|459161303|FG001|Overall Study|Progressive Disease|12|||
127599368|NCT01594125|459161304|FG002|Overall Study|Progressive Disease|3|||
127599369|NCT01594125|459161305|FG003|Overall Study|Progressive Disease|3|||
127599370|NCT01594125|459161306|FG004|Overall Study|Progressive Disease|7|||
127599371|NCT01484873|459161307|FG000|Overall Study|Withdrawal by Subject|2|||
127599372|NCT02618434|459161309|FG000|Overall Study|Withdrawal by Subject|0|||
127599373|NCT02618434|459161310|FG001|Overall Study|Withdrawal by Subject|2|||
127695897|NCT05034952|459514748|FG000|Overall Study|Other|0|||
127695898|NCT05034952|459514749|FG001|Overall Study|Other|0|||
127695899|NCT05034952|459514750|FG002|Overall Study|Other|0|||
127695900|NCT05034952|459514751|FG003|Overall Study|Other|1|||
127695901|NCT04950660|459514752|FG000|Overall Study|Protocol Violation|4|||
127695902|NCT04950660|459514753|FG001|Overall Study|Protocol Violation|2|||
127695903|NCT04950660|459514752|FG000|Overall Study|Poor pain control, switch to Oxycodone|1|||
127695904|NCT04950660|459514753|FG001|Overall Study|Poor pain control, switch to Oxycodone|1|||
127695905|NCT04950660|459514752|FG000|Overall Study|Withdrawal by Subject|0|||
127695906|NCT04950660|459514753|FG001|Overall Study|Withdrawal by Subject|1|||
127695907|NCT04950660|459514752|FG000|Overall Study|Hypotension|1|||
127695908|NCT04950660|459514753|FG001|Overall Study|Hypotension|0|||
127695909|NCT02437318|459514758|FG000|Overall Study|Progressive disease|207|||
127695910|NCT02437318|459514759|FG001|Overall Study|Progressive disease|240|||
127695911|NCT02437318|459514758|FG000|Overall Study|Subject/guardian decision|24|||
127695912|NCT02437318|459514759|FG001|Overall Study|Subject/guardian decision|11|||
127695913|NCT02437318|459514758|FG000|Overall Study|Physician Decision|29|||
127695914|NCT02437318|459514759|FG001|Overall Study|Physician Decision|22|||
127695915|NCT02437318|459514758|FG000|Overall Study|Adverse Event|14|||
127695916|NCT02437318|459514759|FG001|Overall Study|Adverse Event|4|||
127695917|NCT02437318|459514758|FG000|Overall Study|Death|4|||
127695918|NCT02437318|459514759|FG001|Overall Study|Death|4|||
127695919|NCT02437318|459514758|FG000|Overall Study|Protocol deviation|5|||
127695920|NCT02437318|459514759|FG001|Overall Study|Protocol deviation|7|||
127695921|NCT02437318|459514758|FG000|Overall Study|Sponsor decision|1|||
127599374|NCT02618434|459161311|FG002|Overall Study|Withdrawal by Subject|3|||
127599375|NCT02618434|459161309|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
127599376|NCT02618434|459161310|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
127599377|NCT02618434|459161311|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
127599378|NCT02618434|459161309|FG000|Overall Study|Lost to Follow-up|3|||
127599379|NCT02618434|459161310|FG001|Overall Study|Lost to Follow-up|1|||
127599380|NCT02618434|459161311|FG002|Overall Study|Lost to Follow-up|3|||
127599381|NCT02618434|459161309|FG000|Overall Study|Adverse Event|1|||
127599382|NCT02618434|459161310|FG001|Overall Study|Adverse Event|0|||
127599383|NCT02618434|459161311|FG002|Overall Study|Adverse Event|12|||
127599384|NCT02618434|459161309|FG000|Overall Study|Physician Decision|0|||
127599385|NCT02618434|459161310|FG001|Overall Study|Physician Decision|1|||
127599386|NCT02618434|459161311|FG002|Overall Study|Physician Decision|0|||
127599387|NCT02618434|459161309|FG000|Overall Study|Protocol Violation|0|||
127599388|NCT02618434|459161310|FG001|Overall Study|Protocol Violation|0|||
127599389|NCT02618434|459161311|FG002|Overall Study|Protocol Violation|1|||
127599390|NCT02618434|459161309|FG000|Overall Study|Other, Multiple categories|1|||
127599391|NCT02618434|459161310|FG001|Overall Study|Other, Multiple categories|1|||
127599392|NCT02618434|459161311|FG002|Overall Study|Other, Multiple categories|1|||
127599393|NCT01988103|459161312|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
127599394|NCT01988103|459161313|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
127599395|NCT01988103|459161314|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
127599396|NCT01988103|459161315|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
127599397|NCT01988103|459161316|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
127599398|NCT01988103|459161312|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
127599399|NCT01988103|459161313|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
127599400|NCT01988103|459161314|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
127599401|NCT01988103|459161315|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
127599402|NCT01988103|459161316|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
127599403|NCT01988103|459161312|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
127599404|NCT01988103|459161313|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
127599405|NCT01988103|459161314|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
127599406|NCT01988103|459161315|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
127599407|NCT01988103|459161316|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
127599408|NCT01988103|459161312|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
127599409|NCT01988103|459161313|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
127787548|NCT00820950|459846191|FG005|Overall Study|Scheduling Conflict|0|||
127787549|NCT00820950|459846192|FG006|Overall Study|Scheduling Conflict|1|||
127787550|NCT00820950|459846193|FG007|Overall Study|Scheduling Conflict|1|||
127787551|NCT00820950|459846194|FG008|Overall Study|Scheduling Conflict|0|||
127787552|NCT00820950|459846195|FG009|Overall Study|Scheduling Conflict|0|||
127787553|NCT00820950|459846186|FG000|Overall Study|Protocol Violation|1|||
127787554|NCT00820950|459846187|FG001|Overall Study|Protocol Violation|1|||
127599410|NCT01988103|459161314|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
127599411|NCT01988103|459161315|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
127599412|NCT01988103|459161316|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
127695922|NCT02437318|459514759|FG001|Overall Study|Sponsor decision|0|||
127695923|NCT00920621|459514760|FG000|Overall Study|Lost to Follow-up|16|||
127695924|NCT00920621|459514761|FG001|Overall Study|Lost to Follow-up|17|||
127787555|NCT00820950|459846188|FG002|Overall Study|Protocol Violation|0|||
127695925|NCT00920621|459514762|FG002|Overall Study|Lost to Follow-up|19|||
127695926|NCT00920621|459514763|FG003|Overall Study|Lost to Follow-up|21|||
127787556|NCT00820950|459846189|FG003|Overall Study|Protocol Violation|0|||
127599413|NCT01988103|459161312|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
127599414|NCT01988103|459161313|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
127599415|NCT01988103|459161314|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
127599416|NCT01988103|459161315|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
127599417|NCT01988103|459161316|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
127599418|NCT01988103|459161312|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
127599419|NCT01988103|459161313|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
127599420|NCT01988103|459161314|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
127599421|NCT01988103|459161315|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
127599422|NCT01988103|459161316|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
127599423|NCT01988103|459161312|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
127599424|NCT01988103|459161313|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
127599425|NCT01988103|459161314|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
127599426|NCT01988103|459161315|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
127599427|NCT01988103|459161316|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
127599428|NCT03590041|459161317|FG000|Overall Study|Protocol Violation|4|||
127599429|NCT03590041|459161318|FG001|Overall Study|Protocol Violation|3|||
127599430|NCT03590041|459161317|FG000|Overall Study|No session data recorded|14|||
127599431|NCT03590041|459161318|FG001|Overall Study|No session data recorded|2|||
127599432|NCT01828281|459161319|FG000|Overall Study|Withdrawal by Subject|1|||
127599433|NCT01828281|459161320|FG001|Overall Study|Withdrawal by Subject|0|||
127599434|NCT00142584|459161321|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
127599435|NCT00142584|459161322|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
127599436|NCT00142584|459161321|FG000|Overall Study|Withdrawal by Subject|30|||
127599437|NCT00142584|459161322|FG001|Overall Study|Withdrawal by Subject|16|||
127599438|NCT00142584|459161321|FG000|Overall Study|Lost to Follow-up|22|||
127599439|NCT00142584|459161322|FG001|Overall Study|Lost to Follow-up|12|||
127599440|NCT00142584|459161321|FG000|Overall Study|Adverse Event|14|||
127599441|NCT00142584|459161322|FG001|Overall Study|Adverse Event|5|||
127599442|NCT00142584|459161321|FG000|Overall Study|Protocol Violation|4|||
127599443|NCT00142584|459161322|FG001|Overall Study|Protocol Violation|7|||
127599444|NCT00142584|459161321|FG000|Overall Study|Treatment Failure|2|||
127599445|NCT00142584|459161322|FG001|Overall Study|Treatment Failure|0|||
127599446|NCT03070782|459161324|FG000|Overall Study|Adverse Event|3|||
127599447|NCT03070782|459161325|FG001|Overall Study|Adverse Event|0|||
127599448|NCT03070782|459161326|FG002|Overall Study|Adverse Event|3|||
127599449|NCT03070782|459161327|FG003|Overall Study|Adverse Event|1|||
127599450|NCT03070782|459161328|FG004|Overall Study|Adverse Event|6|||
127599451|NCT03070782|459161329|FG005|Overall Study|Adverse Event|2|||
127599452|NCT03070782|459161324|FG000|Overall Study|Withdrawal by Subject|2|||
127599453|NCT03070782|459161325|FG001|Overall Study|Withdrawal by Subject|1|||
127599454|NCT03070782|459161326|FG002|Overall Study|Withdrawal by Subject|1|||
127599455|NCT03070782|459161327|FG003|Overall Study|Withdrawal by Subject|0|||
127599456|NCT03070782|459161328|FG004|Overall Study|Withdrawal by Subject|4|||
127599457|NCT03070782|459161329|FG005|Overall Study|Withdrawal by Subject|3|||
127599458|NCT03070782|459161324|FG000|Overall Study|Reason Not Specified|2|||
127599459|NCT03070782|459161325|FG001|Overall Study|Reason Not Specified|0|||
127599460|NCT03070782|459161326|FG002|Overall Study|Reason Not Specified|0|||
127599461|NCT03070782|459161327|FG003|Overall Study|Reason Not Specified|1|||
127599462|NCT03070782|459161328|FG004|Overall Study|Reason Not Specified|2|||
127599463|NCT03070782|459161329|FG005|Overall Study|Reason Not Specified|1|||
127599464|NCT03070782|459161324|FG000|Overall Study|Ineligibility|0|||
127787557|NCT00820950|459846190|FG004|Overall Study|Protocol Violation|0|||
127787558|NCT00820950|459846191|FG005|Overall Study|Protocol Violation|0|||
127787559|NCT00820950|459846192|FG006|Overall Study|Protocol Violation|0|||
127787560|NCT00820950|459846193|FG007|Overall Study|Protocol Violation|0|||
127787561|NCT00820950|459846194|FG008|Overall Study|Protocol Violation|0|||
127787562|NCT00820950|459846195|FG009|Overall Study|Protocol Violation|0|||
127787563|NCT02186847|459846198|FG000|Overall Study|Protocol Violation|3|||
128036284|NCT01948427|460762155|FG000|Overall Study|Serious Adverse Event|3|||
128036285|NCT01948427|460762156|FG001|Overall Study|Serious Adverse Event|0|||
128036286|NCT01948427|460762157|FG002|Overall Study|Serious Adverse Event|0|||
127599465|NCT03070782|459161325|FG001|Overall Study|Ineligibility|0|||
127599466|NCT03070782|459161326|FG002|Overall Study|Ineligibility|0|||
127787564|NCT02186847|459846199|FG001|Overall Study|Protocol Violation|0|||
127599467|NCT03070782|459161327|FG003|Overall Study|Ineligibility|1|||
127599468|NCT03070782|459161328|FG004|Overall Study|Ineligibility|0|||
127599469|NCT03070782|459161329|FG005|Overall Study|Ineligibility|1|||
127599470|NCT03070782|459161324|FG000|Overall Study|Pregnancy|0|||
127599471|NCT03070782|459161325|FG001|Overall Study|Pregnancy|0|||
127599472|NCT03070782|459161326|FG002|Overall Study|Pregnancy|0|||
127599473|NCT03070782|459161327|FG003|Overall Study|Pregnancy|1|||
127787565|NCT03416153|459846200|FG000|Overall Study|Physician Decision|1|||
127787566|NCT03416153|459846201|FG001|Overall Study|Physician Decision|1|||
127599474|NCT03070782|459161328|FG004|Overall Study|Pregnancy|0|||
127599475|NCT03070782|459161329|FG005|Overall Study|Pregnancy|0|||
127599476|NCT03070782|459161324|FG000|Overall Study|Investigator Judgement|0|||
127599477|NCT03070782|459161325|FG001|Overall Study|Investigator Judgement|0|||
127599478|NCT03070782|459161326|FG002|Overall Study|Investigator Judgement|0|||
127599479|NCT03070782|459161327|FG003|Overall Study|Investigator Judgement|1|||
127599480|NCT03070782|459161328|FG004|Overall Study|Investigator Judgement|0|||
127599481|NCT03070782|459161329|FG005|Overall Study|Investigator Judgement|0|||
127599482|NCT01083576|459161330|FG000|Overall Study|Treatment Failure|6|||
127599483|NCT01083576|459161331|FG001|Overall Study|Treatment Failure|1|||
127599484|NCT03527966|459161332|FG000|Overall Study|Lost to Follow-up|3|||
127599485|NCT03527966|459161333|FG001|Overall Study|Lost to Follow-up|0|||
127599486|NCT00558025|459161334|FG000|Overall Study|Adverse Event|1|||
127599487|NCT00558025|459161335|FG001|Overall Study|Adverse Event|1|||
127599488|NCT00558025|459161334|FG000|Overall Study|Withdrawal by Subject|2|||
127599489|NCT00558025|459161335|FG001|Overall Study|Withdrawal by Subject|2|||
127599490|NCT00558025|459161334|FG000|Overall Study|Protocol Violation|1|||
127599491|NCT00558025|459161335|FG001|Overall Study|Protocol Violation|0|||
127599492|NCT03315208|459161338|FG000|Overall Study|Lost to Follow-up|11|||
127599493|NCT03315208|459161339|FG001|Overall Study|Lost to Follow-up|6|||
127599494|NCT03315208|459161338|FG000|Overall Study|Withdrawal by Subject|2|||
127599495|NCT03315208|459161339|FG001|Overall Study|Withdrawal by Subject|0|||
127599496|NCT02746874|459161341|FG000|Overall Study|Withdrawal by Subject|0|||
127599497|NCT02746874|459161342|FG001|Overall Study|Withdrawal by Subject|1|||
127599498|NCT02746874|459161341|FG000|Overall Study|Surgery Date Changed|0|||
127599499|NCT02746874|459161342|FG001|Overall Study|Surgery Date Changed|2|||
127599500|NCT01881776|459161343|FG000|Overall Study|Lost to Follow-up|1|||
127599501|NCT01881776|459161344|FG001|Overall Study|Lost to Follow-up|2|||
127599502|NCT01881776|459161345|FG002|Overall Study|Lost to Follow-up|1|||
127599503|NCT01881776|459161343|FG000|Overall Study|Protocol Violation|0|||
127599504|NCT01881776|459161344|FG001|Overall Study|Protocol Violation|2|||
127599505|NCT01881776|459161345|FG002|Overall Study|Protocol Violation|1|||
127599506|NCT00487747|459161350|FG000|Overall Study|Adverse Event|1|||
127599507|NCT00487747|459161350|FG000|Overall Study|Lost to Follow-up|9|||
127599508|NCT00487747|459161350|FG000|Overall Study|Lack of Efficacy|1|||
127599509|NCT00276159|459161351|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
127599510|NCT00333866|459161352|FG000|Overall Study|Adverse Event|23|||
127599511|NCT00333866|459161353|FG001|Overall Study|Adverse Event|37|||
127599512|NCT00333866|459161354|FG002|Overall Study|Adverse Event|38|||
127599513|NCT00333866|459161355|FG003|Overall Study|Adverse Event|47|||
127599514|NCT00333866|459161352|FG000|Overall Study|Other|3|||
127599515|NCT00333866|459161353|FG001|Overall Study|Other|2|||
127599516|NCT00333866|459161354|FG002|Overall Study|Other|2|||
127599517|NCT00333866|459161355|FG003|Overall Study|Other|2|||
127599518|NCT00333866|459161352|FG000|Overall Study|Lack of Efficacy|8|||
127599519|NCT00333866|459161353|FG001|Overall Study|Lack of Efficacy|6|||
127599520|NCT00333866|459161354|FG002|Overall Study|Lack of Efficacy|3|||
127599521|NCT00333866|459161355|FG003|Overall Study|Lack of Efficacy|5|||
127599522|NCT00333866|459161352|FG000|Overall Study|Lost to Follow-up|1|||
127599523|NCT00333866|459161353|FG001|Overall Study|Lost to Follow-up|2|||
127599524|NCT00333866|459161354|FG002|Overall Study|Lost to Follow-up|2|||
127599525|NCT00333866|459161355|FG003|Overall Study|Lost to Follow-up|2|||
127599526|NCT00333866|459161352|FG000|Overall Study|Withdrawal by Subject|8|||
127599527|NCT00333866|459161353|FG001|Overall Study|Withdrawal by Subject|14|||
127599528|NCT00333866|459161354|FG002|Overall Study|Withdrawal by Subject|4|||
127599529|NCT00333866|459161355|FG003|Overall Study|Withdrawal by Subject|9|||
127599530|NCT00333866|459161352|FG000|Overall Study|Randomized but not Treated|5|||
127599531|NCT00333866|459161353|FG001|Overall Study|Randomized but not Treated|3|||
127599532|NCT00333866|459161354|FG002|Overall Study|Randomized but not Treated|2|||
127599533|NCT00333866|459161355|FG003|Overall Study|Randomized but not Treated|1|||
127599534|NCT01359449|459161366|FG000|Overall Study|Lost to Follow-up|1|||
127599535|NCT01359449|459161367|FG001|Overall Study|Lost to Follow-up|0|||
127599536|NCT01359449|459161366|FG000|Overall Study|Protocol Violation|0|||
127599537|NCT01359449|459161367|FG001|Overall Study|Protocol Violation|2|||
127599538|NCT01359449|459161366|FG000|Overall Study|Withdrawal by Subject|3|||
127599539|NCT01359449|459161367|FG001|Overall Study|Withdrawal by Subject|2|||
127599540|NCT02393547|459161371|FG000|Overall Study|Adverse Event|2|||
127599541|NCT02393547|459161371|FG000|Overall Study|Withdrawal by Subject|3|||
127599542|NCT02393547|459161371|FG000|Overall Study|Lost to Follow-up|1|||
127599543|NCT02927431|459161372|FG000|Overall Study|Withdrawal by Subject|0|||
127599544|NCT02927431|459161373|FG001|Overall Study|Withdrawal by Subject|0|||
127599545|NCT02927431|459161374|FG002|Overall Study|Withdrawal by Subject|1|||
127787567|NCT03416153|459846200|FG000|Overall Study|Withdrawal by Subject|1|||
127787568|NCT03416153|459846201|FG001|Overall Study|Withdrawal by Subject|0|||
127599546|NCT00673465|459161377|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
127599547|NCT00673465|459161378|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
127599548|NCT00673465|459161379|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
127599549|NCT00673465|459161380|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
127599550|NCT00673465|459161381|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
127599551|NCT00673465|459161382|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
127599552|NCT00673465|459161383|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
127599553|NCT00673465|459161384|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
127599554|NCT00673465|459161385|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
127599555|NCT00673465|459161386|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
127599556|NCT00673465|459161387|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
127599557|NCT00673465|459161388|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
127599558|NCT00673465|459161377|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
127599559|NCT00673465|459161378|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
127599560|NCT00673465|459161379|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
127599561|NCT00673465|459161380|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
127599562|NCT00673465|459161381|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
127599563|NCT00673465|459161382|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
127599564|NCT00673465|459161383|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
127599565|NCT00673465|459161384|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
127599566|NCT00673465|459161385|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
127599567|NCT00673465|459161386|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
127599568|NCT00673465|459161387|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
127599569|NCT00673465|459161388|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
127599570|NCT00429104|459161389|FG000|Overall Study|Protocol Violation|1|||
127599571|NCT01829191|459161390|FG000|Overall Study|Relocation|0|||
127599572|NCT01829191|459161391|FG001|Overall Study|Relocation|1|||
127599573|NCT01829191|459161390|FG000|Overall Study|Lens discomfort|0|||
127599574|NCT01829191|459161391|FG001|Overall Study|Lens discomfort|3|||
127599575|NCT01829191|459161390|FG000|Overall Study|Lens handling difficulty|1|||
127599576|NCT01829191|459161391|FG001|Overall Study|Lens handling difficulty|4|||
127599577|NCT01829191|459161390|FG000|Overall Study|Protocol Violation|4|||
127599578|NCT01829191|459161391|FG001|Overall Study|Protocol Violation|1|||
127599579|NCT01829191|459161390|FG000|Overall Study|Withdrawal by Subject|2|||
127599580|NCT01829191|459161391|FG001|Overall Study|Withdrawal by Subject|3|||
127599581|NCT01829191|459161390|FG000|Overall Study|Lost to Follow-up|0|||
127599582|NCT01829191|459161391|FG001|Overall Study|Lost to Follow-up|1|||
127599583|NCT01829191|459161390|FG000|Overall Study|Subject was fit for ortho - k|0|||
127599584|NCT01829191|459161391|FG001|Overall Study|Subject was fit for ortho - k|1|||
127599585|NCT01907815|459161392|FG000|Overall Study|Withdrawal by Subject|1|||
127599586|NCT01907815|459161393|FG001|Overall Study|Withdrawal by Subject|0|||
127599587|NCT01276353|459161394|FG000|Double-blind|Adverse Event|2|||
127599588|NCT01276353|459161395|FG001|Double-blind|Adverse Event|0|||
127599589|NCT01276353|459161394|FG000|Double-blind|Withdrawal by Subject|1|||
127599590|NCT01276353|459161395|FG001|Double-blind|Withdrawal by Subject|0|||
127599591|NCT01276353|459161394|FG000|Extension|Adverse Event|2|||
127599592|NCT01276353|459161395|FG001|Extension|Adverse Event|5|||
127599593|NCT01276353|459161394|FG000|Extension|Withdrawal by Subject|1|||
127599594|NCT01276353|459161395|FG001|Extension|Withdrawal by Subject|2|||
127599595|NCT01276353|459161394|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
127599596|NCT01276353|459161395|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
127599597|NCT01276353|459161394|FG000|Extension|Physician Decision|1|||
127599598|NCT01276353|459161395|FG001|Extension|Physician Decision|0|||
127599599|NCT01276353|459161394|FG000|Extension|Prohibited concomitant medications|0|||
127599600|NCT01276353|459161395|FG001|Extension|Prohibited concomitant medications|1|||
127599601|NCT00143403|459161396|FG000|Overall Study|Adverse Event|3|||
127599602|NCT00143403|459161397|FG001|Overall Study|Adverse Event|8|||
127599603|NCT00143403|459161396|FG000|Overall Study|Death|1|||
127599604|NCT00143403|459161397|FG001|Overall Study|Death|0|||
127599605|NCT00143403|459161396|FG000|Overall Study|Withdrawal by Subject|3|||
127599606|NCT00143403|459161397|FG001|Overall Study|Withdrawal by Subject|12|||
127599607|NCT00143403|459161396|FG000|Overall Study|Relapse|15|||
127599608|NCT00143403|459161397|FG001|Overall Study|Relapse|7|||
127599609|NCT00143403|459161396|FG000|Overall Study|Protocol Violation|2|||
127599610|NCT00143403|459161397|FG001|Overall Study|Protocol Violation|2|||
127599611|NCT00143403|459161396|FG000|Overall Study|specified by site|4|||
127599612|NCT00143403|459161397|FG001|Overall Study|specified by site|9|||
127599613|NCT00143403|459161396|FG000|Overall Study|Randomized Not Treated|7|||
127599614|NCT00143403|459161397|FG001|Overall Study|Randomized Not Treated|8|||
127599615|NCT00514540|459161398|FG000|First-Line Chemo|Withdrawal by Subject|1|||
127695927|NCT00920621|459514760|FG000|Overall Study|Fetal/neonatal deaths|16|||
127695928|NCT00920621|459514761|FG001|Overall Study|Fetal/neonatal deaths|14|||
127695929|NCT00920621|459514762|FG002|Overall Study|Fetal/neonatal deaths|16|||
127695930|NCT00920621|459514763|FG003|Overall Study|Fetal/neonatal deaths|14|||
127695931|NCT00920621|459514760|FG000|Overall Study|Blood sample not collected|22|||
127695932|NCT00920621|459514761|FG001|Overall Study|Blood sample not collected|14|||
127599616|NCT00514540|459161398|FG000|First-Line Chemo|Protocol Violation|7|||
127599617|NCT00514540|459161398|FG000|Second-Line|Physician/Patient Decision|31|||
127599618|NCT03402386|459161399|FG000|Overall Study|Adverse Event|3|||
127599619|NCT03402386|459161399|FG000|Overall Study|Physician Decision|1|||
127599620|NCT03402386|459161399|FG000|Overall Study|Difficult to control Hb|2|||
127599621|NCT00587639|459161400|FG000|Overall Study|Withdrawal by Subject|1|||
127599622|NCT01996982|459161405|FG000|Overall Study|PI/team left institution|7|||
127599623|NCT01195415|459161406|FG000|Overall Study|No repeat biopsy due to progression|2|||
127599624|NCT00533845|459161407|FG000|Overall Study|Physician Decision|1|||
127599625|NCT00533845|459161408|FG001|Overall Study|Physician Decision|0|||
127599626|NCT01288469|459161416|FG000|Overall Study|Adverse Event|4|||
127599627|NCT01288469|459161417|FG001|Overall Study|Adverse Event|1|||
127599628|NCT01288469|459161418|FG002|Overall Study|Adverse Event|1|||
127599629|NCT01288469|459161416|FG000|Overall Study|Poor compliance to protocol|0|||
127599630|NCT01288469|459161417|FG001|Overall Study|Poor compliance to protocol|1|||
127599631|NCT01288469|459161418|FG002|Overall Study|Poor compliance to protocol|0|||
127599632|NCT01288469|459161416|FG000|Overall Study|Participant Moved|1|||
127599633|NCT01288469|459161417|FG001|Overall Study|Participant Moved|0|||
127599634|NCT01288469|459161418|FG002|Overall Study|Participant Moved|0|||
127599635|NCT01288469|459161416|FG000|Overall Study|Consent withdrawn by subject|1|||
127599636|NCT01288469|459161417|FG001|Overall Study|Consent withdrawn by subject|1|||
127599637|NCT01288469|459161418|FG002|Overall Study|Consent withdrawn by subject|1|||
127599638|NCT01288469|459161416|FG000|Overall Study|Exclusion criteria finally met|1|||
127599639|NCT01288469|459161417|FG001|Overall Study|Exclusion criteria finally met|0|||
127599640|NCT01288469|459161418|FG002|Overall Study|Exclusion criteria finally met|0|||
127599641|NCT00255047|459161419|FG000|Overall Study|Serious Adverse Events|2|||
127599642|NCT00255047|459161420|FG001|Overall Study|Serious Adverse Events|1|||
127599643|NCT00255047|459161421|FG002|Overall Study|Serious Adverse Events|2|||
127599644|NCT00255047|459161422|FG003|Overall Study|Serious Adverse Events|1|||
127599645|NCT00255047|459161419|FG000|Overall Study|Adverse Event|0|||
127599646|NCT00255047|459161420|FG001|Overall Study|Adverse Event|3|||
127599647|NCT00255047|459161421|FG002|Overall Study|Adverse Event|2|||
127599648|NCT00255047|459161422|FG003|Overall Study|Adverse Event|1|||
127599649|NCT00255047|459161419|FG000|Overall Study|Protocol Violation|13|||
127599650|NCT00255047|459161420|FG001|Overall Study|Protocol Violation|13|||
127599651|NCT00255047|459161421|FG002|Overall Study|Protocol Violation|16|||
127599652|NCT00255047|459161422|FG003|Overall Study|Protocol Violation|20|||
127599653|NCT00255047|459161419|FG000|Overall Study|Lost to Follow-up|9|||
127599654|NCT00255047|459161420|FG001|Overall Study|Lost to Follow-up|8|||
127599655|NCT00255047|459161421|FG002|Overall Study|Lost to Follow-up|5|||
127599656|NCT00255047|459161422|FG003|Overall Study|Lost to Follow-up|6|||
127599657|NCT00255047|459161419|FG000|Overall Study|Withdrawal by Subject|24|||
127599658|NCT00255047|459161420|FG001|Overall Study|Withdrawal by Subject|23|||
127599659|NCT00255047|459161421|FG002|Overall Study|Withdrawal by Subject|25|||
127599660|NCT00255047|459161422|FG003|Overall Study|Withdrawal by Subject|18|||
127599661|NCT00110149|459161423|FG000|Overall Study|Physician Decision|3|||
127599662|NCT00563381|459161424|FG000|Overall Study|Adverse Event|264|||
127599663|NCT00563381|459161425|FG001|Overall Study|Adverse Event|292|||
127599664|NCT00563381|459161424|FG000|Overall Study|Protocol Violation|66|||
127599665|NCT00563381|459161425|FG001|Overall Study|Protocol Violation|74|||
127599666|NCT00563381|459161424|FG000|Overall Study|Lost to Follow-up|7|||
127599667|NCT00563381|459161425|FG001|Overall Study|Lost to Follow-up|15|||
127599668|NCT00563381|459161424|FG000|Overall Study|Withdrawal by Subject|192|||
127599669|NCT00563381|459161425|FG001|Overall Study|Withdrawal by Subject|209|||
128036287|NCT01948427|460762158|FG003|Overall Study|Serious Adverse Event|0|||
127599670|NCT00563381|459161424|FG000|Overall Study|Lack of Efficacy|32|||
127599671|NCT00563381|459161425|FG001|Overall Study|Lack of Efficacy|24|||
127599672|NCT00563381|459161424|FG000|Overall Study|Individual different reasons|24|||
127599673|NCT00563381|459161425|FG001|Overall Study|Individual different reasons|34|||
127599674|NCT02452398|459161428|FG000|Overall Study|Adverse Event|1|||
127599675|NCT02452398|459161428|FG000|Overall Study|Lost to Follow-up|28|||
127599676|NCT02452398|459161428|FG000|Overall Study|Physician Decision|2|||
127599677|NCT02452398|459161428|FG000|Overall Study|Withdrawal by Subject|6|||
127599678|NCT02452398|459161428|FG000|Overall Study|Moved away|4|||
127599679|NCT01405742|459161435|FG000|Overall Study|Lost to Follow-up|1|||
127599680|NCT01405742|459161436|FG001|Overall Study|Lost to Follow-up|0|||
127599681|NCT01782495|459161441|FG000|Overall Study|Adverse Event|0|||
127599682|NCT01782495|459161442|FG001|Overall Study|Adverse Event|0|||
127599683|NCT01782495|459161443|FG002|Overall Study|Adverse Event|0|||
127599684|NCT01782495|459161444|FG003|Overall Study|Adverse Event|0|||
127599685|NCT01782495|459161445|FG004|Overall Study|Adverse Event|0|||
127599686|NCT01782495|459161446|FG005|Overall Study|Adverse Event|0|||
127599687|NCT01782495|459161447|FG006|Overall Study|Adverse Event|0|||
127599688|NCT01782495|459161448|FG007|Overall Study|Adverse Event|2|||
127599689|NCT01782495|459161449|FG008|Overall Study|Adverse Event|0|||
127599690|NCT01782495|459161450|FG009|Overall Study|Adverse Event|0|||
127599691|NCT01782495|459161451|FG010|Overall Study|Adverse Event|0|||
128036288|NCT01948427|460762159|FG004|Overall Study|Serious Adverse Event|1|||
127599692|NCT01782495|459161441|FG000|Overall Study|Withdrew Consent|0|||
127599693|NCT01782495|459161442|FG001|Overall Study|Withdrew Consent|1|||
127599694|NCT01782495|459161443|FG002|Overall Study|Withdrew Consent|0|||
127599695|NCT01782495|459161444|FG003|Overall Study|Withdrew Consent|0|||
127599696|NCT01782495|459161445|FG004|Overall Study|Withdrew Consent|0|||
127599697|NCT01782495|459161446|FG005|Overall Study|Withdrew Consent|0|||
127599698|NCT01782495|459161447|FG006|Overall Study|Withdrew Consent|0|||
127599699|NCT01782495|459161448|FG007|Overall Study|Withdrew Consent|1|||
127599700|NCT01782495|459161449|FG008|Overall Study|Withdrew Consent|0|||
127599701|NCT01782495|459161450|FG009|Overall Study|Withdrew Consent|0|||
127599702|NCT01782495|459161451|FG010|Overall Study|Withdrew Consent|0|||
127599703|NCT00071513|459161452|FG000|Intervention Component|Withdrawal by Subject|2|||
127599704|NCT00071513|459161453|FG001|Intervention Component|Withdrawal by Subject|3|||
127599705|NCT00071513|459161452|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
127599706|NCT00071513|459161453|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
127599707|NCT03428360|459161454|FG000|Overall Study|Informed consent withdrawn|5|||
127599708|NCT03428360|459161454|FG000|Overall Study|Withdrawal by Subject|4|||
127599709|NCT03428360|459161454|FG000|Overall Study|Lost to Follow-up|5|||
127599710|NCT03428360|459161454|FG000|Overall Study|Physician Decision|2|||
127599711|NCT03428360|459161454|FG000|Overall Study|Informed consent withdrawn|5|||
127599712|NCT03428360|459161454|FG000|Overall Study|Study terminated by sponsor|10|||
127599713|NCT03428360|459161454|FG000|Overall Study|Non-compliant with study|1|||
127599714|NCT03428360|459161454|FG000|Overall Study|Non-compliant with study drug|3|||
127599715|NCT03428360|459161454|FG000|Overall Study|Death|3|||
127599716|NCT03428360|459161454|FG000|Overall Study|Adverse Event|1|||
127599717|NCT03428360|459161454|FG000|Overall Study|Not on antiepileptic drug|1|||
127599718|NCT02260921|459161455|FG000|Overall Study|Adverse Event|1|||
127599719|NCT02260921|459161456|FG001|Overall Study|Adverse Event|0|||
127599720|NCT02260921|459161455|FG000|Overall Study|Lost to Follow-up|4|||
127599721|NCT02260921|459161456|FG001|Overall Study|Lost to Follow-up|3|||
127599722|NCT02260921|459161455|FG000|Overall Study|Withdraw Consent|4|||
127599723|NCT02260921|459161456|FG001|Overall Study|Withdraw Consent|1|||
127599724|NCT02260921|459161455|FG000|Overall Study|Death|1|||
127599725|NCT02260921|459161456|FG001|Overall Study|Death|0|||
127599726|NCT02260921|459161455|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
127599727|NCT02260921|459161456|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
127599728|NCT03241342|459161460|FG000|Overall Study|Adverse Event|5|||
127599729|NCT03241342|459161461|FG001|Overall Study|Adverse Event|8|||
127599730|NCT03241342|459161462|FG002|Overall Study|Adverse Event|4|||
127599731|NCT03241342|459161460|FG000|Overall Study|Lack of Efficacy|0|||
127599732|NCT03241342|459161461|FG001|Overall Study|Lack of Efficacy|0|||
127599733|NCT03241342|459161462|FG002|Overall Study|Lack of Efficacy|1|||
127599734|NCT03241342|459161460|FG000|Overall Study|noncompliance with study drug|2|||
127599735|NCT03241342|459161461|FG001|Overall Study|noncompliance with study drug|1|||
127599736|NCT03241342|459161462|FG002|Overall Study|noncompliance with study drug|1|||
127599737|NCT03241342|459161460|FG000|Overall Study|sponsor decision|0|||
127599738|NCT03241342|459161461|FG001|Overall Study|sponsor decision|1|||
127599739|NCT03241342|459161462|FG002|Overall Study|sponsor decision|2|||
127599740|NCT03241342|459161460|FG000|Overall Study|not reported|15|||
127599741|NCT03241342|459161461|FG001|Overall Study|not reported|21|||
127599742|NCT03241342|459161462|FG002|Overall Study|not reported|19|||
127599743|NCT01846611|459161464|FG000|Overall Study|Lost to Follow-up|4|||
127599744|NCT01846611|459161465|FG001|Overall Study|Lost to Follow-up|6|||
127599745|NCT01846611|459161464|FG000|Overall Study|Withdrawal by Subject|15|||
127599746|NCT01846611|459161465|FG001|Overall Study|Withdrawal by Subject|19|||
127599747|NCT01846611|459161464|FG000|Overall Study|Other|19|||
127599748|NCT01846611|459161465|FG001|Overall Study|Other|18|||
127599749|NCT04405037|459161466|FG000|Overall Study|Withdrawal by Subject|1|||
127599750|NCT04405037|459161467|FG001|Overall Study|Withdrawal by Subject|0|||
127599751|NCT04405037|459161466|FG000|Overall Study|Screen Failure- Received Alvimopan Preoperatively|1|||
127599752|NCT04405037|459161467|FG001|Overall Study|Screen Failure- Received Alvimopan Preoperatively|0|||
127599753|NCT02759471|459161468|FG000|Overall Study|discomfort|2|||
127599754|NCT02879305|459161469|FG000|Overall Study|Investigator Site Closed|55|||
128036289|NCT01948427|460762155|FG000|Overall Study|Investigator Request|0|||
128036290|NCT01948427|460762156|FG001|Overall Study|Investigator Request|8|||
127599755|NCT02879305|459161470|FG001|Overall Study|Investigator Site Closed|57|||
127599756|NCT02879305|459161469|FG000|Overall Study|Withdrawal by Subject|44|||
127599757|NCT02879305|459161470|FG001|Overall Study|Withdrawal by Subject|42|||
127599758|NCT02879305|459161469|FG000|Overall Study|Lost to Follow-up|17|||
127599759|NCT02879305|459161470|FG001|Overall Study|Lost to Follow-up|12|||
127599760|NCT02879305|459161469|FG000|Overall Study|Other|1|||
127599761|NCT02879305|459161470|FG001|Overall Study|Other|0|||
127599762|NCT02329730|459163055|FG000|Overall Study|Protocol Violation|0|||
128036291|NCT01948427|460762157|FG002|Overall Study|Investigator Request|0|||
127599763|NCT02329730|459163056|FG001|Overall Study|Protocol Violation|0|||
127599764|NCT02329730|459163057|FG002|Overall Study|Protocol Violation|0|||
127599765|NCT02329730|459163058|FG003|Overall Study|Protocol Violation|0|||
127599766|NCT02329730|459163059|FG004|Overall Study|Protocol Violation|2|||
127599767|NCT02329730|459163060|FG005|Overall Study|Protocol Violation|2|||
127599768|NCT02329730|459163061|FG006|Overall Study|Protocol Violation|0|||
127599769|NCT02329730|459163062|FG007|Overall Study|Protocol Violation|0|||
127599770|NCT02329730|459163063|FG008|Overall Study|Protocol Violation|0|||
127599771|NCT02329730|459163064|FG009|Overall Study|Protocol Violation|0|||
127599772|NCT02329730|459163065|FG010|Overall Study|Protocol Violation|0|||
127599773|NCT02329730|459163066|FG011|Overall Study|Protocol Violation|0|||
127599774|NCT02329730|459163055|FG000|Overall Study|Withdrawal by Subject|0|||
127599775|NCT02329730|459163056|FG001|Overall Study|Withdrawal by Subject|0|||
127599776|NCT02329730|459163057|FG002|Overall Study|Withdrawal by Subject|0|||
127599777|NCT02329730|459163058|FG003|Overall Study|Withdrawal by Subject|0|||
127599778|NCT02329730|459163059|FG004|Overall Study|Withdrawal by Subject|1|||
127599779|NCT02329730|459163060|FG005|Overall Study|Withdrawal by Subject|0|||
127599780|NCT02329730|459163061|FG006|Overall Study|Withdrawal by Subject|1|||
127599781|NCT02329730|459163062|FG007|Overall Study|Withdrawal by Subject|1|||
127599782|NCT02329730|459163063|FG008|Overall Study|Withdrawal by Subject|1|||
127599783|NCT02329730|459163064|FG009|Overall Study|Withdrawal by Subject|1|||
127599784|NCT02329730|459163065|FG010|Overall Study|Withdrawal by Subject|0|||
127599785|NCT02329730|459163066|FG011|Overall Study|Withdrawal by Subject|0|||
127599786|NCT02392247|459163071|FG000|Overall Study|Withdrawal by Subject|1|||
127599787|NCT02392247|459163071|FG000|Overall Study|Surgery cancelled; no data|1|||
127599788|NCT03010254|459163072|FG000|Overall Study|Adverse Event|0|||
127599789|NCT03010254|459163073|FG001|Overall Study|Adverse Event|1|||
127599790|NCT03010254|459163072|FG000|Overall Study|Lost to Follow-up|4|||
127599791|NCT03010254|459163073|FG001|Overall Study|Lost to Follow-up|0|||
127599792|NCT03010254|459163072|FG000|Overall Study|Withdrawal by Subject|1|||
127599793|NCT03010254|459163073|FG001|Overall Study|Withdrawal by Subject|1|||
127599794|NCT03010254|459163072|FG000|Overall Study|Other|2|||
127599795|NCT03010254|459163073|FG001|Overall Study|Other|3|||
127599796|NCT02068443|459163079|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
127599797|NCT02068443|459163080|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
127599798|NCT02068443|459163081|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
127599799|NCT02068443|459163079|FG000|Overall Study|Voluntary Withdrawal|4|||
127599800|NCT02068443|459163080|FG001|Overall Study|Voluntary Withdrawal|0|||
127599801|NCT02068443|459163081|FG002|Overall Study|Voluntary Withdrawal|1|||
127599802|NCT02068443|459163079|FG000|Overall Study|Lack of Efficacy|2|||
127599803|NCT02068443|459163080|FG001|Overall Study|Lack of Efficacy|1|||
127599804|NCT02068443|459163081|FG002|Overall Study|Lack of Efficacy|0|||
127599805|NCT02068443|459163079|FG000|Overall Study|Other Reason Not Specified|1|||
127599806|NCT02068443|459163080|FG001|Overall Study|Other Reason Not Specified|0|||
127599807|NCT02068443|459163081|FG002|Overall Study|Other Reason Not Specified|0|||
127599808|NCT01986855|459163082|FG000|Overall Study|Adverse Event|1|||
127599809|NCT01986855|459163083|FG001|Overall Study|Adverse Event|0|||
127599810|NCT01986855|459163084|FG002|Overall Study|Adverse Event|0|||
127599811|NCT01986855|459163082|FG000|Overall Study|Death|3|||
127599812|NCT01986855|459163083|FG001|Overall Study|Death|4|||
127599813|NCT01986855|459163084|FG002|Overall Study|Death|4|||
127599814|NCT01986855|459163082|FG000|Overall Study|Lost to Follow-up|2|||
127599815|NCT01986855|459163083|FG001|Overall Study|Lost to Follow-up|1|||
127599816|NCT01986855|459163084|FG002|Overall Study|Lost to Follow-up|0|||
127599817|NCT01986855|459163082|FG000|Overall Study|Screen Failure|0|||
127599818|NCT01986855|459163083|FG001|Overall Study|Screen Failure|1|||
127599819|NCT01986855|459163084|FG002|Overall Study|Screen Failure|0|||
127599820|NCT01986855|459163082|FG000|Overall Study|Participant Moved|0|||
127599821|NCT01986855|459163083|FG001|Overall Study|Participant Moved|0|||
127599822|NCT01986855|459163084|FG002|Overall Study|Participant Moved|2|||
127599823|NCT01986855|459163082|FG000|Overall Study|Withdrawal by Subject|7|||
127599824|NCT01986855|459163083|FG001|Overall Study|Withdrawal by Subject|8|||
127599825|NCT01986855|459163084|FG002|Overall Study|Withdrawal by Subject|5|||
127599826|NCT00664742|459163085|FG000|Overall Study|Withdrawn due to adverse events|3|||
127599827|NCT00664742|459163085|FG000|Overall Study|Withdrawal by Subject|31|||
127599828|NCT00664742|459163085|FG000|Overall Study|Lost to Follow-up|92|||
127599829|NCT02825992|459163086|FG000|Overall Study|Withdrawal by Subject|4|||
127599830|NCT02825992|459163086|FG000|Overall Study|Lost to Follow-up|2|||
127599831|NCT02825992|459163086|FG000|Overall Study|Procedure terminated|2|||
127599832|NCT02279173|459163087|FG000|Overall Study|Protocol-specified Criteria|67|||
127599833|NCT02279173|459163087|FG000|Overall Study|Withdrawal by Subject|20|||
127599834|NCT02279173|459163087|FG000|Overall Study|Decision by Sponsor|4|||
127599835|NCT02279173|459163087|FG000|Overall Study|Lost to Follow-up|3|||
127599836|NCT00710710|459163088|FG000|Overall Study|Consent withdrawn|2|||
127599837|NCT00710710|459163089|FG001|Overall Study|Consent withdrawn|2|||
127599838|NCT00710710|459163088|FG000|Overall Study|Protocol Violation|0|||
127599839|NCT00710710|459163089|FG001|Overall Study|Protocol Violation|1|||
127599840|NCT00710710|459163088|FG000|Overall Study|Adverse Event|3|||
127599841|NCT00710710|459163089|FG001|Overall Study|Adverse Event|3|||
127599842|NCT00710710|459163088|FG000|Overall Study|Progressive disease|40|||
127599843|NCT00710710|459163089|FG001|Overall Study|Progressive disease|38|||
127599844|NCT00715078|459163090|FG000|Overall Study|Death|29|||
127599845|NCT00715078|459163091|FG001|Overall Study|Death|36|||
127599846|NCT00715078|459163092|FG002|Overall Study|Death|36|||
127599847|NCT00715078|459163090|FG000|Overall Study|Withdrawal by Subject|1|||
127599848|NCT00715078|459163091|FG001|Overall Study|Withdrawal by Subject|0|||
127599849|NCT00715078|459163092|FG002|Overall Study|Withdrawal by Subject|1|||
127599850|NCT00715078|459163090|FG000|Overall Study|Unable to start due to disease prog.|0|||
127599851|NCT00715078|459163091|FG001|Overall Study|Unable to start due to disease prog.|0|||
127599852|NCT00715078|459163092|FG002|Overall Study|Unable to start due to disease prog.|1|||
127599853|NCT00157950|459163093|FG000|Overall Study|Death|1|||
127599854|NCT00157950|459163094|FG001|Overall Study|Death|0|||
127599855|NCT02892760|459163095|FG000|Overall Study|Withdrawal by Subject|3|||
127599856|NCT00386776|459163100|FG000|Overall Study|Withdrawal by Subject|8|||
127599857|NCT01500629|459163101|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
127599858|NCT01500629|459163102|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
127599859|NCT00588848|459163103|FG000|Overall Study|Physician Decision|0|||
127599860|NCT00588848|459163104|FG001|Overall Study|Physician Decision|3|||
127599861|NCT02902965|459163105|FG000|Overall Study|Withdrawal by Subject|10|||
127599862|NCT02673489|459163106|FG000|Treatment Period|Lost to Follow-up|3|||
127599863|NCT02673489|459163107|FG001|Treatment Period|Lost to Follow-up|0|||
127599864|NCT02673489|459163106|FG000|Treatment Period|Participant request to discontinue|1|||
127599865|NCT02673489|459163107|FG001|Treatment Period|Participant request to discontinue|1|||
127599866|NCT02673489|459163106|FG000|Treatment Period|Participant moved to another province|1|||
127599867|NCT02673489|459163107|FG001|Treatment Period|Participant moved to another province|0|||
127599868|NCT02673489|459163106|FG000|Treatment Period|Participant was incarcerated|0|||
127599869|NCT02673489|459163107|FG001|Treatment Period|Participant was incarcerated|1|||
127599870|NCT02673489|459163106|FG000|Treatment Period|Adverse Event|0|||
127599871|NCT02673489|459163107|FG001|Treatment Period|Adverse Event|1|||
127599872|NCT02673489|459163106|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
127599873|NCT02673489|459163107|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
127599874|NCT02673489|459163106|FG000|Follow Up Period|Unable to return for follow-up|0|||
127599875|NCT02673489|459163107|FG001|Follow Up Period|Unable to return for follow-up|1|||
127599876|NCT00293254|459163108|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
127599877|NCT00293254|459163109|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
127599878|NCT00293254|459163108|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
127599879|NCT00293254|459163109|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
127599880|NCT00293254|459163108|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
127599881|NCT00293254|459163109|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
127599882|NCT00293254|459163108|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
127599883|NCT00293254|459163109|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
127599884|NCT00293254|459163108|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
127599885|NCT00293254|459163109|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
127599886|NCT00293254|459163108|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
127599887|NCT00293254|459163109|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
127599888|NCT00293254|459163108|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
127599889|NCT00293254|459163109|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
127599890|NCT00293254|459163108|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
127599891|NCT00293254|459163109|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
127599892|NCT00293254|459163108|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
127599893|NCT00293254|459163109|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
127599894|NCT00293254|459163108|FG000|Extension - Double-Blind Week 49-156|Death|4|||
127599895|NCT00293254|459163109|FG001|Extension - Double-Blind Week 49-156|Death|1|||
127599896|NCT00293254|459163108|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
127599897|NCT00293254|459163109|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
127599898|NCT00293254|459163108|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
127599899|NCT00293254|459163109|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
127599900|NCT00293254|459163108|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
127599901|NCT00293254|459163109|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
127599902|NCT00293254|459163108|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
127599903|NCT00293254|459163109|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
127599904|NCT00293254|459163108|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
127599905|NCT00293254|459163109|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
127599906|NCT00293254|459163108|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
127599907|NCT00293254|459163109|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
127599908|NCT00293254|459163108|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
127599909|NCT00293254|459163109|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
127787569|NCT04342871|459847776|FG000|Overall Study|Death|4|||
127787570|NCT04342871|459847776|FG000|Overall Study|Clinical deterioration/illness progression|2|||
127787571|NCT04342871|459847776|FG000|Overall Study|Did not complete baseline assessments|5|||
127787572|NCT04342871|459847776|FG000|Overall Study|Lost to Follow-up|13|||
127599910|NCT00293254|459163108|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
127599911|NCT00293254|459163109|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
127599912|NCT00293254|459163108|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
127599913|NCT00293254|459163109|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
127599914|NCT00293254|459163108|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
127599915|NCT00293254|459163109|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
127599916|NCT00293254|459163108|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
127599917|NCT00293254|459163109|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
127599918|NCT00293254|459163108|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
127599919|NCT00293254|459163109|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
127599920|NCT00293254|459163108|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
127599921|NCT00293254|459163109|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
127599922|NCT00293254|459163108|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
127599923|NCT00293254|459163109|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
127599924|NCT00293254|459163108|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
127599925|NCT00293254|459163109|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
127599926|NCT00293254|459163108|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
127599927|NCT00293254|459163109|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
127599928|NCT00293254|459163108|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
127599929|NCT00293254|459163109|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
127599930|NCT02335489|459163110|FG000|Overall Study|Sponsor terminated study|4|||
127599931|NCT02335489|459163110|FG000|Overall Study|Lost to Follow-up|1|||
127599932|NCT02335489|459163110|FG000|Overall Study|Withdrawal by Subject|2|||
127599933|NCT02335489|459163110|FG000|Overall Study|Physician Decision|2|||
127599934|NCT02335489|459163110|FG000|Overall Study|Lack of Efficacy|1|||
127599935|NCT02259582|459163111|FG000|Overall Study|Physician Decision|0|||
127599936|NCT02259582|459163112|FG001|Overall Study|Physician Decision|1|||
127599937|NCT02259582|459163113|FG002|Overall Study|Physician Decision|0|||
127599938|NCT02259582|459163111|FG000|Overall Study|Death|0|||
127599939|NCT02259582|459163112|FG001|Overall Study|Death|0|||
127599940|NCT02259582|459163113|FG002|Overall Study|Death|1|||
127599941|NCT02259582|459163111|FG000|Overall Study|Adverse Event|1|||
127599942|NCT02259582|459163112|FG001|Overall Study|Adverse Event|0|||
127599943|NCT02259582|459163113|FG002|Overall Study|Adverse Event|1|||
127599944|NCT02259582|459163111|FG000|Overall Study|Withdrawal by Subject|0|||
127599945|NCT02259582|459163112|FG001|Overall Study|Withdrawal by Subject|0|||
127599946|NCT02259582|459163113|FG002|Overall Study|Withdrawal by Subject|1|||
127599947|NCT02259582|459163111|FG000|Overall Study|Disease progression|14|||
127599948|NCT02259582|459163112|FG001|Overall Study|Disease progression|15|||
127599949|NCT02259582|459163113|FG002|Overall Study|Disease progression|17|||
127599950|NCT02259582|459163111|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
127599951|NCT02259582|459163112|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
127599952|NCT02259582|459163113|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
127599953|NCT00531050|459163114|FG000|Part 1: Period 1|Adverse Event|0|||
127599954|NCT00531050|459163115|FG001|Part 1: Period 1|Adverse Event|1|||
127599955|NCT00531050|459163116|FG002|Part 1: Period 1|Adverse Event|0|||
127599956|NCT00531050|459163117|FG003|Part 1: Period 1|Adverse Event|0|||
127599957|NCT00531050|459163118|FG004|Part 1: Period 1|Adverse Event|0|||
127599958|NCT00531050|459163119|FG005|Part 1: Period 1|Adverse Event|0|||
127599959|NCT00531050|459163114|FG000|Part 1: Period 1|Protocol Deviation|0|||
127599960|NCT00531050|459163115|FG001|Part 1: Period 1|Protocol Deviation|0|||
127599961|NCT00531050|459163116|FG002|Part 1: Period 1|Protocol Deviation|0|||
127599962|NCT00531050|459163117|FG003|Part 1: Period 1|Protocol Deviation|1|||
127599963|NCT00531050|459163118|FG004|Part 1: Period 1|Protocol Deviation|0|||
127599964|NCT00531050|459163119|FG005|Part 1: Period 1|Protocol Deviation|0|||
127599965|NCT00531050|459163114|FG000|Part 1: Period 3|Adverse Event|1|||
127599966|NCT00531050|459163115|FG001|Part 1: Period 3|Adverse Event|0|||
127599967|NCT00531050|459163116|FG002|Part 1: Period 3|Adverse Event|0|||
127599968|NCT00531050|459163117|FG003|Part 1: Period 3|Adverse Event|0|||
127599969|NCT00531050|459163118|FG004|Part 1: Period 3|Adverse Event|0|||
127599970|NCT00531050|459163119|FG005|Part 1: Period 3|Adverse Event|0|||
127599971|NCT00531050|459163114|FG000|Part 2: Period 1|Adverse Event|0|||
127599972|NCT00531050|459163115|FG001|Part 2: Period 1|Adverse Event|0|||
127599973|NCT00531050|459163116|FG002|Part 2: Period 1|Adverse Event|0|||
127599974|NCT00531050|459163117|FG003|Part 2: Period 1|Adverse Event|0|||
127599975|NCT00531050|459163118|FG004|Part 2: Period 1|Adverse Event|0|||
127599976|NCT00531050|459163119|FG005|Part 2: Period 1|Adverse Event|1|||
127599977|NCT00531050|459163114|FG000|Part 2: Period 3|Abnormal test procedure|1|||
127599978|NCT00531050|459163115|FG001|Part 2: Period 3|Abnormal test procedure|0|||
127599979|NCT00531050|459163116|FG002|Part 2: Period 3|Abnormal test procedure|0|||
127599980|NCT00531050|459163117|FG003|Part 2: Period 3|Abnormal test procedure|0|||
127599981|NCT00531050|459163118|FG004|Part 2: Period 3|Abnormal test procedure|0|||
127599982|NCT00531050|459163119|FG005|Part 2: Period 3|Abnormal test procedure|1|||
127599983|NCT02233309|459163122|FG000|Overall Study|Physician Decision|5|||
127599984|NCT00232817|459163124|FG000|Overall Study|Protocol Violation|2|||
127599985|NCT00232817|459163125|FG001|Overall Study|Protocol Violation|1|||
127599986|NCT00799487|459163126|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
127599987|NCT00799487|459163127|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
127599988|NCT00799487|459163128|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
127599989|NCT00799487|459163126|FG000|Dose Adjustment Period|Adverse Event|2|||
127599990|NCT00799487|459163127|FG001|Dose Adjustment Period|Adverse Event|0|||
127599991|NCT00799487|459163128|FG002|Dose Adjustment Period|Adverse Event|0|||
127599992|NCT00799487|459163126|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
127599993|NCT00799487|459163127|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
127599994|NCT00799487|459163128|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
127599995|NCT00799487|459163126|FG000|Dose Adjustment Period|Investigator Discretion|2|||
127599996|NCT00799487|459163127|FG001|Dose Adjustment Period|Investigator Discretion|0|||
127599997|NCT00799487|459163128|FG002|Dose Adjustment Period|Investigator Discretion|0|||
127599998|NCT00799487|459163126|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
127599999|NCT00799487|459163127|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
127600000|NCT00799487|459163128|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
127600001|NCT00799487|459163126|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
127600002|NCT00799487|459163127|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
127600003|NCT00799487|459163128|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
127600004|NCT00799487|459163126|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
127695933|NCT00920621|459514762|FG002|Overall Study|Blood sample not collected|0|||
127695934|NCT00920621|459514763|FG003|Overall Study|Blood sample not collected|0|||
127695935|NCT04321031|459514766|FG000|Overall Study|Adverse Event|0|||
127695936|NCT04321031|459514767|FG001|Overall Study|Adverse Event|2|||
128036292|NCT01948427|460762158|FG003|Overall Study|Investigator Request|0|||
128036293|NCT01948427|460762159|FG004|Overall Study|Investigator Request|6|||
128036294|NCT01948427|460762155|FG000|Overall Study|Lost to Follow-up|1|||
128036295|NCT01948427|460762156|FG001|Overall Study|Lost to Follow-up|0|||
128036296|NCT01948427|460762157|FG002|Overall Study|Lost to Follow-up|0|||
128036297|NCT01948427|460762158|FG003|Overall Study|Lost to Follow-up|0|||
127600005|NCT00799487|459163127|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
127600006|NCT00799487|459163128|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
127695937|NCT04321031|459514768|FG002|Overall Study|Adverse Event|2|||
127695938|NCT04321031|459514769|FG003|Overall Study|Adverse Event|2|||
128036298|NCT01948427|460762159|FG004|Overall Study|Lost to Follow-up|4|||
128036299|NCT01948427|460762155|FG000|Overall Study|Withdrawal by Subject|2|||
128036300|NCT01948427|460762156|FG001|Overall Study|Withdrawal by Subject|0|||
128036301|NCT01948427|460762157|FG002|Overall Study|Withdrawal by Subject|0|||
128036302|NCT01948427|460762158|FG003|Overall Study|Withdrawal by Subject|0|||
128036303|NCT01948427|460762159|FG004|Overall Study|Withdrawal by Subject|1|||
128036304|NCT01948427|460762155|FG000|Overall Study|Other, Not Specified|1|||
128036305|NCT01948427|460762156|FG001|Overall Study|Other, Not Specified|9|||
128036306|NCT01948427|460762157|FG002|Overall Study|Other, Not Specified|0|||
128036307|NCT01948427|460762158|FG003|Overall Study|Other, Not Specified|0|||
128036308|NCT01948427|460762159|FG004|Overall Study|Other, Not Specified|2|||
128036309|NCT00402987|460762160|FG000|Overall Study|Lack of Efficacy|0|||
128036310|NCT00402987|460762161|FG001|Overall Study|Lack of Efficacy|0|||
128036311|NCT00402987|460762162|FG002|Overall Study|Lack of Efficacy|1|||
128036312|NCT00402987|460762163|FG003|Overall Study|Lack of Efficacy|0|||
128036313|NCT01500317|460762168|FG000|Overall Study|Withdrawal by Subject|3|||
128036314|NCT01500317|460762169|FG001|Overall Study|Withdrawal by Subject|2|||
128036315|NCT01500317|460762170|FG002|Overall Study|Withdrawal by Subject|0|||
128036316|NCT00335829|460762171|FG000|Overall Study|Withdrawal by Subject|1|||
128036317|NCT00335829|460762171|FG000|Overall Study|Lost to Follow-up|1|||
128036318|NCT00335829|460762171|FG000|Overall Study|Adverse Event|1|||
128036319|NCT02303262|460762177|FG000|Overall Study|Withdrawal by Subject|2|||
128036320|NCT04138056|460762181|FG000|Primary Study|Lost to Follow-up|3|||
128036321|NCT04138056|460762182|FG001|Primary Study|Lost to Follow-up|4|||
128036322|NCT04138056|460762183|FG002|Primary Study|Lost to Follow-up|1|||
128036323|NCT04138056|460762184|FG003|Primary Study|Lost to Follow-up|1|||
128036324|NCT04138056|460762185|FG004|Primary Study|Lost to Follow-up|4|||
128036325|NCT04138056|460762181|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
128036326|NCT04138056|460762182|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
128036327|NCT04138056|460762183|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
128036328|NCT04138056|460762184|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
128036329|NCT04138056|460762185|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
128036330|NCT04138056|460762181|FG000|Extension Study|Lost to Follow-up|1|||
128036331|NCT04138056|460762182|FG001|Extension Study|Lost to Follow-up|2|||
128036332|NCT04138056|460762183|FG002|Extension Study|Lost to Follow-up|1|||
128036333|NCT04138056|460762184|FG003|Extension Study|Lost to Follow-up|0|||
128036334|NCT04138056|460762185|FG004|Extension Study|Lost to Follow-up|1|||
128036335|NCT01215851|460762186|FG000|Treatment Period|Adverse Event|1|||
128036336|NCT01215851|460762187|FG001|Treatment Period|Adverse Event|1|||
128036337|NCT01215851|460762188|FG002|Treatment Period|Adverse Event|1|||
128036338|NCT01215851|460762189|FG003|Treatment Period|Adverse Event|3|||
128036339|NCT01215851|460762190|FG004|Treatment Period|Adverse Event|0|||
128036340|NCT01215851|460762191|FG005|Treatment Period|Adverse Event|1|||
128036341|NCT01215851|460762186|FG000|Follow up Period|Lost to Follow-up|0|||
128036342|NCT01215851|460762187|FG001|Follow up Period|Lost to Follow-up|0|||
128036343|NCT01215851|460762188|FG002|Follow up Period|Lost to Follow-up|0|||
128036344|NCT01215851|460762189|FG003|Follow up Period|Lost to Follow-up|0|||
128036345|NCT01215851|460762190|FG004|Follow up Period|Lost to Follow-up|0|||
128036346|NCT01215851|460762191|FG005|Follow up Period|Lost to Follow-up|1|||
128036347|NCT00862940|460762194|FG000|Overall Study|Adverse Event|15|||
128036348|NCT00862940|460762195|FG001|Overall Study|Adverse Event|12|||
128036349|NCT00862940|460762194|FG000|Overall Study|Lack of Efficacy|1|||
128036350|NCT00862940|460762195|FG001|Overall Study|Lack of Efficacy|3|||
128036351|NCT00862940|460762194|FG000|Overall Study|Protocol Violation|2|||
128036352|NCT00862940|460762195|FG001|Overall Study|Protocol Violation|5|||
128036353|NCT00862940|460762194|FG000|Overall Study|Withdrawal by Subject|4|||
128036354|NCT00862940|460762195|FG001|Overall Study|Withdrawal by Subject|6|||
128036355|NCT00862940|460762194|FG000|Overall Study|Non-compliance|4|||
128036356|NCT00862940|460762195|FG001|Overall Study|Non-compliance|0|||
128036357|NCT00862940|460762194|FG000|Overall Study|Lost to Follow-up|0|||
128036358|NCT00862940|460762195|FG001|Overall Study|Lost to Follow-up|1|||
128036359|NCT00862940|460762194|FG000|Overall Study|Administrative or other reason(s)|4|||
128036360|NCT00862940|460762195|FG001|Overall Study|Administrative or other reason(s)|3|||
128036361|NCT05552859|460762196|FG000|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
128036362|NCT05552859|460762197|FG001|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
128036363|NCT05643495|460762200|FG000|Overall Study|Adverse Event|0|||
128036364|NCT05643495|460762201|FG001|Overall Study|Adverse Event|1|||
128036365|NCT05643495|460762200|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
128036366|NCT05643495|460762201|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
128036367|NCT02257528|460762202|FG000|Overall Study|Never received study treatment|1|||
128036368|NCT06272383|460762203|FG000|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|6|||
128036369|NCT06272383|460762204|FG001|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|4|||
128036370|NCT04696146|460764164|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
128036371|NCT04696146|460764165|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
128036372|NCT04696146|460764164|FG000|Overall Study|Off hours issue with product|1|||
128036373|NCT04696146|460764165|FG001|Overall Study|Off hours issue with product|0|||
128036374|NCT00529633|460764170|FG000|Overall Study|Withdrawal by Subject|1|||
128036375|NCT00529633|460764171|FG001|Overall Study|Withdrawal by Subject|1|||
128036376|NCT01576783|460764175|FG000|Overall Study|Change in Medical Care|1|||
128036377|NCT01576783|460764176|FG001|Overall Study|Change in Medical Care|0|||
128036378|NCT01576783|460764175|FG000|Overall Study|Lost to Follow-up|14|||
128036379|NCT01576783|460764176|FG001|Overall Study|Lost to Follow-up|16|||
128036380|NCT01576783|460764175|FG000|Overall Study|Withdrawal by Subject|5|||
128036381|NCT01576783|460764176|FG001|Overall Study|Withdrawal by Subject|1|||
128036382|NCT01897493|460764178|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
128036383|NCT05489328|460764179|FG000|Overall Study|Lost to Follow-up|0|||
128036384|NCT05489328|460764180|FG001|Overall Study|Lost to Follow-up|0|||
128036385|NCT05489328|460764181|FG002|Overall Study|Lost to Follow-up|1|||
128036386|NCT05489328|460764182|FG003|Overall Study|Lost to Follow-up|0|||
128036387|NCT05489328|460764183|FG004|Overall Study|Lost to Follow-up|2|||
128036388|NCT05489328|460764184|FG005|Overall Study|Lost to Follow-up|0|||
128036389|NCT05489328|460764185|FG006|Overall Study|Lost to Follow-up|0|||
128036390|NCT05489328|460764186|FG007|Overall Study|Lost to Follow-up|1|||
127695939|NCT04321031|459514770|FG004|Overall Study|Adverse Event|2|||
127695940|NCT04321031|459514771|FG005|Overall Study|Adverse Event|2|||
128036391|NCT05489328|460764187|FG008|Overall Study|Lost to Follow-up|0|||
128036392|NCT05489328|460764179|FG000|Overall Study|Withdrawal by Subject|0|||
128036393|NCT05489328|460764180|FG001|Overall Study|Withdrawal by Subject|0|||
128036394|NCT05489328|460764181|FG002|Overall Study|Withdrawal by Subject|0|||
128036395|NCT05489328|460764182|FG003|Overall Study|Withdrawal by Subject|0|||
128036396|NCT05489328|460764183|FG004|Overall Study|Withdrawal by Subject|0|||
128036397|NCT05489328|460764184|FG005|Overall Study|Withdrawal by Subject|0|||
128036398|NCT05489328|460764185|FG006|Overall Study|Withdrawal by Subject|1|||
128036399|NCT05489328|460764186|FG007|Overall Study|Withdrawal by Subject|1|||
128036400|NCT05489328|460764187|FG008|Overall Study|Withdrawal by Subject|0|||
128036401|NCT05489328|460764179|FG000|Overall Study|Other|0|||
128036402|NCT05489328|460764180|FG001|Overall Study|Other|0|||
128036403|NCT05489328|460764181|FG002|Overall Study|Other|0|||
128036404|NCT05489328|460764182|FG003|Overall Study|Other|0|||
128036405|NCT05489328|460764183|FG004|Overall Study|Other|0|||
128036406|NCT05489328|460764184|FG005|Overall Study|Other|0|||
128036407|NCT05489328|460764185|FG006|Overall Study|Other|0|||
128036408|NCT05489328|460764186|FG007|Overall Study|Other|1|||
128036409|NCT05489328|460764187|FG008|Overall Study|Other|1|||
128036410|NCT01083602|460764188|FG000|Overall Study|Adverse Event|11|||
128036411|NCT01083602|460764188|FG000|Overall Study|New Cancer Therapy|2|||
128036412|NCT01083602|460764188|FG000|Overall Study|Death|1|||
128036413|NCT01083602|460764188|FG000|Overall Study|Withdrawal by Subject|5|||
128036414|NCT01083602|460764188|FG000|Overall Study|Lack of Efficacy|36|||
128036415|NCT03698279|460764190|FG000|Overall Study|Withdrawal by parent/guardian|1|||
128036416|NCT03698279|460764191|FG001|Overall Study|Withdrawal by parent/guardian|1|||
128036417|NCT03698279|460764192|FG002|Overall Study|Withdrawal by parent/guardian|1|||
128036418|NCT03698279|460764193|FG003|Overall Study|Withdrawal by parent/guardian|1|||
128036419|NCT03698279|460764194|FG004|Overall Study|Withdrawal by parent/guardian|0|||
128036420|NCT03698279|460764195|FG005|Overall Study|Withdrawal by parent/guardian|0|||
128036421|NCT03698279|460764190|FG000|Overall Study|Protocol deviation|1|||
128036422|NCT03698279|460764191|FG001|Overall Study|Protocol deviation|0|||
128036423|NCT03698279|460764192|FG002|Overall Study|Protocol deviation|1|||
128036424|NCT03698279|460764193|FG003|Overall Study|Protocol deviation|0|||
128036425|NCT03698279|460764194|FG004|Overall Study|Protocol deviation|0|||
128036426|NCT03698279|460764195|FG005|Overall Study|Protocol deviation|0|||
128036427|NCT03698279|460764190|FG000|Overall Study|Withdrawal by Subject|0|||
128036428|NCT03698279|460764191|FG001|Overall Study|Withdrawal by Subject|0|||
128036429|NCT03698279|460764192|FG002|Overall Study|Withdrawal by Subject|1|||
128036430|NCT03698279|460764193|FG003|Overall Study|Withdrawal by Subject|0|||
128036431|NCT03698279|460764194|FG004|Overall Study|Withdrawal by Subject|0|||
128036432|NCT03698279|460764195|FG005|Overall Study|Withdrawal by Subject|0|||
128036433|NCT03698279|460764190|FG000|Overall Study|Lost to Follow-up|3|||
128036434|NCT03698279|460764191|FG001|Overall Study|Lost to Follow-up|1|||
128036435|NCT03698279|460764192|FG002|Overall Study|Lost to Follow-up|4|||
128036436|NCT03698279|460764193|FG003|Overall Study|Lost to Follow-up|5|||
128036437|NCT03698279|460764194|FG004|Overall Study|Lost to Follow-up|0|||
128036438|NCT03698279|460764195|FG005|Overall Study|Lost to Follow-up|0|||
128036439|NCT01276704|460764198|FG000|Overall Study|Lost to Follow-up|2|||
128036440|NCT01276704|460764199|FG001|Overall Study|Lost to Follow-up|3|||
128036441|NCT01276704|460764198|FG000|Overall Study|Non-compliant|2|||
128036442|NCT01276704|460764199|FG001|Overall Study|Non-compliant|2|||
128036443|NCT01276704|460764198|FG000|Overall Study|Withdrawal by Subject|7|||
128036444|NCT01276704|460764199|FG001|Overall Study|Withdrawal by Subject|1|||
128036445|NCT01276704|460764198|FG000|Overall Study|Physician Decision|3|||
128036446|NCT01276704|460764199|FG001|Overall Study|Physician Decision|5|||
128036447|NCT02276040|460764200|FG000|Overall Study|Physician Decision|15|||
128036448|NCT02239926|460764201|FG000|Overall Study|Withdrawal by Subject|0|||
128036449|NCT02239926|460764202|FG001|Overall Study|Withdrawal by Subject|1|||
128036450|NCT03801525|460764203|FG000|Overall Study|Adverse Event|17|||
128036451|NCT03801525|460764204|FG001|Overall Study|Adverse Event|1|||
128036452|NCT03801525|460764205|FG002|Overall Study|Adverse Event|0|||
128036453|NCT03801525|460764203|FG000|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|1|||
128036454|NCT03801525|460764204|FG001|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
128036455|NCT03801525|460764205|FG002|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
128036456|NCT03801525|460764203|FG000|Overall Study|Death|29|||
128036457|NCT03801525|460764204|FG001|Overall Study|Death|1|||
128036458|NCT03801525|460764205|FG002|Overall Study|Death|4|||
128036459|NCT03801525|460764203|FG000|Overall Study|Disease Progression|6|||
127600007|NCT00799487|459163126|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
127600008|NCT00799487|459163127|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
127600009|NCT00799487|459163128|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
128036460|NCT03801525|460764204|FG001|Overall Study|Disease Progression|0|||
128036461|NCT03801525|460764205|FG002|Overall Study|Disease Progression|1|||
128036462|NCT03801525|460764203|FG000|Overall Study|Inability to Comply With Study Requirements|1|||
128036463|NCT03801525|460764204|FG001|Overall Study|Inability to Comply With Study Requirements|1|||
128036464|NCT03801525|460764205|FG002|Overall Study|Inability to Comply With Study Requirements|0|||
128036465|NCT03801525|460764203|FG000|Overall Study|Investigator Decision|18|||
128036466|NCT03801525|460764204|FG001|Overall Study|Investigator Decision|1|||
128036467|NCT03801525|460764205|FG002|Overall Study|Investigator Decision|0|||
128036468|NCT03801525|460764203|FG000|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|14|||
128036469|NCT03801525|460764204|FG001|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
128036470|NCT03801525|460764205|FG002|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
128036471|NCT03801525|460764203|FG000|Overall Study|Sponsor Discontinuation of the Study|24|||
128036472|NCT03801525|460764204|FG001|Overall Study|Sponsor Discontinuation of the Study|49|||
128036473|NCT03801525|460764205|FG002|Overall Study|Sponsor Discontinuation of the Study|43|||
128036474|NCT03801525|460764203|FG000|Overall Study|Started Non-protocol Anti-cancer Therapy|2|||
128036475|NCT03801525|460764204|FG001|Overall Study|Started Non-protocol Anti-cancer Therapy|1|||
128036476|NCT03801525|460764205|FG002|Overall Study|Started Non-protocol Anti-cancer Therapy|3|||
128036477|NCT03801525|460764203|FG000|Overall Study|Withdrawal of Subject Consent|38|||
128036478|NCT03801525|460764204|FG001|Overall Study|Withdrawal of Subject Consent|2|||
128036479|NCT03801525|460764205|FG002|Overall Study|Withdrawal of Subject Consent|1|||
128036480|NCT03801525|460764203|FG000|Overall Study|Reason not Specified|4|||
128036481|NCT03801525|460764204|FG001|Overall Study|Reason not Specified|0|||
128036482|NCT03801525|460764205|FG002|Overall Study|Reason not Specified|4|||
128036483|NCT04388826|460764209|FG000|Overall Study|Lost to Follow-up|3|||
128036484|NCT04388826|460764210|FG001|Overall Study|Lost to Follow-up|2|||
128036485|NCT04388826|460764209|FG000|Overall Study|Adverse Event|1|||
128036486|NCT04388826|460764210|FG001|Overall Study|Adverse Event|0|||
128036487|NCT00329420|460764211|FG000|Re-induction Phase|Lack of Efficacy|0|||
128036488|NCT00329420|460764212|FG001|Re-induction Phase|Lack of Efficacy|1|||
128036489|NCT00329420|460764213|FG002|Re-induction Phase|Lack of Efficacy|0|||
128036490|NCT00329420|460764211|FG000|Re-induction Phase|Withdrawal of Consent|0|||
128036491|NCT00329420|460764212|FG001|Re-induction Phase|Withdrawal of Consent|0|||
128036492|NCT00329420|460764213|FG002|Re-induction Phase|Withdrawal of Consent|1|||
128036493|NCT00329420|460764211|FG000|Re-induction Phase|Did not respond to re-induction|6|||
128036494|NCT00329420|460764212|FG001|Re-induction Phase|Did not respond to re-induction|5|||
128036495|NCT00329420|460764213|FG002|Re-induction Phase|Did not respond to re-induction|7|||
128036496|NCT00329420|460764211|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
128036497|NCT00329420|460764212|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
128036498|NCT00329420|460764213|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
128036499|NCT00329420|460764211|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
128036500|NCT00329420|460764212|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
128036501|NCT00329420|460764213|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
128036502|NCT00329420|460764211|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
128036503|NCT00329420|460764212|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
128036504|NCT00329420|460764213|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
128036505|NCT02862574|460764214|FG000|Double-Blind Treatment Period|Adverse Event|0|||
127882534|NCT01220128|460192839|FG002|Overall Study|Sponsor study termination|0|||
127882535|NCT01220128|460192840|FG003|Overall Study|Sponsor study termination|0|||
127882536|NCT01220128|460192841|FG004|Overall Study|Sponsor study termination|0|||
127882537|NCT01220128|460192842|FG005|Overall Study|Sponsor study termination|0|||
127882538|NCT01220128|460192843|FG006|Overall Study|Sponsor study termination|1|||
127882539|NCT01220128|460192837|FG000|Overall Study|Adverse event, serious fatal|2|||
127882540|NCT01220128|460192838|FG001|Overall Study|Adverse event, serious fatal|0|||
127882541|NCT01220128|460192839|FG002|Overall Study|Adverse event, serious fatal|0|||
127882542|NCT01220128|460192840|FG003|Overall Study|Adverse event, serious fatal|0|||
127882543|NCT01220128|460192841|FG004|Overall Study|Adverse event, serious fatal|0|||
127882544|NCT01220128|460192842|FG005|Overall Study|Adverse event, serious fatal|0|||
127882545|NCT01220128|460192843|FG006|Overall Study|Adverse event, serious fatal|1|||
127882546|NCT01220128|460192837|FG000|Overall Study|Adverse event, non-fatal|1|||
127882547|NCT01220128|460192838|FG001|Overall Study|Adverse event, non-fatal|0|||
127882548|NCT01220128|460192839|FG002|Overall Study|Adverse event, non-fatal|0|||
127882549|NCT01220128|460192840|FG003|Overall Study|Adverse event, non-fatal|0|||
127882550|NCT01220128|460192841|FG004|Overall Study|Adverse event, non-fatal|0|||
127882551|NCT01220128|460192842|FG005|Overall Study|Adverse event, non-fatal|0|||
128036506|NCT02862574|460764215|FG001|Double-Blind Treatment Period|Adverse Event|1|||
127882552|NCT01220128|460192843|FG006|Overall Study|Adverse event, non-fatal|3|||
127882553|NCT01220128|460192837|FG000|Overall Study|Other|0|||
127882554|NCT01220128|460192838|FG001|Overall Study|Other|0|||
128036507|NCT02862574|460764216|FG002|Double-Blind Treatment Period|Adverse Event|0|||
128036508|NCT02862574|460764214|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
128036509|NCT02862574|460764215|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
127600010|NCT00799487|459163126|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
127600011|NCT00799487|459163127|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
127600012|NCT00799487|459163128|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
127600013|NCT00799487|459163126|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
127882555|NCT01220128|460192839|FG002|Overall Study|Other|1|||
128036510|NCT02862574|460764216|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
128036511|NCT02862574|460764214|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
128036512|NCT02862574|460764215|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
128036513|NCT02862574|460764216|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
128036514|NCT03983421|460764217|FG000|Overall Study|Lost to Follow-up|1|||
127882556|NCT01220128|460192840|FG003|Overall Study|Other|0|||
127787573|NCT00666458|459847778|FG000|Overall Study|Adverse Event|8|||
127787574|NCT00666458|459847779|FG001|Overall Study|Adverse Event|7|||
127787575|NCT00666458|459847778|FG000|Overall Study|Withdrawal by Subject|5|||
127787576|NCT00666458|459847779|FG001|Overall Study|Withdrawal by Subject|4|||
127787577|NCT00666458|459847778|FG000|Overall Study|Lost to Follow-up|0|||
127787578|NCT00666458|459847779|FG001|Overall Study|Lost to Follow-up|3|||
127787579|NCT00666458|459847778|FG000|Overall Study|Administrative reason by sponsor|1|||
127787580|NCT00666458|459847779|FG001|Overall Study|Administrative reason by sponsor|1|||
127787581|NCT00666458|459847778|FG000|Overall Study|Incorrect enrollment|7|||
127787582|NCT00666458|459847779|FG001|Overall Study|Incorrect enrollment|1|||
127787583|NCT00666458|459847778|FG000|Overall Study|Study specific discontinuation criteria|14|||
127787584|NCT00666458|459847779|FG001|Overall Study|Study specific discontinuation criteria|7|||
127787585|NCT00666458|459847778|FG000|Overall Study|Severe non-compliance to the protocol|1|||
127787586|NCT00666458|459847779|FG001|Overall Study|Severe non-compliance to the protocol|1|||
127787587|NCT00666458|459847778|FG000|Overall Study|Safety reasons|1|||
127787588|NCT00666458|459847779|FG001|Overall Study|Safety reasons|0|||
127787589|NCT00666458|459847778|FG000|Overall Study|Medical history of anemia|1|||
127787590|NCT00666458|459847779|FG001|Overall Study|Medical history of anemia|0|||
127787591|NCT02222207|459847780|FG000|Overall Study|Death|1|||
127787592|NCT02222207|459847780|FG000|Overall Study|Other reasons|2|||
127787593|NCT02222207|459847780|FG000|Overall Study|Adverse Event|1|||
127787594|NCT02982954|459847781|FG000|Overall Study|Death|55|||
127787595|NCT02982954|459847782|FG001|Overall Study|Death|29|||
127787596|NCT02982954|459847783|FG002|Overall Study|Death|15|||
127787597|NCT02982954|459847784|FG003|Overall Study|Death|20|||
127787598|NCT02982954|459847781|FG000|Overall Study|Lost to Follow-up|2|||
127787599|NCT02982954|459847782|FG001|Overall Study|Lost to Follow-up|1|||
127787600|NCT02982954|459847783|FG002|Overall Study|Lost to Follow-up|0|||
127787601|NCT02982954|459847784|FG003|Overall Study|Lost to Follow-up|0|||
127787602|NCT02982954|459847781|FG000|Overall Study|Participant withdrew consent|7|||
127787603|NCT02982954|459847782|FG001|Overall Study|Participant withdrew consent|5|||
127787604|NCT02982954|459847783|FG002|Overall Study|Participant withdrew consent|1|||
127787605|NCT02982954|459847784|FG003|Overall Study|Participant withdrew consent|1|||
127787606|NCT02982954|459847781|FG000|Overall Study|Other reasons|42|||
127787607|NCT02982954|459847782|FG001|Overall Study|Other reasons|17|||
127787608|NCT02982954|459847783|FG002|Overall Study|Other reasons|12|||
127787609|NCT02982954|459847784|FG003|Overall Study|Other reasons|3|||
127787610|NCT02982954|459847781|FG000|Overall Study|Premature site closure|0|||
127787611|NCT02982954|459847782|FG001|Overall Study|Premature site closure|0|||
127787612|NCT02982954|459847783|FG002|Overall Study|Premature site closure|0|||
127787613|NCT02982954|459847784|FG003|Overall Study|Premature site closure|1|||
127787614|NCT01429584|459847788|FG000|Overall Study|Withdrawal by Subject|1|||
127787615|NCT01429584|459847789|FG001|Overall Study|Withdrawal by Subject|0|||
127787616|NCT01429584|459847788|FG000|Overall Study|Protocol Violation|0|||
127787617|NCT01429584|459847789|FG001|Overall Study|Protocol Violation|1|||
127787618|NCT00747643|459847790|FG000|Overall Study|Withdrawal by Subject|36|||
127787619|NCT00747643|459847791|FG001|Overall Study|Withdrawal by Subject|27|||
127787620|NCT00750698|459847792|FG000|Overall Study|Withdrawal by Subject|1|||
127787621|NCT00750698|459847793|FG001|Overall Study|Withdrawal by Subject|0|||
127882557|NCT01220128|460192841|FG004|Overall Study|Other|0|||
127882558|NCT01220128|460192842|FG005|Overall Study|Other|0|||
127882559|NCT01220128|460192843|FG006|Overall Study|Other|0|||
128036515|NCT03386773|460764218|FG000|Overall Study|Lost to Follow-up|24|||
128036516|NCT03386773|460764219|FG001|Overall Study|Lost to Follow-up|33|||
128036517|NCT03386773|460764218|FG000|Overall Study|Withdrawal by Subject|3|||
128036518|NCT03386773|460764219|FG001|Overall Study|Withdrawal by Subject|2|||
128036519|NCT03639610|460764220|FG000|Overall Study|Adverse Event|7|||
127600014|NCT00799487|459163127|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
127600015|NCT00799487|459163128|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
127600016|NCT00799487|459163126|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
127787622|NCT00750698|459847792|FG000|Overall Study|Progressive disease|5|||
127787623|NCT00750698|459847793|FG001|Overall Study|Progressive disease|2|||
127787624|NCT02263079|459847794|FG000|Overall Study|Physician Decision|1|||
127787625|NCT02263079|459847795|FG001|Overall Study|Physician Decision|0|||
127787626|NCT02263079|459847796|FG002|Overall Study|Physician Decision|0|||
127787627|NCT02263079|459847794|FG000|Overall Study|Withdrawal by Subject|2|||
127787628|NCT02263079|459847795|FG001|Overall Study|Withdrawal by Subject|8|||
127787629|NCT02263079|459847796|FG002|Overall Study|Withdrawal by Subject|0|||
127787630|NCT00402649|459847797|FG000|Overall Study|Lost to Follow-up|1|||
127787631|NCT00402649|459847797|FG000|Overall Study|Withdrawal by Subject|1|||
127787632|NCT01199042|459847800|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
127882560|NCT01220128|460192837|FG000|Overall Study|Consent withdrawn by subject|1|||
128036520|NCT03639610|460764221|FG001|Overall Study|Adverse Event|1|||
128036521|NCT03639610|460764222|FG002|Overall Study|Adverse Event|0|||
128036522|NCT03639610|460764220|FG000|Overall Study|Physician Decision|3|||
128036523|NCT03639610|460764221|FG001|Overall Study|Physician Decision|1|||
128036524|NCT03639610|460764222|FG002|Overall Study|Physician Decision|0|||
128036525|NCT03639610|460764220|FG000|Overall Study|Disease progression|8|||
128036526|NCT03639610|460764221|FG001|Overall Study|Disease progression|5|||
128036527|NCT03639610|460764222|FG002|Overall Study|Disease progression|3|||
128036528|NCT03639610|460764220|FG000|Overall Study|Study terminated by sponsor|2|||
128036529|NCT03639610|460764221|FG001|Overall Study|Study terminated by sponsor|1|||
128036530|NCT03639610|460764222|FG002|Overall Study|Study terminated by sponsor|1|||
128036531|NCT03639610|460764220|FG000|Overall Study|Patient request to stop treatment|1|||
128036532|NCT03639610|460764221|FG001|Overall Study|Patient request to stop treatment|2|||
128036533|NCT03639610|460764222|FG002|Overall Study|Patient request to stop treatment|0|||
128036534|NCT02410772|460764225|FG000|Overall Study|Death|3|||
128036535|NCT02410772|460764226|FG001|Overall Study|Death|4|||
128036536|NCT02410772|460764227|FG002|Overall Study|Death|8|||
128036537|NCT02410772|460764225|FG000|Overall Study|Lost to Follow-up|31|||
128036538|NCT02410772|460764226|FG001|Overall Study|Lost to Follow-up|23|||
128036539|NCT02410772|460764227|FG002|Overall Study|Lost to Follow-up|22|||
128036540|NCT02410772|460764225|FG000|Overall Study|Pregnancy|8|||
128036541|NCT02410772|460764226|FG001|Overall Study|Pregnancy|4|||
128036542|NCT02410772|460764227|FG002|Overall Study|Pregnancy|5|||
128036543|NCT02410772|460764225|FG000|Overall Study|Protocol Violation|8|||
128036544|NCT02410772|460764226|FG001|Overall Study|Protocol Violation|8|||
128036545|NCT02410772|460764227|FG002|Overall Study|Protocol Violation|4|||
128036546|NCT02410772|460764225|FG000|Overall Study|Baseline Drug Resistance|49|||
128036547|NCT02410772|460764226|FG001|Overall Study|Baseline Drug Resistance|40|||
128036548|NCT02410772|460764227|FG002|Overall Study|Baseline Drug Resistance|51|||
128036549|NCT02410772|460764225|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
128036550|NCT02410772|460764226|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
128036551|NCT02410772|460764227|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
128036552|NCT02410772|460764225|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
128036553|NCT02410772|460764226|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
128036554|NCT02410772|460764227|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
128036555|NCT01645176|460764228|FG000|Overall Study|Lack of Efficacy|4|||
128036556|NCT01645176|460764228|FG000|Overall Study|did not complete final MRI|1|||
128036557|NCT02234362|460764229|FG000|Overall Study|Not eligible after first screening visit|17|||
128036558|NCT02234362|460764229|FG000|Overall Study|Lost to Follow-up|6|||
128036559|NCT02234362|460764229|FG000|Overall Study|Withdrawal by Subject|3|||
128036560|NCT00560417|460764230|FG000|Overall Study|Adverse Event|3|||
128036561|NCT00560417|460764231|FG001|Overall Study|Adverse Event|2|||
128036562|NCT00560417|460764230|FG000|Overall Study|Entry Criteria Not Met|1|||
128036563|NCT00560417|460764231|FG001|Overall Study|Entry Criteria Not Met|0|||
128036564|NCT00560417|460764230|FG000|Overall Study|Lost to Follow-up|0|||
128036565|NCT00560417|460764231|FG001|Overall Study|Lost to Follow-up|1|||
128036566|NCT00560417|460764230|FG000|Overall Study|Physician Decision|2|||
128036567|NCT00560417|460764231|FG001|Overall Study|Physician Decision|6|||
128036568|NCT00560417|460764230|FG000|Overall Study|Protocol Violation|6|||
128036569|NCT00560417|460764231|FG001|Overall Study|Protocol Violation|5|||
128036570|NCT00560417|460764230|FG000|Overall Study|Sponsor Decision|2|||
128036571|NCT00560417|460764231|FG001|Overall Study|Sponsor Decision|0|||
128036572|NCT00560417|460764230|FG000|Overall Study|Withdrawal by Subject|3|||
128036573|NCT00560417|460764231|FG001|Overall Study|Withdrawal by Subject|3|||
128036574|NCT02164864|460764234|FG000|Overall Study|Trial disease worsening|7|||
128036575|NCT02164864|460764235|FG001|Overall Study|Trial disease worsening|5|||
128036576|NCT02164864|460764236|FG002|Overall Study|Trial disease worsening|1|||
128036577|NCT02164864|460764234|FG000|Overall Study|Other pre-existing disease worsening|6|||
128036578|NCT02164864|460764235|FG001|Overall Study|Other pre-existing disease worsening|4|||
128036579|NCT02164864|460764236|FG002|Overall Study|Other pre-existing disease worsening|9|||
128036580|NCT02164864|460764234|FG000|Overall Study|Other Adverse Event (AE)|52|||
128036581|NCT02164864|460764235|FG001|Overall Study|Other Adverse Event (AE)|32|||
128036582|NCT02164864|460764236|FG002|Overall Study|Other Adverse Event (AE)|49|||
128036583|NCT02164864|460764234|FG000|Overall Study|Protocol Violation|2|||
128036584|NCT02164864|460764235|FG001|Overall Study|Protocol Violation|4|||
128036585|NCT02164864|460764236|FG002|Overall Study|Protocol Violation|1|||
128036586|NCT02164864|460764234|FG000|Overall Study|Lost to Follow-up|4|||
128036587|NCT02164864|460764235|FG001|Overall Study|Lost to Follow-up|3|||
128036588|NCT02164864|460764236|FG002|Overall Study|Lost to Follow-up|2|||
128036589|NCT02164864|460764234|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
128036590|NCT02164864|460764235|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
128036591|NCT02164864|460764236|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
128036592|NCT02164864|460764234|FG000|Overall Study|Other than stated|3|||
128036593|NCT02164864|460764235|FG001|Overall Study|Other than stated|4|||
128036594|NCT02164864|460764236|FG002|Overall Study|Other than stated|14|||
128036595|NCT02569853|460764237|FG000|Overall Study|Adverse Event|2|||
128036596|NCT02569853|460764238|FG001|Overall Study|Adverse Event|0|||
128036597|NCT02569853|460764237|FG000|Overall Study|Withdrawal by Subject|3|||
127695941|NCT04321031|459514772|FG006|Overall Study|Adverse Event|0|||
127695942|NCT04321031|459514766|FG000|Overall Study|Lost to Follow-up|0|||
127695943|NCT04321031|459514767|FG001|Overall Study|Lost to Follow-up|0|||
127695944|NCT04321031|459514768|FG002|Overall Study|Lost to Follow-up|0|||
127695945|NCT04321031|459514769|FG003|Overall Study|Lost to Follow-up|1|||
127695946|NCT04321031|459514770|FG004|Overall Study|Lost to Follow-up|0|||
127695947|NCT04321031|459514771|FG005|Overall Study|Lost to Follow-up|2|||
127695948|NCT04321031|459514772|FG006|Overall Study|Lost to Follow-up|1|||
127695949|NCT04321031|459514766|FG000|Overall Study|Withdrawal by Subject|2|||
127695950|NCT04321031|459514767|FG001|Overall Study|Withdrawal by Subject|2|||
127695951|NCT04321031|459514768|FG002|Overall Study|Withdrawal by Subject|1|||
127695952|NCT04321031|459514769|FG003|Overall Study|Withdrawal by Subject|3|||
127695953|NCT04321031|459514770|FG004|Overall Study|Withdrawal by Subject|1|||
127695954|NCT04321031|459514771|FG005|Overall Study|Withdrawal by Subject|0|||
127695955|NCT04321031|459514772|FG006|Overall Study|Withdrawal by Subject|1|||
127695956|NCT04321031|459514766|FG000|Overall Study|Non-compliance with study drug|0|||
127695957|NCT04321031|459514767|FG001|Overall Study|Non-compliance with study drug|0|||
127695958|NCT04321031|459514768|FG002|Overall Study|Non-compliance with study drug|0|||
127695959|NCT04321031|459514769|FG003|Overall Study|Non-compliance with study drug|0|||
127695960|NCT04321031|459514770|FG004|Overall Study|Non-compliance with study drug|0|||
127695961|NCT04321031|459514771|FG005|Overall Study|Non-compliance with study drug|1|||
127695962|NCT04321031|459514772|FG006|Overall Study|Non-compliance with study drug|0|||
127695963|NCT04321031|459514766|FG000|Overall Study|Other|0|||
127695964|NCT04321031|459514767|FG001|Overall Study|Other|0|||
127695965|NCT04321031|459514768|FG002|Overall Study|Other|0|||
127695966|NCT04321031|459514769|FG003|Overall Study|Other|1|||
127695967|NCT04321031|459514770|FG004|Overall Study|Other|0|||
127695968|NCT04321031|459514771|FG005|Overall Study|Other|0|||
127695969|NCT04321031|459514772|FG006|Overall Study|Other|0|||
128036598|NCT02569853|460764238|FG001|Overall Study|Withdrawal by Subject|2|||
128036599|NCT02569853|460764237|FG000|Overall Study|Lost to Follow-up|3|||
128036600|NCT02569853|460764238|FG001|Overall Study|Lost to Follow-up|3|||
128036601|NCT02569853|460764237|FG000|Overall Study|Protocol Violation|1|||
128036602|NCT02569853|460764238|FG001|Overall Study|Protocol Violation|1|||
128036603|NCT02569853|460764237|FG000|Overall Study|Did not experience migraine attack|10|||
128036604|NCT02569853|460764238|FG001|Overall Study|Did not experience migraine attack|7|||
128036605|NCT02569853|460764237|FG000|Overall Study|Physician Decision|1|||
128036606|NCT02569853|460764238|FG001|Overall Study|Physician Decision|1|||
128036607|NCT02434081|460764241|FG000|Overall Study|Death (never started treatment)|2|||
128036608|NCT02434081|460764241|FG000|Overall Study|Death|2|||
128036609|NCT02434081|460764241|FG000|Overall Study|Progression|20|||
128036610|NCT02434081|460764241|FG000|Overall Study|Adverse Event|20|||
128036611|NCT02434081|460764241|FG000|Overall Study|Physician Decision|2|||
128036612|NCT02434081|460764241|FG000|Overall Study|Withdrawal by Subject|1|||
128036613|NCT02434081|460764241|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
128036614|NCT00419744|460764242|FG000|Overall Study|Adverse Event|39|||
128036615|NCT00419744|460764243|FG001|Overall Study|Adverse Event|40|||
128036616|NCT00419744|460764244|FG002|Overall Study|Adverse Event|50|||
128036617|NCT00419744|460764242|FG000|Overall Study|Withdrawal by Subject|45|||
128036618|NCT00419744|460764243|FG001|Overall Study|Withdrawal by Subject|49|||
128036619|NCT00419744|460764244|FG002|Overall Study|Withdrawal by Subject|52|||
128036620|NCT00419744|460764242|FG000|Overall Study|Lost to Follow-up|8|||
128036621|NCT00419744|460764243|FG001|Overall Study|Lost to Follow-up|10|||
127695970|NCT04237298|459514773|FG000|Overall Study|Lost to Follow-up|4|||
128036622|NCT00419744|460764244|FG002|Overall Study|Lost to Follow-up|6|||
127695971|NCT04237298|459514774|FG001|Overall Study|Lost to Follow-up|5|||
127695972|NCT02736409|459514775|FG000|Overall Study|Withdrawal by Subject|4|||
127695973|NCT02736409|459514776|FG001|Overall Study|Withdrawal by Subject|2|||
127695974|NCT02736409|459514777|FG002|Overall Study|Withdrawal by Subject|17|||
127695975|NCT02736409|459514778|FG003|Overall Study|Withdrawal by Subject|3|||
127695976|NCT02736409|459514775|FG000|Overall Study|Non-Compliance with Study Drug|0|||
127695977|NCT02736409|459514776|FG001|Overall Study|Non-Compliance with Study Drug|0|||
128036623|NCT00419744|460764242|FG000|Overall Study|Protocol Violation|4|||
128036624|NCT00419744|460764243|FG001|Overall Study|Protocol Violation|7|||
127787633|NCT01199042|459847800|FG000|At Home (3 Months)|Lost to Follow-up|1|||
127787634|NCT01999465|459847801|FG000|Overall Study|Lost to Follow-up|0|||
127787635|NCT01999465|459847802|FG001|Overall Study|Lost to Follow-up|2|||
127787636|NCT01999465|459847801|FG000|Overall Study|Protocol Violation|0|||
127787637|NCT01999465|459847802|FG001|Overall Study|Protocol Violation|1|||
127787638|NCT02554019|459847808|FG000|Overall Study|Withdrawal by Subject|1|||
127787639|NCT02554019|459847809|FG001|Overall Study|Withdrawal by Subject|0|||
127787640|NCT02554019|459847810|FG002|Overall Study|Withdrawal by Subject|2|||
127787641|NCT02554019|459847808|FG000|Overall Study|Adverse Event|1|||
127787642|NCT02554019|459847809|FG001|Overall Study|Adverse Event|0|||
127787643|NCT02554019|459847810|FG002|Overall Study|Adverse Event|0|||
128036625|NCT00419744|460764244|FG002|Overall Study|Protocol Violation|8|||
128036626|NCT00419744|460764242|FG000|Overall Study|Randomized in error|9|||
128036627|NCT00419744|460764243|FG001|Overall Study|Randomized in error|6|||
128036628|NCT00419744|460764244|FG002|Overall Study|Randomized in error|7|||
128036629|NCT00419744|460764242|FG000|Overall Study|Moving out of state|2|||
128036630|NCT00419744|460764243|FG001|Overall Study|Moving out of state|0|||
128036631|NCT00419744|460764244|FG002|Overall Study|Moving out of state|1|||
128036632|NCT00419744|460764242|FG000|Overall Study|Physician Decision|10|||
128036633|NCT00419744|460764243|FG001|Overall Study|Physician Decision|5|||
128036634|NCT00419744|460764244|FG002|Overall Study|Physician Decision|6|||
128036635|NCT00419744|460764242|FG000|Overall Study|Spirometry mouthpiece issues|0|||
128036636|NCT00419744|460764243|FG001|Overall Study|Spirometry mouthpiece issues|1|||
128036637|NCT00419744|460764244|FG002|Overall Study|Spirometry mouthpiece issues|2|||
128036638|NCT00419744|460764242|FG000|Overall Study|Incorrect medication kit dispensed|0|||
128036639|NCT00419744|460764243|FG001|Overall Study|Incorrect medication kit dispensed|0|||
128036640|NCT00419744|460764244|FG002|Overall Study|Incorrect medication kit dispensed|1|||
128036641|NCT01668004|460764245|FG000|Overall Study|Adverse Event|7|||
128036642|NCT01668004|460764245|FG000|Overall Study|Withdrawal by Subject|2|||
128036643|NCT01668004|460764245|FG000|Overall Study|Lost to Follow-up|5|||
128036644|NCT01668004|460764245|FG000|Overall Study|Lack of Efficacy|9|||
128036645|NCT01668004|460764245|FG000|Overall Study|Non-compliance with treatment|2|||
128036646|NCT02448381|460764250|FG000|Overall Study|Adverse Event|2|||
128036647|NCT02448381|460764251|FG001|Overall Study|Adverse Event|0|||
128036648|NCT02448381|460764250|FG000|Overall Study|Lost to Follow-up|16|||
128036649|NCT02448381|460764251|FG001|Overall Study|Lost to Follow-up|9|||
128036650|NCT02448381|460764250|FG000|Overall Study|Physician Decision|1|||
128036651|NCT02448381|460764251|FG001|Overall Study|Physician Decision|1|||
128036652|NCT02448381|460764250|FG000|Overall Study|Pregnancy|1|||
128036653|NCT02448381|460764251|FG001|Overall Study|Pregnancy|0|||
128036654|NCT02448381|460764250|FG000|Overall Study|Withdrawal by Subject|13|||
128036655|NCT02448381|460764251|FG001|Overall Study|Withdrawal by Subject|9|||
128036656|NCT02448381|460764250|FG000|Overall Study|Noncompliance with Study Procedures|2|||
128036657|NCT02448381|460764251|FG001|Overall Study|Noncompliance with Study Procedures|0|||
128036658|NCT02735200|460764254|FG000|Overall Study|Lost to Follow-up|0|||
128036659|NCT02735200|460764255|FG001|Overall Study|Lost to Follow-up|5|||
128036660|NCT02735200|460764254|FG000|Overall Study|Withdrawal by Subject|8|||
128036661|NCT02735200|460764255|FG001|Overall Study|Withdrawal by Subject|0|||
128036662|NCT00673920|460764256|FG000|Baseline up to Week 48|Withdrew consent|1|||
128036663|NCT00673920|460764257|FG001|Baseline up to Week 48|Withdrew consent|0|||
128036664|NCT00673920|460764258|FG002|Baseline up to Week 48|Withdrew consent|2|||
128036665|NCT00673920|460764259|FG003|Baseline up to Week 48|Withdrew consent|0|||
128036666|NCT00673920|460764260|FG004|Baseline up to Week 48|Withdrew consent|0|||
128036667|NCT00673920|460764261|FG005|Baseline up to Week 48|Withdrew consent|0|||
128036668|NCT00673920|460764262|FG006|Baseline up to Week 48|Withdrew consent|0|||
128036669|NCT00673920|460764263|FG007|Baseline up to Week 48|Withdrew consent|0|||
128036670|NCT00673920|460764256|FG000|Baseline up to Week 48|Refused treatment|1|||
128036671|NCT00673920|460764257|FG001|Baseline up to Week 48|Refused treatment|0|||
128036672|NCT00673920|460764258|FG002|Baseline up to Week 48|Refused treatment|0|||
128036673|NCT00673920|460764259|FG003|Baseline up to Week 48|Refused treatment|0|||
128036674|NCT00673920|460764260|FG004|Baseline up to Week 48|Refused treatment|0|||
128036675|NCT00673920|460764261|FG005|Baseline up to Week 48|Refused treatment|0|||
128036676|NCT00673920|460764262|FG006|Baseline up to Week 48|Refused treatment|0|||
128036677|NCT00673920|460764263|FG007|Baseline up to Week 48|Refused treatment|0|||
128036678|NCT00673920|460764256|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
128036679|NCT00673920|460764257|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
127787644|NCT00880399|459847811|FG000|Overall Study|Adverse Event|4|||
128036680|NCT00673920|460764258|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
128036681|NCT00673920|460764259|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
128036682|NCT00673920|460764260|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
128036683|NCT00673920|460764261|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
127787645|NCT00880399|459847812|FG001|Overall Study|Adverse Event|6|||
127787646|NCT00880399|459847813|FG002|Overall Study|Adverse Event|5|||
127787647|NCT00880399|459847811|FG000|Overall Study|Lack of Efficacy|1|||
128036684|NCT00673920|460764262|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
127787648|NCT00880399|459847812|FG001|Overall Study|Lack of Efficacy|4|||
128036685|NCT00673920|460764263|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
128036686|NCT00673920|460764256|FG000|Baseline up to Week 48|Protocol Violation|0|||
128036687|NCT00673920|460764257|FG001|Baseline up to Week 48|Protocol Violation|0|||
128036688|NCT00673920|460764258|FG002|Baseline up to Week 48|Protocol Violation|1|||
128036689|NCT00673920|460764259|FG003|Baseline up to Week 48|Protocol Violation|0|||
128036690|NCT00673920|460764260|FG004|Baseline up to Week 48|Protocol Violation|0|||
128036691|NCT00673920|460764261|FG005|Baseline up to Week 48|Protocol Violation|0|||
128036692|NCT00673920|460764262|FG006|Baseline up to Week 48|Protocol Violation|0|||
128036693|NCT00673920|460764263|FG007|Baseline up to Week 48|Protocol Violation|0|||
128036694|NCT00673920|460764256|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
128036695|NCT00673920|460764257|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
128036696|NCT00673920|460764258|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
128036697|NCT00673920|460764259|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
128036698|NCT00673920|460764260|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
128036699|NCT00673920|460764261|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
128036700|NCT00673920|460764262|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
128036701|NCT00673920|460764263|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
128036702|NCT00673920|460764256|FG000|Baseline up to Week 48|Administrative/Other|0|||
128036703|NCT00673920|460764257|FG001|Baseline up to Week 48|Administrative/Other|1|||
128036704|NCT00673920|460764258|FG002|Baseline up to Week 48|Administrative/Other|2|||
128036705|NCT00673920|460764259|FG003|Baseline up to Week 48|Administrative/Other|0|||
128036706|NCT00673920|460764260|FG004|Baseline up to Week 48|Administrative/Other|0|||
128036707|NCT00673920|460764261|FG005|Baseline up to Week 48|Administrative/Other|0|||
128036708|NCT00673920|460764262|FG006|Baseline up to Week 48|Administrative/Other|0|||
128036709|NCT00673920|460764263|FG007|Baseline up to Week 48|Administrative/Other|0|||
128036710|NCT00673920|460764256|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
128036711|NCT00673920|460764257|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
128036712|NCT00673920|460764258|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
128036713|NCT00673920|460764259|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
128036714|NCT00673920|460764260|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
128036715|NCT00673920|460764261|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
128036716|NCT00673920|460764262|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
128036717|NCT00673920|460764263|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
128036718|NCT00673920|460764256|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
128036719|NCT00673920|460764257|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
128036720|NCT00673920|460764258|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
128036721|NCT00673920|460764259|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
128036722|NCT00673920|460764260|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
128036723|NCT00673920|460764261|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
128036724|NCT00673920|460764262|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
128036725|NCT00673920|460764263|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
128036726|NCT00673920|460764256|FG000|Week 24 to Week 48|Failure to return|0|||
128036727|NCT00673920|460764257|FG001|Week 24 to Week 48|Failure to return|0|||
128036728|NCT00673920|460764258|FG002|Week 24 to Week 48|Failure to return|0|||
128036729|NCT00673920|460764259|FG003|Week 24 to Week 48|Failure to return|0|||
128036730|NCT00673920|460764260|FG004|Week 24 to Week 48|Failure to return|0|||
128036731|NCT00673920|460764261|FG005|Week 24 to Week 48|Failure to return|1|||
128036732|NCT00673920|460764262|FG006|Week 24 to Week 48|Failure to return|0|||
128036733|NCT00673920|460764263|FG007|Week 24 to Week 48|Failure to return|0|||
128036734|NCT00673920|460764256|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
128036735|NCT00673920|460764257|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
128036736|NCT00673920|460764258|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
128036737|NCT00673920|460764259|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
128036738|NCT00673920|460764260|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
128036739|NCT00673920|460764261|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
128036740|NCT00673920|460764262|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
128036741|NCT00673920|460764263|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
128036742|NCT00673920|460764256|FG000|Week 24 to Week 48|Death|0|||
128036743|NCT00673920|460764257|FG001|Week 24 to Week 48|Death|0|||
128036744|NCT00673920|460764258|FG002|Week 24 to Week 48|Death|0|||
127787649|NCT00880399|459847813|FG002|Overall Study|Lack of Efficacy|2|||
127787650|NCT00880399|459847811|FG000|Overall Study|Protocol Violation|4|||
127787651|NCT00880399|459847812|FG001|Overall Study|Protocol Violation|4|||
128036745|NCT00673920|460764259|FG003|Week 24 to Week 48|Death|0|||
128036746|NCT00673920|460764260|FG004|Week 24 to Week 48|Death|0|||
128036747|NCT00673920|460764261|FG005|Week 24 to Week 48|Death|1|||
128036748|NCT00673920|460764262|FG006|Week 24 to Week 48|Death|0|||
128036749|NCT00673920|460764263|FG007|Week 24 to Week 48|Death|0|||
127787652|NCT00880399|459847813|FG002|Overall Study|Protocol Violation|6|||
127787653|NCT00880399|459847811|FG000|Overall Study|Study closed/terminated|3|||
128036750|NCT00673920|460764256|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
128036751|NCT00673920|460764257|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
128036752|NCT00673920|460764258|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
128036753|NCT00673920|460764259|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
128036754|NCT00673920|460764260|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
128036755|NCT00673920|460764261|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
128036756|NCT00673920|460764262|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
128036757|NCT00673920|460764263|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
128036758|NCT01164007|460764264|FG000|Overall Study|Adverse Event|5|||
128036759|NCT01164007|460764264|FG000|Overall Study|Progression of Disease|30|||
128036760|NCT01164007|460764264|FG000|Overall Study|Protocol Violation|1|||
128036761|NCT01164007|460764264|FG000|Overall Study|Withdrawal by Subject|1|||
128036762|NCT01164007|460764264|FG000|Overall Study|Medical Decision|3|||
128036763|NCT05200845|460764265|FG000|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
128036764|NCT05200845|460764266|FG001|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
128036765|NCT05200845|460764267|FG002|Overall Study|stopped collecting pilot data for metabolic chamber|2|||
128036766|NCT05200845|460764268|FG003|Overall Study|stopped collecting pilot data for metabolic chamber|0|||
128036767|NCT05200845|460764265|FG000|Overall Study|Withdrawal by Subject|0|||
128036768|NCT05200845|460764266|FG001|Overall Study|Withdrawal by Subject|1|||
128036769|NCT05200845|460764267|FG002|Overall Study|Withdrawal by Subject|1|||
128036770|NCT05200845|460764268|FG003|Overall Study|Withdrawal by Subject|0|||
128036771|NCT01656161|460764278|FG000|Overall Study|Death|3|||
128036772|NCT01656161|460764278|FG000|Overall Study|Adverse Event|2|||
128036773|NCT01656161|460764278|FG000|Overall Study|Protocol Violation|1|||
128036774|NCT01656161|460764278|FG000|Overall Study|Withdrawal by Subject|1|||
128036775|NCT03510273|460764279|FG000|Overall Study|Withdrawal by Subject|2|||
128036776|NCT03510273|460764279|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
128036777|NCT03510273|460764279|FG000|Overall Study|Moved away from study area|4|||
128036778|NCT01276106|460764280|FG000|Overall Study|Adverse Event|3|||
128036779|NCT01276106|460764281|FG001|Overall Study|Adverse Event|3|||
128036780|NCT01276106|460764282|FG002|Overall Study|Adverse Event|11|||
128036781|NCT01276106|460764283|FG003|Overall Study|Adverse Event|3|||
128036782|NCT01276106|460764280|FG000|Overall Study|Withdrawal by Subject|6|||
128036783|NCT01276106|460764281|FG001|Overall Study|Withdrawal by Subject|3|||
128036784|NCT01276106|460764282|FG002|Overall Study|Withdrawal by Subject|1|||
128036785|NCT01276106|460764283|FG003|Overall Study|Withdrawal by Subject|6|||
128036786|NCT01276106|460764280|FG000|Overall Study|Lack of Efficacy|0|||
128036787|NCT01276106|460764281|FG001|Overall Study|Lack of Efficacy|1|||
128036788|NCT01276106|460764282|FG002|Overall Study|Lack of Efficacy|0|||
128036789|NCT01276106|460764283|FG003|Overall Study|Lack of Efficacy|1|||
128036790|NCT01276106|460764280|FG000|Overall Study|Lost to Follow-up|2|||
128036791|NCT01276106|460764281|FG001|Overall Study|Lost to Follow-up|1|||
128036792|NCT01276106|460764282|FG002|Overall Study|Lost to Follow-up|1|||
128036793|NCT01276106|460764283|FG003|Overall Study|Lost to Follow-up|0|||
128036794|NCT01276106|460764280|FG000|Overall Study|Physician Decision|0|||
128036795|NCT01276106|460764281|FG001|Overall Study|Physician Decision|0|||
128036796|NCT01276106|460764282|FG002|Overall Study|Physician Decision|1|||
127787654|NCT00880399|459847812|FG001|Overall Study|Study closed/terminated|7|||
128036797|NCT01276106|460764283|FG003|Overall Study|Physician Decision|1|||
128036798|NCT01276106|460764280|FG000|Overall Study|Protocol Violation|1|||
128036799|NCT01276106|460764281|FG001|Overall Study|Protocol Violation|1|||
128036800|NCT01276106|460764282|FG002|Overall Study|Protocol Violation|0|||
128036801|NCT01276106|460764283|FG003|Overall Study|Protocol Violation|2|||
128036802|NCT01276106|460764280|FG000|Overall Study|Insufficient therapeutic effects|0|||
128036803|NCT01276106|460764281|FG001|Overall Study|Insufficient therapeutic effects|0|||
128036804|NCT01276106|460764282|FG002|Overall Study|Insufficient therapeutic effects|2|||
128036805|NCT01276106|460764283|FG003|Overall Study|Insufficient therapeutic effects|0|||
128036806|NCT04079738|460764287|FG000|Study Treatment|Death|1|||
128036807|NCT04079738|460764288|FG001|Study Treatment|Death|0|||
128036808|NCT04079738|460764289|FG002|Study Treatment|Death|0|||
128036809|NCT04079738|460764290|FG003|Study Treatment|Death|0|||
128036810|NCT04079738|460764287|FG000|Study Treatment|Adverse Event|2|||
127787655|NCT00880399|459847813|FG002|Overall Study|Study closed/terminated|4|||
128036811|NCT04079738|460764288|FG001|Study Treatment|Adverse Event|0|||
128036812|NCT04079738|460764289|FG002|Study Treatment|Adverse Event|0|||
128036813|NCT04079738|460764290|FG003|Study Treatment|Adverse Event|0|||
128036814|NCT04079738|460764287|FG000|Study Treatment|withdrawal before treatment|1|||
128036815|NCT04079738|460764288|FG001|Study Treatment|withdrawal before treatment|0|||
128036816|NCT04079738|460764289|FG002|Study Treatment|withdrawal before treatment|0|||
128036817|NCT04079738|460764290|FG003|Study Treatment|withdrawal before treatment|0|||
128036818|NCT04079738|460764287|FG000|Study Treatment|symptomatic deterioration|2|||
128036819|NCT04079738|460764288|FG001|Study Treatment|symptomatic deterioration|0|||
128036820|NCT04079738|460764289|FG002|Study Treatment|symptomatic deterioration|0|||
128036821|NCT04079738|460764290|FG003|Study Treatment|symptomatic deterioration|0|||
128036822|NCT04079738|460764287|FG000|Study Treatment|Disease Progression|1|||
127787656|NCT00880399|459847811|FG000|Overall Study|Lost to Follow-up|8|||
128036823|NCT04079738|460764288|FG001|Study Treatment|Disease Progression|0|||
128036824|NCT04079738|460764289|FG002|Study Treatment|Disease Progression|0|||
128036825|NCT04079738|460764290|FG003|Study Treatment|Disease Progression|0|||
128036826|NCT04079738|460764287|FG000|Study Treatment|withdrawal after treatment|1|||
128036827|NCT04079738|460764288|FG001|Study Treatment|withdrawal after treatment|0|||
128036828|NCT04079738|460764289|FG002|Study Treatment|withdrawal after treatment|0|||
128036829|NCT04079738|460764290|FG003|Study Treatment|withdrawal after treatment|0|||
128036830|NCT04079738|460764287|FG000|Follow up|Withdrawal by Subject|3|||
128036831|NCT04079738|460764288|FG001|Follow up|Withdrawal by Subject|0|||
128036832|NCT04079738|460764289|FG002|Follow up|Withdrawal by Subject|0|||
128036833|NCT04079738|460764290|FG003|Follow up|Withdrawal by Subject|0|||
128036834|NCT04079738|460764287|FG000|Follow up|Death|5|||
128036835|NCT04079738|460764288|FG001|Follow up|Death|0|||
128036836|NCT04079738|460764289|FG002|Follow up|Death|0|||
128036837|NCT04079738|460764290|FG003|Follow up|Death|0|||
128036838|NCT00867035|460764293|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
128036839|NCT00867035|460764294|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
128036840|NCT00867035|460764293|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
128036841|NCT00867035|460764294|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
128036842|NCT00404248|460764295|FG000|Overall Study|pts declining status|0|||
128036843|NCT00404248|460764296|FG001|Overall Study|pts declining status|1|||
128036844|NCT00404248|460764297|FG002|Overall Study|pts declining status|0|||
128036845|NCT00404248|460764298|FG003|Overall Study|pts declining status|0|||
128036846|NCT00404248|460764299|FG004|Overall Study|pts declining status|0|||
128036847|NCT00404248|460764300|FG005|Overall Study|pts declining status|0|||
128036848|NCT00404248|460764301|FG006|Overall Study|pts declining status|0|||
128036849|NCT00404248|460764302|FG007|Overall Study|pts declining status|0|||
128036850|NCT00404248|460764303|FG008|Overall Study|pts declining status|0|||
128036851|NCT00789555|460764304|FG000|Overall Study|Protocol Amendment|78|||
128036852|NCT00789555|460764305|FG001|Overall Study|Protocol Amendment|76|||
128036853|NCT00789555|460764306|FG002|Overall Study|Protocol Amendment|80|||
128036854|NCT00789555|460764304|FG000|Overall Study|Adverse Event|17|||
128036855|NCT00789555|460764305|FG001|Overall Study|Adverse Event|7|||
128036856|NCT00789555|460764306|FG002|Overall Study|Adverse Event|10|||
128036857|NCT00789555|460764304|FG000|Overall Study|Lost to Follow-up|9|||
128036858|NCT00789555|460764305|FG001|Overall Study|Lost to Follow-up|10|||
128036859|NCT00789555|460764306|FG002|Overall Study|Lost to Follow-up|18|||
128036860|NCT00789555|460764304|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
128036861|NCT00789555|460764305|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
128036862|NCT00789555|460764306|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
128036863|NCT00789555|460764304|FG000|Overall Study|Treatment failure|11|||
128036864|NCT00789555|460764305|FG001|Overall Study|Treatment failure|8|||
128036865|NCT00789555|460764306|FG002|Overall Study|Treatment failure|12|||
128036866|NCT00789555|460764304|FG000|Overall Study|Protocol Violation|6|||
128036867|NCT00789555|460764305|FG001|Overall Study|Protocol Violation|9|||
128036868|NCT00789555|460764306|FG002|Overall Study|Protocol Violation|13|||
128036869|NCT04646005|460764307|FG000|Overall Study|Adverse Event|1|||
128036870|NCT04646005|460764307|FG000|Overall Study|Progressive Disease|71|||
128036871|NCT04646005|460764307|FG000|Overall Study|Death|20|||
128036872|NCT04646005|460764307|FG000|Overall Study|Withdrawal by Subject|12|||
128036873|NCT04646005|460764307|FG000|Overall Study|Sponsor Request|9|||
128036874|NCT04398706|460764308|FG000|Overall Study|Adverse Event|0|||
128036875|NCT04398706|460764309|FG001|Overall Study|Adverse Event|0|||
128036876|NCT04398706|460764310|FG002|Overall Study|Adverse Event|0|||
127787657|NCT00880399|459847812|FG001|Overall Study|Lost to Follow-up|5|||
127787658|NCT00880399|459847813|FG002|Overall Study|Lost to Follow-up|3|||
127787659|NCT00880399|459847811|FG000|Overall Study|Physician Decision|5|||
128036877|NCT04398706|460764311|FG003|Overall Study|Adverse Event|0|||
128036878|NCT04398706|460764312|FG004|Overall Study|Adverse Event|0|||
128036879|NCT04398706|460764313|FG005|Overall Study|Adverse Event|1|||
128036880|NCT04398706|460764314|FG006|Overall Study|Adverse Event|1|||
128036881|NCT04398706|460764315|FG007|Overall Study|Adverse Event|0|||
128036882|NCT04398706|460764308|FG000|Overall Study|Lost to Follow-up|0|||
128036883|NCT04398706|460764309|FG001|Overall Study|Lost to Follow-up|1|||
128036884|NCT04398706|460764310|FG002|Overall Study|Lost to Follow-up|2|||
128036885|NCT04398706|460764311|FG003|Overall Study|Lost to Follow-up|1|||
128036886|NCT04398706|460764312|FG004|Overall Study|Lost to Follow-up|6|||
128036887|NCT04398706|460764313|FG005|Overall Study|Lost to Follow-up|3|||
127787660|NCT00880399|459847812|FG001|Overall Study|Physician Decision|0|||
128036888|NCT04398706|460764314|FG006|Overall Study|Lost to Follow-up|8|||
128036889|NCT04398706|460764315|FG007|Overall Study|Lost to Follow-up|2|||
127787661|NCT00880399|459847813|FG002|Overall Study|Physician Decision|3|||
128036890|NCT04398706|460764308|FG000|Overall Study|Withdrawal by parent/guardian|0|||
128036891|NCT04398706|460764309|FG001|Overall Study|Withdrawal by parent/guardian|2|||
128036892|NCT04398706|460764310|FG002|Overall Study|Withdrawal by parent/guardian|1|||
128036893|NCT04398706|460764311|FG003|Overall Study|Withdrawal by parent/guardian|2|||
128036894|NCT04398706|460764312|FG004|Overall Study|Withdrawal by parent/guardian|19|||
127787662|NCT00880399|459847811|FG000|Overall Study|Withdrawal by Subject|6|||
128036895|NCT04398706|460764313|FG005|Overall Study|Withdrawal by parent/guardian|23|||
128036896|NCT04398706|460764314|FG006|Overall Study|Withdrawal by parent/guardian|13|||
128036897|NCT04398706|460764315|FG007|Overall Study|Withdrawal by parent/guardian|11|||
128036898|NCT04398706|460764308|FG000|Overall Study|Protocol deviation|0|||
128036899|NCT04398706|460764309|FG001|Overall Study|Protocol deviation|1|||
128036900|NCT04398706|460764310|FG002|Overall Study|Protocol deviation|0|||
128036901|NCT04398706|460764311|FG003|Overall Study|Protocol deviation|0|||
128036902|NCT04398706|460764312|FG004|Overall Study|Protocol deviation|6|||
128036903|NCT04398706|460764313|FG005|Overall Study|Protocol deviation|4|||
128036904|NCT04398706|460764314|FG006|Overall Study|Protocol deviation|6|||
128036905|NCT04398706|460764315|FG007|Overall Study|Protocol deviation|3|||
127695978|NCT02736409|459514777|FG002|Overall Study|Non-Compliance with Study Drug|0|||
127695979|NCT02736409|459514778|FG003|Overall Study|Non-Compliance with Study Drug|1|||
127695980|NCT02736409|459514775|FG000|Overall Study|Adverse Event|0|||
127695981|NCT02736409|459514776|FG001|Overall Study|Adverse Event|1|||
127695982|NCT02736409|459514777|FG002|Overall Study|Adverse Event|5|||
127695983|NCT02736409|459514778|FG003|Overall Study|Adverse Event|4|||
127695984|NCT02736409|459514775|FG000|Overall Study|Other|0|||
127695985|NCT02736409|459514776|FG001|Overall Study|Other|0|||
128036906|NCT04237584|460764316|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
128036907|NCT04237584|460764317|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
128036908|NCT04237584|460764318|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
128036909|NCT04237584|460764319|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
128036910|NCT04237584|460764316|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
128036911|NCT04237584|460764317|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
128036912|NCT04237584|460764318|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
128036913|NCT04237584|460764319|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
128036914|NCT04237584|460764316|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
128036915|NCT04237584|460764317|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
128036916|NCT04237584|460764318|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
128036917|NCT04237584|460764319|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
128036918|NCT04237584|460764316|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
128036919|NCT04237584|460764317|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
128036920|NCT04237584|460764318|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
128036921|NCT04237584|460764319|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
128036922|NCT04237584|460764316|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
128036923|NCT04237584|460764317|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
128036924|NCT04237584|460764318|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
128036925|NCT04237584|460764319|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
128036926|NCT03586973|460764320|FG000|Overall Study|Death|15|||
128036927|NCT03586973|460764321|FG001|Overall Study|Death|8|||
128036928|NCT03586973|460764320|FG000|Overall Study|Site Terminated by Sponsor|3|||
128036929|NCT03586973|460764321|FG001|Overall Study|Site Terminated by Sponsor|6|||
128036930|NCT03586973|460764320|FG000|Overall Study|Withdrawal by Subject|1|||
128036931|NCT03586973|460764321|FG001|Overall Study|Withdrawal by Subject|0|||
128036932|NCT03586973|460764320|FG000|Overall Study|Lost to Follow-up|1|||
128036933|NCT03586973|460764321|FG001|Overall Study|Lost to Follow-up|0|||
128036934|NCT05239221|460764327|FG000|Overall Study|Adverse Event|0|||
128036935|NCT05239221|460764328|FG001|Overall Study|Adverse Event|0|||
128036936|NCT05239221|460764329|FG002|Overall Study|Adverse Event|0|||
128036937|NCT05239221|460764330|FG003|Overall Study|Adverse Event|0|||
128036938|NCT05239221|460764331|FG004|Overall Study|Adverse Event|0|||
128036939|NCT05239221|460764332|FG005|Overall Study|Adverse Event|0|||
128036940|NCT05239221|460764333|FG006|Overall Study|Adverse Event|1|||
128036941|NCT05239221|460764334|FG007|Overall Study|Adverse Event|0|||
128036942|NCT05239221|460764335|FG008|Overall Study|Adverse Event|0|||
128036943|NCT05239221|460764336|FG009|Overall Study|Adverse Event|0|||
128036944|NCT05239221|460764337|FG010|Overall Study|Adverse Event|1|||
128036945|NCT05239221|460764338|FG011|Overall Study|Adverse Event|1|||
128036946|NCT05239221|460764339|FG012|Overall Study|Adverse Event|0|||
128036947|NCT05239221|460764340|FG013|Overall Study|Adverse Event|0|||
128036948|NCT05239221|460764341|FG014|Overall Study|Adverse Event|0|||
127695986|NCT02736409|459514777|FG002|Overall Study|Other|1|||
127695987|NCT02736409|459514778|FG003|Overall Study|Other|1|||
127695988|NCT02736409|459514775|FG000|Overall Study|Pregnancy|0|||
128036949|NCT05239221|460764342|FG015|Overall Study|Adverse Event|0|||
128036950|NCT05239221|460764327|FG000|Overall Study|Withdrawal by Subject|0|||
128036951|NCT05239221|460764328|FG001|Overall Study|Withdrawal by Subject|0|||
128036952|NCT05239221|460764329|FG002|Overall Study|Withdrawal by Subject|0|||
128036953|NCT05239221|460764330|FG003|Overall Study|Withdrawal by Subject|0|||
128036954|NCT05239221|460764331|FG004|Overall Study|Withdrawal by Subject|0|||
128036955|NCT05239221|460764332|FG005|Overall Study|Withdrawal by Subject|0|||
128036956|NCT05239221|460764333|FG006|Overall Study|Withdrawal by Subject|0|||
128036957|NCT05239221|460764334|FG007|Overall Study|Withdrawal by Subject|0|||
128036958|NCT05239221|460764335|FG008|Overall Study|Withdrawal by Subject|0|||
128036959|NCT05239221|460764336|FG009|Overall Study|Withdrawal by Subject|0|||
128036960|NCT05239221|460764337|FG010|Overall Study|Withdrawal by Subject|1|||
128036961|NCT05239221|460764338|FG011|Overall Study|Withdrawal by Subject|0|||
128036962|NCT05239221|460764339|FG012|Overall Study|Withdrawal by Subject|0|||
128036963|NCT05239221|460764340|FG013|Overall Study|Withdrawal by Subject|0|||
128036964|NCT05239221|460764341|FG014|Overall Study|Withdrawal by Subject|0|||
128036965|NCT05239221|460764342|FG015|Overall Study|Withdrawal by Subject|1|||
128036966|NCT02661672|460764343|FG000|Overall Study|Lost to Follow-up|1|||
128036967|NCT02661672|460764343|FG000|Overall Study|Death|4|||
128036968|NCT02581930|460764344|FG000|Overall Study|Withdrawal by Subject|1|||
128036969|NCT02581930|460764344|FG000|Overall Study|patient declined further treatment|1|||
128036970|NCT01170663|460765385|FG000|Overall Study|Lost to Follow-up|3|||
128036971|NCT01170663|460765386|FG001|Overall Study|Lost to Follow-up|9|||
128036972|NCT01170663|460765385|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
128036973|NCT01170663|460765386|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
128036974|NCT02006927|460765389|FG000|Overall Study|Adverse Event|2|||
128036975|NCT02006927|460765389|FG000|Overall Study|Withdrawal by Subject|1|||
128036976|NCT02746809|460765392|FG000|Enrollment|Inclusion Exclusion not met|9|||
128036977|NCT02746809|460765392|FG000|Enrollment|Withdrawal by Subject|1|||
128036978|NCT02746809|460765392|FG000|Enrollment|Expected Enrollment Met|2|||
128036979|NCT02746809|460765392|FG000|Procedure|Death|1|||
128036980|NCT02746809|460765392|FG000|1-Month|Death|5|||
128036981|NCT02746809|460765392|FG000|6-Month|Death|2|||
128036982|NCT02746809|460765392|FG000|6-Month|Withdrawal by Subject|1|||
128036983|NCT02746809|460765392|FG000|12-Month|Death|3|||
128036984|NCT02746809|460765392|FG000|12-Month|Withdrawal by Subject|2|||
128036985|NCT02746809|460765392|FG000|24-Month|Death|1|||
128036986|NCT02746809|460765392|FG000|24-Month|Withdrawal by Subject|1|||
128036987|NCT02746809|460765392|FG000|36-Month|Death|8|||
128036988|NCT02746809|460765392|FG000|36-Month|Withdrawal by Subject|1|||
128036989|NCT02746809|460765392|FG000|48-Month|Death|7|||
128036990|NCT02746809|460765392|FG000|48-Month|Withdrawal by Subject|1|||
128036991|NCT02746809|460765392|FG000|60-Month|Death|1|||
128036992|NCT02746809|460765392|FG000|60-Month|Lost to Follow-up|2|||
128036993|NCT00894387|460765395|FG000|Overall Study|Adverse Event|44|||
128036994|NCT00894387|460765396|FG001|Overall Study|Adverse Event|45|||
128036995|NCT00894387|460765395|FG000|Overall Study|Abnormal Laboratory values|2|||
128036996|NCT00894387|460765396|FG001|Overall Study|Abnormal Laboratory values|2|||
128036997|NCT00894387|460765395|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
128036998|NCT00894387|460765396|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
128036999|NCT00894387|460765395|FG000|Overall Study|Lost to Follow-up|3|||
128037000|NCT00894387|460765396|FG001|Overall Study|Lost to Follow-up|5|||
128037001|NCT00894387|460765395|FG000|Overall Study|Administrative problems|2|||
128037002|NCT00894387|460765396|FG001|Overall Study|Administrative problems|2|||
128037003|NCT00894387|460765395|FG000|Overall Study|Death|77|||
128037004|NCT00894387|460765396|FG001|Overall Study|Death|76|||
128037005|NCT00894387|460765395|FG000|Overall Study|Protocol Deviation|4|||
128037006|NCT00894387|460765396|FG001|Overall Study|Protocol Deviation|0|||
128037007|NCT00894387|460765395|FG000|Overall Study|Patient's request|25|||
128037008|NCT00894387|460765396|FG001|Overall Study|Patient's request|30|||
128037009|NCT00894387|460765395|FG000|Overall Study|Other (Missing)|5|||
128037010|NCT00894387|460765396|FG001|Overall Study|Other (Missing)|3|||
128037011|NCT00894387|460765395|FG000|Overall Study|Mis-randomized|13|||
128037012|NCT00894387|460765396|FG001|Overall Study|Mis-randomized|9|||
128037013|NCT00894387|460765395|FG000|Overall Study|GCP non-compliance|0|||
128037014|NCT00894387|460765396|FG001|Overall Study|GCP non-compliance|2|||
128037015|NCT04856527|460765397|FG000|Overall Study|Unable to complete experimental task|2|||
128037016|NCT04856527|460765398|FG001|Overall Study|Unable to complete experimental task|0|||
128037017|NCT01816295|460765399|FG000|Double Blind Phase|Adverse Event|11|||
128037018|NCT01816295|460765400|FG001|Double Blind Phase|Adverse Event|8|||
128037019|NCT01816295|460765399|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
128037020|NCT01816295|460765400|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
128037021|NCT01816295|460765399|FG000|Double Blind Phase|Lost to Follow-up|3|||
128037022|NCT01816295|460765400|FG001|Double Blind Phase|Lost to Follow-up|5|||
128037023|NCT01816295|460765399|FG000|Double Blind Phase|Physician Decision|2|||
128037024|NCT01816295|460765400|FG001|Double Blind Phase|Physician Decision|2|||
128037025|NCT01816295|460765399|FG000|Double Blind Phase|Protocol Violation|17|||
128037026|NCT01816295|460765400|FG001|Double Blind Phase|Protocol Violation|11|||
128037027|NCT01816295|460765399|FG000|Double Blind Phase|Sponsor Decision|8|||
128037028|NCT01816295|460765400|FG001|Double Blind Phase|Sponsor Decision|8|||
128037029|NCT01816295|460765399|FG000|Double Blind Phase|Withdrawal by Subject|22|||
128037030|NCT01816295|460765400|FG001|Double Blind Phase|Withdrawal by Subject|20|||
128037031|NCT01816295|460765399|FG000|OLE Phase|Adverse Event|17|||
128037032|NCT01816295|460765400|FG001|OLE Phase|Adverse Event|15|||
128037033|NCT01816295|460765399|FG000|OLE Phase|Death|1|||
128037034|NCT01816295|460765400|FG001|OLE Phase|Death|0|||
128037035|NCT01816295|460765399|FG000|OLE Phase|Entry Criteria Not Met|3|||
128037036|NCT01816295|460765400|FG001|OLE Phase|Entry Criteria Not Met|5|||
128037037|NCT01816295|460765399|FG000|OLE Phase|Lost to Follow-up|5|||
128037038|NCT01816295|460765400|FG001|OLE Phase|Lost to Follow-up|5|||
128037039|NCT01816295|460765399|FG000|OLE Phase|Physician Decision|3|||
128037040|NCT01816295|460765400|FG001|OLE Phase|Physician Decision|1|||
128037041|NCT01816295|460765399|FG000|OLE Phase|Protocol Violation|4|||
128037042|NCT01816295|460765400|FG001|OLE Phase|Protocol Violation|4|||
128037043|NCT01816295|460765399|FG000|OLE Phase|Sponsor Decision|7|||
128037044|NCT01816295|460765400|FG001|OLE Phase|Sponsor Decision|9|||
128037045|NCT01816295|460765399|FG000|OLE Phase|Withdrawal by Subject|10|||
128037046|NCT01816295|460765400|FG001|OLE Phase|Withdrawal by Subject|10|||
128037047|NCT01816295|460765399|FG000|OLE Phase|Lack of Efficacy|3|||
128037048|NCT01816295|460765400|FG001|OLE Phase|Lack of Efficacy|7|||
128037049|NCT04165824|460765401|FG000|Overall Study|Adverse Event|23|||
128037050|NCT04165824|460765401|FG000|Overall Study|Physician Decision|1|||
128037051|NCT04165824|460765401|FG000|Overall Study|Withdrawal by Subject|17|||
128037052|NCT04165824|460765401|FG000|Overall Study|Other|5|||
128037053|NCT04562116|460765408|FG000|Overall Study|Lost to Follow-up|1|||
128037054|NCT04562116|460765408|FG000|Overall Study|Withdrawal by Subject|3|||
128037055|NCT02412670|460765411|FG000|Overall Study|Adverse Event|4|||
128037056|NCT02412670|460765412|FG001|Overall Study|Adverse Event|1|||
128037057|NCT02412670|460765411|FG000|Overall Study|Physician Decision|1|||
128037058|NCT02412670|460765412|FG001|Overall Study|Physician Decision|0|||
128037059|NCT02412670|460765411|FG000|Overall Study|Withdrawal by Subject|1|||
128037060|NCT02412670|460765412|FG001|Overall Study|Withdrawal by Subject|0|||
128037061|NCT02412670|460765411|FG000|Overall Study|Ineligible|1|||
128037062|NCT02412670|460765412|FG001|Overall Study|Ineligible|0|||
128037063|NCT02921256|460765418|FG000|Arm 1a v. Arm II|Adverse Event|6|||
128037064|NCT02921256|460765419|FG001|Arm 1a v. Arm II|Adverse Event|15|||
128037065|NCT02921256|460765420|FG002|Arm 1a v. Arm II|Adverse Event|0|||
128037066|NCT02921256|460765418|FG000|Arm 1a v. Arm II|Death|0|||
128037067|NCT02921256|460765419|FG001|Arm 1a v. Arm II|Death|2|||
128037068|NCT02921256|460765420|FG002|Arm 1a v. Arm II|Death|0|||
128037069|NCT02921256|460765418|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
128037070|NCT02921256|460765419|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
128037071|NCT02921256|460765420|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
128037072|NCT02921256|460765418|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
128037073|NCT02921256|460765419|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
128037074|NCT02921256|460765420|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
128037075|NCT02921256|460765418|FG000|Arm 1a v. Arm II|Physician Decision|1|||
128037076|NCT02921256|460765419|FG001|Arm 1a v. Arm II|Physician Decision|1|||
128037077|NCT02921256|460765420|FG002|Arm 1a v. Arm II|Physician Decision|0|||
128037078|NCT02921256|460765418|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
128037079|NCT02921256|460765419|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
128037080|NCT02921256|460765420|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
128037081|NCT02921256|460765418|FG000|Arm Ib v Arm III|Adverse Event|9|||
128037082|NCT02921256|460765419|FG001|Arm Ib v Arm III|Adverse Event|0|||
128037083|NCT02921256|460765420|FG002|Arm Ib v Arm III|Adverse Event|4|||
128037084|NCT02921256|460765418|FG000|Arm Ib v Arm III|Death|1|||
128037085|NCT02921256|460765419|FG001|Arm Ib v Arm III|Death|0|||
128037086|NCT02921256|460765420|FG002|Arm Ib v Arm III|Death|1|||
128037087|NCT02921256|460765418|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
128037088|NCT02921256|460765419|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
128037089|NCT02921256|460765420|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
128037090|NCT02921256|460765418|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
128037091|NCT02921256|460765419|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
128037092|NCT02921256|460765420|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
128037093|NCT02921256|460765418|FG000|Arm Ib v Arm III|Physician Decision|4|||
128037094|NCT02921256|460765419|FG001|Arm Ib v Arm III|Physician Decision|0|||
128037095|NCT02921256|460765420|FG002|Arm Ib v Arm III|Physician Decision|1|||
128037096|NCT02921256|460765418|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
128037097|NCT02921256|460765419|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
128037098|NCT02921256|460765420|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
128037099|NCT02943473|460765421|FG000|Overall Study|enrolled but not dosed|1|||
128037100|NCT02943473|460765421|FG000|Overall Study|screen failure|1|||
128037101|NCT02943473|460765421|FG000|Overall Study|Physician Decision|4|||
128037102|NCT04211363|460765424|FG000|Overall Study|Adverse Event|5|||
128037103|NCT04211363|460765425|FG001|Overall Study|Adverse Event|2|||
128037104|NCT04211363|460765424|FG000|Overall Study|Physician Decision|0|||
128037105|NCT04211363|460765425|FG001|Overall Study|Physician Decision|1|||
128037106|NCT04211363|460765424|FG000|Overall Study|Protocol Violation|1|||
128037107|NCT04211363|460765425|FG001|Overall Study|Protocol Violation|0|||
128037108|NCT04211363|460765424|FG000|Overall Study|Pregnancy|1|||
128037109|NCT04211363|460765425|FG001|Overall Study|Pregnancy|0|||
128037110|NCT04211363|460765424|FG000|Overall Study|Lost to Follow-up|12|||
128037111|NCT04211363|460765425|FG001|Overall Study|Lost to Follow-up|4|||
128037112|NCT04211363|460765424|FG000|Overall Study|Withdrawal by Subject|11|||
128037113|NCT04211363|460765425|FG001|Overall Study|Withdrawal by Subject|11|||
128037114|NCT04211363|460765424|FG000|Overall Study|Other|1|||
128037115|NCT04211363|460765425|FG001|Overall Study|Other|2|||
128037116|NCT03097289|460765426|FG000|Overall Study|Adverse Event|1|||
128037117|NCT03097289|460765426|FG000|Overall Study|Equipment failure|2|||
128037118|NCT03097289|460765426|FG000|Overall Study|Collected platelet product unusable|3|||
128037119|NCT01823289|460765427|FG000|Overall Study|Lost to Follow-up|5|||
128037120|NCT01823289|460765427|FG000|Overall Study|Adverse Event|5|||
128037121|NCT01823289|460765427|FG000|Overall Study|Lack of Efficacy|1|||
128037122|NCT01823289|460765427|FG000|Overall Study|Physician Decision|9|||
128037123|NCT01823289|460765427|FG000|Overall Study|Administered contraindicated medicine|1|||
128037124|NCT01823289|460765427|FG000|Overall Study|Transaminase increased more than 3 times|1|||
128037125|NCT01823289|460765427|FG000|Overall Study|Drug affected efficacy and safety|1|||
127882561|NCT01220128|460192838|FG001|Overall Study|Consent withdrawn by subject|0|||
128037126|NCT01823289|460765427|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
128037127|NCT01736917|460765428|FG000|Overall Study|Adverse Event|1|||
128037128|NCT01736917|460765428|FG000|Overall Study|Protocol Violation|10|||
128037129|NCT01911260|460765429|FG000|Supplementation Period|transference or evasion of school|7|||
128037130|NCT01911260|460765430|FG001|Supplementation Period|transference or evasion of school|9|||
128037131|NCT01911260|460765431|FG002|Supplementation Period|transference or evasion of school|7|||
128037132|NCT01911260|460765432|FG003|Supplementation Period|transference or evasion of school|6|||
128037133|NCT01911260|460765429|FG000|Supplementation Period|Adverse Event|2|||
128037134|NCT01911260|460765430|FG001|Supplementation Period|Adverse Event|0|||
128037135|NCT01911260|460765431|FG002|Supplementation Period|Adverse Event|1|||
128037136|NCT01911260|460765432|FG003|Supplementation Period|Adverse Event|0|||
128037137|NCT01911260|460765429|FG000|Supplementation Period|refused to receive supplement|1|||
128037138|NCT01911260|460765430|FG001|Supplementation Period|refused to receive supplement|0|||
128037139|NCT01911260|460765431|FG002|Supplementation Period|refused to receive supplement|1|||
128037140|NCT01911260|460765432|FG003|Supplementation Period|refused to receive supplement|0|||
128037141|NCT01911260|460765429|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
128037142|NCT01911260|460765430|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
128037143|NCT01911260|460765431|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
128037144|NCT01911260|460765432|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
128037145|NCT01911260|460765429|FG000|Follow-up Period|transference or evasion of school|13|||
128037146|NCT01911260|460765430|FG001|Follow-up Period|transference or evasion of school|20|||
128037147|NCT01911260|460765431|FG002|Follow-up Period|transference or evasion of school|15|||
128037148|NCT01911260|460765432|FG003|Follow-up Period|transference or evasion of school|12|||
128037149|NCT00654732|460765433|FG000|Overall Study|Adverse Event|4|||
128037150|NCT00654732|460765434|FG001|Overall Study|Adverse Event|6|||
128037151|NCT01734902|460765437|FG000|Overall Study|Other than listed|0|||
128037152|NCT01734902|460765438|FG001|Overall Study|Other than listed|2|||
128037153|NCT01959932|460765439|FG000|Overall Study|Withdrawal by Subject|1|||
128037154|NCT01959932|460765440|FG001|Overall Study|Withdrawal by Subject|0|||
128037155|NCT01959932|460765441|FG002|Overall Study|Withdrawal by Subject|0|||
128037156|NCT00060944|460765444|FG000|Overall Study|Adverse Event|12|||
128037157|NCT00060944|460765445|FG001|Overall Study|Adverse Event|10|||
128037158|NCT00060944|460765444|FG000|Overall Study|Death|2|||
128037159|NCT00060944|460765445|FG001|Overall Study|Death|3|||
128037160|NCT00060944|460765444|FG000|Overall Study|Withdrawal by Subject|18|||
128037161|NCT00060944|460765445|FG001|Overall Study|Withdrawal by Subject|5|||
128037162|NCT00060944|460765444|FG000|Overall Study|Disease Progression|93|||
128037163|NCT00060944|460765445|FG001|Overall Study|Disease Progression|94|||
128037164|NCT00060944|460765444|FG000|Overall Study|Lost to Follow-up|1|||
128037165|NCT00060944|460765445|FG001|Overall Study|Lost to Follow-up|0|||
128037166|NCT00060944|460765444|FG000|Overall Study|Subject Ineligible To Continue|2|||
128037167|NCT00060944|460765445|FG001|Overall Study|Subject Ineligible To Continue|1|||
128037168|NCT00060944|460765444|FG000|Overall Study|Treatment Switch|0|||
128037169|NCT00060944|460765445|FG001|Overall Study|Treatment Switch|13|||
128037170|NCT00060944|460765444|FG000|Overall Study|Other|2|||
128037171|NCT00060944|460765445|FG001|Overall Study|Other|4|||
128037172|NCT00060944|460765444|FG000|Overall Study|randomized but not treated|6|||
128037173|NCT00060944|460765445|FG001|Overall Study|randomized but not treated|4|||
128037174|NCT00776230|460765449|FG000|Overall Study|Lost to Follow-up|2|||
128037175|NCT00776230|460765450|FG001|Overall Study|Lost to Follow-up|1|||
128037176|NCT00776230|460765451|FG002|Overall Study|Lost to Follow-up|5|||
128037177|NCT00776230|460765449|FG000|Overall Study|Not vaccinated at Day 0|1|||
128037178|NCT00776230|460765450|FG001|Overall Study|Not vaccinated at Day 0|0|||
128037179|NCT00776230|460765451|FG002|Overall Study|Not vaccinated at Day 0|0|||
128037180|NCT00776230|460765449|FG000|Overall Study|Withdrawal by Subject|0|||
128037181|NCT00776230|460765450|FG001|Overall Study|Withdrawal by Subject|1|||
128037182|NCT00776230|460765451|FG002|Overall Study|Withdrawal by Subject|0|||
128037183|NCT00776230|460765449|FG000|Overall Study|Subject missed Visit 4|0|||
128037184|NCT00776230|460765450|FG001|Overall Study|Subject missed Visit 4|1|||
128037185|NCT00776230|460765451|FG002|Overall Study|Subject missed Visit 4|0|||
128037186|NCT01242514|460765453|FG000|Overall Study|e.g., project closure|1042|||
128037187|NCT01242514|460765454|FG001|Overall Study|e.g., project closure|305|||
128037188|NCT01242514|460765455|FG002|Overall Study|e.g., project closure|171|||
128037189|NCT01242514|460765453|FG000|Overall Study|Subject decision|33|||
128037190|NCT01242514|460765454|FG001|Overall Study|Subject decision|8|||
128037191|NCT01242514|460765455|FG002|Overall Study|Subject decision|2|||
128037192|NCT01242514|460765453|FG000|Overall Study|Severe non-compliance to protocol|5|||
128037193|NCT01242514|460765454|FG001|Overall Study|Severe non-compliance to protocol|2|||
128037194|NCT01242514|460765455|FG002|Overall Study|Severe non-compliance to protocol|1|||
128037195|NCT01242514|460765453|FG000|Overall Study|Lack of therapeutic response|99|||
128037196|NCT01242514|460765454|FG001|Overall Study|Lack of therapeutic response|16|||
128037197|NCT01242514|460765455|FG002|Overall Study|Lack of therapeutic response|10|||
128037198|NCT01242514|460765453|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
128037199|NCT01242514|460765454|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
128037200|NCT01242514|460765455|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
128037201|NCT01242514|460765453|FG000|Overall Study|Lost to Follow-up|14|||
128037202|NCT01242514|460765454|FG001|Overall Study|Lost to Follow-up|5|||
128037203|NCT01242514|460765455|FG002|Overall Study|Lost to Follow-up|4|||
128037204|NCT01242514|460765453|FG000|Overall Study|Adverse Event|129|||
128037205|NCT01242514|460765454|FG001|Overall Study|Adverse Event|18|||
128037206|NCT01242514|460765455|FG002|Overall Study|Adverse Event|19|||
128037207|NCT03213509|460765469|FG000|Overall Study|Did not consent for verbal autopsy|4|||
128037208|NCT03213509|460765470|FG001|Overall Study|Did not consent for verbal autopsy|5|||
128037209|NCT04549454|460765473|FG000|T1 to T2|Lost to Follow-up|22|||
128037210|NCT04549454|460765474|FG001|T1 to T2|Lost to Follow-up|26|||
128037211|NCT04549454|460765473|FG000|T1 to T3|Lost to Follow-up|31|||
128037212|NCT04549454|460765474|FG001|T1 to T3|Lost to Follow-up|36|||
128037213|NCT00016354|460765475|FG000|Overall Study|Lack of Efficacy|0|||
128037214|NCT00016354|460765476|FG001|Overall Study|Lack of Efficacy|0|||
128037215|NCT00016354|460765477|FG002|Overall Study|Lack of Efficacy|0|||
128037216|NCT00016354|460765478|FG003|Overall Study|Lack of Efficacy|0|||
128037217|NCT00016354|460765479|FG004|Overall Study|Lack of Efficacy|0|||
128037218|NCT00016354|460765480|FG005|Overall Study|Lack of Efficacy|0|||
128037219|NCT00016354|460765481|FG006|Overall Study|Lack of Efficacy|0|||
128037220|NCT00016354|460765482|FG007|Overall Study|Lack of Efficacy|1|||
128037221|NCT03110562|460765483|FG000|Initial Treatment Period|Disease Progression|1|||
128037222|NCT03110562|460765484|FG001|Initial Treatment Period|Disease Progression|1|||
128037223|NCT03110562|460765485|FG002|Initial Treatment Period|Disease Progression|0|||
128037224|NCT03110562|460765486|FG003|Initial Treatment Period|Disease Progression|0|||
128037225|NCT03110562|460765483|FG000|Initial Treatment Period|Withdrawal by Subject|39|||
128037226|NCT03110562|460765484|FG001|Initial Treatment Period|Withdrawal by Subject|41|||
128037227|NCT03110562|460765485|FG002|Initial Treatment Period|Withdrawal by Subject|0|||
128037228|NCT03110562|460765486|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
128037229|NCT03110562|460765483|FG000|Initial Treatment Period|Adverse Event|1|||
128037230|NCT03110562|460765484|FG001|Initial Treatment Period|Adverse Event|0|||
128037231|NCT03110562|460765485|FG002|Initial Treatment Period|Adverse Event|0|||
128037232|NCT03110562|460765486|FG003|Initial Treatment Period|Adverse Event|0|||
128037233|NCT03110562|460765483|FG000|Initial Treatment Period|Death|74|||
128037234|NCT03110562|460765484|FG001|Initial Treatment Period|Death|82|||
128037235|NCT03110562|460765485|FG002|Initial Treatment Period|Death|0|||
128037236|NCT03110562|460765486|FG003|Initial Treatment Period|Death|0|||
128037237|NCT03110562|460765483|FG000|Initial Treatment Period|Lost to Follow-up|13|||
128037238|NCT03110562|460765484|FG001|Initial Treatment Period|Lost to Follow-up|8|||
128037239|NCT03110562|460765485|FG002|Initial Treatment Period|Lost to Follow-up|0|||
128037240|NCT03110562|460765486|FG003|Initial Treatment Period|Lost to Follow-up|0|||
128037241|NCT03110562|460765483|FG000|Initial Treatment Period|Protocol Deviation|1|||
128037242|NCT03110562|460765484|FG001|Initial Treatment Period|Protocol Deviation|0|||
128037243|NCT03110562|460765485|FG002|Initial Treatment Period|Protocol Deviation|0|||
128037244|NCT03110562|460765486|FG003|Initial Treatment Period|Protocol Deviation|0|||
128037245|NCT03110562|460765483|FG000|Initial Treatment Period|Physician Decision|2|||
128037246|NCT03110562|460765484|FG001|Initial Treatment Period|Physician Decision|1|||
128037247|NCT03110562|460765485|FG002|Initial Treatment Period|Physician Decision|0|||
128037248|NCT03110562|460765486|FG003|Initial Treatment Period|Physician Decision|0|||
128037249|NCT03110562|460765483|FG000|Initial Treatment Period|Participants withdrawn due to company goals|59|||
128037250|NCT03110562|460765484|FG001|Initial Treatment Period|Participants withdrawn due to company goals|67|||
128037251|NCT03110562|460765485|FG002|Initial Treatment Period|Participants withdrawn due to company goals|0|||
128037252|NCT03110562|460765486|FG003|Initial Treatment Period|Participants withdrawn due to company goals|0|||
128037253|NCT03110562|460765483|FG000|Initial Treatment Period|Other|5|||
128037254|NCT03110562|460765484|FG001|Initial Treatment Period|Other|4|||
128037255|NCT03110562|460765485|FG002|Initial Treatment Period|Other|0|||
128037256|NCT03110562|460765486|FG003|Initial Treatment Period|Other|0|||
128037257|NCT03110562|460765483|FG000|Initial Treatment Period|Randomized but never treated|0|||
128037258|NCT03110562|460765484|FG001|Initial Treatment Period|Randomized but never treated|3|||
128037259|NCT03110562|460765485|FG002|Initial Treatment Period|Randomized but never treated|0|||
128037260|NCT03110562|460765486|FG003|Initial Treatment Period|Randomized but never treated|0|||
128037261|NCT03110562|460765483|FG000|Crossover Period|Disease Progression|0|||
128037262|NCT03110562|460765484|FG001|Crossover Period|Disease Progression|0|||
128037263|NCT03110562|460765485|FG002|Crossover Period|Disease Progression|1|||
128037264|NCT03110562|460765486|FG003|Crossover Period|Disease Progression|0|||
128037265|NCT03110562|460765483|FG000|Crossover Period|Withdrawal by Subject|0|||
128037266|NCT03110562|460765484|FG001|Crossover Period|Withdrawal by Subject|0|||
128037267|NCT03110562|460765485|FG002|Crossover Period|Withdrawal by Subject|8|||
128037268|NCT03110562|460765486|FG003|Crossover Period|Withdrawal by Subject|6|||
128037269|NCT03110562|460765483|FG000|Crossover Period|Death|0|||
128037270|NCT03110562|460765484|FG001|Crossover Period|Death|0|||
128037271|NCT03110562|460765485|FG002|Crossover Period|Death|37|||
128037272|NCT03110562|460765486|FG003|Crossover Period|Death|3|||
128037273|NCT03110562|460765483|FG000|Crossover Period|Lost to Follow-up|0|||
128037274|NCT03110562|460765484|FG001|Crossover Period|Lost to Follow-up|0|||
128037275|NCT03110562|460765485|FG002|Crossover Period|Lost to Follow-up|0|||
128037276|NCT03110562|460765486|FG003|Crossover Period|Lost to Follow-up|1|||
128037277|NCT03110562|460765483|FG000|Crossover Period|Other|0|||
128037278|NCT03110562|460765484|FG001|Crossover Period|Other|0|||
128037279|NCT03110562|460765485|FG002|Crossover Period|Other|1|||
128037280|NCT03110562|460765486|FG003|Crossover Period|Other|1|||
128037281|NCT03110562|460765483|FG000|Crossover Period|Participants withdrawn due to company goals|0|||
128037282|NCT03110562|460765484|FG001|Crossover Period|Participants withdrawn due to company goals|0|||
128037283|NCT03110562|460765485|FG002|Crossover Period|Participants withdrawn due to company goals|19|||
128037284|NCT03110562|460765486|FG003|Crossover Period|Participants withdrawn due to company goals|3|||
128037285|NCT02936323|460765489|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
128037286|NCT02936323|460765490|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
128037287|NCT02936323|460765491|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
128037288|NCT02936323|460765492|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
128037289|NCT02936323|460765493|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
128037290|NCT02936323|460765494|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
128037291|NCT02936323|460765495|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
128037292|NCT02936323|460765496|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
128037293|NCT02936323|460765497|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
128037294|NCT02936323|460765498|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
128037295|NCT02936323|460765489|FG000|Phase 1 Dose Escalation|Death|2|||
128037296|NCT02936323|460765490|FG001|Phase 1 Dose Escalation|Death|1|||
128037297|NCT02936323|460765491|FG002|Phase 1 Dose Escalation|Death|3|||
128037298|NCT02936323|460765492|FG003|Phase 1 Dose Escalation|Death|1|||
128037299|NCT02936323|460765493|FG004|Phase 1 Dose Escalation|Death|2|||
128037300|NCT02936323|460765494|FG005|Phase 1 Dose Escalation|Death|3|||
128037301|NCT02936323|460765495|FG006|Phase 1 Dose Escalation|Death|3|||
128037302|NCT02936323|460765496|FG007|Phase 1 Dose Escalation|Death|0|||
128037303|NCT02936323|460765497|FG008|Phase 1 Dose Escalation|Death|0|||
128037304|NCT02936323|460765498|FG009|Phase 1 Dose Escalation|Death|0|||
128037305|NCT02936323|460765489|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
128037306|NCT02936323|460765490|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
128037307|NCT02936323|460765491|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
128037308|NCT02936323|460765492|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
128037309|NCT02936323|460765493|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
128037310|NCT02936323|460765494|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
128037311|NCT02936323|460765495|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
128037312|NCT02936323|460765496|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
128037313|NCT02936323|460765497|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
128037314|NCT02936323|460765498|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
128037315|NCT02936323|460765489|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
128037316|NCT02936323|460765490|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
127787663|NCT00880399|459847812|FG001|Overall Study|Withdrawal by Subject|3|||
127787664|NCT00880399|459847813|FG002|Overall Study|Withdrawal by Subject|3|||
128037317|NCT02936323|460765491|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
128037318|NCT02936323|460765492|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
128037319|NCT02936323|460765493|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
128037320|NCT02936323|460765494|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
128037321|NCT02936323|460765495|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
128037322|NCT02936323|460765496|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
128037323|NCT02936323|460765497|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
128037324|NCT02936323|460765498|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
128037325|NCT02936323|460765489|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
128037326|NCT02936323|460765490|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
128037327|NCT02936323|460765491|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
128037328|NCT02936323|460765492|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
128037329|NCT02936323|460765493|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
127787665|NCT04353284|459847814|FG000|Overall Study|Adverse Event|1|||
128037330|NCT02936323|460765494|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
128037331|NCT02936323|460765495|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
128037332|NCT02936323|460765496|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
128037333|NCT02936323|460765497|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
128037334|NCT02936323|460765498|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
128037335|NCT02936323|460765489|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
128037336|NCT02936323|460765490|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
128037337|NCT02936323|460765491|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
128037338|NCT02936323|460765492|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
128037339|NCT02936323|460765493|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
128037340|NCT02936323|460765494|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
128037341|NCT02936323|460765495|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
128037342|NCT02936323|460765496|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
128037343|NCT02936323|460765497|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
128037344|NCT02936323|460765498|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
128037345|NCT02936323|460765489|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
128037346|NCT02936323|460765490|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
128037347|NCT02936323|460765491|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
128037348|NCT02936323|460765492|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
128037349|NCT02936323|460765493|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
128037350|NCT02936323|460765494|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
128037351|NCT02936323|460765495|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
127787666|NCT04353284|459847815|FG001|Overall Study|Adverse Event|1|||
127787667|NCT04353284|459847814|FG000|Overall Study|Lost to Follow-up|1|||
127787668|NCT04353284|459847815|FG001|Overall Study|Lost to Follow-up|0|||
127787669|NCT00751400|459847819|FG000|Overall Study|Lost to Follow-up|10|||
127787670|NCT00441974|459847824|FG000|Overall Study|Adverse Event|6|||
127787671|NCT00441974|459847824|FG000|Overall Study|Consent Withdrawn|35|||
127787672|NCT00441974|459847824|FG000|Overall Study|Lost to Follow-up|80|||
127787673|NCT00441974|459847824|FG000|Overall Study|Protocol Violation|7|||
127787674|NCT02770547|459847825|FG000|Overall Study|Patient non-compliant|1|||
127787675|NCT02770547|459847826|FG001|Overall Study|Patient non-compliant|0|||
127787676|NCT02770547|459847825|FG000|Overall Study|Adverse Event|0|||
127787677|NCT02770547|459847826|FG001|Overall Study|Adverse Event|1|||
127787678|NCT01148537|459847827|FG000|Overall Study|Withdrawal by Subject|1|||
127787679|NCT01148537|459847828|FG001|Overall Study|Withdrawal by Subject|0|||
127787680|NCT01148537|459847829|FG002|Overall Study|Withdrawal by Subject|2|||
127787681|NCT01148537|459847827|FG000|Overall Study|Adverse Event|2|||
127787682|NCT01148537|459847828|FG001|Overall Study|Adverse Event|0|||
127787683|NCT01148537|459847829|FG002|Overall Study|Adverse Event|1|||
127787684|NCT00393887|459847830|FG000|Overall Study|Physician Decision|5|||
127787685|NCT00393887|459847831|FG001|Overall Study|Physician Decision|0|||
127787686|NCT00393887|459847830|FG000|Overall Study|Lost to Follow-up|11|||
127787687|NCT00393887|459847831|FG001|Overall Study|Lost to Follow-up|9|||
127787688|NCT01617070|459847832|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
127787689|NCT00777101|459847833|FG000|Overall Study|Death|48|||
127787690|NCT00777101|459847834|FG001|Overall Study|Death|43|||
127787691|NCT00777101|459847833|FG000|Overall Study|Withdrawal by Subject|11|||
127787692|NCT00777101|459847834|FG001|Overall Study|Withdrawal by Subject|6|||
127787693|NCT00777101|459847833|FG000|Overall Study|Lost to Follow-up|2|||
127787694|NCT00777101|459847834|FG001|Overall Study|Lost to Follow-up|1|||
127787695|NCT00777101|459847833|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
127787696|NCT00777101|459847834|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
127787697|NCT00777101|459847833|FG000|Overall Study|Failed to Return|0|||
127787698|NCT00777101|459847834|FG001|Overall Study|Failed to Return|1|||
127787699|NCT02230384|459847835|FG000|Phase 1|Lost to Follow-up|1|||
127787700|NCT02230384|459847836|FG001|Phase 1|Lost to Follow-up|0|||
128037352|NCT02936323|460765496|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
128037353|NCT02936323|460765497|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
128037354|NCT02936323|460765498|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
128037355|NCT02936323|460765489|FG000|Phase 2a Dose Expansion|Death|0|||
128037356|NCT02936323|460765490|FG001|Phase 2a Dose Expansion|Death|0|||
128037357|NCT02936323|460765491|FG002|Phase 2a Dose Expansion|Death|0|||
127787701|NCT02230384|459847835|FG000|Phase 1|Physician Decision|0|||
127787702|NCT02230384|459847836|FG001|Phase 1|Physician Decision|1|||
127787703|NCT02230384|459847835|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
127787704|NCT02230384|459847836|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
127787705|NCT02230384|459847835|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
127787706|NCT02230384|459847836|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
127787707|NCT02230384|459847835|FG000|Phase 2 - Switch|Adverse Event|2|||
127787708|NCT02230384|459847836|FG001|Phase 2 - Switch|Adverse Event|0|||
127787709|NCT00808236|459847837|FG000|Overall Study|Was not resuscitated|50|||
127787710|NCT00808236|459847838|FG001|Overall Study|Was not resuscitated|56|||
127787711|NCT00808236|459847837|FG000|Overall Study|Pre-defined exclusion|13|||
127787712|NCT00808236|459847838|FG001|Overall Study|Pre-defined exclusion|3|||
127787713|NCT00808236|459847837|FG000|Overall Study|Lost to Follow-up|1|||
128037358|NCT02936323|460765492|FG003|Phase 2a Dose Expansion|Death|0|||
128037359|NCT02936323|460765493|FG004|Phase 2a Dose Expansion|Death|0|||
128037360|NCT02936323|460765494|FG005|Phase 2a Dose Expansion|Death|0|||
128037361|NCT02936323|460765495|FG006|Phase 2a Dose Expansion|Death|0|||
128037362|NCT02936323|460765496|FG007|Phase 2a Dose Expansion|Death|4|||
128037363|NCT02936323|460765497|FG008|Phase 2a Dose Expansion|Death|8|||
128037364|NCT02936323|460765498|FG009|Phase 2a Dose Expansion|Death|10|||
128037365|NCT02611037|460765499|FG000|Overall Study|Withdrawal prior to treatment|2|||
128037366|NCT02611037|460765500|FG001|Overall Study|Withdrawal prior to treatment|0|||
128037367|NCT05788991|460765501|FG000|Overall Study|Not treated with study medication|1|||
128037368|NCT05788991|460765502|FG001|Overall Study|Not treated with study medication|3|||
128037369|NCT05788991|460765501|FG000|Overall Study|Withdrawal by Subject|1|||
128037370|NCT05788991|460765502|FG001|Overall Study|Withdrawal by Subject|0|||
128037371|NCT05788991|460765501|FG000|Overall Study|Lack of Efficacy|0|||
128037372|NCT05788991|460765502|FG001|Overall Study|Lack of Efficacy|1|||
128037373|NCT05788991|460765501|FG000|Overall Study|Protocol Violation|1|||
128037374|NCT05788991|460765502|FG001|Overall Study|Protocol Violation|2|||
128037375|NCT05270863|460765503|FG000|Visit 2 First Intervention|Randomization error|0|||
128037376|NCT05270863|460765504|FG001|Visit 2 First Intervention|Randomization error|0|||
128037377|NCT05270863|460765505|FG002|Visit 2 First Intervention|Randomization error|0|||
128037378|NCT05270863|460765506|FG003|Visit 2 First Intervention|Randomization error|1|||
128037379|NCT05270863|460765507|FG004|Visit 2 First Intervention|Randomization error|0|||
128037380|NCT05270863|460765508|FG005|Visit 2 First Intervention|Randomization error|0|||
128037381|NCT05270863|460765503|FG000|First Washout|Withdrawal by Subject|0|||
128037382|NCT05270863|460765504|FG001|First Washout|Withdrawal by Subject|0|||
128037383|NCT05270863|460765505|FG002|First Washout|Withdrawal by Subject|0|||
128037384|NCT05270863|460765506|FG003|First Washout|Withdrawal by Subject|0|||
128037385|NCT05270863|460765507|FG004|First Washout|Withdrawal by Subject|1|||
128037386|NCT05270863|460765508|FG005|First Washout|Withdrawal by Subject|1|||
128037387|NCT05270863|460765503|FG000|First Washout|Lost to Follow-up|0|||
128037388|NCT05270863|460765504|FG001|First Washout|Lost to Follow-up|0|||
128037389|NCT05270863|460765505|FG002|First Washout|Lost to Follow-up|0|||
128037390|NCT05270863|460765506|FG003|First Washout|Lost to Follow-up|0|||
128037391|NCT05270863|460765507|FG004|First Washout|Lost to Follow-up|0|||
128037392|NCT05270863|460765508|FG005|First Washout|Lost to Follow-up|1|||
128037393|NCT05270863|460765503|FG000|Visit 3 Second Intervention|Inclusion Criteria|1|||
128037394|NCT05270863|460765504|FG001|Visit 3 Second Intervention|Inclusion Criteria|0|||
128037395|NCT05270863|460765505|FG002|Visit 3 Second Intervention|Inclusion Criteria|1|||
128037396|NCT05270863|460765506|FG003|Visit 3 Second Intervention|Inclusion Criteria|0|||
128037397|NCT05270863|460765507|FG004|Visit 3 Second Intervention|Inclusion Criteria|0|||
128037398|NCT05270863|460765508|FG005|Visit 3 Second Intervention|Inclusion Criteria|0|||
128037399|NCT05270863|460765503|FG000|Second Washout|Withdrawal by Subject|1|||
128037400|NCT05270863|460765504|FG001|Second Washout|Withdrawal by Subject|1|||
128037401|NCT05270863|460765505|FG002|Second Washout|Withdrawal by Subject|0|||
128037402|NCT05270863|460765506|FG003|Second Washout|Withdrawal by Subject|0|||
128037403|NCT05270863|460765507|FG004|Second Washout|Withdrawal by Subject|0|||
128037404|NCT05270863|460765508|FG005|Second Washout|Withdrawal by Subject|0|||
128037405|NCT05270863|460765503|FG000|Second Washout|Lost to Follow-up|0|||
128037406|NCT05270863|460765504|FG001|Second Washout|Lost to Follow-up|0|||
128037407|NCT05270863|460765505|FG002|Second Washout|Lost to Follow-up|0|||
128037408|NCT05270863|460765506|FG003|Second Washout|Lost to Follow-up|1|||
128037409|NCT05270863|460765507|FG004|Second Washout|Lost to Follow-up|0|||
128037410|NCT05270863|460765508|FG005|Second Washout|Lost to Follow-up|0|||
128037411|NCT04464473|460765509|FG000|Overall Study|New piercing could not be removed for scanning|0|||
128037412|NCT04464473|460765510|FG001|Overall Study|New piercing could not be removed for scanning|0|||
128037413|NCT04464473|460765511|FG002|Overall Study|New piercing could not be removed for scanning|0|||
128037414|NCT04464473|460765512|FG003|Overall Study|New piercing could not be removed for scanning|1|||
128037415|NCT04464473|460765513|FG004|Overall Study|New piercing could not be removed for scanning|0|||
128037416|NCT04464473|460765514|FG005|Overall Study|New piercing could not be removed for scanning|0|||
128037417|NCT04464473|460765509|FG000|Overall Study|Adverse Event|0|||
128037418|NCT04464473|460765510|FG001|Overall Study|Adverse Event|0|||
128037419|NCT04464473|460765511|FG002|Overall Study|Adverse Event|0|||
128037420|NCT04464473|460765512|FG003|Overall Study|Adverse Event|1|||
128037421|NCT04464473|460765513|FG004|Overall Study|Adverse Event|0|||
128037422|NCT04464473|460765514|FG005|Overall Study|Adverse Event|0|||
128037423|NCT04464473|460765509|FG000|Overall Study|Lost to Follow-up|0|||
128037424|NCT04464473|460765510|FG001|Overall Study|Lost to Follow-up|0|||
128037425|NCT04464473|460765511|FG002|Overall Study|Lost to Follow-up|0|||
128037426|NCT04464473|460765512|FG003|Overall Study|Lost to Follow-up|1|||
128037427|NCT04464473|460765513|FG004|Overall Study|Lost to Follow-up|0|||
128037428|NCT04464473|460765514|FG005|Overall Study|Lost to Follow-up|0|||
128037429|NCT04577404|460765515|FG000|Overall Study|Adverse Event|31|||
128037430|NCT04577404|460765515|FG000|Overall Study|Death|1|||
128037431|NCT04577404|460765515|FG000|Overall Study|Lack of Efficacy|3|||
128037432|NCT04577404|460765515|FG000|Overall Study|Physician Decision|7|||
128037433|NCT04577404|460765515|FG000|Overall Study|Withdrawal by Subject|21|||
128037434|NCT04577404|460765515|FG000|Overall Study|Switched to commercial oral Edaravon etc.|12|||
128037435|NCT03423979|460765525|FG000|Overall Study|Death|1|||
128037436|NCT01334918|460766792|FG000|Overall Study|Did not receive study drug|6|||
128037437|NCT01334918|460766793|FG001|Overall Study|Did not receive study drug|0|||
128037438|NCT01334918|460766792|FG000|Overall Study|Adverse Event|2|||
128037439|NCT01334918|460766793|FG001|Overall Study|Adverse Event|0|||
128037440|NCT01334918|460766792|FG000|Overall Study|Withdrawal by Subject|0|||
128037441|NCT01334918|460766793|FG001|Overall Study|Withdrawal by Subject|1|||
128037442|NCT00805389|460766794|FG000|Overall Study|Adverse Event|0|||
128037443|NCT00805389|460766795|FG001|Overall Study|Adverse Event|0|||
128037444|NCT00805389|460766796|FG002|Overall Study|Adverse Event|1|||
128037445|NCT00805389|460766797|FG003|Overall Study|Adverse Event|2|||
128037446|NCT00805389|460766798|FG004|Overall Study|Adverse Event|0|||
128037447|NCT00805389|460766794|FG000|Overall Study|Lost to Follow-up|4|||
128037448|NCT00805389|460766795|FG001|Overall Study|Lost to Follow-up|3|||
128037449|NCT00805389|460766796|FG002|Overall Study|Lost to Follow-up|6|||
128037450|NCT00805389|460766797|FG003|Overall Study|Lost to Follow-up|10|||
128037451|NCT00805389|460766798|FG004|Overall Study|Lost to Follow-up|9|||
128037452|NCT00805389|460766794|FG000|Overall Study|Protocol Violation|0|||
128037453|NCT00805389|460766795|FG001|Overall Study|Protocol Violation|0|||
128037454|NCT00805389|460766796|FG002|Overall Study|Protocol Violation|1|||
128037455|NCT00805389|460766797|FG003|Overall Study|Protocol Violation|0|||
128037456|NCT00805389|460766798|FG004|Overall Study|Protocol Violation|0|||
128037457|NCT00805389|460766794|FG000|Overall Study|Withdrawal by Subject|3|||
128037458|NCT00805389|460766795|FG001|Overall Study|Withdrawal by Subject|2|||
128037459|NCT00805389|460766796|FG002|Overall Study|Withdrawal by Subject|4|||
128037460|NCT00805389|460766797|FG003|Overall Study|Withdrawal by Subject|5|||
128037461|NCT00805389|460766798|FG004|Overall Study|Withdrawal by Subject|4|||
128037462|NCT02704208|460766801|FG000|Overall Study|Lost to Follow-up|42|||
128037463|NCT02704208|460766802|FG001|Overall Study|Lost to Follow-up|37|||
128037464|NCT02724839|460766807|FG000|Overall Study|Withdrawal by Subject|1|||
128037465|NCT02724839|460766808|FG001|Overall Study|Withdrawal by Subject|1|||
128037466|NCT02724839|460766809|FG002|Overall Study|Withdrawal by Subject|0|||
128037467|NCT02724839|460766807|FG000|Overall Study|Lost to Follow-up|0|||
128037468|NCT02724839|460766808|FG001|Overall Study|Lost to Follow-up|3|||
128037469|NCT02724839|460766809|FG002|Overall Study|Lost to Follow-up|2|||
128037470|NCT02724839|460766807|FG000|Overall Study|Physician Decision|0|||
128037471|NCT02724839|460766808|FG001|Overall Study|Physician Decision|0|||
128037472|NCT02724839|460766809|FG002|Overall Study|Physician Decision|3|||
128037473|NCT01155050|460766811|FG000|Overall Study|Lost to Follow-up|15|||
128037474|NCT01155050|460766812|FG001|Overall Study|Lost to Follow-up|20|||
128037475|NCT01155050|460766813|FG002|Overall Study|Lost to Follow-up|19|||
128037476|NCT01155050|460766814|FG003|Overall Study|Lost to Follow-up|22|||
128037477|NCT05878067|460766815|FG000|Overall Study|Lost to Follow-up|2|||
128037478|NCT00949533|460766816|FG000|Overall Study|Lost to Follow-up|0|||
128037479|NCT00949533|460766817|FG001|Overall Study|Lost to Follow-up|1|||
128037480|NCT01959529|460766818|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
128037481|NCT01959529|460766819|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
128037482|NCT01959529|460766818|FG000|Overall Study|Lost to Follow-up|4|||
128037483|NCT01959529|460766819|FG001|Overall Study|Lost to Follow-up|1|||
128037484|NCT01959529|460766818|FG000|Overall Study|Other|70|||
128037485|NCT01959529|460766819|FG001|Overall Study|Other|68|||
128037486|NCT01959529|460766818|FG000|Overall Study|Hypoglycaemia|1|||
128037487|NCT01959529|460766819|FG001|Overall Study|Hypoglycaemia|1|||
128037488|NCT01959529|460766818|FG000|Overall Study|Lack of glycaemic control|1|||
128037489|NCT01959529|460766819|FG001|Overall Study|Lack of glycaemic control|1|||
128037490|NCT00557193|460766827|FG000|Induction|Adverse Event|2|||
128037491|NCT00557193|460766828|FG001|Induction|Adverse Event|0|||
128037492|NCT00557193|460766829|FG002|Induction|Adverse Event|0|||
128037493|NCT00557193|460766830|FG003|Induction|Adverse Event|0|||
128037494|NCT00557193|460766831|FG004|Induction|Adverse Event|0|||
128037495|NCT00557193|460766832|FG005|Induction|Adverse Event|0|||
128037496|NCT00557193|460766827|FG000|Induction|Death|6|||
128037497|NCT00557193|460766828|FG001|Induction|Death|0|||
128037498|NCT00557193|460766829|FG002|Induction|Death|0|||
128037499|NCT00557193|460766830|FG003|Induction|Death|0|||
128037500|NCT00557193|460766831|FG004|Induction|Death|0|||
128037501|NCT00557193|460766832|FG005|Induction|Death|0|||
128037502|NCT00557193|460766827|FG000|Induction|Physician Decision|3|||
128037503|NCT00557193|460766828|FG001|Induction|Physician Decision|0|||
128037504|NCT00557193|460766829|FG002|Induction|Physician Decision|0|||
128037505|NCT00557193|460766830|FG003|Induction|Physician Decision|0|||
128037506|NCT00557193|460766831|FG004|Induction|Physician Decision|0|||
128037507|NCT00557193|460766832|FG005|Induction|Physician Decision|0|||
127695989|NCT02736409|459514776|FG001|Overall Study|Pregnancy|0|||
128037508|NCT00557193|460766827|FG000|Induction|Withdrawal by Subject|1|||
128037509|NCT00557193|460766828|FG001|Induction|Withdrawal by Subject|0|||
128037510|NCT00557193|460766829|FG002|Induction|Withdrawal by Subject|0|||
128037511|NCT00557193|460766830|FG003|Induction|Withdrawal by Subject|0|||
128037512|NCT00557193|460766831|FG004|Induction|Withdrawal by Subject|0|||
128037513|NCT00557193|460766832|FG005|Induction|Withdrawal by Subject|0|||
128037514|NCT00557193|460766827|FG000|Induction|Refusal of Further Protocol Therapy|2|||
128037515|NCT00557193|460766828|FG001|Induction|Refusal of Further Protocol Therapy|0|||
128037516|NCT00557193|460766829|FG002|Induction|Refusal of Further Protocol Therapy|0|||
128037517|NCT00557193|460766830|FG003|Induction|Refusal of Further Protocol Therapy|0|||
128037518|NCT00557193|460766831|FG004|Induction|Refusal of Further Protocol Therapy|0|||
128037519|NCT00557193|460766832|FG005|Induction|Refusal of Further Protocol Therapy|0|||
128037520|NCT00557193|460766827|FG000|Induction|Ineligible|8|||
128037521|NCT00557193|460766828|FG001|Induction|Ineligible|0|||
128037522|NCT00557193|460766829|FG002|Induction|Ineligible|0|||
128037523|NCT00557193|460766830|FG003|Induction|Ineligible|0|||
128037524|NCT00557193|460766831|FG004|Induction|Ineligible|0|||
128037525|NCT00557193|460766832|FG005|Induction|Ineligible|0|||
128037526|NCT00557193|460766827|FG000|Induction|Inevaluable for post Induction|2|||
128037527|NCT00557193|460766828|FG001|Induction|Inevaluable for post Induction|0|||
128037528|NCT00557193|460766829|FG002|Induction|Inevaluable for post Induction|0|||
128037529|NCT00557193|460766830|FG003|Induction|Inevaluable for post Induction|0|||
128037530|NCT00557193|460766831|FG004|Induction|Inevaluable for post Induction|0|||
128037531|NCT00557193|460766832|FG005|Induction|Inevaluable for post Induction|0|||
128037532|NCT00557193|460766827|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
128037533|NCT00557193|460766828|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
128037534|NCT00557193|460766829|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
128037535|NCT00557193|460766830|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
128037536|NCT00557193|460766831|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
128037537|NCT00557193|460766832|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
128037538|NCT00557193|460766827|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
128037539|NCT00557193|460766828|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
128037540|NCT00557193|460766829|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
128037541|NCT00557193|460766830|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
128037542|NCT00557193|460766831|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
128037543|NCT00557193|460766832|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
128037544|NCT00557193|460766827|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
128037545|NCT00557193|460766828|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
128037546|NCT00557193|460766829|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
128037547|NCT00557193|460766830|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
128037548|NCT00557193|460766831|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
128037549|NCT00557193|460766832|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
128037550|NCT00557193|460766827|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
128037551|NCT00557193|460766828|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
128037552|NCT00557193|460766829|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
128037553|NCT00557193|460766830|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
128037554|NCT00557193|460766831|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
128037555|NCT00557193|460766832|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
128037556|NCT00557193|460766827|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
128037557|NCT00557193|460766828|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
128037558|NCT00557193|460766829|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
128037559|NCT00557193|460766830|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
128037560|NCT00557193|460766831|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
128037561|NCT00557193|460766832|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
128037562|NCT00557193|460766827|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
128037563|NCT00557193|460766828|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
128037564|NCT00557193|460766829|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
128037565|NCT00557193|460766830|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
128037566|NCT00557193|460766831|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
128037567|NCT00557193|460766832|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
128037568|NCT00557193|460766827|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
128037569|NCT00557193|460766828|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
128037570|NCT00557193|460766829|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
128037571|NCT00557193|460766830|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
128037572|NCT00557193|460766831|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
128037573|NCT00557193|460766832|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
128037574|NCT00557193|460766827|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
128037575|NCT00557193|460766828|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
128037576|NCT00557193|460766829|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
128037577|NCT00557193|460766830|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
127695990|NCT02736409|459514777|FG002|Overall Study|Pregnancy|1|||
128037578|NCT00557193|460766831|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
128037579|NCT00557193|460766832|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
128037580|NCT00557193|460766827|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
128037581|NCT00557193|460766828|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
128037582|NCT00557193|460766829|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
128037583|NCT00557193|460766830|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
128037584|NCT00557193|460766831|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
128037585|NCT00557193|460766832|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
128037586|NCT00652834|460766833|FG000|Overall Study|Withdrawal by Subject|3|||
128037587|NCT00652834|460766833|FG000|Overall Study|Lost to Follow-up|2|||
128037588|NCT00320606|460766834|FG000|Overall Study|Adverse Event|1|||
128037589|NCT00320606|460766834|FG000|Overall Study|Protocol Violation|1|||
128037590|NCT00320606|460766834|FG000|Overall Study|Withdrawal by Subject|1|||
128037591|NCT03984825|460766835|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
128037592|NCT03984825|460766835|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
128037593|NCT03984825|460766835|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
128037594|NCT00399035|460766838|FG000|Overall Study|Death|289|||
128037595|NCT00399035|460766839|FG001|Overall Study|Death|141|||
128037596|NCT00399035|460766840|FG002|Overall Study|Death|234|||
128037597|NCT00399035|460766838|FG000|Overall Study|Lost to Follow-up|2|||
128037598|NCT00399035|460766839|FG001|Overall Study|Lost to Follow-up|1|||
128037599|NCT00399035|460766840|FG002|Overall Study|Lost to Follow-up|5|||
128037600|NCT00399035|460766838|FG000|Overall Study|Withdrawal by Subject|19|||
128037601|NCT00399035|460766839|FG001|Overall Study|Withdrawal by Subject|15|||
128037602|NCT00399035|460766840|FG002|Overall Study|Withdrawal by Subject|12|||
128037603|NCT00399035|460766838|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
128037604|NCT00399035|460766839|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
128037605|NCT00399035|460766840|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
128037606|NCT00399035|460766838|FG000|Overall Study|Severe non-compliance with protocol|2|||
128037607|NCT00399035|460766839|FG001|Overall Study|Severe non-compliance with protocol|1|||
128037608|NCT00399035|460766840|FG002|Overall Study|Severe non-compliance with protocol|0|||
128037609|NCT00976456|460766841|FG000|Overall Study|Adverse Event|17|||
128037610|NCT00976456|460766842|FG001|Overall Study|Adverse Event|22|||
128037611|NCT00976456|460766841|FG000|Overall Study|Death|7|||
128037612|NCT00976456|460766842|FG001|Overall Study|Death|9|||
128037613|NCT00976456|460766841|FG000|Overall Study|Lack of Efficacy|5|||
128037614|NCT00976456|460766842|FG001|Overall Study|Lack of Efficacy|2|||
128037615|NCT00976456|460766841|FG000|Overall Study|Withdrawal by Subject|3|||
128037616|NCT00976456|460766842|FG001|Overall Study|Withdrawal by Subject|1|||
128037617|NCT00976456|460766841|FG000|Overall Study|screening failure, unknown|11|||
128037618|NCT00976456|460766842|FG001|Overall Study|screening failure, unknown|4|||
128037619|NCT02037529|460766843|FG000|Overall Study|Withdrawal by Subject|1|||
128037620|NCT02037529|460766844|FG001|Overall Study|Withdrawal by Subject|3|||
128037621|NCT02037529|460766843|FG000|Overall Study|Adverse Event|0|||
128037622|NCT02037529|460766844|FG001|Overall Study|Adverse Event|1|||
128037623|NCT02131766|460766845|FG000|Overall Study|Withdrawal by Subject|4|||
128037624|NCT00718315|460766846|FG000|Overall Study|Adverse Event|1|||
128037625|NCT00718315|460766847|FG001|Overall Study|Adverse Event|2|||
128037626|NCT00718315|460766848|FG002|Overall Study|Adverse Event|3|||
128037627|NCT00718315|460766846|FG000|Overall Study|Death|6|||
128037628|NCT00718315|460766847|FG001|Overall Study|Death|6|||
128037629|NCT00718315|460766848|FG002|Overall Study|Death|5|||
127882562|NCT01220128|460192839|FG002|Overall Study|Consent withdrawn by subject|0|||
127882563|NCT01220128|460192840|FG003|Overall Study|Consent withdrawn by subject|0|||
128037630|NCT00718315|460766846|FG000|Overall Study|Lost to Follow-up|2|||
128037631|NCT00718315|460766847|FG001|Overall Study|Lost to Follow-up|3|||
128037632|NCT00718315|460766848|FG002|Overall Study|Lost to Follow-up|4|||
128037633|NCT00718315|460766846|FG000|Overall Study|Protocol Violation|5|||
128037634|NCT00718315|460766847|FG001|Overall Study|Protocol Violation|5|||
128037635|NCT00718315|460766848|FG002|Overall Study|Protocol Violation|3|||
128037636|NCT00718315|460766846|FG000|Overall Study|Erlotinib dose decreased|4|||
128037637|NCT00718315|460766847|FG001|Overall Study|Erlotinib dose decreased|3|||
128037638|NCT00718315|460766848|FG002|Overall Study|Erlotinib dose decreased|1|||
128037639|NCT00718315|460766846|FG000|Overall Study|Use of Minocyclin|1|||
128037640|NCT00718315|460766847|FG001|Overall Study|Use of Minocyclin|1|||
128037641|NCT00718315|460766848|FG002|Overall Study|Use of Minocyclin|1|||
128037642|NCT00718315|460766846|FG000|Overall Study|Disease progression|0|||
128037643|NCT00718315|460766847|FG001|Overall Study|Disease progression|1|||
128037644|NCT00718315|460766848|FG002|Overall Study|Disease progression|1|||
128037645|NCT00718315|460766846|FG000|Overall Study|Other|0|||
128037646|NCT00718315|460766847|FG001|Overall Study|Other|0|||
128037647|NCT00718315|460766848|FG002|Overall Study|Other|1|||
128037648|NCT00718315|460766846|FG000|Overall Study|Use of ATB and Corticoids|0|||
128037649|NCT00718315|460766847|FG001|Overall Study|Use of ATB and Corticoids|1|||
128037650|NCT00718315|460766848|FG002|Overall Study|Use of ATB and Corticoids|2|||
128037651|NCT01128569|460766852|FG000|Washout Period 1|Adverse Event|0|||
128037652|NCT01128569|460766853|FG001|Washout Period 1|Adverse Event|0|||
128037653|NCT01128569|460766854|FG002|Washout Period 1|Adverse Event|1|||
128037654|NCT01128569|460766855|FG003|Washout Period 1|Adverse Event|0|||
128037655|NCT01128569|460766856|FG004|Washout Period 1|Adverse Event|0|||
128037656|NCT01128569|460766857|FG005|Washout Period 1|Adverse Event|0|||
128037657|NCT01128569|460766852|FG000|Treatment Period 2|Withdrawal by Subject|0|||
128037658|NCT01128569|460766853|FG001|Treatment Period 2|Withdrawal by Subject|1|||
128037659|NCT01128569|460766854|FG002|Treatment Period 2|Withdrawal by Subject|0|||
128037660|NCT01128569|460766855|FG003|Treatment Period 2|Withdrawal by Subject|0|||
128037661|NCT01128569|460766856|FG004|Treatment Period 2|Withdrawal by Subject|0|||
128037662|NCT01128569|460766857|FG005|Treatment Period 2|Withdrawal by Subject|0|||
128037663|NCT02519842|460766858|FG000|Base Study: Cycle 1|Screening Failure|1|||
128037664|NCT02519842|460766859|FG001|Base Study: Cycle 1|Screening Failure|1|||
128037665|NCT02519842|460766860|FG002|Base Study: Cycle 1|Screening Failure|0|||
128037666|NCT02519842|460766858|FG000|Base Study: Cycle 1|Adverse Event|1|||
128037667|NCT02519842|460766859|FG001|Base Study: Cycle 1|Adverse Event|0|||
128037668|NCT02519842|460766860|FG002|Base Study: Cycle 1|Adverse Event|0|||
128037669|NCT02519842|460766858|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
128037670|NCT02519842|460766859|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
128037671|NCT02519842|460766860|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
128037672|NCT02519842|460766858|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
128037673|NCT02519842|460766859|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
128037674|NCT02519842|460766860|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
128037675|NCT02519842|460766858|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
128037676|NCT02519842|460766859|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
128037677|NCT02519842|460766860|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
128037678|NCT02519842|460766858|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
128037679|NCT02519842|460766859|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
128037680|NCT02519842|460766860|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
128037681|NCT02519842|460766858|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
128037682|NCT02519842|460766859|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
128037683|NCT02519842|460766860|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
128037684|NCT02519842|460766858|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
128037685|NCT02519842|460766859|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
128037686|NCT02519842|460766860|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
128037687|NCT02519842|460766858|FG000|Optional Extension: Cycles 2-6|Death|0|||
128037688|NCT02519842|460766859|FG001|Optional Extension: Cycles 2-6|Death|0|||
128037689|NCT02519842|460766860|FG002|Optional Extension: Cycles 2-6|Death|1|||
128037690|NCT02519842|460766858|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
128037691|NCT02519842|460766859|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
128037692|NCT02519842|460766860|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
128037693|NCT02519842|460766858|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
128037694|NCT02519842|460766859|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
128037695|NCT02519842|460766860|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
128037696|NCT02519842|460766858|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
128037697|NCT02519842|460766859|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
128037698|NCT02519842|460766860|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
128037699|NCT02519842|460766858|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
128037700|NCT02519842|460766859|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
128037701|NCT02519842|460766860|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
127600017|NCT00799487|459163127|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
128037702|NCT01493414|460766865|FG000|Overall Study|Adverse Event|405|||
128037703|NCT01493414|460766865|FG000|Overall Study|Disease progression|204|||
128037704|NCT01493414|460766865|FG000|Overall Study|Death|101|||
128037705|NCT01493414|460766865|FG000|Overall Study|Physician Decision|93|||
128037706|NCT01493414|460766865|FG000|Overall Study|Withdrawal by Subject|79|||
128037707|NCT01493414|460766865|FG000|Overall Study|Protocol deviation|27|||
127600018|NCT00799487|459163128|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
127600019|NCT00799487|459163126|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
127600020|NCT00799487|459163127|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
127600021|NCT00799487|459163128|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
127600022|NCT04481750|459163129|FG000|Period 1 (Fasted)|Adverse Event|0|||
127600023|NCT04481750|459163130|FG001|Period 1 (Fasted)|Adverse Event|0|||
127600024|NCT04481750|459163131|FG002|Period 1 (Fasted)|Adverse Event|1|||
127600025|NCT04481750|459163132|FG003|Period 1 (Fasted)|Adverse Event|0|||
127600026|NCT04481750|459163133|FG004|Period 1 (Fasted)|Adverse Event|0|||
127600027|NCT04481750|459163134|FG005|Period 1 (Fasted)|Adverse Event|0|||
127600028|NCT04481750|459163135|FG006|Period 1 (Fasted)|Adverse Event|0|||
127600029|NCT04481750|459163136|FG007|Period 1 (Fasted)|Adverse Event|0|||
127600030|NCT04481750|459163137|FG008|Period 1 (Fasted)|Adverse Event|0|||
127600031|NCT04481750|459163138|FG009|Period 1 (Fasted)|Adverse Event|0|||
127787714|NCT00808236|459847838|FG001|Overall Study|Lost to Follow-up|1|||
127787715|NCT00808236|459847837|FG000|Overall Study|Physician Decision|0|||
128037708|NCT01493414|460766865|FG000|Overall Study|Administrative problems|25|||
128037709|NCT01493414|460766865|FG000|Overall Study|Lost to Follow-up|16|||
128037710|NCT01977222|460766870|FG000|Overall Study|Withdrawal by Subject|1|||
128037711|NCT00107276|460766874|FG000|Overall Study|Progression|46|||
128037712|NCT00107276|460766874|FG000|Overall Study|Adverse Event|6|||
128037713|NCT00107276|460766874|FG000|Overall Study|M.D. decision|2|||
128037714|NCT00107276|460766874|FG000|Overall Study|Patient refusal|1|||
128037715|NCT00107276|460766874|FG000|Overall Study|Death|1|||
128037716|NCT00107276|460766874|FG000|Overall Study|Ineligible|16|||
128037717|NCT04846231|460766875|FG000|Overall Study|Lost to Follow-up|1|||
128037718|NCT04846231|460766876|FG001|Overall Study|Lost to Follow-up|0|||
128037719|NCT04846231|460766877|FG002|Overall Study|Lost to Follow-up|0|||
128037720|NCT04846231|460766878|FG003|Overall Study|Lost to Follow-up|0|||
128037721|NCT04846231|460766879|FG004|Overall Study|Lost to Follow-up|0|||
128037722|NCT04846231|460766880|FG005|Overall Study|Lost to Follow-up|0|||
128037723|NCT04846231|460766881|FG006|Overall Study|Lost to Follow-up|0|||
128037724|NCT04846231|460766882|FG007|Overall Study|Lost to Follow-up|1|||
128037725|NCT04846231|460766875|FG000|Overall Study|Withdrawal by Subject|0|||
128037726|NCT04846231|460766876|FG001|Overall Study|Withdrawal by Subject|1|||
128037727|NCT04846231|460766877|FG002|Overall Study|Withdrawal by Subject|2|||
128037728|NCT04846231|460766878|FG003|Overall Study|Withdrawal by Subject|1|||
128037729|NCT04846231|460766879|FG004|Overall Study|Withdrawal by Subject|0|||
128037730|NCT04846231|460766880|FG005|Overall Study|Withdrawal by Subject|0|||
128037731|NCT04846231|460766881|FG006|Overall Study|Withdrawal by Subject|0|||
128037732|NCT04846231|460766882|FG007|Overall Study|Withdrawal by Subject|0|||
128037733|NCT04846231|460766875|FG000|Overall Study|Protocol Violation|0|||
128037734|NCT04846231|460766876|FG001|Overall Study|Protocol Violation|1|||
128037735|NCT04846231|460766877|FG002|Overall Study|Protocol Violation|0|||
128037736|NCT04846231|460766878|FG003|Overall Study|Protocol Violation|0|||
128037737|NCT04846231|460766879|FG004|Overall Study|Protocol Violation|0|||
128037738|NCT04846231|460766880|FG005|Overall Study|Protocol Violation|0|||
128037739|NCT04846231|460766881|FG006|Overall Study|Protocol Violation|0|||
128037740|NCT04846231|460766882|FG007|Overall Study|Protocol Violation|0|||
128037741|NCT04846231|460766875|FG000|Overall Study|Adverse Event|0|||
128037742|NCT04846231|460766876|FG001|Overall Study|Adverse Event|0|||
128037743|NCT04846231|460766877|FG002|Overall Study|Adverse Event|0|||
128037744|NCT04846231|460766878|FG003|Overall Study|Adverse Event|0|||
128037745|NCT04846231|460766879|FG004|Overall Study|Adverse Event|0|||
128037746|NCT04846231|460766880|FG005|Overall Study|Adverse Event|0|||
128037747|NCT04846231|460766881|FG006|Overall Study|Adverse Event|1|||
128037748|NCT04846231|460766882|FG007|Overall Study|Adverse Event|1|||
128037749|NCT02980107|460766883|FG000|Overall Study|Withdrawal by Subject|51|||
128037750|NCT02980107|460766884|FG001|Overall Study|Withdrawal by Subject|62|||
128037751|NCT00945659|460766885|FG000|Overall Study|Lost to Follow-up|7|||
128037752|NCT00945659|460766886|FG001|Overall Study|Lost to Follow-up|20|||
128037753|NCT00945659|460766887|FG002|Overall Study|Lost to Follow-up|17|||
128037754|NCT03342560|460766888|FG000|Overall Study|Lost to Follow-up|2|||
128037755|NCT02993263|460766900|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
128037756|NCT00545779|460766901|FG000|Overall Study|Violation of selection criteria at entry|8|||
128037757|NCT00545779|460766901|FG000|Overall Study|Other protocol violation|1|||
128037758|NCT00545779|460766901|FG000|Overall Study|Did not cooperate|7|||
128037759|NCT00545779|460766901|FG000|Overall Study|Withdrawal by Subject|20|||
127787716|NCT00808236|459847838|FG001|Overall Study|Physician Decision|1|||
127787717|NCT00808236|459847837|FG000|Overall Study|Death|18|||
127787718|NCT00808236|459847838|FG001|Overall Study|Death|30|||
127787719|NCT00961220|459847839|FG000|Overall Study|Adverse Event|3|||
127787720|NCT00961220|459847839|FG000|Overall Study|Lack of Efficacy|1|||
127787721|NCT00961220|459847839|FG000|Overall Study|No IV access for O6BG|1|||
127787722|NCT00961220|459847839|FG000|Overall Study|O6BG no longer supplied|1|||
127787723|NCT00961220|459847839|FG000|Overall Study|Complete Response prior to 12 courses|1|||
127787724|NCT05376215|459847840|FG000|Overall Study|Withdrawal by Subject|2|||
127787725|NCT05376215|459847841|FG001|Overall Study|Withdrawal by Subject|1|||
127787726|NCT05376215|459847840|FG000|Overall Study|Lost to Follow-up|0|||
128037760|NCT00545779|460766901|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
128037761|NCT00545779|460766901|FG000|Overall Study|Failure to return|3|||
128037762|NCT01405196|460766902|FG000|Overall Study|Study Terminated by Sponsor|0|||
128037763|NCT01405196|460766903|FG001|Overall Study|Study Terminated by Sponsor|0|||
128037764|NCT01405196|460766904|FG002|Overall Study|Study Terminated by Sponsor|9|||
128037765|NCT01405196|460766905|FG003|Overall Study|Study Terminated by Sponsor|0|||
128037766|NCT01405196|460766902|FG000|Overall Study|Other|2|||
128037767|NCT01405196|460766903|FG001|Overall Study|Other|2|||
127787727|NCT05376215|459847841|FG001|Overall Study|Lost to Follow-up|1|||
127787728|NCT01301950|459847850|FG000|Overall Study|Surgery was cancelled by patient|0|||
127787729|NCT01301950|459847851|FG001|Overall Study|Surgery was cancelled by patient|1|||
128037768|NCT01405196|460766904|FG002|Overall Study|Other|5|||
128037769|NCT01405196|460766905|FG003|Overall Study|Other|0|||
127882564|NCT01220128|460192841|FG004|Overall Study|Consent withdrawn by subject|0|||
127882565|NCT01220128|460192842|FG005|Overall Study|Consent withdrawn by subject|0|||
127882566|NCT01220128|460192843|FG006|Overall Study|Consent withdrawn by subject|0|||
127882567|NCT00000135|460192866|FG000|Overall Study|Death|27|||
127882568|NCT00000135|460192867|FG001|Overall Study|Death|14|||
127882569|NCT02340078|460192868|FG000|Overall Study|Protocol Violation|1|||
127882570|NCT01311505|460192869|FG000|First Intervention Period|Protocol Violation|0|||
127882571|NCT01311505|460192870|FG001|First Intervention Period|Protocol Violation|1|||
127882572|NCT00567996|460192871|FG000|Overall Study|Adverse Event|18|||
127882573|NCT00567996|460192872|FG001|Overall Study|Adverse Event|16|||
127882574|NCT00567996|460192873|FG002|Overall Study|Adverse Event|13|||
127882575|NCT00567996|460192871|FG000|Overall Study|Protocol Deviation|9|||
127882576|NCT00567996|460192872|FG001|Overall Study|Protocol Deviation|11|||
127882577|NCT00567996|460192873|FG002|Overall Study|Protocol Deviation|13|||
127882578|NCT00567996|460192871|FG000|Overall Study|Withdrawal by Subject|8|||
127882579|NCT00567996|460192872|FG001|Overall Study|Withdrawal by Subject|12|||
127882580|NCT00567996|460192873|FG002|Overall Study|Withdrawal by Subject|22|||
127882581|NCT00567996|460192871|FG000|Overall Study|Abnormal Lab value(s)|2|||
127882582|NCT00567996|460192872|FG001|Overall Study|Abnormal Lab value(s)|1|||
127882583|NCT00567996|460192873|FG002|Overall Study|Abnormal Lab value(s)|2|||
127882584|NCT00567996|460192871|FG000|Overall Study|Abnormal test procedure result(s)|2|||
127882585|NCT00567996|460192872|FG001|Overall Study|Abnormal test procedure result(s)|1|||
127882586|NCT00567996|460192873|FG002|Overall Study|Abnormal test procedure result(s)|1|||
127882587|NCT00567996|460192871|FG000|Overall Study|Lost to Follow-up|2|||
127882588|NCT00567996|460192872|FG001|Overall Study|Lost to Follow-up|5|||
127882589|NCT00567996|460192873|FG002|Overall Study|Lost to Follow-up|2|||
127882590|NCT00567996|460192871|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
127882591|NCT00567996|460192872|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
127882592|NCT00567996|460192873|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
127882593|NCT00567996|460192871|FG000|Overall Study|Administrative problems|1|||
127882594|NCT00567996|460192872|FG001|Overall Study|Administrative problems|1|||
127882595|NCT00567996|460192873|FG002|Overall Study|Administrative problems|0|||
127882596|NCT00567996|460192871|FG000|Overall Study|Death|1|||
127882597|NCT00567996|460192872|FG001|Overall Study|Death|0|||
127882598|NCT00567996|460192873|FG002|Overall Study|Death|2|||
127882599|NCT00567996|460192871|FG000|Overall Study|Patient's inability to use the device|0|||
127882600|NCT00567996|460192872|FG001|Overall Study|Patient's inability to use the device|1|||
127882601|NCT00567996|460192873|FG002|Overall Study|Patient's inability to use the device|0|||
127882602|NCT00883129|460192876|FG000|Overall Study|Adverse Event|7|||
127882603|NCT00883129|460192877|FG001|Overall Study|Adverse Event|15|||
127882604|NCT00883129|460192876|FG000|Overall Study|Withdrawal by Subject|8|||
127882605|NCT00883129|460192877|FG001|Overall Study|Withdrawal by Subject|9|||
127882606|NCT00883129|460192876|FG000|Overall Study|Non-compliance|3|||
127882607|NCT00883129|460192877|FG001|Overall Study|Non-compliance|6|||
127882608|NCT00883129|460192876|FG000|Overall Study|Lost to Follow-up|1|||
127882609|NCT00883129|460192877|FG001|Overall Study|Lost to Follow-up|2|||
127882610|NCT00883129|460192876|FG000|Overall Study|Death|1|||
127882611|NCT00883129|460192877|FG001|Overall Study|Death|2|||
127882612|NCT00883129|460192876|FG000|Overall Study|Defined Treatment Failure|0|||
127882613|NCT00883129|460192877|FG001|Overall Study|Defined Treatment Failure|2|||
127882614|NCT01898884|460192878|FG000|Multiple Dose Period|Adverse Event|0|||
127882615|NCT01898884|460192879|FG001|Multiple Dose Period|Adverse Event|0|||
127882616|NCT01898884|460192880|FG002|Multiple Dose Period|Adverse Event|0|||
127882617|NCT01898884|460192881|FG003|Multiple Dose Period|Adverse Event|0|||
127882618|NCT01898884|460192882|FG004|Multiple Dose Period|Adverse Event|0|||
127882619|NCT01898884|460192883|FG005|Multiple Dose Period|Adverse Event|0|||
127882620|NCT01898884|460192884|FG006|Multiple Dose Period|Adverse Event|1|||
127882621|NCT01898884|460192885|FG007|Multiple Dose Period|Adverse Event|0|||
127882622|NCT01898884|460192886|FG008|Multiple Dose Period|Adverse Event|0|||
127882623|NCT01898884|460192878|FG000|Multiple Dose Period|Randomized Not Treated|0|||
127882624|NCT01898884|460192879|FG001|Multiple Dose Period|Randomized Not Treated|0|||
127882625|NCT01898884|460192880|FG002|Multiple Dose Period|Randomized Not Treated|0|||
127882626|NCT01898884|460192881|FG003|Multiple Dose Period|Randomized Not Treated|0|||
127882627|NCT01898884|460192882|FG004|Multiple Dose Period|Randomized Not Treated|0|||
127882628|NCT01898884|460192883|FG005|Multiple Dose Period|Randomized Not Treated|0|||
127882629|NCT01898884|460192884|FG006|Multiple Dose Period|Randomized Not Treated|0|||
127882630|NCT01898884|460192885|FG007|Multiple Dose Period|Randomized Not Treated|0|||
127882631|NCT01898884|460192886|FG008|Multiple Dose Period|Randomized Not Treated|1|||
127882632|NCT00759759|460192887|FG000|Overall Study|didn't return for period 2|1|||
127882633|NCT00759759|460192888|FG001|Overall Study|didn't return for period 2|0|||
127882634|NCT00759759|460192887|FG000|Overall Study|Didn't receive drug in period 2|1|||
127882635|NCT00759759|460192888|FG001|Overall Study|Didn't receive drug in period 2|0|||
127882636|NCT00759759|460192887|FG000|Overall Study|Withdrawal by Subject|2|||
128037770|NCT01405196|460766902|FG000|Overall Study|Withdrawal by Subject|4|||
128037771|NCT01405196|460766903|FG001|Overall Study|Withdrawal by Subject|6|||
128037772|NCT01405196|460766904|FG002|Overall Study|Withdrawal by Subject|3|||
128037773|NCT01405196|460766905|FG003|Overall Study|Withdrawal by Subject|6|||
128037774|NCT01405196|460766902|FG000|Overall Study|Adverse Event|2|||
128037775|NCT01405196|460766903|FG001|Overall Study|Adverse Event|2|||
128037776|NCT01405196|460766904|FG002|Overall Study|Adverse Event|0|||
128037777|NCT01405196|460766905|FG003|Overall Study|Adverse Event|2|||
128037778|NCT01405196|460766902|FG000|Overall Study|Death|1|||
128037779|NCT01405196|460766903|FG001|Overall Study|Death|0|||
128037780|NCT01405196|460766904|FG002|Overall Study|Death|3|||
128037781|NCT01405196|460766905|FG003|Overall Study|Death|0|||
128037782|NCT01405196|460766902|FG000|Overall Study|Lost to Follow-up|2|||
128037783|NCT01405196|460766903|FG001|Overall Study|Lost to Follow-up|2|||
128037784|NCT01405196|460766904|FG002|Overall Study|Lost to Follow-up|3|||
128037785|NCT01405196|460766905|FG003|Overall Study|Lost to Follow-up|1|||
128037786|NCT01729039|460766908|FG000|Overall Study|disqualified|2|||
128037787|NCT01729039|460766909|FG001|Overall Study|disqualified|5|||
128037788|NCT01729039|460766908|FG000|Overall Study|Withdrawal by Subject|8|||
128037789|NCT01729039|460766909|FG001|Overall Study|Withdrawal by Subject|7|||
128037790|NCT00698841|460766910|FG000|Overall Study|Withdrawal by Subject|2|||
128037791|NCT00698841|460766910|FG000|Overall Study|Adverse Event|3|||
128037792|NCT00698841|460766910|FG000|Overall Study|Disease progression|7|||
128037793|NCT00698841|460766910|FG000|Overall Study|Failure to meet eligibility criteria|2|||
128037794|NCT00698841|460766910|FG000|Overall Study|Study drug toxicity|2|||
128037795|NCT00698841|460766910|FG000|Overall Study|Other|2|||
128037796|NCT00829998|460766911|FG000|Washout|Adverse Event|0|||
128037797|NCT00829998|460766912|FG001|Washout|Adverse Event|1|||
127787730|NCT00825162|459847856|FG000|Overall Study|Withdrawal by Subject|11|||
127787731|NCT00825162|459847857|FG001|Overall Study|Withdrawal by Subject|13|||
127787732|NCT00825162|459847858|FG002|Overall Study|Withdrawal by Subject|3|||
127787733|NCT00825162|459847856|FG000|Overall Study|Lost to Follow-up|9|||
127787734|NCT00825162|459847857|FG001|Overall Study|Lost to Follow-up|6|||
127787735|NCT00825162|459847858|FG002|Overall Study|Lost to Follow-up|3|||
127787736|NCT00825162|459847856|FG000|Overall Study|Physician Decision|2|||
127787737|NCT00825162|459847857|FG001|Overall Study|Physician Decision|0|||
127787738|NCT00825162|459847858|FG002|Overall Study|Physician Decision|0|||
127787739|NCT00825162|459847856|FG000|Overall Study|Move away from the study area|1|||
127787740|NCT00825162|459847857|FG001|Overall Study|Move away from the study area|0|||
127882637|NCT00759759|460192888|FG001|Overall Study|Withdrawal by Subject|1|||
127787741|NCT00825162|459847858|FG002|Overall Study|Move away from the study area|0|||
127882638|NCT00391092|460194489|FG000|Overall Study|Death|78|||
128037798|NCT02114177|460768425|FG000|Overall Study|Lost to Follow-up|1|||
128037799|NCT02114177|460768426|FG001|Overall Study|Lost to Follow-up|2|||
128037800|NCT02114177|460768425|FG000|Overall Study|Withdrawal by Subject|6|||
128037801|NCT02114177|460768426|FG001|Overall Study|Withdrawal by Subject|1|||
128037802|NCT02114177|460768425|FG000|Overall Study|Other|2|||
128037803|NCT02114177|460768426|FG001|Overall Study|Other|1|||
128037804|NCT01585025|460768427|FG000|Overall Study|Withdrawal by Subject|0|||
128037805|NCT01585025|460768428|FG001|Overall Study|Withdrawal by Subject|3|||
128037806|NCT01585025|460768429|FG002|Overall Study|Withdrawal by Subject|4|||
128037807|NCT00503984|460768430|FG000|Overall Study|Protocol Violation|0|||
128037808|NCT00503984|460768431|FG001|Overall Study|Protocol Violation|1|||
128037809|NCT00503984|460768432|FG002|Overall Study|Protocol Violation|0|||
128037810|NCT00503984|460768433|FG003|Overall Study|Protocol Violation|0|||
128037811|NCT00503984|460768434|FG004|Overall Study|Protocol Violation|0|||
128037812|NCT00503984|460768435|FG005|Overall Study|Protocol Violation|0|||
128037813|NCT00503984|460768430|FG000|Overall Study|Adverse Event|0|||
128037814|NCT00503984|460768431|FG001|Overall Study|Adverse Event|1|||
128037815|NCT00503984|460768432|FG002|Overall Study|Adverse Event|0|||
128037816|NCT00503984|460768433|FG003|Overall Study|Adverse Event|0|||
128037817|NCT00503984|460768434|FG004|Overall Study|Adverse Event|0|||
128037818|NCT00503984|460768435|FG005|Overall Study|Adverse Event|0|||
128037819|NCT00503984|460768430|FG000|Overall Study|Death|0|||
128037820|NCT00503984|460768431|FG001|Overall Study|Death|0|||
128037821|NCT00503984|460768432|FG002|Overall Study|Death|0|||
128037822|NCT00503984|460768433|FG003|Overall Study|Death|0|||
128037823|NCT00503984|460768434|FG004|Overall Study|Death|1|||
128037824|NCT00503984|460768435|FG005|Overall Study|Death|0|||
128037825|NCT01246960|460768436|FG000|Overall Study|Lost to Follow-up|3|||
128037826|NCT01246960|460768437|FG001|Overall Study|Lost to Follow-up|1|||
128037827|NCT01246960|460768436|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
128037828|NCT01246960|460768437|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
128037829|NCT00140140|460768444|FG000|Overall Study|Unacceptable toxicity|1|||
128037830|NCT00140140|460768445|FG001|Overall Study|Unacceptable toxicity|1|||
128037831|NCT00140140|460768446|FG002|Overall Study|Unacceptable toxicity|2|||
128037832|NCT00140140|460768444|FG000|Overall Study|Physician Decision|1|||
128037833|NCT00140140|460768445|FG001|Overall Study|Physician Decision|1|||
128037834|NCT00140140|460768446|FG002|Overall Study|Physician Decision|0|||
128037835|NCT03376516|460768447|FG000|Overall Study|Not treated|1|||
128037836|NCT03376516|460768447|FG000|Overall Study|Consent withdrawn|1|||
128037837|NCT01359956|460768448|FG000|Overall Study|Death|58|||
128037838|NCT01359956|460768449|FG001|Overall Study|Death|60|||
128037839|NCT01359956|460768450|FG002|Overall Study|Death|66|||
128037840|NCT01359956|460768451|FG003|Overall Study|Death|57|||
128037841|NCT01359956|460768448|FG000|Overall Study|Lost to Follow-up|3|||
128037842|NCT01359956|460768449|FG001|Overall Study|Lost to Follow-up|4|||
128037843|NCT01359956|460768450|FG002|Overall Study|Lost to Follow-up|1|||
128037844|NCT01359956|460768451|FG003|Overall Study|Lost to Follow-up|1|||
128037845|NCT00582907|460768452|FG000|1st Course|Withdrawal by Subject|1|||
128037846|NCT00582907|460768453|FG001|1st Course|Withdrawal by Subject|0|||
128037847|NCT00582907|460768454|FG002|1st Course|Withdrawal by Subject|0|||
128037848|NCT00582907|460768455|FG003|1st Course|Withdrawal by Subject|0|||
128037849|NCT00582907|460768452|FG000|1st Course|Lost to Follow-up|0|||
128037850|NCT00582907|460768453|FG001|1st Course|Lost to Follow-up|0|||
128037851|NCT00582907|460768454|FG002|1st Course|Lost to Follow-up|0|||
128037852|NCT00582907|460768455|FG003|1st Course|Lost to Follow-up|1|||
128037853|NCT00582907|460768452|FG000|2nd Course|Lack of Efficacy|1|||
128037854|NCT00582907|460768453|FG001|2nd Course|Lack of Efficacy|0|||
128037855|NCT00582907|460768454|FG002|2nd Course|Lack of Efficacy|0|||
128037856|NCT00582907|460768455|FG003|2nd Course|Lack of Efficacy|0|||
128037857|NCT00370292|460768456|FG000|Overall Study|Disease Progression|4|||
128037858|NCT00370292|460768456|FG000|Overall Study|Adverse Event|7|||
128037859|NCT00370292|460768456|FG000|Overall Study|Physician Decision|2|||
128037860|NCT00276419|460768457|FG000|First Intervention|Adverse Event|1|||
128037861|NCT00276419|460768458|FG001|First Intervention|Adverse Event|0|||
128037862|NCT00276419|460768457|FG000|First Intervention|Withdrawal by Subject|0|||
128037863|NCT00276419|460768458|FG001|First Intervention|Withdrawal by Subject|2|||
128037864|NCT03545672|460768459|FG000|Overall Study|Uncertain diagnosis|2|||
128037865|NCT03545672|460768460|FG001|Overall Study|Uncertain diagnosis|1|||
128037866|NCT03545672|460768459|FG000|Overall Study|Protocol Violation|2|||
128037867|NCT03545672|460768460|FG001|Overall Study|Protocol Violation|2|||
128037868|NCT01628913|460768461|FG000|Overall Study|Adverse Event|12|||
128037869|NCT01628913|460768462|FG001|Overall Study|Adverse Event|5|||
128037870|NCT01628913|460768461|FG000|Overall Study|Disease Progression|11|||
128037871|NCT01628913|460768462|FG001|Overall Study|Disease Progression|14|||
128037872|NCT01628913|460768461|FG000|Overall Study|Protocol Violation|1|||
128037873|NCT01628913|460768462|FG001|Overall Study|Protocol Violation|0|||
128037874|NCT01628913|460768461|FG000|Overall Study|Death|1|||
128037875|NCT01628913|460768462|FG001|Overall Study|Death|0|||
128037876|NCT01628913|460768461|FG000|Overall Study|study terminated by Sponsor|4|||
128037877|NCT01628913|460768462|FG001|Overall Study|study terminated by Sponsor|9|||
128037878|NCT01628913|460768461|FG000|Overall Study|Withdrawal by Subject|1|||
128037879|NCT01628913|460768462|FG001|Overall Study|Withdrawal by Subject|0|||
128037880|NCT01628913|460768461|FG000|Overall Study|Physician Decision|1|||
128037881|NCT01628913|460768462|FG001|Overall Study|Physician Decision|3|||
128037882|NCT04778592|460768464|FG000|Overall Study|Adverse Event|1|||
128037883|NCT04778592|460768465|FG001|Overall Study|Adverse Event|2|||
128037884|NCT04778592|460768464|FG000|Overall Study|Withdrawal by Subject|1|||
128037885|NCT04778592|460768465|FG001|Overall Study|Withdrawal by Subject|2|||
128037886|NCT01192126|460768466|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
128037887|NCT01192126|460768467|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
128037888|NCT01192126|460768466|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
128037889|NCT01192126|460768467|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
128037890|NCT04102007|460768468|FG000|Overall Study|Adverse Event|4|||
128037891|NCT04102007|460768468|FG000|Overall Study|Lost to Follow-up|3|||
128037892|NCT04102007|460768468|FG000|Overall Study|Withdrawal by Subject|12|||
128037893|NCT04102007|460768468|FG000|Overall Study|Eligibility Violation|5|||
128037894|NCT04102007|460768468|FG000|Overall Study|Lack of Efficacy|6|||
128037895|NCT04102007|460768468|FG000|Overall Study|Protocol Deviation|5|||
128037896|NCT04102007|460768468|FG000|Overall Study|Protocol Compliance|1|||
128037897|NCT04102007|460768468|FG000|Overall Study|Withdrew Treatment|2|||
128037898|NCT04102007|460768468|FG000|Overall Study|Pregnancy|1|||
128037899|NCT00892008|460768472|FG000|Overall Study|Death|5|||
128037900|NCT00892008|460768472|FG000|Overall Study|Lack of Efficacy|3|||
128037901|NCT00892008|460768472|FG000|Overall Study|Lost to Follow-up|142|||
128037902|NCT00892008|460768472|FG000|Overall Study|Other|378|||
128037903|NCT00892008|460768472|FG000|Overall Study|Adverse Event|37|||
128037904|NCT03610048|460768474|FG000|Overall Study|Study terminated by sponsor|84|||
128037905|NCT03610048|460768474|FG000|Overall Study|Adverse Event|32|||
128037906|NCT03610048|460768474|FG000|Overall Study|Withdrawal by Subject|31|||
128037907|NCT03610048|460768474|FG000|Overall Study|Lost to Follow-up|8|||
128037908|NCT03610048|460768474|FG000|Overall Study|Other|4|||
128037909|NCT03610048|460768474|FG000|Overall Study|Physician Decision|1|||
128037910|NCT03610048|460768474|FG000|Overall Study|Pregnancy|1|||
128037911|NCT01146613|460768475|FG000|Overall Study|Lost to Follow-up|3|||
128037912|NCT01146613|460768476|FG001|Overall Study|Lost to Follow-up|8|||
128037913|NCT01146613|460768475|FG000|Overall Study|Lack of Efficacy|0|||
128037914|NCT01146613|460768476|FG001|Overall Study|Lack of Efficacy|1|||
128037915|NCT01146613|460768475|FG000|Overall Study|Death|1|||
128037916|NCT01146613|460768476|FG001|Overall Study|Death|0|||
128037917|NCT01146613|460768475|FG000|Overall Study|Physician Decision|1|||
128037918|NCT01146613|460768476|FG001|Overall Study|Physician Decision|0|||
128037919|NCT01146613|460768475|FG000|Overall Study|Withdrawal by Subject|0|||
128037920|NCT01146613|460768476|FG001|Overall Study|Withdrawal by Subject|3|||
128037921|NCT01146613|460768475|FG000|Overall Study|schedule conflict|1|||
128037922|NCT01146613|460768476|FG001|Overall Study|schedule conflict|0|||
128037923|NCT01146613|460768475|FG000|Overall Study|Outpatient detox|1|||
128037924|NCT01146613|460768476|FG001|Overall Study|Outpatient detox|0|||
128037925|NCT00854360|460768483|FG000|Overall Study|Adverse Event|0|||
128037926|NCT00854360|460768484|FG001|Overall Study|Adverse Event|1|||
128037927|NCT00854360|460768485|FG002|Overall Study|Adverse Event|2|||
128037928|NCT00854360|460768486|FG003|Overall Study|Adverse Event|6|||
128037929|NCT00854360|460768483|FG000|Overall Study|Withdrawal by Subject|0|||
128037930|NCT00854360|460768484|FG001|Overall Study|Withdrawal by Subject|0|||
128037931|NCT00854360|460768485|FG002|Overall Study|Withdrawal by Subject|0|||
128037932|NCT00854360|460768486|FG003|Overall Study|Withdrawal by Subject|1|||
128037933|NCT00854360|460768483|FG000|Overall Study|Pregnancy|0|||
128037934|NCT00854360|460768484|FG001|Overall Study|Pregnancy|1|||
128037935|NCT00854360|460768485|FG002|Overall Study|Pregnancy|0|||
128037936|NCT00854360|460768486|FG003|Overall Study|Pregnancy|0|||
128037937|NCT00854360|460768483|FG000|Overall Study|Lack of Efficacy|2|||
128037938|NCT00854360|460768484|FG001|Overall Study|Lack of Efficacy|1|||
127787742|NCT00825162|459847856|FG000|Overall Study|Unable to attend the study visit|5|||
127787743|NCT00825162|459847857|FG001|Overall Study|Unable to attend the study visit|2|||
127787744|NCT00825162|459847858|FG002|Overall Study|Unable to attend the study visit|0|||
128037939|NCT00854360|460768485|FG002|Overall Study|Lack of Efficacy|0|||
128037940|NCT00854360|460768486|FG003|Overall Study|Lack of Efficacy|0|||
128037941|NCT00854360|460768483|FG000|Overall Study|Other|0|||
128037942|NCT00854360|460768484|FG001|Overall Study|Other|0|||
128037943|NCT00854360|460768485|FG002|Overall Study|Other|0|||
128037944|NCT00854360|460768486|FG003|Overall Study|Other|3|||
128037945|NCT02441218|460768487|FG000|Overall Study|Death|503|||
127787745|NCT00964743|459847859|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
128037946|NCT02441218|460768488|FG001|Overall Study|Death|553|||
128037947|NCT02441218|460768487|FG000|Overall Study|Withdrawal by Subject|73|||
128037948|NCT02441218|460768488|FG001|Overall Study|Withdrawal by Subject|58|||
128037949|NCT02441218|460768487|FG000|Overall Study|Lost to Follow-up|2|||
128037950|NCT02441218|460768488|FG001|Overall Study|Lost to Follow-up|1|||
128037951|NCT01541371|460768489|FG000|Overall Study|Withdrawal by Subject|14|||
128037952|NCT01541371|460768489|FG000|Overall Study|Lost to Follow-up|21|||
128037953|NCT01541371|460768489|FG000|Overall Study|Adverse Event|15|||
128037954|NCT01541371|460768489|FG000|Overall Study|Lack of Efficacy|12|||
128037955|NCT01541371|460768489|FG000|Overall Study|Protocol Violation|6|||
128037956|NCT01541371|460768489|FG000|Overall Study|Study medication non-compliance|3|||
128037957|NCT01541371|460768489|FG000|Overall Study|Other|6|||
128037958|NCT00806585|460768493|FG000|Overall Study|Study terminated by Sponsor|0|||
128037959|NCT00806585|460768494|FG001|Overall Study|Study terminated by Sponsor|0|||
128037960|NCT00806585|460768495|FG002|Overall Study|Study terminated by Sponsor|1|||
128037961|NCT00806585|460768496|FG003|Overall Study|Study terminated by Sponsor|2|||
128037962|NCT00806585|460768497|FG004|Overall Study|Study terminated by Sponsor|0|||
128037963|NCT00806585|460768493|FG000|Overall Study|Protocol Violation|3|||
128037964|NCT00806585|460768494|FG001|Overall Study|Protocol Violation|1|||
128037965|NCT00806585|460768495|FG002|Overall Study|Protocol Violation|2|||
128037966|NCT00806585|460768496|FG003|Overall Study|Protocol Violation|0|||
128037967|NCT00806585|460768497|FG004|Overall Study|Protocol Violation|0|||
128037968|NCT00806585|460768493|FG000|Overall Study|Physician Decision|0|||
128037969|NCT00806585|460768494|FG001|Overall Study|Physician Decision|2|||
128037970|NCT00806585|460768495|FG002|Overall Study|Physician Decision|3|||
128037971|NCT00806585|460768496|FG003|Overall Study|Physician Decision|0|||
128037972|NCT00806585|460768497|FG004|Overall Study|Physician Decision|1|||
128037973|NCT00806585|460768493|FG000|Overall Study|Lost to Follow-up|2|||
128037974|NCT00806585|460768494|FG001|Overall Study|Lost to Follow-up|1|||
128037975|NCT00806585|460768495|FG002|Overall Study|Lost to Follow-up|2|||
128037976|NCT00806585|460768496|FG003|Overall Study|Lost to Follow-up|2|||
128037977|NCT00806585|460768497|FG004|Overall Study|Lost to Follow-up|5|||
128037978|NCT00806585|460768493|FG000|Overall Study|Lack of Efficacy|1|||
128037979|NCT00806585|460768494|FG001|Overall Study|Lack of Efficacy|0|||
128037980|NCT00806585|460768495|FG002|Overall Study|Lack of Efficacy|0|||
128037981|NCT00806585|460768496|FG003|Overall Study|Lack of Efficacy|0|||
128037982|NCT00806585|460768497|FG004|Overall Study|Lack of Efficacy|0|||
128037983|NCT00806585|460768493|FG000|Overall Study|Adverse Event|1|||
128037984|NCT00806585|460768494|FG001|Overall Study|Adverse Event|5|||
128037985|NCT00806585|460768495|FG002|Overall Study|Adverse Event|3|||
128037986|NCT00806585|460768496|FG003|Overall Study|Adverse Event|4|||
128037987|NCT00806585|460768497|FG004|Overall Study|Adverse Event|2|||
128037988|NCT00806585|460768493|FG000|Overall Study|Withdrawal by Subject|10|||
128037989|NCT00806585|460768494|FG001|Overall Study|Withdrawal by Subject|8|||
128037990|NCT00806585|460768495|FG002|Overall Study|Withdrawal by Subject|9|||
128037991|NCT00806585|460768496|FG003|Overall Study|Withdrawal by Subject|3|||
128037992|NCT00806585|460768497|FG004|Overall Study|Withdrawal by Subject|11|||
128037993|NCT00806585|460768493|FG000|Overall Study|Completion status unknown|15|||
128037994|NCT00806585|460768494|FG001|Overall Study|Completion status unknown|14|||
128037995|NCT00806585|460768495|FG002|Overall Study|Completion status unknown|12|||
128037996|NCT00806585|460768496|FG003|Overall Study|Completion status unknown|4|||
128037997|NCT00806585|460768497|FG004|Overall Study|Completion status unknown|12|||
128037998|NCT00474903|460768498|FG000|Overall Study|Protocol Violation|1|||
128037999|NCT00474903|460768499|FG001|Overall Study|Protocol Violation|5|||
128038000|NCT00474903|460768500|FG002|Overall Study|Protocol Violation|2|||
128038001|NCT00399529|460768501|FG000|Overall Study|Off Study Prior to Treatment|2|||
128038002|NCT01936831|460768502|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
128038003|NCT01936831|460768503|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
128038004|NCT01936831|460768504|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
128038005|NCT01936831|460768505|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
128038006|NCT01936831|460768506|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
128038007|NCT01936831|460768507|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
128038008|NCT01936831|460768508|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
128038009|NCT01936831|460768509|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
128038010|NCT01936831|460768510|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
128038011|NCT03435380|460768516|FG000|Overall Study|Death|1|||
128038012|NCT03435380|460768517|FG001|Overall Study|Death|2|||
128038013|NCT03435380|460768518|FG002|Overall Study|Death|1|||
128038014|NCT03435380|460768516|FG000|Overall Study|Lost to Follow-up|12|||
128038015|NCT03435380|460768517|FG001|Overall Study|Lost to Follow-up|8|||
128038016|NCT03435380|460768518|FG002|Overall Study|Lost to Follow-up|6|||
128038017|NCT03435380|460768516|FG000|Overall Study|Physician Decision|1|||
128038018|NCT03435380|460768517|FG001|Overall Study|Physician Decision|0|||
128038019|NCT03435380|460768518|FG002|Overall Study|Physician Decision|0|||
128038020|NCT03435380|460768516|FG000|Overall Study|Withdrawal by Subject|0|||
128038021|NCT03435380|460768517|FG001|Overall Study|Withdrawal by Subject|1|||
128038022|NCT03435380|460768518|FG002|Overall Study|Withdrawal by Subject|1|||
128038023|NCT03435380|460768516|FG000|Overall Study|Ineligible|0|||
128038024|NCT03435380|460768517|FG001|Overall Study|Ineligible|1|||
128038025|NCT03435380|460768518|FG002|Overall Study|Ineligible|1|||
128038026|NCT02133573|460768519|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
128038027|NCT02133573|460768520|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
128038028|NCT02133573|460768519|FG000|Overall Study|Child Deaths|3|||
128038029|NCT02133573|460768520|FG001|Overall Study|Child Deaths|5|||
128038030|NCT02133573|460768519|FG000|Overall Study|Child Declined Follow Ups|2|||
128038031|NCT02133573|460768520|FG001|Overall Study|Child Declined Follow Ups|1|||
128038032|NCT02133573|460768519|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
128038033|NCT02133573|460768520|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
128038034|NCT02115321|460768523|FG000|Overall Study|Death|1|||
128038035|NCT02115321|460768524|FG001|Overall Study|Death|0|||
128038036|NCT02493764|460768525|FG000|Overall Study|Adverse Event|2|||
128038037|NCT02493764|460768526|FG001|Overall Study|Adverse Event|2|||
128038038|NCT02493764|460768525|FG000|Overall Study|Death|44|||
128038039|NCT02493764|460768526|FG001|Overall Study|Death|58|||
128038040|NCT02493764|460768525|FG000|Overall Study|Lost to Follow-up|2|||
128038041|NCT02493764|460768526|FG001|Overall Study|Lost to Follow-up|1|||
128038042|NCT02493764|460768525|FG000|Overall Study|Protocol Violation|6|||
128038043|NCT02493764|460768526|FG001|Overall Study|Protocol Violation|7|||
128038044|NCT02493764|460768525|FG000|Overall Study|Physician Decision|1|||
128038045|NCT02493764|460768526|FG001|Overall Study|Physician Decision|1|||
128038046|NCT02493764|460768525|FG000|Overall Study|Participant moved|17|||
128038047|NCT02493764|460768526|FG001|Overall Study|Participant moved|5|||
128038048|NCT02493764|460768525|FG000|Overall Study|Withdrawal parent/guardian|0|||
128038049|NCT02493764|460768526|FG001|Overall Study|Withdrawal parent/guardian|1|||
128038050|NCT02493764|460768525|FG000|Overall Study|Withdrawal by Subject|11|||
128038051|NCT02493764|460768526|FG001|Overall Study|Withdrawal by Subject|7|||
128038052|NCT01307449|460768528|FG000|Overall Study|Adverse Event|1|||
128038053|NCT01307449|460768529|FG001|Overall Study|Adverse Event|0|||
128038054|NCT01307449|460768530|FG002|Overall Study|Adverse Event|0|||
128038055|NCT01307449|460768531|FG003|Overall Study|Adverse Event|0|||
128038056|NCT01561976|460768532|FG000|Period 1|Adverse Event|0|||
128038057|NCT01561976|460768533|FG001|Period 1|Adverse Event|0|||
128038058|NCT01561976|460768534|FG002|Period 1|Adverse Event|1|||
128038059|NCT01561976|460768535|FG003|Period 1|Adverse Event|0|||
128038060|NCT01561976|460768536|FG004|Period 1|Adverse Event|0|||
128038061|NCT01561976|460768537|FG005|Period 1|Adverse Event|0|||
128038062|NCT01561976|460768532|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
128038063|NCT01561976|460768533|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
128038064|NCT01561976|460768534|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
128038065|NCT01561976|460768535|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
128038066|NCT01561976|460768536|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
128038067|NCT01561976|460768537|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
128038068|NCT01561976|460768532|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
128038069|NCT01561976|460768533|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
128038070|NCT01561976|460768534|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
128038071|NCT01561976|460768535|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
128038072|NCT01561976|460768536|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
128038073|NCT01561976|460768537|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
127787746|NCT03317795|459847865|FG000|Overall Study|IUD Expulsion|1|||
127787747|NCT03317795|459847866|FG001|Overall Study|IUD Expulsion|0|||
127787748|NCT03317795|459847865|FG000|Overall Study|Lost to Follow-up|1|||
127787749|NCT03317795|459847866|FG001|Overall Study|Lost to Follow-up|3|||
127787750|NCT03317795|459847865|FG000|Overall Study|Treatment change|0|||
127787751|NCT03317795|459847866|FG001|Overall Study|Treatment change|3|||
127787752|NCT03317795|459847865|FG000|Overall Study|Intolerance of medication|0|||
127787753|NCT03317795|459847866|FG001|Overall Study|Intolerance of medication|1|||
127787754|NCT01549002|459847867|FG000|Overall Study|Excessive pain|0|||
127787755|NCT01549002|459847868|FG001|Overall Study|Excessive pain|2|||
127787756|NCT01549002|459847867|FG000|Overall Study|Moderate sedation required|0|||
127787757|NCT01549002|459847868|FG001|Overall Study|Moderate sedation required|2|||
127787758|NCT02424253|459847871|FG000|Overall Study|Other, unspecified|1|||
127787759|NCT02424253|459847872|FG001|Overall Study|Other, unspecified|0|||
127787760|NCT02424253|459847871|FG000|Overall Study|Compliance problems|1|||
127787761|NCT02424253|459847872|FG001|Overall Study|Compliance problems|0|||
127787762|NCT02424253|459847871|FG000|Overall Study|Physician Decision|2|||
127787763|NCT02424253|459847872|FG001|Overall Study|Physician Decision|0|||
128038074|NCT01561976|460768532|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
127787764|NCT02424253|459847871|FG000|Overall Study|Lack of Efficacy|0|||
128038075|NCT01561976|460768533|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
128038076|NCT01561976|460768534|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
128038077|NCT01561976|460768535|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
128038078|NCT01561976|460768536|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
128038079|NCT01561976|460768537|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
128038080|NCT03218917|460768540|FG000|Overall Study|Adverse Event|3|||
128038081|NCT03218917|460768541|FG001|Overall Study|Adverse Event|3|||
128038082|NCT03218917|460768542|FG002|Overall Study|Adverse Event|2|||
128038083|NCT03218917|460768540|FG000|Overall Study|Subject withdrew consent|2|||
127787765|NCT02424253|459847872|FG001|Overall Study|Lack of Efficacy|7|||
127787766|NCT02424253|459847871|FG000|Overall Study|Adverse Event|2|||
127787767|NCT02424253|459847872|FG001|Overall Study|Adverse Event|0|||
127787768|NCT02424253|459847871|FG000|Overall Study|Consent withdrawn by subject|4|||
127882639|NCT00391092|460194490|FG001|Overall Study|Death|81|||
127882640|NCT00391092|460194489|FG000|Overall Study|Lost to Follow-up|13|||
127882641|NCT00391092|460194490|FG001|Overall Study|Lost to Follow-up|18|||
127882642|NCT00391092|460194489|FG000|Overall Study|Alive on treatment|29|||
127882643|NCT00391092|460194490|FG001|Overall Study|Alive on treatment|33|||
127882644|NCT00391092|460194489|FG000|Overall Study|Alive in follow-up|88|||
127882645|NCT00391092|460194490|FG001|Overall Study|Alive in follow-up|84|||
127882646|NCT01614925|460194492|FG000|Overall Study|Withdrawal by Subject|1|||
127882647|NCT01614925|460194493|FG001|Overall Study|Withdrawal by Subject|0|||
127882648|NCT01614925|460194492|FG000|Overall Study|Protocol Violation|3|||
128038084|NCT03218917|460768541|FG001|Overall Study|Subject withdrew consent|4|||
128038085|NCT03218917|460768542|FG002|Overall Study|Subject withdrew consent|10|||
128038086|NCT03218917|460768540|FG000|Overall Study|Physician Decision|0|||
128038087|NCT03218917|460768541|FG001|Overall Study|Physician Decision|1|||
128038088|NCT03218917|460768542|FG002|Overall Study|Physician Decision|1|||
128038089|NCT03218917|460768540|FG000|Overall Study|Lost to Follow-up|1|||
128038090|NCT03218917|460768541|FG001|Overall Study|Lost to Follow-up|0|||
128038091|NCT03218917|460768542|FG002|Overall Study|Lost to Follow-up|0|||
128038092|NCT03218917|460768540|FG000|Overall Study|Reason Missing|0|||
128038093|NCT03218917|460768541|FG001|Overall Study|Reason Missing|2|||
128038094|NCT03218917|460768542|FG002|Overall Study|Reason Missing|0|||
128038095|NCT03218917|460768540|FG000|Overall Study|Death|0|||
128038096|NCT03218917|460768541|FG001|Overall Study|Death|1|||
128038097|NCT03218917|460768542|FG002|Overall Study|Death|0|||
128038098|NCT03218917|460768540|FG000|Overall Study|Non-Compliance with Study Drug|0|||
128038099|NCT03218917|460768541|FG001|Overall Study|Non-Compliance with Study Drug|1|||
128038100|NCT03218917|460768542|FG002|Overall Study|Non-Compliance with Study Drug|0|||
128038101|NCT05136170|460768545|FG000|Overall Study|Withdrawal by Subject|2|||
128038102|NCT05136170|460768546|FG001|Overall Study|Withdrawal by Subject|2|||
128038103|NCT05136170|460768545|FG000|Overall Study|Can no longer make office visits|1|||
128038104|NCT05136170|460768546|FG001|Overall Study|Can no longer make office visits|0|||
128038105|NCT01463527|460768547|FG000|Overall Study|Protocol Violation|1|||
128038106|NCT01463527|460768548|FG001|Overall Study|Protocol Violation|1|||
128038107|NCT01463527|460768547|FG000|Overall Study|Crying >20% of sedation|5|||
128038108|NCT01463527|460768548|FG001|Overall Study|Crying >20% of sedation|6|||
128038109|NCT01788943|460768549|FG000|Overall Study|Withdrawal by Subject|1|||
128038110|NCT01788943|460768550|FG001|Overall Study|Withdrawal by Subject|0|||
128038111|NCT01119287|460768551|FG000|Overall Study|Patient Decision, not related to AE|0|||
128038112|NCT01119287|460768552|FG001|Overall Study|Patient Decision, not related to AE|0|||
128038113|NCT01119287|460768553|FG002|Overall Study|Patient Decision, not related to AE|2|||
128038114|NCT01119287|460768554|FG003|Overall Study|Patient Decision, not related to AE|2|||
128038115|NCT01119287|460768555|FG004|Overall Study|Patient Decision, not related to AE|1|||
128038116|NCT01119287|460768556|FG005|Overall Study|Patient Decision, not related to AE|0|||
128038117|NCT04403919|460768561|FG000|Overall Study|Lost to Follow-up|0|||
128038118|NCT04403919|460768562|FG001|Overall Study|Lost to Follow-up|0|||
128038119|NCT04403919|460768563|FG002|Overall Study|Lost to Follow-up|0|||
128038120|NCT04403919|460768564|FG003|Overall Study|Lost to Follow-up|1|||
128038121|NCT01612676|460768565|FG000|Overall Study|Adverse Event|2|||
128038122|NCT01612676|460768566|FG001|Overall Study|Adverse Event|3|||
128038123|NCT01612676|460768567|FG002|Overall Study|Adverse Event|1|||
128038124|NCT01612676|460768568|FG003|Overall Study|Adverse Event|3|||
128038125|NCT01612676|460768565|FG000|Overall Study|Protocol Violation|0|||
128038126|NCT01612676|460768566|FG001|Overall Study|Protocol Violation|1|||
128038127|NCT01612676|460768567|FG002|Overall Study|Protocol Violation|0|||
128038128|NCT01612676|460768568|FG003|Overall Study|Protocol Violation|0|||
128038129|NCT01156844|460768571|FG000|Overall Study|Adverse Event|0|||
128038130|NCT01156844|460768572|FG001|Overall Study|Adverse Event|0|||
128038131|NCT01156844|460768573|FG002|Overall Study|Adverse Event|1|||
128038132|NCT01156844|460768574|FG003|Overall Study|Adverse Event|1|||
127787769|NCT02424253|459847872|FG001|Overall Study|Consent withdrawn by subject|1|||
127787770|NCT02424253|459847871|FG000|Overall Study|Lost to Follow-up|1|||
127787771|NCT02424253|459847872|FG001|Overall Study|Lost to Follow-up|1|||
127787772|NCT01378104|459847875|FG000|Overall Study|Adverse Event|8|||
127787773|NCT01378104|459847876|FG001|Overall Study|Adverse Event|8|||
127787774|NCT01378104|459847875|FG000|Overall Study|Lack of Efficacy|7|||
127787775|NCT01378104|459847876|FG001|Overall Study|Lack of Efficacy|5|||
127787776|NCT01378104|459847875|FG000|Overall Study|Withdrawal by Subject|12|||
127787777|NCT01378104|459847876|FG001|Overall Study|Withdrawal by Subject|13|||
127787778|NCT03610724|459847877|FG000|Overall Study|Death|17|||
127787779|NCT03610724|459847877|FG000|Overall Study|Lost to Follow-up|1|||
127882649|NCT01614925|460194493|FG001|Overall Study|Protocol Violation|2|||
128038133|NCT01156844|460768571|FG000|Overall Study|Abnormal test procedure result(s)|0|||
128038134|NCT01156844|460768572|FG001|Overall Study|Abnormal test procedure result(s)|1|||
127787780|NCT03610724|459847877|FG000|Overall Study|Physician Decision|1|||
127787781|NCT03610724|459847877|FG000|Overall Study|Died prior to infusion|1|||
127882650|NCT02437890|460194494|FG000|Overall Study|Non-compliance to study drug|0|||
128038135|NCT01156844|460768573|FG002|Overall Study|Abnormal test procedure result(s)|2|||
128038136|NCT01156844|460768574|FG003|Overall Study|Abnormal test procedure result(s)|2|||
128038137|NCT01156844|460768571|FG000|Overall Study|Withdrawal by Subject|0|||
128038138|NCT01156844|460768572|FG001|Overall Study|Withdrawal by Subject|0|||
128038139|NCT01156844|460768573|FG002|Overall Study|Withdrawal by Subject|2|||
128038140|NCT01156844|460768574|FG003|Overall Study|Withdrawal by Subject|2|||
128038141|NCT01156844|460768571|FG000|Overall Study|Lost to Follow-up|0|||
128038142|NCT01156844|460768572|FG001|Overall Study|Lost to Follow-up|0|||
128038143|NCT01156844|460768573|FG002|Overall Study|Lost to Follow-up|1|||
128038144|NCT01156844|460768574|FG003|Overall Study|Lost to Follow-up|0|||
128038145|NCT01156844|460768571|FG000|Overall Study|Administrative problems|0|||
128038146|NCT01156844|460768572|FG001|Overall Study|Administrative problems|1|||
128038147|NCT01156844|460768573|FG002|Overall Study|Administrative problems|0|||
128038148|NCT01156844|460768574|FG003|Overall Study|Administrative problems|1|||
128038149|NCT01156844|460768571|FG000|Overall Study|Protocol deviation|2|||
128038150|NCT01156844|460768572|FG001|Overall Study|Protocol deviation|0|||
128038151|NCT01156844|460768573|FG002|Overall Study|Protocol deviation|0|||
128038152|NCT01156844|460768574|FG003|Overall Study|Protocol deviation|0|||
128038153|NCT01448616|460768579|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
128038154|NCT01448616|460768580|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
128038155|NCT01448616|460768581|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
128038156|NCT01448616|460768582|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
128038157|NCT01448616|460768579|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
128038158|NCT01448616|460768580|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
128038159|NCT01448616|460768581|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
128038160|NCT01448616|460768582|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
128038161|NCT01448616|460768579|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
128038162|NCT01448616|460768580|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
128038163|NCT01448616|460768581|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
128038164|NCT01448616|460768582|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
128038165|NCT01448616|460768579|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
128038166|NCT01448616|460768580|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
128038167|NCT01448616|460768581|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
128038168|NCT01448616|460768582|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
128038169|NCT01448616|460768579|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
128038170|NCT01448616|460768580|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
128038171|NCT01448616|460768581|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
128038172|NCT01448616|460768582|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
128038173|NCT00397540|460768585|FG000|Overall Study|short follow-up duration < 12 months|1|||
128038174|NCT00397540|460768586|FG001|Overall Study|short follow-up duration < 12 months|0|||
128038175|NCT00485173|460768590|FG000|Overall Study|Death|4|||
128038176|NCT00485173|460768591|FG001|Overall Study|Death|3|||
128038177|NCT00485173|460768590|FG000|Overall Study|Lost to Follow-up|32|||
128038178|NCT00485173|460768591|FG001|Overall Study|Lost to Follow-up|61|||
128038179|NCT00746811|460768592|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
128038180|NCT00746811|460768593|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
128038181|NCT02561962|460768598|FG000|Overall Study|Withdrawal by Subject|1|||
128038182|NCT02561962|460768599|FG001|Overall Study|Withdrawal by Subject|0|||
128038183|NCT02561962|460768600|FG002|Overall Study|Withdrawal by Subject|0|||
128038184|NCT02561962|460768601|FG003|Overall Study|Withdrawal by Subject|0|||
128038185|NCT02561962|460768602|FG004|Overall Study|Withdrawal by Subject|1|||
128038186|NCT02561962|460768603|FG005|Overall Study|Withdrawal by Subject|1|||
128038187|NCT02561962|460768604|FG006|Overall Study|Withdrawal by Subject|2|||
128038188|NCT02561962|460768605|FG007|Overall Study|Withdrawal by Subject|1|||
128038189|NCT02561962|460768606|FG008|Overall Study|Withdrawal by Subject|0|||
128038190|NCT02561962|460768598|FG000|Overall Study|Decision by sponsor|0|||
128038191|NCT02561962|460768599|FG001|Overall Study|Decision by sponsor|0|||
128038192|NCT02561962|460768600|FG002|Overall Study|Decision by sponsor|0|||
128038193|NCT02561962|460768601|FG003|Overall Study|Decision by sponsor|0|||
128038194|NCT02561962|460768602|FG004|Overall Study|Decision by sponsor|1|||
128038195|NCT02561962|460768603|FG005|Overall Study|Decision by sponsor|1|||
128038196|NCT02561962|460768604|FG006|Overall Study|Decision by sponsor|0|||
128038197|NCT02561962|460768605|FG007|Overall Study|Decision by sponsor|3|||
127787782|NCT02354222|459847878|FG000|Overall Study|Adverse Event|0|||
127787783|NCT02354222|459847879|FG001|Overall Study|Adverse Event|3|||
127787784|NCT02354222|459847878|FG000|Overall Study|Physician Decision|1|||
127787785|NCT02354222|459847879|FG001|Overall Study|Physician Decision|1|||
128038198|NCT02561962|460768606|FG008|Overall Study|Decision by sponsor|0|||
128038199|NCT02561962|460768598|FG000|Overall Study|Lost to Follow-up|0|||
128038200|NCT02561962|460768599|FG001|Overall Study|Lost to Follow-up|0|||
128038201|NCT02561962|460768600|FG002|Overall Study|Lost to Follow-up|0|||
128038202|NCT02561962|460768601|FG003|Overall Study|Lost to Follow-up|0|||
128038203|NCT02561962|460768602|FG004|Overall Study|Lost to Follow-up|0|||
128038204|NCT02561962|460768603|FG005|Overall Study|Lost to Follow-up|1|||
127882651|NCT02437890|460194495|FG001|Overall Study|Non-compliance to study drug|1|||
127882652|NCT02437890|460194496|FG002|Overall Study|Non-compliance to study drug|0|||
127882653|NCT02437890|460194497|FG003|Overall Study|Non-compliance to study drug|0|||
127882654|NCT02437890|460194498|FG004|Overall Study|Non-compliance to study drug|1|||
127882655|NCT02437890|460194494|FG000|Overall Study|Sponsor's decision|1|||
127882656|NCT02437890|460194495|FG001|Overall Study|Sponsor's decision|1|||
127882657|NCT02437890|460194496|FG002|Overall Study|Sponsor's decision|4|||
127882658|NCT02437890|460194497|FG003|Overall Study|Sponsor's decision|0|||
127882659|NCT02437890|460194498|FG004|Overall Study|Sponsor's decision|2|||
127882660|NCT02437890|460194494|FG000|Overall Study|Physician Decision|0|||
127882661|NCT02437890|460194495|FG001|Overall Study|Physician Decision|0|||
127882662|NCT02437890|460194496|FG002|Overall Study|Physician Decision|0|||
127882663|NCT02437890|460194497|FG003|Overall Study|Physician Decision|1|||
127882664|NCT02437890|460194498|FG004|Overall Study|Physician Decision|0|||
127882665|NCT02437890|460194494|FG000|Overall Study|Unable to attend visit(s)|1|||
127882666|NCT02437890|460194495|FG001|Overall Study|Unable to attend visit(s)|0|||
127882667|NCT02437890|460194496|FG002|Overall Study|Unable to attend visit(s)|0|||
127882668|NCT02437890|460194497|FG003|Overall Study|Unable to attend visit(s)|0|||
127882669|NCT02437890|460194498|FG004|Overall Study|Unable to attend visit(s)|0|||
127882670|NCT02437890|460194494|FG000|Overall Study|Lack of Efficacy|1|||
127882671|NCT02437890|460194495|FG001|Overall Study|Lack of Efficacy|3|||
127882672|NCT02437890|460194496|FG002|Overall Study|Lack of Efficacy|0|||
127882673|NCT02437890|460194497|FG003|Overall Study|Lack of Efficacy|3|||
127882674|NCT02437890|460194498|FG004|Overall Study|Lack of Efficacy|1|||
127882675|NCT02437890|460194494|FG000|Overall Study|Adverse Event|4|||
127882676|NCT02437890|460194495|FG001|Overall Study|Adverse Event|9|||
127882677|NCT02437890|460194496|FG002|Overall Study|Adverse Event|5|||
127882678|NCT02437890|460194497|FG003|Overall Study|Adverse Event|11|||
127882679|NCT02437890|460194498|FG004|Overall Study|Adverse Event|7|||
127882680|NCT02437890|460194494|FG000|Overall Study|Withdrawal by Subject|1|||
127882681|NCT02437890|460194495|FG001|Overall Study|Withdrawal by Subject|2|||
127882682|NCT02437890|460194496|FG002|Overall Study|Withdrawal by Subject|6|||
127882683|NCT02437890|460194497|FG003|Overall Study|Withdrawal by Subject|5|||
127882684|NCT02437890|460194498|FG004|Overall Study|Withdrawal by Subject|5|||
127882685|NCT02437890|460194494|FG000|Overall Study|Death|0|||
127882686|NCT02437890|460194495|FG001|Overall Study|Death|0|||
127787786|NCT02354222|459847878|FG000|Overall Study|Pregnancy|1|||
127787787|NCT02354222|459847879|FG001|Overall Study|Pregnancy|0|||
127787788|NCT02354222|459847878|FG000|Overall Study|Withdrawal by Subject|2|||
127787789|NCT02354222|459847879|FG001|Overall Study|Withdrawal by Subject|3|||
127787790|NCT02354222|459847878|FG000|Overall Study|Conflict with the stopping criteria|0|||
127787791|NCT02354222|459847879|FG001|Overall Study|Conflict with the stopping criteria|4|||
127787792|NCT00786565|459847880|FG000|Enrollment Prior to Surgery|Site Closed|3|||
127787793|NCT00786565|459847880|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
127787794|NCT00786565|459847880|FG000|Post Surgery|Abnormal macular pucker|1|||
127787795|NCT00786565|459847880|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
127787796|NCT01342484|459847883|FG000|Overall Study|Other Reasons|1|||
127787797|NCT01342484|459847884|FG001|Overall Study|Other Reasons|0|||
127787798|NCT01342484|459847885|FG002|Overall Study|Other Reasons|0|||
127787799|NCT01342484|459847883|FG000|Overall Study|Protocol Violation|0|||
127787800|NCT01342484|459847884|FG001|Overall Study|Protocol Violation|0|||
127787801|NCT01342484|459847885|FG002|Overall Study|Protocol Violation|1|||
127787802|NCT01342484|459847883|FG000|Overall Study|Withdrawal by Subject|1|||
127787803|NCT01342484|459847884|FG001|Overall Study|Withdrawal by Subject|0|||
127787804|NCT01342484|459847885|FG002|Overall Study|Withdrawal by Subject|0|||
127882687|NCT02437890|460194496|FG002|Overall Study|Death|0|||
127882688|NCT02437890|460194497|FG003|Overall Study|Death|2|||
128038205|NCT02561962|460768604|FG006|Overall Study|Lost to Follow-up|0|||
128038206|NCT02561962|460768605|FG007|Overall Study|Lost to Follow-up|0|||
128038207|NCT02561962|460768606|FG008|Overall Study|Lost to Follow-up|0|||
128038208|NCT01819272|460770568|FG000|Overall Study|Adverse Event|1|||
128038209|NCT01819272|460770569|FG001|Overall Study|Adverse Event|0|||
128038210|NCT01819272|460770570|FG002|Overall Study|Adverse Event|0|||
127787805|NCT01840579|459847888|FG000|Overall Study|Status not recorded|0|||
127787806|NCT01840579|459847889|FG001|Overall Study|Status not recorded|0|||
128038211|NCT01819272|460770571|FG003|Overall Study|Adverse Event|2|||
128038212|NCT01819272|460770572|FG004|Overall Study|Adverse Event|0|||
128038213|NCT01819272|460770573|FG005|Overall Study|Adverse Event|0|||
127787807|NCT01840579|459847890|FG002|Overall Study|Status not recorded|2|||
127787808|NCT01840579|459847891|FG003|Overall Study|Status not recorded|3|||
127787809|NCT01840579|459847892|FG004|Overall Study|Status not recorded|4|||
127787810|NCT01840579|459847893|FG005|Overall Study|Status not recorded|3|||
127882689|NCT02437890|460194498|FG004|Overall Study|Death|0|||
127882690|NCT02414854|460194499|FG000|Overall Study|Adverse Event|9|||
127882691|NCT02414854|460194500|FG001|Overall Study|Adverse Event|7|||
127882692|NCT02414854|460194501|FG002|Overall Study|Adverse Event|1|||
127882693|NCT02414854|460194502|FG003|Overall Study|Adverse Event|12|||
127882694|NCT02414854|460194499|FG000|Overall Study|Poor compliance to protocol|1|||
127882695|NCT02414854|460194500|FG001|Overall Study|Poor compliance to protocol|1|||
128038214|NCT01819272|460770568|FG000|Overall Study|Lost to Follow-up|3|||
128038215|NCT01819272|460770569|FG001|Overall Study|Lost to Follow-up|0|||
128038216|NCT01819272|460770570|FG002|Overall Study|Lost to Follow-up|1|||
128038217|NCT01819272|460770571|FG003|Overall Study|Lost to Follow-up|0|||
128038218|NCT01819272|460770572|FG004|Overall Study|Lost to Follow-up|0|||
128038219|NCT01819272|460770573|FG005|Overall Study|Lost to Follow-up|3|||
128038220|NCT01819272|460770568|FG000|Overall Study|Protocol Violation|0|||
128038221|NCT01819272|460770569|FG001|Overall Study|Protocol Violation|0|||
128038222|NCT01819272|460770570|FG002|Overall Study|Protocol Violation|0|||
128038223|NCT01819272|460770571|FG003|Overall Study|Protocol Violation|1|||
128038224|NCT01819272|460770572|FG004|Overall Study|Protocol Violation|2|||
128038225|NCT01819272|460770573|FG005|Overall Study|Protocol Violation|3|||
128038226|NCT01819272|460770568|FG000|Overall Study|Physician Decision|0|||
128038227|NCT01819272|460770569|FG001|Overall Study|Physician Decision|1|||
128038228|NCT01819272|460770570|FG002|Overall Study|Physician Decision|0|||
128038229|NCT01819272|460770571|FG003|Overall Study|Physician Decision|0|||
128038230|NCT01819272|460770572|FG004|Overall Study|Physician Decision|0|||
128038231|NCT01819272|460770573|FG005|Overall Study|Physician Decision|0|||
128038232|NCT01819272|460770568|FG000|Overall Study|Withdrawal of Consent|0|||
128038233|NCT01819272|460770569|FG001|Overall Study|Withdrawal of Consent|1|||
128038234|NCT01819272|460770570|FG002|Overall Study|Withdrawal of Consent|2|||
128038235|NCT01819272|460770571|FG003|Overall Study|Withdrawal of Consent|1|||
128038236|NCT01819272|460770572|FG004|Overall Study|Withdrawal of Consent|0|||
128038237|NCT01819272|460770573|FG005|Overall Study|Withdrawal of Consent|1|||
128038238|NCT01819272|460770568|FG000|Overall Study|Loss of Glucose Control|2|||
128038239|NCT01819272|460770569|FG001|Overall Study|Loss of Glucose Control|1|||
128038240|NCT01819272|460770570|FG002|Overall Study|Loss of Glucose Control|0|||
128038241|NCT01819272|460770571|FG003|Overall Study|Loss of Glucose Control|1|||
128038242|NCT01819272|460770572|FG004|Overall Study|Loss of Glucose Control|2|||
128038243|NCT01819272|460770573|FG005|Overall Study|Loss of Glucose Control|0|||
128038244|NCT02660229|460770580|FG000|Overall Study|Adverse Event|2|||
128038245|NCT02660229|460770581|FG001|Overall Study|Adverse Event|0|||
128038246|NCT02660229|460770580|FG000|Overall Study|Withdrawal by Subject|0|||
128038247|NCT02660229|460770581|FG001|Overall Study|Withdrawal by Subject|1|||
128038248|NCT02271880|460770582|FG000|Overall Study|Premature discontinuation of study|3|||
128038249|NCT02271880|460770583|FG001|Overall Study|Premature discontinuation of study|4|||
128038250|NCT02431325|460770584|FG000|Overall Study|Adverse Event|3|||
128038251|NCT02431325|460770585|FG001|Overall Study|Adverse Event|0|||
128038252|NCT02431325|460770584|FG000|Overall Study|Lost to Follow-up|0|||
128038253|NCT02431325|460770585|FG001|Overall Study|Lost to Follow-up|1|||
127787811|NCT01840579|459847894|FG006|Overall Study|Status not recorded|0|||
127787812|NCT01840579|459847895|FG007|Overall Study|Status not recorded|3|||
127787813|NCT01840579|459847896|FG008|Overall Study|Status not recorded|3|||
127787814|NCT01840579|459847897|FG009|Overall Study|Status not recorded|3|||
127787815|NCT01840579|459847888|FG000|Overall Study|Progressive disease|3|||
127787816|NCT01840579|459847889|FG001|Overall Study|Progressive disease|5|||
127787817|NCT01840579|459847890|FG002|Overall Study|Progressive disease|0|||
127787818|NCT01840579|459847891|FG003|Overall Study|Progressive disease|0|||
127787819|NCT01840579|459847892|FG004|Overall Study|Progressive disease|0|||
127787820|NCT01840579|459847893|FG005|Overall Study|Progressive disease|0|||
127787821|NCT01840579|459847894|FG006|Overall Study|Progressive disease|0|||
127787822|NCT01840579|459847895|FG007|Overall Study|Progressive disease|0|||
127787823|NCT01840579|459847896|FG008|Overall Study|Progressive disease|0|||
127787824|NCT01840579|459847897|FG009|Overall Study|Progressive disease|0|||
127787825|NCT01840579|459847888|FG000|Overall Study|Ongoing in study|0|||
127787826|NCT01840579|459847889|FG001|Overall Study|Ongoing in study|1|||
127787827|NCT01840579|459847890|FG002|Overall Study|Ongoing in study|0|||
127787828|NCT01840579|459847891|FG003|Overall Study|Ongoing in study|0|||
127787829|NCT01840579|459847892|FG004|Overall Study|Ongoing in study|0|||
128038254|NCT02431325|460770584|FG000|Overall Study|Withdrawal by Subject|1|||
127787830|NCT01840579|459847893|FG005|Overall Study|Ongoing in study|0|||
128038255|NCT02431325|460770585|FG001|Overall Study|Withdrawal by Subject|2|||
128038256|NCT02431325|460770584|FG000|Overall Study|Declined to take study medication|1|||
128038257|NCT02431325|460770585|FG001|Overall Study|Declined to take study medication|0|||
128038258|NCT02431325|460770584|FG000|Overall Study|Withdrew before starting study medication|1|||
128038259|NCT02431325|460770585|FG001|Overall Study|Withdrew before starting study medication|0|||
128038260|NCT02431325|460770584|FG000|Overall Study|Placebo shortage|2|||
128038261|NCT02431325|460770585|FG001|Overall Study|Placebo shortage|0|||
127787831|NCT01840579|459847894|FG006|Overall Study|Ongoing in study|0|||
127787832|NCT01840579|459847895|FG007|Overall Study|Ongoing in study|0|||
127787833|NCT01840579|459847896|FG008|Overall Study|Ongoing in study|0|||
127787834|NCT01840579|459847897|FG009|Overall Study|Ongoing in study|0|||
127787835|NCT01840579|459847888|FG000|Overall Study|Death|0|||
127787836|NCT01840579|459847889|FG001|Overall Study|Death|0|||
128038262|NCT04661033|460770586|FG000|Overall Study|Adverse Event|0|||
127787837|NCT01840579|459847890|FG002|Overall Study|Death|0|||
127787838|NCT01840579|459847891|FG003|Overall Study|Death|0|||
127787839|NCT01840579|459847892|FG004|Overall Study|Death|0|||
128038263|NCT04661033|460770587|FG001|Overall Study|Adverse Event|0|||
127787840|NCT01840579|459847893|FG005|Overall Study|Death|1|||
127787841|NCT01840579|459847894|FG006|Overall Study|Death|0|||
127787842|NCT01840579|459847895|FG007|Overall Study|Death|0|||
127787843|NCT01840579|459847896|FG008|Overall Study|Death|0|||
127787844|NCT01840579|459847897|FG009|Overall Study|Death|0|||
127787845|NCT01840579|459847888|FG000|Overall Study|Adverse Event|0|||
127787846|NCT01840579|459847889|FG001|Overall Study|Adverse Event|1|||
127787847|NCT01840579|459847890|FG002|Overall Study|Adverse Event|0|||
127787848|NCT01840579|459847891|FG003|Overall Study|Adverse Event|0|||
127787849|NCT01840579|459847892|FG004|Overall Study|Adverse Event|0|||
127787850|NCT01840579|459847893|FG005|Overall Study|Adverse Event|0|||
127787851|NCT01840579|459847894|FG006|Overall Study|Adverse Event|0|||
127787852|NCT01840579|459847895|FG007|Overall Study|Adverse Event|0|||
127787853|NCT01840579|459847896|FG008|Overall Study|Adverse Event|0|||
127787854|NCT01840579|459847897|FG009|Overall Study|Adverse Event|0|||
127787855|NCT01840579|459847888|FG000|Overall Study|Follow-up ended by Sponsor|0|||
127787856|NCT01840579|459847889|FG001|Overall Study|Follow-up ended by Sponsor|0|||
127787857|NCT01840579|459847890|FG002|Overall Study|Follow-up ended by Sponsor|0|||
127787858|NCT01840579|459847891|FG003|Overall Study|Follow-up ended by Sponsor|0|||
127787859|NCT01840579|459847892|FG004|Overall Study|Follow-up ended by Sponsor|0|||
127787860|NCT01840579|459847893|FG005|Overall Study|Follow-up ended by Sponsor|0|||
127787861|NCT01840579|459847894|FG006|Overall Study|Follow-up ended by Sponsor|2|||
127787862|NCT01840579|459847895|FG007|Overall Study|Follow-up ended by Sponsor|0|||
127787863|NCT01840579|459847896|FG008|Overall Study|Follow-up ended by Sponsor|0|||
127787864|NCT01840579|459847897|FG009|Overall Study|Follow-up ended by Sponsor|0|||
127787865|NCT05248295|459847902|FG000|Overall Study|found ineligible|4|||
127787866|NCT05248295|459847903|FG001|Overall Study|found ineligible|1|||
127787867|NCT05248295|459847902|FG000|Overall Study|Withdrawal by Subject|0|||
127787868|NCT05248295|459847903|FG001|Overall Study|Withdrawal by Subject|1|||
127787869|NCT05248295|459847902|FG000|Overall Study|Data loss: audio recording error|1|||
127787870|NCT05248295|459847903|FG001|Overall Study|Data loss: audio recording error|1|||
127787871|NCT03021499|459847904|FG000|Overall Study|Adverse Event|1|||
127787872|NCT03021499|459847905|FG001|Overall Study|Adverse Event|0|||
127787873|NCT03021499|459847904|FG000|Overall Study|Death|1|||
127787874|NCT03021499|459847905|FG001|Overall Study|Death|5|||
127787875|NCT03021499|459847904|FG000|Overall Study|Lack of Efficacy|0|||
127787876|NCT03021499|459847905|FG001|Overall Study|Lack of Efficacy|1|||
127787877|NCT03021499|459847904|FG000|Overall Study|Lost to Follow-up|1|||
127787878|NCT03021499|459847905|FG001|Overall Study|Lost to Follow-up|3|||
127787879|NCT03021499|459847904|FG000|Overall Study|Physician Decision|2|||
127787880|NCT03021499|459847905|FG001|Overall Study|Physician Decision|3|||
127787881|NCT03021499|459847904|FG000|Overall Study|Pregnancy|1|||
127787882|NCT03021499|459847905|FG001|Overall Study|Pregnancy|0|||
127787883|NCT03021499|459847904|FG000|Overall Study|Withdrawal by Subject|7|||
127787884|NCT03021499|459847905|FG001|Overall Study|Withdrawal by Subject|14|||
127787885|NCT03021499|459847904|FG000|Overall Study|Prohibited medication required|1|||
127787886|NCT03021499|459847905|FG001|Overall Study|Prohibited medication required|0|||
127787887|NCT03021499|459847904|FG000|Overall Study|Protocol non-compliance|1|||
127787888|NCT03021499|459847905|FG001|Overall Study|Protocol non-compliance|1|||
127787889|NCT03021499|459847904|FG000|Overall Study|None of the above|0|||
127787890|NCT03021499|459847905|FG001|Overall Study|None of the above|4|||
127787891|NCT03021499|459847904|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
127787892|NCT03021499|459847905|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
127787893|NCT01210690|459847906|FG000|Overall Study|Adverse Event|7|||
127787894|NCT01210690|459847906|FG000|Overall Study|Lack of Efficacy|12|||
127787895|NCT01210690|459847906|FG000|Overall Study|Lost to Follow-up|3|||
127787896|NCT01210690|459847906|FG000|Overall Study|Disease Remission|1|||
127787897|NCT01210690|459847906|FG000|Overall Study|Withdrawal by Subject|1|||
127787898|NCT01210690|459847906|FG000|Overall Study|Patient refused to swallow|1|||
127787899|NCT01210690|459847906|FG000|Overall Study|Patient could not take glucose|1|||
127787900|NCT00470054|459847907|FG000|Overall Study|Ineligible|1|||
127787901|NCT04869345|459847914|FG000|Overall Study|Lost to Follow-up|8|||
127787902|NCT04869345|459847915|FG001|Overall Study|Lost to Follow-up|3|||
127787903|NCT00528021|459847919|FG000|Overall Study|Lack of Efficacy|17|||
127787904|NCT00528021|459847920|FG001|Overall Study|Lack of Efficacy|13|||
127787905|NCT00528021|459847921|FG002|Overall Study|Lack of Efficacy|7|||
127787906|NCT00528021|459847922|FG003|Overall Study|Lack of Efficacy|9|||
127787907|NCT04050982|459847923|FG000|Overall Study|Did not meet eligibility criteria|0|||
127787908|NCT04050982|459847924|FG001|Overall Study|Did not meet eligibility criteria|1|||
127787909|NCT04050982|459847925|FG002|Overall Study|Did not meet eligibility criteria|0|||
127787910|NCT04050982|459847923|FG000|Overall Study|Withdrawal by Subject|1|||
127787911|NCT04050982|459847924|FG001|Overall Study|Withdrawal by Subject|0|||
127787912|NCT04050982|459847925|FG002|Overall Study|Withdrawal by Subject|0|||
127787913|NCT04050982|459847923|FG000|Overall Study|Unable to enroll on platform|1|||
127787914|NCT04050982|459847924|FG001|Overall Study|Unable to enroll on platform|0|||
127787915|NCT04050982|459847925|FG002|Overall Study|Unable to enroll on platform|0|||
127787916|NCT05054114|459847926|FG000|Overall Study|Protocol Violation|13|||
127787917|NCT05054114|459847927|FG001|Overall Study|Protocol Violation|1|||
128038264|NCT04661033|460770588|FG002|Overall Study|Adverse Event|1|||
127787918|NCT05054114|459847926|FG000|Overall Study|Pregnancy|0|||
127787919|NCT05054114|459847927|FG001|Overall Study|Pregnancy|1|||
127787920|NCT01423851|459847929|FG000|Whole Study|Disease progression|2|||
127787921|NCT01423851|459847930|FG001|Whole Study|Disease progression|1|||
127787922|NCT01423851|459847931|FG002|Whole Study|Disease progression|1|||
127787923|NCT01423851|459847932|FG003|Whole Study|Disease progression|4|||
127787924|NCT01423851|459847933|FG004|Whole Study|Disease progression|1|||
127787925|NCT01423851|459847934|FG005|Whole Study|Disease progression|3|||
127787926|NCT01423851|459847935|FG006|Whole Study|Disease progression|1|||
127787927|NCT01423851|459847936|FG007|Whole Study|Disease progression|4|||
127787928|NCT01423851|459847937|FG008|Whole Study|Disease progression|0|||
127787929|NCT01423851|459847938|FG009|Whole Study|Disease progression|2|||
127787930|NCT01423851|459847939|FG010|Whole Study|Disease progression|10|||
127787931|NCT01423851|459847929|FG000|Whole Study|Physician Decision|0|||
127787932|NCT01423851|459847930|FG001|Whole Study|Physician Decision|1|||
127787933|NCT01423851|459847931|FG002|Whole Study|Physician Decision|2|||
127787934|NCT01423851|459847932|FG003|Whole Study|Physician Decision|0|||
127787935|NCT01423851|459847933|FG004|Whole Study|Physician Decision|2|||
127787936|NCT01423851|459847934|FG005|Whole Study|Physician Decision|0|||
127787937|NCT01423851|459847935|FG006|Whole Study|Physician Decision|2|||
127787938|NCT01423851|459847936|FG007|Whole Study|Physician Decision|1|||
128038265|NCT04661033|460770589|FG003|Overall Study|Adverse Event|0|||
128038266|NCT04661033|460770586|FG000|Overall Study|Switch of cohort due to retreatment criteria met|1|||
127787939|NCT01423851|459847937|FG008|Whole Study|Physician Decision|3|||
127787940|NCT01423851|459847938|FG009|Whole Study|Physician Decision|4|||
127787941|NCT01423851|459847939|FG010|Whole Study|Physician Decision|12|||
127787942|NCT01423851|459847929|FG000|Whole Study|Withdrawal by Subject|1|||
127787943|NCT01423851|459847930|FG001|Whole Study|Withdrawal by Subject|1|||
127787944|NCT01423851|459847931|FG002|Whole Study|Withdrawal by Subject|0|||
127787945|NCT01423851|459847932|FG003|Whole Study|Withdrawal by Subject|0|||
127787946|NCT01423851|459847933|FG004|Whole Study|Withdrawal by Subject|0|||
127787947|NCT01423851|459847934|FG005|Whole Study|Withdrawal by Subject|0|||
127787948|NCT01423851|459847935|FG006|Whole Study|Withdrawal by Subject|0|||
127787949|NCT01423851|459847936|FG007|Whole Study|Withdrawal by Subject|0|||
127787950|NCT01423851|459847937|FG008|Whole Study|Withdrawal by Subject|2|||
127787951|NCT01423851|459847938|FG009|Whole Study|Withdrawal by Subject|0|||
127787952|NCT01423851|459847939|FG010|Whole Study|Withdrawal by Subject|4|||
127787953|NCT01423851|459847929|FG000|Whole Study|Adverse Event|0|||
127787954|NCT01423851|459847930|FG001|Whole Study|Adverse Event|0|||
127787955|NCT01423851|459847931|FG002|Whole Study|Adverse Event|0|||
127787956|NCT01423851|459847932|FG003|Whole Study|Adverse Event|2|||
127787957|NCT01423851|459847933|FG004|Whole Study|Adverse Event|0|||
127787958|NCT01423851|459847934|FG005|Whole Study|Adverse Event|0|||
127787959|NCT01423851|459847935|FG006|Whole Study|Adverse Event|0|||
127787960|NCT01423851|459847936|FG007|Whole Study|Adverse Event|3|||
127787961|NCT01423851|459847937|FG008|Whole Study|Adverse Event|3|||
127787962|NCT01423851|459847938|FG009|Whole Study|Adverse Event|2|||
127787963|NCT01423851|459847939|FG010|Whole Study|Adverse Event|3|||
127787964|NCT00733954|459847940|FG000|Overall Study|Lost to Follow-up|5|||
127787965|NCT00733954|459847941|FG001|Overall Study|Lost to Follow-up|2|||
127787966|NCT00733954|459847940|FG000|Overall Study|Protocol Violation|1|||
127787967|NCT00733954|459847941|FG001|Overall Study|Protocol Violation|0|||
127787968|NCT00733954|459847940|FG000|Overall Study|Withdrawal by Subject|2|||
127787969|NCT00733954|459847941|FG001|Overall Study|Withdrawal by Subject|0|||
127787970|NCT02663453|459847942|FG000|Overall Study|Death|4|||
127787971|NCT02663453|459847943|FG001|Overall Study|Death|4|||
127787972|NCT02663453|459847942|FG000|Overall Study|Withdrawal by Subject|1|||
127787973|NCT02663453|459847943|FG001|Overall Study|Withdrawal by Subject|0|||
127787974|NCT00916357|459849836|FG000|Period 1|Withdrawal by Subject|1|||
127787975|NCT00916357|459849837|FG001|Period 1|Withdrawal by Subject|0|||
127787976|NCT00916357|459849838|FG002|Period 1|Withdrawal by Subject|0|||
127787977|NCT00916357|459849839|FG003|Period 1|Withdrawal by Subject|0|||
127787978|NCT00916357|459849840|FG004|Period 1|Withdrawal by Subject|0|||
127787979|NCT00916357|459849841|FG005|Period 1|Withdrawal by Subject|0|||
127787980|NCT00916357|459849836|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
127787981|NCT00916357|459849837|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
127787982|NCT00916357|459849838|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
127787983|NCT00916357|459849839|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
127787984|NCT00916357|459849840|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
127787985|NCT00916357|459849841|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
127787986|NCT01308008|459849842|FG000|4 Weeks|Illness, disinterest, time|9|||
127787987|NCT01308008|459849843|FG001|4 Weeks|Illness, disinterest, time|2|||
127787988|NCT01417195|459849844|FG000|Overall Study|Stimulation failure|1|||
127882696|NCT02414854|460194501|FG002|Overall Study|Poor compliance to protocol|2|||
127787989|NCT01417195|459849845|FG001|Overall Study|Stimulation failure|0|||
127787990|NCT01417195|459849844|FG000|Overall Study|No embryos for transfer|0|||
127787991|NCT01417195|459849845|FG001|Overall Study|No embryos for transfer|1|||
127787992|NCT01417195|459849844|FG000|Overall Study|No transfer due to risk of OHSS|1|||
127787993|NCT01417195|459849845|FG001|Overall Study|No transfer due to risk of OHSS|0|||
128038267|NCT04661033|460770587|FG001|Overall Study|Switch of cohort due to retreatment criteria met|0|||
128038268|NCT04661033|460770588|FG002|Overall Study|Switch of cohort due to retreatment criteria met|0|||
128038269|NCT04661033|460770589|FG003|Overall Study|Switch of cohort due to retreatment criteria met|0|||
128038270|NCT04661033|460770586|FG000|Overall Study|As per Principal Investigator (PI) decision|1|||
128038271|NCT04661033|460770587|FG001|Overall Study|As per Principal Investigator (PI) decision|0|||
128038272|NCT04661033|460770588|FG002|Overall Study|As per Principal Investigator (PI) decision|0|||
128038273|NCT04661033|460770589|FG003|Overall Study|As per Principal Investigator (PI) decision|0|||
128038274|NCT04661033|460770586|FG000|Overall Study|Early discontinuation as per PI|1|||
128038275|NCT04661033|460770587|FG001|Overall Study|Early discontinuation as per PI|0|||
128038276|NCT04661033|460770588|FG002|Overall Study|Early discontinuation as per PI|0|||
128038277|NCT04661033|460770589|FG003|Overall Study|Early discontinuation as per PI|0|||
128038278|NCT00565409|460770594|FG000|Period 1 Open Label|Adverse Event|17|||
128038279|NCT00565409|460770595|FG001|Period 1 Open Label|Adverse Event|0|||
128038280|NCT00565409|460770596|FG002|Period 1 Open Label|Adverse Event|0|||
128038281|NCT00565409|460770597|FG003|Period 1 Open Label|Adverse Event|0|||
128038282|NCT00565409|460770594|FG000|Period 1 Open Label|Death|2|||
128038283|NCT00565409|460770595|FG001|Period 1 Open Label|Death|0|||
128038284|NCT00565409|460770596|FG002|Period 1 Open Label|Death|0|||
128038285|NCT00565409|460770597|FG003|Period 1 Open Label|Death|0|||
128038286|NCT00565409|460770594|FG000|Period 1 Open Label|Lost to Follow-up|1|||
128038287|NCT00565409|460770595|FG001|Period 1 Open Label|Lost to Follow-up|0|||
128038288|NCT00565409|460770596|FG002|Period 1 Open Label|Lost to Follow-up|0|||
128038289|NCT00565409|460770597|FG003|Period 1 Open Label|Lost to Follow-up|0|||
128038290|NCT00565409|460770594|FG000|Period 1 Open Label|Other|21|||
128038291|NCT00565409|460770595|FG001|Period 1 Open Label|Other|0|||
128038292|NCT00565409|460770596|FG002|Period 1 Open Label|Other|0|||
128038293|NCT00565409|460770597|FG003|Period 1 Open Label|Other|0|||
128038294|NCT00565409|460770594|FG000|Period 1 Open Label|Protocol Violation|14|||
128038295|NCT00565409|460770595|FG001|Period 1 Open Label|Protocol Violation|0|||
128038296|NCT00565409|460770596|FG002|Period 1 Open Label|Protocol Violation|0|||
128038297|NCT00565409|460770597|FG003|Period 1 Open Label|Protocol Violation|0|||
128038298|NCT00565409|460770594|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
128038299|NCT00565409|460770595|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
128038300|NCT00565409|460770596|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
128038301|NCT00565409|460770597|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
128038302|NCT00565409|460770594|FG000|Period 1 Open Label|no conclusion of participation record|1|||
128038303|NCT00565409|460770595|FG001|Period 1 Open Label|no conclusion of participation record|0|||
128038304|NCT00565409|460770596|FG002|Period 1 Open Label|no conclusion of participation record|0|||
128038305|NCT00565409|460770597|FG003|Period 1 Open Label|no conclusion of participation record|0|||
128038306|NCT00565409|460770594|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
128038307|NCT00565409|460770595|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
128038308|NCT00565409|460770596|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
128038309|NCT00565409|460770597|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
128038310|NCT00565409|460770594|FG000|Period 2 Double-Blind|Adverse Event|0|||
128038311|NCT00565409|460770595|FG001|Period 2 Double-Blind|Adverse Event|7|||
128038312|NCT00565409|460770596|FG002|Period 2 Double-Blind|Adverse Event|4|||
128038313|NCT00565409|460770597|FG003|Period 2 Double-Blind|Adverse Event|5|||
128038314|NCT00565409|460770594|FG000|Period 2 Double-Blind|Death|0|||
128038315|NCT00565409|460770595|FG001|Period 2 Double-Blind|Death|2|||
128038316|NCT00565409|460770596|FG002|Period 2 Double-Blind|Death|0|||
128038317|NCT00565409|460770597|FG003|Period 2 Double-Blind|Death|0|||
128038318|NCT00565409|460770594|FG000|Period 2 Double-Blind|Protocol Violation|0|||
128038319|NCT00565409|460770595|FG001|Period 2 Double-Blind|Protocol Violation|4|||
128038320|NCT00565409|460770596|FG002|Period 2 Double-Blind|Protocol Violation|6|||
128038321|NCT00565409|460770597|FG003|Period 2 Double-Blind|Protocol Violation|2|||
128038322|NCT00565409|460770594|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
128038323|NCT00565409|460770595|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
127695991|NCT02736409|459514778|FG003|Overall Study|Pregnancy|0|||
128038324|NCT00565409|460770596|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
128038325|NCT00565409|460770597|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
128038326|NCT00565409|460770594|FG000|Period 2 Double-Blind|Other|0|||
128038327|NCT00565409|460770595|FG001|Period 2 Double-Blind|Other|4|||
128038328|NCT00565409|460770596|FG002|Period 2 Double-Blind|Other|5|||
128038329|NCT00565409|460770597|FG003|Period 2 Double-Blind|Other|9|||
127695992|NCT02736409|459514775|FG000|Overall Study|Lost to Follow-up|0|||
128038330|NCT00565409|460770594|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
128038331|NCT00565409|460770595|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
128038332|NCT00565409|460770596|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
128038333|NCT00565409|460770597|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
128038334|NCT04064905|460770611|FG000|Overall Study|Lost to Follow-up|0|||
127695993|NCT02736409|459514776|FG001|Overall Study|Lost to Follow-up|0|||
127695994|NCT02736409|459514777|FG002|Overall Study|Lost to Follow-up|2|||
127695995|NCT02736409|459514778|FG003|Overall Study|Lost to Follow-up|1|||
127695996|NCT02736409|459514775|FG000|Overall Study|Physician Decision|0|||
127882697|NCT02414854|460194502|FG003|Overall Study|Poor compliance to protocol|2|||
127882698|NCT02414854|460194499|FG000|Overall Study|Other than specified above|12|||
127882699|NCT02414854|460194500|FG001|Overall Study|Other than specified above|37|||
127882700|NCT02414854|460194501|FG002|Overall Study|Other than specified above|17|||
127882701|NCT02414854|460194502|FG003|Overall Study|Other than specified above|37|||
127882702|NCT04723173|460194503|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
127882703|NCT01422720|460194504|FG000|Overall Study|Adverse Event|16|||
127882704|NCT01422720|460194504|FG000|Overall Study|Lack of Efficacy|1|||
128038335|NCT04064905|460770612|FG001|Overall Study|Lost to Follow-up|3|||
128038336|NCT04064905|460770613|FG002|Overall Study|Lost to Follow-up|1|||
128038337|NCT04064905|460770614|FG003|Overall Study|Lost to Follow-up|4|||
128038338|NCT04064905|460770615|FG004|Overall Study|Lost to Follow-up|2|||
128038339|NCT02257684|460770616|FG000|Overall Study|Adverse Event|2|||
128038340|NCT02257684|460770616|FG000|Overall Study|Lack of Efficacy|1|||
128038341|NCT02257684|460770616|FG000|Overall Study|Sponsor's Decision|1|||
128038342|NCT01570387|460770617|FG000|Overall Study|Adverse Event|1|||
128038343|NCT01570387|460770618|FG001|Overall Study|Adverse Event|0|||
128038344|NCT01570387|460770619|FG002|Overall Study|Adverse Event|0|||
128038345|NCT01570387|460770620|FG003|Overall Study|Adverse Event|0|||
128038346|NCT01570387|460770617|FG000|Overall Study|Death|0|||
128038347|NCT01570387|460770618|FG001|Overall Study|Death|0|||
128038348|NCT01570387|460770619|FG002|Overall Study|Death|0|||
128038349|NCT01570387|460770620|FG003|Overall Study|Death|1|||
128038350|NCT01570387|460770617|FG000|Overall Study|Withdrawal by Subject|0|||
128038351|NCT01570387|460770618|FG001|Overall Study|Withdrawal by Subject|0|||
128038352|NCT01570387|460770619|FG002|Overall Study|Withdrawal by Subject|0|||
128038353|NCT01570387|460770620|FG003|Overall Study|Withdrawal by Subject|1|||
128038354|NCT01987557|460770621|FG000|Overall Study|Protocol Violation|1|||
128038355|NCT01987557|460770622|FG001|Overall Study|Protocol Violation|0|||
128038356|NCT01987557|460770623|FG002|Overall Study|Protocol Violation|1|||
128038357|NCT01987557|460770621|FG000|Overall Study|Withdrawal by Subject|2|||
128038358|NCT01987557|460770622|FG001|Overall Study|Withdrawal by Subject|1|||
128038359|NCT01987557|460770623|FG002|Overall Study|Withdrawal by Subject|2|||
128038360|NCT01987557|460770621|FG000|Overall Study|Adverse Event|0|||
128038361|NCT01987557|460770622|FG001|Overall Study|Adverse Event|2|||
128038362|NCT01987557|460770623|FG002|Overall Study|Adverse Event|0|||
128038363|NCT01567722|460770632|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
128038364|NCT01567722|460770633|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
128038365|NCT01567722|460770634|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
128038366|NCT01567722|460770632|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
128038367|NCT01567722|460770633|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
128038368|NCT01567722|460770634|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
128038369|NCT01567722|460770632|FG000|Overall Study|Protocol closure by the OCG|2|||
128038370|NCT01567722|460770633|FG001|Overall Study|Protocol closure by the OCG|0|||
128038371|NCT01567722|460770634|FG002|Overall Study|Protocol closure by the OCG|0|||
128038372|NCT01567722|460770632|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
128038373|NCT01567722|460770633|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
128038374|NCT01567722|460770634|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
128038375|NCT00431964|460770635|FG000|Overall Study|Adverse Event|1|||
128038376|NCT00431964|460770636|FG001|Overall Study|Adverse Event|0|||
128038377|NCT00431964|460770635|FG000|Overall Study|Lost to Follow-up|1|||
128038378|NCT00431964|460770636|FG001|Overall Study|Lost to Follow-up|2|||
128038379|NCT00431964|460770635|FG000|Overall Study|Physician Decision|2|||
128038380|NCT00431964|460770636|FG001|Overall Study|Physician Decision|2|||
127695997|NCT02736409|459514776|FG001|Overall Study|Physician Decision|0|||
128038381|NCT00431964|460770635|FG000|Overall Study|Withdrawal by Subject|2|||
128038382|NCT00431964|460770636|FG001|Overall Study|Withdrawal by Subject|1|||
128038383|NCT00431964|460770635|FG000|Overall Study|Parental Consent Withdrawn|0|||
128038384|NCT00431964|460770636|FG001|Overall Study|Parental Consent Withdrawn|2|||
128038385|NCT00431964|460770635|FG000|Overall Study|Due to Unstable Health|0|||
128038386|NCT00431964|460770636|FG001|Overall Study|Due to Unstable Health|1|||
128038387|NCT00382174|460770638|FG000|Overall Study|Lost to Follow-up|1|||
128038388|NCT00382174|460770639|FG001|Overall Study|Lost to Follow-up|4|||
128038389|NCT00382174|460770640|FG002|Overall Study|Lost to Follow-up|5|||
127882705|NCT01422720|460194504|FG000|Overall Study|Withdrawal by Subject|4|||
128038390|NCT00382174|460770638|FG000|Overall Study|Adverse Event|1|||
128038391|NCT00382174|460770639|FG001|Overall Study|Adverse Event|4|||
128038392|NCT00382174|460770640|FG002|Overall Study|Adverse Event|5|||
128038393|NCT00382174|460770638|FG000|Overall Study|Withdrawal by Subject|1|||
128038394|NCT00382174|460770639|FG001|Overall Study|Withdrawal by Subject|4|||
128038395|NCT00382174|460770640|FG002|Overall Study|Withdrawal by Subject|5|||
128038396|NCT00382174|460770638|FG000|Overall Study|Non compliance|1|||
127695998|NCT02736409|459514777|FG002|Overall Study|Physician Decision|0|||
127882706|NCT01422720|460194504|FG000|Overall Study|Ineligibility|1|||
127882707|NCT01074307|460194506|FG000|Overall Study|No primary endpoint evaluation|14|||
127882708|NCT01074307|460194507|FG001|Overall Study|No primary endpoint evaluation|6|||
127882709|NCT01074307|460194506|FG000|Overall Study|Exclusion criterion|0|||
127882710|NCT01074307|460194507|FG001|Overall Study|Exclusion criterion|1|||
127882711|NCT01074307|460194506|FG000|Overall Study|Protocol Violation|8|||
127882712|NCT01074307|460194507|FG001|Overall Study|Protocol Violation|5|||
127882713|NCT02162511|460194512|FG000|Overall Study|Lack of Efficacy|0|||
127882714|NCT02162511|460194513|FG001|Overall Study|Lack of Efficacy|0|||
127882715|NCT02162511|460194514|FG002|Overall Study|Lack of Efficacy|2|||
127882716|NCT00802529|460194515|FG000|Overall Study|Lost to Follow-up|0|||
127882717|NCT00802529|460194516|FG001|Overall Study|Lost to Follow-up|1|||
127882718|NCT00552617|460194518|FG000|Overall Study|Not Treated|0|||
127882719|NCT00552617|460194519|FG001|Overall Study|Not Treated|0|||
127882720|NCT00552617|460194520|FG002|Overall Study|Not Treated|1|||
127882721|NCT00552617|460194521|FG003|Overall Study|Not Treated|0|||
127882722|NCT00552617|460194522|FG004|Overall Study|Not Treated|0|||
127882723|NCT00552617|460194523|FG005|Overall Study|Not Treated|0|||
127882724|NCT00552617|460194524|FG006|Overall Study|Not Treated|0|||
127882725|NCT00552617|460194525|FG007|Overall Study|Not Treated|0|||
127882726|NCT00552617|460194526|FG008|Overall Study|Not Treated|0|||
128038397|NCT00382174|460770639|FG001|Overall Study|Non compliance|0|||
128038398|NCT00382174|460770640|FG002|Overall Study|Non compliance|1|||
128038399|NCT00382174|460770638|FG000|Overall Study|Physician Decision|0|||
128038400|NCT00382174|460770639|FG001|Overall Study|Physician Decision|2|||
128038401|NCT00382174|460770640|FG002|Overall Study|Physician Decision|2|||
128038402|NCT00382174|460770638|FG000|Overall Study|Failed to meet criteria|0|||
128038403|NCT00382174|460770639|FG001|Overall Study|Failed to meet criteria|1|||
128038404|NCT00382174|460770640|FG002|Overall Study|Failed to meet criteria|1|||
128038405|NCT00382174|460770638|FG000|Overall Study|Wounds merged|0|||
128038406|NCT00382174|460770639|FG001|Overall Study|Wounds merged|2|||
128038407|NCT00382174|460770640|FG002|Overall Study|Wounds merged|2|||
128038408|NCT02170064|460770646|FG000|Overall Study|Withdrawal by Subject|5|||
128038409|NCT02170064|460770647|FG001|Overall Study|Withdrawal by Subject|1|||
128038410|NCT02170064|460770648|FG002|Overall Study|Withdrawal by Subject|1|||
128038411|NCT02170064|460770646|FG000|Overall Study|Physician Decision|1|||
128038412|NCT02170064|460770647|FG001|Overall Study|Physician Decision|1|||
128038413|NCT02170064|460770648|FG002|Overall Study|Physician Decision|0|||
128038414|NCT03323164|460770649|FG000|Overall Study|Poor quality imaging/scans|2|||
128038415|NCT03323164|460770650|FG001|Overall Study|Poor quality imaging/scans|2|||
128038416|NCT03434834|460770651|FG000|Overall Study|unable to swallow OCT probe|16|||
128038417|NCT00518180|460770656|FG000|Overall Study|Withdrawal by Subject|29|||
128038418|NCT00518180|460770657|FG001|Overall Study|Withdrawal by Subject|30|||
128038419|NCT00518180|460770658|FG002|Overall Study|Withdrawal by Subject|42|||
128038420|NCT00518180|460770656|FG000|Overall Study|Lost to Follow-up|30|||
128038421|NCT00518180|460770657|FG001|Overall Study|Lost to Follow-up|28|||
128038422|NCT00518180|460770658|FG002|Overall Study|Lost to Follow-up|34|||
128038423|NCT00518180|460770656|FG000|Overall Study|Administrative reason|0|||
128038424|NCT00518180|460770657|FG001|Overall Study|Administrative reason|2|||
128038425|NCT00518180|460770658|FG002|Overall Study|Administrative reason|2|||
128038426|NCT00518180|460770656|FG000|Overall Study|Protocol Violation|5|||
128038427|NCT00518180|460770657|FG001|Overall Study|Protocol Violation|7|||
128038428|NCT00518180|460770658|FG002|Overall Study|Protocol Violation|4|||
128038429|NCT00518180|460770656|FG000|Overall Study|Unable to classify|0|||
128038430|NCT00518180|460770657|FG001|Overall Study|Unable to classify|2|||
128038431|NCT00518180|460770658|FG002|Overall Study|Unable to classify|0|||
128038432|NCT00518180|460770656|FG000|Overall Study|Adverse Event|1|||
128038433|NCT00518180|460770657|FG001|Overall Study|Adverse Event|0|||
128038434|NCT00518180|460770658|FG002|Overall Study|Adverse Event|0|||
128038435|NCT00956293|460770663|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
128038436|NCT00956293|460770664|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
127882727|NCT00552617|460194527|FG009|Overall Study|Not Treated|1|||
128038437|NCT00956293|460770665|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
127882728|NCT00552617|460194518|FG000|Overall Study|Lost to Follow-up|0|||
127882729|NCT00552617|460194519|FG001|Overall Study|Lost to Follow-up|0|||
128038438|NCT00956293|460770663|FG000|Main Period (Pre-randomization)|Death|0|||
128038439|NCT00956293|460770664|FG001|Main Period (Pre-randomization)|Death|0|||
128038440|NCT00956293|460770665|FG002|Main Period (Pre-randomization)|Death|1|||
127882730|NCT00552617|460194520|FG002|Overall Study|Lost to Follow-up|0|||
127882731|NCT00552617|460194521|FG003|Overall Study|Lost to Follow-up|1|||
127882732|NCT00552617|460194522|FG004|Overall Study|Lost to Follow-up|0|||
128038441|NCT00956293|460770663|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
128038442|NCT00956293|460770664|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
128038443|NCT00956293|460770665|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
128038444|NCT00956293|460770663|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
128038445|NCT00956293|460770664|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
128038446|NCT00956293|460770665|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
127882733|NCT00552617|460194523|FG005|Overall Study|Lost to Follow-up|2|||
128038447|NCT00956293|460770663|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
128038448|NCT00956293|460770664|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
128038449|NCT00956293|460770665|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
128038450|NCT00956293|460770663|FG000|Main Period (Pre-randomization)|Graft loss|0|||
128038451|NCT00956293|460770664|FG001|Main Period (Pre-randomization)|Graft loss|0|||
128038452|NCT00956293|460770665|FG002|Main Period (Pre-randomization)|Graft loss|7|||
128038453|NCT00956293|460770663|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
128038454|NCT00956293|460770664|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
128038455|NCT00956293|460770665|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
128038456|NCT00956293|460770663|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
128038457|NCT00956293|460770664|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
128038458|NCT00956293|460770665|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
128038459|NCT00956293|460770663|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
128038460|NCT00956293|460770664|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
128038461|NCT00956293|460770665|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
128038462|NCT00956293|460770663|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
128038463|NCT00956293|460770664|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
128038464|NCT00956293|460770665|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
128038465|NCT00956293|460770663|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
128038466|NCT00956293|460770664|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
128038467|NCT00956293|460770665|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
128038468|NCT00956293|460770663|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
128038469|NCT00956293|460770664|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
128038470|NCT00956293|460770665|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
128038471|NCT00956293|460770663|FG000|Main Period (Randomization)|Adverse Event|0|||
128038472|NCT00956293|460770664|FG001|Main Period (Randomization)|Adverse Event|15|||
128038473|NCT00956293|460770665|FG002|Main Period (Randomization)|Adverse Event|0|||
128038474|NCT00956293|460770663|FG000|Follow-up Period|Follow-up period was terminated.|20|||
128038475|NCT00956293|460770664|FG001|Follow-up Period|Follow-up period was terminated.|32|||
128038476|NCT00956293|460770665|FG002|Follow-up Period|Follow-up period was terminated.|0|||
128038477|NCT03383666|460770666|FG000|Overall Study|Withdrawal by Subject|2|||
128038478|NCT03383666|460770666|FG000|Overall Study|Lost to Follow-up|2|||
128038479|NCT03508050|460770673|FG000|Overall Study|Pleural adhesions|1|||
128038480|NCT03508050|460770674|FG001|Overall Study|Pleural adhesions|0|||
127600032|NCT04481750|459163139|FG010|Period 1 (Fasted)|Adverse Event|0|||
127600033|NCT03263442|459163140|FG000|Inpatient Phase|Death|1|||
127600034|NCT03263442|459163141|FG001|Inpatient Phase|Death|0|||
127600035|NCT03263442|459163140|FG000|Inpatient Phase|Withdrawal by Subject|1|||
127600036|NCT03263442|459163141|FG001|Inpatient Phase|Withdrawal by Subject|0|||
127600037|NCT03263442|459163140|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
127600038|NCT03263442|459163141|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
127600039|NCT03263442|459163140|FG000|1-month Follow-Up|Lost to Follow-up|1|||
127600040|NCT03263442|459163141|FG001|1-month Follow-Up|Lost to Follow-up|0|||
127600041|NCT03263442|459163140|FG000|3-month Follow-Up|Lost to Follow-up|1|||
127600042|NCT03263442|459163141|FG001|3-month Follow-Up|Lost to Follow-up|3|||
127600043|NCT03263442|459163140|FG000|6-month Follow-Up|Lost to Follow-up|2|||
127600044|NCT03263442|459163141|FG001|6-month Follow-Up|Lost to Follow-up|2|||
127600045|NCT00475176|459163142|FG000|Overall Study|Adverse Event|2|||
127600046|NCT00475176|459163142|FG000|Overall Study|Withdrawal by Subject|1|||
127600047|NCT00475176|459163142|FG000|Overall Study|Protocol Violation|1|||
127600048|NCT01463878|459163143|FG000|Overall Study|no longer met criteria for tube feed|2|||
127600049|NCT01463878|459163144|FG001|Overall Study|no longer met criteria for tube feed|2|||
127600050|NCT03804879|459163145|FG000|Overall Study|Adverse Event|3|||
127600051|NCT03804879|459163146|FG001|Overall Study|Adverse Event|0|||
127600052|NCT03804879|459163145|FG000|Overall Study|Study Terminated By Sponsor|10|||
127600053|NCT03804879|459163146|FG001|Overall Study|Study Terminated By Sponsor|12|||
127600054|NCT03804879|459163145|FG000|Overall Study|Withdrawal by Subject|3|||
127600055|NCT03804879|459163146|FG001|Overall Study|Withdrawal by Subject|1|||
127600056|NCT02436889|459163147|FG000|Overall Study|No improvement in symptoms|1|||
127600057|NCT02436889|459163148|FG001|Overall Study|No improvement in symptoms|0|||
128038481|NCT03508050|460770673|FG000|Overall Study|Mucus plug|1|||
128038482|NCT03508050|460770674|FG001|Overall Study|Mucus plug|0|||
127600058|NCT02436889|459163147|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
127600059|NCT02436889|459163148|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
127695999|NCT02736409|459514778|FG003|Overall Study|Physician Decision|2|||
127696000|NCT00170573|459514782|FG000|Overall Study|Violation of inclusion criteria|13|||
127696001|NCT05536440|459514797|FG000|Overall Study|Adverse Event|0|||
127696002|NCT05536440|459514798|FG001|Overall Study|Adverse Event|0|||
127696003|NCT05536440|459514799|FG002|Overall Study|Adverse Event|0|||
127696004|NCT05536440|459514800|FG003|Overall Study|Adverse Event|0|||
127696005|NCT05536440|459514801|FG004|Overall Study|Adverse Event|0|||
127696006|NCT05536440|459514802|FG005|Overall Study|Adverse Event|0|||
127696007|NCT05536440|459514803|FG006|Overall Study|Adverse Event|0|||
127787994|NCT01417195|459849844|FG000|Overall Study|No transfer due to elevated progesterone|1|||
127787995|NCT01417195|459849845|FG001|Overall Study|No transfer due to elevated progesterone|0|||
127787996|NCT03357731|459849846|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
127787997|NCT03357731|459849847|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
127787998|NCT03357731|459849848|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
127787999|NCT03357731|459849849|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
127788000|NCT03357731|459849850|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
127600060|NCT01585428|459163149|FG000|Overall Study|Death during treatment|1|||
127600061|NCT01585428|459163150|FG001|Overall Study|Death during treatment|0|||
127600062|NCT01084174|459163151|FG000|Overall Study|gastrointestinal symptoms|1|||
127600063|NCT01084174|459163152|FG001|Overall Study|gastrointestinal symptoms|1|||
127600064|NCT01084174|459163151|FG000|Overall Study|Eosinophilic esophagitis|0|||
127600065|NCT01084174|459163152|FG001|Overall Study|Eosinophilic esophagitis|1|||
127600066|NCT01084174|459163151|FG000|Overall Study|Anaphylaxis|0|||
127600067|NCT01084174|459163152|FG001|Overall Study|Anaphylaxis|1|||
127600068|NCT01084174|459163151|FG000|Overall Study|Participant noncompliance|0|||
127600069|NCT01084174|459163152|FG001|Overall Study|Participant noncompliance|1|||
127600070|NCT02289898|459163160|FG000|Overall Study|Death|5|||
127600071|NCT02289898|459163161|FG001|Overall Study|Death|4|||
127600072|NCT02289898|459163162|FG002|Overall Study|Death|3|||
127600073|NCT02289898|459163160|FG000|Overall Study|Physician Decision|2|||
127600074|NCT02289898|459163161|FG001|Overall Study|Physician Decision|5|||
127600075|NCT02289898|459163162|FG002|Overall Study|Physician Decision|2|||
127600076|NCT02289898|459163160|FG000|Overall Study|Withdrawal by Subject|0|||
127600077|NCT02289898|459163161|FG001|Overall Study|Withdrawal by Subject|4|||
127600078|NCT02289898|459163162|FG002|Overall Study|Withdrawal by Subject|1|||
127600079|NCT02289898|459163160|FG000|Overall Study|Adverse Event|3|||
127600080|NCT02289898|459163161|FG001|Overall Study|Adverse Event|5|||
127600081|NCT02289898|459163162|FG002|Overall Study|Adverse Event|5|||
127600082|NCT02289898|459163160|FG000|Overall Study|Disease progression|34|||
127600083|NCT02289898|459163161|FG001|Overall Study|Disease progression|28|||
127600084|NCT02289898|459163162|FG002|Overall Study|Disease progression|34|||
127600085|NCT02289898|459163160|FG000|Overall Study|Use of another anticancer therapy|0|||
127600086|NCT02289898|459163161|FG001|Overall Study|Use of another anticancer therapy|0|||
127600087|NCT02289898|459163162|FG002|Overall Study|Use of another anticancer therapy|1|||
127600088|NCT02289898|459163160|FG000|Overall Study|Other|8|||
127600089|NCT02289898|459163161|FG001|Overall Study|Other|7|||
127600090|NCT02289898|459163162|FG002|Overall Study|Other|10|||
127600091|NCT02611778|459163163|FG000|Overall Study|Withdrawal by Subject|2|||
127600092|NCT02611778|459163164|FG001|Overall Study|Withdrawal by Subject|8|||
127600093|NCT02611778|459163163|FG000|Overall Study|Adverse Event|1|||
127600094|NCT02611778|459163164|FG001|Overall Study|Adverse Event|2|||
127600095|NCT02611778|459163163|FG000|Overall Study|Death|2|||
127600096|NCT02611778|459163164|FG001|Overall Study|Death|1|||
127600097|NCT02611778|459163163|FG000|Overall Study|Protocol Violation|1|||
127600098|NCT02611778|459163164|FG001|Overall Study|Protocol Violation|0|||
127600099|NCT02611778|459163163|FG000|Overall Study|Lost to Follow-up|3|||
127600100|NCT02611778|459163164|FG001|Overall Study|Lost to Follow-up|1|||
127600101|NCT02611778|459163163|FG000|Overall Study|Need for alternative treatment|1|||
127600102|NCT02611778|459163164|FG001|Overall Study|Need for alternative treatment|0|||
127600103|NCT02611778|459163163|FG000|Overall Study|Other Reason|2|||
127600104|NCT02611778|459163164|FG001|Overall Study|Other Reason|1|||
127600105|NCT00022633|459163168|FG000|Overall Study|Adverse Event|11|||
127600106|NCT00022633|459163169|FG001|Overall Study|Adverse Event|1|||
127600107|NCT00022633|459163168|FG000|Overall Study|Refusal unrelated to adverse event|1|||
127600108|NCT00022633|459163169|FG001|Overall Study|Refusal unrelated to adverse event|0|||
127600109|NCT00022633|459163168|FG000|Overall Study|Progression/relapse|9|||
127600110|NCT00022633|459163169|FG001|Overall Study|Progression/relapse|2|||
127600111|NCT00022633|459163168|FG000|Overall Study|Death|4|||
127600112|NCT00022633|459163169|FG001|Overall Study|Death|0|||
127600113|NCT00022633|459163168|FG000|Overall Study|Other - not protocol specified|3|||
127600114|NCT00022633|459163169|FG001|Overall Study|Other - not protocol specified|2|||
127600115|NCT00022633|459163168|FG000|Overall Study|Ineligible|4|||
127600116|NCT00022633|459163169|FG001|Overall Study|Ineligible|0|||
127600117|NCT00330616|459163179|FG000|Overall Study|Adverse Event|13|||
127600118|NCT00330616|459163179|FG000|Overall Study|Lack of Efficacy|1|||
127600119|NCT00330616|459163179|FG000|Overall Study|Lost to Follow-up|2|||
127600120|NCT00330616|459163179|FG000|Overall Study|Withdrawal by Subject|4|||
127600121|NCT00330616|459163179|FG000|Overall Study|Other|1|||
127696008|NCT05536440|459514804|FG007|Overall Study|Adverse Event|0|||
127600122|NCT01957553|459163187|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
127600123|NCT01957553|459163188|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
127600124|NCT01957553|459163187|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
127600125|NCT01957553|459163188|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
127600126|NCT01957553|459163187|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
127600127|NCT01957553|459163188|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
127600128|NCT01957553|459163187|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
127600129|NCT01957553|459163188|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
127600130|NCT01957553|459163187|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
127600131|NCT01957553|459163188|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
127600132|NCT01957553|459163187|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
127600133|NCT01957553|459163188|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
127600134|NCT01957553|459163187|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
127600135|NCT01957553|459163188|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
127600136|NCT01957553|459163187|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
127600137|NCT01957553|459163188|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
127600138|NCT01957553|459163187|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
127600139|NCT01957553|459163188|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
127600140|NCT03672747|459163189|FG000|Overall Study|Lost to Follow-up|1|||
127600141|NCT03672747|459163190|FG001|Overall Study|Lost to Follow-up|1|||
127600142|NCT03672747|459163191|FG002|Overall Study|Lost to Follow-up|2|||
127600143|NCT03672747|459163192|FG003|Overall Study|Lost to Follow-up|2|||
127600144|NCT03672747|459163193|FG004|Overall Study|Lost to Follow-up|2|||
127600145|NCT03672747|459163194|FG005|Overall Study|Lost to Follow-up|1|||
127600146|NCT04772755|459163197|FG000|Overall Study|Withdrawal by Subject|1|||
127600147|NCT04772755|459163198|FG001|Overall Study|Withdrawal by Subject|0|||
127600148|NCT04772755|459163197|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
127600149|NCT04772755|459163198|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
127600150|NCT01905657|459163199|FG000|Overall Study|Adverse Event|23|||
127600151|NCT01905657|459163200|FG001|Overall Study|Adverse Event|17|||
127600152|NCT01905657|459163201|FG002|Overall Study|Adverse Event|18|||
127600153|NCT01905657|459163199|FG000|Overall Study|Clinical Progression|103|||
127600154|NCT01905657|459163200|FG001|Overall Study|Clinical Progression|78|||
127600155|NCT01905657|459163201|FG002|Overall Study|Clinical Progression|59|||
127600156|NCT01905657|459163199|FG000|Overall Study|Death|40|||
127600157|NCT01905657|459163200|FG001|Overall Study|Death|43|||
127600158|NCT01905657|459163201|FG002|Overall Study|Death|47|||
127600159|NCT01905657|459163199|FG000|Overall Study|Excluded Medication|13|||
127600160|NCT01905657|459163200|FG001|Overall Study|Excluded Medication|16|||
127600161|NCT01905657|459163201|FG002|Overall Study|Excluded Medication|9|||
127600162|NCT01905657|459163199|FG000|Overall Study|Lost to Follow-up|1|||
127600163|NCT01905657|459163200|FG001|Overall Study|Lost to Follow-up|2|||
127600164|NCT01905657|459163201|FG002|Overall Study|Lost to Follow-up|1|||
127600165|NCT01905657|459163199|FG000|Overall Study|Physician Decision|5|||
127600166|NCT01905657|459163200|FG001|Overall Study|Physician Decision|8|||
127600167|NCT01905657|459163201|FG002|Overall Study|Physician Decision|12|||
127600168|NCT01905657|459163199|FG000|Overall Study|Protocol Violation|2|||
127600169|NCT01905657|459163200|FG001|Overall Study|Protocol Violation|1|||
127600170|NCT01905657|459163201|FG002|Overall Study|Protocol Violation|1|||
127600171|NCT01905657|459163199|FG000|Overall Study|Screen Failure|0|||
127600172|NCT01905657|459163200|FG001|Overall Study|Screen Failure|1|||
127600173|NCT01905657|459163201|FG002|Overall Study|Screen Failure|0|||
127600174|NCT01905657|459163199|FG000|Overall Study|Withdrawal by Subject|15|||
127600175|NCT01905657|459163200|FG001|Overall Study|Withdrawal by Subject|21|||
127600176|NCT01905657|459163201|FG002|Overall Study|Withdrawal by Subject|53|||
127788001|NCT03357731|459849851|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
127788002|NCT03357731|459849846|FG000|Overall Study|Acute bradycardia and hypotension|0|||
127788003|NCT03357731|459849847|FG001|Overall Study|Acute bradycardia and hypotension|0|||
127788004|NCT03357731|459849848|FG002|Overall Study|Acute bradycardia and hypotension|0|||
127788005|NCT03357731|459849849|FG003|Overall Study|Acute bradycardia and hypotension|1|||
127788006|NCT03357731|459849850|FG004|Overall Study|Acute bradycardia and hypotension|0|||
127600177|NCT01905657|459163199|FG000|Overall Study|Sponsor Decision|1|||
127600178|NCT01905657|459163200|FG001|Overall Study|Sponsor Decision|0|||
127600179|NCT01905657|459163201|FG002|Overall Study|Sponsor Decision|0|||
127600180|NCT01386554|459163205|FG000|Overall Study|Lost to Follow-up|0|||
127600181|NCT01386554|459163206|FG001|Overall Study|Lost to Follow-up|0|||
127600182|NCT01386554|459163207|FG002|Overall Study|Lost to Follow-up|1|||
127600183|NCT01386554|459163205|FG000|Overall Study|Adverse Event|2|||
127788007|NCT03357731|459849851|FG005|Overall Study|Acute bradycardia and hypotension|0|||
127600184|NCT01386554|459163206|FG001|Overall Study|Adverse Event|5|||
127600185|NCT01386554|459163207|FG002|Overall Study|Adverse Event|2|||
127600186|NCT01386554|459163205|FG000|Overall Study|Progressive disease|1|||
127600187|NCT01386554|459163206|FG001|Overall Study|Progressive disease|2|||
127600188|NCT01386554|459163207|FG002|Overall Study|Progressive disease|2|||
127600189|NCT01386554|459163205|FG000|Overall Study|Administration of live vaccines|0|||
127600190|NCT01386554|459163206|FG001|Overall Study|Administration of live vaccines|1|||
127600191|NCT01386554|459163207|FG002|Overall Study|Administration of live vaccines|0|||
127600192|NCT01386554|459163205|FG000|Overall Study|Investigator discretion|0|||
127600193|NCT01386554|459163206|FG001|Overall Study|Investigator discretion|0|||
127600194|NCT01386554|459163207|FG002|Overall Study|Investigator discretion|1|||
127600195|NCT01386554|459163205|FG000|Overall Study|Reason not collected|0|||
127600196|NCT01386554|459163206|FG001|Overall Study|Reason not collected|1|||
127600197|NCT01386554|459163207|FG002|Overall Study|Reason not collected|0|||
127600198|NCT03334903|459163209|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
127600199|NCT03334903|459163210|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
127600200|NCT03334903|459163209|FG000|Overall Study|Protocol Violation|1|||
127600201|NCT03334903|459163210|FG001|Overall Study|Protocol Violation|3|||
127600202|NCT03334903|459163209|FG000|Overall Study|Surgery postponed|1|||
127600203|NCT03334903|459163210|FG001|Overall Study|Surgery postponed|0|||
127600204|NCT03334903|459163209|FG000|Overall Study|Adverse Event|1|||
127600205|NCT03334903|459163210|FG001|Overall Study|Adverse Event|1|||
127600206|NCT03334903|459163209|FG000|Overall Study|Withdrawal by Subject|0|||
127600207|NCT03334903|459163210|FG001|Overall Study|Withdrawal by Subject|1|||
127600208|NCT03032705|459163211|FG000|Overall Study|Lost to Follow-up|16|||
127600209|NCT03032705|459163212|FG001|Overall Study|Lost to Follow-up|17|||
127600210|NCT03032705|459163211|FG000|Overall Study|did not quality|6|||
127600211|NCT03032705|459163212|FG001|Overall Study|did not quality|6|||
127600212|NCT02927080|459165040|FG000|Overall Study|Withdrawal by Subject|0|||
127600213|NCT02927080|459165041|FG001|Overall Study|Withdrawal by Subject|0|||
127600214|NCT02927080|459165042|FG002|Overall Study|Withdrawal by Subject|0|||
127600215|NCT02927080|459165043|FG003|Overall Study|Withdrawal by Subject|0|||
127600216|NCT02927080|459165044|FG004|Overall Study|Withdrawal by Subject|1|||
127600217|NCT02927080|459165045|FG005|Overall Study|Withdrawal by Subject|0|||
127600218|NCT02927080|459165046|FG006|Overall Study|Withdrawal by Subject|1|||
127600219|NCT02927080|459165047|FG007|Overall Study|Withdrawal by Subject|1|||
127600220|NCT02927080|459165048|FG008|Overall Study|Withdrawal by Subject|0|||
127600221|NCT02927080|459165049|FG009|Overall Study|Withdrawal by Subject|2|||
127600222|NCT02927080|459165040|FG000|Overall Study|Willingness to comply with protocol|0|||
127600223|NCT02927080|459165041|FG001|Overall Study|Willingness to comply with protocol|0|||
127600224|NCT02927080|459165042|FG002|Overall Study|Willingness to comply with protocol|0|||
127600225|NCT02927080|459165043|FG003|Overall Study|Willingness to comply with protocol|0|||
127600226|NCT02927080|459165044|FG004|Overall Study|Willingness to comply with protocol|0|||
127600227|NCT02927080|459165045|FG005|Overall Study|Willingness to comply with protocol|0|||
127600228|NCT02927080|459165046|FG006|Overall Study|Willingness to comply with protocol|0|||
127600229|NCT02927080|459165047|FG007|Overall Study|Willingness to comply with protocol|0|||
127600230|NCT02927080|459165048|FG008|Overall Study|Willingness to comply with protocol|0|||
127600231|NCT02927080|459165049|FG009|Overall Study|Willingness to comply with protocol|1|||
127600232|NCT02927080|459165040|FG000|Overall Study|Study terminated by Sponsor|0|||
127600233|NCT02927080|459165041|FG001|Overall Study|Study terminated by Sponsor|0|||
127600234|NCT02927080|459165042|FG002|Overall Study|Study terminated by Sponsor|0|||
127600235|NCT02927080|459165043|FG003|Overall Study|Study terminated by Sponsor|0|||
127600236|NCT02927080|459165044|FG004|Overall Study|Study terminated by Sponsor|0|||
127600237|NCT02927080|459165045|FG005|Overall Study|Study terminated by Sponsor|0|||
127600238|NCT02927080|459165046|FG006|Overall Study|Study terminated by Sponsor|6|||
127600239|NCT02927080|459165047|FG007|Overall Study|Study terminated by Sponsor|7|||
127600240|NCT02927080|459165048|FG008|Overall Study|Study terminated by Sponsor|2|||
127600241|NCT02927080|459165049|FG009|Overall Study|Study terminated by Sponsor|3|||
127600242|NCT02927080|459165040|FG000|Overall Study|Adverse Event|0|||
127600243|NCT02927080|459165041|FG001|Overall Study|Adverse Event|1|||
127600244|NCT02927080|459165042|FG002|Overall Study|Adverse Event|0|||
127600245|NCT02927080|459165043|FG003|Overall Study|Adverse Event|0|||
127600246|NCT02927080|459165044|FG004|Overall Study|Adverse Event|0|||
127600247|NCT02927080|459165045|FG005|Overall Study|Adverse Event|0|||
127600248|NCT02927080|459165046|FG006|Overall Study|Adverse Event|0|||
127600249|NCT02927080|459165047|FG007|Overall Study|Adverse Event|1|||
127600250|NCT02927080|459165048|FG008|Overall Study|Adverse Event|0|||
127600251|NCT02927080|459165049|FG009|Overall Study|Adverse Event|1|||
127600252|NCT02927080|459165040|FG000|Overall Study|Other|0|||
127600253|NCT02927080|459165041|FG001|Overall Study|Other|0|||
127600254|NCT02927080|459165042|FG002|Overall Study|Other|0|||
127600255|NCT02927080|459165043|FG003|Overall Study|Other|0|||
127600256|NCT02927080|459165044|FG004|Overall Study|Other|0|||
127600257|NCT02927080|459165045|FG005|Overall Study|Other|0|||
127600258|NCT02927080|459165046|FG006|Overall Study|Other|1|||
127600259|NCT02927080|459165047|FG007|Overall Study|Other|0|||
127600260|NCT02927080|459165048|FG008|Overall Study|Other|1|||
127600261|NCT02927080|459165049|FG009|Overall Study|Other|0|||
127600262|NCT00503308|459165050|FG000|Overall Study|Protocol Violation|2|||
127600263|NCT00503308|459165051|FG001|Overall Study|Protocol Violation|1|||
127600264|NCT02564042|459165052|FG000|Overall Study|Adverse Event|4|||
127600265|NCT02564042|459165053|FG001|Overall Study|Adverse Event|4|||
127600266|NCT02564042|459165054|FG002|Overall Study|Adverse Event|3|||
127600267|NCT02564042|459165055|FG003|Overall Study|Adverse Event|0|||
127600268|NCT02564042|459165056|FG004|Overall Study|Adverse Event|0|||
127600269|NCT02564042|459165057|FG005|Overall Study|Adverse Event|1|||
127600270|NCT02564042|459165052|FG000|Overall Study|Lost to Follow-up|1|||
127600271|NCT02564042|459165053|FG001|Overall Study|Lost to Follow-up|1|||
127600272|NCT02564042|459165054|FG002|Overall Study|Lost to Follow-up|1|||
127600273|NCT02564042|459165055|FG003|Overall Study|Lost to Follow-up|0|||
127600274|NCT02564042|459165056|FG004|Overall Study|Lost to Follow-up|1|||
127600275|NCT02564042|459165057|FG005|Overall Study|Lost to Follow-up|1|||
127600276|NCT02564042|459165052|FG000|Overall Study|Physician Decision|1|||
127600277|NCT02564042|459165053|FG001|Overall Study|Physician Decision|0|||
127600278|NCT02564042|459165054|FG002|Overall Study|Physician Decision|0|||
127600279|NCT02564042|459165055|FG003|Overall Study|Physician Decision|1|||
127600280|NCT02564042|459165056|FG004|Overall Study|Physician Decision|0|||
127600281|NCT02564042|459165057|FG005|Overall Study|Physician Decision|0|||
127600282|NCT02564042|459165052|FG000|Overall Study|Withdrawal by Subject|5|||
127600283|NCT02564042|459165053|FG001|Overall Study|Withdrawal by Subject|3|||
127600284|NCT02564042|459165054|FG002|Overall Study|Withdrawal by Subject|2|||
127600285|NCT02564042|459165055|FG003|Overall Study|Withdrawal by Subject|2|||
127600286|NCT02564042|459165056|FG004|Overall Study|Withdrawal by Subject|10|||
127600287|NCT02564042|459165057|FG005|Overall Study|Withdrawal by Subject|12|||
127600288|NCT01356966|459165058|FG000|Overall Study|Withdrawal by Subject|1|||
127600289|NCT01356966|459165059|FG001|Overall Study|Withdrawal by Subject|2|||
127600290|NCT01356966|459165058|FG000|Overall Study|Physician Decision|1|||
127600291|NCT01356966|459165059|FG001|Overall Study|Physician Decision|0|||
127600292|NCT01549392|459165060|FG000|Overall Study|Withdrawal by Subject|1|||
127600293|NCT01549392|459165061|FG001|Overall Study|Withdrawal by Subject|0|||
127696009|NCT05536440|459514805|FG008|Overall Study|Adverse Event|1|||
127696010|NCT06283173|459514806|FG000|Overall Study|Did not show for first visit|10|||
127696011|NCT06283173|459514806|FG000|Overall Study|Lost to Follow-up|12|||
127696012|NCT06283173|459514806|FG000|Overall Study|Physician Decision|7|||
127696013|NCT01580488|459514810|FG000|Overall Study|Withdrawal by Subject|1|||
127696014|NCT03338790|459514816|FG000|Overall Study|Disease Progression|65|||
127696015|NCT03338790|459514817|FG001|Overall Study|Disease Progression|43|||
127600294|NCT02743806|459165062|FG000|Overall Study|Adverse Event|9|||
127600295|NCT02743806|459165062|FG000|Overall Study|Lost to Follow-up|8|||
127696016|NCT03338790|459514818|FG002|Overall Study|Disease Progression|50|||
127600296|NCT02743806|459165062|FG000|Overall Study|Voluntary Withdrawal|54|||
127600297|NCT02743806|459165062|FG000|Overall Study|Study Termination|65|||
127600298|NCT02743806|459165062|FG000|Overall Study|Pregnancy|6|||
127600299|NCT02743806|459165062|FG000|Overall Study|No Longer Clinically Benefiting|27|||
127600300|NCT02743806|459165062|FG000|Overall Study|Reason Not Specified|12|||
127600301|NCT00849381|459165064|FG000|Overall Study|Adverse Event|1|||
127600302|NCT00849381|459165064|FG000|Overall Study|Lost to Follow-up|129|||
127600303|NCT00849381|459165064|FG000|Overall Study|Protocol Violation|5|||
127600304|NCT00849381|459165064|FG000|Overall Study|Withdrawal by Subject|6|||
127600305|NCT00849381|459165064|FG000|Overall Study|Other|4|||
127600306|NCT04273217|459165065|FG000|Overall Study|Lost to Follow-up|0|||
127600307|NCT04273217|459165066|FG001|Overall Study|Lost to Follow-up|0|||
127600308|NCT04273217|459165067|FG002|Overall Study|Lost to Follow-up|0|||
127600309|NCT04273217|459165068|FG003|Overall Study|Lost to Follow-up|0|||
127600310|NCT04273217|459165069|FG004|Overall Study|Lost to Follow-up|0|||
127600311|NCT04273217|459165070|FG005|Overall Study|Lost to Follow-up|1|||
127600312|NCT04273217|459165065|FG000|Overall Study|Participant non-compliance|0|||
127600313|NCT04273217|459165066|FG001|Overall Study|Participant non-compliance|0|||
127600314|NCT04273217|459165067|FG002|Overall Study|Participant non-compliance|0|||
127600315|NCT04273217|459165068|FG003|Overall Study|Participant non-compliance|0|||
127600316|NCT04273217|459165069|FG004|Overall Study|Participant non-compliance|1|||
127600317|NCT04273217|459165070|FG005|Overall Study|Participant non-compliance|0|||
127600318|NCT04273217|459165065|FG000|Overall Study|Positive urine drug screen|1|||
127600319|NCT04273217|459165066|FG001|Overall Study|Positive urine drug screen|0|||
127600320|NCT04273217|459165067|FG002|Overall Study|Positive urine drug screen|1|||
127600321|NCT04273217|459165068|FG003|Overall Study|Positive urine drug screen|0|||
127600322|NCT04273217|459165069|FG004|Overall Study|Positive urine drug screen|0|||
127882734|NCT00552617|460194524|FG006|Overall Study|Lost to Follow-up|0|||
127882735|NCT00552617|460194525|FG007|Overall Study|Lost to Follow-up|0|||
127882736|NCT00552617|460194526|FG008|Overall Study|Lost to Follow-up|2|||
127882737|NCT00552617|460194527|FG009|Overall Study|Lost to Follow-up|0|||
127882738|NCT00337129|460194535|FG000|Overall Study|Adverse Event|4|||
127882739|NCT00337129|460194535|FG000|Overall Study|Withdrawal by Subject|1|||
127882740|NCT00337129|460194535|FG000|Overall Study|Lack of Efficacy|32|||
127882741|NCT00337129|460194535|FG000|Overall Study|Death|2|||
127882742|NCT00337129|460194535|FG000|Overall Study|not protocol specified|1|||
127882743|NCT00563524|460194538|FG000|Overall Study|Adverse Event|0|||
127882744|NCT00563524|460194539|FG001|Overall Study|Adverse Event|1|||
127882745|NCT00563524|460194540|FG002|Overall Study|Adverse Event|0|||
127882746|NCT00563524|460194541|FG003|Overall Study|Adverse Event|0|||
127882747|NCT00563524|460194542|FG004|Overall Study|Adverse Event|2|||
127882748|NCT00563524|460194543|FG005|Overall Study|Adverse Event|0|||
127882749|NCT00563524|460194538|FG000|Overall Study|Lost to Follow-up|1|||
127882750|NCT00563524|460194539|FG001|Overall Study|Lost to Follow-up|0|||
127882751|NCT00563524|460194540|FG002|Overall Study|Lost to Follow-up|0|||
127882752|NCT00563524|460194541|FG003|Overall Study|Lost to Follow-up|0|||
127882753|NCT00563524|460194542|FG004|Overall Study|Lost to Follow-up|0|||
127882754|NCT00563524|460194543|FG005|Overall Study|Lost to Follow-up|0|||
127882755|NCT00563524|460194538|FG000|Overall Study|Protocol Violation|0|||
127882756|NCT00563524|460194539|FG001|Overall Study|Protocol Violation|1|||
128038483|NCT03508050|460770673|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
127600323|NCT04273217|459165070|FG005|Overall Study|Positive urine drug screen|1|||
127600324|NCT00303498|459165071|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
127600325|NCT00303498|459165072|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
127600326|NCT00303498|459165071|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
127600327|NCT00303498|459165072|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
127600328|NCT00303498|459165071|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
127600329|NCT00303498|459165072|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
127600330|NCT00303498|459165071|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
127600331|NCT00303498|459165072|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
127600332|NCT00303498|459165071|FG000|Run-In-Phase (10 Weeks)|Other|4|||
127600333|NCT00303498|459165072|FG001|Run-In-Phase (10 Weeks)|Other|1|||
127600334|NCT00303498|459165071|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
127600335|NCT00303498|459165072|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
127600336|NCT00303498|459165071|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
127600337|NCT00303498|459165072|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
127600338|NCT00303498|459165071|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
127600339|NCT00303498|459165072|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
127600340|NCT00303498|459165071|FG000|Maintenance Phase (24 Weeks)|Death|1|||
127600341|NCT00303498|459165072|FG001|Maintenance Phase (24 Weeks)|Death|0|||
127600342|NCT00303498|459165071|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
127600343|NCT00303498|459165072|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
127696017|NCT03338790|459514819|FG003|Overall Study|Disease Progression|37|||
127882757|NCT00563524|460194540|FG002|Overall Study|Protocol Violation|0|||
127882758|NCT00563524|460194541|FG003|Overall Study|Protocol Violation|0|||
127882759|NCT00563524|460194542|FG004|Overall Study|Protocol Violation|0|||
127882760|NCT00563524|460194543|FG005|Overall Study|Protocol Violation|0|||
127600344|NCT00303498|459165071|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
127600345|NCT00303498|459165072|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
127600346|NCT00303498|459165071|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
127600347|NCT00303498|459165072|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
127600348|NCT00303498|459165071|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
127600349|NCT00303498|459165072|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
127600350|NCT00303498|459165071|FG000|Maintenance Phase (24 Weeks)|Other|1|||
127600351|NCT00303498|459165072|FG001|Maintenance Phase (24 Weeks)|Other|0|||
127600352|NCT00303498|459165071|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
127600353|NCT00303498|459165072|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
127600354|NCT00303498|459165071|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
127600355|NCT00303498|459165072|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
127600356|NCT00103142|459165078|FG000|Overall Study|Adverse Event|1|||
127600357|NCT00103142|459165079|FG001|Overall Study|Adverse Event|0|||
127600358|NCT00103142|459165078|FG000|Overall Study|Progression of disease|2|||
127600359|NCT00103142|459165079|FG001|Overall Study|Progression of disease|1|||
127600360|NCT02598076|459165083|FG000|Overall Study|Lost to Follow-up|2|||
127600361|NCT02598076|459165084|FG001|Overall Study|Lost to Follow-up|3|||
127600362|NCT01946425|459165085|FG000|Overall Study|Protocol Violation|1|||
127600363|NCT01946425|459165086|FG001|Overall Study|Protocol Violation|0|||
127600364|NCT01946425|459165085|FG000|Overall Study|Withdrawal by Subject|1|||
127600365|NCT01946425|459165086|FG001|Overall Study|Withdrawal by Subject|0|||
127600366|NCT01896531|459165097|FG000|Overall Study|Death|57|||
127600367|NCT01896531|459165098|FG001|Overall Study|Death|59|||
127600368|NCT01896531|459165097|FG000|Overall Study|Lost to Follow-up|3|||
127600369|NCT01896531|459165098|FG001|Overall Study|Lost to Follow-up|0|||
127600370|NCT01896531|459165097|FG000|Overall Study|Non-compliance|0|||
127600371|NCT01896531|459165098|FG001|Overall Study|Non-compliance|1|||
127600372|NCT01896531|459165097|FG000|Overall Study|Study Ended by Sponsor|7|||
127600373|NCT01896531|459165098|FG001|Overall Study|Study Ended by Sponsor|20|||
127600374|NCT01896531|459165097|FG000|Overall Study|Withdrawal by Subject|3|||
127600375|NCT01896531|459165098|FG001|Overall Study|Withdrawal by Subject|2|||
127600376|NCT01896531|459165097|FG000|Overall Study|Death Prior to Treatment|1|||
127600377|NCT01896531|459165098|FG001|Overall Study|Death Prior to Treatment|0|||
127788008|NCT03357731|459849846|FG000|Overall Study|Adverse Event|0|||
127788009|NCT03357731|459849847|FG001|Overall Study|Adverse Event|0|||
127788010|NCT03357731|459849848|FG002|Overall Study|Adverse Event|0|||
127788011|NCT03357731|459849849|FG003|Overall Study|Adverse Event|0|||
127788012|NCT03357731|459849850|FG004|Overall Study|Adverse Event|0|||
127788013|NCT03357731|459849851|FG005|Overall Study|Adverse Event|1|||
127788014|NCT03357731|459849846|FG000|Overall Study|Hypotension|0|||
127788015|NCT03357731|459849847|FG001|Overall Study|Hypotension|0|||
127788016|NCT03357731|459849848|FG002|Overall Study|Hypotension|1|||
127788017|NCT03357731|459849849|FG003|Overall Study|Hypotension|1|||
127788018|NCT03357731|459849850|FG004|Overall Study|Hypotension|0|||
127788019|NCT03357731|459849851|FG005|Overall Study|Hypotension|0|||
127788020|NCT03357731|459849846|FG000|Overall Study|Lost to Follow-up|0|||
127788021|NCT03357731|459849847|FG001|Overall Study|Lost to Follow-up|0|||
127788022|NCT03357731|459849848|FG002|Overall Study|Lost to Follow-up|0|||
127788023|NCT03357731|459849849|FG003|Overall Study|Lost to Follow-up|1|||
127788024|NCT03357731|459849850|FG004|Overall Study|Lost to Follow-up|0|||
127788025|NCT03357731|459849851|FG005|Overall Study|Lost to Follow-up|0|||
127788026|NCT00772954|459849852|FG000|Overall Study|Adverse Event|0|||
127788027|NCT00772954|459849853|FG001|Overall Study|Adverse Event|0|||
127788028|NCT00772954|459849854|FG002|Overall Study|Adverse Event|1|||
127788029|NCT01773109|459849855|FG000|Overall Study|Symptomatic Progression|2|||
127788030|NCT01773109|459849855|FG000|Overall Study|Death|1|||
127788031|NCT01239342|459849856|FG000|Overall Study|Adverse Event|1|||
127788032|NCT01239342|459849857|FG001|Overall Study|Adverse Event|0|||
127788033|NCT01239342|459849856|FG000|Overall Study|Withdrawal by Subject|1|||
127788034|NCT01239342|459849857|FG001|Overall Study|Withdrawal by Subject|5|||
127788035|NCT01239342|459849856|FG000|Overall Study|Reason Unknown|1|||
127788036|NCT01239342|459849857|FG001|Overall Study|Reason Unknown|1|||
127788037|NCT02495844|459849858|FG000|Overall Study|Lack of Efficacy|1|||
127788038|NCT02495844|459849859|FG001|Overall Study|Lack of Efficacy|2|||
127788039|NCT02495844|459849858|FG000|Overall Study|AE, non-fatal|0|||
127788040|NCT02495844|459849859|FG001|Overall Study|AE, non-fatal|1|||
127788041|NCT02495844|459849858|FG000|Overall Study|Hepatitis Positivity|0|||
127788042|NCT02495844|459849859|FG001|Overall Study|Hepatitis Positivity|1|||
127788043|NCT02325219|459849862|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
127788044|NCT02325219|459849863|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
127788045|NCT02325219|459849864|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
127788046|NCT02325219|459849865|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
127788047|NCT02325219|459849866|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
127788048|NCT02325219|459849862|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
127788049|NCT02325219|459849863|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
128038484|NCT03508050|460770674|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
128038485|NCT03508050|460770673|FG000|Overall Study|Sustained desaturation|0|||
128038486|NCT03508050|460770674|FG001|Overall Study|Sustained desaturation|1|||
128038487|NCT03710889|460770678|FG000|Overall Study|Adverse Event|2|||
128038488|NCT03710889|460770678|FG000|Overall Study|Protocol Deviation|1|||
128038489|NCT00570713|460770679|FG000|Overall Study|Adverse Event|16|||
128038490|NCT00570713|460770680|FG001|Overall Study|Adverse Event|9|||
128038491|NCT00570713|460770679|FG000|Overall Study|Death|7|||
127600378|NCT00770289|459165101|FG000|Overall Study|Other|6|||
127600379|NCT02956486|459165102|FG000|Core Phase|Adverse Event|51|||
127600380|NCT02956486|459165103|FG001|Core Phase|Adverse Event|88|||
127600381|NCT02956486|459165104|FG002|Core Phase|Adverse Event|0|||
127600382|NCT02956486|459165102|FG000|Core Phase|Lost to Follow-up|8|||
127600383|NCT02956486|459165103|FG001|Core Phase|Lost to Follow-up|6|||
127600384|NCT02956486|459165104|FG002|Core Phase|Lost to Follow-up|0|||
127600385|NCT02956486|459165102|FG000|Core Phase|Inadequate therapeutic effect|4|||
127600386|NCT02956486|459165103|FG001|Core Phase|Inadequate therapeutic effect|5|||
127696018|NCT03338790|459514816|FG000|Overall Study|Study Drug Toxicity|9|||
127696019|NCT03338790|459514817|FG001|Overall Study|Study Drug Toxicity|8|||
127696020|NCT03338790|459514818|FG002|Overall Study|Study Drug Toxicity|15|||
127696021|NCT03338790|459514819|FG003|Overall Study|Study Drug Toxicity|0|||
127696022|NCT03338790|459514816|FG000|Overall Study|Death|1|||
127696023|NCT03338790|459514817|FG001|Overall Study|Death|1|||
127696024|NCT03338790|459514818|FG002|Overall Study|Death|1|||
127696025|NCT03338790|459514819|FG003|Overall Study|Death|0|||
127696026|NCT03338790|459514816|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
127696027|NCT03338790|459514817|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
127696028|NCT03338790|459514818|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
127696029|NCT03338790|459514819|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
127696030|NCT03338790|459514816|FG000|Overall Study|Participant request to discontinue study treatment|3|||
127696031|NCT03338790|459514817|FG001|Overall Study|Participant request to discontinue study treatment|3|||
127696032|NCT03338790|459514818|FG002|Overall Study|Participant request to discontinue study treatment|2|||
127696033|NCT03338790|459514819|FG003|Overall Study|Participant request to discontinue study treatment|1|||
127696034|NCT03338790|459514816|FG000|Overall Study|Poor/non-compliance|0|||
127696035|NCT03338790|459514817|FG001|Overall Study|Poor/non-compliance|1|||
127696036|NCT03338790|459514818|FG002|Overall Study|Poor/non-compliance|0|||
127696037|NCT03338790|459514819|FG003|Overall Study|Poor/non-compliance|0|||
127696038|NCT03338790|459514816|FG000|Overall Study|Participant withdrew consent|1|||
127696039|NCT03338790|459514817|FG001|Overall Study|Participant withdrew consent|0|||
127696040|NCT03338790|459514818|FG002|Overall Study|Participant withdrew consent|1|||
127696041|NCT03338790|459514819|FG003|Overall Study|Participant withdrew consent|1|||
127696042|NCT03338790|459514816|FG000|Overall Study|Other reasons|0|||
127696043|NCT03338790|459514817|FG001|Overall Study|Other reasons|5|||
127696044|NCT03338790|459514818|FG002|Overall Study|Other reasons|0|||
127696045|NCT03338790|459514819|FG003|Overall Study|Other reasons|2|||
127696046|NCT03338790|459514816|FG000|Overall Study|Not reported|0|||
127696047|NCT03338790|459514817|FG001|Overall Study|Not reported|0|||
127696048|NCT03338790|459514818|FG002|Overall Study|Not reported|1|||
127696049|NCT03338790|459514819|FG003|Overall Study|Not reported|0|||
127696050|NCT03338790|459514816|FG000|Overall Study|Completed treatment period|1|||
127696051|NCT03338790|459514817|FG001|Overall Study|Completed treatment period|2|||
127696052|NCT03338790|459514818|FG002|Overall Study|Completed treatment period|0|||
127696053|NCT03338790|459514819|FG003|Overall Study|Completed treatment period|0|||
127696054|NCT04588298|459514824|FG000|Overall Study|Adverse Event|0|||
127696055|NCT04588298|459514825|FG001|Overall Study|Adverse Event|0|||
127696056|NCT04588298|459514826|FG002|Overall Study|Adverse Event|1|||
127696057|NCT04588298|459514827|FG003|Overall Study|Adverse Event|0|||
127696058|NCT04588298|459514828|FG004|Overall Study|Adverse Event|2|||
127696059|NCT04588298|459514824|FG000|Overall Study|Withdrawal by Subject|1|||
127696060|NCT04588298|459514825|FG001|Overall Study|Withdrawal by Subject|0|||
127696061|NCT04588298|459514826|FG002|Overall Study|Withdrawal by Subject|0|||
127696062|NCT04588298|459514827|FG003|Overall Study|Withdrawal by Subject|1|||
127696063|NCT04588298|459514828|FG004|Overall Study|Withdrawal by Subject|0|||
127696064|NCT03846505|459514829|FG000|Treatment Phase|Withdrawal by Subject|9|||
127696065|NCT03846505|459514830|FG001|Treatment Phase|Withdrawal by Subject|11|||
127696066|NCT03846505|459514829|FG000|Treatment Phase|Lost to Follow-up|6|||
127696067|NCT03846505|459514830|FG001|Treatment Phase|Lost to Follow-up|2|||
127696068|NCT03846505|459514829|FG000|Treatment Phase|Opted out of intervention but completed assessments|5|||
127788050|NCT02325219|459849864|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
127788051|NCT02325219|459849865|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
127788052|NCT02325219|459849866|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
127788053|NCT02325219|459849862|FG000|Controlled Period (Week 0 - 16)|Other|0|||
127788054|NCT02325219|459849863|FG001|Controlled Period (Week 0 - 16)|Other|0|||
127788055|NCT02325219|459849864|FG002|Controlled Period (Week 0 - 16)|Other|1|||
127788056|NCT02325219|459849865|FG003|Controlled Period (Week 0 - 16)|Other|0|||
128038492|NCT00570713|460770680|FG001|Overall Study|Death|7|||
127600387|NCT02956486|459165104|FG002|Core Phase|Inadequate therapeutic effect|0|||
127600388|NCT02956486|459165102|FG000|Core Phase|Withdrawal by Subject|101|||
127600389|NCT02956486|459165103|FG001|Core Phase|Withdrawal by Subject|104|||
127600390|NCT02956486|459165104|FG002|Core Phase|Withdrawal by Subject|0|||
127600391|NCT02956486|459165102|FG000|Core Phase|Study terminated by sponsor|888|||
127600392|NCT02956486|459165103|FG001|Core Phase|Study terminated by sponsor|848|||
127600393|NCT02956486|459165104|FG002|Core Phase|Study terminated by sponsor|0|||
127600394|NCT02956486|459165102|FG000|Core Phase|Other|27|||
127600395|NCT02956486|459165103|FG001|Core Phase|Other|18|||
127600396|NCT02956486|459165104|FG002|Core Phase|Other|0|||
127600397|NCT02956486|459165102|FG000|Core Phase|Not treated|0|||
127600398|NCT02956486|459165103|FG001|Core Phase|Not treated|3|||
127600399|NCT02956486|459165104|FG002|Core Phase|Not treated|0|||
127600400|NCT02956486|459165102|FG000|Extension Phase|Adverse Event|0|||
127600401|NCT02956486|459165103|FG001|Extension Phase|Adverse Event|0|||
127600402|NCT02956486|459165104|FG002|Extension Phase|Adverse Event|2|||
127600403|NCT02956486|459165102|FG000|Extension Phase|Study terminated by sponsor|0|||
127600404|NCT02956486|459165103|FG001|Extension Phase|Study terminated by sponsor|0|||
127600405|NCT02956486|459165104|FG002|Extension Phase|Study terminated by sponsor|16|||
127600406|NCT02956486|459165102|FG000|Extension Phase|Not Treated|0|||
127600407|NCT02956486|459165103|FG001|Extension Phase|Not Treated|0|||
127600408|NCT02956486|459165104|FG002|Extension Phase|Not Treated|1|||
127600409|NCT03325075|459165107|FG000|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|2|||
127600410|NCT03325075|459165108|FG001|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
127600411|NCT03325075|459165109|FG002|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
127600412|NCT03325075|459165110|FG003|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
127600413|NCT03325075|459165107|FG000|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
127600414|NCT03325075|459165108|FG001|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|1|||
127600415|NCT03325075|459165109|FG002|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
127600416|NCT03325075|459165110|FG003|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
127600417|NCT03325075|459165107|FG000|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
127600418|NCT03325075|459165108|FG001|Part B: Follow-up (Up to 364 Days)|Other than specified|1|||
127600419|NCT03325075|459165109|FG002|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
127600420|NCT03325075|459165110|FG003|Part B: Follow-up (Up to 364 Days)|Other than specified|2|||
127600421|NCT00422591|459165111|FG000|Overall Study|Physician Decision|4|||
127600422|NCT00422591|459165111|FG000|Overall Study|Withdrawal by Subject|2|||
127600423|NCT02485574|459165116|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
127600424|NCT01408914|459165117|FG000|Overall Study|Could not complete tx in protocol period|5|||
127600425|NCT01408914|459165118|FG001|Overall Study|Could not complete tx in protocol period|5|||
127600426|NCT01408914|459165119|FG002|Overall Study|Could not complete tx in protocol period|6|||
127600427|NCT01408914|459165117|FG000|Overall Study|Lost to Follow-up|4|||
127600428|NCT01408914|459165118|FG001|Overall Study|Lost to Follow-up|1|||
127600429|NCT01408914|459165119|FG002|Overall Study|Lost to Follow-up|2|||
127788057|NCT02325219|459849866|FG004|Controlled Period (Week 0 - 16)|Other|0|||
127788058|NCT02325219|459849862|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
127788059|NCT02325219|459849863|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
127788060|NCT02325219|459849864|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
127788061|NCT02325219|459849865|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
127788062|NCT02325219|459849866|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
127788063|NCT02325219|459849862|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
127788064|NCT02325219|459849863|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
127788065|NCT02325219|459849864|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
127788066|NCT02325219|459849865|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
127788067|NCT02325219|459849866|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
127788068|NCT02325219|459849862|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
127788069|NCT02325219|459849863|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
127788070|NCT02325219|459849864|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
127788071|NCT02325219|459849865|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
127882761|NCT00563524|460194538|FG000|Overall Study|Withdrawal by Subject|1|||
128038493|NCT00570713|460770679|FG000|Overall Study|Lack of Efficacy|40|||
128038494|NCT00570713|460770680|FG001|Overall Study|Lack of Efficacy|49|||
128038495|NCT00570713|460770679|FG000|Overall Study|Physician Decision|2|||
127600430|NCT01408914|459165117|FG000|Overall Study|Physician Decision|1|||
127600431|NCT01408914|459165118|FG001|Overall Study|Physician Decision|1|||
127600432|NCT01408914|459165119|FG002|Overall Study|Physician Decision|0|||
127600433|NCT01408914|459165117|FG000|Overall Study|Withdrawal by Subject|1|||
127600434|NCT01408914|459165118|FG001|Overall Study|Withdrawal by Subject|0|||
127600435|NCT01408914|459165119|FG002|Overall Study|Withdrawal by Subject|1|||
127600436|NCT01408914|459165117|FG000|Overall Study|Moved out of study jurisdiction|1|||
127788072|NCT02325219|459849866|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
127788073|NCT02918864|459849867|FG000|Overall Study|Withdrawal by Subject|1|||
127600437|NCT01408914|459165118|FG001|Overall Study|Moved out of study jurisdiction|1|||
127600438|NCT01408914|459165119|FG002|Overall Study|Moved out of study jurisdiction|0|||
127600439|NCT01408914|459165117|FG000|Overall Study|Late exclusion|0|||
127600440|NCT01408914|459165118|FG001|Overall Study|Late exclusion|3|||
127600441|NCT01408914|459165119|FG002|Overall Study|Late exclusion|3|||
127600442|NCT01408914|459165117|FG000|Overall Study|Change in local TB/HIV norms|0|||
127600443|NCT01408914|459165118|FG001|Overall Study|Change in local TB/HIV norms|1|||
127600444|NCT01408914|459165119|FG002|Overall Study|Change in local TB/HIV norms|1|||
127600445|NCT00811473|459165122|FG000|Overall Study|Adverse Event|3|||
127600446|NCT00811473|459165123|FG001|Overall Study|Adverse Event|12|||
127600447|NCT00811473|459165122|FG000|Overall Study|Lost to Follow-up|5|||
127600448|NCT00811473|459165123|FG001|Overall Study|Lost to Follow-up|1|||
127600449|NCT00811473|459165122|FG000|Overall Study|Withdrawal by Subject|2|||
127600450|NCT00811473|459165123|FG001|Overall Study|Withdrawal by Subject|4|||
127600451|NCT00811473|459165122|FG000|Overall Study|Severe non-compliance to protocol|2|||
127600452|NCT00811473|459165123|FG001|Overall Study|Severe non-compliance to protocol|4|||
127600453|NCT00811473|459165122|FG000|Overall Study|Lack of therapeutic response|4|||
127600454|NCT00811473|459165123|FG001|Overall Study|Lack of therapeutic response|1|||
127600455|NCT00811473|459165122|FG000|Overall Study|Condition under investigation worsened|1|||
127600456|NCT00811473|459165123|FG001|Overall Study|Condition under investigation worsened|3|||
127600457|NCT00811473|459165122|FG000|Overall Study|Other 2|4|||
127600458|NCT00811473|459165123|FG001|Overall Study|Other 2|1|||
127600459|NCT00811473|459165122|FG000|Overall Study|Incorrect Enrollment|1|||
127600460|NCT00811473|459165123|FG001|Overall Study|Incorrect Enrollment|0|||
127600461|NCT00811473|459165122|FG000|Overall Study|Safety Reasons|1|||
127600462|NCT00811473|459165123|FG001|Overall Study|Safety Reasons|0|||
127600463|NCT00667368|459165127|FG000|Overall Study|Lost to Follow-up|176|||
127600464|NCT00667368|459165128|FG001|Overall Study|Lost to Follow-up|155|||
127600465|NCT00667368|459165127|FG000|Overall Study|Discontinued early|24|||
127600466|NCT00667368|459165128|FG001|Overall Study|Discontinued early|17|||
127600467|NCT01585194|459165129|FG000|Overall Study|Withdrawal by Subject|1|||
127600468|NCT01585194|459165129|FG000|Overall Study|Physician Decision|2|||
127600469|NCT01585194|459165129|FG000|Overall Study|Lack of insurance|1|||
127600470|NCT00732615|459165130|FG000|Overall Study|Withdrawal by Subject|3|||
127600471|NCT00732615|459165131|FG001|Overall Study|Withdrawal by Subject|1|||
127600472|NCT00732615|459165130|FG000|Overall Study|Lost to Follow-up|0|||
127600473|NCT00732615|459165131|FG001|Overall Study|Lost to Follow-up|1|||
127600474|NCT00732615|459165130|FG000|Overall Study|Adverse Event|0|||
127600475|NCT00732615|459165131|FG001|Overall Study|Adverse Event|2|||
127600476|NCT00732615|459165130|FG000|Overall Study|Physician Decision|3|||
127600477|NCT00732615|459165131|FG001|Overall Study|Physician Decision|0|||
127600478|NCT00732615|459165130|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
127600479|NCT00732615|459165131|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
127600480|NCT01333059|459165132|FG000|Overall Study|Physician Decision|3|||
127600481|NCT01333059|459165133|FG001|Overall Study|Physician Decision|3|||
127600482|NCT01333059|459165132|FG000|Overall Study|Protocol Violation|3|||
127600483|NCT01333059|459165133|FG001|Overall Study|Protocol Violation|0|||
127600484|NCT03566823|459165134|FG000|Overall Study|Lack of Efficacy|0|||
127600485|NCT03566823|459165135|FG001|Overall Study|Lack of Efficacy|1|||
127600486|NCT03566823|459165136|FG002|Overall Study|Lack of Efficacy|0|||
127600487|NCT03566823|459165134|FG000|Overall Study|Withdrawal by Subject|1|||
127600488|NCT03566823|459165135|FG001|Overall Study|Withdrawal by Subject|2|||
127600489|NCT03566823|459165136|FG002|Overall Study|Withdrawal by Subject|0|||
127600490|NCT03566823|459165134|FG000|Overall Study|Adverse Event|1|||
127600491|NCT03566823|459165135|FG001|Overall Study|Adverse Event|0|||
127600492|NCT03566823|459165136|FG002|Overall Study|Adverse Event|2|||
127600493|NCT02733367|459165137|FG000|Overall Study|Withdrawal by Subject|6|||
127600494|NCT01348347|459165138|FG000|Overall Study|Withdrawal by Subject|1|||
127788074|NCT02918864|459849868|FG001|Overall Study|Withdrawal by Subject|1|||
127600495|NCT01348347|459165139|FG001|Overall Study|Withdrawal by Subject|1|||
127600496|NCT01348347|459165140|FG002|Overall Study|Withdrawal by Subject|1|||
127600497|NCT01348347|459165138|FG000|Overall Study|Progressive disease|2|||
127600498|NCT01348347|459165139|FG001|Overall Study|Progressive disease|5|||
127600499|NCT01348347|459165140|FG002|Overall Study|Progressive disease|5|||
127600500|NCT00748033|459165141|FG000|Overall Study|Adverse Event|0|||
127600501|NCT00748033|459165142|FG001|Overall Study|Adverse Event|1|||
127600502|NCT00191789|459165145|FG000|Overall Study|Adverse Event|5|||
127600503|NCT00191789|459165145|FG000|Overall Study|Patient: Satisfactory Response|5|||
127600504|NCT00191789|459165145|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
127788075|NCT02918864|459849867|FG000|Overall Study|Lost to Follow-up|3|||
127600505|NCT00191789|459165145|FG000|Overall Study|Withdrawal by Subject|4|||
127600506|NCT00191789|459165145|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
127600507|NCT00191789|459165145|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
127788076|NCT02918864|459849868|FG001|Overall Study|Lost to Follow-up|2|||
127600508|NCT00191789|459165145|FG000|Overall Study|Death - Not Study-Drug Related|1|||
127600509|NCT01922089|459165148|FG000|Overall Study|Adverse Event|18|||
127600510|NCT01922089|459165149|FG001|Overall Study|Adverse Event|13|||
127600511|NCT01922089|459165148|FG000|Overall Study|Protocol Deviation|10|||
127600512|NCT01922089|459165149|FG001|Overall Study|Protocol Deviation|7|||
127600513|NCT01922089|459165148|FG000|Overall Study|Withdrawal by Subject|3|||
127600514|NCT01922089|459165149|FG001|Overall Study|Withdrawal by Subject|4|||
127600515|NCT01922089|459165148|FG000|Overall Study|administrative problems|4|||
127600516|NCT01922089|459165149|FG001|Overall Study|administrative problems|1|||
127600517|NCT01922089|459165148|FG000|Overall Study|Physician Decision|2|||
127600518|NCT01922089|459165149|FG001|Overall Study|Physician Decision|3|||
127600519|NCT01922089|459165148|FG000|Overall Study|Death|2|||
127600520|NCT01922089|459165149|FG001|Overall Study|Death|1|||
127600521|NCT01922089|459165148|FG000|Overall Study|Lost to Follow-up|0|||
127600522|NCT01922089|459165149|FG001|Overall Study|Lost to Follow-up|1|||
127600523|NCT04903626|459165153|FG000|Overall Study|Lost to Follow-up|6|||
127600524|NCT04903626|459165153|FG000|Overall Study|Withdrawal by Subject|1|||
127600525|NCT04903626|459165153|FG000|Overall Study|Other, Not Specified|1|||
127600526|NCT03358290|459165157|FG000|Overall Study|Study discontinued by Sponsor|0|||
127600527|NCT03358290|459165158|FG001|Overall Study|Study discontinued by Sponsor|1|||
127600528|NCT03358290|459165159|FG002|Overall Study|Study discontinued by Sponsor|1|||
127600529|NCT03358290|459165160|FG003|Overall Study|Study discontinued by Sponsor|0|||
127600530|NCT03358290|459165161|FG004|Overall Study|Study discontinued by Sponsor|0|||
127600531|NCT03358290|459165157|FG000|Overall Study|Adverse Event|0|||
127600532|NCT03358290|459165158|FG001|Overall Study|Adverse Event|0|||
127600533|NCT03358290|459165159|FG002|Overall Study|Adverse Event|1|||
127600534|NCT03358290|459165160|FG003|Overall Study|Adverse Event|2|||
127600535|NCT03358290|459165161|FG004|Overall Study|Adverse Event|0|||
127600536|NCT03358290|459165157|FG000|Overall Study|Withdrawal by Subject|0|||
127600537|NCT03358290|459165158|FG001|Overall Study|Withdrawal by Subject|0|||
127600538|NCT03358290|459165159|FG002|Overall Study|Withdrawal by Subject|0|||
127600539|NCT03358290|459165160|FG003|Overall Study|Withdrawal by Subject|0|||
127600540|NCT03358290|459165161|FG004|Overall Study|Withdrawal by Subject|1|||
127600541|NCT02999854|459165168|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
127600542|NCT02999854|459165169|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
127600543|NCT02999854|459165168|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
127600544|NCT02999854|459165169|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
127600545|NCT02999854|459165168|FG000|Active Study Phase (up to 18 Months)|Death|7|||
127600546|NCT02999854|459165169|FG001|Active Study Phase (up to 18 Months)|Death|5|||
127600547|NCT02999854|459165168|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
127600548|NCT02999854|459165169|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
127600549|NCT02999854|459165168|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
127600550|NCT02999854|459165169|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
127600551|NCT02999854|459165168|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
127600552|NCT02999854|459165169|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
127600553|NCT02999854|459165168|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
127600554|NCT02999854|459165169|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
127600555|NCT02999854|459165168|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
127600556|NCT02999854|459165169|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
127600557|NCT04140292|459165170|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
127600558|NCT04140292|459165171|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
127600559|NCT01013701|459165172|FG000|Overall Study|study prematurely terminated|7|||
127600560|NCT00556712|459165173|FG000|Overall Study|Adverse Event|7|||
127600561|NCT00556712|459165174|FG001|Overall Study|Adverse Event|19|||
127600562|NCT00556712|459165173|FG000|Overall Study|Death|5|||
127600563|NCT00556712|459165174|FG001|Overall Study|Death|10|||
127600564|NCT00556712|459165173|FG000|Overall Study|Progressive Disease|383|||
127600565|NCT00556712|459165174|FG001|Overall Study|Progressive Disease|320|||
127600566|NCT00556712|459165173|FG000|Overall Study|Protocol Violation|3|||
127600567|NCT00556712|459165174|FG001|Overall Study|Protocol Violation|2|||
127600568|NCT00556712|459165173|FG000|Overall Study|Refused Treatment|17|||
127600569|NCT00556712|459165174|FG001|Overall Study|Refused Treatment|16|||
127600570|NCT00556712|459165173|FG000|Overall Study|Failure to Return|2|||
127600571|NCT00556712|459165174|FG001|Overall Study|Failure to Return|3|||
127600572|NCT00556712|459165173|FG000|Overall Study|Other|2|||
127600573|NCT00556712|459165174|FG001|Overall Study|Other|2|||
127600574|NCT00556712|459165173|FG000|Overall Study|Ongoing at Data Cutoff|32|||
127600575|NCT00556712|459165174|FG001|Overall Study|Ongoing at Data Cutoff|66|||
127600576|NCT02671422|459165180|FG000|Overall Study|Lost to Follow-up|1|||
127600577|NCT02671422|459165180|FG000|Overall Study|Adverse Event|68|||
127600578|NCT02671422|459165180|FG000|Overall Study|Lack of Efficacy|1|||
127600579|NCT02671422|459165180|FG000|Overall Study|Lost to Follow-up|4|||
127600580|NCT02671422|459165180|FG000|Overall Study|Withdrawal by Subject|7|||
127600581|NCT02671422|459165180|FG000|Overall Study|Progressive Disease|156|||
127600582|NCT02671422|459165180|FG000|Overall Study|Worsening of Disease|4|||
127600583|NCT02671422|459165180|FG000|Overall Study|Sponsor decision|5|||
127600584|NCT02671422|459165180|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
127600585|NCT02671422|459165180|FG000|Overall Study|Not treated with Vargatef®|3|||
127600586|NCT02671422|459165180|FG000|Overall Study|Other not defined above|3|||
127600587|NCT02626520|459165181|FG000|Overall Study|Physician Decision|1|||
127600588|NCT02626520|459165182|FG001|Overall Study|Physician Decision|1|||
127600589|NCT02626520|459165181|FG000|Overall Study|Adverse Event|0|||
127600590|NCT02626520|459165182|FG001|Overall Study|Adverse Event|4|||
127600591|NCT02626520|459165181|FG000|Overall Study|Lack of Efficacy|0|||
127600592|NCT02626520|459165182|FG001|Overall Study|Lack of Efficacy|2|||
127600593|NCT02626520|459165181|FG000|Overall Study|Did not start protocol therapy|0|||
127600594|NCT02626520|459165182|FG001|Overall Study|Did not start protocol therapy|2|||
127600595|NCT02626520|459165181|FG000|Overall Study|Study terminated|0|||
127600596|NCT02626520|459165182|FG001|Overall Study|Study terminated|1|||
127600597|NCT04702997|459165183|FG000|Overall Study|Withdrawal by Subject|1|||
127600598|NCT04702997|459165184|FG001|Overall Study|Withdrawal by Subject|1|||
127600599|NCT03915496|459165187|FG000|Overall Study|Adverse Event|2|||
127600600|NCT03915496|459165188|FG001|Overall Study|Adverse Event|1|||
127600601|NCT03915496|459165189|FG002|Overall Study|Adverse Event|2|||
127600602|NCT02200445|459165190|FG000|Overall Study|Lack of Efficacy|1|||
127600603|NCT02200445|459165191|FG001|Overall Study|Lack of Efficacy|2|||
127600604|NCT02200445|459165192|FG002|Overall Study|Lack of Efficacy|2|||
127600605|NCT02200445|459165190|FG000|Overall Study|Adverse Event|0|||
127600606|NCT02200445|459165191|FG001|Overall Study|Adverse Event|2|||
127600607|NCT02200445|459165192|FG002|Overall Study|Adverse Event|0|||
127600608|NCT00353262|459165196|FG000|Overall Study|Adverse Event|8|||
127600609|NCT00353262|459165196|FG000|Overall Study|Withdrawal by Subject|2|||
127600610|NCT00353262|459165196|FG000|Overall Study|Insufficient Therapeutic Response|13|||
127600611|NCT00353262|459165196|FG000|Overall Study|Progression|1|||
127600612|NCT00353262|459165196|FG000|Overall Study|Surgery|4|||
127600613|NCT00353262|459165196|FG000|Overall Study|Break from Chemotherapy|1|||
127600614|NCT00001596|459166991|FG000|Overall Study|Death|1|||
127600615|NCT00001596|459166992|FG001|Overall Study|Death|0|||
127600616|NCT00001596|459166991|FG000|Overall Study|Withdrawal by Subject|3|||
127600617|NCT00001596|459166992|FG001|Overall Study|Withdrawal by Subject|1|||
127600618|NCT00001596|459166991|FG000|Overall Study|Study Termination|12|||
127600619|NCT00001596|459166992|FG001|Overall Study|Study Termination|9|||
127600620|NCT00001596|459166991|FG000|Overall Study|Adverse Event|1|||
127600621|NCT00001596|459166992|FG001|Overall Study|Adverse Event|0|||
127600622|NCT00463346|459166997|FG000|Overall Study|Withdrawal by Subject|3|||
127600623|NCT00463346|459166998|FG001|Overall Study|Withdrawal by Subject|3|||
127600624|NCT04067544|459167001|FG000|Overall Study|Unforeseen recruitment issues due to Coronavirus Disease (COVID)-19 pandemic|1|||
127600625|NCT02282020|459167004|FG000|Overall Study|Objective Disease Progression|128|||
127600626|NCT02282020|459167005|FG001|Overall Study|Objective Disease Progression|30|||
127600627|NCT02282020|459167004|FG000|Overall Study|Adverse Event|18|||
127600628|NCT02282020|459167005|FG001|Overall Study|Adverse Event|15|||
127600629|NCT02282020|459167004|FG000|Overall Study|Withdrawal by Subject|7|||
127600630|NCT02282020|459167005|FG001|Overall Study|Withdrawal by Subject|10|||
127600631|NCT02282020|459167004|FG000|Overall Study|Miscellaneous|5|||
128038496|NCT00570713|460770680|FG001|Overall Study|Physician Decision|2|||
128038497|NCT00570713|460770679|FG000|Overall Study|Withdrawal by Subject|3|||
128038498|NCT00570713|460770680|FG001|Overall Study|Withdrawal by Subject|3|||
128038499|NCT00570713|460770679|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
128038500|NCT00570713|460770680|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
128038501|NCT04881760|460770681|FG000|Overall Study|Adverse Event|0|||
128038502|NCT04881760|460770682|FG001|Overall Study|Adverse Event|1|||
128038503|NCT04881760|460770683|FG002|Overall Study|Adverse Event|1|||
127600632|NCT02282020|459167005|FG001|Overall Study|Miscellaneous|19|||
127600633|NCT02282020|459167004|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
127600634|NCT02282020|459167005|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
127600635|NCT02282020|459167004|FG000|Overall Study|Developed Discontinuation Criteria|0|||
127600636|NCT02282020|459167005|FG001|Overall Study|Developed Discontinuation Criteria|2|||
127600637|NCT02282020|459167004|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
127600638|NCT02282020|459167005|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
127600639|NCT00082355|459167006|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
128038504|NCT04881760|460770684|FG003|Overall Study|Adverse Event|0|||
127600640|NCT00082355|459167006|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
127600641|NCT00082355|459167006|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
127600642|NCT00759863|459167008|FG000|Overall Study|Death, moved, or lost contact|20|||
127600643|NCT00759863|459167009|FG001|Overall Study|Death, moved, or lost contact|18|||
127600644|NCT00708162|459167019|FG000|Randomized Phase|Randomized but Not Treated|7|||
127600645|NCT00708162|459167020|FG001|Randomized Phase|Randomized but Not Treated|5|||
127600646|NCT00708162|459167019|FG000|Randomized Phase|Participant Noncompliance|40|||
127600647|NCT00708162|459167020|FG001|Randomized Phase|Participant Noncompliance|32|||
127600648|NCT00708162|459167019|FG000|Randomized Phase|Lost to Follow-up|34|||
127600649|NCT00708162|459167020|FG001|Randomized Phase|Lost to Follow-up|34|||
127600650|NCT00708162|459167019|FG000|Randomized Phase|Withdrew Consent|31|||
127600651|NCT00708162|459167020|FG001|Randomized Phase|Withdrew Consent|22|||
127600652|NCT00708162|459167019|FG000|Randomized Phase|Lack of Efficacy|14|||
127600653|NCT00708162|459167020|FG001|Randomized Phase|Lack of Efficacy|19|||
127600654|NCT00708162|459167019|FG000|Randomized Phase|Protocol Violation|10|||
127600655|NCT00708162|459167020|FG001|Randomized Phase|Protocol Violation|11|||
127600656|NCT00708162|459167019|FG000|Randomized Phase|Adverse Event|8|||
127600657|NCT00708162|459167020|FG001|Randomized Phase|Adverse Event|12|||
127600658|NCT00708162|459167019|FG000|Randomized Phase|Investigator's Discretion|7|||
127600659|NCT00708162|459167020|FG001|Randomized Phase|Investigator's Discretion|10|||
127600660|NCT00708162|459167019|FG000|Randomized Phase|Death|2|||
127600661|NCT00708162|459167020|FG001|Randomized Phase|Death|9|||
127600662|NCT00708162|459167019|FG000|Randomized Phase|Pregnancy|3|||
127600663|NCT00708162|459167020|FG001|Randomized Phase|Pregnancy|0|||
127600664|NCT00708162|459167019|FG000|Open-Label Phase|Lost to Follow-up|10|||
127600665|NCT00708162|459167020|FG001|Open-Label Phase|Lost to Follow-up|8|||
127600666|NCT00708162|459167019|FG000|Open-Label Phase|Withdrew Consent|12|||
127600667|NCT00708162|459167020|FG001|Open-Label Phase|Withdrew Consent|6|||
127600668|NCT00708162|459167019|FG000|Open-Label Phase|Participant Noncompliance|7|||
127600669|NCT00708162|459167020|FG001|Open-Label Phase|Participant Noncompliance|7|||
127600670|NCT00708162|459167019|FG000|Open-Label Phase|Lack of Efficacy|7|||
127600671|NCT00708162|459167020|FG001|Open-Label Phase|Lack of Efficacy|4|||
127600672|NCT00708162|459167019|FG000|Open-Label Phase|Investigator's Discretion|3|||
127600673|NCT00708162|459167020|FG001|Open-Label Phase|Investigator's Discretion|2|||
127600674|NCT00708162|459167019|FG000|Open-Label Phase|Death|3|||
127600675|NCT00708162|459167020|FG001|Open-Label Phase|Death|1|||
127600676|NCT00708162|459167019|FG000|Open-Label Phase|Adverse Event|1|||
127600677|NCT00708162|459167020|FG001|Open-Label Phase|Adverse Event|2|||
127600678|NCT00708162|459167019|FG000|Open-Label Phase|Other|1|||
127600679|NCT00708162|459167020|FG001|Open-Label Phase|Other|0|||
127600680|NCT00708643|459167021|FG000|Overall Study|Adverse Event|0|||
127600681|NCT00708643|459167022|FG001|Overall Study|Adverse Event|1|||
127600682|NCT01244906|459167023|FG000|Overall Study|Death|2|||
127600683|NCT01244906|459167023|FG000|Overall Study|Progression of disease post treatment|6|||
127600684|NCT04532099|459167024|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
127600685|NCT04532099|459167025|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
127600686|NCT04532099|459167026|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
127600687|NCT00644995|459167027|FG000|Overall Study|Lost to Follow-up|1|||
127600688|NCT00644995|459167028|FG001|Overall Study|Lost to Follow-up|4|||
127600689|NCT00644995|459167027|FG000|Overall Study|Refused|1|||
127600690|NCT00644995|459167028|FG001|Overall Study|Refused|0|||
127600691|NCT02066233|459167029|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
127600692|NCT02066233|459167030|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
127600693|NCT02772081|459167031|FG000|Overall Study|Physician Decision|1|||
127600694|NCT02772081|459167032|FG001|Overall Study|Physician Decision|1|||
127600695|NCT02772081|459167031|FG000|Overall Study|Death|1|||
127600696|NCT02772081|459167032|FG001|Overall Study|Death|1|||
127600697|NCT00311623|459167035|FG000|Overall Study|Physician Decision|0|||
127600698|NCT00311623|459167036|FG001|Overall Study|Physician Decision|0|||
127600699|NCT00311623|459167037|FG002|Overall Study|Physician Decision|2|||
127600700|NCT03998189|459167038|FG000|Overall Study|Lack of Efficacy|0|||
127696069|NCT03846505|459514830|FG001|Treatment Phase|Opted out of intervention but completed assessments|3|||
127696070|NCT03846505|459514829|FG000|Completed Follow Up Phase (6-month)|Lost to Follow-up|6|||
127600701|NCT03998189|459167039|FG001|Overall Study|Lack of Efficacy|1|||
127600702|NCT03227029|459167040|FG000|Overall Study|Child Wheezed (no treatment)|0|||
127600703|NCT03227029|459167041|FG001|Overall Study|Child Wheezed (no treatment)|1|||
127600704|NCT03227029|459167042|FG002|Overall Study|Child Wheezed (no treatment)|0|||
127600705|NCT03227029|459167040|FG000|Overall Study|No post RSV season visit due to COVID|3|||
127600706|NCT03227029|459167041|FG001|Overall Study|No post RSV season visit due to COVID|3|||
127600707|NCT03227029|459167042|FG002|Overall Study|No post RSV season visit due to COVID|2|||
127600708|NCT03227029|459167040|FG000|Overall Study|Not able to get to clinic|0|||
127600709|NCT03227029|459167041|FG001|Overall Study|Not able to get to clinic|0|||
127600710|NCT03227029|459167042|FG002|Overall Study|Not able to get to clinic|1|||
127600711|NCT03227029|459167040|FG000|Overall Study|Withdrawal by Subject|1|||
127600712|NCT03227029|459167041|FG001|Overall Study|Withdrawal by Subject|0|||
127600713|NCT03227029|459167042|FG002|Overall Study|Withdrawal by Subject|0|||
127600714|NCT03227029|459167040|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
127788077|NCT04766021|459849869|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|9|||
127788078|NCT04766021|459849869|FG000|Informed Consent/Screening Visit|Met exclusion criteria|10|||
127788079|NCT02634151|459849873|FG000|Overall Study|Withdrawal by Subject|1|||
127788080|NCT02634151|459849874|FG001|Overall Study|Withdrawal by Subject|0|||
127788081|NCT02634151|459849873|FG000|Overall Study|Non-Compliance|0|||
127788082|NCT02634151|459849874|FG001|Overall Study|Non-Compliance|1|||
127600715|NCT03227029|459167041|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
127600716|NCT03227029|459167042|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
127600717|NCT00390858|459167043|FG000|Overall Study|Adverse Event|6|||
127788083|NCT02634151|459849873|FG000|Overall Study|Other|0|||
127600718|NCT00390858|459167044|FG001|Overall Study|Adverse Event|2|||
127600719|NCT00390858|459167043|FG000|Overall Study|Lack of Efficacy|0|||
127600720|NCT00390858|459167044|FG001|Overall Study|Lack of Efficacy|1|||
127600721|NCT00390858|459167043|FG000|Overall Study|Withdrawal by Subject|3|||
127600722|NCT00390858|459167044|FG001|Overall Study|Withdrawal by Subject|4|||
127600723|NCT03414424|459167045|FG000|Overall Study|Screened out after consent|0|||
127600724|NCT03414424|459167046|FG001|Overall Study|Screened out after consent|2|||
127600725|NCT03414424|459167045|FG000|Overall Study|Lost to Follow-up|0|||
127600726|NCT03414424|459167046|FG001|Overall Study|Lost to Follow-up|1|||
127600727|NCT01949051|459167048|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
127600728|NCT01949051|459167049|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
127600729|NCT01949051|459167050|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
127788084|NCT02634151|459849874|FG001|Overall Study|Other|1|||
127788085|NCT02347098|459849875|FG000|Overall Study|Death|1|||
127600730|NCT01949051|459167051|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
127696071|NCT03846505|459514830|FG001|Completed Follow Up Phase (6-month)|Lost to Follow-up|1|||
127696072|NCT04485039|459514831|FG000|TPOXX Only|Adverse Event|2|||
127696073|NCT04485039|459514831|FG000|TPOXX Only|Physician Decision|1|||
127696074|NCT04485039|459514831|FG000|TPOXX With Sevelamer Carbonate|Adverse Event|1|||
127696075|NCT04485039|459514831|FG000|TPOXX With Sevelamer Carbonate|Withdrawal by Subject|1|||
127696076|NCT04005716|459514835|FG000|Overall Study|Death|175|||
127696077|NCT04005716|459514836|FG001|Overall Study|Death|196|||
127696078|NCT04005716|459514835|FG000|Overall Study|Withdrawal by Subject|1|||
127696079|NCT04005716|459514836|FG001|Overall Study|Withdrawal by Subject|6|||
127696080|NCT04005716|459514835|FG000|Overall Study|Lost to Follow-up|2|||
127696081|NCT04005716|459514836|FG001|Overall Study|Lost to Follow-up|2|||
127696082|NCT03445988|459514842|FG000|Overall Study|Lost to Follow-up|14|||
127696083|NCT03445988|459514843|FG001|Overall Study|Lost to Follow-up|26|||
127696084|NCT03445988|459514844|FG002|Overall Study|Lost to Follow-up|27|||
127696085|NCT03445988|459514845|FG003|Overall Study|Lost to Follow-up|66|||
127696086|NCT03445988|459514842|FG000|Overall Study|Withdrawal by Subject|7|||
127696087|NCT03445988|459514843|FG001|Overall Study|Withdrawal by Subject|4|||
127696088|NCT03445988|459514844|FG002|Overall Study|Withdrawal by Subject|3|||
127696089|NCT03445988|459514845|FG003|Overall Study|Withdrawal by Subject|5|||
127696090|NCT03445988|459514842|FG000|Overall Study|Death (unrelated to study)|5|||
127696091|NCT03445988|459514843|FG001|Overall Study|Death (unrelated to study)|1|||
127696092|NCT03445988|459514844|FG002|Overall Study|Death (unrelated to study)|2|||
127696093|NCT03445988|459514845|FG003|Overall Study|Death (unrelated to study)|4|||
127696094|NCT03988608|459514846|FG000|Overall Study|Adverse Event|1|||
127696095|NCT03988608|459514846|FG000|Overall Study|Lost to Follow-up|1|||
127696096|NCT03988608|459514846|FG000|Overall Study|Withdrawal by Subject|3|||
127696097|NCT03988608|459514846|FG000|Overall Study|Death|1|||
127696098|NCT02689284|459514853|FG000|Overall Study|Adverse Event|1|||
127696099|NCT02689284|459514854|FG001|Overall Study|Adverse Event|8|||
127696100|NCT02689284|459514853|FG000|Overall Study|Death|0|||
127696101|NCT02689284|459514854|FG001|Overall Study|Death|1|||
127696102|NCT02689284|459514853|FG000|Overall Study|Physician Decision|1|||
127696103|NCT02689284|459514854|FG001|Overall Study|Physician Decision|2|||
127696104|NCT02689284|459514853|FG000|Overall Study|Withdrawal by Subject|0|||
127696105|NCT02689284|459514854|FG001|Overall Study|Withdrawal by Subject|1|||
127696106|NCT02689284|459514853|FG000|Overall Study|progression of cancer|1|||
127788086|NCT02347098|459849876|FG001|Overall Study|Death|0|||
128038505|NCT04881760|460770685|FG004|Overall Study|Adverse Event|1|||
128038506|NCT04881760|460770686|FG005|Overall Study|Adverse Event|1|||
128038507|NCT04881760|460770687|FG006|Overall Study|Adverse Event|2|||
128038508|NCT04881760|460770681|FG000|Overall Study|Death|0|||
128038509|NCT04881760|460770682|FG001|Overall Study|Death|0|||
128038510|NCT04881760|460770683|FG002|Overall Study|Death|0|||
128038511|NCT04881760|460770684|FG003|Overall Study|Death|1|||
128038512|NCT04881760|460770685|FG004|Overall Study|Death|0|||
128038513|NCT04881760|460770686|FG005|Overall Study|Death|0|||
128038514|NCT04881760|460770687|FG006|Overall Study|Death|0|||
128038515|NCT04881760|460770681|FG000|Overall Study|Lost to Follow-up|5|||
128038516|NCT04881760|460770682|FG001|Overall Study|Lost to Follow-up|7|||
128038517|NCT04881760|460770683|FG002|Overall Study|Lost to Follow-up|5|||
128038518|NCT04881760|460770684|FG003|Overall Study|Lost to Follow-up|1|||
128038519|NCT04881760|460770685|FG004|Overall Study|Lost to Follow-up|2|||
128038520|NCT04881760|460770686|FG005|Overall Study|Lost to Follow-up|4|||
128038521|NCT04881760|460770687|FG006|Overall Study|Lost to Follow-up|4|||
128038522|NCT04881760|460770681|FG000|Overall Study|Withdrawal by Subject|13|||
128038523|NCT04881760|460770682|FG001|Overall Study|Withdrawal by Subject|1|||
128038524|NCT04881760|460770683|FG002|Overall Study|Withdrawal by Subject|1|||
128038525|NCT04881760|460770684|FG003|Overall Study|Withdrawal by Subject|4|||
128038526|NCT04881760|460770685|FG004|Overall Study|Withdrawal by Subject|2|||
128038527|NCT04881760|460770686|FG005|Overall Study|Withdrawal by Subject|1|||
128038528|NCT04881760|460770687|FG006|Overall Study|Withdrawal by Subject|2|||
128038529|NCT04881760|460770681|FG000|Overall Study|Randomized but Never Treated|0|||
128038530|NCT04881760|460770682|FG001|Overall Study|Randomized but Never Treated|0|||
128038531|NCT04881760|460770683|FG002|Overall Study|Randomized but Never Treated|0|||
128038532|NCT04881760|460770684|FG003|Overall Study|Randomized but Never Treated|1|||
128038533|NCT04881760|460770685|FG004|Overall Study|Randomized but Never Treated|0|||
128038534|NCT04881760|460770686|FG005|Overall Study|Randomized but Never Treated|0|||
128038535|NCT04881760|460770687|FG006|Overall Study|Randomized but Never Treated|0|||
128038536|NCT04881760|460770681|FG000|Overall Study|Inadvertent Enrollment|2|||
128038537|NCT04881760|460770682|FG001|Overall Study|Inadvertent Enrollment|0|||
127696107|NCT02689284|459514854|FG001|Overall Study|progression of cancer|72|||
127696108|NCT02689284|459514853|FG000|Overall Study|decreased heart function|0|||
127696109|NCT02689284|459514854|FG001|Overall Study|decreased heart function|1|||
127696110|NCT02689284|459514853|FG000|Overall Study|concern for anemia|0|||
127696111|NCT02689284|459514854|FG001|Overall Study|concern for anemia|1|||
127696112|NCT02689284|459514853|FG000|Overall Study|no measurable cancer for evaluation|0|||
128038538|NCT04881760|460770683|FG002|Overall Study|Inadvertent Enrollment|0|||
127882762|NCT00563524|460194539|FG001|Overall Study|Withdrawal by Subject|1|||
127882763|NCT00563524|460194540|FG002|Overall Study|Withdrawal by Subject|3|||
127600731|NCT01949051|459167052|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
127600732|NCT01949051|459167053|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
127600733|NCT01949051|459167048|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
127600734|NCT01949051|459167049|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
127600735|NCT01949051|459167050|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
127600736|NCT01949051|459167051|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
127600737|NCT01949051|459167052|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
127600738|NCT01949051|459167053|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
127600739|NCT01949051|459167048|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
127600740|NCT01949051|459167049|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
127600741|NCT01949051|459167050|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
127600742|NCT01949051|459167051|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
127600743|NCT01949051|459167052|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
127600744|NCT01949051|459167053|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
127600745|NCT01949051|459167048|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
127600746|NCT01949051|459167049|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
127600747|NCT01949051|459167050|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
127600748|NCT01949051|459167051|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
127600749|NCT01949051|459167052|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
127600750|NCT01949051|459167053|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
127600751|NCT01949051|459167048|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
127600752|NCT01949051|459167049|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
127600753|NCT01949051|459167050|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
127600754|NCT01949051|459167051|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
127600755|NCT01949051|459167052|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
127600756|NCT01949051|459167053|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
127600757|NCT01782859|459167054|FG000|Overall Study|Protocol Violation|6|||
127600758|NCT01782859|459167055|FG001|Overall Study|Protocol Violation|6|||
127600759|NCT01782859|459167054|FG000|Overall Study|Withdrawal by Subject|0|||
127600760|NCT01782859|459167055|FG001|Overall Study|Withdrawal by Subject|1|||
127600761|NCT02659631|459167056|FG000|Overall Study|Lost to Follow-up|0|||
127600762|NCT02659631|459167057|FG001|Overall Study|Lost to Follow-up|0|||
127600763|NCT02659631|459167058|FG002|Overall Study|Lost to Follow-up|2|||
127600764|NCT02659631|459167059|FG003|Overall Study|Lost to Follow-up|0|||
127600765|NCT02659631|459167060|FG004|Overall Study|Lost to Follow-up|0|||
127600766|NCT02659631|459167061|FG005|Overall Study|Lost to Follow-up|1|||
127600767|NCT02659631|459167062|FG006|Overall Study|Lost to Follow-up|0|||
127600768|NCT02659631|459167063|FG007|Overall Study|Lost to Follow-up|0|||
127600769|NCT02659631|459167064|FG008|Overall Study|Lost to Follow-up|0|||
127600770|NCT02659631|459167065|FG009|Overall Study|Lost to Follow-up|0|||
127600771|NCT02659631|459167056|FG000|Overall Study|Withdrawal prior to treatment|0|||
127600772|NCT02659631|459167057|FG001|Overall Study|Withdrawal prior to treatment|0|||
127600773|NCT02659631|459167058|FG002|Overall Study|Withdrawal prior to treatment|0|||
127600774|NCT02659631|459167059|FG003|Overall Study|Withdrawal prior to treatment|0|||
127600775|NCT02659631|459167060|FG004|Overall Study|Withdrawal prior to treatment|1|||
127600776|NCT02659631|459167061|FG005|Overall Study|Withdrawal prior to treatment|0|||
127600777|NCT02659631|459167062|FG006|Overall Study|Withdrawal prior to treatment|0|||
127696113|NCT02689284|459514854|FG001|Overall Study|no measurable cancer for evaluation|1|||
127600778|NCT02659631|459167063|FG007|Overall Study|Withdrawal prior to treatment|0|||
127600779|NCT02659631|459167064|FG008|Overall Study|Withdrawal prior to treatment|0|||
127600780|NCT02659631|459167065|FG009|Overall Study|Withdrawal prior to treatment|0|||
127600781|NCT02659631|459167056|FG000|Overall Study|Participant refused further follow-up|0|||
127600782|NCT02659631|459167057|FG001|Overall Study|Participant refused further follow-up|0|||
127696114|NCT05592418|459514855|FG000|Overall Study|Adverse Event|1|||
127696115|NCT05592418|459514856|FG001|Overall Study|Adverse Event|0|||
127600783|NCT02659631|459167058|FG002|Overall Study|Participant refused further follow-up|0|||
127600784|NCT02659631|459167059|FG003|Overall Study|Participant refused further follow-up|1|||
127600785|NCT02659631|459167060|FG004|Overall Study|Participant refused further follow-up|0|||
127600786|NCT02659631|459167061|FG005|Overall Study|Participant refused further follow-up|0|||
127600787|NCT02659631|459167062|FG006|Overall Study|Participant refused further follow-up|0|||
127600788|NCT02659631|459167063|FG007|Overall Study|Participant refused further follow-up|0|||
127696116|NCT05592418|459514855|FG000|Overall Study|Lost to Follow-up|1|||
127882764|NCT00563524|460194541|FG003|Overall Study|Withdrawal by Subject|0|||
128038539|NCT04881760|460770684|FG003|Overall Study|Inadvertent Enrollment|0|||
128038540|NCT04881760|460770685|FG004|Overall Study|Inadvertent Enrollment|0|||
128038541|NCT04881760|460770686|FG005|Overall Study|Inadvertent Enrollment|0|||
128038542|NCT04881760|460770687|FG006|Overall Study|Inadvertent Enrollment|0|||
128038543|NCT04881760|460770681|FG000|Overall Study|Site Closure|0|||
128038544|NCT04881760|460770682|FG001|Overall Study|Site Closure|0|||
128038545|NCT04881760|460770683|FG002|Overall Study|Site Closure|0|||
128038546|NCT04881760|460770684|FG003|Overall Study|Site Closure|1|||
128038547|NCT04881760|460770685|FG004|Overall Study|Site Closure|0|||
128038548|NCT04881760|460770686|FG005|Overall Study|Site Closure|0|||
128038549|NCT04881760|460770687|FG006|Overall Study|Site Closure|0|||
128038550|NCT02081586|460770688|FG000|Overall Study|Lost to Follow-up|0|||
128038551|NCT02081586|460770689|FG001|Overall Study|Lost to Follow-up|1|||
128038552|NCT02081586|460770690|FG002|Overall Study|Lost to Follow-up|0|||
128038553|NCT02081586|460770691|FG003|Overall Study|Lost to Follow-up|1|||
128038554|NCT02081586|460770688|FG000|Overall Study|Head injury not related to study|0|||
128038555|NCT02081586|460770689|FG001|Overall Study|Head injury not related to study|0|||
128038556|NCT02081586|460770690|FG002|Overall Study|Head injury not related to study|1|||
128038557|NCT02081586|460770691|FG003|Overall Study|Head injury not related to study|0|||
128038558|NCT01677988|460770694|FG000|Overall Study|Lack of Efficacy|2|||
128038559|NCT00659425|460770698|FG000|Overall Study|Disease progression|1|||
128038560|NCT00659425|460770699|FG001|Overall Study|Disease progression|0|||
128038561|NCT00659425|460770700|FG002|Overall Study|Disease progression|0|||
128038562|NCT00659425|460770701|FG003|Overall Study|Disease progression|1|||
128038563|NCT00659425|460770702|FG004|Overall Study|Disease progression|0|||
128038564|NCT00659425|460770703|FG005|Overall Study|Disease progression|2|||
128038565|NCT00659425|460770704|FG006|Overall Study|Disease progression|4|||
128038566|NCT00659425|460770705|FG007|Overall Study|Disease progression|3|||
128038567|NCT00659425|460770706|FG008|Overall Study|Disease progression|5|||
127600789|NCT02659631|459167064|FG008|Overall Study|Participant refused further follow-up|1|||
127600790|NCT02659631|459167065|FG009|Overall Study|Participant refused further follow-up|0|||
127600791|NCT02659631|459167056|FG000|Overall Study|Death (follow-up phase)|1|||
127600792|NCT02659631|459167057|FG001|Overall Study|Death (follow-up phase)|2|||
127600793|NCT02659631|459167058|FG002|Overall Study|Death (follow-up phase)|1|||
127600794|NCT02659631|459167059|FG003|Overall Study|Death (follow-up phase)|1|||
127600795|NCT02659631|459167060|FG004|Overall Study|Death (follow-up phase)|3|||
127600796|NCT02659631|459167061|FG005|Overall Study|Death (follow-up phase)|2|||
127600797|NCT02659631|459167062|FG006|Overall Study|Death (follow-up phase)|0|||
127600798|NCT02659631|459167063|FG007|Overall Study|Death (follow-up phase)|3|||
127600799|NCT02659631|459167064|FG008|Overall Study|Death (follow-up phase)|1|||
127600800|NCT02659631|459167065|FG009|Overall Study|Death (follow-up phase)|0|||
127600801|NCT02659631|459167056|FG000|Overall Study|Death (treatment phase)|0|||
127600802|NCT02659631|459167057|FG001|Overall Study|Death (treatment phase)|0|||
127600803|NCT02659631|459167058|FG002|Overall Study|Death (treatment phase)|0|||
127600804|NCT02659631|459167059|FG003|Overall Study|Death (treatment phase)|0|||
127600805|NCT02659631|459167060|FG004|Overall Study|Death (treatment phase)|1|||
127600806|NCT02659631|459167061|FG005|Overall Study|Death (treatment phase)|0|||
127600807|NCT02659631|459167062|FG006|Overall Study|Death (treatment phase)|1|||
127600808|NCT02659631|459167063|FG007|Overall Study|Death (treatment phase)|0|||
127600809|NCT02659631|459167064|FG008|Overall Study|Death (treatment phase)|0|||
127600810|NCT02659631|459167065|FG009|Overall Study|Death (treatment phase)|0|||
127600811|NCT02377466|459167066|FG000|Overall Study|Other: Randomized and not treated|0|||
127600812|NCT02377466|459167067|FG001|Overall Study|Other: Randomized and not treated|2|||
127600813|NCT00495170|459167068|FG000|Overall Study|Lost to Follow-up|9|||
127600814|NCT00495170|459167068|FG000|Overall Study|Withdrawal by Subject|3|||
127600815|NCT00495170|459167068|FG000|Overall Study|Inappropriate staging|8|||
127600816|NCT00993291|459167074|FG000|Overall Study|Withdrawal by Subject|1|||
127600817|NCT02763189|459167079|FG000|Overall Study|Device failure|0|||
127600818|NCT02763189|459167080|FG001|Overall Study|Device failure|2|||
128038568|NCT00659425|460770707|FG009|Overall Study|Disease progression|3|||
128038569|NCT00659425|460770698|FG000|Overall Study|Death|0|||
127600819|NCT02049957|459167081|FG000|Overall Study|Progressive Disease|5|||
127882765|NCT00563524|460194542|FG004|Overall Study|Withdrawal by Subject|0|||
127882766|NCT00563524|460194543|FG005|Overall Study|Withdrawal by Subject|1|||
127600820|NCT02049957|459167082|FG001|Overall Study|Progressive Disease|4|||
127600821|NCT02049957|459167083|FG002|Overall Study|Progressive Disease|2|||
127600822|NCT02049957|459167084|FG003|Overall Study|Progressive Disease|2|||
127882767|NCT00817778|460194548|FG000|Overall Study|Adverse Event|1|||
128038570|NCT00659425|460770699|FG001|Overall Study|Death|0|||
128038571|NCT00659425|460770700|FG002|Overall Study|Death|0|||
128038572|NCT00659425|460770701|FG003|Overall Study|Death|1|||
128038573|NCT00659425|460770702|FG004|Overall Study|Death|0|||
128038574|NCT00659425|460770703|FG005|Overall Study|Death|0|||
128038575|NCT00659425|460770704|FG006|Overall Study|Death|1|||
127600823|NCT02049957|459167085|FG004|Overall Study|Progressive Disease|6|||
128038576|NCT00659425|460770705|FG007|Overall Study|Death|0|||
127788087|NCT02347098|459849875|FG000|Overall Study|Withdrawal by Subject|1|||
127600824|NCT02049957|459167086|FG005|Overall Study|Progressive Disease|35|||
127600825|NCT02049957|459167087|FG006|Overall Study|Progressive Disease|7|||
127600826|NCT02049957|459167088|FG007|Overall Study|Progressive Disease|26|||
127600827|NCT02049957|459167089|FG008|Overall Study|Progressive Disease|6|||
127600828|NCT02049957|459167081|FG000|Overall Study|Adverse Event|1|||
127600829|NCT02049957|459167082|FG001|Overall Study|Adverse Event|1|||
127600830|NCT02049957|459167083|FG002|Overall Study|Adverse Event|1|||
127600831|NCT02049957|459167084|FG003|Overall Study|Adverse Event|0|||
127600832|NCT02049957|459167085|FG004|Overall Study|Adverse Event|0|||
127600833|NCT02049957|459167086|FG005|Overall Study|Adverse Event|5|||
127600834|NCT02049957|459167087|FG006|Overall Study|Adverse Event|0|||
127600835|NCT02049957|459167088|FG007|Overall Study|Adverse Event|6|||
127600836|NCT02049957|459167089|FG008|Overall Study|Adverse Event|1|||
127600837|NCT02049957|459167081|FG000|Overall Study|Study Terminated by Sponsor|0|||
127600838|NCT02049957|459167082|FG001|Overall Study|Study Terminated by Sponsor|1|||
127600839|NCT02049957|459167083|FG002|Overall Study|Study Terminated by Sponsor|0|||
127600840|NCT02049957|459167084|FG003|Overall Study|Study Terminated by Sponsor|0|||
127600841|NCT02049957|459167085|FG004|Overall Study|Study Terminated by Sponsor|0|||
127600842|NCT02049957|459167086|FG005|Overall Study|Study Terminated by Sponsor|0|||
127600843|NCT02049957|459167087|FG006|Overall Study|Study Terminated by Sponsor|1|||
127600844|NCT02049957|459167088|FG007|Overall Study|Study Terminated by Sponsor|0|||
127600845|NCT02049957|459167089|FG008|Overall Study|Study Terminated by Sponsor|0|||
127600846|NCT02049957|459167081|FG000|Overall Study|Withdrawal by Subject|0|||
127600847|NCT02049957|459167082|FG001|Overall Study|Withdrawal by Subject|0|||
127600848|NCT02049957|459167083|FG002|Overall Study|Withdrawal by Subject|0|||
127600849|NCT02049957|459167084|FG003|Overall Study|Withdrawal by Subject|1|||
127600850|NCT02049957|459167085|FG004|Overall Study|Withdrawal by Subject|0|||
127600851|NCT02049957|459167086|FG005|Overall Study|Withdrawal by Subject|2|||
127600852|NCT02049957|459167087|FG006|Overall Study|Withdrawal by Subject|0|||
127600853|NCT02049957|459167088|FG007|Overall Study|Withdrawal by Subject|3|||
127788088|NCT02347098|459849876|FG001|Overall Study|Withdrawal by Subject|0|||
127788089|NCT02347098|459849875|FG000|Overall Study|Lost to Follow-up|2|||
127788090|NCT02347098|459849876|FG001|Overall Study|Lost to Follow-up|2|||
127788091|NCT02347098|459849875|FG000|Overall Study|Refuse Follow-up Visit|1|||
127788092|NCT02347098|459849876|FG001|Overall Study|Refuse Follow-up Visit|5|||
127788093|NCT02347098|459849875|FG000|Overall Study|no visit due to illness|2|||
127788094|NCT02347098|459849876|FG001|Overall Study|no visit due to illness|1|||
127788095|NCT02187172|459849877|FG000|Overall Study|Lost to Follow-up|1|||
127788096|NCT02187172|459849878|FG001|Overall Study|Lost to Follow-up|2|||
127788097|NCT02187172|459849877|FG000|Overall Study|Lack of Efficacy|1|||
127788098|NCT02187172|459849878|FG001|Overall Study|Lack of Efficacy|2|||
127788099|NCT02187172|459849877|FG000|Overall Study|Adverse Event|0|||
127788100|NCT02187172|459849878|FG001|Overall Study|Adverse Event|1|||
127788101|NCT02187172|459849877|FG000|Overall Study|Physician Decision|1|||
127882768|NCT00817778|460194549|FG001|Overall Study|Adverse Event|0|||
127882769|NCT00817778|460194548|FG000|Overall Study|Withdrawal by Subject|1|||
127882770|NCT00817778|460194549|FG001|Overall Study|Withdrawal by Subject|1|||
127882771|NCT00817778|460194548|FG000|Overall Study|Protocol Violation|0|||
127882772|NCT00817778|460194549|FG001|Overall Study|Protocol Violation|1|||
128038577|NCT00659425|460770706|FG008|Overall Study|Death|0|||
128038578|NCT00659425|460770707|FG009|Overall Study|Death|0|||
128038579|NCT00659425|460770698|FG000|Overall Study|Adverse Event|0|||
128038580|NCT00659425|460770699|FG001|Overall Study|Adverse Event|0|||
128038581|NCT00659425|460770700|FG002|Overall Study|Adverse Event|0|||
128038582|NCT00659425|460770701|FG003|Overall Study|Adverse Event|0|||
128038583|NCT00659425|460770702|FG004|Overall Study|Adverse Event|0|||
128038584|NCT00659425|460770703|FG005|Overall Study|Adverse Event|1|||
128038585|NCT00659425|460770704|FG006|Overall Study|Adverse Event|0|||
128038586|NCT00659425|460770705|FG007|Overall Study|Adverse Event|3|||
128038587|NCT00659425|460770706|FG008|Overall Study|Adverse Event|1|||
128038588|NCT00659425|460770707|FG009|Overall Study|Adverse Event|4|||
127600854|NCT02049957|459167089|FG008|Overall Study|Withdrawal by Subject|1|||
127600855|NCT02049957|459167081|FG000|Overall Study|Physician Decision|0|||
127600856|NCT02049957|459167082|FG001|Overall Study|Physician Decision|0|||
127600857|NCT02049957|459167083|FG002|Overall Study|Physician Decision|0|||
127600858|NCT02049957|459167084|FG003|Overall Study|Physician Decision|0|||
127600859|NCT02049957|459167085|FG004|Overall Study|Physician Decision|0|||
127600860|NCT02049957|459167086|FG005|Overall Study|Physician Decision|1|||
127600861|NCT02049957|459167087|FG006|Overall Study|Physician Decision|0|||
127788102|NCT02187172|459849878|FG001|Overall Study|Physician Decision|1|||
127788103|NCT04640272|459849879|FG000|Overall Study|Subject moved out of area|1|||
127788104|NCT00766532|459849891|FG000|Overall Study|Protocol Violation|2|||
128038589|NCT00659425|460770698|FG000|Overall Study|Investigator Discretion|0|||
128038590|NCT00659425|460770699|FG001|Overall Study|Investigator Discretion|0|||
127600862|NCT02049957|459167088|FG007|Overall Study|Physician Decision|0|||
128038591|NCT00659425|460770700|FG002|Overall Study|Investigator Discretion|0|||
128038592|NCT00659425|460770701|FG003|Overall Study|Investigator Discretion|0|||
128038593|NCT00659425|460770702|FG004|Overall Study|Investigator Discretion|0|||
128038594|NCT00659425|460770703|FG005|Overall Study|Investigator Discretion|1|||
128038595|NCT00659425|460770704|FG006|Overall Study|Investigator Discretion|0|||
128038596|NCT00659425|460770705|FG007|Overall Study|Investigator Discretion|3|||
128038597|NCT00659425|460770706|FG008|Overall Study|Investigator Discretion|0|||
128038598|NCT00659425|460770707|FG009|Overall Study|Investigator Discretion|0|||
128038599|NCT00659425|460770698|FG000|Overall Study|Other|0|||
128038600|NCT00659425|460770699|FG001|Overall Study|Other|1|||
128038601|NCT00659425|460770700|FG002|Overall Study|Other|1|||
128038602|NCT00659425|460770701|FG003|Overall Study|Other|2|||
128038603|NCT00659425|460770702|FG004|Overall Study|Other|4|||
128038604|NCT00659425|460770703|FG005|Overall Study|Other|0|||
128038605|NCT00659425|460770704|FG006|Overall Study|Other|3|||
128038606|NCT00659425|460770705|FG007|Overall Study|Other|2|||
128038607|NCT00659425|460770706|FG008|Overall Study|Other|0|||
128038608|NCT00659425|460770707|FG009|Overall Study|Other|6|||
128038609|NCT00271544|460770708|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
128038610|NCT00271544|460770708|FG000|Overall Study|Model 4196 lead not attempted|9|||
128038611|NCT00271544|460770708|FG000|Overall Study|Implant not attempted|4|||
128038612|NCT03358030|460770709|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
128038613|NCT03358030|460770710|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
128038614|NCT03358030|460770711|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
128038615|NCT03358030|460770712|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
128038616|NCT03358030|460770709|FG000|Overall Study|Ineligibility|0|||
127600863|NCT02049957|459167089|FG008|Overall Study|Physician Decision|0|||
127600864|NCT00573534|459167090|FG000|Overall Study|oppositional behavior|3|||
128038617|NCT03358030|460770710|FG001|Overall Study|Ineligibility|0|||
128038618|NCT03358030|460770711|FG002|Overall Study|Ineligibility|0|||
128038619|NCT03358030|460770712|FG003|Overall Study|Ineligibility|2|||
128038620|NCT03358030|460770709|FG000|Overall Study|Voluntary Withdrawal|1|||
128038621|NCT03358030|460770710|FG001|Overall Study|Voluntary Withdrawal|1|||
128038622|NCT03358030|460770711|FG002|Overall Study|Voluntary Withdrawal|3|||
128038623|NCT03358030|460770712|FG003|Overall Study|Voluntary Withdrawal|1|||
127600865|NCT01129960|459167104|FG000|Overall Study|Withdrawal by Subject|3|||
127600866|NCT01129960|459167105|FG001|Overall Study|Withdrawal by Subject|0|||
127600867|NCT01129960|459167106|FG002|Overall Study|Withdrawal by Subject|3|||
127600868|NCT01129960|459167107|FG003|Overall Study|Withdrawal by Subject|2|||
127600869|NCT01129960|459167104|FG000|Overall Study|Lack of Efficacy|1|||
127600870|NCT01129960|459167105|FG001|Overall Study|Lack of Efficacy|1|||
127600871|NCT01129960|459167106|FG002|Overall Study|Lack of Efficacy|1|||
127600872|NCT01129960|459167107|FG003|Overall Study|Lack of Efficacy|1|||
127600873|NCT01129960|459167104|FG000|Overall Study|Adverse Event|23|||
127600874|NCT01129960|459167105|FG001|Overall Study|Adverse Event|16|||
128038624|NCT03358030|460770709|FG000|Overall Study|Other|0|||
128038625|NCT03358030|460770710|FG001|Overall Study|Other|0|||
128038626|NCT03358030|460770711|FG002|Overall Study|Other|1|||
128038627|NCT03358030|460770712|FG003|Overall Study|Other|0|||
128038628|NCT00829244|460770713|FG000|Overall Study|Adverse Event|1|||
128038629|NCT00829244|460770714|FG001|Overall Study|Adverse Event|3|||
128038630|NCT00829244|460770713|FG000|Overall Study|Protocol Violation|1|||
128038631|NCT00829244|460770714|FG001|Overall Study|Protocol Violation|0|||
128038632|NCT00829244|460770713|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
128038633|NCT00829244|460770714|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
128038634|NCT00829244|460770713|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
128038635|NCT00829244|460770714|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
128038636|NCT00829244|460770713|FG000|Overall Study|No fertilization|2|||
128038637|NCT00829244|460770714|FG001|Overall Study|No fertilization|2|||
128038638|NCT00829244|460770713|FG000|Overall Study|All embryos discarded|0|||
128038639|NCT00829244|460770714|FG001|Overall Study|All embryos discarded|3|||
128038640|NCT00829244|460770713|FG000|Overall Study|No embryo cleavage|0|||
128038641|NCT00829244|460770714|FG001|Overall Study|No embryo cleavage|2|||
128038642|NCT02604511|460770715|FG000|Overall Study|Adverse Event|3|||
128038643|NCT02604511|460770715|FG000|Overall Study|Disease Progression|4|||
128038644|NCT02604511|460770715|FG000|Overall Study|Withdrawal by Subject|3|||
128038645|NCT02604511|460770715|FG000|Overall Study|Participant ineligible|1|||
127600875|NCT01129960|459167106|FG002|Overall Study|Adverse Event|16|||
128038646|NCT02604511|460770715|FG000|Overall Study|Intercurrent illness|1|||
128038647|NCT03770286|460770716|FG000|Overall Study|Lost to Follow-up|6|||
127600876|NCT01129960|459167107|FG003|Overall Study|Adverse Event|7|||
128038648|NCT03770286|460770717|FG001|Overall Study|Lost to Follow-up|4|||
128038649|NCT03770286|460770718|FG002|Overall Study|Lost to Follow-up|3|||
128038650|NCT03770286|460770716|FG000|Overall Study|Protocol Violation|1|||
128038651|NCT03770286|460770717|FG001|Overall Study|Protocol Violation|0|||
128038652|NCT03770286|460770718|FG002|Overall Study|Protocol Violation|2|||
127600877|NCT01129960|459167104|FG000|Overall Study|Protocol Violation|1|||
128038653|NCT02505425|460770719|FG000|Overall Study|Lost to Follow-up|41|||
128038654|NCT02505425|460770720|FG001|Overall Study|Lost to Follow-up|61|||
127696117|NCT05592418|459514856|FG001|Overall Study|Lost to Follow-up|3|||
127696118|NCT05592418|459514855|FG000|Overall Study|Withdrawal by Subject|2|||
127696119|NCT05592418|459514856|FG001|Overall Study|Withdrawal by Subject|7|||
127696120|NCT03110315|459514859|FG000|Overall Study|Withdrawal by Subject|1|||
127696121|NCT03110315|459514860|FG001|Overall Study|Withdrawal by Subject|0|||
127696122|NCT04727554|459514866|FG000|Overall Study|Lost to Follow-up|0|||
127696123|NCT04727554|459514867|FG001|Overall Study|Lost to Follow-up|1|||
127696124|NCT04727554|459514866|FG000|Overall Study|Death|2|||
127696125|NCT04727554|459514867|FG001|Overall Study|Death|6|||
127696126|NCT04727554|459514866|FG000|Overall Study|Withdrawal by Subject|1|||
127696127|NCT04727554|459514867|FG001|Overall Study|Withdrawal by Subject|0|||
127696128|NCT04150718|459515914|FG000|Overall Study|Withdrawal by Subject|2|||
127696129|NCT04150718|459515915|FG001|Overall Study|Withdrawal by Subject|7|||
127696130|NCT04150718|459515916|FG002|Overall Study|Withdrawal by Subject|1|||
127696131|NCT04150718|459515914|FG000|Overall Study|Lost to Follow-up|1|||
127696132|NCT04150718|459515915|FG001|Overall Study|Lost to Follow-up|2|||
127696133|NCT04150718|459515916|FG002|Overall Study|Lost to Follow-up|0|||
127696134|NCT04150718|459515914|FG000|Overall Study|Ineligible|1|||
127882773|NCT00817778|460194548|FG000|Overall Study|Study-specific discontinuation criteria|0|||
127882774|NCT00817778|460194549|FG001|Overall Study|Study-specific discontinuation criteria|1|||
127882775|NCT00817778|460194548|FG000|Overall Study|Poor venous access|1|||
127882776|NCT00817778|460194549|FG001|Overall Study|Poor venous access|0|||
127882777|NCT02360397|460194551|FG000|Overall Study|Incomplete screening|3|||
127882778|NCT02360397|460194551|FG000|Overall Study|Adverse Event|1|||
127882779|NCT01537549|460194552|FG000|Overall Study|Lost to Follow-up|1|||
127882780|NCT01537549|460194552|FG000|Overall Study|Withdrawal by Subject|2|||
127882781|NCT01286207|460194555|FG000|Overall Study|Adverse Event|27|||
127882782|NCT01286207|460194556|FG001|Overall Study|Adverse Event|41|||
127882783|NCT01286207|460194557|FG002|Overall Study|Adverse Event|8|||
127882784|NCT01286207|460194555|FG000|Overall Study|Lost to Follow-up|49|||
127882785|NCT01286207|460194556|FG001|Overall Study|Lost to Follow-up|43|||
127882786|NCT01286207|460194557|FG002|Overall Study|Lost to Follow-up|20|||
127882787|NCT01286207|460194555|FG000|Overall Study|Withdrawal by Subject|93|||
127882788|NCT01286207|460194556|FG001|Overall Study|Withdrawal by Subject|79|||
127882789|NCT01286207|460194557|FG002|Overall Study|Withdrawal by Subject|41|||
127882790|NCT01286207|460194555|FG000|Overall Study|Lack of Response|92|||
127882791|NCT01286207|460194556|FG001|Overall Study|Lack of Response|38|||
127882792|NCT01286207|460194557|FG002|Overall Study|Lack of Response|8|||
127882793|NCT01286207|460194555|FG000|Overall Study|Other|37|||
127882794|NCT01286207|460194556|FG001|Overall Study|Other|47|||
127882795|NCT01286207|460194557|FG002|Overall Study|Other|13|||
127882796|NCT01383954|460194558|FG000|Overall Study|Lack of Efficacy|2|||
127696135|NCT04150718|459515915|FG001|Overall Study|Ineligible|0|||
127696136|NCT04150718|459515916|FG002|Overall Study|Ineligible|10|||
127696137|NCT02729311|459515917|FG000|Overall Study|Withdrawal by Subject|8|||
127696138|NCT02729311|459515918|FG001|Overall Study|Withdrawal by Subject|2|||
127696139|NCT04783935|459515931|FG000|Overall Study|Withdrawal by Subject|6|||
127696140|NCT04783935|459515931|FG000|Overall Study|PROGRESSIVE DISEASE|2|||
127696141|NCT04783935|459515931|FG000|Overall Study|PATIENT HAS MOVED AND GOES TO ANOTHER HOSPITAL|1|||
127696142|NCT04783935|459515931|FG000|Overall Study|Lost to Follow-up|3|||
127696143|NCT04783935|459515931|FG000|Overall Study|PROTOCOL NON-COMPLIANCE|1|||
127696144|NCT06074523|459515936|FG000|Overall Study|missing data in one condition, participant failed to fill out all data forms|9|||
127696145|NCT06074523|459515936|FG000|Overall Study|Withdrawal by Subject|1|||
127696146|NCT04956861|459515937|FG000|Overall Study|Withdrawal by Subject|4|||
127882797|NCT01383954|460194558|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
127882798|NCT01383954|460194558|FG000|Overall Study|Adverse Event|1|||
127882799|NCT01383954|460194558|FG000|Overall Study|Reason Not Specified|9|||
127882800|NCT00450177|460194559|FG000|Overall Study|Adverse Event|7|||
127696147|NCT04956861|459515938|FG001|Overall Study|Withdrawal by Subject|4|||
127882801|NCT00450177|460194560|FG001|Overall Study|Adverse Event|4|||
127882802|NCT00450177|460194559|FG000|Overall Study|Withdrawal by Subject|1|||
127882803|NCT00450177|460194560|FG001|Overall Study|Withdrawal by Subject|6|||
127696148|NCT04956861|459515939|FG002|Overall Study|Withdrawal by Subject|2|||
127696149|NCT04956861|459515937|FG000|Overall Study|Physician Decision|4|||
127696150|NCT04956861|459515938|FG001|Overall Study|Physician Decision|5|||
127696151|NCT04956861|459515939|FG002|Overall Study|Physician Decision|1|||
127696152|NCT05337748|459515943|FG000|Overall Study|Withdrawal by Subject|1|||
127696153|NCT05337748|459515944|FG001|Overall Study|Withdrawal by Subject|0|||
127696154|NCT05337748|459515943|FG000|Overall Study|Death|1|||
128038655|NCT02505425|460770721|FG002|Overall Study|Lost to Follow-up|31|||
128038656|NCT02505425|460770722|FG003|Overall Study|Lost to Follow-up|19|||
128038657|NCT02505425|460770719|FG000|Overall Study|Withdrawal by Subject|39|||
128038658|NCT02505425|460770720|FG001|Overall Study|Withdrawal by Subject|9|||
128038659|NCT02505425|460770721|FG002|Overall Study|Withdrawal by Subject|19|||
128038660|NCT02505425|460770722|FG003|Overall Study|Withdrawal by Subject|7|||
128038661|NCT02505425|460770719|FG000|Overall Study|Death|8|||
128038662|NCT02505425|460770720|FG001|Overall Study|Death|12|||
128038663|NCT02505425|460770721|FG002|Overall Study|Death|0|||
128038664|NCT02505425|460770722|FG003|Overall Study|Death|0|||
128038665|NCT02297412|460770723|FG000|Overall Study|Canceled|1|||
128038666|NCT02297412|460770724|FG001|Overall Study|Canceled|1|||
128038667|NCT02031302|460770725|FG000|Overall Study|Death|115|||
128038668|NCT02031302|460770726|FG001|Overall Study|Death|0|||
128038669|NCT02031302|460770725|FG000|Overall Study|Not treated with study valve system|18|||
128038670|NCT02031302|460770726|FG001|Overall Study|Not treated with study valve system|0|||
128038671|NCT02031302|460770725|FG000|Overall Study|Missed Follow Up|27|||
128038672|NCT02031302|460770726|FG001|Overall Study|Missed Follow Up|0|||
128038673|NCT02031302|460770725|FG000|Overall Study|Lost to Follow-up|4|||
128038674|NCT02031302|460770726|FG001|Overall Study|Lost to Follow-up|0|||
128038675|NCT02781558|460770730|FG000|Overall Study|Lost to Follow-up|2|||
128038676|NCT02781558|460770731|FG001|Overall Study|Lost to Follow-up|2|||
128038677|NCT02781558|460770730|FG000|Overall Study|Adverse Event|1|||
128038678|NCT02781558|460770731|FG001|Overall Study|Adverse Event|0|||
128038679|NCT04712669|460770732|FG000|Double Blind Phase|Adverse Event|4|||
128038680|NCT04712669|460770733|FG001|Double Blind Phase|Adverse Event|4|||
128038681|NCT04712669|460770734|FG002|Double Blind Phase|Adverse Event|3|||
128038682|NCT04712669|460770735|FG003|Double Blind Phase|Adverse Event|0|||
128038683|NCT04712669|460770736|FG004|Double Blind Phase|Adverse Event|0|||
128038684|NCT04712669|460770737|FG005|Double Blind Phase|Adverse Event|0|||
128038685|NCT04712669|460770738|FG006|Double Blind Phase|Adverse Event|0|||
128038686|NCT04712669|460770739|FG007|Double Blind Phase|Adverse Event|0|||
128038687|NCT04712669|460770732|FG000|Double Blind Phase|Physician Decision|1|||
128038688|NCT04712669|460770733|FG001|Double Blind Phase|Physician Decision|0|||
128038689|NCT04712669|460770734|FG002|Double Blind Phase|Physician Decision|0|||
127600878|NCT01129960|459167105|FG001|Overall Study|Protocol Violation|2|||
127600879|NCT01129960|459167106|FG002|Overall Study|Protocol Violation|3|||
127600880|NCT01129960|459167107|FG003|Overall Study|Protocol Violation|0|||
127600881|NCT01129960|459167104|FG000|Overall Study|Lost to Follow-up|0|||
127600882|NCT01129960|459167105|FG001|Overall Study|Lost to Follow-up|2|||
127600883|NCT01129960|459167106|FG002|Overall Study|Lost to Follow-up|3|||
127600884|NCT01129960|459167107|FG003|Overall Study|Lost to Follow-up|3|||
128038690|NCT04712669|460770735|FG003|Double Blind Phase|Physician Decision|0|||
128038691|NCT04712669|460770736|FG004|Double Blind Phase|Physician Decision|0|||
127696155|NCT05337748|459515944|FG001|Overall Study|Death|0|||
127696156|NCT04806594|459515945|FG000|Overall Study|Withdrawal by Subject|2|||
128038692|NCT04712669|460770737|FG005|Double Blind Phase|Physician Decision|0|||
128038693|NCT04712669|460770738|FG006|Double Blind Phase|Physician Decision|0|||
128038694|NCT04712669|460770739|FG007|Double Blind Phase|Physician Decision|0|||
128038695|NCT04712669|460770732|FG000|Double Blind Phase|Withdrawal by Subject|3|||
127600885|NCT01129960|459167104|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
127600886|NCT01129960|459167105|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
127696157|NCT04806594|459515945|FG000|Overall Study|Did never apply the study product and did not attend following visits.|1|||
127696158|NCT02543281|459515946|FG000|Overall Study|Lost to Follow-up|0|||
127696159|NCT02543281|459515947|FG001|Overall Study|Lost to Follow-up|0|||
127696160|NCT02543281|459515948|FG002|Overall Study|Lost to Follow-up|1|||
127696161|NCT03143153|459515949|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
127696162|NCT03143153|459515950|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
127696163|NCT03143153|459515951|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
127696164|NCT03143153|459515949|FG000|Pre-Treatment|Participant withdrew consent|0|||
127696165|NCT03143153|459515950|FG001|Pre-Treatment|Participant withdrew consent|1|||
127696166|NCT03143153|459515951|FG002|Pre-Treatment|Participant withdrew consent|12|||
127696167|NCT03143153|459515949|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
127696168|NCT03143153|459515950|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
127696169|NCT03143153|459515951|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
127696170|NCT03143153|459515949|FG000|Pre-Treatment|Other Reasons|1|||
127696171|NCT03143153|459515950|FG001|Pre-Treatment|Other Reasons|2|||
127788105|NCT01438489|459849892|FG000|Overall Study|Lost to Follow-up|4|||
127788106|NCT01438489|459849893|FG001|Overall Study|Lost to Follow-up|2|||
127696172|NCT03143153|459515951|FG002|Pre-Treatment|Other Reasons|1|||
127696173|NCT03143153|459515949|FG000|Pre-Treatment|Disease Progression|1|||
127788107|NCT01438489|459849894|FG002|Overall Study|Lost to Follow-up|2|||
127788108|NCT01438489|459849892|FG000|Overall Study|Withdrawal by Subject|11|||
127788109|NCT01438489|459849893|FG001|Overall Study|Withdrawal by Subject|3|||
128038696|NCT04712669|460770733|FG001|Double Blind Phase|Withdrawal by Subject|6|||
127696174|NCT03143153|459515950|FG001|Pre-Treatment|Disease Progression|1|||
128038697|NCT04712669|460770734|FG002|Double Blind Phase|Withdrawal by Subject|0|||
128038698|NCT04712669|460770735|FG003|Double Blind Phase|Withdrawal by Subject|0|||
128038699|NCT04712669|460770736|FG004|Double Blind Phase|Withdrawal by Subject|0|||
128038700|NCT04712669|460770737|FG005|Double Blind Phase|Withdrawal by Subject|0|||
128038701|NCT04712669|460770738|FG006|Double Blind Phase|Withdrawal by Subject|0|||
128038702|NCT04712669|460770739|FG007|Double Blind Phase|Withdrawal by Subject|0|||
128038703|NCT04712669|460770732|FG000|Double Blind Phase|Termination by Sponsor|0|||
128038704|NCT04712669|460770733|FG001|Double Blind Phase|Termination by Sponsor|0|||
128038705|NCT04712669|460770734|FG002|Double Blind Phase|Termination by Sponsor|1|||
128038706|NCT04712669|460770735|FG003|Double Blind Phase|Termination by Sponsor|0|||
128038707|NCT04712669|460770736|FG004|Double Blind Phase|Termination by Sponsor|0|||
128038708|NCT04712669|460770737|FG005|Double Blind Phase|Termination by Sponsor|0|||
128038709|NCT04712669|460770738|FG006|Double Blind Phase|Termination by Sponsor|0|||
128038710|NCT04712669|460770739|FG007|Double Blind Phase|Termination by Sponsor|0|||
128038711|NCT04712669|460770732|FG000|Open Label Phase|Adverse Event|0|||
128038712|NCT04712669|460770733|FG001|Open Label Phase|Adverse Event|0|||
128038713|NCT04712669|460770734|FG002|Open Label Phase|Adverse Event|0|||
128038714|NCT04712669|460770735|FG003|Open Label Phase|Adverse Event|1|||
128038715|NCT04712669|460770736|FG004|Open Label Phase|Adverse Event|1|||
128038716|NCT04712669|460770737|FG005|Open Label Phase|Adverse Event|3|||
128038717|NCT04712669|460770738|FG006|Open Label Phase|Adverse Event|1|||
128038718|NCT04712669|460770739|FG007|Open Label Phase|Adverse Event|2|||
128038719|NCT04712669|460770732|FG000|Open Label Phase|Death|0|||
128038720|NCT04712669|460770733|FG001|Open Label Phase|Death|0|||
128038721|NCT04712669|460770734|FG002|Open Label Phase|Death|0|||
128038722|NCT04712669|460770735|FG003|Open Label Phase|Death|1|||
128038723|NCT04712669|460770736|FG004|Open Label Phase|Death|0|||
128038724|NCT04712669|460770737|FG005|Open Label Phase|Death|0|||
128038725|NCT04712669|460770738|FG006|Open Label Phase|Death|0|||
128038726|NCT04712669|460770739|FG007|Open Label Phase|Death|0|||
128038727|NCT04712669|460770732|FG000|Open Label Phase|Lack of Efficacy|0|||
128038728|NCT04712669|460770733|FG001|Open Label Phase|Lack of Efficacy|0|||
128038729|NCT04712669|460770734|FG002|Open Label Phase|Lack of Efficacy|0|||
128038730|NCT04712669|460770735|FG003|Open Label Phase|Lack of Efficacy|0|||
128038731|NCT04712669|460770736|FG004|Open Label Phase|Lack of Efficacy|1|||
128038732|NCT04712669|460770737|FG005|Open Label Phase|Lack of Efficacy|0|||
128038733|NCT04712669|460770738|FG006|Open Label Phase|Lack of Efficacy|0|||
128038734|NCT04712669|460770739|FG007|Open Label Phase|Lack of Efficacy|0|||
128038735|NCT04712669|460770732|FG000|Open Label Phase|Lost to Follow-up|0|||
128038736|NCT04712669|460770733|FG001|Open Label Phase|Lost to Follow-up|0|||
128038737|NCT04712669|460770734|FG002|Open Label Phase|Lost to Follow-up|0|||
128038738|NCT04712669|460770735|FG003|Open Label Phase|Lost to Follow-up|0|||
128038739|NCT04712669|460770736|FG004|Open Label Phase|Lost to Follow-up|0|||
128038740|NCT04712669|460770737|FG005|Open Label Phase|Lost to Follow-up|0|||
128038741|NCT04712669|460770738|FG006|Open Label Phase|Lost to Follow-up|1|||
128038742|NCT04712669|460770739|FG007|Open Label Phase|Lost to Follow-up|1|||
128038743|NCT04712669|460770732|FG000|Open Label Phase|Physician Decision|0|||
128038744|NCT04712669|460770733|FG001|Open Label Phase|Physician Decision|0|||
128038745|NCT04712669|460770734|FG002|Open Label Phase|Physician Decision|0|||
128038746|NCT04712669|460770735|FG003|Open Label Phase|Physician Decision|1|||
128038747|NCT04712669|460770736|FG004|Open Label Phase|Physician Decision|0|||
128038748|NCT04712669|460770737|FG005|Open Label Phase|Physician Decision|0|||
128038749|NCT04712669|460770738|FG006|Open Label Phase|Physician Decision|0|||
128038750|NCT04712669|460770739|FG007|Open Label Phase|Physician Decision|0|||
128038751|NCT04712669|460770732|FG000|Open Label Phase|Withdrawal by Subject|0|||
128038752|NCT04712669|460770733|FG001|Open Label Phase|Withdrawal by Subject|0|||
128038753|NCT04712669|460770734|FG002|Open Label Phase|Withdrawal by Subject|0|||
128038754|NCT04712669|460770735|FG003|Open Label Phase|Withdrawal by Subject|1|||
127600887|NCT01129960|459167106|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
127788110|NCT01438489|459849894|FG002|Overall Study|Withdrawal by Subject|8|||
127788111|NCT01438489|459849892|FG000|Overall Study|Death|0|||
127788112|NCT01438489|459849893|FG001|Overall Study|Death|0|||
127600888|NCT01129960|459167107|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
127600889|NCT01129960|459167104|FG000|Overall Study|Physician Decision|1|||
127600890|NCT01129960|459167105|FG001|Overall Study|Physician Decision|0|||
127788113|NCT01438489|459849894|FG002|Overall Study|Death|1|||
128038755|NCT04712669|460770736|FG004|Open Label Phase|Withdrawal by Subject|5|||
128038756|NCT04712669|460770737|FG005|Open Label Phase|Withdrawal by Subject|5|||
128038757|NCT04712669|460770738|FG006|Open Label Phase|Withdrawal by Subject|0|||
128038758|NCT04712669|460770739|FG007|Open Label Phase|Withdrawal by Subject|4|||
128038759|NCT04712669|460770732|FG000|Open Label Phase|Termination by Sponsor|0|||
128038760|NCT04712669|460770733|FG001|Open Label Phase|Termination by Sponsor|0|||
128038761|NCT04712669|460770734|FG002|Open Label Phase|Termination by Sponsor|0|||
128038762|NCT04712669|460770735|FG003|Open Label Phase|Termination by Sponsor|11|||
128038763|NCT04712669|460770736|FG004|Open Label Phase|Termination by Sponsor|9|||
128038764|NCT04712669|460770737|FG005|Open Label Phase|Termination by Sponsor|14|||
128038765|NCT04712669|460770738|FG006|Open Label Phase|Termination by Sponsor|0|||
128038766|NCT04712669|460770739|FG007|Open Label Phase|Termination by Sponsor|14|||
127882804|NCT00450177|460194559|FG000|Overall Study|Withdrawal by Primary Team|1|||
127882805|NCT00450177|460194560|FG001|Overall Study|Withdrawal by Primary Team|1|||
127882806|NCT00763269|460194563|FG000|Overall Study|Lost to Follow-up|12|||
127882807|NCT00763269|460194564|FG001|Overall Study|Lost to Follow-up|13|||
127882808|NCT04056299|460194572|FG000|Overall Study|Sponsor discontinued study|3|||
127882809|NCT04056299|460194573|FG001|Overall Study|Sponsor discontinued study|3|||
127882810|NCT03174925|460194576|FG000|Overall Study|Elastographic images not retrievable|2|||
127882811|NCT03174925|460194576|FG000|Overall Study|Elastography image not interpretable|1|||
127882812|NCT04247594|460194579|FG000|Overall Study|Withdrawal by Subject|4|||
127882813|NCT00589693|460194585|FG000|Overall Study|randomized in error|12|||
127882814|NCT00589693|460194586|FG001|Overall Study|randomized in error|6|||
127600891|NCT01129960|459167106|FG002|Overall Study|Physician Decision|0|||
127600892|NCT01129960|459167107|FG003|Overall Study|Physician Decision|0|||
127600893|NCT01129960|459167104|FG000|Overall Study|Pregnancy|1|||
127600894|NCT01129960|459167105|FG001|Overall Study|Pregnancy|0|||
127600895|NCT01129960|459167106|FG002|Overall Study|Pregnancy|0|||
127600896|NCT01129960|459167107|FG003|Overall Study|Pregnancy|0|||
127600897|NCT00165776|459167108|FG000|Overall Study|Lack of Efficacy|0|||
127600898|NCT00165776|459167109|FG001|Overall Study|Lack of Efficacy|0|||
127600899|NCT00165776|459167110|FG002|Overall Study|Lack of Efficacy|0|||
127600900|NCT00165776|459167111|FG003|Overall Study|Lack of Efficacy|1|||
127600901|NCT00165776|459167108|FG000|Overall Study|Withdrawal by Subject|4|||
127600902|NCT00165776|459167109|FG001|Overall Study|Withdrawal by Subject|1|||
127600903|NCT00165776|459167110|FG002|Overall Study|Withdrawal by Subject|2|||
127600904|NCT00165776|459167111|FG003|Overall Study|Withdrawal by Subject|0|||
127882815|NCT00589693|460194585|FG000|Overall Study|Adverse Event|4|||
127882816|NCT00589693|460194586|FG001|Overall Study|Adverse Event|4|||
127882817|NCT00589693|460194585|FG000|Overall Study|Death|26|||
127696175|NCT03143153|459515951|FG002|Pre-Treatment|Disease Progression|2|||
127696176|NCT03143153|459515949|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
127696177|NCT03143153|459515950|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
127696178|NCT03143153|459515951|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
127696179|NCT03143153|459515949|FG000|Treatment|Disease progression|174|||
127882818|NCT00589693|460194586|FG001|Overall Study|Death|16|||
127882819|NCT00589693|460194585|FG000|Overall Study|Lack of Efficacy|0|||
127882820|NCT00589693|460194586|FG001|Overall Study|Lack of Efficacy|1|||
127882821|NCT00589693|460194585|FG000|Overall Study|Lost to Follow-up|1|||
127882822|NCT00589693|460194586|FG001|Overall Study|Lost to Follow-up|0|||
127882823|NCT00589693|460194585|FG000|Overall Study|Physician Decision|0|||
127882824|NCT00589693|460194586|FG001|Overall Study|Physician Decision|1|||
127882825|NCT00589693|460194585|FG000|Overall Study|Protocol Violation|1|||
127882826|NCT00589693|460194586|FG001|Overall Study|Protocol Violation|1|||
127882827|NCT03231709|460194587|FG000|Treatment Period 1|Reason not Specified|0|||
127882828|NCT03231709|460194588|FG001|Treatment Period 1|Reason not Specified|1|||
128038767|NCT03802396|460770740|FG000|Overall Study|Withdrawal by Subject|2|||
128038768|NCT03802396|460770741|FG001|Overall Study|Withdrawal by Subject|0|||
128038769|NCT03802396|460770740|FG000|Overall Study|Surgery Cancelled|1|||
128038770|NCT03802396|460770741|FG001|Overall Study|Surgery Cancelled|0|||
128038771|NCT01150357|460770745|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
128038772|NCT01150357|460770746|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
128038773|NCT01150357|460770747|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
128038774|NCT01150357|460770745|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
128038775|NCT01150357|460770746|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
128038776|NCT01150357|460770747|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
128038777|NCT01150357|460770745|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
128038778|NCT01150357|460770746|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
128038779|NCT01150357|460770747|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
128038780|NCT01150357|460770745|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
128038781|NCT01150357|460770746|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
128038782|NCT01150357|460770747|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
128038783|NCT01150357|460770745|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
128038784|NCT01150357|460770746|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
128038785|NCT01150357|460770747|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
128038786|NCT01150357|460770745|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
127600905|NCT00165776|459167108|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
127600906|NCT00165776|459167109|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
127600907|NCT00165776|459167110|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
127600908|NCT00165776|459167111|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
127696180|NCT03143153|459515950|FG001|Treatment|Disease progression|184|||
127882829|NCT03231709|460194587|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
128038787|NCT01150357|460770746|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
128038788|NCT01150357|460770747|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
128038789|NCT01150357|460770745|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
128038790|NCT01150357|460770746|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
127600909|NCT02622321|459167114|FG000|Overall Study|Withdrawal by Subject|2|||
127600910|NCT02622321|459167115|FG001|Overall Study|Withdrawal by Subject|0|||
127600911|NCT02622321|459167116|FG002|Overall Study|Withdrawal by Subject|0|||
127600912|NCT02622321|459167117|FG003|Overall Study|Withdrawal by Subject|0|||
127600913|NCT02622321|459167114|FG000|Overall Study|Death|0|||
127600914|NCT02622321|459167115|FG001|Overall Study|Death|0|||
127600915|NCT02622321|459167116|FG002|Overall Study|Death|1|||
127600916|NCT02622321|459167117|FG003|Overall Study|Death|0|||
127600917|NCT02622321|459167114|FG000|Overall Study|Physician Decision|1|||
127600918|NCT02622321|459167115|FG001|Overall Study|Physician Decision|0|||
127600919|NCT02622321|459167116|FG002|Overall Study|Physician Decision|0|||
127600920|NCT02622321|459167117|FG003|Overall Study|Physician Decision|0|||
127600921|NCT01958008|459167119|FG000|Overall Study|Worsening of disease under study|0|||
127600922|NCT01958008|459167120|FG001|Overall Study|Worsening of disease under study|0|||
127600923|NCT01958008|459167121|FG002|Overall Study|Worsening of disease under study|1|||
127600924|NCT01958008|459167122|FG003|Overall Study|Worsening of disease under study|0|||
127600925|NCT01958008|459167119|FG000|Overall Study|Other adverse event|1|||
127600926|NCT01958008|459167120|FG001|Overall Study|Other adverse event|0|||
127600927|NCT01958008|459167121|FG002|Overall Study|Other adverse event|0|||
127600928|NCT01958008|459167122|FG003|Overall Study|Other adverse event|0|||
127600929|NCT00241280|459167123|FG000|Overall Study|Adverse Event|2|||
127600930|NCT00241280|459167124|FG001|Overall Study|Adverse Event|6|||
127600931|NCT00241280|459167123|FG000|Overall Study|Discomfort|11|||
127600932|NCT00241280|459167124|FG001|Overall Study|Discomfort|16|||
127600933|NCT00241280|459167123|FG000|Overall Study|Pregnancy|1|||
127600934|NCT00241280|459167124|FG001|Overall Study|Pregnancy|5|||
127600935|NCT00241280|459167123|FG000|Overall Study|Lost to Follow-up|5|||
127600936|NCT00241280|459167124|FG001|Overall Study|Lost to Follow-up|8|||
127600937|NCT00241280|459167123|FG000|Overall Study|Withdrawal by Subject|7|||
127600938|NCT00241280|459167124|FG001|Overall Study|Withdrawal by Subject|4|||
127600939|NCT00241280|459167123|FG000|Overall Study|Protocol Violation|4|||
127600940|NCT00241280|459167124|FG001|Overall Study|Protocol Violation|10|||
127600941|NCT00241280|459167123|FG000|Overall Study|Relocation|4|||
127600942|NCT00241280|459167124|FG001|Overall Study|Relocation|4|||
127600943|NCT00241280|459167123|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
127600944|NCT00241280|459167124|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
127600945|NCT00241280|459167123|FG000|Overall Study|Unsatisfactory Visual Response|1|||
127600946|NCT00241280|459167124|FG001|Overall Study|Unsatisfactory Visual Response|1|||
127600947|NCT00241280|459167123|FG000|Overall Study|Diabetic|1|||
127600948|NCT00241280|459167124|FG001|Overall Study|Diabetic|0|||
127600949|NCT00241280|459167123|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
127788114|NCT01438489|459849892|FG000|Overall Study|Sponsor decision|4|||
127788115|NCT01438489|459849893|FG001|Overall Study|Sponsor decision|1|||
127788116|NCT01438489|459849894|FG002|Overall Study|Sponsor decision|4|||
127788117|NCT01438489|459849892|FG000|Overall Study|Subject choice/Subject moved|2|||
127788118|NCT01438489|459849893|FG001|Overall Study|Subject choice/Subject moved|1|||
127788119|NCT01438489|459849894|FG002|Overall Study|Subject choice/Subject moved|1|||
128038791|NCT01150357|460770747|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
128038792|NCT01978145|460772152|FG000|Treatment Period 1|Adverse Event|1|||
128038793|NCT01978145|460772153|FG001|Treatment Period 1|Adverse Event|9|||
128038794|NCT01978145|460772152|FG000|Treatment Period 1|Physician Decision|1|||
128038795|NCT01978145|460772153|FG001|Treatment Period 1|Physician Decision|0|||
128038796|NCT01978145|460772152|FG000|Treatment Period 1|Withdrawal by Subject|5|||
128038797|NCT01978145|460772153|FG001|Treatment Period 1|Withdrawal by Subject|4|||
128038798|NCT01978145|460772152|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
128038799|NCT01978145|460772153|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
128038800|NCT01978145|460772152|FG000|Washout Period 1|Adverse Event|0|||
128038801|NCT01978145|460772153|FG001|Washout Period 1|Adverse Event|1|||
128038802|NCT01978145|460772152|FG000|Washout Period 1|Withdrawal by Subject|1|||
128038803|NCT01978145|460772153|FG001|Washout Period 1|Withdrawal by Subject|1|||
128038804|NCT01978145|460772152|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
128038805|NCT01978145|460772153|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
127788120|NCT01438489|459849892|FG000|Overall Study|Investigator decision|0|||
127788121|NCT01438489|459849893|FG001|Overall Study|Investigator decision|1|||
127600950|NCT00241280|459167124|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
127600951|NCT00241280|459167123|FG000|Overall Study|Dispensed incorrect test article|1|||
127600952|NCT00241280|459167124|FG001|Overall Study|Dispensed incorrect test article|2|||
127600953|NCT00241280|459167123|FG000|Overall Study|Unacceptable Fit|0|||
127600954|NCT00241280|459167124|FG001|Overall Study|Unacceptable Fit|1|||
127600955|NCT00241280|459167123|FG000|Overall Study|Scheduling Conflict|0|||
127600956|NCT00241280|459167124|FG001|Overall Study|Scheduling Conflict|2|||
127600957|NCT00241280|459167123|FG000|Overall Study|History of Ocular Surgery|0|||
127600958|NCT00241280|459167124|FG001|Overall Study|History of Ocular Surgery|1|||
127788122|NCT01438489|459849894|FG002|Overall Study|Investigator decision|0|||
128038806|NCT01978145|460772152|FG000|Treatment Period 2|Adverse Event|3|||
128038807|NCT01978145|460772153|FG001|Treatment Period 2|Adverse Event|3|||
128038808|NCT01978145|460772152|FG000|Treatment Period 2|Protocol Violation|0|||
127696181|NCT03143153|459515951|FG002|Treatment|Disease progression|193|||
127696182|NCT03143153|459515949|FG000|Treatment|Study drug toxicity|59|||
127696183|NCT03143153|459515950|FG001|Treatment|Study drug toxicity|33|||
127696184|NCT03143153|459515951|FG002|Treatment|Study drug toxicity|40|||
127696185|NCT03143153|459515949|FG000|Treatment|Death|5|||
127696186|NCT03143153|459515950|FG001|Treatment|Death|3|||
127696187|NCT03143153|459515951|FG002|Treatment|Death|4|||
127696188|NCT03143153|459515949|FG000|Treatment|Adverse event unrelated to study drug|19|||
127696189|NCT03143153|459515950|FG001|Treatment|Adverse event unrelated to study drug|28|||
127788123|NCT01438489|459849892|FG000|Overall Study|AE/SAEs|2|||
127788124|NCT01438489|459849893|FG001|Overall Study|AE/SAEs|1|||
127788125|NCT01438489|459849894|FG002|Overall Study|AE/SAEs|1|||
127788126|NCT01438489|459849892|FG000|Overall Study|Received prohibited medication|1|||
127788127|NCT01438489|459849893|FG001|Overall Study|Received prohibited medication|0|||
127788128|NCT01438489|459849894|FG002|Overall Study|Received prohibited medication|0|||
127788129|NCT01438489|459849892|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
127788130|NCT01438489|459849893|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
127788131|NCT01438489|459849894|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
127696190|NCT03143153|459515951|FG002|Treatment|Adverse event unrelated to study drug|12|||
127696191|NCT03143153|459515949|FG000|Treatment|Participant request to discontinue study treatment|13|||
127696192|NCT03143153|459515950|FG001|Treatment|Participant request to discontinue study treatment|15|||
127788132|NCT01438489|459849892|FG000|Overall Study|Inadequate venous access|0|||
127696193|NCT03143153|459515951|FG002|Treatment|Participant request to discontinue study treatment|20|||
127696194|NCT03143153|459515949|FG000|Treatment|Participant withdrew consent|3|||
127600959|NCT00241280|459167123|FG000|Overall Study|Coating on Lens|1|||
127600960|NCT00241280|459167124|FG001|Overall Study|Coating on Lens|0|||
127600961|NCT00241280|459167123|FG000|Overall Study|Excessive Dryness|0|||
127600962|NCT00241280|459167124|FG001|Overall Study|Excessive Dryness|1|||
127600963|NCT00965718|459167126|FG000|Overall Study|Withdrawal by Subject|4|||
127600964|NCT01634360|459167127|FG000|Overall Study|Adverse Event|10|||
127600965|NCT01634360|459167128|FG001|Overall Study|Adverse Event|34|||
127600966|NCT01634360|459167127|FG000|Overall Study|subject withdrew consent|13|||
127600967|NCT01634360|459167128|FG001|Overall Study|subject withdrew consent|23|||
127600968|NCT01634360|459167127|FG000|Overall Study|Protocol Violation|1|||
127600969|NCT01634360|459167128|FG001|Overall Study|Protocol Violation|1|||
127600970|NCT01634360|459167127|FG000|Overall Study|Lack of Efficacy|4|||
127600971|NCT01634360|459167128|FG001|Overall Study|Lack of Efficacy|14|||
127600972|NCT01634360|459167127|FG000|Overall Study|Other|3|||
127600973|NCT01634360|459167128|FG001|Overall Study|Other|20|||
127600974|NCT01634360|459167127|FG000|Overall Study|Study termination by sponsor|18|||
127600975|NCT01634360|459167128|FG001|Overall Study|Study termination by sponsor|44|||
127600976|NCT02028065|459167129|FG000|Randomization Through Start Treatment|Not treated|1|||
127600977|NCT02028065|459167130|FG001|Randomization Through Start Treatment|Not treated|3|||
127600978|NCT02028065|459167131|FG002|Randomization Through Start Treatment|Not treated|3|||
127600979|NCT02028065|459167129|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
127600980|NCT02028065|459167130|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
127600981|NCT02028065|459167131|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
127600982|NCT02028065|459167129|FG000|Treatment Through Study Completion|Physician Decision|1|||
127600983|NCT02028065|459167130|FG001|Treatment Through Study Completion|Physician Decision|0|||
127600984|NCT02028065|459167131|FG002|Treatment Through Study Completion|Physician Decision|0|||
127600985|NCT02028065|459167129|FG000|Treatment Through Study Completion|Protocol Violation|1|||
127600986|NCT02028065|459167130|FG001|Treatment Through Study Completion|Protocol Violation|4|||
128038809|NCT01978145|460772153|FG001|Treatment Period 2|Protocol Violation|1|||
127600987|NCT02028065|459167131|FG002|Treatment Through Study Completion|Protocol Violation|0|||
127600988|NCT02028065|459167129|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
127600989|NCT02028065|459167130|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
127600990|NCT02028065|459167131|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
127600991|NCT02028065|459167129|FG000|Treatment Through Study Completion|Adverse Event|3|||
127600992|NCT02028065|459167130|FG001|Treatment Through Study Completion|Adverse Event|3|||
127600993|NCT02028065|459167131|FG002|Treatment Through Study Completion|Adverse Event|5|||
127600994|NCT01414855|459167134|FG000|Overall Study|Death|17|||
127600995|NCT01414855|459167134|FG000|Overall Study|Lost to Follow-up|5|||
127600996|NCT01414855|459167134|FG000|Overall Study|Withdrawal by Subject|7|||
127600997|NCT04851314|459167138|FG000|Overall Study|Unable to complete research set-up procedures|0|||
127600998|NCT04851314|459167139|FG001|Overall Study|Unable to complete research set-up procedures|2|||
127600999|NCT04851314|459167138|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
127601000|NCT04851314|459167139|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
127601001|NCT00877383|459167140|FG000|Overall Study|Adverse Event|13|||
127601002|NCT00877383|459167141|FG001|Overall Study|Adverse Event|14|||
127601003|NCT00877383|459167140|FG000|Overall Study|Lost to Follow-up|5|||
127601004|NCT00877383|459167141|FG001|Overall Study|Lost to Follow-up|3|||
127696195|NCT03143153|459515950|FG001|Treatment|Participant withdrew consent|4|||
127696196|NCT03143153|459515951|FG002|Treatment|Participant withdrew consent|12|||
127696197|NCT03143153|459515949|FG000|Treatment|Pregnancy|1|||
127696198|NCT03143153|459515950|FG001|Treatment|Pregnancy|0|||
127696199|NCT03143153|459515951|FG002|Treatment|Pregnancy|0|||
127696200|NCT03143153|459515949|FG000|Treatment|Maximum clinical benefit|1|||
127696201|NCT03143153|459515950|FG001|Treatment|Maximum clinical benefit|3|||
127696202|NCT03143153|459515951|FG002|Treatment|Maximum clinical benefit|4|||
127696203|NCT03143153|459515949|FG000|Treatment|Completed treatment as per Protocol|13|||
127696204|NCT03143153|459515950|FG001|Treatment|Completed treatment as per Protocol|8|||
127696205|NCT03143153|459515951|FG002|Treatment|Completed treatment as per Protocol|0|||
127696206|NCT03143153|459515949|FG000|Treatment|Other reasons|12|||
127696207|NCT03143153|459515950|FG001|Treatment|Other reasons|7|||
127696208|NCT03143153|459515951|FG002|Treatment|Other reasons|15|||
127696209|NCT03143153|459515949|FG000|Treatment|Not reported|1|||
127696210|NCT03143153|459515950|FG001|Treatment|Not reported|0|||
127696211|NCT03143153|459515951|FG002|Treatment|Not reported|0|||
127696212|NCT02312557|459515952|FG000|Overall Study|Survival follow-up|4|||
127696213|NCT04784559|459515955|FG000|Overall Study|Withdrawal by Subject|3|||
127696214|NCT04784559|459515956|FG001|Overall Study|Withdrawal by Subject|2|||
127696215|NCT04784559|459515957|FG002|Overall Study|Withdrawal by Subject|1|||
127696216|NCT04784559|459515955|FG000|Overall Study|Death|2|||
127696217|NCT04784559|459515956|FG001|Overall Study|Death|1|||
127696218|NCT04784559|459515957|FG002|Overall Study|Death|2|||
127696219|NCT04784559|459515955|FG000|Overall Study|Lost to Follow-up|0|||
127696220|NCT04784559|459515956|FG001|Overall Study|Lost to Follow-up|0|||
127696221|NCT04784559|459515957|FG002|Overall Study|Lost to Follow-up|2|||
127696222|NCT04784559|459515955|FG000|Overall Study|Participant worsened, PI decision|1|||
127601005|NCT00877383|459167140|FG000|Overall Study|Subject withdrew consent|3|||
127601006|NCT00877383|459167141|FG001|Overall Study|Subject withdrew consent|12|||
127601007|NCT00877383|459167140|FG000|Overall Study|Subject no longer requires study drug|2|||
127601008|NCT00877383|459167141|FG001|Overall Study|Subject no longer requires study drug|0|||
127601009|NCT00877383|459167140|FG000|Overall Study|Administrative problems|2|||
127601010|NCT00877383|459167141|FG001|Overall Study|Administrative problems|0|||
127601011|NCT00877383|459167140|FG000|Overall Study|Protocol deviation|2|||
127601012|NCT00877383|459167141|FG001|Overall Study|Protocol deviation|6|||
127601013|NCT00877383|459167140|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
127601014|NCT00877383|459167141|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
127601015|NCT00877383|459167140|FG000|Overall Study|Death|1|||
127601016|NCT00877383|459167141|FG001|Overall Study|Death|2|||
127601017|NCT02107482|459167142|FG000|Overall Study|inconveinence|2|||
127601018|NCT02107482|459167142|FG000|Overall Study|Lost to Follow-up|1|||
127601019|NCT02107482|459167142|FG000|Overall Study|Lack of Efficacy|1|||
127601020|NCT04868890|459167149|FG000|Overall Study|Death|2|||
127601021|NCT04868890|459167150|FG001|Overall Study|Death|1|||
127601022|NCT04868890|459167149|FG000|Overall Study|Withdrawal by Subject|1|||
127601023|NCT04868890|459167150|FG001|Overall Study|Withdrawal by Subject|5|||
127601024|NCT00867009|459167151|FG000|Induction Period|Nonserious Adverse Event|5|||
127601025|NCT00867009|459167151|FG000|Induction Period|Serious Adverse Event|10|||
127788133|NCT01438489|459849893|FG001|Overall Study|Inadequate venous access|2|||
127788134|NCT01438489|459849894|FG002|Overall Study|Inadequate venous access|0|||
127788135|NCT00573430|459849897|FG000|Overall Study|Incorrect enrollment of randomization|0|||
127788136|NCT00573430|459849898|FG001|Overall Study|Incorrect enrollment of randomization|4|||
128038810|NCT01978145|460772152|FG000|Treatment Period 2|Lost to Follow-up|1|||
128038811|NCT01978145|460772153|FG001|Treatment Period 2|Lost to Follow-up|1|||
128038812|NCT01978145|460772152|FG000|Treatment Period 2|Withdrawal by Subject|7|||
128038813|NCT01978145|460772153|FG001|Treatment Period 2|Withdrawal by Subject|4|||
128038814|NCT01978145|460772152|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
128038815|NCT01978145|460772153|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
128038816|NCT01250054|460772158|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
128038817|NCT01250054|460772159|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
128038818|NCT02777086|460772160|FG000|Overall Study|Lost to Follow-up|96|||
128038819|NCT02777086|460772161|FG001|Overall Study|Lost to Follow-up|99|||
128038820|NCT01732536|460772164|FG000|Overall Study|Withdrawal by Subject|1|||
128038821|NCT01732536|460772165|FG001|Overall Study|Withdrawal by Subject|1|||
128038822|NCT02122380|460772166|FG000|First Intervention (30 Days)|Adverse Event|1|||
128038823|NCT02122380|460772167|FG001|First Intervention (30 Days)|Adverse Event|0|||
128038824|NCT02122380|460772166|FG000|First Intervention (30 Days)|Physician Decision|0|||
128038825|NCT02122380|460772167|FG001|First Intervention (30 Days)|Physician Decision|1|||
128038826|NCT02122380|460772166|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
128038827|NCT02122380|460772167|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
128038828|NCT02122380|460772166|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
128038829|NCT02122380|460772167|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
128038830|NCT02122380|460772166|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
128038831|NCT02122380|460772167|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
128038832|NCT01581684|460772170|FG000|Overall Study|Other reason not defined|0|||
128038833|NCT01581684|460772171|FG001|Overall Study|Other reason not defined|0|||
128038834|NCT01581684|460772172|FG002|Overall Study|Other reason not defined|0|||
128038835|NCT01581684|460772173|FG003|Overall Study|Other reason not defined|0|||
128038836|NCT01581684|460772174|FG004|Overall Study|Other reason not defined|0|||
128038837|NCT01581684|460772175|FG005|Overall Study|Other reason not defined|0|||
128038838|NCT01581684|460772176|FG006|Overall Study|Other reason not defined|0|||
128038839|NCT01581684|460772177|FG007|Overall Study|Other reason not defined|0|||
128038840|NCT01581684|460772178|FG008|Overall Study|Other reason not defined|1|||
128038841|NCT01581684|460772179|FG009|Overall Study|Other reason not defined|0|||
128038842|NCT03728933|460772180|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
128038843|NCT03728933|460772181|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
128038844|NCT03728933|460772182|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
128038845|NCT03728933|460772180|FG000|Overall Study|Withdrawal by Subject|0|||
128038846|NCT03728933|460772181|FG001|Overall Study|Withdrawal by Subject|0|||
128038847|NCT03728933|460772182|FG002|Overall Study|Withdrawal by Subject|1|||
128038848|NCT03728933|460772180|FG000|Overall Study|Lost to Follow-up|0|||
128038849|NCT03728933|460772181|FG001|Overall Study|Lost to Follow-up|1|||
128038850|NCT03728933|460772182|FG002|Overall Study|Lost to Follow-up|0|||
127601026|NCT00867009|459167151|FG000|Induction Period|Death due to serious adverse event|6|||
127601027|NCT00867009|459167151|FG000|Induction Period|Death due to Study Disease|4|||
127601028|NCT00867009|459167151|FG000|Induction Period|Protocol Violation|1|||
127601029|NCT00867009|459167151|FG000|Induction Period|Withdrawal by Subject|8|||
127788137|NCT00573430|459849899|FG002|Overall Study|Incorrect enrollment of randomization|3|||
128038851|NCT03728933|460772180|FG000|Overall Study|Adverse Event|1|||
128038852|NCT03728933|460772181|FG001|Overall Study|Adverse Event|0|||
128038853|NCT03728933|460772182|FG002|Overall Study|Adverse Event|0|||
128038854|NCT01784029|460772183|FG000|Overall Study|Lost to Follow-up|19|||
128038855|NCT01784029|460772184|FG001|Overall Study|Lost to Follow-up|20|||
128038856|NCT01784029|460772185|FG002|Overall Study|Lost to Follow-up|22|||
128038857|NCT00639457|460772186|FG000|Overall Study|Withdrawal by Subject|2|||
128038858|NCT00639457|460772187|FG001|Overall Study|Withdrawal by Subject|3|||
128038859|NCT03235050|460772188|FG000|Overall Study|Adverse Event|0|||
128038860|NCT03235050|460772189|FG001|Overall Study|Adverse Event|0|||
128038861|NCT03235050|460772190|FG002|Overall Study|Adverse Event|1|||
128038862|NCT03235050|460772191|FG003|Overall Study|Adverse Event|4|||
128038863|NCT03235050|460772192|FG004|Overall Study|Adverse Event|1|||
128038864|NCT03235050|460772188|FG000|Overall Study|Death|0|||
128038865|NCT03235050|460772189|FG001|Overall Study|Death|0|||
128038866|NCT03235050|460772190|FG002|Overall Study|Death|0|||
128038867|NCT03235050|460772191|FG003|Overall Study|Death|2|||
128038868|NCT03235050|460772192|FG004|Overall Study|Death|1|||
128038869|NCT03235050|460772188|FG000|Overall Study|Lost to Follow-up|1|||
128038870|NCT03235050|460772189|FG001|Overall Study|Lost to Follow-up|2|||
128038871|NCT03235050|460772190|FG002|Overall Study|Lost to Follow-up|1|||
128038872|NCT03235050|460772191|FG003|Overall Study|Lost to Follow-up|2|||
128038873|NCT03235050|460772192|FG004|Overall Study|Lost to Follow-up|0|||
128038874|NCT03235050|460772188|FG000|Overall Study|Withdrawal by Subject|3|||
128038875|NCT03235050|460772189|FG001|Overall Study|Withdrawal by Subject|2|||
128038876|NCT03235050|460772190|FG002|Overall Study|Withdrawal by Subject|2|||
128038877|NCT03235050|460772191|FG003|Overall Study|Withdrawal by Subject|5|||
128038878|NCT03235050|460772192|FG004|Overall Study|Withdrawal by Subject|7|||
128038879|NCT03235050|460772188|FG000|Overall Study|Other reasons|0|||
128038880|NCT03235050|460772189|FG001|Overall Study|Other reasons|1|||
128038881|NCT03235050|460772190|FG002|Overall Study|Other reasons|0|||
128038882|NCT03235050|460772191|FG003|Overall Study|Other reasons|1|||
128038883|NCT03235050|460772192|FG004|Overall Study|Other reasons|2|||
128038884|NCT00598650|460772193|FG000|Overall Study|Withdrawal by Subject|3|||
128038885|NCT00598650|460772193|FG000|Overall Study|Adverse Event|18|||
128038886|NCT00598650|460772193|FG000|Overall Study|No treatment for 3 weeks|1|||
128038887|NCT00598650|460772193|FG000|Overall Study|Not eligible|1|||
128038888|NCT00598650|460772193|FG000|Overall Study|Prohibited Concomitant Medication|2|||
128038889|NCT00598650|460772193|FG000|Overall Study|Physician Decision|2|||
128038890|NCT02415556|460772194|FG000|Overall Study|Adverse Event|3|||
128038891|NCT02415556|460772195|FG001|Overall Study|Adverse Event|4|||
128038892|NCT02415556|460772196|FG002|Overall Study|Adverse Event|2|||
128038893|NCT02415556|460772197|FG003|Overall Study|Adverse Event|4|||
128038894|NCT02415556|460772194|FG000|Overall Study|Lost to Follow-up|4|||
128038895|NCT02415556|460772195|FG001|Overall Study|Lost to Follow-up|5|||
128038896|NCT02415556|460772196|FG002|Overall Study|Lost to Follow-up|4|||
128038897|NCT02415556|460772197|FG003|Overall Study|Lost to Follow-up|1|||
128038898|NCT02415556|460772194|FG000|Overall Study|Withdrawal by Subject|13|||
128038899|NCT02415556|460772195|FG001|Overall Study|Withdrawal by Subject|4|||
128038900|NCT02415556|460772196|FG002|Overall Study|Withdrawal by Subject|14|||
128038901|NCT02415556|460772197|FG003|Overall Study|Withdrawal by Subject|12|||
128038902|NCT02415556|460772194|FG000|Overall Study|Physician Decision|1|||
128038903|NCT02415556|460772195|FG001|Overall Study|Physician Decision|3|||
128038904|NCT02415556|460772196|FG002|Overall Study|Physician Decision|1|||
128038905|NCT02415556|460772197|FG003|Overall Study|Physician Decision|2|||
128038906|NCT02415556|460772194|FG000|Overall Study|Censored - study completion|4|||
128038907|NCT02415556|460772195|FG001|Overall Study|Censored - study completion|5|||
127696223|NCT04784559|459515956|FG001|Overall Study|Participant worsened, PI decision|0|||
127696224|NCT04784559|459515957|FG002|Overall Study|Participant worsened, PI decision|0|||
127696225|NCT04784559|459515955|FG000|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|1|||
127696226|NCT04784559|459515956|FG001|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
127696227|NCT04784559|459515957|FG002|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
127696228|NCT04784559|459515955|FG000|Overall Study|Participant admitted in other hospital due to a serious adverse event|1|||
127696229|NCT04784559|459515956|FG001|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
127696230|NCT04784559|459515957|FG002|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
127696231|NCT04784559|459515955|FG000|Overall Study|Did not meet all inclusion criteria|0|||
127788138|NCT00573430|459849897|FG000|Overall Study|Adverse Event|0|||
127788139|NCT00573430|459849898|FG001|Overall Study|Adverse Event|0|||
127788140|NCT00573430|459849899|FG002|Overall Study|Adverse Event|2|||
128038908|NCT02415556|460772196|FG002|Overall Study|Censored - study completion|1|||
128038909|NCT02415556|460772197|FG003|Overall Study|Censored - study completion|0|||
128038910|NCT02415556|460772194|FG000|Overall Study|Family-related issues|0|||
128038911|NCT02415556|460772195|FG001|Overall Study|Family-related issues|0|||
128038912|NCT02415556|460772196|FG002|Overall Study|Family-related issues|0|||
128038913|NCT02415556|460772197|FG003|Overall Study|Family-related issues|1|||
128038914|NCT00105534|460772198|FG000|Overall Study|Adverse Event|2|||
128038915|NCT00105534|460772199|FG001|Overall Study|Adverse Event|5|||
128038916|NCT00105534|460772198|FG000|Overall Study|Protocol Violation|1|||
128038917|NCT00105534|460772199|FG001|Overall Study|Protocol Violation|4|||
127882830|NCT03231709|460194588|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
127601030|NCT00867009|459167151|FG000|Induction Period|Physician Decision|3|||
127601031|NCT00867009|459167151|FG000|Induction Period|Progressive Disease (PD)|25|||
127601032|NCT00867009|459167151|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
127601033|NCT01850524|459167156|FG000|Overall Study|Lost to Follow-up|5|||
127601034|NCT01850524|459167157|FG001|Overall Study|Lost to Follow-up|10|||
127601035|NCT01850524|459167156|FG000|Overall Study|Withdrawal by Subject|24|||
127601036|NCT01850524|459167157|FG001|Overall Study|Withdrawal by Subject|22|||
127601037|NCT01850524|459167156|FG000|Overall Study|Reason not Specified|142|||
127601038|NCT01850524|459167157|FG001|Overall Study|Reason not Specified|141|||
127601039|NCT00368355|459167159|FG000|Overall Study|Adverse Event|1|||
127601040|NCT00368355|459167160|FG001|Overall Study|Adverse Event|0|||
127601041|NCT00368355|459167159|FG000|Overall Study|Death|2|||
127601042|NCT00368355|459167160|FG001|Overall Study|Death|4|||
127601043|NCT00368355|459167159|FG000|Overall Study|Relapse|6|||
127601044|NCT00368355|459167160|FG001|Overall Study|Relapse|10|||
127601045|NCT00368355|459167159|FG000|Overall Study|Subsequent transplant|0|||
127601046|NCT00368355|459167160|FG001|Overall Study|Subsequent transplant|3|||
127601047|NCT00368355|459167159|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
127601048|NCT00368355|459167160|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
127601049|NCT01339429|459167164|FG000|Overall Study|Withdrawal by Subject|1|||
127601050|NCT01339429|459167164|FG000|Overall Study|Physician Decision|3|||
127601051|NCT01085591|459167165|FG000|Overall Study|Adverse Event|0|||
127601052|NCT01085591|459167166|FG001|Overall Study|Adverse Event|1|||
127601053|NCT01085591|459167167|FG002|Overall Study|Adverse Event|3|||
127601054|NCT01085591|459167165|FG000|Overall Study|Physician Decision|1|||
127601055|NCT01085591|459167166|FG001|Overall Study|Physician Decision|0|||
127601056|NCT01085591|459167167|FG002|Overall Study|Physician Decision|1|||
127601057|NCT01085591|459167165|FG000|Overall Study|Withdrawal by Subject|0|||
127601058|NCT01085591|459167166|FG001|Overall Study|Withdrawal by Subject|2|||
127601059|NCT01085591|459167167|FG002|Overall Study|Withdrawal by Subject|1|||
127601060|NCT01085591|459167165|FG000|Overall Study|Lost to Follow-up|0|||
127601061|NCT01085591|459167166|FG001|Overall Study|Lost to Follow-up|1|||
127601062|NCT01085591|459167167|FG002|Overall Study|Lost to Follow-up|1|||
127601063|NCT01085591|459167165|FG000|Overall Study|Protocol Violation|1|||
127601064|NCT01085591|459167166|FG001|Overall Study|Protocol Violation|1|||
127601065|NCT01085591|459167167|FG002|Overall Study|Protocol Violation|1|||
127601066|NCT01085591|459167165|FG000|Overall Study|Other|0|||
127601067|NCT01085591|459167166|FG001|Overall Study|Other|1|||
127601068|NCT01085591|459167167|FG002|Overall Study|Other|0|||
127601069|NCT01085591|459167165|FG000|Overall Study|Not Properly Consented|1|||
127601070|NCT01085591|459167166|FG001|Overall Study|Not Properly Consented|0|||
127601071|NCT01085591|459167167|FG002|Overall Study|Not Properly Consented|0|||
127601072|NCT00459667|459167168|FG000|Overall Study|Adverse Event|9|||
127601073|NCT00459667|459167169|FG001|Overall Study|Adverse Event|12|||
127601074|NCT00459667|459167170|FG002|Overall Study|Adverse Event|8|||
127601075|NCT00459667|459167168|FG000|Overall Study|Lost to Follow-up|5|||
127601076|NCT00459667|459167169|FG001|Overall Study|Lost to Follow-up|9|||
127601077|NCT00459667|459167170|FG002|Overall Study|Lost to Follow-up|3|||
127601078|NCT00459667|459167168|FG000|Overall Study|Pregnancy|1|||
127601079|NCT00459667|459167169|FG001|Overall Study|Pregnancy|1|||
127601080|NCT00459667|459167170|FG002|Overall Study|Pregnancy|1|||
127601081|NCT00459667|459167168|FG000|Overall Study|Protocol Violation|1|||
127601082|NCT00459667|459167169|FG001|Overall Study|Protocol Violation|0|||
127601083|NCT00459667|459167170|FG002|Overall Study|Protocol Violation|0|||
127601084|NCT00459667|459167168|FG000|Overall Study|Withdrawal by Subject|3|||
127601085|NCT00459667|459167169|FG001|Overall Study|Withdrawal by Subject|5|||
127601086|NCT00459667|459167170|FG002|Overall Study|Withdrawal by Subject|5|||
127601087|NCT00459667|459167168|FG000|Overall Study|Other disease modifying treatment|1|||
127601088|NCT00459667|459167169|FG001|Overall Study|Other disease modifying treatment|2|||
127601089|NCT00459667|459167170|FG002|Overall Study|Other disease modifying treatment|1|||
127601090|NCT00459667|459167168|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
127601091|NCT00459667|459167169|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
127601092|NCT00459667|459167170|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
127601093|NCT00459667|459167168|FG000|Overall Study|No treatment administered|6|||
127601094|NCT00459667|459167169|FG001|Overall Study|No treatment administered|3|||
127601095|NCT00459667|459167170|FG002|Overall Study|No treatment administered|1|||
127601096|NCT00396591|459167171|FG000|Overall Study|Disease Progression|13|||
127601097|NCT00396591|459167171|FG000|Overall Study|Adverse Event|2|||
127601098|NCT00396591|459167171|FG000|Overall Study|Participant request|1|||
127601099|NCT04080297|459167172|FG000|Overall Study|Adverse Event|1|||
127601100|NCT04080297|459167173|FG001|Overall Study|Adverse Event|3|||
127788141|NCT00573430|459849897|FG000|Overall Study|Withdrawal by Subject|1|||
128038918|NCT00105534|460772198|FG000|Overall Study|Withdrawal by Subject|6|||
128038919|NCT00105534|460772199|FG001|Overall Study|Withdrawal by Subject|6|||
128038920|NCT00105534|460772198|FG000|Overall Study|Lost to Follow-up|5|||
128038921|NCT00105534|460772199|FG001|Overall Study|Lost to Follow-up|1|||
128038922|NCT00105534|460772198|FG000|Overall Study|Lack of Efficacy|7|||
128038923|NCT00105534|460772199|FG001|Overall Study|Lack of Efficacy|15|||
128038924|NCT00105534|460772198|FG000|Overall Study|Treatment unmasked|1|||
128038925|NCT00105534|460772199|FG001|Overall Study|Treatment unmasked|0|||
127696232|NCT04784559|459515956|FG001|Overall Study|Did not meet all inclusion criteria|1|||
128038926|NCT00105534|460772198|FG000|Overall Study|Other Reason|0|||
128038927|NCT00105534|460772199|FG001|Overall Study|Other Reason|2|||
128038928|NCT01621178|460772200|FG000|Overall Study|Adverse Event|5|||
128038929|NCT01621178|460772201|FG001|Overall Study|Adverse Event|2|||
128038930|NCT01621178|460772202|FG002|Overall Study|Adverse Event|8|||
128038931|NCT01621178|460772200|FG000|Overall Study|Death|6|||
128038932|NCT01621178|460772201|FG001|Overall Study|Death|7|||
128038933|NCT01621178|460772202|FG002|Overall Study|Death|2|||
128038934|NCT01621178|460772200|FG000|Overall Study|Lost to Follow-up|1|||
128038935|NCT01621178|460772201|FG001|Overall Study|Lost to Follow-up|2|||
128038936|NCT01621178|460772202|FG002|Overall Study|Lost to Follow-up|1|||
128038937|NCT01621178|460772200|FG000|Overall Study|Withdrawal by Subject|14|||
128038938|NCT01621178|460772201|FG001|Overall Study|Withdrawal by Subject|17|||
128038939|NCT01621178|460772202|FG002|Overall Study|Withdrawal by Subject|18|||
128038940|NCT01621178|460772200|FG000|Overall Study|Physician Decision|5|||
128038941|NCT01621178|460772201|FG001|Overall Study|Physician Decision|2|||
128038942|NCT01621178|460772202|FG002|Overall Study|Physician Decision|7|||
128038943|NCT02935192|460772203|FG000|Overall Study|Withdrawal by Subject|8|||
128038944|NCT02935192|460772204|FG001|Overall Study|Withdrawal by Subject|4|||
128038945|NCT02896257|460772205|FG000|Providers|Without eligible patients|21|||
127696233|NCT04784559|459515957|FG002|Overall Study|Did not meet all inclusion criteria|0|||
127696234|NCT04784559|459515955|FG000|Overall Study|The participant was transferred to IRCU|0|||
127696235|NCT04784559|459515956|FG001|Overall Study|The participant was transferred to IRCU|1|||
127696236|NCT04784559|459515957|FG002|Overall Study|The participant was transferred to IRCU|0|||
127696237|NCT04784559|459515955|FG000|Overall Study|SAE|0|||
127696238|NCT04784559|459515956|FG001|Overall Study|SAE|1|||
127696239|NCT04784559|459515957|FG002|Overall Study|SAE|0|||
127696240|NCT04784559|459515955|FG000|Overall Study|Discontinued as was found to be ineligible|0|||
127696241|NCT04784559|459515956|FG001|Overall Study|Discontinued as was found to be ineligible|0|||
127696242|NCT04784559|459515957|FG002|Overall Study|Discontinued as was found to be ineligible|1|||
127696243|NCT03436745|459515958|FG000|Overall Study|Ineligible|0|||
127696244|NCT03436745|459515959|FG001|Overall Study|Ineligible|0|||
127696245|NCT03436745|459515960|FG002|Overall Study|Ineligible|1|||
127696246|NCT04021602|459515966|FG000|Overall Study|Lost to Follow-up|3|||
127696247|NCT04021602|459515967|FG001|Overall Study|Lost to Follow-up|3|||
127696248|NCT04021602|459515968|FG002|Overall Study|Lost to Follow-up|1|||
127696249|NCT04021602|459515966|FG000|Overall Study|Adverse Event|1|||
127696250|NCT04021602|459515967|FG001|Overall Study|Adverse Event|0|||
127696251|NCT04021602|459515968|FG002|Overall Study|Adverse Event|1|||
127696252|NCT03443323|459515969|FG000|Overall Study|Lost to Follow-up|2|||
127696253|NCT03443323|459515970|FG001|Overall Study|Lost to Follow-up|2|||
127696254|NCT03443323|459515969|FG000|Overall Study|PI withdrawal|1|||
127696255|NCT03443323|459515970|FG001|Overall Study|PI withdrawal|0|||
127696256|NCT03135548|459515973|FG000|Overall Study|Lost to Follow-up|3|||
127696257|NCT03135548|459515974|FG001|Overall Study|Lost to Follow-up|0|||
127696258|NCT03135548|459515975|FG002|Overall Study|Lost to Follow-up|0|||
127696259|NCT03135548|459515973|FG000|Overall Study|Withdrawal by Subject|2|||
127696260|NCT03135548|459515974|FG001|Overall Study|Withdrawal by Subject|2|||
127696261|NCT03135548|459515975|FG002|Overall Study|Withdrawal by Subject|1|||
127696262|NCT03135548|459515973|FG000|Overall Study|Other than listed|0|||
127696263|NCT03135548|459515974|FG001|Overall Study|Other than listed|2|||
127696264|NCT03135548|459515975|FG002|Overall Study|Other than listed|2|||
127696265|NCT05569252|459515976|FG000|Overall Study|Adverse event (central vision loss)|1|||
127696266|NCT05569252|459515977|FG001|Overall Study|Adverse event (central vision loss)|0|||
127696267|NCT05569252|459515978|FG002|Overall Study|Adverse event (central vision loss)|0|||
127696268|NCT05569252|459515979|FG003|Overall Study|Adverse event (central vision loss)|0|||
127696269|NCT03665597|459515980|FG000|Period 1|Adverse Event|1|||
127696270|NCT03665597|459515981|FG001|Period 1|Adverse Event|0|||
127696271|NCT03665597|459515982|FG002|Period 1|Adverse Event|0|||
127696272|NCT03665597|459515983|FG003|Period 1|Adverse Event|1|||
127696273|NCT03665597|459515984|FG004|Period 1|Adverse Event|0|||
127696274|NCT03665597|459515985|FG005|Period 1|Adverse Event|0|||
127696275|NCT03665597|459515986|FG006|Period 1|Adverse Event|0|||
127696276|NCT03665597|459515980|FG000|Period 1|Screen Failure|0|||
127696277|NCT03665597|459515981|FG001|Period 1|Screen Failure|0|||
128038946|NCT02896257|460772206|FG001|Providers|Without eligible patients|28|||
128038947|NCT02896257|460772205|FG000|Patients|PFT entry criteria not met|43|||
128038948|NCT02896257|460772206|FG001|Patients|PFT entry criteria not met|50|||
128038949|NCT02896257|460772205|FG000|Patients|No capacity to review|8|||
128038950|NCT02896257|460772206|FG001|Patients|No capacity to review|11|||
127601101|NCT04080297|459167172|FG000|Overall Study|concurrent illness|1|||
127601102|NCT04080297|459167173|FG001|Overall Study|concurrent illness|0|||
127601103|NCT00180414|459168853|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
127601104|NCT00180414|459168854|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
127601105|NCT01199289|459168855|FG000|Overall Study|Ineligibility determined|2|||
127601106|NCT01199289|459168856|FG001|Overall Study|Ineligibility determined|1|||
127601107|NCT01199289|459168857|FG002|Overall Study|Ineligibility determined|0|||
127601108|NCT01199289|459168858|FG003|Overall Study|Ineligibility determined|0|||
127601109|NCT01199289|459168855|FG000|Overall Study|Protocol Violation|1|||
127601110|NCT01199289|459168856|FG001|Overall Study|Protocol Violation|0|||
127788142|NCT00573430|459849898|FG001|Overall Study|Withdrawal by Subject|0|||
127788143|NCT00573430|459849899|FG002|Overall Study|Withdrawal by Subject|1|||
127601111|NCT01199289|459168857|FG002|Overall Study|Protocol Violation|0|||
128038951|NCT02896257|460772205|FG000|Patients|Appointment rescheduled/cancelled|5|||
128038952|NCT02896257|460772206|FG001|Patients|Appointment rescheduled/cancelled|7|||
128038953|NCT02896257|460772205|FG000|Patients|PCP not assigned a clinic|4|||
128038954|NCT02896257|460772206|FG001|Patients|PCP not assigned a clinic|0|||
128038955|NCT02896257|460772205|FG000|Patients|No history of COPD|0|||
128038956|NCT02896257|460772206|FG001|Patients|No history of COPD|1|||
128038957|NCT02896257|460772205|FG000|Patients|Deceased between review and index date|0|||
128038958|NCT02896257|460772206|FG001|Patients|Deceased between review and index date|1|||
128038959|NCT02896257|460772205|FG000|Patients|No ICS Rx upon review|1|||
128038960|NCT02896257|460772206|FG001|Patients|No ICS Rx upon review|1|||
128038961|NCT02896257|460772205|FG000|Patients|Protocol Violation|2|||
128038962|NCT02896257|460772206|FG001|Patients|Protocol Violation|1|||
128038963|NCT02896257|460772205|FG000|Patients|Hospice care|0|||
128038964|NCT02896257|460772206|FG001|Patients|Hospice care|1|||
128038965|NCT02465931|460772207|FG000|Overall Study|Lost to Follow-up|9|||
128038966|NCT02465931|460772208|FG001|Overall Study|Lost to Follow-up|11|||
128038967|NCT02465931|460772207|FG000|Overall Study|Protocol Violation|1|||
128038968|NCT02465931|460772208|FG001|Overall Study|Protocol Violation|0|||
128038969|NCT02465931|460772207|FG000|Overall Study|Withdrawal by Subject|1|||
128038970|NCT02465931|460772208|FG001|Overall Study|Withdrawal by Subject|0|||
128038971|NCT00492557|460772209|FG000|Overall Study|Subject request|12|||
128038972|NCT00492557|460772210|FG001|Overall Study|Subject request|11|||
128038973|NCT00492557|460772209|FG000|Overall Study|Protocol Violation|7|||
128038974|NCT00492557|460772210|FG001|Overall Study|Protocol Violation|8|||
128038975|NCT00492557|460772209|FG000|Overall Study|Other|2|||
128038976|NCT00492557|460772210|FG001|Overall Study|Other|2|||
128038977|NCT00492557|460772209|FG000|Overall Study|Death|1|||
128038978|NCT00492557|460772210|FG001|Overall Study|Death|1|||
128038979|NCT00492557|460772209|FG000|Overall Study|Adverse Event|1|||
128038980|NCT00492557|460772210|FG001|Overall Study|Adverse Event|0|||
128038981|NCT00492557|460772209|FG000|Overall Study|Failed to return|1|||
128038982|NCT00492557|460772210|FG001|Overall Study|Failed to return|0|||
128038983|NCT00492557|460772209|FG000|Overall Study|Lost to Follow-up|0|||
128038984|NCT00492557|460772210|FG001|Overall Study|Lost to Follow-up|1|||
128038985|NCT03423121|460772212|FG000|Overall Study|Lost to Follow-up|2|||
128038986|NCT03423121|460772213|FG001|Overall Study|Lost to Follow-up|6|||
128038987|NCT03423121|460772212|FG000|Overall Study|Adverse Event|1|||
128038988|NCT03423121|460772213|FG001|Overall Study|Adverse Event|0|||
128038989|NCT00560508|460772214|FG000|12 Week Double-blind Period|Adverse Event|3|||
128038990|NCT00560508|460772215|FG001|12 Week Double-blind Period|Adverse Event|2|||
128038991|NCT00560508|460772214|FG000|12 Week Double-blind Period|Protocol Violation|1|||
128038992|NCT00560508|460772215|FG001|12 Week Double-blind Period|Protocol Violation|0|||
128038993|NCT00560508|460772214|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
128038994|NCT00560508|460772215|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
128038995|NCT00560508|460772214|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
128038996|NCT00560508|460772215|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
128038997|NCT00560508|460772214|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
128038998|NCT00560508|460772215|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
128038999|NCT00560508|460772214|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
128039000|NCT00560508|460772215|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
128039001|NCT00560508|460772214|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
128039002|NCT00560508|460772215|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
128039003|NCT02136914|460772221|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
128039004|NCT02136914|460772222|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
128039005|NCT02136914|460772221|FG000|Overall Study|Withdrawal by Subject|3|||
128039006|NCT02136914|460772222|FG001|Overall Study|Withdrawal by Subject|10|||
128039007|NCT02136914|460772221|FG000|Overall Study|Subject Unwilling to Proceed|7|||
128039008|NCT02136914|460772222|FG001|Overall Study|Subject Unwilling to Proceed|2|||
128039009|NCT02136914|460772221|FG000|Overall Study|Lost to Follow-up|1|||
128039010|NCT02136914|460772222|FG001|Overall Study|Lost to Follow-up|1|||
128039011|NCT02136914|460772221|FG000|Overall Study|Did Not Receive Study Drug|2|||
128039012|NCT02136914|460772222|FG001|Overall Study|Did Not Receive Study Drug|0|||
128039013|NCT02136914|460772221|FG000|Overall Study|Lack of Efficacy|1|||
128039014|NCT02136914|460772222|FG001|Overall Study|Lack of Efficacy|0|||
128039015|NCT02136914|460772221|FG000|Overall Study|Death|0|||
128039016|NCT02136914|460772222|FG001|Overall Study|Death|1|||
128039017|NCT01493089|460772225|FG000|Overall Study|Protocol Violation|2|||
128039018|NCT01493089|460772226|FG001|Overall Study|Protocol Violation|2|||
128039019|NCT01493089|460772225|FG000|Overall Study|Withdrawal by Subject|1|||
128039020|NCT01493089|460772226|FG001|Overall Study|Withdrawal by Subject|0|||
128039021|NCT01493089|460772225|FG000|Overall Study|Physician Decision|0|||
127788144|NCT00573430|459849897|FG000|Overall Study|Protocol Violation|0|||
128039022|NCT01493089|460772226|FG001|Overall Study|Physician Decision|1|||
128039023|NCT00329030|460772227|FG000|Overall Study|Withdrawal by Subject|1|||
128039024|NCT00329030|460772228|FG001|Overall Study|Withdrawal by Subject|3|||
128039025|NCT00329030|460772227|FG000|Overall Study|Progressive Disease|6|||
128039026|NCT00329030|460772228|FG001|Overall Study|Progressive Disease|2|||
128039027|NCT00329030|460772227|FG000|Overall Study|Ineligible Pathology|1|||
128039028|NCT00329030|460772228|FG001|Overall Study|Ineligible Pathology|1|||
128039029|NCT03012334|460772229|FG000|Period 1|Withdrawal by Subject|0|||
128039030|NCT03012334|460772230|FG001|Period 1|Withdrawal by Subject|0|||
128039031|NCT03012334|460772231|FG002|Period 1|Withdrawal by Subject|0|||
128039032|NCT03012334|460772232|FG003|Period 1|Withdrawal by Subject|0|||
128039033|NCT03012334|460772233|FG004|Period 1|Withdrawal by Subject|0|||
128039034|NCT03012334|460772234|FG005|Period 1|Withdrawal by Subject|0|||
128039035|NCT03012334|460772235|FG006|Period 1|Withdrawal by Subject|0|||
128039036|NCT03012334|460772236|FG007|Period 1|Withdrawal by Subject|0|||
127696278|NCT03665597|459515982|FG002|Period 1|Screen Failure|0|||
127696279|NCT03665597|459515983|FG003|Period 1|Screen Failure|1|||
127696280|NCT03665597|459515984|FG004|Period 1|Screen Failure|0|||
127696281|NCT03665597|459515985|FG005|Period 1|Screen Failure|0|||
127696282|NCT03665597|459515986|FG006|Period 1|Screen Failure|0|||
127696283|NCT03665597|459515980|FG000|Period 1|Death|0|||
127696284|NCT03665597|459515981|FG001|Period 1|Death|0|||
127696285|NCT03665597|459515982|FG002|Period 1|Death|0|||
127696286|NCT03665597|459515983|FG003|Period 1|Death|0|||
127696287|NCT03665597|459515984|FG004|Period 1|Death|0|||
127696288|NCT03665597|459515985|FG005|Period 1|Death|0|||
127696289|NCT03665597|459515986|FG006|Period 1|Death|45|||
127696290|NCT03665597|459515980|FG000|Period 1|Withdrawal by Subject|0|||
128039037|NCT03012334|460772237|FG008|Period 1|Withdrawal by Subject|0|||
128039038|NCT03012334|460772238|FG009|Period 1|Withdrawal by Subject|1|||
128039039|NCT03012334|460772229|FG000|Period 2|Withdrawal by Subject|0|||
127696291|NCT03665597|459515981|FG001|Period 1|Withdrawal by Subject|0|||
127696292|NCT03665597|459515982|FG002|Period 1|Withdrawal by Subject|0|||
127696293|NCT03665597|459515983|FG003|Period 1|Withdrawal by Subject|0|||
127696294|NCT03665597|459515984|FG004|Period 1|Withdrawal by Subject|0|||
127601112|NCT01199289|459168858|FG003|Overall Study|Protocol Violation|1|||
128039040|NCT03012334|460772230|FG001|Period 2|Withdrawal by Subject|1|||
128039041|NCT03012334|460772231|FG002|Period 2|Withdrawal by Subject|0|||
128039042|NCT03012334|460772232|FG003|Period 2|Withdrawal by Subject|0|||
128039043|NCT03012334|460772233|FG004|Period 2|Withdrawal by Subject|0|||
128039044|NCT03012334|460772234|FG005|Period 2|Withdrawal by Subject|0|||
128039045|NCT03012334|460772235|FG006|Period 2|Withdrawal by Subject|0|||
128039046|NCT03012334|460772236|FG007|Period 2|Withdrawal by Subject|0|||
127601113|NCT01199289|459168855|FG000|Overall Study|Noncompliance|1|||
127788145|NCT00573430|459849898|FG001|Overall Study|Protocol Violation|1|||
127788146|NCT00573430|459849899|FG002|Overall Study|Protocol Violation|1|||
127788147|NCT00573430|459849897|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
127788148|NCT00573430|459849898|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
127788149|NCT00573430|459849899|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
127788150|NCT02037295|459849900|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
127788151|NCT02037295|459849901|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
127788152|NCT02037295|459849902|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
127788153|NCT02037295|459849903|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
127788154|NCT01324232|459849906|FG000|Overall Study|Protocol Violation|0|||
127788155|NCT01324232|459849907|FG001|Overall Study|Protocol Violation|0|||
127788156|NCT01324232|459849908|FG002|Overall Study|Protocol Violation|0|||
127788157|NCT01324232|459849909|FG003|Overall Study|Protocol Violation|2|||
127788158|NCT01324232|459849906|FG000|Overall Study|Missing|0|||
127788159|NCT01324232|459849907|FG001|Overall Study|Missing|0|||
128039047|NCT03012334|460772237|FG008|Period 2|Withdrawal by Subject|0|||
128039048|NCT03012334|460772238|FG009|Period 2|Withdrawal by Subject|0|||
128039049|NCT03012334|460772229|FG000|Period 2|Protocol Violation|0|||
128039050|NCT03012334|460772230|FG001|Period 2|Protocol Violation|0|||
128039051|NCT03012334|460772231|FG002|Period 2|Protocol Violation|1|||
128039052|NCT03012334|460772232|FG003|Period 2|Protocol Violation|0|||
128039053|NCT03012334|460772233|FG004|Period 2|Protocol Violation|0|||
128039054|NCT03012334|460772234|FG005|Period 2|Protocol Violation|0|||
128039055|NCT03012334|460772235|FG006|Period 2|Protocol Violation|0|||
128039056|NCT03012334|460772236|FG007|Period 2|Protocol Violation|1|||
128039057|NCT03012334|460772237|FG008|Period 2|Protocol Violation|0|||
128039058|NCT03012334|460772238|FG009|Period 2|Protocol Violation|0|||
128039059|NCT03012334|460772229|FG000|Period 4|Non-Compliance|0|||
128039060|NCT03012334|460772230|FG001|Period 4|Non-Compliance|0|||
128039061|NCT03012334|460772231|FG002|Period 4|Non-Compliance|0|||
128039062|NCT03012334|460772232|FG003|Period 4|Non-Compliance|0|||
128039063|NCT03012334|460772233|FG004|Period 4|Non-Compliance|0|||
128039064|NCT03012334|460772234|FG005|Period 4|Non-Compliance|0|||
128039065|NCT03012334|460772235|FG006|Period 4|Non-Compliance|1|||
128039066|NCT03012334|460772236|FG007|Period 4|Non-Compliance|0|||
128039067|NCT03012334|460772237|FG008|Period 4|Non-Compliance|0|||
128039068|NCT03012334|460772238|FG009|Period 4|Non-Compliance|0|||
128039069|NCT03012334|460772229|FG000|Period 4|Adverse Event|0|||
128039070|NCT03012334|460772230|FG001|Period 4|Adverse Event|0|||
128039071|NCT03012334|460772231|FG002|Period 4|Adverse Event|0|||
128039072|NCT03012334|460772232|FG003|Period 4|Adverse Event|0|||
128039073|NCT03012334|460772233|FG004|Period 4|Adverse Event|0|||
128039074|NCT03012334|460772234|FG005|Period 4|Adverse Event|0|||
128039075|NCT03012334|460772235|FG006|Period 4|Adverse Event|0|||
128039076|NCT03012334|460772236|FG007|Period 4|Adverse Event|0|||
128039077|NCT03012334|460772237|FG008|Period 4|Adverse Event|1|||
128039078|NCT03012334|460772238|FG009|Period 4|Adverse Event|0|||
128039079|NCT00325143|460772239|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
128039080|NCT00325143|460772239|FG000|Overall Study|Migrated/moved from study area|1|||
128039081|NCT00325143|460772239|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
128039082|NCT00325143|460772239|FG000|Overall Study|Withdrawal by Subject|8|||
128039083|NCT01008618|460772242|FG000|Period 1 (Titration Period)|Physician Decision|2|||
128039084|NCT01008618|460772243|FG001|Period 1 (Titration Period)|Physician Decision|0|||
128039085|NCT01008618|460772244|FG002|Period 1 (Titration Period)|Physician Decision|0|||
128039086|NCT01008618|460772242|FG000|Period 1 (Titration Period)|Adverse Event|33|||
128039087|NCT01008618|460772243|FG001|Period 1 (Titration Period)|Adverse Event|0|||
128039088|NCT01008618|460772244|FG002|Period 1 (Titration Period)|Adverse Event|0|||
128039089|NCT01008618|460772242|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
128039090|NCT01008618|460772243|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
127788160|NCT01324232|459849908|FG002|Overall Study|Missing|1|||
128039091|NCT01008618|460772244|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
128039092|NCT01008618|460772242|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
128039093|NCT01008618|460772243|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
128039094|NCT01008618|460772244|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
128039095|NCT01008618|460772242|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
127788161|NCT01324232|459849909|FG003|Overall Study|Missing|0|||
127788162|NCT01324232|459849906|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
127788163|NCT01324232|459849907|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
127601114|NCT01199289|459168856|FG001|Overall Study|Noncompliance|0|||
127788164|NCT01324232|459849908|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
127788165|NCT01324232|459849909|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
127788166|NCT01324232|459849906|FG000|Overall Study|Lack of Efficacy|2|||
127788167|NCT01324232|459849907|FG001|Overall Study|Lack of Efficacy|1|||
127788168|NCT01324232|459849908|FG002|Overall Study|Lack of Efficacy|2|||
127788169|NCT01324232|459849909|FG003|Overall Study|Lack of Efficacy|2|||
127788170|NCT01324232|459849906|FG000|Overall Study|Participant Refused Medication|0|||
127788171|NCT01324232|459849907|FG001|Overall Study|Participant Refused Medication|1|||
127788172|NCT01324232|459849908|FG002|Overall Study|Participant Refused Medication|0|||
127788173|NCT01324232|459849909|FG003|Overall Study|Participant Refused Medication|0|||
127788174|NCT01324232|459849906|FG000|Overall Study|Intercurrent illness|0|||
127788175|NCT01324232|459849907|FG001|Overall Study|Intercurrent illness|0|||
127788176|NCT01324232|459849908|FG002|Overall Study|Intercurrent illness|0|||
127788177|NCT01324232|459849909|FG003|Overall Study|Intercurrent illness|1|||
127788178|NCT01324232|459849906|FG000|Overall Study|Adverse Event|2|||
127788179|NCT01324232|459849907|FG001|Overall Study|Adverse Event|5|||
127788180|NCT01324232|459849908|FG002|Overall Study|Adverse Event|6|||
127788181|NCT01324232|459849909|FG003|Overall Study|Adverse Event|6|||
127788182|NCT01324232|459849906|FG000|Overall Study|Withdrawal by Subject|0|||
127788183|NCT01324232|459849907|FG001|Overall Study|Withdrawal by Subject|3|||
127788184|NCT01324232|459849908|FG002|Overall Study|Withdrawal by Subject|4|||
127788185|NCT01324232|459849909|FG003|Overall Study|Withdrawal by Subject|0|||
127788186|NCT01324232|459849906|FG000|Overall Study|Lost to Follow-up|1|||
127788187|NCT01324232|459849907|FG001|Overall Study|Lost to Follow-up|0|||
127788188|NCT01324232|459849908|FG002|Overall Study|Lost to Follow-up|0|||
127788189|NCT01324232|459849909|FG003|Overall Study|Lost to Follow-up|0|||
127788190|NCT00661531|459849910|FG000|Overall Study|Withdrawal by Subject|3|||
127788191|NCT03134599|459849912|FG000|Week 1|Lost to Follow-up|0|||
127788192|NCT03134599|459849913|FG001|Week 1|Lost to Follow-up|0|||
127788193|NCT03134599|459849914|FG002|Week 1|Lost to Follow-up|0|||
128039096|NCT01008618|460772243|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
128039097|NCT01008618|460772244|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
128039098|NCT01008618|460772242|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
128039099|NCT01008618|460772243|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
128039100|NCT01008618|460772244|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
128039101|NCT01008618|460772242|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
128039102|NCT01008618|460772243|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
128039103|NCT01008618|460772244|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
128039104|NCT01008618|460772242|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
128039105|NCT01008618|460772243|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
128039106|NCT01008618|460772244|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
128039107|NCT01008618|460772242|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
128039108|NCT01008618|460772243|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
128039109|NCT01008618|460772244|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
128039110|NCT01008618|460772242|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
128039111|NCT01008618|460772243|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
128039112|NCT01008618|460772244|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
128039113|NCT01008618|460772242|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
128039114|NCT01008618|460772243|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
128039115|NCT01008618|460772244|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
128039116|NCT01008618|460772242|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
128039117|NCT01008618|460772243|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
128039118|NCT01008618|460772244|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
128039119|NCT00744861|460772245|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
128039120|NCT00744861|460772246|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
128039121|NCT00744861|460772247|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
128039122|NCT00744861|460772248|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
128039123|NCT00744861|460772245|FG000|Feasibility Stage 1|Pregnancy|0|||
128039124|NCT00744861|460772246|FG001|Feasibility Stage 1|Pregnancy|1|||
128039125|NCT00744861|460772247|FG002|Feasibility Stage 1|Pregnancy|0|||
128039126|NCT00744861|460772248|FG003|Feasibility Stage 1|Pregnancy|0|||
128039127|NCT00744861|460772245|FG000|Pivotal Stage 2|Adverse Event|0|||
128039128|NCT00744861|460772246|FG001|Pivotal Stage 2|Adverse Event|0|||
128039129|NCT00744861|460772247|FG002|Pivotal Stage 2|Adverse Event|6|||
128039130|NCT00744861|460772248|FG003|Pivotal Stage 2|Adverse Event|11|||
128039131|NCT00744861|460772245|FG000|Pivotal Stage 2|Death|0|||
128039132|NCT00744861|460772246|FG001|Pivotal Stage 2|Death|0|||
128039133|NCT00744861|460772247|FG002|Pivotal Stage 2|Death|0|||
128039134|NCT00744861|460772248|FG003|Pivotal Stage 2|Death|1|||
128039135|NCT00744861|460772245|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
128039136|NCT00744861|460772246|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
128039137|NCT00744861|460772247|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
128039138|NCT00744861|460772248|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
128039139|NCT00744861|460772245|FG000|Pivotal Stage 2|Physician Decision|0|||
128039140|NCT00744861|460772246|FG001|Pivotal Stage 2|Physician Decision|0|||
128039141|NCT00744861|460772247|FG002|Pivotal Stage 2|Physician Decision|3|||
128039142|NCT00744861|460772248|FG003|Pivotal Stage 2|Physician Decision|1|||
128039143|NCT00744861|460772245|FG000|Pivotal Stage 2|Protocol Violation|0|||
128039144|NCT00744861|460772246|FG001|Pivotal Stage 2|Protocol Violation|0|||
128039145|NCT00744861|460772247|FG002|Pivotal Stage 2|Protocol Violation|0|||
128039146|NCT00744861|460772248|FG003|Pivotal Stage 2|Protocol Violation|1|||
128039147|NCT00744861|460772245|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
128039148|NCT00744861|460772246|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
128039149|NCT00744861|460772247|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
128039150|NCT00744861|460772248|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
128039151|NCT00744861|460772245|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
128039152|NCT00744861|460772246|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
128039153|NCT00744861|460772247|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
128039154|NCT00744861|460772248|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
128039155|NCT01627691|460772249|FG000|Overall Study|Death|11|||
128039156|NCT01627691|460772249|FG000|Overall Study|Lost to Follow-up|3|||
128039157|NCT01627691|460772249|FG000|Overall Study|Withdrawal by Subject|1|||
128039158|NCT01627691|460772249|FG000|Overall Study|Missed the visit|3|||
128039159|NCT00181844|460772250|FG000|Signed Consent|Withdrawal by Subject|5|||
128039160|NCT00181844|460772250|FG000|Signed Consent|Did not meet entrance criteria|7|||
128039161|NCT00181844|460772250|FG000|Exposed to Study Medication|Adverse Event|10|||
128039162|NCT00181844|460772250|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
128039163|NCT00181844|460772250|FG000|Exposed to Study Medication|Non-compliance|2|||
128039164|NCT00181844|460772250|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
128039165|NCT00181844|460772250|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
128039166|NCT02536664|460772257|FG000|Overall Study|Inadequate completion of documentation|2|||
128039167|NCT02536664|460772258|FG001|Overall Study|Inadequate completion of documentation|4|||
128039168|NCT02536664|460772257|FG000|Overall Study|Progression|13|||
128039169|NCT02536664|460772258|FG001|Overall Study|Progression|18|||
128039170|NCT02536664|460772257|FG000|Overall Study|Death due to lymphoma|2|||
128039171|NCT02536664|460772258|FG001|Overall Study|Death due to lymphoma|1|||
128039172|NCT02536664|460772257|FG000|Overall Study|Death due to other reason|3|||
128039173|NCT02536664|460772258|FG001|Overall Study|Death due to other reason|2|||
128039174|NCT02536664|460772257|FG000|Overall Study|Intolerability|8|||
128039175|NCT02536664|460772258|FG001|Overall Study|Intolerability|6|||
128039176|NCT02536664|460772257|FG000|Overall Study|Withdrawal by Subject|8|||
128039177|NCT02536664|460772258|FG001|Overall Study|Withdrawal by Subject|5|||
128039178|NCT02536664|460772257|FG000|Overall Study|Other|18|||
128039179|NCT02536664|460772258|FG001|Overall Study|Other|24|||
128039180|NCT02536664|460772257|FG000|Overall Study|Missing|53|||
128039181|NCT02536664|460772258|FG001|Overall Study|Missing|20|||
128039182|NCT03507127|460772261|FG000|Overall Study|Withdrawal by Subject|1|||
128039183|NCT03507127|460772262|FG001|Overall Study|Withdrawal by Subject|0|||
128039184|NCT03507127|460772261|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
128039185|NCT03507127|460772262|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
127696295|NCT03665597|459515985|FG005|Period 1|Withdrawal by Subject|0|||
127696296|NCT03665597|459515986|FG006|Period 1|Withdrawal by Subject|5|||
127696297|NCT03665597|459515980|FG000|Period 2|Adverse Event|0|||
127696298|NCT03665597|459515981|FG001|Period 2|Adverse Event|0|||
127696299|NCT03665597|459515982|FG002|Period 2|Adverse Event|0|||
127696300|NCT03665597|459515983|FG003|Period 2|Adverse Event|0|||
127696301|NCT03665597|459515984|FG004|Period 2|Adverse Event|0|||
127696302|NCT03665597|459515985|FG005|Period 2|Adverse Event|1|||
127696303|NCT03665597|459515986|FG006|Period 2|Adverse Event|0|||
127696304|NCT03665597|459515980|FG000|Period 3|Adverse Event|0|||
127696305|NCT03665597|459515981|FG001|Period 3|Adverse Event|1|||
127696306|NCT03665597|459515982|FG002|Period 3|Adverse Event|0|||
127696307|NCT03665597|459515983|FG003|Period 3|Adverse Event|0|||
127696308|NCT03665597|459515984|FG004|Period 3|Adverse Event|0|||
127696309|NCT03665597|459515985|FG005|Period 3|Adverse Event|0|||
127696310|NCT03665597|459515986|FG006|Period 3|Adverse Event|0|||
127696311|NCT03665597|459515980|FG000|Period 3|Death|0|||
127696312|NCT03665597|459515981|FG001|Period 3|Death|0|||
127696313|NCT03665597|459515982|FG002|Period 3|Death|0|||
127696314|NCT03665597|459515983|FG003|Period 3|Death|0|||
127696315|NCT03665597|459515984|FG004|Period 3|Death|1|||
127696316|NCT03665597|459515985|FG005|Period 3|Death|0|||
128039186|NCT03961308|460772266|FG000|Overall Study|Withdrawal by Subject|1|||
128039187|NCT03961308|460772267|FG001|Overall Study|Withdrawal by Subject|0|||
127696317|NCT03665597|459515986|FG006|Period 3|Death|0|||
127696318|NCT03665597|459515980|FG000|Period 4|Adverse Event|2|||
127696319|NCT03665597|459515981|FG001|Period 4|Adverse Event|2|||
127696320|NCT03665597|459515982|FG002|Period 4|Adverse Event|2|||
127696321|NCT03665597|459515983|FG003|Period 4|Adverse Event|2|||
127696322|NCT03665597|459515984|FG004|Period 4|Adverse Event|1|||
127696323|NCT03665597|459515985|FG005|Period 4|Adverse Event|0|||
127696324|NCT03665597|459515986|FG006|Period 4|Adverse Event|0|||
127696325|NCT03665597|459515980|FG000|Period 4|Death|0|||
127882831|NCT02609178|460194589|FG000|First Crown|Withdrawal by Subject|0|||
127882832|NCT02609178|460194590|FG001|First Crown|Withdrawal by Subject|0|||
127696326|NCT03665597|459515981|FG001|Period 4|Death|0|||
127696327|NCT03665597|459515982|FG002|Period 4|Death|2|||
127696328|NCT03665597|459515983|FG003|Period 4|Death|0|||
127696329|NCT03665597|459515984|FG004|Period 4|Death|0|||
127696330|NCT03665597|459515985|FG005|Period 4|Death|0|||
127696331|NCT03665597|459515986|FG006|Period 4|Death|0|||
127696332|NCT03665597|459515980|FG000|Period 4|Physician Decision|1|||
127696333|NCT03665597|459515981|FG001|Period 4|Physician Decision|2|||
127696334|NCT03665597|459515982|FG002|Period 4|Physician Decision|0|||
127696335|NCT03665597|459515983|FG003|Period 4|Physician Decision|0|||
127696336|NCT03665597|459515984|FG004|Period 4|Physician Decision|0|||
127882833|NCT02609178|460194591|FG002|First Crown|Withdrawal by Subject|1|||
127696337|NCT03665597|459515985|FG005|Period 4|Physician Decision|0|||
127696338|NCT03665597|459515986|FG006|Period 4|Physician Decision|0|||
127696339|NCT05371652|459515989|FG000|Overall Study|Non-Compliance with Study Schedule|9|||
127696340|NCT05371652|459515989|FG000|Overall Study|Withdrawal by Subject|12|||
128039188|NCT03961308|460772266|FG000|Overall Study|Other|1|||
128039189|NCT03961308|460772267|FG001|Overall Study|Other|0|||
128039190|NCT03961308|460772266|FG000|Overall Study|Lost to Follow-up|0|||
128039191|NCT03961308|460772267|FG001|Overall Study|Lost to Follow-up|1|||
128039192|NCT03961308|460772266|FG000|Overall Study|Adverse Event|0|||
128039193|NCT03961308|460772267|FG001|Overall Study|Adverse Event|1|||
128039194|NCT01538199|460772271|FG000|Overall Study|Lost to Follow-up|1|||
128039195|NCT01538199|460772272|FG001|Overall Study|Lost to Follow-up|2|||
128039196|NCT01538199|460772273|FG002|Overall Study|Lost to Follow-up|1|||
128039197|NCT01538199|460772274|FG003|Overall Study|Lost to Follow-up|0|||
128039198|NCT01538199|460772271|FG000|Overall Study|participant did not have time|1|||
128039199|NCT01538199|460772272|FG001|Overall Study|participant did not have time|0|||
128039200|NCT01538199|460772273|FG002|Overall Study|participant did not have time|0|||
128039201|NCT01538199|460772274|FG003|Overall Study|participant did not have time|2|||
128039202|NCT01538199|460772271|FG000|Overall Study|Lack of Efficacy|0|||
128039203|NCT01538199|460772272|FG001|Overall Study|Lack of Efficacy|1|||
128039204|NCT01538199|460772273|FG002|Overall Study|Lack of Efficacy|0|||
128039205|NCT01538199|460772274|FG003|Overall Study|Lack of Efficacy|0|||
128039206|NCT03950856|460772275|FG000|Overall Study|Death|1|||
128039207|NCT03950856|460772276|FG001|Overall Study|Death|2|||
128039208|NCT03950856|460772277|FG002|Overall Study|Death|0|||
128039209|NCT03950856|460772278|FG003|Overall Study|Death|0|||
128039210|NCT03950856|460772275|FG000|Overall Study|Lost to Follow-up|5|||
127601115|NCT01199289|459168857|FG002|Overall Study|Noncompliance|2|||
127601116|NCT01199289|459168858|FG003|Overall Study|Noncompliance|0|||
128039211|NCT03950856|460772276|FG001|Overall Study|Lost to Follow-up|6|||
128039212|NCT03950856|460772277|FG002|Overall Study|Lost to Follow-up|8|||
128039213|NCT03950856|460772278|FG003|Overall Study|Lost to Follow-up|2|||
128039214|NCT03950856|460772275|FG000|Overall Study|Protocol Violation|2|||
128039215|NCT03950856|460772276|FG001|Overall Study|Protocol Violation|0|||
128039216|NCT03950856|460772277|FG002|Overall Study|Protocol Violation|0|||
128039217|NCT03950856|460772278|FG003|Overall Study|Protocol Violation|1|||
128039218|NCT03950856|460772275|FG000|Overall Study|Withdrawal by Subject|4|||
128039219|NCT03950856|460772276|FG001|Overall Study|Withdrawal by Subject|1|||
128039220|NCT03950856|460772277|FG002|Overall Study|Withdrawal by Subject|3|||
128039221|NCT03950856|460772278|FG003|Overall Study|Withdrawal by Subject|1|||
128039222|NCT03950856|460772275|FG000|Overall Study|Unable to phone|7|||
128039223|NCT03950856|460772276|FG001|Overall Study|Unable to phone|6|||
128039224|NCT03950856|460772277|FG002|Overall Study|Unable to phone|7|||
128039225|NCT03950856|460772278|FG003|Overall Study|Unable to phone|2|||
128039226|NCT05899829|460772279|FG000|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
128039227|NCT05899829|460772280|FG001|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
128039228|NCT05899829|460772279|FG000|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|0|||
128039229|NCT05899829|460772280|FG001|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|6|||
128039230|NCT01174563|460772287|FG000|Overall Study|Progressive Disease|45|||
128039231|NCT01174563|460772287|FG000|Overall Study|Death|5|||
128039232|NCT01174563|460772287|FG000|Overall Study|Investigator's Discretion|5|||
128039233|NCT01174563|460772287|FG000|Overall Study|Participant Withdrew Consent|3|||
128039234|NCT01174563|460772287|FG000|Overall Study|Rash Adverse Event|1|||
128039235|NCT01174563|460772287|FG000|Overall Study|Sponsor's decision|1|||
128039236|NCT03402841|460772288|FG000|Overall Study|Withdrawal by Subject|3|||
128039237|NCT03402841|460772288|FG000|Overall Study|Lost to Follow-up|2|||
128039238|NCT03402841|460772288|FG000|Overall Study|Death|146|||
128039239|NCT01542788|460772293|FG000|Overall Study|Randomized but Not Treated|2|||
128039240|NCT01542788|460772294|FG001|Overall Study|Randomized but Not Treated|0|||
128039241|NCT01542788|460772293|FG000|Overall Study|Lack of Efficacy|41|||
128039242|NCT01542788|460772294|FG001|Overall Study|Lack of Efficacy|71|||
128039243|NCT01542788|460772293|FG000|Overall Study|Lost to Follow-up|5|||
128039244|NCT01542788|460772294|FG001|Overall Study|Lost to Follow-up|0|||
128039245|NCT01542788|460772293|FG000|Overall Study|Death|3|||
128039246|NCT01542788|460772294|FG001|Overall Study|Death|0|||
128039247|NCT01542788|460772293|FG000|Overall Study|Protocol Violation|2|||
127601117|NCT01199289|459168855|FG000|Overall Study|Adverse Event|0|||
127601118|NCT01199289|459168856|FG001|Overall Study|Adverse Event|3|||
128039248|NCT01542788|460772294|FG001|Overall Study|Protocol Violation|0|||
128039249|NCT01542788|460772293|FG000|Overall Study|Physician Decision|1|||
128039250|NCT01542788|460772294|FG001|Overall Study|Physician Decision|0|||
128039251|NCT01542788|460772293|FG000|Overall Study|Withdrawal by Subject|1|||
128039252|NCT01542788|460772294|FG001|Overall Study|Withdrawal by Subject|0|||
128039253|NCT01280968|460772295|FG000|Overall Study|Lost to Follow-up|8|||
128039254|NCT01280968|460772296|FG001|Overall Study|Lost to Follow-up|2|||
127601119|NCT01199289|459168857|FG002|Overall Study|Adverse Event|1|||
127601120|NCT01199289|459168858|FG003|Overall Study|Adverse Event|4|||
127601121|NCT01199289|459168855|FG000|Overall Study|Full consent withdrawn|2|||
127601122|NCT01199289|459168856|FG001|Overall Study|Full consent withdrawn|2|||
128039255|NCT01280968|460772295|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
127601123|NCT01199289|459168857|FG002|Overall Study|Full consent withdrawn|2|||
128039256|NCT01280968|460772296|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
127788194|NCT03134599|459849915|FG003|Week 1|Lost to Follow-up|0|||
127788195|NCT03134599|459849916|FG004|Week 1|Lost to Follow-up|1|||
127788196|NCT03134599|459849917|FG005|Week 1|Lost to Follow-up|0|||
127788197|NCT03134599|459849912|FG000|Week 2|Lost to Follow-up|1|||
127788198|NCT03134599|459849913|FG001|Week 2|Lost to Follow-up|0|||
127788199|NCT03134599|459849914|FG002|Week 2|Lost to Follow-up|0|||
127788200|NCT03134599|459849915|FG003|Week 2|Lost to Follow-up|1|||
127788201|NCT03134599|459849916|FG004|Week 2|Lost to Follow-up|1|||
127788202|NCT03134599|459849917|FG005|Week 2|Lost to Follow-up|0|||
127788203|NCT03134599|459849912|FG000|Week 3|Lost to Follow-up|0|||
127788204|NCT03134599|459849913|FG001|Week 3|Lost to Follow-up|0|||
127788205|NCT03134599|459849914|FG002|Week 3|Lost to Follow-up|0|||
127882834|NCT02609178|460194592|FG003|First Crown|Withdrawal by Subject|1|||
128039257|NCT01280968|460772295|FG000|Overall Study|Commuting Problems|2|||
128039258|NCT01280968|460772296|FG001|Overall Study|Commuting Problems|0|||
128039259|NCT01280968|460772295|FG000|Overall Study|Anxiety|2|||
128039260|NCT01280968|460772296|FG001|Overall Study|Anxiety|0|||
128039261|NCT01280968|460772295|FG000|Overall Study|Adverse Event|1|||
128039262|NCT01280968|460772296|FG001|Overall Study|Adverse Event|0|||
128039263|NCT01280968|460772295|FG000|Overall Study|Scheduling Conflicts|1|||
128039264|NCT01280968|460772296|FG001|Overall Study|Scheduling Conflicts|1|||
128039265|NCT01280968|460772295|FG000|Overall Study|Pre-existing Neurological Condition|1|||
128039266|NCT01280968|460772296|FG001|Overall Study|Pre-existing Neurological Condition|0|||
128039267|NCT01280968|460772295|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
128039268|NCT01280968|460772296|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
128039269|NCT04704193|460772297|FG000|Overall Study|Withdrawal by Subject|1|||
128039270|NCT00542178|460772298|FG000|Overall Study|did not complete year 4 follow-up|75|||
128039271|NCT00542178|460772299|FG001|Overall Study|did not complete year 4 follow-up|80|||
128039272|NCT00542178|460772300|FG002|Overall Study|did not complete year 4 follow-up|74|||
128039273|NCT00542178|460772301|FG003|Overall Study|did not complete year 4 follow-up|62|||
128039274|NCT00542178|460772302|FG004|Overall Study|did not complete year 4 follow-up|64|||
128039275|NCT00542178|460772303|FG005|Overall Study|did not complete year 4 follow-up|89|||
128039276|NCT00542178|460772304|FG006|Overall Study|did not complete year 4 follow-up|87|||
128039277|NCT00542178|460772305|FG007|Overall Study|did not complete year 4 follow-up|85|||
128039278|NCT03984188|460772311|FG000|Overall Study|Death|2|||
128039279|NCT03984188|460772312|FG001|Overall Study|Death|4|||
128039280|NCT03984188|460772311|FG000|Overall Study|Physician Decision|0|||
128039281|NCT03984188|460772312|FG001|Overall Study|Physician Decision|2|||
128039282|NCT03984188|460772311|FG000|Overall Study|Lost to Follow-up|3|||
128039283|NCT03984188|460772312|FG001|Overall Study|Lost to Follow-up|2|||
128039284|NCT03984188|460772311|FG000|Overall Study|Withdrawal by Subject|6|||
128039285|NCT03984188|460772312|FG001|Overall Study|Withdrawal by Subject|0|||
128039286|NCT01492426|460773919|FG000|Treatment|Death|0|||
128039287|NCT01492426|460773920|FG001|Treatment|Death|1|||
128039288|NCT01492426|460773919|FG000|Treatment|Other|1|||
128039289|NCT01492426|460773920|FG001|Treatment|Other|0|||
128039290|NCT01492426|460773919|FG000|Treatment|Adverse Event|25|||
128039291|NCT01492426|460773920|FG001|Treatment|Adverse Event|25|||
128039292|NCT01492426|460773919|FG000|Treatment|Lack of Efficacy|38|||
128039293|NCT01492426|460773920|FG001|Treatment|Lack of Efficacy|5|||
128039294|NCT01492426|460773919|FG000|Treatment|Participant withdrew consent|1|||
128039295|NCT01492426|460773920|FG001|Treatment|Participant withdrew consent|2|||
128039296|NCT01492426|460773919|FG000|Treatment|Poor compliance/noncompliance|1|||
128039297|NCT01492426|460773920|FG001|Treatment|Poor compliance/noncompliance|0|||
128039298|NCT01492426|460773919|FG000|Treatment|Subject requested discontinue study drug|7|||
128039299|NCT01492426|460773920|FG001|Treatment|Subject requested discontinue study drug|3|||
128039300|NCT01492426|460773919|FG000|Treatment|Lost to Follow-up|9|||
128039301|NCT01492426|460773920|FG001|Treatment|Lost to Follow-up|4|||
128039302|NCT01492426|460773919|FG000|Treatment|Participant does not meet study criteria|1|||
128039303|NCT01492426|460773920|FG001|Treatment|Participant does not meet study criteria|0|||
128039304|NCT01492426|460773919|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
128039305|NCT01492426|460773920|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
128039306|NCT01492426|460773919|FG000|Follow-Up|Death|1|||
128039307|NCT01492426|460773920|FG001|Follow-Up|Death|0|||
127882835|NCT02609178|460194593|FG004|First Crown|Withdrawal by Subject|0|||
128039308|NCT01492426|460773919|FG000|Follow-Up|Other|4|||
128039309|NCT01492426|460773920|FG001|Follow-Up|Other|2|||
128039310|NCT01492426|460773919|FG000|Follow-Up|Participant Withdrew Consent|6|||
128039311|NCT01492426|460773920|FG001|Follow-Up|Participant Withdrew Consent|1|||
128039312|NCT01492426|460773919|FG000|Follow-Up|Lost to Follow-up|12|||
127788206|NCT03134599|459849915|FG003|Week 3|Lost to Follow-up|1|||
128039313|NCT01492426|460773920|FG001|Follow-Up|Lost to Follow-up|6|||
128039314|NCT01173679|460773921|FG000|Overall Study|Death|1|||
128039315|NCT02026011|460773922|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
128039316|NCT02026011|460773923|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
127788207|NCT03134599|459849916|FG004|Week 3|Lost to Follow-up|0|||
127788208|NCT03134599|459849917|FG005|Week 3|Lost to Follow-up|1|||
127788209|NCT04962022|459849920|FG000|Period 1|Withdrawal by Subject|1|||
128039317|NCT02026011|460773922|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
128039318|NCT02026011|460773923|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
128039319|NCT02026011|460773922|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
128039320|NCT02026011|460773923|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
128039321|NCT02026011|460773922|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
128039322|NCT02026011|460773923|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
128039323|NCT01770743|460773924|FG000|Overall Study|Adverse Event|1|||
128039324|NCT01770743|460773925|FG001|Overall Study|Adverse Event|0|||
128039325|NCT01770743|460773926|FG002|Overall Study|Adverse Event|0|||
128039326|NCT01770743|460773927|FG003|Overall Study|Adverse Event|0|||
128039327|NCT01770743|460773928|FG004|Overall Study|Adverse Event|0|||
128039328|NCT01770743|460773924|FG000|Overall Study|Withdrawal by Subject|0|||
128039329|NCT01770743|460773925|FG001|Overall Study|Withdrawal by Subject|0|||
128039330|NCT01770743|460773926|FG002|Overall Study|Withdrawal by Subject|1|||
128039331|NCT01770743|460773927|FG003|Overall Study|Withdrawal by Subject|1|||
128039332|NCT01770743|460773928|FG004|Overall Study|Withdrawal by Subject|1|||
127601124|NCT01199289|459168858|FG003|Overall Study|Full consent withdrawn|3|||
127601125|NCT01199289|459168855|FG000|Overall Study|Administrative decision|0|||
127601126|NCT01199289|459168856|FG001|Overall Study|Administrative decision|0|||
127601127|NCT01199289|459168857|FG002|Overall Study|Administrative decision|0|||
127601128|NCT01199289|459168858|FG003|Overall Study|Administrative decision|1|||
127601129|NCT01199289|459168855|FG000|Overall Study|Lost to Follow-up|0|||
127601130|NCT01199289|459168856|FG001|Overall Study|Lost to Follow-up|0|||
127601131|NCT01199289|459168857|FG002|Overall Study|Lost to Follow-up|0|||
127601132|NCT01199289|459168858|FG003|Overall Study|Lost to Follow-up|1|||
127601133|NCT01199289|459168855|FG000|Overall Study|Protocol-specified criteria|3|||
127601134|NCT01199289|459168856|FG001|Overall Study|Protocol-specified criteria|0|||
127601135|NCT01199289|459168857|FG002|Overall Study|Protocol-specified criteria|0|||
127601136|NCT01199289|459168858|FG003|Overall Study|Protocol-specified criteria|1|||
127601137|NCT01199289|459168855|FG000|Overall Study|Pregnancy|0|||
127601138|NCT01199289|459168856|FG001|Overall Study|Pregnancy|1|||
127601139|NCT01199289|459168857|FG002|Overall Study|Pregnancy|0|||
127601140|NCT01199289|459168858|FG003|Overall Study|Pregnancy|1|||
127601141|NCT00501293|459168861|FG000|Optimization Period|Enrolled in error|1|||
127601142|NCT00501293|459168862|FG001|Optimization Period|Enrolled in error|0|||
127601143|NCT00501293|459168861|FG000|Maintenance Period|Withdrawal by Subject|14|||
127601144|NCT00501293|459168862|FG001|Maintenance Period|Withdrawal by Subject|13|||
127601145|NCT00501293|459168861|FG000|Maintenance Period|Lost to Follow-up|12|||
127601146|NCT00501293|459168862|FG001|Maintenance Period|Lost to Follow-up|7|||
127601147|NCT00501293|459168861|FG000|Maintenance Period|Adverse Event|6|||
127601148|NCT00501293|459168862|FG001|Maintenance Period|Adverse Event|6|||
127601149|NCT00501293|459168861|FG000|Maintenance Period|Protocol Violation|2|||
127601150|NCT00501293|459168862|FG001|Maintenance Period|Protocol Violation|1|||
127601151|NCT00501293|459168861|FG000|Maintenance Period|Lack of Efficacy|4|||
127696341|NCT05371652|459515989|FG000|Overall Study|Adverse Event|1|||
127696342|NCT05371652|459515989|FG000|Overall Study|Other|11|||
127696343|NCT04410042|459515993|FG000|Overall Study|Not Eligible|1|||
127696344|NCT04410042|459515994|FG001|Overall Study|Not Eligible|1|||
127696345|NCT03720795|459515997|FG000|Phase 1|Lost to Follow-up|4|||
127696346|NCT03720795|459515997|FG000|Phase 1|Withdrawal by Subject|6|||
127696347|NCT03720795|459515997|FG000|Phase 1|Protocol Violation|1|||
127696348|NCT03720795|459515997|FG000|Phase 1|Other|1|||
127696349|NCT03720795|459515997|FG000|Phase 2|Lost to Follow-up|5|||
127696350|NCT03720795|459515997|FG000|Phase 2|Withdrawal by Subject|10|||
127696351|NCT03720795|459515997|FG000|Phase 2|Protocol Violation|2|||
127696352|NCT03720795|459515997|FG000|3 Month Follow Up|Lost to Follow-up|2|||
127696353|NCT05134233|459515998|FG000|Overall Study|Pregnancy|1|||
127696354|NCT05134233|459515998|FG000|Overall Study|MEP value too low|2|||
127696355|NCT05134233|459515998|FG000|Overall Study|Lost to Follow-up|1|||
127696356|NCT02724631|459516001|FG000|Overall Study|unable to clear indwelling feeding tube device|1|||
127696357|NCT04763265|459516005|FG000|Overall Study|Adverse Event|1|||
127696358|NCT04763265|459516006|FG001|Overall Study|Adverse Event|0|||
127696359|NCT04763265|459516005|FG000|Overall Study|Lost to Follow-up|2|||
128039333|NCT01770743|460773924|FG000|Overall Study|Lost to Follow-up|0|||
127601152|NCT00501293|459168862|FG001|Maintenance Period|Lack of Efficacy|1|||
127601153|NCT00501293|459168861|FG000|Maintenance Period|Noncompliant with study medication|5|||
127601154|NCT00501293|459168862|FG001|Maintenance Period|Noncompliant with study medication|0|||
127601155|NCT00501293|459168861|FG000|Maintenance Period|Went into rehabilitation|1|||
127696360|NCT04763265|459516006|FG001|Overall Study|Lost to Follow-up|4|||
127696361|NCT04763265|459516005|FG000|Overall Study|Withdrawal by Subject|0|||
127788210|NCT04962022|459849921|FG001|Period 1|Withdrawal by Subject|0|||
127788211|NCT01146873|459849924|FG000|Overall Study|Transfer out|0|||
127788212|NCT01146873|459849925|FG001|Overall Study|Transfer out|6|||
127788213|NCT01967628|459849926|FG000|Overall Study|Withdrawal by Subject|2|||
127788214|NCT01967628|459849927|FG001|Overall Study|Withdrawal by Subject|0|||
127788215|NCT01967628|459849926|FG000|Overall Study|Unable to complete bronchoscopy|4|||
127788216|NCT01967628|459849927|FG001|Overall Study|Unable to complete bronchoscopy|6|||
127788217|NCT01967628|459849926|FG000|Overall Study|Lost to Follow-up|1|||
127788218|NCT01967628|459849927|FG001|Overall Study|Lost to Follow-up|0|||
127788219|NCT01967628|459849926|FG000|Overall Study|Low protein concentration in sample|20|||
127788220|NCT01967628|459849927|FG001|Overall Study|Low protein concentration in sample|25|||
127788221|NCT01356407|459849928|FG000|Overall Study|Lost to Follow-up|2|||
127882836|NCT02609178|460194594|FG005|First Crown|Withdrawal by Subject|0|||
127882837|NCT01128153|460194595|FG000|Overall Study|Adverse Event|1|||
127882838|NCT01128153|460194596|FG001|Overall Study|Adverse Event|3|||
127788222|NCT01356407|459849929|FG001|Overall Study|Lost to Follow-up|0|||
127788223|NCT01356407|459849928|FG000|Overall Study|Patient Withdrew Consent|2|||
127882839|NCT01128153|460194595|FG000|Overall Study|Condition under investigation worsened|8|||
127788224|NCT01356407|459849929|FG001|Overall Study|Patient Withdrew Consent|1|||
127882840|NCT01128153|460194596|FG001|Overall Study|Condition under investigation worsened|7|||
128039334|NCT01770743|460773925|FG001|Overall Study|Lost to Follow-up|2|||
128039335|NCT01770743|460773926|FG002|Overall Study|Lost to Follow-up|0|||
128039336|NCT01770743|460773927|FG003|Overall Study|Lost to Follow-up|0|||
128039337|NCT01770743|460773928|FG004|Overall Study|Lost to Follow-up|1|||
128039338|NCT01770743|460773924|FG000|Overall Study|Sponsor Terminated Subject|1|||
128039339|NCT01770743|460773925|FG001|Overall Study|Sponsor Terminated Subject|0|||
128039340|NCT01770743|460773926|FG002|Overall Study|Sponsor Terminated Subject|0|||
128039341|NCT01770743|460773927|FG003|Overall Study|Sponsor Terminated Subject|1|||
128039342|NCT01770743|460773928|FG004|Overall Study|Sponsor Terminated Subject|0|||
128039343|NCT01770743|460773924|FG000|Overall Study|Moving Out of State|0|||
128039344|NCT01770743|460773925|FG001|Overall Study|Moving Out of State|1|||
128039345|NCT01770743|460773926|FG002|Overall Study|Moving Out of State|0|||
128039346|NCT01770743|460773927|FG003|Overall Study|Moving Out of State|0|||
128039347|NCT01770743|460773928|FG004|Overall Study|Moving Out of State|0|||
128039348|NCT01133665|460773931|FG000|Overall Study|Physician Decision|2|||
128039349|NCT00529243|460773932|FG000|Overall Study|Adverse Event|1|||
128039350|NCT00529243|460773932|FG000|Overall Study|Death|1|||
128039351|NCT00529243|460773932|FG000|Overall Study|Relocated|1|||
128039352|NCT00272792|460773937|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
128039353|NCT00272792|460773938|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
128039354|NCT00272792|460773937|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
128039355|NCT00272792|460773938|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
128039356|NCT00272792|460773937|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
128039357|NCT00272792|460773938|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
128039358|NCT00272792|460773937|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
128039359|NCT00272792|460773938|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
128039360|NCT02921789|460773939|FG000|Overall Study|Adverse Event|0|||
128039361|NCT02921789|460773940|FG001|Overall Study|Adverse Event|1|||
128039362|NCT02921789|460773939|FG000|Overall Study|Lost to Follow-up|1|||
128039363|NCT02921789|460773940|FG001|Overall Study|Lost to Follow-up|0|||
128039364|NCT02921789|460773939|FG000|Overall Study|Protocol Deviation|2|||
128039365|NCT02921789|460773940|FG001|Overall Study|Protocol Deviation|0|||
128039366|NCT02921789|460773939|FG000|Overall Study|Withdrawal by Subject|2|||
128039367|NCT02921789|460773940|FG001|Overall Study|Withdrawal by Subject|1|||
128039368|NCT02921789|460773939|FG000|Overall Study|Miscellaneous|3|||
128039369|NCT02921789|460773940|FG001|Overall Study|Miscellaneous|2|||
128039370|NCT04099277|460773941|FG000|Overall Study|Physician Decision|1|||
128039371|NCT04099277|460773941|FG000|Overall Study|Withdrawal by Subject|1|||
128039372|NCT03423602|460773944|FG000|Overall Study|Death|1|||
128039373|NCT03423602|460773944|FG000|Overall Study|Lost to Follow-up|6|||
128039374|NCT03423602|460773944|FG000|Overall Study|Protocol Violation|1|||
128039375|NCT03423602|460773944|FG000|Overall Study|Withdrawal by Subject|4|||
128039376|NCT01354223|460773945|FG000|Overall Study|Withdrawal by Subject|3|||
128039377|NCT01354223|460773946|FG001|Overall Study|Withdrawal by Subject|1|||
127601156|NCT00501293|459168862|FG001|Maintenance Period|Went into rehabilitation|0|||
127601157|NCT00501293|459168861|FG000|Maintenance Period|Would not wear patch|1|||
127601158|NCT00501293|459168862|FG001|Maintenance Period|Would not wear patch|0|||
127601159|NCT00501293|459168861|FG000|Maintenance Period|Application site reaction|1|||
128039378|NCT00948688|460773951|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
128039379|NCT00948688|460773952|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
128039380|NCT00948688|460773951|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
127601160|NCT00501293|459168862|FG001|Maintenance Period|Application site reaction|0|||
128039381|NCT00948688|460773952|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
128039382|NCT00948688|460773951|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
128039383|NCT00948688|460773952|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
128039384|NCT02852967|460773953|FG000|Overall Study|Adverse Event|3|||
128039385|NCT02852967|460773954|FG001|Overall Study|Adverse Event|1|||
128039386|NCT02852967|460773955|FG002|Overall Study|Adverse Event|0|||
128039387|NCT02852967|460773956|FG003|Overall Study|Adverse Event|1|||
127601161|NCT00127712|459168863|FG000|Overall Study|Adverse Event|3|||
127601162|NCT00127712|459168864|FG001|Overall Study|Adverse Event|0|||
127601163|NCT00127712|459168863|FG000|Overall Study|Lack of GI access to continue|2|||
127601164|NCT00127712|459168864|FG001|Overall Study|Lack of GI access to continue|0|||
127601165|NCT02642614|459168865|FG000|Overall Study|Adverse Event|1|||
127601166|NCT02642614|459168866|FG001|Overall Study|Adverse Event|1|||
127601167|NCT02642614|459168867|FG002|Overall Study|Adverse Event|2|||
127601168|NCT02642614|459168868|FG003|Overall Study|Adverse Event|2|||
127601169|NCT02642614|459168865|FG000|Overall Study|Lost to Follow-up|1|||
127601170|NCT02642614|459168866|FG001|Overall Study|Lost to Follow-up|0|||
127601171|NCT02642614|459168867|FG002|Overall Study|Lost to Follow-up|0|||
127601172|NCT02642614|459168868|FG003|Overall Study|Lost to Follow-up|0|||
127601173|NCT02642614|459168865|FG000|Overall Study|Withdrawal by Subject|1|||
127601174|NCT02642614|459168866|FG001|Overall Study|Withdrawal by Subject|1|||
127601175|NCT02642614|459168867|FG002|Overall Study|Withdrawal by Subject|0|||
127601176|NCT02642614|459168868|FG003|Overall Study|Withdrawal by Subject|0|||
127601177|NCT02450903|459168869|FG000|Overall Study|Adverse Event|3|||
127601178|NCT02450903|459168869|FG000|Overall Study|Progressive disease|15|||
127601179|NCT02450903|459168869|FG000|Overall Study|Switched to commercial drug|1|||
127601180|NCT02450903|459168869|FG000|Overall Study|Subject/guardian decision|1|||
127601181|NCT01164956|459168870|FG000|Overall Study|Side Effects|1|||
127601182|NCT01164956|459168871|FG001|Overall Study|Side Effects|0|||
127601183|NCT01164956|459168872|FG002|Overall Study|Side Effects|1|||
127601184|NCT00967798|459168873|FG000|Overall Study|Withdrawal by Subject|5|||
127601185|NCT00967798|459168874|FG001|Overall Study|Withdrawal by Subject|2|||
127696362|NCT04763265|459516006|FG001|Overall Study|Withdrawal by Subject|1|||
127696363|NCT05609760|459516019|FG000|Overall Study|Lost to Follow-up|0|||
127696364|NCT05609760|459516020|FG001|Overall Study|Lost to Follow-up|1|||
127696365|NCT05609760|459516019|FG000|Overall Study|Withdrawal by Subject|1|||
127696366|NCT05609760|459516020|FG001|Overall Study|Withdrawal by Subject|0|||
127696367|NCT04049643|459516021|FG000|Overall Study|Lack of Efficacy|1|||
127696368|NCT04049643|459516022|FG001|Overall Study|Lack of Efficacy|1|||
127696369|NCT04049643|459516023|FG002|Overall Study|Lack of Efficacy|0|||
127696370|NCT04049643|459516021|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
127696371|NCT04049643|459516022|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
127696372|NCT04049643|459516023|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
127696373|NCT05089734|459516024|FG000|Overall Study|Still on study|122|||
127696374|NCT05089734|459516025|FG001|Overall Study|Still on study|101|||
127696375|NCT05089734|459516024|FG000|Overall Study|Death|161|||
127696376|NCT05089734|459516025|FG001|Overall Study|Death|179|||
127696377|NCT05089734|459516024|FG000|Overall Study|Withdrew consent|11|||
127696378|NCT05089734|459516025|FG001|Overall Study|Withdrew consent|24|||
127696379|NCT05089734|459516024|FG000|Overall Study|Lost to Follow-up|5|||
127696380|NCT05089734|459516025|FG001|Overall Study|Lost to Follow-up|0|||
127696381|NCT05302596|459516026|FG000|Overall Study|Withdrawal by Subject|1|||
127696382|NCT05302596|459516027|FG001|Overall Study|Withdrawal by Subject|1|||
128039388|NCT02852967|460773957|FG004|Overall Study|Adverse Event|0|||
128039389|NCT02852967|460773953|FG000|Overall Study|Death|1|||
128039390|NCT02852967|460773954|FG001|Overall Study|Death|0|||
128039391|NCT02852967|460773955|FG002|Overall Study|Death|0|||
128039392|NCT02852967|460773956|FG003|Overall Study|Death|0|||
128039393|NCT02852967|460773957|FG004|Overall Study|Death|0|||
128039394|NCT02852967|460773953|FG000|Overall Study|Lost to Follow-up|1|||
128039395|NCT02852967|460773954|FG001|Overall Study|Lost to Follow-up|2|||
128039396|NCT02852967|460773955|FG002|Overall Study|Lost to Follow-up|3|||
128039397|NCT02852967|460773956|FG003|Overall Study|Lost to Follow-up|4|||
128039398|NCT02852967|460773957|FG004|Overall Study|Lost to Follow-up|4|||
128039399|NCT02852967|460773953|FG000|Overall Study|Withdrawal by Subject|6|||
128039400|NCT02852967|460773954|FG001|Overall Study|Withdrawal by Subject|12|||
128039401|NCT02852967|460773955|FG002|Overall Study|Withdrawal by Subject|7|||
128039402|NCT02852967|460773956|FG003|Overall Study|Withdrawal by Subject|10|||
128039403|NCT02852967|460773957|FG004|Overall Study|Withdrawal by Subject|10|||
128039404|NCT02852967|460773953|FG000|Overall Study|SAE|0|||
128039405|NCT02852967|460773954|FG001|Overall Study|SAE|0|||
128039406|NCT02852967|460773955|FG002|Overall Study|SAE|0|||
128039407|NCT02852967|460773956|FG003|Overall Study|SAE|3|||
128039408|NCT02852967|460773957|FG004|Overall Study|SAE|0|||
128039409|NCT02852967|460773953|FG000|Overall Study|Elevated Liver Enzymes|2|||
128039410|NCT02852967|460773954|FG001|Overall Study|Elevated Liver Enzymes|0|||
128039411|NCT02852967|460773955|FG002|Overall Study|Elevated Liver Enzymes|0|||
127601186|NCT00967798|459168873|FG000|Overall Study|Lost to Follow-up|4|||
127696383|NCT04060355|459517744|FG000|Overall Study|Lost to Follow-up|41|||
128039412|NCT02852967|460773956|FG003|Overall Study|Elevated Liver Enzymes|2|||
128039413|NCT02852967|460773957|FG004|Overall Study|Elevated Liver Enzymes|2|||
128039414|NCT02852967|460773953|FG000|Overall Study|Physician Decision|0|||
128039415|NCT02852967|460773954|FG001|Overall Study|Physician Decision|0|||
128039416|NCT02852967|460773955|FG002|Overall Study|Physician Decision|0|||
128039417|NCT02852967|460773956|FG003|Overall Study|Physician Decision|1|||
128039418|NCT02852967|460773957|FG004|Overall Study|Physician Decision|0|||
128039419|NCT02852967|460773953|FG000|Overall Study|Lack of Efficacy|0|||
128039420|NCT02852967|460773954|FG001|Overall Study|Lack of Efficacy|1|||
128039421|NCT02852967|460773955|FG002|Overall Study|Lack of Efficacy|0|||
128039422|NCT02852967|460773956|FG003|Overall Study|Lack of Efficacy|0|||
128039423|NCT02852967|460773957|FG004|Overall Study|Lack of Efficacy|0|||
128039424|NCT02852967|460773953|FG000|Overall Study|Non-compliance|0|||
128039425|NCT02852967|460773954|FG001|Overall Study|Non-compliance|0|||
128039426|NCT02852967|460773955|FG002|Overall Study|Non-compliance|1|||
128039427|NCT02852967|460773956|FG003|Overall Study|Non-compliance|1|||
128039428|NCT02852967|460773957|FG004|Overall Study|Non-compliance|0|||
128039429|NCT02852967|460773953|FG000|Overall Study|Dispensing Drug Violation|0|||
128039430|NCT02852967|460773954|FG001|Overall Study|Dispensing Drug Violation|0|||
128039431|NCT02852967|460773955|FG002|Overall Study|Dispensing Drug Violation|1|||
128039432|NCT02852967|460773956|FG003|Overall Study|Dispensing Drug Violation|0|||
128039433|NCT02852967|460773957|FG004|Overall Study|Dispensing Drug Violation|0|||
128039434|NCT02852967|460773953|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
128039435|NCT02852967|460773954|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
128039436|NCT02852967|460773955|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
128039437|NCT02852967|460773956|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
128039438|NCT02852967|460773957|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
128039439|NCT01693367|460773958|FG000|Overall Study|Withdrawal by Subject|1|||
127601187|NCT00967798|459168874|FG001|Overall Study|Lost to Follow-up|1|||
127601188|NCT01320085|459168875|FG000|Overall Study|Disease Progression|26|||
127601189|NCT01320085|459168876|FG001|Overall Study|Disease Progression|93|||
127601190|NCT01320085|459168877|FG002|Overall Study|Disease Progression|17|||
127601191|NCT01320085|459168875|FG000|Overall Study|Adverse Event|12|||
127601192|NCT01320085|459168876|FG001|Overall Study|Adverse Event|20|||
127601193|NCT01320085|459168877|FG002|Overall Study|Adverse Event|5|||
127601194|NCT01320085|459168875|FG000|Overall Study|Withdrawal by Subject|2|||
127601195|NCT01320085|459168876|FG001|Overall Study|Withdrawal by Subject|4|||
127601196|NCT01320085|459168877|FG002|Overall Study|Withdrawal by Subject|1|||
127601197|NCT01320085|459168875|FG000|Overall Study|Protocol Deviation|1|||
127601198|NCT01320085|459168876|FG001|Overall Study|Protocol Deviation|0|||
127601199|NCT01320085|459168877|FG002|Overall Study|Protocol Deviation|1|||
127601200|NCT01320085|459168875|FG000|Overall Study|Administrative problems|0|||
127601201|NCT01320085|459168876|FG001|Overall Study|Administrative problems|0|||
127601202|NCT01320085|459168877|FG002|Overall Study|Administrative problems|1|||
127601203|NCT03316131|459168878|FG000|Treatment Period 2|Protocol deviation|1|||
127601204|NCT03316131|459168879|FG001|Treatment Period 2|Protocol deviation|0|||
127601205|NCT01409564|459168880|FG000|Overall Study|low medication compliance|4|||
127601206|NCT01409564|459168881|FG001|Overall Study|low medication compliance|3|||
127601207|NCT01409564|459168880|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
127601208|NCT01409564|459168881|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
127601209|NCT03020407|459168887|FG000|Overall Study|Withdrawal by Subject|2|||
127601210|NCT03020407|459168888|FG001|Overall Study|Withdrawal by Subject|1|||
128039440|NCT01693367|460773959|FG001|Overall Study|Withdrawal by Subject|1|||
128039441|NCT01693367|460773958|FG000|Overall Study|Physician Decision|0|||
128039442|NCT01693367|460773959|FG001|Overall Study|Physician Decision|1|||
128039443|NCT01870869|460773960|FG000|Overall Study|Implanted with nonstudy device|1|||
128039444|NCT01870869|460773961|FG001|Overall Study|Implanted with nonstudy device|3|||
128039445|NCT01870869|460773962|FG002|Overall Study|Implanted with nonstudy device|14|||
128039446|NCT01870869|460773963|FG003|Overall Study|Implanted with nonstudy device|4|||
128039447|NCT01870869|460773960|FG000|Overall Study|Death|0|||
128039448|NCT01870869|460773961|FG001|Overall Study|Death|0|||
127601211|NCT03020407|459168887|FG000|Overall Study|Lost to Follow-up|2|||
127601212|NCT03020407|459168888|FG001|Overall Study|Lost to Follow-up|3|||
127601213|NCT03020407|459168887|FG000|Overall Study|Protocol Violation|0|||
127601214|NCT03020407|459168888|FG001|Overall Study|Protocol Violation|1|||
127601215|NCT02699554|459168889|FG000|Overall Study|Lost to Follow-up|9|||
127601216|NCT00788151|459168890|FG000|Overall Study|Other adverse event|0|||
127601217|NCT00788151|459168891|FG001|Overall Study|Other adverse event|2|||
127601218|NCT00788151|459168890|FG000|Overall Study|Protocol Violation|0|||
127601219|NCT00788151|459168891|FG001|Overall Study|Protocol Violation|1|||
127601220|NCT00788151|459168890|FG000|Overall Study|Withdrawal by Subject|13|||
127601221|NCT00788151|459168891|FG001|Overall Study|Withdrawal by Subject|6|||
127601222|NCT00788151|459168890|FG000|Overall Study|Enrolled but not treated|1|||
127601223|NCT00788151|459168891|FG001|Overall Study|Enrolled but not treated|1|||
127601224|NCT00503009|459168892|FG000|Overall Study|Protocol Violation|1|||
127601225|NCT00503009|459168893|FG001|Overall Study|Protocol Violation|0|||
128039449|NCT01870869|460773962|FG002|Overall Study|Death|7|||
128039450|NCT01870869|460773963|FG003|Overall Study|Death|1|||
128039451|NCT01870869|460773960|FG000|Overall Study|Subject choice|6|||
128039452|NCT01870869|460773961|FG001|Overall Study|Subject choice|2|||
128039453|NCT01870869|460773962|FG002|Overall Study|Subject choice|22|||
128039454|NCT01870869|460773963|FG003|Overall Study|Subject choice|8|||
128039455|NCT01870869|460773960|FG000|Overall Study|Lost to Follow-up|10|||
128039456|NCT01870869|460773961|FG001|Overall Study|Lost to Follow-up|2|||
128039457|NCT01870869|460773962|FG002|Overall Study|Lost to Follow-up|25|||
128039458|NCT01870869|460773963|FG003|Overall Study|Lost to Follow-up|3|||
128039459|NCT01870869|460773960|FG000|Overall Study|Reason not Specified|1|||
128039460|NCT01870869|460773961|FG001|Overall Study|Reason not Specified|2|||
128039461|NCT01870869|460773962|FG002|Overall Study|Reason not Specified|20|||
128039462|NCT01870869|460773963|FG003|Overall Study|Reason not Specified|4|||
128039463|NCT01870869|460773960|FG000|Overall Study|Not evaluable|10|||
127601226|NCT00503009|459168894|FG002|Overall Study|Protocol Violation|1|||
127601227|NCT00503009|459168892|FG000|Overall Study|Withdrawal by Subject|0|||
127601228|NCT00503009|459168893|FG001|Overall Study|Withdrawal by Subject|1|||
127601229|NCT00503009|459168894|FG002|Overall Study|Withdrawal by Subject|1|||
127601230|NCT00503009|459168892|FG000|Overall Study|Physician Decision|0|||
127601231|NCT00503009|459168893|FG001|Overall Study|Physician Decision|1|||
127601232|NCT00503009|459168894|FG002|Overall Study|Physician Decision|1|||
127601233|NCT01349803|459168895|FG000|Overall Study|Adverse Event|0|||
127601234|NCT01349803|459168896|FG001|Overall Study|Adverse Event|0|||
127696384|NCT01140880|459517745|FG000|Overall Study|Death|0|||
127696385|NCT01140880|459517746|FG001|Overall Study|Death|1|||
127696386|NCT01140880|459517745|FG000|Overall Study|Withdrawal by Subject|6|||
127696387|NCT01140880|459517746|FG001|Overall Study|Withdrawal by Subject|3|||
127696388|NCT01140880|459517745|FG000|Overall Study|Lost to Follow-up|8|||
127696389|NCT01140880|459517746|FG001|Overall Study|Lost to Follow-up|10|||
127696390|NCT01140880|459517745|FG000|Overall Study|Protocol Violation|0|||
127696391|NCT01140880|459517746|FG001|Overall Study|Protocol Violation|30|||
127696392|NCT03131648|459517748|FG000|Initial Treatment Period|Not dosed|2|||
127696393|NCT03131648|459517749|FG001|Initial Treatment Period|Not dosed|2|||
127696394|NCT03131648|459517750|FG002|Initial Treatment Period|Not dosed|0|||
127696395|NCT03131648|459517751|FG003|Initial Treatment Period|Not dosed|0|||
127601235|NCT01349803|459168897|FG002|Overall Study|Adverse Event|0|||
127601236|NCT01349803|459168898|FG003|Overall Study|Adverse Event|2|||
127696396|NCT03131648|459517752|FG004|Initial Treatment Period|Not dosed|0|||
127696397|NCT03131648|459517753|FG005|Initial Treatment Period|Not dosed|0|||
127696398|NCT03131648|459517754|FG006|Initial Treatment Period|Not dosed|0|||
128039464|NCT01870869|460773961|FG001|Overall Study|Not evaluable|5|||
128039465|NCT01870869|460773962|FG002|Overall Study|Not evaluable|42|||
128039466|NCT01870869|460773963|FG003|Overall Study|Not evaluable|10|||
127601237|NCT01349803|459168895|FG000|Overall Study|Withdrawal by Subject|1|||
127601238|NCT01349803|459168896|FG001|Overall Study|Withdrawal by Subject|0|||
127601239|NCT01349803|459168897|FG002|Overall Study|Withdrawal by Subject|0|||
127601240|NCT01349803|459168898|FG003|Overall Study|Withdrawal by Subject|0|||
127601241|NCT01349803|459168895|FG000|Overall Study|Protocol-specified criteria|0|||
127601242|NCT01349803|459168896|FG001|Overall Study|Protocol-specified criteria|1|||
127601243|NCT01349803|459168897|FG002|Overall Study|Protocol-specified criteria|3|||
127601244|NCT01349803|459168898|FG003|Overall Study|Protocol-specified criteria|0|||
127601245|NCT00100815|459168899|FG000|Overall Study|Progression|24|||
127601246|NCT00100815|459168899|FG000|Overall Study|Adverse Event|18|||
127601247|NCT00100815|459168899|FG000|Overall Study|Death|4|||
127601248|NCT00100815|459168899|FG000|Overall Study|Other|3|||
127601249|NCT01710033|459168900|FG000|Stage 2|Adverse Event|0|||
127601250|NCT01710033|459168901|FG001|Stage 2|Adverse Event|0|||
127601251|NCT01710033|459168902|FG002|Stage 2|Adverse Event|0|||
127601252|NCT01710033|459168903|FG003|Stage 2|Adverse Event|0|||
127601253|NCT01710033|459168904|FG004|Stage 2|Adverse Event|1|||
128039467|NCT02286895|460773964|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
128039468|NCT02286895|460773965|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
128039469|NCT02286895|460773964|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
128039470|NCT02286895|460773965|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
128039471|NCT02286895|460773964|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
128039472|NCT02286895|460773965|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
128039473|NCT03036852|460773966|FG000|Overall Study|Death|2|||
128039474|NCT03036852|460773966|FG000|Overall Study|Lack of Efficacy|2|||
128039475|NCT03036852|460773966|FG000|Overall Study|Adverse Event|1|||
128039476|NCT03036852|460773966|FG000|Overall Study|Lost to Follow-up|1|||
128039477|NCT01073293|460773967|FG000|Overall Study|Lost to Follow-up|0|||
128039478|NCT01073293|460773968|FG001|Overall Study|Lost to Follow-up|1|||
128039479|NCT01073293|460773967|FG000|Overall Study|Withdrawal by Subject|5|||
128039480|NCT01073293|460773968|FG001|Overall Study|Withdrawal by Subject|10|||
128039481|NCT00002766|460773971|FG000|Overall Study|Withdrawal by Subject|0|||
128039482|NCT00002766|460773972|FG001|Overall Study|Withdrawal by Subject|1|||
128039483|NCT00002766|460773971|FG000|Overall Study|Patient Not Treated|1|||
128039484|NCT00002766|460773972|FG001|Overall Study|Patient Not Treated|2|||
128039485|NCT00002766|460773971|FG000|Overall Study|Adverse Event|1|||
128039486|NCT00002766|460773972|FG001|Overall Study|Adverse Event|1|||
128039487|NCT00002766|460773971|FG000|Overall Study|Protocol Violation|1|||
128039488|NCT00002766|460773972|FG001|Overall Study|Protocol Violation|0|||
128039489|NCT00077974|460773975|FG000|Overall Study|Adverse Event|22|||
128039490|NCT00077974|460773975|FG000|Overall Study|Protocol Violation|1|||
128039491|NCT00077974|460773975|FG000|Overall Study|Withdrawal by Subject|3|||
128039492|NCT00077974|460773975|FG000|Overall Study|Lack of Efficacy|76|||
128039493|NCT00077974|460773975|FG000|Overall Study|Decision of Sponsor|2|||
128039494|NCT00256126|460773976|FG000|Overall Study|Adverse Event|1|||
128039495|NCT00256126|460773977|FG001|Overall Study|Adverse Event|0|||
128039496|NCT00256126|460773976|FG000|Overall Study|Other|1|||
128039497|NCT00256126|460773977|FG001|Overall Study|Other|2|||
128039498|NCT02949011|460773986|FG000|Overall Study|Adverse Event|6|||
128039499|NCT02949011|460773987|FG001|Overall Study|Adverse Event|7|||
128039500|NCT02949011|460773988|FG002|Overall Study|Adverse Event|3|||
128039501|NCT02949011|460773986|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
128039502|NCT02949011|460773987|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
128039503|NCT02949011|460773988|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
128039504|NCT02949011|460773986|FG000|Overall Study|Protocol Deviation|5|||
128039505|NCT02949011|460773987|FG001|Overall Study|Protocol Deviation|3|||
128039506|NCT02949011|460773988|FG002|Overall Study|Protocol Deviation|3|||
128039507|NCT02949011|460773986|FG000|Overall Study|Lack of Efficacy|0|||
127601254|NCT01647282|459168906|FG000|Overall Study|Physician Decision|7|||
127601255|NCT01647282|459168907|FG001|Overall Study|Physician Decision|5|||
127601256|NCT01525550|459168909|FG000|Overall Study|Lost to Follow-up|8|||
127601257|NCT01525550|459168910|FG001|Overall Study|Lost to Follow-up|2|||
127882841|NCT01128153|460194595|FG000|Overall Study|Withdrawal by Subject|2|||
127601258|NCT01525550|459168909|FG000|Overall Study|Death|19|||
127601259|NCT01525550|459168910|FG001|Overall Study|Death|28|||
127601260|NCT01525550|459168909|FG000|Overall Study|Other|0|||
128039508|NCT02949011|460773987|FG001|Overall Study|Lack of Efficacy|2|||
128039509|NCT02949011|460773988|FG002|Overall Study|Lack of Efficacy|0|||
128039510|NCT02949011|460773986|FG000|Overall Study|Withdrawal by Subject|13|||
128039511|NCT02949011|460773987|FG001|Overall Study|Withdrawal by Subject|13|||
128039512|NCT02949011|460773988|FG002|Overall Study|Withdrawal by Subject|21|||
128039513|NCT02949011|460773986|FG000|Overall Study|Lost to Follow-up|7|||
128039514|NCT02949011|460773987|FG001|Overall Study|Lost to Follow-up|5|||
128039515|NCT02949011|460773988|FG002|Overall Study|Lost to Follow-up|5|||
128039516|NCT02949011|460773986|FG000|Overall Study|Death|0|||
128039517|NCT02949011|460773987|FG001|Overall Study|Death|0|||
128039518|NCT02949011|460773988|FG002|Overall Study|Death|1|||
128039519|NCT02949011|460773986|FG000|Overall Study|Miscellaneous|2|||
128039520|NCT02949011|460773987|FG001|Overall Study|Miscellaneous|4|||
128039521|NCT02949011|460773988|FG002|Overall Study|Miscellaneous|6|||
128039522|NCT00163189|460773989|FG000|Overall Study|Other|6|||
128039523|NCT00163189|460773989|FG000|Overall Study|Lost to Follow-up|1|||
128039524|NCT00163189|460773989|FG000|Overall Study|Protocol Violation|2|||
128039525|NCT00163189|460773989|FG000|Overall Study|Death|3|||
128039526|NCT00163189|460773989|FG000|Overall Study|Adverse Event|6|||
128039527|NCT00163189|460773989|FG000|Overall Study|Lack of Efficacy|7|||
128039528|NCT00163189|460773989|FG000|Overall Study|Study terminated by sponsor|11|||
128039529|NCT00163189|460773989|FG000|Overall Study|Withdrawal by Subject|11|||
128039530|NCT00163189|460773989|FG000|Overall Study|Did not meet continuation criterion|16|||
128039531|NCT02154061|460773990|FG000|Overall Study|Pregnancy|1|||
128039532|NCT02154061|460773991|FG001|Overall Study|Pregnancy|0|||
127788225|NCT01356407|459849928|FG000|Overall Study|Could not afford IMP administration|0|||
127788226|NCT01356407|459849929|FG001|Overall Study|Could not afford IMP administration|1|||
128039533|NCT02154061|460773990|FG000|Overall Study|enrolled but not vaccinated|1|||
128039534|NCT02154061|460773991|FG001|Overall Study|enrolled but not vaccinated|0|||
128039535|NCT00506142|460773992|FG000|Overall Study|Adverse Event|8|||
128039536|NCT00506142|460773993|FG001|Overall Study|Adverse Event|7|||
128039537|NCT00506142|460773992|FG000|Overall Study|Lack of Efficacy|21|||
127788227|NCT01356407|459849928|FG000|Overall Study|Not complete Endoscopy|2|||
127788228|NCT01356407|459849929|FG001|Overall Study|Not complete Endoscopy|2|||
127788229|NCT02055820|459849932|FG000|Phase I: Dose-Finding|Death|1|||
127788230|NCT02055820|459849933|FG001|Phase I: Dose-Finding|Death|0|||
127788231|NCT02055820|459849934|FG002|Phase I: Dose-Finding|Death|1|||
127788232|NCT02055820|459849935|FG003|Phase I: Dose-Finding|Death|2|||
127788233|NCT02055820|459849936|FG004|Phase I: Dose-Finding|Death|0|||
127788234|NCT02055820|459849937|FG005|Phase I: Dose-Finding|Death|1|||
128039538|NCT00506142|460773993|FG001|Overall Study|Lack of Efficacy|7|||
128039539|NCT00506142|460773992|FG000|Overall Study|Withdrawal by Subject|4|||
128039540|NCT00506142|460773993|FG001|Overall Study|Withdrawal by Subject|5|||
128039541|NCT00506142|460773992|FG000|Overall Study|Physician Decision|1|||
128039542|NCT00506142|460773993|FG001|Overall Study|Physician Decision|0|||
128039543|NCT00506142|460773992|FG000|Overall Study|New health condition|1|||
128039544|NCT00506142|460773993|FG001|Overall Study|New health condition|0|||
128039545|NCT00454116|460773994|FG000|Overall Study|Adverse Event|5|||
128039546|NCT00454116|460773995|FG001|Overall Study|Adverse Event|11|||
128039547|NCT00454116|460773996|FG002|Overall Study|Adverse Event|9|||
128039548|NCT00454116|460773994|FG000|Overall Study|Condition under investigation worsened|17|||
128039549|NCT00454116|460773995|FG001|Overall Study|Condition under investigation worsened|13|||
128039550|NCT00454116|460773996|FG002|Overall Study|Condition under investigation worsened|18|||
128039551|NCT00454116|460773994|FG000|Overall Study|Withdrawal by Subject|3|||
128039552|NCT00454116|460773995|FG001|Overall Study|Withdrawal by Subject|3|||
128039553|NCT00454116|460773996|FG002|Overall Study|Withdrawal by Subject|1|||
128039554|NCT00454116|460773994|FG000|Overall Study|Other|2|||
128039555|NCT00454116|460773995|FG001|Overall Study|Other|2|||
128039556|NCT00454116|460773996|FG002|Overall Study|Other|0|||
128039557|NCT01917318|460773999|FG000|First Treatment|Withdrawal by Subject|0|||
128039558|NCT01917318|460774000|FG001|First Treatment|Withdrawal by Subject|1|||
128039559|NCT00742625|460774001|FG000|Remission Induction|Progression|6|||
128039560|NCT00742625|460774001|FG000|Remission Induction|Failed induction|8|||
128039561|NCT00742625|460774001|FG000|Remission Induction|Adverse Event|3|||
128039562|NCT00742625|460774001|FG000|Remission Induction|Death|10|||
128039563|NCT00742625|460774001|FG000|Remission Induction|Refusal|5|||
128039564|NCT00742625|460774001|FG000|Remission Induction|Non protocol treatment|17|||
128039565|NCT00742625|460774001|FG000|Remission Induction|Other, not specified|5|||
128039566|NCT00742625|460774001|FG000|Consolidation|Progression|5|||
128039567|NCT00742625|460774001|FG000|Consolidation|Adverse Event|1|||
128039568|NCT00742625|460774001|FG000|Consolidation|Death|1|||
128039569|NCT00742625|460774001|FG000|Consolidation|Refused|1|||
128039570|NCT00742625|460774001|FG000|Consolidation|Non protocol therapy|13|||
128039571|NCT03338400|460774002|FG000|Overall Study|Lost to Follow-up|1|||
128039572|NCT03338400|460774003|FG001|Overall Study|Lost to Follow-up|2|||
128039573|NCT01865487|460774006|FG000|Overall Study|Lost to Follow-up|0|||
128039574|NCT01865487|460774007|FG001|Overall Study|Lost to Follow-up|0|||
128039575|NCT01865487|460774008|FG002|Overall Study|Lost to Follow-up|0|||
128039576|NCT01865487|460774009|FG003|Overall Study|Lost to Follow-up|1|||
128039577|NCT01865487|460774010|FG004|Overall Study|Lost to Follow-up|0|||
128039578|NCT01865487|460774011|FG005|Overall Study|Lost to Follow-up|0|||
128039579|NCT01865487|460774012|FG006|Overall Study|Lost to Follow-up|1|||
128039580|NCT01865487|460774013|FG007|Overall Study|Lost to Follow-up|0|||
128039581|NCT01865487|460774014|FG008|Overall Study|Lost to Follow-up|0|||
128039582|NCT01865487|460774015|FG009|Overall Study|Lost to Follow-up|0|||
128039583|NCT01865487|460774006|FG000|Overall Study|Withdrawal by Subject|0|||
128039584|NCT01865487|460774007|FG001|Overall Study|Withdrawal by Subject|0|||
128039585|NCT01865487|460774008|FG002|Overall Study|Withdrawal by Subject|0|||
128039586|NCT01865487|460774009|FG003|Overall Study|Withdrawal by Subject|0|||
128039587|NCT01865487|460774010|FG004|Overall Study|Withdrawal by Subject|1|||
128039588|NCT01865487|460774011|FG005|Overall Study|Withdrawal by Subject|0|||
128039589|NCT01865487|460774012|FG006|Overall Study|Withdrawal by Subject|0|||
128039590|NCT01865487|460774013|FG007|Overall Study|Withdrawal by Subject|0|||
128039591|NCT01865487|460774014|FG008|Overall Study|Withdrawal by Subject|0|||
128039592|NCT01865487|460774015|FG009|Overall Study|Withdrawal by Subject|0|||
128039593|NCT01213082|460774016|FG000|Overall Study|Lost to Follow-up|6|||
128039594|NCT01213082|460774017|FG001|Overall Study|Lost to Follow-up|7|||
128039595|NCT01213082|460774018|FG002|Overall Study|Lost to Follow-up|4|||
128039596|NCT01213082|460774016|FG000|Overall Study|Physician Decision|0|||
128039597|NCT01213082|460774017|FG001|Overall Study|Physician Decision|0|||
128039598|NCT01213082|460774018|FG002|Overall Study|Physician Decision|1|||
128039599|NCT03848416|460774024|FG000|Overall Study|Withdrawal by Subject|1|||
128039600|NCT03848416|460774025|FG001|Overall Study|Withdrawal by Subject|0|||
127788235|NCT02055820|459849938|FG006|Phase I: Dose-Finding|Death|1|||
127788236|NCT02055820|459849939|FG007|Phase I: Dose-Finding|Death|0|||
127788237|NCT02055820|459849940|FG008|Phase I: Dose-Finding|Death|0|||
127788238|NCT02055820|459849941|FG009|Phase I: Dose-Finding|Death|0|||
128039601|NCT03848416|460774026|FG002|Overall Study|Withdrawal by Subject|0|||
128039602|NCT03848416|460774024|FG000|Overall Study|Death|0|||
128039603|NCT03848416|460774025|FG001|Overall Study|Death|0|||
128039604|NCT03848416|460774026|FG002|Overall Study|Death|1|||
127601261|NCT01525550|459168910|FG001|Overall Study|Other|4|||
127788239|NCT02055820|459849932|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
127788240|NCT02055820|459849933|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
127788241|NCT02055820|459849934|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
127788242|NCT02055820|459849935|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
127788243|NCT02055820|459849936|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
127788244|NCT02055820|459849937|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
127788245|NCT02055820|459849938|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
127788246|NCT02055820|459849939|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
127788247|NCT02055820|459849940|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
127788248|NCT02055820|459849941|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
127788249|NCT02055820|459849932|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
127788250|NCT02055820|459849933|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
127788251|NCT02055820|459849934|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
127788252|NCT02055820|459849935|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
127788253|NCT02055820|459849936|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
127788254|NCT02055820|459849937|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
127788255|NCT02055820|459849938|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
127788256|NCT02055820|459849939|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
127788257|NCT02055820|459849940|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
127788258|NCT02055820|459849941|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
127788259|NCT02055820|459849932|FG000|Phase II: Expansion|Death|0|||
127788260|NCT02055820|459849933|FG001|Phase II: Expansion|Death|0|||
127788261|NCT02055820|459849934|FG002|Phase II: Expansion|Death|0|||
127788262|NCT02055820|459849935|FG003|Phase II: Expansion|Death|0|||
127788263|NCT02055820|459849936|FG004|Phase II: Expansion|Death|33|||
127788264|NCT02055820|459849937|FG005|Phase II: Expansion|Death|0|||
127788265|NCT02055820|459849938|FG006|Phase II: Expansion|Death|0|||
127788266|NCT02055820|459849939|FG007|Phase II: Expansion|Death|0|||
128039605|NCT02639390|460774027|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
128039606|NCT02639390|460774028|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
128039607|NCT01908140|460774029|FG000|Overall Study|Other or Progressive Disease|5|||
128039608|NCT01908140|460774030|FG001|Overall Study|Other or Progressive Disease|12|||
128039609|NCT01908140|460774029|FG000|Overall Study|Lack of Efficacy|7|||
128039610|NCT01908140|460774030|FG001|Overall Study|Lack of Efficacy|5|||
128039611|NCT01908140|460774029|FG000|Overall Study|Withdrawal by Subject|23|||
128039612|NCT01908140|460774030|FG001|Overall Study|Withdrawal by Subject|24|||
128039613|NCT01908140|460774029|FG000|Overall Study|Lost to Follow-up|1|||
128039614|NCT01908140|460774030|FG001|Overall Study|Lost to Follow-up|6|||
128039615|NCT01908140|460774029|FG000|Overall Study|Protocol Violation|8|||
128039616|NCT01908140|460774030|FG001|Overall Study|Protocol Violation|9|||
128039617|NCT01908140|460774029|FG000|Overall Study|Adverse Event|22|||
128039618|NCT01908140|460774030|FG001|Overall Study|Adverse Event|23|||
128039619|NCT00698828|460774031|FG000|Overall Study|Adverse Event|3|||
128039620|NCT00698828|460774032|FG001|Overall Study|Adverse Event|4|||
128039621|NCT00698828|460774033|FG002|Overall Study|Adverse Event|4|||
128039622|NCT00698828|460774031|FG000|Overall Study|Death|0|||
128039623|NCT00698828|460774032|FG001|Overall Study|Death|0|||
128039624|NCT00698828|460774033|FG002|Overall Study|Death|1|||
128039625|NCT00698828|460774031|FG000|Overall Study|Exacerbation of COPD|1|||
128039626|NCT00698828|460774032|FG001|Overall Study|Exacerbation of COPD|3|||
128039627|NCT00698828|460774033|FG002|Overall Study|Exacerbation of COPD|0|||
127601262|NCT01525550|459168909|FG000|Overall Study|Sponsor's Decision|30|||
127601263|NCT01525550|459168910|FG001|Overall Study|Sponsor's Decision|11|||
127601264|NCT01525550|459168909|FG000|Overall Study|Withdrawal by Subject|4|||
127601265|NCT01525550|459168910|FG001|Overall Study|Withdrawal by Subject|0|||
127601266|NCT03720470|459168919|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
127601267|NCT03720470|459168920|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
127601268|NCT03720470|459168921|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
127696399|NCT03131648|459517755|FG007|Initial Treatment Period|Not dosed|0|||
127696400|NCT03131648|459517748|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
127696401|NCT03131648|459517749|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
128039628|NCT00698828|460774031|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
127696402|NCT03131648|459517750|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
127696403|NCT03131648|459517751|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
127696404|NCT03131648|459517752|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
127696405|NCT03131648|459517753|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
127696406|NCT03131648|459517754|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
128039629|NCT00698828|460774032|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
127601269|NCT03720470|459168922|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
127601270|NCT03720470|459168923|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
127696407|NCT03131648|459517755|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
127696408|NCT03131648|459517748|FG000|Open-label Treatment|Discontinued IMP|0|||
127696409|NCT03131648|459517749|FG001|Open-label Treatment|Discontinued IMP|0|||
127696410|NCT03131648|459517750|FG002|Open-label Treatment|Discontinued IMP|0|||
127788267|NCT02055820|459849940|FG008|Phase II: Expansion|Death|0|||
127788268|NCT02055820|459849941|FG009|Phase II: Expansion|Death|0|||
127788269|NCT02055820|459849932|FG000|Phase II: Expansion|Lost to Follow-up|0|||
127788270|NCT02055820|459849933|FG001|Phase II: Expansion|Lost to Follow-up|0|||
127788271|NCT02055820|459849934|FG002|Phase II: Expansion|Lost to Follow-up|0|||
128039630|NCT00698828|460774033|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
128039631|NCT00698828|460774031|FG000|Overall Study|Investigator/Sponsor decision|1|||
128039632|NCT00698828|460774032|FG001|Overall Study|Investigator/Sponsor decision|0|||
127788272|NCT02055820|459849935|FG003|Phase II: Expansion|Lost to Follow-up|0|||
127788273|NCT02055820|459849936|FG004|Phase II: Expansion|Lost to Follow-up|4|||
127788274|NCT02055820|459849937|FG005|Phase II: Expansion|Lost to Follow-up|0|||
127788275|NCT02055820|459849938|FG006|Phase II: Expansion|Lost to Follow-up|0|||
127788276|NCT02055820|459849939|FG007|Phase II: Expansion|Lost to Follow-up|0|||
128039633|NCT00698828|460774033|FG002|Overall Study|Investigator/Sponsor decision|2|||
128039634|NCT00698828|460774031|FG000|Overall Study|Lost to Follow-up|1|||
128039635|NCT00698828|460774032|FG001|Overall Study|Lost to Follow-up|1|||
128039636|NCT00698828|460774033|FG002|Overall Study|Lost to Follow-up|0|||
128039637|NCT00698828|460774031|FG000|Overall Study|Withdrew consent|0|||
128039638|NCT00698828|460774032|FG001|Overall Study|Withdrew consent|7|||
128039639|NCT00698828|460774033|FG002|Overall Study|Withdrew consent|4|||
128039640|NCT00698828|460774031|FG000|Overall Study|Withdrew consent (not treated)|2|||
128039641|NCT00698828|460774032|FG001|Overall Study|Withdrew consent (not treated)|0|||
127696411|NCT03131648|459517751|FG003|Open-label Treatment|Discontinued IMP|0|||
127696412|NCT03131648|459517752|FG004|Open-label Treatment|Discontinued IMP|0|||
127696413|NCT03131648|459517753|FG005|Open-label Treatment|Discontinued IMP|0|||
127696414|NCT03131648|459517754|FG006|Open-label Treatment|Discontinued IMP|112|||
127696415|NCT03131648|459517755|FG007|Open-label Treatment|Discontinued IMP|0|||
127696416|NCT03131648|459517748|FG000|Open-label Treatment|Completed Week 50|0|||
127696417|NCT03131648|459517749|FG001|Open-label Treatment|Completed Week 50|0|||
127696418|NCT03131648|459517750|FG002|Open-label Treatment|Completed Week 50|0|||
127696419|NCT03131648|459517751|FG003|Open-label Treatment|Completed Week 50|0|||
127696420|NCT03131648|459517752|FG004|Open-label Treatment|Completed Week 50|0|||
127696421|NCT03131648|459517753|FG005|Open-label Treatment|Completed Week 50|0|||
127696422|NCT03131648|459517754|FG006|Open-label Treatment|Completed Week 50|6|||
127696423|NCT03131648|459517755|FG007|Open-label Treatment|Completed Week 50|0|||
127696424|NCT03131648|459517748|FG000|Maintenance Treatment Period|Not dosed|0|||
127696425|NCT03131648|459517749|FG001|Maintenance Treatment Period|Not dosed|0|||
127696426|NCT03131648|459517750|FG002|Maintenance Treatment Period|Not dosed|3|||
127696427|NCT03131648|459517751|FG003|Maintenance Treatment Period|Not dosed|2|||
127788277|NCT02055820|459849940|FG008|Phase II: Expansion|Lost to Follow-up|0|||
127788278|NCT02055820|459849941|FG009|Phase II: Expansion|Lost to Follow-up|0|||
128039642|NCT00698828|460774033|FG002|Overall Study|Withdrew consent (not treated)|0|||
127696428|NCT03131648|459517752|FG004|Maintenance Treatment Period|Not dosed|1|||
127696429|NCT03131648|459517753|FG005|Maintenance Treatment Period|Not dosed|0|||
127696430|NCT03131648|459517754|FG006|Maintenance Treatment Period|Not dosed|0|||
128039643|NCT02013609|460774034|FG000|Overall Study|Withdrawal by Subject|9|||
128039644|NCT02013609|460774034|FG000|Overall Study|Lost to Follow-up|3|||
127696431|NCT03131648|459517755|FG007|Maintenance Treatment Period|Not dosed|0|||
128039645|NCT02013609|460774034|FG000|Overall Study|Adverse Event|3|||
127788279|NCT02055820|459849932|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
128039646|NCT02013609|460774034|FG000|Overall Study|Met Withdrawal Criteria|3|||
128039647|NCT00856609|460774035|FG000|Overall Study|Adverse Event|1|||
128039648|NCT00856609|460774036|FG001|Overall Study|Adverse Event|0|||
128039649|NCT00783432|460774037|FG000|Overall Study|Adverse Event|22|||
128039650|NCT00783432|460774038|FG001|Overall Study|Adverse Event|17|||
128039651|NCT00783432|460774037|FG000|Overall Study|Lack of Efficacy|20|||
128039652|NCT00783432|460774038|FG001|Overall Study|Lack of Efficacy|21|||
128039653|NCT00783432|460774037|FG000|Overall Study|Lost to Follow-up|11|||
128039654|NCT00783432|460774038|FG001|Overall Study|Lost to Follow-up|6|||
128039655|NCT00783432|460774037|FG000|Overall Study|Withdrawal by Subject|23|||
128039656|NCT00783432|460774038|FG001|Overall Study|Withdrawal by Subject|20|||
128039657|NCT00783432|460774037|FG000|Overall Study|subject moved|3|||
128039658|NCT00783432|460774038|FG001|Overall Study|subject moved|5|||
128039659|NCT00783432|460774037|FG000|Overall Study|Protocol Violation|6|||
128039660|NCT00783432|460774038|FG001|Overall Study|Protocol Violation|9|||
128039661|NCT01436110|460774039|FG000|Overall Study|Lack of Efficacy|23|||
128039662|NCT01436110|460774040|FG001|Overall Study|Lack of Efficacy|14|||
128039663|NCT01436110|460774041|FG002|Overall Study|Lack of Efficacy|9|||
128039664|NCT01436110|460774039|FG000|Overall Study|Withdrawal by Subject|6|||
128039665|NCT01436110|460774040|FG001|Overall Study|Withdrawal by Subject|8|||
128039666|NCT01436110|460774041|FG002|Overall Study|Withdrawal by Subject|4|||
128039667|NCT01436110|460774039|FG000|Overall Study|Adverse Event|2|||
128039668|NCT01436110|460774040|FG001|Overall Study|Adverse Event|1|||
128039669|NCT01436110|460774041|FG002|Overall Study|Adverse Event|2|||
128039670|NCT01436110|460774039|FG000|Overall Study|Physician Decision|3|||
128039671|NCT01436110|460774040|FG001|Overall Study|Physician Decision|1|||
128039672|NCT01436110|460774041|FG002|Overall Study|Physician Decision|1|||
128039673|NCT01436110|460774039|FG000|Overall Study|Lost to Follow-up|1|||
128039674|NCT01436110|460774040|FG001|Overall Study|Lost to Follow-up|1|||
128039675|NCT01436110|460774041|FG002|Overall Study|Lost to Follow-up|3|||
128039676|NCT01436110|460774039|FG000|Overall Study|Protocol Violation|3|||
128039677|NCT01436110|460774040|FG001|Overall Study|Protocol Violation|1|||
128039678|NCT01436110|460774041|FG002|Overall Study|Protocol Violation|1|||
128039679|NCT01436110|460774039|FG000|Overall Study|Did Not Receive Trial Medication|1|||
128039680|NCT01436110|460774040|FG001|Overall Study|Did Not Receive Trial Medication|0|||
128039681|NCT01436110|460774041|FG002|Overall Study|Did Not Receive Trial Medication|3|||
128039682|NCT03273907|460774043|FG000|Overall Study|Death|1|||
128039683|NCT03273907|460774043|FG000|Overall Study|Lost to Follow-up|4|||
128039684|NCT03273907|460774043|FG000|Overall Study|Withdrawal by Subject|2|||
128039685|NCT03273907|460774043|FG000|Overall Study|COVID 19|2|||
128039686|NCT00110214|460774044|FG000|Overall Study|Never started treatment|21|||
128039687|NCT00110214|460774045|FG001|Overall Study|Never started treatment|20|||
128039688|NCT00110214|460774044|FG000|Overall Study|Disease progression or death|260|||
128039689|NCT00110214|460774045|FG001|Overall Study|Disease progression or death|151|||
128039690|NCT00110214|460774044|FG000|Overall Study|Adverse Event|115|||
128039691|NCT00110214|460774045|FG001|Overall Study|Adverse Event|192|||
128039692|NCT00110214|460774044|FG000|Overall Study|Refused further treatment|52|||
128039693|NCT00110214|460774045|FG001|Overall Study|Refused further treatment|65|||
128039694|NCT00110214|460774044|FG000|Overall Study|Other (not specified)|61|||
128039695|NCT00110214|460774045|FG001|Overall Study|Other (not specified)|75|||
128039696|NCT01088503|460774046|FG000|Overall Study|Withdrawal by Subject|118|||
128039697|NCT01088503|460774047|FG001|Overall Study|Withdrawal by Subject|327|||
127601271|NCT03720470|459168924|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
127601272|NCT03720470|459168919|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
127601273|NCT03720470|459168920|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
127601274|NCT03720470|459168921|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
127601275|NCT03720470|459168922|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
127601276|NCT03720470|459168923|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
127601277|NCT03720470|459168924|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
127601278|NCT03720470|459168919|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
127601279|NCT03720470|459168920|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
127601280|NCT03720470|459168921|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
127788280|NCT02055820|459849933|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
128039698|NCT01088503|460774048|FG002|Overall Study|Withdrawal by Subject|10|||
128039699|NCT01088503|460774046|FG000|Overall Study|Death|64|||
128039700|NCT01088503|460774047|FG001|Overall Study|Death|358|||
128039701|NCT01088503|460774048|FG002|Overall Study|Death|7|||
128039702|NCT01531998|460774049|FG000|Overall Study|Withdrawal by Subject|3|||
128039703|NCT00186628|460774054|FG000|Overall Study|Death|2|||
128039704|NCT00186628|460774054|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
127601281|NCT03720470|459168922|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
127601282|NCT03720470|459168923|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
128039705|NCT02581891|460774055|FG000|Overall Study|Adverse Event|4|||
128039706|NCT02581891|460774056|FG001|Overall Study|Adverse Event|6|||
128039707|NCT02581891|460774055|FG000|Overall Study|Death|3|||
128039708|NCT02581891|460774056|FG001|Overall Study|Death|4|||
128039709|NCT02581891|460774055|FG000|Overall Study|Lost to Follow-up|1|||
128039710|NCT02581891|460774056|FG001|Overall Study|Lost to Follow-up|2|||
128039711|NCT02581891|460774055|FG000|Overall Study|Physician Decision|0|||
128039712|NCT02581891|460774056|FG001|Overall Study|Physician Decision|1|||
128039713|NCT02581891|460774055|FG000|Overall Study|Withdrawal by Subject|4|||
128039714|NCT02581891|460774056|FG001|Overall Study|Withdrawal by Subject|5|||
128039715|NCT02581891|460774055|FG000|Overall Study|Other Reasons|3|||
128039716|NCT02581891|460774056|FG001|Overall Study|Other Reasons|1|||
128039717|NCT02581891|460774055|FG000|Overall Study|Discontinued during followup|1|||
128039718|NCT02581891|460774056|FG001|Overall Study|Discontinued during followup|0|||
128039719|NCT02927795|460774057|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
128039720|NCT02927795|460774057|FG000|Overall Study|Not Treated|4|||
128039721|NCT01076010|460774058|FG000|Overall Study|Death|15|||
128039722|NCT01076010|460774059|FG001|Overall Study|Death|1|||
128039723|NCT01076010|460774060|FG002|Overall Study|Death|0|||
128039724|NCT01076010|460774058|FG000|Overall Study|Adverse Event|7|||
128039725|NCT01076010|460774059|FG001|Overall Study|Adverse Event|2|||
128039726|NCT01076010|460774060|FG002|Overall Study|Adverse Event|0|||
128039727|NCT01076010|460774058|FG000|Overall Study|Progressive disease|90|||
128039728|NCT01076010|460774059|FG001|Overall Study|Progressive disease|30|||
128039729|NCT01076010|460774060|FG002|Overall Study|Progressive disease|1|||
128039730|NCT01076010|460774058|FG000|Overall Study|Lack of Efficacy|4|||
128039731|NCT01076010|460774059|FG001|Overall Study|Lack of Efficacy|0|||
128039732|NCT01076010|460774060|FG002|Overall Study|Lack of Efficacy|0|||
128039733|NCT01076010|460774058|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
128039734|NCT01076010|460774059|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
128039735|NCT01076010|460774060|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
128039736|NCT01076010|460774058|FG000|Overall Study|Significant Surgical Procedure|0|||
128039737|NCT01076010|460774059|FG001|Overall Study|Significant Surgical Procedure|1|||
128039738|NCT01076010|460774060|FG002|Overall Study|Significant Surgical Procedure|0|||
128039739|NCT01076010|460774058|FG000|Overall Study|Protocol Violation|0|||
128039740|NCT01076010|460774059|FG001|Overall Study|Protocol Violation|1|||
128039741|NCT01076010|460774060|FG002|Overall Study|Protocol Violation|0|||
128039742|NCT01076010|460774058|FG000|Overall Study|Noncompliance|1|||
128039743|NCT01076010|460774059|FG001|Overall Study|Noncompliance|1|||
128039744|NCT01076010|460774060|FG002|Overall Study|Noncompliance|0|||
128039745|NCT01076010|460774058|FG000|Overall Study|Withdrawal by Subject|3|||
128039746|NCT01076010|460774059|FG001|Overall Study|Withdrawal by Subject|0|||
128039747|NCT01076010|460774060|FG002|Overall Study|Withdrawal by Subject|1|||
128039748|NCT01076010|460774058|FG000|Overall Study|Other|5|||
128039749|NCT01076010|460774059|FG001|Overall Study|Other|2|||
128039750|NCT01076010|460774060|FG002|Overall Study|Other|0|||
128039751|NCT03440008|460774065|FG000|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|25|||
128039752|NCT03440008|460774066|FG001|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|7|||
128039753|NCT03440008|460774065|FG000|Overall Study|Withdrawal by Subject|1|||
128039754|NCT03440008|460774066|FG001|Overall Study|Withdrawal by Subject|0|||
128039755|NCT03498716|460774074|FG000|Overall Study|Withdrawal by Subject|88|||
128039756|NCT03498716|460774075|FG001|Overall Study|Withdrawal by Subject|73|||
128039757|NCT03498716|460774074|FG000|Overall Study|Study Terminated By Sponsor|933|||
128039758|NCT03498716|460774075|FG001|Overall Study|Study Terminated By Sponsor|927|||
128039759|NCT03498716|460774074|FG000|Overall Study|Lost to Follow-up|15|||
128039760|NCT03498716|460774075|FG001|Overall Study|Lost to Follow-up|26|||
128039761|NCT03498716|460774074|FG000|Overall Study|Disease Relapse|0|||
128039762|NCT03498716|460774075|FG001|Overall Study|Disease Relapse|1|||
128039763|NCT03498716|460774074|FG000|Overall Study|Death|58|||
128039764|NCT03498716|460774075|FG001|Overall Study|Death|72|||
128039765|NCT03498716|460774074|FG000|Overall Study|Physician Decision|4|||
128039766|NCT03498716|460774075|FG001|Overall Study|Physician Decision|2|||
128039767|NCT00760552|460774079|FG000|Overall Study|Death|2|||
128039768|NCT00760552|460774080|FG001|Overall Study|Death|0|||
128039769|NCT00760552|460774079|FG000|Overall Study|Lost to Follow-up|11|||
128039770|NCT00760552|460774080|FG001|Overall Study|Lost to Follow-up|10|||
128039771|NCT01657305|460774085|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
128039772|NCT01657305|460774085|FG000|Overall Study|Withdrawal by Subject|4|||
128039773|NCT01657305|460774085|FG000|Overall Study|Adverse Event|1|||
128039774|NCT01657305|460774085|FG000|Overall Study|Lost to Follow-up|1|||
128039775|NCT01657305|460774085|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
128039776|NCT04103450|460774086|FG000|Overall Study|Adverse Event|4|||
128039777|NCT04103450|460774087|FG001|Overall Study|Adverse Event|2|||
128039778|NCT04103450|460774086|FG000|Overall Study|Lack of Efficacy|3|||
128039779|NCT04103450|460774087|FG001|Overall Study|Lack of Efficacy|0|||
128039780|NCT04103450|460774086|FG000|Overall Study|Withdrawal by Subject|5|||
128039781|NCT04103450|460774087|FG001|Overall Study|Withdrawal by Subject|3|||
128039782|NCT04103450|460774086|FG000|Overall Study|Lost to Follow-up|1|||
128039783|NCT04103450|460774087|FG001|Overall Study|Lost to Follow-up|2|||
128039784|NCT04103450|460774086|FG000|Overall Study|Physician Decision|1|||
128039785|NCT04103450|460774087|FG001|Overall Study|Physician Decision|2|||
128039786|NCT04103450|460774086|FG000|Overall Study|Protocol Violation|1|||
128039787|NCT04103450|460774087|FG001|Overall Study|Protocol Violation|0|||
128039788|NCT04103450|460774086|FG000|Overall Study|Other|1|||
128039789|NCT04103450|460774087|FG001|Overall Study|Other|1|||
128039790|NCT01696643|460774092|FG000|Overall Study|Adverse Event|15|||
128039791|NCT01696643|460774093|FG001|Overall Study|Adverse Event|7|||
128039792|NCT01696643|460774092|FG000|Overall Study|Death|1|||
128039793|NCT01696643|460774093|FG001|Overall Study|Death|2|||
128039794|NCT01696643|460774092|FG000|Overall Study|Lack of Efficacy|3|||
127696432|NCT03131648|459517748|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
128039795|NCT01696643|460774093|FG001|Overall Study|Lack of Efficacy|0|||
128039796|NCT01696643|460774092|FG000|Overall Study|Lost to Follow-up|67|||
128039797|NCT01696643|460774093|FG001|Overall Study|Lost to Follow-up|67|||
128039798|NCT01696643|460774092|FG000|Overall Study|Physician Decision|3|||
128039799|NCT01696643|460774093|FG001|Overall Study|Physician Decision|2|||
128039800|NCT01696643|460774092|FG000|Overall Study|Pregnancy|0|||
128039801|NCT01696643|460774093|FG001|Overall Study|Pregnancy|1|||
128039802|NCT01696643|460774092|FG000|Overall Study|Protocol Violation|7|||
128039803|NCT01696643|460774093|FG001|Overall Study|Protocol Violation|7|||
128039804|NCT01696643|460774092|FG000|Overall Study|Study Terminated by Sponsor|286|||
128039805|NCT01696643|460774093|FG001|Overall Study|Study Terminated by Sponsor|294|||
128039806|NCT01696643|460774092|FG000|Overall Study|Withdrawal by Subject|142|||
128039807|NCT01696643|460774093|FG001|Overall Study|Withdrawal by Subject|149|||
128039808|NCT01696643|460774092|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
128039809|NCT01696643|460774093|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
128039810|NCT01696643|460774092|FG000|Overall Study|Site Error|2|||
128039811|NCT01696643|460774093|FG001|Overall Study|Site Error|1|||
128039812|NCT01696643|460774092|FG000|Overall Study|Participant Incarcerated|0|||
128039813|NCT01696643|460774093|FG001|Overall Study|Participant Incarcerated|1|||
128039814|NCT01696643|460774092|FG000|Overall Study|Medical Monitor Decision|0|||
128039815|NCT01696643|460774093|FG001|Overall Study|Medical Monitor Decision|2|||
128039816|NCT01696643|460774092|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
128039817|NCT01696643|460774093|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
128039818|NCT03821272|460776007|FG000|Overall Study|Death|1|||
128039819|NCT03821272|460776008|FG001|Overall Study|Death|0|||
128039820|NCT03821272|460776007|FG000|Overall Study|Physician Decision|1|||
128039821|NCT03821272|460776008|FG001|Overall Study|Physician Decision|0|||
128039822|NCT03821272|460776007|FG000|Overall Study|Withdrawal by Subject|1|||
128039823|NCT03821272|460776008|FG001|Overall Study|Withdrawal by Subject|0|||
128039824|NCT05904769|460776011|FG000|Overall Study|Physician Decision|0|||
128039825|NCT05904769|460776012|FG001|Overall Study|Physician Decision|6|||
128039826|NCT02255435|460776017|FG000|Overall Study|Patient's Limited Time Availability|0|||
128039827|NCT02255435|460776018|FG001|Overall Study|Patient's Limited Time Availability|0|||
128039828|NCT02255435|460776019|FG002|Overall Study|Patient's Limited Time Availability|0|||
128039829|NCT02255435|460776020|FG003|Overall Study|Patient's Limited Time Availability|0|||
128039830|NCT02255435|460776021|FG004|Overall Study|Patient's Limited Time Availability|0|||
128039831|NCT02255435|460776022|FG005|Overall Study|Patient's Limited Time Availability|0|||
128039832|NCT02255435|460776023|FG006|Overall Study|Patient's Limited Time Availability|0|||
128039833|NCT02255435|460776024|FG007|Overall Study|Patient's Limited Time Availability|1|||
128039834|NCT02255435|460776025|FG008|Overall Study|Patient's Limited Time Availability|0|||
128039835|NCT02255435|460776026|FG009|Overall Study|Patient's Limited Time Availability|0|||
128039836|NCT02255435|460776017|FG000|Overall Study|Withdrawal by Subject|0|||
128039837|NCT02255435|460776018|FG001|Overall Study|Withdrawal by Subject|0|||
128039838|NCT02255435|460776019|FG002|Overall Study|Withdrawal by Subject|0|||
128039839|NCT02255435|460776020|FG003|Overall Study|Withdrawal by Subject|0|||
128039840|NCT02255435|460776021|FG004|Overall Study|Withdrawal by Subject|0|||
128039841|NCT02255435|460776022|FG005|Overall Study|Withdrawal by Subject|0|||
128039842|NCT02255435|460776023|FG006|Overall Study|Withdrawal by Subject|0|||
128039843|NCT02255435|460776024|FG007|Overall Study|Withdrawal by Subject|0|||
128039844|NCT02255435|460776025|FG008|Overall Study|Withdrawal by Subject|1|||
128039845|NCT02255435|460776026|FG009|Overall Study|Withdrawal by Subject|4|||
128039846|NCT02255435|460776017|FG000|Overall Study|Administrative reasons|0|||
128039847|NCT02255435|460776018|FG001|Overall Study|Administrative reasons|0|||
128039848|NCT02255435|460776019|FG002|Overall Study|Administrative reasons|0|||
128039849|NCT02255435|460776020|FG003|Overall Study|Administrative reasons|0|||
128039850|NCT02255435|460776021|FG004|Overall Study|Administrative reasons|0|||
128039851|NCT02255435|460776022|FG005|Overall Study|Administrative reasons|0|||
127696433|NCT03131648|459517749|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
128039852|NCT02255435|460776023|FG006|Overall Study|Administrative reasons|0|||
128039853|NCT02255435|460776024|FG007|Overall Study|Administrative reasons|0|||
128039854|NCT02255435|460776025|FG008|Overall Study|Administrative reasons|0|||
128039855|NCT02255435|460776026|FG009|Overall Study|Administrative reasons|2|||
128039856|NCT06262477|460776027|FG000|Overall Study|Withdrawal by Subject|1|||
128039857|NCT06262477|460776028|FG001|Overall Study|Withdrawal by Subject|0|||
128039858|NCT06262477|460776027|FG000|Overall Study|Adverse Event|0|||
127601283|NCT03720470|459168924|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
127601284|NCT03720470|459168919|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
127601285|NCT03720470|459168920|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
127601286|NCT03720470|459168921|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
127601287|NCT03720470|459168922|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
127601288|NCT03720470|459168923|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
127601289|NCT03720470|459168924|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
127601290|NCT03720470|459168919|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
127601291|NCT03720470|459168920|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
127601292|NCT03720470|459168921|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
127601293|NCT03720470|459168922|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
127601294|NCT03720470|459168923|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
127601295|NCT03720470|459168924|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
127601296|NCT03720470|459168919|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
127601297|NCT03720470|459168920|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
127601298|NCT03720470|459168921|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
127601299|NCT03720470|459168922|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
127601300|NCT03720470|459168923|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
127601301|NCT03720470|459168924|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
127601302|NCT03720470|459168919|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
127601303|NCT03720470|459168920|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
127601304|NCT03720470|459168921|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
127601305|NCT03720470|459168922|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
127601306|NCT03720470|459168923|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
127601307|NCT03720470|459168924|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
127601308|NCT03720470|459168919|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
127601309|NCT03720470|459168920|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
127601310|NCT03720470|459168921|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
127601311|NCT03720470|459168922|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
127601312|NCT03720470|459168923|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
127601313|NCT03720470|459168924|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
127601314|NCT03720470|459168919|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
127601315|NCT03720470|459168920|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
127601316|NCT03720470|459168921|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
127601317|NCT03720470|459168922|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
127601318|NCT03720470|459168923|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
127601319|NCT03720470|459168924|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
128039859|NCT06262477|460776028|FG001|Overall Study|Adverse Event|1|||
128039860|NCT06262477|460776027|FG000|Overall Study|Lost to Follow-up|0|||
128039861|NCT06262477|460776028|FG001|Overall Study|Lost to Follow-up|1|||
128039862|NCT01064440|460776029|FG000|Overall Study|Lost to Follow-up|1|||
128039863|NCT01064440|460776030|FG001|Overall Study|Lost to Follow-up|1|||
128039864|NCT01064440|460776031|FG002|Overall Study|Lost to Follow-up|1|||
128039865|NCT01064440|460776029|FG000|Overall Study|Non-compliance|0|||
128039866|NCT01064440|460776030|FG001|Overall Study|Non-compliance|1|||
128039867|NCT01064440|460776031|FG002|Overall Study|Non-compliance|0|||
128039868|NCT01064440|460776029|FG000|Overall Study|Death|1|||
128039869|NCT01064440|460776030|FG001|Overall Study|Death|0|||
128039870|NCT01064440|460776031|FG002|Overall Study|Death|1|||
128039871|NCT01064440|460776029|FG000|Overall Study|Withdrawal by Subject|0|||
128039872|NCT01064440|460776030|FG001|Overall Study|Withdrawal by Subject|1|||
128039873|NCT01064440|460776031|FG002|Overall Study|Withdrawal by Subject|1|||
128039874|NCT01064440|460776029|FG000|Overall Study|Other: amputation|1|||
128039875|NCT01064440|460776030|FG001|Overall Study|Other: amputation|0|||
128039876|NCT01064440|460776031|FG002|Overall Study|Other: amputation|0|||
128039877|NCT04108130|460776032|FG000|Overall Study|Verbal Agreement Withdrawn|4|||
128039878|NCT04108130|460776033|FG001|Overall Study|Verbal Agreement Withdrawn|2|||
128039879|NCT04108130|460776032|FG000|Overall Study|Consent Withdrawn|9|||
128039880|NCT04108130|460776033|FG001|Overall Study|Consent Withdrawn|6|||
128039881|NCT04108130|460776032|FG000|Overall Study|Surgery Cancelled|4|||
128039882|NCT04108130|460776033|FG001|Overall Study|Surgery Cancelled|4|||
128039883|NCT04108130|460776032|FG000|Overall Study|Found Ineligible for Study|4|||
128039884|NCT04108130|460776033|FG001|Overall Study|Found Ineligible for Study|3|||
128039885|NCT04108130|460776032|FG000|Overall Study|Consent Not Obtained for Other Reasons|3|||
128039886|NCT04108130|460776033|FG001|Overall Study|Consent Not Obtained for Other Reasons|3|||
128039887|NCT04108130|460776032|FG000|Overall Study|Intervention Not Done and No Data Collected|0|||
128039888|NCT04108130|460776033|FG001|Overall Study|Intervention Not Done and No Data Collected|1|||
128039889|NCT03656562|460776034|FG000|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|19|||
128039890|NCT03656562|460776035|FG001|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|13|||
128039891|NCT03656562|460776036|FG002|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|5|||
128039892|NCT03656562|460776037|FG003|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|4|||
128039893|NCT03656562|460776034|FG000|Overall Study|Physician Decision|1|||
128039894|NCT03656562|460776035|FG001|Overall Study|Physician Decision|2|||
128039895|NCT03656562|460776036|FG002|Overall Study|Physician Decision|0|||
128039896|NCT03656562|460776037|FG003|Overall Study|Physician Decision|0|||
128039897|NCT03656562|460776034|FG000|Overall Study|Subject Decision|3|||
128039898|NCT03656562|460776035|FG001|Overall Study|Subject Decision|5|||
128039899|NCT03656562|460776036|FG002|Overall Study|Subject Decision|0|||
128039900|NCT03656562|460776037|FG003|Overall Study|Subject Decision|2|||
128039901|NCT04269265|460776043|FG000|Overall Study|Physician Decision|1|||
128039902|NCT04269265|460776043|FG000|Overall Study|Withdrawal by Subject|1|||
128039903|NCT04269265|460776043|FG000|Overall Study|Overenrolled (sample size reached)|4|||
128039904|NCT05507333|460776044|FG000|Overall Study|Protocol Violation|1|||
128039905|NCT04189445|460776045|FG000|Overall Study|Withdrawal of consent|8|||
128039906|NCT04189445|460776046|FG001|Overall Study|Withdrawal of consent|1|||
127788281|NCT02055820|459849934|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
127788282|NCT02055820|459849935|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
127788283|NCT02055820|459849936|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
127788284|NCT02055820|459849937|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
127788285|NCT02055820|459849938|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
127788286|NCT02055820|459849939|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
127788287|NCT02055820|459849940|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
127788288|NCT02055820|459849941|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
127788289|NCT01157364|459849942|FG000|Overall Study|Other Reasons|1|||
127788290|NCT01157364|459849943|FG001|Overall Study|Other Reasons|1|||
127788291|NCT01157364|459849944|FG002|Overall Study|Other Reasons|2|||
127788292|NCT01157364|459849945|FG003|Overall Study|Other Reasons|1|||
128039907|NCT04189445|460776047|FG002|Overall Study|Withdrawal of consent|0|||
127601320|NCT03720470|459168919|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
127601321|NCT03720470|459168920|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
127601322|NCT03720470|459168921|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
127601323|NCT03720470|459168922|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
127601324|NCT03720470|459168923|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
127601325|NCT03720470|459168924|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
127601326|NCT03720470|459168919|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
127601327|NCT03720470|459168920|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
127601328|NCT03720470|459168921|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
127601329|NCT03720470|459168922|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
127601330|NCT03720470|459168923|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
127601331|NCT03720470|459168924|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
127601332|NCT03720470|459168919|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
127601333|NCT03720470|459168920|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
127601334|NCT03720470|459168921|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
127601335|NCT03720470|459168922|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
127601336|NCT03720470|459168923|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
127601337|NCT03720470|459168924|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
127601338|NCT03720470|459168919|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
127601339|NCT03720470|459168920|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
127601340|NCT03720470|459168921|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
127601341|NCT03720470|459168922|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
127601342|NCT03720470|459168923|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
127601343|NCT03720470|459168924|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
127601344|NCT03720470|459168919|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
127601345|NCT03720470|459168920|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
127601346|NCT03720470|459168921|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
127601347|NCT03720470|459168922|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
127601348|NCT03720470|459168923|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
127601349|NCT03720470|459168924|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
127601350|NCT03720470|459168919|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
127788293|NCT01157364|459849946|FG004|Overall Study|Other Reasons|0|||
127788294|NCT01157364|459849947|FG005|Overall Study|Other Reasons|0|||
128039908|NCT04189445|460776045|FG000|Overall Study|Study Terminated by Sponsor|25|||
128039909|NCT04189445|460776046|FG001|Overall Study|Study Terminated by Sponsor|3|||
128039910|NCT04189445|460776047|FG002|Overall Study|Study Terminated by Sponsor|0|||
128039911|NCT04189445|460776045|FG000|Overall Study|Death|54|||
128039912|NCT04189445|460776046|FG001|Overall Study|Death|24|||
128039913|NCT04189445|460776047|FG002|Overall Study|Death|0|||
128039914|NCT03959527|460776048|FG000|Overall Study|Withdrawal by Subject|8|||
128039915|NCT03959527|460776049|FG001|Overall Study|Withdrawal by Subject|3|||
128039916|NCT03959527|460776048|FG000|Overall Study|Lost to Follow-up|31|||
128039917|NCT03959527|460776049|FG001|Overall Study|Lost to Follow-up|15|||
128039918|NCT03959527|460776048|FG000|Overall Study|Did not meet eligibility criteria|1|||
128039919|NCT03959527|460776049|FG001|Overall Study|Did not meet eligibility criteria|1|||
128039920|NCT03959527|460776048|FG000|Overall Study|Protocol Violation|10|||
128039921|NCT03959527|460776049|FG001|Overall Study|Protocol Violation|5|||
128039922|NCT04838626|460776050|FG000|Overall Study|Adverse Event|2|||
128039923|NCT04838626|460776050|FG000|Overall Study|Physician Decision|6|||
128039924|NCT04838626|460776050|FG000|Overall Study|Protocol Violation|3|||
127601351|NCT03720470|459168920|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
127601352|NCT03720470|459168921|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
127601353|NCT03720470|459168922|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
127601354|NCT03720470|459168923|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
127788295|NCT01157364|459849942|FG000|Overall Study|Personal Reasons|0|||
128039925|NCT04838626|460776050|FG000|Overall Study|Withdrawal by Subject|9|||
128039926|NCT04838626|460776050|FG000|Overall Study|Technical Problems|2|||
128039927|NCT01688466|460776051|FG000|Overall Study|Withdrawal by Subject|2|||
128039928|NCT01688466|460776052|FG001|Overall Study|Withdrawal by Subject|1|||
128039929|NCT01688466|460776051|FG000|Overall Study|Death|0|||
128039930|NCT01688466|460776052|FG001|Overall Study|Death|1|||
128039931|NCT01688466|460776051|FG000|Overall Study|Adverse Event|0|||
128039932|NCT01688466|460776052|FG001|Overall Study|Adverse Event|4|||
128039933|NCT01688466|460776051|FG000|Overall Study|Not evaluable|0|||
128039934|NCT01688466|460776052|FG001|Overall Study|Not evaluable|1|||
128039935|NCT06029959|460776053|FG000|Overall Study|Physician Decision|6|||
128039936|NCT02867384|460776056|FG000|Overall Study|GVHD requiring change in Treatment Medication|14|||
128039937|NCT02867384|460776057|FG001|Overall Study|GVHD requiring change in Treatment Medication|30|||
128039938|NCT02867384|460776058|FG002|Overall Study|GVHD requiring change in Treatment Medication|0|||
128039939|NCT02867384|460776056|FG000|Overall Study|Progression/ Relapse|15|||
128039940|NCT02867384|460776057|FG001|Overall Study|Progression/ Relapse|19|||
128039941|NCT02867384|460776058|FG002|Overall Study|Progression/ Relapse|0|||
128039942|NCT02867384|460776056|FG000|Overall Study|Adverse Event|13|||
128039943|NCT02867384|460776057|FG001|Overall Study|Adverse Event|1|||
128039944|NCT02867384|460776058|FG002|Overall Study|Adverse Event|0|||
128039945|NCT02867384|460776056|FG000|Overall Study|Withdrawal by Subject|6|||
128039946|NCT02867384|460776057|FG001|Overall Study|Withdrawal by Subject|5|||
128039947|NCT02867384|460776058|FG002|Overall Study|Withdrawal by Subject|0|||
128039948|NCT02867384|460776056|FG000|Overall Study|Physician Decision|1|||
128039949|NCT02867384|460776057|FG001|Overall Study|Physician Decision|2|||
128039950|NCT02867384|460776058|FG002|Overall Study|Physician Decision|0|||
128039951|NCT02867384|460776056|FG000|Overall Study|Patient compliance|1|||
128039952|NCT02867384|460776057|FG001|Overall Study|Patient compliance|0|||
128039953|NCT02867384|460776058|FG002|Overall Study|Patient compliance|0|||
128039954|NCT02867384|460776056|FG000|Overall Study|Intercurrent illness or uncontrolled infection|1|||
128039955|NCT02867384|460776057|FG001|Overall Study|Intercurrent illness or uncontrolled infection|1|||
128039956|NCT02867384|460776058|FG002|Overall Study|Intercurrent illness or uncontrolled infection|0|||
128039957|NCT02867384|460776056|FG000|Overall Study|Never start treatment|3|||
128039958|NCT02867384|460776057|FG001|Overall Study|Never start treatment|0|||
128039959|NCT02867384|460776058|FG002|Overall Study|Never start treatment|0|||
128039960|NCT01130883|460776059|FG000|Overall Study|Patient Noncompliance|6|||
128039961|NCT01130883|460776059|FG000|Overall Study|Reason Unknown|1|||
128039962|NCT01130883|460776059|FG000|Overall Study|Adverse Event|3|||
128039963|NCT02585323|460776060|FG000|Week 13 (RCT Period)|Withdrawal by Subject|2|||
128039964|NCT02585323|460776061|FG001|Week 13 (RCT Period)|Withdrawal by Subject|0|||
128039965|NCT02585323|460776060|FG000|Week 13 (RCT Period)|Participant refused assessment|0|||
128039966|NCT02585323|460776061|FG001|Week 13 (RCT Period)|Participant refused assessment|1|||
128039967|NCT02585323|460776060|FG000|Week 26 (All Received Intervention)|Withdrawal by Subject|2|||
128039968|NCT02585323|460776061|FG001|Week 26 (All Received Intervention)|Withdrawal by Subject|0|||
128039969|NCT02585323|460776060|FG000|Week 39 (All Received Intervention)|Withdrawal by Subject|2|||
128039970|NCT02585323|460776061|FG001|Week 39 (All Received Intervention)|Withdrawal by Subject|0|||
128039971|NCT03901469|460776065|FG000|Overall Study|Radiographic Progression|4|||
128039972|NCT03901469|460776066|FG001|Overall Study|Radiographic Progression|6|||
128039973|NCT03901469|460776067|FG002|Overall Study|Radiographic Progression|3|||
128039974|NCT03901469|460776068|FG003|Overall Study|Radiographic Progression|30|||
128039975|NCT03901469|460776069|FG004|Overall Study|Radiographic Progression|7|||
128039976|NCT03901469|460776070|FG005|Overall Study|Radiographic Progression|2|||
128039977|NCT03901469|460776071|FG006|Overall Study|Radiographic Progression|11|||
128039978|NCT03901469|460776065|FG000|Overall Study|Clinical Progression|0|||
127601355|NCT03720470|459168924|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
127601356|NCT03720470|459168919|FG000|Treatment Period: Final 4 Weeks|Other|0|||
127601357|NCT03720470|459168920|FG001|Treatment Period: Final 4 Weeks|Other|1|||
127601358|NCT03720470|459168921|FG002|Treatment Period: Final 4 Weeks|Other|0|||
127601359|NCT03720470|459168922|FG003|Treatment Period: Final 4 Weeks|Other|2|||
127601360|NCT03720470|459168923|FG004|Treatment Period: Final 4 Weeks|Other|1|||
127601361|NCT03720470|459168924|FG005|Treatment Period: Final 4 Weeks|Other|0|||
127601362|NCT00453921|459168925|FG000|Overall Study|Withdrawal by Subject|1|||
127601363|NCT00453921|459168926|FG001|Overall Study|Withdrawal by Subject|1|||
127601364|NCT00453921|459168927|FG002|Overall Study|Withdrawal by Subject|1|||
128039979|NCT03901469|460776066|FG001|Overall Study|Clinical Progression|2|||
128039980|NCT03901469|460776067|FG002|Overall Study|Clinical Progression|0|||
128039981|NCT03901469|460776068|FG003|Overall Study|Clinical Progression|7|||
128039982|NCT03901469|460776069|FG004|Overall Study|Clinical Progression|6|||
127601365|NCT00453921|459168928|FG003|Overall Study|Withdrawal by Subject|1|||
127601366|NCT00453921|459168925|FG000|Overall Study|Lost to Follow-up|0|||
127601367|NCT00453921|459168926|FG001|Overall Study|Lost to Follow-up|0|||
128039983|NCT03901469|460776070|FG005|Overall Study|Clinical Progression|0|||
128039984|NCT03901469|460776071|FG006|Overall Study|Clinical Progression|2|||
128039985|NCT03901469|460776065|FG000|Overall Study|Adverse Event|1|||
128039986|NCT03901469|460776066|FG001|Overall Study|Adverse Event|0|||
128039987|NCT03901469|460776067|FG002|Overall Study|Adverse Event|0|||
128039988|NCT03901469|460776068|FG003|Overall Study|Adverse Event|0|||
128039989|NCT03901469|460776069|FG004|Overall Study|Adverse Event|0|||
127601368|NCT00453921|459168927|FG002|Overall Study|Lost to Follow-up|1|||
128039990|NCT03901469|460776070|FG005|Overall Study|Adverse Event|0|||
127601369|NCT00453921|459168928|FG003|Overall Study|Lost to Follow-up|0|||
127601370|NCT00460031|459168929|FG000|Overall Study|Adverse Event|5|||
127601371|NCT00460031|459168929|FG000|Overall Study|Withdrawal by Subject|5|||
127601372|NCT00460031|459168929|FG000|Overall Study|Death|1|||
127601373|NCT04210310|459168939|FG000|Overall Study|Lost to Follow-up|32|||
127601374|NCT04210310|459168940|FG001|Overall Study|Lost to Follow-up|1|||
127601375|NCT00467259|459168946|FG000|Overall Study|Adverse Event|24|||
127601376|NCT00467259|459168947|FG001|Overall Study|Adverse Event|90|||
127601377|NCT00467259|459168946|FG000|Overall Study|Protocol Violation|1|||
127601378|NCT00467259|459168947|FG001|Overall Study|Protocol Violation|7|||
127601379|NCT00467259|459168946|FG000|Overall Study|Withdrawal by Subject|34|||
127601380|NCT00467259|459168947|FG001|Overall Study|Withdrawal by Subject|108|||
127601381|NCT00467259|459168946|FG000|Overall Study|Physician Decision|0|||
127601382|NCT00467259|459168947|FG001|Overall Study|Physician Decision|2|||
127601383|NCT00467259|459168946|FG000|Overall Study|Lost to Follow-up|14|||
127601384|NCT00467259|459168947|FG001|Overall Study|Lost to Follow-up|34|||
127601385|NCT00467259|459168946|FG000|Overall Study|Site Closed|2|||
127601386|NCT00467259|459168947|FG001|Overall Study|Site Closed|1|||
127601387|NCT04285879|459168950|FG000|Overall Study|Lost to Follow-up|1|||
127601388|NCT04285879|459168951|FG001|Overall Study|Lost to Follow-up|8|||
127601389|NCT04285879|459168950|FG000|Overall Study|medical/surgical exclusion|16|||
127601390|NCT04285879|459168951|FG001|Overall Study|medical/surgical exclusion|0|||
127601391|NCT02056340|459168952|FG000|Overall Study|Lost to Follow-up|5|||
127601392|NCT02056340|459168953|FG001|Overall Study|Lost to Follow-up|5|||
127601393|NCT02056340|459168952|FG000|Overall Study|Withdrawal by Subject|2|||
127601394|NCT02056340|459168953|FG001|Overall Study|Withdrawal by Subject|6|||
127601395|NCT04900220|459168955|FG000|Overall Study|Lost to Follow-up|1|||
127601396|NCT04900220|459168956|FG001|Overall Study|Lost to Follow-up|1|||
127601397|NCT02196558|459168957|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
127601398|NCT02196558|459168958|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
127601399|NCT02196558|459168959|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
127601400|NCT02196558|459168957|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
127601401|NCT02196558|459168958|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
127601402|NCT02196558|459168959|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
127601403|NCT02196558|459168957|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
127601404|NCT02196558|459168958|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
127601405|NCT02196558|459168959|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
127601406|NCT02196558|459168957|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
127601407|NCT02196558|459168958|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
127601408|NCT02196558|459168959|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
127601409|NCT02196558|459168957|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
127601410|NCT02196558|459168958|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
127601411|NCT02196558|459168959|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
127601412|NCT02669433|459168963|FG000|Overall Study|Protocol Violation|0|||
127601413|NCT02669433|459168964|FG001|Overall Study|Protocol Violation|4|||
127601414|NCT02669433|459168965|FG002|Overall Study|Protocol Violation|1|||
127601415|NCT02669433|459168963|FG000|Overall Study|Disease Progression|1|||
127601416|NCT02669433|459168964|FG001|Overall Study|Disease Progression|0|||
127601417|NCT02669433|459168965|FG002|Overall Study|Disease Progression|0|||
127601418|NCT02669433|459168963|FG000|Overall Study|Physician Decision|1|||
127601419|NCT02669433|459168964|FG001|Overall Study|Physician Decision|1|||
127601420|NCT02669433|459168965|FG002|Overall Study|Physician Decision|0|||
127601421|NCT02669433|459168963|FG000|Overall Study|Adverse Event|6|||
127882842|NCT01128153|460194596|FG001|Overall Study|Withdrawal by Subject|3|||
128039991|NCT03901469|460776071|FG006|Overall Study|Adverse Event|9|||
128039992|NCT03901469|460776065|FG000|Overall Study|Physician Decision|0|||
128039993|NCT03901469|460776066|FG001|Overall Study|Physician Decision|0|||
128039994|NCT03901469|460776067|FG002|Overall Study|Physician Decision|0|||
128039995|NCT03901469|460776068|FG003|Overall Study|Physician Decision|1|||
128039996|NCT03901469|460776069|FG004|Overall Study|Physician Decision|0|||
127601422|NCT02669433|459168964|FG001|Overall Study|Adverse Event|7|||
127601423|NCT02669433|459168965|FG002|Overall Study|Adverse Event|10|||
127601424|NCT02669433|459168963|FG000|Overall Study|Sponsor Termination|1|||
127601425|NCT02669433|459168964|FG001|Overall Study|Sponsor Termination|0|||
127601426|NCT02669433|459168965|FG002|Overall Study|Sponsor Termination|1|||
127601427|NCT02669433|459168963|FG000|Overall Study|Withdrawal by Subject|5|||
127601428|NCT02669433|459168964|FG001|Overall Study|Withdrawal by Subject|1|||
127882843|NCT01128153|460194595|FG000|Overall Study|Incorrect enrolment to study|2|||
127601429|NCT02669433|459168965|FG002|Overall Study|Withdrawal by Subject|0|||
127601430|NCT02669433|459168963|FG000|Overall Study|Withdrawal by Caregiver|1|||
127601431|NCT02669433|459168964|FG001|Overall Study|Withdrawal by Caregiver|0|||
128039997|NCT03901469|460776070|FG005|Overall Study|Physician Decision|0|||
127601432|NCT02669433|459168965|FG002|Overall Study|Withdrawal by Caregiver|2|||
127601433|NCT02669433|459168963|FG000|Overall Study|Death|0|||
127601434|NCT02669433|459168964|FG001|Overall Study|Death|1|||
127696434|NCT03131648|459517750|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
127696435|NCT03131648|459517751|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
127696436|NCT03131648|459517752|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
128039998|NCT03901469|460776071|FG006|Overall Study|Physician Decision|0|||
127696437|NCT03131648|459517753|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
127696438|NCT03131648|459517754|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
127696439|NCT03131648|459517755|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
127696440|NCT03131648|459517748|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
127696441|NCT03131648|459517749|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
127696442|NCT03131648|459517750|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
128039999|NCT03901469|460776065|FG000|Overall Study|Withdrawal by Subject|0|||
128040000|NCT03901469|460776066|FG001|Overall Study|Withdrawal by Subject|0|||
128040001|NCT03901469|460776067|FG002|Overall Study|Withdrawal by Subject|0|||
128040002|NCT03901469|460776068|FG003|Overall Study|Withdrawal by Subject|0|||
128040003|NCT03901469|460776069|FG004|Overall Study|Withdrawal by Subject|2|||
128040004|NCT03901469|460776070|FG005|Overall Study|Withdrawal by Subject|0|||
128040005|NCT03901469|460776071|FG006|Overall Study|Withdrawal by Subject|8|||
128040006|NCT03901469|460776065|FG000|Overall Study|Death|0|||
128040007|NCT03901469|460776066|FG001|Overall Study|Death|0|||
127696443|NCT03131648|459517751|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
128040008|NCT03901469|460776067|FG002|Overall Study|Death|0|||
128040009|NCT03901469|460776068|FG003|Overall Study|Death|3|||
128040010|NCT03901469|460776069|FG004|Overall Study|Death|5|||
127601435|NCT02669433|459168965|FG002|Overall Study|Death|1|||
127601436|NCT00576927|459168966|FG000|Clinical Assessment|Lack of Efficacy|24|||
127601437|NCT00576927|459168966|FG000|Clinical Assessment|Death|1|||
127601438|NCT00576927|459168966|FG000|Clinical Assessment|Withdrawal by Subject|10|||
127601439|NCT00576927|459168966|FG000|Clinical Assessment|Physician Decision|1|||
127601440|NCT00576927|459168966|FG000|Baseline|Physician Decision|9|||
127601441|NCT00576927|459168966|FG000|Baseline|Medication Change by PCP of subject|1|||
127601442|NCT00576927|459168966|FG000|Baseline|Withdrawal by Subject|3|||
127601443|NCT00576927|459168966|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
127601444|NCT00576927|459168966|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
127601445|NCT00576927|459168966|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
127601446|NCT00576927|459168966|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
127601447|NCT00576927|459168966|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
127601448|NCT00459108|459168968|FG000|Overall Study|Withdrawal by Subject|5|||
127601449|NCT00459108|459168968|FG000|Overall Study|Adverse Event|3|||
127601450|NCT00459108|459168968|FG000|Overall Study|Death|2|||
127601451|NCT00459108|459168968|FG000|Overall Study|Progression|1|||
127601452|NCT03473808|459168969|FG000|Overall Study|Withdrawal by Subject|1|||
127601453|NCT03715764|459168970|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
128040011|NCT03901469|460776070|FG005|Overall Study|Death|0|||
128040012|NCT03901469|460776071|FG006|Overall Study|Death|1|||
128040013|NCT03901469|460776065|FG000|Overall Study|Termination of study by sponsor|0|||
128040014|NCT03901469|460776066|FG001|Overall Study|Termination of study by sponsor|0|||
128040015|NCT03901469|460776067|FG002|Overall Study|Termination of study by sponsor|0|||
128040016|NCT03901469|460776068|FG003|Overall Study|Termination of study by sponsor|0|||
128040017|NCT03901469|460776069|FG004|Overall Study|Termination of study by sponsor|1|||
128040018|NCT03901469|460776070|FG005|Overall Study|Termination of study by sponsor|1|||
128040019|NCT03901469|460776071|FG006|Overall Study|Termination of study by sponsor|0|||
128040020|NCT03901469|460776065|FG000|Overall Study|Not Reported|1|||
128040021|NCT03901469|460776066|FG001|Overall Study|Not Reported|0|||
128040022|NCT03901469|460776067|FG002|Overall Study|Not Reported|0|||
128040023|NCT03901469|460776068|FG003|Overall Study|Not Reported|1|||
128040024|NCT03901469|460776069|FG004|Overall Study|Not Reported|0|||
128040025|NCT03901469|460776070|FG005|Overall Study|Not Reported|0|||
128040026|NCT03901469|460776071|FG006|Overall Study|Not Reported|1|||
128040027|NCT02960893|460776075|FG000|Randomization Phase (8 Weeks)|Adverse Event|5|||
128040028|NCT02960893|460776076|FG001|Randomization Phase (8 Weeks)|Adverse Event|0|||
128040029|NCT02960893|460776077|FG002|Randomization Phase (8 Weeks)|Adverse Event|0|||
128040030|NCT02960893|460776078|FG003|Randomization Phase (8 Weeks)|Adverse Event|0|||
128040031|NCT02960893|460776075|FG000|Randomization Phase (8 Weeks)|Withdrawal by Participant|2|||
128040032|NCT02960893|460776076|FG001|Randomization Phase (8 Weeks)|Withdrawal by Participant|1|||
128040033|NCT02960893|460776077|FG002|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
128040034|NCT02960893|460776078|FG003|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
128040035|NCT02960893|460776075|FG000|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
128040036|NCT02960893|460776076|FG001|Randomization Phase (8 Weeks)|Reason Not Specified|1|||
128040037|NCT02960893|460776077|FG002|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
128040038|NCT02960893|460776078|FG003|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
128040039|NCT02960893|460776075|FG000|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
128040040|NCT02960893|460776076|FG001|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
128040041|NCT02960893|460776077|FG002|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
128040042|NCT02960893|460776078|FG003|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
128040043|NCT02960893|460776075|FG000|Open Label Extension Phase (336 Weeks)|Death|0|||
128040044|NCT02960893|460776076|FG001|Open Label Extension Phase (336 Weeks)|Death|0|||
128040045|NCT02960893|460776077|FG002|Open Label Extension Phase (336 Weeks)|Death|0|||
128040046|NCT02960893|460776078|FG003|Open Label Extension Phase (336 Weeks)|Death|1|||
128040047|NCT02960893|460776075|FG000|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
128040048|NCT02960893|460776076|FG001|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
128040049|NCT02960893|460776077|FG002|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
128040050|NCT02960893|460776078|FG003|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
128040051|NCT02960893|460776075|FG000|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
128040052|NCT02960893|460776076|FG001|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
128040053|NCT02960893|460776077|FG002|Open Label Extension Phase (336 Weeks)|Physician Decision|3|||
128040054|NCT02960893|460776078|FG003|Open Label Extension Phase (336 Weeks)|Physician Decision|2|||
128040055|NCT02960893|460776075|FG000|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
128040056|NCT02960893|460776076|FG001|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
128040057|NCT02960893|460776077|FG002|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|19|||
128040058|NCT02960893|460776078|FG003|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|18|||
127601454|NCT03715764|459168971|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
127601455|NCT03715764|459168970|FG000|3 Month Follow-up|Lost to Follow-up|2|||
127601456|NCT03715764|459168971|FG001|3 Month Follow-up|Lost to Follow-up|2|||
128040059|NCT02960893|460776075|FG000|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
128040060|NCT02960893|460776076|FG001|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
128040061|NCT02960893|460776077|FG002|Open Label Extension Phase (336 Weeks)|Sponsor Request|4|||
128040062|NCT02960893|460776078|FG003|Open Label Extension Phase (336 Weeks)|Sponsor Request|2|||
128040063|NCT02960893|460776075|FG000|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
128040064|NCT02960893|460776076|FG001|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
128040065|NCT02960893|460776077|FG002|Open Label Extension Phase (336 Weeks)|Miscellaneous|3|||
128040066|NCT02960893|460776078|FG003|Open Label Extension Phase (336 Weeks)|Miscellaneous|1|||
128040067|NCT03738228|460776081|FG000|Overall Study|Never received study treatment|2|||
128040068|NCT03738228|460776082|FG001|Overall Study|Never received study treatment|2|||
128040069|NCT06170242|460776083|FG000|Overall Study|Lost to Follow-up|0|||
128040070|NCT06170242|460776084|FG001|Overall Study|Lost to Follow-up|0|||
128040071|NCT06170242|460776085|FG002|Overall Study|Lost to Follow-up|1|||
128040072|NCT06170242|460776086|FG003|Overall Study|Lost to Follow-up|1|||
128040073|NCT02586207|460776094|FG000|Overall Study|Physician Decision|1|||
128040074|NCT02586207|460776094|FG000|Overall Study|Withdrawal by Subject|1|||
128040075|NCT04896073|460776096|FG000|Overall Study|Screen failure|0|||
128040076|NCT04896073|460776097|FG001|Overall Study|Screen failure|2|||
128040077|NCT04896073|460776096|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
128040078|NCT04896073|460776097|FG001|Overall Study|Participant declined to participate (before treatment started)|2|||
128040079|NCT01385176|460776098|FG000|Randomization Phase|Death|1|||
128040080|NCT01385176|460776099|FG001|Randomization Phase|Death|2|||
128040081|NCT01385176|460776098|FG000|6-18 Month All VNS Active|Death|1|||
128040082|NCT01385176|460776099|FG001|6-18 Month All VNS Active|Death|2|||
128040083|NCT01385176|460776098|FG000|6-18 Month All VNS Active|Physician Decision|0|||
128040084|NCT01385176|460776099|FG001|6-18 Month All VNS Active|Physician Decision|1|||
128040085|NCT01385176|460776098|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
128040086|NCT01385176|460776099|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
128040087|NCT01385176|460776098|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
128040088|NCT01385176|460776099|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
128040089|NCT02306161|460776103|FG000|Overall Study|Death|1|||
128040090|NCT02306161|460776104|FG001|Overall Study|Death|3|||
128040091|NCT02306161|460776103|FG000|Overall Study|Lack of Efficacy|20|||
127788296|NCT01157364|459849943|FG001|Overall Study|Personal Reasons|2|||
127788297|NCT01157364|459849944|FG002|Overall Study|Personal Reasons|0|||
128040092|NCT02306161|460776104|FG001|Overall Study|Lack of Efficacy|43|||
128040093|NCT02306161|460776103|FG000|Overall Study|Physician Decision|30|||
128040094|NCT02306161|460776104|FG001|Overall Study|Physician Decision|18|||
128040095|NCT02306161|460776103|FG000|Overall Study|Withdrawal by Subject|4|||
128040096|NCT02306161|460776104|FG001|Overall Study|Withdrawal by Subject|0|||
128040097|NCT02306161|460776103|FG000|Overall Study|Ineligible|9|||
127788298|NCT01157364|459849945|FG003|Overall Study|Personal Reasons|0|||
127601457|NCT03715764|459168970|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
127601458|NCT03715764|459168971|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
127601459|NCT03715764|459168970|FG000|6 Month Follow-up|Lost to Follow-up|3|||
127601460|NCT03715764|459168971|FG001|6 Month Follow-up|Lost to Follow-up|0|||
127601461|NCT03715764|459168970|FG000|12 Month Follow-up|Lost to Follow-up|2|||
127601462|NCT03715764|459168971|FG001|12 Month Follow-up|Lost to Follow-up|3|||
127601463|NCT03715764|459168970|FG000|12 Month Follow-up|Pregnancy|0|||
127601464|NCT03715764|459168971|FG001|12 Month Follow-up|Pregnancy|1|||
127601465|NCT03715764|459168970|FG000|12 Month Follow-up|Surgery|2|||
127601466|NCT03715764|459168971|FG001|12 Month Follow-up|Surgery|0|||
127601467|NCT03715764|459168970|FG000|12 Month Follow-up|Wrong address|1|||
127601468|NCT03715764|459168971|FG001|12 Month Follow-up|Wrong address|0|||
127601469|NCT03715764|459168970|FG000|12 Month Follow-up|No symptoms|1|||
127601470|NCT03715764|459168971|FG001|12 Month Follow-up|No symptoms|0|||
127601471|NCT03715764|459168970|FG000|12 Month Follow-up|Changed primary care centre|0|||
127601472|NCT03715764|459168971|FG001|12 Month Follow-up|Changed primary care centre|1|||
127601473|NCT00818662|459168977|FG000|Overall Study|Adverse Event|5|||
127601474|NCT00818662|459168978|FG001|Overall Study|Adverse Event|14|||
127601475|NCT00818662|459168979|FG002|Overall Study|Adverse Event|4|||
127601476|NCT00818662|459168980|FG003|Overall Study|Adverse Event|3|||
127601477|NCT00818662|459168977|FG000|Overall Study|Withdrawal by Subject|5|||
127601478|NCT00818662|459168978|FG001|Overall Study|Withdrawal by Subject|4|||
127601479|NCT00818662|459168979|FG002|Overall Study|Withdrawal by Subject|2|||
127601480|NCT00818662|459168980|FG003|Overall Study|Withdrawal by Subject|2|||
127601481|NCT00818662|459168977|FG000|Overall Study|Death|1|||
127601482|NCT00818662|459168978|FG001|Overall Study|Death|3|||
127601483|NCT00818662|459168979|FG002|Overall Study|Death|0|||
127601484|NCT00818662|459168980|FG003|Overall Study|Death|0|||
127601485|NCT00818662|459168977|FG000|Overall Study|Physician Decision|1|||
127601486|NCT00818662|459168978|FG001|Overall Study|Physician Decision|0|||
127601487|NCT00818662|459168979|FG002|Overall Study|Physician Decision|0|||
127601488|NCT00818662|459168980|FG003|Overall Study|Physician Decision|0|||
127601489|NCT00818662|459168977|FG000|Overall Study|Lost to Follow-up|0|||
127601490|NCT00818662|459168978|FG001|Overall Study|Lost to Follow-up|0|||
127601491|NCT00818662|459168979|FG002|Overall Study|Lost to Follow-up|0|||
127601492|NCT00818662|459168980|FG003|Overall Study|Lost to Follow-up|1|||
127601493|NCT00818662|459168977|FG000|Overall Study|Unwilling or Unable to Participate|4|||
127601494|NCT00818662|459168978|FG001|Overall Study|Unwilling or Unable to Participate|6|||
127601495|NCT00818662|459168979|FG002|Overall Study|Unwilling or Unable to Participate|2|||
127601496|NCT00818662|459168980|FG003|Overall Study|Unwilling or Unable to Participate|4|||
127601497|NCT00818662|459168977|FG000|Overall Study|Protocol Violation|1|||
127601498|NCT00818662|459168978|FG001|Overall Study|Protocol Violation|1|||
127601499|NCT00818662|459168979|FG002|Overall Study|Protocol Violation|0|||
127601500|NCT00818662|459168980|FG003|Overall Study|Protocol Violation|0|||
127601501|NCT00818662|459168977|FG000|Overall Study|Requires a Prohibited Medication|1|||
127601502|NCT00818662|459168978|FG001|Overall Study|Requires a Prohibited Medication|0|||
127601503|NCT00818662|459168979|FG002|Overall Study|Requires a Prohibited Medication|0|||
127601504|NCT00818662|459168980|FG003|Overall Study|Requires a Prohibited Medication|0|||
127601505|NCT00818662|459168977|FG000|Overall Study|Safety Risk|1|||
127601506|NCT00818662|459168978|FG001|Overall Study|Safety Risk|1|||
127601507|NCT00818662|459168979|FG002|Overall Study|Safety Risk|0|||
127601508|NCT00818662|459168980|FG003|Overall Study|Safety Risk|1|||
127601509|NCT00818662|459168977|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
127601510|NCT00818662|459168978|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
127601511|NCT00818662|459168979|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
127601512|NCT00818662|459168980|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
127601513|NCT00818662|459168977|FG000|Overall Study|Participant's health declined|0|||
127601514|NCT00818662|459168978|FG001|Overall Study|Participant's health declined|0|||
127601515|NCT00818662|459168979|FG002|Overall Study|Participant's health declined|0|||
127882844|NCT01128153|460194596|FG001|Overall Study|Incorrect enrolment to study|1|||
127882845|NCT01128153|460194595|FG000|Overall Study|Protocol Violation|2|||
127882846|NCT01128153|460194596|FG001|Overall Study|Protocol Violation|0|||
127882847|NCT01128153|460194595|FG000|Overall Study|Developed discontinuation criteria|1|||
127601516|NCT00818662|459168980|FG003|Overall Study|Participant's health declined|1|||
127601517|NCT00818662|459168977|FG000|Overall Study|Caregiver to pursue other treatment|0|||
127601518|NCT00818662|459168978|FG001|Overall Study|Caregiver to pursue other treatment|1|||
127601519|NCT00818662|459168979|FG002|Overall Study|Caregiver to pursue other treatment|0|||
127601520|NCT00818662|459168980|FG003|Overall Study|Caregiver to pursue other treatment|0|||
127601521|NCT00818662|459168977|FG000|Overall Study|Moving out of state|0|||
127601522|NCT00818662|459168978|FG001|Overall Study|Moving out of state|0|||
127601523|NCT00818662|459168979|FG002|Overall Study|Moving out of state|0|||
127601524|NCT00818662|459168980|FG003|Overall Study|Moving out of state|1|||
127601525|NCT00818662|459168977|FG000|Overall Study|Declined move to another study site|1|||
127601526|NCT00818662|459168978|FG001|Overall Study|Declined move to another study site|0|||
127601527|NCT00818662|459168979|FG002|Overall Study|Declined move to another study site|0|||
127601528|NCT00818662|459168980|FG003|Overall Study|Declined move to another study site|0|||
127601529|NCT00818662|459168977|FG000|Overall Study|Change in living situation|0|||
127601530|NCT00818662|459168978|FG001|Overall Study|Change in living situation|0|||
127601531|NCT00818662|459168979|FG002|Overall Study|Change in living situation|0|||
127601532|NCT00818662|459168980|FG003|Overall Study|Change in living situation|1|||
127601533|NCT00818662|459168977|FG000|Overall Study|Study partner decision|0|||
127601534|NCT00818662|459168978|FG001|Overall Study|Study partner decision|0|||
127601535|NCT00818662|459168979|FG002|Overall Study|Study partner decision|0|||
127601536|NCT00818662|459168980|FG003|Overall Study|Study partner decision|1|||
127601537|NCT00818662|459168977|FG000|Overall Study|Admitted to long term nursing care|0|||
127601538|NCT00818662|459168978|FG001|Overall Study|Admitted to long term nursing care|1|||
127601539|NCT00818662|459168979|FG002|Overall Study|Admitted to long term nursing care|0|||
127601540|NCT00818662|459168980|FG003|Overall Study|Admitted to long term nursing care|0|||
127601541|NCT01472081|459168981|FG000|Overall Study|Continuing treatment at time of analysis|1|||
127601542|NCT01472081|459168982|FG001|Overall Study|Continuing treatment at time of analysis|4|||
127601543|NCT01472081|459168983|FG002|Overall Study|Continuing treatment at time of analysis|1|||
127601544|NCT01472081|459168984|FG003|Overall Study|Continuing treatment at time of analysis|8|||
127601545|NCT01472081|459168985|FG004|Overall Study|Continuing treatment at time of analysis|9|||
127601546|NCT01472081|459168986|FG005|Overall Study|Continuing treatment at time of analysis|0|||
127601547|NCT01472081|459168981|FG000|Overall Study|Disease Progression|4|||
127601548|NCT01472081|459168982|FG001|Overall Study|Disease Progression|10|||
127601549|NCT01472081|459168983|FG002|Overall Study|Disease Progression|12|||
127601550|NCT01472081|459168984|FG003|Overall Study|Disease Progression|31|||
127601551|NCT01472081|459168985|FG004|Overall Study|Disease Progression|22|||
127601552|NCT01472081|459168986|FG005|Overall Study|Disease Progression|3|||
127601553|NCT01472081|459168981|FG000|Overall Study|Study drug toxicity|2|||
127601554|NCT01472081|459168982|FG001|Overall Study|Study drug toxicity|9|||
127601555|NCT01472081|459168983|FG002|Overall Study|Study drug toxicity|4|||
127601556|NCT01472081|459168984|FG003|Overall Study|Study drug toxicity|6|||
127601557|NCT01472081|459168985|FG004|Overall Study|Study drug toxicity|13|||
127601558|NCT01472081|459168986|FG005|Overall Study|Study drug toxicity|2|||
127601559|NCT01472081|459168981|FG000|Overall Study|Death|0|||
127601560|NCT01472081|459168982|FG001|Overall Study|Death|0|||
127601561|NCT01472081|459168983|FG002|Overall Study|Death|0|||
127601562|NCT01472081|459168984|FG003|Overall Study|Death|0|||
127601563|NCT01472081|459168985|FG004|Overall Study|Death|1|||
127601564|NCT01472081|459168986|FG005|Overall Study|Death|0|||
127601565|NCT01472081|459168981|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
127601566|NCT01472081|459168982|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
127601567|NCT01472081|459168983|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
127601568|NCT01472081|459168984|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
127601569|NCT01472081|459168985|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
127601570|NCT01472081|459168986|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
127601571|NCT01472081|459168981|FG000|Overall Study|Withdrawal by Subject|0|||
127601572|NCT01472081|459168982|FG001|Overall Study|Withdrawal by Subject|0|||
127601573|NCT01472081|459168983|FG002|Overall Study|Withdrawal by Subject|0|||
127601574|NCT01472081|459168984|FG003|Overall Study|Withdrawal by Subject|0|||
127601575|NCT01472081|459168985|FG004|Overall Study|Withdrawal by Subject|0|||
127601576|NCT01472081|459168986|FG005|Overall Study|Withdrawal by Subject|1|||
127601577|NCT01472081|459168981|FG000|Overall Study|Poor/non-compliance|0|||
127601578|NCT01472081|459168982|FG001|Overall Study|Poor/non-compliance|0|||
127601579|NCT01472081|459168983|FG002|Overall Study|Poor/non-compliance|1|||
127601580|NCT01472081|459168984|FG003|Overall Study|Poor/non-compliance|0|||
127601581|NCT01472081|459168985|FG004|Overall Study|Poor/non-compliance|1|||
127601582|NCT01472081|459168986|FG005|Overall Study|Poor/non-compliance|0|||
127601583|NCT01472081|459168981|FG000|Overall Study|No longer meets study criteria|0|||
127601584|NCT01472081|459168982|FG001|Overall Study|No longer meets study criteria|0|||
127601585|NCT01472081|459168983|FG002|Overall Study|No longer meets study criteria|1|||
127601586|NCT01472081|459168984|FG003|Overall Study|No longer meets study criteria|0|||
127601587|NCT01472081|459168985|FG004|Overall Study|No longer meets study criteria|0|||
127601588|NCT01472081|459168986|FG005|Overall Study|No longer meets study criteria|0|||
127601589|NCT01472081|459168981|FG000|Overall Study|Subject request to discontinue treatment|0|||
127601590|NCT01472081|459168982|FG001|Overall Study|Subject request to discontinue treatment|3|||
127601591|NCT01472081|459168983|FG002|Overall Study|Subject request to discontinue treatment|1|||
127601592|NCT01472081|459168984|FG003|Overall Study|Subject request to discontinue treatment|1|||
127601593|NCT01472081|459168985|FG004|Overall Study|Subject request to discontinue treatment|0|||
127601594|NCT01472081|459168986|FG005|Overall Study|Subject request to discontinue treatment|0|||
127601595|NCT00847704|459168987|FG000|Overall Study|Withdrawal by Subject|1|||
127601596|NCT01962207|459168988|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
127601597|NCT01962207|459168989|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
127601598|NCT01962207|459168990|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
127601599|NCT01962207|459168991|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
127601600|NCT01962207|459168988|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
127601601|NCT01962207|459168989|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
127601602|NCT01962207|459168990|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
127601603|NCT01962207|459168991|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
127601604|NCT01962207|459168988|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
127601605|NCT01962207|459168989|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
127601606|NCT01962207|459168990|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
127601607|NCT01962207|459168991|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
127601608|NCT01962207|459168988|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
127601609|NCT01962207|459168989|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
127601610|NCT01962207|459168990|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
127601611|NCT01962207|459168991|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
127601612|NCT01962207|459168988|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
127601613|NCT01962207|459168989|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
127696444|NCT03131648|459517752|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
127788299|NCT01157364|459849946|FG004|Overall Study|Personal Reasons|1|||
127601614|NCT01962207|459168990|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
127601615|NCT01962207|459168991|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
127601616|NCT01962207|459168988|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
127601617|NCT01962207|459168989|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
127601618|NCT01962207|459168990|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
127601619|NCT01962207|459168991|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
127601620|NCT03605303|459168992|FG000|Period 1|Study Terminated|2|||
127601621|NCT03605303|459168993|FG001|Period 1|Study Terminated|1|||
127601622|NCT01031069|459168994|FG000|Overall Study|Serious Adverse Event|0|||
127601623|NCT01031069|459168995|FG001|Overall Study|Serious Adverse Event|1|||
127601624|NCT01031069|459168996|FG002|Overall Study|Serious Adverse Event|0|||
127601625|NCT01031069|459168997|FG003|Overall Study|Serious Adverse Event|0|||
127601626|NCT01031069|459168994|FG000|Overall Study|Withdrawal by Subject|2|||
127601627|NCT01031069|459168995|FG001|Overall Study|Withdrawal by Subject|3|||
127601628|NCT01031069|459168996|FG002|Overall Study|Withdrawal by Subject|18|||
127601629|NCT01031069|459168997|FG003|Overall Study|Withdrawal by Subject|18|||
127601630|NCT01031069|459168994|FG000|Overall Study|Migrated/moved from study area|1|||
127601631|NCT01031069|459168995|FG001|Overall Study|Migrated/moved from study area|2|||
127601632|NCT01031069|459168996|FG002|Overall Study|Migrated/moved from study area|1|||
127601633|NCT01031069|459168997|FG003|Overall Study|Migrated/moved from study area|1|||
127601634|NCT01031069|459168994|FG000|Overall Study|Lost to Follow-up|9|||
127601635|NCT01031069|459168995|FG001|Overall Study|Lost to Follow-up|5|||
127601636|NCT01031069|459168996|FG002|Overall Study|Lost to Follow-up|21|||
127601637|NCT01031069|459168997|FG003|Overall Study|Lost to Follow-up|15|||
127601638|NCT01031069|459168994|FG000|Overall Study|Other|0|||
127601639|NCT01031069|459168995|FG001|Overall Study|Other|0|||
127601640|NCT01031069|459168996|FG002|Overall Study|Other|1|||
127601641|NCT01031069|459168997|FG003|Overall Study|Other|0|||
127696445|NCT03131648|459517753|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
127696446|NCT03131648|459517754|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
127696447|NCT03131648|459517755|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
127696448|NCT03131648|459517748|FG000|Maintenance Treatment Period|Completed Week 50|0|||
127696449|NCT03131648|459517749|FG001|Maintenance Treatment Period|Completed Week 50|0|||
127696450|NCT03131648|459517750|FG002|Maintenance Treatment Period|Completed Week 50|0|||
127696451|NCT03131648|459517751|FG003|Maintenance Treatment Period|Completed Week 50|0|||
127696452|NCT03131648|459517752|FG004|Maintenance Treatment Period|Completed Week 50|1|||
127601642|NCT05286307|459168998|FG000|Overall Study|Incomplete outcome assessments|2|||
127601643|NCT05286307|459168999|FG001|Overall Study|Incomplete outcome assessments|1|||
127601644|NCT05286307|459168998|FG000|Overall Study|Discovery of multi-ligamentous injury intra-operatively|0|||
127601645|NCT05286307|459168999|FG001|Overall Study|Discovery of multi-ligamentous injury intra-operatively|1|||
127601646|NCT05286307|459168998|FG000|Overall Study|Lost to follow up at 6 months|25|||
127601647|NCT05286307|459168999|FG001|Overall Study|Lost to follow up at 6 months|35|||
127601648|NCT05286307|459168998|FG000|Overall Study|Study medication not available|1|||
127601649|NCT05286307|459168999|FG001|Overall Study|Study medication not available|1|||
127601650|NCT01103284|459169000|FG000|Overall Study|Death|2|||
127601651|NCT01103284|459169001|FG001|Overall Study|Death|0|||
127601652|NCT01103284|459169000|FG000|Overall Study|Lost to Follow-up|9|||
127601653|NCT01103284|459169001|FG001|Overall Study|Lost to Follow-up|10|||
127601654|NCT01103284|459169000|FG000|Overall Study|Pregnancy|3|||
127601655|NCT01103284|459169001|FG001|Overall Study|Pregnancy|1|||
127601656|NCT01103284|459169000|FG000|Overall Study|Protocol Violation|12|||
127601657|NCT01103284|459169001|FG001|Overall Study|Protocol Violation|5|||
127601658|NCT01103284|459169000|FG000|Overall Study|Adverse Event|0|||
127601659|NCT01103284|459169001|FG001|Overall Study|Adverse Event|5|||
127601660|NCT01103284|459169000|FG000|Overall Study|Withdrawal by Subject|14|||
127696453|NCT03131648|459517753|FG005|Maintenance Treatment Period|Completed Week 50|0|||
127696454|NCT03131648|459517754|FG006|Maintenance Treatment Period|Completed Week 50|0|||
127696455|NCT03131648|459517755|FG007|Maintenance Treatment Period|Completed Week 50|0|||
127696456|NCT03131648|459517748|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
127696457|NCT03131648|459517749|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
127696458|NCT03131648|459517750|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
127696459|NCT03131648|459517751|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
127696460|NCT03131648|459517752|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
127696461|NCT03131648|459517753|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
128040098|NCT02306161|460776104|FG001|Overall Study|Ineligible|5|||
128040099|NCT04995419|460776105|FG000|Overall Study|Withdrawal by Subject|3|||
128040100|NCT04995419|460776105|FG000|Overall Study|Progressive Disease|19|||
128040101|NCT04995419|460776105|FG000|Overall Study|Adverse Event|2|||
128040102|NCT04995419|460776105|FG000|Overall Study|Ongoing|16|||
128040103|NCT03306173|460776106|FG000|Overall Study|Lost to Follow-up|16|||
128040104|NCT03306173|460776107|FG001|Overall Study|Lost to Follow-up|23|||
128040105|NCT03306173|460776106|FG000|Overall Study|Withdrawal by Subject|4|||
128040106|NCT03306173|460776107|FG001|Overall Study|Withdrawal by Subject|3|||
128040107|NCT03306173|460776106|FG000|Overall Study|Discontinued|4|||
128040108|NCT03306173|460776107|FG001|Overall Study|Discontinued|4|||
128040109|NCT03776812|460776111|FG000|Overall Study|Death|53|||
128040110|NCT03776812|460776112|FG001|Overall Study|Death|49|||
128040111|NCT03776812|460776113|FG002|Overall Study|Death|56|||
128040112|NCT03776812|460776111|FG000|Overall Study|Withdrawal by Subject|1|||
128040113|NCT03776812|460776112|FG001|Overall Study|Withdrawal by Subject|7|||
128040114|NCT03776812|460776113|FG002|Overall Study|Withdrawal by Subject|2|||
128040115|NCT03776812|460776111|FG000|Overall Study|Lost to Follow-up|1|||
128040116|NCT03776812|460776112|FG001|Overall Study|Lost to Follow-up|1|||
128040117|NCT03776812|460776113|FG002|Overall Study|Lost to Follow-up|0|||
128040118|NCT03776812|460776111|FG000|Overall Study|Did not enter long-term follow-up|3|||
128040119|NCT03776812|460776112|FG001|Overall Study|Did not enter long-term follow-up|3|||
128040120|NCT03776812|460776113|FG002|Overall Study|Did not enter long-term follow-up|2|||
128040121|NCT01013649|460776116|FG000|First Step|Withdrawal by Subject|36|||
127601661|NCT01103284|459169001|FG001|Overall Study|Withdrawal by Subject|18|||
127601662|NCT01103284|459169000|FG000|Overall Study|Dermal Hypersensitivity|0|||
127601663|NCT01103284|459169001|FG001|Overall Study|Dermal Hypersensitivity|1|||
127696462|NCT03131648|459517754|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
128040122|NCT01013649|460776117|FG001|First Step|Withdrawal by Subject|19|||
128040123|NCT01013649|460776118|FG002|First Step|Withdrawal by Subject|0|||
128040124|NCT01013649|460776119|FG003|First Step|Withdrawal by Subject|0|||
128040125|NCT01013649|460776116|FG000|First Step|Progression|58|||
128040126|NCT01013649|460776117|FG001|First Step|Progression|23|||
128040127|NCT01013649|460776118|FG002|First Step|Progression|0|||
128040128|NCT01013649|460776119|FG003|First Step|Progression|0|||
128040129|NCT01013649|460776116|FG000|First Step|Did not start 5th cycle of first step treatment|15|||
127601664|NCT01103284|459169000|FG000|Overall Study|Termination by the Sponsor|0|||
127601665|NCT01103284|459169001|FG001|Overall Study|Termination by the Sponsor|1|||
127601666|NCT01103284|459169000|FG000|Overall Study|Not described|2|||
127601667|NCT01103284|459169001|FG001|Overall Study|Not described|1|||
127601668|NCT01103284|459169000|FG000|Overall Study|Missing CRF entries for study completion|0|||
127601669|NCT01103284|459169001|FG001|Overall Study|Missing CRF entries for study completion|2|||
127601670|NCT01572909|459171350|FG000|Overall Study|Adverse Event|7|||
127601671|NCT01572909|459171351|FG001|Overall Study|Adverse Event|2|||
127601672|NCT01572909|459171350|FG000|Overall Study|Death|3|||
127601673|NCT01572909|459171351|FG001|Overall Study|Death|1|||
127601674|NCT01572909|459171350|FG000|Overall Study|Lost to Follow-up|8|||
127601675|NCT01572909|459171351|FG001|Overall Study|Lost to Follow-up|7|||
127601676|NCT01572909|459171350|FG000|Overall Study|Physician Decision|1|||
127601677|NCT01572909|459171351|FG001|Overall Study|Physician Decision|1|||
127601678|NCT01572909|459171350|FG000|Overall Study|Technical Issues|1|||
127601679|NCT01572909|459171351|FG001|Overall Study|Technical Issues|0|||
127601680|NCT01572909|459171350|FG000|Overall Study|Withdrawal by Subject|12|||
127601681|NCT01572909|459171351|FG001|Overall Study|Withdrawal by Subject|11|||
127601682|NCT01572909|459171350|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
127601683|NCT01572909|459171351|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
127601684|NCT03641651|459171352|FG000|Overall Study|organizational issues at one study site|1|||
127601685|NCT04779489|459171353|FG000|Overall Study|Physician Decision|1|||
127601686|NCT00623727|459171354|FG000|Double Blind (DB)|Adverse Event|1|||
127601687|NCT00623727|459171355|FG001|Double Blind (DB)|Adverse Event|3|||
127601688|NCT00623727|459171354|FG000|Double Blind (DB)|Physician Decision|0|||
127601689|NCT00623727|459171355|FG001|Double Blind (DB)|Physician Decision|1|||
127601690|NCT00623727|459171354|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
127601691|NCT00623727|459171355|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
127601692|NCT00623727|459171354|FG000|Double Blind (DB)|Lack of Efficacy|2|||
127601693|NCT00623727|459171355|FG001|Double Blind (DB)|Lack of Efficacy|2|||
127601694|NCT00623727|459171354|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
127601695|NCT00623727|459171355|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
127601696|NCT00623727|459171354|FG000|Double Blind (DB)|Lost to Follow-up|1|||
127601697|NCT00623727|459171355|FG001|Double Blind (DB)|Lost to Follow-up|1|||
127601698|NCT00623727|459171354|FG000|Double Blind (DB)|Protocol Violation|2|||
127601699|NCT00623727|459171355|FG001|Double Blind (DB)|Protocol Violation|2|||
127601700|NCT00623727|459171354|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
127601701|NCT00623727|459171355|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
127601702|NCT00623727|459171354|FG000|Open Label Follow-up|Study termination|0|||
127601703|NCT00623727|459171355|FG001|Open Label Follow-up|Study termination|6|||
127601704|NCT00623727|459171354|FG000|Open Label Follow-up|Participant convenience|0|||
127601705|NCT00623727|459171355|FG001|Open Label Follow-up|Participant convenience|1|||
127601706|NCT00951665|459171356|FG000|Phase 1b|Adverse Event|2|||
127601707|NCT00951665|459171357|FG001|Phase 1b|Adverse Event|1|||
127601708|NCT00951665|459171358|FG002|Phase 1b|Adverse Event|0|||
127601709|NCT00951665|459171359|FG003|Phase 1b|Adverse Event|1|||
127601710|NCT00951665|459171360|FG004|Phase 1b|Adverse Event|0|||
127601711|NCT00951665|459171361|FG005|Phase 1b|Adverse Event|0|||
127601712|NCT00951665|459171356|FG000|Phase 1b|Death|1|||
127601713|NCT00951665|459171357|FG001|Phase 1b|Death|0|||
127601714|NCT00951665|459171358|FG002|Phase 1b|Death|2|||
127601715|NCT00951665|459171359|FG003|Phase 1b|Death|0|||
127601716|NCT00951665|459171360|FG004|Phase 1b|Death|0|||
127601717|NCT00951665|459171361|FG005|Phase 1b|Death|0|||
127601718|NCT00951665|459171356|FG000|Phase 1b|Physician Decision|4|||
127601719|NCT00951665|459171357|FG001|Phase 1b|Physician Decision|0|||
127601720|NCT00951665|459171358|FG002|Phase 1b|Physician Decision|1|||
127601721|NCT00951665|459171359|FG003|Phase 1b|Physician Decision|0|||
127601722|NCT00951665|459171360|FG004|Phase 1b|Physician Decision|0|||
127601723|NCT00951665|459171361|FG005|Phase 1b|Physician Decision|0|||
127601724|NCT00951665|459171356|FG000|Phase 1b|Withdrawal by Subject|0|||
127601725|NCT00951665|459171357|FG001|Phase 1b|Withdrawal by Subject|1|||
127601726|NCT00951665|459171358|FG002|Phase 1b|Withdrawal by Subject|0|||
127601727|NCT00951665|459171359|FG003|Phase 1b|Withdrawal by Subject|0|||
127601728|NCT00951665|459171360|FG004|Phase 1b|Withdrawal by Subject|0|||
127601729|NCT00951665|459171361|FG005|Phase 1b|Withdrawal by Subject|0|||
127601730|NCT00951665|459171356|FG000|Phase 1b|Disease Progression|13|||
127601731|NCT00951665|459171357|FG001|Phase 1b|Disease Progression|2|||
127601732|NCT00951665|459171358|FG002|Phase 1b|Disease Progression|14|||
127601733|NCT00951665|459171359|FG003|Phase 1b|Disease Progression|0|||
127601734|NCT00951665|459171360|FG004|Phase 1b|Disease Progression|0|||
127601735|NCT00951665|459171361|FG005|Phase 1b|Disease Progression|0|||
127601736|NCT00951665|459171356|FG000|Phase 1b|Protocol Violation|2|||
127601737|NCT00951665|459171357|FG001|Phase 1b|Protocol Violation|0|||
127601738|NCT00951665|459171358|FG002|Phase 1b|Protocol Violation|0|||
127601739|NCT00951665|459171359|FG003|Phase 1b|Protocol Violation|0|||
127601740|NCT00951665|459171360|FG004|Phase 1b|Protocol Violation|0|||
127601741|NCT00951665|459171361|FG005|Phase 1b|Protocol Violation|0|||
127601742|NCT00951665|459171356|FG000|Phase 2a|Adverse Event|0|||
128040130|NCT01013649|460776117|FG001|First Step|Did not start 5th cycle of first step treatment|10|||
128040131|NCT01013649|460776118|FG002|First Step|Did not start 5th cycle of first step treatment|0|||
128040132|NCT01013649|460776119|FG003|First Step|Did not start 5th cycle of first step treatment|0|||
128040133|NCT01013649|460776116|FG000|First Step|Death|3|||
128040134|NCT01013649|460776117|FG001|First Step|Death|4|||
128040135|NCT01013649|460776118|FG002|First Step|Death|0|||
128040136|NCT01013649|460776119|FG003|First Step|Death|0|||
128040137|NCT01013649|460776116|FG000|First Step|Adverse Event|9|||
128040138|NCT01013649|460776117|FG001|First Step|Adverse Event|5|||
128040139|NCT01013649|460776118|FG002|First Step|Adverse Event|0|||
128040140|NCT01013649|460776119|FG003|First Step|Adverse Event|0|||
128040141|NCT01013649|460776116|FG000|First Step|Other|4|||
128040142|NCT01013649|460776117|FG001|First Step|Other|6|||
128040143|NCT01013649|460776118|FG002|First Step|Other|0|||
128040144|NCT01013649|460776119|FG003|First Step|Other|0|||
128040145|NCT04285567|460776120|FG000|Overall Study|Death|3|||
128040146|NCT04285567|460776121|FG001|Overall Study|Death|3|||
128040147|NCT04285567|460776120|FG000|Overall Study|Lost to Follow-up|1|||
128040148|NCT04285567|460776121|FG001|Overall Study|Lost to Follow-up|1|||
128040149|NCT04285567|460776120|FG000|Overall Study|Reason Not Specified|1|||
128040150|NCT04285567|460776121|FG001|Overall Study|Reason Not Specified|1|||
128040151|NCT04285567|460776120|FG000|Overall Study|Physician Decision|2|||
128040152|NCT04285567|460776121|FG001|Overall Study|Physician Decision|1|||
128040153|NCT04285567|460776120|FG000|Overall Study|Withdrawal by Subject|2|||
128040154|NCT04285567|460776121|FG001|Overall Study|Withdrawal by Subject|6|||
128040155|NCT04285567|460776120|FG000|Overall Study|Adverse Event|1|||
128040156|NCT04285567|460776121|FG001|Overall Study|Adverse Event|0|||
128040157|NCT04285567|460776120|FG000|Overall Study|Participants Ongoing in Follow-up|70|||
128040158|NCT04285567|460776121|FG001|Overall Study|Participants Ongoing in Follow-up|74|||
128040159|NCT04758637|460776122|FG000|Overall Study|Lost to Follow-up|0|||
128040160|NCT04758637|460776123|FG001|Overall Study|Lost to Follow-up|1|||
128040161|NCT04758637|460776124|FG002|Overall Study|Lost to Follow-up|0|||
128040162|NCT04758637|460776125|FG003|Overall Study|Lost to Follow-up|0|||
128040163|NCT03972150|460776138|FG000|Overall Study|Adverse Event|0|||
128040164|NCT03972150|460776139|FG001|Overall Study|Adverse Event|1|||
128040165|NCT03972150|460776140|FG002|Overall Study|Adverse Event|1|||
128040166|NCT03972150|460776141|FG003|Overall Study|Adverse Event|0|||
128040167|NCT03972150|460776142|FG004|Overall Study|Adverse Event|0|||
128040168|NCT03972150|460776138|FG000|Overall Study|Progressive disease|3|||
128040169|NCT03972150|460776139|FG001|Overall Study|Progressive disease|5|||
128040170|NCT03972150|460776140|FG002|Overall Study|Progressive disease|2|||
128040171|NCT03972150|460776141|FG003|Overall Study|Progressive disease|2|||
128040172|NCT03972150|460776142|FG004|Overall Study|Progressive disease|3|||
128040173|NCT04183283|460776143|FG000|Period 1|Withdrawal by Subject|0|||
128040174|NCT04183283|460776144|FG001|Period 1|Withdrawal by Subject|1|||
128040175|NCT04183283|460776145|FG002|Period 1|Withdrawal by Subject|0|||
128040176|NCT04183283|460776146|FG003|Period 1|Withdrawal by Subject|0|||
128040177|NCT04183283|460776143|FG000|Washout 1(14 Days)|Positive Drug Screen|0|||
128040178|NCT04183283|460776144|FG001|Washout 1(14 Days)|Positive Drug Screen|0|||
128040179|NCT04183283|460776145|FG002|Washout 1(14 Days)|Positive Drug Screen|0|||
128040180|NCT04183283|460776146|FG003|Washout 1(14 Days)|Positive Drug Screen|1|||
128040181|NCT06005597|460776150|FG000|Overall Study|Lost to Follow-up|1|||
128040182|NCT06005597|460776151|FG001|Overall Study|Lost to Follow-up|2|||
128040183|NCT06005597|460776152|FG002|Overall Study|Lost to Follow-up|1|||
128040184|NCT06005597|460776153|FG003|Overall Study|Lost to Follow-up|2|||
128040185|NCT06005597|460776150|FG000|Overall Study|Death|1|||
128040186|NCT06005597|460776151|FG001|Overall Study|Death|1|||
128040187|NCT06005597|460776152|FG002|Overall Study|Death|1|||
128040188|NCT06005597|460776153|FG003|Overall Study|Death|0|||
128040189|NCT03375320|460776154|FG000|Overall Study|Adverse Event|34|||
128040190|NCT03375320|460776155|FG001|Overall Study|Adverse Event|9|||
128040191|NCT03375320|460776156|FG002|Overall Study|Adverse Event|10|||
128040192|NCT03375320|460776157|FG003|Overall Study|Adverse Event|0|||
128040193|NCT03375320|460776154|FG000|Overall Study|Death|6|||
128040194|NCT03375320|460776155|FG001|Overall Study|Death|3|||
128040195|NCT03375320|460776156|FG002|Overall Study|Death|0|||
128040196|NCT03375320|460776157|FG003|Overall Study|Death|0|||
127601743|NCT00951665|459171357|FG001|Phase 2a|Adverse Event|0|||
127601744|NCT00951665|459171358|FG002|Phase 2a|Adverse Event|0|||
127601745|NCT00951665|459171359|FG003|Phase 2a|Adverse Event|0|||
128040197|NCT03375320|460776154|FG000|Overall Study|Withdrawal by Subject|7|||
128040198|NCT03375320|460776155|FG001|Overall Study|Withdrawal by Subject|4|||
128040199|NCT03375320|460776156|FG002|Overall Study|Withdrawal by Subject|5|||
128040200|NCT03375320|460776157|FG003|Overall Study|Withdrawal by Subject|4|||
128040201|NCT03375320|460776154|FG000|Overall Study|Progressive disease|55|||
128040202|NCT03375320|460776155|FG001|Overall Study|Progressive disease|41|||
127696463|NCT03131648|459517755|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
127696464|NCT02671903|459517757|FG000|Period 0 (Run-In)|Death|0|||
127696465|NCT02671903|459517758|FG001|Period 0 (Run-In)|Death|0|||
127696466|NCT02671903|459517759|FG002|Period 0 (Run-In)|Death|3|||
127696467|NCT02671903|459517757|FG000|Period 0 (Run-In)|Physician Decision|0|||
127696468|NCT02671903|459517758|FG001|Period 0 (Run-In)|Physician Decision|0|||
127696469|NCT02671903|459517759|FG002|Period 0 (Run-In)|Physician Decision|4|||
127696470|NCT02671903|459517757|FG000|Period 0 (Run-In)|Withdrawal by Subject|0|||
127696471|NCT02671903|459517758|FG001|Period 0 (Run-In)|Withdrawal by Subject|0|||
127696472|NCT02671903|459517759|FG002|Period 0 (Run-In)|Withdrawal by Subject|4|||
127696473|NCT02671903|459517757|FG000|Period 0 (Run-In)|Protocol Violation|0|||
127696474|NCT02671903|459517758|FG001|Period 0 (Run-In)|Protocol Violation|0|||
127696475|NCT02671903|459517759|FG002|Period 0 (Run-In)|Protocol Violation|1|||
127696476|NCT02671903|459517757|FG000|Period 0 (Run-In)|Adverse Event|0|||
127696477|NCT02671903|459517758|FG001|Period 0 (Run-In)|Adverse Event|0|||
127601746|NCT00951665|459171360|FG004|Phase 2a|Adverse Event|2|||
127601747|NCT00951665|459171361|FG005|Phase 2a|Adverse Event|0|||
127601748|NCT00951665|459171356|FG000|Phase 2a|Death|0|||
127696478|NCT02671903|459517759|FG002|Period 0 (Run-In)|Adverse Event|1|||
127696479|NCT02671903|459517757|FG000|Period 0 (Run-In)|Implantation Failure|0|||
128040203|NCT03375320|460776156|FG002|Overall Study|Progressive disease|29|||
128040204|NCT03375320|460776157|FG003|Overall Study|Progressive disease|24|||
127601749|NCT00951665|459171357|FG001|Phase 2a|Death|0|||
127601750|NCT00951665|459171358|FG002|Phase 2a|Death|0|||
127601751|NCT00951665|459171359|FG003|Phase 2a|Death|0|||
127601752|NCT00951665|459171360|FG004|Phase 2a|Death|1|||
127601753|NCT00951665|459171361|FG005|Phase 2a|Death|1|||
127601754|NCT00951665|459171356|FG000|Phase 2a|Lost to Follow-up|0|||
127601755|NCT00951665|459171357|FG001|Phase 2a|Lost to Follow-up|0|||
127601756|NCT00951665|459171358|FG002|Phase 2a|Lost to Follow-up|0|||
127601757|NCT00951665|459171359|FG003|Phase 2a|Lost to Follow-up|0|||
127601758|NCT00951665|459171360|FG004|Phase 2a|Lost to Follow-up|1|||
127601759|NCT00951665|459171361|FG005|Phase 2a|Lost to Follow-up|0|||
127601760|NCT00951665|459171356|FG000|Phase 2a|Physician Decision|0|||
127601761|NCT00951665|459171357|FG001|Phase 2a|Physician Decision|0|||
127601762|NCT00951665|459171358|FG002|Phase 2a|Physician Decision|0|||
127601763|NCT00951665|459171359|FG003|Phase 2a|Physician Decision|0|||
127601764|NCT00951665|459171360|FG004|Phase 2a|Physician Decision|0|||
127601765|NCT00951665|459171361|FG005|Phase 2a|Physician Decision|1|||
127601766|NCT00951665|459171356|FG000|Phase 2a|Withdrawal by Subject|0|||
127601767|NCT00951665|459171357|FG001|Phase 2a|Withdrawal by Subject|0|||
127601768|NCT00951665|459171358|FG002|Phase 2a|Withdrawal by Subject|0|||
127601769|NCT00951665|459171359|FG003|Phase 2a|Withdrawal by Subject|0|||
127601770|NCT00951665|459171360|FG004|Phase 2a|Withdrawal by Subject|2|||
127601771|NCT00951665|459171361|FG005|Phase 2a|Withdrawal by Subject|0|||
127601772|NCT00951665|459171356|FG000|Phase 2a|Disease Progression|0|||
127601773|NCT00951665|459171357|FG001|Phase 2a|Disease Progression|0|||
127601774|NCT00951665|459171358|FG002|Phase 2a|Disease Progression|0|||
127601775|NCT00951665|459171359|FG003|Phase 2a|Disease Progression|0|||
127601776|NCT00951665|459171360|FG004|Phase 2a|Disease Progression|6|||
127601777|NCT00951665|459171361|FG005|Phase 2a|Disease Progression|5|||
127601778|NCT02723084|459171362|FG000|Overall Study|Withdrawal by Subject|1|||
127601779|NCT02723084|459171363|FG001|Overall Study|Withdrawal by Subject|1|||
127601780|NCT02723084|459171362|FG000|Overall Study|Lost to Follow-up|3|||
127601781|NCT02723084|459171363|FG001|Overall Study|Lost to Follow-up|0|||
127601782|NCT05024058|459171364|FG000|Treatment|Study terminated by sponsor|5|||
127601783|NCT05024058|459171365|FG001|Treatment|Study terminated by sponsor|6|||
127601784|NCT05024058|459171366|FG002|Treatment|Study terminated by sponsor|4|||
127601785|NCT05024058|459171367|FG003|Treatment|Study terminated by sponsor|2|||
127601786|NCT05024058|459171368|FG004|Treatment|Study terminated by sponsor|3|||
127601787|NCT05024058|459171369|FG005|Treatment|Study terminated by sponsor|3|||
127601788|NCT05024058|459171370|FG006|Treatment|Study terminated by sponsor|1|||
127601789|NCT05024058|459171371|FG007|Treatment|Study terminated by sponsor|3|||
127601790|NCT05024058|459171372|FG008|Treatment|Study terminated by sponsor|6|||
128040205|NCT03375320|460776154|FG000|Overall Study|Alternative treatment|6|||
128040206|NCT03375320|460776155|FG001|Overall Study|Alternative treatment|1|||
128040207|NCT03375320|460776156|FG002|Overall Study|Alternative treatment|1|||
128040208|NCT03375320|460776157|FG003|Overall Study|Alternative treatment|0|||
128040209|NCT03375320|460776154|FG000|Overall Study|Other disease|1|||
128040210|NCT03375320|460776155|FG001|Overall Study|Other disease|1|||
128040211|NCT03375320|460776156|FG002|Overall Study|Other disease|3|||
128040212|NCT03375320|460776157|FG003|Overall Study|Other disease|0|||
128040213|NCT03375320|460776154|FG000|Overall Study|Withdrawal prior to initiation|2|||
128040214|NCT03375320|460776155|FG001|Overall Study|Withdrawal prior to initiation|2|||
128040215|NCT03375320|460776156|FG002|Overall Study|Withdrawal prior to initiation|1|||
128040216|NCT03375320|460776157|FG003|Overall Study|Withdrawal prior to initiation|0|||
128040217|NCT03375320|460776154|FG000|Overall Study|Physician Decision|1|||
128040218|NCT03375320|460776155|FG001|Overall Study|Physician Decision|1|||
128040219|NCT03375320|460776156|FG002|Overall Study|Physician Decision|1|||
127601791|NCT05024058|459171373|FG009|Treatment|Study terminated by sponsor|6|||
127601792|NCT05024058|459171364|FG000|Follow-up|Withdrawal by Subject|1|||
127601793|NCT05024058|459171365|FG001|Follow-up|Withdrawal by Subject|0|||
128040220|NCT03375320|460776157|FG003|Overall Study|Physician Decision|1|||
128040221|NCT03375320|460776154|FG000|Overall Study|Non-compliance|1|||
127601794|NCT05024058|459171366|FG002|Follow-up|Withdrawal by Subject|1|||
127601795|NCT05024058|459171367|FG003|Follow-up|Withdrawal by Subject|0|||
127601796|NCT05024058|459171368|FG004|Follow-up|Withdrawal by Subject|0|||
127601797|NCT05024058|459171369|FG005|Follow-up|Withdrawal by Subject|0|||
127601798|NCT05024058|459171370|FG006|Follow-up|Withdrawal by Subject|0|||
127601799|NCT05024058|459171371|FG007|Follow-up|Withdrawal by Subject|1|||
128040222|NCT03375320|460776155|FG001|Overall Study|Non-compliance|0|||
127601800|NCT05024058|459171372|FG008|Follow-up|Withdrawal by Subject|0|||
127601801|NCT05024058|459171373|FG009|Follow-up|Withdrawal by Subject|1|||
127601802|NCT00696696|459171381|FG000|Overall Study|Adverse Event|5|||
128040223|NCT03375320|460776156|FG002|Overall Study|Non-compliance|0|||
127601803|NCT00696696|459171381|FG000|Overall Study|Withdrawal by Subject|8|||
127601804|NCT00696696|459171381|FG000|Overall Study|Physician Decision|2|||
127601805|NCT00696696|459171381|FG000|Overall Study|Death|3|||
127601806|NCT02507505|459171382|FG000|Overall Study|Withdrawal by Subject|13|||
127601807|NCT02507505|459171383|FG001|Overall Study|Withdrawal by Subject|11|||
127601808|NCT02507505|459171382|FG000|Overall Study|Participant unable to be contacted within 60-day interview window|56|||
127601809|NCT02507505|459171383|FG001|Overall Study|Participant unable to be contacted within 60-day interview window|44|||
127601810|NCT02507505|459171382|FG000|Overall Study|Participant contacted but walking status was unknown|14|||
127601811|NCT02507505|459171383|FG001|Overall Study|Participant contacted but walking status was unknown|16|||
127601812|NCT02507505|459171382|FG000|Overall Study|Death before receipt of anesthesia|0|||
127601813|NCT02507505|459171383|FG001|Overall Study|Death before receipt of anesthesia|1|||
127601814|NCT03182829|459171384|FG000|Overall Study|Protocol Violation|12|||
127601815|NCT03182829|459171385|FG001|Overall Study|Protocol Violation|12|||
127601816|NCT03182829|459171384|FG000|Overall Study|Other|4|||
127601817|NCT03182829|459171385|FG001|Overall Study|Other|3|||
127601818|NCT00254540|459171386|FG000|Overall Study|Adverse Event|6|||
127601819|NCT00254540|459171387|FG001|Overall Study|Adverse Event|7|||
127601820|NCT00254540|459171386|FG000|Overall Study|Lack of Efficacy|13|||
127601821|NCT00254540|459171387|FG001|Overall Study|Lack of Efficacy|13|||
127601822|NCT00254540|459171386|FG000|Overall Study|Death|0|||
127601823|NCT00254540|459171387|FG001|Overall Study|Death|1|||
127601824|NCT00254540|459171386|FG000|Overall Study|Laboratory Test Abnormality|0|||
127601825|NCT00254540|459171387|FG001|Overall Study|Laboratory Test Abnormality|1|||
127601826|NCT00225251|459171388|FG000|Overall Study|Withdrawal by Subject|1|||
127601827|NCT00225251|459171389|FG001|Overall Study|Withdrawal by Subject|1|||
127601828|NCT03045328|459171395|FG000|Overall Study|Withdrawal by Subject|2|||
127601829|NCT01313767|459171396|FG000|Overall Study|Adverse Event|1|||
127601830|NCT01313767|459171397|FG001|Overall Study|Adverse Event|0|||
127601831|NCT01313767|459171396|FG000|Overall Study|Lost to Follow-up|1|||
127601832|NCT01313767|459171397|FG001|Overall Study|Lost to Follow-up|0|||
127601833|NCT01313767|459171396|FG000|Overall Study|Withdrawal by Subject|2|||
127882848|NCT01128153|460194596|FG001|Overall Study|Developed discontinuation criteria|1|||
127882849|NCT02419469|460194597|FG000|Overall Study|Withdrawal by Subject|1|||
128040224|NCT03375320|460776157|FG003|Overall Study|Non-compliance|0|||
128040225|NCT02589522|460776160|FG000|Overall Study|Physician Decision|1|||
128040226|NCT02589522|460776161|FG001|Overall Study|Physician Decision|2|||
128040227|NCT02589522|460776162|FG002|Overall Study|Physician Decision|0|||
128040228|NCT02589522|460776160|FG000|Overall Study|Did not start treatment|1|||
128040229|NCT02589522|460776161|FG001|Overall Study|Did not start treatment|0|||
128040230|NCT02589522|460776162|FG002|Overall Study|Did not start treatment|0|||
128040231|NCT05564052|460776163|FG000|Overall Study|Withdrawal by Subject|0|||
128040232|NCT05564052|460776164|FG001|Overall Study|Withdrawal by Subject|0|||
128040233|NCT05564052|460776165|FG002|Overall Study|Withdrawal by Subject|0|||
128040234|NCT05564052|460776166|FG003|Overall Study|Withdrawal by Subject|1|||
128040235|NCT03978624|460776167|FG000|Overall Study|Protocol Violation|1|||
128040236|NCT03978624|460776168|FG001|Overall Study|Protocol Violation|0|||
128040237|NCT05611996|460776169|FG000|Overall Study|Ineligible|1|||
128040238|NCT05611996|460776169|FG000|Overall Study|Withdrawal by Subject|9|||
128040239|NCT04479475|460776170|FG000|Overall Study|Withdrawal by Subject|7|||
128040240|NCT05560763|460776173|FG000|Overall Study|Withdrawal by Subject|4|||
128040241|NCT03981926|460776174|FG000|Overall Study|Lost to Follow-up|5|||
128040242|NCT03981926|460776175|FG001|Overall Study|Lost to Follow-up|9|||
128040243|NCT03228537|460776176|FG000|Neoadjuvant|Adverse Event|2|||
128040244|NCT03228537|460776176|FG000|Neoadjuvant|Progression/Relapse|4|||
128040245|NCT03228537|460776176|FG000|Neoadjuvant|Death|1|||
128040246|NCT03228537|460776176|FG000|Surgery|Death|1|||
128040247|NCT03228537|460776176|FG000|Surgery|Other - Not Protocol Specified|2|||
128040248|NCT03228537|460776176|FG000|Maintenance|Refusal Unrelated to Adverse Event|1|||
128040249|NCT03228537|460776176|FG000|Maintenance|Progression/Relapse|10|||
128040250|NCT05064358|460776177|FG000|Overall Study|Death|23|||
128040251|NCT05064358|460776178|FG001|Overall Study|Death|23|||
128040252|NCT05064358|460776179|FG002|Overall Study|Death|25|||
128040253|NCT05064358|460776180|FG003|Overall Study|Death|21|||
128040254|NCT05064358|460776181|FG004|Overall Study|Death|5|||
128040255|NCT05064358|460776177|FG000|Overall Study|Lost to Follow-up|1|||
128040256|NCT05064358|460776178|FG001|Overall Study|Lost to Follow-up|2|||
128040257|NCT05064358|460776179|FG002|Overall Study|Lost to Follow-up|0|||
128040258|NCT05064358|460776180|FG003|Overall Study|Lost to Follow-up|2|||
128040259|NCT05064358|460776181|FG004|Overall Study|Lost to Follow-up|0|||
128040260|NCT05064358|460776177|FG000|Overall Study|Physician Decision|1|||
128040261|NCT05064358|460776178|FG001|Overall Study|Physician Decision|1|||
128040262|NCT05064358|460776179|FG002|Overall Study|Physician Decision|2|||
128040263|NCT05064358|460776180|FG003|Overall Study|Physician Decision|0|||
128040264|NCT05064358|460776181|FG004|Overall Study|Physician Decision|0|||
128040265|NCT05064358|460776177|FG000|Overall Study|Withdrawal by Subject|4|||
128040266|NCT05064358|460776178|FG001|Overall Study|Withdrawal by Subject|5|||
128040267|NCT05064358|460776179|FG002|Overall Study|Withdrawal by Subject|3|||
128040268|NCT05064358|460776180|FG003|Overall Study|Withdrawal by Subject|6|||
128040269|NCT05064358|460776181|FG004|Overall Study|Withdrawal by Subject|3|||
128040270|NCT05064358|460776177|FG000|Overall Study|Ongoing at the time of analysis|1|||
128040271|NCT05064358|460776178|FG001|Overall Study|Ongoing at the time of analysis|2|||
128040272|NCT05064358|460776179|FG002|Overall Study|Ongoing at the time of analysis|2|||
128040273|NCT05064358|460776180|FG003|Overall Study|Ongoing at the time of analysis|2|||
128040274|NCT05064358|460776181|FG004|Overall Study|Ongoing at the time of analysis|2|||
128040275|NCT06972251|460776182|FG000|Overall Study|Withdrawal by Subject|1|||
128040276|NCT06972251|460776183|FG001|Overall Study|Withdrawal by Subject|0|||
128040277|NCT06972251|460776182|FG000|Overall Study|Lost to Follow-up|10|||
128040278|NCT06972251|460776183|FG001|Overall Study|Lost to Follow-up|2|||
128040279|NCT05464069|460776184|FG000|Overall Study|Protocol Violation|3|||
128040280|NCT05464069|460776185|FG001|Overall Study|Protocol Violation|2|||
128040281|NCT04572243|460776186|FG000|Core Study: 14 Weeks|Adverse Event|1|||
128040282|NCT04572243|460776187|FG001|Core Study: 14 Weeks|Adverse Event|2|||
128040283|NCT04572243|460776188|FG002|Core Study: 14 Weeks|Adverse Event|0|||
128040284|NCT04572243|460776189|FG003|Core Study: 14 Weeks|Adverse Event|0|||
128040285|NCT04572243|460776186|FG000|Core Study: 14 Weeks|Subject choice|0|||
128040286|NCT04572243|460776187|FG001|Core Study: 14 Weeks|Subject choice|2|||
128040287|NCT04572243|460776188|FG002|Core Study: 14 Weeks|Subject choice|0|||
128040288|NCT04572243|460776189|FG003|Core Study: 14 Weeks|Subject choice|0|||
128040289|NCT04572243|460776186|FG000|Core Study: 14 Weeks|Withdrawal of consent|1|||
127601834|NCT01313767|459171397|FG001|Overall Study|Withdrawal by Subject|1|||
128040290|NCT04572243|460776187|FG001|Core Study: 14 Weeks|Withdrawal of consent|0|||
127601835|NCT01313767|459171396|FG000|Overall Study|Protocol Violation|3|||
128040291|NCT04572243|460776188|FG002|Core Study: 14 Weeks|Withdrawal of consent|0|||
127601836|NCT01313767|459171397|FG001|Overall Study|Protocol Violation|1|||
127601837|NCT01287897|459171398|FG000|Overall Study|Adverse Event|5|||
127601838|NCT01287897|459171399|FG001|Overall Study|Adverse Event|3|||
127601839|NCT01287897|459171400|FG002|Overall Study|Adverse Event|6|||
127601840|NCT01287897|459171401|FG003|Overall Study|Adverse Event|4|||
127601841|NCT01287897|459171398|FG000|Overall Study|Lack of Efficacy|2|||
127601842|NCT01287897|459171399|FG001|Overall Study|Lack of Efficacy|0|||
127601843|NCT01287897|459171400|FG002|Overall Study|Lack of Efficacy|0|||
127601844|NCT01287897|459171401|FG003|Overall Study|Lack of Efficacy|0|||
127601845|NCT01287897|459171398|FG000|Overall Study|Protocol Violation|1|||
127601846|NCT01287897|459171399|FG001|Overall Study|Protocol Violation|1|||
127788300|NCT01157364|459849947|FG005|Overall Study|Personal Reasons|1|||
127788301|NCT01157364|459849942|FG000|Overall Study|Lost to Follow-up|1|||
127788302|NCT01157364|459849943|FG001|Overall Study|Lost to Follow-up|0|||
127788303|NCT01157364|459849944|FG002|Overall Study|Lost to Follow-up|1|||
128040292|NCT04572243|460776189|FG003|Core Study: 14 Weeks|Withdrawal of consent|0|||
128040293|NCT04572243|460776186|FG000|Core Study: 14 Weeks|Randomized but not treated|1|||
127601847|NCT01287897|459171400|FG002|Overall Study|Protocol Violation|0|||
127601848|NCT01287897|459171401|FG003|Overall Study|Protocol Violation|1|||
127601849|NCT01287897|459171398|FG000|Overall Study|Lost to Follow-up|0|||
127601850|NCT01287897|459171399|FG001|Overall Study|Lost to Follow-up|0|||
127601851|NCT01287897|459171400|FG002|Overall Study|Lost to Follow-up|2|||
127601852|NCT01287897|459171401|FG003|Overall Study|Lost to Follow-up|0|||
127788304|NCT01157364|459849945|FG003|Overall Study|Lost to Follow-up|0|||
128040294|NCT04572243|460776187|FG001|Core Study: 14 Weeks|Randomized but not treated|0|||
128040295|NCT04572243|460776188|FG002|Core Study: 14 Weeks|Randomized but not treated|0|||
128040296|NCT04572243|460776189|FG003|Core Study: 14 Weeks|Randomized but not treated|0|||
128040297|NCT04976192|460777258|FG000|Main Treatment Period (12 Weeks)|Adverse Event|0|||
128040298|NCT04976192|460777259|FG001|Main Treatment Period (12 Weeks)|Adverse Event|1|||
128040299|NCT04976192|460777260|FG002|Main Treatment Period (12 Weeks)|Adverse Event|0|||
128040300|NCT04976192|460777261|FG003|Main Treatment Period (12 Weeks)|Adverse Event|0|||
128040301|NCT04976192|460777262|FG004|Main Treatment Period (12 Weeks)|Adverse Event|0|||
128040302|NCT04976192|460777263|FG005|Main Treatment Period (12 Weeks)|Adverse Event|0|||
128040303|NCT04976192|460777264|FG006|Main Treatment Period (12 Weeks)|Adverse Event|0|||
128040304|NCT04976192|460777265|FG007|Main Treatment Period (12 Weeks)|Adverse Event|0|||
127601853|NCT01287897|459171398|FG000|Overall Study|Withdrawal by Subject|1|||
127601854|NCT01287897|459171399|FG001|Overall Study|Withdrawal by Subject|5|||
127601855|NCT01287897|459171400|FG002|Overall Study|Withdrawal by Subject|3|||
127601856|NCT01287897|459171401|FG003|Overall Study|Withdrawal by Subject|2|||
127601857|NCT01287897|459171398|FG000|Overall Study|Not consented properly|0|||
128040305|NCT04976192|460777266|FG008|Main Treatment Period (12 Weeks)|Adverse Event|0|||
128040306|NCT04976192|460777267|FG009|Main Treatment Period (12 Weeks)|Adverse Event|0|||
128040307|NCT04976192|460777258|FG000|Main Treatment Period (12 Weeks)|Withdrawal by Subject|12|||
128040308|NCT04976192|460777259|FG001|Main Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
128040309|NCT04976192|460777260|FG002|Main Treatment Period (12 Weeks)|Withdrawal by Subject|8|||
128040310|NCT04976192|460777261|FG003|Main Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
128040311|NCT04976192|460777262|FG004|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
128040312|NCT04976192|460777263|FG005|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
128040313|NCT04976192|460777264|FG006|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
128040314|NCT04976192|460777265|FG007|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
128040315|NCT04976192|460777266|FG008|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
128040316|NCT04976192|460777267|FG009|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
128040317|NCT04976192|460777258|FG000|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
128040318|NCT04976192|460777259|FG001|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
128040319|NCT04976192|460777260|FG002|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
128040320|NCT04976192|460777261|FG003|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
128040321|NCT04976192|460777262|FG004|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
128040322|NCT04976192|460777263|FG005|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
128040323|NCT04976192|460777264|FG006|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
128040324|NCT04976192|460777265|FG007|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
128040325|NCT04976192|460777266|FG008|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
128040326|NCT04976192|460777267|FG009|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
128040327|NCT04976192|460777258|FG000|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
128040328|NCT04976192|460777259|FG001|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
128040329|NCT04976192|460777260|FG002|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
128040330|NCT04976192|460777261|FG003|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
128040331|NCT04976192|460777262|FG004|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
128040332|NCT04976192|460777263|FG005|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
128040333|NCT04976192|460777264|FG006|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
128040334|NCT04976192|460777265|FG007|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
127601858|NCT01287897|459171399|FG001|Overall Study|Not consented properly|1|||
127788305|NCT01157364|459849946|FG004|Overall Study|Lost to Follow-up|0|||
128040335|NCT04976192|460777266|FG008|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
128040336|NCT04976192|460777267|FG009|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
128040337|NCT04976192|460777258|FG000|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
127601859|NCT01287897|459171400|FG002|Overall Study|Not consented properly|0|||
127601860|NCT01287897|459171401|FG003|Overall Study|Not consented properly|0|||
127601861|NCT01287897|459171398|FG000|Overall Study|Not meeting entrance criteria|1|||
127601862|NCT01287897|459171399|FG001|Overall Study|Not meeting entrance criteria|1|||
127788306|NCT01157364|459849947|FG005|Overall Study|Lost to Follow-up|0|||
127601863|NCT01287897|459171400|FG002|Overall Study|Not meeting entrance criteria|0|||
127601864|NCT01287897|459171401|FG003|Overall Study|Not meeting entrance criteria|0|||
127601865|NCT01287897|459171398|FG000|Overall Study|Other|1|||
127601866|NCT01287897|459171399|FG001|Overall Study|Other|0|||
127601867|NCT01287897|459171400|FG002|Overall Study|Other|1|||
127601868|NCT01287897|459171401|FG003|Overall Study|Other|0|||
127601869|NCT00065507|459171402|FG000|Overall Study|Death|16|||
127601870|NCT00065507|459171403|FG001|Overall Study|Death|17|||
127601871|NCT00065507|459171402|FG000|Overall Study|Adverse Event|4|||
127601872|NCT00065507|459171403|FG001|Overall Study|Adverse Event|3|||
127601873|NCT00065507|459171402|FG000|Overall Study|Lack of Efficacy|0|||
127601874|NCT00065507|459171403|FG001|Overall Study|Lack of Efficacy|6|||
127601875|NCT00065507|459171402|FG000|Overall Study|Poor/Non-compliance|3|||
127601876|NCT00065507|459171403|FG001|Overall Study|Poor/Non-compliance|2|||
127601877|NCT00065507|459171402|FG000|Overall Study|Lost to Follow-up|3|||
127601878|NCT00065507|459171403|FG001|Overall Study|Lost to Follow-up|0|||
127601879|NCT00065507|459171402|FG000|Overall Study|Subject Withdrew Consent|2|||
127601880|NCT00065507|459171403|FG001|Overall Study|Subject Withdrew Consent|1|||
127601881|NCT00065507|459171402|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
127601882|NCT00065507|459171403|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
127601883|NCT02169739|459171404|FG000|Overall Study|Lost to Follow-up|0|||
127601884|NCT02169739|459171405|FG001|Overall Study|Lost to Follow-up|4|||
127601885|NCT03635957|459171406|FG000|Run-In Period|Lost to Follow-up|1|||
127601886|NCT03635957|459171406|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
127601887|NCT00350636|459171407|FG000|Overall Study|Adverse Event|19|||
127601888|NCT00350636|459171408|FG001|Overall Study|Adverse Event|13|||
127601889|NCT00350636|459171407|FG000|Overall Study|Protocol Violation|1|||
127601890|NCT00350636|459171408|FG001|Overall Study|Protocol Violation|3|||
127601891|NCT00350636|459171407|FG000|Overall Study|Withdrawal by Subject|13|||
127601892|NCT00350636|459171408|FG001|Overall Study|Withdrawal by Subject|17|||
127601893|NCT00350636|459171407|FG000|Overall Study|Lost to Follow-up|9|||
127601894|NCT00350636|459171408|FG001|Overall Study|Lost to Follow-up|8|||
128040338|NCT04976192|460777259|FG001|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
128040339|NCT04976192|460777260|FG002|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
128040340|NCT04976192|460777261|FG003|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
128040341|NCT04976192|460777262|FG004|Transition Treatment Period (12 Weeks)|Other Than Specified|1|||
128040342|NCT04976192|460777263|FG005|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
128040343|NCT04976192|460777264|FG006|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
128040344|NCT04976192|460777265|FG007|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
128040345|NCT04976192|460777266|FG008|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
128040346|NCT04976192|460777267|FG009|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
128040347|NCT04976192|460777258|FG000|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
128040348|NCT04976192|460777259|FG001|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
127601895|NCT00350636|459171407|FG000|Overall Study|Physician Decision|0|||
127601896|NCT00350636|459171408|FG001|Overall Study|Physician Decision|2|||
127601897|NCT00350636|459171407|FG000|Overall Study|Other|1|||
127601898|NCT00350636|459171408|FG001|Overall Study|Other|2|||
127601899|NCT01042236|459171413|FG000|Treatment Period 1|Adverse Event|0|||
127601900|NCT01042236|459171414|FG001|Treatment Period 1|Adverse Event|1|||
127601901|NCT01042236|459171415|FG002|Treatment Period 1|Adverse Event|0|||
128040349|NCT04976192|460777260|FG002|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
128040350|NCT04976192|460777261|FG003|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
128040351|NCT04976192|460777262|FG004|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
128040352|NCT04976192|460777263|FG005|Transition Treatment Period (12 Weeks)|Lost to Follow-up|1|||
128040353|NCT04976192|460777264|FG006|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
128040354|NCT04976192|460777265|FG007|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
128040355|NCT04976192|460777266|FG008|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
127601902|NCT01042236|459171416|FG003|Treatment Period 1|Adverse Event|0|||
127601903|NCT01042236|459171417|FG004|Treatment Period 1|Adverse Event|1|||
127601904|NCT01042236|459171418|FG005|Treatment Period 1|Adverse Event|0|||
127601905|NCT01042236|459171413|FG000|Treatment Period 3|Adverse Event|0|||
127601906|NCT01042236|459171414|FG001|Treatment Period 3|Adverse Event|0|||
127601907|NCT01042236|459171415|FG002|Treatment Period 3|Adverse Event|0|||
127696480|NCT02671903|459517758|FG001|Period 0 (Run-In)|Implantation Failure|0|||
127696481|NCT02671903|459517759|FG002|Period 0 (Run-In)|Implantation Failure|2|||
127696482|NCT02671903|459517757|FG000|Period 0 (Run-In)|Lost to Follow-up|0|||
127696483|NCT02671903|459517758|FG001|Period 0 (Run-In)|Lost to Follow-up|0|||
128040356|NCT04976192|460777267|FG009|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
127601908|NCT01042236|459171416|FG003|Treatment Period 3|Adverse Event|1|||
127601909|NCT01042236|459171417|FG004|Treatment Period 3|Adverse Event|0|||
127696484|NCT02671903|459517759|FG002|Period 0 (Run-In)|Lost to Follow-up|1|||
127601910|NCT01042236|459171418|FG005|Treatment Period 3|Adverse Event|0|||
127601911|NCT01042236|459171413|FG000|Treatment Period 3|Protocol Violation|0|||
127601912|NCT01042236|459171414|FG001|Treatment Period 3|Protocol Violation|0|||
127601913|NCT01042236|459171415|FG002|Treatment Period 3|Protocol Violation|0|||
127601914|NCT01042236|459171416|FG003|Treatment Period 3|Protocol Violation|1|||
127601915|NCT01042236|459171417|FG004|Treatment Period 3|Protocol Violation|0|||
127601916|NCT01042236|459171418|FG005|Treatment Period 3|Protocol Violation|0|||
127601917|NCT00227903|459171419|FG000|Overall Study|Withdrawal by Subject|2|||
127601918|NCT00227903|459171420|FG001|Overall Study|Withdrawal by Subject|5|||
127601919|NCT00227903|459171419|FG000|Overall Study|Subject moved out of area|1|||
127601920|NCT00227903|459171420|FG001|Overall Study|Subject moved out of area|2|||
127601921|NCT00227903|459171419|FG000|Overall Study|Lost to Follow-up|1|||
127601922|NCT00227903|459171420|FG001|Overall Study|Lost to Follow-up|3|||
127601923|NCT00227903|459171419|FG000|Overall Study|Miscarriage|1|||
127601924|NCT00227903|459171420|FG001|Overall Study|Miscarriage|0|||
127601925|NCT01475331|459171421|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
127601926|NCT01475331|459171422|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
127601927|NCT01475331|459171421|FG000|Overall Study|excessive main duct communication|1|||
127601928|NCT01475331|459171422|FG001|Overall Study|excessive main duct communication|1|||
127601929|NCT01475331|459171421|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
127601930|NCT01475331|459171422|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
127601931|NCT01475331|459171421|FG000|Overall Study|Sign of malignancy during the procedure|2|||
127601932|NCT01475331|459171422|FG001|Overall Study|Sign of malignancy during the procedure|0|||
127601933|NCT01475331|459171421|FG000|Overall Study|cyst found to be prohibitively small|0|||
127601934|NCT01475331|459171422|FG001|Overall Study|cyst found to be prohibitively small|1|||
127601935|NCT02411292|459171424|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
127601936|NCT02411292|459171424|FG000|Overall Study|Death|2|||
127601937|NCT02411292|459171424|FG000|Overall Study|Lost to Follow-up|3|||
127601938|NCT01291173|459171428|FG000|Overall Study|Adverse Event|0|||
127601939|NCT01291173|459171429|FG001|Overall Study|Adverse Event|3|||
127601940|NCT01291173|459171430|FG002|Overall Study|Adverse Event|1|||
127601941|NCT01291173|459171431|FG003|Overall Study|Adverse Event|3|||
127601942|NCT01291173|459171428|FG000|Overall Study|Protocol Violation|7|||
127601943|NCT01291173|459171429|FG001|Overall Study|Protocol Violation|2|||
127601944|NCT01291173|459171430|FG002|Overall Study|Protocol Violation|2|||
127601945|NCT01291173|459171431|FG003|Overall Study|Protocol Violation|5|||
127601946|NCT01291173|459171428|FG000|Overall Study|Withdrawal by Subject|6|||
127601947|NCT01291173|459171429|FG001|Overall Study|Withdrawal by Subject|4|||
127601948|NCT01291173|459171430|FG002|Overall Study|Withdrawal by Subject|4|||
127601949|NCT01291173|459171431|FG003|Overall Study|Withdrawal by Subject|2|||
127601950|NCT01291173|459171428|FG000|Overall Study|Lost to Follow-up|4|||
127601951|NCT01291173|459171429|FG001|Overall Study|Lost to Follow-up|6|||
127601952|NCT01291173|459171430|FG002|Overall Study|Lost to Follow-up|3|||
127601953|NCT01291173|459171431|FG003|Overall Study|Lost to Follow-up|2|||
127601954|NCT01291173|459171428|FG000|Overall Study|Unable to meet visit schedule|0|||
127601955|NCT01291173|459171429|FG001|Overall Study|Unable to meet visit schedule|0|||
127601956|NCT01291173|459171430|FG002|Overall Study|Unable to meet visit schedule|1|||
127601957|NCT01291173|459171431|FG003|Overall Study|Unable to meet visit schedule|0|||
127601958|NCT01291173|459171428|FG000|Overall Study|Lack of compliance|0|||
127601959|NCT01291173|459171429|FG001|Overall Study|Lack of compliance|0|||
127601960|NCT01291173|459171430|FG002|Overall Study|Lack of compliance|0|||
127601961|NCT01291173|459171431|FG003|Overall Study|Lack of compliance|1|||
127601962|NCT01291173|459171428|FG000|Overall Study|Subject was unblinded|0|||
127601963|NCT01291173|459171429|FG001|Overall Study|Subject was unblinded|0|||
127601964|NCT01291173|459171430|FG002|Overall Study|Subject was unblinded|1|||
127601965|NCT01291173|459171431|FG003|Overall Study|Subject was unblinded|0|||
127601966|NCT01291173|459171428|FG000|Overall Study|Excluded therapy|0|||
127601967|NCT01291173|459171429|FG001|Overall Study|Excluded therapy|0|||
127601968|NCT01291173|459171430|FG002|Overall Study|Excluded therapy|1|||
127788307|NCT01157364|459849942|FG000|Overall Study|Lack of Efficacy|0|||
127788308|NCT01157364|459849943|FG001|Overall Study|Lack of Efficacy|0|||
127788309|NCT01157364|459849944|FG002|Overall Study|Lack of Efficacy|0|||
127601969|NCT01291173|459171431|FG003|Overall Study|Excluded therapy|0|||
127601970|NCT01113801|459171432|FG000|Overall Study|Adverse Event|4|||
127601971|NCT01113801|459171433|FG001|Overall Study|Adverse Event|0|||
127601972|NCT01113801|459171434|FG002|Overall Study|Adverse Event|2|||
127601973|NCT01113801|459171435|FG003|Overall Study|Adverse Event|6|||
127601974|NCT01113801|459171432|FG000|Overall Study|Death|4|||
127601975|NCT01113801|459171433|FG001|Overall Study|Death|5|||
127601976|NCT01113801|459171434|FG002|Overall Study|Death|3|||
127601977|NCT01113801|459171435|FG003|Overall Study|Death|4|||
127601978|NCT01113801|459171432|FG000|Overall Study|Protocol Violation|0|||
127788310|NCT01157364|459849945|FG003|Overall Study|Lack of Efficacy|1|||
127601979|NCT01113801|459171433|FG001|Overall Study|Protocol Violation|1|||
127601980|NCT01113801|459171434|FG002|Overall Study|Protocol Violation|0|||
127601981|NCT01113801|459171435|FG003|Overall Study|Protocol Violation|0|||
127601982|NCT01113801|459171432|FG000|Overall Study|Withdrawal by Subject|9|||
127601983|NCT01113801|459171433|FG001|Overall Study|Withdrawal by Subject|7|||
127601984|NCT01113801|459171434|FG002|Overall Study|Withdrawal by Subject|7|||
127601985|NCT01113801|459171435|FG003|Overall Study|Withdrawal by Subject|8|||
127601986|NCT01113801|459171432|FG000|Overall Study|Physician Decision|2|||
127601987|NCT01113801|459171433|FG001|Overall Study|Physician Decision|2|||
127601988|NCT01113801|459171434|FG002|Overall Study|Physician Decision|3|||
127601989|NCT01113801|459171435|FG003|Overall Study|Physician Decision|3|||
127601990|NCT01113801|459171432|FG000|Overall Study|Sponsor Decision|15|||
127788311|NCT01157364|459849946|FG004|Overall Study|Lack of Efficacy|0|||
127601991|NCT01113801|459171433|FG001|Overall Study|Sponsor Decision|21|||
127601992|NCT01113801|459171434|FG002|Overall Study|Sponsor Decision|20|||
127601993|NCT01113801|459171435|FG003|Overall Study|Sponsor Decision|15|||
127601994|NCT01113801|459171432|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
127601995|NCT01113801|459171433|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
127601996|NCT01113801|459171434|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
127601997|NCT01113801|459171435|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
127601998|NCT02728895|459171436|FG000|Overall Study|Other|1|||
128040357|NCT04136912|460777268|FG000|Overall Study|Operational reasons|0|||
128040358|NCT04136912|460777269|FG001|Overall Study|Operational reasons|0|||
128040359|NCT04136912|460777270|FG002|Overall Study|Operational reasons|2|||
128040360|NCT02621151|460777271|FG000|Overall Study|Not eligible for trial|6|||
128040361|NCT04073225|460777272|FG000|Overall Study|Lost to Follow-up|4|||
128040362|NCT04073225|460777273|FG001|Overall Study|Lost to Follow-up|3|||
128040363|NCT05976334|460777274|FG000|Part B|Death|0|||
128040364|NCT05976334|460777275|FG001|Part B|Death|1|||
128040365|NCT05976334|460777274|FG000|Part B|Study Terminated by Sponsor|0|||
128040366|NCT05976334|460777275|FG001|Part B|Study Terminated by Sponsor|1|||
128040367|NCT05976334|460777274|FG000|Part B|Reason Not Specified|0|||
128040368|NCT05976334|460777275|FG001|Part B|Reason Not Specified|1|||
128040369|NCT04526886|460777276|FG000|Overall Study|Physician Decision|4|||
128040370|NCT05420012|460777286|FG000|Overall Study|Lost to Follow-up|0|||
128040371|NCT05420012|460777287|FG001|Overall Study|Lost to Follow-up|1|||
128040372|NCT04632225|460777290|FG000|Overall Study|Withdrawal by Subject|2|||
128040373|NCT04632225|460777291|FG001|Overall Study|Withdrawal by Subject|2|||
128040374|NCT03253744|460777292|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
128040375|NCT03253744|460777293|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
128040376|NCT03253744|460777294|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
128040377|NCT03253744|460777295|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
128040378|NCT04134845|460777301|FG000|Overall Study|withdrawl by PI|5|||
128040379|NCT04134845|460777302|FG001|Overall Study|withdrawl by PI|12|||
128040380|NCT02253316|460777303|FG000|Consolidation|Progression|4|||
128040381|NCT02253316|460777304|FG001|Consolidation|Progression|0|||
128040382|NCT02253316|460777305|FG002|Consolidation|Progression|0|||
128040383|NCT02253316|460777303|FG000|Consolidation|Non-Compliance|1|||
128040384|NCT02253316|460777304|FG001|Consolidation|Non-Compliance|0|||
128040385|NCT02253316|460777305|FG002|Consolidation|Non-Compliance|0|||
128040386|NCT02253316|460777303|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
128040387|NCT02253316|460777304|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
128040388|NCT02253316|460777305|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
128040389|NCT02253316|460777303|FG000|Consolidation|Secondary Malignancy|2|||
128040390|NCT02253316|460777304|FG001|Consolidation|Secondary Malignancy|0|||
128040391|NCT02253316|460777305|FG002|Consolidation|Secondary Malignancy|0|||
128040392|NCT02253316|460777303|FG000|Consolidation|Adverse Event|7|||
128040393|NCT02253316|460777304|FG001|Consolidation|Adverse Event|0|||
128040394|NCT02253316|460777305|FG002|Consolidation|Adverse Event|0|||
128040395|NCT02253316|460777303|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
128040396|NCT02253316|460777304|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
128040397|NCT02253316|460777305|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
128040398|NCT02253316|460777303|FG000|Maintenance|Physician Decision|0|||
128040399|NCT02253316|460777304|FG001|Maintenance|Physician Decision|7|||
128040400|NCT02253316|460777305|FG002|Maintenance|Physician Decision|16|||
128040401|NCT02253316|460777303|FG000|Maintenance|Non-Compliance|0|||
128040402|NCT02253316|460777304|FG001|Maintenance|Non-Compliance|1|||
128040403|NCT02253316|460777305|FG002|Maintenance|Non-Compliance|1|||
128040404|NCT02253316|460777303|FG000|Maintenance|Secondary Malignancy|0|||
128040405|NCT02253316|460777304|FG001|Maintenance|Secondary Malignancy|2|||
128040406|NCT02253316|460777305|FG002|Maintenance|Secondary Malignancy|6|||
128040407|NCT02253316|460777303|FG000|Maintenance|Adverse Event|0|||
128040408|NCT02253316|460777304|FG001|Maintenance|Adverse Event|8|||
128040409|NCT02253316|460777305|FG002|Maintenance|Adverse Event|12|||
128040410|NCT02253316|460777303|FG000|Maintenance|Still receiving active treatment|0|||
127601999|NCT02728895|459171437|FG001|Overall Study|Other|2|||
127696485|NCT03376321|459517760|FG000|Overall Study|Other|5|||
128040411|NCT02253316|460777304|FG001|Maintenance|Still receiving active treatment|4|||
128040412|NCT02253316|460777305|FG002|Maintenance|Still receiving active treatment|0|||
128040413|NCT00124306|460777309|FG000|Overall Study|Adverse Event|7|||
128040414|NCT00124306|460777310|FG001|Overall Study|Adverse Event|2|||
128040415|NCT00124306|460777309|FG000|Overall Study|Lost to Follow-up|10|||
128040416|NCT00124306|460777310|FG001|Overall Study|Lost to Follow-up|6|||
128040417|NCT00124306|460777309|FG000|Overall Study|Lack of Efficacy|3|||
128040418|NCT00124306|460777310|FG001|Overall Study|Lack of Efficacy|6|||
128040419|NCT00124306|460777309|FG000|Overall Study|Personal constraints|0|||
128040420|NCT00124306|460777310|FG001|Overall Study|Personal constraints|2|||
128040421|NCT00124306|460777309|FG000|Overall Study|Use of unacceptable medication|1|||
128040422|NCT00124306|460777310|FG001|Overall Study|Use of unacceptable medication|0|||
127602000|NCT02728895|459171436|FG000|Overall Study|Withdrawal by Subject|0|||
127696486|NCT03376321|459517761|FG001|Overall Study|Other|1|||
128040423|NCT00124306|460777309|FG000|Overall Study|Abnormal lab result|0|||
128040424|NCT00124306|460777310|FG001|Overall Study|Abnormal lab result|1|||
128040425|NCT00124306|460777309|FG000|Overall Study|Other|2|||
128040426|NCT00124306|460777310|FG001|Overall Study|Other|0|||
128040427|NCT02112916|460777311|FG000|Overall Study|Adverse Event|6|||
128040428|NCT02112916|460777312|FG001|Overall Study|Adverse Event|9|||
128040429|NCT02112916|460777313|FG002|Overall Study|Adverse Event|3|||
128040430|NCT02112916|460777314|FG003|Overall Study|Adverse Event|2|||
128040431|NCT02112916|460777311|FG000|Overall Study|Death|9|||
128040432|NCT02112916|460777312|FG001|Overall Study|Death|9|||
128040433|NCT02112916|460777313|FG002|Overall Study|Death|3|||
128040434|NCT02112916|460777314|FG003|Overall Study|Death|4|||
128040435|NCT02112916|460777311|FG000|Overall Study|Lost to Follow-up|1|||
128040436|NCT02112916|460777312|FG001|Overall Study|Lost to Follow-up|0|||
128040437|NCT02112916|460777313|FG002|Overall Study|Lost to Follow-up|0|||
128040438|NCT02112916|460777314|FG003|Overall Study|Lost to Follow-up|0|||
128040439|NCT02112916|460777311|FG000|Overall Study|Physician Decision|94|||
128040440|NCT02112916|460777312|FG001|Overall Study|Physician Decision|72|||
128040441|NCT02112916|460777313|FG002|Overall Study|Physician Decision|24|||
128040442|NCT02112916|460777314|FG003|Overall Study|Physician Decision|15|||
128040443|NCT02112916|460777311|FG000|Overall Study|Withdrawal by Subject|5|||
128040444|NCT02112916|460777312|FG001|Overall Study|Withdrawal by Subject|3|||
128040445|NCT02112916|460777313|FG002|Overall Study|Withdrawal by Subject|1|||
128040446|NCT02112916|460777314|FG003|Overall Study|Withdrawal by Subject|1|||
128040447|NCT02112916|460777311|FG000|Overall Study|Ineligible|4|||
128040448|NCT02112916|460777312|FG001|Overall Study|Ineligible|8|||
128040449|NCT02112916|460777313|FG002|Overall Study|Ineligible|3|||
128040450|NCT02112916|460777314|FG003|Overall Study|Ineligible|8|||
128040451|NCT02112916|460777311|FG000|Overall Study|Inevaluable|6|||
128040452|NCT02112916|460777312|FG001|Overall Study|Inevaluable|4|||
128040453|NCT02112916|460777313|FG002|Overall Study|Inevaluable|5|||
128040454|NCT02112916|460777314|FG003|Overall Study|Inevaluable|5|||
128040455|NCT02112916|460777311|FG000|Overall Study|Refusal of further protocol therapy|19|||
128040456|NCT02112916|460777312|FG001|Overall Study|Refusal of further protocol therapy|16|||
128040457|NCT02112916|460777313|FG002|Overall Study|Refusal of further protocol therapy|1|||
128040458|NCT02112916|460777314|FG003|Overall Study|Refusal of further protocol therapy|7|||
128040459|NCT02112916|460777311|FG000|Overall Study|Development of SMN|1|||
128040460|NCT02112916|460777312|FG001|Overall Study|Development of SMN|0|||
128040461|NCT02112916|460777313|FG002|Overall Study|Development of SMN|0|||
128040462|NCT02112916|460777314|FG003|Overall Study|Development of SMN|1|||
128040463|NCT02112916|460777311|FG000|Overall Study|Relapse/Progression|10|||
128040464|NCT02112916|460777312|FG001|Overall Study|Relapse/Progression|18|||
128040465|NCT02112916|460777313|FG002|Overall Study|Relapse/Progression|15|||
128040466|NCT02112916|460777314|FG003|Overall Study|Relapse/Progression|2|||
128040467|NCT02112916|460777311|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
128040468|NCT02112916|460777312|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
128040469|NCT02112916|460777313|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
128040470|NCT02112916|460777314|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
128040471|NCT02112916|460777311|FG000|Overall Study|Still on Therapy|44|||
128040472|NCT02112916|460777312|FG001|Overall Study|Still on Therapy|47|||
128040473|NCT02112916|460777313|FG002|Overall Study|Still on Therapy|3|||
128040474|NCT02112916|460777314|FG003|Overall Study|Still on Therapy|2|||
128040475|NCT02112916|460777311|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
128040476|NCT02112916|460777312|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
128040477|NCT02112916|460777313|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
128040478|NCT02112916|460777314|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
128040479|NCT02112916|460777311|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
128040480|NCT02112916|460777312|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
128040481|NCT02112916|460777313|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
128040482|NCT02112916|460777314|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
128040483|NCT04238819|460777315|FG000|Overall Study|Ongoing Treatment|0|||
128040484|NCT04238819|460777316|FG001|Overall Study|Ongoing Treatment|0|||
128040485|NCT04238819|460777317|FG002|Overall Study|Ongoing Treatment|0|||
128040486|NCT04238819|460777318|FG003|Overall Study|Ongoing Treatment|0|||
128040487|NCT04238819|460777319|FG004|Overall Study|Ongoing Treatment|1|||
127602001|NCT02728895|459171437|FG001|Overall Study|Withdrawal by Subject|3|||
127602002|NCT01506479|459171438|FG000|Overall Study|Lost to Follow-up|1|||
128040488|NCT04238819|460777320|FG005|Overall Study|Ongoing Treatment|4|||
128040489|NCT04238819|460777321|FG006|Overall Study|Ongoing Treatment|0|||
128040490|NCT04238819|460777315|FG000|Overall Study|Withdrawal by Parent/Subject|0|||
128040491|NCT04238819|460777316|FG001|Overall Study|Withdrawal by Parent/Subject|0|||
128040492|NCT04238819|460777317|FG002|Overall Study|Withdrawal by Parent/Subject|0|||
128040493|NCT04238819|460777318|FG003|Overall Study|Withdrawal by Parent/Subject|1|||
128040494|NCT04238819|460777319|FG004|Overall Study|Withdrawal by Parent/Subject|0|||
128040495|NCT04238819|460777320|FG005|Overall Study|Withdrawal by Parent/Subject|0|||
127602003|NCT01506479|459171439|FG001|Overall Study|Lost to Follow-up|2|||
127602004|NCT01506479|459171440|FG002|Overall Study|Lost to Follow-up|2|||
127602005|NCT01506479|459171438|FG000|Overall Study|Withdrawal by Subject|1|||
127602006|NCT01506479|459171439|FG001|Overall Study|Withdrawal by Subject|2|||
127602007|NCT01506479|459171440|FG002|Overall Study|Withdrawal by Subject|1|||
127602008|NCT01506479|459171438|FG000|Overall Study|Missing assessment|1|||
127602009|NCT01506479|459171439|FG001|Overall Study|Missing assessment|0|||
127602010|NCT01506479|459171440|FG002|Overall Study|Missing assessment|0|||
127602011|NCT01506479|459171438|FG000|Overall Study|Adverse Event|0|||
127602012|NCT01506479|459171439|FG001|Overall Study|Adverse Event|1|||
127602013|NCT01506479|459171440|FG002|Overall Study|Adverse Event|0|||
127602014|NCT03318315|459171441|FG000|Overall Study|Lost to Follow-up|3|||
127602015|NCT03318315|459171442|FG001|Overall Study|Lost to Follow-up|2|||
127602016|NCT03318315|459171443|FG002|Overall Study|Lost to Follow-up|1|||
127602017|NCT03318315|459171441|FG000|Overall Study|Protocol Violation|1|||
127696487|NCT03376321|459517760|FG000|Overall Study|Withdrawal by Subject|8|||
127696488|NCT03376321|459517761|FG001|Overall Study|Withdrawal by Subject|14|||
127696489|NCT03376321|459517760|FG000|Overall Study|Lost to Follow-up|1|||
127696490|NCT03376321|459517761|FG001|Overall Study|Lost to Follow-up|7|||
127696491|NCT03376321|459517760|FG000|Overall Study|Death|4|||
127696492|NCT03376321|459517761|FG001|Overall Study|Death|0|||
127696493|NCT03376321|459517760|FG000|Overall Study|Randomized, not treated|5|||
127696494|NCT03376321|459517761|FG001|Overall Study|Randomized, not treated|3|||
127696495|NCT02992925|459517766|FG000|Cohort 2|Physician Decision|0|||
127696496|NCT02992925|459517767|FG001|Cohort 2|Physician Decision|0|||
127696497|NCT02992925|459517768|FG002|Cohort 2|Physician Decision|1|||
127696498|NCT02992925|459517769|FG003|Cohort 2|Physician Decision|0|||
127602018|NCT03318315|459171442|FG001|Overall Study|Protocol Violation|1|||
127602019|NCT03318315|459171443|FG002|Overall Study|Protocol Violation|1|||
127602020|NCT03318315|459171441|FG000|Overall Study|Withdrawal by Subject|0|||
127696499|NCT02992925|459517766|FG000|Cohort 2|Withdrawal by parent/guardian|0|||
127696500|NCT02992925|459517767|FG001|Cohort 2|Withdrawal by parent/guardian|0|||
127696501|NCT02992925|459517768|FG002|Cohort 2|Withdrawal by parent/guardian|0|||
127696502|NCT02992925|459517769|FG003|Cohort 2|Withdrawal by parent/guardian|2|||
127696503|NCT03779204|459517770|FG000|Overall Study|Lost to Follow-up|2|||
127696504|NCT03779204|459517771|FG001|Overall Study|Lost to Follow-up|0|||
127696505|NCT04258709|459517772|FG000|Overall Study|Lost to Follow-up|10|||
127696506|NCT04258709|459517773|FG001|Overall Study|Lost to Follow-up|4|||
127602021|NCT03318315|459171442|FG001|Overall Study|Withdrawal by Subject|0|||
127602022|NCT03318315|459171443|FG002|Overall Study|Withdrawal by Subject|2|||
127602023|NCT02436356|459171444|FG000|Overall Study|Excluded by MRI Screening|0|||
127602024|NCT02436356|459171445|FG001|Overall Study|Excluded by MRI Screening|0|||
127602025|NCT02436356|459171446|FG002|Overall Study|Excluded by MRI Screening|2|||
127602026|NCT02436356|459171444|FG000|Overall Study|Lost to Follow-up|0|||
127602027|NCT02436356|459171445|FG001|Overall Study|Lost to Follow-up|1|||
127602028|NCT02436356|459171446|FG002|Overall Study|Lost to Follow-up|0|||
127602029|NCT02436356|459171444|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
127602030|NCT02436356|459171445|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
127602031|NCT02436356|459171446|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
127602032|NCT02436356|459171444|FG000|Overall Study|Excluded due to other medical conditions|3|||
127602033|NCT02436356|459171445|FG001|Overall Study|Excluded due to other medical conditions|0|||
127602034|NCT02436356|459171446|FG002|Overall Study|Excluded due to other medical conditions|0|||
127788312|NCT01157364|459849947|FG005|Overall Study|Lack of Efficacy|0|||
128040496|NCT04238819|460777321|FG006|Overall Study|Withdrawal by Parent/Subject|1|||
128040497|NCT03892967|460777322|FG000|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1283|||
128040498|NCT03892967|460777323|FG001|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1728|||
128040499|NCT03892967|460777324|FG002|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1823|||
128040500|NCT03892967|460777325|FG003|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1443|||
128040501|NCT03892967|460777326|FG004|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|728|||
128040502|NCT03892967|460777322|FG000|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|474|||
128040503|NCT03892967|460777323|FG001|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|726|||
128040504|NCT03892967|460777324|FG002|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|774|||
128040505|NCT03892967|460777325|FG003|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|552|||
128040506|NCT03892967|460777326|FG004|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|366|||
128040507|NCT03892967|460777322|FG000|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|710|||
128040508|NCT03892967|460777323|FG001|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|993|||
128040509|NCT03892967|460777324|FG002|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|910|||
128040510|NCT03892967|460777325|FG003|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|739|||
128040511|NCT03892967|460777326|FG004|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|280|||
128040512|NCT03892967|460777322|FG000|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|585|||
128040513|NCT03892967|460777323|FG001|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|893|||
128040514|NCT03892967|460777324|FG002|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|962|||
128040515|NCT03892967|460777325|FG003|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|830|||
128040516|NCT03892967|460777326|FG004|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|315|||
128040517|NCT03892967|460777322|FG000|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|508|||
128040518|NCT03892967|460777323|FG001|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|845|||
128040519|NCT03892967|460777324|FG002|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|1025|||
128040520|NCT03892967|460777325|FG003|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|751|||
128040521|NCT03892967|460777326|FG004|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|302|||
128040522|NCT03892967|460777322|FG000|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|797|||
128040523|NCT03892967|460777323|FG001|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1177|||
128040524|NCT03892967|460777324|FG002|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1398|||
128040525|NCT03892967|460777325|FG003|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1069|||
128040526|NCT03892967|460777326|FG004|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|486|||
128040527|NCT02999477|460777327|FG000|Overall Study|found ineligible after first dose|0|||
127602035|NCT02436356|459171444|FG000|Overall Study|Withdrawal by Subject|1|||
127788313|NCT01157364|459849942|FG000|Overall Study|Adverse Event|0|||
127788314|NCT01157364|459849943|FG001|Overall Study|Adverse Event|1|||
127788315|NCT01157364|459849944|FG002|Overall Study|Adverse Event|1|||
127788316|NCT01157364|459849945|FG003|Overall Study|Adverse Event|0|||
127602036|NCT02436356|459171445|FG001|Overall Study|Withdrawal by Subject|0|||
127602037|NCT02436356|459171446|FG002|Overall Study|Withdrawal by Subject|0|||
127602038|NCT04577118|459171447|FG000|Overall Study|Withdrawal by Subject|4|||
127788317|NCT01157364|459849946|FG004|Overall Study|Adverse Event|1|||
127788318|NCT01157364|459849947|FG005|Overall Study|Adverse Event|0|||
127602039|NCT00810407|459171448|FG000|Overall Study|Protocol Violation|3|||
127602040|NCT00810407|459171448|FG000|Overall Study|No Visit After First Day of Treatment|3|||
127602041|NCT00674661|459171449|FG000|Overall Study|Other|5|||
127602042|NCT00674661|459171450|FG001|Overall Study|Other|7|||
127602043|NCT00674661|459171449|FG000|Overall Study|Lost to Follow-up|6|||
127602044|NCT00674661|459171450|FG001|Overall Study|Lost to Follow-up|3|||
127602045|NCT00674661|459171449|FG000|Overall Study|Withdrawal by Subject|0|||
127602046|NCT00674661|459171450|FG001|Overall Study|Withdrawal by Subject|5|||
127602047|NCT03108027|459171452|FG000|Period 1|Subject/Guardian Decision|0|||
127602048|NCT03108027|459171453|FG001|Period 1|Subject/Guardian Decision|0|||
127602049|NCT03108027|459171454|FG002|Period 1|Subject/Guardian Decision|0|||
127602050|NCT03108027|459171455|FG003|Period 1|Subject/Guardian Decision|2|||
127602051|NCT03108027|459171456|FG004|Period 1|Subject/Guardian Decision|0|||
127602052|NCT03108027|459171457|FG005|Period 1|Subject/Guardian Decision|0|||
127602053|NCT03108027|459171452|FG000|Period 3|Adverse Event|0|||
127602054|NCT03108027|459171453|FG001|Period 3|Adverse Event|1|||
127602055|NCT03108027|459171454|FG002|Period 3|Adverse Event|0|||
127602056|NCT03108027|459171455|FG003|Period 3|Adverse Event|0|||
127602057|NCT03108027|459171456|FG004|Period 3|Adverse Event|0|||
127602058|NCT03108027|459171457|FG005|Period 3|Adverse Event|0|||
127602059|NCT02426892|459171458|FG000|Overall Study|Adverse Event|2|||
127602060|NCT02426892|459171458|FG000|Overall Study|Lack of Efficacy|17|||
127602061|NCT02426892|459171458|FG000|Overall Study|Withdrawal by Subject|1|||
127602062|NCT02574247|459171459|FG000|Overall Study|Withdrawal by Subject|1|||
127788319|NCT00841568|459849960|FG000|Overall Study|Adverse Event|1|||
127788320|NCT00841568|459849960|FG000|Overall Study|Death|1|||
127788321|NCT00841568|459849960|FG000|Overall Study|Withdrawal by Subject|2|||
127788322|NCT00841568|459849960|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
127788323|NCT01087775|459849961|FG000|Overall Study|failed inclusion criteria|2|||
127788324|NCT05289570|459849966|FG000|Overall Study|Physician Decision|1|||
127788325|NCT00781911|459849970|FG000|Overall Study|Adverse Event|4|||
127788326|NCT00781911|459849971|FG001|Overall Study|Adverse Event|4|||
127788327|NCT00781911|459849970|FG000|Overall Study|Withdrawal by Subject|1|||
127788328|NCT00781911|459849971|FG001|Overall Study|Withdrawal by Subject|2|||
127882850|NCT01682512|460194598|FG000|Overall Study|Adverse Event|6|||
127602063|NCT02574247|459171460|FG001|Overall Study|Withdrawal by Subject|0|||
127602064|NCT02574247|459171461|FG002|Overall Study|Withdrawal by Subject|0|||
127602065|NCT02574247|459171459|FG000|Overall Study|Did not meet inclusion criteria|4|||
127602066|NCT02574247|459171460|FG001|Overall Study|Did not meet inclusion criteria|3|||
127602067|NCT02574247|459171461|FG002|Overall Study|Did not meet inclusion criteria|5|||
127602068|NCT00268996|459171462|FG000|Overall Study|Adverse Event|11|||
127602069|NCT00268996|459171463|FG001|Overall Study|Adverse Event|7|||
127602070|NCT00268996|459171462|FG000|Overall Study|Lost to Follow-up|3|||
127788329|NCT00781911|459849970|FG000|Overall Study|Physician Decision|0|||
127788330|NCT00781911|459849971|FG001|Overall Study|Physician Decision|2|||
128040528|NCT02999477|460777328|FG001|Overall Study|found ineligible after first dose|1|||
128040529|NCT02999477|460777327|FG000|Overall Study|Withdrawal by Subject|1|||
128040530|NCT02999477|460777328|FG001|Overall Study|Withdrawal by Subject|1|||
128040531|NCT04266795|460777330|FG000|Overall Study|Adverse Event|10|||
128040532|NCT04266795|460777331|FG001|Overall Study|Adverse Event|19|||
128040533|NCT04266795|460777330|FG000|Overall Study|Death|7|||
128040534|NCT04266795|460777331|FG001|Overall Study|Death|8|||
128040535|NCT04266795|460777330|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
128040536|NCT04266795|460777331|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
128040537|NCT04266795|460777330|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
128040538|NCT04266795|460777331|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
128040539|NCT04266795|460777330|FG000|Overall Study|Progressive Disease|12|||
128040540|NCT04266795|460777331|FG001|Overall Study|Progressive Disease|9|||
128040541|NCT04266795|460777330|FG000|Overall Study|Withdrawal by Patient|5|||
128040542|NCT04266795|460777331|FG001|Overall Study|Withdrawal by Patient|6|||
128040543|NCT04266795|460777330|FG000|Overall Study|Disease Relapse|3|||
128040544|NCT04266795|460777331|FG001|Overall Study|Disease Relapse|6|||
128040545|NCT04266795|460777330|FG000|Overall Study|Reason not Specified|12|||
127788331|NCT00781911|459849970|FG000|Overall Study|Sponsor Decision|1|||
127788332|NCT00781911|459849971|FG001|Overall Study|Sponsor Decision|0|||
127788333|NCT02290873|459849974|FG000|Overall Study|Withdrawal by Subject|0|||
127788334|NCT02290873|459849975|FG001|Overall Study|Withdrawal by Subject|1|||
128040546|NCT04266795|460777331|FG001|Overall Study|Reason not Specified|10|||
127602071|NCT00268996|459171463|FG001|Overall Study|Lost to Follow-up|1|||
127602072|NCT00268996|459171462|FG000|Overall Study|Withdrawal by Subject|5|||
127602073|NCT00268996|459171463|FG001|Overall Study|Withdrawal by Subject|11|||
127602074|NCT00268996|459171462|FG000|Overall Study|Non-compliance|1|||
127602075|NCT00268996|459171463|FG001|Overall Study|Non-compliance|0|||
127602076|NCT00268996|459171462|FG000|Overall Study|Other|1|||
127602077|NCT00268996|459171463|FG001|Overall Study|Other|1|||
127788335|NCT02290873|459849976|FG002|Overall Study|Withdrawal by Subject|1|||
127788336|NCT02290873|459849974|FG000|Overall Study|Nellcor device error|1|||
128040547|NCT04266795|460777330|FG000|Overall Study|Participants Ongoing on Treatment|25|||
128040548|NCT04266795|460777331|FG001|Overall Study|Participants Ongoing on Treatment|23|||
128040549|NCT01475786|460777332|FG000|Overall Study|Adverse Event|0|||
128040550|NCT01475786|460777333|FG001|Overall Study|Adverse Event|1|||
128040551|NCT01475786|460777334|FG002|Overall Study|Adverse Event|0|||
128040552|NCT01475786|460777332|FG000|Overall Study|Lost to Follow-up|1|||
128040553|NCT01475786|460777333|FG001|Overall Study|Lost to Follow-up|2|||
128040554|NCT01475786|460777334|FG002|Overall Study|Lost to Follow-up|1|||
128040555|NCT01475786|460777332|FG000|Overall Study|Withdrawal by Subject|0|||
128040556|NCT01475786|460777333|FG001|Overall Study|Withdrawal by Subject|1|||
128040557|NCT01475786|460777334|FG002|Overall Study|Withdrawal by Subject|1|||
128040558|NCT01475786|460777332|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
128040559|NCT01475786|460777333|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
128040560|NCT01475786|460777334|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
128040561|NCT03568461|460777335|FG000|Overall Study|Death|7|||
128040562|NCT03568461|460777335|FG000|Overall Study|Physician Decision|5|||
128040563|NCT03568461|460777335|FG000|Overall Study|Subject decision|5|||
128040564|NCT03568461|460777335|FG000|Overall Study|Lost to Follow-up|1|||
128040565|NCT05109234|460777338|FG000|Overall Study|Adverse Event|2|||
128040566|NCT05109234|460777339|FG001|Overall Study|Adverse Event|2|||
128040567|NCT05109234|460777338|FG000|Overall Study|Lack of Efficacy|5|||
128040568|NCT05109234|460777339|FG001|Overall Study|Lack of Efficacy|0|||
128040569|NCT05109234|460777338|FG000|Overall Study|Consent withdrawn by Participant (not due to AE)|1|||
128040570|NCT05109234|460777339|FG001|Overall Study|Consent withdrawn by Participant (not due to AE)|0|||
128040571|NCT05109234|460777338|FG000|Overall Study|Consent withdrawn by parent/guardian (not AE)|3|||
128040572|NCT05109234|460777339|FG001|Overall Study|Consent withdrawn by parent/guardian (not AE)|4|||
128040573|NCT05109234|460777338|FG000|Overall Study|Evacuated from Ukraine due to the war|2|||
128040574|NCT05109234|460777339|FG001|Overall Study|Evacuated from Ukraine due to the war|0|||
128040575|NCT05109234|460777338|FG000|Overall Study|Missed safety visit; study incomplete per protocol|1|||
128040576|NCT05109234|460777339|FG001|Overall Study|Missed safety visit; study incomplete per protocol|0|||
128040577|NCT02039401|460777340|FG000|Overall Study|Adverse Event|0|||
128040578|NCT02039401|460777341|FG001|Overall Study|Adverse Event|1|||
128040579|NCT02355184|460777342|FG000|Overall Study|Lost to Follow-up|2|||
128040580|NCT02355184|460777342|FG000|Overall Study|Study Terminated|10|||
128040581|NCT02655016|460777343|FG000|Overall Study|Disease progression|6|||
128040582|NCT02655016|460777344|FG001|Overall Study|Disease progression|4|||
128040583|NCT02655016|460777343|FG000|Overall Study|Site closed|0|||
128040584|NCT02655016|460777344|FG001|Overall Study|Site closed|1|||
128040585|NCT02655016|460777343|FG000|Overall Study|Death|30|||
128040586|NCT02655016|460777344|FG001|Overall Study|Death|48|||
128040587|NCT02655016|460777343|FG000|Overall Study|Lost to Follow-up|1|||
128040588|NCT02655016|460777344|FG001|Overall Study|Lost to Follow-up|1|||
128040589|NCT02655016|460777343|FG000|Overall Study|Withdrawal by Subject|18|||
128040590|NCT02655016|460777344|FG001|Overall Study|Withdrawal by Subject|36|||
128040591|NCT03057054|460777345|FG000|Overall Study|Death|4|||
128040592|NCT03057054|460777346|FG001|Overall Study|Death|4|||
128040593|NCT03057054|460777345|FG000|Overall Study|Withdrawal by Subject|6|||
128040594|NCT03057054|460777346|FG001|Overall Study|Withdrawal by Subject|3|||
128040595|NCT03057054|460777345|FG000|Overall Study|Ineligible|1|||
128040596|NCT03057054|460777346|FG001|Overall Study|Ineligible|1|||
128040597|NCT04459715|460777351|FG000|Overall Study|Adverse Event|3|||
128040598|NCT04459715|460777352|FG001|Overall Study|Adverse Event|3|||
128040599|NCT04459715|460777351|FG000|Overall Study|Death|111|||
128040600|NCT04459715|460777352|FG001|Overall Study|Death|93|||
128040601|NCT04459715|460777351|FG000|Overall Study|Lost to Follow-up|10|||
128040602|NCT04459715|460777352|FG001|Overall Study|Lost to Follow-up|9|||
128040603|NCT04459715|460777351|FG000|Overall Study|Other Reasons|4|||
128040604|NCT04459715|460777352|FG001|Overall Study|Other Reasons|5|||
128040605|NCT04459715|460777351|FG000|Overall Study|PROTOCOL DEVIATION|0|||
128040606|NCT04459715|460777352|FG001|Overall Study|PROTOCOL DEVIATION|1|||
128040607|NCT04459715|460777351|FG000|Overall Study|RANDOMIZED BY MISTAKE|0|||
128040608|NCT04459715|460777352|FG001|Overall Study|RANDOMIZED BY MISTAKE|1|||
128040609|NCT04459715|460777351|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|214|||
128040610|NCT04459715|460777352|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|232|||
128040611|NCT04459715|460777351|FG000|Overall Study|Withdrawal by Subject|22|||
128040612|NCT04459715|460777352|FG001|Overall Study|Withdrawal by Subject|22|||
128040613|NCT03734029|460777353|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
128040614|NCT03734029|460777354|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
128040615|NCT03734029|460777353|FG000|Overall Study|Adverse Event|60|||
128040616|NCT03734029|460777354|FG001|Overall Study|Adverse Event|14|||
128040617|NCT03734029|460777353|FG000|Overall Study|Withdrawal by Subject|12|||
128040618|NCT03734029|460777354|FG001|Overall Study|Withdrawal by Subject|11|||
127788337|NCT02290873|459849975|FG001|Overall Study|Nellcor device error|0|||
127788338|NCT02290873|459849976|FG002|Overall Study|Nellcor device error|0|||
127788339|NCT02290873|459849974|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
127788340|NCT02290873|459849975|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
127788341|NCT02290873|459849976|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
127788342|NCT02290873|459849974|FG000|Overall Study|Protocol Violation|0|||
127788343|NCT02290873|459849975|FG001|Overall Study|Protocol Violation|0|||
127788344|NCT02290873|459849976|FG002|Overall Study|Protocol Violation|1|||
127788345|NCT01473563|459849977|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
127788346|NCT01519765|459849978|FG000|Overall Study|Adverse Event|0|||
127788347|NCT01519765|459849979|FG001|Overall Study|Adverse Event|1|||
127788348|NCT01519765|459849978|FG000|Overall Study|Lack of Efficacy|2|||
127788349|NCT01519765|459849979|FG001|Overall Study|Lack of Efficacy|0|||
127788350|NCT01519765|459849978|FG000|Overall Study|Protocol Violation|1|||
127788351|NCT01519765|459849979|FG001|Overall Study|Protocol Violation|0|||
127788352|NCT01519765|459849978|FG000|Overall Study|Withdrawal by Subject|0|||
127788353|NCT01519765|459849979|FG001|Overall Study|Withdrawal by Subject|1|||
127788354|NCT00432042|459849982|FG000|Overall Study|Protocol Violation|2|||
127788355|NCT00432042|459849983|FG001|Overall Study|Protocol Violation|0|||
127788356|NCT00432042|459849984|FG002|Overall Study|Protocol Violation|0|||
127788357|NCT00432042|459849982|FG000|Overall Study|Withdrawal by Subject|0|||
127788358|NCT00432042|459849983|FG001|Overall Study|Withdrawal by Subject|0|||
127788359|NCT00432042|459849984|FG002|Overall Study|Withdrawal by Subject|2|||
127788360|NCT00432042|459849982|FG000|Overall Study|Lost to Follow-up|5|||
127788361|NCT00432042|459849983|FG001|Overall Study|Lost to Follow-up|1|||
127788362|NCT00432042|459849984|FG002|Overall Study|Lost to Follow-up|0|||
127788363|NCT02577146|459849985|FG000|Overall Study|Lost to Follow-up|8|||
127788364|NCT02577146|459849985|FG000|Overall Study|Physician Decision|3|||
127788365|NCT02577146|459849985|FG000|Overall Study|Screen Failure|17|||
127788366|NCT03765138|459849986|FG000|Overall Study|Lost to Follow-up|1|||
127788367|NCT01970501|459849987|FG000|Overall Study|Discontinuation of study by sponsor|16|||
127788368|NCT01970501|459849988|FG001|Overall Study|Discontinuation of study by sponsor|14|||
127788369|NCT01970501|459849987|FG000|Overall Study|Withdrawal by Subject|6|||
127788370|NCT01970501|459849988|FG001|Overall Study|Withdrawal by Subject|7|||
127788371|NCT01970501|459849987|FG000|Overall Study|Adverse Event|2|||
127788372|NCT01970501|459849988|FG001|Overall Study|Adverse Event|4|||
127788373|NCT01970501|459849987|FG000|Overall Study|Death|1|||
127788374|NCT01970501|459849988|FG001|Overall Study|Death|3|||
127788375|NCT01970501|459849987|FG000|Overall Study|Physician Decision|2|||
127788376|NCT01970501|459849988|FG001|Overall Study|Physician Decision|0|||
127788377|NCT03803059|459849990|FG000|Overall Study|Protocol Violation|2|||
127788378|NCT03803059|459849990|FG000|Overall Study|Lost to Follow-up|1|||
127788379|NCT04013529|459849993|FG000|Overall Study|Withdrawal by Subject|1|||
128040619|NCT03734029|460777353|FG000|Overall Study|Clinical progression by investigator|10|||
128040620|NCT03734029|460777354|FG001|Overall Study|Clinical progression by investigator|8|||
128040621|NCT03734029|460777353|FG000|Overall Study|Death|5|||
128040622|NCT03734029|460777354|FG001|Overall Study|Death|2|||
128040623|NCT03734029|460777353|FG000|Overall Study|Physician Decision|4|||
128040624|NCT03734029|460777354|FG001|Overall Study|Physician Decision|3|||
128040625|NCT03734029|460777353|FG000|Overall Study|Other|2|||
128040626|NCT03734029|460777354|FG001|Overall Study|Other|0|||
128040627|NCT03734029|460777353|FG000|Overall Study|Lost to Follow-up|0|||
128040628|NCT03734029|460777354|FG001|Overall Study|Lost to Follow-up|1|||
128040629|NCT03734029|460777353|FG000|Overall Study|Randomized, but not treated|2|||
128040630|NCT03734029|460777354|FG001|Overall Study|Randomized, but not treated|12|||
127788380|NCT04013529|459849994|FG001|Overall Study|Withdrawal by Subject|1|||
127788381|NCT03116698|459849995|FG000|Overall Study|Adverse Event|1|||
127788382|NCT03116698|459849996|FG001|Overall Study|Adverse Event|1|||
127788383|NCT03116698|459849997|FG002|Overall Study|Adverse Event|1|||
127788384|NCT03116698|459849998|FG003|Overall Study|Adverse Event|0|||
127788385|NCT03116698|459849995|FG000|Overall Study|Withdrawal by Subject|1|||
127788386|NCT03116698|459849996|FG001|Overall Study|Withdrawal by Subject|4|||
127788387|NCT03116698|459849997|FG002|Overall Study|Withdrawal by Subject|5|||
127788388|NCT03116698|459849998|FG003|Overall Study|Withdrawal by Subject|2|||
127788389|NCT03116698|459849995|FG000|Overall Study|Lost to Follow-up|2|||
127788390|NCT03116698|459849996|FG001|Overall Study|Lost to Follow-up|0|||
127696507|NCT04258709|459517772|FG000|Overall Study|Withdrawal by Subject|1|||
127696508|NCT04258709|459517773|FG001|Overall Study|Withdrawal by Subject|0|||
127696509|NCT04258709|459517772|FG000|Overall Study|Fetal demise|0|||
127696510|NCT04258709|459517773|FG001|Overall Study|Fetal demise|1|||
127696511|NCT04258709|459517772|FG000|Overall Study|Protocol Violation|1|||
127696512|NCT04258709|459517773|FG001|Overall Study|Protocol Violation|1|||
127696513|NCT04034251|459517774|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
127696514|NCT04034251|459517775|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
127696515|NCT04034251|459517776|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
127788391|NCT03116698|459849997|FG002|Overall Study|Lost to Follow-up|0|||
127788392|NCT03116698|459849998|FG003|Overall Study|Lost to Follow-up|0|||
127696516|NCT05273749|459517777|FG000|Overall Study|Adverse Event|14|||
127696517|NCT05273749|459517778|FG001|Overall Study|Adverse Event|8|||
127696518|NCT05273749|459517777|FG000|Overall Study|Lack of Efficacy|2|||
127696519|NCT05273749|459517778|FG001|Overall Study|Lack of Efficacy|8|||
127788393|NCT03116698|459849995|FG000|Overall Study|Physician Decision|1|||
127882851|NCT01682512|460194599|FG001|Overall Study|Adverse Event|5|||
127882852|NCT01682512|460194600|FG002|Overall Study|Adverse Event|2|||
127882853|NCT01682512|460194598|FG000|Overall Study|Withdrawal by Subject|2|||
127882854|NCT01682512|460194599|FG001|Overall Study|Withdrawal by Subject|6|||
127882855|NCT01682512|460194600|FG002|Overall Study|Withdrawal by Subject|3|||
127882856|NCT01682512|460194598|FG000|Overall Study|Physician Decision|0|||
127882857|NCT01682512|460194599|FG001|Overall Study|Physician Decision|2|||
127882858|NCT01682512|460194600|FG002|Overall Study|Physician Decision|0|||
127602078|NCT00451321|459171468|FG000|Overall Study|Lost to Follow-up|3|||
127882859|NCT01682512|460194598|FG000|Overall Study|Study terminated by sponsor|46|||
127882860|NCT01682512|460194599|FG001|Overall Study|Study terminated by sponsor|43|||
127882861|NCT01682512|460194600|FG002|Overall Study|Study terminated by sponsor|0|||
127602079|NCT00451321|459171469|FG001|Overall Study|Lost to Follow-up|3|||
127602080|NCT00451321|459171470|FG002|Overall Study|Lost to Follow-up|1|||
127602081|NCT00451321|459171471|FG003|Overall Study|Lost to Follow-up|3|||
127602082|NCT00451321|459171472|FG004|Overall Study|Lost to Follow-up|0|||
127602083|NCT00451321|459171473|FG005|Overall Study|Lost to Follow-up|1|||
127602084|NCT00451321|459171474|FG006|Overall Study|Lost to Follow-up|0|||
127602085|NCT00451321|459171475|FG007|Overall Study|Lost to Follow-up|0|||
127602086|NCT00451321|459171468|FG000|Overall Study|Withdrawal by Subject|3|||
127602087|NCT00451321|459171469|FG001|Overall Study|Withdrawal by Subject|1|||
127602088|NCT00451321|459171470|FG002|Overall Study|Withdrawal by Subject|0|||
127602089|NCT00451321|459171471|FG003|Overall Study|Withdrawal by Subject|4|||
127602090|NCT00451321|459171472|FG004|Overall Study|Withdrawal by Subject|0|||
127602091|NCT00451321|459171473|FG005|Overall Study|Withdrawal by Subject|0|||
127602092|NCT00451321|459171474|FG006|Overall Study|Withdrawal by Subject|0|||
127602093|NCT00451321|459171475|FG007|Overall Study|Withdrawal by Subject|0|||
127602094|NCT00451321|459171468|FG000|Overall Study|Study closed/terminated|1|||
127602095|NCT00451321|459171469|FG001|Overall Study|Study closed/terminated|1|||
127602096|NCT00451321|459171470|FG002|Overall Study|Study closed/terminated|17|||
127696520|NCT05273749|459517777|FG000|Overall Study|Physician Decision|0|||
127602097|NCT00451321|459171471|FG003|Overall Study|Study closed/terminated|5|||
127696521|NCT05273749|459517778|FG001|Overall Study|Physician Decision|2|||
127602098|NCT00451321|459171472|FG004|Overall Study|Study closed/terminated|7|||
127602099|NCT00451321|459171473|FG005|Overall Study|Study closed/terminated|7|||
127602100|NCT00451321|459171474|FG006|Overall Study|Study closed/terminated|5|||
127602101|NCT00451321|459171475|FG007|Overall Study|Study closed/terminated|3|||
127602102|NCT00451321|459171468|FG000|Overall Study|Sponsor decision to amend protocol|0|||
127602103|NCT00451321|459171469|FG001|Overall Study|Sponsor decision to amend protocol|0|||
127602104|NCT00451321|459171470|FG002|Overall Study|Sponsor decision to amend protocol|0|||
127602105|NCT00451321|459171471|FG003|Overall Study|Sponsor decision to amend protocol|0|||
127602106|NCT00451321|459171472|FG004|Overall Study|Sponsor decision to amend protocol|0|||
127602107|NCT00451321|459171473|FG005|Overall Study|Sponsor decision to amend protocol|1|||
127602108|NCT00451321|459171474|FG006|Overall Study|Sponsor decision to amend protocol|1|||
127602109|NCT00451321|459171475|FG007|Overall Study|Sponsor decision to amend protocol|3|||
127602110|NCT01528254|459171478|FG000|Overall Study|Administrative problems|96|||
127602111|NCT01528254|459171479|FG001|Overall Study|Administrative problems|94|||
127602112|NCT01528254|459171478|FG000|Overall Study|Adverse Event|28|||
127602113|NCT01528254|459171479|FG001|Overall Study|Adverse Event|44|||
127602114|NCT01528254|459171478|FG000|Overall Study|Lost to Follow-up|17|||
127602115|NCT01528254|459171479|FG001|Overall Study|Lost to Follow-up|24|||
127602116|NCT01528254|459171478|FG000|Overall Study|Death|13|||
127602117|NCT01528254|459171479|FG001|Overall Study|Death|9|||
127602118|NCT01528254|459171478|FG000|Overall Study|Protocol deviation|9|||
127602119|NCT01528254|459171479|FG001|Overall Study|Protocol deviation|19|||
127602120|NCT01528254|459171478|FG000|Overall Study|New therapy for study indication|8|||
127602121|NCT01528254|459171479|FG001|Overall Study|New therapy for study indication|6|||
127602122|NCT01528254|459171478|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
127602123|NCT01528254|459171479|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
127602124|NCT01528254|459171478|FG000|Overall Study|Withdrawal by Subject|5|||
127602125|NCT01528254|459171479|FG001|Overall Study|Withdrawal by Subject|4|||
127602126|NCT01528254|459171478|FG000|Overall Study|Abnormal laboratory value(s)|3|||
127602127|NCT01528254|459171479|FG001|Overall Study|Abnormal laboratory value(s)|7|||
127602128|NCT01528254|459171478|FG000|Overall Study|Abnormal test procedure result(s)|1|||
127602129|NCT01528254|459171479|FG001|Overall Study|Abnormal test procedure result(s)|0|||
127602130|NCT01528254|459171478|FG000|Overall Study|No longer requires study drug|1|||
127602131|NCT01528254|459171479|FG001|Overall Study|No longer requires study drug|1|||
127602132|NCT01166763|459171480|FG000|Overall Study|Withdrawal by Subject|3|||
127602133|NCT04339296|459171481|FG000|Overall Study|Refuse to participate after allocation|1|||
127602134|NCT04339296|459171482|FG001|Overall Study|Refuse to participate after allocation|1|||
127602135|NCT04339296|459171481|FG000|Overall Study|Withdrew after completion of baseline|2|||
127602136|NCT04339296|459171482|FG001|Overall Study|Withdrew after completion of baseline|1|||
127602137|NCT04339296|459171481|FG000|Overall Study|Lost to Follow-up|0|||
127602138|NCT04339296|459171482|FG001|Overall Study|Lost to Follow-up|4|||
127602139|NCT04339296|459171481|FG000|Overall Study|Discontinued intervention|5|||
127602140|NCT04339296|459171482|FG001|Overall Study|Discontinued intervention|3|||
127602141|NCT01909479|459171483|FG000|From Baseline to Week 26|Adverse Event|3|||
127602142|NCT01909479|459171484|FG001|From Baseline to Week 26|Adverse Event|2|||
127602143|NCT01909479|459171483|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
127602144|NCT01909479|459171484|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
127602145|NCT01909479|459171483|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
127602146|NCT01909479|459171484|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
127602147|NCT01909479|459171483|FG000|26 - 52 Weeks|Adverse Event|0|||
127602148|NCT01909479|459171484|FG001|26 - 52 Weeks|Adverse Event|1|||
127602149|NCT01909479|459171483|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
127602150|NCT01909479|459171484|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
127602151|NCT01909479|459171483|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
127602152|NCT01909479|459171484|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
127602153|NCT01909479|459171483|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
127602154|NCT01909479|459171484|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
127602155|NCT01909479|459171483|FG000|52 Weeks to End of Study|Adverse Event|2|||
127602156|NCT01909479|459171484|FG001|52 Weeks to End of Study|Adverse Event|1|||
127602157|NCT01909479|459171483|FG000|52 Weeks to End of Study|Death|0|||
127602158|NCT01909479|459171484|FG001|52 Weeks to End of Study|Death|1|||
127602159|NCT01909479|459171483|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
127788394|NCT03116698|459849996|FG001|Overall Study|Physician Decision|1|||
127788395|NCT03116698|459849997|FG002|Overall Study|Physician Decision|0|||
127602160|NCT01909479|459171484|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
127602161|NCT01909479|459171483|FG000|52 Weeks to End of Study|Protocol Violation|1|||
127602162|NCT01909479|459171484|FG001|52 Weeks to End of Study|Protocol Violation|0|||
127602163|NCT01909479|459171483|FG000|52 Weeks to End of Study|Progressive disease|1|||
127602164|NCT01909479|459171484|FG001|52 Weeks to End of Study|Progressive disease|1|||
127602165|NCT01909479|459171483|FG000|52 Weeks to End of Study|Personal reasons|2|||
127602166|NCT01909479|459171484|FG001|52 Weeks to End of Study|Personal reasons|1|||
127602167|NCT01909479|459171483|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
127602168|NCT01909479|459171484|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
127602169|NCT01909479|459171483|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
127602170|NCT01909479|459171484|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
127602171|NCT01909479|459171483|FG000|52 Weeks to End of Study|Lack of contact|1|||
127602172|NCT01909479|459171484|FG001|52 Weeks to End of Study|Lack of contact|0|||
127602173|NCT01909479|459171483|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
127602174|NCT01909479|459171484|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
127602175|NCT01909479|459171483|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
127602176|NCT01909479|459171484|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
127602177|NCT04446377|459171485|FG000|Overall Study|Withdrawal by Subject|6|||
127602178|NCT04446377|459171486|FG001|Overall Study|Withdrawal by Subject|1|||
127602179|NCT04446377|459171485|FG000|Overall Study|Physician Decision|1|||
127602180|NCT04446377|459171486|FG001|Overall Study|Physician Decision|1|||
127602181|NCT04446377|459171485|FG000|Overall Study|Lost to Follow-up|0|||
127602182|NCT04446377|459171486|FG001|Overall Study|Lost to Follow-up|2|||
127602183|NCT04446377|459171485|FG000|Overall Study|Not eligible|0|||
127602184|NCT04446377|459171486|FG001|Overall Study|Not eligible|1|||
127602185|NCT03557151|459171489|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
127602186|NCT03557151|459171490|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
127602187|NCT03557151|459171489|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
127602188|NCT03557151|459171490|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
127602189|NCT03557151|459171489|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
127602190|NCT03557151|459171490|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
127602191|NCT01414075|459171491|FG000|Overall Study|Adverse Event|1|||
127602192|NCT01414075|459171492|FG001|Overall Study|Adverse Event|0|||
127602193|NCT01414075|459171493|FG002|Overall Study|Adverse Event|1|||
127602194|NCT01414075|459171494|FG003|Overall Study|Adverse Event|0|||
127602195|NCT01414075|459171491|FG000|Overall Study|Death|1|||
127602196|NCT01414075|459171492|FG001|Overall Study|Death|0|||
127602197|NCT01414075|459171493|FG002|Overall Study|Death|0|||
127602198|NCT01414075|459171494|FG003|Overall Study|Death|1|||
127602199|NCT01414075|459171491|FG000|Overall Study|Withdrawal by Subject|0|||
127602200|NCT01414075|459171492|FG001|Overall Study|Withdrawal by Subject|0|||
127602201|NCT01414075|459171493|FG002|Overall Study|Withdrawal by Subject|0|||
127602202|NCT01414075|459171494|FG003|Overall Study|Withdrawal by Subject|1|||
127602203|NCT01414075|459171491|FG000|Overall Study|Other than specified|1|||
127602204|NCT01414075|459171492|FG001|Overall Study|Other than specified|0|||
127602205|NCT01414075|459171493|FG002|Overall Study|Other than specified|1|||
127602206|NCT01414075|459171494|FG003|Overall Study|Other than specified|0|||
127602207|NCT01187043|459171496|FG000|Overall Study|Adverse Event|0|||
127602208|NCT01187043|459171497|FG001|Overall Study|Adverse Event|0|||
127602209|NCT01187043|459171498|FG002|Overall Study|Adverse Event|0|||
127602210|NCT01187043|459171499|FG003|Overall Study|Adverse Event|0|||
127602211|NCT01187043|459171500|FG004|Overall Study|Adverse Event|1|||
127602212|NCT01187043|459171496|FG000|Overall Study|Unable to make scheduled visits|1|||
127602213|NCT01187043|459171497|FG001|Overall Study|Unable to make scheduled visits|0|||
127602214|NCT01187043|459171498|FG002|Overall Study|Unable to make scheduled visits|4|||
127602215|NCT01187043|459171499|FG003|Overall Study|Unable to make scheduled visits|0|||
127602216|NCT01187043|459171500|FG004|Overall Study|Unable to make scheduled visits|1|||
127602217|NCT03198234|459171502|FG000|Overall Study|Relapse of primary disease|0|||
127602218|NCT03198234|459171503|FG001|Overall Study|Relapse of primary disease|1|||
127602219|NCT03198234|459171504|FG002|Overall Study|Relapse of primary disease|0|||
127602220|NCT01340898|459171505|FG000|Primary Phase|Serious Adverse Events|0|||
127602221|NCT01340898|459171506|FG001|Primary Phase|Serious Adverse Events|0|||
127602222|NCT01340898|459171507|FG002|Primary Phase|Serious Adverse Events|1|||
127602223|NCT01340898|459171505|FG000|Primary Phase|Withdrawal by Subject|8|||
127602224|NCT01340898|459171506|FG001|Primary Phase|Withdrawal by Subject|7|||
127602225|NCT01340898|459171507|FG002|Primary Phase|Withdrawal by Subject|5|||
127602226|NCT01340898|459171505|FG000|Primary Phase|Migrated/moved from study area|4|||
127602227|NCT01340898|459171506|FG001|Primary Phase|Migrated/moved from study area|1|||
127602228|NCT01340898|459171507|FG002|Primary Phase|Migrated/moved from study area|0|||
127602229|NCT01340898|459171505|FG000|Primary Phase|Lost to Follow-up|4|||
127602230|NCT01340898|459171506|FG001|Primary Phase|Lost to Follow-up|1|||
127602231|NCT01340898|459171507|FG002|Primary Phase|Lost to Follow-up|0|||
127602232|NCT01340898|459171505|FG000|Booster Phase|Withdrawal by Subject|3|||
127602233|NCT01340898|459171506|FG001|Booster Phase|Withdrawal by Subject|0|||
127602234|NCT01340898|459171507|FG002|Booster Phase|Withdrawal by Subject|4|||
127602235|NCT01340898|459171505|FG000|Booster Phase|Migrated/moved from study area|3|||
127602236|NCT01340898|459171506|FG001|Booster Phase|Migrated/moved from study area|0|||
127602237|NCT01340898|459171507|FG002|Booster Phase|Migrated/moved from study area|0|||
127602238|NCT01340898|459171505|FG000|Booster Phase|Lost to Follow-up|4|||
127602239|NCT01340898|459171506|FG001|Booster Phase|Lost to Follow-up|2|||
127602240|NCT01340898|459171507|FG002|Booster Phase|Lost to Follow-up|3|||
127602241|NCT01214629|459171509|FG000|Overall Study|Progressive Disease|1|||
127602242|NCT01214629|459171510|FG001|Overall Study|Progressive Disease|1|||
127602243|NCT01214629|459171511|FG002|Overall Study|Progressive Disease|0|||
127602244|NCT01214629|459171512|FG003|Overall Study|Progressive Disease|1|||
127602245|NCT01214629|459171513|FG004|Overall Study|Progressive Disease|2|||
127602246|NCT01214629|459171514|FG005|Overall Study|Progressive Disease|3|||
127602247|NCT01214629|459171515|FG006|Overall Study|Progressive Disease|1|||
127602248|NCT01214629|459171516|FG007|Overall Study|Progressive Disease|1|||
127602249|NCT01214629|459171517|FG008|Overall Study|Progressive Disease|1|||
127602250|NCT01214629|459171518|FG009|Overall Study|Progressive Disease|5|||
127602251|NCT01214629|459171519|FG010|Overall Study|Progressive Disease|1|||
127602252|NCT01214629|459171509|FG000|Overall Study|Adverse Event|0|||
127602253|NCT01214629|459171510|FG001|Overall Study|Adverse Event|0|||
127602254|NCT01214629|459171511|FG002|Overall Study|Adverse Event|0|||
127602255|NCT01214629|459171512|FG003|Overall Study|Adverse Event|1|||
127602256|NCT01214629|459171513|FG004|Overall Study|Adverse Event|0|||
127602257|NCT01214629|459171514|FG005|Overall Study|Adverse Event|1|||
127602258|NCT01214629|459171515|FG006|Overall Study|Adverse Event|0|||
127602259|NCT01214629|459171516|FG007|Overall Study|Adverse Event|0|||
127602260|NCT01214629|459171517|FG008|Overall Study|Adverse Event|0|||
127602261|NCT01214629|459171518|FG009|Overall Study|Adverse Event|1|||
127602262|NCT01214629|459171519|FG010|Overall Study|Adverse Event|0|||
127602263|NCT01214629|459171509|FG000|Overall Study|Physician Decision|0|||
127602264|NCT01214629|459171510|FG001|Overall Study|Physician Decision|0|||
127602265|NCT01214629|459171511|FG002|Overall Study|Physician Decision|0|||
127602266|NCT01214629|459171512|FG003|Overall Study|Physician Decision|0|||
127602267|NCT01214629|459171513|FG004|Overall Study|Physician Decision|0|||
127602268|NCT01214629|459171514|FG005|Overall Study|Physician Decision|0|||
127602269|NCT01214629|459171515|FG006|Overall Study|Physician Decision|0|||
127602270|NCT01214629|459171516|FG007|Overall Study|Physician Decision|0|||
127602271|NCT01214629|459171517|FG008|Overall Study|Physician Decision|0|||
127602272|NCT01214629|459171518|FG009|Overall Study|Physician Decision|0|||
127602273|NCT01214629|459171519|FG010|Overall Study|Physician Decision|1|||
127602274|NCT01214629|459171509|FG000|Overall Study|Withdrawal by Subject|0|||
127602275|NCT01214629|459171510|FG001|Overall Study|Withdrawal by Subject|0|||
127602276|NCT01214629|459171511|FG002|Overall Study|Withdrawal by Subject|0|||
127602277|NCT01214629|459171512|FG003|Overall Study|Withdrawal by Subject|0|||
127602278|NCT01214629|459171513|FG004|Overall Study|Withdrawal by Subject|0|||
127602279|NCT01214629|459171514|FG005|Overall Study|Withdrawal by Subject|0|||
127602280|NCT01214629|459171515|FG006|Overall Study|Withdrawal by Subject|0|||
127602281|NCT01214629|459171516|FG007|Overall Study|Withdrawal by Subject|0|||
127602282|NCT01214629|459171517|FG008|Overall Study|Withdrawal by Subject|0|||
127602283|NCT01214629|459171518|FG009|Overall Study|Withdrawal by Subject|1|||
127602284|NCT01214629|459171519|FG010|Overall Study|Withdrawal by Subject|0|||
127602285|NCT03266094|459171520|FG000|Overall Study|Lost to Follow-up|1|||
127602286|NCT03266094|459171520|FG000|Overall Study|Withdrawal by Subject|1|||
127602287|NCT03128892|459171521|FG000|Overall Study|Withdrawal by Subject|2|||
127602288|NCT03128892|459171521|FG000|Overall Study|Physician Decision|1|||
127602289|NCT03036072|459171526|FG000|Overall Study|Death|0|||
127602290|NCT03036072|459171527|FG001|Overall Study|Death|1|||
127602291|NCT03036072|459171526|FG000|Overall Study|Withdrawal by Subject|0|||
127602292|NCT03036072|459171527|FG001|Overall Study|Withdrawal by Subject|1|||
127602293|NCT03036072|459171526|FG000|Overall Study|Physician Decision|0|||
127602294|NCT03036072|459171527|FG001|Overall Study|Physician Decision|1|||
127602295|NCT02484729|459171528|FG000|Overall Study|Failure of IntelliCap Error|0|||
127602296|NCT02484729|459171529|FG001|Overall Study|Failure of IntelliCap Error|0|||
127602297|NCT02484729|459171530|FG002|Overall Study|Failure of IntelliCap Error|0|||
127602298|NCT02484729|459171531|FG003|Overall Study|Failure of IntelliCap Error|0|||
127602299|NCT02484729|459171532|FG004|Overall Study|Failure of IntelliCap Error|0|||
127602300|NCT02484729|459171533|FG005|Overall Study|Failure of IntelliCap Error|0|||
127602301|NCT02484729|459171534|FG006|Overall Study|Failure of IntelliCap Error|0|||
127602302|NCT02484729|459171535|FG007|Overall Study|Failure of IntelliCap Error|0|||
127602303|NCT02484729|459171536|FG008|Overall Study|Failure of IntelliCap Error|0|||
127602304|NCT02484729|459171537|FG009|Overall Study|Failure of IntelliCap Error|1|||
127602305|NCT02111850|459171538|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
127602306|NCT02111850|459171539|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
127602307|NCT02111850|459171540|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
127602308|NCT02111850|459171541|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
127602309|NCT02111850|459171542|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
127602310|NCT02111850|459171543|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
127602311|NCT02111850|459171544|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
127602312|NCT02111850|459171545|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
127602313|NCT02111850|459171546|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
127602314|NCT02111850|459171547|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
127602315|NCT02111850|459171548|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
127602316|NCT00665847|459171551|FG000|Overall Study|Adverse Event|8|||
127602317|NCT00665847|459171551|FG000|Overall Study|Withdrawal by Subject|2|||
127602318|NCT00665847|459171551|FG000|Overall Study|Subject non-compliant|8|||
127602319|NCT00665847|459171551|FG000|Overall Study|Subject reached a virologic endpoint|4|||
127602320|NCT00665847|459171551|FG000|Overall Study|Resistance to TMC125|1|||
127602321|NCT00665847|459171551|FG000|Overall Study|Subject ineligible to continue the trial|1|||
127602322|NCT00665847|459171551|FG000|Overall Study|Switch to Commercial Medication|1|||
127602323|NCT00492115|459171556|FG000|Overall Study|Withdrawal by Subject|3|||
127602324|NCT00492115|459171557|FG001|Overall Study|Withdrawal by Subject|4|||
127602325|NCT03564145|459171558|FG000|Overall Study|Adverse Event|4|||
127788396|NCT03116698|459849998|FG003|Overall Study|Physician Decision|0|||
127602326|NCT03564145|459171558|FG000|Overall Study|Lost to Follow-up|21|||
127602327|NCT03564145|459171558|FG000|Overall Study|Protocol Violation|2|||
127602328|NCT03564145|459171558|FG000|Overall Study|Withdrawal by Subject|48|||
127602329|NCT03564145|459171558|FG000|Overall Study|Study Terminated by Sponsor|146|||
127602330|NCT03564145|459171558|FG000|Overall Study|Physician Decision|1|||
127602331|NCT03564145|459171558|FG000|Overall Study|Other Than Specified|1|||
127602332|NCT03564145|459171558|FG000|Overall Study|Pregnancy|1|||
127602333|NCT01853826|459173442|FG000|Overall Study|Patients who switched to commercial drug|11|||
127602334|NCT01853826|459173442|FG000|Overall Study|Patient refused to continue medication|21|||
127602335|NCT01853826|459173442|FG000|Overall Study|Lost to Follow-up|2|||
127602336|NCT01853826|459173442|FG000|Overall Study|Non-compliant with protocol|4|||
127602337|NCT01853826|459173442|FG000|Overall Study|Other adverse events (AE)|62|||
127602338|NCT01853826|459173442|FG000|Overall Study|Worsening or AE of underlying cancer disease|24|||
127602339|NCT01853826|459173442|FG000|Overall Study|Progressive disease|342|||
127602340|NCT01853826|459173442|FG000|Overall Study|Other than listed|13|||
127602341|NCT01853826|459173442|FG000|Overall Study|Not treated - not signed privacy informed consent|2|||
127602342|NCT00982488|459173444|FG000|Overall Study|Administrative reason by sponsor|81|||
127602343|NCT00982488|459173445|FG001|Overall Study|Administrative reason by sponsor|3|||
127602344|NCT00982488|459173446|FG002|Overall Study|Administrative reason by sponsor|11|||
127602345|NCT00982488|459173447|FG003|Overall Study|Administrative reason by sponsor|0|||
127602346|NCT00982488|459173448|FG004|Overall Study|Administrative reason by sponsor|0|||
127602347|NCT00982488|459173444|FG000|Overall Study|Adverse event unrelated to study drug|5|||
127602348|NCT00982488|459173445|FG001|Overall Study|Adverse event unrelated to study drug|1|||
127602349|NCT00982488|459173446|FG002|Overall Study|Adverse event unrelated to study drug|0|||
127602350|NCT00982488|459173447|FG003|Overall Study|Adverse event unrelated to study drug|0|||
127602351|NCT00982488|459173448|FG004|Overall Study|Adverse event unrelated to study drug|0|||
127602352|NCT00982488|459173444|FG000|Overall Study|Death|11|||
127602353|NCT00982488|459173445|FG001|Overall Study|Death|0|||
127602354|NCT00982488|459173446|FG002|Overall Study|Death|2|||
127602355|NCT00982488|459173447|FG003|Overall Study|Death|0|||
127602356|NCT00982488|459173448|FG004|Overall Study|Death|0|||
127602357|NCT00982488|459173444|FG000|Overall Study|Disease progression|30|||
127602358|NCT00982488|459173445|FG001|Overall Study|Disease progression|5|||
127602359|NCT00982488|459173446|FG002|Overall Study|Disease progression|10|||
127602360|NCT00982488|459173447|FG003|Overall Study|Disease progression|1|||
127602361|NCT00982488|459173448|FG004|Overall Study|Disease progression|1|||
127602362|NCT00982488|459173444|FG000|Overall Study|Lost to Follow-up|1|||
127602363|NCT00982488|459173445|FG001|Overall Study|Lost to Follow-up|0|||
127602364|NCT00982488|459173446|FG002|Overall Study|Lost to Follow-up|0|||
127602365|NCT00982488|459173447|FG003|Overall Study|Lost to Follow-up|0|||
127602366|NCT00982488|459173448|FG004|Overall Study|Lost to Follow-up|0|||
127602367|NCT00982488|459173444|FG000|Overall Study|Maximum clinical benefit|1|||
127602368|NCT00982488|459173445|FG001|Overall Study|Maximum clinical benefit|1|||
127602369|NCT00982488|459173446|FG002|Overall Study|Maximum clinical benefit|1|||
127602370|NCT00982488|459173447|FG003|Overall Study|Maximum clinical benefit|0|||
127602371|NCT00982488|459173448|FG004|Overall Study|Maximum clinical benefit|0|||
127602372|NCT00982488|459173444|FG000|Overall Study|Other|15|||
127602373|NCT00982488|459173445|FG001|Overall Study|Other|1|||
127602374|NCT00982488|459173446|FG002|Overall Study|Other|3|||
127602375|NCT00982488|459173447|FG003|Overall Study|Other|1|||
127602376|NCT00982488|459173448|FG004|Overall Study|Other|0|||
127602377|NCT00982488|459173444|FG000|Overall Study|Poor compliance/noncompliance|0|||
127602378|NCT00982488|459173445|FG001|Overall Study|Poor compliance/noncompliance|1|||
127602379|NCT00982488|459173446|FG002|Overall Study|Poor compliance/noncompliance|0|||
127602380|NCT00982488|459173447|FG003|Overall Study|Poor compliance/noncompliance|0|||
127602381|NCT00982488|459173448|FG004|Overall Study|Poor compliance/noncompliance|0|||
127602382|NCT00982488|459173444|FG000|Overall Study|Stem cell transplant|2|||
127602383|NCT00982488|459173445|FG001|Overall Study|Stem cell transplant|0|||
127602384|NCT00982488|459173446|FG002|Overall Study|Stem cell transplant|0|||
127602385|NCT00982488|459173447|FG003|Overall Study|Stem cell transplant|1|||
127602386|NCT00982488|459173448|FG004|Overall Study|Stem cell transplant|0|||
127602387|NCT00982488|459173444|FG000|Overall Study|Study drug toxicity|34|||
127602388|NCT00982488|459173445|FG001|Overall Study|Study drug toxicity|1|||
127602389|NCT00982488|459173446|FG002|Overall Study|Study drug toxicity|6|||
127602390|NCT00982488|459173447|FG003|Overall Study|Study drug toxicity|0|||
127602391|NCT00982488|459173448|FG004|Overall Study|Study drug toxicity|0|||
127788397|NCT03116698|459849995|FG000|Overall Study|Protocol Violation|1|||
127602392|NCT00982488|459173444|FG000|Overall Study|Withdrawal by Subject|5|||
127602393|NCT00982488|459173445|FG001|Overall Study|Withdrawal by Subject|1|||
127602394|NCT00982488|459173446|FG002|Overall Study|Withdrawal by Subject|1|||
127602395|NCT00982488|459173447|FG003|Overall Study|Withdrawal by Subject|0|||
127602396|NCT00982488|459173448|FG004|Overall Study|Withdrawal by Subject|0|||
127602397|NCT04244786|459173449|FG000|Overall Study|Adverse Event|0|||
127602398|NCT04244786|459173450|FG001|Overall Study|Adverse Event|0|||
127788398|NCT03116698|459849996|FG001|Overall Study|Protocol Violation|0|||
127788399|NCT03116698|459849997|FG002|Overall Study|Protocol Violation|0|||
127788400|NCT03116698|459849998|FG003|Overall Study|Protocol Violation|0|||
127788401|NCT03116698|459849995|FG000|Overall Study|Death|0|||
127788402|NCT03116698|459849996|FG001|Overall Study|Death|0|||
127788403|NCT03116698|459849997|FG002|Overall Study|Death|2|||
127602399|NCT04244786|459173451|FG002|Overall Study|Adverse Event|2|||
127602400|NCT04244786|459173449|FG000|Overall Study|Withdrawal by Subject|0|||
127602401|NCT04244786|459173450|FG001|Overall Study|Withdrawal by Subject|0|||
127602402|NCT04244786|459173451|FG002|Overall Study|Withdrawal by Subject|5|||
127602403|NCT00613938|459173458|FG000|Overall Study|Withdrawal by Subject|2|||
127602404|NCT00613938|459173459|FG001|Overall Study|Withdrawal by Subject|4|||
127602405|NCT00613938|459173460|FG002|Overall Study|Withdrawal by Subject|9|||
127602406|NCT00613938|459173461|FG003|Overall Study|Withdrawal by Subject|9|||
127602407|NCT00613938|459173458|FG000|Overall Study|Adverse Event|1|||
127602408|NCT00613938|459173459|FG001|Overall Study|Adverse Event|4|||
127602409|NCT00613938|459173460|FG002|Overall Study|Adverse Event|8|||
127602410|NCT00613938|459173461|FG003|Overall Study|Adverse Event|5|||
127602411|NCT00613938|459173458|FG000|Overall Study|Lack of Efficacy|16|||
127602412|NCT00613938|459173459|FG001|Overall Study|Lack of Efficacy|18|||
127602413|NCT00613938|459173460|FG002|Overall Study|Lack of Efficacy|5|||
127602414|NCT00613938|459173461|FG003|Overall Study|Lack of Efficacy|9|||
127602415|NCT00613938|459173458|FG000|Overall Study|Other|1|||
127602416|NCT00613938|459173459|FG001|Overall Study|Other|2|||
127602417|NCT00613938|459173460|FG002|Overall Study|Other|1|||
127602418|NCT00613938|459173461|FG003|Overall Study|Other|3|||
127602419|NCT02636868|459173462|FG000|Overall Study|Death|0|||
127602420|NCT02636868|459173463|FG001|Overall Study|Death|1|||
127602421|NCT02636868|459173464|FG002|Overall Study|Death|2|||
127602422|NCT03220217|459173465|FG000|Overall Study|Withdrawal by Subject|0|||
127602423|NCT03220217|459173466|FG001|Overall Study|Withdrawal by Subject|1|||
127602424|NCT03220217|459173467|FG002|Overall Study|Withdrawal by Subject|0|||
127602425|NCT03220217|459173465|FG000|Overall Study|Subject Missed Procedure|0|||
127602426|NCT03220217|459173466|FG001|Overall Study|Subject Missed Procedure|0|||
127602427|NCT03220217|459173467|FG002|Overall Study|Subject Missed Procedure|1|||
127602428|NCT03025542|459173468|FG000|Overall Study|Adverse Event|0|||
127602429|NCT03025542|459173469|FG001|Overall Study|Adverse Event|2|||
127602430|NCT03025542|459173468|FG000|Overall Study|Lost to Follow-up|1|||
127602431|NCT03025542|459173469|FG001|Overall Study|Lost to Follow-up|0|||
127602432|NCT03025542|459173468|FG000|Overall Study|Withdrawal by Subject|1|||
127602433|NCT03025542|459173469|FG001|Overall Study|Withdrawal by Subject|0|||
127602434|NCT03745937|459173470|FG000|Overall Study|Withdrawal by Subject|0|||
127602435|NCT03745937|459173471|FG001|Overall Study|Withdrawal by Subject|0|||
127602436|NCT03745937|459173472|FG002|Overall Study|Withdrawal by Subject|0|||
127602437|NCT03745937|459173473|FG003|Overall Study|Withdrawal by Subject|1|||
127602438|NCT03745937|459173470|FG000|Overall Study|Not-specifed|0|||
127602439|NCT03745937|459173471|FG001|Overall Study|Not-specifed|1|||
127602440|NCT03745937|459173472|FG002|Overall Study|Not-specifed|0|||
127602441|NCT03745937|459173473|FG003|Overall Study|Not-specifed|1|||
127602442|NCT02734810|459173477|FG000|Overall Study|Adverse Event|1|||
127602443|NCT02734810|459173478|FG001|Overall Study|Adverse Event|0|||
127602444|NCT02734810|459173477|FG000|Overall Study|Lack of Efficacy|1|||
127602445|NCT02734810|459173478|FG001|Overall Study|Lack of Efficacy|0|||
127602446|NCT00488345|459173479|FG000|Overall Study|Adverse Event|0|||
127602447|NCT00488345|459173480|FG001|Overall Study|Adverse Event|1|||
127602448|NCT00488345|459173481|FG002|Overall Study|Adverse Event|1|||
127602449|NCT00488345|459173479|FG000|Overall Study|Unable to administer antibiotics at home|0|||
127602450|NCT00488345|459173480|FG001|Overall Study|Unable to administer antibiotics at home|1|||
127602451|NCT00488345|459173481|FG002|Overall Study|Unable to administer antibiotics at home|0|||
127602452|NCT00488345|459173479|FG000|Overall Study|Institutional Review Board review|0|||
127602453|NCT00488345|459173480|FG001|Overall Study|Institutional Review Board review|0|||
127602454|NCT00488345|459173481|FG002|Overall Study|Institutional Review Board review|1|||
127602455|NCT00488345|459173479|FG000|Overall Study|Surgical team recommendation|0|||
127602456|NCT00488345|459173480|FG001|Overall Study|Surgical team recommendation|1|||
127602457|NCT00488345|459173481|FG002|Overall Study|Surgical team recommendation|0|||
127602458|NCT00488345|459173479|FG000|Overall Study|Parent/legal guardian request|0|||
127602459|NCT00488345|459173480|FG001|Overall Study|Parent/legal guardian request|1|||
127602460|NCT00488345|459173481|FG002|Overall Study|Parent/legal guardian request|1|||
127602461|NCT01104636|459173487|FG000|Overall Study|Lack of Efficacy|43|||
127602462|NCT01104636|459173487|FG000|Overall Study|Lost to Follow-up|24|||
127602463|NCT01104636|459173487|FG000|Overall Study|Withdrawal by Subject|4|||
127602464|NCT01104636|459173487|FG000|Overall Study|Other|43|||
127602465|NCT01104636|459173487|FG000|Overall Study|Study terminated by sponsor|1|||
127788404|NCT03116698|459849998|FG003|Overall Study|Death|0|||
127788405|NCT00788372|459849999|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
127788406|NCT00788372|459849999|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
127602466|NCT01104636|459173487|FG000|Overall Study|Pregnancy|2|||
127602467|NCT01104636|459173487|FG000|Overall Study|Adverse Event|40|||
127602468|NCT01104636|459173487|FG000|Overall Study|Ongoing|21|||
127602469|NCT01706003|459173488|FG000|Overall Study|Withdrawal by Subject|2|||
127602470|NCT01706003|459173489|FG001|Overall Study|Withdrawal by Subject|0|||
127602471|NCT01706003|459173488|FG000|Overall Study|Not scheduled|3|||
127602472|NCT01706003|459173489|FG001|Overall Study|Not scheduled|0|||
127602473|NCT01706003|459173488|FG000|Overall Study|Lost to Follow-up|6|||
127602474|NCT01706003|459173489|FG001|Overall Study|Lost to Follow-up|4|||
127602475|NCT00407563|459173490|FG000|Overall Study|Patient continues on treatment|1|||
127602476|NCT03055260|459173491|FG000|Overall Study|Withdrawal by Subject|1|||
127602477|NCT03055260|459173492|FG001|Overall Study|Withdrawal by Subject|0|||
127602478|NCT00592839|459173493|FG000|Overall Study|Withdrawal by Subject|1|||
127602479|NCT00592839|459173494|FG001|Overall Study|Withdrawal by Subject|1|||
127602480|NCT00592839|459173495|FG002|Overall Study|Withdrawal by Subject|3|||
127602481|NCT00592839|459173493|FG000|Overall Study|Protocol Violation|1|||
127602482|NCT00592839|459173494|FG001|Overall Study|Protocol Violation|1|||
127602483|NCT00592839|459173495|FG002|Overall Study|Protocol Violation|2|||
127602484|NCT00592839|459173493|FG000|Overall Study|Adverse Event|0|||
127602485|NCT00592839|459173494|FG001|Overall Study|Adverse Event|1|||
127602486|NCT00592839|459173495|FG002|Overall Study|Adverse Event|0|||
127602487|NCT00592839|459173493|FG000|Overall Study|Lost to Follow-up|0|||
127602488|NCT00592839|459173494|FG001|Overall Study|Lost to Follow-up|1|||
127602489|NCT00592839|459173495|FG002|Overall Study|Lost to Follow-up|1|||
127602490|NCT03518073|459173506|FG000|Overall Study|Adverse Event|2|||
127602491|NCT03518073|459173507|FG001|Overall Study|Adverse Event|4|||
127602492|NCT03518073|459173508|FG002|Overall Study|Adverse Event|2|||
127602493|NCT03518073|459173506|FG000|Overall Study|Death|2|||
127602494|NCT03518073|459173507|FG001|Overall Study|Death|1|||
127602495|NCT03518073|459173508|FG002|Overall Study|Death|3|||
127602496|NCT03518073|459173506|FG000|Overall Study|Lost to Follow-up|1|||
127602497|NCT03518073|459173507|FG001|Overall Study|Lost to Follow-up|0|||
127602498|NCT03518073|459173508|FG002|Overall Study|Lost to Follow-up|1|||
127602499|NCT03518073|459173506|FG000|Overall Study|Physician Decision|5|||
127602500|NCT03518073|459173507|FG001|Overall Study|Physician Decision|0|||
127602501|NCT03518073|459173508|FG002|Overall Study|Physician Decision|2|||
127602502|NCT03518073|459173506|FG000|Overall Study|Progressive disease|1|||
127602503|NCT03518073|459173507|FG001|Overall Study|Progressive disease|1|||
127602504|NCT03518073|459173508|FG002|Overall Study|Progressive disease|1|||
127602505|NCT03518073|459173506|FG000|Overall Study|Protocol Violation|1|||
127602506|NCT03518073|459173507|FG001|Overall Study|Protocol Violation|0|||
127602507|NCT03518073|459173508|FG002|Overall Study|Protocol Violation|0|||
127602508|NCT03518073|459173506|FG000|Overall Study|Withdrawal by Subject|30|||
127602509|NCT03518073|459173507|FG001|Overall Study|Withdrawal by Subject|34|||
127602510|NCT03518073|459173508|FG002|Overall Study|Withdrawal by Subject|29|||
127602511|NCT03518073|459173506|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
127602512|NCT03518073|459173507|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
127602513|NCT03518073|459173508|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
127602514|NCT03518073|459173506|FG000|Overall Study|Covid-19|1|||
127602515|NCT03518073|459173507|FG001|Overall Study|Covid-19|2|||
127602516|NCT03518073|459173508|FG002|Overall Study|Covid-19|1|||
127602517|NCT01853046|459173509|FG000|Overall Study|Withdrawal by Subject|1|||
127602518|NCT01853046|459173510|FG001|Overall Study|Withdrawal by Subject|1|||
127602519|NCT01853046|459173509|FG000|Overall Study|Adverse Event|4|||
127602520|NCT01853046|459173510|FG001|Overall Study|Adverse Event|2|||
127602521|NCT01853046|459173509|FG000|Overall Study|Disease progression|13|||
127788407|NCT00788372|459849999|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
127788408|NCT00788372|459849999|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
127788409|NCT00788372|459849999|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
127788410|NCT00788372|459849999|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
127602522|NCT01853046|459173510|FG001|Overall Study|Disease progression|3|||
127602523|NCT01485640|459173511|FG000|Overall Study|Adverse Event|10|||
127602524|NCT01485640|459173511|FG000|Overall Study|Lack of Efficacy|2|||
127602525|NCT01485640|459173511|FG000|Overall Study|Protocol Violation|1|||
127602526|NCT01485640|459173511|FG000|Overall Study|Withdrawal by Subject|14|||
127602527|NCT01485640|459173511|FG000|Overall Study|Terminated by Sponsor|95|||
127602528|NCT02057198|459173517|FG000|Overall Study|Death|0|||
127602529|NCT02057198|459173518|FG001|Overall Study|Death|0|||
127602530|NCT02057198|459173519|FG002|Overall Study|Death|1|||
127602531|NCT02057198|459173517|FG000|Overall Study|Discharged early; lost to followup|0|||
127602532|NCT02057198|459173518|FG001|Overall Study|Discharged early; lost to followup|1|||
127602533|NCT02057198|459173519|FG002|Overall Study|Discharged early; lost to followup|0|||
127602534|NCT03683758|459173525|FG000|Overall Study|Non-study commitment conflict|1|||
127788411|NCT00788372|459849999|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
127602535|NCT03683758|459173526|FG001|Overall Study|Non-study commitment conflict|3|||
127602536|NCT03683758|459173525|FG000|Overall Study|Illness preventing participation|1|||
127602537|NCT03683758|459173526|FG001|Overall Study|Illness preventing participation|0|||
127602538|NCT03683758|459173525|FG000|Overall Study|Adverse Event|1|||
127602539|NCT03683758|459173526|FG001|Overall Study|Adverse Event|0|||
127602540|NCT00723892|459173527|FG000|Overall Study|Participant not tracked|33|||
127602541|NCT00723892|459173528|FG001|Overall Study|Participant not tracked|35|||
127602542|NCT00723892|459173527|FG000|Overall Study|Virological criterion|24|||
127602543|NCT00723892|459173528|FG001|Overall Study|Virological criterion|9|||
127602544|NCT00723892|459173527|FG000|Overall Study|Withdrawal by Subject|6|||
127602545|NCT00723892|459173528|FG001|Overall Study|Withdrawal by Subject|9|||
127602546|NCT00723892|459173527|FG000|Overall Study|End planned|11|||
127602547|NCT00723892|459173528|FG001|Overall Study|End planned|7|||
127602548|NCT00723892|459173527|FG000|Overall Study|Bad tolerance|5|||
127602549|NCT00723892|459173528|FG001|Overall Study|Bad tolerance|5|||
127602550|NCT00723892|459173527|FG000|Overall Study|Multiple reasons|17|||
127602551|NCT00723892|459173528|FG001|Overall Study|Multiple reasons|12|||
127602552|NCT00723892|459173527|FG000|Overall Study|Other|6|||
127602553|NCT00723892|459173528|FG001|Overall Study|Other|3|||
127602554|NCT00723892|459173527|FG000|Overall Study|Study end|1|||
127602555|NCT00723892|459173528|FG001|Overall Study|Study end|3|||
127602556|NCT00723892|459173527|FG000|Overall Study|Weight loss|1|||
127602557|NCT00723892|459173528|FG001|Overall Study|Weight loss|3|||
127602558|NCT00723892|459173527|FG000|Overall Study|Alcohol abuse|0|||
127602559|NCT00723892|459173528|FG001|Overall Study|Alcohol abuse|1|||
127602560|NCT00723892|459173527|FG000|Overall Study|Intercurrent infection|2|||
127602561|NCT00723892|459173528|FG001|Overall Study|Intercurrent infection|0|||
127602562|NCT00723892|459173527|FG000|Overall Study|Drug addiction|1|||
127602563|NCT00723892|459173528|FG001|Overall Study|Drug addiction|0|||
127602564|NCT01172847|459173531|FG000|Overall Study|Withdrawal by Subject|3|||
127602565|NCT01163279|459173532|FG000|Overall Study|Withdrawal by Subject|2|||
127602566|NCT01163279|459173533|FG001|Overall Study|Withdrawal by Subject|0|||
127602567|NCT02232425|459173535|FG000|Overall Study|Lost to Follow-up|6|||
127602568|NCT02232425|459173536|FG001|Overall Study|Lost to Follow-up|2|||
127602569|NCT02232425|459173535|FG000|Overall Study|Adverse Event|2|||
127602570|NCT02232425|459173536|FG001|Overall Study|Adverse Event|0|||
127602571|NCT02232425|459173535|FG000|Overall Study|Withdrawal by Subject|5|||
127602572|NCT02232425|459173536|FG001|Overall Study|Withdrawal by Subject|6|||
127602573|NCT02232425|459173535|FG000|Overall Study|Lack of Efficacy|1|||
127602574|NCT02232425|459173536|FG001|Overall Study|Lack of Efficacy|0|||
127602575|NCT00665353|459173537|FG000|Study Step 1|Adverse Event|1|||
127602576|NCT00665353|459173537|FG000|Study Step 1|Withdrawal by Subject|2|||
127602577|NCT00665353|459173537|FG000|Study Step 2|Lost to Follow-up|2|||
127602578|NCT00665353|459173537|FG000|Study Step 2|Lack of Efficacy|12|||
127602579|NCT01601626|459173538|FG000|Overall Study|Death|1|||
127602580|NCT01601626|459173539|FG001|Overall Study|Death|1|||
127602581|NCT01601626|459173540|FG002|Overall Study|Death|1|||
127602582|NCT01601626|459173538|FG000|Overall Study|Lost to Follow-up|1|||
127602583|NCT01601626|459173539|FG001|Overall Study|Lost to Follow-up|2|||
127602584|NCT01601626|459173540|FG002|Overall Study|Lost to Follow-up|0|||
127602585|NCT01601626|459173538|FG000|Overall Study|Unable to Get to Clinic|0|||
127602586|NCT01601626|459173539|FG001|Overall Study|Unable to Get to Clinic|1|||
127602587|NCT01601626|459173540|FG002|Overall Study|Unable to Get to Clinic|0|||
127602588|NCT01601626|459173538|FG000|Overall Study|Withdrawal by Subject|0|||
127602589|NCT01601626|459173539|FG001|Overall Study|Withdrawal by Subject|1|||
127602590|NCT01601626|459173540|FG002|Overall Study|Withdrawal by Subject|1|||
127602591|NCT01601626|459173538|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
127602592|NCT01601626|459173539|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
127696522|NCT05273749|459517777|FG000|Overall Study|Withdrawal by Subject|14|||
127696523|NCT05273749|459517778|FG001|Overall Study|Withdrawal by Subject|16|||
127696524|NCT05273749|459517777|FG000|Overall Study|Lost to Follow-up|10|||
127696525|NCT05273749|459517778|FG001|Overall Study|Lost to Follow-up|10|||
127696526|NCT05273749|459517777|FG000|Overall Study|Pregnancy|1|||
127696527|NCT05273749|459517778|FG001|Overall Study|Pregnancy|0|||
127696528|NCT05273749|459517777|FG000|Overall Study|Non-Compliance|3|||
127696529|NCT05273749|459517778|FG001|Overall Study|Non-Compliance|2|||
127696530|NCT05273749|459517777|FG000|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|0|||
127602593|NCT01601626|459173540|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
127602594|NCT00498602|459173541|FG000|Overall Study|Death|0|||
127602595|NCT00498602|459173542|FG001|Overall Study|Death|0|||
127602596|NCT00498602|459173543|FG002|Overall Study|Death|0|||
127602597|NCT00498602|459173544|FG003|Overall Study|Death|0|||
127696531|NCT05273749|459517778|FG001|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|1|||
127602598|NCT00498602|459173545|FG004|Overall Study|Death|0|||
127602599|NCT00498602|459173546|FG005|Overall Study|Death|1|||
127602600|NCT00498602|459173547|FG006|Overall Study|Death|0|||
127602601|NCT00498602|459173541|FG000|Overall Study|Lack of Efficacy|1|||
127602602|NCT00498602|459173542|FG001|Overall Study|Lack of Efficacy|0|||
127602603|NCT00498602|459173543|FG002|Overall Study|Lack of Efficacy|0|||
127602604|NCT00498602|459173544|FG003|Overall Study|Lack of Efficacy|0|||
127602605|NCT00498602|459173545|FG004|Overall Study|Lack of Efficacy|0|||
127788412|NCT02116777|459850002|FG000|Overall Study|Adverse Event|0|||
127788413|NCT02116777|459850003|FG001|Overall Study|Adverse Event|0|||
127788414|NCT02116777|459850004|FG002|Overall Study|Adverse Event|0|||
127788415|NCT02116777|459850005|FG003|Overall Study|Adverse Event|0|||
127788416|NCT02116777|459850006|FG004|Overall Study|Adverse Event|2|||
127602606|NCT00498602|459173546|FG005|Overall Study|Lack of Efficacy|0|||
127602607|NCT00498602|459173547|FG006|Overall Study|Lack of Efficacy|0|||
127602608|NCT00498602|459173541|FG000|Overall Study|Lost to Follow-up|0|||
127788417|NCT02116777|459850007|FG005|Overall Study|Adverse Event|2|||
127788418|NCT02116777|459850008|FG006|Overall Study|Adverse Event|0|||
127788419|NCT02116777|459850002|FG000|Overall Study|Death|0|||
127788420|NCT02116777|459850003|FG001|Overall Study|Death|0|||
127788421|NCT02116777|459850004|FG002|Overall Study|Death|0|||
127788422|NCT02116777|459850005|FG003|Overall Study|Death|1|||
127788423|NCT02116777|459850006|FG004|Overall Study|Death|0|||
127788424|NCT02116777|459850007|FG005|Overall Study|Death|0|||
127788425|NCT02116777|459850008|FG006|Overall Study|Death|0|||
127788426|NCT02116777|459850002|FG000|Overall Study|Lack of Efficacy|3|||
127602609|NCT00498602|459173542|FG001|Overall Study|Lost to Follow-up|2|||
127602610|NCT00498602|459173543|FG002|Overall Study|Lost to Follow-up|0|||
127602611|NCT00498602|459173544|FG003|Overall Study|Lost to Follow-up|2|||
127602612|NCT00498602|459173545|FG004|Overall Study|Lost to Follow-up|0|||
127602613|NCT00498602|459173546|FG005|Overall Study|Lost to Follow-up|0|||
127602614|NCT00498602|459173547|FG006|Overall Study|Lost to Follow-up|0|||
127602615|NCT00498602|459173541|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
127602616|NCT00498602|459173542|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
127602617|NCT00498602|459173543|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
127602618|NCT00498602|459173544|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
127602619|NCT00498602|459173545|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
127602620|NCT00498602|459173546|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
127602621|NCT00498602|459173547|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
127602622|NCT00498602|459173541|FG000|Overall Study|AE not related to Study Drug|1|||
127602623|NCT00498602|459173542|FG001|Overall Study|AE not related to Study Drug|3|||
127602624|NCT00498602|459173543|FG002|Overall Study|AE not related to Study Drug|0|||
127602625|NCT00498602|459173544|FG003|Overall Study|AE not related to Study Drug|0|||
127602626|NCT00498602|459173545|FG004|Overall Study|AE not related to Study Drug|2|||
127602627|NCT00498602|459173546|FG005|Overall Study|AE not related to Study Drug|2|||
127602628|NCT00498602|459173547|FG006|Overall Study|AE not related to Study Drug|1|||
127602629|NCT00498602|459173541|FG000|Overall Study|Caregiver Request|2|||
127602630|NCT00498602|459173542|FG001|Overall Study|Caregiver Request|2|||
127602631|NCT00498602|459173543|FG002|Overall Study|Caregiver Request|2|||
127602632|NCT00498602|459173544|FG003|Overall Study|Caregiver Request|0|||
127602633|NCT00498602|459173545|FG004|Overall Study|Caregiver Request|1|||
127602634|NCT00498602|459173546|FG005|Overall Study|Caregiver Request|2|||
127602635|NCT00498602|459173547|FG006|Overall Study|Caregiver Request|0|||
127602636|NCT00498602|459173541|FG000|Overall Study|Investigator Request|0|||
127602637|NCT00498602|459173542|FG001|Overall Study|Investigator Request|0|||
127602638|NCT00498602|459173543|FG002|Overall Study|Investigator Request|1|||
127602639|NCT00498602|459173544|FG003|Overall Study|Investigator Request|0|||
127602640|NCT00498602|459173545|FG004|Overall Study|Investigator Request|0|||
127602641|NCT00498602|459173546|FG005|Overall Study|Investigator Request|0|||
127602642|NCT00498602|459173547|FG006|Overall Study|Investigator Request|0|||
127602643|NCT00498602|459173541|FG000|Overall Study|Subject Request|3|||
127602644|NCT00498602|459173542|FG001|Overall Study|Subject Request|0|||
127602645|NCT00498602|459173543|FG002|Overall Study|Subject Request|1|||
127602646|NCT00498602|459173544|FG003|Overall Study|Subject Request|1|||
127602647|NCT00498602|459173545|FG004|Overall Study|Subject Request|1|||
127602648|NCT00498602|459173546|FG005|Overall Study|Subject Request|4|||
127602649|NCT00498602|459173547|FG006|Overall Study|Subject Request|1|||
127602650|NCT00498602|459173541|FG000|Overall Study|Other|2|||
127788427|NCT02116777|459850003|FG001|Overall Study|Lack of Efficacy|3|||
127788428|NCT02116777|459850004|FG002|Overall Study|Lack of Efficacy|3|||
127788429|NCT02116777|459850005|FG003|Overall Study|Lack of Efficacy|8|||
127788430|NCT02116777|459850006|FG004|Overall Study|Lack of Efficacy|4|||
127788431|NCT02116777|459850007|FG005|Overall Study|Lack of Efficacy|1|||
127788432|NCT02116777|459850008|FG006|Overall Study|Lack of Efficacy|9|||
127788433|NCT02116777|459850002|FG000|Overall Study|Physician Decision|0|||
127602651|NCT00498602|459173542|FG001|Overall Study|Other|3|||
127788434|NCT02116777|459850003|FG001|Overall Study|Physician Decision|0|||
127788435|NCT02116777|459850004|FG002|Overall Study|Physician Decision|0|||
127602652|NCT00498602|459173543|FG002|Overall Study|Other|1|||
127602653|NCT00498602|459173544|FG003|Overall Study|Other|0|||
127602654|NCT00498602|459173545|FG004|Overall Study|Other|0|||
127602655|NCT00498602|459173546|FG005|Overall Study|Other|3|||
127602656|NCT00498602|459173547|FG006|Overall Study|Other|0|||
127602657|NCT02632552|459173551|FG000|Overall Study|Lost to Follow-up|14|||
127602658|NCT02632552|459173552|FG001|Overall Study|Lost to Follow-up|8|||
127602659|NCT02632552|459173551|FG000|Overall Study|Withdrawal by Subject|2|||
127788436|NCT02116777|459850005|FG003|Overall Study|Physician Decision|2|||
127602660|NCT02632552|459173552|FG001|Overall Study|Withdrawal by Subject|0|||
127602661|NCT02632552|459173551|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
127602662|NCT02632552|459173552|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
127602663|NCT03103919|459173553|FG000|Overall Study|Adverse Event|2|||
127602664|NCT03103919|459173554|FG001|Overall Study|Adverse Event|2|||
127602665|NCT01846507|459173555|FG000|Overall Study|Lost to Follow-up|4|||
127602666|NCT01846507|459173555|FG000|Overall Study|Protocol Violation|1|||
127602667|NCT01846507|459173555|FG000|Overall Study|Missing data|2|||
127602668|NCT00450450|459173556|FG000|Overall Study|Death|1|||
127602669|NCT00450450|459173557|FG001|Overall Study|Death|3|||
127602670|NCT00450450|459173556|FG000|Overall Study|Relapse|2|||
127602671|NCT00450450|459173557|FG001|Overall Study|Relapse|0|||
127602672|NCT00450450|459173556|FG000|Overall Study|Missing Data|2|||
127602673|NCT00450450|459173557|FG001|Overall Study|Missing Data|0|||
127602674|NCT02707991|459173558|FG000|Overall Study|Protocol Violation|1|||
127602675|NCT02707991|459173559|FG001|Overall Study|Protocol Violation|0|||
127602676|NCT02707991|459173558|FG000|Overall Study|Became ineligible|0|||
127602677|NCT02707991|459173559|FG001|Overall Study|Became ineligible|1|||
127602678|NCT00737282|459173563|FG000|Overall Study|Study prematurely terminated|175|||
127602679|NCT02157298|459173566|FG000|Overall Study|Adverse Event|1|||
127602680|NCT02157298|459173567|FG001|Overall Study|Adverse Event|0|||
127602681|NCT02157298|459173566|FG000|Overall Study|Subject no longer meets study criteria|1|||
127602682|NCT02157298|459173567|FG001|Overall Study|Subject no longer meets study criteria|2|||
127602683|NCT02157298|459173566|FG000|Overall Study|Poor/Non-compliance|1|||
127602684|NCT02157298|459173567|FG001|Overall Study|Poor/Non-compliance|0|||
127602685|NCT02157298|459173566|FG000|Overall Study|Withdrawal by Subject|1|||
127602686|NCT02157298|459173567|FG001|Overall Study|Withdrawal by Subject|0|||
127602687|NCT03171415|459173568|FG000|Overall Study|Lost to Follow-up|0|||
127602688|NCT03171415|459173569|FG001|Overall Study|Lost to Follow-up|0|||
127602689|NCT03171415|459173570|FG002|Overall Study|Lost to Follow-up|0|||
127602690|NCT03171415|459173571|FG003|Overall Study|Lost to Follow-up|0|||
127602691|NCT03171415|459173572|FG004|Overall Study|Lost to Follow-up|2|||
127602692|NCT04059094|459173573|FG000|Overall Study|Adverse Event|0|||
127602693|NCT04059094|459173574|FG001|Overall Study|Adverse Event|0|||
127602694|NCT04059094|459173575|FG002|Overall Study|Adverse Event|0|||
127602695|NCT04059094|459173576|FG003|Overall Study|Adverse Event|0|||
127602696|NCT04059094|459173577|FG004|Overall Study|Adverse Event|1|||
127602697|NCT04059094|459173573|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
127602698|NCT04059094|459173574|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
127602699|NCT04059094|459173575|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
127602700|NCT04059094|459173576|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
127602701|NCT04059094|459173577|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
127602702|NCT01338493|459173585|FG000|Enrolled|Withdrawal by Subject|1|||
127602703|NCT01338493|459173585|FG000|Enrolled|Patient not implanted|4|||
127602704|NCT01338493|459173585|FG000|Discharge|Death|1|||
127602705|NCT01338493|459173585|FG000|Discharge|Missed visit|1|||
127602706|NCT01338493|459173585|FG000|6 Months Follow up|Lost to Follow-up|11|||
127602707|NCT01338493|459173585|FG000|6 Months Follow up|Missed visit|8|||
127602708|NCT01338493|459173585|FG000|12 Months Follow up|Lost to Follow-up|9|||
127602709|NCT01705652|459173586|FG000|Overall Study|Adverse Event|1|||
127602710|NCT01705652|459173587|FG001|Overall Study|Adverse Event|0|||
127602711|NCT01705652|459173586|FG000|Overall Study|Withdrawal by Subject|1|||
127602712|NCT01705652|459173587|FG001|Overall Study|Withdrawal by Subject|2|||
127602713|NCT01705652|459173586|FG000|Overall Study|non-compliance|1|||
127602714|NCT01705652|459173587|FG001|Overall Study|non-compliance|1|||
127602715|NCT00541034|459173589|FG000|Overall Study|Non-Compliance|3|||
127602716|NCT00656474|459173590|FG000|Overall Study|Other Reason|1|||
127602717|NCT01980875|459173591|FG000|Overall Study|Withdrew Consent|1|||
127602718|NCT01980875|459173592|FG001|Overall Study|Withdrew Consent|1|||
127602719|NCT01980875|459173593|FG002|Overall Study|Withdrew Consent|1|||
127602720|NCT01980875|459173591|FG000|Overall Study|Study Terminated by Sponsor|7|||
127602721|NCT01980875|459173592|FG001|Overall Study|Study Terminated by Sponsor|24|||
127602722|NCT01980875|459173593|FG002|Overall Study|Study Terminated by Sponsor|22|||
127602723|NCT01980875|459173591|FG000|Overall Study|Lost to Follow-up|0|||
127602724|NCT01980875|459173592|FG001|Overall Study|Lost to Follow-up|0|||
127602725|NCT01980875|459173593|FG002|Overall Study|Lost to Follow-up|1|||
127602726|NCT02625259|459173594|FG000|First Intervention (Day 1)|Other|0|||
127602727|NCT02625259|459173595|FG001|First Intervention (Day 1)|Other|0|||
127602728|NCT02625259|459173596|FG002|First Intervention (Day 1)|Other|1|||
127602729|NCT02625259|459173597|FG003|First Intervention (Day 1)|Other|0|||
127602730|NCT02625259|459173598|FG004|First Intervention (Day 1)|Other|0|||
127602731|NCT02625259|459173594|FG000|First Intervention (Day 1)|Adverse Event|2|||
127602732|NCT02625259|459173595|FG001|First Intervention (Day 1)|Adverse Event|1|||
127602733|NCT02625259|459173596|FG002|First Intervention (Day 1)|Adverse Event|0|||
127602734|NCT02625259|459173597|FG003|First Intervention (Day 1)|Adverse Event|0|||
127602735|NCT02625259|459173598|FG004|First Intervention (Day 1)|Adverse Event|0|||
127602736|NCT02625259|459173594|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
127602737|NCT02625259|459173595|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
127602738|NCT02625259|459173596|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
127602739|NCT02625259|459173597|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
127602740|NCT02625259|459173598|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
127602741|NCT00513474|459173599|FG000|Overall Study|Death|6|||
127602742|NCT00513474|459173600|FG001|Overall Study|Death|9|||
127602743|NCT00513474|459173599|FG000|Overall Study|Participant Withdrew Consent|1|||
127602744|NCT00513474|459173600|FG001|Overall Study|Participant Withdrew Consent|0|||
127602745|NCT02663674|459173606|FG000|Overall Study|Lost to Follow-up|5|||
127602746|NCT02663674|459173607|FG001|Overall Study|Lost to Follow-up|4|||
127602747|NCT02663674|459173606|FG000|Overall Study|Withdrawal by Subject|1|||
127602748|NCT02663674|459173607|FG001|Overall Study|Withdrawal by Subject|4|||
127602749|NCT02663674|459173606|FG000|Overall Study|Physician Decision|1|||
127602750|NCT02663674|459173607|FG001|Overall Study|Physician Decision|1|||
127602751|NCT02663674|459173606|FG000|Overall Study|Other Event (Health Related)|0|||
127788437|NCT02116777|459850006|FG004|Overall Study|Physician Decision|0|||
127788438|NCT02116777|459850007|FG005|Overall Study|Physician Decision|0|||
127788439|NCT02116777|459850008|FG006|Overall Study|Physician Decision|0|||
127788440|NCT02116777|459850002|FG000|Overall Study|Protocol Violation|0|||
127788441|NCT02116777|459850003|FG001|Overall Study|Protocol Violation|0|||
127788442|NCT02116777|459850004|FG002|Overall Study|Protocol Violation|0|||
127788443|NCT02116777|459850005|FG003|Overall Study|Protocol Violation|1|||
127788444|NCT02116777|459850006|FG004|Overall Study|Protocol Violation|0|||
127788445|NCT02116777|459850007|FG005|Overall Study|Protocol Violation|0|||
127788446|NCT02116777|459850008|FG006|Overall Study|Protocol Violation|0|||
127788447|NCT02116777|459850002|FG000|Overall Study|Withdrawal by Subject|0|||
127788448|NCT02116777|459850003|FG001|Overall Study|Withdrawal by Subject|0|||
127788449|NCT02116777|459850004|FG002|Overall Study|Withdrawal by Subject|0|||
127788450|NCT02116777|459850005|FG003|Overall Study|Withdrawal by Subject|1|||
127788451|NCT02116777|459850006|FG004|Overall Study|Withdrawal by Subject|0|||
127788452|NCT02116777|459850007|FG005|Overall Study|Withdrawal by Subject|0|||
127788453|NCT02116777|459850008|FG006|Overall Study|Withdrawal by Subject|0|||
127788454|NCT00980200|459851197|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
127788455|NCT00980200|459851198|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
127788456|NCT00980200|459851199|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
127788457|NCT00980200|459851200|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
127788458|NCT00980200|459851201|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
127788459|NCT00980200|459851197|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
127788460|NCT00980200|459851198|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
127788461|NCT00980200|459851199|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
127788462|NCT00980200|459851200|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
127788463|NCT00980200|459851201|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
127788464|NCT00457015|459851202|FG000|Overall Study|Left study site against medical advice|0|||
127788465|NCT00457015|459851203|FG001|Overall Study|Left study site against medical advice|1|||
127788466|NCT03557281|459851204|FG000|Overall Study|Investigator discretion|0|||
127788467|NCT03557281|459851205|FG001|Overall Study|Investigator discretion|0|||
127788468|NCT03557281|459851206|FG002|Overall Study|Investigator discretion|1|||
127788469|NCT03557281|459851207|FG003|Overall Study|Investigator discretion|0|||
127788470|NCT03557281|459851208|FG004|Overall Study|Investigator discretion|0|||
127788471|NCT03557281|459851204|FG000|Overall Study|Withdrawal by Subject|0|||
127788472|NCT03557281|459851205|FG001|Overall Study|Withdrawal by Subject|1|||
127788473|NCT03557281|459851206|FG002|Overall Study|Withdrawal by Subject|1|||
127788474|NCT03557281|459851207|FG003|Overall Study|Withdrawal by Subject|1|||
127788475|NCT03557281|459851208|FG004|Overall Study|Withdrawal by Subject|2|||
127788476|NCT03557281|459851204|FG000|Overall Study|Randomized, but did not receive treatment|0|||
127788477|NCT03557281|459851205|FG001|Overall Study|Randomized, but did not receive treatment|0|||
127788478|NCT03557281|459851206|FG002|Overall Study|Randomized, but did not receive treatment|0|||
127788479|NCT03557281|459851207|FG003|Overall Study|Randomized, but did not receive treatment|0|||
127788480|NCT03557281|459851208|FG004|Overall Study|Randomized, but did not receive treatment|1|||
127788481|NCT01611974|459851214|FG000|Overall Study|Death|10|||
127788482|NCT01611974|459851215|FG001|Overall Study|Death|12|||
127788483|NCT01611974|459851216|FG002|Overall Study|Death|10|||
127602752|NCT02663674|459173607|FG001|Overall Study|Other Event (Health Related)|1|||
127602753|NCT02081690|459175599|FG000|Overall Study|Death|3|||
127788484|NCT01611974|459851214|FG000|Overall Study|Lost to Follow-up|0|||
127788485|NCT01611974|459851215|FG001|Overall Study|Lost to Follow-up|1|||
127788486|NCT01611974|459851216|FG002|Overall Study|Lost to Follow-up|0|||
127788487|NCT01611974|459851214|FG000|Overall Study|Physician Decision|5|||
127788488|NCT01611974|459851215|FG001|Overall Study|Physician Decision|1|||
127788489|NCT01611974|459851216|FG002|Overall Study|Physician Decision|2|||
127788490|NCT01611974|459851214|FG000|Overall Study|Withdrawal by Subject|0|||
127788491|NCT01611974|459851215|FG001|Overall Study|Withdrawal by Subject|1|||
127788492|NCT01611974|459851216|FG002|Overall Study|Withdrawal by Subject|4|||
127788493|NCT02257372|459851222|FG000|Overall Study|Adverse Event|3|||
127788494|NCT02257372|459851223|FG001|Overall Study|Adverse Event|7|||
127788495|NCT02257372|459851222|FG000|Overall Study|Lack of Efficacy|2|||
127788496|NCT02257372|459851223|FG001|Overall Study|Lack of Efficacy|1|||
127788497|NCT02257372|459851222|FG000|Overall Study|Protocol Violation|1|||
127788498|NCT02257372|459851223|FG001|Overall Study|Protocol Violation|1|||
127788499|NCT02257372|459851222|FG000|Overall Study|Lost to Follow-up|0|||
127788500|NCT02257372|459851223|FG001|Overall Study|Lost to Follow-up|1|||
127788501|NCT02257372|459851222|FG000|Overall Study|Withdrew consent|1|||
127788502|NCT02257372|459851223|FG001|Overall Study|Withdrew consent|0|||
127788503|NCT00789529|459851224|FG000|Overall Study|Withdrawal by Subject|0|||
127788504|NCT00789529|459851225|FG001|Overall Study|Withdrawal by Subject|1|||
127788505|NCT00789529|459851224|FG000|Overall Study|Other Reason|1|||
127788506|NCT00789529|459851225|FG001|Overall Study|Other Reason|0|||
127788507|NCT01849874|459851227|FG000|Overall Study|Death|89|||
127788508|NCT01849874|459851228|FG001|Overall Study|Death|42|||
127788509|NCT01849874|459851227|FG000|Overall Study|Withdrawal by Subject|17|||
127788510|NCT01849874|459851228|FG001|Overall Study|Withdrawal by Subject|16|||
127788511|NCT01849874|459851227|FG000|Overall Study|Lost to Follow-up|3|||
127788512|NCT01849874|459851228|FG001|Overall Study|Lost to Follow-up|2|||
127788513|NCT01849874|459851227|FG000|Overall Study|Study Termination By Sponsor|93|||
127788514|NCT01849874|459851228|FG001|Overall Study|Study Termination By Sponsor|48|||
127788515|NCT01849874|459851227|FG000|Overall Study|Completed as per protocol amendment 6|3|||
127788516|NCT01849874|459851228|FG001|Overall Study|Completed as per protocol amendment 6|0|||
127788517|NCT01849874|459851227|FG000|Overall Study|Physician Decision|7|||
127602754|NCT02081690|459175599|FG000|Overall Study|Physician Decision|3|||
127602755|NCT02081690|459175599|FG000|Overall Study|Withdrawal by Subject|1|||
127602756|NCT03204981|459175601|FG000|Overall Study|Physician Decision|2|||
127602757|NCT03204981|459175601|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
127602758|NCT00397982|459175605|FG000|Overall Study|Withdrawal by Subject|1|||
127602759|NCT00397982|459175605|FG000|Overall Study|Adverse Event|1|||
127602760|NCT00397982|459175605|FG000|Overall Study|noncompliance|1|||
127602761|NCT00397982|459175605|FG000|Overall Study|Unrelated health issues|1|||
127602762|NCT00249444|459175610|FG000|Overall Study|Lost to Follow-up|2|||
127602763|NCT00249444|459175611|FG001|Overall Study|Lost to Follow-up|2|||
127602764|NCT00249444|459175610|FG000|Overall Study|non-compliant|9|||
127602765|NCT00249444|459175611|FG001|Overall Study|non-compliant|11|||
127602766|NCT00249444|459175610|FG000|Overall Study|Adverse Event|1|||
127602767|NCT00249444|459175611|FG001|Overall Study|Adverse Event|1|||
127602768|NCT00249444|459175610|FG000|Overall Study|life event|0|||
127602769|NCT00249444|459175611|FG001|Overall Study|life event|1|||
127602770|NCT00936910|459175612|FG000|Overall Study|Lack of Efficacy|3|||
127602771|NCT00412854|459175613|FG000|Overall Study|Withdrawn due to adverse events|1|||
127602772|NCT00412854|459175614|FG001|Overall Study|Withdrawn due to adverse events|5|||
127788518|NCT01849874|459851228|FG001|Overall Study|Physician Decision|1|||
127602773|NCT00412854|459175613|FG000|Overall Study|Withdrawn for other reasons|13|||
127788519|NCT01849874|459851227|FG000|Overall Study|Other|16|||
127882862|NCT01682512|460194598|FG000|Overall Study|Lost to Follow-up|3|||
127882863|NCT01682512|460194599|FG001|Overall Study|Lost to Follow-up|0|||
127602774|NCT00412854|459175614|FG001|Overall Study|Withdrawn for other reasons|11|||
127602775|NCT04483011|459175615|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
127602776|NCT04483011|459175616|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
127602777|NCT03045081|459175617|FG000|Overall Study|Withdrawal by Subject|6|||
127602778|NCT03045081|459175618|FG001|Overall Study|Withdrawal by Subject|11|||
127602779|NCT02345811|459175621|FG000|First Intervention|Withdrawal by Subject|1|||
127788520|NCT01849874|459851228|FG001|Overall Study|Other|4|||
127788521|NCT01230242|459851233|FG000|Overall Study|Physician Decision|2|||
127788522|NCT01230242|459851233|FG000|Overall Study|Withdrawal by Subject|1|||
127788523|NCT04329702|459851234|FG000|Overall Study|illness|3|||
127788524|NCT04329702|459851235|FG001|Overall Study|illness|4|||
127882864|NCT01682512|460194600|FG002|Overall Study|Lost to Follow-up|2|||
127788525|NCT04329702|459851236|FG002|Overall Study|illness|0|||
127696532|NCT01416831|459517783|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
127696533|NCT01416831|459517784|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
127696534|NCT05215314|459517785|FG000|Overall Study|Lost to Follow-up|2|||
127696535|NCT05215314|459517786|FG001|Overall Study|Lost to Follow-up|2|||
127696536|NCT05215314|459517785|FG000|Overall Study|Withdrawal by Subject|2|||
127696537|NCT05215314|459517786|FG001|Overall Study|Withdrawal by Subject|0|||
127696538|NCT05215314|459517785|FG000|Overall Study|Physician Decision|1|||
127696539|NCT05215314|459517786|FG001|Overall Study|Physician Decision|0|||
127696540|NCT04294225|459517791|FG000|Anastrozole 1 mg/Day|Discontinued due to COVID|1|||
127696541|NCT04294225|459517791|FG000|Anastrozole 1 mg/Day|Discontinued due to adverse events|3|||
127696542|NCT04294225|459517791|FG000|Anastrozole 1 mg/Day|Withdrawal by Subject|5|||
127696543|NCT04294225|459517791|FG000|Anastrozole 1 mg/Day|Ineligible|2|||
127696544|NCT04294225|459517791|FG000|Anastrozole 10 mg/Day|Withdrawal by Subject|1|||
127696545|NCT04812535|459517793|FG000|Overall Study|Withdrawal by Subject|0|||
127696546|NCT04812535|459517794|FG001|Overall Study|Withdrawal by Subject|0|||
127788526|NCT04329702|459851234|FG000|Overall Study|Lost to Follow-up|0|||
127788527|NCT04329702|459851235|FG001|Overall Study|Lost to Follow-up|0|||
127788528|NCT04329702|459851236|FG002|Overall Study|Lost to Follow-up|2|||
127788529|NCT04329702|459851234|FG000|Overall Study|Death|0|||
127788530|NCT04329702|459851235|FG001|Overall Study|Death|2|||
127696547|NCT04812535|459517795|FG002|Overall Study|Withdrawal by Subject|0|||
127788531|NCT04329702|459851236|FG002|Overall Study|Death|0|||
127788532|NCT01140451|459851240|FG000|Overall Study|Withdrawal by Subject|26|||
127788533|NCT01140451|459851241|FG001|Overall Study|Withdrawal by Subject|33|||
127882865|NCT01682512|460194598|FG000|Overall Study|Protocol Violation|2|||
127788534|NCT01140451|459851240|FG000|Overall Study|Adverse Event|2|||
127882866|NCT01682512|460194599|FG001|Overall Study|Protocol Violation|3|||
127602780|NCT02345811|459175622|FG001|First Intervention|Withdrawal by Subject|1|||
127602781|NCT02877082|459175623|FG000|Overall Study|Trial was closed early|5|||
127602782|NCT02489344|459175624|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
127602783|NCT02489344|459175624|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
127602784|NCT02489344|459175624|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
127602785|NCT02489344|459175624|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
127602786|NCT03480750|459175625|FG000|Overall Study|Withdrawal by Subject|0|||
127602787|NCT03480750|459175626|FG001|Overall Study|Withdrawal by Subject|1|||
127602788|NCT03480750|459175627|FG002|Overall Study|Withdrawal by Subject|0|||
127602789|NCT03480750|459175628|FG003|Overall Study|Withdrawal by Subject|0|||
127602790|NCT03480750|459175629|FG004|Overall Study|Withdrawal by Subject|0|||
127602791|NCT03480750|459175630|FG005|Overall Study|Withdrawal by Subject|0|||
127602792|NCT03480750|459175625|FG000|Overall Study|The interruption in Trientine shippment|0|||
127602793|NCT03480750|459175626|FG001|Overall Study|The interruption in Trientine shippment|0|||
127602794|NCT03480750|459175627|FG002|Overall Study|The interruption in Trientine shippment|0|||
127602795|NCT03480750|459175628|FG003|Overall Study|The interruption in Trientine shippment|0|||
127602796|NCT03480750|459175629|FG004|Overall Study|The interruption in Trientine shippment|0|||
127602797|NCT03480750|459175630|FG005|Overall Study|The interruption in Trientine shippment|1|||
127602798|NCT01132482|459175631|FG000|Overall Study|Adverse Event|1|||
127602799|NCT01132482|459175632|FG001|Overall Study|Adverse Event|0|||
127602800|NCT00546637|459175641|FG000|Overall Study|Adverse Event|46|||
127602801|NCT00546637|459175642|FG001|Overall Study|Adverse Event|20|||
127602802|NCT00546637|459175641|FG000|Overall Study|Lack of Efficacy|5|||
127602803|NCT00546637|459175642|FG001|Overall Study|Lack of Efficacy|5|||
127602804|NCT00546637|459175641|FG000|Overall Study|Lost to Follow-up|2|||
127602805|NCT00546637|459175642|FG001|Overall Study|Lost to Follow-up|2|||
127602806|NCT00546637|459175641|FG000|Overall Study|Other|10|||
127602807|NCT00546637|459175642|FG001|Overall Study|Other|12|||
127602808|NCT00546637|459175641|FG000|Overall Study|Withdrawal by Subject|7|||
127602809|NCT00546637|459175642|FG001|Overall Study|Withdrawal by Subject|9|||
127602810|NCT00546637|459175641|FG000|Overall Study|Randomized, but not treated|3|||
127602811|NCT00546637|459175642|FG001|Overall Study|Randomized, but not treated|1|||
127602812|NCT03274440|459175643|FG000|Overall Study|Time commitment too great|1|||
127602813|NCT03274440|459175644|FG001|Overall Study|Time commitment too great|0|||
127602814|NCT03274440|459175645|FG002|Overall Study|Time commitment too great|0|||
127602815|NCT03274440|459175646|FG003|Overall Study|Time commitment too great|1|||
127602816|NCT03274440|459175647|FG004|Overall Study|Time commitment too great|0|||
127602817|NCT03274440|459175648|FG005|Overall Study|Time commitment too great|0|||
127602818|NCT01074450|459175649|FG000|First Intervention|Emesis in Dosing Interval|0|||
127602819|NCT01074450|459175650|FG001|First Intervention|Emesis in Dosing Interval|2|||
127602820|NCT01074450|459175649|FG000|Second Intervention|Protocol Violation|1|||
127602821|NCT01074450|459175650|FG001|Second Intervention|Protocol Violation|0|||
127602822|NCT01074450|459175649|FG000|Second Intervention|Physician Decision|0|||
127602823|NCT01074450|459175650|FG001|Second Intervention|Physician Decision|1|||
127602824|NCT04984993|459175651|FG000|Overall Study|Withdrawal by Subject|8|||
127602825|NCT04984993|459175652|FG001|Overall Study|Withdrawal by Subject|2|||
127602826|NCT04984993|459175651|FG000|Overall Study|Lost to Follow-up|2|||
127602827|NCT04984993|459175652|FG001|Overall Study|Lost to Follow-up|2|||
127602828|NCT04984993|459175651|FG000|Overall Study|Both patients moved to another country|4|||
127602829|NCT04984993|459175652|FG001|Overall Study|Both patients moved to another country|0|||
127602830|NCT02865187|459175655|FG000|Overall Study|Lost to Follow-up|12|||
127602831|NCT02865187|459175656|FG001|Overall Study|Lost to Follow-up|7|||
127602832|NCT02865187|459175655|FG000|Overall Study|Adverse Event|1|||
127602833|NCT02865187|459175656|FG001|Overall Study|Adverse Event|0|||
127602834|NCT01110707|459175657|FG000|Overall Study|Protocol Violation|0|||
127602835|NCT01110707|459175658|FG001|Overall Study|Protocol Violation|3|||
127602836|NCT02968563|459175663|FG000|Overall Study|Adverse Event|0|||
127696548|NCT04812535|459517796|FG003|Overall Study|Withdrawal by Subject|1|||
127696549|NCT04812535|459517793|FG000|Overall Study|Death|7|||
127696550|NCT04812535|459517794|FG001|Overall Study|Death|2|||
127696551|NCT04812535|459517795|FG002|Overall Study|Death|4|||
127696552|NCT04812535|459517796|FG003|Overall Study|Death|1|||
127696553|NCT04812535|459517793|FG000|Overall Study|Due to premature study termination by sponsor|2|||
127696554|NCT04812535|459517794|FG001|Overall Study|Due to premature study termination by sponsor|0|||
127696555|NCT04812535|459517795|FG002|Overall Study|Due to premature study termination by sponsor|1|||
127696556|NCT04812535|459517796|FG003|Overall Study|Due to premature study termination by sponsor|3|||
127696557|NCT03336333|459517797|FG000|Overall Study|Remained on study at time of data cut-off|202|||
127696558|NCT03336333|459517798|FG001|Overall Study|Remained on study at time of data cut-off|219|||
127696559|NCT03336333|459517799|FG002|Overall Study|Remained on study at time of data cut-off|102|||
127696560|NCT03336333|459517797|FG000|Overall Study|Death|14|||
127696561|NCT03336333|459517798|FG001|Overall Study|Death|16|||
127696562|NCT03336333|459517799|FG002|Overall Study|Death|8|||
127882867|NCT01682512|460194600|FG002|Overall Study|Protocol Violation|2|||
127602837|NCT02968563|459175664|FG001|Overall Study|Adverse Event|6|||
127788535|NCT01140451|459851241|FG001|Overall Study|Adverse Event|6|||
127602838|NCT02968563|459175663|FG000|Overall Study|Death|1|||
127602839|NCT02968563|459175664|FG001|Overall Study|Death|1|||
127602840|NCT02968563|459175663|FG000|Overall Study|Lost to Follow-up|0|||
127602841|NCT02968563|459175664|FG001|Overall Study|Lost to Follow-up|1|||
127602842|NCT02369341|459175665|FG000|Overall Study|Migrated/moved from study area|1|||
127602843|NCT02369341|459175666|FG001|Overall Study|Migrated/moved from study area|0|||
127602844|NCT03287804|459175667|FG000|Overall Study|Death|1|||
127602845|NCT03287804|459175667|FG000|Overall Study|Physician Decision|2|||
127602846|NCT03287804|459175667|FG000|Overall Study|Progressive disease|8|||
127602847|NCT02710045|459175673|FG000|Overall Study|Death|1|||
127602848|NCT02710045|459175674|FG001|Overall Study|Death|2|||
127602849|NCT02710045|459175675|FG002|Overall Study|Death|0|||
127602850|NCT02710045|459175673|FG000|Overall Study|Withdrawal by Subject|6|||
127602851|NCT02710045|459175674|FG001|Overall Study|Withdrawal by Subject|6|||
127602852|NCT02710045|459175675|FG002|Overall Study|Withdrawal by Subject|2|||
127602853|NCT02710045|459175673|FG000|Overall Study|Protocol Violation|1|||
127602854|NCT02710045|459175674|FG001|Overall Study|Protocol Violation|2|||
127602855|NCT02710045|459175675|FG002|Overall Study|Protocol Violation|3|||
127602856|NCT02710045|459175673|FG000|Overall Study|Lost to Follow-up|3|||
127602857|NCT02710045|459175674|FG001|Overall Study|Lost to Follow-up|6|||
127602858|NCT02710045|459175675|FG002|Overall Study|Lost to Follow-up|7|||
127602859|NCT02710045|459175673|FG000|Overall Study|Physician Decision|0|||
127602860|NCT02710045|459175674|FG001|Overall Study|Physician Decision|0|||
127602861|NCT02710045|459175675|FG002|Overall Study|Physician Decision|1|||
127602862|NCT02710045|459175673|FG000|Overall Study|Poor Attendance|0|||
127602863|NCT02710045|459175674|FG001|Overall Study|Poor Attendance|1|||
127602864|NCT02710045|459175675|FG002|Overall Study|Poor Attendance|0|||
127602865|NCT03178773|459175676|FG000|Overall Study|Death|0|||
127602866|NCT03178773|459175677|FG001|Overall Study|Death|1|||
127602867|NCT03178773|459175676|FG000|Overall Study|Lost to Follow-up|29|||
127602868|NCT03178773|459175677|FG001|Overall Study|Lost to Follow-up|25|||
127602869|NCT03178773|459175676|FG000|Overall Study|Withdrawal by Subject|10|||
127602870|NCT03178773|459175677|FG001|Overall Study|Withdrawal by Subject|14|||
127602871|NCT01382446|459175678|FG000|Overall Study|Withdrawal by Subject|0|||
127602872|NCT01382446|459175679|FG001|Overall Study|Withdrawal by Subject|1|||
127602873|NCT01382446|459175678|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
127602874|NCT01382446|459175679|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
127602875|NCT02733991|459175681|FG000|Overall Study|Adverse Event|1|||
127602876|NCT02733991|459175682|FG001|Overall Study|Adverse Event|0|||
127602877|NCT02733991|459175681|FG000|Overall Study|Withdrawal by Subject|0|||
127602878|NCT02733991|459175682|FG001|Overall Study|Withdrawal by Subject|5|||
127602879|NCT02604212|459175685|FG000|Overall Study|Study Terminated by Sponsor|2|||
127602880|NCT02604212|459175686|FG001|Overall Study|Study Terminated by Sponsor|1|||
127602881|NCT02604212|459175687|FG002|Overall Study|Study Terminated by Sponsor|3|||
127602882|NCT02604212|459175688|FG003|Overall Study|Study Terminated by Sponsor|3|||
127602883|NCT02604212|459175685|FG000|Overall Study|Withdrawal by Subject|0|||
127602884|NCT02604212|459175686|FG001|Overall Study|Withdrawal by Subject|0|||
127602885|NCT02604212|459175687|FG002|Overall Study|Withdrawal by Subject|1|||
127602886|NCT02604212|459175688|FG003|Overall Study|Withdrawal by Subject|0|||
127602887|NCT01119131|459175689|FG000|Overall Study|Adverse Event|1|||
127602888|NCT01119131|459175690|FG001|Overall Study|Adverse Event|1|||
127602889|NCT01119131|459175691|FG002|Overall Study|Adverse Event|1|||
127602890|NCT01119131|459175689|FG000|Overall Study|Non-Compliance|1|||
127602891|NCT01119131|459175690|FG001|Overall Study|Non-Compliance|0|||
127602892|NCT01119131|459175691|FG002|Overall Study|Non-Compliance|4|||
127602893|NCT01119131|459175689|FG000|Overall Study|Physician Decision|0|||
127602894|NCT01119131|459175690|FG001|Overall Study|Physician Decision|0|||
127602895|NCT01119131|459175691|FG002|Overall Study|Physician Decision|1|||
127602896|NCT02810392|459175695|FG000|Overall Study|Subject too ill to continue|1|||
127602897|NCT02810392|459175696|FG001|Overall Study|Subject too ill to continue|0|||
127602898|NCT02810392|459175695|FG000|Overall Study|COVID 19 research restrictions|0|||
127788536|NCT01140451|459851240|FG000|Overall Study|Physician Decision|5|||
127602899|NCT02810392|459175696|FG001|Overall Study|COVID 19 research restrictions|1|||
127602900|NCT00840294|459175697|FG000|Overall Study|Withdrawal by Subject|2|||
127602901|NCT00840294|459175698|FG001|Overall Study|Withdrawal by Subject|1|||
127602902|NCT00840294|459175697|FG000|Overall Study|Protocol Violation|1|||
127602903|NCT00840294|459175698|FG001|Overall Study|Protocol Violation|3|||
127602904|NCT00840294|459175697|FG000|Overall Study|Illness|0|||
127602905|NCT00840294|459175698|FG001|Overall Study|Illness|1|||
127602906|NCT00461682|459175699|FG000|Overall Study|Protocol Violation|1|||
127602907|NCT00883116|459175702|FG000|Overall Study|Adverse event unrelated to study drug|5|||
127602908|NCT00883116|459175703|FG001|Overall Study|Adverse event unrelated to study drug|10|||
127602909|NCT00883116|459175702|FG000|Overall Study|Death|6|||
127788537|NCT01140451|459851241|FG001|Overall Study|Physician Decision|3|||
127602910|NCT00883116|459175703|FG001|Overall Study|Death|2|||
127602911|NCT00883116|459175702|FG000|Overall Study|Disease progression|130|||
127602912|NCT00883116|459175703|FG001|Overall Study|Disease progression|128|||
127602913|NCT00883116|459175702|FG000|Overall Study|Lost to Follow-up|0|||
127602914|NCT00883116|459175703|FG001|Overall Study|Lost to Follow-up|1|||
127602915|NCT00883116|459175702|FG000|Overall Study|Maximum clinical benefit|13|||
127602916|NCT00883116|459175703|FG001|Overall Study|Maximum clinical benefit|46|||
127602917|NCT00883116|459175702|FG000|Overall Study|Not identified|3|||
127602918|NCT00883116|459175703|FG001|Overall Study|Not identified|6|||
127602919|NCT00883116|459175702|FG000|Overall Study|Study drug toxicity|36|||
127602920|NCT00883116|459175703|FG001|Overall Study|Study drug toxicity|16|||
127602921|NCT00883116|459175702|FG000|Overall Study|Withdrawal by Subject|14|||
127602922|NCT00883116|459175703|FG001|Overall Study|Withdrawal by Subject|8|||
127602923|NCT00883116|459175702|FG000|Overall Study|No longer meets study criteria|2|||
127602924|NCT00883116|459175703|FG001|Overall Study|No longer meets study criteria|2|||
127602925|NCT01361464|459175704|FG000|Overall Study|Death|1|||
127602926|NCT01361464|459175704|FG000|Overall Study|Withdrawal by Subject|2|||
127602927|NCT04501666|459175706|FG000|Overall Study|Physician Decision|0|||
127602928|NCT04501666|459175707|FG001|Overall Study|Physician Decision|1|||
127602929|NCT04501666|459175706|FG000|Overall Study|Adverse Event|12|||
127602930|NCT04501666|459175707|FG001|Overall Study|Adverse Event|4|||
127602931|NCT04501666|459175706|FG000|Overall Study|Subject's request|10|||
127602932|NCT04501666|459175707|FG001|Overall Study|Subject's request|6|||
127602933|NCT04501666|459175706|FG000|Overall Study|Protocol Deviation|2|||
127602934|NCT04501666|459175707|FG001|Overall Study|Protocol Deviation|1|||
127602935|NCT04501666|459175706|FG000|Overall Study|Other-- site permanently closing|0|||
127602936|NCT04501666|459175707|FG001|Overall Study|Other-- site permanently closing|1|||
127602937|NCT01106898|459175710|FG000|Overall Study|Adverse Event|6|||
127602938|NCT01722071|459175711|FG000|Overall Study|Protocol Violation|1|||
127602939|NCT01722071|459175712|FG001|Overall Study|Protocol Violation|0|||
127602940|NCT03021265|459175713|FG000|Overall Study|Adverse Event|29|||
127602941|NCT03021265|459175713|FG000|Overall Study|Lack of Efficacy|3|||
127602942|NCT03021265|459175713|FG000|Overall Study|Improved|17|||
127602943|NCT03021265|459175713|FG000|Overall Study|Lost to Follow-up|67|||
127602944|NCT03021265|459175713|FG000|Overall Study|No reason given|2|||
127602945|NCT03021265|459175713|FG000|Overall Study|No visit since the first visit|4|||
127602946|NCT00642941|459175714|FG000|Overall Study|Physician Decision|3|||
127602947|NCT00642941|459175715|FG001|Overall Study|Physician Decision|1|||
127602948|NCT00642941|459175716|FG002|Overall Study|Physician Decision|0|||
127602949|NCT00642941|459175717|FG003|Overall Study|Physician Decision|0|||
127602950|NCT00642941|459175718|FG004|Overall Study|Physician Decision|0|||
127602951|NCT00642941|459175719|FG005|Overall Study|Physician Decision|0|||
127602952|NCT00642941|459175720|FG006|Overall Study|Physician Decision|1|||
127602953|NCT00642941|459175721|FG007|Overall Study|Physician Decision|0|||
127602954|NCT00642941|459175722|FG008|Overall Study|Physician Decision|0|||
127602955|NCT00642941|459175723|FG009|Overall Study|Physician Decision|1|||
127602956|NCT00642941|459175724|FG010|Overall Study|Physician Decision|0|||
127602957|NCT00642941|459175725|FG011|Overall Study|Physician Decision|1|||
127602958|NCT00642941|459175714|FG000|Overall Study|Death|4|||
127602959|NCT00642941|459175715|FG001|Overall Study|Death|0|||
127602960|NCT00642941|459175716|FG002|Overall Study|Death|1|||
127602961|NCT00642941|459175717|FG003|Overall Study|Death|1|||
127602962|NCT00642941|459175718|FG004|Overall Study|Death|2|||
127602963|NCT00642941|459175719|FG005|Overall Study|Death|1|||
127602964|NCT00642941|459175720|FG006|Overall Study|Death|0|||
127602965|NCT00642941|459175721|FG007|Overall Study|Death|0|||
127602966|NCT00642941|459175722|FG008|Overall Study|Death|0|||
127602967|NCT00642941|459175723|FG009|Overall Study|Death|0|||
127602968|NCT00642941|459175724|FG010|Overall Study|Death|0|||
127602969|NCT00642941|459175725|FG011|Overall Study|Death|1|||
127788538|NCT01140451|459851240|FG000|Overall Study|Lost to Follow-up|2|||
127788539|NCT01140451|459851241|FG001|Overall Study|Lost to Follow-up|0|||
127788540|NCT01140451|459851240|FG000|Overall Study|Participants Planning Pregnancy|3|||
127788541|NCT01140451|459851241|FG001|Overall Study|Participants Planning Pregnancy|0|||
127788542|NCT02614859|459851243|FG000|Overall Study|Physician Decision|0|||
127788543|NCT02614859|459851244|FG001|Overall Study|Physician Decision|1|||
127602970|NCT00642941|459175714|FG000|Overall Study|Study closed by Sponsor|0|||
127602971|NCT00642941|459175715|FG001|Overall Study|Study closed by Sponsor|1|||
127602972|NCT00642941|459175716|FG002|Overall Study|Study closed by Sponsor|0|||
127602973|NCT00642941|459175717|FG003|Overall Study|Study closed by Sponsor|0|||
127602974|NCT00642941|459175718|FG004|Overall Study|Study closed by Sponsor|0|||
127602975|NCT00642941|459175719|FG005|Overall Study|Study closed by Sponsor|0|||
127602976|NCT00642941|459175720|FG006|Overall Study|Study closed by Sponsor|0|||
127602977|NCT00642941|459175721|FG007|Overall Study|Study closed by Sponsor|0|||
127602978|NCT00642941|459175722|FG008|Overall Study|Study closed by Sponsor|0|||
127602979|NCT00642941|459175723|FG009|Overall Study|Study closed by Sponsor|0|||
127602980|NCT00642941|459175724|FG010|Overall Study|Study closed by Sponsor|0|||
127602981|NCT00642941|459175725|FG011|Overall Study|Study closed by Sponsor|0|||
127602982|NCT00642941|459175714|FG000|Overall Study|Withdrawal by Subject|1|||
127602983|NCT00642941|459175715|FG001|Overall Study|Withdrawal by Subject|0|||
127602984|NCT00642941|459175716|FG002|Overall Study|Withdrawal by Subject|0|||
127602985|NCT00642941|459175717|FG003|Overall Study|Withdrawal by Subject|2|||
127602986|NCT00642941|459175718|FG004|Overall Study|Withdrawal by Subject|0|||
127602987|NCT00642941|459175719|FG005|Overall Study|Withdrawal by Subject|0|||
127602988|NCT00642941|459175720|FG006|Overall Study|Withdrawal by Subject|2|||
127602989|NCT00642941|459175721|FG007|Overall Study|Withdrawal by Subject|0|||
127602990|NCT00642941|459175722|FG008|Overall Study|Withdrawal by Subject|1|||
127602991|NCT00642941|459175723|FG009|Overall Study|Withdrawal by Subject|0|||
127602992|NCT00642941|459175724|FG010|Overall Study|Withdrawal by Subject|0|||
127602993|NCT00642941|459175725|FG011|Overall Study|Withdrawal by Subject|1|||
127602994|NCT00642941|459175714|FG000|Overall Study|Protocol Violation|0|||
127602995|NCT00642941|459175715|FG001|Overall Study|Protocol Violation|0|||
127602996|NCT00642941|459175716|FG002|Overall Study|Protocol Violation|0|||
127602997|NCT00642941|459175717|FG003|Overall Study|Protocol Violation|0|||
127602998|NCT00642941|459175718|FG004|Overall Study|Protocol Violation|0|||
127602999|NCT00642941|459175719|FG005|Overall Study|Protocol Violation|0|||
127603000|NCT00642941|459175720|FG006|Overall Study|Protocol Violation|1|||
127603001|NCT00642941|459175721|FG007|Overall Study|Protocol Violation|0|||
127603002|NCT00642941|459175722|FG008|Overall Study|Protocol Violation|0|||
127603003|NCT00642941|459175723|FG009|Overall Study|Protocol Violation|0|||
127603004|NCT00642941|459175724|FG010|Overall Study|Protocol Violation|0|||
127603005|NCT00642941|459175725|FG011|Overall Study|Protocol Violation|0|||
127603006|NCT00642941|459175714|FG000|Overall Study|Adverse Event|1|||
127603007|NCT00642941|459175715|FG001|Overall Study|Adverse Event|1|||
127603008|NCT00642941|459175716|FG002|Overall Study|Adverse Event|0|||
127603009|NCT00642941|459175717|FG003|Overall Study|Adverse Event|0|||
127603010|NCT00642941|459175718|FG004|Overall Study|Adverse Event|0|||
127603011|NCT00642941|459175719|FG005|Overall Study|Adverse Event|0|||
127603012|NCT00642941|459175720|FG006|Overall Study|Adverse Event|1|||
127603013|NCT00642941|459175721|FG007|Overall Study|Adverse Event|1|||
127603014|NCT00642941|459175722|FG008|Overall Study|Adverse Event|0|||
127603015|NCT00642941|459175723|FG009|Overall Study|Adverse Event|1|||
127603016|NCT00642941|459175724|FG010|Overall Study|Adverse Event|0|||
127603017|NCT00642941|459175725|FG011|Overall Study|Adverse Event|0|||
127603018|NCT00642941|459175714|FG000|Overall Study|Other|1|||
127603019|NCT00642941|459175715|FG001|Overall Study|Other|1|||
127603020|NCT00642941|459175716|FG002|Overall Study|Other|1|||
127603021|NCT00642941|459175717|FG003|Overall Study|Other|1|||
127603022|NCT00642941|459175718|FG004|Overall Study|Other|0|||
127603023|NCT00642941|459175719|FG005|Overall Study|Other|1|||
127603024|NCT00642941|459175720|FG006|Overall Study|Other|0|||
127603025|NCT00642941|459175721|FG007|Overall Study|Other|1|||
127603026|NCT00642941|459175722|FG008|Overall Study|Other|0|||
127603027|NCT00642941|459175723|FG009|Overall Study|Other|0|||
127603028|NCT00642941|459175724|FG010|Overall Study|Other|0|||
127603029|NCT00642941|459175725|FG011|Overall Study|Other|1|||
127603030|NCT00642941|459175714|FG000|Overall Study|Disease progression|60|||
127603031|NCT00642941|459175715|FG001|Overall Study|Disease progression|50|||
127603032|NCT00642941|459175716|FG002|Overall Study|Disease progression|5|||
127603033|NCT00642941|459175717|FG003|Overall Study|Disease progression|36|||
127603034|NCT00642941|459175718|FG004|Overall Study|Disease progression|23|||
127603035|NCT00642941|459175719|FG005|Overall Study|Disease progression|39|||
127603036|NCT00642941|459175720|FG006|Overall Study|Disease progression|18|||
127603037|NCT00642941|459175721|FG007|Overall Study|Disease progression|12|||
127603038|NCT00642941|459175722|FG008|Overall Study|Disease progression|10|||
127603039|NCT00642941|459175723|FG009|Overall Study|Disease progression|7|||
127603040|NCT00642941|459175724|FG010|Overall Study|Disease progression|12|||
127603041|NCT00642941|459175725|FG011|Overall Study|Disease progression|7|||
127603042|NCT02062879|459175726|FG000|Overall Study|Withdrawal by Subject|4|||
127603043|NCT02062879|459175727|FG001|Overall Study|Withdrawal by Subject|1|||
127603044|NCT02289079|459175728|FG000|Overall Study|Physician Decision|2|||
127696563|NCT03336333|459517797|FG000|Overall Study|Withdrawal by Subject|16|||
127603045|NCT02289079|459175729|FG001|Overall Study|Physician Decision|0|||
127603046|NCT02289079|459175728|FG000|Overall Study|Lost to Follow-up|0|||
127603047|NCT02289079|459175729|FG001|Overall Study|Lost to Follow-up|1|||
127603048|NCT00553150|459175730|FG000|Overall Study|Withdrawal by Subject|0|||
127603049|NCT00553150|459175731|FG001|Overall Study|Withdrawal by Subject|0|||
127603050|NCT00553150|459175732|FG002|Overall Study|Withdrawal by Subject|0|||
127603051|NCT00553150|459175733|FG003|Overall Study|Withdrawal by Subject|2|||
127603052|NCT00553150|459175730|FG000|Overall Study|Protocol Violation|0|||
127603053|NCT00553150|459175731|FG001|Overall Study|Protocol Violation|0|||
127603054|NCT00553150|459175732|FG002|Overall Study|Protocol Violation|0|||
127603055|NCT00553150|459175733|FG003|Overall Study|Protocol Violation|1|||
127603056|NCT00553150|459175730|FG000|Overall Study|Ineligible|0|||
127603057|NCT00553150|459175731|FG001|Overall Study|Ineligible|0|||
127603058|NCT00553150|459175732|FG002|Overall Study|Ineligible|0|||
127603059|NCT00553150|459175733|FG003|Overall Study|Ineligible|1|||
127603060|NCT03061331|459175734|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
127603061|NCT03061331|459175735|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
127696564|NCT03336333|459517798|FG001|Overall Study|Withdrawal by Subject|5|||
127603062|NCT02998840|459175736|FG000|Overall Study|Lost to Follow-up|1|||
127603063|NCT02998840|459175737|FG001|Overall Study|Lost to Follow-up|1|||
127603064|NCT02998840|459175738|FG002|Overall Study|Lost to Follow-up|2|||
127603065|NCT02998840|459175739|FG003|Overall Study|Lost to Follow-up|3|||
127603066|NCT02998840|459175736|FG000|Overall Study|Withdrawal by Subject|1|||
127603067|NCT02998840|459175737|FG001|Overall Study|Withdrawal by Subject|1|||
127603068|NCT02998840|459175738|FG002|Overall Study|Withdrawal by Subject|0|||
127603069|NCT02998840|459175739|FG003|Overall Study|Withdrawal by Subject|1|||
127603070|NCT02998840|459175736|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
127603071|NCT02998840|459175737|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
127603072|NCT02998840|459175738|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
127603073|NCT02998840|459175739|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
127603074|NCT01686633|459175743|FG000|Overall Study|Lack of Efficacy|33|||
127603075|NCT01686633|459175744|FG001|Overall Study|Lack of Efficacy|13|||
127603076|NCT01686633|459175745|FG002|Overall Study|Lack of Efficacy|11|||
127603077|NCT01686633|459175743|FG000|Overall Study|Withdrawal by Subject|8|||
127603078|NCT01686633|459175744|FG001|Overall Study|Withdrawal by Subject|8|||
127603079|NCT01686633|459175745|FG002|Overall Study|Withdrawal by Subject|5|||
127603080|NCT01686633|459175743|FG000|Overall Study|Physician Decision|3|||
127603081|NCT01686633|459175744|FG001|Overall Study|Physician Decision|4|||
127603082|NCT01686633|459175745|FG002|Overall Study|Physician Decision|4|||
127603083|NCT01686633|459175743|FG000|Overall Study|Adverse Event|4|||
127603084|NCT01686633|459175744|FG001|Overall Study|Adverse Event|3|||
127603085|NCT01686633|459175745|FG002|Overall Study|Adverse Event|3|||
127603086|NCT01686633|459175743|FG000|Overall Study|Protocol Violation|2|||
127603087|NCT01686633|459175744|FG001|Overall Study|Protocol Violation|3|||
127603088|NCT01686633|459175745|FG002|Overall Study|Protocol Violation|0|||
127603089|NCT01686633|459175743|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
127603090|NCT01686633|459175744|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
127603091|NCT01686633|459175745|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
127603092|NCT01686633|459175743|FG000|Overall Study|Lost to Follow-up|0|||
127603093|NCT01686633|459175744|FG001|Overall Study|Lost to Follow-up|1|||
127603094|NCT01686633|459175745|FG002|Overall Study|Lost to Follow-up|1|||
127603095|NCT00535223|459175746|FG000|Overall Study|Withdrawal by Subject|4|||
127603096|NCT00535223|459175747|FG001|Overall Study|Withdrawal by Subject|1|||
127603097|NCT02953314|459175748|FG000|Overall Study|Adverse Event|0|||
127603098|NCT02953314|459175749|FG001|Overall Study|Adverse Event|1|||
127603099|NCT02953314|459175748|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
127603100|NCT02953314|459175749|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
127603101|NCT01765153|459175750|FG000|Training Phase 1|Format of intervention differed|1|||
127603102|NCT01765153|459175751|FG001|Training Phase 1|Format of intervention differed|0|||
127603103|NCT01765153|459175750|FG000|Training Phase 1|Poor participation in intervention|0|||
127603104|NCT01765153|459175751|FG001|Training Phase 1|Poor participation in intervention|1|||
127603105|NCT01765153|459175750|FG000|Rest Phase 1|Withdrawal by Subject|0|||
127603106|NCT01765153|459175751|FG001|Rest Phase 1|Withdrawal by Subject|1|||
127603107|NCT01765153|459175750|FG000|Training Phase 2|Withdrawal by Subject|0|||
127603108|NCT01765153|459175751|FG001|Training Phase 2|Withdrawal by Subject|1|||
127603109|NCT01765153|459175750|FG000|Rest Phase 2|Lost to Follow-up|2|||
127603110|NCT01765153|459175751|FG001|Rest Phase 2|Lost to Follow-up|1|||
127603111|NCT02554812|459175754|FG000|Overall Study|Adverse Event|2|||
127603112|NCT02554812|459175755|FG001|Overall Study|Adverse Event|5|||
127603113|NCT02554812|459175756|FG002|Overall Study|Adverse Event|3|||
127603114|NCT02554812|459175757|FG003|Overall Study|Adverse Event|0|||
127603115|NCT02554812|459175758|FG004|Overall Study|Adverse Event|5|||
127603116|NCT02554812|459175759|FG005|Overall Study|Adverse Event|0|||
127603117|NCT02554812|459175760|FG006|Overall Study|Adverse Event|1|||
127603118|NCT02554812|459175761|FG007|Overall Study|Adverse Event|6|||
127603119|NCT02554812|459175762|FG008|Overall Study|Adverse Event|2|||
127603120|NCT02554812|459175763|FG009|Overall Study|Adverse Event|2|||
127603121|NCT02554812|459175764|FG010|Overall Study|Adverse Event|1|||
127603122|NCT02554812|459175765|FG011|Overall Study|Adverse Event|2|||
127603123|NCT02554812|459175766|FG012|Overall Study|Adverse Event|0|||
127603124|NCT02554812|459175767|FG013|Overall Study|Adverse Event|3|||
127603125|NCT02554812|459175768|FG014|Overall Study|Adverse Event|2|||
127603126|NCT02554812|459175769|FG015|Overall Study|Adverse Event|1|||
127603127|NCT02554812|459175770|FG016|Overall Study|Adverse Event|0|||
127603128|NCT02554812|459175771|FG017|Overall Study|Adverse Event|1|||
127603129|NCT02554812|459175772|FG018|Overall Study|Adverse Event|0|||
127603130|NCT02554812|459175773|FG019|Overall Study|Adverse Event|0|||
127603131|NCT02554812|459175774|FG020|Overall Study|Adverse Event|0|||
127603132|NCT02554812|459175775|FG021|Overall Study|Adverse Event|2|||
127603133|NCT02554812|459175776|FG022|Overall Study|Adverse Event|1|||
127603134|NCT02554812|459175777|FG023|Overall Study|Adverse Event|1|||
127603135|NCT02554812|459175778|FG024|Overall Study|Adverse Event|1|||
127603136|NCT02554812|459175779|FG025|Overall Study|Adverse Event|2|||
127603137|NCT02554812|459175780|FG026|Overall Study|Adverse Event|1|||
127603138|NCT02554812|459175754|FG000|Overall Study|Death|1|||
127696565|NCT03336333|459517799|FG002|Overall Study|Withdrawal by Subject|1|||
127696566|NCT03336333|459517797|FG000|Overall Study|Physician Decision|5|||
127696567|NCT03336333|459517798|FG001|Overall Study|Physician Decision|1|||
127696568|NCT03336333|459517799|FG002|Overall Study|Physician Decision|0|||
127696569|NCT03336333|459517797|FG000|Overall Study|Lost to Follow-up|1|||
127696570|NCT03336333|459517798|FG001|Overall Study|Lost to Follow-up|0|||
127696571|NCT03336333|459517799|FG002|Overall Study|Lost to Follow-up|0|||
127696572|NCT03366649|459517804|FG000|Overall Study|Failed preoperative screening|4|||
127696573|NCT03366649|459517805|FG001|Overall Study|Failed preoperative screening|0|||
127696574|NCT03366649|459517806|FG002|Overall Study|Failed preoperative screening|0|||
127696575|NCT03366649|459517804|FG000|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|4|||
127696576|NCT03366649|459517805|FG001|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
127696577|NCT03366649|459517806|FG002|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
127696578|NCT03673111|459517807|FG000|Overall Study|Protocol Violation|0|||
127696579|NCT03673111|459517808|FG001|Overall Study|Protocol Violation|0|||
127696580|NCT03673111|459517809|FG002|Overall Study|Protocol Violation|0|||
127696581|NCT03673111|459517810|FG003|Overall Study|Protocol Violation|0|||
127603139|NCT02554812|459175755|FG001|Overall Study|Death|2|||
127603140|NCT02554812|459175756|FG002|Overall Study|Death|2|||
127603141|NCT02554812|459175757|FG003|Overall Study|Death|2|||
127603142|NCT02554812|459175758|FG004|Overall Study|Death|0|||
127603143|NCT02554812|459175759|FG005|Overall Study|Death|1|||
127603144|NCT02554812|459175760|FG006|Overall Study|Death|1|||
127603145|NCT02554812|459175761|FG007|Overall Study|Death|1|||
127603146|NCT02554812|459175762|FG008|Overall Study|Death|0|||
127603147|NCT02554812|459175763|FG009|Overall Study|Death|0|||
127603148|NCT02554812|459175764|FG010|Overall Study|Death|0|||
127603149|NCT02554812|459175765|FG011|Overall Study|Death|0|||
127603150|NCT02554812|459175766|FG012|Overall Study|Death|0|||
127603151|NCT02554812|459175767|FG013|Overall Study|Death|0|||
127603152|NCT02554812|459175768|FG014|Overall Study|Death|1|||
127603153|NCT02554812|459175769|FG015|Overall Study|Death|1|||
127603154|NCT02554812|459175770|FG016|Overall Study|Death|1|||
127603155|NCT02554812|459175771|FG017|Overall Study|Death|0|||
127603156|NCT02554812|459175772|FG018|Overall Study|Death|1|||
127603157|NCT02554812|459175773|FG019|Overall Study|Death|2|||
127603158|NCT02554812|459175774|FG020|Overall Study|Death|0|||
127603159|NCT02554812|459175775|FG021|Overall Study|Death|1|||
127603160|NCT02554812|459175776|FG022|Overall Study|Death|1|||
127603161|NCT02554812|459175777|FG023|Overall Study|Death|0|||
127603162|NCT02554812|459175778|FG024|Overall Study|Death|0|||
127603163|NCT02554812|459175779|FG025|Overall Study|Death|0|||
127603164|NCT02554812|459175780|FG026|Overall Study|Death|0|||
127603165|NCT02554812|459175754|FG000|Overall Study|Lost to Follow-up|0|||
127603166|NCT02554812|459175755|FG001|Overall Study|Lost to Follow-up|1|||
127603167|NCT02554812|459175756|FG002|Overall Study|Lost to Follow-up|0|||
127603168|NCT02554812|459175757|FG003|Overall Study|Lost to Follow-up|0|||
127603169|NCT02554812|459175758|FG004|Overall Study|Lost to Follow-up|0|||
127603170|NCT02554812|459175759|FG005|Overall Study|Lost to Follow-up|0|||
127603171|NCT02554812|459175760|FG006|Overall Study|Lost to Follow-up|0|||
127603172|NCT02554812|459175761|FG007|Overall Study|Lost to Follow-up|0|||
127603173|NCT02554812|459175762|FG008|Overall Study|Lost to Follow-up|0|||
127603174|NCT02554812|459175763|FG009|Overall Study|Lost to Follow-up|0|||
127603175|NCT02554812|459175764|FG010|Overall Study|Lost to Follow-up|0|||
127603176|NCT02554812|459175765|FG011|Overall Study|Lost to Follow-up|0|||
127603177|NCT02554812|459175766|FG012|Overall Study|Lost to Follow-up|0|||
127603178|NCT02554812|459175767|FG013|Overall Study|Lost to Follow-up|0|||
127603179|NCT02554812|459175768|FG014|Overall Study|Lost to Follow-up|0|||
127603180|NCT02554812|459175769|FG015|Overall Study|Lost to Follow-up|0|||
127696582|NCT03673111|459517811|FG004|Overall Study|Protocol Violation|0|||
127696583|NCT03673111|459517812|FG005|Overall Study|Protocol Violation|0|||
127696584|NCT03673111|459517813|FG006|Overall Study|Protocol Violation|0|||
127603181|NCT02554812|459175770|FG016|Overall Study|Lost to Follow-up|0|||
127696585|NCT03673111|459517814|FG007|Overall Study|Protocol Violation|0|||
127603182|NCT02554812|459175771|FG017|Overall Study|Lost to Follow-up|0|||
127696586|NCT03673111|459517815|FG008|Overall Study|Protocol Violation|0|||
127696587|NCT03673111|459517816|FG009|Overall Study|Protocol Violation|0|||
127696588|NCT03673111|459517817|FG010|Overall Study|Protocol Violation|1|||
127603183|NCT02554812|459175772|FG018|Overall Study|Lost to Follow-up|0|||
127603184|NCT02554812|459175773|FG019|Overall Study|Lost to Follow-up|0|||
127603185|NCT02554812|459175774|FG020|Overall Study|Lost to Follow-up|0|||
127696589|NCT03673111|459517818|FG011|Overall Study|Protocol Violation|0|||
127696590|NCT03673111|459517819|FG012|Overall Study|Protocol Violation|0|||
127603186|NCT02554812|459175775|FG021|Overall Study|Lost to Follow-up|0|||
127603187|NCT02554812|459175776|FG022|Overall Study|Lost to Follow-up|0|||
127603188|NCT02554812|459175777|FG023|Overall Study|Lost to Follow-up|0|||
127603189|NCT02554812|459175778|FG024|Overall Study|Lost to Follow-up|0|||
127603190|NCT02554812|459175779|FG025|Overall Study|Lost to Follow-up|0|||
127603191|NCT02554812|459175780|FG026|Overall Study|Lost to Follow-up|0|||
127603192|NCT02554812|459175754|FG000|Overall Study|Global deterioration of health status|4|||
127603193|NCT02554812|459175755|FG001|Overall Study|Global deterioration of health status|3|||
127603194|NCT02554812|459175756|FG002|Overall Study|Global deterioration of health status|3|||
127603195|NCT02554812|459175757|FG003|Overall Study|Global deterioration of health status|2|||
127603196|NCT02554812|459175758|FG004|Overall Study|Global deterioration of health status|5|||
127603197|NCT02554812|459175759|FG005|Overall Study|Global deterioration of health status|0|||
127603198|NCT02554812|459175760|FG006|Overall Study|Global deterioration of health status|2|||
127603199|NCT02554812|459175761|FG007|Overall Study|Global deterioration of health status|1|||
127603200|NCT02554812|459175762|FG008|Overall Study|Global deterioration of health status|1|||
127603201|NCT02554812|459175763|FG009|Overall Study|Global deterioration of health status|1|||
127603202|NCT02554812|459175764|FG010|Overall Study|Global deterioration of health status|2|||
127603203|NCT02554812|459175765|FG011|Overall Study|Global deterioration of health status|1|||
127603204|NCT02554812|459175766|FG012|Overall Study|Global deterioration of health status|0|||
127603205|NCT02554812|459175767|FG013|Overall Study|Global deterioration of health status|0|||
127603206|NCT02554812|459175768|FG014|Overall Study|Global deterioration of health status|0|||
127603207|NCT02554812|459175769|FG015|Overall Study|Global deterioration of health status|1|||
127603208|NCT02554812|459175770|FG016|Overall Study|Global deterioration of health status|0|||
127603209|NCT02554812|459175771|FG017|Overall Study|Global deterioration of health status|0|||
127603210|NCT02554812|459175772|FG018|Overall Study|Global deterioration of health status|0|||
127603211|NCT02554812|459175773|FG019|Overall Study|Global deterioration of health status|0|||
127603212|NCT02554812|459175774|FG020|Overall Study|Global deterioration of health status|0|||
127603213|NCT02554812|459175775|FG021|Overall Study|Global deterioration of health status|0|||
127603214|NCT02554812|459175776|FG022|Overall Study|Global deterioration of health status|0|||
127603215|NCT02554812|459175777|FG023|Overall Study|Global deterioration of health status|0|||
127603216|NCT02554812|459175778|FG024|Overall Study|Global deterioration of health status|0|||
127603217|NCT02554812|459175779|FG025|Overall Study|Global deterioration of health status|0|||
127603218|NCT02554812|459175780|FG026|Overall Study|Global deterioration of health status|0|||
127603219|NCT02554812|459175754|FG000|Overall Study|Progressive disease|20|||
127603220|NCT02554812|459175755|FG001|Overall Study|Progressive disease|16|||
127603221|NCT02554812|459175756|FG002|Overall Study|Progressive disease|19|||
127603222|NCT02554812|459175757|FG003|Overall Study|Progressive disease|18|||
127603223|NCT02554812|459175758|FG004|Overall Study|Progressive disease|21|||
127603224|NCT02554812|459175759|FG005|Overall Study|Progressive disease|15|||
127603225|NCT02554812|459175760|FG006|Overall Study|Progressive disease|6|||
127603226|NCT02554812|459175761|FG007|Overall Study|Progressive disease|13|||
127603227|NCT02554812|459175762|FG008|Overall Study|Progressive disease|6|||
127603228|NCT02554812|459175763|FG009|Overall Study|Progressive disease|6|||
127603229|NCT02554812|459175764|FG010|Overall Study|Progressive disease|8|||
127603230|NCT02554812|459175765|FG011|Overall Study|Progressive disease|8|||
127603231|NCT02554812|459175766|FG012|Overall Study|Progressive disease|6|||
127603232|NCT02554812|459175767|FG013|Overall Study|Progressive disease|10|||
127603233|NCT02554812|459175768|FG014|Overall Study|Progressive disease|20|||
127603234|NCT02554812|459175769|FG015|Overall Study|Progressive disease|6|||
127603235|NCT02554812|459175770|FG016|Overall Study|Progressive disease|3|||
127603236|NCT02554812|459175771|FG017|Overall Study|Progressive disease|3|||
127603237|NCT02554812|459175772|FG018|Overall Study|Progressive disease|11|||
127603238|NCT02554812|459175773|FG019|Overall Study|Progressive disease|7|||
127603239|NCT02554812|459175774|FG020|Overall Study|Progressive disease|11|||
127603240|NCT02554812|459175775|FG021|Overall Study|Progressive disease|6|||
127603241|NCT02554812|459175776|FG022|Overall Study|Progressive disease|9|||
127603242|NCT02554812|459175777|FG023|Overall Study|Progressive disease|9|||
127696591|NCT03673111|459517820|FG013|Overall Study|Protocol Violation|0|||
127696592|NCT03673111|459517807|FG000|Overall Study|Adverse Event|1|||
127696593|NCT03673111|459517808|FG001|Overall Study|Adverse Event|0|||
127696594|NCT03673111|459517809|FG002|Overall Study|Adverse Event|0|||
127696595|NCT03673111|459517810|FG003|Overall Study|Adverse Event|0|||
127696596|NCT03673111|459517811|FG004|Overall Study|Adverse Event|0|||
127696597|NCT03673111|459517812|FG005|Overall Study|Adverse Event|0|||
127696598|NCT03673111|459517813|FG006|Overall Study|Adverse Event|0|||
127696599|NCT03673111|459517814|FG007|Overall Study|Adverse Event|0|||
127696600|NCT03673111|459517815|FG008|Overall Study|Adverse Event|0|||
127696601|NCT03673111|459517816|FG009|Overall Study|Adverse Event|0|||
127696602|NCT03673111|459517817|FG010|Overall Study|Adverse Event|0|||
127696603|NCT03673111|459517818|FG011|Overall Study|Adverse Event|0|||
127696604|NCT03673111|459517819|FG012|Overall Study|Adverse Event|0|||
127696605|NCT03673111|459517820|FG013|Overall Study|Adverse Event|0|||
127696606|NCT03792555|459517825|FG000|Titration Period: up to 9 Weeks|COVID-19|0|||
127696607|NCT03792555|459517826|FG001|Titration Period: up to 9 Weeks|COVID-19|0|||
127696608|NCT03792555|459517827|FG002|Titration Period: up to 9 Weeks|COVID-19|1|||
127696609|NCT03792555|459517825|FG000|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
127696610|NCT03792555|459517826|FG001|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
127696611|NCT03792555|459517827|FG002|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|5|||
127696612|NCT03792555|459517825|FG000|Follow-up Period: up to 4 Weeks|COVID-19|0|||
127603243|NCT02554812|459175778|FG024|Overall Study|Progressive disease|4|||
127603244|NCT02554812|459175779|FG025|Overall Study|Progressive disease|5|||
127603245|NCT02554812|459175780|FG026|Overall Study|Progressive disease|5|||
127603246|NCT02554812|459175754|FG000|Overall Study|Other|0|||
127603247|NCT02554812|459175755|FG001|Overall Study|Other|0|||
127603248|NCT02554812|459175756|FG002|Overall Study|Other|2|||
127603249|NCT02554812|459175757|FG003|Overall Study|Other|3|||
127603250|NCT02554812|459175758|FG004|Overall Study|Other|2|||
127603251|NCT02554812|459175759|FG005|Overall Study|Other|1|||
127603252|NCT02554812|459175760|FG006|Overall Study|Other|0|||
127603253|NCT02554812|459175761|FG007|Overall Study|Other|0|||
127603254|NCT02554812|459175762|FG008|Overall Study|Other|1|||
127603255|NCT02554812|459175763|FG009|Overall Study|Other|1|||
127603256|NCT02554812|459175764|FG010|Overall Study|Other|0|||
127603257|NCT02554812|459175765|FG011|Overall Study|Other|0|||
127603258|NCT02554812|459175766|FG012|Overall Study|Other|1|||
127603259|NCT02554812|459175767|FG013|Overall Study|Other|0|||
127603260|NCT02554812|459175768|FG014|Overall Study|Other|1|||
127603261|NCT02554812|459175769|FG015|Overall Study|Other|0|||
127603262|NCT02554812|459175770|FG016|Overall Study|Other|0|||
127603263|NCT02554812|459175771|FG017|Overall Study|Other|0|||
127603264|NCT02554812|459175772|FG018|Overall Study|Other|0|||
127603265|NCT02554812|459175773|FG019|Overall Study|Other|0|||
127603266|NCT02554812|459175774|FG020|Overall Study|Other|0|||
127603267|NCT02554812|459175775|FG021|Overall Study|Other|2|||
127603268|NCT02554812|459175776|FG022|Overall Study|Other|0|||
127603269|NCT02554812|459175777|FG023|Overall Study|Other|0|||
127603270|NCT02554812|459175778|FG024|Overall Study|Other|0|||
127603271|NCT02554812|459175779|FG025|Overall Study|Other|0|||
127603272|NCT02554812|459175780|FG026|Overall Study|Other|0|||
127603273|NCT02554812|459175754|FG000|Overall Study|Withdrawal by Subject|1|||
127696613|NCT03792555|459517826|FG001|Follow-up Period: up to 4 Weeks|COVID-19|1|||
127696614|NCT03792555|459517827|FG002|Follow-up Period: up to 4 Weeks|COVID-19|0|||
127696615|NCT02120456|459517831|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
127696616|NCT02120456|459517832|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
127696617|NCT02120456|459517833|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
127696618|NCT02120456|459517834|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
127696619|NCT02120456|459517835|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
127696620|NCT02120456|459517836|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
127696621|NCT02120456|459517837|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
127696622|NCT02120456|459517838|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
127696623|NCT02120456|459517839|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
127696624|NCT02120456|459517831|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
127696625|NCT02120456|459517832|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
127696626|NCT02120456|459517833|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
127696627|NCT02120456|459517834|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
127696628|NCT02120456|459517835|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
127696629|NCT02120456|459517836|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
127696630|NCT02120456|459517837|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
127696631|NCT02120456|459517838|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
127696632|NCT02120456|459517839|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
127696633|NCT02120456|459517831|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
127696634|NCT02120456|459517832|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
127696635|NCT02120456|459517833|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
127696636|NCT02120456|459517834|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
127696637|NCT02120456|459517835|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
127696638|NCT02120456|459517836|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
127696639|NCT02120456|459517837|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
127696640|NCT02120456|459517838|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
127696641|NCT02120456|459517839|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
127696642|NCT03623321|459517840|FG000|Overall Study|Adverse Event|32|||
127696643|NCT03623321|459517840|FG000|Overall Study|Death|9|||
127696644|NCT03623321|459517840|FG000|Overall Study|Lack of Efficacy|9|||
127696645|NCT03623321|459517840|FG000|Overall Study|Lost to Follow-up|6|||
127696646|NCT03623321|459517840|FG000|Overall Study|Noncompliance with study drug|6|||
127696647|NCT03623321|459517840|FG000|Overall Study|Use of prohibited medication|3|||
127696648|NCT03623321|459517840|FG000|Overall Study|Physician Decision|5|||
127696649|NCT03623321|459517840|FG000|Overall Study|Protocol Violation|1|||
127696650|NCT03623321|459517840|FG000|Overall Study|Consent withdrawn by patient or legally accepted representative|29|||
127696651|NCT03623321|459517840|FG000|Overall Study|Not further specified|43|||
127696652|NCT02243709|459517842|FG000|Phase 1|Lost to Follow-up|0|||
127603274|NCT02554812|459175755|FG001|Overall Study|Withdrawal by Subject|0|||
127603275|NCT02554812|459175756|FG002|Overall Study|Withdrawal by Subject|0|||
127603276|NCT02554812|459175757|FG003|Overall Study|Withdrawal by Subject|2|||
127603277|NCT02554812|459175758|FG004|Overall Study|Withdrawal by Subject|2|||
127603278|NCT02554812|459175759|FG005|Overall Study|Withdrawal by Subject|3|||
127696653|NCT02243709|459517843|FG001|Phase 1|Lost to Follow-up|1|||
127696654|NCT02243709|459517842|FG000|Phase 1|Withdrawal by Subject|1|||
127696655|NCT02243709|459517843|FG001|Phase 1|Withdrawal by Subject|0|||
127696656|NCT02243709|459517842|FG000|Phase 1|Protocol Violation|0|||
127696657|NCT02243709|459517843|FG001|Phase 1|Protocol Violation|1|||
127696658|NCT02243709|459517842|FG000|Phase 1|Adverse Event|0|||
127696659|NCT02243709|459517843|FG001|Phase 1|Adverse Event|1|||
127696660|NCT01785719|459517846|FG000|4-week Baseline Evaluation|Physician Decision|1|||
127696661|NCT01785719|459517847|FG001|4-week Baseline Evaluation|Physician Decision|0|||
127696662|NCT01785719|459517846|FG000|4-week Baseline Evaluation|Withdrawal by Subject|1|||
127696663|NCT01785719|459517847|FG001|4-week Baseline Evaluation|Withdrawal by Subject|2|||
127696664|NCT01785719|459517846|FG000|4-week Baseline Evaluation|Lost to Follow-up|0|||
127696665|NCT01785719|459517847|FG001|4-week Baseline Evaluation|Lost to Follow-up|1|||
127696666|NCT01785719|459517846|FG000|4-week Baseline Evaluation|Pregnancy|0|||
127696667|NCT01785719|459517847|FG001|4-week Baseline Evaluation|Pregnancy|2|||
127696668|NCT01785719|459517846|FG000|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|4|||
127696669|NCT01785719|459517847|FG001|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|8|||
127603279|NCT02554812|459175760|FG006|Overall Study|Withdrawal by Subject|0|||
127603280|NCT02554812|459175761|FG007|Overall Study|Withdrawal by Subject|0|||
127603281|NCT02554812|459175762|FG008|Overall Study|Withdrawal by Subject|1|||
127603282|NCT02554812|459175763|FG009|Overall Study|Withdrawal by Subject|1|||
127603283|NCT02554812|459175764|FG010|Overall Study|Withdrawal by Subject|0|||
127603284|NCT02554812|459175765|FG011|Overall Study|Withdrawal by Subject|1|||
127603285|NCT02554812|459175766|FG012|Overall Study|Withdrawal by Subject|1|||
127603286|NCT02554812|459175767|FG013|Overall Study|Withdrawal by Subject|1|||
127603287|NCT02554812|459175768|FG014|Overall Study|Withdrawal by Subject|1|||
127603288|NCT02554812|459175769|FG015|Overall Study|Withdrawal by Subject|1|||
127603289|NCT02554812|459175770|FG016|Overall Study|Withdrawal by Subject|3|||
127603290|NCT02554812|459175771|FG017|Overall Study|Withdrawal by Subject|1|||
127603291|NCT02554812|459175772|FG018|Overall Study|Withdrawal by Subject|0|||
127603292|NCT02554812|459175773|FG019|Overall Study|Withdrawal by Subject|2|||
127603293|NCT02554812|459175774|FG020|Overall Study|Withdrawal by Subject|0|||
127603294|NCT02554812|459175775|FG021|Overall Study|Withdrawal by Subject|1|||
127603295|NCT02554812|459175776|FG022|Overall Study|Withdrawal by Subject|0|||
127603296|NCT02554812|459175777|FG023|Overall Study|Withdrawal by Subject|1|||
127603297|NCT02554812|459175778|FG024|Overall Study|Withdrawal by Subject|0|||
127603298|NCT02554812|459175779|FG025|Overall Study|Withdrawal by Subject|0|||
127603299|NCT02554812|459175780|FG026|Overall Study|Withdrawal by Subject|1|||
127603300|NCT02554812|459175754|FG000|Overall Study|Physician Decision|1|||
127603301|NCT02554812|459175755|FG001|Overall Study|Physician Decision|0|||
127603302|NCT02554812|459175756|FG002|Overall Study|Physician Decision|0|||
127603303|NCT02554812|459175757|FG003|Overall Study|Physician Decision|1|||
127603304|NCT02554812|459175758|FG004|Overall Study|Physician Decision|0|||
127603305|NCT02554812|459175759|FG005|Overall Study|Physician Decision|1|||
127603306|NCT02554812|459175760|FG006|Overall Study|Physician Decision|0|||
127603307|NCT02554812|459175761|FG007|Overall Study|Physician Decision|0|||
127603308|NCT02554812|459175762|FG008|Overall Study|Physician Decision|0|||
127603309|NCT02554812|459175763|FG009|Overall Study|Physician Decision|0|||
127603310|NCT02554812|459175764|FG010|Overall Study|Physician Decision|1|||
127603311|NCT02554812|459175765|FG011|Overall Study|Physician Decision|0|||
127603312|NCT02554812|459175766|FG012|Overall Study|Physician Decision|0|||
127603313|NCT02554812|459175767|FG013|Overall Study|Physician Decision|0|||
127603314|NCT02554812|459175768|FG014|Overall Study|Physician Decision|0|||
127603315|NCT02554812|459175769|FG015|Overall Study|Physician Decision|0|||
127696670|NCT01785719|459517846|FG000|4-week Baseline Evaluation|Exclusionary medication|2|||
127696671|NCT01785719|459517847|FG001|4-week Baseline Evaluation|Exclusionary medication|0|||
127696672|NCT01785719|459517846|FG000|Hypocaloric Dietary Intervention|Adverse Event|1|||
127696673|NCT01785719|459517847|FG001|Hypocaloric Dietary Intervention|Adverse Event|0|||
127696674|NCT01785719|459517846|FG000|Hypocaloric Dietary Intervention|Physician Decision|1|||
127696675|NCT01785719|459517847|FG001|Hypocaloric Dietary Intervention|Physician Decision|0|||
127696676|NCT01785719|459517846|FG000|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|1|||
127696677|NCT01785719|459517847|FG001|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|2|||
127696678|NCT01785719|459517846|FG000|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|1|||
127696679|NCT01785719|459517847|FG001|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|2|||
127788544|NCT01399788|459851246|FG000|First Intervention Period|Adverse Event|1|||
127603316|NCT02554812|459175770|FG016|Overall Study|Physician Decision|1|||
127603317|NCT02554812|459175771|FG017|Overall Study|Physician Decision|1|||
127603318|NCT02554812|459175772|FG018|Overall Study|Physician Decision|0|||
127603319|NCT02554812|459175773|FG019|Overall Study|Physician Decision|1|||
127603320|NCT02554812|459175774|FG020|Overall Study|Physician Decision|1|||
127603321|NCT02554812|459175775|FG021|Overall Study|Physician Decision|0|||
127603322|NCT02554812|459175776|FG022|Overall Study|Physician Decision|1|||
127603323|NCT02554812|459175777|FG023|Overall Study|Physician Decision|0|||
127603324|NCT02554812|459175778|FG024|Overall Study|Physician Decision|0|||
127603325|NCT02554812|459175779|FG025|Overall Study|Physician Decision|0|||
127603326|NCT02554812|459175780|FG026|Overall Study|Physician Decision|0|||
127603327|NCT02554812|459175754|FG000|Overall Study|Study terminated by sponsor|0|||
127603328|NCT02554812|459175755|FG001|Overall Study|Study terminated by sponsor|0|||
127603329|NCT02554812|459175756|FG002|Overall Study|Study terminated by sponsor|0|||
127603330|NCT02554812|459175757|FG003|Overall Study|Study terminated by sponsor|0|||
127603331|NCT02554812|459175758|FG004|Overall Study|Study terminated by sponsor|0|||
127603332|NCT02554812|459175759|FG005|Overall Study|Study terminated by sponsor|0|||
127603333|NCT02554812|459175760|FG006|Overall Study|Study terminated by sponsor|0|||
127603334|NCT02554812|459175761|FG007|Overall Study|Study terminated by sponsor|0|||
127603335|NCT02554812|459175762|FG008|Overall Study|Study terminated by sponsor|0|||
127603336|NCT02554812|459175763|FG009|Overall Study|Study terminated by sponsor|0|||
127603337|NCT02554812|459175764|FG010|Overall Study|Study terminated by sponsor|0|||
127603338|NCT02554812|459175765|FG011|Overall Study|Study terminated by sponsor|0|||
127603339|NCT02554812|459175766|FG012|Overall Study|Study terminated by sponsor|0|||
127603340|NCT02554812|459175767|FG013|Overall Study|Study terminated by sponsor|0|||
127603341|NCT02554812|459175768|FG014|Overall Study|Study terminated by sponsor|0|||
127603342|NCT02554812|459175769|FG015|Overall Study|Study terminated by sponsor|0|||
127603343|NCT02554812|459175770|FG016|Overall Study|Study terminated by sponsor|0|||
127603344|NCT02554812|459175771|FG017|Overall Study|Study terminated by sponsor|0|||
127603345|NCT02554812|459175772|FG018|Overall Study|Study terminated by sponsor|0|||
127603346|NCT02554812|459175773|FG019|Overall Study|Study terminated by sponsor|0|||
127788545|NCT01399788|459851247|FG001|First Intervention Period|Adverse Event|0|||
127788546|NCT04718974|459851251|FG000|Overall Study|Death|0|||
127788547|NCT04718974|459851252|FG001|Overall Study|Death|2|||
127788548|NCT04718974|459851251|FG000|Overall Study|Lost to Follow-up|10|||
127788549|NCT04718974|459851252|FG001|Overall Study|Lost to Follow-up|20|||
127788550|NCT04718974|459851251|FG000|Overall Study|Transferred out|2|||
127788551|NCT04718974|459851252|FG001|Overall Study|Transferred out|4|||
127788552|NCT00183274|459851255|FG000|Phase 1: Open-Label|Adverse Event|31|||
127788553|NCT00183274|459851256|FG001|Phase 1: Open-Label|Adverse Event|0|||
127603347|NCT02554812|459175774|FG020|Overall Study|Study terminated by sponsor|0|||
127603348|NCT02554812|459175775|FG021|Overall Study|Study terminated by sponsor|0|||
127603349|NCT02554812|459175776|FG022|Overall Study|Study terminated by sponsor|0|||
127603350|NCT02554812|459175777|FG023|Overall Study|Study terminated by sponsor|0|||
127603351|NCT02554812|459175778|FG024|Overall Study|Study terminated by sponsor|1|||
127603352|NCT02554812|459175779|FG025|Overall Study|Study terminated by sponsor|0|||
127603353|NCT02554812|459175780|FG026|Overall Study|Study terminated by sponsor|0|||
127603354|NCT02554812|459175754|FG000|Overall Study|No longer meets eligibility criteria|0|||
127603355|NCT02554812|459175755|FG001|Overall Study|No longer meets eligibility criteria|1|||
127603356|NCT02554812|459175756|FG002|Overall Study|No longer meets eligibility criteria|0|||
127603357|NCT02554812|459175757|FG003|Overall Study|No longer meets eligibility criteria|0|||
127603358|NCT02554812|459175758|FG004|Overall Study|No longer meets eligibility criteria|0|||
127603359|NCT02554812|459175759|FG005|Overall Study|No longer meets eligibility criteria|0|||
127603360|NCT02554812|459175760|FG006|Overall Study|No longer meets eligibility criteria|0|||
127603361|NCT02554812|459175761|FG007|Overall Study|No longer meets eligibility criteria|0|||
127603362|NCT02554812|459175762|FG008|Overall Study|No longer meets eligibility criteria|0|||
127603363|NCT02554812|459175763|FG009|Overall Study|No longer meets eligibility criteria|0|||
127603364|NCT02554812|459175764|FG010|Overall Study|No longer meets eligibility criteria|0|||
127603365|NCT02554812|459175765|FG011|Overall Study|No longer meets eligibility criteria|0|||
127603366|NCT02554812|459175766|FG012|Overall Study|No longer meets eligibility criteria|0|||
127603367|NCT02554812|459175767|FG013|Overall Study|No longer meets eligibility criteria|0|||
127603368|NCT02554812|459175768|FG014|Overall Study|No longer meets eligibility criteria|0|||
127603369|NCT02554812|459175769|FG015|Overall Study|No longer meets eligibility criteria|0|||
127603370|NCT02554812|459175770|FG016|Overall Study|No longer meets eligibility criteria|0|||
127603371|NCT02554812|459175771|FG017|Overall Study|No longer meets eligibility criteria|0|||
127603372|NCT02554812|459175772|FG018|Overall Study|No longer meets eligibility criteria|0|||
127603373|NCT02554812|459175773|FG019|Overall Study|No longer meets eligibility criteria|0|||
127603374|NCT02554812|459175774|FG020|Overall Study|No longer meets eligibility criteria|0|||
127603375|NCT02554812|459175775|FG021|Overall Study|No longer meets eligibility criteria|0|||
127603376|NCT02554812|459175776|FG022|Overall Study|No longer meets eligibility criteria|0|||
127603377|NCT02554812|459175777|FG023|Overall Study|No longer meets eligibility criteria|0|||
127603378|NCT02554812|459175778|FG024|Overall Study|No longer meets eligibility criteria|0|||
127603379|NCT02554812|459175779|FG025|Overall Study|No longer meets eligibility criteria|0|||
127603380|NCT02554812|459175780|FG026|Overall Study|No longer meets eligibility criteria|0|||
127603381|NCT00415909|459176979|FG000|Overall Study|Withdrawal by Subject|2|||
127603382|NCT00415909|459176979|FG000|Overall Study|Death|1|||
127603383|NCT00312494|459176980|FG000|Overall Study|Randomized; not treated with study drug|9|||
127603384|NCT00312494|459176981|FG001|Overall Study|Randomized; not treated with study drug|10|||
127788554|NCT00183274|459851257|FG002|Phase 1: Open-Label|Adverse Event|0|||
127696680|NCT01785719|459517846|FG000|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|0|||
127696681|NCT01785719|459517847|FG001|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|1|||
127696682|NCT01785719|459517846|FG000|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|0|||
127696683|NCT01785719|459517847|FG001|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|1|||
127696684|NCT01785719|459517846|FG000|6-month Post-intervention Follow-up|Lost to Follow-up|12|||
127603385|NCT00312494|459176982|FG002|Overall Study|Randomized; not treated with study drug|5|||
127603386|NCT00312494|459176980|FG000|Overall Study|Adverse Event|33|||
127603387|NCT00312494|459176981|FG001|Overall Study|Adverse Event|15|||
127603388|NCT00312494|459176982|FG002|Overall Study|Adverse Event|11|||
127603389|NCT00312494|459176980|FG000|Overall Study|Lack of Efficacy|4|||
127603390|NCT00312494|459176981|FG001|Overall Study|Lack of Efficacy|6|||
127603391|NCT00312494|459176982|FG002|Overall Study|Lack of Efficacy|8|||
127603392|NCT00312494|459176980|FG000|Overall Study|Laboratory abnormality|1|||
127603393|NCT00312494|459176981|FG001|Overall Study|Laboratory abnormality|0|||
127603394|NCT00312494|459176982|FG002|Overall Study|Laboratory abnormality|0|||
127603395|NCT00312494|459176980|FG000|Overall Study|Lost to Follow-up|8|||
127603396|NCT00312494|459176981|FG001|Overall Study|Lost to Follow-up|8|||
127603397|NCT00312494|459176982|FG002|Overall Study|Lost to Follow-up|8|||
127603398|NCT00312494|459176980|FG000|Overall Study|Withdrawal by Subject|6|||
127603399|NCT00312494|459176981|FG001|Overall Study|Withdrawal by Subject|9|||
127603400|NCT00312494|459176982|FG002|Overall Study|Withdrawal by Subject|10|||
127603401|NCT00312494|459176980|FG000|Overall Study|Other|10|||
127603402|NCT00312494|459176981|FG001|Overall Study|Other|10|||
127603403|NCT00312494|459176982|FG002|Overall Study|Other|1|||
127603404|NCT00903617|459176983|FG000|Overall Study|Adverse Event|0|||
127603405|NCT00903617|459176984|FG001|Overall Study|Adverse Event|1|||
127603406|NCT00903617|459176985|FG002|Overall Study|Adverse Event|1|||
127603407|NCT00903617|459176986|FG003|Overall Study|Adverse Event|0|||
127603408|NCT00903617|459176983|FG000|Overall Study|Protocol-defined stopping criteria|0|||
127603409|NCT00903617|459176984|FG001|Overall Study|Protocol-defined stopping criteria|2|||
127603410|NCT00903617|459176985|FG002|Overall Study|Protocol-defined stopping criteria|0|||
127603411|NCT00903617|459176986|FG003|Overall Study|Protocol-defined stopping criteria|0|||
127603412|NCT00903617|459176983|FG000|Overall Study|Lost to Follow-up|2|||
127603413|NCT00903617|459176984|FG001|Overall Study|Lost to Follow-up|0|||
127603414|NCT00903617|459176985|FG002|Overall Study|Lost to Follow-up|1|||
127603415|NCT00903617|459176986|FG003|Overall Study|Lost to Follow-up|1|||
127603416|NCT00903617|459176983|FG000|Overall Study|Withdrawal by Subject|1|||
127603417|NCT00903617|459176984|FG001|Overall Study|Withdrawal by Subject|2|||
127603418|NCT00903617|459176985|FG002|Overall Study|Withdrawal by Subject|3|||
127603419|NCT00903617|459176986|FG003|Overall Study|Withdrawal by Subject|0|||
127603420|NCT02355691|459176987|FG000|Overall Study|Loss of Research Personnel|7|||
127603421|NCT02355691|459176988|FG001|Overall Study|Loss of Research Personnel|9|||
127603422|NCT00462761|459176989|FG000|Overall Study|Adverse Event|6|||
127603423|NCT00462761|459176989|FG000|Overall Study|Withdrawal by Subject|9|||
127603424|NCT00462761|459176989|FG000|Overall Study|Physician Decision|5|||
127603425|NCT00462761|459176989|FG000|Overall Study|Disease progression|43|||
127603426|NCT00462761|459176989|FG000|Overall Study|Death|12|||
127603427|NCT00462761|459176989|FG000|Overall Study|Other|1|||
127603428|NCT02522286|459176990|FG000|Overall Study|Withdrawal by Subject|3|||
127603429|NCT02522286|459176991|FG001|Overall Study|Withdrawal by Subject|0|||
127603430|NCT02522286|459176992|FG002|Overall Study|Withdrawal by Subject|0|||
127603431|NCT02522286|459176993|FG003|Overall Study|Withdrawal by Subject|3|||
127603432|NCT00605813|459176994|FG000|Overall Study|Protocol Violation|25|||
127603433|NCT00573755|459176995|FG000|Overall Study|Still receiving treatment|1|||
127603434|NCT00573755|459176996|FG001|Overall Study|Still receiving treatment|0|||
127603435|NCT02132767|459176997|FG000|Overall Study|Death|3|||
127603436|NCT02132767|459176998|FG001|Overall Study|Death|2|||
127603437|NCT02132767|459176997|FG000|Overall Study|Withdrawal by Subject|10|||
127603438|NCT02132767|459176998|FG001|Overall Study|Withdrawal by Subject|9|||
127603439|NCT02132767|459176997|FG000|Overall Study|Lost to Follow-up|4|||
127603440|NCT02132767|459176998|FG001|Overall Study|Lost to Follow-up|4|||
127603441|NCT01275833|459177001|FG000|Overall Study|Study terminated|1|||
127603442|NCT01275833|459177002|FG001|Overall Study|Study terminated|1|||
127696685|NCT01785719|459517847|FG001|6-month Post-intervention Follow-up|Lost to Follow-up|2|||
127696686|NCT01785719|459517846|FG000|6-month Post-intervention Follow-up|Pregnancy|0|||
127696687|NCT01785719|459517847|FG001|6-month Post-intervention Follow-up|Pregnancy|1|||
127696688|NCT01785719|459517846|FG000|6-month Post-intervention Follow-up|Exclusionary medication|0|||
127696689|NCT01785719|459517847|FG001|6-month Post-intervention Follow-up|Exclusionary medication|1|||
127696690|NCT04347161|459517852|FG000|Overall Study|Death|0|||
127696691|NCT04347161|459517853|FG001|Overall Study|Death|2|||
127696692|NCT04347161|459517852|FG000|Overall Study|Withdrawal by Subject|1|||
127603443|NCT00003901|459177005|FG000|Overall Study|Adverse Event|1|||
127603444|NCT00003901|459177005|FG000|Overall Study|Withdrawal by Subject|1|||
127603445|NCT00003901|459177005|FG000|Overall Study|Ineligible|6|||
127603446|NCT00003901|459177005|FG000|Overall Study|CT Scan not within protocol requirement|2|||
127603447|NCT00003901|459177005|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
127603448|NCT00003901|459177005|FG000|Overall Study|Medical problems|6|||
127603449|NCT00680745|459177008|FG000|Overall Study|Withdrawal by Subject|8|||
127603450|NCT00680745|459177009|FG001|Overall Study|Withdrawal by Subject|3|||
127603451|NCT00680745|459177010|FG002|Overall Study|Withdrawal by Subject|2|||
127603452|NCT00680745|459177011|FG003|Overall Study|Withdrawal by Subject|8|||
127603453|NCT00680745|459177008|FG000|Overall Study|Lost to Follow-up|0|||
127603454|NCT00680745|459177009|FG001|Overall Study|Lost to Follow-up|1|||
127603455|NCT00680745|459177010|FG002|Overall Study|Lost to Follow-up|1|||
127603456|NCT00680745|459177011|FG003|Overall Study|Lost to Follow-up|0|||
127603457|NCT00680745|459177008|FG000|Overall Study|Death|1|||
127603458|NCT00680745|459177009|FG001|Overall Study|Death|0|||
127603459|NCT00680745|459177010|FG002|Overall Study|Death|1|||
127603460|NCT00680745|459177011|FG003|Overall Study|Death|0|||
127603461|NCT00680745|459177008|FG000|Overall Study|Adverse Event|5|||
127603462|NCT00680745|459177009|FG001|Overall Study|Adverse Event|3|||
127603463|NCT00680745|459177010|FG002|Overall Study|Adverse Event|3|||
127603464|NCT00680745|459177011|FG003|Overall Study|Adverse Event|3|||
127603465|NCT00680745|459177008|FG000|Overall Study|Poor/Non-compliance|0|||
127603466|NCT00680745|459177009|FG001|Overall Study|Poor/Non-compliance|3|||
127603467|NCT00680745|459177010|FG002|Overall Study|Poor/Non-compliance|0|||
127603468|NCT00680745|459177011|FG003|Overall Study|Poor/Non-compliance|0|||
127603469|NCT00680745|459177008|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
127603470|NCT00680745|459177009|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
127603471|NCT00680745|459177010|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
127603472|NCT00680745|459177011|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
127603473|NCT00680745|459177008|FG000|Overall Study|False Treatment|0|||
127603474|NCT00680745|459177009|FG001|Overall Study|False Treatment|1|||
127603475|NCT00680745|459177010|FG002|Overall Study|False Treatment|3|||
127603476|NCT00680745|459177011|FG003|Overall Study|False Treatment|0|||
127603477|NCT02612428|459177012|FG000|VTL-308|Death|14|||
127603478|NCT02612428|459177013|FG001|VTL-308|Death|16|||
127603479|NCT02612428|459177012|FG000|VTL-308|Withdrawal by Subject|0|||
127603480|NCT02612428|459177013|FG001|VTL-308|Withdrawal by Subject|1|||
127603481|NCT02612428|459177012|FG000|VTL-308E|Death|9|||
127603482|NCT02612428|459177013|FG001|VTL-308E|Death|7|||
127603483|NCT02612428|459177012|FG000|VTL-308E|Lost to Follow-up|2|||
127603484|NCT02612428|459177013|FG001|VTL-308E|Lost to Follow-up|0|||
127696693|NCT04347161|459517853|FG001|Overall Study|Withdrawal by Subject|0|||
127696694|NCT04347161|459517852|FG000|Overall Study|Lost to Follow-up|0|||
127696695|NCT04347161|459517853|FG001|Overall Study|Lost to Follow-up|1|||
127696696|NCT04347161|459517852|FG000|Overall Study|No longer on study medication|1|||
127696697|NCT04347161|459517853|FG001|Overall Study|No longer on study medication|1|||
127603485|NCT00137423|459177014|FG000|Overall Study|Adverse Event|7|||
127603486|NCT00137423|459177015|FG001|Overall Study|Adverse Event|9|||
127603487|NCT00137423|459177014|FG000|Overall Study|consent withdrawn|1|||
127603488|NCT00137423|459177015|FG001|Overall Study|consent withdrawn|1|||
127696698|NCT04169373|459517854|FG000|Week 1 to Week 14|Adverse Event|1|||
127603489|NCT00137423|459177014|FG000|Overall Study|Lack of Efficacy|31|||
127603490|NCT00137423|459177015|FG001|Overall Study|Lack of Efficacy|33|||
127603491|NCT00137423|459177014|FG000|Overall Study|Death|0|||
127788555|NCT00183274|459851258|FG003|Phase 1: Open-Label|Adverse Event|0|||
127603492|NCT00137423|459177015|FG001|Overall Study|Death|1|||
127603493|NCT01928329|459177016|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
127603494|NCT01928329|459177017|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
127603495|NCT01928329|459177016|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
127603496|NCT01928329|459177017|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
127603497|NCT01928329|459177016|FG000|Overall Study|Adverse Event|5|||
127603498|NCT01928329|459177017|FG001|Overall Study|Adverse Event|3|||
127603499|NCT01928329|459177016|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
127603500|NCT01928329|459177017|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
127603501|NCT01928329|459177016|FG000|Overall Study|Withdrawal by Subject|1|||
127603502|NCT01928329|459177017|FG001|Overall Study|Withdrawal by Subject|5|||
127603503|NCT01928329|459177016|FG000|Overall Study|Physician Decision|1|||
127603504|NCT01928329|459177017|FG001|Overall Study|Physician Decision|1|||
127603505|NCT03187262|459177019|FG000|Induction|Lack of Efficacy|2|||
127603506|NCT03187262|459177019|FG000|Induction|Progressive Disease|4|||
127603507|NCT03187262|459177019|FG000|Consolidation|Progressive Disease|5|||
127603508|NCT02617511|459177020|FG000|Overall Study|Withdrawal by Subject|1|||
127603509|NCT02617511|459177021|FG001|Overall Study|Withdrawal by Subject|0|||
127603510|NCT02141997|459177022|FG000|Overall Study|Adverse Event|0|||
127603511|NCT02141997|459177023|FG001|Overall Study|Adverse Event|2|||
127603512|NCT02141997|459177024|FG002|Overall Study|Adverse Event|0|||
127603513|NCT02141997|459177025|FG003|Overall Study|Adverse Event|1|||
127603514|NCT02141997|459177022|FG000|Overall Study|Participant noncompliance|1|||
127603515|NCT02141997|459177023|FG001|Overall Study|Participant noncompliance|0|||
127603516|NCT02141997|459177024|FG002|Overall Study|Participant noncompliance|0|||
127603517|NCT02141997|459177025|FG003|Overall Study|Participant noncompliance|0|||
127603518|NCT02141997|459177022|FG000|Overall Study|Withdrew consent|1|||
127603519|NCT02141997|459177023|FG001|Overall Study|Withdrew consent|0|||
127603520|NCT02141997|459177024|FG002|Overall Study|Withdrew consent|3|||
127603521|NCT02141997|459177025|FG003|Overall Study|Withdrew consent|0|||
127603522|NCT02141997|459177022|FG000|Overall Study|Other|1|||
127603523|NCT02141997|459177023|FG001|Overall Study|Other|4|||
127603524|NCT02141997|459177024|FG002|Overall Study|Other|0|||
127603525|NCT02141997|459177025|FG003|Overall Study|Other|0|||
127603526|NCT04105998|459177026|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
127603527|NCT04105998|459177027|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
127603528|NCT00909389|459177030|FG000|Overall Study|Adverse Event|6|||
127603529|NCT00909389|459177030|FG000|Overall Study|Death|4|||
127603530|NCT00909389|459177030|FG000|Overall Study|Poor Compliance|16|||
127603531|NCT00909389|459177030|FG000|Overall Study|Lost to Follow-up|4|||
127603532|NCT00909389|459177030|FG000|Overall Study|No Information|103|||
127603533|NCT00003492|459177031|FG000|Overall Study|Not evaluable|6|||
127603534|NCT00597766|459177034|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
127603535|NCT00597766|459177035|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
127603536|NCT00597766|459177036|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
127603537|NCT00597766|459177034|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
127603538|NCT00597766|459177035|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
127603539|NCT00597766|459177036|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
127603540|NCT00453544|459177038|FG000|Overall Study|Withdrawal by Subject|1|||
127603541|NCT00453544|459177039|FG001|Overall Study|Withdrawal by Subject|0|||
127603542|NCT00453544|459177040|FG002|Overall Study|Withdrawal by Subject|0|||
127603543|NCT00453544|459177041|FG003|Overall Study|Withdrawal by Subject|0|||
127603544|NCT00453544|459177038|FG000|Overall Study|Primary outcome measure not completed|1|||
127603545|NCT00453544|459177039|FG001|Overall Study|Primary outcome measure not completed|1|||
127603546|NCT00453544|459177040|FG002|Overall Study|Primary outcome measure not completed|0|||
127603547|NCT00453544|459177041|FG003|Overall Study|Primary outcome measure not completed|1|||
127603548|NCT03721276|459177042|FG000|Overall Study|Lost to Follow-up|5|||
127603549|NCT03721276|459177043|FG001|Overall Study|Lost to Follow-up|3|||
127603550|NCT03721276|459177042|FG000|Overall Study|Adverse Event|0|||
127603551|NCT03721276|459177043|FG001|Overall Study|Adverse Event|1|||
127603552|NCT00416078|459177049|FG000|Overall Study|Death|3|||
127603553|NCT00416078|459177050|FG001|Overall Study|Death|4|||
127603554|NCT00416078|459177049|FG000|Overall Study|Withdrawal by Subject|3|||
127603555|NCT00416078|459177050|FG001|Overall Study|Withdrawal by Subject|2|||
127603556|NCT00416078|459177049|FG000|Overall Study|Physician Decision|1|||
127603557|NCT00416078|459177050|FG001|Overall Study|Physician Decision|0|||
127603558|NCT00416078|459177049|FG000|Overall Study|Lost to Follow-up|4|||
127603559|NCT00416078|459177050|FG001|Overall Study|Lost to Follow-up|2|||
127603560|NCT01829230|459177058|FG000|Overall Study|Protocol Violation|0|||
127603561|NCT01829230|459177059|FG001|Overall Study|Protocol Violation|2|||
127603562|NCT01829230|459177058|FG000|Overall Study|Withdrawal by Subject|0|||
127603563|NCT01829230|459177059|FG001|Overall Study|Withdrawal by Subject|1|||
127603564|NCT01829230|459177058|FG000|Overall Study|Lost to Follow-up|1|||
127603565|NCT01829230|459177059|FG001|Overall Study|Lost to Follow-up|1|||
127788556|NCT00183274|459851259|FG004|Phase 1: Open-Label|Adverse Event|0|||
127603566|NCT04387435|459177060|FG000|Overall Study|Physician Decision|1|||
127603567|NCT03855280|459177061|FG000|Treatment Phase|Adverse Event|1|||
127603568|NCT03855280|459177061|FG000|Treatment Phase|Withdrawal by Subject|1|||
127603569|NCT03855280|459177061|FG000|Continuation Phase|Protocol Violation|1|||
127603570|NCT03855280|459177061|FG000|Continuation Phase|Adverse Event|1|||
127603571|NCT03855280|459177061|FG000|Continuation Phase|Sponsor Concluded Study|1|||
127603572|NCT00969150|459177069|FG000|Overall Study|Adverse Event|4|||
127603573|NCT00969150|459177070|FG001|Overall Study|Adverse Event|14|||
127603574|NCT00969150|459177069|FG000|Overall Study|Lack of Efficacy|1|||
127603575|NCT00969150|459177070|FG001|Overall Study|Lack of Efficacy|1|||
127603576|NCT00969150|459177069|FG000|Overall Study|Protocol Violation|9|||
127603577|NCT00969150|459177070|FG001|Overall Study|Protocol Violation|12|||
127603578|NCT00969150|459177069|FG000|Overall Study|Withdrawal by Subject|13|||
127603579|NCT00969150|459177070|FG001|Overall Study|Withdrawal by Subject|9|||
127603580|NCT00969150|459177069|FG000|Overall Study|Lost to Follow-up|5|||
127603581|NCT00969150|459177070|FG001|Overall Study|Lost to Follow-up|4|||
127603582|NCT00969150|459177069|FG000|Overall Study|Other reasons|1|||
127603583|NCT00969150|459177070|FG001|Overall Study|Other reasons|0|||
127788557|NCT00183274|459851260|FG005|Phase 1: Open-Label|Adverse Event|0|||
127788558|NCT00183274|459851255|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
127788559|NCT00183274|459851256|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
127788560|NCT00183274|459851257|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
127603584|NCT04128267|459177074|FG000|Overall Study|Withdrawal by Subject|6|||
127603585|NCT04128267|459177074|FG000|Overall Study|Death|2|||
127603586|NCT04128267|459177074|FG000|Overall Study|Disease progression|1|||
127603587|NCT04128267|459177074|FG000|Overall Study|Participant had other medical issues|4|||
127603588|NCT04128267|459177074|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
127603589|NCT01698801|459177075|FG000|Treatment Phase|Adverse Event|4|||
127603590|NCT01698801|459177075|FG000|Treatment Phase|Protocol Violation|1|||
127603591|NCT01698801|459177075|FG000|Treatment Phase|Other|4|||
127603592|NCT01698801|459177075|FG000|Treatment Phase|Withdrawal by Subject|1|||
127603593|NCT01698801|459177075|FG000|Treatment Phase|Disease progression|1|||
127603594|NCT01698801|459177075|FG000|Follow Up Phase|Withdrawal by Subject|1|||
127603595|NCT01698801|459177075|FG000|Follow Up Phase|Death|4|||
127603596|NCT01614067|459177077|FG000|Overall Study|Pregnancy|1|||
127603597|NCT01614067|459177078|FG001|Overall Study|Pregnancy|0|||
127603598|NCT01614067|459177077|FG000|Overall Study|Physician Decision|6|||
127603599|NCT01614067|459177078|FG001|Overall Study|Physician Decision|5|||
127603600|NCT01614067|459177077|FG000|Overall Study|Withdrawal by Subject|0|||
127603601|NCT01614067|459177078|FG001|Overall Study|Withdrawal by Subject|1|||
127603602|NCT01614067|459177077|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
127603603|NCT01614067|459177078|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
127603604|NCT01505868|459177079|FG000|Overall Study|Withdrawal by Subject|1|||
127603605|NCT01505868|459177080|FG001|Overall Study|Withdrawal by Subject|0|||
127603606|NCT01505868|459177081|FG002|Overall Study|Withdrawal by Subject|0|||
127603607|NCT01505868|459177082|FG003|Overall Study|Withdrawal by Subject|0|||
127603608|NCT01505868|459177083|FG004|Overall Study|Withdrawal by Subject|0|||
127603609|NCT00680043|459177084|FG000|Overall Study|Withdrawal by Subject|1|||
127603610|NCT00680043|459177085|FG001|Overall Study|Withdrawal by Subject|0|||
127603611|NCT00680043|459177086|FG002|Overall Study|Withdrawal by Subject|0|||
127603612|NCT00680043|459177084|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
127603613|NCT00680043|459177085|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
127603614|NCT00680043|459177086|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
127603615|NCT00680043|459177084|FG000|Overall Study|Renal Transplant|1|||
127603616|NCT00680043|459177085|FG001|Overall Study|Renal Transplant|0|||
127603617|NCT00680043|459177086|FG002|Overall Study|Renal Transplant|4|||
127603618|NCT00195676|459177088|FG000|Period O - Open-label Treatment|Adverse Event|82|||
127603619|NCT00195676|459177088|FG000|Period O - Open-label Treatment|Death|6|||
127603620|NCT00195676|459177088|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
127603621|NCT00195676|459177088|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
127603622|NCT00195676|459177088|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
127603623|NCT00195676|459177088|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
127788561|NCT00183274|459851258|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
127788562|NCT00183274|459851259|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
127603624|NCT00195676|459177088|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
127603625|NCT00195676|459177088|FG000|Period O - Open-label Treatment|Other reasons|68|||
127603626|NCT00195676|459177088|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
127603627|NCT00195676|459177088|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
127603628|NCT00195676|459177088|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
127603629|NCT00195676|459177088|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
127603630|NCT00195676|459177088|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
127603631|NCT00195676|459177088|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
127603632|NCT00195676|459177088|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
127603633|NCT00195676|459177088|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
127603634|NCT00195676|459177088|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
127603635|NCT00195676|459177088|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
127603636|NCT00195676|459177088|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
127603637|NCT00195676|459177088|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
127603638|NCT00195676|459177088|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
127603639|NCT01189812|459177089|FG000|Overall Study|Withdrawal by Subject|2|||
127603640|NCT01189812|459177090|FG001|Overall Study|Withdrawal by Subject|3|||
127603641|NCT01189812|459177089|FG000|Overall Study|Adverse Event|1|||
127603642|NCT01189812|459177090|FG001|Overall Study|Adverse Event|0|||
127603643|NCT01189812|459177089|FG000|Overall Study|Out of Window|4|||
127603644|NCT01189812|459177090|FG001|Overall Study|Out of Window|3|||
127603645|NCT01189812|459177089|FG000|Overall Study|Moved out of State|1|||
127603646|NCT01189812|459177090|FG001|Overall Study|Moved out of State|2|||
127603647|NCT00616655|459177091|FG000|Overall Study|Adverse Event|10|||
127603648|NCT00616655|459177092|FG001|Overall Study|Adverse Event|7|||
127603649|NCT00616655|459177093|FG002|Overall Study|Adverse Event|12|||
127603650|NCT00616655|459177091|FG000|Overall Study|Lack of Efficacy|5|||
127603651|NCT00616655|459177092|FG001|Overall Study|Lack of Efficacy|5|||
127603652|NCT00616655|459177093|FG002|Overall Study|Lack of Efficacy|5|||
127603653|NCT00616655|459177091|FG000|Overall Study|Lost to Follow-up|3|||
127603654|NCT00616655|459177092|FG001|Overall Study|Lost to Follow-up|12|||
127603655|NCT00616655|459177093|FG002|Overall Study|Lost to Follow-up|10|||
127603656|NCT00616655|459177091|FG000|Overall Study|Protocol Violation|2|||
127603657|NCT00616655|459177092|FG001|Overall Study|Protocol Violation|4|||
127603658|NCT00616655|459177093|FG002|Overall Study|Protocol Violation|3|||
127603659|NCT00616655|459177091|FG000|Overall Study|Withdrawal by Subject|9|||
127603660|NCT00616655|459177092|FG001|Overall Study|Withdrawal by Subject|7|||
127603661|NCT00616655|459177093|FG002|Overall Study|Withdrawal by Subject|11|||
127603662|NCT00616655|459177091|FG000|Overall Study|Does not meet in/ex criteria|0|||
127603663|NCT00616655|459177092|FG001|Overall Study|Does not meet in/ex criteria|0|||
127603664|NCT00616655|459177093|FG002|Overall Study|Does not meet in/ex criteria|2|||
127603665|NCT00616655|459177091|FG000|Overall Study|Other|6|||
127603666|NCT00616655|459177092|FG001|Overall Study|Other|6|||
127603667|NCT00616655|459177093|FG002|Overall Study|Other|5|||
127603668|NCT03761147|459177094|FG000|Overall Study|Withdrawal by Subject|6|||
127603669|NCT03761147|459177095|FG001|Overall Study|Withdrawal by Subject|1|||
127603670|NCT03761147|459177094|FG000|Overall Study|Adverse Event|1|||
127603671|NCT03761147|459177095|FG001|Overall Study|Adverse Event|3|||
127603672|NCT00309842|459177097|FG000|Overall Study|Lost to Follow-up|1|||
127603673|NCT02045797|459177098|FG000|Overall Study|Adverse Event|3|||
127603674|NCT02045797|459177099|FG001|Overall Study|Adverse Event|1|||
127603675|NCT02045797|459177100|FG002|Overall Study|Adverse Event|0|||
127603676|NCT02045797|459177098|FG000|Overall Study|Lack of Efficacy|1|||
127603677|NCT02045797|459177099|FG001|Overall Study|Lack of Efficacy|0|||
127603678|NCT02045797|459177100|FG002|Overall Study|Lack of Efficacy|0|||
127603679|NCT02045797|459177098|FG000|Overall Study|Lost to Follow-up|2|||
127603680|NCT02045797|459177099|FG001|Overall Study|Lost to Follow-up|3|||
127603681|NCT02045797|459177100|FG002|Overall Study|Lost to Follow-up|1|||
127603682|NCT02045797|459177098|FG000|Overall Study|Physician Decision|0|||
127603683|NCT02045797|459177099|FG001|Overall Study|Physician Decision|1|||
127603684|NCT02045797|459177100|FG002|Overall Study|Physician Decision|0|||
127603685|NCT02045797|459177098|FG000|Overall Study|Withdrawal by Subject|1|||
127603686|NCT02045797|459177099|FG001|Overall Study|Withdrawal by Subject|2|||
127603687|NCT02045797|459177100|FG002|Overall Study|Withdrawal by Subject|0|||
127603688|NCT03232281|459178570|FG000|Overall Study|Adverse Event|1|||
127603689|NCT03232281|459178571|FG001|Overall Study|Adverse Event|1|||
127603690|NCT03232281|459178570|FG000|Overall Study|Withdrawal by Subject|5|||
127603691|NCT03232281|459178571|FG001|Overall Study|Withdrawal by Subject|4|||
127603692|NCT03232281|459178570|FG000|Overall Study|Protocol Deviation|1|||
127603693|NCT03232281|459178571|FG001|Overall Study|Protocol Deviation|1|||
127603694|NCT00174915|459178573|FG000|Overall Study|Lost to Follow-up|19|||
127603695|NCT00174915|459178574|FG001|Overall Study|Lost to Follow-up|17|||
127603696|NCT00174915|459178575|FG002|Overall Study|Lost to Follow-up|9|||
127603697|NCT00174915|459178576|FG003|Overall Study|Lost to Follow-up|17|||
127603698|NCT00174915|459178577|FG004|Overall Study|Lost to Follow-up|10|||
127603699|NCT00174915|459178573|FG000|Overall Study|Adverse Event|18|||
127603700|NCT00174915|459178574|FG001|Overall Study|Adverse Event|16|||
127603701|NCT00174915|459178575|FG002|Overall Study|Adverse Event|11|||
127603702|NCT00174915|459178576|FG003|Overall Study|Adverse Event|18|||
127603703|NCT00174915|459178577|FG004|Overall Study|Adverse Event|5|||
127603704|NCT00174915|459178573|FG000|Overall Study|Personal Reason(s)|16|||
127603705|NCT00174915|459178574|FG001|Overall Study|Personal Reason(s)|16|||
127603706|NCT00174915|459178575|FG002|Overall Study|Personal Reason(s)|9|||
127603707|NCT00174915|459178576|FG003|Overall Study|Personal Reason(s)|9|||
127603708|NCT00174915|459178577|FG004|Overall Study|Personal Reason(s)|9|||
127603709|NCT00174915|459178573|FG000|Overall Study|Other|15|||
127603710|NCT00174915|459178574|FG001|Overall Study|Other|8|||
127603711|NCT00174915|459178575|FG002|Overall Study|Other|6|||
127603712|NCT00174915|459178576|FG003|Overall Study|Other|5|||
127603713|NCT00174915|459178577|FG004|Overall Study|Other|3|||
127603714|NCT00174915|459178573|FG000|Overall Study|Gout Flare|13|||
127603715|NCT00174915|459178574|FG001|Overall Study|Gout Flare|6|||
127603716|NCT00174915|459178575|FG002|Overall Study|Gout Flare|8|||
127603717|NCT00174915|459178576|FG003|Overall Study|Gout Flare|1|||
127603718|NCT00174915|459178577|FG004|Overall Study|Gout Flare|0|||
127603719|NCT00174915|459178573|FG000|Overall Study|Protocol Violation|6|||
127603720|NCT00174915|459178574|FG001|Overall Study|Protocol Violation|3|||
127603721|NCT00174915|459178575|FG002|Overall Study|Protocol Violation|3|||
127603722|NCT00174915|459178576|FG003|Overall Study|Protocol Violation|6|||
127603723|NCT00174915|459178577|FG004|Overall Study|Protocol Violation|3|||
127603724|NCT00174915|459178573|FG000|Overall Study|Therapeutic Failure|6|||
127882868|NCT01682512|460194598|FG000|Overall Study|Primary lack of efficacy|10|||
127882869|NCT01682512|460194599|FG001|Overall Study|Primary lack of efficacy|7|||
127603725|NCT00174915|459178574|FG001|Overall Study|Therapeutic Failure|3|||
127603726|NCT00174915|459178575|FG002|Overall Study|Therapeutic Failure|2|||
127603727|NCT00174915|459178576|FG003|Overall Study|Therapeutic Failure|1|||
127603728|NCT00174915|459178577|FG004|Overall Study|Therapeutic Failure|3|||
127603729|NCT03060447|459178582|FG000|Overall Study|Withdrawal by Subject|2|||
127603730|NCT03060447|459178583|FG001|Overall Study|Withdrawal by Subject|0|||
127603731|NCT00778700|459178584|FG000|Overall Study|Adverse Event|6|||
127603732|NCT00778700|459178585|FG001|Overall Study|Adverse Event|1|||
127603733|NCT00778700|459178586|FG002|Overall Study|Adverse Event|3|||
127603734|NCT00778700|459178587|FG003|Overall Study|Adverse Event|5|||
127603735|NCT00778700|459178584|FG000|Overall Study|Protocol Violation|1|||
127603736|NCT00778700|459178585|FG001|Overall Study|Protocol Violation|1|||
127603737|NCT00778700|459178586|FG002|Overall Study|Protocol Violation|0|||
127603738|NCT00778700|459178587|FG003|Overall Study|Protocol Violation|0|||
127603739|NCT00778700|459178584|FG000|Overall Study|Subject Withdrew Consent|6|||
127603740|NCT00778700|459178585|FG001|Overall Study|Subject Withdrew Consent|4|||
127603741|NCT00778700|459178586|FG002|Overall Study|Subject Withdrew Consent|1|||
127603742|NCT00778700|459178587|FG003|Overall Study|Subject Withdrew Consent|4|||
127603743|NCT00778700|459178584|FG000|Overall Study|Lost to Follow-up|3|||
127603744|NCT00778700|459178585|FG001|Overall Study|Lost to Follow-up|1|||
127603745|NCT00778700|459178586|FG002|Overall Study|Lost to Follow-up|0|||
127603746|NCT00778700|459178587|FG003|Overall Study|Lost to Follow-up|1|||
127603747|NCT00778700|459178584|FG000|Overall Study|Reason not Specified|2|||
127603748|NCT00778700|459178585|FG001|Overall Study|Reason not Specified|0|||
127603749|NCT00778700|459178586|FG002|Overall Study|Reason not Specified|1|||
127603750|NCT00778700|459178587|FG003|Overall Study|Reason not Specified|3|||
127603751|NCT00778700|459178584|FG000|Overall Study|Other|0|||
127603752|NCT00778700|459178585|FG001|Overall Study|Other|0|||
127603753|NCT00778700|459178586|FG002|Overall Study|Other|1|||
127603754|NCT00778700|459178587|FG003|Overall Study|Other|0|||
127603755|NCT04267133|459178591|FG000|Overall Study|Withdrawal by Subject|1|||
127603756|NCT04267133|459178591|FG000|Overall Study|Adverse Event|4|||
127603757|NCT00742001|459178595|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
127603758|NCT00742001|459178596|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
127603759|NCT00742001|459178597|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
127603760|NCT01050257|459178602|FG000|Overall Study|Adverse Event|4|||
127603761|NCT01050257|459178603|FG001|Overall Study|Adverse Event|4|||
127603762|NCT01050257|459178604|FG002|Overall Study|Adverse Event|2|||
127603763|NCT01050257|459178602|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
127603764|NCT01050257|459178603|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
127603765|NCT01050257|459178604|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
127603766|NCT01050257|459178602|FG000|Overall Study|Withdrawal by Subject|0|||
127603767|NCT01050257|459178603|FG001|Overall Study|Withdrawal by Subject|3|||
127603768|NCT01050257|459178604|FG002|Overall Study|Withdrawal by Subject|0|||
127603769|NCT01050257|459178602|FG000|Overall Study|No reason specified|0|||
127603770|NCT01050257|459178603|FG001|Overall Study|No reason specified|0|||
127603771|NCT01050257|459178604|FG002|Overall Study|No reason specified|2|||
127603772|NCT01050257|459178602|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
127603773|NCT01050257|459178603|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
127696699|NCT04169373|459517855|FG001|Week 1 to Week 14|Adverse Event|0|||
127788563|NCT00183274|459851260|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
127788564|NCT00183274|459851255|FG000|Phase 1: Open-Label|Protocol Violation|11|||
127788565|NCT00183274|459851256|FG001|Phase 1: Open-Label|Protocol Violation|0|||
127788566|NCT00183274|459851257|FG002|Phase 1: Open-Label|Protocol Violation|0|||
127788567|NCT00183274|459851258|FG003|Phase 1: Open-Label|Protocol Violation|0|||
127788568|NCT00183274|459851259|FG004|Phase 1: Open-Label|Protocol Violation|0|||
127788569|NCT00183274|459851260|FG005|Phase 1: Open-Label|Protocol Violation|0|||
127788570|NCT00183274|459851255|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
127788571|NCT00183274|459851256|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
127603774|NCT01050257|459178604|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
127603775|NCT01050257|459178602|FG000|Overall Study|Violation criteria|0|||
127603776|NCT01050257|459178603|FG001|Overall Study|Violation criteria|1|||
127603777|NCT01050257|459178604|FG002|Overall Study|Violation criteria|0|||
127603778|NCT01050257|459178602|FG000|Overall Study|Failure to return|0|||
127603779|NCT01050257|459178603|FG001|Overall Study|Failure to return|2|||
127603780|NCT01050257|459178604|FG002|Overall Study|Failure to return|0|||
127603781|NCT01050257|459178602|FG000|Overall Study|Death|0|||
127603782|NCT01050257|459178603|FG001|Overall Study|Death|0|||
127603783|NCT01050257|459178604|FG002|Overall Study|Death|1|||
127603784|NCT00278109|459178606|FG000|Overall Study|Adverse Event|3|||
127603785|NCT00278109|459178606|FG000|Overall Study|social circumstances|1|||
127603786|NCT02580357|459178607|FG000|Overall Study|Lost to Follow-up|2|||
127603787|NCT02580357|459178608|FG001|Overall Study|Lost to Follow-up|0|||
127603788|NCT02580357|459178609|FG002|Overall Study|Lost to Follow-up|0|||
127603789|NCT02580357|459178607|FG000|Overall Study|Protocol Violation|1|||
127603790|NCT02580357|459178608|FG001|Overall Study|Protocol Violation|0|||
127603791|NCT02580357|459178609|FG002|Overall Study|Protocol Violation|0|||
127603792|NCT02064166|459178610|FG000|Overall Study|Adverse Event|1|||
127603793|NCT02064166|459178611|FG001|Overall Study|Adverse Event|0|||
127603794|NCT00383149|459178612|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
127603795|NCT00383149|459178612|FG000|Overall Study|Death|2|||
127603796|NCT00383149|459178612|FG000|Overall Study|Disease Progression|38|||
127696700|NCT04169373|459517856|FG002|Week 1 to Week 14|Adverse Event|1|||
127696701|NCT04169373|459517857|FG003|Week 1 to Week 14|Adverse Event|2|||
127696702|NCT04169373|459517854|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
127696703|NCT04169373|459517855|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
127696704|NCT04169373|459517856|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
127696705|NCT04169373|459517857|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
127696706|NCT04169373|459517854|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
127696707|NCT04169373|459517855|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
127696708|NCT04169373|459517856|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
127696709|NCT04169373|459517857|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
127696710|NCT04169373|459517854|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
127696711|NCT04169373|459517855|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
127696712|NCT04169373|459517856|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
127696713|NCT04169373|459517857|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
127696714|NCT04169373|459517854|FG000|Week 1 to Week 14|Other|1|||
127696715|NCT04169373|459517855|FG001|Week 1 to Week 14|Other|3|||
127696716|NCT04169373|459517856|FG002|Week 1 to Week 14|Other|3|||
127696717|NCT04169373|459517857|FG003|Week 1 to Week 14|Other|5|||
127696718|NCT04169373|459517854|FG000|Week 14 to Week 52|Adverse Event|1|||
127696719|NCT04169373|459517855|FG001|Week 14 to Week 52|Adverse Event|0|||
127696720|NCT04169373|459517856|FG002|Week 14 to Week 52|Adverse Event|0|||
127696721|NCT04169373|459517857|FG003|Week 14 to Week 52|Adverse Event|1|||
127696722|NCT04169373|459517854|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
127696723|NCT04169373|459517855|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
127788572|NCT00183274|459851257|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
127788573|NCT00183274|459851258|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
127603797|NCT00383149|459178612|FG000|Overall Study|Lost to Follow-up|1|||
127788574|NCT00183274|459851259|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
127603798|NCT00383149|459178612|FG000|Overall Study|Other|1|||
127603799|NCT00383149|459178612|FG000|Overall Study|Study Drug Toxicity|4|||
127603800|NCT00383149|459178612|FG000|Overall Study|Request to Discontinue Treatment|4|||
127603801|NCT00383149|459178612|FG000|Overall Study|Participant Withdrew Consent|1|||
127696724|NCT04169373|459517856|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
127696725|NCT04169373|459517857|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
127696726|NCT04169373|459517854|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
127603802|NCT02457910|459178623|FG000|Overall Study|Withdrawal by Subject|0|||
127603803|NCT02457910|459178624|FG001|Overall Study|Withdrawal by Subject|0|||
127696727|NCT04169373|459517855|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
127696728|NCT04169373|459517856|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
127696729|NCT04169373|459517857|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
127696730|NCT04169373|459517854|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
127696731|NCT04169373|459517855|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
127696732|NCT04169373|459517856|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
127696733|NCT04169373|459517857|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
127696734|NCT04169373|459517854|FG000|Week 14 to Week 52|Other|4|||
127696735|NCT04169373|459517855|FG001|Week 14 to Week 52|Other|5|||
127696736|NCT04169373|459517856|FG002|Week 14 to Week 52|Other|4|||
127696737|NCT04169373|459517857|FG003|Week 14 to Week 52|Other|5|||
127696738|NCT04169373|459517854|FG000|Week 14 to Week 52|Ongoing|0|||
127696739|NCT04169373|459517855|FG001|Week 14 to Week 52|Ongoing|1|||
127696740|NCT04169373|459517856|FG002|Week 14 to Week 52|Ongoing|0|||
127696741|NCT04169373|459517857|FG003|Week 14 to Week 52|Ongoing|0|||
127696742|NCT04610892|459517858|FG000|Overall Study|Adverse Event|1|||
127696743|NCT04610892|459517859|FG001|Overall Study|Adverse Event|0|||
127696744|NCT04610892|459517860|FG002|Overall Study|Adverse Event|0|||
127696745|NCT04610892|459517861|FG003|Overall Study|Adverse Event|1|||
127696746|NCT04610892|459517862|FG004|Overall Study|Adverse Event|3|||
127696747|NCT04610892|459517858|FG000|Overall Study|Death|0|||
127696748|NCT04610892|459517859|FG001|Overall Study|Death|1|||
127696749|NCT04610892|459517860|FG002|Overall Study|Death|0|||
127696750|NCT04610892|459517861|FG003|Overall Study|Death|1|||
127696751|NCT04610892|459517862|FG004|Overall Study|Death|0|||
127696752|NCT04610892|459517858|FG000|Overall Study|Withdrawal by Subject|3|||
127696753|NCT04610892|459517859|FG001|Overall Study|Withdrawal by Subject|2|||
127696754|NCT04610892|459517860|FG002|Overall Study|Withdrawal by Subject|0|||
127696755|NCT04610892|459517861|FG003|Overall Study|Withdrawal by Subject|6|||
127696756|NCT04610892|459517862|FG004|Overall Study|Withdrawal by Subject|6|||
127696757|NCT04610892|459517858|FG000|Overall Study|Subjects who did not receive treatment|1|||
127696758|NCT04610892|459517859|FG001|Overall Study|Subjects who did not receive treatment|0|||
127696759|NCT04610892|459517860|FG002|Overall Study|Subjects who did not receive treatment|0|||
127696760|NCT04610892|459517861|FG003|Overall Study|Subjects who did not receive treatment|0|||
127696761|NCT04610892|459517862|FG004|Overall Study|Subjects who did not receive treatment|2|||
127696762|NCT05520190|459517863|FG000|Overall Study|Lost to Follow-up|7|||
127696763|NCT05520190|459517863|FG000|Overall Study|Withdrawal by Subject|2|||
127696764|NCT01999075|459517864|FG000|Overall Study|Lost to Follow-up|0|||
127696765|NCT01999075|459517865|FG001|Overall Study|Lost to Follow-up|2|||
127696766|NCT01999075|459517864|FG000|Overall Study|Withdrawal by Subject|2|||
127696767|NCT01999075|459517865|FG001|Overall Study|Withdrawal by Subject|7|||
127696768|NCT01999075|459517864|FG000|Overall Study|Enrolled in drug trial|3|||
127696769|NCT01999075|459517865|FG001|Overall Study|Enrolled in drug trial|1|||
127696770|NCT01999075|459517864|FG000|Overall Study|Became ineligible|0|||
127696771|NCT01999075|459517865|FG001|Overall Study|Became ineligible|2|||
127696772|NCT03683719|459517866|FG000|Overall Study|Lack of Efficacy|1|||
127696773|NCT03683719|459517867|FG001|Overall Study|Lack of Efficacy|3|||
127696774|NCT03683719|459517868|FG002|Overall Study|Lack of Efficacy|4|||
127696775|NCT03683719|459517869|FG003|Overall Study|Lack of Efficacy|0|||
127696776|NCT03683719|459517870|FG004|Overall Study|Lack of Efficacy|4|||
127696777|NCT03683719|459517866|FG000|Overall Study|Adverse Event|6|||
127696778|NCT03683719|459517867|FG001|Overall Study|Adverse Event|6|||
127696779|NCT03683719|459517868|FG002|Overall Study|Adverse Event|0|||
127696780|NCT03683719|459517869|FG003|Overall Study|Adverse Event|1|||
127696781|NCT03683719|459517870|FG004|Overall Study|Adverse Event|3|||
127696782|NCT03683719|459517866|FG000|Overall Study|Withdrawal by Subject|4|||
127696783|NCT03683719|459517867|FG001|Overall Study|Withdrawal by Subject|4|||
127696784|NCT03683719|459517868|FG002|Overall Study|Withdrawal by Subject|3|||
127696785|NCT03683719|459517869|FG003|Overall Study|Withdrawal by Subject|5|||
127696786|NCT03683719|459517870|FG004|Overall Study|Withdrawal by Subject|5|||
127696787|NCT03683719|459517866|FG000|Overall Study|Lost to Follow-up|1|||
127696788|NCT03683719|459517867|FG001|Overall Study|Lost to Follow-up|0|||
127696789|NCT03683719|459517868|FG002|Overall Study|Lost to Follow-up|0|||
127696790|NCT03683719|459517869|FG003|Overall Study|Lost to Follow-up|1|||
127696791|NCT03683719|459517870|FG004|Overall Study|Lost to Follow-up|1|||
127696792|NCT03683719|459517866|FG000|Overall Study|Other personal reasons|0|||
127696793|NCT03683719|459517867|FG001|Overall Study|Other personal reasons|0|||
127696794|NCT03683719|459517868|FG002|Overall Study|Other personal reasons|1|||
127696795|NCT03683719|459517869|FG003|Overall Study|Other personal reasons|0|||
127696796|NCT03683719|459517870|FG004|Overall Study|Other personal reasons|1|||
127696797|NCT04896476|459517880|FG000|Overall Study|Withdrawal by Subject|1|||
127696798|NCT04896476|459517880|FG000|Overall Study|Lost to Follow-up|2|||
127696799|NCT03476187|459517881|FG000|Overall Study|Protocol Violation|7|||
127696800|NCT03476187|459517881|FG000|Overall Study|Physician Decision|5|||
127696801|NCT03924986|459517882|FG000|Overall Study|Death|57|||
127696802|NCT03924986|459517883|FG001|Overall Study|Death|66|||
127696803|NCT03924986|459517882|FG000|Overall Study|Study Concluded by Sponsor|51|||
127696804|NCT03924986|459517883|FG001|Overall Study|Study Concluded by Sponsor|41|||
127696805|NCT03924986|459517882|FG000|Overall Study|Withdrawal by Subject|15|||
127696806|NCT03924986|459517883|FG001|Overall Study|Withdrawal by Subject|20|||
127696807|NCT03924986|459517882|FG000|Overall Study|Lost to Follow-up|7|||
127696808|NCT03924986|459517883|FG001|Overall Study|Lost to Follow-up|5|||
127696809|NCT03924986|459517882|FG000|Overall Study|Miscellaneous|1|||
127696810|NCT03924986|459517883|FG001|Overall Study|Miscellaneous|0|||
127603804|NCT02457910|459178625|FG002|Overall Study|Withdrawal by Subject|0|||
127603805|NCT02457910|459178626|FG003|Overall Study|Withdrawal by Subject|0|||
127603806|NCT02457910|459178627|FG004|Overall Study|Withdrawal by Subject|0|||
127603807|NCT02457910|459178628|FG005|Overall Study|Withdrawal by Subject|1|||
127603808|NCT02457910|459178623|FG000|Overall Study|Adverse Event|0|||
127603809|NCT02457910|459178624|FG001|Overall Study|Adverse Event|2|||
127603810|NCT02457910|459178625|FG002|Overall Study|Adverse Event|1|||
127603811|NCT02457910|459178626|FG003|Overall Study|Adverse Event|1|||
127603812|NCT02457910|459178627|FG004|Overall Study|Adverse Event|1|||
127603813|NCT02457910|459178628|FG005|Overall Study|Adverse Event|3|||
127603814|NCT02457910|459178623|FG000|Overall Study|Disease progression|3|||
127603815|NCT02457910|459178624|FG001|Overall Study|Disease progression|3|||
127603816|NCT02457910|459178625|FG002|Overall Study|Disease progression|1|||
127603817|NCT02457910|459178626|FG003|Overall Study|Disease progression|1|||
127603818|NCT02457910|459178627|FG004|Overall Study|Disease progression|4|||
127603819|NCT02457910|459178628|FG005|Overall Study|Disease progression|6|||
127603820|NCT02457910|459178623|FG000|Overall Study|Other complicating illness|0|||
127603821|NCT02457910|459178624|FG001|Overall Study|Other complicating illness|0|||
127603822|NCT02457910|459178625|FG002|Overall Study|Other complicating illness|0|||
127603823|NCT02457910|459178626|FG003|Overall Study|Other complicating illness|0|||
127603824|NCT02457910|459178627|FG004|Overall Study|Other complicating illness|0|||
127603825|NCT02457910|459178628|FG005|Overall Study|Other complicating illness|1|||
127696811|NCT05948670|459517885|FG000|Overall Study|Protocol Violation|6|||
127696812|NCT05948670|459517886|FG001|Overall Study|Protocol Violation|8|||
127696813|NCT05948670|459517885|FG000|Overall Study|Withdrawal by Subject|0|||
127696814|NCT05948670|459517886|FG001|Overall Study|Withdrawal by Subject|1|||
127696815|NCT03699709|459517887|FG000|Overall Study|Death|1|||
127696816|NCT03699709|459517888|FG001|Overall Study|Death|2|||
127788575|NCT00183274|459851260|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
127788576|NCT00183274|459851255|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
127788577|NCT00183274|459851256|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
127788578|NCT00183274|459851257|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
127696817|NCT03699709|459517887|FG000|Overall Study|Lost to Follow-up|10|||
127696818|NCT03699709|459517888|FG001|Overall Study|Lost to Follow-up|3|||
127696819|NCT03699709|459517887|FG000|Overall Study|Withdrawal by Subject|5|||
127696820|NCT03699709|459517888|FG001|Overall Study|Withdrawal by Subject|0|||
127696821|NCT03699709|459517887|FG000|Overall Study|incarcerated|1|||
127696822|NCT03699709|459517888|FG001|Overall Study|incarcerated|0|||
127696823|NCT03699709|459517887|FG000|Overall Study|scheduled, but no show|0|||
127696824|NCT03699709|459517888|FG001|Overall Study|scheduled, but no show|1|||
127696825|NCT04562649|459517890|FG000|Overall Study|Withdrawal by Subject|11|||
127696826|NCT04562649|459517891|FG001|Overall Study|Withdrawal by Subject|8|||
127696827|NCT04562649|459517890|FG000|Overall Study|Lost to Follow-up|26|||
127696828|NCT04562649|459517891|FG001|Overall Study|Lost to Follow-up|20|||
127788579|NCT00183274|459851258|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
127788580|NCT00183274|459851259|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
127788581|NCT00183274|459851260|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
127788582|NCT00183274|459851255|FG000|Phase 1: Open-Label|Other|9|||
127788583|NCT00183274|459851256|FG001|Phase 1: Open-Label|Other|0|||
127603826|NCT02457910|459178623|FG000|Overall Study|Death|0|||
127696829|NCT03056040|459517900|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
127696830|NCT03056040|459517901|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
127696831|NCT03056040|459517900|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
127696832|NCT03056040|459517901|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
127696833|NCT03056040|459517900|FG000|Primary Evaluation Period|Pregnancy|0|||
127696834|NCT03056040|459517901|FG001|Primary Evaluation Period|Pregnancy|1|||
127696835|NCT03056040|459517900|FG000|Primary Evaluation Period|Randomized, not treated|1|||
127696836|NCT03056040|459517901|FG001|Primary Evaluation Period|Randomized, not treated|1|||
127603827|NCT02457910|459178624|FG001|Overall Study|Death|0|||
127603828|NCT02457910|459178625|FG002|Overall Study|Death|1|||
127603829|NCT02457910|459178626|FG003|Overall Study|Death|0|||
127603830|NCT02457910|459178627|FG004|Overall Study|Death|0|||
127603831|NCT02457910|459178628|FG005|Overall Study|Death|0|||
127603832|NCT00619801|459178631|FG000|Overall Study|Lack of Efficacy|0|||
127696837|NCT03056040|459517900|FG000|Extension Period|Physician Decision|3|||
127696838|NCT03056040|459517901|FG001|Extension Period|Physician Decision|3|||
127696839|NCT03056040|459517900|FG000|Extension Period|Lost to Follow-up|0|||
127603833|NCT00619801|459178632|FG001|Overall Study|Lack of Efficacy|1|||
127603834|NCT00619801|459178631|FG000|Overall Study|Withdrawal by Subject|1|||
127603835|NCT00619801|459178632|FG001|Overall Study|Withdrawal by Subject|1|||
127603836|NCT00619801|459178631|FG000|Overall Study|Loss of efficacy|0|||
127603837|NCT00619801|459178632|FG001|Overall Study|Loss of efficacy|1|||
127603838|NCT00450333|459178633|FG000|Overall Study|Study terminated|47|||
127603839|NCT00450333|459178634|FG001|Overall Study|Study terminated|54|||
127603840|NCT00450333|459178635|FG002|Overall Study|Study terminated|16|||
127603841|NCT00450333|459178636|FG003|Overall Study|Study terminated|21|||
127603842|NCT00450333|459178633|FG000|Overall Study|Adverse Event|1|||
127603843|NCT00450333|459178634|FG001|Overall Study|Adverse Event|7|||
127603844|NCT00450333|459178635|FG002|Overall Study|Adverse Event|2|||
127603845|NCT00450333|459178636|FG003|Overall Study|Adverse Event|2|||
127603846|NCT00450333|459178633|FG000|Overall Study|Protocol Violation|1|||
127603847|NCT00450333|459178634|FG001|Overall Study|Protocol Violation|0|||
127603848|NCT00450333|459178635|FG002|Overall Study|Protocol Violation|1|||
127603849|NCT00450333|459178636|FG003|Overall Study|Protocol Violation|0|||
127603850|NCT00450333|459178633|FG000|Overall Study|Withdrawal by Subject|1|||
127603851|NCT00450333|459178634|FG001|Overall Study|Withdrawal by Subject|0|||
127603852|NCT00450333|459178635|FG002|Overall Study|Withdrawal by Subject|3|||
127603853|NCT00450333|459178636|FG003|Overall Study|Withdrawal by Subject|0|||
127603854|NCT00450333|459178633|FG000|Overall Study|Kidney transplant|1|||
127603855|NCT00450333|459178634|FG001|Overall Study|Kidney transplant|0|||
127603856|NCT00450333|459178635|FG002|Overall Study|Kidney transplant|1|||
127603857|NCT00450333|459178636|FG003|Overall Study|Kidney transplant|3|||
127603858|NCT00450333|459178633|FG000|Overall Study|Death|3|||
127603859|NCT00450333|459178634|FG001|Overall Study|Death|2|||
127603860|NCT00450333|459178635|FG002|Overall Study|Death|2|||
127603861|NCT00450333|459178636|FG003|Overall Study|Death|2|||
127603862|NCT02375113|459178639|FG000|Overall Study|Undisclosed Reason(s).|1|||
127603863|NCT02375113|459178640|FG001|Overall Study|Undisclosed Reason(s).|1|||
127603864|NCT02375113|459178639|FG000|Overall Study|Poor adherence (<70%).|1|||
127603865|NCT02375113|459178640|FG001|Overall Study|Poor adherence (<70%).|0|||
127603866|NCT02375113|459178639|FG000|Overall Study|Discomfort of ingesting daily protein sh|0|||
127603867|NCT02375113|459178640|FG001|Overall Study|Discomfort of ingesting daily protein sh|1|||
127603868|NCT03338855|459178650|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
127603869|NCT03338855|459178651|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
127603870|NCT00511667|459178652|FG000|Overall Study|Adverse Event|1|||
127603871|NCT00511667|459178653|FG001|Overall Study|Adverse Event|0|||
127603872|NCT00511667|459178652|FG000|Overall Study|Protocol Violation|1|||
127603873|NCT00511667|459178653|FG001|Overall Study|Protocol Violation|1|||
127603874|NCT00511667|459178652|FG000|Overall Study|Withdrawal by Subject|2|||
127603875|NCT00511667|459178653|FG001|Overall Study|Withdrawal by Subject|0|||
127603876|NCT00511667|459178652|FG000|Overall Study|Site terminated|6|||
127603877|NCT00511667|459178653|FG001|Overall Study|Site terminated|1|||
127603878|NCT00511667|459178652|FG000|Overall Study|Other|2|||
127696840|NCT03056040|459517901|FG001|Extension Period|Lost to Follow-up|1|||
127696841|NCT03056040|459517900|FG000|Extension Period|Death|0|||
127696842|NCT03056040|459517901|FG001|Extension Period|Death|3|||
127696843|NCT03056040|459517900|FG000|Extension Period|Withdrawal by Subject|1|||
127696844|NCT03056040|459517901|FG001|Extension Period|Withdrawal by Subject|0|||
127696845|NCT04029688|459517904|FG000|Overall Study|Death|8|||
127696846|NCT04029688|459517905|FG001|Overall Study|Death|3|||
127696847|NCT04029688|459517906|FG002|Overall Study|Death|6|||
127696848|NCT04029688|459517907|FG003|Overall Study|Death|2|||
127696849|NCT04029688|459517908|FG004|Overall Study|Death|5|||
127696850|NCT04029688|459517909|FG005|Overall Study|Death|0|||
127882870|NCT01682512|460194600|FG002|Overall Study|Primary lack of efficacy|7|||
127603879|NCT00511667|459178653|FG001|Overall Study|Other|1|||
127603880|NCT00056407|459178654|FG000|Overall Study|Adverse Event|282|||
127603881|NCT00056407|459178655|FG001|Overall Study|Adverse Event|364|||
127603882|NCT00056407|459178654|FG000|Overall Study|Withdrawal by Subject|377|||
127603883|NCT00056407|459178655|FG001|Overall Study|Withdrawal by Subject|361|||
127603884|NCT00056407|459178654|FG000|Overall Study|Lost to Follow-up|123|||
127603885|NCT00056407|459178655|FG001|Overall Study|Lost to Follow-up|113|||
127603886|NCT00056407|459178654|FG000|Overall Study|Protocol Violation|104|||
127603887|NCT00056407|459178655|FG001|Overall Study|Protocol Violation|95|||
127603888|NCT00056407|459178654|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
127603889|NCT00056407|459178655|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
127603890|NCT00056407|459178654|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
127603891|NCT00056407|459178655|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
127696851|NCT04029688|459517910|FG006|Overall Study|Death|2|||
127603892|NCT00056407|459178654|FG000|Overall Study|Missing|25|||
127603893|NCT00056407|459178655|FG001|Overall Study|Missing|34|||
127603894|NCT01026792|459178656|FG000|Overall Study|Protocol Violation|1|||
127603895|NCT00423150|459178657|FG000|Overall Study|Adverse Event|11|||
127603896|NCT00423150|459178657|FG000|Overall Study|Progression of disease being studied|69|||
127603897|NCT00423150|459178657|FG000|Overall Study|Withdrawal by Subject|1|||
127603898|NCT00423150|459178657|FG000|Overall Study|Non-compliance with protocol|1|||
127603899|NCT00423150|459178657|FG000|Overall Study|Administrative|4|||
127603900|NCT03204305|459178658|FG000|Overall Study|Lost to Follow-up|6|||
127603901|NCT03204305|459178659|FG001|Overall Study|Lost to Follow-up|4|||
127603902|NCT03204305|459178660|FG002|Overall Study|Lost to Follow-up|0|||
127603903|NCT03204305|459178661|FG003|Overall Study|Lost to Follow-up|0|||
127696852|NCT04029688|459517911|FG007|Overall Study|Death|3|||
127696853|NCT04029688|459517904|FG000|Overall Study|Study Terminated by Sponsor|0|||
127696854|NCT04029688|459517905|FG001|Overall Study|Study Terminated by Sponsor|0|||
127696855|NCT04029688|459517906|FG002|Overall Study|Study Terminated by Sponsor|0|||
127696856|NCT04029688|459517907|FG003|Overall Study|Study Terminated by Sponsor|0|||
127696857|NCT04029688|459517908|FG004|Overall Study|Study Terminated by Sponsor|1|||
127696858|NCT04029688|459517909|FG005|Overall Study|Study Terminated by Sponsor|3|||
127696859|NCT04029688|459517910|FG006|Overall Study|Study Terminated by Sponsor|1|||
127696860|NCT04029688|459517911|FG007|Overall Study|Study Terminated by Sponsor|3|||
127696861|NCT04029688|459517904|FG000|Overall Study|Withdrawal by Subject|0|||
127696862|NCT04029688|459517905|FG001|Overall Study|Withdrawal by Subject|0|||
127696863|NCT04029688|459517906|FG002|Overall Study|Withdrawal by Subject|0|||
127696864|NCT04029688|459517907|FG003|Overall Study|Withdrawal by Subject|1|||
127696865|NCT04029688|459517908|FG004|Overall Study|Withdrawal by Subject|0|||
127696866|NCT04029688|459517909|FG005|Overall Study|Withdrawal by Subject|0|||
127696867|NCT04029688|459517910|FG006|Overall Study|Withdrawal by Subject|0|||
127696868|NCT04029688|459517911|FG007|Overall Study|Withdrawal by Subject|0|||
127696869|NCT00450658|459517912|FG000|Overall Study|Adverse Event|24|||
127696870|NCT00450658|459517913|FG001|Overall Study|Adverse Event|15|||
127696871|NCT00450658|459517912|FG000|Overall Study|Withdrawal by Subject|43|||
127696872|NCT00450658|459517913|FG001|Overall Study|Withdrawal by Subject|26|||
127696873|NCT00450658|459517912|FG000|Overall Study|Lost to Follow-up|22|||
127696874|NCT00450658|459517913|FG001|Overall Study|Lost to Follow-up|5|||
127696875|NCT00450658|459517912|FG000|Overall Study|UGI ulcer|33|||
127696876|NCT00450658|459517913|FG001|Overall Study|UGI ulcer|34|||
127696877|NCT00450658|459517912|FG000|Overall Study|misc|21|||
127696878|NCT00450658|459517913|FG001|Overall Study|misc|10|||
127696879|NCT05763823|459517914|FG000|Overall Study|Death|6|||
127696880|NCT05763823|459517914|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
127696881|NCT05763823|459517914|FG000|Overall Study|Withdrawal by Subject|6|||
127696882|NCT01494662|459517917|FG000|Overall Study|Withdrawal by Subject|0|||
127696883|NCT01494662|459517918|FG001|Overall Study|Withdrawal by Subject|0|||
127696884|NCT01494662|459517919|FG002|Overall Study|Withdrawal by Subject|1|||
127696885|NCT01494662|459517920|FG003|Overall Study|Withdrawal by Subject|0|||
127696886|NCT01494662|459517921|FG004|Overall Study|Withdrawal by Subject|0|||
127696887|NCT01494662|459517922|FG005|Overall Study|Withdrawal by Subject|0|||
127696888|NCT01494662|459517923|FG006|Overall Study|Withdrawal by Subject|0|||
127696889|NCT01494662|459517917|FG000|Overall Study|Physician Decision|0|||
127696890|NCT01494662|459517918|FG001|Overall Study|Physician Decision|0|||
127696891|NCT01494662|459517919|FG002|Overall Study|Physician Decision|1|||
127696892|NCT01494662|459517920|FG003|Overall Study|Physician Decision|0|||
127696893|NCT01494662|459517921|FG004|Overall Study|Physician Decision|0|||
127696894|NCT01494662|459517922|FG005|Overall Study|Physician Decision|0|||
127696895|NCT01494662|459517923|FG006|Overall Study|Physician Decision|0|||
127696896|NCT05311384|459517924|FG000|Overall Study|Uncontrolled health conditions|2|||
127696897|NCT05311384|459517924|FG000|Overall Study|Withdrawal by Subject|1|||
127696898|NCT03302494|459517925|FG000|Overall Study|Other|7|||
127696899|NCT03302494|459517926|FG001|Overall Study|Other|4|||
127696900|NCT03302494|459517927|FG002|Overall Study|Other|6|||
127696901|NCT03302494|459517925|FG000|Overall Study|Withdrawal by Subject|10|||
127696902|NCT03302494|459517926|FG001|Overall Study|Withdrawal by Subject|2|||
127696903|NCT03302494|459517927|FG002|Overall Study|Withdrawal by Subject|9|||
127696904|NCT03302494|459517925|FG000|Overall Study|Study Terminated by Sponsor|32|||
127696905|NCT03302494|459517926|FG001|Overall Study|Study Terminated by Sponsor|29|||
127696906|NCT03302494|459517927|FG002|Overall Study|Study Terminated by Sponsor|30|||
127696907|NCT03302494|459517925|FG000|Overall Study|Physician Decision|1|||
127696908|NCT03302494|459517926|FG001|Overall Study|Physician Decision|0|||
127696909|NCT03302494|459517927|FG002|Overall Study|Physician Decision|1|||
127696910|NCT03302494|459517925|FG000|Overall Study|Lost to Follow-up|1|||
127603904|NCT03204305|459178658|FG000|Overall Study|Physician Decision|1|||
127603905|NCT03204305|459178659|FG001|Overall Study|Physician Decision|0|||
127603906|NCT03204305|459178660|FG002|Overall Study|Physician Decision|0|||
127603907|NCT03204305|459178661|FG003|Overall Study|Physician Decision|0|||
127603908|NCT03204305|459178658|FG000|Overall Study|failure to place arterial line|2|||
127603909|NCT03204305|459178659|FG001|Overall Study|failure to place arterial line|1|||
127603910|NCT03204305|459178660|FG002|Overall Study|failure to place arterial line|0|||
127603911|NCT03204305|459178661|FG003|Overall Study|failure to place arterial line|0|||
127603912|NCT03204305|459178658|FG000|Overall Study|Withdrawal by Subject|2|||
127603913|NCT03204305|459178659|FG001|Overall Study|Withdrawal by Subject|0|||
127603914|NCT03204305|459178660|FG002|Overall Study|Withdrawal by Subject|0|||
127603915|NCT03204305|459178661|FG003|Overall Study|Withdrawal by Subject|0|||
127603916|NCT02335099|459178662|FG000|Treatment|Withdrawal by Subject|1|||
127603917|NCT02335099|459178663|FG001|Treatment|Withdrawal by Subject|3|||
127603918|NCT02335099|459178662|FG000|Treatment|Lost to Follow-up|2|||
127603919|NCT02335099|459178663|FG001|Treatment|Lost to Follow-up|0|||
127603920|NCT02335099|459178662|FG000|Treatment|Death|1|||
127603921|NCT02335099|459178663|FG001|Treatment|Death|0|||
127603922|NCT02335099|459178662|FG000|Treatment|Adverse Event|1|||
127603923|NCT02335099|459178663|FG001|Treatment|Adverse Event|2|||
127603924|NCT02335099|459178662|FG000|Follow-up|Death|0|||
127603925|NCT02335099|459178663|FG001|Follow-up|Death|1|||
127603926|NCT00484939|459178666|FG000|Overall Study|Death|9|||
127603927|NCT00484939|459178667|FG001|Overall Study|Death|13|||
127603928|NCT00484939|459178666|FG000|Overall Study|Adverse Event|22|||
127603929|NCT00484939|459178667|FG001|Overall Study|Adverse Event|12|||
127603930|NCT00484939|459178666|FG000|Overall Study|Patient Withdrew Consent|19|||
127603931|NCT00484939|459178667|FG001|Overall Study|Patient Withdrew Consent|10|||
127603932|NCT00484939|459178666|FG000|Overall Study|Protocol Violation|3|||
127603933|NCT00484939|459178667|FG001|Overall Study|Protocol Violation|3|||
127603934|NCT00484939|459178666|FG000|Overall Study|Lost to Follow-up|0|||
127603935|NCT00484939|459178667|FG001|Overall Study|Lost to Follow-up|3|||
127603936|NCT00484939|459178666|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
127603937|NCT00484939|459178667|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
127603938|NCT00484939|459178666|FG000|Overall Study|Disease progression|67|||
127603939|NCT00484939|459178667|FG001|Overall Study|Disease progression|88|||
127603940|NCT00484939|459178666|FG000|Overall Study|Screen Failure|2|||
127603941|NCT00484939|459178667|FG001|Overall Study|Screen Failure|2|||
127603942|NCT00484939|459178666|FG000|Overall Study|Reason Not Specified|11|||
127603943|NCT00484939|459178667|FG001|Overall Study|Reason Not Specified|6|||
127603944|NCT00101907|459178671|FG000|Overall Study|Adverse Event|1|||
127603945|NCT00101907|459178672|FG001|Overall Study|Adverse Event|0|||
127603946|NCT00101907|459178673|FG002|Overall Study|Adverse Event|0|||
127603947|NCT00101907|459178674|FG003|Overall Study|Adverse Event|0|||
127603948|NCT00101907|459178675|FG004|Overall Study|Adverse Event|0|||
127603949|NCT00101907|459178676|FG005|Overall Study|Adverse Event|0|||
127603950|NCT00101907|459178671|FG000|Overall Study|Death|0|||
127603951|NCT00101907|459178672|FG001|Overall Study|Death|1|||
127603952|NCT00101907|459178673|FG002|Overall Study|Death|0|||
127603953|NCT00101907|459178674|FG003|Overall Study|Death|0|||
127603954|NCT00101907|459178675|FG004|Overall Study|Death|3|||
127603955|NCT00101907|459178676|FG005|Overall Study|Death|0|||
127603956|NCT00101907|459178671|FG000|Overall Study|Physician Decision|0|||
127603957|NCT00101907|459178672|FG001|Overall Study|Physician Decision|0|||
127603958|NCT00101907|459178673|FG002|Overall Study|Physician Decision|0|||
127603959|NCT00101907|459178674|FG003|Overall Study|Physician Decision|1|||
127603960|NCT00101907|459178675|FG004|Overall Study|Physician Decision|1|||
127603961|NCT00101907|459178676|FG005|Overall Study|Physician Decision|0|||
127603962|NCT00101907|459178671|FG000|Overall Study|Withdrawal by Subject|1|||
127696911|NCT03302494|459517926|FG001|Overall Study|Lost to Follow-up|3|||
127696912|NCT03302494|459517927|FG002|Overall Study|Lost to Follow-up|3|||
127696913|NCT03302494|459517925|FG000|Overall Study|Death|13|||
127696914|NCT03302494|459517926|FG001|Overall Study|Death|11|||
127696915|NCT03302494|459517927|FG002|Overall Study|Death|4|||
127696916|NCT03302494|459517925|FG000|Overall Study|Adverse Event|1|||
127696917|NCT03302494|459517926|FG001|Overall Study|Adverse Event|2|||
127696918|NCT03302494|459517927|FG002|Overall Study|Adverse Event|0|||
127696919|NCT03302494|459517925|FG000|Overall Study|Randomized but not treated and discontinued during study hold|0|||
127603963|NCT00101907|459178672|FG001|Overall Study|Withdrawal by Subject|0|||
127603964|NCT00101907|459178673|FG002|Overall Study|Withdrawal by Subject|1|||
127603965|NCT00101907|459178674|FG003|Overall Study|Withdrawal by Subject|0|||
127603966|NCT00101907|459178675|FG004|Overall Study|Withdrawal by Subject|1|||
127603967|NCT00101907|459178676|FG005|Overall Study|Withdrawal by Subject|0|||
127696920|NCT03302494|459517926|FG001|Overall Study|Randomized but not treated and discontinued during study hold|2|||
127696921|NCT03302494|459517927|FG002|Overall Study|Randomized but not treated and discontinued during study hold|2|||
127603968|NCT01474876|459178681|FG000|Overall Study|Adverse Event|11|||
127603969|NCT01474876|459178682|FG001|Overall Study|Adverse Event|5|||
127603970|NCT01474876|459178683|FG002|Overall Study|Adverse Event|0|||
127603971|NCT01474876|459178681|FG000|Overall Study|Serious Adverse Event|2|||
127603972|NCT01474876|459178682|FG001|Overall Study|Serious Adverse Event|3|||
127603973|NCT01474876|459178683|FG002|Overall Study|Serious Adverse Event|0|||
127603974|NCT01474876|459178681|FG000|Overall Study|Lost to Follow-up|5|||
127603975|NCT01474876|459178682|FG001|Overall Study|Lost to Follow-up|4|||
127603976|NCT01474876|459178683|FG002|Overall Study|Lost to Follow-up|0|||
127603977|NCT01474876|459178681|FG000|Overall Study|Investigator's decision|28|||
127603978|NCT01474876|459178682|FG001|Overall Study|Investigator's decision|6|||
127603979|NCT01474876|459178683|FG002|Overall Study|Investigator's decision|0|||
127603980|NCT01474876|459178681|FG000|Overall Study|Patient's request|19|||
127603981|NCT01474876|459178682|FG001|Overall Study|Patient's request|5|||
127603982|NCT01474876|459178683|FG002|Overall Study|Patient's request|0|||
127603983|NCT01474876|459178681|FG000|Overall Study|Investigator's decision and pt request|1|||
127603984|NCT01474876|459178682|FG001|Overall Study|Investigator's decision and pt request|0|||
127603985|NCT01474876|459178683|FG002|Overall Study|Investigator's decision and pt request|0|||
127603986|NCT01523886|459178684|FG000|Overall Study|surgery cancelled|0|||
127603987|NCT01523886|459178685|FG001|Overall Study|surgery cancelled|1|||
127603988|NCT01173718|459178695|FG000|Overall Study|Death|17|||
127603989|NCT01173718|459178695|FG000|Overall Study|Abandonment of study graft|27|||
127603990|NCT01367158|459178696|FG000|Overall Study|Withdrew consent|0|||
127603991|NCT01367158|459178697|FG001|Overall Study|Withdrew consent|2|||
127603992|NCT01367158|459178698|FG002|Overall Study|Withdrew consent|1|||
127603993|NCT01367158|459178699|FG003|Overall Study|Withdrew consent|0|||
127603994|NCT01367158|459178700|FG004|Overall Study|Withdrew consent|2|||
127603995|NCT01367158|459178701|FG005|Overall Study|Withdrew consent|0|||
127603996|NCT01367158|459178702|FG006|Overall Study|Withdrew consent|0|||
127603997|NCT01367158|459178703|FG007|Overall Study|Withdrew consent|1|||
127603998|NCT01367158|459178704|FG008|Overall Study|Withdrew consent|0|||
127603999|NCT01367158|459178705|FG009|Overall Study|Withdrew consent|0|||
127604000|NCT01367158|459178706|FG010|Overall Study|Withdrew consent|0|||
127604001|NCT01367158|459178696|FG000|Overall Study|Lost to Follow-up|0|||
127604002|NCT01367158|459178697|FG001|Overall Study|Lost to Follow-up|0|||
127604003|NCT01367158|459178698|FG002|Overall Study|Lost to Follow-up|0|||
127604004|NCT01367158|459178699|FG003|Overall Study|Lost to Follow-up|1|||
127604005|NCT01367158|459178700|FG004|Overall Study|Lost to Follow-up|0|||
127604006|NCT01367158|459178701|FG005|Overall Study|Lost to Follow-up|2|||
127604007|NCT01367158|459178702|FG006|Overall Study|Lost to Follow-up|0|||
127604008|NCT01367158|459178703|FG007|Overall Study|Lost to Follow-up|1|||
127604009|NCT01367158|459178704|FG008|Overall Study|Lost to Follow-up|0|||
127604010|NCT01367158|459178705|FG009|Overall Study|Lost to Follow-up|0|||
127604011|NCT01367158|459178706|FG010|Overall Study|Lost to Follow-up|1|||
127604012|NCT01367158|459178696|FG000|Overall Study|Protocol Violation|0|||
127604013|NCT01367158|459178697|FG001|Overall Study|Protocol Violation|1|||
127604014|NCT01367158|459178698|FG002|Overall Study|Protocol Violation|0|||
127604015|NCT01367158|459178699|FG003|Overall Study|Protocol Violation|0|||
127604016|NCT01367158|459178700|FG004|Overall Study|Protocol Violation|0|||
127604017|NCT01367158|459178701|FG005|Overall Study|Protocol Violation|0|||
127604018|NCT01367158|459178702|FG006|Overall Study|Protocol Violation|0|||
127604019|NCT01367158|459178703|FG007|Overall Study|Protocol Violation|0|||
127604020|NCT01367158|459178704|FG008|Overall Study|Protocol Violation|0|||
127604021|NCT01367158|459178705|FG009|Overall Study|Protocol Violation|0|||
127604022|NCT01367158|459178706|FG010|Overall Study|Protocol Violation|0|||
127604023|NCT02226003|459178707|FG000|Overall Study|Lost to Follow-up|2|||
127604024|NCT02226003|459178708|FG001|Overall Study|Lost to Follow-up|1|||
127604025|NCT02226003|459178709|FG002|Overall Study|Lost to Follow-up|3|||
127604026|NCT02226003|459178707|FG000|Overall Study|Withdrawal by Subject|0|||
127604027|NCT02226003|459178708|FG001|Overall Study|Withdrawal by Subject|0|||
127604028|NCT02226003|459178709|FG002|Overall Study|Withdrawal by Subject|3|||
127604029|NCT04219891|459178716|FG000|Overall Study|Lost to Follow-up|3|||
127604030|NCT04219891|459178716|FG000|Overall Study|Withdrawal by Subject|2|||
127604031|NCT04958785|459180339|FG000|Overall Study|Study Terminated by Sponsor|4|||
127604032|NCT04958785|459180340|FG001|Overall Study|Study Terminated by Sponsor|10|||
127604033|NCT04958785|459180341|FG002|Overall Study|Study Terminated by Sponsor|7|||
127604034|NCT04958785|459180342|FG003|Overall Study|Study Terminated by Sponsor|6|||
127604035|NCT04958785|459180343|FG004|Overall Study|Study Terminated by Sponsor|34|||
127604036|NCT04958785|459180339|FG000|Overall Study|Death|2|||
127604037|NCT04958785|459180340|FG001|Overall Study|Death|3|||
127604038|NCT04958785|459180341|FG002|Overall Study|Death|4|||
127604039|NCT04958785|459180342|FG003|Overall Study|Death|5|||
127604040|NCT04958785|459180343|FG004|Overall Study|Death|5|||
127604041|NCT04958785|459180339|FG000|Overall Study|Withdrew consent|2|||
127604042|NCT04958785|459180340|FG001|Overall Study|Withdrew consent|0|||
127604043|NCT04958785|459180341|FG002|Overall Study|Withdrew consent|3|||
127604044|NCT04958785|459180342|FG003|Overall Study|Withdrew consent|1|||
127604045|NCT04958785|459180343|FG004|Overall Study|Withdrew consent|0|||
127604046|NCT04958785|459180339|FG000|Overall Study|Investigator's discretion|0|||
127604047|NCT04958785|459180340|FG001|Overall Study|Investigator's discretion|1|||
127604048|NCT04958785|459180341|FG002|Overall Study|Investigator's discretion|0|||
127604049|NCT04958785|459180342|FG003|Overall Study|Investigator's discretion|1|||
127604050|NCT04958785|459180343|FG004|Overall Study|Investigator's discretion|2|||
127604051|NCT04958785|459180339|FG000|Overall Study|Adverse Event|0|||
127604052|NCT04958785|459180340|FG001|Overall Study|Adverse Event|0|||
127604053|NCT04958785|459180341|FG002|Overall Study|Adverse Event|0|||
127604054|NCT04958785|459180342|FG003|Overall Study|Adverse Event|0|||
127604055|NCT04958785|459180343|FG004|Overall Study|Adverse Event|1|||
127604056|NCT04958785|459180339|FG000|Overall Study|Lost to Follow-up|0|||
127604057|NCT04958785|459180340|FG001|Overall Study|Lost to Follow-up|0|||
127604058|NCT04958785|459180341|FG002|Overall Study|Lost to Follow-up|0|||
127604059|NCT04958785|459180342|FG003|Overall Study|Lost to Follow-up|0|||
127604060|NCT04958785|459180343|FG004|Overall Study|Lost to Follow-up|1|||
127604061|NCT00587561|459180344|FG000|Overall Study|Lost to Follow-up|6|||
127604062|NCT00587561|459180345|FG001|Overall Study|Lost to Follow-up|4|||
127696922|NCT01573442|459517928|FG000|Overall Study|Cancels|9|||
127696923|NCT01573442|459517929|FG001|Overall Study|Cancels|10|||
127696924|NCT05710107|459517930|FG000|Overall Study|Withdrawal by Subject|1|||
127696925|NCT05710107|459517931|FG001|Overall Study|Withdrawal by Subject|1|||
127696926|NCT05710107|459517930|FG000|Overall Study|Lost to Follow-up|8|||
127696927|NCT05710107|459517931|FG001|Overall Study|Lost to Follow-up|9|||
127696928|NCT05710107|459517930|FG000|Overall Study|Unable to place assigned block|2|||
127696929|NCT05710107|459517931|FG001|Overall Study|Unable to place assigned block|0|||
127696930|NCT05710107|459517930|FG000|Overall Study|Withdrawn by study team|0|||
127696931|NCT05710107|459517931|FG001|Overall Study|Withdrawn by study team|1|||
127696932|NCT04055090|459517932|FG000|Overall Study|screen failure|1|||
127696933|NCT04055090|459517933|FG001|Overall Study|screen failure|0|||
127696934|NCT04055090|459517932|FG000|Overall Study|Withdrawal by Subject|1|||
127696935|NCT04055090|459517933|FG001|Overall Study|Withdrawal by Subject|0|||
127696936|NCT05071807|459517934|FG000|Overall Study|Withdrawal by Subject|4|||
127696937|NCT05071807|459517935|FG001|Overall Study|Withdrawal by Subject|0|||
127696938|NCT05071807|459517934|FG000|Overall Study|Unrelated medical issues|3|||
127696939|NCT05071807|459517935|FG001|Overall Study|Unrelated medical issues|0|||
127696940|NCT05071807|459517934|FG000|Overall Study|Relocated|0|||
127696941|NCT05071807|459517935|FG001|Overall Study|Relocated|1|||
127696942|NCT05551637|459517936|FG000|Overall Study|Lack of Efficacy|0|||
127696943|NCT05551637|459517937|FG001|Overall Study|Lack of Efficacy|6|||
127696944|NCT05551637|459517936|FG000|Overall Study|Lost to Follow-up|1|||
127696945|NCT05551637|459517937|FG001|Overall Study|Lost to Follow-up|1|||
127696946|NCT05633953|459520062|FG000|Overall Study|Adverse Event|7|||
127696947|NCT05633953|459520062|FG000|Overall Study|Death|30|||
127696948|NCT05633953|459520062|FG000|Overall Study|Lost to Follow-up|1|||
127788584|NCT00183274|459851257|FG002|Phase 1: Open-Label|Other|0|||
127788585|NCT00183274|459851258|FG003|Phase 1: Open-Label|Other|0|||
127788586|NCT00183274|459851259|FG004|Phase 1: Open-Label|Other|0|||
127788587|NCT00183274|459851260|FG005|Phase 1: Open-Label|Other|0|||
127788588|NCT00183274|459851255|FG000|Phase 2: Double-Blind|Relapsed|0|||
127696949|NCT05633953|459520062|FG000|Overall Study|Osilodrostat discontinued|4|||
127696950|NCT05633953|459520062|FG000|Overall Study|Physician Decision|1|||
127696951|NCT05633953|459520062|FG000|Overall Study|Planned surgery related to Cushing Syndrome (CS)|15|||
127788589|NCT00183274|459851256|FG001|Phase 2: Double-Blind|Relapsed|8|||
127788590|NCT00183274|459851257|FG002|Phase 2: Double-Blind|Relapsed|29|||
127696952|NCT05633953|459520062|FG000|Overall Study|Progressive disease|2|||
127696953|NCT05324124|459520063|FG000|Period 1|Withdrawal by Subject|1|||
127696954|NCT05324124|459520064|FG001|Period 1|Withdrawal by Subject|0|||
127788591|NCT00183274|459851258|FG003|Phase 2: Double-Blind|Relapsed|0|||
127604114|NCT03274687|459180376|FG000|Overall Study|Protocol Violation|1|||
127604115|NCT03274687|459180377|FG001|Overall Study|Protocol Violation|1|||
127696955|NCT05324124|459520063|FG000|Period 1|Physician Decision|0|||
127696956|NCT05324124|459520064|FG001|Period 1|Physician Decision|1|||
127696957|NCT02287610|459520065|FG000|Overall Study|Lost to Follow-up|3|||
127696958|NCT02287610|459520065|FG000|Overall Study|Withdrawal by Subject|8|||
127696959|NCT02287610|459520065|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
127696960|NCT05247489|459520073|FG000|Overall Study|Lost to Follow-up|5|||
127696961|NCT05247489|459520074|FG001|Overall Study|Lost to Follow-up|1|||
127696962|NCT05247489|459520073|FG000|Overall Study|Withdrawal by Subject|6|||
127696963|NCT05247489|459520074|FG001|Overall Study|Withdrawal by Subject|7|||
127696964|NCT05247489|459520073|FG000|Overall Study|Withdrawn by Sponsor: Noncompliance|0|||
127696965|NCT05247489|459520074|FG001|Overall Study|Withdrawn by Sponsor: Noncompliance|1|||
127696966|NCT05247489|459520073|FG000|Overall Study|Left Country|1|||
127696967|NCT05247489|459520074|FG001|Overall Study|Left Country|0|||
127696968|NCT05247489|459520073|FG000|Overall Study|Noncompliance with Investigational Product|1|||
127696969|NCT05247489|459520074|FG001|Overall Study|Noncompliance with Investigational Product|0|||
127696970|NCT05247489|459520073|FG000|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|1|||
127696971|NCT05247489|459520074|FG001|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|0|||
127696972|NCT03771898|459520075|FG000|Overall Study|Adverse Event|1|||
127696973|NCT03771898|459520076|FG001|Overall Study|Adverse Event|0|||
127696974|NCT03771898|459520077|FG002|Overall Study|Adverse Event|0|||
127696975|NCT03771898|459520078|FG003|Overall Study|Adverse Event|0|||
127696976|NCT03771898|459520079|FG004|Overall Study|Adverse Event|0|||
127604140|NCT04734652|459180384|FG000|Overall Study|Withdrawal by Subject|2|||
127604141|NCT04734652|459180385|FG001|Overall Study|Withdrawal by Subject|0|||
127604142|NCT04734652|459180384|FG000|Overall Study|Death|0|||
127604143|NCT04734652|459180385|FG001|Overall Study|Death|1|||
127696977|NCT03771898|459520075|FG000|Overall Study|Lost to Follow-up|1|||
127696978|NCT03771898|459520076|FG001|Overall Study|Lost to Follow-up|1|||
127696979|NCT03771898|459520077|FG002|Overall Study|Lost to Follow-up|1|||
127696980|NCT03771898|459520078|FG003|Overall Study|Lost to Follow-up|0|||
127696981|NCT03771898|459520079|FG004|Overall Study|Lost to Follow-up|0|||
127696982|NCT03771898|459520075|FG000|Overall Study|Withdrawal by parent/guardian|1|||
127696983|NCT03771898|459520076|FG001|Overall Study|Withdrawal by parent/guardian|1|||
127696984|NCT03771898|459520077|FG002|Overall Study|Withdrawal by parent/guardian|0|||
127696985|NCT03771898|459520078|FG003|Overall Study|Withdrawal by parent/guardian|0|||
127696986|NCT03771898|459520079|FG004|Overall Study|Withdrawal by parent/guardian|0|||
127696987|NCT03771898|459520075|FG000|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
127696988|NCT03771898|459520076|FG001|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
127696989|NCT03771898|459520077|FG002|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
127696990|NCT03771898|459520078|FG003|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
127696991|NCT03771898|459520079|FG004|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|33|||
127696992|NCT04541706|459520080|FG000|Overall Study|Withdrawal by Subject|3|||
127696993|NCT04541706|459520080|FG000|Overall Study|Progressive disease|33|||
127696994|NCT04541706|459520080|FG000|Overall Study|Physician Decision|1|||
127696995|NCT04541706|459520080|FG000|Overall Study|Lost to Follow-up|2|||
127696996|NCT04541706|459520080|FG000|Overall Study|Death|5|||
127696997|NCT04541706|459520080|FG000|Overall Study|Adverse Event|1|||
127696998|NCT05563246|459520081|FG000|Overall Study|Withdrawal by Subject|1|||
127696999|NCT05563246|459520082|FG001|Overall Study|Withdrawal by Subject|2|||
127697000|NCT05563246|459520083|FG002|Overall Study|Withdrawal by Subject|0|||
127604244|NCT05104476|459180417|FG000|Overall Study|Randomized But Not Treated|1|||
127604245|NCT05104476|459180418|FG001|Overall Study|Randomized But Not Treated|2|||
127604246|NCT05104476|459180417|FG000|Overall Study|Adverse Event|2|||
127604247|NCT05104476|459180418|FG001|Overall Study|Adverse Event|2|||
127604248|NCT05104476|459180417|FG000|Overall Study|Withdrawal by Subject|3|||
127604249|NCT05104476|459180418|FG001|Overall Study|Withdrawal by Subject|3|||
127604250|NCT05104476|459180417|FG000|Overall Study|Other Than Specified|0|||
127604251|NCT05104476|459180418|FG001|Overall Study|Other Than Specified|3|||
127604264|NCT04008030|459180434|FG000|Pre-Treatment|Withdrawal by Subject|0|||
127604265|NCT04008030|459180435|FG001|Pre-Treatment|Withdrawal by Subject|0|||
127604266|NCT04008030|459180436|FG002|Pre-Treatment|Withdrawal by Subject|9|||
127604267|NCT04008030|459180434|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
127604268|NCT04008030|459180435|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
127604269|NCT04008030|459180436|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
127604270|NCT04008030|459180434|FG000|Pre-Treatment|Other reasons|0|||
127604271|NCT04008030|459180435|FG001|Pre-Treatment|Other reasons|1|||
127604272|NCT04008030|459180436|FG002|Pre-Treatment|Other reasons|6|||
127604273|NCT04008030|459180434|FG000|Treatment|Withdrawal by Subject|1|||
127604274|NCT04008030|459180435|FG001|Treatment|Withdrawal by Subject|1|||
127604275|NCT04008030|459180436|FG002|Treatment|Withdrawal by Subject|1|||
127604276|NCT04008030|459180434|FG000|Treatment|Death|2|||
127604277|NCT04008030|459180435|FG001|Treatment|Death|4|||
127604278|NCT04008030|459180436|FG002|Treatment|Death|0|||
127604279|NCT04008030|459180434|FG000|Treatment|Pregnancy|0|||
127604280|NCT04008030|459180435|FG001|Treatment|Pregnancy|1|||
127604281|NCT04008030|459180436|FG002|Treatment|Pregnancy|0|||
127604282|NCT04008030|459180434|FG000|Treatment|Participant no longer meets study criteria|0|||
127604283|NCT04008030|459180435|FG001|Treatment|Participant no longer meets study criteria|1|||
127604284|NCT04008030|459180436|FG002|Treatment|Participant no longer meets study criteria|0|||
127604285|NCT04008030|459180434|FG000|Treatment|Other reasons|5|||
127604286|NCT04008030|459180435|FG001|Treatment|Other reasons|13|||
127604287|NCT04008030|459180436|FG002|Treatment|Other reasons|6|||
127604288|NCT04008030|459180434|FG000|Treatment|Disease Progression|137|||
127604289|NCT04008030|459180435|FG001|Treatment|Disease Progression|82|||
127604290|NCT04008030|459180436|FG002|Treatment|Disease Progression|85|||
127604291|NCT04008030|459180434|FG000|Treatment|Study drug toxicity|28|||
127604292|NCT04008030|459180435|FG001|Treatment|Study drug toxicity|48|||
127604293|NCT04008030|459180436|FG002|Treatment|Study drug toxicity|8|||
127604294|NCT04008030|459180434|FG000|Treatment|Adverse Event unrelated to study drug|28|||
127604295|NCT04008030|459180435|FG001|Treatment|Adverse Event unrelated to study drug|22|||
127604296|NCT04008030|459180436|FG002|Treatment|Adverse Event unrelated to study drug|6|||
127604297|NCT04008030|459180434|FG000|Treatment|Maximum Clinical Benefit|0|||
127604298|NCT04008030|459180435|FG001|Treatment|Maximum Clinical Benefit|1|||
127604299|NCT04008030|459180436|FG002|Treatment|Maximum Clinical Benefit|9|||
127604300|NCT04008030|459180434|FG000|Treatment|On-going treatment|13|||
127604301|NCT04008030|459180435|FG001|Treatment|On-going treatment|20|||
127604302|NCT04008030|459180436|FG002|Treatment|On-going treatment|0|||
127697001|NCT05563246|459520084|FG003|Overall Study|Withdrawal by Subject|0|||
127697002|NCT05563246|459520081|FG000|Overall Study|Protocol Deviation|0|||
127697003|NCT05563246|459520082|FG001|Overall Study|Protocol Deviation|1|||
127697004|NCT05563246|459520083|FG002|Overall Study|Protocol Deviation|0|||
127697005|NCT05563246|459520084|FG003|Overall Study|Protocol Deviation|0|||
127604345|NCT05407675|459180456|FG000|Overall Study|Withdrawal by Subject|0|||
127604346|NCT05407675|459180457|FG001|Overall Study|Withdrawal by Subject|2|||
127604347|NCT05407675|459180458|FG002|Overall Study|Withdrawal by Subject|3|||
127604348|NCT05407675|459180459|FG003|Overall Study|Withdrawal by Subject|5|||
127604349|NCT05407675|459180460|FG004|Overall Study|Withdrawal by Subject|0|||
127604350|NCT05407675|459180461|FG005|Overall Study|Withdrawal by Subject|2|||
127604351|NCT05407675|459180462|FG006|Overall Study|Withdrawal by Subject|0|||
127604352|NCT05407675|459180463|FG007|Overall Study|Withdrawal by Subject|0|||
127604353|NCT05407675|459180464|FG008|Overall Study|Withdrawal by Subject|2|||
127604354|NCT05407675|459180465|FG009|Overall Study|Withdrawal by Subject|0|||
127604355|NCT05407675|459180466|FG010|Overall Study|Withdrawal by Subject|1|||
127604356|NCT05407675|459180467|FG011|Overall Study|Withdrawal by Subject|0|||
127604357|NCT05407675|459180468|FG012|Overall Study|Withdrawal by Subject|0|||
127604358|NCT05407675|459180456|FG000|Overall Study|Site terminated by sponsor|0|||
127604359|NCT05407675|459180457|FG001|Overall Study|Site terminated by sponsor|0|||
127604360|NCT05407675|459180458|FG002|Overall Study|Site terminated by sponsor|1|||
127604361|NCT05407675|459180459|FG003|Overall Study|Site terminated by sponsor|0|||
127604362|NCT05407675|459180460|FG004|Overall Study|Site terminated by sponsor|2|||
127604363|NCT05407675|459180461|FG005|Overall Study|Site terminated by sponsor|0|||
127604364|NCT05407675|459180462|FG006|Overall Study|Site terminated by sponsor|1|||
127604365|NCT05407675|459180463|FG007|Overall Study|Site terminated by sponsor|0|||
127604366|NCT05407675|459180464|FG008|Overall Study|Site terminated by sponsor|0|||
127604367|NCT05407675|459180465|FG009|Overall Study|Site terminated by sponsor|2|||
127604368|NCT05407675|459180466|FG010|Overall Study|Site terminated by sponsor|2|||
127604369|NCT05407675|459180467|FG011|Overall Study|Site terminated by sponsor|2|||
127604370|NCT05407675|459180468|FG012|Overall Study|Site terminated by sponsor|1|||
127604371|NCT05407675|459180456|FG000|Overall Study|Disease Progression|0|||
127604372|NCT05407675|459180457|FG001|Overall Study|Disease Progression|0|||
127604373|NCT05407675|459180458|FG002|Overall Study|Disease Progression|0|||
127604374|NCT05407675|459180459|FG003|Overall Study|Disease Progression|0|||
127604375|NCT05407675|459180460|FG004|Overall Study|Disease Progression|0|||
127604376|NCT05407675|459180461|FG005|Overall Study|Disease Progression|0|||
127604377|NCT05407675|459180462|FG006|Overall Study|Disease Progression|0|||
127604378|NCT05407675|459180463|FG007|Overall Study|Disease Progression|0|||
127604379|NCT05407675|459180464|FG008|Overall Study|Disease Progression|0|||
127604380|NCT05407675|459180465|FG009|Overall Study|Disease Progression|0|||
127604381|NCT05407675|459180466|FG010|Overall Study|Disease Progression|1|||
127604382|NCT05407675|459180467|FG011|Overall Study|Disease Progression|0|||
127604383|NCT05407675|459180468|FG012|Overall Study|Disease Progression|0|||
127604384|NCT05407675|459180456|FG000|Overall Study|Physician Decision|0|||
127604385|NCT05407675|459180457|FG001|Overall Study|Physician Decision|0|||
127604386|NCT05407675|459180458|FG002|Overall Study|Physician Decision|0|||
127604387|NCT05407675|459180459|FG003|Overall Study|Physician Decision|0|||
127604388|NCT05407675|459180460|FG004|Overall Study|Physician Decision|0|||
127604389|NCT05407675|459180461|FG005|Overall Study|Physician Decision|0|||
127604390|NCT05407675|459180462|FG006|Overall Study|Physician Decision|0|||
127604391|NCT05407675|459180463|FG007|Overall Study|Physician Decision|0|||
127604392|NCT05407675|459180464|FG008|Overall Study|Physician Decision|0|||
127604393|NCT05407675|459180465|FG009|Overall Study|Physician Decision|0|||
127604394|NCT05407675|459180466|FG010|Overall Study|Physician Decision|1|||
127604395|NCT05407675|459180467|FG011|Overall Study|Physician Decision|0|||
127604396|NCT05407675|459180468|FG012|Overall Study|Physician Decision|0|||
127604397|NCT05407675|459180456|FG000|Overall Study|Other reasons|0|||
127604398|NCT05407675|459180457|FG001|Overall Study|Other reasons|0|||
127604399|NCT05407675|459180458|FG002|Overall Study|Other reasons|0|||
127604400|NCT05407675|459180459|FG003|Overall Study|Other reasons|0|||
127788592|NCT00183274|459851259|FG004|Phase 2: Double-Blind|Relapsed|0|||
127788593|NCT00183274|459851260|FG005|Phase 2: Double-Blind|Relapsed|0|||
127788594|NCT00183274|459851255|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
127788595|NCT00183274|459851256|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
127788596|NCT00183274|459851257|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
127788597|NCT00183274|459851258|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
127788598|NCT00183274|459851259|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
127788599|NCT00183274|459851260|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
127788600|NCT00183274|459851255|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
127788601|NCT00183274|459851256|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
127788602|NCT00183274|459851257|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
127788603|NCT00183274|459851258|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
127788604|NCT00183274|459851259|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
127788605|NCT00183274|459851260|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
127788606|NCT00183274|459851255|FG000|Phase 3: Double-Blind|Relapsed|0|||
127788607|NCT00183274|459851256|FG001|Phase 3: Double-Blind|Relapsed|0|||
127788608|NCT00183274|459851257|FG002|Phase 3: Double-Blind|Relapsed|0|||
127788609|NCT00183274|459851258|FG003|Phase 3: Double-Blind|Relapsed|1|||
127788610|NCT00183274|459851259|FG004|Phase 3: Double-Blind|Relapsed|11|||
127788611|NCT00183274|459851260|FG005|Phase 3: Double-Blind|Relapsed|2|||
127788612|NCT04081363|459851263|FG000|Overall Study|Withdrawal by Subject|1|||
127788613|NCT04081363|459851264|FG001|Overall Study|Withdrawal by Subject|0|||
127788614|NCT02409290|459851265|FG000|Overall Study|Protocol Violation|3|||
127788615|NCT02409290|459851266|FG001|Overall Study|Protocol Violation|6|||
127788616|NCT02409290|459851267|FG002|Overall Study|Protocol Violation|9|||
127788617|NCT02409290|459851268|FG003|Overall Study|Protocol Violation|4|||
127788618|NCT02409290|459851265|FG000|Overall Study|No positive culture/no baseline sample|3|||
127788619|NCT02409290|459851266|FG001|Overall Study|No positive culture/no baseline sample|9|||
127788620|NCT02409290|459851267|FG002|Overall Study|No positive culture/no baseline sample|6|||
127788621|NCT02409290|459851268|FG003|Overall Study|No positive culture/no baseline sample|5|||
127788622|NCT02409290|459851265|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
127788623|NCT02409290|459851266|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
127788624|NCT02409290|459851267|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
127788625|NCT02409290|459851268|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
127788626|NCT00708500|459851269|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
127788627|NCT00708500|459851270|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
127788628|NCT00708500|459851271|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
127788629|NCT00708500|459851269|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
127788630|NCT00708500|459851270|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
127788631|NCT00708500|459851271|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
127788632|NCT00708500|459851269|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
127604401|NCT05407675|459180460|FG004|Overall Study|Other reasons|0|||
127604402|NCT05407675|459180461|FG005|Overall Study|Other reasons|0|||
127604403|NCT05407675|459180462|FG006|Overall Study|Other reasons|0|||
127604404|NCT05407675|459180463|FG007|Overall Study|Other reasons|0|||
127604405|NCT05407675|459180464|FG008|Overall Study|Other reasons|1|||
127604406|NCT05407675|459180465|FG009|Overall Study|Other reasons|1|||
127604407|NCT05407675|459180466|FG010|Overall Study|Other reasons|1|||
127604408|NCT05407675|459180467|FG011|Overall Study|Other reasons|1|||
127604409|NCT05407675|459180468|FG012|Overall Study|Other reasons|0|||
127604410|NCT05407675|459180456|FG000|Overall Study|Death|3|||
127604411|NCT05407675|459180457|FG001|Overall Study|Death|4|||
127604412|NCT05407675|459180458|FG002|Overall Study|Death|3|||
127604413|NCT05407675|459180459|FG003|Overall Study|Death|6|||
127604414|NCT05407675|459180460|FG004|Overall Study|Death|0|||
127604415|NCT05407675|459180461|FG005|Overall Study|Death|2|||
127604416|NCT05407675|459180462|FG006|Overall Study|Death|4|||
127604417|NCT05407675|459180463|FG007|Overall Study|Death|2|||
127604418|NCT05407675|459180464|FG008|Overall Study|Death|2|||
127604419|NCT05407675|459180465|FG009|Overall Study|Death|4|||
127604420|NCT05407675|459180466|FG010|Overall Study|Death|2|||
127604421|NCT05407675|459180467|FG011|Overall Study|Death|1|||
127604422|NCT05407675|459180468|FG012|Overall Study|Death|0|||
127604423|NCT05407675|459180456|FG000|Overall Study|Adverse Event|0|||
127604424|NCT05407675|459180457|FG001|Overall Study|Adverse Event|0|||
127604425|NCT05407675|459180458|FG002|Overall Study|Adverse Event|0|||
127604426|NCT05407675|459180459|FG003|Overall Study|Adverse Event|0|||
127604427|NCT05407675|459180460|FG004|Overall Study|Adverse Event|1|||
127604428|NCT05407675|459180461|FG005|Overall Study|Adverse Event|0|||
127604429|NCT05407675|459180462|FG006|Overall Study|Adverse Event|0|||
127788633|NCT00708500|459851270|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
127788634|NCT00708500|459851271|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
127788635|NCT00708500|459851269|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
127604430|NCT05407675|459180463|FG007|Overall Study|Adverse Event|0|||
127604431|NCT05407675|459180464|FG008|Overall Study|Adverse Event|0|||
127604432|NCT05407675|459180465|FG009|Overall Study|Adverse Event|0|||
127604433|NCT05407675|459180466|FG010|Overall Study|Adverse Event|0|||
127604434|NCT05407675|459180467|FG011|Overall Study|Adverse Event|1|||
127604435|NCT05407675|459180468|FG012|Overall Study|Adverse Event|0|||
127604436|NCT05407675|459180456|FG000|Overall Study|Ongoing Treatment|0|||
127604437|NCT05407675|459180457|FG001|Overall Study|Ongoing Treatment|0|||
127604438|NCT05407675|459180458|FG002|Overall Study|Ongoing Treatment|0|||
127604439|NCT05407675|459180459|FG003|Overall Study|Ongoing Treatment|0|||
127604440|NCT05407675|459180460|FG004|Overall Study|Ongoing Treatment|0|||
127604441|NCT05407675|459180461|FG005|Overall Study|Ongoing Treatment|0|||
127604442|NCT05407675|459180462|FG006|Overall Study|Ongoing Treatment|0|||
127604443|NCT05407675|459180463|FG007|Overall Study|Ongoing Treatment|0|||
127604444|NCT05407675|459180464|FG008|Overall Study|Ongoing Treatment|1|||
127604445|NCT05407675|459180465|FG009|Overall Study|Ongoing Treatment|0|||
127604446|NCT05407675|459180466|FG010|Overall Study|Ongoing Treatment|0|||
127604447|NCT05407675|459180467|FG011|Overall Study|Ongoing Treatment|0|||
127604448|NCT05407675|459180468|FG012|Overall Study|Ongoing Treatment|0|||
127604449|NCT04191499|459180469|FG000|Overall Study|Adverse Event|1|||
127604450|NCT04191499|459180470|FG001|Overall Study|Adverse Event|0|||
127604451|NCT04191499|459180469|FG000|Overall Study|Death|42|||
127604452|NCT04191499|459180470|FG001|Overall Study|Death|55|||
127604453|NCT04191499|459180469|FG000|Overall Study|Lost to Follow-up|4|||
127604454|NCT04191499|459180470|FG001|Overall Study|Lost to Follow-up|1|||
127604455|NCT04191499|459180469|FG000|Overall Study|Physician Decision|1|||
127604456|NCT04191499|459180470|FG001|Overall Study|Physician Decision|0|||
127604457|NCT04191499|459180469|FG000|Overall Study|Progressive Disease|1|||
127604458|NCT04191499|459180470|FG001|Overall Study|Progressive Disease|0|||
127604459|NCT04191499|459180469|FG000|Overall Study|Symptomatic Deterioration|1|||
127604460|NCT04191499|459180470|FG001|Overall Study|Symptomatic Deterioration|0|||
127604461|NCT04191499|459180469|FG000|Overall Study|Withdrawal by Subject|7|||
127604462|NCT04191499|459180470|FG001|Overall Study|Withdrawal by Subject|11|||
127604463|NCT04191499|459180469|FG000|Overall Study|Ongoing in the study|104|||
127604464|NCT04191499|459180470|FG001|Overall Study|Ongoing in the study|97|||
127604469|NCT01496313|459180476|FG000|Randomized Period (up to 14 Months)|Adverse Event|1|||
127604470|NCT01496313|459180477|FG001|Randomized Period (up to 14 Months)|Adverse Event|5|||
127604471|NCT01496313|459180478|FG002|Randomized Period (up to 14 Months)|Adverse Event|0|||
127604472|NCT01496313|459180479|FG003|Randomized Period (up to 14 Months)|Adverse Event|0|||
127604473|NCT01496313|459180480|FG004|Randomized Period (up to 14 Months)|Adverse Event|0|||
127604474|NCT01496313|459180481|FG005|Randomized Period (up to 14 Months)|Adverse Event|0|||
127604475|NCT01496313|459180476|FG000|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|2|||
127604476|NCT01496313|459180477|FG001|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|3|||
127604477|NCT01496313|459180478|FG002|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
127604478|NCT01496313|459180479|FG003|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
127604479|NCT01496313|459180480|FG004|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
127604480|NCT01496313|459180481|FG005|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
127604481|NCT01496313|459180476|FG000|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
127604482|NCT01496313|459180477|FG001|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|2|||
127604483|NCT01496313|459180478|FG002|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
127604484|NCT01496313|459180479|FG003|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
127604485|NCT01496313|459180480|FG004|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
127604486|NCT01496313|459180481|FG005|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
127604487|NCT01496313|459180476|FG000|Randomized Period (up to 14 Months)|Participant Decision|1|||
127604488|NCT01496313|459180477|FG001|Randomized Period (up to 14 Months)|Participant Decision|3|||
127604489|NCT01496313|459180478|FG002|Randomized Period (up to 14 Months)|Participant Decision|0|||
127604490|NCT01496313|459180479|FG003|Randomized Period (up to 14 Months)|Participant Decision|0|||
127604491|NCT01496313|459180480|FG004|Randomized Period (up to 14 Months)|Participant Decision|0|||
127604492|NCT01496313|459180481|FG005|Randomized Period (up to 14 Months)|Participant Decision|0|||
127604493|NCT01496313|459180476|FG000|Randomized Period (up to 14 Months)|Other|1|||
127604494|NCT01496313|459180477|FG001|Randomized Period (up to 14 Months)|Other|2|||
127604495|NCT01496313|459180478|FG002|Randomized Period (up to 14 Months)|Other|0|||
127604496|NCT01496313|459180479|FG003|Randomized Period (up to 14 Months)|Other|0|||
127604497|NCT01496313|459180480|FG004|Randomized Period (up to 14 Months)|Other|0|||
127604498|NCT01496313|459180481|FG005|Randomized Period (up to 14 Months)|Other|0|||
127604499|NCT01496313|459180476|FG000|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
127604500|NCT01496313|459180477|FG001|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
127604501|NCT01496313|459180478|FG002|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
127604502|NCT01496313|459180479|FG003|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
127604503|NCT01496313|459180480|FG004|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
127604504|NCT01496313|459180481|FG005|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|1|||
127604505|NCT01496313|459180476|FG000|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
127604506|NCT01496313|459180477|FG001|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
127604507|NCT01496313|459180478|FG002|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
127604508|NCT01496313|459180479|FG003|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
127604509|NCT01496313|459180480|FG004|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
127604510|NCT01496313|459180481|FG005|Open-Label Period (Month 14 to 2 Years)|Participant Decision|3|||
127604511|NCT01496313|459180476|FG000|Open-Label Period (Month 14 to 2 Years)|Other|0|||
127604512|NCT01496313|459180477|FG001|Open-Label Period (Month 14 to 2 Years)|Other|0|||
127604513|NCT01496313|459180478|FG002|Open-Label Period (Month 14 to 2 Years)|Other|2|||
127604514|NCT01496313|459180479|FG003|Open-Label Period (Month 14 to 2 Years)|Other|2|||
127604515|NCT01496313|459180480|FG004|Open-Label Period (Month 14 to 2 Years)|Other|1|||
127604516|NCT01496313|459180481|FG005|Open-Label Period (Month 14 to 2 Years)|Other|7|||
127604535|NCT04519645|459180499|FG000|Enrollment Period (Up to 36 Hours)|Adverse Event|1|||
127604536|NCT04519645|459180500|FG001|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
127604537|NCT04519645|459180501|FG002|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
127604538|NCT04519645|459180499|FG000|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|1|||
127604539|NCT04519645|459180500|FG001|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
127604540|NCT04519645|459180501|FG002|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
127604541|NCT04519645|459180499|FG000|Enrollment Period (Up to 36 Hours)|Protocol Violation|1|||
127604542|NCT04519645|459180500|FG001|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
127604543|NCT04519645|459180501|FG002|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
127604544|NCT04519645|459180499|FG000|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
127604545|NCT04519645|459180500|FG001|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|1|||
127788636|NCT00708500|459851270|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
127788637|NCT00708500|459851271|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
127788638|NCT00708500|459851269|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
127788639|NCT00708500|459851270|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
127604546|NCT04519645|459180501|FG002|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
127604547|NCT03742037|459180502|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
127604548|NCT03742037|459180503|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
127604549|NCT03742037|459180504|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
127604550|NCT03742037|459180505|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
127604551|NCT03742037|459180506|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
127604552|NCT03742037|459180507|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
127788640|NCT00708500|459851271|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
127604553|NCT03742037|459180508|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
127604554|NCT03742037|459180502|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
127604555|NCT03742037|459180503|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
127604556|NCT03742037|459180504|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
127604557|NCT03742037|459180505|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
127604558|NCT03742037|459180506|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
127604559|NCT03742037|459180507|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
127604560|NCT03742037|459180508|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
127604561|NCT03742037|459180502|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
127604562|NCT03742037|459180503|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
127604563|NCT03742037|459180504|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
127604564|NCT03742037|459180505|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
127604565|NCT03742037|459180506|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
127604566|NCT03742037|459180507|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
127604567|NCT03742037|459180508|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
127604568|NCT03742037|459180502|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
127604569|NCT03742037|459180503|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
127604570|NCT03742037|459180504|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
127604571|NCT03742037|459180505|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
127604572|NCT03742037|459180506|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
127604573|NCT03742037|459180507|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
127604574|NCT03742037|459180508|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
127604575|NCT03742037|459180502|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
127604576|NCT03742037|459180503|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
127604577|NCT03742037|459180504|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
127604578|NCT03742037|459180505|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
127604579|NCT03742037|459180506|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
127604580|NCT03742037|459180507|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
127604581|NCT03742037|459180508|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
127604582|NCT03742037|459180502|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
127604583|NCT03742037|459180503|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
127604584|NCT03742037|459180504|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
127604585|NCT03742037|459180505|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
127604586|NCT03742037|459180506|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
127604587|NCT03742037|459180507|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
127604588|NCT03742037|459180508|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
127604589|NCT03742037|459180502|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
127604590|NCT03742037|459180503|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
127604591|NCT03742037|459180504|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
127604592|NCT03742037|459180505|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
127604593|NCT03742037|459180506|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
127604594|NCT03742037|459180507|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
127697006|NCT05563246|459520081|FG000|Overall Study|Physician Decision|0|||
127697007|NCT05563246|459520082|FG001|Overall Study|Physician Decision|1|||
127697008|NCT05563246|459520083|FG002|Overall Study|Physician Decision|0|||
127697009|NCT05563246|459520084|FG003|Overall Study|Physician Decision|0|||
127697010|NCT05563246|459520081|FG000|Overall Study|Adverse Event|0|||
127697011|NCT05563246|459520082|FG001|Overall Study|Adverse Event|0|||
127697012|NCT05563246|459520083|FG002|Overall Study|Adverse Event|2|||
127697013|NCT05563246|459520084|FG003|Overall Study|Adverse Event|0|||
127697014|NCT05563246|459520081|FG000|Overall Study|Lost to Follow-up|0|||
127697015|NCT05563246|459520082|FG001|Overall Study|Lost to Follow-up|0|||
127697016|NCT05563246|459520083|FG002|Overall Study|Lost to Follow-up|1|||
127604595|NCT03742037|459180508|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
127604596|NCT03742037|459180502|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
127604597|NCT03742037|459180503|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
127604598|NCT03742037|459180504|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
127604599|NCT03742037|459180505|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
127604600|NCT03742037|459180506|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
127604601|NCT03742037|459180507|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
127604602|NCT03742037|459180508|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
127604603|NCT03742037|459180502|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
127604604|NCT03742037|459180503|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
127604605|NCT03742037|459180504|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
127604606|NCT03742037|459180505|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
127604607|NCT03742037|459180506|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
127604608|NCT03742037|459180507|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
127604609|NCT03742037|459180508|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
127604610|NCT03742037|459180502|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
127604611|NCT03742037|459180503|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
127604612|NCT03742037|459180504|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
127788641|NCT00708500|459851269|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
127788642|NCT00708500|459851270|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
127788643|NCT00708500|459851271|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
127788644|NCT00708500|459851269|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
127788645|NCT00708500|459851270|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
127788646|NCT00708500|459851271|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
127788647|NCT00708500|459851269|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
127788648|NCT00708500|459851270|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
127788649|NCT00708500|459851271|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
127788650|NCT00708500|459851269|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
127788651|NCT00708500|459851270|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
127788652|NCT00708500|459851271|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
127788653|NCT00708500|459851269|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
127788654|NCT00708500|459851270|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
127604613|NCT03742037|459180505|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
127604614|NCT03742037|459180506|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
127604615|NCT03742037|459180507|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
127604616|NCT03742037|459180508|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
127604617|NCT03742037|459180502|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
127604618|NCT03742037|459180503|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
127604619|NCT03742037|459180504|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
127604620|NCT03742037|459180505|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
127604621|NCT03742037|459180506|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
127604622|NCT03742037|459180507|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
127604623|NCT03742037|459180508|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
127604624|NCT03742037|459180502|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
127604625|NCT03742037|459180503|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
127604626|NCT03742037|459180504|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
127604627|NCT03742037|459180505|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
127604628|NCT03742037|459180506|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
127604629|NCT03742037|459180507|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
127604630|NCT03742037|459180508|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
127604631|NCT03742037|459180502|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
127604632|NCT03742037|459180503|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
127604633|NCT03742037|459180504|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
127604634|NCT03742037|459180505|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
127604635|NCT03742037|459180506|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
127604636|NCT03742037|459180507|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
127604637|NCT03742037|459180508|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
127604638|NCT03742037|459180502|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
127604639|NCT03742037|459180503|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
127604640|NCT03742037|459180504|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
127604641|NCT03742037|459180505|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
127604642|NCT03742037|459180506|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
127604643|NCT03742037|459180507|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
127604644|NCT03742037|459180508|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
127604645|NCT03742037|459180502|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
127604646|NCT03742037|459180503|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
127604647|NCT03742037|459180504|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
127604648|NCT03742037|459180505|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
127604649|NCT03742037|459180506|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
127604650|NCT03742037|459180507|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
127604651|NCT03742037|459180508|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
127604652|NCT04447755|459180509|FG000|Overall Study|Death|9|||
127604653|NCT04447755|459180510|FG001|Overall Study|Death|16|||
127604654|NCT04447755|459180511|FG002|Overall Study|Death|8|||
127604655|NCT04447755|459180512|FG003|Overall Study|Death|9|||
127604656|NCT04447755|459180513|FG004|Overall Study|Death|8|||
127604657|NCT04447755|459180514|FG005|Overall Study|Death|9|||
127604658|NCT04447755|459180515|FG006|Overall Study|Death|55|||
127604659|NCT04447755|459180509|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
127604660|NCT04447755|459180510|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
127604661|NCT04447755|459180511|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
127604662|NCT04447755|459180512|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
127604663|NCT04447755|459180513|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
127604664|NCT04447755|459180514|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
127604665|NCT04447755|459180515|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
127604666|NCT04447755|459180509|FG000|Overall Study|Sponsor Decision|0|||
127604667|NCT04447755|459180510|FG001|Overall Study|Sponsor Decision|0|||
127604668|NCT04447755|459180511|FG002|Overall Study|Sponsor Decision|0|||
127604669|NCT04447755|459180512|FG003|Overall Study|Sponsor Decision|0|||
127604670|NCT04447755|459180513|FG004|Overall Study|Sponsor Decision|1|||
127604671|NCT04447755|459180514|FG005|Overall Study|Sponsor Decision|0|||
127604672|NCT04447755|459180515|FG006|Overall Study|Sponsor Decision|10|||
127604673|NCT04447755|459180509|FG000|Overall Study|Lost to Follow-up|0|||
127604674|NCT04447755|459180510|FG001|Overall Study|Lost to Follow-up|0|||
127604675|NCT04447755|459180511|FG002|Overall Study|Lost to Follow-up|0|||
127604676|NCT04447755|459180512|FG003|Overall Study|Lost to Follow-up|0|||
127604677|NCT04447755|459180513|FG004|Overall Study|Lost to Follow-up|0|||
127604678|NCT04447755|459180514|FG005|Overall Study|Lost to Follow-up|0|||
127604679|NCT04447755|459180515|FG006|Overall Study|Lost to Follow-up|1|||
127697017|NCT05563246|459520084|FG003|Overall Study|Lost to Follow-up|0|||
127697018|NCT04927065|459520087|FG000|First Booster|Adverse Event|1|||
127697019|NCT04927065|459520088|FG001|First Booster|Adverse Event|0|||
127697020|NCT04927065|459520089|FG002|First Booster|Adverse Event|0|||
127697021|NCT04927065|459520090|FG003|First Booster|Adverse Event|0|||
127697022|NCT04927065|459520091|FG004|First Booster|Adverse Event|0|||
127697023|NCT04927065|459520092|FG005|First Booster|Adverse Event|0|||
127697024|NCT04927065|459520093|FG006|First Booster|Adverse Event|0|||
127697025|NCT04927065|459520094|FG007|First Booster|Adverse Event|1|||
127697026|NCT04927065|459520095|FG008|First Booster|Adverse Event|0|||
127697027|NCT04927065|459520096|FG009|First Booster|Adverse Event|0|||
127697028|NCT04927065|459520097|FG010|First Booster|Adverse Event|0|||
127697029|NCT04927065|459520098|FG011|First Booster|Adverse Event|0|||
127697030|NCT04927065|459520099|FG012|First Booster|Adverse Event|0|||
127697031|NCT04927065|459520100|FG013|First Booster|Adverse Event|0|||
127697032|NCT04927065|459520101|FG014|First Booster|Adverse Event|0|||
127788655|NCT00708500|459851271|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
127788656|NCT00708500|459851269|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
127788657|NCT00708500|459851270|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
127788658|NCT00708500|459851271|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
127788659|NCT00708500|459851269|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
127788660|NCT00708500|459851270|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
127788661|NCT00708500|459851271|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
127788662|NCT00708500|459851269|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
127788663|NCT00708500|459851270|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
127788664|NCT00708500|459851271|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
127788665|NCT00708500|459851269|FG000|FOLLOWUP|Adverse Event|0|||
127788666|NCT00708500|459851270|FG001|FOLLOWUP|Adverse Event|1|||
127788667|NCT00708500|459851271|FG002|FOLLOWUP|Adverse Event|0|||
127788668|NCT00708500|459851269|FG000|FOLLOWUP|Lost to Follow-up|1|||
127788669|NCT00708500|459851270|FG001|FOLLOWUP|Lost to Follow-up|6|||
127788670|NCT00708500|459851271|FG002|FOLLOWUP|Lost to Follow-up|4|||
127788671|NCT00708500|459851269|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
127788672|NCT00708500|459851270|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
127788673|NCT00708500|459851271|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
127788674|NCT00708500|459851269|FG000|FOLLOWUP|Subject withdrew consent|31|||
127788675|NCT00708500|459851270|FG001|FOLLOWUP|Subject withdrew consent|4|||
127788676|NCT00708500|459851271|FG002|FOLLOWUP|Subject withdrew consent|5|||
127788677|NCT00708500|459851269|FG000|FOLLOWUP|Non-compliance with protocol|5|||
127788678|NCT00708500|459851270|FG001|FOLLOWUP|Non-compliance with protocol|0|||
127788679|NCT00708500|459851271|FG002|FOLLOWUP|Non-compliance with protocol|1|||
127788680|NCT00618410|459851276|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
127788681|NCT00618410|459851277|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
127788682|NCT00705783|459851278|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
127788683|NCT00705783|459851279|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
127788684|NCT00705783|459851280|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
127788685|NCT00705783|459851278|FG000|Conversion Phase|Lost to Follow-up|13|||
127788686|NCT00705783|459851279|FG001|Conversion Phase|Lost to Follow-up|0|||
127788687|NCT00705783|459851280|FG002|Conversion Phase|Lost to Follow-up|0|||
127788688|NCT00705783|459851278|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
127788689|NCT00705783|459851279|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
127788690|NCT00705783|459851280|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
127697033|NCT04927065|459520102|FG015|First Booster|Adverse Event|0|||
127697034|NCT04927065|459520087|FG000|First Booster|Death|1|||
127697035|NCT04927065|459520088|FG001|First Booster|Death|0|||
127697036|NCT04927065|459520089|FG002|First Booster|Death|0|||
127788691|NCT00705783|459851278|FG000|Conversion Phase|Withdrawn by Investigator|4|||
127697037|NCT04927065|459520090|FG003|First Booster|Death|1|||
127697038|NCT04927065|459520091|FG004|First Booster|Death|0|||
127697039|NCT04927065|459520092|FG005|First Booster|Death|1|||
127697040|NCT04927065|459520093|FG006|First Booster|Death|0|||
127697041|NCT04927065|459520094|FG007|First Booster|Death|0|||
127604779|NCT01499563|459181761|FG000|Overall Study|Withdrawal by Subject|10|||
127604780|NCT01499563|459181762|FG001|Overall Study|Withdrawal by Subject|11|||
127604781|NCT01499563|459181763|FG002|Overall Study|Withdrawal by Subject|7|||
127604782|NCT01499563|459181764|FG003|Overall Study|Withdrawal by Subject|8|||
127604783|NCT01499563|459181761|FG000|Overall Study|Physician Decision|2|||
127604784|NCT01499563|459181762|FG001|Overall Study|Physician Decision|1|||
127604785|NCT01499563|459181763|FG002|Overall Study|Physician Decision|3|||
127604786|NCT01499563|459181764|FG003|Overall Study|Physician Decision|0|||
127604787|NCT01499563|459181761|FG000|Overall Study|Specific Request of Sponsor or Investigator|2|||
127604788|NCT01499563|459181762|FG001|Overall Study|Specific Request of Sponsor or Investigator|0|||
127604789|NCT01499563|459181763|FG002|Overall Study|Specific Request of Sponsor or Investigator|1|||
127604790|NCT01499563|459181764|FG003|Overall Study|Specific Request of Sponsor or Investigator|1|||
127604791|NCT01499563|459181761|FG000|Overall Study|Adverse Event|2|||
127604792|NCT01499563|459181762|FG001|Overall Study|Adverse Event|0|||
127604793|NCT01499563|459181763|FG002|Overall Study|Adverse Event|1|||
127604794|NCT01499563|459181764|FG003|Overall Study|Adverse Event|3|||
127604795|NCT01499563|459181761|FG000|Overall Study|Lack of Efficacy|0|||
127604796|NCT01499563|459181762|FG001|Overall Study|Lack of Efficacy|1|||
127604797|NCT01499563|459181763|FG002|Overall Study|Lack of Efficacy|6|||
127604798|NCT01499563|459181764|FG003|Overall Study|Lack of Efficacy|3|||
127604799|NCT01499563|459181761|FG000|Overall Study|Other|8|||
127604800|NCT01499563|459181762|FG001|Overall Study|Other|6|||
127604801|NCT01499563|459181763|FG002|Overall Study|Other|6|||
127604802|NCT01499563|459181764|FG003|Overall Study|Other|4|||
127604812|NCT03279692|459181779|FG000|Overall Study|Withdrawal by Subject|1|||
127604815|NCT05198843|459181784|FG000|Overall Study|Lack of Efficacy|1|||
127697042|NCT04927065|459520095|FG008|First Booster|Death|0|||
127697043|NCT04927065|459520096|FG009|First Booster|Death|0|||
127697044|NCT04927065|459520097|FG010|First Booster|Death|0|||
127697045|NCT04927065|459520098|FG011|First Booster|Death|0|||
127697046|NCT04927065|459520099|FG012|First Booster|Death|0|||
127697047|NCT04927065|459520100|FG013|First Booster|Death|0|||
127697048|NCT04927065|459520101|FG014|First Booster|Death|0|||
127697049|NCT04927065|459520102|FG015|First Booster|Death|0|||
127697050|NCT04927065|459520087|FG000|First Booster|Lost to Follow-up|8|||
127697051|NCT04927065|459520088|FG001|First Booster|Lost to Follow-up|20|||
127697052|NCT04927065|459520089|FG002|First Booster|Lost to Follow-up|0|||
127697053|NCT04927065|459520090|FG003|First Booster|Lost to Follow-up|11|||
127697054|NCT04927065|459520091|FG004|First Booster|Lost to Follow-up|43|||
127697055|NCT04927065|459520092|FG005|First Booster|Lost to Follow-up|30|||
127697056|NCT04927065|459520093|FG006|First Booster|Lost to Follow-up|28|||
127697057|NCT04927065|459520094|FG007|First Booster|Lost to Follow-up|23|||
127697058|NCT04927065|459520095|FG008|First Booster|Lost to Follow-up|4|||
127697059|NCT04927065|459520096|FG009|First Booster|Lost to Follow-up|15|||
127697060|NCT04927065|459520097|FG010|First Booster|Lost to Follow-up|0|||
127697061|NCT04927065|459520098|FG011|First Booster|Lost to Follow-up|0|||
127697062|NCT04927065|459520099|FG012|First Booster|Lost to Follow-up|0|||
127697063|NCT04927065|459520100|FG013|First Booster|Lost to Follow-up|0|||
127697064|NCT04927065|459520101|FG014|First Booster|Lost to Follow-up|0|||
127697065|NCT04927065|459520102|FG015|First Booster|Lost to Follow-up|0|||
127697066|NCT04927065|459520087|FG000|First Booster|Physician Decision|1|||
127697067|NCT04927065|459520088|FG001|First Booster|Physician Decision|0|||
127697068|NCT04927065|459520089|FG002|First Booster|Physician Decision|0|||
127697069|NCT04927065|459520090|FG003|First Booster|Physician Decision|3|||
127697070|NCT04927065|459520091|FG004|First Booster|Physician Decision|1|||
127697071|NCT04927065|459520092|FG005|First Booster|Physician Decision|1|||
127697072|NCT04927065|459520093|FG006|First Booster|Physician Decision|0|||
127697073|NCT04927065|459520094|FG007|First Booster|Physician Decision|3|||
127697074|NCT04927065|459520095|FG008|First Booster|Physician Decision|0|||
127697075|NCT04927065|459520096|FG009|First Booster|Physician Decision|0|||
127697076|NCT04927065|459520097|FG010|First Booster|Physician Decision|0|||
127697077|NCT04927065|459520098|FG011|First Booster|Physician Decision|0|||
127697078|NCT04927065|459520099|FG012|First Booster|Physician Decision|0|||
127697079|NCT04927065|459520100|FG013|First Booster|Physician Decision|0|||
127697080|NCT04927065|459520101|FG014|First Booster|Physician Decision|0|||
127697081|NCT04927065|459520102|FG015|First Booster|Physician Decision|0|||
127697082|NCT04927065|459520087|FG000|First Booster|Protocol Violation|4|||
127697083|NCT04927065|459520088|FG001|First Booster|Protocol Violation|4|||
127697084|NCT04927065|459520089|FG002|First Booster|Protocol Violation|0|||
127697085|NCT04927065|459520090|FG003|First Booster|Protocol Violation|3|||
127697086|NCT04927065|459520091|FG004|First Booster|Protocol Violation|0|||
127697087|NCT04927065|459520092|FG005|First Booster|Protocol Violation|0|||
127697088|NCT04927065|459520093|FG006|First Booster|Protocol Violation|0|||
127697089|NCT04927065|459520094|FG007|First Booster|Protocol Violation|2|||
127697090|NCT04927065|459520095|FG008|First Booster|Protocol Violation|0|||
127697091|NCT04927065|459520096|FG009|First Booster|Protocol Violation|0|||
127697092|NCT04927065|459520097|FG010|First Booster|Protocol Violation|0|||
127697093|NCT04927065|459520098|FG011|First Booster|Protocol Violation|0|||
127697094|NCT04927065|459520099|FG012|First Booster|Protocol Violation|0|||
127697095|NCT04927065|459520100|FG013|First Booster|Protocol Violation|0|||
127697096|NCT04927065|459520101|FG014|First Booster|Protocol Violation|0|||
127697097|NCT04927065|459520102|FG015|First Booster|Protocol Violation|0|||
127697098|NCT04927065|459520087|FG000|First Booster|Withdrawal by Subject|8|||
127697099|NCT04927065|459520088|FG001|First Booster|Withdrawal by Subject|23|||
127697100|NCT04927065|459520089|FG002|First Booster|Withdrawal by Subject|0|||
127697101|NCT04927065|459520090|FG003|First Booster|Withdrawal by Subject|19|||
127697102|NCT04927065|459520091|FG004|First Booster|Withdrawal by Subject|20|||
127697103|NCT04927065|459520092|FG005|First Booster|Withdrawal by Subject|15|||
127697104|NCT04927065|459520093|FG006|First Booster|Withdrawal by Subject|6|||
127697105|NCT04927065|459520094|FG007|First Booster|Withdrawal by Subject|24|||
127697106|NCT04927065|459520095|FG008|First Booster|Withdrawal by Subject|0|||
127697107|NCT04927065|459520096|FG009|First Booster|Withdrawal by Subject|4|||
127697108|NCT04927065|459520097|FG010|First Booster|Withdrawal by Subject|0|||
127697109|NCT04927065|459520098|FG011|First Booster|Withdrawal by Subject|0|||
127697110|NCT04927065|459520099|FG012|First Booster|Withdrawal by Subject|0|||
127697111|NCT04927065|459520100|FG013|First Booster|Withdrawal by Subject|0|||
127697112|NCT04927065|459520101|FG014|First Booster|Withdrawal by Subject|0|||
127697113|NCT04927065|459520102|FG015|First Booster|Withdrawal by Subject|0|||
127697114|NCT04927065|459520087|FG000|First Booster|Other Than Specified|1|||
127697115|NCT04927065|459520088|FG001|First Booster|Other Than Specified|1|||
127697116|NCT04927065|459520089|FG002|First Booster|Other Than Specified|0|||
127697117|NCT04927065|459520090|FG003|First Booster|Other Than Specified|1|||
127697118|NCT04927065|459520091|FG004|First Booster|Other Than Specified|2|||
127697119|NCT04927065|459520092|FG005|First Booster|Other Than Specified|3|||
127697120|NCT04927065|459520093|FG006|First Booster|Other Than Specified|2|||
127697121|NCT04927065|459520094|FG007|First Booster|Other Than Specified|6|||
127697122|NCT04927065|459520095|FG008|First Booster|Other Than Specified|0|||
127697123|NCT04927065|459520096|FG009|First Booster|Other Than Specified|4|||
127697124|NCT04927065|459520097|FG010|First Booster|Other Than Specified|0|||
127697125|NCT04927065|459520098|FG011|First Booster|Other Than Specified|0|||
127697126|NCT04927065|459520099|FG012|First Booster|Other Than Specified|0|||
127697127|NCT04927065|459520100|FG013|First Booster|Other Than Specified|0|||
127697128|NCT04927065|459520101|FG014|First Booster|Other Than Specified|0|||
127697129|NCT04927065|459520102|FG015|First Booster|Other Than Specified|0|||
127697130|NCT04927065|459520087|FG000|Second Booster|Death|0|||
127697131|NCT04927065|459520088|FG001|Second Booster|Death|0|||
127697132|NCT04927065|459520089|FG002|Second Booster|Death|0|||
127697133|NCT04927065|459520090|FG003|Second Booster|Death|0|||
127697134|NCT04927065|459520091|FG004|Second Booster|Death|0|||
127697135|NCT04927065|459520092|FG005|Second Booster|Death|0|||
127697136|NCT04927065|459520093|FG006|Second Booster|Death|0|||
127697137|NCT04927065|459520094|FG007|Second Booster|Death|0|||
127697138|NCT04927065|459520095|FG008|Second Booster|Death|0|||
127697139|NCT04927065|459520096|FG009|Second Booster|Death|0|||
127697140|NCT04927065|459520097|FG010|Second Booster|Death|2|||
127697141|NCT04927065|459520098|FG011|Second Booster|Death|0|||
127697142|NCT04927065|459520099|FG012|Second Booster|Death|2|||
127697143|NCT04927065|459520100|FG013|Second Booster|Death|2|||
127697144|NCT04927065|459520101|FG014|Second Booster|Death|0|||
127697145|NCT04927065|459520102|FG015|Second Booster|Death|0|||
127697146|NCT04927065|459520087|FG000|Second Booster|Lost to Follow-up|0|||
127697147|NCT04927065|459520088|FG001|Second Booster|Lost to Follow-up|0|||
127697148|NCT04927065|459520089|FG002|Second Booster|Lost to Follow-up|3|||
127697149|NCT04927065|459520090|FG003|Second Booster|Lost to Follow-up|0|||
127697150|NCT04927065|459520091|FG004|Second Booster|Lost to Follow-up|0|||
127697151|NCT04927065|459520092|FG005|Second Booster|Lost to Follow-up|0|||
127697152|NCT04927065|459520093|FG006|Second Booster|Lost to Follow-up|0|||
127697153|NCT04927065|459520094|FG007|Second Booster|Lost to Follow-up|0|||
127697154|NCT04927065|459520095|FG008|Second Booster|Lost to Follow-up|0|||
127697155|NCT04927065|459520096|FG009|Second Booster|Lost to Follow-up|0|||
127697156|NCT04927065|459520097|FG010|Second Booster|Lost to Follow-up|14|||
127697157|NCT04927065|459520098|FG011|Second Booster|Lost to Follow-up|10|||
127697158|NCT04927065|459520099|FG012|Second Booster|Lost to Follow-up|13|||
127697159|NCT04927065|459520100|FG013|Second Booster|Lost to Follow-up|16|||
127697160|NCT04927065|459520101|FG014|Second Booster|Lost to Follow-up|0|||
127697161|NCT04927065|459520102|FG015|Second Booster|Lost to Follow-up|0|||
127697162|NCT04927065|459520087|FG000|Second Booster|Physician Decision|0|||
127697163|NCT04927065|459520088|FG001|Second Booster|Physician Decision|0|||
127697164|NCT04927065|459520089|FG002|Second Booster|Physician Decision|0|||
127697165|NCT04927065|459520090|FG003|Second Booster|Physician Decision|0|||
127697166|NCT04927065|459520091|FG004|Second Booster|Physician Decision|0|||
127697167|NCT04927065|459520092|FG005|Second Booster|Physician Decision|0|||
127788692|NCT00705783|459851279|FG001|Conversion Phase|Withdrawn by Investigator|0|||
127788693|NCT00705783|459851280|FG002|Conversion Phase|Withdrawn by Investigator|0|||
127788694|NCT00705783|459851278|FG000|Conversion Phase|Withdrew Consent|24|||
127788695|NCT00705783|459851279|FG001|Conversion Phase|Withdrew Consent|0|||
127788696|NCT00705783|459851280|FG002|Conversion Phase|Withdrew Consent|0|||
127788697|NCT00705783|459851278|FG000|Conversion Phase|Protocol Deviation|2|||
127788698|NCT00705783|459851279|FG001|Conversion Phase|Protocol Deviation|0|||
127788699|NCT00705783|459851280|FG002|Conversion Phase|Protocol Deviation|0|||
127788700|NCT00705783|459851278|FG000|Conversion Phase|Adverse Event|11|||
127788701|NCT00705783|459851279|FG001|Conversion Phase|Adverse Event|0|||
127788702|NCT00705783|459851280|FG002|Conversion Phase|Adverse Event|0|||
127788703|NCT00705783|459851278|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
127788704|NCT00705783|459851279|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
127788705|NCT00705783|459851280|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
127788706|NCT00705783|459851278|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
127788707|NCT00705783|459851279|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
127788708|NCT00705783|459851280|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
127788709|NCT00705783|459851278|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
127788710|NCT00705783|459851279|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
127788711|NCT00705783|459851280|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
127788712|NCT00705783|459851278|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
127788713|NCT00705783|459851279|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
127788714|NCT00705783|459851280|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
127788715|NCT00705783|459851278|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
127788716|NCT00705783|459851279|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
127788717|NCT00705783|459851280|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
127788718|NCT00705783|459851278|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
127788719|NCT00705783|459851279|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
127788720|NCT00705783|459851280|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
127788721|NCT00705783|459851278|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
127788722|NCT00705783|459851279|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
127697168|NCT04927065|459520093|FG006|Second Booster|Physician Decision|0|||
127697169|NCT04927065|459520094|FG007|Second Booster|Physician Decision|0|||
127697170|NCT04927065|459520095|FG008|Second Booster|Physician Decision|0|||
127697171|NCT04927065|459520096|FG009|Second Booster|Physician Decision|0|||
127697172|NCT04927065|459520097|FG010|Second Booster|Physician Decision|0|||
127697173|NCT04927065|459520098|FG011|Second Booster|Physician Decision|3|||
127697174|NCT04927065|459520099|FG012|Second Booster|Physician Decision|0|||
127697175|NCT04927065|459520100|FG013|Second Booster|Physician Decision|1|||
127697176|NCT04927065|459520101|FG014|Second Booster|Physician Decision|0|||
127697177|NCT04927065|459520102|FG015|Second Booster|Physician Decision|0|||
127604963|NCT02472795|459181814|FG000|Overall Study|Adverse Event|0|||
127604964|NCT02472795|459181815|FG001|Overall Study|Adverse Event|1|||
127604965|NCT02472795|459181816|FG002|Overall Study|Adverse Event|0|||
127604966|NCT02472795|459181817|FG003|Overall Study|Adverse Event|0|||
127604967|NCT02472795|459181818|FG004|Overall Study|Adverse Event|2|||
127604968|NCT02472795|459181814|FG000|Overall Study|Withdrawal by Subject|0|||
127604969|NCT02472795|459181815|FG001|Overall Study|Withdrawal by Subject|0|||
127604970|NCT02472795|459181816|FG002|Overall Study|Withdrawal by Subject|0|||
127604971|NCT02472795|459181817|FG003|Overall Study|Withdrawal by Subject|0|||
127604972|NCT02472795|459181818|FG004|Overall Study|Withdrawal by Subject|1|||
127604985|NCT04166513|459181823|FG000|Behavioral Assessment 1|Withdrawal by Subject|0|||
127604986|NCT04166513|459181824|FG001|Behavioral Assessment 1|Withdrawal by Subject|1|||
127604987|NCT04166513|459181825|FG002|Behavioral Assessment 1|Withdrawal by Subject|0|||
127604988|NCT04166513|459181826|FG003|Behavioral Assessment 1|Withdrawal by Subject|0|||
127604989|NCT04166513|459181823|FG000|Behavioral Assessment 1|Investigator Withdrawn|0|||
127604990|NCT04166513|459181824|FG001|Behavioral Assessment 1|Investigator Withdrawn|0|||
127604991|NCT04166513|459181825|FG002|Behavioral Assessment 1|Investigator Withdrawn|0|||
127604992|NCT04166513|459181826|FG003|Behavioral Assessment 1|Investigator Withdrawn|1|||
127604993|NCT04166513|459181823|FG000|Therapy Cycle B|Withdrawal by Subject|0|||
127604994|NCT04166513|459181824|FG001|Therapy Cycle B|Withdrawal by Subject|1|||
127604995|NCT04166513|459181825|FG002|Therapy Cycle B|Withdrawal by Subject|0|||
127604996|NCT04166513|459181826|FG003|Therapy Cycle B|Withdrawal by Subject|0|||
127604997|NCT04166513|459181823|FG000|Behavioral Assessment 4|Lost to Follow-up|1|||
127604998|NCT04166513|459181824|FG001|Behavioral Assessment 4|Lost to Follow-up|0|||
127604999|NCT04166513|459181825|FG002|Behavioral Assessment 4|Lost to Follow-up|1|||
127605000|NCT04166513|459181826|FG003|Behavioral Assessment 4|Lost to Follow-up|1|||
127605001|NCT04166513|459181823|FG000|Behavioral Assessment 4|Withdrawal by Subject|2|||
127882871|NCT01682512|460194598|FG000|Overall Study|Secondary lack of efficacy|1|||
127882872|NCT01682512|460194599|FG001|Overall Study|Secondary lack of efficacy|1|||
127605002|NCT04166513|459181824|FG001|Behavioral Assessment 4|Withdrawal by Subject|2|||
127605003|NCT04166513|459181825|FG002|Behavioral Assessment 4|Withdrawal by Subject|1|||
127605004|NCT04166513|459181826|FG003|Behavioral Assessment 4|Withdrawal by Subject|0|||
127605031|NCT00597012|459181843|FG000|Overall Study|Death|1|||
127605032|NCT00597012|459181844|FG001|Overall Study|Death|1|||
127605033|NCT00597012|459181843|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
127788723|NCT00705783|459851280|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
127788724|NCT00705783|459851278|FG000|Oral Stabilization Phase|Adverse Event|14|||
127788725|NCT00705783|459851279|FG001|Oral Stabilization Phase|Adverse Event|0|||
127788726|NCT00705783|459851280|FG002|Oral Stabilization Phase|Adverse Event|0|||
127788727|NCT00705783|459851278|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
127605034|NCT00597012|459181844|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
127605035|NCT00597012|459181843|FG000|Overall Study|Withdrawal by Subject|7|||
127605036|NCT00597012|459181844|FG001|Overall Study|Withdrawal by Subject|4|||
127788728|NCT00705783|459851279|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
127605037|NCT00597012|459181843|FG000|Overall Study|Ineligible|2|||
127605038|NCT00597012|459181844|FG001|Overall Study|Ineligible|0|||
127605039|NCT00597012|459181843|FG000|Overall Study|Lost to Follow-up|0|||
127605040|NCT00597012|459181844|FG001|Overall Study|Lost to Follow-up|2|||
127642571|NCT04124926|459313073|FG001|Maintenance Phase|Withdrawal of Consent|0|||
127642572|NCT04124926|459313074|FG002|Maintenance Phase|Withdrawal of Consent|5|||
127642573|NCT04124926|459313075|FG003|Maintenance Phase|Withdrawal of Consent|5|||
127642574|NCT04124926|459313076|FG004|Maintenance Phase|Withdrawal of Consent|5|||
127642575|NCT04124926|459313072|FG000|Maintenance Phase|Miscellaneous|0|||
127642576|NCT04124926|459313073|FG001|Maintenance Phase|Miscellaneous|0|||
127642577|NCT04124926|459313074|FG002|Maintenance Phase|Miscellaneous|1|||
127642578|NCT04124926|459313075|FG003|Maintenance Phase|Miscellaneous|2|||
127642579|NCT04124926|459313076|FG004|Maintenance Phase|Miscellaneous|4|||
127642580|NCT04124926|459313072|FG000|Maintenance Phase|Randomized but not Treated|0|||
127642581|NCT04124926|459313073|FG001|Maintenance Phase|Randomized but not Treated|0|||
127605059|NCT04568590|459183283|FG000|Overall Study|Subjects were not Vaccine-hesitant|437|||
127605060|NCT00202644|459183286|FG000|Overall Study|Adverse Event|12|||
127605061|NCT00202644|459183287|FG001|Overall Study|Adverse Event|13|||
127605062|NCT00202644|459183286|FG000|Overall Study|Withdrawal by Subject|8|||
127605063|NCT00202644|459183287|FG001|Overall Study|Withdrawal by Subject|6|||
127605064|NCT00202644|459183286|FG000|Overall Study|Lack of Efficacy|6|||
127605065|NCT00202644|459183287|FG001|Overall Study|Lack of Efficacy|6|||
127605066|NCT00202644|459183286|FG000|Overall Study|Lost to Follow-up|0|||
127605067|NCT00202644|459183287|FG001|Overall Study|Lost to Follow-up|1|||
127605068|NCT00202644|459183286|FG000|Overall Study|Other|9|||
127605069|NCT00202644|459183287|FG001|Overall Study|Other|1|||
127605070|NCT01851720|459183294|FG000|Overall Study|Lost to Follow-up|0|||
127605071|NCT01851720|459183295|FG001|Overall Study|Lost to Follow-up|1|||
127605072|NCT01870583|459183298|FG000|Overall Study|Protocol Violation|0|||
127605073|NCT01870583|459183299|FG001|Overall Study|Protocol Violation|5|||
127605074|NCT01870583|459183300|FG002|Overall Study|Protocol Violation|3|||
127605075|NCT01870583|459183298|FG000|Overall Study|Lost to Follow-up|11|||
127605076|NCT01870583|459183299|FG001|Overall Study|Lost to Follow-up|13|||
127605077|NCT01870583|459183300|FG002|Overall Study|Lost to Follow-up|5|||
127605078|NCT00937157|459183301|FG000|Overall Study|Pregnancy|1|||
127605079|NCT00937157|459183301|FG000|Overall Study|Lost to Follow-up|3|||
127605080|NCT00469092|459183302|FG000|Overall Study|Adverse Event|5|||
127605081|NCT00469092|459183303|FG001|Overall Study|Adverse Event|4|||
127605082|NCT00469092|459183302|FG000|Overall Study|Lack of Efficacy|1|||
127605083|NCT00469092|459183303|FG001|Overall Study|Lack of Efficacy|0|||
127605084|NCT00469092|459183302|FG000|Overall Study|Lost to Follow-up|1|||
127605085|NCT00469092|459183303|FG001|Overall Study|Lost to Follow-up|2|||
127605086|NCT00469092|459183302|FG000|Overall Study|Protocol Violation|3|||
127605087|NCT00469092|459183303|FG001|Overall Study|Protocol Violation|3|||
127605088|NCT00469092|459183302|FG000|Overall Study|Withdrawal by Subject|4|||
127605089|NCT00469092|459183303|FG001|Overall Study|Withdrawal by Subject|4|||
127605090|NCT00469092|459183302|FG000|Overall Study|Withdrawal Criteria|3|||
127605091|NCT00469092|459183303|FG001|Overall Study|Withdrawal Criteria|4|||
127605092|NCT00469092|459183302|FG000|Overall Study|Incorrectly Randomised|4|||
127605093|NCT00469092|459183303|FG001|Overall Study|Incorrectly Randomised|3|||
127605094|NCT00469092|459183302|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
127605095|NCT00469092|459183303|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
127605096|NCT00469092|459183302|FG000|Overall Study|Use of lipid lowering drug|1|||
127605097|NCT00469092|459183303|FG001|Overall Study|Use of lipid lowering drug|0|||
127605098|NCT00469092|459183302|FG000|Overall Study|Hypoglycaemic Episodes|1|||
127605099|NCT00469092|459183303|FG001|Overall Study|Hypoglycaemic Episodes|1|||
127605100|NCT00469092|459183302|FG000|Overall Study|Abnormal lab value|1|||
127605101|NCT00469092|459183303|FG001|Overall Study|Abnormal lab value|0|||
127605102|NCT00469092|459183302|FG000|Overall Study|Use of Corticosteroid|1|||
127605103|NCT00469092|459183303|FG001|Overall Study|Use of Corticosteroid|0|||
127605104|NCT02024867|459183304|FG000|Overall Study|Protocol Violation|3|||
127605105|NCT02024867|459183305|FG001|Overall Study|Protocol Violation|3|||
127605106|NCT02024867|459183304|FG000|Overall Study|Lost to Follow-up|6|||
127605107|NCT02024867|459183305|FG001|Overall Study|Lost to Follow-up|4|||
127605108|NCT01998633|459183307|FG000|Overall Study|Death|1|||
127605109|NCT00413192|459183308|FG000|Overall Study|Disease progression|26|||
127605110|NCT00413192|459183309|FG001|Overall Study|Disease progression|31|||
127605111|NCT00413192|459183310|FG002|Overall Study|Disease progression|16|||
127605112|NCT00413192|459183311|FG003|Overall Study|Disease progression|25|||
127697178|NCT04927065|459520087|FG000|Second Booster|Withdrawal by Subject|0|||
127605113|NCT00413192|459183308|FG000|Overall Study|Toxicity|3|||
127605114|NCT00413192|459183309|FG001|Overall Study|Toxicity|2|||
127605115|NCT00413192|459183310|FG002|Overall Study|Toxicity|2|||
127605116|NCT00413192|459183311|FG003|Overall Study|Toxicity|2|||
127605117|NCT00413192|459183308|FG000|Overall Study|Withdrawal by Subject|3|||
127605118|NCT00413192|459183309|FG001|Overall Study|Withdrawal by Subject|5|||
127605119|NCT00413192|459183310|FG002|Overall Study|Withdrawal by Subject|0|||
127605120|NCT00413192|459183311|FG003|Overall Study|Withdrawal by Subject|1|||
127605121|NCT00413192|459183308|FG000|Overall Study|Intercurrent illness|0|||
127605122|NCT00413192|459183309|FG001|Overall Study|Intercurrent illness|0|||
127605123|NCT00413192|459183310|FG002|Overall Study|Intercurrent illness|0|||
127605124|NCT00413192|459183311|FG003|Overall Study|Intercurrent illness|1|||
127605125|NCT00413192|459183308|FG000|Overall Study|Intercurrent death|0|||
127605126|NCT00413192|459183309|FG001|Overall Study|Intercurrent death|1|||
127605127|NCT00413192|459183310|FG002|Overall Study|Intercurrent death|0|||
127605128|NCT00413192|459183311|FG003|Overall Study|Intercurrent death|0|||
127605129|NCT00413192|459183308|FG000|Overall Study|Other|5|||
127697179|NCT04927065|459520088|FG001|Second Booster|Withdrawal by Subject|0|||
127605130|NCT00413192|459183309|FG001|Overall Study|Other|1|||
127605131|NCT00413192|459183310|FG002|Overall Study|Other|1|||
127605132|NCT00413192|459183311|FG003|Overall Study|Other|2|||
127605133|NCT00413192|459183308|FG000|Overall Study|Not treated|0|||
127605134|NCT00413192|459183309|FG001|Overall Study|Not treated|0|||
127605135|NCT00413192|459183310|FG002|Overall Study|Not treated|0|||
127605136|NCT00413192|459183311|FG003|Overall Study|Not treated|1|||
127605137|NCT03992781|459183319|FG000|Overall Study|Lost to Follow-up|5|||
127605138|NCT03992781|459183319|FG000|Overall Study|Adverse Event|1|||
127605139|NCT03992781|459183319|FG000|Overall Study|Lack of Efficacy|5|||
127605140|NCT01086540|459183320|FG000|Overall Study|Death|3|||
127605141|NCT01086540|459183321|FG001|Overall Study|Death|1|||
127605142|NCT01086540|459183320|FG000|Overall Study|Physician Decision|2|||
127605143|NCT01086540|459183321|FG001|Overall Study|Physician Decision|1|||
127605144|NCT01086540|459183320|FG000|Overall Study|Addition of new therapy for PAH|1|||
127605145|NCT01086540|459183321|FG001|Overall Study|Addition of new therapy for PAH|0|||
127605146|NCT03164928|459183322|FG000|Overall Study|Lost to Follow-up|1|||
127605147|NCT03164928|459183323|FG001|Overall Study|Lost to Follow-up|0|||
127605148|NCT02118012|459183324|FG000|Overall Study|Adverse Event|0|||
127605149|NCT02118012|459183325|FG001|Overall Study|Adverse Event|1|||
127605150|NCT02118012|459183324|FG000|Overall Study|Physician Decision|0|||
127605151|NCT02118012|459183325|FG001|Overall Study|Physician Decision|1|||
127605152|NCT02268864|459183326|FG000|Overall Study|Withdrawal by Subject|2|||
127605153|NCT02268864|459183327|FG001|Overall Study|Withdrawal by Subject|0|||
127605154|NCT02268864|459183328|FG002|Overall Study|Withdrawal by Subject|0|||
127605155|NCT02268864|459183326|FG000|Overall Study|Death|0|||
127605156|NCT02268864|459183327|FG001|Overall Study|Death|1|||
127605157|NCT02268864|459183328|FG002|Overall Study|Death|0|||
127605158|NCT00857220|459183329|FG000|Overall Study|Adverse Event|35|||
127605159|NCT00857220|459183329|FG000|Overall Study|Death|1|||
127605160|NCT00857220|459183329|FG000|Overall Study|Lack of Efficacy|11|||
127605161|NCT00857220|459183329|FG000|Overall Study|Lost to Follow-up|30|||
127605162|NCT00857220|459183329|FG000|Overall Study|Physician Decision|4|||
127605163|NCT00857220|459183329|FG000|Overall Study|Protocol Violation|16|||
127605164|NCT00857220|459183329|FG000|Overall Study|Withdrawal by Subject|67|||
127605165|NCT00857220|459183329|FG000|Overall Study|Clinical Hold|6|||
127605166|NCT00857220|459183329|FG000|Overall Study|Site Closed|5|||
127605167|NCT00857220|459183329|FG000|Overall Study|Miscellaneous|8|||
127605168|NCT03698994|459183330|FG000|Overall Study|Adverse Event|2|||
127605169|NCT03698994|459183330|FG000|Overall Study|Death|1|||
127605170|NCT03698994|459183330|FG000|Overall Study|Physician Decision|1|||
127605171|NCT03698994|459183330|FG000|Overall Study|Withdrawal by Subject|3|||
127605172|NCT03698994|459183330|FG000|Overall Study|Progressive Disease|12|||
127605173|NCT00171223|459183331|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
127605174|NCT00171223|459183332|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
127605175|NCT00171223|459183333|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
127605176|NCT00171223|459183331|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
127605177|NCT00171223|459183332|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
127605178|NCT00171223|459183333|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
127605179|NCT00171223|459183331|FG000|Overall Study|Abnormal Procedure|1|||
127605180|NCT00171223|459183332|FG001|Overall Study|Abnormal Procedure|0|||
127605181|NCT00171223|459183333|FG002|Overall Study|Abnormal Procedure|0|||
127605182|NCT00171223|459183331|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
127605183|NCT00171223|459183332|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
127605184|NCT00171223|459183333|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
127605185|NCT00171223|459183331|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
127605186|NCT00171223|459183332|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
127605187|NCT00171223|459183333|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
127605188|NCT00171223|459183331|FG000|Overall Study|Protocol Violation|2|||
127605189|NCT00171223|459183332|FG001|Overall Study|Protocol Violation|2|||
127605190|NCT00171223|459183333|FG002|Overall Study|Protocol Violation|3|||
127605191|NCT00171223|459183331|FG000|Overall Study|Participant Withdrew Consent|12|||
127605192|NCT00171223|459183332|FG001|Overall Study|Participant Withdrew Consent|21|||
127605193|NCT00171223|459183333|FG002|Overall Study|Participant Withdrew Consent|15|||
127605194|NCT00171223|459183331|FG000|Overall Study|Lost to Follow-up|5|||
127605195|NCT00171223|459183332|FG001|Overall Study|Lost to Follow-up|2|||
127605196|NCT00171223|459183333|FG002|Overall Study|Lost to Follow-up|3|||
127605197|NCT00171223|459183331|FG000|Overall Study|Administrative Problems|4|||
127605198|NCT00171223|459183332|FG001|Overall Study|Administrative Problems|7|||
127605199|NCT00171223|459183333|FG002|Overall Study|Administrative Problems|6|||
127605200|NCT00171223|459183331|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
127605201|NCT00171223|459183332|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
127605202|NCT00171223|459183333|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
127605203|NCT00171223|459183331|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
127605204|NCT00171223|459183332|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
127605205|NCT00171223|459183333|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
127605206|NCT00730912|459183347|FG000|Overall Study|Discontinued|0|||
127605207|NCT00730912|459183348|FG001|Overall Study|Discontinued|0|||
127605208|NCT00730912|459183349|FG002|Overall Study|Discontinued|1|||
127605209|NCT04053023|459183352|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
127605210|NCT04053023|459183353|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
127605211|NCT03424265|459183354|FG000|Overall Study|screening failure|1|||
127605212|NCT03424265|459183355|FG001|Overall Study|screening failure|0|||
127605213|NCT03424265|459183354|FG000|Overall Study|Withdrawal by Subject|0|||
127605214|NCT03424265|459183355|FG001|Overall Study|Withdrawal by Subject|2|||
127605215|NCT00894322|459183356|FG000|Overall Study|Withdrawal by Subject|1|||
127605216|NCT00894322|459183357|FG001|Overall Study|Withdrawal by Subject|0|||
127605217|NCT00894322|459183358|FG002|Overall Study|Withdrawal by Subject|0|||
127605218|NCT03251079|459183359|FG000|Overall Study|Withdrawal by Subject|1|||
127605219|NCT00455429|459183365|FG000|Overall Study|Study Terminated by Sponsor|0|||
127605220|NCT00455429|459183366|FG001|Overall Study|Study Terminated by Sponsor|0|||
127605221|NCT00455429|459183367|FG002|Overall Study|Study Terminated by Sponsor|0|||
127605222|NCT00455429|459183368|FG003|Overall Study|Study Terminated by Sponsor|3|||
127605223|NCT00455429|459183365|FG000|Overall Study|Lost to Follow-up|1|||
127605224|NCT00455429|459183366|FG001|Overall Study|Lost to Follow-up|0|||
127605225|NCT00455429|459183367|FG002|Overall Study|Lost to Follow-up|0|||
127605226|NCT00455429|459183368|FG003|Overall Study|Lost to Follow-up|3|||
127605227|NCT00455429|459183365|FG000|Overall Study|Withdrawal by Subject|0|||
127605228|NCT00455429|459183366|FG001|Overall Study|Withdrawal by Subject|1|||
127605229|NCT00455429|459183367|FG002|Overall Study|Withdrawal by Subject|1|||
127605230|NCT00455429|459183368|FG003|Overall Study|Withdrawal by Subject|0|||
127605231|NCT00455429|459183365|FG000|Overall Study|Lack of Efficacy|0|||
127605232|NCT00455429|459183366|FG001|Overall Study|Lack of Efficacy|1|||
127605233|NCT00455429|459183367|FG002|Overall Study|Lack of Efficacy|0|||
127605234|NCT00455429|459183368|FG003|Overall Study|Lack of Efficacy|1|||
127605235|NCT00455429|459183365|FG000|Overall Study|Adverse Event|0|||
127605236|NCT00455429|459183366|FG001|Overall Study|Adverse Event|1|||
127605237|NCT00455429|459183367|FG002|Overall Study|Adverse Event|0|||
127605238|NCT00455429|459183368|FG003|Overall Study|Adverse Event|3|||
127605239|NCT00455429|459183365|FG000|Overall Study|Randomly assigned but not treated|0|||
127605240|NCT00455429|459183366|FG001|Overall Study|Randomly assigned but not treated|0|||
127605241|NCT00455429|459183367|FG002|Overall Study|Randomly assigned but not treated|0|||
127605242|NCT00455429|459183368|FG003|Overall Study|Randomly assigned but not treated|2|||
127605243|NCT00455429|459183365|FG000|Overall Study|Personal Reason|1|||
127605244|NCT00455429|459183366|FG001|Overall Study|Personal Reason|0|||
127605245|NCT00455429|459183367|FG002|Overall Study|Personal Reason|0|||
127605246|NCT00455429|459183368|FG003|Overall Study|Personal Reason|0|||
127697180|NCT04927065|459520089|FG002|Second Booster|Withdrawal by Subject|4|||
127697181|NCT04927065|459520090|FG003|Second Booster|Withdrawal by Subject|0|||
127697182|NCT04927065|459520091|FG004|Second Booster|Withdrawal by Subject|0|||
127697183|NCT04927065|459520092|FG005|Second Booster|Withdrawal by Subject|0|||
127697184|NCT04927065|459520093|FG006|Second Booster|Withdrawal by Subject|0|||
127697185|NCT04927065|459520094|FG007|Second Booster|Withdrawal by Subject|0|||
127697186|NCT04927065|459520095|FG008|Second Booster|Withdrawal by Subject|0|||
127697187|NCT04927065|459520096|FG009|Second Booster|Withdrawal by Subject|0|||
127605247|NCT00455429|459183365|FG000|Overall Study|Non-compliance|0|||
127605248|NCT00455429|459183366|FG001|Overall Study|Non-compliance|0|||
127605249|NCT00455429|459183367|FG002|Overall Study|Non-compliance|0|||
127605250|NCT00455429|459183368|FG003|Overall Study|Non-compliance|1|||
127605251|NCT00455429|459183365|FG000|Overall Study|Other|0|||
127605252|NCT00455429|459183366|FG001|Overall Study|Other|2|||
127605253|NCT00455429|459183367|FG002|Overall Study|Other|0|||
127605254|NCT00455429|459183368|FG003|Overall Study|Other|1|||
127605255|NCT01165554|459183369|FG000|Overall Study|Withdrawal by Subject|23|||
127697188|NCT04927065|459520097|FG010|Second Booster|Withdrawal by Subject|3|||
127605256|NCT02951156|459183376|FG000|Overall Study|Death|3|||
127605257|NCT02951156|459183377|FG001|Overall Study|Death|8|||
127605258|NCT02951156|459183378|FG002|Overall Study|Death|5|||
127697189|NCT04927065|459520098|FG011|Second Booster|Withdrawal by Subject|16|||
127697190|NCT04927065|459520099|FG012|Second Booster|Withdrawal by Subject|13|||
127697191|NCT04927065|459520100|FG013|Second Booster|Withdrawal by Subject|9|||
127605259|NCT02951156|459183376|FG000|Overall Study|Progressive disease|1|||
127605260|NCT02951156|459183377|FG001|Overall Study|Progressive disease|0|||
127605261|NCT02951156|459183378|FG002|Overall Study|Progressive disease|1|||
127605262|NCT02951156|459183376|FG000|Overall Study|Withdrawal by Subject|0|||
127605263|NCT02951156|459183377|FG001|Overall Study|Withdrawal by Subject|0|||
127605264|NCT02951156|459183378|FG002|Overall Study|Withdrawal by Subject|1|||
127605265|NCT02951156|459183376|FG000|Overall Study|Study terminated by sponsor|0|||
127605266|NCT02951156|459183377|FG001|Overall Study|Study terminated by sponsor|0|||
127605267|NCT02951156|459183378|FG002|Overall Study|Study terminated by sponsor|1|||
127605268|NCT02951156|459183376|FG000|Overall Study|Other|5|||
127605269|NCT02951156|459183377|FG001|Overall Study|Other|1|||
127605270|NCT02951156|459183378|FG002|Overall Study|Other|2|||
127605271|NCT04351087|459183379|FG000|Overall Study|Lost to Follow-up|7|||
127605272|NCT04351087|459183380|FG001|Overall Study|Lost to Follow-up|3|||
127605273|NCT04351087|459183379|FG000|Overall Study|Withdrawal by Subject|3|||
127605274|NCT04351087|459183380|FG001|Overall Study|Withdrawal by Subject|4|||
127605275|NCT04351087|459183379|FG000|Overall Study|Lack of Efficacy|3|||
127605276|NCT04351087|459183380|FG001|Overall Study|Lack of Efficacy|2|||
127605277|NCT03519347|459183383|FG000|Interventional Crossover Period 1|Death|0|||
127605278|NCT03519347|459183384|FG001|Interventional Crossover Period 1|Death|0|||
127605279|NCT03519347|459183385|FG002|Interventional Crossover Period 1|Death|0|||
127605280|NCT03519347|459183386|FG003|Interventional Crossover Period 1|Death|1|||
127605281|NCT05517382|459183387|FG000|Overall Study|Lost to Follow-up|0|||
127605282|NCT05517382|459183388|FG001|Overall Study|Lost to Follow-up|1|||
127605283|NCT01641692|459183389|FG000|Treatment Period 1|Adverse Event|1|||
127605284|NCT01641692|459183390|FG001|Treatment Period 1|Adverse Event|0|||
127605285|NCT01641692|459183391|FG002|Treatment Period 1|Adverse Event|0|||
127605286|NCT01641692|459183392|FG003|Treatment Period 1|Adverse Event|0|||
127605287|NCT01641692|459183393|FG004|Treatment Period 1|Adverse Event|0|||
127605288|NCT01641692|459183394|FG005|Treatment Period 1|Adverse Event|0|||
127605289|NCT01641692|459183395|FG006|Treatment Period 1|Adverse Event|0|||
127605290|NCT01641692|459183396|FG007|Treatment Period 1|Adverse Event|0|||
127605291|NCT01641692|459183389|FG000|Treatment Period 1|Lack of Efficacy|0|||
127605292|NCT01641692|459183390|FG001|Treatment Period 1|Lack of Efficacy|0|||
127605293|NCT01641692|459183391|FG002|Treatment Period 1|Lack of Efficacy|0|||
127605294|NCT01641692|459183392|FG003|Treatment Period 1|Lack of Efficacy|0|||
127605295|NCT01641692|459183393|FG004|Treatment Period 1|Lack of Efficacy|0|||
127605296|NCT01641692|459183394|FG005|Treatment Period 1|Lack of Efficacy|0|||
127605297|NCT01641692|459183395|FG006|Treatment Period 1|Lack of Efficacy|0|||
127605298|NCT01641692|459183396|FG007|Treatment Period 1|Lack of Efficacy|1|||
127605299|NCT01641692|459183389|FG000|Treatment Period 1|Protocol Violation|1|||
127605300|NCT01641692|459183390|FG001|Treatment Period 1|Protocol Violation|0|||
127605301|NCT01641692|459183391|FG002|Treatment Period 1|Protocol Violation|0|||
127605302|NCT01641692|459183392|FG003|Treatment Period 1|Protocol Violation|0|||
127605303|NCT01641692|459183393|FG004|Treatment Period 1|Protocol Violation|2|||
127605304|NCT01641692|459183394|FG005|Treatment Period 1|Protocol Violation|0|||
127605305|NCT01641692|459183395|FG006|Treatment Period 1|Protocol Violation|0|||
127605306|NCT01641692|459183396|FG007|Treatment Period 1|Protocol Violation|0|||
127605307|NCT01641692|459183389|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
127605308|NCT01641692|459183390|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
127605309|NCT01641692|459183391|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
127605310|NCT01641692|459183392|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
127605311|NCT01641692|459183393|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
127605312|NCT01641692|459183394|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
127605313|NCT01641692|459183395|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
127605314|NCT01641692|459183396|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
127605315|NCT01641692|459183389|FG000|Treatment Period 1|Lost to Follow-up|0|||
127605316|NCT01641692|459183390|FG001|Treatment Period 1|Lost to Follow-up|0|||
127605317|NCT01641692|459183391|FG002|Treatment Period 1|Lost to Follow-up|1|||
127605318|NCT01641692|459183392|FG003|Treatment Period 1|Lost to Follow-up|0|||
127697192|NCT04927065|459520101|FG014|Second Booster|Withdrawal by Subject|0|||
127697193|NCT04927065|459520102|FG015|Second Booster|Withdrawal by Subject|0|||
127697194|NCT04927065|459520087|FG000|Second Booster|Other Than Specified|0|||
127697195|NCT04927065|459520088|FG001|Second Booster|Other Than Specified|0|||
127697196|NCT04927065|459520089|FG002|Second Booster|Other Than Specified|0|||
127697197|NCT04927065|459520090|FG003|Second Booster|Other Than Specified|0|||
127697198|NCT04927065|459520091|FG004|Second Booster|Other Than Specified|0|||
127697199|NCT04927065|459520092|FG005|Second Booster|Other Than Specified|0|||
127697200|NCT04927065|459520093|FG006|Second Booster|Other Than Specified|0|||
127605319|NCT01641692|459183393|FG004|Treatment Period 1|Lost to Follow-up|0|||
127605320|NCT01641692|459183394|FG005|Treatment Period 1|Lost to Follow-up|0|||
127605321|NCT01641692|459183395|FG006|Treatment Period 1|Lost to Follow-up|0|||
127605322|NCT01641692|459183396|FG007|Treatment Period 1|Lost to Follow-up|0|||
127605323|NCT01641692|459183389|FG000|Treatment Period 1|Physician Decision|0|||
127605324|NCT01641692|459183390|FG001|Treatment Period 1|Physician Decision|0|||
127605325|NCT01641692|459183391|FG002|Treatment Period 1|Physician Decision|0|||
127697201|NCT04927065|459520094|FG007|Second Booster|Other Than Specified|0|||
127697202|NCT04927065|459520095|FG008|Second Booster|Other Than Specified|0|||
127605326|NCT01641692|459183392|FG003|Treatment Period 1|Physician Decision|0|||
127605327|NCT01641692|459183393|FG004|Treatment Period 1|Physician Decision|1|||
127605328|NCT01641692|459183394|FG005|Treatment Period 1|Physician Decision|0|||
127605329|NCT01641692|459183395|FG006|Treatment Period 1|Physician Decision|0|||
127605330|NCT01641692|459183396|FG007|Treatment Period 1|Physician Decision|0|||
127605331|NCT01641692|459183389|FG000|Treatment Period 1|Withdrawal by Subject|0|||
127605332|NCT01641692|459183390|FG001|Treatment Period 1|Withdrawal by Subject|0|||
127605333|NCT01641692|459183391|FG002|Treatment Period 1|Withdrawal by Subject|0|||
127605334|NCT01641692|459183392|FG003|Treatment Period 1|Withdrawal by Subject|0|||
127605335|NCT01641692|459183393|FG004|Treatment Period 1|Withdrawal by Subject|0|||
127605336|NCT01641692|459183394|FG005|Treatment Period 1|Withdrawal by Subject|2|||
127605337|NCT01641692|459183395|FG006|Treatment Period 1|Withdrawal by Subject|0|||
127605338|NCT01641692|459183396|FG007|Treatment Period 1|Withdrawal by Subject|1|||
127605339|NCT01641692|459183389|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
127605340|NCT01641692|459183390|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
127605341|NCT01641692|459183391|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
127605342|NCT01641692|459183392|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
127605343|NCT01641692|459183393|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
127605344|NCT01641692|459183394|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
127605345|NCT01641692|459183395|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
127605346|NCT01641692|459183396|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
127605347|NCT01641692|459183389|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
127605348|NCT01641692|459183390|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
127605349|NCT01641692|459183391|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
127605350|NCT01641692|459183392|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
127605351|NCT01641692|459183393|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
127605352|NCT01641692|459183394|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
127605353|NCT01641692|459183395|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
127605354|NCT01641692|459183396|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
127605355|NCT01641692|459183389|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
127605356|NCT01641692|459183390|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
127605357|NCT01641692|459183391|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
127605358|NCT01641692|459183392|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
127605359|NCT01641692|459183393|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
127605360|NCT01641692|459183394|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
127605361|NCT01641692|459183395|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
127605362|NCT01641692|459183396|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
127605363|NCT01641692|459183389|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
127605364|NCT01641692|459183390|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
127605365|NCT01641692|459183391|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
127605366|NCT01641692|459183392|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
127605367|NCT01641692|459183393|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
127605368|NCT01641692|459183394|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
127605369|NCT01641692|459183395|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
127605370|NCT01641692|459183396|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
127605371|NCT01641692|459183389|FG000|Treatment Period 2|Lack of Efficacy|1|||
127605372|NCT01641692|459183390|FG001|Treatment Period 2|Lack of Efficacy|0|||
127605373|NCT01641692|459183391|FG002|Treatment Period 2|Lack of Efficacy|0|||
127605374|NCT01641692|459183392|FG003|Treatment Period 2|Lack of Efficacy|0|||
127605375|NCT01641692|459183393|FG004|Treatment Period 2|Lack of Efficacy|0|||
127605376|NCT01641692|459183394|FG005|Treatment Period 2|Lack of Efficacy|0|||
127605377|NCT01641692|459183395|FG006|Treatment Period 2|Lack of Efficacy|0|||
127605378|NCT01641692|459183396|FG007|Treatment Period 2|Lack of Efficacy|0|||
127605379|NCT01641692|459183389|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
127605380|NCT01641692|459183390|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
127605381|NCT01641692|459183391|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
127605382|NCT01641692|459183392|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
127605383|NCT01641692|459183393|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
127605384|NCT01641692|459183394|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
127605385|NCT01641692|459183395|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
127697203|NCT04927065|459520096|FG009|Second Booster|Other Than Specified|0|||
127697204|NCT04927065|459520097|FG010|Second Booster|Other Than Specified|1|||
127697205|NCT04927065|459520098|FG011|Second Booster|Other Than Specified|1|||
127697206|NCT04927065|459520099|FG012|Second Booster|Other Than Specified|4|||
127605386|NCT01641692|459183396|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
127605387|NCT01641692|459183389|FG000|Treatment Period 2|Lost to Follow-up|0|||
127605388|NCT01641692|459183390|FG001|Treatment Period 2|Lost to Follow-up|0|||
127605389|NCT01641692|459183391|FG002|Treatment Period 2|Lost to Follow-up|0|||
127605390|NCT01641692|459183392|FG003|Treatment Period 2|Lost to Follow-up|0|||
127605391|NCT01641692|459183393|FG004|Treatment Period 2|Lost to Follow-up|0|||
127605392|NCT01641692|459183394|FG005|Treatment Period 2|Lost to Follow-up|1|||
127605393|NCT01641692|459183395|FG006|Treatment Period 2|Lost to Follow-up|0|||
127605394|NCT01641692|459183396|FG007|Treatment Period 2|Lost to Follow-up|0|||
127605395|NCT01641692|459183389|FG000|Treatment Period 2|Withdrawal by Subject|1|||
127605396|NCT01641692|459183390|FG001|Treatment Period 2|Withdrawal by Subject|0|||
127605397|NCT01641692|459183391|FG002|Treatment Period 2|Withdrawal by Subject|0|||
127605398|NCT01641692|459183392|FG003|Treatment Period 2|Withdrawal by Subject|0|||
127605399|NCT01641692|459183393|FG004|Treatment Period 2|Withdrawal by Subject|0|||
127605400|NCT01641692|459183394|FG005|Treatment Period 2|Withdrawal by Subject|1|||
127605401|NCT01641692|459183395|FG006|Treatment Period 2|Withdrawal by Subject|0|||
127605402|NCT01641692|459183396|FG007|Treatment Period 2|Withdrawal by Subject|1|||
127605403|NCT01641692|459183389|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
127605404|NCT01641692|459183390|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
127605405|NCT01641692|459183391|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
127605406|NCT01641692|459183392|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
127605407|NCT01641692|459183393|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
127605408|NCT01641692|459183394|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
127605409|NCT01641692|459183395|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
127605410|NCT01641692|459183396|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
127605411|NCT01641692|459183389|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
127605412|NCT01641692|459183390|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
127605413|NCT01641692|459183391|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
127605414|NCT01641692|459183392|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
127605415|NCT01641692|459183393|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
127605416|NCT01641692|459183394|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
127605417|NCT01641692|459183395|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
127605418|NCT01641692|459183396|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
127605419|NCT01641692|459183389|FG000|Treatment Period 3|Adverse Event|0|||
127605420|NCT01641692|459183390|FG001|Treatment Period 3|Adverse Event|0|||
127605421|NCT01641692|459183391|FG002|Treatment Period 3|Adverse Event|0|||
127605422|NCT01641692|459183392|FG003|Treatment Period 3|Adverse Event|0|||
127605423|NCT01641692|459183393|FG004|Treatment Period 3|Adverse Event|0|||
127605424|NCT01641692|459183394|FG005|Treatment Period 3|Adverse Event|0|||
127605425|NCT01641692|459183395|FG006|Treatment Period 3|Adverse Event|1|||
127605426|NCT01641692|459183396|FG007|Treatment Period 3|Adverse Event|0|||
127605427|NCT01641692|459183389|FG000|Treatment Period 3|Protocol Violation|0|||
127605428|NCT01641692|459183390|FG001|Treatment Period 3|Protocol Violation|0|||
127605429|NCT01641692|459183391|FG002|Treatment Period 3|Protocol Violation|1|||
127605430|NCT01641692|459183392|FG003|Treatment Period 3|Protocol Violation|0|||
127605431|NCT01641692|459183393|FG004|Treatment Period 3|Protocol Violation|0|||
127605432|NCT01641692|459183394|FG005|Treatment Period 3|Protocol Violation|0|||
127605433|NCT01641692|459183395|FG006|Treatment Period 3|Protocol Violation|0|||
127605434|NCT01641692|459183396|FG007|Treatment Period 3|Protocol Violation|0|||
127605435|NCT01641692|459183389|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
127605436|NCT01641692|459183390|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
127788729|NCT00705783|459851280|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
127788730|NCT00705783|459851278|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
127605437|NCT01641692|459183391|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
127605438|NCT01641692|459183392|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
127605439|NCT01641692|459183393|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
127605440|NCT01641692|459183394|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
127788731|NCT00705783|459851279|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
127788732|NCT00705783|459851280|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
127697207|NCT04927065|459520100|FG013|Second Booster|Other Than Specified|0|||
127697208|NCT04927065|459520101|FG014|Second Booster|Other Than Specified|0|||
127697209|NCT04927065|459520102|FG015|Second Booster|Other Than Specified|0|||
127697210|NCT04927065|459520087|FG000|Third Booster|Lost to Follow-up|0|||
127697211|NCT04927065|459520088|FG001|Third Booster|Lost to Follow-up|0|||
127697212|NCT04927065|459520089|FG002|Third Booster|Lost to Follow-up|0|||
127697213|NCT04927065|459520090|FG003|Third Booster|Lost to Follow-up|0|||
127697214|NCT04927065|459520091|FG004|Third Booster|Lost to Follow-up|0|||
127697215|NCT04927065|459520092|FG005|Third Booster|Lost to Follow-up|0|||
127697216|NCT04927065|459520093|FG006|Third Booster|Lost to Follow-up|0|||
127697217|NCT04927065|459520094|FG007|Third Booster|Lost to Follow-up|0|||
127697218|NCT04927065|459520095|FG008|Third Booster|Lost to Follow-up|0|||
127697219|NCT04927065|459520096|FG009|Third Booster|Lost to Follow-up|0|||
127697220|NCT04927065|459520097|FG010|Third Booster|Lost to Follow-up|0|||
127697221|NCT04927065|459520098|FG011|Third Booster|Lost to Follow-up|0|||
127697222|NCT04927065|459520099|FG012|Third Booster|Lost to Follow-up|0|||
127697223|NCT04927065|459520100|FG013|Third Booster|Lost to Follow-up|0|||
127697224|NCT04927065|459520101|FG014|Third Booster|Lost to Follow-up|0|||
127697225|NCT04927065|459520102|FG015|Third Booster|Lost to Follow-up|1|||
127697226|NCT04927065|459520087|FG000|Third Booster|Withdrawal by Subject|0|||
127697227|NCT04927065|459520088|FG001|Third Booster|Withdrawal by Subject|0|||
127697228|NCT04927065|459520089|FG002|Third Booster|Withdrawal by Subject|0|||
127697229|NCT04927065|459520090|FG003|Third Booster|Withdrawal by Subject|0|||
127697230|NCT04927065|459520091|FG004|Third Booster|Withdrawal by Subject|0|||
127697231|NCT04927065|459520092|FG005|Third Booster|Withdrawal by Subject|0|||
127697232|NCT04927065|459520093|FG006|Third Booster|Withdrawal by Subject|0|||
127697233|NCT04927065|459520094|FG007|Third Booster|Withdrawal by Subject|0|||
127697234|NCT04927065|459520095|FG008|Third Booster|Withdrawal by Subject|0|||
127697235|NCT04927065|459520096|FG009|Third Booster|Withdrawal by Subject|0|||
127697236|NCT04927065|459520097|FG010|Third Booster|Withdrawal by Subject|0|||
127697237|NCT04927065|459520098|FG011|Third Booster|Withdrawal by Subject|0|||
127697238|NCT04927065|459520099|FG012|Third Booster|Withdrawal by Subject|0|||
127697239|NCT04927065|459520100|FG013|Third Booster|Withdrawal by Subject|0|||
127697240|NCT04927065|459520101|FG014|Third Booster|Withdrawal by Subject|0|||
127697241|NCT04927065|459520102|FG015|Third Booster|Withdrawal by Subject|1|||
127697242|NCT03406871|459520103|FG000|Dose Escalation Cohort|DLT assesment cancellation**|1|||
127697243|NCT03406871|459520104|FG001|Dose Escalation Cohort|DLT assesment cancellation**|1|||
127697244|NCT03406871|459520105|FG002|Dose Escalation Cohort|DLT assesment cancellation**|0|||
127697245|NCT03406871|459520103|FG000|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|4|||
127697246|NCT03406871|459520104|FG001|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|2|||
127697247|NCT03406871|459520105|FG002|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|1|||
127697248|NCT03406871|459520103|FG000|Expansion Cohort(Final Analysis)|Progression of primary disease|17|||
127697249|NCT03406871|459520104|FG001|Expansion Cohort(Final Analysis)|Progression of primary disease|22|||
127697250|NCT03406871|459520105|FG002|Expansion Cohort(Final Analysis)|Progression of primary disease|1|||
127697251|NCT03406871|459520103|FG000|Expansion Cohort(Final Analysis)|Physician Decision|1|||
127697252|NCT03406871|459520104|FG001|Expansion Cohort(Final Analysis)|Physician Decision|0|||
127697253|NCT03406871|459520105|FG002|Expansion Cohort(Final Analysis)|Physician Decision|0|||
127697254|NCT03406871|459520103|FG000|Expansion Cohort(Final Analysis)|Death|0|||
127697255|NCT03406871|459520104|FG001|Expansion Cohort(Final Analysis)|Death|1|||
127697256|NCT03406871|459520105|FG002|Expansion Cohort(Final Analysis)|Death|0|||
127697257|NCT03406871|459520103|FG000|Expansion Cohort(Final Analysis)|Adverse Event|0|||
127697258|NCT03406871|459520104|FG001|Expansion Cohort(Final Analysis)|Adverse Event|0|||
127697259|NCT03406871|459520105|FG002|Expansion Cohort(Final Analysis)|Adverse Event|1|||
127697260|NCT01744782|459520106|FG000|Overall Study|Death|1|||
127697261|NCT01413100|459520109|FG000|Overall Study|Withdrawal by Subject|1|||
127697262|NCT05369403|459520110|FG000|Treatment Period 1: Week 0 to Week 16|Adverse Event|5|||
127697263|NCT05369403|459520111|FG001|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
127697264|NCT05369403|459520112|FG002|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
127697265|NCT05369403|459520110|FG000|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|1|||
127697266|NCT05369403|459520111|FG001|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
127697267|NCT05369403|459520112|FG002|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
127697268|NCT05369403|459520110|FG000|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|1|||
127697269|NCT05369403|459520111|FG001|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
127697270|NCT05369403|459520112|FG002|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
127697271|NCT05369403|459520110|FG000|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|12|||
127697272|NCT05369403|459520111|FG001|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
127697273|NCT05369403|459520112|FG002|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
127697274|NCT05369403|459520110|FG000|Treatment Period 1: Week 0 to Week 16|Physician Decision|2|||
127605441|NCT01641692|459183395|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
127605442|NCT01641692|459183396|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
127605443|NCT01641692|459183389|FG000|Treatment Period 3|Lost to Follow-up|0|||
127605444|NCT01641692|459183390|FG001|Treatment Period 3|Lost to Follow-up|1|||
127605445|NCT01641692|459183391|FG002|Treatment Period 3|Lost to Follow-up|0|||
127605446|NCT01641692|459183392|FG003|Treatment Period 3|Lost to Follow-up|0|||
127605447|NCT01641692|459183393|FG004|Treatment Period 3|Lost to Follow-up|0|||
127605448|NCT01641692|459183394|FG005|Treatment Period 3|Lost to Follow-up|0|||
127605449|NCT01641692|459183395|FG006|Treatment Period 3|Lost to Follow-up|0|||
127605450|NCT01641692|459183396|FG007|Treatment Period 3|Lost to Follow-up|0|||
127605451|NCT01641692|459183389|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
127605452|NCT01641692|459183390|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
127605453|NCT01641692|459183391|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
127605454|NCT01641692|459183392|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
127605455|NCT01641692|459183393|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
127605456|NCT01641692|459183394|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
127605457|NCT01641692|459183395|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
127605458|NCT01641692|459183396|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
127605459|NCT01641692|459183389|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
127605460|NCT01641692|459183390|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
127605461|NCT01641692|459183391|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
127605462|NCT01641692|459183392|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
127605463|NCT01641692|459183393|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
127605464|NCT01641692|459183394|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
127605465|NCT01641692|459183395|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
127605466|NCT01641692|459183396|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
127605467|NCT04948450|459183401|FG000|Overall Study|Return home|1|||
127605468|NCT04948450|459183402|FG001|Overall Study|Return home|3|||
127605469|NCT00670800|459184846|FG000|Overall Study|2 controls were insulin resistant|0|||
127605470|NCT00670800|459184847|FG001|Overall Study|2 controls were insulin resistant|2|||
127605471|NCT01786629|459184848|FG000|Overall Study|Lack of Efficacy|0|||
127605472|NCT01786629|459184849|FG001|Overall Study|Lack of Efficacy|4|||
127605473|NCT01786629|459184848|FG000|Overall Study|Adverse Event|0|||
127605474|NCT01786629|459184849|FG001|Overall Study|Adverse Event|1|||
127605475|NCT04736199|459184850|FG000|Overall Study|Adverse Event|28|||
127605476|NCT04736199|459184851|FG001|Overall Study|Adverse Event|22|||
127605477|NCT04736199|459184850|FG000|Overall Study|Death|9|||
127605478|NCT04736199|459184851|FG001|Overall Study|Death|3|||
127605479|NCT04736199|459184850|FG000|Overall Study|Lost to Follow-up|4|||
127605480|NCT04736199|459184851|FG001|Overall Study|Lost to Follow-up|1|||
127605481|NCT04736199|459184850|FG000|Overall Study|Physician Decision|5|||
127605482|NCT04736199|459184851|FG001|Overall Study|Physician Decision|9|||
127605483|NCT04736199|459184850|FG000|Overall Study|Withdrawal by Subject|21|||
127605484|NCT04736199|459184851|FG001|Overall Study|Withdrawal by Subject|9|||
127605485|NCT04736199|459184850|FG000|Overall Study|Progressive disease|120|||
127605486|NCT04736199|459184851|FG001|Overall Study|Progressive disease|101|||
127605487|NCT04736199|459184850|FG000|Overall Study|Subject decision|13|||
127605488|NCT04736199|459184851|FG001|Overall Study|Subject decision|13|||
127605489|NCT04736199|459184850|FG000|Overall Study|Required study drug interruption longer than allowed per protocol|2|||
127605490|NCT04736199|459184851|FG001|Overall Study|Required study drug interruption longer than allowed per protocol|0|||
127605491|NCT04736199|459184850|FG000|Overall Study|Additional primary malignancy|1|||
127605492|NCT04736199|459184851|FG001|Overall Study|Additional primary malignancy|0|||
127605493|NCT04736199|459184850|FG000|Overall Study|Non-compliance with study drug|0|||
127605494|NCT04736199|459184851|FG001|Overall Study|Non-compliance with study drug|1|||
127605495|NCT04736199|459184850|FG000|Overall Study|Other reason|0|||
127605496|NCT04736199|459184851|FG001|Overall Study|Other reason|1|||
127605497|NCT04736199|459184850|FG000|Overall Study|Ongoing with study drug|240|||
127605498|NCT04736199|459184851|FG001|Overall Study|Ongoing with study drug|63|||
127605499|NCT04736199|459184850|FG000|Overall Study|Study drug never administered|3|||
127697275|NCT05369403|459520111|FG001|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
127697276|NCT05369403|459520112|FG002|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
127697277|NCT05369403|459520110|FG000|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|4|||
127697278|NCT05369403|459520111|FG001|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
127605500|NCT04736199|459184851|FG001|Overall Study|Study drug never administered|0|||
127605501|NCT04318080|459184852|FG000|Overall Study|Study closed by sponsor|10|||
127605502|NCT04318080|459184853|FG001|Overall Study|Study closed by sponsor|22|||
127605503|NCT04318080|459184852|FG000|Overall Study|Death|3|||
127605504|NCT04318080|459184853|FG001|Overall Study|Death|9|||
127697279|NCT05369403|459520112|FG002|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
127605505|NCT04318080|459184852|FG000|Overall Study|Withdrawal by Subject|1|||
127605506|NCT04318080|459184853|FG001|Overall Study|Withdrawal by Subject|0|||
127605507|NCT04318080|459184852|FG000|Overall Study|Protocol Deviation|1|||
127697280|NCT05369403|459520110|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|1|||
127697281|NCT05369403|459520111|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
127697282|NCT05369403|459520112|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
127697283|NCT05369403|459520110|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|1|||
127697284|NCT05369403|459520111|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
127697285|NCT05369403|459520112|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
127697286|NCT05369403|459520110|FG000|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|0|||
127697287|NCT05369403|459520111|FG001|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|1|||
127697288|NCT05369403|459520112|FG002|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|4|||
127697289|NCT05369403|459520110|FG000|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
127697290|NCT05369403|459520111|FG001|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|1|||
127697291|NCT05369403|459520112|FG002|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
127697292|NCT05369403|459520110|FG000|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
127697293|NCT05369403|459520111|FG001|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|1|||
127697294|NCT05369403|459520112|FG002|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
127697295|NCT05368103|459520118|FG000|Overall Study|Withdrawal by Subject|4|||
127697296|NCT05368103|459520118|FG000|Overall Study|Lost to Follow-up|1|||
127697297|NCT05368103|459520118|FG000|Overall Study|Lack of Efficacy|3|||
127697298|NCT03675282|459520119|FG000|Overall Study|Lost to Follow-up|4|||
127697299|NCT03675282|459520120|FG001|Overall Study|Lost to Follow-up|8|||
127697300|NCT03675282|459520121|FG002|Overall Study|Lost to Follow-up|1|||
127697301|NCT03675282|459520122|FG003|Overall Study|Lost to Follow-up|0|||
127697302|NCT03675282|459520123|FG004|Overall Study|Lost to Follow-up|2|||
127697303|NCT03675282|459520124|FG005|Overall Study|Lost to Follow-up|7|||
127697304|NCT03675282|459520119|FG000|Overall Study|received clinical care that was exclusionary to the study|0|||
127697305|NCT03675282|459520120|FG001|Overall Study|received clinical care that was exclusionary to the study|2|||
127697306|NCT03675282|459520121|FG002|Overall Study|received clinical care that was exclusionary to the study|0|||
127697307|NCT03675282|459520122|FG003|Overall Study|received clinical care that was exclusionary to the study|0|||
127697308|NCT03675282|459520123|FG004|Overall Study|received clinical care that was exclusionary to the study|0|||
127697309|NCT03675282|459520124|FG005|Overall Study|received clinical care that was exclusionary to the study|0|||
127697310|NCT03675282|459520119|FG000|Overall Study|Physician Decision|1|||
127697311|NCT03675282|459520120|FG001|Overall Study|Physician Decision|0|||
127697312|NCT03675282|459520121|FG002|Overall Study|Physician Decision|0|||
127697313|NCT03675282|459520122|FG003|Overall Study|Physician Decision|0|||
127697314|NCT03675282|459520123|FG004|Overall Study|Physician Decision|0|||
127697315|NCT03675282|459520124|FG005|Overall Study|Physician Decision|0|||
127697316|NCT04977947|459520125|FG000|Overall Study|Lost to Follow-up|1|||
127697317|NCT04977947|459520126|FG001|Overall Study|Lost to Follow-up|1|||
127697318|NCT05875142|459520127|FG000|Overall Study|Lost to Follow-up|0|||
127697319|NCT05875142|459520128|FG001|Overall Study|Lost to Follow-up|1|||
127697320|NCT05875142|459520129|FG002|Overall Study|Lost to Follow-up|1|||
127697321|NCT05784662|459520130|FG000|Overall Study|Lost to Follow-up|21|||
127697322|NCT05784662|459520131|FG001|Overall Study|Lost to Follow-up|17|||
127697323|NCT03039023|459520155|FG000|Overall Study|Withdrawal by Subject|1|||
127697324|NCT03039023|459520156|FG001|Overall Study|Withdrawal by Subject|0|||
127697325|NCT03039023|459520157|FG002|Overall Study|Withdrawal by Subject|1|||
127697326|NCT03039023|459520158|FG003|Overall Study|Withdrawal by Subject|1|||
127697327|NCT03039023|459520159|FG004|Overall Study|Withdrawal by Subject|0|||
127697328|NCT03039023|459520155|FG000|Overall Study|Physician Decision|0|||
127697329|NCT03039023|459520156|FG001|Overall Study|Physician Decision|0|||
127697330|NCT03039023|459520157|FG002|Overall Study|Physician Decision|0|||
127697331|NCT03039023|459520158|FG003|Overall Study|Physician Decision|1|||
127697332|NCT03039023|459520159|FG004|Overall Study|Physician Decision|0|||
127697333|NCT04130438|459520160|FG000|Overall Study|Lost to Follow-up|0|||
127697334|NCT04130438|459520161|FG001|Overall Study|Lost to Follow-up|0|||
127697335|NCT04130438|459520162|FG002|Overall Study|Lost to Follow-up|1|||
127697336|NCT04739956|459520166|FG000|Overall Study|Withdrawal by Subject|1|||
127697337|NCT04739956|459520167|FG001|Overall Study|Withdrawal by Subject|1|||
127697338|NCT03920111|459520168|FG000|Overall Study|suspected covid - unable to attend study visit|0|||
127697339|NCT03920111|459520169|FG001|Overall Study|suspected covid - unable to attend study visit|0|||
127697340|NCT03920111|459520170|FG002|Overall Study|suspected covid - unable to attend study visit|1|||
127697341|NCT03519581|459520173|FG000|Overall Study|Lost to Follow-up|3|||
127697342|NCT03519581|459520174|FG001|Overall Study|Lost to Follow-up|2|||
127697343|NCT03519581|459520173|FG000|Overall Study|Adverse Event|5|||
127605508|NCT04318080|459184853|FG001|Overall Study|Protocol Deviation|0|||
127605509|NCT00410761|459184854|FG000|Randomized Treatment Period|Adverse Event|34|||
127605510|NCT00410761|459184855|FG001|Randomized Treatment Period|Adverse Event|3|||
127605511|NCT00410761|459184854|FG000|Randomized Treatment Period|Objective Disease Progression|103|||
127605512|NCT00410761|459184855|FG001|Randomized Treatment Period|Objective Disease Progression|68|||
127605513|NCT00410761|459184854|FG000|Randomized Treatment Period|Withdrawal by Subject|11|||
127605514|NCT00410761|459184855|FG001|Randomized Treatment Period|Withdrawal by Subject|6|||
127605515|NCT00410761|459184854|FG000|Randomized Treatment Period|Other|69|||
127605516|NCT00410761|459184855|FG001|Randomized Treatment Period|Other|21|||
127605517|NCT00410761|459184854|FG000|Randomized Treatment Period|Randomized but did not Receive Treatment|0|||
127605518|NCT00410761|459184855|FG001|Randomized Treatment Period|Randomized but did not Receive Treatment|1|||
127605519|NCT00410761|459184854|FG000|Open-Label Treatment Period|Adverse Event|13|||
127605520|NCT00410761|459184855|FG001|Open-Label Treatment Period|Adverse Event|15|||
127605521|NCT00410761|459184854|FG000|Open-Label Treatment Period|Objective Disease Progression|42|||
127605522|NCT00410761|459184855|FG001|Open-Label Treatment Period|Objective Disease Progression|27|||
127605523|NCT00410761|459184854|FG000|Open-Label Treatment Period|Withdrawal by Subject|8|||
127605524|NCT00410761|459184855|FG001|Open-Label Treatment Period|Withdrawal by Subject|7|||
127605525|NCT00410761|459184854|FG000|Open-Label Treatment Period|Other|18|||
127605526|NCT00410761|459184855|FG001|Open-Label Treatment Period|Other|9|||
127605527|NCT02926924|459184856|FG000|Overall Study|withdrawal - reason unknown|0|||
127605528|NCT02926924|459184857|FG001|Overall Study|withdrawal - reason unknown|1|||
127605529|NCT02750592|459184859|FG000|Overall Study|Adverse Event|3|||
127605530|NCT02750592|459184859|FG000|Overall Study|Lack of Efficacy|2|||
127605531|NCT02981342|459184862|FG000|Overall Study|Adverse Event|0|||
127605532|NCT02981342|459184863|FG001|Overall Study|Adverse Event|0|||
127605533|NCT02981342|459184864|FG002|Overall Study|Adverse Event|0|||
127605534|NCT02981342|459184865|FG003|Overall Study|Adverse Event|1|||
127605535|NCT02981342|459184862|FG000|Overall Study|Death|0|||
127605536|NCT02981342|459184863|FG001|Overall Study|Death|9|||
127605537|NCT02981342|459184864|FG002|Overall Study|Death|9|||
127605538|NCT02981342|459184865|FG003|Overall Study|Death|4|||
127605539|NCT02981342|459184862|FG000|Overall Study|Withdrawal by Subject|0|||
127605540|NCT02981342|459184863|FG001|Overall Study|Withdrawal by Subject|0|||
127605541|NCT02981342|459184864|FG002|Overall Study|Withdrawal by Subject|3|||
127605542|NCT02981342|459184865|FG003|Overall Study|Withdrawal by Subject|1|||
127605543|NCT02981342|459184862|FG000|Overall Study|Study closed by sponsor|0|||
127605544|NCT02981342|459184863|FG001|Overall Study|Study closed by sponsor|0|||
127605545|NCT02981342|459184864|FG002|Overall Study|Study closed by sponsor|1|||
127605546|NCT02981342|459184865|FG003|Overall Study|Study closed by sponsor|1|||
127605547|NCT02981342|459184862|FG000|Overall Study|Randomized, Never Treated|0|||
127605548|NCT02981342|459184863|FG001|Overall Study|Randomized, Never Treated|1|||
127605549|NCT02981342|459184864|FG002|Overall Study|Randomized, Never Treated|0|||
127605550|NCT02981342|459184865|FG003|Overall Study|Randomized, Never Treated|7|||
127605551|NCT02981342|459184862|FG000|Overall Study|Lost to Follow-up|0|||
127605552|NCT02981342|459184863|FG001|Overall Study|Lost to Follow-up|1|||
127605553|NCT02981342|459184864|FG002|Overall Study|Lost to Follow-up|0|||
127605554|NCT02981342|459184865|FG003|Overall Study|Lost to Follow-up|0|||
127605555|NCT05333900|459184866|FG000|Overall Study|Protocol Violation|0|||
127605556|NCT05333900|459184867|FG001|Overall Study|Protocol Violation|1|||
127605557|NCT05333900|459184866|FG000|Overall Study|Withdrawal by Subject|0|||
127605558|NCT05333900|459184867|FG001|Overall Study|Withdrawal by Subject|1|||
127697344|NCT03519581|459520174|FG001|Overall Study|Adverse Event|2|||
127697345|NCT03519581|459520173|FG000|Overall Study|Withdrawal by Subject|2|||
127697346|NCT03519581|459520174|FG001|Overall Study|Withdrawal by Subject|0|||
127697347|NCT03519581|459520173|FG000|Overall Study|Change to insurance|2|||
127697348|NCT03519581|459520174|FG001|Overall Study|Change to insurance|1|||
127697349|NCT03519581|459520173|FG000|Overall Study|Other|2|||
127697350|NCT03519581|459520174|FG001|Overall Study|Other|4|||
127697351|NCT05268393|459520175|FG000|Overall Study|Withdrawal by Subject|2|||
127697352|NCT05268393|459520176|FG001|Overall Study|Withdrawal by Subject|1|||
127697353|NCT03396926|459520177|FG000|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|0|||
127697354|NCT03396926|459520178|FG001|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|4|||
127697355|NCT04764448|459520179|FG000|Overall Study|Study terminated by sponsor|2|||
127697356|NCT04764448|459520180|FG001|Overall Study|Study terminated by sponsor|2|||
127697357|NCT04764448|459520181|FG002|Overall Study|Study terminated by sponsor|5|||
127697358|NCT04764448|459520179|FG000|Overall Study|Withdrawal by Subject|3|||
127697359|NCT04764448|459520180|FG001|Overall Study|Withdrawal by Subject|3|||
127697360|NCT04764448|459520181|FG002|Overall Study|Withdrawal by Subject|1|||
127697361|NCT05256706|459520185|FG000|Overall Study|Lost to Follow-up|9|||
127697362|NCT05256706|459520186|FG001|Overall Study|Lost to Follow-up|3|||
127605559|NCT05333900|459184866|FG000|Overall Study|COVID-19 Pandemic|1|||
127605560|NCT05333900|459184867|FG001|Overall Study|COVID-19 Pandemic|1|||
127605561|NCT03724812|459184868|FG000|Overall Study|Missed Visit|1|||
127605562|NCT03724812|459184868|FG000|Overall Study|Death|2|||
127605563|NCT03724812|459184868|FG000|Overall Study|Withdrawal by Subject|1|||
127605564|NCT01394523|459184869|FG000|Overall Study|Unable to place block|1|||
127605565|NCT01394523|459184870|FG001|Overall Study|Unable to place block|0|||
127605566|NCT01394523|459184871|FG002|Overall Study|Unable to place block|0|||
127605567|NCT03525574|459184872|FG000|Overall Study|Adverse Event|15|||
127605568|NCT03525574|459184873|FG001|Overall Study|Adverse Event|0|||
127605569|NCT03525574|459184872|FG000|Overall Study|Withdrawal of consent (not due to AE)|18|||
127605570|NCT03525574|459184873|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
127605571|NCT03525574|459184872|FG000|Overall Study|Lost to Follow-up|4|||
127605572|NCT03525574|459184873|FG001|Overall Study|Lost to Follow-up|0|||
127605573|NCT03525574|459184872|FG000|Overall Study|Commercial drug is Available for participant|48|||
127605574|NCT03525574|459184873|FG001|Overall Study|Commercial drug is Available for participant|0|||
127605575|NCT03525574|459184872|FG000|Overall Study|Death|1|||
127605576|NCT03525574|459184873|FG001|Overall Study|Death|0|||
127605577|NCT03525574|459184872|FG000|Overall Study|Other non-compliance|2|||
127605578|NCT03525574|459184873|FG001|Overall Study|Other non-compliance|0|||
127605579|NCT03525574|459184872|FG000|Overall Study|Physician Decision|6|||
127605580|NCT03525574|459184873|FG001|Overall Study|Physician Decision|0|||
127605581|NCT03525574|459184872|FG000|Overall Study|Other|58|||
127605582|NCT03525574|459184873|FG001|Overall Study|Other|0|||
127605583|NCT03525574|459184872|FG000|Overall Study|Enrolled but never dosed|1|||
127605584|NCT03525574|459184873|FG001|Overall Study|Enrolled but never dosed|0|||
127605585|NCT03525574|459184872|FG000|Overall Study|Not enrolled in 105 study|0|||
127605586|NCT03525574|459184873|FG001|Overall Study|Not enrolled in 105 study|3|||
127605587|NCT04741074|459184876|FG000|Overall Study|Withdrawal by Subject|1|||
127605588|NCT04741074|459184877|FG001|Overall Study|Withdrawal by Subject|1|||
127605589|NCT04741074|459184876|FG000|Overall Study|Study terminated prematurely|1|||
127605590|NCT04741074|459184877|FG001|Overall Study|Study terminated prematurely|0|||
127605591|NCT02432846|459184878|FG000|Overall Study (4 Arms/Strata)|Death|3|||
127605592|NCT02432846|459184879|FG001|Overall Study (4 Arms/Strata)|Death|2|||
127605593|NCT02432846|459184880|FG002|Overall Study (4 Arms/Strata)|Death|4|||
127605594|NCT02432846|459184881|FG003|Overall Study (4 Arms/Strata)|Death|3|||
127605595|NCT02432846|459184882|FG004|Overall Study (4 Arms/Strata)|Death|0|||
127605596|NCT02432846|459184883|FG005|Overall Study (4 Arms/Strata)|Death|0|||
127605597|NCT02432846|459184878|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
127605598|NCT02432846|459184879|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
127605599|NCT02432846|459184880|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
127605600|NCT02432846|459184881|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
127605601|NCT02432846|459184882|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
127605602|NCT02432846|459184883|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
127605603|NCT02432846|459184878|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
127605604|NCT02432846|459184879|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
127605605|NCT02432846|459184880|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
127605606|NCT02432846|459184881|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
127605607|NCT02432846|459184882|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
127605608|NCT02432846|459184883|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
127605609|NCT02432846|459184878|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
127605610|NCT02432846|459184879|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
127605611|NCT02432846|459184880|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
127605612|NCT02432846|459184881|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
127605613|NCT02432846|459184882|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
127605614|NCT02432846|459184883|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
127605615|NCT02432846|459184878|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
127605616|NCT02432846|459184879|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
127605617|NCT02432846|459184880|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
127605618|NCT02432846|459184881|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
127605619|NCT02432846|459184882|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
127605620|NCT02432846|459184883|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
127605621|NCT02432846|459184878|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
127605622|NCT02432846|459184879|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
127605623|NCT02432846|459184880|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
127605624|NCT02432846|459184881|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
127697363|NCT05256706|459520185|FG000|Overall Study|Withdrawal by Subject|7|||
127697364|NCT05256706|459520186|FG001|Overall Study|Withdrawal by Subject|11|||
127605625|NCT02432846|459184882|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
127605626|NCT02432846|459184883|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
127605627|NCT02432846|459184878|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
127605628|NCT02432846|459184879|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
127605629|NCT02432846|459184880|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
127605630|NCT02432846|459184881|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
127605631|NCT02432846|459184882|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
127697365|NCT05256706|459520185|FG000|Overall Study|Screen Failures|3|||
127697366|NCT05256706|459520186|FG001|Overall Study|Screen Failures|0|||
127605632|NCT02432846|459184883|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
127605633|NCT02432846|459184878|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
127605634|NCT02432846|459184879|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
127605635|NCT02432846|459184880|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
127605636|NCT02432846|459184881|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
127605637|NCT02432846|459184882|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
127605638|NCT02432846|459184883|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
127605639|NCT02432846|459184878|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
127605640|NCT02432846|459184879|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
127605641|NCT02432846|459184880|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
127605642|NCT02432846|459184881|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
127605643|NCT02432846|459184882|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
127605644|NCT02432846|459184883|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
127882873|NCT01682512|460194600|FG002|Overall Study|Secondary lack of efficacy|0|||
127605645|NCT02432846|459184878|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
127605646|NCT02432846|459184879|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
127605647|NCT02432846|459184880|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
127605648|NCT02432846|459184881|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
127882874|NCT01682512|460194598|FG000|Overall Study|Other than stated above|2|||
127882875|NCT01682512|460194599|FG001|Overall Study|Other than stated above|4|||
127882876|NCT01682512|460194600|FG002|Overall Study|Other than stated above|2|||
127882877|NCT00054275|460194603|FG000|Overall Study|Withdrawal by Subject|4|||
127882878|NCT00054275|460194603|FG000|Overall Study|Adverse Event|5|||
127882879|NCT00054275|460194603|FG000|Overall Study|Progressive disease in cycle 1|1|||
127882880|NCT00054275|460194603|FG000|Overall Study|Physician Decision|1|||
127882881|NCT02030834|460194611|FG000|Overall Study|Death|4|||
127882882|NCT02030834|460194612|FG001|Overall Study|Death|0|||
127882883|NCT02030834|460194613|FG002|Overall Study|Death|0|||
127882884|NCT02030834|460194611|FG000|Overall Study|Manufacturing failure|2|||
127882885|NCT02030834|460194612|FG001|Overall Study|Manufacturing failure|0|||
127882886|NCT02030834|460194613|FG002|Overall Study|Manufacturing failure|1|||
127882887|NCT02030834|460194611|FG000|Overall Study|Disease progression|2|||
127882888|NCT02030834|460194612|FG001|Overall Study|Disease progression|0|||
127882889|NCT02030834|460194613|FG002|Overall Study|Disease progression|2|||
127882890|NCT02030834|460194611|FG000|Overall Study|Lost to Follow-up|1|||
127882891|NCT02030834|460194612|FG001|Overall Study|Lost to Follow-up|0|||
127882892|NCT02030834|460194613|FG002|Overall Study|Lost to Follow-up|0|||
127882893|NCT02030834|460194611|FG000|Overall Study|Withdrawal by Subject|1|||
127882894|NCT02030834|460194612|FG001|Overall Study|Withdrawal by Subject|0|||
127882895|NCT02030834|460194613|FG002|Overall Study|Withdrawal by Subject|0|||
127882896|NCT02030834|460194611|FG000|Overall Study|Lack of funding|1|||
127882897|NCT02030834|460194612|FG001|Overall Study|Lack of funding|0|||
127882898|NCT02030834|460194613|FG002|Overall Study|Lack of funding|0|||
127882899|NCT00996918|460194616|FG000|Overall Study|Lack of Efficacy|1|||
127882900|NCT00996918|460194617|FG001|Overall Study|Lack of Efficacy|1|||
127882901|NCT00996918|460194618|FG002|Overall Study|Lack of Efficacy|2|||
127882902|NCT00996918|460194619|FG003|Overall Study|Lack of Efficacy|2|||
127882903|NCT00996918|460194620|FG004|Overall Study|Lack of Efficacy|0|||
127882904|NCT00996918|460194616|FG000|Overall Study|Adverse Event|2|||
127882905|NCT00996918|460194617|FG001|Overall Study|Adverse Event|5|||
127605649|NCT02432846|459184882|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
127605650|NCT02432846|459184883|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
127605651|NCT02432846|459184878|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
127605652|NCT02432846|459184879|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
127605653|NCT02432846|459184880|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
127605654|NCT02432846|459184881|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
127605655|NCT02432846|459184882|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
127605656|NCT02432846|459184883|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
127605657|NCT02432846|459184878|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
127605658|NCT02432846|459184879|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
127605659|NCT02432846|459184880|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
127882906|NCT00996918|460194618|FG002|Overall Study|Adverse Event|2|||
127882907|NCT00996918|460194619|FG003|Overall Study|Adverse Event|6|||
127882908|NCT00996918|460194620|FG004|Overall Study|Adverse Event|0|||
127882909|NCT00996918|460194616|FG000|Overall Study|Withdrawal by Subject|1|||
127882910|NCT00996918|460194617|FG001|Overall Study|Withdrawal by Subject|4|||
127882911|NCT00996918|460194618|FG002|Overall Study|Withdrawal by Subject|3|||
127882912|NCT00996918|460194619|FG003|Overall Study|Withdrawal by Subject|3|||
127882913|NCT00996918|460194620|FG004|Overall Study|Withdrawal by Subject|2|||
127882914|NCT00996918|460194616|FG000|Overall Study|Physician Decision|1|||
127882915|NCT00996918|460194617|FG001|Overall Study|Physician Decision|0|||
127882916|NCT00996918|460194618|FG002|Overall Study|Physician Decision|0|||
127697367|NCT01997840|459520187|FG000|Overall Study|Lost to Follow-up|0|||
127697368|NCT01997840|459520188|FG001|Overall Study|Lost to Follow-up|0|||
127697369|NCT01997840|459520189|FG002|Overall Study|Lost to Follow-up|1|||
127697370|NCT01997840|459520190|FG003|Overall Study|Lost to Follow-up|0|||
127697371|NCT01997840|459520187|FG000|Overall Study|Withdrawal by participant|0|||
127697372|NCT01997840|459520188|FG001|Overall Study|Withdrawal by participant|0|||
127697373|NCT01997840|459520189|FG002|Overall Study|Withdrawal by participant|8|||
127697374|NCT01997840|459520190|FG003|Overall Study|Withdrawal by participant|1|||
127697375|NCT01997840|459520187|FG000|Overall Study|Physician Decision|0|||
127697376|NCT01997840|459520188|FG001|Overall Study|Physician Decision|0|||
127697377|NCT01997840|459520189|FG002|Overall Study|Physician Decision|3|||
127788733|NCT00705783|459851278|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
127788734|NCT00705783|459851279|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
127788735|NCT00705783|459851280|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
127788736|NCT00705783|459851278|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
127788737|NCT00705783|459851279|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
127605660|NCT02432846|459184881|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
127605661|NCT02432846|459184882|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
127605662|NCT02432846|459184883|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
127605663|NCT02432846|459184878|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
127605664|NCT02432846|459184879|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
127605665|NCT02432846|459184880|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
127605666|NCT02432846|459184881|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
127605667|NCT02432846|459184882|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
127605668|NCT02432846|459184883|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
127605669|NCT02432846|459184878|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
127605670|NCT02432846|459184879|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
127605671|NCT02432846|459184880|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
127605672|NCT02432846|459184881|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
127605673|NCT02432846|459184882|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
127605674|NCT02432846|459184883|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
127605675|NCT01770379|459184884|FG000|Overall Study|Technical issues|1|||
127605676|NCT01770379|459184885|FG001|Overall Study|Technical issues|0|||
127605677|NCT01770379|459184886|FG002|Overall Study|Technical issues|0|||
127605678|NCT01770379|459184884|FG000|Overall Study|Withdrawal by Subject|7|||
127605679|NCT01770379|459184885|FG001|Overall Study|Withdrawal by Subject|10|||
127605680|NCT01770379|459184886|FG002|Overall Study|Withdrawal by Subject|7|||
127605681|NCT01770379|459184884|FG000|Overall Study|study terminated by sponsor|22|||
127605682|NCT01770379|459184885|FG001|Overall Study|study terminated by sponsor|23|||
127605683|NCT01770379|459184886|FG002|Overall Study|study terminated by sponsor|22|||
127605684|NCT01770379|459184884|FG000|Overall Study|Protocol Violation|0|||
127605685|NCT01770379|459184885|FG001|Overall Study|Protocol Violation|1|||
127605686|NCT01770379|459184886|FG002|Overall Study|Protocol Violation|1|||
127605687|NCT01770379|459184884|FG000|Overall Study|Physician Decision|0|||
127605688|NCT01770379|459184885|FG001|Overall Study|Physician Decision|1|||
127605689|NCT01770379|459184886|FG002|Overall Study|Physician Decision|2|||
127605690|NCT01770379|459184884|FG000|Overall Study|Lost to Follow-up|0|||
127605691|NCT01770379|459184885|FG001|Overall Study|Lost to Follow-up|0|||
127605692|NCT01770379|459184886|FG002|Overall Study|Lost to Follow-up|2|||
127605693|NCT01770379|459184884|FG000|Overall Study|Lack of Efficacy|8|||
127605694|NCT01770379|459184885|FG001|Overall Study|Lack of Efficacy|6|||
127605695|NCT01770379|459184886|FG002|Overall Study|Lack of Efficacy|6|||
127605696|NCT01770379|459184884|FG000|Overall Study|Adverse Event|1|||
127605697|NCT01770379|459184885|FG001|Overall Study|Adverse Event|3|||
127605698|NCT01770379|459184886|FG002|Overall Study|Adverse Event|2|||
127605699|NCT03045887|459184887|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
127605700|NCT03045887|459184888|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
127605701|NCT03045887|459184889|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
127605702|NCT03045887|459184890|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
127605703|NCT03045887|459184891|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
127605704|NCT03045887|459184892|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
127697378|NCT01997840|459520190|FG003|Overall Study|Physician Decision|0|||
127788738|NCT00705783|459851280|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
127788739|NCT00705783|459851278|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
127605705|NCT03045887|459184893|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
127788740|NCT00705783|459851279|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
127605706|NCT03045887|459184894|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
127605707|NCT03045887|459184895|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
127605708|NCT03045887|459184896|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
127697379|NCT01997840|459520187|FG000|Overall Study|Progressive disease|3|||
127697380|NCT01997840|459520188|FG001|Overall Study|Progressive disease|4|||
127697381|NCT01997840|459520189|FG002|Overall Study|Progressive disease|57|||
127605709|NCT03045887|459184887|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
127605710|NCT03045887|459184888|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
127605711|NCT03045887|459184889|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
127605712|NCT03045887|459184890|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
127605713|NCT03045887|459184891|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
127605714|NCT03045887|459184892|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
127605715|NCT03045887|459184893|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
127605716|NCT03045887|459184894|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
127605717|NCT03045887|459184895|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
127605718|NCT03045887|459184896|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
127605719|NCT03045887|459184887|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
127605720|NCT03045887|459184888|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
127605721|NCT03045887|459184889|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
127605722|NCT03045887|459184890|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
127605723|NCT03045887|459184891|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
127605724|NCT03045887|459184892|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
127605725|NCT03045887|459184893|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
127605726|NCT03045887|459184894|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
127605727|NCT03045887|459184895|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
127605728|NCT03045887|459184896|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
127605729|NCT03045887|459184887|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
127605730|NCT03045887|459184888|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
127605731|NCT03045887|459184889|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
127605732|NCT03045887|459184890|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
127605733|NCT03045887|459184891|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
127605734|NCT03045887|459184892|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
127605735|NCT03045887|459184893|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
127605736|NCT03045887|459184894|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
127605737|NCT03045887|459184895|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
127605738|NCT03045887|459184896|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
127605739|NCT03045887|459184887|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
127605740|NCT03045887|459184888|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
127605741|NCT03045887|459184889|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
127605742|NCT03045887|459184890|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
127605743|NCT03045887|459184891|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
127605744|NCT03045887|459184892|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
127605745|NCT03045887|459184893|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
127605746|NCT03045887|459184894|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
127605747|NCT03045887|459184895|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
127605748|NCT03045887|459184896|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
127605749|NCT01912287|459184898|FG000|Overall Study|Ineligible|1|||
127605750|NCT01912287|459184899|FG001|Overall Study|Ineligible|0|||
127788741|NCT00705783|459851280|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
127788742|NCT00705783|459851278|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
127788743|NCT00705783|459851279|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
127788744|NCT00705783|459851280|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
127788745|NCT00705783|459851278|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
127788746|NCT00705783|459851279|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
127788747|NCT00705783|459851280|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
127788748|NCT00705783|459851278|FG000|Depot Stabilization Phase|Adverse Event|17|||
127788749|NCT00705783|459851279|FG001|Depot Stabilization Phase|Adverse Event|0|||
127788750|NCT00705783|459851280|FG002|Depot Stabilization Phase|Adverse Event|0|||
127788751|NCT00705783|459851278|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
127788752|NCT00705783|459851279|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
127788753|NCT00705783|459851280|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
127788754|NCT00705783|459851278|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
127788755|NCT00705783|459851279|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
127788756|NCT00705783|459851280|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
127788757|NCT00705783|459851278|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
127788758|NCT00705783|459851279|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
127788759|NCT00705783|459851280|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
127605751|NCT01912287|459184900|FG002|Overall Study|Ineligible|1|||
127605752|NCT01912287|459184898|FG000|Overall Study|No-show|0|||
127605753|NCT01912287|459184899|FG001|Overall Study|No-show|0|||
127605754|NCT01912287|459184900|FG002|Overall Study|No-show|1|||
127605755|NCT01912287|459184898|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
127605756|NCT01912287|459184899|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
127605757|NCT01912287|459184900|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
127788760|NCT00705783|459851278|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
127605758|NCT01912287|459184898|FG000|Overall Study|Felt treatment no longer needed|0|||
127605759|NCT01912287|459184899|FG001|Overall Study|Felt treatment no longer needed|1|||
127605760|NCT01912287|459184900|FG002|Overall Study|Felt treatment no longer needed|0|||
127605761|NCT01912287|459184898|FG000|Overall Study|Life circumstances|4|||
127605762|NCT01912287|459184899|FG001|Overall Study|Life circumstances|2|||
127605763|NCT01912287|459184900|FG002|Overall Study|Life circumstances|0|||
127605764|NCT01912287|459184898|FG000|Overall Study|Lost Interest|1|||
127605765|NCT01912287|459184899|FG001|Overall Study|Lost Interest|0|||
127605766|NCT01912287|459184900|FG002|Overall Study|Lost Interest|0|||
127605767|NCT01912287|459184898|FG000|Overall Study|Uknown reason - subject drop out|5|||
127605768|NCT01912287|459184899|FG001|Overall Study|Uknown reason - subject drop out|7|||
127605769|NCT01912287|459184900|FG002|Overall Study|Uknown reason - subject drop out|3|||
127605770|NCT01912287|459184898|FG000|Overall Study|Missed Assesment|1|||
127605771|NCT01912287|459184899|FG001|Overall Study|Missed Assesment|1|||
127605772|NCT01912287|459184900|FG002|Overall Study|Missed Assesment|1|||
127605773|NCT01912287|459184898|FG000|Overall Study|Scheduling/change in availability|17|||
127605774|NCT01912287|459184899|FG001|Overall Study|Scheduling/change in availability|10|||
127605775|NCT01912287|459184900|FG002|Overall Study|Scheduling/change in availability|8|||
127605776|NCT03914326|459184903|FG000|Overall Study|Withdrawal by Subject|27|||
127605777|NCT03914326|459184904|FG001|Overall Study|Withdrawal by Subject|34|||
127605778|NCT03914326|459184903|FG000|Overall Study|Lost to Follow-up|43|||
127605779|NCT03914326|459184904|FG001|Overall Study|Lost to Follow-up|51|||
127605780|NCT03914326|459184903|FG000|Overall Study|Randomised more than once|0|||
127605781|NCT03914326|459184904|FG001|Overall Study|Randomised more than once|1|||
127605782|NCT03226392|459184909|FG000|Overall Study|Protocol Deviation|1|||
127605783|NCT03226392|459184910|FG001|Overall Study|Protocol Deviation|0|||
127605784|NCT03226392|459184909|FG000|Overall Study|Physician Decision|1|||
127605785|NCT03226392|459184910|FG001|Overall Study|Physician Decision|0|||
127605786|NCT03226392|459184909|FG000|Overall Study|Lost to Follow-up|1|||
127605787|NCT03226392|459184910|FG001|Overall Study|Lost to Follow-up|0|||
127605788|NCT03226392|459184909|FG000|Overall Study|Adverse Event|1|||
127605789|NCT03226392|459184910|FG001|Overall Study|Adverse Event|0|||
127605790|NCT03226392|459184909|FG000|Overall Study|Technical Problems|0|||
127605791|NCT03226392|459184910|FG001|Overall Study|Technical Problems|2|||
127605792|NCT03226392|459184909|FG000|Overall Study|Subject/Guardian Decision|7|||
127605793|NCT03226392|459184910|FG001|Overall Study|Subject/Guardian Decision|6|||
127605794|NCT02357901|459184911|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
127605795|NCT02357901|459184912|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
127605796|NCT02357901|459184913|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
127605797|NCT02357901|459184914|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
127605798|NCT02357901|459184911|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
127605799|NCT02357901|459184912|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
127605800|NCT02357901|459184913|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
127605801|NCT02357901|459184914|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
127605802|NCT02357901|459184911|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
127605803|NCT02357901|459184912|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
127605804|NCT02357901|459184913|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
127605805|NCT02357901|459184914|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
127605806|NCT02357901|459184911|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
127605807|NCT02357901|459184912|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
127605808|NCT02357901|459184913|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
127605809|NCT02357901|459184914|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
127605810|NCT02357901|459184911|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
127605811|NCT02357901|459184912|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
127605812|NCT02357901|459184913|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
127605813|NCT02357901|459184914|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
127605814|NCT02357901|459184911|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
127605815|NCT02357901|459184912|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
127605816|NCT02357901|459184913|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
127605817|NCT02357901|459184914|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
127605818|NCT02357901|459184911|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
127605819|NCT02357901|459184912|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
127605820|NCT02357901|459184913|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
127605821|NCT02357901|459184914|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
127605822|NCT02357901|459184911|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
127605823|NCT02357901|459184912|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
127605824|NCT02357901|459184913|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
127605825|NCT02357901|459184914|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
127605826|NCT02357901|459184911|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
127697382|NCT01997840|459520190|FG003|Overall Study|Progressive disease|8|||
127697383|NCT01997840|459520187|FG000|Overall Study|Other reasons|0|||
127697384|NCT01997840|459520188|FG001|Overall Study|Other reasons|0|||
127697385|NCT01997840|459520189|FG002|Overall Study|Other reasons|1|||
127697386|NCT01997840|459520190|FG003|Overall Study|Other reasons|0|||
127697387|NCT01997840|459520187|FG000|Overall Study|Adverse Event|0|||
127697388|NCT01997840|459520188|FG001|Overall Study|Adverse Event|0|||
127697389|NCT01997840|459520189|FG002|Overall Study|Adverse Event|15|||
127697390|NCT01997840|459520190|FG003|Overall Study|Adverse Event|2|||
127697391|NCT03850678|459520191|FG000|Overall Study|Withdrawal by Subject|3|||
127697392|NCT03850678|459520192|FG001|Overall Study|Withdrawal by Subject|0|||
127697393|NCT03850678|459520191|FG000|Overall Study|Experimenter Error|1|||
127697394|NCT03850678|459520192|FG001|Overall Study|Experimenter Error|1|||
127697395|NCT03850678|459520191|FG000|Overall Study|Did Not Condition To Experiment|7|||
127697396|NCT03850678|459520192|FG001|Overall Study|Did Not Condition To Experiment|2|||
127697397|NCT04322643|459520203|FG000|Overall Study|Study halted prematurely therefore treatment halted.|4|||
127697398|NCT03891667|459520204|FG000|Overall Study|Physician Decision|1|||
127697399|NCT03891667|459520205|FG001|Overall Study|Physician Decision|1|||
127697400|NCT03891667|459520204|FG000|Overall Study|COVID related pause|1|||
127605827|NCT02357901|459184912|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
127605828|NCT02357901|459184913|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
127605829|NCT02357901|459184914|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
127605830|NCT02357901|459184911|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
127605831|NCT02357901|459184912|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
127605832|NCT02357901|459184913|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
127605833|NCT02357901|459184914|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
127605834|NCT02357901|459184911|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
127605835|NCT02357901|459184912|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
127605836|NCT02357901|459184913|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
127605837|NCT02357901|459184914|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
127605838|NCT04788953|459184915|FG000|Overall Study|Adverse Event|1|||
127605839|NCT04788953|459184916|FG001|Overall Study|Adverse Event|1|||
127605840|NCT04788953|459184915|FG000|Overall Study|Withdrawal by Subject|1|||
127605841|NCT04788953|459184916|FG001|Overall Study|Withdrawal by Subject|0|||
127605842|NCT04788953|459184915|FG000|Overall Study|Protocol Violation|0|||
127605843|NCT04788953|459184916|FG001|Overall Study|Protocol Violation|1|||
127605844|NCT00491387|459184917|FG000|Overall Study|study terminated|20|||
127605845|NCT02631850|459184918|FG000|Treatment Period|Lost to Follow-up|0|||
127605846|NCT02631850|459184919|FG001|Treatment Period|Lost to Follow-up|1|||
127605847|NCT02631850|459184920|FG002|Treatment Period|Lost to Follow-up|0|||
127605848|NCT02631850|459184921|FG003|Treatment Period|Lost to Follow-up|0|||
127605849|NCT02631850|459184918|FG000|Treatment Period|Protocol Violation|1|||
127605850|NCT02631850|459184919|FG001|Treatment Period|Protocol Violation|0|||
127605851|NCT02631850|459184920|FG002|Treatment Period|Protocol Violation|0|||
127605852|NCT02631850|459184921|FG003|Treatment Period|Protocol Violation|0|||
127605853|NCT02631850|459184918|FG000|Treatment Period|Withdrawal by Subject|0|||
127605854|NCT02631850|459184919|FG001|Treatment Period|Withdrawal by Subject|5|||
127605855|NCT02631850|459184920|FG002|Treatment Period|Withdrawal by Subject|2|||
127605856|NCT02631850|459184921|FG003|Treatment Period|Withdrawal by Subject|2|||
127605857|NCT02631850|459184918|FG000|Treatment Period|Adverse Event|1|||
127605858|NCT02631850|459184919|FG001|Treatment Period|Adverse Event|0|||
127605859|NCT02631850|459184920|FG002|Treatment Period|Adverse Event|2|||
127605860|NCT02631850|459184921|FG003|Treatment Period|Adverse Event|3|||
127605861|NCT02631850|459184918|FG000|Treatment Period|Family medical issue|1|||
127605862|NCT02631850|459184919|FG001|Treatment Period|Family medical issue|0|||
127605863|NCT02631850|459184920|FG002|Treatment Period|Family medical issue|0|||
127605864|NCT02631850|459184921|FG003|Treatment Period|Family medical issue|0|||
127605865|NCT02631850|459184918|FG000|6 Month Follow up|Lost to Follow-up|5|||
127605866|NCT02631850|459184919|FG001|6 Month Follow up|Lost to Follow-up|8|||
127605867|NCT02631850|459184920|FG002|6 Month Follow up|Lost to Follow-up|3|||
127605868|NCT02631850|459184921|FG003|6 Month Follow up|Lost to Follow-up|5|||
127605869|NCT02631850|459184918|FG000|6 Month Follow up|Withdrawal by Subject|1|||
127605870|NCT02631850|459184919|FG001|6 Month Follow up|Withdrawal by Subject|0|||
127605871|NCT02631850|459184920|FG002|6 Month Follow up|Withdrawal by Subject|0|||
127605872|NCT02631850|459184921|FG003|6 Month Follow up|Withdrawal by Subject|2|||
127605873|NCT02631850|459184918|FG000|6 Month Follow up|Adverse Event|1|||
127605874|NCT02631850|459184919|FG001|6 Month Follow up|Adverse Event|4|||
127605875|NCT02631850|459184920|FG002|6 Month Follow up|Adverse Event|1|||
127697401|NCT03891667|459520205|FG001|Overall Study|COVID related pause|0|||
127697402|NCT03891667|459520204|FG000|Overall Study|Withdrawal by Subject|0|||
127697403|NCT03891667|459520205|FG001|Overall Study|Withdrawal by Subject|1|||
127605876|NCT02631850|459184921|FG003|6 Month Follow up|Adverse Event|3|||
127605877|NCT02631850|459184918|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
127605878|NCT02631850|459184919|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
127605879|NCT02631850|459184920|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
127605880|NCT02631850|459184921|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
127605881|NCT01998737|459184922|FG000|Overall Study|Corrupted database|23|||
127605882|NCT01998737|459184923|FG001|Overall Study|Corrupted database|0|||
127605883|NCT00227305|459184928|FG000|Overall Study|Adverse Event|40|||
127605884|NCT00227305|459184928|FG000|Overall Study|Withdrawal by Subject|42|||
127605885|NCT00227305|459184928|FG000|Overall Study|Lost to Follow-up|33|||
127605886|NCT00227305|459184928|FG000|Overall Study|Study specific discontinuation|13|||
127605887|NCT00227305|459184928|FG000|Overall Study|MOVED OUT OF AREA|3|||
127605888|NCT00227305|459184928|FG000|Overall Study|Lack of Efficacy|7|||
127605889|NCT00227305|459184928|FG000|Overall Study|Physician Decision|3|||
127605890|NCT00227305|459184928|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
127605891|NCT00227305|459184928|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
127605892|NCT00227305|459184928|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
127605893|NCT03311659|459184933|FG000|Overall Study|Protocol Violation|1|||
127605894|NCT00071760|459184934|FG000|Overall Study|Adverse Event|2|||
127605895|NCT00071760|459184935|FG001|Overall Study|Adverse Event|1|||
127605896|NCT00071760|459184934|FG000|Overall Study|Lost to Follow-up|0|||
127605897|NCT00071760|459184935|FG001|Overall Study|Lost to Follow-up|3|||
127605898|NCT00071760|459184934|FG000|Overall Study|Protocol Violation|1|||
127605899|NCT00071760|459184935|FG001|Overall Study|Protocol Violation|0|||
127605900|NCT00071760|459184934|FG000|Overall Study|Withdrawal by Subject|0|||
127605901|NCT00071760|459184935|FG001|Overall Study|Withdrawal by Subject|1|||
127605902|NCT00071760|459184934|FG000|Overall Study|Insufficient Viral Load Response|1|||
127605903|NCT00071760|459184935|FG001|Overall Study|Insufficient Viral Load Response|1|||
127605904|NCT00071760|459184934|FG000|Overall Study|Lack of availability of RTV|1|||
127605905|NCT00071760|459184935|FG001|Overall Study|Lack of availability of RTV|0|||
127605906|NCT00071760|459184934|FG000|Overall Study|Physician Decision|2|||
127605907|NCT00071760|459184935|FG001|Overall Study|Physician Decision|1|||
127605908|NCT00071760|459184934|FG000|Overall Study|Relocation|0|||
127605909|NCT00071760|459184935|FG001|Overall Study|Relocation|1|||
127605910|NCT01994629|459184936|FG000|Overall Study|Withdrawal by Subject|1|||
127605911|NCT01994629|459184937|FG001|Overall Study|Withdrawal by Subject|0|||
127605912|NCT01994629|459184936|FG000|Overall Study|Lost to Follow-up|0|||
127605913|NCT01994629|459184937|FG001|Overall Study|Lost to Follow-up|3|||
127605914|NCT01558752|459184938|FG000|Overall Study|Physician Decision|2|||
127605915|NCT01558752|459184939|FG001|Overall Study|Physician Decision|0|||
127605916|NCT02738450|459184948|FG000|Overall Study|Withdrawal by Subject|0|||
127605917|NCT02738450|459184949|FG001|Overall Study|Withdrawal by Subject|2|||
127605918|NCT02738450|459184950|FG002|Overall Study|Withdrawal by Subject|0|||
127605919|NCT07114198|459184961|FG000|Overall Study|Protocol Violation|1|||
127605920|NCT07114198|459184962|FG001|Overall Study|Protocol Violation|1|||
127605921|NCT01721330|459184963|FG000|Overall Study|Withdrawal by Subject|0|||
127605922|NCT01721330|459184964|FG001|Overall Study|Withdrawal by Subject|1|||
127605923|NCT00296374|459184965|FG000|Overall Study|Adverse Event|14|||
127605924|NCT00296374|459184966|FG001|Overall Study|Adverse Event|10|||
127605925|NCT00296374|459184967|FG002|Overall Study|Adverse Event|7|||
127605926|NCT00296374|459184965|FG000|Overall Study|Withdrawal by Subject|3|||
127605927|NCT00296374|459184966|FG001|Overall Study|Withdrawal by Subject|5|||
127605928|NCT00296374|459184967|FG002|Overall Study|Withdrawal by Subject|11|||
127605929|NCT00296374|459184965|FG000|Overall Study|Incorrect enrollment|3|||
127605930|NCT00296374|459184966|FG001|Overall Study|Incorrect enrollment|3|||
127605931|NCT00296374|459184967|FG002|Overall Study|Incorrect enrollment|4|||
127605932|NCT00296374|459184965|FG000|Overall Study|Protocol Violation|1|||
127605933|NCT00296374|459184966|FG001|Overall Study|Protocol Violation|2|||
127605934|NCT00296374|459184967|FG002|Overall Study|Protocol Violation|3|||
127605935|NCT00296374|459184965|FG000|Overall Study|Lost to Follow-up|3|||
127605936|NCT00296374|459184966|FG001|Overall Study|Lost to Follow-up|1|||
127605937|NCT00296374|459184967|FG002|Overall Study|Lost to Follow-up|1|||
127605938|NCT00296374|459184965|FG000|Overall Study|Relocated to another state|1|||
127605939|NCT00296374|459184966|FG001|Overall Study|Relocated to another state|0|||
127605940|NCT00296374|459184967|FG002|Overall Study|Relocated to another state|0|||
127605941|NCT00296374|459184965|FG000|Overall Study|Stopped drug before end of study visit|0|||
127605942|NCT00296374|459184966|FG001|Overall Study|Stopped drug before end of study visit|1|||
127605943|NCT00296374|459184967|FG002|Overall Study|Stopped drug before end of study visit|0|||
127605944|NCT00296374|459184965|FG000|Overall Study|Nephrologist introduced ACE|0|||
127605945|NCT00296374|459184966|FG001|Overall Study|Nephrologist introduced ACE|1|||
127605946|NCT00296374|459184967|FG002|Overall Study|Nephrologist introduced ACE|0|||
127605947|NCT00296374|459184965|FG000|Overall Study|Pregnancy|0|||
127605948|NCT00296374|459184966|FG001|Overall Study|Pregnancy|0|||
127697404|NCT03891667|459520204|FG000|Overall Study|Adverse Event|0|||
127697405|NCT03891667|459520205|FG001|Overall Study|Adverse Event|1|||
127697406|NCT04166773|459520216|FG000|Overall Study|Adverse Event|2|||
127697407|NCT04166773|459520217|FG001|Overall Study|Adverse Event|0|||
127697408|NCT04166773|459520218|FG002|Overall Study|Adverse Event|2|||
127697409|NCT04166773|459520219|FG003|Overall Study|Adverse Event|1|||
127697410|NCT04166773|459520216|FG000|Overall Study|Lost to Follow-up|4|||
127697411|NCT04166773|459520217|FG001|Overall Study|Lost to Follow-up|2|||
127697412|NCT04166773|459520218|FG002|Overall Study|Lost to Follow-up|1|||
127697413|NCT04166773|459520219|FG003|Overall Study|Lost to Follow-up|3|||
127697414|NCT04166773|459520216|FG000|Overall Study|Physician Decision|0|||
127697415|NCT04166773|459520217|FG001|Overall Study|Physician Decision|0|||
127697416|NCT04166773|459520218|FG002|Overall Study|Physician Decision|0|||
127697417|NCT04166773|459520219|FG003|Overall Study|Physician Decision|1|||
127697418|NCT04166773|459520216|FG000|Overall Study|Withdrawal by Subject|1|||
127697419|NCT04166773|459520217|FG001|Overall Study|Withdrawal by Subject|1|||
127788761|NCT00705783|459851279|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
127788762|NCT00705783|459851280|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
127788763|NCT00705783|459851278|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
127788764|NCT00705783|459851279|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
127605949|NCT00296374|459184967|FG002|Overall Study|Pregnancy|2|||
127605950|NCT00296374|459184965|FG000|Overall Study|Other|0|||
127605951|NCT00296374|459184966|FG001|Overall Study|Other|0|||
127605952|NCT00296374|459184967|FG002|Overall Study|Other|1|||
127605953|NCT06308822|459186968|FG000|Overall Study|Mutation Status Not Confirmed|17|||
127605954|NCT06308822|459186968|FG000|Overall Study|Adverse Event|1|||
127605955|NCT06308822|459186968|FG000|Overall Study|Death|5|||
127605956|NCT06308822|459186968|FG000|Overall Study|Disease progression|8|||
127605957|NCT06308822|459186968|FG000|Overall Study|Withdrawal by Subject|1|||
127605958|NCT06308822|459186968|FG000|Overall Study|Physician Decision|3|||
127605959|NCT03712904|459186969|FG000|Overall Study|Death|0|||
127605960|NCT03712904|459186970|FG001|Overall Study|Death|1|||
127605961|NCT03712904|459186969|FG000|Overall Study|Withdrawal by Subject|0|||
127605962|NCT03712904|459186970|FG001|Overall Study|Withdrawal by Subject|1|||
127605963|NCT03712904|459186969|FG000|Overall Study|progression/eye removed before 2 years (unable to complete testing)|1|||
127605964|NCT03712904|459186970|FG001|Overall Study|progression/eye removed before 2 years (unable to complete testing)|0|||
127605965|NCT01852942|459186972|FG000|Overall Study|Physician Decision|1|||
127605966|NCT01852942|459186973|FG001|Overall Study|Physician Decision|0|||
127605967|NCT01852942|459186972|FG000|Overall Study|Death|1|||
127605968|NCT01852942|459186973|FG001|Overall Study|Death|1|||
127605969|NCT01852942|459186972|FG000|Overall Study|Withdrawal by Subject|2|||
127605970|NCT01852942|459186973|FG001|Overall Study|Withdrawal by Subject|3|||
127605971|NCT01852942|459186972|FG000|Overall Study|Lost to Follow-up|1|||
127605972|NCT01852942|459186973|FG001|Overall Study|Lost to Follow-up|2|||
127605973|NCT01921179|459186974|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
127605974|NCT01921179|459186975|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
127605975|NCT01921179|459186974|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
127605976|NCT01921179|459186975|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
127605977|NCT00858442|459186980|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
127605978|NCT00858442|459186981|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
127605979|NCT05608005|459186984|FG000|Overall Study|Adverse Event|2|||
127605980|NCT05608005|459186985|FG001|Overall Study|Adverse Event|1|||
127605981|NCT05608005|459186986|FG002|Overall Study|Adverse Event|3|||
127605982|NCT05608005|459186984|FG000|Overall Study|Protocol Violation|2|||
127605983|NCT05608005|459186985|FG001|Overall Study|Protocol Violation|3|||
127605984|NCT05608005|459186986|FG002|Overall Study|Protocol Violation|0|||
127605985|NCT05608005|459186984|FG000|Overall Study|Withdrawal by Subject|10|||
127605986|NCT05608005|459186985|FG001|Overall Study|Withdrawal by Subject|12|||
127605987|NCT05608005|459186986|FG002|Overall Study|Withdrawal by Subject|4|||
127605988|NCT05608005|459186984|FG000|Overall Study|Lost to Follow-up|25|||
127605989|NCT05608005|459186985|FG001|Overall Study|Lost to Follow-up|27|||
127788765|NCT00705783|459851280|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
127788766|NCT00705783|459851278|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
127697420|NCT04166773|459520218|FG002|Overall Study|Withdrawal by Subject|2|||
127788767|NCT00705783|459851279|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
127605990|NCT05608005|459186986|FG002|Overall Study|Lost to Follow-up|15|||
127697421|NCT04166773|459520219|FG003|Overall Study|Withdrawal by Subject|5|||
127697422|NCT05076708|459520220|FG000|Overall Study|Withdrawal by Subject|4|||
127605991|NCT05608005|459186984|FG000|Overall Study|Participants were not vaccinated or withdrew for other reasons|6|||
127605992|NCT05608005|459186985|FG001|Overall Study|Participants were not vaccinated or withdrew for other reasons|7|||
127605993|NCT05608005|459186986|FG002|Overall Study|Participants were not vaccinated or withdrew for other reasons|0|||
127605994|NCT04708886|459186987|FG000|Year 2: Alendronate|Withdrawal by Subject|1|||
127697423|NCT05076708|459520220|FG000|Overall Study|Lost to study during switch phase|8|||
127697424|NCT03269136|459520224|FG000|Part 1: Dose Escalation|Other|0|||
127697425|NCT03269136|459520225|FG001|Part 1: Dose Escalation|Other|0|||
127882917|NCT00996918|460194619|FG003|Overall Study|Physician Decision|0|||
127605995|NCT04708886|459186987|FG000|Year 2: Alendronate|Lost to Follow-up|1|||
127605996|NCT01372501|459186988|FG000|Overall Study|Adverse Event|4|||
127605997|NCT01372501|459186988|FG000|Overall Study|Device migration|1|||
127605998|NCT01466348|459186989|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
127605999|NCT01466348|459186990|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
127606000|NCT03989440|459186991|FG000|Overall Study|COVID-19 travel restrictions|0|||
127606001|NCT03989440|459186992|FG001|Overall Study|COVID-19 travel restrictions|0|||
127606002|NCT03989440|459186993|FG002|Overall Study|COVID-19 travel restrictions|1|||
127606003|NCT03989440|459186994|FG003|Overall Study|COVID-19 travel restrictions|0|||
127606004|NCT03989440|459186995|FG004|Overall Study|COVID-19 travel restrictions|0|||
127606005|NCT03989440|459186996|FG005|Overall Study|COVID-19 travel restrictions|0|||
127606006|NCT03989440|459186991|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
127606007|NCT03989440|459186992|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
127606008|NCT03989440|459186993|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
127606009|NCT03989440|459186994|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
127606010|NCT03989440|459186995|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
127606011|NCT03989440|459186996|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
127606012|NCT03970733|459186999|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
127606013|NCT03970733|459187000|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
127606014|NCT03970733|459187001|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
127606015|NCT03970733|459187002|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
127606016|NCT03970733|459187003|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
127606017|NCT03970733|459186999|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
127606018|NCT03970733|459187000|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
127606019|NCT03970733|459187001|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
127606020|NCT03970733|459187002|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
127606021|NCT03970733|459187003|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
127606022|NCT03970733|459186999|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
127606023|NCT03970733|459187000|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
127606024|NCT03970733|459187001|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
127606025|NCT03970733|459187002|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
127606026|NCT03970733|459187003|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
127606027|NCT03970733|459186999|FG000|Main Study Phase (18 Months)|Other|1|||
127606028|NCT03970733|459187000|FG001|Main Study Phase (18 Months)|Other|1|||
127606029|NCT03970733|459187001|FG002|Main Study Phase (18 Months)|Other|0|||
127606030|NCT03970733|459187002|FG003|Main Study Phase (18 Months)|Other|0|||
127606031|NCT03970733|459187003|FG004|Main Study Phase (18 Months)|Other|0|||
127606032|NCT03970733|459186999|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
127606033|NCT03970733|459187000|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
127606034|NCT03970733|459187001|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
127606035|NCT03970733|459187002|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
127606036|NCT03970733|459187003|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
127606037|NCT02150954|459187014|FG000|Overall Study|Protocol Violation|1|||
127606038|NCT02150954|459187015|FG001|Overall Study|Protocol Violation|0|||
127606039|NCT03814746|459187016|FG000|Overall Study|Participant decision|9|||
127606040|NCT03814746|459187017|FG001|Overall Study|Participant decision|6|||
127606041|NCT03814746|459187018|FG002|Overall Study|Participant decision|15|||
127606042|NCT03814746|459187016|FG000|Overall Study|Physician Decision|2|||
127606043|NCT03814746|459187017|FG001|Overall Study|Physician Decision|2|||
127606044|NCT03814746|459187018|FG002|Overall Study|Physician Decision|4|||
127606045|NCT03814746|459187016|FG000|Overall Study|Death|2|||
127606046|NCT03814746|459187017|FG001|Overall Study|Death|2|||
127606047|NCT03814746|459187018|FG002|Overall Study|Death|2|||
127606048|NCT03814746|459187016|FG000|Overall Study|Adverse Event|2|||
127606049|NCT03814746|459187017|FG001|Overall Study|Adverse Event|2|||
127606050|NCT03814746|459187018|FG002|Overall Study|Adverse Event|1|||
127606051|NCT03814746|459187016|FG000|Overall Study|Lost to Follow-up|2|||
127606052|NCT03814746|459187017|FG001|Overall Study|Lost to Follow-up|1|||
127606053|NCT03814746|459187018|FG002|Overall Study|Lost to Follow-up|2|||
127697426|NCT03269136|459520226|FG002|Part 1: Dose Escalation|Other|0|||
127606054|NCT03814746|459187016|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
127606055|NCT03814746|459187017|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
127606056|NCT03814746|459187018|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
127606057|NCT03814746|459187016|FG000|Overall Study|Pregnancy|0|||
127606058|NCT03814746|459187017|FG001|Overall Study|Pregnancy|1|||
127606059|NCT03814746|459187018|FG002|Overall Study|Pregnancy|1|||
127606060|NCT03814746|459187016|FG000|Overall Study|Protocol Violation|1|||
127606061|NCT03814746|459187017|FG001|Overall Study|Protocol Violation|0|||
127606062|NCT03814746|459187018|FG002|Overall Study|Protocol Violation|0|||
127606063|NCT02278263|459187021|FG000|Overall Study|Protocol Violation|7|||
127606064|NCT02278263|459187022|FG001|Overall Study|Protocol Violation|0|||
127606065|NCT02278263|459187023|FG002|Overall Study|Protocol Violation|9|||
127697427|NCT03269136|459520227|FG003|Part 1: Dose Escalation|Other|0|||
127697428|NCT03269136|459520228|FG004|Part 1: Dose Escalation|Other|0|||
127606066|NCT03997383|459187026|FG000|Double-blind Treatment Period|Adverse Event|4|||
127606067|NCT03997383|459187027|FG001|Double-blind Treatment Period|Adverse Event|3|||
127606068|NCT03997383|459187026|FG000|Double-blind Treatment Period|Death|4|||
127606069|NCT03997383|459187027|FG001|Double-blind Treatment Period|Death|4|||
127606070|NCT03997383|459187026|FG000|Double-blind Treatment Period|Physician Decision|2|||
127606071|NCT03997383|459187027|FG001|Double-blind Treatment Period|Physician Decision|0|||
127606072|NCT03997383|459187026|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
127606073|NCT03997383|459187027|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
127606074|NCT03997383|459187026|FG000|Open-label Extension Period|Ongoing|148|||
127606075|NCT03997383|459187027|FG001|Open-label Extension Period|Ongoing|151|||
127606076|NCT03997383|459187026|FG000|Open-label Extension Period|Adverse Event|4|||
127606077|NCT03997383|459187027|FG001|Open-label Extension Period|Adverse Event|1|||
127606078|NCT03997383|459187026|FG000|Open-label Extension Period|Death|8|||
127606079|NCT03997383|459187027|FG001|Open-label Extension Period|Death|9|||
127606080|NCT03997383|459187026|FG000|Open-label Extension Period|Physician Decision|1|||
127606081|NCT03997383|459187027|FG001|Open-label Extension Period|Physician Decision|1|||
127606082|NCT03997383|459187026|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
127606083|NCT03997383|459187027|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
127606084|NCT03997383|459187026|FG000|Open-label Extension Period|Reason Not Specified|2|||
127606085|NCT03997383|459187027|FG001|Open-label Extension Period|Reason Not Specified|0|||
127606086|NCT03880019|459187028|FG000|Overall Study|Competing disease|1|||
127606087|NCT00326950|459187029|FG000|Overall Study|Progressive Disease|1|||
127606088|NCT01266460|459187035|FG000|Overall Study|Adverse Event|3|||
127606089|NCT01266460|459187035|FG000|Overall Study|Withdrawal by Subject|5|||
127606090|NCT01266460|459187035|FG000|Overall Study|Disease Progression|18|||
127606091|NCT01266460|459187035|FG000|Overall Study|Not otherwise specified|8|||
127606092|NCT01132547|459187040|FG000|Overall Study|Withdrawal by Subject|3|||
127606093|NCT01132547|459187041|FG001|Overall Study|Withdrawal by Subject|1|||
127606094|NCT01132547|459187040|FG000|Overall Study|Death|1|||
127606095|NCT01132547|459187041|FG001|Overall Study|Death|0|||
127606096|NCT05811234|459187042|FG000|Overall Study|Loss of Effectiveness|2|||
127606097|NCT05811234|459187042|FG000|Overall Study|Adverse Event|4|||
127606098|NCT05811234|459187042|FG000|Overall Study|Pregnancy|1|||
127606099|NCT05811234|459187042|FG000|Overall Study|Disease progression|1|||
127606100|NCT05811234|459187042|FG000|Overall Study|Withdrawal by Subject|4|||
127606101|NCT05811234|459187042|FG000|Overall Study|Lost to Follow-up|13|||
127606102|NCT05811234|459187042|FG000|Overall Study|Personal reason, or the patient stops taking the study treatment|1|||
127606103|NCT04499781|459187043|FG000|Overall Study|Lost to Follow-up|2|||
127606104|NCT04499781|459187044|FG001|Overall Study|Lost to Follow-up|3|||
127606105|NCT04499781|459187043|FG000|Overall Study|Withdrawal by Subject|2|||
127606106|NCT04499781|459187044|FG001|Overall Study|Withdrawal by Subject|0|||
127606107|NCT00483379|459187045|FG000|Treatment Period|Adverse Event|1|||
127606108|NCT00483379|459187046|FG001|Treatment Period|Adverse Event|0|||
127606109|NCT00483379|459187045|FG000|Treatment Period|Withdrawal by Subject|1|||
127606110|NCT00483379|459187046|FG001|Treatment Period|Withdrawal by Subject|0|||
127606111|NCT04103892|459187049|FG000|Overall Study|Adverse Event|0|||
127606112|NCT04103892|459187050|FG001|Overall Study|Adverse Event|0|||
127606113|NCT04103892|459187051|FG002|Overall Study|Adverse Event|0|||
127606114|NCT04103892|459187052|FG003|Overall Study|Adverse Event|3|||
127606115|NCT04103892|459187049|FG000|Overall Study|Lost to Follow-up|0|||
127606116|NCT04103892|459187050|FG001|Overall Study|Lost to Follow-up|0|||
127606117|NCT04103892|459187051|FG002|Overall Study|Lost to Follow-up|2|||
127606118|NCT04103892|459187052|FG003|Overall Study|Lost to Follow-up|0|||
127606119|NCT04103892|459187049|FG000|Overall Study|Protocol Violation|0|||
127606120|NCT04103892|459187050|FG001|Overall Study|Protocol Violation|0|||
127606121|NCT04103892|459187051|FG002|Overall Study|Protocol Violation|1|||
127606122|NCT04103892|459187052|FG003|Overall Study|Protocol Violation|1|||
127606123|NCT04103892|459187049|FG000|Overall Study|Withdrawal by Subject|1|||
127606124|NCT04103892|459187050|FG001|Overall Study|Withdrawal by Subject|0|||
127606125|NCT04103892|459187051|FG002|Overall Study|Withdrawal by Subject|2|||
127606126|NCT04103892|459187052|FG003|Overall Study|Withdrawal by Subject|5|||
127606127|NCT04103892|459187049|FG000|Overall Study|Requirement of prohibited concomitant medication|0|||
127606128|NCT04103892|459187050|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
127606129|NCT04103892|459187051|FG002|Overall Study|Requirement of prohibited concomitant medication|1|||
127606130|NCT04103892|459187052|FG003|Overall Study|Requirement of prohibited concomitant medication|1|||
127606131|NCT03051607|459187059|FG000|Overall Study|Adverse Event|66|||
127606132|NCT03341533|459187060|FG000|Overall Study|Withdrawal by Subject|1|||
127606133|NCT03341533|459187061|FG001|Overall Study|Withdrawal by Subject|1|||
127606134|NCT03341533|459187060|FG000|Overall Study|Not eligible after randomization|2|||
127606135|NCT03341533|459187061|FG001|Overall Study|Not eligible after randomization|1|||
127606136|NCT01603459|459187071|FG000|Overall Study|Adverse Event|5|||
127606137|NCT01603459|459187071|FG000|Overall Study|Withdrawal by Subject|5|||
127606138|NCT01603459|459187071|FG000|Overall Study|Lost to Follow-up|3|||
127606139|NCT01603459|459187071|FG000|Overall Study|Predefined discontinuation criteria|3|||
127606140|NCT01603459|459187071|FG000|Overall Study|Non-compliance|1|||
127606141|NCT01603459|459187071|FG000|Overall Study|Administrative reason|1|||
127606142|NCT00399360|459187073|FG000|Overall Study|Lost to Follow-up|2|||
127606143|NCT00399360|459187074|FG001|Overall Study|Lost to Follow-up|1|||
127606144|NCT00399360|459187075|FG002|Overall Study|Lost to Follow-up|2|||
127606145|NCT00399360|459187076|FG003|Overall Study|Lost to Follow-up|4|||
127606146|NCT00399360|459187073|FG000|Overall Study|Adverse Event|0|||
127606147|NCT00399360|459187074|FG001|Overall Study|Adverse Event|0|||
127606148|NCT00399360|459187075|FG002|Overall Study|Adverse Event|1|||
127606149|NCT00399360|459187076|FG003|Overall Study|Adverse Event|0|||
127606150|NCT00399360|459187073|FG000|Overall Study|Withdrawal by Subject|0|||
127606151|NCT00399360|459187074|FG001|Overall Study|Withdrawal by Subject|2|||
127606152|NCT00399360|459187075|FG002|Overall Study|Withdrawal by Subject|0|||
127606153|NCT00399360|459187076|FG003|Overall Study|Withdrawal by Subject|2|||
127606154|NCT01412021|459187077|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
127606155|NCT01412021|459187077|FG000|Overall Study|Treatment Prior to Approval|3|||
127606156|NCT01412021|459187077|FG000|Overall Study|Transferred to Other Hospital|9|||
127606157|NCT01166178|459187078|FG000|Overall Study|Withdrawal by Subject|1|||
127606158|NCT01166178|459187079|FG001|Overall Study|Withdrawal by Subject|0|||
127606159|NCT01166178|459187078|FG000|Overall Study|Study was terminated|20|||
127606160|NCT01166178|459187079|FG001|Overall Study|Study was terminated|8|||
127606161|NCT03658538|459187089|FG000|Overall Study|Death|2|||
127606162|NCT03658538|459187090|FG001|Overall Study|Death|1|||
127606163|NCT03658538|459187089|FG000|Overall Study|Cancer diagnosis|1|||
127606164|NCT03658538|459187090|FG001|Overall Study|Cancer diagnosis|0|||
127606165|NCT03658538|459187089|FG000|Overall Study|Change residence|1|||
127606166|NCT03658538|459187090|FG001|Overall Study|Change residence|2|||
127606167|NCT03658538|459187089|FG000|Overall Study|Lost to Follow-up|3|||
127606168|NCT03658538|459187090|FG001|Overall Study|Lost to Follow-up|3|||
127606169|NCT03658538|459187089|FG000|Overall Study|Unblinded|2|||
127606170|NCT03658538|459187090|FG001|Overall Study|Unblinded|3|||
127606171|NCT03658538|459187089|FG000|Overall Study|Physician Decision|0|||
127606172|NCT03658538|459187090|FG001|Overall Study|Physician Decision|1|||
127606173|NCT03658538|459187089|FG000|Overall Study|Incomplete clinical visit at 6 months due to illness|1|||
127606174|NCT03658538|459187090|FG001|Overall Study|Incomplete clinical visit at 6 months due to illness|0|||
127606175|NCT03658538|459187089|FG000|Overall Study|Evicted from home|1|||
127606176|NCT03658538|459187090|FG001|Overall Study|Evicted from home|0|||
127606177|NCT02446990|459187091|FG000|Overall Study|Death|485|||
127606178|NCT02446990|459187092|FG001|Overall Study|Death|458|||
127606179|NCT02446990|459187091|FG000|Overall Study|Lost to Follow-up|3|||
127606180|NCT02446990|459187092|FG001|Overall Study|Lost to Follow-up|1|||
127606181|NCT02446990|459187091|FG000|Overall Study|Physician Decision|1|||
127606182|NCT02446990|459187092|FG001|Overall Study|Physician Decision|0|||
127606183|NCT02446990|459187091|FG000|Overall Study|Withdrawal by Subject|231|||
127606184|NCT02446990|459187092|FG001|Overall Study|Withdrawal by Subject|199|||
127606185|NCT03333044|459187093|FG000|Overall Study|Pregnancy|1|||
127606186|NCT03333044|459187094|FG001|Overall Study|Pregnancy|0|||
127606187|NCT03333044|459187095|FG002|Overall Study|Pregnancy|0|||
127606188|NCT03333044|459187093|FG000|Overall Study|Lost to Follow-up|0|||
127606189|NCT03333044|459187094|FG001|Overall Study|Lost to Follow-up|14|||
127606190|NCT03333044|459187095|FG002|Overall Study|Lost to Follow-up|6|||
127606191|NCT03188094|459187096|FG000|Overall Study|Screen failure|1|||
127606192|NCT03188094|459187097|FG001|Overall Study|Screen failure|0|||
127606193|NCT03188094|459187098|FG002|Overall Study|Screen failure|0|||
127606194|NCT03188094|459187096|FG000|Overall Study|Pregnancy|3|||
127606195|NCT03188094|459187097|FG001|Overall Study|Pregnancy|0|||
127606196|NCT03188094|459187098|FG002|Overall Study|Pregnancy|0|||
127606197|NCT03188094|459187096|FG000|Overall Study|Ineligible|1|||
127606198|NCT03188094|459187097|FG001|Overall Study|Ineligible|0|||
127606199|NCT03188094|459187098|FG002|Overall Study|Ineligible|0|||
127606200|NCT03188094|459187096|FG000|Overall Study|Lost to Follow-up|0|||
127606201|NCT03188094|459187097|FG001|Overall Study|Lost to Follow-up|0|||
127606202|NCT03188094|459187098|FG002|Overall Study|Lost to Follow-up|17|||
127606203|NCT02921776|459187099|FG000|Overall Study|patient deterioration, fatigue|2|||
127606204|NCT02921776|459187100|FG001|Overall Study|patient deterioration, fatigue|6|||
127606205|NCT02921776|459187101|FG002|Overall Study|patient deterioration, fatigue|0|||
127606206|NCT02921776|459187102|FG003|Overall Study|patient deterioration, fatigue|0|||
127606207|NCT02921776|459187103|FG004|Overall Study|patient deterioration, fatigue|0|||
127606208|NCT02921776|459187104|FG005|Overall Study|patient deterioration, fatigue|0|||
127606209|NCT02921776|459187105|FG006|Overall Study|patient deterioration, fatigue|0|||
127606210|NCT02921776|459187106|FG007|Overall Study|patient deterioration, fatigue|0|||
127606211|NCT02921776|459187099|FG000|Overall Study|Withdrawal by Subject|0|||
127606212|NCT02921776|459187100|FG001|Overall Study|Withdrawal by Subject|2|||
127606213|NCT02921776|459187101|FG002|Overall Study|Withdrawal by Subject|0|||
127606214|NCT02921776|459187102|FG003|Overall Study|Withdrawal by Subject|1|||
127606215|NCT02921776|459187103|FG004|Overall Study|Withdrawal by Subject|1|||
127606216|NCT02921776|459187104|FG005|Overall Study|Withdrawal by Subject|0|||
127882918|NCT00996918|460194620|FG004|Overall Study|Physician Decision|0|||
127606217|NCT02921776|459187105|FG006|Overall Study|Withdrawal by Subject|8|||
127606218|NCT02921776|459187106|FG007|Overall Study|Withdrawal by Subject|1|||
127606219|NCT02921776|459187099|FG000|Overall Study|Death|0|||
127606220|NCT02921776|459187100|FG001|Overall Study|Death|0|||
127606221|NCT02921776|459187101|FG002|Overall Study|Death|0|||
127606222|NCT02921776|459187102|FG003|Overall Study|Death|2|||
127606223|NCT02921776|459187103|FG004|Overall Study|Death|0|||
127606224|NCT02921776|459187104|FG005|Overall Study|Death|0|||
127606225|NCT02921776|459187105|FG006|Overall Study|Death|0|||
127606226|NCT02921776|459187106|FG007|Overall Study|Death|0|||
127606227|NCT02921776|459187099|FG000|Overall Study|extubation or early discharge|0|||
127606228|NCT02921776|459187100|FG001|Overall Study|extubation or early discharge|0|||
127606229|NCT02921776|459187101|FG002|Overall Study|extubation or early discharge|0|||
127606230|NCT02921776|459187102|FG003|Overall Study|extubation or early discharge|5|||
127606231|NCT02921776|459187103|FG004|Overall Study|extubation or early discharge|5|||
127606232|NCT02921776|459187104|FG005|Overall Study|extubation or early discharge|0|||
127606233|NCT02921776|459187105|FG006|Overall Study|extubation or early discharge|0|||
127606234|NCT02921776|459187106|FG007|Overall Study|extubation or early discharge|0|||
127606235|NCT02921776|459187099|FG000|Overall Study|Lost to Follow-up|0|||
127606236|NCT02921776|459187100|FG001|Overall Study|Lost to Follow-up|0|||
127606237|NCT02921776|459187101|FG002|Overall Study|Lost to Follow-up|0|||
127606238|NCT02921776|459187102|FG003|Overall Study|Lost to Follow-up|0|||
127606239|NCT02921776|459187103|FG004|Overall Study|Lost to Follow-up|0|||
127606240|NCT02921776|459187104|FG005|Overall Study|Lost to Follow-up|2|||
127606241|NCT02921776|459187105|FG006|Overall Study|Lost to Follow-up|3|||
127606242|NCT02921776|459187106|FG007|Overall Study|Lost to Follow-up|6|||
127606243|NCT04537234|459187110|FG000|Overall Study|Withdrawal by Subject|2|||
127606244|NCT04537234|459187111|FG001|Overall Study|Withdrawal by Subject|0|||
127606245|NCT05478252|459187114|FG000|Overall Study|Withdrawal by Subject|2|||
127606246|NCT05478252|459187115|FG001|Overall Study|Withdrawal by Subject|3|||
127606247|NCT05478252|459187114|FG000|Overall Study|Lost to Follow-up|4|||
127606248|NCT05478252|459187115|FG001|Overall Study|Lost to Follow-up|2|||
127606249|NCT05478252|459187114|FG000|Overall Study|Physician Decision|1|||
127606250|NCT05478252|459187115|FG001|Overall Study|Physician Decision|1|||
127606251|NCT05478252|459187114|FG000|Overall Study|Death|1|||
127606252|NCT05478252|459187115|FG001|Overall Study|Death|0|||
127606253|NCT02189473|459188481|FG000|Overall Study|Death|22|||
127606254|NCT02189473|459188482|FG001|Overall Study|Death|23|||
127606255|NCT02189473|459188481|FG000|Overall Study|Lost to Follow-up|1|||
127606256|NCT02189473|459188482|FG001|Overall Study|Lost to Follow-up|2|||
127606257|NCT01955161|459188483|FG000|Overall Study|Withdrawal before treatment|2|||
127606258|NCT01955161|459188484|FG001|Overall Study|Withdrawal before treatment|0|||
127606259|NCT01955161|459188485|FG002|Overall Study|Withdrawal before treatment|1|||
127606260|NCT01955161|459188483|FG000|Overall Study|Adverse Event|10|||
127606261|NCT01955161|459188484|FG001|Overall Study|Adverse Event|14|||
127606262|NCT01955161|459188485|FG002|Overall Study|Adverse Event|15|||
127606263|NCT01955161|459188483|FG000|Overall Study|Death|1|||
127606264|NCT01955161|459188484|FG001|Overall Study|Death|1|||
127606265|NCT01955161|459188485|FG002|Overall Study|Death|3|||
127606266|NCT01955161|459188483|FG000|Overall Study|Withdrawal by Subject|9|||
127606267|NCT01955161|459188484|FG001|Overall Study|Withdrawal by Subject|8|||
127606268|NCT01955161|459188485|FG002|Overall Study|Withdrawal by Subject|12|||
127606269|NCT01955161|459188483|FG000|Overall Study|Protocol Violation|2|||
127606270|NCT01955161|459188484|FG001|Overall Study|Protocol Violation|0|||
127606271|NCT01955161|459188485|FG002|Overall Study|Protocol Violation|0|||
127606272|NCT01955161|459188483|FG000|Overall Study|Other reason: physician decision|0|||
127606273|NCT01955161|459188484|FG001|Overall Study|Other reason: physician decision|1|||
127606274|NCT01955161|459188485|FG002|Overall Study|Other reason: physician decision|1|||
127606275|NCT01955161|459188483|FG000|Overall Study|Other reason: disallowed medication|1|||
127882919|NCT00996918|460194616|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
127882920|NCT00996918|460194617|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
127606276|NCT01955161|459188484|FG001|Overall Study|Other reason: disallowed medication|0|||
127606277|NCT01955161|459188485|FG002|Overall Study|Other reason: disallowed medication|1|||
127606278|NCT01955161|459188483|FG000|Overall Study|Other reason: caregiver unavailable|1|||
127606279|NCT01955161|459188484|FG001|Overall Study|Other reason: caregiver unavailable|0|||
127606280|NCT01955161|459188485|FG002|Overall Study|Other reason: caregiver unavailable|0|||
127606281|NCT01955161|459188483|FG000|Overall Study|Other reason: moved to nursing home|0|||
127606282|NCT01955161|459188484|FG001|Overall Study|Other reason: moved to nursing home|1|||
127606283|NCT01955161|459188485|FG002|Overall Study|Other reason: moved to nursing home|0|||
127606284|NCT01955161|459188483|FG000|Overall Study|Other reason: insufficient compliance|0|||
127606285|NCT01955161|459188484|FG001|Overall Study|Other reason: insufficient compliance|0|||
127606286|NCT01955161|459188485|FG002|Overall Study|Other reason: insufficient compliance|1|||
127606287|NCT01955161|459188483|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
127606288|NCT01955161|459188484|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
127697429|NCT03269136|459520229|FG005|Part 1: Dose Escalation|Other|0|||
127882921|NCT00996918|460194618|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
127697430|NCT03269136|459520230|FG006|Part 1: Dose Escalation|Other|0|||
127697431|NCT03269136|459520231|FG007|Part 1: Dose Escalation|Other|0|||
127697432|NCT03269136|459520232|FG008|Part 1: Dose Escalation|Other|0|||
127697433|NCT03269136|459520233|FG009|Part 1: Dose Escalation|Other|0|||
127697434|NCT03269136|459520234|FG010|Part 1: Dose Escalation|Other|1|||
127697435|NCT03269136|459520235|FG011|Part 1: Dose Escalation|Other|1|||
127697436|NCT03269136|459520236|FG012|Part 1: Dose Escalation|Other|1|||
127697437|NCT03269136|459520237|FG013|Part 1: Dose Escalation|Other|0|||
127697438|NCT03269136|459520238|FG014|Part 1: Dose Escalation|Other|3|||
127697439|NCT03269136|459520239|FG015|Part 1: Dose Escalation|Other|1|||
127697440|NCT03269136|459520240|FG016|Part 1: Dose Escalation|Other|1|||
127697441|NCT03269136|459520241|FG017|Part 1: Dose Escalation|Other|0|||
127697442|NCT03269136|459520224|FG000|Part 1: Dose Escalation|Refused Further Treatment|0|||
127697443|NCT03269136|459520225|FG001|Part 1: Dose Escalation|Refused Further Treatment|0|||
127697444|NCT03269136|459520226|FG002|Part 1: Dose Escalation|Refused Further Treatment|0|||
127697445|NCT03269136|459520227|FG003|Part 1: Dose Escalation|Refused Further Treatment|0|||
127697446|NCT03269136|459520228|FG004|Part 1: Dose Escalation|Refused Further Treatment|0|||
127697447|NCT03269136|459520229|FG005|Part 1: Dose Escalation|Refused Further Treatment|0|||
127697448|NCT03269136|459520230|FG006|Part 1: Dose Escalation|Refused Further Treatment|1|||
127697449|NCT03269136|459520231|FG007|Part 1: Dose Escalation|Refused Further Treatment|0|||
127697450|NCT03269136|459520232|FG008|Part 1: Dose Escalation|Refused Further Treatment|1|||
127697451|NCT03269136|459520233|FG009|Part 1: Dose Escalation|Refused Further Treatment|0|||
127697452|NCT03269136|459520234|FG010|Part 1: Dose Escalation|Refused Further Treatment|0|||
127697453|NCT03269136|459520235|FG011|Part 1: Dose Escalation|Refused Further Treatment|0|||
127697454|NCT03269136|459520236|FG012|Part 1: Dose Escalation|Refused Further Treatment|1|||
127697455|NCT03269136|459520237|FG013|Part 1: Dose Escalation|Refused Further Treatment|0|||
127697456|NCT03269136|459520238|FG014|Part 1: Dose Escalation|Refused Further Treatment|0|||
127697457|NCT03269136|459520239|FG015|Part 1: Dose Escalation|Refused Further Treatment|0|||
127697458|NCT03269136|459520240|FG016|Part 1: Dose Escalation|Refused Further Treatment|0|||
127697459|NCT03269136|459520241|FG017|Part 1: Dose Escalation|Refused Further Treatment|0|||
127697460|NCT03269136|459520224|FG000|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
127697461|NCT03269136|459520225|FG001|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
127697462|NCT03269136|459520226|FG002|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
127697463|NCT03269136|459520227|FG003|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
127697464|NCT03269136|459520228|FG004|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
127697465|NCT03269136|459520229|FG005|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
127697466|NCT03269136|459520230|FG006|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
127697467|NCT03269136|459520231|FG007|Part 1: Dose Escalation|Global Deterioration of Health Status|1|||
127697468|NCT03269136|459520232|FG008|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
127697469|NCT03269136|459520233|FG009|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
127697470|NCT03269136|459520234|FG010|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
127697471|NCT03269136|459520235|FG011|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
127697472|NCT03269136|459520236|FG012|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
127697473|NCT03269136|459520237|FG013|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
127697474|NCT03269136|459520238|FG014|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
127697475|NCT03269136|459520239|FG015|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
127697476|NCT03269136|459520240|FG016|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
127697477|NCT03269136|459520241|FG017|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
127697478|NCT03269136|459520224|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
127697479|NCT03269136|459520225|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
127697480|NCT03269136|459520226|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
127606289|NCT01955161|459188485|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
127606290|NCT01955161|459188483|FG000|Overall Study|Other reason: patient's will|0|||
127606291|NCT01955161|459188484|FG001|Overall Study|Other reason: patient's will|0|||
127606292|NCT01955161|459188485|FG002|Overall Study|Other reason: patient's will|1|||
127606293|NCT02784821|459188488|FG000|Overall Study|Death|0|||
127606294|NCT02784821|459188489|FG001|Overall Study|Death|5|||
127606295|NCT02784821|459188490|FG002|Overall Study|Death|4|||
127606296|NCT02784821|459188491|FG003|Overall Study|Death|5|||
127606297|NCT01277523|459188492|FG000|Overall Study|Adverse Event|1|||
127606298|NCT01277523|459188493|FG001|Overall Study|Adverse Event|0|||
127697481|NCT03269136|459520227|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
127697482|NCT03269136|459520228|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
127697483|NCT03269136|459520229|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
127697484|NCT03269136|459520230|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
127697485|NCT03269136|459520231|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
127697486|NCT03269136|459520232|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
127697487|NCT03269136|459520233|FG009|Part 1: Dose Escalation|Lost to Follow-up|1|||
127606299|NCT01277523|459188494|FG002|Overall Study|Adverse Event|0|||
127606300|NCT01277523|459188492|FG000|Overall Study|Protocol Violation|2|||
127606301|NCT01277523|459188493|FG001|Overall Study|Protocol Violation|0|||
127606302|NCT01277523|459188494|FG002|Overall Study|Protocol Violation|0|||
127606303|NCT01277523|459188492|FG000|Overall Study|Other Reason not Defined|0|||
127606304|NCT01277523|459188493|FG001|Overall Study|Other Reason not Defined|1|||
127606305|NCT01277523|459188494|FG002|Overall Study|Other Reason not Defined|0|||
127606306|NCT01881230|459188500|FG000|Overall Study|Death|2|||
127606307|NCT01881230|459188501|FG001|Overall Study|Death|0|||
127606308|NCT01881230|459188502|FG002|Overall Study|Death|1|||
127606309|NCT01881230|459188500|FG000|Overall Study|Adverse Event|9|||
127606310|NCT01881230|459188501|FG001|Overall Study|Adverse Event|13|||
127606311|NCT01881230|459188502|FG002|Overall Study|Adverse Event|12|||
127606312|NCT01881230|459188500|FG000|Overall Study|Progressive Disease|31|||
127606313|NCT01881230|459188501|FG001|Overall Study|Progressive Disease|35|||
127606314|NCT01881230|459188502|FG002|Overall Study|Progressive Disease|36|||
127606315|NCT01881230|459188500|FG000|Overall Study|Symptomatic Deterioration|3|||
127606316|NCT01881230|459188501|FG001|Overall Study|Symptomatic Deterioration|3|||
127606317|NCT01881230|459188502|FG002|Overall Study|Symptomatic Deterioration|1|||
127606318|NCT01881230|459188500|FG000|Overall Study|Withdrawal by Subject|6|||
127606319|NCT01881230|459188501|FG001|Overall Study|Withdrawal by Subject|4|||
127606320|NCT01881230|459188502|FG002|Overall Study|Withdrawal by Subject|6|||
127606321|NCT01881230|459188500|FG000|Overall Study|Physician Decision|4|||
127606322|NCT01881230|459188501|FG001|Overall Study|Physician Decision|3|||
127606323|NCT01881230|459188502|FG002|Overall Study|Physician Decision|6|||
127606324|NCT01881230|459188500|FG000|Overall Study|Non-Compliance with Study Drug|1|||
127606325|NCT01881230|459188501|FG001|Overall Study|Non-Compliance with Study Drug|2|||
127606326|NCT01881230|459188502|FG002|Overall Study|Non-Compliance with Study Drug|0|||
127606327|NCT01881230|459188500|FG000|Overall Study|Given Commercially Available Drug|0|||
127606328|NCT01881230|459188501|FG001|Overall Study|Given Commercially Available Drug|0|||
127606329|NCT01881230|459188502|FG002|Overall Study|Given Commercially Available Drug|2|||
127606330|NCT01881230|459188500|FG000|Overall Study|Protocol Violation|1|||
127606331|NCT01881230|459188501|FG001|Overall Study|Protocol Violation|1|||
127606332|NCT01881230|459188502|FG002|Overall Study|Protocol Violation|0|||
127606333|NCT01881230|459188500|FG000|Overall Study|Miscellaneous|3|||
127606334|NCT01881230|459188501|FG001|Overall Study|Miscellaneous|3|||
127606335|NCT01881230|459188502|FG002|Overall Study|Miscellaneous|0|||
127606336|NCT01881230|459188500|FG000|Overall Study|Untreated: Other|0|||
127606337|NCT01881230|459188501|FG001|Overall Study|Untreated: Other|0|||
127606338|NCT01881230|459188502|FG002|Overall Study|Untreated: Other|1|||
127606339|NCT01881230|459188500|FG000|Overall Study|Untreated: Death|0|||
127606340|NCT01881230|459188501|FG001|Overall Study|Untreated: Death|0|||
127606341|NCT01881230|459188502|FG002|Overall Study|Untreated: Death|1|||
127606342|NCT01881230|459188500|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
127606343|NCT01881230|459188501|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
127606344|NCT01881230|459188502|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
127606345|NCT02385266|459188503|FG000|Overall Study|Withdrawal by Subject|1|||
127606346|NCT02385266|459188504|FG001|Overall Study|Withdrawal by Subject|3|||
127606347|NCT01030523|459188505|FG000|Initial Study (5 Years)|Death|1|||
127606348|NCT01030523|459188506|FG001|Initial Study (5 Years)|Death|0|||
127606349|NCT01030523|459188505|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
127606350|NCT01030523|459188506|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
127606351|NCT01030523|459188505|FG000|Initial Study (5 Years)|Implant failure|1|||
127606352|NCT01030523|459188506|FG001|Initial Study (5 Years)|Implant failure|0|||
127606353|NCT01030523|459188505|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
127606354|NCT01030523|459188506|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
127606355|NCT01030523|459188505|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
127606356|NCT01030523|459188506|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
127606357|NCT01030523|459188505|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
127606358|NCT01030523|459188506|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
127606359|NCT01859494|459188511|FG000|Overall Study|Adverse Event|1|||
127606360|NCT02389998|459188514|FG000|Overall Study|car accident|1|||
127606361|NCT02389998|459188515|FG001|Overall Study|car accident|0|||
127606362|NCT02769247|459188516|FG000|Overall Study|Withdrawal by Subject|1|||
127606363|NCT02769247|459188517|FG001|Overall Study|Withdrawal by Subject|0|||
127606364|NCT02769247|459188518|FG002|Overall Study|Withdrawal by Subject|0|||
127606365|NCT02769247|459188519|FG003|Overall Study|Withdrawal by Subject|1|||
127606366|NCT02769247|459188516|FG000|Overall Study|Protocol Violation|0|||
127606367|NCT02769247|459188517|FG001|Overall Study|Protocol Violation|0|||
127606368|NCT02769247|459188518|FG002|Overall Study|Protocol Violation|1|||
127606369|NCT02769247|459188519|FG003|Overall Study|Protocol Violation|0|||
127606370|NCT02769247|459188516|FG000|Overall Study|Physician Decision|1|||
127606371|NCT02769247|459188517|FG001|Overall Study|Physician Decision|0|||
127606372|NCT02769247|459188518|FG002|Overall Study|Physician Decision|0|||
127606373|NCT02769247|459188519|FG003|Overall Study|Physician Decision|0|||
127606374|NCT05089682|459188520|FG000|Overall Study|Withdrawal by Subject|2|||
127606375|NCT01996826|459188523|FG000|Overall Study|Lost to Follow-up|6|||
127606376|NCT01996826|459188524|FG001|Overall Study|Lost to Follow-up|2|||
127606377|NCT01996826|459188523|FG000|Overall Study|Physician Decision|1|||
127606378|NCT01996826|459188524|FG001|Overall Study|Physician Decision|1|||
127606379|NCT00518323|459188525|FG000|Overall Study|Lack of Efficacy|14|||
127606380|NCT00518323|459188526|FG001|Overall Study|Lack of Efficacy|2|||
127606381|NCT00518323|459188527|FG002|Overall Study|Lack of Efficacy|4|||
127606382|NCT00518323|459188528|FG003|Overall Study|Lack of Efficacy|20|||
127606383|NCT00518323|459188525|FG000|Overall Study|Withdrawal by Subject|1|||
127606384|NCT00518323|459188526|FG001|Overall Study|Withdrawal by Subject|2|||
127606385|NCT00518323|459188527|FG002|Overall Study|Withdrawal by Subject|4|||
127606386|NCT00518323|459188528|FG003|Overall Study|Withdrawal by Subject|2|||
127606387|NCT00518323|459188525|FG000|Overall Study|Lost to Follow-up|0|||
127606388|NCT00518323|459188526|FG001|Overall Study|Lost to Follow-up|2|||
127606389|NCT00518323|459188527|FG002|Overall Study|Lost to Follow-up|1|||
127606390|NCT00518323|459188528|FG003|Overall Study|Lost to Follow-up|3|||
127606391|NCT00518323|459188525|FG000|Overall Study|Adverse Event|1|||
127606392|NCT00518323|459188526|FG001|Overall Study|Adverse Event|1|||
127606393|NCT00518323|459188527|FG002|Overall Study|Adverse Event|1|||
127606394|NCT00518323|459188528|FG003|Overall Study|Adverse Event|0|||
127606395|NCT00518323|459188525|FG000|Overall Study|Prohibited medication and others|3|||
127606396|NCT00518323|459188526|FG001|Overall Study|Prohibited medication and others|1|||
127606397|NCT00518323|459188527|FG002|Overall Study|Prohibited medication and others|1|||
127606398|NCT00518323|459188528|FG003|Overall Study|Prohibited medication and others|0|||
127606399|NCT01514760|459188529|FG000|Overall Study|Lost to Follow-up|2|||
127606400|NCT02092662|459188530|FG000|Overall Study|Lost to Follow-up|13|||
127606401|NCT02092662|459188531|FG001|Overall Study|Lost to Follow-up|0|||
127606402|NCT02914769|459188535|FG000|Overall Study|Protocol Violation|3|||
127606403|NCT02914769|459188536|FG001|Overall Study|Protocol Violation|2|||
127606404|NCT02914769|459188535|FG000|Overall Study|Withdrawal by Subject|0|||
127606405|NCT02914769|459188536|FG001|Overall Study|Withdrawal by Subject|1|||
127606406|NCT01592344|459188540|FG000|Overall Study|Adverse Event|1|||
127606407|NCT01592344|459188541|FG001|Overall Study|Adverse Event|1|||
127606408|NCT01592344|459188540|FG000|Overall Study|Lack of Efficacy|1|||
127606409|NCT01592344|459188541|FG001|Overall Study|Lack of Efficacy|0|||
127606410|NCT01592344|459188540|FG000|Overall Study|not available at primary outcome visit|2|||
127606411|NCT01592344|459188541|FG001|Overall Study|not available at primary outcome visit|4|||
127606412|NCT00099437|459188542|FG000|Overall Study|Lost to Follow-up|30|||
127606413|NCT00099437|459188543|FG001|Overall Study|Lost to Follow-up|33|||
127606414|NCT00099437|459188542|FG000|Overall Study|Death|293|||
127606415|NCT00099437|459188543|FG001|Overall Study|Death|261|||
127606416|NCT00099437|459188542|FG000|Overall Study|Withdrawal by Subject|6|||
127606417|NCT00099437|459188543|FG001|Overall Study|Withdrawal by Subject|10|||
127606418|NCT00099437|459188542|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
127606419|NCT00099437|459188543|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
127606420|NCT02488681|459188546|FG000|Overall Study|Implant unsuccessful|7|||
127606421|NCT02809677|459188547|FG000|Overall Study|Withdrawal by Subject|8|||
127606422|NCT04969224|459188548|FG000|Overall Study|Adverse Event|1|||
127606423|NCT04969224|459188548|FG000|Overall Study|Enrolled but never dosed|1|||
127606424|NCT03165110|459188549|FG000|Overall Study|Anroid phone software incompatibility|1|||
127606425|NCT05533632|459188550|FG000|Overall Study|Participant no longer wants to participate in study, has other priorities|1|||
127606426|NCT05533632|459188550|FG000|Overall Study|Participant moved to another city and will not come back to Santiago|1|||
127606427|NCT05533632|459188550|FG000|Overall Study|Lost to Follow-up|1|||
127606428|NCT05533632|459188550|FG000|Overall Study|Withdrawal by Subject|4|||
127606429|NCT05533632|459188550|FG000|Overall Study|Adverse Event|4|||
127606430|NCT04327388|459188553|FG000|Overall Study|Adverse Event|17|||
127606431|NCT04327388|459188554|FG001|Overall Study|Adverse Event|18|||
127606432|NCT04327388|459188555|FG002|Overall Study|Adverse Event|9|||
127606433|NCT04327388|459188553|FG000|Overall Study|Other|1|||
127606434|NCT04327388|459188554|FG001|Overall Study|Other|2|||
127606435|NCT04327388|459188555|FG002|Overall Study|Other|0|||
127606436|NCT04327388|459188553|FG000|Overall Study|Randomized and not treated|2|||
127606437|NCT04327388|459188554|FG001|Overall Study|Randomized and not treated|0|||
127606438|NCT04327388|459188555|FG002|Overall Study|Randomized and not treated|2|||
127606439|NCT01170091|459188558|FG000|Overall Study|Missing efficacy evaluation|3|||
127606440|NCT01170091|459188558|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
127606441|NCT00391274|459188559|FG000|Overall Study|Death Due to Study Disease|55|||
127606442|NCT00391274|459188560|FG001|Overall Study|Death Due to Study Disease|45|||
127606443|NCT00391274|459188559|FG000|Overall Study|Lost to Follow-up|0|||
127606444|NCT00391274|459188560|FG001|Overall Study|Lost to Follow-up|3|||
127606445|NCT00391274|459188559|FG000|Overall Study|Physician Decision|4|||
127606446|NCT00391274|459188560|FG001|Overall Study|Physician Decision|2|||
127697488|NCT03269136|459520234|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
127697489|NCT03269136|459520235|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
127697490|NCT03269136|459520236|FG012|Part 1: Dose Escalation|Lost to Follow-up|0|||
127606447|NCT00391274|459188559|FG000|Overall Study|Withdrawal by Subject|0|||
127606448|NCT00391274|459188560|FG001|Overall Study|Withdrawal by Subject|3|||
127606449|NCT00391274|459188559|FG000|Overall Study|Death Due to Adverse Event|1|||
127606450|NCT00391274|459188560|FG001|Overall Study|Death Due to Adverse Event|3|||
127606451|NCT00391274|459188559|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
127606452|NCT00391274|459188560|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
127606453|NCT00391274|459188559|FG000|Overall Study|Death Not Study Related|0|||
127606454|NCT00391274|459188560|FG001|Overall Study|Death Not Study Related|1|||
127606455|NCT01387347|459188561|FG000|Overall Study|Lost to Follow-up|2|||
127606456|NCT01387347|459188562|FG001|Overall Study|Lost to Follow-up|1|||
127606457|NCT01519960|459188563|FG000|Overall Study|Withdrawal from the study|26|||
127606458|NCT01519960|459188564|FG001|Overall Study|Withdrawal from the study|22|||
127606459|NCT01519960|459188565|FG002|Overall Study|Withdrawal from the study|5|||
127606460|NCT00561080|459188568|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
127606461|NCT00561080|459188569|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
127606462|NCT00561080|459188570|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
127606463|NCT00561080|459188568|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
127606464|NCT00561080|459188569|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
127606465|NCT00561080|459188570|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
127606466|NCT00561080|459188568|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
127606467|NCT00561080|459188569|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
127606468|NCT00561080|459188570|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
127606469|NCT00561080|459188568|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
127606470|NCT00561080|459188569|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
127606471|NCT00561080|459188570|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
127606472|NCT00561080|459188568|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
127606473|NCT00561080|459188569|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
127606474|NCT00561080|459188570|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
127606475|NCT00561080|459188568|FG000|Vaccination Period (up to Month 4)|Other|0|||
127606476|NCT00561080|459188569|FG001|Vaccination Period (up to Month 4)|Other|2|||
127606477|NCT00561080|459188570|FG002|Vaccination Period (up to Month 4)|Other|1|||
127606478|NCT00561080|459188568|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
127606479|NCT00561080|459188569|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
127606480|NCT00561080|459188570|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
127606481|NCT00561080|459188568|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
127606482|NCT00561080|459188569|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
127606483|NCT00561080|459188570|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
127606484|NCT00561080|459188568|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
127606485|NCT00561080|459188569|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
127606486|NCT00561080|459188570|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
127606487|NCT00561080|459188568|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
127606488|NCT00561080|459188569|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
127606489|NCT00561080|459188570|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
127606490|NCT05778786|459188573|FG000|Period 1|COVID-19 Related|3|||
127606491|NCT05778786|459188574|FG001|Period 1|COVID-19 Related|3|||
127606492|NCT05778786|459188573|FG000|Period 1|Withdrew Consent during Study|1|||
127606493|NCT05778786|459188574|FG001|Period 1|Withdrew Consent during Study|0|||
127606494|NCT05778786|459188573|FG000|Period 2|Unsatisfactory Lens Fitting due to Study Lens|0|||
127606495|NCT05778786|459188574|FG001|Period 2|Unsatisfactory Lens Fitting due to Study Lens|1|||
127606496|NCT05778786|459188573|FG000|Period 2|Other: Incorrect Study Lens Dispensed|0|||
127606497|NCT05778786|459188574|FG001|Period 2|Other: Incorrect Study Lens Dispensed|1|||
127606498|NCT01602380|459188575|FG000|Overall Study|Death|147|||
127606499|NCT01602380|459188576|FG001|Overall Study|Death|145|||
127606500|NCT01602380|459188575|FG000|Overall Study|Withdrawal by Subject|39|||
127606501|NCT01602380|459188576|FG001|Overall Study|Withdrawal by Subject|41|||
127606502|NCT01602380|459188575|FG000|Overall Study|Lost to Follow-up|15|||
127606503|NCT01602380|459188576|FG001|Overall Study|Lost to Follow-up|12|||
127606504|NCT01602380|459188575|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
127606505|NCT01602380|459188576|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
127606506|NCT01602380|459188575|FG000|Overall Study|Other|2|||
127606507|NCT01602380|459188576|FG001|Overall Study|Other|0|||
127606508|NCT01064401|459188578|FG000|Overall Study|Adverse Event|47|||
127697491|NCT03269136|459520237|FG013|Part 1: Dose Escalation|Lost to Follow-up|0|||
127606509|NCT01064401|459188579|FG001|Overall Study|Adverse Event|56|||
127606510|NCT01064401|459188578|FG000|Overall Study|Lack of Efficacy|46|||
127606511|NCT01064401|459188579|FG001|Overall Study|Lack of Efficacy|23|||
127606512|NCT01064401|459188578|FG000|Overall Study|Lost to Follow-up|12|||
127606513|NCT01064401|459188579|FG001|Overall Study|Lost to Follow-up|9|||
127606514|NCT01064401|459188578|FG000|Overall Study|Consent Withdrawn|98|||
127606515|NCT01064401|459188579|FG001|Overall Study|Consent Withdrawn|80|||
127606516|NCT01064401|459188578|FG000|Overall Study|Investigator Decision|4|||
127606517|NCT01064401|459188579|FG001|Overall Study|Investigator Decision|6|||
127697492|NCT03269136|459520238|FG014|Part 1: Dose Escalation|Lost to Follow-up|0|||
127697493|NCT03269136|459520239|FG015|Part 1: Dose Escalation|Lost to Follow-up|0|||
127697494|NCT03269136|459520240|FG016|Part 1: Dose Escalation|Lost to Follow-up|0|||
127697495|NCT03269136|459520241|FG017|Part 1: Dose Escalation|Lost to Follow-up|0|||
127697496|NCT03269136|459520224|FG000|Part 1: Dose Escalation|Death|0|||
127697497|NCT03269136|459520225|FG001|Part 1: Dose Escalation|Death|0|||
127697498|NCT03269136|459520226|FG002|Part 1: Dose Escalation|Death|0|||
127697499|NCT03269136|459520227|FG003|Part 1: Dose Escalation|Death|0|||
127697500|NCT03269136|459520228|FG004|Part 1: Dose Escalation|Death|0|||
127697501|NCT03269136|459520229|FG005|Part 1: Dose Escalation|Death|0|||
127697502|NCT03269136|459520230|FG006|Part 1: Dose Escalation|Death|0|||
127697503|NCT03269136|459520231|FG007|Part 1: Dose Escalation|Death|0|||
127697504|NCT03269136|459520232|FG008|Part 1: Dose Escalation|Death|0|||
127697505|NCT03269136|459520233|FG009|Part 1: Dose Escalation|Death|1|||
127697506|NCT03269136|459520234|FG010|Part 1: Dose Escalation|Death|0|||
127697507|NCT03269136|459520235|FG011|Part 1: Dose Escalation|Death|1|||
127697508|NCT03269136|459520236|FG012|Part 1: Dose Escalation|Death|0|||
127697509|NCT03269136|459520237|FG013|Part 1: Dose Escalation|Death|1|||
127697510|NCT03269136|459520238|FG014|Part 1: Dose Escalation|Death|0|||
127697511|NCT03269136|459520239|FG015|Part 1: Dose Escalation|Death|0|||
127697512|NCT03269136|459520240|FG016|Part 1: Dose Escalation|Death|2|||
127697513|NCT03269136|459520241|FG017|Part 1: Dose Escalation|Death|0|||
127697514|NCT03269136|459520224|FG000|Part 1: Dose Escalation|Disease Relapse|0|||
127697515|NCT03269136|459520225|FG001|Part 1: Dose Escalation|Disease Relapse|0|||
127697516|NCT03269136|459520226|FG002|Part 1: Dose Escalation|Disease Relapse|0|||
127697517|NCT03269136|459520227|FG003|Part 1: Dose Escalation|Disease Relapse|0|||
127697518|NCT03269136|459520228|FG004|Part 1: Dose Escalation|Disease Relapse|0|||
127697519|NCT03269136|459520229|FG005|Part 1: Dose Escalation|Disease Relapse|0|||
127697520|NCT03269136|459520230|FG006|Part 1: Dose Escalation|Disease Relapse|0|||
127697521|NCT03269136|459520231|FG007|Part 1: Dose Escalation|Disease Relapse|0|||
127697522|NCT03269136|459520232|FG008|Part 1: Dose Escalation|Disease Relapse|0|||
127697523|NCT03269136|459520233|FG009|Part 1: Dose Escalation|Disease Relapse|1|||
127697524|NCT03269136|459520234|FG010|Part 1: Dose Escalation|Disease Relapse|0|||
127697525|NCT03269136|459520235|FG011|Part 1: Dose Escalation|Disease Relapse|0|||
127606518|NCT01064401|459188578|FG000|Overall Study|Death|4|||
127606519|NCT01064401|459188579|FG001|Overall Study|Death|0|||
127606520|NCT01064401|459188578|FG000|Overall Study|Pregnancy|4|||
127606521|NCT01064401|459188579|FG001|Overall Study|Pregnancy|7|||
127606522|NCT01064401|459188578|FG000|Overall Study|Noncompliance|7|||
127606523|NCT01064401|459188579|FG001|Overall Study|Noncompliance|8|||
127606524|NCT01064401|459188578|FG000|Overall Study|Site Closure|4|||
127606525|NCT01064401|459188579|FG001|Overall Study|Site Closure|5|||
127606526|NCT01064401|459188578|FG000|Overall Study|Other|2|||
127606527|NCT01064401|459188579|FG001|Overall Study|Other|1|||
127606528|NCT03158051|459188580|FG000|Overall Study|Lost to Follow-up|41|||
127606529|NCT03158051|459188581|FG001|Overall Study|Lost to Follow-up|47|||
127606530|NCT03158051|459188580|FG000|Overall Study|Physician Decision|6|||
127606531|NCT03158051|459188581|FG001|Overall Study|Physician Decision|7|||
127697526|NCT03269136|459520236|FG012|Part 1: Dose Escalation|Disease Relapse|0|||
127697527|NCT03269136|459520237|FG013|Part 1: Dose Escalation|Disease Relapse|0|||
127697528|NCT03269136|459520238|FG014|Part 1: Dose Escalation|Disease Relapse|0|||
127697529|NCT03269136|459520239|FG015|Part 1: Dose Escalation|Disease Relapse|0|||
127697530|NCT03269136|459520240|FG016|Part 1: Dose Escalation|Disease Relapse|0|||
127697531|NCT03269136|459520241|FG017|Part 1: Dose Escalation|Disease Relapse|0|||
127697532|NCT03269136|459520224|FG000|Part 1: Dose Escalation|Adverse Event|0|||
127697533|NCT03269136|459520225|FG001|Part 1: Dose Escalation|Adverse Event|0|||
127697534|NCT03269136|459520226|FG002|Part 1: Dose Escalation|Adverse Event|0|||
127697535|NCT03269136|459520227|FG003|Part 1: Dose Escalation|Adverse Event|0|||
127697536|NCT03269136|459520228|FG004|Part 1: Dose Escalation|Adverse Event|0|||
127697537|NCT03269136|459520229|FG005|Part 1: Dose Escalation|Adverse Event|0|||
127697538|NCT03269136|459520230|FG006|Part 1: Dose Escalation|Adverse Event|2|||
127697539|NCT03269136|459520231|FG007|Part 1: Dose Escalation|Adverse Event|0|||
127697540|NCT03269136|459520232|FG008|Part 1: Dose Escalation|Adverse Event|0|||
127697541|NCT03269136|459520233|FG009|Part 1: Dose Escalation|Adverse Event|0|||
127697542|NCT03269136|459520234|FG010|Part 1: Dose Escalation|Adverse Event|1|||
127697543|NCT03269136|459520235|FG011|Part 1: Dose Escalation|Adverse Event|2|||
127697544|NCT03269136|459520236|FG012|Part 1: Dose Escalation|Adverse Event|0|||
127697545|NCT03269136|459520237|FG013|Part 1: Dose Escalation|Adverse Event|1|||
127697546|NCT03269136|459520238|FG014|Part 1: Dose Escalation|Adverse Event|0|||
127606532|NCT03158051|459188580|FG000|Overall Study|Withdrawal by Subject|24|||
127606533|NCT03158051|459188581|FG001|Overall Study|Withdrawal by Subject|15|||
127606534|NCT03158051|459188580|FG000|Overall Study|Death|0|||
127697547|NCT03269136|459520239|FG015|Part 1: Dose Escalation|Adverse Event|0|||
127606535|NCT03158051|459188581|FG001|Overall Study|Death|1|||
127697548|NCT03269136|459520240|FG016|Part 1: Dose Escalation|Adverse Event|1|||
127697549|NCT03269136|459520241|FG017|Part 1: Dose Escalation|Adverse Event|0|||
127606536|NCT02738151|459188582|FG000|Overall Study|Randomized but not treated|4|||
127606537|NCT02738151|459188583|FG001|Overall Study|Randomized but not treated|1|||
127606538|NCT02738151|459188582|FG000|Overall Study|Adverse Event|4|||
127606539|NCT02738151|459188583|FG001|Overall Study|Adverse Event|5|||
127606540|NCT02738151|459188582|FG000|Overall Study|Hypoglycemia|0|||
127606541|NCT02738151|459188583|FG001|Overall Study|Hypoglycemia|1|||
127606542|NCT02738151|459188582|FG000|Overall Study|Poor Compliance to Protocol|4|||
127606543|NCT02738151|459188583|FG001|Overall Study|Poor Compliance to Protocol|3|||
127606544|NCT02738151|459188582|FG000|Overall Study|Other than specified above|11|||
127606545|NCT02738151|459188583|FG001|Overall Study|Other than specified above|21|||
127606546|NCT02588833|459188584|FG000|Part 1|Withdrawal by Subject|1|||
127606547|NCT02588833|459188585|FG001|Part 1|Withdrawal by Subject|0|||
127606548|NCT02588833|459188584|FG000|Part 2A|Physician Decision|0|||
127606549|NCT02588833|459188585|FG001|Part 2A|Physician Decision|1|||
127606550|NCT02588833|459188584|FG000|Part 2A|Withdrawal by Subject|0|||
127606551|NCT02588833|459188585|FG001|Part 2A|Withdrawal by Subject|1|||
127606552|NCT02588833|459188584|FG000|Part 2B|Adverse Event|0|||
127606553|NCT02588833|459188585|FG001|Part 2B|Adverse Event|1|||
127606554|NCT02588833|459188584|FG000|Part 2C|Adverse Event|0|||
127606555|NCT02588833|459188585|FG001|Part 2C|Adverse Event|1|||
127606556|NCT02588833|459188584|FG000|Part 2C|Withdrawal by Subject|0|||
127606557|NCT02588833|459188585|FG001|Part 2C|Withdrawal by Subject|1|||
127606558|NCT02588833|459188584|FG000|Part 3 (Safety Follow-up)|Other|0|||
127606559|NCT02588833|459188585|FG001|Part 3 (Safety Follow-up)|Other|2|||
127606560|NCT02005250|459188586|FG000|Overall Study|Lost to Follow-up|15|||
127606561|NCT02005250|459188587|FG001|Overall Study|Lost to Follow-up|5|||
127606562|NCT03649711|459188589|FG000|Overall Study|Adverse Event|0|||
127606563|NCT03649711|459188590|FG001|Overall Study|Adverse Event|1|||
127606564|NCT03649711|459188591|FG002|Overall Study|Adverse Event|0|||
127606565|NCT03649711|459188589|FG000|Overall Study|Kidney Transplant|1|||
127606566|NCT03649711|459188590|FG001|Overall Study|Kidney Transplant|0|||
127606567|NCT03649711|459188591|FG002|Overall Study|Kidney Transplant|0|||
127606568|NCT04007094|459188596|FG000|Overall Study|Lost to Follow-up|1|||
127606569|NCT04007094|459188597|FG001|Overall Study|Lost to Follow-up|1|||
127606570|NCT02070744|459188598|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
127606571|NCT02070744|459188599|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
127606572|NCT02070744|459188600|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
127606573|NCT02070744|459188601|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
127606574|NCT02070744|459188602|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
127606575|NCT02070744|459188598|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
127606576|NCT02070744|459188599|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
127606577|NCT02070744|459188600|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
127606578|NCT02070744|459188601|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
127606579|NCT02070744|459188602|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
127606580|NCT02070744|459188598|FG000|OLE Phase (48 Weeks)|Other|0|||
127606581|NCT02070744|459188599|FG001|OLE Phase (48 Weeks)|Other|0|||
127606582|NCT02070744|459188600|FG002|OLE Phase (48 Weeks)|Other|0|||
127606583|NCT02070744|459188601|FG003|OLE Phase (48 Weeks)|Other|0|||
127606584|NCT02070744|459188602|FG004|OLE Phase (48 Weeks)|Other|1|||
127606585|NCT04199117|459188603|FG000|Overall Study|Withdrawal by Subject|3|||
127606586|NCT04199117|459188604|FG001|Overall Study|Withdrawal by Subject|0|||
127606587|NCT04199117|459188605|FG002|Overall Study|Withdrawal by Subject|0|||
127606588|NCT04199117|459188606|FG003|Overall Study|Withdrawal by Subject|1|||
127606589|NCT04199117|459188607|FG004|Overall Study|Withdrawal by Subject|1|||
127606590|NCT04199117|459188608|FG005|Overall Study|Withdrawal by Subject|0|||
127606591|NCT04199117|459188609|FG006|Overall Study|Withdrawal by Subject|0|||
127606592|NCT04199117|459188610|FG007|Overall Study|Withdrawal by Subject|2|||
127606593|NCT04199117|459188611|FG008|Overall Study|Withdrawal by Subject|0|||
127606594|NCT04199117|459188612|FG009|Overall Study|Withdrawal by Subject|0|||
127606595|NCT04199117|459188613|FG010|Overall Study|Withdrawal by Subject|1|||
127606596|NCT04199117|459188614|FG011|Overall Study|Withdrawal by Subject|1|||
127606597|NCT04199117|459188615|FG012|Overall Study|Withdrawal by Subject|2|||
127606598|NCT04199117|459188616|FG013|Overall Study|Withdrawal by Subject|1|||
127606599|NCT04199117|459188617|FG014|Overall Study|Withdrawal by Subject|1|||
127606600|NCT04199117|459188618|FG015|Overall Study|Withdrawal by Subject|1|||
127606601|NCT04199117|459188603|FG000|Overall Study|Death|1|||
127606602|NCT04199117|459188604|FG001|Overall Study|Death|1|||
127606603|NCT04199117|459188605|FG002|Overall Study|Death|0|||
127606604|NCT04199117|459188606|FG003|Overall Study|Death|0|||
127606605|NCT04199117|459188607|FG004|Overall Study|Death|0|||
127606606|NCT04199117|459188608|FG005|Overall Study|Death|0|||
127606607|NCT04199117|459188609|FG006|Overall Study|Death|0|||
127606608|NCT04199117|459188610|FG007|Overall Study|Death|0|||
127606609|NCT04199117|459188611|FG008|Overall Study|Death|0|||
127606610|NCT04199117|459188612|FG009|Overall Study|Death|0|||
127606611|NCT04199117|459188613|FG010|Overall Study|Death|0|||
127606612|NCT04199117|459188614|FG011|Overall Study|Death|1|||
127606613|NCT04199117|459188615|FG012|Overall Study|Death|0|||
127606614|NCT04199117|459188616|FG013|Overall Study|Death|1|||
127606615|NCT04199117|459188617|FG014|Overall Study|Death|0|||
127606616|NCT04199117|459188618|FG015|Overall Study|Death|0|||
127606617|NCT04199117|459188603|FG000|Overall Study|Withdrawal by PI|0|||
127606618|NCT04199117|459188604|FG001|Overall Study|Withdrawal by PI|0|||
127606619|NCT04199117|459188605|FG002|Overall Study|Withdrawal by PI|0|||
127606620|NCT04199117|459188606|FG003|Overall Study|Withdrawal by PI|0|||
127606621|NCT04199117|459188607|FG004|Overall Study|Withdrawal by PI|0|||
127606622|NCT04199117|459188608|FG005|Overall Study|Withdrawal by PI|0|||
127606623|NCT04199117|459188609|FG006|Overall Study|Withdrawal by PI|0|||
127606624|NCT04199117|459188610|FG007|Overall Study|Withdrawal by PI|0|||
127606625|NCT04199117|459188611|FG008|Overall Study|Withdrawal by PI|0|||
127606626|NCT04199117|459188612|FG009|Overall Study|Withdrawal by PI|0|||
127606627|NCT04199117|459188613|FG010|Overall Study|Withdrawal by PI|0|||
127606628|NCT04199117|459188614|FG011|Overall Study|Withdrawal by PI|0|||
127606629|NCT04199117|459188615|FG012|Overall Study|Withdrawal by PI|1|||
127606630|NCT04199117|459188616|FG013|Overall Study|Withdrawal by PI|0|||
127606631|NCT04199117|459188617|FG014|Overall Study|Withdrawal by PI|0|||
127606632|NCT04199117|459188618|FG015|Overall Study|Withdrawal by PI|0|||
127606633|NCT00702403|459190310|FG000|From Consent to Engraftment|Progressive leukemia|6|||
127606634|NCT00702403|459190310|FG000|From Consent to Engraftment|Critically ill|2|||
127606635|NCT00702403|459190310|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
127606636|NCT00702403|459190310|FG000|From Consent to Engraftment|Myocardial infarction|1|||
127606637|NCT00702403|459190310|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
127606638|NCT00702403|459190310|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
127606639|NCT00702403|459190310|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
127606640|NCT00702403|459190310|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
127606641|NCT00702403|459190310|FG000|From Engraftment to Study Completion|Non-compliance|2|||
127606642|NCT00702403|459190310|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
127606643|NCT00702403|459190310|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
127606644|NCT00702403|459190310|FG000|From Engraftment to Study Completion|Suicide|1|||
127606645|NCT00702403|459190310|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
127606646|NCT00702403|459190310|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
127606647|NCT00702403|459190310|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
127606648|NCT00380978|459190312|FG000|Overall Study|Refused allocated intervention|0|||
127606649|NCT00380978|459190313|FG001|Overall Study|Refused allocated intervention|6|||
127606650|NCT00380978|459190312|FG000|Overall Study|Wrong study envelope|0|||
127606651|NCT00380978|459190313|FG001|Overall Study|Wrong study envelope|2|||
127606652|NCT00380978|459190312|FG000|Overall Study|Allocation prior to analgesia request|1|||
127606653|NCT00380978|459190313|FG001|Overall Study|Allocation prior to analgesia request|2|||
127606654|NCT00380978|459190312|FG000|Overall Study|Parous patient|1|||
127606655|NCT00380978|459190313|FG001|Overall Study|Parous patient|0|||
127606656|NCT04146545|459190314|FG000|Overall Study|deemed ineligible after randomization|1|||
127606657|NCT04146545|459190315|FG001|Overall Study|deemed ineligible after randomization|0|||
127606658|NCT01729754|459190316|FG000|Part 1|Adverse Event|2|||
127606659|NCT01729754|459190317|FG001|Part 1|Adverse Event|0|||
127606660|NCT01729754|459190318|FG002|Part 1|Adverse Event|0|||
127606661|NCT01729754|459190319|FG003|Part 1|Adverse Event|1|||
127606662|NCT01729754|459190320|FG004|Part 1|Adverse Event|0|||
127606663|NCT01729754|459190321|FG005|Part 1|Adverse Event|0|||
127606664|NCT01729754|459190322|FG006|Part 1|Adverse Event|2|||
127606665|NCT01729754|459190323|FG007|Part 1|Adverse Event|0|||
127606666|NCT01729754|459190324|FG008|Part 1|Adverse Event|0|||
127606667|NCT01729754|459190325|FG009|Part 1|Adverse Event|5|||
127606668|NCT01729754|459190316|FG000|Part 1|Lack of Efficacy|1|||
127606669|NCT01729754|459190317|FG001|Part 1|Lack of Efficacy|0|||
127606670|NCT01729754|459190318|FG002|Part 1|Lack of Efficacy|0|||
127606671|NCT01729754|459190319|FG003|Part 1|Lack of Efficacy|0|||
127606672|NCT01729754|459190320|FG004|Part 1|Lack of Efficacy|0|||
127606673|NCT01729754|459190321|FG005|Part 1|Lack of Efficacy|0|||
127606674|NCT01729754|459190322|FG006|Part 1|Lack of Efficacy|2|||
127606675|NCT01729754|459190323|FG007|Part 1|Lack of Efficacy|0|||
127606676|NCT01729754|459190324|FG008|Part 1|Lack of Efficacy|0|||
127606677|NCT01729754|459190325|FG009|Part 1|Lack of Efficacy|0|||
127606678|NCT01729754|459190316|FG000|Part 1|Lost to Follow-up|1|||
127606679|NCT01729754|459190317|FG001|Part 1|Lost to Follow-up|0|||
127606680|NCT01729754|459190318|FG002|Part 1|Lost to Follow-up|0|||
127606681|NCT01729754|459190319|FG003|Part 1|Lost to Follow-up|2|||
127606682|NCT01729754|459190320|FG004|Part 1|Lost to Follow-up|0|||
127606683|NCT01729754|459190321|FG005|Part 1|Lost to Follow-up|0|||
127606684|NCT01729754|459190322|FG006|Part 1|Lost to Follow-up|3|||
127606685|NCT01729754|459190323|FG007|Part 1|Lost to Follow-up|0|||
127606686|NCT01729754|459190324|FG008|Part 1|Lost to Follow-up|0|||
127606687|NCT01729754|459190325|FG009|Part 1|Lost to Follow-up|3|||
127606688|NCT01729754|459190316|FG000|Part 1|Non-compliance with Study Drug|1|||
127606689|NCT01729754|459190317|FG001|Part 1|Non-compliance with Study Drug|0|||
127606690|NCT01729754|459190318|FG002|Part 1|Non-compliance with Study Drug|0|||
127606691|NCT01729754|459190319|FG003|Part 1|Non-compliance with Study Drug|0|||
127606692|NCT01729754|459190320|FG004|Part 1|Non-compliance with Study Drug|0|||
127606693|NCT01729754|459190321|FG005|Part 1|Non-compliance with Study Drug|0|||
127788768|NCT00705783|459851280|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
127606694|NCT01729754|459190322|FG006|Part 1|Non-compliance with Study Drug|0|||
127697550|NCT03269136|459520224|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
127697551|NCT03269136|459520225|FG001|Part 1: Dose Escalation|Progressive Disease|3|||
127697552|NCT03269136|459520226|FG002|Part 1: Dose Escalation|Progressive Disease|2|||
127697553|NCT03269136|459520227|FG003|Part 1: Dose Escalation|Progressive Disease|3|||
127697554|NCT03269136|459520228|FG004|Part 1: Dose Escalation|Progressive Disease|2|||
127697555|NCT03269136|459520229|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
127697556|NCT03269136|459520230|FG006|Part 1: Dose Escalation|Progressive Disease|3|||
127697557|NCT03269136|459520231|FG007|Part 1: Dose Escalation|Progressive Disease|5|||
127697558|NCT03269136|459520232|FG008|Part 1: Dose Escalation|Progressive Disease|3|||
127697559|NCT03269136|459520233|FG009|Part 1: Dose Escalation|Progressive Disease|1|||
127697560|NCT03269136|459520234|FG010|Part 1: Dose Escalation|Progressive Disease|2|||
127697561|NCT03269136|459520235|FG011|Part 1: Dose Escalation|Progressive Disease|2|||
127697562|NCT03269136|459520236|FG012|Part 1: Dose Escalation|Progressive Disease|3|||
127697563|NCT03269136|459520237|FG013|Part 1: Dose Escalation|Progressive Disease|3|||
127697564|NCT03269136|459520238|FG014|Part 1: Dose Escalation|Progressive Disease|8|||
127697565|NCT03269136|459520239|FG015|Part 1: Dose Escalation|Progressive Disease|3|||
127697566|NCT03269136|459520240|FG016|Part 1: Dose Escalation|Progressive Disease|4|||
127697567|NCT03269136|459520241|FG017|Part 1: Dose Escalation|Progressive Disease|0|||
127697568|NCT03269136|459520224|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
127697569|NCT03269136|459520225|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
127697570|NCT03269136|459520226|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
127697571|NCT03269136|459520227|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
127697572|NCT03269136|459520228|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
127697573|NCT03269136|459520229|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
127697574|NCT03269136|459520230|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
127697575|NCT03269136|459520231|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
127697576|NCT03269136|459520232|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
127697577|NCT03269136|459520233|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
127697578|NCT03269136|459520234|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
127697579|NCT03269136|459520235|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
127697580|NCT03269136|459520236|FG012|Part 1: Dose Escalation|Withdrawal by Subject|1|||
127697581|NCT03269136|459520237|FG013|Part 1: Dose Escalation|Withdrawal by Subject|2|||
127697582|NCT03269136|459520238|FG014|Part 1: Dose Escalation|Withdrawal by Subject|2|||
127697583|NCT03269136|459520239|FG015|Part 1: Dose Escalation|Withdrawal by Subject|0|||
127697584|NCT03269136|459520240|FG016|Part 1: Dose Escalation|Withdrawal by Subject|1|||
127697585|NCT03269136|459520241|FG017|Part 1: Dose Escalation|Withdrawal by Subject|0|||
127697586|NCT03269136|459520224|FG000|Part 2A: Dose Expansion|Other|0|||
127697587|NCT03269136|459520225|FG001|Part 2A: Dose Expansion|Other|0|||
127697588|NCT03269136|459520226|FG002|Part 2A: Dose Expansion|Other|0|||
127697589|NCT03269136|459520227|FG003|Part 2A: Dose Expansion|Other|0|||
127697590|NCT03269136|459520228|FG004|Part 2A: Dose Expansion|Other|0|||
127697591|NCT03269136|459520229|FG005|Part 2A: Dose Expansion|Other|0|||
127697592|NCT03269136|459520230|FG006|Part 2A: Dose Expansion|Other|0|||
127697593|NCT03269136|459520231|FG007|Part 2A: Dose Expansion|Other|0|||
127697594|NCT03269136|459520232|FG008|Part 2A: Dose Expansion|Other|0|||
127697595|NCT03269136|459520233|FG009|Part 2A: Dose Expansion|Other|0|||
127697596|NCT03269136|459520234|FG010|Part 2A: Dose Expansion|Other|0|||
127697597|NCT03269136|459520235|FG011|Part 2A: Dose Expansion|Other|0|||
127697598|NCT03269136|459520236|FG012|Part 2A: Dose Expansion|Other|0|||
127697599|NCT03269136|459520237|FG013|Part 2A: Dose Expansion|Other|0|||
127697600|NCT03269136|459520238|FG014|Part 2A: Dose Expansion|Other|0|||
127697601|NCT03269136|459520239|FG015|Part 2A: Dose Expansion|Other|0|||
127697602|NCT03269136|459520240|FG016|Part 2A: Dose Expansion|Other|0|||
127697603|NCT03269136|459520241|FG017|Part 2A: Dose Expansion|Other|1|||
127697604|NCT03269136|459520224|FG000|Part 2A: Dose Expansion|Refused Further Treatment|0|||
127697605|NCT03269136|459520225|FG001|Part 2A: Dose Expansion|Refused Further Treatment|0|||
127697606|NCT03269136|459520226|FG002|Part 2A: Dose Expansion|Refused Further Treatment|0|||
127697607|NCT03269136|459520227|FG003|Part 2A: Dose Expansion|Refused Further Treatment|0|||
127697608|NCT03269136|459520228|FG004|Part 2A: Dose Expansion|Refused Further Treatment|0|||
127697609|NCT03269136|459520229|FG005|Part 2A: Dose Expansion|Refused Further Treatment|0|||
127697610|NCT03269136|459520230|FG006|Part 2A: Dose Expansion|Refused Further Treatment|0|||
127697611|NCT03269136|459520231|FG007|Part 2A: Dose Expansion|Refused Further Treatment|0|||
127697612|NCT03269136|459520232|FG008|Part 2A: Dose Expansion|Refused Further Treatment|0|||
127697613|NCT03269136|459520233|FG009|Part 2A: Dose Expansion|Refused Further Treatment|0|||
127697614|NCT03269136|459520234|FG010|Part 2A: Dose Expansion|Refused Further Treatment|0|||
127697615|NCT03269136|459520235|FG011|Part 2A: Dose Expansion|Refused Further Treatment|0|||
127697616|NCT03269136|459520236|FG012|Part 2A: Dose Expansion|Refused Further Treatment|0|||
127697617|NCT03269136|459520237|FG013|Part 2A: Dose Expansion|Refused Further Treatment|0|||
127697618|NCT03269136|459520238|FG014|Part 2A: Dose Expansion|Refused Further Treatment|0|||
127697619|NCT03269136|459520239|FG015|Part 2A: Dose Expansion|Refused Further Treatment|0|||
127697620|NCT03269136|459520240|FG016|Part 2A: Dose Expansion|Refused Further Treatment|0|||
127697621|NCT03269136|459520241|FG017|Part 2A: Dose Expansion|Refused Further Treatment|2|||
127697622|NCT03269136|459520224|FG000|Part 2A: Dose Expansion|Disease Relapse|0|||
127697623|NCT03269136|459520225|FG001|Part 2A: Dose Expansion|Disease Relapse|0|||
127697624|NCT03269136|459520226|FG002|Part 2A: Dose Expansion|Disease Relapse|0|||
127697625|NCT03269136|459520227|FG003|Part 2A: Dose Expansion|Disease Relapse|0|||
127697626|NCT03269136|459520228|FG004|Part 2A: Dose Expansion|Disease Relapse|0|||
127697627|NCT03269136|459520229|FG005|Part 2A: Dose Expansion|Disease Relapse|0|||
127697628|NCT03269136|459520230|FG006|Part 2A: Dose Expansion|Disease Relapse|0|||
127697629|NCT03269136|459520231|FG007|Part 2A: Dose Expansion|Disease Relapse|0|||
127697630|NCT03269136|459520232|FG008|Part 2A: Dose Expansion|Disease Relapse|0|||
127697631|NCT03269136|459520233|FG009|Part 2A: Dose Expansion|Disease Relapse|0|||
127697632|NCT03269136|459520234|FG010|Part 2A: Dose Expansion|Disease Relapse|0|||
127697633|NCT03269136|459520235|FG011|Part 2A: Dose Expansion|Disease Relapse|0|||
127697634|NCT03269136|459520236|FG012|Part 2A: Dose Expansion|Disease Relapse|0|||
127697635|NCT03269136|459520237|FG013|Part 2A: Dose Expansion|Disease Relapse|0|||
127697636|NCT03269136|459520238|FG014|Part 2A: Dose Expansion|Disease Relapse|0|||
127697637|NCT03269136|459520239|FG015|Part 2A: Dose Expansion|Disease Relapse|0|||
127697638|NCT03269136|459520240|FG016|Part 2A: Dose Expansion|Disease Relapse|0|||
127697639|NCT03269136|459520241|FG017|Part 2A: Dose Expansion|Disease Relapse|1|||
127697640|NCT03269136|459520224|FG000|Part 2A: Dose Expansion|Progressive Disease|0|||
127697641|NCT03269136|459520225|FG001|Part 2A: Dose Expansion|Progressive Disease|0|||
127697642|NCT03269136|459520226|FG002|Part 2A: Dose Expansion|Progressive Disease|0|||
127697643|NCT03269136|459520227|FG003|Part 2A: Dose Expansion|Progressive Disease|0|||
127697644|NCT03269136|459520228|FG004|Part 2A: Dose Expansion|Progressive Disease|0|||
127697645|NCT03269136|459520229|FG005|Part 2A: Dose Expansion|Progressive Disease|0|||
127697646|NCT03269136|459520230|FG006|Part 2A: Dose Expansion|Progressive Disease|0|||
127697647|NCT03269136|459520231|FG007|Part 2A: Dose Expansion|Progressive Disease|0|||
127697648|NCT03269136|459520232|FG008|Part 2A: Dose Expansion|Progressive Disease|0|||
127697649|NCT03269136|459520233|FG009|Part 2A: Dose Expansion|Progressive Disease|0|||
127697650|NCT03269136|459520234|FG010|Part 2A: Dose Expansion|Progressive Disease|0|||
127697651|NCT03269136|459520235|FG011|Part 2A: Dose Expansion|Progressive Disease|0|||
127697652|NCT03269136|459520236|FG012|Part 2A: Dose Expansion|Progressive Disease|0|||
127697653|NCT03269136|459520237|FG013|Part 2A: Dose Expansion|Progressive Disease|0|||
127697654|NCT03269136|459520238|FG014|Part 2A: Dose Expansion|Progressive Disease|0|||
127697655|NCT03269136|459520239|FG015|Part 2A: Dose Expansion|Progressive Disease|0|||
127697656|NCT03269136|459520240|FG016|Part 2A: Dose Expansion|Progressive Disease|0|||
127697657|NCT03269136|459520241|FG017|Part 2A: Dose Expansion|Progressive Disease|9|||
127697658|NCT03269136|459520224|FG000|Part 2A: Dose Expansion|Adverse Event|0|||
127697659|NCT03269136|459520225|FG001|Part 2A: Dose Expansion|Adverse Event|0|||
127697660|NCT03269136|459520226|FG002|Part 2A: Dose Expansion|Adverse Event|0|||
127697661|NCT03269136|459520227|FG003|Part 2A: Dose Expansion|Adverse Event|0|||
127697662|NCT03269136|459520228|FG004|Part 2A: Dose Expansion|Adverse Event|0|||
127697663|NCT03269136|459520229|FG005|Part 2A: Dose Expansion|Adverse Event|0|||
127697664|NCT03269136|459520230|FG006|Part 2A: Dose Expansion|Adverse Event|0|||
127697665|NCT03269136|459520231|FG007|Part 2A: Dose Expansion|Adverse Event|0|||
127697666|NCT03269136|459520232|FG008|Part 2A: Dose Expansion|Adverse Event|0|||
127697667|NCT03269136|459520233|FG009|Part 2A: Dose Expansion|Adverse Event|0|||
127697668|NCT03269136|459520234|FG010|Part 2A: Dose Expansion|Adverse Event|0|||
127697669|NCT03269136|459520235|FG011|Part 2A: Dose Expansion|Adverse Event|0|||
127697670|NCT03269136|459520236|FG012|Part 2A: Dose Expansion|Adverse Event|0|||
127697671|NCT03269136|459520237|FG013|Part 2A: Dose Expansion|Adverse Event|0|||
127697672|NCT03269136|459520238|FG014|Part 2A: Dose Expansion|Adverse Event|0|||
127697673|NCT03269136|459520239|FG015|Part 2A: Dose Expansion|Adverse Event|0|||
127697674|NCT03269136|459520240|FG016|Part 2A: Dose Expansion|Adverse Event|0|||
127697675|NCT03269136|459520241|FG017|Part 2A: Dose Expansion|Adverse Event|2|||
127697676|NCT04717492|459520242|FG000|Overall Study|Withdrawal by Subject|2|||
127788769|NCT00705783|459851278|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
127788770|NCT00705783|459851279|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
127788771|NCT00705783|459851280|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
127788772|NCT00705783|459851278|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
127697677|NCT04717492|459520243|FG001|Overall Study|Withdrawal by Subject|13|||
127697678|NCT04717492|459520242|FG000|Overall Study|Lost to Follow-up|2|||
127697679|NCT04717492|459520243|FG001|Overall Study|Lost to Follow-up|9|||
127697680|NCT04456517|459520244|FG000|First Intervention:Baseline to 12 Weeks|Adverse Event|0|||
127697681|NCT04456517|459520245|FG001|First Intervention:Baseline to 12 Weeks|Adverse Event|1|||
127697682|NCT05282173|459520247|FG000|Overall Study|Missed|3|||
127788773|NCT00705783|459851279|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
127788774|NCT00705783|459851280|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
127788775|NCT00705783|459851278|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
127788776|NCT00705783|459851279|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
127697683|NCT05282173|459520248|FG001|Overall Study|Missed|2|||
127697684|NCT05282173|459520249|FG002|Overall Study|Missed|4|||
127697685|NCT05351554|459520250|FG000|Overall Study|Study terminated by sponsor|1|||
127697686|NCT03774082|459520251|FG000|Overall Study|Death|6|||
127697687|NCT03774082|459520252|FG001|Overall Study|Death|3|||
127606695|NCT01729754|459190323|FG007|Part 1|Non-compliance with Study Drug|0|||
127606696|NCT01729754|459190324|FG008|Part 1|Non-compliance with Study Drug|0|||
127606697|NCT01729754|459190325|FG009|Part 1|Non-compliance with Study Drug|0|||
127606698|NCT01729754|459190316|FG000|Part 1|Physician Decision|0|||
127606699|NCT01729754|459190317|FG001|Part 1|Physician Decision|0|||
127606700|NCT01729754|459190318|FG002|Part 1|Physician Decision|0|||
127606701|NCT01729754|459190319|FG003|Part 1|Physician Decision|0|||
127606702|NCT01729754|459190320|FG004|Part 1|Physician Decision|0|||
127606703|NCT01729754|459190321|FG005|Part 1|Physician Decision|0|||
127606704|NCT01729754|459190322|FG006|Part 1|Physician Decision|0|||
127606705|NCT01729754|459190323|FG007|Part 1|Physician Decision|0|||
127606706|NCT01729754|459190324|FG008|Part 1|Physician Decision|0|||
127606707|NCT01729754|459190325|FG009|Part 1|Physician Decision|4|||
127606708|NCT01729754|459190316|FG000|Part 1|Pregnancy|0|||
127606709|NCT01729754|459190317|FG001|Part 1|Pregnancy|0|||
127606710|NCT01729754|459190318|FG002|Part 1|Pregnancy|0|||
127606711|NCT01729754|459190319|FG003|Part 1|Pregnancy|1|||
127606712|NCT01729754|459190320|FG004|Part 1|Pregnancy|0|||
127606713|NCT01729754|459190321|FG005|Part 1|Pregnancy|0|||
127606714|NCT01729754|459190322|FG006|Part 1|Pregnancy|0|||
127606715|NCT01729754|459190323|FG007|Part 1|Pregnancy|0|||
127606716|NCT01729754|459190324|FG008|Part 1|Pregnancy|0|||
127606717|NCT01729754|459190325|FG009|Part 1|Pregnancy|1|||
127606718|NCT01729754|459190316|FG000|Part 1|Progressive Disease|0|||
127606719|NCT01729754|459190317|FG001|Part 1|Progressive Disease|0|||
127606720|NCT01729754|459190318|FG002|Part 1|Progressive Disease|0|||
127606721|NCT01729754|459190319|FG003|Part 1|Progressive Disease|0|||
127606722|NCT01729754|459190320|FG004|Part 1|Progressive Disease|0|||
127606723|NCT01729754|459190321|FG005|Part 1|Progressive Disease|0|||
127606724|NCT01729754|459190322|FG006|Part 1|Progressive Disease|0|||
127606725|NCT01729754|459190323|FG007|Part 1|Progressive Disease|0|||
127606726|NCT01729754|459190324|FG008|Part 1|Progressive Disease|0|||
127606727|NCT01729754|459190325|FG009|Part 1|Progressive Disease|1|||
127606728|NCT01729754|459190316|FG000|Part 1|Protocol Violation|2|||
127606729|NCT01729754|459190317|FG001|Part 1|Protocol Violation|0|||
127606730|NCT01729754|459190318|FG002|Part 1|Protocol Violation|0|||
127606731|NCT01729754|459190319|FG003|Part 1|Protocol Violation|1|||
127606732|NCT01729754|459190320|FG004|Part 1|Protocol Violation|0|||
127606733|NCT01729754|459190321|FG005|Part 1|Protocol Violation|0|||
127606734|NCT01729754|459190322|FG006|Part 1|Protocol Violation|1|||
127606735|NCT01729754|459190323|FG007|Part 1|Protocol Violation|0|||
127606736|NCT01729754|459190324|FG008|Part 1|Protocol Violation|0|||
127606737|NCT01729754|459190325|FG009|Part 1|Protocol Violation|0|||
127606738|NCT01729754|459190316|FG000|Part 1|Withdrawal by Subject|5|||
127606739|NCT01729754|459190317|FG001|Part 1|Withdrawal by Subject|0|||
127606740|NCT01729754|459190318|FG002|Part 1|Withdrawal by Subject|0|||
127606741|NCT01729754|459190319|FG003|Part 1|Withdrawal by Subject|7|||
127606742|NCT01729754|459190320|FG004|Part 1|Withdrawal by Subject|0|||
127606743|NCT01729754|459190321|FG005|Part 1|Withdrawal by Subject|0|||
127606744|NCT01729754|459190322|FG006|Part 1|Withdrawal by Subject|5|||
127606745|NCT01729754|459190323|FG007|Part 1|Withdrawal by Subject|0|||
127606746|NCT01729754|459190324|FG008|Part 1|Withdrawal by Subject|0|||
127606747|NCT01729754|459190325|FG009|Part 1|Withdrawal by Subject|6|||
127606748|NCT01729754|459190316|FG000|Part 1|Other Protocol Specified Criteria|2|||
127606749|NCT01729754|459190317|FG001|Part 1|Other Protocol Specified Criteria|0|||
127606750|NCT01729754|459190318|FG002|Part 1|Other Protocol Specified Criteria|0|||
127606751|NCT01729754|459190319|FG003|Part 1|Other Protocol Specified Criteria|0|||
127606752|NCT01729754|459190320|FG004|Part 1|Other Protocol Specified Criteria|0|||
127606753|NCT01729754|459190321|FG005|Part 1|Other Protocol Specified Criteria|0|||
127606754|NCT01729754|459190322|FG006|Part 1|Other Protocol Specified Criteria|1|||
127606755|NCT01729754|459190323|FG007|Part 1|Other Protocol Specified Criteria|0|||
127606756|NCT01729754|459190324|FG008|Part 1|Other Protocol Specified Criteria|0|||
127606757|NCT01729754|459190325|FG009|Part 1|Other Protocol Specified Criteria|4|||
127606758|NCT01729754|459190316|FG000|Part 2|Adverse Event|2|||
127697688|NCT03774082|459520253|FG002|Overall Study|Death|2|||
127606759|NCT01729754|459190317|FG001|Part 2|Adverse Event|0|||
127606760|NCT01729754|459190318|FG002|Part 2|Adverse Event|0|||
127606761|NCT01729754|459190319|FG003|Part 2|Adverse Event|0|||
127606762|NCT01729754|459190320|FG004|Part 2|Adverse Event|0|||
127697689|NCT03774082|459520251|FG000|Overall Study|Subject decision|0|||
127606763|NCT01729754|459190321|FG005|Part 2|Adverse Event|0|||
127606764|NCT01729754|459190322|FG006|Part 2|Adverse Event|0|||
127606765|NCT01729754|459190323|FG007|Part 2|Adverse Event|0|||
127606766|NCT01729754|459190324|FG008|Part 2|Adverse Event|1|||
127606767|NCT01729754|459190325|FG009|Part 2|Adverse Event|2|||
127606768|NCT01729754|459190316|FG000|Part 2|Lack of Efficacy|0|||
127606769|NCT01729754|459190317|FG001|Part 2|Lack of Efficacy|0|||
127606770|NCT01729754|459190318|FG002|Part 2|Lack of Efficacy|0|||
127606771|NCT01729754|459190319|FG003|Part 2|Lack of Efficacy|0|||
127606772|NCT01729754|459190320|FG004|Part 2|Lack of Efficacy|0|||
127606773|NCT01729754|459190321|FG005|Part 2|Lack of Efficacy|0|||
127606774|NCT01729754|459190322|FG006|Part 2|Lack of Efficacy|0|||
127606775|NCT01729754|459190323|FG007|Part 2|Lack of Efficacy|0|||
127606776|NCT01729754|459190324|FG008|Part 2|Lack of Efficacy|2|||
127606777|NCT01729754|459190325|FG009|Part 2|Lack of Efficacy|2|||
127606778|NCT01729754|459190316|FG000|Part 2|Lost to Follow-up|0|||
127606779|NCT01729754|459190317|FG001|Part 2|Lost to Follow-up|0|||
127606780|NCT01729754|459190318|FG002|Part 2|Lost to Follow-up|0|||
127606781|NCT01729754|459190319|FG003|Part 2|Lost to Follow-up|2|||
127606782|NCT01729754|459190320|FG004|Part 2|Lost to Follow-up|0|||
127606783|NCT01729754|459190321|FG005|Part 2|Lost to Follow-up|0|||
127606784|NCT01729754|459190322|FG006|Part 2|Lost to Follow-up|0|||
127606785|NCT01729754|459190323|FG007|Part 2|Lost to Follow-up|1|||
127606786|NCT01729754|459190324|FG008|Part 2|Lost to Follow-up|0|||
127606787|NCT01729754|459190325|FG009|Part 2|Lost to Follow-up|2|||
127606788|NCT01729754|459190316|FG000|Part 2|Non-Compliance with Study Drug|0|||
127606789|NCT01729754|459190317|FG001|Part 2|Non-Compliance with Study Drug|0|||
127606790|NCT01729754|459190318|FG002|Part 2|Non-Compliance with Study Drug|0|||
127606791|NCT01729754|459190319|FG003|Part 2|Non-Compliance with Study Drug|0|||
127606792|NCT01729754|459190320|FG004|Part 2|Non-Compliance with Study Drug|0|||
127606793|NCT01729754|459190321|FG005|Part 2|Non-Compliance with Study Drug|0|||
127606794|NCT01729754|459190322|FG006|Part 2|Non-Compliance with Study Drug|0|||
127606795|NCT01729754|459190323|FG007|Part 2|Non-Compliance with Study Drug|0|||
127606796|NCT01729754|459190324|FG008|Part 2|Non-Compliance with Study Drug|0|||
127606797|NCT01729754|459190325|FG009|Part 2|Non-Compliance with Study Drug|1|||
127606798|NCT01729754|459190316|FG000|Part 2|Pregnancy|0|||
127606799|NCT01729754|459190317|FG001|Part 2|Pregnancy|0|||
127606800|NCT01729754|459190318|FG002|Part 2|Pregnancy|0|||
127606801|NCT01729754|459190319|FG003|Part 2|Pregnancy|1|||
127606802|NCT01729754|459190320|FG004|Part 2|Pregnancy|0|||
127606803|NCT01729754|459190321|FG005|Part 2|Pregnancy|0|||
127606804|NCT01729754|459190322|FG006|Part 2|Pregnancy|0|||
127606805|NCT01729754|459190323|FG007|Part 2|Pregnancy|0|||
127606806|NCT01729754|459190324|FG008|Part 2|Pregnancy|0|||
127606807|NCT01729754|459190325|FG009|Part 2|Pregnancy|1|||
127606808|NCT01729754|459190316|FG000|Part 2|Withdrawal by Subject|3|||
127606809|NCT01729754|459190317|FG001|Part 2|Withdrawal by Subject|0|||
127606810|NCT01729754|459190318|FG002|Part 2|Withdrawal by Subject|0|||
127606811|NCT01729754|459190319|FG003|Part 2|Withdrawal by Subject|2|||
127606812|NCT01729754|459190320|FG004|Part 2|Withdrawal by Subject|0|||
127606813|NCT01729754|459190321|FG005|Part 2|Withdrawal by Subject|0|||
127606814|NCT01729754|459190322|FG006|Part 2|Withdrawal by Subject|0|||
127606815|NCT01729754|459190323|FG007|Part 2|Withdrawal by Subject|1|||
127606816|NCT01729754|459190324|FG008|Part 2|Withdrawal by Subject|1|||
127606817|NCT01729754|459190325|FG009|Part 2|Withdrawal by Subject|4|||
127606818|NCT01729754|459190316|FG000|Part 2|Other Protocol Specified Criteria|1|||
127606819|NCT01729754|459190317|FG001|Part 2|Other Protocol Specified Criteria|0|||
127606820|NCT01729754|459190318|FG002|Part 2|Other Protocol Specified Criteria|0|||
127606821|NCT01729754|459190319|FG003|Part 2|Other Protocol Specified Criteria|0|||
127606822|NCT01729754|459190320|FG004|Part 2|Other Protocol Specified Criteria|0|||
127606823|NCT01729754|459190321|FG005|Part 2|Other Protocol Specified Criteria|0|||
127606824|NCT01729754|459190322|FG006|Part 2|Other Protocol Specified Criteria|0|||
127606825|NCT01729754|459190323|FG007|Part 2|Other Protocol Specified Criteria|1|||
127606826|NCT01729754|459190324|FG008|Part 2|Other Protocol Specified Criteria|0|||
127606827|NCT01729754|459190325|FG009|Part 2|Other Protocol Specified Criteria|0|||
127606828|NCT01729754|459190316|FG000|Part 3|Adverse Event|0|||
127606829|NCT01729754|459190317|FG001|Part 3|Adverse Event|0|||
127606830|NCT01729754|459190318|FG002|Part 3|Adverse Event|1|||
127606831|NCT01729754|459190319|FG003|Part 3|Adverse Event|0|||
127606832|NCT01729754|459190320|FG004|Part 3|Adverse Event|0|||
127606833|NCT01729754|459190321|FG005|Part 3|Adverse Event|5|||
127606834|NCT01729754|459190322|FG006|Part 3|Adverse Event|0|||
127606835|NCT01729754|459190323|FG007|Part 3|Adverse Event|0|||
127606836|NCT01729754|459190324|FG008|Part 3|Adverse Event|0|||
127606837|NCT01729754|459190325|FG009|Part 3|Adverse Event|3|||
127606838|NCT01729754|459190316|FG000|Part 3|Death|0|||
127606839|NCT01729754|459190317|FG001|Part 3|Death|0|||
127606840|NCT01729754|459190318|FG002|Part 3|Death|0|||
127606841|NCT01729754|459190319|FG003|Part 3|Death|0|||
127606842|NCT01729754|459190320|FG004|Part 3|Death|0|||
127606843|NCT01729754|459190321|FG005|Part 3|Death|2|||
127606844|NCT01729754|459190322|FG006|Part 3|Death|0|||
127606845|NCT01729754|459190323|FG007|Part 3|Death|0|||
127606846|NCT01729754|459190324|FG008|Part 3|Death|0|||
127606847|NCT01729754|459190325|FG009|Part 3|Death|0|||
127606848|NCT01729754|459190316|FG000|Part 3|Lack of Efficacy|0|||
127606849|NCT01729754|459190317|FG001|Part 3|Lack of Efficacy|0|||
127606850|NCT01729754|459190318|FG002|Part 3|Lack of Efficacy|0|||
127606851|NCT01729754|459190319|FG003|Part 3|Lack of Efficacy|0|||
127606852|NCT01729754|459190320|FG004|Part 3|Lack of Efficacy|2|||
127606853|NCT01729754|459190321|FG005|Part 3|Lack of Efficacy|0|||
127606854|NCT01729754|459190322|FG006|Part 3|Lack of Efficacy|0|||
127606855|NCT01729754|459190323|FG007|Part 3|Lack of Efficacy|0|||
127606856|NCT01729754|459190324|FG008|Part 3|Lack of Efficacy|0|||
127606857|NCT01729754|459190325|FG009|Part 3|Lack of Efficacy|4|||
127606858|NCT01729754|459190316|FG000|Part 3|Lost to Follow-up|0|||
127606859|NCT01729754|459190317|FG001|Part 3|Lost to Follow-up|1|||
127606860|NCT01729754|459190318|FG002|Part 3|Lost to Follow-up|2|||
127606861|NCT01729754|459190319|FG003|Part 3|Lost to Follow-up|0|||
127606862|NCT01729754|459190320|FG004|Part 3|Lost to Follow-up|0|||
127606863|NCT01729754|459190321|FG005|Part 3|Lost to Follow-up|3|||
127606864|NCT01729754|459190322|FG006|Part 3|Lost to Follow-up|0|||
127606865|NCT01729754|459190323|FG007|Part 3|Lost to Follow-up|0|||
127606866|NCT01729754|459190324|FG008|Part 3|Lost to Follow-up|1|||
127606867|NCT01729754|459190325|FG009|Part 3|Lost to Follow-up|0|||
127606868|NCT01729754|459190316|FG000|Part 3|Physician Decision|0|||
127606869|NCT01729754|459190317|FG001|Part 3|Physician Decision|0|||
127606870|NCT01729754|459190318|FG002|Part 3|Physician Decision|1|||
127606871|NCT01729754|459190319|FG003|Part 3|Physician Decision|0|||
127606872|NCT01729754|459190320|FG004|Part 3|Physician Decision|0|||
127606873|NCT01729754|459190321|FG005|Part 3|Physician Decision|0|||
127606874|NCT01729754|459190322|FG006|Part 3|Physician Decision|0|||
127606875|NCT01729754|459190323|FG007|Part 3|Physician Decision|0|||
127606876|NCT01729754|459190324|FG008|Part 3|Physician Decision|0|||
127606877|NCT01729754|459190325|FG009|Part 3|Physician Decision|0|||
127606878|NCT01729754|459190316|FG000|Part 3|Withdrawal by Subject|0|||
127606879|NCT01729754|459190317|FG001|Part 3|Withdrawal by Subject|4|||
127606880|NCT01729754|459190318|FG002|Part 3|Withdrawal by Subject|1|||
127606881|NCT01729754|459190319|FG003|Part 3|Withdrawal by Subject|0|||
127606882|NCT01729754|459190320|FG004|Part 3|Withdrawal by Subject|2|||
127606883|NCT01729754|459190321|FG005|Part 3|Withdrawal by Subject|1|||
127606884|NCT01729754|459190322|FG006|Part 3|Withdrawal by Subject|0|||
127606885|NCT01729754|459190323|FG007|Part 3|Withdrawal by Subject|2|||
127606886|NCT01729754|459190324|FG008|Part 3|Withdrawal by Subject|0|||
127606887|NCT01729754|459190325|FG009|Part 3|Withdrawal by Subject|0|||
127606888|NCT01729754|459190316|FG000|Part 3|Other Protocol Specified Criteria|0|||
127606889|NCT01729754|459190317|FG001|Part 3|Other Protocol Specified Criteria|0|||
127606890|NCT01729754|459190318|FG002|Part 3|Other Protocol Specified Criteria|0|||
127606891|NCT01729754|459190319|FG003|Part 3|Other Protocol Specified Criteria|0|||
127606892|NCT01729754|459190320|FG004|Part 3|Other Protocol Specified Criteria|0|||
127606893|NCT01729754|459190321|FG005|Part 3|Other Protocol Specified Criteria|2|||
127606894|NCT01729754|459190322|FG006|Part 3|Other Protocol Specified Criteria|0|||
127606895|NCT01729754|459190323|FG007|Part 3|Other Protocol Specified Criteria|1|||
127606896|NCT01729754|459190324|FG008|Part 3|Other Protocol Specified Criteria|0|||
127606897|NCT01729754|459190325|FG009|Part 3|Other Protocol Specified Criteria|0|||
127606898|NCT00773292|459190326|FG000|Treatment 48 Weeks|Adverse Event|1|||
127606899|NCT00773292|459190326|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
127606900|NCT00542919|459190327|FG000|Overall Study|Adverse Event|1|||
127606901|NCT00542919|459190328|FG001|Overall Study|Adverse Event|5|||
127606902|NCT00542919|459190329|FG002|Overall Study|Adverse Event|1|||
127606903|NCT00542919|459190327|FG000|Overall Study|Withdrawal by Subject|1|||
127606904|NCT00542919|459190328|FG001|Overall Study|Withdrawal by Subject|0|||
127606905|NCT00542919|459190329|FG002|Overall Study|Withdrawal by Subject|3|||
127606906|NCT00542919|459190327|FG000|Overall Study|Physician Decision|2|||
127606907|NCT00542919|459190328|FG001|Overall Study|Physician Decision|2|||
127606908|NCT00542919|459190329|FG002|Overall Study|Physician Decision|1|||
127606909|NCT00542919|459190327|FG000|Overall Study|Sponsor Decision|1|||
127606910|NCT00542919|459190328|FG001|Overall Study|Sponsor Decision|0|||
127606911|NCT00542919|459190329|FG002|Overall Study|Sponsor Decision|0|||
127606912|NCT00542919|459190327|FG000|Overall Study|Lost to Follow-up|2|||
127606913|NCT00542919|459190328|FG001|Overall Study|Lost to Follow-up|0|||
127606914|NCT00542919|459190329|FG002|Overall Study|Lost to Follow-up|1|||
127606915|NCT00112502|459190330|FG000|Overall Study|Withdrawal by Subject|0|||
127606916|NCT00112502|459190331|FG001|Overall Study|Withdrawal by Subject|1|||
127606917|NCT00112502|459190332|FG002|Overall Study|Withdrawal by Subject|1|||
127606918|NCT00112502|459190333|FG003|Overall Study|Withdrawal by Subject|4|||
127606919|NCT00112502|459190334|FG004|Overall Study|Withdrawal by Subject|2|||
127606920|NCT00112502|459190335|FG005|Overall Study|Withdrawal by Subject|5|||
127606921|NCT00112502|459190336|FG006|Overall Study|Withdrawal by Subject|3|||
127606922|NCT00112502|459190337|FG007|Overall Study|Withdrawal by Subject|7|||
127606923|NCT01217060|459190343|FG000|Overall Study|Withdrawal by Subject|1|||
127606924|NCT03388138|459190346|FG000|Overall Study|Protocol Violation|1|||
127606925|NCT03388138|459190347|FG001|Overall Study|Protocol Violation|0|||
127606926|NCT01528072|459190350|FG000|Overall Study|Withdrawal by Subject|5|||
127606927|NCT01528072|459190350|FG000|Overall Study|Physician Decision|1|||
127606928|NCT01528072|459190350|FG000|Overall Study|Determined not eligible by AEAC|1|||
127606929|NCT01528072|459190350|FG000|Overall Study|Missed Visit|2|||
127606930|NCT01528072|459190350|FG000|Overall Study|Lost to Follow-up|5|||
127606931|NCT01528072|459190350|FG000|Overall Study|Explanted|2|||
127606932|NCT01528072|459190350|FG000|Overall Study|Site Closure|4|||
127606933|NCT01528072|459190350|FG000|Overall Study|Death|2|||
127606934|NCT01528072|459190350|FG000|Overall Study|Early Termination of Study|52|||
127606935|NCT03329690|459190355|FG000|Overall Study|Progressive disease per RECIST|85|||
127606936|NCT03329690|459190356|FG001|Overall Study|Progressive disease per RECIST|44|||
127606937|NCT03329690|459190357|FG002|Overall Study|Progressive disease per RECIST|6|||
127606938|NCT03329690|459190358|FG003|Overall Study|Progressive disease per RECIST|16|||
127606939|NCT03329690|459190359|FG004|Overall Study|Progressive disease per RECIST|20|||
127606940|NCT03329690|459190355|FG000|Overall Study|Clinical progression|7|||
127606941|NCT03329690|459190356|FG001|Overall Study|Clinical progression|4|||
127606942|NCT03329690|459190357|FG002|Overall Study|Clinical progression|1|||
127606943|NCT03329690|459190358|FG003|Overall Study|Clinical progression|1|||
127606944|NCT03329690|459190359|FG004|Overall Study|Clinical progression|1|||
127606945|NCT03329690|459190355|FG000|Overall Study|Adverse Event|22|||
127606946|NCT03329690|459190356|FG001|Overall Study|Adverse Event|4|||
127606947|NCT03329690|459190357|FG002|Overall Study|Adverse Event|0|||
127606948|NCT03329690|459190358|FG003|Overall Study|Adverse Event|1|||
127606949|NCT03329690|459190359|FG004|Overall Study|Adverse Event|2|||
127606950|NCT03329690|459190355|FG000|Overall Study|Death|2|||
127606951|NCT03329690|459190356|FG001|Overall Study|Death|0|||
127606952|NCT03329690|459190357|FG002|Overall Study|Death|0|||
127606953|NCT03329690|459190358|FG003|Overall Study|Death|1|||
127606954|NCT03329690|459190359|FG004|Overall Study|Death|0|||
127606955|NCT03329690|459190355|FG000|Overall Study|Withdrawal by Subject|2|||
127606956|NCT03329690|459190356|FG001|Overall Study|Withdrawal by Subject|3|||
127606957|NCT03329690|459190357|FG002|Overall Study|Withdrawal by Subject|0|||
127606958|NCT03329690|459190358|FG003|Overall Study|Withdrawal by Subject|1|||
127606959|NCT03329690|459190359|FG004|Overall Study|Withdrawal by Subject|0|||
127606960|NCT03329690|459190355|FG000|Overall Study|Physician Decision|1|||
127606961|NCT03329690|459190356|FG001|Overall Study|Physician Decision|0|||
127606962|NCT03329690|459190357|FG002|Overall Study|Physician Decision|0|||
127606963|NCT03329690|459190358|FG003|Overall Study|Physician Decision|0|||
127606964|NCT03329690|459190359|FG004|Overall Study|Physician Decision|1|||
127606965|NCT03329690|459190355|FG000|Overall Study|Miscellaneous|6|||
127606966|NCT03329690|459190356|FG001|Overall Study|Miscellaneous|0|||
127606967|NCT03329690|459190357|FG002|Overall Study|Miscellaneous|0|||
127606968|NCT03329690|459190358|FG003|Overall Study|Miscellaneous|0|||
127606969|NCT03329690|459190359|FG004|Overall Study|Miscellaneous|0|||
127606970|NCT03329690|459190355|FG000|Overall Study|Did not receive treatment|1|||
127606971|NCT03329690|459190356|FG001|Overall Study|Did not receive treatment|0|||
127606972|NCT03329690|459190357|FG002|Overall Study|Did not receive treatment|0|||
127606973|NCT03329690|459190358|FG003|Overall Study|Did not receive treatment|1|||
127606974|NCT03329690|459190359|FG004|Overall Study|Did not receive treatment|0|||
127606975|NCT02418468|459190361|FG000|Overall Study|Adverse Event|1|||
127606976|NCT02418468|459190362|FG001|Overall Study|Adverse Event|0|||
127606977|NCT02418468|459190361|FG000|Overall Study|Withdrawal of informed consent|1|||
127606978|NCT02418468|459190362|FG001|Overall Study|Withdrawal of informed consent|1|||
127606979|NCT02337907|459190363|FG000|Overall Study|Other than listed|1|||
127606980|NCT02337907|459190364|FG001|Overall Study|Other than listed|0|||
127606981|NCT02337907|459190365|FG002|Overall Study|Other than listed|0|||
127606982|NCT02337907|459190366|FG003|Overall Study|Other than listed|1|||
127606983|NCT02337907|459190367|FG004|Overall Study|Other than listed|1|||
127606984|NCT02337907|459190368|FG005|Overall Study|Other than listed|0|||
127606985|NCT02337907|459190363|FG000|Overall Study|Withdrawal by Subject|2|||
127606986|NCT02337907|459190364|FG001|Overall Study|Withdrawal by Subject|3|||
127606987|NCT02337907|459190365|FG002|Overall Study|Withdrawal by Subject|0|||
127606988|NCT02337907|459190366|FG003|Overall Study|Withdrawal by Subject|2|||
127606989|NCT02337907|459190367|FG004|Overall Study|Withdrawal by Subject|5|||
127606990|NCT02337907|459190368|FG005|Overall Study|Withdrawal by Subject|0|||
127606991|NCT02337907|459190363|FG000|Overall Study|Lost to Follow-up|0|||
127606992|NCT02337907|459190364|FG001|Overall Study|Lost to Follow-up|0|||
127606993|NCT02337907|459190365|FG002|Overall Study|Lost to Follow-up|0|||
127606994|NCT02337907|459190366|FG003|Overall Study|Lost to Follow-up|0|||
127606995|NCT02337907|459190367|FG004|Overall Study|Lost to Follow-up|0|||
127606996|NCT02337907|459190368|FG005|Overall Study|Lost to Follow-up|1|||
127606997|NCT02337907|459190363|FG000|Overall Study|Adverse Event|1|||
127606998|NCT02337907|459190364|FG001|Overall Study|Adverse Event|1|||
127606999|NCT02337907|459190365|FG002|Overall Study|Adverse Event|1|||
127607000|NCT02337907|459190366|FG003|Overall Study|Adverse Event|1|||
127607001|NCT02337907|459190367|FG004|Overall Study|Adverse Event|4|||
127607002|NCT02337907|459190368|FG005|Overall Study|Adverse Event|0|||
127607003|NCT00613015|459190370|FG000|Overall Study|Lost to Follow-up|0|||
127607004|NCT00613015|459190371|FG001|Overall Study|Lost to Follow-up|1|||
127607005|NCT00613015|459190372|FG002|Overall Study|Lost to Follow-up|3|||
127607006|NCT00613015|459190373|FG003|Overall Study|Lost to Follow-up|3|||
127607007|NCT00613015|459190374|FG004|Overall Study|Lost to Follow-up|2|||
127607008|NCT00613015|459190375|FG005|Overall Study|Lost to Follow-up|3|||
127607009|NCT04120974|459190376|FG000|Overall Study|Death|1|||
127607010|NCT04120974|459190376|FG000|Overall Study|Physician Decision|1|||
127607011|NCT04120974|459190376|FG000|Overall Study|Lost to Follow-up|6|||
127607012|NCT03338062|459190377|FG000|Overall Study|Alternative Therapy|1|||
127607013|NCT03338062|459190378|FG001|Overall Study|Alternative Therapy|0|||
127607014|NCT04340362|459190379|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
127607015|NCT03447990|459190383|FG000|Overall Study|Withdrawal by Subject|0|||
127607016|NCT03447990|459190384|FG001|Overall Study|Withdrawal by Subject|0|||
127607017|NCT03447990|459190385|FG002|Overall Study|Withdrawal by Subject|0|||
127607018|NCT03447990|459190386|FG003|Overall Study|Withdrawal by Subject|0|||
127607019|NCT03447990|459190387|FG004|Overall Study|Withdrawal by Subject|0|||
127607020|NCT03447990|459190388|FG005|Overall Study|Withdrawal by Subject|0|||
127607021|NCT03447990|459190389|FG006|Overall Study|Withdrawal by Subject|1|||
127607022|NCT03255382|459190390|FG000|Overall Study|Adverse Event|3|||
127607023|NCT03255382|459190391|FG001|Overall Study|Adverse Event|0|||
127607024|NCT03255382|459190390|FG000|Overall Study|Lost to Follow-up|2|||
127607025|NCT03255382|459190391|FG001|Overall Study|Lost to Follow-up|0|||
127607026|NCT03255382|459190390|FG000|Overall Study|Withdrawal by Subject|2|||
127607027|NCT03255382|459190391|FG001|Overall Study|Withdrawal by Subject|0|||
127607028|NCT03255382|459190390|FG000|Overall Study|Other|6|||
127607029|NCT03255382|459190391|FG001|Overall Study|Other|0|||
127607030|NCT00238121|459190392|FG000|Overall Study|Withdrawal by Subject|1|||
127607031|NCT00238121|459190393|FG001|Overall Study|Withdrawal by Subject|1|||
127607032|NCT00238121|459190392|FG000|Overall Study|Adverse Event|2|||
127607033|NCT00238121|459190393|FG001|Overall Study|Adverse Event|1|||
127607034|NCT02221284|459190394|FG000|Overall Study|Case Report Forms Uncollected|56|||
127607035|NCT02221284|459190394|FG000|Overall Study|Protocol Deviation|5|||
127607036|NCT01675128|459190397|FG000|Overall Study|Disease progression on study|1|||
127607037|NCT01675128|459190398|FG001|Overall Study|Disease progression on study|1|||
127607038|NCT01675128|459190399|FG002|Overall Study|Disease progression on study|1|||
127607039|NCT01675128|459190397|FG000|Overall Study|Refused further treatment|1|||
127607040|NCT01675128|459190398|FG001|Overall Study|Refused further treatment|0|||
127607041|NCT01675128|459190399|FG002|Overall Study|Refused further treatment|0|||
127607042|NCT01675128|459190397|FG000|Overall Study|Pulmonary complication; off study|0|||
127607043|NCT01675128|459190398|FG001|Overall Study|Pulmonary complication; off study|1|||
127607044|NCT01675128|459190399|FG002|Overall Study|Pulmonary complication; off study|0|||
127607045|NCT00832585|459190408|FG000|Overall Study|Withdrawal by Subject|1|||
127607046|NCT00832585|459190408|FG000|Overall Study|Lost to Follow-up|1|||
127607047|NCT01374087|459190414|FG000|Overall Study|Adverse Event|1|||
127607048|NCT01374087|459190415|FG001|Overall Study|Adverse Event|0|||
127607049|NCT01374087|459190414|FG000|Overall Study|Disease progression|2|||
127607050|NCT01374087|459190415|FG001|Overall Study|Disease progression|2|||
127607051|NCT01374087|459190414|FG000|Overall Study|Study discontinued|13|||
127607052|NCT01374087|459190415|FG001|Overall Study|Study discontinued|13|||
127607053|NCT03011307|459190416|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
127607054|NCT03011307|459190417|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
127607055|NCT03011307|459190416|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
127607056|NCT03011307|459190417|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
127607057|NCT03011307|459190416|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
127607058|NCT03011307|459190417|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
127607059|NCT03526458|459190418|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
127607060|NCT03526458|459190419|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
127607061|NCT03526458|459190418|FG000|Overall Study|Stone passed, surgery cancelled|2|||
127607062|NCT03526458|459190419|FG001|Overall Study|Stone passed, surgery cancelled|1|||
127607063|NCT03526458|459190418|FG000|Overall Study|Withdrawal by Subject|1|||
127607064|NCT03526458|459190419|FG001|Overall Study|Withdrawal by Subject|0|||
127607065|NCT03526458|459190418|FG000|Overall Study|Physician Decision|2|||
127607066|NCT03526458|459190419|FG001|Overall Study|Physician Decision|1|||
127607067|NCT03526458|459190418|FG000|Overall Study|Lack of equipment|1|||
127607068|NCT03526458|459190419|FG001|Overall Study|Lack of equipment|1|||
127607069|NCT00271947|459190420|FG000|Overall Study|Lost to Follow-up|1|||
127607070|NCT02466555|459190421|FG000|Overall Study|Lost to Follow-up|2|||
127607071|NCT04170348|459190422|FG000|Overall Study|Lost to Follow-up|2|||
127607072|NCT04170348|459190423|FG001|Overall Study|Lost to Follow-up|2|||
127607073|NCT04170348|459190422|FG000|Overall Study|Withdrawal by Subject|1|||
127607074|NCT04170348|459190423|FG001|Overall Study|Withdrawal by Subject|5|||
127607075|NCT04170348|459190422|FG000|Overall Study|Non-adherence|1|||
127607076|NCT04170348|459190423|FG001|Overall Study|Non-adherence|1|||
127607077|NCT04170348|459190422|FG000|Overall Study|Adverse Event|1|||
127607078|NCT04170348|459190423|FG001|Overall Study|Adverse Event|0|||
127607079|NCT00529542|459190424|FG000|Overall Study|Withdrawal by Subject|1|||
127607080|NCT00529542|459190425|FG001|Overall Study|Withdrawal by Subject|0|||
127607081|NCT00529542|459190424|FG000|Overall Study|Lost to Follow-up|0|||
127607082|NCT00529542|459190425|FG001|Overall Study|Lost to Follow-up|1|||
127607083|NCT01082965|459190426|FG000|Overall Study|Protocol Violation|0|||
127607084|NCT01082965|459190427|FG001|Overall Study|Protocol Violation|1|||
127607085|NCT01082965|459190426|FG000|Overall Study|Other|1|||
127607086|NCT01082965|459190427|FG001|Overall Study|Other|1|||
127607087|NCT02587065|459190428|FG000|Overall Study|Adverse Event|14|||
127607088|NCT02587065|459190428|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
127607089|NCT02587065|459190428|FG000|Overall Study|Non-adherence to the Protocol|3|||
127607090|NCT02587065|459190428|FG000|Overall Study|Discontinuation of Study Medication|2|||
127607091|NCT02587065|459190428|FG000|Overall Study|Reason not Specified|3|||
127607092|NCT00445965|459190432|FG000|Overall Study|Adverse Event|2|||
127607093|NCT00445965|459190432|FG000|Overall Study|Physician Decision|1|||
127607094|NCT00445965|459190432|FG000|Overall Study|Enrolled but not treated|1|||
127607095|NCT00445965|459190432|FG000|Overall Study|Removed due to progressive disease|29|||
127607096|NCT05104567|459190433|FG000|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
127607097|NCT05104567|459190434|FG001|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|1|||
127607098|NCT05104567|459190435|FG002|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
127607099|NCT05104567|459190436|FG003|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
127607100|NCT05104567|459190437|FG004|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
127607101|NCT05104567|459190438|FG005|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
127607102|NCT05104567|459190439|FG006|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
127607103|NCT05104567|459190433|FG000|Overall Study|Adverse event: Not related to COVID-19|0|||
127607104|NCT05104567|459190434|FG001|Overall Study|Adverse event: Not related to COVID-19|5|||
127607105|NCT05104567|459190435|FG002|Overall Study|Adverse event: Not related to COVID-19|3|||
127607106|NCT05104567|459190436|FG003|Overall Study|Adverse event: Not related to COVID-19|1|||
127607107|NCT05104567|459190437|FG004|Overall Study|Adverse event: Not related to COVID-19|3|||
127607108|NCT05104567|459190438|FG005|Overall Study|Adverse event: Not related to COVID-19|2|||
127607109|NCT05104567|459190439|FG006|Overall Study|Adverse event: Not related to COVID-19|0|||
127607110|NCT05104567|459190433|FG000|Overall Study|Progressive disease|3|||
127607111|NCT05104567|459190434|FG001|Overall Study|Progressive disease|13|||
127607112|NCT05104567|459190435|FG002|Overall Study|Progressive disease|13|||
127607113|NCT05104567|459190436|FG003|Overall Study|Progressive disease|17|||
127607114|NCT05104567|459190437|FG004|Overall Study|Progressive disease|17|||
127607115|NCT05104567|459190438|FG005|Overall Study|Progressive disease|28|||
127607116|NCT05104567|459190439|FG006|Overall Study|Progressive disease|24|||
127607117|NCT05104567|459190433|FG000|Overall Study|Withdrawal by Subject|1|||
127607118|NCT05104567|459190434|FG001|Overall Study|Withdrawal by Subject|1|||
127607119|NCT05104567|459190435|FG002|Overall Study|Withdrawal by Subject|2|||
127607120|NCT05104567|459190436|FG003|Overall Study|Withdrawal by Subject|0|||
127607121|NCT05104567|459190437|FG004|Overall Study|Withdrawal by Subject|0|||
127607122|NCT05104567|459190438|FG005|Overall Study|Withdrawal by Subject|0|||
127607123|NCT05104567|459190439|FG006|Overall Study|Withdrawal by Subject|0|||
127607124|NCT05104567|459190433|FG000|Overall Study|Other|1|||
127607125|NCT05104567|459190434|FG001|Overall Study|Other|1|||
127607126|NCT05104567|459190435|FG002|Overall Study|Other|1|||
127607127|NCT05104567|459190436|FG003|Overall Study|Other|0|||
127607128|NCT05104567|459190437|FG004|Overall Study|Other|0|||
127607129|NCT05104567|459190438|FG005|Overall Study|Other|0|||
127607130|NCT05104567|459190439|FG006|Overall Study|Other|0|||
127607131|NCT00733746|459190443|FG000|Overall Study|Ineligible|5|||
127607132|NCT03999892|459190444|FG000|Overall Study|Lost to Follow-up|1|||
127607133|NCT02295995|459190445|FG000|Overall Study|Lost to Follow-up|5|||
127607134|NCT02295995|459190446|FG001|Overall Study|Lost to Follow-up|1|||
127788777|NCT00705783|459851280|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
127607135|NCT02447081|459190447|FG000|Overall Study|Death|161|||
127607136|NCT02447081|459190447|FG000|Overall Study|Lost to Follow-up|36|||
127607137|NCT02447081|459190447|FG000|Overall Study|Visit not completed|17|||
127607138|NCT02447081|459190447|FG000|Overall Study|unsuccessful implant procedure|10|||
127607139|NCT02113956|459190453|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
127607140|NCT02113956|459190454|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
127607141|NCT02113956|459190453|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
127607142|NCT02113956|459190454|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
127607143|NCT02113956|459190453|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
127607144|NCT02113956|459190454|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
127607145|NCT02406651|459190455|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
127607146|NCT02946047|459190459|FG000|Overall Study|Adverse Event|1|||
127607147|NCT02946047|459190460|FG001|Overall Study|Adverse Event|0|||
127607148|NCT02946047|459190461|FG002|Overall Study|Adverse Event|0|||
127607149|NCT02946047|459190462|FG003|Overall Study|Adverse Event|0|||
127607150|NCT01581307|459190463|FG000|Overall Study|Withdrawal by Subject|1|||
127607151|NCT00378209|459190466|FG000|Overall Study|Progressive disease|11|||
127607152|NCT00378209|459190466|FG000|Overall Study|Adverse Event|3|||
127607153|NCT00378209|459190466|FG000|Overall Study|Initiation of non-protocol therapy|3|||
127607154|NCT00378209|459190466|FG000|Overall Study|Physician Decision|3|||
127607155|NCT00378209|459190466|FG000|Overall Study|Death|1|||
127607156|NCT00378209|459190466|FG000|Overall Study|Treatment delay|1|||
127607157|NCT04814433|459190472|FG000|Overall Study|Survey not returned|4|||
127607158|NCT04814433|459190473|FG001|Overall Study|Survey not returned|8|||
127607159|NCT04814433|459190474|FG002|Overall Study|Survey not returned|4|||
127607160|NCT04814433|459190475|FG003|Overall Study|Survey not returned|5|||
127607161|NCT02496533|459190478|FG000|Overall Study|Lack of data on outcome|3|||
127607162|NCT02496533|459190479|FG001|Overall Study|Lack of data on outcome|0|||
127607163|NCT02496533|459190478|FG000|Overall Study|Patient did not complete all measures|0|||
127607164|NCT02496533|459190479|FG001|Overall Study|Patient did not complete all measures|4|||
127607165|NCT02496533|459190478|FG000|Overall Study|Late for radiologic testing|0|||
127607166|NCT02496533|459190479|FG001|Overall Study|Late for radiologic testing|2|||
127607167|NCT01816893|459190481|FG000|Washout Period|Withdrawal by Subject|2|||
127607168|NCT01816893|459190482|FG001|Washout Period|Withdrawal by Subject|0|||
127607169|NCT04439253|459192313|FG000|Overall Study|Adverse Event|1|||
127607170|NCT04439253|459192313|FG000|Overall Study|Disease progression|2|||
127607171|NCT04439253|459192313|FG000|Overall Study|Complicating disease|1|||
127607172|NCT02016625|459192314|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
127607173|NCT02016625|459192315|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
127607174|NCT02016625|459192314|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
127607175|NCT02016625|459192315|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
127607176|NCT02016625|459192314|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
127607177|NCT02016625|459192315|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
127607178|NCT00887354|459192316|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
127607179|NCT00887354|459192317|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
127607180|NCT00887354|459192316|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
127607181|NCT00887354|459192317|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
127607182|NCT00887354|459192316|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
127607183|NCT00887354|459192317|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
127607184|NCT00887354|459192316|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
127607185|NCT00887354|459192317|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
127607186|NCT00887354|459192316|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
127607187|NCT00887354|459192317|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
127607188|NCT00887354|459192316|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
127607189|NCT00887354|459192317|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
127607190|NCT00887354|459192316|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
127607191|NCT00887354|459192317|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
127607192|NCT00887354|459192316|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
127607193|NCT00887354|459192317|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
127607194|NCT00887354|459192316|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
127607195|NCT00887354|459192317|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
127607196|NCT00887354|459192316|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
127607197|NCT00887354|459192317|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
127607198|NCT00887354|459192316|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
127607199|NCT00887354|459192317|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
127607200|NCT00887354|459192316|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
127607201|NCT00887354|459192317|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
127607202|NCT00887354|459192316|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
127697690|NCT03774082|459520252|FG001|Overall Study|Subject decision|3|||
127607203|NCT00887354|459192317|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
127607204|NCT00887354|459192316|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
127607205|NCT00887354|459192317|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
127607206|NCT00887354|459192316|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
127607207|NCT00887354|459192317|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
127607208|NCT02794103|459192320|FG000|Overall Study|Loss to follow up due to high sedation|3|||
127607209|NCT04608500|459192321|FG000|Overall Study|Adverse Event|2|||
127607210|NCT04608500|459192322|FG001|Overall Study|Adverse Event|0|||
127607211|NCT04608500|459192321|FG000|Overall Study|Lost to Follow-up|15|||
127607212|NCT04608500|459192322|FG001|Overall Study|Lost to Follow-up|9|||
127607213|NCT04608500|459192321|FG000|Overall Study|Participant request|11|||
127607214|NCT04608500|459192322|FG001|Overall Study|Participant request|7|||
127607215|NCT04608500|459192321|FG000|Overall Study|Protocol Violation|1|||
127607216|NCT04608500|459192322|FG001|Overall Study|Protocol Violation|0|||
127607217|NCT04608500|459192321|FG000|Overall Study|Other|6|||
127607218|NCT04608500|459192322|FG001|Overall Study|Other|2|||
127607219|NCT02747420|459192323|FG000|Overall Study|Lost to Follow-up|4|||
127607220|NCT02747420|459192324|FG001|Overall Study|Lost to Follow-up|2|||
127607221|NCT02747420|459192323|FG000|Overall Study|Withdrawal by Subject|3|||
127607222|NCT02747420|459192324|FG001|Overall Study|Withdrawal by Subject|2|||
127607223|NCT00914810|459192325|FG000|Overall Study|Withdrawal by Subject|1|||
127607224|NCT00914810|459192326|FG001|Overall Study|Withdrawal by Subject|0|||
127607225|NCT00914810|459192325|FG000|Overall Study|Relocated out of state|1|||
127607226|NCT00914810|459192326|FG001|Overall Study|Relocated out of state|0|||
127607227|NCT00914810|459192325|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
127607228|NCT00914810|459192326|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
127607229|NCT01465022|459192327|FG000|Overall Study|Lost to Follow-up|15|||
127607230|NCT01465022|459192328|FG001|Overall Study|Lost to Follow-up|14|||
127607231|NCT01465022|459192329|FG002|Overall Study|Lost to Follow-up|0|||
127607232|NCT01465022|459192327|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
127607233|NCT01465022|459192328|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
127607234|NCT01465022|459192329|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
127607235|NCT01465022|459192327|FG000|Overall Study|Not Randomized|0|||
127607236|NCT01465022|459192328|FG001|Overall Study|Not Randomized|0|||
127607237|NCT01465022|459192329|FG002|Overall Study|Not Randomized|70|||
127607238|NCT01327300|459192330|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
127607239|NCT01327300|459192331|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
127607240|NCT03020823|459192332|FG000|Overall Study|Physician Decision|4|||
127607241|NCT03020823|459192332|FG000|Overall Study|Lack of Efficacy|4|||
127607242|NCT03020823|459192332|FG000|Overall Study|Adverse Event|2|||
127607243|NCT03662542|459192335|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
127607244|NCT03662542|459192336|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
127607245|NCT03662542|459192337|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
127607246|NCT03662542|459192338|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
127607247|NCT03662542|459192339|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
127607248|NCT03662542|459192340|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
127607249|NCT03662542|459192341|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
127607250|NCT03662542|459192342|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
127607251|NCT03662542|459192343|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
127607252|NCT03662542|459192335|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
127607253|NCT03662542|459192336|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
127607254|NCT03662542|459192337|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
127607255|NCT03662542|459192338|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
127697691|NCT03774082|459520253|FG002|Overall Study|Subject decision|0|||
127697692|NCT03774082|459520251|FG000|Overall Study|Lost to Follow-up|2|||
127697693|NCT03774082|459520252|FG001|Overall Study|Lost to Follow-up|0|||
127697694|NCT03774082|459520253|FG002|Overall Study|Lost to Follow-up|0|||
127697695|NCT03774082|459520251|FG000|Overall Study|Guardian decision|0|||
127697696|NCT03774082|459520252|FG001|Overall Study|Guardian decision|0|||
127697697|NCT03774082|459520253|FG002|Overall Study|Guardian decision|1|||
127697698|NCT03774082|459520251|FG000|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
127697699|NCT03774082|459520252|FG001|Overall Study|Enrolled but received treatment beyond protocol requirement|1|||
127697700|NCT03774082|459520253|FG002|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
127697701|NCT05093829|459520254|FG000|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
127697702|NCT05093829|459520255|FG001|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
127697703|NCT05093829|459520256|FG002|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|123|||
127697704|NCT05093829|459520257|FG003|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
127697705|NCT05093829|459520258|FG004|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
127697706|NCT04353661|459521929|FG000|Overall Study|Protocol Violation|0|||
127697707|NCT04353661|459521930|FG001|Overall Study|Protocol Violation|0|||
127607256|NCT03662542|459192339|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
127607257|NCT03662542|459192340|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
127607258|NCT03662542|459192341|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
127607259|NCT03662542|459192342|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
127607260|NCT03662542|459192343|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
127607261|NCT03662542|459192335|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
127607262|NCT03662542|459192336|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
127607263|NCT03662542|459192337|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
127607264|NCT03662542|459192338|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
127607265|NCT03662542|459192339|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
127607266|NCT03662542|459192340|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
127607267|NCT03662542|459192341|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
127607268|NCT03662542|459192342|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
127607269|NCT03662542|459192343|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
127607270|NCT03662542|459192335|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
127607271|NCT03662542|459192336|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
127607272|NCT03662542|459192337|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
127607273|NCT03662542|459192338|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
127607274|NCT03662542|459192339|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
127607275|NCT03662542|459192340|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
127607276|NCT03662542|459192341|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
127607277|NCT03662542|459192342|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
127607278|NCT03662542|459192343|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
127607279|NCT03662542|459192335|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
127607280|NCT03662542|459192336|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
127607281|NCT03662542|459192337|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
127607282|NCT03662542|459192338|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
127607283|NCT03662542|459192339|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
127607284|NCT03662542|459192340|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
127607285|NCT03662542|459192341|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
127607286|NCT03662542|459192342|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
127607287|NCT03662542|459192343|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
127697708|NCT04353661|459521931|FG002|Overall Study|Protocol Violation|1|||
127607288|NCT03662542|459192335|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
127607289|NCT03662542|459192336|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
127607290|NCT03662542|459192337|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
127607291|NCT03662542|459192338|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
127607292|NCT03662542|459192339|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
127607293|NCT03662542|459192340|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
127607294|NCT03662542|459192341|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
127607295|NCT03662542|459192342|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
127607296|NCT03662542|459192343|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
127607297|NCT03662542|459192335|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
127607298|NCT03662542|459192336|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
127607299|NCT03662542|459192337|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
127607300|NCT03662542|459192338|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
127607301|NCT03662542|459192339|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
127607302|NCT03662542|459192340|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
127607303|NCT03662542|459192341|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
127607304|NCT03662542|459192342|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
127607305|NCT03662542|459192343|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
127607306|NCT03662542|459192335|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
127607307|NCT03662542|459192336|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
127607308|NCT03662542|459192337|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
127607309|NCT03662542|459192338|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
127607310|NCT03662542|459192339|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
127607311|NCT03662542|459192340|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
127607312|NCT03662542|459192341|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
127607313|NCT03662542|459192342|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
127607314|NCT03662542|459192343|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
127607315|NCT03662542|459192335|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
127607316|NCT03662542|459192336|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
127607317|NCT03662542|459192337|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
127607318|NCT03662542|459192338|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
127607319|NCT03662542|459192339|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
127607320|NCT03662542|459192340|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
127607321|NCT03662542|459192341|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
127607322|NCT03662542|459192342|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
127607323|NCT03662542|459192343|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
127607324|NCT03662542|459192335|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
127607325|NCT03662542|459192336|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
127607326|NCT03662542|459192337|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
127607327|NCT03662542|459192338|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
127607328|NCT03662542|459192339|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
127607329|NCT03662542|459192340|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
127607330|NCT03662542|459192341|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
127607331|NCT03662542|459192342|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
127697709|NCT04353661|459521929|FG000|Overall Study|Study termination by the Sponsor|1|||
127607332|NCT03662542|459192343|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
127607333|NCT03662542|459192335|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
127607334|NCT03662542|459192336|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
127607335|NCT03662542|459192337|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
127607336|NCT03662542|459192338|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
127607337|NCT03662542|459192339|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
127607338|NCT03662542|459192340|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
127607339|NCT03662542|459192341|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
127607340|NCT03662542|459192342|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
127607341|NCT03662542|459192343|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
127607342|NCT03662542|459192335|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
127607343|NCT03662542|459192336|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
127607344|NCT03662542|459192337|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
127607345|NCT03662542|459192338|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
127607346|NCT03662542|459192339|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
127607347|NCT03662542|459192340|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
127607348|NCT03662542|459192341|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
127607349|NCT03662542|459192342|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
127607350|NCT03662542|459192343|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
127607351|NCT03662542|459192335|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
127607352|NCT03662542|459192336|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
127607353|NCT03662542|459192337|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
127607354|NCT03662542|459192338|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
127607355|NCT03662542|459192339|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
127607356|NCT03662542|459192340|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
127607357|NCT03662542|459192341|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
127607358|NCT03662542|459192342|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
127607359|NCT03662542|459192343|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
127607360|NCT03739112|459192345|FG000|Overall Study|Adverse Event|2|||
127607361|NCT03739112|459192346|FG001|Overall Study|Adverse Event|2|||
127607362|NCT03739112|459192345|FG000|Overall Study|Withdrawal by Subject|38|||
127607363|NCT03739112|459192346|FG001|Overall Study|Withdrawal by Subject|19|||
127607364|NCT03739112|459192345|FG000|Overall Study|Lost to Follow-up|31|||
127607365|NCT03739112|459192346|FG001|Overall Study|Lost to Follow-up|33|||
127607366|NCT03739112|459192345|FG000|Overall Study|Protocol Deviation|12|||
127607367|NCT03739112|459192346|FG001|Overall Study|Protocol Deviation|9|||
127607368|NCT03739112|459192345|FG000|Overall Study|Physician Decision|1|||
127607369|NCT03739112|459192346|FG001|Overall Study|Physician Decision|0|||
127607370|NCT03739112|459192345|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
127607371|NCT03739112|459192346|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
127607372|NCT03739112|459192345|FG000|Overall Study|Site went on hold|65|||
127607373|NCT03739112|459192346|FG001|Overall Study|Site went on hold|67|||
127607374|NCT03739112|459192345|FG000|Overall Study|Other than specified|8|||
127607375|NCT03739112|459192346|FG001|Overall Study|Other than specified|5|||
127607376|NCT03739112|459192345|FG000|Overall Study|Randomized but not vaccinated|31|||
127607377|NCT03739112|459192346|FG001|Overall Study|Randomized but not vaccinated|25|||
127607378|NCT01290666|459192357|FG000|Overall Study|Lost to Follow-up|11|||
127607379|NCT01290666|459192357|FG000|Overall Study|Withdrawal by Subject|23|||
127607380|NCT01290666|459192357|FG000|Overall Study|Early Termination of Study|4|||
127607381|NCT02063854|459192363|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
127607382|NCT02063854|459192364|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
127607383|NCT02063854|459192365|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
127607384|NCT02063854|459192366|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
127607385|NCT02063854|459192367|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
127607386|NCT02063854|459192368|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
127607387|NCT02063854|459192369|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
127607388|NCT02063854|459192363|FG000|Overall Study|Major Protocol Deviation|0|||
127607389|NCT02063854|459192364|FG001|Overall Study|Major Protocol Deviation|0|||
127607390|NCT02063854|459192365|FG002|Overall Study|Major Protocol Deviation|3|||
127607391|NCT02063854|459192366|FG003|Overall Study|Major Protocol Deviation|0|||
127607392|NCT02063854|459192367|FG004|Overall Study|Major Protocol Deviation|0|||
127607393|NCT02063854|459192368|FG005|Overall Study|Major Protocol Deviation|0|||
127607394|NCT02063854|459192369|FG006|Overall Study|Major Protocol Deviation|0|||
127607395|NCT02063854|459192363|FG000|Overall Study|Voluntary Withdrawal|2|||
127697710|NCT04353661|459521930|FG001|Overall Study|Study termination by the Sponsor|1|||
127607396|NCT02063854|459192364|FG001|Overall Study|Voluntary Withdrawal|0|||
127607397|NCT02063854|459192365|FG002|Overall Study|Voluntary Withdrawal|8|||
127607398|NCT02063854|459192366|FG003|Overall Study|Voluntary Withdrawal|1|||
127607399|NCT02063854|459192367|FG004|Overall Study|Voluntary Withdrawal|3|||
127607400|NCT02063854|459192368|FG005|Overall Study|Voluntary Withdrawal|6|||
127607401|NCT02063854|459192369|FG006|Overall Study|Voluntary Withdrawal|1|||
127607402|NCT02063854|459192363|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
127607403|NCT02063854|459192364|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
127607404|NCT02063854|459192365|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
127607405|NCT02063854|459192366|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
127607406|NCT02063854|459192367|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
127607407|NCT02063854|459192368|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
127607408|NCT02063854|459192369|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
127607409|NCT02063854|459192363|FG000|Overall Study|Reason Not Specified|1|||
127607410|NCT02063854|459192364|FG001|Overall Study|Reason Not Specified|0|||
127697711|NCT04353661|459521931|FG002|Overall Study|Study termination by the Sponsor|1|||
127697712|NCT00667251|459521932|FG000|Overall Study|Disease progression|232|||
127697713|NCT00667251|459521933|FG001|Overall Study|Disease progression|203|||
127697714|NCT00667251|459521932|FG000|Overall Study|Toxicity|44|||
127697715|NCT00667251|459521933|FG001|Overall Study|Toxicity|23|||
127697716|NCT00667251|459521932|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|18|||
127697717|NCT00667251|459521933|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|70|||
127697718|NCT00667251|459521932|FG000|Overall Study|Refused further treatment (not due to toxicity)|8|||
127697719|NCT00667251|459521933|FG001|Overall Study|Refused further treatment (not due to toxicity)|7|||
127697720|NCT00667251|459521932|FG000|Overall Study|Symptomatic progression|8|||
127697721|NCT00667251|459521933|FG001|Overall Study|Symptomatic progression|4|||
127697722|NCT00667251|459521932|FG000|Overall Study|Death|6|||
127697723|NCT00667251|459521933|FG001|Overall Study|Death|11|||
127607411|NCT02063854|459192365|FG002|Overall Study|Reason Not Specified|0|||
127607412|NCT02063854|459192366|FG003|Overall Study|Reason Not Specified|0|||
127607413|NCT02063854|459192367|FG004|Overall Study|Reason Not Specified|0|||
127607414|NCT02063854|459192368|FG005|Overall Study|Reason Not Specified|0|||
127607415|NCT02063854|459192369|FG006|Overall Study|Reason Not Specified|0|||
127607416|NCT02063854|459192363|FG000|Overall Study|Did Not Receive Study Drug|0|||
127607417|NCT02063854|459192364|FG001|Overall Study|Did Not Receive Study Drug|0|||
127607418|NCT02063854|459192365|FG002|Overall Study|Did Not Receive Study Drug|0|||
127607419|NCT02063854|459192366|FG003|Overall Study|Did Not Receive Study Drug|0|||
127607420|NCT02063854|459192367|FG004|Overall Study|Did Not Receive Study Drug|0|||
127607421|NCT02063854|459192368|FG005|Overall Study|Did Not Receive Study Drug|1|||
127607422|NCT02063854|459192369|FG006|Overall Study|Did Not Receive Study Drug|0|||
127607423|NCT01462084|459192370|FG000|Overall Study|Withdrawal by Subject|1|||
127607424|NCT01462084|459192371|FG001|Overall Study|Withdrawal by Subject|0|||
127607425|NCT01462084|459192370|FG000|Overall Study|Protocol Violation|1|||
127607426|NCT01462084|459192371|FG001|Overall Study|Protocol Violation|1|||
127607427|NCT03538158|459192372|FG000|Overall Study|Lost to Follow-up|13|||
127607428|NCT03538158|459192373|FG001|Overall Study|Lost to Follow-up|7|||
127607429|NCT03538158|459192372|FG000|Overall Study|Withdrawal by Subject|2|||
127607430|NCT03538158|459192373|FG001|Overall Study|Withdrawal by Subject|1|||
127607431|NCT00695396|459192374|FG000|Overall Study|Study Closed Prematurely|5|||
127607432|NCT00695396|459192375|FG001|Overall Study|Study Closed Prematurely|6|||
127607433|NCT00695396|459192376|FG002|Overall Study|Study Closed Prematurely|8|||
127607434|NCT00695396|459192374|FG000|Overall Study|Withdrawal by Subject|2|||
127607435|NCT00695396|459192375|FG001|Overall Study|Withdrawal by Subject|2|||
127607436|NCT00695396|459192376|FG002|Overall Study|Withdrawal by Subject|0|||
127607437|NCT02255981|459192378|FG000|Overall Study|Lost to Follow-up|3|||
127607438|NCT02255981|459192378|FG000|Overall Study|Withdrawal by Subject|1|||
127607439|NCT00371254|459192379|FG000|Overall Study|Disease progression|13|||
127607440|NCT00371254|459192380|FG001|Overall Study|Disease progression|13|||
127607441|NCT00371254|459192379|FG000|Overall Study|Study drug toxicity|3|||
127607442|NCT00371254|459192380|FG001|Overall Study|Study drug toxicity|5|||
127607443|NCT00371254|459192379|FG000|Overall Study|Subject request|5|||
127607444|NCT00371254|459192380|FG001|Overall Study|Subject request|0|||
127607445|NCT00371254|459192379|FG000|Overall Study|Investigator Decision|2|||
127607446|NCT00371254|459192380|FG001|Overall Study|Investigator Decision|0|||
127607447|NCT00371254|459192379|FG000|Overall Study|Adverse event unrelated to study drug|0|||
127607448|NCT00371254|459192380|FG001|Overall Study|Adverse event unrelated to study drug|1|||
127607449|NCT00371254|459192379|FG000|Overall Study|Lost to Follow-up|0|||
127607450|NCT00371254|459192380|FG001|Overall Study|Lost to Follow-up|1|||
127607451|NCT00371254|459192379|FG000|Overall Study|Withdrawal by Subject|0|||
127697724|NCT00667251|459521932|FG000|Overall Study|Intercurrent illness|5|||
127697725|NCT00667251|459521933|FG001|Overall Study|Intercurrent illness|6|||
127607452|NCT00371254|459192380|FG001|Overall Study|Withdrawal by Subject|1|||
127607453|NCT02246673|459192383|FG000|Overall Study|Sponsor Decision|1|||
127607454|NCT02246673|459192384|FG001|Overall Study|Sponsor Decision|0|||
127607455|NCT02246673|459192385|FG002|Overall Study|Sponsor Decision|0|||
127607456|NCT02246673|459192386|FG003|Overall Study|Sponsor Decision|0|||
127607457|NCT02246673|459192387|FG004|Overall Study|Sponsor Decision|0|||
127607458|NCT02246673|459192383|FG000|Overall Study|Withdrawal by Subject|0|||
127607459|NCT02246673|459192384|FG001|Overall Study|Withdrawal by Subject|0|||
127607460|NCT02246673|459192385|FG002|Overall Study|Withdrawal by Subject|0|||
127607461|NCT02246673|459192386|FG003|Overall Study|Withdrawal by Subject|0|||
127607462|NCT02246673|459192387|FG004|Overall Study|Withdrawal by Subject|1|||
127607463|NCT02246673|459192383|FG000|Overall Study|Lost to Follow-up|0|||
127607464|NCT02246673|459192384|FG001|Overall Study|Lost to Follow-up|0|||
127607465|NCT02246673|459192385|FG002|Overall Study|Lost to Follow-up|0|||
127607466|NCT02246673|459192386|FG003|Overall Study|Lost to Follow-up|1|||
127607467|NCT02246673|459192387|FG004|Overall Study|Lost to Follow-up|0|||
127607468|NCT02246673|459192383|FG000|Overall Study|Protocol Violation|0|||
127607469|NCT02246673|459192384|FG001|Overall Study|Protocol Violation|0|||
127607470|NCT02246673|459192385|FG002|Overall Study|Protocol Violation|0|||
127607471|NCT02246673|459192386|FG003|Overall Study|Protocol Violation|1|||
127607472|NCT02246673|459192387|FG004|Overall Study|Protocol Violation|0|||
127607473|NCT05413369|459192392|FG000|Overall Study|Adverse Event|1|||
127607474|NCT05413369|459192393|FG001|Overall Study|Adverse Event|1|||
127607475|NCT05413369|459192392|FG000|Overall Study|Withdrawal by Subject|13|||
127607476|NCT05413369|459192393|FG001|Overall Study|Withdrawal by Subject|4|||
127607477|NCT05413369|459192392|FG000|Overall Study|Non-compliance with study schedule|2|||
127607478|NCT05413369|459192393|FG001|Overall Study|Non-compliance with study schedule|1|||
127607479|NCT05413369|459192392|FG000|Overall Study|Other|1|||
127607480|NCT05413369|459192393|FG001|Overall Study|Other|1|||
127607481|NCT00720057|459192394|FG000|Overall Study|Lost to Follow-up|0|||
127607482|NCT00720057|459192395|FG001|Overall Study|Lost to Follow-up|2|||
127607483|NCT00720057|459192394|FG000|Overall Study|Protocol Violation|1|||
127607484|NCT00720057|459192395|FG001|Overall Study|Protocol Violation|0|||
127607485|NCT00720057|459192394|FG000|Overall Study|Withdrawal by Subject|0|||
127607486|NCT00720057|459192395|FG001|Overall Study|Withdrawal by Subject|1|||
127607487|NCT02726074|459192399|FG000|Overall Study|Withdrawal by Subject|4|||
127607488|NCT02726074|459192399|FG000|Overall Study|Adverse Event|14|||
127607489|NCT02726074|459192399|FG000|Overall Study|Protocol Violation|3|||
127607490|NCT02726074|459192399|FG000|Overall Study|Lost to Follow-up|2|||
127607491|NCT02726074|459192399|FG000|Overall Study|Others|3|||
127607492|NCT04256785|459192403|FG000|Overall Study|Adverse Event|8|||
127607493|NCT04256785|459192404|FG001|Overall Study|Adverse Event|6|||
127607494|NCT04256785|459192403|FG000|Overall Study|Lack of Efficacy|3|||
127607495|NCT04256785|459192404|FG001|Overall Study|Lack of Efficacy|4|||
127607496|NCT04256785|459192403|FG000|Overall Study|Lost to Follow-up|7|||
127607497|NCT04256785|459192404|FG001|Overall Study|Lost to Follow-up|7|||
127607498|NCT04256785|459192403|FG000|Overall Study|Protocol Violation|1|||
127607499|NCT04256785|459192404|FG001|Overall Study|Protocol Violation|0|||
127607500|NCT04256785|459192403|FG000|Overall Study|Withdrawal by Subject|4|||
127607501|NCT04256785|459192404|FG001|Overall Study|Withdrawal by Subject|1|||
127607502|NCT04256785|459192403|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
127607503|NCT04256785|459192404|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
127607504|NCT03559257|459192410|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
127607505|NCT03559257|459192411|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
127607506|NCT03559257|459192410|FG000|Double Blind Treatment Period|Protocol Violation|1|||
127607507|NCT03559257|459192411|FG001|Double Blind Treatment Period|Protocol Violation|4|||
127607508|NCT03559257|459192410|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
127607509|NCT03559257|459192411|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
127607510|NCT03559257|459192410|FG000|Double Blind Treatment Period|Adverse Event|0|||
127607511|NCT03559257|459192411|FG001|Double Blind Treatment Period|Adverse Event|1|||
127607512|NCT03559257|459192410|FG000|Double Blind Treatment Period|Screen Failure|0|||
127607513|NCT03559257|459192411|FG001|Double Blind Treatment Period|Screen Failure|1|||
127607514|NCT03559257|459192410|FG000|Open-label Treatment Period|Adverse Event|1|||
127607515|NCT03559257|459192411|FG001|Open-label Treatment Period|Adverse Event|4|||
127607516|NCT03559257|459192410|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
127607517|NCT03559257|459192411|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
127607518|NCT03559257|459192410|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
127607519|NCT03559257|459192411|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
127607520|NCT03559257|459192410|FG000|Open-label Treatment Period|Protocol Violation|2|||
127607521|NCT03559257|459192411|FG001|Open-label Treatment Period|Protocol Violation|0|||
127607522|NCT03559257|459192410|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
127607523|NCT03559257|459192411|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
127607524|NCT03559257|459192410|FG000|Open-label Treatment Period|Physician Decision|0|||
127607525|NCT03559257|459192411|FG001|Open-label Treatment Period|Physician Decision|1|||
127607526|NCT03630120|459192412|FG000|Overall Study|Disease progression|0|||
127607527|NCT03630120|459192413|FG001|Overall Study|Disease progression|1|||
127607528|NCT03630120|459192414|FG002|Overall Study|Disease progression|1|||
127607529|NCT03630120|459192415|FG003|Overall Study|Disease progression|1|||
127607530|NCT02153112|459192416|FG000|Overall Study|Adverse Event|0|||
127607531|NCT02153112|459192417|FG001|Overall Study|Adverse Event|0|||
127607532|NCT02153112|459192418|FG002|Overall Study|Adverse Event|1|||
127607533|NCT02153112|459192419|FG003|Overall Study|Adverse Event|0|||
127607534|NCT02153112|459192420|FG004|Overall Study|Adverse Event|0|||
127607535|NCT02153112|459192421|FG005|Overall Study|Adverse Event|0|||
127607536|NCT02153112|459192422|FG006|Overall Study|Adverse Event|0|||
127607537|NCT02153112|459192423|FG007|Overall Study|Adverse Event|0|||
127607538|NCT02153112|459192424|FG008|Overall Study|Adverse Event|0|||
127607539|NCT02153112|459192425|FG009|Overall Study|Adverse Event|0|||
127607540|NCT02153112|459192416|FG000|Overall Study|Lost to Follow-up|1|||
127607541|NCT02153112|459192417|FG001|Overall Study|Lost to Follow-up|1|||
127607542|NCT02153112|459192418|FG002|Overall Study|Lost to Follow-up|0|||
127607543|NCT02153112|459192419|FG003|Overall Study|Lost to Follow-up|0|||
127607544|NCT02153112|459192420|FG004|Overall Study|Lost to Follow-up|2|||
127607545|NCT02153112|459192421|FG005|Overall Study|Lost to Follow-up|1|||
127607546|NCT02153112|459192422|FG006|Overall Study|Lost to Follow-up|1|||
127607547|NCT02153112|459192423|FG007|Overall Study|Lost to Follow-up|0|||
127607548|NCT02153112|459192424|FG008|Overall Study|Lost to Follow-up|1|||
127607549|NCT02153112|459192425|FG009|Overall Study|Lost to Follow-up|1|||
127607550|NCT02153112|459192416|FG000|Overall Study|Withdrawal by Subject|3|||
127607551|NCT02153112|459192417|FG001|Overall Study|Withdrawal by Subject|1|||
127607552|NCT02153112|459192418|FG002|Overall Study|Withdrawal by Subject|2|||
127607553|NCT02153112|459192419|FG003|Overall Study|Withdrawal by Subject|2|||
127607554|NCT02153112|459192420|FG004|Overall Study|Withdrawal by Subject|1|||
127607555|NCT02153112|459192421|FG005|Overall Study|Withdrawal by Subject|1|||
127607556|NCT02153112|459192422|FG006|Overall Study|Withdrawal by Subject|7|||
127607557|NCT02153112|459192423|FG007|Overall Study|Withdrawal by Subject|2|||
127607558|NCT02153112|459192424|FG008|Overall Study|Withdrawal by Subject|13|||
127607559|NCT02153112|459192425|FG009|Overall Study|Withdrawal by Subject|12|||
127607560|NCT02153112|459192416|FG000|Overall Study|Reason not Specified|0|||
127607561|NCT02153112|459192417|FG001|Overall Study|Reason not Specified|0|||
127607562|NCT02153112|459192418|FG002|Overall Study|Reason not Specified|0|||
127607563|NCT02153112|459192419|FG003|Overall Study|Reason not Specified|0|||
127607564|NCT02153112|459192420|FG004|Overall Study|Reason not Specified|0|||
127607565|NCT02153112|459192421|FG005|Overall Study|Reason not Specified|0|||
127607566|NCT02153112|459192422|FG006|Overall Study|Reason not Specified|0|||
127607567|NCT02153112|459192423|FG007|Overall Study|Reason not Specified|0|||
127607568|NCT02153112|459192424|FG008|Overall Study|Reason not Specified|1|||
127607569|NCT02153112|459192425|FG009|Overall Study|Reason not Specified|1|||
127607570|NCT01288287|459192426|FG000|Overall Study|Lost to Follow-up|8|||
127607571|NCT01288287|459192426|FG000|Overall Study|Withdrawal by Subject|4|||
127607572|NCT01288287|459192426|FG000|Overall Study|Lack of Efficacy|13|||
127607573|NCT01288287|459192426|FG000|Overall Study|Other Reason|13|||
127607574|NCT01288287|459192426|FG000|Overall Study|Unknown Reason|1|||
127607575|NCT01288287|459192426|FG000|Overall Study|Unknown Status|7|||
127607576|NCT02677987|459192430|FG000|Overall Study|Withdrawal by Subject|3|||
127607577|NCT02677987|459192431|FG001|Overall Study|Withdrawal by Subject|0|||
127607578|NCT02677987|459192430|FG000|Overall Study|Lost to Follow-up|1|||
127607579|NCT02677987|459192431|FG001|Overall Study|Lost to Follow-up|0|||
127607580|NCT01120756|459192432|FG000|Overall Study|Withdrawal by Subject|1|||
127607581|NCT01120756|459192433|FG001|Overall Study|Withdrawal by Subject|1|||
127607582|NCT03760146|459192439|FG000|Overall Study|Adverse Event|11|||
127607583|NCT03760146|459192440|FG001|Overall Study|Adverse Event|8|||
127607584|NCT03760146|459192441|FG002|Overall Study|Adverse Event|0|||
127607585|NCT03760146|459192442|FG003|Overall Study|Adverse Event|0|||
127607586|NCT03760146|459192443|FG004|Overall Study|Adverse Event|0|||
127607587|NCT03760146|459192444|FG005|Overall Study|Adverse Event|0|||
127607588|NCT03760146|459192439|FG000|Overall Study|Death|1|||
127607589|NCT03760146|459192440|FG001|Overall Study|Death|0|||
127607590|NCT03760146|459192441|FG002|Overall Study|Death|0|||
127607591|NCT03760146|459192442|FG003|Overall Study|Death|0|||
127607592|NCT03760146|459192443|FG004|Overall Study|Death|0|||
127607593|NCT03760146|459192444|FG005|Overall Study|Death|0|||
127607594|NCT03760146|459192439|FG000|Overall Study|Lost to Follow-up|41|||
127607595|NCT03760146|459192440|FG001|Overall Study|Lost to Follow-up|28|||
127607596|NCT03760146|459192441|FG002|Overall Study|Lost to Follow-up|9|||
127607597|NCT03760146|459192442|FG003|Overall Study|Lost to Follow-up|2|||
127607598|NCT03760146|459192443|FG004|Overall Study|Lost to Follow-up|14|||
127607599|NCT03760146|459192444|FG005|Overall Study|Lost to Follow-up|8|||
127607600|NCT03760146|459192439|FG000|Overall Study|No longer met eligibility criteria|3|||
127607601|NCT03760146|459192440|FG001|Overall Study|No longer met eligibility criteria|9|||
127607602|NCT03760146|459192441|FG002|Overall Study|No longer met eligibility criteria|0|||
127607603|NCT03760146|459192442|FG003|Overall Study|No longer met eligibility criteria|0|||
127607604|NCT03760146|459192443|FG004|Overall Study|No longer met eligibility criteria|1|||
127607605|NCT03760146|459192444|FG005|Overall Study|No longer met eligibility criteria|0|||
127607606|NCT03760146|459192439|FG000|Overall Study|Protocol Violation|21|||
127607607|NCT03760146|459192440|FG001|Overall Study|Protocol Violation|13|||
127607608|NCT03760146|459192441|FG002|Overall Study|Protocol Violation|1|||
127607609|NCT03760146|459192442|FG003|Overall Study|Protocol Violation|0|||
127607610|NCT03760146|459192443|FG004|Overall Study|Protocol Violation|1|||
127607611|NCT03760146|459192444|FG005|Overall Study|Protocol Violation|0|||
127607612|NCT03760146|459192439|FG000|Overall Study|Withdrawal by Subject|19|||
127607613|NCT03760146|459192440|FG001|Overall Study|Withdrawal by Subject|20|||
127607614|NCT03760146|459192441|FG002|Overall Study|Withdrawal by Subject|1|||
127607615|NCT03760146|459192442|FG003|Overall Study|Withdrawal by Subject|0|||
127607616|NCT03760146|459192443|FG004|Overall Study|Withdrawal by Subject|1|||
127607617|NCT03760146|459192444|FG005|Overall Study|Withdrawal by Subject|0|||
127607618|NCT01559012|459192447|FG000|Overall Study|Withdrawal by Subject|0|||
127607619|NCT01559012|459192448|FG001|Overall Study|Withdrawal by Subject|1|||
127607620|NCT00946712|459192449|FG000|Overall Study|Adverse Event|118|||
127607621|NCT00946712|459192450|FG001|Overall Study|Adverse Event|124|||
127607622|NCT00946712|459192449|FG000|Overall Study|Disease progression|308|||
127607623|NCT00946712|459192450|FG001|Overall Study|Disease progression|404|||
127607624|NCT00946712|459192449|FG000|Overall Study|Death|21|||
127607625|NCT00946712|459192450|FG001|Overall Study|Death|22|||
127607626|NCT00946712|459192449|FG000|Overall Study|No treatment given|25|||
127607627|NCT00946712|459192450|FG001|Overall Study|No treatment given|29|||
127607628|NCT00946712|459192449|FG000|Overall Study|Other reasons|61|||
127607629|NCT00946712|459192450|FG001|Overall Study|Other reasons|73|||
127607630|NCT00946712|459192449|FG000|Overall Study|On Treatment|0|||
127607631|NCT00946712|459192450|FG001|Overall Study|On Treatment|4|||
127607632|NCT00946712|459192449|FG000|Overall Study|Ineligible|14|||
127607633|NCT00946712|459192450|FG001|Overall Study|Ineligible|6|||
127607634|NCT02291055|459192451|FG000|Overall Study|Death|2|||
127607635|NCT02291055|459192452|FG001|Overall Study|Death|2|||
127607636|NCT02291055|459192453|FG002|Overall Study|Death|5|||
127607637|NCT02291055|459192454|FG003|Overall Study|Death|8|||
127607638|NCT02291055|459192455|FG004|Overall Study|Death|12|||
127607639|NCT02291055|459192451|FG000|Overall Study|Lost to Follow-up|0|||
127607640|NCT02291055|459192452|FG001|Overall Study|Lost to Follow-up|0|||
127607641|NCT02291055|459192453|FG002|Overall Study|Lost to Follow-up|0|||
127607642|NCT02291055|459192454|FG003|Overall Study|Lost to Follow-up|1|||
127607643|NCT02291055|459192455|FG004|Overall Study|Lost to Follow-up|2|||
127607644|NCT02291055|459192451|FG000|Overall Study|Withdrawal by Subject|3|||
127607645|NCT02291055|459192452|FG001|Overall Study|Withdrawal by Subject|1|||
127607646|NCT02291055|459192453|FG002|Overall Study|Withdrawal by Subject|1|||
127607647|NCT02291055|459192454|FG003|Overall Study|Withdrawal by Subject|5|||
127607648|NCT02291055|459192455|FG004|Overall Study|Withdrawal by Subject|10|||
127607649|NCT02291055|459192451|FG000|Overall Study|Progressive Disease|0|||
127607650|NCT02291055|459192452|FG001|Overall Study|Progressive Disease|0|||
127607651|NCT02291055|459192453|FG002|Overall Study|Progressive Disease|1|||
127607652|NCT02291055|459192454|FG003|Overall Study|Progressive Disease|4|||
127607653|NCT02291055|459192455|FG004|Overall Study|Progressive Disease|2|||
127607654|NCT02291055|459192451|FG000|Overall Study|Study Terminated by Sponsor|0|||
127607655|NCT02291055|459192452|FG001|Overall Study|Study Terminated by Sponsor|0|||
127607656|NCT02291055|459192453|FG002|Overall Study|Study Terminated by Sponsor|0|||
127607657|NCT02291055|459192454|FG003|Overall Study|Study Terminated by Sponsor|5|||
127607658|NCT02291055|459192455|FG004|Overall Study|Study Terminated by Sponsor|1|||
127607659|NCT02291055|459192451|FG000|Overall Study|Other|0|||
127607660|NCT02291055|459192452|FG001|Overall Study|Other|2|||
127607661|NCT02291055|459192453|FG002|Overall Study|Other|1|||
127607662|NCT02291055|459192454|FG003|Overall Study|Other|4|||
127607663|NCT02291055|459192455|FG004|Overall Study|Other|0|||
127607664|NCT03839212|459192456|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
127607665|NCT00679263|459192457|FG000|Visit 2/Dose 1|Adverse Event|1|||
127607666|NCT00679263|459192458|FG001|Visit 2/Dose 1|Adverse Event|0|||
127607667|NCT00679263|459192459|FG002|Visit 2/Dose 1|Adverse Event|0|||
127607668|NCT00679263|459192457|FG000|Visit 2/Dose 1|subject not compliance|1|||
127607669|NCT00679263|459192458|FG001|Visit 2/Dose 1|subject not compliance|1|||
127607670|NCT00679263|459192459|FG002|Visit 2/Dose 1|subject not compliance|0|||
127607671|NCT01464346|459192460|FG000|Overall Study|Withdrawal by Subject|0|||
127607672|NCT01464346|459192461|FG001|Overall Study|Withdrawal by Subject|0|||
127607673|NCT01464346|459192462|FG002|Overall Study|Withdrawal by Subject|1|||
127607674|NCT01498458|459192463|FG000|Overall Study|Adverse Event|4|||
127607675|NCT01498458|459192463|FG000|Overall Study|Physician Decision|3|||
127607676|NCT00718328|459192464|FG000|Overall Study|Lost to Follow-up|1|||
127607677|NCT00718328|459192465|FG001|Overall Study|Lost to Follow-up|0|||
127607678|NCT00939809|459193879|FG000|Overall Study|Adverse Event|2|||
127607679|NCT00939809|459193879|FG000|Overall Study|Death|1|||
127607680|NCT04447417|459193880|FG000|Overall Study|Withdrawal by Subject|1|||
127607681|NCT04447417|459193881|FG001|Overall Study|Withdrawal by Subject|0|||
127607682|NCT04447417|459193880|FG000|Overall Study|Failure to meet inclusion criteria|1|||
127607683|NCT04447417|459193881|FG001|Overall Study|Failure to meet inclusion criteria|0|||
127607684|NCT04447417|459193880|FG000|Overall Study|Lost to Follow-up|1|||
127607685|NCT04447417|459193881|FG001|Overall Study|Lost to Follow-up|0|||
127607686|NCT01190254|459193882|FG000|Overall Study|Adverse Event|3|||
127607687|NCT01190254|459193883|FG001|Overall Study|Adverse Event|6|||
127607688|NCT01190254|459193884|FG002|Overall Study|Adverse Event|8|||
127607689|NCT01190254|459193882|FG000|Overall Study|Lack of Efficacy|7|||
127607690|NCT01190254|459193883|FG001|Overall Study|Lack of Efficacy|4|||
127607691|NCT01190254|459193884|FG002|Overall Study|Lack of Efficacy|5|||
127607692|NCT01190254|459193882|FG000|Overall Study|Lost to Follow-up|4|||
127607693|NCT01190254|459193883|FG001|Overall Study|Lost to Follow-up|2|||
127607694|NCT01190254|459193884|FG002|Overall Study|Lost to Follow-up|0|||
127607695|NCT01190254|459193882|FG000|Overall Study|Withdrawal by Subject|4|||
127607696|NCT01190254|459193883|FG001|Overall Study|Withdrawal by Subject|5|||
127607697|NCT01190254|459193884|FG002|Overall Study|Withdrawal by Subject|7|||
127607698|NCT01190254|459193882|FG000|Overall Study|Protocol Violation|2|||
127607699|NCT01190254|459193883|FG001|Overall Study|Protocol Violation|0|||
127607700|NCT01190254|459193884|FG002|Overall Study|Protocol Violation|2|||
127607701|NCT01190254|459193882|FG000|Overall Study|Did not meet protocol eligibility|1|||
127607702|NCT01190254|459193883|FG001|Overall Study|Did not meet protocol eligibility|0|||
127607703|NCT01190254|459193884|FG002|Overall Study|Did not meet protocol eligibility|0|||
127607704|NCT02356783|459193885|FG000|Overall Study|Lost to Follow-up|1|||
127607705|NCT02356783|459193886|FG001|Overall Study|Lost to Follow-up|3|||
127607706|NCT04729127|459193887|FG000|Overall Study|Suspended/Terminated EI Services|4|||
127607707|NCT04729127|459193888|FG001|Overall Study|Suspended/Terminated EI Services|0|||
127607708|NCT04729127|459193889|FG002|Overall Study|Suspended/Terminated EI Services|4|||
127607709|NCT04729127|459193890|FG003|Overall Study|Suspended/Terminated EI Services|6|||
127607710|NCT04729127|459193891|FG004|Overall Study|Suspended/Terminated EI Services|0|||
127607711|NCT04729127|459193892|FG005|Overall Study|Suspended/Terminated EI Services|6|||
127607712|NCT04729127|459193893|FG006|Overall Study|Suspended/Terminated EI Services|2|||
127607713|NCT04729127|459193894|FG007|Overall Study|Suspended/Terminated EI Services|0|||
127607714|NCT04729127|459193895|FG008|Overall Study|Suspended/Terminated EI Services|2|||
127607715|NCT04729127|459193887|FG000|Overall Study|Withdrawal by Subject|1|||
127607716|NCT04729127|459193888|FG001|Overall Study|Withdrawal by Subject|0|||
127607717|NCT04729127|459193889|FG002|Overall Study|Withdrawal by Subject|1|||
127607718|NCT04729127|459193890|FG003|Overall Study|Withdrawal by Subject|0|||
127607719|NCT04729127|459193891|FG004|Overall Study|Withdrawal by Subject|0|||
127697726|NCT00667251|459521932|FG000|Overall Study|Primary reason for withdrawal = missing|1|||
127697727|NCT00667251|459521933|FG001|Overall Study|Primary reason for withdrawal = missing|1|||
127697728|NCT00667251|459521932|FG000|Overall Study|Randomized not Treated|4|||
127607720|NCT04729127|459193892|FG005|Overall Study|Withdrawal by Subject|0|||
127607721|NCT04729127|459193893|FG006|Overall Study|Withdrawal by Subject|0|||
127607722|NCT04729127|459193894|FG007|Overall Study|Withdrawal by Subject|0|||
127607723|NCT04729127|459193895|FG008|Overall Study|Withdrawal by Subject|0|||
127607724|NCT04729127|459193887|FG000|Overall Study|Switched Agency/Setting|1|||
127607725|NCT04729127|459193888|FG001|Overall Study|Switched Agency/Setting|0|||
127607726|NCT04729127|459193889|FG002|Overall Study|Switched Agency/Setting|1|||
127607727|NCT04729127|459193890|FG003|Overall Study|Switched Agency/Setting|1|||
127607728|NCT04729127|459193891|FG004|Overall Study|Switched Agency/Setting|0|||
127607729|NCT04729127|459193892|FG005|Overall Study|Switched Agency/Setting|1|||
127607730|NCT04729127|459193893|FG006|Overall Study|Switched Agency/Setting|1|||
127607731|NCT04729127|459193894|FG007|Overall Study|Switched Agency/Setting|0|||
127607732|NCT04729127|459193895|FG008|Overall Study|Switched Agency/Setting|1|||
127607733|NCT01365507|459193896|FG000|Overall Study|Withdrawal Criteria|8|||
127607734|NCT01365507|459193897|FG001|Overall Study|Withdrawal Criteria|5|||
127607735|NCT01365507|459193896|FG000|Overall Study|Unclassified|1|||
127607736|NCT01365507|459193897|FG001|Overall Study|Unclassified|4|||
127607737|NCT00192504|459193900|FG000|Overall Study|Lost to Follow-up|1|||
127607738|NCT00192504|459193901|FG001|Overall Study|Lost to Follow-up|0|||
127607739|NCT00192504|459193902|FG002|Overall Study|Lost to Follow-up|0|||
127607740|NCT00192504|459193903|FG003|Overall Study|Lost to Follow-up|0|||
127607741|NCT00192504|459193900|FG000|Overall Study|Dosing window missed|0|||
127607742|NCT00192504|459193901|FG001|Overall Study|Dosing window missed|0|||
127607743|NCT00192504|459193902|FG002|Overall Study|Dosing window missed|1|||
127607744|NCT00192504|459193903|FG003|Overall Study|Dosing window missed|0|||
127607745|NCT01139450|459193904|FG000|Overall Study|Withdrawal by Subject|7|||
127607746|NCT01139450|459193905|FG001|Overall Study|Withdrawal by Subject|10|||
127607747|NCT01139450|459193906|FG002|Overall Study|Withdrawal by Subject|13|||
127607748|NCT01139450|459193904|FG000|Overall Study|Lack of Efficacy|3|||
127607749|NCT01139450|459193905|FG001|Overall Study|Lack of Efficacy|1|||
127607750|NCT01139450|459193906|FG002|Overall Study|Lack of Efficacy|8|||
127607751|NCT01139450|459193904|FG000|Overall Study|Protocol Violation|6|||
127607752|NCT01139450|459193905|FG001|Overall Study|Protocol Violation|5|||
127607753|NCT01139450|459193906|FG002|Overall Study|Protocol Violation|2|||
127607754|NCT01139450|459193904|FG000|Overall Study|Lost to Follow-up|9|||
127607755|NCT01139450|459193905|FG001|Overall Study|Lost to Follow-up|7|||
127607756|NCT01139450|459193906|FG002|Overall Study|Lost to Follow-up|11|||
127607757|NCT01139450|459193904|FG000|Overall Study|Administrative|0|||
127607758|NCT01139450|459193905|FG001|Overall Study|Administrative|0|||
127607759|NCT01139450|459193906|FG002|Overall Study|Administrative|1|||
127607760|NCT01139450|459193904|FG000|Overall Study|Adverse Event|2|||
127607761|NCT01139450|459193905|FG001|Overall Study|Adverse Event|2|||
127607762|NCT01139450|459193906|FG002|Overall Study|Adverse Event|3|||
127607763|NCT04782856|459193907|FG000|Overall Study|Withdrawal by Subject|0|||
127607764|NCT04782856|459193908|FG001|Overall Study|Withdrawal by Subject|1|||
127607765|NCT04307446|459193913|FG000|Overall Study|Lost to Follow-up|2|||
127607766|NCT04307446|459193914|FG001|Overall Study|Lost to Follow-up|0|||
127607767|NCT03257631|459193917|FG000|Overall Study|Death|1|||
127607768|NCT03257631|459193918|FG001|Overall Study|Death|0|||
127607769|NCT03257631|459193919|FG002|Overall Study|Death|1|||
127607770|NCT03257631|459193920|FG003|Overall Study|Death|1|||
127607771|NCT03257631|459193917|FG000|Overall Study|Progressive Disease|10|||
127607772|NCT03257631|459193918|FG001|Overall Study|Progressive Disease|9|||
127607773|NCT03257631|459193919|FG002|Overall Study|Progressive Disease|17|||
127607774|NCT03257631|459193920|FG003|Overall Study|Progressive Disease|8|||
127607775|NCT03257631|459193917|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
127607776|NCT03257631|459193918|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
127607777|NCT03257631|459193919|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
127607778|NCT03257631|459193920|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
127607779|NCT03257631|459193917|FG000|Overall Study|Adverse Event|0|||
127607780|NCT03257631|459193918|FG001|Overall Study|Adverse Event|0|||
127607781|NCT03257631|459193919|FG002|Overall Study|Adverse Event|2|||
127607782|NCT03257631|459193920|FG003|Overall Study|Adverse Event|0|||
127607783|NCT02529137|459193921|FG000|Overall Study|Discontinuation for different reasons|8|||
127607784|NCT03036098|459193925|FG000|Pre-Treatment|Other Reasons|1|||
127607785|NCT03036098|459193926|FG001|Pre-Treatment|Other Reasons|2|||
127607786|NCT03036098|459193927|FG002|Pre-Treatment|Other Reasons|0|||
127607787|NCT03036098|459193928|FG003|Pre-Treatment|Other Reasons|5|||
127607788|NCT03036098|459193925|FG000|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
127607789|NCT03036098|459193926|FG001|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
127607790|NCT03036098|459193927|FG002|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
127607791|NCT03036098|459193928|FG003|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
127607792|NCT03036098|459193925|FG000|Pre-Treatment|Withdrawal by Subject|1|||
127607793|NCT03036098|459193926|FG001|Pre-Treatment|Withdrawal by Subject|14|||
127607794|NCT03036098|459193927|FG002|Pre-Treatment|Withdrawal by Subject|0|||
127697729|NCT00667251|459521933|FG001|Overall Study|Randomized not Treated|1|||
127697730|NCT02727699|459521934|FG000|Overall Study|Adverse Event|2|||
127607795|NCT03036098|459193928|FG003|Pre-Treatment|Withdrawal by Subject|5|||
127607796|NCT03036098|459193925|FG000|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
127607797|NCT03036098|459193926|FG001|Pre-Treatment|Participant Request to Discontinue Study Treatment|3|||
127607798|NCT03036098|459193927|FG002|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
127607799|NCT03036098|459193928|FG003|Pre-Treatment|Participant Request to Discontinue Study Treatment|1|||
127607800|NCT03036098|459193925|FG000|Treatment|Disease Progression|130|||
127607801|NCT03036098|459193926|FG001|Treatment|Disease Progression|77|||
127607802|NCT03036098|459193927|FG002|Treatment|Disease Progression|168|||
127607803|NCT03036098|459193928|FG003|Treatment|Disease Progression|50|||
127607804|NCT03036098|459193925|FG000|Treatment|Study Drug Toxicity|95|||
127607805|NCT03036098|459193926|FG001|Treatment|Study Drug Toxicity|45|||
127607806|NCT03036098|459193927|FG002|Treatment|Study Drug Toxicity|26|||
127607807|NCT03036098|459193928|FG003|Treatment|Study Drug Toxicity|22|||
127607808|NCT03036098|459193925|FG000|Treatment|Death|9|||
127607809|NCT03036098|459193926|FG001|Treatment|Death|3|||
127607810|NCT03036098|459193927|FG002|Treatment|Death|1|||
127607811|NCT03036098|459193928|FG003|Treatment|Death|2|||
127607812|NCT03036098|459193925|FG000|Treatment|Adverse Event Unrelated to Study Drug|18|||
127607813|NCT03036098|459193926|FG001|Treatment|Adverse Event Unrelated to Study Drug|15|||
127607814|NCT03036098|459193927|FG002|Treatment|Adverse Event Unrelated to Study Drug|10|||
127607815|NCT03036098|459193928|FG003|Treatment|Adverse Event Unrelated to Study Drug|14|||
127607816|NCT03036098|459193925|FG000|Treatment|Participant Request to Discontinue Study Treatment|6|||
127607817|NCT03036098|459193926|FG001|Treatment|Participant Request to Discontinue Study Treatment|18|||
127607818|NCT03036098|459193927|FG002|Treatment|Participant Request to Discontinue Study Treatment|15|||
127607819|NCT03036098|459193928|FG003|Treatment|Participant Request to Discontinue Study Treatment|18|||
127607820|NCT03036098|459193925|FG000|Treatment|Withdrawal by Subject|2|||
127607821|NCT03036098|459193926|FG001|Treatment|Withdrawal by Subject|9|||
127607822|NCT03036098|459193927|FG002|Treatment|Withdrawal by Subject|2|||
127607823|NCT03036098|459193928|FG003|Treatment|Withdrawal by Subject|4|||
127607824|NCT03036098|459193925|FG000|Treatment|Maximum Clinical Benefit|6|||
127607825|NCT03036098|459193926|FG001|Treatment|Maximum Clinical Benefit|1|||
127607826|NCT03036098|459193927|FG002|Treatment|Maximum Clinical Benefit|6|||
127607827|NCT03036098|459193928|FG003|Treatment|Maximum Clinical Benefit|10|||
127607828|NCT03036098|459193925|FG000|Treatment|Poor/Non Compliance|1|||
127607829|NCT03036098|459193926|FG001|Treatment|Poor/Non Compliance|2|||
127607830|NCT03036098|459193927|FG002|Treatment|Poor/Non Compliance|0|||
127607831|NCT03036098|459193928|FG003|Treatment|Poor/Non Compliance|1|||
127607832|NCT03036098|459193925|FG000|Treatment|Participant No Longer Meets Study Criteria|0|||
127607833|NCT03036098|459193926|FG001|Treatment|Participant No Longer Meets Study Criteria|1|||
127607834|NCT03036098|459193927|FG002|Treatment|Participant No Longer Meets Study Criteria|1|||
127607835|NCT03036098|459193928|FG003|Treatment|Participant No Longer Meets Study Criteria|1|||
127607836|NCT03036098|459193925|FG000|Treatment|Administrative Reason by Sponsor|1|||
127607837|NCT03036098|459193926|FG001|Treatment|Administrative Reason by Sponsor|0|||
127607838|NCT03036098|459193927|FG002|Treatment|Administrative Reason by Sponsor|2|||
127607839|NCT03036098|459193928|FG003|Treatment|Administrative Reason by Sponsor|1|||
127607840|NCT03036098|459193925|FG000|Treatment|Other Reasons|31|||
127607841|NCT03036098|459193926|FG001|Treatment|Other Reasons|5|||
127697731|NCT02727699|459521935|FG001|Overall Study|Adverse Event|0|||
127697732|NCT02727699|459521934|FG000|Overall Study|Withdrawal by Subject|5|||
127607842|NCT03036098|459193927|FG002|Treatment|Other Reasons|21|||
127697733|NCT02727699|459521935|FG001|Overall Study|Withdrawal by Subject|3|||
127697734|NCT02727699|459521934|FG000|Overall Study|Protocol Violation|0|||
127697735|NCT02727699|459521935|FG001|Overall Study|Protocol Violation|1|||
127697736|NCT02727699|459521934|FG000|Overall Study|Physician Decision|0|||
127697737|NCT02727699|459521935|FG001|Overall Study|Physician Decision|1|||
127697738|NCT02727699|459521934|FG000|Overall Study|Lost to Follow-up|1|||
127697739|NCT02727699|459521935|FG001|Overall Study|Lost to Follow-up|0|||
127697740|NCT02727699|459521934|FG000|Overall Study|Sponsor Decision|1|||
127697741|NCT02727699|459521935|FG001|Overall Study|Sponsor Decision|0|||
127697742|NCT03047928|459521940|FG000|Overall Study|Adverse Event|0|||
127697743|NCT03047928|459521941|FG001|Overall Study|Adverse Event|2|||
127697744|NCT03047928|459521942|FG002|Overall Study|Adverse Event|0|||
127697745|NCT03047928|459521940|FG000|Overall Study|Protocol Violation|0|||
127697746|NCT03047928|459521941|FG001|Overall Study|Protocol Violation|1|||
127697747|NCT03047928|459521942|FG002|Overall Study|Protocol Violation|0|||
127697748|NCT03047928|459521940|FG000|Overall Study|included in another protocol|0|||
127697749|NCT03047928|459521941|FG001|Overall Study|included in another protocol|1|||
127697750|NCT03047928|459521942|FG002|Overall Study|included in another protocol|0|||
127607843|NCT03036098|459193928|FG003|Treatment|Other Reasons|8|||
127607844|NCT03036098|459193925|FG000|Treatment|Ongoing Treatment|0|||
127607845|NCT03036098|459193926|FG001|Treatment|Ongoing Treatment|0|||
127607846|NCT03036098|459193927|FG002|Treatment|Ongoing Treatment|23|||
127607847|NCT03036098|459193928|FG003|Treatment|Ongoing Treatment|0|||
127607848|NCT00930579|459193931|FG000|Overall Study|Withdrawal by Subject|1|||
127607849|NCT00930579|459193931|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
127697751|NCT04318548|459521943|FG000|Overall Study|Adverse Event|0|||
127697752|NCT04318548|459521944|FG001|Overall Study|Adverse Event|0|||
127697753|NCT04318548|459521945|FG002|Overall Study|Adverse Event|1|||
127697754|NCT04318548|459521943|FG000|Overall Study|Lost to Follow-up|6|||
127697755|NCT04318548|459521944|FG001|Overall Study|Lost to Follow-up|13|||
127697756|NCT04318548|459521945|FG002|Overall Study|Lost to Follow-up|9|||
127697757|NCT04318548|459521943|FG000|Overall Study|Protocol Violation|1|||
127697758|NCT04318548|459521944|FG001|Overall Study|Protocol Violation|0|||
127697759|NCT04318548|459521945|FG002|Overall Study|Protocol Violation|2|||
127697760|NCT04318548|459521943|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|5|||
127697761|NCT04318548|459521944|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|9|||
127697762|NCT04318548|459521945|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
127697763|NCT04318548|459521943|FG000|Overall Study|Migrated / moved from the study area|0|||
127788778|NCT00705783|459851278|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
127788779|NCT00705783|459851279|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
127788780|NCT00705783|459851280|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
127788781|NCT00705783|459851278|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
127788782|NCT00705783|459851279|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
127788783|NCT00705783|459851280|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
127788784|NCT02184195|459851281|FG000|Overall Study|Patient decision|5|||
127788785|NCT02184195|459851282|FG001|Overall Study|Patient decision|2|||
127788786|NCT02184195|459851281|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
127788787|NCT02184195|459851282|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
127788788|NCT02184195|459851281|FG000|Overall Study|Death|67|||
127788789|NCT02184195|459851282|FG001|Overall Study|Death|44|||
127788790|NCT02184195|459851281|FG000|Overall Study|Lost to Follow-up|1|||
127788791|NCT02184195|459851282|FG001|Overall Study|Lost to Follow-up|5|||
127788792|NCT02184195|459851281|FG000|Overall Study|Other|0|||
127788793|NCT02184195|459851282|FG001|Overall Study|Other|3|||
127788794|NCT00939783|459851286|FG000|Overall Study|Death|6|||
127788795|NCT00939783|459851286|FG000|Overall Study|Adverse Event|39|||
127788796|NCT00939783|459851286|FG000|Overall Study|Study Terminated by Sponsor|498|||
127788797|NCT00939783|459851286|FG000|Overall Study|Withdrawal by Subject|78|||
127788798|NCT00939783|459851286|FG000|Overall Study|Other|16|||
127788799|NCT00939783|459851286|FG000|Overall Study|Lost to Follow-up|8|||
127788800|NCT00939783|459851286|FG000|Overall Study|Protocol Violation|3|||
127788801|NCT00939783|459851286|FG000|Overall Study|Enrolled but not treated|1|||
127788802|NCT01251367|459851294|FG000|Overall Study|Protocol Violation|1|||
127788803|NCT01251367|459851294|FG000|Overall Study|Lack of Efficacy|2|||
127788804|NCT01251367|459851294|FG000|Overall Study|Adverse Event|19|||
127788805|NCT01251367|459851294|FG000|Overall Study|Withdrawal by Subject|36|||
127788806|NCT01251367|459851294|FG000|Overall Study|Lost to Follow-up|5|||
127788807|NCT01251367|459851294|FG000|Overall Study|Subject Required Alternative Treatment|7|||
127788808|NCT01251367|459851294|FG000|Overall Study|No Study Drug Available|1|||
127788809|NCT01251367|459851294|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
127788810|NCT01251367|459851294|FG000|Overall Study|End of Study Visit Performed in Error|1|||
127788811|NCT02255409|459851295|FG000|Overall Study|Administrative Reason|3|||
127788812|NCT02255409|459851296|FG001|Overall Study|Administrative Reason|7|||
127788813|NCT02255409|459851295|FG000|Overall Study|Withdrawal by Subject|1|||
127788814|NCT02255409|459851296|FG001|Overall Study|Withdrawal by Subject|5|||
127788815|NCT02255409|459851295|FG000|Overall Study|Lost to Follow-up|10|||
127788816|NCT02255409|459851296|FG001|Overall Study|Lost to Follow-up|19|||
127788817|NCT02016820|459851299|FG000|Overall Study|Lost to Follow-up|2|||
127788818|NCT02016820|459851300|FG001|Overall Study|Lost to Follow-up|4|||
127788819|NCT01227044|459851301|FG000|Overall Study|Lost to Follow-up|5|||
127788820|NCT01227044|459851302|FG001|Overall Study|Lost to Follow-up|7|||
127788821|NCT01227044|459851301|FG000|Overall Study|Discontinued Intervention|1|||
127788822|NCT01227044|459851302|FG001|Overall Study|Discontinued Intervention|2|||
127788823|NCT00583362|459851303|FG000|Overall Study|Adverse Event|44|||
127788824|NCT00583362|459851303|FG000|Overall Study|Lack of Efficacy|22|||
127788825|NCT00583362|459851303|FG000|Overall Study|Lost to Follow-up|4|||
127788826|NCT00583362|459851303|FG000|Overall Study|Non-compliance with study drug|28|||
127697764|NCT04318548|459521944|FG001|Overall Study|Migrated / moved from the study area|0|||
127788827|NCT00583362|459851303|FG000|Overall Study|Pregnancy|7|||
127788828|NCT00583362|459851303|FG000|Overall Study|Miscommunication of visit window|5|||
127788829|NCT00583362|459851303|FG000|Overall Study|Current site closed|7|||
127788830|NCT00583362|459851303|FG000|Overall Study|Subject not dosed in LBSL99|1|||
127788831|NCT00583362|459851303|FG000|Overall Study|Subject moved out of the country/state|2|||
127788832|NCT00583362|459851303|FG000|Overall Study|Missed visits due to staff changes|1|||
127788833|NCT00583362|459851303|FG000|Overall Study|Misunderstanding of protocol|1|||
127788834|NCT00583362|459851303|FG000|Overall Study|Behavioral problems and non-compliance|1|||
127788835|NCT00583362|459851303|FG000|Overall Study|Sponsor request due to missed doses|1|||
127788836|NCT00583362|459851303|FG000|Overall Study|Physician Decision|19|||
127788837|NCT00583362|459851303|FG000|Overall Study|Protocol Violation|2|||
127788838|NCT00583362|459851303|FG000|Overall Study|Withdrawal by Subject|57|||
127788839|NCT00473343|459851304|FG000|Overall Study|Adverse Event|9|||
127788840|NCT00473343|459851304|FG000|Overall Study|Lost to Follow-up|8|||
127607850|NCT01046682|459193935|FG000|Overall Study|Adverse Event|2|||
127607851|NCT01046682|459193936|FG001|Overall Study|Adverse Event|0|||
127788841|NCT00473343|459851304|FG000|Overall Study|Treatment failure|27|||
127607852|NCT01454570|459193937|FG000|Overall Study|Withdrawal by Subject|2|||
127607853|NCT01454570|459193937|FG000|Overall Study|Screen Failure|7|||
127607854|NCT00772707|459193938|FG000|Overall Study|Withdrawn|3|||
127607855|NCT00536107|459193939|FG000|Overall Study|Death|5|||
127607856|NCT00536107|459193940|FG001|Overall Study|Death|1|||
127607857|NCT00536107|459193939|FG000|Overall Study|Incorrect enrolment|1|||
127607858|NCT00536107|459193940|FG001|Overall Study|Incorrect enrolment|0|||
127607859|NCT00536107|459193939|FG000|Overall Study|Withdrawal by Subject|0|||
127607860|NCT00536107|459193940|FG001|Overall Study|Withdrawal by Subject|1|||
127607861|NCT00536107|459193939|FG000|Overall Study|Study Termination|2|||
127607862|NCT00536107|459193940|FG001|Overall Study|Study Termination|4|||
127607863|NCT04356963|459193942|FG000|First Session|Withdrawal by Subject|1|||
127607864|NCT04356963|459193942|FG000|Second Session|Withdrawal by Subject|3|||
127607865|NCT04356963|459193942|FG000|Second Session|Lost to Follow-up|1|||
127607866|NCT04356963|459193942|FG000|Third Session|Lost to Follow-up|6|||
127607867|NCT04356963|459193942|FG000|Third Session|Withdrawal by Subject|1|||
127607868|NCT01679002|459193947|FG000|Overall Study|Adverse Event|1|||
127607869|NCT01679002|459193948|FG001|Overall Study|Adverse Event|1|||
127607870|NCT01679002|459193949|FG002|Overall Study|Adverse Event|0|||
127607871|NCT01176266|459193952|FG000|Overall Study|Death|6|||
127607872|NCT01176266|459193952|FG000|Overall Study|Withdrawal by Subject|3|||
127607873|NCT01179477|459193953|FG000|Overall Study|Death|542|||
127607874|NCT01179477|459193953|FG000|Overall Study|Unsuccessful implant|80|||
127607875|NCT01179477|459193953|FG000|Overall Study|Non-death withdrawal|438|||
127607876|NCT01179477|459193953|FG000|Overall Study|Did not complete final visit|27|||
127607877|NCT05075850|459193961|FG000|Overall Study|Did not completed follow-up questionnaires|34|||
127607878|NCT03194321|459193962|FG000|Overall Study|Withdrawal by Subject|1|||
127607879|NCT03194321|459193962|FG000|Overall Study|Lost to Follow-up|1|||
127607880|NCT03194321|459193962|FG000|Overall Study|Travel for Follow-up|1|||
127607881|NCT00975481|459193967|FG000|Second Intervention Period|Adverse Event|2|||
127607882|NCT00975481|459193968|FG001|Second Intervention Period|Adverse Event|1|||
127607883|NCT00975481|459193969|FG002|Second Intervention Period|Adverse Event|0|||
127607884|NCT00975481|459193970|FG003|Second Intervention Period|Adverse Event|0|||
127607885|NCT00975481|459193971|FG004|Second Intervention Period|Adverse Event|0|||
127607886|NCT00975481|459193972|FG005|Second Intervention Period|Adverse Event|0|||
127697765|NCT04318548|459521945|FG002|Overall Study|Migrated / moved from the study area|1|||
127697766|NCT04318548|459521943|FG000|Overall Study|Other|1|||
127697767|NCT04318548|459521944|FG001|Overall Study|Other|2|||
127697768|NCT04318548|459521945|FG002|Overall Study|Other|3|||
127697769|NCT04179500|459521946|FG000|Treatment|Withdrawal by Subject|1|||
127697770|NCT04179500|459521946|FG000|Treatment|Adverse Event|2|||
127607887|NCT00975481|459193967|FG000|Second Intervention Period|Withdrawal by Subject|0|||
127607888|NCT00975481|459193968|FG001|Second Intervention Period|Withdrawal by Subject|0|||
127607889|NCT00975481|459193969|FG002|Second Intervention Period|Withdrawal by Subject|1|||
127607890|NCT00975481|459193970|FG003|Second Intervention Period|Withdrawal by Subject|0|||
127607891|NCT00975481|459193971|FG004|Second Intervention Period|Withdrawal by Subject|0|||
127607892|NCT00975481|459193972|FG005|Second Intervention Period|Withdrawal by Subject|0|||
127607893|NCT00975481|459193967|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
127607894|NCT00975481|459193968|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
127607895|NCT00975481|459193969|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
127607896|NCT00975481|459193970|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
127607897|NCT00975481|459193971|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
127607898|NCT00975481|459193972|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
127607899|NCT00975481|459193967|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
127607900|NCT00975481|459193968|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
127607901|NCT00975481|459193969|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
127607902|NCT00975481|459193970|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
127607903|NCT00975481|459193971|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
127607904|NCT00975481|459193972|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
127607905|NCT00643682|459193973|FG000|Overall Study|did not keep appointment|522|||
127607906|NCT00643682|459193974|FG001|Overall Study|did not keep appointment|509|||
127607907|NCT03755414|459193979|FG000|Overall Study|Did not continue with treatment due to low donor collection|2|||
127607908|NCT03755414|459193980|FG001|Overall Study|Did not continue with treatment due to low donor collection|1|||
127607909|NCT03755414|459193981|FG002|Overall Study|Did not continue with treatment due to low donor collection|0|||
127697771|NCT04179500|459521946|FG000|Treatment|pyrazinamide resistance|1|||
127697772|NCT04241068|459521947|FG000|Core Treatment Period|Adverse Event|91|||
127607910|NCT03755414|459193979|FG000|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
127607911|NCT03755414|459193980|FG001|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
127607912|NCT03755414|459193981|FG002|Overall Study|Recipient did not continue with treatment due to low donor cell collection|2|||
127607913|NCT03755414|459193979|FG000|Overall Study|Non-compliance|0|||
127607914|NCT03755414|459193980|FG001|Overall Study|Non-compliance|1|||
127697773|NCT04241068|459521947|FG000|Core Treatment Period|Change of Treatment|4|||
127697774|NCT04241068|459521947|FG000|Core Treatment Period|Consent Withdrawn|143|||
127607915|NCT03755414|459193981|FG002|Overall Study|Non-compliance|0|||
127607916|NCT00741039|459193988|FG000|Overall Study|Patient non-compliance|2|||
127607917|NCT00741039|459193989|FG001|Overall Study|Patient non-compliance|0|||
127607918|NCT01092182|459193990|FG000|Overall Study|Death|0|||
127607919|NCT01092182|459193991|FG001|Overall Study|Death|5|||
127607920|NCT01092182|459193992|FG002|Overall Study|Death|3|||
127607921|NCT01092182|459193990|FG000|Overall Study|participant safety|1|||
127607922|NCT01092182|459193991|FG001|Overall Study|participant safety|2|||
127607923|NCT01092182|459193992|FG002|Overall Study|participant safety|0|||
127607924|NCT01092182|459193990|FG000|Overall Study|Physician Decision|0|||
127607925|NCT01092182|459193991|FG001|Overall Study|Physician Decision|6|||
127607926|NCT01092182|459193992|FG002|Overall Study|Physician Decision|0|||
127607927|NCT01092182|459193990|FG000|Overall Study|Did not meet criteria|0|||
127607928|NCT01092182|459193991|FG001|Overall Study|Did not meet criteria|0|||
127607929|NCT01092182|459193992|FG002|Overall Study|Did not meet criteria|25|||
127607930|NCT01092182|459193990|FG000|Overall Study|Non-compliance|0|||
127607931|NCT01092182|459193991|FG001|Overall Study|Non-compliance|3|||
127607932|NCT01092182|459193992|FG002|Overall Study|Non-compliance|0|||
127607933|NCT01092182|459193990|FG000|Overall Study|Participant refused follow-up|0|||
127607934|NCT01092182|459193991|FG001|Overall Study|Participant refused follow-up|2|||
127607935|NCT01092182|459193992|FG002|Overall Study|Participant refused follow-up|0|||
127607936|NCT02515045|459193998|FG000|Overall Study|Adverse Event|0|||
127607937|NCT02515045|459193999|FG001|Overall Study|Adverse Event|3|||
127607938|NCT02515045|459194000|FG002|Overall Study|Adverse Event|3|||
127607939|NCT02515045|459193998|FG000|Overall Study|Lost to Follow-up|0|||
127607940|NCT02515045|459193999|FG001|Overall Study|Lost to Follow-up|1|||
127607941|NCT02515045|459194000|FG002|Overall Study|Lost to Follow-up|1|||
127607942|NCT01782664|459194003|FG000|Overall Study|Adverse Event|2|||
127607943|NCT01782664|459194004|FG001|Overall Study|Adverse Event|2|||
127607944|NCT01782664|459194005|FG002|Overall Study|Adverse Event|2|||
127607945|NCT01782664|459194006|FG003|Overall Study|Adverse Event|2|||
127607946|NCT01782664|459194007|FG004|Overall Study|Adverse Event|0|||
127607947|NCT01782664|459194008|FG005|Overall Study|Adverse Event|0|||
127607948|NCT01782664|459194003|FG000|Overall Study|Lack of Efficacy|2|||
127607949|NCT01782664|459194004|FG001|Overall Study|Lack of Efficacy|0|||
127607950|NCT01782664|459194005|FG002|Overall Study|Lack of Efficacy|2|||
127607951|NCT01782664|459194006|FG003|Overall Study|Lack of Efficacy|2|||
127607952|NCT01782664|459194007|FG004|Overall Study|Lack of Efficacy|0|||
127607953|NCT01782664|459194008|FG005|Overall Study|Lack of Efficacy|0|||
127607954|NCT01782664|459194003|FG000|Overall Study|Protocol Violation|0|||
127607955|NCT01782664|459194004|FG001|Overall Study|Protocol Violation|1|||
127607956|NCT01782664|459194005|FG002|Overall Study|Protocol Violation|0|||
127607957|NCT01782664|459194006|FG003|Overall Study|Protocol Violation|1|||
127607958|NCT01782664|459194007|FG004|Overall Study|Protocol Violation|0|||
127607959|NCT01782664|459194008|FG005|Overall Study|Protocol Violation|0|||
127607960|NCT01782664|459194003|FG000|Overall Study|Withdrawal by Subject|2|||
127607961|NCT01782664|459194004|FG001|Overall Study|Withdrawal by Subject|2|||
127607962|NCT01782664|459194005|FG002|Overall Study|Withdrawal by Subject|0|||
127607963|NCT01782664|459194006|FG003|Overall Study|Withdrawal by Subject|0|||
127607964|NCT01782664|459194007|FG004|Overall Study|Withdrawal by Subject|0|||
127607965|NCT01782664|459194008|FG005|Overall Study|Withdrawal by Subject|0|||
127607966|NCT01522365|459194012|FG000|Overall Study|Withdrawal by Subject|1|||
127607967|NCT01522365|459194013|FG001|Overall Study|Withdrawal by Subject|1|||
127607968|NCT01522365|459194012|FG000|Overall Study|Lost to Follow-up|1|||
127607969|NCT01522365|459194013|FG001|Overall Study|Lost to Follow-up|1|||
127607970|NCT00673179|459194014|FG000|Overall Study|Toxicity/Complications|3|||
127607971|NCT00673179|459194015|FG001|Overall Study|Toxicity/Complications|0|||
127607972|NCT00651755|459194016|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
127607973|NCT00651755|459194017|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
127607974|NCT00651755|459194016|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
127607975|NCT00651755|459194017|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
127607976|NCT03642717|459194018|FG000|Overall Study|Lost to Follow-up|2|||
127607977|NCT03642717|459194018|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
127607978|NCT03642717|459194018|FG000|Overall Study|Taken study drug prior to contract date|3|||
127607979|NCT01848756|459194019|FG000|Overall Study|Adverse Event|1|||
127607980|NCT01848756|459194019|FG000|Overall Study|Withdrawal by Subject|1|||
127607981|NCT01848756|459194019|FG000|Overall Study|Enrolled in Error|1|||
127607982|NCT02075658|459194020|FG000|Overall Study|Physician Decision|2|||
127607983|NCT02075658|459194021|FG001|Overall Study|Physician Decision|2|||
127607984|NCT02865915|459194022|FG000|Overall Study|Pregnancy|1|||
127607985|NCT02865915|459194023|FG001|Overall Study|Pregnancy|0|||
127607986|NCT02865915|459194022|FG000|Overall Study|Withdrawal by Subject|1|||
127607987|NCT02865915|459194023|FG001|Overall Study|Withdrawal by Subject|1|||
127607988|NCT02865915|459194022|FG000|Overall Study|Adverse Event|0|||
127607989|NCT02865915|459194023|FG001|Overall Study|Adverse Event|4|||
127697775|NCT04241068|459521947|FG000|Core Treatment Period|Death|26|||
127607990|NCT02865915|459194022|FG000|Overall Study|Lost to Follow-up|0|||
127697776|NCT04241068|459521947|FG000|Core Treatment Period|Disease Progression|67|||
127607991|NCT02865915|459194023|FG001|Overall Study|Lost to Follow-up|1|||
127788842|NCT00473343|459851304|FG000|Overall Study|Withdrew consent|3|||
127607992|NCT02865915|459194022|FG000|Overall Study|Protocol Violation|0|||
127607993|NCT02865915|459194023|FG001|Overall Study|Protocol Violation|1|||
127607994|NCT02865915|459194022|FG000|Overall Study|Study terminated by sponsor|23|||
127607995|NCT02865915|459194023|FG001|Overall Study|Study terminated by sponsor|18|||
127607996|NCT02865915|459194022|FG000|Overall Study|Dosing group discontinued|0|||
127607997|NCT02865915|459194023|FG001|Overall Study|Dosing group discontinued|5|||
127607998|NCT00663052|459194024|FG000|Overall Study|Adverse Event|6|||
127607999|NCT00663052|459194025|FG001|Overall Study|Adverse Event|3|||
127608000|NCT00663052|459194024|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
127788843|NCT00473343|459851304|FG000|Overall Study|Other un-specified reason|3|||
127608001|NCT00663052|459194025|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
127608002|NCT00663052|459194024|FG000|Overall Study|Protocol Violation|1|||
127608003|NCT00663052|459194025|FG001|Overall Study|Protocol Violation|0|||
127608004|NCT00663052|459194024|FG000|Overall Study|Withdrawal by Subject|2|||
127608005|NCT00663052|459194025|FG001|Overall Study|Withdrawal by Subject|5|||
127608006|NCT00663052|459194024|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
127608007|NCT00663052|459194025|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
127608008|NCT00663052|459194024|FG000|Overall Study|Other|0|||
127608009|NCT00663052|459194025|FG001|Overall Study|Other|1|||
127608010|NCT05760300|459194026|FG000|Overall Study|Adverse Event|0|||
127608011|NCT05760300|459194027|FG001|Overall Study|Adverse Event|0|||
127608012|NCT05760300|459194028|FG002|Overall Study|Adverse Event|1|||
127608013|NCT05760300|459194029|FG003|Overall Study|Adverse Event|0|||
127608014|NCT05760300|459194026|FG000|Overall Study|Participant Decision|1|||
127608015|NCT05760300|459194027|FG001|Overall Study|Participant Decision|0|||
127608016|NCT05760300|459194028|FG002|Overall Study|Participant Decision|0|||
127608017|NCT05760300|459194029|FG003|Overall Study|Participant Decision|0|||
127608018|NCT04350788|459194043|FG000|Overall Study|Lost to Follow-up|6|||
127608019|NCT04350788|459194044|FG001|Overall Study|Lost to Follow-up|2|||
127608020|NCT04350788|459194043|FG000|Overall Study|Withdrawal by Subject|2|||
127608021|NCT04350788|459194044|FG001|Overall Study|Withdrawal by Subject|4|||
127608022|NCT04350788|459194043|FG000|Overall Study|Protocol Violation|4|||
127608023|NCT04350788|459194044|FG001|Overall Study|Protocol Violation|0|||
127608024|NCT01894581|459194045|FG000|Overall Study|Withdrawal by Subject|2|||
127608025|NCT01894581|459194046|FG001|Overall Study|Withdrawal by Subject|3|||
127608026|NCT01894581|459194045|FG000|Overall Study|Screen Failure|3|||
127608027|NCT01894581|459194046|FG001|Overall Study|Screen Failure|4|||
127608028|NCT03313804|459194047|FG000|Treatment|Death|5|||
127608029|NCT03313804|459194047|FG000|Treatment|still on treatment|2|||
127608030|NCT03313804|459194047|FG000|Follow Up|still on follow up|3|||
127608031|NCT01252940|459194048|FG000|Main Study Phase|Randomized but not treated|4|||
127608032|NCT01252940|459194049|FG001|Main Study Phase|Randomized but not treated|2|||
127608033|NCT01252940|459194048|FG000|Main Study Phase|Adverse Event|3|||
127608034|NCT01252940|459194049|FG001|Main Study Phase|Adverse Event|1|||
127608035|NCT01252940|459194048|FG000|Main Study Phase|Lack of Efficacy|1|||
127608036|NCT01252940|459194049|FG001|Main Study Phase|Lack of Efficacy|0|||
127608037|NCT01252940|459194048|FG000|Main Study Phase|Lost to Follow-up|6|||
127608038|NCT01252940|459194049|FG001|Main Study Phase|Lost to Follow-up|1|||
127608039|NCT01252940|459194048|FG000|Main Study Phase|Physician Decision|1|||
127788844|NCT04247061|459851305|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
127788845|NCT04247061|459851305|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
127788846|NCT04247061|459851305|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
127788847|NCT02370615|459851310|FG000|Overall Study|Adverse Event|1|||
127788848|NCT02370615|459851311|FG001|Overall Study|Adverse Event|0|||
127788849|NCT01136655|459851315|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
127788850|NCT01136655|459851315|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
127788851|NCT01136655|459851315|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
127788852|NCT01136655|459851315|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
127608040|NCT01252940|459194049|FG001|Main Study Phase|Physician Decision|0|||
127608041|NCT01252940|459194048|FG000|Main Study Phase|Protocol Violation|4|||
127608042|NCT01252940|459194049|FG001|Main Study Phase|Protocol Violation|2|||
127608043|NCT01252940|459194048|FG000|Main Study Phase|Withdrawal by Subject|6|||
127608044|NCT01252940|459194049|FG001|Main Study Phase|Withdrawal by Subject|5|||
127608045|NCT01252940|459194048|FG000|Main Study Phase|Subject Non-compliance|1|||
127608046|NCT01252940|459194049|FG001|Main Study Phase|Subject Non-compliance|1|||
127788853|NCT02287623|459851316|FG000|Overall Study|Protocol Violation|0|||
127788854|NCT02287623|459851317|FG001|Overall Study|Protocol Violation|1|||
127788855|NCT02700997|459851318|FG000|Overall Study|Did not undergo CT imaging|1|||
127788856|NCT02700997|459851318|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
127788857|NCT01585272|459851319|FG000|Overall Study|Adverse Event|22|||
127788858|NCT01585272|459851319|FG000|Overall Study|Protocol Violation|7|||
127788859|NCT01585272|459851319|FG000|Overall Study|Withdrawal by Subject|10|||
127882922|NCT00996918|460194619|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
127882923|NCT00996918|460194620|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
127608047|NCT01252940|459194048|FG000|Extension Phase|Adverse Event|2|||
127608048|NCT01252940|459194049|FG001|Extension Phase|Adverse Event|1|||
127608049|NCT01252940|459194048|FG000|Extension Phase|Lack of Efficacy|1|||
127608050|NCT01252940|459194049|FG001|Extension Phase|Lack of Efficacy|0|||
127608051|NCT01252940|459194048|FG000|Extension Phase|Lost to Follow-up|5|||
127608052|NCT01252940|459194049|FG001|Extension Phase|Lost to Follow-up|0|||
127608053|NCT01252940|459194048|FG000|Extension Phase|Physician Decision|0|||
127608054|NCT01252940|459194049|FG001|Extension Phase|Physician Decision|1|||
127608055|NCT01252940|459194048|FG000|Extension Phase|Subject Non-compliance|1|||
127608056|NCT01252940|459194049|FG001|Extension Phase|Subject Non-compliance|0|||
127608057|NCT01252940|459194048|FG000|Extension Phase|Withdrawal by Subject|1|||
127608058|NCT01252940|459194049|FG001|Extension Phase|Withdrawal by Subject|1|||
127608059|NCT04690751|459194050|FG000|Overall Study|Protocol Violation|0|||
127608060|NCT04690751|459194051|FG001|Overall Study|Protocol Violation|1|||
127608061|NCT04690751|459194052|FG002|Overall Study|Protocol Violation|0|||
127608062|NCT04690751|459194053|FG003|Overall Study|Protocol Violation|1|||
127608063|NCT04690751|459194054|FG004|Overall Study|Protocol Violation|2|||
127608064|NCT04690751|459194055|FG005|Overall Study|Protocol Violation|0|||
127608065|NCT04690751|459194050|FG000|Overall Study|Adverse Event|0|||
127608066|NCT04690751|459194051|FG001|Overall Study|Adverse Event|0|||
127608067|NCT04690751|459194052|FG002|Overall Study|Adverse Event|1|||
127608068|NCT04690751|459194053|FG003|Overall Study|Adverse Event|0|||
127608069|NCT04690751|459194054|FG004|Overall Study|Adverse Event|0|||
127608070|NCT04690751|459194055|FG005|Overall Study|Adverse Event|0|||
127608071|NCT04690751|459194050|FG000|Overall Study|Positive urine drug screen test|0|||
127608072|NCT04690751|459194051|FG001|Overall Study|Positive urine drug screen test|0|||
127608073|NCT04690751|459194052|FG002|Overall Study|Positive urine drug screen test|0|||
127608074|NCT04690751|459194053|FG003|Overall Study|Positive urine drug screen test|0|||
127608075|NCT04690751|459194054|FG004|Overall Study|Positive urine drug screen test|1|||
127608076|NCT04690751|459194055|FG005|Overall Study|Positive urine drug screen test|0|||
127608077|NCT04364620|459194056|FG000|Overall Study|Disease Progression|20|||
127608078|NCT04364620|459194056|FG000|Overall Study|Adverse Event|5|||
127608079|NCT04364620|459194056|FG000|Overall Study|Physician Decision|4|||
127608080|NCT04364620|459194056|FG000|Overall Study|Death|3|||
127608081|NCT04364620|459194056|FG000|Overall Study|Other|2|||
127608082|NCT04364620|459194056|FG000|Overall Study|Withdrawal by Subject|1|||
127608083|NCT03971695|459195357|FG000|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
127608084|NCT03971695|459195358|FG001|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
127608085|NCT03971695|459195359|FG002|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
127608086|NCT03971695|459195360|FG003|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
127608087|NCT03971695|459195361|FG004|End of Part I and Part II - Washout|Did not participate in part II of study|9|||
127608088|NCT03971695|459195362|FG005|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
127608089|NCT03971695|459195363|FG006|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
127608090|NCT03971695|459195364|FG007|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
127608091|NCT03971695|459195365|FG008|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
127608092|NCT03971695|459195366|FG009|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
127608093|NCT03971695|459195367|FG010|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
127608094|NCT03971695|459195368|FG011|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
127608095|NCT03971695|459195369|FG012|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
127608096|NCT02155738|459195377|FG000|Overall Study|Missing critical information|1|||
127608097|NCT02155738|459195378|FG001|Overall Study|Missing critical information|0|||
127608098|NCT02155738|459195379|FG002|Overall Study|Missing critical information|0|||
127608099|NCT02155738|459195380|FG003|Overall Study|Missing critical information|1|||
127608100|NCT02603809|459195381|FG000|Overall Study|Withdrawal by Subject|4|||
127608101|NCT02603809|459195382|FG001|Overall Study|Withdrawal by Subject|1|||
127608102|NCT02603809|459195383|FG002|Overall Study|Withdrawal by Subject|2|||
127608103|NCT02603809|459195384|FG003|Overall Study|Withdrawal by Subject|3|||
127608104|NCT02603809|459195385|FG004|Overall Study|Withdrawal by Subject|3|||
127608105|NCT02603809|459195386|FG005|Overall Study|Withdrawal by Subject|4|||
127608106|NCT02603809|459195381|FG000|Overall Study|Lost to Follow-up|2|||
127608107|NCT02603809|459195382|FG001|Overall Study|Lost to Follow-up|3|||
127697777|NCT04241068|459521947|FG000|Core Treatment Period|Investigator Decision|40|||
127608108|NCT02603809|459195383|FG002|Overall Study|Lost to Follow-up|1|||
127608109|NCT02603809|459195384|FG003|Overall Study|Lost to Follow-up|4|||
127697778|NCT04241068|459521947|FG000|Core Treatment Period|Loss of Capacity|9|||
127697779|NCT04241068|459521947|FG000|Core Treatment Period|Lost to Follow-up|11|||
127697780|NCT04241068|459521947|FG000|Core Treatment Period|Relocation|4|||
127697781|NCT04241068|459521947|FG000|Core Treatment Period|Study Terminated by Sponsor|1|||
127697782|NCT04241068|459521947|FG000|Core Treatment Period|Study Visit Burden|40|||
127697783|NCT04241068|459521947|FG000|Core Treatment Period|Withdrawal by Guardian/caretaker|99|||
127697784|NCT04241068|459521947|FG000|Core Treatment Period|Missing|2|||
127697785|NCT04241068|459521947|FG000|Core Treatment Period|Reason Not Specified|41|||
127697786|NCT04241068|459521947|FG000|LTE Period|Adverse Event|19|||
127697787|NCT04241068|459521947|FG000|LTE Period|Change of Treatment|1|||
127697788|NCT04241068|459521947|FG000|LTE Period|Consent Withdrawn|71|||
127697789|NCT04241068|459521947|FG000|LTE Period|Death|8|||
127697790|NCT04241068|459521947|FG000|LTE Period|Disease Progression|11|||
127697791|NCT04241068|459521947|FG000|LTE Period|Investigator Decision|12|||
127697792|NCT04241068|459521947|FG000|LTE Period|Loss of Capacity|2|||
127697793|NCT04241068|459521947|FG000|LTE Period|Lost to Follow-up|7|||
127697794|NCT04241068|459521947|FG000|LTE Period|Relocation|6|||
127697795|NCT04241068|459521947|FG000|LTE Period|Site Terminated by Sponsor|26|||
127697796|NCT04241068|459521947|FG000|LTE Period|Study Terminated by Sponsor|276|||
127697797|NCT04241068|459521947|FG000|LTE Period|Study Visit Burden|10|||
127697798|NCT04241068|459521947|FG000|LTE Period|Withdrawal by Guardian/caretaker|19|||
127697799|NCT04241068|459521947|FG000|LTE Period|Reason Not Specified|65|||
127697800|NCT04492007|459521948|FG000|Overall Study|Lost to Follow-up|1|||
127697801|NCT04492007|459521949|FG001|Overall Study|Lost to Follow-up|1|||
127697802|NCT04492007|459521950|FG002|Overall Study|Lost to Follow-up|2|||
127697803|NCT04492007|459521951|FG003|Overall Study|Lost to Follow-up|2|||
127697804|NCT04492007|459521948|FG000|Overall Study|Protocol Violation|1|||
127697805|NCT04492007|459521949|FG001|Overall Study|Protocol Violation|1|||
127697806|NCT04492007|459521950|FG002|Overall Study|Protocol Violation|1|||
127697807|NCT04492007|459521951|FG003|Overall Study|Protocol Violation|1|||
127697808|NCT04492007|459521948|FG000|Overall Study|Withdrawal by Subject|0|||
127697809|NCT04492007|459521949|FG001|Overall Study|Withdrawal by Subject|0|||
127697810|NCT04492007|459521950|FG002|Overall Study|Withdrawal by Subject|1|||
127697811|NCT04492007|459521951|FG003|Overall Study|Withdrawal by Subject|1|||
127697812|NCT04177823|459521954|FG000|Overall Study|Physician Decision|1|||
127697813|NCT04177823|459521954|FG000|Overall Study|Withdrawal by Subject|1|||
127697814|NCT05178316|459521955|FG000|Overall Study|Adverse Event|5|||
127697815|NCT05178316|459521956|FG001|Overall Study|Adverse Event|4|||
127697816|NCT05178316|459521957|FG002|Overall Study|Adverse Event|9|||
127697817|NCT05178316|459521955|FG000|Overall Study|Enrolled in Error|1|||
127697818|NCT05178316|459521956|FG001|Overall Study|Enrolled in Error|2|||
127697819|NCT05178316|459521957|FG002|Overall Study|Enrolled in Error|1|||
127697820|NCT05178316|459521955|FG000|Overall Study|Lost to Follow-up|3|||
127697821|NCT05178316|459521956|FG001|Overall Study|Lost to Follow-up|15|||
127697822|NCT05178316|459521957|FG002|Overall Study|Lost to Follow-up|11|||
127697823|NCT05178316|459521955|FG000|Overall Study|Noncompliance|1|||
127697824|NCT05178316|459521956|FG001|Overall Study|Noncompliance|3|||
127697825|NCT05178316|459521957|FG002|Overall Study|Noncompliance|1|||
127697826|NCT05178316|459521955|FG000|Overall Study|Other|0|||
127697827|NCT05178316|459521956|FG001|Overall Study|Other|1|||
127697828|NCT05178316|459521957|FG002|Overall Study|Other|0|||
127697829|NCT05178316|459521955|FG000|Overall Study|Physician Decision|0|||
127697830|NCT05178316|459521956|FG001|Overall Study|Physician Decision|3|||
127697831|NCT05178316|459521957|FG002|Overall Study|Physician Decision|2|||
127697832|NCT05178316|459521955|FG000|Overall Study|Protocol deviation|1|||
127697833|NCT05178316|459521956|FG001|Overall Study|Protocol deviation|0|||
127697834|NCT05178316|459521957|FG002|Overall Study|Protocol deviation|1|||
127697835|NCT05178316|459521955|FG000|Overall Study|Sponsor decision|1|||
127697836|NCT05178316|459521956|FG001|Overall Study|Sponsor decision|0|||
127697837|NCT05178316|459521957|FG002|Overall Study|Sponsor decision|1|||
127697838|NCT05178316|459521955|FG000|Overall Study|Withdrawal by Subject|5|||
127697839|NCT05178316|459521956|FG001|Overall Study|Withdrawal by Subject|11|||
127697840|NCT05178316|459521957|FG002|Overall Study|Withdrawal by Subject|5|||
127697841|NCT03457142|459521958|FG000|Overall Study|Death|1|||
127697842|NCT01748448|459521959|FG000|Treatment Period|Consent withdrawn by subject|1|||
127697843|NCT01748448|459521960|FG001|Treatment Period|Consent withdrawn by subject|0|||
127697844|NCT01748448|459521959|FG000|Treatment Period|Adverse Event|1|||
127697845|NCT01748448|459521960|FG001|Treatment Period|Adverse Event|0|||
127697846|NCT01748448|459521959|FG000|Treatment Period|Personal|0|||
127697847|NCT01748448|459521960|FG001|Treatment Period|Personal|1|||
127697848|NCT02907099|459521961|FG000|Overall Study|Adverse Event|1|||
127697849|NCT02907099|459521961|FG000|Overall Study|Withdrawal by Subject|2|||
127697850|NCT02907099|459521961|FG000|Overall Study|Screen Fail|2|||
127697851|NCT04274764|459521962|FG000|Overall Study|Date of scheduled followup visit was after trial stop date|62|||
127697852|NCT04274764|459521963|FG001|Overall Study|Date of scheduled followup visit was after trial stop date|70|||
127697853|NCT02677298|459521964|FG000|Double Blind Phase|Adverse Event|2|||
127697854|NCT02677298|459521965|FG001|Double Blind Phase|Adverse Event|1|||
127697855|NCT02677298|459521966|FG002|Double Blind Phase|Adverse Event|0|||
127697856|NCT02677298|459521964|FG000|Double Blind Phase|Physician Decision|5|||
127697857|NCT02677298|459521965|FG001|Double Blind Phase|Physician Decision|0|||
127697858|NCT02677298|459521966|FG002|Double Blind Phase|Physician Decision|0|||
127697859|NCT02677298|459521964|FG000|Double Blind Phase|Lost to Follow-up|11|||
127697860|NCT02677298|459521965|FG001|Double Blind Phase|Lost to Follow-up|7|||
127697861|NCT02677298|459521966|FG002|Double Blind Phase|Lost to Follow-up|0|||
127697862|NCT02677298|459521964|FG000|Double Blind Phase|Withdrawal by Subject|11|||
127697863|NCT02677298|459521965|FG001|Double Blind Phase|Withdrawal by Subject|8|||
127697864|NCT02677298|459521966|FG002|Double Blind Phase|Withdrawal by Subject|0|||
127697865|NCT02677298|459521964|FG000|Double Blind Phase|No study drug available at site|0|||
127697866|NCT02677298|459521965|FG001|Double Blind Phase|No study drug available at site|1|||
127697867|NCT02677298|459521966|FG002|Double Blind Phase|No study drug available at site|0|||
127697868|NCT02677298|459521964|FG000|Open Label Phase|Adverse Event|0|||
127697869|NCT02677298|459521965|FG001|Open Label Phase|Adverse Event|0|||
127697870|NCT02677298|459521966|FG002|Open Label Phase|Adverse Event|4|||
127697871|NCT02677298|459521964|FG000|Open Label Phase|Physician Decision|0|||
127697872|NCT02677298|459521965|FG001|Open Label Phase|Physician Decision|0|||
127697873|NCT02677298|459521966|FG002|Open Label Phase|Physician Decision|1|||
127697874|NCT02677298|459521964|FG000|Open Label Phase|Lost to Follow-up|0|||
127697875|NCT02677298|459521965|FG001|Open Label Phase|Lost to Follow-up|0|||
127697876|NCT02677298|459521966|FG002|Open Label Phase|Lost to Follow-up|17|||
127697877|NCT02677298|459521964|FG000|Open Label Phase|Withdrawal by Subject|0|||
127608110|NCT02603809|459195385|FG004|Overall Study|Lost to Follow-up|2|||
127608111|NCT02603809|459195386|FG005|Overall Study|Lost to Follow-up|2|||
127608112|NCT02603809|459195381|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
127608113|NCT02603809|459195382|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
127608114|NCT02603809|459195383|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
127608115|NCT02603809|459195384|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
127608116|NCT02603809|459195385|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
127608117|NCT02603809|459195386|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
127608118|NCT02603809|459195381|FG000|Overall Study|Physician Decision|0|||
127608119|NCT02603809|459195382|FG001|Overall Study|Physician Decision|0|||
127608120|NCT02603809|459195383|FG002|Overall Study|Physician Decision|0|||
127608121|NCT02603809|459195384|FG003|Overall Study|Physician Decision|1|||
127608122|NCT02603809|459195385|FG004|Overall Study|Physician Decision|2|||
127608123|NCT02603809|459195386|FG005|Overall Study|Physician Decision|1|||
127608124|NCT02603809|459195381|FG000|Overall Study|Adverse Event|3|||
127608125|NCT02603809|459195382|FG001|Overall Study|Adverse Event|0|||
127608126|NCT02603809|459195383|FG002|Overall Study|Adverse Event|2|||
127608127|NCT02603809|459195384|FG003|Overall Study|Adverse Event|2|||
127608128|NCT02603809|459195385|FG004|Overall Study|Adverse Event|1|||
127608129|NCT02603809|459195386|FG005|Overall Study|Adverse Event|1|||
127608130|NCT02603809|459195381|FG000|Overall Study|Lack of Efficacy|0|||
127608131|NCT02603809|459195382|FG001|Overall Study|Lack of Efficacy|1|||
127608132|NCT02603809|459195383|FG002|Overall Study|Lack of Efficacy|0|||
127608133|NCT02603809|459195384|FG003|Overall Study|Lack of Efficacy|0|||
127608134|NCT02603809|459195385|FG004|Overall Study|Lack of Efficacy|0|||
127608135|NCT02603809|459195386|FG005|Overall Study|Lack of Efficacy|1|||
127608136|NCT01652664|459195395|FG000|Overall Study|Treatment Failure|5|||
127608137|NCT01652664|459195396|FG001|Overall Study|Treatment Failure|1|||
127608138|NCT01652664|459195395|FG000|Overall Study|Inadequate IOP control|1|||
127608139|NCT01652664|459195396|FG001|Overall Study|Inadequate IOP control|0|||
127608140|NCT02672423|459195400|FG000|Period 1|Adverse Event|0|||
127608141|NCT02672423|459195401|FG001|Period 1|Adverse Event|0|||
127608142|NCT02672423|459195402|FG002|Period 1|Adverse Event|0|||
127608143|NCT02672423|459195403|FG003|Period 1|Adverse Event|0|||
127608144|NCT02672423|459195404|FG004|Period 1|Adverse Event|1|||
127608145|NCT02672423|459195405|FG005|Period 1|Adverse Event|0|||
127697878|NCT02677298|459521965|FG001|Open Label Phase|Withdrawal by Subject|0|||
127697879|NCT02677298|459521966|FG002|Open Label Phase|Withdrawal by Subject|38|||
127697880|NCT03611621|459521967|FG000|Overall Study|Graft loss|3|||
127697881|NCT03611621|459521967|FG000|Overall Study|Death|3|||
127697882|NCT03611621|459521967|FG000|Overall Study|Lost to Follow-up|1|||
127697883|NCT03232138|459521970|FG000|Overall Study|Physician Decision|1|||
127697884|NCT03232138|459521971|FG001|Overall Study|Physician Decision|0|||
127608146|NCT02672423|459195406|FG006|Period 1|Adverse Event|0|||
127608147|NCT02672423|459195407|FG007|Period 1|Adverse Event|0|||
127608148|NCT02672423|459195408|FG008|Period 1|Adverse Event|0|||
127608149|NCT02672423|459195409|FG009|Period 1|Adverse Event|0|||
127608150|NCT02672423|459195400|FG000|Period 2|Withdrawal by Subject|0|||
127608151|NCT02672423|459195401|FG001|Period 2|Withdrawal by Subject|0|||
127608152|NCT02672423|459195402|FG002|Period 2|Withdrawal by Subject|1|||
127608153|NCT02672423|459195403|FG003|Period 2|Withdrawal by Subject|0|||
127608154|NCT02672423|459195404|FG004|Period 2|Withdrawal by Subject|0|||
127608155|NCT02672423|459195405|FG005|Period 2|Withdrawal by Subject|0|||
127697885|NCT03232138|459521970|FG000|Overall Study|Adverse Event|2|||
127697886|NCT03232138|459521971|FG001|Overall Study|Adverse Event|0|||
127882924|NCT00996918|460194616|FG000|Overall Study|Loss of Caregiver|0|||
127608156|NCT02672423|459195406|FG006|Period 2|Withdrawal by Subject|0|||
127608157|NCT02672423|459195407|FG007|Period 2|Withdrawal by Subject|0|||
127608158|NCT02672423|459195408|FG008|Period 2|Withdrawal by Subject|0|||
127608159|NCT02672423|459195409|FG009|Period 2|Withdrawal by Subject|0|||
127608160|NCT02672423|459195400|FG000|Period 3|Withdrawal by Subject|0|||
127608161|NCT02672423|459195401|FG001|Period 3|Withdrawal by Subject|0|||
127608162|NCT02672423|459195402|FG002|Period 3|Withdrawal by Subject|0|||
127608163|NCT02672423|459195403|FG003|Period 3|Withdrawal by Subject|0|||
127608164|NCT02672423|459195404|FG004|Period 3|Withdrawal by Subject|0|||
127608165|NCT02672423|459195405|FG005|Period 3|Withdrawal by Subject|0|||
127608166|NCT02672423|459195406|FG006|Period 3|Withdrawal by Subject|0|||
127608167|NCT02672423|459195407|FG007|Period 3|Withdrawal by Subject|1|||
127608168|NCT02672423|459195408|FG008|Period 3|Withdrawal by Subject|0|||
127608169|NCT02672423|459195409|FG009|Period 3|Withdrawal by Subject|0|||
127608170|NCT02672423|459195400|FG000|Period 3|Physician Decision|0|||
127608171|NCT02672423|459195401|FG001|Period 3|Physician Decision|0|||
127608172|NCT02672423|459195402|FG002|Period 3|Physician Decision|0|||
127608173|NCT02672423|459195403|FG003|Period 3|Physician Decision|0|||
127608174|NCT02672423|459195404|FG004|Period 3|Physician Decision|0|||
127608175|NCT02672423|459195405|FG005|Period 3|Physician Decision|1|||
127608176|NCT02672423|459195406|FG006|Period 3|Physician Decision|0|||
127608177|NCT02672423|459195407|FG007|Period 3|Physician Decision|0|||
127608178|NCT02672423|459195408|FG008|Period 3|Physician Decision|0|||
127608179|NCT02672423|459195409|FG009|Period 3|Physician Decision|0|||
127608180|NCT02410954|459195413|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
127608181|NCT02410954|459195414|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
127608182|NCT02410954|459195413|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
127608183|NCT02410954|459195414|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
127608184|NCT00751348|459195415|FG000|Overall Study|Withdrawal by Subject|5|||
127608185|NCT00751348|459195416|FG001|Overall Study|Withdrawal by Subject|2|||
127608186|NCT00751348|459195415|FG000|Overall Study|Migration from study area|1|||
127608187|NCT00751348|459195416|FG001|Overall Study|Migration from study area|0|||
127608188|NCT04829318|459195417|FG000|Overall Study|Adverse Event|6|||
127608189|NCT04829318|459195417|FG000|Overall Study|Death|1|||
127608190|NCT04829318|459195417|FG000|Overall Study|Lost to Follow-up|1|||
127608191|NCT04829318|459195417|FG000|Overall Study|Physician Decision|1|||
127608192|NCT04829318|459195417|FG000|Overall Study|Withdrawal by Subject|19|||
127608193|NCT04829318|459195417|FG000|Overall Study|Site terminated by sponsor|1|||
127608194|NCT04829318|459195417|FG000|Overall Study|Sponsor decision|5|||
127608195|NCT04829318|459195417|FG000|Overall Study|Other|1|||
127608196|NCT01265849|459195420|FG000|Overall Study|Randomized//Treatment not initiated|1|||
127608197|NCT01265849|459195421|FG001|Overall Study|Randomized//Treatment not initiated|4|||
127608198|NCT01265849|459195422|FG002|Overall Study|Randomized//Treatment not initiated|0|||
127608199|NCT01265849|459195420|FG000|Overall Study|Physician Decision|1|||
127608200|NCT01265849|459195421|FG001|Overall Study|Physician Decision|2|||
127608201|NCT01265849|459195422|FG002|Overall Study|Physician Decision|0|||
127608202|NCT01265849|459195420|FG000|Overall Study|Lost to Follow-up|18|||
127608203|NCT01265849|459195421|FG001|Overall Study|Lost to Follow-up|15|||
127608204|NCT01265849|459195422|FG002|Overall Study|Lost to Follow-up|5|||
127608205|NCT01265849|459195420|FG000|Overall Study|Not otherwise specified|1|||
127788860|NCT00645593|459851320|FG000|Overall Study|Later found to be ineligible|1|||
127788861|NCT00645593|459851321|FG001|Overall Study|Later found to be ineligible|0|||
127608206|NCT01265849|459195421|FG001|Overall Study|Not otherwise specified|6|||
127608207|NCT01265849|459195422|FG002|Overall Study|Not otherwise specified|1|||
127608208|NCT01265849|459195420|FG000|Overall Study|Withdrawal by Subject|25|||
127608209|NCT01265849|459195421|FG001|Overall Study|Withdrawal by Subject|34|||
127608210|NCT01265849|459195422|FG002|Overall Study|Withdrawal by Subject|13|||
127608211|NCT00271609|459195424|FG000|Overall Study|Adverse Event|11|||
127608212|NCT00271609|459195425|FG001|Overall Study|Adverse Event|3|||
127608213|NCT00271609|459195424|FG000|Overall Study|Withdrawal by Subject|2|||
127608214|NCT00271609|459195425|FG001|Overall Study|Withdrawal by Subject|0|||
127608215|NCT02188589|459195426|FG000|Overall Study|Withdrawal by Subject|5|||
127608216|NCT00003641|459195427|FG000|Overall Study|Withdrawal by Subject|0|||
127608217|NCT00003641|459195428|FG001|Overall Study|Withdrawal by Subject|100|||
127608218|NCT00003641|459195427|FG000|Overall Study|Adverse Event|0|||
127608219|NCT00003641|459195428|FG001|Overall Study|Adverse Event|38|||
127608220|NCT00003641|459195427|FG000|Overall Study|Disease progression|0|||
127697887|NCT03232138|459521970|FG000|Overall Study|Withdrawal by Subject|1|||
127697888|NCT03232138|459521971|FG001|Overall Study|Withdrawal by Subject|2|||
127697889|NCT04142788|459521972|FG000|Overall Study|Trial terminated prematurely|2|||
127697890|NCT04142788|459521973|FG001|Overall Study|Trial terminated prematurely|2|||
127697891|NCT03853746|459521976|FG000|Overall Study|Withdrawal by Subject|1|||
127697892|NCT00999804|459521977|FG000|Overall Study|Lack of Efficacy|9|||
127697893|NCT00999804|459521978|FG001|Overall Study|Lack of Efficacy|2|||
127697894|NCT00999804|459521977|FG000|Overall Study|Adverse Event|4|||
127697895|NCT00999804|459521978|FG001|Overall Study|Adverse Event|3|||
127697896|NCT00999804|459521977|FG000|Overall Study|Withdrawal by Subject|4|||
127697897|NCT00999804|459521978|FG001|Overall Study|Withdrawal by Subject|0|||
127697898|NCT00999804|459521977|FG000|Overall Study|Death|1|||
127697899|NCT00999804|459521978|FG001|Overall Study|Death|0|||
127697900|NCT00999804|459521977|FG000|Overall Study|Ineligible|3|||
127697901|NCT00999804|459521978|FG001|Overall Study|Ineligible|0|||
127697902|NCT03150810|459521995|FG000|Overall Study|Death|4|||
127697903|NCT03150810|459521996|FG001|Overall Study|Death|8|||
127697904|NCT03150810|459521997|FG002|Overall Study|Death|7|||
127697905|NCT03150810|459521998|FG003|Overall Study|Death|2|||
127697906|NCT03150810|459521999|FG004|Overall Study|Death|2|||
127697907|NCT03150810|459522000|FG005|Overall Study|Death|10|||
127697908|NCT03150810|459522001|FG006|Overall Study|Death|8|||
127697909|NCT03150810|459522002|FG007|Overall Study|Death|6|||
127697910|NCT03150810|459522003|FG008|Overall Study|Death|18|||
127697911|NCT03150810|459522004|FG009|Overall Study|Death|3|||
127697912|NCT03150810|459522005|FG010|Overall Study|Death|19|||
127697913|NCT03150810|459522006|FG011|Overall Study|Death|1|||
127697914|NCT03150810|459522007|FG012|Overall Study|Death|19|||
127697915|NCT03150810|459521995|FG000|Overall Study|Withdrawal by Subject|0|||
127697916|NCT03150810|459521996|FG001|Overall Study|Withdrawal by Subject|1|||
127697917|NCT03150810|459521997|FG002|Overall Study|Withdrawal by Subject|1|||
127697918|NCT03150810|459521998|FG003|Overall Study|Withdrawal by Subject|1|||
127697919|NCT03150810|459521999|FG004|Overall Study|Withdrawal by Subject|0|||
127697920|NCT03150810|459522000|FG005|Overall Study|Withdrawal by Subject|0|||
127697921|NCT03150810|459522001|FG006|Overall Study|Withdrawal by Subject|2|||
127697922|NCT03150810|459522002|FG007|Overall Study|Withdrawal by Subject|0|||
127697923|NCT03150810|459522003|FG008|Overall Study|Withdrawal by Subject|2|||
127697924|NCT03150810|459522004|FG009|Overall Study|Withdrawal by Subject|0|||
127697925|NCT03150810|459522005|FG010|Overall Study|Withdrawal by Subject|1|||
127697926|NCT03150810|459522006|FG011|Overall Study|Withdrawal by Subject|0|||
127697927|NCT03150810|459522007|FG012|Overall Study|Withdrawal by Subject|1|||
127697928|NCT03150810|459521995|FG000|Overall Study|Sponsor Decision|0|||
127697929|NCT03150810|459521996|FG001|Overall Study|Sponsor Decision|2|||
127697930|NCT03150810|459521997|FG002|Overall Study|Sponsor Decision|0|||
127697931|NCT03150810|459521998|FG003|Overall Study|Sponsor Decision|0|||
127697932|NCT03150810|459521999|FG004|Overall Study|Sponsor Decision|1|||
127697933|NCT03150810|459522000|FG005|Overall Study|Sponsor Decision|1|||
127697934|NCT03150810|459522001|FG006|Overall Study|Sponsor Decision|0|||
127697935|NCT03150810|459522002|FG007|Overall Study|Sponsor Decision|0|||
127697936|NCT03150810|459522003|FG008|Overall Study|Sponsor Decision|1|||
127697937|NCT03150810|459522004|FG009|Overall Study|Sponsor Decision|0|||
127697938|NCT03150810|459522005|FG010|Overall Study|Sponsor Decision|0|||
127697939|NCT03150810|459522006|FG011|Overall Study|Sponsor Decision|0|||
127697940|NCT03150810|459522007|FG012|Overall Study|Sponsor Decision|5|||
127697941|NCT03150810|459521995|FG000|Overall Study|Lost to Follow-up|0|||
127697942|NCT03150810|459521996|FG001|Overall Study|Lost to Follow-up|1|||
127697943|NCT03150810|459521997|FG002|Overall Study|Lost to Follow-up|1|||
127697944|NCT03150810|459521998|FG003|Overall Study|Lost to Follow-up|0|||
127697945|NCT03150810|459521999|FG004|Overall Study|Lost to Follow-up|0|||
127697946|NCT03150810|459522000|FG005|Overall Study|Lost to Follow-up|0|||
127697947|NCT03150810|459522001|FG006|Overall Study|Lost to Follow-up|1|||
127697948|NCT03150810|459522002|FG007|Overall Study|Lost to Follow-up|0|||
127697949|NCT03150810|459522003|FG008|Overall Study|Lost to Follow-up|0|||
127697950|NCT03150810|459522004|FG009|Overall Study|Lost to Follow-up|0|||
127697951|NCT03150810|459522005|FG010|Overall Study|Lost to Follow-up|1|||
127697952|NCT03150810|459522006|FG011|Overall Study|Lost to Follow-up|0|||
127697953|NCT03150810|459522007|FG012|Overall Study|Lost to Follow-up|0|||
127697954|NCT03150810|459521995|FG000|Overall Study|Physician Decision|0|||
127697955|NCT03150810|459521996|FG001|Overall Study|Physician Decision|0|||
127697956|NCT03150810|459521997|FG002|Overall Study|Physician Decision|0|||
127697957|NCT03150810|459521998|FG003|Overall Study|Physician Decision|0|||
127697958|NCT03150810|459521999|FG004|Overall Study|Physician Decision|0|||
127697959|NCT03150810|459522000|FG005|Overall Study|Physician Decision|1|||
127697960|NCT03150810|459522001|FG006|Overall Study|Physician Decision|1|||
127697961|NCT03150810|459522002|FG007|Overall Study|Physician Decision|0|||
127697962|NCT03150810|459522003|FG008|Overall Study|Physician Decision|0|||
127608221|NCT00003641|459195428|FG001|Overall Study|Disease progression|2|||
127608222|NCT00003641|459195427|FG000|Overall Study|Unknown/missing|0|||
127608223|NCT00003641|459195428|FG001|Overall Study|Unknown/missing|22|||
127608224|NCT00003641|459195427|FG000|Overall Study|Should not receive interferon therapy|2|||
127608225|NCT00003641|459195428|FG001|Overall Study|Should not receive interferon therapy|0|||
127608226|NCT00003641|459195427|FG000|Overall Study|Never started interferon|567|||
127608227|NCT00003641|459195428|FG001|Overall Study|Never started interferon|12|||
127608228|NCT02154581|459195430|FG000|Overall Study|Lost to Follow-up|7|||
127608229|NCT02154581|459195431|FG001|Overall Study|Lost to Follow-up|8|||
127608230|NCT03659916|459195432|FG000|Treatment Period (72 Weeks)|Adverse Event|2|||
127608231|NCT03659916|459195433|FG001|Treatment Period (72 Weeks)|Adverse Event|1|||
127608232|NCT03659916|459195434|FG002|Treatment Period (72 Weeks)|Adverse Event|6|||
127608233|NCT03659916|459195432|FG000|Treatment Period (72 Weeks)|Withdrawal by Subject|1|||
127608234|NCT03659916|459195433|FG001|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
127608235|NCT03659916|459195434|FG002|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
127608236|NCT03659916|459195432|FG000|Treatment Period (72 Weeks)|Physician Decision|0|||
127608237|NCT03659916|459195433|FG001|Treatment Period (72 Weeks)|Physician Decision|1|||
127608238|NCT03659916|459195434|FG002|Treatment Period (72 Weeks)|Physician Decision|0|||
127608239|NCT03659916|459195432|FG000|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
127608240|NCT03659916|459195433|FG001|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
127608241|NCT03659916|459195434|FG002|Treatment Period (72 Weeks)|Lost to Follow-up|1|||
127608242|NCT03659916|459195432|FG000|Treatment Period (72 Weeks)|Other|1|||
127608243|NCT03659916|459195433|FG001|Treatment Period (72 Weeks)|Other|3|||
127608244|NCT03659916|459195434|FG002|Treatment Period (72 Weeks)|Other|9|||
127608245|NCT03659916|459195432|FG000|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
127608246|NCT03659916|459195433|FG001|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
127608247|NCT03659916|459195434|FG002|Optional Extension Treatment (176 Weeks)|Adverse Event|1|||
127608248|NCT03659916|459195432|FG000|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
127608249|NCT03659916|459195433|FG001|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|1|||
127608250|NCT03659916|459195434|FG002|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
127608251|NCT03659916|459195432|FG000|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
127608252|NCT03659916|459195433|FG001|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
127608253|NCT03659916|459195434|FG002|Optional Extension Treatment (176 Weeks)|Physician Decision|1|||
127608254|NCT03659916|459195432|FG000|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|5|||
127608255|NCT03659916|459195433|FG001|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|17|||
127608256|NCT03659916|459195434|FG002|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|11|||
127608257|NCT03659916|459195432|FG000|Optional Extension Treatment (176 Weeks)|Other|4|||
127608258|NCT03659916|459195433|FG001|Optional Extension Treatment (176 Weeks)|Other|0|||
127608259|NCT03659916|459195434|FG002|Optional Extension Treatment (176 Weeks)|Other|3|||
127608260|NCT03659916|459195432|FG000|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|5|||
127608261|NCT03659916|459195433|FG001|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|9|||
127608262|NCT03659916|459195434|FG002|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|17|||
127608263|NCT00878709|459195435|FG000|Overall Study|Withdrawal by Subject|197|||
127608264|NCT00878709|459195436|FG001|Overall Study|Withdrawal by Subject|120|||
127608265|NCT00878709|459195435|FG000|Overall Study|Lost to Follow-up|35|||
127608266|NCT00878709|459195436|FG001|Overall Study|Lost to Follow-up|33|||
127608267|NCT00878709|459195435|FG000|Overall Study|Other Reasons|93|||
127608268|NCT00878709|459195436|FG001|Overall Study|Other Reasons|84|||
127608269|NCT03886220|459195439|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
127608270|NCT03886220|459195440|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
127608271|NCT03886220|459195439|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
127608272|NCT03886220|459195440|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
127608273|NCT03886220|459195439|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
127608274|NCT03886220|459195440|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
127608275|NCT00768300|459195441|FG000|Overall Study|Randomized but not treated|1|||
127608276|NCT00768300|459195442|FG001|Overall Study|Randomized but not treated|1|||
127608277|NCT00768300|459195441|FG000|Overall Study|Adverse Event|10|||
127608278|NCT00768300|459195442|FG001|Overall Study|Adverse Event|2|||
127608279|NCT00768300|459195441|FG000|Overall Study|Protocol Violation|6|||
127608280|NCT00768300|459195442|FG001|Overall Study|Protocol Violation|1|||
127608281|NCT00768300|459195441|FG000|Overall Study|Withdrawal by Subject|13|||
127608282|NCT00768300|459195442|FG001|Overall Study|Withdrawal by Subject|7|||
127608283|NCT00768300|459195441|FG000|Overall Study|Physician Decision|2|||
127608284|NCT00768300|459195442|FG001|Overall Study|Physician Decision|3|||
127608285|NCT00768300|459195441|FG000|Overall Study|Study discontinued by Sponsor|271|||
127608286|NCT00768300|459195442|FG001|Overall Study|Study discontinued by Sponsor|140|||
127608287|NCT00768300|459195441|FG000|Overall Study|Death|21|||
127608288|NCT00768300|459195442|FG001|Overall Study|Death|5|||
127608289|NCT00768300|459195441|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
127608290|NCT00768300|459195442|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
127608291|NCT00768300|459195441|FG000|Overall Study|Screen failure following randomization|1|||
127608292|NCT00768300|459195442|FG001|Overall Study|Screen failure following randomization|0|||
127608293|NCT00768300|459195441|FG000|Overall Study|Received lung transplant|1|||
127608294|NCT00768300|459195442|FG001|Overall Study|Received lung transplant|1|||
127608295|NCT00768300|459195441|FG000|Overall Study|Lost to Follow-up|0|||
127608296|NCT00768300|459195442|FG001|Overall Study|Lost to Follow-up|1|||
127608297|NCT00768300|459195441|FG000|Overall Study|Began prohibited concomitant medication|0|||
127608298|NCT00768300|459195442|FG001|Overall Study|Began prohibited concomitant medication|1|||
127608299|NCT00768300|459195441|FG000|Overall Study|Treated but never dosed with Study drug|1|||
127608300|NCT00768300|459195442|FG001|Overall Study|Treated but never dosed with Study drug|0|||
127608301|NCT00768300|459195441|FG000|Overall Study|Missing data|1|||
127608302|NCT00768300|459195442|FG001|Overall Study|Missing data|0|||
127608303|NCT00624052|459195450|FG000|Overall Study|Adverse Event|7|||
127608304|NCT00624052|459195451|FG001|Overall Study|Adverse Event|6|||
127608305|NCT00624052|459195452|FG002|Overall Study|Adverse Event|0|||
127608306|NCT00624052|459195453|FG003|Overall Study|Adverse Event|3|||
127608307|NCT00624052|459195450|FG000|Overall Study|Lack of Efficacy|1|||
127608308|NCT00624052|459195451|FG001|Overall Study|Lack of Efficacy|1|||
127608309|NCT00624052|459195452|FG002|Overall Study|Lack of Efficacy|0|||
127608310|NCT00624052|459195453|FG003|Overall Study|Lack of Efficacy|0|||
127608311|NCT00624052|459195450|FG000|Overall Study|Lost to Follow-up|2|||
127608312|NCT00624052|459195451|FG001|Overall Study|Lost to Follow-up|3|||
127608313|NCT00624052|459195452|FG002|Overall Study|Lost to Follow-up|1|||
127608314|NCT00624052|459195453|FG003|Overall Study|Lost to Follow-up|0|||
127608315|NCT00624052|459195450|FG000|Overall Study|Non compliant with the protocol|2|||
127608316|NCT00624052|459195451|FG001|Overall Study|Non compliant with the protocol|1|||
127608317|NCT00624052|459195452|FG002|Overall Study|Non compliant with the protocol|1|||
127608318|NCT00624052|459195453|FG003|Overall Study|Non compliant with the protocol|1|||
127608319|NCT00624052|459195450|FG000|Overall Study|Consent withdrawn|3|||
127608320|NCT00624052|459195451|FG001|Overall Study|Consent withdrawn|1|||
127608321|NCT00624052|459195452|FG002|Overall Study|Consent withdrawn|1|||
127608322|NCT00624052|459195453|FG003|Overall Study|Consent withdrawn|0|||
127608323|NCT00624052|459195450|FG000|Overall Study|Changed job/ran out if meds|0|||
127608324|NCT00624052|459195451|FG001|Overall Study|Changed job/ran out if meds|2|||
127608325|NCT00624052|459195452|FG002|Overall Study|Changed job/ran out if meds|0|||
127608326|NCT00624052|459195453|FG003|Overall Study|Changed job/ran out if meds|0|||
127608327|NCT00281684|459195456|FG000|Overall Study|Lost to Follow-up|0|||
127608328|NCT00281684|459195457|FG001|Overall Study|Lost to Follow-up|0|||
127608329|NCT00281684|459195458|FG002|Overall Study|Lost to Follow-up|1|||
127608330|NCT00281684|459195459|FG003|Overall Study|Lost to Follow-up|0|||
127608331|NCT00281684|459195456|FG000|Overall Study|Withdrawal by Subject|1|||
127608332|NCT00281684|459195457|FG001|Overall Study|Withdrawal by Subject|0|||
127608333|NCT00281684|459195458|FG002|Overall Study|Withdrawal by Subject|0|||
127608334|NCT00281684|459195459|FG003|Overall Study|Withdrawal by Subject|0|||
127608335|NCT00698581|459195462|FG000|Overall Study|Lack of Efficacy|23|||
127608336|NCT00698581|459195463|FG001|Overall Study|Lack of Efficacy|11|||
127608337|NCT00698581|459195462|FG000|Overall Study|Withdrawal by Subject|6|||
127608338|NCT00698581|459195463|FG001|Overall Study|Withdrawal by Subject|0|||
127608339|NCT00698581|459195462|FG000|Overall Study|Other reason|9|||
127608340|NCT00698581|459195463|FG001|Overall Study|Other reason|1|||
127608341|NCT00698581|459195462|FG000|Overall Study|SAE, non-fatal|1|||
127608342|NCT00698581|459195463|FG001|Overall Study|SAE, non-fatal|0|||
127608343|NCT00698581|459195462|FG000|Overall Study|AE, non-serious non-fatal|4|||
127608344|NCT00698581|459195463|FG001|Overall Study|AE, non-serious non-fatal|0|||
127608345|NCT00698581|459195462|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
127608346|NCT00698581|459195463|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
127608347|NCT00698581|459195462|FG000|Overall Study|AE of unknown type|1|||
127608348|NCT00698581|459195463|FG001|Overall Study|AE of unknown type|0|||
127608349|NCT00449644|459195464|FG000|Overall Study|Adverse Event|0|||
127608350|NCT00449644|459195465|FG001|Overall Study|Adverse Event|0|||
127608351|NCT00449644|459195466|FG002|Overall Study|Adverse Event|3|||
127608352|NCT00449644|459195467|FG003|Overall Study|Adverse Event|5|||
127608353|NCT00449644|459195464|FG000|Overall Study|Death|1|||
127608354|NCT00449644|459195465|FG001|Overall Study|Death|0|||
127608355|NCT00449644|459195466|FG002|Overall Study|Death|6|||
127608356|NCT00449644|459195467|FG003|Overall Study|Death|1|||
127608357|NCT00449644|459195464|FG000|Overall Study|Lost to Follow-up|1|||
127608358|NCT00449644|459195465|FG001|Overall Study|Lost to Follow-up|1|||
127608359|NCT00449644|459195466|FG002|Overall Study|Lost to Follow-up|5|||
127608360|NCT00449644|459195467|FG003|Overall Study|Lost to Follow-up|3|||
127608361|NCT00449644|459195464|FG000|Overall Study|Pregnancy|0|||
127608362|NCT00449644|459195465|FG001|Overall Study|Pregnancy|0|||
127608363|NCT00449644|459195466|FG002|Overall Study|Pregnancy|3|||
127608364|NCT00449644|459195467|FG003|Overall Study|Pregnancy|2|||
127608365|NCT00449644|459195464|FG000|Overall Study|Protocol Violation|4|||
127608366|NCT00449644|459195465|FG001|Overall Study|Protocol Violation|4|||
127608367|NCT00449644|459195466|FG002|Overall Study|Protocol Violation|3|||
127608368|NCT00449644|459195467|FG003|Overall Study|Protocol Violation|7|||
127608369|NCT00449644|459195464|FG000|Overall Study|Withdrawal by Subject|3|||
127608370|NCT00449644|459195465|FG001|Overall Study|Withdrawal by Subject|4|||
127608371|NCT00449644|459195466|FG002|Overall Study|Withdrawal by Subject|6|||
127608372|NCT00449644|459195467|FG003|Overall Study|Withdrawal by Subject|7|||
127608373|NCT00449644|459195464|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
127608374|NCT00449644|459195465|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
127608375|NCT00449644|459195466|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
127608376|NCT00449644|459195467|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
127608377|NCT00449644|459195464|FG000|Overall Study|Other|1|||
127608378|NCT00449644|459195465|FG001|Overall Study|Other|4|||
127608379|NCT00449644|459195466|FG002|Overall Study|Other|1|||
127608380|NCT00449644|459195467|FG003|Overall Study|Other|0|||
127608381|NCT00449644|459195464|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
127608382|NCT00449644|459195465|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
127608383|NCT00449644|459195466|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
127608384|NCT00449644|459195467|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
127608385|NCT00853723|459195468|FG000|Overall Study|Adverse Event|3|||
127608386|NCT00853723|459195469|FG001|Overall Study|Adverse Event|4|||
127608387|NCT00853723|459195470|FG002|Overall Study|Adverse Event|1|||
127608388|NCT00853723|459195468|FG000|Overall Study|Withdrawal by Subject|2|||
127608389|NCT00853723|459195469|FG001|Overall Study|Withdrawal by Subject|1|||
127608390|NCT00853723|459195470|FG002|Overall Study|Withdrawal by Subject|0|||
127608391|NCT00853723|459195468|FG000|Overall Study|Protocol Violation|1|||
127608392|NCT00853723|459195469|FG001|Overall Study|Protocol Violation|2|||
127608393|NCT00853723|459195470|FG002|Overall Study|Protocol Violation|1|||
127608394|NCT01531387|459195471|FG000|Overall Study|Early termination of study|11|||
127608395|NCT01531387|459195472|FG001|Overall Study|Early termination of study|11|||
127608396|NCT02642432|459195475|FG000|Overall Study|Adverse Event|2|||
127608397|NCT02642432|459195475|FG000|Overall Study|Withdrew Consent|1|||
127608398|NCT02642432|459195475|FG000|Overall Study|Lost to Follow-up|2|||
127608399|NCT02642432|459195475|FG000|Overall Study|Other|3|||
127608400|NCT03245008|459195476|FG000|Overall Study|Adverse Event|15|||
127608401|NCT03245008|459195477|FG001|Overall Study|Adverse Event|18|||
127608402|NCT03245008|459195478|FG002|Overall Study|Adverse Event|15|||
127608403|NCT03245008|459195479|FG003|Overall Study|Adverse Event|0|||
127608404|NCT03245008|459195480|FG004|Overall Study|Adverse Event|1|||
127608405|NCT03245008|459195476|FG000|Overall Study|Lack of Efficacy|0|||
127608406|NCT03245008|459195477|FG001|Overall Study|Lack of Efficacy|1|||
127608407|NCT03245008|459195478|FG002|Overall Study|Lack of Efficacy|0|||
127608408|NCT03245008|459195479|FG003|Overall Study|Lack of Efficacy|0|||
127608409|NCT03245008|459195480|FG004|Overall Study|Lack of Efficacy|0|||
127608410|NCT03245008|459195476|FG000|Overall Study|Lost to Follow-up|4|||
127608411|NCT03245008|459195477|FG001|Overall Study|Lost to Follow-up|1|||
127608412|NCT03245008|459195478|FG002|Overall Study|Lost to Follow-up|0|||
127608413|NCT03245008|459195479|FG003|Overall Study|Lost to Follow-up|0|||
127608414|NCT03245008|459195480|FG004|Overall Study|Lost to Follow-up|1|||
127608415|NCT03245008|459195476|FG000|Overall Study|Physician Decision|1|||
127608416|NCT03245008|459195477|FG001|Overall Study|Physician Decision|3|||
127608417|NCT03245008|459195478|FG002|Overall Study|Physician Decision|4|||
127608418|NCT03245008|459195479|FG003|Overall Study|Physician Decision|0|||
127608419|NCT03245008|459195480|FG004|Overall Study|Physician Decision|0|||
127697963|NCT03150810|459522004|FG009|Overall Study|Physician Decision|0|||
127608420|NCT03245008|459195476|FG000|Overall Study|Protocol Violation|0|||
127608421|NCT03245008|459195477|FG001|Overall Study|Protocol Violation|1|||
127608422|NCT03245008|459195478|FG002|Overall Study|Protocol Violation|0|||
127608423|NCT03245008|459195479|FG003|Overall Study|Protocol Violation|0|||
127608424|NCT03245008|459195480|FG004|Overall Study|Protocol Violation|0|||
127697964|NCT03150810|459522005|FG010|Overall Study|Physician Decision|0|||
127608425|NCT03245008|459195476|FG000|Overall Study|Withdrawal by Subject|20|||
127608426|NCT03245008|459195477|FG001|Overall Study|Withdrawal by Subject|19|||
127608427|NCT03245008|459195478|FG002|Overall Study|Withdrawal by Subject|11|||
127608428|NCT03245008|459195479|FG003|Overall Study|Withdrawal by Subject|0|||
127697965|NCT03150810|459522006|FG011|Overall Study|Physician Decision|0|||
127608429|NCT03245008|459195480|FG004|Overall Study|Withdrawal by Subject|0|||
127608430|NCT03245008|459195476|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
127608431|NCT03245008|459195477|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
127608432|NCT03245008|459195478|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
127608433|NCT03245008|459195479|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
127608434|NCT03245008|459195480|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
127608435|NCT03245008|459195476|FG000|Overall Study|Failure to meet randomization criteria|0|||
127608436|NCT03245008|459195477|FG001|Overall Study|Failure to meet randomization criteria|1|||
127608437|NCT03245008|459195478|FG002|Overall Study|Failure to meet randomization criteria|0|||
127608438|NCT03245008|459195479|FG003|Overall Study|Failure to meet randomization criteria|1|||
127608439|NCT03245008|459195480|FG004|Overall Study|Failure to meet randomization criteria|0|||
127608440|NCT01286012|459195481|FG000|Overall Study|Adverse Event|3|||
127608441|NCT01286012|459195482|FG001|Overall Study|Adverse Event|3|||
127608442|NCT01286012|459195481|FG000|Overall Study|Death|2|||
127608443|NCT01286012|459195482|FG001|Overall Study|Death|3|||
127608444|NCT01286012|459195481|FG000|Overall Study|Protocol Violation|1|||
127608445|NCT01286012|459195482|FG001|Overall Study|Protocol Violation|1|||
127608446|NCT01286012|459195481|FG000|Overall Study|Withdrawal by Subject|4|||
127608447|NCT01286012|459195482|FG001|Overall Study|Withdrawal by Subject|4|||
127608448|NCT01286012|459195481|FG000|Overall Study|Physician Decision|2|||
127608449|NCT01286012|459195482|FG001|Overall Study|Physician Decision|0|||
127608450|NCT01286012|459195481|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
127608451|NCT01286012|459195482|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
127608452|NCT03795298|459195486|FG000|Overall Study|Death|34|||
127608453|NCT03795298|459195487|FG001|Overall Study|Death|29|||
127608454|NCT03795298|459195486|FG000|Overall Study|Death > 1095 day (not included in endpoint analyses)|1|||
127608455|NCT03795298|459195487|FG001|Overall Study|Death > 1095 day (not included in endpoint analyses)|2|||
127608456|NCT03795298|459195486|FG000|Overall Study|Lost to Follow-up|28|||
127608457|NCT03795298|459195487|FG001|Overall Study|Lost to Follow-up|17|||
127608458|NCT03795298|459195486|FG000|Overall Study|Physician Decision|5|||
127608459|NCT03795298|459195487|FG001|Overall Study|Physician Decision|4|||
127608460|NCT03795298|459195486|FG000|Overall Study|Withdrawal by Subject|43|||
127608461|NCT03795298|459195487|FG001|Overall Study|Withdrawal by Subject|28|||
127608462|NCT03795298|459195486|FG000|Overall Study|Reason not reported|7|||
127608463|NCT03795298|459195487|FG001|Overall Study|Reason not reported|9|||
127608464|NCT03759379|459197812|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
127608465|NCT03759379|459197813|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
127608466|NCT03759379|459197812|FG000|Treatment Period|Death|2|||
127608467|NCT03759379|459197813|FG001|Treatment Period|Death|3|||
127608468|NCT03759379|459197812|FG000|Treatment Period|Lost to Follow-up|1|||
127608469|NCT03759379|459197813|FG001|Treatment Period|Lost to Follow-up|0|||
127608470|NCT03759379|459197812|FG000|Treatment Period|Physician Decision|0|||
127608471|NCT03759379|459197813|FG001|Treatment Period|Physician Decision|1|||
127608472|NCT04579380|459197815|FG000|Overall Study|Death|9|||
127608473|NCT04579380|459197816|FG001|Overall Study|Death|22|||
127608474|NCT04579380|459197817|FG002|Overall Study|Death|22|||
127608475|NCT04579380|459197818|FG003|Overall Study|Death|17|||
127608476|NCT04579380|459197819|FG004|Overall Study|Death|6|||
127608477|NCT04579380|459197820|FG005|Overall Study|Death|21|||
127608478|NCT04579380|459197821|FG006|Overall Study|Death|10|||
127608479|NCT04579380|459197822|FG007|Overall Study|Death|11|||
127608480|NCT04579380|459197823|FG008|Overall Study|Death|25|||
127608481|NCT04579380|459197815|FG000|Overall Study|Withdrawal by Subject|0|||
127608482|NCT04579380|459197816|FG001|Overall Study|Withdrawal by Subject|3|||
127608483|NCT04579380|459197817|FG002|Overall Study|Withdrawal by Subject|4|||
127788862|NCT03723707|459853433|FG000|Overall Study|Death|32|||
127788863|NCT03723707|459853434|FG001|Overall Study|Death|32|||
127788864|NCT03723707|459853433|FG000|Overall Study|Admitted to long term care|12|||
127788865|NCT03723707|459853434|FG001|Overall Study|Admitted to long term care|12|||
127788866|NCT03723707|459853433|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
127788867|NCT03723707|459853434|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
127788868|NCT03723707|459853433|FG000|Overall Study|Lost to Follow-up|40|||
127788869|NCT03723707|459853434|FG001|Overall Study|Lost to Follow-up|22|||
127788870|NCT03723707|459853433|FG000|Overall Study|Discontinued after study closure|24|||
127788871|NCT03723707|459853434|FG001|Overall Study|Discontinued after study closure|12|||
127608484|NCT04579380|459197818|FG003|Overall Study|Withdrawal by Subject|0|||
127608485|NCT04579380|459197819|FG004|Overall Study|Withdrawal by Subject|1|||
127608486|NCT04579380|459197820|FG005|Overall Study|Withdrawal by Subject|2|||
127608487|NCT04579380|459197821|FG006|Overall Study|Withdrawal by Subject|0|||
127608488|NCT04579380|459197822|FG007|Overall Study|Withdrawal by Subject|1|||
127608489|NCT04579380|459197823|FG008|Overall Study|Withdrawal by Subject|2|||
127608490|NCT04579380|459197815|FG000|Overall Study|Ongoing|2|||
127608491|NCT04579380|459197816|FG001|Overall Study|Ongoing|6|||
127608492|NCT04579380|459197817|FG002|Overall Study|Ongoing|4|||
127608493|NCT04579380|459197818|FG003|Overall Study|Ongoing|8|||
127608494|NCT04579380|459197819|FG004|Overall Study|Ongoing|5|||
127608495|NCT04579380|459197820|FG005|Overall Study|Ongoing|8|||
127608496|NCT04579380|459197821|FG006|Overall Study|Ongoing|3|||
127608497|NCT04579380|459197822|FG007|Overall Study|Ongoing|19|||
127608498|NCT04579380|459197823|FG008|Overall Study|Ongoing|6|||
127608499|NCT01536379|459197824|FG000|Overall Study|Adverse Event|1|||
127608500|NCT01536379|459197825|FG001|Overall Study|Adverse Event|2|||
127608501|NCT01536379|459197824|FG000|Overall Study|Withdrawal by Subject|1|||
127608502|NCT01536379|459197825|FG001|Overall Study|Withdrawal by Subject|1|||
127608503|NCT00156533|459197828|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
127608504|NCT00156533|459197829|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
127608505|NCT00156533|459197830|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
127608506|NCT00156533|459197831|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
127608507|NCT00156533|459197828|FG000|Overall Study|Withdrawal by Subject|1|||
127608508|NCT00156533|459197829|FG001|Overall Study|Withdrawal by Subject|0|||
127608509|NCT00156533|459197830|FG002|Overall Study|Withdrawal by Subject|0|||
127608510|NCT00156533|459197831|FG003|Overall Study|Withdrawal by Subject|1|||
127608511|NCT00156533|459197828|FG000|Overall Study|Failed Screening|1|||
127608512|NCT00156533|459197829|FG001|Overall Study|Failed Screening|0|||
127608513|NCT00156533|459197830|FG002|Overall Study|Failed Screening|1|||
127608514|NCT00156533|459197831|FG003|Overall Study|Failed Screening|1|||
127608515|NCT01254227|459197834|FG000|Overall Study|Withdrawal by Subject|6|||
127608516|NCT01254227|459197834|FG000|Overall Study|Lost to Follow-up|6|||
127608517|NCT01254227|459197834|FG000|Overall Study|Adverse Event|5|||
127608518|NCT01254227|459197834|FG000|Overall Study|Abnormal test procedure result|5|||
127608519|NCT01254227|459197834|FG000|Overall Study|Administrative problems|2|||
127608520|NCT01254227|459197834|FG000|Overall Study|Death|1|||
127608521|NCT01254227|459197834|FG000|Overall Study|Protocol deviation|1|||
127608522|NCT03265249|459197837|FG000|Overall Study|Withdrawal by Subject|0|||
127608523|NCT03265249|459197838|FG001|Overall Study|Withdrawal by Subject|1|||
127608524|NCT02608268|459197841|FG000|Overall Study|Adverse Event|0|||
127608525|NCT02608268|459197842|FG001|Overall Study|Adverse Event|0|||
127608526|NCT02608268|459197843|FG002|Overall Study|Adverse Event|1|||
127608527|NCT02608268|459197844|FG003|Overall Study|Adverse Event|0|||
127608528|NCT02608268|459197845|FG004|Overall Study|Adverse Event|0|||
127608529|NCT02608268|459197846|FG005|Overall Study|Adverse Event|0|||
127608530|NCT02608268|459197847|FG006|Overall Study|Adverse Event|0|||
127608531|NCT02608268|459197848|FG007|Overall Study|Adverse Event|0|||
127608532|NCT02608268|459197849|FG008|Overall Study|Adverse Event|0|||
127608533|NCT02608268|459197850|FG009|Overall Study|Adverse Event|0|||
127608534|NCT02608268|459197851|FG010|Overall Study|Adverse Event|0|||
127608535|NCT02608268|459197852|FG011|Overall Study|Adverse Event|0|||
127608536|NCT02608268|459197853|FG012|Overall Study|Adverse Event|2|||
127608537|NCT02608268|459197854|FG013|Overall Study|Adverse Event|0|||
127608538|NCT02608268|459197855|FG014|Overall Study|Adverse Event|0|||
127608539|NCT02608268|459197856|FG015|Overall Study|Adverse Event|0|||
127608540|NCT02608268|459197857|FG016|Overall Study|Adverse Event|0|||
127608541|NCT02608268|459197858|FG017|Overall Study|Adverse Event|0|||
127608542|NCT02608268|459197859|FG018|Overall Study|Adverse Event|0|||
127608543|NCT02608268|459197860|FG019|Overall Study|Adverse Event|0|||
127608544|NCT02608268|459197861|FG020|Overall Study|Adverse Event|1|||
127608545|NCT02608268|459197862|FG021|Overall Study|Adverse Event|1|||
127608546|NCT02608268|459197863|FG022|Overall Study|Adverse Event|0|||
127608547|NCT02608268|459197864|FG023|Overall Study|Adverse Event|0|||
127608548|NCT02608268|459197865|FG024|Overall Study|Adverse Event|1|||
127608549|NCT02608268|459197866|FG025|Overall Study|Adverse Event|0|||
127608550|NCT02608268|459197867|FG026|Overall Study|Adverse Event|0|||
127608551|NCT02608268|459197868|FG027|Overall Study|Adverse Event|0|||
127608552|NCT02608268|459197869|FG028|Overall Study|Adverse Event|1|||
127608553|NCT02608268|459197870|FG029|Overall Study|Adverse Event|0|||
127608554|NCT02608268|459197841|FG000|Overall Study|Death|1|||
127608555|NCT02608268|459197842|FG001|Overall Study|Death|0|||
127608556|NCT02608268|459197843|FG002|Overall Study|Death|0|||
127608557|NCT02608268|459197844|FG003|Overall Study|Death|0|||
127608558|NCT02608268|459197845|FG004|Overall Study|Death|0|||
127608559|NCT02608268|459197846|FG005|Overall Study|Death|0|||
127608560|NCT02608268|459197847|FG006|Overall Study|Death|0|||
127697966|NCT03150810|459522007|FG012|Overall Study|Physician Decision|0|||
127697967|NCT03150810|459521995|FG000|Overall Study|Site withdrawal from study|0|||
127697968|NCT03150810|459521996|FG001|Overall Study|Site withdrawal from study|1|||
127697969|NCT03150810|459521997|FG002|Overall Study|Site withdrawal from study|0|||
127697970|NCT03150810|459521998|FG003|Overall Study|Site withdrawal from study|0|||
127608561|NCT02608268|459197848|FG007|Overall Study|Death|0|||
127608562|NCT02608268|459197849|FG008|Overall Study|Death|1|||
127608563|NCT02608268|459197850|FG009|Overall Study|Death|1|||
127608564|NCT02608268|459197851|FG010|Overall Study|Death|0|||
127608565|NCT02608268|459197852|FG011|Overall Study|Death|0|||
127608566|NCT02608268|459197853|FG012|Overall Study|Death|0|||
127608567|NCT02608268|459197854|FG013|Overall Study|Death|0|||
127608568|NCT02608268|459197855|FG014|Overall Study|Death|0|||
127608569|NCT02608268|459197856|FG015|Overall Study|Death|1|||
127608570|NCT02608268|459197857|FG016|Overall Study|Death|0|||
127608571|NCT02608268|459197858|FG017|Overall Study|Death|1|||
127697971|NCT03150810|459521999|FG004|Overall Study|Site withdrawal from study|0|||
127608572|NCT02608268|459197859|FG018|Overall Study|Death|0|||
127608573|NCT02608268|459197860|FG019|Overall Study|Death|1|||
127608574|NCT02608268|459197861|FG020|Overall Study|Death|1|||
127608575|NCT02608268|459197862|FG021|Overall Study|Death|0|||
127608576|NCT02608268|459197863|FG022|Overall Study|Death|0|||
127608577|NCT02608268|459197864|FG023|Overall Study|Death|0|||
127608578|NCT02608268|459197865|FG024|Overall Study|Death|1|||
127608579|NCT02608268|459197866|FG025|Overall Study|Death|2|||
127608580|NCT02608268|459197867|FG026|Overall Study|Death|0|||
127608581|NCT02608268|459197868|FG027|Overall Study|Death|1|||
127608582|NCT02608268|459197869|FG028|Overall Study|Death|4|||
127608583|NCT02608268|459197870|FG029|Overall Study|Death|0|||
127608584|NCT02608268|459197841|FG000|Overall Study|Physician Decision|0|||
127608585|NCT02608268|459197842|FG001|Overall Study|Physician Decision|0|||
127608586|NCT02608268|459197843|FG002|Overall Study|Physician Decision|0|||
127608587|NCT02608268|459197844|FG003|Overall Study|Physician Decision|0|||
127608588|NCT02608268|459197845|FG004|Overall Study|Physician Decision|0|||
127608589|NCT02608268|459197846|FG005|Overall Study|Physician Decision|0|||
127608590|NCT02608268|459197847|FG006|Overall Study|Physician Decision|0|||
127608591|NCT02608268|459197848|FG007|Overall Study|Physician Decision|0|||
127608592|NCT02608268|459197849|FG008|Overall Study|Physician Decision|0|||
127608593|NCT02608268|459197850|FG009|Overall Study|Physician Decision|0|||
127608594|NCT02608268|459197851|FG010|Overall Study|Physician Decision|1|||
127608595|NCT02608268|459197852|FG011|Overall Study|Physician Decision|0|||
127608596|NCT02608268|459197853|FG012|Overall Study|Physician Decision|0|||
127608597|NCT02608268|459197854|FG013|Overall Study|Physician Decision|1|||
127608598|NCT02608268|459197855|FG014|Overall Study|Physician Decision|0|||
127608599|NCT02608268|459197856|FG015|Overall Study|Physician Decision|0|||
127608600|NCT02608268|459197857|FG016|Overall Study|Physician Decision|0|||
127608601|NCT02608268|459197858|FG017|Overall Study|Physician Decision|0|||
127608602|NCT02608268|459197859|FG018|Overall Study|Physician Decision|0|||
127608603|NCT02608268|459197860|FG019|Overall Study|Physician Decision|0|||
127608604|NCT02608268|459197861|FG020|Overall Study|Physician Decision|0|||
127608605|NCT02608268|459197862|FG021|Overall Study|Physician Decision|0|||
127608606|NCT02608268|459197863|FG022|Overall Study|Physician Decision|1|||
127608607|NCT02608268|459197864|FG023|Overall Study|Physician Decision|1|||
127608608|NCT02608268|459197865|FG024|Overall Study|Physician Decision|1|||
127608609|NCT02608268|459197866|FG025|Overall Study|Physician Decision|0|||
127608610|NCT02608268|459197867|FG026|Overall Study|Physician Decision|0|||
127608611|NCT02608268|459197868|FG027|Overall Study|Physician Decision|2|||
127608612|NCT02608268|459197869|FG028|Overall Study|Physician Decision|1|||
127608613|NCT02608268|459197870|FG029|Overall Study|Physician Decision|1|||
127608614|NCT02608268|459197841|FG000|Overall Study|Progressive disease|12|||
127608615|NCT02608268|459197842|FG001|Overall Study|Progressive disease|8|||
127608616|NCT02608268|459197843|FG002|Overall Study|Progressive disease|13|||
127608617|NCT02608268|459197844|FG003|Overall Study|Progressive disease|5|||
127608618|NCT02608268|459197845|FG004|Overall Study|Progressive disease|2|||
127608619|NCT02608268|459197846|FG005|Overall Study|Progressive disease|4|||
127608620|NCT02608268|459197847|FG006|Overall Study|Progressive disease|6|||
127608621|NCT02608268|459197848|FG007|Overall Study|Progressive disease|2|||
127608622|NCT02608268|459197849|FG008|Overall Study|Progressive disease|5|||
127608623|NCT02608268|459197850|FG009|Overall Study|Progressive disease|6|||
127608624|NCT02608268|459197851|FG010|Overall Study|Progressive disease|5|||
127608625|NCT02608268|459197852|FG011|Overall Study|Progressive disease|5|||
127608626|NCT02608268|459197853|FG012|Overall Study|Progressive disease|4|||
127608627|NCT02608268|459197854|FG013|Overall Study|Progressive disease|11|||
127608628|NCT02608268|459197855|FG014|Overall Study|Progressive disease|6|||
127608629|NCT02608268|459197856|FG015|Overall Study|Progressive disease|3|||
127608630|NCT02608268|459197857|FG016|Overall Study|Progressive disease|5|||
127608631|NCT02608268|459197858|FG017|Overall Study|Progressive disease|5|||
127608632|NCT02608268|459197859|FG018|Overall Study|Progressive disease|5|||
127608633|NCT02608268|459197860|FG019|Overall Study|Progressive disease|2|||
127608634|NCT02608268|459197861|FG020|Overall Study|Progressive disease|10|||
127608635|NCT02608268|459197862|FG021|Overall Study|Progressive disease|4|||
127608636|NCT02608268|459197863|FG022|Overall Study|Progressive disease|5|||
127608637|NCT02608268|459197864|FG023|Overall Study|Progressive disease|5|||
127608638|NCT02608268|459197865|FG024|Overall Study|Progressive disease|3|||
127608639|NCT02608268|459197866|FG025|Overall Study|Progressive disease|11|||
127608640|NCT02608268|459197867|FG026|Overall Study|Progressive disease|16|||
127608641|NCT02608268|459197868|FG027|Overall Study|Progressive disease|11|||
127608642|NCT02608268|459197869|FG028|Overall Study|Progressive disease|10|||
127608643|NCT02608268|459197870|FG029|Overall Study|Progressive disease|15|||
127608644|NCT02608268|459197841|FG000|Overall Study|Subject/guardian decision|1|||
127608645|NCT02608268|459197842|FG001|Overall Study|Subject/guardian decision|1|||
127608646|NCT02608268|459197843|FG002|Overall Study|Subject/guardian decision|2|||
127608647|NCT02608268|459197844|FG003|Overall Study|Subject/guardian decision|0|||
127608648|NCT02608268|459197845|FG004|Overall Study|Subject/guardian decision|0|||
127608649|NCT02608268|459197846|FG005|Overall Study|Subject/guardian decision|0|||
127608650|NCT02608268|459197847|FG006|Overall Study|Subject/guardian decision|0|||
127608651|NCT02608268|459197848|FG007|Overall Study|Subject/guardian decision|0|||
127608652|NCT02608268|459197849|FG008|Overall Study|Subject/guardian decision|2|||
127608653|NCT02608268|459197850|FG009|Overall Study|Subject/guardian decision|2|||
127608654|NCT02608268|459197851|FG010|Overall Study|Subject/guardian decision|0|||
127608655|NCT02608268|459197852|FG011|Overall Study|Subject/guardian decision|1|||
127608656|NCT02608268|459197853|FG012|Overall Study|Subject/guardian decision|0|||
127608657|NCT02608268|459197854|FG013|Overall Study|Subject/guardian decision|1|||
127608658|NCT02608268|459197855|FG014|Overall Study|Subject/guardian decision|0|||
127608659|NCT02608268|459197856|FG015|Overall Study|Subject/guardian decision|1|||
127608660|NCT02608268|459197857|FG016|Overall Study|Subject/guardian decision|0|||
127608661|NCT02608268|459197858|FG017|Overall Study|Subject/guardian decision|0|||
127608662|NCT02608268|459197859|FG018|Overall Study|Subject/guardian decision|1|||
127608663|NCT02608268|459197860|FG019|Overall Study|Subject/guardian decision|0|||
127608664|NCT02608268|459197861|FG020|Overall Study|Subject/guardian decision|0|||
127608665|NCT02608268|459197862|FG021|Overall Study|Subject/guardian decision|0|||
127608666|NCT02608268|459197863|FG022|Overall Study|Subject/guardian decision|1|||
127608667|NCT02608268|459197864|FG023|Overall Study|Subject/guardian decision|0|||
127608668|NCT02608268|459197865|FG024|Overall Study|Subject/guardian decision|0|||
127608669|NCT02608268|459197866|FG025|Overall Study|Subject/guardian decision|1|||
127608670|NCT02608268|459197867|FG026|Overall Study|Subject/guardian decision|1|||
127608671|NCT02608268|459197868|FG027|Overall Study|Subject/guardian decision|1|||
127608672|NCT02608268|459197869|FG028|Overall Study|Subject/guardian decision|1|||
127608673|NCT02608268|459197870|FG029|Overall Study|Subject/guardian decision|0|||
127608674|NCT03873987|459197874|FG000|Overall Study|Adverse Event|1|||
127608675|NCT03873987|459197875|FG001|Overall Study|Adverse Event|0|||
127608676|NCT03873987|459197874|FG000|Overall Study|staff was unable to start a new IV line|1|||
127608677|NCT03873987|459197875|FG001|Overall Study|staff was unable to start a new IV line|0|||
127608678|NCT03873987|459197874|FG000|Overall Study|Lost to Follow-up|0|||
127608679|NCT03873987|459197875|FG001|Overall Study|Lost to Follow-up|1|||
127608680|NCT04014075|459197876|FG000|Overall Study|Progressive Disease|53|||
127608681|NCT04014075|459197876|FG000|Overall Study|Adverse Event|15|||
127608682|NCT04014075|459197876|FG000|Overall Study|Clinical Progression|4|||
127608683|NCT04014075|459197876|FG000|Overall Study|Death|2|||
127608684|NCT04014075|459197876|FG000|Overall Study|Withdrawal by Subject|2|||
127608685|NCT04014075|459197876|FG000|Overall Study|Miscellaneous|2|||
127608686|NCT04014075|459197876|FG000|Overall Study|Physician Decision|1|||
127608687|NCT05954052|459197877|FG000|Overall Study|Adverse Event|1|||
127608688|NCT01957462|459197878|FG000|Test Period 1|Withdrawal by Subject|1|||
127608689|NCT01957462|459197879|FG001|Test Period 1|Withdrawal by Subject|0|||
127608690|NCT01957462|459197878|FG000|Test Period 1|Adverse Event|1|||
127608691|NCT01957462|459197879|FG001|Test Period 1|Adverse Event|0|||
127608692|NCT02584504|459197880|FG000|Double-blind Treatment|Participant withdrew consent|0|||
127608693|NCT02584504|459197881|FG001|Double-blind Treatment|Participant withdrew consent|0|||
127608694|NCT02584504|459197882|FG002|Double-blind Treatment|Participant withdrew consent|1|||
127608695|NCT02584504|459197880|FG000|Double-blind Treatment|Adverse Event|0|||
127608696|NCT02584504|459197881|FG001|Double-blind Treatment|Adverse Event|1|||
127608697|NCT02584504|459197882|FG002|Double-blind Treatment|Adverse Event|0|||
127608698|NCT02584504|459197880|FG000|Double-blind Treatment|Family Matter|0|||
127608699|NCT02584504|459197881|FG001|Double-blind Treatment|Family Matter|1|||
127608700|NCT02584504|459197882|FG002|Double-blind Treatment|Family Matter|0|||
127608701|NCT02584504|459197880|FG000|Open-label Treatment|Participant withdrew consent|0|||
127608702|NCT02584504|459197881|FG001|Open-label Treatment|Participant withdrew consent|0|||
127608703|NCT02584504|459197882|FG002|Open-label Treatment|Participant withdrew consent|4|||
127608704|NCT02584504|459197880|FG000|Open-label Treatment|Adverse Event|2|||
127608705|NCT02584504|459197881|FG001|Open-label Treatment|Adverse Event|2|||
127608706|NCT02584504|459197882|FG002|Open-label Treatment|Adverse Event|3|||
127608707|NCT02584504|459197880|FG000|Open-label Treatment|Physician Decision|0|||
127608708|NCT02584504|459197881|FG001|Open-label Treatment|Physician Decision|1|||
127608709|NCT02584504|459197882|FG002|Open-label Treatment|Physician Decision|0|||
127608710|NCT02584504|459197880|FG000|Open-label Treatment|Entered but not treated|0|||
127608711|NCT02584504|459197881|FG001|Open-label Treatment|Entered but not treated|1|||
127608712|NCT02584504|459197882|FG002|Open-label Treatment|Entered but not treated|1|||
127608713|NCT03102918|459197883|FG000|Overall Study|Protocol Violation|1|||
127697972|NCT03150810|459522000|FG005|Overall Study|Site withdrawal from study|0|||
127697973|NCT03150810|459522001|FG006|Overall Study|Site withdrawal from study|0|||
127697974|NCT03150810|459522002|FG007|Overall Study|Site withdrawal from study|0|||
127608714|NCT03102918|459197884|FG001|Overall Study|Protocol Violation|0|||
127608715|NCT03446040|459197891|FG000|Overall Study|Disease progression|3|||
127697975|NCT03150810|459522003|FG008|Overall Study|Site withdrawal from study|0|||
127697976|NCT03150810|459522004|FG009|Overall Study|Site withdrawal from study|1|||
127697977|NCT03150810|459522005|FG010|Overall Study|Site withdrawal from study|1|||
127697978|NCT03150810|459522006|FG011|Overall Study|Site withdrawal from study|0|||
127697979|NCT03150810|459522007|FG012|Overall Study|Site withdrawal from study|0|||
127697980|NCT03150810|459521995|FG000|Overall Study|Hospice|0|||
127697981|NCT03150810|459521996|FG001|Overall Study|Hospice|0|||
127697982|NCT03150810|459521997|FG002|Overall Study|Hospice|0|||
127697983|NCT03150810|459521998|FG003|Overall Study|Hospice|0|||
127697984|NCT03150810|459521999|FG004|Overall Study|Hospice|0|||
127697985|NCT03150810|459522000|FG005|Overall Study|Hospice|1|||
127697986|NCT03150810|459522001|FG006|Overall Study|Hospice|0|||
127697987|NCT03150810|459522002|FG007|Overall Study|Hospice|0|||
127697988|NCT03150810|459522003|FG008|Overall Study|Hospice|0|||
127697989|NCT03150810|459522004|FG009|Overall Study|Hospice|0|||
127697990|NCT03150810|459522005|FG010|Overall Study|Hospice|0|||
127697991|NCT03150810|459522006|FG011|Overall Study|Hospice|0|||
127697992|NCT03150810|459522007|FG012|Overall Study|Hospice|0|||
127697993|NCT03150810|459521995|FG000|Overall Study|Participant relocated abroad.|0|||
127697994|NCT03150810|459521996|FG001|Overall Study|Participant relocated abroad.|0|||
127697995|NCT03150810|459521997|FG002|Overall Study|Participant relocated abroad.|0|||
127697996|NCT03150810|459521998|FG003|Overall Study|Participant relocated abroad.|0|||
127697997|NCT03150810|459521999|FG004|Overall Study|Participant relocated abroad.|0|||
127697998|NCT03150810|459522000|FG005|Overall Study|Participant relocated abroad.|1|||
127697999|NCT03150810|459522001|FG006|Overall Study|Participant relocated abroad.|0|||
127698000|NCT03150810|459522002|FG007|Overall Study|Participant relocated abroad.|0|||
127698001|NCT03150810|459522003|FG008|Overall Study|Participant relocated abroad.|0|||
127698002|NCT03150810|459522004|FG009|Overall Study|Participant relocated abroad.|0|||
127698003|NCT03150810|459522005|FG010|Overall Study|Participant relocated abroad.|0|||
127698004|NCT03150810|459522006|FG011|Overall Study|Participant relocated abroad.|0|||
127698005|NCT03150810|459522007|FG012|Overall Study|Participant relocated abroad.|0|||
127698006|NCT03150810|459521995|FG000|Overall Study|Transferred care to oncologist|0|||
127698007|NCT03150810|459521996|FG001|Overall Study|Transferred care to oncologist|0|||
127698008|NCT03150810|459521997|FG002|Overall Study|Transferred care to oncologist|0|||
127698009|NCT03150810|459521998|FG003|Overall Study|Transferred care to oncologist|0|||
127698010|NCT03150810|459521999|FG004|Overall Study|Transferred care to oncologist|0|||
127698011|NCT03150810|459522000|FG005|Overall Study|Transferred care to oncologist|0|||
127698012|NCT03150810|459522001|FG006|Overall Study|Transferred care to oncologist|2|||
127698013|NCT03150810|459522002|FG007|Overall Study|Transferred care to oncologist|0|||
127698014|NCT03150810|459522003|FG008|Overall Study|Transferred care to oncologist|0|||
127698015|NCT03150810|459522004|FG009|Overall Study|Transferred care to oncologist|0|||
127698016|NCT03150810|459522005|FG010|Overall Study|Transferred care to oncologist|0|||
127698017|NCT03150810|459522006|FG011|Overall Study|Transferred care to oncologist|0|||
127698018|NCT03150810|459522007|FG012|Overall Study|Transferred care to oncologist|0|||
127698019|NCT05116787|459522008|FG000|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|0|||
127698020|NCT05116787|459522009|FG001|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|1|||
127698021|NCT05116787|459522008|FG000|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|1|||
127698022|NCT05116787|459522009|FG001|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|0|||
127698023|NCT05116787|459522008|FG000|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|1|||
127698024|NCT05116787|459522009|FG001|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|0|||
127698025|NCT05116787|459522008|FG000|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|4|||
127698026|NCT05116787|459522009|FG001|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|0|||
127698027|NCT06393088|459522011|FG000|Overall Study|Withdrawal by Subject|0|||
127698028|NCT06393088|459522012|FG001|Overall Study|Withdrawal by Subject|2|||
127698029|NCT04176965|459522013|FG000|Overall Study|Death|1|||
127698030|NCT04176965|459522014|FG001|Overall Study|Death|2|||
127698031|NCT04176965|459522013|FG000|Overall Study|Lost to Follow-up|10|||
127788872|NCT05121480|459853435|FG000|Overall Study|Lack of Efficacy|2|||
127788873|NCT05121480|459853436|FG001|Overall Study|Lack of Efficacy|2|||
127788874|NCT05121480|459853437|FG002|Overall Study|Lack of Efficacy|1|||
127788875|NCT05121480|459853438|FG003|Overall Study|Lack of Efficacy|4|||
127788876|NCT05121480|459853439|FG004|Overall Study|Lack of Efficacy|0|||
127698032|NCT04176965|459522014|FG001|Overall Study|Lost to Follow-up|2|||
127698033|NCT04176965|459522013|FG000|Overall Study|Withdrawal by Subject|6|||
127698034|NCT04176965|459522014|FG001|Overall Study|Withdrawal by Subject|1|||
127698035|NCT03903146|459522015|FG000|Overall Study|Lost to Follow-up|6|||
127698036|NCT03903146|459522016|FG001|Overall Study|Lost to Follow-up|4|||
127698037|NCT03903146|459522015|FG000|Overall Study|Withdrawal by Subject|0|||
127698038|NCT03903146|459522016|FG001|Overall Study|Withdrawal by Subject|1|||
127698039|NCT02919683|459522017|FG000|Post-Surgery Follow-Up|Death|2|||
127698040|NCT02919683|459522018|FG001|Post-Surgery Follow-Up|Death|2|||
127698041|NCT02919683|459522017|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
127698042|NCT02919683|459522018|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
127698043|NCT04072380|459522019|FG000|Overall Study|Adverse Event|4|||
127788877|NCT05121480|459853440|FG005|Overall Study|Lack of Efficacy|1|||
127608716|NCT03446040|459197892|FG001|Overall Study|Disease progression|3|||
127608717|NCT03446040|459197893|FG002|Overall Study|Disease progression|3|||
127608718|NCT03446040|459197894|FG003|Overall Study|Disease progression|4|||
127608719|NCT03446040|459197895|FG004|Overall Study|Disease progression|4|||
127608720|NCT03446040|459197896|FG005|Overall Study|Disease progression|6|||
127608721|NCT03446040|459197897|FG006|Overall Study|Disease progression|3|||
127608722|NCT03446040|459197898|FG007|Overall Study|Disease progression|4|||
127608723|NCT03446040|459197899|FG008|Overall Study|Disease progression|2|||
127608724|NCT03446040|459197900|FG009|Overall Study|Disease progression|4|||
127608725|NCT03446040|459197901|FG010|Overall Study|Disease progression|9|||
127608726|NCT03446040|459197902|FG011|Overall Study|Disease progression|3|||
127608727|NCT03446040|459197903|FG012|Overall Study|Disease progression|7|||
127608728|NCT03446040|459197904|FG013|Overall Study|Disease progression|7|||
127608729|NCT03446040|459197891|FG000|Overall Study|Study drug toxicity|0|||
127608730|NCT03446040|459197892|FG001|Overall Study|Study drug toxicity|0|||
127608731|NCT03446040|459197893|FG002|Overall Study|Study drug toxicity|0|||
127608732|NCT03446040|459197894|FG003|Overall Study|Study drug toxicity|0|||
127608733|NCT03446040|459197895|FG004|Overall Study|Study drug toxicity|0|||
127608734|NCT03446040|459197896|FG005|Overall Study|Study drug toxicity|0|||
127608735|NCT03446040|459197897|FG006|Overall Study|Study drug toxicity|0|||
127608736|NCT03446040|459197898|FG007|Overall Study|Study drug toxicity|0|||
127608737|NCT03446040|459197899|FG008|Overall Study|Study drug toxicity|1|||
127608738|NCT03446040|459197900|FG009|Overall Study|Study drug toxicity|0|||
127608739|NCT03446040|459197901|FG010|Overall Study|Study drug toxicity|0|||
127788878|NCT05121480|459853441|FG006|Overall Study|Lack of Efficacy|0|||
127788879|NCT05121480|459853442|FG007|Overall Study|Lack of Efficacy|2|||
127788880|NCT05121480|459853435|FG000|Overall Study|Treatment Failure|0|||
127788881|NCT05121480|459853436|FG001|Overall Study|Treatment Failure|2|||
127788882|NCT05121480|459853437|FG002|Overall Study|Treatment Failure|0|||
127788883|NCT05121480|459853438|FG003|Overall Study|Treatment Failure|1|||
127788884|NCT05121480|459853439|FG004|Overall Study|Treatment Failure|0|||
127788885|NCT05121480|459853440|FG005|Overall Study|Treatment Failure|0|||
127788886|NCT05121480|459853441|FG006|Overall Study|Treatment Failure|0|||
127788887|NCT05121480|459853442|FG007|Overall Study|Treatment Failure|0|||
127788888|NCT05121480|459853435|FG000|Overall Study|Adverse Event|0|||
127788889|NCT05121480|459853436|FG001|Overall Study|Adverse Event|1|||
127788890|NCT05121480|459853437|FG002|Overall Study|Adverse Event|0|||
127788891|NCT05121480|459853438|FG003|Overall Study|Adverse Event|5|||
127788892|NCT05121480|459853439|FG004|Overall Study|Adverse Event|3|||
127788893|NCT05121480|459853440|FG005|Overall Study|Adverse Event|2|||
127788894|NCT05121480|459853441|FG006|Overall Study|Adverse Event|0|||
127788895|NCT05121480|459853442|FG007|Overall Study|Adverse Event|4|||
127788896|NCT05121480|459853435|FG000|Overall Study|Withdrawal by Subject|4|||
127788897|NCT05121480|459853436|FG001|Overall Study|Withdrawal by Subject|9|||
127788898|NCT05121480|459853437|FG002|Overall Study|Withdrawal by Subject|1|||
127788899|NCT05121480|459853438|FG003|Overall Study|Withdrawal by Subject|8|||
127788900|NCT05121480|459853439|FG004|Overall Study|Withdrawal by Subject|0|||
127788901|NCT05121480|459853440|FG005|Overall Study|Withdrawal by Subject|9|||
127788902|NCT05121480|459853441|FG006|Overall Study|Withdrawal by Subject|0|||
127788903|NCT05121480|459853442|FG007|Overall Study|Withdrawal by Subject|4|||
127788904|NCT05121480|459853435|FG000|Overall Study|Non-compliance with the protocol|0|||
127608740|NCT03446040|459197902|FG011|Overall Study|Study drug toxicity|0|||
127608741|NCT03446040|459197903|FG012|Overall Study|Study drug toxicity|0|||
127608742|NCT03446040|459197904|FG013|Overall Study|Study drug toxicity|0|||
127608743|NCT03446040|459197891|FG000|Overall Study|Adverse Event|0|||
127608744|NCT03446040|459197892|FG001|Overall Study|Adverse Event|0|||
127608745|NCT03446040|459197893|FG002|Overall Study|Adverse Event|0|||
127608746|NCT03446040|459197894|FG003|Overall Study|Adverse Event|0|||
127608747|NCT03446040|459197895|FG004|Overall Study|Adverse Event|0|||
127608748|NCT03446040|459197896|FG005|Overall Study|Adverse Event|2|||
127608749|NCT03446040|459197897|FG006|Overall Study|Adverse Event|0|||
127608750|NCT03446040|459197898|FG007|Overall Study|Adverse Event|0|||
127608751|NCT03446040|459197899|FG008|Overall Study|Adverse Event|1|||
127608752|NCT03446040|459197900|FG009|Overall Study|Adverse Event|0|||
127608753|NCT03446040|459197901|FG010|Overall Study|Adverse Event|0|||
127608754|NCT03446040|459197902|FG011|Overall Study|Adverse Event|0|||
127608755|NCT03446040|459197903|FG012|Overall Study|Adverse Event|0|||
127608756|NCT03446040|459197904|FG013|Overall Study|Adverse Event|0|||
127608757|NCT03446040|459197891|FG000|Overall Study|Death|0|||
127608758|NCT03446040|459197892|FG001|Overall Study|Death|0|||
127608759|NCT03446040|459197893|FG002|Overall Study|Death|0|||
127608760|NCT03446040|459197894|FG003|Overall Study|Death|0|||
127608761|NCT03446040|459197895|FG004|Overall Study|Death|0|||
127608762|NCT03446040|459197896|FG005|Overall Study|Death|0|||
127608763|NCT03446040|459197897|FG006|Overall Study|Death|0|||
127608764|NCT03446040|459197898|FG007|Overall Study|Death|0|||
127608765|NCT03446040|459197899|FG008|Overall Study|Death|0|||
127608766|NCT03446040|459197900|FG009|Overall Study|Death|0|||
127608767|NCT03446040|459197901|FG010|Overall Study|Death|1|||
127608768|NCT03446040|459197902|FG011|Overall Study|Death|0|||
127608769|NCT03446040|459197903|FG012|Overall Study|Death|0|||
127608770|NCT03446040|459197904|FG013|Overall Study|Death|2|||
127608771|NCT03446040|459197891|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
127608772|NCT03446040|459197892|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
127608773|NCT03446040|459197893|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
127608774|NCT03446040|459197894|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
127608775|NCT03446040|459197895|FG004|Overall Study|Participant requested to discontinue study treatment|0|||
127608776|NCT03446040|459197896|FG005|Overall Study|Participant requested to discontinue study treatment|0|||
127608777|NCT03446040|459197897|FG006|Overall Study|Participant requested to discontinue study treatment|0|||
127608778|NCT03446040|459197898|FG007|Overall Study|Participant requested to discontinue study treatment|0|||
127788905|NCT05121480|459853436|FG001|Overall Study|Non-compliance with the protocol|0|||
127788906|NCT05121480|459853437|FG002|Overall Study|Non-compliance with the protocol|0|||
127788907|NCT05121480|459853438|FG003|Overall Study|Non-compliance with the protocol|0|||
127788908|NCT05121480|459853439|FG004|Overall Study|Non-compliance with the protocol|1|||
127788909|NCT05121480|459853440|FG005|Overall Study|Non-compliance with the protocol|6|||
127788910|NCT05121480|459853441|FG006|Overall Study|Non-compliance with the protocol|0|||
127788911|NCT05121480|459853442|FG007|Overall Study|Non-compliance with the protocol|1|||
127788912|NCT05121480|459853435|FG000|Overall Study|Lost to Follow-up|0|||
127608779|NCT03446040|459197899|FG008|Overall Study|Participant requested to discontinue study treatment|0|||
127608780|NCT03446040|459197900|FG009|Overall Study|Participant requested to discontinue study treatment|0|||
127608781|NCT03446040|459197901|FG010|Overall Study|Participant requested to discontinue study treatment|0|||
127608782|NCT03446040|459197902|FG011|Overall Study|Participant requested to discontinue study treatment|1|||
127608783|NCT03446040|459197903|FG012|Overall Study|Participant requested to discontinue study treatment|0|||
127608784|NCT03446040|459197904|FG013|Overall Study|Participant requested to discontinue study treatment|0|||
127608785|NCT03446040|459197891|FG000|Overall Study|Participant withdrew consent|0|||
127608786|NCT03446040|459197892|FG001|Overall Study|Participant withdrew consent|0|||
127608787|NCT03446040|459197893|FG002|Overall Study|Participant withdrew consent|0|||
127608788|NCT03446040|459197894|FG003|Overall Study|Participant withdrew consent|0|||
127608789|NCT03446040|459197895|FG004|Overall Study|Participant withdrew consent|0|||
127608790|NCT03446040|459197896|FG005|Overall Study|Participant withdrew consent|1|||
127608791|NCT03446040|459197897|FG006|Overall Study|Participant withdrew consent|0|||
127608792|NCT03446040|459197898|FG007|Overall Study|Participant withdrew consent|1|||
127608793|NCT03446040|459197899|FG008|Overall Study|Participant withdrew consent|0|||
127608794|NCT03446040|459197900|FG009|Overall Study|Participant withdrew consent|0|||
127608795|NCT03446040|459197901|FG010|Overall Study|Participant withdrew consent|0|||
127608796|NCT03446040|459197902|FG011|Overall Study|Participant withdrew consent|0|||
127608797|NCT03446040|459197903|FG012|Overall Study|Participant withdrew consent|0|||
127608798|NCT03446040|459197904|FG013|Overall Study|Participant withdrew consent|0|||
127608799|NCT03446040|459197891|FG000|Overall Study|Not reported|0|||
127608800|NCT03446040|459197892|FG001|Overall Study|Not reported|0|||
127608801|NCT03446040|459197893|FG002|Overall Study|Not reported|1|||
127608802|NCT03446040|459197894|FG003|Overall Study|Not reported|0|||
127608803|NCT03446040|459197895|FG004|Overall Study|Not reported|0|||
127608804|NCT03446040|459197896|FG005|Overall Study|Not reported|0|||
127608805|NCT03446040|459197897|FG006|Overall Study|Not reported|0|||
127608806|NCT03446040|459197898|FG007|Overall Study|Not reported|0|||
127608807|NCT03446040|459197899|FG008|Overall Study|Not reported|0|||
127608808|NCT03446040|459197900|FG009|Overall Study|Not reported|0|||
127608809|NCT03446040|459197901|FG010|Overall Study|Not reported|0|||
127608810|NCT03446040|459197902|FG011|Overall Study|Not reported|0|||
127608811|NCT03446040|459197903|FG012|Overall Study|Not reported|0|||
127608812|NCT03446040|459197904|FG013|Overall Study|Not reported|0|||
127608813|NCT02066467|459197905|FG000|Overall Study|Did not undergo implant procedure|24|||
127608814|NCT02066467|459197905|FG000|Overall Study|Attempted to implant withoput success|43|||
127608815|NCT02066467|459197905|FG000|Overall Study|Consent ineligible|1|||
127608816|NCT02066467|459197905|FG000|Overall Study|Death|54|||
127608817|NCT02066467|459197905|FG000|Overall Study|Lost to Follow-up|51|||
127608818|NCT02066467|459197905|FG000|Overall Study|Adverse Event|20|||
127608819|NCT02066467|459197905|FG000|Overall Study|Withdrawal by Subject|16|||
127608820|NCT02066467|459197905|FG000|Overall Study|Physician Decision|2|||
127608821|NCT02066467|459197905|FG000|Overall Study|Not defined|4|||
127608822|NCT01316276|459197906|FG000|Overall Study|Death|1|||
127608823|NCT01316276|459197906|FG000|Overall Study|Adverse Event|19|||
127608824|NCT01316276|459197906|FG000|Overall Study|Withdrawal of consent|24|||
127608825|NCT01316276|459197906|FG000|Overall Study|Lost to Follow-up|1|||
127608826|NCT01316276|459197906|FG000|Overall Study|Other|22|||
127608827|NCT02596854|459197907|FG000|Overall Study|Withdrawn|8|||
127608828|NCT00405587|459197912|FG000|Overall Study|Death|0|||
127608829|NCT00405587|459197913|FG001|Overall Study|Death|0|||
127608830|NCT00405587|459197914|FG002|Overall Study|Death|0|||
127608831|NCT00405587|459197915|FG003|Overall Study|Death|1|||
127608832|NCT00405587|459197912|FG000|Overall Study|Disease Progression|22|||
127608833|NCT00405587|459197913|FG001|Overall Study|Disease Progression|23|||
127608834|NCT00405587|459197914|FG002|Overall Study|Disease Progression|21|||
127608835|NCT00405587|459197915|FG003|Overall Study|Disease Progression|17|||
127608836|NCT00405587|459197912|FG000|Overall Study|Physician Decision|3|||
127608837|NCT00405587|459197913|FG001|Overall Study|Physician Decision|2|||
127608838|NCT00405587|459197914|FG002|Overall Study|Physician Decision|0|||
127608839|NCT00405587|459197915|FG003|Overall Study|Physician Decision|0|||
127608840|NCT00405587|459197912|FG000|Overall Study|Adverse Event|1|||
127608841|NCT00405587|459197913|FG001|Overall Study|Adverse Event|0|||
127608842|NCT00405587|459197914|FG002|Overall Study|Adverse Event|0|||
127608843|NCT00405587|459197915|FG003|Overall Study|Adverse Event|0|||
127608844|NCT00405587|459197912|FG000|Overall Study|Lost to Follow-up|0|||
127608845|NCT00405587|459197913|FG001|Overall Study|Lost to Follow-up|1|||
127608846|NCT00405587|459197914|FG002|Overall Study|Lost to Follow-up|1|||
127608847|NCT00405587|459197915|FG003|Overall Study|Lost to Follow-up|0|||
127608848|NCT00405587|459197912|FG000|Overall Study|Radiation induced necrosis|0|||
127698044|NCT04072380|459522020|FG001|Overall Study|Adverse Event|6|||
127698045|NCT04072380|459522021|FG002|Overall Study|Adverse Event|0|||
127698046|NCT04072380|459522019|FG000|Overall Study|Withdrawal by Subject|3|||
127698047|NCT04072380|459522020|FG001|Overall Study|Withdrawal by Subject|1|||
127698048|NCT04072380|459522021|FG002|Overall Study|Withdrawal by Subject|1|||
127698049|NCT04072380|459522019|FG000|Overall Study|Physician Decision|2|||
127608849|NCT00405587|459197913|FG001|Overall Study|Radiation induced necrosis|1|||
127608850|NCT00405587|459197914|FG002|Overall Study|Radiation induced necrosis|0|||
127608851|NCT00405587|459197915|FG003|Overall Study|Radiation induced necrosis|0|||
127608852|NCT00405587|459197912|FG000|Overall Study|Withdrawal by Subject|0|||
127608853|NCT00405587|459197913|FG001|Overall Study|Withdrawal by Subject|0|||
127608854|NCT00405587|459197914|FG002|Overall Study|Withdrawal by Subject|0|||
127608855|NCT00405587|459197915|FG003|Overall Study|Withdrawal by Subject|2|||
127608856|NCT00405587|459197912|FG000|Overall Study|Participant not dosed|0|||
127608857|NCT00405587|459197913|FG001|Overall Study|Participant not dosed|1|||
127608858|NCT00405587|459197914|FG002|Overall Study|Participant not dosed|0|||
127608859|NCT00405587|459197915|FG003|Overall Study|Participant not dosed|0|||
127608860|NCT06027866|459197916|FG000|Overall Study|Withdrawal by Subject|2|||
127608861|NCT00507442|459197917|FG000|Overall Study|Adverse Event|8|||
127608862|NCT00507442|459197918|FG001|Overall Study|Adverse Event|11|||
127608863|NCT00507442|459197919|FG002|Overall Study|Adverse Event|4|||
127608864|NCT00507442|459197920|FG003|Overall Study|Adverse Event|1|||
127608865|NCT00507442|459197917|FG000|Overall Study|Protocol Violation|0|||
127608866|NCT00507442|459197918|FG001|Overall Study|Protocol Violation|1|||
127608867|NCT00507442|459197919|FG002|Overall Study|Protocol Violation|0|||
127608868|NCT00507442|459197920|FG003|Overall Study|Protocol Violation|0|||
127608869|NCT00507442|459197917|FG000|Overall Study|Lost to Follow-up|0|||
127608870|NCT00507442|459197918|FG001|Overall Study|Lost to Follow-up|0|||
127608871|NCT00507442|459197919|FG002|Overall Study|Lost to Follow-up|1|||
127608872|NCT00507442|459197920|FG003|Overall Study|Lost to Follow-up|0|||
127608873|NCT00507442|459197917|FG000|Overall Study|Physician Decision|0|||
127608874|NCT00507442|459197918|FG001|Overall Study|Physician Decision|2|||
127608875|NCT00507442|459197919|FG002|Overall Study|Physician Decision|4|||
127608876|NCT00507442|459197920|FG003|Overall Study|Physician Decision|1|||
127608877|NCT00507442|459197917|FG000|Overall Study|Progressive Disease|2|||
127608878|NCT00507442|459197918|FG001|Overall Study|Progressive Disease|4|||
127608879|NCT00507442|459197919|FG002|Overall Study|Progressive Disease|2|||
127608880|NCT00507442|459197920|FG003|Overall Study|Progressive Disease|0|||
127608881|NCT00507442|459197917|FG000|Overall Study|Withdrawal by Subject|4|||
127608882|NCT00507442|459197918|FG001|Overall Study|Withdrawal by Subject|4|||
127608883|NCT00507442|459197919|FG002|Overall Study|Withdrawal by Subject|2|||
127608884|NCT00507442|459197920|FG003|Overall Study|Withdrawal by Subject|1|||
127608885|NCT00507442|459197917|FG000|Overall Study|Other|2|||
127608886|NCT00507442|459197918|FG001|Overall Study|Other|5|||
127608887|NCT00507442|459197919|FG002|Overall Study|Other|2|||
127608888|NCT00507442|459197920|FG003|Overall Study|Other|2|||
127608889|NCT05442554|459197921|FG000|Overall Study|Adverse Event|1|||
127608890|NCT05172544|459197926|FG000|Overall Study|Withdrawal by Subject|1|||
127608891|NCT05172544|459197927|FG001|Overall Study|Withdrawal by Subject|0|||
127608892|NCT05172544|459197928|FG002|Overall Study|Withdrawal by Subject|0|||
127608893|NCT05172544|459197926|FG000|Overall Study|Physician Decision|0|||
127608894|NCT05172544|459197927|FG001|Overall Study|Physician Decision|0|||
127608895|NCT05172544|459197928|FG002|Overall Study|Physician Decision|1|||
127608896|NCT00362115|459197929|FG000|Overall Study|Adverse Event|0|||
127608897|NCT00362115|459197930|FG001|Overall Study|Adverse Event|1|||
127608898|NCT00362115|459197931|FG002|Overall Study|Adverse Event|1|||
127608899|NCT00362115|459197932|FG003|Overall Study|Adverse Event|1|||
127608900|NCT00362115|459197933|FG004|Overall Study|Adverse Event|2|||
127608901|NCT00362115|459197934|FG005|Overall Study|Adverse Event|2|||
127608902|NCT00362115|459197935|FG006|Overall Study|Adverse Event|1|||
127608903|NCT00362115|459197929|FG000|Overall Study|Protocol Violation|0|||
127608904|NCT00362115|459197930|FG001|Overall Study|Protocol Violation|0|||
127608905|NCT00362115|459197931|FG002|Overall Study|Protocol Violation|0|||
127608906|NCT00362115|459197932|FG003|Overall Study|Protocol Violation|0|||
127788913|NCT05121480|459853436|FG001|Overall Study|Lost to Follow-up|4|||
127608907|NCT00362115|459197933|FG004|Overall Study|Protocol Violation|0|||
127608908|NCT00362115|459197934|FG005|Overall Study|Protocol Violation|1|||
127608909|NCT00362115|459197935|FG006|Overall Study|Protocol Violation|0|||
127608910|NCT00362115|459197929|FG000|Overall Study|Lost to Follow-up|0|||
127608911|NCT00362115|459197930|FG001|Overall Study|Lost to Follow-up|1|||
127608912|NCT00362115|459197931|FG002|Overall Study|Lost to Follow-up|0|||
127608913|NCT00362115|459197932|FG003|Overall Study|Lost to Follow-up|0|||
127608914|NCT00362115|459197933|FG004|Overall Study|Lost to Follow-up|2|||
127788914|NCT05121480|459853437|FG002|Overall Study|Lost to Follow-up|1|||
127788915|NCT05121480|459853438|FG003|Overall Study|Lost to Follow-up|3|||
127788916|NCT05121480|459853439|FG004|Overall Study|Lost to Follow-up|1|||
127608915|NCT00362115|459197934|FG005|Overall Study|Lost to Follow-up|0|||
127608916|NCT00362115|459197935|FG006|Overall Study|Lost to Follow-up|1|||
127608917|NCT00362115|459197929|FG000|Overall Study|Withdrawal by Subject|1|||
127608918|NCT00362115|459197930|FG001|Overall Study|Withdrawal by Subject|3|||
127608919|NCT00362115|459197931|FG002|Overall Study|Withdrawal by Subject|1|||
127608920|NCT00362115|459197932|FG003|Overall Study|Withdrawal by Subject|0|||
127698050|NCT04072380|459522020|FG001|Overall Study|Physician Decision|0|||
127698051|NCT04072380|459522021|FG002|Overall Study|Physician Decision|0|||
127698052|NCT04072380|459522019|FG000|Overall Study|Protocol Violation|0|||
127698053|NCT04072380|459522020|FG001|Overall Study|Protocol Violation|2|||
127698054|NCT04072380|459522021|FG002|Overall Study|Protocol Violation|3|||
127698055|NCT04072380|459522019|FG000|Overall Study|Intercurrent Illness and Others|3|||
127698056|NCT04072380|459522020|FG001|Overall Study|Intercurrent Illness and Others|5|||
127698057|NCT04072380|459522021|FG002|Overall Study|Intercurrent Illness and Others|6|||
127698058|NCT03033576|459522024|FG000|Overall Study|Ineligible|1|||
127698059|NCT03033576|459522025|FG001|Overall Study|Ineligible|1|||
127698060|NCT03033576|459522024|FG000|Overall Study|Adverse Event|4|||
127698061|NCT03033576|459522025|FG001|Overall Study|Adverse Event|20|||
127698062|NCT03033576|459522024|FG000|Overall Study|Progression/relapse|9|||
127698063|NCT03033576|459522025|FG001|Overall Study|Progression/relapse|36|||
127698064|NCT03033576|459522024|FG000|Overall Study|Death|1|||
127698065|NCT03033576|459522025|FG001|Overall Study|Death|1|||
127698066|NCT03033576|459522024|FG000|Overall Study|Patient refusal|1|||
127698067|NCT03033576|459522025|FG001|Overall Study|Patient refusal|6|||
127698068|NCT03033576|459522024|FG000|Overall Study|Other, unspecified reasons|0|||
127698069|NCT03033576|459522025|FG001|Overall Study|Other, unspecified reasons|4|||
127698070|NCT03033576|459522024|FG000|Overall Study|Currently on protocol therapy|0|||
127698071|NCT03033576|459522025|FG001|Overall Study|Currently on protocol therapy|2|||
127698072|NCT05179837|459522026|FG000|Overall Study|Lesion turned out to be scar tissue and not a polyp|1|||
127698073|NCT05179837|459522026|FG000|Overall Study|Device malfunctioned|1|||
127698074|NCT05179837|459522026|FG000|Overall Study|Image quality too low|2|||
127698075|NCT05051124|459522027|FG000|Overall Study|Lost to Follow-up|2|||
127698076|NCT05051124|459522027|FG000|Overall Study|Withdrawal by Subject|1|||
127698077|NCT05051124|459522027|FG000|Overall Study|Residential relocation|2|||
127698078|NCT05051124|459522027|FG000|Overall Study|Death|1|||
127698079|NCT04782973|459522028|FG000|Overall Study|Withdrawal by Subject|5|||
127698080|NCT04782973|459522028|FG000|Overall Study|Protocol Violation|6|||
127698081|NCT04782973|459522028|FG000|Overall Study|No Longer Eligible Post-Consent|8|||
127698082|NCT06491433|459522029|FG000|Overall Study|Protocol Violation|51|||
127698083|NCT06491433|459522029|FG000|Overall Study|consent withdrawal|2|||
127698084|NCT06491433|459522029|FG000|Overall Study|screen failure|1|||
127698085|NCT05478499|459522035|FG000|Overall Study|Adverse Event|4|||
127698086|NCT05478499|459522036|FG001|Overall Study|Adverse Event|2|||
127698087|NCT05478499|459522035|FG000|Overall Study|Withdrawal by Subject|3|||
127698088|NCT05478499|459522036|FG001|Overall Study|Withdrawal by Subject|2|||
127698089|NCT05478499|459522035|FG000|Overall Study|Lack of Efficacy|1|||
127698090|NCT05478499|459522036|FG001|Overall Study|Lack of Efficacy|0|||
127698091|NCT05478499|459522035|FG000|Overall Study|Lost to Follow-up|1|||
127698092|NCT05478499|459522036|FG001|Overall Study|Lost to Follow-up|0|||
127698093|NCT05478499|459522035|FG000|Overall Study|Other reasons|0|||
127698094|NCT05478499|459522036|FG001|Overall Study|Other reasons|1|||
127698095|NCT02962895|459522037|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
127698096|NCT02962895|459522038|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
127698097|NCT02962895|459522039|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|2|||
127698098|NCT02962895|459522040|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
127698099|NCT02962895|459522041|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
127698100|NCT02962895|459522042|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
127698101|NCT02962895|459522043|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
127698102|NCT02962895|459522037|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
127698103|NCT02962895|459522038|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|1|||
127698104|NCT02962895|459522039|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
127698105|NCT02962895|459522040|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
127698106|NCT02962895|459522041|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
127698107|NCT02962895|459522042|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
127698108|NCT02962895|459522043|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
127698109|NCT02962895|459522037|FG000|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
127698110|NCT02962895|459522038|FG001|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
127698111|NCT02962895|459522039|FG002|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
127698112|NCT02962895|459522040|FG003|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
127698113|NCT02962895|459522041|FG004|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
127698114|NCT02962895|459522042|FG005|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
127698115|NCT02962895|459522043|FG006|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
127698116|NCT02962895|459522037|FG000|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|1|||
127698117|NCT02962895|459522038|FG001|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
127698118|NCT02962895|459522039|FG002|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
127698119|NCT02962895|459522040|FG003|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
127698120|NCT02962895|459522041|FG004|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
127698121|NCT02962895|459522042|FG005|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
127698122|NCT02962895|459522043|FG006|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
127698123|NCT02962895|459522037|FG000|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
127698124|NCT02962895|459522038|FG001|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|1|||
127698125|NCT02962895|459522039|FG002|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
127698126|NCT02962895|459522040|FG003|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
127698127|NCT02962895|459522041|FG004|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
127698128|NCT02962895|459522042|FG005|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
127698129|NCT02962895|459522043|FG006|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
127698130|NCT02962895|459522037|FG000|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
127698131|NCT02962895|459522038|FG001|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
127698132|NCT02962895|459522039|FG002|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
127698133|NCT02962895|459522040|FG003|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|1|||
127698134|NCT02962895|459522041|FG004|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
127698135|NCT02962895|459522042|FG005|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
127698136|NCT02962895|459522043|FG006|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
127698137|NCT02962895|459522037|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
127698138|NCT02962895|459522038|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
127698139|NCT02962895|459522039|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
127698140|NCT02962895|459522040|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
127698141|NCT02962895|459522041|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
127698142|NCT02962895|459522042|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
127698143|NCT02962895|459522043|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|1|||
127698144|NCT02962895|459522037|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
127698145|NCT02962895|459522038|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
127698146|NCT02962895|459522039|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
127698147|NCT02962895|459522040|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
127698148|NCT02962895|459522041|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|5|||
127698149|NCT02962895|459522042|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
127698150|NCT02962895|459522043|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|2|||
127698151|NCT02962895|459522037|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
127698152|NCT02962895|459522038|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
127698153|NCT02962895|459522039|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
127698154|NCT02962895|459522040|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
127698155|NCT02962895|459522041|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
127698156|NCT02962895|459522042|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
127608921|NCT00362115|459197933|FG004|Overall Study|Withdrawal by Subject|1|||
127608922|NCT00362115|459197934|FG005|Overall Study|Withdrawal by Subject|3|||
127608923|NCT00362115|459197935|FG006|Overall Study|Withdrawal by Subject|4|||
127608924|NCT00362115|459197929|FG000|Overall Study|Lack of Efficacy|1|||
127608925|NCT00362115|459197930|FG001|Overall Study|Lack of Efficacy|0|||
127608926|NCT00362115|459197931|FG002|Overall Study|Lack of Efficacy|5|||
127608927|NCT00362115|459197932|FG003|Overall Study|Lack of Efficacy|2|||
127608928|NCT00362115|459197933|FG004|Overall Study|Lack of Efficacy|2|||
127608929|NCT00362115|459197934|FG005|Overall Study|Lack of Efficacy|0|||
127608930|NCT00362115|459197935|FG006|Overall Study|Lack of Efficacy|3|||
127608931|NCT00362115|459197929|FG000|Overall Study|Physician Decision|0|||
127608932|NCT00362115|459197930|FG001|Overall Study|Physician Decision|0|||
127608933|NCT00362115|459197931|FG002|Overall Study|Physician Decision|0|||
127608934|NCT00362115|459197932|FG003|Overall Study|Physician Decision|0|||
127608935|NCT00362115|459197933|FG004|Overall Study|Physician Decision|0|||
127608936|NCT00362115|459197934|FG005|Overall Study|Physician Decision|0|||
127608937|NCT00362115|459197935|FG006|Overall Study|Physician Decision|3|||
127608938|NCT00362115|459197929|FG000|Overall Study|Other|0|||
127608939|NCT00362115|459197930|FG001|Overall Study|Other|1|||
127608940|NCT00362115|459197931|FG002|Overall Study|Other|0|||
127608941|NCT00362115|459197932|FG003|Overall Study|Other|1|||
127608942|NCT00362115|459197933|FG004|Overall Study|Other|0|||
127608943|NCT00362115|459197934|FG005|Overall Study|Other|1|||
127608944|NCT00362115|459197935|FG006|Overall Study|Other|0|||
127608945|NCT03803774|459197936|FG000|Dose Escalation|Withdrawal by Subject|0|||
127608946|NCT03803774|459197937|FG001|Dose Escalation|Withdrawal by Subject|0|||
127608947|NCT03803774|459197938|FG002|Dose Escalation|Withdrawal by Subject|0|||
127608948|NCT03803774|459197939|FG003|Dose Escalation|Withdrawal by Subject|1|||
127608949|NCT03803774|459197940|FG004|Dose Escalation|Withdrawal by Subject|0|||
127608950|NCT01826487|459197942|FG000|Overall Study|Adverse Event|1|||
127608951|NCT01826487|459197943|FG001|Overall Study|Adverse Event|1|||
127608952|NCT01826487|459197942|FG000|Overall Study|Lost to Follow-up|1|||
127608953|NCT01826487|459197943|FG001|Overall Study|Lost to Follow-up|0|||
127608954|NCT01826487|459197942|FG000|Overall Study|Withdrawal by Subject|1|||
127608955|NCT01826487|459197943|FG001|Overall Study|Withdrawal by Subject|3|||
127608956|NCT01826487|459197942|FG000|Overall Study|Protocol Violation|1|||
127608957|NCT01826487|459197943|FG001|Overall Study|Protocol Violation|1|||
127608958|NCT01408030|459197944|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
127608959|NCT01408030|459197945|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
127608960|NCT01408030|459197946|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
127608961|NCT01408030|459197947|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
127608962|NCT01408030|459197944|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
127608963|NCT01408030|459197945|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
127608964|NCT01408030|459197946|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
127608965|NCT01408030|459197947|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
127608966|NCT01408030|459197944|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
127608967|NCT01408030|459197945|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
127608968|NCT01408030|459197946|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
127608969|NCT01408030|459197947|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
127608970|NCT01408030|459197944|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
127608971|NCT01408030|459197945|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
127608972|NCT01408030|459197946|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
127608973|NCT01408030|459197947|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
127608974|NCT01408030|459197944|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
127698157|NCT02962895|459522043|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|1|||
127698158|NCT02962895|459522037|FG000|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
127698159|NCT02962895|459522038|FG001|Period 4 (Safety Follow-Up)|Lack of Efficacy|1|||
127698160|NCT02962895|459522039|FG002|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
127698161|NCT02962895|459522040|FG003|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
127608975|NCT01408030|459197945|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
127608976|NCT01408030|459197946|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
127608977|NCT01408030|459197947|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
127698162|NCT02962895|459522041|FG004|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
127698163|NCT02962895|459522042|FG005|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
127608978|NCT01408030|459197944|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
127608979|NCT01408030|459197945|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
127698164|NCT02962895|459522043|FG006|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
127698165|NCT02962895|459522037|FG000|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
127698166|NCT02962895|459522038|FG001|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
127698167|NCT02962895|459522039|FG002|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
127698168|NCT02962895|459522040|FG003|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
127698169|NCT02962895|459522041|FG004|Period 4 (Safety Follow-Up)|Lost to Follow-up|1|||
127698170|NCT02962895|459522042|FG005|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
127698171|NCT02962895|459522043|FG006|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
127698172|NCT02962895|459522037|FG000|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
127698173|NCT02962895|459522038|FG001|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
127698174|NCT02962895|459522039|FG002|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
127698175|NCT02962895|459522040|FG003|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
127698176|NCT02962895|459522041|FG004|Period 4 (Safety Follow-Up)|New therapy for indication|1|||
127698177|NCT02962895|459522042|FG005|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
127698178|NCT02962895|459522043|FG006|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
127698179|NCT02962895|459522037|FG000|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
127698180|NCT02962895|459522038|FG001|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|3|||
127698181|NCT02962895|459522039|FG002|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|1|||
127698182|NCT02962895|459522040|FG003|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|2|||
127698183|NCT02962895|459522041|FG004|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
127698184|NCT02962895|459522042|FG005|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
127698185|NCT02962895|459522043|FG006|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
127698186|NCT02962895|459522037|FG000|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
127698187|NCT02962895|459522038|FG001|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
127698188|NCT02962895|459522039|FG002|Period 4 (Safety Follow-Up)|Withdrawal by Subject|3|||
127698189|NCT02962895|459522040|FG003|Period 4 (Safety Follow-Up)|Withdrawal by Subject|1|||
127698190|NCT02962895|459522041|FG004|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
127698191|NCT02962895|459522042|FG005|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
127698192|NCT02962895|459522043|FG006|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
127698193|NCT03364647|459522046|FG000|Overall Study|Withdrawal by Subject|3|||
127698194|NCT03364647|459522047|FG001|Overall Study|Withdrawal by Subject|1|||
127698195|NCT03476460|459522050|FG000|Overall Study|Withdrawal by Subject|3|||
127698196|NCT03476460|459522051|FG001|Overall Study|Withdrawal by Subject|2|||
127698197|NCT03476460|459522050|FG000|Overall Study|Non-compliance with treatment|3|||
127698198|NCT03476460|459522051|FG001|Overall Study|Non-compliance with treatment|0|||
127698199|NCT03476460|459522050|FG000|Overall Study|Missing laboratory tests|5|||
127698200|NCT03476460|459522051|FG001|Overall Study|Missing laboratory tests|5|||
127698201|NCT03476460|459522050|FG000|Overall Study|Adverse Event|0|||
127698202|NCT03476460|459522051|FG001|Overall Study|Adverse Event|1|||
127608980|NCT01408030|459197946|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
127608981|NCT01408030|459197947|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
127608982|NCT01408030|459197944|FG000|Observation Phase (Off Drug)|Other|1|||
127608983|NCT01408030|459197945|FG001|Observation Phase (Off Drug)|Other|1|||
127608984|NCT01408030|459197946|FG002|Observation Phase (Off Drug)|Other|1|||
127608985|NCT01408030|459197947|FG003|Observation Phase (Off Drug)|Other|1|||
127608986|NCT02081079|459197950|FG000|Overall Study|Lack of Efficacy|3|||
127608987|NCT02081079|459197951|FG001|Overall Study|Lack of Efficacy|2|||
127608988|NCT02081079|459197950|FG000|Overall Study|Lost to Follow-up|1|||
127608989|NCT02081079|459197951|FG001|Overall Study|Lost to Follow-up|0|||
127608990|NCT01712854|459197952|FG000|Overall Study|Physician Decision|1|||
127608991|NCT02225743|459197953|FG000|Overall Study|Withdrawal by Subject|18|||
127608992|NCT00322842|459197958|FG000|Overall Study|Withdrawal by Subject|0|||
127608993|NCT00322842|459197959|FG001|Overall Study|Withdrawal by Subject|1|||
127698203|NCT01606215|459522056|FG000|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
127698204|NCT01606215|459522057|FG001|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
127698205|NCT04592549|459522058|FG000|Overall Study|Withdrawal by Subject|0|||
127698206|NCT04592549|459522059|FG001|Overall Study|Withdrawal by Subject|1|||
127698207|NCT04592549|459522060|FG002|Overall Study|Withdrawal by Subject|0|||
127698208|NCT04592549|459522061|FG003|Overall Study|Withdrawal by Subject|1|||
127608994|NCT00322842|459197958|FG000|Overall Study|Lost to Follow-up|0|||
127608995|NCT00322842|459197959|FG001|Overall Study|Lost to Follow-up|1|||
127788917|NCT05121480|459853440|FG005|Overall Study|Lost to Follow-up|1|||
127788918|NCT05121480|459853441|FG006|Overall Study|Lost to Follow-up|1|||
127788919|NCT05121480|459853442|FG007|Overall Study|Lost to Follow-up|4|||
127788920|NCT05121480|459853435|FG000|Overall Study|Physician Decision|0|||
127608996|NCT00322842|459197958|FG000|Overall Study|Refused transplant|1|||
127608997|NCT00322842|459197959|FG001|Overall Study|Refused transplant|0|||
127608998|NCT00322842|459197958|FG000|Overall Study|Death|1|||
127608999|NCT00322842|459197959|FG001|Overall Study|Death|0|||
127609000|NCT02068222|459197960|FG000|Overall Study|Lost to Follow-up|1|||
127609001|NCT00302458|459197963|FG000|Overall Study|Lost to Follow-up|1|||
127609002|NCT00302458|459197963|FG000|Overall Study|Ineligible after screening|1|||
127609003|NCT00302458|459197963|FG000|Overall Study|Withdrawal by Subject|1|||
127609004|NCT02867709|459197964|FG000|Treatment Period|Adverse Event|1|||
127609005|NCT02867709|459197965|FG001|Treatment Period|Adverse Event|1|||
127609006|NCT02867709|459197966|FG002|Treatment Period|Adverse Event|2|||
127609007|NCT02867709|459197964|FG000|Treatment Period|Withdrawal of Consent|7|||
127609008|NCT02867709|459197965|FG001|Treatment Period|Withdrawal of Consent|9|||
127609009|NCT02867709|459197966|FG002|Treatment Period|Withdrawal of Consent|8|||
127609010|NCT02867709|459197964|FG000|Treatment Period|Lost to Follow-up|17|||
127609011|NCT02867709|459197965|FG001|Treatment Period|Lost to Follow-up|20|||
127609012|NCT02867709|459197966|FG002|Treatment Period|Lost to Follow-up|20|||
127609013|NCT02867709|459197964|FG000|Treatment Period|Lack of Qualifying Event|42|||
127609014|NCT02867709|459197965|FG001|Treatment Period|Lack of Qualifying Event|55|||
127609015|NCT02867709|459197966|FG002|Treatment Period|Lack of Qualifying Event|42|||
127609016|NCT02867709|459197964|FG000|Treatment Period|Protocol Violation|3|||
127609017|NCT02867709|459197965|FG001|Treatment Period|Protocol Violation|2|||
127609018|NCT02867709|459197966|FG002|Treatment Period|Protocol Violation|3|||
127609019|NCT02867709|459197964|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
127609020|NCT02867709|459197965|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
127609021|NCT02867709|459197966|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
127609022|NCT02867709|459197964|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
127609023|NCT02867709|459197965|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
127609024|NCT02867709|459197966|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
127609025|NCT02867709|459197964|FG000|Safety Follow-up Period|Pregnancy|0|||
127609026|NCT02867709|459197965|FG001|Safety Follow-up Period|Pregnancy|1|||
127609027|NCT02867709|459197966|FG002|Safety Follow-up Period|Pregnancy|0|||
127609028|NCT02867709|459197964|FG000|Safety Follow-up Period|Protocol Violation|0|||
127609029|NCT02867709|459197965|FG001|Safety Follow-up Period|Protocol Violation|1|||
127609030|NCT02867709|459197966|FG002|Safety Follow-up Period|Protocol Violation|1|||
127609031|NCT03615105|459197973|FG000|Overall Study|Protocol Violation|1|||
127609032|NCT03615105|459197974|FG001|Overall Study|Protocol Violation|0|||
127609033|NCT03615105|459197975|FG002|Overall Study|Protocol Violation|0|||
127609034|NCT03615105|459197973|FG000|Overall Study|Death|0|||
127609035|NCT03615105|459197974|FG001|Overall Study|Death|2|||
127609036|NCT03615105|459197975|FG002|Overall Study|Death|0|||
127609037|NCT05214768|459197976|FG000|Induction Period|Withdrawal by Subject|1|||
127609038|NCT05214768|459197977|FG001|Induction Period|Withdrawal by Subject|0|||
127609039|NCT05214768|459197978|FG002|Induction Period|Withdrawal by Subject|0|||
127609040|NCT05214768|459197979|FG003|Induction Period|Withdrawal by Subject|0|||
127609041|NCT05214768|459197980|FG004|Induction Period|Withdrawal by Subject|0|||
127609042|NCT05214768|459197981|FG005|Induction Period|Withdrawal by Subject|0|||
127609043|NCT05214768|459197976|FG000|Induction Period|Physician Decision|1|||
127609044|NCT05214768|459197977|FG001|Induction Period|Physician Decision|0|||
127609045|NCT05214768|459197978|FG002|Induction Period|Physician Decision|0|||
127609046|NCT05214768|459197979|FG003|Induction Period|Physician Decision|0|||
127609047|NCT05214768|459197980|FG004|Induction Period|Physician Decision|0|||
127609048|NCT05214768|459197981|FG005|Induction Period|Physician Decision|0|||
127609049|NCT05214768|459197976|FG000|Maintenance Period|Other Reasons|0|||
127609050|NCT05214768|459197977|FG001|Maintenance Period|Other Reasons|0|||
127609051|NCT05214768|459197978|FG002|Maintenance Period|Other Reasons|1|||
127609052|NCT05214768|459197979|FG003|Maintenance Period|Other Reasons|1|||
127609053|NCT05214768|459197980|FG004|Maintenance Period|Other Reasons|0|||
127609054|NCT05214768|459197981|FG005|Maintenance Period|Other Reasons|0|||
127788921|NCT05121480|459853436|FG001|Overall Study|Physician Decision|0|||
127609055|NCT05214768|459197976|FG000|Maintenance Period|Withdrawal by Subject|0|||
127609056|NCT05214768|459197977|FG001|Maintenance Period|Withdrawal by Subject|0|||
127609057|NCT05214768|459197978|FG002|Maintenance Period|Withdrawal by Subject|0|||
127609058|NCT05214768|459197979|FG003|Maintenance Period|Withdrawal by Subject|1|||
127609059|NCT05214768|459197980|FG004|Maintenance Period|Withdrawal by Subject|0|||
127609060|NCT05214768|459197981|FG005|Maintenance Period|Withdrawal by Subject|0|||
127609061|NCT05214768|459197976|FG000|Maintenance Period|Lack of Efficacy|0|||
127788922|NCT05121480|459853437|FG002|Overall Study|Physician Decision|0|||
127609062|NCT05214768|459197977|FG001|Maintenance Period|Lack of Efficacy|0|||
127788923|NCT05121480|459853438|FG003|Overall Study|Physician Decision|0|||
127609063|NCT05214768|459197978|FG002|Maintenance Period|Lack of Efficacy|1|||
127609064|NCT05214768|459197979|FG003|Maintenance Period|Lack of Efficacy|0|||
127609065|NCT05214768|459197980|FG004|Maintenance Period|Lack of Efficacy|1|||
127609066|NCT05214768|459197981|FG005|Maintenance Period|Lack of Efficacy|0|||
127788924|NCT05121480|459853439|FG004|Overall Study|Physician Decision|0|||
127609067|NCT05214768|459197976|FG000|Open Label Extension Period|Physician Decision|0|||
127609068|NCT05214768|459197977|FG001|Open Label Extension Period|Physician Decision|0|||
127609069|NCT05214768|459197978|FG002|Open Label Extension Period|Physician Decision|0|||
127609070|NCT05214768|459197979|FG003|Open Label Extension Period|Physician Decision|0|||
127609071|NCT05214768|459197980|FG004|Open Label Extension Period|Physician Decision|0|||
127609072|NCT05214768|459197981|FG005|Open Label Extension Period|Physician Decision|1|||
127609073|NCT05214768|459197976|FG000|Open Label Extension Period|Lack of Efficacy|0|||
127609074|NCT05214768|459197977|FG001|Open Label Extension Period|Lack of Efficacy|0|||
127609075|NCT05214768|459197978|FG002|Open Label Extension Period|Lack of Efficacy|0|||
127609076|NCT05214768|459197979|FG003|Open Label Extension Period|Lack of Efficacy|0|||
127609077|NCT05214768|459197980|FG004|Open Label Extension Period|Lack of Efficacy|0|||
127609078|NCT05214768|459197981|FG005|Open Label Extension Period|Lack of Efficacy|1|||
127609079|NCT05214768|459197976|FG000|Open Label Extension Period|Ongoing Study|0|||
127609080|NCT05214768|459197977|FG001|Open Label Extension Period|Ongoing Study|0|||
127609081|NCT05214768|459197978|FG002|Open Label Extension Period|Ongoing Study|0|||
127609082|NCT05214768|459197979|FG003|Open Label Extension Period|Ongoing Study|0|||
127609083|NCT05214768|459197980|FG004|Open Label Extension Period|Ongoing Study|0|||
127609084|NCT05214768|459197981|FG005|Open Label Extension Period|Ongoing Study|42|||
127609085|NCT05041322|459197982|FG000|Baseline|Withdrawal by Subject|1|||
127609086|NCT05041322|459197983|FG001|Baseline|Withdrawal by Subject|0|||
127609087|NCT05041322|459197982|FG000|Treatment 1 (14 Days)|Adverse Event|1|||
127609088|NCT05041322|459197983|FG001|Treatment 1 (14 Days)|Adverse Event|0|||
127609089|NCT05041322|459197982|FG000|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
127609090|NCT05041322|459197983|FG001|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
127609091|NCT04383743|459197984|FG000|Overall Study|Withdrawal by Subject|1|||
127609092|NCT04383743|459197984|FG000|Overall Study|Adverse Event|1|||
127609093|NCT04837131|459197985|FG000|Overall Study|Death|1|||
127609094|NCT04837131|459197985|FG000|Overall Study|Withdrawal by Subject|1|||
127609095|NCT04837131|459197985|FG000|Overall Study|Adverse Event|1|||
127609096|NCT04837131|459197985|FG000|Overall Study|Protocol Violation|1|||
127609097|NCT04303780|459197986|FG000|Overall Study|Death|104|||
127609098|NCT04303780|459197987|FG001|Overall Study|Death|85|||
127609099|NCT04303780|459197986|FG000|Overall Study|Lost to Follow-up|5|||
127609100|NCT04303780|459197987|FG001|Overall Study|Lost to Follow-up|2|||
127609101|NCT04303780|459197986|FG000|Overall Study|Withdrawal by Subject|12|||
127609102|NCT04303780|459197987|FG001|Overall Study|Withdrawal by Subject|39|||
127609103|NCT04303780|459197986|FG000|Overall Study|Ongoing in study|50|||
127609104|NCT04303780|459197987|FG001|Overall Study|Ongoing in study|45|||
127609105|NCT03482791|459197988|FG000|Overall Study|Patient did not start treatment due to physician decision|1|||
127609106|NCT03482791|459197989|FG001|Overall Study|Patient did not start treatment due to physician decision|0|||
127609107|NCT01344161|459197990|FG000|Overall Study|Lost to Follow-up|4|||
127609108|NCT01344161|459197991|FG001|Overall Study|Lost to Follow-up|1|||
127609109|NCT01344161|459197990|FG000|Overall Study|Pregnancy|0|||
127609110|NCT01344161|459197991|FG001|Overall Study|Pregnancy|1|||
127609111|NCT01344161|459197990|FG000|Overall Study|Protocol Violation|1|||
127609112|NCT01344161|459197991|FG001|Overall Study|Protocol Violation|1|||
127609113|NCT01239368|459199773|FG000|Overall Study|Principal investigator discretion|1|||
127609114|NCT01239368|459199774|FG001|Overall Study|Principal investigator discretion|0|||
127609115|NCT01239368|459199775|FG002|Overall Study|Principal investigator discretion|0|||
127609116|NCT01239368|459199776|FG003|Overall Study|Principal investigator discretion|0|||
127882925|NCT00996918|460194617|FG001|Overall Study|Loss of Caregiver|1|||
127609117|NCT01239368|459199777|FG004|Overall Study|Principal investigator discretion|1|||
127609118|NCT01239368|459199778|FG005|Overall Study|Principal investigator discretion|2|||
127609119|NCT01239368|459199779|FG006|Overall Study|Principal investigator discretion|0|||
127609120|NCT01239368|459199780|FG007|Overall Study|Principal investigator discretion|0|||
127609121|NCT01239368|459199781|FG008|Overall Study|Principal investigator discretion|0|||
127609122|NCT01239368|459199782|FG009|Overall Study|Principal investigator discretion|1|||
127609123|NCT01239368|459199773|FG000|Overall Study|Disease progression on study|1|||
127609124|NCT01239368|459199774|FG001|Overall Study|Disease progression on study|1|||
127609125|NCT01239368|459199775|FG002|Overall Study|Disease progression on study|1|||
127609126|NCT01239368|459199776|FG003|Overall Study|Disease progression on study|1|||
127609127|NCT01239368|459199777|FG004|Overall Study|Disease progression on study|4|||
127609128|NCT01239368|459199778|FG005|Overall Study|Disease progression on study|2|||
127609129|NCT01239368|459199779|FG006|Overall Study|Disease progression on study|5|||
127609130|NCT01239368|459199780|FG007|Overall Study|Disease progression on study|0|||
127882926|NCT00996918|460194618|FG002|Overall Study|Loss of Caregiver|0|||
127882927|NCT00996918|460194619|FG003|Overall Study|Loss of Caregiver|0|||
127609131|NCT01239368|459199781|FG008|Overall Study|Disease progression on study|0|||
127609132|NCT01239368|459199782|FG009|Overall Study|Disease progression on study|2|||
127609133|NCT01239368|459199773|FG000|Overall Study|Refused further treatment|0|||
127609134|NCT01239368|459199774|FG001|Overall Study|Refused further treatment|0|||
127609135|NCT01239368|459199775|FG002|Overall Study|Refused further treatment|0|||
127609136|NCT01239368|459199776|FG003|Overall Study|Refused further treatment|0|||
127609137|NCT01239368|459199777|FG004|Overall Study|Refused further treatment|0|||
127609138|NCT01239368|459199778|FG005|Overall Study|Refused further treatment|0|||
127609139|NCT01239368|459199779|FG006|Overall Study|Refused further treatment|0|||
127609140|NCT01239368|459199780|FG007|Overall Study|Refused further treatment|0|||
127609141|NCT01239368|459199781|FG008|Overall Study|Refused further treatment|0|||
127609142|NCT01239368|459199782|FG009|Overall Study|Refused further treatment|1|||
127609143|NCT01239368|459199773|FG000|Overall Study|Death|0|||
127609144|NCT01239368|459199774|FG001|Overall Study|Death|0|||
127609145|NCT01239368|459199775|FG002|Overall Study|Death|0|||
127609146|NCT01239368|459199776|FG003|Overall Study|Death|0|||
127609147|NCT01239368|459199777|FG004|Overall Study|Death|0|||
127609148|NCT01239368|459199778|FG005|Overall Study|Death|0|||
127609149|NCT01239368|459199779|FG006|Overall Study|Death|1|||
127609150|NCT01239368|459199780|FG007|Overall Study|Death|0|||
127609151|NCT01239368|459199781|FG008|Overall Study|Death|0|||
127609152|NCT01239368|459199782|FG009|Overall Study|Death|0|||
127609153|NCT02967692|459199783|FG000|Overall Study|Progressive disease|3|||
127609154|NCT02967692|459199784|FG001|Overall Study|Progressive disease|15|||
127609155|NCT02967692|459199785|FG002|Overall Study|Progressive disease|114|||
127609156|NCT02967692|459199786|FG003|Overall Study|Progressive disease|151|||
127609157|NCT02967692|459199783|FG000|Overall Study|Subject/guardian decision|1|||
127609158|NCT02967692|459199784|FG001|Overall Study|Subject/guardian decision|1|||
127609159|NCT02967692|459199785|FG002|Overall Study|Subject/guardian decision|14|||
127609160|NCT02967692|459199786|FG003|Overall Study|Subject/guardian decision|22|||
127609161|NCT02967692|459199783|FG000|Overall Study|Death|0|||
127609162|NCT02967692|459199784|FG001|Overall Study|Death|1|||
127609163|NCT02967692|459199785|FG002|Overall Study|Death|13|||
127609164|NCT02967692|459199786|FG003|Overall Study|Death|13|||
127609165|NCT02967692|459199783|FG000|Overall Study|Protocol deviation|1|||
127609166|NCT02967692|459199784|FG001|Overall Study|Protocol deviation|0|||
127609167|NCT02967692|459199785|FG002|Overall Study|Protocol deviation|1|||
127609168|NCT02967692|459199786|FG003|Overall Study|Protocol deviation|1|||
127609169|NCT02967692|459199783|FG000|Overall Study|Lost to Follow-up|0|||
127609170|NCT02967692|459199784|FG001|Overall Study|Lost to Follow-up|0|||
127609171|NCT02967692|459199785|FG002|Overall Study|Lost to Follow-up|1|||
127609172|NCT02967692|459199786|FG003|Overall Study|Lost to Follow-up|0|||
127609173|NCT02967692|459199783|FG000|Overall Study|Physician Decision|0|||
127609174|NCT02967692|459199784|FG001|Overall Study|Physician Decision|0|||
127609175|NCT02967692|459199785|FG002|Overall Study|Physician Decision|22|||
127609176|NCT02967692|459199786|FG003|Overall Study|Physician Decision|13|||
127609177|NCT02967692|459199783|FG000|Overall Study|Adverse Event|2|||
127609178|NCT02967692|459199784|FG001|Overall Study|Adverse Event|9|||
127609179|NCT02967692|459199785|FG002|Overall Study|Adverse Event|60|||
127609180|NCT02967692|459199786|FG003|Overall Study|Adverse Event|28|||
127788925|NCT05121480|459853440|FG005|Overall Study|Physician Decision|1|||
127788926|NCT05121480|459853441|FG006|Overall Study|Physician Decision|0|||
127788927|NCT05121480|459853442|FG007|Overall Study|Physician Decision|1|||
127788928|NCT05121480|459853435|FG000|Overall Study|Other Reason|0|||
127609181|NCT02967692|459199783|FG000|Overall Study|Study terminated by sponsor|2|||
127609182|NCT02967692|459199784|FG001|Overall Study|Study terminated by sponsor|1|||
127609183|NCT02967692|459199785|FG002|Overall Study|Study terminated by sponsor|42|||
127609184|NCT02967692|459199786|FG003|Overall Study|Study terminated by sponsor|37|||
127609185|NCT00066066|459199789|FG000|Overall Study|Lost to Follow-up|6|||
127609186|NCT00066066|459199790|FG001|Overall Study|Lost to Follow-up|4|||
127609187|NCT00066066|459199791|FG002|Overall Study|Lost to Follow-up|7|||
127609188|NCT00066066|459199792|FG003|Overall Study|Lost to Follow-up|4|||
127609189|NCT00066066|459199793|FG004|Overall Study|Lost to Follow-up|3|||
127609190|NCT00066066|459199794|FG005|Overall Study|Lost to Follow-up|5|||
127609191|NCT02268409|459199795|FG000|Overall Study|Reason for discontinuation not reported by the investigator|2|||
127788929|NCT05121480|459853436|FG001|Overall Study|Other Reason|0|||
127609192|NCT02268409|459199795|FG000|Overall Study|Death|1|||
127609193|NCT02268409|459199795|FG000|Overall Study|Lost to Follow-up|1|||
127609194|NCT02268409|459199795|FG000|Overall Study|Protocol Violation|3|||
127609195|NCT02268409|459199795|FG000|Overall Study|Participation in study terminated by Sponsor|25|||
127609196|NCT02268409|459199795|FG000|Overall Study|Withdrawal by Subject|5|||
127609197|NCT01614990|459199799|FG000|Overall Study|Protocol Violation|1|||
127609198|NCT01614990|459199800|FG001|Overall Study|Protocol Violation|1|||
127788930|NCT05121480|459853437|FG002|Overall Study|Other Reason|0|||
127609199|NCT05129488|459199801|FG000|Overall Study|Protocol Violation|3|||
127609200|NCT01012622|459199802|FG000|Overall Study|Withdrawal by Subject|6|||
127609201|NCT01012622|459199802|FG000|Overall Study|Lost to Follow-up|5|||
127609202|NCT01012622|459199802|FG000|Overall Study|Adverse Event|7|||
127609203|NCT01012622|459199802|FG000|Overall Study|non-compliance with the drug|9|||
127609204|NCT01012622|459199802|FG000|Overall Study|Other|1|||
127609205|NCT01012622|459199802|FG000|Overall Study|screening failure|1|||
127609206|NCT01012622|459199802|FG000|Overall Study|withdrawal of consent by a parent|2|||
127609207|NCT02535741|459199803|FG000|Overall Study|Adverse Event|3|||
127609208|NCT02535741|459199803|FG000|Overall Study|Withdrawal by Subject|9|||
127609209|NCT02535741|459199803|FG000|Overall Study|Lost to Follow-up|10|||
127609210|NCT02535741|459199803|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
127609211|NCT02535741|459199803|FG000|Overall Study|Missing data|6|||
127609212|NCT00798369|459199804|FG000|Overall Study|Subject withdrew consent|0|||
127609213|NCT00798369|459199805|FG001|Overall Study|Subject withdrew consent|0|||
127609214|NCT00798369|459199806|FG002|Overall Study|Subject withdrew consent|1|||
127609215|NCT00798369|459199807|FG003|Overall Study|Subject withdrew consent|1|||
127609216|NCT00798369|459199808|FG004|Overall Study|Subject withdrew consent|0|||
127609217|NCT00798369|459199809|FG005|Overall Study|Subject withdrew consent|2|||
127609218|NCT00798369|459199804|FG000|Overall Study|Lost to Follow-up|1|||
127609219|NCT00798369|459199805|FG001|Overall Study|Lost to Follow-up|1|||
127609220|NCT00798369|459199806|FG002|Overall Study|Lost to Follow-up|1|||
127609221|NCT00798369|459199807|FG003|Overall Study|Lost to Follow-up|0|||
127609222|NCT00798369|459199808|FG004|Overall Study|Lost to Follow-up|1|||
127609223|NCT00798369|459199809|FG005|Overall Study|Lost to Follow-up|0|||
127609224|NCT00798369|459199804|FG000|Overall Study|Adminstrative problems|0|||
127609225|NCT00798369|459199805|FG001|Overall Study|Adminstrative problems|0|||
127609226|NCT00798369|459199806|FG002|Overall Study|Adminstrative problems|0|||
127609227|NCT00798369|459199807|FG003|Overall Study|Adminstrative problems|0|||
127609228|NCT00798369|459199808|FG004|Overall Study|Adminstrative problems|0|||
127609229|NCT00798369|459199809|FG005|Overall Study|Adminstrative problems|1|||
127609230|NCT04475588|459199810|FG000|Overall Study|Adverse Event|2|||
127609231|NCT04475588|459199811|FG001|Overall Study|Adverse Event|0|||
127609232|NCT02082210|459199812|FG000|Overall Study|Death|0|||
127609233|NCT02082210|459199813|FG001|Overall Study|Death|0|||
127609234|NCT02082210|459199814|FG002|Overall Study|Death|1|||
127609235|NCT02082210|459199815|FG003|Overall Study|Death|1|||
127609236|NCT02082210|459199816|FG004|Overall Study|Death|1|||
127609237|NCT02082210|459199817|FG005|Overall Study|Death|0|||
127609238|NCT02082210|459199812|FG000|Overall Study|Withdrawal by Subject|0|||
127609239|NCT02082210|459199813|FG001|Overall Study|Withdrawal by Subject|0|||
127609240|NCT02082210|459199814|FG002|Overall Study|Withdrawal by Subject|0|||
127609241|NCT02082210|459199815|FG003|Overall Study|Withdrawal by Subject|1|||
127609242|NCT02082210|459199816|FG004|Overall Study|Withdrawal by Subject|2|||
127609243|NCT02082210|459199817|FG005|Overall Study|Withdrawal by Subject|2|||
127609244|NCT02082210|459199812|FG000|Overall Study|Clinical Progression|0|||
127609245|NCT02082210|459199813|FG001|Overall Study|Clinical Progression|0|||
127609246|NCT02082210|459199814|FG002|Overall Study|Clinical Progression|0|||
127609247|NCT02082210|459199815|FG003|Overall Study|Clinical Progression|1|||
127609248|NCT02082210|459199816|FG004|Overall Study|Clinical Progression|0|||
127609249|NCT02082210|459199817|FG005|Overall Study|Clinical Progression|0|||
127609250|NCT02082210|459199812|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
127609251|NCT02082210|459199813|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
127609252|NCT02082210|459199814|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
127609253|NCT02082210|459199815|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
127609254|NCT02082210|459199816|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
127609255|NCT02082210|459199817|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
127609256|NCT02082210|459199812|FG000|Overall Study|Physician Decision|0|||
127609257|NCT02082210|459199813|FG001|Overall Study|Physician Decision|0|||
127609258|NCT02082210|459199814|FG002|Overall Study|Physician Decision|1|||
127609259|NCT02082210|459199815|FG003|Overall Study|Physician Decision|1|||
127698209|NCT04592549|459522062|FG004|Overall Study|Withdrawal by Subject|1|||
127698210|NCT04592549|459522063|FG005|Overall Study|Withdrawal by Subject|0|||
127698211|NCT04592549|459522058|FG000|Overall Study|Lost to Follow-up|2|||
127609260|NCT02082210|459199816|FG004|Overall Study|Physician Decision|0|||
127609261|NCT02082210|459199817|FG005|Overall Study|Physician Decision|0|||
127609262|NCT01063764|459199818|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
127609263|NCT01063764|459199818|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
127609264|NCT01063764|459199818|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
127609265|NCT01063764|459199818|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
127609266|NCT01063764|459199818|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
127609267|NCT01063764|459199818|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
127609268|NCT01063764|459199818|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
127609269|NCT00697515|459199819|FG000|Dose Optimization Period|Adverse Event|4|||
127609270|NCT00697515|459199820|FG001|Dose Optimization Period|Adverse Event|0|||
127609271|NCT00697515|459199819|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
127609272|NCT00697515|459199820|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
127609273|NCT00697515|459199819|FG000|Dose Optimization Period|Lost to Follow-up|2|||
127698212|NCT04592549|459522059|FG001|Overall Study|Lost to Follow-up|0|||
127609274|NCT00697515|459199820|FG001|Dose Optimization Period|Lost to Follow-up|0|||
127609275|NCT00697515|459199819|FG000|Dose Optimization Period|sponsor request|2|||
127609276|NCT00697515|459199820|FG001|Dose Optimization Period|sponsor request|0|||
127609277|NCT00697515|459199819|FG000|Dose Optimization Period|called to active duty|1|||
127609278|NCT00697515|459199820|FG001|Dose Optimization Period|called to active duty|0|||
127609279|NCT00697515|459199819|FG000|Dose Optimization Period|elevated QTc|1|||
127609280|NCT00697515|459199820|FG001|Dose Optimization Period|elevated QTc|0|||
127609281|NCT00697515|459199819|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
127609282|NCT00697515|459199820|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
127609283|NCT00697515|459199819|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
127609284|NCT00697515|459199820|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
127609285|NCT00697515|459199819|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
127609286|NCT00697515|459199820|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
127609287|NCT00697515|459199819|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
127609288|NCT00697515|459199820|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
127609289|NCT01727141|459199822|FG000|Overall Study|Physician Decision|0|||
127609290|NCT01727141|459199823|FG001|Overall Study|Physician Decision|1|||
127609291|NCT01727141|459199824|FG002|Overall Study|Physician Decision|0|||
127609292|NCT01727141|459199825|FG003|Overall Study|Physician Decision|2|||
127609293|NCT01727141|459199822|FG000|Overall Study|Lost to Follow-up|0|||
127609294|NCT01727141|459199823|FG001|Overall Study|Lost to Follow-up|2|||
127609295|NCT01727141|459199824|FG002|Overall Study|Lost to Follow-up|0|||
127609296|NCT01727141|459199825|FG003|Overall Study|Lost to Follow-up|0|||
127609297|NCT01727141|459199822|FG000|Overall Study|Death|0|||
127609298|NCT01727141|459199823|FG001|Overall Study|Death|1|||
127609299|NCT01727141|459199824|FG002|Overall Study|Death|1|||
127609300|NCT01727141|459199825|FG003|Overall Study|Death|1|||
127609301|NCT01727141|459199822|FG000|Overall Study|Protocol deviation|1|||
127609302|NCT01727141|459199823|FG001|Overall Study|Protocol deviation|1|||
127609303|NCT01727141|459199824|FG002|Overall Study|Protocol deviation|0|||
127609304|NCT01727141|459199825|FG003|Overall Study|Protocol deviation|1|||
127609305|NCT01727141|459199822|FG000|Overall Study|Withdrawal by Subject|4|||
127609306|NCT01727141|459199823|FG001|Overall Study|Withdrawal by Subject|4|||
127609307|NCT01727141|459199824|FG002|Overall Study|Withdrawal by Subject|2|||
127609308|NCT01727141|459199825|FG003|Overall Study|Withdrawal by Subject|11|||
127609309|NCT02603432|459199828|FG000|Overall Study|Adverse Event|1|||
127609310|NCT02603432|459199829|FG001|Overall Study|Adverse Event|0|||
127609311|NCT02603432|459199828|FG000|Overall Study|Death|221|||
127609312|NCT02603432|459199829|FG001|Overall Study|Death|242|||
127609313|NCT02603432|459199828|FG000|Overall Study|Lost to Follow-up|3|||
127609314|NCT02603432|459199829|FG001|Overall Study|Lost to Follow-up|9|||
127609315|NCT02603432|459199828|FG000|Overall Study|Progressive Disease|7|||
127609316|NCT02603432|459199829|FG001|Overall Study|Progressive Disease|5|||
127609317|NCT02603432|459199828|FG000|Overall Study|Withdrawal by Subject|12|||
127609318|NCT02603432|459199829|FG001|Overall Study|Withdrawal by Subject|18|||
127609319|NCT02603432|459199828|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
127609320|NCT02603432|459199829|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
127609321|NCT02603432|459199828|FG000|Overall Study|Study terminated by sponsor|74|||
127609322|NCT02603432|459199829|FG001|Overall Study|Study terminated by sponsor|75|||
127609323|NCT02603432|459199828|FG000|Overall Study|Other|13|||
127609324|NCT02603432|459199829|FG001|Overall Study|Other|0|||
127609325|NCT04765358|459199833|FG000|Overall Study|Withdrawal by Subject|1|||
127609326|NCT02731729|459199834|FG000|Overall Study|Death|2|||
127609327|NCT02731729|459199835|FG001|Overall Study|Death|2|||
127609328|NCT02731729|459199834|FG000|Overall Study|Study terminated by Sponsor|6|||
127609329|NCT02731729|459199835|FG001|Overall Study|Study terminated by Sponsor|6|||
127609330|NCT02731729|459199834|FG000|Overall Study|Withdrawal by Subject|1|||
127609331|NCT02731729|459199835|FG001|Overall Study|Withdrawal by Subject|0|||
127609332|NCT00456521|459199836|FG000|Overall Study|Adverse Event|150|||
127609333|NCT00456521|459199837|FG001|Overall Study|Adverse Event|25|||
127609334|NCT00456521|459199836|FG000|Overall Study|Withdrawal by Subject|43|||
127609335|NCT00456521|459199837|FG001|Overall Study|Withdrawal by Subject|24|||
127609336|NCT00456521|459199836|FG000|Overall Study|Lost to Follow-up|22|||
127609337|NCT00456521|459199837|FG001|Overall Study|Lost to Follow-up|17|||
127609338|NCT00456521|459199836|FG000|Overall Study|Lack of Efficacy|3|||
127609339|NCT00456521|459199837|FG001|Overall Study|Lack of Efficacy|6|||
127609340|NCT00456521|459199836|FG000|Overall Study|Protocol Violation|4|||
127609341|NCT00456521|459199837|FG001|Overall Study|Protocol Violation|0|||
127609342|NCT00456521|459199836|FG000|Overall Study|Pregnancy|1|||
127609343|NCT00456521|459199837|FG001|Overall Study|Pregnancy|1|||
127609344|NCT00456521|459199836|FG000|Overall Study|Drug non-compliance, moved, other|26|||
127609345|NCT00456521|459199837|FG001|Overall Study|Drug non-compliance, moved, other|11|||
127609346|NCT00605475|459199838|FG000|Overall Study|Abnormal Laboratory Values|0|||
127609347|NCT00605475|459199839|FG001|Overall Study|Abnormal Laboratory Values|0|||
127609348|NCT00605475|459199840|FG002|Overall Study|Abnormal Laboratory Values|0|||
127609349|NCT00605475|459199841|FG003|Overall Study|Abnormal Laboratory Values|0|||
127609350|NCT00605475|459199842|FG004|Overall Study|Abnormal Laboratory Values|0|||
127788931|NCT05121480|459853438|FG003|Overall Study|Other Reason|0|||
127788932|NCT05121480|459853439|FG004|Overall Study|Other Reason|0|||
127609351|NCT00605475|459199843|FG005|Overall Study|Abnormal Laboratory Values|0|||
127788933|NCT05121480|459853440|FG005|Overall Study|Other Reason|1|||
127788934|NCT05121480|459853441|FG006|Overall Study|Other Reason|1|||
127788935|NCT05121480|459853442|FG007|Overall Study|Other Reason|1|||
127788936|NCT02831673|459853445|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
127788937|NCT02831673|459853446|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
127788938|NCT02831673|459853447|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
127788939|NCT02831673|459853448|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
127788940|NCT02831673|459853449|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
127788941|NCT02831673|459853445|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
127882928|NCT00996918|460194620|FG004|Overall Study|Loss of Caregiver|0|||
127609352|NCT00605475|459199844|FG006|Overall Study|Abnormal Laboratory Values|0|||
127609353|NCT00605475|459199845|FG007|Overall Study|Abnormal Laboratory Values|0|||
127609354|NCT00605475|459199846|FG008|Overall Study|Abnormal Laboratory Values|1|||
127609355|NCT00605475|459199847|FG009|Overall Study|Abnormal Laboratory Values|0|||
127609356|NCT00605475|459199838|FG000|Overall Study|Administrative problems|0|||
127609357|NCT00605475|459199839|FG001|Overall Study|Administrative problems|0|||
127609358|NCT00605475|459199840|FG002|Overall Study|Administrative problems|0|||
127609359|NCT00605475|459199841|FG003|Overall Study|Administrative problems|0|||
127609360|NCT00605475|459199842|FG004|Overall Study|Administrative problems|0|||
127609361|NCT00605475|459199843|FG005|Overall Study|Administrative problems|0|||
127609362|NCT00605475|459199844|FG006|Overall Study|Administrative problems|1|||
127609363|NCT00605475|459199845|FG007|Overall Study|Administrative problems|0|||
127609364|NCT00605475|459199846|FG008|Overall Study|Administrative problems|0|||
127609365|NCT00605475|459199847|FG009|Overall Study|Administrative problems|0|||
127609366|NCT00605475|459199838|FG000|Overall Study|Lost to Follow-up|0|||
127609367|NCT00605475|459199839|FG001|Overall Study|Lost to Follow-up|0|||
127609368|NCT00605475|459199840|FG002|Overall Study|Lost to Follow-up|0|||
127609369|NCT00605475|459199841|FG003|Overall Study|Lost to Follow-up|0|||
127609370|NCT00605475|459199842|FG004|Overall Study|Lost to Follow-up|0|||
127609371|NCT00605475|459199843|FG005|Overall Study|Lost to Follow-up|0|||
127609372|NCT00605475|459199844|FG006|Overall Study|Lost to Follow-up|0|||
127609373|NCT00605475|459199845|FG007|Overall Study|Lost to Follow-up|0|||
127609374|NCT00605475|459199846|FG008|Overall Study|Lost to Follow-up|1|||
127609375|NCT00605475|459199847|FG009|Overall Study|Lost to Follow-up|1|||
127609376|NCT00605475|459199838|FG000|Overall Study|Protocol Violation|0|||
127609377|NCT00605475|459199839|FG001|Overall Study|Protocol Violation|0|||
127609378|NCT00605475|459199840|FG002|Overall Study|Protocol Violation|0|||
127609379|NCT00605475|459199841|FG003|Overall Study|Protocol Violation|0|||
127609380|NCT00605475|459199842|FG004|Overall Study|Protocol Violation|1|||
127609381|NCT00605475|459199843|FG005|Overall Study|Protocol Violation|0|||
127788942|NCT02831673|459853446|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
127609382|NCT00605475|459199844|FG006|Overall Study|Protocol Violation|0|||
127609383|NCT00605475|459199845|FG007|Overall Study|Protocol Violation|0|||
127609384|NCT00605475|459199846|FG008|Overall Study|Protocol Violation|0|||
127609385|NCT00605475|459199847|FG009|Overall Study|Protocol Violation|0|||
127609386|NCT00605475|459199838|FG000|Overall Study|Withdrawal by Subject|0|||
127609387|NCT00605475|459199839|FG001|Overall Study|Withdrawal by Subject|0|||
127609388|NCT00605475|459199840|FG002|Overall Study|Withdrawal by Subject|0|||
127609389|NCT00605475|459199841|FG003|Overall Study|Withdrawal by Subject|0|||
127609390|NCT00605475|459199842|FG004|Overall Study|Withdrawal by Subject|0|||
127609391|NCT00605475|459199843|FG005|Overall Study|Withdrawal by Subject|2|||
127609392|NCT00605475|459199844|FG006|Overall Study|Withdrawal by Subject|0|||
127609393|NCT00605475|459199845|FG007|Overall Study|Withdrawal by Subject|0|||
127609394|NCT00605475|459199846|FG008|Overall Study|Withdrawal by Subject|0|||
127609395|NCT00605475|459199847|FG009|Overall Study|Withdrawal by Subject|1|||
127609396|NCT00297037|459199850|FG000|Overall Study|Withdrawal by Subject|2|||
127609397|NCT00297037|459199851|FG001|Overall Study|Withdrawal by Subject|0|||
127609398|NCT00076011|459199852|FG000|Overall Study|Death|1|||
127609399|NCT00076011|459199852|FG000|Overall Study|Adverse Event|10|||
127609400|NCT00076011|459199852|FG000|Overall Study|Lack of Efficacy|25|||
127609401|NCT00076011|459199852|FG000|Overall Study|Withdrawal by Subject|1|||
127609402|NCT00076011|459199852|FG000|Overall Study|Study terminated by sponsor|3|||
127609403|NCT00076011|459199852|FG000|Overall Study|Other|11|||
127609404|NCT00076011|459199852|FG000|Overall Study|Ongoing|1|||
127609405|NCT00581776|459199853|FG000|Overall Study|Disease progression or no response|3|||
127609406|NCT04461015|459199864|FG000|Overall Study|IV access lost during the study|0|||
127609407|NCT04461015|459199865|FG001|Overall Study|IV access lost during the study|1|||
127609408|NCT04461015|459199864|FG000|Overall Study|Withdrawal by Subject|0|||
127609409|NCT04461015|459199865|FG001|Overall Study|Withdrawal by Subject|1|||
127609410|NCT00464568|459199867|FG000|Overall Study|Adverse Event|2|||
127609411|NCT03615326|459199868|FG000|Overall Study|Death|266|||
127609412|NCT03615326|459199869|FG001|Overall Study|Death|286|||
127609413|NCT03615326|459199870|FG002|Overall Study|Death|14|||
127609414|NCT03615326|459199871|FG003|Overall Study|Death|17|||
127609415|NCT03615326|459199868|FG000|Overall Study|Lost to Follow-up|0|||
127609416|NCT03615326|459199869|FG001|Overall Study|Lost to Follow-up|1|||
127609417|NCT03615326|459199870|FG002|Overall Study|Lost to Follow-up|0|||
127609418|NCT03615326|459199871|FG003|Overall Study|Lost to Follow-up|0|||
127609419|NCT03615326|459199868|FG000|Overall Study|Withdrawal by Subject|1|||
127609420|NCT03615326|459199869|FG001|Overall Study|Withdrawal by Subject|3|||
127609421|NCT03615326|459199870|FG002|Overall Study|Withdrawal by Subject|0|||
127609422|NCT03615326|459199871|FG003|Overall Study|Withdrawal by Subject|0|||
127609423|NCT03615326|459199868|FG000|Overall Study|Participants Ongoing|83|||
127609424|NCT03615326|459199869|FG001|Overall Study|Participants Ongoing|58|||
127609425|NCT03615326|459199870|FG002|Overall Study|Participants Ongoing|6|||
127609426|NCT03615326|459199871|FG003|Overall Study|Participants Ongoing|3|||
127609427|NCT03425331|459199878|FG000|Overall Study|Withdrawal by Subject|1|||
127609428|NCT03425331|459199878|FG000|Overall Study|Death|1|||
127609429|NCT03425331|459199878|FG000|Overall Study|Adverse Event|1|||
127609430|NCT03425331|459199878|FG000|Overall Study|Disease Progression|2|||
127609431|NCT02864251|459199881|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
127609432|NCT02864251|459199882|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
127609433|NCT02864251|459199883|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
127609434|NCT02864251|459199881|FG000|Pre-Treatment|Withdrawal by Participant|0|||
127609435|NCT02864251|459199882|FG001|Pre-Treatment|Withdrawal by Participant|0|||
127609436|NCT02864251|459199883|FG002|Pre-Treatment|Withdrawal by Participant|4|||
127609437|NCT02864251|459199881|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
127609438|NCT02864251|459199882|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
127609439|NCT02864251|459199883|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
127609440|NCT02864251|459199881|FG000|Pre-Treatment|Other Reasons|0|||
127609441|NCT02864251|459199882|FG001|Pre-Treatment|Other Reasons|1|||
127609442|NCT02864251|459199883|FG002|Pre-Treatment|Other Reasons|1|||
127609443|NCT02864251|459199881|FG000|Treatment|Disease Progression|109|||
127609444|NCT02864251|459199882|FG001|Treatment|Disease Progression|52|||
127609445|NCT02864251|459199883|FG002|Treatment|Disease Progression|101|||
127882929|NCT00996918|460194616|FG000|Overall Study|Other|3|||
127609446|NCT02864251|459199881|FG000|Treatment|Study Drug Toxicity|9|||
127609447|NCT02864251|459199882|FG001|Treatment|Study Drug Toxicity|4|||
127609448|NCT02864251|459199883|FG002|Treatment|Study Drug Toxicity|10|||
127609449|NCT02864251|459199881|FG000|Treatment|Death|0|||
127609450|NCT02864251|459199882|FG001|Treatment|Death|2|||
127609451|NCT02864251|459199883|FG002|Treatment|Death|3|||
127609452|NCT02864251|459199881|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
127609453|NCT02864251|459199882|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
127609454|NCT02864251|459199883|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
127609455|NCT02864251|459199881|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
127609456|NCT02864251|459199882|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
127882930|NCT00996918|460194617|FG001|Overall Study|Other|1|||
127609457|NCT02864251|459199883|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
127609458|NCT02864251|459199881|FG000|Treatment|Withdrawal by Participant|8|||
127609459|NCT02864251|459199882|FG001|Treatment|Withdrawal by Participant|5|||
127609460|NCT02864251|459199883|FG002|Treatment|Withdrawal by Participant|13|||
127609461|NCT02864251|459199881|FG000|Treatment|Maximum Clinical Benefit|1|||
127609462|NCT02864251|459199882|FG001|Treatment|Maximum Clinical Benefit|0|||
127609463|NCT02864251|459199883|FG002|Treatment|Maximum Clinical Benefit|1|||
127609464|NCT02864251|459199881|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
127609465|NCT02864251|459199882|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
127609466|NCT02864251|459199883|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
127609467|NCT02864251|459199881|FG000|Treatment|Other Reasons|1|||
127609468|NCT02864251|459199882|FG001|Treatment|Other Reasons|1|||
127609469|NCT02864251|459199883|FG002|Treatment|Other Reasons|4|||
127609470|NCT02864251|459199881|FG000|Treatment|Administrative Reason by Sponsor|1|||
127609471|NCT02864251|459199882|FG001|Treatment|Administrative Reason by Sponsor|0|||
127609472|NCT02864251|459199883|FG002|Treatment|Administrative Reason by Sponsor|0|||
127609473|NCT03506373|459199886|FG000|Overall Study|Adverse Event|6|||
127609474|NCT03506373|459199886|FG000|Overall Study|Withdrawal by Subject|2|||
127609475|NCT03506373|459199886|FG000|Overall Study|Disease progression|5|||
127609476|NCT03506373|459199886|FG000|Overall Study|Other|3|||
127609477|NCT00885755|459199887|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
127609478|NCT00885755|459199888|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
127609479|NCT00885755|459199889|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
127609480|NCT00885755|459199887|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
127609481|NCT00885755|459199888|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
127609482|NCT00885755|459199889|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
127609483|NCT00885755|459199887|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
127609484|NCT00885755|459199888|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
127609485|NCT00885755|459199889|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
127609486|NCT00885755|459199887|FG000|Part I: Trastuzumab+Taxane|Death|0|||
127609487|NCT00885755|459199888|FG001|Part I: Trastuzumab+Taxane|Death|0|||
127609488|NCT00885755|459199889|FG002|Part I: Trastuzumab+Taxane|Death|1|||
127609489|NCT00885755|459199887|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
127609490|NCT00885755|459199888|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
127609491|NCT00885755|459199889|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
127609492|NCT04343521|459199890|FG000|Overall Study|Adverse Event|0|||
127609493|NCT04343521|459199891|FG001|Overall Study|Adverse Event|2|||
127609494|NCT04343521|459199890|FG000|Overall Study|Death|1|||
127609495|NCT04343521|459199891|FG001|Overall Study|Death|2|||
127609496|NCT04343521|459199890|FG000|Overall Study|Lost to follow-up due to moving from the cluster|327|||
127609497|NCT04343521|459199891|FG001|Overall Study|Lost to follow-up due to moving from the cluster|393|||
127609498|NCT04343521|459199890|FG000|Overall Study|Withdrawal by Subject|70|||
127609499|NCT04343521|459199891|FG001|Overall Study|Withdrawal by Subject|95|||
127609500|NCT04343521|459199890|FG000|Overall Study|Withdrawal by study team|6|||
127609501|NCT04343521|459199891|FG001|Overall Study|Withdrawal by study team|12|||
127609502|NCT00107198|459199892|FG000|Overall Study|Lack of Efficacy|28|||
127609503|NCT00107198|459199892|FG000|Overall Study|Lost to Follow-up|12|||
127609504|NCT00107198|459199892|FG000|Overall Study|Protocol Violation|1|||
127609505|NCT00107198|459199892|FG000|Overall Study|Withdrawal by Subject|6|||
127609506|NCT00107198|459199892|FG000|Overall Study|Ineligible|5|||
127609507|NCT01852812|459199893|FG000|Overall Study|Adverse Event|0|||
127609508|NCT01852812|459199894|FG001|Overall Study|Adverse Event|0|||
127609509|NCT01852812|459199895|FG002|Overall Study|Adverse Event|1|||
127609510|NCT01852812|459199893|FG000|Overall Study|Non-compliance With Study Drug|0|||
127609511|NCT01852812|459199894|FG001|Overall Study|Non-compliance With Study Drug|1|||
127609512|NCT01852812|459199895|FG002|Overall Study|Non-compliance With Study Drug|0|||
127609513|NCT02250443|459199896|FG000|Overall Study|Administrative problems|7|||
127609514|NCT02250443|459199896|FG000|Overall Study|Adverse Event|3|||
127609515|NCT01549964|459199897|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
127609516|NCT01549964|459199898|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
127609517|NCT01549964|459199899|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
127609518|NCT01549964|459199900|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
127609519|NCT01549964|459199897|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
127609520|NCT01549964|459199898|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
127609521|NCT01549964|459199899|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
127609522|NCT01549964|459199900|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
127609523|NCT01549964|459199897|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
127609524|NCT01549964|459199898|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
127609525|NCT01549964|459199899|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
127609526|NCT01549964|459199900|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
127609527|NCT01549964|459199897|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
127609528|NCT01549964|459199898|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
127609529|NCT01549964|459199899|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
127609530|NCT01549964|459199900|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
127609531|NCT01549964|459199897|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
127609532|NCT01549964|459199898|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
127609533|NCT01549964|459199899|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
127609534|NCT01549964|459199900|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
127609535|NCT01549964|459199897|FG000|24-Week Treatment Period|Other|1|||
127609536|NCT01549964|459199898|FG001|24-Week Treatment Period|Other|0|||
127609537|NCT01549964|459199899|FG002|24-Week Treatment Period|Other|1|||
127609538|NCT01549964|459199900|FG003|24-Week Treatment Period|Other|0|||
127609539|NCT01549964|459199897|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
127609540|NCT01549964|459199898|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
127609541|NCT01549964|459199899|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
127609542|NCT01549964|459199900|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
127609543|NCT01549964|459199897|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
127609544|NCT01549964|459199898|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
127609545|NCT01549964|459199899|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
127609546|NCT01549964|459199900|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
127609547|NCT01549964|459199897|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
127609548|NCT01549964|459199898|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
127609549|NCT01549964|459199899|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
127609550|NCT01549964|459199900|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
127609551|NCT01549964|459199897|FG000|80-Week Extension Period|Pregnancy|0|||
127609552|NCT01549964|459199898|FG001|80-Week Extension Period|Pregnancy|0|||
127609553|NCT01549964|459199899|FG002|80-Week Extension Period|Pregnancy|1|||
127609554|NCT01549964|459199900|FG003|80-Week Extension Period|Pregnancy|0|||
127609555|NCT01549964|459199897|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
127609556|NCT01549964|459199898|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
127609557|NCT01549964|459199899|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
127609558|NCT01549964|459199900|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
127609559|NCT01549964|459199897|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
127609560|NCT01549964|459199898|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
127609561|NCT01549964|459199899|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
127609562|NCT01549964|459199900|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
127609563|NCT01549964|459199897|FG000|80-Week Extension Period|Lost to Follow-up|1|||
127609564|NCT01549964|459199898|FG001|80-Week Extension Period|Lost to Follow-up|0|||
127609565|NCT01549964|459199899|FG002|80-Week Extension Period|Lost to Follow-up|2|||
127609566|NCT01549964|459199900|FG003|80-Week Extension Period|Lost to Follow-up|1|||
127609567|NCT01549964|459199897|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
127609568|NCT01549964|459199898|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
127609569|NCT01549964|459199899|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
127609570|NCT01549964|459199900|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
127609571|NCT02290821|459199901|FG000|Overall Study|Withdrawal by Subject|1|||
127698213|NCT04592549|459522060|FG002|Overall Study|Lost to Follow-up|0|||
127698214|NCT04592549|459522061|FG003|Overall Study|Lost to Follow-up|1|||
127698215|NCT04592549|459522062|FG004|Overall Study|Lost to Follow-up|1|||
127698216|NCT04592549|459522063|FG005|Overall Study|Lost to Follow-up|1|||
127698217|NCT05184192|459522064|FG000|Overall Study|Lost to Follow-up|4|||
127698218|NCT05184192|459522065|FG001|Overall Study|Lost to Follow-up|7|||
127698219|NCT05184192|459522064|FG000|Overall Study|Adverse Event|1|||
127698220|NCT05184192|459522065|FG001|Overall Study|Adverse Event|4|||
127698221|NCT05184192|459522064|FG000|Overall Study|PI withdrawal|1|||
127698222|NCT05184192|459522065|FG001|Overall Study|PI withdrawal|2|||
127698223|NCT05184192|459522064|FG000|Overall Study|Withdrew due to adverse effect|1|||
127698224|NCT05184192|459522065|FG001|Overall Study|Withdrew due to adverse effect|0|||
127698225|NCT05184192|459522064|FG000|Overall Study|Medication schedule|1|||
127698226|NCT05184192|459522065|FG001|Overall Study|Medication schedule|0|||
127609572|NCT02290821|459199902|FG001|Overall Study|Withdrawal by Subject|1|||
127698227|NCT05184192|459522064|FG000|Overall Study|Concern for adverse effects|0|||
127698228|NCT05184192|459522065|FG001|Overall Study|Concern for adverse effects|4|||
127698229|NCT02995434|459523745|FG000|Overall Study|Adverse Event|1|||
127698230|NCT02995434|459523746|FG001|Overall Study|Adverse Event|0|||
127698231|NCT02995434|459523745|FG000|Overall Study|Withdrawal by Subject|6|||
127882931|NCT00996918|460194618|FG002|Overall Study|Other|0|||
127698232|NCT02995434|459523746|FG001|Overall Study|Withdrawal by Subject|3|||
127698233|NCT03792256|459523751|FG000|Overall Study|Death|0|||
127698234|NCT03792256|459523752|FG001|Overall Study|Death|1|||
127698235|NCT03792256|459523751|FG000|Overall Study|Lack of Efficacy|0|||
127698236|NCT03792256|459523752|FG001|Overall Study|Lack of Efficacy|1|||
127698237|NCT03792256|459523751|FG000|Overall Study|Withdrawal by Subject|0|||
127698238|NCT03792256|459523752|FG001|Overall Study|Withdrawal by Subject|1|||
127698239|NCT04760678|459523755|FG000|Overall Study|Death|13|||
127698240|NCT04760678|459523755|FG000|Overall Study|Lost to Follow-up|48|||
127698241|NCT04760678|459523755|FG000|Overall Study|Withdrawal by Subject|1|||
127698242|NCT03436290|459523758|FG000|Overall Study|Post-randomization Exclusion|1|||
127698243|NCT03436290|459523759|FG001|Overall Study|Post-randomization Exclusion|0|||
127698244|NCT03436290|459523758|FG000|Overall Study|Death|6|||
127698245|NCT03436290|459523759|FG001|Overall Study|Death|0|||
127698246|NCT03436290|459523758|FG000|Overall Study|Withdrawal by Subject|4|||
127698247|NCT03436290|459523759|FG001|Overall Study|Withdrawal by Subject|0|||
127698248|NCT03436290|459523758|FG000|Overall Study|Protocol Violation|30|||
127698249|NCT03436290|459523759|FG001|Overall Study|Protocol Violation|0|||
127698250|NCT05516147|459523760|FG000|Overall Study|Scheduling Conflicts Made it Impossible for them to participate|2|||
127698251|NCT04952909|459523764|FG000|Overall Study|Death|3|||
127698252|NCT02515773|459523765|FG000|Overall Study|Withdrawal by Subject|12|||
127698253|NCT02515773|459523766|FG001|Overall Study|Withdrawal by Subject|2|||
127698254|NCT02515773|459523765|FG000|Overall Study|Lost to Follow-up|119|||
127698255|NCT02515773|459523766|FG001|Overall Study|Lost to Follow-up|126|||
127698256|NCT02515773|459523765|FG000|Overall Study|Discharged from Clinic Services|53|||
127698257|NCT02515773|459523766|FG001|Overall Study|Discharged from Clinic Services|84|||
127698258|NCT02515773|459523765|FG000|Overall Study|Censored (study ended before participant could complete)|18|||
127698259|NCT02515773|459523766|FG001|Overall Study|Censored (study ended before participant could complete)|24|||
127698260|NCT02515773|459523765|FG000|Overall Study|Follow-up at non-study site|8|||
127698261|NCT02515773|459523766|FG001|Overall Study|Follow-up at non-study site|16|||
127698262|NCT02515773|459523765|FG000|Overall Study|Moved from area|9|||
127698263|NCT02515773|459523766|FG001|Overall Study|Moved from area|14|||
127698264|NCT03468218|459523767|FG000|Overall Study|Adverse Event|5|||
127698265|NCT03468218|459523767|FG000|Overall Study|Progressive Disease|16|||
127698266|NCT03468218|459523767|FG000|Overall Study|Death|1|||
127698267|NCT03468218|459523767|FG000|Overall Study|Alternate therapy|1|||
127698268|NCT03468218|459523767|FG000|Overall Study|Withdrawal by Subject|2|||
127698269|NCT03829410|459523769|FG000|Overall Study|Adverse Event|1|||
127698270|NCT03829410|459523770|FG001|Overall Study|Adverse Event|0|||
127698271|NCT03829410|459523771|FG002|Overall Study|Adverse Event|1|||
127698272|NCT03829410|459523772|FG003|Overall Study|Adverse Event|4|||
127698273|NCT03829410|459523769|FG000|Overall Study|Physician Decision|0|||
127698274|NCT03829410|459523770|FG001|Overall Study|Physician Decision|0|||
127698275|NCT03829410|459523771|FG002|Overall Study|Physician Decision|0|||
127698276|NCT03829410|459523772|FG003|Overall Study|Physician Decision|2|||
127698277|NCT03829410|459523769|FG000|Overall Study|Disease Progressing|3|||
127698278|NCT03829410|459523770|FG001|Overall Study|Disease Progressing|4|||
127698279|NCT03829410|459523771|FG002|Overall Study|Disease Progressing|2|||
127698280|NCT03829410|459523772|FG003|Overall Study|Disease Progressing|31|||
127698281|NCT03829410|459523769|FG000|Overall Study|Miscellaneous|2|||
127698282|NCT03829410|459523770|FG001|Overall Study|Miscellaneous|4|||
127698283|NCT03829410|459523771|FG002|Overall Study|Miscellaneous|3|||
127698284|NCT03829410|459523772|FG003|Overall Study|Miscellaneous|10|||
127698285|NCT03719443|459523773|FG000|Overall Study|Lost to Follow-up|0|||
127698286|NCT03719443|459523774|FG001|Overall Study|Lost to Follow-up|0|||
127698287|NCT03719443|459523775|FG002|Overall Study|Lost to Follow-up|1|||
127698288|NCT03719443|459523776|FG003|Overall Study|Lost to Follow-up|0|||
127698289|NCT03719443|459523777|FG004|Overall Study|Lost to Follow-up|1|||
127698290|NCT03719443|459523778|FG005|Overall Study|Lost to Follow-up|0|||
127698291|NCT03719443|459523779|FG006|Overall Study|Lost to Follow-up|1|||
127788943|NCT02831673|459853447|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
127788944|NCT02831673|459853448|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
127788945|NCT02831673|459853449|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
127698292|NCT03719443|459523773|FG000|Overall Study|Withdrawal by Subject|0|||
127698293|NCT03719443|459523774|FG001|Overall Study|Withdrawal by Subject|0|||
127788946|NCT02831673|459853445|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
127698294|NCT03719443|459523775|FG002|Overall Study|Withdrawal by Subject|1|||
127698295|NCT03719443|459523776|FG003|Overall Study|Withdrawal by Subject|0|||
127698296|NCT03719443|459523777|FG004|Overall Study|Withdrawal by Subject|0|||
127698297|NCT03719443|459523778|FG005|Overall Study|Withdrawal by Subject|0|||
127698298|NCT03719443|459523779|FG006|Overall Study|Withdrawal by Subject|0|||
127698299|NCT04924660|459523780|FG000|United States|Death|29|||
127698300|NCT04924660|459523781|FG001|United States|Death|32|||
127698301|NCT04924660|459523782|FG002|United States|Death|34|||
127698302|NCT04924660|459523783|FG003|United States|Death|25|||
127698303|NCT04924660|459523784|FG004|United States|Death|26|||
127698304|NCT04924660|459523785|FG005|United States|Death|23|||
127698305|NCT04924660|459523780|FG000|United States|Lost to Follow-up|15|||
127698306|NCT04924660|459523781|FG001|United States|Lost to Follow-up|10|||
127698307|NCT04924660|459523782|FG002|United States|Lost to Follow-up|13|||
127698308|NCT04924660|459523783|FG003|United States|Lost to Follow-up|5|||
127698309|NCT04924660|459523784|FG004|United States|Lost to Follow-up|19|||
127698310|NCT04924660|459523785|FG005|United States|Lost to Follow-up|20|||
127698311|NCT04924660|459523780|FG000|United States|Withdrawal by Subject|8|||
127698312|NCT04924660|459523781|FG001|United States|Withdrawal by Subject|3|||
127698313|NCT04924660|459523782|FG002|United States|Withdrawal by Subject|3|||
127698314|NCT04924660|459523783|FG003|United States|Withdrawal by Subject|3|||
127698315|NCT04924660|459523784|FG004|United States|Withdrawal by Subject|8|||
127698316|NCT04924660|459523785|FG005|United States|Withdrawal by Subject|4|||
127698317|NCT04924660|459523780|FG000|Spain|Death|0|||
127698318|NCT04924660|459523781|FG001|Spain|Death|0|||
127698319|NCT04924660|459523782|FG002|Spain|Death|0|||
127698320|NCT04924660|459523783|FG003|Spain|Death|0|||
127698321|NCT04924660|459523784|FG004|Spain|Death|0|||
127698322|NCT04924660|459523785|FG005|Spain|Death|2|||
127698323|NCT04924660|459523780|FG000|Spain|Lost to Follow-up|0|||
127698324|NCT04924660|459523781|FG001|Spain|Lost to Follow-up|0|||
127698325|NCT04924660|459523782|FG002|Spain|Lost to Follow-up|0|||
127698326|NCT04924660|459523783|FG003|Spain|Lost to Follow-up|0|||
127698327|NCT04924660|459523784|FG004|Spain|Lost to Follow-up|1|||
127698328|NCT04924660|459523785|FG005|Spain|Lost to Follow-up|0|||
127698329|NCT04924660|459523780|FG000|Brazil|Death|0|||
127698330|NCT04924660|459523781|FG001|Brazil|Death|0|||
127698331|NCT04924660|459523782|FG002|Brazil|Death|0|||
127698332|NCT04924660|459523783|FG003|Brazil|Death|0|||
127698333|NCT04924660|459523784|FG004|Brazil|Death|1|||
127698334|NCT04924660|459523785|FG005|Brazil|Death|0|||
127698335|NCT04924660|459523780|FG000|Italy|Lost to Follow-up|0|||
127609573|NCT02290821|459199901|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
127609574|NCT02290821|459199902|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
127609575|NCT02290821|459199901|FG000|Overall Study|Lost to Follow-up|3|||
127609576|NCT02290821|459199902|FG001|Overall Study|Lost to Follow-up|2|||
127609577|NCT02438722|459199903|FG000|Overall Study|Adverse Event|12|||
127609578|NCT02438722|459199904|FG001|Overall Study|Adverse Event|9|||
127609579|NCT02438722|459199903|FG000|Overall Study|Refusal unrelated to AE|2|||
127609580|NCT02438722|459199904|FG001|Overall Study|Refusal unrelated to AE|5|||
127609581|NCT02438722|459199903|FG000|Overall Study|Disease progression/relapse|46|||
127609582|NCT02438722|459199904|FG001|Overall Study|Disease progression/relapse|51|||
127609583|NCT02438722|459199903|FG000|Overall Study|Death|0|||
127609584|NCT02438722|459199904|FG001|Overall Study|Death|3|||
127609585|NCT02438722|459199903|FG000|Overall Study|Physician Decision|2|||
127609586|NCT02438722|459199904|FG001|Overall Study|Physician Decision|2|||
127609587|NCT02438722|459199903|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
127609588|NCT02438722|459199904|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
127609589|NCT02438722|459199903|FG000|Overall Study|Withdrawal by Subject|0|||
127609590|NCT02438722|459199904|FG001|Overall Study|Withdrawal by Subject|1|||
127609591|NCT02438722|459199903|FG000|Overall Study|On protocol treatment|15|||
127609592|NCT02438722|459199904|FG001|Overall Study|On protocol treatment|14|||
127609593|NCT02438722|459199903|FG000|Overall Study|Did not receive protocol treatment|5|||
127609594|NCT02438722|459199904|FG001|Overall Study|Did not receive protocol treatment|0|||
127609595|NCT00909779|459199905|FG000|Overall Study|Adverse Event|53|||
127609596|NCT00909779|459199906|FG001|Overall Study|Adverse Event|55|||
127609597|NCT00909779|459199905|FG000|Overall Study|Lack of Efficacy|7|||
127609598|NCT00909779|459199906|FG001|Overall Study|Lack of Efficacy|4|||
127698336|NCT04924660|459523781|FG001|Italy|Lost to Follow-up|0|||
127698337|NCT04924660|459523782|FG002|Italy|Lost to Follow-up|0|||
127698338|NCT04924660|459523783|FG003|Italy|Lost to Follow-up|0|||
127788947|NCT02831673|459853446|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
127788948|NCT02831673|459853447|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
127609599|NCT00909779|459199905|FG000|Overall Study|Lost to Follow-up|19|||
127609600|NCT00909779|459199906|FG001|Overall Study|Lost to Follow-up|15|||
127698339|NCT04924660|459523784|FG004|Italy|Lost to Follow-up|0|||
127698340|NCT04924660|459523785|FG005|Italy|Lost to Follow-up|1|||
127698341|NCT04924660|459523780|FG000|South Africa|Death|0|||
127698342|NCT04924660|459523781|FG001|South Africa|Death|0|||
127698343|NCT04924660|459523782|FG002|South Africa|Death|0|||
127882932|NCT00996918|460194619|FG003|Overall Study|Other|0|||
127609601|NCT00909779|459199905|FG000|Overall Study|Physician Decision|8|||
127698344|NCT04924660|459523783|FG003|South Africa|Death|0|||
127698345|NCT04924660|459523784|FG004|South Africa|Death|0|||
127698346|NCT04924660|459523785|FG005|South Africa|Death|1|||
127698347|NCT04924660|459523780|FG000|South Africa|Lost to Follow-up|0|||
127698348|NCT04924660|459523781|FG001|South Africa|Lost to Follow-up|0|||
127698349|NCT04924660|459523782|FG002|South Africa|Lost to Follow-up|0|||
127609602|NCT00909779|459199906|FG001|Overall Study|Physician Decision|2|||
127609603|NCT00909779|459199905|FG000|Overall Study|Protocol Violation|2|||
127609604|NCT00909779|459199906|FG001|Overall Study|Protocol Violation|5|||
127609605|NCT00909779|459199905|FG000|Overall Study|Withdrawal by Subject|116|||
127609606|NCT00909779|459199906|FG001|Overall Study|Withdrawal by Subject|80|||
127609607|NCT00909779|459199905|FG000|Overall Study|Site Ceasing Operation|2|||
127609608|NCT00909779|459199906|FG001|Overall Study|Site Ceasing Operation|2|||
127609609|NCT00909779|459199905|FG000|Overall Study|Medical Monitor Decision|1|||
127609610|NCT00909779|459199906|FG001|Overall Study|Medical Monitor Decision|0|||
127609611|NCT00909779|459199905|FG000|Overall Study|Noncompliance|1|||
127609612|NCT00909779|459199906|FG001|Overall Study|Noncompliance|1|||
127609613|NCT00909779|459199905|FG000|Overall Study|Randomized in error|1|||
127609614|NCT00909779|459199906|FG001|Overall Study|Randomized in error|1|||
127609615|NCT00949325|459199909|FG000|Overall Study|Adverse Event|0|||
127609616|NCT00949325|459199910|FG001|Overall Study|Adverse Event|2|||
127609617|NCT00949325|459199911|FG002|Overall Study|Adverse Event|0|||
127609618|NCT01520363|459199912|FG000|Overall Study|Withdrawal by Subject|2|||
127609619|NCT01520363|459199913|FG001|Overall Study|Withdrawal by Subject|0|||
127609620|NCT01498952|459199917|FG000|Overall Study|Death|2|||
127609621|NCT01498952|459199918|FG001|Overall Study|Death|2|||
127609622|NCT01498952|459199919|FG002|Overall Study|Death|0|||
127609623|NCT01498952|459199920|FG003|Overall Study|Death|0|||
127609624|NCT01498952|459199921|FG004|Overall Study|Death|0|||
127609625|NCT00579826|459199922|FG000|Overall Study|Withdrawal by Subject|5|||
127609626|NCT00579826|459199923|FG001|Overall Study|Withdrawal by Subject|3|||
127609627|NCT04191382|459199924|FG000|Overall Study|Withdrawal by Subject|1|||
127609628|NCT04191382|459199925|FG001|Overall Study|Withdrawal by Subject|0|||
127609629|NCT04191382|459199926|FG002|Overall Study|Withdrawal by Subject|0|||
127609630|NCT05237206|459199927|FG000|Overall Study|screen failure-did not receive treatment|8|||
127609631|NCT05237206|459199927|FG000|Overall Study|did not receive treatment|3|||
127609632|NCT00728130|459199928|FG000|Overall Study|Withdrawal by Subject|1|||
127609633|NCT00728130|459199928|FG000|Overall Study|Paperwork not completed in time|1|||
127609634|NCT00728130|459199928|FG000|Overall Study|Physician Decision|1|||
127609635|NCT00729183|459199929|FG000|Overall Study|Adverse Event|11|||
127609636|NCT00729183|459199930|FG001|Overall Study|Adverse Event|5|||
127609637|NCT00729183|459199929|FG000|Overall Study|Lack of Efficacy|0|||
127609638|NCT00729183|459199930|FG001|Overall Study|Lack of Efficacy|1|||
127609639|NCT00729183|459199929|FG000|Overall Study|Lost to Follow-up|3|||
127609640|NCT00729183|459199930|FG001|Overall Study|Lost to Follow-up|1|||
127609641|NCT00729183|459199929|FG000|Overall Study|Physician Decision|1|||
127609642|NCT00729183|459199930|FG001|Overall Study|Physician Decision|1|||
127609643|NCT00729183|459199929|FG000|Overall Study|Protocol Violation|1|||
127609644|NCT00729183|459199930|FG001|Overall Study|Protocol Violation|0|||
127609645|NCT00729183|459199929|FG000|Overall Study|Withdrawal by Subject|9|||
127609646|NCT00729183|459199930|FG001|Overall Study|Withdrawal by Subject|7|||
127609647|NCT03878446|459199933|FG000|Overall Study|Withdrawn by parent or guardian|1|||
127609648|NCT03878446|459199934|FG001|Overall Study|Withdrawn by parent or guardian|0|||
127609649|NCT03878446|459199935|FG002|Overall Study|Withdrawn by parent or guardian|0|||
127609650|NCT03878446|459199936|FG003|Overall Study|Withdrawn by parent or guardian|0|||
127609651|NCT03878446|459199937|FG004|Overall Study|Withdrawn by parent or guardian|0|||
127609652|NCT00489853|459201753|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
127609653|NCT00489853|459201754|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
127609654|NCT00489853|459201755|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
127609655|NCT00489853|459201753|FG000|Wash-out Period 1|Adverse Event|0|||
127609656|NCT00489853|459201754|FG001|Wash-out Period 1|Adverse Event|1|||
127609657|NCT00489853|459201755|FG002|Wash-out Period 1|Adverse Event|1|||
127609658|NCT00489853|459201753|FG000|Wash-out Period 1|Protocol Violation|0|||
127609659|NCT00489853|459201754|FG001|Wash-out Period 1|Protocol Violation|1|||
127609660|NCT00489853|459201755|FG002|Wash-out Period 1|Protocol Violation|1|||
127609661|NCT00489853|459201753|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
127609662|NCT00489853|459201754|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
127609663|NCT00489853|459201755|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
127609664|NCT00489853|459201753|FG000|Wash-out Period 2|Adverse Event|1|||
127609665|NCT00489853|459201754|FG001|Wash-out Period 2|Adverse Event|1|||
127609666|NCT00489853|459201755|FG002|Wash-out Period 2|Adverse Event|0|||
127609667|NCT00489853|459201753|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
127609668|NCT00489853|459201754|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
127609669|NCT00489853|459201755|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
127609670|NCT00489853|459201753|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
127609671|NCT00489853|459201754|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
127609672|NCT00489853|459201755|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
127609673|NCT01541969|459201758|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
127609674|NCT01541969|459201759|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
127609675|NCT01541969|459201758|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
127698350|NCT04924660|459523783|FG003|South Africa|Lost to Follow-up|0|||
127609676|NCT01541969|459201759|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
127609677|NCT01541969|459201758|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
127609678|NCT01541969|459201759|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
127609679|NCT01541969|459201758|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
127609680|NCT01541969|459201759|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
127609681|NCT01541969|459201758|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
127609682|NCT01541969|459201759|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
127609683|NCT01541969|459201758|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
127609684|NCT01541969|459201759|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
127609685|NCT01541969|459201758|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
127609686|NCT01541969|459201759|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
127609687|NCT01541969|459201758|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
127609688|NCT01541969|459201759|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
127609689|NCT01541969|459201758|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
127609690|NCT01541969|459201759|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
127609691|NCT01541969|459201758|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
127609692|NCT01541969|459201759|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
127609693|NCT05123222|459201760|FG000|Overall Study|Lost to Follow-up|2|||
127609694|NCT05123222|459201761|FG001|Overall Study|Lost to Follow-up|0|||
127609695|NCT05123222|459201762|FG002|Overall Study|Lost to Follow-up|0|||
127609696|NCT05123222|459201763|FG003|Overall Study|Lost to Follow-up|0|||
127609697|NCT05123222|459201760|FG000|Overall Study|Protocol Violation|0|||
127609698|NCT05123222|459201761|FG001|Overall Study|Protocol Violation|0|||
127609699|NCT05123222|459201762|FG002|Overall Study|Protocol Violation|1|||
127609700|NCT05123222|459201763|FG003|Overall Study|Protocol Violation|0|||
127609701|NCT02255500|459201768|FG000|Overall Study|Withdrawal by Subject|1|||
127788949|NCT02831673|459853448|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
127788950|NCT02831673|459853449|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
127788951|NCT02831673|459853445|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
127788952|NCT02831673|459853446|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
127788953|NCT02831673|459853447|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
127788954|NCT02831673|459853448|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
127788955|NCT02831673|459853449|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
127788956|NCT02831673|459853445|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
127788957|NCT02831673|459853446|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
127788958|NCT02831673|459853447|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
127788959|NCT02831673|459853448|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
127788960|NCT02831673|459853449|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
127788961|NCT02831673|459853445|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
127788962|NCT02831673|459853446|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
127788963|NCT02831673|459853447|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
127788964|NCT02831673|459853448|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
127788965|NCT02831673|459853449|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
127788966|NCT02831673|459853445|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
127788967|NCT02831673|459853446|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
127788968|NCT02831673|459853447|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
127788969|NCT02831673|459853448|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
127788970|NCT02831673|459853449|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
127609702|NCT02255500|459201769|FG001|Overall Study|Withdrawal by Subject|0|||
127609703|NCT00265343|459201770|FG000|Overall Study|Adverse Event|10|||
127609704|NCT00265343|459201771|FG001|Overall Study|Adverse Event|7|||
127788971|NCT02831673|459853445|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
127788972|NCT02831673|459853446|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
127788973|NCT02831673|459853447|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
127788974|NCT02831673|459853448|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
127788975|NCT02831673|459853449|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
127788976|NCT02831673|459853445|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
127788977|NCT02831673|459853446|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
127609705|NCT00265343|459201770|FG000|Overall Study|Withdrawal by Subject|3|||
127609706|NCT00265343|459201771|FG001|Overall Study|Withdrawal by Subject|9|||
127788978|NCT02831673|459853447|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
127882933|NCT00996918|460194620|FG004|Overall Study|Other|0|||
127609707|NCT00265343|459201770|FG000|Overall Study|Other|8|||
127609708|NCT00265343|459201771|FG001|Overall Study|Other|3|||
127609709|NCT04865354|459201772|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
127609710|NCT04865354|459201773|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
127609711|NCT04865354|459201772|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
127609712|NCT04865354|459201773|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
127609713|NCT04865354|459201772|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
127609714|NCT04865354|459201773|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
127609715|NCT00706641|459201778|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
127609716|NCT00706641|459201778|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
127609717|NCT00706641|459201778|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
127609718|NCT00588822|459201779|FG000|Overall Study|progression of disease|8|||
127609719|NCT04762680|459201781|FG000|Phase 2|Adverse Event|0|||
127609720|NCT04762680|459201782|FG001|Phase 2|Adverse Event|1|||
127609721|NCT04762680|459201783|FG002|Phase 2|Adverse Event|0|||
127609722|NCT04762680|459201784|FG003|Phase 2|Adverse Event|0|||
127609723|NCT04762680|459201785|FG004|Phase 2|Adverse Event|0|||
127609724|NCT04762680|459201786|FG005|Phase 2|Adverse Event|0|||
127609725|NCT04762680|459201787|FG006|Phase 2|Adverse Event|0|||
127609726|NCT04762680|459201788|FG007|Phase 2|Adverse Event|0|||
127609727|NCT04762680|459201789|FG008|Phase 2|Adverse Event|0|||
127609728|NCT04762680|459201790|FG009|Phase 2|Adverse Event|0|||
127609729|NCT04762680|459201791|FG010|Phase 2|Adverse Event|0|||
127609730|NCT04762680|459201792|FG011|Phase 2|Adverse Event|0|||
127609731|NCT04762680|459201793|FG012|Phase 2|Adverse Event|0|||
127609732|NCT04762680|459201794|FG013|Phase 2|Adverse Event|0|||
127609733|NCT04762680|459201795|FG014|Phase 2|Adverse Event|0|||
127609734|NCT04762680|459201796|FG015|Phase 2|Adverse Event|0|||
127609735|NCT04762680|459201797|FG016|Phase 2|Adverse Event|0|||
127609736|NCT04762680|459201798|FG017|Phase 2|Adverse Event|0|||
127609737|NCT04762680|459201799|FG018|Phase 2|Adverse Event|0|||
127609738|NCT04762680|459201800|FG019|Phase 2|Adverse Event|0|||
127609739|NCT04762680|459201801|FG020|Phase 2|Adverse Event|0|||
127609740|NCT04762680|459201802|FG021|Phase 2|Adverse Event|0|||
127609741|NCT04762680|459201781|FG000|Phase 2|Protocol Violation|5|||
127609742|NCT04762680|459201782|FG001|Phase 2|Protocol Violation|5|||
127609743|NCT04762680|459201783|FG002|Phase 2|Protocol Violation|1|||
127609744|NCT04762680|459201784|FG003|Phase 2|Protocol Violation|0|||
127609745|NCT04762680|459201785|FG004|Phase 2|Protocol Violation|0|||
127609746|NCT04762680|459201786|FG005|Phase 2|Protocol Violation|0|||
127609747|NCT04762680|459201787|FG006|Phase 2|Protocol Violation|0|||
127609748|NCT04762680|459201788|FG007|Phase 2|Protocol Violation|0|||
127609749|NCT04762680|459201789|FG008|Phase 2|Protocol Violation|0|||
127609750|NCT04762680|459201790|FG009|Phase 2|Protocol Violation|0|||
127609751|NCT04762680|459201791|FG010|Phase 2|Protocol Violation|0|||
127609752|NCT04762680|459201792|FG011|Phase 2|Protocol Violation|0|||
127609753|NCT04762680|459201793|FG012|Phase 2|Protocol Violation|0|||
127609754|NCT04762680|459201794|FG013|Phase 2|Protocol Violation|0|||
127609755|NCT04762680|459201795|FG014|Phase 2|Protocol Violation|0|||
127609756|NCT04762680|459201796|FG015|Phase 2|Protocol Violation|0|||
127609757|NCT04762680|459201797|FG016|Phase 2|Protocol Violation|0|||
127609758|NCT04762680|459201798|FG017|Phase 2|Protocol Violation|0|||
127609759|NCT04762680|459201799|FG018|Phase 2|Protocol Violation|0|||
127609760|NCT04762680|459201800|FG019|Phase 2|Protocol Violation|0|||
127609761|NCT04762680|459201801|FG020|Phase 2|Protocol Violation|0|||
127609762|NCT04762680|459201802|FG021|Phase 2|Protocol Violation|0|||
127609763|NCT04762680|459201781|FG000|Phase 2|Withdrawal by Subject|23|||
127609764|NCT04762680|459201782|FG001|Phase 2|Withdrawal by Subject|21|||
127609765|NCT04762680|459201783|FG002|Phase 2|Withdrawal by Subject|28|||
127609766|NCT04762680|459201784|FG003|Phase 2|Withdrawal by Subject|0|||
127609767|NCT04762680|459201785|FG004|Phase 2|Withdrawal by Subject|0|||
127609768|NCT04762680|459201786|FG005|Phase 2|Withdrawal by Subject|0|||
127609769|NCT04762680|459201787|FG006|Phase 2|Withdrawal by Subject|0|||
127609770|NCT04762680|459201788|FG007|Phase 2|Withdrawal by Subject|0|||
127609771|NCT04762680|459201789|FG008|Phase 2|Withdrawal by Subject|0|||
127609772|NCT04762680|459201790|FG009|Phase 2|Withdrawal by Subject|0|||
127609773|NCT04762680|459201791|FG010|Phase 2|Withdrawal by Subject|0|||
127609774|NCT04762680|459201792|FG011|Phase 2|Withdrawal by Subject|0|||
127609775|NCT04762680|459201793|FG012|Phase 2|Withdrawal by Subject|0|||
127609776|NCT04762680|459201794|FG013|Phase 2|Withdrawal by Subject|0|||
127609777|NCT04762680|459201795|FG014|Phase 2|Withdrawal by Subject|0|||
127609778|NCT04762680|459201796|FG015|Phase 2|Withdrawal by Subject|0|||
127609779|NCT04762680|459201797|FG016|Phase 2|Withdrawal by Subject|0|||
127609780|NCT04762680|459201798|FG017|Phase 2|Withdrawal by Subject|0|||
127609781|NCT04762680|459201799|FG018|Phase 2|Withdrawal by Subject|0|||
127609782|NCT04762680|459201800|FG019|Phase 2|Withdrawal by Subject|0|||
127609783|NCT04762680|459201801|FG020|Phase 2|Withdrawal by Subject|0|||
127609784|NCT04762680|459201802|FG021|Phase 2|Withdrawal by Subject|0|||
127609785|NCT04762680|459201781|FG000|Phase 2|Lost to Follow-up|14|||
127609786|NCT04762680|459201782|FG001|Phase 2|Lost to Follow-up|8|||
127609787|NCT04762680|459201783|FG002|Phase 2|Lost to Follow-up|9|||
127609788|NCT04762680|459201784|FG003|Phase 2|Lost to Follow-up|0|||
127609789|NCT04762680|459201785|FG004|Phase 2|Lost to Follow-up|0|||
127609790|NCT04762680|459201786|FG005|Phase 2|Lost to Follow-up|0|||
127609791|NCT04762680|459201787|FG006|Phase 2|Lost to Follow-up|0|||
127609792|NCT04762680|459201788|FG007|Phase 2|Lost to Follow-up|0|||
127609793|NCT04762680|459201789|FG008|Phase 2|Lost to Follow-up|0|||
127609794|NCT04762680|459201790|FG009|Phase 2|Lost to Follow-up|0|||
127609795|NCT04762680|459201791|FG010|Phase 2|Lost to Follow-up|0|||
127609796|NCT04762680|459201792|FG011|Phase 2|Lost to Follow-up|0|||
127609797|NCT04762680|459201793|FG012|Phase 2|Lost to Follow-up|0|||
127609798|NCT04762680|459201794|FG013|Phase 2|Lost to Follow-up|0|||
127609799|NCT04762680|459201795|FG014|Phase 2|Lost to Follow-up|0|||
127609800|NCT04762680|459201796|FG015|Phase 2|Lost to Follow-up|0|||
127609801|NCT04762680|459201797|FG016|Phase 2|Lost to Follow-up|0|||
127609802|NCT04762680|459201798|FG017|Phase 2|Lost to Follow-up|0|||
127609803|NCT04762680|459201799|FG018|Phase 2|Lost to Follow-up|0|||
127609804|NCT04762680|459201800|FG019|Phase 2|Lost to Follow-up|0|||
127609805|NCT04762680|459201801|FG020|Phase 2|Lost to Follow-up|0|||
127609806|NCT04762680|459201802|FG021|Phase 2|Lost to Follow-up|0|||
127609807|NCT04762680|459201781|FG000|Phase 3|Adverse Event|0|||
127609808|NCT04762680|459201782|FG001|Phase 3|Adverse Event|0|||
127609809|NCT04762680|459201783|FG002|Phase 3|Adverse Event|0|||
127609810|NCT04762680|459201784|FG003|Phase 3|Adverse Event|1|||
127609811|NCT04762680|459201785|FG004|Phase 3|Adverse Event|0|||
127609812|NCT04762680|459201786|FG005|Phase 3|Adverse Event|0|||
127609813|NCT04762680|459201787|FG006|Phase 3|Adverse Event|0|||
127609814|NCT04762680|459201788|FG007|Phase 3|Adverse Event|0|||
127609815|NCT04762680|459201789|FG008|Phase 3|Adverse Event|0|||
127609816|NCT04762680|459201790|FG009|Phase 3|Adverse Event|0|||
127609817|NCT04762680|459201791|FG010|Phase 3|Adverse Event|0|||
127609818|NCT04762680|459201792|FG011|Phase 3|Adverse Event|0|||
127609819|NCT04762680|459201793|FG012|Phase 3|Adverse Event|0|||
127609820|NCT04762680|459201794|FG013|Phase 3|Adverse Event|0|||
127609821|NCT04762680|459201795|FG014|Phase 3|Adverse Event|0|||
127609822|NCT04762680|459201796|FG015|Phase 3|Adverse Event|0|||
127609823|NCT04762680|459201797|FG016|Phase 3|Adverse Event|0|||
127609824|NCT04762680|459201798|FG017|Phase 3|Adverse Event|3|||
127609825|NCT04762680|459201799|FG018|Phase 3|Adverse Event|0|||
127609826|NCT04762680|459201800|FG019|Phase 3|Adverse Event|0|||
127609827|NCT04762680|459201801|FG020|Phase 3|Adverse Event|0|||
127609828|NCT04762680|459201802|FG021|Phase 3|Adverse Event|0|||
127609829|NCT04762680|459201781|FG000|Phase 3|Protocol Violation|0|||
127609830|NCT04762680|459201782|FG001|Phase 3|Protocol Violation|0|||
127609831|NCT04762680|459201783|FG002|Phase 3|Protocol Violation|0|||
127609832|NCT04762680|459201784|FG003|Phase 3|Protocol Violation|4|||
127609833|NCT04762680|459201785|FG004|Phase 3|Protocol Violation|1|||
127609834|NCT04762680|459201786|FG005|Phase 3|Protocol Violation|5|||
127609835|NCT04762680|459201787|FG006|Phase 3|Protocol Violation|1|||
127609836|NCT04762680|459201788|FG007|Phase 3|Protocol Violation|0|||
127609837|NCT04762680|459201789|FG008|Phase 3|Protocol Violation|0|||
127609838|NCT04762680|459201790|FG009|Phase 3|Protocol Violation|0|||
127609839|NCT04762680|459201791|FG010|Phase 3|Protocol Violation|0|||
127609840|NCT04762680|459201792|FG011|Phase 3|Protocol Violation|2|||
127609841|NCT04762680|459201793|FG012|Phase 3|Protocol Violation|3|||
127609842|NCT04762680|459201794|FG013|Phase 3|Protocol Violation|0|||
127609843|NCT04762680|459201795|FG014|Phase 3|Protocol Violation|0|||
127609844|NCT04762680|459201796|FG015|Phase 3|Protocol Violation|1|||
127609845|NCT04762680|459201797|FG016|Phase 3|Protocol Violation|0|||
127609846|NCT04762680|459201798|FG017|Phase 3|Protocol Violation|10|||
127609847|NCT04762680|459201799|FG018|Phase 3|Protocol Violation|0|||
127609848|NCT04762680|459201800|FG019|Phase 3|Protocol Violation|0|||
127609849|NCT04762680|459201801|FG020|Phase 3|Protocol Violation|0|||
127698351|NCT04924660|459523784|FG004|South Africa|Lost to Follow-up|0|||
127698352|NCT04924660|459523785|FG005|South Africa|Lost to Follow-up|1|||
127609850|NCT04762680|459201802|FG021|Phase 3|Protocol Violation|0|||
127609851|NCT04762680|459201781|FG000|Phase 3|Withdrawal by Subject|0|||
127609852|NCT04762680|459201782|FG001|Phase 3|Withdrawal by Subject|0|||
127609853|NCT04762680|459201783|FG002|Phase 3|Withdrawal by Subject|0|||
127609854|NCT04762680|459201784|FG003|Phase 3|Withdrawal by Subject|13|||
127609855|NCT04762680|459201785|FG004|Phase 3|Withdrawal by Subject|17|||
127609856|NCT04762680|459201786|FG005|Phase 3|Withdrawal by Subject|12|||
127609857|NCT04762680|459201787|FG006|Phase 3|Withdrawal by Subject|8|||
127609858|NCT04762680|459201788|FG007|Phase 3|Withdrawal by Subject|3|||
127609859|NCT04762680|459201789|FG008|Phase 3|Withdrawal by Subject|2|||
127609860|NCT04762680|459201790|FG009|Phase 3|Withdrawal by Subject|4|||
127609861|NCT04762680|459201791|FG010|Phase 3|Withdrawal by Subject|3|||
127609862|NCT04762680|459201792|FG011|Phase 3|Withdrawal by Subject|1|||
127609863|NCT04762680|459201793|FG012|Phase 3|Withdrawal by Subject|3|||
127609864|NCT04762680|459201794|FG013|Phase 3|Withdrawal by Subject|2|||
127609865|NCT04762680|459201795|FG014|Phase 3|Withdrawal by Subject|1|||
127609866|NCT04762680|459201796|FG015|Phase 3|Withdrawal by Subject|4|||
127609867|NCT04762680|459201797|FG016|Phase 3|Withdrawal by Subject|6|||
127609868|NCT04762680|459201798|FG017|Phase 3|Withdrawal by Subject|32|||
127609869|NCT04762680|459201799|FG018|Phase 3|Withdrawal by Subject|0|||
127609870|NCT04762680|459201800|FG019|Phase 3|Withdrawal by Subject|0|||
127698353|NCT03557697|459523786|FG000|Overall Study|Withdrawal by Subject|2|||
127698354|NCT03557697|459523787|FG001|Overall Study|Withdrawal by Subject|4|||
127698355|NCT04749615|459523789|FG000|Overall Study|Lost to Follow-up|6|||
127698356|NCT04749615|459523790|FG001|Overall Study|Lost to Follow-up|10|||
127698357|NCT03611491|459523791|FG000|Overall Study|Lost to Follow-up|1|||
127698358|NCT04676022|459523792|FG000|Overall Study|Screen Failure/|1|||
127698359|NCT04676022|459523793|FG001|Overall Study|Screen Failure/|1|||
127698360|NCT04676022|459523794|FG002|Overall Study|Screen Failure/|85|||
127698361|NCT04676022|459523792|FG000|Overall Study|Lost to Follow-up|1|||
127698362|NCT04676022|459523793|FG001|Overall Study|Lost to Follow-up|1|||
127698363|NCT04676022|459523794|FG002|Overall Study|Lost to Follow-up|0|||
127698364|NCT04676022|459523792|FG000|Overall Study|Adverse Event|2|||
127698365|NCT04676022|459523793|FG001|Overall Study|Adverse Event|0|||
127698366|NCT04676022|459523794|FG002|Overall Study|Adverse Event|1|||
127698367|NCT04676022|459523792|FG000|Overall Study|Physician Decision|2|||
127698368|NCT04676022|459523793|FG001|Overall Study|Physician Decision|0|||
127698369|NCT04676022|459523794|FG002|Overall Study|Physician Decision|1|||
127698370|NCT04676022|459523792|FG000|Overall Study|Withdrawal by Subject|3|||
127698371|NCT04676022|459523793|FG001|Overall Study|Withdrawal by Subject|1|||
127698372|NCT04676022|459523794|FG002|Overall Study|Withdrawal by Subject|6|||
127698373|NCT04676022|459523792|FG000|Overall Study|Will not move forward with permanent implant|6|||
127698374|NCT04676022|459523793|FG001|Overall Study|Will not move forward with permanent implant|0|||
127698375|NCT04676022|459523794|FG002|Overall Study|Will not move forward with permanent implant|0|||
127698376|NCT04676022|459523792|FG000|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|7|||
127698377|NCT04676022|459523793|FG001|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
127882934|NCT04440007|460194625|FG000|Overall Study|Adverse Event|0|||
127609871|NCT04762680|459201801|FG020|Phase 3|Withdrawal by Subject|0|||
127609872|NCT04762680|459201802|FG021|Phase 3|Withdrawal by Subject|0|||
127609873|NCT04762680|459201781|FG000|Phase 3|Lost to Follow-up|0|||
127609874|NCT04762680|459201782|FG001|Phase 3|Lost to Follow-up|0|||
127609875|NCT04762680|459201783|FG002|Phase 3|Lost to Follow-up|0|||
127609876|NCT04762680|459201784|FG003|Phase 3|Lost to Follow-up|9|||
127609877|NCT04762680|459201785|FG004|Phase 3|Lost to Follow-up|22|||
127609878|NCT04762680|459201786|FG005|Phase 3|Lost to Follow-up|24|||
127609879|NCT04762680|459201787|FG006|Phase 3|Lost to Follow-up|2|||
127609880|NCT04762680|459201788|FG007|Phase 3|Lost to Follow-up|4|||
127609881|NCT04762680|459201789|FG008|Phase 3|Lost to Follow-up|6|||
127609882|NCT04762680|459201790|FG009|Phase 3|Lost to Follow-up|4|||
127609883|NCT04762680|459201791|FG010|Phase 3|Lost to Follow-up|3|||
127609884|NCT04762680|459201792|FG011|Phase 3|Lost to Follow-up|0|||
127609885|NCT04762680|459201793|FG012|Phase 3|Lost to Follow-up|5|||
127609886|NCT04762680|459201794|FG013|Phase 3|Lost to Follow-up|4|||
127609887|NCT04762680|459201795|FG014|Phase 3|Lost to Follow-up|6|||
127609888|NCT04762680|459201796|FG015|Phase 3|Lost to Follow-up|1|||
127609889|NCT04762680|459201797|FG016|Phase 3|Lost to Follow-up|1|||
127609890|NCT04762680|459201798|FG017|Phase 3|Lost to Follow-up|66|||
127609891|NCT04762680|459201799|FG018|Phase 3|Lost to Follow-up|0|||
127609892|NCT04762680|459201800|FG019|Phase 3|Lost to Follow-up|0|||
127609893|NCT04762680|459201801|FG020|Phase 3|Lost to Follow-up|0|||
127609894|NCT04762680|459201802|FG021|Phase 3|Lost to Follow-up|0|||
127609895|NCT04762680|459201781|FG000|Phase 3 - Exploratory|Withdrawal by Subject|0|||
127609896|NCT04762680|459201782|FG001|Phase 3 - Exploratory|Withdrawal by Subject|0|||
127609897|NCT04762680|459201783|FG002|Phase 3 - Exploratory|Withdrawal by Subject|0|||
127609898|NCT04762680|459201784|FG003|Phase 3 - Exploratory|Withdrawal by Subject|0|||
127609899|NCT04762680|459201785|FG004|Phase 3 - Exploratory|Withdrawal by Subject|0|||
127609900|NCT04762680|459201786|FG005|Phase 3 - Exploratory|Withdrawal by Subject|0|||
127609901|NCT04762680|459201787|FG006|Phase 3 - Exploratory|Withdrawal by Subject|0|||
127609902|NCT04762680|459201788|FG007|Phase 3 - Exploratory|Withdrawal by Subject|0|||
127609903|NCT04762680|459201789|FG008|Phase 3 - Exploratory|Withdrawal by Subject|0|||
127609904|NCT04762680|459201790|FG009|Phase 3 - Exploratory|Withdrawal by Subject|0|||
127609905|NCT04762680|459201791|FG010|Phase 3 - Exploratory|Withdrawal by Subject|0|||
127609906|NCT04762680|459201792|FG011|Phase 3 - Exploratory|Withdrawal by Subject|0|||
127609907|NCT04762680|459201793|FG012|Phase 3 - Exploratory|Withdrawal by Subject|0|||
127609908|NCT04762680|459201794|FG013|Phase 3 - Exploratory|Withdrawal by Subject|0|||
127609909|NCT04762680|459201795|FG014|Phase 3 - Exploratory|Withdrawal by Subject|0|||
127609910|NCT04762680|459201796|FG015|Phase 3 - Exploratory|Withdrawal by Subject|0|||
127609911|NCT04762680|459201797|FG016|Phase 3 - Exploratory|Withdrawal by Subject|0|||
127609912|NCT04762680|459201798|FG017|Phase 3 - Exploratory|Withdrawal by Subject|0|||
127609913|NCT04762680|459201799|FG018|Phase 3 - Exploratory|Withdrawal by Subject|0|||
127609914|NCT04762680|459201800|FG019|Phase 3 - Exploratory|Withdrawal by Subject|0|||
127609915|NCT04762680|459201801|FG020|Phase 3 - Exploratory|Withdrawal by Subject|0|||
127609916|NCT04762680|459201802|FG021|Phase 3 - Exploratory|Withdrawal by Subject|1|||
127609917|NCT04762680|459201781|FG000|Phase 3 - Exploratory|Lost to Follow-up|0|||
127609918|NCT04762680|459201782|FG001|Phase 3 - Exploratory|Lost to Follow-up|0|||
127609919|NCT04762680|459201783|FG002|Phase 3 - Exploratory|Lost to Follow-up|0|||
127609920|NCT04762680|459201784|FG003|Phase 3 - Exploratory|Lost to Follow-up|0|||
127609921|NCT04762680|459201785|FG004|Phase 3 - Exploratory|Lost to Follow-up|0|||
127609922|NCT04762680|459201786|FG005|Phase 3 - Exploratory|Lost to Follow-up|0|||
127609923|NCT04762680|459201787|FG006|Phase 3 - Exploratory|Lost to Follow-up|0|||
127609924|NCT04762680|459201788|FG007|Phase 3 - Exploratory|Lost to Follow-up|0|||
127609925|NCT04762680|459201789|FG008|Phase 3 - Exploratory|Lost to Follow-up|0|||
127609926|NCT04762680|459201790|FG009|Phase 3 - Exploratory|Lost to Follow-up|0|||
127609927|NCT04762680|459201791|FG010|Phase 3 - Exploratory|Lost to Follow-up|0|||
127609928|NCT04762680|459201792|FG011|Phase 3 - Exploratory|Lost to Follow-up|0|||
127609929|NCT04762680|459201793|FG012|Phase 3 - Exploratory|Lost to Follow-up|0|||
127609930|NCT04762680|459201794|FG013|Phase 3 - Exploratory|Lost to Follow-up|0|||
127609931|NCT04762680|459201795|FG014|Phase 3 - Exploratory|Lost to Follow-up|0|||
127609932|NCT04762680|459201796|FG015|Phase 3 - Exploratory|Lost to Follow-up|0|||
127609933|NCT04762680|459201797|FG016|Phase 3 - Exploratory|Lost to Follow-up|0|||
127609934|NCT04762680|459201798|FG017|Phase 3 - Exploratory|Lost to Follow-up|0|||
127609935|NCT04762680|459201799|FG018|Phase 3 - Exploratory|Lost to Follow-up|0|||
127609936|NCT04762680|459201800|FG019|Phase 3 - Exploratory|Lost to Follow-up|1|||
127609937|NCT04762680|459201801|FG020|Phase 3 - Exploratory|Lost to Follow-up|0|||
127609938|NCT04762680|459201802|FG021|Phase 3 - Exploratory|Lost to Follow-up|0|||
127609939|NCT02520011|459201806|FG000|Overall Study|Adverse Event|0|||
127609940|NCT02520011|459201807|FG001|Overall Study|Adverse Event|1|||
127609941|NCT02520011|459201808|FG002|Overall Study|Adverse Event|2|||
127609942|NCT02520011|459201806|FG000|Overall Study|Death|0|||
127609943|NCT02520011|459201807|FG001|Overall Study|Death|8|||
127609944|NCT02520011|459201808|FG002|Overall Study|Death|1|||
127609945|NCT02520011|459201806|FG000|Overall Study|Lack of Efficacy|4|||
127609946|NCT02520011|459201807|FG001|Overall Study|Lack of Efficacy|26|||
127609947|NCT02520011|459201808|FG002|Overall Study|Lack of Efficacy|4|||
127609948|NCT02520011|459201806|FG000|Overall Study|Physician Decision|0|||
127609949|NCT02520011|459201807|FG001|Overall Study|Physician Decision|2|||
127609950|NCT02520011|459201808|FG002|Overall Study|Physician Decision|0|||
127609951|NCT02520011|459201806|FG000|Overall Study|Withdrawal by Subject|1|||
127609952|NCT02520011|459201807|FG001|Overall Study|Withdrawal by Subject|3|||
127609953|NCT02520011|459201808|FG002|Overall Study|Withdrawal by Subject|0|||
127609954|NCT02520011|459201806|FG000|Overall Study|Protocol Deviation|0|||
127609955|NCT02520011|459201807|FG001|Overall Study|Protocol Deviation|1|||
127609956|NCT02520011|459201808|FG002|Overall Study|Protocol Deviation|0|||
127609957|NCT02520011|459201806|FG000|Overall Study|Patient went to hospice|0|||
127609958|NCT02520011|459201807|FG001|Overall Study|Patient went to hospice|1|||
127609959|NCT02520011|459201808|FG002|Overall Study|Patient went to hospice|0|||
127609960|NCT02520011|459201806|FG000|Overall Study|Progressive disease following response|0|||
127609961|NCT02520011|459201807|FG001|Overall Study|Progressive disease following response|4|||
127609962|NCT02520011|459201808|FG002|Overall Study|Progressive disease following response|2|||
127609963|NCT02436759|459201814|FG000|Overall Study|Adverse Event|3|||
127609964|NCT02436759|459201815|FG001|Overall Study|Adverse Event|0|||
127609965|NCT02436759|459201814|FG000|Overall Study|Protocol Violation|1|||
127609966|NCT02436759|459201815|FG001|Overall Study|Protocol Violation|0|||
127609967|NCT02436759|459201814|FG000|Overall Study|Withdrawal by Subject|0|||
127609968|NCT02436759|459201815|FG001|Overall Study|Withdrawal by Subject|1|||
127609969|NCT00902564|459201816|FG000|Overall Study|Withdrawal by Subject|2|||
127609970|NCT00922766|459201817|FG000|Overall Study|Death|3|||
127609971|NCT00922766|459201817|FG000|Overall Study|Withdrawal by Subject|2|||
127609972|NCT00922766|459201817|FG000|Overall Study|Other|1|||
127609973|NCT00922766|459201817|FG000|Overall Study|Adverse Event|1|||
127609974|NCT03616912|459201820|FG000|Overall Study|Adverse Event|17|||
127609975|NCT03616912|459201821|FG001|Overall Study|Adverse Event|21|||
127788979|NCT02831673|459853448|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
127788980|NCT02831673|459853449|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
127609976|NCT03616912|459201822|FG002|Overall Study|Adverse Event|9|||
127609977|NCT03616912|459201823|FG003|Overall Study|Adverse Event|0|||
127788981|NCT02831673|459853445|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
127788982|NCT02831673|459853446|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
127609978|NCT03616912|459201824|FG004|Overall Study|Adverse Event|0|||
127609979|NCT03616912|459201825|FG005|Overall Study|Adverse Event|0|||
127609980|NCT03616912|459201820|FG000|Overall Study|Death|1|||
127609981|NCT03616912|459201821|FG001|Overall Study|Death|1|||
127609982|NCT03616912|459201822|FG002|Overall Study|Death|0|||
127609983|NCT03616912|459201823|FG003|Overall Study|Death|0|||
127609984|NCT03616912|459201824|FG004|Overall Study|Death|0|||
127609985|NCT03616912|459201825|FG005|Overall Study|Death|0|||
127609986|NCT03616912|459201820|FG000|Overall Study|Lack of Efficacy|13|||
127609987|NCT03616912|459201821|FG001|Overall Study|Lack of Efficacy|6|||
127609988|NCT03616912|459201822|FG002|Overall Study|Lack of Efficacy|8|||
127609989|NCT03616912|459201823|FG003|Overall Study|Lack of Efficacy|4|||
127609990|NCT03616912|459201824|FG004|Overall Study|Lack of Efficacy|5|||
127609991|NCT03616912|459201825|FG005|Overall Study|Lack of Efficacy|1|||
127609992|NCT03616912|459201820|FG000|Overall Study|Lost to Follow-up|1|||
127609993|NCT03616912|459201821|FG001|Overall Study|Lost to Follow-up|2|||
127609994|NCT03616912|459201822|FG002|Overall Study|Lost to Follow-up|3|||
127609995|NCT03616912|459201823|FG003|Overall Study|Lost to Follow-up|0|||
127609996|NCT03616912|459201824|FG004|Overall Study|Lost to Follow-up|0|||
127609997|NCT03616912|459201825|FG005|Overall Study|Lost to Follow-up|0|||
127609998|NCT03616912|459201820|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
127609999|NCT03616912|459201821|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
127610000|NCT03616912|459201822|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
127610001|NCT03616912|459201823|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
127610002|NCT03616912|459201824|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
127610003|NCT03616912|459201825|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
127610004|NCT03616912|459201820|FG000|Overall Study|Withdrawal by Subject|12|||
127610005|NCT03616912|459201821|FG001|Overall Study|Withdrawal by Subject|12|||
127610006|NCT03616912|459201822|FG002|Overall Study|Withdrawal by Subject|15|||
127610007|NCT03616912|459201823|FG003|Overall Study|Withdrawal by Subject|2|||
127610008|NCT03616912|459201824|FG004|Overall Study|Withdrawal by Subject|0|||
127610009|NCT03616912|459201825|FG005|Overall Study|Withdrawal by Subject|2|||
127610010|NCT03616912|459201820|FG000|Overall Study|Study Terminated by Sponsor|0|||
127610011|NCT03616912|459201821|FG001|Overall Study|Study Terminated by Sponsor|0|||
127610012|NCT03616912|459201822|FG002|Overall Study|Study Terminated by Sponsor|0|||
127610013|NCT03616912|459201823|FG003|Overall Study|Study Terminated by Sponsor|10|||
127610014|NCT03616912|459201824|FG004|Overall Study|Study Terminated by Sponsor|9|||
127610015|NCT03616912|459201825|FG005|Overall Study|Study Terminated by Sponsor|11|||
127610016|NCT03616912|459201820|FG000|Overall Study|Protocol Deviation|1|||
127610017|NCT03616912|459201821|FG001|Overall Study|Protocol Deviation|1|||
127610018|NCT03616912|459201822|FG002|Overall Study|Protocol Deviation|0|||
127610019|NCT03616912|459201823|FG003|Overall Study|Protocol Deviation|0|||
127610020|NCT03616912|459201824|FG004|Overall Study|Protocol Deviation|0|||
127610021|NCT03616912|459201825|FG005|Overall Study|Protocol Deviation|0|||
127610022|NCT03616912|459201820|FG000|Overall Study|Pregnancy|1|||
127610023|NCT03616912|459201821|FG001|Overall Study|Pregnancy|0|||
127610024|NCT03616912|459201822|FG002|Overall Study|Pregnancy|4|||
127610025|NCT03616912|459201823|FG003|Overall Study|Pregnancy|0|||
127610026|NCT03616912|459201824|FG004|Overall Study|Pregnancy|0|||
127610027|NCT03616912|459201825|FG005|Overall Study|Pregnancy|0|||
127610028|NCT03616912|459201820|FG000|Overall Study|Protocol Violation|1|||
127610029|NCT03616912|459201821|FG001|Overall Study|Protocol Violation|0|||
127610030|NCT03616912|459201822|FG002|Overall Study|Protocol Violation|2|||
127610031|NCT03616912|459201823|FG003|Overall Study|Protocol Violation|0|||
127610032|NCT03616912|459201824|FG004|Overall Study|Protocol Violation|0|||
127610033|NCT03616912|459201825|FG005|Overall Study|Protocol Violation|0|||
127610034|NCT03616912|459201820|FG000|Overall Study|Physician Decision|2|||
127610035|NCT03616912|459201821|FG001|Overall Study|Physician Decision|0|||
127610036|NCT03616912|459201822|FG002|Overall Study|Physician Decision|0|||
127610037|NCT03616912|459201823|FG003|Overall Study|Physician Decision|0|||
127610038|NCT03616912|459201824|FG004|Overall Study|Physician Decision|1|||
127610039|NCT03616912|459201825|FG005|Overall Study|Physician Decision|0|||
127610040|NCT03616912|459201820|FG000|Overall Study|Randomized But Never Treated|0|||
127610041|NCT03616912|459201821|FG001|Overall Study|Randomized But Never Treated|2|||
127610042|NCT03616912|459201822|FG002|Overall Study|Randomized But Never Treated|0|||
127610043|NCT03616912|459201823|FG003|Overall Study|Randomized But Never Treated|0|||
127610044|NCT03616912|459201824|FG004|Overall Study|Randomized But Never Treated|0|||
127610045|NCT03616912|459201825|FG005|Overall Study|Randomized But Never Treated|0|||
127610046|NCT01649375|459201826|FG000|Up to Week 16|Adverse Event|2|||
127610047|NCT01649375|459201827|FG001|Up to Week 16|Adverse Event|5|||
127610048|NCT01649375|459201828|FG002|Up to Week 16|Adverse Event|4|||
127610049|NCT01649375|459201829|FG003|Up to Week 16|Adverse Event|0|||
127610050|NCT01649375|459201830|FG004|Up to Week 16|Adverse Event|0|||
127610051|NCT01649375|459201826|FG000|Up to Week 16|Lack of Efficacy|0|||
127610052|NCT01649375|459201827|FG001|Up to Week 16|Lack of Efficacy|0|||
127610053|NCT01649375|459201828|FG002|Up to Week 16|Lack of Efficacy|1|||
127610054|NCT01649375|459201829|FG003|Up to Week 16|Lack of Efficacy|0|||
127610055|NCT01649375|459201830|FG004|Up to Week 16|Lack of Efficacy|0|||
127610056|NCT01649375|459201826|FG000|Up to Week 16|Physician Decision|0|||
127788983|NCT02831673|459853447|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
127788984|NCT02831673|459853448|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
127788985|NCT02831673|459853449|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
127610057|NCT01649375|459201827|FG001|Up to Week 16|Physician Decision|0|||
127610058|NCT01649375|459201828|FG002|Up to Week 16|Physician Decision|1|||
127610059|NCT01649375|459201829|FG003|Up to Week 16|Physician Decision|0|||
127610060|NCT01649375|459201830|FG004|Up to Week 16|Physician Decision|0|||
127610061|NCT01649375|459201826|FG000|Up to Week 16|Withdrawal by Subject|2|||
127610062|NCT01649375|459201827|FG001|Up to Week 16|Withdrawal by Subject|1|||
127610063|NCT01649375|459201828|FG002|Up to Week 16|Withdrawal by Subject|2|||
127610064|NCT01649375|459201829|FG003|Up to Week 16|Withdrawal by Subject|0|||
127610065|NCT01649375|459201830|FG004|Up to Week 16|Withdrawal by Subject|0|||
127610066|NCT01649375|459201826|FG000|Up to Week 16|Death|1|||
127610067|NCT01649375|459201827|FG001|Up to Week 16|Death|0|||
127610068|NCT01649375|459201828|FG002|Up to Week 16|Death|0|||
127610069|NCT01649375|459201829|FG003|Up to Week 16|Death|0|||
127610070|NCT01649375|459201830|FG004|Up to Week 16|Death|0|||
127610071|NCT01649375|459201826|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
127610072|NCT01649375|459201827|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
127610073|NCT01649375|459201828|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
127610074|NCT01649375|459201829|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
127610075|NCT01649375|459201830|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
127610076|NCT01649375|459201826|FG000|Week 16 up to Week 260|Non-compliance|0|||
127610077|NCT01649375|459201827|FG001|Week 16 up to Week 260|Non-compliance|1|||
127610078|NCT01649375|459201828|FG002|Week 16 up to Week 260|Non-compliance|0|||
127610079|NCT01649375|459201829|FG003|Week 16 up to Week 260|Non-compliance|1|||
127610080|NCT01649375|459201830|FG004|Week 16 up to Week 260|Non-compliance|0|||
127610081|NCT01649375|459201826|FG000|Week 16 up to Week 260|Physician Decision|0|||
127610082|NCT01649375|459201827|FG001|Week 16 up to Week 260|Physician Decision|2|||
127610083|NCT01649375|459201828|FG002|Week 16 up to Week 260|Physician Decision|0|||
127610084|NCT01649375|459201829|FG003|Week 16 up to Week 260|Physician Decision|0|||
127610085|NCT01649375|459201830|FG004|Week 16 up to Week 260|Physician Decision|0|||
127610086|NCT01649375|459201826|FG000|Week 16 up to Week 260|Technical issues|0|||
127610087|NCT01649375|459201827|FG001|Week 16 up to Week 260|Technical issues|1|||
127610088|NCT01649375|459201828|FG002|Week 16 up to Week 260|Technical issues|0|||
127610089|NCT01649375|459201829|FG003|Week 16 up to Week 260|Technical issues|1|||
127610090|NCT01649375|459201830|FG004|Week 16 up to Week 260|Technical issues|0|||
127610091|NCT01649375|459201826|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
127610092|NCT01649375|459201827|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
127610093|NCT01649375|459201828|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
127610094|NCT01649375|459201829|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
127610095|NCT01649375|459201830|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
127610096|NCT01649375|459201826|FG000|Week 16 up to Week 260|Death|1|||
127610097|NCT01649375|459201827|FG001|Week 16 up to Week 260|Death|1|||
127610098|NCT01649375|459201828|FG002|Week 16 up to Week 260|Death|0|||
127610099|NCT01649375|459201829|FG003|Week 16 up to Week 260|Death|0|||
127610100|NCT01649375|459201830|FG004|Week 16 up to Week 260|Death|0|||
127610101|NCT01649375|459201826|FG000|Week 16 up to Week 260|Adverse Event|5|||
127610102|NCT01649375|459201827|FG001|Week 16 up to Week 260|Adverse Event|2|||
127610103|NCT01649375|459201828|FG002|Week 16 up to Week 260|Adverse Event|0|||
127610104|NCT01649375|459201829|FG003|Week 16 up to Week 260|Adverse Event|3|||
127610105|NCT01649375|459201830|FG004|Week 16 up to Week 260|Adverse Event|2|||
127610106|NCT01124604|459201831|FG000|Overall Study|Adverse Event|10|||
127610107|NCT01124604|459201832|FG001|Overall Study|Adverse Event|1|||
127610108|NCT01124604|459201831|FG000|Overall Study|Lack of Efficacy|1|||
127610109|NCT01124604|459201832|FG001|Overall Study|Lack of Efficacy|0|||
127610110|NCT01124604|459201831|FG000|Overall Study|Withdrawal by Subject|4|||
127610111|NCT01124604|459201832|FG001|Overall Study|Withdrawal by Subject|0|||
127610112|NCT01124604|459201831|FG000|Overall Study|Disease Progression|0|||
127610113|NCT01124604|459201832|FG001|Overall Study|Disease Progression|1|||
127610114|NCT01856790|459201835|FG000|Closed Loop Control|Withdrawal by Subject|2|||
127610115|NCT01856790|459201835|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
127610116|NCT04091646|459201836|FG000|Overall Study|Adverse Event|2|||
127610117|NCT04091646|459201837|FG001|Overall Study|Adverse Event|1|||
127610118|NCT04091646|459201836|FG000|Overall Study|Lost to Follow-up|6|||
127610119|NCT04091646|459201837|FG001|Overall Study|Lost to Follow-up|2|||
127610120|NCT04091646|459201836|FG000|Overall Study|Protocol Violation|0|||
127610121|NCT04091646|459201837|FG001|Overall Study|Protocol Violation|1|||
127610122|NCT04091646|459201836|FG000|Overall Study|Withdrawal by Subject|4|||
127610123|NCT04091646|459201837|FG001|Overall Study|Withdrawal by Subject|1|||
127610124|NCT04091646|459201836|FG000|Overall Study|Participant Incarcerated|1|||
127610125|NCT04091646|459201837|FG001|Overall Study|Participant Incarcerated|0|||
127610126|NCT01762943|459201838|FG000|Overall Study|Physician Decision|1|||
127610127|NCT01762943|459201839|FG001|Overall Study|Physician Decision|1|||
127610128|NCT01762943|459201838|FG000|Overall Study|Protocol Violation|1|||
127610129|NCT01762943|459201839|FG001|Overall Study|Protocol Violation|0|||
127610130|NCT01762943|459201838|FG000|Overall Study|Withdrawal by Subject|2|||
127610131|NCT01762943|459201839|FG001|Overall Study|Withdrawal by Subject|1|||
127610132|NCT02474199|459201840|FG000|Overall Study|Lost to Follow-up|1|||
127610133|NCT02474199|459201841|FG001|Overall Study|Lost to Follow-up|0|||
127610134|NCT02474199|459201842|FG002|Overall Study|Lost to Follow-up|0|||
127610135|NCT02474199|459201843|FG003|Overall Study|Lost to Follow-up|0|||
127610136|NCT02474199|459201840|FG000|Overall Study|Withdrawal by Subject|1|||
127610137|NCT02474199|459201841|FG001|Overall Study|Withdrawal by Subject|2|||
127610138|NCT02474199|459201842|FG002|Overall Study|Withdrawal by Subject|0|||
127610139|NCT02474199|459201843|FG003|Overall Study|Withdrawal by Subject|1|||
127610140|NCT02474199|459201840|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
127610141|NCT02474199|459201841|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
127610142|NCT02474199|459201842|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
127610143|NCT02474199|459201843|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
127610144|NCT02474199|459201840|FG000|Overall Study|Did not meet eligibility criteria|0|||
127610145|NCT02474199|459201841|FG001|Overall Study|Did not meet eligibility criteria|0|||
127610146|NCT02474199|459201842|FG002|Overall Study|Did not meet eligibility criteria|2|||
127610147|NCT02474199|459201843|FG003|Overall Study|Did not meet eligibility criteria|2|||
127610148|NCT03897179|459201844|FG000|Overall Study|Withdrawal by Subject|1|||
127610149|NCT02120950|459201846|FG000|Overall Study|Adverse Event|5|||
127610150|NCT02120950|459201847|FG001|Overall Study|Adverse Event|4|||
127610151|NCT02120950|459201848|FG002|Overall Study|Adverse Event|3|||
127610152|NCT02120950|459201846|FG000|Overall Study|Death|3|||
127610153|NCT02120950|459201847|FG001|Overall Study|Death|0|||
127610154|NCT02120950|459201848|FG002|Overall Study|Death|1|||
127610155|NCT02120950|459201846|FG000|Overall Study|Withdrawal by Subject|6|||
127610156|NCT02120950|459201847|FG001|Overall Study|Withdrawal by Subject|3|||
127610157|NCT02120950|459201848|FG002|Overall Study|Withdrawal by Subject|2|||
127610158|NCT02120950|459201846|FG000|Overall Study|Protocol Violation|1|||
127610159|NCT02120950|459201847|FG001|Overall Study|Protocol Violation|1|||
127610160|NCT02120950|459201848|FG002|Overall Study|Protocol Violation|7|||
127610161|NCT02120950|459201846|FG000|Overall Study|Other reasons|5|||
127610162|NCT02120950|459201847|FG001|Overall Study|Other reasons|4|||
127610163|NCT02120950|459201848|FG002|Overall Study|Other reasons|1|||
127610164|NCT02120950|459201846|FG000|Overall Study|Lost to Follow-up|0|||
127610165|NCT02120950|459201847|FG001|Overall Study|Lost to Follow-up|2|||
127610166|NCT02120950|459201848|FG002|Overall Study|Lost to Follow-up|1|||
127610167|NCT02424383|459201849|FG000|Overall Study|Withdrawal by Subject|32|||
127610168|NCT02424383|459201849|FG000|Overall Study|Death|170|||
127610169|NCT02424383|459201849|FG000|Overall Study|Sponsor's decision|3|||
127610170|NCT02424383|459201849|FG000|Overall Study|Investigator's decision|44|||
127610171|NCT02424383|459201849|FG000|Overall Study|Lost to Follow-up|81|||
127610172|NCT02424383|459201849|FG000|Overall Study|Other|7|||
127610173|NCT02424383|459201849|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
127610174|NCT02738333|459201853|FG000|Overall Study|Death|1|||
127610175|NCT02738333|459201854|FG001|Overall Study|Death|0|||
127610176|NCT02738333|459201855|FG002|Overall Study|Death|0|||
127610177|NCT02738333|459201853|FG000|Overall Study|Lost to Follow-up|1|||
127610178|NCT02738333|459201854|FG001|Overall Study|Lost to Follow-up|0|||
127610179|NCT02738333|459201855|FG002|Overall Study|Lost to Follow-up|0|||
127610180|NCT00791518|459201856|FG000|Overall Study|Protocol Violation|93|||
127610181|NCT00454987|459201862|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
127610182|NCT00454987|459201863|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
127610183|NCT00454987|459201864|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
127610184|NCT00454987|459201862|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
127610185|NCT00454987|459201863|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
127610186|NCT00454987|459201864|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
127610187|NCT00454987|459201862|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
127610188|NCT00454987|459201863|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
127610189|NCT00454987|459201864|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
127610190|NCT02205333|459201865|FG000|Overall Study|Death|5|||
127610191|NCT02205333|459201866|FG001|Overall Study|Death|6|||
127610192|NCT02205333|459201867|FG002|Overall Study|Death|2|||
127610193|NCT02205333|459201868|FG003|Overall Study|Death|6|||
127610194|NCT02205333|459201869|FG004|Overall Study|Death|5|||
127610195|NCT02205333|459201870|FG005|Overall Study|Death|3|||
127610196|NCT02205333|459201871|FG006|Overall Study|Death|3|||
127610197|NCT02205333|459201872|FG007|Overall Study|Death|2|||
127610198|NCT02205333|459201873|FG008|Overall Study|Death|0|||
127610199|NCT02205333|459201865|FG000|Overall Study|Withdrawal by Subject|1|||
127610200|NCT02205333|459201866|FG001|Overall Study|Withdrawal by Subject|0|||
127610201|NCT02205333|459201867|FG002|Overall Study|Withdrawal by Subject|0|||
127610202|NCT02205333|459201868|FG003|Overall Study|Withdrawal by Subject|1|||
127610203|NCT02205333|459201869|FG004|Overall Study|Withdrawal by Subject|0|||
127610204|NCT02205333|459201870|FG005|Overall Study|Withdrawal by Subject|0|||
127610205|NCT02205333|459201871|FG006|Overall Study|Withdrawal by Subject|2|||
127610206|NCT02205333|459201872|FG007|Overall Study|Withdrawal by Subject|0|||
127610207|NCT02205333|459201873|FG008|Overall Study|Withdrawal by Subject|0|||
127610208|NCT01476696|459201874|FG000|Overall Study|Sponsor decision|2|||
127610209|NCT01476696|459201875|FG001|Overall Study|Sponsor decision|1|||
127610210|NCT01476696|459201876|FG002|Overall Study|Sponsor decision|0|||
127610211|NCT01476696|459201874|FG000|Overall Study|Withdrawal by Subject|1|||
127610212|NCT01476696|459201875|FG001|Overall Study|Withdrawal by Subject|0|||
127610213|NCT01476696|459201876|FG002|Overall Study|Withdrawal by Subject|0|||
127610214|NCT02009046|459201877|FG000|Overall Study|Lost to Follow-up|256|||
127610215|NCT02009046|459201878|FG001|Overall Study|Lost to Follow-up|206|||
127610216|NCT02073279|459201885|FG000|Double-blind Period|Adverse Event|1|||
127610217|NCT02073279|459201886|FG001|Double-blind Period|Adverse Event|1|||
127610218|NCT02073279|459201885|FG000|Double-blind Period|Switched to another treatment|1|||
127610219|NCT02073279|459201886|FG001|Double-blind Period|Switched to another treatment|2|||
127610220|NCT02073279|459201885|FG000|Double-blind Period|Protocol Violation|0|||
127610221|NCT02073279|459201886|FG001|Double-blind Period|Protocol Violation|1|||
127610222|NCT02073279|459201885|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
127610223|NCT02073279|459201886|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
127610224|NCT02073279|459201885|FG000|Double-blind Period|Withdrawal by Subject|2|||
127610225|NCT02073279|459201886|FG001|Double-blind Period|Withdrawal by Subject|2|||
127610226|NCT02073279|459201885|FG000|Open-label Extension Period|Adverse Event|1|||
127610227|NCT02073279|459201886|FG001|Open-label Extension Period|Adverse Event|0|||
127610228|NCT02073279|459201885|FG000|Open-label Extension Period|Lack of Efficacy|1|||
127610229|NCT02073279|459201886|FG001|Open-label Extension Period|Lack of Efficacy|0|||
127610230|NCT02073279|459201885|FG000|Open-label Extension Period|Lost to Follow-up|0|||
127610231|NCT02073279|459201886|FG001|Open-label Extension Period|Lost to Follow-up|4|||
127610232|NCT02073279|459201885|FG000|Open-label Extension Period|Switched to another treatment|1|||
127610233|NCT02073279|459201886|FG001|Open-label Extension Period|Switched to another treatment|4|||
127610234|NCT02073279|459201885|FG000|Open-label Extension Period|Protocol Violation|0|||
127610235|NCT02073279|459201886|FG001|Open-label Extension Period|Protocol Violation|1|||
127610236|NCT02073279|459201885|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
127610237|NCT02073279|459201886|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
127610238|NCT02073279|459201885|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
127610239|NCT02073279|459201886|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
127610240|NCT00973479|459201887|FG000|Overall Study|Lost to Follow-up|0|||
127610241|NCT00973479|459201888|FG001|Overall Study|Lost to Follow-up|3|||
127610242|NCT00973479|459201887|FG000|Overall Study|Death|2|||
127610243|NCT00973479|459201888|FG001|Overall Study|Death|2|||
127610244|NCT00973479|459201887|FG000|Overall Study|Withdrawal by Subject|15|||
127610245|NCT00973479|459201888|FG001|Overall Study|Withdrawal by Subject|16|||
127610246|NCT00973479|459201887|FG000|Overall Study|Lack of Efficacy|5|||
127610247|NCT00973479|459201888|FG001|Overall Study|Lack of Efficacy|7|||
127610248|NCT00973479|459201887|FG000|Overall Study|Adverse Event|12|||
127610249|NCT00973479|459201888|FG001|Overall Study|Adverse Event|32|||
127610250|NCT00973479|459201887|FG000|Overall Study|Protocol Violation|2|||
127610251|NCT00973479|459201888|FG001|Overall Study|Protocol Violation|2|||
127610252|NCT00973479|459201887|FG000|Overall Study|Other|1|||
127610253|NCT00973479|459201888|FG001|Overall Study|Other|7|||
127610254|NCT01737047|459201889|FG000|Overall Study|Death|10|||
127610255|NCT01737047|459201890|FG001|Overall Study|Death|0|||
127610256|NCT01737047|459201891|FG002|Overall Study|Death|1|||
127610257|NCT01737047|459201889|FG000|Overall Study|Withdrawal by Subject|17|||
127610258|NCT01737047|459201890|FG001|Overall Study|Withdrawal by Subject|11|||
127610259|NCT01737047|459201891|FG002|Overall Study|Withdrawal by Subject|4|||
127610260|NCT00335972|459201892|FG000|Overall Study|not given treatments|0|||
127610261|NCT00335972|459201893|FG001|Overall Study|not given treatments|3|||
127610262|NCT03965962|459201894|FG000|Overall Study|Adverse Event|1|||
127610263|NCT03965962|459201895|FG001|Overall Study|Adverse Event|0|||
127610264|NCT03965962|459201896|FG002|Overall Study|Adverse Event|0|||
127610265|NCT03965962|459201897|FG003|Overall Study|Adverse Event|0|||
127610266|NCT03965962|459201894|FG000|Overall Study|Protocol Violation|21|||
127610267|NCT03965962|459201895|FG001|Overall Study|Protocol Violation|4|||
127610268|NCT03965962|459201896|FG002|Overall Study|Protocol Violation|10|||
127610269|NCT03965962|459201897|FG003|Overall Study|Protocol Violation|5|||
127610270|NCT03965962|459201894|FG000|Overall Study|Lost to Follow-up|0|||
127610271|NCT03965962|459201895|FG001|Overall Study|Lost to Follow-up|1|||
127610272|NCT03965962|459201896|FG002|Overall Study|Lost to Follow-up|0|||
127610273|NCT03965962|459201897|FG003|Overall Study|Lost to Follow-up|0|||
127610274|NCT03965962|459201894|FG000|Overall Study|Withdrawal by Subject|3|||
127610275|NCT03965962|459201895|FG001|Overall Study|Withdrawal by Subject|0|||
127610276|NCT03965962|459201896|FG002|Overall Study|Withdrawal by Subject|0|||
127610277|NCT03965962|459201897|FG003|Overall Study|Withdrawal by Subject|1|||
127610278|NCT02039674|459201898|FG000|Overall Study|Adverse Event|0|||
127610279|NCT02039674|459201899|FG001|Overall Study|Adverse Event|0|||
127610280|NCT02039674|459201900|FG002|Overall Study|Adverse Event|0|||
127610281|NCT02039674|459201901|FG003|Overall Study|Adverse Event|1|||
127610282|NCT02039674|459201902|FG004|Overall Study|Adverse Event|0|||
127610283|NCT02039674|459201903|FG005|Overall Study|Adverse Event|0|||
127610284|NCT02039674|459201904|FG006|Overall Study|Adverse Event|0|||
127610285|NCT02039674|459201905|FG007|Overall Study|Adverse Event|0|||
127610286|NCT02039674|459201906|FG008|Overall Study|Adverse Event|2|||
127610287|NCT02039674|459201907|FG009|Overall Study|Adverse Event|1|||
127610288|NCT02039674|459201908|FG010|Overall Study|Adverse Event|0|||
127610289|NCT02039674|459201909|FG011|Overall Study|Adverse Event|2|||
127610290|NCT02039674|459201910|FG012|Overall Study|Adverse Event|3|||
127610291|NCT02039674|459201911|FG013|Overall Study|Adverse Event|1|||
127610292|NCT02039674|459201898|FG000|Overall Study|Death|2|||
127610293|NCT02039674|459201899|FG001|Overall Study|Death|0|||
127610294|NCT02039674|459201900|FG002|Overall Study|Death|2|||
127610295|NCT02039674|459201901|FG003|Overall Study|Death|3|||
127610296|NCT02039674|459201902|FG004|Overall Study|Death|0|||
127610297|NCT02039674|459201903|FG005|Overall Study|Death|0|||
127610298|NCT02039674|459201904|FG006|Overall Study|Death|1|||
127610299|NCT02039674|459201905|FG007|Overall Study|Death|0|||
127610300|NCT02039674|459201906|FG008|Overall Study|Death|2|||
127610301|NCT02039674|459201907|FG009|Overall Study|Death|0|||
127610302|NCT02039674|459201908|FG010|Overall Study|Death|1|||
127610303|NCT02039674|459201909|FG011|Overall Study|Death|3|||
127610304|NCT02039674|459201910|FG012|Overall Study|Death|2|||
127610305|NCT02039674|459201911|FG013|Overall Study|Death|8|||
127610306|NCT02039674|459201898|FG000|Overall Study|Excluded Medication|1|||
127610307|NCT02039674|459201899|FG001|Overall Study|Excluded Medication|1|||
127610308|NCT02039674|459201900|FG002|Overall Study|Excluded Medication|0|||
127610309|NCT02039674|459201901|FG003|Overall Study|Excluded Medication|1|||
127610310|NCT02039674|459201902|FG004|Overall Study|Excluded Medication|0|||
127610311|NCT02039674|459201903|FG005|Overall Study|Excluded Medication|1|||
127610312|NCT02039674|459201904|FG006|Overall Study|Excluded Medication|0|||
127610313|NCT02039674|459201905|FG007|Overall Study|Excluded Medication|0|||
127610314|NCT02039674|459201906|FG008|Overall Study|Excluded Medication|2|||
127610315|NCT02039674|459201907|FG009|Overall Study|Excluded Medication|3|||
127610316|NCT02039674|459201908|FG010|Overall Study|Excluded Medication|5|||
127610317|NCT02039674|459201909|FG011|Overall Study|Excluded Medication|6|||
127610318|NCT02039674|459201910|FG012|Overall Study|Excluded Medication|8|||
127610319|NCT02039674|459201911|FG013|Overall Study|Excluded Medication|3|||
127610320|NCT02039674|459201898|FG000|Overall Study|Lost to Follow-up|0|||
127610321|NCT02039674|459201899|FG001|Overall Study|Lost to Follow-up|0|||
127610322|NCT02039674|459201900|FG002|Overall Study|Lost to Follow-up|0|||
127610323|NCT02039674|459201901|FG003|Overall Study|Lost to Follow-up|0|||
127610324|NCT02039674|459201902|FG004|Overall Study|Lost to Follow-up|1|||
127610325|NCT02039674|459201903|FG005|Overall Study|Lost to Follow-up|1|||
127610326|NCT02039674|459201904|FG006|Overall Study|Lost to Follow-up|0|||
127610327|NCT02039674|459201905|FG007|Overall Study|Lost to Follow-up|0|||
127610328|NCT02039674|459201906|FG008|Overall Study|Lost to Follow-up|0|||
127610329|NCT02039674|459201907|FG009|Overall Study|Lost to Follow-up|0|||
127610330|NCT02039674|459201908|FG010|Overall Study|Lost to Follow-up|0|||
127610331|NCT02039674|459201909|FG011|Overall Study|Lost to Follow-up|2|||
127610332|NCT02039674|459201910|FG012|Overall Study|Lost to Follow-up|2|||
127610333|NCT02039674|459201911|FG013|Overall Study|Lost to Follow-up|1|||
127610334|NCT02039674|459201898|FG000|Overall Study|Physician Decision|0|||
127610335|NCT02039674|459201899|FG001|Overall Study|Physician Decision|0|||
127610336|NCT02039674|459201900|FG002|Overall Study|Physician Decision|0|||
127610337|NCT02039674|459201901|FG003|Overall Study|Physician Decision|0|||
127610338|NCT02039674|459201902|FG004|Overall Study|Physician Decision|0|||
127610339|NCT02039674|459201903|FG005|Overall Study|Physician Decision|0|||
127610340|NCT02039674|459201904|FG006|Overall Study|Physician Decision|0|||
127610341|NCT02039674|459201905|FG007|Overall Study|Physician Decision|0|||
127610342|NCT02039674|459201906|FG008|Overall Study|Physician Decision|0|||
127610343|NCT02039674|459201907|FG009|Overall Study|Physician Decision|0|||
127610344|NCT02039674|459201908|FG010|Overall Study|Physician Decision|0|||
127610345|NCT02039674|459201909|FG011|Overall Study|Physician Decision|1|||
127610346|NCT02039674|459201910|FG012|Overall Study|Physician Decision|1|||
127610347|NCT02039674|459201911|FG013|Overall Study|Physician Decision|0|||
127610348|NCT02039674|459201898|FG000|Overall Study|Progressive Disease|8|||
127610349|NCT02039674|459201899|FG001|Overall Study|Progressive Disease|8|||
127610350|NCT02039674|459201900|FG002|Overall Study|Progressive Disease|6|||
127610351|NCT02039674|459201901|FG003|Overall Study|Progressive Disease|7|||
127610352|NCT02039674|459201902|FG004|Overall Study|Progressive Disease|9|||
127610353|NCT02039674|459201903|FG005|Overall Study|Progressive Disease|10|||
127610354|NCT02039674|459201904|FG006|Overall Study|Progressive Disease|1|||
127610355|NCT02039674|459201905|FG007|Overall Study|Progressive Disease|3|||
127610356|NCT02039674|459201906|FG008|Overall Study|Progressive Disease|6|||
127610357|NCT02039674|459201907|FG009|Overall Study|Progressive Disease|4|||
127610358|NCT02039674|459201908|FG010|Overall Study|Progressive Disease|0|||
127610359|NCT02039674|459201909|FG011|Overall Study|Progressive Disease|34|||
127610360|NCT02039674|459201910|FG012|Overall Study|Progressive Disease|34|||
127610361|NCT02039674|459201911|FG013|Overall Study|Progressive Disease|18|||
127610362|NCT02039674|459201898|FG000|Overall Study|Withdrawal by Subject|1|||
127610363|NCT02039674|459201899|FG001|Overall Study|Withdrawal by Subject|2|||
127610364|NCT02039674|459201900|FG002|Overall Study|Withdrawal by Subject|3|||
127610365|NCT02039674|459201901|FG003|Overall Study|Withdrawal by Subject|0|||
127610366|NCT02039674|459201902|FG004|Overall Study|Withdrawal by Subject|1|||
127610367|NCT02039674|459201903|FG005|Overall Study|Withdrawal by Subject|0|||
127610368|NCT02039674|459201904|FG006|Overall Study|Withdrawal by Subject|0|||
127610369|NCT02039674|459201905|FG007|Overall Study|Withdrawal by Subject|0|||
127610370|NCT02039674|459201906|FG008|Overall Study|Withdrawal by Subject|0|||
127610371|NCT02039674|459201907|FG009|Overall Study|Withdrawal by Subject|1|||
127610372|NCT02039674|459201908|FG010|Overall Study|Withdrawal by Subject|1|||
127610373|NCT02039674|459201909|FG011|Overall Study|Withdrawal by Subject|4|||
127610374|NCT02039674|459201910|FG012|Overall Study|Withdrawal by Subject|6|||
127610375|NCT02039674|459201911|FG013|Overall Study|Withdrawal by Subject|2|||
127610376|NCT02039674|459201898|FG000|Overall Study|Clinical Progression|0|||
127610377|NCT02039674|459201899|FG001|Overall Study|Clinical Progression|0|||
127610378|NCT02039674|459201900|FG002|Overall Study|Clinical Progression|0|||
127610379|NCT02039674|459201901|FG003|Overall Study|Clinical Progression|0|||
127610380|NCT02039674|459201902|FG004|Overall Study|Clinical Progression|0|||
127610381|NCT02039674|459201903|FG005|Overall Study|Clinical Progression|0|||
127610382|NCT02039674|459201904|FG006|Overall Study|Clinical Progression|1|||
127610383|NCT02039674|459201905|FG007|Overall Study|Clinical Progression|0|||
127610384|NCT02039674|459201906|FG008|Overall Study|Clinical Progression|0|||
127610385|NCT02039674|459201907|FG009|Overall Study|Clinical Progression|0|||
127610386|NCT02039674|459201908|FG010|Overall Study|Clinical Progression|0|||
127610387|NCT02039674|459201909|FG011|Overall Study|Clinical Progression|0|||
127610388|NCT02039674|459201910|FG012|Overall Study|Clinical Progression|1|||
127610389|NCT02039674|459201911|FG013|Overall Study|Clinical Progression|0|||
127610390|NCT02039674|459201898|FG000|Overall Study|Sponsor Decision|1|||
127610391|NCT02039674|459201899|FG001|Overall Study|Sponsor Decision|1|||
127610392|NCT02039674|459201900|FG002|Overall Study|Sponsor Decision|1|||
127610393|NCT02039674|459201901|FG003|Overall Study|Sponsor Decision|1|||
127610394|NCT02039674|459201902|FG004|Overall Study|Sponsor Decision|1|||
127610395|NCT02039674|459201903|FG005|Overall Study|Sponsor Decision|0|||
127610396|NCT02039674|459201904|FG006|Overall Study|Sponsor Decision|0|||
127610397|NCT02039674|459201905|FG007|Overall Study|Sponsor Decision|0|||
127610398|NCT02039674|459201906|FG008|Overall Study|Sponsor Decision|0|||
127610399|NCT02039674|459201907|FG009|Overall Study|Sponsor Decision|3|||
127610400|NCT02039674|459201908|FG010|Overall Study|Sponsor Decision|0|||
127610401|NCT02039674|459201909|FG011|Overall Study|Sponsor Decision|8|||
127610402|NCT02039674|459201910|FG012|Overall Study|Sponsor Decision|5|||
127610403|NCT02039674|459201911|FG013|Overall Study|Sponsor Decision|0|||
127610404|NCT02039674|459201898|FG000|Overall Study|Other|0|||
127610405|NCT02039674|459201899|FG001|Overall Study|Other|0|||
127610406|NCT02039674|459201900|FG002|Overall Study|Other|0|||
127610407|NCT02039674|459201901|FG003|Overall Study|Other|0|||
127610408|NCT02039674|459201902|FG004|Overall Study|Other|0|||
127610409|NCT02039674|459201903|FG005|Overall Study|Other|0|||
127610410|NCT02039674|459201904|FG006|Overall Study|Other|0|||
127610411|NCT02039674|459201905|FG007|Overall Study|Other|0|||
127610412|NCT02039674|459201906|FG008|Overall Study|Other|0|||
127610413|NCT02039674|459201907|FG009|Overall Study|Other|0|||
127610414|NCT02039674|459201908|FG010|Overall Study|Other|0|||
127610415|NCT02039674|459201909|FG011|Overall Study|Other|0|||
127610416|NCT02039674|459201910|FG012|Overall Study|Other|1|||
127610417|NCT02039674|459201911|FG013|Overall Study|Other|0|||
127610418|NCT05497284|459201912|FG000|Overall Study|Adverse Event|1|||
127610419|NCT05497284|459201913|FG001|Overall Study|Adverse Event|0|||
127610420|NCT05497284|459201912|FG000|Overall Study|Physician Decision|0|||
127610421|NCT05497284|459201913|FG001|Overall Study|Physician Decision|1|||
127610422|NCT05497284|459201912|FG000|Overall Study|Study terminated by sponsor|7|||
127610423|NCT05497284|459201913|FG001|Overall Study|Study terminated by sponsor|4|||
127610424|NCT05497284|459201912|FG000|Overall Study|Subject Decision|0|||
127610425|NCT05497284|459201913|FG001|Overall Study|Subject Decision|1|||
127610426|NCT01502423|459201914|FG000|Overall Study|Withdrawal by Subject|0|||
127610427|NCT01502423|459201915|FG001|Overall Study|Withdrawal by Subject|1|||
127610428|NCT00567892|459201916|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
127610429|NCT00567892|459201917|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
127610430|NCT00567892|459201918|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
127610431|NCT00567892|459201919|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
127610432|NCT00567892|459201916|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
127610433|NCT00567892|459201917|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
127610434|NCT00567892|459201918|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
127610435|NCT00567892|459201919|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
127610436|NCT00004888|459203928|FG000|Overall Study|Adverse Event|5|||
127610437|NCT00004888|459203929|FG001|Overall Study|Adverse Event|10|||
127610438|NCT00004888|459203928|FG000|Overall Study|Withdrawal by Subject|0|||
127610439|NCT00004888|459203929|FG001|Overall Study|Withdrawal by Subject|3|||
127610440|NCT00004888|459203928|FG000|Overall Study|Physician Decision|1|||
127610441|NCT00004888|459203929|FG001|Overall Study|Physician Decision|1|||
127610442|NCT00004888|459203928|FG000|Overall Study|Progressive Disease|4|||
127610443|NCT00004888|459203929|FG001|Overall Study|Progressive Disease|9|||
127610444|NCT00004888|459203928|FG000|Overall Study|Death without progressive disease|0|||
127610445|NCT00004888|459203929|FG001|Overall Study|Death without progressive disease|1|||
127610446|NCT00004888|459203928|FG000|Overall Study|Toxic death|1|||
127610447|NCT00004888|459203929|FG001|Overall Study|Toxic death|0|||
127610448|NCT02579265|459203930|FG000|Overall Study|Weaned off earlier than 28 days|44|||
127610449|NCT02579265|459203931|FG001|Overall Study|Weaned off earlier than 28 days|43|||
127610450|NCT02579265|459203930|FG000|Overall Study|Adverse Event|2|||
127610451|NCT02579265|459203931|FG001|Overall Study|Adverse Event|0|||
127610452|NCT02579265|459203930|FG000|Overall Study|Any other reason not specified|0|||
127610453|NCT02579265|459203931|FG001|Overall Study|Any other reason not specified|2|||
127610454|NCT02579265|459203930|FG000|Overall Study|Withdrawal by Subject|2|||
127610455|NCT02579265|459203931|FG001|Overall Study|Withdrawal by Subject|0|||
127610456|NCT02579265|459203930|FG000|Overall Study|Physician Decision|1|||
127610457|NCT02579265|459203931|FG001|Overall Study|Physician Decision|0|||
127610458|NCT02579265|459203930|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
127610459|NCT02579265|459203931|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
127610460|NCT02174848|459203932|FG000|Overall Study|Adverse Event|2|||
127610461|NCT02174848|459203933|FG001|Overall Study|Adverse Event|1|||
127610462|NCT02174848|459203932|FG000|Overall Study|Withdrawal by Subject|3|||
127610463|NCT02174848|459203933|FG001|Overall Study|Withdrawal by Subject|3|||
127610464|NCT02174848|459203932|FG000|Overall Study|Lost to Follow-up|0|||
127610465|NCT02174848|459203933|FG001|Overall Study|Lost to Follow-up|1|||
127610466|NCT02174848|459203932|FG000|Overall Study|Worsening of disease|1|||
127610467|NCT02174848|459203933|FG001|Overall Study|Worsening of disease|1|||
127610468|NCT02174848|459203932|FG000|Overall Study|Unable to comply with study requirements|1|||
127610469|NCT02174848|459203933|FG001|Overall Study|Unable to comply with study requirements|0|||
127610470|NCT00644969|459203935|FG000|Treatment Phase|Randomized, not treated|1|||
127610471|NCT00644969|459203936|FG001|Treatment Phase|Randomized, not treated|0|||
127610472|NCT00644969|459203935|FG000|Treatment Phase|Adverse Event|3|||
127610473|NCT00644969|459203936|FG001|Treatment Phase|Adverse Event|0|||
127610474|NCT00644969|459203935|FG000|Treatment Phase|Withdrawal by Subject|4|||
127610475|NCT00644969|459203936|FG001|Treatment Phase|Withdrawal by Subject|0|||
127610476|NCT00644969|459203935|FG000|Treatment Phase|Lost to Follow-up|2|||
127610477|NCT00644969|459203936|FG001|Treatment Phase|Lost to Follow-up|2|||
127610478|NCT00644969|459203935|FG000|Treatment Phase|Other|4|||
127610479|NCT00644969|459203936|FG001|Treatment Phase|Other|1|||
127610480|NCT00644969|459203935|FG000|Post Treatment Phase|Death|1|||
127610481|NCT00644969|459203936|FG001|Post Treatment Phase|Death|0|||
127610482|NCT00644969|459203935|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
127610483|NCT00644969|459203936|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
127610484|NCT00644969|459203935|FG000|Post Treatment Phase|Lost to Follow-up|4|||
127610485|NCT00644969|459203936|FG001|Post Treatment Phase|Lost to Follow-up|1|||
127610486|NCT00644969|459203935|FG000|Post Treatment Phase|Other|1|||
127610487|NCT00644969|459203936|FG001|Post Treatment Phase|Other|0|||
127610488|NCT02515942|459203937|FG000|Overall Study|Adverse Event|5|||
127610489|NCT02515942|459203938|FG001|Overall Study|Adverse Event|0|||
127610490|NCT02515942|459203939|FG002|Overall Study|Adverse Event|0|||
127610491|NCT02515942|459203937|FG000|Overall Study|Death|0|||
127610492|NCT02515942|459203938|FG001|Overall Study|Death|0|||
127610493|NCT02515942|459203939|FG002|Overall Study|Death|1|||
127610494|NCT02515942|459203937|FG000|Overall Study|Lack of Efficacy|0|||
127610495|NCT02515942|459203938|FG001|Overall Study|Lack of Efficacy|0|||
127610496|NCT02515942|459203939|FG002|Overall Study|Lack of Efficacy|1|||
127610497|NCT02515942|459203937|FG000|Overall Study|Lost to Follow-up|2|||
127610498|NCT02515942|459203938|FG001|Overall Study|Lost to Follow-up|0|||
127610499|NCT02515942|459203939|FG002|Overall Study|Lost to Follow-up|0|||
127610500|NCT02515942|459203937|FG000|Overall Study|Withdrawal by Subject|0|||
127610501|NCT02515942|459203938|FG001|Overall Study|Withdrawal by Subject|3|||
127610502|NCT02515942|459203939|FG002|Overall Study|Withdrawal by Subject|2|||
127610503|NCT00666757|459203940|FG000|Overall Study|Lost to Follow-up|39|||
127610504|NCT00666757|459203941|FG001|Overall Study|Lost to Follow-up|35|||
127610505|NCT00666757|459203940|FG000|Overall Study|Protocol Violation|23|||
127610506|NCT00666757|459203941|FG001|Overall Study|Protocol Violation|24|||
127610507|NCT00666757|459203940|FG000|Overall Study|Adverse Event|22|||
127610508|NCT00666757|459203941|FG001|Overall Study|Adverse Event|12|||
127610509|NCT00666757|459203940|FG000|Overall Study|Withdrawal by Subject|13|||
127610510|NCT00666757|459203941|FG001|Overall Study|Withdrawal by Subject|17|||
127610511|NCT00666757|459203940|FG000|Overall Study|Lack of Efficacy|3|||
127610512|NCT00666757|459203941|FG001|Overall Study|Lack of Efficacy|6|||
127610513|NCT00666757|459203940|FG000|Overall Study|Physician Decision|0|||
127610514|NCT00666757|459203941|FG001|Overall Study|Physician Decision|2|||
127610515|NCT00666757|459203940|FG000|Overall Study|Sponsor decision|0|||
127610516|NCT00666757|459203941|FG001|Overall Study|Sponsor decision|1|||
127610517|NCT01231581|459203942|FG000|Overall Study|Lost to Follow-up|2|||
127610518|NCT01231581|459203943|FG001|Overall Study|Lost to Follow-up|2|||
127610519|NCT01231581|459203942|FG000|Overall Study|Withdrawal by Subject|6|||
127610520|NCT01231581|459203943|FG001|Overall Study|Withdrawal by Subject|9|||
127610521|NCT01231581|459203942|FG000|Overall Study|Study Closed/Terminated|6|||
127610522|NCT01231581|459203943|FG001|Overall Study|Study Closed/Terminated|5|||
127610523|NCT01231581|459203942|FG000|Overall Study|Death|65|||
127610524|NCT01231581|459203943|FG001|Overall Study|Death|64|||
127610525|NCT01231581|459203942|FG000|Overall Study|Ongoing|1|||
127610526|NCT01231581|459203943|FG001|Overall Study|Ongoing|0|||
127610527|NCT02510794|459203944|FG000|Overall Study|Adverse Event|0|||
127698378|NCT04676022|459523794|FG002|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
127610528|NCT02510794|459203945|FG001|Overall Study|Adverse Event|1|||
127610529|NCT02510794|459203946|FG002|Overall Study|Adverse Event|0|||
127610530|NCT02510794|459203947|FG003|Overall Study|Adverse Event|0|||
127610531|NCT02510794|459203944|FG000|Overall Study|Death|1|||
127610532|NCT02510794|459203945|FG001|Overall Study|Death|2|||
127610533|NCT02510794|459203946|FG002|Overall Study|Death|1|||
127610534|NCT02510794|459203947|FG003|Overall Study|Death|1|||
127610535|NCT02510794|459203944|FG000|Overall Study|Lack of Efficacy|3|||
127610536|NCT02510794|459203945|FG001|Overall Study|Lack of Efficacy|1|||
127610537|NCT02510794|459203946|FG002|Overall Study|Lack of Efficacy|1|||
127610538|NCT02510794|459203947|FG003|Overall Study|Lack of Efficacy|0|||
127610539|NCT02510794|459203944|FG000|Overall Study|Participant moved out of the area|0|||
127610540|NCT02510794|459203945|FG001|Overall Study|Participant moved out of the area|0|||
127610541|NCT02510794|459203946|FG002|Overall Study|Participant moved out of the area|0|||
127610542|NCT02510794|459203947|FG003|Overall Study|Participant moved out of the area|1|||
127610543|NCT02510794|459203944|FG000|Overall Study|Physician Decision|3|||
127610544|NCT02510794|459203945|FG001|Overall Study|Physician Decision|0|||
127610545|NCT02510794|459203946|FG002|Overall Study|Physician Decision|0|||
127610546|NCT02510794|459203947|FG003|Overall Study|Physician Decision|0|||
127610547|NCT02510794|459203944|FG000|Overall Study|Protocol Violation|0|||
127610548|NCT02510794|459203945|FG001|Overall Study|Protocol Violation|0|||
127610549|NCT02510794|459203946|FG002|Overall Study|Protocol Violation|1|||
127610550|NCT02510794|459203947|FG003|Overall Study|Protocol Violation|0|||
127610551|NCT02510794|459203944|FG000|Overall Study|Withdrawal by Subject|1|||
127610552|NCT02510794|459203945|FG001|Overall Study|Withdrawal by Subject|2|||
127610553|NCT02510794|459203946|FG002|Overall Study|Withdrawal by Subject|4|||
127610554|NCT02510794|459203947|FG003|Overall Study|Withdrawal by Subject|3|||
127610555|NCT02658890|459203948|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610556|NCT02658890|459203949|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610557|NCT02658890|459203950|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610558|NCT02658890|459203951|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610559|NCT02658890|459203952|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610560|NCT02658890|459203953|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610561|NCT02658890|459203954|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610562|NCT02658890|459203955|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610563|NCT02658890|459203956|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
127610564|NCT02658890|459203957|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610565|NCT02658890|459203958|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610566|NCT02658890|459203959|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610567|NCT02658890|459203960|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610568|NCT02658890|459203961|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610569|NCT02658890|459203962|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610570|NCT02658890|459203963|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610571|NCT02658890|459203964|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610572|NCT02658890|459203965|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610573|NCT02658890|459203966|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610574|NCT02658890|459203967|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610575|NCT02658890|459203968|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610576|NCT02658890|459203969|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610577|NCT02658890|459203970|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610578|NCT02658890|459203971|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610579|NCT02658890|459203972|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610580|NCT02658890|459203973|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610581|NCT02658890|459203974|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610582|NCT02658890|459203948|FG000|Treatment Phase|Adverse Event|0|||
127610583|NCT02658890|459203949|FG001|Treatment Phase|Adverse Event|1|||
127610584|NCT02658890|459203950|FG002|Treatment Phase|Adverse Event|2|||
127610585|NCT02658890|459203951|FG003|Treatment Phase|Adverse Event|2|||
127610586|NCT02658890|459203952|FG004|Treatment Phase|Adverse Event|1|||
127610587|NCT02658890|459203953|FG005|Treatment Phase|Adverse Event|0|||
127610588|NCT02658890|459203954|FG006|Treatment Phase|Adverse Event|0|||
127610589|NCT02658890|459203955|FG007|Treatment Phase|Adverse Event|2|||
127610590|NCT02658890|459203956|FG008|Treatment Phase|Adverse Event|1|||
127610591|NCT02658890|459203957|FG009|Treatment Phase|Adverse Event|2|||
127610592|NCT02658890|459203958|FG010|Treatment Phase|Adverse Event|3|||
127610593|NCT02658890|459203959|FG011|Treatment Phase|Adverse Event|0|||
127610594|NCT02658890|459203960|FG012|Treatment Phase|Adverse Event|1|||
127610595|NCT02658890|459203961|FG013|Treatment Phase|Adverse Event|4|||
127610596|NCT02658890|459203962|FG014|Treatment Phase|Adverse Event|0|||
127610597|NCT02658890|459203963|FG015|Treatment Phase|Adverse Event|0|||
127610598|NCT02658890|459203964|FG016|Treatment Phase|Adverse Event|0|||
127788986|NCT02831673|459853445|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
127788987|NCT02831673|459853446|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
127788988|NCT02831673|459853447|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
127788989|NCT02831673|459853448|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
127788990|NCT02831673|459853449|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
127788991|NCT02831673|459853445|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
127788992|NCT02831673|459853446|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
127788993|NCT02831673|459853447|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
127788994|NCT02831673|459853448|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
127788995|NCT02831673|459853449|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
127788996|NCT02831673|459853445|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
127788997|NCT02831673|459853446|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
127788998|NCT02831673|459853447|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
127788999|NCT02831673|459853448|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
127789000|NCT02831673|459853449|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
127789001|NCT02831673|459853445|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
127789002|NCT02831673|459853446|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
127789003|NCT02831673|459853447|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
127789004|NCT02831673|459853448|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
127789005|NCT02831673|459853449|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
127789006|NCT02831673|459853445|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
127789007|NCT02831673|459853446|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
127789008|NCT02831673|459853447|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
127789009|NCT02831673|459853448|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
127789010|NCT02831673|459853449|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
127789011|NCT02831673|459853445|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
127789012|NCT02831673|459853446|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
127789013|NCT02831673|459853447|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
127789014|NCT02831673|459853448|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
127789015|NCT02831673|459853449|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
127789016|NCT02831673|459853445|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
127789017|NCT02831673|459853446|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
127789018|NCT02831673|459853447|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
127789019|NCT02831673|459853448|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
127789020|NCT02831673|459853449|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
127789021|NCT02831673|459853445|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
127789022|NCT02831673|459853446|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
127789023|NCT02831673|459853447|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
127789024|NCT02831673|459853448|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
127789025|NCT02831673|459853449|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
127789026|NCT02831673|459853445|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
127789027|NCT02831673|459853446|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
127789028|NCT02831673|459853447|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
127789029|NCT02831673|459853448|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
127789030|NCT02831673|459853449|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
127789031|NCT02831673|459853445|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
127789032|NCT02831673|459853446|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
127789033|NCT02831673|459853447|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
127789034|NCT02831673|459853448|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
127789035|NCT02831673|459853449|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
127789036|NCT02356562|459853451|FG000|Overall Study|Withdrawal by Subject|0|||
127789037|NCT02356562|459853452|FG001|Overall Study|Withdrawal by Subject|1|||
127789038|NCT02356562|459853451|FG000|Overall Study|Re-entered treatment in a previous study|1|||
127789039|NCT02356562|459853452|FG001|Overall Study|Re-entered treatment in a previous study|0|||
127789040|NCT02356562|459853451|FG000|Overall Study|site closure|1|||
127610599|NCT02658890|459203965|FG017|Treatment Phase|Adverse Event|0|||
127610600|NCT02658890|459203966|FG018|Treatment Phase|Adverse Event|5|||
127610601|NCT02658890|459203967|FG019|Treatment Phase|Adverse Event|1|||
127610602|NCT02658890|459203968|FG020|Treatment Phase|Adverse Event|3|||
127610603|NCT02658890|459203969|FG021|Treatment Phase|Adverse Event|0|||
127610604|NCT02658890|459203970|FG022|Treatment Phase|Adverse Event|5|||
127610605|NCT02658890|459203971|FG023|Treatment Phase|Adverse Event|0|||
127610606|NCT02658890|459203972|FG024|Treatment Phase|Adverse Event|0|||
127610607|NCT02658890|459203973|FG025|Treatment Phase|Adverse Event|2|||
127610608|NCT02658890|459203974|FG026|Treatment Phase|Adverse Event|1|||
127610609|NCT02658890|459203948|FG000|Treatment Phase|Death|0|||
127610610|NCT02658890|459203949|FG001|Treatment Phase|Death|0|||
127610611|NCT02658890|459203950|FG002|Treatment Phase|Death|0|||
127610612|NCT02658890|459203951|FG003|Treatment Phase|Death|0|||
127610613|NCT02658890|459203952|FG004|Treatment Phase|Death|0|||
127610614|NCT02658890|459203953|FG005|Treatment Phase|Death|0|||
127610615|NCT02658890|459203954|FG006|Treatment Phase|Death|0|||
127610616|NCT02658890|459203955|FG007|Treatment Phase|Death|0|||
127610617|NCT02658890|459203956|FG008|Treatment Phase|Death|0|||
127610618|NCT02658890|459203957|FG009|Treatment Phase|Death|0|||
127610619|NCT02658890|459203958|FG010|Treatment Phase|Death|0|||
127610620|NCT02658890|459203959|FG011|Treatment Phase|Death|0|||
127610621|NCT02658890|459203960|FG012|Treatment Phase|Death|0|||
127610622|NCT02658890|459203961|FG013|Treatment Phase|Death|0|||
127610623|NCT02658890|459203962|FG014|Treatment Phase|Death|0|||
127610624|NCT02658890|459203963|FG015|Treatment Phase|Death|0|||
127610625|NCT02658890|459203964|FG016|Treatment Phase|Death|0|||
127610626|NCT02658890|459203965|FG017|Treatment Phase|Death|0|||
127610627|NCT02658890|459203966|FG018|Treatment Phase|Death|1|||
127610628|NCT02658890|459203967|FG019|Treatment Phase|Death|0|||
127610629|NCT02658890|459203968|FG020|Treatment Phase|Death|0|||
127610630|NCT02658890|459203969|FG021|Treatment Phase|Death|0|||
127610631|NCT02658890|459203970|FG022|Treatment Phase|Death|0|||
127610632|NCT02658890|459203971|FG023|Treatment Phase|Death|0|||
127610633|NCT02658890|459203972|FG024|Treatment Phase|Death|0|||
127610634|NCT02658890|459203973|FG025|Treatment Phase|Death|0|||
127610635|NCT02658890|459203974|FG026|Treatment Phase|Death|0|||
127610636|NCT02658890|459203948|FG000|Treatment Phase|Lost to Follow-up|0|||
127610637|NCT02658890|459203949|FG001|Treatment Phase|Lost to Follow-up|0|||
127610638|NCT02658890|459203950|FG002|Treatment Phase|Lost to Follow-up|0|||
127610639|NCT02658890|459203951|FG003|Treatment Phase|Lost to Follow-up|0|||
127610640|NCT02658890|459203952|FG004|Treatment Phase|Lost to Follow-up|0|||
127610641|NCT02658890|459203953|FG005|Treatment Phase|Lost to Follow-up|0|||
127610642|NCT02658890|459203954|FG006|Treatment Phase|Lost to Follow-up|1|||
127610643|NCT02658890|459203955|FG007|Treatment Phase|Lost to Follow-up|0|||
127610644|NCT02658890|459203956|FG008|Treatment Phase|Lost to Follow-up|0|||
127610645|NCT02658890|459203957|FG009|Treatment Phase|Lost to Follow-up|0|||
127610646|NCT02658890|459203958|FG010|Treatment Phase|Lost to Follow-up|0|||
127610647|NCT02658890|459203959|FG011|Treatment Phase|Lost to Follow-up|0|||
127610648|NCT02658890|459203960|FG012|Treatment Phase|Lost to Follow-up|0|||
127610649|NCT02658890|459203961|FG013|Treatment Phase|Lost to Follow-up|0|||
127610650|NCT02658890|459203962|FG014|Treatment Phase|Lost to Follow-up|0|||
127610651|NCT02658890|459203963|FG015|Treatment Phase|Lost to Follow-up|0|||
127610652|NCT02658890|459203964|FG016|Treatment Phase|Lost to Follow-up|0|||
127610653|NCT02658890|459203965|FG017|Treatment Phase|Lost to Follow-up|0|||
127610654|NCT02658890|459203966|FG018|Treatment Phase|Lost to Follow-up|0|||
127610655|NCT02658890|459203967|FG019|Treatment Phase|Lost to Follow-up|0|||
127610656|NCT02658890|459203968|FG020|Treatment Phase|Lost to Follow-up|0|||
127610657|NCT02658890|459203969|FG021|Treatment Phase|Lost to Follow-up|0|||
127610658|NCT02658890|459203970|FG022|Treatment Phase|Lost to Follow-up|0|||
127610659|NCT02658890|459203971|FG023|Treatment Phase|Lost to Follow-up|0|||
127610660|NCT02658890|459203972|FG024|Treatment Phase|Lost to Follow-up|0|||
127610661|NCT02658890|459203973|FG025|Treatment Phase|Lost to Follow-up|0|||
127610662|NCT02658890|459203974|FG026|Treatment Phase|Lost to Follow-up|0|||
127610663|NCT02658890|459203948|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
127610664|NCT02658890|459203949|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
127610665|NCT02658890|459203950|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
127610666|NCT02658890|459203951|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
127610667|NCT02658890|459203952|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
127610668|NCT02658890|459203953|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
127610669|NCT02658890|459203954|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
127610670|NCT02658890|459203955|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
127610671|NCT02658890|459203956|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
127610672|NCT02658890|459203957|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
127610673|NCT02658890|459203958|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
127610674|NCT02658890|459203959|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
127610675|NCT02658890|459203960|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
127610676|NCT02658890|459203961|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
127610677|NCT02658890|459203962|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
127610678|NCT02658890|459203963|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
127610679|NCT02658890|459203964|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
127610680|NCT02658890|459203965|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
127610681|NCT02658890|459203966|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
127610682|NCT02658890|459203967|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
127610683|NCT02658890|459203968|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
127610684|NCT02658890|459203969|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
127610685|NCT02658890|459203970|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
127610686|NCT02658890|459203971|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
127610687|NCT02658890|459203972|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
127610688|NCT02658890|459203973|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
127610689|NCT02658890|459203974|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
127610690|NCT02658890|459203948|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
127610691|NCT02658890|459203949|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
127610692|NCT02658890|459203950|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
127610693|NCT02658890|459203951|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
127610694|NCT02658890|459203952|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
127610695|NCT02658890|459203953|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
127610696|NCT02658890|459203954|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
127610697|NCT02658890|459203955|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
127610698|NCT02658890|459203956|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
127610699|NCT02658890|459203957|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
127610700|NCT02658890|459203958|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
127610701|NCT02658890|459203959|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
127610702|NCT02658890|459203960|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
127610703|NCT02658890|459203961|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
127610704|NCT02658890|459203962|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
127610705|NCT02658890|459203963|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
127610706|NCT02658890|459203964|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
127610707|NCT02658890|459203965|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
127610708|NCT02658890|459203966|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
127610709|NCT02658890|459203967|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
127610710|NCT02658890|459203968|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
127610711|NCT02658890|459203969|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
127610712|NCT02658890|459203970|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
127610713|NCT02658890|459203971|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
127610714|NCT02658890|459203972|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
127610715|NCT02658890|459203973|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
127610716|NCT02658890|459203974|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
127610717|NCT02658890|459203948|FG000|Treatment Phase|Other Reasons|0|||
127610718|NCT02658890|459203949|FG001|Treatment Phase|Other Reasons|0|||
127610719|NCT02658890|459203950|FG002|Treatment Phase|Other Reasons|0|||
127610720|NCT02658890|459203951|FG003|Treatment Phase|Other Reasons|0|||
127610721|NCT02658890|459203952|FG004|Treatment Phase|Other Reasons|0|||
127610722|NCT02658890|459203953|FG005|Treatment Phase|Other Reasons|0|||
127698379|NCT03194217|459523809|FG000|Overall Study|Adverse Event|0|||
127698380|NCT03194217|459523810|FG001|Overall Study|Adverse Event|2|||
127610723|NCT02658890|459203954|FG006|Treatment Phase|Other Reasons|1|||
127610724|NCT02658890|459203955|FG007|Treatment Phase|Other Reasons|0|||
127610725|NCT02658890|459203956|FG008|Treatment Phase|Other Reasons|1|||
127610726|NCT02658890|459203957|FG009|Treatment Phase|Other Reasons|0|||
127698381|NCT03194217|459523811|FG002|Overall Study|Adverse Event|3|||
127610727|NCT02658890|459203958|FG010|Treatment Phase|Other Reasons|0|||
127610728|NCT02658890|459203959|FG011|Treatment Phase|Other Reasons|0|||
127610729|NCT02658890|459203960|FG012|Treatment Phase|Other Reasons|0|||
127610730|NCT02658890|459203961|FG013|Treatment Phase|Other Reasons|2|||
127610731|NCT02658890|459203962|FG014|Treatment Phase|Other Reasons|0|||
127610732|NCT02658890|459203963|FG015|Treatment Phase|Other Reasons|0|||
127610733|NCT02658890|459203964|FG016|Treatment Phase|Other Reasons|0|||
127610734|NCT02658890|459203965|FG017|Treatment Phase|Other Reasons|0|||
127610735|NCT02658890|459203966|FG018|Treatment Phase|Other Reasons|1|||
127610736|NCT02658890|459203967|FG019|Treatment Phase|Other Reasons|0|||
127610737|NCT02658890|459203968|FG020|Treatment Phase|Other Reasons|0|||
127610738|NCT02658890|459203969|FG021|Treatment Phase|Other Reasons|0|||
127610739|NCT02658890|459203970|FG022|Treatment Phase|Other Reasons|0|||
127610740|NCT02658890|459203971|FG023|Treatment Phase|Other Reasons|0|||
127610741|NCT02658890|459203972|FG024|Treatment Phase|Other Reasons|1|||
127610742|NCT02658890|459203973|FG025|Treatment Phase|Other Reasons|0|||
127610743|NCT02658890|459203974|FG026|Treatment Phase|Other Reasons|1|||
127610744|NCT02658890|459203948|FG000|Treatment Phase|Progressive Disease|6|||
127610745|NCT02658890|459203949|FG001|Treatment Phase|Progressive Disease|7|||
127610746|NCT02658890|459203950|FG002|Treatment Phase|Progressive Disease|6|||
127610747|NCT02658890|459203951|FG003|Treatment Phase|Progressive Disease|12|||
127610748|NCT02658890|459203952|FG004|Treatment Phase|Progressive Disease|6|||
127610749|NCT02658890|459203953|FG005|Treatment Phase|Progressive Disease|18|||
127610750|NCT02658890|459203954|FG006|Treatment Phase|Progressive Disease|12|||
127610751|NCT02658890|459203955|FG007|Treatment Phase|Progressive Disease|19|||
127610752|NCT02658890|459203956|FG008|Treatment Phase|Progressive Disease|26|||
127610753|NCT02658890|459203957|FG009|Treatment Phase|Progressive Disease|8|||
127610754|NCT02658890|459203958|FG010|Treatment Phase|Progressive Disease|7|||
127610755|NCT02658890|459203959|FG011|Treatment Phase|Progressive Disease|9|||
127610756|NCT02658890|459203960|FG012|Treatment Phase|Progressive Disease|8|||
127610757|NCT02658890|459203961|FG013|Treatment Phase|Progressive Disease|29|||
127610758|NCT02658890|459203962|FG014|Treatment Phase|Progressive Disease|6|||
127610759|NCT02658890|459203963|FG015|Treatment Phase|Progressive Disease|2|||
127610760|NCT02658890|459203964|FG016|Treatment Phase|Progressive Disease|32|||
127610761|NCT02658890|459203965|FG017|Treatment Phase|Progressive Disease|14|||
127610762|NCT02658890|459203966|FG018|Treatment Phase|Progressive Disease|40|||
127610763|NCT02658890|459203967|FG019|Treatment Phase|Progressive Disease|32|||
127610764|NCT02658890|459203968|FG020|Treatment Phase|Progressive Disease|19|||
127610765|NCT02658890|459203969|FG021|Treatment Phase|Progressive Disease|30|||
127610766|NCT02658890|459203970|FG022|Treatment Phase|Progressive Disease|15|||
127610767|NCT02658890|459203971|FG023|Treatment Phase|Progressive Disease|0|||
127610768|NCT02658890|459203972|FG024|Treatment Phase|Progressive Disease|0|||
127610769|NCT02658890|459203973|FG025|Treatment Phase|Progressive Disease|14|||
127610770|NCT02658890|459203974|FG026|Treatment Phase|Progressive Disease|11|||
127610771|NCT02658890|459203948|FG000|Treatment Phase|Study Drug Toxicity|0|||
127610772|NCT02658890|459203949|FG001|Treatment Phase|Study Drug Toxicity|0|||
127610773|NCT02658890|459203950|FG002|Treatment Phase|Study Drug Toxicity|2|||
127610774|NCT02658890|459203951|FG003|Treatment Phase|Study Drug Toxicity|0|||
127610775|NCT02658890|459203952|FG004|Treatment Phase|Study Drug Toxicity|0|||
127610776|NCT02658890|459203953|FG005|Treatment Phase|Study Drug Toxicity|0|||
127610777|NCT02658890|459203954|FG006|Treatment Phase|Study Drug Toxicity|0|||
127610778|NCT02658890|459203955|FG007|Treatment Phase|Study Drug Toxicity|0|||
127610779|NCT02658890|459203956|FG008|Treatment Phase|Study Drug Toxicity|3|||
127610780|NCT02658890|459203957|FG009|Treatment Phase|Study Drug Toxicity|0|||
127610781|NCT02658890|459203958|FG010|Treatment Phase|Study Drug Toxicity|1|||
127610782|NCT02658890|459203959|FG011|Treatment Phase|Study Drug Toxicity|1|||
127610783|NCT02658890|459203960|FG012|Treatment Phase|Study Drug Toxicity|2|||
127610784|NCT02658890|459203961|FG013|Treatment Phase|Study Drug Toxicity|9|||
127610785|NCT02658890|459203962|FG014|Treatment Phase|Study Drug Toxicity|0|||
127610786|NCT02658890|459203963|FG015|Treatment Phase|Study Drug Toxicity|1|||
127610787|NCT02658890|459203964|FG016|Treatment Phase|Study Drug Toxicity|1|||
127610788|NCT02658890|459203965|FG017|Treatment Phase|Study Drug Toxicity|0|||
127789041|NCT02356562|459853452|FG001|Overall Study|site closure|0|||
127882935|NCT04440007|460194626|FG001|Overall Study|Adverse Event|1|||
127610789|NCT02658890|459203966|FG018|Treatment Phase|Study Drug Toxicity|8|||
127610790|NCT02658890|459203967|FG019|Treatment Phase|Study Drug Toxicity|3|||
127610791|NCT02658890|459203968|FG020|Treatment Phase|Study Drug Toxicity|2|||
127610792|NCT02658890|459203969|FG021|Treatment Phase|Study Drug Toxicity|0|||
127610793|NCT02658890|459203970|FG022|Treatment Phase|Study Drug Toxicity|8|||
127610794|NCT02658890|459203971|FG023|Treatment Phase|Study Drug Toxicity|0|||
127610795|NCT02658890|459203972|FG024|Treatment Phase|Study Drug Toxicity|0|||
127610796|NCT02658890|459203973|FG025|Treatment Phase|Study Drug Toxicity|2|||
127610797|NCT02658890|459203974|FG026|Treatment Phase|Study Drug Toxicity|0|||
127610798|NCT02658890|459203948|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610799|NCT02658890|459203949|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610800|NCT02658890|459203950|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610801|NCT02658890|459203951|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
127610802|NCT02658890|459203952|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610803|NCT02658890|459203953|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610804|NCT02658890|459203954|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610805|NCT02658890|459203955|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610806|NCT02658890|459203956|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610807|NCT02658890|459203957|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
127610808|NCT02658890|459203958|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610809|NCT02658890|459203959|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610810|NCT02658890|459203960|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610811|NCT02658890|459203961|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610812|NCT02658890|459203962|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610813|NCT02658890|459203963|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610814|NCT02658890|459203964|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610815|NCT02658890|459203965|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610816|NCT02658890|459203966|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
127610817|NCT02658890|459203967|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610818|NCT02658890|459203968|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610819|NCT02658890|459203969|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610820|NCT02658890|459203970|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
127610821|NCT02658890|459203971|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610822|NCT02658890|459203972|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610823|NCT02658890|459203973|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610824|NCT02658890|459203974|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
127610825|NCT02658890|459203948|FG000|Treatment Phase|Withdrawal by Subject|0|||
127610826|NCT02658890|459203949|FG001|Treatment Phase|Withdrawal by Subject|1|||
127610827|NCT02658890|459203950|FG002|Treatment Phase|Withdrawal by Subject|0|||
127610828|NCT02658890|459203951|FG003|Treatment Phase|Withdrawal by Subject|0|||
127610829|NCT02658890|459203952|FG004|Treatment Phase|Withdrawal by Subject|0|||
127610830|NCT02658890|459203953|FG005|Treatment Phase|Withdrawal by Subject|0|||
127610831|NCT02658890|459203954|FG006|Treatment Phase|Withdrawal by Subject|1|||
127610832|NCT02658890|459203955|FG007|Treatment Phase|Withdrawal by Subject|0|||
127610833|NCT02658890|459203956|FG008|Treatment Phase|Withdrawal by Subject|0|||
127610834|NCT02658890|459203957|FG009|Treatment Phase|Withdrawal by Subject|1|||
127610835|NCT02658890|459203958|FG010|Treatment Phase|Withdrawal by Subject|0|||
127610836|NCT02658890|459203959|FG011|Treatment Phase|Withdrawal by Subject|0|||
127610837|NCT02658890|459203960|FG012|Treatment Phase|Withdrawal by Subject|1|||
127610838|NCT02658890|459203961|FG013|Treatment Phase|Withdrawal by Subject|3|||
127610839|NCT02658890|459203962|FG014|Treatment Phase|Withdrawal by Subject|0|||
127610840|NCT02658890|459203963|FG015|Treatment Phase|Withdrawal by Subject|0|||
127610841|NCT02658890|459203964|FG016|Treatment Phase|Withdrawal by Subject|1|||
127610842|NCT02658890|459203965|FG017|Treatment Phase|Withdrawal by Subject|0|||
127610843|NCT02658890|459203966|FG018|Treatment Phase|Withdrawal by Subject|4|||
127610844|NCT02658890|459203967|FG019|Treatment Phase|Withdrawal by Subject|3|||
127610845|NCT02658890|459203968|FG020|Treatment Phase|Withdrawal by Subject|0|||
127610846|NCT02658890|459203969|FG021|Treatment Phase|Withdrawal by Subject|4|||
127610847|NCT02658890|459203970|FG022|Treatment Phase|Withdrawal by Subject|1|||
127610848|NCT02658890|459203971|FG023|Treatment Phase|Withdrawal by Subject|1|||
127610849|NCT02658890|459203972|FG024|Treatment Phase|Withdrawal by Subject|0|||
127610850|NCT02658890|459203973|FG025|Treatment Phase|Withdrawal by Subject|0|||
127610851|NCT02658890|459203974|FG026|Treatment Phase|Withdrawal by Subject|0|||
127610852|NCT00159588|459203978|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
127610853|NCT00159588|459203979|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
127610854|NCT00159588|459203980|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
127610855|NCT03253848|459203982|FG000|Overall Study|Adverse Event|7|||
127610856|NCT03253848|459203982|FG000|Overall Study|Death|5|||
127610857|NCT03253848|459203982|FG000|Overall Study|initiation of other treatments|3|||
127610858|NCT03253848|459203982|FG000|Overall Study|Other complicating disease|1|||
127610859|NCT03253848|459203982|FG000|Overall Study|Withdrawal by Subject|1|||
127610860|NCT03253848|459203982|FG000|Overall Study|Declining health|1|||
127610861|NCT05352815|459203983|FG000|Overall Study|Withdrawal by Subject|28|||
127610862|NCT05352815|459203984|FG001|Overall Study|Withdrawal by Subject|24|||
127610863|NCT05352815|459203983|FG000|Overall Study|Lost to Follow-up|4|||
127610864|NCT05352815|459203984|FG001|Overall Study|Lost to Follow-up|7|||
127610865|NCT05352815|459203983|FG000|Overall Study|Death|2|||
127610866|NCT05352815|459203984|FG001|Overall Study|Death|3|||
127610867|NCT05352815|459203983|FG000|Overall Study|Site closure|1|||
127610868|NCT05352815|459203984|FG001|Overall Study|Site closure|0|||
127610869|NCT02759120|459203985|FG000|Overall Study|Death|34|||
127610870|NCT02759120|459203986|FG001|Overall Study|Death|36|||
127610871|NCT02759120|459203985|FG000|Overall Study|Lost to Follow-up|4|||
127610872|NCT02759120|459203986|FG001|Overall Study|Lost to Follow-up|7|||
127610873|NCT02759120|459203985|FG000|Overall Study|Physician Decision|3|||
127610874|NCT02759120|459203986|FG001|Overall Study|Physician Decision|0|||
127610875|NCT02759120|459203985|FG000|Overall Study|Withdrawal by Subject|28|||
127610876|NCT02759120|459203986|FG001|Overall Study|Withdrawal by Subject|15|||
127610877|NCT02759120|459203985|FG000|Overall Study|Moved out of area|3|||
127610878|NCT02759120|459203986|FG001|Overall Study|Moved out of area|4|||
127610879|NCT02759120|459203985|FG000|Overall Study|Lung transplant|3|||
127610880|NCT02759120|459203986|FG001|Overall Study|Lung transplant|5|||
127610881|NCT02759120|459203985|FG000|Overall Study|Other reason not completed|10|||
127610882|NCT02759120|459203986|FG001|Overall Study|Other reason not completed|12|||
127610883|NCT03056755|459203988|FG000|Treatment- Core Phase|Progressive disease|89|||
127610884|NCT03056755|459203989|FG001|Treatment- Core Phase|Progressive disease|88|||
127610885|NCT03056755|459203990|FG002|Treatment- Core Phase|Progressive disease|90|||
127882936|NCT04440007|460194625|FG000|Overall Study|Lost to Follow-up|1|||
127610886|NCT03056755|459203988|FG000|Treatment- Core Phase|Adverse Event|20|||
127610887|NCT03056755|459203989|FG001|Treatment- Core Phase|Adverse Event|14|||
127610888|NCT03056755|459203990|FG002|Treatment- Core Phase|Adverse Event|13|||
127882937|NCT04440007|460194626|FG001|Overall Study|Lost to Follow-up|3|||
127610889|NCT03056755|459203988|FG000|Treatment- Core Phase|Physician Decision|7|||
127610890|NCT03056755|459203989|FG001|Treatment- Core Phase|Physician Decision|13|||
127610891|NCT03056755|459203990|FG002|Treatment- Core Phase|Physician Decision|5|||
127698382|NCT03194217|459523812|FG003|Overall Study|Adverse Event|3|||
127698383|NCT03194217|459523809|FG000|Overall Study|Failure to meet randomisation criteria|0|||
127698384|NCT03194217|459523810|FG001|Overall Study|Failure to meet randomisation criteria|0|||
127698385|NCT03194217|459523811|FG002|Overall Study|Failure to meet randomisation criteria|0|||
127698386|NCT03194217|459523812|FG003|Overall Study|Failure to meet randomisation criteria|1|||
127698387|NCT03194217|459523809|FG000|Overall Study|Other|0|||
127698388|NCT03194217|459523810|FG001|Overall Study|Other|1|||
127698389|NCT03194217|459523811|FG002|Overall Study|Other|1|||
127698390|NCT03194217|459523812|FG003|Overall Study|Other|0|||
127698391|NCT05481320|459523813|FG000|Overall Study|Withdrawal by Subject|1|||
127698392|NCT05481320|459523814|FG001|Overall Study|Withdrawal by Subject|1|||
127698393|NCT05481320|459523813|FG000|Overall Study|Care recipent passed away|0|||
127698394|NCT05481320|459523814|FG001|Overall Study|Care recipent passed away|1|||
127698395|NCT05481320|459523813|FG000|Overall Study|Out-of-window assessment|0|||
127698396|NCT05481320|459523814|FG001|Overall Study|Out-of-window assessment|1|||
127698397|NCT05481320|459523813|FG000|Overall Study|No longer a primary caregiver|3|||
127698398|NCT05481320|459523814|FG001|Overall Study|No longer a primary caregiver|0|||
127698399|NCT05481320|459523813|FG000|Overall Study|Unable to contact|1|||
127698400|NCT05481320|459523814|FG001|Overall Study|Unable to contact|0|||
127698401|NCT05894577|459523815|FG000|Overall Study|No receipt of study drug|14|||
127698402|NCT05894577|459523816|FG001|Overall Study|No receipt of study drug|13|||
127698403|NCT05894577|459523815|FG000|Overall Study|Randomized not enrolled (Drug not received)|11|||
127698404|NCT05894577|459523816|FG001|Overall Study|Randomized not enrolled (Drug not received)|14|||
127698405|NCT05894577|459523815|FG000|Overall Study|Screen Fail|2|||
127698406|NCT05894577|459523816|FG001|Overall Study|Screen Fail|0|||
127698407|NCT05894577|459523815|FG000|Overall Study|Study drug recall|86|||
127698408|NCT05894577|459523816|FG001|Overall Study|Study drug recall|63|||
127698409|NCT04509674|459523818|FG000|Overall Study|Not treated|33|||
127698410|NCT04509674|459523819|FG001|Overall Study|Not treated|26|||
127698411|NCT04509674|459523818|FG000|Overall Study|Protocol Violation|9|||
127882938|NCT04440007|460194625|FG000|Overall Study|Death|7|||
127610892|NCT03056755|459203988|FG000|Treatment- Core Phase|Subject/guardian decision|5|||
127610893|NCT03056755|459203989|FG001|Treatment- Core Phase|Subject/guardian decision|8|||
127610894|NCT03056755|459203990|FG002|Treatment- Core Phase|Subject/guardian decision|4|||
127610895|NCT03056755|459203988|FG000|Treatment- Core Phase|Death|3|||
127610896|NCT03056755|459203989|FG001|Treatment- Core Phase|Death|2|||
127610897|NCT03056755|459203990|FG002|Treatment- Core Phase|Death|4|||
127610898|NCT03056755|459203988|FG000|Treatment- Core Phase|Protocol deviation|1|||
127610899|NCT03056755|459203989|FG001|Treatment- Core Phase|Protocol deviation|1|||
127610900|NCT03056755|459203990|FG002|Treatment- Core Phase|Protocol deviation|0|||
127610901|NCT03056755|459203988|FG000|Treatment- Core Phase|Technical problems|1|||
127610902|NCT03056755|459203989|FG001|Treatment- Core Phase|Technical problems|0|||
127610903|NCT03056755|459203990|FG002|Treatment- Core Phase|Technical problems|0|||
127610904|NCT03056755|459203988|FG000|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
127610905|NCT03056755|459203989|FG001|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
127610906|NCT03056755|459203990|FG002|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|2|||
127610907|NCT03056755|459203988|FG000|Post-treatment Efficacy - Core Phase|Progressive disease|11|||
127610908|NCT03056755|459203989|FG001|Post-treatment Efficacy - Core Phase|Progressive disease|9|||
127610909|NCT03056755|459203990|FG002|Post-treatment Efficacy - Core Phase|Progressive disease|5|||
127610910|NCT03056755|459203988|FG000|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
127610911|NCT03056755|459203989|FG001|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
127610912|NCT03056755|459203990|FG002|Post-treatment Efficacy - Core Phase|Adverse Event|0|||
127610913|NCT03056755|459203988|FG000|Post-treatment Efficacy - Core Phase|Death|1|||
127610914|NCT03056755|459203989|FG001|Post-treatment Efficacy - Core Phase|Death|3|||
127610915|NCT03056755|459203990|FG002|Post-treatment Efficacy - Core Phase|Death|0|||
127610916|NCT02419742|459203993|FG000|Overall Study|Adverse Event|2|||
127610917|NCT02419742|459203994|FG001|Overall Study|Adverse Event|0|||
127610918|NCT02419742|459203993|FG000|Overall Study|Disease Progression|0|||
127610919|NCT02419742|459203994|FG001|Overall Study|Disease Progression|1|||
127610920|NCT02419742|459203993|FG000|Overall Study|Withdrew Consent|2|||
127610921|NCT02419742|459203994|FG001|Overall Study|Withdrew Consent|1|||
127610922|NCT02419742|459203993|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
127610923|NCT02419742|459203994|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
127610924|NCT05071183|459204001|FG000|Overall Study|Death|1|||
127610925|NCT05071183|459204002|FG001|Overall Study|Death|2|||
127610926|NCT05071183|459204003|FG002|Overall Study|Death|0|||
127610927|NCT05071183|459204001|FG000|Overall Study|Other Reasons|1|||
127610928|NCT05071183|459204002|FG001|Overall Study|Other Reasons|3|||
127610929|NCT05071183|459204003|FG002|Overall Study|Other Reasons|2|||
127610930|NCT02211131|459204015|FG000|Overall Study|Death|26|||
127610931|NCT02211131|459204016|FG001|Overall Study|Death|16|||
127610932|NCT02211131|459204015|FG000|Overall Study|Lost to Follow-up|4|||
127610933|NCT02211131|459204016|FG001|Overall Study|Lost to Follow-up|3|||
127610934|NCT02211131|459204015|FG000|Overall Study|Decision by Sponsor|1|||
127610935|NCT02211131|459204016|FG001|Overall Study|Decision by Sponsor|1|||
127610936|NCT02211131|459204015|FG000|Overall Study|Withdrawal by Subject|3|||
127610937|NCT02211131|459204016|FG001|Overall Study|Withdrawal by Subject|8|||
127610938|NCT02939560|459204018|FG000|Overall Study|Withdrawal by Subject|2|||
127610939|NCT02939560|459204018|FG000|Overall Study|Protocol Violation|1|||
127610940|NCT03340025|459204019|FG000|Overall Study|Lost to Follow-up|2|||
127610941|NCT03340025|459204020|FG001|Overall Study|Lost to Follow-up|2|||
127610942|NCT02420691|459204025|FG000|Overall Study|Adverse Event|3|||
127610943|NCT02420691|459204025|FG000|Overall Study|Withdrawal by Subject|3|||
127610944|NCT01480076|459204031|FG000|Overall Study|Run-in Failure|52|||
127610945|NCT01480076|459204031|FG000|Overall Study|Adverse Event|39|||
127610946|NCT01480076|459204031|FG000|Overall Study|Death|2|||
127610947|NCT01480076|459204031|FG000|Overall Study|Disease Progression|5|||
127610948|NCT01480076|459204031|FG000|Overall Study|Non-compliance With Study Protocol|15|||
127610949|NCT01480076|459204031|FG000|Overall Study|Withdrawal by Subject|105|||
127610950|NCT01480076|459204031|FG000|Overall Study|Lost to Follow-up|7|||
127610951|NCT01480076|459204031|FG000|Overall Study|Investigator Decision|13|||
127610952|NCT01480076|459204031|FG000|Overall Study|Other|52|||
127610953|NCT00704535|459204032|FG000|Overall Study|Adverse Event|2|||
127610954|NCT00704535|459204032|FG000|Overall Study|Death|2|||
127610955|NCT00704535|459204032|FG000|Overall Study|Lost to Follow-up|8|||
127610956|NCT00704535|459204032|FG000|Overall Study|Protocol Violation|10|||
127610957|NCT00704535|459204032|FG000|Overall Study|Completed status not on Case Report Form|124|||
127610958|NCT02503332|459204033|FG000|Overall Study|Adverse Event|17|||
127610959|NCT02503332|459204034|FG001|Overall Study|Adverse Event|5|||
127610960|NCT02503332|459204035|FG002|Overall Study|Adverse Event|3|||
127610961|NCT02503332|459204036|FG003|Overall Study|Adverse Event|1|||
127610962|NCT02503332|459204033|FG000|Overall Study|Investigator's Decision|5|||
127610963|NCT02503332|459204034|FG001|Overall Study|Investigator's Decision|1|||
127610964|NCT02503332|459204035|FG002|Overall Study|Investigator's Decision|0|||
127610965|NCT02503332|459204036|FG003|Overall Study|Investigator's Decision|0|||
127610966|NCT02503332|459204033|FG000|Overall Study|Sponsor's Decision|1|||
127610967|NCT02503332|459204034|FG001|Overall Study|Sponsor's Decision|0|||
127610968|NCT02503332|459204035|FG002|Overall Study|Sponsor's Decision|0|||
127610969|NCT02503332|459204036|FG003|Overall Study|Sponsor's Decision|1|||
127610970|NCT02503332|459204033|FG000|Overall Study|Subject Request|6|||
127610971|NCT02503332|459204034|FG001|Overall Study|Subject Request|5|||
127610972|NCT02503332|459204035|FG002|Overall Study|Subject Request|2|||
127610973|NCT02503332|459204036|FG003|Overall Study|Subject Request|1|||
127610974|NCT02503332|459204033|FG000|Overall Study|Death|0|||
127610975|NCT02503332|459204034|FG001|Overall Study|Death|2|||
127610976|NCT02503332|459204035|FG002|Overall Study|Death|2|||
127610977|NCT02503332|459204036|FG003|Overall Study|Death|0|||
127610978|NCT02503332|459204033|FG000|Overall Study|Other|5|||
127610979|NCT02503332|459204034|FG001|Overall Study|Other|6|||
127610980|NCT02503332|459204035|FG002|Overall Study|Other|1|||
127610981|NCT02503332|459204036|FG003|Overall Study|Other|1|||
127610982|NCT01413360|459204037|FG000|Overall Study|Lost to Follow-up|2|||
127610983|NCT01413360|459204037|FG000|Overall Study|Adverse Event|1|||
127610984|NCT01488097|459204040|FG000|Overall Study|Lost to Follow-up|1|||
127610985|NCT02016482|459204044|FG000|Period A|Adverse Event|3|||
127610986|NCT02016482|459204045|FG001|Period A|Adverse Event|5|||
127610987|NCT02016482|459204044|FG000|Period A|Withdrawal by Subject|3|||
127610988|NCT02016482|459204045|FG001|Period A|Withdrawal by Subject|4|||
127610989|NCT02016482|459204044|FG000|Period A|Lost to Follow-up|3|||
127610990|NCT02016482|459204045|FG001|Period A|Lost to Follow-up|3|||
127610991|NCT02016482|459204044|FG000|Period A|Lack of Efficacy|2|||
127610992|NCT02016482|459204045|FG001|Period A|Lack of Efficacy|1|||
127610993|NCT02016482|459204044|FG000|Period A|Other|3|||
127610994|NCT02016482|459204045|FG001|Period A|Other|0|||
127610995|NCT02016482|459204044|FG000|Period A|Protocol Violation|0|||
127610996|NCT02016482|459204045|FG001|Period A|Protocol Violation|1|||
127610997|NCT02016482|459204044|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
127610998|NCT02016482|459204045|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
127610999|NCT02016482|459204044|FG000|Period B|Withdrawal by Subject|1|||
127611000|NCT02016482|459204045|FG001|Period B|Withdrawal by Subject|1|||
127611001|NCT02016482|459204044|FG000|Period B|Lost to Follow-up|2|||
127611002|NCT02016482|459204045|FG001|Period B|Lost to Follow-up|0|||
127611003|NCT02016482|459204044|FG000|Period B|Lack of Efficacy|6|||
127611004|NCT02016482|459204045|FG001|Period B|Lack of Efficacy|4|||
127611005|NCT02016482|459204044|FG000|Period B|Other|4|||
127611006|NCT02016482|459204045|FG001|Period B|Other|0|||
127611007|NCT02016482|459204044|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
127611008|NCT02016482|459204045|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
127611009|NCT03054870|459204046|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
127611010|NCT03054870|459204046|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
127611011|NCT00304356|459204050|FG000|Nitazoxanide|Physician Decision|5|||
127611012|NCT00304356|459204050|FG000|Nitazoxanide|Physician Decision|1|||
127611013|NCT00304356|459204050|FG000|Nitazoxanide|number is 0|1|||
127611014|NCT00304356|459204050|FG000|Nitazoxanide|Physician Decision|1|||
127611015|NCT00304356|459204050|FG000|Nitazoxanide|Physician Decision|1|||
127611016|NCT00304356|459204050|FG000|Nitazoxanide|Physician Decision|1|||
127611017|NCT01154218|459204051|FG000|Third Intervention Period|Adverse Event|0|||
127611018|NCT01154218|459204052|FG001|Third Intervention Period|Adverse Event|1|||
127611019|NCT01154218|459204053|FG002|Third Intervention Period|Adverse Event|0|||
127611020|NCT01154218|459204054|FG003|Third Intervention Period|Adverse Event|0|||
127611021|NCT01154218|459204051|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
127611022|NCT01154218|459204052|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
127611023|NCT01154218|459204053|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
127611024|NCT01154218|459204054|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
127611025|NCT01154218|459204051|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
127611026|NCT01154218|459204052|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
127611027|NCT01154218|459204053|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
127611028|NCT01154218|459204054|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
127611029|NCT02140567|459204061|FG000|Overall Study|Problems with recording equipment|6|||
127611030|NCT01709695|459204062|FG000|Overall Study|Withdrawal by Subject|1|||
127611031|NCT01709695|459204063|FG001|Overall Study|Withdrawal by Subject|1|||
127611032|NCT02802592|459204064|FG000|Overall Study|Study terminated due to loss of funding|4|||
127611033|NCT02882854|459204065|FG000|Overall Study|Lost to Follow-up|1|||
127611034|NCT02882854|459204066|FG001|Overall Study|Lost to Follow-up|2|||
127611035|NCT02882854|459204065|FG000|Overall Study|Physician Decision|0|||
127611036|NCT02882854|459204066|FG001|Overall Study|Physician Decision|1|||
127611037|NCT01358357|459204070|FG000|Open Label Phase|Adverse Event|0|||
127698412|NCT04509674|459523819|FG001|Overall Study|Protocol Violation|10|||
127698413|NCT04509674|459523818|FG000|Overall Study|Lost to Follow-up|31|||
127698414|NCT04509674|459523819|FG001|Overall Study|Lost to Follow-up|39|||
127698415|NCT04509674|459523818|FG000|Overall Study|Patient refusal to continue, not due to adverse event|452|||
127698416|NCT04509674|459523819|FG001|Overall Study|Patient refusal to continue, not due to adverse event|418|||
127698417|NCT04509674|459523818|FG000|Overall Study|Adverse event, serious fatal event|11|||
127698418|NCT04509674|459523819|FG001|Overall Study|Adverse event, serious fatal event|4|||
127698419|NCT04509674|459523818|FG000|Overall Study|Adverse event, non-fatal event|107|||
127698420|NCT04509674|459523819|FG001|Overall Study|Adverse event, non-fatal event|118|||
127698421|NCT04509674|459523818|FG000|Overall Study|Other reason than listed|106|||
127698422|NCT04509674|459523819|FG001|Overall Study|Other reason than listed|95|||
127698423|NCT01214616|459523820|FG000|Overall Study|Progressive disease|2|||
127698424|NCT01214616|459523821|FG001|Overall Study|Progressive disease|2|||
127698425|NCT01214616|459523822|FG002|Overall Study|Progressive disease|2|||
127698426|NCT01214616|459523823|FG003|Overall Study|Progressive disease|4|||
127698427|NCT01214616|459523820|FG000|Overall Study|Dose limiting toxicity|0|||
127698428|NCT01214616|459523821|FG001|Overall Study|Dose limiting toxicity|2|||
127698429|NCT01214616|459523822|FG002|Overall Study|Dose limiting toxicity|0|||
127698430|NCT01214616|459523823|FG003|Overall Study|Dose limiting toxicity|0|||
127698431|NCT01214616|459523820|FG000|Overall Study|Other adverse events|0|||
127698432|NCT01214616|459523821|FG001|Overall Study|Other adverse events|1|||
127698433|NCT01214616|459523822|FG002|Overall Study|Other adverse events|1|||
127698434|NCT01214616|459523823|FG003|Overall Study|Other adverse events|1|||
127698435|NCT01214616|459523820|FG000|Overall Study|Withdrawal by Subject|1|||
127698436|NCT01214616|459523821|FG001|Overall Study|Withdrawal by Subject|0|||
127698437|NCT01214616|459523822|FG002|Overall Study|Withdrawal by Subject|0|||
127698438|NCT01214616|459523823|FG003|Overall Study|Withdrawal by Subject|1|||
127698439|NCT03721952|459523824|FG000|Overall Study|Lost to Follow-up|0|||
127698440|NCT03721952|459523825|FG001|Overall Study|Lost to Follow-up|0|||
127698441|NCT03721952|459523826|FG002|Overall Study|Lost to Follow-up|2|||
127698442|NCT03721952|459523827|FG003|Overall Study|Lost to Follow-up|0|||
127698443|NCT03721952|459523828|FG004|Overall Study|Lost to Follow-up|0|||
127698444|NCT03721952|459523824|FG000|Overall Study|Protocol Violation|0|||
127698445|NCT03721952|459523825|FG001|Overall Study|Protocol Violation|1|||
127698446|NCT03721952|459523826|FG002|Overall Study|Protocol Violation|0|||
127698447|NCT03721952|459523827|FG003|Overall Study|Protocol Violation|0|||
127698448|NCT03721952|459523828|FG004|Overall Study|Protocol Violation|0|||
127698449|NCT03721952|459523824|FG000|Overall Study|Withdrawal by Subject|1|||
127882939|NCT04440007|460194626|FG001|Overall Study|Death|2|||
127882940|NCT04440007|460194625|FG000|Overall Study|Physician Decision|1|||
127882941|NCT04440007|460194626|FG001|Overall Study|Physician Decision|1|||
127882942|NCT04440007|460194625|FG000|Overall Study|Withdrawal by Subject|2|||
127882943|NCT04440007|460194626|FG001|Overall Study|Withdrawal by Subject|1|||
127882944|NCT04440007|460194625|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
127882945|NCT04440007|460194626|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
127698450|NCT03721952|459523825|FG001|Overall Study|Withdrawal by Subject|0|||
127698451|NCT03721952|459523826|FG002|Overall Study|Withdrawal by Subject|40|||
127698452|NCT03721952|459523827|FG003|Overall Study|Withdrawal by Subject|28|||
127698453|NCT03721952|459523828|FG004|Overall Study|Withdrawal by Subject|0|||
127698454|NCT05292365|459523831|FG000|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
127698455|NCT05292365|459523832|FG001|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
127698456|NCT05292365|459523833|FG002|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
127698457|NCT05292365|459523834|FG003|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
127698458|NCT04495894|459523838|FG000|Overall Study|Withdrawal by Subject|2|||
127698459|NCT04495894|459523839|FG001|Overall Study|Withdrawal by Subject|0|||
127698460|NCT04495894|459523840|FG002|Overall Study|Withdrawal by Subject|2|||
127698461|NCT04495894|459523841|FG003|Overall Study|Withdrawal by Subject|3|||
127698462|NCT04495894|459523838|FG000|Overall Study|Early termination|0|||
127698463|NCT04495894|459523839|FG001|Overall Study|Early termination|0|||
127698464|NCT04495894|459523840|FG002|Overall Study|Early termination|3|||
127698465|NCT04495894|459523841|FG003|Overall Study|Early termination|0|||
127698466|NCT05579899|459523843|FG000|Overall Study|Lost to Follow-up|3|||
127698467|NCT05579899|459523844|FG001|Overall Study|Lost to Follow-up|1|||
127698468|NCT05579899|459523843|FG000|Overall Study|Adverse Event|0|||
127698469|NCT05579899|459523844|FG001|Overall Study|Adverse Event|3|||
127698470|NCT05579899|459523843|FG000|Overall Study|Pregnancy|0|||
127698471|NCT05579899|459523844|FG001|Overall Study|Pregnancy|1|||
127698472|NCT05579899|459523843|FG000|Overall Study|Withdrawal by Subject|0|||
127698473|NCT05579899|459523844|FG001|Overall Study|Withdrawal by Subject|3|||
127698474|NCT01000961|459523846|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
127698475|NCT01000961|459523847|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
127698476|NCT01000961|459523846|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
127882946|NCT04440007|460194625|FG000|Overall Study|Discontinued prior to dosing|0|||
127611038|NCT01358357|459204071|FG001|Open Label Phase|Adverse Event|0|||
127611039|NCT01358357|459204072|FG002|Open Label Phase|Adverse Event|59|||
127611040|NCT01358357|459204070|FG000|Open Label Phase|Lack of Efficacy|0|||
127611041|NCT01358357|459204071|FG001|Open Label Phase|Lack of Efficacy|0|||
127611042|NCT01358357|459204072|FG002|Open Label Phase|Lack of Efficacy|107|||
127611043|NCT01358357|459204070|FG000|Open Label Phase|Lost to Follow-up|0|||
127611044|NCT01358357|459204071|FG001|Open Label Phase|Lost to Follow-up|0|||
127611045|NCT01358357|459204072|FG002|Open Label Phase|Lost to Follow-up|76|||
127611046|NCT01358357|459204070|FG000|Open Label Phase|Protocol Violation|0|||
127882947|NCT04440007|460194626|FG001|Overall Study|Discontinued prior to dosing|2|||
127882948|NCT01466673|460194627|FG000|Overall Study|Non-compliance with study treatment|2|||
127882949|NCT01466673|460194628|FG001|Overall Study|Non-compliance with study treatment|0|||
127882950|NCT01466673|460194627|FG000|Overall Study|Lost to Follow-up|3|||
127611047|NCT01358357|459204071|FG001|Open Label Phase|Protocol Violation|0|||
127611048|NCT01358357|459204072|FG002|Open Label Phase|Protocol Violation|45|||
127882951|NCT01466673|460194628|FG001|Overall Study|Lost to Follow-up|5|||
127882952|NCT01466673|460194627|FG000|Overall Study|Adverse Event|2|||
127882953|NCT01466673|460194628|FG001|Overall Study|Adverse Event|1|||
127882954|NCT00854607|460194629|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
127882955|NCT03959137|460194632|FG000|Overall Study|Protocol Violation|6|||
127882956|NCT02720094|460194633|FG000|Overall Study|Scheduled exit visit/end of study|2|||
127882957|NCT02720094|460194634|FG001|Overall Study|Scheduled exit visit/end of study|1|||
127882958|NCT02720094|460194633|FG000|Overall Study|Death|4|||
127882959|NCT02720094|460194634|FG001|Overall Study|Death|7|||
127882960|NCT02720094|460194633|FG000|Overall Study|Withdrawal by Subject|55|||
127882961|NCT02720094|460194634|FG001|Overall Study|Withdrawal by Subject|56|||
127882962|NCT02720094|460194633|FG000|Overall Study|Lost to Follow-up|2|||
127611049|NCT01358357|459204070|FG000|Open Label Phase|Withdrawal by Subject|0|||
127611050|NCT01358357|459204071|FG001|Open Label Phase|Withdrawal by Subject|0|||
127611051|NCT01358357|459204072|FG002|Open Label Phase|Withdrawal by Subject|112|||
127611052|NCT01358357|459204070|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
127611053|NCT01358357|459204071|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
127611054|NCT01358357|459204072|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
127611055|NCT01358357|459204070|FG000|Open Label Phase|Terminated at study completion|0|||
127611056|NCT01358357|459204071|FG001|Open Label Phase|Terminated at study completion|0|||
127611057|NCT01358357|459204072|FG002|Open Label Phase|Terminated at study completion|5|||
127611058|NCT01358357|459204070|FG000|Open Label Phase|Mood episode|0|||
127611059|NCT01358357|459204071|FG001|Open Label Phase|Mood episode|0|||
127611060|NCT01358357|459204072|FG002|Open Label Phase|Mood episode|42|||
127611061|NCT01358357|459204070|FG000|Double-Blind Phase|Adverse Event|8|||
127611062|NCT01358357|459204071|FG001|Double-Blind Phase|Adverse Event|5|||
127611063|NCT01358357|459204072|FG002|Double-Blind Phase|Adverse Event|0|||
127611064|NCT01358357|459204070|FG000|Double-Blind Phase|Lost to Follow-up|5|||
127611065|NCT01358357|459204071|FG001|Double-Blind Phase|Lost to Follow-up|7|||
127611066|NCT01358357|459204072|FG002|Double-Blind Phase|Lost to Follow-up|0|||
127611067|NCT01358357|459204070|FG000|Double-Blind Phase|Protocol Violation|1|||
127611068|NCT01358357|459204071|FG001|Double-Blind Phase|Protocol Violation|11|||
127611069|NCT01358357|459204072|FG002|Double-Blind Phase|Protocol Violation|0|||
127611070|NCT01358357|459204070|FG000|Double-Blind Phase|Protocol Violation|16|||
127611071|NCT01358357|459204071|FG001|Double-Blind Phase|Protocol Violation|12|||
127611072|NCT01358357|459204072|FG002|Double-Blind Phase|Protocol Violation|0|||
127611073|NCT01358357|459204070|FG000|Double-Blind Phase|Terminated at study completion|2|||
127611074|NCT01358357|459204071|FG001|Double-Blind Phase|Terminated at study completion|0|||
127611075|NCT01358357|459204072|FG002|Double-Blind Phase|Terminated at study completion|0|||
127611076|NCT01358357|459204070|FG000|Double-Blind Phase|Recurrence of mood event|48|||
127611077|NCT01358357|459204071|FG001|Double-Blind Phase|Recurrence of mood event|64|||
127611078|NCT01358357|459204072|FG002|Double-Blind Phase|Recurrence of mood event|0|||
127611079|NCT01358357|459204070|FG000|Double-Blind Phase|Administrative|0|||
127611080|NCT01358357|459204071|FG001|Double-Blind Phase|Administrative|1|||
127611081|NCT01358357|459204072|FG002|Double-Blind Phase|Administrative|0|||
127698477|NCT01000961|459523847|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
127698478|NCT04185298|459523851|FG000|Overall Study|Lost to Follow-up|1|||
127698479|NCT04185298|459523852|FG001|Overall Study|Lost to Follow-up|3|||
127882963|NCT02720094|460194634|FG001|Overall Study|Lost to Follow-up|7|||
127882964|NCT02720094|460194633|FG000|Overall Study|Physician Decision|1|||
127882965|NCT02720094|460194634|FG001|Overall Study|Physician Decision|3|||
127882966|NCT02720094|460194633|FG000|Overall Study|Inappropriate enrollment|1|||
127611082|NCT02136576|459204073|FG000|Overall Study|Lost to Follow-up|2|||
127611083|NCT02136576|459204074|FG001|Overall Study|Lost to Follow-up|0|||
127611084|NCT02136576|459204075|FG002|Overall Study|Lost to Follow-up|0|||
127611085|NCT00537381|459204076|FG000|Overall Study|Adverse Event|13|||
127611086|NCT00537381|459204077|FG001|Overall Study|Adverse Event|9|||
127611087|NCT00537381|459204076|FG000|Overall Study|Death|3|||
127611088|NCT00537381|459204077|FG001|Overall Study|Death|3|||
127882967|NCT02720094|460194634|FG001|Overall Study|Inappropriate enrollment|3|||
127882968|NCT02720094|460194633|FG000|Overall Study|Ongoing|2210|||
127611089|NCT00537381|459204076|FG000|Overall Study|Withdrawal by Subject|5|||
127611090|NCT00537381|459204077|FG001|Overall Study|Withdrawal by Subject|14|||
127611091|NCT00537381|459204076|FG000|Overall Study|Physician Decision|7|||
127611092|NCT00537381|459204077|FG001|Overall Study|Physician Decision|6|||
127611093|NCT00537381|459204076|FG000|Overall Study|Disease Progression|9|||
127611094|NCT00537381|459204077|FG001|Overall Study|Disease Progression|18|||
127611095|NCT00537381|459204076|FG000|Overall Study|Sponsor decision|14|||
127611096|NCT00537381|459204077|FG001|Overall Study|Sponsor decision|9|||
127611097|NCT00537381|459204076|FG000|Overall Study|Other|5|||
127611098|NCT00537381|459204077|FG001|Overall Study|Other|3|||
127611099|NCT02590939|459204078|FG000|Overall Study|Withdrawal by Subject|3|||
127611100|NCT02590939|459204079|FG001|Overall Study|Withdrawal by Subject|1|||
127611101|NCT02590939|459204078|FG000|Overall Study|Failed the nociceptive test|2|||
127611102|NCT02590939|459204079|FG001|Overall Study|Failed the nociceptive test|1|||
127611103|NCT03774433|459204084|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
127611104|NCT00108160|459204085|FG000|Overall Study|Lost to Follow-up|25|||
127611105|NCT00108160|459204086|FG001|Overall Study|Lost to Follow-up|12|||
127611106|NCT00108160|459204085|FG000|Overall Study|Death|1|||
127611107|NCT00108160|459204086|FG001|Overall Study|Death|2|||
127611108|NCT00108160|459204085|FG000|Overall Study|Withdrawal by Subject|4|||
127611109|NCT00108160|459204086|FG001|Overall Study|Withdrawal by Subject|2|||
127611110|NCT00108160|459204085|FG000|Overall Study|Protocol Violation|9|||
127611111|NCT00108160|459204086|FG001|Overall Study|Protocol Violation|5|||
127611112|NCT03082599|459204090|FG000|Overall Study|Lost to Follow-up|1|||
127611113|NCT03082599|459204091|FG001|Overall Study|Lost to Follow-up|0|||
127611114|NCT02347189|459204092|FG000|Overall Study|No implant attempted of study device|9|||
127611115|NCT02347189|459204092|FG000|Overall Study|No primary outcome data available|2|||
127611116|NCT00735878|459204093|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
127611117|NCT00735878|459204094|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
127611118|NCT00735878|459204095|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
127611119|NCT00994240|459204096|FG000|Overall Study|Lost to Follow-up|3|||
127611120|NCT00994240|459204097|FG001|Overall Study|Lost to Follow-up|2|||
127789042|NCT02830880|459853460|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
127789043|NCT02830880|459853460|FG000|Overall Study|Death|1|||
127789044|NCT02830880|459853460|FG000|Overall Study|Physician Decision|1|||
127789045|NCT03551509|459853469|FG000|Overall Study|Lost to Follow-up|0|||
127789046|NCT03551509|459853470|FG001|Overall Study|Lost to Follow-up|1|||
127789047|NCT03551509|459853471|FG002|Overall Study|Lost to Follow-up|0|||
127789048|NCT01040351|459853472|FG000|Overall Study|poor ovarian response|1|||
127789049|NCT01040351|459853473|FG001|Overall Study|poor ovarian response|2|||
127789050|NCT01230307|459853474|FG000|Overall Study|LVAD Placement|0|||
127789051|NCT01230307|459853475|FG001|Overall Study|LVAD Placement|2|||
127789052|NCT00530894|459853483|FG000|Overall Study|Death|84|||
127789053|NCT00530894|459853484|FG001|Overall Study|Death|89|||
127789054|NCT00530894|459853485|FG002|Overall Study|Death|55|||
127789055|NCT00530894|459853486|FG003|Overall Study|Death|89|||
127789056|NCT00530894|459853483|FG000|Overall Study|Lost to Follow-up|1|||
127789057|NCT00530894|459853484|FG001|Overall Study|Lost to Follow-up|3|||
127789058|NCT00530894|459853485|FG002|Overall Study|Lost to Follow-up|0|||
127789059|NCT00530894|459853486|FG003|Overall Study|Lost to Follow-up|0|||
127789060|NCT00530894|459853483|FG000|Overall Study|Withdrawal by Subject|1|||
127789061|NCT00530894|459853484|FG001|Overall Study|Withdrawal by Subject|23|||
127789062|NCT00530894|459853485|FG002|Overall Study|Withdrawal by Subject|0|||
127789063|NCT00530894|459853486|FG003|Overall Study|Withdrawal by Subject|5|||
127789064|NCT00530894|459853483|FG000|Overall Study|Alive and censored prior to 1 year|2|||
127789065|NCT00530894|459853484|FG001|Overall Study|Alive and censored prior to 1 year|0|||
127789066|NCT00530894|459853485|FG002|Overall Study|Alive and censored prior to 1 year|0|||
127789067|NCT00530894|459853486|FG003|Overall Study|Alive and censored prior to 1 year|0|||
127789068|NCT02256540|459853487|FG000|Overall Study|Withdrawal by Subject|0|||
127789069|NCT02256540|459853488|FG001|Overall Study|Withdrawal by Subject|1|||
127611121|NCT00994240|459204096|FG000|Overall Study|Withdrawal by Subject|1|||
127611122|NCT00994240|459204097|FG001|Overall Study|Withdrawal by Subject|0|||
127611123|NCT00994240|459204096|FG000|Overall Study|study termination|2|||
127611124|NCT00994240|459204097|FG001|Overall Study|study termination|3|||
127611125|NCT04709575|459205705|FG000|Overall Study|Withdrawal by Subject|6|||
127611126|NCT04709575|459205706|FG001|Overall Study|Withdrawal by Subject|2|||
127789070|NCT02256540|459853489|FG002|Overall Study|Withdrawal by Subject|1|||
127789071|NCT02256540|459853487|FG000|Overall Study|Back pain preventing exercise|0|||
127789072|NCT02256540|459853488|FG001|Overall Study|Back pain preventing exercise|0|||
127789073|NCT02256540|459853489|FG002|Overall Study|Back pain preventing exercise|1|||
127611127|NCT04709575|459205705|FG000|Overall Study|Lost to Follow-up|2|||
127611128|NCT04709575|459205706|FG001|Overall Study|Lost to Follow-up|2|||
127611129|NCT04709575|459205705|FG000|Overall Study|Adverse Event|1|||
127611130|NCT04709575|459205706|FG001|Overall Study|Adverse Event|0|||
127611131|NCT04709575|459205705|FG000|Overall Study|Protocol Violation|1|||
127789074|NCT03719690|459853498|FG000|Overall Study|Withdrawal by Subject|5|||
127789075|NCT03719690|459853499|FG001|Overall Study|Withdrawal by Subject|10|||
127611132|NCT04709575|459205706|FG001|Overall Study|Protocol Violation|1|||
127611133|NCT03181399|459205707|FG000|6 Months on Treatment|Protocol non-compliance|7|||
127611134|NCT03181399|459205707|FG000|6 Months on Treatment|Adverse Event|4|||
127611135|NCT03181399|459205707|FG000|6 Months on Treatment|Tried alternative treatment|2|||
127611136|NCT03181399|459205707|FG000|6 Months on Treatment|Lost to Follow-up|2|||
127611137|NCT03181399|459205707|FG000|6 Months on Treatment|Personal reasons|1|||
127611138|NCT03181399|459205707|FG000|3 Months Off-treatment|Parent unable to travel|1|||
127611139|NCT04254978|459205719|FG000|Initial Treatment Period (ITP)|Withdrawal by Subject|3|||
127611140|NCT04254978|459205719|FG000|Initial Treatment Period (ITP)|Adverse Event|5|||
127611141|NCT04254978|459205719|FG000|Initial Treatment Period (ITP)|Lack of Efficacy|1|||
127611142|NCT04254978|459205719|FG000|Additional Treatment Period (ATP)|Withdrawal by Subject|3|||
127611143|NCT04254978|459205719|FG000|Additional Treatment Period (ATP)|Physician Decision|1|||
127611144|NCT04254978|459205719|FG000|Additional Treatment Period (ATP)|Adverse Event|7|||
127611145|NCT00277212|459205720|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
127611146|NCT00277212|459205721|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
127611147|NCT00277212|459205722|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
127611148|NCT00277212|459205720|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
127611149|NCT00277212|459205721|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
127611150|NCT00277212|459205722|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
127611151|NCT00277212|459205720|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
127611152|NCT00277212|459205721|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
127611153|NCT00277212|459205722|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
127611154|NCT00277212|459205720|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
127611155|NCT00277212|459205721|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
127611156|NCT00277212|459205722|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
127611157|NCT00277212|459205720|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
127611158|NCT00277212|459205721|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
127611159|NCT00277212|459205722|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
127611160|NCT00277212|459205720|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
127611161|NCT00277212|459205721|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
127611162|NCT00277212|459205722|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
127611163|NCT00277212|459205720|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
127789076|NCT03719690|459853498|FG000|Overall Study|Death|40|||
127789077|NCT03719690|459853499|FG001|Overall Study|Death|149|||
127789078|NCT03719690|459853498|FG000|Overall Study|Miscellaneous|12|||
127789079|NCT03719690|459853499|FG001|Overall Study|Miscellaneous|56|||
127789080|NCT03719690|459853498|FG000|Overall Study|Lost to Follow-up|2|||
127789081|NCT03719690|459853499|FG001|Overall Study|Lost to Follow-up|18|||
127789082|NCT03719690|459853498|FG000|Overall Study|Unwilling or unable to comply with study requirements|0|||
127789083|NCT03719690|459853499|FG001|Overall Study|Unwilling or unable to comply with study requirements|4|||
127789084|NCT01918007|459853500|FG000|Overall Study|Baseline oximetry not acceptable|11|||
127789085|NCT01918007|459853501|FG001|Overall Study|Baseline oximetry not acceptable|7|||
127789086|NCT01918007|459853500|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
127789087|NCT01918007|459853501|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
127789088|NCT01918007|459853500|FG000|Overall Study|Lost to Follow-up|4|||
127789089|NCT01918007|459853501|FG001|Overall Study|Lost to Follow-up|7|||
127789090|NCT00960661|459853504|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
127789091|NCT00960661|459853505|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
127789092|NCT00960661|459853506|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
127789093|NCT00960661|459853504|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
127789094|NCT00960661|459853505|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
127789095|NCT00960661|459853506|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
127789096|NCT00960661|459853504|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
127789097|NCT00960661|459853505|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
127789098|NCT00960661|459853506|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
127789099|NCT00960661|459853504|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
127789100|NCT00960661|459853505|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
127789101|NCT00960661|459853506|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
127789102|NCT00960661|459853504|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
127789103|NCT00960661|459853505|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
127789104|NCT00960661|459853506|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
127611164|NCT00277212|459205721|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
127789105|NCT00960661|459853504|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
127789106|NCT00960661|459853505|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
127882969|NCT02720094|460194634|FG001|Overall Study|Ongoing|2203|||
127882970|NCT02720094|460194633|FG000|Overall Study|Relocation|1|||
127882971|NCT02720094|460194634|FG001|Overall Study|Relocation|1|||
127882972|NCT02913261|460194635|FG000|Overall Study|Technical problems|0|||
127611165|NCT00277212|459205722|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
127611166|NCT00277212|459205720|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
127611167|NCT00277212|459205721|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
127611168|NCT00277212|459205722|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
127611169|NCT00277212|459205720|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
127611170|NCT00277212|459205721|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
127611171|NCT00277212|459205722|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
127611172|NCT00277212|459205720|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
127611173|NCT00277212|459205721|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
127611174|NCT00277212|459205722|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
127789107|NCT00960661|459853506|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
127789108|NCT00960661|459853504|FG000|Interventional Phase|Adverse Event|0|||
127789109|NCT00960661|459853505|FG001|Interventional Phase|Adverse Event|17|||
127789110|NCT00960661|459853506|FG002|Interventional Phase|Adverse Event|8|||
127789111|NCT00960661|459853504|FG000|Interventional Phase|Death|0|||
127789112|NCT00960661|459853505|FG001|Interventional Phase|Death|1|||
127789113|NCT00960661|459853506|FG002|Interventional Phase|Death|0|||
127789114|NCT00960661|459853504|FG000|Interventional Phase|Lost to Follow-up|0|||
127789115|NCT00960661|459853505|FG001|Interventional Phase|Lost to Follow-up|0|||
127789116|NCT00960661|459853506|FG002|Interventional Phase|Lost to Follow-up|2|||
127789117|NCT00960661|459853504|FG000|Interventional Phase|entry criteria not met|0|||
127789118|NCT00960661|459853505|FG001|Interventional Phase|entry criteria not met|3|||
127789119|NCT00960661|459853506|FG002|Interventional Phase|entry criteria not met|0|||
127789120|NCT00960661|459853504|FG000|Interventional Phase|Protocol Violation|0|||
127789121|NCT00960661|459853505|FG001|Interventional Phase|Protocol Violation|7|||
127789122|NCT00960661|459853506|FG002|Interventional Phase|Protocol Violation|2|||
127789123|NCT00960661|459853504|FG000|Interventional Phase|Withdrawal by Subject|0|||
127789124|NCT00960661|459853505|FG001|Interventional Phase|Withdrawal by Subject|18|||
127789125|NCT00960661|459853506|FG002|Interventional Phase|Withdrawal by Subject|29|||
127789126|NCT00960661|459853504|FG000|Interventional Phase|Physician Decision|0|||
127789127|NCT00960661|459853505|FG001|Interventional Phase|Physician Decision|3|||
127789128|NCT00960661|459853506|FG002|Interventional Phase|Physician Decision|5|||
127789129|NCT00960661|459853504|FG000|Interventional Phase|sponsor decision|0|||
127789130|NCT00960661|459853505|FG001|Interventional Phase|sponsor decision|1|||
127789131|NCT00960661|459853506|FG002|Interventional Phase|sponsor decision|0|||
127789132|NCT00960661|459853504|FG000|Interventional Phase|Lack of Efficacy|0|||
127789133|NCT00960661|459853505|FG001|Interventional Phase|Lack of Efficacy|2|||
127789134|NCT00960661|459853506|FG002|Interventional Phase|Lack of Efficacy|0|||
127789135|NCT02699892|459853507|FG000|Overall Study|Other|36|||
127789136|NCT00530270|459853519|FG000|Overall Study|Protocol Violation|1|||
127789137|NCT00530270|459853520|FG001|Overall Study|Protocol Violation|0|||
127789138|NCT02919436|459853526|FG000|Overall Study|Did not undergo surgery|16|||
127789139|NCT02919436|459853527|FG001|Overall Study|Did not undergo surgery|20|||
127789140|NCT02919436|459853526|FG000|Overall Study|Enrolled before trial registration|44|||
127789141|NCT02919436|459853527|FG001|Overall Study|Enrolled before trial registration|33|||
127789142|NCT03699007|459853528|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
127789143|NCT03699007|459853529|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
127789144|NCT03699007|459853528|FG000|6-month Follow Up|Lost to Follow-up|2|||
127789145|NCT03699007|459853529|FG001|6-month Follow Up|Lost to Follow-up|3|||
127789146|NCT03259074|459853530|FG000|Overall Study|Adverse Event|9|||
127789147|NCT03259074|459853531|FG001|Overall Study|Adverse Event|12|||
127789148|NCT03259074|459853532|FG002|Overall Study|Adverse Event|8|||
127789149|NCT03259074|459853530|FG000|Overall Study|Death|1|||
127789150|NCT03259074|459853531|FG001|Overall Study|Death|1|||
127789151|NCT03259074|459853532|FG002|Overall Study|Death|3|||
127789152|NCT03259074|459853530|FG000|Overall Study|Lost to Follow-up|2|||
127789153|NCT03259074|459853531|FG001|Overall Study|Lost to Follow-up|4|||
127789154|NCT03259074|459853532|FG002|Overall Study|Lost to Follow-up|3|||
127789155|NCT03259074|459853530|FG000|Overall Study|New Therapy For Study Indication|1|||
127789156|NCT03259074|459853531|FG001|Overall Study|New Therapy For Study Indication|2|||
127789157|NCT03259074|459853532|FG002|Overall Study|New Therapy For Study Indication|2|||
127882973|NCT02913261|460194636|FG001|Overall Study|Technical problems|1|||
127611175|NCT00277212|459205720|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
127611176|NCT00277212|459205721|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
127611177|NCT00277212|459205722|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
127611178|NCT00277212|459205720|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
127611179|NCT00277212|459205721|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
127789158|NCT03259074|459853530|FG000|Overall Study|Physician Decision|4|||
127789159|NCT03259074|459853531|FG001|Overall Study|Physician Decision|12|||
127789160|NCT03259074|459853532|FG002|Overall Study|Physician Decision|10|||
127789161|NCT03259074|459853530|FG000|Overall Study|Pregnancy|1|||
127789162|NCT03259074|459853531|FG001|Overall Study|Pregnancy|1|||
127789163|NCT03259074|459853532|FG002|Overall Study|Pregnancy|0|||
127789164|NCT03259074|459853530|FG000|Overall Study|Progressive Disease|1|||
127882974|NCT02913261|460194635|FG000|Overall Study|Lack of Efficacy|32|||
127882975|NCT02913261|460194636|FG001|Overall Study|Lack of Efficacy|69|||
127882976|NCT02913261|460194635|FG000|Overall Study|Adverse Event|27|||
127882977|NCT02913261|460194636|FG001|Overall Study|Adverse Event|5|||
127882978|NCT02913261|460194635|FG000|Overall Study|Death|25|||
127882979|NCT02913261|460194636|FG001|Overall Study|Death|22|||
127882980|NCT02913261|460194635|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
127882981|NCT02913261|460194636|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
127882982|NCT02913261|460194635|FG000|Overall Study|Disease relapse|8|||
127882983|NCT02913261|460194636|FG001|Overall Study|Disease relapse|13|||
127882984|NCT02913261|460194635|FG000|Overall Study|Physician Decision|8|||
127882985|NCT02913261|460194636|FG001|Overall Study|Physician Decision|9|||
127882986|NCT02913261|460194635|FG000|Overall Study|Subject/guardian decision|4|||
127882987|NCT02913261|460194636|FG001|Overall Study|Subject/guardian decision|6|||
127882988|NCT02913261|460194635|FG000|Overall Study|Graft loss|2|||
127882989|NCT02913261|460194636|FG001|Overall Study|Graft loss|0|||
127611180|NCT00277212|459205722|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
127882990|NCT01211613|460196297|FG000|Overall Study|Lost to Follow-up|2|||
127882991|NCT01211613|460196298|FG001|Overall Study|Lost to Follow-up|2|||
127882992|NCT01211613|460196299|FG002|Overall Study|Lost to Follow-up|2|||
127882993|NCT01211613|460196297|FG000|Overall Study|Withdrawal by Subject|1|||
127882994|NCT01211613|460196298|FG001|Overall Study|Withdrawal by Subject|0|||
127882995|NCT01211613|460196299|FG002|Overall Study|Withdrawal by Subject|0|||
127611181|NCT00277212|459205720|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
127611182|NCT00277212|459205721|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
127611183|NCT00277212|459205722|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
127611184|NCT00277212|459205720|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
127611185|NCT00277212|459205721|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
127611186|NCT00277212|459205722|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
127611187|NCT00277212|459205720|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
127611188|NCT00277212|459205721|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
127611189|NCT00277212|459205722|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
127611190|NCT00277212|459205720|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
127611191|NCT00277212|459205721|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
127611192|NCT00277212|459205722|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
127611193|NCT00277212|459205720|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
127611194|NCT00277212|459205721|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
127611195|NCT00277212|459205722|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
127611196|NCT00277212|459205720|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
127611197|NCT00277212|459205721|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
127611198|NCT00277212|459205722|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
127611199|NCT03336216|459205723|FG000|Randomization|Not reported|2|||
127611200|NCT03336216|459205724|FG001|Randomization|Not reported|0|||
127611201|NCT03336216|459205725|FG002|Randomization|Not reported|1|||
127611202|NCT03336216|459205726|FG003|Randomization|Not reported|0|||
127611203|NCT03336216|459205723|FG000|Randomization|Other reasons|1|||
127611204|NCT03336216|459205724|FG001|Randomization|Other reasons|1|||
127611205|NCT03336216|459205725|FG002|Randomization|Other reasons|1|||
127882996|NCT03853213|460196300|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
127882997|NCT03853213|460196301|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
127882998|NCT03853213|460196300|FG000|Overall Study|Other (e.g., too busy)|0|||
127882999|NCT03853213|460196301|FG001|Overall Study|Other (e.g., too busy)|2|||
127611206|NCT03336216|459205726|FG003|Randomization|Other reasons|0|||
127698480|NCT04185298|459523851|FG000|Overall Study|Withdrawal by Subject|0|||
127698481|NCT04185298|459523852|FG001|Overall Study|Withdrawal by Subject|3|||
127698482|NCT04015167|459523864|FG000|Overall Study|Lost to Follow-up|40|||
127698483|NCT04015167|459523864|FG000|Overall Study|Adverse Event|5|||
127698484|NCT04015167|459523864|FG000|Overall Study|Withdrawal by Subject|2|||
127698485|NCT04015167|459523864|FG000|Overall Study|Subject went to jail|1|||
127698486|NCT03640312|459523865|FG000|Overall Study|Lost to Follow-up|3|||
127698487|NCT03640312|459523866|FG001|Overall Study|Lost to Follow-up|6|||
127698488|NCT03382652|459523867|FG000|Overall Study|Lost to Follow-up|6|||
127698489|NCT03382652|459523867|FG000|Overall Study|Death|4|||
127698490|NCT03382652|459523867|FG000|Overall Study|Revision|5|||
127698491|NCT03382652|459523867|FG000|Overall Study|Patient withdrew|3|||
127698492|NCT03382652|459523867|FG000|Overall Study|Other reasons|21|||
127698493|NCT04810650|459523871|FG000|Overall Study|Disenrolled in error|0|||
127698494|NCT04810650|459523872|FG001|Overall Study|Disenrolled in error|0|||
127698495|NCT04810650|459523873|FG002|Overall Study|Disenrolled in error|0|||
127698496|NCT04810650|459523874|FG003|Overall Study|Disenrolled in error|0|||
127698497|NCT04810650|459523875|FG004|Overall Study|Disenrolled in error|0|||
127698498|NCT04810650|459523876|FG005|Overall Study|Disenrolled in error|0|||
127698499|NCT04810650|459523877|FG006|Overall Study|Disenrolled in error|0|||
127698500|NCT04810650|459523878|FG007|Overall Study|Disenrolled in error|0|||
127789165|NCT03259074|459853531|FG001|Overall Study|Progressive Disease|0|||
127789166|NCT03259074|459853532|FG002|Overall Study|Progressive Disease|0|||
127789167|NCT03259074|459853530|FG000|Overall Study|Protocol Deviation|1|||
127789168|NCT03259074|459853531|FG001|Overall Study|Protocol Deviation|1|||
127789169|NCT03259074|459853532|FG002|Overall Study|Protocol Deviation|3|||
127789170|NCT03259074|459853530|FG000|Overall Study|Subject/Guardian Decision|13|||
127789171|NCT03259074|459853531|FG001|Overall Study|Subject/Guardian Decision|16|||
127611207|NCT03336216|459205723|FG000|Randomization|Participant no longer meets study criteria|0|||
127611208|NCT03336216|459205724|FG001|Randomization|Participant no longer meets study criteria|2|||
127611209|NCT03336216|459205725|FG002|Randomization|Participant no longer meets study criteria|4|||
127611210|NCT03336216|459205726|FG003|Randomization|Participant no longer meets study criteria|1|||
127789172|NCT03259074|459853532|FG002|Overall Study|Subject/Guardian Decision|14|||
127789173|NCT01780662|459853533|FG000|Overall Study|Adverse Event|1|||
127789174|NCT01780662|459853534|FG001|Overall Study|Adverse Event|0|||
127789175|NCT01780662|459853535|FG002|Overall Study|Adverse Event|2|||
127789176|NCT01780662|459853533|FG000|Overall Study|Physician Decision|0|||
127789177|NCT01780662|459853534|FG001|Overall Study|Physician Decision|5|||
127789178|NCT01780662|459853535|FG002|Overall Study|Physician Decision|7|||
127789179|NCT01780662|459853533|FG000|Overall Study|Protocol Violation|0|||
127789180|NCT01780662|459853534|FG001|Overall Study|Protocol Violation|1|||
127789181|NCT01780662|459853535|FG002|Overall Study|Protocol Violation|0|||
127789182|NCT01780662|459853533|FG000|Overall Study|Ineligible|0|||
127789183|NCT01780662|459853534|FG001|Overall Study|Ineligible|0|||
127789184|NCT01780662|459853535|FG002|Overall Study|Ineligible|1|||
127789185|NCT00053417|459853536|FG000|Overall Study|Adverse Event|1|||
127789186|NCT00053417|459853537|FG001|Overall Study|Adverse Event|0|||
127789187|NCT00053417|459853538|FG002|Overall Study|Adverse Event|1|||
127611211|NCT03336216|459205723|FG000|Randomization|Lost to Follow-up|1|||
127611212|NCT03336216|459205724|FG001|Randomization|Lost to Follow-up|0|||
127611213|NCT03336216|459205725|FG002|Randomization|Lost to Follow-up|0|||
127611214|NCT03336216|459205726|FG003|Randomization|Lost to Follow-up|0|||
127789188|NCT00053417|459853539|FG003|Overall Study|Adverse Event|5|||
127789189|NCT00053417|459853536|FG000|Overall Study|Non-Compliance|0|||
127789190|NCT00053417|459853537|FG001|Overall Study|Non-Compliance|0|||
127789191|NCT00053417|459853538|FG002|Overall Study|Non-Compliance|0|||
127611215|NCT03336216|459205723|FG000|Randomization|Participant withdrew consent|9|||
127611216|NCT03336216|459205724|FG001|Randomization|Participant withdrew consent|1|||
127611217|NCT03336216|459205725|FG002|Randomization|Participant withdrew consent|0|||
127611218|NCT03336216|459205726|FG003|Randomization|Participant withdrew consent|0|||
127611219|NCT03336216|459205723|FG000|Randomization|Adverse Event|1|||
127611220|NCT03336216|459205724|FG001|Randomization|Adverse Event|1|||
127611221|NCT03336216|459205725|FG002|Randomization|Adverse Event|0|||
127611222|NCT03336216|459205726|FG003|Randomization|Adverse Event|0|||
127611223|NCT03336216|459205723|FG000|Treatment|Adverse Event|2|||
127611224|NCT03336216|459205724|FG001|Treatment|Adverse Event|3|||
127611225|NCT03336216|459205725|FG002|Treatment|Adverse Event|4|||
127611226|NCT03336216|459205726|FG003|Treatment|Adverse Event|4|||
127611227|NCT03336216|459205723|FG000|Treatment|Participant request to discontinue treatment|2|||
127611228|NCT03336216|459205724|FG001|Treatment|Participant request to discontinue treatment|1|||
127611229|NCT03336216|459205725|FG002|Treatment|Participant request to discontinue treatment|2|||
127611230|NCT03336216|459205726|FG003|Treatment|Participant request to discontinue treatment|2|||
127611231|NCT03336216|459205723|FG000|Treatment|Participant withdrew consent|7|||
127611232|NCT03336216|459205724|FG001|Treatment|Participant withdrew consent|2|||
127611233|NCT03336216|459205725|FG002|Treatment|Participant withdrew consent|3|||
127611234|NCT03336216|459205726|FG003|Treatment|Participant withdrew consent|2|||
127611235|NCT03336216|459205723|FG000|Treatment|Death|2|||
127611236|NCT03336216|459205724|FG001|Treatment|Death|3|||
127611237|NCT03336216|459205725|FG002|Treatment|Death|3|||
127611238|NCT03336216|459205726|FG003|Treatment|Death|4|||
127611239|NCT03336216|459205723|FG000|Treatment|Participant no longer meets study criteria|0|||
127611240|NCT03336216|459205724|FG001|Treatment|Participant no longer meets study criteria|1|||
127611241|NCT03336216|459205725|FG002|Treatment|Participant no longer meets study criteria|0|||
127611242|NCT03336216|459205726|FG003|Treatment|Participant no longer meets study criteria|0|||
127611243|NCT03336216|459205723|FG000|Treatment|Other reasons|2|||
127611244|NCT03336216|459205724|FG001|Treatment|Other reasons|0|||
127611245|NCT03336216|459205725|FG002|Treatment|Other reasons|0|||
127611246|NCT03336216|459205726|FG003|Treatment|Other reasons|3|||
127611247|NCT03336216|459205723|FG000|Treatment|Disease progression|23|||
127611248|NCT03336216|459205724|FG001|Treatment|Disease progression|34|||
127611249|NCT03336216|459205725|FG002|Treatment|Disease progression|33|||
127611250|NCT03336216|459205726|FG003|Treatment|Disease progression|26|||
127611251|NCT03336216|459205723|FG000|Treatment|Study drug toxicity|0|||
127611252|NCT03336216|459205724|FG001|Treatment|Study drug toxicity|3|||
127611253|NCT03336216|459205725|FG002|Treatment|Study drug toxicity|2|||
127611254|NCT03336216|459205726|FG003|Treatment|Study drug toxicity|0|||
127611255|NCT03336216|459205723|FG000|Treatment|Adverse Event unrelated to study drug|1|||
127611256|NCT03336216|459205724|FG001|Treatment|Adverse Event unrelated to study drug|1|||
127611257|NCT03336216|459205725|FG002|Treatment|Adverse Event unrelated to study drug|1|||
127611258|NCT03336216|459205726|FG003|Treatment|Adverse Event unrelated to study drug|0|||
127611259|NCT03336216|459205723|FG000|Treatment|Disease Recurrence|1|||
127611260|NCT03336216|459205724|FG001|Treatment|Disease Recurrence|0|||
127611261|NCT03336216|459205725|FG002|Treatment|Disease Recurrence|0|||
127611262|NCT03336216|459205726|FG003|Treatment|Disease Recurrence|0|||
127611263|NCT03239470|459205734|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
127611264|NCT03239470|459205735|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
127611265|NCT00539838|459205736|FG000|Overall Study|Fail to return|2|||
127611266|NCT00539838|459205737|FG001|Overall Study|Fail to return|0|||
127611267|NCT00539838|459205738|FG002|Overall Study|Fail to return|0|||
127611268|NCT00539838|459205736|FG000|Overall Study|Withdrawal by Subject|0|||
127611269|NCT00539838|459205737|FG001|Overall Study|Withdrawal by Subject|4|||
127611270|NCT00539838|459205738|FG002|Overall Study|Withdrawal by Subject|0|||
127611271|NCT00539838|459205736|FG000|Overall Study|Death|0|||
127611272|NCT00539838|459205737|FG001|Overall Study|Death|2|||
127611273|NCT00539838|459205738|FG002|Overall Study|Death|0|||
127611274|NCT00539838|459205736|FG000|Overall Study|Did not cooperate|1|||
127611275|NCT00539838|459205737|FG001|Overall Study|Did not cooperate|0|||
127611276|NCT00539838|459205738|FG002|Overall Study|Did not cooperate|1|||
127611277|NCT00539838|459205736|FG000|Overall Study|Administrative|4|||
127611278|NCT00539838|459205737|FG001|Overall Study|Administrative|0|||
127611279|NCT00539838|459205738|FG002|Overall Study|Administrative|8|||
127611280|NCT03090100|459205739|FG000|Overall Study|Adverse Event|9|||
127698501|NCT04810650|459523879|FG008|Overall Study|Disenrolled in error|1|||
127698502|NCT04810650|459523880|FG009|Overall Study|Disenrolled in error|0|||
127698503|NCT04810650|459523881|FG010|Overall Study|Disenrolled in error|0|||
127698504|NCT04810650|459523882|FG011|Overall Study|Disenrolled in error|0|||
127698505|NCT04810650|459523883|FG012|Overall Study|Disenrolled in error|0|||
127698506|NCT04810650|459523884|FG013|Overall Study|Disenrolled in error|0|||
127698507|NCT04810650|459523871|FG000|Overall Study|Death|0|||
127698508|NCT04810650|459523872|FG001|Overall Study|Death|0|||
127698509|NCT04810650|459523873|FG002|Overall Study|Death|0|||
127789192|NCT00053417|459853539|FG003|Overall Study|Non-Compliance|1|||
127883000|NCT01458132|460196302|FG000|Overall Study|Other|15|||
127883001|NCT01458132|460196303|FG001|Overall Study|Other|3|||
127883002|NCT00833976|460196308|FG000|Overall Study|Withdrawal by Subject|5|||
127883003|NCT00833976|460196308|FG000|Overall Study|Lost to Follow-up|4|||
127611281|NCT03090100|459205740|FG001|Overall Study|Adverse Event|11|||
127611282|NCT03090100|459205739|FG000|Overall Study|Pregnancy|1|||
127611283|NCT03090100|459205740|FG001|Overall Study|Pregnancy|1|||
127611284|NCT03090100|459205739|FG000|Overall Study|Lack of Efficacy|2|||
127611285|NCT03090100|459205740|FG001|Overall Study|Lack of Efficacy|7|||
127611286|NCT03090100|459205739|FG000|Overall Study|Lost to Follow-up|2|||
127789193|NCT00053417|459853536|FG000|Overall Study|Withdrawal by Subject|0|||
127789194|NCT00053417|459853537|FG001|Overall Study|Withdrawal by Subject|1|||
127789195|NCT00053417|459853538|FG002|Overall Study|Withdrawal by Subject|0|||
127789196|NCT00053417|459853539|FG003|Overall Study|Withdrawal by Subject|0|||
127789197|NCT00053417|459853536|FG000|Overall Study|Lost to Follow-up|1|||
127789198|NCT00053417|459853537|FG001|Overall Study|Lost to Follow-up|1|||
127789199|NCT00053417|459853538|FG002|Overall Study|Lost to Follow-up|0|||
127789200|NCT00053417|459853539|FG003|Overall Study|Lost to Follow-up|0|||
127789201|NCT02182687|459853545|FG000|Overall Study|Withdrawal by Subject|4|||
127789202|NCT02182687|459853546|FG001|Overall Study|Withdrawal by Subject|0|||
127789203|NCT02182687|459853545|FG000|Overall Study|Adverse Event|1|||
127789204|NCT02182687|459853546|FG001|Overall Study|Adverse Event|0|||
127789205|NCT02182687|459853545|FG000|Overall Study|Lost to Follow-up|0|||
127789206|NCT02182687|459853546|FG001|Overall Study|Lost to Follow-up|1|||
127611287|NCT03090100|459205740|FG001|Overall Study|Lost to Follow-up|2|||
127611288|NCT03090100|459205739|FG000|Overall Study|Withdrawal by Subject|7|||
127883004|NCT00833976|460196308|FG000|Overall Study|Did not meet eligibility criteria|41|||
127883005|NCT00833976|460196308|FG000|Overall Study|Physician Decision|1|||
127789207|NCT03029143|459853550|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
127698510|NCT04810650|459523874|FG003|Overall Study|Death|0|||
127698511|NCT04810650|459523875|FG004|Overall Study|Death|0|||
127698512|NCT04810650|459523876|FG005|Overall Study|Death|0|||
127698513|NCT04810650|459523877|FG006|Overall Study|Death|2|||
127698514|NCT04810650|459523878|FG007|Overall Study|Death|2|||
127698515|NCT04810650|459523879|FG008|Overall Study|Death|0|||
127698516|NCT04810650|459523880|FG009|Overall Study|Death|1|||
127698517|NCT04810650|459523881|FG010|Overall Study|Death|0|||
127698518|NCT04810650|459523882|FG011|Overall Study|Death|0|||
127698519|NCT04810650|459523883|FG012|Overall Study|Death|2|||
127698520|NCT04810650|459523884|FG013|Overall Study|Death|1|||
127698521|NCT04810650|459523871|FG000|Overall Study|Moved/transferred care|0|||
127698522|NCT04810650|459523872|FG001|Overall Study|Moved/transferred care|0|||
127698523|NCT04810650|459523873|FG002|Overall Study|Moved/transferred care|0|||
127698524|NCT04810650|459523874|FG003|Overall Study|Moved/transferred care|0|||
127698525|NCT04810650|459523875|FG004|Overall Study|Moved/transferred care|0|||
127698526|NCT04810650|459523876|FG005|Overall Study|Moved/transferred care|0|||
127883006|NCT03911960|460196309|FG000|Overall Study|Lost to Follow-up|5|||
127883007|NCT03911960|460196310|FG001|Overall Study|Lost to Follow-up|3|||
127883008|NCT02239692|460196311|FG000|Overall Study|Incomplete colonoscopy|1|||
127883009|NCT02239692|460196312|FG001|Overall Study|Incomplete colonoscopy|2|||
127883010|NCT02239692|460196311|FG000|Overall Study|Adverse Event|0|||
127883011|NCT02239692|460196312|FG001|Overall Study|Adverse Event|1|||
127883012|NCT02239692|460196311|FG000|Overall Study|Physician Decision|0|||
127883013|NCT02239692|460196312|FG001|Overall Study|Physician Decision|1|||
127883014|NCT02239692|460196311|FG000|Overall Study|Lost to Follow-up|1|||
127883015|NCT02239692|460196312|FG001|Overall Study|Lost to Follow-up|4|||
127883016|NCT02239692|460196311|FG000|Overall Study|Withdrawal by Subject|3|||
127883017|NCT02239692|460196312|FG001|Overall Study|Withdrawal by Subject|5|||
127883018|NCT02239692|460196311|FG000|Overall Study|Other reason|1|||
127883019|NCT02239692|460196312|FG001|Overall Study|Other reason|0|||
127883020|NCT00297492|460196313|FG000|Set Quit Date|Lost to Follow-up|7|||
127883021|NCT00297492|460196314|FG001|Set Quit Date|Lost to Follow-up|13|||
127883022|NCT00297492|460196315|FG002|Set Quit Date|Lost to Follow-up|5|||
127883023|NCT00297492|460196313|FG000|6 Month Follow-up|Lost to Follow-up|63|||
127883024|NCT00297492|460196314|FG001|6 Month Follow-up|Lost to Follow-up|49|||
127883025|NCT00297492|460196315|FG002|6 Month Follow-up|Lost to Follow-up|27|||
127883026|NCT02923115|460196322|FG000|Overall Study|Lost to Follow-up|0|||
127883027|NCT02923115|460196323|FG001|Overall Study|Lost to Follow-up|0|||
127883028|NCT02923115|460196324|FG002|Overall Study|Lost to Follow-up|0|||
127883029|NCT02923115|460196325|FG003|Overall Study|Lost to Follow-up|1|||
127883030|NCT02923115|460196326|FG004|Overall Study|Lost to Follow-up|0|||
127611289|NCT03090100|459205740|FG001|Overall Study|Withdrawal by Subject|19|||
127611290|NCT03090100|459205739|FG000|Overall Study|Protocol Violation|2|||
127611291|NCT03090100|459205740|FG001|Overall Study|Protocol Violation|6|||
127611292|NCT03090100|459205739|FG000|Overall Study|Non-compliance|2|||
127611293|NCT03090100|459205740|FG001|Overall Study|Non-compliance|0|||
127611294|NCT03090100|459205739|FG000|Overall Study|Other|2|||
127611295|NCT03090100|459205740|FG001|Overall Study|Other|2|||
127611296|NCT01660711|459205741|FG000|Overall Study|Adverse Event|7|||
127611297|NCT01660711|459205741|FG000|Overall Study|Withdrawal by Subject|1|||
127611298|NCT00952341|459205742|FG000|Cycle 1|Adverse Event|4|||
127611299|NCT00952341|459205743|FG001|Cycle 1|Adverse Event|1|||
127611300|NCT00952341|459205742|FG000|Cycle 1|Withdrawal by Subject|3|||
127611301|NCT00952341|459205743|FG001|Cycle 1|Withdrawal by Subject|8|||
127611302|NCT00952341|459205742|FG000|Cycle 1|Protocol Violation|2|||
127611303|NCT00952341|459205743|FG001|Cycle 1|Protocol Violation|1|||
127611304|NCT00952341|459205742|FG000|Cycle 1|Lost to Follow-up|11|||
127611305|NCT00952341|459205743|FG001|Cycle 1|Lost to Follow-up|2|||
127611306|NCT00952341|459205742|FG000|Cycle 1|Physician Decision|0|||
127611307|NCT00952341|459205743|FG001|Cycle 1|Physician Decision|1|||
127611308|NCT00952341|459205742|FG000|Cycle 2|Withdrawal by Subject|1|||
127611309|NCT00952341|459205743|FG001|Cycle 2|Withdrawal by Subject|1|||
127611310|NCT00952341|459205742|FG000|Cycle 2|Protocol Violation|1|||
127698527|NCT04810650|459523877|FG006|Overall Study|Moved/transferred care|0|||
127883031|NCT02923115|460196327|FG005|Overall Study|Lost to Follow-up|0|||
127883032|NCT02923115|460196322|FG000|Overall Study|Withdrawal by Subject|0|||
127883033|NCT02923115|460196323|FG001|Overall Study|Withdrawal by Subject|1|||
127883034|NCT02923115|460196324|FG002|Overall Study|Withdrawal by Subject|0|||
127883035|NCT02923115|460196325|FG003|Overall Study|Withdrawal by Subject|0|||
127611311|NCT00952341|459205743|FG001|Cycle 2|Protocol Violation|0|||
127611312|NCT00952341|459205742|FG000|Cycle 2|Lost to Follow-up|6|||
127611313|NCT00952341|459205743|FG001|Cycle 2|Lost to Follow-up|9|||
127611314|NCT00952341|459205742|FG000|Cycle 2|Physician Decision|1|||
127611315|NCT00952341|459205743|FG001|Cycle 2|Physician Decision|1|||
127698528|NCT04810650|459523878|FG007|Overall Study|Moved/transferred care|1|||
127698529|NCT04810650|459523879|FG008|Overall Study|Moved/transferred care|12|||
127698530|NCT04810650|459523880|FG009|Overall Study|Moved/transferred care|10|||
127698531|NCT04810650|459523881|FG010|Overall Study|Moved/transferred care|0|||
127698532|NCT04810650|459523882|FG011|Overall Study|Moved/transferred care|0|||
127698533|NCT04810650|459523883|FG012|Overall Study|Moved/transferred care|0|||
127883036|NCT02923115|460196326|FG004|Overall Study|Withdrawal by Subject|0|||
127883037|NCT02923115|460196327|FG005|Overall Study|Withdrawal by Subject|0|||
127883038|NCT02923115|460196322|FG000|Overall Study|Randomized, but not dosed|0|||
127883039|NCT02923115|460196323|FG001|Overall Study|Randomized, but not dosed|0|||
127883040|NCT02923115|460196324|FG002|Overall Study|Randomized, but not dosed|3|||
127883041|NCT02923115|460196325|FG003|Overall Study|Randomized, but not dosed|1|||
127883042|NCT02923115|460196326|FG004|Overall Study|Randomized, but not dosed|5|||
127883043|NCT02923115|460196327|FG005|Overall Study|Randomized, but not dosed|0|||
127883044|NCT00068406|460196328|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
127883045|NCT00068406|460196328|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
127883046|NCT03451331|460196329|FG000|Overall Study|Withdrawal by Subject|1|||
127883047|NCT03451331|460196330|FG001|Overall Study|Withdrawal by Subject|0|||
127883048|NCT03451331|460196329|FG000|Overall Study|Unable to start treatment.|1|||
127883049|NCT03451331|460196330|FG001|Overall Study|Unable to start treatment.|1|||
127883050|NCT01875991|460196331|FG000|Overall Study|Withdrawal by Subject|6|||
127883051|NCT01875991|460196332|FG001|Overall Study|Withdrawal by Subject|6|||
127883052|NCT01875991|460196331|FG000|Overall Study|Sponsor Decision|1|||
127883053|NCT01875991|460196332|FG001|Overall Study|Sponsor Decision|0|||
127883054|NCT02454972|460196333|FG000|Overall Study|Progressive disease|17|||
127883055|NCT02454972|460196334|FG001|Overall Study|Progressive disease|16|||
127883056|NCT02454972|460196335|FG002|Overall Study|Progressive disease|59|||
127883057|NCT02454972|460196336|FG003|Overall Study|Progressive disease|23|||
127883058|NCT02454972|460196337|FG004|Overall Study|Progressive disease|16|||
127883059|NCT02454972|460196338|FG005|Overall Study|Progressive disease|12|||
127883060|NCT02454972|460196339|FG006|Overall Study|Progressive disease|19|||
127883061|NCT02454972|460196340|FG007|Overall Study|Progressive disease|27|||
127883062|NCT02454972|460196341|FG008|Overall Study|Progressive disease|0|||
127883063|NCT02454972|460196333|FG000|Overall Study|Death|0|||
127883064|NCT02454972|460196334|FG001|Overall Study|Death|0|||
127611316|NCT00952341|459205742|FG000|Cycle 2|Progressive Disease|0|||
127611317|NCT00952341|459205743|FG001|Cycle 2|Progressive Disease|1|||
127611318|NCT03406858|459205746|FG000|Overall Study|Failure to receive treatment drug.|1|||
127611319|NCT03406858|459205746|FG000|Overall Study|ineligible|1|||
127611320|NCT02532647|459205754|FG000|Overall Study|Did not receive trial medication|1|||
127611321|NCT02532647|459205755|FG001|Overall Study|Did not receive trial medication|0|||
127611322|NCT02532647|459205756|FG002|Overall Study|Did not receive trial medication|1|||
127611323|NCT05694546|459205762|FG000|Overall Study|Lost to Follow-up|11|||
127611324|NCT01589445|459205763|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
127611325|NCT01589445|459205763|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
127611326|NCT01589445|459205763|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
127611327|NCT01589445|459205763|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
127611328|NCT01589445|459205763|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
127611329|NCT01589445|459205763|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
127611330|NCT01589445|459205763|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
127611331|NCT01589445|459205763|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
127611332|NCT01589445|459205763|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
127611333|NCT01589445|459205763|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
127611334|NCT00325754|459205767|FG000|Overall Study|Adverse Event|4|||
127611335|NCT00325754|459205768|FG001|Overall Study|Adverse Event|1|||
127611336|NCT01817725|459205771|FG000|Overall Study|Withdrawal by Subject|1|||
127611337|NCT02625090|459205781|FG000|Overall Study|Participant wants to be pregnant|2|||
127698534|NCT04810650|459523884|FG013|Overall Study|Moved/transferred care|0|||
127698535|NCT04810650|459523871|FG000|Overall Study|Lost to Follow-up|15|||
127698536|NCT04810650|459523872|FG001|Overall Study|Lost to Follow-up|12|||
127698537|NCT04810650|459523873|FG002|Overall Study|Lost to Follow-up|7|||
127698538|NCT04810650|459523874|FG003|Overall Study|Lost to Follow-up|9|||
127698539|NCT04810650|459523875|FG004|Overall Study|Lost to Follow-up|10|||
127698540|NCT04810650|459523876|FG005|Overall Study|Lost to Follow-up|6|||
127698541|NCT04810650|459523877|FG006|Overall Study|Lost to Follow-up|0|||
127698542|NCT04810650|459523878|FG007|Overall Study|Lost to Follow-up|0|||
127698543|NCT04810650|459523879|FG008|Overall Study|Lost to Follow-up|0|||
127698544|NCT04810650|459523880|FG009|Overall Study|Lost to Follow-up|0|||
127698545|NCT04810650|459523881|FG010|Overall Study|Lost to Follow-up|1|||
127883065|NCT02454972|460196335|FG002|Overall Study|Death|5|||
127883066|NCT02454972|460196336|FG003|Overall Study|Death|1|||
127611338|NCT02625090|459205781|FG000|Overall Study|For the Promoter|1|||
127883067|NCT02454972|460196337|FG004|Overall Study|Death|0|||
127883068|NCT02454972|460196338|FG005|Overall Study|Death|0|||
127883069|NCT02454972|460196339|FG006|Overall Study|Death|0|||
127611339|NCT02625090|459205781|FG000|Overall Study|Sponsor's Decision|9|||
127698546|NCT04810650|459523882|FG011|Overall Study|Lost to Follow-up|0|||
127698547|NCT04810650|459523883|FG012|Overall Study|Lost to Follow-up|3|||
127698548|NCT04810650|459523884|FG013|Overall Study|Lost to Follow-up|9|||
127883070|NCT02454972|460196340|FG007|Overall Study|Death|0|||
127789208|NCT03029143|459853551|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
127789209|NCT03029143|459853552|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
127789210|NCT03029143|459853550|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
127789211|NCT03029143|459853551|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
127789212|NCT03029143|459853552|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
127789213|NCT03029143|459853550|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
127789214|NCT03029143|459853551|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
127789215|NCT03029143|459853552|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
127789216|NCT03029143|459853550|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
127789217|NCT03029143|459853551|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
127789218|NCT03029143|459853552|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
127789219|NCT03029143|459853550|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
127789220|NCT03029143|459853551|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
127789221|NCT03029143|459853552|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
127789222|NCT03029143|459853550|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
127789223|NCT03029143|459853551|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
127789224|NCT03029143|459853552|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
127789225|NCT03029143|459853550|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
127789226|NCT03029143|459853551|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
127789227|NCT03029143|459853552|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
127789228|NCT03029143|459853550|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
127789229|NCT03029143|459853551|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
127789230|NCT03029143|459853552|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
127789231|NCT03029143|459853550|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
127789232|NCT03029143|459853551|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
127789233|NCT03029143|459853552|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
127611340|NCT02625090|459205781|FG000|Overall Study|Somnolence|1|||
127611341|NCT02625090|459205781|FG000|Overall Study|Study terminated by Sponsor|7|||
127611342|NCT02625090|459205781|FG000|Overall Study|Negative Benefit/Risk|1|||
127611343|NCT02625090|459205781|FG000|Overall Study|Protocol Deviation|2|||
127611344|NCT02625090|459205781|FG000|Overall Study|Lack of Efficacy|16|||
127611345|NCT02625090|459205781|FG000|Overall Study|Adverse Event|3|||
127611346|NCT02439320|459205786|FG000|Overall Study|Adverse Event|0|||
127611347|NCT02439320|459205787|FG001|Overall Study|Adverse Event|2|||
127611348|NCT02439320|459205788|FG002|Overall Study|Adverse Event|0|||
127611349|NCT02439320|459205786|FG000|Overall Study|Lost to Follow-up|37|||
127611350|NCT02439320|459205787|FG001|Overall Study|Lost to Follow-up|34|||
127611351|NCT02439320|459205788|FG002|Overall Study|Lost to Follow-up|42|||
127611352|NCT02439320|459205786|FG000|Overall Study|Death|0|||
127611353|NCT02439320|459205787|FG001|Overall Study|Death|1|||
127611354|NCT02439320|459205788|FG002|Overall Study|Death|0|||
127611355|NCT02439320|459205786|FG000|Overall Study|Noncompliance with Protocol|10|||
127611356|NCT02439320|459205787|FG001|Overall Study|Noncompliance with Protocol|11|||
127611357|NCT02439320|459205788|FG002|Overall Study|Noncompliance with Protocol|7|||
127611358|NCT02439320|459205786|FG000|Overall Study|Pregnancy|0|||
127611359|NCT02439320|459205787|FG001|Overall Study|Pregnancy|1|||
127611360|NCT02439320|459205788|FG002|Overall Study|Pregnancy|1|||
127611361|NCT02439320|459205786|FG000|Overall Study|Withdrawal by Subject|12|||
127611362|NCT02439320|459205787|FG001|Overall Study|Withdrawal by Subject|16|||
127611363|NCT02439320|459205788|FG002|Overall Study|Withdrawal by Subject|14|||
127611364|NCT02439320|459205786|FG000|Overall Study|Physician Decision|2|||
127611365|NCT02439320|459205787|FG001|Overall Study|Physician Decision|1|||
127611366|NCT02439320|459205788|FG002|Overall Study|Physician Decision|0|||
127611367|NCT02439320|459205786|FG000|Overall Study|Sponsor Request|0|||
127611368|NCT02439320|459205787|FG001|Overall Study|Sponsor Request|2|||
127611369|NCT02439320|459205788|FG002|Overall Study|Sponsor Request|1|||
127611370|NCT02439320|459205786|FG000|Overall Study|Randomization Failure|35|||
127611371|NCT02439320|459205787|FG001|Overall Study|Randomization Failure|46|||
127611372|NCT02439320|459205788|FG002|Overall Study|Randomization Failure|34|||
127611373|NCT02972632|459205789|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
127611374|NCT02972632|459205789|FG000|Overall Study|Lost to Follow-up|4|||
127611375|NCT02972632|459205789|FG000|Overall Study|Voluntary Withdrawal|10|||
127611376|NCT01251380|459205810|FG000|Overall Study|Other (Not otherwise specified)|12|||
127611377|NCT01251380|459205810|FG000|Overall Study|Withdrawal by Subject|6|||
127611378|NCT01251380|459205810|FG000|Overall Study|Lack of Efficacy|1|||
127611379|NCT01251380|459205810|FG000|Overall Study|Adverse Event|1|||
127611380|NCT01251380|459205810|FG000|Overall Study|Lost to Follow-up|2|||
127611381|NCT00129129|459205819|FG000|Primary Phase|Adverse Event|2|||
127611382|NCT00129129|459205820|FG001|Primary Phase|Adverse Event|1|||
127611383|NCT00129129|459205821|FG002|Primary Phase|Adverse Event|0|||
127611384|NCT00129129|459205822|FG003|Primary Phase|Adverse Event|0|||
127611385|NCT00129129|459205823|FG004|Primary Phase|Adverse Event|0|||
127611386|NCT00129129|459205819|FG000|Primary Phase|Withdrawal by Subject|12|||
127611387|NCT00129129|459205820|FG001|Primary Phase|Withdrawal by Subject|10|||
127611388|NCT00129129|459205821|FG002|Primary Phase|Withdrawal by Subject|0|||
127611389|NCT00129129|459205822|FG003|Primary Phase|Withdrawal by Subject|0|||
127611390|NCT00129129|459205823|FG004|Primary Phase|Withdrawal by Subject|0|||
127611391|NCT00129129|459205819|FG000|Primary Phase|Migration from study area|1|||
127611392|NCT00129129|459205820|FG001|Primary Phase|Migration from study area|3|||
127611393|NCT00129129|459205821|FG002|Primary Phase|Migration from study area|0|||
127611394|NCT00129129|459205822|FG003|Primary Phase|Migration from study area|0|||
127611395|NCT00129129|459205823|FG004|Primary Phase|Migration from study area|0|||
127611396|NCT00129129|459205819|FG000|Primary Phase|Lost to Follow-up|8|||
127611397|NCT00129129|459205820|FG001|Primary Phase|Lost to Follow-up|6|||
127611398|NCT00129129|459205821|FG002|Primary Phase|Lost to Follow-up|0|||
127611399|NCT00129129|459205822|FG003|Primary Phase|Lost to Follow-up|0|||
127611400|NCT00129129|459205823|FG004|Primary Phase|Lost to Follow-up|0|||
127611401|NCT00129129|459205819|FG000|Primary Phase|Other|2|||
127611402|NCT00129129|459205820|FG001|Primary Phase|Other|5|||
127611403|NCT00129129|459205821|FG002|Primary Phase|Other|0|||
127611404|NCT00129129|459205822|FG003|Primary Phase|Other|0|||
127611405|NCT00129129|459205823|FG004|Primary Phase|Other|0|||
127611406|NCT00129129|459205819|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
127611407|NCT00129129|459205820|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
127611408|NCT00129129|459205821|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
127611409|NCT00129129|459205822|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
127611410|NCT00129129|459205823|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
127611411|NCT00129129|459205819|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
127611412|NCT00129129|459205820|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
127611413|NCT00129129|459205821|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
127611414|NCT00129129|459205822|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
127611415|NCT00129129|459205823|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
127611416|NCT00129129|459205819|FG000|Fourth Dose Phase|Migration from study area|0|||
127611417|NCT00129129|459205820|FG001|Fourth Dose Phase|Migration from study area|0|||
127611418|NCT00129129|459205821|FG002|Fourth Dose Phase|Migration from study area|0|||
127611419|NCT00129129|459205822|FG003|Fourth Dose Phase|Migration from study area|0|||
127611420|NCT00129129|459205823|FG004|Fourth Dose Phase|Migration from study area|2|||
127611421|NCT00129129|459205819|FG000|Fourth Dose Phase|Other|0|||
127611422|NCT00129129|459205820|FG001|Fourth Dose Phase|Other|0|||
127611423|NCT00129129|459205821|FG002|Fourth Dose Phase|Other|0|||
127611424|NCT00129129|459205822|FG003|Fourth Dose Phase|Other|1|||
127611425|NCT00129129|459205823|FG004|Fourth Dose Phase|Other|1|||
127611426|NCT00129129|459205819|FG000|Fourth Dose Phase|Protocol Violation|0|||
127611427|NCT00129129|459205820|FG001|Fourth Dose Phase|Protocol Violation|0|||
127611428|NCT00129129|459205821|FG002|Fourth Dose Phase|Protocol Violation|0|||
127611429|NCT00129129|459205822|FG003|Fourth Dose Phase|Protocol Violation|1|||
127611430|NCT00129129|459205823|FG004|Fourth Dose Phase|Protocol Violation|0|||
127611431|NCT03089606|459205824|FG000|Overall Study|Progression after Cycle 1|1|||
127611432|NCT01150123|459205826|FG000|Overall Study|Withdrawal by Subject|1|||
127611433|NCT01150123|459205827|FG001|Overall Study|Withdrawal by Subject|1|||
127611434|NCT01150123|459205828|FG002|Overall Study|Withdrawal by Subject|2|||
127611435|NCT01150123|459205829|FG003|Overall Study|Withdrawal by Subject|1|||
127611436|NCT01150123|459205830|FG004|Overall Study|Withdrawal by Subject|1|||
127611437|NCT01150123|459205831|FG005|Overall Study|Withdrawal by Subject|1|||
127611438|NCT01150123|459205832|FG006|Overall Study|Withdrawal by Subject|0|||
127611439|NCT01150123|459205833|FG007|Overall Study|Withdrawal by Subject|3|||
127611440|NCT01150123|459205834|FG008|Overall Study|Withdrawal by Subject|2|||
127611441|NCT01150123|459205835|FG009|Overall Study|Withdrawal by Subject|0|||
127611442|NCT01150123|459205836|FG010|Overall Study|Withdrawal by Subject|1|||
127611443|NCT01150123|459205837|FG011|Overall Study|Withdrawal by Subject|0|||
127611444|NCT01150123|459205838|FG012|Overall Study|Withdrawal by Subject|1|||
127611445|NCT01150123|459205839|FG013|Overall Study|Withdrawal by Subject|0|||
127611446|NCT01150123|459205840|FG014|Overall Study|Withdrawal by Subject|0|||
127611447|NCT01150123|459205841|FG015|Overall Study|Withdrawal by Subject|1|||
127611448|NCT01150123|459205842|FG016|Overall Study|Withdrawal by Subject|0|||
127611449|NCT01150123|459205843|FG017|Overall Study|Withdrawal by Subject|1|||
127611450|NCT01150123|459205826|FG000|Overall Study|Lost to Follow-up|2|||
127611451|NCT01150123|459205827|FG001|Overall Study|Lost to Follow-up|1|||
127611452|NCT01150123|459205828|FG002|Overall Study|Lost to Follow-up|2|||
127611453|NCT01150123|459205829|FG003|Overall Study|Lost to Follow-up|2|||
127611454|NCT01150123|459205830|FG004|Overall Study|Lost to Follow-up|2|||
127611455|NCT01150123|459205831|FG005|Overall Study|Lost to Follow-up|5|||
127611456|NCT01150123|459205832|FG006|Overall Study|Lost to Follow-up|0|||
127611457|NCT01150123|459205833|FG007|Overall Study|Lost to Follow-up|0|||
127611458|NCT01150123|459205834|FG008|Overall Study|Lost to Follow-up|3|||
127611459|NCT01150123|459205835|FG009|Overall Study|Lost to Follow-up|1|||
127611460|NCT01150123|459205836|FG010|Overall Study|Lost to Follow-up|1|||
127611461|NCT01150123|459205837|FG011|Overall Study|Lost to Follow-up|1|||
127611462|NCT01150123|459205838|FG012|Overall Study|Lost to Follow-up|2|||
127611463|NCT01150123|459205839|FG013|Overall Study|Lost to Follow-up|0|||
127883071|NCT02454972|460196341|FG008|Overall Study|Death|95|||
127883072|NCT02454972|460196333|FG000|Overall Study|Physician Decision|0|||
127883073|NCT02454972|460196334|FG001|Overall Study|Physician Decision|1|||
127883074|NCT02454972|460196335|FG002|Overall Study|Physician Decision|2|||
127883075|NCT02454972|460196336|FG003|Overall Study|Physician Decision|1|||
127883076|NCT02454972|460196337|FG004|Overall Study|Physician Decision|2|||
127883077|NCT02454972|460196338|FG005|Overall Study|Physician Decision|0|||
127883078|NCT02454972|460196339|FG006|Overall Study|Physician Decision|0|||
127883079|NCT02454972|460196340|FG007|Overall Study|Physician Decision|1|||
127883080|NCT02454972|460196341|FG008|Overall Study|Physician Decision|0|||
127883081|NCT02454972|460196333|FG000|Overall Study|Non treatment-related adverse event|2|||
127883082|NCT02454972|460196334|FG001|Overall Study|Non treatment-related adverse event|0|||
127883083|NCT02454972|460196335|FG002|Overall Study|Non treatment-related adverse event|1|||
127883084|NCT02454972|460196336|FG003|Overall Study|Non treatment-related adverse event|0|||
127883085|NCT02454972|460196337|FG004|Overall Study|Non treatment-related adverse event|0|||
127883086|NCT02454972|460196338|FG005|Overall Study|Non treatment-related adverse event|1|||
127883087|NCT02454972|460196339|FG006|Overall Study|Non treatment-related adverse event|0|||
127883088|NCT02454972|460196340|FG007|Overall Study|Non treatment-related adverse event|1|||
127883089|NCT02454972|460196341|FG008|Overall Study|Non treatment-related adverse event|0|||
127883090|NCT02454972|460196333|FG000|Overall Study|Treatment-related adverse events|0|||
127883091|NCT02454972|460196334|FG001|Overall Study|Treatment-related adverse events|1|||
127883092|NCT02454972|460196335|FG002|Overall Study|Treatment-related adverse events|1|||
127883093|NCT02454972|460196336|FG003|Overall Study|Treatment-related adverse events|0|||
127883094|NCT02454972|460196337|FG004|Overall Study|Treatment-related adverse events|2|||
127883095|NCT02454972|460196338|FG005|Overall Study|Treatment-related adverse events|0|||
127883096|NCT02454972|460196339|FG006|Overall Study|Treatment-related adverse events|0|||
127883097|NCT02454972|460196340|FG007|Overall Study|Treatment-related adverse events|2|||
127611464|NCT01150123|459205840|FG014|Overall Study|Lost to Follow-up|0|||
127611465|NCT01150123|459205841|FG015|Overall Study|Lost to Follow-up|0|||
127611466|NCT01150123|459205842|FG016|Overall Study|Lost to Follow-up|0|||
127611467|NCT01150123|459205843|FG017|Overall Study|Lost to Follow-up|0|||
127611468|NCT00352846|459205850|FG000|Overall Study|Disease progression|0|||
127611469|NCT00352846|459205851|FG001|Overall Study|Disease progression|2|||
127611470|NCT00352846|459205850|FG000|Overall Study|Withdrawal by Subject|3|||
127611471|NCT00352846|459205851|FG001|Overall Study|Withdrawal by Subject|8|||
127611472|NCT00352846|459205850|FG000|Overall Study|Ineligible|3|||
127611473|NCT00352846|459205851|FG001|Overall Study|Ineligible|2|||
127611474|NCT00352846|459205850|FG000|Overall Study|Non-compliance|2|||
127611475|NCT00352846|459205851|FG001|Overall Study|Non-compliance|0|||
127611476|NCT00352846|459205850|FG000|Overall Study|Death|0|||
127611477|NCT00352846|459205851|FG001|Overall Study|Death|1|||
127611478|NCT01527682|459205852|FG000|Overall Study|Protocol Violation|8|||
127611479|NCT00549562|459205854|FG000|Overall Study|Adverse Event|1|||
127611480|NCT00549562|459205854|FG000|Overall Study|Lack of Efficacy|1|||
127611481|NCT00323115|459205857|FG000|Vaccine Administration|Adverse Event|1|||
127611482|NCT00323115|459205857|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
127611483|NCT04365556|459205858|FG000|Overall Study|No longer eligible due to treatment plan|1|||
127611484|NCT04365556|459205859|FG001|Overall Study|No longer eligible due to treatment plan|0|||
127611485|NCT04365556|459205858|FG000|Overall Study|Lost to Follow-up|3|||
127611486|NCT04365556|459205859|FG001|Overall Study|Lost to Follow-up|2|||
127611487|NCT01023581|459207190|FG000|Overall Study|Adverse Event|4|||
127611488|NCT01023581|459207191|FG001|Overall Study|Adverse Event|4|||
127611489|NCT01023581|459207192|FG002|Overall Study|Adverse Event|7|||
127611490|NCT01023581|459207193|FG003|Overall Study|Adverse Event|3|||
127611491|NCT01023581|459207194|FG004|Overall Study|Adverse Event|2|||
127611492|NCT01023581|459207195|FG005|Overall Study|Adverse Event|5|||
127611493|NCT01023581|459207196|FG006|Overall Study|Adverse Event|11|||
127611494|NCT01023581|459207190|FG000|Overall Study|Major protocol deviation|2|||
127883098|NCT02454972|460196341|FG008|Overall Study|Treatment-related adverse events|0|||
127883099|NCT02454972|460196333|FG000|Overall Study|Patient moves to compassionate use|0|||
127883100|NCT02454972|460196334|FG001|Overall Study|Patient moves to compassionate use|0|||
127883101|NCT02454972|460196335|FG002|Overall Study|Patient moves to compassionate use|0|||
127883102|NCT02454972|460196336|FG003|Overall Study|Patient moves to compassionate use|0|||
127883103|NCT02454972|460196337|FG004|Overall Study|Patient moves to compassionate use|0|||
127611495|NCT01023581|459207191|FG001|Overall Study|Major protocol deviation|0|||
127883104|NCT02454972|460196338|FG005|Overall Study|Patient moves to compassionate use|0|||
127611496|NCT01023581|459207192|FG002|Overall Study|Major protocol deviation|3|||
127611497|NCT01023581|459207193|FG003|Overall Study|Major protocol deviation|0|||
127611498|NCT01023581|459207194|FG004|Overall Study|Major protocol deviation|0|||
127611499|NCT01023581|459207195|FG005|Overall Study|Major protocol deviation|0|||
127611500|NCT01023581|459207196|FG006|Overall Study|Major protocol deviation|0|||
127883105|NCT02454972|460196339|FG006|Overall Study|Patient moves to compassionate use|2|||
127883106|NCT02454972|460196340|FG007|Overall Study|Patient moves to compassionate use|0|||
127883107|NCT02454972|460196341|FG008|Overall Study|Patient moves to compassionate use|0|||
127883108|NCT02454972|460196333|FG000|Overall Study|Withdrawal by Subject|0|||
127789234|NCT03029143|459853550|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
127789235|NCT03029143|459853551|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
127789236|NCT03029143|459853552|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
127789237|NCT03029143|459853550|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
127789238|NCT03029143|459853551|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
127789239|NCT03029143|459853552|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
127789240|NCT00974675|459853555|FG000|Overall Study|Adverse Event|2|||
127789241|NCT00974675|459853556|FG001|Overall Study|Adverse Event|1|||
127611501|NCT01023581|459207190|FG000|Overall Study|Lost to Follow-up|4|||
127611502|NCT01023581|459207191|FG001|Overall Study|Lost to Follow-up|8|||
127611503|NCT01023581|459207192|FG002|Overall Study|Lost to Follow-up|7|||
127611504|NCT01023581|459207193|FG003|Overall Study|Lost to Follow-up|2|||
127611505|NCT01023581|459207194|FG004|Overall Study|Lost to Follow-up|5|||
127611506|NCT01023581|459207195|FG005|Overall Study|Lost to Follow-up|2|||
127611507|NCT01023581|459207196|FG006|Overall Study|Lost to Follow-up|2|||
127611508|NCT01023581|459207190|FG000|Overall Study|Withdrawal by Subject|13|||
127611509|NCT01023581|459207191|FG001|Overall Study|Withdrawal by Subject|8|||
127611510|NCT01023581|459207192|FG002|Overall Study|Withdrawal by Subject|16|||
127611511|NCT01023581|459207193|FG003|Overall Study|Withdrawal by Subject|10|||
127611512|NCT01023581|459207194|FG004|Overall Study|Withdrawal by Subject|6|||
127611513|NCT01023581|459207195|FG005|Overall Study|Withdrawal by Subject|8|||
127611514|NCT01023581|459207196|FG006|Overall Study|Withdrawal by Subject|5|||
127611515|NCT01023581|459207190|FG000|Overall Study|Pregnancy|0|||
127611516|NCT01023581|459207191|FG001|Overall Study|Pregnancy|0|||
127611517|NCT01023581|459207192|FG002|Overall Study|Pregnancy|0|||
127611518|NCT01023581|459207193|FG003|Overall Study|Pregnancy|2|||
127611519|NCT01023581|459207194|FG004|Overall Study|Pregnancy|0|||
127611520|NCT01023581|459207195|FG005|Overall Study|Pregnancy|1|||
127611521|NCT01023581|459207196|FG006|Overall Study|Pregnancy|0|||
127611522|NCT01023581|459207190|FG000|Overall Study|Lack of Efficacy|9|||
127611523|NCT01023581|459207191|FG001|Overall Study|Lack of Efficacy|3|||
127611524|NCT01023581|459207192|FG002|Overall Study|Lack of Efficacy|6|||
127611525|NCT01023581|459207193|FG003|Overall Study|Lack of Efficacy|2|||
127611526|NCT01023581|459207194|FG004|Overall Study|Lack of Efficacy|1|||
127611527|NCT01023581|459207195|FG005|Overall Study|Lack of Efficacy|2|||
127611528|NCT01023581|459207196|FG006|Overall Study|Lack of Efficacy|1|||
127611529|NCT01023581|459207190|FG000|Overall Study|Physician Decision|2|||
127611530|NCT01023581|459207191|FG001|Overall Study|Physician Decision|0|||
127611531|NCT01023581|459207192|FG002|Overall Study|Physician Decision|2|||
127611532|NCT01023581|459207193|FG003|Overall Study|Physician Decision|1|||
127611533|NCT01023581|459207194|FG004|Overall Study|Physician Decision|1|||
127611534|NCT01023581|459207195|FG005|Overall Study|Physician Decision|1|||
127611535|NCT01023581|459207196|FG006|Overall Study|Physician Decision|1|||
127611536|NCT01023581|459207190|FG000|Overall Study|Other|1|||
127611537|NCT01023581|459207191|FG001|Overall Study|Other|0|||
127611538|NCT01023581|459207192|FG002|Overall Study|Other|1|||
127611539|NCT01023581|459207193|FG003|Overall Study|Other|0|||
127611540|NCT01023581|459207194|FG004|Overall Study|Other|1|||
127611541|NCT01023581|459207195|FG005|Overall Study|Other|0|||
127611542|NCT01023581|459207196|FG006|Overall Study|Other|0|||
127611543|NCT04920123|459207200|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
127611544|NCT04920123|459207201|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
127611545|NCT04920123|459207202|FG002|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
127611546|NCT00278954|459207203|FG000|Overall Study|Adverse Event|3|||
127611547|NCT00278954|459207203|FG000|Overall Study|Lost to Follow-up|1|||
127611548|NCT00278954|459207203|FG000|Overall Study|Withdrawal by Subject|1|||
127611549|NCT05664490|459207205|FG000|Overall Study|Withdrawal by Subject|0|||
127789242|NCT00974675|459853557|FG002|Overall Study|Adverse Event|1|||
127789243|NCT00974675|459853558|FG003|Overall Study|Adverse Event|1|||
127789244|NCT00974675|459853555|FG000|Overall Study|Physician Decision|0|||
127789245|NCT00974675|459853556|FG001|Overall Study|Physician Decision|0|||
127611550|NCT05664490|459207206|FG001|Overall Study|Withdrawal by Subject|1|||
127611551|NCT05664490|459207205|FG000|Overall Study|Lost to Follow-up|14|||
127611552|NCT05664490|459207206|FG001|Overall Study|Lost to Follow-up|22|||
127611553|NCT03412084|459207207|FG000|Overall Study|Withdrawal by Subject|2|||
127611554|NCT03412084|459207208|FG001|Overall Study|Withdrawal by Subject|0|||
127611555|NCT03412084|459207207|FG000|Overall Study|Participant moved|1|||
127611556|NCT03412084|459207208|FG001|Overall Study|Participant moved|0|||
127611557|NCT03412084|459207207|FG000|Overall Study|Lost to Follow-up|1|||
127611558|NCT03412084|459207208|FG001|Overall Study|Lost to Follow-up|1|||
127611559|NCT02023151|459207215|FG000|Overall Study|Lost to Follow-up|4|||
127611560|NCT04064294|459207216|FG000|Overall Study|Adverse Event|1|||
127611561|NCT04064294|459207217|FG001|Overall Study|Adverse Event|0|||
127611562|NCT04064294|459207218|FG002|Overall Study|Adverse Event|0|||
127611563|NCT03450707|459207219|FG000|Overall Study|Outside enrollment window|4|||
127611564|NCT03450707|459207220|FG001|Overall Study|Outside enrollment window|1|||
127611565|NCT03450707|459207219|FG000|Overall Study|Death|1|||
127611566|NCT03450707|459207220|FG001|Overall Study|Death|0|||
127611567|NCT03450707|459207219|FG000|Overall Study|Indication for thiamine|1|||
127611568|NCT03450707|459207220|FG001|Overall Study|Indication for thiamine|1|||
127611569|NCT03450707|459207219|FG000|Overall Study|Evidence of traumatic brain injury|1|||
127611570|NCT03450707|459207220|FG001|Overall Study|Evidence of traumatic brain injury|0|||
127611571|NCT03450707|459207219|FG000|Overall Study|Following commands|0|||
127611572|NCT03450707|459207220|FG001|Overall Study|Following commands|3|||
127611573|NCT03450707|459207219|FG000|Overall Study|Lactate < 3.5|0|||
127611574|NCT03450707|459207220|FG001|Overall Study|Lactate < 3.5|2|||
127611575|NCT03450707|459207219|FG000|Overall Study|Rearrest with ECMO|0|||
127611576|NCT03450707|459207220|FG001|Overall Study|Rearrest with ECMO|1|||
127611577|NCT03450707|459207219|FG000|Overall Study|Indication for thiamine + head CT results|0|||
127611578|NCT03450707|459207220|FG001|Overall Study|Indication for thiamine + head CT results|1|||
127611579|NCT03450707|459207219|FG000|Overall Study|Family/patient goals of care|0|||
127611580|NCT03450707|459207220|FG001|Overall Study|Family/patient goals of care|1|||
127611581|NCT00481195|459207221|FG000|Overall Study|Adverse Event|16|||
127611582|NCT00481195|459207222|FG001|Overall Study|Adverse Event|11|||
127789246|NCT00974675|459853557|FG002|Overall Study|Physician Decision|1|||
127789247|NCT00974675|459853558|FG003|Overall Study|Physician Decision|0|||
127789248|NCT00974675|459853555|FG000|Overall Study|Participant on holiday; unable to attend|0|||
127789249|NCT00974675|459853556|FG001|Overall Study|Participant on holiday; unable to attend|0|||
127789250|NCT00974675|459853557|FG002|Overall Study|Participant on holiday; unable to attend|0|||
127789251|NCT00974675|459853558|FG003|Overall Study|Participant on holiday; unable to attend|1|||
127789252|NCT02121262|459853559|FG000|Overall Study|Adverse Event|6|||
127789253|NCT02121262|459853560|FG001|Overall Study|Adverse Event|3|||
127789254|NCT02121262|459853559|FG000|Overall Study|Lack of Efficacy|3|||
127789255|NCT02121262|459853560|FG001|Overall Study|Lack of Efficacy|0|||
127789256|NCT02121262|459853559|FG000|Overall Study|Personal Reasons|19|||
127789257|NCT02121262|459853560|FG001|Overall Study|Personal Reasons|5|||
127789258|NCT02121262|459853559|FG000|Overall Study|Protocol Violation|1|||
127789259|NCT02121262|459853560|FG001|Overall Study|Protocol Violation|1|||
127789260|NCT02121262|459853559|FG000|Overall Study|Participant Dropped-out|0|||
127789261|NCT02121262|459853560|FG001|Overall Study|Participant Dropped-out|1|||
127789262|NCT02121262|459853559|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
127789263|NCT02121262|459853560|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
127789264|NCT02121262|459853559|FG000|Overall Study|Consent Withdrawn|1|||
127789265|NCT02121262|459853560|FG001|Overall Study|Consent Withdrawn|0|||
127789266|NCT01394627|459853562|FG000|First Intervention (1 Day)|poor intravenous access|0|||
127789267|NCT01394627|459853563|FG001|First Intervention (1 Day)|poor intravenous access|1|||
127789268|NCT01394627|459853562|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
127789269|NCT01394627|459853563|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
127789270|NCT01765920|459853568|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
127789271|NCT01765920|459853569|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
127789272|NCT01765920|459853568|FG000|Overall Study|Patient code disclosure|0|||
127789273|NCT01765920|459853569|FG001|Overall Study|Patient code disclosure|1|||
127789274|NCT01081249|459853570|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
127789275|NCT01081249|459853571|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
127789276|NCT02025907|459853572|FG000|Overall Study|Lack of Efficacy|1|||
127789277|NCT02025907|459853573|FG001|Overall Study|Lack of Efficacy|0|||
127789278|NCT02025907|459853572|FG000|Overall Study|Withdrawal by Subject|15|||
127611583|NCT00481195|459207221|FG000|Overall Study|Lack of Efficacy|1|||
127611584|NCT00481195|459207222|FG001|Overall Study|Lack of Efficacy|3|||
127611585|NCT00481195|459207221|FG000|Overall Study|Lost to Follow-up|4|||
127611586|NCT00481195|459207222|FG001|Overall Study|Lost to Follow-up|6|||
127611587|NCT00481195|459207221|FG000|Overall Study|Physician Decision|3|||
127789279|NCT02025907|459853573|FG001|Overall Study|Withdrawal by Subject|8|||
127611588|NCT00481195|459207222|FG001|Overall Study|Physician Decision|1|||
127611589|NCT00481195|459207221|FG000|Overall Study|Protocol Violation|10|||
127611590|NCT00481195|459207222|FG001|Overall Study|Protocol Violation|7|||
127611591|NCT00481195|459207221|FG000|Overall Study|Withdrawal by Subject|3|||
127789280|NCT02025907|459853572|FG000|Overall Study|Protocol Violation|2|||
127789281|NCT02025907|459853573|FG001|Overall Study|Protocol Violation|0|||
127883109|NCT02454972|460196334|FG001|Overall Study|Withdrawal by Subject|1|||
127883110|NCT02454972|460196335|FG002|Overall Study|Withdrawal by Subject|5|||
127883111|NCT02454972|460196336|FG003|Overall Study|Withdrawal by Subject|2|||
127883112|NCT02454972|460196337|FG004|Overall Study|Withdrawal by Subject|3|||
127883113|NCT02454972|460196338|FG005|Overall Study|Withdrawal by Subject|2|||
127883114|NCT02454972|460196339|FG006|Overall Study|Withdrawal by Subject|0|||
127883115|NCT02454972|460196340|FG007|Overall Study|Withdrawal by Subject|1|||
127883116|NCT02454972|460196341|FG008|Overall Study|Withdrawal by Subject|2|||
127883117|NCT02454972|460196333|FG000|Overall Study|Multiple delay/holds on treatment|0|||
127883118|NCT02454972|460196334|FG001|Overall Study|Multiple delay/holds on treatment|0|||
127883119|NCT02454972|460196335|FG002|Overall Study|Multiple delay/holds on treatment|0|||
127883120|NCT02454972|460196336|FG003|Overall Study|Multiple delay/holds on treatment|1|||
127883121|NCT02454972|460196337|FG004|Overall Study|Multiple delay/holds on treatment|0|||
127883122|NCT02454972|460196338|FG005|Overall Study|Multiple delay/holds on treatment|0|||
127883123|NCT02454972|460196339|FG006|Overall Study|Multiple delay/holds on treatment|0|||
127883124|NCT02454972|460196340|FG007|Overall Study|Multiple delay/holds on treatment|0|||
127883125|NCT02454972|460196341|FG008|Overall Study|Multiple delay/holds on treatment|0|||
127883126|NCT02454972|460196333|FG000|Overall Study|Never treated|0|||
127883127|NCT02454972|460196334|FG001|Overall Study|Never treated|0|||
127883128|NCT02454972|460196335|FG002|Overall Study|Never treated|3|||
127883129|NCT02454972|460196336|FG003|Overall Study|Never treated|1|||
127883130|NCT02454972|460196337|FG004|Overall Study|Never treated|1|||
127883131|NCT02454972|460196338|FG005|Overall Study|Never treated|0|||
127883132|NCT02454972|460196339|FG006|Overall Study|Never treated|0|||
127883133|NCT02454972|460196340|FG007|Overall Study|Never treated|0|||
127883134|NCT02454972|460196341|FG008|Overall Study|Never treated|5|||
127883135|NCT02454972|460196333|FG000|Overall Study|Lost to Follow-up|0|||
127883136|NCT02454972|460196334|FG001|Overall Study|Lost to Follow-up|0|||
127883137|NCT02454972|460196335|FG002|Overall Study|Lost to Follow-up|0|||
127883138|NCT02454972|460196336|FG003|Overall Study|Lost to Follow-up|0|||
127883139|NCT02454972|460196337|FG004|Overall Study|Lost to Follow-up|0|||
127883140|NCT02454972|460196338|FG005|Overall Study|Lost to Follow-up|0|||
127883141|NCT02454972|460196339|FG006|Overall Study|Lost to Follow-up|0|||
127611592|NCT00481195|459207222|FG001|Overall Study|Withdrawal by Subject|9|||
127611593|NCT00481195|459207221|FG000|Overall Study|Miscellaneous|2|||
127611594|NCT00481195|459207222|FG001|Overall Study|Miscellaneous|2|||
127611595|NCT03343483|459207223|FG000|Overall Study|Death|0|||
127611596|NCT03343483|459207224|FG001|Overall Study|Death|3|||
127611597|NCT03343483|459207223|FG000|Overall Study|Lost to Follow-up|9|||
127611598|NCT03343483|459207224|FG001|Overall Study|Lost to Follow-up|13|||
127611599|NCT03343483|459207223|FG000|Overall Study|Withdrawal by Subject|8|||
127611600|NCT03343483|459207224|FG001|Overall Study|Withdrawal by Subject|17|||
127611601|NCT01505608|459207225|FG000|Phase I|Lack of Efficacy|0|||
127611602|NCT01505608|459207226|FG001|Phase I|Lack of Efficacy|4|||
127611603|NCT01505608|459207225|FG000|Phase I|Adverse Event|0|||
127611604|NCT01505608|459207226|FG001|Phase I|Adverse Event|1|||
127611605|NCT01505608|459207225|FG000|Phase I|Withdrawal by Subject|0|||
127611606|NCT01505608|459207226|FG001|Phase I|Withdrawal by Subject|1|||
127883142|NCT02454972|460196340|FG007|Overall Study|Lost to Follow-up|0|||
127883143|NCT02454972|460196341|FG008|Overall Study|Lost to Follow-up|2|||
127883144|NCT02454972|460196333|FG000|Overall Study|Study termination|0|||
127883145|NCT02454972|460196334|FG001|Overall Study|Study termination|0|||
127883146|NCT02454972|460196335|FG002|Overall Study|Study termination|0|||
127883147|NCT02454972|460196336|FG003|Overall Study|Study termination|0|||
127611607|NCT01505608|459207225|FG000|Phase II|Lack of Efficacy|2|||
127611608|NCT01505608|459207226|FG001|Phase II|Lack of Efficacy|1|||
127611609|NCT01505608|459207225|FG000|Phase II|Protocol Violation|0|||
127611610|NCT01505608|459207226|FG001|Phase II|Protocol Violation|1|||
127611611|NCT01708174|459207229|FG000|Treatment Period|Withdrawal by Subject|1|||
127611612|NCT01708174|459207230|FG001|Treatment Period|Withdrawal by Subject|0|||
127611613|NCT01708174|459207231|FG002|Treatment Period|Withdrawal by Subject|0|||
127611614|NCT01708174|459207229|FG000|Treatment Period|Progressive disease|0|||
127611615|NCT01708174|459207230|FG001|Treatment Period|Progressive disease|1|||
127611616|NCT01708174|459207231|FG002|Treatment Period|Progressive disease|0|||
127611617|NCT01708174|459207229|FG000|Treatment Period|Death|0|||
127611618|NCT01708174|459207230|FG001|Treatment Period|Death|0|||
127611619|NCT01708174|459207231|FG002|Treatment Period|Death|1|||
127611620|NCT01708174|459207229|FG000|Treatment Period|Adverse Event|0|||
127611621|NCT01708174|459207230|FG001|Treatment Period|Adverse Event|1|||
127611622|NCT01708174|459207231|FG002|Treatment Period|Adverse Event|0|||
127611623|NCT00075582|459207232|FG000|Overall Study|Adverse Event|3|||
127611624|NCT00075582|459207233|FG001|Overall Study|Adverse Event|1|||
127611625|NCT00075582|459207232|FG000|Overall Study|Lack of Efficacy|4|||
127611626|NCT00075582|459207233|FG001|Overall Study|Lack of Efficacy|8|||
127611627|NCT00075582|459207232|FG000|Overall Study|Physician Decision|5|||
127883148|NCT02454972|460196337|FG004|Overall Study|Study termination|0|||
127611628|NCT00075582|459207233|FG001|Overall Study|Physician Decision|8|||
127611629|NCT00075582|459207232|FG000|Overall Study|Withdrawal by Subject|2|||
127883149|NCT02454972|460196338|FG005|Overall Study|Study termination|0|||
127883150|NCT02454972|460196339|FG006|Overall Study|Study termination|0|||
127883151|NCT02454972|460196340|FG007|Overall Study|Study termination|0|||
127883152|NCT02454972|460196341|FG008|Overall Study|Study termination|6|||
127883153|NCT01377233|460196342|FG000|Open-label|Adverse Event|1|||
127883154|NCT01377233|460196343|FG001|Open-label|Adverse Event|0|||
127883155|NCT01377233|460196344|FG002|Open-label|Adverse Event|0|||
127883156|NCT01377233|460196345|FG003|Open-label|Adverse Event|0|||
127883157|NCT01377233|460196346|FG004|Open-label|Adverse Event|0|||
127883158|NCT01377233|460196342|FG000|Open-label|Withdrawal by Subject|3|||
127611630|NCT00075582|459207233|FG001|Overall Study|Withdrawal by Subject|2|||
127611631|NCT00075582|459207232|FG000|Overall Study|Ineligible for study|36|||
127611632|NCT00075582|459207233|FG001|Overall Study|Ineligible for study|16|||
127611633|NCT05045144|459207234|FG000|Overall Study|Lost to Follow-up|3|||
127611634|NCT05045144|459207235|FG001|Overall Study|Lost to Follow-up|2|||
127611635|NCT05045144|459207236|FG002|Overall Study|Lost to Follow-up|3|||
127611636|NCT05045144|459207237|FG003|Overall Study|Lost to Follow-up|5|||
127611637|NCT05045144|459207238|FG004|Overall Study|Lost to Follow-up|13|||
127611638|NCT05045144|459207234|FG000|Overall Study|Withdrawal by Subject|0|||
127611639|NCT05045144|459207235|FG001|Overall Study|Withdrawal by Subject|1|||
127611640|NCT05045144|459207236|FG002|Overall Study|Withdrawal by Subject|0|||
127611641|NCT05045144|459207237|FG003|Overall Study|Withdrawal by Subject|0|||
127611642|NCT05045144|459207238|FG004|Overall Study|Withdrawal by Subject|0|||
127611643|NCT05045144|459207234|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127611644|NCT05045144|459207235|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127611645|NCT05045144|459207236|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
127611646|NCT05045144|459207237|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127611647|NCT05045144|459207238|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127611648|NCT01466387|459207239|FG000|Overall Study|Adverse Event|0|||
127611649|NCT01466387|459207240|FG001|Overall Study|Adverse Event|0|||
127611650|NCT01466387|459207241|FG002|Overall Study|Adverse Event|1|||
127611651|NCT01466387|459207242|FG003|Overall Study|Adverse Event|1|||
127611652|NCT01466387|459207243|FG004|Overall Study|Adverse Event|0|||
127611653|NCT01466387|459207244|FG005|Overall Study|Adverse Event|0|||
127611654|NCT01466387|459207239|FG000|Overall Study|Lost to Follow-up|0|||
127611655|NCT01466387|459207240|FG001|Overall Study|Lost to Follow-up|0|||
127611656|NCT01466387|459207241|FG002|Overall Study|Lost to Follow-up|0|||
127611657|NCT01466387|459207242|FG003|Overall Study|Lost to Follow-up|0|||
127611658|NCT01466387|459207243|FG004|Overall Study|Lost to Follow-up|0|||
127611659|NCT01466387|459207244|FG005|Overall Study|Lost to Follow-up|1|||
127611660|NCT01466387|459207239|FG000|Overall Study|Protocol Violation|1|||
127611661|NCT01466387|459207240|FG001|Overall Study|Protocol Violation|0|||
127611662|NCT01466387|459207241|FG002|Overall Study|Protocol Violation|0|||
127611663|NCT01466387|459207242|FG003|Overall Study|Protocol Violation|1|||
127611664|NCT01466387|459207243|FG004|Overall Study|Protocol Violation|0|||
127611665|NCT01466387|459207244|FG005|Overall Study|Protocol Violation|0|||
127611666|NCT02968979|459207245|FG000|Overall Study|Protocol Violation|7|||
127611667|NCT02968979|459207245|FG000|Overall Study|Withdrawal by Subject|1|||
127611668|NCT04404855|459207247|FG000|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|69|||
127611669|NCT04404855|459207248|FG001|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|35|||
127611670|NCT03320564|459207249|FG000|Overall Study|Protocol Violation|1|||
127611671|NCT00788827|459207250|FG000|Overall Study|Lack of Efficacy|2|||
127611672|NCT01586819|459207257|FG000|Overall Study|Withdrawal by Subject|1|||
127611673|NCT01586819|459207258|FG001|Overall Study|Withdrawal by Subject|0|||
127611674|NCT01359254|459207259|FG000|Overall Study|Death|1|||
127611675|NCT01359254|459207260|FG001|Overall Study|Death|0|||
127611676|NCT04668950|459207262|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
127611677|NCT04668950|459207263|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
127611678|NCT04668950|459207262|FG000|Overall Study|Could not confirm started study medication|15|||
127883159|NCT01377233|460196343|FG001|Open-label|Withdrawal by Subject|0|||
127883160|NCT01377233|460196344|FG002|Open-label|Withdrawal by Subject|0|||
127611679|NCT04668950|459207263|FG001|Overall Study|Could not confirm started study medication|15|||
127611680|NCT04668950|459207262|FG000|Overall Study|Could not confirm baseline status|6|||
127611681|NCT04668950|459207263|FG001|Overall Study|Could not confirm baseline status|2|||
127611682|NCT04668950|459207262|FG000|Overall Study|Drop out and did not start medication|15|||
127611683|NCT04668950|459207263|FG001|Overall Study|Drop out and did not start medication|17|||
127611684|NCT04668950|459207262|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
127883161|NCT01377233|460196345|FG003|Open-label|Withdrawal by Subject|0|||
127698549|NCT04810650|459523871|FG000|Overall Study|Participant declined|0|||
127698550|NCT04810650|459523872|FG001|Overall Study|Participant declined|0|||
127883162|NCT01377233|460196346|FG004|Open-label|Withdrawal by Subject|0|||
127698551|NCT04810650|459523873|FG002|Overall Study|Participant declined|0|||
127698552|NCT04810650|459523874|FG003|Overall Study|Participant declined|0|||
127698553|NCT04810650|459523875|FG004|Overall Study|Participant declined|0|||
127698554|NCT04810650|459523876|FG005|Overall Study|Participant declined|0|||
127698555|NCT04810650|459523877|FG006|Overall Study|Participant declined|0|||
127698556|NCT04810650|459523878|FG007|Overall Study|Participant declined|0|||
127698557|NCT04810650|459523879|FG008|Overall Study|Participant declined|0|||
127698558|NCT04810650|459523880|FG009|Overall Study|Participant declined|0|||
127698559|NCT04810650|459523881|FG010|Overall Study|Participant declined|2|||
127698560|NCT04810650|459523882|FG011|Overall Study|Participant declined|0|||
127698561|NCT04810650|459523883|FG012|Overall Study|Participant declined|0|||
127698562|NCT04810650|459523884|FG013|Overall Study|Participant declined|0|||
127698563|NCT05794243|459523885|FG000|Overall Study|Withdrawal by Subject|1|||
127698564|NCT05794243|459523886|FG001|Overall Study|Withdrawal by Subject|0|||
127698565|NCT05794243|459523887|FG002|Overall Study|Withdrawal by Subject|1|||
127698566|NCT05794243|459523885|FG000|Overall Study|Physician Decision|0|||
127698567|NCT05794243|459523886|FG001|Overall Study|Physician Decision|3|||
127698568|NCT05794243|459523887|FG002|Overall Study|Physician Decision|1|||
127698569|NCT02761057|459523893|FG000|Overall Study|Ineligible - No Measurable Disease|1|||
127698570|NCT02761057|459523894|FG001|Overall Study|Ineligible - No Measurable Disease|1|||
127698571|NCT02761057|459523895|FG002|Overall Study|Ineligible - No Measurable Disease|0|||
127698572|NCT02761057|459523896|FG003|Overall Study|Ineligible - No Measurable Disease|1|||
127698573|NCT02761057|459523893|FG000|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
127698574|NCT02761057|459523894|FG001|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
127698575|NCT02761057|459523895|FG002|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
127698576|NCT02761057|459523896|FG003|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
127698577|NCT02761057|459523893|FG000|Overall Study|Currently On Study Treatment|0|||
127698578|NCT02761057|459523894|FG001|Overall Study|Currently On Study Treatment|3|||
127698579|NCT02761057|459523895|FG002|Overall Study|Currently On Study Treatment|0|||
127883163|NCT01377233|460196342|FG000|Double-blind|Adverse Event|0|||
127883164|NCT01377233|460196343|FG001|Double-blind|Adverse Event|1|||
127883165|NCT01377233|460196344|FG002|Double-blind|Adverse Event|2|||
127883166|NCT01377233|460196345|FG003|Double-blind|Adverse Event|2|||
127883167|NCT01377233|460196346|FG004|Double-blind|Adverse Event|0|||
127883168|NCT01377233|460196342|FG000|Double-blind|Protocol Violation|0|||
127883169|NCT01377233|460196343|FG001|Double-blind|Protocol Violation|0|||
127883170|NCT01377233|460196344|FG002|Double-blind|Protocol Violation|0|||
127883171|NCT01377233|460196345|FG003|Double-blind|Protocol Violation|0|||
127883172|NCT01377233|460196346|FG004|Double-blind|Protocol Violation|1|||
127883173|NCT01377233|460196342|FG000|Double-blind|Withdrawal by Subject|0|||
127883174|NCT01377233|460196343|FG001|Double-blind|Withdrawal by Subject|0|||
127883175|NCT01377233|460196344|FG002|Double-blind|Withdrawal by Subject|0|||
127883176|NCT01377233|460196345|FG003|Double-blind|Withdrawal by Subject|1|||
127883177|NCT01377233|460196346|FG004|Double-blind|Withdrawal by Subject|0|||
127883178|NCT01377233|460196342|FG000|Double-blind|Administrative or other|0|||
127698580|NCT02761057|459523896|FG003|Overall Study|Currently On Study Treatment|0|||
127698581|NCT02761057|459523893|FG000|Overall Study|Adverse Event|11|||
127698582|NCT02761057|459523894|FG001|Overall Study|Adverse Event|9|||
127698583|NCT02761057|459523895|FG002|Overall Study|Adverse Event|5|||
127883179|NCT01377233|460196343|FG001|Double-blind|Administrative or other|0|||
127883180|NCT01377233|460196344|FG002|Double-blind|Administrative or other|0|||
127883181|NCT01377233|460196345|FG003|Double-blind|Administrative or other|1|||
127883182|NCT01377233|460196346|FG004|Double-blind|Administrative or other|1|||
127883183|NCT01785875|460196347|FG000|Overall Study|Withdrawal by Subject|41|||
127883184|NCT01785875|460196348|FG001|Overall Study|Withdrawal by Subject|34|||
127883185|NCT01785875|460196349|FG002|Overall Study|Withdrawal by Subject|36|||
127698584|NCT02761057|459523896|FG003|Overall Study|Adverse Event|3|||
127698585|NCT02761057|459523893|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
127883186|NCT01785875|460196347|FG000|Overall Study|Lost to Follow-up|19|||
127883187|NCT01785875|460196348|FG001|Overall Study|Lost to Follow-up|22|||
127883188|NCT01785875|460196349|FG002|Overall Study|Lost to Follow-up|6|||
127883189|NCT01785875|460196347|FG000|Overall Study|Death|27|||
127611685|NCT04668950|459207263|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
127611686|NCT04668950|459207262|FG000|Overall Study|Other|2|||
127611687|NCT04668950|459207263|FG001|Overall Study|Other|4|||
127611688|NCT03979638|459207266|FG000|Period 1|Physician Decision|1|||
127611689|NCT03979638|459207267|FG001|Period 1|Physician Decision|1|||
127611690|NCT03979638|459207266|FG000|Period 1|Withdrawal by Subject|4|||
127611691|NCT03979638|459207267|FG001|Period 1|Withdrawal by Subject|3|||
127611692|NCT03979638|459207266|FG000|Period 1|Study terminated by Sponsor|1|||
127611693|NCT03979638|459207267|FG001|Period 1|Study terminated by Sponsor|3|||
127611694|NCT03979638|459207266|FG000|Period 1|Protocol Violation|1|||
127611695|NCT03979638|459207267|FG001|Period 1|Protocol Violation|0|||
127611696|NCT03979638|459207266|FG000|Period 2|Study terminated by Sponsor|1|||
127611697|NCT03979638|459207267|FG001|Period 2|Study terminated by Sponsor|1|||
127611698|NCT04248933|459207268|FG000|Overall Study|Lost to Follow-up|9|||
127611699|NCT04248933|459207268|FG000|Overall Study|Withdrawal by Subject|2|||
127611700|NCT00578942|459207271|FG000|Overall Study|Lost to Follow-up|1|||
127611701|NCT00600938|459207280|FG000|Core Study|Abnormal test procedure result(s)|3|||
127611702|NCT00600938|459207281|FG001|Core Study|Abnormal test procedure result(s)|2|||
127611703|NCT00600938|459207282|FG002|Core Study|Abnormal test procedure result(s)|0|||
127698586|NCT02761057|459523894|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
127698587|NCT02761057|459523895|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
127698588|NCT02761057|459523896|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
127698589|NCT02761057|459523893|FG000|Overall Study|Progression/Relapse|29|||
127698590|NCT02761057|459523894|FG001|Overall Study|Progression/Relapse|27|||
127698591|NCT02761057|459523895|FG002|Overall Study|Progression/Relapse|20|||
127698592|NCT02761057|459523896|FG003|Overall Study|Progression/Relapse|23|||
127698593|NCT02761057|459523893|FG000|Overall Study|Death|2|||
127698594|NCT02761057|459523894|FG001|Overall Study|Death|2|||
127698595|NCT02761057|459523895|FG002|Overall Study|Death|1|||
127698596|NCT02761057|459523896|FG003|Overall Study|Death|1|||
127698597|NCT02761057|459523893|FG000|Overall Study|Other - Not Protocol Specified|2|||
127698598|NCT02761057|459523894|FG001|Overall Study|Other - Not Protocol Specified|1|||
127698599|NCT02761057|459523895|FG002|Overall Study|Other - Not Protocol Specified|2|||
127698600|NCT02761057|459523896|FG003|Overall Study|Other - Not Protocol Specified|0|||
127698601|NCT06037369|459523899|FG000|Overall Study|Lost to Follow-up|0|||
127698602|NCT06037369|459523900|FG001|Overall Study|Lost to Follow-up|1|||
127698603|NCT04876118|459523905|FG000|Overall Study|Pregnancy|1|||
127698604|NCT04876118|459523905|FG000|Overall Study|Withdrawal by Subject|14|||
127698605|NCT04948697|459523908|FG000|Overall Study|Progressive disease|27|||
127698606|NCT04948697|459523909|FG001|Overall Study|Progressive disease|18|||
127698607|NCT04948697|459523908|FG000|Overall Study|Adverse Event|14|||
127698608|NCT04948697|459523909|FG001|Overall Study|Adverse Event|4|||
127698609|NCT04948697|459523908|FG000|Overall Study|Participant moved to long term extension study|7|||
127698610|NCT04948697|459523909|FG001|Overall Study|Participant moved to long term extension study|4|||
127698611|NCT04948697|459523908|FG000|Overall Study|Withdrawal by Subject|10|||
127698612|NCT04948697|459523909|FG001|Overall Study|Withdrawal by Subject|0|||
127698613|NCT04948697|459523908|FG000|Overall Study|Closed by Sponsor|3|||
127698614|NCT04948697|459523909|FG001|Overall Study|Closed by Sponsor|2|||
127698615|NCT04948697|459523908|FG000|Overall Study|Physician Decision|0|||
127698616|NCT04948697|459523909|FG001|Overall Study|Physician Decision|2|||
127698617|NCT04948697|459523908|FG000|Overall Study|Lost to Follow-up|0|||
127698618|NCT04948697|459523909|FG001|Overall Study|Lost to Follow-up|1|||
127698619|NCT04948697|459523908|FG000|Overall Study|Other-Miscellaneous|1|||
127698620|NCT04948697|459523909|FG001|Overall Study|Other-Miscellaneous|0|||
127698621|NCT04948697|459523908|FG000|Overall Study|Randomized but not treated|0|||
127698622|NCT04948697|459523909|FG001|Overall Study|Randomized but not treated|1|||
127698623|NCT04338061|459523910|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|59|||
127698624|NCT04338061|459523911|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|52|||
127698625|NCT04338061|459523910|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|11|||
127698626|NCT04338061|459523911|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|16|||
127698627|NCT04338061|459523910|FG000|Double-blind Treatment Period: 156 Weeks|Other Reasons|17|||
127698628|NCT04338061|459523911|FG001|Double-blind Treatment Period: 156 Weeks|Other Reasons|22|||
127698629|NCT04338061|459523910|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|67|||
127698630|NCT04338061|459523911|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|70|||
127698631|NCT04338061|459523910|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|9|||
127698632|NCT04338061|459523911|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|8|||
127698633|NCT04338061|459523910|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|11|||
127698634|NCT04338061|459523911|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|3|||
127698635|NCT04338061|459523910|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|0|||
127611704|NCT00600938|459207283|FG003|Core Study|Abnormal test procedure result(s)|0|||
127611705|NCT00600938|459207280|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
127611706|NCT00600938|459207281|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
127611707|NCT00600938|459207282|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
127611708|NCT00600938|459207283|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
127611709|NCT00600938|459207280|FG000|Core Study|Patient withdrew consent|7|||
127611710|NCT00600938|459207281|FG001|Core Study|Patient withdrew consent|12|||
127611711|NCT00600938|459207282|FG002|Core Study|Patient withdrew consent|0|||
127611712|NCT00600938|459207283|FG003|Core Study|Patient withdrew consent|0|||
127611713|NCT00600938|459207280|FG000|Core Study|Lost to Follow-up|3|||
127611714|NCT00600938|459207281|FG001|Core Study|Lost to Follow-up|2|||
127611715|NCT00600938|459207282|FG002|Core Study|Lost to Follow-up|0|||
127611716|NCT00600938|459207283|FG003|Core Study|Lost to Follow-up|0|||
127611717|NCT00600938|459207280|FG000|Core Study|Death|1|||
127611718|NCT00600938|459207281|FG001|Core Study|Death|1|||
127611719|NCT00600938|459207282|FG002|Core Study|Death|0|||
127611720|NCT00600938|459207283|FG003|Core Study|Death|0|||
127611721|NCT00600938|459207280|FG000|Core Study|Protocol Violation|1|||
127611722|NCT00600938|459207281|FG001|Core Study|Protocol Violation|2|||
127611723|NCT00600938|459207282|FG002|Core Study|Protocol Violation|0|||
127611724|NCT00600938|459207283|FG003|Core Study|Protocol Violation|0|||
127611725|NCT00600938|459207280|FG000|Extension Study|Adverse Event|1|||
127611726|NCT00600938|459207281|FG001|Extension Study|Adverse Event|0|||
127611727|NCT00600938|459207282|FG002|Extension Study|Adverse Event|2|||
127611728|NCT00600938|459207283|FG003|Extension Study|Adverse Event|0|||
127611729|NCT00600938|459207280|FG000|Extension Study|Abnormal test procedure results|0|||
127611730|NCT00600938|459207281|FG001|Extension Study|Abnormal test procedure results|1|||
127611731|NCT00600938|459207282|FG002|Extension Study|Abnormal test procedure results|1|||
127611732|NCT00600938|459207283|FG003|Extension Study|Abnormal test procedure results|1|||
127611733|NCT00600938|459207280|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
127611734|NCT00600938|459207281|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
127611735|NCT00600938|459207282|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
127611736|NCT00600938|459207283|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
127611737|NCT00600938|459207280|FG000|Extension Study|Withdrawal by Subject|2|||
127611738|NCT00600938|459207281|FG001|Extension Study|Withdrawal by Subject|2|||
127611739|NCT00600938|459207282|FG002|Extension Study|Withdrawal by Subject|3|||
127611740|NCT00600938|459207283|FG003|Extension Study|Withdrawal by Subject|0|||
127611741|NCT00600938|459207280|FG000|Extension Study|Lost to Follow-up|1|||
127611742|NCT00600938|459207281|FG001|Extension Study|Lost to Follow-up|1|||
127611743|NCT00600938|459207282|FG002|Extension Study|Lost to Follow-up|2|||
127611744|NCT00600938|459207283|FG003|Extension Study|Lost to Follow-up|0|||
127611745|NCT00600938|459207280|FG000|Extension Study|Death|1|||
127611746|NCT00600938|459207281|FG001|Extension Study|Death|0|||
127611747|NCT00600938|459207282|FG002|Extension Study|Death|0|||
127611748|NCT00600938|459207283|FG003|Extension Study|Death|0|||
127611749|NCT01124643|459207284|FG000|Overall Study|Death|1|||
127611750|NCT04220411|459207285|FG000|Overall Study|Adverse Event|0|||
127611751|NCT04220411|459207286|FG001|Overall Study|Adverse Event|0|||
127698636|NCT04338061|459523911|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|2|||
127789282|NCT02025907|459853572|FG000|Overall Study|Physician Decision|2|||
127789283|NCT02025907|459853573|FG001|Overall Study|Physician Decision|0|||
127789284|NCT02025907|459853572|FG000|Overall Study|Lost to Follow-up|2|||
127789285|NCT02025907|459853573|FG001|Overall Study|Lost to Follow-up|2|||
127789286|NCT02025907|459853572|FG000|Overall Study|Adverse Event|3|||
127789287|NCT02025907|459853573|FG001|Overall Study|Adverse Event|1|||
127789288|NCT02025907|459853572|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
127789289|NCT02025907|459853573|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
127789290|NCT00282334|459853574|FG000|Overall Study|Withdrawal by Subject|8|||
127883190|NCT01785875|460196348|FG001|Overall Study|Death|16|||
127883191|NCT01785875|460196349|FG002|Overall Study|Death|7|||
127698637|NCT04338061|459523910|FG000|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|2|||
127698638|NCT04338061|459523911|FG001|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|1|||
127698639|NCT04338061|459523910|FG000|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|1|||
127698640|NCT04338061|459523911|FG001|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|2|||
127698641|NCT04338061|459523910|FG000|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
127698642|NCT04338061|459523911|FG001|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
127698643|NCT04338061|459523910|FG000|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|1|||
127883192|NCT01785875|460196347|FG000|Overall Study|Sponsor Decision|0|||
127611752|NCT04220411|459207287|FG002|Overall Study|Adverse Event|0|||
127611753|NCT04220411|459207288|FG003|Overall Study|Adverse Event|1|||
127611754|NCT02680639|459207291|FG000|Screening Period|Screen Failure|7|||
127611755|NCT02680639|459207292|FG001|Screening Period|Screen Failure|0|||
127611756|NCT02680639|459207293|FG002|Screening Period|Screen Failure|0|||
127611757|NCT01063595|459207294|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
127611758|NCT01063595|459207295|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
127611759|NCT01063595|459207294|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
127611760|NCT01063595|459207295|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
127611761|NCT01063595|459207294|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
127611762|NCT01063595|459207295|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
127698644|NCT04338061|459523911|FG001|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|0|||
127698645|NCT04338061|459523910|FG000|Double-blind Extension Period: 96 Weeks|Other Reasons|4|||
127698646|NCT04338061|459523911|FG001|Double-blind Extension Period: 96 Weeks|Other Reasons|8|||
127698647|NCT03365882|459523912|FG000|Randomization|Still Receiving Protocol Treatment|2|||
127698648|NCT03365882|459523913|FG001|Randomization|Still Receiving Protocol Treatment|0|||
127698649|NCT03365882|459523912|FG000|Randomization|Adverse Event|1|||
127698650|NCT03365882|459523913|FG001|Randomization|Adverse Event|2|||
127698651|NCT03365882|459523912|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
127698652|NCT03365882|459523913|FG001|Randomization|Refusal Unrelated to Adverse Event|1|||
127698653|NCT03365882|459523912|FG000|Randomization|Progression/Relapse|21|||
127698654|NCT03365882|459523913|FG001|Randomization|Progression/Relapse|3|||
127698655|NCT03365882|459523912|FG000|Randomization|Death|1|||
127698656|NCT03365882|459523913|FG001|Randomization|Death|0|||
127698657|NCT03365882|459523912|FG000|Randomization|Other - Not Protocol Specified|1|||
127698658|NCT03365882|459523913|FG001|Randomization|Other - Not Protocol Specified|1|||
127698659|NCT03365882|459523912|FG000|Randomization|Major Protocol Deviation|0|||
127698660|NCT03365882|459523913|FG001|Randomization|Major Protocol Deviation|1|||
127698661|NCT03365882|459523912|FG000|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|0|||
127698662|NCT03365882|459523913|FG001|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|1|||
127698663|NCT03365882|459523912|FG000|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|0|||
127698664|NCT03365882|459523913|FG001|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|13|||
127698665|NCT03365882|459523912|FG000|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|0|||
127698666|NCT03365882|459523913|FG001|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|4|||
127698667|NCT03365882|459523912|FG000|Crossover: Trastuzumab + Pertuzumab|Adverse Event|0|||
127698668|NCT03365882|459523913|FG001|Crossover: Trastuzumab + Pertuzumab|Adverse Event|2|||
127698669|NCT04229992|459526462|FG000|Overall Study|Withdrawal by Subject|0|||
127698670|NCT04229992|459526463|FG001|Overall Study|Withdrawal by Subject|2|||
127698671|NCT04229992|459526464|FG002|Overall Study|Withdrawal by Subject|1|||
127698672|NCT04229992|459526465|FG003|Overall Study|Withdrawal by Subject|1|||
127698673|NCT04229992|459526462|FG000|Overall Study|Adverse Event|1|||
127698674|NCT04229992|459526463|FG001|Overall Study|Adverse Event|1|||
127698675|NCT04229992|459526464|FG002|Overall Study|Adverse Event|3|||
127698676|NCT04229992|459526465|FG003|Overall Study|Adverse Event|1|||
127698677|NCT04229992|459526462|FG000|Overall Study|Lost to Follow-up|0|||
127698678|NCT04229992|459526463|FG001|Overall Study|Lost to Follow-up|0|||
127698679|NCT04229992|459526464|FG002|Overall Study|Lost to Follow-up|0|||
127698680|NCT04229992|459526465|FG003|Overall Study|Lost to Follow-up|1|||
127883193|NCT01785875|460196348|FG001|Overall Study|Sponsor Decision|2|||
127883194|NCT01785875|460196349|FG002|Overall Study|Sponsor Decision|0|||
127883195|NCT01785875|460196347|FG000|Overall Study|Protocol Specified Criteria|207|||
127883196|NCT01785875|460196348|FG001|Overall Study|Protocol Specified Criteria|214|||
127698681|NCT03770273|459526466|FG000|Overall Study|Adverse Event|2|||
127698682|NCT03770273|459526467|FG001|Overall Study|Adverse Event|0|||
127698683|NCT03770273|459526466|FG000|Overall Study|Lost to Follow-up|1|||
127698684|NCT03770273|459526467|FG001|Overall Study|Lost to Follow-up|1|||
127698685|NCT04060654|459526468|FG000|Overall Study|Withdrawal by Subject|1|||
127698686|NCT04060654|459526468|FG000|Overall Study|Lost to Follow-up|5|||
127698687|NCT02921230|459526471|FG000|Overall Study|Withdrawal by Subject|20|||
127698688|NCT02921230|459526472|FG001|Overall Study|Withdrawal by Subject|8|||
127698689|NCT02921230|459526471|FG000|Overall Study|Death|12|||
127698690|NCT02921230|459526472|FG001|Overall Study|Death|3|||
127698691|NCT02921230|459526471|FG000|Overall Study|Protocol Violation|17|||
127698692|NCT02921230|459526472|FG001|Overall Study|Protocol Violation|6|||
127698693|NCT02921230|459526471|FG000|Overall Study|Early completion|5|||
127698694|NCT02921230|459526472|FG001|Overall Study|Early completion|1|||
127698695|NCT02921230|459526471|FG000|Overall Study|Pending data entry|1|||
127698696|NCT02921230|459526472|FG001|Overall Study|Pending data entry|0|||
127698697|NCT03338933|459526481|FG000|Screening Visit|Lost to Follow-up|1|||
127698698|NCT03338933|459526482|FG001|Screening Visit|Lost to Follow-up|3|||
127698699|NCT03338933|459526483|FG002|Screening Visit|Lost to Follow-up|1|||
127611763|NCT01063595|459207294|FG000|First Intervention|Adverse Event|1|||
127611764|NCT01063595|459207295|FG001|First Intervention|Adverse Event|4|||
127611765|NCT01063595|459207294|FG000|First Intervention|Withdrawal by Subject|1|||
127611766|NCT01063595|459207295|FG001|First Intervention|Withdrawal by Subject|0|||
127611767|NCT01063595|459207294|FG000|First Intervention|Reason not Specified|0|||
127611768|NCT01063595|459207295|FG001|First Intervention|Reason not Specified|1|||
127611769|NCT00747435|459207296|FG000|Overall Study|Lost to Follow-up|2|||
127611770|NCT00747435|459207296|FG000|Overall Study|Withdrawal by Subject|3|||
127611771|NCT00747435|459207296|FG000|Overall Study|Still undergoing follow up|1|||
127611772|NCT02678676|459207297|FG000|Overall Study|Death|619|||
127611773|NCT02678676|459207298|FG001|Overall Study|Death|649|||
127611774|NCT02678676|459207297|FG000|Overall Study|Withdrawal by Subject|13|||
127611775|NCT02678676|459207298|FG001|Overall Study|Withdrawal by Subject|5|||
127611776|NCT02678676|459207297|FG000|Overall Study|Lost to Follow-up|171|||
127611777|NCT02678676|459207298|FG001|Overall Study|Lost to Follow-up|151|||
127611778|NCT02678676|459207297|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
127611779|NCT02678676|459207298|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
127611780|NCT04059146|459207299|FG000|Overall Study|Withdrawal by Subject|0|||
127611781|NCT04059146|459207300|FG001|Overall Study|Withdrawal by Subject|1|||
127611782|NCT00851799|459207301|FG000|Overall Study|Death|1|||
127611783|NCT00851799|459207302|FG001|Overall Study|Death|0|||
127611784|NCT00851799|459207303|FG002|Overall Study|Death|1|||
127611785|NCT00851799|459207301|FG000|Overall Study|Lost to Follow-up|5|||
127611786|NCT00851799|459207302|FG001|Overall Study|Lost to Follow-up|3|||
127611787|NCT00851799|459207303|FG002|Overall Study|Lost to Follow-up|10|||
127611788|NCT00851799|459207301|FG000|Overall Study|Not able to get to clinic|8|||
127611789|NCT00851799|459207302|FG001|Overall Study|Not able to get to clinic|5|||
127611790|NCT00851799|459207303|FG002|Overall Study|Not able to get to clinic|9|||
127611791|NCT00851799|459207301|FG000|Overall Study|Not willing to adhere to requirements|1|||
127611792|NCT00851799|459207302|FG001|Overall Study|Not willing to adhere to requirements|2|||
127611793|NCT00851799|459207303|FG002|Overall Study|Not willing to adhere to requirements|2|||
127611794|NCT00851799|459207301|FG000|Overall Study|Withdrew consent prior study completion|1|||
127611795|NCT00851799|459207302|FG001|Overall Study|Withdrew consent prior study completion|2|||
127611796|NCT00851799|459207303|FG002|Overall Study|Withdrew consent prior study completion|1|||
127611797|NCT00851799|459207301|FG000|Overall Study|Severe Debilitation|0|||
127611798|NCT00851799|459207302|FG001|Overall Study|Severe Debilitation|1|||
127611799|NCT00851799|459207303|FG002|Overall Study|Severe Debilitation|0|||
127611800|NCT00851799|459207301|FG000|Overall Study|Completed protocol due to pregnancy|0|||
127611801|NCT00851799|459207302|FG001|Overall Study|Completed protocol due to pregnancy|0|||
127698700|NCT03338933|459526484|FG003|Screening Visit|Lost to Follow-up|4|||
127611802|NCT00851799|459207303|FG002|Overall Study|Completed protocol due to pregnancy|1|||
127611803|NCT04056195|459207307|FG000|Overall Study|Adverse Event|1|||
127611804|NCT04056195|459207308|FG001|Overall Study|Adverse Event|0|||
127611805|NCT04056195|459207309|FG002|Overall Study|Adverse Event|0|||
127611806|NCT04056195|459207307|FG000|Overall Study|Withdrawal by Subject|0|||
127611807|NCT04056195|459207308|FG001|Overall Study|Withdrawal by Subject|1|||
127611808|NCT04056195|459207309|FG002|Overall Study|Withdrawal by Subject|1|||
127611809|NCT04056195|459207307|FG000|Overall Study|Physician Decision|1|||
127611810|NCT04056195|459207308|FG001|Overall Study|Physician Decision|1|||
127611811|NCT04056195|459207309|FG002|Overall Study|Physician Decision|1|||
127611812|NCT01380184|459207325|FG000|Part 1 (19 Days)|Adverse Event|1|||
127611813|NCT01380184|459207325|FG000|Part 2|Adverse Event|5|||
127611814|NCT01380184|459207325|FG000|Part 2|Disease Progression|8|||
127611815|NCT01380184|459207325|FG000|Part 2|Lost to Follow-up|1|||
127611816|NCT03532295|459207326|FG000|Overall Study|Did not start treatment|0|||
127611817|NCT03532295|459207327|FG001|Overall Study|Did not start treatment|2|||
127611818|NCT02776917|459207328|FG000|Overall Study|Screen failures. One subject ended treatment early due to disease related symptoms|7|||
127611819|NCT04439318|459207331|FG000|Overall Study|Ineligible|1|||
127611820|NCT04439318|459207331|FG000|Overall Study|Never Started Treatment|3|||
127611821|NCT04439318|459207331|FG000|Overall Study|Adverse Event|10|||
127611822|NCT04439318|459207331|FG000|Overall Study|Death|2|||
127611823|NCT04439318|459207331|FG000|Overall Study|Disease Progression|25|||
127611824|NCT04439318|459207331|FG000|Overall Study|Other Complicating Disease|2|||
127611825|NCT04439318|459207331|FG000|Overall Study|Withdrawal by Subject|4|||
127611826|NCT04439318|459207331|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
127611827|NCT04439318|459207331|FG000|Overall Study|Non-Compliance|1|||
127789291|NCT00282334|459853575|FG001|Overall Study|Withdrawal by Subject|5|||
127789292|NCT03681119|459853576|FG000|Overall Study|No specific reason|4|||
127789293|NCT03681119|459853577|FG001|Overall Study|No specific reason|0|||
127789294|NCT03681119|459853576|FG000|Overall Study|Sickness|2|||
127789295|NCT03681119|459853577|FG001|Overall Study|Sickness|0|||
127789296|NCT00879645|459853583|FG000|Overall Study|Adverse Event|1|||
127789297|NCT00879645|459853584|FG001|Overall Study|Adverse Event|0|||
127789298|NCT00879645|459853585|FG002|Overall Study|Adverse Event|0|||
127789299|NCT00879645|459853586|FG003|Overall Study|Adverse Event|0|||
127789300|NCT03631732|459853587|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
127789301|NCT03631732|459853588|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
127789302|NCT03631732|459853587|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
127789303|NCT03631732|459853588|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
127789304|NCT03631732|459853587|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
127789305|NCT03631732|459853588|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
127789306|NCT03631732|459853587|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
127789307|NCT03631732|459853588|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
127789308|NCT03631732|459853587|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
127789309|NCT03631732|459853588|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
127789310|NCT03631732|459853587|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
127789311|NCT03631732|459853588|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
127789312|NCT03631732|459853587|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
127789313|NCT03631732|459853588|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
127789314|NCT03631732|459853587|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
127789315|NCT03631732|459853588|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
127789316|NCT03631732|459853587|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
127789317|NCT03631732|459853588|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
127789318|NCT03631732|459853587|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
127789319|NCT03631732|459853588|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
127789320|NCT04288154|459853589|FG000|Overall Study|Withdrawal by Subject|9|||
127789321|NCT04288154|459853590|FG001|Overall Study|Withdrawal by Subject|9|||
127789322|NCT02873936|459853594|FG000|Overall Study|Withdrew Consent|4|||
127789323|NCT02873936|459853595|FG001|Overall Study|Withdrew Consent|11|||
127789324|NCT02873936|459853596|FG002|Overall Study|Withdrew Consent|20|||
127611828|NCT04439318|459207331|FG000|Overall Study|Still on Treatment|1|||
127611829|NCT00699972|459208994|FG000|Overall Study|Adverse Event|7|||
127611830|NCT00699972|459208995|FG001|Overall Study|Adverse Event|9|||
127611831|NCT00699972|459208996|FG002|Overall Study|Adverse Event|24|||
127611832|NCT00699972|459208994|FG000|Overall Study|Lost to Follow-up|0|||
127611833|NCT00699972|459208995|FG001|Overall Study|Lost to Follow-up|2|||
127611834|NCT00699972|459208996|FG002|Overall Study|Lost to Follow-up|0|||
127611835|NCT00699972|459208994|FG000|Overall Study|Withdrawal by Subject|3|||
127611836|NCT00699972|459208995|FG001|Overall Study|Withdrawal by Subject|7|||
127611837|NCT00699972|459208996|FG002|Overall Study|Withdrawal by Subject|4|||
127611838|NCT00699972|459208994|FG000|Overall Study|Lack of Efficacy|2|||
127611839|NCT00699972|459208995|FG001|Overall Study|Lack of Efficacy|0|||
127611840|NCT00699972|459208996|FG002|Overall Study|Lack of Efficacy|2|||
127611841|NCT00699972|459208994|FG000|Overall Study|Administrative/Other|3|||
127611842|NCT00699972|459208995|FG001|Overall Study|Administrative/Other|1|||
127611843|NCT00699972|459208996|FG002|Overall Study|Administrative/Other|4|||
127611844|NCT00699972|459208994|FG000|Overall Study|Randomized, Not Treated|1|||
127611845|NCT00699972|459208995|FG001|Overall Study|Randomized, Not Treated|0|||
127611846|NCT00699972|459208996|FG002|Overall Study|Randomized, Not Treated|1|||
127611847|NCT03509675|459208998|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
127611848|NCT03509675|459208999|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
127611849|NCT03509675|459208998|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
127611850|NCT03509675|459208999|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
127611851|NCT03509675|459208998|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
127611852|NCT03509675|459208999|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
127611853|NCT03509675|459208998|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
127611854|NCT03509675|459208999|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
127611855|NCT02286193|459209012|FG000|Overall Study|Referred: CRS unable to make contact|62|||
127611856|NCT02286193|459209012|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
127611857|NCT02286193|459209012|FG000|Overall Study|Referred: Declined service|38|||
127611858|NCT02932904|459209013|FG000|Overall Study|Reason not Specified|1|||
127611859|NCT02932904|459209014|FG001|Overall Study|Reason not Specified|0|||
127611860|NCT02932904|459209015|FG002|Overall Study|Reason not Specified|2|||
127611861|NCT02932904|459209016|FG003|Overall Study|Reason not Specified|2|||
127611862|NCT02932904|459209013|FG000|Overall Study|Noncompliance with Study Drug|2|||
127611863|NCT02932904|459209014|FG001|Overall Study|Noncompliance with Study Drug|3|||
127611864|NCT02932904|459209015|FG002|Overall Study|Noncompliance with Study Drug|3|||
127611865|NCT02932904|459209016|FG003|Overall Study|Noncompliance with Study Drug|4|||
127611866|NCT02932904|459209013|FG000|Overall Study|Pregnancy|0|||
127611867|NCT02932904|459209014|FG001|Overall Study|Pregnancy|1|||
127611868|NCT02932904|459209015|FG002|Overall Study|Pregnancy|1|||
127611869|NCT02932904|459209016|FG003|Overall Study|Pregnancy|0|||
127611870|NCT02932904|459209013|FG000|Overall Study|Study Termination|0|||
127611871|NCT02932904|459209014|FG001|Overall Study|Study Termination|1|||
127611872|NCT02932904|459209015|FG002|Overall Study|Study Termination|0|||
127611873|NCT02932904|459209016|FG003|Overall Study|Study Termination|0|||
127611874|NCT02932904|459209013|FG000|Overall Study|Voluntary Withdrawal|2|||
127611875|NCT02932904|459209014|FG001|Overall Study|Voluntary Withdrawal|1|||
127611876|NCT02932904|459209015|FG002|Overall Study|Voluntary Withdrawal|4|||
127611877|NCT02932904|459209016|FG003|Overall Study|Voluntary Withdrawal|2|||
127611878|NCT02932904|459209013|FG000|Overall Study|Lost to Follow-up|5|||
127611879|NCT02932904|459209014|FG001|Overall Study|Lost to Follow-up|3|||
127611880|NCT02932904|459209015|FG002|Overall Study|Lost to Follow-up|6|||
127611881|NCT02932904|459209016|FG003|Overall Study|Lost to Follow-up|0|||
127611882|NCT02932904|459209013|FG000|Overall Study|Significant Protocol Deviation|2|||
127611883|NCT02932904|459209014|FG001|Overall Study|Significant Protocol Deviation|3|||
127611884|NCT02932904|459209015|FG002|Overall Study|Significant Protocol Deviation|6|||
127611885|NCT02932904|459209016|FG003|Overall Study|Significant Protocol Deviation|1|||
127611886|NCT02932904|459209013|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
127611887|NCT02932904|459209014|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
127611888|NCT02932904|459209015|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
127611889|NCT02932904|459209016|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
127611890|NCT02932904|459209013|FG000|Overall Study|Randomized But Not Treated|1|||
127611891|NCT02932904|459209014|FG001|Overall Study|Randomized But Not Treated|1|||
127611892|NCT02932904|459209015|FG002|Overall Study|Randomized But Not Treated|0|||
127611893|NCT02932904|459209016|FG003|Overall Study|Randomized But Not Treated|2|||
127611894|NCT00337103|459209017|FG000|Overall Study|Progressive Disease|414|||
127611895|NCT00337103|459209018|FG001|Overall Study|Progressive Disease|410|||
127611896|NCT00337103|459209017|FG000|Overall Study|Adverse Event|45|||
127789325|NCT02873936|459853594|FG000|Overall Study|Investigator's Discretion|3|||
127789326|NCT02873936|459853595|FG001|Overall Study|Investigator's Discretion|5|||
127789327|NCT02873936|459853596|FG002|Overall Study|Investigator's Discretion|4|||
127789328|NCT02873936|459853594|FG000|Overall Study|Adverse Event|3|||
127789329|NCT02873936|459853595|FG001|Overall Study|Adverse Event|5|||
127789330|NCT02873936|459853596|FG002|Overall Study|Adverse Event|3|||
127789331|NCT02873936|459853594|FG000|Overall Study|Protocol Violation|0|||
127789332|NCT02873936|459853595|FG001|Overall Study|Protocol Violation|1|||
127789333|NCT02873936|459853596|FG002|Overall Study|Protocol Violation|3|||
127789334|NCT02873936|459853594|FG000|Overall Study|Lost to Follow-up|1|||
127789335|NCT02873936|459853595|FG001|Overall Study|Lost to Follow-up|1|||
127789336|NCT02873936|459853596|FG002|Overall Study|Lost to Follow-up|1|||
127789337|NCT02873936|459853594|FG000|Overall Study|Non-compliance With Study Drug|1|||
127789338|NCT02873936|459853595|FG001|Overall Study|Non-compliance With Study Drug|0|||
127789339|NCT02873936|459853596|FG002|Overall Study|Non-compliance With Study Drug|1|||
127789340|NCT02873936|459853594|FG000|Overall Study|Randomized but not Dosed|1|||
127789341|NCT02873936|459853595|FG001|Overall Study|Randomized but not Dosed|0|||
127789342|NCT02873936|459853596|FG002|Overall Study|Randomized but not Dosed|0|||
127789343|NCT00917150|459853597|FG000|Overall Study|Adverse Event|12|||
127789344|NCT00917150|459853598|FG001|Overall Study|Adverse Event|7|||
127789345|NCT00917150|459853599|FG002|Overall Study|Adverse Event|12|||
127883197|NCT01785875|460196349|FG002|Overall Study|Protocol Specified Criteria|55|||
127883198|NCT01785875|460196347|FG000|Overall Study|Missing|0|||
127611897|NCT00337103|459209018|FG001|Overall Study|Adverse Event|59|||
127611898|NCT00337103|459209017|FG000|Overall Study|Subject Choice|34|||
127789346|NCT00917150|459853600|FG003|Overall Study|Adverse Event|11|||
127611899|NCT00337103|459209018|FG001|Overall Study|Subject Choice|27|||
127789347|NCT00917150|459853597|FG000|Overall Study|Death|1|||
127611900|NCT00337103|459209017|FG000|Overall Study|Clinical Progression|27|||
127611901|NCT00337103|459209018|FG001|Overall Study|Clinical Progression|24|||
127611902|NCT00337103|459209017|FG000|Overall Study|Physician Decision|15|||
127611903|NCT00337103|459209018|FG001|Overall Study|Physician Decision|14|||
127611904|NCT00337103|459209017|FG000|Overall Study|Withdrawal by Subject|8|||
127611905|NCT00337103|459209018|FG001|Overall Study|Withdrawal by Subject|5|||
127611906|NCT00337103|459209017|FG000|Overall Study|Other|5|||
127611907|NCT00337103|459209018|FG001|Overall Study|Other|6|||
127611908|NCT00337103|459209017|FG000|Overall Study|Entry Criteria Not Met|4|||
127611909|NCT00337103|459209018|FG001|Overall Study|Entry Criteria Not Met|1|||
127611910|NCT00337103|459209017|FG000|Overall Study|Lost to Follow-up|1|||
127611911|NCT00337103|459209018|FG001|Overall Study|Lost to Follow-up|2|||
127611912|NCT00337103|459209017|FG000|Overall Study|Death|1|||
127611913|NCT00337103|459209018|FG001|Overall Study|Death|0|||
127611914|NCT01577758|459209019|FG000|Dose Escalation Phase|Adverse Event|0|||
127611915|NCT01577758|459209020|FG001|Dose Escalation Phase|Adverse Event|0|||
127611916|NCT01577758|459209021|FG002|Dose Escalation Phase|Adverse Event|0|||
127611917|NCT01577758|459209022|FG003|Dose Escalation Phase|Adverse Event|0|||
127611918|NCT01577758|459209023|FG004|Dose Escalation Phase|Adverse Event|0|||
127611919|NCT01577758|459209024|FG005|Dose Escalation Phase|Adverse Event|2|||
127611920|NCT01577758|459209025|FG006|Dose Escalation Phase|Adverse Event|1|||
127611921|NCT01577758|459209026|FG007|Dose Escalation Phase|Adverse Event|0|||
127611922|NCT01577758|459209019|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
127611923|NCT01577758|459209020|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
127611924|NCT01577758|459209021|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
127611925|NCT01577758|459209022|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
127611926|NCT01577758|459209023|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
127611927|NCT01577758|459209024|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
127611928|NCT01577758|459209025|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
127611929|NCT01577758|459209026|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
127611930|NCT01577758|459209019|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
127611931|NCT01577758|459209020|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
127789348|NCT00917150|459853598|FG001|Overall Study|Death|4|||
127789349|NCT00917150|459853599|FG002|Overall Study|Death|3|||
127611932|NCT01577758|459209021|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
127611933|NCT01577758|459209022|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
127611934|NCT01577758|459209023|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
127789350|NCT00917150|459853600|FG003|Overall Study|Death|2|||
127789351|NCT00917150|459853597|FG000|Overall Study|Lost to Follow-up|1|||
127698701|NCT03338933|459526481|FG000|Screening Visit|Screen fail after consent|2|||
127698702|NCT03338933|459526482|FG001|Screening Visit|Screen fail after consent|7|||
127698703|NCT03338933|459526483|FG002|Screening Visit|Screen fail after consent|1|||
127698704|NCT03338933|459526484|FG003|Screening Visit|Screen fail after consent|4|||
127698705|NCT03338933|459526481|FG000|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
127698706|NCT03338933|459526482|FG001|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
127698707|NCT03338933|459526483|FG002|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|2|||
127698708|NCT03338933|459526484|FG003|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|9|||
127698709|NCT03338933|459526481|FG000|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
127698710|NCT03338933|459526482|FG001|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
127698711|NCT03338933|459526483|FG002|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
127698712|NCT03338933|459526484|FG003|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
127698713|NCT03338933|459526481|FG000|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
127698714|NCT03338933|459526482|FG001|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
127611935|NCT01577758|459209024|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
127611936|NCT01577758|459209025|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
127611937|NCT01577758|459209026|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
127611938|NCT01577758|459209019|FG000|Dose Escalation Phase|Progression Disease|2|||
127611939|NCT01577758|459209020|FG001|Dose Escalation Phase|Progression Disease|2|||
127611940|NCT01577758|459209021|FG002|Dose Escalation Phase|Progression Disease|1|||
127611941|NCT01577758|459209022|FG003|Dose Escalation Phase|Progression Disease|2|||
127611942|NCT01577758|459209023|FG004|Dose Escalation Phase|Progression Disease|5|||
127611943|NCT01577758|459209024|FG005|Dose Escalation Phase|Progression Disease|0|||
127611944|NCT01577758|459209025|FG006|Dose Escalation Phase|Progression Disease|0|||
127611945|NCT01577758|459209026|FG007|Dose Escalation Phase|Progression Disease|0|||
127611946|NCT01577758|459209019|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
127611947|NCT01577758|459209020|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
127611948|NCT01577758|459209021|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
127611949|NCT01577758|459209022|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
127611950|NCT01577758|459209023|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
127611951|NCT01577758|459209024|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
127611952|NCT01577758|459209025|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
127611953|NCT01577758|459209026|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
127611954|NCT01577758|459209019|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
127611955|NCT01577758|459209020|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
127611956|NCT01577758|459209021|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
127611957|NCT01577758|459209022|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
127611958|NCT01577758|459209023|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
127611959|NCT01577758|459209024|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
127611960|NCT01577758|459209025|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
127611961|NCT01577758|459209026|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
127611962|NCT01577758|459209019|FG000|mCRC Expansion Phase|Progression Disease|0|||
127611963|NCT01577758|459209020|FG001|mCRC Expansion Phase|Progression Disease|0|||
127611964|NCT01577758|459209021|FG002|mCRC Expansion Phase|Progression Disease|0|||
127611965|NCT01577758|459209022|FG003|mCRC Expansion Phase|Progression Disease|0|||
127611966|NCT01577758|459209023|FG004|mCRC Expansion Phase|Progression Disease|0|||
127611967|NCT01577758|459209024|FG005|mCRC Expansion Phase|Progression Disease|0|||
127611968|NCT01577758|459209025|FG006|mCRC Expansion Phase|Progression Disease|0|||
127611969|NCT01577758|459209026|FG007|mCRC Expansion Phase|Progression Disease|19|||
127611970|NCT03387813|459209029|FG000|Overall Study|Death|40|||
127698715|NCT03338933|459526483|FG002|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|1|||
127698716|NCT03338933|459526484|FG003|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|2|||
127698717|NCT01084876|459526485|FG000|Main Study Treatment Period|Adverse Event|12|||
127698718|NCT01084876|459526486|FG001|Main Study Treatment Period|Adverse Event|7|||
127698719|NCT01084876|459526485|FG000|Main Study Treatment Period|Disease Progression|41|||
127698720|NCT01084876|459526486|FG001|Main Study Treatment Period|Disease Progression|24|||
127698721|NCT01084876|459526485|FG000|Main Study Treatment Period|Physician Decision|2|||
127698722|NCT01084876|459526486|FG001|Main Study Treatment Period|Physician Decision|0|||
127698723|NCT01084876|459526485|FG000|Main Study Treatment Period|Withdrawal by Subject|4|||
127698724|NCT01084876|459526486|FG001|Main Study Treatment Period|Withdrawal by Subject|6|||
127698725|NCT01084876|459526485|FG000|Main Study Treatment Period|Other Reason|0|||
127698726|NCT01084876|459526486|FG001|Main Study Treatment Period|Other Reason|1|||
127698727|NCT01084876|459526485|FG000|Main Study Treatment Period|Other|0|||
127698728|NCT01084876|459526486|FG001|Main Study Treatment Period|Other|1|||
127698729|NCT01084876|459526485|FG000|Treatment Period Beyond Cycle 8|Adverse Event|8|||
127698730|NCT01084876|459526486|FG001|Treatment Period Beyond Cycle 8|Adverse Event|2|||
127698731|NCT01084876|459526485|FG000|Treatment Period Beyond Cycle 8|Disease Progression|129|||
127698732|NCT01084876|459526486|FG001|Treatment Period Beyond Cycle 8|Disease Progression|119|||
127698733|NCT01084876|459526485|FG000|Treatment Period Beyond Cycle 8|Physician Decision|6|||
127789352|NCT00917150|459853598|FG001|Overall Study|Lost to Follow-up|0|||
127789353|NCT00917150|459853599|FG002|Overall Study|Lost to Follow-up|4|||
127789354|NCT00917150|459853600|FG003|Overall Study|Lost to Follow-up|2|||
127789355|NCT00917150|459853597|FG000|Overall Study|Physician Decision|0|||
127789356|NCT00917150|459853598|FG001|Overall Study|Physician Decision|2|||
127789357|NCT00917150|459853599|FG002|Overall Study|Physician Decision|0|||
127789358|NCT00917150|459853600|FG003|Overall Study|Physician Decision|1|||
127789359|NCT00917150|459853597|FG000|Overall Study|Protocol Violation|5|||
127789360|NCT00917150|459853598|FG001|Overall Study|Protocol Violation|5|||
127789361|NCT00917150|459853599|FG002|Overall Study|Protocol Violation|3|||
127611971|NCT03387813|459209030|FG001|Overall Study|Death|37|||
127611972|NCT03387813|459209031|FG002|Overall Study|Death|190|||
127611973|NCT03387813|459209029|FG000|Overall Study|Withdrawal by Subject|9|||
127611974|NCT03387813|459209030|FG001|Overall Study|Withdrawal by Subject|19|||
127611975|NCT03387813|459209031|FG002|Overall Study|Withdrawal by Subject|32|||
127611976|NCT03387813|459209029|FG000|Overall Study|Lost to Follow-up|3|||
127611977|NCT03387813|459209030|FG001|Overall Study|Lost to Follow-up|9|||
127611978|NCT03387813|459209031|FG002|Overall Study|Lost to Follow-up|15|||
127611979|NCT03387813|459209029|FG000|Overall Study|Non-Compliance|6|||
127611980|NCT03387813|459209030|FG001|Overall Study|Non-Compliance|6|||
127611981|NCT03387813|459209031|FG002|Overall Study|Non-Compliance|31|||
127611982|NCT03387813|459209029|FG000|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|7|||
127611983|NCT03387813|459209030|FG001|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|10|||
127611984|NCT03387813|459209031|FG002|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|14|||
127611985|NCT01289847|459209032|FG000|Overall Study|Patient could not comply with visits|1|||
127611986|NCT03975647|459209035|FG000|Overall Study|Death|71|||
127611987|NCT03975647|459209036|FG001|Overall Study|Death|63|||
127611988|NCT03975647|459209035|FG000|Overall Study|Lost to Follow-up|2|||
127611989|NCT03975647|459209036|FG001|Overall Study|Lost to Follow-up|2|||
127611990|NCT03975647|459209035|FG000|Overall Study|Subject withdrawal of consent|7|||
127611991|NCT03975647|459209036|FG001|Overall Study|Subject withdrawal of consent|11|||
127611992|NCT02872116|459209037|FG000|Pre-Treatment|Disease Progression|0|||
127611993|NCT02872116|459209038|FG001|Pre-Treatment|Disease Progression|1|||
127611994|NCT02872116|459209039|FG002|Pre-Treatment|Disease Progression|0|||
127611995|NCT02872116|459209037|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
127611996|NCT02872116|459209038|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
127611997|NCT02872116|459209039|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
127611998|NCT02872116|459209037|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
127611999|NCT02872116|459209038|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
127612000|NCT02872116|459209039|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
127612001|NCT02872116|459209037|FG000|Pre-Treatment|Participant withdrew consent|2|||
127612002|NCT02872116|459209038|FG001|Pre-Treatment|Participant withdrew consent|20|||
127612003|NCT02872116|459209039|FG002|Pre-Treatment|Participant withdrew consent|3|||
127612004|NCT02872116|459209037|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
127612005|NCT02872116|459209038|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
127612006|NCT02872116|459209039|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
127612007|NCT02872116|459209037|FG000|Pre-Treatment|Other reasons|1|||
127612008|NCT02872116|459209038|FG001|Pre-Treatment|Other reasons|2|||
127612009|NCT02872116|459209039|FG002|Pre-Treatment|Other reasons|2|||
127612010|NCT02872116|459209037|FG000|Treatment|Death|121|||
127612011|NCT02872116|459209038|FG001|Treatment|Death|94|||
127612012|NCT02872116|459209039|FG002|Treatment|Death|68|||
127612013|NCT02872116|459209037|FG000|Treatment|Lost to Follow-up|5|||
127612014|NCT02872116|459209038|FG001|Treatment|Lost to Follow-up|7|||
127612015|NCT02872116|459209039|FG002|Treatment|Lost to Follow-up|3|||
127612016|NCT02872116|459209037|FG000|Treatment|Participant withdrew consent|20|||
127612017|NCT02872116|459209038|FG001|Treatment|Participant withdrew consent|40|||
127612018|NCT02872116|459209039|FG002|Treatment|Participant withdrew consent|8|||
127612019|NCT02872116|459209037|FG000|Treatment|Other reasons|13|||
127612020|NCT02872116|459209038|FG001|Treatment|Other reasons|12|||
127612021|NCT02872116|459209039|FG002|Treatment|Other reasons|5|||
127612022|NCT02404350|459209044|FG000|Overall Study|Adverse Event|2|||
127612023|NCT02404350|459209045|FG001|Overall Study|Adverse Event|2|||
127612024|NCT02404350|459209046|FG002|Overall Study|Adverse Event|3|||
127612025|NCT02404350|459209047|FG003|Overall Study|Adverse Event|9|||
127612026|NCT02404350|459209044|FG000|Overall Study|Lack of Efficacy|3|||
127612027|NCT02404350|459209045|FG001|Overall Study|Lack of Efficacy|1|||
127612028|NCT02404350|459209046|FG002|Overall Study|Lack of Efficacy|0|||
127789362|NCT00917150|459853600|FG003|Overall Study|Protocol Violation|5|||
127789363|NCT00917150|459853597|FG000|Overall Study|Withdrawal by Subject|15|||
127789364|NCT00917150|459853598|FG001|Overall Study|Withdrawal by Subject|16|||
127789365|NCT00917150|459853599|FG002|Overall Study|Withdrawal by Subject|18|||
127789366|NCT00917150|459853600|FG003|Overall Study|Withdrawal by Subject|11|||
127612029|NCT02404350|459209047|FG003|Overall Study|Lack of Efficacy|3|||
127612030|NCT02404350|459209044|FG000|Overall Study|Lost to Follow-up|2|||
127612031|NCT02404350|459209045|FG001|Overall Study|Lost to Follow-up|0|||
127612032|NCT02404350|459209046|FG002|Overall Study|Lost to Follow-up|0|||
127612033|NCT02404350|459209047|FG003|Overall Study|Lost to Follow-up|1|||
127612034|NCT02404350|459209044|FG000|Overall Study|Physician Decision|1|||
127612035|NCT02404350|459209045|FG001|Overall Study|Physician Decision|0|||
127612036|NCT02404350|459209046|FG002|Overall Study|Physician Decision|0|||
127612037|NCT02404350|459209047|FG003|Overall Study|Physician Decision|2|||
127612038|NCT02404350|459209044|FG000|Overall Study|Pregnancy|0|||
127612039|NCT02404350|459209045|FG001|Overall Study|Pregnancy|0|||
127612040|NCT02404350|459209046|FG002|Overall Study|Pregnancy|0|||
127612041|NCT02404350|459209047|FG003|Overall Study|Pregnancy|1|||
127612042|NCT02404350|459209044|FG000|Overall Study|Withdrawal by Subject|7|||
127612043|NCT02404350|459209045|FG001|Overall Study|Withdrawal by Subject|3|||
127612044|NCT02404350|459209046|FG002|Overall Study|Withdrawal by Subject|3|||
127612045|NCT02404350|459209047|FG003|Overall Study|Withdrawal by Subject|19|||
127612046|NCT02404350|459209044|FG000|Overall Study|Due to Non-compliance with treatment|0|||
127612047|NCT02404350|459209045|FG001|Overall Study|Due to Non-compliance with treatment|0|||
127612048|NCT02404350|459209046|FG002|Overall Study|Due to Non-compliance with treatment|0|||
127612049|NCT02404350|459209047|FG003|Overall Study|Due to Non-compliance with treatment|1|||
127612050|NCT02404350|459209044|FG000|Overall Study|Due to Technical problems|0|||
127612051|NCT02404350|459209045|FG001|Overall Study|Due to Technical problems|0|||
127612052|NCT02404350|459209046|FG002|Overall Study|Due to Technical problems|0|||
127612053|NCT02404350|459209047|FG003|Overall Study|Due to Technical problems|1|||
127612054|NCT01324388|459209048|FG000|Part 1 of Study|Adverse Event|2|||
127612055|NCT01324388|459209049|FG001|Part 1 of Study|Adverse Event|0|||
127612056|NCT01324388|459209050|FG002|Part 1 of Study|Adverse Event|0|||
127612057|NCT01324388|459209051|FG003|Part 1 of Study|Adverse Event|0|||
127612058|NCT01324388|459209048|FG000|Part 1 of Study|Protocol Violation|1|||
127612059|NCT01324388|459209049|FG001|Part 1 of Study|Protocol Violation|2|||
127612060|NCT01324388|459209050|FG002|Part 1 of Study|Protocol Violation|0|||
127612061|NCT01324388|459209051|FG003|Part 1 of Study|Protocol Violation|0|||
127612062|NCT01324388|459209048|FG000|Part 1 of Study|Physician Decision|1|||
127612063|NCT01324388|459209049|FG001|Part 1 of Study|Physician Decision|0|||
127612064|NCT01324388|459209050|FG002|Part 1 of Study|Physician Decision|0|||
127612065|NCT01324388|459209051|FG003|Part 1 of Study|Physician Decision|0|||
127612066|NCT01324388|459209048|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
127612067|NCT01324388|459209049|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
127612068|NCT01324388|459209050|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
127612069|NCT01324388|459209051|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
127612070|NCT01324388|459209048|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
127612071|NCT01324388|459209049|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
127612072|NCT01324388|459209050|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
127612073|NCT01324388|459209051|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
127612074|NCT01085097|459209052|FG000|Overall Study|Adverse Event|0|||
127612075|NCT01085097|459209053|FG001|Overall Study|Adverse Event|0|||
127612076|NCT01085097|459209054|FG002|Overall Study|Adverse Event|2|||
127612077|NCT01085097|459209052|FG000|Overall Study|Treatment failure|2|||
127612078|NCT01085097|459209053|FG001|Overall Study|Treatment failure|0|||
127612079|NCT01085097|459209054|FG002|Overall Study|Treatment failure|0|||
127612080|NCT01498640|459209055|FG000|Overall Study|Lost to Follow-up|1|||
127612081|NCT01498640|459209055|FG000|Overall Study|Death|1|||
127612082|NCT01498640|459209055|FG000|Overall Study|Other|3|||
127612083|NCT01524692|459209060|FG000|Overall Study|Withdrawal by Subject|3|||
127612084|NCT04007523|459209062|FG000|Overall Study|Withdrawal by Subject|0|||
127612085|NCT04007523|459209063|FG001|Overall Study|Withdrawal by Subject|1|||
127612086|NCT04007523|459209064|FG002|Overall Study|Withdrawal by Subject|1|||
127612087|NCT04007523|459209065|FG003|Overall Study|Withdrawal by Subject|0|||
127612088|NCT04007523|459209062|FG000|Overall Study|ICU Transfer|0|||
127612089|NCT04007523|459209063|FG001|Overall Study|ICU Transfer|1|||
127612090|NCT04007523|459209064|FG002|Overall Study|ICU Transfer|0|||
127612091|NCT04007523|459209065|FG003|Overall Study|ICU Transfer|0|||
127612092|NCT04007523|459209062|FG000|Overall Study|COVID hospital closure|0|||
127612093|NCT04007523|459209063|FG001|Overall Study|COVID hospital closure|0|||
127612094|NCT04007523|459209064|FG002|Overall Study|COVID hospital closure|1|||
127612095|NCT04007523|459209065|FG003|Overall Study|COVID hospital closure|2|||
127612096|NCT04007523|459209062|FG000|Overall Study|Surgery cancelled|0|||
127612097|NCT04007523|459209063|FG001|Overall Study|Surgery cancelled|0|||
127612098|NCT04007523|459209064|FG002|Overall Study|Surgery cancelled|1|||
127612099|NCT04007523|459209065|FG003|Overall Study|Surgery cancelled|1|||
127612100|NCT02197806|459209070|FG000|Overall Study|Adverse Event|0|||
127612101|NCT02197806|459209071|FG001|Overall Study|Adverse Event|1|||
127612102|NCT02197806|459209072|FG002|Overall Study|Adverse Event|0|||
127612103|NCT02197806|459209073|FG003|Overall Study|Adverse Event|1|||
127612104|NCT03065244|459209081|FG000|Overall Study|Lost to Follow-up|1|||
127612105|NCT03065244|459209082|FG001|Overall Study|Lost to Follow-up|1|||
127612106|NCT03065244|459209081|FG000|Overall Study|Diagnosed with a different disease|1|||
127612107|NCT03065244|459209082|FG001|Overall Study|Diagnosed with a different disease|1|||
127612108|NCT03065244|459209081|FG000|Overall Study|Protocol Violation|0|||
127612109|NCT03065244|459209082|FG001|Overall Study|Protocol Violation|1|||
127612110|NCT03065244|459209081|FG000|Overall Study|Withdrawal by Subject|1|||
127612111|NCT03065244|459209082|FG001|Overall Study|Withdrawal by Subject|1|||
127612112|NCT03717480|459209083|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
127612113|NCT01894152|459209084|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
127612114|NCT02268812|459209085|FG000|Overall Study|Adverse Event|8|||
127612115|NCT02268812|459209086|FG001|Overall Study|Adverse Event|26|||
127612116|NCT02268812|459209087|FG002|Overall Study|Adverse Event|7|||
127612117|NCT02268812|459209088|FG003|Overall Study|Adverse Event|10|||
127612118|NCT02268812|459209085|FG000|Overall Study|Protocol deviation|0|||
127612119|NCT02268812|459209086|FG001|Overall Study|Protocol deviation|0|||
127612120|NCT02268812|459209087|FG002|Overall Study|Protocol deviation|1|||
127612121|NCT02268812|459209088|FG003|Overall Study|Protocol deviation|0|||
127612122|NCT02268812|459209085|FG000|Overall Study|Withdrawal by Subject|0|||
127612123|NCT02268812|459209086|FG001|Overall Study|Withdrawal by Subject|1|||
127612124|NCT02268812|459209087|FG002|Overall Study|Withdrawal by Subject|0|||
127612125|NCT02268812|459209088|FG003|Overall Study|Withdrawal by Subject|0|||
127612126|NCT02268812|459209085|FG000|Overall Study|Physician Decision|3|||
127612127|NCT02268812|459209086|FG001|Overall Study|Physician Decision|1|||
127612128|NCT02268812|459209087|FG002|Overall Study|Physician Decision|0|||
127612129|NCT02268812|459209088|FG003|Overall Study|Physician Decision|1|||
127612130|NCT02268812|459209085|FG000|Overall Study|Other|5|||
127612131|NCT02268812|459209086|FG001|Overall Study|Other|4|||
127612132|NCT02268812|459209087|FG002|Overall Study|Other|1|||
127612133|NCT02268812|459209088|FG003|Overall Study|Other|3|||
127612134|NCT00768144|459209089|FG000|Overall Study|Adverse Event|13|||
127612135|NCT00768144|459209089|FG000|Overall Study|Progressive Disease|21|||
127612136|NCT00768144|459209089|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
127612137|NCT00768144|459209089|FG000|Overall Study|Pt Withdrew Consent|1|||
127612138|NCT00744627|459209090|FG000|Overall Study|Adverse Event|6|||
127612139|NCT00744627|459209091|FG001|Overall Study|Adverse Event|9|||
127612140|NCT00744627|459209090|FG000|Overall Study|Lack of Efficacy|7|||
127612141|NCT00744627|459209091|FG001|Overall Study|Lack of Efficacy|3|||
127612142|NCT00744627|459209090|FG000|Overall Study|Noncompliance|0|||
127612143|NCT00744627|459209091|FG001|Overall Study|Noncompliance|1|||
127612144|NCT00744627|459209090|FG000|Overall Study|Protocol Deviations|0|||
127612145|NCT00744627|459209091|FG001|Overall Study|Protocol Deviations|2|||
127612146|NCT00744627|459209090|FG000|Overall Study|Voluntary Withdrawal|9|||
127612147|NCT00744627|459209091|FG001|Overall Study|Voluntary Withdrawal|6|||
127612148|NCT00744627|459209090|FG000|Overall Study|Lost to Follow-up|2|||
127612149|NCT00744627|459209091|FG001|Overall Study|Lost to Follow-up|1|||
127612150|NCT00744627|459209090|FG000|Overall Study|Other|1|||
127612151|NCT00744627|459209091|FG001|Overall Study|Other|0|||
127612152|NCT02268786|459209092|FG000|Overall Study|No Euploid Embryos available|42|||
127612153|NCT02268786|459209093|FG001|Overall Study|No Euploid Embryos available|0|||
127612154|NCT02268786|459209092|FG000|Overall Study|Withdrawal by Subject|7|||
127612155|NCT02268786|459209093|FG001|Overall Study|Withdrawal by Subject|14|||
127612156|NCT02268786|459209092|FG000|Overall Study|Thaw Failure|6|||
127612157|NCT02268786|459209093|FG001|Overall Study|Thaw Failure|4|||
127612158|NCT02268786|459209092|FG000|Overall Study|Protocol Violation|1|||
127612159|NCT02268786|459209093|FG001|Overall Study|Protocol Violation|0|||
127612160|NCT04251221|459209094|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
127612161|NCT04251221|459209095|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
127612162|NCT02171260|459209096|FG000|Overall Study|Death|0|||
127612163|NCT02171260|459209097|FG001|Overall Study|Death|0|||
127612164|NCT02171260|459209098|FG002|Overall Study|Death|0|||
127612165|NCT02171260|459209099|FG003|Overall Study|Death|1|||
127612166|NCT02171260|459209096|FG000|Overall Study|Physician Decision|1|||
127612167|NCT02171260|459209097|FG001|Overall Study|Physician Decision|0|||
127612168|NCT02171260|459209098|FG002|Overall Study|Physician Decision|1|||
127612169|NCT02171260|459209099|FG003|Overall Study|Physician Decision|0|||
127612170|NCT02171260|459209096|FG000|Overall Study|Withdrawal by Subject|1|||
127789367|NCT00917150|459853597|FG000|Overall Study|Other than specified|3|||
127789368|NCT00917150|459853598|FG001|Overall Study|Other than specified|3|||
127789369|NCT00917150|459853599|FG002|Overall Study|Other than specified|2|||
127789370|NCT00917150|459853600|FG003|Overall Study|Other than specified|2|||
127789371|NCT01624662|459853601|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
127789372|NCT01624662|459853602|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
127789373|NCT01624662|459853603|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
127789374|NCT01624662|459853604|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
127789375|NCT01624662|459853601|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
127789376|NCT01624662|459853602|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
127789377|NCT01624662|459853603|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
127789378|NCT01624662|459853604|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
127789379|NCT01624662|459853601|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
127789380|NCT01624662|459853602|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
127789381|NCT01624662|459853603|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
127789382|NCT01624662|459853604|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
127789383|NCT01624662|459853601|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
127789384|NCT01624662|459853602|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
127789385|NCT01624662|459853603|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
127789386|NCT01624662|459853604|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
127789387|NCT01624662|459853601|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
127789388|NCT01624662|459853602|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
127789389|NCT01624662|459853603|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
127789390|NCT01624662|459853604|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
127789391|NCT01624662|459853601|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
127789392|NCT01624662|459853602|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
127789393|NCT01624662|459853603|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
127789394|NCT01624662|459853604|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
127789395|NCT01624662|459853601|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
127789396|NCT01624662|459853602|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
127789397|NCT01624662|459853603|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
127789398|NCT01624662|459853604|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
127789399|NCT03099187|459853610|FG000|Double-blind Treatment|Adverse Event|19|||
127789400|NCT03099187|459853611|FG001|Double-blind Treatment|Adverse Event|1|||
127789401|NCT03099187|459853612|FG002|Double-blind Treatment|Adverse Event|0|||
127789402|NCT03099187|459853613|FG003|Double-blind Treatment|Adverse Event|0|||
127789403|NCT03099187|459853610|FG000|Double-blind Treatment|Death|1|||
127789404|NCT03099187|459853611|FG001|Double-blind Treatment|Death|3|||
127789405|NCT03099187|459853612|FG002|Double-blind Treatment|Death|0|||
127789406|NCT03099187|459853613|FG003|Double-blind Treatment|Death|0|||
127612171|NCT02171260|459209097|FG001|Overall Study|Withdrawal by Subject|0|||
127612172|NCT02171260|459209098|FG002|Overall Study|Withdrawal by Subject|0|||
127612173|NCT02171260|459209099|FG003|Overall Study|Withdrawal by Subject|0|||
127612174|NCT02171260|459209096|FG000|Overall Study|Evidence of progressive disease|4|||
127612175|NCT02171260|459209097|FG001|Overall Study|Evidence of progressive disease|6|||
127612176|NCT02171260|459209098|FG002|Overall Study|Evidence of progressive disease|4|||
127612177|NCT02171260|459209099|FG003|Overall Study|Evidence of progressive disease|4|||
127612178|NCT00323492|459209100|FG000|Study Phase 1|Adverse Event|2|||
127612179|NCT00323492|459209101|FG001|Study Phase 1|Adverse Event|0|||
127612180|NCT00323492|459209102|FG002|Study Phase 1|Adverse Event|0|||
127612181|NCT00323492|459209100|FG000|Study Phase 2|Adverse Event|1|||
127612182|NCT00323492|459209101|FG001|Study Phase 2|Adverse Event|0|||
127612183|NCT00323492|459209102|FG002|Study Phase 2|Adverse Event|0|||
127612184|NCT00323492|459209100|FG000|Study Phase 2|Physician Decision|1|||
127612185|NCT00323492|459209101|FG001|Study Phase 2|Physician Decision|0|||
127612186|NCT00323492|459209102|FG002|Study Phase 2|Physician Decision|0|||
127789407|NCT03099187|459853610|FG000|Double-blind Treatment|Lack of Efficacy|1|||
127789408|NCT03099187|459853611|FG001|Double-blind Treatment|Lack of Efficacy|0|||
127789409|NCT03099187|459853612|FG002|Double-blind Treatment|Lack of Efficacy|0|||
127789410|NCT03099187|459853613|FG003|Double-blind Treatment|Lack of Efficacy|0|||
127612187|NCT00323492|459209100|FG000|Study Phase 2|Lost to Follow-up|1|||
127612188|NCT00323492|459209101|FG001|Study Phase 2|Lost to Follow-up|0|||
127612189|NCT00323492|459209102|FG002|Study Phase 2|Lost to Follow-up|0|||
127612190|NCT00323492|459209100|FG000|Study Phase 2|Withdrawal by Subject|0|||
127612191|NCT00323492|459209101|FG001|Study Phase 2|Withdrawal by Subject|1|||
127612192|NCT00323492|459209102|FG002|Study Phase 2|Withdrawal by Subject|0|||
127612193|NCT00323492|459209100|FG000|Study Phase 2|Noncompliance with study schedule|0|||
127612194|NCT00323492|459209101|FG001|Study Phase 2|Noncompliance with study schedule|0|||
127612195|NCT00323492|459209102|FG002|Study Phase 2|Noncompliance with study schedule|1|||
127612196|NCT00323492|459209100|FG000|Study Phase 2|Protocol Violation|1|||
127612197|NCT00323492|459209101|FG001|Study Phase 2|Protocol Violation|0|||
127612198|NCT00323492|459209102|FG002|Study Phase 2|Protocol Violation|0|||
127612199|NCT02486042|459209103|FG000|Overall Study|Physician Decision|1|||
127612200|NCT02486042|459209104|FG001|Overall Study|Physician Decision|7|||
127612201|NCT02486042|459209103|FG000|Overall Study|Hospital transfer|2|||
127612202|NCT02486042|459209104|FG001|Overall Study|Hospital transfer|2|||
127612203|NCT02486042|459209103|FG000|Overall Study|Withdrawal by Subject|0|||
127612204|NCT02486042|459209104|FG001|Overall Study|Withdrawal by Subject|2|||
127612205|NCT01319877|459209107|FG000|Overall Study|Lost to Follow-up|100|||
127612206|NCT01319877|459209108|FG001|Overall Study|Lost to Follow-up|37|||
127612207|NCT01319877|459209107|FG000|Overall Study|Physician Decision|2|||
127612208|NCT01319877|459209108|FG001|Overall Study|Physician Decision|0|||
127612209|NCT01319877|459209107|FG000|Overall Study|Disease Progression|2|||
127612210|NCT01319877|459209108|FG001|Overall Study|Disease Progression|2|||
127612211|NCT01319877|459209107|FG000|Overall Study|Withdrawal by Subject|0|||
127612212|NCT01319877|459209108|FG001|Overall Study|Withdrawal by Subject|1|||
127612213|NCT01319877|459209107|FG000|Overall Study|Reason Not Specified|4|||
127612214|NCT01319877|459209108|FG001|Overall Study|Reason Not Specified|5|||
127612215|NCT03745144|459209109|FG000|Run-in-Period (Day 0 to Day 28)|Other|4|||
127612216|NCT03745144|459209110|FG001|Run-in-Period (Day 0 to Day 28)|Other|0|||
127612217|NCT03745144|459209111|FG002|Run-in-Period (Day 0 to Day 28)|Other|0|||
127612218|NCT03745144|459209109|FG000|Period 1|Other|0|||
127612219|NCT03745144|459209110|FG001|Period 1|Other|0|||
127612220|NCT03745144|459209111|FG002|Period 1|Other|1|||
127612221|NCT00896337|459209112|FG000|Overall Study|Death|7|||
127612222|NCT00896337|459209112|FG000|Overall Study|Withdrawal by Subject|7|||
127612223|NCT00896337|459209112|FG000|Overall Study|Lost to Follow-up|11|||
127612224|NCT02910167|459209116|FG000|Overall Study|Adverse Event|1|||
127612225|NCT02910167|459209116|FG000|Overall Study|Lost to Follow-up|18|||
127612226|NCT02028988|459209117|FG000|Overall Study|Withdrawal by Subject|2|||
127612227|NCT01342510|459209118|FG000|Overall Study|Protocol Violation|12|||
127612228|NCT01342510|459209119|FG001|Overall Study|Protocol Violation|6|||
127612229|NCT01342510|459209120|FG002|Overall Study|Protocol Violation|13|||
127612230|NCT01342510|459209121|FG003|Overall Study|Protocol Violation|11|||
127612231|NCT01400516|459209123|FG000|Primary Trial|Withdrawal by Subject|0|||
127612232|NCT01400516|459209124|FG001|Primary Trial|Withdrawal by Subject|2|||
127612233|NCT01796197|459209132|FG000|Overall Study|Lost to Follow-up|1|||
127612234|NCT01796197|459209132|FG000|Overall Study|Lack of Efficacy|1|||
127612235|NCT04243538|459209133|FG000|Overall Study|Withdrawal by Subject|0|||
127612236|NCT04243538|459209134|FG001|Overall Study|Withdrawal by Subject|2|||
127612237|NCT04243538|459209133|FG000|Overall Study|Lost to Follow-up|0|||
127612238|NCT04243538|459209134|FG001|Overall Study|Lost to Follow-up|3|||
127612239|NCT00502697|459210434|FG000|Overall Study|Withdrawal by Subject|3|||
127612240|NCT00502697|459210435|FG001|Overall Study|Withdrawal by Subject|1|||
127612241|NCT00502697|459210434|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
127612242|NCT00502697|459210435|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
127612243|NCT00502697|459210434|FG000|Overall Study|found not to meet eligibility criteria|3|||
127612244|NCT00502697|459210435|FG001|Overall Study|found not to meet eligibility criteria|4|||
127612245|NCT00502697|459210434|FG000|Overall Study|did not meet assignment criteria|4|||
127612246|NCT00502697|459210435|FG001|Overall Study|did not meet assignment criteria|2|||
127612247|NCT01545817|459210437|FG000|Pazopanib|Disease progression|51|||
127612248|NCT01545817|459210438|FG001|Pazopanib|Disease progression|0|||
127612249|NCT01545817|459210437|FG000|Pazopanib|Adverse Event|19|||
127612250|NCT01545817|459210438|FG001|Pazopanib|Adverse Event|0|||
127612251|NCT01545817|459210437|FG000|Pazopanib|Other reason|4|||
127612252|NCT01545817|459210438|FG001|Pazopanib|Other reason|0|||
127612253|NCT01545817|459210437|FG000|Everolimus|Other reason|0|||
127698734|NCT01084876|459526486|FG001|Treatment Period Beyond Cycle 8|Physician Decision|5|||
127612254|NCT01545817|459210438|FG001|Everolimus|Other reason|7|||
127612255|NCT01545817|459210437|FG000|Everolimus|Disease progression|0|||
127612256|NCT01545817|459210438|FG001|Everolimus|Disease progression|25|||
127612257|NCT01545817|459210437|FG000|Everolimus|Adverse Event|0|||
127612258|NCT01545817|459210438|FG001|Everolimus|Adverse Event|6|||
127612259|NCT00589108|459210443|FG000|Overall Study|Lost to Follow-up|1|||
127612260|NCT00589108|459210444|FG001|Overall Study|Lost to Follow-up|1|||
127789411|NCT03099187|459853610|FG000|Double-blind Treatment|Physician Decision|2|||
127789412|NCT03099187|459853611|FG001|Double-blind Treatment|Physician Decision|1|||
127789413|NCT03099187|459853612|FG002|Double-blind Treatment|Physician Decision|0|||
127612261|NCT00589108|459210445|FG002|Overall Study|Lost to Follow-up|1|||
127612262|NCT00589108|459210443|FG000|Overall Study|Death|3|||
127612263|NCT00589108|459210444|FG001|Overall Study|Death|3|||
127612264|NCT00589108|459210445|FG002|Overall Study|Death|4|||
127612265|NCT04380857|459210450|FG000|Overall Study|Lost to Follow-up|3|||
127612266|NCT04380857|459210451|FG001|Overall Study|Lost to Follow-up|3|||
127612267|NCT02558790|459210452|FG000|Overall Study|Lost to Follow-up|2|||
127612268|NCT02558790|459210452|FG000|Overall Study|Physician Decision|1|||
127612269|NCT02558790|459210452|FG000|Overall Study|Withdrawal by Subject|1|||
127612270|NCT02558790|459210452|FG000|Overall Study|Screen Fail|3|||
127612271|NCT00838201|459210453|FG000|Overall Study|Investigator decision, or other reasons|2|||
127789414|NCT03099187|459853613|FG003|Double-blind Treatment|Physician Decision|0|||
127789415|NCT03099187|459853610|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
127789416|NCT03099187|459853611|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
127789417|NCT03099187|459853612|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
127789418|NCT03099187|459853613|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
127789419|NCT03099187|459853610|FG000|Double-blind Treatment|Lung transplantation|0|||
127789420|NCT03099187|459853611|FG001|Double-blind Treatment|Lung transplantation|1|||
127789421|NCT03099187|459853612|FG002|Double-blind Treatment|Lung transplantation|0|||
127789422|NCT03099187|459853613|FG003|Double-blind Treatment|Lung transplantation|0|||
127789423|NCT03099187|459853610|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
127789424|NCT03099187|459853611|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
127789425|NCT03099187|459853612|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
127789426|NCT03099187|459853613|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
127789427|NCT03099187|459853610|FG000|Double-blind Treatment|Disease progression|0|||
127789428|NCT03099187|459853611|FG001|Double-blind Treatment|Disease progression|1|||
127789429|NCT03099187|459853612|FG002|Double-blind Treatment|Disease progression|0|||
127789430|NCT03099187|459853613|FG003|Double-blind Treatment|Disease progression|0|||
127789431|NCT03099187|459853610|FG000|Double-blind Treatment|Randomization error|0|||
127789432|NCT03099187|459853611|FG001|Double-blind Treatment|Randomization error|2|||
127789433|NCT03099187|459853612|FG002|Double-blind Treatment|Randomization error|0|||
127789434|NCT03099187|459853613|FG003|Double-blind Treatment|Randomization error|0|||
127789435|NCT03099187|459853610|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
127789436|NCT03099187|459853611|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
127789437|NCT03099187|459853612|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
127789438|NCT03099187|459853613|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
127789439|NCT03099187|459853610|FG000|12-month Safety Follow-up|Adverse Event|0|||
127789440|NCT03099187|459853611|FG001|12-month Safety Follow-up|Adverse Event|0|||
127789441|NCT03099187|459853612|FG002|12-month Safety Follow-up|Adverse Event|5|||
127789442|NCT03099187|459853613|FG003|12-month Safety Follow-up|Adverse Event|12|||
127789443|NCT03099187|459853610|FG000|12-month Safety Follow-up|Death|0|||
127789444|NCT03099187|459853611|FG001|12-month Safety Follow-up|Death|0|||
127789445|NCT03099187|459853612|FG002|12-month Safety Follow-up|Death|7|||
127789446|NCT03099187|459853613|FG003|12-month Safety Follow-up|Death|9|||
127789447|NCT03099187|459853610|FG000|12-month Safety Follow-up|Lung transplantation|0|||
127789448|NCT03099187|459853611|FG001|12-month Safety Follow-up|Lung transplantation|0|||
127789449|NCT03099187|459853612|FG002|12-month Safety Follow-up|Lung transplantation|2|||
127789450|NCT03099187|459853613|FG003|12-month Safety Follow-up|Lung transplantation|1|||
127789451|NCT03099187|459853610|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
127789452|NCT03099187|459853611|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
127789453|NCT03099187|459853612|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
127789454|NCT03099187|459853613|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
127789455|NCT03099187|459853610|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
127789456|NCT03099187|459853611|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
127789457|NCT03099187|459853612|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
127789458|NCT03099187|459853613|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
127789459|NCT03099187|459853610|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
127612272|NCT00838201|459210454|FG001|Overall Study|Investigator decision, or other reasons|3|||
127612273|NCT00838201|459210453|FG000|Overall Study|Noncompliance|0|||
127612274|NCT00838201|459210454|FG001|Overall Study|Noncompliance|1|||
127612275|NCT00838201|459210453|FG000|Overall Study|Administrative decision|1|||
127612276|NCT00838201|459210454|FG001|Overall Study|Administrative decision|2|||
127789460|NCT03099187|459853611|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
127789461|NCT03099187|459853612|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
127789462|NCT03099187|459853613|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
127612277|NCT00838201|459210453|FG000|Overall Study|Disease progression|3|||
127612278|NCT00838201|459210454|FG001|Overall Study|Disease progression|3|||
127612279|NCT00838201|459210453|FG000|Overall Study|Consent withdrawn|16|||
127612280|NCT00838201|459210454|FG001|Overall Study|Consent withdrawn|19|||
127612281|NCT00838201|459210453|FG000|Overall Study|Lost to Follow-up|4|||
127612282|NCT00838201|459210454|FG001|Overall Study|Lost to Follow-up|3|||
127612283|NCT00838201|459210453|FG000|Overall Study|Adverse Event|5|||
127612284|NCT00838201|459210454|FG001|Overall Study|Adverse Event|9|||
127612285|NCT00838201|459210453|FG000|Overall Study|Death|11|||
127612286|NCT00838201|459210454|FG001|Overall Study|Death|13|||
127612287|NCT05228470|459210455|FG000|Overall Study|Death|6|||
127612288|NCT05228470|459210456|FG001|Overall Study|Death|11|||
127612289|NCT05228470|459210455|FG000|Overall Study|Withdrawal by Subject|1|||
127612290|NCT05228470|459210456|FG001|Overall Study|Withdrawal by Subject|8|||
127612291|NCT05228470|459210455|FG000|Overall Study|Ongoing|1|||
127789463|NCT03099187|459853610|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
127789464|NCT03099187|459853611|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
127789465|NCT03099187|459853612|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
127789466|NCT03099187|459853613|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
127789467|NCT01439555|459853614|FG000|Overall Study|Protocol Violation|1|||
127789468|NCT01246583|459853615|FG000|Overall Study|Lost to Follow-up|0|||
127789469|NCT01246583|459853616|FG001|Overall Study|Lost to Follow-up|0|||
127789470|NCT01246583|459853617|FG002|Overall Study|Lost to Follow-up|0|||
127789471|NCT01246583|459853618|FG003|Overall Study|Lost to Follow-up|1|||
127789472|NCT01246583|459853615|FG000|Overall Study|Protocol Violation|0|||
127789473|NCT01246583|459853616|FG001|Overall Study|Protocol Violation|0|||
127789474|NCT01246583|459853617|FG002|Overall Study|Protocol Violation|1|||
127789475|NCT01246583|459853618|FG003|Overall Study|Protocol Violation|0|||
127789476|NCT01246583|459853615|FG000|Overall Study|Withdrawal by Subject|1|||
127789477|NCT01246583|459853616|FG001|Overall Study|Withdrawal by Subject|0|||
127789478|NCT01246583|459853617|FG002|Overall Study|Withdrawal by Subject|0|||
127789479|NCT01246583|459853618|FG003|Overall Study|Withdrawal by Subject|0|||
127789480|NCT00102960|459853620|FG000|Overall Study|Death|23|||
127789481|NCT00102960|459853621|FG001|Overall Study|Death|11|||
127789482|NCT00102960|459853622|FG002|Overall Study|Death|11|||
127789483|NCT00102960|459853620|FG000|Overall Study|Lost to Follow-up|6|||
127789484|NCT00102960|459853621|FG001|Overall Study|Lost to Follow-up|12|||
127789485|NCT00102960|459853622|FG002|Overall Study|Lost to Follow-up|16|||
127789486|NCT00102960|459853620|FG000|Overall Study|Withdrawal by Subject|1|||
127789487|NCT00102960|459853621|FG001|Overall Study|Withdrawal by Subject|0|||
127612292|NCT05228470|459210456|FG001|Overall Study|Ongoing|11|||
127789488|NCT00102960|459853622|FG002|Overall Study|Withdrawal by Subject|1|||
127789489|NCT04218201|459855083|FG000|Overall Study|Death|0|||
127789490|NCT04218201|459855084|FG001|Overall Study|Death|0|||
127612293|NCT02449239|459210457|FG000|Induction Phase|Lack of Efficacy|64|||
127612294|NCT02449239|459210457|FG000|Induction Phase|Adverse Event|1|||
127883199|NCT01785875|460196348|FG001|Overall Study|Missing|1|||
127883200|NCT01785875|460196349|FG002|Overall Study|Missing|3|||
127883201|NCT04991311|460196350|FG000|Overall Study|Adverse Event|1|||
127883202|NCT00755937|460196351|FG000|Recruitment|Unknown if infliximab received|164|||
127883203|NCT00755937|460196351|FG000|Observational Follow-up|Lost to Follow-up|148|||
127883204|NCT01440595|460196354|FG000|Overall Study|Lost to Follow-up|0|||
127883205|NCT01440595|460196355|FG001|Overall Study|Lost to Follow-up|1|||
127883206|NCT01440595|460196356|FG002|Overall Study|Lost to Follow-up|0|||
127883207|NCT01440595|460196354|FG000|Overall Study|Study terminated by sponsor.|1|||
127883208|NCT01440595|460196355|FG001|Overall Study|Study terminated by sponsor.|2|||
127883209|NCT01440595|460196356|FG002|Overall Study|Study terminated by sponsor.|1|||
127883210|NCT01347879|460196357|FG000|Overall Study|Adverse Event|0|||
127883211|NCT01347879|460196358|FG001|Overall Study|Adverse Event|12|||
127883212|NCT01347879|460196357|FG000|Overall Study|Lost to Follow-up|2|||
127883213|NCT01347879|460196358|FG001|Overall Study|Lost to Follow-up|0|||
127883214|NCT01347879|460196357|FG000|Overall Study|Withdrawal by Subject|3|||
127883215|NCT01347879|460196358|FG001|Overall Study|Withdrawal by Subject|2|||
127883216|NCT01347879|460196357|FG000|Overall Study|Other|2|||
127883217|NCT01347879|460196358|FG001|Overall Study|Other|3|||
127883218|NCT01223196|460196359|FG000|Overall Study|Lost to Follow-up|2|||
127883219|NCT01223196|460196360|FG001|Overall Study|Lost to Follow-up|0|||
127883220|NCT01223196|460196359|FG000|Overall Study|Physician Decision|1|||
127883221|NCT01223196|460196360|FG001|Overall Study|Physician Decision|0|||
127883222|NCT01223196|460196359|FG000|Overall Study|Withdrawal by Subject|1|||
127883223|NCT01223196|460196360|FG001|Overall Study|Withdrawal by Subject|0|||
127883224|NCT01238822|460196365|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
127883225|NCT02725671|460196374|FG000|Overall Study|Lost to Follow-up|1|||
127883226|NCT00965263|460196375|FG000|Overall Study|Physician Decision|2|||
127883227|NCT00965263|460196376|FG001|Overall Study|Physician Decision|0|||
127883228|NCT00965263|460196375|FG000|Overall Study|Family emergency|0|||
127883229|NCT00965263|460196376|FG001|Overall Study|Family emergency|1|||
127883230|NCT00965263|460196375|FG000|Overall Study|Protocol Violation|0|||
127883231|NCT00965263|460196376|FG001|Overall Study|Protocol Violation|2|||
127883232|NCT00963599|460196377|FG000|Overall Study|Adverse Event|2|||
127883233|NCT00963599|460196378|FG001|Overall Study|Adverse Event|0|||
127883234|NCT00963599|460196379|FG002|Overall Study|Adverse Event|1|||
127883235|NCT00963599|460196380|FG003|Overall Study|Adverse Event|2|||
127883236|NCT00963599|460196377|FG000|Overall Study|Lack of Efficacy|0|||
127883237|NCT00963599|460196378|FG001|Overall Study|Lack of Efficacy|2|||
127883238|NCT00963599|460196379|FG002|Overall Study|Lack of Efficacy|1|||
127883239|NCT00963599|460196380|FG003|Overall Study|Lack of Efficacy|4|||
127883240|NCT00963599|460196377|FG000|Overall Study|Lost to Follow-up|0|||
127883241|NCT00963599|460196378|FG001|Overall Study|Lost to Follow-up|1|||
127883242|NCT00963599|460196379|FG002|Overall Study|Lost to Follow-up|1|||
127883243|NCT00963599|460196380|FG003|Overall Study|Lost to Follow-up|1|||
127883244|NCT00963599|460196377|FG000|Overall Study|Protocol Violation|2|||
127883245|NCT00963599|460196378|FG001|Overall Study|Protocol Violation|2|||
127883246|NCT00963599|460196379|FG002|Overall Study|Protocol Violation|3|||
127883247|NCT00963599|460196380|FG003|Overall Study|Protocol Violation|4|||
127883248|NCT00963599|460196377|FG000|Overall Study|Withdrawal by Subject|2|||
127883249|NCT00963599|460196378|FG001|Overall Study|Withdrawal by Subject|1|||
127883250|NCT00963599|460196379|FG002|Overall Study|Withdrawal by Subject|3|||
127789491|NCT04218201|459855085|FG002|Overall Study|Death|2|||
127789492|NCT04218201|459855086|FG003|Overall Study|Death|0|||
127789493|NCT04218201|459855083|FG000|Overall Study|Unable to contact participant|4|||
127789494|NCT04218201|459855084|FG001|Overall Study|Unable to contact participant|0|||
127789495|NCT04218201|459855085|FG002|Overall Study|Unable to contact participant|3|||
127789496|NCT04218201|459855086|FG003|Overall Study|Unable to contact participant|0|||
127789497|NCT04218201|459855083|FG000|Overall Study|Practical problems (e.g., no childcare or transportation)|3|||
127789498|NCT04218201|459855084|FG001|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
127789499|NCT04218201|459855085|FG002|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
127789500|NCT04218201|459855086|FG003|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
127883251|NCT00963599|460196380|FG003|Overall Study|Withdrawal by Subject|3|||
127883252|NCT00123487|460196383|FG000|Randomized|Death prior to starting treatment|0|||
127883253|NCT00123487|460196384|FG001|Randomized|Death prior to starting treatment|1|||
127883254|NCT00123487|460196383|FG000|Randomized|SAE prior to starting treatment|1|||
127883255|NCT00123487|460196384|FG001|Randomized|SAE prior to starting treatment|0|||
127883256|NCT00123487|460196383|FG000|Treated With Study Drug|Adverse Event|23|||
127883257|NCT00123487|460196384|FG001|Treated With Study Drug|Adverse Event|22|||
127883258|NCT00123487|460196383|FG000|Treated With Study Drug|Disease Progression|141|||
127883259|NCT00123487|460196384|FG001|Treated With Study Drug|Disease Progression|122|||
127883260|NCT00123487|460196383|FG000|Treated With Study Drug|Physician Decision|8|||
127883261|NCT00123487|460196384|FG001|Treated With Study Drug|Physician Decision|9|||
127612295|NCT02449239|459210457|FG000|Induction Phase|Lost to Follow-up|1|||
127612296|NCT02449239|459210457|FG000|Induction Phase|Protocol Violation|1|||
127612297|NCT02449239|459210457|FG000|Induction Phase|Physician Decision|1|||
127612298|NCT02449239|459210457|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
127612299|NCT02449239|459210457|FG000|Induction Phase|Withdrawal by Subject|1|||
127612300|NCT02449239|459210457|FG000|Maintenance Month 3|Lack of Efficacy|14|||
127612301|NCT02449239|459210457|FG000|Maintenance Month 6|Lack of Efficacy|10|||
127612302|NCT02449239|459210457|FG000|Maintenance Month 6|Adverse Event|2|||
127883262|NCT00123487|460196383|FG000|Treated With Study Drug|Other|59|||
127883263|NCT00123487|460196384|FG001|Treated With Study Drug|Other|58|||
127883264|NCT00123487|460196383|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
127883265|NCT00123487|460196384|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
127883266|NCT00123487|460196383|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
127883267|NCT00123487|460196384|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
127883268|NCT00123487|460196383|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
127883269|NCT00123487|460196384|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
127883270|NCT03835975|460196385|FG000|Overall Study|Lost to Follow-up|1|||
127883271|NCT03835975|460196386|FG001|Overall Study|Lost to Follow-up|1|||
127883272|NCT03835975|460196387|FG002|Overall Study|Lost to Follow-up|0|||
127883273|NCT03835975|460196388|FG003|Overall Study|Lost to Follow-up|0|||
127883274|NCT03835975|460196389|FG004|Overall Study|Lost to Follow-up|0|||
127883275|NCT03835975|460196385|FG000|Overall Study|No longer met eligibility criteria|0|||
127883276|NCT03835975|460196386|FG001|Overall Study|No longer met eligibility criteria|1|||
127883277|NCT03835975|460196387|FG002|Overall Study|No longer met eligibility criteria|0|||
127883278|NCT03835975|460196388|FG003|Overall Study|No longer met eligibility criteria|0|||
127883279|NCT03835975|460196389|FG004|Overall Study|No longer met eligibility criteria|0|||
127883280|NCT03835975|460196385|FG000|Overall Study|Protocol Violation|1|||
127883281|NCT03835975|460196386|FG001|Overall Study|Protocol Violation|1|||
127883282|NCT03835975|460196387|FG002|Overall Study|Protocol Violation|2|||
127883283|NCT03835975|460196388|FG003|Overall Study|Protocol Violation|0|||
127883284|NCT03835975|460196389|FG004|Overall Study|Protocol Violation|0|||
127883285|NCT03835975|460196385|FG000|Overall Study|Withdrawal by Subject|1|||
127883286|NCT03835975|460196386|FG001|Overall Study|Withdrawal by Subject|0|||
127883287|NCT03835975|460196387|FG002|Overall Study|Withdrawal by Subject|1|||
127883288|NCT03835975|460196388|FG003|Overall Study|Withdrawal by Subject|1|||
127883289|NCT03835975|460196389|FG004|Overall Study|Withdrawal by Subject|0|||
127883290|NCT00995488|460196390|FG000|Overall Study|Withdrawal by Subject|1|||
127612303|NCT02449239|459210457|FG000|Maintenance Month 6|Physician Decision|1|||
127612304|NCT02449239|459210457|FG000|Maintenance Month 9|Lack of Efficacy|2|||
127612305|NCT02449239|459210457|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
127612306|NCT02449239|459210457|FG000|Maintenance Month 12|Lack of Efficacy|5|||
127612307|NCT02449239|459210457|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
127612308|NCT02449239|459210457|FG000|Maintenance Month 12|Subject moved from area|1|||
127612309|NCT02449239|459210457|FG000|Maintenance Month 15|Lack of Efficacy|1|||
127612310|NCT02449239|459210457|FG000|Maintenance Month 21|Lack of Efficacy|1|||
127612311|NCT02449239|459210457|FG000|Maintenance Month 21|Sponsor decision|1|||
127612312|NCT05620576|459210459|FG000|Overall Study|Adverse Event|1|||
127612313|NCT05620576|459210460|FG001|Overall Study|Adverse Event|1|||
127612314|NCT05620576|459210459|FG000|Overall Study|Lost to Follow-up|3|||
127612315|NCT05620576|459210460|FG001|Overall Study|Lost to Follow-up|1|||
127612316|NCT05620576|459210459|FG000|Overall Study|Physician Decision|0|||
127612317|NCT05620576|459210460|FG001|Overall Study|Physician Decision|1|||
127612318|NCT05620576|459210459|FG000|Overall Study|Protocol Deviation|1|||
127612319|NCT05620576|459210460|FG001|Overall Study|Protocol Deviation|1|||
127612320|NCT05620576|459210459|FG000|Overall Study|Withdrawal by Subject|2|||
127612321|NCT05620576|459210460|FG001|Overall Study|Withdrawal by Subject|3|||
127612322|NCT02622828|459210461|FG000|Overall Study|participant withdrew|3|||
127612323|NCT01723163|459210462|FG000|Treatment Phase|Withdrawal by Subject|14|||
127612324|NCT01723163|459210463|FG001|Treatment Phase|Withdrawal by Subject|6|||
127789501|NCT04218201|459855083|FG000|Overall Study|Withdrawal by Subject|2|||
127789502|NCT04218201|459855084|FG001|Overall Study|Withdrawal by Subject|0|||
127789503|NCT04218201|459855085|FG002|Overall Study|Withdrawal by Subject|0|||
127789504|NCT04218201|459855086|FG003|Overall Study|Withdrawal by Subject|0|||
127789505|NCT04218201|459855083|FG000|Overall Study|PCP plans to leave practice|0|||
127789506|NCT04218201|459855084|FG001|Overall Study|PCP plans to leave practice|8|||
127789507|NCT04218201|459855085|FG002|Overall Study|PCP plans to leave practice|0|||
127883291|NCT00061945|460196391|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
127612325|NCT01723163|459210462|FG000|Treatment Phase|Withdrawal by PI|5|||
127612326|NCT01723163|459210463|FG001|Treatment Phase|Withdrawal by PI|1|||
127883292|NCT00061945|460196392|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
127883293|NCT00061945|460196391|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
127612327|NCT01723163|459210462|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
127612328|NCT01723163|459210463|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
127887323|NCT01298596|460210578|FG000|Overall Study|Referred for further management|16|||
127612329|NCT01723163|459210462|FG000|3-Month Follow-up|Unable to Contact|12|||
127612330|NCT01723163|459210463|FG001|3-Month Follow-up|Unable to Contact|19|||
127612331|NCT01723163|459210462|FG000|6-Month Follow-up|Death|1|||
127612332|NCT01723163|459210463|FG001|6-Month Follow-up|Death|0|||
127612333|NCT01723163|459210462|FG000|6-Month Follow-up|Unable to Contact|17|||
127612334|NCT01723163|459210463|FG001|6-Month Follow-up|Unable to Contact|15|||
127612335|NCT01723163|459210462|FG000|12-Month Follow-up|Death|1|||
127612336|NCT01723163|459210463|FG001|12-Month Follow-up|Death|0|||
127612337|NCT01723163|459210462|FG000|12-Month Follow-up|Unable to Contact|23|||
127612338|NCT01723163|459210463|FG001|12-Month Follow-up|Unable to Contact|28|||
127612339|NCT03314584|459210482|FG000|Overall Study|Withdrawal by Subject|3|||
127612340|NCT03314584|459210483|FG001|Overall Study|Withdrawal by Subject|3|||
127612341|NCT03314584|459210482|FG000|Overall Study|Lost to Follow-up|4|||
127612342|NCT03314584|459210483|FG001|Overall Study|Lost to Follow-up|0|||
127612343|NCT06134817|459210484|FG000|Overall Study|Physician Departure - termination of study|1|||
127612344|NCT04214288|459210488|FG000|Overall Study|Ongoing in the study|41|||
127612345|NCT04214288|459210489|FG001|Overall Study|Ongoing in the study|51|||
127612346|NCT04214288|459210490|FG002|Overall Study|Ongoing in the study|12|||
127612347|NCT04214288|459210491|FG003|Overall Study|Ongoing in the study|39|||
127612348|NCT04214288|459210488|FG000|Overall Study|Adverse Event|1|||
127612349|NCT04214288|459210489|FG001|Overall Study|Adverse Event|0|||
127612350|NCT04214288|459210490|FG002|Overall Study|Adverse Event|0|||
127612351|NCT04214288|459210491|FG003|Overall Study|Adverse Event|0|||
127612352|NCT04214288|459210488|FG000|Overall Study|Death|22|||
127612353|NCT04214288|459210489|FG001|Overall Study|Death|13|||
127612354|NCT04214288|459210490|FG002|Overall Study|Death|7|||
127612355|NCT04214288|459210491|FG003|Overall Study|Death|19|||
127612356|NCT04214288|459210488|FG000|Overall Study|Lost to Follow-up|1|||
127612357|NCT04214288|459210489|FG001|Overall Study|Lost to Follow-up|2|||
127612358|NCT04214288|459210490|FG002|Overall Study|Lost to Follow-up|1|||
127612359|NCT04214288|459210491|FG003|Overall Study|Lost to Follow-up|0|||
127612360|NCT04214288|459210488|FG000|Overall Study|Other|1|||
127612361|NCT04214288|459210489|FG001|Overall Study|Other|2|||
127612362|NCT04214288|459210490|FG002|Overall Study|Other|0|||
127612363|NCT04214288|459210491|FG003|Overall Study|Other|6|||
127612364|NCT04214288|459210488|FG000|Overall Study|Protocol Violation|0|||
127612365|NCT04214288|459210489|FG001|Overall Study|Protocol Violation|1|||
127612366|NCT04214288|459210490|FG002|Overall Study|Protocol Violation|0|||
127612367|NCT04214288|459210491|FG003|Overall Study|Protocol Violation|0|||
127612368|NCT04214288|459210488|FG000|Overall Study|Withdrawal by Subject|8|||
127612369|NCT04214288|459210489|FG001|Overall Study|Withdrawal by Subject|4|||
127612370|NCT04214288|459210490|FG002|Overall Study|Withdrawal by Subject|0|||
127612371|NCT04214288|459210491|FG003|Overall Study|Withdrawal by Subject|9|||
127612372|NCT04327999|459210492|FG000|Overall Study|Protocol Violation|1|||
127612373|NCT03792672|459210493|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
127612374|NCT03792672|459210494|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
127612375|NCT03792672|459210495|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
127612376|NCT03792672|459210496|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
127612377|NCT03792672|459210497|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
127612378|NCT03792672|459210498|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
127612379|NCT03792672|459210493|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
127612380|NCT03792672|459210494|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
127612381|NCT03792672|459210495|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
127612382|NCT03792672|459210496|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
127612383|NCT03792672|459210497|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
127612384|NCT03792672|459210498|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
127612385|NCT03792672|459210493|FG000|Treatment Period 4 (2 Days)|Other|1|||
127612386|NCT03792672|459210494|FG001|Treatment Period 4 (2 Days)|Other|0|||
127612387|NCT03792672|459210495|FG002|Treatment Period 4 (2 Days)|Other|0|||
127612388|NCT03792672|459210496|FG003|Treatment Period 4 (2 Days)|Other|0|||
127612389|NCT03792672|459210497|FG004|Treatment Period 4 (2 Days)|Other|0|||
127612390|NCT03792672|459210498|FG005|Treatment Period 4 (2 Days)|Other|0|||
127612391|NCT03161483|459210505|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
127612392|NCT03161483|459210506|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
127612393|NCT03161483|459210507|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
127612394|NCT03161483|459210508|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
127612395|NCT03161483|459210505|FG000|Treatment Period|Death|1|||
127612396|NCT03161483|459210506|FG001|Treatment Period|Death|0|||
127612397|NCT03161483|459210507|FG002|Treatment Period|Death|0|||
127612398|NCT03161483|459210508|FG003|Treatment Period|Death|0|||
127612399|NCT03161483|459210505|FG000|Treatment Period|Adverse Event|5|||
127612400|NCT03161483|459210506|FG001|Treatment Period|Adverse Event|2|||
127612401|NCT03161483|459210507|FG002|Treatment Period|Adverse Event|1|||
127612402|NCT03161483|459210508|FG003|Treatment Period|Adverse Event|11|||
127612403|NCT03161483|459210505|FG000|Treatment Period|Pregnancy|1|||
127612404|NCT03161483|459210506|FG001|Treatment Period|Pregnancy|0|||
127612405|NCT03161483|459210507|FG002|Treatment Period|Pregnancy|0|||
127612406|NCT03161483|459210508|FG003|Treatment Period|Pregnancy|0|||
127612407|NCT03161483|459210505|FG000|Treatment Period|Lack of Efficacy|0|||
127612408|NCT03161483|459210506|FG001|Treatment Period|Lack of Efficacy|0|||
127612409|NCT03161483|459210507|FG002|Treatment Period|Lack of Efficacy|0|||
127612410|NCT03161483|459210508|FG003|Treatment Period|Lack of Efficacy|1|||
127612411|NCT03161483|459210505|FG000|Treatment Period|Withdrawal by Subject|2|||
127612412|NCT03161483|459210506|FG001|Treatment Period|Withdrawal by Subject|5|||
127612413|NCT03161483|459210507|FG002|Treatment Period|Withdrawal by Subject|2|||
127612414|NCT03161483|459210508|FG003|Treatment Period|Withdrawal by Subject|6|||
127789508|NCT04218201|459855086|FG003|Overall Study|PCP plans to leave practice|5|||
127612415|NCT03161483|459210505|FG000|Treatment Period|Lost to Follow-up|0|||
127612416|NCT03161483|459210506|FG001|Treatment Period|Lost to Follow-up|0|||
127612417|NCT03161483|459210507|FG002|Treatment Period|Lost to Follow-up|0|||
127789509|NCT04218201|459855083|FG000|Overall Study|Reduced panel|0|||
127789510|NCT04218201|459855084|FG001|Overall Study|Reduced panel|0|||
127789511|NCT04218201|459855085|FG002|Overall Study|Reduced panel|0|||
127789512|NCT04218201|459855086|FG003|Overall Study|Reduced panel|1|||
127789513|NCT04218201|459855083|FG000|Overall Study|No longer interested in participating|0|||
127789514|NCT04218201|459855084|FG001|Overall Study|No longer interested in participating|1|||
127612418|NCT03161483|459210508|FG003|Treatment Period|Lost to Follow-up|1|||
127612419|NCT03161483|459210505|FG000|Treatment Period|Protocol Violation|0|||
127789515|NCT04218201|459855085|FG002|Overall Study|No longer interested in participating|0|||
127612420|NCT03161483|459210506|FG001|Treatment Period|Protocol Violation|0|||
127612421|NCT03161483|459210507|FG002|Treatment Period|Protocol Violation|0|||
127612422|NCT03161483|459210508|FG003|Treatment Period|Protocol Violation|1|||
127612423|NCT03161483|459210505|FG000|Treatment Period|Other reasons|1|||
127612424|NCT03161483|459210506|FG001|Treatment Period|Other reasons|1|||
127612425|NCT03161483|459210507|FG002|Treatment Period|Other reasons|0|||
127612426|NCT03161483|459210508|FG003|Treatment Period|Other reasons|0|||
127612427|NCT04238728|459210517|FG000|Overall Study|Withdrawal by Subject|1|||
127612428|NCT04238728|459210517|FG000|Overall Study|Lost to Follow-up|2|||
127612429|NCT05389657|459210519|FG000|Overall Study|Lost to Follow-up|7|||
127612430|NCT05389657|459210520|FG001|Overall Study|Lost to Follow-up|8|||
127612431|NCT01907828|459210521|FG000|Overall Study|Exclusion criteria not met|0|||
127612432|NCT01907828|459210522|FG001|Overall Study|Exclusion criteria not met|1|||
127612433|NCT01907828|459210521|FG000|Overall Study|Withdrawal by Subject|3|||
127612434|NCT01907828|459210522|FG001|Overall Study|Withdrawal by Subject|4|||
127612435|NCT01907828|459210521|FG000|Overall Study|Lost to Follow-up|3|||
127612436|NCT01907828|459210522|FG001|Overall Study|Lost to Follow-up|0|||
127612437|NCT01907828|459210521|FG000|Overall Study|Participant refused 24-month follow-up|1|||
127612438|NCT01907828|459210522|FG001|Overall Study|Participant refused 24-month follow-up|0|||
127612439|NCT01907828|459210521|FG000|Overall Study|Participant met exclusion criteria|0|||
127612440|NCT01907828|459210522|FG001|Overall Study|Participant met exclusion criteria|1|||
127612441|NCT01256593|459210524|FG000|Overall Study|Protocol Violation|26|||
127612442|NCT01256593|459210524|FG000|Overall Study|No Drug Administration Information|2|||
127612443|NCT01256593|459210524|FG000|Overall Study|No Visit After Treatment|186|||
127612444|NCT04414553|459210525|FG000|Overall Study|Lost to Follow-up|20|||
127612445|NCT02319031|459210531|FG000|Treatment Period|Death|1|||
127612446|NCT02319031|459210532|FG001|Treatment Period|Death|0|||
127612447|NCT03519971|459210537|FG000|Overall Study|Death|142|||
127612448|NCT03519971|459210538|FG001|Overall Study|Death|69|||
127612449|NCT03519971|459210537|FG000|Overall Study|Lost to Follow-up|0|||
127612450|NCT03519971|459210538|FG001|Overall Study|Lost to Follow-up|1|||
127612451|NCT03519971|459210537|FG000|Overall Study|Ongoing treatment and in follow-up at data cut off|73|||
127789516|NCT04218201|459855086|FG003|Overall Study|No longer interested in participating|0|||
127789517|NCT00412750|459855093|FG000|Overall Study|Abnormal laboratory value(s)|1|||
127789518|NCT00412750|459855094|FG001|Overall Study|Abnormal laboratory value(s)|0|||
127789519|NCT00412750|459855095|FG002|Overall Study|Abnormal laboratory value(s)|0|||
127789520|NCT00412750|459855093|FG000|Overall Study|Administrative problems|21|||
127789521|NCT00412750|459855094|FG001|Overall Study|Administrative problems|17|||
127789522|NCT00412750|459855095|FG002|Overall Study|Administrative problems|14|||
127789523|NCT00412750|459855093|FG000|Overall Study|Adverse Event|8|||
127789524|NCT00412750|459855094|FG001|Overall Study|Adverse Event|3|||
127789525|NCT00412750|459855095|FG002|Overall Study|Adverse Event|3|||
127789526|NCT00412750|459855093|FG000|Overall Study|Lost to Follow-up|1|||
127789527|NCT00412750|459855094|FG001|Overall Study|Lost to Follow-up|0|||
127789528|NCT00412750|459855095|FG002|Overall Study|Lost to Follow-up|1|||
127789529|NCT00412750|459855093|FG000|Overall Study|Withdrawal by Subject|0|||
127789530|NCT00412750|459855094|FG001|Overall Study|Withdrawal by Subject|1|||
127789531|NCT00412750|459855095|FG002|Overall Study|Withdrawal by Subject|2|||
127789532|NCT00412750|459855093|FG000|Overall Study|Lack of Efficacy|0|||
127789533|NCT00412750|459855094|FG001|Overall Study|Lack of Efficacy|0|||
127789534|NCT00412750|459855095|FG002|Overall Study|Lack of Efficacy|3|||
127789535|NCT01135498|459855097|FG000|Overall Study|Adverse Event|20|||
127789536|NCT01135498|459855097|FG000|Overall Study|Progressive disease|38|||
127789537|NCT01135498|459855097|FG000|Overall Study|Investigator judgement|25|||
127789538|NCT01135498|459855097|FG000|Overall Study|Withdrawal by Subject|4|||
127789539|NCT01135498|459855097|FG000|Overall Study|Death|1|||
127789540|NCT01135498|459855097|FG000|Overall Study|Ongoing at time of analysis|2|||
127789541|NCT02104583|459855098|FG000|Overall Study|New ICD or CRT-D implanted|2|||
127887324|NCT01298596|460210579|FG001|Overall Study|Referred for further management|15|||
127612452|NCT03519971|459210538|FG001|Overall Study|Ongoing treatment and in follow-up at data cut off|37|||
127612453|NCT03519971|459210537|FG000|Overall Study|Withdrawal by Subject|3|||
127612454|NCT03519971|459210538|FG001|Overall Study|Withdrawal by Subject|2|||
127612455|NCT03519971|459210537|FG000|Overall Study|Other|1|||
127612456|NCT03519971|459210538|FG001|Overall Study|Other|0|||
127789542|NCT02104583|459855099|FG001|Overall Study|New ICD or CRT-D implanted|0|||
127612457|NCT01774786|459210539|FG000|Overall Study|Death|300|||
127612458|NCT01774786|459210540|FG001|Overall Study|Death|319|||
127612459|NCT01774786|459210539|FG000|Overall Study|Lost to Follow-up|6|||
127612460|NCT01774786|459210540|FG001|Overall Study|Lost to Follow-up|7|||
127612461|NCT01774786|459210539|FG000|Overall Study|Withdrawal by Subject|18|||
127612462|NCT01774786|459210540|FG001|Overall Study|Withdrawal by Subject|14|||
127612463|NCT01774786|459210539|FG000|Overall Study|Physician Decision|2|||
127612464|NCT01774786|459210540|FG001|Overall Study|Physician Decision|0|||
127612465|NCT01774786|459210539|FG000|Overall Study|Non-compliance|0|||
127612466|NCT01774786|459210540|FG001|Overall Study|Non-compliance|1|||
127612467|NCT01774786|459210539|FG000|Overall Study|Reason Not Specified|2|||
127612468|NCT01774786|459210540|FG001|Overall Study|Reason Not Specified|5|||
127612469|NCT02385084|459210541|FG000|Period 2|Protocol Violation|0|||
127612470|NCT02385084|459210542|FG001|Period 2|Protocol Violation|0|||
127612471|NCT02385084|459210543|FG002|Period 2|Protocol Violation|1|||
127612472|NCT02385084|459210544|FG003|Period 2|Protocol Violation|0|||
127612473|NCT02385084|459210545|FG004|Period 2|Protocol Violation|0|||
127612474|NCT02385084|459210546|FG005|Period 2|Protocol Violation|0|||
127612475|NCT02965703|459210552|FG000|Overall Study|Withdrawal by Subject|6|||
127612476|NCT02965703|459210553|FG001|Overall Study|Withdrawal by Subject|3|||
127612477|NCT02965703|459210554|FG002|Overall Study|Withdrawal by Subject|1|||
127612478|NCT02965703|459210552|FG000|Overall Study|Protocol Violation|1|||
127612479|NCT02965703|459210553|FG001|Overall Study|Protocol Violation|0|||
127612480|NCT02965703|459210554|FG002|Overall Study|Protocol Violation|0|||
127612481|NCT02965703|459210552|FG000|Overall Study|Adverse Event|1|||
127612482|NCT02965703|459210553|FG001|Overall Study|Adverse Event|1|||
127612483|NCT02965703|459210554|FG002|Overall Study|Adverse Event|0|||
127612484|NCT02965703|459210552|FG000|Overall Study|Lost to Follow-up|2|||
127612485|NCT02965703|459210553|FG001|Overall Study|Lost to Follow-up|1|||
127612486|NCT02965703|459210554|FG002|Overall Study|Lost to Follow-up|1|||
127612487|NCT00642668|459210555|FG000|Overall Study|Lost to Follow-up|1|||
127612488|NCT00642668|459210555|FG000|Overall Study|Adverse Event|2|||
127612489|NCT00642668|459210555|FG000|Overall Study|Death|2|||
127612490|NCT00642668|459210555|FG000|Overall Study|Insufficient Therapeutic Response|1|||
127612491|NCT00642668|459210555|FG000|Overall Study|Failure to Return|1|||
127612492|NCT00642668|459210555|FG000|Overall Study|Dialysis Initiation|5|||
127612493|NCT00642668|459210555|FG000|Overall Study|Blood Transfusion|2|||
127789543|NCT02104583|459855100|FG002|Overall Study|New ICD or CRT-D implanted|1|||
127789544|NCT02104583|459855101|FG003|Overall Study|New ICD or CRT-D implanted|0|||
127789545|NCT02104583|459855102|FG004|Overall Study|New ICD or CRT-D implanted|0|||
127789546|NCT02104583|459855098|FG000|Overall Study|Death|2|||
127789547|NCT02104583|459855099|FG001|Overall Study|Death|1|||
127789548|NCT02104583|459855100|FG002|Overall Study|Death|3|||
127789549|NCT02104583|459855101|FG003|Overall Study|Death|3|||
127789550|NCT02104583|459855102|FG004|Overall Study|Death|5|||
127789551|NCT02104583|459855098|FG000|Overall Study|Subject required cardiac ablation|6|||
127789552|NCT02104583|459855099|FG001|Overall Study|Subject required cardiac ablation|4|||
127789553|NCT02104583|459855100|FG002|Overall Study|Subject required cardiac ablation|4|||
127789554|NCT02104583|459855101|FG003|Overall Study|Subject required cardiac ablation|5|||
127789555|NCT02104583|459855102|FG004|Overall Study|Subject required cardiac ablation|4|||
127789556|NCT02104583|459855098|FG000|Overall Study|Subject required prohibited medication|0|||
127789557|NCT02104583|459855099|FG001|Overall Study|Subject required prohibited medication|1|||
127789558|NCT02104583|459855100|FG002|Overall Study|Subject required prohibited medication|1|||
127789559|NCT02104583|459855101|FG003|Overall Study|Subject required prohibited medication|0|||
127789560|NCT02104583|459855102|FG004|Overall Study|Subject required prohibited medication|1|||
127789561|NCT02104583|459855098|FG000|Overall Study|Withdrew Consent|3|||
127789562|NCT02104583|459855099|FG001|Overall Study|Withdrew Consent|2|||
127789563|NCT02104583|459855100|FG002|Overall Study|Withdrew Consent|0|||
127789564|NCT02104583|459855101|FG003|Overall Study|Withdrew Consent|2|||
127789565|NCT02104583|459855102|FG004|Overall Study|Withdrew Consent|1|||
127789566|NCT02104583|459855098|FG000|Overall Study|Investigator's Discretion|1|||
127789567|NCT02104583|459855099|FG001|Overall Study|Investigator's Discretion|0|||
127612494|NCT01449526|459210558|FG000|Overall Study|Lost to Follow-up|1|||
127612495|NCT01449526|459210559|FG001|Overall Study|Lost to Follow-up|2|||
127789568|NCT02104583|459855100|FG002|Overall Study|Investigator's Discretion|0|||
127789569|NCT02104583|459855101|FG003|Overall Study|Investigator's Discretion|0|||
127789570|NCT02104583|459855102|FG004|Overall Study|Investigator's Discretion|0|||
127789571|NCT02104583|459855098|FG000|Overall Study|Protocol Violation|0|||
127789572|NCT02104583|459855099|FG001|Overall Study|Protocol Violation|0|||
127789573|NCT02104583|459855100|FG002|Overall Study|Protocol Violation|1|||
127789574|NCT02104583|459855101|FG003|Overall Study|Protocol Violation|0|||
127883294|NCT00061945|460196392|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
127612496|NCT01449526|459210558|FG000|Overall Study|Withdrawal by Subject|1|||
127612497|NCT01449526|459210559|FG001|Overall Study|Withdrawal by Subject|1|||
127612498|NCT01449526|459210558|FG000|Overall Study|Symptoms/complaints|0|||
127612499|NCT01449526|459210559|FG001|Overall Study|Symptoms/complaints|1|||
127612500|NCT01449526|459210558|FG000|Overall Study|Lack of Motivation|0|||
127612501|NCT01449526|459210559|FG001|Overall Study|Lack of Motivation|1|||
127612502|NCT01449526|459210558|FG000|Overall Study|Cannot maintain visits|0|||
127612503|NCT01449526|459210559|FG001|Overall Study|Cannot maintain visits|1|||
127612504|NCT01132495|459210560|FG000|Overall Study|Various reasons|40|||
127612505|NCT01132495|459210561|FG001|Overall Study|Various reasons|38|||
127612506|NCT01132495|459210562|FG002|Overall Study|Various reasons|20|||
127612507|NCT01132495|459210563|FG003|Overall Study|Various reasons|12|||
127612508|NCT00082433|459210567|FG000|Overall Study|Adverse Event|12|||
127612509|NCT00082433|459210568|FG001|Overall Study|Adverse Event|17|||
127612510|NCT00082433|459210567|FG000|Overall Study|Death|8|||
127612511|NCT00082433|459210568|FG001|Overall Study|Death|18|||
127612512|NCT00082433|459210567|FG000|Overall Study|Disease Progression/Relapse|270|||
127789575|NCT02104583|459855102|FG004|Overall Study|Protocol Violation|0|||
127789576|NCT02104583|459855098|FG000|Overall Study|Adverse Event|3|||
127789577|NCT02104583|459855099|FG001|Overall Study|Adverse Event|3|||
127789578|NCT02104583|459855100|FG002|Overall Study|Adverse Event|6|||
127789579|NCT02104583|459855101|FG003|Overall Study|Adverse Event|6|||
127789580|NCT02104583|459855102|FG004|Overall Study|Adverse Event|1|||
127789581|NCT02104583|459855098|FG000|Overall Study|Lost to Follow-up|1|||
127789582|NCT02104583|459855099|FG001|Overall Study|Lost to Follow-up|0|||
127789583|NCT02104583|459855100|FG002|Overall Study|Lost to Follow-up|0|||
127789584|NCT02104583|459855101|FG003|Overall Study|Lost to Follow-up|0|||
127789585|NCT02104583|459855102|FG004|Overall Study|Lost to Follow-up|0|||
127789586|NCT02104583|459855098|FG000|Overall Study|Randomized but Never Treated|0|||
127789587|NCT02104583|459855099|FG001|Overall Study|Randomized but Never Treated|0|||
127789588|NCT02104583|459855100|FG002|Overall Study|Randomized but Never Treated|0|||
127789589|NCT02104583|459855101|FG003|Overall Study|Randomized but Never Treated|1|||
127789590|NCT02104583|459855102|FG004|Overall Study|Randomized but Never Treated|0|||
127789591|NCT01351389|459855103|FG000|Overall Study|Withdrawal by Subject|7|||
127789592|NCT01351389|459855104|FG001|Overall Study|Withdrawal by Subject|0|||
127789593|NCT01351389|459855103|FG000|Overall Study|did not complete intervention|23|||
127789594|NCT01351389|459855104|FG001|Overall Study|did not complete intervention|15|||
127789595|NCT02646982|459855105|FG000|Overall Study|Adverse Event|1|||
127789596|NCT02646982|459855106|FG001|Overall Study|Adverse Event|1|||
127789597|NCT02646982|459855105|FG000|Overall Study|Withdrawal by Subject|2|||
127789598|NCT02646982|459855106|FG001|Overall Study|Withdrawal by Subject|1|||
127789599|NCT00713700|459855107|FG000|Overall Study|Lost to Follow-up|3|||
127789600|NCT00713700|459855107|FG000|Overall Study|Withdrawal by Subject|1|||
127789601|NCT03923426|459855109|FG000|Overall Study|Other|19|||
127789602|NCT03923426|459855109|FG000|Overall Study|Lost to Follow-up|16|||
127789603|NCT03923426|459855109|FG000|Overall Study|Death|107|||
127789604|NCT03923426|459855109|FG000|Overall Study|Incomplete response to question|13|||
127789605|NCT00769002|459855110|FG000|Overall Study|Study was not completed, no data|9|||
127789606|NCT00769002|459855111|FG001|Overall Study|Study was not completed, no data|9|||
127789607|NCT00847912|459855121|FG000|Overall Study|Protocol Violation|6|||
127789608|NCT00847912|459855122|FG001|Overall Study|Protocol Violation|7|||
127789609|NCT00847912|459855121|FG000|Overall Study|Withdrawal by Subject|3|||
127789610|NCT00847912|459855122|FG001|Overall Study|Withdrawal by Subject|6|||
127789611|NCT01732796|459855123|FG000|Overall Study|Adverse Event|16|||
127612513|NCT00082433|459210568|FG001|Overall Study|Disease Progression/Relapse|388|||
127789612|NCT01732796|459855124|FG001|Overall Study|Adverse Event|16|||
127789613|NCT01732796|459855125|FG002|Overall Study|Adverse Event|4|||
127789614|NCT01732796|459855123|FG000|Overall Study|Lack of Efficacy|21|||
127789615|NCT01732796|459855124|FG001|Overall Study|Lack of Efficacy|18|||
127789616|NCT01732796|459855125|FG002|Overall Study|Lack of Efficacy|5|||
127789617|NCT01732796|459855123|FG000|Overall Study|Lost to Follow-up|2|||
127789618|NCT01732796|459855124|FG001|Overall Study|Lost to Follow-up|0|||
127789619|NCT01732796|459855125|FG002|Overall Study|Lost to Follow-up|0|||
127883295|NCT00061945|460196391|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
127883296|NCT00061945|460196392|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
127883297|NCT00061945|460196391|FG000|Course IV: Alemtuzumab|Early exits|6|||
127789620|NCT01732796|459855123|FG000|Overall Study|Withdrawal by Subject|6|||
127789621|NCT01732796|459855124|FG001|Overall Study|Withdrawal by Subject|8|||
127789622|NCT01732796|459855125|FG002|Overall Study|Withdrawal by Subject|2|||
127789623|NCT01732796|459855123|FG000|Overall Study|Other reason not defined above|1|||
127789624|NCT01732796|459855124|FG001|Overall Study|Other reason not defined above|0|||
127789625|NCT01732796|459855125|FG002|Overall Study|Other reason not defined above|2|||
127789626|NCT00838331|459855129|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
127789627|NCT03972969|459855130|FG000|3-month Follow-up|Death|1|||
127789628|NCT03972969|459855131|FG001|3-month Follow-up|Death|1|||
127789629|NCT03972969|459855132|FG002|3-month Follow-up|Death|0|||
127789630|NCT03972969|459855130|FG000|6-month Follow-up|Death|1|||
127789631|NCT03972969|459855131|FG001|6-month Follow-up|Death|1|||
127789632|NCT03972969|459855132|FG002|6-month Follow-up|Death|1|||
127789633|NCT03972969|459855130|FG000|6-month Follow-up|Lost to Follow-up|2|||
127789634|NCT03972969|459855131|FG001|6-month Follow-up|Lost to Follow-up|2|||
127789635|NCT03972969|459855132|FG002|6-month Follow-up|Lost to Follow-up|2|||
127789636|NCT00732303|459855133|FG000|Overall Study|Study Terminated|2|||
127789637|NCT01074190|459855134|FG000|Overall Study|Emergency Cesarean Delivery|1|||
127789638|NCT01074190|459855135|FG001|Overall Study|Emergency Cesarean Delivery|2|||
127789639|NCT01074190|459855136|FG002|Overall Study|Emergency Cesarean Delivery|1|||
127789640|NCT01074190|459855134|FG000|Overall Study|Protocol Violation|2|||
127789641|NCT01074190|459855135|FG001|Overall Study|Protocol Violation|1|||
127789642|NCT01074190|459855136|FG002|Overall Study|Protocol Violation|0|||
127612514|NCT00082433|459210567|FG000|Overall Study|Physician Decision|50|||
127789643|NCT01074190|459855134|FG000|Overall Study|Delivered in under 90 minutes|0|||
127789644|NCT01074190|459855135|FG001|Overall Study|Delivered in under 90 minutes|2|||
127789645|NCT01074190|459855136|FG002|Overall Study|Delivered in under 90 minutes|1|||
127789646|NCT01074190|459855134|FG000|Overall Study|Subject withdrew consent|1|||
127789647|NCT01074190|459855135|FG001|Overall Study|Subject withdrew consent|1|||
127789648|NCT01074190|459855136|FG002|Overall Study|Subject withdrew consent|1|||
127789649|NCT00264875|459855137|FG000|Overall Study|Adverse Event|6|||
127789650|NCT00264875|459855137|FG000|Overall Study|Lost to Follow-up|6|||
127883298|NCT00061945|460196392|FG001|Course IV: Alemtuzumab|Early exits|15|||
127789651|NCT00264875|459855137|FG000|Overall Study|Protocol Violation|11|||
127789652|NCT00264875|459855137|FG000|Overall Study|Withdrawal by Subject|7|||
127789653|NCT01500278|459855144|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
127789654|NCT01500278|459855145|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
127883299|NCT01039584|460196393|FG000|Overall Study|Withdrawal by Subject|4|||
127612515|NCT00082433|459210568|FG001|Overall Study|Physician Decision|61|||
127612516|NCT00082433|459210567|FG000|Overall Study|Lost to Follow-up|1|||
127612517|NCT00082433|459210568|FG001|Overall Study|Lost to Follow-up|2|||
127612518|NCT00082433|459210567|FG000|Overall Study|Study Drug Toxicity|179|||
127612519|NCT00082433|459210568|FG001|Overall Study|Study Drug Toxicity|66|||
127612520|NCT00082433|459210567|FG000|Overall Study|Withdrawal by Subject|55|||
127612521|NCT00082433|459210568|FG001|Overall Study|Withdrawal by Subject|30|||
127612522|NCT00082433|459210567|FG000|Overall Study|Still On Treatment|2|||
127612523|NCT00082433|459210568|FG001|Overall Study|Still On Treatment|1|||
127612524|NCT00082433|459210567|FG000|Overall Study|Not Treated|12|||
127612525|NCT00082433|459210568|FG001|Overall Study|Not Treated|11|||
127612526|NCT00082433|459210567|FG000|Overall Study|Ineligible|2|||
127612527|NCT00082433|459210568|FG001|Overall Study|Ineligible|1|||
127612528|NCT00082433|459210567|FG000|Overall Study|Noncompliance|2|||
127612529|NCT00082433|459210568|FG001|Overall Study|Noncompliance|1|||
127612530|NCT00082433|459210567|FG000|Overall Study|New primary cancer|1|||
127612531|NCT00082433|459210568|FG001|Overall Study|New primary cancer|0|||
127612532|NCT00082433|459210567|FG000|Overall Study|Impending surgery|0|||
127612533|NCT00082433|459210568|FG001|Overall Study|Impending surgery|1|||
127612534|NCT04097821|459210569|FG000|Overall Study|Subject Decision|0|||
127612535|NCT04097821|459210570|FG001|Overall Study|Subject Decision|0|||
127612536|NCT04097821|459210571|FG002|Overall Study|Subject Decision|0|||
127612537|NCT04097821|459210572|FG003|Overall Study|Subject Decision|1|||
127612538|NCT04097821|459210573|FG004|Overall Study|Subject Decision|2|||
127612539|NCT04097821|459210574|FG005|Overall Study|Subject Decision|2|||
127612540|NCT04097821|459210575|FG006|Overall Study|Subject Decision|0|||
127612541|NCT04097821|459210576|FG007|Overall Study|Subject Decision|1|||
127612542|NCT04097821|459210569|FG000|Overall Study|Death|0|||
127612543|NCT04097821|459210570|FG001|Overall Study|Death|0|||
127612544|NCT04097821|459210571|FG002|Overall Study|Death|3|||
127612545|NCT04097821|459210572|FG003|Overall Study|Death|1|||
127612546|NCT04097821|459210573|FG004|Overall Study|Death|0|||
127612547|NCT04097821|459210574|FG005|Overall Study|Death|0|||
127612548|NCT04097821|459210575|FG006|Overall Study|Death|0|||
127612549|NCT04097821|459210576|FG007|Overall Study|Death|0|||
127612550|NCT04097821|459210569|FG000|Overall Study|Physician Decision|1|||
127612551|NCT04097821|459210570|FG001|Overall Study|Physician Decision|2|||
127612552|NCT04097821|459210571|FG002|Overall Study|Physician Decision|0|||
127612553|NCT04097821|459210572|FG003|Overall Study|Physician Decision|0|||
127612554|NCT04097821|459210573|FG004|Overall Study|Physician Decision|0|||
127612555|NCT04097821|459210574|FG005|Overall Study|Physician Decision|0|||
127612556|NCT04097821|459210575|FG006|Overall Study|Physician Decision|0|||
127612557|NCT04097821|459210576|FG007|Overall Study|Physician Decision|0|||
127612558|NCT04097821|459210569|FG000|Overall Study|Adverse Event|0|||
127612559|NCT04097821|459210570|FG001|Overall Study|Adverse Event|0|||
127612560|NCT04097821|459210571|FG002|Overall Study|Adverse Event|1|||
127612561|NCT04097821|459210572|FG003|Overall Study|Adverse Event|1|||
127612562|NCT04097821|459210573|FG004|Overall Study|Adverse Event|0|||
127612563|NCT04097821|459210574|FG005|Overall Study|Adverse Event|0|||
127612564|NCT04097821|459210575|FG006|Overall Study|Adverse Event|0|||
127612565|NCT04097821|459210576|FG007|Overall Study|Adverse Event|0|||
127612566|NCT04097821|459210569|FG000|Overall Study|New Therapy For Study Indication|0|||
127612567|NCT04097821|459210570|FG001|Overall Study|New Therapy For Study Indication|0|||
127789655|NCT01500278|459855144|FG000|Week 0 - Week 12|Protocol Violation|10|||
127789656|NCT01500278|459855145|FG001|Week 0 - Week 12|Protocol Violation|16|||
127789657|NCT01500278|459855144|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
127789658|NCT01500278|459855145|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
127789659|NCT01500278|459855144|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
127789660|NCT01500278|459855145|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
127789661|NCT01500278|459855144|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
127789662|NCT01500278|459855145|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
127789663|NCT01500278|459855144|FG000|Week 0 - Week 12|Patient decision|1|||
127789664|NCT01500278|459855145|FG001|Week 0 - Week 12|Patient decision|0|||
127789665|NCT01500278|459855144|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
127612568|NCT04097821|459210571|FG002|Overall Study|New Therapy For Study Indication|0|||
127612569|NCT04097821|459210572|FG003|Overall Study|New Therapy For Study Indication|0|||
127612570|NCT04097821|459210573|FG004|Overall Study|New Therapy For Study Indication|0|||
127612571|NCT04097821|459210574|FG005|Overall Study|New Therapy For Study Indication|0|||
127789666|NCT01500278|459855145|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
127612572|NCT04097821|459210575|FG006|Overall Study|New Therapy For Study Indication|1|||
127612573|NCT04097821|459210576|FG007|Overall Study|New Therapy For Study Indication|0|||
127612574|NCT04477304|459210577|FG000|Overall Study|No valid opioid prescriptions during study timeframe|47|||
127612575|NCT04477304|459210578|FG001|Overall Study|No valid opioid prescriptions during study timeframe|26|||
127612576|NCT05756790|459210581|FG000|Overall Study|Withdrawal by Subject|1|||
127612577|NCT05756790|459210582|FG001|Overall Study|Withdrawal by Subject|1|||
127612578|NCT05756790|459210583|FG002|Overall Study|Withdrawal by Subject|1|||
127612579|NCT05756790|459210584|FG003|Overall Study|Withdrawal by Subject|1|||
127612580|NCT05756790|459210585|FG004|Overall Study|Withdrawal by Subject|0|||
127612581|NCT05756790|459210586|FG005|Overall Study|Withdrawal by Subject|0|||
127612582|NCT05756790|459210581|FG000|Overall Study|Protocol Violation|0|||
127612583|NCT05756790|459210582|FG001|Overall Study|Protocol Violation|0|||
127612584|NCT05756790|459210583|FG002|Overall Study|Protocol Violation|1|||
127612585|NCT05756790|459210584|FG003|Overall Study|Protocol Violation|1|||
127612586|NCT05756790|459210585|FG004|Overall Study|Protocol Violation|0|||
127612587|NCT05756790|459210586|FG005|Overall Study|Protocol Violation|0|||
127612588|NCT05756790|459210581|FG000|Overall Study|Ineligible|0|||
127612589|NCT05756790|459210582|FG001|Overall Study|Ineligible|0|||
127612590|NCT05756790|459210583|FG002|Overall Study|Ineligible|0|||
127612591|NCT05756790|459210584|FG003|Overall Study|Ineligible|0|||
127612592|NCT05756790|459210585|FG004|Overall Study|Ineligible|2|||
127612593|NCT05756790|459210586|FG005|Overall Study|Ineligible|2|||
127612594|NCT03256552|459212303|FG000|Overall Study|Protocol Violation|1|||
127612595|NCT03256552|459212303|FG000|Overall Study|Physician Decision|1|||
127612596|NCT03256552|459212303|FG000|Overall Study|Adverse Event|1|||
127612597|NCT03256552|459212303|FG000|Overall Study|Withdrawal by Subject|2|||
127612598|NCT03026257|459212304|FG000|Overall Study|Adverse Event|3|||
127612599|NCT03026257|459212305|FG001|Overall Study|Adverse Event|0|||
127612600|NCT03026257|459212306|FG002|Overall Study|Adverse Event|0|||
127612601|NCT03026257|459212307|FG003|Overall Study|Adverse Event|0|||
127789667|NCT01500278|459855144|FG000|Week 0 - Week 12|Investigator decision|1|||
127789668|NCT01500278|459855145|FG001|Week 0 - Week 12|Investigator decision|0|||
127789669|NCT01500278|459855144|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
127789670|NCT01500278|459855145|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
127789671|NCT01500278|459855144|FG000|Week 0 - Week 12|Sponsor decision|1|||
127789672|NCT01500278|459855145|FG001|Week 0 - Week 12|Sponsor decision|0|||
127789673|NCT01500278|459855144|FG000|Week 0 - Week 12|Personal reason|0|||
127789674|NCT01500278|459855145|FG001|Week 0 - Week 12|Personal reason|1|||
127789675|NCT01500278|459855144|FG000|Week 0 - Week 12|Other serious disease|0|||
127789676|NCT01500278|459855145|FG001|Week 0 - Week 12|Other serious disease|1|||
127789677|NCT01500278|459855144|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
127789678|NCT01500278|459855145|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
127789679|NCT01500278|459855144|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
127789680|NCT01500278|459855145|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
127789681|NCT01500278|459855144|FG000|Week 13 - Week 104|Protocol Violation|6|||
127789682|NCT01500278|459855145|FG001|Week 13 - Week 104|Protocol Violation|6|||
127789683|NCT01500278|459855144|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
127789684|NCT01500278|459855145|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
127789685|NCT01500278|459855144|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
127789686|NCT01500278|459855145|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
127789687|NCT01500278|459855144|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
127789688|NCT01500278|459855145|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
127789689|NCT01500278|459855144|FG000|Week 13 - Week 104|Non/bad compliance|7|||
127789690|NCT01500278|459855145|FG001|Week 13 - Week 104|Non/bad compliance|5|||
127789691|NCT01500278|459855144|FG000|Week 13 - Week 104|Recurrent infections|1|||
127789692|NCT01500278|459855145|FG001|Week 13 - Week 104|Recurrent infections|0|||
127789693|NCT01500278|459855144|FG000|Week 13 - Week 104|False positive test|1|||
127789694|NCT01500278|459855145|FG001|Week 13 - Week 104|False positive test|2|||
127789695|NCT01500278|459855144|FG000|Week 13 - Week 104|Sponsor request|4|||
127789696|NCT01500278|459855145|FG001|Week 13 - Week 104|Sponsor request|0|||
127789697|NCT01500278|459855144|FG000|Week 13 - Week 104|Withdrawn in error|1|||
127789698|NCT01500278|459855145|FG001|Week 13 - Week 104|Withdrawn in error|0|||
127789699|NCT01500278|459855144|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
127612602|NCT03026257|459212308|FG004|Overall Study|Adverse Event|0|||
127612603|NCT03026257|459212309|FG005|Overall Study|Adverse Event|0|||
127612604|NCT03026257|459212304|FG000|Overall Study|Lost to Follow-up|1|||
127612605|NCT03026257|459212305|FG001|Overall Study|Lost to Follow-up|0|||
127612606|NCT03026257|459212306|FG002|Overall Study|Lost to Follow-up|0|||
127612607|NCT03026257|459212307|FG003|Overall Study|Lost to Follow-up|0|||
127789700|NCT01500278|459855145|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
127789701|NCT01500278|459855144|FG000|Week 13 - Week 104|Protocol deviation|1|||
127789702|NCT01500278|459855145|FG001|Week 13 - Week 104|Protocol deviation|0|||
127789703|NCT01500278|459855144|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
127887325|NCT04128696|460210582|FG000|Overall Study|Lost to Follow-up|3|||
127789704|NCT01500278|459855145|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
127789705|NCT01500278|459855144|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
127789706|NCT01500278|459855145|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
127789707|NCT01500278|459855144|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
127789708|NCT01500278|459855145|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
127789709|NCT01500278|459855144|FG000|Week 13 - Week 104|Relocation|0|||
127789710|NCT01500278|459855145|FG001|Week 13 - Week 104|Relocation|1|||
127789711|NCT01500278|459855144|FG000|Week 13 - Week 104|Sponsor decision|0|||
127789712|NCT01500278|459855145|FG001|Week 13 - Week 104|Sponsor decision|2|||
127789713|NCT01500278|459855144|FG000|Week 13 - Week 104|Medical monitor decision|0|||
127789714|NCT01500278|459855145|FG001|Week 13 - Week 104|Medical monitor decision|2|||
127789715|NCT01500278|459855144|FG000|Week 13 - Week 104|Personal reason|0|||
127789716|NCT01500278|459855145|FG001|Week 13 - Week 104|Personal reason|1|||
127789717|NCT01500278|459855144|FG000|Week 13 - Week 104|Not completed|0|||
127789718|NCT01500278|459855145|FG001|Week 13 - Week 104|Not completed|1|||
127789719|NCT01500278|459855144|FG000|Week 13 - Week 104|Death|2|||
127789720|NCT01500278|459855145|FG001|Week 13 - Week 104|Death|4|||
127789721|NCT01500278|459855144|FG000|Week 13 - Week 104|Adverse Event|54|||
127789722|NCT01500278|459855145|FG001|Week 13 - Week 104|Adverse Event|54|||
127789723|NCT01709435|459855149|FG000|Overall Study|Adverse Event|1|||
127789724|NCT01709435|459855150|FG001|Overall Study|Adverse Event|1|||
127612608|NCT03026257|459212308|FG004|Overall Study|Lost to Follow-up|0|||
127612609|NCT03026257|459212309|FG005|Overall Study|Lost to Follow-up|0|||
127612610|NCT03026257|459212304|FG000|Overall Study|Protocol Violation|1|||
127612611|NCT03026257|459212305|FG001|Overall Study|Protocol Violation|0|||
127612612|NCT03026257|459212306|FG002|Overall Study|Protocol Violation|0|||
127612613|NCT03026257|459212307|FG003|Overall Study|Protocol Violation|1|||
127612614|NCT03026257|459212308|FG004|Overall Study|Protocol Violation|1|||
127612615|NCT03026257|459212309|FG005|Overall Study|Protocol Violation|0|||
127612616|NCT03026257|459212304|FG000|Overall Study|Withdrawal by Subject|1|||
127612617|NCT03026257|459212305|FG001|Overall Study|Withdrawal by Subject|1|||
127612618|NCT03026257|459212306|FG002|Overall Study|Withdrawal by Subject|0|||
127612619|NCT03026257|459212307|FG003|Overall Study|Withdrawal by Subject|0|||
127612620|NCT03026257|459212308|FG004|Overall Study|Withdrawal by Subject|0|||
127612621|NCT03026257|459212309|FG005|Overall Study|Withdrawal by Subject|0|||
127612622|NCT05083442|459212310|FG000|Overall Study|Lost to Follow-up|1|||
127612623|NCT05083442|459212311|FG001|Overall Study|Lost to Follow-up|0|||
127612624|NCT05083442|459212310|FG000|Overall Study|Lack of Efficacy|0|||
127612625|NCT05083442|459212311|FG001|Overall Study|Lack of Efficacy|1|||
127612626|NCT05083442|459212310|FG000|Overall Study|Withdrawal by Subject|1|||
127612627|NCT05083442|459212311|FG001|Overall Study|Withdrawal by Subject|3|||
127612628|NCT05083442|459212310|FG000|Overall Study|scheduling difficulties|1|||
127612629|NCT05083442|459212311|FG001|Overall Study|scheduling difficulties|2|||
127612630|NCT00136084|459212317|FG000|Overall Study|Death|12|||
127612631|NCT00136084|459212318|FG001|Overall Study|Death|5|||
127612632|NCT00136084|459212317|FG000|Overall Study|Unacceptable toxicity|8|||
127612633|NCT00136084|459212318|FG001|Overall Study|Unacceptable toxicity|11|||
127612634|NCT00136084|459212317|FG000|Overall Study|Relapse|20|||
127612635|NCT00136084|459212318|FG001|Overall Study|Relapse|23|||
127612636|NCT00136084|459212317|FG000|Overall Study|Lost to Follow-up|2|||
127612637|NCT00136084|459212318|FG001|Overall Study|Lost to Follow-up|0|||
127612638|NCT00136084|459212317|FG000|Overall Study|No Response|1|||
127612639|NCT00136084|459212318|FG001|Overall Study|No Response|2|||
127612640|NCT00136084|459212317|FG000|Overall Study|Withdrawal by Subject|5|||
127612641|NCT00136084|459212318|FG001|Overall Study|Withdrawal by Subject|1|||
127612642|NCT02476968|459212319|FG000|Overall Study|Other|0|||
127612643|NCT02476968|459212320|FG001|Overall Study|Other|2|||
127612644|NCT02476968|459212321|FG002|Overall Study|Other|0|||
127789725|NCT01709435|459855151|FG002|Overall Study|Adverse Event|1|||
127789726|NCT01709435|459855152|FG003|Overall Study|Adverse Event|0|||
127789727|NCT01709435|459855153|FG004|Overall Study|Adverse Event|0|||
127789728|NCT01709435|459855154|FG005|Overall Study|Adverse Event|1|||
127789729|NCT01709435|459855149|FG000|Overall Study|Lack of Efficacy|5|||
127789730|NCT01709435|459855150|FG001|Overall Study|Lack of Efficacy|7|||
127789731|NCT01709435|459855151|FG002|Overall Study|Lack of Efficacy|2|||
127789732|NCT01709435|459855152|FG003|Overall Study|Lack of Efficacy|2|||
127789733|NCT01709435|459855153|FG004|Overall Study|Lack of Efficacy|6|||
127789734|NCT01709435|459855154|FG005|Overall Study|Lack of Efficacy|3|||
127612645|NCT02476968|459212319|FG000|Overall Study|Lost to Follow-up|10|||
127612646|NCT02476968|459212320|FG001|Overall Study|Lost to Follow-up|0|||
127612647|NCT02476968|459212321|FG002|Overall Study|Lost to Follow-up|1|||
127612648|NCT02476968|459212319|FG000|Overall Study|Death|48|||
127612649|NCT02476968|459212320|FG001|Overall Study|Death|8|||
127612650|NCT02476968|459212321|FG002|Overall Study|Death|1|||
127612651|NCT02476968|459212319|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
127612652|NCT02476968|459212320|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
127612653|NCT02476968|459212321|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
127612654|NCT02476968|459212319|FG000|Overall Study|Patient decision|37|||
127789735|NCT01709435|459855149|FG000|Overall Study|Physician Decision|0|||
127612655|NCT02476968|459212320|FG001|Overall Study|Patient decision|8|||
127612656|NCT02476968|459212321|FG002|Overall Study|Patient decision|0|||
127612657|NCT02256891|459212324|FG000|Overall Study|Death|0|||
127612658|NCT02256891|459212325|FG001|Overall Study|Death|2|||
127612659|NCT02256891|459212324|FG000|Overall Study|Lost to Follow-up|0|||
127612660|NCT02256891|459212325|FG001|Overall Study|Lost to Follow-up|3|||
127612661|NCT02256891|459212324|FG000|Overall Study|Physician Decision|7|||
127612662|NCT02256891|459212325|FG001|Overall Study|Physician Decision|3|||
127612663|NCT02256891|459212324|FG000|Overall Study|Screen Fail|5|||
127612664|NCT02256891|459212325|FG001|Overall Study|Screen Fail|4|||
127612665|NCT02256891|459212324|FG000|Overall Study|Equipment Malfunction|0|||
127612666|NCT02256891|459212325|FG001|Overall Study|Equipment Malfunction|1|||
127612667|NCT01344447|459212326|FG000|Overall Study|Adverse Event|1|||
127612668|NCT01344447|459212326|FG000|Overall Study|Protocol Violation|1|||
127612669|NCT01344447|459212326|FG000|Overall Study|Withdrawal by Subject|1|||
127612670|NCT01344447|459212326|FG000|Overall Study|The contrast was not seen|1|||
127612671|NCT01344447|459212326|FG000|Overall Study|Physician Decision|1|||
127612672|NCT01344447|459212326|FG000|Overall Study|MRA unsuccessful|1|||
127612673|NCT01344447|459212326|FG000|Overall Study|Bolus tracking failed|1|||
127612674|NCT01344447|459212326|FG000|Overall Study|Error of power injector|1|||
127612675|NCT01990495|459212333|FG000|Overall Study|Physician Decision|5|||
127612676|NCT01990495|459212334|FG001|Overall Study|Physician Decision|4|||
127612677|NCT01928862|459212335|FG000|Overall Study|Lost to Follow-up|1|||
127612678|NCT01928862|459212336|FG001|Overall Study|Lost to Follow-up|0|||
127612679|NCT01928862|459212337|FG002|Overall Study|Lost to Follow-up|0|||
127612680|NCT01928862|459212338|FG003|Overall Study|Lost to Follow-up|0|||
127612681|NCT01928862|459212339|FG004|Overall Study|Lost to Follow-up|1|||
127612682|NCT01478321|459212340|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
127612683|NCT01478321|459212340|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
127612684|NCT01478321|459212340|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
127612685|NCT01478321|459212340|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
127612686|NCT01478321|459212340|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
127612687|NCT01478321|459212340|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
127612688|NCT01478321|459212340|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
127612689|NCT01478321|459212340|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
127612690|NCT03168464|459212341|FG000|Overall Study|Death|9|||
127612691|NCT03168464|459212341|FG000|Overall Study|Progression of disease|6|||
127698735|NCT01084876|459526485|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|12|||
127698736|NCT01084876|459526486|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|20|||
127698737|NCT01084876|459526485|FG000|Treatment Period Beyond Cycle 8|Other Reason|7|||
127698738|NCT01084876|459526486|FG001|Treatment Period Beyond Cycle 8|Other Reason|13|||
127698739|NCT01084876|459526485|FG000|Treatment Period Beyond Cycle 8|Other|6|||
127698740|NCT01084876|459526486|FG001|Treatment Period Beyond Cycle 8|Other|9|||
127698741|NCT02924272|459526494|FG000|Overall Study|Site Terminated by Sponsor|4|||
127698742|NCT02924272|459526495|FG001|Overall Study|Site Terminated by Sponsor|1|||
127698743|NCT02924272|459526494|FG000|Overall Study|Withdrawal by Subject|2|||
127698744|NCT02924272|459526495|FG001|Overall Study|Withdrawal by Subject|0|||
127698745|NCT02924272|459526494|FG000|Overall Study|Adverse Event|3|||
127698746|NCT02924272|459526495|FG001|Overall Study|Adverse Event|0|||
127698747|NCT02924272|459526494|FG000|Overall Study|Progressive Disease|11|||
127698748|NCT02924272|459526495|FG001|Overall Study|Progressive Disease|8|||
127698749|NCT02924272|459526494|FG000|Overall Study|Clinical Deterioration|1|||
127698750|NCT02924272|459526495|FG001|Overall Study|Clinical Deterioration|0|||
127698751|NCT02924272|459526494|FG000|Overall Study|Death|1|||
127698752|NCT02924272|459526495|FG001|Overall Study|Death|0|||
127698753|NCT02924272|459526494|FG000|Overall Study|Reason Not Specified|1|||
127698754|NCT02924272|459526495|FG001|Overall Study|Reason Not Specified|0|||
127698755|NCT02100813|459526500|FG000|Overall Study|Adverse Event|0|||
127698756|NCT02100813|459526501|FG001|Overall Study|Adverse Event|0|||
127698757|NCT02100813|459526502|FG002|Overall Study|Adverse Event|0|||
127698758|NCT02100813|459526503|FG003|Overall Study|Adverse Event|0|||
127698759|NCT02100813|459526504|FG004|Overall Study|Adverse Event|0|||
127612692|NCT04649164|459212342|FG000|Overall Study|Withdrawal by Subject|1|||
127612693|NCT04649164|459212343|FG001|Overall Study|Withdrawal by Subject|1|||
127612694|NCT04649164|459212344|FG002|Overall Study|Withdrawal by Subject|2|||
127612695|NCT04649164|459212342|FG000|Overall Study|Participant's care recipient expired|0|||
127612696|NCT04649164|459212343|FG001|Overall Study|Participant's care recipient expired|0|||
127612697|NCT04649164|459212344|FG002|Overall Study|Participant's care recipient expired|2|||
127612698|NCT02053753|459212345|FG000|Overall Study|Withdrawal by Subject|2|||
127612699|NCT02053753|459212346|FG001|Overall Study|Withdrawal by Subject|4|||
127698760|NCT02100813|459526505|FG005|Overall Study|Adverse Event|0|||
127698761|NCT02100813|459526506|FG006|Overall Study|Adverse Event|0|||
127698762|NCT02100813|459526507|FG007|Overall Study|Adverse Event|1|||
127612700|NCT02053753|459212345|FG000|Overall Study|Decision by Sponsor|1|||
127612701|NCT02053753|459212346|FG001|Overall Study|Decision by Sponsor|1|||
127612702|NCT02053753|459212345|FG000|Overall Study|Lost to Follow-up|4|||
127612703|NCT02053753|459212346|FG001|Overall Study|Lost to Follow-up|3|||
127612704|NCT01203072|459212353|FG000|Overall Study|Adverse Event|5|||
127612705|NCT01203072|459212354|FG001|Overall Study|Adverse Event|3|||
127612706|NCT01203072|459212355|FG002|Overall Study|Adverse Event|2|||
127612707|NCT01203072|459212356|FG003|Overall Study|Adverse Event|4|||
127612708|NCT01203072|459212357|FG004|Overall Study|Adverse Event|2|||
127612709|NCT01203072|459212353|FG000|Overall Study|Lack of Efficacy|1|||
127612710|NCT01203072|459212354|FG001|Overall Study|Lack of Efficacy|0|||
127612711|NCT01203072|459212355|FG002|Overall Study|Lack of Efficacy|0|||
127612712|NCT01203072|459212356|FG003|Overall Study|Lack of Efficacy|0|||
127612713|NCT01203072|459212357|FG004|Overall Study|Lack of Efficacy|0|||
127612714|NCT01203072|459212353|FG000|Overall Study|Lost to Follow-up|0|||
127612715|NCT01203072|459212354|FG001|Overall Study|Lost to Follow-up|1|||
127612716|NCT01203072|459212355|FG002|Overall Study|Lost to Follow-up|0|||
127612717|NCT01203072|459212356|FG003|Overall Study|Lost to Follow-up|0|||
127612718|NCT01203072|459212357|FG004|Overall Study|Lost to Follow-up|0|||
127612719|NCT01203072|459212353|FG000|Overall Study|Protocol Violation|2|||
127612720|NCT01203072|459212354|FG001|Overall Study|Protocol Violation|0|||
127612721|NCT01203072|459212355|FG002|Overall Study|Protocol Violation|0|||
127612722|NCT01203072|459212356|FG003|Overall Study|Protocol Violation|0|||
127612723|NCT01203072|459212357|FG004|Overall Study|Protocol Violation|1|||
127612724|NCT01203072|459212353|FG000|Overall Study|Withdrawal by Subject|2|||
127612725|NCT01203072|459212354|FG001|Overall Study|Withdrawal by Subject|2|||
127612726|NCT01203072|459212355|FG002|Overall Study|Withdrawal by Subject|1|||
127612727|NCT01203072|459212356|FG003|Overall Study|Withdrawal by Subject|2|||
127612728|NCT01203072|459212357|FG004|Overall Study|Withdrawal by Subject|3|||
127612729|NCT00006478|459212367|FG000|Overall Study|Vaccine could not be produced|1|||
127612730|NCT00006478|459212367|FG000|Overall Study|Physician Decision|6|||
127612731|NCT01987427|459212375|FG000|Overall Study|Adverse Event|4|||
127612732|NCT01987427|459212376|FG001|Overall Study|Adverse Event|2|||
127612733|NCT01987427|459212377|FG002|Overall Study|Adverse Event|8|||
127612734|NCT01987427|459212375|FG000|Overall Study|Lost to Follow-up|6|||
127612735|NCT01987427|459212376|FG001|Overall Study|Lost to Follow-up|6|||
127612736|NCT01987427|459212377|FG002|Overall Study|Lost to Follow-up|9|||
127612737|NCT01987427|459212375|FG000|Overall Study|Withdrawal by Subject|2|||
127612738|NCT01987427|459212376|FG001|Overall Study|Withdrawal by Subject|1|||
127612739|NCT01987427|459212377|FG002|Overall Study|Withdrawal by Subject|3|||
127612740|NCT01987427|459212375|FG000|Overall Study|Lack of Efficacy|1|||
127612741|NCT01987427|459212376|FG001|Overall Study|Lack of Efficacy|0|||
127612742|NCT01987427|459212377|FG002|Overall Study|Lack of Efficacy|0|||
127612743|NCT01987427|459212375|FG000|Overall Study|Other|1|||
127612744|NCT01987427|459212376|FG001|Overall Study|Other|1|||
127612745|NCT01987427|459212377|FG002|Overall Study|Other|0|||
127789736|NCT01709435|459855150|FG001|Overall Study|Physician Decision|1|||
127789737|NCT01709435|459855151|FG002|Overall Study|Physician Decision|0|||
127789738|NCT01709435|459855152|FG003|Overall Study|Physician Decision|1|||
127789739|NCT01709435|459855153|FG004|Overall Study|Physician Decision|2|||
127789740|NCT01709435|459855154|FG005|Overall Study|Physician Decision|0|||
127789741|NCT01709435|459855149|FG000|Overall Study|Withdrawal by Subject|0|||
127789742|NCT01709435|459855150|FG001|Overall Study|Withdrawal by Subject|0|||
127789743|NCT01709435|459855151|FG002|Overall Study|Withdrawal by Subject|3|||
127789744|NCT01709435|459855152|FG003|Overall Study|Withdrawal by Subject|0|||
127789745|NCT01709435|459855153|FG004|Overall Study|Withdrawal by Subject|2|||
127612746|NCT01073865|459212378|FG000|Overall Study|Reasons other than below|19|||
127612747|NCT01073865|459212379|FG001|Overall Study|Reasons other than below|31|||
127789746|NCT01709435|459855154|FG005|Overall Study|Withdrawal by Subject|2|||
127789747|NCT01297270|459855158|FG000|Overall Study|Adverse Event|19|||
127789748|NCT01297270|459855159|FG001|Overall Study|Adverse Event|32|||
127612748|NCT01073865|459212378|FG000|Overall Study|Lost to Follow-up|1|||
127612749|NCT01073865|459212379|FG001|Overall Study|Lost to Follow-up|1|||
127789749|NCT01297270|459855160|FG002|Overall Study|Adverse Event|5|||
127789750|NCT01297270|459855158|FG000|Overall Study|Lack of Efficacy|15|||
127612750|NCT01073865|459212378|FG000|Overall Study|Death|3|||
127789751|NCT01297270|459855159|FG001|Overall Study|Lack of Efficacy|17|||
127612751|NCT01073865|459212379|FG001|Overall Study|Death|2|||
127612752|NCT01073865|459212378|FG000|Overall Study|Withdrawal by Subject|5|||
127612753|NCT01073865|459212379|FG001|Overall Study|Withdrawal by Subject|5|||
127612754|NCT00805766|459212380|FG000|Screening Period|Adverse Event|1|||
127612755|NCT00805766|459212380|FG000|Screening Period|Lack of Efficacy|2|||
127612756|NCT00805766|459212380|FG000|Screening Period|Pregnancy|1|||
127612757|NCT00805766|459212380|FG000|Screening Period|Responder|2|||
127612758|NCT00805766|459212380|FG000|Increased Dose Period|Adverse Event|4|||
127612759|NCT00805766|459212380|FG000|Increased Dose Period|Lack of Efficacy|7|||
127612760|NCT00805766|459212380|FG000|Increased Dose Period|Pregnancy|1|||
127612761|NCT00805766|459212380|FG000|Increased Dose Period|Withdrawal by Subject|1|||
127612762|NCT00600756|459212381|FG000|Analysis After 6 Months|Adverse Event|43|||
127612763|NCT00600756|459212382|FG001|Analysis After 6 Months|Adverse Event|33|||
127612764|NCT00600756|459212381|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
127612765|NCT00600756|459212382|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
127612766|NCT00600756|459212381|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
127612767|NCT00600756|459212382|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
127612768|NCT00600756|459212381|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
127612769|NCT00600756|459212382|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
127612770|NCT00600756|459212381|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
127612771|NCT00600756|459212382|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
127612772|NCT00600756|459212381|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
127612773|NCT00600756|459212382|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
127612774|NCT00600756|459212381|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
127612775|NCT00600756|459212382|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
127612776|NCT00600756|459212381|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
127612777|NCT00600756|459212382|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
127612778|NCT00600756|459212381|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
127612779|NCT00600756|459212382|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
127612780|NCT00600756|459212381|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
127612781|NCT00600756|459212382|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
127612782|NCT00600756|459212381|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
127612783|NCT00600756|459212382|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
127612784|NCT00600756|459212381|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
127612785|NCT00600756|459212382|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
127698763|NCT05308004|459526509|FG000|Overall Study|Not seen by Palliative Care NP|0|||
127883300|NCT01039584|460196394|FG001|Overall Study|Withdrawal by Subject|2|||
127883301|NCT01039584|460196395|FG002|Overall Study|Withdrawal by Subject|1|||
127883302|NCT01039584|460196393|FG000|Overall Study|Protocol Violation|10|||
127883303|NCT01039584|460196394|FG001|Overall Study|Protocol Violation|4|||
127883304|NCT01039584|460196395|FG002|Overall Study|Protocol Violation|6|||
127883305|NCT01039584|460196393|FG000|Overall Study|Lost to Follow-up|5|||
127883306|NCT01039584|460196394|FG001|Overall Study|Lost to Follow-up|3|||
127883307|NCT01039584|460196395|FG002|Overall Study|Lost to Follow-up|4|||
127883308|NCT01039584|460196393|FG000|Overall Study|Negative Baseline culture for Candida|59|||
127883309|NCT01039584|460196394|FG001|Overall Study|Negative Baseline culture for Candida|59|||
127883310|NCT01039584|460196395|FG002|Overall Study|Negative Baseline culture for Candida|24|||
127883311|NCT01039584|460196393|FG000|Overall Study|Lack of Efficacy|7|||
127883312|NCT01039584|460196394|FG001|Overall Study|Lack of Efficacy|6|||
127883313|NCT01039584|460196395|FG002|Overall Study|Lack of Efficacy|10|||
127883314|NCT01039584|460196393|FG000|Overall Study|other|1|||
127883315|NCT01039584|460196394|FG001|Overall Study|other|3|||
127883316|NCT01039584|460196395|FG002|Overall Study|other|1|||
127883317|NCT01039584|460196393|FG000|Overall Study|Pap smear with significant pathology|10|||
127883318|NCT01039584|460196394|FG001|Overall Study|Pap smear with significant pathology|10|||
127883319|NCT01039584|460196395|FG002|Overall Study|Pap smear with significant pathology|3|||
127883320|NCT01039584|460196393|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
127883321|NCT01039584|460196394|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
127883322|NCT01039584|460196395|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
127883323|NCT03611751|460196396|FG000|Pre-treatment|Randomized but not treated|1|||
127883324|NCT03611751|460196397|FG001|Pre-treatment|Randomized but not treated|1|||
127883325|NCT03611751|460196398|FG002|Pre-treatment|Randomized but not treated|0|||
127883326|NCT03611751|460196396|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
127883327|NCT03611751|460196397|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
127883328|NCT03611751|460196398|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
127612786|NCT00600756|459212381|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
127612787|NCT00600756|459212382|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
127883329|NCT03611751|460196396|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
127883330|NCT03611751|460196397|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
127883331|NCT03611751|460196398|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
127883332|NCT03611751|460196396|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
127883333|NCT03611751|460196397|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
127883334|NCT03611751|460196398|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
127612788|NCT00600756|459212381|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
127612789|NCT00600756|459212382|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
127612790|NCT03261947|459212386|FG000|Overall Study|Death|10|||
127612791|NCT03261947|459212387|FG001|Overall Study|Death|13|||
127612792|NCT03261947|459212388|FG002|Overall Study|Death|17|||
127612793|NCT03261947|459212389|FG003|Overall Study|Death|12|||
127612794|NCT03261947|459212390|FG004|Overall Study|Death|8|||
127612795|NCT03261947|459212386|FG000|Overall Study|Lost to Follow-up|0|||
127612796|NCT03261947|459212387|FG001|Overall Study|Lost to Follow-up|0|||
127612797|NCT03261947|459212388|FG002|Overall Study|Lost to Follow-up|2|||
127612798|NCT03261947|459212389|FG003|Overall Study|Lost to Follow-up|1|||
127612799|NCT03261947|459212390|FG004|Overall Study|Lost to Follow-up|0|||
127612800|NCT03261947|459212386|FG000|Overall Study|Withdrawal by Subject|0|||
127612801|NCT03261947|459212387|FG001|Overall Study|Withdrawal by Subject|0|||
127612802|NCT03261947|459212388|FG002|Overall Study|Withdrawal by Subject|3|||
127612803|NCT03261947|459212389|FG003|Overall Study|Withdrawal by Subject|0|||
127612804|NCT03261947|459212390|FG004|Overall Study|Withdrawal by Subject|1|||
127612805|NCT03261947|459212386|FG000|Overall Study|Site Terminated by Sponsor|0|||
127612806|NCT03261947|459212387|FG001|Overall Study|Site Terminated by Sponsor|0|||
127612807|NCT03261947|459212388|FG002|Overall Study|Site Terminated by Sponsor|4|||
127612808|NCT03261947|459212389|FG003|Overall Study|Site Terminated by Sponsor|7|||
127612809|NCT03261947|459212390|FG004|Overall Study|Site Terminated by Sponsor|5|||
127612810|NCT03261947|459212386|FG000|Overall Study|Reason not Specified|2|||
127612811|NCT03261947|459212387|FG001|Overall Study|Reason not Specified|0|||
127612812|NCT03261947|459212388|FG002|Overall Study|Reason not Specified|4|||
127612813|NCT03261947|459212389|FG003|Overall Study|Reason not Specified|1|||
127612814|NCT03261947|459212390|FG004|Overall Study|Reason not Specified|3|||
127612815|NCT03969992|459212391|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|1|||
127612816|NCT03969992|459212392|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|0|||
127612817|NCT03969992|459212393|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|3|||
127612818|NCT03969992|459212391|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
127612819|NCT03969992|459212392|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Death|3|||
127612820|NCT03969992|459212393|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
127612821|NCT03969992|459212391|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|12|||
127612822|NCT03969992|459212392|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|8|||
127612823|NCT03969992|459212393|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|9|||
127612824|NCT03969992|459212391|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
127612825|NCT03969992|459212392|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
127612826|NCT03969992|459212393|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|1|||
127612827|NCT03969992|459212391|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|3|||
127612828|NCT03969992|459212392|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|1|||
127612829|NCT03969992|459212393|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|0|||
127612830|NCT00439556|459212398|FG000|Overall Study|Patient was taken off study for non-comp|0|||
127612831|NCT00439556|459212399|FG001|Overall Study|Patient was taken off study for non-comp|1|||
127612832|NCT00439556|459212400|FG002|Overall Study|Patient was taken off study for non-comp|0|||
127612833|NCT02871739|459212401|FG000|Overall Study|Lost to Follow-up|3|||
127612834|NCT02871739|459212402|FG001|Overall Study|Lost to Follow-up|2|||
127612835|NCT02871739|459212403|FG002|Overall Study|Lost to Follow-up|0|||
127612836|NCT02871739|459212404|FG003|Overall Study|Lost to Follow-up|2|||
127612837|NCT03818516|459212405|FG000|Overall Study|Exclusion due to positive UDS (THC) test|1|||
127612838|NCT04372602|459212408|FG000|Overall Study|Withdrawal by Subject|1|||
127612839|NCT04372602|459212409|FG001|Overall Study|Withdrawal by Subject|1|||
127612840|NCT04372602|459212408|FG000|Overall Study|Adverse Event|0|||
127612841|NCT04372602|459212409|FG001|Overall Study|Adverse Event|1|||
127612842|NCT04372602|459212408|FG000|Overall Study|Transitioned to comfort care|0|||
127612843|NCT04372602|459212409|FG001|Overall Study|Transitioned to comfort care|1|||
127612844|NCT02907359|459212410|FG000|Overall Study|Death|234|||
127612845|NCT02907359|459212411|FG001|Overall Study|Death|117|||
127612846|NCT02907359|459212410|FG000|Overall Study|Withdrawal by Subject|6|||
127612847|NCT02907359|459212411|FG001|Overall Study|Withdrawal by Subject|11|||
127612848|NCT02907359|459212410|FG000|Overall Study|Lost to Follow-up|1|||
127612849|NCT02907359|459212411|FG001|Overall Study|Lost to Follow-up|0|||
127612850|NCT01405963|459212412|FG000|Overall Study|Moved Away|2|||
127612851|NCT01405963|459212413|FG001|Overall Study|Moved Away|0|||
127612852|NCT01405963|459212412|FG000|Overall Study|Adverse Event|0|||
127612853|NCT01405963|459212413|FG001|Overall Study|Adverse Event|1|||
127612854|NCT01405963|459212412|FG000|Overall Study|Lost to Follow-up|0|||
127612855|NCT01405963|459212413|FG001|Overall Study|Lost to Follow-up|1|||
127612856|NCT04544293|459212420|FG000|Double-blind|Adverse Event|2|||
127612857|NCT04544293|459212421|FG001|Double-blind|Adverse Event|1|||
127612858|NCT04544293|459212420|FG000|Double-blind|Pregnancy|0|||
127612859|NCT04544293|459212421|FG001|Double-blind|Pregnancy|1|||
127612860|NCT04544293|459212420|FG000|Double-blind|Lost to Follow-up|0|||
127612861|NCT04544293|459212421|FG001|Double-blind|Lost to Follow-up|1|||
127612862|NCT04544293|459212420|FG000|Open-Label Extension|Study ongoing|79|||
127612863|NCT04544293|459212421|FG001|Open-Label Extension|Study ongoing|81|||
127612864|NCT00329407|459212422|FG000|Overall Study|Withdrawal by Subject|1|||
127612865|NCT03560531|459212423|FG000|Overall Study|Death|4|||
127612866|NCT03560531|459212424|FG001|Overall Study|Death|1|||
127612867|NCT03560531|459212425|FG002|Overall Study|Death|1|||
127612868|NCT03560531|459212426|FG003|Overall Study|Death|2|||
127612869|NCT03560531|459212427|FG004|Overall Study|Death|6|||
127612870|NCT03560531|459212428|FG005|Overall Study|Death|1|||
127612871|NCT03560531|459212429|FG006|Overall Study|Death|4|||
127612872|NCT03560531|459212430|FG007|Overall Study|Death|8|||
127612873|NCT03560531|459212431|FG008|Overall Study|Death|1|||
127612874|NCT03560531|459212432|FG009|Overall Study|Death|3|||
127612875|NCT03560531|459212433|FG010|Overall Study|Death|2|||
127612876|NCT03560531|459212434|FG011|Overall Study|Death|0|||
127612877|NCT03560531|459212435|FG012|Overall Study|Death|4|||
127612878|NCT03560531|459212436|FG013|Overall Study|Death|1|||
127612879|NCT03560531|459212423|FG000|Overall Study|Lost to Follow-up|1|||
127612880|NCT03560531|459212424|FG001|Overall Study|Lost to Follow-up|1|||
127612881|NCT03560531|459212425|FG002|Overall Study|Lost to Follow-up|0|||
127612882|NCT03560531|459212426|FG003|Overall Study|Lost to Follow-up|0|||
127612883|NCT03560531|459212427|FG004|Overall Study|Lost to Follow-up|0|||
127612884|NCT03560531|459212428|FG005|Overall Study|Lost to Follow-up|0|||
127612885|NCT03560531|459212429|FG006|Overall Study|Lost to Follow-up|1|||
127612886|NCT03560531|459212430|FG007|Overall Study|Lost to Follow-up|0|||
127612887|NCT03560531|459212431|FG008|Overall Study|Lost to Follow-up|0|||
127612888|NCT03560531|459212432|FG009|Overall Study|Lost to Follow-up|0|||
127612889|NCT03560531|459212433|FG010|Overall Study|Lost to Follow-up|0|||
127612890|NCT03560531|459212434|FG011|Overall Study|Lost to Follow-up|0|||
127612891|NCT03560531|459212435|FG012|Overall Study|Lost to Follow-up|0|||
127612892|NCT03560531|459212436|FG013|Overall Study|Lost to Follow-up|0|||
127612893|NCT03560531|459212423|FG000|Overall Study|Withdrawal by Subject|1|||
127789752|NCT01297270|459855160|FG002|Overall Study|Lack of Efficacy|15|||
127789753|NCT01297270|459855158|FG000|Overall Study|Lost to Follow-up|1|||
127789754|NCT01297270|459855159|FG001|Overall Study|Lost to Follow-up|2|||
127789755|NCT01297270|459855160|FG002|Overall Study|Lost to Follow-up|1|||
127789756|NCT01297270|459855158|FG000|Overall Study|Protocol Violation|0|||
127789757|NCT01297270|459855159|FG001|Overall Study|Protocol Violation|2|||
127789758|NCT01297270|459855160|FG002|Overall Study|Protocol Violation|0|||
127789759|NCT01297270|459855158|FG000|Overall Study|Withdrawal by Subject|7|||
127789760|NCT01297270|459855159|FG001|Overall Study|Withdrawal by Subject|15|||
127789761|NCT01297270|459855160|FG002|Overall Study|Withdrawal by Subject|7|||
127789762|NCT01297270|459855158|FG000|Overall Study|Other reason not defined above|3|||
127789763|NCT01297270|459855159|FG001|Overall Study|Other reason not defined above|3|||
127789764|NCT01297270|459855160|FG002|Overall Study|Other reason not defined above|1|||
127789765|NCT01297270|459855158|FG000|Overall Study|Not treated|0|||
127789766|NCT01297270|459855159|FG001|Overall Study|Not treated|1|||
127789767|NCT01297270|459855160|FG002|Overall Study|Not treated|0|||
127789768|NCT03882970|459855163|FG000|Overall Study|Adverse Event|5|||
127789769|NCT03882970|459855164|FG001|Overall Study|Adverse Event|7|||
127883335|NCT03611751|460196396|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
127883336|NCT03611751|460196397|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
127612894|NCT03560531|459212424|FG001|Overall Study|Withdrawal by Subject|0|||
127612895|NCT03560531|459212425|FG002|Overall Study|Withdrawal by Subject|0|||
127612896|NCT03560531|459212426|FG003|Overall Study|Withdrawal by Subject|0|||
127612897|NCT03560531|459212427|FG004|Overall Study|Withdrawal by Subject|0|||
127612898|NCT03560531|459212428|FG005|Overall Study|Withdrawal by Subject|0|||
127612899|NCT03560531|459212429|FG006|Overall Study|Withdrawal by Subject|0|||
127612900|NCT03560531|459212430|FG007|Overall Study|Withdrawal by Subject|3|||
127612901|NCT03560531|459212431|FG008|Overall Study|Withdrawal by Subject|2|||
127612902|NCT03560531|459212432|FG009|Overall Study|Withdrawal by Subject|0|||
127612903|NCT03560531|459212433|FG010|Overall Study|Withdrawal by Subject|0|||
127612904|NCT03560531|459212434|FG011|Overall Study|Withdrawal by Subject|0|||
127612905|NCT03560531|459212435|FG012|Overall Study|Withdrawal by Subject|2|||
127612906|NCT03560531|459212436|FG013|Overall Study|Withdrawal by Subject|0|||
127612907|NCT03560531|459212423|FG000|Overall Study|Study end per-protocol|1|||
127612908|NCT03560531|459212424|FG001|Overall Study|Study end per-protocol|1|||
127612909|NCT03560531|459212425|FG002|Overall Study|Study end per-protocol|2|||
127612910|NCT03560531|459212426|FG003|Overall Study|Study end per-protocol|0|||
127612911|NCT03560531|459212427|FG004|Overall Study|Study end per-protocol|1|||
127612912|NCT03560531|459212428|FG005|Overall Study|Study end per-protocol|0|||
127612913|NCT03560531|459212429|FG006|Overall Study|Study end per-protocol|0|||
127612914|NCT03560531|459212430|FG007|Overall Study|Study end per-protocol|0|||
127612915|NCT03560531|459212431|FG008|Overall Study|Study end per-protocol|0|||
127612916|NCT03560531|459212432|FG009|Overall Study|Study end per-protocol|0|||
127612917|NCT03560531|459212433|FG010|Overall Study|Study end per-protocol|0|||
127612918|NCT03560531|459212434|FG011|Overall Study|Study end per-protocol|0|||
127612919|NCT03560531|459212435|FG012|Overall Study|Study end per-protocol|0|||
127612920|NCT03560531|459212436|FG013|Overall Study|Study end per-protocol|0|||
127612921|NCT03560531|459212423|FG000|Overall Study|Early study termination by sponsor|9|||
127612922|NCT03560531|459212424|FG001|Overall Study|Early study termination by sponsor|0|||
127612923|NCT03560531|459212425|FG002|Overall Study|Early study termination by sponsor|0|||
127612924|NCT03560531|459212426|FG003|Overall Study|Early study termination by sponsor|4|||
127612925|NCT03560531|459212427|FG004|Overall Study|Early study termination by sponsor|8|||
127612926|NCT03560531|459212428|FG005|Overall Study|Early study termination by sponsor|2|||
127612927|NCT03560531|459212429|FG006|Overall Study|Early study termination by sponsor|5|||
127612928|NCT03560531|459212430|FG007|Overall Study|Early study termination by sponsor|64|||
127612929|NCT03560531|459212431|FG008|Overall Study|Early study termination by sponsor|7|||
127612930|NCT03560531|459212432|FG009|Overall Study|Early study termination by sponsor|2|||
127612931|NCT03560531|459212433|FG010|Overall Study|Early study termination by sponsor|16|||
127612932|NCT03560531|459212434|FG011|Overall Study|Early study termination by sponsor|2|||
127612933|NCT03560531|459212435|FG012|Overall Study|Early study termination by sponsor|6|||
127612934|NCT03560531|459212436|FG013|Overall Study|Early study termination by sponsor|2|||
127612935|NCT01200797|459212439|FG000|Overall Study|symptomatic deterioration|2|||
127612936|NCT01200797|459212439|FG000|Overall Study|Adverse Event|4|||
127612937|NCT01200797|459212439|FG000|Overall Study|Disease Progression|13|||
127612938|NCT03608774|459212444|FG000|Overall Study|Lost to Follow-up|5|||
127612939|NCT03608774|459212445|FG001|Overall Study|Lost to Follow-up|5|||
127612940|NCT03608774|459212444|FG000|Overall Study|Withdrawal by Subject|1|||
127612941|NCT03608774|459212445|FG001|Overall Study|Withdrawal by Subject|0|||
127612942|NCT03608774|459212444|FG000|Overall Study|Protocol Violation|1|||
127612943|NCT03608774|459212445|FG001|Overall Study|Protocol Violation|0|||
127612944|NCT03608774|459212444|FG000|Overall Study|Not eligible at enrollment|0|||
127612945|NCT03608774|459212445|FG001|Overall Study|Not eligible at enrollment|1|||
127612946|NCT03608774|459212444|FG000|Overall Study|Health related event|0|||
127612947|NCT03608774|459212445|FG001|Overall Study|Health related event|1|||
127612948|NCT01177540|459212446|FG000|Overall Study|Adverse Event|1|||
127612949|NCT01177540|459212447|FG001|Overall Study|Adverse Event|0|||
127612950|NCT01623596|459212466|FG000|Overall Study|Abnormal laboratory values|2|||
127612951|NCT01623596|459212467|FG001|Overall Study|Abnormal laboratory values|0|||
127612952|NCT01623596|459212466|FG000|Overall Study|Administrative problems|9|||
127612953|NCT01623596|459212467|FG001|Overall Study|Administrative problems|13|||
127612954|NCT01623596|459212466|FG000|Overall Study|Adverse Event|20|||
127612955|NCT01623596|459212467|FG001|Overall Study|Adverse Event|29|||
127612956|NCT01623596|459212466|FG000|Overall Study|Death|0|||
127612957|NCT01623596|459212467|FG001|Overall Study|Death|2|||
127612958|NCT01623596|459212466|FG000|Overall Study|Lost to Follow-up|12|||
127789770|NCT03882970|459855165|FG002|Overall Study|Adverse Event|3|||
127789771|NCT03882970|459855166|FG003|Overall Study|Adverse Event|1|||
127789772|NCT03882970|459855163|FG000|Overall Study|Death|1|||
127789773|NCT03882970|459855164|FG001|Overall Study|Death|2|||
127789774|NCT03882970|459855165|FG002|Overall Study|Death|1|||
127789775|NCT03882970|459855166|FG003|Overall Study|Death|1|||
127612959|NCT01623596|459212467|FG001|Overall Study|Lost to Follow-up|16|||
127612960|NCT01623596|459212466|FG000|Overall Study|Withdrawal by Subject|13|||
127612961|NCT01623596|459212467|FG001|Overall Study|Withdrawal by Subject|31|||
127789776|NCT03882970|459855163|FG000|Overall Study|Lost to Follow-up|8|||
127612962|NCT01623596|459212466|FG000|Overall Study|Patient no longer requires study drug|1|||
127612963|NCT01623596|459212467|FG001|Overall Study|Patient no longer requires study drug|0|||
127789777|NCT03882970|459855164|FG001|Overall Study|Lost to Follow-up|9|||
127789778|NCT03882970|459855165|FG002|Overall Study|Lost to Follow-up|5|||
127789779|NCT03882970|459855166|FG003|Overall Study|Lost to Follow-up|5|||
127612964|NCT01623596|459212466|FG000|Overall Study|Protocol Violation|0|||
127789780|NCT03882970|459855163|FG000|Overall Study|Physician Decision|0|||
127612965|NCT01623596|459212467|FG001|Overall Study|Protocol Violation|6|||
127612966|NCT01623596|459212466|FG000|Overall Study|Lack of Efficacy|5|||
127612967|NCT01623596|459212467|FG001|Overall Study|Lack of Efficacy|3|||
127789781|NCT03882970|459855164|FG001|Overall Study|Physician Decision|2|||
127789782|NCT03882970|459855165|FG002|Overall Study|Physician Decision|2|||
127612968|NCT01070316|459212468|FG000|Extension Phase|Lack of Efficacy|3|||
127612969|NCT01070316|459212468|FG000|Extension Phase|Withdrawal by Subject|1|||
127612970|NCT00748215|459212471|FG000|Overall Study|Withdrawal by Subject|7|||
127612971|NCT00748215|459212472|FG001|Overall Study|Withdrawal by Subject|7|||
127612972|NCT00748215|459212471|FG000|Overall Study|Treatment change|2|||
127612973|NCT00748215|459212472|FG001|Overall Study|Treatment change|1|||
127612974|NCT00748215|459212471|FG000|Overall Study|Change in patient condition|0|||
127612975|NCT00748215|459212472|FG001|Overall Study|Change in patient condition|3|||
127612976|NCT00748215|459212471|FG000|Overall Study|Non-compliant|0|||
127612977|NCT00748215|459212472|FG001|Overall Study|Non-compliant|2|||
127612978|NCT00748215|459212471|FG000|Overall Study|Adverse Event|0|||
127612979|NCT00748215|459212472|FG001|Overall Study|Adverse Event|5|||
127612980|NCT03200899|459212479|FG000|Overall Study|Lost to Follow-up|10|||
127612981|NCT03200899|459212480|FG001|Overall Study|Lost to Follow-up|23|||
127612982|NCT00026793|459212482|FG000|Overall Study|Death on study due to underlying disease|4|||
127612983|NCT00026793|459212482|FG000|Overall Study|Physician Decision|2|||
127612984|NCT00026793|459212482|FG000|Overall Study|Off study|2|||
127612985|NCT04151290|459212483|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
127612986|NCT00969553|459212484|FG000|Overall Study|Progressive disease (PD)|2|||
127612987|NCT00969553|459212485|FG001|Overall Study|Progressive disease (PD)|2|||
127612988|NCT00969553|459212486|FG002|Overall Study|Progressive disease (PD)|6|||
127612989|NCT00969553|459212487|FG003|Overall Study|Progressive disease (PD)|9|||
127612990|NCT00969553|459212488|FG004|Overall Study|Progressive disease (PD)|2|||
127612991|NCT00969553|459212489|FG005|Overall Study|Progressive disease (PD)|4|||
127612992|NCT00969553|459212490|FG006|Overall Study|Progressive disease (PD)|2|||
127612993|NCT00969553|459212491|FG007|Overall Study|Progressive disease (PD)|12|||
127612994|NCT00969553|459212492|FG008|Overall Study|Progressive disease (PD)|3|||
127612995|NCT00969553|459212484|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
127612996|NCT00969553|459212485|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
127612997|NCT00969553|459212486|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
127612998|NCT00969553|459212487|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
127612999|NCT00969553|459212488|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
127613000|NCT00969553|459212489|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
127613001|NCT00969553|459212490|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
127613002|NCT00969553|459212491|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
127613003|NCT00969553|459212492|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
127789783|NCT03882970|459855166|FG003|Overall Study|Physician Decision|2|||
127789784|NCT03882970|459855163|FG000|Overall Study|Protocol Violation|2|||
127789785|NCT03882970|459855164|FG001|Overall Study|Protocol Violation|0|||
127789786|NCT03882970|459855165|FG002|Overall Study|Protocol Violation|0|||
127789787|NCT03882970|459855166|FG003|Overall Study|Protocol Violation|0|||
127789788|NCT03882970|459855163|FG000|Overall Study|Withdrawal by Subject|8|||
127789789|NCT03882970|459855164|FG001|Overall Study|Withdrawal by Subject|17|||
127789790|NCT03882970|459855165|FG002|Overall Study|Withdrawal by Subject|7|||
127789791|NCT03882970|459855166|FG003|Overall Study|Withdrawal by Subject|22|||
127789792|NCT03882970|459855163|FG000|Overall Study|Personal Reason|2|||
127789793|NCT03882970|459855164|FG001|Overall Study|Personal Reason|3|||
127789794|NCT03882970|459855165|FG002|Overall Study|Personal Reason|1|||
127789795|NCT03882970|459855166|FG003|Overall Study|Personal Reason|3|||
127789796|NCT02863809|459855168|FG000|Overall Study|Adverse Event|8|||
127789797|NCT02863809|459855169|FG001|Overall Study|Adverse Event|8|||
127789798|NCT02863809|459855168|FG000|Overall Study|Withdrawal by Subject|0|||
127789799|NCT02863809|459855169|FG001|Overall Study|Withdrawal by Subject|1|||
127789800|NCT02863809|459855168|FG000|Overall Study|Lost to Follow-up|1|||
127789801|NCT02863809|459855169|FG001|Overall Study|Lost to Follow-up|1|||
127789802|NCT02863809|459855168|FG000|Overall Study|Death|1|||
127789803|NCT02863809|459855169|FG001|Overall Study|Death|0|||
127613004|NCT00969553|459212484|FG000|Overall Study|Other Adverse Event|0|||
127613005|NCT00969553|459212485|FG001|Overall Study|Other Adverse Event|0|||
127613006|NCT00969553|459212486|FG002|Overall Study|Other Adverse Event|0|||
127613007|NCT00969553|459212487|FG003|Overall Study|Other Adverse Event|1|||
127613008|NCT00969553|459212488|FG004|Overall Study|Other Adverse Event|0|||
127789804|NCT02830776|459855170|FG000|Overall Study|Lost to Follow-up|1|||
127789805|NCT02829138|459855171|FG000|Overall Study|Withdrawal by Subject|1|||
127789806|NCT02829138|459855172|FG001|Overall Study|Withdrawal by Subject|0|||
127789807|NCT02411539|459855173|FG000|Overall Study|Lost to Follow-up|2|||
127613009|NCT00969553|459212489|FG005|Overall Study|Other Adverse Event|0|||
127613010|NCT00969553|459212490|FG006|Overall Study|Other Adverse Event|1|||
127613011|NCT00969553|459212491|FG007|Overall Study|Other Adverse Event|0|||
127613012|NCT00969553|459212492|FG008|Overall Study|Other Adverse Event|0|||
127613013|NCT00969553|459212484|FG000|Overall Study|Refused cont. medication|1|||
127613014|NCT00969553|459212485|FG001|Overall Study|Refused cont. medication|1|||
127613015|NCT00969553|459212486|FG002|Overall Study|Refused cont. medication|0|||
127613016|NCT00969553|459212487|FG003|Overall Study|Refused cont. medication|2|||
127613017|NCT00969553|459212488|FG004|Overall Study|Refused cont. medication|0|||
127613018|NCT00969553|459212489|FG005|Overall Study|Refused cont. medication|0|||
127613019|NCT00969553|459212490|FG006|Overall Study|Refused cont. medication|0|||
127613020|NCT00969553|459212491|FG007|Overall Study|Refused cont. medication|1|||
127613021|NCT00969553|459212492|FG008|Overall Study|Refused cont. medication|0|||
127613022|NCT00969553|459212484|FG000|Overall Study|Not specified above|0|||
127613023|NCT00969553|459212485|FG001|Overall Study|Not specified above|0|||
127613024|NCT00969553|459212486|FG002|Overall Study|Not specified above|0|||
127613025|NCT00969553|459212487|FG003|Overall Study|Not specified above|4|||
127613026|NCT00969553|459212488|FG004|Overall Study|Not specified above|0|||
127613027|NCT00969553|459212489|FG005|Overall Study|Not specified above|0|||
127613028|NCT00969553|459212490|FG006|Overall Study|Not specified above|1|||
127613029|NCT00969553|459212491|FG007|Overall Study|Not specified above|1|||
127613030|NCT00969553|459212492|FG008|Overall Study|Not specified above|0|||
127613031|NCT02780804|459213943|FG000|Overall Study|Death|1|||
127613032|NCT02780804|459213944|FG001|Overall Study|Death|0|||
127613033|NCT02780804|459213945|FG002|Overall Study|Death|0|||
127613034|NCT02780804|459213943|FG000|Overall Study|Lack of Efficacy|5|||
127613035|NCT02780804|459213944|FG001|Overall Study|Lack of Efficacy|8|||
127613036|NCT02780804|459213945|FG002|Overall Study|Lack of Efficacy|4|||
127613037|NCT02780804|459213943|FG000|Overall Study|Physician Decision|0|||
127613038|NCT02780804|459213944|FG001|Overall Study|Physician Decision|0|||
127613039|NCT02780804|459213945|FG002|Overall Study|Physician Decision|2|||
127613040|NCT02780804|459213943|FG000|Overall Study|Withdrawal by Subject|0|||
127613041|NCT02780804|459213944|FG001|Overall Study|Withdrawal by Subject|1|||
127613042|NCT02780804|459213945|FG002|Overall Study|Withdrawal by Subject|0|||
127613043|NCT01859507|459213948|FG000|Overall Study|left the country|4|||
127613044|NCT01921829|459213949|FG000|Overall Study|Withdrawal by Subject|0|||
127613045|NCT01921829|459213950|FG001|Overall Study|Withdrawal by Subject|1|||
127613046|NCT04476030|459213951|FG000|Overall Study|Withdrawal by Subject|20|||
127613047|NCT04476030|459213952|FG001|Overall Study|Withdrawal by Subject|16|||
127613048|NCT04476030|459213951|FG000|Overall Study|Adverse Event|10|||
127613049|NCT04476030|459213952|FG001|Overall Study|Adverse Event|11|||
127613050|NCT04476030|459213951|FG000|Overall Study|Lost to Follow-up|7|||
127613051|NCT04476030|459213952|FG001|Overall Study|Lost to Follow-up|4|||
127613052|NCT04476030|459213951|FG000|Overall Study|Physician Decision|1|||
127613053|NCT04476030|459213952|FG001|Overall Study|Physician Decision|1|||
127613054|NCT04476030|459213951|FG000|Overall Study|Protocol Deviation|2|||
127613055|NCT04476030|459213952|FG001|Overall Study|Protocol Deviation|0|||
127613056|NCT04476030|459213951|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
127613057|NCT04476030|459213952|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
127613058|NCT04476030|459213951|FG000|Overall Study|Randomized but not Dosed|2|||
127613059|NCT04476030|459213952|FG001|Overall Study|Randomized but not Dosed|8|||
127613060|NCT02404311|459213953|FG000|Part A: Month 0-18|Death|2|||
127789808|NCT02411539|459855174|FG001|Overall Study|Lost to Follow-up|0|||
127613061|NCT02404311|459213954|FG001|Part A: Month 0-18|Death|0|||
127789809|NCT02411539|459855173|FG000|Overall Study|Confounding medical condition|0|||
127789810|NCT02411539|459855174|FG001|Overall Study|Confounding medical condition|1|||
127613062|NCT02404311|459213955|FG002|Part A: Month 0-18|Death|0|||
127613063|NCT02404311|459213956|FG003|Part A: Month 0-18|Death|0|||
127613064|NCT02404311|459213957|FG004|Part A: Month 0-18|Death|0|||
127613065|NCT02404311|459213953|FG000|Part A: Month 0-18|Physician Decision|1|||
127613066|NCT02404311|459213954|FG001|Part A: Month 0-18|Physician Decision|0|||
127613067|NCT02404311|459213955|FG002|Part A: Month 0-18|Physician Decision|0|||
127613068|NCT02404311|459213956|FG003|Part A: Month 0-18|Physician Decision|0|||
127613069|NCT02404311|459213957|FG004|Part A: Month 0-18|Physician Decision|0|||
127613070|NCT02404311|459213953|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
127613071|NCT02404311|459213954|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
127613072|NCT02404311|459213955|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
127613073|NCT02404311|459213956|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
127613074|NCT02404311|459213957|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
127613075|NCT02404311|459213953|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
127613076|NCT02404311|459213954|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
127613077|NCT02404311|459213955|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
127613078|NCT02404311|459213956|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
127613079|NCT02404311|459213957|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
127613080|NCT02404311|459213953|FG000|Part A: Month 0-18|HIV Infection|6|||
127613081|NCT02404311|459213954|FG001|Part A: Month 0-18|HIV Infection|2|||
127613082|NCT02404311|459213955|FG002|Part A: Month 0-18|HIV Infection|0|||
127613083|NCT02404311|459213956|FG003|Part A: Month 0-18|HIV Infection|0|||
127613084|NCT02404311|459213957|FG004|Part A: Month 0-18|HIV Infection|0|||
127613085|NCT02404311|459213953|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
127613086|NCT02404311|459213954|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
127613087|NCT02404311|459213955|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
127613088|NCT02404311|459213956|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
127613089|NCT02404311|459213957|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
127613090|NCT00218296|459213958|FG000|Overall Study|Lost to Follow-up|9|||
127613091|NCT00218296|459213959|FG001|Overall Study|Lost to Follow-up|7|||
127613092|NCT00218296|459213958|FG000|Overall Study|Withdrawal by Subject|36|||
127613093|NCT00218296|459213959|FG001|Overall Study|Withdrawal by Subject|47|||
127613094|NCT00218296|459213958|FG000|Overall Study|Randomized but did not enter treatment|66|||
127613095|NCT00218296|459213959|FG001|Overall Study|Randomized but did not enter treatment|67|||
127613096|NCT00634088|459213960|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
127613097|NCT00634088|459213961|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
127613098|NCT00634088|459213962|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
127613099|NCT00634088|459213963|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
127613100|NCT00634088|459213960|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
127613101|NCT00634088|459213961|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
127613102|NCT00634088|459213962|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
127613103|NCT00634088|459213963|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
127613104|NCT00634088|459213960|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
127613105|NCT00634088|459213961|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
127613106|NCT00634088|459213962|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
127613107|NCT00634088|459213963|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
127613108|NCT00634088|459213960|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
127613109|NCT00634088|459213961|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
127613110|NCT00634088|459213962|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
127613111|NCT00634088|459213963|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
127613112|NCT00634088|459213960|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
127613113|NCT00634088|459213961|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
127613114|NCT00634088|459213962|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
127613115|NCT00634088|459213963|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
127613116|NCT00634088|459213960|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
127613117|NCT00634088|459213961|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
127613118|NCT00634088|459213962|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
127613119|NCT00634088|459213963|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
127613120|NCT01293240|459213967|FG000|Overall Study|Noncompliance|2|||
127613121|NCT03735667|459213971|FG000|1 Year PE Main Randomized and Roll-in|Death|40|||
127613122|NCT03735667|459213972|FG001|1 Year PE Main Randomized and Roll-in|Death|31|||
127613123|NCT03735667|459213973|FG002|1 Year PE Main Randomized and Roll-in|Death|7|||
127613124|NCT03735667|459213971|FG000|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|3|||
127613125|NCT03735667|459213972|FG001|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|2|||
127613126|NCT03735667|459213973|FG002|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|0|||
127613127|NCT03735667|459213971|FG000|1 Year PE Main Randomized and Roll-in|Physician Decision|4|||
127613128|NCT03735667|459213972|FG001|1 Year PE Main Randomized and Roll-in|Physician Decision|2|||
127613129|NCT03735667|459213973|FG002|1 Year PE Main Randomized and Roll-in|Physician Decision|0|||
127613130|NCT03735667|459213971|FG000|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|27|||
127613131|NCT03735667|459213972|FG001|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|24|||
127613132|NCT03735667|459213973|FG002|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|2|||
127613133|NCT03735667|459213971|FG000|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|28|||
127613134|NCT03735667|459213972|FG001|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|29|||
127613135|NCT03735667|459213973|FG002|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|9|||
127613136|NCT03735667|459213971|FG000|1 Year PE Main Randomized and Roll-in|Other|1|||
127613137|NCT03735667|459213972|FG001|1 Year PE Main Randomized and Roll-in|Other|2|||
127698764|NCT05308004|459526510|FG001|Overall Study|Not seen by Palliative Care NP|1|||
127698765|NCT03575897|459526511|FG000|Overall Study|Lost to Follow-up|12|||
127613138|NCT03735667|459213973|FG002|1 Year PE Main Randomized and Roll-in|Other|0|||
127613139|NCT03735667|459213971|FG000|4D-CT Substudy (Subset of Main RCT)|Death|8|||
127613140|NCT03735667|459213972|FG001|4D-CT Substudy (Subset of Main RCT)|Death|5|||
127613141|NCT03735667|459213973|FG002|4D-CT Substudy (Subset of Main RCT)|Death|0|||
127613142|NCT03735667|459213971|FG000|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|4|||
127613143|NCT03735667|459213972|FG001|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|4|||
127613144|NCT03735667|459213973|FG002|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|0|||
127613145|NCT03735667|459213971|FG000|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|1|||
127613146|NCT03735667|459213972|FG001|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|0|||
127613147|NCT03735667|459213973|FG002|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|0|||
127613148|NCT03735667|459213971|FG000|4D-CT Substudy (Subset of Main RCT)|Physician Decision|1|||
127613149|NCT03735667|459213972|FG001|4D-CT Substudy (Subset of Main RCT)|Physician Decision|1|||
127613150|NCT03735667|459213973|FG002|4D-CT Substudy (Subset of Main RCT)|Physician Decision|0|||
127613151|NCT03735667|459213971|FG000|4D-CT Substudy (Subset of Main RCT)|Other|0|||
127613152|NCT03735667|459213972|FG001|4D-CT Substudy (Subset of Main RCT)|Other|1|||
127613153|NCT03735667|459213973|FG002|4D-CT Substudy (Subset of Main RCT)|Other|0|||
127613154|NCT03735667|459213971|FG000|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|3|||
127613155|NCT03735667|459213972|FG001|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|3|||
127613156|NCT03735667|459213973|FG002|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|0|||
127613157|NCT02547129|459213980|FG000|Overall Study|Difficulty with ongoing infection|1|||
127613158|NCT02547129|459213981|FG001|Overall Study|Difficulty with ongoing infection|0|||
127613159|NCT00228917|459213985|FG000|Overall Study|Migrated/moved from study area|0|||
127613160|NCT00228917|459213986|FG001|Overall Study|Migrated/moved from study area|0|||
127613161|NCT00228917|459213987|FG002|Overall Study|Migrated/moved from study area|0|||
127613162|NCT00228917|459213988|FG003|Overall Study|Migrated/moved from study area|0|||
127613163|NCT00228917|459213989|FG004|Overall Study|Migrated/moved from study area|0|||
127613164|NCT00228917|459213990|FG005|Overall Study|Migrated/moved from study area|2|||
127613165|NCT00228917|459213991|FG006|Overall Study|Migrated/moved from study area|0|||
127613166|NCT00228917|459213992|FG007|Overall Study|Migrated/moved from study area|0|||
127613167|NCT00409617|459213993|FG000|Overall Study|Adverse Event|57|||
127613168|NCT00409617|459213993|FG000|Overall Study|Lack of Efficacy|54|||
127613169|NCT00409617|459213993|FG000|Overall Study|Lost to Follow-up|2|||
127613170|NCT00409617|459213993|FG000|Overall Study|Protocol Violation|24|||
127613171|NCT00409617|459213993|FG000|Overall Study|Withdrawal by Subject|8|||
127789811|NCT04041284|459855177|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
127789812|NCT04041284|459855178|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
127789813|NCT04041284|459855177|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
127789814|NCT04041284|459855178|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
127789815|NCT04041284|459855177|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
127789816|NCT04041284|459855178|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
127789817|NCT04041284|459855177|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
127789818|NCT04041284|459855178|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
127789819|NCT04041284|459855177|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
127789820|NCT04041284|459855178|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
127789821|NCT04041284|459855177|FG000|DB Phase (12 Weeks)|Other than specified|1|||
127789822|NCT04041284|459855178|FG001|DB Phase (12 Weeks)|Other than specified|0|||
127789823|NCT04041284|459855177|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
127789824|NCT04041284|459855178|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
127789825|NCT04041284|459855177|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
127789826|NCT04041284|459855178|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
127789827|NCT04041284|459855177|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
127789828|NCT04041284|459855178|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
127789829|NCT04041284|459855177|FG000|OL Phase (12 Weeks)|Other than specified|6|||
127613172|NCT00409617|459213993|FG000|Overall Study|Administrative reasons|1|||
127613173|NCT00409617|459213993|FG000|Overall Study|Not described|14|||
127613174|NCT02063737|459213996|FG000|Overall Study|Lost to Follow-up|11|||
127613175|NCT02063737|459213997|FG001|Overall Study|Lost to Follow-up|4|||
127613176|NCT03373383|459213998|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
127613177|NCT03373383|459213999|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
127613178|NCT03373383|459214000|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
127613179|NCT03373383|459214001|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
127789830|NCT04041284|459855178|FG001|OL Phase (12 Weeks)|Other than specified|2|||
127613180|NCT03373383|459214002|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
127613181|NCT03373383|459213998|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
127789831|NCT00563186|459855179|FG000|Overall Study|LOS<48 hours|97|||
127789832|NCT00563186|459855180|FG001|Overall Study|LOS<48 hours|74|||
127789833|NCT00563186|459855179|FG000|Overall Study|Incomplete data|1|||
127789834|NCT00563186|459855180|FG001|Overall Study|Incomplete data|1|||
127789835|NCT00886600|459855181|FG000|Double-blind Monotherapy|Adverse Event|1|||
127789836|NCT00886600|459855182|FG001|Double-blind Monotherapy|Adverse Event|1|||
127789837|NCT00886600|459855183|FG002|Double-blind Monotherapy|Adverse Event|1|||
127789838|NCT00886600|459855184|FG003|Double-blind Monotherapy|Adverse Event|1|||
127789839|NCT00886600|459855181|FG000|Double-blind Monotherapy|Protocol Violation|0|||
127789840|NCT00886600|459855182|FG001|Double-blind Monotherapy|Protocol Violation|0|||
127613182|NCT03373383|459213999|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
127613183|NCT03373383|459214000|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
127613184|NCT03373383|459214001|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
127789841|NCT00886600|459855183|FG002|Double-blind Monotherapy|Protocol Violation|0|||
127789842|NCT00886600|459855184|FG003|Double-blind Monotherapy|Protocol Violation|1|||
127789843|NCT00886600|459855181|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
127789844|NCT00886600|459855182|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
127789845|NCT00886600|459855183|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
127789846|NCT00886600|459855184|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
127789847|NCT00886600|459855181|FG000|Combination Therapy Period|Adverse Event|0|||
127789848|NCT00886600|459855182|FG001|Combination Therapy Period|Adverse Event|0|||
127789849|NCT00886600|459855183|FG002|Combination Therapy Period|Adverse Event|1|||
127613185|NCT03373383|459214002|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
127613186|NCT03373383|459213998|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
127613187|NCT03373383|459213999|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
127613188|NCT03373383|459214000|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
127613189|NCT03373383|459214001|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
127613190|NCT03373383|459214002|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
127613191|NCT03373383|459213998|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
127613192|NCT03373383|459213999|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
127613193|NCT03373383|459214000|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
127613194|NCT03373383|459214001|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
127613195|NCT03373383|459214002|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
127613196|NCT03373383|459213998|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
127613197|NCT03373383|459213999|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
127613198|NCT03373383|459214000|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
127613199|NCT03373383|459214001|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
127613200|NCT03373383|459214002|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
127613201|NCT03373383|459213998|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
127613202|NCT03373383|459213999|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
127613203|NCT03373383|459214000|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
127613204|NCT03373383|459214001|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
127613205|NCT03373383|459214002|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
127613206|NCT03373383|459213998|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
127613207|NCT03373383|459213999|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
127613208|NCT03373383|459214000|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
127613209|NCT03373383|459214001|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
127613210|NCT03373383|459214002|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
127613211|NCT03373383|459213998|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
127613212|NCT03373383|459213999|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
127613213|NCT03373383|459214000|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
127613214|NCT03373383|459214001|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
127613215|NCT03373383|459214002|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
127613216|NCT03373383|459213998|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
127789850|NCT00886600|459855184|FG003|Combination Therapy Period|Adverse Event|0|||
127789851|NCT00886600|459855181|FG000|Combination Therapy Period|Protocol Violation|0|||
127789852|NCT00886600|459855182|FG001|Combination Therapy Period|Protocol Violation|0|||
127613217|NCT03373383|459213999|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
127613218|NCT03373383|459214000|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
127789853|NCT00886600|459855183|FG002|Combination Therapy Period|Protocol Violation|1|||
127789854|NCT00886600|459855184|FG003|Combination Therapy Period|Protocol Violation|0|||
127789855|NCT01439204|459855185|FG000|Overall Study|Withdrawal by Subject|0|||
127613219|NCT03373383|459214001|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
127789856|NCT01439204|459855186|FG001|Overall Study|Withdrawal by Subject|1|||
127613220|NCT03373383|459214002|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
127613221|NCT02689258|459214003|FG000|Overall Study|Subject Non-Compliance|0|||
127613222|NCT02689258|459214004|FG001|Overall Study|Subject Non-Compliance|1|||
127613223|NCT02689258|459214005|FG002|Overall Study|Subject Non-Compliance|0|||
127613224|NCT02689258|459214006|FG003|Overall Study|Subject Non-Compliance|0|||
127613225|NCT02689258|459214007|FG004|Overall Study|Subject Non-Compliance|0|||
127613226|NCT02689258|459214008|FG005|Overall Study|Subject Non-Compliance|0|||
127789857|NCT01439204|459855185|FG000|Overall Study|Lost to Follow-up|0|||
127789858|NCT01439204|459855186|FG001|Overall Study|Lost to Follow-up|2|||
127789859|NCT01439204|459855185|FG000|Overall Study|No longer meets study criteria|1|||
127789860|NCT01439204|459855186|FG001|Overall Study|No longer meets study criteria|0|||
127789861|NCT01439204|459855185|FG000|Overall Study|poor/non-compliance|3|||
127613227|NCT02689258|459214009|FG006|Overall Study|Subject Non-Compliance|0|||
127613228|NCT02689258|459214010|FG007|Overall Study|Subject Non-Compliance|0|||
127613229|NCT02689258|459214011|FG008|Overall Study|Subject Non-Compliance|0|||
127613230|NCT02689258|459214012|FG009|Overall Study|Subject Non-Compliance|0|||
127613231|NCT02689258|459214013|FG010|Overall Study|Subject Non-Compliance|0|||
127613232|NCT02689258|459214014|FG011|Overall Study|Subject Non-Compliance|0|||
127613233|NCT02689258|459214003|FG000|Overall Study|Subject Refusal to Continue|0|||
127613234|NCT02689258|459214004|FG001|Overall Study|Subject Refusal to Continue|1|||
127613235|NCT02689258|459214005|FG002|Overall Study|Subject Refusal to Continue|0|||
127613236|NCT02689258|459214006|FG003|Overall Study|Subject Refusal to Continue|0|||
127613237|NCT02689258|459214007|FG004|Overall Study|Subject Refusal to Continue|0|||
127613238|NCT02689258|459214008|FG005|Overall Study|Subject Refusal to Continue|0|||
127613239|NCT02689258|459214009|FG006|Overall Study|Subject Refusal to Continue|0|||
127613240|NCT02689258|459214010|FG007|Overall Study|Subject Refusal to Continue|0|||
127613241|NCT02689258|459214011|FG008|Overall Study|Subject Refusal to Continue|1|||
127613242|NCT02689258|459214012|FG009|Overall Study|Subject Refusal to Continue|0|||
127613243|NCT02689258|459214013|FG010|Overall Study|Subject Refusal to Continue|0|||
127613244|NCT02689258|459214014|FG011|Overall Study|Subject Refusal to Continue|1|||
127613245|NCT02689258|459214003|FG000|Overall Study|Other|0|||
127613246|NCT02689258|459214004|FG001|Overall Study|Other|2|||
127613247|NCT02689258|459214005|FG002|Overall Study|Other|0|||
127613248|NCT02689258|459214006|FG003|Overall Study|Other|0|||
127613249|NCT02689258|459214007|FG004|Overall Study|Other|1|||
127613250|NCT02689258|459214008|FG005|Overall Study|Other|0|||
127613251|NCT02689258|459214009|FG006|Overall Study|Other|0|||
127613252|NCT02689258|459214010|FG007|Overall Study|Other|0|||
127613253|NCT02689258|459214011|FG008|Overall Study|Other|1|||
127613254|NCT02689258|459214012|FG009|Overall Study|Other|0|||
127613255|NCT02689258|459214013|FG010|Overall Study|Other|0|||
127613256|NCT02689258|459214014|FG011|Overall Study|Other|0|||
127613257|NCT04753164|459214018|FG000|Overall Study|Adverse Event|0|||
127613258|NCT04753164|459214019|FG001|Overall Study|Adverse Event|2|||
127613259|NCT04753164|459214018|FG000|Overall Study|Withdrawal by Subject|9|||
127613260|NCT04753164|459214019|FG001|Overall Study|Withdrawal by Subject|7|||
127613261|NCT04753164|459214018|FG000|Overall Study|Lost to Follow-up|6|||
127613262|NCT04753164|459214019|FG001|Overall Study|Lost to Follow-up|6|||
127613263|NCT04753164|459214018|FG000|Overall Study|Other|12|||
127613264|NCT04753164|459214019|FG001|Overall Study|Other|5|||
127613265|NCT00694369|459214020|FG000|Overall Study|Adverse Event|0|||
127613266|NCT00694369|459214021|FG001|Overall Study|Adverse Event|1|||
127613267|NCT00694369|459214022|FG002|Overall Study|Adverse Event|0|||
127613268|NCT00694369|459214023|FG003|Overall Study|Adverse Event|1|||
127613269|NCT00694369|459214024|FG004|Overall Study|Adverse Event|3|||
127613270|NCT00694369|459214020|FG000|Overall Study|Lost to Follow-up|0|||
127613271|NCT00694369|459214021|FG001|Overall Study|Lost to Follow-up|0|||
127613272|NCT00694369|459214022|FG002|Overall Study|Lost to Follow-up|1|||
127613273|NCT00694369|459214023|FG003|Overall Study|Lost to Follow-up|1|||
127613274|NCT00694369|459214024|FG004|Overall Study|Lost to Follow-up|0|||
127613275|NCT00694369|459214020|FG000|Overall Study|Physician Decision|0|||
127613276|NCT00694369|459214021|FG001|Overall Study|Physician Decision|0|||
127613277|NCT00694369|459214022|FG002|Overall Study|Physician Decision|0|||
127613278|NCT00694369|459214023|FG003|Overall Study|Physician Decision|0|||
127613279|NCT00694369|459214024|FG004|Overall Study|Physician Decision|1|||
127613280|NCT00694369|459214020|FG000|Overall Study|Protocol Violation|0|||
127613281|NCT00694369|459214021|FG001|Overall Study|Protocol Violation|1|||
127613282|NCT00694369|459214022|FG002|Overall Study|Protocol Violation|0|||
127613283|NCT00694369|459214023|FG003|Overall Study|Protocol Violation|0|||
127613284|NCT00694369|459214024|FG004|Overall Study|Protocol Violation|0|||
127789862|NCT01439204|459855186|FG001|Overall Study|poor/non-compliance|0|||
127789863|NCT03917823|459855189|FG000|Overall Study|Lost to Follow-up|1|||
127789864|NCT03917823|459855190|FG001|Overall Study|Lost to Follow-up|1|||
127789865|NCT03917823|459855189|FG000|Overall Study|Withdrawal by Subject|0|||
127789866|NCT03917823|459855190|FG001|Overall Study|Withdrawal by Subject|1|||
127613285|NCT00694369|459214020|FG000|Overall Study|Withdrawal by Subject|1|||
127789867|NCT03775421|459855191|FG000|Overall Study|Lost to Follow-up|2|||
127789868|NCT03775421|459855191|FG000|Overall Study|Withdrawal by Subject|10|||
127613286|NCT00694369|459214021|FG001|Overall Study|Withdrawal by Subject|1|||
127613287|NCT00694369|459214022|FG002|Overall Study|Withdrawal by Subject|1|||
127613288|NCT00694369|459214023|FG003|Overall Study|Withdrawal by Subject|1|||
127613289|NCT00694369|459214024|FG004|Overall Study|Withdrawal by Subject|2|||
127613290|NCT00907374|459214027|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
127613291|NCT00907374|459214028|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
127613292|NCT04371380|459214037|FG000|Oral Lead-in Phase (Up to Day 28)|Physician Decision|1|||
127613293|NCT04371380|459214038|FG001|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
127613294|NCT04371380|459214039|FG002|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
127613295|NCT01951157|459214048|FG000|Overall Study|Progressive Disease|12|||
127613296|NCT01951157|459214049|FG001|Overall Study|Progressive Disease|13|||
127613297|NCT01951157|459214050|FG002|Overall Study|Progressive Disease|10|||
127613298|NCT01951157|459214048|FG000|Overall Study|Treatment-unrelated AE|1|||
127613299|NCT01951157|459214049|FG001|Overall Study|Treatment-unrelated AE|0|||
127613300|NCT01951157|459214050|FG002|Overall Study|Treatment-unrelated AE|3|||
127613301|NCT01951157|459214048|FG000|Overall Study|Study Termination|0|||
127613302|NCT01951157|459214049|FG001|Overall Study|Study Termination|0|||
127613303|NCT01951157|459214050|FG002|Overall Study|Study Termination|1|||
127613304|NCT01951157|459214048|FG000|Overall Study|Physician Decision|5|||
127613305|NCT01951157|459214049|FG001|Overall Study|Physician Decision|3|||
127613306|NCT01951157|459214050|FG002|Overall Study|Physician Decision|2|||
127613307|NCT01951157|459214048|FG000|Overall Study|Non-treatmentrelated death|2|||
127613308|NCT01951157|459214049|FG001|Overall Study|Non-treatmentrelated death|2|||
127613309|NCT01951157|459214050|FG002|Overall Study|Non-treatmentrelated death|2|||
127613310|NCT01951157|459214048|FG000|Overall Study|No treated|0|||
127613311|NCT01951157|459214049|FG001|Overall Study|No treated|1|||
127613312|NCT01951157|459214050|FG002|Overall Study|No treated|0|||
127613313|NCT01951157|459214048|FG000|Overall Study|Treatment-related AE|2|||
127613314|NCT01951157|459214049|FG001|Overall Study|Treatment-related AE|0|||
127613315|NCT01951157|459214050|FG002|Overall Study|Treatment-related AE|4|||
127613316|NCT01951157|459214048|FG000|Overall Study|Consent withdrawn by subject|0|||
127613317|NCT01951157|459214049|FG001|Overall Study|Consent withdrawn by subject|1|||
127613318|NCT01951157|459214050|FG002|Overall Study|Consent withdrawn by subject|3|||
127613319|NCT01951157|459214048|FG000|Overall Study|Treatment-related death|0|||
127613320|NCT01951157|459214049|FG001|Overall Study|Treatment-related death|2|||
127613321|NCT01951157|459214050|FG002|Overall Study|Treatment-related death|0|||
127613322|NCT04809220|459214051|FG000|Overall Study|Adverse Event|4|||
127613323|NCT04809220|459214052|FG001|Overall Study|Adverse Event|0|||
127613324|NCT04809220|459214051|FG000|Overall Study|Death|1|||
127613325|NCT04809220|459214052|FG001|Overall Study|Death|0|||
127613326|NCT04809220|459214051|FG000|Overall Study|Lost to Follow-up|3|||
127613327|NCT04809220|459214052|FG001|Overall Study|Lost to Follow-up|0|||
127613328|NCT04809220|459214051|FG000|Overall Study|Physician Decision|0|||
127613329|NCT04809220|459214052|FG001|Overall Study|Physician Decision|1|||
127613330|NCT04809220|459214051|FG000|Overall Study|Withdrawal by Subject|9|||
127613331|NCT04809220|459214052|FG001|Overall Study|Withdrawal by Subject|5|||
127613332|NCT04809220|459214051|FG000|Overall Study|Due to long-term overseas business trips|1|||
127613333|NCT04809220|459214052|FG001|Overall Study|Due to long-term overseas business trips|0|||
127613334|NCT01062555|459214058|FG000|Phase 1|Death|10|||
127613335|NCT01062555|459214059|FG001|Phase 1|Death|17|||
127613336|NCT01062555|459214060|FG002|Phase 1|Death|0|||
127613337|NCT01062555|459214061|FG003|Phase 1|Death|0|||
127613338|NCT01062555|459214058|FG000|Phase 1|Graft Failure|12|||
127613339|NCT01062555|459214059|FG001|Phase 1|Graft Failure|8|||
127613340|NCT01062555|459214060|FG002|Phase 1|Graft Failure|0|||
127613341|NCT01062555|459214061|FG003|Phase 1|Graft Failure|0|||
127613342|NCT01062555|459214058|FG000|Phase 1|Withdrawal by Subject|1|||
127613343|NCT01062555|459214059|FG001|Phase 1|Withdrawal by Subject|1|||
127613344|NCT01062555|459214060|FG002|Phase 1|Withdrawal by Subject|0|||
127613345|NCT01062555|459214061|FG003|Phase 1|Withdrawal by Subject|0|||
127698766|NCT03575897|459526512|FG001|Overall Study|Lost to Follow-up|13|||
127698767|NCT04359108|459526513|FG000|Overall Study|Withdrawal by Subject|1|||
127698768|NCT04359108|459526514|FG001|Overall Study|Withdrawal by Subject|0|||
127613346|NCT01062555|459214058|FG000|Phase 2|Death|0|||
127613347|NCT01062555|459214059|FG001|Phase 2|Death|0|||
127613348|NCT01062555|459214060|FG002|Phase 2|Death|8|||
127613349|NCT01062555|459214061|FG003|Phase 2|Death|3|||
127698769|NCT04359108|459526513|FG000|Overall Study|Unable or too feeble to walk independently|0|||
127698770|NCT04359108|459526514|FG001|Overall Study|Unable or too feeble to walk independently|2|||
127698771|NCT04359108|459526513|FG000|Overall Study|Argus II system stopped functioning|0|||
127698772|NCT04359108|459526514|FG001|Overall Study|Argus II system stopped functioning|1|||
127698773|NCT04359108|459526513|FG000|Overall Study|Died of natural causes unrelated to the study before study ended|0|||
127698774|NCT04359108|459526514|FG001|Overall Study|Died of natural causes unrelated to the study before study ended|2|||
127698775|NCT03652688|459526515|FG000|Baseline|Withdrawal by Subject|0|||
127698776|NCT03652688|459526516|FG001|Baseline|Withdrawal by Subject|3|||
127698777|NCT03652688|459526515|FG000|Follow-up|Lost to Follow-up|56|||
127789869|NCT03775421|459855191|FG000|Overall Study|Physician Decision|3|||
127613350|NCT01062555|459214058|FG000|Phase 2|Graft failure|0|||
127613351|NCT01062555|459214059|FG001|Phase 2|Graft failure|0|||
127613352|NCT01062555|459214060|FG002|Phase 2|Graft failure|7|||
127613353|NCT01062555|459214061|FG003|Phase 2|Graft failure|4|||
127613354|NCT01062555|459214058|FG000|Phase 2|Withdrawal by Subject|0|||
127698778|NCT03652688|459526516|FG001|Follow-up|Lost to Follow-up|54|||
127789870|NCT03775421|459855191|FG000|Overall Study|Death|1|||
127613355|NCT01062555|459214059|FG001|Phase 2|Withdrawal by Subject|0|||
127613356|NCT01062555|459214060|FG002|Phase 2|Withdrawal by Subject|0|||
127613357|NCT01062555|459214061|FG003|Phase 2|Withdrawal by Subject|7|||
127698779|NCT06205407|459526517|FG000|Period 2|Withdrawal by Subject|0|||
127613358|NCT01062555|459214058|FG000|Phase 2|Protocol Violation|0|||
127613359|NCT01062555|459214059|FG001|Phase 2|Protocol Violation|0|||
127613360|NCT01062555|459214060|FG002|Phase 2|Protocol Violation|0|||
127613361|NCT01062555|459214061|FG003|Phase 2|Protocol Violation|3|||
127613362|NCT01062555|459214058|FG000|Phase 2|Physician Decision|0|||
127613363|NCT01062555|459214059|FG001|Phase 2|Physician Decision|0|||
127613364|NCT01062555|459214060|FG002|Phase 2|Physician Decision|0|||
127613365|NCT01062555|459214061|FG003|Phase 2|Physician Decision|17|||
127613366|NCT00978068|459214064|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
127613367|NCT00978068|459214065|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
127613368|NCT00978068|459214064|FG000|Overall Study|Death|1|||
127613369|NCT00978068|459214065|FG001|Overall Study|Death|2|||
127613370|NCT00978068|459214064|FG000|Overall Study|Lost to Follow-up|1|||
127613371|NCT00978068|459214065|FG001|Overall Study|Lost to Follow-up|2|||
127613372|NCT00978068|459214064|FG000|Overall Study|Physician Decision|0|||
127613373|NCT00978068|459214065|FG001|Overall Study|Physician Decision|1|||
127613374|NCT00978068|459214064|FG000|Overall Study|Unable to Comply with Study|0|||
127613375|NCT00978068|459214065|FG001|Overall Study|Unable to Comply with Study|2|||
127613376|NCT04964128|459214066|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
127613377|NCT04964128|459214066|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
127613378|NCT01471379|459214067|FG000|Overall Study|Adverse Event|1|||
127613379|NCT01471379|459214068|FG001|Overall Study|Adverse Event|0|||
127613380|NCT01471379|459214069|FG002|Overall Study|Adverse Event|0|||
127613381|NCT01471379|459214067|FG000|Overall Study|Study terminated|0|||
127613382|NCT01471379|459214068|FG001|Overall Study|Study terminated|1|||
127613383|NCT01471379|459214069|FG002|Overall Study|Study terminated|0|||
127613384|NCT02120794|459214070|FG000|Overall Study|Withdrawal by Subject|43|||
127613385|NCT02120794|459214070|FG000|Overall Study|Adverse Event|10|||
127613386|NCT02120794|459214070|FG000|Overall Study|Physician Decision|4|||
127613387|NCT02120794|459214070|FG000|Overall Study|Due to insurance coverage|1|||
127613388|NCT02818777|459214074|FG000|Overall Study|Adverse Event|3|||
127613389|NCT00856908|459214085|FG000|Overall Study|Lost to Follow-up|1|||
127613390|NCT00856908|459214086|FG001|Overall Study|Lost to Follow-up|0|||
127613391|NCT01324349|459214090|FG000|Overall Study|Death|1|||
127613392|NCT01324349|459214091|FG001|Overall Study|Death|1|||
127613393|NCT01324349|459214090|FG000|Overall Study|Withdrawal by Subject|0|||
127613394|NCT01324349|459214091|FG001|Overall Study|Withdrawal by Subject|1|||
127613395|NCT03913091|459214092|FG000|Overall Study|Lost to Follow-up|18|||
127613396|NCT03913091|459214093|FG001|Overall Study|Lost to Follow-up|11|||
127613397|NCT03913091|459214092|FG000|Overall Study|Required additional meds/surgery|1|||
127613398|NCT03913091|459214093|FG001|Overall Study|Required additional meds/surgery|2|||
127613399|NCT03913091|459214092|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
127698780|NCT06205407|459526518|FG001|Period 2|Withdrawal by Subject|1|||
127698781|NCT06205407|459526517|FG000|Period 2|Adverse Event|2|||
127698782|NCT06205407|459526518|FG001|Period 2|Adverse Event|1|||
127698783|NCT05409183|459526521|FG000|Complete Study|Adverse Event|1|||
127698784|NCT05409183|459526522|FG001|Complete Study|Adverse Event|2|||
127698785|NCT05409183|459526521|FG000|Complete Study|Withdrawal by Subject|3|||
127698786|NCT05409183|459526522|FG001|Complete Study|Withdrawal by Subject|0|||
127698787|NCT02274662|459526523|FG000|Overall Study|Death|1|||
127698788|NCT02274662|459526523|FG000|Overall Study|Lost to Follow-up|3|||
127698789|NCT02936752|459526524|FG000|Overall Study|Death|2|||
127698790|NCT02936752|459526525|FG001|Overall Study|Death|1|||
127698791|NCT02936752|459526524|FG000|Overall Study|Physician Decision|4|||
127789871|NCT03775421|459855191|FG000|Overall Study|Study Terminated by Sponsor|94|||
127789872|NCT00135668|459855192|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
127789873|NCT00135668|459855193|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
127789874|NCT00135668|459855194|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
127789875|NCT00135668|459855195|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
127789876|NCT00455013|459855200|FG000|Short Term Period|Adverse Event|2|||
127789877|NCT00455013|459855201|FG001|Short Term Period|Adverse Event|5|||
127789878|NCT00455013|459855202|FG002|Short Term Period|Adverse Event|0|||
127789879|NCT00455013|459855200|FG000|Short Term Period|Withdrawal by Subject|0|||
127789880|NCT00455013|459855201|FG001|Short Term Period|Withdrawal by Subject|0|||
127789881|NCT00455013|459855202|FG002|Short Term Period|Withdrawal by Subject|1|||
127789882|NCT00455013|459855200|FG000|Short Term Period|Lack of Efficacy|4|||
127789883|NCT00455013|459855201|FG001|Short Term Period|Lack of Efficacy|0|||
127789884|NCT00455013|459855202|FG002|Short Term Period|Lack of Efficacy|0|||
127789885|NCT00455013|459855200|FG000|Short Term Period|Other|0|||
127613400|NCT03913091|459214093|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
127613401|NCT02196324|459214095|FG000|Overall Study|Withdrawal by Subject|8|||
127613402|NCT02196324|459214096|FG001|Overall Study|Withdrawal by Subject|4|||
127613403|NCT02196324|459214095|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
127698792|NCT02936752|459526525|FG001|Overall Study|Physician Decision|0|||
127698793|NCT02936752|459526524|FG000|Overall Study|Withdrawal by Subject|0|||
127613404|NCT02196324|459214096|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
127613405|NCT02196324|459214095|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
127613406|NCT02196324|459214096|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
127613407|NCT02196324|459214095|FG000|Overall Study|Other|1|||
127613408|NCT02196324|459214096|FG001|Overall Study|Other|0|||
127613409|NCT00692770|459214097|FG000|Overall Study|Protocol Violation|2|||
127613410|NCT00692770|459214098|FG001|Overall Study|Protocol Violation|7|||
127613411|NCT00692770|459214097|FG000|Overall Study|Withdrawal by Subject|97|||
127613412|NCT00692770|459214098|FG001|Overall Study|Withdrawal by Subject|36|||
127613413|NCT00692770|459214097|FG000|Overall Study|Adverse Event|136|||
127613414|NCT00692770|459214098|FG001|Overall Study|Adverse Event|41|||
127613415|NCT00692770|459214097|FG000|Overall Study|Death|10|||
127613416|NCT00692770|459214098|FG001|Overall Study|Death|5|||
127613417|NCT00692770|459214097|FG000|Overall Study|Lost to Follow-up|7|||
127613418|NCT00692770|459214098|FG001|Overall Study|Lost to Follow-up|3|||
127613419|NCT00692770|459214097|FG000|Overall Study|Non-compliant with study medication|11|||
127613420|NCT00692770|459214098|FG001|Overall Study|Non-compliant with study medication|5|||
127613421|NCT00692770|459214097|FG000|Overall Study|Progression by clinical judgment|2|||
127613422|NCT00692770|459214098|FG001|Overall Study|Progression by clinical judgment|3|||
127613423|NCT00692770|459214097|FG000|Overall Study|Physician decision not protocol driven|10|||
127613424|NCT00692770|459214098|FG001|Overall Study|Physician decision not protocol driven|14|||
127613425|NCT00692770|459214097|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
127613426|NCT00692770|459214098|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
127613427|NCT00692770|459214097|FG000|Overall Study|Protocol driven decision point|3|||
127613428|NCT00692770|459214098|FG001|Overall Study|Protocol driven decision point|7|||
127613429|NCT00692770|459214097|FG000|Overall Study|Completed all planned assessments|79|||
127613430|NCT00692770|459214098|FG001|Overall Study|Completed all planned assessments|101|||
127613431|NCT00692770|459214097|FG000|Overall Study|Radiological and clinical progression|8|||
127613432|NCT00692770|459214098|FG001|Overall Study|Radiological and clinical progression|8|||
127613433|NCT00692770|459214097|FG000|Overall Study|Clinical endpoint reached|16|||
127613434|NCT00692770|459214098|FG001|Overall Study|Clinical endpoint reached|43|||
127613435|NCT00692770|459214097|FG000|Overall Study|Study terminated by sponsor|2|||
127613436|NCT00692770|459214098|FG001|Overall Study|Study terminated by sponsor|2|||
127613437|NCT00692770|459214097|FG000|Overall Study|Randomized but not treated|3|||
127613438|NCT00692770|459214098|FG001|Overall Study|Randomized but not treated|4|||
127613439|NCT01077804|459214099|FG000|Overall Study|Unreachable|102|||
127613440|NCT01077804|459214099|FG000|Overall Study|Refused to continue|79|||
127613441|NCT01077804|459214099|FG000|Overall Study|Other|18|||
127613442|NCT02620046|459214101|FG000|Overall Study|Adverse Event|22|||
127613443|NCT02620046|459214102|FG001|Overall Study|Adverse Event|42|||
127613444|NCT02620046|459214101|FG000|Overall Study|Lost to Follow-up|4|||
127613445|NCT02620046|459214102|FG001|Overall Study|Lost to Follow-up|10|||
127613446|NCT02620046|459214101|FG000|Overall Study|Withdrawal by Subject|36|||
127613447|NCT02620046|459214102|FG001|Overall Study|Withdrawal by Subject|66|||
127613448|NCT02620046|459214101|FG000|Overall Study|Site Termination|3|||
127613449|NCT02620046|459214102|FG001|Overall Study|Site Termination|3|||
127613450|NCT02620046|459214101|FG000|Overall Study|Pregnancy|3|||
127613451|NCT02620046|459214102|FG001|Overall Study|Pregnancy|7|||
127613452|NCT02620046|459214101|FG000|Overall Study|Lack of Efficacy|81|||
127613453|NCT02620046|459214102|FG001|Overall Study|Lack of Efficacy|146|||
127613454|NCT02620046|459214101|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
127613455|NCT02620046|459214102|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
127613456|NCT02620046|459214101|FG000|Overall Study|Reason Not Specified|13|||
127613457|NCT02620046|459214102|FG001|Overall Study|Reason Not Specified|21|||
127613458|NCT02620046|459214101|FG000|Overall Study|Significant Protocol Deviation|0|||
127613459|NCT02620046|459214102|FG001|Overall Study|Significant Protocol Deviation|1|||
127613460|NCT03711162|459215590|FG000|Overall Study|Adverse Event|5|||
127613461|NCT03711162|459215591|FG001|Overall Study|Adverse Event|2|||
127789886|NCT00455013|459855201|FG001|Short Term Period|Other|0|||
127789887|NCT00455013|459855202|FG002|Short Term Period|Other|1|||
127789888|NCT00455013|459855200|FG000|Long Term Extension (LTE)|Adverse Event|0|||
127789889|NCT00455013|459855201|FG001|Long Term Extension (LTE)|Adverse Event|1|||
127789890|NCT00455013|459855202|FG002|Long Term Extension (LTE)|Adverse Event|1|||
127789891|NCT00455013|459855200|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
127789892|NCT00455013|459855201|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
127789893|NCT00455013|459855202|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
127789894|NCT00455013|459855200|FG000|Long Term Extension (LTE)|Death|1|||
127789895|NCT00455013|459855201|FG001|Long Term Extension (LTE)|Death|1|||
127613462|NCT03711162|459215592|FG002|Overall Study|Adverse Event|4|||
127613463|NCT03711162|459215590|FG000|Overall Study|Death|11|||
127613464|NCT03711162|459215591|FG001|Overall Study|Death|7|||
127613465|NCT03711162|459215592|FG002|Overall Study|Death|8|||
127613466|NCT03711162|459215590|FG000|Overall Study|Lost to Follow-up|1|||
127613467|NCT03711162|459215591|FG001|Overall Study|Lost to Follow-up|0|||
127613468|NCT03711162|459215592|FG002|Overall Study|Lost to Follow-up|1|||
127613469|NCT03711162|459215590|FG000|Overall Study|Study Terminated by Sponsor|139|||
127613470|NCT03711162|459215591|FG001|Overall Study|Study Terminated by Sponsor|152|||
127613471|NCT03711162|459215592|FG002|Overall Study|Study Terminated by Sponsor|146|||
127613472|NCT03711162|459215590|FG000|Overall Study|Withdrawal by Subject|17|||
127613473|NCT03711162|459215591|FG001|Overall Study|Withdrawal by Subject|10|||
127613474|NCT03711162|459215592|FG002|Overall Study|Withdrawal by Subject|10|||
127613475|NCT03711162|459215590|FG000|Overall Study|Miscellaneous|1|||
127613476|NCT03711162|459215591|FG001|Overall Study|Miscellaneous|2|||
127613477|NCT03711162|459215592|FG002|Overall Study|Miscellaneous|2|||
127613478|NCT03711162|459215590|FG000|Overall Study|Not Treated|1|||
127613479|NCT03711162|459215591|FG001|Overall Study|Not Treated|0|||
127613480|NCT03711162|459215592|FG002|Overall Study|Not Treated|1|||
127613481|NCT03711162|459215590|FG000|Overall Study|Physician Decision|0|||
127613482|NCT03711162|459215591|FG001|Overall Study|Physician Decision|2|||
127613483|NCT03711162|459215592|FG002|Overall Study|Physician Decision|0|||
127613484|NCT03711162|459215590|FG000|Overall Study|Lack of Efficacy|0|||
127613485|NCT03711162|459215591|FG001|Overall Study|Lack of Efficacy|0|||
127613486|NCT03711162|459215592|FG002|Overall Study|Lack of Efficacy|2|||
127613487|NCT03711162|459215590|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
127613488|NCT03711162|459215591|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
127613489|NCT03711162|459215592|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
127613490|NCT03034954|459215593|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
127613491|NCT03034954|459215594|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
127613492|NCT00394212|459215597|FG000|Overall Study|Lost to Follow-up|3|||
127613493|NCT00394212|459215598|FG001|Overall Study|Lost to Follow-up|0|||
127613494|NCT00394212|459215597|FG000|Overall Study|Withdrawal by Subject|4|||
127613495|NCT00394212|459215598|FG001|Overall Study|Withdrawal by Subject|1|||
127613496|NCT00588445|459215599|FG000|Overall Study|Protocol Violation|1|||
127613497|NCT00588445|459215599|FG000|Overall Study|Withdrawal by Subject|3|||
127613498|NCT00588445|459215599|FG000|Overall Study|Disease Progression|1|||
127613499|NCT00588445|459215599|FG000|Overall Study|Not Treated|10|||
127613500|NCT03240133|459215600|FG000|Overall Study|Withdrawal by Subject|0|||
127613501|NCT03240133|459215601|FG001|Overall Study|Withdrawal by Subject|1|||
127613502|NCT03240133|459215602|FG002|Overall Study|Withdrawal by Subject|0|||
127613503|NCT03240133|459215600|FG000|Overall Study|Adverse Event|1|||
127613504|NCT03240133|459215601|FG001|Overall Study|Adverse Event|1|||
127613505|NCT03240133|459215602|FG002|Overall Study|Adverse Event|0|||
127613506|NCT03240133|459215600|FG000|Overall Study|Rash|1|||
127613507|NCT03240133|459215601|FG001|Overall Study|Rash|0|||
127613508|NCT03240133|459215602|FG002|Overall Study|Rash|0|||
127613509|NCT03240133|459215600|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
127613510|NCT03240133|459215601|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
127613511|NCT03240133|459215602|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
127613512|NCT03240133|459215600|FG000|Overall Study|Intercurrent illness.|0|||
127698794|NCT02936752|459526525|FG001|Overall Study|Withdrawal by Subject|2|||
127698795|NCT04489771|459526526|FG000|Overall Study|Death|27|||
127698796|NCT04489771|459526527|FG001|Overall Study|Death|25|||
127698797|NCT04489771|459526526|FG000|Overall Study|Withdrawal by Subject|1|||
127698798|NCT04489771|459526527|FG001|Overall Study|Withdrawal by Subject|0|||
127698799|NCT04489771|459526526|FG000|Overall Study|Participants Ongoing in Study|50|||
127698800|NCT04489771|459526527|FG001|Overall Study|Participants Ongoing in Study|51|||
127698801|NCT03197662|459526534|FG000|Overall Study|Withdrawn by family|0|||
127698802|NCT03197662|459526535|FG001|Overall Study|Withdrawn by family|2|||
127698803|NCT04064164|459526543|FG000|Overall Study|Withdrawal by Subject|8|||
127698804|NCT04064164|459526544|FG001|Overall Study|Withdrawal by Subject|8|||
127698805|NCT04059484|459526545|FG000|Overall Study|Adverse Event|2|||
127698806|NCT04059484|459526546|FG001|Overall Study|Adverse Event|5|||
127698807|NCT04059484|459526545|FG000|Overall Study|Withdrawal by Subject|5|||
127698808|NCT04059484|459526546|FG001|Overall Study|Withdrawal by Subject|3|||
127698809|NCT04059484|459526545|FG000|Overall Study|Progressive disease|112|||
127698810|NCT04059484|459526546|FG001|Overall Study|Progressive disease|112|||
127698811|NCT04059484|459526545|FG000|Overall Study|Other|8|||
127698812|NCT04059484|459526546|FG001|Overall Study|Other|3|||
127698813|NCT04059484|459526545|FG000|Overall Study|Ongoing|20|||
127698814|NCT04059484|459526546|FG001|Overall Study|Ongoing|20|||
127789896|NCT00455013|459855202|FG002|Long Term Extension (LTE)|Death|0|||
127613513|NCT03240133|459215601|FG001|Overall Study|Intercurrent illness.|1|||
127613514|NCT03240133|459215602|FG002|Overall Study|Intercurrent illness.|0|||
127613515|NCT03240133|459215600|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
127698815|NCT02949362|459526547|FG000|Retrospective Period|Inform consent not signed by participant|4|||
127698816|NCT02949362|459526548|FG001|Retrospective Period|Inform consent not signed by participant|1|||
127789897|NCT00455013|459855200|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
127789898|NCT00455013|459855201|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
127698817|NCT02949362|459526549|FG002|Retrospective Period|Inform consent not signed by participant|0|||
127698818|NCT02949362|459526550|FG003|Retrospective Period|Inform consent not signed by participant|0|||
127698819|NCT02949362|459526547|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
127698820|NCT02949362|459526548|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
127698821|NCT02949362|459526549|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
127698822|NCT02949362|459526550|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
127698823|NCT02949362|459526547|FG000|Prospective Period|Other|0|||
127698824|NCT02949362|459526548|FG001|Prospective Period|Other|0|||
127698825|NCT02949362|459526549|FG002|Prospective Period|Other|0|||
127698826|NCT02949362|459526550|FG003|Prospective Period|Other|4|||
127698827|NCT04633122|459526554|FG000|Overall Study|Remained on treatment|19|||
127698828|NCT04633122|459526555|FG001|Overall Study|Remained on treatment|14|||
127698829|NCT04633122|459526554|FG000|Overall Study|Survival follow-up stopped|22|||
127789899|NCT00455013|459855202|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
127789900|NCT00455013|459855200|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
127789901|NCT00455013|459855201|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
127789902|NCT00455013|459855202|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
127789903|NCT00455013|459855200|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
127789904|NCT00455013|459855201|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
127789905|NCT00455013|459855202|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
127789906|NCT00455013|459855200|FG000|Long Term Extension (LTE)|non-specified|0|||
127789907|NCT00455013|459855201|FG001|Long Term Extension (LTE)|non-specified|0|||
127789908|NCT00455013|459855202|FG002|Long Term Extension (LTE)|non-specified|1|||
127789909|NCT02739620|459855205|FG000|Overall Study|Lost to Follow-up|3|||
127789910|NCT02739620|459855206|FG001|Overall Study|Lost to Follow-up|1|||
127789911|NCT02739620|459855205|FG000|Overall Study|Adverse Event|0|||
127789912|NCT02739620|459855206|FG001|Overall Study|Adverse Event|1|||
127789913|NCT00754793|459855208|FG000|Overall Study|voluntary withdrawn from study|0|||
127789914|NCT00754793|459855209|FG001|Overall Study|voluntary withdrawn from study|1|||
127789915|NCT02943564|459855210|FG000|Overall Study|Miscellaneous Reasons|0|||
127789916|NCT02943564|459855211|FG001|Overall Study|Miscellaneous Reasons|0|||
127789917|NCT02943564|459855212|FG002|Overall Study|Miscellaneous Reasons|3|||
127789918|NCT02943564|459855210|FG000|Overall Study|Site terminated by sponsor|0|||
127789919|NCT02943564|459855211|FG001|Overall Study|Site terminated by sponsor|1|||
127789920|NCT02943564|459855212|FG002|Overall Study|Site terminated by sponsor|0|||
127789921|NCT02943564|459855210|FG000|Overall Study|Non-compliance with study drug|0|||
127789922|NCT02943564|459855211|FG001|Overall Study|Non-compliance with study drug|1|||
127789923|NCT02943564|459855212|FG002|Overall Study|Non-compliance with study drug|0|||
127789924|NCT02943564|459855210|FG000|Overall Study|Pregnancy|0|||
127789925|NCT02943564|459855211|FG001|Overall Study|Pregnancy|1|||
127789926|NCT02943564|459855212|FG002|Overall Study|Pregnancy|1|||
127789927|NCT02943564|459855210|FG000|Overall Study|Protocol Violation|2|||
127789928|NCT02943564|459855211|FG001|Overall Study|Protocol Violation|2|||
127789929|NCT02943564|459855212|FG002|Overall Study|Protocol Violation|2|||
127789930|NCT02943564|459855210|FG000|Overall Study|Lost to Follow-up|1|||
127789931|NCT02943564|459855211|FG001|Overall Study|Lost to Follow-up|0|||
127789932|NCT02943564|459855212|FG002|Overall Study|Lost to Follow-up|0|||
127789933|NCT02943564|459855210|FG000|Overall Study|Withdrawal by Subject|6|||
127789934|NCT02943564|459855211|FG001|Overall Study|Withdrawal by Subject|5|||
127789935|NCT02943564|459855212|FG002|Overall Study|Withdrawal by Subject|2|||
127789936|NCT02943564|459855210|FG000|Overall Study|Adverse Event|1|||
127789937|NCT02943564|459855211|FG001|Overall Study|Adverse Event|2|||
127789938|NCT02943564|459855212|FG002|Overall Study|Adverse Event|1|||
127789939|NCT02943564|459855210|FG000|Overall Study|Lack of Efficacy|0|||
127789940|NCT02943564|459855211|FG001|Overall Study|Lack of Efficacy|1|||
127789941|NCT02943564|459855212|FG002|Overall Study|Lack of Efficacy|0|||
127789942|NCT01073267|459855216|FG000|Overall Study|Disease Progression|3|||
127789943|NCT01225731|459855217|FG000|Part 1|Did not meet eligibility criteria|1|||
127789944|NCT01225731|459855218|FG001|Part 1|Did not meet eligibility criteria|0|||
127789945|NCT01225731|459855219|FG002|Part 1|Did not meet eligibility criteria|0|||
127698830|NCT04633122|459526555|FG001|Overall Study|Survival follow-up stopped|25|||
127698831|NCT03307343|459526556|FG000|Overall Study|Withdrawal by Subject|1|||
127698832|NCT03307343|459526557|FG001|Overall Study|Withdrawal by Subject|2|||
127789946|NCT01225731|459855220|FG003|Part 1|Did not meet eligibility criteria|0|||
127789947|NCT01225731|459855221|FG004|Part 1|Did not meet eligibility criteria|1|||
127789948|NCT01225731|459855222|FG005|Part 1|Did not meet eligibility criteria|0|||
127789949|NCT01225731|459855223|FG006|Part 1|Did not meet eligibility criteria|0|||
127789950|NCT01225731|459855224|FG007|Part 1|Did not meet eligibility criteria|0|||
127789951|NCT01225731|459855225|FG008|Part 1|Did not meet eligibility criteria|0|||
127789952|NCT01225731|459855226|FG009|Part 1|Did not meet eligibility criteria|0|||
127789953|NCT01225731|459855227|FG010|Part 1|Did not meet eligibility criteria|0|||
127789954|NCT01225731|459855228|FG011|Part 1|Did not meet eligibility criteria|0|||
127789955|NCT01225731|459855229|FG012|Part 1|Did not meet eligibility criteria|0|||
127698833|NCT03307343|459526556|FG000|Overall Study|Pregnancy|0|||
127698834|NCT03307343|459526557|FG001|Overall Study|Pregnancy|2|||
127613516|NCT03240133|459215601|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
127613517|NCT03240133|459215602|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
127613518|NCT01176292|459215603|FG000|Overall Study|Lost to Follow-up|2|||
127613519|NCT01176292|459215604|FG001|Overall Study|Lost to Follow-up|4|||
127613520|NCT01176292|459215603|FG000|Overall Study|Adverse Event|1|||
127613521|NCT01176292|459215604|FG001|Overall Study|Adverse Event|1|||
127613522|NCT01176292|459215603|FG000|Overall Study|Physician Decision|0|||
127613523|NCT01176292|459215604|FG001|Overall Study|Physician Decision|2|||
127613524|NCT01176292|459215603|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
127613525|NCT01176292|459215604|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
127613526|NCT00997503|459215605|FG000|Overall Study|Death|53|||
127613527|NCT00997503|459215605|FG000|Overall Study|Withdrawal by Subject|76|||
127613528|NCT00997503|459215605|FG000|Overall Study|Lost to Follow-up|33|||
127613529|NCT00997503|459215605|FG000|Overall Study|Adverse Event|3|||
127613530|NCT00997503|459215605|FG000|Overall Study|Physician Decision|10|||
127613531|NCT00997503|459215605|FG000|Overall Study|Missed 12-month follow-up|85|||
127613532|NCT00997503|459215605|FG000|Overall Study|Other reason|13|||
127613533|NCT00116831|459215606|FG000|Overall Study|Adverse Event|14|||
127613534|NCT00116831|459215607|FG001|Overall Study|Adverse Event|16|||
127613535|NCT00116831|459215606|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
127613536|NCT00116831|459215607|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
127613537|NCT00116831|459215606|FG000|Overall Study|Lost to Follow-up|8|||
127613538|NCT00116831|459215607|FG001|Overall Study|Lost to Follow-up|6|||
127613539|NCT00116831|459215606|FG000|Overall Study|Protocol Violation|3|||
127613540|NCT00116831|459215607|FG001|Overall Study|Protocol Violation|6|||
127613541|NCT00116831|459215606|FG000|Overall Study|Hypoglycaemic events|1|||
127613542|NCT00116831|459215607|FG001|Overall Study|Hypoglycaemic events|0|||
127613543|NCT00116831|459215606|FG000|Overall Study|Low haemoglobin on screening|1|||
127613544|NCT00116831|459215607|FG001|Overall Study|Low haemoglobin on screening|0|||
127613545|NCT00116831|459215606|FG000|Overall Study|Withdrawn investigational product|1|||
127613546|NCT00116831|459215607|FG001|Overall Study|Withdrawn investigational product|0|||
127613547|NCT00116831|459215606|FG000|Overall Study|Withdrawal by Subject|32|||
127613548|NCT00116831|459215607|FG001|Overall Study|Withdrawal by Subject|32|||
127613549|NCT00116831|459215606|FG000|Overall Study|Insufficient therapeutic effect|0|||
127613550|NCT00116831|459215607|FG001|Overall Study|Insufficient therapeutic effect|1|||
127613551|NCT00116831|459215606|FG000|Overall Study|Missing data for participant|1|||
127613552|NCT00116831|459215607|FG001|Overall Study|Missing data for participant|0|||
127613553|NCT00380393|459215608|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
127613554|NCT00380393|459215609|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
127613555|NCT00380393|459215608|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
127613556|NCT00380393|459215609|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
127613557|NCT00380393|459215608|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
127613558|NCT00380393|459215609|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
127613559|NCT00380393|459215608|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
127613560|NCT00380393|459215609|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
127613561|NCT00380393|459215608|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
127613562|NCT00380393|459215609|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
127613563|NCT00380393|459215608|FG000|Month 14|Withdrawal by Subject|9|||
127613564|NCT00380393|459215609|FG001|Month 14|Withdrawal by Subject|7|||
127613565|NCT00380393|459215608|FG000|Month 14|Death|1|||
127613566|NCT00380393|459215609|FG001|Month 14|Death|0|||
127613567|NCT00380393|459215608|FG000|Month 14|Lost to Follow-up|0|||
127613568|NCT00380393|459215609|FG001|Month 14|Lost to Follow-up|1|||
127613569|NCT00380393|459215608|FG000|Month 14|Migrated/moved from study area|39|||
127613570|NCT00380393|459215609|FG001|Month 14|Migrated/moved from study area|42|||
127789956|NCT01225731|459855217|FG000|Part 1|Adverse Event|1|||
127789957|NCT01225731|459855218|FG001|Part 1|Adverse Event|2|||
127789958|NCT01225731|459855219|FG002|Part 1|Adverse Event|1|||
127789959|NCT01225731|459855220|FG003|Part 1|Adverse Event|1|||
127613571|NCT00380393|459215608|FG000|Month 14|Protocol Violation|2|||
127613572|NCT00380393|459215609|FG001|Month 14|Protocol Violation|0|||
127613573|NCT00380393|459215608|FG000|Month 14|Others|6|||
127613574|NCT00380393|459215609|FG001|Month 14|Others|6|||
127613575|NCT01933048|459215610|FG000|Overall Study|Lost to Follow-up|15|||
127613576|NCT01933048|459215611|FG001|Overall Study|Lost to Follow-up|18|||
127613577|NCT01933048|459215610|FG000|Overall Study|personal reasons|1|||
127613578|NCT01933048|459215611|FG001|Overall Study|personal reasons|1|||
127613579|NCT01933048|459215610|FG000|Overall Study|Protocol Violation|7|||
127613580|NCT01933048|459215611|FG001|Overall Study|Protocol Violation|8|||
127789960|NCT01225731|459855221|FG004|Part 1|Adverse Event|1|||
127789961|NCT01225731|459855222|FG005|Part 1|Adverse Event|0|||
127789962|NCT01225731|459855223|FG006|Part 1|Adverse Event|0|||
127613581|NCT01933048|459215610|FG000|Overall Study|Physician Decision|1|||
127613582|NCT01933048|459215611|FG001|Overall Study|Physician Decision|0|||
127613583|NCT01933048|459215610|FG000|Overall Study|unknown reasons|1|||
127613584|NCT01933048|459215611|FG001|Overall Study|unknown reasons|1|||
127789963|NCT01225731|459855224|FG007|Part 1|Adverse Event|0|||
127789964|NCT01225731|459855225|FG008|Part 1|Adverse Event|0|||
127789965|NCT01225731|459855226|FG009|Part 1|Adverse Event|0|||
127789966|NCT01225731|459855227|FG010|Part 1|Adverse Event|0|||
127789967|NCT01225731|459855228|FG011|Part 1|Adverse Event|0|||
127789968|NCT01225731|459855229|FG012|Part 1|Adverse Event|0|||
127613585|NCT00110812|459215612|FG000|Main Study|Death|0|||
127613586|NCT00110812|459215613|FG001|Main Study|Death|0|||
127613587|NCT00110812|459215614|FG002|Main Study|Death|2|||
127613588|NCT00110812|459215612|FG000|Main Study|Withdrawal by Subject|0|||
127613589|NCT00110812|459215613|FG001|Main Study|Withdrawal by Subject|0|||
127613590|NCT00110812|459215614|FG002|Main Study|Withdrawal by Subject|1|||
127613591|NCT00110812|459215612|FG000|Main Study|Lost to Follow-up|8|||
127613592|NCT00110812|459215613|FG001|Main Study|Lost to Follow-up|11|||
127613593|NCT00110812|459215614|FG002|Main Study|Lost to Follow-up|10|||
127613594|NCT00110812|459215612|FG000|Extended Follow-up|Death|1|||
127613595|NCT00110812|459215613|FG001|Extended Follow-up|Death|0|||
127613596|NCT00110812|459215614|FG002|Extended Follow-up|Death|3|||
127613597|NCT00110812|459215612|FG000|Extended Follow-up|Withdrawal by Subject|0|||
127613598|NCT00110812|459215613|FG001|Extended Follow-up|Withdrawal by Subject|1|||
127613599|NCT00110812|459215614|FG002|Extended Follow-up|Withdrawal by Subject|0|||
127613600|NCT00110812|459215612|FG000|Extended Follow-up|Lost to Follow-up|1|||
127613601|NCT00110812|459215613|FG001|Extended Follow-up|Lost to Follow-up|3|||
127613602|NCT00110812|459215614|FG002|Extended Follow-up|Lost to Follow-up|1|||
127789969|NCT01225731|459855217|FG000|Part 1|Withdrawal by Subject|0|||
127789970|NCT01225731|459855218|FG001|Part 1|Withdrawal by Subject|3|||
127789971|NCT01225731|459855219|FG002|Part 1|Withdrawal by Subject|0|||
127789972|NCT01225731|459855220|FG003|Part 1|Withdrawal by Subject|0|||
127789973|NCT01225731|459855221|FG004|Part 1|Withdrawal by Subject|4|||
127613603|NCT00097721|459215623|FG000|Overall Study|Adverse Event|8|||
127789974|NCT01225731|459855222|FG005|Part 1|Withdrawal by Subject|0|||
127789975|NCT01225731|459855223|FG006|Part 1|Withdrawal by Subject|0|||
127613604|NCT00097721|459215624|FG001|Overall Study|Adverse Event|1|||
127613605|NCT00097721|459215623|FG000|Overall Study|Withdrawal by Subject|6|||
127613606|NCT00097721|459215624|FG001|Overall Study|Withdrawal by Subject|1|||
127613607|NCT00097721|459215623|FG000|Overall Study|Progressive Disease|55|||
127613608|NCT00097721|459215624|FG001|Overall Study|Progressive Disease|27|||
127789976|NCT01225731|459855224|FG007|Part 1|Withdrawal by Subject|0|||
127789977|NCT01225731|459855225|FG008|Part 1|Withdrawal by Subject|0|||
127613609|NCT00097721|459215623|FG000|Overall Study|Physician Decision|1|||
127613610|NCT00097721|459215624|FG001|Overall Study|Physician Decision|3|||
127613611|NCT00097721|459215623|FG000|Overall Study|Reason not given|1|||
127613612|NCT00097721|459215624|FG001|Overall Study|Reason not given|1|||
127613613|NCT01752855|459215628|FG000|Overall Study|Adverse Event|1|||
127613614|NCT01752855|459215629|FG001|Overall Study|Adverse Event|0|||
127613615|NCT01752855|459215628|FG000|Overall Study|Withdrew Consent|0|||
127613616|NCT01752855|459215629|FG001|Overall Study|Withdrew Consent|2|||
127613617|NCT01752855|459215628|FG000|Overall Study|Lack of Efficacy|0|||
127613618|NCT01752855|459215629|FG001|Overall Study|Lack of Efficacy|2|||
127613619|NCT01364428|459215635|FG000|Overall Study|Adverse Event|1|||
127613620|NCT01364428|459215636|FG001|Overall Study|Adverse Event|2|||
127613621|NCT01364428|459215635|FG000|Overall Study|Protocol Violation|2|||
127613622|NCT01364428|459215636|FG001|Overall Study|Protocol Violation|0|||
127613623|NCT01364428|459215635|FG000|Overall Study|Withdrawal Criteria|14|||
127613624|NCT01364428|459215636|FG001|Overall Study|Withdrawal Criteria|10|||
127613625|NCT01364428|459215635|FG000|Overall Study|Other|3|||
127613626|NCT01364428|459215636|FG001|Overall Study|Other|3|||
127613627|NCT03925324|459215637|FG000|Overall Study|Death|1|||
127613628|NCT03925324|459215638|FG001|Overall Study|Death|1|||
127613629|NCT02159521|459215640|FG000|Overall Study|Enrolled but not treated|3|||
127613630|NCT02159521|459215640|FG000|Overall Study|Withdrawal by Subject|7|||
127613631|NCT02159521|459215640|FG000|Overall Study|Lost to Follow-up|6|||
127613632|NCT02159521|459215640|FG000|Overall Study|Death|1|||
127613633|NCT02159521|459215640|FG000|Overall Study|Other than specified|1|||
127613634|NCT00594464|459215645|FG000|Overall Study|Withdrawal by Subject|1|||
127613635|NCT00594464|459215645|FG000|Overall Study|Delay in operation|2|||
127613636|NCT00775437|459215646|FG000|Overall Study|Loss of efficacy|2|||
127613637|NCT00775437|459215646|FG000|Overall Study|Withdrawal by Subject|3|||
127613638|NCT00775437|459215646|FG000|Overall Study|Lost to Follow-up|1|||
127613639|NCT03131440|459215647|FG000|Overall Study|Withdrawal by Subject|1|||
127613640|NCT03131440|459215648|FG001|Overall Study|Withdrawal by Subject|3|||
127613641|NCT03131440|459215649|FG002|Overall Study|Withdrawal by Subject|0|||
127613642|NCT03131440|459215650|FG003|Overall Study|Withdrawal by Subject|0|||
127613643|NCT03131440|459215651|FG004|Overall Study|Withdrawal by Subject|1|||
127613644|NCT03131440|459215652|FG005|Overall Study|Withdrawal by Subject|0|||
127613645|NCT03131440|459215653|FG006|Overall Study|Withdrawal by Subject|0|||
127613646|NCT03131440|459215654|FG007|Overall Study|Withdrawal by Subject|1|||
127613647|NCT03131440|459215655|FG008|Overall Study|Withdrawal by Subject|1|||
127613648|NCT03131440|459215656|FG009|Overall Study|Withdrawal by Subject|1|||
127613649|NCT03131440|459215657|FG010|Overall Study|Withdrawal by Subject|0|||
127613650|NCT03131440|459215658|FG011|Overall Study|Withdrawal by Subject|1|||
127613651|NCT03131440|459215659|FG012|Overall Study|Withdrawal by Subject|1|||
127613652|NCT03131440|459215660|FG013|Overall Study|Withdrawal by Subject|0|||
127613653|NCT03131440|459215661|FG014|Overall Study|Withdrawal by Subject|1|||
127613654|NCT03131440|459215662|FG015|Overall Study|Withdrawal by Subject|0|||
127613655|NCT03131440|459215663|FG016|Overall Study|Withdrawal by Subject|0|||
127613656|NCT03131440|459215664|FG017|Overall Study|Withdrawal by Subject|0|||
127613657|NCT03131440|459215665|FG018|Overall Study|Withdrawal by Subject|1|||
127613658|NCT03131440|459215666|FG019|Overall Study|Withdrawal by Subject|0|||
127613659|NCT03131440|459215667|FG020|Overall Study|Withdrawal by Subject|1|||
127613660|NCT03131440|459215668|FG021|Overall Study|Withdrawal by Subject|1|||
127613661|NCT03131440|459215669|FG022|Overall Study|Withdrawal by Subject|1|||
127613662|NCT03131440|459215670|FG023|Overall Study|Withdrawal by Subject|0|||
127613663|NCT03131440|459215671|FG024|Overall Study|Withdrawal by Subject|0|||
127613664|NCT03131440|459215672|FG025|Overall Study|Withdrawal by Subject|0|||
127613665|NCT03131440|459215673|FG026|Overall Study|Withdrawal by Subject|0|||
127613666|NCT03131440|459215674|FG027|Overall Study|Withdrawal by Subject|0|||
127613667|NCT03131440|459215675|FG028|Overall Study|Withdrawal by Subject|0|||
127613668|NCT03131440|459215676|FG029|Overall Study|Withdrawal by Subject|0|||
127613669|NCT03131440|459215677|FG030|Overall Study|Withdrawal by Subject|1|||
127613670|NCT03131440|459215678|FG031|Overall Study|Withdrawal by Subject|0|||
127613671|NCT03131440|459215647|FG000|Overall Study|Lost to Follow-up|0|||
127613672|NCT03131440|459215648|FG001|Overall Study|Lost to Follow-up|0|||
127613673|NCT03131440|459215649|FG002|Overall Study|Lost to Follow-up|0|||
127613674|NCT03131440|459215650|FG003|Overall Study|Lost to Follow-up|0|||
127613675|NCT03131440|459215651|FG004|Overall Study|Lost to Follow-up|0|||
127613676|NCT03131440|459215652|FG005|Overall Study|Lost to Follow-up|1|||
127613677|NCT03131440|459215653|FG006|Overall Study|Lost to Follow-up|0|||
127613678|NCT03131440|459215654|FG007|Overall Study|Lost to Follow-up|0|||
127613679|NCT03131440|459215655|FG008|Overall Study|Lost to Follow-up|0|||
127613680|NCT03131440|459215656|FG009|Overall Study|Lost to Follow-up|0|||
127613681|NCT03131440|459215657|FG010|Overall Study|Lost to Follow-up|0|||
127613682|NCT03131440|459215658|FG011|Overall Study|Lost to Follow-up|0|||
127613683|NCT03131440|459215659|FG012|Overall Study|Lost to Follow-up|0|||
127613684|NCT03131440|459215660|FG013|Overall Study|Lost to Follow-up|0|||
127613685|NCT03131440|459215661|FG014|Overall Study|Lost to Follow-up|0|||
127613686|NCT03131440|459215662|FG015|Overall Study|Lost to Follow-up|0|||
127613687|NCT03131440|459215663|FG016|Overall Study|Lost to Follow-up|0|||
127613688|NCT03131440|459215664|FG017|Overall Study|Lost to Follow-up|0|||
127613689|NCT03131440|459215665|FG018|Overall Study|Lost to Follow-up|0|||
127613690|NCT03131440|459215666|FG019|Overall Study|Lost to Follow-up|2|||
127613691|NCT03131440|459215667|FG020|Overall Study|Lost to Follow-up|1|||
127613692|NCT03131440|459215668|FG021|Overall Study|Lost to Follow-up|0|||
127613693|NCT03131440|459215669|FG022|Overall Study|Lost to Follow-up|1|||
127613694|NCT03131440|459215670|FG023|Overall Study|Lost to Follow-up|0|||
127613695|NCT03131440|459215671|FG024|Overall Study|Lost to Follow-up|1|||
127613696|NCT03131440|459215672|FG025|Overall Study|Lost to Follow-up|0|||
127613697|NCT03131440|459215673|FG026|Overall Study|Lost to Follow-up|0|||
127613698|NCT03131440|459215674|FG027|Overall Study|Lost to Follow-up|2|||
127613699|NCT03131440|459215675|FG028|Overall Study|Lost to Follow-up|0|||
127613700|NCT03131440|459215676|FG029|Overall Study|Lost to Follow-up|2|||
127613701|NCT03131440|459215677|FG030|Overall Study|Lost to Follow-up|0|||
127613702|NCT03131440|459215678|FG031|Overall Study|Lost to Follow-up|0|||
127613703|NCT03131440|459215647|FG000|Overall Study|Death|0|||
127613704|NCT03131440|459215648|FG001|Overall Study|Death|0|||
127613705|NCT03131440|459215649|FG002|Overall Study|Death|0|||
127613706|NCT03131440|459215650|FG003|Overall Study|Death|0|||
127613707|NCT03131440|459215651|FG004|Overall Study|Death|0|||
127613708|NCT03131440|459215652|FG005|Overall Study|Death|0|||
127613709|NCT03131440|459215653|FG006|Overall Study|Death|0|||
127613710|NCT03131440|459215654|FG007|Overall Study|Death|0|||
127613711|NCT03131440|459215655|FG008|Overall Study|Death|0|||
127613712|NCT03131440|459215656|FG009|Overall Study|Death|0|||
127613713|NCT03131440|459215657|FG010|Overall Study|Death|0|||
127613714|NCT03131440|459215658|FG011|Overall Study|Death|0|||
127613715|NCT03131440|459215659|FG012|Overall Study|Death|0|||
127613716|NCT03131440|459215660|FG013|Overall Study|Death|0|||
127613717|NCT03131440|459215661|FG014|Overall Study|Death|0|||
127613718|NCT03131440|459215662|FG015|Overall Study|Death|0|||
127613719|NCT03131440|459215663|FG016|Overall Study|Death|0|||
127613720|NCT03131440|459215664|FG017|Overall Study|Death|0|||
127613721|NCT03131440|459215665|FG018|Overall Study|Death|0|||
127613722|NCT03131440|459215666|FG019|Overall Study|Death|0|||
127613723|NCT03131440|459215667|FG020|Overall Study|Death|0|||
127613724|NCT03131440|459215668|FG021|Overall Study|Death|0|||
127613725|NCT03131440|459215669|FG022|Overall Study|Death|0|||
127613726|NCT03131440|459215670|FG023|Overall Study|Death|0|||
127613727|NCT03131440|459215671|FG024|Overall Study|Death|0|||
127613728|NCT03131440|459215672|FG025|Overall Study|Death|1|||
127613729|NCT03131440|459215673|FG026|Overall Study|Death|0|||
127613730|NCT03131440|459215674|FG027|Overall Study|Death|0|||
127613731|NCT03131440|459215675|FG028|Overall Study|Death|0|||
127613732|NCT03131440|459215676|FG029|Overall Study|Death|0|||
127613733|NCT03131440|459215677|FG030|Overall Study|Death|0|||
127789978|NCT01225731|459855226|FG009|Part 1|Withdrawal by Subject|0|||
127789979|NCT01225731|459855227|FG010|Part 1|Withdrawal by Subject|0|||
127789980|NCT01225731|459855228|FG011|Part 1|Withdrawal by Subject|0|||
127789981|NCT01225731|459855229|FG012|Part 1|Withdrawal by Subject|0|||
127789982|NCT01225731|459855217|FG000|Part 1|Protocol Violation|0|||
127789983|NCT01225731|459855218|FG001|Part 1|Protocol Violation|0|||
127789984|NCT01225731|459855219|FG002|Part 1|Protocol Violation|0|||
127789985|NCT01225731|459855220|FG003|Part 1|Protocol Violation|1|||
127789986|NCT01225731|459855221|FG004|Part 1|Protocol Violation|0|||
127789987|NCT01225731|459855222|FG005|Part 1|Protocol Violation|0|||
127789988|NCT01225731|459855223|FG006|Part 1|Protocol Violation|0|||
127789989|NCT01225731|459855224|FG007|Part 1|Protocol Violation|0|||
127789990|NCT01225731|459855225|FG008|Part 1|Protocol Violation|0|||
127883337|NCT03611751|460196398|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
127883338|NCT03611751|460196396|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
127883339|NCT03611751|460196397|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
127883340|NCT03611751|460196398|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
127613734|NCT03131440|459215678|FG031|Overall Study|Death|0|||
127613735|NCT00746941|459215681|FG000|Overall Study|Death|2|||
127613736|NCT00746941|459215682|FG001|Overall Study|Death|0|||
127613737|NCT00746941|459215683|FG002|Overall Study|Death|0|||
127613738|NCT00746941|459215684|FG003|Overall Study|Death|6|||
127613739|NCT00746941|459215681|FG000|Overall Study|Physician Decision|0|||
127789991|NCT01225731|459855226|FG009|Part 1|Protocol Violation|0|||
127789992|NCT01225731|459855227|FG010|Part 1|Protocol Violation|0|||
127613740|NCT00746941|459215682|FG001|Overall Study|Physician Decision|0|||
127613741|NCT00746941|459215683|FG002|Overall Study|Physician Decision|2|||
127613742|NCT00746941|459215684|FG003|Overall Study|Physician Decision|0|||
127613743|NCT00746941|459215681|FG000|Overall Study|Withdrawal by Subject|3|||
127613744|NCT00746941|459215682|FG001|Overall Study|Withdrawal by Subject|0|||
127613745|NCT00746941|459215683|FG002|Overall Study|Withdrawal by Subject|0|||
127613746|NCT00746941|459215684|FG003|Overall Study|Withdrawal by Subject|2|||
127613747|NCT00746941|459215681|FG000|Overall Study|Other, reason not provided|2|||
127613748|NCT00746941|459215682|FG001|Overall Study|Other, reason not provided|4|||
127613749|NCT00746941|459215683|FG002|Overall Study|Other, reason not provided|0|||
127613750|NCT00746941|459215684|FG003|Overall Study|Other, reason not provided|4|||
127789993|NCT01225731|459855228|FG011|Part 1|Protocol Violation|0|||
127789994|NCT01225731|459855229|FG012|Part 1|Protocol Violation|0|||
127613751|NCT00746941|459215681|FG000|Overall Study|Adverse Event|0|||
127613752|NCT00746941|459215682|FG001|Overall Study|Adverse Event|0|||
127613753|NCT00746941|459215683|FG002|Overall Study|Adverse Event|0|||
127613754|NCT00746941|459215684|FG003|Overall Study|Adverse Event|1|||
127613755|NCT03316885|459215685|FG000|Overall Study|Adverse Event|1|||
127613756|NCT03316885|459215685|FG000|Overall Study|Death|10|||
127613757|NCT03316885|459215685|FG000|Overall Study|Lost to Follow-up|4|||
127613758|NCT03316885|459215685|FG000|Overall Study|Withdrawal by Subject|9|||
127613759|NCT03316885|459215685|FG000|Overall Study|COVID related|8|||
127613760|NCT02739269|459215692|FG000|Overall Study|Protocol Violation|5|||
127613761|NCT02739269|459215693|FG001|Overall Study|Protocol Violation|0|||
127613762|NCT02739269|459215692|FG000|Overall Study|Cycle cancellation|2|||
127613763|NCT02739269|459215693|FG001|Overall Study|Cycle cancellation|2|||
127613764|NCT02739269|459215692|FG000|Overall Study|Withdrawal by Subject|0|||
127613765|NCT02739269|459215693|FG001|Overall Study|Withdrawal by Subject|2|||
127613766|NCT03216850|459215694|FG000|Overall Study|Pre-analytical error|6|||
127613767|NCT03190889|459215695|FG000|Overall Study|Lost to Follow-up|7|||
127613768|NCT03190889|459215696|FG001|Overall Study|Lost to Follow-up|7|||
127613769|NCT03190889|459215697|FG002|Overall Study|Lost to Follow-up|3|||
127613770|NCT03190889|459215695|FG000|Overall Study|Withdrawal by Subject|1|||
127613771|NCT03190889|459215696|FG001|Overall Study|Withdrawal by Subject|1|||
127613772|NCT03190889|459215697|FG002|Overall Study|Withdrawal by Subject|2|||
127613773|NCT03190889|459215695|FG000|Overall Study|Did not complete protocol|4|||
127613774|NCT03190889|459215696|FG001|Overall Study|Did not complete protocol|9|||
127613775|NCT03190889|459215697|FG002|Overall Study|Did not complete protocol|0|||
127613776|NCT03190889|459215695|FG000|Overall Study|COVID-19|1|||
127613777|NCT03190889|459215696|FG001|Overall Study|COVID-19|0|||
127613778|NCT03190889|459215697|FG002|Overall Study|COVID-19|2|||
127613779|NCT00405548|459215698|FG000|Overall Study|Cognitive Memory problems on study day|1|||
127613780|NCT00405548|459215699|FG001|Overall Study|Cognitive Memory problems on study day|0|||
127613781|NCT00405548|459215698|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
127613782|NCT00405548|459215699|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
127613783|NCT00405548|459215698|FG000|Overall Study|Unable to self-administer shots|1|||
127613784|NCT00405548|459215699|FG001|Overall Study|Unable to self-administer shots|0|||
127613785|NCT00405548|459215698|FG000|Overall Study|Venous access failed during study day|1|||
127613786|NCT00405548|459215699|FG001|Overall Study|Venous access failed during study day|0|||
127613787|NCT00405548|459215698|FG000|Overall Study|Withdrawal by Subject|1|||
127613788|NCT00405548|459215699|FG001|Overall Study|Withdrawal by Subject|0|||
127613789|NCT03554291|459215700|FG000|Overall Study|Death|2|||
127613790|NCT03554291|459215701|FG001|Overall Study|Death|1|||
127698835|NCT03307343|459526556|FG000|Overall Study|Physician Decision|1|||
127698836|NCT03307343|459526557|FG001|Overall Study|Physician Decision|0|||
127698837|NCT03307343|459526556|FG000|Overall Study|Lost to Follow-up|0|||
127698838|NCT03307343|459526557|FG001|Overall Study|Lost to Follow-up|2|||
127698839|NCT01798498|459526558|FG000|Overall Study|Lost to Follow-up|1|||
127698840|NCT03896789|459526559|FG000|Baseline|Lost to Follow-up|1|||
127698841|NCT03896789|459526560|FG001|Baseline|Lost to Follow-up|2|||
127698842|NCT03896789|459526559|FG000|Baseline|Death|3|||
127698843|NCT03896789|459526560|FG001|Baseline|Death|6|||
127698844|NCT03896789|459526559|FG000|Post-Randomization|Lost to Follow-up|12|||
127698845|NCT03896789|459526560|FG001|Post-Randomization|Lost to Follow-up|11|||
127698846|NCT03896789|459526559|FG000|Post-Randomization|Death|12|||
127698847|NCT03896789|459526560|FG001|Post-Randomization|Death|13|||
127698848|NCT03447470|459526561|FG000|Overall Study|Death|0|||
127698849|NCT03447470|459526562|FG001|Overall Study|Death|1|||
127698850|NCT03447470|459526563|FG002|Overall Study|Death|3|||
127698851|NCT03447470|459526564|FG003|Overall Study|Death|0|||
127698852|NCT03447470|459526565|FG004|Overall Study|Death|1|||
127698853|NCT03447470|459526566|FG005|Overall Study|Death|0|||
127698854|NCT03447470|459526567|FG006|Overall Study|Death|3|||
127698855|NCT03447470|459526568|FG007|Overall Study|Death|3|||
127698856|NCT03447470|459526569|FG008|Overall Study|Death|1|||
127698857|NCT03447470|459526561|FG000|Overall Study|Withdrawal by Subject|1|||
127698858|NCT03447470|459526562|FG001|Overall Study|Withdrawal by Subject|0|||
127789995|NCT01225731|459855217|FG000|Part 2|Protocol Violation|0|||
127789996|NCT01225731|459855218|FG001|Part 2|Protocol Violation|0|||
127698859|NCT03447470|459526563|FG002|Overall Study|Withdrawal by Subject|0|||
127698860|NCT03447470|459526564|FG003|Overall Study|Withdrawal by Subject|0|||
127789997|NCT01225731|459855219|FG002|Part 2|Protocol Violation|0|||
127698861|NCT03447470|459526565|FG004|Overall Study|Withdrawal by Subject|1|||
127698862|NCT03447470|459526566|FG005|Overall Study|Withdrawal by Subject|0|||
127698863|NCT03447470|459526567|FG006|Overall Study|Withdrawal by Subject|1|||
127698864|NCT03447470|459526568|FG007|Overall Study|Withdrawal by Subject|1|||
127698865|NCT03447470|459526569|FG008|Overall Study|Withdrawal by Subject|3|||
127613791|NCT03554291|459215700|FG000|Overall Study|Lost to Follow-up|1|||
127613792|NCT03554291|459215701|FG001|Overall Study|Lost to Follow-up|0|||
127613793|NCT03554291|459215700|FG000|Overall Study|Withdrawal by Subject|1|||
127613794|NCT03554291|459215701|FG001|Overall Study|Withdrawal by Subject|0|||
127789998|NCT01225731|459855220|FG003|Part 2|Protocol Violation|0|||
127789999|NCT01225731|459855221|FG004|Part 2|Protocol Violation|0|||
127613795|NCT03554291|459215700|FG000|Overall Study|COVID Travel Restriction- Partial Data Collected|3|||
127613796|NCT03554291|459215701|FG001|Overall Study|COVID Travel Restriction- Partial Data Collected|0|||
127613797|NCT00680901|459215702|FG000|Overall Study|Ongoing: On Study Treatment|1|||
127613798|NCT00680901|459215703|FG001|Overall Study|Ongoing: On Study Treatment|0|||
127613799|NCT00680901|459215702|FG000|Overall Study|Ongoing: In Follow Up|1|||
127613800|NCT00680901|459215703|FG001|Overall Study|Ongoing: In Follow Up|0|||
127613801|NCT00680901|459215702|FG000|Overall Study|Adverse Event|1|||
127613802|NCT00680901|459215703|FG001|Overall Study|Adverse Event|1|||
127613803|NCT00680901|459215702|FG000|Overall Study|Lost to Follow-up|3|||
127613804|NCT00680901|459215703|FG001|Overall Study|Lost to Follow-up|5|||
127613805|NCT00680901|459215702|FG000|Overall Study|Subject decided to withdraw from the study|4|||
127613806|NCT00680901|459215703|FG001|Overall Study|Subject decided to withdraw from the study|15|||
127613807|NCT00680901|459215702|FG000|Overall Study|Sponsor decision|1|||
127613808|NCT00680901|459215703|FG001|Overall Study|Sponsor decision|0|||
127613809|NCT00680901|459215702|FG000|Overall Study|Physician Decision|0|||
127613810|NCT00680901|459215703|FG001|Overall Study|Physician Decision|2|||
127613811|NCT00680901|459215702|FG000|Overall Study|Subject reached protocol defined stopping criteria|1|||
127613812|NCT00680901|459215703|FG001|Overall Study|Subject reached protocol defined stopping criteria|0|||
127613813|NCT00680901|459215702|FG000|Overall Study|Other protocol defined stopping criteria|17|||
127613814|NCT00680901|459215703|FG001|Overall Study|Other protocol defined stopping criteria|17|||
127613815|NCT00923559|459215704|FG000|Overall Study|Lost to Follow-up|2|||
127613816|NCT00923559|459215705|FG001|Overall Study|Lost to Follow-up|3|||
127613817|NCT01148511|459215708|FG000|Exposed to Study Drug|Protocol Violation|2|||
127613818|NCT01148511|459215709|FG001|Exposed to Study Drug|Protocol Violation|0|||
127613819|NCT01148511|459215710|FG002|Exposed to Study Drug|Protocol Violation|0|||
127613820|NCT01148511|459215708|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
127613821|NCT01148511|459215709|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
127613822|NCT01148511|459215710|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
127698866|NCT03447470|459526561|FG000|Overall Study|Treatment discontinued|3|||
127613823|NCT01148511|459215708|FG000|Randomized|Adverse Event|0|||
127613824|NCT01148511|459215709|FG001|Randomized|Adverse Event|1|||
127698867|NCT03447470|459526562|FG001|Overall Study|Treatment discontinued|2|||
127698868|NCT03447470|459526563|FG002|Overall Study|Treatment discontinued|4|||
127698869|NCT03447470|459526564|FG003|Overall Study|Treatment discontinued|6|||
127698870|NCT03447470|459526565|FG004|Overall Study|Treatment discontinued|2|||
127698871|NCT03447470|459526566|FG005|Overall Study|Treatment discontinued|1|||
127698872|NCT03447470|459526567|FG006|Overall Study|Treatment discontinued|2|||
127698873|NCT03447470|459526568|FG007|Overall Study|Treatment discontinued|4|||
127698874|NCT03447470|459526569|FG008|Overall Study|Treatment discontinued|3|||
127698875|NCT05780437|459526572|FG000|Overall Study|Withdrawal by Subject|22|||
127698876|NCT05780437|459526573|FG001|Overall Study|Withdrawal by Subject|16|||
127698877|NCT03452579|459526574|FG000|Overall Study|Death|0|||
127698878|NCT03452579|459526575|FG001|Overall Study|Death|1|||
127698879|NCT03452579|459526574|FG000|Overall Study|Withdrawal by Subject|2|||
127698880|NCT03452579|459526575|FG001|Overall Study|Withdrawal by Subject|0|||
127698881|NCT03452579|459526574|FG000|Overall Study|Disease progression, relapse during active treatment|38|||
127698882|NCT03452579|459526575|FG001|Overall Study|Disease progression, relapse during active treatment|37|||
127698883|NCT03452579|459526574|FG000|Overall Study|Physician Decision|1|||
127698884|NCT03452579|459526575|FG001|Overall Study|Physician Decision|1|||
127698885|NCT03452579|459526574|FG000|Overall Study|Adverse Event|1|||
127698886|NCT03452579|459526575|FG001|Overall Study|Adverse Event|4|||
127698887|NCT04788511|459526588|FG000|Overall Study|Withdrawal by Subject|2|||
127698888|NCT04788511|459526589|FG001|Overall Study|Withdrawal by Subject|1|||
127698889|NCT04788511|459526588|FG000|Overall Study|Lost to Follow-up|2|||
127698890|NCT04788511|459526589|FG001|Overall Study|Lost to Follow-up|7|||
127698891|NCT04788511|459526588|FG000|Overall Study|Death|3|||
127698892|NCT04788511|459526589|FG001|Overall Study|Death|4|||
127698893|NCT05603143|459526592|FG000|Overall Study|Withdrew consent|6|||
127698894|NCT05603143|459526593|FG001|Overall Study|Withdrew consent|2|||
127698895|NCT05603143|459526592|FG000|Overall Study|Randomized but never treated|0|||
127698896|NCT05603143|459526593|FG001|Overall Study|Randomized but never treated|3|||
127698897|NCT05603143|459526592|FG000|Overall Study|Adverse Event|2|||
127698898|NCT05603143|459526593|FG001|Overall Study|Adverse Event|0|||
127698899|NCT05603143|459526592|FG000|Overall Study|Death|0|||
127698900|NCT05603143|459526593|FG001|Overall Study|Death|1|||
127698901|NCT05603143|459526592|FG000|Overall Study|Investigator's discretion|1|||
127698902|NCT05603143|459526593|FG001|Overall Study|Investigator's discretion|0|||
127698903|NCT05603143|459526592|FG000|Overall Study|Lost to Follow-up|0|||
127698904|NCT05603143|459526593|FG001|Overall Study|Lost to Follow-up|1|||
127698905|NCT05603143|459526592|FG000|Overall Study|Protocol Violation|0|||
127698906|NCT05603143|459526593|FG001|Overall Study|Protocol Violation|1|||
127613825|NCT01148511|459215710|FG002|Randomized|Adverse Event|0|||
127698907|NCT04209465|459526594|FG000|Overall Study|Adverse Event|0|||
127698908|NCT04209465|459526595|FG001|Overall Study|Adverse Event|0|||
127698909|NCT04209465|459526596|FG002|Overall Study|Adverse Event|0|||
127698910|NCT04209465|459526597|FG003|Overall Study|Adverse Event|0|||
127613826|NCT01148511|459215708|FG000|Randomized|Protocol Violation|0|||
127613827|NCT01148511|459215709|FG001|Randomized|Protocol Violation|2|||
127698911|NCT04209465|459526598|FG004|Overall Study|Adverse Event|0|||
127613828|NCT01148511|459215710|FG002|Randomized|Protocol Violation|1|||
127613829|NCT01148511|459215708|FG000|Randomized|Lost to Follow-up|0|||
127613830|NCT01148511|459215709|FG001|Randomized|Lost to Follow-up|1|||
127613831|NCT01148511|459215710|FG002|Randomized|Lost to Follow-up|1|||
127613832|NCT01148511|459215708|FG000|Randomized|Consent withdrawal|0|||
127613833|NCT01148511|459215709|FG001|Randomized|Consent withdrawal|5|||
127790000|NCT01225731|459855222|FG005|Part 2|Protocol Violation|1|||
127790001|NCT01225731|459855223|FG006|Part 2|Protocol Violation|0|||
127790002|NCT01225731|459855224|FG007|Part 2|Protocol Violation|0|||
127790003|NCT01225731|459855225|FG008|Part 2|Protocol Violation|1|||
127790004|NCT01225731|459855226|FG009|Part 2|Protocol Violation|0|||
127790005|NCT01225731|459855227|FG010|Part 2|Protocol Violation|0|||
127790006|NCT01225731|459855228|FG011|Part 2|Protocol Violation|0|||
127790007|NCT01225731|459855229|FG012|Part 2|Protocol Violation|0|||
127790008|NCT01225731|459855217|FG000|Part 2|Adverse Event|0|||
127790009|NCT01225731|459855218|FG001|Part 2|Adverse Event|0|||
127790010|NCT01225731|459855219|FG002|Part 2|Adverse Event|0|||
127790011|NCT01225731|459855220|FG003|Part 2|Adverse Event|0|||
127790012|NCT01225731|459855221|FG004|Part 2|Adverse Event|0|||
127790013|NCT01225731|459855222|FG005|Part 2|Adverse Event|0|||
127790014|NCT01225731|459855223|FG006|Part 2|Adverse Event|4|||
127790015|NCT01225731|459855224|FG007|Part 2|Adverse Event|4|||
127790016|NCT01225731|459855225|FG008|Part 2|Adverse Event|2|||
127790017|NCT01225731|459855226|FG009|Part 2|Adverse Event|0|||
127790018|NCT01225731|459855227|FG010|Part 2|Adverse Event|0|||
127790019|NCT01225731|459855228|FG011|Part 2|Adverse Event|0|||
127790020|NCT01225731|459855229|FG012|Part 2|Adverse Event|0|||
127790021|NCT01225731|459855217|FG000|Part 2|Lack of Efficacy|0|||
127790022|NCT01225731|459855218|FG001|Part 2|Lack of Efficacy|0|||
127790023|NCT01225731|459855219|FG002|Part 2|Lack of Efficacy|0|||
127790024|NCT01225731|459855220|FG003|Part 2|Lack of Efficacy|0|||
127790025|NCT01225731|459855221|FG004|Part 2|Lack of Efficacy|0|||
127790026|NCT01225731|459855222|FG005|Part 2|Lack of Efficacy|1|||
127790027|NCT01225731|459855223|FG006|Part 2|Lack of Efficacy|0|||
127790028|NCT01225731|459855224|FG007|Part 2|Lack of Efficacy|12|||
127790029|NCT01225731|459855225|FG008|Part 2|Lack of Efficacy|3|||
127790030|NCT01225731|459855226|FG009|Part 2|Lack of Efficacy|0|||
127790031|NCT01225731|459855227|FG010|Part 2|Lack of Efficacy|0|||
127790032|NCT01225731|459855228|FG011|Part 2|Lack of Efficacy|0|||
127790033|NCT01225731|459855229|FG012|Part 2|Lack of Efficacy|0|||
127790034|NCT01225731|459855217|FG000|Part 2|Pregnancy|0|||
127790035|NCT01225731|459855218|FG001|Part 2|Pregnancy|0|||
127790036|NCT01225731|459855219|FG002|Part 2|Pregnancy|0|||
127790037|NCT01225731|459855220|FG003|Part 2|Pregnancy|0|||
127790038|NCT01225731|459855221|FG004|Part 2|Pregnancy|0|||
127790039|NCT01225731|459855222|FG005|Part 2|Pregnancy|0|||
127790040|NCT01225731|459855223|FG006|Part 2|Pregnancy|1|||
127790041|NCT01225731|459855224|FG007|Part 2|Pregnancy|0|||
127790042|NCT01225731|459855225|FG008|Part 2|Pregnancy|1|||
127790043|NCT01225731|459855226|FG009|Part 2|Pregnancy|0|||
127790044|NCT01225731|459855227|FG010|Part 2|Pregnancy|0|||
127790045|NCT01225731|459855228|FG011|Part 2|Pregnancy|0|||
127790046|NCT01225731|459855229|FG012|Part 2|Pregnancy|0|||
127790047|NCT01225731|459855217|FG000|Part 2|Lost to Follow-up|0|||
127790048|NCT01225731|459855218|FG001|Part 2|Lost to Follow-up|0|||
127790049|NCT01225731|459855219|FG002|Part 2|Lost to Follow-up|0|||
127790050|NCT01225731|459855220|FG003|Part 2|Lost to Follow-up|0|||
127790051|NCT01225731|459855221|FG004|Part 2|Lost to Follow-up|0|||
127790052|NCT01225731|459855222|FG005|Part 2|Lost to Follow-up|0|||
127790053|NCT01225731|459855223|FG006|Part 2|Lost to Follow-up|0|||
127790054|NCT01225731|459855224|FG007|Part 2|Lost to Follow-up|3|||
127790055|NCT01225731|459855225|FG008|Part 2|Lost to Follow-up|1|||
127790056|NCT01225731|459855226|FG009|Part 2|Lost to Follow-up|0|||
127790057|NCT01225731|459855227|FG010|Part 2|Lost to Follow-up|0|||
127790058|NCT01225731|459855228|FG011|Part 2|Lost to Follow-up|0|||
127790059|NCT01225731|459855229|FG012|Part 2|Lost to Follow-up|0|||
127613834|NCT01148511|459215710|FG002|Randomized|Consent withdrawal|3|||
127613835|NCT01148511|459215708|FG000|Randomized|Other|0|||
127613836|NCT01148511|459215709|FG001|Randomized|Other|1|||
127790060|NCT01225731|459855217|FG000|Part 2|Physician Decision|0|||
127790061|NCT01225731|459855218|FG001|Part 2|Physician Decision|0|||
127790062|NCT01225731|459855219|FG002|Part 2|Physician Decision|0|||
127790063|NCT01225731|459855220|FG003|Part 2|Physician Decision|0|||
127790064|NCT01225731|459855221|FG004|Part 2|Physician Decision|0|||
127613837|NCT01148511|459215710|FG002|Randomized|Other|1|||
127790065|NCT01225731|459855222|FG005|Part 2|Physician Decision|0|||
127790066|NCT01225731|459855223|FG006|Part 2|Physician Decision|0|||
127790067|NCT01225731|459855224|FG007|Part 2|Physician Decision|2|||
127790068|NCT01225731|459855225|FG008|Part 2|Physician Decision|2|||
127790069|NCT01225731|459855226|FG009|Part 2|Physician Decision|0|||
127790070|NCT01225731|459855227|FG010|Part 2|Physician Decision|0|||
127790071|NCT01225731|459855228|FG011|Part 2|Physician Decision|0|||
127790072|NCT01225731|459855229|FG012|Part 2|Physician Decision|0|||
127790073|NCT01225731|459855217|FG000|Part 2|Withdrawal by Subject|0|||
127790074|NCT01225731|459855218|FG001|Part 2|Withdrawal by Subject|0|||
127790075|NCT01225731|459855219|FG002|Part 2|Withdrawal by Subject|0|||
127790076|NCT01225731|459855220|FG003|Part 2|Withdrawal by Subject|0|||
127790077|NCT01225731|459855221|FG004|Part 2|Withdrawal by Subject|0|||
127790078|NCT01225731|459855222|FG005|Part 2|Withdrawal by Subject|1|||
127883341|NCT03611751|460196396|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
127883342|NCT03611751|460196397|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
127883343|NCT03611751|460196398|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
127883344|NCT03611751|460196396|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
127883345|NCT03611751|460196397|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
127883346|NCT03611751|460196398|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
127883347|NCT03611751|460196396|FG000|Treatment Week 0 - Week 16|Death|0|||
127883348|NCT03611751|460196397|FG001|Treatment Week 0 - Week 16|Death|0|||
127883349|NCT03611751|460196398|FG002|Treatment Week 0 - Week 16|Death|1|||
127883350|NCT03611751|460196396|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
127883351|NCT03611751|460196397|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
127883352|NCT03611751|460196398|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
127883353|NCT03611751|460196396|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
127883354|NCT03611751|460196397|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
127883355|NCT03611751|460196398|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
127883356|NCT03611751|460196396|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
127883357|NCT03611751|460196397|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
127883358|NCT03611751|460196398|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
127883359|NCT03611751|460196396|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
127883360|NCT03611751|460196397|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
127883361|NCT03611751|460196398|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
127883362|NCT03611751|460196396|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
127883363|NCT03611751|460196397|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
127883364|NCT03611751|460196398|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
127883365|NCT03611751|460196396|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
127883366|NCT03611751|460196397|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
127883367|NCT03611751|460196398|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
127883368|NCT03611751|460196396|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
127883369|NCT03611751|460196397|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
127883370|NCT03611751|460196398|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
127883371|NCT03611751|460196396|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
127883372|NCT03611751|460196397|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
127883373|NCT03611751|460196398|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
127883374|NCT03611751|460196396|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
127883375|NCT03611751|460196397|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
127883376|NCT03611751|460196398|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
127883377|NCT03611751|460196396|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
127883378|NCT03611751|460196397|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
127883379|NCT03611751|460196398|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
127883380|NCT03611751|460196396|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
127883381|NCT03611751|460196397|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
127883382|NCT03611751|460196398|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
127883383|NCT03611751|460196396|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
127883384|NCT03611751|460196397|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
127883385|NCT03611751|460196398|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
127883386|NCT03611751|460196396|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
127883387|NCT03611751|460196397|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
127883388|NCT03611751|460196398|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
127883389|NCT03611751|460196396|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
127883390|NCT03611751|460196397|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
127883391|NCT03611751|460196398|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
127883392|NCT03672396|460196401|FG000|Overall Study|Withdrawal by Subject|4|||
127883393|NCT03672396|460196401|FG000|Overall Study|Physician Decision|1|||
127883394|NCT03672396|460196401|FG000|Overall Study|Adverse Event|1|||
127883395|NCT02441179|460196402|FG000|Overall Study|Withdrawal by Subject|1|||
127883396|NCT02441179|460196403|FG001|Overall Study|Withdrawal by Subject|1|||
127883397|NCT02702271|460196405|FG000|Overall Study|Death|36|||
127883398|NCT02702271|460196406|FG001|Overall Study|Death|7|||
127883399|NCT02702271|460196405|FG000|Overall Study|Lost to Follow-up|12|||
127883400|NCT02702271|460196406|FG001|Overall Study|Lost to Follow-up|0|||
127883401|NCT02702271|460196405|FG000|Overall Study|Withdrawal by Subject|8|||
127883402|NCT02702271|460196406|FG001|Overall Study|Withdrawal by Subject|1|||
127613838|NCT04258605|459215711|FG000|Overall Study|Death|1|||
127613839|NCT04258605|459215712|FG001|Overall Study|Death|0|||
127883403|NCT02702271|460196405|FG000|Overall Study|Physician Decision|2|||
127883404|NCT02702271|460196406|FG001|Overall Study|Physician Decision|0|||
127883405|NCT02702271|460196405|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
127613840|NCT04258605|459215711|FG000|Overall Study|Early study termination|21|||
127883406|NCT02702271|460196406|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
127883407|NCT00051636|460196407|FG000|Period 1 - Core|Adverse Event|2|||
127883408|NCT00051636|460196408|FG001|Period 1 - Core|Adverse Event|2|||
127883409|NCT00051636|460196407|FG000|Period 1 - Core|Protocol Violation|1|||
127613841|NCT04258605|459215712|FG001|Overall Study|Early study termination|2|||
127883410|NCT00051636|460196408|FG001|Period 1 - Core|Protocol Violation|0|||
127883411|NCT00051636|460196407|FG000|Period 1 - Core|Withdrawal by Subject|1|||
127883412|NCT00051636|460196408|FG001|Period 1 - Core|Withdrawal by Subject|2|||
127883413|NCT00051636|460196407|FG000|Period 1 - Core|Lost to Follow-up|0|||
127883414|NCT00051636|460196408|FG001|Period 1 - Core|Lost to Follow-up|2|||
127883415|NCT00051636|460196407|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
127883416|NCT00051636|460196408|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
127883417|NCT00051636|460196407|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
127883418|NCT00051636|460196408|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
127613842|NCT01712256|459215717|FG000|Overall Study|Lost to Follow-up|1|||
127613843|NCT00962104|459215718|FG000|Overall Study|Adverse Event|10|||
127613844|NCT00962104|459215719|FG001|Overall Study|Adverse Event|3|||
127613845|NCT00962104|459215718|FG000|Overall Study|Entry Criteria Not Met|1|||
127613846|NCT00962104|459215719|FG001|Overall Study|Entry Criteria Not Met|2|||
127883419|NCT00051636|460196407|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
127887326|NCT04128696|460210583|FG001|Overall Study|Lost to Follow-up|7|||
127613847|NCT00962104|459215718|FG000|Overall Study|Lack of Efficacy|0|||
127613848|NCT00962104|459215719|FG001|Overall Study|Lack of Efficacy|1|||
127613849|NCT00962104|459215718|FG000|Overall Study|Lost to Follow-up|10|||
127613850|NCT00962104|459215719|FG001|Overall Study|Lost to Follow-up|4|||
127613851|NCT00962104|459215718|FG000|Overall Study|Physician Decision|1|||
127613852|NCT00962104|459215719|FG001|Overall Study|Physician Decision|0|||
127613853|NCT00962104|459215718|FG000|Overall Study|Protocol Violation|6|||
127613854|NCT00962104|459215719|FG001|Overall Study|Protocol Violation|8|||
127613855|NCT00962104|459215718|FG000|Overall Study|Sponsor Decision|0|||
127613856|NCT00962104|459215719|FG001|Overall Study|Sponsor Decision|1|||
127613857|NCT00962104|459215718|FG000|Overall Study|Withdrawal by Subject|10|||
127613858|NCT00962104|459215719|FG001|Overall Study|Withdrawal by Subject|6|||
127613859|NCT00962104|459215718|FG000|Overall Study|Other|2|||
127613860|NCT00962104|459215719|FG001|Overall Study|Other|0|||
127613861|NCT02013167|459215720|FG000|Overall Study|Withdrawal by Subject|15|||
127613862|NCT02013167|459215721|FG001|Overall Study|Withdrawal by Subject|14|||
127613863|NCT02013167|459215720|FG000|Overall Study|Sponsor Decision|1|||
127613864|NCT02013167|459215721|FG001|Overall Study|Sponsor Decision|3|||
127613865|NCT02013167|459215720|FG000|Overall Study|Lost to Follow-up|0|||
127613866|NCT02013167|459215721|FG001|Overall Study|Lost to Follow-up|1|||
127790079|NCT01225731|459855223|FG006|Part 2|Withdrawal by Subject|3|||
127790080|NCT01225731|459855224|FG007|Part 2|Withdrawal by Subject|4|||
127790081|NCT01225731|459855225|FG008|Part 2|Withdrawal by Subject|1|||
127790082|NCT01225731|459855226|FG009|Part 2|Withdrawal by Subject|0|||
127790083|NCT01225731|459855227|FG010|Part 2|Withdrawal by Subject|0|||
127790084|NCT01225731|459855228|FG011|Part 2|Withdrawal by Subject|0|||
127790085|NCT01225731|459855229|FG012|Part 2|Withdrawal by Subject|0|||
127790086|NCT01225731|459855217|FG000|Part 3|Adverse Event|0|||
127790087|NCT01225731|459855218|FG001|Part 3|Adverse Event|0|||
127790088|NCT01225731|459855219|FG002|Part 3|Adverse Event|0|||
127790089|NCT01225731|459855220|FG003|Part 3|Adverse Event|0|||
127790090|NCT01225731|459855221|FG004|Part 3|Adverse Event|0|||
127790091|NCT01225731|459855222|FG005|Part 3|Adverse Event|0|||
127790092|NCT01225731|459855223|FG006|Part 3|Adverse Event|0|||
127790093|NCT01225731|459855224|FG007|Part 3|Adverse Event|0|||
127790094|NCT01225731|459855225|FG008|Part 3|Adverse Event|0|||
127790095|NCT01225731|459855226|FG009|Part 3|Adverse Event|0|||
127790096|NCT01225731|459855227|FG010|Part 3|Adverse Event|1|||
127790097|NCT01225731|459855228|FG011|Part 3|Adverse Event|1|||
127790098|NCT01225731|459855229|FG012|Part 3|Adverse Event|0|||
127790099|NCT01225731|459855217|FG000|Part 3|Lost to Follow-up|0|||
127790100|NCT01225731|459855218|FG001|Part 3|Lost to Follow-up|0|||
127790101|NCT01225731|459855219|FG002|Part 3|Lost to Follow-up|0|||
127790102|NCT01225731|459855220|FG003|Part 3|Lost to Follow-up|0|||
127790103|NCT01225731|459855221|FG004|Part 3|Lost to Follow-up|0|||
127790104|NCT01225731|459855222|FG005|Part 3|Lost to Follow-up|0|||
127790105|NCT01225731|459855223|FG006|Part 3|Lost to Follow-up|0|||
127790106|NCT01225731|459855224|FG007|Part 3|Lost to Follow-up|0|||
127790107|NCT01225731|459855225|FG008|Part 3|Lost to Follow-up|0|||
127790108|NCT01225731|459855226|FG009|Part 3|Lost to Follow-up|0|||
127790109|NCT01225731|459855227|FG010|Part 3|Lost to Follow-up|1|||
127790110|NCT01225731|459855228|FG011|Part 3|Lost to Follow-up|2|||
127790111|NCT01225731|459855229|FG012|Part 3|Lost to Follow-up|1|||
127790112|NCT01225731|459855217|FG000|Part 3|Physician Decision|0|||
127790113|NCT01225731|459855218|FG001|Part 3|Physician Decision|0|||
127790114|NCT01225731|459855219|FG002|Part 3|Physician Decision|0|||
127790115|NCT01225731|459855220|FG003|Part 3|Physician Decision|0|||
127790116|NCT01225731|459855221|FG004|Part 3|Physician Decision|0|||
127790117|NCT01225731|459855222|FG005|Part 3|Physician Decision|0|||
127790118|NCT01225731|459855223|FG006|Part 3|Physician Decision|0|||
127790119|NCT01225731|459855224|FG007|Part 3|Physician Decision|0|||
127790120|NCT01225731|459855225|FG008|Part 3|Physician Decision|0|||
127790121|NCT01225731|459855226|FG009|Part 3|Physician Decision|0|||
127613867|NCT02013167|459215720|FG000|Overall Study|Death|85|||
127613868|NCT02013167|459215721|FG001|Overall Study|Death|160|||
127613869|NCT01113879|459215724|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
127613870|NCT01113879|459215725|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
127613871|NCT00615056|459215727|FG000|Overall Study|Death|31|||
127613872|NCT00615056|459215728|FG001|Overall Study|Death|31|||
127790122|NCT01225731|459855227|FG010|Part 3|Physician Decision|0|||
127790123|NCT01225731|459855228|FG011|Part 3|Physician Decision|1|||
127790124|NCT01225731|459855229|FG012|Part 3|Physician Decision|2|||
127790125|NCT01225731|459855217|FG000|Part 3|Withdrawal by Subject|0|||
127790126|NCT01225731|459855218|FG001|Part 3|Withdrawal by Subject|0|||
127790127|NCT01225731|459855219|FG002|Part 3|Withdrawal by Subject|0|||
127790128|NCT01225731|459855220|FG003|Part 3|Withdrawal by Subject|0|||
127790129|NCT01225731|459855221|FG004|Part 3|Withdrawal by Subject|0|||
127790130|NCT01225731|459855222|FG005|Part 3|Withdrawal by Subject|0|||
127790131|NCT01225731|459855223|FG006|Part 3|Withdrawal by Subject|0|||
127790132|NCT01225731|459855224|FG007|Part 3|Withdrawal by Subject|0|||
127790133|NCT01225731|459855225|FG008|Part 3|Withdrawal by Subject|0|||
127790134|NCT01225731|459855226|FG009|Part 3|Withdrawal by Subject|0|||
127790135|NCT01225731|459855227|FG010|Part 3|Withdrawal by Subject|4|||
127790136|NCT01225731|459855228|FG011|Part 3|Withdrawal by Subject|6|||
127698912|NCT04209465|459526599|FG005|Overall Study|Adverse Event|1|||
127698913|NCT04209465|459526600|FG006|Overall Study|Adverse Event|0|||
127698914|NCT04209465|459526601|FG007|Overall Study|Adverse Event|0|||
127698915|NCT04209465|459526602|FG008|Overall Study|Adverse Event|1|||
127698916|NCT04209465|459526603|FG009|Overall Study|Adverse Event|0|||
127698917|NCT04209465|459526604|FG010|Overall Study|Adverse Event|2|||
127698918|NCT04209465|459526605|FG011|Overall Study|Adverse Event|1|||
127698919|NCT04209465|459526606|FG012|Overall Study|Adverse Event|1|||
127698920|NCT04209465|459526594|FG000|Overall Study|Death|1|||
127698921|NCT04209465|459526595|FG001|Overall Study|Death|0|||
127698922|NCT04209465|459526596|FG002|Overall Study|Death|0|||
127698923|NCT04209465|459526597|FG003|Overall Study|Death|0|||
127698924|NCT04209465|459526598|FG004|Overall Study|Death|2|||
127698925|NCT04209465|459526599|FG005|Overall Study|Death|7|||
127698926|NCT04209465|459526600|FG006|Overall Study|Death|2|||
127698927|NCT04209465|459526601|FG007|Overall Study|Death|2|||
127698928|NCT04209465|459526602|FG008|Overall Study|Death|1|||
127698929|NCT04209465|459526603|FG009|Overall Study|Death|1|||
127698930|NCT04209465|459526604|FG010|Overall Study|Death|1|||
127698931|NCT04209465|459526605|FG011|Overall Study|Death|0|||
127698932|NCT04209465|459526606|FG012|Overall Study|Death|10|||
127698933|NCT04209465|459526594|FG000|Overall Study|Physician Decision|0|||
127698934|NCT04209465|459526595|FG001|Overall Study|Physician Decision|1|||
127698935|NCT04209465|459526596|FG002|Overall Study|Physician Decision|0|||
127698936|NCT04209465|459526597|FG003|Overall Study|Physician Decision|0|||
127698937|NCT04209465|459526598|FG004|Overall Study|Physician Decision|0|||
127698938|NCT04209465|459526599|FG005|Overall Study|Physician Decision|0|||
127698939|NCT04209465|459526600|FG006|Overall Study|Physician Decision|0|||
127698940|NCT04209465|459526601|FG007|Overall Study|Physician Decision|0|||
127698941|NCT04209465|459526602|FG008|Overall Study|Physician Decision|0|||
127698942|NCT04209465|459526603|FG009|Overall Study|Physician Decision|0|||
127698943|NCT04209465|459526604|FG010|Overall Study|Physician Decision|0|||
127698944|NCT04209465|459526605|FG011|Overall Study|Physician Decision|0|||
127698945|NCT04209465|459526606|FG012|Overall Study|Physician Decision|0|||
127698946|NCT04209465|459526594|FG000|Overall Study|Progressive Disease|0|||
127698947|NCT04209465|459526595|FG001|Overall Study|Progressive Disease|0|||
127698948|NCT04209465|459526596|FG002|Overall Study|Progressive Disease|1|||
127698949|NCT04209465|459526597|FG003|Overall Study|Progressive Disease|2|||
127698950|NCT04209465|459526598|FG004|Overall Study|Progressive Disease|8|||
127698951|NCT04209465|459526599|FG005|Overall Study|Progressive Disease|5|||
127698952|NCT04209465|459526600|FG006|Overall Study|Progressive Disease|3|||
127698953|NCT04209465|459526601|FG007|Overall Study|Progressive Disease|4|||
127698954|NCT04209465|459526602|FG008|Overall Study|Progressive Disease|1|||
127698955|NCT04209465|459526603|FG009|Overall Study|Progressive Disease|3|||
127698956|NCT04209465|459526604|FG010|Overall Study|Progressive Disease|2|||
127698957|NCT04209465|459526605|FG011|Overall Study|Progressive Disease|1|||
127698958|NCT04209465|459526606|FG012|Overall Study|Progressive Disease|0|||
127698959|NCT04209465|459526594|FG000|Overall Study|Withdrawal by Subject|0|||
127698960|NCT04209465|459526595|FG001|Overall Study|Withdrawal by Subject|0|||
127698961|NCT04209465|459526596|FG002|Overall Study|Withdrawal by Subject|0|||
127698962|NCT04209465|459526597|FG003|Overall Study|Withdrawal by Subject|0|||
127698963|NCT04209465|459526598|FG004|Overall Study|Withdrawal by Subject|0|||
127698964|NCT04209465|459526599|FG005|Overall Study|Withdrawal by Subject|1|||
127698965|NCT04209465|459526600|FG006|Overall Study|Withdrawal by Subject|2|||
127698966|NCT04209465|459526601|FG007|Overall Study|Withdrawal by Subject|0|||
127698967|NCT04209465|459526602|FG008|Overall Study|Withdrawal by Subject|1|||
127698968|NCT04209465|459526603|FG009|Overall Study|Withdrawal by Subject|0|||
127698969|NCT04209465|459526604|FG010|Overall Study|Withdrawal by Subject|0|||
127698970|NCT04209465|459526605|FG011|Overall Study|Withdrawal by Subject|2|||
127698971|NCT04209465|459526606|FG012|Overall Study|Withdrawal by Subject|2|||
127698972|NCT04209465|459526594|FG000|Overall Study|Lost to Follow-up|0|||
127698973|NCT04209465|459526595|FG001|Overall Study|Lost to Follow-up|0|||
127698974|NCT04209465|459526596|FG002|Overall Study|Lost to Follow-up|0|||
127698975|NCT04209465|459526597|FG003|Overall Study|Lost to Follow-up|0|||
127698976|NCT04209465|459526598|FG004|Overall Study|Lost to Follow-up|0|||
127698977|NCT04209465|459526599|FG005|Overall Study|Lost to Follow-up|1|||
127698978|NCT04209465|459526600|FG006|Overall Study|Lost to Follow-up|0|||
127698979|NCT04209465|459526601|FG007|Overall Study|Lost to Follow-up|0|||
127698980|NCT04209465|459526602|FG008|Overall Study|Lost to Follow-up|1|||
127698981|NCT04209465|459526603|FG009|Overall Study|Lost to Follow-up|0|||
127698982|NCT04209465|459526604|FG010|Overall Study|Lost to Follow-up|0|||
127698983|NCT04209465|459526605|FG011|Overall Study|Lost to Follow-up|1|||
127698984|NCT04209465|459526606|FG012|Overall Study|Lost to Follow-up|0|||
127698985|NCT04209465|459526594|FG000|Overall Study|Started new therapy|0|||
127698986|NCT04209465|459526595|FG001|Overall Study|Started new therapy|0|||
127698987|NCT04209465|459526596|FG002|Overall Study|Started new therapy|0|||
127698988|NCT04209465|459526597|FG003|Overall Study|Started new therapy|0|||
127698989|NCT04209465|459526598|FG004|Overall Study|Started new therapy|0|||
127698990|NCT04209465|459526599|FG005|Overall Study|Started new therapy|1|||
127698991|NCT04209465|459526600|FG006|Overall Study|Started new therapy|0|||
127698992|NCT04209465|459526601|FG007|Overall Study|Started new therapy|0|||
127698993|NCT04209465|459526602|FG008|Overall Study|Started new therapy|0|||
127883420|NCT00051636|460196408|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
127883421|NCT00051636|460196407|FG000|Period 2- Extended Observation Period|Death|4|||
127883422|NCT00051636|460196408|FG001|Period 2- Extended Observation Period|Death|5|||
127883423|NCT00051636|460196407|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
127883424|NCT00051636|460196408|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
127883425|NCT00975884|460196409|FG000|Overall Study|Adverse Event|1|||
127883426|NCT00975884|460196410|FG001|Overall Study|Adverse Event|0|||
127883427|NCT00975884|460196409|FG000|Overall Study|Lost to Follow-up|5|||
127883428|NCT00975884|460196410|FG001|Overall Study|Lost to Follow-up|3|||
127883429|NCT00975884|460196409|FG000|Overall Study|Withdrawal by Subject|9|||
127883430|NCT00975884|460196410|FG001|Overall Study|Withdrawal by Subject|9|||
127883431|NCT00975884|460196409|FG000|Overall Study|Other|1|||
127883432|NCT00975884|460196410|FG001|Overall Study|Other|3|||
127883433|NCT01656967|460196411|FG000|Overall Study|faulty monitor|1|||
127883434|NCT01656967|460196412|FG001|Overall Study|faulty monitor|0|||
127883435|NCT01656967|460196411|FG000|Overall Study|unsuccessful ETT insertion|3|||
127883436|NCT01656967|460196412|FG001|Overall Study|unsuccessful ETT insertion|2|||
127883437|NCT00479765|460196413|FG000|Overall Study|study terminated|4|||
127883438|NCT05166512|460196414|FG000|Randomized|Lost to Follow-up|2|||
127883439|NCT05166512|460196415|FG001|Randomized|Lost to Follow-up|0|||
127883440|NCT05166512|460196414|FG000|Randomized|Withdrawal by Subject|1|||
127883441|NCT05166512|460196415|FG001|Randomized|Withdrawal by Subject|0|||
127883442|NCT05166512|460196414|FG000|Baseline Data Collection|Lost to Follow-up|0|||
127883443|NCT05166512|460196415|FG001|Baseline Data Collection|Lost to Follow-up|3|||
127883444|NCT05166512|460196414|FG000|Baseline Data Collection|Withdrawal by Subject|1|||
127883445|NCT05166512|460196415|FG001|Baseline Data Collection|Withdrawal by Subject|0|||
127883446|NCT05166512|460196414|FG000|Baseline Data Collection|Protocol Violation|2|||
127883447|NCT05166512|460196415|FG001|Baseline Data Collection|Protocol Violation|0|||
127883448|NCT05166512|460196414|FG000|4 Month Data Collection|Lost to Follow-up|1|||
127883449|NCT05166512|460196415|FG001|4 Month Data Collection|Lost to Follow-up|0|||
127883450|NCT05166512|460196414|FG000|4 Month Data Collection|Withdrawal by Subject|1|||
127883451|NCT05166512|460196415|FG001|4 Month Data Collection|Withdrawal by Subject|5|||
127883452|NCT05166512|460196414|FG000|12 Month Data Collection|Lost to Follow-up|3|||
127883453|NCT05166512|460196415|FG001|12 Month Data Collection|Lost to Follow-up|1|||
127883454|NCT05166512|460196414|FG000|12 Month Data Collection|Withdrawal by Subject|1|||
127883455|NCT05166512|460196415|FG001|12 Month Data Collection|Withdrawal by Subject|0|||
127883456|NCT02139306|460196418|FG000|Overall Study|Withdrawal by Subject|4|||
127883457|NCT02139306|460196419|FG001|Overall Study|Withdrawal by Subject|6|||
127883458|NCT02139306|460196418|FG000|Overall Study|Adverse Event|3|||
127883459|NCT02139306|460196419|FG001|Overall Study|Adverse Event|4|||
127883460|NCT02139306|460196418|FG000|Overall Study|Physician Decision|0|||
127883461|NCT02139306|460196419|FG001|Overall Study|Physician Decision|1|||
127883462|NCT02139306|460196418|FG000|Overall Study|Other Unspecified|2|||
127698994|NCT04209465|459526603|FG009|Overall Study|Started new therapy|0|||
127698995|NCT04209465|459526604|FG010|Overall Study|Started new therapy|0|||
127698996|NCT04209465|459526605|FG011|Overall Study|Started new therapy|0|||
127698997|NCT04209465|459526606|FG012|Overall Study|Started new therapy|0|||
127698998|NCT04209465|459526594|FG000|Overall Study|Study terminated early by sponsor|0|||
127698999|NCT04209465|459526595|FG001|Overall Study|Study terminated early by sponsor|0|||
127699000|NCT04209465|459526596|FG002|Overall Study|Study terminated early by sponsor|0|||
127699001|NCT04209465|459526597|FG003|Overall Study|Study terminated early by sponsor|0|||
127699002|NCT04209465|459526598|FG004|Overall Study|Study terminated early by sponsor|0|||
127699003|NCT04209465|459526599|FG005|Overall Study|Study terminated early by sponsor|0|||
127699004|NCT04209465|459526600|FG006|Overall Study|Study terminated early by sponsor|3|||
127699005|NCT04209465|459526601|FG007|Overall Study|Study terminated early by sponsor|0|||
127699006|NCT04209465|459526602|FG008|Overall Study|Study terminated early by sponsor|0|||
127699007|NCT04209465|459526603|FG009|Overall Study|Study terminated early by sponsor|0|||
127699008|NCT04209465|459526604|FG010|Overall Study|Study terminated early by sponsor|0|||
127883463|NCT02139306|460196419|FG001|Overall Study|Other Unspecified|3|||
127883464|NCT02139306|460196418|FG000|Overall Study|Protocol Violation|4|||
127883465|NCT02139306|460196419|FG001|Overall Study|Protocol Violation|0|||
127883466|NCT02956005|460196420|FG000|Overall Study|Not eligible|1|||
127883467|NCT02956005|460196420|FG000|Overall Study|Withdrawal by Subject|3|||
127883468|NCT02956005|460196420|FG000|Overall Study|Physician Decision|12|||
127883469|NCT03022799|460196421|FG000|Overall Study|Adverse Event|0|||
127883470|NCT03022799|460196422|FG001|Overall Study|Adverse Event|0|||
127613873|NCT00615056|459215729|FG002|Overall Study|Death|21|||
127613874|NCT00615056|459215730|FG003|Overall Study|Death|23|||
127613875|NCT00615056|459215727|FG000|Overall Study|Lost to Follow-up|1|||
127613876|NCT00615056|459215728|FG001|Overall Study|Lost to Follow-up|2|||
127613877|NCT00615056|459215729|FG002|Overall Study|Lost to Follow-up|4|||
127613878|NCT00615056|459215730|FG003|Overall Study|Lost to Follow-up|5|||
127613879|NCT00615056|459215727|FG000|Overall Study|Other|13|||
127613880|NCT00615056|459215728|FG001|Overall Study|Other|15|||
127883471|NCT03022799|460196423|FG002|Overall Study|Adverse Event|0|||
127613881|NCT00615056|459215729|FG002|Overall Study|Other|10|||
127613882|NCT00615056|459215730|FG003|Overall Study|Other|7|||
127613883|NCT00615056|459215727|FG000|Overall Study|Objective progression or relapse|0|||
127613884|NCT00615056|459215728|FG001|Overall Study|Objective progression or relapse|2|||
127613885|NCT00615056|459215729|FG002|Overall Study|Objective progression or relapse|0|||
127613886|NCT00615056|459215730|FG003|Overall Study|Objective progression or relapse|0|||
127613887|NCT00615056|459215727|FG000|Overall Study|Withdrawal by Subject|0|||
127613888|NCT00615056|459215728|FG001|Overall Study|Withdrawal by Subject|1|||
127613889|NCT00615056|459215729|FG002|Overall Study|Withdrawal by Subject|1|||
127613890|NCT00615056|459215730|FG003|Overall Study|Withdrawal by Subject|0|||
127613891|NCT00615056|459215727|FG000|Overall Study|Discontinued by Sponsor|1|||
127613892|NCT00615056|459215728|FG001|Overall Study|Discontinued by Sponsor|0|||
127613893|NCT00615056|459215729|FG002|Overall Study|Discontinued by Sponsor|0|||
127613894|NCT00615056|459215730|FG003|Overall Study|Discontinued by Sponsor|0|||
127613895|NCT00615056|459215727|FG000|Overall Study|Randomized but not treated|3|||
127613896|NCT00615056|459215728|FG001|Overall Study|Randomized but not treated|0|||
127613897|NCT00615056|459215729|FG002|Overall Study|Randomized but not treated|0|||
127699009|NCT04209465|459526605|FG011|Overall Study|Study terminated early by sponsor|0|||
127613898|NCT00615056|459215730|FG003|Overall Study|Randomized but not treated|0|||
127613899|NCT02276612|459215731|FG000|Overall Study|Death|1|||
127613900|NCT02276612|459215732|FG001|Overall Study|Death|0|||
127613901|NCT02276612|459215731|FG000|Overall Study|Pregnancy|1|||
127613902|NCT02276612|459215732|FG001|Overall Study|Pregnancy|0|||
127699010|NCT04209465|459526606|FG012|Overall Study|Study terminated early by sponsor|3|||
127699011|NCT04209465|459526594|FG000|Overall Study|Other|0|||
127699012|NCT04209465|459526595|FG001|Overall Study|Other|0|||
127699013|NCT04209465|459526596|FG002|Overall Study|Other|0|||
127699014|NCT04209465|459526597|FG003|Overall Study|Other|0|||
127699015|NCT04209465|459526598|FG004|Overall Study|Other|0|||
127699016|NCT04209465|459526599|FG005|Overall Study|Other|0|||
127699017|NCT04209465|459526600|FG006|Overall Study|Other|0|||
127699018|NCT04209465|459526601|FG007|Overall Study|Other|0|||
127699019|NCT04209465|459526602|FG008|Overall Study|Other|1|||
127699020|NCT04209465|459526603|FG009|Overall Study|Other|0|||
127699021|NCT04209465|459526604|FG010|Overall Study|Other|0|||
127699022|NCT04209465|459526605|FG011|Overall Study|Other|0|||
127699023|NCT04209465|459526606|FG012|Overall Study|Other|0|||
127699024|NCT05783102|459526607|FG000|Overall Study|Lost to Follow-up|1|||
127699025|NCT05783102|459526607|FG000|Overall Study|Withdrawal by Subject|2|||
127699026|NCT05008835|459526609|FG000|Overall Study|Adverse Event|5|||
127699027|NCT05008835|459526610|FG001|Overall Study|Adverse Event|2|||
127699028|NCT05008835|459526611|FG002|Overall Study|Adverse Event|1|||
127699029|NCT05008835|459526609|FG000|Overall Study|Lack of Efficacy|0|||
127699030|NCT05008835|459526610|FG001|Overall Study|Lack of Efficacy|0|||
127699031|NCT05008835|459526611|FG002|Overall Study|Lack of Efficacy|1|||
127699032|NCT05008835|459526609|FG000|Overall Study|Study terminated by sponsor|0|||
127699033|NCT05008835|459526610|FG001|Overall Study|Study terminated by sponsor|0|||
127699034|NCT05008835|459526611|FG002|Overall Study|Study terminated by sponsor|1|||
127699035|NCT05008835|459526609|FG000|Overall Study|Not further specified|3|||
127699036|NCT05008835|459526610|FG001|Overall Study|Not further specified|2|||
127699037|NCT05008835|459526611|FG002|Overall Study|Not further specified|1|||
127699038|NCT04171999|459526612|FG000|Overall Study|deemed ineligible after randomization|2|||
127699039|NCT04171999|459526613|FG001|Overall Study|deemed ineligible after randomization|1|||
127699040|NCT04505904|459526614|FG000|Overall Study|Withdrawal by Subject|1|||
127699041|NCT04505904|459526615|FG001|Overall Study|Withdrawal by Subject|2|||
127699042|NCT04505904|459526616|FG002|Overall Study|Withdrawal by Subject|0|||
127699043|NCT04505904|459526617|FG003|Overall Study|Withdrawal by Subject|0|||
127699044|NCT04505904|459526614|FG000|Overall Study|Physician Decision|1|||
127699045|NCT04505904|459526615|FG001|Overall Study|Physician Decision|0|||
127699046|NCT04505904|459526616|FG002|Overall Study|Physician Decision|0|||
127699047|NCT04505904|459526617|FG003|Overall Study|Physician Decision|0|||
127699048|NCT04505904|459526614|FG000|Overall Study|Adverse Event|0|||
127699049|NCT04505904|459526615|FG001|Overall Study|Adverse Event|1|||
127699050|NCT04505904|459526616|FG002|Overall Study|Adverse Event|0|||
127699051|NCT04505904|459526617|FG003|Overall Study|Adverse Event|0|||
127699052|NCT04277442|459526620|FG000|Overall Study|Death|1|||
127699053|NCT03544281|459526621|FG000|Main Study Phase|Death|3|||
127699054|NCT03544281|459526622|FG001|Main Study Phase|Death|2|||
127699055|NCT03544281|459526623|FG002|Main Study Phase|Death|6|||
127699056|NCT03544281|459526624|FG003|Main Study Phase|Death|8|||
127699057|NCT03544281|459526625|FG004|Main Study Phase|Death|4|||
127699058|NCT03544281|459526626|FG005|Main Study Phase|Death|2|||
127699059|NCT03544281|459526627|FG006|Main Study Phase|Death|4|||
127613903|NCT02276612|459215731|FG000|Overall Study|Withdrew Consent|1|||
127699060|NCT03544281|459526628|FG007|Main Study Phase|Death|5|||
127699061|NCT03544281|459526629|FG008|Main Study Phase|Death|5|||
127699062|NCT03544281|459526630|FG009|Main Study Phase|Death|8|||
127699063|NCT03544281|459526631|FG010|Main Study Phase|Death|6|||
127699064|NCT03544281|459526632|FG011|Main Study Phase|Death|4|||
127699065|NCT03544281|459526633|FG012|Main Study Phase|Death|0|||
127699066|NCT03544281|459526634|FG013|Main Study Phase|Death|0|||
127699067|NCT03544281|459526635|FG014|Main Study Phase|Death|0|||
127699068|NCT03544281|459526636|FG015|Main Study Phase|Death|0|||
127613904|NCT02276612|459215732|FG001|Overall Study|Withdrew Consent|0|||
127613905|NCT02276612|459215731|FG000|Overall Study|Lost to Follow-up|1|||
127613906|NCT02276612|459215732|FG001|Overall Study|Lost to Follow-up|0|||
127613907|NCT04327986|459215733|FG000|Overall Study|Physician Decision|2|||
127613908|NCT04327986|459215734|FG001|Overall Study|Physician Decision|0|||
127613909|NCT04327986|459215735|FG002|Overall Study|Physician Decision|0|||
127613910|NCT04327986|459215733|FG000|Overall Study|Death|1|||
127613911|NCT04327986|459215734|FG001|Overall Study|Death|0|||
127613912|NCT04327986|459215735|FG002|Overall Study|Death|0|||
127613913|NCT04248816|459215736|FG000|Overall Study|Ineligible post-randomization|7|||
127613914|NCT04248816|459215737|FG001|Overall Study|Ineligible post-randomization|21|||
127613915|NCT04248816|459215738|FG002|Overall Study|Ineligible post-randomization|25|||
127613916|NCT00262067|459215739|FG000|Overall Study|Death|190|||
127613917|NCT00262067|459215740|FG001|Overall Study|Death|89|||
127613918|NCT00262067|459215741|FG002|Overall Study|Death|186|||
127613919|NCT00262067|459215742|FG003|Overall Study|Death|99|||
127613920|NCT00262067|459215739|FG000|Overall Study|Lost to Follow-up|5|||
127613921|NCT00262067|459215740|FG001|Overall Study|Lost to Follow-up|4|||
127613922|NCT00262067|459215741|FG002|Overall Study|Lost to Follow-up|7|||
127613923|NCT00262067|459215742|FG003|Overall Study|Lost to Follow-up|5|||
127613924|NCT00262067|459215739|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
127613925|NCT00262067|459215740|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
127613926|NCT00262067|459215741|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
127613927|NCT00262067|459215742|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
127790137|NCT01225731|459855229|FG012|Part 3|Withdrawal by Subject|4|||
127790138|NCT00577642|459855230|FG000|Overall Study|Clinical Disease Progression|1|||
127790139|NCT03891264|459855235|FG000|Overall Study|Adverse Event|1|||
127790140|NCT03891264|459855235|FG000|Overall Study|Withdrawal by Subject|2|||
127790141|NCT03891264|459855235|FG000|Overall Study|Physician Decision|2|||
127790142|NCT01379274|459857036|FG000|Overall Study|funding withdrawn|1|||
127790143|NCT00631020|459857037|FG000|Overall Study|Lost to Follow-up|7|||
127790144|NCT00631020|459857037|FG000|Overall Study|Incarcerated|1|||
127790145|NCT03548935|459857038|FG000|Overall Study|Withdrawal by Subject|26|||
127790146|NCT03548935|459857039|FG001|Overall Study|Withdrawal by Subject|17|||
127790147|NCT03548935|459857038|FG000|Overall Study|Lost to Follow-up|39|||
127790148|NCT03548935|459857039|FG001|Overall Study|Lost to Follow-up|28|||
127790149|NCT03548935|459857038|FG000|Overall Study|Death|1|||
127790150|NCT03548935|459857039|FG001|Overall Study|Death|1|||
127790151|NCT00283595|459857040|FG000|Overall Study|Withdrawal by Subject|1|||
127790152|NCT00283595|459857041|FG001|Overall Study|Withdrawal by Subject|2|||
127790153|NCT01263639|459857042|FG000|Overall Study|Lost to Follow-up|66|||
127790154|NCT01263639|459857043|FG001|Overall Study|Lost to Follow-up|70|||
127790155|NCT01263639|459857042|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
127790156|NCT01263639|459857043|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
127790157|NCT01576549|459857044|FG000|Overall Study|Sponsor Decision|2|||
127790158|NCT00607386|459857045|FG000|Overall Study|Physician Decision|1|||
127790159|NCT00440947|459857046|FG000|36-Week Induction Phase|Adverse Event|16|||
127790160|NCT00440947|459857047|FG001|36-Week Induction Phase|Adverse Event|0|||
127790161|NCT00440947|459857048|FG002|36-Week Induction Phase|Adverse Event|0|||
127790162|NCT00440947|459857049|FG003|36-Week Induction Phase|Adverse Event|0|||
127790163|NCT00440947|459857050|FG004|36-Week Induction Phase|Adverse Event|0|||
127790164|NCT00440947|459857046|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
127790165|NCT00440947|459857047|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
127790166|NCT00440947|459857048|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
127790167|NCT00440947|459857049|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
127790168|NCT00440947|459857050|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
127790169|NCT00440947|459857046|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
127790170|NCT00440947|459857047|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
127790171|NCT00440947|459857048|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
127790172|NCT00440947|459857049|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
127790173|NCT00440947|459857050|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
127790174|NCT00440947|459857046|FG000|36-Week Induction Phase|Non-compliance|10|||
127790175|NCT00440947|459857047|FG001|36-Week Induction Phase|Non-compliance|0|||
127790176|NCT00440947|459857048|FG002|36-Week Induction Phase|Non-compliance|0|||
127613928|NCT00262067|459215739|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
127613929|NCT00262067|459215740|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
127613930|NCT00262067|459215741|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
127613931|NCT00262067|459215742|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
127613932|NCT00655564|459215743|FG000|Overall Study|Adverse Event|1|||
127613933|NCT00655564|459215743|FG000|Overall Study|Lost to Follow-up|1|||
127790177|NCT00440947|459857049|FG003|36-Week Induction Phase|Non-compliance|0|||
127790178|NCT00440947|459857050|FG004|36-Week Induction Phase|Non-compliance|0|||
127790179|NCT00440947|459857046|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
127790180|NCT00440947|459857047|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
127790181|NCT00440947|459857048|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
127883472|NCT03022799|460196424|FG003|Overall Study|Adverse Event|0|||
127613934|NCT00655564|459215743|FG000|Overall Study|Desired Alternate Therapy|1|||
127613935|NCT00560950|459215745|FG000|Overall Study|Lost to Follow-up|1|||
127613936|NCT00560950|459215746|FG001|Overall Study|Lost to Follow-up|0|||
127613937|NCT02181556|459217717|FG000|Overall Study|Withdrawal by Subject|1|||
127613938|NCT01940120|459217718|FG000|Overall Study|Death|40|||
127613939|NCT01940120|459217718|FG000|Overall Study|Withdrawal by Subject|8|||
127613940|NCT00427635|459217719|FG000|Treatment Phase|Withdrawal by Subject|1|||
127613941|NCT00427635|459217720|FG001|Treatment Phase|Withdrawal by Subject|0|||
127613942|NCT00427635|459217719|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
127613943|NCT00427635|459217720|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
127613944|NCT03277846|459217721|FG000|Overall Study|Inpatient stay too brief|12|||
127613945|NCT03277846|459217722|FG001|Overall Study|Inpatient stay too brief|11|||
127613946|NCT01572038|459217724|FG000|Overall Study|Death|648|||
127613947|NCT01572038|459217724|FG000|Overall Study|Withdrawal by Subject|204|||
127613948|NCT01572038|459217724|FG000|Overall Study|Lost to Follow-up|81|||
127613949|NCT01572038|459217724|FG000|Overall Study|Physician Decision|20|||
127613950|NCT01572038|459217724|FG000|Overall Study|Patient Decision|14|||
127613951|NCT01572038|459217724|FG000|Overall Study|Progressive Disease|8|||
127613952|NCT01572038|459217724|FG000|Overall Study|Site Closed Before Completing Form|6|||
127613953|NCT01572038|459217724|FG000|Overall Study|Enrolled into Another Trial|3|||
127613954|NCT01572038|459217724|FG000|Overall Study|Participated in Another Trial|3|||
127613955|NCT01572038|459217724|FG000|Overall Study|Termination by Sponsor|2|||
127613956|NCT01572038|459217724|FG000|Overall Study|Patient Deterioration|1|||
127613957|NCT01572038|459217724|FG000|Overall Study|Sponsor Decision|1|||
127613958|NCT01888497|459217725|FG000|Washout Period 1|Withdrawal by Subject|0|||
127613959|NCT01888497|459217726|FG001|Washout Period 1|Withdrawal by Subject|0|||
127613960|NCT01888497|459217727|FG002|Washout Period 1|Withdrawal by Subject|1|||
127613961|NCT01888497|459217728|FG003|Washout Period 1|Withdrawal by Subject|1|||
127613962|NCT01888497|459217725|FG000|Washout Period 2|Adverse Event|0|||
127613963|NCT01888497|459217726|FG001|Washout Period 2|Adverse Event|0|||
127613964|NCT01888497|459217727|FG002|Washout Period 2|Adverse Event|0|||
127883473|NCT03022799|460196425|FG004|Overall Study|Adverse Event|0|||
127883474|NCT03022799|460196426|FG005|Overall Study|Adverse Event|0|||
127883475|NCT03022799|460196427|FG006|Overall Study|Adverse Event|0|||
127883476|NCT03022799|460196428|FG007|Overall Study|Adverse Event|0|||
127883477|NCT03022799|460196429|FG008|Overall Study|Adverse Event|0|||
127883478|NCT03022799|460196430|FG009|Overall Study|Adverse Event|1|||
127613965|NCT01888497|459217728|FG003|Washout Period 2|Adverse Event|1|||
127613966|NCT01888497|459217725|FG000|Washout Period 2|Withdrawal by Subject|0|||
127613967|NCT01888497|459217726|FG001|Washout Period 2|Withdrawal by Subject|0|||
127613968|NCT01888497|459217727|FG002|Washout Period 2|Withdrawal by Subject|0|||
127613969|NCT01888497|459217728|FG003|Washout Period 2|Withdrawal by Subject|1|||
127883479|NCT03022799|460196431|FG010|Overall Study|Adverse Event|1|||
127883480|NCT03022799|460196432|FG011|Overall Study|Adverse Event|0|||
127883481|NCT03022799|460196433|FG012|Overall Study|Adverse Event|0|||
127883482|NCT03273257|460196434|FG000|Overall Study|Death|0|||
127883483|NCT03273257|460196435|FG001|Overall Study|Death|1|||
127883484|NCT03273257|460196434|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
127883485|NCT03273257|460196435|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
127883486|NCT03273257|460196434|FG000|Overall Study|Study terminated|3|||
127613970|NCT04152447|459217729|FG000|Overall Study|Lost to Follow-up|1|||
127613971|NCT04152447|459217730|FG001|Overall Study|Lost to Follow-up|0|||
127613972|NCT04152447|459217729|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
127613973|NCT04152447|459217730|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
127613974|NCT04152447|459217729|FG000|Overall Study|Withdrawal by Subject|0|||
127613975|NCT04152447|459217730|FG001|Overall Study|Withdrawal by Subject|1|||
127613976|NCT04152447|459217729|FG000|Overall Study|Found ineligible after enrolling|1|||
127613977|NCT04152447|459217730|FG001|Overall Study|Found ineligible after enrolling|1|||
127613978|NCT04152447|459217729|FG000|Overall Study|Did not receive VR headset in time.|0|||
127613979|NCT04152447|459217730|FG001|Overall Study|Did not receive VR headset in time.|2|||
127613980|NCT04013191|459217731|FG000|Overall Study|Adverse Event|1|||
127613981|NCT04013191|459217732|FG001|Overall Study|Adverse Event|0|||
127613982|NCT01275066|459217745|FG000|Overall Study|Withdrawal by Subject|0|||
127613983|NCT01275066|459217746|FG001|Overall Study|Withdrawal by Subject|0|||
127613984|NCT01275066|459217747|FG002|Overall Study|Withdrawal by Subject|1|||
127613985|NCT01275066|459217745|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
127613986|NCT01275066|459217746|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
127613987|NCT01275066|459217747|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
127613988|NCT04200248|459217755|FG000|Overall Study|Personal reasons|0|||
127883487|NCT03273257|460196435|FG001|Overall Study|Study terminated|2|||
127883488|NCT01185639|460196436|FG000|Overall Study|Progressed and didn't receive therapy|2|||
127883489|NCT01861717|460196437|FG000|Overall Study|Lost to Follow-up|1|||
127613989|NCT04200248|459217756|FG001|Overall Study|Personal reasons|0|||
127883490|NCT01861717|460196437|FG000|Overall Study|Withdrawal by Subject|1|||
127883491|NCT03033069|460196438|FG000|Overall Study|Adverse Event|6|||
127883492|NCT03033069|460196439|FG001|Overall Study|Adverse Event|7|||
127883493|NCT03033069|460196440|FG002|Overall Study|Adverse Event|4|||
127883494|NCT03033069|460196441|FG003|Overall Study|Adverse Event|6|||
127883495|NCT03033069|460196438|FG000|Overall Study|Lack of Efficacy|0|||
127883496|NCT03033069|460196439|FG001|Overall Study|Lack of Efficacy|0|||
127883497|NCT03033069|460196440|FG002|Overall Study|Lack of Efficacy|1|||
127883498|NCT03033069|460196441|FG003|Overall Study|Lack of Efficacy|0|||
127883499|NCT03033069|460196438|FG000|Overall Study|Lost to Follow-up|6|||
127883500|NCT03033069|460196439|FG001|Overall Study|Lost to Follow-up|5|||
127883501|NCT03033069|460196440|FG002|Overall Study|Lost to Follow-up|5|||
127883502|NCT03033069|460196441|FG003|Overall Study|Lost to Follow-up|6|||
127883503|NCT03033069|460196438|FG000|Overall Study|Non-Compliance With Study Drug|1|||
127883504|NCT03033069|460196439|FG001|Overall Study|Non-Compliance With Study Drug|1|||
127883505|NCT03033069|460196440|FG002|Overall Study|Non-Compliance With Study Drug|1|||
127883506|NCT03033069|460196441|FG003|Overall Study|Non-Compliance With Study Drug|0|||
127883507|NCT03033069|460196438|FG000|Overall Study|Protocol Deviation|0|||
127883508|NCT03033069|460196439|FG001|Overall Study|Protocol Deviation|1|||
127883509|NCT03033069|460196440|FG002|Overall Study|Protocol Deviation|0|||
127883510|NCT03033069|460196441|FG003|Overall Study|Protocol Deviation|0|||
127883511|NCT03033069|460196438|FG000|Overall Study|Withdrawal by Subject|10|||
127883512|NCT03033069|460196439|FG001|Overall Study|Withdrawal by Subject|10|||
127883513|NCT03033069|460196440|FG002|Overall Study|Withdrawal by Subject|11|||
127883514|NCT03033069|460196441|FG003|Overall Study|Withdrawal by Subject|6|||
127883515|NCT03033069|460196438|FG000|Overall Study|Withdrawal By Caregiver|1|||
127883516|NCT03033069|460196439|FG001|Overall Study|Withdrawal By Caregiver|0|||
127883517|NCT03033069|460196440|FG002|Overall Study|Withdrawal By Caregiver|0|||
127883518|NCT03033069|460196441|FG003|Overall Study|Withdrawal By Caregiver|0|||
127883519|NCT03033069|460196438|FG000|Overall Study|Reason not Specified|0|||
127883520|NCT03033069|460196439|FG001|Overall Study|Reason not Specified|1|||
127883521|NCT03033069|460196440|FG002|Overall Study|Reason not Specified|0|||
127883522|NCT03033069|460196441|FG003|Overall Study|Reason not Specified|1|||
127883523|NCT05458895|460196447|FG000|Overall Study|Withdrawal by Subject|8|||
127883524|NCT05458895|460196447|FG000|Overall Study|Lost to Follow-up|17|||
127883525|NCT05458895|460196447|FG000|Overall Study|Pregnancy|2|||
127883526|NCT05458895|460196447|FG000|Overall Study|Withdrawal by Study Team|1|||
127883527|NCT04639310|460196448|FG000|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|0|||
127883528|NCT04639310|460196449|FG001|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|1|||
127883529|NCT02082262|460197860|FG000|Overall Study|Withdrawal by Subject|3|||
127883530|NCT02082262|460197860|FG000|Overall Study|Adverse Event|48|||
127883531|NCT01408576|460197861|FG000|Overall Study|Lack of Efficacy|17|||
127883532|NCT01408576|460197862|FG001|Overall Study|Lack of Efficacy|30|||
127883533|NCT01408576|460197863|FG002|Overall Study|Lack of Efficacy|48|||
127883534|NCT01408576|460197861|FG000|Overall Study|Protocol Violation|1|||
127883535|NCT01408576|460197862|FG001|Overall Study|Protocol Violation|2|||
127883536|NCT01408576|460197863|FG002|Overall Study|Protocol Violation|2|||
127883537|NCT01408576|460197861|FG000|Overall Study|Lost to Follow-up|10|||
127883538|NCT01408576|460197862|FG001|Overall Study|Lost to Follow-up|9|||
127883539|NCT01408576|460197863|FG002|Overall Study|Lost to Follow-up|17|||
127883540|NCT01408576|460197861|FG000|Overall Study|Withdrawal by Subject|34|||
127883541|NCT01408576|460197862|FG001|Overall Study|Withdrawal by Subject|60|||
127883542|NCT01408576|460197863|FG002|Overall Study|Withdrawal by Subject|66|||
127883543|NCT01408576|460197861|FG000|Overall Study|Sponsor terminated study|89|||
127883544|NCT01408576|460197862|FG001|Overall Study|Sponsor terminated study|333|||
127883545|NCT01408576|460197863|FG002|Overall Study|Sponsor terminated study|330|||
127883546|NCT01408576|460197861|FG000|Overall Study|AE, serious fatal|4|||
127883547|NCT01408576|460197862|FG001|Overall Study|AE, serious fatal|4|||
127883548|NCT01408576|460197863|FG002|Overall Study|AE, serious fatal|1|||
127883549|NCT01408576|460197861|FG000|Overall Study|SAE, non-fatal|11|||
127883550|NCT01408576|460197862|FG001|Overall Study|SAE, non-fatal|23|||
127883551|NCT01408576|460197863|FG002|Overall Study|SAE, non-fatal|14|||
127883552|NCT01408576|460197861|FG000|Overall Study|AE, non-serious non-fatal|12|||
127883553|NCT01408576|460197862|FG001|Overall Study|AE, non-serious non-fatal|19|||
127883554|NCT01408576|460197863|FG002|Overall Study|AE, non-serious non-fatal|11|||
127883555|NCT01408576|460197861|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
127883556|NCT01408576|460197862|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
127883557|NCT01408576|460197863|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
127883558|NCT01408576|460197861|FG000|Overall Study|AE, unknown type|0|||
127883559|NCT01408576|460197862|FG001|Overall Study|AE, unknown type|1|||
127883560|NCT01408576|460197863|FG002|Overall Study|AE, unknown type|0|||
127883561|NCT01408576|460197861|FG000|Overall Study|Other|10|||
127883562|NCT01408576|460197862|FG001|Overall Study|Other|16|||
127883563|NCT01408576|460197863|FG002|Overall Study|Other|18|||
127883564|NCT01791127|460197864|FG000|Overall Study|Death|356|||
127883565|NCT01791127|460197864|FG000|Overall Study|Patient has withdrawn from study|293|||
127883566|NCT01791127|460197864|FG000|Overall Study|Lost to Follow-up|42|||
127613990|NCT04200248|459217757|FG002|Overall Study|Personal reasons|1|||
127613991|NCT04200248|459217755|FG000|Overall Study|Discontinued prior to treatment|3|||
127613992|NCT04200248|459217756|FG001|Overall Study|Discontinued prior to treatment|3|||
127613993|NCT04200248|459217757|FG002|Overall Study|Discontinued prior to treatment|2|||
127613994|NCT00934544|459217761|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
127613995|NCT00934544|459217762|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
127613996|NCT00934544|459217763|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
127613997|NCT00934544|459217761|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
127613998|NCT00934544|459217762|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
127613999|NCT00934544|459217763|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
127614000|NCT00934544|459217761|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
127883567|NCT01791127|460197864|FG000|Overall Study|All Siello leads are explanted|31|||
127883568|NCT01791127|460197864|FG000|Overall Study|Completion of 30 day safety registry|1|||
127883569|NCT01791127|460197864|FG000|Overall Study|Study terminated for EP Passion|749|||
127883570|NCT00520494|460197865|FG000|Overall Study|Withdrawal by Subject|1|||
127883571|NCT03471182|460197868|FG000|Overall Study|Withdrawal by Subject|1|||
127883572|NCT03471182|460197869|FG001|Overall Study|Withdrawal by Subject|1|||
127883573|NCT03471182|460197870|FG002|Overall Study|Withdrawal by Subject|0|||
127883574|NCT03471182|460197868|FG000|Overall Study|Technical failure|2|||
127883575|NCT03471182|460197869|FG001|Overall Study|Technical failure|0|||
127883576|NCT03471182|460197870|FG002|Overall Study|Technical failure|0|||
127883577|NCT04440163|460197872|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
127883578|NCT04440163|460197873|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
127883579|NCT04440163|460197874|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
127883580|NCT04440163|460197875|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
127883581|NCT04440163|460197876|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
127883582|NCT04440163|460197877|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
127883583|NCT04440163|460197878|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
127883584|NCT04440163|460197879|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
127883585|NCT04440163|460197872|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
127883586|NCT04440163|460197873|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
127883587|NCT04440163|460197874|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
127883588|NCT04440163|460197875|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
127883589|NCT04440163|460197876|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
127883590|NCT04440163|460197877|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
127883591|NCT04440163|460197878|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
127883592|NCT04440163|460197879|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
127883593|NCT04440163|460197872|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
127883594|NCT04440163|460197873|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
127883595|NCT04440163|460197874|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
127883596|NCT04440163|460197875|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
127883597|NCT04440163|460197876|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
127883598|NCT04440163|460197877|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
127883599|NCT04440163|460197878|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
127883600|NCT04440163|460197879|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
127883601|NCT04440163|460197872|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
127883602|NCT04440163|460197873|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
127883603|NCT04440163|460197874|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
127883604|NCT04440163|460197875|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
127883605|NCT04440163|460197876|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
127883606|NCT04440163|460197877|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
127883607|NCT04440163|460197878|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
127883608|NCT04440163|460197879|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
127883609|NCT04440163|460197872|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
127883610|NCT04440163|460197873|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
127883611|NCT04440163|460197874|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
127883612|NCT04440163|460197875|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
127883613|NCT04440163|460197876|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
127883614|NCT04440163|460197877|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
127883615|NCT04440163|460197878|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
127883616|NCT04440163|460197879|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
127883617|NCT04440163|460197872|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
127699069|NCT03544281|459526637|FG016|Main Study Phase|Death|0|||
127699070|NCT03544281|459526638|FG017|Main Study Phase|Death|0|||
127699071|NCT03544281|459526639|FG018|Main Study Phase|Death|0|||
127699072|NCT03544281|459526640|FG019|Main Study Phase|Death|0|||
127699073|NCT03544281|459526641|FG020|Main Study Phase|Death|0|||
127699074|NCT03544281|459526642|FG021|Main Study Phase|Death|0|||
127699075|NCT03544281|459526621|FG000|Main Study Phase|Lost to Follow-up|0|||
127699076|NCT03544281|459526622|FG001|Main Study Phase|Lost to Follow-up|0|||
127699077|NCT03544281|459526623|FG002|Main Study Phase|Lost to Follow-up|0|||
127790182|NCT00440947|459857049|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
127790183|NCT00440947|459857050|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
127790184|NCT00440947|459857046|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
127790185|NCT00440947|459857047|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
127790186|NCT00440947|459857048|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
127790187|NCT00440947|459857049|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
127790188|NCT00440947|459857050|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
127790189|NCT00440947|459857046|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
127790190|NCT00440947|459857047|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
127790191|NCT00440947|459857048|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
127790192|NCT00440947|459857049|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
127790193|NCT00440947|459857050|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
127790194|NCT00440947|459857046|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
127790195|NCT00440947|459857047|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
127790196|NCT00440947|459857048|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
127790197|NCT00440947|459857049|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
127790198|NCT00440947|459857050|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
127790199|NCT00440947|459857046|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
127790200|NCT00440947|459857047|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
127790201|NCT00440947|459857048|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
127790202|NCT00440947|459857049|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
127790203|NCT00440947|459857050|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
127790204|NCT00440947|459857046|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
127790205|NCT00440947|459857047|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
127790206|NCT00440947|459857048|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
127790207|NCT00440947|459857049|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
127790208|NCT00440947|459857050|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
127790209|NCT00440947|459857046|FG000|36-Week Induction Phase|Incarceration|3|||
127790210|NCT00440947|459857047|FG001|36-Week Induction Phase|Incarceration|0|||
127790211|NCT00440947|459857048|FG002|36-Week Induction Phase|Incarceration|0|||
127790212|NCT00440947|459857049|FG003|36-Week Induction Phase|Incarceration|0|||
127790213|NCT00440947|459857050|FG004|36-Week Induction Phase|Incarceration|0|||
127790214|NCT00440947|459857046|FG000|36-Week Induction Phase|Pregnancy|1|||
127790215|NCT00440947|459857047|FG001|36-Week Induction Phase|Pregnancy|0|||
127790216|NCT00440947|459857048|FG002|36-Week Induction Phase|Pregnancy|0|||
127790217|NCT00440947|459857049|FG003|36-Week Induction Phase|Pregnancy|0|||
127790218|NCT00440947|459857050|FG004|36-Week Induction Phase|Pregnancy|0|||
127790219|NCT00440947|459857046|FG000|48-Week Randomization Phase|Adverse Event|0|||
127790220|NCT00440947|459857047|FG001|48-Week Randomization Phase|Adverse Event|2|||
127790221|NCT00440947|459857048|FG002|48-Week Randomization Phase|Adverse Event|5|||
127699078|NCT03544281|459526624|FG003|Main Study Phase|Lost to Follow-up|0|||
127699079|NCT03544281|459526625|FG004|Main Study Phase|Lost to Follow-up|0|||
127699080|NCT03544281|459526626|FG005|Main Study Phase|Lost to Follow-up|0|||
127699081|NCT03544281|459526627|FG006|Main Study Phase|Lost to Follow-up|0|||
127699082|NCT03544281|459526628|FG007|Main Study Phase|Lost to Follow-up|0|||
127699083|NCT03544281|459526629|FG008|Main Study Phase|Lost to Follow-up|0|||
127699084|NCT03544281|459526630|FG009|Main Study Phase|Lost to Follow-up|0|||
127699085|NCT03544281|459526631|FG010|Main Study Phase|Lost to Follow-up|1|||
127699086|NCT03544281|459526632|FG011|Main Study Phase|Lost to Follow-up|0|||
127699087|NCT03544281|459526633|FG012|Main Study Phase|Lost to Follow-up|0|||
127699088|NCT03544281|459526634|FG013|Main Study Phase|Lost to Follow-up|0|||
127699089|NCT03544281|459526635|FG014|Main Study Phase|Lost to Follow-up|0|||
127699090|NCT03544281|459526636|FG015|Main Study Phase|Lost to Follow-up|0|||
127699091|NCT03544281|459526637|FG016|Main Study Phase|Lost to Follow-up|0|||
127790222|NCT00440947|459857049|FG003|48-Week Randomization Phase|Adverse Event|0|||
127790223|NCT00440947|459857050|FG004|48-Week Randomization Phase|Adverse Event|0|||
127699092|NCT03544281|459526638|FG017|Main Study Phase|Lost to Follow-up|0|||
127699093|NCT03544281|459526639|FG018|Main Study Phase|Lost to Follow-up|0|||
127699094|NCT03544281|459526640|FG019|Main Study Phase|Lost to Follow-up|0|||
127699095|NCT03544281|459526641|FG020|Main Study Phase|Lost to Follow-up|0|||
127699096|NCT03544281|459526642|FG021|Main Study Phase|Lost to Follow-up|0|||
127699097|NCT03544281|459526621|FG000|Main Study Phase|Physician Decision|0|||
127699098|NCT03544281|459526622|FG001|Main Study Phase|Physician Decision|0|||
127699099|NCT03544281|459526623|FG002|Main Study Phase|Physician Decision|0|||
127699100|NCT03544281|459526624|FG003|Main Study Phase|Physician Decision|0|||
127699101|NCT03544281|459526625|FG004|Main Study Phase|Physician Decision|0|||
127699102|NCT03544281|459526626|FG005|Main Study Phase|Physician Decision|0|||
127699103|NCT03544281|459526627|FG006|Main Study Phase|Physician Decision|0|||
127699104|NCT03544281|459526628|FG007|Main Study Phase|Physician Decision|1|||
127699105|NCT03544281|459526629|FG008|Main Study Phase|Physician Decision|0|||
127699106|NCT03544281|459526630|FG009|Main Study Phase|Physician Decision|0|||
127699107|NCT03544281|459526631|FG010|Main Study Phase|Physician Decision|0|||
127699108|NCT03544281|459526632|FG011|Main Study Phase|Physician Decision|0|||
127699109|NCT03544281|459526633|FG012|Main Study Phase|Physician Decision|0|||
127699110|NCT03544281|459526634|FG013|Main Study Phase|Physician Decision|0|||
127699111|NCT03544281|459526635|FG014|Main Study Phase|Physician Decision|0|||
127699112|NCT03544281|459526636|FG015|Main Study Phase|Physician Decision|0|||
127699113|NCT03544281|459526637|FG016|Main Study Phase|Physician Decision|0|||
127699114|NCT03544281|459526638|FG017|Main Study Phase|Physician Decision|0|||
127699115|NCT03544281|459526639|FG018|Main Study Phase|Physician Decision|0|||
127699116|NCT03544281|459526640|FG019|Main Study Phase|Physician Decision|0|||
127699117|NCT03544281|459526641|FG020|Main Study Phase|Physician Decision|0|||
127699118|NCT03544281|459526642|FG021|Main Study Phase|Physician Decision|0|||
127699119|NCT03544281|459526621|FG000|Main Study Phase|Withdrawal by Subject|2|||
127699120|NCT03544281|459526622|FG001|Main Study Phase|Withdrawal by Subject|0|||
127699121|NCT03544281|459526623|FG002|Main Study Phase|Withdrawal by Subject|1|||
127699122|NCT03544281|459526624|FG003|Main Study Phase|Withdrawal by Subject|2|||
127699123|NCT03544281|459526625|FG004|Main Study Phase|Withdrawal by Subject|0|||
127699124|NCT03544281|459526626|FG005|Main Study Phase|Withdrawal by Subject|0|||
127699125|NCT03544281|459526627|FG006|Main Study Phase|Withdrawal by Subject|0|||
127699126|NCT03544281|459526628|FG007|Main Study Phase|Withdrawal by Subject|0|||
127699127|NCT03544281|459526629|FG008|Main Study Phase|Withdrawal by Subject|2|||
127699128|NCT03544281|459526630|FG009|Main Study Phase|Withdrawal by Subject|3|||
127699129|NCT03544281|459526631|FG010|Main Study Phase|Withdrawal by Subject|0|||
127699130|NCT03544281|459526632|FG011|Main Study Phase|Withdrawal by Subject|4|||
127699131|NCT03544281|459526633|FG012|Main Study Phase|Withdrawal by Subject|0|||
127699132|NCT03544281|459526634|FG013|Main Study Phase|Withdrawal by Subject|0|||
127699133|NCT03544281|459526635|FG014|Main Study Phase|Withdrawal by Subject|0|||
127699134|NCT03544281|459526636|FG015|Main Study Phase|Withdrawal by Subject|0|||
127699135|NCT03544281|459526637|FG016|Main Study Phase|Withdrawal by Subject|0|||
127699136|NCT03544281|459526638|FG017|Main Study Phase|Withdrawal by Subject|0|||
127699137|NCT03544281|459526639|FG018|Main Study Phase|Withdrawal by Subject|0|||
127699138|NCT03544281|459526640|FG019|Main Study Phase|Withdrawal by Subject|0|||
127699139|NCT03544281|459526641|FG020|Main Study Phase|Withdrawal by Subject|0|||
127699140|NCT03544281|459526642|FG021|Main Study Phase|Withdrawal by Subject|0|||
127699141|NCT03544281|459526621|FG000|Main Study Phase|Ongoing|3|||
127699142|NCT03544281|459526622|FG001|Main Study Phase|Ongoing|1|||
127699143|NCT03544281|459526623|FG002|Main Study Phase|Ongoing|2|||
127699144|NCT03544281|459526624|FG003|Main Study Phase|Ongoing|4|||
127699145|NCT03544281|459526625|FG004|Main Study Phase|Ongoing|2|||
127699146|NCT03544281|459526626|FG005|Main Study Phase|Ongoing|4|||
127699147|NCT03544281|459526627|FG006|Main Study Phase|Ongoing|4|||
127699148|NCT03544281|459526628|FG007|Main Study Phase|Ongoing|0|||
127699149|NCT03544281|459526629|FG008|Main Study Phase|Ongoing|2|||
127699150|NCT03544281|459526630|FG009|Main Study Phase|Ongoing|2|||
127699151|NCT03544281|459526631|FG010|Main Study Phase|Ongoing|1|||
127699152|NCT03544281|459526632|FG011|Main Study Phase|Ongoing|0|||
127699153|NCT03544281|459526633|FG012|Main Study Phase|Ongoing|0|||
127699154|NCT03544281|459526634|FG013|Main Study Phase|Ongoing|0|||
127699155|NCT03544281|459526635|FG014|Main Study Phase|Ongoing|0|||
127699156|NCT03544281|459526636|FG015|Main Study Phase|Ongoing|0|||
127699157|NCT03544281|459526637|FG016|Main Study Phase|Ongoing|0|||
127699158|NCT03544281|459526638|FG017|Main Study Phase|Ongoing|0|||
127699159|NCT03544281|459526639|FG018|Main Study Phase|Ongoing|0|||
127699160|NCT03544281|459526640|FG019|Main Study Phase|Ongoing|0|||
127699161|NCT03544281|459526641|FG020|Main Study Phase|Ongoing|0|||
127699162|NCT03544281|459526642|FG021|Main Study Phase|Ongoing|0|||
127699163|NCT03544281|459526621|FG000|Main Study Phase|Investigator Site Closed|0|||
127699164|NCT03544281|459526622|FG001|Main Study Phase|Investigator Site Closed|0|||
127699165|NCT03544281|459526623|FG002|Main Study Phase|Investigator Site Closed|0|||
127699166|NCT03544281|459526624|FG003|Main Study Phase|Investigator Site Closed|0|||
127699167|NCT03544281|459526625|FG004|Main Study Phase|Investigator Site Closed|0|||
127699168|NCT03544281|459526626|FG005|Main Study Phase|Investigator Site Closed|0|||
127699169|NCT03544281|459526627|FG006|Main Study Phase|Investigator Site Closed|0|||
127614001|NCT00934544|459217762|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
127614002|NCT00934544|459217763|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
127614003|NCT00934544|459217761|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
127614004|NCT00934544|459217762|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
127614005|NCT00934544|459217763|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
127614006|NCT00934544|459217761|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
127614007|NCT00934544|459217762|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
127614008|NCT00934544|459217763|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
127614009|NCT00934544|459217761|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
127614010|NCT00934544|459217762|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
127614011|NCT00934544|459217763|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
127614012|NCT00934544|459217761|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
127614013|NCT00934544|459217762|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
127614014|NCT00934544|459217763|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
127614015|NCT00934544|459217761|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
127790224|NCT00440947|459857046|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
127614016|NCT00934544|459217762|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
127614017|NCT00934544|459217763|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
127614018|NCT00934544|459217761|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
127614019|NCT00934544|459217762|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
127614020|NCT00934544|459217763|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
127614021|NCT00934544|459217761|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
127614022|NCT00934544|459217762|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
127614023|NCT00934544|459217763|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
127614024|NCT00934544|459217761|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
127614025|NCT00934544|459217762|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
127614026|NCT00934544|459217763|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
127614027|NCT00934544|459217761|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
127614028|NCT00934544|459217762|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
127614029|NCT00934544|459217763|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
127614030|NCT00934544|459217761|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
127614031|NCT00934544|459217762|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
127614032|NCT00934544|459217763|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
127614033|NCT00934544|459217761|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
127614034|NCT00934544|459217762|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
127614035|NCT00934544|459217763|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
127614036|NCT00934544|459217761|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
127614037|NCT00934544|459217762|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
127790225|NCT00440947|459857047|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
127790226|NCT00440947|459857048|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
127790227|NCT00440947|459857049|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
127790228|NCT00440947|459857050|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
127790229|NCT00440947|459857046|FG000|48-Week Randomization Phase|Non-compliance|0|||
127790230|NCT00440947|459857047|FG001|48-Week Randomization Phase|Non-compliance|3|||
127790231|NCT00440947|459857048|FG002|48-Week Randomization Phase|Non-compliance|4|||
127790232|NCT00440947|459857049|FG003|48-Week Randomization Phase|Non-compliance|0|||
127790233|NCT00440947|459857050|FG004|48-Week Randomization Phase|Non-compliance|0|||
127790234|NCT00440947|459857046|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
127790235|NCT00440947|459857047|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
127790236|NCT00440947|459857048|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
127790237|NCT00440947|459857049|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
127790238|NCT00440947|459857050|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
127790239|NCT00440947|459857046|FG000|48-Week Randomization Phase|Protocol Violation|0|||
127790240|NCT00440947|459857047|FG001|48-Week Randomization Phase|Protocol Violation|0|||
127790241|NCT00440947|459857048|FG002|48-Week Randomization Phase|Protocol Violation|1|||
127790242|NCT00440947|459857049|FG003|48-Week Randomization Phase|Protocol Violation|0|||
127790243|NCT00440947|459857050|FG004|48-Week Randomization Phase|Protocol Violation|0|||
127790244|NCT00440947|459857046|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
127790245|NCT00440947|459857047|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
127790246|NCT00440947|459857048|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
127790247|NCT00440947|459857049|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
127790248|NCT00440947|459857050|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
127790249|NCT00440947|459857046|FG000|48-Week Randomization Phase|Pregnancy|0|||
127790250|NCT00440947|459857047|FG001|48-Week Randomization Phase|Pregnancy|0|||
127790251|NCT00440947|459857048|FG002|48-Week Randomization Phase|Pregnancy|1|||
127790252|NCT00440947|459857049|FG003|48-Week Randomization Phase|Pregnancy|0|||
127790253|NCT00440947|459857050|FG004|48-Week Randomization Phase|Pregnancy|0|||
127790254|NCT00440947|459857046|FG000|48-Week Randomization Phase|Incarceration|0|||
127790255|NCT00440947|459857047|FG001|48-Week Randomization Phase|Incarceration|3|||
127790256|NCT00440947|459857048|FG002|48-Week Randomization Phase|Incarceration|0|||
127790257|NCT00440947|459857049|FG003|48-Week Randomization Phase|Incarceration|0|||
127790258|NCT00440947|459857050|FG004|48-Week Randomization Phase|Incarceration|0|||
127790259|NCT00440947|459857046|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
127790260|NCT00440947|459857047|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
127790261|NCT00440947|459857048|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
127790262|NCT00440947|459857049|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
127790263|NCT00440947|459857050|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
127790264|NCT00440947|459857046|FG000|48-Week Randomization Phase|Physician Decision|0|||
127790265|NCT00440947|459857047|FG001|48-Week Randomization Phase|Physician Decision|2|||
127790266|NCT00440947|459857048|FG002|48-Week Randomization Phase|Physician Decision|0|||
127790267|NCT00440947|459857049|FG003|48-Week Randomization Phase|Physician Decision|0|||
127790268|NCT00440947|459857050|FG004|48-Week Randomization Phase|Physician Decision|0|||
127790269|NCT00440947|459857046|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
127790270|NCT00440947|459857047|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
127790271|NCT00440947|459857048|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
127790272|NCT00440947|459857049|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
127790273|NCT00440947|459857050|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
127790274|NCT00440947|459857046|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
127790275|NCT00440947|459857047|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
127790276|NCT00440947|459857048|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
127790277|NCT00440947|459857049|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
127883618|NCT04440163|460197873|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
127883619|NCT04440163|460197874|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
127883620|NCT04440163|460197875|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
127883621|NCT04440163|460197876|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
127883622|NCT04440163|460197877|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
127883623|NCT04440163|460197878|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
127883624|NCT04440163|460197879|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
127883625|NCT04440163|460197872|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
127883626|NCT04440163|460197873|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
127883627|NCT04440163|460197874|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
127883628|NCT04440163|460197875|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
127883629|NCT04440163|460197876|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
127883630|NCT04440163|460197877|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
127883631|NCT04440163|460197878|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
127883632|NCT04440163|460197879|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
127883633|NCT04440163|460197872|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
127883634|NCT04440163|460197873|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
127883635|NCT04440163|460197874|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
127883636|NCT04440163|460197875|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
127883637|NCT04440163|460197876|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
127883638|NCT04440163|460197877|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
127883639|NCT04440163|460197878|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
127883640|NCT04440163|460197879|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
127883641|NCT04440163|460197872|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
127883642|NCT04440163|460197873|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
127883643|NCT04440163|460197874|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
127883644|NCT04440163|460197875|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
127883645|NCT04440163|460197876|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
127883646|NCT04440163|460197877|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
127883647|NCT04440163|460197878|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
127883648|NCT04440163|460197879|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
127883649|NCT04440163|460197872|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
127883650|NCT04440163|460197873|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
127790278|NCT00440947|459857050|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
127790279|NCT00440947|459857046|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
127790280|NCT00440947|459857047|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
127790281|NCT00440947|459857048|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
127790282|NCT00440947|459857049|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
127790283|NCT00440947|459857050|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
127790284|NCT00440947|459857046|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
127790285|NCT00440947|459857047|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
127790286|NCT00440947|459857048|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
127790287|NCT00440947|459857049|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
127790288|NCT00440947|459857050|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
127790289|NCT00440947|459857046|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
127790290|NCT00440947|459857047|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
127790291|NCT00440947|459857048|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
127790292|NCT00440947|459857049|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
127790293|NCT00440947|459857050|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
127790294|NCT00440947|459857046|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
127790295|NCT00440947|459857047|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
127790296|NCT00440947|459857048|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
127790297|NCT00440947|459857049|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
127790298|NCT00440947|459857050|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
127790299|NCT00440947|459857046|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
127790300|NCT00440947|459857047|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
127790301|NCT00440947|459857048|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
127790302|NCT00440947|459857049|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
127790303|NCT00440947|459857050|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
127790304|NCT00440947|459857046|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
127790305|NCT00440947|459857047|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
127790306|NCT00440947|459857048|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
127790307|NCT00440947|459857049|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
127790308|NCT00440947|459857050|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
127790309|NCT00440947|459857046|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
127614038|NCT00934544|459217763|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
127614039|NCT00934544|459217761|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
127614040|NCT00934544|459217762|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
127614041|NCT00934544|459217763|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
127614042|NCT01218516|459217764|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
127614043|NCT01218516|459217765|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
127614044|NCT01218516|459217766|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
127614045|NCT01218516|459217767|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
127614046|NCT01218516|459217764|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
127614047|NCT01218516|459217765|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
127614048|NCT01218516|459217766|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
127614049|NCT01218516|459217767|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
127614050|NCT01218516|459217764|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
127614051|NCT01218516|459217765|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
127614052|NCT01218516|459217766|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
127790310|NCT00440947|459857047|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
127790311|NCT00440947|459857048|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
127790312|NCT00440947|459857049|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
127790313|NCT00440947|459857050|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
127790314|NCT00440947|459857046|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
127790315|NCT00440947|459857047|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
127790316|NCT00440947|459857048|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
127790317|NCT00440947|459857049|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
127790318|NCT00440947|459857050|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
127790319|NCT00440947|459857046|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
127790320|NCT00440947|459857047|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
127790321|NCT00440947|459857048|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
127790322|NCT00440947|459857049|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
127790323|NCT00440947|459857050|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
127790324|NCT00440947|459857046|FG000|Optional 60-Week Extension Phase|Other|0|||
127790325|NCT00440947|459857047|FG001|Optional 60-Week Extension Phase|Other|0|||
127790326|NCT00440947|459857048|FG002|Optional 60-Week Extension Phase|Other|0|||
127790327|NCT00440947|459857049|FG003|Optional 60-Week Extension Phase|Other|1|||
127790328|NCT00440947|459857050|FG004|Optional 60-Week Extension Phase|Other|0|||
127790329|NCT00440947|459857046|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
127790330|NCT00440947|459857047|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
127790331|NCT00440947|459857048|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
127790332|NCT00440947|459857049|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
127790333|NCT00440947|459857050|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
127883651|NCT04440163|460197874|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
127614053|NCT01218516|459217767|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
127614054|NCT01218516|459217764|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
127614055|NCT01218516|459217765|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
127614056|NCT01218516|459217766|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
127614057|NCT01218516|459217767|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
127614058|NCT01218516|459217764|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
127614059|NCT01218516|459217765|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
127614060|NCT01218516|459217766|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
127614061|NCT01218516|459217767|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
127614062|NCT01218516|459217764|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
127614063|NCT01218516|459217765|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
127614064|NCT01218516|459217766|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
127614065|NCT01218516|459217767|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
127614066|NCT01218516|459217764|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
127614067|NCT01218516|459217765|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
127614068|NCT01218516|459217766|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
127614069|NCT01218516|459217767|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
127614070|NCT01218516|459217764|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
127614071|NCT01218516|459217765|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
127614072|NCT01218516|459217766|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
127614073|NCT01218516|459217767|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
127614074|NCT01218516|459217764|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
127614075|NCT01218516|459217765|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
127614076|NCT01218516|459217766|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
127614077|NCT01218516|459217767|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
127614078|NCT01218516|459217764|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
127614079|NCT01218516|459217765|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
127614080|NCT01218516|459217766|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
127614081|NCT01218516|459217767|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
127699170|NCT03544281|459526628|FG007|Main Study Phase|Investigator Site Closed|0|||
127699171|NCT03544281|459526629|FG008|Main Study Phase|Investigator Site Closed|0|||
127699172|NCT03544281|459526630|FG009|Main Study Phase|Investigator Site Closed|1|||
127699173|NCT03544281|459526631|FG010|Main Study Phase|Investigator Site Closed|0|||
127699174|NCT03544281|459526632|FG011|Main Study Phase|Investigator Site Closed|0|||
127699175|NCT03544281|459526633|FG012|Main Study Phase|Investigator Site Closed|0|||
127699176|NCT03544281|459526634|FG013|Main Study Phase|Investigator Site Closed|0|||
127699177|NCT03544281|459526635|FG014|Main Study Phase|Investigator Site Closed|0|||
127699178|NCT03544281|459526636|FG015|Main Study Phase|Investigator Site Closed|0|||
127699179|NCT03544281|459526637|FG016|Main Study Phase|Investigator Site Closed|0|||
127699180|NCT03544281|459526638|FG017|Main Study Phase|Investigator Site Closed|0|||
127699181|NCT03544281|459526639|FG018|Main Study Phase|Investigator Site Closed|0|||
127699182|NCT03544281|459526640|FG019|Main Study Phase|Investigator Site Closed|0|||
127699183|NCT03544281|459526641|FG020|Main Study Phase|Investigator Site Closed|0|||
127699184|NCT03544281|459526642|FG021|Main Study Phase|Investigator Site Closed|0|||
127699185|NCT03544281|459526621|FG000|Main Study Phase|Did not receive study treatment|0|||
127699186|NCT03544281|459526622|FG001|Main Study Phase|Did not receive study treatment|0|||
127699187|NCT03544281|459526623|FG002|Main Study Phase|Did not receive study treatment|0|||
127699188|NCT03544281|459526624|FG003|Main Study Phase|Did not receive study treatment|0|||
127699189|NCT03544281|459526625|FG004|Main Study Phase|Did not receive study treatment|0|||
127699190|NCT03544281|459526626|FG005|Main Study Phase|Did not receive study treatment|0|||
127699191|NCT03544281|459526627|FG006|Main Study Phase|Did not receive study treatment|1|||
127699192|NCT03544281|459526628|FG007|Main Study Phase|Did not receive study treatment|0|||
127699193|NCT03544281|459526629|FG008|Main Study Phase|Did not receive study treatment|0|||
127699194|NCT03544281|459526630|FG009|Main Study Phase|Did not receive study treatment|0|||
127699195|NCT03544281|459526631|FG010|Main Study Phase|Did not receive study treatment|0|||
127699196|NCT03544281|459526632|FG011|Main Study Phase|Did not receive study treatment|0|||
127699197|NCT03544281|459526633|FG012|Main Study Phase|Did not receive study treatment|0|||
127699198|NCT03544281|459526634|FG013|Main Study Phase|Did not receive study treatment|0|||
127699199|NCT03544281|459526635|FG014|Main Study Phase|Did not receive study treatment|0|||
127699200|NCT03544281|459526636|FG015|Main Study Phase|Did not receive study treatment|0|||
127699201|NCT03544281|459526637|FG016|Main Study Phase|Did not receive study treatment|0|||
127699202|NCT03544281|459526638|FG017|Main Study Phase|Did not receive study treatment|0|||
127699203|NCT03544281|459526639|FG018|Main Study Phase|Did not receive study treatment|0|||
127699204|NCT03544281|459526640|FG019|Main Study Phase|Did not receive study treatment|0|||
127699205|NCT03544281|459526641|FG020|Main Study Phase|Did not receive study treatment|0|||
127699206|NCT03544281|459526642|FG021|Main Study Phase|Did not receive study treatment|0|||
127699207|NCT03544281|459526621|FG000|PACT Phase|Adverse Event|0|||
127699208|NCT03544281|459526622|FG001|PACT Phase|Adverse Event|0|||
127699209|NCT03544281|459526623|FG002|PACT Phase|Adverse Event|0|||
127699210|NCT03544281|459526624|FG003|PACT Phase|Adverse Event|0|||
127699211|NCT03544281|459526625|FG004|PACT Phase|Adverse Event|0|||
127699212|NCT03544281|459526626|FG005|PACT Phase|Adverse Event|0|||
127699213|NCT03544281|459526627|FG006|PACT Phase|Adverse Event|0|||
127699214|NCT03544281|459526628|FG007|PACT Phase|Adverse Event|0|||
127699215|NCT03544281|459526629|FG008|PACT Phase|Adverse Event|0|||
127699216|NCT03544281|459526630|FG009|PACT Phase|Adverse Event|0|||
127699217|NCT03544281|459526631|FG010|PACT Phase|Adverse Event|0|||
127699218|NCT03544281|459526632|FG011|PACT Phase|Adverse Event|0|||
127699219|NCT03544281|459526633|FG012|PACT Phase|Adverse Event|1|||
127699220|NCT03544281|459526634|FG013|PACT Phase|Adverse Event|0|||
127699221|NCT03544281|459526635|FG014|PACT Phase|Adverse Event|0|||
127699222|NCT03544281|459526636|FG015|PACT Phase|Adverse Event|0|||
127699223|NCT03544281|459526637|FG016|PACT Phase|Adverse Event|0|||
127699224|NCT03544281|459526638|FG017|PACT Phase|Adverse Event|1|||
127699225|NCT03544281|459526639|FG018|PACT Phase|Adverse Event|1|||
127699226|NCT03544281|459526640|FG019|PACT Phase|Adverse Event|0|||
127699227|NCT03544281|459526641|FG020|PACT Phase|Adverse Event|0|||
127699228|NCT03544281|459526642|FG021|PACT Phase|Adverse Event|0|||
127699229|NCT03092518|459526644|FG000|Overall Study|Ineligible|2|||
127699230|NCT02547987|459526647|FG000|Overall Study|Withdrawal by Subject|1|||
127699231|NCT02547987|459526647|FG000|Overall Study|Adverse Event|2|||
127699232|NCT04925986|459526648|FG000|Overall Study|Death|0|||
127699233|NCT04925986|459526649|FG001|Overall Study|Death|0|||
127699234|NCT04925986|459526650|FG002|Overall Study|Death|2|||
127699235|NCT04925986|459526651|FG003|Overall Study|Death|0|||
127699236|NCT04925986|459526648|FG000|Overall Study|Lack of Efficacy|1|||
127699237|NCT04925986|459526649|FG001|Overall Study|Lack of Efficacy|2|||
127699238|NCT04925986|459526650|FG002|Overall Study|Lack of Efficacy|0|||
127699239|NCT04925986|459526651|FG003|Overall Study|Lack of Efficacy|1|||
127699240|NCT04925986|459526648|FG000|Overall Study|Withdrawal by Subject|0|||
127699241|NCT04925986|459526649|FG001|Overall Study|Withdrawal by Subject|0|||
127699242|NCT04925986|459526650|FG002|Overall Study|Withdrawal by Subject|1|||
127699243|NCT04925986|459526651|FG003|Overall Study|Withdrawal by Subject|2|||
127699244|NCT06181760|459526652|FG000|First Intervention (Fasted)|Withdrawal by Subject|0|||
127699245|NCT06181760|459526653|FG001|First Intervention (Fasted)|Withdrawal by Subject|0|||
127699246|NCT06181760|459526654|FG002|First Intervention (Fasted)|Withdrawal by Subject|0|||
127790334|NCT00440947|459857046|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
127790335|NCT00440947|459857047|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
127790336|NCT00440947|459857048|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
127790337|NCT00440947|459857049|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
127790338|NCT00440947|459857050|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
127790339|NCT02716987|459857051|FG000|Overall Study|Ligand synthesis failure|0|||
127790340|NCT02716987|459857052|FG001|Overall Study|Ligand synthesis failure|0|||
127790341|NCT02716987|459857053|FG002|Overall Study|Ligand synthesis failure|1|||
127614082|NCT01218516|459217764|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
127614083|NCT01218516|459217765|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
127614084|NCT01218516|459217766|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
127614085|NCT01218516|459217767|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
127614086|NCT01218516|459217764|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
127614087|NCT01218516|459217765|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
127614088|NCT01218516|459217766|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
127614089|NCT01218516|459217767|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
127790342|NCT02716987|459857054|FG003|Overall Study|Ligand synthesis failure|0|||
127790343|NCT02716987|459857055|FG004|Overall Study|Ligand synthesis failure|0|||
127790344|NCT02716987|459857056|FG005|Overall Study|Ligand synthesis failure|0|||
127790345|NCT02716987|459857051|FG000|Overall Study|Withdrawal by Subject|0|||
127790346|NCT02716987|459857052|FG001|Overall Study|Withdrawal by Subject|0|||
127790347|NCT02716987|459857053|FG002|Overall Study|Withdrawal by Subject|0|||
127790348|NCT02716987|459857054|FG003|Overall Study|Withdrawal by Subject|0|||
127614090|NCT04033003|459217769|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|113|||
127790349|NCT02716987|459857055|FG004|Overall Study|Withdrawal by Subject|1|||
127614091|NCT04033003|459217770|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|190|||
127614092|NCT04033003|459217769|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|115|||
127614093|NCT04033003|459217770|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|0|||
127614094|NCT04033003|459217769|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|2|||
127614095|NCT04033003|459217770|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|6|||
127614096|NCT04033003|459217769|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|30|||
127614097|NCT04033003|459217770|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|19|||
127614098|NCT04033003|459217769|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|0|||
127614099|NCT04033003|459217770|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|1|||
127614100|NCT04033003|459217769|FG000|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|133|||
127614101|NCT04033003|459217770|FG001|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|247|||
127614102|NCT04033003|459217769|FG000|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|4|||
127614103|NCT04033003|459217770|FG001|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|0|||
127614104|NCT04033003|459217769|FG000|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|5|||
127614105|NCT04033003|459217770|FG001|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|3|||
127614106|NCT04033003|459217769|FG000|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|1|||
127614107|NCT04033003|459217770|FG001|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|10|||
127614108|NCT04033003|459217769|FG000|T2 (6 - 12 Weeks Postpartum)|Death|2|||
127614109|NCT04033003|459217770|FG001|T2 (6 - 12 Weeks Postpartum)|Death|2|||
127614110|NCT04033003|459217769|FG000|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|96|||
127614111|NCT04033003|459217770|FG001|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|165|||
127614112|NCT04033003|459217769|FG000|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|3|||
127614113|NCT04033003|459217770|FG001|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|5|||
127699247|NCT06181760|459526655|FG003|First Intervention (Fasted)|Withdrawal by Subject|1|||
127699248|NCT04770532|459526656|FG000|Overall Study|Withdrawal by Subject|0|||
127699249|NCT04770532|459526657|FG001|Overall Study|Withdrawal by Subject|3|||
127699250|NCT04770532|459526656|FG000|Overall Study|Physician Decision|1|||
127699251|NCT04770532|459526657|FG001|Overall Study|Physician Decision|0|||
127699252|NCT04770532|459526656|FG000|Overall Study|Death|2|||
127699253|NCT04770532|459526657|FG001|Overall Study|Death|2|||
127699254|NCT04938492|459526658|FG000|Overall Study|Lost to Follow-up|17|||
127699255|NCT04938492|459526659|FG001|Overall Study|Lost to Follow-up|18|||
127699256|NCT05084508|459526660|FG000|Overall Study|Lost to Follow-up|6|||
127699257|NCT05084508|459526661|FG001|Overall Study|Lost to Follow-up|3|||
127699258|NCT05084508|459526662|FG002|Overall Study|Lost to Follow-up|7|||
127699259|NCT05084508|459526663|FG003|Overall Study|Lost to Follow-up|3|||
127699260|NCT05084508|459526660|FG000|Overall Study|Withdrawal by Subject|0|||
127699261|NCT05084508|459526661|FG001|Overall Study|Withdrawal by Subject|2|||
127699262|NCT05084508|459526662|FG002|Overall Study|Withdrawal by Subject|3|||
127699263|NCT05084508|459526663|FG003|Overall Study|Withdrawal by Subject|1|||
127699264|NCT05084508|459526660|FG000|Overall Study|Other|0|||
127699265|NCT05084508|459526661|FG001|Overall Study|Other|0|||
127699266|NCT05084508|459526662|FG002|Overall Study|Other|0|||
127699267|NCT05084508|459526663|FG003|Overall Study|Other|1|||
127699268|NCT04437615|459526668|FG000|Overall Study|Screen Fails/Withdrawal|1089|||
127699269|NCT00418886|459528633|FG000|Randomized Period|discontinue treatment survival follow-up|90|||
127699270|NCT00418886|459528634|FG001|Randomized Period|discontinue treatment survival follow-up|91|||
127699271|NCT00418886|459528633|FG000|Randomized Period|Death|122|||
127699272|NCT00418886|459528634|FG001|Randomized Period|Death|147|||
127699273|NCT00418886|459528633|FG000|Randomized Period|Withdrawal by Subject|9|||
127699274|NCT00418886|459528634|FG001|Randomized Period|Withdrawal by Subject|10|||
127699275|NCT00418886|459528633|FG000|Randomized Period|Lost to Follow-up|4|||
127699276|NCT00418886|459528634|FG001|Randomized Period|Lost to Follow-up|6|||
127699277|NCT00418886|459528633|FG000|Randomized Period|withdrawn due to other reason|1|||
127699278|NCT00418886|459528634|FG001|Randomized Period|withdrawn due to other reason|0|||
127699279|NCT00418886|459528633|FG000|Randomized Period|randomised but no treatment received|0|||
127699280|NCT00418886|459528634|FG001|Randomized Period|randomised but no treatment received|1|||
127699281|NCT03707951|459528635|FG000|Overall Study|Lost to Follow-up|8|||
127699282|NCT03707951|459528636|FG001|Overall Study|Lost to Follow-up|17|||
127699283|NCT03707951|459528635|FG000|Overall Study|Withdrawal by Subject|6|||
127699284|NCT03707951|459528636|FG001|Overall Study|Withdrawal by Subject|6|||
127614114|NCT04033003|459217769|FG000|T4 (11 -14 Months Postpartum)|Lost to Follow-up|89|||
127614115|NCT04033003|459217770|FG001|T4 (11 -14 Months Postpartum)|Lost to Follow-up|150|||
127614116|NCT01714310|459217771|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
127699285|NCT04887129|459528637|FG000|Overall Study|Lost to Follow-up|0|||
127699286|NCT04887129|459528638|FG001|Overall Study|Lost to Follow-up|24|||
127614117|NCT01714310|459217772|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
127614118|NCT01714310|459217773|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
127614119|NCT01714310|459217771|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
127614120|NCT01714310|459217772|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
127614121|NCT01714310|459217773|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
127614122|NCT01714310|459217771|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
127614123|NCT01714310|459217772|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
127614124|NCT01714310|459217773|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
127614125|NCT01714310|459217771|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
127614126|NCT01714310|459217772|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
127883652|NCT04440163|460197875|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
127883653|NCT04440163|460197876|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
127883654|NCT04440163|460197877|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
127883655|NCT04440163|460197878|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
127883656|NCT04440163|460197879|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
127883657|NCT04440163|460197872|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
127883658|NCT04440163|460197873|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
127883659|NCT04440163|460197874|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
127883660|NCT04440163|460197875|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
127883661|NCT04440163|460197876|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
127883662|NCT04440163|460197877|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
127883663|NCT04440163|460197878|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
127883664|NCT04440163|460197879|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
127883665|NCT04440163|460197872|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
127883666|NCT04440163|460197873|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
127883667|NCT04440163|460197874|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
127883668|NCT04440163|460197875|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
127883669|NCT04440163|460197876|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
127883670|NCT04440163|460197877|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
127883671|NCT04440163|460197878|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
127883672|NCT04440163|460197879|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
127883673|NCT02018042|460197882|FG000|Overall Study|Withdrawal by Subject|1|||
127883674|NCT01954082|460197883|FG000|Overall Study|Study Suspension|42|||
127883675|NCT01954082|460197884|FG001|Overall Study|Study Suspension|36|||
127883676|NCT01954082|460197883|FG000|Overall Study|Adverse Event|10|||
127883677|NCT01954082|460197884|FG001|Overall Study|Adverse Event|4|||
127883678|NCT01954082|460197883|FG000|Overall Study|Intolerance|0|||
127883679|NCT01954082|460197884|FG001|Overall Study|Intolerance|1|||
127883680|NCT01954082|460197883|FG000|Overall Study|Non-compliance|6|||
127883681|NCT01954082|460197884|FG001|Overall Study|Non-compliance|4|||
127883682|NCT01954082|460197883|FG000|Overall Study|Physician Decision|2|||
127883683|NCT01954082|460197884|FG001|Overall Study|Physician Decision|0|||
127883684|NCT01954082|460197883|FG000|Overall Study|Parent Decision|1|||
127883685|NCT01954082|460197884|FG001|Overall Study|Parent Decision|0|||
127883686|NCT01954082|460197883|FG000|Overall Study|Withdrawal by Subject|0|||
127883687|NCT01954082|460197884|FG001|Overall Study|Withdrawal by Subject|1|||
127883688|NCT01954082|460197883|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
127614127|NCT01714310|459217773|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
127614128|NCT04164901|459217782|FG000|Overall Study|Withdrawal by Subject|4|||
127614129|NCT04164901|459217783|FG001|Overall Study|Withdrawal by Subject|4|||
127614130|NCT02046148|459217787|FG000|Overall Study|Lost to Follow-up|1|||
127614131|NCT02046148|459217788|FG001|Overall Study|Lost to Follow-up|1|||
127699287|NCT04887129|459528637|FG000|Overall Study|Withdrawal by Subject|9|||
127614132|NCT02046148|459217787|FG000|Overall Study|Withdrawal by Subject|0|||
127699288|NCT04887129|459528638|FG001|Overall Study|Withdrawal by Subject|57|||
127699289|NCT04887129|459528637|FG000|Overall Study|Other|2|||
127883689|NCT01954082|460197884|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
127883690|NCT01954082|460197883|FG000|Overall Study|Redirection of Care|0|||
127883691|NCT01954082|460197884|FG001|Overall Study|Redirection of Care|2|||
127883692|NCT01954082|460197883|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
127614133|NCT02046148|459217788|FG001|Overall Study|Withdrawal by Subject|2|||
127614134|NCT01828034|459217798|FG000|Overall Study|Withdrawal by Subject|0|||
127614135|NCT01828034|459217799|FG001|Overall Study|Withdrawal by Subject|0|||
127614136|NCT01828034|459217800|FG002|Overall Study|Withdrawal by Subject|0|||
127614137|NCT01828034|459217801|FG003|Overall Study|Withdrawal by Subject|1|||
127614138|NCT00453999|459217810|FG000|Overall Study|Adverse Event|1|||
127614139|NCT00453999|459217811|FG001|Overall Study|Adverse Event|2|||
127614140|NCT00453999|459217812|FG002|Overall Study|Adverse Event|1|||
127614141|NCT00453999|459217810|FG000|Overall Study|Lost to Follow-up|0|||
127614142|NCT00453999|459217811|FG001|Overall Study|Lost to Follow-up|1|||
127614143|NCT00453999|459217812|FG002|Overall Study|Lost to Follow-up|1|||
127614144|NCT00453999|459217810|FG000|Overall Study|Withdrawal by Subject|2|||
127614145|NCT00453999|459217811|FG001|Overall Study|Withdrawal by Subject|1|||
127614146|NCT00453999|459217812|FG002|Overall Study|Withdrawal by Subject|1|||
127614147|NCT00453999|459217810|FG000|Overall Study|Subject Request|2|||
127614148|NCT00453999|459217811|FG001|Overall Study|Subject Request|1|||
127614149|NCT00453999|459217812|FG002|Overall Study|Subject Request|0|||
127614150|NCT00743652|459217818|FG000|Overall Study|Parent/Legal Guardian Request|3|||
127614151|NCT00743652|459217819|FG001|Overall Study|Parent/Legal Guardian Request|2|||
127614152|NCT00743652|459217820|FG002|Overall Study|Parent/Legal Guardian Request|2|||
127614153|NCT00743652|459217821|FG003|Overall Study|Parent/Legal Guardian Request|2|||
127614154|NCT00743652|459217822|FG004|Overall Study|Parent/Legal Guardian Request|0|||
127614155|NCT00743652|459217818|FG000|Overall Study|Adverse Event|3|||
127614156|NCT00743652|459217819|FG001|Overall Study|Adverse Event|0|||
127614157|NCT00743652|459217820|FG002|Overall Study|Adverse Event|0|||
127614158|NCT00743652|459217821|FG003|Overall Study|Adverse Event|0|||
127614159|NCT00743652|459217822|FG004|Overall Study|Adverse Event|0|||
127614160|NCT00743652|459217818|FG000|Overall Study|Death|2|||
127614161|NCT00743652|459217819|FG001|Overall Study|Death|0|||
127614162|NCT00743652|459217820|FG002|Overall Study|Death|0|||
127614163|NCT00743652|459217821|FG003|Overall Study|Death|0|||
127614164|NCT00743652|459217822|FG004|Overall Study|Death|0|||
127614165|NCT00743652|459217818|FG000|Overall Study|Investigator Request|0|||
127614166|NCT00743652|459217819|FG001|Overall Study|Investigator Request|0|||
127614167|NCT00743652|459217820|FG002|Overall Study|Investigator Request|0|||
127614168|NCT00743652|459217821|FG003|Overall Study|Investigator Request|2|||
127614169|NCT00743652|459217822|FG004|Overall Study|Investigator Request|0|||
127614170|NCT00743652|459217818|FG000|Overall Study|Other|1|||
127614171|NCT00743652|459217819|FG001|Overall Study|Other|1|||
127614172|NCT00743652|459217820|FG002|Overall Study|Other|0|||
127614173|NCT00743652|459217821|FG003|Overall Study|Other|0|||
127614174|NCT00743652|459217822|FG004|Overall Study|Other|0|||
127614175|NCT00743652|459217818|FG000|Overall Study|Lost to Follow-up|1|||
127614176|NCT00743652|459217819|FG001|Overall Study|Lost to Follow-up|0|||
127614177|NCT00743652|459217820|FG002|Overall Study|Lost to Follow-up|0|||
127614178|NCT00743652|459217821|FG003|Overall Study|Lost to Follow-up|0|||
127614179|NCT00743652|459217822|FG004|Overall Study|Lost to Follow-up|0|||
127614180|NCT00149747|459217823|FG000|Overall Study|Death|1|||
127614181|NCT00149747|459217824|FG001|Overall Study|Death|0|||
127614182|NCT00149747|459217823|FG000|Overall Study|Withdrawal by Subject|3|||
127614183|NCT00149747|459217824|FG001|Overall Study|Withdrawal by Subject|3|||
127614184|NCT01183975|459217828|FG000|Overall Study|Lost to Follow-up|73|||
127614185|NCT06049043|459217831|FG000|Overall Study|Lost to Follow-up|11|||
127614186|NCT06049043|459217832|FG001|Overall Study|Lost to Follow-up|9|||
127614187|NCT01354496|459217834|FG000|Period 1|Adverse Event|0|||
127614188|NCT01354496|459217835|FG001|Period 1|Adverse Event|0|||
127614189|NCT01354496|459217836|FG002|Period 1|Adverse Event|1|||
127614190|NCT01354496|459217837|FG003|Period 1|Adverse Event|0|||
127790350|NCT02716987|459857056|FG005|Overall Study|Withdrawal by Subject|1|||
127790351|NCT03223428|459857060|FG000|Overall Study|No longer taking Xermelo|27|||
127790352|NCT03223428|459857060|FG000|Overall Study|Declined Consent|1|||
127790353|NCT03223428|459857060|FG000|Overall Study|Non-responders|56|||
127790354|NCT03223428|459857060|FG000|Overall Study|Withdrawal by Subject|14|||
127790355|NCT01834274|459857061|FG000|Overall Study|Study Termination|41|||
127790356|NCT01834274|459857062|FG001|Overall Study|Study Termination|38|||
127790357|NCT01834274|459857061|FG000|Overall Study|Withdrawal by Subject|1|||
127790358|NCT01834274|459857062|FG001|Overall Study|Withdrawal by Subject|1|||
127883693|NCT01954082|460197884|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
127790359|NCT01834274|459857061|FG000|Overall Study|Lost to Follow-up|3|||
127883694|NCT01954082|460197883|FG000|Overall Study|Comfort Care|0|||
127883695|NCT01954082|460197884|FG001|Overall Study|Comfort Care|1|||
127883696|NCT01954082|460197883|FG000|Overall Study|Infant Moved|0|||
127883697|NCT01954082|460197884|FG001|Overall Study|Infant Moved|1|||
127883698|NCT01954082|460197883|FG000|Overall Study|Randomized not Treated|4|||
127883699|NCT01954082|460197884|FG001|Overall Study|Randomized not Treated|2|||
127883700|NCT00707174|460197887|FG000|Overall Study|Adverse Event|1|||
127883701|NCT00707174|460197888|FG001|Overall Study|Adverse Event|6|||
127883702|NCT00707174|460197887|FG000|Overall Study|Withdrawal by Subject|4|||
127883703|NCT00707174|460197888|FG001|Overall Study|Withdrawal by Subject|1|||
127883704|NCT00572156|460197889|FG000|Overall Study|Adverse Event|3|||
127883705|NCT00572156|460197890|FG001|Overall Study|Adverse Event|1|||
127883706|NCT00572156|460197891|FG002|Overall Study|Adverse Event|5|||
127883707|NCT00572156|460197892|FG003|Overall Study|Adverse Event|1|||
127883708|NCT00572156|460197889|FG000|Overall Study|Lost to Follow-up|1|||
127883709|NCT00572156|460197890|FG001|Overall Study|Lost to Follow-up|1|||
127883710|NCT00572156|460197891|FG002|Overall Study|Lost to Follow-up|1|||
127883711|NCT00572156|460197892|FG003|Overall Study|Lost to Follow-up|0|||
127883712|NCT00572156|460197889|FG000|Overall Study|Protocol Violation|1|||
127883713|NCT00572156|460197890|FG001|Overall Study|Protocol Violation|2|||
127883714|NCT00572156|460197891|FG002|Overall Study|Protocol Violation|0|||
127883715|NCT00572156|460197892|FG003|Overall Study|Protocol Violation|2|||
127883716|NCT00572156|460197889|FG000|Overall Study|Patient/Parent Decision|1|||
127883717|NCT00572156|460197890|FG001|Overall Study|Patient/Parent Decision|6|||
127883718|NCT00572156|460197891|FG002|Overall Study|Patient/Parent Decision|4|||
127883719|NCT00572156|460197892|FG003|Overall Study|Patient/Parent Decision|3|||
127883720|NCT00572156|460197889|FG000|Overall Study|Sponsor Decision|20|||
127883721|NCT00572156|460197890|FG001|Overall Study|Sponsor Decision|16|||
127883722|NCT00572156|460197891|FG002|Overall Study|Sponsor Decision|17|||
127883723|NCT00572156|460197892|FG003|Overall Study|Sponsor Decision|19|||
127883724|NCT02261974|460197893|FG000|Overall Study|Withdrawal by Subject|3|||
127883725|NCT02261974|460197894|FG001|Overall Study|Withdrawal by Subject|2|||
127883726|NCT02261974|460197893|FG000|Overall Study|Pregnancy|0|||
127883727|NCT02261974|460197894|FG001|Overall Study|Pregnancy|1|||
127883728|NCT02261974|460197893|FG000|Overall Study|Missed treatment cut-off date|6|||
127883729|NCT02261974|460197894|FG001|Overall Study|Missed treatment cut-off date|3|||
127883730|NCT02261974|460197893|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
127883731|NCT02261974|460197894|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
127883732|NCT02261974|460197893|FG000|Overall Study|Lost to Follow-up|2|||
127883733|NCT02261974|460197894|FG001|Overall Study|Lost to Follow-up|0|||
127883734|NCT02261974|460197893|FG000|Overall Study|Adverse Event|1|||
127883735|NCT02261974|460197894|FG001|Overall Study|Adverse Event|0|||
127699290|NCT04887129|459528638|FG001|Overall Study|Other|9|||
127883736|NCT01453374|460197895|FG000|Overall Study|Adverse Event|7|||
127883737|NCT01453374|460197895|FG000|Overall Study|Lack of Efficacy|1|||
127883738|NCT01453374|460197895|FG000|Overall Study|Lost to Follow-up|3|||
127883739|NCT01453374|460197895|FG000|Overall Study|Withdrawal by Subject|5|||
127883740|NCT01453374|460197895|FG000|Overall Study|Incarcerated|2|||
127883741|NCT05180630|460197896|FG000|First Intervention|Physician Decision|0|||
127883742|NCT05180630|460197897|FG001|First Intervention|Physician Decision|0|||
127883743|NCT05180630|460197898|FG002|First Intervention|Physician Decision|3|||
127883744|NCT00709735|460197906|FG000|Overall Study|Lost to Follow-up|1|||
127883745|NCT00709735|460197907|FG001|Overall Study|Lost to Follow-up|1|||
127883746|NCT00709735|460197906|FG000|Overall Study|Relapse into Opioid Abuse|0|||
127883747|NCT00709735|460197907|FG001|Overall Study|Relapse into Opioid Abuse|1|||
127699291|NCT05177848|459528639|FG000|Overall Study|Lost to Follow-up|1|||
127699292|NCT05177848|459528640|FG001|Overall Study|Lost to Follow-up|4|||
127699293|NCT05177848|459528639|FG000|Overall Study|Discontinued|2|||
127699294|NCT05177848|459528640|FG001|Overall Study|Discontinued|1|||
127699295|NCT02035787|459528641|FG000|Overall Study- 12 Months|Adverse Event|3|||
127699296|NCT02035787|459528642|FG001|Overall Study- 12 Months|Adverse Event|0|||
127699297|NCT02035787|459528641|FG000|Overall Study- 12 Months|Complete response|4|||
127699298|NCT02035787|459528642|FG001|Overall Study- 12 Months|Complete response|1|||
127699299|NCT02035787|459528641|FG000|Overall Study- 12 Months|Protocol Violation|1|||
127699300|NCT02035787|459528642|FG001|Overall Study- 12 Months|Protocol Violation|1|||
127699301|NCT06414213|459528643|FG000|Overall Study|Lost to Follow-up|1|||
127699302|NCT06414213|459528644|FG001|Overall Study|Lost to Follow-up|1|||
127699303|NCT06414213|459528645|FG002|Overall Study|Lost to Follow-up|3|||
127883748|NCT00709735|460197906|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
127883749|NCT00709735|460197907|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
127883750|NCT00666718|460197908|FG000|Overall Study|Adverse Event|0|||
127883751|NCT00666718|460197909|FG001|Overall Study|Adverse Event|1|||
127883752|NCT00666718|460197908|FG000|Overall Study|Death|1|||
127883753|NCT00666718|460197909|FG001|Overall Study|Death|0|||
127883754|NCT00666718|460197908|FG000|Overall Study|Lost to Follow-up|1|||
127883755|NCT00666718|460197909|FG001|Overall Study|Lost to Follow-up|0|||
127699304|NCT00881621|459528647|FG000|Overall Study|Physician Decision|34|||
127699305|NCT03936322|459528652|FG000|Overall Study|Lost to Follow-up|1|||
127883756|NCT00666718|460197908|FG000|Overall Study|Entry Criteria Not Met|2|||
127614191|NCT01354496|459217838|FG004|Period 1|Adverse Event|0|||
127614192|NCT01354496|459217839|FG005|Period 1|Adverse Event|0|||
127614193|NCT01354496|459217834|FG000|Period 1|Physician Decision|0|||
127614194|NCT01354496|459217835|FG001|Period 1|Physician Decision|0|||
127614195|NCT01354496|459217836|FG002|Period 1|Physician Decision|1|||
127614196|NCT01354496|459217837|FG003|Period 1|Physician Decision|0|||
127614197|NCT01354496|459217838|FG004|Period 1|Physician Decision|0|||
127614198|NCT01354496|459217839|FG005|Period 1|Physician Decision|0|||
127614199|NCT01354496|459217834|FG000|Period 2|Adverse Event|0|||
127699306|NCT03936322|459528652|FG000|Overall Study|Infant Death after delivery; therefore, no further follow up occurred|1|||
127699307|NCT05434078|459528654|FG000|Overall Study|Lost to Follow-up|2|||
127614200|NCT01354496|459217835|FG001|Period 2|Adverse Event|0|||
127699308|NCT05434078|459528655|FG001|Overall Study|Lost to Follow-up|1|||
127699309|NCT05434078|459528654|FG000|Overall Study|Withdrawal by Subject|1|||
127699310|NCT05434078|459528655|FG001|Overall Study|Withdrawal by Subject|0|||
127699311|NCT01160211|459528656|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
127699312|NCT01160211|459528657|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
127699313|NCT01160211|459528658|FG002|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|59|||
127699314|NCT01160211|459528656|FG000|Overall Study|Lost to Follow-up|4|||
127699315|NCT01160211|459528657|FG001|Overall Study|Lost to Follow-up|8|||
127699316|NCT01160211|459528658|FG002|Overall Study|Lost to Follow-up|4|||
127699317|NCT01160211|459528656|FG000|Overall Study|Physician Decision|1|||
127699318|NCT01160211|459528657|FG001|Overall Study|Physician Decision|0|||
127699319|NCT01160211|459528658|FG002|Overall Study|Physician Decision|0|||
127699320|NCT01160211|459528656|FG000|Overall Study|Withdrawal by Subject|4|||
127699321|NCT01160211|459528657|FG001|Overall Study|Withdrawal by Subject|2|||
127699322|NCT01160211|459528658|FG002|Overall Study|Withdrawal by Subject|2|||
127699323|NCT01160211|459528656|FG000|Overall Study|Data unavailable due to regulatory issues|2|||
127614201|NCT01354496|459217836|FG002|Period 2|Adverse Event|0|||
127614202|NCT01354496|459217837|FG003|Period 2|Adverse Event|1|||
127614203|NCT01354496|459217838|FG004|Period 2|Adverse Event|0|||
127883757|NCT00666718|460197909|FG001|Overall Study|Entry Criteria Not Met|0|||
127883758|NCT00666718|460197908|FG000|Overall Study|Protocol Violation|1|||
127883759|NCT00666718|460197909|FG001|Overall Study|Protocol Violation|3|||
127883760|NCT00666718|460197908|FG000|Overall Study|Withdrawal by Subject|7|||
127883761|NCT00666718|460197909|FG001|Overall Study|Withdrawal by Subject|12|||
127883762|NCT00666718|460197908|FG000|Overall Study|Physician Decision|0|||
127883763|NCT00666718|460197909|FG001|Overall Study|Physician Decision|2|||
127883764|NCT03496207|460197910|FG000|Base Study|Adverse Event|0|||
127883765|NCT03496207|460197911|FG001|Base Study|Adverse Event|0|||
127883766|NCT03496207|460197912|FG002|Base Study|Adverse Event|1|||
127883767|NCT03496207|460197913|FG003|Base Study|Adverse Event|1|||
127883768|NCT03496207|460197914|FG004|Base Study|Adverse Event|4|||
127883769|NCT03496207|460197910|FG000|Base Study|Death|0|||
127883770|NCT03496207|460197911|FG001|Base Study|Death|0|||
127883771|NCT03496207|460197912|FG002|Base Study|Death|0|||
127883772|NCT03496207|460197913|FG003|Base Study|Death|0|||
127883773|NCT03496207|460197914|FG004|Base Study|Death|1|||
127883774|NCT03496207|460197910|FG000|Base Study|Withdrawal by Subject|0|||
127883775|NCT03496207|460197911|FG001|Base Study|Withdrawal by Subject|0|||
127614204|NCT01354496|459217839|FG005|Period 2|Adverse Event|0|||
127614205|NCT01354496|459217834|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
127614206|NCT01354496|459217835|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
127614207|NCT01354496|459217836|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
127614208|NCT01354496|459217837|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
127614209|NCT01354496|459217838|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
127614210|NCT01354496|459217839|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
127614211|NCT01228747|459217840|FG000|Overall Study|Adverse Event|8|||
127614212|NCT01228747|459217841|FG001|Overall Study|Adverse Event|4|||
127614213|NCT01228747|459217840|FG000|Overall Study|Lack of Efficacy|40|||
127614214|NCT01228747|459217841|FG001|Overall Study|Lack of Efficacy|27|||
127614215|NCT01228747|459217840|FG000|Overall Study|Protocol Violation|6|||
127699324|NCT01160211|459528657|FG001|Overall Study|Data unavailable due to regulatory issues|0|||
127699325|NCT01160211|459528658|FG002|Overall Study|Data unavailable due to regulatory issues|2|||
127883776|NCT03496207|460197912|FG002|Base Study|Withdrawal by Subject|1|||
127614216|NCT01228747|459217841|FG001|Overall Study|Protocol Violation|5|||
127883777|NCT03496207|460197913|FG003|Base Study|Withdrawal by Subject|0|||
127883778|NCT03496207|460197914|FG004|Base Study|Withdrawal by Subject|1|||
127883779|NCT03496207|460197910|FG000|Extension Period|Adverse Event|0|||
127883780|NCT03496207|460197911|FG001|Extension Period|Adverse Event|0|||
127883781|NCT03496207|460197912|FG002|Extension Period|Adverse Event|0|||
127614217|NCT01228747|459217840|FG000|Overall Study|Lost to Follow-up|4|||
127883782|NCT03496207|460197913|FG003|Extension Period|Adverse Event|1|||
127699326|NCT02734290|459528662|FG000|Overall Study|Adverse Event|1|||
127699327|NCT02734290|459528663|FG001|Overall Study|Adverse Event|0|||
127699328|NCT02734290|459528662|FG000|Overall Study|Death|1|||
127699329|NCT02734290|459528663|FG001|Overall Study|Death|0|||
127699330|NCT03158129|459528664|FG000|Overall Study|Adverse Event|0|||
127699331|NCT03158129|459528665|FG001|Overall Study|Adverse Event|1|||
127699332|NCT03158129|459528666|FG002|Overall Study|Adverse Event|0|||
127699333|NCT03158129|459528667|FG003|Overall Study|Adverse Event|0|||
127699334|NCT03158129|459528664|FG000|Overall Study|Death|0|||
127699335|NCT03158129|459528665|FG001|Overall Study|Death|0|||
127699336|NCT03158129|459528666|FG002|Overall Study|Death|0|||
127699337|NCT03158129|459528667|FG003|Overall Study|Death|1|||
127699338|NCT03158129|459528664|FG000|Overall Study|High surgical risk|1|||
127699339|NCT03158129|459528665|FG001|Overall Study|High surgical risk|1|||
127699340|NCT03158129|459528666|FG002|Overall Study|High surgical risk|0|||
127699341|NCT03158129|459528667|FG003|Overall Study|High surgical risk|0|||
127699342|NCT03158129|459528664|FG000|Overall Study|Progression|1|||
127699343|NCT03158129|459528665|FG001|Overall Study|Progression|1|||
127699344|NCT03158129|459528666|FG002|Overall Study|Progression|0|||
127699345|NCT03158129|459528667|FG003|Overall Study|Progression|0|||
127699346|NCT03158129|459528664|FG000|Overall Study|Lack of resectability|0|||
127699347|NCT03158129|459528665|FG001|Overall Study|Lack of resectability|1|||
127699348|NCT03158129|459528666|FG002|Overall Study|Lack of resectability|0|||
127699349|NCT03158129|459528667|FG003|Overall Study|Lack of resectability|0|||
127699350|NCT03158129|459528664|FG000|Overall Study|Declined surgery|0|||
127699351|NCT03158129|459528665|FG001|Overall Study|Declined surgery|1|||
127699352|NCT03158129|459528666|FG002|Overall Study|Declined surgery|0|||
127699353|NCT03158129|459528667|FG003|Overall Study|Declined surgery|0|||
127699354|NCT03158129|459528664|FG000|Overall Study|No longer surgical candidate|0|||
127699355|NCT03158129|459528665|FG001|Overall Study|No longer surgical candidate|0|||
127699356|NCT03158129|459528666|FG002|Overall Study|No longer surgical candidate|0|||
127699357|NCT03158129|459528667|FG003|Overall Study|No longer surgical candidate|1|||
127699358|NCT02577835|459528668|FG000|Overall Study|Ambulatory blood pressure recordings were not valid for the analysis|142|||
127699359|NCT04342494|459528669|FG000|Overall Study|Questionnaire partially completed|1|||
127699360|NCT04342494|459528670|FG001|Overall Study|Questionnaire partially completed|0|||
127699361|NCT04342494|459528671|FG002|Overall Study|Questionnaire partially completed|2|||
127699362|NCT04342494|459528672|FG003|Overall Study|Questionnaire partially completed|0|||
127699363|NCT04342494|459528673|FG004|Overall Study|Questionnaire partially completed|1|||
127699364|NCT04342494|459528669|FG000|Overall Study|Lost to Follow-up|49|||
127699365|NCT04342494|459528670|FG001|Overall Study|Lost to Follow-up|38|||
127699366|NCT04342494|459528671|FG002|Overall Study|Lost to Follow-up|34|||
127699367|NCT04342494|459528672|FG003|Overall Study|Lost to Follow-up|34|||
127699368|NCT04342494|459528673|FG004|Overall Study|Lost to Follow-up|35|||
127699369|NCT04806451|459528674|FG000|DB Treatment Period (28 Weeks)|Withdrawal by Subject|3|||
127699370|NCT04806451|459528675|FG001|DB Treatment Period (28 Weeks)|Withdrawal by Subject|1|||
127699371|NCT04806451|459528674|FG000|DB Treatment Period (28 Weeks)|Adverse Event|0|||
127699372|NCT04806451|459528675|FG001|DB Treatment Period (28 Weeks)|Adverse Event|2|||
127699373|NCT04806451|459528674|FG000|OL Treatment Period (24 Weeks)|Ongoing in the Study|16|||
127699374|NCT04806451|459528675|FG001|OL Treatment Period (24 Weeks)|Ongoing in the Study|37|||
127790360|NCT01834274|459857062|FG001|Overall Study|Lost to Follow-up|1|||
127790361|NCT01834274|459857061|FG000|Overall Study|Other|2|||
127790362|NCT01834274|459857062|FG001|Overall Study|Other|1|||
127790363|NCT02813694|459857071|FG000|Overall Study|Physician Decision|0|||
127790364|NCT02813694|459857072|FG001|Overall Study|Physician Decision|1|||
127790365|NCT02813694|459857071|FG000|Overall Study|Withdrawal by Subject|10|||
127790366|NCT02813694|459857072|FG001|Overall Study|Withdrawal by Subject|9|||
127790367|NCT02813694|459857071|FG000|Overall Study|Lost to Follow-up|1|||
127790368|NCT02813694|459857072|FG001|Overall Study|Lost to Follow-up|1|||
127790369|NCT02813694|459857071|FG000|Overall Study|Death|3|||
127790370|NCT02813694|459857072|FG001|Overall Study|Death|3|||
127790371|NCT02813694|459857071|FG000|Overall Study|Randomized- did not receive study drug|2|||
127790372|NCT02813694|459857072|FG001|Overall Study|Randomized- did not receive study drug|0|||
127790373|NCT02813694|459857071|FG000|Overall Study|Patient hospitalized|1|||
127790374|NCT02813694|459857072|FG001|Overall Study|Patient hospitalized|0|||
127790375|NCT01265797|459857075|FG000|Run-in Month|Withdrawal by Subject|0|||
127790376|NCT01265797|459857076|FG001|Run-in Month|Withdrawal by Subject|4|||
127790377|NCT01265797|459857075|FG000|Run-in Month|1st seizure during run-in month|0|||
127790378|NCT01265797|459857076|FG001|Run-in Month|1st seizure during run-in month|1|||
127790379|NCT01265797|459857075|FG000|Blinded Month|Lack of Efficacy|5|||
127790380|NCT01265797|459857076|FG001|Blinded Month|Lack of Efficacy|0|||
127790381|NCT01265797|459857075|FG000|Blinded Month|Lost to Follow-up|1|||
127790382|NCT01265797|459857076|FG001|Blinded Month|Lost to Follow-up|0|||
127790383|NCT01265797|459857075|FG000|Blinded Month|Protocol Violation|2|||
127790384|NCT01265797|459857076|FG001|Blinded Month|Protocol Violation|1|||
127790385|NCT01265797|459857075|FG000|Blinded Month|Adverse Event|2|||
127790386|NCT01265797|459857076|FG001|Blinded Month|Adverse Event|0|||
127790387|NCT01265797|459857075|FG000|Blinded Month|Diary data incomplete|0|||
127790388|NCT01265797|459857076|FG001|Blinded Month|Diary data incomplete|1|||
127790389|NCT01265797|459857075|FG000|Open Label Month|Lost to Follow-up|0|||
127790390|NCT01265797|459857076|FG001|Open Label Month|Lost to Follow-up|1|||
127790391|NCT02980224|459857077|FG000|Overall Study|Adverse Event|4|||
127790392|NCT02980224|459857078|FG001|Overall Study|Adverse Event|1|||
127790393|NCT02980224|459857077|FG000|Overall Study|Withdrawal by Subject|0|||
127790394|NCT02980224|459857078|FG001|Overall Study|Withdrawal by Subject|2|||
127790395|NCT00606320|459857079|FG000|Overall Study|Adverse Event|3|||
127790396|NCT00606320|459857079|FG000|Overall Study|Lack of Efficacy|5|||
127790397|NCT00606320|459857079|FG000|Overall Study|Physician Decision|7|||
127790398|NCT00606320|459857079|FG000|Overall Study|Protocol Violation|8|||
127790399|NCT00606320|459857079|FG000|Overall Study|Withdrawal by Subject|10|||
127790400|NCT00606320|459857079|FG000|Overall Study|Progression to depressive phase|4|||
127883783|NCT03496207|460197914|FG004|Extension Period|Adverse Event|1|||
127790401|NCT04839380|459857080|FG000|Overall Study|Withdrawal by Subject|2|||
127790402|NCT04839380|459857080|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
127790403|NCT01087905|459857081|FG000|Overall Study|Lost to Follow-up|24|||
127790404|NCT01087905|459857082|FG001|Overall Study|Lost to Follow-up|28|||
127790405|NCT01087905|459857083|FG002|Overall Study|Lost to Follow-up|18|||
127790406|NCT01087905|459857084|FG003|Overall Study|Lost to Follow-up|31|||
127790407|NCT01087905|459857085|FG004|Overall Study|Lost to Follow-up|27|||
127790408|NCT01087905|459857086|FG005|Overall Study|Lost to Follow-up|25|||
127790409|NCT01087905|459857087|FG006|Overall Study|Lost to Follow-up|20|||
127790410|NCT01087905|459857088|FG007|Overall Study|Lost to Follow-up|24|||
127790411|NCT01087905|459857081|FG000|Overall Study|Withdrawal by Subject|5|||
127790412|NCT01087905|459857082|FG001|Overall Study|Withdrawal by Subject|4|||
127790413|NCT01087905|459857083|FG002|Overall Study|Withdrawal by Subject|4|||
127790414|NCT01087905|459857084|FG003|Overall Study|Withdrawal by Subject|5|||
127790415|NCT01087905|459857085|FG004|Overall Study|Withdrawal by Subject|4|||
127790416|NCT01087905|459857086|FG005|Overall Study|Withdrawal by Subject|3|||
127614218|NCT01228747|459217841|FG001|Overall Study|Lost to Follow-up|3|||
127614219|NCT01228747|459217840|FG000|Overall Study|Withdrawal by Subject|5|||
127614220|NCT01228747|459217841|FG001|Overall Study|Withdrawal by Subject|1|||
127614221|NCT01228747|459217840|FG000|Overall Study|Other Reason|2|||
127614222|NCT01228747|459217841|FG001|Overall Study|Other Reason|5|||
127614223|NCT02036502|459217842|FG000|Part 1:Dose Determination/Escalation|Death|3|||
127614224|NCT02036502|459217843|FG001|Part 1:Dose Determination/Escalation|Death|2|||
127614225|NCT02036502|459217844|FG002|Part 1:Dose Determination/Escalation|Death|0|||
127614226|NCT02036502|459217845|FG003|Part 1:Dose Determination/Escalation|Death|0|||
127883784|NCT03496207|460197910|FG000|Extension Period|Death|1|||
127883785|NCT03496207|460197911|FG001|Extension Period|Death|0|||
127883786|NCT03496207|460197912|FG002|Extension Period|Death|0|||
127883787|NCT03496207|460197913|FG003|Extension Period|Death|1|||
127883788|NCT03496207|460197914|FG004|Extension Period|Death|2|||
127883789|NCT03496207|460197910|FG000|Extension Period|Withdrawal by Subject|1|||
127883790|NCT03496207|460197911|FG001|Extension Period|Withdrawal by Subject|0|||
127883791|NCT03496207|460197912|FG002|Extension Period|Withdrawal by Subject|0|||
127883792|NCT03496207|460197913|FG003|Extension Period|Withdrawal by Subject|1|||
127883793|NCT03496207|460197914|FG004|Extension Period|Withdrawal by Subject|1|||
127883794|NCT03496207|460197910|FG000|Extension Period|Elevated hemoglobin levels|0|||
127883795|NCT03496207|460197911|FG001|Extension Period|Elevated hemoglobin levels|0|||
127883796|NCT03496207|460197912|FG002|Extension Period|Elevated hemoglobin levels|0|||
127883797|NCT03496207|460197913|FG003|Extension Period|Elevated hemoglobin levels|0|||
127883798|NCT03496207|460197914|FG004|Extension Period|Elevated hemoglobin levels|1|||
127883799|NCT00810615|460197917|FG000|Overall Study|Withdrawal by Subject|1|||
127883800|NCT00810615|460197918|FG001|Overall Study|Withdrawal by Subject|1|||
127883801|NCT02525562|460197919|FG000|Overall Study|Death|9|||
127883802|NCT02525562|460197920|FG001|Overall Study|Death|0|||
127883803|NCT02525562|460197921|FG002|Overall Study|Death|0|||
127883804|NCT02525562|460197919|FG000|Overall Study|Lost to Follow-up|19|||
127883805|NCT02525562|460197920|FG001|Overall Study|Lost to Follow-up|0|||
127883806|NCT02525562|460197921|FG002|Overall Study|Lost to Follow-up|0|||
127883807|NCT02525562|460197919|FG000|Overall Study|Withdrawal by Subject|37|||
127883808|NCT02525562|460197920|FG001|Overall Study|Withdrawal by Subject|0|||
127883809|NCT02525562|460197921|FG002|Overall Study|Withdrawal by Subject|0|||
127883810|NCT02525562|460197919|FG000|Overall Study|Revision/Removal of Study Device|4|||
127883811|NCT02525562|460197920|FG001|Overall Study|Revision/Removal of Study Device|0|||
127883812|NCT02525562|460197921|FG002|Overall Study|Revision/Removal of Study Device|0|||
127883813|NCT02525562|460197919|FG000|Overall Study|Study Closed by Sponsor|154|||
127883814|NCT02525562|460197920|FG001|Overall Study|Study Closed by Sponsor|0|||
127883815|NCT02525562|460197921|FG002|Overall Study|Study Closed by Sponsor|0|||
127883816|NCT02567266|460197922|FG000|Overall Study|Withdrawal by Subject|10|||
127883817|NCT02567266|460197923|FG001|Overall Study|Withdrawal by Subject|7|||
127883818|NCT02567266|460197924|FG002|Overall Study|Withdrawal by Subject|6|||
127883819|NCT02567266|460197922|FG000|Overall Study|Lost to Follow-up|13|||
127883820|NCT02567266|460197923|FG001|Overall Study|Lost to Follow-up|8|||
127883821|NCT02567266|460197924|FG002|Overall Study|Lost to Follow-up|10|||
127883822|NCT02164539|460197925|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
127883823|NCT02164539|460197926|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
127883824|NCT02164539|460197927|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
127883825|NCT02164539|460197928|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
127883826|NCT02164539|460197929|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
127883827|NCT02164539|460197930|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
127883828|NCT02164539|460197931|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
127883829|NCT02164539|460197925|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
127883830|NCT02164539|460197926|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
127883831|NCT02164539|460197927|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
127883832|NCT02164539|460197928|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
127883833|NCT02164539|460197929|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
127883834|NCT02164539|460197930|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
127883835|NCT02164539|460197931|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
127883836|NCT02164539|460197925|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
127883837|NCT02164539|460197926|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
127883838|NCT02164539|460197927|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
127883839|NCT02164539|460197928|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
127883840|NCT02164539|460197929|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
127883841|NCT02164539|460197930|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
127883842|NCT02164539|460197931|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
127883843|NCT02164539|460197925|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
127883844|NCT02164539|460197926|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
127883845|NCT02164539|460197927|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
127883846|NCT02164539|460197928|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
127883847|NCT02164539|460197929|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
127883848|NCT02164539|460197930|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
127883849|NCT02164539|460197931|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
127883850|NCT02164539|460197925|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
127883851|NCT02164539|460197926|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
127883852|NCT02164539|460197927|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
127883853|NCT02164539|460197928|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
127883854|NCT02164539|460197929|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
127790417|NCT01087905|459857087|FG006|Overall Study|Withdrawal by Subject|3|||
127790418|NCT01087905|459857088|FG007|Overall Study|Withdrawal by Subject|5|||
127790419|NCT01347554|459857089|FG000|Overall Study|Lack of Efficacy|7|||
127790420|NCT01347554|459857090|FG001|Overall Study|Lack of Efficacy|11|||
127790421|NCT02937818|459857094|FG000|Overall Study|Participants decision|2|||
127790422|NCT02937818|459857095|FG001|Overall Study|Participants decision|1|||
127790423|NCT02937818|459857096|FG002|Overall Study|Participants decision|1|||
127790424|NCT02937818|459857097|FG003|Overall Study|Participants decision|1|||
127790425|NCT02937818|459857094|FG000|Overall Study|Adverse Event|2|||
127790426|NCT02937818|459857095|FG001|Overall Study|Adverse Event|4|||
127790427|NCT02937818|459857096|FG002|Overall Study|Adverse Event|1|||
127790428|NCT02937818|459857097|FG003|Overall Study|Adverse Event|1|||
127790429|NCT02937818|459857094|FG000|Overall Study|Disease progression|17|||
127790430|NCT02937818|459857095|FG001|Overall Study|Disease progression|15|||
127790431|NCT02937818|459857096|FG002|Overall Study|Disease progression|7|||
127790432|NCT02937818|459857097|FG003|Overall Study|Disease progression|19|||
127790433|NCT02937818|459857094|FG000|Overall Study|Condition under investigation worsened|0|||
127790434|NCT02937818|459857095|FG001|Overall Study|Condition under investigation worsened|0|||
127790435|NCT02937818|459857096|FG002|Overall Study|Condition under investigation worsened|1|||
127790436|NCT02937818|459857097|FG003|Overall Study|Condition under investigation worsened|0|||
127790437|NCT00205855|459857100|FG000|Overall Study|Only received temporary implants|16|||
127790438|NCT00205855|459857100|FG000|Overall Study|Withdrawal by Subject|5|||
127790439|NCT05513625|459857101|FG000|Overall Study|Withdrawal by Subject|1|||
127790440|NCT01015768|459857102|FG000|Overall Study|Some subject data unuseable|4|||
127790441|NCT01015768|459857103|FG001|Overall Study|Some subject data unuseable|4|||
127790442|NCT01505634|459857108|FG000|Overall Study|Withdrawal by Subject|2|||
127790443|NCT01505634|459857109|FG001|Overall Study|Withdrawal by Subject|5|||
127790444|NCT01505634|459857110|FG002|Overall Study|Withdrawal by Subject|1|||
127790445|NCT01505634|459857108|FG000|Overall Study|Physician Decision|1|||
127790446|NCT01505634|459857109|FG001|Overall Study|Physician Decision|1|||
127790447|NCT01505634|459857110|FG002|Overall Study|Physician Decision|0|||
127790448|NCT01505634|459857108|FG000|Overall Study|Adverse Event|1|||
127790449|NCT01505634|459857109|FG001|Overall Study|Adverse Event|0|||
127790450|NCT01505634|459857110|FG002|Overall Study|Adverse Event|0|||
127790451|NCT01505634|459857108|FG000|Overall Study|Insufficient supply of drug at site|1|||
127790452|NCT01505634|459857109|FG001|Overall Study|Insufficient supply of drug at site|0|||
127790453|NCT01505634|459857110|FG002|Overall Study|Insufficient supply of drug at site|0|||
127790454|NCT01505634|459857108|FG000|Overall Study|Protocol Violation|2|||
127790455|NCT01505634|459857109|FG001|Overall Study|Protocol Violation|0|||
127790456|NCT01505634|459857110|FG002|Overall Study|Protocol Violation|0|||
127790457|NCT01505634|459857108|FG000|Overall Study|Lost to Follow-up|1|||
127790458|NCT01505634|459857109|FG001|Overall Study|Lost to Follow-up|4|||
127790459|NCT01505634|459857110|FG002|Overall Study|Lost to Follow-up|4|||
127790460|NCT01505634|459857108|FG000|Overall Study|Death|1|||
127790461|NCT01505634|459857109|FG001|Overall Study|Death|0|||
127790462|NCT01505634|459857110|FG002|Overall Study|Death|0|||
127790463|NCT01505634|459857108|FG000|Overall Study|In a conflict zone|0|||
127790464|NCT01505634|459857109|FG001|Overall Study|In a conflict zone|0|||
127790465|NCT01505634|459857110|FG002|Overall Study|In a conflict zone|1|||
127790466|NCT02054897|459857111|FG000|Overall Study|Withdrawal by Subject|2|||
127790467|NCT02054897|459857112|FG001|Overall Study|Withdrawal by Subject|0|||
127790468|NCT02054897|459857113|FG002|Overall Study|Withdrawal by Subject|2|||
127790469|NCT02054897|459857111|FG000|Overall Study|Missing follow-up information|3|||
127790470|NCT02054897|459857112|FG001|Overall Study|Missing follow-up information|5|||
127790471|NCT02054897|459857113|FG002|Overall Study|Missing follow-up information|3|||
127790472|NCT02054897|459857111|FG000|Overall Study|Lost to Follow-up|4|||
127790473|NCT02054897|459857112|FG001|Overall Study|Lost to Follow-up|2|||
127790474|NCT02054897|459857113|FG002|Overall Study|Lost to Follow-up|7|||
127790475|NCT02054897|459857111|FG000|Overall Study|Randomized but not exposed|1|||
127790476|NCT02054897|459857112|FG001|Overall Study|Randomized but not exposed|0|||
127790477|NCT02054897|459857113|FG002|Overall Study|Randomized but not exposed|0|||
127790478|NCT00794157|459857114|FG000|Overall Study|Adverse Event|4|||
127790479|NCT00794157|459857115|FG001|Overall Study|Adverse Event|1|||
127790480|NCT00794157|459857116|FG002|Overall Study|Adverse Event|8|||
127790481|NCT00794157|459857114|FG000|Overall Study|Subject withdrew consent|2|||
127790482|NCT00794157|459857115|FG001|Overall Study|Subject withdrew consent|0|||
127790483|NCT00794157|459857116|FG002|Overall Study|Subject withdrew consent|3|||
127790484|NCT00794157|459857114|FG000|Overall Study|Lost to Follow-up|2|||
127790485|NCT00794157|459857115|FG001|Overall Study|Lost to Follow-up|0|||
127790486|NCT00794157|459857116|FG002|Overall Study|Lost to Follow-up|1|||
127790487|NCT00794157|459857114|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
127790488|NCT00794157|459857115|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
127790489|NCT00794157|459857116|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
127790490|NCT00794157|459857114|FG000|Overall Study|Administrative problems|1|||
127790491|NCT00794157|459857115|FG001|Overall Study|Administrative problems|7|||
127790492|NCT00794157|459857116|FG002|Overall Study|Administrative problems|4|||
127790493|NCT00794157|459857114|FG000|Overall Study|Abnormal test procedure result(s)|0|||
127699375|NCT05835336|459528676|FG000|Overall Study|Withdrawal by Subject|5|||
127699376|NCT05835336|459528676|FG000|Overall Study|Did not complete the personalization process|3|||
127699377|NCT02979522|459528677|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
127699378|NCT02979522|459528678|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
127699379|NCT02979522|459528677|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
127699380|NCT02979522|459528678|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
127699381|NCT03199469|459528682|FG000|Overall Study|Randomized, not treated|0|||
127699382|NCT03199469|459528683|FG001|Overall Study|Randomized, not treated|3|||
127699383|NCT03199469|459528682|FG000|Overall Study|Withdrawal by Subject|1|||
127699384|NCT03199469|459528683|FG001|Overall Study|Withdrawal by Subject|0|||
127699385|NCT03199469|459528682|FG000|Overall Study|Death|1|||
127699386|NCT03199469|459528683|FG001|Overall Study|Death|3|||
127699387|NCT03199469|459528682|FG000|Overall Study|Ongoing|5|||
127699388|NCT03199469|459528683|FG001|Overall Study|Ongoing|14|||
127699389|NCT05453773|459528687|FG000|Overall Study|Withdrawal by Subject|3|||
127699390|NCT05453773|459528687|FG000|Overall Study|Lost to Follow-up|3|||
127699391|NCT05453773|459528687|FG000|Overall Study|Difficult Blood Draw|3|||
127699392|NCT02023866|459528690|FG000|Overall Study|Non-compliance|2|||
127699393|NCT02023866|459528690|FG000|Overall Study|Adverse Event|3|||
127699394|NCT02023866|459528690|FG000|Overall Study|Withdrawal by Subject|1|||
127699395|NCT04683744|459528691|FG000|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
127699396|NCT04683744|459528692|FG001|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
127699397|NCT04683744|459528693|FG002|Overall Study|withdrawn (determined not eligible after enrollment)|1|||
127699398|NCT04963270|459528695|FG000|Double-Blind Period (24 Weeks)|Adverse Event|1|||
127699399|NCT04963270|459528696|FG001|Double-Blind Period (24 Weeks)|Adverse Event|2|||
127699400|NCT04963270|459528697|FG002|Double-Blind Period (24 Weeks)|Adverse Event|0|||
127699401|NCT04963270|459528698|FG003|Double-Blind Period (24 Weeks)|Adverse Event|0|||
127699402|NCT04963270|459528695|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
127699403|NCT04963270|459528696|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|1|||
127790494|NCT00794157|459857115|FG001|Overall Study|Abnormal test procedure result(s)|1|||
127790495|NCT00794157|459857116|FG002|Overall Study|Abnormal test procedure result(s)|0|||
127790496|NCT00794157|459857114|FG000|Overall Study|Protocol deviation|0|||
127790497|NCT00794157|459857115|FG001|Overall Study|Protocol deviation|1|||
127790498|NCT00794157|459857116|FG002|Overall Study|Protocol deviation|1|||
127790499|NCT01692275|459857117|FG000|Overall Study|Lost to Follow-up|57|||
127790500|NCT01692275|459857118|FG001|Overall Study|Lost to Follow-up|48|||
127790501|NCT01692275|459857117|FG000|Overall Study|Withdrawal by Subject|9|||
127790502|NCT01692275|459857118|FG001|Overall Study|Withdrawal by Subject|11|||
127790503|NCT00361270|459857121|FG000|Overall Study|Death|0|||
127790504|NCT00361270|459857122|FG001|Overall Study|Death|0|||
127790505|NCT00361270|459857123|FG002|Overall Study|Death|0|||
127790506|NCT00361270|459857124|FG003|Overall Study|Death|2|||
127790507|NCT00361270|459857121|FG000|Overall Study|Lost to Follow-up|4|||
127790508|NCT00361270|459857122|FG001|Overall Study|Lost to Follow-up|1|||
127790509|NCT00361270|459857123|FG002|Overall Study|Lost to Follow-up|0|||
127790510|NCT00361270|459857124|FG003|Overall Study|Lost to Follow-up|0|||
127790511|NCT00361270|459857121|FG000|Overall Study|Physician Decision|0|||
127790512|NCT00361270|459857122|FG001|Overall Study|Physician Decision|0|||
127790513|NCT00361270|459857123|FG002|Overall Study|Physician Decision|1|||
127790514|NCT00361270|459857124|FG003|Overall Study|Physician Decision|0|||
127790515|NCT00361270|459857121|FG000|Overall Study|Protocol Violation|9|||
127790516|NCT00361270|459857122|FG001|Overall Study|Protocol Violation|4|||
127790517|NCT00361270|459857123|FG002|Overall Study|Protocol Violation|5|||
127790518|NCT00361270|459857124|FG003|Overall Study|Protocol Violation|4|||
127790519|NCT00361270|459857121|FG000|Overall Study|Withdrawal by Subject|6|||
127790520|NCT00361270|459857122|FG001|Overall Study|Withdrawal by Subject|6|||
127790521|NCT00361270|459857123|FG002|Overall Study|Withdrawal by Subject|3|||
127790522|NCT00361270|459857124|FG003|Overall Study|Withdrawal by Subject|7|||
127790523|NCT00361270|459857121|FG000|Overall Study|Afraid of Hypnosis|1|||
127790524|NCT00361270|459857122|FG001|Overall Study|Afraid of Hypnosis|2|||
127790525|NCT00361270|459857123|FG002|Overall Study|Afraid of Hypnosis|0|||
127790526|NCT00361270|459857124|FG003|Overall Study|Afraid of Hypnosis|0|||
127790527|NCT00361270|459857121|FG000|Overall Study|Problems with Transportation|4|||
127790528|NCT00361270|459857122|FG001|Overall Study|Problems with Transportation|0|||
127790529|NCT00361270|459857123|FG002|Overall Study|Problems with Transportation|0|||
127790530|NCT00361270|459857124|FG003|Overall Study|Problems with Transportation|0|||
127790531|NCT00361270|459857121|FG000|Overall Study|Adverse Event|0|||
127699404|NCT04963270|459528697|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
127699405|NCT04963270|459528698|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
127699406|NCT04963270|459528695|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
127790532|NCT00361270|459857122|FG001|Overall Study|Adverse Event|1|||
127790533|NCT00361270|459857123|FG002|Overall Study|Adverse Event|1|||
127790534|NCT00361270|459857124|FG003|Overall Study|Adverse Event|0|||
127790535|NCT00677014|459857126|FG000|Overall Study|Lost to Follow-up|20|||
127790536|NCT00677014|459857127|FG001|Overall Study|Lost to Follow-up|12|||
127699407|NCT04963270|459528696|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
127699408|NCT04963270|459528697|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
127699409|NCT04963270|459528698|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
127699410|NCT04963270|459528695|FG000|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|2|||
127699411|NCT04963270|459528696|FG001|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
127699412|NCT04963270|459528697|FG002|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
127699413|NCT04963270|459528698|FG003|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
127699414|NCT04963270|459528695|FG000|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
127699415|NCT04963270|459528696|FG001|Double-Blind Period (24 Weeks)|Reason Not Specified|1|||
127699416|NCT04963270|459528697|FG002|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
127699417|NCT04963270|459528698|FG003|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
127699418|NCT04963270|459528695|FG000|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
127699419|NCT04963270|459528696|FG001|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
127699420|NCT04963270|459528697|FG002|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
127699421|NCT04963270|459528698|FG003|Open Label Extension Period (92 Weeks)|Lack of Efficacy|1|||
127699422|NCT04963270|459528695|FG000|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
127699423|NCT04963270|459528696|FG001|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
127699424|NCT04963270|459528697|FG002|Open Label Extension Period (92 Weeks)|Lost to Follow-up|2|||
127699425|NCT04963270|459528698|FG003|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
127699426|NCT04963270|459528695|FG000|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
127790537|NCT00677014|459857128|FG002|Overall Study|Lost to Follow-up|24|||
127790538|NCT00677014|459857126|FG000|Overall Study|Death|6|||
127790539|NCT00677014|459857127|FG001|Overall Study|Death|15|||
127790540|NCT00677014|459857128|FG002|Overall Study|Death|7|||
127790541|NCT00677014|459857126|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
127790542|NCT00677014|459857127|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
127790543|NCT00677014|459857128|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
127790544|NCT00640328|459857129|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
127790545|NCT00640328|459857130|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
127790546|NCT00640328|459857131|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
127790547|NCT00640328|459857132|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
127790548|NCT00640328|459857133|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
127790549|NCT00640328|459857134|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
127790550|NCT00640328|459857129|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
127790551|NCT00640328|459857130|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
127790552|NCT00640328|459857131|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
127790553|NCT00640328|459857132|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
127790554|NCT00640328|459857133|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
127790555|NCT00640328|459857134|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
127790556|NCT00640328|459857129|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
127790557|NCT00640328|459857130|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
127790558|NCT00640328|459857131|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
127790559|NCT00640328|459857132|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
127790560|NCT00640328|459857133|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
127790561|NCT00640328|459857134|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
127790562|NCT00640328|459857129|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
127790563|NCT00640328|459857130|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
127790564|NCT00640328|459857131|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
127790565|NCT00640328|459857132|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
127790566|NCT00640328|459857133|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
127790567|NCT00640328|459857134|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
127790568|NCT02374099|459857135|FG000|Overall Study|Adverse Event|1|||
127790569|NCT02374099|459857136|FG001|Overall Study|Adverse Event|0|||
127790570|NCT02374099|459857135|FG000|Overall Study|Progressive Disease|35|||
127790571|NCT02374099|459857136|FG001|Overall Study|Progressive Disease|40|||
127790572|NCT02374099|459857135|FG000|Overall Study|Withdrawal by Subject|5|||
127790573|NCT02374099|459857136|FG001|Overall Study|Withdrawal by Subject|1|||
127790574|NCT02374099|459857135|FG000|Overall Study|Miscellaneous|2|||
127790575|NCT02374099|459857136|FG001|Overall Study|Miscellaneous|3|||
127790576|NCT02374099|459857135|FG000|Overall Study|Randomized, but not treated|2|||
127790577|NCT02374099|459857136|FG001|Overall Study|Randomized, but not treated|1|||
127790578|NCT02374099|459857135|FG000|Overall Study|Study Terminated by Sponsor|3|||
127790579|NCT02374099|459857136|FG001|Overall Study|Study Terminated by Sponsor|4|||
127699427|NCT04963270|459528696|FG001|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
127699428|NCT04963270|459528697|FG002|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|2|||
127699429|NCT04963270|459528698|FG003|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|6|||
127699430|NCT04963270|459528695|FG000|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
127883855|NCT02164539|460197930|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
127883856|NCT02164539|460197931|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
127883857|NCT02164539|460197925|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
127883858|NCT02164539|460197926|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
127883859|NCT02164539|460197927|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
127883860|NCT02164539|460197928|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
127883861|NCT02164539|460197929|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
127883862|NCT02164539|460197930|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
127883863|NCT02164539|460197931|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
127883864|NCT01255722|460197932|FG000|Overall Study|Adverse Event|0|||
127883865|NCT01255722|460197933|FG001|Overall Study|Adverse Event|1|||
127883866|NCT01255722|460197934|FG002|Overall Study|Adverse Event|1|||
127883867|NCT01255722|460197932|FG000|Overall Study|asymptomatic patient|1|||
127883868|NCT01255722|460197933|FG001|Overall Study|asymptomatic patient|0|||
127883869|NCT01255722|460197934|FG002|Overall Study|asymptomatic patient|0|||
127883870|NCT01255722|460197932|FG000|Overall Study|beta-blocker contraindicated|2|||
127883871|NCT01255722|460197933|FG001|Overall Study|beta-blocker contraindicated|0|||
127883872|NCT01255722|460197934|FG002|Overall Study|beta-blocker contraindicated|0|||
127883873|NCT02643966|460197935|FG000|First Screening Round|ineligible|1|||
127883874|NCT02643966|460197935|FG000|First Screening Round|excluded from analysis|2|||
127883875|NCT02643966|460197935|FG000|First Screening Round|Lost to Follow-up|56|||
127883876|NCT02643966|460197935|FG000|First Screening Round|Withdrawal by Subject|28|||
127883877|NCT02643966|460197935|FG000|First Screening Round|Death|1|||
127883878|NCT02643966|460197935|FG000|Between First and Second Screening|Lost to Follow-up|65|||
127883879|NCT02643966|460197935|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
127883880|NCT02643966|460197935|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
127883881|NCT02643966|460197935|FG000|Second Screening Round|Withdrawal by Subject|20|||
127883882|NCT02643966|460197935|FG000|Second Screening Round|Lost to Follow-up|57|||
127883883|NCT02643966|460197935|FG000|Second Screening Round|Physician Decision|2|||
127883884|NCT02643966|460197935|FG000|Second Screening Round|Death|4|||
127883885|NCT02643966|460197935|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
127883886|NCT02643966|460197935|FG000|Between Second and Third Screening|Death|1|||
127883887|NCT02643966|460197935|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
127883888|NCT02643966|460197935|FG000|Third Screening Round|PI excluded|2|||
127883889|NCT02643966|460197935|FG000|Third Screening Round|Lost to Follow-up|241|||
127883890|NCT01612702|460197938|FG000|Overall Study|Protocol Violation|11|||
127883891|NCT01612702|460197939|FG001|Overall Study|Protocol Violation|11|||
127883892|NCT01542736|460197940|FG000|Overall Study|Death|1|||
127883893|NCT02400905|460197941|FG000|Overall Study|Death|24|||
127883894|NCT02400905|460197941|FG000|Overall Study|Lost to Follow-up|18|||
127883895|NCT02400905|460197941|FG000|Overall Study|Withdrawal by Subject|16|||
127883896|NCT02400905|460197941|FG000|Overall Study|Physician Decision|4|||
127883897|NCT02400905|460197941|FG000|Overall Study|Other|1|||
127883898|NCT03091400|460197942|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
127883899|NCT03091400|460197943|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
127883900|NCT00420849|460197948|FG000|Overall Study|Lack of Efficacy|154|||
127883901|NCT00420849|460197948|FG000|Overall Study|Adverse Event|107|||
127883902|NCT00420849|460197948|FG000|Overall Study|Withdrawal by Subject|28|||
127883903|NCT00420849|460197948|FG000|Overall Study|Death|18|||
127883904|NCT00420849|460197948|FG000|Overall Study|Other|14|||
127883905|NCT00420849|460197948|FG000|Overall Study|Transplant|8|||
127883906|NCT00420849|460197948|FG000|Overall Study|Protocol Violation|1|||
127883907|NCT00420849|460197948|FG000|Overall Study|Lost to Follow-up|1|||
127883908|NCT00944125|460197949|FG000|3 to 6 Months|Withdrawal by Subject|0|||
127883909|NCT00944125|460197950|FG001|3 to 6 Months|Withdrawal by Subject|2|||
127883910|NCT00944125|460197949|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
127883911|NCT00944125|460197950|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
127614227|NCT02036502|459217846|FG004|Part 1:Dose Determination/Escalation|Death|0|||
127614228|NCT02036502|459217847|FG005|Part 1:Dose Determination/Escalation|Death|0|||
127614229|NCT02036502|459217848|FG006|Part 1:Dose Determination/Escalation|Death|0|||
127614230|NCT02036502|459217849|FG007|Part 1:Dose Determination/Escalation|Death|0|||
127614231|NCT02036502|459217842|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
127614232|NCT02036502|459217843|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
127614233|NCT02036502|459217844|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
127883912|NCT00446134|460197951|FG000|Overall Study|Adverse Event|7|||
127883913|NCT00446134|460197952|FG001|Overall Study|Adverse Event|17|||
127883914|NCT00446134|460197953|FG002|Overall Study|Adverse Event|13|||
127883915|NCT00446134|460197954|FG003|Overall Study|Adverse Event|18|||
127883916|NCT00446134|460197951|FG000|Overall Study|Lack of Efficacy|19|||
127883917|NCT00446134|460197952|FG001|Overall Study|Lack of Efficacy|19|||
127614234|NCT02036502|459217845|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
127614235|NCT02036502|459217846|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
127614236|NCT02036502|459217847|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
127614237|NCT02036502|459217848|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
127614238|NCT02036502|459217849|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
127614239|NCT02036502|459217842|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
127614240|NCT02036502|459217843|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
127699431|NCT04963270|459528696|FG001|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
127699432|NCT04963270|459528697|FG002|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
127699433|NCT04963270|459528698|FG003|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
127699434|NCT04963270|459528695|FG000|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
127699435|NCT04963270|459528696|FG001|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
127699436|NCT04963270|459528697|FG002|Open Label Extension Period (92 Weeks)|Pregnancy|1|||
127699437|NCT04963270|459528698|FG003|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
127699438|NCT04963270|459528695|FG000|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
127699439|NCT04963270|459528696|FG001|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
127699440|NCT04963270|459528697|FG002|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|82|||
127699441|NCT04963270|459528698|FG003|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|81|||
127699442|NCT04963270|459528695|FG000|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
127699443|NCT04963270|459528696|FG001|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
127699444|NCT04963270|459528697|FG002|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
127614241|NCT02036502|459217844|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
127614242|NCT02036502|459217845|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
127614243|NCT02036502|459217846|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
127614244|NCT02036502|459217847|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
127614245|NCT02036502|459217848|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
127614246|NCT02036502|459217849|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
127614247|NCT02036502|459217842|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
127614248|NCT02036502|459217843|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
127614249|NCT02036502|459217844|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
127614250|NCT02036502|459217845|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
127614251|NCT02036502|459217846|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
127614252|NCT02036502|459217847|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
127614253|NCT02036502|459217848|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
127614254|NCT02036502|459217849|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
127614255|NCT02036502|459217842|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
127614256|NCT02036502|459217843|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
127614257|NCT02036502|459217844|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
127614258|NCT02036502|459217845|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
127614259|NCT02036502|459217846|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
127614260|NCT02036502|459217847|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
127614261|NCT02036502|459217848|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
127790580|NCT01326546|459857137|FG000|Overall Study|Lost to Follow-up|8|||
127790581|NCT01326546|459857138|FG001|Overall Study|Lost to Follow-up|7|||
127790582|NCT01326546|459857137|FG000|Overall Study|Protocol Violation|3|||
127790583|NCT01326546|459857138|FG001|Overall Study|Protocol Violation|4|||
127790584|NCT01326546|459857137|FG000|Overall Study|Pregnancy|0|||
127790585|NCT01326546|459857138|FG001|Overall Study|Pregnancy|1|||
127790586|NCT01326546|459857137|FG000|Overall Study|Adverse Event|1|||
127790587|NCT01326546|459857138|FG001|Overall Study|Adverse Event|0|||
127790588|NCT01326546|459857137|FG000|Overall Study|Withdrawal by Subject|5|||
127790589|NCT01326546|459857138|FG001|Overall Study|Withdrawal by Subject|1|||
127790590|NCT01033825|459857139|FG000|Overall Study|Withdrawal by Subject|2|||
127790591|NCT01033825|459857140|FG001|Overall Study|Withdrawal by Subject|3|||
127790592|NCT01033825|459857141|FG002|Overall Study|Withdrawal by Subject|2|||
127790593|NCT01033825|459857142|FG003|Overall Study|Withdrawal by Subject|1|||
127790594|NCT01033825|459857143|FG004|Overall Study|Withdrawal by Subject|1|||
127790595|NCT01033825|459857144|FG005|Overall Study|Withdrawal by Subject|0|||
127790596|NCT01033825|459857145|FG006|Overall Study|Withdrawal by Subject|0|||
127790597|NCT01033825|459857139|FG000|Overall Study|Adverse Event|0|||
127790598|NCT01033825|459857140|FG001|Overall Study|Adverse Event|0|||
127790599|NCT01033825|459857141|FG002|Overall Study|Adverse Event|0|||
127790600|NCT01033825|459857142|FG003|Overall Study|Adverse Event|1|||
127790601|NCT01033825|459857143|FG004|Overall Study|Adverse Event|0|||
127790602|NCT01033825|459857144|FG005|Overall Study|Adverse Event|0|||
127790603|NCT01033825|459857145|FG006|Overall Study|Adverse Event|0|||
127790604|NCT01033825|459857139|FG000|Overall Study|Protocol Violation|1|||
127790605|NCT01033825|459857140|FG001|Overall Study|Protocol Violation|0|||
127790606|NCT01033825|459857141|FG002|Overall Study|Protocol Violation|0|||
127790607|NCT01033825|459857142|FG003|Overall Study|Protocol Violation|0|||
127790608|NCT01033825|459857143|FG004|Overall Study|Protocol Violation|0|||
127790609|NCT01033825|459857144|FG005|Overall Study|Protocol Violation|0|||
127790610|NCT01033825|459857145|FG006|Overall Study|Protocol Violation|0|||
127790611|NCT01033825|459857139|FG000|Overall Study|Other|0|||
127790612|NCT01033825|459857140|FG001|Overall Study|Other|0|||
127790613|NCT01033825|459857141|FG002|Overall Study|Other|0|||
127883918|NCT00446134|460197953|FG002|Overall Study|Lack of Efficacy|24|||
127883919|NCT00446134|460197954|FG003|Overall Study|Lack of Efficacy|19|||
127614262|NCT02036502|459217849|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
127790614|NCT01033825|459857142|FG003|Overall Study|Other|0|||
127790615|NCT01033825|459857143|FG004|Overall Study|Other|1|||
127790616|NCT01033825|459857144|FG005|Overall Study|Other|0|||
127790617|NCT01033825|459857145|FG006|Overall Study|Other|0|||
127614263|NCT02036502|459217842|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
127790618|NCT04294719|459857146|FG000|Overall Study|Withdrawal by Subject|1|||
127614264|NCT02036502|459217843|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
127614265|NCT02036502|459217844|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
127614266|NCT02036502|459217845|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
127614267|NCT02036502|459217846|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
127614268|NCT02036502|459217847|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
127614269|NCT02036502|459217848|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
127614270|NCT02036502|459217849|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
127614271|NCT02036502|459217842|FG000|Part 2:Dose Confirmation|Death|0|||
127614272|NCT02036502|459217843|FG001|Part 2:Dose Confirmation|Death|0|||
127614273|NCT02036502|459217844|FG002|Part 2:Dose Confirmation|Death|1|||
127614274|NCT02036502|459217845|FG003|Part 2:Dose Confirmation|Death|0|||
127614275|NCT02036502|459217846|FG004|Part 2:Dose Confirmation|Death|0|||
127614276|NCT02036502|459217847|FG005|Part 2:Dose Confirmation|Death|0|||
127614277|NCT02036502|459217848|FG006|Part 2:Dose Confirmation|Death|0|||
127614278|NCT02036502|459217849|FG007|Part 2:Dose Confirmation|Death|0|||
127614279|NCT02036502|459217842|FG000|Part 2:Dose Confirmation|Not treated|0|||
127614280|NCT02036502|459217843|FG001|Part 2:Dose Confirmation|Not treated|0|||
127614281|NCT02036502|459217844|FG002|Part 2:Dose Confirmation|Not treated|0|||
127614282|NCT02036502|459217845|FG003|Part 2:Dose Confirmation|Not treated|1|||
127614283|NCT02036502|459217846|FG004|Part 2:Dose Confirmation|Not treated|0|||
127614284|NCT02036502|459217847|FG005|Part 2:Dose Confirmation|Not treated|0|||
127614285|NCT02036502|459217848|FG006|Part 2:Dose Confirmation|Not treated|0|||
127614286|NCT02036502|459217849|FG007|Part 2:Dose Confirmation|Not treated|0|||
127614287|NCT02036502|459217842|FG000|Part 3:Dose Expansion|Adverse Event|0|||
127614288|NCT02036502|459217843|FG001|Part 3:Dose Expansion|Adverse Event|0|||
127614289|NCT02036502|459217844|FG002|Part 3:Dose Expansion|Adverse Event|0|||
127614290|NCT02036502|459217845|FG003|Part 3:Dose Expansion|Adverse Event|0|||
127614291|NCT02036502|459217846|FG004|Part 3:Dose Expansion|Adverse Event|0|||
127614292|NCT02036502|459217847|FG005|Part 3:Dose Expansion|Adverse Event|4|||
127614293|NCT02036502|459217848|FG006|Part 3:Dose Expansion|Adverse Event|0|||
127614294|NCT02036502|459217849|FG007|Part 3:Dose Expansion|Adverse Event|2|||
127614295|NCT02036502|459217842|FG000|Part 3:Dose Expansion|Death|0|||
127614296|NCT02036502|459217843|FG001|Part 3:Dose Expansion|Death|0|||
127614297|NCT02036502|459217844|FG002|Part 3:Dose Expansion|Death|0|||
127614298|NCT02036502|459217845|FG003|Part 3:Dose Expansion|Death|0|||
127614299|NCT02036502|459217846|FG004|Part 3:Dose Expansion|Death|0|||
127614300|NCT02036502|459217847|FG005|Part 3:Dose Expansion|Death|24|||
127614301|NCT02036502|459217848|FG006|Part 3:Dose Expansion|Death|0|||
127614302|NCT02036502|459217849|FG007|Part 3:Dose Expansion|Death|3|||
127614303|NCT02036502|459217842|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
127614304|NCT02036502|459217843|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
127614305|NCT02036502|459217844|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
127614306|NCT02036502|459217845|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
127614307|NCT02036502|459217846|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
127614308|NCT02036502|459217847|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
127614309|NCT02036502|459217848|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
127614310|NCT02036502|459217849|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
127614311|NCT02036502|459217842|FG000|Part 3:Dose Expansion|Physician Decision|0|||
127614312|NCT02036502|459217843|FG001|Part 3:Dose Expansion|Physician Decision|0|||
127614313|NCT02036502|459217844|FG002|Part 3:Dose Expansion|Physician Decision|0|||
127614314|NCT02036502|459217845|FG003|Part 3:Dose Expansion|Physician Decision|0|||
127614315|NCT02036502|459217846|FG004|Part 3:Dose Expansion|Physician Decision|0|||
127614316|NCT02036502|459217847|FG005|Part 3:Dose Expansion|Physician Decision|1|||
127614317|NCT02036502|459217848|FG006|Part 3:Dose Expansion|Physician Decision|0|||
127614318|NCT02036502|459217849|FG007|Part 3:Dose Expansion|Physician Decision|0|||
127614319|NCT02036502|459217842|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
127614320|NCT02036502|459217843|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
127614321|NCT02036502|459217844|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
127614322|NCT02036502|459217845|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
127614323|NCT02036502|459217846|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
127614324|NCT02036502|459217847|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
127614325|NCT02036502|459217848|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
127614326|NCT02036502|459217849|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
127614327|NCT02036502|459217842|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
127614328|NCT02036502|459217843|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
127614329|NCT02036502|459217844|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
127614330|NCT02036502|459217845|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
127699445|NCT04963270|459528698|FG003|Open Label Extension Period (92 Weeks)|Reason Not Specified|1|||
127699446|NCT04963270|459528695|FG000|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
127699447|NCT04963270|459528696|FG001|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
127699448|NCT04963270|459528697|FG002|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
127699449|NCT04963270|459528698|FG003|Open Label Extension Period (92 Weeks)|Reason Unknown|1|||
127699450|NCT04963270|459528695|FG000|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
127699451|NCT04963270|459528696|FG001|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
127699452|NCT04963270|459528697|FG002|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
127699453|NCT04963270|459528698|FG003|Open Label Extension Period (92 Weeks)|Adverse Event|1|||
127699454|NCT04624633|459528703|FG000|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|0|||
127699455|NCT04624633|459528704|FG001|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|1|||
127699456|NCT04624633|459528703|FG000|Overall Study|Death|1|||
127699457|NCT04624633|459528704|FG001|Overall Study|Death|0|||
127699458|NCT04316871|459528705|FG000|Overall Study|Protocol Violation|2|||
127699459|NCT04316871|459528706|FG001|Overall Study|Protocol Violation|2|||
127699460|NCT04316871|459528707|FG002|Overall Study|Protocol Violation|2|||
127699461|NCT04316871|459528708|FG003|Overall Study|Protocol Violation|2|||
127699462|NCT05087992|459528709|FG000|Overall Study|Adverse Event|0|||
127699463|NCT05087992|459528710|FG001|Overall Study|Adverse Event|1|||
127699464|NCT05087992|459528711|FG002|Overall Study|Adverse Event|0|||
127699465|NCT05087992|459528709|FG000|Overall Study|Withdrawal by Subject|2|||
127699466|NCT05087992|459528710|FG001|Overall Study|Withdrawal by Subject|0|||
127699467|NCT05087992|459528711|FG002|Overall Study|Withdrawal by Subject|0|||
127699468|NCT05087992|459528709|FG000|Overall Study|clinical disease progression|3|||
127699469|NCT05087992|459528710|FG001|Overall Study|clinical disease progression|1|||
127699470|NCT05087992|459528711|FG002|Overall Study|clinical disease progression|0|||
127699471|NCT05087992|459528709|FG000|Overall Study|objective disease progression|4|||
127699472|NCT05087992|459528710|FG001|Overall Study|objective disease progression|1|||
127699473|NCT05087992|459528711|FG002|Overall Study|objective disease progression|0|||
127699474|NCT01842542|459528712|FG000|Overall Study|Withdrawal by Subject|2|||
127699475|NCT01842542|459528712|FG000|Overall Study|Lack of Efficacy|1|||
127699476|NCT01842542|459528712|FG000|Overall Study|Protocol Non-compliance|2|||
127699477|NCT01842542|459528712|FG000|Overall Study|Lost to Follow-up|1|||
127699478|NCT01824394|459528718|FG000|Overall Study|Early Termination|1|||
127699479|NCT01824394|459528719|FG001|Overall Study|Early Termination|1|||
127699480|NCT01824394|459528720|FG002|Overall Study|Early Termination|3|||
127614331|NCT02036502|459217846|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
127614332|NCT02036502|459217847|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
127614333|NCT02036502|459217848|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
127614334|NCT02036502|459217849|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
127614335|NCT02036502|459217842|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
127614336|NCT02036502|459217843|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
127614337|NCT02036502|459217844|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
127614338|NCT02036502|459217845|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
127614339|NCT02036502|459217846|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
127614340|NCT02036502|459217847|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
127614341|NCT02036502|459217848|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
127614342|NCT02036502|459217849|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
127614343|NCT02036502|459217842|FG000|Part 3:Dose Expansion|Not Treated|0|||
127614344|NCT02036502|459217843|FG001|Part 3:Dose Expansion|Not Treated|0|||
127614345|NCT02036502|459217844|FG002|Part 3:Dose Expansion|Not Treated|0|||
127614346|NCT02036502|459217845|FG003|Part 3:Dose Expansion|Not Treated|0|||
127614347|NCT02036502|459217846|FG004|Part 3:Dose Expansion|Not Treated|0|||
127614348|NCT02036502|459217847|FG005|Part 3:Dose Expansion|Not Treated|2|||
127614349|NCT02036502|459217848|FG006|Part 3:Dose Expansion|Not Treated|0|||
127614350|NCT02036502|459217849|FG007|Part 3:Dose Expansion|Not Treated|0|||
127699481|NCT01824394|459528718|FG000|Overall Study|Withdrawn due to Study Termination|91|||
127699482|NCT01824394|459528719|FG001|Overall Study|Withdrawn due to Study Termination|83|||
127699483|NCT01824394|459528720|FG002|Overall Study|Withdrawn due to Study Termination|41|||
127699484|NCT01824394|459528718|FG000|Overall Study|Lost to Follow-up|0|||
127699485|NCT01824394|459528719|FG001|Overall Study|Lost to Follow-up|9|||
127699486|NCT01824394|459528720|FG002|Overall Study|Lost to Follow-up|3|||
127699487|NCT01824394|459528718|FG000|Overall Study|Death|3|||
127614351|NCT00500292|459217853|FG000|Overall Study|Adverse Event|3|||
127614352|NCT00500292|459217854|FG001|Overall Study|Adverse Event|6|||
127614353|NCT00500292|459217855|FG002|Overall Study|Adverse Event|4|||
127614354|NCT00500292|459217853|FG000|Overall Study|Condition under investigation worsened|21|||
127614355|NCT00500292|459217854|FG001|Overall Study|Condition under investigation worsened|23|||
127614356|NCT00500292|459217855|FG002|Overall Study|Condition under investigation worsened|19|||
127614357|NCT00500292|459217853|FG000|Overall Study|Withdrawal by Subject|0|||
127614358|NCT00500292|459217854|FG001|Overall Study|Withdrawal by Subject|1|||
127614359|NCT00500292|459217855|FG002|Overall Study|Withdrawal by Subject|0|||
127614360|NCT00500292|459217853|FG000|Overall Study|Other|1|||
127614361|NCT00500292|459217854|FG001|Overall Study|Other|1|||
127614362|NCT00500292|459217855|FG002|Overall Study|Other|4|||
127614363|NCT02741700|459217856|FG000|Overall Study|Lost to Follow-up|17|||
127614364|NCT02741700|459217857|FG001|Overall Study|Lost to Follow-up|8|||
127614365|NCT02741700|459217856|FG000|Overall Study|Withdrawal by Subject|2|||
127614366|NCT02741700|459217857|FG001|Overall Study|Withdrawal by Subject|5|||
127614367|NCT02741700|459217856|FG000|Overall Study|Physician Decision|3|||
127614368|NCT02741700|459217857|FG001|Overall Study|Physician Decision|0|||
127614369|NCT02741700|459217856|FG000|Overall Study|Moved out of State|0|||
127614370|NCT02741700|459217857|FG001|Overall Study|Moved out of State|1|||
127614371|NCT02741700|459217856|FG000|Overall Study|Death|4|||
127614372|NCT02741700|459217857|FG001|Overall Study|Death|5|||
127614373|NCT00811577|459217858|FG000|Overall Study|Lost to Follow-up|7|||
127614374|NCT00811577|459217859|FG001|Overall Study|Lost to Follow-up|1|||
127614375|NCT00811577|459217858|FG000|Overall Study|Withdrawal by Subject|3|||
127614376|NCT00811577|459217859|FG001|Overall Study|Withdrawal by Subject|0|||
127614377|NCT01068509|459217860|FG000|Overall Study|Death|0|||
127614378|NCT01068509|459217861|FG001|Overall Study|Death|0|||
127614379|NCT01068509|459217862|FG002|Overall Study|Death|1|||
127614380|NCT01068509|459217860|FG000|Overall Study|Disease Progression|5|||
127614381|NCT01068509|459217861|FG001|Overall Study|Disease Progression|20|||
127614382|NCT01068509|459217862|FG002|Overall Study|Disease Progression|18|||
127614383|NCT01068509|459217860|FG000|Overall Study|Lost to Follow-up|1|||
127614384|NCT01068509|459217861|FG001|Overall Study|Lost to Follow-up|0|||
127614385|NCT01068509|459217862|FG002|Overall Study|Lost to Follow-up|0|||
127614386|NCT01068509|459217860|FG000|Overall Study|Withdrew Consent|0|||
127614387|NCT01068509|459217861|FG001|Overall Study|Withdrew Consent|1|||
127614388|NCT01068509|459217862|FG002|Overall Study|Withdrew Consent|2|||
127614389|NCT01068509|459217860|FG000|Overall Study|Reason Not Specified|0|||
127614390|NCT01068509|459217861|FG001|Overall Study|Reason Not Specified|1|||
127614391|NCT01068509|459217862|FG002|Overall Study|Reason Not Specified|0|||
127614392|NCT02442778|459217863|FG000|Overall Study|Adverse Event|2|||
127614393|NCT02442778|459217864|FG001|Overall Study|Adverse Event|6|||
127614394|NCT02442778|459217865|FG002|Overall Study|Adverse Event|6|||
127614395|NCT02442778|459217863|FG000|Overall Study|Death|0|||
127614396|NCT02442778|459217864|FG001|Overall Study|Death|2|||
127614397|NCT02442778|459217865|FG002|Overall Study|Death|0|||
127614398|NCT02442778|459217863|FG000|Overall Study|Lack of Efficacy|1|||
127614399|NCT02442778|459217864|FG001|Overall Study|Lack of Efficacy|0|||
127614400|NCT02442778|459217865|FG002|Overall Study|Lack of Efficacy|0|||
127614401|NCT02442778|459217863|FG000|Overall Study|Lost to Follow-up|1|||
127614402|NCT02442778|459217864|FG001|Overall Study|Lost to Follow-up|1|||
127614403|NCT02442778|459217865|FG002|Overall Study|Lost to Follow-up|1|||
127614404|NCT02442778|459217863|FG000|Overall Study|Non-compliance with study drug|2|||
127614405|NCT02442778|459217864|FG001|Overall Study|Non-compliance with study drug|0|||
127614406|NCT02442778|459217865|FG002|Overall Study|Non-compliance with study drug|1|||
127614407|NCT02442778|459217863|FG000|Overall Study|Physician Decision|1|||
127614408|NCT02442778|459217864|FG001|Overall Study|Physician Decision|1|||
127614409|NCT02442778|459217865|FG002|Overall Study|Physician Decision|1|||
127614410|NCT02442778|459217863|FG000|Overall Study|Protocol Deviation|3|||
127614411|NCT02442778|459217864|FG001|Overall Study|Protocol Deviation|0|||
127614412|NCT02442778|459217865|FG002|Overall Study|Protocol Deviation|1|||
127883920|NCT00446134|460197951|FG000|Overall Study|Protocol Violation|0|||
127883921|NCT00446134|460197952|FG001|Overall Study|Protocol Violation|2|||
127883922|NCT00446134|460197953|FG002|Overall Study|Protocol Violation|1|||
127883923|NCT00446134|460197954|FG003|Overall Study|Protocol Violation|0|||
127883924|NCT00446134|460197951|FG000|Overall Study|Lost to Follow-up|1|||
127883925|NCT00446134|460197952|FG001|Overall Study|Lost to Follow-up|3|||
127883926|NCT00446134|460197953|FG002|Overall Study|Lost to Follow-up|1|||
127614413|NCT02442778|459217863|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
127614414|NCT02442778|459217864|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
127614415|NCT02442778|459217865|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
127614416|NCT02442778|459217863|FG000|Overall Study|Withdrawal by Subject|4|||
127614417|NCT02442778|459217864|FG001|Overall Study|Withdrawal by Subject|4|||
127614418|NCT02442778|459217865|FG002|Overall Study|Withdrawal by Subject|3|||
127614419|NCT02442778|459217863|FG000|Overall Study|Reason not specified|1|||
127614420|NCT02442778|459217864|FG001|Overall Study|Reason not specified|4|||
127699488|NCT01824394|459528719|FG001|Overall Study|Death|2|||
127699489|NCT01824394|459528720|FG002|Overall Study|Death|4|||
127699490|NCT01824394|459528718|FG000|Overall Study|Discontinued Subjects|1|||
127699491|NCT01824394|459528719|FG001|Overall Study|Discontinued Subjects|1|||
127699492|NCT01824394|459528720|FG002|Overall Study|Discontinued Subjects|2|||
127699493|NCT01824394|459528718|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
127699494|NCT01824394|459528719|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
127699495|NCT01824394|459528720|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
127614421|NCT02442778|459217865|FG002|Overall Study|Reason not specified|0|||
127614422|NCT01165138|459217868|FG000|Overall Study|Adverse Event|0|||
127614423|NCT01165138|459217869|FG001|Overall Study|Adverse Event|1|||
127699496|NCT00227344|459528721|FG000|Overall Study|study terminated early|12|||
127699497|NCT00227344|459528722|FG001|Overall Study|study terminated early|5|||
127699498|NCT01987895|459528723|FG000|Overall Study|Withdrawal by Subject|12|||
127699499|NCT01987895|459528724|FG001|Overall Study|Withdrawal by Subject|7|||
127699500|NCT01987895|459528723|FG000|Overall Study|Physician Decision|8|||
127614424|NCT01165138|459217870|FG002|Overall Study|Adverse Event|0|||
127614425|NCT01165138|459217871|FG003|Overall Study|Adverse Event|2|||
127614426|NCT01165138|459217868|FG000|Overall Study|Lack of Efficacy|0|||
127614427|NCT01165138|459217869|FG001|Overall Study|Lack of Efficacy|32|||
127614428|NCT01165138|459217870|FG002|Overall Study|Lack of Efficacy|6|||
127614429|NCT01165138|459217871|FG003|Overall Study|Lack of Efficacy|7|||
127614430|NCT01165138|459217868|FG000|Overall Study|Protocol Violation|0|||
127614431|NCT01165138|459217869|FG001|Overall Study|Protocol Violation|7|||
127614432|NCT01165138|459217870|FG002|Overall Study|Protocol Violation|0|||
127614433|NCT01165138|459217871|FG003|Overall Study|Protocol Violation|2|||
127614434|NCT01165138|459217868|FG000|Overall Study|Lost to Follow-up|0|||
127614435|NCT01165138|459217869|FG001|Overall Study|Lost to Follow-up|0|||
127614436|NCT01165138|459217870|FG002|Overall Study|Lost to Follow-up|1|||
127614437|NCT01165138|459217871|FG003|Overall Study|Lost to Follow-up|2|||
127614438|NCT01165138|459217868|FG000|Overall Study|Physician Decision|0|||
127614439|NCT01165138|459217869|FG001|Overall Study|Physician Decision|6|||
127614440|NCT01165138|459217870|FG002|Overall Study|Physician Decision|7|||
127614441|NCT01165138|459217871|FG003|Overall Study|Physician Decision|6|||
127614442|NCT01165138|459217868|FG000|Overall Study|Withdrawal by Subject|0|||
127614443|NCT01165138|459217869|FG001|Overall Study|Withdrawal by Subject|6|||
127614444|NCT01165138|459217870|FG002|Overall Study|Withdrawal by Subject|6|||
127790619|NCT00081159|459857147|FG000|Overall Study|Withdrawal by Subject|0|||
127790620|NCT00081159|459857148|FG001|Overall Study|Withdrawal by Subject|3|||
127790621|NCT00081159|459857147|FG000|Overall Study|Myelosuppression prior to treatment|0|||
127790622|NCT00081159|459857148|FG001|Overall Study|Myelosuppression prior to treatment|1|||
127790623|NCT00081159|459857147|FG000|Overall Study|Lost to Follow-up|2|||
127790624|NCT00081159|459857148|FG001|Overall Study|Lost to Follow-up|1|||
127790625|NCT01714687|459857151|FG000|Overall Study|Withdrawal by Subject|1|||
127790626|NCT01714687|459857152|FG001|Overall Study|Withdrawal by Subject|0|||
127790627|NCT01714687|459857151|FG000|Overall Study|Lost to Follow-up|2|||
127790628|NCT01714687|459857152|FG001|Overall Study|Lost to Follow-up|4|||
127790629|NCT01553136|459857155|FG000|Overall Study|Adverse Event|3|||
127614445|NCT01165138|459217871|FG003|Overall Study|Withdrawal by Subject|3|||
127614446|NCT02641379|459217872|FG000|Overall Study|Exclusion criterion during screening|1|||
127614447|NCT02641379|459217873|FG001|Overall Study|Exclusion criterion during screening|0|||
127614448|NCT02641379|459217874|FG002|Overall Study|Exclusion criterion during screening|0|||
127614449|NCT02641379|459217875|FG003|Overall Study|Exclusion criterion during screening|1|||
127614450|NCT02641379|459217876|FG004|Overall Study|Exclusion criterion during screening|2|||
127614451|NCT02641379|459217877|FG005|Overall Study|Exclusion criterion during screening|0|||
127614452|NCT02641379|459217878|FG006|Overall Study|Exclusion criterion during screening|0|||
127614453|NCT02641379|459217879|FG007|Overall Study|Exclusion criterion during screening|0|||
127614454|NCT02641379|459217880|FG008|Overall Study|Exclusion criterion during screening|0|||
127614455|NCT02641379|459217881|FG009|Overall Study|Exclusion criterion during screening|0|||
127614456|NCT02641379|459217882|FG010|Overall Study|Exclusion criterion during screening|0|||
127614457|NCT02641379|459217872|FG000|Overall Study|Withdrawal of informed consent|0|||
127614458|NCT02641379|459217873|FG001|Overall Study|Withdrawal of informed consent|1|||
127614459|NCT02641379|459217874|FG002|Overall Study|Withdrawal of informed consent|0|||
127614460|NCT02641379|459217875|FG003|Overall Study|Withdrawal of informed consent|0|||
127614461|NCT02641379|459217876|FG004|Overall Study|Withdrawal of informed consent|0|||
127614462|NCT02641379|459217877|FG005|Overall Study|Withdrawal of informed consent|0|||
127614463|NCT02641379|459217878|FG006|Overall Study|Withdrawal of informed consent|0|||
127614464|NCT02641379|459217879|FG007|Overall Study|Withdrawal of informed consent|1|||
127614465|NCT02641379|459217880|FG008|Overall Study|Withdrawal of informed consent|0|||
127614466|NCT02641379|459217881|FG009|Overall Study|Withdrawal of informed consent|0|||
127614467|NCT02641379|459217882|FG010|Overall Study|Withdrawal of informed consent|0|||
127614468|NCT02641379|459217872|FG000|Overall Study|Adverse Event|7|||
127790630|NCT01553136|459857156|FG001|Overall Study|Adverse Event|2|||
127790631|NCT01553136|459857155|FG000|Overall Study|Withdrawal by Subject|2|||
127790632|NCT01553136|459857156|FG001|Overall Study|Withdrawal by Subject|3|||
127614469|NCT02641379|459217873|FG001|Overall Study|Adverse Event|8|||
127614470|NCT02641379|459217874|FG002|Overall Study|Adverse Event|2|||
127614471|NCT02641379|459217875|FG003|Overall Study|Adverse Event|2|||
127614472|NCT02641379|459217876|FG004|Overall Study|Adverse Event|5|||
127614473|NCT02641379|459217877|FG005|Overall Study|Adverse Event|1|||
127614474|NCT02641379|459217878|FG006|Overall Study|Adverse Event|5|||
127614475|NCT02641379|459217879|FG007|Overall Study|Adverse Event|0|||
127614476|NCT02641379|459217880|FG008|Overall Study|Adverse Event|1|||
127614477|NCT02641379|459217881|FG009|Overall Study|Adverse Event|1|||
127614478|NCT02641379|459217882|FG010|Overall Study|Adverse Event|5|||
127790633|NCT01553136|459857155|FG000|Overall Study|Lost to Follow-up|4|||
127614479|NCT02641379|459217872|FG000|Overall Study|Lack of Efficacy|0|||
127790634|NCT01553136|459857156|FG001|Overall Study|Lost to Follow-up|10|||
127614480|NCT02641379|459217873|FG001|Overall Study|Lack of Efficacy|0|||
127614481|NCT02641379|459217874|FG002|Overall Study|Lack of Efficacy|2|||
127614482|NCT02641379|459217875|FG003|Overall Study|Lack of Efficacy|0|||
127614483|NCT02641379|459217876|FG004|Overall Study|Lack of Efficacy|0|||
127614484|NCT02641379|459217877|FG005|Overall Study|Lack of Efficacy|2|||
127614485|NCT02641379|459217878|FG006|Overall Study|Lack of Efficacy|0|||
127614486|NCT02641379|459217879|FG007|Overall Study|Lack of Efficacy|5|||
127614487|NCT02641379|459217880|FG008|Overall Study|Lack of Efficacy|0|||
127614488|NCT02641379|459217881|FG009|Overall Study|Lack of Efficacy|0|||
127614489|NCT02641379|459217882|FG010|Overall Study|Lack of Efficacy|0|||
127790635|NCT01553136|459857155|FG000|Overall Study|Physician Decision|2|||
127790636|NCT01553136|459857156|FG001|Overall Study|Physician Decision|3|||
127614490|NCT02641379|459217872|FG000|Overall Study|Participant unable to attend study visit|4|||
127614491|NCT02641379|459217873|FG001|Overall Study|Participant unable to attend study visit|10|||
127614492|NCT02641379|459217874|FG002|Overall Study|Participant unable to attend study visit|1|||
127614493|NCT02641379|459217875|FG003|Overall Study|Participant unable to attend study visit|2|||
127614494|NCT02641379|459217876|FG004|Overall Study|Participant unable to attend study visit|5|||
127614495|NCT02641379|459217877|FG005|Overall Study|Participant unable to attend study visit|1|||
127614496|NCT02641379|459217878|FG006|Overall Study|Participant unable to attend study visit|1|||
127614497|NCT02641379|459217879|FG007|Overall Study|Participant unable to attend study visit|1|||
127614498|NCT02641379|459217880|FG008|Overall Study|Participant unable to attend study visit|0|||
127614499|NCT02641379|459217881|FG009|Overall Study|Participant unable to attend study visit|2|||
127614500|NCT02641379|459217882|FG010|Overall Study|Participant unable to attend study visit|0|||
127614501|NCT02641379|459217872|FG000|Overall Study|Participant's compliance|0|||
127614502|NCT02641379|459217873|FG001|Overall Study|Participant's compliance|1|||
127614503|NCT02641379|459217874|FG002|Overall Study|Participant's compliance|0|||
127614504|NCT02641379|459217875|FG003|Overall Study|Participant's compliance|1|||
127614505|NCT02641379|459217876|FG004|Overall Study|Participant's compliance|0|||
127614506|NCT02641379|459217877|FG005|Overall Study|Participant's compliance|2|||
127614507|NCT02641379|459217878|FG006|Overall Study|Participant's compliance|0|||
127614508|NCT02641379|459217879|FG007|Overall Study|Participant's compliance|0|||
127614509|NCT02641379|459217880|FG008|Overall Study|Participant's compliance|1|||
127614510|NCT02641379|459217881|FG009|Overall Study|Participant's compliance|1|||
127614511|NCT02641379|459217882|FG010|Overall Study|Participant's compliance|1|||
127614512|NCT02641379|459217872|FG000|Overall Study|Participant cannot be reached|4|||
127614513|NCT02641379|459217873|FG001|Overall Study|Participant cannot be reached|4|||
127614514|NCT02641379|459217874|FG002|Overall Study|Participant cannot be reached|0|||
127614515|NCT02641379|459217875|FG003|Overall Study|Participant cannot be reached|8|||
127614516|NCT02641379|459217876|FG004|Overall Study|Participant cannot be reached|2|||
127614517|NCT02641379|459217877|FG005|Overall Study|Participant cannot be reached|1|||
127614518|NCT02641379|459217878|FG006|Overall Study|Participant cannot be reached|0|||
127614519|NCT02641379|459217879|FG007|Overall Study|Participant cannot be reached|1|||
127614520|NCT02641379|459217880|FG008|Overall Study|Participant cannot be reached|0|||
127614521|NCT02641379|459217881|FG009|Overall Study|Participant cannot be reached|2|||
127614522|NCT02641379|459217882|FG010|Overall Study|Participant cannot be reached|1|||
127614523|NCT02641379|459217872|FG000|Overall Study|PCR positive at Week 24|15|||
127614524|NCT02641379|459217873|FG001|Overall Study|PCR positive at Week 24|21|||
127614525|NCT02641379|459217874|FG002|Overall Study|PCR positive at Week 24|62|||
127614526|NCT02641379|459217875|FG003|Overall Study|PCR positive at Week 24|0|||
127614527|NCT02641379|459217876|FG004|Overall Study|PCR positive at Week 24|0|||
127614528|NCT02641379|459217877|FG005|Overall Study|PCR positive at Week 24|6|||
127790637|NCT01553136|459857155|FG000|Overall Study|Scheduling Difficulties|5|||
127790638|NCT01553136|459857156|FG001|Overall Study|Scheduling Difficulties|4|||
127790639|NCT01100437|459857157|FG000|Titration/Stabilization|Adverse Event|0|||
127790640|NCT01100437|459857158|FG001|Titration/Stabilization|Adverse Event|0|||
127790641|NCT01100437|459857159|FG002|Titration/Stabilization|Adverse Event|4|||
127790642|NCT01100437|459857157|FG000|Titration/Stabilization|Non-compliance|0|||
127790643|NCT01100437|459857158|FG001|Titration/Stabilization|Non-compliance|0|||
127790644|NCT01100437|459857159|FG002|Titration/Stabilization|Non-compliance|1|||
127790645|NCT01100437|459857157|FG000|Titration/Stabilization|Sponsor canceled study|0|||
127790646|NCT01100437|459857158|FG001|Titration/Stabilization|Sponsor canceled study|0|||
127790647|NCT01100437|459857159|FG002|Titration/Stabilization|Sponsor canceled study|1|||
127790648|NCT01100437|459857157|FG000|Maintenance|Withdrawal by Subject|0|||
127790649|NCT01100437|459857158|FG001|Maintenance|Withdrawal by Subject|0|||
127790650|NCT01100437|459857159|FG002|Maintenance|Withdrawal by Subject|1|||
127790651|NCT01100437|459857157|FG000|Maintenance|Sponsor termination of study|0|||
127790652|NCT01100437|459857158|FG001|Maintenance|Sponsor termination of study|0|||
127790653|NCT01100437|459857159|FG002|Maintenance|Sponsor termination of study|1|||
127790654|NCT00894556|459857162|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
127790655|NCT00894556|459857163|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
127790656|NCT00894556|459857164|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
127790657|NCT00894556|459857165|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
127790658|NCT00894556|459857162|FG000|Treatment Phase|Lost to Follow-up|2|||
127790659|NCT00894556|459857163|FG001|Treatment Phase|Lost to Follow-up|3|||
127790660|NCT00894556|459857164|FG002|Treatment Phase|Lost to Follow-up|1|||
127790661|NCT00894556|459857165|FG003|Treatment Phase|Lost to Follow-up|0|||
127790662|NCT00894556|459857162|FG000|Treatment Phase|Lack of Qualifying Event|2|||
127790663|NCT00894556|459857163|FG001|Treatment Phase|Lack of Qualifying Event|1|||
127790664|NCT00894556|459857164|FG002|Treatment Phase|Lack of Qualifying Event|0|||
127790665|NCT00894556|459857165|FG003|Treatment Phase|Lack of Qualifying Event|0|||
127790666|NCT01979536|459857168|FG000|Overall Study|Physician Decision|2|||
127790667|NCT01979536|459857169|FG001|Overall Study|Physician Decision|3|||
127614529|NCT02641379|459217878|FG006|Overall Study|PCR positive at Week 24|3|||
127614530|NCT02641379|459217879|FG007|Overall Study|PCR positive at Week 24|8|||
127790668|NCT01979536|459857168|FG000|Overall Study|Withdrawal by Subject|0|||
127790669|NCT01979536|459857169|FG001|Overall Study|Withdrawal by Subject|1|||
127790670|NCT01979536|459857168|FG000|Overall Study|Refusal|0|||
127790671|NCT01979536|459857169|FG001|Overall Study|Refusal|1|||
127790672|NCT01979536|459857168|FG000|Overall Study|Relapse|0|||
127790673|NCT01979536|459857169|FG001|Overall Study|Relapse|1|||
127790674|NCT01979536|459857168|FG000|Overall Study|Study terminated by Sponsor|0|||
127614531|NCT02641379|459217880|FG008|Overall Study|PCR positive at Week 24|0|||
127614532|NCT02641379|459217881|FG009|Overall Study|PCR positive at Week 24|1|||
127614533|NCT02641379|459217882|FG010|Overall Study|PCR positive at Week 24|0|||
127614534|NCT02641379|459217872|FG000|Overall Study|PCR positive at follow up 2|1|||
127614535|NCT02641379|459217873|FG001|Overall Study|PCR positive at follow up 2|0|||
127614536|NCT02641379|459217874|FG002|Overall Study|PCR positive at follow up 2|0|||
127614537|NCT02641379|459217875|FG003|Overall Study|PCR positive at follow up 2|0|||
127614538|NCT02641379|459217876|FG004|Overall Study|PCR positive at follow up 2|0|||
127614539|NCT02641379|459217877|FG005|Overall Study|PCR positive at follow up 2|0|||
127614540|NCT02641379|459217878|FG006|Overall Study|PCR positive at follow up 2|0|||
127614541|NCT02641379|459217879|FG007|Overall Study|PCR positive at follow up 2|0|||
127614542|NCT02641379|459217880|FG008|Overall Study|PCR positive at follow up 2|0|||
127614543|NCT02641379|459217881|FG009|Overall Study|PCR positive at follow up 2|0|||
127614544|NCT02641379|459217882|FG010|Overall Study|PCR positive at follow up 2|0|||
127614545|NCT02641379|459217872|FG000|Overall Study|Participant showed relapse|1|||
127614546|NCT02641379|459217873|FG001|Overall Study|Participant showed relapse|0|||
127614547|NCT02641379|459217874|FG002|Overall Study|Participant showed relapse|0|||
127614548|NCT02641379|459217875|FG003|Overall Study|Participant showed relapse|0|||
127614549|NCT02641379|459217876|FG004|Overall Study|Participant showed relapse|0|||
127614550|NCT02641379|459217877|FG005|Overall Study|Participant showed relapse|0|||
127614551|NCT02641379|459217878|FG006|Overall Study|Participant showed relapse|1|||
127614552|NCT02641379|459217879|FG007|Overall Study|Participant showed relapse|0|||
127614553|NCT02641379|459217880|FG008|Overall Study|Participant showed relapse|0|||
127614554|NCT02641379|459217881|FG009|Overall Study|Participant showed relapse|0|||
127614555|NCT02641379|459217882|FG010|Overall Study|Participant showed relapse|0|||
127614556|NCT02641379|459217872|FG000|Overall Study|Participant stopped study/treatment|1|||
127614557|NCT02641379|459217873|FG001|Overall Study|Participant stopped study/treatment|3|||
127614558|NCT02641379|459217874|FG002|Overall Study|Participant stopped study/treatment|1|||
127614559|NCT02641379|459217875|FG003|Overall Study|Participant stopped study/treatment|0|||
127614560|NCT02641379|459217876|FG004|Overall Study|Participant stopped study/treatment|0|||
127614561|NCT02641379|459217877|FG005|Overall Study|Participant stopped study/treatment|1|||
127614562|NCT02641379|459217878|FG006|Overall Study|Participant stopped study/treatment|2|||
127614563|NCT02641379|459217879|FG007|Overall Study|Participant stopped study/treatment|0|||
127614564|NCT02641379|459217880|FG008|Overall Study|Participant stopped study/treatment|1|||
127614565|NCT02641379|459217881|FG009|Overall Study|Participant stopped study/treatment|0|||
127614566|NCT02641379|459217882|FG010|Overall Study|Participant stopped study/treatment|0|||
127614567|NCT02641379|459217872|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
127614568|NCT02641379|459217873|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
127614569|NCT02641379|459217874|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
127614570|NCT02641379|459217875|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
127614571|NCT02641379|459217876|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
127614572|NCT02641379|459217877|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
127614573|NCT02641379|459217878|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
127614574|NCT02641379|459217879|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
127614575|NCT02641379|459217880|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
127614576|NCT02641379|459217881|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
127790675|NCT01979536|459857169|FG001|Overall Study|Study terminated by Sponsor|1|||
127699501|NCT01987895|459528724|FG001|Overall Study|Physician Decision|10|||
127699502|NCT01987895|459528723|FG000|Overall Study|Death|7|||
127699503|NCT01987895|459528724|FG001|Overall Study|Death|7|||
127699504|NCT01987895|459528723|FG000|Overall Study|Lost to Follow-up|3|||
127699505|NCT01987895|459528724|FG001|Overall Study|Lost to Follow-up|5|||
127883927|NCT00446134|460197954|FG003|Overall Study|Lost to Follow-up|1|||
127883928|NCT00446134|460197951|FG000|Overall Study|Withdrawal by Subject|3|||
127883929|NCT00446134|460197952|FG001|Overall Study|Withdrawal by Subject|3|||
127883930|NCT00446134|460197953|FG002|Overall Study|Withdrawal by Subject|1|||
127883931|NCT00446134|460197954|FG003|Overall Study|Withdrawal by Subject|3|||
127883932|NCT00446134|460197951|FG000|Overall Study|Physician Decision|0|||
127883933|NCT00446134|460197952|FG001|Overall Study|Physician Decision|0|||
127883934|NCT00446134|460197953|FG002|Overall Study|Physician Decision|0|||
127883935|NCT00446134|460197954|FG003|Overall Study|Physician Decision|2|||
127883936|NCT00446134|460197951|FG000|Overall Study|Adverse Event-Diarrhea|1|||
127883937|NCT00446134|460197952|FG001|Overall Study|Adverse Event-Diarrhea|1|||
127883938|NCT00446134|460197953|FG002|Overall Study|Adverse Event-Diarrhea|2|||
127883939|NCT00446134|460197954|FG003|Overall Study|Adverse Event-Diarrhea|0|||
127883940|NCT00446134|460197951|FG000|Overall Study|Reason Not Completed|3|||
127883941|NCT00446134|460197952|FG001|Overall Study|Reason Not Completed|0|||
127883942|NCT00446134|460197953|FG002|Overall Study|Reason Not Completed|1|||
127883943|NCT00446134|460197954|FG003|Overall Study|Reason Not Completed|2|||
127883944|NCT00743119|460197955|FG000|Overall Study|unreliable|3|||
127883945|NCT00743119|460197955|FG000|Overall Study|Withdrawal by Subject|1|||
127883946|NCT04816877|460197956|FG000|Overall Study|Withdrawal by Subject|1|||
127883947|NCT04816877|460197957|FG001|Overall Study|Withdrawal by Subject|0|||
127883948|NCT02176642|460197959|FG000|Overall Study|Withdrawal by Subject|0|||
127883949|NCT02176642|460197960|FG001|Overall Study|Withdrawal by Subject|1|||
127883950|NCT01309828|460197961|FG000|Overall Study|Adverse Event|10|||
127883951|NCT01309828|460197962|FG001|Overall Study|Adverse Event|11|||
127883952|NCT01309828|460197961|FG000|Overall Study|Voluntary Withdrawal|5|||
127883953|NCT01309828|460197962|FG001|Overall Study|Voluntary Withdrawal|4|||
127699506|NCT01987895|459528723|FG000|Overall Study|randomized before giving IC|0|||
127699507|NCT01987895|459528724|FG001|Overall Study|randomized before giving IC|1|||
127883954|NCT01309828|460197961|FG000|Overall Study|Major Protocol Deviation|0|||
127614577|NCT02641379|459217882|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
127614578|NCT02641379|459217872|FG000|Overall Study|Financial problems|0|||
127614579|NCT02641379|459217873|FG001|Overall Study|Financial problems|1|||
127614580|NCT02641379|459217874|FG002|Overall Study|Financial problems|0|||
127614581|NCT02641379|459217875|FG003|Overall Study|Financial problems|0|||
127614582|NCT02641379|459217876|FG004|Overall Study|Financial problems|0|||
127614583|NCT02641379|459217877|FG005|Overall Study|Financial problems|0|||
127614584|NCT02641379|459217878|FG006|Overall Study|Financial problems|0|||
127614585|NCT02641379|459217879|FG007|Overall Study|Financial problems|0|||
127614586|NCT02641379|459217880|FG008|Overall Study|Financial problems|0|||
127614587|NCT02641379|459217881|FG009|Overall Study|Financial problems|0|||
127614588|NCT02641379|459217882|FG010|Overall Study|Financial problems|0|||
127614589|NCT02641379|459217872|FG000|Overall Study|PCR positive at Week 68|0|||
127614590|NCT02641379|459217873|FG001|Overall Study|PCR positive at Week 68|1|||
127614591|NCT02641379|459217874|FG002|Overall Study|PCR positive at Week 68|0|||
127614592|NCT02641379|459217875|FG003|Overall Study|PCR positive at Week 68|0|||
127614593|NCT02641379|459217876|FG004|Overall Study|PCR positive at Week 68|0|||
127614594|NCT02641379|459217877|FG005|Overall Study|PCR positive at Week 68|0|||
127614595|NCT02641379|459217878|FG006|Overall Study|PCR positive at Week 68|0|||
127614596|NCT02641379|459217879|FG007|Overall Study|PCR positive at Week 68|0|||
127614597|NCT02641379|459217880|FG008|Overall Study|PCR positive at Week 68|0|||
127614598|NCT02641379|459217881|FG009|Overall Study|PCR positive at Week 68|0|||
127614599|NCT02641379|459217882|FG010|Overall Study|PCR positive at Week 68|0|||
127614600|NCT02641379|459217872|FG000|Overall Study|PCR positive at Week 48|0|||
127614601|NCT02641379|459217873|FG001|Overall Study|PCR positive at Week 48|1|||
127614602|NCT02641379|459217874|FG002|Overall Study|PCR positive at Week 48|0|||
127614603|NCT02641379|459217875|FG003|Overall Study|PCR positive at Week 48|0|||
127883955|NCT01309828|460197962|FG001|Overall Study|Major Protocol Deviation|1|||
127883956|NCT01309828|460197961|FG000|Overall Study|Other|1|||
127883957|NCT01309828|460197962|FG001|Overall Study|Other|0|||
127883958|NCT00295620|460197963|FG000|Overall Study|Lost to Follow-up|9|||
127883959|NCT00295620|460197964|FG001|Overall Study|Lost to Follow-up|5|||
127699508|NCT05364671|459528725|FG000|Overall Study|Negative PCR result for SARS-CoV-2|20|||
127614604|NCT02641379|459217876|FG004|Overall Study|PCR positive at Week 48|0|||
127614605|NCT02641379|459217877|FG005|Overall Study|PCR positive at Week 48|0|||
127614606|NCT02641379|459217878|FG006|Overall Study|PCR positive at Week 48|0|||
127614607|NCT02641379|459217879|FG007|Overall Study|PCR positive at Week 48|0|||
127614608|NCT02641379|459217880|FG008|Overall Study|PCR positive at Week 48|0|||
127699509|NCT05364671|459528726|FG001|Overall Study|Negative PCR result for SARS-CoV-2|26|||
127883960|NCT00295620|460197963|FG000|Overall Study|Withdrawal by Subject|37|||
127883961|NCT00295620|460197964|FG001|Overall Study|Withdrawal by Subject|50|||
127883962|NCT00295620|460197963|FG000|Overall Study|Death|206|||
127614609|NCT02641379|459217881|FG009|Overall Study|PCR positive at Week 48|0|||
127614610|NCT02641379|459217882|FG010|Overall Study|PCR positive at Week 48|0|||
127614611|NCT02641379|459217872|FG000|Overall Study|PCR not performed at Week 12|0|||
127614612|NCT02641379|459217873|FG001|Overall Study|PCR not performed at Week 12|0|||
127614613|NCT02641379|459217874|FG002|Overall Study|PCR not performed at Week 12|1|||
127614614|NCT02641379|459217875|FG003|Overall Study|PCR not performed at Week 12|0|||
127614615|NCT02641379|459217876|FG004|Overall Study|PCR not performed at Week 12|0|||
127614616|NCT02641379|459217877|FG005|Overall Study|PCR not performed at Week 12|0|||
127614617|NCT02641379|459217878|FG006|Overall Study|PCR not performed at Week 12|0|||
127614618|NCT02641379|459217879|FG007|Overall Study|PCR not performed at Week 12|0|||
127614619|NCT02641379|459217880|FG008|Overall Study|PCR not performed at Week 12|0|||
127614620|NCT02641379|459217881|FG009|Overall Study|PCR not performed at Week 12|0|||
127614621|NCT02641379|459217882|FG010|Overall Study|PCR not performed at Week 12|0|||
127614622|NCT02641379|459217872|FG000|Overall Study|No PCR at baseline|0|||
127614623|NCT02641379|459217873|FG001|Overall Study|No PCR at baseline|0|||
127614624|NCT02641379|459217874|FG002|Overall Study|No PCR at baseline|1|||
127614625|NCT02641379|459217875|FG003|Overall Study|No PCR at baseline|0|||
127614626|NCT02641379|459217876|FG004|Overall Study|No PCR at baseline|0|||
127614627|NCT02641379|459217877|FG005|Overall Study|No PCR at baseline|0|||
127614628|NCT02641379|459217878|FG006|Overall Study|No PCR at baseline|0|||
127614629|NCT02641379|459217879|FG007|Overall Study|No PCR at baseline|0|||
127614630|NCT02641379|459217880|FG008|Overall Study|No PCR at baseline|0|||
127614631|NCT02641379|459217881|FG009|Overall Study|No PCR at baseline|0|||
127614632|NCT02641379|459217882|FG010|Overall Study|No PCR at baseline|0|||
127614633|NCT02641379|459217872|FG000|Overall Study|PCR positive at Week 28|0|||
127705233|NCT01928394|459551567|FG000|Follow-up Period|Participant withdrew consent|3|||
127614634|NCT02641379|459217873|FG001|Overall Study|PCR positive at Week 28|0|||
127614635|NCT02641379|459217874|FG002|Overall Study|PCR positive at Week 28|1|||
127614636|NCT02641379|459217875|FG003|Overall Study|PCR positive at Week 28|0|||
127614637|NCT02641379|459217876|FG004|Overall Study|PCR positive at Week 28|0|||
127614638|NCT02641379|459217877|FG005|Overall Study|PCR positive at Week 28|0|||
127614639|NCT02641379|459217878|FG006|Overall Study|PCR positive at Week 28|0|||
127883963|NCT00295620|460197964|FG001|Overall Study|Death|207|||
127883964|NCT00295620|460197963|FG000|Overall Study|Other reasons|10|||
127883965|NCT00295620|460197964|FG001|Overall Study|Other reasons|9|||
127883966|NCT00295620|460197963|FG000|Overall Study|Discontinuation by sponsor|580|||
127883967|NCT00295620|460197964|FG001|Overall Study|Discontinuation by sponsor|593|||
127883968|NCT00295620|460197963|FG000|Overall Study|Protocol Violation|30|||
127883969|NCT00295620|460197964|FG001|Overall Study|Protocol Violation|32|||
127883970|NCT00217971|460197965|FG000|Overall Study|Adverse Event|1|||
127883971|NCT00217971|460197966|FG001|Overall Study|Adverse Event|1|||
127883972|NCT00217971|460197965|FG000|Overall Study|Lost to Follow-up|15|||
127883973|NCT00217971|460197966|FG001|Overall Study|Lost to Follow-up|19|||
127883974|NCT00217971|460197965|FG000|Overall Study|Physician Decision|0|||
127883975|NCT00217971|460197966|FG001|Overall Study|Physician Decision|1|||
127883976|NCT00217971|460197965|FG000|Overall Study|Withdrawal by Subject|7|||
127883977|NCT00217971|460197966|FG001|Overall Study|Withdrawal by Subject|12|||
127883978|NCT00217971|460197965|FG000|Overall Study|non compliant|1|||
127883979|NCT00217971|460197966|FG001|Overall Study|non compliant|0|||
127883980|NCT02989610|460197967|FG000|Overall Study|Withdrawal by Subject|20|||
127883981|NCT02989610|460197967|FG000|Overall Study|Departure of PI from Site|8|||
127883982|NCT02989610|460197967|FG000|Overall Study|Subject Participation Terminated by Investigator|6|||
127883983|NCT02989610|460197967|FG000|Overall Study|Lost to Follow-up|3|||
127883984|NCT02989610|460197967|FG000|Overall Study|Death|3|||
127883985|NCT02989610|460197967|FG000|Overall Study|System Explant|3|||
127883986|NCT02989610|460197967|FG000|Overall Study|Subject Non-Compliance|2|||
127883987|NCT02989610|460197967|FG000|Overall Study|System Revision|2|||
127883988|NCT02989610|460197967|FG000|Overall Study|PI Left, Study Closing|1|||
127883989|NCT02989610|460197967|FG000|Overall Study|Site Discontinued Participation in the Study|1|||
127883990|NCT02989610|460197967|FG000|Overall Study|Unable to Complete Visit Due to PI Leaving University|1|||
127883991|NCT02556632|460197972|FG000|Overall Study|Lost to Follow-up|1|||
127883992|NCT02556632|460197973|FG001|Overall Study|Lost to Follow-up|0|||
127883993|NCT02556632|460197974|FG002|Overall Study|Lost to Follow-up|0|||
127883994|NCT02556632|460197972|FG000|Overall Study|Disliked Intervention|1|||
127883995|NCT02556632|460197973|FG001|Overall Study|Disliked Intervention|1|||
127883996|NCT02556632|460197974|FG002|Overall Study|Disliked Intervention|1|||
127883997|NCT02556632|460197972|FG000|Overall Study|No Reason|1|||
127883998|NCT02556632|460197973|FG001|Overall Study|No Reason|0|||
127883999|NCT02556632|460197974|FG002|Overall Study|No Reason|1|||
127884000|NCT02556632|460197972|FG000|Overall Study|Personal Issues|0|||
127884001|NCT02556632|460197973|FG001|Overall Study|Personal Issues|1|||
127884002|NCT02556632|460197974|FG002|Overall Study|Personal Issues|1|||
127884003|NCT02556632|460197972|FG000|Overall Study|Changed Mind|0|||
127884004|NCT02556632|460197973|FG001|Overall Study|Changed Mind|1|||
127884005|NCT02556632|460197974|FG002|Overall Study|Changed Mind|0|||
127884006|NCT02556632|460197972|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
127884007|NCT02556632|460197973|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
127884008|NCT02556632|460197974|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
127884009|NCT02556632|460197972|FG000|Overall Study|Unrelated Adverse Event|1|||
127884010|NCT02556632|460197973|FG001|Overall Study|Unrelated Adverse Event|0|||
127884011|NCT02556632|460197974|FG002|Overall Study|Unrelated Adverse Event|3|||
127884012|NCT02556632|460197972|FG000|Overall Study|Related Adverse Event|0|||
127884013|NCT02556632|460197973|FG001|Overall Study|Related Adverse Event|1|||
127884014|NCT02556632|460197974|FG002|Overall Study|Related Adverse Event|0|||
127884015|NCT02556632|460197972|FG000|Overall Study|Possibly Related Adverse Event|0|||
127884016|NCT02556632|460197973|FG001|Overall Study|Possibly Related Adverse Event|0|||
127884017|NCT02556632|460197974|FG002|Overall Study|Possibly Related Adverse Event|1|||
127884018|NCT02556632|460197972|FG000|Overall Study|Did Not Start RT|0|||
127884019|NCT02556632|460197973|FG001|Overall Study|Did Not Start RT|1|||
127884020|NCT02556632|460197974|FG002|Overall Study|Did Not Start RT|0|||
127884021|NCT02556632|460197972|FG000|Overall Study|Ineligible|0|||
127884022|NCT02556632|460197973|FG001|Overall Study|Ineligible|1|||
127884023|NCT02556632|460197974|FG002|Overall Study|Ineligible|0|||
127884024|NCT02556632|460197972|FG000|Overall Study|Disliked Study Procedures|0|||
127884025|NCT02556632|460197973|FG001|Overall Study|Disliked Study Procedures|0|||
127884026|NCT02556632|460197974|FG002|Overall Study|Disliked Study Procedures|1|||
127884027|NCT02556632|460197972|FG000|Overall Study|Treatment or Change Delay|0|||
127884028|NCT02556632|460197973|FG001|Overall Study|Treatment or Change Delay|0|||
127614640|NCT02641379|459217879|FG007|Overall Study|PCR positive at Week 28|0|||
127884029|NCT02556632|460197974|FG002|Overall Study|Treatment or Change Delay|1|||
127884030|NCT02574260|460197977|FG000|Overall Study|Disease Progression|1|||
127884031|NCT01066039|460197978|FG000|Overall Study|Adverse Event|6|||
127884032|NCT01066039|460197978|FG000|Overall Study|Withdrawal by Subject|17|||
127884033|NCT01066039|460197978|FG000|Overall Study|Protocol Violation|2|||
127884034|NCT01066039|460197978|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
127884035|NCT01066039|460197978|FG000|Overall Study|Investigator's Request|1|||
127884036|NCT01066039|460197978|FG000|Overall Study|Dropout due to Insulin Administration|1|||
127884037|NCT01066039|460197978|FG000|Overall Study|Additional Antihypertensive Required|4|||
127884038|NCT01066039|460197978|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
127614641|NCT02641379|459217880|FG008|Overall Study|PCR positive at Week 28|0|||
127614642|NCT02641379|459217881|FG009|Overall Study|PCR positive at Week 28|0|||
127614643|NCT02641379|459217882|FG010|Overall Study|PCR positive at Week 28|0|||
127614644|NCT02641379|459217872|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
127614645|NCT02641379|459217873|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
127614646|NCT02641379|459217874|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
127614647|NCT02641379|459217875|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
127614648|NCT02641379|459217876|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
127614649|NCT02641379|459217877|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
127614650|NCT02641379|459217878|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
127614651|NCT02641379|459217879|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
127614652|NCT02641379|459217880|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
127614653|NCT02641379|459217881|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
127614654|NCT02641379|459217882|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
127614655|NCT02641379|459217872|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
127614656|NCT02641379|459217873|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
127614657|NCT02641379|459217874|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
127614658|NCT02641379|459217875|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
127614659|NCT02641379|459217876|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
127614660|NCT02641379|459217877|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
127614661|NCT02641379|459217878|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
127614662|NCT02641379|459217879|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
127614663|NCT02641379|459217880|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
127614664|NCT02641379|459217881|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
127884039|NCT01066039|460197978|FG000|Overall Study|Failure to Control Blood Pressure|1|||
127884040|NCT01066039|460197978|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
127884041|NCT04508621|460197984|FG000|Overall Study|Adverse Event|39|||
127884042|NCT04508621|460197985|FG001|Overall Study|Adverse Event|16|||
127884043|NCT04508621|460197984|FG000|Overall Study|Lack of Efficacy|2|||
127884044|NCT04508621|460197985|FG001|Overall Study|Lack of Efficacy|8|||
127884045|NCT04508621|460197984|FG000|Overall Study|Physician Decision|0|||
127884046|NCT04508621|460197985|FG001|Overall Study|Physician Decision|1|||
127884047|NCT04508621|460197984|FG000|Overall Study|Withdrawal by Subject|10|||
127884048|NCT04508621|460197985|FG001|Overall Study|Withdrawal by Subject|14|||
127884049|NCT04508621|460197984|FG000|Overall Study|Lost to Follow-up|12|||
127884050|NCT04508621|460197985|FG001|Overall Study|Lost to Follow-up|9|||
127884051|NCT04508621|460197984|FG000|Overall Study|COVID-19 related crisis|3|||
127884052|NCT04508621|460197985|FG001|Overall Study|COVID-19 related crisis|0|||
127884053|NCT04508621|460197984|FG000|Overall Study|Subject non-compliance|1|||
127614665|NCT02641379|459217882|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
127884054|NCT04508621|460197985|FG001|Overall Study|Subject non-compliance|0|||
127614666|NCT02641379|459217872|FG000|Overall Study|Baseline viral load unavailable|0|||
127614667|NCT02641379|459217873|FG001|Overall Study|Baseline viral load unavailable|0|||
127614668|NCT02641379|459217874|FG002|Overall Study|Baseline viral load unavailable|0|||
127614669|NCT02641379|459217875|FG003|Overall Study|Baseline viral load unavailable|1|||
127614670|NCT02641379|459217876|FG004|Overall Study|Baseline viral load unavailable|0|||
127614671|NCT02641379|459217877|FG005|Overall Study|Baseline viral load unavailable|0|||
127614672|NCT02641379|459217878|FG006|Overall Study|Baseline viral load unavailable|0|||
127614673|NCT02641379|459217879|FG007|Overall Study|Baseline viral load unavailable|0|||
127614674|NCT02641379|459217880|FG008|Overall Study|Baseline viral load unavailable|0|||
127614675|NCT02641379|459217881|FG009|Overall Study|Baseline viral load unavailable|0|||
127614676|NCT02641379|459217882|FG010|Overall Study|Baseline viral load unavailable|0|||
127614677|NCT02641379|459217872|FG000|Overall Study|Blood could not be drawn|0|||
127614678|NCT02641379|459217873|FG001|Overall Study|Blood could not be drawn|0|||
127614679|NCT02641379|459217874|FG002|Overall Study|Blood could not be drawn|0|||
127614680|NCT02641379|459217875|FG003|Overall Study|Blood could not be drawn|0|||
127614681|NCT02641379|459217876|FG004|Overall Study|Blood could not be drawn|1|||
127614682|NCT02641379|459217877|FG005|Overall Study|Blood could not be drawn|0|||
127614683|NCT02641379|459217878|FG006|Overall Study|Blood could not be drawn|0|||
127614684|NCT02641379|459217879|FG007|Overall Study|Blood could not be drawn|0|||
127884055|NCT00808015|460197986|FG000|Overall Study|Death|1|||
127884056|NCT00808015|460197986|FG000|Overall Study|Lack of Efficacy|58|||
127884057|NCT00808015|460197986|FG000|Overall Study|Lost to Follow-up|76|||
127884058|NCT00808015|460197986|FG000|Overall Study|Participants not willing to participate|158|||
127884059|NCT00808015|460197986|FG000|Overall Study|Adverse Event|22|||
127614685|NCT02641379|459217880|FG008|Overall Study|Blood could not be drawn|0|||
127614686|NCT02641379|459217881|FG009|Overall Study|Blood could not be drawn|0|||
127614687|NCT02641379|459217882|FG010|Overall Study|Blood could not be drawn|0|||
127614688|NCT02641379|459217872|FG000|Overall Study|Protocol Violation|0|||
127614689|NCT02641379|459217873|FG001|Overall Study|Protocol Violation|0|||
127614690|NCT02641379|459217874|FG002|Overall Study|Protocol Violation|0|||
127614691|NCT02641379|459217875|FG003|Overall Study|Protocol Violation|0|||
127614692|NCT02641379|459217876|FG004|Overall Study|Protocol Violation|2|||
127614693|NCT02641379|459217877|FG005|Overall Study|Protocol Violation|0|||
127614694|NCT02641379|459217878|FG006|Overall Study|Protocol Violation|0|||
127614695|NCT02641379|459217879|FG007|Overall Study|Protocol Violation|0|||
127614696|NCT02641379|459217880|FG008|Overall Study|Protocol Violation|1|||
127614697|NCT02641379|459217881|FG009|Overall Study|Protocol Violation|0|||
127614698|NCT02641379|459217882|FG010|Overall Study|Protocol Violation|0|||
127614699|NCT02641379|459217872|FG000|Overall Study|Participation in sili rescue study|0|||
127614700|NCT02641379|459217873|FG001|Overall Study|Participation in sili rescue study|0|||
127614701|NCT02641379|459217874|FG002|Overall Study|Participation in sili rescue study|0|||
127614702|NCT02641379|459217875|FG003|Overall Study|Participation in sili rescue study|0|||
127614703|NCT02641379|459217876|FG004|Overall Study|Participation in sili rescue study|0|||
127614704|NCT02641379|459217877|FG005|Overall Study|Participation in sili rescue study|1|||
127614705|NCT02641379|459217878|FG006|Overall Study|Participation in sili rescue study|0|||
127614706|NCT02641379|459217879|FG007|Overall Study|Participation in sili rescue study|0|||
127614707|NCT02641379|459217880|FG008|Overall Study|Participation in sili rescue study|0|||
127614708|NCT02641379|459217881|FG009|Overall Study|Participation in sili rescue study|0|||
127614709|NCT02641379|459217882|FG010|Overall Study|Participation in sili rescue study|0|||
127614710|NCT02641379|459217872|FG000|Overall Study|Lost to Follow-up|0|||
127614711|NCT02641379|459217873|FG001|Overall Study|Lost to Follow-up|0|||
127614712|NCT02641379|459217874|FG002|Overall Study|Lost to Follow-up|0|||
127614713|NCT02641379|459217875|FG003|Overall Study|Lost to Follow-up|0|||
127614714|NCT02641379|459217876|FG004|Overall Study|Lost to Follow-up|0|||
127614715|NCT02641379|459217877|FG005|Overall Study|Lost to Follow-up|0|||
127614716|NCT02641379|459217878|FG006|Overall Study|Lost to Follow-up|0|||
127614717|NCT02641379|459217879|FG007|Overall Study|Lost to Follow-up|0|||
127614718|NCT02641379|459217880|FG008|Overall Study|Lost to Follow-up|1|||
127614719|NCT02641379|459217881|FG009|Overall Study|Lost to Follow-up|0|||
127614720|NCT02641379|459217882|FG010|Overall Study|Lost to Follow-up|0|||
127614721|NCT02641379|459217872|FG000|Overall Study|Source data not found|0|||
127614722|NCT02641379|459217873|FG001|Overall Study|Source data not found|0|||
127614723|NCT02641379|459217874|FG002|Overall Study|Source data not found|0|||
127614724|NCT02641379|459217875|FG003|Overall Study|Source data not found|0|||
127614725|NCT02641379|459217876|FG004|Overall Study|Source data not found|0|||
127614726|NCT02641379|459217877|FG005|Overall Study|Source data not found|1|||
127614727|NCT02641379|459217878|FG006|Overall Study|Source data not found|0|||
127614728|NCT02641379|459217879|FG007|Overall Study|Source data not found|0|||
127614729|NCT02641379|459217880|FG008|Overall Study|Source data not found|0|||
127614730|NCT02641379|459217881|FG009|Overall Study|Source data not found|0|||
127614731|NCT02641379|459217882|FG010|Overall Study|Source data not found|0|||
127614732|NCT02641379|459217872|FG000|Overall Study|Participant showed weight reduction|0|||
127614733|NCT02641379|459217873|FG001|Overall Study|Participant showed weight reduction|0|||
127614734|NCT02641379|459217874|FG002|Overall Study|Participant showed weight reduction|0|||
127614735|NCT02641379|459217875|FG003|Overall Study|Participant showed weight reduction|0|||
127614736|NCT02641379|459217876|FG004|Overall Study|Participant showed weight reduction|0|||
127614737|NCT02641379|459217877|FG005|Overall Study|Participant showed weight reduction|0|||
127614738|NCT02641379|459217878|FG006|Overall Study|Participant showed weight reduction|0|||
127614739|NCT02641379|459217879|FG007|Overall Study|Participant showed weight reduction|1|||
127614740|NCT02641379|459217880|FG008|Overall Study|Participant showed weight reduction|0|||
127614741|NCT02641379|459217881|FG009|Overall Study|Participant showed weight reduction|0|||
127614742|NCT02641379|459217882|FG010|Overall Study|Participant showed weight reduction|0|||
127614743|NCT02641379|459217872|FG000|Overall Study|Non-response Week 12|0|||
127614744|NCT02641379|459217873|FG001|Overall Study|Non-response Week 12|0|||
127614745|NCT02641379|459217874|FG002|Overall Study|Non-response Week 12|0|||
127614746|NCT02641379|459217875|FG003|Overall Study|Non-response Week 12|0|||
127614747|NCT02641379|459217876|FG004|Overall Study|Non-response Week 12|0|||
127614748|NCT02641379|459217877|FG005|Overall Study|Non-response Week 12|0|||
127614749|NCT02641379|459217878|FG006|Overall Study|Non-response Week 12|0|||
127614750|NCT02641379|459217879|FG007|Overall Study|Non-response Week 12|1|||
127614751|NCT02641379|459217880|FG008|Overall Study|Non-response Week 12|0|||
127614752|NCT02641379|459217881|FG009|Overall Study|Non-response Week 12|0|||
127614753|NCT02641379|459217882|FG010|Overall Study|Non-response Week 12|0|||
127614754|NCT02641379|459217872|FG000|Overall Study|No 2 Log drop at Week 12|0|||
127614755|NCT02641379|459217873|FG001|Overall Study|No 2 Log drop at Week 12|0|||
127614756|NCT02641379|459217874|FG002|Overall Study|No 2 Log drop at Week 12|0|||
127614757|NCT02641379|459217875|FG003|Overall Study|No 2 Log drop at Week 12|0|||
127614758|NCT02641379|459217876|FG004|Overall Study|No 2 Log drop at Week 12|0|||
127705234|NCT01928394|459551568|FG001|Follow-up Period|Participant withdrew consent|0|||
127614759|NCT02641379|459217877|FG005|Overall Study|No 2 Log drop at Week 12|0|||
127614760|NCT02641379|459217878|FG006|Overall Study|No 2 Log drop at Week 12|0|||
127614761|NCT02641379|459217879|FG007|Overall Study|No 2 Log drop at Week 12|0|||
127614762|NCT02641379|459217880|FG008|Overall Study|No 2 Log drop at Week 12|0|||
127614763|NCT02641379|459217881|FG009|Overall Study|No 2 Log drop at Week 12|0|||
127614764|NCT02641379|459217882|FG010|Overall Study|No 2 Log drop at Week 12|1|||
127614765|NCT02641379|459217872|FG000|Overall Study|Negative PCR result|0|||
127705235|NCT01928394|459551569|FG002|Follow-up Period|Participant withdrew consent|1|||
127614766|NCT02641379|459217873|FG001|Overall Study|Negative PCR result|0|||
127614767|NCT02641379|459217874|FG002|Overall Study|Negative PCR result|0|||
127614768|NCT02641379|459217875|FG003|Overall Study|Negative PCR result|0|||
127614769|NCT02641379|459217876|FG004|Overall Study|Negative PCR result|0|||
127614770|NCT02641379|459217877|FG005|Overall Study|Negative PCR result|0|||
127614771|NCT02641379|459217878|FG006|Overall Study|Negative PCR result|0|||
127614772|NCT02641379|459217879|FG007|Overall Study|Negative PCR result|0|||
127614773|NCT02641379|459217880|FG008|Overall Study|Negative PCR result|0|||
127614774|NCT02641379|459217881|FG009|Overall Study|Negative PCR result|1|||
127614775|NCT02641379|459217882|FG010|Overall Study|Negative PCR result|0|||
127614776|NCT02641379|459217872|FG000|Overall Study|Participant's PCR high|0|||
127614777|NCT02641379|459217873|FG001|Overall Study|Participant's PCR high|0|||
127614778|NCT02641379|459217874|FG002|Overall Study|Participant's PCR high|0|||
127614779|NCT02641379|459217875|FG003|Overall Study|Participant's PCR high|0|||
127614780|NCT02641379|459217876|FG004|Overall Study|Participant's PCR high|0|||
127614781|NCT02641379|459217877|FG005|Overall Study|Participant's PCR high|0|||
127614782|NCT02641379|459217878|FG006|Overall Study|Participant's PCR high|0|||
127614783|NCT02641379|459217879|FG007|Overall Study|Participant's PCR high|1|||
127614784|NCT02641379|459217880|FG008|Overall Study|Participant's PCR high|0|||
127614785|NCT02641379|459217881|FG009|Overall Study|Participant's PCR high|0|||
127614786|NCT02641379|459217882|FG010|Overall Study|Participant's PCR high|0|||
127614787|NCT02641379|459217872|FG000|Overall Study|Participant treated after Week 24|0|||
127614788|NCT02641379|459217873|FG001|Overall Study|Participant treated after Week 24|0|||
127614789|NCT02641379|459217874|FG002|Overall Study|Participant treated after Week 24|0|||
127614790|NCT02641379|459217875|FG003|Overall Study|Participant treated after Week 24|0|||
127614791|NCT02641379|459217876|FG004|Overall Study|Participant treated after Week 24|0|||
127614792|NCT02641379|459217877|FG005|Overall Study|Participant treated after Week 24|0|||
127614793|NCT02641379|459217878|FG006|Overall Study|Participant treated after Week 24|0|||
127614794|NCT02641379|459217879|FG007|Overall Study|Participant treated after Week 24|0|||
127614795|NCT02641379|459217880|FG008|Overall Study|Participant treated after Week 24|1|||
127614796|NCT02641379|459217881|FG009|Overall Study|Participant treated after Week 24|0|||
127614797|NCT02641379|459217882|FG010|Overall Study|Participant treated after Week 24|0|||
127614798|NCT02641379|459217872|FG000|Overall Study|Missing PCR result at Week 8|0|||
127614799|NCT02641379|459217873|FG001|Overall Study|Missing PCR result at Week 8|0|||
127614800|NCT02641379|459217874|FG002|Overall Study|Missing PCR result at Week 8|0|||
127614801|NCT02641379|459217875|FG003|Overall Study|Missing PCR result at Week 8|0|||
127614802|NCT02641379|459217876|FG004|Overall Study|Missing PCR result at Week 8|0|||
127614803|NCT02641379|459217877|FG005|Overall Study|Missing PCR result at Week 8|0|||
127614804|NCT02641379|459217878|FG006|Overall Study|Missing PCR result at Week 8|0|||
127614805|NCT02641379|459217879|FG007|Overall Study|Missing PCR result at Week 8|0|||
127614806|NCT02641379|459217880|FG008|Overall Study|Missing PCR result at Week 8|0|||
127614807|NCT02641379|459217881|FG009|Overall Study|Missing PCR result at Week 8|1|||
127614808|NCT02641379|459217882|FG010|Overall Study|Missing PCR result at Week 8|0|||
127614809|NCT02641379|459217872|FG000|Overall Study|PCR positive|0|||
127614810|NCT02641379|459217873|FG001|Overall Study|PCR positive|0|||
127614811|NCT02641379|459217874|FG002|Overall Study|PCR positive|0|||
127614812|NCT02641379|459217875|FG003|Overall Study|PCR positive|0|||
127614813|NCT02641379|459217876|FG004|Overall Study|PCR positive|0|||
127614814|NCT02641379|459217877|FG005|Overall Study|PCR positive|0|||
127614815|NCT02641379|459217878|FG006|Overall Study|PCR positive|1|||
127614816|NCT02641379|459217879|FG007|Overall Study|PCR positive|0|||
127614817|NCT02641379|459217880|FG008|Overall Study|PCR positive|0|||
127790676|NCT01979536|459857168|FG000|Overall Study|Did not start treatment|0|||
127614818|NCT02641379|459217881|FG009|Overall Study|PCR positive|0|||
127614819|NCT02641379|459217882|FG010|Overall Study|PCR positive|0|||
127614820|NCT04982250|459217883|FG000|Overall Study|Lost to Follow-up|0|||
127614821|NCT04982250|459217884|FG001|Overall Study|Lost to Follow-up|26|||
127614822|NCT04982250|459217885|FG002|Overall Study|Lost to Follow-up|0|||
127614823|NCT04982250|459217886|FG003|Overall Study|Lost to Follow-up|0|||
127614824|NCT04982250|459217887|FG004|Overall Study|Lost to Follow-up|72|||
127614825|NCT04982250|459217888|FG005|Overall Study|Lost to Follow-up|69|||
127614826|NCT04982250|459217883|FG000|Overall Study|Not Eligible to Enroll|0|||
127614827|NCT04982250|459217884|FG001|Overall Study|Not Eligible to Enroll|0|||
127614828|NCT04982250|459217885|FG002|Overall Study|Not Eligible to Enroll|0|||
127614829|NCT04982250|459217886|FG003|Overall Study|Not Eligible to Enroll|0|||
127614830|NCT04982250|459217887|FG004|Overall Study|Not Eligible to Enroll|10|||
127614831|NCT04982250|459217888|FG005|Overall Study|Not Eligible to Enroll|7|||
127614832|NCT01644175|459217892|FG000|Overall Study|Randomized But Not Treated|0|||
127614833|NCT01644175|459217893|FG001|Overall Study|Randomized But Not Treated|2|||
127614834|NCT01644175|459217892|FG000|Overall Study|Adverse Event|8|||
127614835|NCT01644175|459217893|FG001|Overall Study|Adverse Event|13|||
127614836|NCT01644175|459217892|FG000|Overall Study|Death|1|||
127614837|NCT01644175|459217893|FG001|Overall Study|Death|2|||
127614838|NCT01644175|459217892|FG000|Overall Study|Poor compliance to protocol|9|||
127614839|NCT01644175|459217893|FG001|Overall Study|Poor compliance to protocol|10|||
127614840|NCT01644175|459217892|FG000|Overall Study|Physician Decision|1|||
127790677|NCT01979536|459857169|FG001|Overall Study|Did not start treatment|1|||
127790678|NCT03077685|459857170|FG000|Overall Study|Lost to Follow-up|0|||
127614841|NCT01644175|459217893|FG001|Overall Study|Physician Decision|2|||
127790679|NCT03077685|459857171|FG001|Overall Study|Lost to Follow-up|0|||
127614842|NCT01644175|459217892|FG000|Overall Study|Participant Moved|1|||
127614843|NCT01644175|459217893|FG001|Overall Study|Participant Moved|2|||
127614844|NCT01644175|459217892|FG000|Overall Study|Consent withdrawn by participant|3|||
127614845|NCT01644175|459217893|FG001|Overall Study|Consent withdrawn by participant|4|||
127614846|NCT01644175|459217892|FG000|Overall Study|Related to Autoinjector Administration|2|||
127614847|NCT01644175|459217893|FG001|Overall Study|Related to Autoinjector Administration|1|||
127614848|NCT01644175|459217892|FG000|Overall Study|Last visit outside protocol visit window|4|||
127614849|NCT01644175|459217893|FG001|Overall Study|Last visit outside protocol visit window|11|||
127614850|NCT01644175|459217892|FG000|Overall Study|Selection criteria finally not met|0|||
127614851|NCT01644175|459217893|FG001|Overall Study|Selection criteria finally not met|1|||
127614852|NCT01644175|459217892|FG000|Overall Study|Site closure|2|||
127614853|NCT01644175|459217893|FG001|Overall Study|Site closure|2|||
127614854|NCT01644175|459217892|FG000|Overall Study|Lost to Follow-up|1|||
127614855|NCT01644175|459217893|FG001|Overall Study|Lost to Follow-up|0|||
127614856|NCT01644175|459217892|FG000|Overall Study|Other than specified above|0|||
127614857|NCT01644175|459217893|FG001|Overall Study|Other than specified above|3|||
127614858|NCT01418937|459217897|FG000|Overall Study|Lost to Follow-up|5|||
127614859|NCT01418937|459217897|FG000|Overall Study|Protocol Violation|1|||
127614860|NCT01418937|459217897|FG000|Overall Study|Pregnancy|1|||
127614861|NCT01418937|459217897|FG000|Overall Study|Withdrawal by Subject|1|||
127614862|NCT00842348|459217898|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
127614863|NCT00842348|459217899|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
127614864|NCT00842348|459217898|FG000|Study 729|Disease progression/death|19|||
127614865|NCT00842348|459217899|FG001|Study 729|Disease progression/death|30|||
127614866|NCT00842348|459217898|FG000|Study 729|Adverse Event|1|||
127614867|NCT00842348|459217899|FG001|Study 729|Adverse Event|1|||
127614868|NCT00842348|459217898|FG000|Study 729|Protocol Violation|1|||
127614869|NCT00842348|459217899|FG001|Study 729|Protocol Violation|1|||
127614870|NCT00842348|459217898|FG000|Study 729|Withdrawal by Subject|2|||
127614871|NCT00842348|459217899|FG001|Study 729|Withdrawal by Subject|4|||
127614872|NCT00842348|459217898|FG000|Study 729|Due to Sponsor stopping the study|1|||
127614873|NCT00842348|459217899|FG001|Study 729|Due to Sponsor stopping the study|1|||
127614874|NCT00842348|459217898|FG000|Study 729|Due to non-availability of IP|0|||
127614875|NCT00842348|459217899|FG001|Study 729|Due to non-availability of IP|1|||
127614876|NCT00842348|459217898|FG000|Study 729|Sponsor's decision|1|||
127614877|NCT00842348|459217899|FG001|Study 729|Sponsor's decision|0|||
127614878|NCT00842348|459217898|FG000|Study 729|Surgical resection|1|||
127614879|NCT00842348|459217899|FG001|Study 729|Surgical resection|0|||
127614880|NCT03323658|459217900|FG000|Overall Study|Adverse Event|0|||
127614881|NCT03323658|459217901|FG001|Overall Study|Adverse Event|1|||
127614882|NCT03323658|459217902|FG002|Overall Study|Adverse Event|0|||
127614883|NCT02849548|459217903|FG000|Overall Study|Lost to Follow-up|1|||
127614884|NCT02849548|459217904|FG001|Overall Study|Lost to Follow-up|2|||
127614885|NCT02849548|459217903|FG000|Overall Study|Protocol Violation|1|||
127614886|NCT02849548|459217904|FG001|Overall Study|Protocol Violation|0|||
127614887|NCT02357147|459217906|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
127614888|NCT02357147|459217907|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
127614889|NCT02357147|459217906|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
127614890|NCT02357147|459217907|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
127614891|NCT02357147|459217906|FG000|Combination Treatment Phase|Investigator Discretion|1|||
127614892|NCT02357147|459217907|FG001|Combination Treatment Phase|Investigator Discretion|1|||
127614893|NCT02357147|459217906|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
127614894|NCT02357147|459217907|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
127614895|NCT02357147|459217906|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
127614896|NCT02357147|459217907|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
127614897|NCT02357147|459217906|FG000|Combination Treatment Phase|Adverse Event|12|||
127614898|NCT02357147|459217907|FG001|Combination Treatment Phase|Adverse Event|4|||
127614899|NCT02357147|459217906|FG000|Combination Treatment Phase|Death|1|||
127614900|NCT02357147|459217907|FG001|Combination Treatment Phase|Death|1|||
127614901|NCT02357147|459217906|FG000|Combination Treatment Phase|Sponsor Decision|0|||
127614902|NCT02357147|459217907|FG001|Combination Treatment Phase|Sponsor Decision|12|||
127699510|NCT05364671|459528725|FG000|Overall Study|Patient's inability or refusal to comply with protocol requirements|3|||
127699511|NCT05364671|459528726|FG001|Overall Study|Patient's inability or refusal to comply with protocol requirements|1|||
127699512|NCT05364671|459528725|FG000|Overall Study|Need to prescribe prohibited drugs in this study|1|||
127614903|NCT02357147|459217906|FG000|Combination Treatment Phase|Other|1|||
127614904|NCT02357147|459217907|FG001|Combination Treatment Phase|Other|0|||
127614905|NCT02357147|459217906|FG000|Combination Treatment Phase|Not treated|0|||
127614906|NCT02357147|459217907|FG001|Combination Treatment Phase|Not treated|2|||
127699513|NCT05364671|459528726|FG001|Overall Study|Need to prescribe prohibited drugs in this study|3|||
127614907|NCT02357147|459217906|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
127614908|NCT02357147|459217907|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
127790680|NCT03077685|459857172|FG002|Overall Study|Lost to Follow-up|0|||
127614909|NCT02357147|459217906|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
127614910|NCT02357147|459217907|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
127614911|NCT02357147|459217906|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
127884060|NCT00808015|460197986|FG000|Overall Study|Other|25|||
127884061|NCT00808015|460197986|FG000|Overall Study|Enrolled but not treated|4|||
127884062|NCT00084617|460197997|FG000|Overall Study|Withdrawal by Subject|7|||
127884063|NCT00084617|460197997|FG000|Overall Study|Lack of Efficacy|1|||
127884064|NCT00084617|460197997|FG000|Overall Study|Protocol Violation|1|||
127884065|NCT01625286|460197998|FG000|Overall Study|Adverse Event|0|||
127884066|NCT01625286|460197999|FG001|Overall Study|Adverse Event|0|||
127884067|NCT01625286|460198000|FG002|Overall Study|Adverse Event|0|||
127884068|NCT01625286|460198001|FG003|Overall Study|Adverse Event|0|||
127884069|NCT01625286|460198002|FG004|Overall Study|Adverse Event|1|||
127884070|NCT01625286|460198003|FG005|Overall Study|Adverse Event|2|||
127884071|NCT01625286|460198004|FG006|Overall Study|Adverse Event|1|||
127884072|NCT01625286|460197998|FG000|Overall Study|Death|0|||
127884073|NCT01625286|460197999|FG001|Overall Study|Death|0|||
127884074|NCT01625286|460198000|FG002|Overall Study|Death|1|||
127884075|NCT01625286|460198001|FG003|Overall Study|Death|1|||
127614912|NCT02357147|459217907|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
127614913|NCT02357147|459217906|FG000|Maintenance Treatment Phase|Adverse Event|0|||
127614914|NCT02357147|459217907|FG001|Maintenance Treatment Phase|Adverse Event|3|||
127614915|NCT02357147|459217906|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
127614916|NCT02357147|459217907|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
127614917|NCT02357147|459217906|FG000|Maintenance Treatment Phase|Not Treated|1|||
127614918|NCT02357147|459217907|FG001|Maintenance Treatment Phase|Not Treated|0|||
127614919|NCT03962543|459217908|FG000|Treatment Phase|Death|0|||
127614920|NCT03962543|459217909|FG001|Treatment Phase|Death|1|||
127614921|NCT03962543|459217908|FG000|Treatment Phase|Withdrawal by Subject|3|||
127614922|NCT03962543|459217909|FG001|Treatment Phase|Withdrawal by Subject|0|||
127614923|NCT03962543|459217908|FG000|Treatment Phase|Adverse Event|3|||
127614924|NCT03962543|459217909|FG001|Treatment Phase|Adverse Event|12|||
127614925|NCT03962543|459217908|FG000|Treatment Phase|Lost to Follow-up|1|||
127614926|NCT03962543|459217909|FG001|Treatment Phase|Lost to Follow-up|2|||
127614927|NCT03962543|459217908|FG000|Treatment Phase|Radiographic PD|9|||
127884076|NCT01625286|460198002|FG004|Overall Study|Death|0|||
127884077|NCT01625286|460198003|FG005|Overall Study|Death|11|||
127884078|NCT01625286|460198004|FG006|Overall Study|Death|16|||
127614928|NCT03962543|459217909|FG001|Treatment Phase|Radiographic PD|3|||
127614929|NCT03962543|459217908|FG000|Treatment Phase|Participant Decision|3|||
127614930|NCT03962543|459217909|FG001|Treatment Phase|Participant Decision|8|||
127884079|NCT01625286|460197998|FG000|Overall Study|Withdrawal by Subject|0|||
127884080|NCT01625286|460197999|FG001|Overall Study|Withdrawal by Subject|1|||
127699514|NCT05364671|459528725|FG000|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|2|||
127614931|NCT03962543|459217908|FG000|Treatment Phase|Received procedure not compatible with MRI|0|||
127614932|NCT03962543|459217909|FG001|Treatment Phase|Received procedure not compatible with MRI|1|||
127614933|NCT03962543|459217908|FG000|Treatment Phase|Ongoing in the Treatment Phase|4|||
127614934|NCT03962543|459217909|FG001|Treatment Phase|Ongoing in the Treatment Phase|0|||
127614935|NCT03962543|459217908|FG000|Long Term Follow-Up Phase|Withdrawal by Subject|0|||
127614936|NCT03962543|459217909|FG001|Long Term Follow-Up Phase|Withdrawal by Subject|1|||
127614937|NCT03962543|459217908|FG000|Long Term Follow-Up Phase|Adverse Event|1|||
127614938|NCT03962543|459217909|FG001|Long Term Follow-Up Phase|Adverse Event|0|||
127614939|NCT03962543|459217908|FG000|Long Term Follow-Up Phase|Physician Decision|0|||
127614940|NCT03962543|459217909|FG001|Long Term Follow-Up Phase|Physician Decision|1|||
127614941|NCT03962543|459217908|FG000|Long Term Follow-Up Phase|Radiographic PD|1|||
127614942|NCT03962543|459217909|FG001|Long Term Follow-Up Phase|Radiographic PD|0|||
127614943|NCT03962543|459217908|FG000|Long Term Follow-Up Phase|Sponsor Request|1|||
127614944|NCT03962543|459217909|FG001|Long Term Follow-Up Phase|Sponsor Request|0|||
127614945|NCT03962543|459217908|FG000|Long Term Follow-Up Phase|Participant Decision|0|||
127614946|NCT03962543|459217909|FG001|Long Term Follow-Up Phase|Participant Decision|1|||
127614947|NCT03962543|459217908|FG000|Long Term Follow-Up Phase|Positive pregnancy test|0|||
127614948|NCT03962543|459217909|FG001|Long Term Follow-Up Phase|Positive pregnancy test|1|||
127614949|NCT03962543|459217908|FG000|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|25|||
127614950|NCT03962543|459217909|FG001|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|22|||
127614951|NCT03264404|459219782|FG000|Overall Study|Death|2|||
127614952|NCT03264404|459219782|FG000|Overall Study|Physician Decision|1|||
127614953|NCT03264404|459219782|FG000|Overall Study|Disease Progression|28|||
127614954|NCT03264404|459219782|FG000|Overall Study|Adverse Event|1|||
127614955|NCT03264404|459219782|FG000|Overall Study|Off study prior to treatment|2|||
127614956|NCT03036566|459219783|FG000|Overall Study|Lost to Follow-up|3|||
127614957|NCT01454726|459219785|FG000|Overall Study|Withdrawal by Subject|0|||
127614958|NCT01454726|459219786|FG001|Overall Study|Withdrawal by Subject|1|||
127614959|NCT00283439|459219789|FG000|Overall Study|Adverse Event|0|||
127614960|NCT00283439|459219790|FG001|Overall Study|Adverse Event|0|||
127614961|NCT00283439|459219791|FG002|Overall Study|Adverse Event|0|||
127614962|NCT00283439|459219792|FG003|Overall Study|Adverse Event|1|||
127614963|NCT00283439|459219789|FG000|Overall Study|Death|0|||
127614964|NCT00283439|459219790|FG001|Overall Study|Death|0|||
127614965|NCT00283439|459219791|FG002|Overall Study|Death|1|||
127614966|NCT00283439|459219792|FG003|Overall Study|Death|0|||
127614967|NCT00283439|459219789|FG000|Overall Study|Disease progression|0|||
127614968|NCT00283439|459219790|FG001|Overall Study|Disease progression|1|||
127614969|NCT00283439|459219791|FG002|Overall Study|Disease progression|0|||
127614970|NCT00283439|459219792|FG003|Overall Study|Disease progression|0|||
127614971|NCT00283439|459219789|FG000|Overall Study|Requirement for alternative therapy|1|||
127614972|NCT00283439|459219790|FG001|Overall Study|Requirement for alternative therapy|2|||
127614973|NCT00283439|459219791|FG002|Overall Study|Requirement for alternative therapy|5|||
127614974|NCT00283439|459219792|FG003|Overall Study|Requirement for alternative therapy|2|||
127614975|NCT00283439|459219789|FG000|Overall Study|Stem cell transplant|6|||
127614976|NCT00283439|459219790|FG001|Overall Study|Stem cell transplant|6|||
127614977|NCT00283439|459219791|FG002|Overall Study|Stem cell transplant|4|||
127614978|NCT00283439|459219792|FG003|Overall Study|Stem cell transplant|3|||
127614979|NCT00283439|459219789|FG000|Overall Study|Treatment discontinued|0|||
127614980|NCT00283439|459219790|FG001|Overall Study|Treatment discontinued|2|||
127614981|NCT00283439|459219791|FG002|Overall Study|Treatment discontinued|1|||
127614982|NCT00283439|459219792|FG003|Overall Study|Treatment discontinued|3|||
127614983|NCT00283439|459219789|FG000|Overall Study|Other|1|||
127614984|NCT00283439|459219790|FG001|Overall Study|Other|0|||
127614985|NCT00283439|459219791|FG002|Overall Study|Other|0|||
127614986|NCT00283439|459219792|FG003|Overall Study|Other|0|||
127614987|NCT02042924|459219793|FG000|Overall Study|Early Death|1|||
127614988|NCT04171414|459219799|FG000|Overall Study|Death|1|||
127614989|NCT04171414|459219799|FG000|Overall Study|Withdrawal by Subject|1|||
127614990|NCT00706966|459219800|FG000|Overall Study|Adverse Event|1|||
127884081|NCT01625286|460198000|FG002|Overall Study|Withdrawal by Subject|0|||
127884082|NCT01625286|460198001|FG003|Overall Study|Withdrawal by Subject|1|||
127614991|NCT02884089|459219803|FG000|Period 1|Dosing error|2|||
127614992|NCT02884089|459219804|FG001|Period 1|Dosing error|2|||
127614993|NCT02884089|459219805|FG002|Period 1|Dosing error|0|||
127699515|NCT05364671|459528726|FG001|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|0|||
127884083|NCT01625286|460198002|FG004|Overall Study|Withdrawal by Subject|0|||
127884084|NCT01625286|460198003|FG005|Overall Study|Withdrawal by Subject|0|||
127614994|NCT02884089|459219806|FG003|Period 1|Dosing error|0|||
127614995|NCT02884089|459219803|FG000|Washout Period 1|Lost to Follow-up|0|||
127614996|NCT02884089|459219804|FG001|Washout Period 1|Lost to Follow-up|1|||
127614997|NCT02884089|459219805|FG002|Washout Period 1|Lost to Follow-up|0|||
127614998|NCT02884089|459219806|FG003|Washout Period 1|Lost to Follow-up|1|||
127614999|NCT02884089|459219803|FG000|Washout Period 1|Withdrawal by Subject|0|||
127615000|NCT02884089|459219804|FG001|Washout Period 1|Withdrawal by Subject|1|||
127884085|NCT01625286|460198004|FG006|Overall Study|Withdrawal by Subject|1|||
127615001|NCT02884089|459219805|FG002|Washout Period 1|Withdrawal by Subject|0|||
127615002|NCT02884089|459219806|FG003|Washout Period 1|Withdrawal by Subject|0|||
127615003|NCT02884089|459219803|FG000|Period 2|Adverse Event|1|||
127615004|NCT02884089|459219804|FG001|Period 2|Adverse Event|0|||
127615005|NCT02884089|459219805|FG002|Period 2|Adverse Event|0|||
127615006|NCT02884089|459219806|FG003|Period 2|Adverse Event|0|||
127615007|NCT02884089|459219803|FG000|Period 3|Withdrawal by Subject|0|||
127615008|NCT02884089|459219804|FG001|Period 3|Withdrawal by Subject|0|||
127615009|NCT02884089|459219805|FG002|Period 3|Withdrawal by Subject|1|||
127615010|NCT02884089|459219806|FG003|Period 3|Withdrawal by Subject|0|||
127615011|NCT02884089|459219803|FG000|Washout Period 3|Withdrawal by Subject|0|||
127615012|NCT02884089|459219804|FG001|Washout Period 3|Withdrawal by Subject|0|||
127615013|NCT02884089|459219805|FG002|Washout Period 3|Withdrawal by Subject|1|||
127615014|NCT02884089|459219806|FG003|Washout Period 3|Withdrawal by Subject|0|||
127615015|NCT02884089|459219803|FG000|Washout Period 3|Lost to Follow-up|0|||
127615016|NCT02884089|459219804|FG001|Washout Period 3|Lost to Follow-up|0|||
127615017|NCT02884089|459219805|FG002|Washout Period 3|Lost to Follow-up|0|||
127615018|NCT02884089|459219806|FG003|Washout Period 3|Lost to Follow-up|1|||
127615019|NCT02884089|459219803|FG000|Period 4|Withdrawal by Subject|0|||
127615020|NCT02884089|459219804|FG001|Period 4|Withdrawal by Subject|1|||
127615021|NCT02884089|459219805|FG002|Period 4|Withdrawal by Subject|0|||
127615022|NCT02884089|459219806|FG003|Period 4|Withdrawal by Subject|0|||
127615023|NCT02884089|459219803|FG000|Period 4|Lost to Follow-up|1|||
127615024|NCT02884089|459219804|FG001|Period 4|Lost to Follow-up|0|||
127615025|NCT02884089|459219805|FG002|Period 4|Lost to Follow-up|0|||
127615026|NCT02884089|459219806|FG003|Period 4|Lost to Follow-up|0|||
127615027|NCT02884089|459219803|FG000|Follow-up Visit|Withdrawal by Subject|1|||
127615028|NCT02884089|459219804|FG001|Follow-up Visit|Withdrawal by Subject|0|||
127615029|NCT02884089|459219805|FG002|Follow-up Visit|Withdrawal by Subject|0|||
127615030|NCT02884089|459219806|FG003|Follow-up Visit|Withdrawal by Subject|1|||
127615031|NCT01631474|459219807|FG000|Overall Study|Lost to Follow-up|8|||
127615032|NCT01631474|459219808|FG001|Overall Study|Lost to Follow-up|5|||
127615033|NCT01631474|459219809|FG002|Overall Study|Lost to Follow-up|7|||
127615034|NCT01631474|459219810|FG003|Overall Study|Lost to Follow-up|5|||
127615035|NCT01631474|459219811|FG004|Overall Study|Lost to Follow-up|5|||
127615036|NCT01631474|459219807|FG000|Overall Study|Withdrawal by Subject|4|||
127615037|NCT01631474|459219808|FG001|Overall Study|Withdrawal by Subject|4|||
127615038|NCT01631474|459219809|FG002|Overall Study|Withdrawal by Subject|2|||
127615039|NCT01631474|459219810|FG003|Overall Study|Withdrawal by Subject|6|||
127615040|NCT01631474|459219811|FG004|Overall Study|Withdrawal by Subject|5|||
127615041|NCT01631474|459219807|FG000|Overall Study|Lack of Efficacy|2|||
127615042|NCT01631474|459219808|FG001|Overall Study|Lack of Efficacy|2|||
127615043|NCT01631474|459219809|FG002|Overall Study|Lack of Efficacy|0|||
127615044|NCT01631474|459219810|FG003|Overall Study|Lack of Efficacy|0|||
127615045|NCT01631474|459219811|FG004|Overall Study|Lack of Efficacy|2|||
127615046|NCT01631474|459219807|FG000|Overall Study|Noncompliance with Study Drug|0|||
127615047|NCT01631474|459219808|FG001|Overall Study|Noncompliance with Study Drug|0|||
127615048|NCT01631474|459219809|FG002|Overall Study|Noncompliance with Study Drug|0|||
127615049|NCT01631474|459219810|FG003|Overall Study|Noncompliance with Study Drug|0|||
127615050|NCT01631474|459219811|FG004|Overall Study|Noncompliance with Study Drug|1|||
127615051|NCT01631474|459219807|FG000|Overall Study|Adverse Event|0|||
127615052|NCT01631474|459219808|FG001|Overall Study|Adverse Event|1|||
127615053|NCT01631474|459219809|FG002|Overall Study|Adverse Event|0|||
127615054|NCT01631474|459219810|FG003|Overall Study|Adverse Event|0|||
127615055|NCT01631474|459219811|FG004|Overall Study|Adverse Event|0|||
127615056|NCT02624284|459219812|FG000|Overall Study|Withdrawal by Subject|3|||
127615057|NCT02624284|459219813|FG001|Overall Study|Withdrawal by Subject|6|||
127615058|NCT02624284|459219814|FG002|Overall Study|Withdrawal by Subject|3|||
127699516|NCT05364671|459528725|FG000|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|0|||
127615059|NCT02624284|459219812|FG000|Overall Study|Protocol Violation|9|||
127615060|NCT02624284|459219813|FG001|Overall Study|Protocol Violation|10|||
127615061|NCT02624284|459219814|FG002|Overall Study|Protocol Violation|7|||
127615062|NCT02624284|459219812|FG000|Overall Study|Revealed exclusionary condition|2|||
127615063|NCT02624284|459219813|FG001|Overall Study|Revealed exclusionary condition|2|||
127615064|NCT02624284|459219814|FG002|Overall Study|Revealed exclusionary condition|0|||
127615065|NCT02624284|459219812|FG000|Overall Study|Adverse Event|0|||
127615066|NCT02624284|459219813|FG001|Overall Study|Adverse Event|0|||
127615067|NCT02624284|459219814|FG002|Overall Study|Adverse Event|1|||
127615068|NCT02487394|459219815|FG000|Phase 1|Withdrawal by Subject|0|||
127615069|NCT02487394|459219816|FG001|Phase 1|Withdrawal by Subject|1|||
127615070|NCT01641367|459219820|FG000|Cohorts|Death|18|||
127615071|NCT01641367|459219821|FG001|Cohorts|Death|1|||
127615072|NCT01641367|459219822|FG002|Cohorts|Death|2|||
127615073|NCT01641367|459219823|FG003|Cohorts|Death|0|||
127615074|NCT01641367|459219824|FG004|Cohorts|Death|1|||
127615075|NCT01641367|459219825|FG005|Cohorts|Death|1|||
127615076|NCT01641367|459219826|FG006|Cohorts|Death|0|||
127615077|NCT01641367|459219827|FG007|Cohorts|Death|0|||
127615078|NCT01641367|459219820|FG000|Cohorts|Lost to Follow-up|16|||
127615079|NCT01641367|459219821|FG001|Cohorts|Lost to Follow-up|0|||
127615080|NCT01641367|459219822|FG002|Cohorts|Lost to Follow-up|2|||
127615081|NCT01641367|459219823|FG003|Cohorts|Lost to Follow-up|0|||
127615082|NCT01641367|459219824|FG004|Cohorts|Lost to Follow-up|2|||
127615083|NCT01641367|459219825|FG005|Cohorts|Lost to Follow-up|0|||
127615084|NCT01641367|459219826|FG006|Cohorts|Lost to Follow-up|0|||
127884086|NCT01625286|460197998|FG000|Overall Study|Any reason not specifically recorded|0|||
127884087|NCT01625286|460197999|FG001|Overall Study|Any reason not specifically recorded|0|||
127884088|NCT01625286|460198000|FG002|Overall Study|Any reason not specifically recorded|0|||
127884089|NCT01625286|460198001|FG003|Overall Study|Any reason not specifically recorded|0|||
127884090|NCT01625286|460198002|FG004|Overall Study|Any reason not specifically recorded|0|||
127884091|NCT01625286|460198003|FG005|Overall Study|Any reason not specifically recorded|1|||
127884092|NCT01625286|460198004|FG006|Overall Study|Any reason not specifically recorded|0|||
127884093|NCT01625286|460197998|FG000|Overall Study|Progressive disease|6|||
127884094|NCT01625286|460197999|FG001|Overall Study|Progressive disease|3|||
127884095|NCT01625286|460198000|FG002|Overall Study|Progressive disease|4|||
127884096|NCT01625286|460198001|FG003|Overall Study|Progressive disease|5|||
127884097|NCT01625286|460198002|FG004|Overall Study|Progressive disease|5|||
127884098|NCT01625286|460198003|FG005|Overall Study|Progressive disease|0|||
127884099|NCT01625286|460198004|FG006|Overall Study|Progressive disease|0|||
127884100|NCT01625286|460197998|FG000|Overall Study|Lost to Follow-up|0|||
127884101|NCT01625286|460197999|FG001|Overall Study|Lost to Follow-up|0|||
127884102|NCT01625286|460198000|FG002|Overall Study|Lost to Follow-up|0|||
127884103|NCT01625286|460198001|FG003|Overall Study|Lost to Follow-up|0|||
127884104|NCT01625286|460198002|FG004|Overall Study|Lost to Follow-up|0|||
127884105|NCT01625286|460198003|FG005|Overall Study|Lost to Follow-up|0|||
127884106|NCT01625286|460198004|FG006|Overall Study|Lost to Follow-up|1|||
127884107|NCT00928135|460198005|FG000|Overall Study|Withdrawal by Subject|1|||
127884108|NCT00928135|460198006|FG001|Overall Study|Withdrawal by Subject|0|||
127884109|NCT03338673|460198009|FG000|Overall Study|Lost to Follow-up|1|||
127884110|NCT03338673|460198010|FG001|Overall Study|Lost to Follow-up|1|||
127884111|NCT00434148|460198011|FG000|Overall Study|Adverse Event|18|||
127884112|NCT00434148|460198012|FG001|Overall Study|Adverse Event|18|||
127884113|NCT00434148|460198011|FG000|Overall Study|Lack of Efficacy|25|||
127884114|NCT00434148|460198012|FG001|Overall Study|Lack of Efficacy|28|||
127884115|NCT00434148|460198011|FG000|Overall Study|Withdrawal by Subject|15|||
127884116|NCT00434148|460198012|FG001|Overall Study|Withdrawal by Subject|15|||
127884117|NCT00434148|460198011|FG000|Overall Study|Protocol Violation|4|||
127884118|NCT00434148|460198012|FG001|Overall Study|Protocol Violation|0|||
127884119|NCT00434148|460198011|FG000|Overall Study|Administrative problems|6|||
127884120|NCT00434148|460198012|FG001|Overall Study|Administrative problems|10|||
127884121|NCT00434148|460198011|FG000|Overall Study|Lost to Follow-up|0|||
127884122|NCT00434148|460198012|FG001|Overall Study|Lost to Follow-up|1|||
127884123|NCT00434148|460198011|FG000|Overall Study|Condition no longer requires study drug|1|||
127884124|NCT00434148|460198012|FG001|Overall Study|Condition no longer requires study drug|0|||
127884125|NCT00434148|460198011|FG000|Overall Study|Abnormal test procedure result|0|||
127884126|NCT00434148|460198012|FG001|Overall Study|Abnormal test procedure result|1|||
127884127|NCT00828516|460198016|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
127884128|NCT03724968|460199800|FG000|Overall Study|Insurance issues|0|||
127884129|NCT03724968|460199801|FG001|Overall Study|Insurance issues|1|||
127884130|NCT03724968|460199800|FG000|Overall Study|Study closed|0|||
127884131|NCT03724968|460199801|FG001|Overall Study|Study closed|1|||
127884132|NCT01142466|460199802|FG000|Overall Study|Adverse Event|2|||
127884133|NCT01142466|460199803|FG001|Overall Study|Adverse Event|1|||
127884134|NCT01142466|460199802|FG000|Overall Study|Withdrawal by Subject|1|||
127884135|NCT01142466|460199803|FG001|Overall Study|Withdrawal by Subject|1|||
127615085|NCT01641367|459219827|FG007|Cohorts|Lost to Follow-up|0|||
127615086|NCT01641367|459219820|FG000|Randomized Adherence Intervention|Death|0|||
127615087|NCT01641367|459219821|FG001|Randomized Adherence Intervention|Death|0|||
127615088|NCT01641367|459219822|FG002|Randomized Adherence Intervention|Death|0|||
127615089|NCT01641367|459219823|FG003|Randomized Adherence Intervention|Death|0|||
127615090|NCT01641367|459219824|FG004|Randomized Adherence Intervention|Death|0|||
127615091|NCT01641367|459219825|FG005|Randomized Adherence Intervention|Death|0|||
127615092|NCT01641367|459219826|FG006|Randomized Adherence Intervention|Death|11|||
127615093|NCT01641367|459219827|FG007|Randomized Adherence Intervention|Death|12|||
127884136|NCT00569231|460199808|FG000|Overall Study|Study unrelated surgery|1|||
127884137|NCT00569231|460199808|FG000|Overall Study|Airfare expense|2|||
127884138|NCT00569231|460199808|FG000|Overall Study|Withdrawal by Subject|1|||
127884139|NCT00569231|460199808|FG000|Overall Study|Car accident injury|1|||
127884140|NCT00569231|460199808|FG000|Overall Study|Non-compliance|2|||
127615094|NCT01641367|459219820|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
127615095|NCT01641367|459219821|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
127615096|NCT01641367|459219822|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
127615097|NCT01641367|459219823|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
127615098|NCT01641367|459219824|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
127615099|NCT01641367|459219825|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
127615100|NCT01641367|459219826|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
127615101|NCT01641367|459219827|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
127615102|NCT00654381|459219830|FG000|1st Stage|Adverse Event|3|||
127615103|NCT00654381|459219831|FG001|1st Stage|Adverse Event|3|||
127615104|NCT00654381|459219832|FG002|1st Stage|Adverse Event|3|||
127615105|NCT00654381|459219833|FG003|1st Stage|Adverse Event|3|||
127615106|NCT00654381|459219834|FG004|1st Stage|Adverse Event|2|||
127615107|NCT00654381|459219835|FG005|1st Stage|Adverse Event|1|||
127615108|NCT00654381|459219830|FG000|1st Stage|Withdrawal by Subject|0|||
127615109|NCT00654381|459219831|FG001|1st Stage|Withdrawal by Subject|0|||
127615110|NCT00654381|459219832|FG002|1st Stage|Withdrawal by Subject|0|||
127615111|NCT00654381|459219833|FG003|1st Stage|Withdrawal by Subject|1|||
127615112|NCT00654381|459219834|FG004|1st Stage|Withdrawal by Subject|0|||
127615113|NCT00654381|459219835|FG005|1st Stage|Withdrawal by Subject|1|||
127615114|NCT00654381|459219830|FG000|1st Stage|Investigator's decision|0|||
127615115|NCT00654381|459219831|FG001|1st Stage|Investigator's decision|0|||
127615116|NCT00654381|459219832|FG002|1st Stage|Investigator's decision|0|||
127615117|NCT00654381|459219833|FG003|1st Stage|Investigator's decision|1|||
127615118|NCT00654381|459219834|FG004|1st Stage|Investigator's decision|0|||
127615119|NCT00654381|459219835|FG005|1st Stage|Investigator's decision|0|||
127615120|NCT00654381|459219830|FG000|2nd Stage|Adverse Event|2|||
127615121|NCT00654381|459219831|FG001|2nd Stage|Adverse Event|0|||
127615122|NCT00654381|459219832|FG002|2nd Stage|Adverse Event|2|||
127615123|NCT00654381|459219833|FG003|2nd Stage|Adverse Event|3|||
127615124|NCT00654381|459219834|FG004|2nd Stage|Adverse Event|7|||
127615125|NCT00654381|459219835|FG005|2nd Stage|Adverse Event|2|||
127615126|NCT00654381|459219830|FG000|2nd Stage|Withdrawal by Subject|0|||
127615127|NCT00654381|459219831|FG001|2nd Stage|Withdrawal by Subject|0|||
127615128|NCT00654381|459219832|FG002|2nd Stage|Withdrawal by Subject|0|||
127615129|NCT00654381|459219833|FG003|2nd Stage|Withdrawal by Subject|0|||
127615130|NCT00654381|459219834|FG004|2nd Stage|Withdrawal by Subject|1|||
127615131|NCT00654381|459219835|FG005|2nd Stage|Withdrawal by Subject|1|||
127615132|NCT00654381|459219830|FG000|2nd Stage|Investigator's decision|0|||
127615133|NCT00654381|459219831|FG001|2nd Stage|Investigator's decision|0|||
127615134|NCT00654381|459219832|FG002|2nd Stage|Investigator's decision|1|||
127615135|NCT00654381|459219833|FG003|2nd Stage|Investigator's decision|1|||
127615136|NCT00654381|459219834|FG004|2nd Stage|Investigator's decision|0|||
127615137|NCT00654381|459219835|FG005|2nd Stage|Investigator's decision|0|||
127615138|NCT00654381|459219830|FG000|Extension Stage|Adverse Event|1|||
127615139|NCT00654381|459219831|FG001|Extension Stage|Adverse Event|2|||
127615140|NCT00654381|459219832|FG002|Extension Stage|Adverse Event|9|||
127615141|NCT00654381|459219833|FG003|Extension Stage|Adverse Event|7|||
127615142|NCT00654381|459219834|FG004|Extension Stage|Adverse Event|1|||
127615143|NCT00654381|459219835|FG005|Extension Stage|Adverse Event|1|||
127615144|NCT00654381|459219830|FG000|Extension Stage|Protocol Violation|0|||
127790681|NCT03077685|459857173|FG003|Overall Study|Lost to Follow-up|0|||
127615145|NCT00654381|459219831|FG001|Extension Stage|Protocol Violation|0|||
127615146|NCT00654381|459219832|FG002|Extension Stage|Protocol Violation|0|||
127615147|NCT00654381|459219833|FG003|Extension Stage|Protocol Violation|1|||
127615148|NCT00654381|459219834|FG004|Extension Stage|Protocol Violation|0|||
127615149|NCT00654381|459219835|FG005|Extension Stage|Protocol Violation|0|||
127615150|NCT00654381|459219830|FG000|Extension Stage|Lack of Efficacy|0|||
127790682|NCT03077685|459857174|FG004|Overall Study|Lost to Follow-up|1|||
127790683|NCT03077685|459857170|FG000|Overall Study|Death|0|||
127615151|NCT00654381|459219831|FG001|Extension Stage|Lack of Efficacy|0|||
127615152|NCT00654381|459219832|FG002|Extension Stage|Lack of Efficacy|1|||
127615153|NCT00654381|459219833|FG003|Extension Stage|Lack of Efficacy|0|||
127615154|NCT00654381|459219834|FG004|Extension Stage|Lack of Efficacy|0|||
127615155|NCT00654381|459219835|FG005|Extension Stage|Lack of Efficacy|0|||
127615156|NCT00654381|459219830|FG000|Extension Stage|Withdrawal by Subject|0|||
127615157|NCT00654381|459219831|FG001|Extension Stage|Withdrawal by Subject|0|||
127615158|NCT00654381|459219832|FG002|Extension Stage|Withdrawal by Subject|1|||
127615159|NCT00654381|459219833|FG003|Extension Stage|Withdrawal by Subject|1|||
127615160|NCT00654381|459219834|FG004|Extension Stage|Withdrawal by Subject|1|||
127615161|NCT00654381|459219835|FG005|Extension Stage|Withdrawal by Subject|1|||
127615162|NCT00654381|459219830|FG000|Extension Stage|Closure of the trial site|0|||
127615163|NCT00654381|459219831|FG001|Extension Stage|Closure of the trial site|0|||
127615164|NCT00654381|459219832|FG002|Extension Stage|Closure of the trial site|0|||
127615165|NCT00654381|459219833|FG003|Extension Stage|Closure of the trial site|0|||
127615166|NCT00654381|459219834|FG004|Extension Stage|Closure of the trial site|1|||
127615167|NCT00654381|459219835|FG005|Extension Stage|Closure of the trial site|1|||
127615168|NCT01604343|459219843|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
127615169|NCT01604343|459219844|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
127615170|NCT01604343|459219845|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
127615171|NCT01604343|459219846|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
127615172|NCT01604343|459219847|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
127615173|NCT01604343|459219843|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
127615174|NCT01604343|459219844|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
127615175|NCT01604343|459219845|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
127615176|NCT01604343|459219846|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
127615177|NCT01604343|459219847|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
127615178|NCT01604343|459219843|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
127615179|NCT01604343|459219844|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
127615180|NCT01604343|459219845|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
127615181|NCT01604343|459219846|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
127615182|NCT01604343|459219847|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
127615183|NCT01604343|459219843|FG000|Prior to W52 Administration(Through W52)|Death|5|||
127615184|NCT01604343|459219844|FG001|Prior to W52 Administration(Through W52)|Death|0|||
127615185|NCT01604343|459219845|FG002|Prior to W52 Administration(Through W52)|Death|2|||
127615186|NCT01604343|459219846|FG003|Prior to W52 Administration(Through W52)|Death|0|||
127615187|NCT01604343|459219847|FG004|Prior to W52 Administration(Through W52)|Death|4|||
127699517|NCT05364671|459528726|FG001|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|1|||
127699518|NCT05256017|459528727|FG000|Treatment Period|Withdrawal by Subject|1|||
127884141|NCT00700310|460199811|FG000|Overall Study|Adverse Event|6|||
127615188|NCT01604343|459219843|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
127615189|NCT01604343|459219844|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
127615190|NCT01604343|459219845|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
127615191|NCT01604343|459219846|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
127615192|NCT01604343|459219847|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
127615193|NCT01604343|459219843|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
127615194|NCT01604343|459219844|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
127615195|NCT01604343|459219845|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
127615196|NCT01604343|459219846|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
127615197|NCT01604343|459219847|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
127615198|NCT01604343|459219843|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
127615199|NCT01604343|459219844|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
127615200|NCT01604343|459219845|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
127615201|NCT01604343|459219846|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
127615202|NCT01604343|459219847|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
127615203|NCT01604343|459219843|FG000|Prior to W52 Administration(Through W52)|Other|15|||
127615204|NCT01604343|459219844|FG001|Prior to W52 Administration(Through W52)|Other|0|||
127615205|NCT01604343|459219845|FG002|Prior to W52 Administration(Through W52)|Other|10|||
127615206|NCT01604343|459219846|FG003|Prior to W52 Administration(Through W52)|Other|0|||
127615207|NCT01604343|459219847|FG004|Prior to W52 Administration(Through W52)|Other|6|||
127615208|NCT01604343|459219843|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
127615209|NCT01604343|459219844|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
127884142|NCT00700310|460199812|FG001|Overall Study|Adverse Event|10|||
127884143|NCT00700310|460199813|FG002|Overall Study|Adverse Event|5|||
127884144|NCT00700310|460199814|FG003|Overall Study|Adverse Event|11|||
127884145|NCT00700310|460199811|FG000|Overall Study|Lost to Follow-up|4|||
127884146|NCT00700310|460199812|FG001|Overall Study|Lost to Follow-up|1|||
127884147|NCT00700310|460199813|FG002|Overall Study|Lost to Follow-up|0|||
127884148|NCT00700310|460199814|FG003|Overall Study|Lost to Follow-up|1|||
127884149|NCT00700310|460199811|FG000|Overall Study|Withdrawal by Subject|8|||
127884150|NCT00700310|460199812|FG001|Overall Study|Withdrawal by Subject|9|||
127884151|NCT00700310|460199813|FG002|Overall Study|Withdrawal by Subject|8|||
127884152|NCT00700310|460199814|FG003|Overall Study|Withdrawal by Subject|8|||
127884153|NCT00700310|460199811|FG000|Overall Study|Lack of Efficacy|0|||
127884154|NCT00700310|460199812|FG001|Overall Study|Lack of Efficacy|3|||
127884155|NCT00700310|460199813|FG002|Overall Study|Lack of Efficacy|0|||
127884156|NCT00700310|460199814|FG003|Overall Study|Lack of Efficacy|1|||
127884157|NCT00700310|460199811|FG000|Overall Study|Administrative/Other|1|||
127884158|NCT00700310|460199812|FG001|Overall Study|Administrative/Other|3|||
127884159|NCT00700310|460199813|FG002|Overall Study|Administrative/Other|1|||
127884160|NCT00700310|460199814|FG003|Overall Study|Administrative/Other|3|||
127884161|NCT00700310|460199811|FG000|Overall Study|Randomized, Not Treated|2|||
127615210|NCT01604343|459219845|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
127615211|NCT01604343|459219846|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
127615212|NCT01604343|459219847|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
127615213|NCT01604343|459219843|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
127615214|NCT01604343|459219844|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
127615215|NCT01604343|459219845|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
127615216|NCT01604343|459219846|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
127615217|NCT01604343|459219847|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
127615218|NCT01604343|459219843|FG000|Week 52 to Week 104|Adverse Event|0|||
127615219|NCT01604343|459219844|FG001|Week 52 to Week 104|Adverse Event|12|||
127615220|NCT01604343|459219845|FG002|Week 52 to Week 104|Adverse Event|26|||
127615221|NCT01604343|459219846|FG003|Week 52 to Week 104|Adverse Event|21|||
127615222|NCT01604343|459219847|FG004|Week 52 to Week 104|Adverse Event|27|||
127615223|NCT01604343|459219843|FG000|Week 52 to Week 104|Death|0|||
127615224|NCT01604343|459219844|FG001|Week 52 to Week 104|Death|4|||
127615225|NCT01604343|459219845|FG002|Week 52 to Week 104|Death|2|||
127615226|NCT01604343|459219846|FG003|Week 52 to Week 104|Death|5|||
127615227|NCT01604343|459219847|FG004|Week 52 to Week 104|Death|0|||
127615228|NCT01604343|459219843|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
127615229|NCT01604343|459219844|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
127615230|NCT01604343|459219845|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
127615231|NCT01604343|459219846|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
127615232|NCT01604343|459219847|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
127615233|NCT01604343|459219843|FG000|Week 52 to Week 104|Physician Decision|0|||
127615234|NCT01604343|459219844|FG001|Week 52 to Week 104|Physician Decision|1|||
127615235|NCT01604343|459219845|FG002|Week 52 to Week 104|Physician Decision|0|||
127615236|NCT01604343|459219846|FG003|Week 52 to Week 104|Physician Decision|0|||
127615237|NCT01604343|459219847|FG004|Week 52 to Week 104|Physician Decision|2|||
127615238|NCT01604343|459219843|FG000|Week 52 to Week 104|Pregnancy|0|||
127615239|NCT01604343|459219844|FG001|Week 52 to Week 104|Pregnancy|0|||
127615240|NCT01604343|459219845|FG002|Week 52 to Week 104|Pregnancy|1|||
127615241|NCT01604343|459219846|FG003|Week 52 to Week 104|Pregnancy|2|||
127615242|NCT01604343|459219847|FG004|Week 52 to Week 104|Pregnancy|1|||
127884162|NCT00700310|460199812|FG001|Overall Study|Randomized, Not Treated|0|||
127615243|NCT01604343|459219843|FG000|Week 52 to Week 104|Other|0|||
127884163|NCT00700310|460199813|FG002|Overall Study|Randomized, Not Treated|2|||
127884164|NCT00700310|460199814|FG003|Overall Study|Randomized, Not Treated|2|||
127884165|NCT00681824|460199819|FG000|Overall Study|withdrawn by investigator|0|||
127884166|NCT00681824|460199820|FG001|Overall Study|withdrawn by investigator|0|||
127615244|NCT01604343|459219844|FG001|Week 52 to Week 104|Other|11|||
127615245|NCT01604343|459219845|FG002|Week 52 to Week 104|Other|11|||
127615246|NCT01604343|459219846|FG003|Week 52 to Week 104|Other|6|||
127615247|NCT01604343|459219847|FG004|Week 52 to Week 104|Other|3|||
127615248|NCT01604343|459219843|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
127615249|NCT01604343|459219844|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
127615250|NCT01604343|459219845|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
127615251|NCT01604343|459219846|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
127615252|NCT01604343|459219847|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
127615253|NCT01604343|459219843|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
127884167|NCT00681824|460199821|FG002|Overall Study|withdrawn by investigator|1|||
127884168|NCT00681824|460199819|FG000|Overall Study|scheduling conflict|1|||
127884169|NCT00681824|460199820|FG001|Overall Study|scheduling conflict|0|||
127615254|NCT01604343|459219844|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
127615255|NCT01604343|459219845|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
127615256|NCT01604343|459219846|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
127615257|NCT01604343|459219847|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
127615258|NCT01604343|459219843|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
127615259|NCT01604343|459219844|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
127615260|NCT01604343|459219845|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
127615261|NCT01604343|459219846|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
127615262|NCT01604343|459219847|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
127615263|NCT00850200|459219851|FG000|Overall Study|Physician Decision|2|||
127615264|NCT00850200|459219851|FG000|Overall Study|Did not recieve treatment|2|||
127615265|NCT00850200|459219851|FG000|Overall Study|Withdrawal by Subject|1|||
127615266|NCT02711800|459219852|FG000|Overall Study|Lost to Follow-up|1|||
127615267|NCT02711800|459219852|FG000|Overall Study|Withdrawal by Subject|1|||
127615268|NCT05040152|459219855|FG000|Overall Study|Withdrawal by Subject|5|||
127615269|NCT05040152|459219856|FG001|Overall Study|Withdrawal by Subject|0|||
127615270|NCT05040152|459219855|FG000|Overall Study|Lost to Follow-up|0|||
127615271|NCT05040152|459219856|FG001|Overall Study|Lost to Follow-up|2|||
127615272|NCT00314574|459219869|FG000|Overall Study|Death|3|||
127615273|NCT00314574|459219870|FG001|Overall Study|Death|0|||
127615274|NCT00314574|459219869|FG000|Overall Study|Adverse Event|11|||
127615275|NCT00314574|459219870|FG001|Overall Study|Adverse Event|16|||
127615276|NCT00314574|459219869|FG000|Overall Study|Lost to Follow-up|19|||
127615277|NCT00314574|459219870|FG001|Overall Study|Lost to Follow-up|25|||
127615278|NCT00314574|459219869|FG000|Overall Study|Withdrawal by Subject|33|||
127615279|NCT00314574|459219870|FG001|Overall Study|Withdrawal by Subject|22|||
127615280|NCT00314574|459219869|FG000|Overall Study|Physician Decision|22|||
127615281|NCT00314574|459219870|FG001|Overall Study|Physician Decision|15|||
127615282|NCT00314574|459219869|FG000|Overall Study|Pregnancy|6|||
127615283|NCT00314574|459219870|FG001|Overall Study|Pregnancy|4|||
127615284|NCT00314574|459219869|FG000|Overall Study|Data unknown at database lock|0|||
127615285|NCT00314574|459219870|FG001|Overall Study|Data unknown at database lock|1|||
127615286|NCT00449956|459219871|FG000|Overall Study|Adverse Event|7|||
127615287|NCT00449956|459219872|FG001|Overall Study|Adverse Event|1|||
127615288|NCT00449956|459219873|FG002|Overall Study|Adverse Event|6|||
127615289|NCT00449956|459219871|FG000|Overall Study|Lack of Efficacy|0|||
127790684|NCT03077685|459857171|FG001|Overall Study|Death|0|||
127615290|NCT00449956|459219872|FG001|Overall Study|Lack of Efficacy|0|||
127615291|NCT00449956|459219873|FG002|Overall Study|Lack of Efficacy|1|||
127615292|NCT00449956|459219871|FG000|Overall Study|Protocol Violation|1|||
127615293|NCT00449956|459219872|FG001|Overall Study|Protocol Violation|1|||
127615294|NCT00449956|459219873|FG002|Overall Study|Protocol Violation|1|||
127615295|NCT00449956|459219871|FG000|Overall Study|Withdrawal by Subject|0|||
127615296|NCT00449956|459219872|FG001|Overall Study|Withdrawal by Subject|1|||
127615297|NCT00449956|459219873|FG002|Overall Study|Withdrawal by Subject|0|||
127615298|NCT00449956|459219871|FG000|Overall Study|Physician Decision|2|||
127615299|NCT00449956|459219872|FG001|Overall Study|Physician Decision|1|||
127615300|NCT00449956|459219873|FG002|Overall Study|Physician Decision|1|||
127615301|NCT01446965|459219874|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
127615302|NCT01446965|459219875|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
127615303|NCT01446965|459219874|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
127615304|NCT01446965|459219875|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
127615305|NCT02852265|459219876|FG000|3-month Follow-up|Lost to Follow-up|1|||
127615306|NCT02852265|459219877|FG001|3-month Follow-up|Lost to Follow-up|1|||
127615307|NCT02871375|459219878|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
127615308|NCT02871375|459219879|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
127615309|NCT01988571|459219880|FG000|Overall Study|Death|3|||
127615310|NCT01988571|459219881|FG001|Overall Study|Death|1|||
127699519|NCT05256017|459528728|FG001|Treatment Period|Withdrawal by Subject|1|||
127699520|NCT05256017|459528727|FG000|Follow-up|Lost to Follow-up|7|||
127699521|NCT05256017|459528728|FG001|Follow-up|Lost to Follow-up|1|||
127699522|NCT05256017|459528727|FG000|Follow-up|Withdrawal by Subject|1|||
127615311|NCT01988571|459219880|FG000|Overall Study|Physician Decision|2|||
127615312|NCT01988571|459219881|FG001|Overall Study|Physician Decision|1|||
127615313|NCT01988571|459219880|FG000|Overall Study|Lost to Follow-up|3|||
127699523|NCT05256017|459528728|FG001|Follow-up|Withdrawal by Subject|0|||
127699524|NCT05256017|459528727|FG000|Follow-up|Death|0|||
127615314|NCT01988571|459219881|FG001|Overall Study|Lost to Follow-up|0|||
127699525|NCT05256017|459528728|FG001|Follow-up|Death|1|||
127699526|NCT03536754|459528733|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
127699527|NCT03536754|459528734|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
127699528|NCT03536754|459528735|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
127699529|NCT03536754|459528736|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
127699530|NCT03536754|459528737|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
127699531|NCT03536754|459528733|FG000|Open Label Extension|Other|0|||
127699532|NCT03536754|459528734|FG001|Open Label Extension|Other|0|||
127699533|NCT03536754|459528735|FG002|Open Label Extension|Other|0|||
127699534|NCT03536754|459528736|FG003|Open Label Extension|Other|0|||
127699535|NCT03536754|459528737|FG004|Open Label Extension|Other|1|||
127699536|NCT04858321|459528738|FG000|Overall Study|Withdrawal by Subject|3|||
127699537|NCT05057247|459528739|FG000|Overall Study|Death|4|||
127790685|NCT03077685|459857172|FG002|Overall Study|Death|1|||
127615315|NCT01988571|459219880|FG000|Overall Study|Withdrawal by Subject|31|||
127699538|NCT05057247|459528739|FG000|Overall Study|Physician Decision|3|||
127699539|NCT05057247|459528739|FG000|Overall Study|Progressive Disease|7|||
127699540|NCT05057247|459528739|FG000|Overall Study|Withdrawal by Subject|3|||
127615316|NCT01988571|459219881|FG001|Overall Study|Withdrawal by Subject|33|||
127615317|NCT00004412|459219882|FG000|Randomized Period|Moved to Crossover Period|3|||
127615318|NCT00004412|459219883|FG001|Randomized Period|Moved to Crossover Period|0|||
127615319|NCT00004412|459219884|FG002|Randomized Period|Moved to Crossover Period|0|||
127615320|NCT03144180|459219889|FG000|Overall Study|STAT Delivery|1|||
127615321|NCT03144180|459219890|FG001|Overall Study|STAT Delivery|1|||
127615322|NCT03144180|459219889|FG000|Overall Study|Provider forgot to fill out forms|1|||
127615323|NCT03144180|459219890|FG001|Overall Study|Provider forgot to fill out forms|3|||
127615324|NCT03144180|459219889|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
127615325|NCT03144180|459219890|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
127615326|NCT03144180|459219889|FG000|Overall Study|Scrub tech removed tube cap|0|||
127615327|NCT03144180|459219890|FG001|Overall Study|Scrub tech removed tube cap|1|||
127615328|NCT02346136|459219895|FG000|Overall Study|Withdrawal by Subject|7|||
127790686|NCT03077685|459857173|FG003|Overall Study|Death|1|||
127790687|NCT03077685|459857174|FG004|Overall Study|Death|3|||
127790688|NCT03077685|459857170|FG000|Overall Study|Withdrawal by Subject|0|||
127790689|NCT03077685|459857171|FG001|Overall Study|Withdrawal by Subject|0|||
127790690|NCT03077685|459857172|FG002|Overall Study|Withdrawal by Subject|0|||
127790691|NCT03077685|459857173|FG003|Overall Study|Withdrawal by Subject|2|||
127790692|NCT03077685|459857174|FG004|Overall Study|Withdrawal by Subject|1|||
127790693|NCT03077685|459857170|FG000|Overall Study|Physician Decision|0|||
127790694|NCT03077685|459857171|FG001|Overall Study|Physician Decision|0|||
127790695|NCT03077685|459857172|FG002|Overall Study|Physician Decision|1|||
127790696|NCT03077685|459857173|FG003|Overall Study|Physician Decision|0|||
127790697|NCT03077685|459857174|FG004|Overall Study|Physician Decision|3|||
127790698|NCT03077685|459857170|FG000|Overall Study|Disease Progression|1|||
127790699|NCT03077685|459857171|FG001|Overall Study|Disease Progression|0|||
127790700|NCT03077685|459857172|FG002|Overall Study|Disease Progression|0|||
127790701|NCT03077685|459857173|FG003|Overall Study|Disease Progression|2|||
127790702|NCT03077685|459857174|FG004|Overall Study|Disease Progression|1|||
127790703|NCT03077685|459857170|FG000|Overall Study|Withdrawn to proceed to surgery|0|||
127790704|NCT03077685|459857171|FG001|Overall Study|Withdrawn to proceed to surgery|0|||
127790705|NCT03077685|459857172|FG002|Overall Study|Withdrawn to proceed to surgery|0|||
127790706|NCT03077685|459857173|FG003|Overall Study|Withdrawn to proceed to surgery|1|||
127790707|NCT03077685|459857174|FG004|Overall Study|Withdrawn to proceed to surgery|1|||
127790708|NCT03077685|459857170|FG000|Overall Study|Subject entered hospice care|0|||
127790709|NCT03077685|459857171|FG001|Overall Study|Subject entered hospice care|0|||
127790710|NCT03077685|459857172|FG002|Overall Study|Subject entered hospice care|0|||
127790711|NCT03077685|459857173|FG003|Overall Study|Subject entered hospice care|0|||
127790712|NCT03077685|459857174|FG004|Overall Study|Subject entered hospice care|1|||
127790713|NCT03921424|459857180|FG000|Overall Study|Lost to Follow-up|0|||
127790714|NCT03921424|459857181|FG001|Overall Study|Lost to Follow-up|1|||
127790715|NCT03921424|459857180|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
127790716|NCT03921424|459857181|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
127790717|NCT02581202|459857191|FG000|Overall Study|Lack of Efficacy|2|||
127790718|NCT02581202|459857191|FG000|Overall Study|Withdrawal by Subject|4|||
127790719|NCT02581202|459857191|FG000|Overall Study|Lost to Follow-up|5|||
127790720|NCT02581202|459857191|FG000|Overall Study|Pregnancy|3|||
127790721|NCT01806779|459857197|FG000|Overall Study|Physician Decision|2|||
127790722|NCT01806779|459857198|FG001|Overall Study|Physician Decision|0|||
127790723|NCT01806779|459857199|FG002|Overall Study|Physician Decision|1|||
127790724|NCT01806779|459857197|FG000|Overall Study|Lack of Efficacy|1|||
127790725|NCT01806779|459857198|FG001|Overall Study|Lack of Efficacy|1|||
127790726|NCT01806779|459857199|FG002|Overall Study|Lack of Efficacy|0|||
127790727|NCT01806779|459857197|FG000|Overall Study|Lost to Follow-up|19|||
127790728|NCT01806779|459857198|FG001|Overall Study|Lost to Follow-up|20|||
127790729|NCT01806779|459857199|FG002|Overall Study|Lost to Follow-up|0|||
127790730|NCT01806779|459857197|FG000|Overall Study|Withdrawal by Subject|20|||
127790731|NCT01806779|459857198|FG001|Overall Study|Withdrawal by Subject|23|||
127790732|NCT01806779|459857199|FG002|Overall Study|Withdrawal by Subject|22|||
127790733|NCT02595450|459857202|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
127790734|NCT02595450|459857202|FG000|Overall Study|Enrolled, but not treated|8|||
127790735|NCT04294901|459857204|FG000|Overall Study|Death|86|||
127790736|NCT04294901|459857205|FG001|Overall Study|Death|110|||
127790737|NCT04294901|459857204|FG000|Overall Study|Provider did not have historical control patients|581|||
127790738|NCT04294901|459857205|FG001|Overall Study|Provider did not have historical control patients|0|||
127790739|NCT04294901|459857204|FG000|Overall Study|Provider did not have intervention patients|0|||
127615329|NCT02346136|459219896|FG001|Overall Study|Withdrawal by Subject|5|||
127790740|NCT04294901|459857205|FG001|Overall Study|Provider did not have intervention patients|98|||
127790741|NCT01934556|459857208|FG000|Overall Study|Withdrawal by Subject|0|||
127790742|NCT01934556|459857209|FG001|Overall Study|Withdrawal by Subject|1|||
127615330|NCT02346136|459219895|FG000|Overall Study|Death|1|||
127615331|NCT02346136|459219896|FG001|Overall Study|Death|0|||
127615332|NCT02346136|459219895|FG000|Overall Study|Study termination|14|||
127615333|NCT02346136|459219896|FG001|Overall Study|Study termination|18|||
127615334|NCT03742141|459219904|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
127615335|NCT00850395|459219905|FG000|Overall Study|Death|1|||
127615336|NCT00850395|459219905|FG000|Overall Study|Adverse Event|1|||
127615337|NCT00850395|459219905|FG000|Overall Study|Insufficient clinical response|3|||
127615338|NCT00850395|459219905|FG000|Overall Study|Other|5|||
127615339|NCT02376166|459219906|FG000|Overall Study|Adverse Event|1|||
127615340|NCT02376166|459219906|FG000|Overall Study|Discontinued metformin early|2|||
127615341|NCT04180020|459219907|FG000|Overall Study|missed visit|18|||
127615342|NCT04180020|459219908|FG001|Overall Study|missed visit|16|||
127615343|NCT04180020|459219907|FG000|Overall Study|Death|2|||
127615344|NCT04180020|459219908|FG001|Overall Study|Death|3|||
127615345|NCT04180020|459219907|FG000|Overall Study|Withdrawal by Subject|1|||
127615346|NCT04180020|459219908|FG001|Overall Study|Withdrawal by Subject|5|||
127615347|NCT04180020|459219907|FG000|Overall Study|incarcerated|1|||
127615348|NCT04180020|459219908|FG001|Overall Study|incarcerated|1|||
127615349|NCT04180020|459219907|FG000|Overall Study|Physician Decision|0|||
127615350|NCT04180020|459219908|FG001|Overall Study|Physician Decision|2|||
127615351|NCT03274986|459219912|FG000|Overall Study|Withdrawal by Subject|0|||
127615352|NCT03274986|459219913|FG001|Overall Study|Withdrawal by Subject|1|||
127615353|NCT03274986|459219912|FG000|Overall Study|Lost to Follow-up|0|||
127615354|NCT03274986|459219913|FG001|Overall Study|Lost to Follow-up|1|||
127615355|NCT00603746|459219914|FG000|Overall Study|Adverse Event|2|||
127615356|NCT00603746|459219915|FG001|Overall Study|Adverse Event|3|||
127615357|NCT00603746|459219916|FG002|Overall Study|Adverse Event|0|||
127615358|NCT00603746|459219917|FG003|Overall Study|Adverse Event|1|||
127615359|NCT00603746|459219918|FG004|Overall Study|Adverse Event|0|||
127615360|NCT00603746|459219919|FG005|Overall Study|Adverse Event|4|||
127615361|NCT00603746|459219914|FG000|Overall Study|Lack of Efficacy|34|||
127615362|NCT00603746|459219915|FG001|Overall Study|Lack of Efficacy|11|||
127615363|NCT00603746|459219916|FG002|Overall Study|Lack of Efficacy|6|||
127615364|NCT00603746|459219917|FG003|Overall Study|Lack of Efficacy|11|||
127615365|NCT00603746|459219918|FG004|Overall Study|Lack of Efficacy|12|||
127615366|NCT00603746|459219919|FG005|Overall Study|Lack of Efficacy|8|||
127615367|NCT00603746|459219914|FG000|Overall Study|Protocol Violation|0|||
127615368|NCT00603746|459219915|FG001|Overall Study|Protocol Violation|3|||
127615369|NCT00603746|459219916|FG002|Overall Study|Protocol Violation|1|||
127615370|NCT00603746|459219917|FG003|Overall Study|Protocol Violation|0|||
127615371|NCT00603746|459219918|FG004|Overall Study|Protocol Violation|1|||
127615372|NCT00603746|459219919|FG005|Overall Study|Protocol Violation|0|||
127615373|NCT00603746|459219914|FG000|Overall Study|Lost to Follow-up|0|||
127615374|NCT00603746|459219915|FG001|Overall Study|Lost to Follow-up|1|||
127615375|NCT00603746|459219916|FG002|Overall Study|Lost to Follow-up|1|||
127615376|NCT00603746|459219917|FG003|Overall Study|Lost to Follow-up|0|||
127615377|NCT00603746|459219918|FG004|Overall Study|Lost to Follow-up|0|||
127615378|NCT00603746|459219919|FG005|Overall Study|Lost to Follow-up|0|||
127615379|NCT00603746|459219914|FG000|Overall Study|Physician Decision|1|||
127615380|NCT00603746|459219915|FG001|Overall Study|Physician Decision|0|||
127615381|NCT00603746|459219916|FG002|Overall Study|Physician Decision|0|||
127615382|NCT00603746|459219917|FG003|Overall Study|Physician Decision|0|||
127615383|NCT00603746|459219918|FG004|Overall Study|Physician Decision|1|||
127615384|NCT00603746|459219919|FG005|Overall Study|Physician Decision|0|||
127615385|NCT00603746|459219914|FG000|Overall Study|Withdrawal by Subject|1|||
127615386|NCT00603746|459219915|FG001|Overall Study|Withdrawal by Subject|0|||
127615387|NCT00603746|459219916|FG002|Overall Study|Withdrawal by Subject|0|||
127615388|NCT00603746|459219917|FG003|Overall Study|Withdrawal by Subject|1|||
127615389|NCT00603746|459219918|FG004|Overall Study|Withdrawal by Subject|3|||
127615390|NCT00603746|459219919|FG005|Overall Study|Withdrawal by Subject|1|||
127615391|NCT01524627|459219924|FG000|Overall Study|Physician Decision|0|||
127615392|NCT01524627|459219925|FG001|Overall Study|Physician Decision|1|||
127615393|NCT01524627|459219924|FG000|Overall Study|Lost to Follow-up|1|||
127615394|NCT01524627|459219925|FG001|Overall Study|Lost to Follow-up|1|||
127615395|NCT00717769|459219926|FG000|Overall Study|Adverse Event|9|||
127615396|NCT00717769|459219927|FG001|Overall Study|Adverse Event|6|||
127615397|NCT00717769|459219928|FG002|Overall Study|Adverse Event|1|||
127615398|NCT00717769|459219926|FG000|Overall Study|Lack of compliance|0|||
127615399|NCT00717769|459219927|FG001|Overall Study|Lack of compliance|2|||
127615400|NCT00717769|459219928|FG002|Overall Study|Lack of compliance|0|||
127615401|NCT00717769|459219926|FG000|Overall Study|Lost to Follow-up|3|||
127615402|NCT00717769|459219927|FG001|Overall Study|Lost to Follow-up|4|||
127615403|NCT00717769|459219928|FG002|Overall Study|Lost to Follow-up|0|||
127615404|NCT00717769|459219926|FG000|Overall Study|Lack of Efficacy|1|||
127615405|NCT00717769|459219927|FG001|Overall Study|Lack of Efficacy|2|||
127615406|NCT00717769|459219928|FG002|Overall Study|Lack of Efficacy|0|||
127615407|NCT00717769|459219926|FG000|Overall Study|Protocol Violation|0|||
127615408|NCT00717769|459219927|FG001|Overall Study|Protocol Violation|2|||
127615409|NCT00717769|459219928|FG002|Overall Study|Protocol Violation|0|||
127615410|NCT00717769|459219926|FG000|Overall Study|Sponsor decision|1|||
127615411|NCT00717769|459219927|FG001|Overall Study|Sponsor decision|0|||
127615412|NCT00717769|459219928|FG002|Overall Study|Sponsor decision|10|||
127615413|NCT00717769|459219926|FG000|Overall Study|Withdrew consent|2|||
127615414|NCT00717769|459219927|FG001|Overall Study|Withdrew consent|2|||
127615415|NCT00717769|459219928|FG002|Overall Study|Withdrew consent|0|||
127615416|NCT04536727|459219941|FG000|Overall Study|Lost to Follow-up|1|||
127615417|NCT04536727|459219942|FG001|Overall Study|Lost to Follow-up|1|||
127615418|NCT04536727|459219941|FG000|Overall Study|Death|0|||
127615419|NCT04536727|459219942|FG001|Overall Study|Death|1|||
127615420|NCT00256698|459219943|FG000|Overall Study|Withdrawal by Subject|7|||
127615421|NCT00256698|459219944|FG001|Overall Study|Withdrawal by Subject|7|||
127615422|NCT00256698|459219943|FG000|Overall Study|Adverse Event|13|||
127615423|NCT00256698|459219944|FG001|Overall Study|Adverse Event|6|||
127615424|NCT00256698|459219943|FG000|Overall Study|Protocol Violation|6|||
127615425|NCT00256698|459219944|FG001|Overall Study|Protocol Violation|5|||
127615426|NCT00256698|459219943|FG000|Overall Study|Lost to Follow-up|1|||
127615427|NCT00256698|459219944|FG001|Overall Study|Lost to Follow-up|3|||
127615428|NCT00256698|459219943|FG000|Overall Study|disease progression|97|||
127615429|NCT00256698|459219944|FG001|Overall Study|disease progression|105|||
127615430|NCT00256698|459219943|FG000|Overall Study|still ongoing at data cut-off|41|||
127615431|NCT00256698|459219944|FG001|Overall Study|still ongoing at data cut-off|46|||
127615432|NCT00256698|459219943|FG000|Overall Study|withdrawn due to osteoporosis|1|||
127615433|NCT00256698|459219944|FG001|Overall Study|withdrawn due to osteoporosis|0|||
127615434|NCT00256698|459219943|FG000|Overall Study|Prematurely Discontinued|1|||
127615435|NCT00256698|459219944|FG001|Overall Study|Prematurely Discontinued|0|||
127615436|NCT02917031|459219946|FG000|Overall Study|Reason not specified|7|||
127615437|NCT02917031|459219947|FG001|Overall Study|Reason not specified|5|||
127615438|NCT02917031|459219948|FG002|Overall Study|Reason not specified|6|||
127615439|NCT02917031|459219946|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
127615440|NCT02917031|459219947|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
127615441|NCT02917031|459219948|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
127615442|NCT02917031|459219946|FG000|Overall Study|Withdrawal by Subject|3|||
127615443|NCT02917031|459219947|FG001|Overall Study|Withdrawal by Subject|3|||
127790743|NCT01934556|459857210|FG002|Overall Study|Withdrawal by Subject|1|||
127790744|NCT01934556|459857208|FG000|Overall Study|Lost to Follow-up|4|||
127790745|NCT01934556|459857209|FG001|Overall Study|Lost to Follow-up|10|||
127790746|NCT01934556|459857210|FG002|Overall Study|Lost to Follow-up|7|||
127790747|NCT01934556|459857208|FG000|Overall Study|Death|1|||
127790748|NCT01934556|459857209|FG001|Overall Study|Death|5|||
127790749|NCT01934556|459857210|FG002|Overall Study|Death|2|||
127790750|NCT03770260|459858839|FG000|Overall Study|Disease progression|0|||
127790751|NCT03770260|459858840|FG001|Overall Study|Disease progression|1|||
127790752|NCT03770260|459858841|FG002|Overall Study|Disease progression|0|||
127790753|NCT03770260|459858842|FG003|Overall Study|Disease progression|0|||
127790754|NCT04649255|459858843|FG000|Overall Study|Death|9|||
127790755|NCT04649255|459858843|FG000|Overall Study|Withdrawal by Subject|1|||
127790756|NCT01652885|459858844|FG000|Overall Study|Adverse Event|1|||
127790757|NCT00075400|459858845|FG000|Overall Study|Ineligible: wrong primary|1|||
127790758|NCT00075400|459858845|FG000|Overall Study|Never treated|2|||
127790759|NCT00490568|459858846|FG000|Overall Study|Adverse Event|116|||
127790760|NCT00490568|459858846|FG000|Overall Study|Lost to Follow-up|13|||
127790761|NCT00490568|459858846|FG000|Overall Study|Protocol Violation|45|||
127790762|NCT00490568|459858846|FG000|Overall Study|Withdrawal by Subject|135|||
127790763|NCT00490568|459858846|FG000|Overall Study|Still in the study at termination|974|||
127790764|NCT00490568|459858846|FG000|Overall Study|Other|1|||
127790765|NCT00490568|459858846|FG000|Overall Study|Exclusion criteria met|1|||
127790766|NCT00490568|459858846|FG000|Overall Study|Caregiver related|20|||
127790767|NCT00490568|459858846|FG000|Overall Study|Abnormal ECG|25|||
127790768|NCT00490568|459858846|FG000|Overall Study|Participant refused follow-up|9|||
127790769|NCT00490568|459858846|FG000|Overall Study|Legal representative withdrew consent|1|||
127790770|NCT00490568|459858846|FG000|Overall Study|Disease progression|4|||
127790771|NCT00490568|459858846|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
127790772|NCT00490568|459858846|FG000|Overall Study|Investigator decision|3|||
127790773|NCT00490568|459858846|FG000|Overall Study|Non-Compliance|7|||
127790774|NCT00490568|459858846|FG000|Overall Study|Efficacy related|3|||
127615444|NCT02917031|459219948|FG002|Overall Study|Withdrawal by Subject|0|||
127615445|NCT02917031|459219946|FG000|Overall Study|Physician Decision|1|||
127790775|NCT00490568|459858846|FG000|Overall Study|Participant died|1|||
127790776|NCT00490568|459858846|FG000|Overall Study|Participant withdrawal due to surgery|1|||
127615446|NCT02917031|459219947|FG001|Overall Study|Physician Decision|0|||
127790777|NCT03451773|459858849|FG000|Overall Study|Death on study|1|||
127790778|NCT03451773|459858850|FG001|Overall Study|Death on study|5|||
127790779|NCT03451773|459858849|FG000|Overall Study|Death during follow-up period|0|||
127790780|NCT03451773|459858850|FG001|Overall Study|Death during follow-up period|1|||
127790781|NCT03468855|459858851|FG000|Overall Study|Adverse Event|2|||
127790782|NCT03468855|459858851|FG000|Overall Study|Lost to Follow-up|5|||
127790783|NCT03468855|459858851|FG000|Overall Study|Withdrawal by Subject|3|||
127790784|NCT03468855|459858851|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
127790785|NCT01908101|459858852|FG000|Overall Study|Physician Decision|1|||
127615447|NCT02917031|459219948|FG002|Overall Study|Physician Decision|0|||
127615448|NCT02917031|459219946|FG000|Overall Study|Adverse Event|4|||
127615449|NCT02917031|459219947|FG001|Overall Study|Adverse Event|1|||
127615450|NCT02917031|459219948|FG002|Overall Study|Adverse Event|5|||
127615451|NCT02917031|459219946|FG000|Overall Study|Death|2|||
127615452|NCT02917031|459219947|FG001|Overall Study|Death|3|||
127615453|NCT02917031|459219948|FG002|Overall Study|Death|4|||
127615454|NCT01852292|459221517|FG000|Overall Study|Untreated - did not receive study drug|3|||
127615455|NCT01852292|459221518|FG001|Overall Study|Untreated - did not receive study drug|1|||
127615456|NCT01852292|459221517|FG000|Overall Study|Death|9|||
127615457|NCT01852292|459221518|FG001|Overall Study|Death|8|||
127615458|NCT01852292|459221517|FG000|Overall Study|Patient/guardian decision|8|||
127615459|NCT01852292|459221518|FG001|Overall Study|Patient/guardian decision|4|||
127615460|NCT01852292|459221517|FG000|Overall Study|Adverse Event|8|||
127615461|NCT01852292|459221518|FG001|Overall Study|Adverse Event|11|||
127615462|NCT01852292|459221517|FG000|Overall Study|Physician Decision|6|||
127615463|NCT01852292|459221518|FG001|Overall Study|Physician Decision|2|||
127615464|NCT01852292|459221517|FG000|Overall Study|Protocol Violation|2|||
127615465|NCT01852292|459221518|FG001|Overall Study|Protocol Violation|0|||
127615466|NCT01852292|459221517|FG000|Overall Study|Non-compliance with study treatment|1|||
127615467|NCT01852292|459221518|FG001|Overall Study|Non-compliance with study treatment|0|||
127615468|NCT01852292|459221517|FG000|Overall Study|Study terminated by Sponsor|0|||
127615469|NCT01852292|459221518|FG001|Overall Study|Study terminated by Sponsor|1|||
127615470|NCT01852292|459221517|FG000|Overall Study|Progressive disease|42|||
127615471|NCT01852292|459221518|FG001|Overall Study|Progressive disease|52|||
127615472|NCT01914666|459221521|FG000|Treatment Period|Lack of Efficacy|0|||
127615473|NCT01914666|459221522|FG001|Treatment Period|Lack of Efficacy|0|||
127615474|NCT01914666|459221523|FG002|Treatment Period|Lack of Efficacy|2|||
127615475|NCT01914666|459221521|FG000|Treatment Period|Adverse Event|10|||
127615476|NCT01914666|459221522|FG001|Treatment Period|Adverse Event|4|||
127615477|NCT01914666|459221523|FG002|Treatment Period|Adverse Event|2|||
127615478|NCT01914666|459221521|FG000|Treatment Period|Withdrawal by Subject|3|||
127615479|NCT01914666|459221522|FG001|Treatment Period|Withdrawal by Subject|2|||
127615480|NCT01914666|459221523|FG002|Treatment Period|Withdrawal by Subject|2|||
127615481|NCT01914666|459221521|FG000|Treatment Period|Physician Decision|0|||
127615482|NCT01914666|459221522|FG001|Treatment Period|Physician Decision|0|||
127615483|NCT01914666|459221523|FG002|Treatment Period|Physician Decision|2|||
127615484|NCT02586012|459221524|FG000|Overall Study|Withdrawal by Subject|1|||
127615485|NCT02586012|459221525|FG001|Overall Study|Withdrawal by Subject|1|||
127615486|NCT02586012|459221526|FG002|Overall Study|Withdrawal by Subject|0|||
127615487|NCT02586012|459221527|FG003|Overall Study|Withdrawal by Subject|1|||
127615488|NCT02586012|459221528|FG004|Overall Study|Withdrawal by Subject|0|||
127615489|NCT02586012|459221529|FG005|Overall Study|Withdrawal by Subject|2|||
127615490|NCT02586012|459221524|FG000|Overall Study|Protocol Violation|0|||
127615491|NCT02586012|459221525|FG001|Overall Study|Protocol Violation|0|||
127615492|NCT02586012|459221526|FG002|Overall Study|Protocol Violation|0|||
127615493|NCT02586012|459221527|FG003|Overall Study|Protocol Violation|0|||
127615494|NCT02586012|459221528|FG004|Overall Study|Protocol Violation|0|||
127615495|NCT02586012|459221529|FG005|Overall Study|Protocol Violation|1|||
127615496|NCT02586012|459221524|FG000|Overall Study|study terminated|0|||
127615497|NCT02586012|459221525|FG001|Overall Study|study terminated|2|||
127615498|NCT02586012|459221526|FG002|Overall Study|study terminated|1|||
127615499|NCT02586012|459221527|FG003|Overall Study|study terminated|1|||
127615500|NCT02586012|459221528|FG004|Overall Study|study terminated|1|||
127615501|NCT02586012|459221529|FG005|Overall Study|study terminated|0|||
127615502|NCT02342704|459221530|FG000|Overall Study|Physician Decision|0|||
127615503|NCT02342704|459221531|FG001|Overall Study|Physician Decision|3|||
127615504|NCT02342704|459221530|FG000|Overall Study|Sponsor Termination|49|||
127615505|NCT02342704|459221531|FG001|Overall Study|Sponsor Termination|43|||
127615506|NCT02342704|459221530|FG000|Overall Study|Other|0|||
127615507|NCT02342704|459221531|FG001|Overall Study|Other|1|||
127615508|NCT02342704|459221530|FG000|Overall Study|Withdrawal by Subject|1|||
127615509|NCT02342704|459221531|FG001|Overall Study|Withdrawal by Subject|0|||
127615510|NCT02342704|459221530|FG000|Overall Study|Lost to Follow-up|2|||
127615511|NCT02342704|459221531|FG001|Overall Study|Lost to Follow-up|1|||
127615512|NCT02342704|459221530|FG000|Overall Study|Adverse Event|1|||
127615513|NCT02342704|459221531|FG001|Overall Study|Adverse Event|3|||
127615514|NCT02347527|459221532|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
127615515|NCT02347527|459221533|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
127615516|NCT02347527|459221534|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
127615517|NCT02347527|459221535|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
127615518|NCT02347527|459221532|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
127790786|NCT01908101|459858852|FG000|Overall Study|Withdrawal by Subject|1|||
127615519|NCT02347527|459221533|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
127615520|NCT02347527|459221534|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
127615521|NCT02347527|459221535|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
127615522|NCT02347527|459221532|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
127615523|NCT02347527|459221533|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
127615524|NCT02347527|459221534|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
127615525|NCT02347527|459221535|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
127615526|NCT02347527|459221532|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
127615527|NCT02347527|459221533|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
127615528|NCT02347527|459221534|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
127615529|NCT02347527|459221535|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
127615530|NCT02347527|459221532|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
127615531|NCT02347527|459221533|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
127615532|NCT02347527|459221534|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
127615533|NCT02347527|459221535|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
127615534|NCT00302003|459221536|FG000|Overall Study|Lack of Efficacy|62|||
127615535|NCT00302003|459221536|FG000|Overall Study|Lost to Follow-up|1|||
127615536|NCT00302003|459221536|FG000|Overall Study|Physician Decision|2|||
127615537|NCT00302003|459221536|FG000|Overall Study|Withdrawal by Subject|5|||
127615538|NCT00302003|459221536|FG000|Overall Study|Ineligible|9|||
127615539|NCT00302003|459221536|FG000|Overall Study|Protocol Violation|1|||
127699541|NCT05057247|459528739|FG000|Overall Study|Adverse Event|6|||
127790787|NCT01908101|459858852|FG000|Overall Study|Incorrect Diagnosis|2|||
127790788|NCT01908101|459858852|FG000|Overall Study|Incorrect Starting Dose|1|||
127790789|NCT01908101|459858852|FG000|Overall Study|Did not complete the first cycle|4|||
127790790|NCT02135692|459858854|FG000|Overall Study|Adverse Event|3|||
127790791|NCT02135692|459858854|FG000|Overall Study|Lack of Efficacy|2|||
127615540|NCT01632891|459221537|FG000|Overall Study|Lost to Follow-up|0|||
127615541|NCT01632891|459221538|FG001|Overall Study|Lost to Follow-up|1|||
127615542|NCT01632891|459221537|FG000|Overall Study|Withdrawal by Subject|1|||
127615543|NCT01632891|459221538|FG001|Overall Study|Withdrawal by Subject|0|||
127615544|NCT02919670|459221539|FG000|Overall Study|Only 17 participants met compliance|43|||
127615545|NCT02919670|459221540|FG001|Overall Study|Only 17 participants met compliance|39|||
127615546|NCT01466270|459221541|FG000|Overall Study|Withdrawal by Subject|4|||
127615547|NCT01466270|459221542|FG001|Overall Study|Withdrawal by Subject|1|||
127615548|NCT01466270|459221541|FG000|Overall Study|Physician Decision|1|||
127615549|NCT01466270|459221542|FG001|Overall Study|Physician Decision|0|||
127615550|NCT01466270|459221541|FG000|Overall Study|Lost to Follow-up|1|||
127615551|NCT01466270|459221542|FG001|Overall Study|Lost to Follow-up|3|||
127615552|NCT01466270|459221541|FG000|Overall Study|Progression|1|||
127615553|NCT01466270|459221542|FG001|Overall Study|Progression|0|||
127615554|NCT01466270|459221541|FG000|Overall Study|Toxicity|4|||
127615555|NCT01466270|459221542|FG001|Overall Study|Toxicity|1|||
127615556|NCT01466270|459221541|FG000|Overall Study|Multiple|1|||
127615557|NCT01466270|459221542|FG001|Overall Study|Multiple|1|||
127615558|NCT04206293|459221547|FG000|Overall Study|Consent withdrawal|1|||
127615559|NCT01454934|459221548|FG000|Overall Study|Clinical progression|28|||
127615560|NCT01454934|459221549|FG001|Overall Study|Clinical progression|25|||
127615561|NCT01454934|459221548|FG000|Overall Study|Other|6|||
127615562|NCT01454934|459221549|FG001|Overall Study|Other|17|||
127615563|NCT01454934|459221548|FG000|Overall Study|Adverse Event|28|||
127615564|NCT01454934|459221549|FG001|Overall Study|Adverse Event|24|||
127615565|NCT01454934|459221548|FG000|Overall Study|Withdrawn consent|2|||
127615566|NCT01454934|459221549|FG001|Overall Study|Withdrawn consent|5|||
127615567|NCT01454934|459221548|FG000|Overall Study|Withdrawal by Subject|11|||
127615568|NCT01454934|459221549|FG001|Overall Study|Withdrawal by Subject|15|||
127615569|NCT01454934|459221548|FG000|Overall Study|Disease progression|194|||
127615570|NCT01454934|459221549|FG001|Overall Study|Disease progression|181|||
127615571|NCT01454934|459221548|FG000|Overall Study|Lost to Follow-up|0|||
127790792|NCT02135692|459858854|FG000|Overall Study|Protocol Violation|2|||
127790793|NCT02135692|459858854|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
127790794|NCT02135692|459858854|FG000|Overall Study|Product commercially available|159|||
127790795|NCT02135692|459858854|FG000|Overall Study|Study closed/terminated|153|||
127790796|NCT02135692|459858854|FG000|Overall Study|Lost to Follow-up|4|||
127790797|NCT02135692|459858854|FG000|Overall Study|Withdrawal by Subject|15|||
127790798|NCT04429061|459858857|FG000|Overall Study|Lost to Follow-up|62|||
127790799|NCT04429061|459858858|FG001|Overall Study|Lost to Follow-up|87|||
127790800|NCT04429061|459858857|FG000|Overall Study|Withdrawal by Subject|3|||
127790801|NCT04429061|459858858|FG001|Overall Study|Withdrawal by Subject|4|||
127790802|NCT00879229|459858864|FG000|Overall Study|Study terminated by Sponsor|13|||
127790803|NCT00879229|459858865|FG001|Overall Study|Study terminated by Sponsor|12|||
127790804|NCT00879229|459858864|FG000|Overall Study|Death|4|||
127790805|NCT00879229|459858865|FG001|Overall Study|Death|2|||
127790806|NCT00879229|459858864|FG000|Overall Study|Adverse Event|2|||
127790807|NCT00879229|459858865|FG001|Overall Study|Adverse Event|0|||
127790808|NCT00879229|459858864|FG000|Overall Study|Withdrawal by Subject|1|||
127790809|NCT00879229|459858865|FG001|Overall Study|Withdrawal by Subject|0|||
127790810|NCT00879229|459858864|FG000|Overall Study|Clinical status did not improve|1|||
127790811|NCT00879229|459858865|FG001|Overall Study|Clinical status did not improve|0|||
127790812|NCT00879229|459858864|FG000|Overall Study|Other|1|||
127790813|NCT00879229|459858865|FG001|Overall Study|Other|0|||
127790814|NCT01097746|459858866|FG000|Overall Study|Adverse Event|4|||
127790815|NCT01097746|459858866|FG000|Overall Study|taken off study before any treatment given|1|||
127615572|NCT01454934|459221549|FG001|Overall Study|Lost to Follow-up|1|||
127790816|NCT00631371|459858873|FG000|Overall Study|Lost to Follow-up|24|||
127790817|NCT00631371|459858874|FG001|Overall Study|Lost to Follow-up|19|||
127790818|NCT00631371|459858873|FG000|Overall Study|Other reason|5|||
127790819|NCT00631371|459858874|FG001|Overall Study|Other reason|12|||
127790820|NCT00631371|459858873|FG000|Overall Study|subject request|38|||
127615573|NCT01454934|459221548|FG000|Overall Study|Not treated|1|||
127615574|NCT01454934|459221549|FG001|Overall Study|Not treated|2|||
127615575|NCT00430092|459221552|FG000|Overall Study|Adverse Event|0|||
127615576|NCT00430092|459221553|FG001|Overall Study|Adverse Event|0|||
127615577|NCT00430092|459221554|FG002|Overall Study|Adverse Event|1|||
127615578|NCT00430092|459221552|FG000|Overall Study|Lack of Efficacy|5|||
127615579|NCT00430092|459221553|FG001|Overall Study|Lack of Efficacy|2|||
127790821|NCT00631371|459858874|FG001|Overall Study|subject request|45|||
127790822|NCT00631371|459858873|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
127790823|NCT00631371|459858874|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
127699542|NCT05057247|459528739|FG000|Overall Study|Subject Non-Compliance|1|||
127699543|NCT05057247|459528739|FG000|Overall Study|On treatment|2|||
127699544|NCT04652700|459528740|FG000|Part 1: Blinded Study Medication|Adverse Event|1|||
127699545|NCT04652700|459528741|FG001|Part 1: Blinded Study Medication|Adverse Event|0|||
127699546|NCT04652700|459528740|FG000|Part 1: Blinded Study Medication|Lost to Follow-up|7|||
127699547|NCT04652700|459528741|FG001|Part 1: Blinded Study Medication|Lost to Follow-up|2|||
127699548|NCT04652700|459528740|FG000|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|308|||
127699549|NCT04652700|459528741|FG001|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|160|||
127699550|NCT04652700|459528740|FG000|Part 1: Blinded Study Medication|Withdrawal by Subject|12|||
127699551|NCT04652700|459528741|FG001|Part 1: Blinded Study Medication|Withdrawal by Subject|4|||
127699552|NCT04652700|459528740|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|34|||
127699553|NCT04652700|459528741|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|9|||
127699554|NCT04652700|459528740|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|6|||
127699555|NCT04652700|459528741|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|1|||
127699556|NCT04652700|459528740|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|0|||
127699557|NCT04652700|459528741|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|2|||
127699558|NCT04652700|459528740|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|227|||
127699559|NCT04652700|459528741|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|119|||
127699560|NCT04652700|459528740|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|39|||
127699561|NCT04652700|459528741|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|23|||
127699562|NCT04187833|459528742|FG000|Overall Study|Withdrawal by Subject|1|||
127699563|NCT03097549|459528743|FG000|Overall Study|Withdrawal by Subject|1|||
127699564|NCT03097549|459528744|FG001|Overall Study|Withdrawal by Subject|0|||
127699565|NCT03097549|459528743|FG000|Overall Study|Lost to Follow-up|1|||
127699566|NCT03097549|459528744|FG001|Overall Study|Lost to Follow-up|0|||
127699567|NCT05647304|459528745|FG000|Overall Study|Withdrawal by Subject|1|||
127699568|NCT05647304|459528746|FG001|Overall Study|Withdrawal by Subject|0|||
127699569|NCT04282148|459528747|FG000|Overall Study|Death|7|||
127699570|NCT04282148|459528747|FG000|Overall Study|Withdrawal by Subject|1|||
127699571|NCT04282148|459528747|FG000|Overall Study|Physician Decision|1|||
127615580|NCT00430092|459221554|FG002|Overall Study|Lack of Efficacy|54|||
127615581|NCT00430092|459221552|FG000|Overall Study|Lost to Follow-up|1|||
127615582|NCT00430092|459221553|FG001|Overall Study|Lost to Follow-up|0|||
127615583|NCT00430092|459221554|FG002|Overall Study|Lost to Follow-up|0|||
127615584|NCT00430092|459221552|FG000|Overall Study|Protocol Violation|0|||
127615585|NCT00430092|459221553|FG001|Overall Study|Protocol Violation|1|||
127615586|NCT00430092|459221554|FG002|Overall Study|Protocol Violation|1|||
127615587|NCT00430092|459221552|FG000|Overall Study|Withdrawal by Subject|0|||
127615588|NCT00430092|459221553|FG001|Overall Study|Withdrawal by Subject|1|||
127615589|NCT00430092|459221554|FG002|Overall Study|Withdrawal by Subject|1|||
127615590|NCT00782210|459221556|FG000|Overall Study|Adverse Event|21|||
127615591|NCT00782210|459221557|FG001|Overall Study|Adverse Event|17|||
127615592|NCT00782210|459221558|FG002|Overall Study|Adverse Event|16|||
127615593|NCT00782210|459221556|FG000|Overall Study|Lost to Follow-up|2|||
127615594|NCT00782210|459221557|FG001|Overall Study|Lost to Follow-up|1|||
127615595|NCT00782210|459221558|FG002|Overall Study|Lost to Follow-up|2|||
127615596|NCT00782210|459221556|FG000|Overall Study|Withdrawal by Subject|11|||
127615597|NCT00782210|459221557|FG001|Overall Study|Withdrawal by Subject|8|||
127615598|NCT00782210|459221558|FG002|Overall Study|Withdrawal by Subject|11|||
127615599|NCT00782210|459221556|FG000|Overall Study|Non compliance with protocol|0|||
127615600|NCT00782210|459221557|FG001|Overall Study|Non compliance with protocol|3|||
127615601|NCT00782210|459221558|FG002|Overall Study|Non compliance with protocol|2|||
127615602|NCT00782210|459221556|FG000|Overall Study|Lack of Efficacy|13|||
127615603|NCT00782210|459221557|FG001|Overall Study|Lack of Efficacy|4|||
127615604|NCT00782210|459221558|FG002|Overall Study|Lack of Efficacy|1|||
127615605|NCT00782210|459221556|FG000|Overall Study|Other reason not described above|3|||
127615606|NCT00782210|459221557|FG001|Overall Study|Other reason not described above|2|||
127615607|NCT00782210|459221558|FG002|Overall Study|Other reason not described above|3|||
127615608|NCT02586493|459221559|FG000|Overall Study|Adverse Event|4|||
127615609|NCT02586493|459221559|FG000|Overall Study|Protocol Violation|6|||
127615610|NCT02586493|459221559|FG000|Overall Study|Lost to Follow-up|1|||
127615611|NCT02586493|459221559|FG000|Overall Study|Withdrawal by Subject|1|||
127615612|NCT01675882|459221564|FG000|Overall Study|Adverse Event|0|||
127615613|NCT01675882|459221565|FG001|Overall Study|Adverse Event|2|||
127615614|NCT01675882|459221566|FG002|Overall Study|Adverse Event|1|||
127615615|NCT01675882|459221567|FG003|Overall Study|Adverse Event|0|||
127615616|NCT01675882|459221564|FG000|Overall Study|Participant unwilling to continue|2|||
127699572|NCT02146378|459528748|FG000|Overall Study|No information of administration|2|||
127615617|NCT01675882|459221565|FG001|Overall Study|Participant unwilling to continue|4|||
127615618|NCT01675882|459221566|FG002|Overall Study|Participant unwilling to continue|2|||
127615619|NCT01675882|459221567|FG003|Overall Study|Participant unwilling to continue|1|||
127615620|NCT01675882|459221564|FG000|Overall Study|Lost to Follow-up|0|||
127699573|NCT02683447|459528749|FG000|Overall Study|Lost to Follow-up|2|||
127699574|NCT03448107|459528750|FG000|Overall Study|Lost to Follow-up|229|||
127699575|NCT03448107|459528751|FG001|Overall Study|Lost to Follow-up|258|||
127699576|NCT04025554|459528752|FG000|Overall Study|Adverse Event|3|||
127699577|NCT03115476|459528753|FG000|LP0084-1369|Death|1|||
127699578|NCT03115476|459528754|FG001|LP0084-1369|Death|0|||
127699579|NCT03115476|459528755|FG002|LP0084-1369|Death|2|||
127699580|NCT03115476|459528753|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
127699581|NCT03115476|459528754|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
127699582|NCT03115476|459528755|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
127699583|NCT00613106|459528759|FG000|Overall Study|Adverse Event|3|||
127699584|NCT00613106|459528760|FG001|Overall Study|Adverse Event|1|||
127699585|NCT00613106|459528759|FG000|Overall Study|Withdrawal by Subject|6|||
127699586|NCT00613106|459528760|FG001|Overall Study|Withdrawal by Subject|3|||
127699587|NCT00613106|459528759|FG000|Overall Study|Lost to Follow-up|7|||
127699588|NCT00613106|459528760|FG001|Overall Study|Lost to Follow-up|2|||
127699589|NCT00613106|459528759|FG000|Overall Study|misc|4|||
127699590|NCT00613106|459528760|FG001|Overall Study|misc|3|||
127699591|NCT05296525|459528769|FG000|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
127699592|NCT05296525|459528770|FG001|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
127615621|NCT01675882|459221565|FG001|Overall Study|Lost to Follow-up|1|||
127615622|NCT01675882|459221566|FG002|Overall Study|Lost to Follow-up|0|||
127615623|NCT01675882|459221567|FG003|Overall Study|Lost to Follow-up|0|||
127615624|NCT01675882|459221564|FG000|Overall Study|Non-compliance|0|||
127615625|NCT01675882|459221565|FG001|Overall Study|Non-compliance|0|||
127615626|NCT01675882|459221566|FG002|Overall Study|Non-compliance|0|||
127615627|NCT01675882|459221567|FG003|Overall Study|Non-compliance|1|||
127615628|NCT00735371|459221568|FG000|Overall Study|Adverse Event|3|||
127615629|NCT00735371|459221569|FG001|Overall Study|Adverse Event|3|||
127615630|NCT00735371|459221570|FG002|Overall Study|Adverse Event|4|||
127615631|NCT00735371|459221571|FG003|Overall Study|Adverse Event|1|||
127615632|NCT00735371|459221568|FG000|Overall Study|Protocol Violation|2|||
127615633|NCT00735371|459221569|FG001|Overall Study|Protocol Violation|2|||
127615634|NCT00735371|459221570|FG002|Overall Study|Protocol Violation|0|||
127615635|NCT00735371|459221571|FG003|Overall Study|Protocol Violation|3|||
127699593|NCT05296525|459528771|FG002|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
127699594|NCT05296525|459528772|FG003|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|3|||
127699595|NCT04065841|459528775|FG000|Overall Study|Adverse Event|4|||
127699596|NCT04065841|459528776|FG001|Overall Study|Adverse Event|2|||
127615636|NCT00735371|459221568|FG000|Overall Study|Withdrawal by Subject|0|||
127615637|NCT00735371|459221569|FG001|Overall Study|Withdrawal by Subject|2|||
127615638|NCT00735371|459221570|FG002|Overall Study|Withdrawal by Subject|2|||
127615639|NCT00735371|459221571|FG003|Overall Study|Withdrawal by Subject|0|||
127699597|NCT04065841|459528777|FG002|Overall Study|Adverse Event|10|||
127699598|NCT04065841|459528778|FG003|Overall Study|Adverse Event|1|||
127699599|NCT04065841|459528775|FG000|Overall Study|Lost to Follow-up|1|||
127699600|NCT04065841|459528776|FG001|Overall Study|Lost to Follow-up|2|||
127699601|NCT04065841|459528777|FG002|Overall Study|Lost to Follow-up|2|||
127699602|NCT04065841|459528778|FG003|Overall Study|Lost to Follow-up|2|||
127699603|NCT04065841|459528775|FG000|Overall Study|Physician Decision|1|||
127699604|NCT04065841|459528776|FG001|Overall Study|Physician Decision|0|||
127699605|NCT04065841|459528777|FG002|Overall Study|Physician Decision|0|||
127699606|NCT04065841|459528778|FG003|Overall Study|Physician Decision|0|||
127699607|NCT04065841|459528775|FG000|Overall Study|Protocol Violation|0|||
127699608|NCT04065841|459528776|FG001|Overall Study|Protocol Violation|1|||
127699609|NCT04065841|459528777|FG002|Overall Study|Protocol Violation|0|||
127699610|NCT04065841|459528778|FG003|Overall Study|Protocol Violation|0|||
127699611|NCT04065841|459528775|FG000|Overall Study|Study terminated by Sponsor|22|||
127699612|NCT04065841|459528776|FG001|Overall Study|Study terminated by Sponsor|16|||
127699613|NCT04065841|459528777|FG002|Overall Study|Study terminated by Sponsor|28|||
127699614|NCT04065841|459528778|FG003|Overall Study|Study terminated by Sponsor|17|||
127699615|NCT04065841|459528775|FG000|Overall Study|Withdrawal by Subject|1|||
127699616|NCT04065841|459528776|FG001|Overall Study|Withdrawal by Subject|1|||
127699617|NCT04065841|459528777|FG002|Overall Study|Withdrawal by Subject|2|||
127699618|NCT04065841|459528778|FG003|Overall Study|Withdrawal by Subject|0|||
127699619|NCT01420237|459528779|FG000|Overall Study|Death|13|||
127699620|NCT01420237|459528779|FG000|Overall Study|Withdrawal by Subject|41|||
127699621|NCT01420237|459528779|FG000|Overall Study|Lost to Follow-up|32|||
127699622|NCT01420237|459528779|FG000|Overall Study|Adverse Event|10|||
127699623|NCT01420237|459528779|FG000|Overall Study|Investigative Site Termination|43|||
127699624|NCT01420237|459528779|FG000|Overall Study|Censored because study device not implanted|21|||
127699625|NCT01420237|459528779|FG000|Overall Study|Censored because surgery not performed|2|||
127699626|NCT01420237|459528779|FG000|Overall Study|Censored because of Inclusion Exclusion Violation|11|||
127615640|NCT00735371|459221568|FG000|Overall Study|Lost to Follow-up|1|||
127615641|NCT00735371|459221569|FG001|Overall Study|Lost to Follow-up|1|||
127615642|NCT00735371|459221570|FG002|Overall Study|Lost to Follow-up|3|||
127615643|NCT00735371|459221571|FG003|Overall Study|Lost to Follow-up|1|||
127615644|NCT00735371|459221568|FG000|Overall Study|Lack of Efficacy|4|||
127615645|NCT00735371|459221569|FG001|Overall Study|Lack of Efficacy|2|||
127615646|NCT00735371|459221570|FG002|Overall Study|Lack of Efficacy|0|||
127615647|NCT00735371|459221571|FG003|Overall Study|Lack of Efficacy|4|||
127615648|NCT00735371|459221568|FG000|Overall Study|Sponsor Decision|3|||
127615649|NCT00735371|459221569|FG001|Overall Study|Sponsor Decision|1|||
127615650|NCT00735371|459221570|FG002|Overall Study|Sponsor Decision|0|||
127615651|NCT00735371|459221571|FG003|Overall Study|Sponsor Decision|1|||
127615652|NCT00735371|459221568|FG000|Overall Study|Protocol Violation|0|||
127615653|NCT00735371|459221569|FG001|Overall Study|Protocol Violation|1|||
127615654|NCT00735371|459221570|FG002|Overall Study|Protocol Violation|2|||
127615655|NCT00735371|459221571|FG003|Overall Study|Protocol Violation|0|||
127615656|NCT00735371|459221568|FG000|Overall Study|Prior Vyvanse Exposure|1|||
127615657|NCT00735371|459221569|FG001|Overall Study|Prior Vyvanse Exposure|1|||
127615658|NCT00735371|459221570|FG002|Overall Study|Prior Vyvanse Exposure|0|||
127615659|NCT00735371|459221571|FG003|Overall Study|Prior Vyvanse Exposure|0|||
127615660|NCT00735371|459221568|FG000|Overall Study|Exclusion criteria|1|||
127615661|NCT00735371|459221569|FG001|Overall Study|Exclusion criteria|0|||
127615662|NCT00735371|459221570|FG002|Overall Study|Exclusion criteria|0|||
127615663|NCT00735371|459221571|FG003|Overall Study|Exclusion criteria|0|||
127615664|NCT00994448|459221572|FG000|Overall Study|Adverse Event|1|||
127615665|NCT00994448|459221573|FG001|Overall Study|Adverse Event|0|||
127615666|NCT00994448|459221572|FG000|Overall Study|Lost to Follow-up|5|||
127615667|NCT00994448|459221573|FG001|Overall Study|Lost to Follow-up|1|||
127615668|NCT00994448|459221572|FG000|Overall Study|Withdrawal by Subject|1|||
127615669|NCT00994448|459221573|FG001|Overall Study|Withdrawal by Subject|1|||
127615670|NCT00994448|459221572|FG000|Overall Study|Physician Decision|1|||
127615671|NCT00994448|459221573|FG001|Overall Study|Physician Decision|0|||
127615672|NCT00436748|459221576|FG000|Overall Study|Ineligibility Determined|1|||
127615673|NCT00436748|459221577|FG001|Overall Study|Ineligibility Determined|1|||
127615674|NCT00436748|459221576|FG000|Overall Study|Adverse Event|0|||
127615675|NCT00436748|459221577|FG001|Overall Study|Adverse Event|2|||
127615676|NCT00436748|459221576|FG000|Overall Study|Consent Withdrawn|1|||
127615677|NCT00436748|459221577|FG001|Overall Study|Consent Withdrawn|4|||
127615678|NCT00436748|459221576|FG000|Overall Study|Administrative Decision|1|||
127615679|NCT00436748|459221577|FG001|Overall Study|Administrative Decision|0|||
127615680|NCT00436748|459221576|FG000|Overall Study|Lost to Follow-up|0|||
127615681|NCT00436748|459221577|FG001|Overall Study|Lost to Follow-up|1|||
127615682|NCT00436748|459221576|FG000|Overall Study|Protocol-specified Criteria|5|||
127615683|NCT00436748|459221577|FG001|Overall Study|Protocol-specified Criteria|4|||
127615684|NCT00436748|459221576|FG000|Overall Study|Other|3|||
127615685|NCT00436748|459221577|FG001|Overall Study|Other|0|||
127615686|NCT01610791|459221578|FG000|Overall Study|Lost to Follow-up|7|||
127615687|NCT01610791|459221578|FG000|Overall Study|Adverse Event|6|||
127790824|NCT00631371|459858873|FG000|Overall Study|Death|263|||
127790825|NCT00631371|459858874|FG001|Overall Study|Death|239|||
127615688|NCT01610791|459221578|FG000|Overall Study|Physician Decision|1|||
127615689|NCT01610791|459221578|FG000|Overall Study|Adverse event and Investigator decision|1|||
127615690|NCT01610791|459221578|FG000|Overall Study|Death|1|||
127615691|NCT01610791|459221578|FG000|Overall Study|Not determined|5|||
127615692|NCT02086110|459221583|FG000|Overall Study|Withdrawal by Subject|1|||
127615693|NCT02086110|459221584|FG001|Overall Study|Withdrawal by Subject|1|||
127615694|NCT01869192|459221585|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
127615695|NCT01869192|459221586|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
127615696|NCT01869192|459221585|FG000|Postoperative Chemotherapy|Physician Decision|0|||
127615697|NCT01869192|459221586|FG001|Postoperative Chemotherapy|Physician Decision|2|||
127615698|NCT00235872|459221590|FG000|Overall Study|Adverse Event|34|||
127615699|NCT00235872|459221590|FG000|Overall Study|Death|1|||
127615700|NCT00235872|459221590|FG000|Overall Study|Lost to Follow-up|1|||
127615701|NCT00235872|459221590|FG000|Overall Study|Withdrawal by Subject|50|||
127615702|NCT00235872|459221590|FG000|Overall Study|Administrative reason|61|||
127615703|NCT02126969|459221591|FG000|Overall Study|Withdrawal by Subject|1|||
127615704|NCT02126969|459221592|FG001|Overall Study|Withdrawal by Subject|2|||
127615705|NCT00423891|459221593|FG000|Enrolled|Withdrawal by Subject|0|||
127615706|NCT00423891|459221594|FG001|Enrolled|Withdrawal by Subject|0|||
127615707|NCT00423891|459221595|FG002|Enrolled|Withdrawal by Subject|1|||
127615708|NCT00423891|459221593|FG000|Enrolled|Lost to Follow-up|0|||
127615709|NCT00423891|459221594|FG001|Enrolled|Lost to Follow-up|0|||
127615710|NCT00423891|459221595|FG002|Enrolled|Lost to Follow-up|1|||
127615711|NCT00423891|459221593|FG000|Enrolled|No longer met criteria|11|||
127615712|NCT00423891|459221594|FG001|Enrolled|No longer met criteria|2|||
127615713|NCT00423891|459221595|FG002|Enrolled|No longer met criteria|1|||
127615714|NCT00423891|459221593|FG000|Treatment|Withdrawal by Subject|1|||
127615715|NCT00423891|459221594|FG001|Treatment|Withdrawal by Subject|0|||
127615716|NCT00423891|459221595|FG002|Treatment|Withdrawal by Subject|0|||
127615717|NCT00423891|459221593|FG000|Treatment|Lost to Follow-up|1|||
127615718|NCT00423891|459221594|FG001|Treatment|Lost to Follow-up|0|||
127615719|NCT00423891|459221595|FG002|Treatment|Lost to Follow-up|0|||
127615720|NCT00423891|459221593|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
127615721|NCT00423891|459221594|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
127615722|NCT00423891|459221595|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
127615723|NCT00423891|459221593|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
127615724|NCT00423891|459221594|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
127615725|NCT00423891|459221595|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
127615726|NCT00414661|459221596|FG000|Overall Study|Death|2|||
127615727|NCT00414661|459221597|FG001|Overall Study|Death|5|||
127615728|NCT00414661|459221598|FG002|Overall Study|Death|0|||
127615729|NCT00414661|459221599|FG003|Overall Study|Death|0|||
127615730|NCT00414661|459221596|FG000|Overall Study|Lost to Follow-up|1|||
127615731|NCT00414661|459221597|FG001|Overall Study|Lost to Follow-up|4|||
127615732|NCT00414661|459221598|FG002|Overall Study|Lost to Follow-up|0|||
127615733|NCT00414661|459221599|FG003|Overall Study|Lost to Follow-up|1|||
127615734|NCT00414661|459221596|FG000|Overall Study|Withdrawal by Subject|5|||
127615735|NCT00414661|459221597|FG001|Overall Study|Withdrawal by Subject|2|||
127615736|NCT00414661|459221598|FG002|Overall Study|Withdrawal by Subject|2|||
127615737|NCT00414661|459221599|FG003|Overall Study|Withdrawal by Subject|2|||
127615738|NCT00414661|459221596|FG000|Overall Study|Other|6|||
127615739|NCT00414661|459221597|FG001|Overall Study|Other|3|||
127615740|NCT00414661|459221598|FG002|Overall Study|Other|0|||
127615741|NCT00414661|459221599|FG003|Overall Study|Other|0|||
127615742|NCT00357370|459221600|FG000|Cohort 2|Lack of Efficacy|0|||
127615743|NCT00357370|459221601|FG001|Cohort 2|Lack of Efficacy|2|||
127615744|NCT00357370|459221602|FG002|Cohort 2|Lack of Efficacy|1|||
127615745|NCT00357370|459221600|FG000|Cohort 2|Adverse Event|1|||
127615746|NCT00357370|459221601|FG001|Cohort 2|Adverse Event|1|||
127615747|NCT00357370|459221602|FG002|Cohort 2|Adverse Event|1|||
127615748|NCT00357370|459221600|FG000|Cohort 2|Lost to Follow-up|0|||
127615749|NCT00357370|459221601|FG001|Cohort 2|Lost to Follow-up|1|||
127615750|NCT00357370|459221602|FG002|Cohort 2|Lost to Follow-up|0|||
127615751|NCT00357370|459221600|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
127615752|NCT00357370|459221601|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
127615753|NCT00357370|459221602|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
127615754|NCT00357370|459221600|FG000|Cohort 2|Withdrawal by Subject|0|||
127615755|NCT00357370|459221601|FG001|Cohort 2|Withdrawal by Subject|2|||
127615756|NCT00357370|459221602|FG002|Cohort 2|Withdrawal by Subject|0|||
127615757|NCT01232296|459221603|FG000|Overall Study|Adverse Event|24|||
127615758|NCT01232296|459221604|FG001|Overall Study|Adverse Event|12|||
127615759|NCT01232296|459221603|FG000|Overall Study|Physician Decision|1|||
127615760|NCT01232296|459221604|FG001|Overall Study|Physician Decision|1|||
127615761|NCT01232296|459221603|FG000|Overall Study|Progressive disease|43|||
127615762|NCT01232296|459221604|FG001|Overall Study|Progressive disease|61|||
127615763|NCT01232296|459221603|FG000|Overall Study|Study terminated by sponsor|0|||
127615764|NCT01232296|459221604|FG001|Overall Study|Study terminated by sponsor|1|||
127790826|NCT00390546|459858875|FG000|Overall Study|Renal impairment|1|||
127790827|NCT00390546|459858876|FG001|Overall Study|Renal impairment|0|||
127790828|NCT00390546|459858875|FG000|Overall Study|Physician Decision|5|||
127790829|NCT00390546|459858876|FG001|Overall Study|Physician Decision|5|||
127790830|NCT00812214|459858882|FG000|Overall Study|Lost to Follow-up|3|||
127790831|NCT00812214|459858883|FG001|Overall Study|Lost to Follow-up|1|||
127790832|NCT02145741|459858884|FG000|Overall Study|Progressive disease|3|||
127790833|NCT02145741|459858885|FG001|Overall Study|Progressive disease|6|||
127790834|NCT02145741|459858886|FG002|Overall Study|Progressive disease|6|||
127615765|NCT01232296|459221603|FG000|Overall Study|Technical problems|3|||
127615766|NCT01232296|459221604|FG001|Overall Study|Technical problems|0|||
127615767|NCT01232296|459221603|FG000|Overall Study|Subject/guardian decision|10|||
127615768|NCT01232296|459221604|FG001|Overall Study|Subject/guardian decision|2|||
127615769|NCT01232296|459221603|FG000|Overall Study|Death|1|||
127615770|NCT01232296|459221604|FG001|Overall Study|Death|6|||
127615771|NCT00404352|459221605|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
127615772|NCT00404352|459221606|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
127615773|NCT00404352|459221607|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
127615774|NCT00404352|459221608|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
127615775|NCT00404352|459221609|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
127615776|NCT00404352|459221610|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
127615777|NCT00404352|459221611|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
127615778|NCT00404352|459221612|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
127615779|NCT00404352|459221613|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
127615780|NCT00404352|459221605|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
127615781|NCT00404352|459221606|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
127615782|NCT00404352|459221607|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
127615783|NCT00404352|459221608|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
127615784|NCT00404352|459221609|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
127615785|NCT00404352|459221610|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
127615786|NCT00404352|459221611|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
127615787|NCT00404352|459221612|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
127615788|NCT00404352|459221613|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
127615789|NCT00404352|459221605|FG000|Double Blind (up to 24 Month)|Death|0|||
127615790|NCT00404352|459221606|FG001|Double Blind (up to 24 Month)|Death|0|||
127615791|NCT00404352|459221607|FG002|Double Blind (up to 24 Month)|Death|1|||
127615792|NCT00404352|459221608|FG003|Double Blind (up to 24 Month)|Death|0|||
127615793|NCT00404352|459221609|FG004|Double Blind (up to 24 Month)|Death|0|||
127615794|NCT00404352|459221610|FG005|Double Blind (up to 24 Month)|Death|0|||
127615795|NCT00404352|459221611|FG006|Double Blind (up to 24 Month)|Death|0|||
127615796|NCT00404352|459221612|FG007|Double Blind (up to 24 Month)|Death|0|||
127615797|NCT00404352|459221613|FG008|Double Blind (up to 24 Month)|Death|0|||
127615798|NCT00404352|459221605|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
127615799|NCT00404352|459221606|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
127615800|NCT00404352|459221607|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
127615801|NCT00404352|459221608|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
127615802|NCT00404352|459221609|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
127615803|NCT00404352|459221610|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
127615804|NCT00404352|459221611|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
127615805|NCT00404352|459221612|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
127615806|NCT00404352|459221613|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
127615807|NCT00404352|459221605|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
127615808|NCT00404352|459221606|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
127615809|NCT00404352|459221607|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
127790835|NCT02145741|459858884|FG000|Overall Study|quality issue with the administered drug|3|||
127790836|NCT02145741|459858885|FG001|Overall Study|quality issue with the administered drug|0|||
127615810|NCT00404352|459221608|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
127790837|NCT02145741|459858886|FG002|Overall Study|quality issue with the administered drug|0|||
127790838|NCT00129766|459858888|FG000|Overall Study|Death|3|||
127615811|NCT00404352|459221609|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
127615812|NCT00404352|459221610|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
127615813|NCT00404352|459221611|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
127615814|NCT00404352|459221612|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
127615815|NCT00404352|459221613|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
127615816|NCT00404352|459221605|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
127615817|NCT00404352|459221606|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
127615818|NCT00404352|459221607|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
127615819|NCT00404352|459221608|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
127615820|NCT00404352|459221609|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
127615821|NCT00404352|459221610|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
127615822|NCT00404352|459221611|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
127615823|NCT00404352|459221612|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
127615824|NCT00404352|459221613|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
127615825|NCT00404352|459221605|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
127615826|NCT00404352|459221606|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
127615827|NCT00404352|459221607|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
127615828|NCT00404352|459221608|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
127615829|NCT00404352|459221609|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
127615830|NCT00404352|459221610|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
127615831|NCT00404352|459221611|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
127615832|NCT00404352|459221612|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
127790839|NCT00129766|459858889|FG001|Overall Study|Death|8|||
127790840|NCT00129766|459858888|FG000|Overall Study|Withdrawal of consent|31|||
127790841|NCT00129766|459858889|FG001|Overall Study|Withdrawal of consent|30|||
127790842|NCT00129766|459858888|FG000|Overall Study|Lost to Follow-up|26|||
127790843|NCT00129766|459858889|FG001|Overall Study|Lost to Follow-up|21|||
127790844|NCT04091087|459858891|FG000|Overall Study|Not treated|1|||
127790845|NCT04091087|459858892|FG001|Overall Study|Not treated|0|||
127790846|NCT04091087|459858891|FG000|Overall Study|Adverse Event|4|||
127790847|NCT04091087|459858892|FG001|Overall Study|Adverse Event|4|||
127790848|NCT04091087|459858891|FG000|Overall Study|Protocol Violation|0|||
127790849|NCT04091087|459858892|FG001|Overall Study|Protocol Violation|1|||
127790850|NCT04091087|459858891|FG000|Overall Study|Withdrawal by Subject|5|||
127790851|NCT04091087|459858892|FG001|Overall Study|Withdrawal by Subject|2|||
127790852|NCT05440539|459858893|FG000|Overall Study|Lost to Follow-up|4|||
127790853|NCT05440539|459858894|FG001|Overall Study|Lost to Follow-up|4|||
127790854|NCT05440539|459858893|FG000|Overall Study|Fetal demise, no longer pregnant|3|||
127790855|NCT05440539|459858894|FG001|Overall Study|Fetal demise, no longer pregnant|4|||
127790856|NCT03808077|459858895|FG000|Overall Study|Physician Decision|2|||
127790857|NCT03808077|459858896|FG001|Overall Study|Physician Decision|3|||
127790858|NCT03808077|459858895|FG000|Overall Study|Withdrawal by Subject|1|||
127790859|NCT03808077|459858896|FG001|Overall Study|Withdrawal by Subject|0|||
127790860|NCT03808077|459858895|FG000|Overall Study|Equipment Issues|2|||
127615833|NCT00404352|459221613|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
127615834|NCT00404352|459221605|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
127615835|NCT00404352|459221606|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
127615836|NCT00404352|459221607|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
127615837|NCT00404352|459221608|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
127615838|NCT00404352|459221609|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
127615839|NCT00404352|459221610|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
127615840|NCT00404352|459221611|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
127615841|NCT00404352|459221612|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
127615842|NCT00404352|459221613|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
127615843|NCT00404352|459221605|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
127615844|NCT00404352|459221606|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
127615845|NCT00404352|459221607|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
127615846|NCT00404352|459221608|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
127615847|NCT00404352|459221609|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
127615848|NCT00404352|459221610|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
127615849|NCT00404352|459221611|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
127615850|NCT00404352|459221612|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
127790861|NCT03808077|459858896|FG001|Overall Study|Equipment Issues|1|||
127615851|NCT00404352|459221613|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
127790862|NCT04152161|459858897|FG000|Overall Study|Death|0|||
127790863|NCT04152161|459858898|FG001|Overall Study|Death|1|||
127790864|NCT04152161|459858897|FG000|Overall Study|Physician Decision|0|||
127790865|NCT04152161|459858898|FG001|Overall Study|Physician Decision|1|||
127790866|NCT04152161|459858897|FG000|Overall Study|Lost to Follow-up|9|||
127790867|NCT04152161|459858898|FG001|Overall Study|Lost to Follow-up|3|||
127790868|NCT04152161|459858897|FG000|Overall Study|Protocol Violation|1|||
127790869|NCT04152161|459858898|FG001|Overall Study|Protocol Violation|0|||
127790870|NCT04152161|459858897|FG000|Overall Study|Withdrawal by Subject|29|||
127790871|NCT04152161|459858898|FG001|Overall Study|Withdrawal by Subject|28|||
127790872|NCT04152161|459858897|FG000|Overall Study|Sponsor termination of study|750|||
127790873|NCT04152161|459858898|FG001|Overall Study|Sponsor termination of study|755|||
127790874|NCT04152161|459858897|FG000|Overall Study|Other|20|||
127790875|NCT04152161|459858898|FG001|Overall Study|Other|18|||
127790876|NCT03246958|459858899|FG000|Overall Study|Withdrawal by Subject|0|||
127790877|NCT03246958|459858900|FG001|Overall Study|Withdrawal by Subject|1|||
127790878|NCT03246958|459858901|FG002|Overall Study|Withdrawal by Subject|0|||
127790879|NCT03246958|459858902|FG003|Overall Study|Withdrawal by Subject|0|||
127790880|NCT03246958|459858903|FG004|Overall Study|Withdrawal by Subject|0|||
127790881|NCT03246958|459858904|FG005|Overall Study|Withdrawal by Subject|1|||
127790882|NCT03246958|459858905|FG006|Overall Study|Withdrawal by Subject|0|||
127790883|NCT03246958|459858899|FG000|Overall Study|Progression|13|||
127790884|NCT03246958|459858900|FG001|Overall Study|Progression|9|||
127790885|NCT03246958|459858901|FG002|Overall Study|Progression|3|||
127790886|NCT03246958|459858902|FG003|Overall Study|Progression|2|||
127790887|NCT03246958|459858903|FG004|Overall Study|Progression|1|||
127790888|NCT03246958|459858904|FG005|Overall Study|Progression|2|||
127790889|NCT03246958|459858905|FG006|Overall Study|Progression|1|||
127790890|NCT03246958|459858899|FG000|Overall Study|Adverse Event|2|||
127790891|NCT03246958|459858900|FG001|Overall Study|Adverse Event|2|||
127790892|NCT03246958|459858901|FG002|Overall Study|Adverse Event|0|||
127790893|NCT03246958|459858902|FG003|Overall Study|Adverse Event|1|||
127790894|NCT03246958|459858903|FG004|Overall Study|Adverse Event|1|||
127790895|NCT03246958|459858904|FG005|Overall Study|Adverse Event|0|||
127790896|NCT03246958|459858905|FG006|Overall Study|Adverse Event|2|||
127790897|NCT03246958|459858899|FG000|Overall Study|Death|0|||
127790898|NCT03246958|459858900|FG001|Overall Study|Death|1|||
127790899|NCT03246958|459858901|FG002|Overall Study|Death|0|||
127790900|NCT03246958|459858902|FG003|Overall Study|Death|0|||
127790901|NCT03246958|459858903|FG004|Overall Study|Death|0|||
127790902|NCT03246958|459858904|FG005|Overall Study|Death|0|||
127790903|NCT03246958|459858905|FG006|Overall Study|Death|0|||
127790904|NCT03246958|459858899|FG000|Overall Study|Physician Decision|0|||
127790905|NCT03246958|459858900|FG001|Overall Study|Physician Decision|0|||
127790906|NCT03246958|459858901|FG002|Overall Study|Physician Decision|0|||
127790907|NCT03246958|459858902|FG003|Overall Study|Physician Decision|1|||
127790908|NCT03246958|459858903|FG004|Overall Study|Physician Decision|0|||
127790909|NCT03246958|459858904|FG005|Overall Study|Physician Decision|0|||
127790910|NCT03246958|459858905|FG006|Overall Study|Physician Decision|0|||
127790911|NCT03246958|459858899|FG000|Overall Study|Never start treatment|1|||
127790912|NCT03246958|459858900|FG001|Overall Study|Never start treatment|0|||
127790913|NCT03246958|459858901|FG002|Overall Study|Never start treatment|0|||
127790914|NCT03246958|459858902|FG003|Overall Study|Never start treatment|0|||
127790915|NCT03246958|459858903|FG004|Overall Study|Never start treatment|0|||
127790916|NCT03246958|459858904|FG005|Overall Study|Never start treatment|0|||
127790917|NCT03246958|459858905|FG006|Overall Study|Never start treatment|0|||
127790918|NCT03246958|459858899|FG000|Overall Study|Over enrollment|0|||
127790919|NCT03246958|459858900|FG001|Overall Study|Over enrollment|2|||
127790920|NCT03246958|459858901|FG002|Overall Study|Over enrollment|0|||
127790921|NCT03246958|459858902|FG003|Overall Study|Over enrollment|0|||
127790922|NCT03246958|459858903|FG004|Overall Study|Over enrollment|0|||
127790923|NCT03246958|459858904|FG005|Overall Study|Over enrollment|0|||
127790924|NCT03246958|459858905|FG006|Overall Study|Over enrollment|0|||
127790925|NCT03703102|459858906|FG000|Overall Study|Adverse Event|4|||
127790926|NCT03703102|459858907|FG001|Overall Study|Adverse Event|3|||
127790927|NCT03703102|459858908|FG002|Overall Study|Adverse Event|7|||
127790928|NCT03703102|459858909|FG003|Overall Study|Adverse Event|3|||
127884170|NCT00681824|460199821|FG002|Overall Study|scheduling conflict|0|||
127790929|NCT03703102|459858910|FG004|Overall Study|Adverse Event|13|||
127790930|NCT03703102|459858906|FG000|Overall Study|Lack of Efficacy|4|||
127790931|NCT03703102|459858907|FG001|Overall Study|Lack of Efficacy|0|||
127790932|NCT03703102|459858908|FG002|Overall Study|Lack of Efficacy|1|||
127790933|NCT03703102|459858909|FG003|Overall Study|Lack of Efficacy|4|||
127790934|NCT03703102|459858910|FG004|Overall Study|Lack of Efficacy|1|||
127790935|NCT03703102|459858906|FG000|Overall Study|Lost to Follow-up|0|||
127790936|NCT03703102|459858907|FG001|Overall Study|Lost to Follow-up|0|||
127790937|NCT03703102|459858908|FG002|Overall Study|Lost to Follow-up|1|||
127790938|NCT03703102|459858909|FG003|Overall Study|Lost to Follow-up|2|||
127790939|NCT03703102|459858910|FG004|Overall Study|Lost to Follow-up|2|||
127790940|NCT03703102|459858906|FG000|Overall Study|Physician Decision|2|||
127790941|NCT03703102|459858907|FG001|Overall Study|Physician Decision|2|||
127790942|NCT03703102|459858908|FG002|Overall Study|Physician Decision|2|||
127790943|NCT03703102|459858909|FG003|Overall Study|Physician Decision|2|||
127615852|NCT00404352|459221605|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
127884171|NCT00681824|460199819|FG000|Overall Study|Death|0|||
127884172|NCT00681824|460199820|FG001|Overall Study|Death|1|||
127884173|NCT00681824|460199821|FG002|Overall Study|Death|0|||
127884174|NCT03724916|460199822|FG000|Overall Study|Withdrawal by Subject|0|||
127615853|NCT00404352|459221606|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
127615854|NCT00404352|459221607|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
127615855|NCT00404352|459221608|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
127615856|NCT00404352|459221609|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
127884175|NCT03724916|460199823|FG001|Overall Study|Withdrawal by Subject|1|||
127884176|NCT03724916|460199824|FG002|Overall Study|Withdrawal by Subject|1|||
127884177|NCT03724916|460199825|FG003|Overall Study|Withdrawal by Subject|2|||
127884178|NCT03724916|460199822|FG000|Overall Study|Randomized but not Treated|1|||
127884179|NCT03724916|460199823|FG001|Overall Study|Randomized but not Treated|0|||
127884180|NCT03724916|460199824|FG002|Overall Study|Randomized but not Treated|0|||
127884181|NCT03724916|460199825|FG003|Overall Study|Randomized but not Treated|0|||
127884182|NCT04575038|460199826|FG000|Overall Study|Withdrawal by Subject|1|||
127884183|NCT04575038|460199827|FG001|Overall Study|Withdrawal by Subject|1|||
127884184|NCT03591107|460199833|FG000|Overall Study|Same patient in both arms|1|||
127884185|NCT03591107|460199834|FG001|Overall Study|Same patient in both arms|1|||
127884186|NCT03591107|460199833|FG000|Overall Study|Sought care at other clinics|0|||
127615857|NCT00404352|459221610|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
127615858|NCT00404352|459221611|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
127615859|NCT00404352|459221612|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
127615860|NCT00404352|459221613|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
127615861|NCT00404352|459221605|FG000|Double Blind (up to 24 Month)|Other|0|||
127615862|NCT00404352|459221606|FG001|Double Blind (up to 24 Month)|Other|1|||
127615863|NCT00404352|459221607|FG002|Double Blind (up to 24 Month)|Other|0|||
127615864|NCT00404352|459221608|FG003|Double Blind (up to 24 Month)|Other|0|||
127615865|NCT00404352|459221609|FG004|Double Blind (up to 24 Month)|Other|0|||
127615866|NCT00404352|459221610|FG005|Double Blind (up to 24 Month)|Other|0|||
127615867|NCT00404352|459221611|FG006|Double Blind (up to 24 Month)|Other|0|||
127615868|NCT00404352|459221612|FG007|Double Blind (up to 24 Month)|Other|0|||
127615869|NCT00404352|459221613|FG008|Double Blind (up to 24 Month)|Other|0|||
127615870|NCT00404352|459221605|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
127615871|NCT00404352|459221606|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
127615872|NCT00404352|459221607|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
127615873|NCT00404352|459221608|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
127615874|NCT00404352|459221609|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
127615875|NCT00404352|459221610|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
127615876|NCT00404352|459221611|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
127615877|NCT00404352|459221612|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
127615878|NCT00404352|459221613|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
127615879|NCT00404352|459221605|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
127615880|NCT00404352|459221606|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
127615881|NCT00404352|459221607|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
127615882|NCT00404352|459221608|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
127615883|NCT00404352|459221609|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
127615884|NCT00404352|459221610|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
127615885|NCT00404352|459221611|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
127615886|NCT00404352|459221612|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
127615887|NCT00404352|459221613|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
127615888|NCT00404352|459221605|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
127615889|NCT00404352|459221606|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
127615890|NCT00404352|459221607|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
127615891|NCT00404352|459221608|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
127615892|NCT00404352|459221609|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
127615893|NCT00404352|459221610|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
127615894|NCT00404352|459221611|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
127615895|NCT00404352|459221612|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
127615896|NCT00404352|459221613|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
127615897|NCT00404352|459221605|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
127615898|NCT00404352|459221606|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
127615899|NCT00404352|459221607|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
127615900|NCT00404352|459221608|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
127615901|NCT00404352|459221609|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
127615902|NCT00404352|459221610|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
127615903|NCT00404352|459221611|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
127615904|NCT00404352|459221612|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
127615905|NCT00404352|459221613|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
127615906|NCT00404352|459221605|FG000|Open Label (up to 24 Month)|Disease progression|0|||
127615907|NCT00404352|459221606|FG001|Open Label (up to 24 Month)|Disease progression|0|||
127615908|NCT00404352|459221607|FG002|Open Label (up to 24 Month)|Disease progression|0|||
127615909|NCT00404352|459221608|FG003|Open Label (up to 24 Month)|Disease progression|1|||
127615910|NCT00404352|459221609|FG004|Open Label (up to 24 Month)|Disease progression|0|||
127615911|NCT00404352|459221610|FG005|Open Label (up to 24 Month)|Disease progression|0|||
127615912|NCT00404352|459221611|FG006|Open Label (up to 24 Month)|Disease progression|0|||
127615913|NCT00404352|459221612|FG007|Open Label (up to 24 Month)|Disease progression|0|||
127615914|NCT00404352|459221613|FG008|Open Label (up to 24 Month)|Disease progression|0|||
127615915|NCT00404352|459221605|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
127615916|NCT00404352|459221606|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
127615917|NCT00404352|459221607|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
127615918|NCT00404352|459221608|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
127615919|NCT00404352|459221609|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
127615920|NCT00404352|459221610|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
127615921|NCT00404352|459221611|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
127615922|NCT00404352|459221612|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
127615923|NCT00404352|459221613|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
127615924|NCT00404352|459221605|FG000|Open Label Extension (up to 36 Months)|Other|0|||
127615925|NCT00404352|459221606|FG001|Open Label Extension (up to 36 Months)|Other|0|||
127615926|NCT00404352|459221607|FG002|Open Label Extension (up to 36 Months)|Other|0|||
127615927|NCT00404352|459221608|FG003|Open Label Extension (up to 36 Months)|Other|0|||
127615928|NCT00404352|459221609|FG004|Open Label Extension (up to 36 Months)|Other|0|||
127615929|NCT00404352|459221610|FG005|Open Label Extension (up to 36 Months)|Other|0|||
127615930|NCT00404352|459221611|FG006|Open Label Extension (up to 36 Months)|Other|0|||
127615931|NCT00404352|459221612|FG007|Open Label Extension (up to 36 Months)|Other|0|||
127615932|NCT00404352|459221613|FG008|Open Label Extension (up to 36 Months)|Other|2|||
127615933|NCT02308735|459221614|FG000|Overall Study|Physician Decision|2|||
127615934|NCT02308735|459221615|FG001|Overall Study|Physician Decision|0|||
127615935|NCT02308735|459221616|FG002|Overall Study|Physician Decision|0|||
127615936|NCT02308735|459221617|FG003|Overall Study|Physician Decision|2|||
127615937|NCT00606892|459221623|FG000|First Intervention|Protocol Violation|1|||
127615938|NCT00606892|459221624|FG001|First Intervention|Protocol Violation|4|||
127615939|NCT04960228|459221632|FG000|Overall Study|Withdrawal by Subject|216|||
127615940|NCT04960228|459221633|FG001|Overall Study|Withdrawal by Subject|35|||
127615941|NCT04960228|459221632|FG000|Overall Study|Failed attention check|69|||
127615942|NCT04960228|459221633|FG001|Overall Study|Failed attention check|148|||
127884187|NCT03591107|460199834|FG001|Overall Study|Sought care at other clinics|2|||
127615943|NCT04960228|459221632|FG000|Overall Study|Flagged for response quality by Dynata|3|||
127615944|NCT04960228|459221633|FG001|Overall Study|Flagged for response quality by Dynata|3|||
127615945|NCT00794196|459221635|FG000|Overall Study|Lost to Follow-up|5|||
127615946|NCT00794196|459221636|FG001|Overall Study|Lost to Follow-up|23|||
127615947|NCT02129803|459221639|FG000|Overall Study|Protocol Violation|4|||
127615948|NCT02129803|459221640|FG001|Overall Study|Protocol Violation|0|||
127615949|NCT02129803|459221639|FG000|Overall Study|Physician Decision|0|||
127615950|NCT02129803|459221640|FG001|Overall Study|Physician Decision|1|||
127615951|NCT02129803|459221639|FG000|Overall Study|Difficulty sleeping|1|||
127615952|NCT02129803|459221640|FG001|Overall Study|Difficulty sleeping|0|||
127615953|NCT02129803|459221639|FG000|Overall Study|Morning headache|0|||
127615954|NCT02129803|459221640|FG001|Overall Study|Morning headache|1|||
127615955|NCT02129803|459221639|FG000|Overall Study|Withdrawal by Subject|1|||
127615956|NCT02129803|459221640|FG001|Overall Study|Withdrawal by Subject|1|||
127615957|NCT00696137|459221642|FG000|Overall Study|Withdrawal by Subject|2|||
127615958|NCT01116232|459221651|FG000|Overall Study|Progressive diease|4|||
127615959|NCT02357940|459221652|FG000|Overall Study|Adverse Event|0|||
127615960|NCT02357940|459221653|FG001|Overall Study|Adverse Event|1|||
127615961|NCT02357940|459221652|FG000|Overall Study|Investigator's judgement|0|||
127615962|NCT02357940|459221653|FG001|Overall Study|Investigator's judgement|1|||
127615963|NCT02275481|459221654|FG000|Overall Study|Death|2|||
127615964|NCT02275481|459221655|FG001|Overall Study|Death|1|||
127615965|NCT02275481|459221654|FG000|Overall Study|Lost to Follow-up|2|||
127615966|NCT02275481|459221655|FG001|Overall Study|Lost to Follow-up|0|||
127615967|NCT02275481|459221654|FG000|Overall Study|Withdrawal by Subject|3|||
127615968|NCT02275481|459221655|FG001|Overall Study|Withdrawal by Subject|0|||
127615969|NCT02275481|459221654|FG000|Overall Study|all other reasons combined|2|||
127615970|NCT02275481|459221655|FG001|Overall Study|all other reasons combined|1|||
127615971|NCT02275481|459221654|FG000|Overall Study|Physician Decision|0|||
127615972|NCT02275481|459221655|FG001|Overall Study|Physician Decision|1|||
127615973|NCT03350503|459221660|FG000|Overall Study|Adverse Event|5|||
127615974|NCT03350503|459221660|FG000|Overall Study|Withdrawal by Subject|5|||
127615975|NCT03350503|459221660|FG000|Overall Study|Continuation impossible due to move|4|||
127615976|NCT03350503|459221660|FG000|Overall Study|Physician Decision|3|||
127615977|NCT01399593|459221661|FG000|Overall Study|Physician Decision|1|||
127615978|NCT01399593|459221662|FG001|Overall Study|Physician Decision|0|||
127615979|NCT01399593|459221661|FG000|Overall Study|Adverse Event|1|||
127615980|NCT01399593|459221662|FG001|Overall Study|Adverse Event|0|||
127615981|NCT01399593|459221661|FG000|Overall Study|Death|1|||
127615982|NCT01399593|459221662|FG001|Overall Study|Death|1|||
127790944|NCT03703102|459858910|FG004|Overall Study|Physician Decision|4|||
127790945|NCT03703102|459858906|FG000|Overall Study|Withdrawal by Subject|7|||
127790946|NCT03703102|459858907|FG001|Overall Study|Withdrawal by Subject|5|||
127790947|NCT03703102|459858908|FG002|Overall Study|Withdrawal by Subject|5|||
127790948|NCT03703102|459858909|FG003|Overall Study|Withdrawal by Subject|5|||
127790949|NCT03703102|459858910|FG004|Overall Study|Withdrawal by Subject|9|||
127790950|NCT03703102|459858906|FG000|Overall Study|Ineligibility|0|||
127615983|NCT01399593|459221661|FG000|Overall Study|Transplantectomy|0|||
127615984|NCT01399593|459221662|FG001|Overall Study|Transplantectomy|1|||
127615985|NCT00403273|459223587|FG000|Overall Study|Lost to Follow-up|3|||
127615986|NCT00403273|459223588|FG001|Overall Study|Lost to Follow-up|2|||
127615987|NCT00403273|459223587|FG000|Overall Study|Physician Decision|0|||
127615988|NCT00403273|459223588|FG001|Overall Study|Physician Decision|1|||
127615989|NCT00403273|459223587|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
127790951|NCT03703102|459858907|FG001|Overall Study|Ineligibility|0|||
127790952|NCT03703102|459858908|FG002|Overall Study|Ineligibility|1|||
127790953|NCT03703102|459858909|FG003|Overall Study|Ineligibility|0|||
127790954|NCT03703102|459858910|FG004|Overall Study|Ineligibility|0|||
127615990|NCT00403273|459223588|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
127615991|NCT01336738|459223590|FG000|Overall Study|Adverse Event|0|||
127615992|NCT01336738|459223591|FG001|Overall Study|Adverse Event|3|||
127615993|NCT01336738|459223592|FG002|Overall Study|Adverse Event|2|||
127790955|NCT03703102|459858906|FG000|Overall Study|Protocol Deviation|4|||
127790956|NCT03703102|459858907|FG001|Overall Study|Protocol Deviation|4|||
127615994|NCT01336738|459223593|FG003|Overall Study|Adverse Event|1|||
127615995|NCT01336738|459223594|FG004|Overall Study|Adverse Event|3|||
127790957|NCT03703102|459858908|FG002|Overall Study|Protocol Deviation|3|||
127615996|NCT01336738|459223590|FG000|Overall Study|Lost to Follow-up|2|||
127615997|NCT01336738|459223591|FG001|Overall Study|Lost to Follow-up|1|||
127615998|NCT01336738|459223592|FG002|Overall Study|Lost to Follow-up|2|||
127615999|NCT01336738|459223593|FG003|Overall Study|Lost to Follow-up|2|||
127616000|NCT01336738|459223594|FG004|Overall Study|Lost to Follow-up|2|||
127616001|NCT01336738|459223590|FG000|Overall Study|Did not meet entrance criteria|0|||
127616002|NCT01336738|459223591|FG001|Overall Study|Did not meet entrance criteria|1|||
127616003|NCT01336738|459223592|FG002|Overall Study|Did not meet entrance criteria|0|||
127616004|NCT01336738|459223593|FG003|Overall Study|Did not meet entrance criteria|0|||
127616005|NCT01336738|459223594|FG004|Overall Study|Did not meet entrance criteria|0|||
127790958|NCT03703102|459858909|FG003|Overall Study|Protocol Deviation|0|||
127790959|NCT03703102|459858910|FG004|Overall Study|Protocol Deviation|0|||
127790960|NCT03703102|459858906|FG000|Overall Study|Non-Compliance with Study Drug|1|||
127790961|NCT03703102|459858907|FG001|Overall Study|Non-Compliance with Study Drug|1|||
127790962|NCT03703102|459858908|FG002|Overall Study|Non-Compliance with Study Drug|2|||
127790963|NCT03703102|459858909|FG003|Overall Study|Non-Compliance with Study Drug|1|||
127790964|NCT03703102|459858910|FG004|Overall Study|Non-Compliance with Study Drug|4|||
127616006|NCT01336738|459223590|FG000|Overall Study|Protocol Violation|0|||
127616007|NCT01336738|459223591|FG001|Overall Study|Protocol Violation|1|||
127616008|NCT01336738|459223592|FG002|Overall Study|Protocol Violation|0|||
127616009|NCT01336738|459223593|FG003|Overall Study|Protocol Violation|0|||
127616010|NCT01336738|459223594|FG004|Overall Study|Protocol Violation|0|||
127616011|NCT01336738|459223590|FG000|Overall Study|Withdrawal by Subject|2|||
127616012|NCT01336738|459223591|FG001|Overall Study|Withdrawal by Subject|0|||
127616013|NCT01336738|459223592|FG002|Overall Study|Withdrawal by Subject|2|||
127616014|NCT01336738|459223593|FG003|Overall Study|Withdrawal by Subject|1|||
127616015|NCT01336738|459223594|FG004|Overall Study|Withdrawal by Subject|1|||
127616016|NCT01336738|459223590|FG000|Overall Study|Other|3|||
127616017|NCT01336738|459223591|FG001|Overall Study|Other|3|||
127616018|NCT01336738|459223592|FG002|Overall Study|Other|2|||
127616019|NCT01336738|459223593|FG003|Overall Study|Other|3|||
127790965|NCT01650636|459858911|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
127616020|NCT01336738|459223594|FG004|Overall Study|Other|4|||
127616021|NCT02970968|459223596|FG000|Overall Study|Withdrawal by Subject|3|||
127616022|NCT02970968|459223597|FG001|Overall Study|Withdrawal by Subject|3|||
127616023|NCT02970968|459223596|FG000|Overall Study|Adverse Event|1|||
127616024|NCT02970968|459223597|FG001|Overall Study|Adverse Event|2|||
127616025|NCT02970968|459223596|FG000|Overall Study|Lost to Follow-up|1|||
127616026|NCT02970968|459223597|FG001|Overall Study|Lost to Follow-up|1|||
127616027|NCT02970968|459223596|FG000|Overall Study|Non-Compliance|0|||
127616028|NCT02970968|459223597|FG001|Overall Study|Non-Compliance|1|||
127616029|NCT02388737|459223599|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
127616030|NCT02388737|459223600|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
127616031|NCT02388737|459223601|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
127616032|NCT02388737|459223599|FG000|Overall Study|Major Protocol Deviation|18|||
127616033|NCT02388737|459223600|FG001|Overall Study|Major Protocol Deviation|25|||
127616034|NCT02388737|459223601|FG002|Overall Study|Major Protocol Deviation|22|||
127616035|NCT02388737|459223599|FG000|Overall Study|Lost to Follow-up|5|||
127616036|NCT02388737|459223600|FG001|Overall Study|Lost to Follow-up|1|||
127616037|NCT02388737|459223601|FG002|Overall Study|Lost to Follow-up|4|||
127616038|NCT02388737|459223599|FG000|Overall Study|Voluntary Withdrawal|10|||
127616039|NCT02388737|459223600|FG001|Overall Study|Voluntary Withdrawal|18|||
127616040|NCT02388737|459223601|FG002|Overall Study|Voluntary Withdrawal|17|||
127616041|NCT02388737|459223599|FG000|Overall Study|Lack of Efficacy|3|||
127616042|NCT02388737|459223600|FG001|Overall Study|Lack of Efficacy|0|||
127616043|NCT02388737|459223601|FG002|Overall Study|Lack of Efficacy|3|||
127616044|NCT02388737|459223599|FG000|Overall Study|Reason Not Specified|5|||
127616045|NCT02388737|459223600|FG001|Overall Study|Reason Not Specified|5|||
127616046|NCT02388737|459223601|FG002|Overall Study|Reason Not Specified|4|||
127616047|NCT03252522|459223602|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
127616048|NCT03252522|459223603|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
127616049|NCT03252522|459223604|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
127616050|NCT03252522|459223602|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
127616051|NCT03252522|459223603|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
127616052|NCT03252522|459223604|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
127616053|NCT03252522|459223602|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
127616054|NCT03252522|459223603|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
127616055|NCT03252522|459223604|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
127616056|NCT03252522|459223602|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
127616057|NCT03252522|459223603|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
127616058|NCT03252522|459223604|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
127616059|NCT03252522|459223602|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
127616060|NCT03252522|459223603|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
127616061|NCT03252522|459223604|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
127616062|NCT03252522|459223602|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
127616063|NCT03252522|459223603|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
127616064|NCT03252522|459223604|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
127616065|NCT03252522|459223602|FG000|Phase 2: Open Label|Adverse Event|0|||
127616066|NCT03252522|459223603|FG001|Phase 2: Open Label|Adverse Event|0|||
127616067|NCT03252522|459223604|FG002|Phase 2: Open Label|Adverse Event|2|||
127616068|NCT03252522|459223602|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
127616069|NCT03252522|459223603|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
127616070|NCT03252522|459223604|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
127616071|NCT03299842|459223606|FG000|Overall Study|Caregiver withdrew consent|2|||
127616072|NCT03299842|459223606|FG000|Overall Study|Child would not keep the watch on|3|||
127616073|NCT01816139|459223607|FG000|Overall Study|Adverse Event|6|||
127616074|NCT01816139|459223608|FG001|Overall Study|Adverse Event|8|||
127616075|NCT01816139|459223607|FG000|Overall Study|Lack of Efficacy|1|||
127616076|NCT01816139|459223608|FG001|Overall Study|Lack of Efficacy|2|||
127790966|NCT01650636|459858912|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
127790967|NCT01650636|459858911|FG000|Washout up to 5 Months|Physician Decision|2|||
127790968|NCT01650636|459858912|FG001|Washout up to 5 Months|Physician Decision|2|||
127790969|NCT01650636|459858911|FG000|Washout up to 5 Months|Death|1|||
127790970|NCT01650636|459858912|FG001|Washout up to 5 Months|Death|0|||
127790971|NCT01650636|459858911|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
127790972|NCT01650636|459858912|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
127616077|NCT01816139|459223607|FG000|Overall Study|Lost to Follow-up|5|||
127616078|NCT01816139|459223608|FG001|Overall Study|Lost to Follow-up|3|||
127616079|NCT01816139|459223607|FG000|Overall Study|Withdrew Consent|6|||
127616080|NCT01816139|459223608|FG001|Overall Study|Withdrew Consent|4|||
127616081|NCT01816139|459223607|FG000|Overall Study|Protocol Violation|6|||
127616082|NCT01816139|459223608|FG001|Overall Study|Protocol Violation|3|||
127616083|NCT01816139|459223607|FG000|Overall Study|Reason not Specified|4|||
127616084|NCT01816139|459223608|FG001|Overall Study|Reason not Specified|2|||
127790973|NCT01650636|459858911|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
127616085|NCT03240575|459223611|FG000|Overall Study|Adverse Event|0|||
127616086|NCT03240575|459223612|FG001|Overall Study|Adverse Event|2|||
127616087|NCT03240575|459223613|FG002|Overall Study|Adverse Event|0|||
127616088|NCT03240575|459223614|FG003|Overall Study|Adverse Event|1|||
127790974|NCT01650636|459858912|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
127616089|NCT03240575|459223611|FG000|Overall Study|Withdrawal by Subject|2|||
127616090|NCT03240575|459223612|FG001|Overall Study|Withdrawal by Subject|11|||
127616091|NCT03240575|459223613|FG002|Overall Study|Withdrawal by Subject|0|||
127616092|NCT03240575|459223614|FG003|Overall Study|Withdrawal by Subject|1|||
127616093|NCT03240575|459223611|FG000|Overall Study|Other|0|||
127616094|NCT03240575|459223612|FG001|Overall Study|Other|1|||
127616095|NCT03240575|459223613|FG002|Overall Study|Other|0|||
127616096|NCT03240575|459223614|FG003|Overall Study|Other|0|||
127616097|NCT03643562|459223617|FG000|Overall Study|Adverse Event|1|||
127616098|NCT03643562|459223618|FG001|Overall Study|Adverse Event|0|||
127790975|NCT01650636|459858911|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
127616099|NCT03643562|459223617|FG000|Overall Study|Lack of Efficacy|0|||
127616100|NCT03643562|459223618|FG001|Overall Study|Lack of Efficacy|1|||
127616101|NCT03643562|459223617|FG000|Overall Study|Physician Decision|0|||
127616102|NCT03643562|459223618|FG001|Overall Study|Physician Decision|1|||
127616103|NCT03643562|459223617|FG000|Overall Study|Study Terminated by Sponsor|2|||
127616104|NCT03643562|459223618|FG001|Overall Study|Study Terminated by Sponsor|10|||
127616105|NCT03643562|459223617|FG000|Overall Study|Withdrawal by Subject|2|||
127616106|NCT03643562|459223618|FG001|Overall Study|Withdrawal by Subject|2|||
127616107|NCT03643562|459223617|FG000|Overall Study|Other than specified|3|||
127616108|NCT03643562|459223618|FG001|Overall Study|Other than specified|2|||
127616109|NCT01982253|459223619|FG000|Overall Study|Withdrawal by Subject|1|||
127616110|NCT01982253|459223620|FG001|Overall Study|Withdrawal by Subject|0|||
127616111|NCT01982253|459223621|FG002|Overall Study|Withdrawal by Subject|0|||
127616112|NCT01982253|459223619|FG000|Overall Study|Study terminated by sponsor|1|||
127616113|NCT01982253|459223620|FG001|Overall Study|Study terminated by sponsor|4|||
127616114|NCT01982253|459223621|FG002|Overall Study|Study terminated by sponsor|4|||
127616115|NCT00913744|459223623|FG000|Overall Study|Adverse Event|2|||
127616116|NCT00913744|459223624|FG001|Overall Study|Adverse Event|0|||
127616117|NCT00913744|459223623|FG000|Overall Study|Withdrawal by Subject|2|||
127616118|NCT00913744|459223624|FG001|Overall Study|Withdrawal by Subject|1|||
127616119|NCT00913744|459223623|FG000|Overall Study|Death|1|||
127616120|NCT00913744|459223624|FG001|Overall Study|Death|0|||
127616121|NCT00805935|459223625|FG000|Overall Study|Stimulation Failure|1|||
127616122|NCT00805935|459223626|FG001|Overall Study|Stimulation Failure|5|||
127616123|NCT00805935|459223627|FG002|Overall Study|Stimulation Failure|2|||
127616124|NCT00805935|459223628|FG003|Overall Study|Stimulation Failure|2|||
127616125|NCT00805935|459223625|FG000|Overall Study|Cycle cancelled|0|||
127616126|NCT00805935|459223626|FG001|Overall Study|Cycle cancelled|0|||
127616127|NCT00805935|459223627|FG002|Overall Study|Cycle cancelled|2|||
127616128|NCT00805935|459223628|FG003|Overall Study|Cycle cancelled|0|||
127616129|NCT00805935|459223625|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
127616130|NCT00805935|459223626|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
127616131|NCT00805935|459223627|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
127616132|NCT00805935|459223628|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
127616133|NCT00805935|459223625|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
127616134|NCT00805935|459223626|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
127616135|NCT00805935|459223627|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
127616136|NCT00805935|459223628|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
127616137|NCT00805935|459223625|FG000|Overall Study|Lost to Follow-up|1|||
127616138|NCT00805935|459223626|FG001|Overall Study|Lost to Follow-up|0|||
127616139|NCT00805935|459223627|FG002|Overall Study|Lost to Follow-up|0|||
127616140|NCT00805935|459223628|FG003|Overall Study|Lost to Follow-up|0|||
127616141|NCT00805935|459223625|FG000|Overall Study|No positive serum pregnancy|8|||
127616142|NCT00805935|459223626|FG001|Overall Study|No positive serum pregnancy|7|||
127616143|NCT00805935|459223627|FG002|Overall Study|No positive serum pregnancy|6|||
127616144|NCT00805935|459223628|FG003|Overall Study|No positive serum pregnancy|5|||
127616145|NCT00805935|459223625|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
127616146|NCT00805935|459223626|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
127616147|NCT00805935|459223627|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
127616148|NCT00805935|459223628|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
127616149|NCT00805935|459223625|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
127616150|NCT00805935|459223626|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
127616151|NCT00805935|459223627|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
127616152|NCT00805935|459223628|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
127616153|NCT00805935|459223625|FG000|Overall Study|Biochemical pregnancy|0|||
127790976|NCT01650636|459858912|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
127790977|NCT01577186|459858914|FG000|Overall Study|Adverse Event|23|||
127616154|NCT00805935|459223626|FG001|Overall Study|Biochemical pregnancy|1|||
127616155|NCT00805935|459223627|FG002|Overall Study|Biochemical pregnancy|0|||
127616156|NCT00805935|459223628|FG003|Overall Study|Biochemical pregnancy|0|||
127616157|NCT00805935|459223625|FG000|Overall Study|Chemical pregnancy|0|||
127616158|NCT00805935|459223626|FG001|Overall Study|Chemical pregnancy|5|||
127616159|NCT00805935|459223627|FG002|Overall Study|Chemical pregnancy|3|||
127616160|NCT00805935|459223628|FG003|Overall Study|Chemical pregnancy|2|||
127616161|NCT00805935|459223625|FG000|Overall Study|Ectopic pregnancy|0|||
127790978|NCT01577186|459858914|FG000|Overall Study|Death|1|||
127616162|NCT00805935|459223626|FG001|Overall Study|Ectopic pregnancy|0|||
127616163|NCT00805935|459223627|FG002|Overall Study|Ectopic pregnancy|1|||
127616164|NCT00805935|459223628|FG003|Overall Study|Ectopic pregnancy|0|||
127616165|NCT00805935|459223625|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
127616166|NCT00805935|459223626|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
127616167|NCT00805935|459223627|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
127616168|NCT00805935|459223628|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
127616169|NCT02945410|459223629|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
127616170|NCT02945410|459223630|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
127616171|NCT02945410|459223631|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
127616172|NCT02945410|459223632|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
127616173|NCT02945410|459223633|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
127616174|NCT02945410|459223634|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
127616175|NCT02945410|459223629|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
127616176|NCT02945410|459223630|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
127616177|NCT02945410|459223631|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
127616178|NCT02945410|459223632|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
127616179|NCT02945410|459223633|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
127616180|NCT02945410|459223634|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
127616181|NCT02945410|459223629|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
127616182|NCT02945410|459223630|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
127616183|NCT02945410|459223631|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
127616184|NCT02945410|459223632|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
127616185|NCT02945410|459223633|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
127616186|NCT02945410|459223634|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
127616187|NCT01344369|459223637|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
127616188|NCT01344369|459223638|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
127616189|NCT01344369|459223637|FG000|Washout of 28 Days|Physician Decision|0|||
127616190|NCT01344369|459223638|FG001|Washout of 28 Days|Physician Decision|1|||
127616191|NCT01344369|459223637|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
127616192|NCT01344369|459223638|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
127616193|NCT03848845|459223639|FG000|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
127884188|NCT03591107|460199833|FG000|Overall Study|Discharged from clinic|0|||
127884189|NCT03591107|460199834|FG001|Overall Study|Discharged from clinic|1|||
127884190|NCT03591107|460199833|FG000|Overall Study|Withdrawal by Subject|0|||
127884191|NCT03591107|460199834|FG001|Overall Study|Withdrawal by Subject|1|||
127884192|NCT01902134|460199837|FG000|Overall Study|Adverse Event|3|||
127884193|NCT01902134|460199838|FG001|Overall Study|Adverse Event|1|||
127884194|NCT01902134|460199839|FG002|Overall Study|Adverse Event|2|||
127884195|NCT01902134|460199840|FG003|Overall Study|Adverse Event|1|||
127884196|NCT01902134|460199841|FG004|Overall Study|Adverse Event|1|||
127884197|NCT01902134|460199842|FG005|Overall Study|Adverse Event|3|||
127884198|NCT01902134|460199837|FG000|Overall Study|Lack of Efficacy|0|||
127884199|NCT01902134|460199838|FG001|Overall Study|Lack of Efficacy|0|||
127884200|NCT01902134|460199839|FG002|Overall Study|Lack of Efficacy|2|||
127884201|NCT01902134|460199840|FG003|Overall Study|Lack of Efficacy|0|||
127884202|NCT01902134|460199841|FG004|Overall Study|Lack of Efficacy|0|||
127884203|NCT01902134|460199842|FG005|Overall Study|Lack of Efficacy|1|||
127884204|NCT01902134|460199837|FG000|Overall Study|Physician Decision|0|||
127884205|NCT01902134|460199838|FG001|Overall Study|Physician Decision|1|||
127884206|NCT01902134|460199839|FG002|Overall Study|Physician Decision|0|||
127884207|NCT01902134|460199840|FG003|Overall Study|Physician Decision|0|||
127884208|NCT01902134|460199841|FG004|Overall Study|Physician Decision|0|||
127884209|NCT01902134|460199842|FG005|Overall Study|Physician Decision|0|||
127884210|NCT01902134|460199837|FG000|Overall Study|Protocol Violation|0|||
127884211|NCT01902134|460199838|FG001|Overall Study|Protocol Violation|0|||
127884212|NCT01902134|460199839|FG002|Overall Study|Protocol Violation|0|||
127884213|NCT01902134|460199840|FG003|Overall Study|Protocol Violation|0|||
127884214|NCT01902134|460199841|FG004|Overall Study|Protocol Violation|0|||
127616194|NCT03848845|459223640|FG001|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|1|||
127616195|NCT03848845|459223641|FG002|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
127884215|NCT01902134|460199842|FG005|Overall Study|Protocol Violation|1|||
127884216|NCT01902134|460199837|FG000|Overall Study|Withdrawal by Subject|4|||
127884217|NCT01902134|460199838|FG001|Overall Study|Withdrawal by Subject|8|||
127884218|NCT01902134|460199839|FG002|Overall Study|Withdrawal by Subject|9|||
127884219|NCT01902134|460199840|FG003|Overall Study|Withdrawal by Subject|1|||
127616196|NCT03848845|459223642|FG003|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
127616197|NCT03848845|459223639|FG000|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
127616198|NCT03848845|459223640|FG001|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
127884220|NCT01902134|460199841|FG004|Overall Study|Withdrawal by Subject|5|||
127884221|NCT01902134|460199842|FG005|Overall Study|Withdrawal by Subject|4|||
127884222|NCT01902134|460199837|FG000|Overall Study|no compliance|1|||
127884223|NCT01902134|460199838|FG001|Overall Study|no compliance|0|||
127884224|NCT01902134|460199839|FG002|Overall Study|no compliance|0|||
127884225|NCT01902134|460199840|FG003|Overall Study|no compliance|0|||
127884226|NCT01902134|460199841|FG004|Overall Study|no compliance|0|||
127884227|NCT01902134|460199842|FG005|Overall Study|no compliance|0|||
127884228|NCT01902134|460199837|FG000|Overall Study|Other|0|||
127884229|NCT01902134|460199838|FG001|Overall Study|Other|1|||
127884230|NCT01902134|460199839|FG002|Overall Study|Other|2|||
127884231|NCT01902134|460199840|FG003|Overall Study|Other|0|||
127884232|NCT01902134|460199841|FG004|Overall Study|Other|1|||
127884233|NCT01902134|460199842|FG005|Overall Study|Other|0|||
127884234|NCT00305110|460199843|FG000|Overall Study|Missing data|29|||
127884235|NCT00678379|460199844|FG000|Overall Study|Injection performed after tonsillectomy|2|||
127884236|NCT00678379|460199845|FG001|Overall Study|Injection performed after tonsillectomy|0|||
127884237|NCT00678379|460199846|FG002|Overall Study|Injection performed after tonsillectomy|1|||
127884238|NCT00678379|460199844|FG000|Overall Study|Incomplete Data|4|||
127884239|NCT00678379|460199845|FG001|Overall Study|Incomplete Data|3|||
127884240|NCT00678379|460199846|FG002|Overall Study|Incomplete Data|3|||
127884241|NCT01084603|460199853|FG000|Baseline|Withdrawal by Subject|2|||
127884242|NCT01084603|460199853|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
127884243|NCT01084603|460199853|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
127884244|NCT01084603|460199853|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
127884245|NCT01084603|460199853|FG000|Washout Period 4|Adverse Event|1|||
127884246|NCT00350519|460199860|FG000|Overall Study|Death|0|||
127884247|NCT00350519|460199861|FG001|Overall Study|Death|1|||
127884248|NCT00350519|460199860|FG000|Overall Study|Physician Decision|0|||
127884249|NCT00350519|460199861|FG001|Overall Study|Physician Decision|1|||
127884250|NCT00350519|460199860|FG000|Overall Study|Protocol Violation|1|||
127884251|NCT00350519|460199861|FG001|Overall Study|Protocol Violation|2|||
127884252|NCT00350519|460199860|FG000|Overall Study|Withdrawal by Subject|3|||
127884253|NCT00350519|460199861|FG001|Overall Study|Withdrawal by Subject|2|||
127884254|NCT03836729|460199862|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
127884255|NCT03862625|460199863|FG000|Overall Study|Lost to Follow-up|0|||
127884256|NCT03862625|460199864|FG001|Overall Study|Lost to Follow-up|1|||
127884257|NCT01270841|460199865|FG000|Overall Study|Adverse Event|0|||
127790979|NCT01577186|459858914|FG000|Overall Study|Lost to Follow-up|28|||
127790980|NCT01577186|459858914|FG000|Overall Study|Withdrawal by Subject|35|||
127790981|NCT01577186|459858914|FG000|Overall Study|Insufficient Response|18|||
127790982|NCT01577186|459858914|FG000|Overall Study|Ineligible to Continue|15|||
127790983|NCT01577186|459858914|FG000|Overall Study|Non-Compliant|8|||
127790984|NCT01577186|459858914|FG000|Overall Study|Other|2|||
127790985|NCT03363321|459858915|FG000|Overall Study|Withdrawal by Subject|0|||
127790986|NCT03363321|459858916|FG001|Overall Study|Withdrawal by Subject|1|||
127790987|NCT03363321|459858917|FG002|Overall Study|Withdrawal by Subject|0|||
127790988|NCT03363321|459858918|FG003|Overall Study|Withdrawal by Subject|1|||
127790989|NCT03363321|459858919|FG004|Overall Study|Withdrawal by Subject|0|||
127790990|NCT02915523|459858922|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
127790991|NCT02915523|459858923|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
127790992|NCT02915523|459858924|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
127790993|NCT02915523|459858925|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
127790994|NCT02915523|459858922|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
127790995|NCT02915523|459858923|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
127790996|NCT02915523|459858924|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
127790997|NCT02915523|459858925|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
127790998|NCT02915523|459858922|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
127790999|NCT02915523|459858923|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
127791000|NCT02915523|459858924|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
127791001|NCT02915523|459858925|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
127791002|NCT02915523|459858922|FG000|Expansion Phase (Phase 2)|Death|0|||
127791003|NCT02915523|459858923|FG001|Expansion Phase (Phase 2)|Death|0|||
127791004|NCT02915523|459858924|FG002|Expansion Phase (Phase 2)|Death|26|||
127791005|NCT02915523|459858925|FG003|Expansion Phase (Phase 2)|Death|53|||
127791006|NCT02915523|459858922|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
127791007|NCT02915523|459858923|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
127884258|NCT01270841|460199866|FG001|Overall Study|Adverse Event|1|||
127791008|NCT02915523|459858924|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
127791009|NCT02915523|459858925|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
127791010|NCT02915523|459858922|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
127884259|NCT01270841|460199867|FG002|Overall Study|Adverse Event|0|||
127884260|NCT01270841|460199868|FG003|Overall Study|Adverse Event|3|||
127884261|NCT01270841|460199865|FG000|Overall Study|Withdrawal by Subject|3|||
127884262|NCT01270841|460199866|FG001|Overall Study|Withdrawal by Subject|2|||
127884263|NCT01270841|460199867|FG002|Overall Study|Withdrawal by Subject|3|||
127616199|NCT03848845|459223641|FG002|Main Study Phase (Day 1 to Week 178)|Physician Decision|1|||
127616200|NCT03848845|459223642|FG003|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
127616201|NCT03848845|459223639|FG000|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|3|||
127616202|NCT03848845|459223640|FG001|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|2|||
127616203|NCT03848845|459223641|FG002|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|8|||
127616204|NCT03848845|459223642|FG003|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|0|||
127616205|NCT03848845|459223639|FG000|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
127616206|NCT03848845|459223640|FG001|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
127616207|NCT03848845|459223641|FG002|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
127616208|NCT03848845|459223642|FG003|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|1|||
127616209|NCT01886833|459223645|FG000|Overall Study|IgA not available from both periods|204|||
127616210|NCT02223767|459223651|FG000|Overall Study|Withdrawal by Subject|4|||
127616211|NCT02223767|459223652|FG001|Overall Study|Withdrawal by Subject|4|||
127616212|NCT02118428|459223654|FG000|Overall Study|Physician Decision|0|||
127616213|NCT02118428|459223655|FG001|Overall Study|Physician Decision|1|||
127616214|NCT02118428|459223656|FG002|Overall Study|Physician Decision|0|||
127616215|NCT02118428|459223654|FG000|Overall Study|Withdrawal by Subject|2|||
127616216|NCT02118428|459223655|FG001|Overall Study|Withdrawal by Subject|2|||
127616217|NCT02118428|459223656|FG002|Overall Study|Withdrawal by Subject|0|||
127616218|NCT02118428|459223654|FG000|Overall Study|Death|7|||
127616219|NCT02118428|459223655|FG001|Overall Study|Death|5|||
127616220|NCT02118428|459223656|FG002|Overall Study|Death|0|||
127616221|NCT02118428|459223654|FG000|Overall Study|Lost to Follow-up|3|||
127616222|NCT02118428|459223655|FG001|Overall Study|Lost to Follow-up|1|||
127616223|NCT02118428|459223656|FG002|Overall Study|Lost to Follow-up|0|||
127616224|NCT02118428|459223654|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
127616225|NCT02118428|459223655|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
127616226|NCT02118428|459223656|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
127616227|NCT03100825|459223671|FG000|Overall Study|Participant/Guardian Decision|7|||
127616228|NCT03100825|459223671|FG000|Overall Study|Physician Decision|1|||
127616229|NCT00826267|459223672|FG000|Overall Study|Other Adverse Event|1|||
127791011|NCT02915523|459858923|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
127791012|NCT02915523|459858924|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
127616230|NCT00826267|459223673|FG001|Overall Study|Other Adverse Event|0|||
127616231|NCT00826267|459223674|FG002|Overall Study|Other Adverse Event|0|||
127616232|NCT00048542|459223690|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
127616233|NCT00048542|459223691|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
127616234|NCT00048542|459223692|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
127616235|NCT00048542|459223693|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
127616236|NCT00048542|459223694|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
127616237|NCT00048542|459223695|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
127616238|NCT00048542|459223696|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
127616239|NCT00048542|459223697|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
127616240|NCT00048542|459223690|FG000|Double-Blind Phase|Protocol Violation|0|||
127616241|NCT00048542|459223691|FG001|Double-Blind Phase|Protocol Violation|0|||
127616242|NCT00048542|459223692|FG002|Double-Blind Phase|Protocol Violation|1|||
127616243|NCT00048542|459223693|FG003|Double-Blind Phase|Protocol Violation|0|||
127616244|NCT00048542|459223694|FG004|Double-Blind Phase|Protocol Violation|0|||
127616245|NCT00048542|459223695|FG005|Double-Blind Phase|Protocol Violation|0|||
127616246|NCT00048542|459223696|FG006|Double-Blind Phase|Protocol Violation|0|||
127616247|NCT00048542|459223697|FG007|Double-Blind Phase|Protocol Violation|0|||
127616248|NCT00048542|459223690|FG000|Double-Blind Phase|Sponsor request or decision|2|||
127616249|NCT00048542|459223691|FG001|Double-Blind Phase|Sponsor request or decision|0|||
127616250|NCT00048542|459223692|FG002|Double-Blind Phase|Sponsor request or decision|0|||
127616251|NCT00048542|459223693|FG003|Double-Blind Phase|Sponsor request or decision|0|||
127616252|NCT00048542|459223694|FG004|Double-Blind Phase|Sponsor request or decision|0|||
127616253|NCT00048542|459223695|FG005|Double-Blind Phase|Sponsor request or decision|0|||
127616254|NCT00048542|459223696|FG006|Double-Blind Phase|Sponsor request or decision|0|||
127616255|NCT00048542|459223697|FG007|Double-Blind Phase|Sponsor request or decision|0|||
127616256|NCT00048542|459223690|FG000|Double-Blind Phase|Randomized in error|1|||
127791013|NCT02915523|459858925|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
127791014|NCT02915523|459858922|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
127791015|NCT02915523|459858923|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
127616257|NCT00048542|459223691|FG001|Double-Blind Phase|Randomized in error|0|||
127616258|NCT00048542|459223692|FG002|Double-Blind Phase|Randomized in error|0|||
127616259|NCT00048542|459223693|FG003|Double-Blind Phase|Randomized in error|0|||
127791016|NCT02915523|459858924|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
127791017|NCT02915523|459858925|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
127616260|NCT00048542|459223694|FG004|Double-Blind Phase|Randomized in error|0|||
127616261|NCT00048542|459223695|FG005|Double-Blind Phase|Randomized in error|0|||
127616262|NCT00048542|459223696|FG006|Double-Blind Phase|Randomized in error|0|||
127616263|NCT00048542|459223697|FG007|Double-Blind Phase|Randomized in error|0|||
127616264|NCT00048542|459223690|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
127616265|NCT00048542|459223691|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
127616266|NCT00048542|459223692|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
127616267|NCT00048542|459223693|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
127616268|NCT00048542|459223694|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
127616269|NCT00048542|459223695|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
127616270|NCT00048542|459223696|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
127616271|NCT00048542|459223697|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
127616272|NCT00048542|459223690|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
127616273|NCT00048542|459223691|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
127616274|NCT00048542|459223692|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
127616275|NCT00048542|459223693|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
127616276|NCT00048542|459223694|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
127616277|NCT00048542|459223695|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
127616278|NCT00048542|459223696|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
127616279|NCT00048542|459223697|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
127616280|NCT00048542|459223690|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
127616281|NCT00048542|459223691|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
127791018|NCT03287219|459858926|FG000|Overall Study|Protocol Violation|0|||
127791019|NCT03287219|459858927|FG001|Overall Study|Protocol Violation|2|||
127791020|NCT00930761|459858928|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
127791021|NCT00930761|459858929|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
127791022|NCT00930761|459858928|FG000|Overall Study|less than 3 music therapy sessions|0|||
127791023|NCT00930761|459858929|FG001|Overall Study|less than 3 music therapy sessions|3|||
127791024|NCT00957008|459858930|FG000|Overall Study|Withdrawal by Subject|13|||
127791025|NCT00957008|459858931|FG001|Overall Study|Withdrawal by Subject|10|||
127791026|NCT00957008|459858932|FG002|Overall Study|Withdrawal by Subject|12|||
127791027|NCT00957008|459858933|FG003|Overall Study|Withdrawal by Subject|16|||
127791028|NCT00957008|459858930|FG000|Overall Study|Lost to Follow-up|3|||
127791029|NCT00957008|459858931|FG001|Overall Study|Lost to Follow-up|1|||
127791030|NCT00957008|459858932|FG002|Overall Study|Lost to Follow-up|3|||
127791031|NCT00957008|459858933|FG003|Overall Study|Lost to Follow-up|4|||
127791032|NCT00957008|459858930|FG000|Overall Study|Physician Decision|1|||
127791033|NCT00957008|459858931|FG001|Overall Study|Physician Decision|0|||
127791034|NCT00957008|459858932|FG002|Overall Study|Physician Decision|1|||
127791035|NCT00957008|459858933|FG003|Overall Study|Physician Decision|1|||
127791036|NCT00957008|459858930|FG000|Overall Study|Relocated; Family conflict|4|||
127616282|NCT00048542|459223692|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
127616283|NCT00048542|459223693|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
127616284|NCT00048542|459223694|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
127616285|NCT00048542|459223695|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
127616286|NCT00048542|459223696|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
127616287|NCT00048542|459223697|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
127616288|NCT00048542|459223690|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
127616289|NCT00048542|459223691|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
127616290|NCT00048542|459223692|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
127616291|NCT00048542|459223693|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
127616292|NCT00048542|459223694|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
127616293|NCT00048542|459223695|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
127616294|NCT00048542|459223696|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
127616295|NCT00048542|459223697|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
127616296|NCT00048542|459223690|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
127616297|NCT00048542|459223691|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
127616298|NCT00048542|459223692|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
127616299|NCT00048542|459223693|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
127616300|NCT00048542|459223694|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
127616301|NCT00048542|459223695|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
127791037|NCT00957008|459858931|FG001|Overall Study|Relocated; Family conflict|1|||
127791038|NCT00957008|459858932|FG002|Overall Study|Relocated; Family conflict|1|||
127791039|NCT00957008|459858933|FG003|Overall Study|Relocated; Family conflict|3|||
127791040|NCT03221751|459858935|FG000|Overall Study|lumbar puncture not performed at early termination.|1|||
127791041|NCT03221751|459858936|FG001|Overall Study|lumbar puncture not performed at early termination.|0|||
127791042|NCT03571646|459858937|FG000|Overall Study|Adverse Event|1|||
127791043|NCT03571646|459858938|FG001|Overall Study|Adverse Event|0|||
127791044|NCT03571646|459858937|FG000|Overall Study|Withdrawal by Subject|1|||
127791045|NCT03571646|459858938|FG001|Overall Study|Withdrawal by Subject|1|||
127791046|NCT04677959|459858939|FG000|Overall Study|Adverse Event|1|||
127791047|NCT04677959|459858940|FG001|Overall Study|Adverse Event|9|||
127791048|NCT04677959|459858939|FG000|Overall Study|Withdrawal by Subject|2|||
127791049|NCT04677959|459858940|FG001|Overall Study|Withdrawal by Subject|15|||
127791050|NCT04677959|459858939|FG000|Overall Study|Withdrawal by parent/guardian|0|||
127791051|NCT04677959|459858940|FG001|Overall Study|Withdrawal by parent/guardian|1|||
127791052|NCT04677959|459858939|FG000|Overall Study|Non-compliance with study drug|0|||
127791053|NCT04677959|459858940|FG001|Overall Study|Non-compliance with study drug|2|||
127791054|NCT04677959|459858939|FG000|Overall Study|Protocol deviation|0|||
127791055|NCT04677959|459858940|FG001|Overall Study|Protocol deviation|11|||
127791056|NCT04677959|459858939|FG000|Overall Study|Lost to Follow-up|9|||
127791057|NCT04677959|459858940|FG001|Overall Study|Lost to Follow-up|13|||
127791058|NCT04677959|459858939|FG000|Overall Study|Other than specified|0|||
127791059|NCT04677959|459858940|FG001|Overall Study|Other than specified|8|||
127791060|NCT00763815|459858941|FG000|Overall Study|Adverse Event|14|||
127791061|NCT00763815|459858942|FG001|Overall Study|Adverse Event|29|||
127791062|NCT00763815|459858941|FG000|Overall Study|Lack of Efficacy|10|||
127791063|NCT00763815|459858942|FG001|Overall Study|Lack of Efficacy|11|||
127791064|NCT00763815|459858941|FG000|Overall Study|Poor Compliance to Protocol|6|||
127791065|NCT00763815|459858942|FG001|Overall Study|Poor Compliance to Protocol|6|||
127791066|NCT00763815|459858941|FG000|Overall Study|Lost to Follow-up|2|||
127791067|NCT00763815|459858942|FG001|Overall Study|Lost to Follow-up|4|||
127791068|NCT00763815|459858941|FG000|Overall Study|Early Termination|1|||
127791069|NCT00763815|459858942|FG001|Overall Study|Early Termination|0|||
127791070|NCT00763815|459858941|FG000|Overall Study|Familial and Personal Reasons|9|||
127791071|NCT00763815|459858942|FG001|Overall Study|Familial and Personal Reasons|16|||
127791072|NCT00763815|459858941|FG000|Overall Study|Physician Decision|1|||
127791073|NCT00763815|459858942|FG001|Overall Study|Physician Decision|0|||
127791074|NCT00763815|459858941|FG000|Overall Study|Withdrawal by Subject|7|||
127791075|NCT00763815|459858942|FG001|Overall Study|Withdrawal by Subject|12|||
127791076|NCT00763815|459858941|FG000|Overall Study|Protocol Violation|2|||
127791077|NCT00763815|459858942|FG001|Overall Study|Protocol Violation|5|||
127791078|NCT00763815|459858941|FG000|Overall Study|Sponsor's Decision|0|||
127791079|NCT00763815|459858942|FG001|Overall Study|Sponsor's Decision|1|||
127791080|NCT01970995|459858943|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
127791081|NCT01970995|459858944|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
127791082|NCT01970995|459858945|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
127791083|NCT01970995|459858943|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
127791084|NCT01970995|459858944|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
127616302|NCT00048542|459223696|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
127791085|NCT01970995|459858945|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
127791086|NCT00586495|459858946|FG000|Treatment Period|Adverse Event|11|||
127791087|NCT00586495|459858946|FG000|Treatment Period|Death|1|||
127791088|NCT00586495|459858946|FG000|Treatment Period|Protocol Violation|1|||
127616303|NCT00048542|459223697|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
127616304|NCT00048542|459223690|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
127616305|NCT00048542|459223691|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
127616306|NCT00048542|459223692|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
127616307|NCT00048542|459223693|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
127616308|NCT00048542|459223694|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
127616309|NCT00048542|459223695|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
127616310|NCT00048542|459223696|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
127616311|NCT00048542|459223697|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
127616312|NCT00048542|459223690|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
127616313|NCT00048542|459223691|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
127616314|NCT00048542|459223692|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
127616315|NCT00048542|459223693|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
127616316|NCT00048542|459223694|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
127699627|NCT01420237|459528779|FG000|Overall Study|Sponsor terminated study early|127|||
127699628|NCT04492722|459528780|FG000|Overall Study|Adverse Event|7|||
127616317|NCT00048542|459223695|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
127884264|NCT01270841|460199868|FG003|Overall Study|Withdrawal by Subject|3|||
127884265|NCT01270841|460199865|FG000|Overall Study|Lost to Follow-up|3|||
127884266|NCT01270841|460199866|FG001|Overall Study|Lost to Follow-up|1|||
127884267|NCT01270841|460199867|FG002|Overall Study|Lost to Follow-up|4|||
127884268|NCT01270841|460199868|FG003|Overall Study|Lost to Follow-up|2|||
127884269|NCT01270841|460199865|FG000|Overall Study|Physician Decision|0|||
127884270|NCT01270841|460199866|FG001|Overall Study|Physician Decision|1|||
127884271|NCT01270841|460199867|FG002|Overall Study|Physician Decision|0|||
127884272|NCT01270841|460199868|FG003|Overall Study|Physician Decision|0|||
127884273|NCT01270841|460199865|FG000|Overall Study|Did not qualify|6|||
127884274|NCT01270841|460199866|FG001|Overall Study|Did not qualify|3|||
127884275|NCT01270841|460199867|FG002|Overall Study|Did not qualify|4|||
127884276|NCT01270841|460199868|FG003|Overall Study|Did not qualify|5|||
127884277|NCT01270841|460199865|FG000|Overall Study|Protocol Violation|1|||
127884278|NCT01270841|460199866|FG001|Overall Study|Protocol Violation|5|||
127884279|NCT01270841|460199867|FG002|Overall Study|Protocol Violation|0|||
127884280|NCT01270841|460199868|FG003|Overall Study|Protocol Violation|0|||
127884281|NCT01270841|460199865|FG000|Overall Study|Enrolled in error|0|||
127884282|NCT01270841|460199866|FG001|Overall Study|Enrolled in error|1|||
127884283|NCT01270841|460199867|FG002|Overall Study|Enrolled in error|0|||
127884284|NCT01270841|460199868|FG003|Overall Study|Enrolled in error|0|||
127884285|NCT04388527|460199869|FG000|Overall Study|Death|14|||
127884286|NCT04388527|460199869|FG000|Overall Study|Withdrawal by Subject|2|||
127884287|NCT04388527|460199869|FG000|Overall Study|Lost to Follow-up|1|||
127884288|NCT00550420|460199870|FG000|Overall Study|Adverse Event|28|||
127884289|NCT00550420|460199870|FG000|Overall Study|Lost to Follow-up|8|||
127884290|NCT00550420|460199870|FG000|Overall Study|Protocol Violation|11|||
127884291|NCT00550420|460199870|FG000|Overall Study|Withdrawal by Subject|30|||
127884292|NCT00550420|460199870|FG000|Overall Study|Still in study at termination|206|||
127884293|NCT00550420|460199870|FG000|Overall Study|Missing|2|||
127884294|NCT00550420|460199870|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
127884295|NCT00550420|460199870|FG000|Overall Study|Investigators opinion|1|||
127884296|NCT00550420|460199870|FG000|Overall Study|Lack of curative effect|1|||
127884297|NCT00550420|460199870|FG000|Overall Study|Unethical stop of enrollment|2|||
127884298|NCT00550420|460199870|FG000|Overall Study|Caregiver's decision to withdraw|1|||
127884299|NCT00550420|460199870|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
127884300|NCT00550420|460199870|FG000|Overall Study|Exclusion criteria|1|||
127884301|NCT00550420|460199870|FG000|Overall Study|Prohibited medicine|1|||
127884302|NCT01613131|460199873|FG000|Overall Study|Withdrawal by Subject|3|||
127884303|NCT01613131|460199874|FG001|Overall Study|Withdrawal by Subject|5|||
127616318|NCT00048542|459223696|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
127616319|NCT00048542|459223697|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
127616320|NCT00048542|459223690|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
127616321|NCT00048542|459223691|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
127616322|NCT00048542|459223692|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
127616323|NCT00048542|459223693|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
127616324|NCT00048542|459223694|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
127616325|NCT00048542|459223695|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
127616326|NCT00048542|459223696|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
127616327|NCT00048542|459223697|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
127616328|NCT00048542|459223690|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
127616329|NCT00048542|459223691|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
127616330|NCT00048542|459223692|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
127616331|NCT00048542|459223693|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
127616332|NCT00048542|459223694|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
127616333|NCT00048542|459223695|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
127616334|NCT00048542|459223696|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
127616335|NCT00048542|459223697|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
127616336|NCT00048542|459223690|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
127616337|NCT00048542|459223691|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
127616338|NCT00048542|459223692|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
127616339|NCT00048542|459223693|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
127616340|NCT00048542|459223694|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
127884304|NCT00417027|460199877|FG000|Overall Study|Protocol Violation|0|||
127884305|NCT00417027|460199878|FG001|Overall Study|Protocol Violation|5|||
127884306|NCT00417027|460199879|FG002|Overall Study|Protocol Violation|5|||
127884307|NCT01017029|460199887|FG000|Overall Study|Lost to Follow-up|1|||
127884308|NCT01017029|460199888|FG001|Overall Study|Lost to Follow-up|0|||
127884309|NCT01017029|460199887|FG000|Overall Study|Administrative problem|0|||
127616341|NCT00048542|459223695|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
127616342|NCT00048542|459223696|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
127616343|NCT00048542|459223697|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
127616344|NCT00048542|459223690|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
127616345|NCT00048542|459223691|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
127616346|NCT00048542|459223692|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
127616347|NCT00048542|459223693|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
127616348|NCT00048542|459223694|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
127616349|NCT00048542|459223695|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
127616350|NCT00048542|459223696|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
127699629|NCT04492722|459528781|FG001|Overall Study|Adverse Event|2|||
127699630|NCT04492722|459528782|FG002|Overall Study|Adverse Event|3|||
127699631|NCT04492722|459528783|FG003|Overall Study|Adverse Event|0|||
127699632|NCT04492722|459528780|FG000|Overall Study|Death|0|||
127699633|NCT04492722|459528781|FG001|Overall Study|Death|0|||
127699634|NCT04492722|459528782|FG002|Overall Study|Death|0|||
127699635|NCT04492722|459528783|FG003|Overall Study|Death|1|||
127699636|NCT04492722|459528780|FG000|Overall Study|Lost to Follow-up|0|||
127699637|NCT04492722|459528781|FG001|Overall Study|Lost to Follow-up|1|||
127699638|NCT04492722|459528782|FG002|Overall Study|Lost to Follow-up|0|||
127699639|NCT04492722|459528783|FG003|Overall Study|Lost to Follow-up|1|||
127699640|NCT04492722|459528780|FG000|Overall Study|Physician Decision|0|||
127699641|NCT04492722|459528781|FG001|Overall Study|Physician Decision|3|||
127699642|NCT04492722|459528782|FG002|Overall Study|Physician Decision|1|||
127699643|NCT04492722|459528783|FG003|Overall Study|Physician Decision|1|||
127699644|NCT04492722|459528780|FG000|Overall Study|Withdrawal by Subject|6|||
127699645|NCT04492722|459528781|FG001|Overall Study|Withdrawal by Subject|6|||
127699646|NCT04492722|459528782|FG002|Overall Study|Withdrawal by Subject|0|||
127699647|NCT04492722|459528783|FG003|Overall Study|Withdrawal by Subject|3|||
127699648|NCT04492722|459528780|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
127699649|NCT04492722|459528781|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
127699650|NCT04492722|459528782|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
127699651|NCT04492722|459528783|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
127699652|NCT04492722|459528780|FG000|Overall Study|Due to Covid-19 pandemic|7|||
127699653|NCT04492722|459528781|FG001|Overall Study|Due to Covid-19 pandemic|3|||
127699654|NCT04492722|459528782|FG002|Overall Study|Due to Covid-19 pandemic|7|||
127699655|NCT04492722|459528783|FG003|Overall Study|Due to Covid-19 pandemic|6|||
127699656|NCT04492722|459528780|FG000|Overall Study|Failure to meet randomisation criteria|2|||
127699657|NCT04492722|459528781|FG001|Overall Study|Failure to meet randomisation criteria|3|||
127699658|NCT04492722|459528782|FG002|Overall Study|Failure to meet randomisation criteria|4|||
127699659|NCT04492722|459528783|FG003|Overall Study|Failure to meet randomisation criteria|2|||
127699660|NCT04492722|459528780|FG000|Overall Study|Early termination from the study|54|||
127699661|NCT04492722|459528781|FG001|Overall Study|Early termination from the study|51|||
127699662|NCT04492722|459528782|FG002|Overall Study|Early termination from the study|50|||
127699663|NCT04492722|459528783|FG003|Overall Study|Early termination from the study|50|||
127699664|NCT04492722|459528780|FG000|Overall Study|Missing|3|||
127699665|NCT04492722|459528781|FG001|Overall Study|Missing|0|||
127699666|NCT04492722|459528782|FG002|Overall Study|Missing|0|||
127699667|NCT04492722|459528783|FG003|Overall Study|Missing|5|||
127699668|NCT04492722|459528780|FG000|Overall Study|Participants who did not receive treatment|0|||
127699669|NCT04492722|459528781|FG001|Overall Study|Participants who did not receive treatment|1|||
127699670|NCT04492722|459528782|FG002|Overall Study|Participants who did not receive treatment|4|||
127699671|NCT04492722|459528783|FG003|Overall Study|Participants who did not receive treatment|0|||
127699672|NCT03631784|459528785|FG000|Overall Study|Participants Ongoing|1|||
127699673|NCT03631784|459528786|FG001|Overall Study|Participants Ongoing|0|||
127699674|NCT03631784|459528785|FG000|Overall Study|Withdrawal by Subject|3|||
127699675|NCT03631784|459528786|FG001|Overall Study|Withdrawal by Subject|3|||
127699676|NCT03631784|459528785|FG000|Overall Study|Sponsor's Decision|36|||
127699677|NCT03631784|459528786|FG001|Overall Study|Sponsor's Decision|52|||
127699678|NCT03631784|459528785|FG000|Overall Study|Lost to Follow-up|1|||
127699679|NCT03631784|459528786|FG001|Overall Study|Lost to Follow-up|0|||
127699680|NCT03631784|459528785|FG000|Overall Study|Death|71|||
127616351|NCT00048542|459223697|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
127699681|NCT03631784|459528786|FG001|Overall Study|Death|49|||
127699682|NCT05030233|459528790|FG000|Overall Study|withdrawn for transfer|1|||
127699683|NCT05030233|459528791|FG001|Overall Study|withdrawn for transfer|0|||
127699684|NCT01396278|459530750|FG000|Overall Study|Adverse Event|0|||
127699685|NCT01396278|459530751|FG001|Overall Study|Adverse Event|0|||
127699686|NCT01396278|459530752|FG002|Overall Study|Adverse Event|0|||
127699687|NCT01396278|459530753|FG003|Overall Study|Adverse Event|2|||
127699688|NCT01396278|459530754|FG004|Overall Study|Adverse Event|0|||
127699689|NCT01396278|459530750|FG000|Overall Study|Withdraw due to trial termination|2|||
127699690|NCT01396278|459530751|FG001|Overall Study|Withdraw due to trial termination|1|||
127699691|NCT01396278|459530752|FG002|Overall Study|Withdraw due to trial termination|1|||
127616352|NCT00578175|459223698|FG000|Overall Study|Adverse Event|0|||
127616353|NCT00578175|459223699|FG001|Overall Study|Adverse Event|1|||
127616354|NCT00578175|459223700|FG002|Overall Study|Adverse Event|1|||
127616355|NCT00578175|459223698|FG000|Overall Study|Other reasons|70|||
127616356|NCT00578175|459223699|FG001|Overall Study|Other reasons|42|||
127699692|NCT01396278|459530753|FG003|Overall Study|Withdraw due to trial termination|0|||
127699693|NCT01396278|459530754|FG004|Overall Study|Withdraw due to trial termination|2|||
127699694|NCT04515576|459530757|FG000|Overall Study|Withdrawal by Subject|0|||
127699695|NCT04515576|459530758|FG001|Overall Study|Withdrawal by Subject|0|||
127699696|NCT04515576|459530759|FG002|Overall Study|Withdrawal by Subject|0|||
127699697|NCT04515576|459530760|FG003|Overall Study|Withdrawal by Subject|0|||
127699698|NCT04515576|459530761|FG004|Overall Study|Withdrawal by Subject|0|||
127699699|NCT04515576|459530762|FG005|Overall Study|Withdrawal by Subject|1|||
127699700|NCT05028634|459530763|FG000|Overall Study|Withdrawal by Subject|0|||
127699701|NCT05028634|459530764|FG001|Overall Study|Withdrawal by Subject|1|||
127699702|NCT05653427|459530765|FG000|Overall Study|Study Terminated by Sponsor|13|||
127699703|NCT04256941|459530773|FG000|Overall Study|Withdrawal by Subject|0|||
127699704|NCT04256941|459530774|FG001|Overall Study|Withdrawal by Subject|1|||
127699705|NCT04256941|459530773|FG000|Overall Study|Death|1|||
127699706|NCT04256941|459530774|FG001|Overall Study|Death|0|||
127699707|NCT04256941|459530773|FG000|Overall Study|Disease Progession|0|||
127699708|NCT04256941|459530774|FG001|Overall Study|Disease Progession|2|||
127699709|NCT02908477|459530781|FG000|Overall Study|Withdrawal by Subject|8|||
127699710|NCT02908477|459530782|FG001|Overall Study|Withdrawal by Subject|28|||
127699711|NCT02140554|459530783|FG000|Overall Study|Withdrawal of consent|1|||
127699712|NCT02140554|459530784|FG001|Overall Study|Withdrawal of consent|0|||
127699713|NCT02140554|459530785|FG002|Overall Study|Withdrawal of consent|4|||
127699714|NCT02140554|459530783|FG000|Overall Study|Physician Decision|1|||
127699715|NCT02140554|459530784|FG001|Overall Study|Physician Decision|0|||
127699716|NCT02140554|459530785|FG002|Overall Study|Physician Decision|2|||
127884310|NCT01017029|460199888|FG001|Overall Study|Administrative problem|1|||
127884311|NCT01017029|460199887|FG000|Overall Study|Death|3|||
127884312|NCT01017029|460199888|FG001|Overall Study|Death|1|||
127884313|NCT00618774|460199889|FG000|Overall Study|Adverse Event|5|||
127699717|NCT02140554|459530783|FG000|Overall Study|Death|0|||
127699718|NCT02140554|459530784|FG001|Overall Study|Death|0|||
127884314|NCT00618774|460199890|FG001|Overall Study|Adverse Event|3|||
127884315|NCT00618774|460199889|FG000|Overall Study|Withdrawal by Subject|1|||
127884316|NCT00618774|460199890|FG001|Overall Study|Withdrawal by Subject|0|||
127884317|NCT02753400|460199892|FG000|Overall Study|Adverse Event|3|||
127699719|NCT02140554|459530785|FG002|Overall Study|Death|1|||
127699720|NCT02140554|459530783|FG000|Overall Study|Discontinued due to failure to mobilize|0|||
127699721|NCT02140554|459530784|FG001|Overall Study|Discontinued due to failure to mobilize|0|||
127699722|NCT02140554|459530785|FG002|Overall Study|Discontinued due to failure to mobilize|1|||
127699723|NCT05659537|459530786|FG000|Overall Study|Adverse Event|5|||
127699724|NCT05659537|459530786|FG000|Overall Study|Lost to Follow-up|4|||
127699725|NCT05659537|459530786|FG000|Overall Study|Withdrawal by Subject|13|||
127699726|NCT05659537|459530786|FG000|Overall Study|Migration from the Study Site Such That Follow Up Visits are not Possible|3|||
127884318|NCT02753400|460199893|FG001|Overall Study|Adverse Event|0|||
127884319|NCT02753400|460199892|FG000|Overall Study|Withdrawal by Subject|2|||
127699727|NCT05659537|459530786|FG000|Overall Study|Participant had low absolute neutrophil count value|1|||
127699728|NCT05659537|459530786|FG000|Overall Study|Participant was suffering from anaemia|1|||
127699729|NCT04728347|459530787|FG000|Overall Study|Sponsor decision|0|||
127699730|NCT04728347|459530788|FG001|Overall Study|Sponsor decision|0|||
127699731|NCT04728347|459530789|FG002|Overall Study|Sponsor decision|1|||
127699732|NCT04728347|459530790|FG003|Overall Study|Sponsor decision|0|||
127699733|NCT04971395|459530792|FG000|Overall Study|Withdrawal by Subject|0|||
127884320|NCT02753400|460199893|FG001|Overall Study|Withdrawal by Subject|1|||
127884321|NCT01415921|460199894|FG000|Overall Study|Adverse Event|0|||
127616357|NCT00578175|459223700|FG002|Overall Study|Other reasons|23|||
127616358|NCT02272413|459223702|FG000|Randomized Through Treatment Start|Not treated|3|||
127616359|NCT02272413|459223703|FG001|Randomized Through Treatment Start|Not treated|5|||
127616360|NCT02272413|459223702|FG000|Pre-switch Period|Adverse Event|38|||
127616361|NCT02272413|459223703|FG001|Pre-switch Period|Adverse Event|37|||
127616362|NCT02272413|459223702|FG000|Pre-switch Period|Death|26|||
127616363|NCT02272413|459223703|FG001|Pre-switch Period|Death|26|||
127616364|NCT02272413|459223702|FG000|Pre-switch Period|Withdrawal by Subject|27|||
127616365|NCT02272413|459223703|FG001|Pre-switch Period|Withdrawal by Subject|15|||
127616366|NCT02272413|459223702|FG000|Pre-switch Period|Physician Decision|6|||
127616367|NCT02272413|459223703|FG001|Pre-switch Period|Physician Decision|18|||
127616368|NCT02272413|459223702|FG000|Pre-switch Period|Progressive disease|185|||
127616369|NCT02272413|459223703|FG001|Pre-switch Period|Progressive disease|173|||
127616370|NCT02272413|459223702|FG000|Pre-switch Period|Lost to Follow-up|0|||
127616371|NCT02272413|459223703|FG001|Pre-switch Period|Lost to Follow-up|2|||
127616372|NCT02272413|459223702|FG000|Pre-switch Period|Protocol Violation|1|||
127616373|NCT02272413|459223703|FG001|Pre-switch Period|Protocol Violation|0|||
127616374|NCT02272413|459223702|FG000|Pre-switch Period|Other than listed|10|||
127616375|NCT02272413|459223703|FG001|Pre-switch Period|Other than listed|11|||
127616376|NCT02272413|459223702|FG000|Post-switch Period|Adverse Event|4|||
127616377|NCT02272413|459223703|FG001|Post-switch Period|Adverse Event|4|||
127616378|NCT02272413|459223702|FG000|Post-switch Period|Death|3|||
127616379|NCT02272413|459223703|FG001|Post-switch Period|Death|2|||
127616380|NCT02272413|459223702|FG000|Post-switch Period|Withdrawal by Subject|1|||
127616381|NCT02272413|459223703|FG001|Post-switch Period|Withdrawal by Subject|2|||
127616382|NCT02272413|459223702|FG000|Post-switch Period|Physician Decision|1|||
127616383|NCT02272413|459223703|FG001|Post-switch Period|Physician Decision|1|||
127616384|NCT02272413|459223702|FG000|Post-switch Period|Progressive disease|21|||
127616385|NCT02272413|459223703|FG001|Post-switch Period|Progressive disease|21|||
127616386|NCT02272413|459223702|FG000|Post-switch Period|Study terminated by sponsor|8|||
127616387|NCT02272413|459223703|FG001|Post-switch Period|Study terminated by sponsor|11|||
127616388|NCT02272413|459223702|FG000|Post-switch Period|Other than listed|4|||
127616389|NCT02272413|459223703|FG001|Post-switch Period|Other than listed|5|||
127616390|NCT00937547|459223704|FG000|Overall Study|misdiagnosis|1|||
127616391|NCT00937547|459223705|FG001|Overall Study|misdiagnosis|6|||
127616392|NCT00937547|459223706|FG002|Overall Study|misdiagnosis|7|||
127616393|NCT04370691|459223707|FG000|Overall Study|Pending visit|48|||
127616394|NCT04370691|459223707|FG000|Overall Study|Have Not Reached Lower Window|15|||
127616395|NCT04370691|459223707|FG000|Overall Study|Termination|14|||
127616396|NCT04370691|459223707|FG000|Overall Study|Missed or Overdue|10|||
127616397|NCT00855309|459223709|FG000|Overall Study|patient never recieved drug|1|||
127616398|NCT00855309|459223710|FG001|Overall Study|patient never recieved drug|0|||
127616399|NCT03837899|459223714|FG000|Overall Study|Death|6|||
127616400|NCT03837899|459223715|FG001|Overall Study|Death|8|||
127616401|NCT03837899|459223716|FG002|Overall Study|Death|3|||
127616402|NCT03837899|459223717|FG003|Overall Study|Death|7|||
127616403|NCT03837899|459223718|FG004|Overall Study|Death|8|||
127616404|NCT03837899|459223719|FG005|Overall Study|Death|7|||
127616405|NCT03837899|459223714|FG000|Overall Study|Moved to post-trial access program|0|||
127616406|NCT03837899|459223715|FG001|Overall Study|Moved to post-trial access program|1|||
127699734|NCT04971395|459530793|FG001|Overall Study|Withdrawal by Subject|1|||
127699735|NCT04971395|459530794|FG002|Overall Study|Withdrawal by Subject|0|||
127699736|NCT03953508|459530795|FG000|Baseline|Lost to Follow-up|3|||
127699737|NCT03953508|459530796|FG001|Baseline|Lost to Follow-up|2|||
127699738|NCT03953508|459530795|FG000|6-month Follow-up|Lost to Follow-up|62|||
127699739|NCT03953508|459530796|FG001|6-month Follow-up|Lost to Follow-up|70|||
127699740|NCT03771417|459530797|FG000|Overall Study|Withdrawal by Subject|1|||
127699741|NCT03771417|459530798|FG001|Overall Study|Withdrawal by Subject|0|||
127699742|NCT03771417|459530799|FG002|Overall Study|Withdrawal by Subject|0|||
127699743|NCT03771417|459530797|FG000|Overall Study|Covid-19 Shutdown|0|||
127699744|NCT03771417|459530798|FG001|Overall Study|Covid-19 Shutdown|1|||
127699745|NCT03771417|459530799|FG002|Overall Study|Covid-19 Shutdown|0|||
127699746|NCT04856163|459530800|FG000|Overall Study|Lost to Follow-up|97|||
127699747|NCT04856163|459530801|FG001|Overall Study|Lost to Follow-up|100|||
127699748|NCT02105766|459530816|FG000|Overall Study|Physician Decision|1|||
127699749|NCT02105766|459530817|FG001|Overall Study|Physician Decision|1|||
127699750|NCT02105766|459530818|FG002|Overall Study|Physician Decision|0|||
127699751|NCT02105766|459530816|FG000|Overall Study|Lost to Follow-up|2|||
127699752|NCT02105766|459530817|FG001|Overall Study|Lost to Follow-up|0|||
127699753|NCT02105766|459530818|FG002|Overall Study|Lost to Follow-up|0|||
127699754|NCT02105766|459530816|FG000|Overall Study|Death|1|||
127699755|NCT02105766|459530817|FG001|Overall Study|Death|1|||
127699756|NCT02105766|459530818|FG002|Overall Study|Death|0|||
127699757|NCT03897465|459530819|FG000|Overall Study|Lost to Follow-up|2|||
127699758|NCT03897465|459530820|FG001|Overall Study|Lost to Follow-up|1|||
127616407|NCT03837899|459223716|FG002|Overall Study|Moved to post-trial access program|0|||
127616408|NCT03837899|459223717|FG003|Overall Study|Moved to post-trial access program|0|||
127616409|NCT03837899|459223718|FG004|Overall Study|Moved to post-trial access program|0|||
127616410|NCT03837899|459223719|FG005|Overall Study|Moved to post-trial access program|0|||
127616411|NCT03837899|459223714|FG000|Overall Study|Other|0|||
127616412|NCT03837899|459223715|FG001|Overall Study|Other|0|||
127616413|NCT03837899|459223716|FG002|Overall Study|Other|0|||
127616414|NCT03837899|459223717|FG003|Overall Study|Other|0|||
127616415|NCT03837899|459223718|FG004|Overall Study|Other|0|||
127616416|NCT03837899|459223719|FG005|Overall Study|Other|2|||
127616417|NCT03837899|459223714|FG000|Overall Study|Lost to Follow-up|0|||
127616418|NCT03837899|459223715|FG001|Overall Study|Lost to Follow-up|1|||
127616419|NCT03837899|459223716|FG002|Overall Study|Lost to Follow-up|0|||
127616420|NCT03837899|459223717|FG003|Overall Study|Lost to Follow-up|0|||
127616421|NCT03837899|459223718|FG004|Overall Study|Lost to Follow-up|0|||
127616422|NCT03837899|459223719|FG005|Overall Study|Lost to Follow-up|0|||
127616423|NCT03837899|459223714|FG000|Overall Study|Withdrawal by Subject|0|||
127616424|NCT03837899|459223715|FG001|Overall Study|Withdrawal by Subject|0|||
127616425|NCT03837899|459223716|FG002|Overall Study|Withdrawal by Subject|0|||
127616426|NCT03837899|459223717|FG003|Overall Study|Withdrawal by Subject|1|||
127616427|NCT03837899|459223718|FG004|Overall Study|Withdrawal by Subject|0|||
127616428|NCT03837899|459223719|FG005|Overall Study|Withdrawal by Subject|0|||
127616429|NCT03837899|459223714|FG000|Overall Study|Study specific discontinuation criteria|0|||
127616430|NCT03837899|459223715|FG001|Overall Study|Study specific discontinuation criteria|1|||
127616431|NCT03837899|459223716|FG002|Overall Study|Study specific discontinuation criteria|0|||
127616432|NCT03837899|459223717|FG003|Overall Study|Study specific discontinuation criteria|0|||
127616433|NCT03837899|459223718|FG004|Overall Study|Study specific discontinuation criteria|3|||
127616434|NCT03837899|459223719|FG005|Overall Study|Study specific discontinuation criteria|1|||
127616435|NCT01371656|459223720|FG000|Overall Study|Death|7|||
127616436|NCT01371656|459223721|FG001|Overall Study|Death|4|||
127616437|NCT01371656|459223720|FG000|Overall Study|Physician Decision|46|||
127616438|NCT01371656|459223721|FG001|Overall Study|Physician Decision|7|||
127616439|NCT01371656|459223720|FG000|Overall Study|Withdrawal by Subject|7|||
127616440|NCT01371656|459223721|FG001|Overall Study|Withdrawal by Subject|0|||
127616441|NCT01371656|459223720|FG000|Overall Study|Ineligible|4|||
127616442|NCT01371656|459223721|FG001|Overall Study|Ineligible|3|||
127616443|NCT01465464|459223722|FG000|Overall Study|Adverse Event|96|||
127616444|NCT01465464|459223723|FG001|Overall Study|Adverse Event|49|||
127616445|NCT01465464|459223722|FG000|Overall Study|Lack of Efficacy|139|||
127616446|NCT01465464|459223723|FG001|Overall Study|Lack of Efficacy|190|||
127616447|NCT01465464|459223722|FG000|Overall Study|Physician Decision|13|||
127616448|NCT01465464|459223723|FG001|Overall Study|Physician Decision|5|||
127616449|NCT01465464|459223722|FG000|Overall Study|Protocol Violation|1|||
127616450|NCT01465464|459223723|FG001|Overall Study|Protocol Violation|1|||
127616451|NCT01465464|459223722|FG000|Overall Study|Withdrawal by Subject|46|||
127616452|NCT01465464|459223723|FG001|Overall Study|Withdrawal by Subject|30|||
127616453|NCT01465464|459223722|FG000|Overall Study|Other|9|||
127616454|NCT01465464|459223723|FG001|Overall Study|Other|3|||
127616455|NCT01465464|459223722|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
127616456|NCT01465464|459223723|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
127616457|NCT00785486|459223724|FG000|Midazolam Alone|Withdrawal by Subject|1|||
127616458|NCT01554618|459223725|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
127616459|NCT01554618|459223726|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
127616460|NCT01554618|459223725|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
127616461|NCT01554618|459223726|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
127616462|NCT01554618|459223725|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
127616463|NCT01554618|459223726|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
127616464|NCT01554618|459223725|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
127884322|NCT01415921|460199895|FG001|Overall Study|Adverse Event|1|||
127616465|NCT01554618|459223726|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
127616466|NCT01554618|459223725|FG000|Open-Label Extension Period|Physician Decision|0|||
127616467|NCT01554618|459223726|FG001|Open-Label Extension Period|Physician Decision|1|||
127616468|NCT01554618|459223725|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
127884323|NCT01415921|460199894|FG000|Overall Study|Physician Decision|1|||
127616469|NCT01554618|459223726|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
127616470|NCT01640366|459223728|FG000|Overall Study|Withdrawal by Subject|1|||
127616471|NCT01640366|459223728|FG000|Overall Study|Protocol Violation|16|||
127616472|NCT01640366|459223728|FG000|Overall Study|Lost to Follow-up|5|||
127616473|NCT00291668|459223735|FG000|Overall Study|Lack of Efficacy|1|||
127616474|NCT00291668|459223736|FG001|Overall Study|Lack of Efficacy|0|||
127616475|NCT00291668|459223737|FG002|Overall Study|Lack of Efficacy|0|||
127616476|NCT00291668|459223735|FG000|Overall Study|SAE, non-fatal|1|||
127616477|NCT00291668|459223736|FG001|Overall Study|SAE, non-fatal|1|||
127616478|NCT00291668|459223737|FG002|Overall Study|SAE, non-fatal|1|||
127616479|NCT00291668|459223735|FG000|Overall Study|AE, non-serious non-fatal|1|||
127616480|NCT00291668|459223736|FG001|Overall Study|AE, non-serious non-fatal|0|||
127616481|NCT00291668|459223737|FG002|Overall Study|AE, non-serious non-fatal|0|||
127616482|NCT00291668|459223735|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
127616483|NCT00291668|459223736|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
127616484|NCT00291668|459223737|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
127616485|NCT00313612|459223740|FG000|Overall Study|Patient never received treatment|0|||
127616486|NCT00313612|459223741|FG001|Overall Study|Patient never received treatment|1|||
127616487|NCT00451035|459223742|FG000|Overall Study|Disease progression|11|||
127616488|NCT00451035|459223742|FG000|Overall Study|Death|3|||
127616489|NCT00451035|459223742|FG000|Overall Study|New anti-neoplastic therapy|3|||
127616490|NCT00344773|459223745|FG000|Overall Study|Adverse Event|2|||
127616491|NCT00344773|459223745|FG000|Overall Study|Objective Disease Progression|16|||
127616492|NCT00344773|459223745|FG000|Overall Study|Withdrawal by Subject|1|||
127616493|NCT00344773|459223745|FG000|Overall Study|Not Eligible for the study|2|||
127616494|NCT00714259|459223747|FG000|Overall Study|Death|2|||
127616495|NCT02141074|459223748|FG000|Pre-prophylaxis|Adverse Event|3|||
127616496|NCT02141074|459223749|FG001|Pre-prophylaxis|Adverse Event|0|||
127616497|NCT02141074|459223748|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
127616498|NCT02141074|459223749|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
127616499|NCT02141074|459223748|FG000|Prophylaxis|Adverse Event|0|||
127616500|NCT02141074|459223749|FG001|Prophylaxis|Adverse Event|4|||
127616501|NCT02141074|459223748|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
127616502|NCT02141074|459223749|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
127616503|NCT02141074|459223748|FG000|Prophylaxis|Withdrawal by Subject|0|||
127616504|NCT02141074|459223749|FG001|Prophylaxis|Withdrawal by Subject|1|||
127616505|NCT05627518|459223750|FG000|Treatment Period 1|Adverse Event|0|||
127616506|NCT05627518|459223751|FG001|Treatment Period 1|Adverse Event|0|||
127616507|NCT05627518|459223752|FG002|Treatment Period 1|Adverse Event|1|||
127616508|NCT05627518|459223753|FG003|Treatment Period 1|Adverse Event|0|||
127616509|NCT05627518|459223754|FG004|Treatment Period 1|Adverse Event|0|||
127616510|NCT05627518|459223755|FG005|Treatment Period 1|Adverse Event|0|||
127616511|NCT05627518|459223756|FG006|Treatment Period 1|Adverse Event|0|||
127616512|NCT05627518|459223757|FG007|Treatment Period 1|Adverse Event|1|||
127616513|NCT05627518|459223750|FG000|Treatment Period 1|Withdrawal by Subject|0|||
127616514|NCT05627518|459223751|FG001|Treatment Period 1|Withdrawal by Subject|0|||
127616515|NCT05627518|459223752|FG002|Treatment Period 1|Withdrawal by Subject|1|||
127616516|NCT05627518|459223753|FG003|Treatment Period 1|Withdrawal by Subject|0|||
127616517|NCT05627518|459223754|FG004|Treatment Period 1|Withdrawal by Subject|0|||
127616518|NCT05627518|459223755|FG005|Treatment Period 1|Withdrawal by Subject|1|||
127616519|NCT05627518|459223756|FG006|Treatment Period 1|Withdrawal by Subject|0|||
127616520|NCT05627518|459223757|FG007|Treatment Period 1|Withdrawal by Subject|0|||
127616521|NCT05627518|459223750|FG000|Treatment Period 1|Protocol Violation|0|||
127616522|NCT05627518|459223751|FG001|Treatment Period 1|Protocol Violation|0|||
127616523|NCT05627518|459223752|FG002|Treatment Period 1|Protocol Violation|0|||
127616524|NCT05627518|459223753|FG003|Treatment Period 1|Protocol Violation|0|||
127616525|NCT05627518|459223754|FG004|Treatment Period 1|Protocol Violation|0|||
127616526|NCT05627518|459223755|FG005|Treatment Period 1|Protocol Violation|0|||
127616527|NCT05627518|459223756|FG006|Treatment Period 1|Protocol Violation|6|||
127616528|NCT05627518|459223757|FG007|Treatment Period 1|Protocol Violation|6|||
127616529|NCT05627518|459223750|FG000|Treatment Period 2|Adverse Event|1|||
127791089|NCT00586495|459858946|FG000|Treatment Period|Withdrawal by Subject|1|||
127791090|NCT00586495|459858946|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
127791091|NCT00586495|459858946|FG000|Treatment Period|Switch to commercial drug|10|||
127791092|NCT00586495|459858946|FG000|Follow-up|Death|40|||
127791093|NCT00586495|459858946|FG000|Follow-up|Lost to Follow-up|1|||
127791094|NCT00586495|459858946|FG000|Follow-up|Withdrawal by Subject|4|||
127616530|NCT05627518|459223751|FG001|Treatment Period 2|Adverse Event|0|||
127616531|NCT05627518|459223752|FG002|Treatment Period 2|Adverse Event|0|||
127616532|NCT05627518|459223753|FG003|Treatment Period 2|Adverse Event|0|||
127616533|NCT05627518|459223754|FG004|Treatment Period 2|Adverse Event|0|||
127791095|NCT00586495|459858946|FG000|Follow-up|Protocol driven decision point|37|||
127791096|NCT00586495|459858946|FG000|Follow-up|Switch to commercial drug|10|||
127616534|NCT05627518|459223755|FG005|Treatment Period 2|Adverse Event|0|||
127616535|NCT05627518|459223756|FG006|Treatment Period 2|Adverse Event|0|||
127616536|NCT05627518|459223757|FG007|Treatment Period 2|Adverse Event|0|||
127616537|NCT05627518|459223750|FG000|Treatment Period 2|Withdrawal by Subject|1|||
127616538|NCT05627518|459223751|FG001|Treatment Period 2|Withdrawal by Subject|0|||
127616539|NCT05627518|459223752|FG002|Treatment Period 2|Withdrawal by Subject|0|||
127616540|NCT05627518|459223753|FG003|Treatment Period 2|Withdrawal by Subject|0|||
127616541|NCT05627518|459223754|FG004|Treatment Period 2|Withdrawal by Subject|0|||
127616542|NCT05627518|459223755|FG005|Treatment Period 2|Withdrawal by Subject|0|||
127616543|NCT05627518|459223756|FG006|Treatment Period 2|Withdrawal by Subject|0|||
127884324|NCT01415921|460199895|FG001|Overall Study|Physician Decision|1|||
127884325|NCT01415921|460199894|FG000|Overall Study|Withdrawal by Subject|0|||
127884326|NCT01415921|460199895|FG001|Overall Study|Withdrawal by Subject|1|||
127884327|NCT01415921|460199894|FG000|Overall Study|Other|2|||
127884328|NCT01415921|460199895|FG001|Overall Study|Other|0|||
127884329|NCT01830920|460199900|FG000|Overall Study|Adverse Event|1|||
127616544|NCT05627518|459223757|FG007|Treatment Period 2|Withdrawal by Subject|0|||
127616545|NCT00574405|459225013|FG000|Overall Study|Withdrawal by Subject|3|||
127616546|NCT00574405|459225014|FG001|Overall Study|Withdrawal by Subject|2|||
127616547|NCT03003520|459225015|FG000|Overall Study|Adverse Event|9|||
127616548|NCT03003520|459225016|FG001|Overall Study|Adverse Event|0|||
127884330|NCT01830920|460199901|FG001|Overall Study|Adverse Event|0|||
127884331|NCT01830920|460199902|FG002|Overall Study|Adverse Event|1|||
127884332|NCT01830920|460199903|FG003|Overall Study|Adverse Event|0|||
127884333|NCT01830920|460199904|FG004|Overall Study|Adverse Event|0|||
127616549|NCT03003520|459225015|FG000|Overall Study|Death|1|||
127616550|NCT03003520|459225016|FG001|Overall Study|Death|0|||
127616551|NCT03003520|459225015|FG000|Overall Study|Other reasons|4|||
127616552|NCT03003520|459225016|FG001|Overall Study|Other reasons|0|||
127884334|NCT01830920|460199900|FG000|Overall Study|Withdrawal by Subject|2|||
127616553|NCT03003520|459225015|FG000|Overall Study|Withdrawal by Subject|6|||
127616554|NCT03003520|459225016|FG001|Overall Study|Withdrawal by Subject|0|||
127616555|NCT03003520|459225015|FG000|Overall Study|Progressive disease|9|||
127616556|NCT03003520|459225016|FG001|Overall Study|Progressive disease|1|||
127616557|NCT01332149|459225017|FG000|Overall Study|Adverse Event|11|||
127616558|NCT01332149|459225018|FG001|Overall Study|Adverse Event|9|||
127616559|NCT01332149|459225017|FG000|Overall Study|Other unspecified|5|||
127616560|NCT01332149|459225018|FG001|Overall Study|Other unspecified|7|||
127616561|NCT01332149|459225017|FG000|Overall Study|Protocol Violation|1|||
127616562|NCT01332149|459225018|FG001|Overall Study|Protocol Violation|3|||
127616563|NCT01332149|459225017|FG000|Overall Study|Withdrawal by Subject|4|||
127616564|NCT01332149|459225018|FG001|Overall Study|Withdrawal by Subject|5|||
127616565|NCT01332149|459225017|FG000|Overall Study|Lost to Follow-up|1|||
127616566|NCT01332149|459225018|FG001|Overall Study|Lost to Follow-up|1|||
127616567|NCT01332149|459225017|FG000|Overall Study|Insufficient clinical response|4|||
127616568|NCT01332149|459225018|FG001|Overall Study|Insufficient clinical response|7|||
127616569|NCT01332149|459225017|FG000|Overall Study|Did not meet entrance criteria|3|||
127699759|NCT03897465|459530819|FG000|Overall Study|Adverse Event|2|||
127699760|NCT03897465|459530820|FG001|Overall Study|Adverse Event|0|||
127699761|NCT03897465|459530819|FG000|Overall Study|complete healing by V2|1|||
127699762|NCT03897465|459530820|FG001|Overall Study|complete healing by V2|0|||
127699763|NCT03897465|459530819|FG000|Overall Study|occurence of exclusion criterion|1|||
127699764|NCT03897465|459530820|FG001|Overall Study|occurence of exclusion criterion|1|||
127699765|NCT03897465|459530819|FG000|Overall Study|Other|1|||
127699766|NCT03897465|459530820|FG001|Overall Study|Other|0|||
127699767|NCT05119023|459530821|FG000|Characterization of Learning-visits 1&2|Withdrawal by Subject|1|||
127699768|NCT05119023|459530821|FG000|Characterization of Learning-visits 1&2|Change in health status unrelated to study rendered unable to participate|2|||
127699769|NCT05119023|459530821|FG000|Characterization of Learning-visits 1&2|Lost to Follow-up|1|||
127699770|NCT06516705|459530834|FG000|T1( Before Hypoglycemia Education)|Withdrawal by Subject|1|||
127699771|NCT06516705|459530835|FG001|T1( Before Hypoglycemia Education)|Withdrawal by Subject|0|||
127699772|NCT06516705|459530834|FG000|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
127699773|NCT06516705|459530835|FG001|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
127699774|NCT06516705|459530834|FG000|T3 ( 3 Month After Education)|covid-19|1|||
127699775|NCT06516705|459530835|FG001|T3 ( 3 Month After Education)|covid-19|2|||
127699776|NCT06516705|459530834|FG000|T3 ( 3 Month After Education)|Refused to respond|0|||
127699777|NCT06516705|459530835|FG001|T3 ( 3 Month After Education)|Refused to respond|1|||
127699778|NCT06516705|459530834|FG000|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
127699779|NCT06516705|459530835|FG001|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
127699780|NCT06516705|459530834|FG000|T4 ( 6 Month After Education)|covid-19|3|||
127699781|NCT06516705|459530835|FG001|T4 ( 6 Month After Education)|covid-19|2|||
127699782|NCT06516705|459530834|FG000|T4 ( 6 Month After Education)|Refused to respond|0|||
127699783|NCT06516705|459530835|FG001|T4 ( 6 Month After Education)|Refused to respond|1|||
127884335|NCT01830920|460199901|FG001|Overall Study|Withdrawal by Subject|2|||
127884336|NCT01830920|460199902|FG002|Overall Study|Withdrawal by Subject|1|||
127616570|NCT01332149|459225018|FG001|Overall Study|Did not meet entrance criteria|4|||
127616571|NCT01332149|459225017|FG000|Overall Study|Randomized but not treated|1|||
127616572|NCT01332149|459225018|FG001|Overall Study|Randomized but not treated|2|||
127616573|NCT02565381|459225019|FG000|Overall Study|Lost to Follow-up|1|||
127616574|NCT02565381|459225020|FG001|Overall Study|Lost to Follow-up|0|||
127616575|NCT02565381|459225021|FG002|Overall Study|Lost to Follow-up|1|||
127616576|NCT04615949|459225024|FG000|Overall Study|Withdrawal by Subject|2|||
127616577|NCT04615949|459225025|FG001|Overall Study|Withdrawal by Subject|4|||
127616578|NCT04615949|459225024|FG000|Overall Study|Lost to Follow-up|2|||
127616579|NCT04615949|459225025|FG001|Overall Study|Lost to Follow-up|2|||
127616580|NCT04615949|459225024|FG000|Overall Study|Death|0|||
127616581|NCT04615949|459225025|FG001|Overall Study|Death|2|||
127616582|NCT05084053|459225026|FG000|Epoch 1: Up to 6 Months|Withdrawal by Subject|1|||
127616583|NCT05084053|459225027|FG001|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
127616584|NCT05084053|459225028|FG002|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
127616585|NCT05084053|459225029|FG003|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
127616586|NCT05084053|459225026|FG000|Epoch 1: Up to 6 Months|Physician Decision|1|||
127616587|NCT05084053|459225027|FG001|Epoch 1: Up to 6 Months|Physician Decision|0|||
127616588|NCT05084053|459225028|FG002|Epoch 1: Up to 6 Months|Physician Decision|0|||
127616589|NCT05084053|459225029|FG003|Epoch 1: Up to 6 Months|Physician Decision|0|||
127616590|NCT05084053|459225026|FG000|Epoch 2: Up to 6 Months|Physician Decision|0|||
127616591|NCT05084053|459225027|FG001|Epoch 2: Up to 6 Months|Physician Decision|0|||
127616592|NCT05084053|459225028|FG002|Epoch 2: Up to 6 Months|Physician Decision|1|||
127616593|NCT05084053|459225029|FG003|Epoch 2: Up to 6 Months|Physician Decision|0|||
127616594|NCT01920932|459225030|FG000|Overall Study|Death|1|||
127616595|NCT01920932|459225030|FG000|Overall Study|Withdrawal of consent|1|||
127616596|NCT00071812|459225031|FG000|24-Week Double-Blind Period|Adverse Event|2|||
127616597|NCT00071812|459225032|FG001|24-Week Double-Blind Period|Adverse Event|3|||
127616598|NCT00071812|459225033|FG002|24-Week Double-Blind Period|Adverse Event|4|||
127616599|NCT00071812|459225034|FG003|24-Week Double-Blind Period|Adverse Event|4|||
127616600|NCT00071812|459225031|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
127616601|NCT00071812|459225032|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
127616602|NCT00071812|459225033|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
127616603|NCT00071812|459225034|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
127616604|NCT00071812|459225031|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
127616605|NCT00071812|459225032|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
127616606|NCT00071812|459225033|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
127616607|NCT00071812|459225034|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
127616608|NCT00071812|459225031|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
127616609|NCT00071812|459225032|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
127616610|NCT00071812|459225033|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
127616611|NCT00071812|459225034|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
127616612|NCT00071812|459225031|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
127616613|NCT00071812|459225032|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
127616614|NCT00071812|459225033|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
127616615|NCT00071812|459225034|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
127616616|NCT00071812|459225031|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
127616617|NCT00071812|459225032|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
127616618|NCT00071812|459225033|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
127616619|NCT00071812|459225034|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
127616620|NCT00071812|459225031|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
127616621|NCT00071812|459225032|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
127616622|NCT00071812|459225033|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
127616623|NCT00071812|459225034|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
127616624|NCT00071812|459225031|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
127616625|NCT00071812|459225032|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
127616626|NCT00071812|459225033|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
127616627|NCT00071812|459225034|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
127616628|NCT00071812|459225031|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
127616629|NCT00071812|459225032|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
127616630|NCT00071812|459225033|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
127616631|NCT00071812|459225034|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
127616632|NCT00071812|459225031|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
127616633|NCT00071812|459225032|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
127616634|NCT00071812|459225033|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
127616635|NCT00071812|459225034|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
127616636|NCT02554656|459225035|FG000|Overall Study|Protocol Violation|3|||
127616637|NCT00749463|459225040|FG000|Overall Study|Adverse Event|0|||
127616638|NCT00749463|459225041|FG001|Overall Study|Adverse Event|4|||
127616639|NCT00749463|459225042|FG002|Overall Study|Adverse Event|1|||
127616640|NCT00749463|459225040|FG000|Overall Study|Withdrawal by Subject|1|||
127616641|NCT00749463|459225041|FG001|Overall Study|Withdrawal by Subject|0|||
127616642|NCT00749463|459225042|FG002|Overall Study|Withdrawal by Subject|0|||
127616643|NCT00697346|459225047|FG000|Overall Study|Adverse Event|4|||
127616644|NCT00697346|459225048|FG001|Overall Study|Adverse Event|5|||
127616645|NCT00697346|459225049|FG002|Overall Study|Adverse Event|0|||
127616646|NCT00697346|459225047|FG000|Overall Study|Progressive Disease|19|||
127616647|NCT00697346|459225048|FG001|Overall Study|Progressive Disease|18|||
127616648|NCT00697346|459225049|FG002|Overall Study|Progressive Disease|0|||
127616649|NCT00697346|459225047|FG000|Overall Study|Symptomatic Deterioration|0|||
127616650|NCT00697346|459225048|FG001|Overall Study|Symptomatic Deterioration|1|||
127616651|NCT00697346|459225049|FG002|Overall Study|Symptomatic Deterioration|0|||
127616652|NCT00697346|459225047|FG000|Overall Study|Withdrawal by Subject|2|||
127616653|NCT00697346|459225048|FG001|Overall Study|Withdrawal by Subject|2|||
127616654|NCT00697346|459225049|FG002|Overall Study|Withdrawal by Subject|0|||
127616655|NCT00697346|459225047|FG000|Overall Study|Reason not Specified|3|||
127616656|NCT00697346|459225048|FG001|Overall Study|Reason not Specified|0|||
127616657|NCT00697346|459225049|FG002|Overall Study|Reason not Specified|1|||
127616658|NCT00240071|459225054|FG000|Overall Study|Withdrawal by Subject|3|||
127616659|NCT01533246|459225059|FG000|Overall Study|Adverse Event|1|||
127616660|NCT01533246|459225059|FG000|Overall Study|Withdrawal by Subject|1|||
127616661|NCT01143090|459225060|FG000|Overall Study|Lack of Efficacy|2|||
127616662|NCT01143090|459225060|FG000|Overall Study|Adverse Event|17|||
127616663|NCT01143090|459225060|FG000|Overall Study|Lost to Follow-up|9|||
127616664|NCT01143090|459225060|FG000|Overall Study|Protocol Violation|2|||
127616665|NCT01143090|459225060|FG000|Overall Study|Withdrawal by Subject|18|||
127616666|NCT01143090|459225060|FG000|Overall Study|Non-compliance with study drug|1|||
127616667|NCT01143090|459225060|FG000|Overall Study|Failure to meet eligibility criteria|1|||
127616668|NCT01143090|459225060|FG000|Overall Study|Administrative|1|||
127616669|NCT01461096|459225063|FG000|Overall Study|Death|3|||
127616670|NCT01461096|459225064|FG001|Overall Study|Death|6|||
127616671|NCT01461096|459225063|FG000|Overall Study|Severe debilitation, unable to continue|1|||
127616672|NCT01461096|459225064|FG001|Overall Study|Severe debilitation, unable to continue|1|||
127616673|NCT01461096|459225063|FG000|Overall Study|Subj not able to get to clinic|15|||
127616674|NCT01461096|459225064|FG001|Overall Study|Subj not able to get to clinic|13|||
127616675|NCT01461096|459225063|FG000|Overall Study|Site is closing|27|||
127616676|NCT01461096|459225064|FG001|Overall Study|Site is closing|30|||
127616677|NCT01461096|459225063|FG000|Overall Study|Withdrawal by Subject|5|||
127616678|NCT01461096|459225064|FG001|Overall Study|Withdrawal by Subject|3|||
127616679|NCT01461096|459225063|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
127616680|NCT01461096|459225064|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
127616681|NCT01461096|459225063|FG000|Overall Study|Lost to Follow-up|8|||
127616682|NCT01461096|459225064|FG001|Overall Study|Lost to Follow-up|4|||
127616683|NCT01452412|459225070|FG000|Overall Study|Withdrawal by Subject|15|||
127616684|NCT01452412|459225071|FG001|Overall Study|Withdrawal by Subject|11|||
127616685|NCT01452412|459225070|FG000|Overall Study|Adverse Event|4|||
127616686|NCT01452412|459225071|FG001|Overall Study|Adverse Event|3|||
127616687|NCT01452412|459225070|FG000|Overall Study|Lost to Follow-up|5|||
127616688|NCT01452412|459225071|FG001|Overall Study|Lost to Follow-up|3|||
127616689|NCT01452412|459225070|FG000|Overall Study|Death|1|||
127616690|NCT01452412|459225071|FG001|Overall Study|Death|0|||
127616691|NCT01452412|459225070|FG000|Overall Study|Initiated dialysis|1|||
127699784|NCT04292223|459530836|FG000|Overall Study|Adverse Event|1|||
127699785|NCT04292223|459530836|FG000|Overall Study|Lost to Follow-up|1|||
127699786|NCT04292223|459530836|FG000|Overall Study|Noncompliance with study drug|2|||
127699787|NCT04292223|459530836|FG000|Overall Study|Patient moved out of the state|1|||
127699788|NCT03023410|459530837|FG000|Overall Study|study termination|0|||
127699789|NCT03023410|459530838|FG001|Overall Study|study termination|1|||
127699790|NCT04799899|459530839|FG000|Overall Study|Lost to Follow-up|2|||
127699791|NCT04799899|459530840|FG001|Overall Study|Lost to Follow-up|4|||
127699792|NCT04019873|459530841|FG000|Overall Study|Discontinued from the treatment|1|||
127699793|NCT04019873|459530842|FG001|Overall Study|Discontinued from the treatment|39|||
127699794|NCT04019873|459530843|FG002|Overall Study|Discontinued from the treatment|2|||
127699795|NCT04927364|459530853|FG000|Overall Study|Withdrawal by Subject|3|||
127699796|NCT04927364|459530853|FG000|Overall Study|Unable to complete preassessment MRI|1|||
127699797|NCT04091750|459530856|FG000|Overall Study|Adverse Event|4|||
127699798|NCT04091750|459530856|FG000|Overall Study|Withdrawal by Subject|1|||
127699799|NCT04473222|459530857|FG000|Overall Study|Lost to Follow-up|13|||
127699800|NCT04473222|459530858|FG001|Overall Study|Lost to Follow-up|13|||
127699801|NCT04473222|459530857|FG000|Overall Study|Withdrawal by Subject|0|||
127699802|NCT04473222|459530858|FG001|Overall Study|Withdrawal by Subject|1|||
127699803|NCT04473222|459530857|FG000|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|0|||
127699804|NCT04473222|459530858|FG001|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|1|||
127699805|NCT02919306|459530859|FG000|Overall Study|Withdrawal by Subject|1|||
127699806|NCT02919306|459530860|FG001|Overall Study|Withdrawal by Subject|0|||
127699807|NCT02919306|459530859|FG000|Overall Study|Protocol Violation|1|||
127699808|NCT02919306|459530860|FG001|Overall Study|Protocol Violation|0|||
127699809|NCT04293055|459530861|FG000|Overall Study|Lost to Follow-up|1|||
127699810|NCT04293055|459530862|FG001|Overall Study|Lost to Follow-up|1|||
127699811|NCT04293055|459530861|FG000|Overall Study|Did not trigger randomization|6|||
127699812|NCT04293055|459530862|FG001|Overall Study|Did not trigger randomization|5|||
127705236|NCT01928394|459551570|FG003|Follow-up Period|Participant withdrew consent|4|||
127616692|NCT01452412|459225071|FG001|Overall Study|Initiated dialysis|0|||
127616693|NCT01452412|459225070|FG000|Overall Study|Other|2|||
127616694|NCT01452412|459225071|FG001|Overall Study|Other|0|||
127616695|NCT03013543|459225074|FG000|Overall Study|Withdrawal by Subject|0|||
127616696|NCT03013543|459225075|FG001|Overall Study|Withdrawal by Subject|2|||
127616697|NCT03013543|459225076|FG002|Overall Study|Withdrawal by Subject|0|||
127616698|NCT03013543|459225077|FG003|Overall Study|Withdrawal by Subject|5|||
127616699|NCT03013543|459225078|FG004|Overall Study|Withdrawal by Subject|6|||
127616700|NCT03013543|459225079|FG005|Overall Study|Withdrawal by Subject|2|||
127616701|NCT03013543|459225080|FG006|Overall Study|Withdrawal by Subject|3|||
127616702|NCT03013543|459225081|FG007|Overall Study|Withdrawal by Subject|1|||
127616703|NCT03013543|459225082|FG008|Overall Study|Withdrawal by Subject|0|||
127616704|NCT03013543|459225083|FG009|Overall Study|Withdrawal by Subject|4|||
127616705|NCT03013543|459225074|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
127616706|NCT03013543|459225075|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
127616707|NCT03013543|459225076|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
127616708|NCT03013543|459225077|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
127616709|NCT03013543|459225078|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
127616710|NCT03013543|459225079|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
127616711|NCT03013543|459225080|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
127616712|NCT03013543|459225081|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
127616713|NCT03013543|459225082|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
127616714|NCT03013543|459225083|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
127616715|NCT03013543|459225074|FG000|Overall Study|Other|0|||
127616716|NCT03013543|459225075|FG001|Overall Study|Other|0|||
127616717|NCT03013543|459225076|FG002|Overall Study|Other|2|||
127616718|NCT03013543|459225077|FG003|Overall Study|Other|0|||
127616719|NCT03013543|459225078|FG004|Overall Study|Other|2|||
127616720|NCT03013543|459225079|FG005|Overall Study|Other|0|||
127616721|NCT03013543|459225080|FG006|Overall Study|Other|0|||
127616722|NCT03013543|459225081|FG007|Overall Study|Other|0|||
127616723|NCT03013543|459225082|FG008|Overall Study|Other|1|||
127616724|NCT03013543|459225083|FG009|Overall Study|Other|0|||
127616725|NCT03013543|459225074|FG000|Overall Study|Adverse Event|0|||
127616726|NCT03013543|459225075|FG001|Overall Study|Adverse Event|0|||
127616727|NCT03013543|459225076|FG002|Overall Study|Adverse Event|0|||
127699813|NCT03560609|459530863|FG000|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|3|||
127699814|NCT03560609|459530864|FG001|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|0|||
127699815|NCT04195698|459530875|FG000|Overall Study|Adverse Event|4|||
127699816|NCT04195698|459530876|FG001|Overall Study|Adverse Event|11|||
127699817|NCT04195698|459530875|FG000|Overall Study|Withdrawal by Subject|9|||
127699818|NCT04195698|459530876|FG001|Overall Study|Withdrawal by Subject|10|||
127699819|NCT04195698|459530875|FG000|Overall Study|Lost to Follow-up|5|||
127699820|NCT04195698|459530876|FG001|Overall Study|Lost to Follow-up|4|||
127699821|NCT04195698|459530875|FG000|Overall Study|Lack of Efficacy|2|||
127699822|NCT04195698|459530876|FG001|Overall Study|Lack of Efficacy|10|||
127699823|NCT04195698|459530875|FG000|Overall Study|Other|5|||
127699824|NCT04195698|459530876|FG001|Overall Study|Other|4|||
127616728|NCT03013543|459225077|FG003|Overall Study|Adverse Event|3|||
127616729|NCT03013543|459225078|FG004|Overall Study|Adverse Event|2|||
127616730|NCT03013543|459225079|FG005|Overall Study|Adverse Event|1|||
127616731|NCT03013543|459225080|FG006|Overall Study|Adverse Event|3|||
127616732|NCT03013543|459225081|FG007|Overall Study|Adverse Event|8|||
127616733|NCT03013543|459225082|FG008|Overall Study|Adverse Event|0|||
127616734|NCT03013543|459225083|FG009|Overall Study|Adverse Event|2|||
127616735|NCT03013543|459225074|FG000|Overall Study|Death|0|||
127616736|NCT03013543|459225075|FG001|Overall Study|Death|0|||
127616737|NCT03013543|459225076|FG002|Overall Study|Death|0|||
127616738|NCT03013543|459225077|FG003|Overall Study|Death|1|||
127616739|NCT03013543|459225078|FG004|Overall Study|Death|0|||
127616740|NCT03013543|459225079|FG005|Overall Study|Death|0|||
127616741|NCT03013543|459225080|FG006|Overall Study|Death|0|||
127616742|NCT03013543|459225081|FG007|Overall Study|Death|0|||
127616743|NCT03013543|459225082|FG008|Overall Study|Death|0|||
127616744|NCT03013543|459225083|FG009|Overall Study|Death|0|||
127616745|NCT03013543|459225074|FG000|Overall Study|Lack of Efficacy|0|||
127616746|NCT03013543|459225075|FG001|Overall Study|Lack of Efficacy|0|||
127616747|NCT03013543|459225076|FG002|Overall Study|Lack of Efficacy|0|||
127616748|NCT03013543|459225077|FG003|Overall Study|Lack of Efficacy|1|||
127616749|NCT03013543|459225078|FG004|Overall Study|Lack of Efficacy|0|||
127616750|NCT03013543|459225079|FG005|Overall Study|Lack of Efficacy|0|||
127616751|NCT03013543|459225080|FG006|Overall Study|Lack of Efficacy|0|||
127884337|NCT01830920|460199903|FG003|Overall Study|Withdrawal by Subject|7|||
127884338|NCT01830920|460199904|FG004|Overall Study|Withdrawal by Subject|1|||
127884339|NCT01830920|460199900|FG000|Overall Study|Death|3|||
127884340|NCT01830920|460199901|FG001|Overall Study|Death|3|||
127884341|NCT01830920|460199902|FG002|Overall Study|Death|5|||
127884342|NCT01830920|460199903|FG003|Overall Study|Death|4|||
127884343|NCT01830920|460199904|FG004|Overall Study|Death|4|||
127884344|NCT01830920|460199900|FG000|Overall Study|Other|15|||
127884345|NCT01830920|460199901|FG001|Overall Study|Other|1|||
127884346|NCT01830920|460199902|FG002|Overall Study|Other|1|||
127884347|NCT01830920|460199903|FG003|Overall Study|Other|5|||
127884348|NCT01830920|460199904|FG004|Overall Study|Other|3|||
127884349|NCT03876873|460199905|FG000|Overall Study|Physician Decision|0|||
127616752|NCT03013543|459225081|FG007|Overall Study|Lack of Efficacy|0|||
127616753|NCT03013543|459225082|FG008|Overall Study|Lack of Efficacy|0|||
127616754|NCT03013543|459225083|FG009|Overall Study|Lack of Efficacy|0|||
127616755|NCT03013543|459225074|FG000|Overall Study|Lost to Follow-up|0|||
127616756|NCT03013543|459225075|FG001|Overall Study|Lost to Follow-up|0|||
127616757|NCT03013543|459225076|FG002|Overall Study|Lost to Follow-up|0|||
127616758|NCT03013543|459225077|FG003|Overall Study|Lost to Follow-up|1|||
127616759|NCT03013543|459225078|FG004|Overall Study|Lost to Follow-up|0|||
127616760|NCT03013543|459225079|FG005|Overall Study|Lost to Follow-up|0|||
127616761|NCT03013543|459225080|FG006|Overall Study|Lost to Follow-up|1|||
127616762|NCT03013543|459225081|FG007|Overall Study|Lost to Follow-up|0|||
127616763|NCT03013543|459225082|FG008|Overall Study|Lost to Follow-up|0|||
127616764|NCT03013543|459225083|FG009|Overall Study|Lost to Follow-up|2|||
127616765|NCT03013543|459225074|FG000|Overall Study|Non-Compliance With Study Drug|0|||
127616766|NCT03013543|459225075|FG001|Overall Study|Non-Compliance With Study Drug|0|||
127616767|NCT03013543|459225076|FG002|Overall Study|Non-Compliance With Study Drug|0|||
127616768|NCT03013543|459225077|FG003|Overall Study|Non-Compliance With Study Drug|0|||
127616769|NCT03013543|459225078|FG004|Overall Study|Non-Compliance With Study Drug|0|||
127616770|NCT03013543|459225079|FG005|Overall Study|Non-Compliance With Study Drug|0|||
127616771|NCT03013543|459225080|FG006|Overall Study|Non-Compliance With Study Drug|0|||
127616772|NCT03013543|459225081|FG007|Overall Study|Non-Compliance With Study Drug|0|||
127616773|NCT03013543|459225082|FG008|Overall Study|Non-Compliance With Study Drug|1|||
127616774|NCT03013543|459225083|FG009|Overall Study|Non-Compliance With Study Drug|0|||
127616775|NCT03013543|459225074|FG000|Overall Study|Physician Decision|0|||
127616776|NCT03013543|459225075|FG001|Overall Study|Physician Decision|0|||
127616777|NCT03013543|459225076|FG002|Overall Study|Physician Decision|0|||
127616778|NCT03013543|459225077|FG003|Overall Study|Physician Decision|0|||
127616779|NCT03013543|459225078|FG004|Overall Study|Physician Decision|1|||
127616780|NCT03013543|459225079|FG005|Overall Study|Physician Decision|0|||
127616781|NCT03013543|459225080|FG006|Overall Study|Physician Decision|0|||
127616782|NCT03013543|459225081|FG007|Overall Study|Physician Decision|0|||
127616783|NCT03013543|459225082|FG008|Overall Study|Physician Decision|0|||
127616784|NCT03013543|459225083|FG009|Overall Study|Physician Decision|0|||
127616785|NCT03013543|459225074|FG000|Overall Study|Protocol Violation|0|||
127884350|NCT03876873|460199906|FG001|Overall Study|Physician Decision|1|||
127616786|NCT03013543|459225075|FG001|Overall Study|Protocol Violation|0|||
127616787|NCT03013543|459225076|FG002|Overall Study|Protocol Violation|0|||
127616788|NCT03013543|459225077|FG003|Overall Study|Protocol Violation|0|||
127616789|NCT03013543|459225078|FG004|Overall Study|Protocol Violation|0|||
127616790|NCT03013543|459225079|FG005|Overall Study|Protocol Violation|0|||
127616791|NCT03013543|459225080|FG006|Overall Study|Protocol Violation|0|||
127616792|NCT03013543|459225081|FG007|Overall Study|Protocol Violation|0|||
127616793|NCT03013543|459225082|FG008|Overall Study|Protocol Violation|0|||
127884351|NCT03402126|460199908|FG000|Overall Study|Lost to Follow-up|6|||
127884352|NCT03402126|460199908|FG000|Overall Study|Protocol Violation|10|||
127616794|NCT03013543|459225083|FG009|Overall Study|Protocol Violation|1|||
127616795|NCT04225923|459225084|FG000|Overall Study|Protocol Violation|1|||
127616796|NCT04225923|459225085|FG001|Overall Study|Protocol Violation|0|||
127616797|NCT04225923|459225086|FG002|Overall Study|Protocol Violation|1|||
127616798|NCT04225923|459225084|FG000|Overall Study|Withdrawal by Subject|4|||
127616799|NCT04225923|459225085|FG001|Overall Study|Withdrawal by Subject|1|||
127616800|NCT04225923|459225086|FG002|Overall Study|Withdrawal by Subject|3|||
127884353|NCT03402126|460199908|FG000|Overall Study|Sponsor request/Study termination|29|||
127699825|NCT01369355|459530878|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
127699826|NCT01369355|459530879|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
127616801|NCT04225923|459225084|FG000|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
127616802|NCT04225923|459225085|FG001|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
127616803|NCT04225923|459225086|FG002|Overall Study|A subject completed the study but was reported incorrectly in the report form|1|||
127616804|NCT01417481|459225087|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
127616805|NCT01417481|459225088|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
127616806|NCT00829296|459225089|FG000|Overall Study|Adverse Event|5|||
127616807|NCT00829296|459225090|FG001|Overall Study|Adverse Event|4|||
127616808|NCT03029624|459225091|FG000|Overall Study|Adverse Event|1|||
127616809|NCT03029624|459225091|FG000|Overall Study|Withdrawal by Subject|1|||
127616810|NCT03029624|459225091|FG000|Overall Study|Lack of Efficacy|1|||
127616811|NCT03029624|459225091|FG000|Overall Study|MRI need|2|||
127616812|NCT04116710|459225092|FG000|Overall Study|Death|4|||
127616813|NCT04116710|459225093|FG001|Overall Study|Death|6|||
127616814|NCT04116710|459225094|FG002|Overall Study|Death|3|||
127616815|NCT04116710|459225095|FG003|Overall Study|Death|1|||
127616816|NCT04116710|459225092|FG000|Overall Study|Withdrawal by Subject|0|||
127616817|NCT04116710|459225093|FG001|Overall Study|Withdrawal by Subject|0|||
127616818|NCT04116710|459225094|FG002|Overall Study|Withdrawal by Subject|0|||
127616819|NCT04116710|459225095|FG003|Overall Study|Withdrawal by Subject|1|||
127616820|NCT00582933|459225098|FG000|Overall Study|Physician Decision|3|||
127616821|NCT01077960|459225099|FG000|Overall Study|Adverse Event|6|||
127616822|NCT01077960|459225099|FG000|Overall Study|Protocol Violation|3|||
127616823|NCT01077960|459225099|FG000|Overall Study|Lost to Follow-up|5|||
127616824|NCT01077960|459225099|FG000|Overall Study|Subject decision|1|||
127616825|NCT01077960|459225099|FG000|Overall Study|Reason unspecified|1|||
127699827|NCT01369355|459530880|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
127699828|NCT01369355|459530881|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
127699829|NCT01369355|459530882|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
127699830|NCT01369355|459530883|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
127699831|NCT01369355|459530884|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
127699832|NCT01369355|459530885|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
127791097|NCT02595723|459858959|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
127791098|NCT02595723|459858960|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
127791099|NCT02595723|459858961|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
127791100|NCT02595723|459858959|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
127791101|NCT02595723|459858960|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
127791102|NCT02595723|459858961|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
127791103|NCT00004259|459858962|FG000|Overall Study|Protocol Violation|1|||
127791104|NCT00004259|459858963|FG001|Overall Study|Protocol Violation|2|||
127791105|NCT00004259|459858964|FG002|Overall Study|Protocol Violation|0|||
127791106|NCT00004259|459858965|FG003|Overall Study|Protocol Violation|0|||
127791107|NCT00004259|459858962|FG000|Overall Study|Withdrawal by Subject|0|||
127791108|NCT00004259|459858963|FG001|Overall Study|Withdrawal by Subject|2|||
127791109|NCT00004259|459858964|FG002|Overall Study|Withdrawal by Subject|0|||
127791110|NCT00004259|459858965|FG003|Overall Study|Withdrawal by Subject|0|||
127791111|NCT00996944|459858966|FG000|Double-blind Treatment Period|Adverse Event|2|||
127791112|NCT00996944|459858967|FG001|Double-blind Treatment Period|Adverse Event|1|||
127791113|NCT00996944|459858966|FG000|Double-blind Treatment Period|Protocol Violation|1|||
127791114|NCT00996944|459858967|FG001|Double-blind Treatment Period|Protocol Violation|0|||
127791115|NCT00996944|459858966|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
127791116|NCT00996944|459858967|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
127791117|NCT00996944|459858966|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
127791118|NCT00996944|459858967|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
127791119|NCT00996944|459858966|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
127791120|NCT00996944|459858967|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
127791121|NCT00769184|459858968|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
127791122|NCT00769184|459858969|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
127791123|NCT00769184|459858968|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
127791124|NCT00769184|459858969|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
127616826|NCT01537783|459225102|FG000|Overall Study|Lost to Follow-up|11|||
127791125|NCT00769184|459858968|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
127616827|NCT01537783|459225103|FG001|Overall Study|Lost to Follow-up|2|||
127791126|NCT00769184|459858969|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
127791127|NCT00385255|459858970|FG000|Overall Study|Serious Adverse Event|1|||
127791128|NCT00385255|459858971|FG001|Overall Study|Serious Adverse Event|2|||
127616828|NCT01393405|459225106|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
127616829|NCT01393405|459225107|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
127616830|NCT01393405|459225108|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
127699833|NCT01369355|459530886|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
127699834|NCT01369355|459530878|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
127699835|NCT01369355|459530879|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
127699836|NCT01369355|459530880|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
127699837|NCT01369355|459530881|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
127699838|NCT01369355|459530882|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
127699839|NCT01369355|459530883|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
127699840|NCT01369355|459530884|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
127699841|NCT01369355|459530885|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
127699842|NCT01369355|459530886|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
127699843|NCT01369355|459530878|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
127699844|NCT01369355|459530879|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
127699845|NCT01369355|459530880|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
127699846|NCT01369355|459530881|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
127699847|NCT01369355|459530882|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
127699848|NCT01369355|459530883|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
127699849|NCT01369355|459530884|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
127699850|NCT01369355|459530885|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
127699851|NCT01369355|459530886|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
127699852|NCT01369355|459530878|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
127699853|NCT01369355|459530879|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
127699854|NCT01369355|459530880|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
127699855|NCT01369355|459530881|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
127699856|NCT01369355|459530882|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
127699857|NCT01369355|459530883|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
127699858|NCT01369355|459530884|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
127699859|NCT01369355|459530885|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
127699860|NCT01369355|459530886|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
127699861|NCT01369355|459530878|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
127699862|NCT01369355|459530879|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
127699863|NCT01369355|459530880|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
127699864|NCT01369355|459530881|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
127699865|NCT01369355|459530882|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
127699866|NCT01369355|459530883|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
127699867|NCT01369355|459530884|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
127699868|NCT01369355|459530885|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
127699869|NCT01369355|459530886|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
127699870|NCT01369355|459530878|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
127699871|NCT01369355|459530879|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
127699872|NCT01369355|459530880|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
127699873|NCT01369355|459530881|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
127699874|NCT01369355|459530882|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
127699875|NCT01369355|459530883|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
127699876|NCT01369355|459530884|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
127699877|NCT01369355|459530885|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
127699878|NCT01369355|459530886|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
127699879|NCT01369355|459530878|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
127699880|NCT01369355|459530879|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
127699881|NCT01369355|459530880|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
127699882|NCT01369355|459530881|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
127699883|NCT01369355|459530882|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
127699884|NCT01369355|459530883|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
127699885|NCT01369355|459530884|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
127699886|NCT01369355|459530885|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
127699887|NCT01369355|459530886|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
127791129|NCT00385255|459858970|FG000|Overall Study|Protocol Violation|0|||
127791130|NCT00385255|459858971|FG001|Overall Study|Protocol Violation|4|||
127791131|NCT00385255|459858970|FG000|Overall Study|Withdrawal by Subject|0|||
127791132|NCT00385255|459858971|FG001|Overall Study|Withdrawal by Subject|8|||
127791133|NCT00385255|459858970|FG000|Overall Study|Migrated/moved from study area|0|||
127791134|NCT00385255|459858971|FG001|Overall Study|Migrated/moved from study area|1|||
127699888|NCT01369355|459530878|FG000|Long-term Extension (Week 44-272)|Death|0|||
127699889|NCT01369355|459530879|FG001|Long-term Extension (Week 44-272)|Death|0|||
127699890|NCT01369355|459530880|FG002|Long-term Extension (Week 44-272)|Death|0|||
127699891|NCT01369355|459530881|FG003|Long-term Extension (Week 44-272)|Death|0|||
127699892|NCT01369355|459530882|FG004|Long-term Extension (Week 44-272)|Death|0|||
127791135|NCT00385255|459858970|FG000|Overall Study|Lost to Follow-up|20|||
127791136|NCT00385255|459858971|FG001|Overall Study|Lost to Follow-up|58|||
127616831|NCT01393405|459225106|FG000|Induction Period (week1-16)|Adverse Event|16|||
127616832|NCT01393405|459225107|FG001|Induction Period (week1-16)|Adverse Event|0|||
127616833|NCT01393405|459225108|FG002|Induction Period (week1-16)|Adverse Event|0|||
127616834|NCT01393405|459225106|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
127616835|NCT01393405|459225107|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
127616836|NCT01393405|459225108|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
127616837|NCT01393405|459225106|FG000|Maintenance Period Week|Lack of Efficacy|0|||
127616838|NCT01393405|459225107|FG001|Maintenance Period Week|Lack of Efficacy|22|||
127616839|NCT01393405|459225108|FG002|Maintenance Period Week|Lack of Efficacy|22|||
127616840|NCT01393405|459225106|FG000|Maintenance Period Week|Adverse Event|0|||
127616841|NCT01393405|459225107|FG001|Maintenance Period Week|Adverse Event|5|||
127616842|NCT01393405|459225108|FG002|Maintenance Period Week|Adverse Event|2|||
127616843|NCT01393405|459225106|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
127616844|NCT01393405|459225107|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
127616845|NCT01393405|459225108|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
127616846|NCT01393405|459225106|FG000|Maintenance Period Week|Lost to Follow-up|0|||
127616847|NCT01393405|459225107|FG001|Maintenance Period Week|Lost to Follow-up|1|||
127616848|NCT01393405|459225108|FG002|Maintenance Period Week|Lost to Follow-up|0|||
127616849|NCT04365699|459225111|FG000|Overall Study|Death|2|||
127616850|NCT04365699|459225112|FG001|Overall Study|Death|5|||
127616851|NCT04365699|459225113|FG002|Overall Study|Death|15|||
127616852|NCT02540954|459225114|FG000|Overall Study|Physician Decision|3|||
127616853|NCT02540954|459225115|FG001|Overall Study|Physician Decision|1|||
127616854|NCT02540954|459225114|FG000|Overall Study|Withdrawal by Subject|6|||
127616855|NCT02540954|459225115|FG001|Overall Study|Withdrawal by Subject|5|||
127616856|NCT02540954|459225114|FG000|Overall Study|Lost to Follow-up|1|||
127616857|NCT02540954|459225115|FG001|Overall Study|Lost to Follow-up|1|||
127616858|NCT02540954|459225114|FG000|Overall Study|Adverse Event|4|||
127616859|NCT02540954|459225115|FG001|Overall Study|Adverse Event|2|||
127616860|NCT02540954|459225114|FG000|Overall Study|Death|0|||
127616861|NCT02540954|459225115|FG001|Overall Study|Death|3|||
127616862|NCT02540954|459225114|FG000|Overall Study|Treatment failure|1|||
127616863|NCT02540954|459225115|FG001|Overall Study|Treatment failure|0|||
127616864|NCT02540954|459225114|FG000|Overall Study|Other reason|4|||
127616865|NCT02540954|459225115|FG001|Overall Study|Other reason|2|||
127616866|NCT00834912|459225118|FG000|Treatment Period 1|Adverse Event|0|||
127616867|NCT00834912|459225119|FG001|Treatment Period 1|Adverse Event|1|||
127616868|NCT00834912|459225120|FG002|Treatment Period 1|Adverse Event|0|||
127616869|NCT00834912|459225121|FG003|Treatment Period 1|Adverse Event|1|||
127616870|NCT00834912|459225122|FG004|Treatment Period 1|Adverse Event|0|||
127616871|NCT00834912|459225123|FG005|Treatment Period 1|Adverse Event|0|||
127616872|NCT00834912|459225118|FG000|Treatment Period 2|Withdrawal by Subject|0|||
127616873|NCT00834912|459225119|FG001|Treatment Period 2|Withdrawal by Subject|0|||
127616874|NCT00834912|459225120|FG002|Treatment Period 2|Withdrawal by Subject|1|||
127791137|NCT02443883|459858972|FG000|Overall Study|Adverse Event|0|||
127791138|NCT02443883|459858973|FG001|Overall Study|Adverse Event|1|||
127791139|NCT02443883|459858974|FG002|Overall Study|Adverse Event|0|||
127791140|NCT02443883|459858975|FG003|Overall Study|Adverse Event|0|||
127791141|NCT02443883|459858972|FG000|Overall Study|Lost to Follow-up|3|||
127791142|NCT02443883|459858973|FG001|Overall Study|Lost to Follow-up|2|||
127791143|NCT02443883|459858974|FG002|Overall Study|Lost to Follow-up|1|||
127791144|NCT02443883|459858975|FG003|Overall Study|Lost to Follow-up|0|||
127791145|NCT02443883|459858972|FG000|Overall Study|Physician Decision|1|||
127791146|NCT02443883|459858973|FG001|Overall Study|Physician Decision|1|||
127791147|NCT02443883|459858974|FG002|Overall Study|Physician Decision|0|||
127791148|NCT02443883|459858975|FG003|Overall Study|Physician Decision|3|||
127791149|NCT02443883|459858972|FG000|Overall Study|Withdrawal by Subject|1|||
127791150|NCT02443883|459858973|FG001|Overall Study|Withdrawal by Subject|0|||
127791151|NCT02443883|459858974|FG002|Overall Study|Withdrawal by Subject|0|||
127791152|NCT02443883|459858975|FG003|Overall Study|Withdrawal by Subject|2|||
127791153|NCT02443883|459858972|FG000|Overall Study|Randomized, but never treated|1|||
127791154|NCT02443883|459858973|FG001|Overall Study|Randomized, but never treated|0|||
127791155|NCT02443883|459858974|FG002|Overall Study|Randomized, but never treated|0|||
127791156|NCT02443883|459858975|FG003|Overall Study|Randomized, but never treated|0|||
127616875|NCT00834912|459225121|FG003|Treatment Period 2|Withdrawal by Subject|0|||
127616876|NCT00834912|459225122|FG004|Treatment Period 2|Withdrawal by Subject|1|||
127616877|NCT00834912|459225123|FG005|Treatment Period 2|Withdrawal by Subject|0|||
127616878|NCT03829046|459225124|FG000|Overall Study|Withdrawal by Subject|1|||
127616879|NCT03829046|459225125|FG001|Overall Study|Withdrawal by Subject|0|||
127616880|NCT00244712|459225134|FG000|Overall Study|Adverse Event|20|||
127616881|NCT00244712|459225135|FG001|Overall Study|Adverse Event|21|||
127616882|NCT00244712|459225134|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
127616883|NCT00244712|459225135|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
127616884|NCT00244712|459225134|FG000|Overall Study|Lack of Compliance|10|||
127791157|NCT00506883|459858987|FG000|Overall Study|Lost to Follow-up|1|||
127791158|NCT00506883|459858988|FG001|Overall Study|Lost to Follow-up|1|||
127616885|NCT00244712|459225135|FG001|Overall Study|Lack of Compliance|11|||
127616886|NCT00244712|459225134|FG000|Overall Study|Lost to Follow-up|45|||
127699893|NCT01369355|459530883|FG005|Long-term Extension (Week 44-272)|Death|0|||
127699894|NCT01369355|459530884|FG006|Long-term Extension (Week 44-272)|Death|0|||
127699895|NCT01369355|459530885|FG007|Long-term Extension (Week 44-272)|Death|1|||
127699896|NCT01369355|459530886|FG008|Long-term Extension (Week 44-272)|Death|3|||
127699897|NCT01369355|459530878|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
127699898|NCT01369355|459530879|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
127699899|NCT01369355|459530880|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
127699900|NCT01369355|459530881|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
127699901|NCT01369355|459530882|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
127699902|NCT01369355|459530883|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
127616887|NCT00244712|459225135|FG001|Overall Study|Lost to Follow-up|52|||
127616888|NCT00244712|459225134|FG000|Overall Study|Withdrawal by Subject|13|||
127616889|NCT00244712|459225135|FG001|Overall Study|Withdrawal by Subject|23|||
127699903|NCT01369355|459530884|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
127699904|NCT01369355|459530885|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
127699905|NCT01369355|459530886|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
127699906|NCT01369355|459530878|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
127699907|NCT01369355|459530879|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
127699908|NCT01369355|459530880|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
127699909|NCT01369355|459530881|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
127699910|NCT01369355|459530882|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
127699911|NCT01369355|459530883|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
127699912|NCT01369355|459530884|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
127699913|NCT01369355|459530885|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
127699914|NCT01369355|459530886|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
127699915|NCT01369355|459530878|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
127699916|NCT01369355|459530879|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
127699917|NCT01369355|459530880|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
127699918|NCT01369355|459530881|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
127699919|NCT01369355|459530882|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
127699920|NCT01369355|459530883|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
127699921|NCT01369355|459530884|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
127699922|NCT01369355|459530885|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
127699923|NCT01369355|459530886|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
127699924|NCT01369355|459530878|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
127699925|NCT01369355|459530879|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
127699926|NCT01369355|459530880|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
127699927|NCT01369355|459530881|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
127699928|NCT01369355|459530882|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
127699929|NCT01369355|459530883|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
127699930|NCT01369355|459530884|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
127699931|NCT01369355|459530885|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
127699932|NCT01369355|459530886|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
127699933|NCT01369355|459530878|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
127699934|NCT01369355|459530879|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
127699935|NCT01369355|459530880|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
127699936|NCT01369355|459530881|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
127699937|NCT01369355|459530882|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
127616890|NCT00244712|459225134|FG000|Overall Study|Protocol Violation, disease progression|13|||
127616891|NCT00244712|459225135|FG001|Overall Study|Protocol Violation, disease progression|11|||
127616892|NCT00500370|459225140|FG000|Overall Study|Adverse Event|9|||
127616893|NCT00500370|459225141|FG001|Overall Study|Adverse Event|3|||
127616894|NCT00500370|459225140|FG000|Overall Study|Lost to Follow-up|10|||
127616895|NCT00500370|459225141|FG001|Overall Study|Lost to Follow-up|10|||
127616896|NCT00500370|459225140|FG000|Overall Study|Protocol Violation|2|||
127616897|NCT00500370|459225141|FG001|Overall Study|Protocol Violation|4|||
127616898|NCT00500370|459225140|FG000|Overall Study|Sponsor Decision|2|||
127616899|NCT00500370|459225141|FG001|Overall Study|Sponsor Decision|0|||
127616900|NCT00500370|459225140|FG000|Overall Study|Subject Decision|10|||
127699938|NCT01369355|459530883|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
127616901|NCT00500370|459225141|FG001|Overall Study|Subject Decision|17|||
127699939|NCT01369355|459530884|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
127791159|NCT00506883|459858989|FG002|Overall Study|Lost to Follow-up|1|||
127791160|NCT00506883|459858987|FG000|Overall Study|Withdrawal by Subject|1|||
127791161|NCT00506883|459858988|FG001|Overall Study|Withdrawal by Subject|0|||
127791162|NCT00506883|459858989|FG002|Overall Study|Withdrawal by Subject|1|||
127791163|NCT00506883|459858987|FG000|Overall Study|Lack of Efficacy|0|||
127791164|NCT00506883|459858988|FG001|Overall Study|Lack of Efficacy|1|||
127616902|NCT02777125|459225144|FG000|Overall Study|Consent form violation|14|||
127616903|NCT02777125|459225145|FG001|Overall Study|Consent form violation|12|||
127616904|NCT02777125|459225144|FG000|Overall Study|Assent form violation|21|||
127616905|NCT02777125|459225145|FG001|Overall Study|Assent form violation|23|||
127616906|NCT02777125|459225144|FG000|Overall Study|Protocol Violation|8|||
127616907|NCT02777125|459225145|FG001|Overall Study|Protocol Violation|12|||
127616908|NCT06023394|459225147|FG000|Overall Study|Surgery was not performed laparoscopically|4|||
127616909|NCT06023394|459225148|FG001|Overall Study|Surgery was not performed laparoscopically|2|||
127616910|NCT06023394|459225147|FG000|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|0|||
127616911|NCT06023394|459225148|FG001|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|3|||
127616912|NCT06023394|459225147|FG000|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|1|||
127616913|NCT06023394|459225148|FG001|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|0|||
127616914|NCT06023394|459225147|FG000|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
127616915|NCT06023394|459225148|FG001|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
127616916|NCT02283788|459225150|FG000|Overall Study|Adverse Event|1|||
127616917|NCT02283788|459225151|FG001|Overall Study|Adverse Event|3|||
127616918|NCT02283788|459225152|FG002|Overall Study|Adverse Event|5|||
127616919|NCT02283788|459225153|FG003|Overall Study|Adverse Event|1|||
127616920|NCT02283788|459225150|FG000|Overall Study|Withdrawal by Subject|0|||
127616921|NCT02283788|459225151|FG001|Overall Study|Withdrawal by Subject|1|||
127616922|NCT02283788|459225152|FG002|Overall Study|Withdrawal by Subject|0|||
127616923|NCT02283788|459225153|FG003|Overall Study|Withdrawal by Subject|1|||
127616924|NCT01945489|459226708|FG000|Cycle 1|Adverse Event|2|||
127616925|NCT01945489|459226709|FG001|Cycle 1|Adverse Event|0|||
127616926|NCT01945489|459226708|FG000|Cycle 1|Lost to Follow-up|4|||
127616927|NCT01945489|459226709|FG001|Cycle 1|Lost to Follow-up|0|||
127616928|NCT01945489|459226708|FG000|Cycle 1|Personal Reasons|4|||
127616929|NCT01945489|459226709|FG001|Cycle 1|Personal Reasons|2|||
127616930|NCT01945489|459226708|FG000|Cycle 1|Protocol Violation|0|||
127616931|NCT01945489|459226709|FG001|Cycle 1|Protocol Violation|1|||
127616932|NCT01945489|459226708|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
127616933|NCT01945489|459226709|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
127616934|NCT01945489|459226708|FG000|Cycle 2|Adverse Event|1|||
127616935|NCT01945489|459226709|FG001|Cycle 2|Adverse Event|0|||
127616936|NCT01945489|459226708|FG000|Cycle 2|Lost to Follow-up|0|||
127616937|NCT01945489|459226709|FG001|Cycle 2|Lost to Follow-up|1|||
127616938|NCT03569371|459226710|FG000|Overall Study|Lack of Efficacy|1|||
127616939|NCT03569371|459226710|FG000|Overall Study|Lost to Follow-up|1|||
127616940|NCT03569371|459226710|FG000|Overall Study|Adverse Event|1|||
127616941|NCT01236755|459226711|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
127616942|NCT01236755|459226711|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
127616943|NCT01236755|459226711|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
127616944|NCT01236755|459226711|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
127616945|NCT04904185|459226712|FG000|Overall Study|Expansion failure|1|||
127616946|NCT04904185|459226713|FG001|Overall Study|Expansion failure|0|||
127616947|NCT04904185|459226712|FG000|Overall Study|Late response on prior treatment|1|||
127616948|NCT04904185|459226713|FG001|Overall Study|Late response on prior treatment|0|||
127616949|NCT02433834|459226717|FG000|Overall Study|Protocol-specified criteria|7|||
127616950|NCT02433834|459226717|FG000|Overall Study|Protocol Violation|3|||
127616951|NCT02433834|459226717|FG000|Overall Study|Lost to Follow-up|6|||
127616952|NCT02433834|459226717|FG000|Overall Study|Withdrawal by Subject|14|||
127616953|NCT02433834|459226717|FG000|Overall Study|Adverse Event|6|||
127616954|NCT02433834|459226717|FG000|Overall Study|Physician Decision|1|||
127616955|NCT01539226|459226718|FG000|Overall Study|Withdrawal by Subject|24|||
127616956|NCT01539226|459226719|FG001|Overall Study|Withdrawal by Subject|54|||
127616957|NCT01539226|459226718|FG000|Overall Study|Lost to Follow-up|20|||
127616958|NCT01539226|459226719|FG001|Overall Study|Lost to Follow-up|54|||
127616959|NCT01539226|459226718|FG000|Overall Study|Death|1|||
127616960|NCT01539226|459226719|FG001|Overall Study|Death|2|||
127616961|NCT01539226|459226718|FG000|Overall Study|Adverse Event|2|||
127616962|NCT01539226|459226719|FG001|Overall Study|Adverse Event|0|||
127616963|NCT01539226|459226718|FG000|Overall Study|Pregnancy|13|||
127616964|NCT01539226|459226719|FG001|Overall Study|Pregnancy|29|||
127616965|NCT01539226|459226718|FG000|Overall Study|inappropriate enrollment|0|||
127616966|NCT01539226|459226719|FG001|Overall Study|inappropriate enrollment|1|||
127616967|NCT01539226|459226718|FG000|Overall Study|Multiple Reasons|3|||
127616968|NCT01539226|459226719|FG001|Overall Study|Multiple Reasons|1|||
127616969|NCT01539226|459226718|FG000|Overall Study|not HIV seroconversion-related|93|||
127616970|NCT01539226|459226719|FG001|Overall Study|not HIV seroconversion-related|176|||
127616971|NCT01539226|459226718|FG000|Overall Study|HIV seroconversion-related|55|||
127616972|NCT01539226|459226719|FG001|Overall Study|HIV seroconversion-related|80|||
127616973|NCT01539226|459226718|FG000|Overall Study|Non-compliance|6|||
127616974|NCT01539226|459226719|FG001|Overall Study|Non-compliance|8|||
127616975|NCT02643251|459226720|FG000|Overall Study|Adverse Event|3|||
127616976|NCT02643251|459226721|FG001|Overall Study|Adverse Event|1|||
127616977|NCT02643251|459226720|FG000|Overall Study|Withdrawal by Subject|2|||
127616978|NCT02643251|459226721|FG001|Overall Study|Withdrawal by Subject|0|||
127616979|NCT02643251|459226720|FG000|Overall Study|Lost to Follow-up|4|||
127616980|NCT02643251|459226721|FG001|Overall Study|Lost to Follow-up|1|||
127616981|NCT02643251|459226720|FG000|Overall Study|Protocol Violation|1|||
127616982|NCT02643251|459226721|FG001|Overall Study|Protocol Violation|0|||
127616983|NCT02643251|459226720|FG000|Overall Study|PI Decision to terminate patient|1|||
127616984|NCT02643251|459226721|FG001|Overall Study|PI Decision to terminate patient|0|||
127616985|NCT00348556|459226724|FG000|Overall Study|Adverse Event|1|||
127616986|NCT00333229|459226725|FG000|Overall Study|Lack of Efficacy|0|||
127616987|NCT00333229|459226726|FG001|Overall Study|Lack of Efficacy|1|||
127616988|NCT01944059|459226727|FG000|Overall Study|Lost to Follow-up|1|||
127616989|NCT01944059|459226727|FG000|Overall Study|Physician Decision|3|||
127616990|NCT01944059|459226727|FG000|Overall Study|Withdrawal by Subject|1|||
127616991|NCT01944059|459226727|FG000|Overall Study|Adverse Event|2|||
127616992|NCT00463060|459226734|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
127616993|NCT00463060|459226734|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
127616994|NCT05923229|459226737|FG000|Overall Study|Withdrawal by Subject|3|||
127616995|NCT05923229|459226738|FG001|Overall Study|Withdrawal by Subject|0|||
127616996|NCT05923229|459226737|FG000|Overall Study|Health related|2|||
127616997|NCT05923229|459226738|FG001|Overall Study|Health related|1|||
127616998|NCT03064126|459226739|FG000|Overall Study|Death|40|||
127616999|NCT03064126|459226740|FG001|Overall Study|Death|16|||
127617000|NCT03064126|459226741|FG002|Overall Study|Death|4|||
127617001|NCT03064126|459226742|FG003|Overall Study|Death|2|||
127617002|NCT03064126|459226739|FG000|Overall Study|Withdrawal by Subject|17|||
127617003|NCT03064126|459226740|FG001|Overall Study|Withdrawal by Subject|9|||
127617004|NCT03064126|459226741|FG002|Overall Study|Withdrawal by Subject|0|||
127617005|NCT03064126|459226742|FG003|Overall Study|Withdrawal by Subject|2|||
127617006|NCT03064126|459226739|FG000|Overall Study|Lost to Follow-up|7|||
127617007|NCT03064126|459226740|FG001|Overall Study|Lost to Follow-up|3|||
127617008|NCT03064126|459226741|FG002|Overall Study|Lost to Follow-up|0|||
127617009|NCT03064126|459226742|FG003|Overall Study|Lost to Follow-up|0|||
127617010|NCT03064126|459226739|FG000|Overall Study|Adverse Event|2|||
127617011|NCT03064126|459226740|FG001|Overall Study|Adverse Event|0|||
127617012|NCT03064126|459226741|FG002|Overall Study|Adverse Event|0|||
127617013|NCT03064126|459226742|FG003|Overall Study|Adverse Event|0|||
127617014|NCT03064126|459226739|FG000|Overall Study|Physician Decision|3|||
127617015|NCT03064126|459226740|FG001|Overall Study|Physician Decision|0|||
127617016|NCT03064126|459226741|FG002|Overall Study|Physician Decision|0|||
127617017|NCT03064126|459226742|FG003|Overall Study|Physician Decision|0|||
127617018|NCT03064126|459226739|FG000|Overall Study|Other reason for early termination|3|||
127617019|NCT03064126|459226740|FG001|Overall Study|Other reason for early termination|2|||
127617020|NCT03064126|459226741|FG002|Overall Study|Other reason for early termination|0|||
127617021|NCT03064126|459226742|FG003|Overall Study|Other reason for early termination|0|||
127617022|NCT03064126|459226739|FG000|Overall Study|Missed Visit|3|||
127617023|NCT03064126|459226740|FG001|Overall Study|Missed Visit|1|||
127617024|NCT03064126|459226741|FG002|Overall Study|Missed Visit|0|||
127617025|NCT03064126|459226742|FG003|Overall Study|Missed Visit|0|||
127617026|NCT05288556|459226746|FG000|Overall Study|Protocol Violation|1|||
127617027|NCT05288556|459226746|FG000|Overall Study|Withdrawal by Subject|1|||
127617028|NCT02775344|459226748|FG000|Overall Study|No ovarian cyst identified|3|||
127617029|NCT02775344|459226749|FG001|Overall Study|No ovarian cyst identified|2|||
127617030|NCT04627064|459226750|FG000|Overall Study|Progressive disease|8|||
127617031|NCT04627064|459226751|FG001|Overall Study|Progressive disease|0|||
127617032|NCT04627064|459226750|FG000|Overall Study|Withdrawal by Subject|2|||
127617033|NCT04627064|459226751|FG001|Overall Study|Withdrawal by Subject|0|||
127617034|NCT04627064|459226750|FG000|Overall Study|Physician Decision|1|||
127617035|NCT04627064|459226751|FG001|Overall Study|Physician Decision|0|||
127617036|NCT03491150|459226752|FG000|Overall Study|Adverse Event|1|||
127617037|NCT03491150|459226753|FG001|Overall Study|Adverse Event|0|||
127617038|NCT03491150|459226752|FG000|Overall Study|Study Terminated by Sponsor|74|||
127617039|NCT03491150|459226753|FG001|Overall Study|Study Terminated by Sponsor|70|||
127617040|NCT03491150|459226752|FG000|Overall Study|Other|0|||
127617041|NCT03491150|459226753|FG001|Overall Study|Other|1|||
127617042|NCT03491150|459226752|FG000|Overall Study|Withdrawal by Subject|1|||
127617043|NCT03491150|459226753|FG001|Overall Study|Withdrawal by Subject|2|||
127617044|NCT01800916|459226754|FG000|Test Period 1 (1 Week)|Convex product user|0|||
127617045|NCT01800916|459226755|FG001|Test Period 1 (1 Week)|Convex product user|0|||
127617046|NCT01800916|459226756|FG002|Test Period 1 (1 Week)|Convex product user|0|||
127617047|NCT01800916|459226757|FG003|Test Period 1 (1 Week)|Convex product user|1|||
127617048|NCT01800916|459226758|FG004|Test Period 1 (1 Week)|Convex product user|0|||
127617049|NCT01800916|459226759|FG005|Test Period 1 (1 Week)|Convex product user|0|||
127617050|NCT01800916|459226760|FG006|Test Period 1 (1 Week)|Convex product user|0|||
127617051|NCT01800916|459226761|FG007|Test Period 1 (1 Week)|Convex product user|0|||
127617052|NCT01800916|459226762|FG008|Test Period 1 (1 Week)|Convex product user|0|||
127617053|NCT01800916|459226754|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
127617054|NCT01800916|459226755|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
127617055|NCT01800916|459226756|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
127617056|NCT01800916|459226757|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
127617057|NCT01800916|459226758|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
127617058|NCT01800916|459226759|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
127617059|NCT01800916|459226760|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
127617060|NCT01800916|459226761|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
127617061|NCT01800916|459226762|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
127617062|NCT00727714|459226763|FG000|Overall Study|Lost to Follow-up|2|||
127617063|NCT00325234|459226766|FG000|Overall Study|Adverse Event|10|||
127617064|NCT00325234|459226767|FG001|Overall Study|Adverse Event|7|||
127617065|NCT00325234|459226766|FG000|Overall Study|Death due to Study Disease|1|||
127617066|NCT00325234|459226767|FG001|Overall Study|Death due to Study Disease|0|||
127617067|NCT00325234|459226766|FG000|Overall Study|Entry Criteria Not Met|1|||
127617068|NCT00325234|459226767|FG001|Overall Study|Entry Criteria Not Met|2|||
127617069|NCT00325234|459226766|FG000|Overall Study|Subject Decision|6|||
127617070|NCT00325234|459226767|FG001|Overall Study|Subject Decision|8|||
127617071|NCT00325234|459226766|FG000|Overall Study|Physician Decision|17|||
127617072|NCT00325234|459226767|FG001|Overall Study|Physician Decision|12|||
127617073|NCT00325234|459226766|FG000|Overall Study|Progressive Disease|34|||
127617074|NCT00325234|459226767|FG001|Overall Study|Progressive Disease|37|||
127617075|NCT01234467|459226768|FG000|Overall Study|Adverse Event|3|||
127617076|NCT01234467|459226768|FG000|Overall Study|Death|2|||
127617077|NCT01234467|459226768|FG000|Overall Study|Withdrawal by Subject|2|||
127617078|NCT01234467|459226768|FG000|Overall Study|Disease Progression|2|||
127617079|NCT01234467|459226768|FG000|Overall Study|Clinical deterioration|1|||
127617080|NCT01234467|459226768|FG000|Overall Study|Physician Decision|1|||
127617081|NCT01234467|459226768|FG000|Overall Study|Other complicating disease (stroke)|1|||
127617082|NCT00559962|459226771|FG000|Overall Study|Adverse Event|1|||
127617083|NCT00559962|459226772|FG001|Overall Study|Adverse Event|7|||
127617084|NCT00559962|459226773|FG002|Overall Study|Adverse Event|8|||
127617085|NCT00559962|459226774|FG003|Overall Study|Adverse Event|5|||
127617086|NCT00559962|459226775|FG004|Overall Study|Adverse Event|11|||
127617087|NCT00559962|459226776|FG005|Overall Study|Adverse Event|4|||
127617088|NCT00559962|459226777|FG006|Overall Study|Adverse Event|4|||
127617089|NCT00559962|459226778|FG007|Overall Study|Adverse Event|2|||
127617090|NCT00559962|459226771|FG000|Overall Study|Lost to Follow-up|0|||
127617091|NCT00559962|459226772|FG001|Overall Study|Lost to Follow-up|1|||
127617092|NCT00559962|459226773|FG002|Overall Study|Lost to Follow-up|0|||
127617093|NCT00559962|459226774|FG003|Overall Study|Lost to Follow-up|0|||
127617094|NCT00559962|459226775|FG004|Overall Study|Lost to Follow-up|0|||
127617095|NCT00559962|459226776|FG005|Overall Study|Lost to Follow-up|0|||
127617096|NCT00559962|459226777|FG006|Overall Study|Lost to Follow-up|0|||
127617097|NCT00559962|459226778|FG007|Overall Study|Lost to Follow-up|0|||
127617098|NCT00559962|459226771|FG000|Overall Study|Withdrawal by Subject|1|||
127617099|NCT00559962|459226772|FG001|Overall Study|Withdrawal by Subject|1|||
127617100|NCT00559962|459226773|FG002|Overall Study|Withdrawal by Subject|2|||
127617101|NCT00559962|459226774|FG003|Overall Study|Withdrawal by Subject|0|||
127617102|NCT00559962|459226775|FG004|Overall Study|Withdrawal by Subject|3|||
127617103|NCT00559962|459226776|FG005|Overall Study|Withdrawal by Subject|1|||
127617104|NCT00559962|459226777|FG006|Overall Study|Withdrawal by Subject|0|||
127617105|NCT00559962|459226778|FG007|Overall Study|Withdrawal by Subject|2|||
127617106|NCT00559962|459226771|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
127617107|NCT00559962|459226772|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
127699940|NCT01369355|459530885|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
127617108|NCT00559962|459226773|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
127617109|NCT00559962|459226774|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
127617110|NCT00559962|459226775|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
127617111|NCT00559962|459226776|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
127617112|NCT00559962|459226777|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
127617113|NCT00559962|459226778|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
127617114|NCT01479621|459226779|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
127617115|NCT01479621|459226780|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
127617116|NCT01479621|459226781|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
127617117|NCT01479621|459226782|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
127617118|NCT01479621|459226783|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
127617119|NCT01479621|459226784|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
127617120|NCT01479621|459226785|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
127617121|NCT01479621|459226779|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
127617122|NCT01479621|459226780|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
127617123|NCT01479621|459226781|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
127617124|NCT01479621|459226782|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
127617125|NCT01479621|459226783|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
127617126|NCT01479621|459226784|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
127617127|NCT01479621|459226785|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
127617128|NCT01479621|459226779|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
127617129|NCT01479621|459226780|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
127617130|NCT01479621|459226781|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
127617131|NCT01479621|459226782|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
127617132|NCT01479621|459226783|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
127617133|NCT01479621|459226784|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
127617134|NCT01479621|459226785|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
127617135|NCT01479621|459226779|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
127617136|NCT01479621|459226780|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
127617137|NCT01479621|459226781|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
127617138|NCT01479621|459226782|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
127617139|NCT01479621|459226783|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
127617140|NCT01479621|459226784|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
127617141|NCT01479621|459226785|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
127617142|NCT01479621|459226779|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
127617143|NCT01479621|459226780|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
127617144|NCT01479621|459226781|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
127617145|NCT01479621|459226782|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
127617146|NCT01479621|459226783|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
127617147|NCT01479621|459226784|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
127617148|NCT01479621|459226785|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
127617149|NCT01479621|459226779|FG000|Treatment Period|Adverse Event|0|||
127617150|NCT01479621|459226780|FG001|Treatment Period|Adverse Event|0|||
127617151|NCT01479621|459226781|FG002|Treatment Period|Adverse Event|0|||
127617152|NCT01479621|459226782|FG003|Treatment Period|Adverse Event|0|||
127617153|NCT01479621|459226783|FG004|Treatment Period|Adverse Event|1|||
127617154|NCT01479621|459226784|FG005|Treatment Period|Adverse Event|2|||
127617155|NCT01479621|459226785|FG006|Treatment Period|Adverse Event|2|||
127617156|NCT01479621|459226779|FG000|Treatment Period|Withdrawal by Subject|0|||
127617157|NCT01479621|459226780|FG001|Treatment Period|Withdrawal by Subject|4|||
127617158|NCT01479621|459226781|FG002|Treatment Period|Withdrawal by Subject|2|||
127617159|NCT01479621|459226782|FG003|Treatment Period|Withdrawal by Subject|2|||
127617160|NCT01479621|459226783|FG004|Treatment Period|Withdrawal by Subject|5|||
127617161|NCT01479621|459226784|FG005|Treatment Period|Withdrawal by Subject|5|||
127617162|NCT01479621|459226785|FG006|Treatment Period|Withdrawal by Subject|1|||
127617163|NCT01479621|459226779|FG000|Treatment Period|Physician Decision|0|||
127699941|NCT01369355|459530886|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
127617164|NCT01479621|459226780|FG001|Treatment Period|Physician Decision|0|||
127617165|NCT01479621|459226781|FG002|Treatment Period|Physician Decision|0|||
127617166|NCT01479621|459226782|FG003|Treatment Period|Physician Decision|0|||
127617167|NCT01479621|459226783|FG004|Treatment Period|Physician Decision|1|||
127617168|NCT01479621|459226784|FG005|Treatment Period|Physician Decision|1|||
127617169|NCT01479621|459226785|FG006|Treatment Period|Physician Decision|0|||
127617170|NCT01479621|459226779|FG000|Treatment Period|Non-compliance to study drug|0|||
127617171|NCT01479621|459226780|FG001|Treatment Period|Non-compliance to study drug|1|||
127617172|NCT01479621|459226781|FG002|Treatment Period|Non-compliance to study drug|0|||
127617173|NCT01479621|459226782|FG003|Treatment Period|Non-compliance to study drug|0|||
127617174|NCT01479621|459226783|FG004|Treatment Period|Non-compliance to study drug|0|||
127617175|NCT01479621|459226784|FG005|Treatment Period|Non-compliance to study drug|0|||
127617176|NCT01479621|459226785|FG006|Treatment Period|Non-compliance to study drug|1|||
127617177|NCT01479621|459226779|FG000|Treatment Period|Protocol Violation|0|||
127617178|NCT01479621|459226780|FG001|Treatment Period|Protocol Violation|9|||
127617179|NCT01479621|459226781|FG002|Treatment Period|Protocol Violation|6|||
127617180|NCT01479621|459226782|FG003|Treatment Period|Protocol Violation|5|||
127617181|NCT01479621|459226783|FG004|Treatment Period|Protocol Violation|2|||
127617182|NCT01479621|459226784|FG005|Treatment Period|Protocol Violation|10|||
127617183|NCT01479621|459226785|FG006|Treatment Period|Protocol Violation|6|||
127617184|NCT01479621|459226779|FG000|Treatment Period|Pregnancy|0|||
127617185|NCT01479621|459226780|FG001|Treatment Period|Pregnancy|0|||
127617186|NCT01479621|459226781|FG002|Treatment Period|Pregnancy|2|||
127699942|NCT01369355|459530878|FG000|Long-term Extension (Week 44-272)|Other|0|||
127699943|NCT01369355|459530879|FG001|Long-term Extension (Week 44-272)|Other|0|||
127699944|NCT01369355|459530880|FG002|Long-term Extension (Week 44-272)|Other|0|||
127699945|NCT01369355|459530881|FG003|Long-term Extension (Week 44-272)|Other|0|||
127699946|NCT01369355|459530882|FG004|Long-term Extension (Week 44-272)|Other|0|||
127699947|NCT01369355|459530883|FG005|Long-term Extension (Week 44-272)|Other|0|||
127699948|NCT01369355|459530884|FG006|Long-term Extension (Week 44-272)|Other|110|||
127699949|NCT01369355|459530885|FG007|Long-term Extension (Week 44-272)|Other|9|||
127699950|NCT01369355|459530886|FG008|Long-term Extension (Week 44-272)|Other|17|||
127884354|NCT03402126|460199908|FG000|Overall Study|Study product no longer in use|1|||
127884355|NCT03402126|460199908|FG000|Overall Study|Technical problems|1|||
127884356|NCT03402126|460199908|FG000|Overall Study|Withdrawal by Subject|6|||
127884357|NCT03402126|460199908|FG000|Overall Study|Physician Decision|2|||
127884358|NCT03402126|460199908|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
127884359|NCT03402126|460199908|FG000|Overall Study|Death|4|||
127884360|NCT02117479|460199909|FG000|Overall Study|Death|13|||
127617187|NCT01479621|459226782|FG003|Treatment Period|Pregnancy|0|||
127617188|NCT01479621|459226783|FG004|Treatment Period|Pregnancy|0|||
127617189|NCT01479621|459226784|FG005|Treatment Period|Pregnancy|0|||
127617190|NCT01479621|459226785|FG006|Treatment Period|Pregnancy|0|||
127617191|NCT01479621|459226779|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
127617192|NCT01479621|459226780|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
127617193|NCT01479621|459226781|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
127617194|NCT01479621|459226782|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
127617195|NCT01479621|459226783|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
127617196|NCT01479621|459226784|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
127617197|NCT01479621|459226785|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
127617198|NCT01479621|459226779|FG000|Treatment Period|Lost to Follow-up|0|||
127617199|NCT01479621|459226780|FG001|Treatment Period|Lost to Follow-up|0|||
127617200|NCT01479621|459226781|FG002|Treatment Period|Lost to Follow-up|1|||
127617201|NCT01479621|459226782|FG003|Treatment Period|Lost to Follow-up|0|||
127617202|NCT01479621|459226783|FG004|Treatment Period|Lost to Follow-up|2|||
127617203|NCT01479621|459226784|FG005|Treatment Period|Lost to Follow-up|2|||
127617204|NCT01479621|459226785|FG006|Treatment Period|Lost to Follow-up|1|||
127617205|NCT01479621|459226779|FG000|Treatment Period|Met stopping criteria|0|||
127617206|NCT01479621|459226780|FG001|Treatment Period|Met stopping criteria|8|||
127617207|NCT01479621|459226781|FG002|Treatment Period|Met stopping criteria|7|||
127617208|NCT01479621|459226782|FG003|Treatment Period|Met stopping criteria|4|||
127617209|NCT01479621|459226783|FG004|Treatment Period|Met stopping criteria|9|||
127617210|NCT01479621|459226784|FG005|Treatment Period|Met stopping criteria|20|||
127617211|NCT01479621|459226785|FG006|Treatment Period|Met stopping criteria|6|||
127617212|NCT00486265|459226789|FG000|Overall Study|Adverse Event|1|||
127617213|NCT00486265|459226789|FG000|Overall Study|Lack of Efficacy|8|||
127617214|NCT03047135|459226790|FG000|Overall Study|Still being treated|3|||
127617215|NCT02244580|459226797|FG000|Overall Study|No cancer tissues available|241|||
127617216|NCT02722928|459226798|FG000|Overall Study|Standard CT was not as required per prot|5|||
127617217|NCT02722928|459226799|FG001|Overall Study|Standard CT was not as required per prot|13|||
127617218|NCT02722928|459226798|FG000|Overall Study|Required Intraoperative MRI|5|||
127617219|NCT02722928|459226799|FG001|Overall Study|Required Intraoperative MRI|7|||
127617220|NCT03571516|459226800|FG000|Overall Study|Severe diarrhea|1|||
127617221|NCT03571516|459226801|FG001|Overall Study|Severe diarrhea|0|||
127617222|NCT03571516|459226800|FG000|Overall Study|Withdrawal by Subject|0|||
127617223|NCT03571516|459226801|FG001|Overall Study|Withdrawal by Subject|1|||
127699951|NCT01902173|459530887|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
127699952|NCT01902173|459530888|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
127699953|NCT01902173|459530889|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
127884361|NCT02117479|460199910|FG001|Overall Study|Death|8|||
127617224|NCT04011410|459226802|FG000|Overall Study|Withdrawal by Subject|1|||
127617225|NCT01838642|459226804|FG000|Overall Study|Died on study|1|||
127617226|NCT01398956|459226806|FG000|Overall Study|Withdrawal by Subject|4|||
127617227|NCT01398956|459226806|FG000|Overall Study|AE, non-serious non-fatal|4|||
127617228|NCT01398956|459226806|FG000|Overall Study|Withdrawal Criteria No.3|1|||
127617229|NCT01398956|459226806|FG000|Overall Study|Subject moved a long distance|1|||
127617230|NCT01557400|459226807|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
127617231|NCT01557400|459226807|FG000|Overall Study|Adverse Event|3|||
127699954|NCT01902173|459530890|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
127699955|NCT01902173|459530891|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
127699956|NCT01902173|459530892|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
127699957|NCT01902173|459530887|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
127699958|NCT01902173|459530888|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
127699959|NCT01902173|459530889|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
127617232|NCT01557400|459226807|FG000|Overall Study|Lost to Follow-up|5|||
127617233|NCT01557400|459226807|FG000|Overall Study|Withdrawal by Subject|9|||
127617234|NCT02281552|459226808|FG000|Overall Study|Medication error|1|||
127617235|NCT02281552|459226809|FG001|Overall Study|Medication error|0|||
127617236|NCT02281552|459226808|FG000|Overall Study|Insufficient clinical response|0|||
127617237|NCT02281552|459226809|FG001|Overall Study|Insufficient clinical response|1|||
127617238|NCT02281552|459226808|FG000|Overall Study|Adverse Event|3|||
127617239|NCT02281552|459226809|FG001|Overall Study|Adverse Event|9|||
127617240|NCT01224639|459226812|FG000|Overall Study|Withdrawal by Subject|0|||
127617241|NCT01224639|459226813|FG001|Overall Study|Withdrawal by Subject|0|||
127699960|NCT01902173|459530890|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
127699961|NCT01902173|459530891|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
127699962|NCT01902173|459530892|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
127791165|NCT00506883|459858989|FG002|Overall Study|Lack of Efficacy|1|||
127791166|NCT00506883|459858987|FG000|Overall Study|Other|5|||
127791167|NCT00506883|459858988|FG001|Overall Study|Other|1|||
127791168|NCT00506883|459858989|FG002|Overall Study|Other|1|||
127791169|NCT01445951|459858990|FG000|Overall Study|Adverse Event|16|||
127791170|NCT01445951|459858991|FG001|Overall Study|Adverse Event|9|||
127791171|NCT01445951|459858992|FG002|Overall Study|Adverse Event|0|||
127791172|NCT01445951|459858990|FG000|Overall Study|Protocol Violation|2|||
127791173|NCT01445951|459858991|FG001|Overall Study|Protocol Violation|2|||
127791174|NCT01445951|459858992|FG002|Overall Study|Protocol Violation|2|||
127791175|NCT01445951|459858990|FG000|Overall Study|Withdrawal by Subject|21|||
127791176|NCT01445951|459858991|FG001|Overall Study|Withdrawal by Subject|16|||
127791177|NCT01445951|459858992|FG002|Overall Study|Withdrawal by Subject|8|||
127791178|NCT01445951|459858990|FG000|Overall Study|Physician Decision|3|||
127791179|NCT01445951|459858991|FG001|Overall Study|Physician Decision|1|||
127791180|NCT01445951|459858992|FG002|Overall Study|Physician Decision|0|||
127791181|NCT01445951|459858990|FG000|Overall Study|Lost to Follow-up|1|||
127791182|NCT01445951|459858991|FG001|Overall Study|Lost to Follow-up|2|||
127791183|NCT01445951|459858992|FG002|Overall Study|Lost to Follow-up|4|||
127791184|NCT01445951|459858990|FG000|Overall Study|Pregnancy|0|||
127791185|NCT01445951|459858991|FG001|Overall Study|Pregnancy|1|||
127791186|NCT01445951|459858992|FG002|Overall Study|Pregnancy|4|||
127791187|NCT01445951|459858990|FG000|Overall Study|Death|0|||
127791188|NCT01445951|459858991|FG001|Overall Study|Death|0|||
127791189|NCT01445951|459858992|FG002|Overall Study|Death|1|||
127791190|NCT01445951|459858990|FG000|Overall Study|Non-compliance with study drug|1|||
127791191|NCT01445951|459858991|FG001|Overall Study|Non-compliance with study drug|2|||
127791192|NCT01445951|459858992|FG002|Overall Study|Non-compliance with study drug|0|||
127791193|NCT01445951|459858990|FG000|Overall Study|Non-compliance with protocol|0|||
127791194|NCT01445951|459858991|FG001|Overall Study|Non-compliance with protocol|1|||
127791195|NCT01445951|459858992|FG002|Overall Study|Non-compliance with protocol|0|||
127791196|NCT01445951|459858990|FG000|Overall Study|Sponsor decision - subject travel|0|||
127791197|NCT01445951|459858991|FG001|Overall Study|Sponsor decision - subject travel|1|||
127791198|NCT01445951|459858992|FG002|Overall Study|Sponsor decision - subject travel|0|||
127791199|NCT01445951|459858990|FG000|Overall Study|Cough|0|||
127791200|NCT01445951|459858991|FG001|Overall Study|Cough|1|||
127791201|NCT01445951|459858992|FG002|Overall Study|Cough|0|||
127791202|NCT00531752|459858997|FG000|First Double-blind Intervention Period|Adverse Event|2|||
127791203|NCT00531752|459858998|FG001|First Double-blind Intervention Period|Adverse Event|0|||
127791204|NCT00531752|459858999|FG002|First Double-blind Intervention Period|Adverse Event|1|||
127791205|NCT00531752|459859000|FG003|First Double-blind Intervention Period|Adverse Event|1|||
127791206|NCT00531752|459858997|FG000|First Double-blind Intervention Period|Other|1|||
127791207|NCT00531752|459858998|FG001|First Double-blind Intervention Period|Other|4|||
127791208|NCT00531752|459858999|FG002|First Double-blind Intervention Period|Other|4|||
127617242|NCT01224639|459226814|FG002|Overall Study|Withdrawal by Subject|0|||
127791209|NCT00531752|459859000|FG003|First Double-blind Intervention Period|Other|0|||
127791210|NCT00531752|459858997|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
127791211|NCT00531752|459858998|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
127617243|NCT01224639|459226815|FG003|Overall Study|Withdrawal by Subject|0|||
127617244|NCT01224639|459226816|FG004|Overall Study|Withdrawal by Subject|2|||
127617245|NCT01224639|459226817|FG005|Overall Study|Withdrawal by Subject|0|||
127617246|NCT01224639|459226818|FG006|Overall Study|Withdrawal by Subject|1|||
127617247|NCT01224639|459226819|FG007|Overall Study|Withdrawal by Subject|1|||
127617248|NCT01224639|459226812|FG000|Overall Study|Adverse Event|0|||
127617249|NCT01224639|459226813|FG001|Overall Study|Adverse Event|0|||
127617250|NCT01224639|459226814|FG002|Overall Study|Adverse Event|0|||
127617251|NCT01224639|459226815|FG003|Overall Study|Adverse Event|0|||
127617252|NCT01224639|459226816|FG004|Overall Study|Adverse Event|0|||
127617253|NCT01224639|459226817|FG005|Overall Study|Adverse Event|0|||
127617254|NCT01224639|459226818|FG006|Overall Study|Adverse Event|0|||
127617255|NCT01224639|459226819|FG007|Overall Study|Adverse Event|1|||
127617256|NCT03465878|459226820|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
127617257|NCT03465878|459226821|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
127617258|NCT03465878|459226822|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
127617259|NCT03465878|459226823|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
127617260|NCT03465878|459226820|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
127617261|NCT03465878|459226821|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
127617262|NCT03465878|459226822|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
127617263|NCT03465878|459226823|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
127617264|NCT03465878|459226820|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
127617265|NCT03465878|459226821|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
127617266|NCT03465878|459226822|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
127617267|NCT03465878|459226823|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
127617268|NCT04656132|459226824|FG000|Overall Study|Lost to Follow-up|4|||
127617269|NCT04656132|459226824|FG000|Overall Study|Lost to Follow-Up Prior to Baseline Data Collection|4|||
127617270|NCT00677807|459226825|FG000|Overall Study|Adverse Event|4|||
127617271|NCT00677807|459226826|FG001|Overall Study|Adverse Event|1|||
127617272|NCT00677807|459226827|FG002|Overall Study|Adverse Event|6|||
127617273|NCT00677807|459226825|FG000|Overall Study|Lack of Efficacy|0|||
127617274|NCT00677807|459226826|FG001|Overall Study|Lack of Efficacy|0|||
127617275|NCT00677807|459226827|FG002|Overall Study|Lack of Efficacy|2|||
127617276|NCT00677807|459226825|FG000|Overall Study|Participant no longer needs study drug|0|||
127617277|NCT00677807|459226826|FG001|Overall Study|Participant no longer needs study drug|0|||
127617278|NCT00677807|459226827|FG002|Overall Study|Participant no longer needs study drug|1|||
127617279|NCT00677807|459226825|FG000|Overall Study|Withdrawal by Subject|10|||
127617280|NCT00677807|459226826|FG001|Overall Study|Withdrawal by Subject|3|||
127617281|NCT00677807|459226827|FG002|Overall Study|Withdrawal by Subject|6|||
127617282|NCT00677807|459226825|FG000|Overall Study|Lost to Follow-up|2|||
127617283|NCT00677807|459226826|FG001|Overall Study|Lost to Follow-up|2|||
127617284|NCT00677807|459226827|FG002|Overall Study|Lost to Follow-up|2|||
127617285|NCT00677807|459226825|FG000|Overall Study|Administrative problems|1|||
127617286|NCT00677807|459226826|FG001|Overall Study|Administrative problems|1|||
127617287|NCT00677807|459226827|FG002|Overall Study|Administrative problems|2|||
127617288|NCT00677807|459226825|FG000|Overall Study|Death|0|||
127617289|NCT00677807|459226826|FG001|Overall Study|Death|1|||
127617290|NCT00677807|459226827|FG002|Overall Study|Death|1|||
127617291|NCT00677807|459226825|FG000|Overall Study|Protocol Deviation|1|||
127617292|NCT00677807|459226826|FG001|Overall Study|Protocol Deviation|3|||
127617293|NCT00677807|459226827|FG002|Overall Study|Protocol Deviation|0|||
127617294|NCT04019041|459226828|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
127617295|NCT04019041|459226829|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
127617296|NCT04019041|459226830|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
127617297|NCT04019041|459226831|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
127617298|NCT04019041|459226832|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
127617299|NCT04019041|459226833|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
127617300|NCT04019041|459226828|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
127617301|NCT04019041|459226829|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
127617302|NCT04019041|459226830|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
127884362|NCT02117479|460199909|FG000|Overall Study|Adverse Event|8|||
127617303|NCT04019041|459226831|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
127617304|NCT04019041|459226832|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
127617305|NCT04019041|459226833|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
127617306|NCT04019041|459226828|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
127699963|NCT01902173|459530887|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
127699964|NCT01902173|459530888|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
127699965|NCT01902173|459530889|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
127617307|NCT04019041|459226829|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
127617308|NCT04019041|459226830|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
127617309|NCT04019041|459226831|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
127617310|NCT04019041|459226832|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
127617311|NCT04019041|459226833|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
127617312|NCT04019041|459226828|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
127617313|NCT04019041|459226829|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
127617314|NCT04019041|459226830|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
127617315|NCT04019041|459226831|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
127617316|NCT04019041|459226832|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
127617317|NCT04019041|459226833|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
127699966|NCT01902173|459530890|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
127699967|NCT01902173|459530891|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
127884363|NCT02117479|460199910|FG001|Overall Study|Adverse Event|16|||
127884364|NCT02117479|460199909|FG000|Overall Study|Subject decision|8|||
127699968|NCT01902173|459530892|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
127699969|NCT01902173|459530887|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
127699970|NCT01902173|459530888|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
127699971|NCT01902173|459530889|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
127699972|NCT01902173|459530890|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
127699973|NCT01902173|459530891|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
127699974|NCT01902173|459530892|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
127699975|NCT01902173|459530887|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
127699976|NCT01902173|459530888|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
127699977|NCT01902173|459530889|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
127699978|NCT01902173|459530890|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
127699979|NCT01902173|459530891|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
127699980|NCT01902173|459530892|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
127699981|NCT01902173|459530887|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
127699982|NCT01902173|459530888|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
127699983|NCT01902173|459530889|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
127699984|NCT01902173|459530890|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
127699985|NCT01902173|459530891|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
127699986|NCT01902173|459530892|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
127699987|NCT01902173|459530887|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
127699988|NCT01902173|459530888|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
127884365|NCT02117479|460199910|FG001|Overall Study|Subject decision|9|||
127884366|NCT02117479|460199909|FG000|Overall Study|Disease progression|104|||
127617318|NCT04019041|459226828|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
127699989|NCT01902173|459530889|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
127617319|NCT04019041|459226829|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
127617320|NCT04019041|459226830|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
127617321|NCT04019041|459226831|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
127617322|NCT04019041|459226832|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
127617323|NCT04019041|459226833|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
127617324|NCT04019041|459226828|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
127617325|NCT04019041|459226829|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
127617326|NCT04019041|459226830|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
127617327|NCT04019041|459226831|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
127617328|NCT04019041|459226832|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
127617329|NCT04019041|459226833|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
127617330|NCT04019041|459226828|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
127617331|NCT04019041|459226829|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
127617332|NCT04019041|459226830|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
127617333|NCT04019041|459226831|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
127617334|NCT04019041|459226832|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
127617335|NCT04019041|459226833|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
127617336|NCT04019041|459226828|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
127617337|NCT04019041|459226829|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
127884367|NCT02117479|460199910|FG001|Overall Study|Disease progression|108|||
127617338|NCT04019041|459226830|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
127617339|NCT04019041|459226831|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
127699990|NCT01902173|459530890|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
127699991|NCT01902173|459530891|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
127617340|NCT04019041|459226832|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
127617341|NCT04019041|459226833|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
127617342|NCT04019041|459226828|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
127617343|NCT04019041|459226829|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
127617344|NCT04019041|459226830|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
127617345|NCT04019041|459226831|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
127617346|NCT04019041|459226832|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
127617347|NCT04019041|459226833|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
127617348|NCT03925727|459226834|FG000|Overall Study|Adverse Event|4|||
127617349|NCT03925727|459226835|FG001|Overall Study|Adverse Event|0|||
127617350|NCT03925727|459226836|FG002|Overall Study|Adverse Event|3|||
127617351|NCT03925727|459226834|FG000|Overall Study|Protocol Violation|1|||
127617352|NCT03925727|459226835|FG001|Overall Study|Protocol Violation|2|||
127617353|NCT03925727|459226836|FG002|Overall Study|Protocol Violation|2|||
127617354|NCT03925727|459226834|FG000|Overall Study|Withdrawal by Subject|3|||
127617355|NCT03925727|459226835|FG001|Overall Study|Withdrawal by Subject|2|||
127617356|NCT03925727|459226836|FG002|Overall Study|Withdrawal by Subject|4|||
127617357|NCT03925727|459226834|FG000|Overall Study|Administrative Reasons|3|||
127617358|NCT03925727|459226835|FG001|Overall Study|Administrative Reasons|1|||
127617359|NCT03925727|459226836|FG002|Overall Study|Administrative Reasons|2|||
127617360|NCT03925727|459226834|FG000|Overall Study|Randomized in error or Disqualified|8|||
127617361|NCT03925727|459226835|FG001|Overall Study|Randomized in error or Disqualified|1|||
127617362|NCT03925727|459226836|FG002|Overall Study|Randomized in error or Disqualified|7|||
127617363|NCT00314366|459226837|FG000|Overall Study|not treated due to patient medical condi|1|||
127617364|NCT00314366|459226838|FG001|Overall Study|not treated due to patient medical condi|0|||
127617365|NCT01393743|459226839|FG000|Core Study|Adverse Event|5|||
127617366|NCT01393743|459226840|FG001|Core Study|Adverse Event|9|||
127617367|NCT01393743|459226841|FG002|Core Study|Adverse Event|0|||
127617368|NCT01393743|459226839|FG000|Core Study|Lost to Follow-up|1|||
127617369|NCT01393743|459226840|FG001|Core Study|Lost to Follow-up|1|||
127617370|NCT01393743|459226841|FG002|Core Study|Lost to Follow-up|0|||
127617371|NCT01393743|459226839|FG000|Core Study|Participant's Choice|2|||
127617372|NCT01393743|459226840|FG001|Core Study|Participant's Choice|3|||
127617373|NCT01393743|459226841|FG002|Core Study|Participant's Choice|0|||
127617374|NCT01393743|459226839|FG000|Core Study|Inadequate therapeutic effect|2|||
127617375|NCT01393743|459226840|FG001|Core Study|Inadequate therapeutic effect|0|||
127617376|NCT01393743|459226841|FG002|Core Study|Inadequate therapeutic effect|0|||
127617377|NCT01393743|459226839|FG000|Extension Phase|Adverse Event|0|||
127617378|NCT01393743|459226840|FG001|Extension Phase|Adverse Event|0|||
127617379|NCT01393743|459226841|FG002|Extension Phase|Adverse Event|12|||
127617380|NCT01393743|459226839|FG000|Extension Phase|Lost to Follow-up|0|||
127617381|NCT01393743|459226840|FG001|Extension Phase|Lost to Follow-up|0|||
127617382|NCT01393743|459226841|FG002|Extension Phase|Lost to Follow-up|2|||
127617383|NCT01393743|459226839|FG000|Extension Phase|Participant choice|0|||
127617384|NCT01393743|459226840|FG001|Extension Phase|Participant choice|0|||
127617385|NCT01393743|459226841|FG002|Extension Phase|Participant choice|16|||
127617386|NCT01393743|459226839|FG000|Extension Phase|Inadequate therapeutic effect|0|||
127617387|NCT01393743|459226840|FG001|Extension Phase|Inadequate therapeutic effect|0|||
127617388|NCT01393743|459226841|FG002|Extension Phase|Inadequate therapeutic effect|7|||
127617389|NCT01393743|459226839|FG000|Extension Phase|Withdrawal by Subject|0|||
127617390|NCT01393743|459226840|FG001|Extension Phase|Withdrawal by Subject|0|||
127617391|NCT01393743|459226841|FG002|Extension Phase|Withdrawal by Subject|8|||
127617392|NCT01393743|459226839|FG000|Extension Phase|Pregnancy|0|||
127617393|NCT01393743|459226840|FG001|Extension Phase|Pregnancy|0|||
127617394|NCT01393743|459226841|FG002|Extension Phase|Pregnancy|1|||
127617395|NCT01393743|459226839|FG000|Extension Phase|Other|0|||
127617396|NCT01393743|459226840|FG001|Extension Phase|Other|0|||
127617397|NCT01393743|459226841|FG002|Extension Phase|Other|14|||
127617398|NCT02321462|459226845|FG000|Overall Study|Withdrawal by Subject|5|||
127617399|NCT02321462|459226846|FG001|Overall Study|Withdrawal by Subject|2|||
127617400|NCT02321462|459226845|FG000|Overall Study|Subject withdrawn before any treatment|1|||
127617401|NCT02321462|459226846|FG001|Overall Study|Subject withdrawn before any treatment|1|||
127617402|NCT03044197|459226855|FG000|Overall Study|Withdrawal by Subject|3|||
127617403|NCT03044197|459226856|FG001|Overall Study|Withdrawal by Subject|1|||
127617404|NCT00989833|459226865|FG000|Overall Study|Lost to Follow-up|0|||
127617405|NCT00989833|459226866|FG001|Overall Study|Lost to Follow-up|1|||
127617406|NCT00989833|459226867|FG002|Overall Study|Lost to Follow-up|0|||
127617407|NCT00989833|459226865|FG000|Overall Study|Protocol Violation|1|||
127617408|NCT00989833|459226866|FG001|Overall Study|Protocol Violation|2|||
127617409|NCT00989833|459226867|FG002|Overall Study|Protocol Violation|1|||
127617410|NCT00989833|459226865|FG000|Overall Study|Withdrawal by Subject|0|||
127617411|NCT00989833|459226866|FG001|Overall Study|Withdrawal by Subject|0|||
127617412|NCT00989833|459226867|FG002|Overall Study|Withdrawal by Subject|1|||
127617413|NCT00989833|459226865|FG000|Overall Study|Incorrectly randomized|1|||
127617414|NCT00989833|459226866|FG001|Overall Study|Incorrectly randomized|0|||
127617415|NCT00989833|459226867|FG002|Overall Study|Incorrectly randomized|0|||
127617416|NCT01282424|459226868|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
127617417|NCT01282424|459226868|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
127617418|NCT01282424|459226868|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
127617419|NCT01282424|459226868|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
127617420|NCT01282424|459226868|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
127617421|NCT01282424|459226868|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
127617422|NCT01282424|459226868|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
127617423|NCT01282424|459226868|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
127617424|NCT04804813|459226869|FG000|Overall Study|Protocol Violation|2|||
127617425|NCT04804813|459226870|FG001|Overall Study|Protocol Violation|0|||
127617426|NCT04804813|459226869|FG000|Overall Study|Withdrawal by Subject|1|||
127617427|NCT04804813|459226870|FG001|Overall Study|Withdrawal by Subject|0|||
127617428|NCT01083433|459228967|FG000|Overall Study|Lost to Follow-up|2|||
127617429|NCT01083433|459228968|FG001|Overall Study|Lost to Follow-up|1|||
127617430|NCT01083433|459228969|FG002|Overall Study|Lost to Follow-up|1|||
127617431|NCT01083433|459228967|FG000|Overall Study|Withdrawal by Subject|0|||
127617432|NCT01083433|459228968|FG001|Overall Study|Withdrawal by Subject|5|||
127617433|NCT01083433|459228969|FG002|Overall Study|Withdrawal by Subject|3|||
127617434|NCT01083433|459228967|FG000|Overall Study|Pregnancy|0|||
127617435|NCT01083433|459228968|FG001|Overall Study|Pregnancy|0|||
127617436|NCT01083433|459228969|FG002|Overall Study|Pregnancy|1|||
127617437|NCT01581593|459228970|FG000|Overall Study|Withdrawal by Subject|1|||
127617438|NCT04982029|459228971|FG000|Overall Study|Lost to Follow-up|2|||
127791212|NCT00531752|459858999|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
127617439|NCT04982029|459228972|FG001|Overall Study|Lost to Follow-up|3|||
127617440|NCT05458856|459228973|FG000|Overall Study|Withdrawal by Subject|5|||
127617441|NCT05458856|459228973|FG000|Overall Study|Death|4|||
127617442|NCT05458856|459228973|FG000|Overall Study|Protocol Deviation|3|||
127791213|NCT00531752|459859000|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
127617443|NCT05458856|459228973|FG000|Overall Study|Physician Decision|1|||
127617444|NCT01589822|459228974|FG000|Overall Study|Withdrawal by Subject|1|||
127617445|NCT01589822|459228975|FG001|Overall Study|Withdrawal by Subject|2|||
127617446|NCT01589822|459228976|FG002|Overall Study|Withdrawal by Subject|0|||
127617447|NCT01589822|459228974|FG000|Overall Study|Death|1|||
127617448|NCT01589822|459228975|FG001|Overall Study|Death|0|||
127617449|NCT01589822|459228976|FG002|Overall Study|Death|0|||
127617450|NCT01589822|459228974|FG000|Overall Study|Missed 90 day visit|2|||
127617451|NCT01589822|459228975|FG001|Overall Study|Missed 90 day visit|1|||
127617452|NCT01589822|459228976|FG002|Overall Study|Missed 90 day visit|1|||
127617453|NCT05168475|459228977|FG000|Period 1|Protocol Violation|1|||
127617454|NCT05168475|459228977|FG000|Period 1|IMP shortage|2|||
127617455|NCT05168475|459228977|FG000|Period 1|Not randomised|2|||
127617456|NCT05168475|459228977|FG000|Period 2|IMP shortage|1|||
127617457|NCT01140477|459228980|FG000|Overall Study|Lost to Follow-up|4|||
127617458|NCT01140477|459228981|FG001|Overall Study|Lost to Follow-up|0|||
127617459|NCT01140477|459228980|FG000|Overall Study|Withdrawal by Subject|1|||
127617460|NCT01140477|459228981|FG001|Overall Study|Withdrawal by Subject|4|||
127617461|NCT01140477|459228980|FG000|Overall Study|Surgical complication preventing implant|2|||
127617462|NCT01140477|459228981|FG001|Overall Study|Surgical complication preventing implant|0|||
127617463|NCT01140477|459228980|FG000|Overall Study|Death|1|||
127617464|NCT01140477|459228981|FG001|Overall Study|Death|1|||
127617465|NCT01140477|459228980|FG000|Overall Study|Subject explanted|0|||
127617466|NCT01140477|459228981|FG001|Overall Study|Subject explanted|1|||
127617467|NCT00773175|459228982|FG000|Overall Study|Adverse Event|2|||
127617468|NCT00773175|459228983|FG001|Overall Study|Adverse Event|0|||
127617469|NCT00773175|459228982|FG000|Overall Study|Consent Withdrawn|0|||
127617470|NCT00773175|459228983|FG001|Overall Study|Consent Withdrawn|2|||
127617471|NCT04127786|459228990|FG000|Primary Series|Adverse Event|1|||
127617472|NCT04127786|459228991|FG001|Primary Series|Adverse Event|0|||
127617473|NCT04127786|459228992|FG002|Primary Series|Adverse Event|0|||
127617474|NCT04127786|459228993|FG003|Primary Series|Adverse Event|1|||
127617475|NCT04127786|459228994|FG004|Primary Series|Adverse Event|0|||
127617476|NCT04127786|459228995|FG005|Primary Series|Adverse Event|1|||
127617477|NCT04127786|459228990|FG000|Primary Series|Protocol Violation|5|||
127617478|NCT04127786|459228991|FG001|Primary Series|Protocol Violation|3|||
127617479|NCT04127786|459228992|FG002|Primary Series|Protocol Violation|4|||
127617480|NCT04127786|459228993|FG003|Primary Series|Protocol Violation|3|||
127617481|NCT04127786|459228994|FG004|Primary Series|Protocol Violation|2|||
127617482|NCT04127786|459228995|FG005|Primary Series|Protocol Violation|0|||
127617483|NCT04127786|459228990|FG000|Primary Series|Withdrawal by Subject|0|||
127617484|NCT04127786|459228991|FG001|Primary Series|Withdrawal by Subject|0|||
127617485|NCT04127786|459228992|FG002|Primary Series|Withdrawal by Subject|0|||
127617486|NCT04127786|459228993|FG003|Primary Series|Withdrawal by Subject|1|||
127617487|NCT04127786|459228994|FG004|Primary Series|Withdrawal by Subject|0|||
127617488|NCT04127786|459228995|FG005|Primary Series|Withdrawal by Subject|0|||
127617489|NCT04127786|459228990|FG000|Primary Series|Withdrawal by Parent/Guardian|2|||
127617490|NCT04127786|459228991|FG001|Primary Series|Withdrawal by Parent/Guardian|1|||
127617491|NCT04127786|459228992|FG002|Primary Series|Withdrawal by Parent/Guardian|0|||
127617492|NCT04127786|459228993|FG003|Primary Series|Withdrawal by Parent/Guardian|0|||
127617493|NCT04127786|459228994|FG004|Primary Series|Withdrawal by Parent/Guardian|0|||
127617494|NCT04127786|459228995|FG005|Primary Series|Withdrawal by Parent/Guardian|0|||
127617495|NCT04127786|459228990|FG000|Booster Phase|Withdrawal by Subject|2|||
127617496|NCT04127786|459228991|FG001|Booster Phase|Withdrawal by Subject|0|||
127617497|NCT04127786|459228992|FG002|Booster Phase|Withdrawal by Subject|0|||
127617498|NCT04127786|459228993|FG003|Booster Phase|Withdrawal by Subject|0|||
127617499|NCT04127786|459228994|FG004|Booster Phase|Withdrawal by Subject|0|||
127617500|NCT04127786|459228995|FG005|Booster Phase|Withdrawal by Subject|0|||
127617501|NCT01904604|459228996|FG000|Overall Study|Withdrew before receiving dosing|0|||
127617502|NCT01904604|459228997|FG001|Overall Study|Withdrew before receiving dosing|1|||
127617503|NCT01904604|459228998|FG002|Overall Study|Withdrew before receiving dosing|0|||
127617504|NCT01904604|459228996|FG000|Overall Study|Non-compliance|1|||
127699992|NCT01902173|459530892|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
127699993|NCT01902173|459530887|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
127699994|NCT01902173|459530888|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
127699995|NCT01902173|459530889|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
127699996|NCT01902173|459530890|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
127699997|NCT01902173|459530891|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
127699998|NCT01902173|459530892|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
127699999|NCT01902173|459530887|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
127700000|NCT01902173|459530888|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
127700001|NCT01902173|459530889|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
127700002|NCT01902173|459530890|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
127617505|NCT01904604|459228997|FG001|Overall Study|Non-compliance|0|||
127617506|NCT01904604|459228998|FG002|Overall Study|Non-compliance|0|||
127617507|NCT01904604|459228996|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
127617508|NCT01904604|459228997|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
127617509|NCT01904604|459228998|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
127700003|NCT01902173|459530891|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
127700004|NCT01902173|459530892|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
127700005|NCT01902173|459530887|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
127700006|NCT01902173|459530888|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
127700007|NCT01902173|459530889|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
127700008|NCT01902173|459530890|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
127700009|NCT01902173|459530891|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
127700010|NCT01902173|459530892|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
127700011|NCT01902173|459530887|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
127700012|NCT01902173|459530888|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
127700013|NCT01902173|459530889|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
127700014|NCT01902173|459530890|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
127700015|NCT01902173|459530891|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
127700016|NCT01902173|459530892|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
127700017|NCT01902173|459530887|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
127700018|NCT01902173|459530888|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
127700019|NCT01902173|459530889|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
127700020|NCT01902173|459530890|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
127700021|NCT01902173|459530891|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
127700022|NCT01902173|459530892|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
127700023|NCT01902173|459530887|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
127700024|NCT01902173|459530888|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
127700025|NCT01902173|459530889|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
127700026|NCT01902173|459530890|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
127700027|NCT01902173|459530891|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
127700028|NCT01902173|459530892|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
127617510|NCT01904604|459228996|FG000|Overall Study|Patch site reactions|1|||
127617511|NCT01904604|459228997|FG001|Overall Study|Patch site reactions|1|||
127617512|NCT01904604|459228998|FG002|Overall Study|Patch site reactions|0|||
127617513|NCT01904604|459228996|FG000|Overall Study|Increased syncope|0|||
127617514|NCT01904604|459228997|FG001|Overall Study|Increased syncope|1|||
127617515|NCT01904604|459228998|FG002|Overall Study|Increased syncope|0|||
127617516|NCT01904604|459228996|FG000|Overall Study|Unrelated illness|0|||
127617517|NCT01904604|459228997|FG001|Overall Study|Unrelated illness|1|||
127617518|NCT01904604|459228998|FG002|Overall Study|Unrelated illness|0|||
127617519|NCT01904604|459228996|FG000|Overall Study|Passed Week 52 OFC|1|||
127617520|NCT01904604|459228997|FG001|Overall Study|Passed Week 52 OFC|0|||
127617521|NCT01904604|459228998|FG002|Overall Study|Passed Week 52 OFC|0|||
127617522|NCT01904604|459228996|FG000|Overall Study|Withdrawal by Subject|1|||
127617523|NCT01904604|459228997|FG001|Overall Study|Withdrawal by Subject|2|||
127617524|NCT01904604|459228998|FG002|Overall Study|Withdrawal by Subject|0|||
127617525|NCT01904604|459228996|FG000|Overall Study|Participant Relocated|1|||
127617526|NCT01904604|459228997|FG001|Overall Study|Participant Relocated|1|||
127617527|NCT01904604|459228998|FG002|Overall Study|Participant Relocated|1|||
127617528|NCT01904604|459228996|FG000|Overall Study|Lost to Follow-up|0|||
127617529|NCT01904604|459228997|FG001|Overall Study|Lost to Follow-up|0|||
127617530|NCT01904604|459228998|FG002|Overall Study|Lost to Follow-up|1|||
127617531|NCT03568942|459229001|FG000|Overall Study|Family emergency|1|||
127617532|NCT03568942|459229001|FG000|Overall Study|Lost to Follow-up|1|||
127617533|NCT00358527|459229003|FG000|Overall Study|Adverse Event|4|||
127700029|NCT01902173|459530887|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
127700030|NCT01902173|459530888|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
127700031|NCT01902173|459530889|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
127617534|NCT00358527|459229004|FG001|Overall Study|Adverse Event|0|||
127617535|NCT00358527|459229003|FG000|Overall Study|Withdrawal by Subject|1|||
127617536|NCT00358527|459229004|FG001|Overall Study|Withdrawal by Subject|1|||
127617537|NCT00358527|459229003|FG000|Overall Study|Non-compliance with protocol|6|||
127617538|NCT00358527|459229004|FG001|Overall Study|Non-compliance with protocol|1|||
127617539|NCT00358527|459229003|FG000|Overall Study|Administrative|2|||
127700032|NCT01902173|459530890|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
127700033|NCT01902173|459530891|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
127700034|NCT01902173|459530892|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
127700035|NCT02262728|459530894|FG000|Follow-up Phase (3 Years)|Death|0|||
127700036|NCT02262728|459530895|FG001|Follow-up Phase (3 Years)|Death|1|||
127617540|NCT00358527|459229004|FG001|Overall Study|Administrative|1|||
127617541|NCT04144166|459229005|FG000|Overall Study|Discharged before study start|1|||
127700037|NCT02262728|459530894|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
127700038|NCT02262728|459530895|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
127700039|NCT02262728|459530894|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
127700040|NCT02262728|459530895|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
127617542|NCT04144166|459229005|FG000|Overall Study|Pregnancy|1|||
127617543|NCT04144166|459229005|FG000|Overall Study|Nail polish could not be removed from finger|1|||
127617544|NCT04145895|459229007|FG000|Overall Study|Physician Decision|2|||
127617545|NCT04145895|459229008|FG001|Overall Study|Physician Decision|0|||
127617546|NCT04145895|459229007|FG000|Overall Study|Withdrawal by Subject|0|||
127617547|NCT04145895|459229008|FG001|Overall Study|Withdrawal by Subject|2|||
127617548|NCT01481116|459229009|FG000|Overall Study|Adverse Event|26|||
127617549|NCT01481116|459229010|FG001|Overall Study|Adverse Event|26|||
127617550|NCT01481116|459229011|FG002|Overall Study|Adverse Event|42|||
127617551|NCT01481116|459229009|FG000|Overall Study|Major Protocol Deviation|3|||
127617552|NCT01481116|459229010|FG001|Overall Study|Major Protocol Deviation|7|||
127617553|NCT01481116|459229011|FG002|Overall Study|Major Protocol Deviation|1|||
127617554|NCT01481116|459229009|FG000|Overall Study|Lost to Follow-up|8|||
127617555|NCT01481116|459229010|FG001|Overall Study|Lost to Follow-up|12|||
127617556|NCT01481116|459229011|FG002|Overall Study|Lost to Follow-up|11|||
127617557|NCT01481116|459229009|FG000|Overall Study|Withdrawal by Subject|37|||
127617558|NCT01481116|459229010|FG001|Overall Study|Withdrawal by Subject|33|||
127617559|NCT01481116|459229011|FG002|Overall Study|Withdrawal by Subject|37|||
127617560|NCT01481116|459229009|FG000|Overall Study|Study Termination|730|||
127617561|NCT01481116|459229010|FG001|Overall Study|Study Termination|729|||
127617562|NCT01481116|459229011|FG002|Overall Study|Study Termination|713|||
127617563|NCT01481116|459229009|FG000|Overall Study|Pregnancy|0|||
127617564|NCT01481116|459229010|FG001|Overall Study|Pregnancy|0|||
127617565|NCT01481116|459229011|FG002|Overall Study|Pregnancy|1|||
127617566|NCT01481116|459229009|FG000|Overall Study|Lack of Efficacy|3|||
127617567|NCT01481116|459229010|FG001|Overall Study|Lack of Efficacy|3|||
127617568|NCT01481116|459229011|FG002|Overall Study|Lack of Efficacy|1|||
127617569|NCT01481116|459229009|FG000|Overall Study|Contraindications|1|||
127617570|NCT01481116|459229010|FG001|Overall Study|Contraindications|1|||
127617571|NCT01481116|459229011|FG002|Overall Study|Contraindications|0|||
127617572|NCT01481116|459229009|FG000|Overall Study|Other|1|||
127617573|NCT01481116|459229010|FG001|Overall Study|Other|1|||
127617574|NCT01481116|459229011|FG002|Overall Study|Other|0|||
127617575|NCT01481116|459229009|FG000|Overall Study|Participant Started Taking Glipizide|1|||
127617576|NCT01481116|459229010|FG001|Overall Study|Participant Started Taking Glipizide|0|||
127617577|NCT01481116|459229011|FG002|Overall Study|Participant Started Taking Glipizide|0|||
127617578|NCT01481116|459229009|FG000|Overall Study|Participant Moved Out of Area|2|||
127617579|NCT01481116|459229010|FG001|Overall Study|Participant Moved Out of Area|0|||
127617580|NCT01481116|459229011|FG002|Overall Study|Participant Moved Out of Area|1|||
127617581|NCT01481116|459229009|FG000|Overall Study|Participant Moved Out of Country|1|||
127617582|NCT01481116|459229010|FG001|Overall Study|Participant Moved Out of Country|0|||
127617583|NCT01481116|459229011|FG002|Overall Study|Participant Moved Out of Country|1|||
127617584|NCT01481116|459229009|FG000|Overall Study|Investigator Decision|3|||
127617585|NCT01481116|459229010|FG001|Overall Study|Investigator Decision|2|||
127617586|NCT01481116|459229011|FG002|Overall Study|Investigator Decision|1|||
127617587|NCT01481116|459229009|FG000|Overall Study|Sponsor Decision|0|||
127617588|NCT01481116|459229010|FG001|Overall Study|Sponsor Decision|1|||
127617589|NCT01481116|459229011|FG002|Overall Study|Sponsor Decision|3|||
127617590|NCT01481116|459229009|FG000|Overall Study|Non-Compliant With Study Drug|0|||
127617591|NCT01481116|459229010|FG001|Overall Study|Non-Compliant With Study Drug|1|||
127617592|NCT01481116|459229011|FG002|Overall Study|Non-Compliant With Study Drug|1|||
127617593|NCT01481116|459229009|FG000|Overall Study|Investigator's Discretion|2|||
127617594|NCT01481116|459229010|FG001|Overall Study|Investigator's Discretion|0|||
127617595|NCT01481116|459229011|FG002|Overall Study|Investigator's Discretion|0|||
127617596|NCT01481116|459229009|FG000|Overall Study|Death|2|||
127617597|NCT01481116|459229010|FG001|Overall Study|Death|1|||
127617598|NCT01481116|459229011|FG002|Overall Study|Death|0|||
127617599|NCT01481116|459229009|FG000|Overall Study|Hypoglycemic Event|4|||
127617600|NCT01481116|459229010|FG001|Overall Study|Hypoglycemic Event|0|||
127617601|NCT01481116|459229011|FG002|Overall Study|Hypoglycemic Event|0|||
127617602|NCT02365636|459229017|FG000|Overall Study|Adverse Event|3|||
127617603|NCT02365636|459229018|FG001|Overall Study|Adverse Event|3|||
127617604|NCT02365636|459229019|FG002|Overall Study|Adverse Event|2|||
127617605|NCT02365636|459229017|FG000|Overall Study|Protocol Violation|1|||
127617606|NCT02365636|459229018|FG001|Overall Study|Protocol Violation|4|||
127617607|NCT02365636|459229019|FG002|Overall Study|Protocol Violation|0|||
127617608|NCT02365636|459229017|FG000|Overall Study|Lost to Follow-up|0|||
127617609|NCT02365636|459229018|FG001|Overall Study|Lost to Follow-up|0|||
127617610|NCT02365636|459229019|FG002|Overall Study|Lost to Follow-up|1|||
127617611|NCT02365636|459229017|FG000|Overall Study|Other|2|||
127617612|NCT02365636|459229018|FG001|Overall Study|Other|0|||
127617613|NCT02365636|459229019|FG002|Overall Study|Other|0|||
127617614|NCT01782313|459229028|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
127617615|NCT01782313|459229028|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
127617616|NCT01782313|459229028|FG000|Treated Cycle 3|Progressive Disease|21|||
127617617|NCT01782313|459229028|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
127617618|NCT01782313|459229028|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
127700041|NCT05540665|459530896|FG000|Overall Study|Study terminated by sponsor|6|||
127617619|NCT01782313|459229028|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
127617620|NCT01782313|459229028|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
127617621|NCT01782313|459229028|FG000|Survival Follow up|Lost to Follow-up|1|||
127617622|NCT01802775|459229031|FG000|Overall Study|Death|0|||
127617623|NCT01802775|459229032|FG001|Overall Study|Death|3|||
127617624|NCT01802775|459229031|FG000|Overall Study|Reason not provided|0|||
127617625|NCT01802775|459229032|FG001|Overall Study|Reason not provided|1|||
127617626|NCT01802775|459229031|FG000|Overall Study|Physician Decision|1|||
127617627|NCT01802775|459229032|FG001|Overall Study|Physician Decision|0|||
127617628|NCT01802775|459229031|FG000|Overall Study|Adverse Event|1|||
127617629|NCT01802775|459229032|FG001|Overall Study|Adverse Event|1|||
127617630|NCT01802775|459229031|FG000|Overall Study|Withdrawal by Subject|3|||
127617631|NCT01802775|459229032|FG001|Overall Study|Withdrawal by Subject|5|||
127617632|NCT01802775|459229031|FG000|Overall Study|Lost to Follow-up|1|||
127617633|NCT01802775|459229032|FG001|Overall Study|Lost to Follow-up|2|||
127617634|NCT01067352|459229039|FG000|Overall Study|Withdrawal by Subject|1|||
127617635|NCT01067352|459229040|FG001|Overall Study|Withdrawal by Subject|2|||
127617636|NCT01067352|459229041|FG002|Overall Study|Withdrawal by Subject|1|||
127617637|NCT01067352|459229039|FG000|Overall Study|Physician Decision|0|||
127617638|NCT01067352|459229040|FG001|Overall Study|Physician Decision|1|||
127617639|NCT01067352|459229041|FG002|Overall Study|Physician Decision|0|||
127617640|NCT01096784|459229042|FG000|Overall Study|Withdrawal by Subject|2|||
127617641|NCT01096784|459229043|FG001|Overall Study|Withdrawal by Subject|1|||
127617642|NCT01096784|459229042|FG000|Overall Study|Adverse Event|11|||
127617643|NCT01096784|459229043|FG001|Overall Study|Adverse Event|9|||
127617644|NCT01096784|459229042|FG000|Overall Study|Protocol Deviation|2|||
127617645|NCT01096784|459229043|FG001|Overall Study|Protocol Deviation|2|||
127617646|NCT01096784|459229042|FG000|Overall Study|Administrative Decision|0|||
127617647|NCT01096784|459229043|FG001|Overall Study|Administrative Decision|1|||
127617648|NCT01096784|459229042|FG000|Overall Study|Other Unspecified|0|||
127617649|NCT01096784|459229043|FG001|Overall Study|Other Unspecified|1|||
127617650|NCT03761628|459229044|FG000|Overall Study|Withdrawal by Subject|3|||
127617651|NCT03761628|459229044|FG000|Overall Study|Physician Decision|1|||
127617652|NCT03761628|459229044|FG000|Overall Study|Pregnancy|1|||
127617653|NCT03761628|459229044|FG000|Overall Study|Lost to Follow-up|1|||
127617654|NCT02465528|459229045|FG000|Overall Study|Progressive disease|0|||
127617655|NCT02465528|459229046|FG001|Overall Study|Progressive disease|2|||
127617656|NCT02465528|459229047|FG002|Overall Study|Progressive disease|9|||
127617657|NCT02465528|459229048|FG003|Overall Study|Progressive disease|4|||
127617658|NCT02465528|459229045|FG000|Overall Study|Study terminated by sponsor|1|||
127617659|NCT02465528|459229046|FG001|Overall Study|Study terminated by sponsor|2|||
127617660|NCT02465528|459229047|FG002|Overall Study|Study terminated by sponsor|0|||
127617661|NCT02465528|459229048|FG003|Overall Study|Study terminated by sponsor|0|||
127617662|NCT02465528|459229045|FG000|Overall Study|Withdrawal by Subject|0|||
127617663|NCT02465528|459229046|FG001|Overall Study|Withdrawal by Subject|0|||
127617664|NCT02465528|459229047|FG002|Overall Study|Withdrawal by Subject|2|||
127617665|NCT02465528|459229048|FG003|Overall Study|Withdrawal by Subject|0|||
127617666|NCT02465528|459229045|FG000|Overall Study|Adverse Event|0|||
127617667|NCT02465528|459229046|FG001|Overall Study|Adverse Event|0|||
127617668|NCT02465528|459229047|FG002|Overall Study|Adverse Event|0|||
127617669|NCT02465528|459229048|FG003|Overall Study|Adverse Event|1|||
127617670|NCT02465528|459229045|FG000|Overall Study|Physician Decision|0|||
127617671|NCT02465528|459229046|FG001|Overall Study|Physician Decision|0|||
127617672|NCT02465528|459229047|FG002|Overall Study|Physician Decision|1|||
127617673|NCT02465528|459229048|FG003|Overall Study|Physician Decision|0|||
127617674|NCT04649151|459229051|FG000|Overall Study|Pregnancy|0|||
127617675|NCT04649151|459229052|FG001|Overall Study|Pregnancy|0|||
127617676|NCT04649151|459229053|FG002|Overall Study|Pregnancy|0|||
127617677|NCT04649151|459229054|FG003|Overall Study|Pregnancy|0|||
127617678|NCT04649151|459229055|FG004|Overall Study|Pregnancy|3|||
127617679|NCT04649151|459229051|FG000|Overall Study|Physician Decision|10|||
127617680|NCT04649151|459229052|FG001|Overall Study|Physician Decision|0|||
127617681|NCT04649151|459229053|FG002|Overall Study|Physician Decision|0|||
127617682|NCT04649151|459229054|FG003|Overall Study|Physician Decision|1|||
127617683|NCT04649151|459229055|FG004|Overall Study|Physician Decision|1|||
127617684|NCT04649151|459229051|FG000|Overall Study|Protocol Deviation|25|||
127617685|NCT04649151|459229052|FG001|Overall Study|Protocol Deviation|3|||
127617686|NCT04649151|459229053|FG002|Overall Study|Protocol Deviation|0|||
127617687|NCT04649151|459229054|FG003|Overall Study|Protocol Deviation|0|||
127617688|NCT04649151|459229055|FG004|Overall Study|Protocol Deviation|0|||
127617689|NCT04649151|459229051|FG000|Overall Study|Received another COVID-19 vaccine under EUA|495|||
127617690|NCT04649151|459229052|FG001|Overall Study|Received another COVID-19 vaccine under EUA|730|||
127617691|NCT04649151|459229053|FG002|Overall Study|Received another COVID-19 vaccine under EUA|0|||
127617692|NCT04649151|459229054|FG003|Overall Study|Received another COVID-19 vaccine under EUA|0|||
127617693|NCT04649151|459229055|FG004|Overall Study|Received another COVID-19 vaccine under EUA|0|||
127617694|NCT04649151|459229051|FG000|Overall Study|Withdrawal by Subject|370|||
127617695|NCT04649151|459229052|FG001|Overall Study|Withdrawal by Subject|113|||
127617696|NCT04649151|459229053|FG002|Overall Study|Withdrawal by Subject|2|||
127617697|NCT04649151|459229054|FG003|Overall Study|Withdrawal by Subject|7|||
127617698|NCT04649151|459229055|FG004|Overall Study|Withdrawal by Subject|15|||
127617699|NCT04649151|459229051|FG000|Overall Study|Adverse Event|1|||
127617700|NCT04649151|459229052|FG001|Overall Study|Adverse Event|0|||
127617701|NCT04649151|459229053|FG002|Overall Study|Adverse Event|0|||
127617702|NCT04649151|459229054|FG003|Overall Study|Adverse Event|0|||
127791214|NCT00531752|459858997|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
127791215|NCT00531752|459858998|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
127791216|NCT00531752|459858999|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
127791217|NCT00531752|459859000|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
127791218|NCT00531752|459858997|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
127791219|NCT00531752|459858998|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
127791220|NCT00531752|459858999|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
127791221|NCT00531752|459859000|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
127791222|NCT00531752|459858997|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
127791223|NCT00531752|459858998|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
127791224|NCT00531752|459858999|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
127791225|NCT00531752|459859000|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
127791226|NCT00531752|459858997|FG000|Second Double-blind Intervention Period|Other|1|||
127791227|NCT00531752|459858998|FG001|Second Double-blind Intervention Period|Other|1|||
127791228|NCT00531752|459858999|FG002|Second Double-blind Intervention Period|Other|0|||
127791229|NCT00531752|459859000|FG003|Second Double-blind Intervention Period|Other|0|||
127791230|NCT00531752|459858997|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
127791231|NCT00531752|459858998|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
127791232|NCT00531752|459858999|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
127791233|NCT00531752|459859000|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
127791234|NCT00531752|459858997|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
127791235|NCT00531752|459858998|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
127791236|NCT00531752|459858999|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
127791237|NCT00531752|459859000|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
127791238|NCT00401375|459859001|FG000|Overall Study|Protocol Violation|2|||
127791239|NCT00401375|459859002|FG001|Overall Study|Protocol Violation|2|||
127791240|NCT00401375|459859003|FG002|Overall Study|Protocol Violation|1|||
127791241|NCT00401375|459859001|FG000|Overall Study|Adverse Event|6|||
127791242|NCT00401375|459859002|FG001|Overall Study|Adverse Event|11|||
127791243|NCT00401375|459859003|FG002|Overall Study|Adverse Event|10|||
127791244|NCT00401375|459859001|FG000|Overall Study|Withdrawal by Subject|9|||
127791245|NCT00401375|459859002|FG001|Overall Study|Withdrawal by Subject|7|||
127791246|NCT00401375|459859003|FG002|Overall Study|Withdrawal by Subject|7|||
127791247|NCT00401375|459859001|FG000|Overall Study|Lost to Follow-up|0|||
127791248|NCT00401375|459859002|FG001|Overall Study|Lost to Follow-up|1|||
127791249|NCT00401375|459859003|FG002|Overall Study|Lost to Follow-up|1|||
127791250|NCT00401375|459859001|FG000|Overall Study|Other than specified|2|||
127791251|NCT00401375|459859002|FG001|Overall Study|Other than specified|1|||
127791252|NCT00401375|459859003|FG002|Overall Study|Other than specified|3|||
127791253|NCT00401375|459859001|FG000|Overall Study|Randomized but not treated|3|||
127791254|NCT00401375|459859002|FG001|Overall Study|Randomized but not treated|3|||
127791255|NCT00401375|459859003|FG002|Overall Study|Randomized but not treated|3|||
127791256|NCT00950664|459859004|FG000|First Intervention|Lost to Follow-up|1|||
127791257|NCT00950664|459859005|FG001|First Intervention|Lost to Follow-up|3|||
127791258|NCT00950664|459859004|FG000|First Intervention|Withdrawal by Subject|2|||
127791259|NCT00950664|459859005|FG001|First Intervention|Withdrawal by Subject|2|||
127791260|NCT02821715|459859006|FG000|Overall Study|Protocol Violation|1|||
127791261|NCT02821715|459859007|FG001|Overall Study|Protocol Violation|0|||
127791262|NCT02821715|459859008|FG002|Overall Study|Protocol Violation|0|||
127791263|NCT02821715|459859009|FG003|Overall Study|Protocol Violation|0|||
127791264|NCT02821715|459859010|FG004|Overall Study|Protocol Violation|0|||
127791265|NCT02821715|459859011|FG005|Overall Study|Protocol Violation|0|||
127791266|NCT03152019|459859012|FG000|Overall Study|Adverse Event|0|||
127791267|NCT03152019|459859013|FG001|Overall Study|Adverse Event|1|||
127791268|NCT00254501|459859019|FG000|Overall Study|Lost to Follow-up|1|||
127791269|NCT00254501|459859020|FG001|Overall Study|Lost to Follow-up|1|||
127617703|NCT04649151|459229055|FG004|Overall Study|Adverse Event|0|||
127791270|NCT00923130|459859021|FG000|Overall Study|Stopped treatment due to progression|17|||
127617704|NCT04649151|459229051|FG000|Overall Study|Lost to Follow-up|256|||
127617705|NCT04649151|459229052|FG001|Overall Study|Lost to Follow-up|29|||
127617706|NCT04649151|459229053|FG002|Overall Study|Lost to Follow-up|10|||
127617707|NCT04649151|459229054|FG003|Overall Study|Lost to Follow-up|3|||
127617708|NCT04649151|459229055|FG004|Overall Study|Lost to Follow-up|6|||
127617709|NCT04649151|459229051|FG000|Overall Study|Other than specified|59|||
127617710|NCT04649151|459229052|FG001|Overall Study|Other than specified|294|||
127617711|NCT04649151|459229053|FG002|Overall Study|Other than specified|0|||
127617712|NCT04649151|459229054|FG003|Overall Study|Other than specified|0|||
127617713|NCT04649151|459229055|FG004|Overall Study|Other than specified|4|||
127617714|NCT04649151|459229051|FG000|Overall Study|Death|0|||
127617715|NCT04649151|459229052|FG001|Overall Study|Death|0|||
127617716|NCT04649151|459229053|FG002|Overall Study|Death|0|||
127617717|NCT04649151|459229054|FG003|Overall Study|Death|0|||
127617718|NCT04649151|459229055|FG004|Overall Study|Death|1|||
127617719|NCT03752619|459229056|FG000|Overall Study|Lost to Follow-up|2|||
127617720|NCT03752619|459229057|FG001|Overall Study|Lost to Follow-up|1|||
127617721|NCT03752619|459229056|FG000|Overall Study|Withdrawal by Subject|1|||
127617722|NCT03752619|459229057|FG001|Overall Study|Withdrawal by Subject|1|||
127617723|NCT03752619|459229056|FG000|Overall Study|Adverse Event|0|||
127617724|NCT03752619|459229057|FG001|Overall Study|Adverse Event|1|||
127617725|NCT03907683|459229058|FG000|Overall Study|Pregnancy|1|||
127791271|NCT00923130|459859021|FG000|Overall Study|Death|1|||
127791272|NCT00923130|459859021|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
127791273|NCT00923130|459859021|FG000|Overall Study|Switched to alternative treatment|2|||
127791274|NCT00923130|459859021|FG000|Overall Study|Refused further treatment|2|||
127791275|NCT05038020|459859027|FG000|Overall Study|Early Termination|3|||
127791276|NCT05038020|459859028|FG001|Overall Study|Early Termination|0|||
127791277|NCT02484911|459860625|FG000|Overall Study|Withdrawal by Subject|2|||
127791278|NCT02484911|459860626|FG001|Overall Study|Withdrawal by Subject|1|||
127791279|NCT02484911|459860625|FG000|Overall Study|Protocol Violation|2|||
127791280|NCT02484911|459860626|FG001|Overall Study|Protocol Violation|1|||
127791281|NCT04129528|459860627|FG000|Overall Study|Adverse Event|1|||
127791282|NCT04129528|459860628|FG001|Overall Study|Adverse Event|0|||
127791283|NCT04129528|459860627|FG000|Overall Study|Physician Decision|1|||
127791284|NCT04129528|459860628|FG001|Overall Study|Physician Decision|1|||
127791285|NCT04129528|459860627|FG000|Overall Study|Withdrawal by Subject|1|||
127791286|NCT04129528|459860628|FG001|Overall Study|Withdrawal by Subject|1|||
127617726|NCT03907683|459229058|FG000|Overall Study|Withdrawal by Subject|1|||
127617727|NCT03400332|459229060|FG000|Pre-Treatment|Other reasons|0|||
127617728|NCT03400332|459229061|FG001|Pre-Treatment|Other reasons|0|||
127617729|NCT03400332|459229062|FG002|Pre-Treatment|Other reasons|0|||
127617730|NCT03400332|459229063|FG003|Pre-Treatment|Other reasons|0|||
127617731|NCT03400332|459229064|FG004|Pre-Treatment|Other reasons|0|||
127617732|NCT03400332|459229065|FG005|Pre-Treatment|Other reasons|0|||
127617733|NCT03400332|459229066|FG006|Pre-Treatment|Other reasons|0|||
127617734|NCT03400332|459229067|FG007|Pre-Treatment|Other reasons|0|||
127617735|NCT03400332|459229068|FG008|Pre-Treatment|Other reasons|1|||
127617736|NCT03400332|459229060|FG000|Pre-Treatment|No longer met study criteria|0|||
127617737|NCT03400332|459229061|FG001|Pre-Treatment|No longer met study criteria|0|||
127617738|NCT03400332|459229062|FG002|Pre-Treatment|No longer met study criteria|0|||
127617739|NCT03400332|459229063|FG003|Pre-Treatment|No longer met study criteria|0|||
127617740|NCT03400332|459229064|FG004|Pre-Treatment|No longer met study criteria|0|||
127617741|NCT03400332|459229065|FG005|Pre-Treatment|No longer met study criteria|0|||
127617742|NCT03400332|459229066|FG006|Pre-Treatment|No longer met study criteria|0|||
127617743|NCT03400332|459229067|FG007|Pre-Treatment|No longer met study criteria|0|||
127617744|NCT03400332|459229068|FG008|Pre-Treatment|No longer met study criteria|1|||
127617745|NCT03400332|459229060|FG000|Pre-Treatment|Withdrawal by Subject|0|||
127617746|NCT03400332|459229061|FG001|Pre-Treatment|Withdrawal by Subject|0|||
127617747|NCT03400332|459229062|FG002|Pre-Treatment|Withdrawal by Subject|0|||
127617748|NCT03400332|459229063|FG003|Pre-Treatment|Withdrawal by Subject|0|||
127617749|NCT03400332|459229064|FG004|Pre-Treatment|Withdrawal by Subject|0|||
127617750|NCT03400332|459229065|FG005|Pre-Treatment|Withdrawal by Subject|0|||
127617751|NCT03400332|459229066|FG006|Pre-Treatment|Withdrawal by Subject|0|||
127617752|NCT03400332|459229067|FG007|Pre-Treatment|Withdrawal by Subject|0|||
127617753|NCT03400332|459229068|FG008|Pre-Treatment|Withdrawal by Subject|1|||
127617754|NCT03400332|459229060|FG000|Treatment|Participant withdrew consent|2|||
127617755|NCT03400332|459229061|FG001|Treatment|Participant withdrew consent|2|||
127791287|NCT01395394|459860633|FG000|Baseline Study Visit|Protocol Violation|1|||
127791288|NCT01395394|459860634|FG001|Baseline Study Visit|Protocol Violation|0|||
127617756|NCT03400332|459229062|FG002|Treatment|Participant withdrew consent|0|||
127617757|NCT03400332|459229063|FG003|Treatment|Participant withdrew consent|0|||
127617758|NCT03400332|459229064|FG004|Treatment|Participant withdrew consent|3|||
127617759|NCT03400332|459229065|FG005|Treatment|Participant withdrew consent|3|||
127617760|NCT03400332|459229066|FG006|Treatment|Participant withdrew consent|1|||
127791289|NCT01395394|459860635|FG002|Baseline Study Visit|Protocol Violation|0|||
127791290|NCT01964352|459860636|FG000|Overall Study|Adverse Event|13|||
127884368|NCT02117479|460199909|FG000|Overall Study|Noncompliance with study treatment|1|||
127884369|NCT02117479|460199910|FG001|Overall Study|Noncompliance with study treatment|0|||
127884370|NCT02117479|460199909|FG000|Overall Study|Study terminated by the sponsor|4|||
127884371|NCT02117479|460199910|FG001|Overall Study|Study terminated by the sponsor|6|||
127617761|NCT03400332|459229067|FG007|Treatment|Participant withdrew consent|1|||
127884372|NCT02117479|460199909|FG000|Overall Study|Physician Decision|7|||
127884373|NCT02117479|460199910|FG001|Overall Study|Physician Decision|2|||
127884374|NCT02117479|460199909|FG000|Overall Study|Other unspecified|11|||
127884375|NCT02117479|460199910|FG001|Overall Study|Other unspecified|7|||
127884376|NCT01959230|460199911|FG000|Overall Study|Failure to follow study procedures|0|||
127884377|NCT01959230|460199912|FG001|Overall Study|Failure to follow study procedures|1|||
127884378|NCT01959230|460199911|FG000|Overall Study|Administrative reasons|2|||
127884379|NCT01959230|460199912|FG001|Overall Study|Administrative reasons|0|||
127884380|NCT01959230|460199911|FG000|Overall Study|Withdrawal by Subject|2|||
127884381|NCT01959230|460199912|FG001|Overall Study|Withdrawal by Subject|0|||
127884382|NCT00720304|460199913|FG000|Overall Study|Withdrawal by Subject|14|||
127884383|NCT00720304|460199914|FG001|Overall Study|Withdrawal by Subject|1|||
127884384|NCT00720304|460199913|FG000|Overall Study|Death|1|||
127884385|NCT00720304|460199914|FG001|Overall Study|Death|0|||
127884386|NCT00720304|460199913|FG000|Overall Study|Physician Decision|5|||
127884387|NCT00720304|460199914|FG001|Overall Study|Physician Decision|2|||
127884388|NCT00720304|460199913|FG000|Overall Study|Adverse Event|3|||
127884389|NCT00720304|460199914|FG001|Overall Study|Adverse Event|1|||
127884390|NCT00720304|460199913|FG000|Overall Study|Disease progression|6|||
127884391|NCT00720304|460199914|FG001|Overall Study|Disease progression|1|||
127884392|NCT01333475|460199915|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
127884393|NCT01333475|460199916|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
127884394|NCT01333475|460199915|FG000|Overall Study|Toxicity|1|||
127884395|NCT01333475|460199916|FG001|Overall Study|Toxicity|3|||
127617762|NCT03400332|459229068|FG008|Treatment|Participant withdrew consent|1|||
127617763|NCT03400332|459229060|FG000|Treatment|Other reasons|0|||
127617764|NCT03400332|459229061|FG001|Treatment|Other reasons|1|||
127617765|NCT03400332|459229062|FG002|Treatment|Other reasons|1|||
127617766|NCT03400332|459229063|FG003|Treatment|Other reasons|0|||
127617767|NCT03400332|459229064|FG004|Treatment|Other reasons|3|||
127617768|NCT03400332|459229065|FG005|Treatment|Other reasons|1|||
127617769|NCT03400332|459229066|FG006|Treatment|Other reasons|2|||
127617770|NCT03400332|459229067|FG007|Treatment|Other reasons|0|||
127617771|NCT03400332|459229068|FG008|Treatment|Other reasons|1|||
127617772|NCT03400332|459229060|FG000|Treatment|Lost to Follow-up|0|||
127617773|NCT03400332|459229061|FG001|Treatment|Lost to Follow-up|1|||
127617774|NCT03400332|459229062|FG002|Treatment|Lost to Follow-up|0|||
127617775|NCT03400332|459229063|FG003|Treatment|Lost to Follow-up|0|||
127617776|NCT03400332|459229064|FG004|Treatment|Lost to Follow-up|0|||
127617777|NCT03400332|459229065|FG005|Treatment|Lost to Follow-up|0|||
127617778|NCT03400332|459229066|FG006|Treatment|Lost to Follow-up|0|||
127617779|NCT03400332|459229067|FG007|Treatment|Lost to Follow-up|0|||
127617780|NCT03400332|459229068|FG008|Treatment|Lost to Follow-up|0|||
127617781|NCT03400332|459229060|FG000|Treatment|Death|3|||
127617782|NCT03400332|459229061|FG001|Treatment|Death|1|||
127617783|NCT03400332|459229062|FG002|Treatment|Death|2|||
127617784|NCT03400332|459229063|FG003|Treatment|Death|3|||
127617785|NCT03400332|459229064|FG004|Treatment|Death|6|||
127617786|NCT03400332|459229065|FG005|Treatment|Death|2|||
127700042|NCT05540665|459530897|FG001|Overall Study|Study terminated by sponsor|6|||
127700043|NCT05540665|459530898|FG002|Overall Study|Study terminated by sponsor|7|||
127700044|NCT02359890|459530899|FG000|Overall Study|Not meeting eligibility|4|||
127700045|NCT02359890|459530899|FG000|Overall Study|Never treated with study catheter|6|||
127884396|NCT00370396|460199919|FG000|Overall Study|Withdrawal by Subject|0|||
127884397|NCT00370396|460199920|FG001|Overall Study|Withdrawal by Subject|0|||
127884398|NCT00370396|460199921|FG002|Overall Study|Withdrawal by Subject|1|||
127884399|NCT00370396|460199919|FG000|Overall Study|Lost to Follow-up|11|||
127617787|NCT03400332|459229066|FG006|Treatment|Death|1|||
127617788|NCT03400332|459229067|FG007|Treatment|Death|3|||
127617789|NCT03400332|459229068|FG008|Treatment|Death|6|||
127617790|NCT04476017|459229073|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
127884400|NCT00370396|460199920|FG001|Overall Study|Lost to Follow-up|1|||
127617791|NCT04476017|459229074|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
127617792|NCT02704364|459229075|FG000|Overall Study|Adverse Event|1|||
127617793|NCT02704364|459229076|FG001|Overall Study|Adverse Event|1|||
127617794|NCT02704364|459229077|FG002|Overall Study|Adverse Event|0|||
127617795|NCT02704364|459229075|FG000|Overall Study|Noncompliance with study drug|1|||
127617796|NCT02704364|459229076|FG001|Overall Study|Noncompliance with study drug|1|||
127617797|NCT02704364|459229077|FG002|Overall Study|Noncompliance with study drug|0|||
127617798|NCT02704364|459229075|FG000|Overall Study|Other|0|||
127617799|NCT02704364|459229076|FG001|Overall Study|Other|1|||
127700046|NCT04066244|459530900|FG000|Part 2 (Cohort 5)|Adverse Event|0|||
127884401|NCT00370396|460199921|FG002|Overall Study|Lost to Follow-up|0|||
127884402|NCT01364298|460199928|FG000|Overall Study|Adverse Event|3|||
127884403|NCT01364298|460199929|FG001|Overall Study|Adverse Event|4|||
127884404|NCT01364298|460199928|FG000|Overall Study|Lack of adherence to treatment|1|||
127884405|NCT01364298|460199929|FG001|Overall Study|Lack of adherence to treatment|3|||
127884406|NCT01364298|460199928|FG000|Overall Study|Lack of Efficacy|1|||
127884407|NCT01364298|460199929|FG001|Overall Study|Lack of Efficacy|0|||
127884408|NCT01364298|460199928|FG000|Overall Study|Lost to Follow-up|5|||
127884409|NCT01364298|460199929|FG001|Overall Study|Lost to Follow-up|10|||
127884410|NCT01364298|460199928|FG000|Overall Study|Withdrawal by Subject|3|||
127884411|NCT01364298|460199929|FG001|Overall Study|Withdrawal by Subject|3|||
127884412|NCT01364298|460199928|FG000|Overall Study|Other|1|||
127884413|NCT01364298|460199929|FG001|Overall Study|Other|3|||
127884414|NCT00659581|460199930|FG000|Overall Study|Adverse Event|1006|||
127884415|NCT00659581|460199930|FG000|Overall Study|Lack of Efficacy|1183|||
127884416|NCT00659581|460199930|FG000|Overall Study|Other|6393|||
127884417|NCT03125629|460199936|FG000|Overall Study|Withdrawal by Subject|2|||
127884418|NCT03125629|460199936|FG000|Overall Study|Equipment malfunction|1|||
127884419|NCT03909971|460199937|FG000|Overall Study|Other Reasons Not Specified|0|||
127884420|NCT03909971|460199938|FG001|Overall Study|Other Reasons Not Specified|1|||
127884421|NCT03909971|460199937|FG000|Overall Study|Global Deterioration of Health Status|2|||
127884422|NCT03909971|460199938|FG001|Overall Study|Global Deterioration of Health Status|1|||
127884423|NCT03909971|460199937|FG000|Overall Study|Progressive Disease|6|||
127884424|NCT03909971|460199938|FG001|Overall Study|Progressive Disease|14|||
127884425|NCT03909971|460199937|FG000|Overall Study|Death|2|||
127884426|NCT03909971|460199938|FG001|Overall Study|Death|6|||
127884427|NCT04523831|460199946|FG000|Overall Study|Lost to Follow-up|15|||
127884428|NCT04523831|460199947|FG001|Overall Study|Lost to Follow-up|17|||
127884429|NCT04523831|460199946|FG000|Overall Study|Death|0|||
127884430|NCT04523831|460199947|FG001|Overall Study|Death|3|||
127700047|NCT04066244|459530901|FG001|Part 2 (Cohort 5)|Adverse Event|0|||
127700048|NCT04066244|459530902|FG002|Part 2 (Cohort 5)|Adverse Event|0|||
127700049|NCT04066244|459530903|FG003|Part 2 (Cohort 5)|Adverse Event|0|||
127700050|NCT04066244|459530904|FG004|Part 2 (Cohort 5)|Adverse Event|0|||
127700051|NCT04066244|459530905|FG005|Part 2 (Cohort 5)|Adverse Event|1|||
127700052|NCT04066244|459530900|FG000|Part 2 (Cohort 5)|Death|0|||
127700053|NCT04066244|459530901|FG001|Part 2 (Cohort 5)|Death|0|||
127700054|NCT04066244|459530902|FG002|Part 2 (Cohort 5)|Death|0|||
127700055|NCT04066244|459530903|FG003|Part 2 (Cohort 5)|Death|0|||
127700056|NCT04066244|459530904|FG004|Part 2 (Cohort 5)|Death|0|||
127700057|NCT04066244|459530905|FG005|Part 2 (Cohort 5)|Death|2|||
127884431|NCT04523831|460199946|FG000|Overall Study|Adverse Event|2|||
127884432|NCT04523831|460199947|FG001|Overall Study|Adverse Event|0|||
127617800|NCT02704364|459229077|FG002|Overall Study|Other|1|||
127700058|NCT04066244|459530900|FG000|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
127700059|NCT04066244|459530901|FG001|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
127700060|NCT04066244|459530902|FG002|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
127884433|NCT00430638|460199952|FG000|Overall Study|Adverse Event|15|||
127884434|NCT00430638|460199953|FG001|Overall Study|Adverse Event|15|||
127884435|NCT00430638|460199952|FG000|Overall Study|Uncontrolled blood pressure|48|||
127884436|NCT00430638|460199953|FG001|Overall Study|Uncontrolled blood pressure|13|||
127700061|NCT04066244|459530903|FG003|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
127700062|NCT04066244|459530904|FG004|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
127884437|NCT00430638|460199952|FG000|Overall Study|Lost to Follow-up|1|||
127884438|NCT00430638|460199953|FG001|Overall Study|Lost to Follow-up|7|||
127617801|NCT02975934|459229078|FG000|Treatment Phase|Never initiated study drug|0|||
127617802|NCT02975934|459229079|FG001|Treatment Phase|Never initiated study drug|5|||
127617803|NCT02975934|459229080|FG002|Treatment Phase|Never initiated study drug|0|||
127617804|NCT03362502|459229081|FG000|Overall Study|Death|0|||
127617805|NCT03362502|459229082|FG001|Overall Study|Death|0|||
127617806|NCT03362502|459229083|FG002|Overall Study|Death|1|||
127617807|NCT02075840|459229084|FG000|Overall Study|Withdrawal by Subject|13|||
127617808|NCT02075840|459229085|FG001|Overall Study|Withdrawal by Subject|22|||
127617809|NCT02075840|459229084|FG000|Overall Study|Reason not specified|1|||
127617810|NCT02075840|459229085|FG001|Overall Study|Reason not specified|0|||
127617811|NCT02075840|459229084|FG000|Overall Study|Adverse Event|0|||
127617812|NCT02075840|459229085|FG001|Overall Study|Adverse Event|2|||
127617813|NCT02075840|459229084|FG000|Overall Study|Death|35|||
127617814|NCT02075840|459229085|FG001|Overall Study|Death|40|||
127617815|NCT02075840|459229084|FG000|Overall Study|Lost to Follow-up|3|||
127617816|NCT02075840|459229085|FG001|Overall Study|Lost to Follow-up|2|||
127617817|NCT02075840|459229084|FG000|Overall Study|Physician Decision|1|||
127617818|NCT02075840|459229085|FG001|Overall Study|Physician Decision|3|||
127617819|NCT02075840|459229084|FG000|Overall Study|Ongoing at CCOD|99|||
127617820|NCT02075840|459229085|FG001|Overall Study|Ongoing at CCOD|82|||
127617821|NCT00846742|459229086|FG000|Overall Study|Withdrawal by Subject|1|||
127617822|NCT03795610|459229087|FG000|Overall Study|Screen Failure (Did not meet inclusion/exclusion)|4|||
127617823|NCT03795610|459229087|FG000|Overall Study|Withdrawal by Subject|1|||
127617824|NCT03795610|459229087|FG000|Overall Study|Screen Failure (Unknown)|1|||
127617825|NCT03909165|459229098|FG000|Overall Study|Physician Decision|0|||
127617826|NCT03909165|459229099|FG001|Overall Study|Physician Decision|1|||
127617827|NCT03909165|459229100|FG002|Overall Study|Physician Decision|0|||
127617828|NCT03909165|459229101|FG003|Overall Study|Physician Decision|0|||
127617829|NCT03909165|459229102|FG004|Overall Study|Physician Decision|0|||
127617830|NCT03909165|459229098|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
127617831|NCT03909165|459229099|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
127617832|NCT03909165|459229100|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
127617833|NCT03909165|459229101|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
127617834|NCT03909165|459229102|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
127617835|NCT03909165|459229098|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
127617836|NCT03909165|459229099|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
127617837|NCT03909165|459229100|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
127617838|NCT03909165|459229101|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
127617839|NCT03909165|459229102|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
127617840|NCT03909165|459229098|FG000|Overall Study|Previous Drug Exposure|0|||
127617841|NCT03909165|459229099|FG001|Overall Study|Previous Drug Exposure|0|||
127617842|NCT03909165|459229100|FG002|Overall Study|Previous Drug Exposure|1|||
127617843|NCT03909165|459229101|FG003|Overall Study|Previous Drug Exposure|0|||
127700063|NCT04066244|459530905|FG005|Part 2 (Cohort 5)|Study terminated by sponsor|1|||
127700064|NCT04066244|459530900|FG000|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
127700065|NCT04066244|459530901|FG001|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
127700066|NCT04066244|459530902|FG002|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
127700067|NCT04066244|459530903|FG003|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
127700068|NCT04066244|459530904|FG004|Part 2 (Cohort 5)|Withdrawal by Subject|1|||
127700069|NCT04066244|459530905|FG005|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
127700070|NCT04632992|459530908|FG000|Overall Study|Adverse Event|0|||
127700071|NCT04632992|459530909|FG001|Overall Study|Adverse Event|0|||
127700072|NCT04632992|459530910|FG002|Overall Study|Adverse Event|0|||
127700073|NCT04632992|459530911|FG003|Overall Study|Adverse Event|0|||
127700074|NCT04632992|459530912|FG004|Overall Study|Adverse Event|0|||
127700075|NCT04632992|459530913|FG005|Overall Study|Adverse Event|0|||
127700076|NCT04632992|459530914|FG006|Overall Study|Adverse Event|0|||
127700077|NCT04632992|459530915|FG007|Overall Study|Adverse Event|0|||
127700078|NCT04632992|459530916|FG008|Overall Study|Adverse Event|0|||
127700079|NCT04632992|459530917|FG009|Overall Study|Adverse Event|0|||
127700080|NCT04632992|459530918|FG010|Overall Study|Adverse Event|0|||
127700081|NCT04632992|459530919|FG011|Overall Study|Adverse Event|0|||
127700082|NCT04632992|459530920|FG012|Overall Study|Adverse Event|1|||
127700083|NCT04632992|459530921|FG013|Overall Study|Adverse Event|0|||
127700084|NCT04632992|459530908|FG000|Overall Study|Death|17|||
127700085|NCT04632992|459530909|FG001|Overall Study|Death|1|||
127700086|NCT04632992|459530910|FG002|Overall Study|Death|14|||
127700087|NCT04632992|459530911|FG003|Overall Study|Death|14|||
127700088|NCT04632992|459530912|FG004|Overall Study|Death|13|||
127700089|NCT04632992|459530913|FG005|Overall Study|Death|6|||
127700090|NCT04632992|459530914|FG006|Overall Study|Death|7|||
127791291|NCT01964352|459860637|FG001|Overall Study|Adverse Event|3|||
127791292|NCT01964352|459860638|FG002|Overall Study|Adverse Event|4|||
127617844|NCT03909165|459229102|FG004|Overall Study|Previous Drug Exposure|0|||
127617845|NCT03909165|459229098|FG000|Overall Study|Early Discharge|1|||
127617846|NCT03909165|459229099|FG001|Overall Study|Early Discharge|0|||
127617847|NCT03909165|459229100|FG002|Overall Study|Early Discharge|0|||
127617848|NCT03909165|459229101|FG003|Overall Study|Early Discharge|0|||
127617849|NCT03909165|459229102|FG004|Overall Study|Early Discharge|0|||
127617850|NCT02018458|459229104|FG000|Overall Study|Death|4|||
127617851|NCT04098458|459229130|FG000|Overall Study|Death|1|||
127617852|NCT04098458|459229130|FG000|Overall Study|did not meet study inclusion criteria|3|||
127617853|NCT04033159|459229131|FG000|Washout Period|Physician Decision|0|||
127617854|NCT04033159|459229132|FG001|Washout Period|Physician Decision|1|||
127617855|NCT04033159|459229133|FG002|Washout Period|Physician Decision|0|||
127617856|NCT04033159|459229131|FG000|Washout Period|Study terminated by Sponsor|0|||
127617857|NCT04033159|459229132|FG001|Washout Period|Study terminated by Sponsor|7|||
127617858|NCT04033159|459229133|FG002|Washout Period|Study terminated by Sponsor|0|||
127617859|NCT04033159|459229131|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
127617860|NCT04033159|459229132|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
127617861|NCT04033159|459229133|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
127617862|NCT00006489|459229136|FG000|Overall Study|Adverse Event|3|||
127617863|NCT00006489|459229137|FG001|Overall Study|Adverse Event|2|||
127617864|NCT00006489|459229138|FG002|Overall Study|Adverse Event|4|||
127617865|NCT00006489|459229139|FG003|Overall Study|Adverse Event|3|||
127617866|NCT00006489|459229136|FG000|Overall Study|Withdrawal by Subject|10|||
127617867|NCT00006489|459229137|FG001|Overall Study|Withdrawal by Subject|9|||
127617868|NCT00006489|459229138|FG002|Overall Study|Withdrawal by Subject|9|||
127617869|NCT00006489|459229139|FG003|Overall Study|Withdrawal by Subject|6|||
127617870|NCT00006489|459229136|FG000|Overall Study|Scheduling Conflict|0|||
127617871|NCT00006489|459229137|FG001|Overall Study|Scheduling Conflict|3|||
127617872|NCT00006489|459229138|FG002|Overall Study|Scheduling Conflict|2|||
127617873|NCT00006489|459229139|FG003|Overall Study|Scheduling Conflict|1|||
127617874|NCT00006489|459229136|FG000|Overall Study|Death|0|||
127617875|NCT00006489|459229137|FG001|Overall Study|Death|0|||
127617876|NCT00006489|459229138|FG002|Overall Study|Death|0|||
127617877|NCT00006489|459229139|FG003|Overall Study|Death|1|||
127617878|NCT00354172|459229140|FG000|Overall Study|Did not receive transplant|1|||
127617879|NCT01585766|459229144|FG000|Overall Study|Withdrawal by Subject|0|||
127617880|NCT01585766|459229145|FG001|Overall Study|Withdrawal by Subject|1|||
127617881|NCT01585766|459229146|FG002|Overall Study|Withdrawal by Subject|1|||
127617882|NCT01585766|459229147|FG003|Overall Study|Withdrawal by Subject|0|||
127617883|NCT01585766|459229148|FG004|Overall Study|Withdrawal by Subject|0|||
127617884|NCT01585766|459229149|FG005|Overall Study|Withdrawal by Subject|0|||
127700091|NCT04632992|459530915|FG007|Overall Study|Death|12|||
127700092|NCT04632992|459530916|FG008|Overall Study|Death|15|||
127700093|NCT04632992|459530917|FG009|Overall Study|Death|20|||
127700094|NCT04632992|459530918|FG010|Overall Study|Death|8|||
127700095|NCT04632992|459530919|FG011|Overall Study|Death|2|||
127700096|NCT04632992|459530920|FG012|Overall Study|Death|10|||
127700097|NCT04632992|459530921|FG013|Overall Study|Death|1|||
127700098|NCT04632992|459530908|FG000|Overall Study|Lost to Follow-up|1|||
127700099|NCT04632992|459530909|FG001|Overall Study|Lost to Follow-up|0|||
127700100|NCT04632992|459530910|FG002|Overall Study|Lost to Follow-up|1|||
127700101|NCT04632992|459530911|FG003|Overall Study|Lost to Follow-up|0|||
127700102|NCT04632992|459530912|FG004|Overall Study|Lost to Follow-up|2|||
127700103|NCT04632992|459530913|FG005|Overall Study|Lost to Follow-up|0|||
127700104|NCT04632992|459530914|FG006|Overall Study|Lost to Follow-up|1|||
127700105|NCT04632992|459530915|FG007|Overall Study|Lost to Follow-up|1|||
127700106|NCT04632992|459530916|FG008|Overall Study|Lost to Follow-up|1|||
127700107|NCT04632992|459530917|FG009|Overall Study|Lost to Follow-up|1|||
127700108|NCT04632992|459530918|FG010|Overall Study|Lost to Follow-up|2|||
127700109|NCT04632992|459530919|FG011|Overall Study|Lost to Follow-up|0|||
127700110|NCT04632992|459530920|FG012|Overall Study|Lost to Follow-up|0|||
127700111|NCT04632992|459530921|FG013|Overall Study|Lost to Follow-up|0|||
127700112|NCT04632992|459530908|FG000|Overall Study|Reason not Specified|2|||
127700113|NCT04632992|459530909|FG001|Overall Study|Reason not Specified|0|||
127700114|NCT04632992|459530910|FG002|Overall Study|Reason not Specified|1|||
127700115|NCT04632992|459530911|FG003|Overall Study|Reason not Specified|1|||
127700116|NCT04632992|459530912|FG004|Overall Study|Reason not Specified|0|||
127700117|NCT04632992|459530913|FG005|Overall Study|Reason not Specified|0|||
127884439|NCT00430638|460199952|FG000|Overall Study|Protocol Violation|6|||
127884440|NCT00430638|460199953|FG001|Overall Study|Protocol Violation|4|||
127617885|NCT01585766|459229144|FG000|Overall Study|Death|0|||
127617886|NCT01585766|459229145|FG001|Overall Study|Death|1|||
127617887|NCT01585766|459229146|FG002|Overall Study|Death|0|||
127617888|NCT01585766|459229147|FG003|Overall Study|Death|0|||
127617889|NCT01585766|459229148|FG004|Overall Study|Death|0|||
127617890|NCT01585766|459229149|FG005|Overall Study|Death|0|||
127617891|NCT01585766|459229144|FG000|Overall Study|Physician Decision|0|||
127617892|NCT01585766|459229145|FG001|Overall Study|Physician Decision|0|||
127700118|NCT04632992|459530914|FG006|Overall Study|Reason not Specified|0|||
127617893|NCT01585766|459229146|FG002|Overall Study|Physician Decision|1|||
127617894|NCT01585766|459229147|FG003|Overall Study|Physician Decision|0|||
127617895|NCT01585766|459229148|FG004|Overall Study|Physician Decision|0|||
127617896|NCT01585766|459229149|FG005|Overall Study|Physician Decision|0|||
127617897|NCT02385799|459229150|FG000|Overall Study|Lost to Follow-up|1|||
127617898|NCT02385799|459229151|FG001|Overall Study|Lost to Follow-up|2|||
127617899|NCT02385799|459229150|FG000|Overall Study|Adverse Event|4|||
127617900|NCT02385799|459229151|FG001|Overall Study|Adverse Event|2|||
127617901|NCT02385799|459229150|FG000|Overall Study|Withdrawal by Subject|0|||
127617902|NCT02385799|459229151|FG001|Overall Study|Withdrawal by Subject|4|||
127617903|NCT02130765|459229153|FG000|Overall Study|Did not receive treatment|4|||
127617904|NCT02130765|459229154|FG001|Overall Study|Did not receive treatment|0|||
127617905|NCT02130765|459229155|FG002|Overall Study|Did not receive treatment|0|||
127617906|NCT02130765|459229156|FG003|Overall Study|Did not receive treatment|0|||
127617907|NCT00058825|459229159|FG000|Overall Study|Relapse|9|||
127617908|NCT00058825|459229159|FG000|Overall Study|Progressive Disease|5|||
127617909|NCT00058825|459229159|FG000|Overall Study|Graft Failure|5|||
127617910|NCT00058825|459229159|FG000|Overall Study|Death|3|||
127617911|NCT02469610|459229160|FG000|Overall Study|Death|1|||
127617912|NCT02469610|459229161|FG001|Overall Study|Death|0|||
127617913|NCT02469610|459229160|FG000|Overall Study|Lost to Follow-up|1|||
127617914|NCT02469610|459229161|FG001|Overall Study|Lost to Follow-up|0|||
127617915|NCT02469610|459229160|FG000|Overall Study|exclusion criteria|2|||
127617916|NCT02469610|459229161|FG001|Overall Study|exclusion criteria|1|||
127617917|NCT01806896|459229162|FG000|Overall Study|Adverse Event|2|||
127617918|NCT01806896|459229163|FG001|Overall Study|Adverse Event|0|||
127791293|NCT01964352|459860639|FG003|Overall Study|Adverse Event|3|||
127791294|NCT01964352|459860636|FG000|Overall Study|Lack of Efficacy|6|||
127791295|NCT01964352|459860637|FG001|Overall Study|Lack of Efficacy|0|||
127791296|NCT01964352|459860638|FG002|Overall Study|Lack of Efficacy|0|||
127791297|NCT01964352|459860639|FG003|Overall Study|Lack of Efficacy|0|||
127791298|NCT01964352|459860636|FG000|Overall Study|Protocol Violation|2|||
127791299|NCT01964352|459860637|FG001|Overall Study|Protocol Violation|4|||
127791300|NCT01964352|459860638|FG002|Overall Study|Protocol Violation|0|||
127791301|NCT01964352|459860639|FG003|Overall Study|Protocol Violation|2|||
127791302|NCT01964352|459860636|FG000|Overall Study|Lost to Follow-up|1|||
127791303|NCT01964352|459860637|FG001|Overall Study|Lost to Follow-up|0|||
127791304|NCT01964352|459860638|FG002|Overall Study|Lost to Follow-up|0|||
127791305|NCT01964352|459860639|FG003|Overall Study|Lost to Follow-up|1|||
127791306|NCT01964352|459860636|FG000|Overall Study|Withdrawal by Subject|4|||
127791307|NCT01964352|459860637|FG001|Overall Study|Withdrawal by Subject|2|||
127617919|NCT01806896|459229162|FG000|Overall Study|Other|1|||
127617920|NCT01806896|459229163|FG001|Overall Study|Other|0|||
127617921|NCT01574352|459229164|FG000|Overall Study|Withdrawal by Subject|6|||
127617922|NCT01574352|459229165|FG001|Overall Study|Withdrawal by Subject|13|||
127617923|NCT01574352|459229164|FG000|Overall Study|Injury in non-camp related sport|1|||
127617924|NCT01574352|459229165|FG001|Overall Study|Injury in non-camp related sport|0|||
127791308|NCT01964352|459860638|FG002|Overall Study|Withdrawal by Subject|1|||
127791309|NCT01964352|459860639|FG003|Overall Study|Withdrawal by Subject|0|||
127791310|NCT01964352|459860636|FG000|Overall Study|Other than stated above|0|||
127791311|NCT01964352|459860637|FG001|Overall Study|Other than stated above|2|||
127791312|NCT01964352|459860638|FG002|Overall Study|Other than stated above|1|||
127791313|NCT01964352|459860639|FG003|Overall Study|Other than stated above|2|||
127617925|NCT03316872|459229166|FG000|Overall Study|Death|1|||
127617926|NCT00640510|459230528|FG000|Overall Study|Lack of Efficacy|0|||
127617927|NCT00640510|459230529|FG001|Overall Study|Lack of Efficacy|1|||
127617928|NCT00640510|459230528|FG000|Overall Study|Protocol Violation|1|||
127617929|NCT00640510|459230529|FG001|Overall Study|Protocol Violation|0|||
127617930|NCT00640510|459230528|FG000|Overall Study|Physician Decision|0|||
127617931|NCT00640510|459230529|FG001|Overall Study|Physician Decision|1|||
127617932|NCT00355238|459230531|FG000|Overall Study|Adverse event unrelated to study drug|2|||
127617933|NCT00355238|459230532|FG001|Overall Study|Adverse event unrelated to study drug|2|||
127617934|NCT00355238|459230533|FG002|Overall Study|Adverse event unrelated to study drug|0|||
127617935|NCT00355238|459230534|FG003|Overall Study|Adverse event unrelated to study drug|1|||
127617936|NCT00355238|459230531|FG000|Overall Study|Death|1|||
127617937|NCT00355238|459230532|FG001|Overall Study|Death|0|||
127617938|NCT00355238|459230533|FG002|Overall Study|Death|0|||
127617939|NCT00355238|459230534|FG003|Overall Study|Death|0|||
127617940|NCT00355238|459230531|FG000|Overall Study|Disease progression|37|||
127617941|NCT00355238|459230532|FG001|Overall Study|Disease progression|36|||
127617942|NCT00355238|459230533|FG002|Overall Study|Disease progression|16|||
127617943|NCT00355238|459230534|FG003|Overall Study|Disease progression|11|||
127617944|NCT00355238|459230531|FG000|Overall Study|Study drug toxicity|11|||
127617945|NCT00355238|459230532|FG001|Overall Study|Study drug toxicity|7|||
127791314|NCT00477165|459860642|FG000|Overall Study|Adverse Event|7|||
127791315|NCT00477165|459860643|FG001|Overall Study|Adverse Event|2|||
127791316|NCT00105443|459860644|FG000|Double-Blind Treatment|Adverse Event|1|||
127791317|NCT00105443|459860645|FG001|Double-Blind Treatment|Adverse Event|0|||
127791318|NCT00105443|459860646|FG002|Double-Blind Treatment|Adverse Event|0|||
127700119|NCT04632992|459530915|FG007|Overall Study|Reason not Specified|0|||
127700120|NCT04632992|459530916|FG008|Overall Study|Reason not Specified|0|||
127700121|NCT04632992|459530917|FG009|Overall Study|Reason not Specified|0|||
127700122|NCT04632992|459530918|FG010|Overall Study|Reason not Specified|1|||
127700123|NCT04632992|459530919|FG011|Overall Study|Reason not Specified|0|||
127700124|NCT04632992|459530920|FG012|Overall Study|Reason not Specified|0|||
127700125|NCT04632992|459530921|FG013|Overall Study|Reason not Specified|0|||
127700126|NCT04632992|459530908|FG000|Overall Study|Physician Decision|0|||
127700127|NCT04632992|459530909|FG001|Overall Study|Physician Decision|0|||
127700128|NCT04632992|459530910|FG002|Overall Study|Physician Decision|0|||
127617946|NCT00355238|459230533|FG002|Overall Study|Study drug toxicity|5|||
127700129|NCT04632992|459530911|FG003|Overall Study|Physician Decision|2|||
127700130|NCT04632992|459530912|FG004|Overall Study|Physician Decision|1|||
127700131|NCT04632992|459530913|FG005|Overall Study|Physician Decision|0|||
127700132|NCT04632992|459530914|FG006|Overall Study|Physician Decision|0|||
127700133|NCT04632992|459530915|FG007|Overall Study|Physician Decision|0|||
127700134|NCT04632992|459530916|FG008|Overall Study|Physician Decision|0|||
127700135|NCT04632992|459530917|FG009|Overall Study|Physician Decision|0|||
127700136|NCT04632992|459530918|FG010|Overall Study|Physician Decision|0|||
127700137|NCT04632992|459530919|FG011|Overall Study|Physician Decision|0|||
127700138|NCT04632992|459530920|FG012|Overall Study|Physician Decision|3|||
127700139|NCT04632992|459530921|FG013|Overall Study|Physician Decision|0|||
127700140|NCT04632992|459530908|FG000|Overall Study|Progressive Disease|0|||
127700141|NCT04632992|459530909|FG001|Overall Study|Progressive Disease|0|||
127700142|NCT04632992|459530910|FG002|Overall Study|Progressive Disease|0|||
127700143|NCT04632992|459530911|FG003|Overall Study|Progressive Disease|0|||
127617947|NCT00355238|459230534|FG003|Overall Study|Study drug toxicity|2|||
127617948|NCT00355238|459230531|FG000|Overall Study|Participant withdrew consent|3|||
127617949|NCT00355238|459230532|FG001|Overall Study|Participant withdrew consent|1|||
127617950|NCT00355238|459230533|FG002|Overall Study|Participant withdrew consent|0|||
127617951|NCT00355238|459230534|FG003|Overall Study|Participant withdrew consent|0|||
127617952|NCT00355238|459230531|FG000|Overall Study|Participant request to discontinue study treatment|1|||
127617953|NCT00355238|459230532|FG001|Overall Study|Participant request to discontinue study treatment|0|||
127617954|NCT00355238|459230533|FG002|Overall Study|Participant request to discontinue study treatment|1|||
127617955|NCT00355238|459230534|FG003|Overall Study|Participant request to discontinue study treatment|0|||
127617956|NCT01956110|459230535|FG000|Overall Study|Protocol Violation|25|||
127617957|NCT01956110|459230536|FG001|Overall Study|Protocol Violation|11|||
127617958|NCT01956110|459230535|FG000|Overall Study|Adverse Event|9|||
127700144|NCT04632992|459530912|FG004|Overall Study|Progressive Disease|1|||
127700145|NCT04632992|459530913|FG005|Overall Study|Progressive Disease|0|||
127700146|NCT04632992|459530914|FG006|Overall Study|Progressive Disease|0|||
127700147|NCT04632992|459530915|FG007|Overall Study|Progressive Disease|0|||
127700148|NCT04632992|459530916|FG008|Overall Study|Progressive Disease|0|||
127700149|NCT04632992|459530917|FG009|Overall Study|Progressive Disease|1|||
127700150|NCT04632992|459530918|FG010|Overall Study|Progressive Disease|1|||
127700151|NCT04632992|459530919|FG011|Overall Study|Progressive Disease|0|||
127700152|NCT04632992|459530920|FG012|Overall Study|Progressive Disease|2|||
127700153|NCT04632992|459530921|FG013|Overall Study|Progressive Disease|0|||
127700154|NCT04632992|459530908|FG000|Overall Study|Withdrawal by Subject|4|||
127700155|NCT04632992|459530909|FG001|Overall Study|Withdrawal by Subject|1|||
127700156|NCT04632992|459530910|FG002|Overall Study|Withdrawal by Subject|5|||
127700157|NCT04632992|459530911|FG003|Overall Study|Withdrawal by Subject|4|||
127700158|NCT04632992|459530912|FG004|Overall Study|Withdrawal by Subject|3|||
127700159|NCT04632992|459530913|FG005|Overall Study|Withdrawal by Subject|3|||
127700160|NCT04632992|459530914|FG006|Overall Study|Withdrawal by Subject|0|||
127700161|NCT04632992|459530915|FG007|Overall Study|Withdrawal by Subject|5|||
127700162|NCT04632992|459530916|FG008|Overall Study|Withdrawal by Subject|0|||
127700163|NCT04632992|459530917|FG009|Overall Study|Withdrawal by Subject|2|||
127700164|NCT04632992|459530918|FG010|Overall Study|Withdrawal by Subject|8|||
127700165|NCT04632992|459530919|FG011|Overall Study|Withdrawal by Subject|0|||
127700166|NCT04632992|459530920|FG012|Overall Study|Withdrawal by Subject|1|||
127700167|NCT04632992|459530921|FG013|Overall Study|Withdrawal by Subject|1|||
127700168|NCT02547233|459530922|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
127700169|NCT02547233|459530923|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
127700170|NCT02547233|459530922|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
127700171|NCT02547233|459530923|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
127700172|NCT02547233|459530922|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
127700173|NCT02547233|459530923|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
127700174|NCT02547233|459530922|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
127700175|NCT02547233|459530923|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
127700176|NCT02547233|459530922|FG000|12-month Follow-up|Withdrawal by Subject|10|||
127700177|NCT02547233|459530923|FG001|12-month Follow-up|Withdrawal by Subject|10|||
127700178|NCT02547233|459530922|FG000|12-month Follow-up|Lost to Follow-up|3|||
127617959|NCT01956110|459230536|FG001|Overall Study|Adverse Event|10|||
127700179|NCT02547233|459530923|FG001|12-month Follow-up|Lost to Follow-up|3|||
127617960|NCT01956110|459230535|FG000|Overall Study|Personal reasons|1|||
127617961|NCT01956110|459230536|FG001|Overall Study|Personal reasons|1|||
127617962|NCT00910715|459230545|FG000|Overall Study|Lost to Follow-up|22|||
127617963|NCT00910715|459230546|FG001|Overall Study|Lost to Follow-up|26|||
127617964|NCT00910715|459230547|FG002|Overall Study|Lost to Follow-up|0|||
127617965|NCT01467076|459230550|FG000|Overall Study|Lost to Follow-up|1|||
127617966|NCT01467076|459230551|FG001|Overall Study|Lost to Follow-up|0|||
127617967|NCT01467076|459230552|FG002|Overall Study|Lost to Follow-up|0|||
127617968|NCT02506816|459230553|FG000|Overall Study|Adverse Event|3|||
127617969|NCT00418691|459230555|FG000|Overall Study|Lost to Follow-up|1|||
127617970|NCT00418691|459230556|FG001|Overall Study|Lost to Follow-up|2|||
127617971|NCT00418691|459230557|FG002|Overall Study|Lost to Follow-up|3|||
127617972|NCT00418691|459230555|FG000|Overall Study|Started new medication voiding entry|0|||
127617973|NCT00418691|459230556|FG001|Overall Study|Started new medication voiding entry|0|||
127617974|NCT00418691|459230557|FG002|Overall Study|Started new medication voiding entry|1|||
127617975|NCT00418691|459230555|FG000|Overall Study|Progressive Disease|1|||
127617976|NCT00418691|459230556|FG001|Overall Study|Progressive Disease|0|||
127617977|NCT00418691|459230557|FG002|Overall Study|Progressive Disease|1|||
127617978|NCT03762083|459230558|FG000|Overall Study|Withdrawal by Subject|2|||
127617979|NCT03762083|459230558|FG000|Overall Study|Physician Decision|1|||
127617980|NCT00116558|459230559|FG000|Overall Study|Death|11|||
127617981|NCT00116558|459230560|FG001|Overall Study|Death|5|||
127617982|NCT00116558|459230561|FG002|Overall Study|Death|3|||
127617983|NCT00116558|459230559|FG000|Overall Study|Withdrawal by Subject|17|||
127617984|NCT00116558|459230560|FG001|Overall Study|Withdrawal by Subject|3|||
127617985|NCT00116558|459230561|FG002|Overall Study|Withdrawal by Subject|12|||
127617986|NCT00116558|459230559|FG000|Overall Study|disease progression|3|||
127617987|NCT00116558|459230560|FG001|Overall Study|disease progression|7|||
127617988|NCT00116558|459230561|FG002|Overall Study|disease progression|18|||
127617989|NCT02027844|459230562|FG000|Overall Study|Withdrawal by Subject|3|||
127617990|NCT02027844|459230563|FG001|Overall Study|Withdrawal by Subject|2|||
127617991|NCT02027844|459230564|FG002|Overall Study|Withdrawal by Subject|1|||
127617992|NCT02027844|459230562|FG000|Overall Study|Lost to Follow-up|0|||
127617993|NCT02027844|459230563|FG001|Overall Study|Lost to Follow-up|2|||
127617994|NCT02027844|459230564|FG002|Overall Study|Lost to Follow-up|1|||
127617995|NCT02027844|459230562|FG000|Overall Study|Protocol Violation|0|||
127617996|NCT02027844|459230563|FG001|Overall Study|Protocol Violation|2|||
127617997|NCT02027844|459230564|FG002|Overall Study|Protocol Violation|0|||
127617998|NCT02027844|459230562|FG000|Overall Study|Incomlete data|2|||
127617999|NCT02027844|459230563|FG001|Overall Study|Incomlete data|0|||
127618000|NCT02027844|459230564|FG002|Overall Study|Incomlete data|0|||
127618001|NCT00378014|459230565|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
127618002|NCT00378014|459230566|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
127618003|NCT00378014|459230565|FG000|Core (Randomization to Month 11)|Graft loss|1|||
127618004|NCT00378014|459230566|FG001|Core (Randomization to Month 11)|Graft loss|2|||
127618005|NCT00378014|459230565|FG000|Core (Randomization to Month 11)|Death|5|||
127618006|NCT00378014|459230566|FG001|Core (Randomization to Month 11)|Death|3|||
127618007|NCT00378014|459230565|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
127618008|NCT00378014|459230566|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
127618009|NCT00378014|459230565|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
127618010|NCT00378014|459230566|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
127618011|NCT00378014|459230565|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
127618012|NCT00378014|459230566|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
127618013|NCT00378014|459230565|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
127618014|NCT00378014|459230566|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
127618015|NCT00378014|459230565|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
127618016|NCT00378014|459230566|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
127618017|NCT00378014|459230565|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
127618018|NCT00378014|459230566|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
127618019|NCT00378014|459230565|FG000|Extension (Month 12 to Month 59)|Death|1|||
127618020|NCT00378014|459230566|FG001|Extension (Month 12 to Month 59)|Death|2|||
127618021|NCT00378014|459230565|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
127618022|NCT00378014|459230566|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
127618023|NCT00378014|459230565|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
127618024|NCT00378014|459230566|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
127618025|NCT00378014|459230565|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
127618026|NCT00378014|459230566|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
127618027|NCT00378014|459230565|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
127618028|NCT00378014|459230566|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
127618029|NCT02287896|459230579|FG000|Second Injection Visit|Withdrawal by Subject|0|||
127618030|NCT02287896|459230580|FG001|Second Injection Visit|Withdrawal by Subject|1|||
127618031|NCT04889625|459230581|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
127618032|NCT04889625|459230582|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
127618033|NCT04889625|459230581|FG000|Period 1|Subject out of window|0|||
127618034|NCT04889625|459230582|FG001|Period 1|Subject out of window|1|||
127618035|NCT04889625|459230581|FG000|Period 1|Wrong add power dispensed|0|||
127618036|NCT04889625|459230582|FG001|Period 1|Wrong add power dispensed|1|||
127618037|NCT04889625|459230581|FG000|Period 1|Discontinued due to fitting guide error|1|||
127618038|NCT04889625|459230582|FG001|Period 1|Discontinued due to fitting guide error|1|||
127618039|NCT04889625|459230581|FG000|Period 2|Test article no longer available|1|||
127618040|NCT04889625|459230582|FG001|Period 2|Test article no longer available|0|||
127618041|NCT04889625|459230581|FG000|Period 2|Incorrect lens dispensed|1|||
127618042|NCT04889625|459230582|FG001|Period 2|Incorrect lens dispensed|0|||
127618043|NCT04889625|459230581|FG000|Period 2|Wrong add power dispensed|0|||
127618044|NCT04889625|459230582|FG001|Period 2|Wrong add power dispensed|1|||
127618045|NCT03746522|459230592|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
127618046|NCT03746522|459230593|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
127618047|NCT03746522|459230594|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
127618048|NCT03746522|459230592|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
127618049|NCT03746522|459230593|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
127618050|NCT03746522|459230594|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
127618051|NCT03746522|459230592|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
127618052|NCT03746522|459230593|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
127618053|NCT03746522|459230594|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
127618054|NCT03746522|459230592|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
127618055|NCT03746522|459230593|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
127618056|NCT03746522|459230594|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
127618057|NCT03746522|459230592|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
127618058|NCT03746522|459230593|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
127618059|NCT03746522|459230594|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
127618060|NCT01639040|459230595|FG000|Overall Study|Adverse Event|1|||
127618061|NCT01639040|459230596|FG001|Overall Study|Adverse Event|0|||
127618062|NCT00323414|459230599|FG000|Overall Study|Withdrawal by Subject|0|||
127618063|NCT00323414|459230600|FG001|Overall Study|Withdrawal by Subject|1|||
127618064|NCT02552316|459230602|FG000|Overall Study|Withdrawal by Subject|1|||
127618065|NCT02552316|459230602|FG000|Overall Study|Withdrawal due to non-compliance|1|||
127618066|NCT02659020|459230603|FG000|Overall Study|Adverse Event|0|||
127618067|NCT02659020|459230604|FG001|Overall Study|Adverse Event|0|||
127618068|NCT02659020|459230605|FG002|Overall Study|Adverse Event|0|||
127618069|NCT02659020|459230606|FG003|Overall Study|Adverse Event|2|||
127618070|NCT02659020|459230607|FG004|Overall Study|Adverse Event|0|||
127618071|NCT02659020|459230608|FG005|Overall Study|Adverse Event|0|||
127618072|NCT02659020|459230609|FG006|Overall Study|Adverse Event|2|||
127618073|NCT02659020|459230603|FG000|Overall Study|Lost to Follow-up|1|||
127618074|NCT02659020|459230604|FG001|Overall Study|Lost to Follow-up|2|||
127618075|NCT02659020|459230605|FG002|Overall Study|Lost to Follow-up|1|||
127618076|NCT02659020|459230606|FG003|Overall Study|Lost to Follow-up|6|||
127618077|NCT02659020|459230607|FG004|Overall Study|Lost to Follow-up|1|||
127618078|NCT02659020|459230608|FG005|Overall Study|Lost to Follow-up|5|||
127618079|NCT02659020|459230609|FG006|Overall Study|Lost to Follow-up|0|||
127618080|NCT02659020|459230603|FG000|Overall Study|Physician Decision|0|||
127618081|NCT02659020|459230604|FG001|Overall Study|Physician Decision|0|||
127618082|NCT02659020|459230605|FG002|Overall Study|Physician Decision|0|||
127618083|NCT02659020|459230606|FG003|Overall Study|Physician Decision|1|||
127618084|NCT02659020|459230607|FG004|Overall Study|Physician Decision|1|||
127618085|NCT02659020|459230608|FG005|Overall Study|Physician Decision|0|||
127618086|NCT02659020|459230609|FG006|Overall Study|Physician Decision|1|||
127618087|NCT02659020|459230603|FG000|Overall Study|Withdrawal by Subject|2|||
127618088|NCT02659020|459230604|FG001|Overall Study|Withdrawal by Subject|1|||
127618089|NCT02659020|459230605|FG002|Overall Study|Withdrawal by Subject|0|||
127618090|NCT02659020|459230606|FG003|Overall Study|Withdrawal by Subject|3|||
127618091|NCT02659020|459230607|FG004|Overall Study|Withdrawal by Subject|3|||
127618092|NCT02659020|459230608|FG005|Overall Study|Withdrawal by Subject|6|||
127618093|NCT02659020|459230609|FG006|Overall Study|Withdrawal by Subject|3|||
127618094|NCT02659020|459230603|FG000|Overall Study|Progressive Disease|0|||
127618095|NCT02659020|459230604|FG001|Overall Study|Progressive Disease|0|||
127618096|NCT02659020|459230605|FG002|Overall Study|Progressive Disease|0|||
127618097|NCT02659020|459230606|FG003|Overall Study|Progressive Disease|4|||
127618098|NCT02659020|459230607|FG004|Overall Study|Progressive Disease|1|||
127618099|NCT02659020|459230608|FG005|Overall Study|Progressive Disease|0|||
127618100|NCT02659020|459230609|FG006|Overall Study|Progressive Disease|2|||
127618101|NCT04382911|459230610|FG000|Overall Study|unable to be imaged prior to surgery|2|||
127700180|NCT02547233|459530922|FG000|12-month Follow-up|Lack of Efficacy|1|||
127700181|NCT02547233|459530923|FG001|12-month Follow-up|Lack of Efficacy|2|||
127618102|NCT01120210|459230611|FG000|MAIN INFUSION|Adverse Event|1|||
127618103|NCT01120210|459230612|FG001|MAIN INFUSION|Adverse Event|0|||
127618104|NCT01120210|459230611|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
127618105|NCT01120210|459230612|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
127618106|NCT02043015|459230623|FG000|Overall Study|Lost to Follow-up|4|||
127618107|NCT02043015|459230623|FG000|Overall Study|Withdrawal by Subject|4|||
127700182|NCT02547233|459530922|FG000|12-month Follow-up|Protocol Violation|0|||
127700183|NCT02547233|459530923|FG001|12-month Follow-up|Protocol Violation|1|||
127700184|NCT02547233|459530922|FG000|12-month Follow-up|Other|0|||
127700185|NCT02547233|459530923|FG001|12-month Follow-up|Other|1|||
127700186|NCT03603600|459530924|FG000|Overall Study|Withdrawal by Subject|5|||
127700187|NCT03603600|459530925|FG001|Overall Study|Withdrawal by Subject|7|||
127700188|NCT03603600|459530924|FG000|Overall Study|Lost to Follow-up|2|||
127700189|NCT03603600|459530925|FG001|Overall Study|Lost to Follow-up|3|||
127700190|NCT03603600|459530924|FG000|Overall Study|Death|3|||
127700191|NCT03603600|459530925|FG001|Overall Study|Death|1|||
127700192|NCT03603600|459530924|FG000|Overall Study|Physician Decision|2|||
127700193|NCT03603600|459530925|FG001|Overall Study|Physician Decision|1|||
127700194|NCT03603600|459530924|FG000|Overall Study|Other reason|1|||
127884441|NCT00430638|460199952|FG000|Overall Study|Withdrawal by Subject|4|||
127884442|NCT00430638|460199953|FG001|Overall Study|Withdrawal by Subject|6|||
127700195|NCT03603600|459530925|FG001|Overall Study|Other reason|0|||
127700196|NCT05170009|459530926|FG000|Overall Study|Physician Decision|0|||
127700197|NCT05170009|459530927|FG001|Overall Study|Physician Decision|1|||
127700198|NCT03524612|459530933|FG000|Overall Study|Lack of Efficacy|10|||
127700199|NCT03524612|459530933|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
127700200|NCT03524612|459530933|FG000|Overall Study|Adverse Event|10|||
127700201|NCT03524612|459530933|FG000|Overall Study|Withdrawal by Subject|7|||
127700202|NCT03524612|459530933|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
127618108|NCT02043015|459230623|FG000|Overall Study|Removed once target enrollment reached|15|||
127618109|NCT02043015|459230623|FG000|Overall Study|Participant moved away from study city|4|||
127618110|NCT02043015|459230623|FG000|Overall Study|Incarceration|1|||
127618111|NCT04399161|459230628|FG000|Overall Study|Withdrawal by Subject|1|||
127618112|NCT04399161|459230629|FG001|Overall Study|Withdrawal by Subject|0|||
127618113|NCT04399161|459230630|FG002|Overall Study|Withdrawal by Subject|2|||
127618114|NCT04399161|459230628|FG000|Overall Study|Protocol Violation|1|||
127618115|NCT04399161|459230629|FG001|Overall Study|Protocol Violation|2|||
127618116|NCT04399161|459230630|FG002|Overall Study|Protocol Violation|0|||
127618117|NCT00477672|459230631|FG000|Overall Study|Adverse Event|3|||
127618118|NCT00477672|459230632|FG001|Overall Study|Adverse Event|5|||
127618119|NCT00477672|459230633|FG002|Overall Study|Adverse Event|6|||
127618120|NCT00477672|459230631|FG000|Overall Study|Death|0|||
127618121|NCT00477672|459230632|FG001|Overall Study|Death|1|||
127618122|NCT00477672|459230633|FG002|Overall Study|Death|0|||
127618123|NCT00477672|459230631|FG000|Overall Study|Disease progression|0|||
127618124|NCT00477672|459230632|FG001|Overall Study|Disease progression|1|||
127700203|NCT03524612|459530933|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
127618125|NCT00477672|459230633|FG002|Overall Study|Disease progression|0|||
127618126|NCT00477672|459230631|FG000|Overall Study|Physician Decision|1|||
127700204|NCT03524612|459530933|FG000|Overall Study|New therapy for study indication|6|||
127700205|NCT03524612|459530933|FG000|Overall Study|Death|3|||
127700206|NCT03524612|459530933|FG000|Overall Study|Lost to Follow-up|2|||
127700207|NCT03524612|459530933|FG000|Overall Study|Protocol Violation|1|||
127700208|NCT05457647|459530935|FG000|Overall Study|Lost to Follow-up|3|||
127700209|NCT02489903|459530936|FG000|Screening|Screen Failure|24|||
127700210|NCT02489903|459530937|FG001|Screening|Screen Failure|0|||
127700211|NCT02489903|459530938|FG002|Screening|Screen Failure|0|||
127700212|NCT02489903|459530939|FG003|Screening|Screen Failure|8|||
127700213|NCT02489903|459530936|FG000|Randomized and Received Treatment|Protocol Violation|0|||
127700214|NCT02489903|459530937|FG001|Randomized and Received Treatment|Protocol Violation|1|||
127700215|NCT02489903|459530938|FG002|Randomized and Received Treatment|Protocol Violation|0|||
127700216|NCT02489903|459530939|FG003|Randomized and Received Treatment|Protocol Violation|0|||
127700217|NCT02489903|459530936|FG000|Randomized and Received Treatment|Baseline Drop Out|3|||
127700218|NCT02489903|459530937|FG001|Randomized and Received Treatment|Baseline Drop Out|0|||
127700219|NCT02489903|459530938|FG002|Randomized and Received Treatment|Baseline Drop Out|0|||
127700220|NCT02489903|459530939|FG003|Randomized and Received Treatment|Baseline Drop Out|0|||
127700221|NCT02489903|459530936|FG000|Randomized and Received Treatment|Withdrawal by Subject|6|||
127700222|NCT02489903|459530937|FG001|Randomized and Received Treatment|Withdrawal by Subject|2|||
127700223|NCT02489903|459530938|FG002|Randomized and Received Treatment|Withdrawal by Subject|0|||
127884443|NCT00430638|460199952|FG000|Overall Study|Non-compliant|2|||
127884444|NCT00430638|460199953|FG001|Overall Study|Non-compliant|1|||
127700224|NCT02489903|459530939|FG003|Randomized and Received Treatment|Withdrawal by Subject|0|||
127700225|NCT02489903|459530936|FG000|Randomized and Received Treatment|Death|10|||
127700226|NCT02489903|459530937|FG001|Randomized and Received Treatment|Death|1|||
127700227|NCT02489903|459530938|FG002|Randomized and Received Treatment|Death|0|||
127700228|NCT02489903|459530939|FG003|Randomized and Received Treatment|Death|0|||
127700229|NCT05257486|459530940|FG000|Overall Study|Protocol Violation|3|||
127700230|NCT04542317|459530941|FG000|Overall Study|Care recipients passed away|18|||
127700231|NCT04542317|459530942|FG001|Overall Study|Care recipients passed away|13|||
127884445|NCT00430638|460199952|FG000|Overall Study|Other|2|||
127618127|NCT00477672|459230632|FG001|Overall Study|Physician Decision|0|||
127618128|NCT00477672|459230633|FG002|Overall Study|Physician Decision|0|||
127618129|NCT00477672|459230631|FG000|Overall Study|Protocol noncompliance|0|||
127884446|NCT00430638|460199953|FG001|Overall Study|Other|2|||
127618130|NCT00477672|459230632|FG001|Overall Study|Protocol noncompliance|2|||
127618131|NCT00477672|459230633|FG002|Overall Study|Protocol noncompliance|0|||
127618132|NCT00477672|459230631|FG000|Overall Study|Consent withdrawn|2|||
127618133|NCT00477672|459230632|FG001|Overall Study|Consent withdrawn|5|||
127618134|NCT00477672|459230633|FG002|Overall Study|Consent withdrawn|10|||
127618135|NCT00477672|459230631|FG000|Overall Study|Discretion of Sponsor|1|||
127618136|NCT00477672|459230632|FG001|Overall Study|Discretion of Sponsor|2|||
127618137|NCT00477672|459230633|FG002|Overall Study|Discretion of Sponsor|0|||
127618138|NCT00838565|459230634|FG000|Overall Study|Withdrawal by Subject|0|||
127618139|NCT00838565|459230635|FG001|Overall Study|Withdrawal by Subject|0|||
127618140|NCT00838565|459230636|FG002|Overall Study|Withdrawal by Subject|1|||
127618141|NCT00838565|459230637|FG003|Overall Study|Withdrawal by Subject|0|||
127618142|NCT00838565|459230638|FG004|Overall Study|Withdrawal by Subject|0|||
127618143|NCT00838565|459230639|FG005|Overall Study|Withdrawal by Subject|2|||
127618144|NCT00838565|459230634|FG000|Overall Study|Other|0|||
127618145|NCT00838565|459230635|FG001|Overall Study|Other|2|||
127618146|NCT00838565|459230636|FG002|Overall Study|Other|0|||
127618147|NCT00838565|459230637|FG003|Overall Study|Other|0|||
127618148|NCT00838565|459230638|FG004|Overall Study|Other|0|||
127618149|NCT00838565|459230639|FG005|Overall Study|Other|0|||
127618150|NCT00838565|459230634|FG000|Overall Study|Randomized but not Treated|0|||
127618151|NCT00838565|459230635|FG001|Overall Study|Randomized but not Treated|1|||
127618152|NCT00838565|459230636|FG002|Overall Study|Randomized but not Treated|0|||
127618153|NCT00838565|459230637|FG003|Overall Study|Randomized but not Treated|0|||
127618154|NCT00838565|459230638|FG004|Overall Study|Randomized but not Treated|0|||
127618155|NCT00838565|459230639|FG005|Overall Study|Randomized but not Treated|0|||
127618156|NCT01455012|459230643|FG000|Overall Study|Adverse Event|0|||
127618157|NCT01455012|459230644|FG001|Overall Study|Adverse Event|2|||
127618158|NCT01455012|459230643|FG000|Overall Study|Lack of Efficacy|6|||
127618159|NCT01455012|459230644|FG001|Overall Study|Lack of Efficacy|1|||
127618160|NCT01455012|459230643|FG000|Overall Study|Withdrawal by Subject|3|||
127884447|NCT02623426|460199956|FG000|Overall Study|Lost to Follow-up|0|||
127884448|NCT02623426|460199957|FG001|Overall Study|Lost to Follow-up|0|||
127884449|NCT02623426|460199958|FG002|Overall Study|Lost to Follow-up|1|||
127884450|NCT02623426|460199956|FG000|Overall Study|Withdrawal by Subject|1|||
127884451|NCT02623426|460199957|FG001|Overall Study|Withdrawal by Subject|2|||
127884452|NCT02623426|460199958|FG002|Overall Study|Withdrawal by Subject|2|||
127884453|NCT03185949|460199959|FG000|ITT Analysis|Withdrawal by Subject|4|||
127884454|NCT03185949|460199960|FG001|ITT Analysis|Withdrawal by Subject|3|||
127884455|NCT03185949|460199959|FG000|PP Analysis|Protocol Violation|2|||
127884456|NCT03185949|460199960|FG001|PP Analysis|Protocol Violation|2|||
127884457|NCT03185949|460199959|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
127884458|NCT03185949|460199960|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
127884459|NCT05166421|460199969|FG000|Overall Study|Other|3|||
127884460|NCT05166421|460199970|FG001|Overall Study|Other|1|||
127884461|NCT05166421|460199971|FG002|Overall Study|Other|1|||
127618161|NCT01455012|459230644|FG001|Overall Study|Withdrawal by Subject|1|||
127618162|NCT01455012|459230643|FG000|Overall Study|Unknown reason|2|||
127618163|NCT01455012|459230644|FG001|Overall Study|Unknown reason|0|||
127618164|NCT01215227|459230645|FG000|Overall Study|Adverse Event|11|||
127618165|NCT01215227|459230646|FG001|Overall Study|Adverse Event|11|||
127618166|NCT01215227|459230647|FG002|Overall Study|Adverse Event|4|||
127618167|NCT01215227|459230648|FG003|Overall Study|Adverse Event|8|||
127618168|NCT01215227|459230649|FG004|Overall Study|Adverse Event|7|||
127618169|NCT01215227|459230650|FG005|Overall Study|Adverse Event|6|||
127618170|NCT01215227|459230645|FG000|Overall Study|Treatment Failure|8|||
127618171|NCT01215227|459230646|FG001|Overall Study|Treatment Failure|4|||
127618172|NCT01215227|459230647|FG002|Overall Study|Treatment Failure|1|||
127618173|NCT01215227|459230648|FG003|Overall Study|Treatment Failure|5|||
127618174|NCT01215227|459230649|FG004|Overall Study|Treatment Failure|1|||
127618175|NCT01215227|459230650|FG005|Overall Study|Treatment Failure|1|||
127618176|NCT01215227|459230645|FG000|Overall Study|Lost to Follow-up|1|||
127618177|NCT01215227|459230646|FG001|Overall Study|Lost to Follow-up|4|||
127618178|NCT01215227|459230647|FG002|Overall Study|Lost to Follow-up|1|||
127618179|NCT01215227|459230648|FG003|Overall Study|Lost to Follow-up|1|||
127618180|NCT01215227|459230649|FG004|Overall Study|Lost to Follow-up|1|||
127618181|NCT01215227|459230650|FG005|Overall Study|Lost to Follow-up|2|||
127618182|NCT01215227|459230645|FG000|Overall Study|Subject Withdrew Consent|16|||
127618183|NCT01215227|459230646|FG001|Overall Study|Subject Withdrew Consent|20|||
127618184|NCT01215227|459230647|FG002|Overall Study|Subject Withdrew Consent|7|||
127618185|NCT01215227|459230648|FG003|Overall Study|Subject Withdrew Consent|10|||
127618186|NCT01215227|459230649|FG004|Overall Study|Subject Withdrew Consent|11|||
127618187|NCT01215227|459230650|FG005|Overall Study|Subject Withdrew Consent|8|||
127618188|NCT01215227|459230645|FG000|Overall Study|Non-Compliance With Protocol|2|||
127884462|NCT05166421|460199969|FG000|Overall Study|Withdrawal by Subject|5|||
127884463|NCT05166421|460199970|FG001|Overall Study|Withdrawal by Subject|3|||
127618189|NCT01215227|459230646|FG001|Overall Study|Non-Compliance With Protocol|6|||
127884464|NCT05166421|460199971|FG002|Overall Study|Withdrawal by Subject|6|||
127618190|NCT01215227|459230647|FG002|Overall Study|Non-Compliance With Protocol|1|||
127618191|NCT01215227|459230648|FG003|Overall Study|Non-Compliance With Protocol|0|||
127618192|NCT01215227|459230649|FG004|Overall Study|Non-Compliance With Protocol|0|||
127618193|NCT01215227|459230650|FG005|Overall Study|Non-Compliance With Protocol|0|||
127618194|NCT01215227|459230645|FG000|Overall Study|Administrative|83|||
127618195|NCT01215227|459230646|FG001|Overall Study|Administrative|73|||
127618196|NCT01215227|459230647|FG002|Overall Study|Administrative|42|||
127618197|NCT01215227|459230648|FG003|Overall Study|Administrative|24|||
127618198|NCT01215227|459230649|FG004|Overall Study|Administrative|28|||
127618199|NCT01215227|459230650|FG005|Overall Study|Administrative|40|||
127618200|NCT01215227|459230645|FG000|Overall Study|Missing Status|0|||
127618201|NCT01215227|459230646|FG001|Overall Study|Missing Status|1|||
127618202|NCT01215227|459230647|FG002|Overall Study|Missing Status|0|||
127618203|NCT01215227|459230648|FG003|Overall Study|Missing Status|0|||
127618204|NCT01215227|459230649|FG004|Overall Study|Missing Status|0|||
127618205|NCT01215227|459230650|FG005|Overall Study|Missing Status|0|||
127618206|NCT01215227|459230645|FG000|Overall Study|Randomized but not treated|0|||
127618207|NCT01215227|459230646|FG001|Overall Study|Randomized but not treated|0|||
127618208|NCT01215227|459230647|FG002|Overall Study|Randomized but not treated|1|||
127618209|NCT01215227|459230648|FG003|Overall Study|Randomized but not treated|1|||
127618210|NCT01215227|459230649|FG004|Overall Study|Randomized but not treated|0|||
127618211|NCT01215227|459230650|FG005|Overall Study|Randomized but not treated|1|||
127618212|NCT02253810|459230651|FG000|Overall Study|Withdrawal by Subject|2|||
127618213|NCT02253810|459230652|FG001|Overall Study|Withdrawal by Subject|1|||
127618214|NCT02253810|459230651|FG000|Overall Study|Unknown concomitant procedure|3|||
127618215|NCT02253810|459230652|FG001|Overall Study|Unknown concomitant procedure|2|||
127618216|NCT01434290|459230659|FG000|Overall Study|Protocol Violation|6|||
127618217|NCT01434290|459230660|FG001|Overall Study|Protocol Violation|3|||
127618218|NCT01434290|459230659|FG000|Overall Study|No protocol treatment|2|||
127618219|NCT01434290|459230660|FG001|Overall Study|No protocol treatment|4|||
127618220|NCT00213148|459230662|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
127618221|NCT00213148|459230663|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
127618222|NCT00213148|459230664|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
127618223|NCT00213148|459230665|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
127618224|NCT00213148|459230666|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
127618225|NCT00213148|459230662|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
127618226|NCT00213148|459230663|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
127618227|NCT00213148|459230664|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
127618228|NCT00213148|459230665|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
127618229|NCT00213148|459230666|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
127618230|NCT00213148|459230662|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
127618231|NCT00213148|459230663|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
127618232|NCT00213148|459230664|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
127618233|NCT00213148|459230665|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
127618234|NCT00213148|459230666|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
127618235|NCT00213148|459230662|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
127618236|NCT00213148|459230663|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
127618237|NCT00213148|459230664|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
127618238|NCT00213148|459230665|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
127618239|NCT00213148|459230666|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
127618240|NCT00213148|459230662|FG000|Cycle 1 (1 Month)|Other|3|||
127618241|NCT00213148|459230663|FG001|Cycle 1 (1 Month)|Other|0|||
127618242|NCT00213148|459230664|FG002|Cycle 1 (1 Month)|Other|2|||
127618243|NCT00213148|459230665|FG003|Cycle 1 (1 Month)|Other|2|||
127618244|NCT00213148|459230666|FG004|Cycle 1 (1 Month)|Other|7|||
127618245|NCT00213148|459230662|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
127618246|NCT00213148|459230663|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
127618247|NCT00213148|459230664|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
127618248|NCT00213148|459230665|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
127618249|NCT00213148|459230666|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
127618250|NCT00213148|459230662|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
127618251|NCT00213148|459230663|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
127618252|NCT00213148|459230664|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
127618253|NCT00213148|459230665|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
127618254|NCT00213148|459230666|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
127791319|NCT00105443|459860647|FG003|Double-Blind Treatment|Adverse Event|0|||
127618255|NCT00213148|459230662|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
127618256|NCT00213148|459230663|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
127618257|NCT00213148|459230664|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
127618258|NCT00213148|459230665|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
127618259|NCT00213148|459230666|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
127618260|NCT00213148|459230662|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
127618261|NCT00213148|459230663|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
127618262|NCT00213148|459230664|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
127791320|NCT00105443|459860644|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
127618263|NCT00213148|459230665|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
127618264|NCT00213148|459230666|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
127618265|NCT00213148|459230662|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
127618266|NCT00213148|459230663|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
127618267|NCT00213148|459230664|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
127618268|NCT00213148|459230665|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
127618269|NCT00213148|459230666|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
127618270|NCT00213148|459230662|FG000|Cycle 2 (1 Month)|Other|2|||
127618271|NCT00213148|459230663|FG001|Cycle 2 (1 Month)|Other|1|||
127618272|NCT00213148|459230664|FG002|Cycle 2 (1 Month)|Other|2|||
127618273|NCT00213148|459230665|FG003|Cycle 2 (1 Month)|Other|8|||
127618274|NCT00213148|459230666|FG004|Cycle 2 (1 Month)|Other|7|||
127618275|NCT00213148|459230662|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
127618276|NCT00213148|459230663|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
127791321|NCT00105443|459860645|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
127618277|NCT00213148|459230664|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
127618278|NCT00213148|459230665|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
127618279|NCT00213148|459230666|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
127618280|NCT00213148|459230662|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
127618281|NCT00213148|459230663|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
127618282|NCT00213148|459230664|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
127618283|NCT00213148|459230665|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
127618284|NCT00213148|459230666|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
127618285|NCT00213148|459230662|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
127618286|NCT00213148|459230663|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
127618287|NCT00213148|459230664|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
127618288|NCT00213148|459230665|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
127618289|NCT00213148|459230666|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
127618290|NCT00213148|459230662|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
127618291|NCT00213148|459230663|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
127618292|NCT00213148|459230664|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
127618293|NCT00213148|459230665|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
127618294|NCT00213148|459230666|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
127618295|NCT00213148|459230662|FG000|Cycle 3 (1 Month)|Other|0|||
127618296|NCT00213148|459230663|FG001|Cycle 3 (1 Month)|Other|0|||
127618297|NCT00213148|459230664|FG002|Cycle 3 (1 Month)|Other|1|||
127618298|NCT00213148|459230665|FG003|Cycle 3 (1 Month)|Other|1|||
127618299|NCT00213148|459230666|FG004|Cycle 3 (1 Month)|Other|0|||
127618300|NCT00558103|459230667|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
127618301|NCT00558103|459230668|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
127618302|NCT00558103|459230669|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
127618303|NCT00558103|459230670|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
127791322|NCT00105443|459860646|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
127791323|NCT00105443|459860647|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
127791324|NCT00105443|459860644|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
127791325|NCT00105443|459860645|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
127791326|NCT00105443|459860646|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
127791327|NCT00105443|459860647|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
127791328|NCT00105443|459860644|FG000|Double-Blind Treatment|Physician Decision|1|||
127791329|NCT00105443|459860645|FG001|Double-Blind Treatment|Physician Decision|0|||
127791330|NCT00105443|459860646|FG002|Double-Blind Treatment|Physician Decision|2|||
127791331|NCT00105443|459860647|FG003|Double-Blind Treatment|Physician Decision|0|||
127791332|NCT00105443|459860644|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
127791333|NCT00105443|459860645|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
127791334|NCT00105443|459860646|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
127791335|NCT00105443|459860647|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
127791336|NCT00105443|459860644|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
127791337|NCT00105443|459860645|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
127618304|NCT00558103|459230671|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
127618305|NCT00558103|459230672|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
127618306|NCT00558103|459230667|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
127618307|NCT00558103|459230668|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
127618308|NCT00558103|459230669|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
127618309|NCT00558103|459230670|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
127618310|NCT00558103|459230671|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
127618311|NCT00558103|459230672|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
127618312|NCT00558103|459230667|FG000|Randomized Treatment Phase|Disease Progression|1|||
127618313|NCT00558103|459230668|FG001|Randomized Treatment Phase|Disease Progression|0|||
127791338|NCT00105443|459860646|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
127618314|NCT00558103|459230669|FG002|Randomized Treatment Phase|Disease Progression|1|||
127618315|NCT00558103|459230670|FG003|Randomized Treatment Phase|Disease Progression|0|||
127618316|NCT00558103|459230671|FG004|Randomized Treatment Phase|Disease Progression|0|||
127618317|NCT00558103|459230672|FG005|Randomized Treatment Phase|Disease Progression|0|||
127618318|NCT00558103|459230667|FG000|Randomized Treatment Phase|Adverse Event|0|||
127618319|NCT00558103|459230668|FG001|Randomized Treatment Phase|Adverse Event|0|||
127618320|NCT00558103|459230669|FG002|Randomized Treatment Phase|Adverse Event|0|||
127618321|NCT00558103|459230670|FG003|Randomized Treatment Phase|Adverse Event|1|||
127618322|NCT00558103|459230671|FG004|Randomized Treatment Phase|Adverse Event|1|||
127618323|NCT00558103|459230672|FG005|Randomized Treatment Phase|Adverse Event|0|||
127618324|NCT00558103|459230667|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
127618325|NCT00558103|459230668|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
127618326|NCT00558103|459230669|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
127618327|NCT00558103|459230670|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
127618328|NCT00558103|459230671|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
127618329|NCT00558103|459230672|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
127618330|NCT00558103|459230667|FG000|Monotherapy Extension Phase|Disease Progression|0|||
127618331|NCT00558103|459230668|FG001|Monotherapy Extension Phase|Disease Progression|0|||
127618332|NCT00558103|459230669|FG002|Monotherapy Extension Phase|Disease Progression|0|||
127618333|NCT00558103|459230670|FG003|Monotherapy Extension Phase|Disease Progression|0|||
127618334|NCT00558103|459230671|FG004|Monotherapy Extension Phase|Disease Progression|0|||
127618335|NCT00558103|459230672|FG005|Monotherapy Extension Phase|Disease Progression|8|||
127618336|NCT02434770|459230675|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
127618337|NCT02434770|459230676|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
127618338|NCT02434770|459230677|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
127618339|NCT02434770|459230675|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
127618340|NCT02434770|459230676|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
127618341|NCT02434770|459230677|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
127618342|NCT02434770|459230675|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
127618343|NCT02434770|459230676|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
127618344|NCT02434770|459230677|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
127618345|NCT02434770|459230675|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
127618346|NCT02434770|459230676|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
127700232|NCT04542317|459530941|FG000|Overall Study|No longer a primary caregiver|5|||
127618347|NCT02434770|459230677|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
127700233|NCT04542317|459530942|FG001|Overall Study|No longer a primary caregiver|1|||
127618348|NCT02434770|459230675|FG000|Week 1 to Week 18|Death|1|||
127700234|NCT04542317|459530941|FG000|Overall Study|Withdrawal by Subject|4|||
127700235|NCT04542317|459530942|FG001|Overall Study|Withdrawal by Subject|2|||
127700236|NCT04542317|459530941|FG000|Overall Study|Caregivers passed away|0|||
127700237|NCT04542317|459530942|FG001|Overall Study|Caregivers passed away|2|||
127700238|NCT03976362|459530945|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|198|||
127700239|NCT03976362|459530946|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
127700240|NCT03976362|459530947|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
127700241|NCT03976362|459530945|FG000|Induction Phase|Death|62|||
127700242|NCT03976362|459530946|FG001|Induction Phase|Death|0|||
127700243|NCT03976362|459530947|FG002|Induction Phase|Death|0|||
127700244|NCT03976362|459530945|FG000|Maintenance Phase|Participants Ongoing|0|||
127700245|NCT03976362|459530946|FG001|Maintenance Phase|Participants Ongoing|106|||
127700246|NCT03976362|459530947|FG002|Maintenance Phase|Participants Ongoing|103|||
127700247|NCT03976362|459530945|FG000|Maintenance Phase|Withdrawal by Subject|0|||
127700248|NCT03976362|459530946|FG001|Maintenance Phase|Withdrawal by Subject|4|||
127700249|NCT03976362|459530947|FG002|Maintenance Phase|Withdrawal by Subject|4|||
127700250|NCT03976362|459530945|FG000|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
127700251|NCT03976362|459530946|FG001|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
127700252|NCT03976362|459530947|FG002|Maintenance Phase|Failure To Meet Randomization Criteria|1|||
127700253|NCT03976362|459530945|FG000|Maintenance Phase|Death|0|||
127700254|NCT03976362|459530946|FG001|Maintenance Phase|Death|186|||
127700255|NCT03976362|459530947|FG002|Maintenance Phase|Death|187|||
127700256|NCT05126433|459530952|FG000|Overall Study|Withdrawal by Subject|3|||
127700257|NCT05126433|459530953|FG001|Overall Study|Withdrawal by Subject|0|||
127700258|NCT05126433|459530954|FG002|Overall Study|Withdrawal by Subject|4|||
127700259|NCT05126433|459530952|FG000|Overall Study|Death|9|||
127700260|NCT05126433|459530953|FG001|Overall Study|Death|3|||
127700261|NCT05126433|459530954|FG002|Overall Study|Death|5|||
127700262|NCT05126433|459530952|FG000|Overall Study|Study Terminated by sponsor|0|||
127618349|NCT02434770|459230676|FG001|Week 1 to Week 18|Death|0|||
127700263|NCT05126433|459530953|FG001|Overall Study|Study Terminated by sponsor|1|||
127700264|NCT05126433|459530954|FG002|Overall Study|Study Terminated by sponsor|2|||
127700265|NCT05126433|459530952|FG000|Overall Study|Progressive Disease|1|||
127618350|NCT02434770|459230677|FG002|Week 1 to Week 18|Death|0|||
127618351|NCT02434770|459230675|FG000|Week 18 to Week|Lost to Follow-up|2|||
127618352|NCT02434770|459230676|FG001|Week 18 to Week|Lost to Follow-up|2|||
127618353|NCT02434770|459230677|FG002|Week 18 to Week|Lost to Follow-up|1|||
127618354|NCT02434770|459230675|FG000|Week 18 to Week|Withdrawal by Subject|0|||
127618355|NCT02434770|459230676|FG001|Week 18 to Week|Withdrawal by Subject|0|||
127618356|NCT02434770|459230677|FG002|Week 18 to Week|Withdrawal by Subject|2|||
127618357|NCT02434770|459230675|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
127618358|NCT02434770|459230676|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
127618359|NCT02434770|459230677|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
127618360|NCT00245765|459230678|FG000|Overall Study|Adverse Event|1|||
127618361|NCT00245765|459230679|FG001|Overall Study|Adverse Event|1|||
127618362|NCT00245765|459230680|FG002|Overall Study|Adverse Event|0|||
127618363|NCT00245765|459230678|FG000|Overall Study|Lack of Efficacy|14|||
127618364|NCT00245765|459230679|FG001|Overall Study|Lack of Efficacy|7|||
127618365|NCT00245765|459230680|FG002|Overall Study|Lack of Efficacy|0|||
127618366|NCT00245765|459230678|FG000|Overall Study|Lost to Follow-up|1|||
127618367|NCT00245765|459230679|FG001|Overall Study|Lost to Follow-up|2|||
127618368|NCT00245765|459230680|FG002|Overall Study|Lost to Follow-up|0|||
127618369|NCT00245765|459230678|FG000|Overall Study|Withdrawal by Subject|1|||
127618370|NCT00245765|459230679|FG001|Overall Study|Withdrawal by Subject|0|||
127618371|NCT00245765|459230680|FG002|Overall Study|Withdrawal by Subject|3|||
127618372|NCT00245765|459230678|FG000|Overall Study|Other reason|2|||
127618373|NCT00245765|459230679|FG001|Overall Study|Other reason|0|||
127618374|NCT00245765|459230680|FG002|Overall Study|Other reason|1|||
127618375|NCT00245765|459230678|FG000|Overall Study|Other|13|||
127618376|NCT00245765|459230679|FG001|Overall Study|Other|4|||
127618377|NCT00245765|459230680|FG002|Overall Study|Other|4|||
127618378|NCT00660348|459230681|FG000|Overall Study|Withdrawal by Subject|1|||
127618379|NCT00660348|459230682|FG001|Overall Study|Withdrawal by Subject|0|||
127618380|NCT04074317|459230688|FG000|Third Period|Withdrawal by Subject|0|||
127618381|NCT04074317|459230689|FG001|Third Period|Withdrawal by Subject|0|||
127618382|NCT04074317|459230690|FG002|Third Period|Withdrawal by Subject|0|||
127618383|NCT04074317|459230691|FG003|Third Period|Withdrawal by Subject|1|||
127618384|NCT04074317|459230692|FG004|Third Period|Withdrawal by Subject|0|||
127618385|NCT04074317|459230693|FG005|Third Period|Withdrawal by Subject|0|||
127618386|NCT03548584|459232962|FG000|Overall Study|Lost to Follow-up|0|||
127618387|NCT03548584|459232963|FG001|Overall Study|Lost to Follow-up|0|||
127618388|NCT03548584|459232964|FG002|Overall Study|Lost to Follow-up|1|||
127618389|NCT03548584|459232962|FG000|Overall Study|Adverse Event|1|||
127618390|NCT03548584|459232963|FG001|Overall Study|Adverse Event|11|||
127618391|NCT03548584|459232964|FG002|Overall Study|Adverse Event|5|||
127618392|NCT03548584|459232962|FG000|Overall Study|Site Terminated by Sponsor|1|||
127618393|NCT03548584|459232963|FG001|Overall Study|Site Terminated by Sponsor|3|||
127618394|NCT03548584|459232964|FG002|Overall Study|Site Terminated by Sponsor|2|||
127618395|NCT03548584|459232962|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
127618396|NCT03548584|459232963|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
127618397|NCT03548584|459232964|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
127618398|NCT03548584|459232962|FG000|Overall Study|Lack of Efficacy|0|||
127618399|NCT03548584|459232963|FG001|Overall Study|Lack of Efficacy|1|||
127618400|NCT03548584|459232964|FG002|Overall Study|Lack of Efficacy|0|||
127618401|NCT03548584|459232962|FG000|Overall Study|Non-compliance with Study Drug|0|||
127618402|NCT03548584|459232963|FG001|Overall Study|Non-compliance with Study Drug|1|||
127618403|NCT03548584|459232964|FG002|Overall Study|Non-compliance with Study Drug|0|||
127618404|NCT03548584|459232962|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
127618405|NCT03548584|459232963|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
127618406|NCT03548584|459232964|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
127700266|NCT05126433|459530953|FG001|Overall Study|Progressive Disease|4|||
127700267|NCT05126433|459530954|FG002|Overall Study|Progressive Disease|3|||
127618407|NCT00653224|459232971|FG000|Overall Study|Adverse Event|2|||
127618408|NCT00653224|459232972|FG001|Overall Study|Adverse Event|1|||
127618409|NCT00653224|459232971|FG000|Overall Study|Lack of Efficacy|1|||
127618410|NCT00653224|459232972|FG001|Overall Study|Lack of Efficacy|2|||
127618411|NCT00653224|459232971|FG000|Overall Study|Loss of efficacy|1|||
127618412|NCT00653224|459232972|FG001|Overall Study|Loss of efficacy|0|||
127618413|NCT00653224|459232971|FG000|Overall Study|Lost to Follow-up|1|||
127618414|NCT00653224|459232972|FG001|Overall Study|Lost to Follow-up|0|||
127618415|NCT00653224|459232971|FG000|Overall Study|Other|2|||
127618416|NCT00653224|459232972|FG001|Overall Study|Other|4|||
127618417|NCT05308901|459232973|FG000|Overall Study|Death|6|||
127618418|NCT00978731|459232974|FG000|Overall Study|Death|4|||
127618419|NCT00978731|459232975|FG001|Overall Study|Death|1|||
127618420|NCT00978731|459232976|FG002|Overall Study|Death|1|||
127618421|NCT00978731|459232977|FG003|Overall Study|Death|0|||
127618422|NCT00978731|459232974|FG000|Overall Study|Lost to Follow-up|0|||
127618423|NCT00978731|459232975|FG001|Overall Study|Lost to Follow-up|0|||
127618424|NCT00978731|459232976|FG002|Overall Study|Lost to Follow-up|0|||
127618425|NCT00978731|459232977|FG003|Overall Study|Lost to Follow-up|1|||
127618426|NCT00978731|459232974|FG000|Overall Study|Adverse Event|5|||
127618427|NCT00978731|459232975|FG001|Overall Study|Adverse Event|2|||
127618428|NCT00978731|459232976|FG002|Overall Study|Adverse Event|0|||
127618429|NCT00978731|459232977|FG003|Overall Study|Adverse Event|0|||
127618430|NCT00978731|459232974|FG000|Overall Study|Participant's request|1|||
127618431|NCT00978731|459232975|FG001|Overall Study|Participant's request|0|||
127618432|NCT00978731|459232976|FG002|Overall Study|Participant's request|0|||
127618433|NCT00978731|459232977|FG003|Overall Study|Participant's request|0|||
127618434|NCT00978731|459232974|FG000|Overall Study|Administrative reason|3|||
127618435|NCT00978731|459232975|FG001|Overall Study|Administrative reason|3|||
127618436|NCT00978731|459232976|FG002|Overall Study|Administrative reason|1|||
127618437|NCT00978731|459232977|FG003|Overall Study|Administrative reason|0|||
127618438|NCT00978731|459232974|FG000|Overall Study|Deterioration without progression|0|||
127618439|NCT00978731|459232975|FG001|Overall Study|Deterioration without progression|1|||
127618440|NCT00978731|459232976|FG002|Overall Study|Deterioration without progression|0|||
127618441|NCT00978731|459232977|FG003|Overall Study|Deterioration without progression|0|||
127618442|NCT00978731|459232974|FG000|Overall Study|Disease progression/relapse|5|||
127618443|NCT00978731|459232975|FG001|Overall Study|Disease progression/relapse|4|||
127618444|NCT00978731|459232976|FG002|Overall Study|Disease progression/relapse|2|||
127618445|NCT00978731|459232977|FG003|Overall Study|Disease progression/relapse|2|||
127618446|NCT00978731|459232974|FG000|Overall Study|Study closure|3|||
127618447|NCT00978731|459232975|FG001|Overall Study|Study closure|4|||
127618448|NCT00978731|459232976|FG002|Overall Study|Study closure|1|||
127618449|NCT00978731|459232977|FG003|Overall Study|Study closure|1|||
127618450|NCT00978731|459232974|FG000|Overall Study|No response|1|||
127618451|NCT00978731|459232975|FG001|Overall Study|No response|0|||
127884465|NCT05166421|460199969|FG000|Overall Study|Lost to Follow-up|4|||
127618452|NCT00978731|459232976|FG002|Overall Study|No response|0|||
127618453|NCT00978731|459232977|FG003|Overall Study|No response|0|||
127618454|NCT04482179|459232978|FG000|Overall Study|Death|1|||
127618455|NCT04482179|459232979|FG001|Overall Study|Death|0|||
127618456|NCT04482179|459232978|FG000|Overall Study|Withdrawal by Subject|1|||
127618457|NCT04482179|459232979|FG001|Overall Study|Withdrawal by Subject|0|||
127618458|NCT04988295|459232980|FG000|Overall Study|Withdrawal by Subject|9|||
127618459|NCT04988295|459232981|FG001|Overall Study|Withdrawal by Subject|29|||
127618460|NCT04988295|459232982|FG002|Overall Study|Withdrawal by Subject|6|||
127618461|NCT04988295|459232983|FG003|Overall Study|Withdrawal by Subject|0|||
127618462|NCT04988295|459232980|FG000|Overall Study|Lost to Follow-up|1|||
127618463|NCT04988295|459232981|FG001|Overall Study|Lost to Follow-up|0|||
127618464|NCT04988295|459232982|FG002|Overall Study|Lost to Follow-up|0|||
127618465|NCT04988295|459232983|FG003|Overall Study|Lost to Follow-up|0|||
127618466|NCT04988295|459232980|FG000|Overall Study|Study participation ongoing|186|||
127618467|NCT04988295|459232981|FG001|Overall Study|Study participation ongoing|169|||
127618468|NCT04988295|459232982|FG002|Overall Study|Study participation ongoing|99|||
127618469|NCT04988295|459232983|FG003|Overall Study|Study participation ongoing|119|||
127618470|NCT04083976|459232984|FG000|Overall Study|Lost to Follow-up|3|||
127618471|NCT04083976|459232985|FG001|Overall Study|Lost to Follow-up|0|||
127618472|NCT04083976|459232986|FG002|Overall Study|Lost to Follow-up|0|||
127618473|NCT04083976|459232987|FG003|Overall Study|Lost to Follow-up|1|||
127618474|NCT04083976|459232984|FG000|Overall Study|Withdrawal by Subject|16|||
127618475|NCT04083976|459232985|FG001|Overall Study|Withdrawal by Subject|1|||
127618476|NCT04083976|459232986|FG002|Overall Study|Withdrawal by Subject|9|||
127618477|NCT04083976|459232987|FG003|Overall Study|Withdrawal by Subject|0|||
127618478|NCT04083976|459232984|FG000|Overall Study|Sponsor Decision|14|||
127618479|NCT04083976|459232985|FG001|Overall Study|Sponsor Decision|0|||
127618480|NCT04083976|459232986|FG002|Overall Study|Sponsor Decision|0|||
127618481|NCT04083976|459232987|FG003|Overall Study|Sponsor Decision|7|||
127618482|NCT04083976|459232984|FG000|Overall Study|Other|1|||
127618483|NCT04083976|459232985|FG001|Overall Study|Other|0|||
127618484|NCT04083976|459232986|FG002|Overall Study|Other|1|||
127618485|NCT04083976|459232987|FG003|Overall Study|Other|0|||
127618486|NCT05358821|459232988|FG000|Overall Study|Withdrawal by Subject|0|||
127700268|NCT05126433|459530952|FG000|Overall Study|Sponsor decision- no further OS follow up required|2|||
127700269|NCT05126433|459530953|FG001|Overall Study|Sponsor decision- no further OS follow up required|4|||
127700270|NCT05126433|459530954|FG002|Overall Study|Sponsor decision- no further OS follow up required|6|||
127700271|NCT04137289|459530956|FG000|Overall Study|Death|0|||
127700272|NCT04137289|459530957|FG001|Overall Study|Death|0|||
127700273|NCT04137289|459530958|FG002|Overall Study|Death|0|||
127700274|NCT04137289|459530959|FG003|Overall Study|Death|0|||
127700275|NCT04137289|459530960|FG004|Overall Study|Death|0|||
127700276|NCT04137289|459530961|FG005|Overall Study|Death|0|||
127700277|NCT04137289|459530962|FG006|Overall Study|Death|1|||
127700278|NCT04137289|459530963|FG007|Overall Study|Death|0|||
127700279|NCT04137289|459530964|FG008|Overall Study|Death|0|||
127700280|NCT04137289|459530956|FG000|Overall Study|Clinical disease progression|0|||
127700281|NCT04137289|459530957|FG001|Overall Study|Clinical disease progression|0|||
127700282|NCT04137289|459530958|FG002|Overall Study|Clinical disease progression|0|||
127700283|NCT04137289|459530959|FG003|Overall Study|Clinical disease progression|4|||
127700284|NCT04137289|459530960|FG004|Overall Study|Clinical disease progression|4|||
127700285|NCT04137289|459530961|FG005|Overall Study|Clinical disease progression|2|||
127700286|NCT04137289|459530962|FG006|Overall Study|Clinical disease progression|5|||
127700287|NCT04137289|459530963|FG007|Overall Study|Clinical disease progression|1|||
127700288|NCT04137289|459530964|FG008|Overall Study|Clinical disease progression|0|||
127700289|NCT04137289|459530956|FG000|Overall Study|Lost to Follow-up|0|||
127700290|NCT04137289|459530957|FG001|Overall Study|Lost to Follow-up|0|||
127700291|NCT04137289|459530958|FG002|Overall Study|Lost to Follow-up|0|||
127700292|NCT04137289|459530959|FG003|Overall Study|Lost to Follow-up|1|||
127700293|NCT04137289|459530960|FG004|Overall Study|Lost to Follow-up|0|||
127700294|NCT04137289|459530961|FG005|Overall Study|Lost to Follow-up|0|||
127700295|NCT04137289|459530962|FG006|Overall Study|Lost to Follow-up|0|||
127700296|NCT04137289|459530963|FG007|Overall Study|Lost to Follow-up|0|||
127700297|NCT04137289|459530964|FG008|Overall Study|Lost to Follow-up|0|||
127700298|NCT04137289|459530956|FG000|Overall Study|Adverse Event|0|||
127700299|NCT04137289|459530957|FG001|Overall Study|Adverse Event|0|||
127700300|NCT04137289|459530958|FG002|Overall Study|Adverse Event|1|||
127700301|NCT04137289|459530959|FG003|Overall Study|Adverse Event|0|||
127700302|NCT04137289|459530960|FG004|Overall Study|Adverse Event|0|||
127700303|NCT04137289|459530961|FG005|Overall Study|Adverse Event|1|||
127700304|NCT04137289|459530962|FG006|Overall Study|Adverse Event|0|||
127700305|NCT04137289|459530963|FG007|Overall Study|Adverse Event|0|||
127700306|NCT04137289|459530964|FG008|Overall Study|Adverse Event|0|||
127700307|NCT04137289|459530956|FG000|Overall Study|Lack of clinical benefit|0|||
127700308|NCT04137289|459530957|FG001|Overall Study|Lack of clinical benefit|0|||
127700309|NCT04137289|459530958|FG002|Overall Study|Lack of clinical benefit|0|||
127700310|NCT04137289|459530959|FG003|Overall Study|Lack of clinical benefit|0|||
127700311|NCT04137289|459530960|FG004|Overall Study|Lack of clinical benefit|0|||
127700312|NCT04137289|459530961|FG005|Overall Study|Lack of clinical benefit|0|||
127700313|NCT04137289|459530962|FG006|Overall Study|Lack of clinical benefit|0|||
127700314|NCT04137289|459530963|FG007|Overall Study|Lack of clinical benefit|0|||
127700315|NCT04137289|459530964|FG008|Overall Study|Lack of clinical benefit|1|||
127700316|NCT04137289|459530956|FG000|Overall Study|Objective disease progression|1|||
127700317|NCT04137289|459530957|FG001|Overall Study|Objective disease progression|1|||
127700318|NCT04137289|459530958|FG002|Overall Study|Objective disease progression|6|||
127700319|NCT04137289|459530959|FG003|Overall Study|Objective disease progression|18|||
127700320|NCT04137289|459530960|FG004|Overall Study|Objective disease progression|12|||
127700321|NCT04137289|459530961|FG005|Overall Study|Objective disease progression|20|||
127700322|NCT04137289|459530962|FG006|Overall Study|Objective disease progression|18|||
127700323|NCT04137289|459530963|FG007|Overall Study|Objective disease progression|7|||
127700324|NCT04137289|459530964|FG008|Overall Study|Objective disease progression|6|||
127700325|NCT03812679|459532936|FG000|Overall Study|Adverse Event|2|||
127700326|NCT03812679|459532936|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
127700327|NCT03812679|459532936|FG000|Overall Study|Renal transplant|1|||
127700328|NCT03812679|459532936|FG000|Overall Study|Withdrawal by Subject|1|||
127700329|NCT03812679|459532936|FG000|Overall Study|Termination of study|2|||
127700330|NCT03812679|459532936|FG000|Overall Study|Water device replacement|1|||
127700331|NCT05486078|459532937|FG000|Overall Study|4 drop out and one withdrawn|5|||
127700332|NCT05590403|459532938|FG000|Overall Study|Lost to Follow-up|13|||
127700333|NCT05590403|459532939|FG001|Overall Study|Lost to Follow-up|1|||
127700334|NCT05590403|459532940|FG002|Overall Study|Lost to Follow-up|7|||
127700335|NCT05590403|459532941|FG003|Overall Study|Lost to Follow-up|3|||
127700336|NCT05590403|459532942|FG004|Overall Study|Lost to Follow-up|4|||
127700337|NCT05590403|459532938|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
127700338|NCT05590403|459532939|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
127700339|NCT05590403|459532940|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
127700340|NCT05590403|459532941|FG003|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
127884466|NCT05166421|460199970|FG001|Overall Study|Lost to Follow-up|1|||
127700341|NCT05590403|459532942|FG004|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
127700342|NCT05590403|459532938|FG000|Overall Study|Other|2|||
127618487|NCT05358821|459232989|FG001|Overall Study|Withdrawal by Subject|1|||
127618488|NCT05358821|459232990|FG002|Overall Study|Withdrawal by Subject|0|||
127618489|NCT05358821|459232988|FG000|Overall Study|Withdrawal of Consent|0|||
127791339|NCT00105443|459860647|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
127791340|NCT00105443|459860644|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
127791341|NCT00105443|459860645|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
127618490|NCT05358821|459232989|FG001|Overall Study|Withdrawal of Consent|0|||
127618491|NCT05358821|459232990|FG002|Overall Study|Withdrawal of Consent|1|||
127618492|NCT02504372|459232991|FG000|Overall Study|Death|136|||
127618493|NCT02504372|459232992|FG001|Overall Study|Death|154|||
127618494|NCT02504372|459232991|FG000|Overall Study|Lost to Follow-up|0|||
127618495|NCT02504372|459232992|FG001|Overall Study|Lost to Follow-up|2|||
127618496|NCT02504372|459232991|FG000|Overall Study|Withdrawal of consent|25|||
127618497|NCT02504372|459232992|FG001|Overall Study|Withdrawal of consent|16|||
127618498|NCT02504372|459232991|FG000|Overall Study|Participants ongoing|429|||
127618499|NCT02504372|459232992|FG001|Overall Study|Participants ongoing|415|||
127618500|NCT03901963|459232993|FG000|Overall Study|Lost to Follow-up|1|||
127618501|NCT03901963|459232994|FG001|Overall Study|Lost to Follow-up|1|||
127618502|NCT03901963|459232993|FG000|Overall Study|Physician Decision|1|||
127618503|NCT03901963|459232994|FG001|Overall Study|Physician Decision|2|||
127618504|NCT03901963|459232993|FG000|Overall Study|Protocol Violation|1|||
127618505|NCT03901963|459232994|FG001|Overall Study|Protocol Violation|1|||
127618506|NCT03901963|459232993|FG000|Overall Study|Withdrawal by Subject|4|||
127618507|NCT03901963|459232994|FG001|Overall Study|Withdrawal by Subject|11|||
127618508|NCT03901963|459232993|FG000|Overall Study|Ongoing|84|||
127618509|NCT03901963|459232994|FG001|Overall Study|Ongoing|73|||
127618510|NCT03901963|459232993|FG000|Overall Study|Randomized but not treated|3|||
127618511|NCT03901963|459232994|FG001|Overall Study|Randomized but not treated|3|||
127618512|NCT00433654|459233000|FG000|Overall Study|Death|4|||
127618513|NCT00433654|459233001|FG001|Overall Study|Death|0|||
127618514|NCT00433654|459233000|FG000|Overall Study|Missed visit|6|||
127618515|NCT00433654|459233001|FG001|Overall Study|Missed visit|3|||
127618516|NCT00433654|459233000|FG000|Overall Study|Subject not yet due for visit|4|||
127618517|NCT00433654|459233001|FG001|Overall Study|Subject not yet due for visit|0|||
127618518|NCT00433654|459233000|FG000|Overall Study|Withdrawal by Subject|1|||
127618519|NCT00433654|459233001|FG001|Overall Study|Withdrawal by Subject|2|||
127618520|NCT03748641|459233002|FG000|Overall Study|Ongoing|155|||
127618521|NCT03748641|459233003|FG001|Overall Study|Ongoing|148|||
127618522|NCT03748641|459233004|FG002|Overall Study|Ongoing|66|||
127618523|NCT03748641|459233005|FG003|Overall Study|Ongoing|79|||
127618524|NCT03748641|459233006|FG004|Overall Study|Ongoing|84|||
127618525|NCT03748641|459233002|FG000|Overall Study|Death|54|||
127618526|NCT03748641|459233003|FG001|Overall Study|Death|59|||
127618527|NCT03748641|459233004|FG002|Overall Study|Death|51|||
127618528|NCT03748641|459233005|FG003|Overall Study|Death|42|||
127618529|NCT03748641|459233006|FG004|Overall Study|Death|9|||
127618530|NCT03748641|459233002|FG000|Overall Study|Lost to Follow-up|0|||
127618531|NCT03748641|459233003|FG001|Overall Study|Lost to Follow-up|2|||
127618532|NCT03748641|459233004|FG002|Overall Study|Lost to Follow-up|1|||
127618533|NCT03748641|459233005|FG003|Overall Study|Lost to Follow-up|0|||
127618534|NCT03748641|459233006|FG004|Overall Study|Lost to Follow-up|0|||
127618535|NCT03748641|459233002|FG000|Overall Study|Withdrawal by Subject|3|||
127618536|NCT03748641|459233003|FG001|Overall Study|Withdrawal by Subject|2|||
127618537|NCT03748641|459233004|FG002|Overall Study|Withdrawal by Subject|5|||
127791342|NCT00105443|459860646|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
127791343|NCT00105443|459860647|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
127791344|NCT00105443|459860644|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
127618538|NCT03748641|459233005|FG003|Overall Study|Withdrawal by Subject|3|||
127618539|NCT03748641|459233006|FG004|Overall Study|Withdrawal by Subject|2|||
127618540|NCT01428193|459233007|FG000|Overall Study|Physician Decision|1|||
127618541|NCT01428193|459233007|FG000|Overall Study|Elevated screening liver enzymes|1|||
127618542|NCT05179421|459233008|FG000|First Infusion Day|Adverse Event|1|||
127618543|NCT05179421|459233009|FG001|First Infusion Day|Adverse Event|0|||
127791345|NCT00105443|459860645|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
127618544|NCT03473743|459233011|FG000|Overall Study|Withdrawal by Subject|0|||
127618545|NCT03473743|459233012|FG001|Overall Study|Withdrawal by Subject|0|||
127618546|NCT03473743|459233013|FG002|Overall Study|Withdrawal by Subject|0|||
127618547|NCT03473743|459233014|FG003|Overall Study|Withdrawal by Subject|0|||
127618548|NCT03473743|459233015|FG004|Overall Study|Withdrawal by Subject|0|||
127618549|NCT03473743|459233016|FG005|Overall Study|Withdrawal by Subject|0|||
127618550|NCT03473743|459233017|FG006|Overall Study|Withdrawal by Subject|0|||
127618551|NCT03473743|459233018|FG007|Overall Study|Withdrawal by Subject|3|||
127618552|NCT03473743|459233011|FG000|Overall Study|Other|0|||
127618553|NCT03473743|459233012|FG001|Overall Study|Other|0|||
127618554|NCT03473743|459233013|FG002|Overall Study|Other|0|||
127618555|NCT03473743|459233014|FG003|Overall Study|Other|1|||
127618556|NCT03473743|459233015|FG004|Overall Study|Other|0|||
127618557|NCT03473743|459233016|FG005|Overall Study|Other|0|||
127618558|NCT03473743|459233017|FG006|Overall Study|Other|0|||
127618559|NCT03473743|459233018|FG007|Overall Study|Other|0|||
127618560|NCT03473743|459233011|FG000|Overall Study|Ongoing|0|||
127618561|NCT03473743|459233012|FG001|Overall Study|Ongoing|0|||
127618562|NCT03473743|459233013|FG002|Overall Study|Ongoing|6|||
127618563|NCT03473743|459233014|FG003|Overall Study|Ongoing|8|||
127618564|NCT03473743|459233015|FG004|Overall Study|Ongoing|1|||
127618565|NCT03473743|459233016|FG005|Overall Study|Ongoing|1|||
127618566|NCT03473743|459233017|FG006|Overall Study|Ongoing|22|||
127618567|NCT03473743|459233018|FG007|Overall Study|Ongoing|24|||
127618568|NCT03473743|459233011|FG000|Overall Study|Randomized but not treated|0|||
127618569|NCT03473743|459233012|FG001|Overall Study|Randomized but not treated|0|||
127618570|NCT03473743|459233013|FG002|Overall Study|Randomized but not treated|0|||
127618571|NCT03473743|459233014|FG003|Overall Study|Randomized but not treated|0|||
127618572|NCT03473743|459233015|FG004|Overall Study|Randomized but not treated|0|||
127618573|NCT03473743|459233016|FG005|Overall Study|Randomized but not treated|0|||
127618574|NCT03473743|459233017|FG006|Overall Study|Randomized but not treated|1|||
127618575|NCT03473743|459233018|FG007|Overall Study|Randomized but not treated|1|||
127618576|NCT02052739|459233024|FG000|Overall Study|Withdrew due to Adverse Event|3|||
127618577|NCT02052739|459233025|FG001|Overall Study|Withdrew due to Adverse Event|0|||
127618578|NCT02052739|459233024|FG000|Overall Study|Participant Died|2|||
127618579|NCT02052739|459233025|FG001|Overall Study|Participant Died|1|||
127618580|NCT05619692|459233026|FG000|Overall Study|Adverse Event|2|||
127618581|NCT05619692|459233027|FG001|Overall Study|Adverse Event|2|||
127618582|NCT05619692|459233026|FG000|Overall Study|Withdrawal by Participant|3|||
127618583|NCT05619692|459233027|FG001|Overall Study|Withdrawal by Participant|4|||
127618584|NCT05619692|459233026|FG000|Overall Study|Lost to Follow-up|2|||
127618585|NCT05619692|459233027|FG001|Overall Study|Lost to Follow-up|1|||
127618586|NCT05619692|459233026|FG000|Overall Study|Randomized but not treated|1|||
127618587|NCT05619692|459233027|FG001|Overall Study|Randomized but not treated|3|||
127618588|NCT05267054|459233029|FG000|Overall Study|Death|13|||
127618589|NCT05267054|459233030|FG001|Overall Study|Death|14|||
127618590|NCT05267054|459233029|FG000|Overall Study|Study Ended by Sponsor|9|||
127618591|NCT05267054|459233030|FG001|Overall Study|Study Ended by Sponsor|13|||
127618592|NCT05267054|459233029|FG000|Overall Study|Lost to Follow-up|1|||
127618593|NCT05267054|459233030|FG001|Overall Study|Lost to Follow-up|1|||
127618594|NCT05267054|459233029|FG000|Overall Study|Withdrawal by Subject|1|||
127618595|NCT05267054|459233030|FG001|Overall Study|Withdrawal by Subject|1|||
127618596|NCT04049760|459233031|FG000|Overall Study|Withdrawal by Subject|1|||
127618597|NCT02457598|459233032|FG000|Overall Study|Progressive Disease|2|||
127618598|NCT02457598|459233033|FG001|Overall Study|Progressive Disease|2|||
127618599|NCT02457598|459233034|FG002|Overall Study|Progressive Disease|1|||
127618600|NCT02457598|459233035|FG003|Overall Study|Progressive Disease|11|||
127618601|NCT02457598|459233036|FG004|Overall Study|Progressive Disease|7|||
127618602|NCT02457598|459233037|FG005|Overall Study|Progressive Disease|3|||
127618603|NCT02457598|459233038|FG006|Overall Study|Progressive Disease|2|||
127618604|NCT02457598|459233039|FG007|Overall Study|Progressive Disease|1|||
127618605|NCT02457598|459233040|FG008|Overall Study|Progressive Disease|1|||
127618606|NCT02457598|459233041|FG009|Overall Study|Progressive Disease|2|||
127791346|NCT00105443|459860646|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
127791347|NCT00105443|459860647|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
127791348|NCT00105443|459860644|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
127791349|NCT00105443|459860645|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
127791350|NCT00105443|459860646|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
127791351|NCT00105443|459860647|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
127791352|NCT00105443|459860644|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
127618607|NCT02457598|459233042|FG010|Overall Study|Progressive Disease|45|||
127618608|NCT02457598|459233043|FG011|Overall Study|Progressive Disease|6|||
127618609|NCT02457598|459233044|FG012|Overall Study|Progressive Disease|2|||
127618610|NCT02457598|459233045|FG013|Overall Study|Progressive Disease|2|||
127618611|NCT02457598|459233046|FG014|Overall Study|Progressive Disease|10|||
127618612|NCT02457598|459233047|FG015|Overall Study|Progressive Disease|1|||
127618613|NCT02457598|459233048|FG016|Overall Study|Progressive Disease|1|||
127618614|NCT02457598|459233032|FG000|Overall Study|Investigator's Discretion|0|||
127618615|NCT02457598|459233033|FG001|Overall Study|Investigator's Discretion|2|||
127791353|NCT00105443|459860645|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
127618616|NCT02457598|459233034|FG002|Overall Study|Investigator's Discretion|2|||
127618617|NCT02457598|459233035|FG003|Overall Study|Investigator's Discretion|2|||
127618618|NCT02457598|459233036|FG004|Overall Study|Investigator's Discretion|0|||
127618619|NCT02457598|459233037|FG005|Overall Study|Investigator's Discretion|0|||
127618620|NCT02457598|459233038|FG006|Overall Study|Investigator's Discretion|0|||
127618621|NCT02457598|459233039|FG007|Overall Study|Investigator's Discretion|1|||
127618622|NCT02457598|459233040|FG008|Overall Study|Investigator's Discretion|2|||
127618623|NCT02457598|459233041|FG009|Overall Study|Investigator's Discretion|0|||
127618624|NCT02457598|459233042|FG010|Overall Study|Investigator's Discretion|10|||
127618625|NCT02457598|459233043|FG011|Overall Study|Investigator's Discretion|2|||
127618626|NCT02457598|459233044|FG012|Overall Study|Investigator's Discretion|2|||
127618627|NCT02457598|459233045|FG013|Overall Study|Investigator's Discretion|1|||
127618628|NCT02457598|459233046|FG014|Overall Study|Investigator's Discretion|5|||
127618629|NCT02457598|459233047|FG015|Overall Study|Investigator's Discretion|0|||
127618630|NCT02457598|459233048|FG016|Overall Study|Investigator's Discretion|0|||
127618631|NCT02457598|459233032|FG000|Overall Study|Study Terminated by Sponsor|0|||
127618632|NCT02457598|459233033|FG001|Overall Study|Study Terminated by Sponsor|1|||
127618633|NCT02457598|459233034|FG002|Overall Study|Study Terminated by Sponsor|0|||
127618634|NCT02457598|459233035|FG003|Overall Study|Study Terminated by Sponsor|4|||
127618635|NCT02457598|459233036|FG004|Overall Study|Study Terminated by Sponsor|1|||
127618636|NCT02457598|459233037|FG005|Overall Study|Study Terminated by Sponsor|0|||
127618637|NCT02457598|459233038|FG006|Overall Study|Study Terminated by Sponsor|1|||
127618638|NCT02457598|459233039|FG007|Overall Study|Study Terminated by Sponsor|0|||
127618639|NCT02457598|459233040|FG008|Overall Study|Study Terminated by Sponsor|0|||
127618640|NCT02457598|459233041|FG009|Overall Study|Study Terminated by Sponsor|0|||
127618641|NCT02457598|459233042|FG010|Overall Study|Study Terminated by Sponsor|4|||
127618642|NCT02457598|459233043|FG011|Overall Study|Study Terminated by Sponsor|0|||
127618643|NCT02457598|459233044|FG012|Overall Study|Study Terminated by Sponsor|1|||
127618644|NCT02457598|459233045|FG013|Overall Study|Study Terminated by Sponsor|0|||
127618645|NCT02457598|459233046|FG014|Overall Study|Study Terminated by Sponsor|8|||
127618646|NCT02457598|459233047|FG015|Overall Study|Study Terminated by Sponsor|1|||
127618647|NCT02457598|459233048|FG016|Overall Study|Study Terminated by Sponsor|0|||
127618648|NCT02457598|459233032|FG000|Overall Study|Adverse Event|0|||
127618649|NCT02457598|459233033|FG001|Overall Study|Adverse Event|1|||
127618650|NCT02457598|459233034|FG002|Overall Study|Adverse Event|1|||
127618651|NCT02457598|459233035|FG003|Overall Study|Adverse Event|4|||
127618652|NCT02457598|459233036|FG004|Overall Study|Adverse Event|1|||
127618653|NCT02457598|459233037|FG005|Overall Study|Adverse Event|0|||
127618654|NCT02457598|459233038|FG006|Overall Study|Adverse Event|0|||
127618655|NCT02457598|459233039|FG007|Overall Study|Adverse Event|1|||
127618656|NCT02457598|459233040|FG008|Overall Study|Adverse Event|0|||
127618657|NCT02457598|459233041|FG009|Overall Study|Adverse Event|1|||
127618658|NCT02457598|459233042|FG010|Overall Study|Adverse Event|6|||
127618659|NCT02457598|459233043|FG011|Overall Study|Adverse Event|0|||
127618660|NCT02457598|459233044|FG012|Overall Study|Adverse Event|0|||
127618661|NCT02457598|459233045|FG013|Overall Study|Adverse Event|1|||
127618662|NCT02457598|459233046|FG014|Overall Study|Adverse Event|2|||
127618663|NCT02457598|459233047|FG015|Overall Study|Adverse Event|0|||
127618664|NCT02457598|459233048|FG016|Overall Study|Adverse Event|0|||
127618665|NCT02457598|459233032|FG000|Overall Study|Death|0|||
127618666|NCT02457598|459233033|FG001|Overall Study|Death|0|||
127618667|NCT02457598|459233034|FG002|Overall Study|Death|0|||
127618668|NCT02457598|459233035|FG003|Overall Study|Death|3|||
127618669|NCT02457598|459233036|FG004|Overall Study|Death|0|||
127618670|NCT02457598|459233037|FG005|Overall Study|Death|1|||
127618671|NCT02457598|459233038|FG006|Overall Study|Death|0|||
127618672|NCT02457598|459233039|FG007|Overall Study|Death|0|||
127618673|NCT02457598|459233040|FG008|Overall Study|Death|0|||
127618674|NCT02457598|459233041|FG009|Overall Study|Death|0|||
127618675|NCT02457598|459233042|FG010|Overall Study|Death|3|||
127618676|NCT02457598|459233043|FG011|Overall Study|Death|0|||
127618677|NCT02457598|459233044|FG012|Overall Study|Death|0|||
127618678|NCT02457598|459233045|FG013|Overall Study|Death|1|||
127618679|NCT02457598|459233046|FG014|Overall Study|Death|2|||
127618680|NCT02457598|459233047|FG015|Overall Study|Death|0|||
127618681|NCT02457598|459233048|FG016|Overall Study|Death|1|||
127618682|NCT02457598|459233032|FG000|Overall Study|Transition to the MHRA's Special Scheme|0|||
127618683|NCT02457598|459233033|FG001|Overall Study|Transition to the MHRA's Special Scheme|2|||
127618684|NCT02457598|459233034|FG002|Overall Study|Transition to the MHRA's Special Scheme|0|||
127618685|NCT02457598|459233035|FG003|Overall Study|Transition to the MHRA's Special Scheme|1|||
127618686|NCT02457598|459233036|FG004|Overall Study|Transition to the MHRA's Special Scheme|0|||
127618687|NCT02457598|459233037|FG005|Overall Study|Transition to the MHRA's Special Scheme|0|||
127618688|NCT02457598|459233038|FG006|Overall Study|Transition to the MHRA's Special Scheme|0|||
127618689|NCT02457598|459233039|FG007|Overall Study|Transition to the MHRA's Special Scheme|1|||
127618690|NCT02457598|459233040|FG008|Overall Study|Transition to the MHRA's Special Scheme|0|||
127700343|NCT05590403|459532939|FG001|Overall Study|Other|0|||
127618691|NCT02457598|459233041|FG009|Overall Study|Transition to the MHRA's Special Scheme|0|||
127618692|NCT02457598|459233042|FG010|Overall Study|Transition to the MHRA's Special Scheme|4|||
127618693|NCT02457598|459233043|FG011|Overall Study|Transition to the MHRA's Special Scheme|0|||
127618694|NCT02457598|459233044|FG012|Overall Study|Transition to the MHRA's Special Scheme|0|||
127618695|NCT02457598|459233045|FG013|Overall Study|Transition to the MHRA's Special Scheme|0|||
127618696|NCT02457598|459233046|FG014|Overall Study|Transition to the MHRA's Special Scheme|1|||
127618697|NCT02457598|459233047|FG015|Overall Study|Transition to the MHRA's Special Scheme|1|||
127618698|NCT02457598|459233048|FG016|Overall Study|Transition to the MHRA's Special Scheme|1|||
127618699|NCT02457598|459233032|FG000|Overall Study|Withdrew Consent|0|||
127618700|NCT02457598|459233033|FG001|Overall Study|Withdrew Consent|0|||
127618701|NCT02457598|459233034|FG002|Overall Study|Withdrew Consent|0|||
127618702|NCT02457598|459233035|FG003|Overall Study|Withdrew Consent|0|||
127618703|NCT02457598|459233036|FG004|Overall Study|Withdrew Consent|0|||
127618704|NCT02457598|459233037|FG005|Overall Study|Withdrew Consent|0|||
127618705|NCT02457598|459233038|FG006|Overall Study|Withdrew Consent|0|||
127618706|NCT02457598|459233039|FG007|Overall Study|Withdrew Consent|2|||
127618707|NCT02457598|459233040|FG008|Overall Study|Withdrew Consent|0|||
127618708|NCT02457598|459233041|FG009|Overall Study|Withdrew Consent|0|||
127618709|NCT02457598|459233042|FG010|Overall Study|Withdrew Consent|3|||
127618710|NCT02457598|459233043|FG011|Overall Study|Withdrew Consent|0|||
127618711|NCT02457598|459233044|FG012|Overall Study|Withdrew Consent|0|||
127618712|NCT02457598|459233045|FG013|Overall Study|Withdrew Consent|1|||
127618713|NCT02457598|459233046|FG014|Overall Study|Withdrew Consent|0|||
127618714|NCT02457598|459233047|FG015|Overall Study|Withdrew Consent|0|||
127618715|NCT02457598|459233048|FG016|Overall Study|Withdrew Consent|0|||
127618716|NCT02457598|459233032|FG000|Overall Study|Unacceptable Toxicity|0|||
127618717|NCT02457598|459233033|FG001|Overall Study|Unacceptable Toxicity|0|||
127618718|NCT02457598|459233034|FG002|Overall Study|Unacceptable Toxicity|0|||
127618719|NCT02457598|459233035|FG003|Overall Study|Unacceptable Toxicity|0|||
127618720|NCT02457598|459233036|FG004|Overall Study|Unacceptable Toxicity|0|||
127618721|NCT02457598|459233037|FG005|Overall Study|Unacceptable Toxicity|0|||
127618722|NCT02457598|459233038|FG006|Overall Study|Unacceptable Toxicity|0|||
127618723|NCT02457598|459233039|FG007|Overall Study|Unacceptable Toxicity|0|||
127618724|NCT02457598|459233040|FG008|Overall Study|Unacceptable Toxicity|0|||
127618725|NCT02457598|459233041|FG009|Overall Study|Unacceptable Toxicity|0|||
127618726|NCT02457598|459233042|FG010|Overall Study|Unacceptable Toxicity|1|||
127618727|NCT02457598|459233043|FG011|Overall Study|Unacceptable Toxicity|0|||
127618728|NCT02457598|459233044|FG012|Overall Study|Unacceptable Toxicity|1|||
127618729|NCT02457598|459233045|FG013|Overall Study|Unacceptable Toxicity|1|||
127618730|NCT02457598|459233046|FG014|Overall Study|Unacceptable Toxicity|1|||
127618731|NCT02457598|459233047|FG015|Overall Study|Unacceptable Toxicity|0|||
127618732|NCT02457598|459233048|FG016|Overall Study|Unacceptable Toxicity|0|||
127618733|NCT02457598|459233032|FG000|Overall Study|Intercurrent Illness|0|||
127618734|NCT02457598|459233033|FG001|Overall Study|Intercurrent Illness|0|||
127618735|NCT02457598|459233034|FG002|Overall Study|Intercurrent Illness|0|||
127618736|NCT02457598|459233035|FG003|Overall Study|Intercurrent Illness|0|||
127618737|NCT02457598|459233036|FG004|Overall Study|Intercurrent Illness|0|||
127618738|NCT02457598|459233037|FG005|Overall Study|Intercurrent Illness|0|||
127618739|NCT02457598|459233038|FG006|Overall Study|Intercurrent Illness|0|||
127618740|NCT02457598|459233039|FG007|Overall Study|Intercurrent Illness|0|||
127618741|NCT02457598|459233040|FG008|Overall Study|Intercurrent Illness|0|||
127618742|NCT02457598|459233041|FG009|Overall Study|Intercurrent Illness|0|||
127618743|NCT02457598|459233042|FG010|Overall Study|Intercurrent Illness|1|||
127618744|NCT02457598|459233043|FG011|Overall Study|Intercurrent Illness|0|||
127618745|NCT02457598|459233044|FG012|Overall Study|Intercurrent Illness|0|||
127618746|NCT02457598|459233045|FG013|Overall Study|Intercurrent Illness|0|||
127618747|NCT02457598|459233046|FG014|Overall Study|Intercurrent Illness|0|||
127618748|NCT02457598|459233047|FG015|Overall Study|Intercurrent Illness|0|||
127618749|NCT02457598|459233048|FG016|Overall Study|Intercurrent Illness|0|||
127618750|NCT02457598|459233032|FG000|Overall Study|Protocol Violation|0|||
127618751|NCT02457598|459233033|FG001|Overall Study|Protocol Violation|0|||
127618752|NCT02457598|459233034|FG002|Overall Study|Protocol Violation|0|||
127618753|NCT02457598|459233035|FG003|Overall Study|Protocol Violation|0|||
127618754|NCT02457598|459233036|FG004|Overall Study|Protocol Violation|0|||
127618755|NCT02457598|459233037|FG005|Overall Study|Protocol Violation|0|||
127618756|NCT02457598|459233038|FG006|Overall Study|Protocol Violation|0|||
127618757|NCT02457598|459233039|FG007|Overall Study|Protocol Violation|0|||
127618758|NCT02457598|459233040|FG008|Overall Study|Protocol Violation|0|||
127618759|NCT02457598|459233041|FG009|Overall Study|Protocol Violation|0|||
127618760|NCT02457598|459233042|FG010|Overall Study|Protocol Violation|1|||
127618761|NCT02457598|459233043|FG011|Overall Study|Protocol Violation|0|||
127618762|NCT02457598|459233044|FG012|Overall Study|Protocol Violation|0|||
127618763|NCT02457598|459233045|FG013|Overall Study|Protocol Violation|0|||
127618764|NCT02457598|459233046|FG014|Overall Study|Protocol Violation|0|||
127618765|NCT02457598|459233047|FG015|Overall Study|Protocol Violation|0|||
127618766|NCT02457598|459233048|FG016|Overall Study|Protocol Violation|0|||
127700344|NCT05590403|459532940|FG002|Overall Study|Other|2|||
127618767|NCT01403974|459233049|FG000|Overall Study|Progressive disease according to RECIST|3|||
127618768|NCT01403974|459233050|FG001|Overall Study|Progressive disease according to RECIST|3|||
127618769|NCT01403974|459233051|FG002|Overall Study|Progressive disease according to RECIST|2|||
127618770|NCT01403974|459233052|FG003|Overall Study|Progressive disease according to RECIST|3|||
127618771|NCT01403974|459233053|FG004|Overall Study|Progressive disease according to RECIST|3|||
127618772|NCT01403974|459233054|FG005|Overall Study|Progressive disease according to RECIST|2|||
127618773|NCT01403974|459233055|FG006|Overall Study|Progressive disease according to RECIST|3|||
127618774|NCT01403974|459233056|FG007|Overall Study|Progressive disease according to RECIST|2|||
127618775|NCT01403974|459233057|FG008|Overall Study|Progressive disease according to RECIST|6|||
127618776|NCT01403974|459233058|FG009|Overall Study|Progressive disease according to RECIST|2|||
127618777|NCT01403974|459233059|FG010|Overall Study|Progressive disease according to RECIST|3|||
127618778|NCT01403974|459233060|FG011|Overall Study|Progressive disease according to RECIST|2|||
127618779|NCT01403974|459233061|FG012|Overall Study|Progressive disease according to RECIST|2|||
127618780|NCT01403974|459233062|FG013|Overall Study|Progressive disease according to RECIST|3|||
127618781|NCT01403974|459233063|FG014|Overall Study|Progressive disease according to RECIST|1|||
127618782|NCT01403974|459233064|FG015|Overall Study|Progressive disease according to RECIST|8|||
127618783|NCT01403974|459233049|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
127618784|NCT01403974|459233050|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
127618785|NCT01403974|459233051|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
127618786|NCT01403974|459233052|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
127618787|NCT01403974|459233053|FG004|Overall Study|Dose limiting toxicity (DLT)|0|||
127618788|NCT01403974|459233054|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
127618789|NCT01403974|459233055|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
127618790|NCT01403974|459233056|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
127618791|NCT01403974|459233057|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
127618792|NCT01403974|459233058|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
127618793|NCT01403974|459233059|FG010|Overall Study|Dose limiting toxicity (DLT)|0|||
127618794|NCT01403974|459233060|FG011|Overall Study|Dose limiting toxicity (DLT)|0|||
127618795|NCT01403974|459233061|FG012|Overall Study|Dose limiting toxicity (DLT)|0|||
127618796|NCT01403974|459233062|FG013|Overall Study|Dose limiting toxicity (DLT)|0|||
127618797|NCT01403974|459233063|FG014|Overall Study|Dose limiting toxicity (DLT)|0|||
127618798|NCT01403974|459233064|FG015|Overall Study|Dose limiting toxicity (DLT)|0|||
127618799|NCT01403974|459233049|FG000|Overall Study|Refused to continue study medication|0|||
127618800|NCT01403974|459233050|FG001|Overall Study|Refused to continue study medication|0|||
127618801|NCT01403974|459233051|FG002|Overall Study|Refused to continue study medication|0|||
127618802|NCT01403974|459233052|FG003|Overall Study|Refused to continue study medication|0|||
127618803|NCT01403974|459233053|FG004|Overall Study|Refused to continue study medication|0|||
127618804|NCT01403974|459233054|FG005|Overall Study|Refused to continue study medication|1|||
127618805|NCT01403974|459233055|FG006|Overall Study|Refused to continue study medication|0|||
127618806|NCT01403974|459233056|FG007|Overall Study|Refused to continue study medication|0|||
127618807|NCT01403974|459233057|FG008|Overall Study|Refused to continue study medication|1|||
127618808|NCT01403974|459233058|FG009|Overall Study|Refused to continue study medication|0|||
127618809|NCT01403974|459233059|FG010|Overall Study|Refused to continue study medication|1|||
127618810|NCT01403974|459233060|FG011|Overall Study|Refused to continue study medication|0|||
127618811|NCT01403974|459233061|FG012|Overall Study|Refused to continue study medication|0|||
127618812|NCT01403974|459233062|FG013|Overall Study|Refused to continue study medication|0|||
127618813|NCT01403974|459233063|FG014|Overall Study|Refused to continue study medication|0|||
127618814|NCT01403974|459233064|FG015|Overall Study|Refused to continue study medication|4|||
127618815|NCT01403974|459233049|FG000|Overall Study|Adverse Event|0|||
127618816|NCT01403974|459233050|FG001|Overall Study|Adverse Event|0|||
127618817|NCT01403974|459233051|FG002|Overall Study|Adverse Event|1|||
127618818|NCT01403974|459233052|FG003|Overall Study|Adverse Event|0|||
127618819|NCT01403974|459233053|FG004|Overall Study|Adverse Event|0|||
127618820|NCT01403974|459233054|FG005|Overall Study|Adverse Event|0|||
127618821|NCT01403974|459233055|FG006|Overall Study|Adverse Event|0|||
127618822|NCT01403974|459233056|FG007|Overall Study|Adverse Event|1|||
127618823|NCT01403974|459233057|FG008|Overall Study|Adverse Event|0|||
127618824|NCT01403974|459233058|FG009|Overall Study|Adverse Event|0|||
127618825|NCT01403974|459233059|FG010|Overall Study|Adverse Event|0|||
127618826|NCT01403974|459233060|FG011|Overall Study|Adverse Event|0|||
127618827|NCT01403974|459233061|FG012|Overall Study|Adverse Event|1|||
127618828|NCT01403974|459233062|FG013|Overall Study|Adverse Event|0|||
127791354|NCT00105443|459860646|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
127618829|NCT01403974|459233063|FG014|Overall Study|Adverse Event|0|||
127618830|NCT01403974|459233064|FG015|Overall Study|Adverse Event|0|||
127618831|NCT01403974|459233049|FG000|Overall Study|Other than specified|0|||
127618832|NCT01403974|459233050|FG001|Overall Study|Other than specified|0|||
127618833|NCT01403974|459233051|FG002|Overall Study|Other than specified|0|||
127618834|NCT01403974|459233052|FG003|Overall Study|Other than specified|0|||
127618835|NCT01403974|459233053|FG004|Overall Study|Other than specified|0|||
127618836|NCT01403974|459233054|FG005|Overall Study|Other than specified|0|||
127618837|NCT01403974|459233055|FG006|Overall Study|Other than specified|0|||
127618838|NCT01403974|459233056|FG007|Overall Study|Other than specified|0|||
127618839|NCT01403974|459233057|FG008|Overall Study|Other than specified|0|||
127618840|NCT01403974|459233058|FG009|Overall Study|Other than specified|1|||
127618841|NCT01403974|459233059|FG010|Overall Study|Other than specified|0|||
127618842|NCT01403974|459233060|FG011|Overall Study|Other than specified|1|||
127618843|NCT01403974|459233061|FG012|Overall Study|Other than specified|0|||
127618844|NCT01403974|459233062|FG013|Overall Study|Other than specified|0|||
127618845|NCT01403974|459233063|FG014|Overall Study|Other than specified|0|||
127618846|NCT01403974|459233064|FG015|Overall Study|Other than specified|0|||
127618847|NCT01526889|459233065|FG000|Treatment Period|Adverse Event|2|||
127618848|NCT01526889|459233066|FG001|Treatment Period|Adverse Event|0|||
127618849|NCT01526889|459233065|FG000|Treatment Extension Period|Administrative problems|1|||
127618850|NCT01526889|459233066|FG001|Treatment Extension Period|Administrative problems|0|||
127618851|NCT00974571|459233067|FG000|Overall Study|Adverse Event|31|||
127618852|NCT00974571|459233068|FG001|Overall Study|Adverse Event|4|||
127618853|NCT00974571|459233069|FG002|Overall Study|Adverse Event|27|||
127618854|NCT00974571|459233067|FG000|Overall Study|Lack of Efficacy|3|||
127618855|NCT00974571|459233068|FG001|Overall Study|Lack of Efficacy|2|||
127618856|NCT00974571|459233069|FG002|Overall Study|Lack of Efficacy|9|||
127618857|NCT00974571|459233067|FG000|Overall Study|Lost to Follow-up|2|||
127618858|NCT00974571|459233068|FG001|Overall Study|Lost to Follow-up|1|||
127618859|NCT00974571|459233069|FG002|Overall Study|Lost to Follow-up|2|||
127618860|NCT00974571|459233067|FG000|Overall Study|Protocol Violation|13|||
127618861|NCT00974571|459233068|FG001|Overall Study|Protocol Violation|4|||
127618862|NCT00974571|459233069|FG002|Overall Study|Protocol Violation|18|||
127618863|NCT00974571|459233067|FG000|Overall Study|Withdrawal by Subject|14|||
127618864|NCT00974571|459233068|FG001|Overall Study|Withdrawal by Subject|5|||
127618865|NCT00974571|459233069|FG002|Overall Study|Withdrawal by Subject|16|||
127618866|NCT00974571|459233067|FG000|Overall Study|Patient Moved|1|||
127618867|NCT00974571|459233068|FG001|Overall Study|Patient Moved|0|||
127618868|NCT00974571|459233069|FG002|Overall Study|Patient Moved|1|||
127618869|NCT00974571|459233067|FG000|Overall Study|Other|4|||
127618870|NCT00974571|459233068|FG001|Overall Study|Other|0|||
127618871|NCT00974571|459233069|FG002|Overall Study|Other|10|||
127618872|NCT01494610|459233088|FG000|Period 1|Withdrawal by Subject|1|||
127618873|NCT01494610|459233089|FG001|Period 1|Withdrawal by Subject|1|||
127618874|NCT01494610|459233088|FG000|Period 3|Adverse Event|1|||
127618875|NCT01494610|459233089|FG001|Period 3|Adverse Event|0|||
127618876|NCT01494610|459233088|FG000|Period 3|Withdrawal by Subject|1|||
127618877|NCT01494610|459233089|FG001|Period 3|Withdrawal by Subject|0|||
127618878|NCT01494610|459233088|FG000|Period 4|Protocol Violation|1|||
127618879|NCT01494610|459233089|FG001|Period 4|Protocol Violation|0|||
127618880|NCT04334460|459233090|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
127618881|NCT04334460|459233091|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
127618882|NCT04334460|459233090|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
127618883|NCT04334460|459233091|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
127618884|NCT00547703|459233094|FG000|Overall Study|Lost to Follow-up|1|||
127618885|NCT00547703|459233095|FG001|Overall Study|Lost to Follow-up|0|||
127618886|NCT03995953|459233098|FG000|Overall Study|Death|3|||
127618887|NCT03995953|459233099|FG001|Overall Study|Death|0|||
127618888|NCT03995953|459233100|FG002|Overall Study|Death|3|||
127618889|NCT03995953|459233101|FG003|Overall Study|Death|0|||
127618890|NCT03995953|459233102|FG004|Overall Study|Death|3|||
127618891|NCT03995953|459233103|FG005|Overall Study|Death|0|||
127618892|NCT03995953|459233104|FG006|Overall Study|Death|0|||
127618893|NCT03995953|459233105|FG007|Overall Study|Death|0|||
127618894|NCT03995953|459233106|FG008|Overall Study|Death|1|||
127618895|NCT03995953|459233107|FG009|Overall Study|Death|0|||
127618896|NCT03995953|459233108|FG010|Overall Study|Death|0|||
127618897|NCT03995953|459233109|FG011|Overall Study|Death|0|||
127618898|NCT03995953|459233098|FG000|Overall Study|Lost to Follow-up|6|||
127618899|NCT03995953|459233099|FG001|Overall Study|Lost to Follow-up|54|||
127618900|NCT03995953|459233100|FG002|Overall Study|Lost to Follow-up|3|||
127618901|NCT03995953|459233101|FG003|Overall Study|Lost to Follow-up|32|||
127618902|NCT03995953|459233102|FG004|Overall Study|Lost to Follow-up|5|||
127618903|NCT03995953|459233103|FG005|Overall Study|Lost to Follow-up|44|||
127618904|NCT03995953|459233104|FG006|Overall Study|Lost to Follow-up|0|||
127618905|NCT03995953|459233105|FG007|Overall Study|Lost to Follow-up|31|||
127618906|NCT03995953|459233106|FG008|Overall Study|Lost to Follow-up|8|||
127618907|NCT03995953|459233107|FG009|Overall Study|Lost to Follow-up|36|||
127618908|NCT03995953|459233108|FG010|Overall Study|Lost to Follow-up|5|||
127700345|NCT05590403|459532941|FG003|Overall Study|Other|2|||
127884467|NCT05166421|460199971|FG002|Overall Study|Lost to Follow-up|7|||
127618909|NCT03995953|459233109|FG011|Overall Study|Lost to Follow-up|41|||
127618910|NCT03995953|459233098|FG000|Overall Study|Withdrawal by Subject|4|||
127618911|NCT03995953|459233099|FG001|Overall Study|Withdrawal by Subject|0|||
127700346|NCT05590403|459532942|FG004|Overall Study|Other|0|||
127700347|NCT05590403|459532938|FG000|Overall Study|Migrated / moved from the study area|1|||
127700348|NCT05590403|459532939|FG001|Overall Study|Migrated / moved from the study area|1|||
127700349|NCT05590403|459532940|FG002|Overall Study|Migrated / moved from the study area|0|||
127700350|NCT05590403|459532941|FG003|Overall Study|Migrated / moved from the study area|3|||
127700351|NCT05590403|459532942|FG004|Overall Study|Migrated / moved from the study area|1|||
127700352|NCT05590403|459532938|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
127700353|NCT05590403|459532939|FG001|Overall Study|Adverse event requiring expedited reporting|0|||
127700354|NCT05590403|459532940|FG002|Overall Study|Adverse event requiring expedited reporting|4|||
127700355|NCT05590403|459532941|FG003|Overall Study|Adverse event requiring expedited reporting|1|||
127700356|NCT05590403|459532942|FG004|Overall Study|Adverse event requiring expedited reporting|0|||
127700357|NCT04552223|459532943|FG000|Overall Study|Withdrawal by Subject|1|||
127700358|NCT04526704|459532944|FG000|Overall Study|Adverse Event|1|||
127700359|NCT04526704|459532945|FG001|Overall Study|Adverse Event|0|||
127700360|NCT04526704|459532944|FG000|Overall Study|Physician Decision|1|||
127700361|NCT04526704|459532945|FG001|Overall Study|Physician Decision|0|||
127700362|NCT04526704|459532944|FG000|Overall Study|Withdrawal by Subject|2|||
127700363|NCT04526704|459532945|FG001|Overall Study|Withdrawal by Subject|0|||
127700364|NCT02737436|459532946|FG000|Washout Period|Lost to Follow-up|5|||
127700365|NCT02737436|459532947|FG001|Washout Period|Lost to Follow-up|11|||
127700366|NCT02737436|459532946|FG000|Data Analysis|Scanning data problems|5|||
127700367|NCT02737436|459532947|FG001|Data Analysis|Scanning data problems|8|||
127700368|NCT03701399|459532948|FG000|Overall Study|Adverse Event|3|||
127700369|NCT03701399|459532949|FG001|Overall Study|Adverse Event|5|||
127700370|NCT03701399|459532948|FG000|Overall Study|Withdrawal by Subject|6|||
127700371|NCT03701399|459532949|FG001|Overall Study|Withdrawal by Subject|3|||
127700372|NCT03701399|459532948|FG000|Overall Study|Investigators decision|1|||
127700373|NCT03701399|459532949|FG001|Overall Study|Investigators decision|2|||
127700374|NCT03701399|459532948|FG000|Overall Study|Lost to Follow-up|1|||
127700375|NCT03701399|459532949|FG001|Overall Study|Lost to Follow-up|2|||
127700376|NCT03701399|459532948|FG000|Overall Study|Death|1|||
127700377|NCT03701399|459532949|FG001|Overall Study|Death|1|||
127700378|NCT03701399|459532948|FG000|Overall Study|Randomized but not treated|1|||
127700379|NCT03701399|459532949|FG001|Overall Study|Randomized but not treated|0|||
127700380|NCT00554788|459532950|FG000|Overall Study|Adverse Event|0|||
127700381|NCT00554788|459532951|FG001|Overall Study|Adverse Event|1|||
127700382|NCT00554788|459532952|FG002|Overall Study|Adverse Event|2|||
127700383|NCT00554788|459532950|FG000|Overall Study|Lost to Follow-up|4|||
127700384|NCT00554788|459532951|FG001|Overall Study|Lost to Follow-up|3|||
127700385|NCT00554788|459532952|FG002|Overall Study|Lost to Follow-up|3|||
127700386|NCT00554788|459532950|FG000|Overall Study|Physician Decision|1|||
127700387|NCT00554788|459532951|FG001|Overall Study|Physician Decision|1|||
127700388|NCT00554788|459532952|FG002|Overall Study|Physician Decision|3|||
127700389|NCT00554788|459532950|FG000|Overall Study|Withdrawal by Subject|0|||
127700390|NCT00554788|459532951|FG001|Overall Study|Withdrawal by Subject|0|||
127700391|NCT00554788|459532952|FG002|Overall Study|Withdrawal by Subject|1|||
127700392|NCT00554788|459532950|FG000|Overall Study|Refusal of further protocol therapy|0|||
127700393|NCT00554788|459532951|FG001|Overall Study|Refusal of further protocol therapy|1|||
127700394|NCT00554788|459532952|FG002|Overall Study|Refusal of further protocol therapy|1|||
127700395|NCT00554788|459532950|FG000|Overall Study|Progressive disease|0|||
127700396|NCT00554788|459532951|FG001|Overall Study|Progressive disease|0|||
127700397|NCT00554788|459532952|FG002|Overall Study|Progressive disease|3|||
127700398|NCT00554788|459532950|FG000|Overall Study|Ineligible|2|||
127700399|NCT00554788|459532951|FG001|Overall Study|Ineligible|0|||
127700400|NCT00554788|459532952|FG002|Overall Study|Ineligible|1|||
127700401|NCT03134196|459532966|FG000|Overall Study|Death|2|||
127700402|NCT03134196|459532967|FG001|Overall Study|Death|1|||
127700403|NCT03134196|459532966|FG000|Overall Study|Lost to Follow-up|13|||
127700404|NCT03134196|459532967|FG001|Overall Study|Lost to Follow-up|15|||
127700405|NCT03134196|459532966|FG000|Overall Study|Physician Decision|0|||
127700406|NCT03134196|459532967|FG001|Overall Study|Physician Decision|1|||
127700407|NCT03134196|459532966|FG000|Overall Study|Withdrawal by Subject|19|||
127700408|NCT03134196|459532967|FG001|Overall Study|Withdrawal by Subject|12|||
127700409|NCT03134196|459532966|FG000|Overall Study|Site Unable to Contact Participant|2|||
127700410|NCT03134196|459532967|FG001|Overall Study|Site Unable to Contact Participant|0|||
127700411|NCT03134196|459532966|FG000|Overall Study|Site Closed Scheduling Conflict|1|||
127700412|NCT03134196|459532967|FG001|Overall Study|Site Closed Scheduling Conflict|0|||
127700413|NCT03134196|459532966|FG000|Overall Study|Scheduling Conflict|1|||
127700414|NCT03134196|459532967|FG001|Overall Study|Scheduling Conflict|0|||
127700415|NCT04719390|459532970|FG000|Overall Study|Withdrawal by Subject|1|||
127700416|NCT00753545|459532971|FG000|Overall Study|Death|98|||
127700417|NCT00753545|459532972|FG001|Overall Study|Death|112|||
127700418|NCT00753545|459532971|FG000|Overall Study|Lost to Follow-up|2|||
127700419|NCT00753545|459532972|FG001|Overall Study|Lost to Follow-up|3|||
127700420|NCT00753545|459532971|FG000|Overall Study|Protocol Violation|1|||
127700421|NCT00753545|459532972|FG001|Overall Study|Protocol Violation|0|||
127700422|NCT00753545|459532971|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
127884468|NCT01858558|460202007|FG000|Overall Study|Death|1|||
127884469|NCT01858558|460202008|FG001|Overall Study|Death|1|||
127884470|NCT01858558|460202007|FG000|Overall Study|Lost to Follow-up|1|||
127884471|NCT01858558|460202008|FG001|Overall Study|Lost to Follow-up|0|||
127884472|NCT01858558|460202007|FG000|Overall Study|Disease progression|3|||
127884473|NCT01858558|460202008|FG001|Overall Study|Disease progression|1|||
127884474|NCT01858558|460202007|FG000|Overall Study|Product contamination|2|||
127884475|NCT01858558|460202008|FG001|Overall Study|Product contamination|0|||
127884476|NCT01858558|460202007|FG000|Overall Study|Failed expansion of cell product|2|||
127884477|NCT01858558|460202008|FG001|Overall Study|Failed expansion of cell product|0|||
127884478|NCT02598622|460202010|FG000|Overall Study|Withdrawal by Subject|3|||
127884479|NCT02598622|460202011|FG001|Overall Study|Withdrawal by Subject|0|||
127884480|NCT02598622|460202010|FG000|Overall Study|Physician Decision|3|||
127884481|NCT02598622|460202011|FG001|Overall Study|Physician Decision|0|||
127884482|NCT04335110|460202027|FG000|Overall Study|Withdrawal by Subject|1|||
127884483|NCT04335110|460202028|FG001|Overall Study|Withdrawal by Subject|1|||
127884484|NCT04335110|460202027|FG000|Overall Study|Death|0|||
127884485|NCT04335110|460202028|FG001|Overall Study|Death|1|||
127884486|NCT02595528|460202029|FG000|Overall Study|Withdrawal by Subject|1|||
127884487|NCT02595528|460202030|FG001|Overall Study|Withdrawal by Subject|2|||
127884488|NCT02595528|460202031|FG002|Overall Study|Withdrawal by Subject|1|||
127884489|NCT02595528|460202032|FG003|Overall Study|Withdrawal by Subject|3|||
127884490|NCT02595528|460202029|FG000|Overall Study|Lost to Follow-up|1|||
127884491|NCT02595528|460202030|FG001|Overall Study|Lost to Follow-up|1|||
127884492|NCT02595528|460202031|FG002|Overall Study|Lost to Follow-up|0|||
127884493|NCT02595528|460202032|FG003|Overall Study|Lost to Follow-up|1|||
127618912|NCT03995953|459233100|FG002|Overall Study|Withdrawal by Subject|1|||
127618913|NCT03995953|459233101|FG003|Overall Study|Withdrawal by Subject|0|||
127618914|NCT03995953|459233102|FG004|Overall Study|Withdrawal by Subject|1|||
127618915|NCT03995953|459233103|FG005|Overall Study|Withdrawal by Subject|0|||
127618916|NCT03995953|459233104|FG006|Overall Study|Withdrawal by Subject|1|||
127618917|NCT03995953|459233105|FG007|Overall Study|Withdrawal by Subject|0|||
127618918|NCT03995953|459233106|FG008|Overall Study|Withdrawal by Subject|3|||
127618919|NCT03995953|459233107|FG009|Overall Study|Withdrawal by Subject|0|||
127618920|NCT03995953|459233108|FG010|Overall Study|Withdrawal by Subject|3|||
127618921|NCT03995953|459233109|FG011|Overall Study|Withdrawal by Subject|0|||
127618922|NCT03995953|459233098|FG000|Overall Study|Health Issues|0|||
127618923|NCT03995953|459233099|FG001|Overall Study|Health Issues|0|||
127618924|NCT03995953|459233100|FG002|Overall Study|Health Issues|0|||
127618925|NCT03995953|459233101|FG003|Overall Study|Health Issues|0|||
127618926|NCT03995953|459233102|FG004|Overall Study|Health Issues|1|||
127618927|NCT03995953|459233103|FG005|Overall Study|Health Issues|0|||
127618928|NCT03995953|459233104|FG006|Overall Study|Health Issues|0|||
127618929|NCT03995953|459233105|FG007|Overall Study|Health Issues|0|||
127618930|NCT03995953|459233106|FG008|Overall Study|Health Issues|4|||
127618931|NCT03995953|459233107|FG009|Overall Study|Health Issues|0|||
127618932|NCT03995953|459233108|FG010|Overall Study|Health Issues|0|||
127618933|NCT03995953|459233109|FG011|Overall Study|Health Issues|0|||
127618934|NCT03995953|459233098|FG000|Overall Study|Relocated|11|||
127618935|NCT03995953|459233099|FG001|Overall Study|Relocated|0|||
127618936|NCT03995953|459233100|FG002|Overall Study|Relocated|16|||
127618937|NCT03995953|459233101|FG003|Overall Study|Relocated|0|||
127618938|NCT03995953|459233102|FG004|Overall Study|Relocated|14|||
127618939|NCT03995953|459233103|FG005|Overall Study|Relocated|0|||
127618940|NCT03995953|459233104|FG006|Overall Study|Relocated|16|||
127618941|NCT03995953|459233105|FG007|Overall Study|Relocated|0|||
127618942|NCT03995953|459233106|FG008|Overall Study|Relocated|14|||
127618943|NCT03995953|459233107|FG009|Overall Study|Relocated|0|||
127618944|NCT03995953|459233108|FG010|Overall Study|Relocated|15|||
127618945|NCT03995953|459233109|FG011|Overall Study|Relocated|0|||
127618946|NCT04951622|459233117|FG000|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|7|||
127618947|NCT04951622|459233118|FG001|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|5|||
127618948|NCT04951622|459233119|FG002|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
127618949|NCT04951622|459233120|FG003|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
127618950|NCT04951622|459233121|FG004|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
127618951|NCT04951622|459233117|FG000|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
127618952|NCT04951622|459233118|FG001|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
127618953|NCT04951622|459233119|FG002|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
127618954|NCT04951622|459233120|FG003|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
127618955|NCT04951622|459233121|FG004|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
127884494|NCT03101293|460202036|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
127884495|NCT03101293|460202037|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
127618956|NCT04951622|459233117|FG000|DB Phase: Day 1 (Week 0) to Week 24|Death|2|||
127618957|NCT04951622|459233118|FG001|DB Phase: Day 1 (Week 0) to Week 24|Death|1|||
127618958|NCT04951622|459233119|FG002|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
127618959|NCT04951622|459233120|FG003|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
127618960|NCT04951622|459233121|FG004|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
127618961|NCT04951622|459233117|FG000|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
127618962|NCT04951622|459233118|FG001|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|1|||
127618963|NCT04951622|459233119|FG002|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
127618964|NCT04951622|459233120|FG003|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
127618965|NCT04951622|459233121|FG004|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
127618966|NCT04951622|459233117|FG000|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
127618967|NCT04951622|459233118|FG001|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
127618968|NCT04951622|459233119|FG002|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
127618969|NCT04951622|459233120|FG003|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
127618970|NCT04951622|459233121|FG004|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
127618971|NCT04951622|459233117|FG000|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
127700423|NCT00753545|459532972|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
127618972|NCT04951622|459233118|FG001|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|1|||
127618973|NCT04951622|459233119|FG002|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
127618974|NCT04951622|459233120|FG003|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
127618975|NCT04951622|459233121|FG004|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
127618976|NCT04951622|459233117|FG000|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|2|||
127618977|NCT04951622|459233118|FG001|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
127618978|NCT04951622|459233119|FG002|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
127618979|NCT04951622|459233120|FG003|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
127618980|NCT04951622|459233121|FG004|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
127618981|NCT04951622|459233117|FG000|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|1|||
127618982|NCT04951622|459233118|FG001|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
127618983|NCT04951622|459233119|FG002|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
127618984|NCT04951622|459233120|FG003|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
127618985|NCT04951622|459233121|FG004|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
127618986|NCT04951622|459233117|FG000|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|1|||
127791355|NCT00105443|459860647|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
127791356|NCT00105443|459860644|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
127791357|NCT00105443|459860645|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
127791358|NCT00105443|459860646|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
127791359|NCT00105443|459860647|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
127791360|NCT00105443|459860644|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
127791361|NCT00105443|459860645|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
127791362|NCT00105443|459860646|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
127791363|NCT00105443|459860647|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
127791364|NCT00105443|459860644|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
127791365|NCT00105443|459860645|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
127791366|NCT00105443|459860646|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
127791367|NCT00105443|459860647|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
127791368|NCT00105443|459860644|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
127791369|NCT00105443|459860645|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
127791370|NCT00105443|459860646|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
127791371|NCT00105443|459860647|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
127791372|NCT00105443|459860644|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
127618987|NCT04951622|459233118|FG001|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
127618988|NCT04951622|459233119|FG002|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
127618989|NCT04951622|459233120|FG003|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
127618990|NCT04951622|459233121|FG004|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
127618991|NCT04951622|459233117|FG000|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
127618992|NCT04951622|459233118|FG001|DB Phase: Day 1 (Week 0) to Week 24|Other|1|||
127618993|NCT04951622|459233119|FG002|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
127618994|NCT04951622|459233120|FG003|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
127618995|NCT04951622|459233121|FG004|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
127618996|NCT04951622|459233117|FG000|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|1|||
127618997|NCT04951622|459233118|FG001|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
127618998|NCT04951622|459233119|FG002|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
127618999|NCT04951622|459233120|FG003|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
127619000|NCT04951622|459233121|FG004|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
127619001|NCT04951622|459233117|FG000|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
127619002|NCT04951622|459233118|FG001|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|1|||
127619003|NCT04951622|459233119|FG002|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
127619004|NCT04951622|459233120|FG003|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
127619005|NCT04951622|459233121|FG004|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
127619006|NCT04951622|459233117|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
127619007|NCT04951622|459233118|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
127619008|NCT04951622|459233119|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|5|||
127619009|NCT04951622|459233120|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
127619010|NCT04951622|459233121|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|2|||
127619011|NCT04951622|459233117|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
127619012|NCT04951622|459233118|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
127619013|NCT04951622|459233119|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
127619014|NCT04951622|459233120|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
127619015|NCT04951622|459233121|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
127619016|NCT04951622|459233117|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
127619017|NCT04951622|459233118|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
127619018|NCT04951622|459233119|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
127619019|NCT04951622|459233120|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|5|||
127619020|NCT04951622|459233121|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
127619021|NCT04951622|459233117|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
127619022|NCT04951622|459233118|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
127619023|NCT04951622|459233119|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|3|||
127619024|NCT04951622|459233120|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|7|||
127619025|NCT04951622|459233121|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
127619026|NCT04951622|459233117|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
127619027|NCT04951622|459233118|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
127619028|NCT04951622|459233119|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|1|||
127619029|NCT04951622|459233120|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
127619030|NCT04951622|459233121|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
127619031|NCT04951622|459233117|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
127619032|NCT04951622|459233118|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
127619033|NCT04951622|459233119|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
127619034|NCT04951622|459233120|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
127619035|NCT04951622|459233121|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
127619036|NCT04951622|459233117|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
127619037|NCT04951622|459233118|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
127619038|NCT04951622|459233119|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|77|||
127619039|NCT04951622|459233120|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|74|||
127619040|NCT04951622|459233121|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|15|||
127619041|NCT04951622|459233117|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
127619042|NCT04951622|459233118|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
127619043|NCT04951622|459233119|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
127791373|NCT00105443|459860645|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
127791374|NCT00105443|459860646|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
127791375|NCT00105443|459860647|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
127791376|NCT00105443|459860644|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
127791377|NCT00105443|459860645|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
127791378|NCT00105443|459860646|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
127791379|NCT00105443|459860647|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
127791380|NCT00105443|459860644|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
127791381|NCT00105443|459860645|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
127791382|NCT00105443|459860646|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
127791383|NCT00105443|459860647|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
127791384|NCT00105443|459860644|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
127791385|NCT00105443|459860645|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
127791386|NCT00105443|459860646|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
127791387|NCT00105443|459860647|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
127791388|NCT00105443|459860644|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
127791389|NCT00105443|459860645|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
127619044|NCT04951622|459233120|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
127619045|NCT04951622|459233121|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|1|||
127700424|NCT06190691|459532973|FG000|Overall Study|Adverse Event|2|||
127791390|NCT00105443|459860646|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
127791391|NCT00105443|459860647|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
127791392|NCT01157078|459860648|FG000|Overall Study|Withdrawal by Subject|12|||
127884496|NCT03333382|460202039|FG000|Overall Study|Lost to Follow-up|1|||
127700425|NCT06190691|459532974|FG001|Overall Study|Adverse Event|0|||
127700426|NCT06190691|459532975|FG002|Overall Study|Adverse Event|0|||
127700427|NCT06190691|459532976|FG003|Overall Study|Adverse Event|0|||
127700428|NCT05746455|459532977|FG000|Overall Study|Discharged from Clinical Service|1|||
127700429|NCT05746455|459532977|FG000|Overall Study|Lost to Follow-up|1|||
127700430|NCT02485938|459532979|FG000|Overall Study|Withdrawal of consent|2|||
127700431|NCT02485938|459532980|FG001|Overall Study|Withdrawal of consent|0|||
127700432|NCT03016754|459532983|FG000|Overall Study|Death|5|||
127700433|NCT03016754|459532984|FG001|Overall Study|Death|4|||
127700434|NCT03016754|459532985|FG002|Overall Study|Death|5|||
127700435|NCT03016754|459532986|FG003|Overall Study|Death|1|||
127700436|NCT03016754|459532983|FG000|Overall Study|Lost to Follow-up|23|||
127700437|NCT03016754|459532984|FG001|Overall Study|Lost to Follow-up|17|||
127700438|NCT03016754|459532985|FG002|Overall Study|Lost to Follow-up|4|||
127700439|NCT03016754|459532986|FG003|Overall Study|Lost to Follow-up|2|||
127700440|NCT03016754|459532983|FG000|Overall Study|Withdrawal by Subject|6|||
127700441|NCT03016754|459532984|FG001|Overall Study|Withdrawal by Subject|6|||
127619046|NCT04108208|459233122|FG000|Overall Study|Withdrawal by Subject|2|||
127619047|NCT04108208|459233123|FG001|Overall Study|Withdrawal by Subject|6|||
127619048|NCT04108208|459233122|FG000|Overall Study|other-ongoing|20|||
127619049|NCT04108208|459233123|FG001|Overall Study|other-ongoing|40|||
127619050|NCT04108208|459233122|FG000|Overall Study|Death|1|||
127619051|NCT04108208|459233123|FG001|Overall Study|Death|4|||
127700442|NCT03016754|459532985|FG002|Overall Study|Withdrawal by Subject|2|||
127700443|NCT03016754|459532986|FG003|Overall Study|Withdrawal by Subject|2|||
127700444|NCT03016754|459532983|FG000|Overall Study|Other/Unknown|2|||
127700445|NCT03016754|459532984|FG001|Overall Study|Other/Unknown|4|||
127700446|NCT03016754|459532985|FG002|Overall Study|Other/Unknown|2|||
127700447|NCT03016754|459532986|FG003|Overall Study|Other/Unknown|1|||
127700448|NCT03016754|459532983|FG000|Overall Study|Protocol Violation|0|||
127700449|NCT03016754|459532984|FG001|Overall Study|Protocol Violation|0|||
127700450|NCT03016754|459532985|FG002|Overall Study|Protocol Violation|0|||
127700451|NCT03016754|459532986|FG003|Overall Study|Protocol Violation|4|||
127700452|NCT03839940|459532987|FG000|Overall Study|Withdrawal by Subject|3|||
127700453|NCT03839940|459532988|FG001|Overall Study|Withdrawal by Subject|0|||
127700454|NCT03839940|459532987|FG000|Overall Study|Protocol Violation|0|||
127700455|NCT03839940|459532988|FG001|Overall Study|Protocol Violation|1|||
127700456|NCT03839940|459532987|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
127700457|NCT03839940|459532988|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
127700458|NCT03241745|459532989|FG000|Overall Study|Adverse Event|7|||
127700459|NCT03241745|459532989|FG000|Overall Study|Death|1|||
127700460|NCT03241745|459532989|FG000|Overall Study|Withdrawal by Subject|5|||
127700461|NCT03241745|459532989|FG000|Overall Study|Treatment delay >28 days|2|||
127700462|NCT03241745|459532989|FG000|Overall Study|Lack of Efficacy|14|||
127700463|NCT00470704|459532991|FG000|Overall Study|Withdrawal by Subject|4|||
127700464|NCT00470704|459532992|FG001|Overall Study|Withdrawal by Subject|3|||
127700465|NCT00470704|459532991|FG000|Overall Study|Relapse/Progression|37|||
127700466|NCT00470704|459532992|FG001|Overall Study|Relapse/Progression|42|||
127700467|NCT00470704|459532991|FG000|Overall Study|toxicity|0|||
127619052|NCT04108208|459233122|FG000|Overall Study|Lost to Follow-up|2|||
127791393|NCT01157078|459860649|FG001|Overall Study|Withdrawal by Subject|14|||
127791394|NCT01157078|459860648|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
127791395|NCT01157078|459860649|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
127791396|NCT01157078|459860648|FG000|Overall Study|Adverse Event|6|||
127791397|NCT01157078|459860649|FG001|Overall Study|Adverse Event|6|||
127791398|NCT01157078|459860648|FG000|Overall Study|Severe non-compliance to protocol|2|||
127791399|NCT01157078|459860649|FG001|Overall Study|Severe non-compliance to protocol|4|||
127619053|NCT04108208|459233123|FG001|Overall Study|Lost to Follow-up|0|||
127619054|NCT02948842|459233126|FG000|Overall Study|Withdrawal by Subject|4|||
127619055|NCT00376168|459233129|FG000|Overall Study|Adverse Event|1|||
127619056|NCT00376168|459233130|FG001|Overall Study|Adverse Event|1|||
127619057|NCT00376168|459233129|FG000|Overall Study|Pregnancy|1|||
127619058|NCT00376168|459233130|FG001|Overall Study|Pregnancy|0|||
127619059|NCT02350309|459233131|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
127619060|NCT02350309|459233132|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
127619061|NCT02350309|459233133|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
127619062|NCT02350309|459233134|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
127619063|NCT02350309|459233135|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
127619064|NCT02350309|459233136|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
127619065|NCT02350309|459233131|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
127619066|NCT02350309|459233132|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
127619067|NCT02350309|459233133|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
127619068|NCT02350309|459233134|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
127619069|NCT02350309|459233135|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
127619070|NCT02350309|459233136|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
127619071|NCT01736696|459233137|FG000|Overall Study|Withdrawal by Subject|0|||
127700468|NCT00470704|459532992|FG001|Overall Study|toxicity|1|||
127700469|NCT04295798|459532994|FG000|Overall Study|Lost to Follow-up|1|||
127700470|NCT04650269|459533000|FG000|Overall Study|Death|3|||
127700471|NCT04650269|459533000|FG000|Overall Study|Lost to Follow-up|6|||
127700472|NCT01437709|459533001|FG000|Overall Study|Adverse Event|0|||
127700473|NCT01437709|459533002|FG001|Overall Study|Adverse Event|1|||
127619072|NCT01736696|459233138|FG001|Overall Study|Withdrawal by Subject|0|||
127619073|NCT01736696|459233139|FG002|Overall Study|Withdrawal by Subject|1|||
127619074|NCT01736696|459233140|FG003|Overall Study|Withdrawal by Subject|0|||
127619075|NCT01736696|459233141|FG004|Overall Study|Withdrawal by Subject|0|||
127619076|NCT01736696|459233142|FG005|Overall Study|Withdrawal by Subject|0|||
127619077|NCT01736696|459233143|FG006|Overall Study|Withdrawal by Subject|0|||
127700474|NCT01437709|459533003|FG002|Overall Study|Adverse Event|0|||
127700475|NCT01437709|459533001|FG000|Overall Study|Pt trasnferred care|0|||
127791400|NCT01157078|459860648|FG000|Overall Study|Condition under investigation worsened|0|||
127619078|NCT02114879|459233144|FG000|Overall Study|Withdrawal by Subject|9|||
127619079|NCT02114879|459233145|FG001|Overall Study|Withdrawal by Subject|5|||
127619080|NCT02114879|459233144|FG000|Overall Study|Death|6|||
127619081|NCT02114879|459233145|FG001|Overall Study|Death|11|||
127619082|NCT02114879|459233144|FG000|Overall Study|Lost to Follow-up|4|||
127619083|NCT02114879|459233145|FG001|Overall Study|Lost to Follow-up|6|||
127619084|NCT02114879|459233144|FG000|Overall Study|Physician Decision|0|||
127619085|NCT02114879|459233145|FG001|Overall Study|Physician Decision|2|||
127619086|NCT03400033|459233148|FG000|Overall Study|Withdrawal by Subject|1|||
127619087|NCT03400033|459233149|FG001|Overall Study|Withdrawal by Subject|2|||
127619088|NCT02741115|459233155|FG000|Overall Study|Adverse Event|1|||
127619089|NCT02741115|459233156|FG001|Overall Study|Adverse Event|0|||
127700476|NCT01437709|459533002|FG001|Overall Study|Pt trasnferred care|1|||
127700477|NCT01437709|459533003|FG002|Overall Study|Pt trasnferred care|0|||
127700478|NCT05459688|459533004|FG000|Overall Study|Lost to Follow-up|6|||
127700479|NCT05459688|459533004|FG000|Overall Study|Physician Decision|1|||
127700480|NCT05459688|459533004|FG000|Overall Study|Withdrawal by Subject|19|||
127700481|NCT05459688|459533004|FG000|Overall Study|Noncompliance, Subject unable to complete last visit.|3|||
127700482|NCT04908722|459533005|FG000|Overall Study|Protocol deviation|1|||
127700483|NCT04908722|459533006|FG001|Overall Study|Protocol deviation|0|||
127700484|NCT04908722|459533007|FG002|Overall Study|Protocol deviation|0|||
127700485|NCT04908722|459533008|FG003|Overall Study|Protocol deviation|0|||
127700486|NCT04908722|459533009|FG004|Overall Study|Protocol deviation|0|||
127700487|NCT04908722|459533010|FG005|Overall Study|Protocol deviation|1|||
127700488|NCT04908722|459533005|FG000|Overall Study|Lost to Follow-up|33|||
127700489|NCT04908722|459533006|FG001|Overall Study|Lost to Follow-up|33|||
127700490|NCT04908722|459533007|FG002|Overall Study|Lost to Follow-up|36|||
127700491|NCT04908722|459533008|FG003|Overall Study|Lost to Follow-up|30|||
127700492|NCT04908722|459533009|FG004|Overall Study|Lost to Follow-up|32|||
127700493|NCT04908722|459533010|FG005|Overall Study|Lost to Follow-up|34|||
127700494|NCT04908722|459533005|FG000|Overall Study|Physician Decision|1|||
127700495|NCT04908722|459533006|FG001|Overall Study|Physician Decision|1|||
127700496|NCT04908722|459533007|FG002|Overall Study|Physician Decision|1|||
127700497|NCT04908722|459533008|FG003|Overall Study|Physician Decision|2|||
127700498|NCT04908722|459533009|FG004|Overall Study|Physician Decision|0|||
127700499|NCT04908722|459533010|FG005|Overall Study|Physician Decision|0|||
127700500|NCT04908722|459533005|FG000|Overall Study|Death|1|||
127700501|NCT04908722|459533006|FG001|Overall Study|Death|0|||
127700502|NCT04908722|459533007|FG002|Overall Study|Death|0|||
127700503|NCT04908722|459533008|FG003|Overall Study|Death|0|||
127700504|NCT04908722|459533009|FG004|Overall Study|Death|0|||
127700505|NCT04908722|459533010|FG005|Overall Study|Death|1|||
127700506|NCT04908722|459533005|FG000|Overall Study|Withdrawal by Subject|12|||
127700507|NCT04908722|459533006|FG001|Overall Study|Withdrawal by Subject|8|||
127700508|NCT04908722|459533007|FG002|Overall Study|Withdrawal by Subject|7|||
127700509|NCT04908722|459533008|FG003|Overall Study|Withdrawal by Subject|6|||
127700510|NCT04908722|459533009|FG004|Overall Study|Withdrawal by Subject|12|||
127700511|NCT04908722|459533010|FG005|Overall Study|Withdrawal by Subject|14|||
127700512|NCT04908722|459533005|FG000|Overall Study|Other|3|||
127700513|NCT04908722|459533006|FG001|Overall Study|Other|1|||
127700514|NCT04908722|459533007|FG002|Overall Study|Other|3|||
127700515|NCT04908722|459533008|FG003|Overall Study|Other|2|||
127700516|NCT04908722|459533009|FG004|Overall Study|Other|4|||
127700517|NCT04908722|459533010|FG005|Overall Study|Other|1|||
127700518|NCT04908722|459533005|FG000|Overall Study|Initiated prohibited medication|0|||
127700519|NCT04908722|459533006|FG001|Overall Study|Initiated prohibited medication|0|||
127700520|NCT04908722|459533007|FG002|Overall Study|Initiated prohibited medication|0|||
127700521|NCT04908722|459533008|FG003|Overall Study|Initiated prohibited medication|1|||
127700522|NCT04908722|459533009|FG004|Overall Study|Initiated prohibited medication|0|||
127700523|NCT04908722|459533010|FG005|Overall Study|Initiated prohibited medication|1|||
127700524|NCT04908722|459533005|FG000|Overall Study|Randomized but not vaccinated|3|||
127700525|NCT04908722|459533006|FG001|Overall Study|Randomized but not vaccinated|1|||
127700526|NCT04908722|459533007|FG002|Overall Study|Randomized but not vaccinated|2|||
127700527|NCT04908722|459533008|FG003|Overall Study|Randomized but not vaccinated|2|||
127700528|NCT04908722|459533009|FG004|Overall Study|Randomized but not vaccinated|3|||
127700529|NCT04908722|459533010|FG005|Overall Study|Randomized but not vaccinated|4|||
127700530|NCT02319759|459533011|FG000|Week 0 - 16|Lack of Efficacy|1|||
127700531|NCT02319759|459533012|FG001|Week 0 - 16|Lack of Efficacy|0|||
127700532|NCT02319759|459533013|FG002|Week 0 - 16|Lack of Efficacy|0|||
127700533|NCT02319759|459533014|FG003|Week 0 - 16|Lack of Efficacy|0|||
127700534|NCT02319759|459533015|FG004|Week 0 - 16|Lack of Efficacy|0|||
127700535|NCT02319759|459533011|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
127700536|NCT02319759|459533012|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
127700537|NCT02319759|459533013|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
127700538|NCT02319759|459533014|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
127700539|NCT02319759|459533015|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
127619090|NCT02741115|459233155|FG000|Overall Study|Lost to Follow-up|7|||
127619091|NCT02741115|459233156|FG001|Overall Study|Lost to Follow-up|4|||
127619092|NCT02741115|459233155|FG000|Overall Study|Withdrawal by Subject|4|||
127619093|NCT02741115|459233156|FG001|Overall Study|Withdrawal by Subject|2|||
127619094|NCT01101841|459234943|FG000|Overall Study|Adverse Event|15|||
127619095|NCT01101841|459234944|FG001|Overall Study|Adverse Event|15|||
127619096|NCT01101841|459234943|FG000|Overall Study|Lost to Follow-up|9|||
127619097|NCT01101841|459234944|FG001|Overall Study|Lost to Follow-up|3|||
127619098|NCT01101841|459234943|FG000|Overall Study|Withdrawal by Subject|21|||
127619099|NCT01101841|459234944|FG001|Overall Study|Withdrawal by Subject|40|||
127619100|NCT01101841|459234943|FG000|Overall Study|Protocol Violation|1|||
127619101|NCT01101841|459234944|FG001|Overall Study|Protocol Violation|1|||
127619102|NCT01101841|459234943|FG000|Overall Study|Physician Decision|0|||
127619103|NCT01101841|459234944|FG001|Overall Study|Physician Decision|2|||
127619104|NCT01101841|459234943|FG000|Overall Study|Lack of Efficacy|0|||
127619105|NCT01101841|459234944|FG001|Overall Study|Lack of Efficacy|2|||
127619106|NCT01101841|459234943|FG000|Overall Study|Other|0|||
127619107|NCT01101841|459234944|FG001|Overall Study|Other|1|||
127619108|NCT01101841|459234943|FG000|Overall Study|Suicidality Tracking Scale|3|||
127619109|NCT01101841|459234944|FG001|Overall Study|Suicidality Tracking Scale|1|||
127619110|NCT01101841|459234943|FG000|Overall Study|Eligibility Criteria|1|||
127619111|NCT01101841|459234944|FG001|Overall Study|Eligibility Criteria|2|||
127619112|NCT03633396|459234947|FG000|Overall Study|Withdrawal by Subject|4|||
127619113|NCT03633396|459234948|FG001|Overall Study|Withdrawal by Subject|4|||
127619114|NCT03633396|459234947|FG000|Overall Study|Adverse Event|1|||
127619115|NCT03633396|459234948|FG001|Overall Study|Adverse Event|1|||
127619116|NCT03633396|459234947|FG000|Overall Study|Lack of Efficacy|1|||
127619117|NCT03633396|459234948|FG001|Overall Study|Lack of Efficacy|0|||
127619118|NCT03633396|459234947|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
127619119|NCT03633396|459234948|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
127619120|NCT01012817|459234949|FG000|Overall Study|Withdrawal by Subject|0|||
127619121|NCT01012817|459234950|FG001|Overall Study|Withdrawal by Subject|0|||
127619122|NCT01012817|459234951|FG002|Overall Study|Withdrawal by Subject|0|||
127619123|NCT01012817|459234952|FG003|Overall Study|Withdrawal by Subject|1|||
127619124|NCT01012817|459234953|FG004|Overall Study|Withdrawal by Subject|0|||
127619125|NCT01012817|459234954|FG005|Overall Study|Withdrawal by Subject|0|||
127619126|NCT01012817|459234955|FG006|Overall Study|Withdrawal by Subject|0|||
127619127|NCT01012817|459234956|FG007|Overall Study|Withdrawal by Subject|1|||
127619128|NCT01012817|459234957|FG008|Overall Study|Withdrawal by Subject|0|||
127619129|NCT01012817|459234958|FG009|Overall Study|Withdrawal by Subject|0|||
127619130|NCT01012817|459234959|FG010|Overall Study|Withdrawal by Subject|1|||
127619131|NCT01012817|459234960|FG011|Overall Study|Withdrawal by Subject|1|||
127619132|NCT01012817|459234961|FG012|Overall Study|Withdrawal by Subject|0|||
127619133|NCT01012817|459234962|FG013|Overall Study|Withdrawal by Subject|1|||
127619134|NCT01012817|459234949|FG000|Overall Study|Adverse Event|0|||
127619135|NCT01012817|459234950|FG001|Overall Study|Adverse Event|0|||
127619136|NCT01012817|459234951|FG002|Overall Study|Adverse Event|0|||
127619137|NCT01012817|459234952|FG003|Overall Study|Adverse Event|0|||
127619138|NCT01012817|459234953|FG004|Overall Study|Adverse Event|0|||
127619139|NCT01012817|459234954|FG005|Overall Study|Adverse Event|1|||
127619140|NCT01012817|459234955|FG006|Overall Study|Adverse Event|0|||
127619141|NCT01012817|459234956|FG007|Overall Study|Adverse Event|0|||
127619142|NCT01012817|459234957|FG008|Overall Study|Adverse Event|0|||
127619143|NCT01012817|459234958|FG009|Overall Study|Adverse Event|0|||
127619144|NCT01012817|459234959|FG010|Overall Study|Adverse Event|1|||
127619145|NCT01012817|459234960|FG011|Overall Study|Adverse Event|0|||
127619146|NCT01012817|459234961|FG012|Overall Study|Adverse Event|0|||
127619147|NCT01012817|459234962|FG013|Overall Study|Adverse Event|1|||
127619148|NCT03756558|459234963|FG000|Overall Study|Death|1|||
127619149|NCT03756558|459234963|FG000|Overall Study|Lost to Follow-up|2|||
127619150|NCT03756558|459234963|FG000|Overall Study|Withdrawal by Subject|2|||
127700540|NCT02319759|459533011|FG000|Week 16 - 24|Lack of Efficacy|1|||
127700541|NCT02319759|459533012|FG001|Week 16 - 24|Lack of Efficacy|0|||
127700542|NCT02319759|459533013|FG002|Week 16 - 24|Lack of Efficacy|1|||
127700543|NCT02319759|459533014|FG003|Week 16 - 24|Lack of Efficacy|0|||
127700544|NCT02319759|459533015|FG004|Week 16 - 24|Lack of Efficacy|0|||
127700545|NCT02319759|459533011|FG000|Week 16 - 24|Lost to Follow-up|1|||
127700546|NCT02319759|459533012|FG001|Week 16 - 24|Lost to Follow-up|0|||
127700547|NCT02319759|459533013|FG002|Week 16 - 24|Lost to Follow-up|0|||
127700548|NCT02319759|459533014|FG003|Week 16 - 24|Lost to Follow-up|0|||
127700549|NCT02319759|459533015|FG004|Week 16 - 24|Lost to Follow-up|0|||
127700550|NCT02319759|459533011|FG000|Week 16 - 24|Withdrawal by Subject|0|||
127700551|NCT02319759|459533012|FG001|Week 16 - 24|Withdrawal by Subject|0|||
127700552|NCT02319759|459533013|FG002|Week 16 - 24|Withdrawal by Subject|2|||
127700553|NCT02319759|459533014|FG003|Week 16 - 24|Withdrawal by Subject|0|||
127700554|NCT02319759|459533015|FG004|Week 16 - 24|Withdrawal by Subject|0|||
127619151|NCT01896895|459234964|FG000|Double-blind MP|Physician Decision|0|||
127619152|NCT01896895|459234965|FG001|Double-blind MP|Physician Decision|0|||
127619153|NCT01896895|459234966|FG002|Double-blind MP|Physician Decision|1|||
127619154|NCT01896895|459234967|FG003|Double-blind MP|Physician Decision|0|||
127619155|NCT01896895|459234964|FG000|Double-blind MP|Withdrawal by Subject|0|||
127619156|NCT01896895|459234965|FG001|Double-blind MP|Withdrawal by Subject|2|||
127619157|NCT01896895|459234966|FG002|Double-blind MP|Withdrawal by Subject|1|||
127619158|NCT01896895|459234967|FG003|Double-blind MP|Withdrawal by Subject|0|||
127619159|NCT01896895|459234964|FG000|Double-blind MP|Lost to Follow-up|1|||
127619160|NCT01896895|459234965|FG001|Double-blind MP|Lost to Follow-up|0|||
127619161|NCT01896895|459234966|FG002|Double-blind MP|Lost to Follow-up|1|||
127619162|NCT01896895|459234967|FG003|Double-blind MP|Lost to Follow-up|0|||
127619163|NCT00293384|459234968|FG000|Overall Study|Non-compliance|2|||
127619164|NCT00293384|459234968|FG000|Overall Study|Missed dosage/study drug|1|||
127619165|NCT00293384|459234968|FG000|Overall Study|Ineligible|2|||
127619166|NCT04709237|459234969|FG000|Overall Study|Lost to Follow-up|1|||
127619167|NCT04709237|459234970|FG001|Overall Study|Lost to Follow-up|0|||
127791401|NCT01157078|459860649|FG001|Overall Study|Condition under investigation worsened|1|||
127791402|NCT01157078|459860648|FG000|Overall Study|Lack of Efficacy|2|||
127791403|NCT01157078|459860649|FG001|Overall Study|Lack of Efficacy|0|||
127791404|NCT01157078|459860648|FG000|Overall Study|Study-specific withdrawal criteria|2|||
127791405|NCT01157078|459860649|FG001|Overall Study|Study-specific withdrawal criteria|2|||
127791406|NCT01157078|459860648|FG000|Overall Study|Lost to Follow-up|7|||
127619168|NCT04709237|459234971|FG002|Overall Study|Lost to Follow-up|0|||
127619169|NCT01302964|459234973|FG000|Overall Study|Adverse Event|1|||
127619170|NCT01302964|459234974|FG001|Overall Study|Adverse Event|0|||
127619171|NCT00145509|459234978|FG000|Overall Study|Adverse Event|10|||
127619172|NCT00145509|459234979|FG001|Overall Study|Adverse Event|3|||
127791407|NCT01157078|459860649|FG001|Overall Study|Lost to Follow-up|5|||
127791408|NCT01157078|459860648|FG000|Overall Study|Other|2|||
127619173|NCT00145509|459234978|FG000|Overall Study|Lack of Efficacy|3|||
127619174|NCT00145509|459234979|FG001|Overall Study|Lack of Efficacy|1|||
127619175|NCT00145509|459234978|FG000|Overall Study|Lost to Follow-up|5|||
127791409|NCT01157078|459860649|FG001|Overall Study|Other|4|||
127700555|NCT02319759|459533011|FG000|Week 24 - 56|Adverse Event|0|||
127700556|NCT02319759|459533012|FG001|Week 24 - 56|Adverse Event|0|||
127700557|NCT02319759|459533013|FG002|Week 24 - 56|Adverse Event|2|||
127700558|NCT02319759|459533014|FG003|Week 24 - 56|Adverse Event|0|||
127700559|NCT02319759|459533015|FG004|Week 24 - 56|Adverse Event|0|||
127700560|NCT02319759|459533011|FG000|Week 24 - 56|Lack of Efficacy|0|||
127700561|NCT02319759|459533012|FG001|Week 24 - 56|Lack of Efficacy|0|||
127700562|NCT02319759|459533013|FG002|Week 24 - 56|Lack of Efficacy|0|||
127700563|NCT02319759|459533014|FG003|Week 24 - 56|Lack of Efficacy|2|||
127700564|NCT02319759|459533015|FG004|Week 24 - 56|Lack of Efficacy|1|||
127700565|NCT02319759|459533011|FG000|Week 24 - 56|Withdrawal by Subject|0|||
127700566|NCT02319759|459533012|FG001|Week 24 - 56|Withdrawal by Subject|1|||
127700567|NCT02319759|459533013|FG002|Week 24 - 56|Withdrawal by Subject|0|||
127700568|NCT02319759|459533014|FG003|Week 24 - 56|Withdrawal by Subject|0|||
127700569|NCT02319759|459533015|FG004|Week 24 - 56|Withdrawal by Subject|0|||
127700570|NCT02319759|459533011|FG000|Week 24 - 56|Lost to Follow-up|0|||
127700571|NCT02319759|459533012|FG001|Week 24 - 56|Lost to Follow-up|0|||
127700572|NCT02319759|459533013|FG002|Week 24 - 56|Lost to Follow-up|0|||
127700573|NCT02319759|459533014|FG003|Week 24 - 56|Lost to Follow-up|0|||
127700574|NCT02319759|459533015|FG004|Week 24 - 56|Lost to Follow-up|1|||
127700575|NCT06424236|459533018|FG000|Overall Study|Adverse Event|0|||
127700576|NCT06424236|459533019|FG001|Overall Study|Adverse Event|1|||
127700577|NCT06424236|459533020|FG002|Overall Study|Adverse Event|0|||
127700578|NCT06424236|459533018|FG000|Overall Study|Withdrawal by Subject|3|||
127700579|NCT06424236|459533019|FG001|Overall Study|Withdrawal by Subject|1|||
127700580|NCT06424236|459533020|FG002|Overall Study|Withdrawal by Subject|2|||
127700581|NCT06424236|459533018|FG000|Overall Study|Physician Decision|0|||
127700582|NCT06424236|459533019|FG001|Overall Study|Physician Decision|1|||
127700583|NCT06424236|459533020|FG002|Overall Study|Physician Decision|0|||
127700584|NCT06424236|459533018|FG000|Overall Study|Study Terminated by Sponsor|11|||
127700585|NCT06424236|459533019|FG001|Overall Study|Study Terminated by Sponsor|20|||
127700586|NCT06424236|459533020|FG002|Overall Study|Study Terminated by Sponsor|16|||
127700587|NCT06424236|459533018|FG000|Overall Study|Lost to Follow-up|0|||
127700588|NCT06424236|459533019|FG001|Overall Study|Lost to Follow-up|1|||
127700589|NCT06424236|459533020|FG002|Overall Study|Lost to Follow-up|0|||
127700590|NCT06424236|459533018|FG000|Overall Study|Disease Progression|0|||
127700591|NCT06424236|459533019|FG001|Overall Study|Disease Progression|1|||
127700592|NCT06424236|459533020|FG002|Overall Study|Disease Progression|2|||
127700593|NCT06424236|459533018|FG000|Overall Study|Other|0|||
127700594|NCT06424236|459533019|FG001|Overall Study|Other|0|||
127700595|NCT06424236|459533020|FG002|Overall Study|Other|1|||
127700596|NCT03339713|459533022|FG000|Overall Study|Lost to Follow-up|2|||
127791410|NCT00513409|459860654|FG000|Overall Study|Adverse Event|0|||
127791411|NCT00513409|459860655|FG001|Overall Study|Adverse Event|1|||
127791412|NCT00513409|459860654|FG000|Overall Study|Withdrawal by Subject|0|||
127791413|NCT00513409|459860655|FG001|Overall Study|Withdrawal by Subject|2|||
127791414|NCT00513409|459860654|FG000|Overall Study|Lost to Follow-up|0|||
127791415|NCT00513409|459860655|FG001|Overall Study|Lost to Follow-up|1|||
127791416|NCT00513409|459860654|FG000|Overall Study|Physician Decision|1|||
127791417|NCT00513409|459860655|FG001|Overall Study|Physician Decision|0|||
127791418|NCT00513409|459860654|FG000|Overall Study|Visit 3 not done|1|||
127791419|NCT00513409|459860655|FG001|Overall Study|Visit 3 not done|2|||
127791420|NCT03189446|459860657|FG000|Overall Study|Adverse Event|2|||
127791421|NCT03189446|459860657|FG000|Overall Study|Withdrawal by Subject|2|||
127791422|NCT03189446|459860657|FG000|Overall Study|Physician Decision|1|||
127791423|NCT05634577|459860658|FG000|Overall Study|Lost to Follow-up|1|||
127791424|NCT05634577|459860658|FG000|Overall Study|Withdrawal by Subject|1|||
127791425|NCT01192022|459860659|FG000|Overall Study|Withdrawal of Consent|3|||
127791426|NCT01192022|459860660|FG001|Overall Study|Withdrawal of Consent|1|||
127791427|NCT01192022|459860661|FG002|Overall Study|Withdrawal of Consent|0|||
127791428|NCT01192022|459860662|FG003|Overall Study|Withdrawal of Consent|0|||
127791429|NCT01192022|459860663|FG004|Overall Study|Withdrawal of Consent|0|||
127700597|NCT03339713|459533023|FG001|Overall Study|Lost to Follow-up|1|||
127700598|NCT03339713|459533022|FG000|Overall Study|Protocol Violation|1|||
127700599|NCT03339713|459533023|FG001|Overall Study|Protocol Violation|0|||
127700600|NCT03339713|459533022|FG000|Overall Study|Withdrawal by Subject|1|||
127700601|NCT03339713|459533023|FG001|Overall Study|Withdrawal by Subject|1|||
127700602|NCT01959425|459533024|FG000|Overall Study|Withdrawal by Subject|5|||
127700603|NCT01959425|459533025|FG001|Overall Study|Withdrawal by Subject|4|||
127700604|NCT01959425|459533024|FG000|Overall Study|Lost to Follow-up|1|||
127700605|NCT01959425|459533025|FG001|Overall Study|Lost to Follow-up|0|||
127700606|NCT01959425|459533024|FG000|Overall Study|Discontinued Subjects|6|||
127700607|NCT01959425|459533025|FG001|Overall Study|Discontinued Subjects|4|||
127700608|NCT02619838|459533026|FG000|Overall Study|Lost to Follow-up|9|||
127791430|NCT01192022|459860659|FG000|Overall Study|Lost to Follow-up|4|||
127791431|NCT01192022|459860660|FG001|Overall Study|Lost to Follow-up|2|||
127791432|NCT01192022|459860661|FG002|Overall Study|Lost to Follow-up|1|||
127791433|NCT01192022|459860662|FG003|Overall Study|Lost to Follow-up|1|||
127791434|NCT01192022|459860663|FG004|Overall Study|Lost to Follow-up|0|||
127619176|NCT00145509|459234979|FG001|Overall Study|Lost to Follow-up|9|||
127619177|NCT00145509|459234978|FG000|Overall Study|Withdrew Consent|2|||
127619178|NCT00145509|459234979|FG001|Overall Study|Withdrew Consent|7|||
127619179|NCT00145509|459234978|FG000|Overall Study|Reason not provided|2|||
127619180|NCT00145509|459234979|FG001|Overall Study|Reason not provided|1|||
127619181|NCT00419562|459234982|FG000|Overall Study|Lost to Follow-up|12|||
127619182|NCT00419562|459234983|FG001|Overall Study|Lost to Follow-up|13|||
127619183|NCT00419562|459234982|FG000|Overall Study|Withdrawal by Subject|20|||
127700609|NCT02619838|459533026|FG000|Overall Study|Withdrawal by Subject|15|||
127700610|NCT01715285|459533027|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
127700611|NCT01715285|459533028|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
127700612|NCT01715285|459533029|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
127700613|NCT01715285|459533027|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
127700614|NCT01715285|459533028|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
127700615|NCT01715285|459533029|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
127700616|NCT01715285|459533027|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
127700617|NCT01715285|459533028|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
127700618|NCT01715285|459533029|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
127700619|NCT01715285|459533027|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
127700620|NCT01715285|459533028|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
127700621|NCT01715285|459533029|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
127700622|NCT01715285|459533027|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
127700623|NCT01715285|459533028|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
127700624|NCT01715285|459533029|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
127700625|NCT01715285|459533027|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
127700626|NCT01715285|459533028|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
127700627|NCT01715285|459533029|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
127700628|NCT01715285|459533027|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
127700629|NCT01715285|459533028|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
127700630|NCT01715285|459533029|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
127700631|NCT01715285|459533027|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
127700632|NCT01715285|459533028|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
127700633|NCT01715285|459533029|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
127700634|NCT01715285|459533027|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
127700635|NCT01715285|459533028|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
127700636|NCT01715285|459533029|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
127700637|NCT01715285|459533027|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
127700638|NCT01715285|459533028|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
127700639|NCT01715285|459533029|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
127700640|NCT01715285|459533027|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
127700641|NCT01715285|459533028|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
127700642|NCT01715285|459533029|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
127700643|NCT01715285|459533027|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
127700644|NCT01715285|459533028|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
127700645|NCT01715285|459533029|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
127700646|NCT01715285|459533027|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
127700647|NCT01715285|459533028|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
127700648|NCT01715285|459533029|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
127700649|NCT01715285|459533027|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
127700650|NCT01715285|459533028|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
127700651|NCT01715285|459533029|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
127700652|NCT01073566|459533032|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
127700653|NCT01073566|459533033|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
127700654|NCT05006872|459533044|FG000|Overall Study|Lost to Follow-up|37|||
127700655|NCT05006872|459533045|FG001|Overall Study|Lost to Follow-up|31|||
127700656|NCT04111536|459533046|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
127700657|NCT04111536|459533047|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
127700658|NCT04111536|459533046|FG000|First Intervention (8 Weeks)|Adverse Event|0|||
127700659|NCT04111536|459533047|FG001|First Intervention (8 Weeks)|Adverse Event|1|||
127700660|NCT04111536|459533046|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
127700661|NCT04111536|459533047|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
127700662|NCT04111536|459533046|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
127884497|NCT03333382|460202040|FG001|Overall Study|Lost to Follow-up|0|||
127619184|NCT00419562|459234983|FG001|Overall Study|Withdrawal by Subject|18|||
127700663|NCT04111536|459533047|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
127700664|NCT04350463|459533048|FG000|Overall Study|Other reason|0|||
127700665|NCT04350463|459533049|FG001|Overall Study|Other reason|0|||
127700666|NCT04350463|459533050|FG002|Overall Study|Other reason|0|||
127619185|NCT00419562|459234982|FG000|Overall Study|Participant Institutionalized|1|||
127619186|NCT00419562|459234983|FG001|Overall Study|Participant Institutionalized|0|||
127619187|NCT02789176|459234984|FG000|Overall Study|Death|0|||
127619188|NCT02789176|459234985|FG001|Overall Study|Death|0|||
127619189|NCT02789176|459234986|FG002|Overall Study|Death|3|||
127619190|NCT02789176|459234987|FG003|Overall Study|Death|0|||
127619191|NCT02789176|459234984|FG000|Overall Study|Withdrawal by Subject|0|||
127619192|NCT02789176|459234985|FG001|Overall Study|Withdrawal by Subject|0|||
127619193|NCT02789176|459234986|FG002|Overall Study|Withdrawal by Subject|1|||
127619194|NCT02789176|459234987|FG003|Overall Study|Withdrawal by Subject|0|||
127619195|NCT02789176|459234984|FG000|Overall Study|Lost to Follow-up|8|||
127619196|NCT02789176|459234985|FG001|Overall Study|Lost to Follow-up|2|||
127619197|NCT02789176|459234986|FG002|Overall Study|Lost to Follow-up|6|||
127619198|NCT02789176|459234987|FG003|Overall Study|Lost to Follow-up|1|||
127619199|NCT00596011|459234989|FG000|Overall Study|Withdrawal by Subject|2|||
127619200|NCT00596011|459234990|FG001|Overall Study|Withdrawal by Subject|3|||
127619201|NCT00596011|459234989|FG000|Overall Study|Adverse Event|11|||
127619202|NCT00596011|459234990|FG001|Overall Study|Adverse Event|7|||
127791435|NCT01192022|459860659|FG000|Overall Study|Adverse Event|1|||
127619203|NCT00192075|459234991|FG000|Overall Study|Disease Progression|23|||
127791436|NCT01192022|459860660|FG001|Overall Study|Adverse Event|0|||
127791437|NCT01192022|459860661|FG002|Overall Study|Adverse Event|0|||
127791438|NCT01192022|459860662|FG003|Overall Study|Adverse Event|0|||
127791439|NCT01192022|459860663|FG004|Overall Study|Adverse Event|0|||
127791440|NCT01192022|459860659|FG000|Overall Study|Fatal Adverse Event|4|||
127791441|NCT01192022|459860660|FG001|Overall Study|Fatal Adverse Event|6|||
127619204|NCT00192075|459234992|FG001|Overall Study|Disease Progression|6|||
127619205|NCT00192075|459234991|FG000|Overall Study|Adverse Event|1|||
127619206|NCT00192075|459234992|FG001|Overall Study|Adverse Event|3|||
127619207|NCT00192075|459234991|FG000|Overall Study|Death|0|||
127619208|NCT00192075|459234992|FG001|Overall Study|Death|1|||
127619209|NCT00192075|459234991|FG000|Overall Study|Lack of Efficacy|0|||
127619210|NCT00192075|459234992|FG001|Overall Study|Lack of Efficacy|0|||
127619211|NCT00192075|459234991|FG000|Overall Study|Physician Decision|3|||
127619212|NCT00192075|459234992|FG001|Overall Study|Physician Decision|0|||
127619213|NCT00192075|459234991|FG000|Overall Study|Withdrawal by Subject|5|||
127619214|NCT00192075|459234992|FG001|Overall Study|Withdrawal by Subject|5|||
127619215|NCT00192075|459234991|FG000|Overall Study|Patient Non-Compliance|0|||
127619216|NCT00192075|459234992|FG001|Overall Study|Patient Non-Compliance|1|||
127619217|NCT00192075|459234991|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
127619218|NCT00192075|459234992|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
127619219|NCT00192075|459234991|FG000|Overall Study|Other|5|||
127619220|NCT00192075|459234992|FG001|Overall Study|Other|2|||
127619221|NCT00779675|459234993|FG000|Treatment Period|Adverse Event|87|||
127619222|NCT00779675|459234993|FG000|Treatment Period|Treatment Failure|80|||
127619223|NCT00779675|459234993|FG000|Treatment Period|Transferred to Another Study|38|||
127619224|NCT00779675|459234993|FG000|Treatment Period|Lost to Follow-up|23|||
127619225|NCT00779675|459234993|FG000|Treatment Period|Withdrawal by Subject|46|||
127619226|NCT00779675|459234993|FG000|Treatment Period|Protocol Violation|54|||
127619227|NCT00779675|459234993|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
127619228|NCT00779675|459234993|FG000|Treatment Period|Administrative|3|||
127619229|NCT00779675|459234993|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
127619230|NCT00779675|459234993|FG000|Extended Treatment Period|Protocol Violation|13|||
127619231|NCT00779675|459234993|FG000|Extended Treatment Period|Adverse Event|6|||
127619232|NCT00779675|459234993|FG000|Extended Treatment Period|Treatment Failure|11|||
127619233|NCT00779675|459234993|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
127619234|NCT00779675|459234993|FG000|Extended Treatment Period|Lost to Follow-up|6|||
127619235|NCT02821962|459234994|FG000|Overall Study|Lost to Follow-up|2|||
127619236|NCT02821962|459234995|FG001|Overall Study|Lost to Follow-up|0|||
127619237|NCT04300296|459235000|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
127619238|NCT04300296|459235001|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
127619239|NCT04300296|459235002|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
127791442|NCT01192022|459860661|FG002|Overall Study|Fatal Adverse Event|0|||
127619240|NCT04300296|459235003|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
127619241|NCT04300296|459235004|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
127619242|NCT04300296|459235005|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
127619243|NCT04300296|459235000|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
127619244|NCT04300296|459235001|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
127619245|NCT04300296|459235002|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
127619246|NCT04300296|459235003|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
127619247|NCT04300296|459235004|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
127619248|NCT04300296|459235005|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
127791443|NCT01192022|459860662|FG003|Overall Study|Fatal Adverse Event|0|||
127791444|NCT01192022|459860663|FG004|Overall Study|Fatal Adverse Event|1|||
127791445|NCT01192022|459860659|FG000|Overall Study|Physician withdrew-patient hardship|1|||
127700667|NCT04350463|459533051|FG003|Overall Study|Other reason|1|||
127700668|NCT04350463|459533048|FG000|Overall Study|Lost to Follow-up|0|||
127700669|NCT04350463|459533049|FG001|Overall Study|Lost to Follow-up|0|||
127700670|NCT04350463|459533050|FG002|Overall Study|Lost to Follow-up|0|||
127700671|NCT04350463|459533051|FG003|Overall Study|Lost to Follow-up|2|||
127884498|NCT02773446|460202046|FG000|First Admission|Withdrawal by Subject|0|||
127884499|NCT02773446|460202047|FG001|First Admission|Withdrawal by Subject|0|||
127884500|NCT02773446|460202048|FG002|First Admission|Withdrawal by Subject|0|||
127884501|NCT02773446|460202049|FG003|First Admission|Withdrawal by Subject|1|||
127884502|NCT02773446|460202050|FG004|First Admission|Withdrawal by Subject|0|||
127884503|NCT02773446|460202051|FG005|First Admission|Withdrawal by Subject|0|||
127884504|NCT02773446|460202046|FG000|First Admission|Lost to Follow-up|1|||
127884505|NCT02773446|460202047|FG001|First Admission|Lost to Follow-up|0|||
127884506|NCT02773446|460202048|FG002|First Admission|Lost to Follow-up|0|||
127884507|NCT02773446|460202049|FG003|First Admission|Lost to Follow-up|0|||
127884508|NCT02773446|460202050|FG004|First Admission|Lost to Follow-up|0|||
127884509|NCT02773446|460202051|FG005|First Admission|Lost to Follow-up|0|||
127884510|NCT04378010|460202052|FG000|Overall Study|Adverse Event|8|||
127884511|NCT04378010|460202053|FG001|Overall Study|Adverse Event|14|||
127884512|NCT04378010|460202054|FG002|Overall Study|Adverse Event|4|||
127884513|NCT04378010|460202052|FG000|Overall Study|Withdrawal by Subject|0|||
127884514|NCT04378010|460202053|FG001|Overall Study|Withdrawal by Subject|2|||
127884515|NCT04378010|460202054|FG002|Overall Study|Withdrawal by Subject|1|||
127884516|NCT04378010|460202052|FG000|Overall Study|Protocol Violation|2|||
127884517|NCT04378010|460202053|FG001|Overall Study|Protocol Violation|1|||
127884518|NCT04378010|460202054|FG002|Overall Study|Protocol Violation|4|||
127884519|NCT04378010|460202052|FG000|Overall Study|Study terminated by Sponsor|22|||
127700672|NCT04350463|459533048|FG000|Overall Study|Withdrawal by Subject|4|||
127700673|NCT04350463|459533049|FG001|Overall Study|Withdrawal by Subject|0|||
127884520|NCT04378010|460202053|FG001|Overall Study|Study terminated by Sponsor|16|||
127619249|NCT04300296|459235000|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
127619250|NCT04300296|459235001|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
127619251|NCT04300296|459235002|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
127619252|NCT04300296|459235003|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
127619253|NCT04300296|459235004|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
127619254|NCT04300296|459235005|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
127619255|NCT04300296|459235000|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
127619256|NCT04300296|459235001|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
127619257|NCT04300296|459235002|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
127619258|NCT04300296|459235003|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
127619259|NCT04300296|459235004|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
127619260|NCT04300296|459235005|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
127619261|NCT04300296|459235000|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
127619262|NCT04300296|459235001|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
127619263|NCT04300296|459235002|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
127619264|NCT04300296|459235003|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
127619265|NCT04300296|459235004|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
127619266|NCT04300296|459235005|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
127619267|NCT04300296|459235000|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
127619268|NCT04300296|459235001|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
127619269|NCT04300296|459235002|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
127619270|NCT04300296|459235003|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
127619271|NCT04300296|459235004|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
127619272|NCT04300296|459235005|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
127619273|NCT04300296|459235000|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
127619274|NCT04300296|459235001|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
127619275|NCT04300296|459235002|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
127619276|NCT04300296|459235003|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
127619277|NCT04300296|459235004|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
127619278|NCT04300296|459235005|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
127619279|NCT03325166|459235006|FG000|Overall Study|Adverse Event|1|||
127619280|NCT01633944|459235007|FG000|Open-label Titration Phase|Adverse Event|109|||
127619281|NCT01633944|459235008|FG001|Open-label Titration Phase|Adverse Event|0|||
127619282|NCT01633944|459235009|FG002|Open-label Titration Phase|Adverse Event|0|||
127619283|NCT01633944|459235007|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
127619284|NCT01633944|459235008|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
127619285|NCT01633944|459235009|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
127619286|NCT01633944|459235007|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
127619287|NCT01633944|459235008|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
127619288|NCT01633944|459235009|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
127619289|NCT01633944|459235007|FG000|Open-label Titration Phase|Protocol Violation|24|||
127619290|NCT01633944|459235008|FG001|Open-label Titration Phase|Protocol Violation|0|||
127619291|NCT01633944|459235009|FG002|Open-label Titration Phase|Protocol Violation|0|||
127619292|NCT01633944|459235007|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
127619293|NCT01633944|459235008|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
127619294|NCT01633944|459235009|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
127619295|NCT01633944|459235007|FG000|Open-label Titration Phase|Other|68|||
127619296|NCT01633944|459235008|FG001|Open-label Titration Phase|Other|0|||
127619297|NCT01633944|459235009|FG002|Open-label Titration Phase|Other|0|||
127619298|NCT01633944|459235007|FG000|Double-blind Treatment Phase|Adverse Event|0|||
127619299|NCT01633944|459235008|FG001|Double-blind Treatment Phase|Adverse Event|13|||
127619300|NCT01633944|459235009|FG002|Double-blind Treatment Phase|Adverse Event|7|||
127619301|NCT01633944|459235007|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
127619302|NCT01633944|459235008|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
127619303|NCT01633944|459235009|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
127619304|NCT01633944|459235007|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
127619305|NCT01633944|459235008|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
127619306|NCT01633944|459235009|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
127619307|NCT01633944|459235007|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
127619308|NCT01633944|459235008|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
127619309|NCT01633944|459235009|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
127619310|NCT01633944|459235007|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
127619311|NCT01633944|459235008|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
127619312|NCT01633944|459235009|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
127619313|NCT01633944|459235007|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
127619314|NCT01633944|459235008|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
127700674|NCT04350463|459533050|FG002|Overall Study|Withdrawal by Subject|1|||
127884521|NCT04378010|460202054|FG002|Overall Study|Study terminated by Sponsor|22|||
127884522|NCT04378010|460202052|FG000|Overall Study|Subject inability to complete study visit|0|||
127884523|NCT04378010|460202053|FG001|Overall Study|Subject inability to complete study visit|0|||
127884524|NCT04378010|460202054|FG002|Overall Study|Subject inability to complete study visit|1|||
127884525|NCT04378010|460202052|FG000|Overall Study|Subject never dosed|0|||
127884526|NCT04378010|460202053|FG001|Overall Study|Subject never dosed|1|||
127884527|NCT04378010|460202054|FG002|Overall Study|Subject never dosed|0|||
127619315|NCT01633944|459235009|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
127619316|NCT01633944|459235007|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
127619317|NCT01633944|459235008|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
127619318|NCT01633944|459235009|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
127619319|NCT01633944|459235007|FG000|Double-blind Treatment Phase|Other|0|||
127619320|NCT01633944|459235008|FG001|Double-blind Treatment Phase|Other|7|||
127619321|NCT01633944|459235009|FG002|Double-blind Treatment Phase|Other|0|||
127619322|NCT00701129|459235011|FG000|Overall Study|Death|2|||
127619323|NCT01400841|459235012|FG000|Initial Study Phase (6 Months)|Death|1|||
127619324|NCT01400841|459235012|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
127619325|NCT00770120|459235013|FG000|Overall Study|Progression|31|||
127619326|NCT00770120|459235013|FG000|Overall Study|Adverse Event|11|||
127619327|NCT00770120|459235013|FG000|Overall Study|Not Protocol Specified|11|||
127619328|NCT00770120|459235013|FG000|Overall Study|Death|3|||
127619329|NCT00770120|459235013|FG000|Overall Study|Withdrawal by Subject|2|||
127619330|NCT00770120|459235013|FG000|Overall Study|Ineligible|1|||
127619331|NCT00770120|459235013|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
127619332|NCT00770120|459235013|FG000|Overall Study|Reason under Review|1|||
127619333|NCT02412631|459235014|FG000|Overall Study|Adverse Event|1|||
127619334|NCT02412631|459235015|FG001|Overall Study|Adverse Event|2|||
127619335|NCT02412631|459235014|FG000|Overall Study|Lost to Follow-up|5|||
127619336|NCT02412631|459235015|FG001|Overall Study|Lost to Follow-up|9|||
127619337|NCT02412631|459235014|FG000|Overall Study|Withdrawal by Subject|9|||
127619338|NCT02412631|459235015|FG001|Overall Study|Withdrawal by Subject|3|||
127619339|NCT02412631|459235014|FG000|Overall Study|Early stop by FDA|5|||
127619340|NCT02412631|459235015|FG001|Overall Study|Early stop by FDA|2|||
127619341|NCT02412631|459235014|FG000|Overall Study|Unspecified reason|6|||
127619342|NCT02412631|459235015|FG001|Overall Study|Unspecified reason|8|||
127619343|NCT00958776|459235016|FG000|Overall Study|Adverse Event|0|||
127619344|NCT00958776|459235017|FG001|Overall Study|Adverse Event|1|||
127619345|NCT00958776|459235016|FG000|Overall Study|Physician Decision|1|||
127619346|NCT00958776|459235017|FG001|Overall Study|Physician Decision|0|||
127619347|NCT00958776|459235016|FG000|Overall Study|Lost to Follow-up|2|||
127619348|NCT00958776|459235017|FG001|Overall Study|Lost to Follow-up|6|||
127619349|NCT00958776|459235016|FG000|Overall Study|Withdrawal by Subject|7|||
127619350|NCT00958776|459235017|FG001|Overall Study|Withdrawal by Subject|16|||
127619351|NCT00958776|459235016|FG000|Overall Study|Protocol Violation|1|||
127619352|NCT00958776|459235017|FG001|Overall Study|Protocol Violation|1|||
127619353|NCT00958776|459235016|FG000|Overall Study|Death|2|||
127619354|NCT00958776|459235017|FG001|Overall Study|Death|1|||
127619355|NCT00958776|459235016|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
127619356|NCT00958776|459235017|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
127619357|NCT00958776|459235016|FG000|Overall Study|Missing|1|||
127619358|NCT00958776|459235017|FG001|Overall Study|Missing|1|||
127619359|NCT00480636|459235018|FG000|Overall Study|Death|12|||
127619360|NCT00480636|459235018|FG000|Overall Study|Lost to Follow-up|4|||
127619361|NCT00480636|459235018|FG000|Overall Study|Other|2|||
127619362|NCT00480636|459235018|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
127619363|NCT00326911|459235019|FG000|Overall Study|Hospitalization prior to treatment|0|||
127619364|NCT00326911|459235020|FG001|Overall Study|Hospitalization prior to treatment|1|||
127619365|NCT00326911|459235019|FG000|Overall Study|Physician decision prior to treatment|1|||
127619366|NCT00326911|459235020|FG001|Overall Study|Physician decision prior to treatment|0|||
127619367|NCT00326911|459235019|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
127619368|NCT00326911|459235020|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
127619369|NCT02583256|459235021|FG000|Overall Study|Withdrawal by Subject|0|||
127619370|NCT02583256|459235022|FG001|Overall Study|Withdrawal by Subject|1|||
127619371|NCT02583256|459235023|FG002|Overall Study|Withdrawal by Subject|1|||
127619372|NCT02583256|459235024|FG003|Overall Study|Withdrawal by Subject|0|||
127619373|NCT02583256|459235021|FG000|Overall Study|Lost to Follow-up|1|||
127619374|NCT02583256|459235022|FG001|Overall Study|Lost to Follow-up|1|||
127619375|NCT02583256|459235023|FG002|Overall Study|Lost to Follow-up|0|||
127619376|NCT02583256|459235024|FG003|Overall Study|Lost to Follow-up|1|||
127619377|NCT02583256|459235021|FG000|Overall Study|Administrative/Other|2|||
127619378|NCT02583256|459235022|FG001|Overall Study|Administrative/Other|0|||
127884528|NCT02513459|460202055|FG000|Overall Study|Adverse Event|7|||
127619379|NCT02583256|459235023|FG002|Overall Study|Administrative/Other|1|||
127884529|NCT02513459|460202055|FG000|Overall Study|Withdrew consent|5|||
127619380|NCT02583256|459235024|FG003|Overall Study|Administrative/Other|2|||
127619381|NCT03364049|459235033|FG000|Overall Study|Death|6|||
127619382|NCT03364049|459235034|FG001|Overall Study|Death|4|||
127619383|NCT03364049|459235035|FG002|Overall Study|Death|5|||
127619384|NCT03364049|459235036|FG003|Overall Study|Death|14|||
127619385|NCT03364049|459235033|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
127619386|NCT03364049|459235034|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
127619387|NCT03364049|459235035|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
127619388|NCT03364049|459235036|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
127619389|NCT03364049|459235033|FG000|Overall Study|Withdrawal by Subject|0|||
127619390|NCT03364049|459235034|FG001|Overall Study|Withdrawal by Subject|1|||
127619391|NCT03364049|459235035|FG002|Overall Study|Withdrawal by Subject|1|||
127619392|NCT03364049|459235036|FG003|Overall Study|Withdrawal by Subject|1|||
127619393|NCT02953821|459235037|FG000|Overall Study|Adverse Event|0|||
127619394|NCT02953821|459235038|FG001|Overall Study|Adverse Event|4|||
127619395|NCT02953821|459235037|FG000|Overall Study|Death|1|||
127619396|NCT02953821|459235038|FG001|Overall Study|Death|0|||
127619397|NCT02953821|459235037|FG000|Overall Study|Progressive Disease|5|||
127619398|NCT02953821|459235038|FG001|Overall Study|Progressive Disease|1|||
127619399|NCT02953821|459235037|FG000|Overall Study|Lost to Follow-up|2|||
127619400|NCT02953821|459235038|FG001|Overall Study|Lost to Follow-up|0|||
127619401|NCT02953821|459235037|FG000|Overall Study|Physician Decision|1|||
127619402|NCT02953821|459235038|FG001|Overall Study|Physician Decision|1|||
127619403|NCT02953821|459235037|FG000|Overall Study|Withdrawal by Subject|3|||
127619404|NCT02953821|459235038|FG001|Overall Study|Withdrawal by Subject|3|||
127619405|NCT02953821|459235037|FG000|Overall Study|Change of address|0|||
127619406|NCT02953821|459235038|FG001|Overall Study|Change of address|1|||
127619407|NCT02953821|459235037|FG000|Overall Study|Lack of Efficacy|1|||
127619408|NCT02953821|459235038|FG001|Overall Study|Lack of Efficacy|0|||
127619409|NCT02953821|459235037|FG000|Overall Study|Out of state for indeterminate time|0|||
127619410|NCT02953821|459235038|FG001|Overall Study|Out of state for indeterminate time|1|||
127619411|NCT02953821|459235037|FG000|Overall Study|No improvement|0|||
127619412|NCT02953821|459235038|FG001|Overall Study|No improvement|1|||
127619413|NCT02953821|459235037|FG000|Overall Study|Refused follow-up visit|2|||
127884530|NCT02513459|460202055|FG000|Overall Study|Loss of efficacy|2|||
127619414|NCT02953821|459235038|FG001|Overall Study|Refused follow-up visit|1|||
127619415|NCT02103478|459235039|FG000|Overall Study|Adverse Event|0|||
127619416|NCT02103478|459235040|FG001|Overall Study|Adverse Event|0|||
127619417|NCT02103478|459235041|FG002|Overall Study|Adverse Event|1|||
127619418|NCT02103478|459235042|FG003|Overall Study|Adverse Event|1|||
127619419|NCT02103478|459235043|FG004|Overall Study|Adverse Event|2|||
127619420|NCT02103478|459235044|FG005|Overall Study|Adverse Event|1|||
127619421|NCT02103478|459235045|FG006|Overall Study|Adverse Event|0|||
127619422|NCT02103478|459235046|FG007|Overall Study|Adverse Event|0|||
127619423|NCT02103478|459235047|FG008|Overall Study|Adverse Event|0|||
127619424|NCT02103478|459235039|FG000|Overall Study|Death|2|||
127619425|NCT02103478|459235040|FG001|Overall Study|Death|2|||
127619426|NCT02103478|459235041|FG002|Overall Study|Death|1|||
127619427|NCT02103478|459235042|FG003|Overall Study|Death|1|||
127619428|NCT02103478|459235043|FG004|Overall Study|Death|5|||
127619429|NCT02103478|459235044|FG005|Overall Study|Death|15|||
127619430|NCT02103478|459235045|FG006|Overall Study|Death|14|||
127619431|NCT02103478|459235046|FG007|Overall Study|Death|10|||
127619432|NCT02103478|459235047|FG008|Overall Study|Death|11|||
127619433|NCT02103478|459235039|FG000|Overall Study|Progressive Disease|2|||
127619434|NCT02103478|459235040|FG001|Overall Study|Progressive Disease|1|||
127619435|NCT02103478|459235041|FG002|Overall Study|Progressive Disease|2|||
127619436|NCT02103478|459235042|FG003|Overall Study|Progressive Disease|0|||
127619437|NCT02103478|459235043|FG004|Overall Study|Progressive Disease|9|||
127619438|NCT02103478|459235044|FG005|Overall Study|Progressive Disease|1|||
127619439|NCT02103478|459235045|FG006|Overall Study|Progressive Disease|2|||
127619440|NCT02103478|459235046|FG007|Overall Study|Progressive Disease|0|||
127619441|NCT02103478|459235047|FG008|Overall Study|Progressive Disease|1|||
127619442|NCT02103478|459235039|FG000|Overall Study|Withdrawal by Subject|2|||
127619443|NCT02103478|459235040|FG001|Overall Study|Withdrawal by Subject|0|||
127619444|NCT02103478|459235041|FG002|Overall Study|Withdrawal by Subject|0|||
127619445|NCT02103478|459235042|FG003|Overall Study|Withdrawal by Subject|4|||
127619446|NCT02103478|459235043|FG004|Overall Study|Withdrawal by Subject|0|||
127700675|NCT04350463|459533051|FG003|Overall Study|Withdrawal by Subject|4|||
127700676|NCT04350463|459533048|FG000|Overall Study|Adverse Event|0|||
127700677|NCT04350463|459533049|FG001|Overall Study|Adverse Event|0|||
127700678|NCT04350463|459533050|FG002|Overall Study|Adverse Event|0|||
127700679|NCT04350463|459533051|FG003|Overall Study|Adverse Event|2|||
127700680|NCT04350463|459533048|FG000|Overall Study|Death|27|||
127700681|NCT04350463|459533049|FG001|Overall Study|Death|2|||
127884531|NCT02513459|460202055|FG000|Overall Study|Pregnancy|2|||
127700682|NCT04350463|459533050|FG002|Overall Study|Death|13|||
127700683|NCT04350463|459533051|FG003|Overall Study|Death|26|||
127700684|NCT05362487|459533052|FG000|Overall Study|Study was prematurely terminated as per Sponsor's decision|4|||
127700685|NCT04096040|459533053|FG000|Overall Study|Protocol Violation|12|||
127700686|NCT04096040|459533053|FG000|Overall Study|Non-compliant site|4|||
127700687|NCT04973254|459533056|FG000|Overall Study|Not adherent|0|||
127700688|NCT04973254|459533057|FG001|Overall Study|Not adherent|1|||
127700689|NCT04973254|459533058|FG002|Overall Study|Not adherent|0|||
127700690|NCT04629716|459533059|FG000|Overall Study|Lost to Follow-up|7|||
127700691|NCT04629716|459533060|FG001|Overall Study|Lost to Follow-up|3|||
127700692|NCT04537715|459533061|FG000|Overall Study|Death|3|||
127700693|NCT04537715|459533062|FG001|Overall Study|Death|1|||
127700694|NCT04537715|459533061|FG000|Overall Study|Withdrawal by Subject|3|||
127700695|NCT04537715|459533062|FG001|Overall Study|Withdrawal by Subject|1|||
127700696|NCT04537715|459533061|FG000|Overall Study|Other|4|||
127700697|NCT04537715|459533062|FG001|Overall Study|Other|3|||
127700698|NCT04537715|459533061|FG000|Overall Study|Progressive disease|1|||
127700699|NCT04537715|459533062|FG001|Overall Study|Progressive disease|0|||
127700700|NCT03461276|459533063|FG000|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
127700701|NCT03461276|459533064|FG001|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
127700702|NCT03461276|459533063|FG000|Part A (18-24 Months Duration)|Physician Decision|1|||
127700703|NCT03461276|459533064|FG001|Part A (18-24 Months Duration)|Physician Decision|0|||
127700704|NCT03461276|459533063|FG000|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
127700705|NCT03461276|459533064|FG001|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
127700706|NCT03461276|459533063|FG000|Part A (18-24 Months Duration)|Adverse event, non-fatal|3|||
127700707|NCT03461276|459533064|FG001|Part A (18-24 Months Duration)|Adverse event, non-fatal|1|||
127700708|NCT03461276|459533063|FG000|Part A (18-24 Months Duration)|Patient heath status|0|||
127700709|NCT03461276|459533064|FG001|Part A (18-24 Months Duration)|Patient heath status|1|||
127700710|NCT03461276|459533063|FG000|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
127700711|NCT03461276|459533064|FG001|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
127700712|NCT03461276|459533063|FG000|Part B (18 Months Duration)|Lost to Follow-up|1|||
127700713|NCT03461276|459533064|FG001|Part B (18 Months Duration)|Lost to Follow-up|0|||
127791446|NCT01192022|459860660|FG001|Overall Study|Physician withdrew-patient hardship|0|||
127791447|NCT01192022|459860661|FG002|Overall Study|Physician withdrew-patient hardship|0|||
127791448|NCT01192022|459860662|FG003|Overall Study|Physician withdrew-patient hardship|0|||
127791449|NCT01192022|459860663|FG004|Overall Study|Physician withdrew-patient hardship|0|||
127791450|NCT01192022|459860659|FG000|Overall Study|Patient too sick from chemotherapy|0|||
127791451|NCT01192022|459860660|FG001|Overall Study|Patient too sick from chemotherapy|1|||
127791452|NCT01192022|459860661|FG002|Overall Study|Patient too sick from chemotherapy|0|||
127791453|NCT01192022|459860662|FG003|Overall Study|Patient too sick from chemotherapy|0|||
127791454|NCT01192022|459860663|FG004|Overall Study|Patient too sick from chemotherapy|0|||
127791455|NCT01192022|459860659|FG000|Overall Study|Patient needed surgery|0|||
127791456|NCT01192022|459860660|FG001|Overall Study|Patient needed surgery|1|||
127791457|NCT01192022|459860661|FG002|Overall Study|Patient needed surgery|0|||
127791458|NCT01192022|459860662|FG003|Overall Study|Patient needed surgery|0|||
127791459|NCT01192022|459860663|FG004|Overall Study|Patient needed surgery|0|||
127791460|NCT01192022|459860659|FG000|Overall Study|Parents did not allow all follow up|0|||
127791461|NCT01192022|459860660|FG001|Overall Study|Parents did not allow all follow up|0|||
127791462|NCT01192022|459860661|FG002|Overall Study|Parents did not allow all follow up|0|||
127791463|NCT01192022|459860662|FG003|Overall Study|Parents did not allow all follow up|1|||
127791464|NCT01192022|459860663|FG004|Overall Study|Parents did not allow all follow up|0|||
127791465|NCT04839978|459860664|FG000|Overall Study|Lost to Follow-up|135|||
127791466|NCT04839978|459860665|FG001|Overall Study|Lost to Follow-up|147|||
127791467|NCT03865706|459860666|FG000|Overall Study|Death|0|||
127791468|NCT03865706|459860667|FG001|Overall Study|Death|3|||
127791469|NCT03865706|459860668|FG002|Overall Study|Death|1|||
127791470|NCT00781456|459860669|FG000|Overall Study|Adverse Event|3|||
127791471|NCT00781456|459860670|FG001|Overall Study|Adverse Event|3|||
127791472|NCT00781456|459860669|FG000|Overall Study|Withdrawal by Subject|3|||
127791473|NCT00781456|459860670|FG001|Overall Study|Withdrawal by Subject|5|||
127791474|NCT00781456|459860669|FG000|Overall Study|Protocol Violation|4|||
127791475|NCT00781456|459860670|FG001|Overall Study|Protocol Violation|1|||
127700714|NCT03461276|459533063|FG000|Part B (18 Months Duration)|Withdrawal by Subject|0|||
127700715|NCT03461276|459533064|FG001|Part B (18 Months Duration)|Withdrawal by Subject|1|||
127700716|NCT03461276|459533063|FG000|Part B (18 Months Duration)|Adverse event, non-fatal|0|||
127791476|NCT00781456|459860669|FG000|Overall Study|Noncompliance With Protocol|1|||
127791477|NCT00781456|459860670|FG001|Overall Study|Noncompliance With Protocol|1|||
127791478|NCT00781456|459860669|FG000|Overall Study|Lost to Follow-up|10|||
127791479|NCT00781456|459860670|FG001|Overall Study|Lost to Follow-up|5|||
127619447|NCT02103478|459235044|FG005|Overall Study|Withdrawal by Subject|0|||
127619448|NCT02103478|459235045|FG006|Overall Study|Withdrawal by Subject|1|||
127619449|NCT02103478|459235046|FG007|Overall Study|Withdrawal by Subject|1|||
127619450|NCT02103478|459235047|FG008|Overall Study|Withdrawal by Subject|0|||
127619451|NCT02103478|459235039|FG000|Overall Study|Lost to Follow-up|0|||
127619452|NCT02103478|459235040|FG001|Overall Study|Lost to Follow-up|0|||
127619453|NCT02103478|459235041|FG002|Overall Study|Lost to Follow-up|0|||
127619454|NCT02103478|459235042|FG003|Overall Study|Lost to Follow-up|0|||
127619455|NCT02103478|459235043|FG004|Overall Study|Lost to Follow-up|0|||
127619456|NCT02103478|459235044|FG005|Overall Study|Lost to Follow-up|0|||
127619457|NCT02103478|459235045|FG006|Overall Study|Lost to Follow-up|0|||
127619458|NCT02103478|459235046|FG007|Overall Study|Lost to Follow-up|1|||
127619459|NCT02103478|459235047|FG008|Overall Study|Lost to Follow-up|0|||
127619460|NCT02103478|459235039|FG000|Overall Study|Other|1|||
127619461|NCT02103478|459235040|FG001|Overall Study|Other|3|||
127619462|NCT02103478|459235041|FG002|Overall Study|Other|2|||
127619463|NCT02103478|459235042|FG003|Overall Study|Other|0|||
127619464|NCT02103478|459235043|FG004|Overall Study|Other|3|||
127619465|NCT02103478|459235044|FG005|Overall Study|Other|8|||
127619466|NCT02103478|459235045|FG006|Overall Study|Other|8|||
127619467|NCT02103478|459235046|FG007|Overall Study|Other|4|||
127619468|NCT02103478|459235047|FG008|Overall Study|Other|2|||
127619469|NCT03219333|459235048|FG000|Overall Study|Withdrawal by Subject|9|||
127619470|NCT03219333|459235049|FG001|Overall Study|Withdrawal by Subject|4|||
127619471|NCT03219333|459235048|FG000|Overall Study|Lost to Follow-up|1|||
127619472|NCT03219333|459235049|FG001|Overall Study|Lost to Follow-up|1|||
127619473|NCT03219333|459235048|FG000|Overall Study|Death|104|||
127619474|NCT03219333|459235049|FG001|Overall Study|Death|72|||
127619475|NCT03219333|459235048|FG000|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
127619476|NCT03219333|459235049|FG001|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
127619477|NCT03219333|459235048|FG000|Overall Study|Other|2|||
127619478|NCT03219333|459235049|FG001|Overall Study|Other|2|||
127619479|NCT00976898|459235050|FG000|Overall Study|Protocol Violation|1|||
127619480|NCT00976898|459235050|FG000|Overall Study|Adverse Event|1|||
127619481|NCT00976898|459235050|FG000|Overall Study|Physician Decision|1|||
127619482|NCT00976898|459235050|FG000|Overall Study|Liver Transplant|1|||
127619483|NCT00976898|459235050|FG000|Overall Study|Progressive Disease|1|||
127619484|NCT05107128|459235051|FG000|Overall Study|Adverse Event|2|||
127619485|NCT05107128|459235052|FG001|Overall Study|Adverse Event|0|||
127619486|NCT05107128|459235051|FG000|Overall Study|Withdrawal by Subject|3|||
127619487|NCT05107128|459235052|FG001|Overall Study|Withdrawal by Subject|3|||
127619488|NCT05107128|459235051|FG000|Overall Study|Withdrawal of Consent|0|||
127619489|NCT05107128|459235052|FG001|Overall Study|Withdrawal of Consent|1|||
127619490|NCT05107128|459235051|FG000|Overall Study|Reason Not Specified|2|||
127700717|NCT03461276|459533064|FG001|Part B (18 Months Duration)|Adverse event, non-fatal|1|||
127619491|NCT05107128|459235052|FG001|Overall Study|Reason Not Specified|0|||
127619492|NCT01470469|459235053|FG000|Overall Study|Withdrawal by Subject|4|||
127619493|NCT01470469|459235054|FG001|Overall Study|Withdrawal by Subject|6|||
127619494|NCT01470469|459235053|FG000|Overall Study|Lack of Efficacy|1|||
127619495|NCT01470469|459235054|FG001|Overall Study|Lack of Efficacy|7|||
127619496|NCT01470469|459235053|FG000|Overall Study|Adverse Event|0|||
127619497|NCT01470469|459235054|FG001|Overall Study|Adverse Event|7|||
127619498|NCT01470469|459235053|FG000|Overall Study|Lost to Follow-up|2|||
127619499|NCT01470469|459235054|FG001|Overall Study|Lost to Follow-up|2|||
127619500|NCT01470469|459235053|FG000|Overall Study|Protocol Violation|1|||
127619501|NCT01470469|459235054|FG001|Overall Study|Protocol Violation|1|||
127619502|NCT01470469|459235053|FG000|Overall Study|Other|2|||
127619503|NCT01470469|459235054|FG001|Overall Study|Other|1|||
127619504|NCT04182100|459235055|FG000|Overall Study|Adverse Event|1|||
127619505|NCT04182100|459235055|FG000|Overall Study|Withdrawal by Subject|1|||
127619506|NCT04397263|459235057|FG000|Overall Study|Withdrawal by Subject|2|||
127619507|NCT05132127|459235058|FG000|Overall Study|Adverse Event|1|||
127619508|NCT03604692|459235059|FG000|Overall Study|Investigator's Decision|0|||
127619509|NCT03604692|459235060|FG001|Overall Study|Investigator's Decision|0|||
127619510|NCT03604692|459235061|FG002|Overall Study|Investigator's Decision|0|||
127619511|NCT03604692|459235062|FG003|Overall Study|Investigator's Decision|1|||
127619512|NCT03604692|459235063|FG004|Overall Study|Investigator's Decision|0|||
127619513|NCT03604692|459235064|FG005|Overall Study|Investigator's Decision|7|||
127619514|NCT03604692|459235059|FG000|Overall Study|Withdrawal by Subject|0|||
127619515|NCT03604692|459235060|FG001|Overall Study|Withdrawal by Subject|0|||
127619516|NCT03604692|459235061|FG002|Overall Study|Withdrawal by Subject|0|||
127619517|NCT03604692|459235062|FG003|Overall Study|Withdrawal by Subject|0|||
127619518|NCT03604692|459235063|FG004|Overall Study|Withdrawal by Subject|0|||
127619519|NCT03604692|459235064|FG005|Overall Study|Withdrawal by Subject|2|||
127619520|NCT03604692|459235059|FG000|Overall Study|Progressive Disease|1|||
127619521|NCT03604692|459235060|FG001|Overall Study|Progressive Disease|0|||
127619522|NCT03604692|459235061|FG002|Overall Study|Progressive Disease|1|||
127619523|NCT03604692|459235062|FG003|Overall Study|Progressive Disease|0|||
127619524|NCT03604692|459235063|FG004|Overall Study|Progressive Disease|3|||
127619525|NCT03604692|459235064|FG005|Overall Study|Progressive Disease|4|||
127619526|NCT03604692|459235059|FG000|Overall Study|Difficulty Coming into Site|0|||
127619527|NCT03604692|459235060|FG001|Overall Study|Difficulty Coming into Site|0|||
127619528|NCT03604692|459235061|FG002|Overall Study|Difficulty Coming into Site|0|||
127619529|NCT03604692|459235062|FG003|Overall Study|Difficulty Coming into Site|0|||
127619530|NCT03604692|459235063|FG004|Overall Study|Difficulty Coming into Site|0|||
127619531|NCT03604692|459235064|FG005|Overall Study|Difficulty Coming into Site|1|||
127619532|NCT03604692|459235059|FG000|Overall Study|Death|0|||
127619533|NCT03604692|459235060|FG001|Overall Study|Death|0|||
127619534|NCT03604692|459235061|FG002|Overall Study|Death|1|||
127619535|NCT03604692|459235062|FG003|Overall Study|Death|0|||
127884532|NCT02513459|460202055|FG000|Overall Study|Subject decision|2|||
127884533|NCT02513459|460202055|FG000|Overall Study|Lack of response|1|||
127884534|NCT02513459|460202055|FG000|Overall Study|Reproductive plans|1|||
127884535|NCT02513459|460202055|FG000|Overall Study|Surgery planned-- not done|1|||
127884536|NCT03237611|460202056|FG000|Overall Study|Withdrawal by Subject|1|||
127884537|NCT03237611|460202056|FG000|Overall Study|Ineligible|1|||
127884538|NCT00787566|460202057|FG000|Overall Study|AE related to chemotherapy|0|||
127884539|NCT00787566|460202058|FG001|Overall Study|AE related to chemotherapy|1|||
127884540|NCT00787566|460202059|FG002|Overall Study|AE related to chemotherapy|0|||
127884541|NCT01814761|460202060|FG000|Overall Study|Other Reasons|1|||
127884542|NCT01814761|460202061|FG001|Overall Study|Other Reasons|10|||
127884543|NCT01814761|460202060|FG000|Overall Study|Ocular Adverse Event|6|||
127884544|NCT01814761|460202061|FG001|Overall Study|Ocular Adverse Event|15|||
127884545|NCT01814761|460202060|FG000|Overall Study|Lost to Follow-up|1|||
127884546|NCT01814761|460202061|FG001|Overall Study|Lost to Follow-up|5|||
127884547|NCT03137082|460202062|FG000|Overall Study|Withdrawal by Subject|1|||
127884548|NCT03137082|460202063|FG001|Overall Study|Withdrawal by Subject|1|||
127884549|NCT03137082|460202062|FG000|Overall Study|Lost to Follow-up|1|||
127884550|NCT03137082|460202063|FG001|Overall Study|Lost to Follow-up|0|||
127884551|NCT00544557|460202064|FG000|Overall Study|Adverse Event|140|||
127884552|NCT00544557|460202064|FG000|Overall Study|Lack of Efficacy|196|||
127884553|NCT00544557|460202064|FG000|Overall Study|Other|98|||
127884554|NCT01020305|460202065|FG000|Overall Study|Adverse Event|2|||
127884555|NCT01313728|460202069|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
127884556|NCT03547531|460202072|FG000|Overall Study|not coming in data collection : sick|2|||
127884557|NCT03547531|460202073|FG001|Overall Study|not coming in data collection : sick|2|||
127884558|NCT03547531|460202072|FG000|Overall Study|having family occasion|0|||
127884559|NCT03547531|460202073|FG001|Overall Study|having family occasion|2|||
127884560|NCT02444182|460202081|FG000|Overall Study|non-compliance|2|||
127884561|NCT02444182|460202082|FG001|Overall Study|non-compliance|1|||
127884562|NCT02444182|460202081|FG000|Overall Study|Lost to Follow-up|0|||
127884563|NCT02444182|460202082|FG001|Overall Study|Lost to Follow-up|4|||
127884564|NCT02981602|460202085|FG000|Overall Study|Adverse Event|0|||
127884565|NCT02981602|460202086|FG001|Overall Study|Adverse Event|0|||
127884566|NCT02981602|460202087|FG002|Overall Study|Adverse Event|0|||
127884567|NCT02981602|460202088|FG003|Overall Study|Adverse Event|1|||
127884568|NCT02981602|460202089|FG004|Overall Study|Adverse Event|0|||
127884569|NCT01169987|460202090|FG000|Overall Study|Withdrawal by Subject|3|||
127884570|NCT01169987|460202090|FG000|Overall Study|Lost to Follow-up|24|||
127884571|NCT01169987|460202090|FG000|Overall Study|Other|4|||
127884572|NCT00386100|460202091|FG000|Overall Study|Did not receive study medication|6|||
127884573|NCT00386100|460202092|FG001|Overall Study|Did not receive study medication|4|||
127884574|NCT00386100|460202091|FG000|Overall Study|Adverse Event|15|||
127619536|NCT03604692|459235063|FG004|Overall Study|Death|0|||
127619537|NCT03604692|459235064|FG005|Overall Study|Death|0|||
127619538|NCT03604692|459235059|FG000|Overall Study|Drug Intolerance|0|||
127619539|NCT03604692|459235060|FG001|Overall Study|Drug Intolerance|0|||
127619540|NCT03604692|459235061|FG002|Overall Study|Drug Intolerance|0|||
127619541|NCT03604692|459235062|FG003|Overall Study|Drug Intolerance|1|||
127619542|NCT03604692|459235063|FG004|Overall Study|Drug Intolerance|0|||
127619543|NCT03604692|459235064|FG005|Overall Study|Drug Intolerance|0|||
127619544|NCT03604692|459235059|FG000|Overall Study|Noncompliance with follow-up visit|0|||
127619545|NCT03604692|459235060|FG001|Overall Study|Noncompliance with follow-up visit|0|||
127619546|NCT03604692|459235061|FG002|Overall Study|Noncompliance with follow-up visit|0|||
127619547|NCT03604692|459235062|FG003|Overall Study|Noncompliance with follow-up visit|1|||
127884575|NCT00386100|460202092|FG001|Overall Study|Adverse Event|25|||
127884576|NCT00386100|460202091|FG000|Overall Study|Death|0|||
127884577|NCT00386100|460202092|FG001|Overall Study|Death|1|||
127619548|NCT03604692|459235063|FG004|Overall Study|Noncompliance with follow-up visit|0|||
127619549|NCT03604692|459235064|FG005|Overall Study|Noncompliance with follow-up visit|0|||
127619550|NCT03604692|459235059|FG000|Overall Study|Not Treated|0|||
127619551|NCT03604692|459235060|FG001|Overall Study|Not Treated|0|||
127884578|NCT00386100|460202091|FG000|Overall Study|Insufficient therapeutic effect|30|||
127884579|NCT00386100|460202092|FG001|Overall Study|Insufficient therapeutic effect|6|||
127884580|NCT00386100|460202091|FG000|Overall Study|Lost to Follow-up|29|||
127619552|NCT03604692|459235061|FG002|Overall Study|Not Treated|0|||
127619553|NCT03604692|459235062|FG003|Overall Study|Not Treated|0|||
127619554|NCT03604692|459235063|FG004|Overall Study|Not Treated|1|||
127619555|NCT03604692|459235064|FG005|Overall Study|Not Treated|0|||
127619556|NCT02703636|459235065|FG000|Overall Study|Adverse Event|14|||
127619557|NCT02703636|459235065|FG000|Overall Study|Study stopped by sponsor|1|||
127619558|NCT02703636|459235065|FG000|Overall Study|Withdrawal by Subject|1|||
127619559|NCT02161718|459235066|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
127619560|NCT02161718|459235067|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
127619561|NCT02161718|459235068|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
127619562|NCT02161718|459235066|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
127619563|NCT02161718|459235067|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
127619564|NCT02161718|459235068|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
127619565|NCT02161718|459235066|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
127619566|NCT02161718|459235067|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
127619567|NCT02161718|459235068|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
127619568|NCT02161718|459235066|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
127619569|NCT02161718|459235067|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
127619570|NCT02161718|459235068|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
127619571|NCT02161718|459235066|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
127619572|NCT02161718|459235067|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
127619573|NCT02161718|459235068|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
127619574|NCT02161718|459235066|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
127619575|NCT02161718|459235067|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
127619576|NCT02161718|459235068|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
127619577|NCT02161718|459235066|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
127619578|NCT02161718|459235067|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
127619579|NCT02161718|459235068|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
127619580|NCT02161718|459235066|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
127619581|NCT02161718|459235067|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
127619582|NCT02161718|459235068|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
127619583|NCT02161718|459235066|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
127619584|NCT02161718|459235067|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
127619585|NCT02161718|459235068|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
127619586|NCT02161718|459235066|FG000|Post- Randomization Period|Lost to Follow-up|0|||
127619587|NCT02161718|459235067|FG001|Post- Randomization Period|Lost to Follow-up|9|||
127619588|NCT02161718|459235068|FG002|Post- Randomization Period|Lost to Follow-up|15|||
127619589|NCT02161718|459235066|FG000|Post- Randomization Period|Adverse Event|0|||
127619590|NCT02161718|459235067|FG001|Post- Randomization Period|Adverse Event|9|||
127619591|NCT02161718|459235068|FG002|Post- Randomization Period|Adverse Event|10|||
127619592|NCT02161718|459235066|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
127619593|NCT02161718|459235067|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
127619594|NCT02161718|459235068|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
127619595|NCT02161718|459235066|FG000|Post- Randomization Period|Physician Decision|0|||
127619596|NCT02161718|459235067|FG001|Post- Randomization Period|Physician Decision|2|||
127619597|NCT02161718|459235068|FG002|Post- Randomization Period|Physician Decision|4|||
127619598|NCT02161718|459235066|FG000|Post- Randomization Period|Protocol Violation|0|||
127619599|NCT02161718|459235067|FG001|Post- Randomization Period|Protocol Violation|2|||
127619600|NCT02161718|459235068|FG002|Post- Randomization Period|Protocol Violation|3|||
127619601|NCT02161718|459235066|FG000|Post- Randomization Period|Lack of Efficacy|0|||
127619602|NCT02161718|459235067|FG001|Post- Randomization Period|Lack of Efficacy|0|||
127619603|NCT02161718|459235068|FG002|Post- Randomization Period|Lack of Efficacy|1|||
127619604|NCT02161718|459235066|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
127619605|NCT02161718|459235067|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
127619606|NCT02161718|459235068|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
127619607|NCT02161718|459235066|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
127619608|NCT02161718|459235067|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
127619609|NCT02161718|459235068|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
127619610|NCT02161718|459235066|FG000|Post- Randomization Period|Relocation|0|||
127619611|NCT02161718|459235067|FG001|Post- Randomization Period|Relocation|3|||
127619612|NCT02161718|459235068|FG002|Post- Randomization Period|Relocation|0|||
127619613|NCT01256710|459235073|FG000|Overall Study|Death|449|||
127619614|NCT01256710|459235073|FG000|Overall Study|System Explant|67|||
127619615|NCT01256710|459235073|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
127619616|NCT01256710|459235073|FG000|Overall Study|Lost to Follow-up|67|||
127619617|NCT01256710|459235073|FG000|Overall Study|Withdrawal by Subject|29|||
127619618|NCT01256710|459235073|FG000|Overall Study|Physician Decision|9|||
127619619|NCT01256710|459235073|FG000|Overall Study|Subject Noncompliance|2|||
127619620|NCT01256710|459235073|FG000|Overall Study|Study Terminated by Sponsor|273|||
127619621|NCT01205165|459235074|FG000|Overall Study|Lost to Follow-up|2|||
127619622|NCT02681302|459235075|FG000|Overall Study|Withdrawal by Subject|1|||
127619623|NCT02681302|459235076|FG001|Overall Study|Withdrawal by Subject|1|||
127619624|NCT02681302|459235077|FG002|Overall Study|Withdrawal by Subject|0|||
127619625|NCT02681302|459235078|FG003|Overall Study|Withdrawal by Subject|0|||
127619626|NCT02681302|459235079|FG004|Overall Study|Withdrawal by Subject|1|||
127619627|NCT02681302|459235080|FG005|Overall Study|Withdrawal by Subject|0|||
127619628|NCT02681302|459235075|FG000|Overall Study|Screen Failure|2|||
127619629|NCT02681302|459235076|FG001|Overall Study|Screen Failure|4|||
127619630|NCT02681302|459235077|FG002|Overall Study|Screen Failure|2|||
127791480|NCT00781456|459860669|FG000|Overall Study|Other Reason, Unknown|0|||
127791481|NCT00781456|459860670|FG001|Overall Study|Other Reason, Unknown|1|||
127791482|NCT01594853|459860671|FG000|Overall Study|Withdrawal by Subject|1|||
127791483|NCT01594853|459860672|FG001|Overall Study|Withdrawal by Subject|1|||
127791484|NCT01594853|459860671|FG000|Overall Study|Lost to Follow-up|1|||
127791485|NCT01594853|459860672|FG001|Overall Study|Lost to Follow-up|1|||
127791486|NCT01594853|459860671|FG000|Overall Study|noncompliance with exercise|0|||
127791487|NCT01594853|459860672|FG001|Overall Study|noncompliance with exercise|1|||
127791488|NCT04677712|459860674|FG000|Overall Study|Lost to Follow-up|0|||
127791489|NCT04677712|459860675|FG001|Overall Study|Lost to Follow-up|1|||
127791490|NCT04677712|459860676|FG002|Overall Study|Lost to Follow-up|0|||
127791491|NCT04677712|459860677|FG003|Overall Study|Lost to Follow-up|0|||
127791492|NCT04677712|459860678|FG004|Overall Study|Lost to Follow-up|0|||
127791493|NCT04677712|459860679|FG005|Overall Study|Lost to Follow-up|0|||
127791494|NCT00711100|459860680|FG000|Overall Study|Lack of Efficacy|5|||
127791495|NCT00711100|459860680|FG000|Overall Study|Withdrawal by Subject|8|||
127791496|NCT00783094|459860681|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
127791497|NCT00783094|459860682|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
127791498|NCT00783094|459860683|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
127791499|NCT00783094|459860681|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
127791500|NCT00783094|459860682|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
127791501|NCT00783094|459860683|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
127619631|NCT02681302|459235078|FG003|Overall Study|Screen Failure|0|||
127619632|NCT02681302|459235079|FG004|Overall Study|Screen Failure|1|||
127619633|NCT02681302|459235080|FG005|Overall Study|Screen Failure|1|||
127619634|NCT02681302|459235075|FG000|Overall Study|Discontinued Due to Updated FDA Risks|0|||
127619635|NCT02681302|459235076|FG001|Overall Study|Discontinued Due to Updated FDA Risks|0|||
127619636|NCT02681302|459235077|FG002|Overall Study|Discontinued Due to Updated FDA Risks|0|||
127619637|NCT02681302|459235078|FG003|Overall Study|Discontinued Due to Updated FDA Risks|0|||
127619638|NCT02681302|459235079|FG004|Overall Study|Discontinued Due to Updated FDA Risks|0|||
127619639|NCT02681302|459235080|FG005|Overall Study|Discontinued Due to Updated FDA Risks|1|||
127619640|NCT02942017|459235081|FG000|Overall Study|Adverse Event|0|||
127619641|NCT02942017|459235082|FG001|Overall Study|Adverse Event|1|||
127619642|NCT02942017|459235081|FG000|Overall Study|Withdrawal by Subject|0|||
127619643|NCT02942017|459235082|FG001|Overall Study|Withdrawal by Subject|1|||
127619644|NCT02942017|459235081|FG000|Overall Study|Lost to Follow-up|1|||
127619645|NCT02942017|459235082|FG001|Overall Study|Lost to Follow-up|1|||
127619646|NCT02942017|459235081|FG000|Overall Study|Randomized but not dosed|1|||
127619647|NCT02942017|459235082|FG001|Overall Study|Randomized but not dosed|3|||
127619648|NCT00458484|459235085|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
127619649|NCT00458484|459235086|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
127619650|NCT00458484|459235087|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
127619651|NCT00458484|459235088|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
127619652|NCT00458484|459235089|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
127619653|NCT00458484|459235090|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
127619654|NCT00458484|459235091|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
127619655|NCT05059600|459235092|FG000|Overall Study|Enrolled but not Treated|10|||
127619656|NCT02152995|459235093|FG000|Overall Study|Withdrawal by Subject|1|||
127619657|NCT02152995|459235094|FG001|Overall Study|Withdrawal by Subject|0|||
127619658|NCT04538664|459235095|FG000|Overall Study|Withdrawal by Subject|5|||
127619659|NCT04538664|459235096|FG001|Overall Study|Withdrawal by Subject|9|||
127619660|NCT04538664|459235095|FG000|Overall Study|Lost to Follow-up|2|||
127619661|NCT04538664|459235096|FG001|Overall Study|Lost to Follow-up|1|||
127619662|NCT04538664|459235095|FG000|Overall Study|Ongoing|106|||
127619663|NCT04538664|459235096|FG001|Overall Study|Ongoing|115|||
127619664|NCT04552587|459235098|FG000|Overall Study|Lost to Follow-up|4|||
127791502|NCT00783094|459860681|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
127791503|NCT00783094|459860682|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
127791504|NCT00783094|459860683|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
127619665|NCT04907032|459235100|FG000|Overall Study|Withdrawal by Subject|7|||
127619666|NCT04907032|459235101|FG001|Overall Study|Withdrawal by Subject|1|||
127619667|NCT00613509|459235102|FG000|Cycle 1|Adverse Event|2|||
127791505|NCT00783094|459860681|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
127791506|NCT00783094|459860682|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
127619668|NCT00613509|459235103|FG001|Cycle 1|Adverse Event|1|||
127619669|NCT00613509|459235102|FG000|Cycle 1|Disease Progression|2|||
127619670|NCT00613509|459235103|FG001|Cycle 1|Disease Progression|6|||
127619671|NCT00613509|459235102|FG000|Cycle 1|Unacceptable Toxicity|1|||
127619672|NCT00613509|459235103|FG001|Cycle 1|Unacceptable Toxicity|0|||
127884581|NCT00386100|460202092|FG001|Overall Study|Lost to Follow-up|29|||
127884582|NCT00386100|460202091|FG000|Overall Study|Non-compliance|18|||
127884583|NCT00386100|460202092|FG001|Overall Study|Non-compliance|19|||
127884584|NCT00386100|460202091|FG000|Overall Study|Protocol Violation|5|||
127884585|NCT00386100|460202092|FG001|Overall Study|Protocol Violation|3|||
127884586|NCT00386100|460202091|FG000|Overall Study|Withdrawal by Subject|32|||
127884587|NCT00386100|460202092|FG001|Overall Study|Withdrawal by Subject|31|||
127884588|NCT00386100|460202091|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
127884589|NCT00386100|460202092|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
127884590|NCT00386100|460202091|FG000|Overall Study|BMD <2.5|1|||
127884591|NCT00386100|460202092|FG001|Overall Study|BMD <2.5|0|||
127884592|NCT00386100|460202091|FG000|Overall Study|Consecutive elevated Hba1C|1|||
127884593|NCT00386100|460202092|FG001|Overall Study|Consecutive elevated Hba1C|0|||
127884594|NCT00386100|460202091|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
127884595|NCT00386100|460202092|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
127884596|NCT00386100|460202091|FG000|Overall Study|Laboratory findings|1|||
127884597|NCT00386100|460202092|FG001|Overall Study|Laboratory findings|0|||
127884598|NCT00386100|460202091|FG000|Overall Study|Participant's concern due to CPK levels|1|||
127884599|NCT00386100|460202092|FG001|Overall Study|Participant's concern due to CPK levels|0|||
127619673|NCT00613509|459235102|FG000|Cycle 1|Other administrative reason|0|||
127619674|NCT00613509|459235103|FG001|Cycle 1|Other administrative reason|1|||
127884600|NCT00386100|460202091|FG000|Overall Study|Participant moving out of state|2|||
127884601|NCT00386100|460202092|FG001|Overall Study|Participant moving out of state|0|||
127884602|NCT00386100|460202091|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
127884603|NCT00386100|460202092|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
127884604|NCT00386100|460202091|FG000|Overall Study|Didn't meet entry criteria|1|||
127884605|NCT00386100|460202092|FG001|Overall Study|Didn't meet entry criteria|1|||
127884606|NCT00386100|460202091|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
127884607|NCT00386100|460202092|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
127884608|NCT00386100|460202091|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
127884609|NCT00386100|460202092|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
127884610|NCT00386100|460202091|FG000|Overall Study|Bad metabolic control & patient security|1|||
127884611|NCT00386100|460202092|FG001|Overall Study|Bad metabolic control & patient security|0|||
127884612|NCT00386100|460202091|FG000|Overall Study|Bone loss by DXA bone scan|1|||
127884613|NCT00386100|460202092|FG001|Overall Study|Bone loss by DXA bone scan|0|||
127884614|NCT00386100|460202091|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
127884615|NCT00386100|460202092|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
127884616|NCT00386100|460202091|FG000|Overall Study|7.6% bone loss|1|||
127884617|NCT00386100|460202092|FG001|Overall Study|7.6% bone loss|0|||
127884618|NCT00386100|460202091|FG000|Overall Study|Osteoporosis|0|||
127884619|NCT00386100|460202092|FG001|Overall Study|Osteoporosis|1|||
127884620|NCT00386100|460202091|FG000|Overall Study|Positive pregnancy test|1|||
127884621|NCT00386100|460202092|FG001|Overall Study|Positive pregnancy test|3|||
127884622|NCT00386100|460202091|FG000|Overall Study|Out of country for 5 months|1|||
127884623|NCT00386100|460202092|FG001|Overall Study|Out of country for 5 months|0|||
127884624|NCT00386100|460202091|FG000|Overall Study|Hb1Ac >8%|0|||
127884625|NCT00386100|460202092|FG001|Overall Study|Hb1Ac >8%|1|||
127884626|NCT00386100|460202091|FG000|Overall Study|Participant randomized in error|1|||
127884627|NCT00386100|460202092|FG001|Overall Study|Participant randomized in error|0|||
127884628|NCT01706770|460202095|FG000|Overall Study|Lost to Follow-up|1|||
127884629|NCT01706770|460202096|FG001|Overall Study|Lost to Follow-up|0|||
127884630|NCT01706770|460202095|FG000|Overall Study|Physician Decision|1|||
127884631|NCT01706770|460202096|FG001|Overall Study|Physician Decision|0|||
127884632|NCT00886782|460202102|FG000|Overall Study|Disease progression|3|||
127884633|NCT00886782|460202103|FG001|Overall Study|Disease progression|3|||
127884634|NCT00886782|460202104|FG002|Overall Study|Disease progression|3|||
127619675|NCT02448875|459235106|FG000|Overall Study|Adverse Event|2|||
127619676|NCT02448875|459235107|FG001|Overall Study|Adverse Event|1|||
127619677|NCT02448875|459235108|FG002|Overall Study|Adverse Event|0|||
127619678|NCT02448875|459235106|FG000|Overall Study|Lost to Follow-up|1|||
127884635|NCT00886782|460202102|FG000|Overall Study|Study drug toxicity|0|||
127884636|NCT00886782|460202103|FG001|Overall Study|Study drug toxicity|0|||
127884637|NCT00886782|460202104|FG002|Overall Study|Study drug toxicity|1|||
127884638|NCT00886782|460202102|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
127884639|NCT00886782|460202103|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
127619679|NCT02448875|459235107|FG001|Overall Study|Lost to Follow-up|0|||
127619680|NCT02448875|459235108|FG002|Overall Study|Lost to Follow-up|0|||
127619681|NCT02448875|459235106|FG000|Overall Study|Investigator Decision|3|||
127884640|NCT00886782|460202104|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
127884641|NCT03636542|460202105|FG000|Overall Study|Lost to Follow-up|1|||
127884642|NCT03636542|460202106|FG001|Overall Study|Lost to Follow-up|1|||
127619682|NCT02448875|459235107|FG001|Overall Study|Investigator Decision|0|||
127619683|NCT02448875|459235108|FG002|Overall Study|Investigator Decision|1|||
127619684|NCT02448875|459235106|FG000|Overall Study|Withdrawal by Subject|1|||
127619685|NCT02448875|459235107|FG001|Overall Study|Withdrawal by Subject|0|||
127619686|NCT02448875|459235108|FG002|Overall Study|Withdrawal by Subject|0|||
127619687|NCT00689481|459235109|FG000|Overall Study|Adverse Event|7|||
127619688|NCT00689481|459235110|FG001|Overall Study|Adverse Event|1|||
127619689|NCT00689481|459235109|FG000|Overall Study|Lost to Follow-up|4|||
127619690|NCT00689481|459235110|FG001|Overall Study|Lost to Follow-up|3|||
127619691|NCT00689481|459235109|FG000|Overall Study|Lack of Efficacy|4|||
127619692|NCT00689481|459235110|FG001|Overall Study|Lack of Efficacy|3|||
127619693|NCT00689481|459235109|FG000|Overall Study|Non-compliance with study treatment|1|||
127619694|NCT00689481|459235110|FG001|Overall Study|Non-compliance with study treatment|1|||
127619695|NCT00689481|459235109|FG000|Overall Study|Withdrawal by Subject|8|||
127619696|NCT00689481|459235110|FG001|Overall Study|Withdrawal by Subject|4|||
127619697|NCT00689481|459235109|FG000|Overall Study|Excluded medication started during study|0|||
127619698|NCT00689481|459235110|FG001|Overall Study|Excluded medication started during study|1|||
127619699|NCT00689481|459235109|FG000|Overall Study|Subject early term, left on vacation|0|||
127619700|NCT00689481|459235110|FG001|Overall Study|Subject early term, left on vacation|1|||
127619701|NCT06425458|459235111|FG000|Overall Study|Removed by study team|2|||
127619702|NCT06425458|459235111|FG000|Overall Study|Lost to Follow-up|5|||
127619703|NCT04466891|459235112|FG000|Overall Study|Death|60|||
127619704|NCT04466891|459235113|FG001|Overall Study|Death|6|||
127619705|NCT04466891|459235112|FG000|Overall Study|Withdrawal by Subject|8|||
127619706|NCT04466891|459235113|FG001|Overall Study|Withdrawal by Subject|1|||
127619707|NCT04466891|459235112|FG000|Overall Study|Study terminated by sponsor|5|||
127619708|NCT04466891|459235113|FG001|Overall Study|Study terminated by sponsor|0|||
127619709|NCT04466891|459235112|FG000|Overall Study|Lost to Follow-up|2|||
127619710|NCT04466891|459235113|FG001|Overall Study|Lost to Follow-up|0|||
127619711|NCT04466891|459235112|FG000|Overall Study|Transitioned to Named Patient Supply (NPS) program|5|||
127619712|NCT04466891|459235113|FG001|Overall Study|Transitioned to Named Patient Supply (NPS) program|0|||
127619713|NCT00445328|459235114|FG000|Overall Study|Death|0|||
127619714|NCT00445328|459235115|FG001|Overall Study|Death|1|||
127619715|NCT00445328|459235114|FG000|Overall Study|Adverse Event|0|||
127619716|NCT00445328|459235115|FG001|Overall Study|Adverse Event|3|||
127619717|NCT00445328|459235114|FG000|Overall Study|Other|0|||
127619718|NCT00445328|459235115|FG001|Overall Study|Other|2|||
127619719|NCT00445328|459235114|FG000|Overall Study|Withdrawal by Subject|2|||
127619720|NCT00445328|459235115|FG001|Overall Study|Withdrawal by Subject|0|||
127619721|NCT00445328|459235114|FG000|Overall Study|Protocol Violation|1|||
127619722|NCT00445328|459235115|FG001|Overall Study|Protocol Violation|0|||
127619723|NCT02254278|459235116|FG000|Overall Study|Protocol Violation|1|||
127791507|NCT00783094|459860683|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
127791508|NCT00783094|459860681|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
127791509|NCT00783094|459860682|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
127791510|NCT00783094|459860683|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
127791511|NCT00783094|459860681|FG000|Open-Label Extension Period|Adverse Event|12|||
127791512|NCT00783094|459860682|FG001|Open-Label Extension Period|Adverse Event|7|||
127791513|NCT00783094|459860683|FG002|Open-Label Extension Period|Adverse Event|16|||
127791514|NCT00783094|459860681|FG000|Open-Label Extension Period|Death|0|||
127791515|NCT00783094|459860682|FG001|Open-Label Extension Period|Death|0|||
127791516|NCT00783094|459860683|FG002|Open-Label Extension Period|Death|1|||
127791517|NCT00783094|459860681|FG000|Open-Label Extension Period|Protocol Violation|4|||
127791518|NCT00783094|459860682|FG001|Open-Label Extension Period|Protocol Violation|5|||
127791519|NCT00783094|459860683|FG002|Open-Label Extension Period|Protocol Violation|7|||
127791520|NCT00783094|459860681|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
127791521|NCT00783094|459860682|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
127791522|NCT00783094|459860683|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
127791523|NCT00783094|459860681|FG000|Open-Label Extension Period|Physician Decision|4|||
127791524|NCT00783094|459860682|FG001|Open-Label Extension Period|Physician Decision|2|||
127619724|NCT02254278|459235117|FG001|Overall Study|Protocol Violation|1|||
127619725|NCT00316199|459235120|FG000|Overall Study|Adverse Event|2|||
127619726|NCT00316199|459235120|FG000|Overall Study|Death|8|||
127619727|NCT00316199|459235120|FG000|Overall Study|Lost to Follow-up|2|||
127619728|NCT00590954|459235121|FG000|Overall Study|Inevaluable|2|||
127619729|NCT02782949|459235123|FG000|Overall Study|Protocol Violation|1|||
127619730|NCT02782949|459235124|FG001|Overall Study|Protocol Violation|0|||
127619731|NCT02782949|459235123|FG000|Overall Study|Withdrawal by Subject|0|||
127619732|NCT02782949|459235124|FG001|Overall Study|Withdrawal by Subject|1|||
127619733|NCT01433263|459236345|FG000|Overall Study|Adverse Event|3|||
127619734|NCT01433263|459236346|FG001|Overall Study|Adverse Event|1|||
127619735|NCT01433263|459236345|FG000|Overall Study|Death|5|||
127619736|NCT01433263|459236346|FG001|Overall Study|Death|3|||
127791525|NCT00783094|459860683|FG002|Open-Label Extension Period|Physician Decision|3|||
127791526|NCT00783094|459860681|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
127791527|NCT00783094|459860682|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
127884643|NCT03636542|460202105|FG000|Overall Study|Physician Decision|0|||
127884644|NCT03636542|460202106|FG001|Overall Study|Physician Decision|1|||
127884645|NCT03636542|460202105|FG000|Overall Study|Withdrawal by Subject|1|||
127884646|NCT03636542|460202106|FG001|Overall Study|Withdrawal by Subject|0|||
127884647|NCT03674827|460202109|FG000|Treatment Phase|Adverse Event|0|||
127884648|NCT03674827|460202110|FG001|Treatment Phase|Adverse Event|0|||
127884649|NCT03674827|460202111|FG002|Treatment Phase|Adverse Event|0|||
127884650|NCT03674827|460202112|FG003|Treatment Phase|Adverse Event|0|||
127884651|NCT03674827|460202113|FG004|Treatment Phase|Adverse Event|0|||
127884652|NCT03674827|460202114|FG005|Treatment Phase|Adverse Event|2|||
127884653|NCT03674827|460202109|FG000|Treatment Phase|Death|2|||
127884654|NCT03674827|460202110|FG001|Treatment Phase|Death|0|||
127884655|NCT03674827|460202111|FG002|Treatment Phase|Death|0|||
127884656|NCT03674827|460202112|FG003|Treatment Phase|Death|0|||
127884657|NCT03674827|460202113|FG004|Treatment Phase|Death|1|||
127884658|NCT03674827|460202114|FG005|Treatment Phase|Death|0|||
127884659|NCT03674827|460202109|FG000|Treatment Phase|Progressive Disease|0|||
127884660|NCT03674827|460202110|FG001|Treatment Phase|Progressive Disease|4|||
127884661|NCT03674827|460202111|FG002|Treatment Phase|Progressive Disease|3|||
127619737|NCT01433263|459236345|FG000|Overall Study|Lost to Follow-up|0|||
127791528|NCT00783094|459860683|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
127791529|NCT02513329|459860684|FG000|Overall Study|Lost to Follow-up|5|||
127791530|NCT02513329|459860685|FG001|Overall Study|Lost to Follow-up|2|||
127791531|NCT01294670|459860686|FG000|Overall Study|Not treated|1|||
127791532|NCT01294670|459860687|FG001|Overall Study|Not treated|0|||
127791533|NCT01294670|459860688|FG002|Overall Study|Not treated|0|||
127791534|NCT01294670|459860689|FG003|Overall Study|Not treated|0|||
127791535|NCT01294670|459860690|FG004|Overall Study|Not treated|0|||
127791536|NCT02083380|459860694|FG000|Overall Study|Lack of Efficacy|68|||
127791537|NCT02083380|459860695|FG001|Overall Study|Lack of Efficacy|79|||
127791538|NCT02083380|459860696|FG002|Overall Study|Lack of Efficacy|64|||
127791539|NCT02083380|459860694|FG000|Overall Study|Withdrawal by Subject|9|||
127791540|NCT02083380|459860695|FG001|Overall Study|Withdrawal by Subject|3|||
127791541|NCT02083380|459860696|FG002|Overall Study|Withdrawal by Subject|7|||
127791542|NCT02083380|459860694|FG000|Overall Study|Physician Decision|1|||
127791543|NCT02083380|459860695|FG001|Overall Study|Physician Decision|6|||
127791544|NCT02083380|459860696|FG002|Overall Study|Physician Decision|3|||
127791545|NCT02083380|459860694|FG000|Overall Study|Adverse Event|0|||
127791546|NCT02083380|459860695|FG001|Overall Study|Adverse Event|0|||
127791547|NCT02083380|459860696|FG002|Overall Study|Adverse Event|1|||
127791548|NCT02083380|459860694|FG000|Overall Study|Lost to Follow-up|5|||
127791549|NCT02083380|459860695|FG001|Overall Study|Lost to Follow-up|3|||
127791550|NCT02083380|459860696|FG002|Overall Study|Lost to Follow-up|3|||
127791551|NCT02083380|459860694|FG000|Overall Study|Other|8|||
127791552|NCT02083380|459860695|FG001|Overall Study|Other|4|||
127791553|NCT02083380|459860696|FG002|Overall Study|Other|6|||
127791554|NCT00001379|459860697|FG000|Initial Treatment|Disease progression|21|||
127791555|NCT00001379|459860698|FG001|Initial Treatment|Disease progression|3|||
127791556|NCT00001379|459860699|FG002|Initial Treatment|Disease progression|0|||
127791557|NCT00001379|459860700|FG003|Initial Treatment|Disease progression|0|||
127791558|NCT00001379|459860697|FG000|Initial Treatment|Complicating disease/intercurrent illness|6|||
127791559|NCT00001379|459860698|FG001|Initial Treatment|Complicating disease/intercurrent illness|1|||
127884662|NCT03674827|460202112|FG003|Treatment Phase|Progressive Disease|4|||
127884663|NCT03674827|460202113|FG004|Treatment Phase|Progressive Disease|4|||
127619738|NCT01433263|459236346|FG001|Overall Study|Lost to Follow-up|1|||
127619739|NCT01433263|459236345|FG000|Overall Study|Protocol Deviation|1|||
127619740|NCT01433263|459236346|FG001|Overall Study|Protocol Deviation|0|||
127619741|NCT01433263|459236345|FG000|Overall Study|Withdrawal by Subject|10|||
127619742|NCT01433263|459236346|FG001|Overall Study|Withdrawal by Subject|7|||
127619743|NCT03107988|459236347|FG000|Overall Study|Adverse Event|0|||
127619744|NCT03107988|459236348|FG001|Overall Study|Adverse Event|0|||
127619745|NCT03107988|459236349|FG002|Overall Study|Adverse Event|0|||
127619746|NCT03107988|459236350|FG003|Overall Study|Adverse Event|1|||
127791560|NCT00001379|459860699|FG002|Initial Treatment|Complicating disease/intercurrent illness|0|||
127791561|NCT00001379|459860700|FG003|Initial Treatment|Complicating disease/intercurrent illness|0|||
127791562|NCT00001379|459860697|FG000|Initial Treatment|Received alternative treatment|2|||
127791563|NCT00001379|459860698|FG001|Initial Treatment|Received alternative treatment|1|||
127791564|NCT00001379|459860699|FG002|Initial Treatment|Received alternative treatment|0|||
127791565|NCT00001379|459860700|FG003|Initial Treatment|Received alternative treatment|0|||
127791566|NCT00001379|459860697|FG000|Initial Treatment|Refused further treatment|2|||
127791567|NCT00001379|459860698|FG001|Initial Treatment|Refused further treatment|0|||
127791568|NCT00001379|459860699|FG002|Initial Treatment|Refused further treatment|0|||
127791569|NCT00001379|459860700|FG003|Initial Treatment|Refused further treatment|0|||
127791570|NCT00001379|459860697|FG000|Initial Treatment|Did not receive protocol treatment|0|||
127791571|NCT00001379|459860698|FG001|Initial Treatment|Did not receive protocol treatment|0|||
127791572|NCT00001379|459860699|FG002|Initial Treatment|Did not receive protocol treatment|5|||
127791573|NCT00001379|459860700|FG003|Initial Treatment|Did not receive protocol treatment|0|||
127791574|NCT00001379|459860697|FG000|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
127791575|NCT00001379|459860698|FG001|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
127619747|NCT03107988|459236351|FG004|Overall Study|Adverse Event|0|||
127619748|NCT03107988|459236352|FG005|Overall Study|Adverse Event|1|||
127619749|NCT03107988|459236353|FG006|Overall Study|Adverse Event|0|||
127619750|NCT03107988|459236354|FG007|Overall Study|Adverse Event|1|||
127619751|NCT03107988|459236355|FG008|Overall Study|Adverse Event|0|||
127619752|NCT03107988|459236356|FG009|Overall Study|Adverse Event|0|||
127619753|NCT03107988|459236357|FG010|Overall Study|Adverse Event|0|||
127619754|NCT03107988|459236358|FG011|Overall Study|Adverse Event|0|||
127619755|NCT03107988|459236359|FG012|Overall Study|Adverse Event|0|||
127619756|NCT03107988|459236347|FG000|Overall Study|Disease Progression or Relapse|1|||
127619757|NCT03107988|459236348|FG001|Overall Study|Disease Progression or Relapse|2|||
127619758|NCT03107988|459236349|FG002|Overall Study|Disease Progression or Relapse|2|||
127619759|NCT03107988|459236350|FG003|Overall Study|Disease Progression or Relapse|5|||
127619760|NCT03107988|459236351|FG004|Overall Study|Disease Progression or Relapse|1|||
127619761|NCT03107988|459236352|FG005|Overall Study|Disease Progression or Relapse|1|||
127700718|NCT03461276|459533063|FG000|Part B (18 Months Duration)|Patient/caregiver's decision|3|||
127700719|NCT03461276|459533064|FG001|Part B (18 Months Duration)|Patient/caregiver's decision|0|||
127700720|NCT04663737|459533065|FG000|Overall Study|Withdrawal by Subject|2|||
127791576|NCT00001379|459860699|FG002|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
127791577|NCT00001379|459860700|FG003|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|1|||
127791578|NCT00001379|459860697|FG000|Cross-Over After Initial Treatment|Disease progression|4|||
127791579|NCT00001379|459860698|FG001|Cross-Over After Initial Treatment|Disease progression|2|||
127791580|NCT00001379|459860699|FG002|Cross-Over After Initial Treatment|Disease progression|0|||
127791581|NCT00001379|459860700|FG003|Cross-Over After Initial Treatment|Disease progression|0|||
127791582|NCT00001379|459860697|FG000|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
127791583|NCT00001379|459860698|FG001|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
127791584|NCT00001379|459860699|FG002|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
127884664|NCT03674827|460202114|FG005|Treatment Phase|Progressive Disease|9|||
127884665|NCT03674827|460202109|FG000|Treatment Phase|Study Terminated by Sponsor|0|||
127619762|NCT03107988|459236353|FG006|Overall Study|Disease Progression or Relapse|0|||
127619763|NCT03107988|459236354|FG007|Overall Study|Disease Progression or Relapse|0|||
127700721|NCT04663737|459533066|FG001|Overall Study|Withdrawal by Subject|0|||
127700722|NCT04700163|459533067|FG000|Overall Study|Lost to Follow-up|0|||
127700723|NCT04700163|459533068|FG001|Overall Study|Lost to Follow-up|0|||
127700724|NCT04700163|459533069|FG002|Overall Study|Lost to Follow-up|0|||
127619764|NCT03107988|459236355|FG008|Overall Study|Disease Progression or Relapse|0|||
127619765|NCT03107988|459236356|FG009|Overall Study|Disease Progression or Relapse|1|||
127619766|NCT03107988|459236357|FG010|Overall Study|Disease Progression or Relapse|4|||
127619767|NCT03107988|459236358|FG011|Overall Study|Disease Progression or Relapse|0|||
127700725|NCT04700163|459533070|FG003|Overall Study|Lost to Follow-up|0|||
127700726|NCT04700163|459533071|FG004|Overall Study|Lost to Follow-up|0|||
127619768|NCT03107988|459236359|FG012|Overall Study|Disease Progression or Relapse|0|||
127619769|NCT03107988|459236347|FG000|Overall Study|Ineligible|0|||
127619770|NCT03107988|459236348|FG001|Overall Study|Ineligible|0|||
127619771|NCT03107988|459236349|FG002|Overall Study|Ineligible|0|||
127619772|NCT03107988|459236350|FG003|Overall Study|Ineligible|0|||
127619773|NCT03107988|459236351|FG004|Overall Study|Ineligible|0|||
127619774|NCT03107988|459236352|FG005|Overall Study|Ineligible|0|||
127619775|NCT03107988|459236353|FG006|Overall Study|Ineligible|0|||
127619776|NCT03107988|459236354|FG007|Overall Study|Ineligible|0|||
127619777|NCT03107988|459236355|FG008|Overall Study|Ineligible|1|||
127619778|NCT03107988|459236356|FG009|Overall Study|Ineligible|0|||
127619779|NCT03107988|459236357|FG010|Overall Study|Ineligible|0|||
127619780|NCT03107988|459236358|FG011|Overall Study|Ineligible|0|||
127619781|NCT03107988|459236359|FG012|Overall Study|Ineligible|0|||
127619782|NCT02489318|459236360|FG000|Randomized|Withdrawal by Subject|0|||
127791585|NCT00001379|459860700|FG003|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
127791586|NCT00001379|459860697|FG000|Cross-Over After Initial Treatment|Received alternative treatment|4|||
127791587|NCT00001379|459860698|FG001|Cross-Over After Initial Treatment|Received alternative treatment|0|||
127791588|NCT00001379|459860699|FG002|Cross-Over After Initial Treatment|Received alternative treatment|0|||
127791589|NCT00001379|459860700|FG003|Cross-Over After Initial Treatment|Received alternative treatment|0|||
127791590|NCT00001379|459860697|FG000|Cross-Over After Initial Treatment|Refused further treatment|1|||
127791591|NCT00001379|459860698|FG001|Cross-Over After Initial Treatment|Refused further treatment|0|||
127791592|NCT00001379|459860699|FG002|Cross-Over After Initial Treatment|Refused further treatment|0|||
127791593|NCT00001379|459860700|FG003|Cross-Over After Initial Treatment|Refused further treatment|0|||
127791594|NCT00876187|459860703|FG000|Overall Study|Adverse Event|14|||
127791595|NCT00876187|459860704|FG001|Overall Study|Adverse Event|12|||
127884666|NCT03674827|460202110|FG001|Treatment Phase|Study Terminated by Sponsor|0|||
127619783|NCT02489318|459236361|FG001|Randomized|Withdrawal by Subject|1|||
127619784|NCT02489318|459236360|FG000|Treated|Adverse Event|19|||
127619785|NCT02489318|459236361|FG001|Treated|Adverse Event|62|||
127619786|NCT02489318|459236360|FG000|Treated|Death|13|||
127619787|NCT02489318|459236361|FG001|Treated|Death|11|||
127619788|NCT02489318|459236360|FG000|Treated|Physician Decision|4|||
127619789|NCT02489318|459236361|FG001|Treated|Physician Decision|6|||
127619790|NCT02489318|459236360|FG000|Treated|Protocol Violation|1|||
127619791|NCT02489318|459236361|FG001|Treated|Protocol Violation|2|||
127619792|NCT02489318|459236360|FG000|Treated|Withdrawal by Subject|37|||
127619793|NCT02489318|459236361|FG001|Treated|Withdrawal by Subject|36|||
127619794|NCT02489318|459236360|FG000|Treated|Other: Progressive Disease|245|||
127619795|NCT02489318|459236361|FG001|Treated|Other: Progressive Disease|138|||
127619796|NCT02489318|459236360|FG000|Treated|Other|0|||
127619797|NCT02489318|459236361|FG001|Treated|Other|2|||
127619798|NCT02489318|459236360|FG000|Treated|Ongoing|0|||
127619799|NCT02489318|459236361|FG001|Treated|Ongoing|267|||
127619800|NCT05723770|459236362|FG000|Overall Study|Lost to Follow-up|4|||
127619801|NCT05723770|459236362|FG000|Overall Study|Withdrawal by Subject|2|||
127619802|NCT01171898|459236363|FG000|Overall Study|Death|0|||
127619803|NCT01171898|459236364|FG001|Overall Study|Death|0|||
127619804|NCT01171898|459236365|FG002|Overall Study|Death|2|||
127619805|NCT01171898|459236366|FG003|Overall Study|Death|0|||
127619806|NCT01171898|459236363|FG000|Overall Study|Lost to Follow-up|0|||
127619807|NCT01171898|459236364|FG001|Overall Study|Lost to Follow-up|1|||
127619808|NCT01171898|459236365|FG002|Overall Study|Lost to Follow-up|1|||
127619809|NCT01171898|459236366|FG003|Overall Study|Lost to Follow-up|1|||
127619810|NCT01171898|459236363|FG000|Overall Study|Withdrawal by Subject|1|||
127619811|NCT01171898|459236364|FG001|Overall Study|Withdrawal by Subject|4|||
127619812|NCT01171898|459236365|FG002|Overall Study|Withdrawal by Subject|6|||
127619813|NCT01171898|459236366|FG003|Overall Study|Withdrawal by Subject|3|||
127619814|NCT01171898|459236363|FG000|Overall Study|Terminated by Sponsor|1|||
127619815|NCT01171898|459236364|FG001|Overall Study|Terminated by Sponsor|0|||
127619816|NCT01171898|459236365|FG002|Overall Study|Terminated by Sponsor|0|||
127619817|NCT01171898|459236366|FG003|Overall Study|Terminated by Sponsor|0|||
127619818|NCT01171898|459236363|FG000|Overall Study|Ongoing|1|||
127619819|NCT01171898|459236364|FG001|Overall Study|Ongoing|9|||
127619820|NCT01171898|459236365|FG002|Overall Study|Ongoing|3|||
127619821|NCT01171898|459236366|FG003|Overall Study|Ongoing|0|||
127619822|NCT01171898|459236363|FG000|Overall Study|Other|1|||
127619823|NCT01171898|459236364|FG001|Overall Study|Other|5|||
127619824|NCT01171898|459236365|FG002|Overall Study|Other|0|||
127619825|NCT01171898|459236366|FG003|Overall Study|Other|2|||
127619826|NCT01359592|459236367|FG000|Initial Registration|Adverse Event|1|||
127619827|NCT01359592|459236368|FG001|Initial Registration|Adverse Event|0|||
127619828|NCT01359592|459236369|FG002|Initial Registration|Adverse Event|0|||
127619829|NCT01359592|459236370|FG003|Initial Registration|Adverse Event|0|||
127619830|NCT01359592|459236367|FG000|Initial Registration|Death|1|||
127619831|NCT01359592|459236368|FG001|Initial Registration|Death|0|||
127619832|NCT01359592|459236369|FG002|Initial Registration|Death|0|||
127619833|NCT01359592|459236370|FG003|Initial Registration|Death|0|||
127619834|NCT01359592|459236367|FG000|Initial Registration|Other reason not protocol specified|1|||
127619835|NCT01359592|459236368|FG001|Initial Registration|Other reason not protocol specified|0|||
127619836|NCT01359592|459236369|FG002|Initial Registration|Other reason not protocol specified|0|||
127619837|NCT01359592|459236370|FG003|Initial Registration|Other reason not protocol specified|0|||
127619838|NCT01359592|459236367|FG000|Initial Registration|Ineligible|26|||
127619839|NCT01359592|459236368|FG001|Initial Registration|Ineligible|0|||
127619840|NCT01359592|459236369|FG002|Initial Registration|Ineligible|0|||
127619841|NCT01359592|459236370|FG003|Initial Registration|Ineligible|0|||
127619842|NCT01359592|459236367|FG000|PET-Directed Therapy|Adverse Event|0|||
127619843|NCT01359592|459236368|FG001|PET-Directed Therapy|Adverse Event|0|||
127619844|NCT01359592|459236369|FG002|PET-Directed Therapy|Adverse Event|1|||
127619845|NCT01359592|459236370|FG003|PET-Directed Therapy|Adverse Event|0|||
127619846|NCT01359592|459236367|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
127700727|NCT04700163|459533072|FG005|Overall Study|Lost to Follow-up|1|||
127700728|NCT03865498|459533073|FG000|Overall Study|Lack of Efficacy|12|||
127700729|NCT03865498|459533074|FG001|Overall Study|Lack of Efficacy|11|||
127700730|NCT03865498|459533073|FG000|Overall Study|Lost to Follow-up|125|||
127700731|NCT03865498|459533074|FG001|Overall Study|Lost to Follow-up|133|||
127700732|NCT03865498|459533073|FG000|Overall Study|Withdrawal by Subject|2|||
127700733|NCT03865498|459533074|FG001|Overall Study|Withdrawal by Subject|4|||
127700734|NCT03270501|459533077|FG000|Overall Study|Screen failure|6|||
127700735|NCT03270501|459533077|FG000|Overall Study|Lost to Follow-up|2|||
127700736|NCT03270501|459533077|FG000|Overall Study|Adverse Event|1|||
127700737|NCT05329220|459533080|FG000|Active Trial Period|Adverse Event|0|||
127700738|NCT05329220|459533081|FG001|Active Trial Period|Adverse Event|0|||
127700739|NCT05329220|459533082|FG002|Active Trial Period|Adverse Event|0|||
127700740|NCT05329220|459533083|FG003|Active Trial Period|Adverse Event|0|||
127700741|NCT05329220|459533084|FG004|Active Trial Period|Adverse Event|1|||
127700742|NCT05329220|459533085|FG005|Active Trial Period|Adverse Event|0|||
127700743|NCT05329220|459533080|FG000|Active Trial Period|Lost to Follow-up|0|||
127700744|NCT05329220|459533081|FG001|Active Trial Period|Lost to Follow-up|0|||
127700745|NCT05329220|459533082|FG002|Active Trial Period|Lost to Follow-up|0|||
127700746|NCT05329220|459533083|FG003|Active Trial Period|Lost to Follow-up|0|||
127700747|NCT05329220|459533084|FG004|Active Trial Period|Lost to Follow-up|32|||
127619847|NCT01359592|459236368|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
127619848|NCT01359592|459236369|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
127619849|NCT01359592|459236370|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
127619850|NCT01359592|459236367|FG000|PET-Directed Therapy|Ineligible|0|||
127619851|NCT01359592|459236368|FG001|PET-Directed Therapy|Ineligible|0|||
127619852|NCT01359592|459236369|FG002|PET-Directed Therapy|Ineligible|24|||
127619853|NCT01359592|459236370|FG003|PET-Directed Therapy|Ineligible|0|||
127619854|NCT00749775|459236377|FG000|Overall Study|Protocol Violation|24|||
127619855|NCT00749775|459236377|FG000|Overall Study|Lost to Follow-up|36|||
127700748|NCT05329220|459533085|FG005|Active Trial Period|Lost to Follow-up|28|||
127700749|NCT05329220|459533080|FG000|Active Trial Period|Physician Decision|0|||
127700750|NCT05329220|459533081|FG001|Active Trial Period|Physician Decision|0|||
127700751|NCT05329220|459533082|FG002|Active Trial Period|Physician Decision|0|||
127700752|NCT05329220|459533083|FG003|Active Trial Period|Physician Decision|0|||
127700753|NCT05329220|459533084|FG004|Active Trial Period|Physician Decision|2|||
127619856|NCT00749775|459236377|FG000|Overall Study|No visit after first day of treatment|44|||
127619857|NCT00749775|459236377|FG000|Overall Study|No drug administration|3|||
127619858|NCT04537806|459236383|FG000|Overall Study|Randomized but not treated|1|||
127619859|NCT04537806|459236384|FG001|Overall Study|Randomized but not treated|0|||
127619860|NCT04537806|459236383|FG000|Overall Study|Adverse Event|1|||
127619861|NCT04537806|459236384|FG001|Overall Study|Adverse Event|1|||
127619862|NCT03019627|459236385|FG000|Overall Study|Adverse Event|8|||
127619863|NCT03019627|459236386|FG001|Overall Study|Adverse Event|0|||
127619864|NCT03019627|459236385|FG000|Overall Study|Unrelated to adverse event|1|||
127619865|NCT03019627|459236386|FG001|Overall Study|Unrelated to adverse event|3|||
127619866|NCT03019627|459236385|FG000|Overall Study|Lost to Follow-up|2|||
127619867|NCT03019627|459236386|FG001|Overall Study|Lost to Follow-up|1|||
127619868|NCT03019627|459236385|FG000|Overall Study|not compliance|2|||
127619869|NCT03019627|459236386|FG001|Overall Study|not compliance|2|||
127619870|NCT03019627|459236385|FG000|Overall Study|Other|2|||
127619871|NCT03019627|459236386|FG001|Overall Study|Other|2|||
127619872|NCT05459129|459236387|FG000|Overall Study|Death|1|||
127619873|NCT05459129|459236388|FG001|Overall Study|Death|0|||
127619874|NCT05459129|459236387|FG000|Overall Study|Study Terminated By Sponsor|5|||
127619875|NCT05459129|459236388|FG001|Overall Study|Study Terminated By Sponsor|6|||
127619876|NCT04530552|459236391|FG000|Overall Study|Physician Decision|0|||
127619877|NCT04530552|459236392|FG001|Overall Study|Physician Decision|1|||
127619878|NCT04530552|459236391|FG000|Overall Study|Withdrawal by Subject|0|||
127619879|NCT04530552|459236392|FG001|Overall Study|Withdrawal by Subject|1|||
127619880|NCT04530552|459236391|FG000|Overall Study|Adverse Event|0|||
127619881|NCT04530552|459236392|FG001|Overall Study|Adverse Event|1|||
127619882|NCT04530552|459236391|FG000|Overall Study|No surgery|0|||
127619883|NCT04530552|459236392|FG001|Overall Study|No surgery|1|||
127619884|NCT06034496|459236393|FG000|Overall Study|Did not meet minimum stimulation threshold|2|||
127619885|NCT06034496|459236394|FG001|Overall Study|Did not meet minimum stimulation threshold|1|||
127791596|NCT00876187|459860705|FG002|Overall Study|Adverse Event|19|||
127791597|NCT00876187|459860706|FG003|Overall Study|Adverse Event|29|||
127791598|NCT00876187|459860707|FG004|Overall Study|Adverse Event|10|||
127791599|NCT00876187|459860703|FG000|Overall Study|Lack of Efficacy|59|||
127791600|NCT00876187|459860704|FG001|Overall Study|Lack of Efficacy|34|||
127791601|NCT00876187|459860705|FG002|Overall Study|Lack of Efficacy|45|||
127791602|NCT00876187|459860706|FG003|Overall Study|Lack of Efficacy|34|||
127791603|NCT00876187|459860707|FG004|Overall Study|Lack of Efficacy|59|||
127791604|NCT00876187|459860703|FG000|Overall Study|Lost to Follow-up|9|||
127791605|NCT00876187|459860704|FG001|Overall Study|Lost to Follow-up|10|||
127791606|NCT00876187|459860705|FG002|Overall Study|Lost to Follow-up|8|||
127791607|NCT00876187|459860706|FG003|Overall Study|Lost to Follow-up|8|||
127791608|NCT00876187|459860707|FG004|Overall Study|Lost to Follow-up|11|||
127791609|NCT00876187|459860703|FG000|Overall Study|Protocol Violation|6|||
127791610|NCT00876187|459860704|FG001|Overall Study|Protocol Violation|7|||
127791611|NCT00876187|459860705|FG002|Overall Study|Protocol Violation|7|||
127791612|NCT00876187|459860706|FG003|Overall Study|Protocol Violation|6|||
127791613|NCT00876187|459860707|FG004|Overall Study|Protocol Violation|3|||
127884667|NCT03674827|460202111|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
127619886|NCT06034496|459236393|FG000|Overall Study|Withdrawal by Subject|5|||
127619887|NCT06034496|459236394|FG001|Overall Study|Withdrawal by Subject|4|||
127619888|NCT03277261|459236397|FG000|Overall Study|Adverse Event|17|||
127619889|NCT03277261|459236398|FG001|Overall Study|Adverse Event|1|||
127619890|NCT03277261|459236397|FG000|Overall Study|Participant Withdrawal of Consent|6|||
127619891|NCT03277261|459236398|FG001|Overall Study|Participant Withdrawal of Consent|15|||
127619892|NCT03277261|459236397|FG000|Overall Study|Investigator / Sponsor Decision|4|||
127619893|NCT03277261|459236398|FG001|Overall Study|Investigator / Sponsor Decision|2|||
127619894|NCT03277261|459236397|FG000|Overall Study|Pregnancy|2|||
127619895|NCT03277261|459236398|FG001|Overall Study|Pregnancy|0|||
127619896|NCT03277261|459236397|FG000|Overall Study|Lost to Follow-up|2|||
127619897|NCT03277261|459236398|FG001|Overall Study|Lost to Follow-up|2|||
127619898|NCT03277261|459236397|FG000|Overall Study|Lack of Efficacy|2|||
127619899|NCT03277261|459236398|FG001|Overall Study|Lack of Efficacy|2|||
127791614|NCT00876187|459860703|FG000|Overall Study|Withdrawal by Subject|16|||
127791615|NCT00876187|459860704|FG001|Overall Study|Withdrawal by Subject|26|||
127791616|NCT00876187|459860705|FG002|Overall Study|Withdrawal by Subject|32|||
127884668|NCT03674827|460202112|FG003|Treatment Phase|Study Terminated by Sponsor|0|||
127619900|NCT03277261|459236397|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
127619901|NCT03277261|459236398|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
127619902|NCT00499603|459236402|FG000|Overall Study|Adverse Event|0|||
127619903|NCT00499603|459236403|FG001|Overall Study|Adverse Event|1|||
127619904|NCT04697628|459236404|FG000|Overall Study|Withdrawal by Subject|17|||
127619905|NCT04697628|459236405|FG001|Overall Study|Withdrawal by Subject|23|||
127619906|NCT04697628|459236404|FG000|Overall Study|Lost to Follow-up|0|||
127619907|NCT04697628|459236405|FG001|Overall Study|Lost to Follow-up|4|||
127619908|NCT04697628|459236404|FG000|Overall Study|On-going in study|122|||
127619909|NCT04697628|459236405|FG001|Overall Study|On-going in study|91|||
127791617|NCT00876187|459860706|FG003|Overall Study|Withdrawal by Subject|38|||
127619910|NCT01946204|459236406|FG000|Overall Study|Death|38|||
127619911|NCT01946204|459236407|FG001|Overall Study|Death|59|||
127619912|NCT01946204|459236406|FG000|Overall Study|Withdrawal by Subject|37|||
127619913|NCT01946204|459236407|FG001|Overall Study|Withdrawal by Subject|50|||
127619914|NCT01946204|459236406|FG000|Overall Study|Lost to Follow-up|3|||
127619915|NCT01946204|459236407|FG001|Overall Study|Lost to Follow-up|7|||
127619916|NCT01946204|459236406|FG000|Overall Study|Ongoing|316|||
127619917|NCT01946204|459236407|FG001|Overall Study|Ongoing|687|||
127619918|NCT01946204|459236406|FG000|Overall Study|Other|7|||
127619919|NCT01946204|459236407|FG001|Overall Study|Other|3|||
127619920|NCT03466411|459236408|FG000|Overall Study|Lost to Follow-up|0|||
127619921|NCT03466411|459236409|FG001|Overall Study|Lost to Follow-up|1|||
127619922|NCT03466411|459236410|FG002|Overall Study|Lost to Follow-up|1|||
127619923|NCT03466411|459236411|FG003|Overall Study|Lost to Follow-up|0|||
127619924|NCT03466411|459236412|FG004|Overall Study|Lost to Follow-up|0|||
127619925|NCT03466411|459236413|FG005|Overall Study|Lost to Follow-up|0|||
127619926|NCT03466411|459236414|FG006|Overall Study|Lost to Follow-up|1|||
127619927|NCT03466411|459236415|FG007|Overall Study|Lost to Follow-up|1|||
127619928|NCT03466411|459236416|FG008|Overall Study|Lost to Follow-up|0|||
127619929|NCT03466411|459236417|FG009|Overall Study|Lost to Follow-up|1|||
127619930|NCT03466411|459236418|FG010|Overall Study|Lost to Follow-up|1|||
127619931|NCT03466411|459236419|FG011|Overall Study|Lost to Follow-up|1|||
127619932|NCT03466411|459236420|FG012|Overall Study|Lost to Follow-up|0|||
127619933|NCT03466411|459236408|FG000|Overall Study|Withdrawal by Subject|14|||
127619934|NCT03466411|459236409|FG001|Overall Study|Withdrawal by Subject|7|||
127619935|NCT03466411|459236410|FG002|Overall Study|Withdrawal by Subject|8|||
127619936|NCT03466411|459236411|FG003|Overall Study|Withdrawal by Subject|4|||
127619937|NCT03466411|459236412|FG004|Overall Study|Withdrawal by Subject|6|||
127619938|NCT03466411|459236413|FG005|Overall Study|Withdrawal by Subject|3|||
127619939|NCT03466411|459236414|FG006|Overall Study|Withdrawal by Subject|6|||
127619940|NCT03466411|459236415|FG007|Overall Study|Withdrawal by Subject|9|||
127619941|NCT03466411|459236416|FG008|Overall Study|Withdrawal by Subject|6|||
127619942|NCT03466411|459236417|FG009|Overall Study|Withdrawal by Subject|11|||
127619943|NCT03466411|459236418|FG010|Overall Study|Withdrawal by Subject|14|||
127619944|NCT03466411|459236419|FG011|Overall Study|Withdrawal by Subject|12|||
127619945|NCT03466411|459236420|FG012|Overall Study|Withdrawal by Subject|7|||
127619946|NCT03466411|459236408|FG000|Overall Study|Other|1|||
127619947|NCT03466411|459236409|FG001|Overall Study|Other|1|||
127619948|NCT03466411|459236410|FG002|Overall Study|Other|0|||
127619949|NCT03466411|459236411|FG003|Overall Study|Other|1|||
127619950|NCT03466411|459236412|FG004|Overall Study|Other|2|||
127619951|NCT03466411|459236413|FG005|Overall Study|Other|0|||
127619952|NCT03466411|459236414|FG006|Overall Study|Other|0|||
127619953|NCT03466411|459236415|FG007|Overall Study|Other|0|||
127619954|NCT03466411|459236416|FG008|Overall Study|Other|0|||
127619955|NCT03466411|459236417|FG009|Overall Study|Other|1|||
127619956|NCT03466411|459236418|FG010|Overall Study|Other|2|||
127619957|NCT03466411|459236419|FG011|Overall Study|Other|0|||
127619958|NCT03466411|459236420|FG012|Overall Study|Other|0|||
127619959|NCT03466411|459236408|FG000|Overall Study|Randomized but not Treated|0|||
127619960|NCT03466411|459236409|FG001|Overall Study|Randomized but not Treated|0|||
127619961|NCT03466411|459236410|FG002|Overall Study|Randomized but not Treated|0|||
127619962|NCT03466411|459236411|FG003|Overall Study|Randomized but not Treated|0|||
127619963|NCT03466411|459236412|FG004|Overall Study|Randomized but not Treated|0|||
127619964|NCT03466411|459236413|FG005|Overall Study|Randomized but not Treated|0|||
127619965|NCT03466411|459236414|FG006|Overall Study|Randomized but not Treated|1|||
127619966|NCT03466411|459236415|FG007|Overall Study|Randomized but not Treated|0|||
127619967|NCT03466411|459236416|FG008|Overall Study|Randomized but not Treated|0|||
127619968|NCT03466411|459236417|FG009|Overall Study|Randomized but not Treated|0|||
127619969|NCT03466411|459236418|FG010|Overall Study|Randomized but not Treated|0|||
127619970|NCT03466411|459236419|FG011|Overall Study|Randomized but not Treated|0|||
127619971|NCT03466411|459236420|FG012|Overall Study|Randomized but not Treated|0|||
127619972|NCT00393939|459236421|FG000|Overall Study|Protocol Violation|1|||
127619973|NCT00393939|459236422|FG001|Overall Study|Protocol Violation|1|||
127619974|NCT00393939|459236421|FG000|Overall Study|Lost to Follow-up|2|||
127619975|NCT00393939|459236422|FG001|Overall Study|Lost to Follow-up|4|||
127619976|NCT00393939|459236421|FG000|Overall Study|Death|10|||
127619977|NCT00393939|459236422|FG001|Overall Study|Death|4|||
127619978|NCT00393939|459236421|FG000|Overall Study|Sponsor|5|||
127619979|NCT00393939|459236422|FG001|Overall Study|Sponsor|13|||
127619980|NCT00393939|459236421|FG000|Overall Study|Objective progression or relapse|239|||
127619981|NCT00393939|459236422|FG001|Overall Study|Objective progression or relapse|223|||
127619982|NCT00393939|459236421|FG000|Overall Study|Withdrawal by Subject|2|||
127619983|NCT00393939|459236422|FG001|Overall Study|Withdrawal by Subject|7|||
127619984|NCT00393939|459236421|FG000|Overall Study|Other|37|||
127619985|NCT00393939|459236422|FG001|Overall Study|Other|45|||
127619986|NCT03778931|459236423|FG000|Overall Study|Withdrawal by Subject|12|||
127884669|NCT03674827|460202113|FG004|Treatment Phase|Study Terminated by Sponsor|0|||
127884670|NCT03674827|460202114|FG005|Treatment Phase|Study Terminated by Sponsor|1|||
127884671|NCT03674827|460202109|FG000|Treatment Phase|Withdrawal by Subject|0|||
127884672|NCT03674827|460202110|FG001|Treatment Phase|Withdrawal by Subject|0|||
127884673|NCT03674827|460202111|FG002|Treatment Phase|Withdrawal by Subject|0|||
127884674|NCT03674827|460202112|FG003|Treatment Phase|Withdrawal by Subject|0|||
127884675|NCT03674827|460202113|FG004|Treatment Phase|Withdrawal by Subject|0|||
127884676|NCT03674827|460202114|FG005|Treatment Phase|Withdrawal by Subject|1|||
127884677|NCT03674827|460202109|FG000|Treatment Phase|Global Deterioration of Health Status|1|||
127884678|NCT03674827|460202110|FG001|Treatment Phase|Global Deterioration of Health Status|0|||
127619987|NCT03778931|459236424|FG001|Overall Study|Withdrawal by Subject|25|||
127619988|NCT03778931|459236423|FG000|Overall Study|Physician Decision|1|||
127619989|NCT03778931|459236424|FG001|Overall Study|Physician Decision|3|||
127619990|NCT03778931|459236423|FG000|Overall Study|Participant Noncompliance|1|||
127619991|NCT03778931|459236424|FG001|Overall Study|Participant Noncompliance|1|||
127619992|NCT03778931|459236423|FG000|Overall Study|Lost to Follow-up|4|||
127619993|NCT03778931|459236424|FG001|Overall Study|Lost to Follow-up|1|||
127619994|NCT03778931|459236423|FG000|Overall Study|Death|69|||
127619995|NCT03778931|459236424|FG001|Overall Study|Death|79|||
127619996|NCT00006184|459236425|FG000|Overall Study|Death|1|||
127619997|NCT00006184|459236426|FG001|Overall Study|Death|0|||
127619998|NCT04181827|459236431|FG000|Overall Study|Ongoing|124|||
127619999|NCT04181827|459236432|FG001|Overall Study|Ongoing|157|||
127620000|NCT04181827|459236431|FG000|Overall Study|Death|82|||
127620001|NCT04181827|459236432|FG001|Overall Study|Death|50|||
127620002|NCT04181827|459236431|FG000|Overall Study|Lost to Follow-up|0|||
127620003|NCT04181827|459236432|FG001|Overall Study|Lost to Follow-up|1|||
127620004|NCT04181827|459236431|FG000|Overall Study|Withdrawal by Subject|5|||
127620005|NCT04181827|459236432|FG001|Overall Study|Withdrawal by Subject|0|||
127620006|NCT01857063|459236433|FG000|Period 1 (7 Days)|Adverse Event|0|||
127620007|NCT01857063|459236434|FG001|Period 1 (7 Days)|Adverse Event|1|||
127620008|NCT01857063|459236433|FG000|Period 1 (7 Days)|Physician Decision|1|||
127620009|NCT01857063|459236434|FG001|Period 1 (7 Days)|Physician Decision|0|||
127620010|NCT01857063|459236433|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
127620011|NCT01857063|459236434|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
127620012|NCT01857063|459236433|FG000|Period 2 (7 Days)|Adverse Event|2|||
127620013|NCT01857063|459236434|FG001|Period 2 (7 Days)|Adverse Event|1|||
127620014|NCT01857063|459236433|FG000|Period 2 (7 Days)|Physician Decision|1|||
127620015|NCT01857063|459236434|FG001|Period 2 (7 Days)|Physician Decision|1|||
127620016|NCT01857063|459236433|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
127620017|NCT01857063|459236434|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
127620018|NCT04115358|459236435|FG000|Overall Study|exfoliation|0|||
127620019|NCT04115358|459236436|FG001|Overall Study|exfoliation|0|||
127620020|NCT04115358|459236437|FG002|Overall Study|exfoliation|1|||
127620021|NCT02115282|459236440|FG000|Overall Study|Disease progression during treatment|216|||
127884679|NCT03674827|460202111|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
127884680|NCT03674827|460202112|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
127620022|NCT02115282|459236441|FG001|Overall Study|Disease progression during treatment|229|||
127620023|NCT02115282|459236440|FG000|Overall Study|Adverse Event|49|||
127620024|NCT02115282|459236441|FG001|Overall Study|Adverse Event|23|||
127620025|NCT02115282|459236440|FG000|Overall Study|Death|1|||
127620026|NCT02115282|459236441|FG001|Overall Study|Death|3|||
127620027|NCT02115282|459236440|FG000|Overall Study|Alternative therapy|1|||
127620028|NCT02115282|459236441|FG001|Overall Study|Alternative therapy|1|||
127620029|NCT02115282|459236440|FG000|Overall Study|Complicating disease|0|||
127620030|NCT02115282|459236441|FG001|Overall Study|Complicating disease|3|||
127620031|NCT02115282|459236440|FG000|Overall Study|Withdrawal by Subject|12|||
127620032|NCT02115282|459236441|FG001|Overall Study|Withdrawal by Subject|10|||
127620033|NCT02115282|459236440|FG000|Overall Study|Symptomatic progression/deterioration|7|||
127620034|NCT02115282|459236441|FG001|Overall Study|Symptomatic progression/deterioration|18|||
127620035|NCT02115282|459236440|FG000|Overall Study|Non-compliance|5|||
127620036|NCT02115282|459236441|FG001|Overall Study|Non-compliance|1|||
127620037|NCT02115282|459236440|FG000|Overall Study|Protocol Violation|2|||
127620038|NCT02115282|459236441|FG001|Overall Study|Protocol Violation|2|||
127620039|NCT02115282|459236440|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
127620040|NCT02115282|459236441|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
127620041|NCT02115282|459236440|FG000|Overall Study|Not start protocol therapy|9|||
127620042|NCT02115282|459236441|FG001|Overall Study|Not start protocol therapy|10|||
127620043|NCT01723228|459236448|FG000|Overall Study|Adverse Event|2|||
127620044|NCT01723228|459236449|FG001|Overall Study|Adverse Event|6|||
127620045|NCT01723228|459236448|FG000|Overall Study|Withdrawal by Subject|2|||
127620046|NCT01723228|459236449|FG001|Overall Study|Withdrawal by Subject|1|||
127620047|NCT01723228|459236448|FG000|Overall Study|Protocol Violation|0|||
127620048|NCT01723228|459236449|FG001|Overall Study|Protocol Violation|2|||
127620049|NCT01723228|459236448|FG000|Overall Study|Lost to Follow-up|2|||
127620050|NCT01723228|459236449|FG001|Overall Study|Lost to Follow-up|1|||
127620051|NCT01723228|459236448|FG000|Overall Study|Other|2|||
127620052|NCT01723228|459236449|FG001|Overall Study|Other|1|||
127620053|NCT00218543|459236451|FG000|Overall Study|Lost to Follow-up|8|||
127620054|NCT00218543|459236451|FG000|Overall Study|relocated|1|||
127620055|NCT00218543|459236451|FG000|Overall Study|Withdrawal by Subject|1|||
127620056|NCT00218543|459236451|FG000|Overall Study|Physician Decision|3|||
127620057|NCT00218543|459236451|FG000|Overall Study|Adverse Event|2|||
127620058|NCT01864291|459236452|FG000|Overall Study|need for revision surgery|2|||
127620059|NCT01451424|459236454|FG000|Overall Study|Withdrawal by Subject|1|||
127620060|NCT01451424|459236455|FG001|Overall Study|Withdrawal by Subject|1|||
127620061|NCT01451424|459236456|FG002|Overall Study|Withdrawal by Subject|0|||
127620062|NCT01451424|459236457|FG003|Overall Study|Withdrawal by Subject|2|||
127620063|NCT01451424|459236454|FG000|Overall Study|Lost to Follow-up|0|||
127620064|NCT01451424|459236455|FG001|Overall Study|Lost to Follow-up|1|||
127620065|NCT01451424|459236456|FG002|Overall Study|Lost to Follow-up|0|||
127620066|NCT01451424|459236457|FG003|Overall Study|Lost to Follow-up|1|||
127620067|NCT01451424|459236454|FG000|Overall Study|Physician Decision|0|||
127620068|NCT01451424|459236455|FG001|Overall Study|Physician Decision|0|||
127620069|NCT01451424|459236456|FG002|Overall Study|Physician Decision|1|||
127620070|NCT01451424|459236457|FG003|Overall Study|Physician Decision|1|||
127620071|NCT01451424|459236454|FG000|Overall Study|Adverse Event|0|||
127620072|NCT01451424|459236455|FG001|Overall Study|Adverse Event|0|||
127620073|NCT01451424|459236456|FG002|Overall Study|Adverse Event|0|||
127620074|NCT01451424|459236457|FG003|Overall Study|Adverse Event|1|||
127620075|NCT00528528|459236459|FG000|Overall Study|Lost to Follow-up|0|||
127620076|NCT00528528|459236460|FG001|Overall Study|Lost to Follow-up|0|||
127620077|NCT00528528|459236461|FG002|Overall Study|Lost to Follow-up|1|||
127620078|NCT00528528|459236462|FG003|Overall Study|Lost to Follow-up|1|||
127620079|NCT00528528|459236459|FG000|Overall Study|Ineligible to continue the trial|0|||
127620080|NCT00528528|459236460|FG001|Overall Study|Ineligible to continue the trial|0|||
127620081|NCT00528528|459236461|FG002|Overall Study|Ineligible to continue the trial|0|||
127620082|NCT00528528|459236462|FG003|Overall Study|Ineligible to continue the trial|1|||
127620083|NCT00528528|459236459|FG000|Overall Study|Other|0|||
127620084|NCT00528528|459236460|FG001|Overall Study|Other|1|||
127700754|NCT05329220|459533085|FG005|Active Trial Period|Physician Decision|0|||
127620085|NCT00528528|459236461|FG002|Overall Study|Other|0|||
127620086|NCT00528528|459236462|FG003|Overall Study|Other|0|||
127620087|NCT00528528|459236459|FG000|Overall Study|Withdrawal by Subject|3|||
127620088|NCT00528528|459236460|FG001|Overall Study|Withdrawal by Subject|2|||
127620089|NCT00528528|459236461|FG002|Overall Study|Withdrawal by Subject|1|||
127620090|NCT00528528|459236462|FG003|Overall Study|Withdrawal by Subject|1|||
127620091|NCT00528528|459236459|FG000|Overall Study|Ongoing participant|0|||
127620092|NCT00528528|459236460|FG001|Overall Study|Ongoing participant|0|||
127620093|NCT00528528|459236461|FG002|Overall Study|Ongoing participant|1|||
127620094|NCT00528528|459236462|FG003|Overall Study|Ongoing participant|0|||
127620095|NCT04325828|459236463|FG000|Overall Study|Ongoing|26|||
127620096|NCT04602624|459236464|FG000|Overall Study|Protocol Deviation|1|||
127620097|NCT04602624|459236464|FG000|Overall Study|Withdrawal by Participant|1|||
127884681|NCT03674827|460202113|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
127884682|NCT03674827|460202114|FG005|Treatment Phase|Global Deterioration of Health Status|2|||
127884683|NCT03674827|460202109|FG000|Treatment Phase|Other|0|||
127884684|NCT03674827|460202110|FG001|Treatment Phase|Other|1|||
127884685|NCT03674827|460202111|FG002|Treatment Phase|Other|0|||
127884686|NCT03674827|460202112|FG003|Treatment Phase|Other|0|||
127884687|NCT03674827|460202113|FG004|Treatment Phase|Other|0|||
127884688|NCT03674827|460202114|FG005|Treatment Phase|Other|1|||
127884689|NCT03674827|460202109|FG000|Long-Term Follow-up Phase|Death|2|||
127884690|NCT03674827|460202110|FG001|Long-Term Follow-up Phase|Death|4|||
127620098|NCT03508219|459236465|FG000|Overall Study|Death|2|||
127620099|NCT03508219|459236465|FG000|Overall Study|Withdrawal by Subject|1|||
127884691|NCT03674827|460202111|FG002|Long-Term Follow-up Phase|Death|2|||
127620100|NCT03508219|459236465|FG000|Overall Study|Lost to Follow-up|4|||
127620101|NCT03508219|459236465|FG000|Overall Study|Missed visit|2|||
127620102|NCT04745689|459236468|FG000|Overall Study|Death|9|||
127620103|NCT04745689|459236469|FG001|Overall Study|Death|6|||
127620104|NCT04745689|459236468|FG000|Overall Study|Lost to Follow-up|1|||
127620105|NCT04745689|459236469|FG001|Overall Study|Lost to Follow-up|0|||
127620106|NCT04745689|459236468|FG000|Overall Study|Withdrawal by Subject|2|||
127620107|NCT04745689|459236469|FG001|Overall Study|Withdrawal by Subject|0|||
127620108|NCT04745689|459236468|FG000|Overall Study|Study terminated by sponsor|10|||
127620109|NCT04745689|459236469|FG001|Overall Study|Study terminated by sponsor|3|||
127620110|NCT03091192|459236470|FG000|Overall Study|Study terminated by sponsor|21|||
127620111|NCT03091192|459236471|FG001|Overall Study|Study terminated by sponsor|14|||
127620112|NCT03091192|459236470|FG000|Overall Study|Death|9|||
127620113|NCT03091192|459236471|FG001|Overall Study|Death|13|||
127620114|NCT03091192|459236470|FG000|Overall Study|Withdrawal by Subject|2|||
127620115|NCT03091192|459236471|FG001|Overall Study|Withdrawal by Subject|0|||
127620116|NCT03091192|459236470|FG000|Overall Study|Lost to Follow-up|1|||
127620117|NCT03091192|459236471|FG001|Overall Study|Lost to Follow-up|0|||
127642582|NCT04124926|459313074|FG002|Maintenance Phase|Randomized but not Treated|2|||
127642583|NCT04124926|459313075|FG003|Maintenance Phase|Randomized but not Treated|2|||
127884692|NCT03674827|460202112|FG003|Long-Term Follow-up Phase|Death|3|||
127884693|NCT03674827|460202113|FG004|Long-Term Follow-up Phase|Death|2|||
127884694|NCT03674827|460202114|FG005|Long-Term Follow-up Phase|Death|6|||
127884695|NCT03674827|460202109|FG000|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
127642584|NCT04124926|459313076|FG004|Maintenance Phase|Randomized but not Treated|0|||
127642585|NCT00423176|459313077|FG000|Overall Study|Adverse Event|4|||
127642586|NCT00423176|459313078|FG001|Overall Study|Adverse Event|6|||
127642587|NCT00423176|459313077|FG000|Overall Study|Treatment Failure|1|||
127642588|NCT00423176|459313078|FG001|Overall Study|Treatment Failure|6|||
127642589|NCT00423176|459313077|FG000|Overall Study|Lost to Follow-up|4|||
127642590|NCT00423176|459313078|FG001|Overall Study|Lost to Follow-up|7|||
127642591|NCT00423176|459313077|FG000|Overall Study|Withdrawal by Subject|4|||
127642592|NCT00423176|459313078|FG001|Overall Study|Withdrawal by Subject|3|||
127642593|NCT00423176|459313077|FG000|Overall Study|Protocol Violation|1|||
127642594|NCT00423176|459313078|FG001|Overall Study|Protocol Violation|3|||
127642595|NCT00423176|459313077|FG000|Overall Study|Did not meet protocol eligibility|2|||
127642596|NCT00423176|459313078|FG001|Overall Study|Did not meet protocol eligibility|4|||
127884696|NCT03674827|460202110|FG001|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
127884697|NCT03674827|460202111|FG002|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
127642597|NCT03152526|459313081|FG000|Overall Study|Withdrawal by Subject|0|||
127884698|NCT03674827|460202112|FG003|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
127884699|NCT03674827|460202113|FG004|Long-Term Follow-up Phase|Study Terminated by Sponsor|2|||
127884700|NCT03674827|460202114|FG005|Long-Term Follow-up Phase|Study Terminated by Sponsor|8|||
127642598|NCT03152526|459313082|FG001|Overall Study|Withdrawal by Subject|1|||
127642599|NCT04867369|459313083|FG000|Overall Study|Withdrawal by Subject|1|||
127642600|NCT04867369|459313084|FG001|Overall Study|Withdrawal by Subject|0|||
127642601|NCT05554237|459313085|FG000|Part 2 (7 Days)|Adverse Event|0|||
127642602|NCT05554237|459313086|FG001|Part 2 (7 Days)|Adverse Event|0|||
127642603|NCT05554237|459313087|FG002|Part 2 (7 Days)|Adverse Event|0|||
127642604|NCT05554237|459313088|FG003|Part 2 (7 Days)|Adverse Event|0|||
127642605|NCT05554237|459313089|FG004|Part 2 (7 Days)|Adverse Event|2|||
127884701|NCT03674827|460202109|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
127642606|NCT05554237|459313090|FG005|Part 2 (7 Days)|Adverse Event|0|||
127642607|NCT05554237|459313091|FG006|Part 2 (7 Days)|Adverse Event|0|||
127642608|NCT05554237|459313092|FG007|Part 2 (7 Days)|Adverse Event|0|||
127884702|NCT03674827|460202110|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
127620118|NCT02472756|459237657|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
127620119|NCT02472756|459237657|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
127620120|NCT02472756|459237657|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
127620121|NCT02472756|459237657|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
127620122|NCT02472756|459237657|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
127620123|NCT02143414|459237658|FG000|Induction|Adverse Event|1|||
127620124|NCT02143414|459237659|FG001|Induction|Adverse Event|2|||
127620125|NCT02143414|459237658|FG000|Induction|Death|1|||
127620126|NCT02143414|459237659|FG001|Induction|Death|2|||
127620127|NCT02143414|459237658|FG000|Induction|Patient refusal|1|||
127620128|NCT02143414|459237659|FG001|Induction|Patient refusal|1|||
127620129|NCT02143414|459237658|FG000|Induction|Refractory|1|||
127620130|NCT02143414|459237659|FG001|Induction|Refractory|0|||
127620131|NCT02143414|459237658|FG000|Induction|Began alternative treatment|1|||
127620132|NCT02143414|459237659|FG001|Induction|Began alternative treatment|0|||
127620133|NCT02143414|459237658|FG000|Induction|Ineligible for postremission|5|||
127620134|NCT02143414|459237659|FG001|Induction|Ineligible for postremission|1|||
127620135|NCT02143414|459237658|FG000|Post-remission|Adverse Event|0|||
127620136|NCT02143414|459237659|FG001|Post-remission|Adverse Event|2|||
127620137|NCT02143414|459237658|FG000|Post-remission|Disease progression/relapse|5|||
127620138|NCT02143414|459237659|FG001|Post-remission|Disease progression/relapse|0|||
127620139|NCT02143414|459237658|FG000|Maintenance|Adverse Event|4|||
127620140|NCT02143414|459237659|FG001|Maintenance|Adverse Event|6|||
127620141|NCT02143414|459237658|FG000|Maintenance|Disease progression/relapse|3|||
127620142|NCT02143414|459237659|FG001|Maintenance|Disease progression/relapse|2|||
127620143|NCT02143414|459237658|FG000|Maintenance|Patient refusal|2|||
127620144|NCT02143414|459237659|FG001|Maintenance|Patient refusal|1|||
127620145|NCT02143414|459237658|FG000|Maintenance|Physician Decision|1|||
127620146|NCT02143414|459237659|FG001|Maintenance|Physician Decision|0|||
127620147|NCT02143414|459237658|FG000|Maintenance|Death|0|||
127620148|NCT02143414|459237659|FG001|Maintenance|Death|1|||
127620149|NCT02143414|459237658|FG000|Maintenance|On protocol treatment|0|||
127620150|NCT02143414|459237659|FG001|Maintenance|On protocol treatment|6|||
127620151|NCT00110266|459237661|FG000|Overall Study|Adverse Event|27|||
127620152|NCT00110266|459237661|FG000|Overall Study|Abnormal laboratory value|15|||
127620153|NCT00110266|459237661|FG000|Overall Study|Withdrawal by Subject|16|||
127620154|NCT00110266|459237661|FG000|Overall Study|Death|17|||
127620155|NCT00110266|459237661|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
127620156|NCT00110266|459237661|FG000|Overall Study|Participant condition no longer requires study drug|1|||
127620157|NCT02896400|459237662|FG000|1 Month Follow-up|Lost to Follow-up|7|||
127620158|NCT02896400|459237663|FG001|1 Month Follow-up|Lost to Follow-up|7|||
127620159|NCT02896400|459237664|FG002|1 Month Follow-up|Lost to Follow-up|5|||
127620160|NCT02896400|459237665|FG003|1 Month Follow-up|Lost to Follow-up|8|||
127620161|NCT02896400|459237666|FG004|1 Month Follow-up|Lost to Follow-up|9|||
127620162|NCT02896400|459237667|FG005|1 Month Follow-up|Lost to Follow-up|6|||
127620163|NCT02896400|459237668|FG006|1 Month Follow-up|Lost to Follow-up|5|||
127620164|NCT02896400|459237669|FG007|1 Month Follow-up|Lost to Follow-up|6|||
127620165|NCT02896400|459237670|FG008|1 Month Follow-up|Lost to Follow-up|4|||
127620166|NCT02896400|459237671|FG009|1 Month Follow-up|Lost to Follow-up|7|||
127620167|NCT02896400|459237672|FG010|1 Month Follow-up|Lost to Follow-up|5|||
127620168|NCT02896400|459237673|FG011|1 Month Follow-up|Lost to Follow-up|5|||
127620169|NCT02896400|459237674|FG012|1 Month Follow-up|Lost to Follow-up|3|||
127620170|NCT02896400|459237675|FG013|1 Month Follow-up|Lost to Follow-up|4|||
127620171|NCT02896400|459237676|FG014|1 Month Follow-up|Lost to Follow-up|1|||
127620172|NCT02896400|459237677|FG015|1 Month Follow-up|Lost to Follow-up|2|||
127620173|NCT02896400|459237662|FG000|1 Month Follow-up|Death|0|||
127620174|NCT02896400|459237663|FG001|1 Month Follow-up|Death|0|||
127620175|NCT02896400|459237664|FG002|1 Month Follow-up|Death|0|||
127620176|NCT02896400|459237665|FG003|1 Month Follow-up|Death|0|||
127620177|NCT02896400|459237666|FG004|1 Month Follow-up|Death|0|||
127620178|NCT02896400|459237667|FG005|1 Month Follow-up|Death|0|||
127620179|NCT02896400|459237668|FG006|1 Month Follow-up|Death|0|||
127700755|NCT05329220|459533080|FG000|Active Trial Period|Protocol Violation|0|||
127620180|NCT02896400|459237669|FG007|1 Month Follow-up|Death|0|||
127620181|NCT02896400|459237670|FG008|1 Month Follow-up|Death|0|||
127620182|NCT02896400|459237671|FG009|1 Month Follow-up|Death|0|||
127620183|NCT02896400|459237672|FG010|1 Month Follow-up|Death|0|||
127620184|NCT02896400|459237673|FG011|1 Month Follow-up|Death|0|||
127620185|NCT02896400|459237674|FG012|1 Month Follow-up|Death|0|||
127620186|NCT02896400|459237675|FG013|1 Month Follow-up|Death|0|||
127620187|NCT02896400|459237676|FG014|1 Month Follow-up|Death|0|||
127620188|NCT02896400|459237677|FG015|1 Month Follow-up|Death|1|||
127620189|NCT02896400|459237662|FG000|3 Month Follow-up|Lost to Follow-up|6|||
127620190|NCT02896400|459237663|FG001|3 Month Follow-up|Lost to Follow-up|3|||
127620191|NCT02896400|459237664|FG002|3 Month Follow-up|Lost to Follow-up|6|||
127620192|NCT02896400|459237665|FG003|3 Month Follow-up|Lost to Follow-up|11|||
127620193|NCT02896400|459237666|FG004|3 Month Follow-up|Lost to Follow-up|12|||
127620194|NCT02896400|459237667|FG005|3 Month Follow-up|Lost to Follow-up|6|||
127700756|NCT05329220|459533081|FG001|Active Trial Period|Protocol Violation|0|||
127620195|NCT02896400|459237668|FG006|3 Month Follow-up|Lost to Follow-up|4|||
127620196|NCT02896400|459237669|FG007|3 Month Follow-up|Lost to Follow-up|3|||
127620197|NCT02896400|459237670|FG008|3 Month Follow-up|Lost to Follow-up|6|||
127620198|NCT02896400|459237671|FG009|3 Month Follow-up|Lost to Follow-up|5|||
127620199|NCT02896400|459237672|FG010|3 Month Follow-up|Lost to Follow-up|6|||
127620200|NCT02896400|459237673|FG011|3 Month Follow-up|Lost to Follow-up|6|||
127620201|NCT02896400|459237674|FG012|3 Month Follow-up|Lost to Follow-up|3|||
127620202|NCT02896400|459237675|FG013|3 Month Follow-up|Lost to Follow-up|5|||
127620203|NCT02896400|459237676|FG014|3 Month Follow-up|Lost to Follow-up|3|||
127620204|NCT02896400|459237677|FG015|3 Month Follow-up|Lost to Follow-up|2|||
127620205|NCT02896400|459237662|FG000|3 Month Follow-up|Death|0|||
127620206|NCT02896400|459237663|FG001|3 Month Follow-up|Death|0|||
127620207|NCT02896400|459237664|FG002|3 Month Follow-up|Death|0|||
127620208|NCT02896400|459237665|FG003|3 Month Follow-up|Death|0|||
127620209|NCT02896400|459237666|FG004|3 Month Follow-up|Death|0|||
127620210|NCT02896400|459237667|FG005|3 Month Follow-up|Death|0|||
127620211|NCT02896400|459237668|FG006|3 Month Follow-up|Death|0|||
127620212|NCT02896400|459237669|FG007|3 Month Follow-up|Death|0|||
127620213|NCT02896400|459237670|FG008|3 Month Follow-up|Death|0|||
127620214|NCT02896400|459237671|FG009|3 Month Follow-up|Death|0|||
127620215|NCT02896400|459237672|FG010|3 Month Follow-up|Death|0|||
127620216|NCT02896400|459237673|FG011|3 Month Follow-up|Death|0|||
127620217|NCT02896400|459237674|FG012|3 Month Follow-up|Death|0|||
127620218|NCT02896400|459237675|FG013|3 Month Follow-up|Death|1|||
127620219|NCT02896400|459237676|FG014|3 Month Follow-up|Death|1|||
127620220|NCT02896400|459237677|FG015|3 Month Follow-up|Death|0|||
127620221|NCT02896400|459237662|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
127620222|NCT02896400|459237663|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
127620223|NCT02896400|459237664|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
127620224|NCT02896400|459237665|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
127620225|NCT02896400|459237666|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
127620226|NCT02896400|459237667|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
127620227|NCT02896400|459237668|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
127620228|NCT02896400|459237669|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
127620229|NCT02896400|459237670|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
127620230|NCT02896400|459237671|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
127620231|NCT02896400|459237672|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
127620232|NCT02896400|459237673|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
127620233|NCT02896400|459237674|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
127620234|NCT02896400|459237675|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
127620235|NCT02896400|459237676|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
127620236|NCT02896400|459237677|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
127620237|NCT02896400|459237662|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
127620238|NCT02896400|459237663|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
127620239|NCT02896400|459237664|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
127620240|NCT02896400|459237665|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
127620241|NCT02896400|459237666|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
127620242|NCT02896400|459237667|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
127620243|NCT02896400|459237668|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
127620244|NCT02896400|459237669|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
127620245|NCT02896400|459237670|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
127620246|NCT02896400|459237671|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
127620247|NCT02896400|459237672|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
127620248|NCT02896400|459237673|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
127620249|NCT02896400|459237674|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
127620250|NCT02896400|459237675|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
127620251|NCT02896400|459237676|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
127620252|NCT02896400|459237677|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
127620253|NCT00679341|459237678|FG000|Overall Study|Disease progression|42|||
127620254|NCT00679341|459237679|FG001|Overall Study|Disease progression|36|||
127620255|NCT00679341|459237678|FG000|Overall Study|Adverse Event|5|||
127620256|NCT00679341|459237679|FG001|Overall Study|Adverse Event|6|||
127620257|NCT00679341|459237678|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
127620258|NCT00679341|459237679|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
127620259|NCT00679341|459237678|FG000|Overall Study|Death|1|||
127620260|NCT00679341|459237679|FG001|Overall Study|Death|1|||
127620261|NCT00679341|459237678|FG000|Overall Study|Other|1|||
127620262|NCT00679341|459237679|FG001|Overall Study|Other|0|||
127620263|NCT00679341|459237678|FG000|Overall Study|Physician Decision|1|||
127620264|NCT00679341|459237679|FG001|Overall Study|Physician Decision|0|||
127620265|NCT00679341|459237678|FG000|Overall Study|Not treated|0|||
127620266|NCT00679341|459237679|FG001|Overall Study|Not treated|2|||
127620267|NCT00679341|459237678|FG000|Overall Study|Physician/patient decision to withdraw|0|||
127620268|NCT00679341|459237679|FG001|Overall Study|Physician/patient decision to withdraw|6|||
127620269|NCT00326612|459237680|FG000|Overall Study|They did not have a seizure requiring tx|129|||
127620270|NCT00326612|459237681|FG001|Overall Study|They did not have a seizure requiring tx|137|||
127620271|NCT00548808|459237683|FG000|Overall Study|Lost to Follow-up|9|||
127620272|NCT00548808|459237684|FG001|Overall Study|Lost to Follow-up|3|||
127620273|NCT00548808|459237683|FG000|Overall Study|Protocol Violation|8|||
127620274|NCT00548808|459237684|FG001|Overall Study|Protocol Violation|8|||
127620275|NCT00548808|459237683|FG000|Overall Study|Withdrawal by Subject|8|||
127620276|NCT00548808|459237684|FG001|Overall Study|Withdrawal by Subject|4|||
127620277|NCT00548808|459237683|FG000|Overall Study|Physician Decision|6|||
127620278|NCT00548808|459237684|FG001|Overall Study|Physician Decision|3|||
127620279|NCT00548808|459237683|FG000|Overall Study|Adverse Event|4|||
127620280|NCT00548808|459237684|FG001|Overall Study|Adverse Event|5|||
127620281|NCT00548808|459237683|FG000|Overall Study|Death|2|||
127620282|NCT00548808|459237684|FG001|Overall Study|Death|0|||
127620283|NCT00548808|459237683|FG000|Overall Study|Entry Criteria Not Met|2|||
127620284|NCT00548808|459237684|FG001|Overall Study|Entry Criteria Not Met|2|||
127620285|NCT00548808|459237683|FG000|Overall Study|Lack of Efficacy|2|||
127620286|NCT00548808|459237684|FG001|Overall Study|Lack of Efficacy|0|||
127620287|NCT00548808|459237683|FG000|Overall Study|Sponsor Decision|1|||
127620288|NCT00548808|459237684|FG001|Overall Study|Sponsor Decision|1|||
127620289|NCT03912233|459237685|FG000|Overall Study|Adverse Event|1|||
127620290|NCT03912233|459237686|FG001|Overall Study|Adverse Event|0|||
127620291|NCT03912233|459237687|FG002|Overall Study|Adverse Event|0|||
127620292|NCT03912233|459237688|FG003|Overall Study|Adverse Event|0|||
127620293|NCT03912233|459237689|FG004|Overall Study|Adverse Event|0|||
127620294|NCT03912233|459237690|FG005|Overall Study|Adverse Event|0|||
127620295|NCT03912233|459237685|FG000|Overall Study|Physician Decision|1|||
127620296|NCT03912233|459237686|FG001|Overall Study|Physician Decision|0|||
127620297|NCT03912233|459237687|FG002|Overall Study|Physician Decision|0|||
127620298|NCT03912233|459237688|FG003|Overall Study|Physician Decision|0|||
127620299|NCT03912233|459237689|FG004|Overall Study|Physician Decision|0|||
127620300|NCT03912233|459237690|FG005|Overall Study|Physician Decision|0|||
127620301|NCT03912233|459237685|FG000|Overall Study|Other|0|||
127620302|NCT03912233|459237686|FG001|Overall Study|Other|0|||
127620303|NCT03912233|459237687|FG002|Overall Study|Other|0|||
127620304|NCT03912233|459237688|FG003|Overall Study|Other|0|||
127620305|NCT03912233|459237689|FG004|Overall Study|Other|7|||
127620306|NCT03912233|459237690|FG005|Overall Study|Other|12|||
127620307|NCT02177266|459237691|FG000|Overall Study|Adverse Event|0|||
127620308|NCT02177266|459237692|FG001|Overall Study|Adverse Event|1|||
127620309|NCT02177266|459237691|FG000|Overall Study|Withdrawal by Subject|1|||
127620310|NCT02177266|459237692|FG001|Overall Study|Withdrawal by Subject|0|||
127620311|NCT00546715|459237694|FG000|Overall Study|Withdrawal by Subject|0|||
127791618|NCT00876187|459860707|FG004|Overall Study|Withdrawal by Subject|37|||
127791619|NCT00876187|459860703|FG000|Overall Study|Entered extension study|101|||
127791620|NCT00876187|459860704|FG001|Overall Study|Entered extension study|120|||
127791621|NCT00876187|459860705|FG002|Overall Study|Entered extension study|156|||
127791622|NCT00876187|459860706|FG003|Overall Study|Entered extension study|151|||
127791623|NCT00876187|459860707|FG004|Overall Study|Entered extension study|144|||
127791624|NCT00876187|459860703|FG000|Overall Study|Randomized but not treated|3|||
127791625|NCT00876187|459860704|FG001|Overall Study|Randomized but not treated|1|||
127791626|NCT00876187|459860705|FG002|Overall Study|Randomized but not treated|3|||
127791627|NCT00876187|459860706|FG003|Overall Study|Randomized but not treated|2|||
127791628|NCT00876187|459860707|FG004|Overall Study|Randomized but not treated|3|||
127791629|NCT00876187|459860703|FG000|Overall Study|Other|2|||
127791630|NCT00876187|459860704|FG001|Overall Study|Other|5|||
127791631|NCT00876187|459860705|FG002|Overall Study|Other|9|||
127791632|NCT00876187|459860706|FG003|Overall Study|Other|7|||
127791633|NCT00876187|459860707|FG004|Overall Study|Other|4|||
127620312|NCT00546715|459237695|FG001|Overall Study|Withdrawal by Subject|1|||
127620313|NCT00546715|459237696|FG002|Overall Study|Withdrawal by Subject|0|||
127620314|NCT00546715|459237697|FG003|Overall Study|Withdrawal by Subject|0|||
127791634|NCT00405067|459860708|FG000|Overall Study|Adverse Event|4|||
127791635|NCT00405067|459860709|FG001|Overall Study|Adverse Event|9|||
127620315|NCT00723606|459237698|FG000|Overall Study|Adverse Event|2|||
127620316|NCT00723606|459237699|FG001|Overall Study|Adverse Event|5|||
127620317|NCT00723606|459237698|FG000|Overall Study|Other|2|||
127620318|NCT00723606|459237699|FG001|Overall Study|Other|0|||
127620319|NCT00723606|459237698|FG000|Overall Study|Withdrawal by Subject|0|||
127620320|NCT00723606|459237699|FG001|Overall Study|Withdrawal by Subject|2|||
127791636|NCT00405067|459860710|FG002|Overall Study|Adverse Event|4|||
127620321|NCT02365597|459237704|FG000|Overall Study|Lost to Follow-up|0|||
127620322|NCT02365597|459237705|FG001|Overall Study|Lost to Follow-up|1|||
127620323|NCT02365597|459237706|FG002|Overall Study|Lost to Follow-up|0|||
127791637|NCT00405067|459860708|FG000|Overall Study|Lost to Follow-up|0|||
127620324|NCT02365597|459237707|FG003|Overall Study|Lost to Follow-up|1|||
127620325|NCT02365597|459237704|FG000|Overall Study|Withdrawal by Subject|1|||
127620326|NCT02365597|459237705|FG001|Overall Study|Withdrawal by Subject|8|||
127620327|NCT02365597|459237706|FG002|Overall Study|Withdrawal by Subject|5|||
127620328|NCT02365597|459237707|FG003|Overall Study|Withdrawal by Subject|1|||
127620329|NCT02365597|459237704|FG000|Overall Study|Sponsor's decision|1|||
127620330|NCT02365597|459237705|FG001|Overall Study|Sponsor's decision|3|||
127620331|NCT02365597|459237706|FG002|Overall Study|Sponsor's decision|13|||
127620332|NCT02365597|459237707|FG003|Overall Study|Sponsor's decision|0|||
127620333|NCT02365597|459237704|FG000|Overall Study|Other|0|||
127620334|NCT02365597|459237705|FG001|Overall Study|Other|4|||
127620335|NCT02365597|459237706|FG002|Overall Study|Other|0|||
127620336|NCT02365597|459237707|FG003|Overall Study|Other|0|||
127620337|NCT02365597|459237704|FG000|Overall Study|Enrolled but not treated|0|||
127620338|NCT02365597|459237705|FG001|Overall Study|Enrolled but not treated|1|||
127620339|NCT02365597|459237706|FG002|Overall Study|Enrolled but not treated|1|||
127620340|NCT02365597|459237707|FG003|Overall Study|Enrolled but not treated|0|||
127620341|NCT02365597|459237704|FG000|Overall Study|Ongoing|0|||
127620342|NCT02365597|459237705|FG001|Overall Study|Ongoing|0|||
127620343|NCT02365597|459237706|FG002|Overall Study|Ongoing|0|||
127620344|NCT02365597|459237707|FG003|Overall Study|Ongoing|17|||
127620345|NCT01552226|459237708|FG000|Overall Study|Withdrawal by Subject|4|||
127620346|NCT01552226|459237709|FG001|Overall Study|Withdrawal by Subject|4|||
127620347|NCT01110915|459237710|FG000|Overall Study|Death|2|||
127620348|NCT01110915|459237711|FG001|Overall Study|Death|1|||
127620349|NCT01110915|459237710|FG000|Overall Study|Lost to Follow-up|1|||
127620350|NCT01110915|459237711|FG001|Overall Study|Lost to Follow-up|0|||
127620351|NCT01110915|459237710|FG000|Overall Study|Withdrawal by Subject|7|||
127620352|NCT01110915|459237711|FG001|Overall Study|Withdrawal by Subject|1|||
127620353|NCT05091528|459237712|FG000|Overall Study|Study Termination by Sponsor|0|||
127620354|NCT05091528|459237713|FG001|Overall Study|Study Termination by Sponsor|1|||
127620355|NCT05091528|459237714|FG002|Overall Study|Study Termination by Sponsor|0|||
127620356|NCT05091528|459237715|FG003|Overall Study|Study Termination by Sponsor|1|||
127620357|NCT03306264|459237719|FG000|Overall Study|Death|33|||
127620358|NCT03306264|459237720|FG001|Overall Study|Death|25|||
127620359|NCT03306264|459237721|FG002|Overall Study|Death|34|||
127620360|NCT03306264|459237722|FG003|Overall Study|Death|34|||
127620361|NCT03306264|459237719|FG000|Overall Study|Complete Consent Withdrawal|4|||
127620362|NCT03306264|459237720|FG001|Overall Study|Complete Consent Withdrawal|4|||
127620363|NCT03306264|459237721|FG002|Overall Study|Complete Consent Withdrawal|1|||
127620364|NCT03306264|459237722|FG003|Overall Study|Complete Consent Withdrawal|8|||
127620365|NCT03306264|459237719|FG000|Overall Study|Lost to Follow-up|1|||
127620366|NCT03306264|459237720|FG001|Overall Study|Lost to Follow-up|0|||
127620367|NCT03306264|459237721|FG002|Overall Study|Lost to Follow-up|1|||
127620368|NCT03306264|459237722|FG003|Overall Study|Lost to Follow-up|0|||
127620369|NCT03306264|459237719|FG000|Overall Study|Rollover to ASTX727-06|10|||
127620370|NCT03306264|459237720|FG001|Overall Study|Rollover to ASTX727-06|18|||
127620371|NCT03306264|459237721|FG002|Overall Study|Rollover to ASTX727-06|4|||
127620372|NCT03306264|459237722|FG003|Overall Study|Rollover to ASTX727-06|2|||
127620373|NCT03306264|459237719|FG000|Overall Study|Study Centre Terminated by Sponsor|21|||
127620374|NCT03306264|459237720|FG001|Overall Study|Study Centre Terminated by Sponsor|22|||
127620375|NCT03306264|459237721|FG002|Overall Study|Study Centre Terminated by Sponsor|4|||
127620376|NCT03306264|459237722|FG003|Overall Study|Study Centre Terminated by Sponsor|1|||
127620377|NCT00480779|459237723|FG000|Overall Study|Other|2|||
127620378|NCT00480779|459237724|FG001|Overall Study|Other|0|||
127620379|NCT00480779|459237723|FG000|Overall Study|Job and Health-related|0|||
127620380|NCT00480779|459237724|FG001|Overall Study|Job and Health-related|3|||
127620381|NCT02257736|459237735|FG000|Overall Study|Progressive disease|365|||
127620382|NCT02257736|459237736|FG001|Overall Study|Progressive disease|327|||
127620383|NCT02257736|459237735|FG000|Overall Study|Adverse Event|45|||
127620384|NCT02257736|459237736|FG001|Overall Study|Adverse Event|56|||
127620385|NCT02257736|459237735|FG000|Overall Study|Withdrawal by Subject|21|||
127620386|NCT02257736|459237736|FG001|Overall Study|Withdrawal by Subject|38|||
127620387|NCT02257736|459237735|FG000|Overall Study|Death|11|||
127620388|NCT02257736|459237736|FG001|Overall Study|Death|6|||
127884703|NCT03674827|460202111|FG002|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
127620389|NCT02257736|459237735|FG000|Overall Study|Physician Decision|5|||
127620390|NCT02257736|459237736|FG001|Overall Study|Physician Decision|9|||
127620391|NCT02257736|459237735|FG000|Overall Study|Non-Compliance with study drug|1|||
127620392|NCT02257736|459237736|FG001|Overall Study|Non-Compliance with study drug|2|||
127620393|NCT02257736|459237735|FG000|Overall Study|Protocol Violation|1|||
127620394|NCT02257736|459237736|FG001|Overall Study|Protocol Violation|0|||
127620395|NCT02257736|459237735|FG000|Overall Study|Other|1|||
127620396|NCT02257736|459237736|FG001|Overall Study|Other|7|||
127620397|NCT02257736|459237735|FG000|Overall Study|Randomized, not treated|1|||
127620398|NCT02257736|459237736|FG001|Overall Study|Randomized, not treated|2|||
127620399|NCT00308711|459237737|FG000|Overall Study|Withdrawal by Subject|1|||
127620400|NCT00308711|459237738|FG001|Overall Study|Withdrawal by Subject|0|||
127620401|NCT00308711|459237739|FG002|Overall Study|Withdrawal by Subject|1|||
127620402|NCT00308711|459237737|FG000|Overall Study|Protocol Violation|0|||
127620403|NCT00308711|459237738|FG001|Overall Study|Protocol Violation|1|||
127620404|NCT00308711|459237739|FG002|Overall Study|Protocol Violation|1|||
127620405|NCT00308711|459237737|FG000|Overall Study|Lost to Follow-up|0|||
127620406|NCT00308711|459237738|FG001|Overall Study|Lost to Follow-up|1|||
127620407|NCT00308711|459237739|FG002|Overall Study|Lost to Follow-up|0|||
127620408|NCT00308711|459237737|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
127620409|NCT00308711|459237738|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
127620410|NCT00308711|459237739|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
127620411|NCT00308711|459237737|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
127620412|NCT00308711|459237738|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
127620413|NCT00308711|459237739|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
127620414|NCT02167256|459237740|FG000|Overall Study|Adverse Event|13|||
127620415|NCT02167256|459237741|FG001|Overall Study|Adverse Event|6|||
127620416|NCT02167256|459237740|FG000|Overall Study|Withdrawal by Subject|4|||
127620417|NCT02167256|459237741|FG001|Overall Study|Withdrawal by Subject|4|||
127620418|NCT02167256|459237740|FG000|Overall Study|non-compliance|3|||
127620419|NCT02167256|459237741|FG001|Overall Study|non-compliance|0|||
127620420|NCT02167256|459237740|FG000|Overall Study|Study partner unable to participate|1|||
127620421|NCT02167256|459237741|FG001|Overall Study|Study partner unable to participate|0|||
127620422|NCT01420081|459237742|FG000|Overall Study|Death|1|||
127620423|NCT01420081|459237743|FG001|Overall Study|Death|0|||
127620424|NCT01420081|459237744|FG002|Overall Study|Death|8|||
127620425|NCT01420081|459237745|FG003|Overall Study|Death|0|||
127620426|NCT01420081|459237746|FG004|Overall Study|Death|7|||
127620427|NCT01420081|459237747|FG005|Overall Study|Death|12|||
127620428|NCT01420081|459237748|FG006|Overall Study|Death|0|||
127620429|NCT01420081|459237749|FG007|Overall Study|Death|1|||
127620430|NCT01420081|459237750|FG008|Overall Study|Death|1|||
127620431|NCT01420081|459237742|FG000|Overall Study|Lost to Follow-up|0|||
127620432|NCT01420081|459237743|FG001|Overall Study|Lost to Follow-up|0|||
127620433|NCT01420081|459237744|FG002|Overall Study|Lost to Follow-up|0|||
127620434|NCT01420081|459237745|FG003|Overall Study|Lost to Follow-up|0|||
127620435|NCT01420081|459237746|FG004|Overall Study|Lost to Follow-up|1|||
127620436|NCT01420081|459237747|FG005|Overall Study|Lost to Follow-up|1|||
127620437|NCT01420081|459237748|FG006|Overall Study|Lost to Follow-up|0|||
127620438|NCT01420081|459237749|FG007|Overall Study|Lost to Follow-up|0|||
127620439|NCT01420081|459237750|FG008|Overall Study|Lost to Follow-up|0|||
127620440|NCT01420081|459237742|FG000|Overall Study|Study Terminated by Sponsor|2|||
127620441|NCT01420081|459237743|FG001|Overall Study|Study Terminated by Sponsor|1|||
127620442|NCT01420081|459237744|FG002|Overall Study|Study Terminated by Sponsor|1|||
127620443|NCT01420081|459237745|FG003|Overall Study|Study Terminated by Sponsor|3|||
127620444|NCT01420081|459237746|FG004|Overall Study|Study Terminated by Sponsor|11|||
127620445|NCT01420081|459237747|FG005|Overall Study|Study Terminated by Sponsor|7|||
127620446|NCT01420081|459237748|FG006|Overall Study|Study Terminated by Sponsor|3|||
127620447|NCT01420081|459237749|FG007|Overall Study|Study Terminated by Sponsor|2|||
127620448|NCT01420081|459237750|FG008|Overall Study|Study Terminated by Sponsor|2|||
127620449|NCT01420081|459237742|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
127620450|NCT01420081|459237743|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
127620451|NCT01420081|459237744|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
127620452|NCT01420081|459237745|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
127620453|NCT01420081|459237746|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
127620454|NCT01420081|459237747|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
127620455|NCT01420081|459237748|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
127620456|NCT01420081|459237749|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
127620457|NCT01420081|459237750|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
127620458|NCT01420081|459237742|FG000|Overall Study|Other Reasons|0|||
127700757|NCT05329220|459533082|FG002|Active Trial Period|Protocol Violation|0|||
127700758|NCT05329220|459533083|FG003|Active Trial Period|Protocol Violation|0|||
127700759|NCT05329220|459533084|FG004|Active Trial Period|Protocol Violation|1|||
127700760|NCT05329220|459533085|FG005|Active Trial Period|Protocol Violation|3|||
127700761|NCT05329220|459533080|FG000|Active Trial Period|Withdrawal by Subject|0|||
127700762|NCT05329220|459533081|FG001|Active Trial Period|Withdrawal by Subject|0|||
127700763|NCT05329220|459533082|FG002|Active Trial Period|Withdrawal by Subject|0|||
127884704|NCT03674827|460202112|FG003|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
127884705|NCT03674827|460202113|FG004|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
127884706|NCT03674827|460202114|FG005|Long-Term Follow-up Phase|Withdrawal by Subject|2|||
127620459|NCT01420081|459237743|FG001|Overall Study|Other Reasons|0|||
127620460|NCT01420081|459237744|FG002|Overall Study|Other Reasons|1|||
127620461|NCT01420081|459237745|FG003|Overall Study|Other Reasons|0|||
127620462|NCT01420081|459237746|FG004|Overall Study|Other Reasons|0|||
127620463|NCT01420081|459237747|FG005|Overall Study|Other Reasons|0|||
127620464|NCT01420081|459237748|FG006|Overall Study|Other Reasons|0|||
127620465|NCT01420081|459237749|FG007|Overall Study|Other Reasons|0|||
127620466|NCT01420081|459237750|FG008|Overall Study|Other Reasons|0|||
127620467|NCT03431350|459237753|FG000|Overall Study|ONGOING|0|||
127700764|NCT05329220|459533083|FG003|Active Trial Period|Withdrawal by Subject|1|||
127620468|NCT03431350|459237754|FG001|Overall Study|ONGOING|0|||
127620469|NCT03431350|459237755|FG002|Overall Study|ONGOING|2|||
127620470|NCT03431350|459237756|FG003|Overall Study|ONGOING|0|||
127620471|NCT03431350|459237757|FG004|Overall Study|ONGOING|1|||
127620472|NCT03431350|459237758|FG005|Overall Study|ONGOING|3|||
127620473|NCT03431350|459237759|FG006|Overall Study|ONGOING|0|||
127620474|NCT03431350|459237760|FG007|Overall Study|ONGOING|1|||
127620475|NCT03431350|459237761|FG008|Overall Study|ONGOING|3|||
127620476|NCT03431350|459237762|FG009|Overall Study|ONGOING|4|||
127620477|NCT03431350|459237763|FG010|Overall Study|ONGOING|2|||
127620478|NCT03431350|459237764|FG011|Overall Study|ONGOING|1|||
127620479|NCT03431350|459237753|FG000|Overall Study|Death|6|||
127620480|NCT03431350|459237754|FG001|Overall Study|Death|5|||
127620481|NCT03431350|459237755|FG002|Overall Study|Death|18|||
127620482|NCT03431350|459237756|FG003|Overall Study|Death|7|||
127620483|NCT03431350|459237757|FG004|Overall Study|Death|4|||
127620484|NCT03431350|459237758|FG005|Overall Study|Death|3|||
127620485|NCT03431350|459237759|FG006|Overall Study|Death|2|||
127620486|NCT03431350|459237760|FG007|Overall Study|Death|0|||
127620487|NCT03431350|459237761|FG008|Overall Study|Death|0|||
127620488|NCT03431350|459237762|FG009|Overall Study|Death|0|||
127620489|NCT03431350|459237763|FG010|Overall Study|Death|4|||
127620490|NCT03431350|459237764|FG011|Overall Study|Death|0|||
127620491|NCT03431350|459237753|FG000|Overall Study|Lost to Follow-up|0|||
127620492|NCT03431350|459237754|FG001|Overall Study|Lost to Follow-up|1|||
127620493|NCT03431350|459237755|FG002|Overall Study|Lost to Follow-up|0|||
127620494|NCT03431350|459237756|FG003|Overall Study|Lost to Follow-up|0|||
127620495|NCT03431350|459237757|FG004|Overall Study|Lost to Follow-up|0|||
127620496|NCT03431350|459237758|FG005|Overall Study|Lost to Follow-up|0|||
127620497|NCT03431350|459237759|FG006|Overall Study|Lost to Follow-up|0|||
127620498|NCT03431350|459237760|FG007|Overall Study|Lost to Follow-up|0|||
127620499|NCT03431350|459237761|FG008|Overall Study|Lost to Follow-up|0|||
127620500|NCT03431350|459237762|FG009|Overall Study|Lost to Follow-up|0|||
127620501|NCT03431350|459237763|FG010|Overall Study|Lost to Follow-up|0|||
127620502|NCT03431350|459237764|FG011|Overall Study|Lost to Follow-up|0|||
127620503|NCT03431350|459237753|FG000|Overall Study|Withdrawal by Subject|0|||
127620504|NCT03431350|459237754|FG001|Overall Study|Withdrawal by Subject|0|||
127620505|NCT03431350|459237755|FG002|Overall Study|Withdrawal by Subject|0|||
127620506|NCT03431350|459237756|FG003|Overall Study|Withdrawal by Subject|1|||
127620507|NCT03431350|459237757|FG004|Overall Study|Withdrawal by Subject|1|||
127620508|NCT03431350|459237758|FG005|Overall Study|Withdrawal by Subject|1|||
127620509|NCT03431350|459237759|FG006|Overall Study|Withdrawal by Subject|0|||
127620510|NCT03431350|459237760|FG007|Overall Study|Withdrawal by Subject|0|||
127620511|NCT03431350|459237761|FG008|Overall Study|Withdrawal by Subject|0|||
127620512|NCT03431350|459237762|FG009|Overall Study|Withdrawal by Subject|2|||
127620513|NCT03431350|459237763|FG010|Overall Study|Withdrawal by Subject|0|||
127620514|NCT03431350|459237764|FG011|Overall Study|Withdrawal by Subject|1|||
127620515|NCT03431350|459237753|FG000|Overall Study|Other|0|||
127620516|NCT03431350|459237754|FG001|Overall Study|Other|0|||
127620517|NCT03431350|459237755|FG002|Overall Study|Other|1|||
127791638|NCT00405067|459860709|FG001|Overall Study|Lost to Follow-up|0|||
127620518|NCT03431350|459237756|FG003|Overall Study|Other|3|||
127620519|NCT03431350|459237757|FG004|Overall Study|Other|2|||
127620520|NCT03431350|459237758|FG005|Overall Study|Other|2|||
127620521|NCT03431350|459237759|FG006|Overall Study|Other|4|||
127620522|NCT03431350|459237760|FG007|Overall Study|Other|0|||
127620523|NCT03431350|459237761|FG008|Overall Study|Other|14|||
127620524|NCT03431350|459237762|FG009|Overall Study|Other|11|||
127620525|NCT03431350|459237763|FG010|Overall Study|Other|11|||
127791639|NCT00405067|459860710|FG002|Overall Study|Lost to Follow-up|1|||
127620526|NCT03431350|459237764|FG011|Overall Study|Other|15|||
127620527|NCT00414388|459237765|FG000|Overall Study|Adverse Event|1|||
127620528|NCT03591575|459237767|FG000|Overall Study|Adverse Event|2|||
127620529|NCT03591575|459237768|FG001|Overall Study|Adverse Event|0|||
127620530|NCT03591575|459237767|FG000|Overall Study|Withdrawal by Subject|4|||
127620531|NCT03591575|459237768|FG001|Overall Study|Withdrawal by Subject|1|||
127620532|NCT03945981|459237769|FG000|Overall Study|Lost to Follow-up|12|||
127620533|NCT03945981|459237769|FG000|Overall Study|Physician Decision|4|||
127620534|NCT03945981|459237769|FG000|Overall Study|Withdrawal by Subject|6|||
127620535|NCT03945981|459237769|FG000|Overall Study|Protocol Violation|1|||
127620536|NCT03665038|459237770|FG000|Overall Study|Lost to Follow-up|0|||
127620537|NCT03665038|459237771|FG001|Overall Study|Lost to Follow-up|0|||
127620538|NCT03665038|459237772|FG002|Overall Study|Lost to Follow-up|1|||
127620539|NCT04579679|459237773|FG000|Overall Study|New Antitumor Therapy|6|||
127620540|NCT04579679|459237774|FG001|Overall Study|New Antitumor Therapy|4|||
127620541|NCT04579679|459237775|FG002|Overall Study|New Antitumor Therapy|7|||
127620542|NCT04579679|459237776|FG003|Overall Study|New Antitumor Therapy|0|||
127620543|NCT04579679|459237773|FG000|Overall Study|Withdrawal of Consent|1|||
127620544|NCT04579679|459237774|FG001|Overall Study|Withdrawal of Consent|1|||
127620545|NCT04579679|459237775|FG002|Overall Study|Withdrawal of Consent|2|||
127620546|NCT04579679|459237776|FG003|Overall Study|Withdrawal of Consent|4|||
127791640|NCT01560780|459860711|FG000|Overall Study|Death|2|||
127620547|NCT04579679|459237773|FG000|Overall Study|Death|2|||
127620548|NCT04579679|459237774|FG001|Overall Study|Death|2|||
127620549|NCT04579679|459237775|FG002|Overall Study|Death|2|||
127620550|NCT04579679|459237776|FG003|Overall Study|Death|0|||
127620551|NCT04579679|459237773|FG000|Overall Study|Adverse Event|0|||
127620552|NCT04579679|459237774|FG001|Overall Study|Adverse Event|4|||
127620553|NCT04579679|459237775|FG002|Overall Study|Adverse Event|0|||
127620554|NCT04579679|459237776|FG003|Overall Study|Adverse Event|0|||
127620555|NCT04579679|459237773|FG000|Overall Study|Disease Progression|9|||
127620556|NCT04579679|459237774|FG001|Overall Study|Disease Progression|13|||
127620557|NCT04579679|459237775|FG002|Overall Study|Disease Progression|7|||
127620558|NCT04579679|459237776|FG003|Overall Study|Disease Progression|0|||
127620559|NCT04579679|459237773|FG000|Overall Study|Physician Decision|0|||
127620560|NCT04579679|459237774|FG001|Overall Study|Physician Decision|0|||
127620561|NCT04579679|459237775|FG002|Overall Study|Physician Decision|1|||
127620562|NCT04579679|459237776|FG003|Overall Study|Physician Decision|0|||
127620563|NCT04579679|459237773|FG000|Overall Study|Study Terminated by Sponsor|2|||
127620564|NCT04579679|459237774|FG001|Overall Study|Study Terminated by Sponsor|7|||
127620565|NCT04579679|459237775|FG002|Overall Study|Study Terminated by Sponsor|1|||
127620566|NCT04579679|459237776|FG003|Overall Study|Study Terminated by Sponsor|0|||
127620567|NCT04487080|459237779|FG000|Overall Study|Withdrawal by Subject|19|||
127620568|NCT04487080|459237780|FG001|Overall Study|Withdrawal by Subject|18|||
127620569|NCT04487080|459237781|FG002|Overall Study|Withdrawal by Subject|13|||
127620570|NCT04487080|459237779|FG000|Overall Study|Lost to Follow-up|3|||
127620571|NCT04487080|459237780|FG001|Overall Study|Lost to Follow-up|1|||
127620572|NCT04487080|459237781|FG002|Overall Study|Lost to Follow-up|0|||
127620573|NCT04487080|459237779|FG000|Overall Study|Ongoing|313|||
127620574|NCT04487080|459237780|FG001|Overall Study|Ongoing|297|||
127620575|NCT04487080|459237781|FG002|Overall Study|Ongoing|149|||
127620576|NCT05645432|459237782|FG000|Overall Study|Withdrawal by Subject|1|||
127620577|NCT03195478|459237783|FG000|Overall Study|Disease Progression|5|||
127620578|NCT03195478|459237784|FG001|Overall Study|Disease Progression|4|||
127620579|NCT03195478|459237785|FG002|Overall Study|Disease Progression|6|||
127620580|NCT03195478|459237786|FG003|Overall Study|Disease Progression|1|||
127620581|NCT03195478|459237783|FG000|Overall Study|Study Drug Toxicity|2|||
127620582|NCT03195478|459237784|FG001|Overall Study|Study Drug Toxicity|0|||
127620583|NCT03195478|459237785|FG002|Overall Study|Study Drug Toxicity|0|||
127620584|NCT03195478|459237786|FG003|Overall Study|Study Drug Toxicity|1|||
127620585|NCT03195478|459237783|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
127620586|NCT03195478|459237784|FG001|Overall Study|Participant requested to discontinue study treatment|1|||
127620587|NCT03195478|459237785|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
127620588|NCT03195478|459237786|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
127620589|NCT03195478|459237783|FG000|Overall Study|Participant Withdrew Consent|1|||
127620590|NCT03195478|459237784|FG001|Overall Study|Participant Withdrew Consent|0|||
127620591|NCT03195478|459237785|FG002|Overall Study|Participant Withdrew Consent|0|||
127620592|NCT03195478|459237786|FG003|Overall Study|Participant Withdrew Consent|0|||
127620593|NCT03195478|459237783|FG000|Overall Study|Maximum Clinical benefit|0|||
127620594|NCT03195478|459237784|FG001|Overall Study|Maximum Clinical benefit|0|||
127620595|NCT03195478|459237785|FG002|Overall Study|Maximum Clinical benefit|1|||
127620596|NCT03195478|459237786|FG003|Overall Study|Maximum Clinical benefit|0|||
127620597|NCT03195478|459237783|FG000|Overall Study|Other Reasons|0|||
127620598|NCT03195478|459237784|FG001|Overall Study|Other Reasons|0|||
127620599|NCT03195478|459237785|FG002|Overall Study|Other Reasons|1|||
127620600|NCT03195478|459237786|FG003|Overall Study|Other Reasons|0|||
127620601|NCT03890367|459237787|FG000|Overall Study|Withdrawal by parent/guardian|1|||
127620602|NCT03890367|459237788|FG001|Overall Study|Withdrawal by parent/guardian|3|||
127620603|NCT03890367|459237789|FG002|Overall Study|Withdrawal by parent/guardian|0|||
127620604|NCT03890367|459237787|FG000|Overall Study|Protocol deviation|2|||
127620605|NCT03890367|459237788|FG001|Overall Study|Protocol deviation|2|||
127620606|NCT03890367|459237789|FG002|Overall Study|Protocol deviation|1|||
127884707|NCT01783483|460202115|FG000|Overall Study|Death|3|||
127620607|NCT03890367|459237787|FG000|Overall Study|Lost to Follow-up|1|||
127620608|NCT03890367|459237788|FG001|Overall Study|Lost to Follow-up|1|||
127620609|NCT03890367|459237789|FG002|Overall Study|Lost to Follow-up|0|||
127620610|NCT03370341|459239186|FG000|Overall Study|Lost to Follow-up|0|||
127620611|NCT03370341|459239187|FG001|Overall Study|Lost to Follow-up|1|||
127620612|NCT01707004|459239190|FG000|Overall Study|Physician Decision|3|||
127620613|NCT00533949|459239191|FG000|Overall Study|Protocol Violation|12|||
127620614|NCT00533949|459239192|FG001|Overall Study|Protocol Violation|12|||
127620615|NCT00533949|459239193|FG002|Overall Study|Protocol Violation|9|||
127620616|NCT00533949|459239194|FG003|Overall Study|Protocol Violation|9|||
127620617|NCT00533949|459239191|FG000|Overall Study|Withdrawal by Subject|3|||
127620618|NCT00533949|459239192|FG001|Overall Study|Withdrawal by Subject|2|||
127620619|NCT00533949|459239193|FG002|Overall Study|Withdrawal by Subject|1|||
127620620|NCT00533949|459239194|FG003|Overall Study|Withdrawal by Subject|1|||
127620621|NCT00727194|459239195|FG000|Screening Period|Low QMG scores|0|||
127620622|NCT00727194|459239196|FG001|Screening Period|Low QMG scores|0|||
127620623|NCT00727194|459239197|FG002|Screening Period|Low QMG scores|6|||
127620624|NCT00727194|459239195|FG000|Screening Period|Lacked AChR antibodies|0|||
127620625|NCT00727194|459239196|FG001|Screening Period|Lacked AChR antibodies|0|||
127620626|NCT00727194|459239197|FG002|Screening Period|Lacked AChR antibodies|5|||
127620627|NCT00727194|459239195|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
127620628|NCT00727194|459239196|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
127620629|NCT00727194|459239197|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
127620630|NCT00727194|459239195|FG000|Screening Period|Severe infections|0|||
127620631|NCT00727194|459239196|FG001|Screening Period|Severe infections|0|||
127620632|NCT00727194|459239197|FG002|Screening Period|Severe infections|2|||
127620633|NCT00727194|459239195|FG000|Screening Period|History of thymoma|0|||
127620634|NCT00727194|459239196|FG001|Screening Period|History of thymoma|0|||
127620635|NCT00727194|459239197|FG002|Screening Period|History of thymoma|1|||
127620636|NCT00727194|459239195|FG000|Treatment Period 2|Lack of Efficacy|0|||
127620637|NCT00727194|459239196|FG001|Treatment Period 2|Lack of Efficacy|1|||
127620638|NCT00727194|459239197|FG002|Treatment Period 2|Lack of Efficacy|0|||
127620639|NCT04269161|459239203|FG000|Overall Study|Change of modality and no longer eligible|3|||
127620640|NCT04269161|459239204|FG001|Overall Study|Change of modality and no longer eligible|3|||
127620641|NCT04269161|459239203|FG000|Overall Study|Required procedure outside of NICU|1|||
127620642|NCT04269161|459239204|FG001|Overall Study|Required procedure outside of NICU|0|||
127620643|NCT04269161|459239203|FG000|Overall Study|Equipment issue|1|||
127620644|NCT04269161|459239204|FG001|Overall Study|Equipment issue|1|||
127620645|NCT01677195|459239205|FG000|Overall Study|Lost to Follow-up|14|||
127620646|NCT01677195|459239206|FG001|Overall Study|Lost to Follow-up|22|||
127620647|NCT01677195|459239207|FG002|Overall Study|Lost to Follow-up|22|||
127620648|NCT01677195|459239205|FG000|Overall Study|Withdrawal by Subject|1|||
127620649|NCT01677195|459239206|FG001|Overall Study|Withdrawal by Subject|0|||
127620650|NCT01677195|459239207|FG002|Overall Study|Withdrawal by Subject|1|||
127620651|NCT01677195|459239205|FG000|Overall Study|Adverse Event|6|||
127620652|NCT01677195|459239206|FG001|Overall Study|Adverse Event|4|||
127620653|NCT01677195|459239207|FG002|Overall Study|Adverse Event|1|||
127620654|NCT01677195|459239205|FG000|Overall Study|Physician Decision|1|||
127620655|NCT01677195|459239206|FG001|Overall Study|Physician Decision|2|||
127620656|NCT01677195|459239207|FG002|Overall Study|Physician Decision|2|||
127620657|NCT01677195|459239205|FG000|Overall Study|Pregnancy|0|||
127620658|NCT01677195|459239206|FG001|Overall Study|Pregnancy|1|||
127620659|NCT01677195|459239207|FG002|Overall Study|Pregnancy|0|||
127620660|NCT01677195|459239205|FG000|Overall Study|Protocol Violation|7|||
127620661|NCT01677195|459239206|FG001|Overall Study|Protocol Violation|3|||
127620662|NCT01677195|459239207|FG002|Overall Study|Protocol Violation|4|||
127620663|NCT04368429|459239208|FG000|Overall Study|Adverse Event|1|||
127620664|NCT04368429|459239209|FG001|Overall Study|Adverse Event|0|||
127620665|NCT00634647|459239214|FG000|Overall Study|death on study|3|||
127620666|NCT00634647|459239214|FG000|Overall Study|refused further treatment|3|||
127620667|NCT00634647|459239214|FG000|Overall Study|declined to participate before treatment|1|||
127620668|NCT02984020|459239215|FG000|Overall Study|Experienced off-label use against Xeljanz local product document|21|||
127620669|NCT02984020|459239215|FG000|Overall Study|Not met the inclusion/exclusion criterion|9|||
127620670|NCT02984020|459239215|FG000|Overall Study|Other significant protocol violation|2|||
127620671|NCT01700179|459239217|FG000|Overall Study|Physician Decision|2|||
127620672|NCT00667342|459239218|FG000|Overall Study|Protocol Violation|1|||
127620673|NCT00667342|459239219|FG001|Overall Study|Protocol Violation|0|||
127620674|NCT00667342|459239220|FG002|Overall Study|Protocol Violation|0|||
127620675|NCT00667342|459239218|FG000|Overall Study|Withdrawal by Subject|1|||
127620676|NCT00667342|459239219|FG001|Overall Study|Withdrawal by Subject|0|||
127620677|NCT00667342|459239220|FG002|Overall Study|Withdrawal by Subject|0|||
127620678|NCT00667342|459239218|FG000|Overall Study|Physician Decision|3|||
127620679|NCT00667342|459239219|FG001|Overall Study|Physician Decision|0|||
127620680|NCT00667342|459239220|FG002|Overall Study|Physician Decision|0|||
127620681|NCT00667342|459239218|FG000|Overall Study|Relapse or tumor progression|9|||
127791641|NCT01560780|459860712|FG001|Overall Study|Death|1|||
127791642|NCT01560780|459860711|FG000|Overall Study|Patient Preference|11|||
127791643|NCT01560780|459860712|FG001|Overall Study|Patient Preference|11|||
127791644|NCT01032915|459860713|FG000|Overall Study|Adverse Event|2|||
127791645|NCT01032915|459860714|FG001|Overall Study|Adverse Event|2|||
127791646|NCT01032915|459860715|FG002|Overall Study|Adverse Event|1|||
127620682|NCT00667342|459239219|FG001|Overall Study|Relapse or tumor progression|0|||
127620683|NCT00667342|459239220|FG002|Overall Study|Relapse or tumor progression|7|||
127620684|NCT00667342|459239218|FG000|Overall Study|Adverse Event|0|||
127791647|NCT01032915|459860716|FG003|Overall Study|Adverse Event|1|||
127620685|NCT00667342|459239219|FG001|Overall Study|Adverse Event|0|||
127620686|NCT00667342|459239220|FG002|Overall Study|Adverse Event|1|||
127620687|NCT00667342|459239218|FG000|Overall Study|Ineligible|0|||
127620688|NCT00667342|459239219|FG001|Overall Study|Ineligible|0|||
127620689|NCT00667342|459239220|FG002|Overall Study|Ineligible|1|||
127620690|NCT01207778|459239221|FG000|Overall Study|Lost to Follow-up|0|||
127620691|NCT01207778|459239222|FG001|Overall Study|Lost to Follow-up|3|||
127620692|NCT01207778|459239223|FG002|Overall Study|Lost to Follow-up|3|||
127620693|NCT00646204|459239224|FG000|Overall Study|Adverse Event|3|||
127620694|NCT00646204|459239225|FG001|Overall Study|Adverse Event|0|||
127620695|NCT00646204|459239224|FG000|Overall Study|Withdrawal by Subject|1|||
127620696|NCT00646204|459239225|FG001|Overall Study|Withdrawal by Subject|0|||
127620697|NCT00953329|459239231|FG000|Overall Study|Lack of Efficacy|1|||
127620698|NCT02477020|459239234|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
127620699|NCT02477020|459239235|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
127620700|NCT02477020|459239234|FG000|Overall Study|Voluntary Withdrawal|7|||
127620701|NCT02477020|459239235|FG001|Overall Study|Voluntary Withdrawal|16|||
127620702|NCT02477020|459239234|FG000|Overall Study|Reason not Specified|3|||
127620703|NCT02477020|459239235|FG001|Overall Study|Reason not Specified|1|||
127620704|NCT02477020|459239234|FG000|Overall Study|Lack of Efficacy|14|||
127620705|NCT02477020|459239235|FG001|Overall Study|Lack of Efficacy|5|||
127620706|NCT01340976|459239237|FG000|Overall Study|Physician Decision|2|||
127620707|NCT01340976|459239238|FG001|Overall Study|Physician Decision|0|||
127620708|NCT01340976|459239239|FG002|Overall Study|Physician Decision|1|||
127620709|NCT01340976|459239240|FG003|Overall Study|Physician Decision|1|||
127620710|NCT01340976|459239241|FG004|Overall Study|Physician Decision|1|||
127620711|NCT01340976|459239242|FG005|Overall Study|Physician Decision|0|||
127620712|NCT01340976|459239237|FG000|Overall Study|Death|0|||
127620713|NCT01340976|459239238|FG001|Overall Study|Death|1|||
127620714|NCT01340976|459239239|FG002|Overall Study|Death|0|||
127620715|NCT01340976|459239240|FG003|Overall Study|Death|0|||
127620716|NCT01340976|459239241|FG004|Overall Study|Death|0|||
127620717|NCT01340976|459239242|FG005|Overall Study|Death|0|||
127620718|NCT01340976|459239237|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
127620719|NCT01340976|459239238|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
127620720|NCT01340976|459239239|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
127620721|NCT01340976|459239240|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
127620722|NCT01340976|459239241|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
127620723|NCT01340976|459239242|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
127620724|NCT01340976|459239237|FG000|Overall Study|Withdrawal by Subject|0|||
127620725|NCT01340976|459239238|FG001|Overall Study|Withdrawal by Subject|0|||
127620726|NCT01340976|459239239|FG002|Overall Study|Withdrawal by Subject|0|||
127620727|NCT01340976|459239240|FG003|Overall Study|Withdrawal by Subject|1|||
127620728|NCT01340976|459239241|FG004|Overall Study|Withdrawal by Subject|1|||
127620729|NCT01340976|459239242|FG005|Overall Study|Withdrawal by Subject|0|||
127620730|NCT01340976|459239237|FG000|Overall Study|Other anemia treatment|1|||
127620731|NCT01340976|459239238|FG001|Overall Study|Other anemia treatment|0|||
127620732|NCT01340976|459239239|FG002|Overall Study|Other anemia treatment|2|||
127620733|NCT01340976|459239240|FG003|Overall Study|Other anemia treatment|1|||
127620734|NCT01340976|459239241|FG004|Overall Study|Other anemia treatment|0|||
127620735|NCT01340976|459239242|FG005|Overall Study|Other anemia treatment|1|||
127620736|NCT01340976|459239237|FG000|Overall Study|Adverse Event|0|||
127620737|NCT01340976|459239238|FG001|Overall Study|Adverse Event|1|||
127620738|NCT01340976|459239239|FG002|Overall Study|Adverse Event|0|||
127620739|NCT01340976|459239240|FG003|Overall Study|Adverse Event|0|||
127620740|NCT01340976|459239241|FG004|Overall Study|Adverse Event|0|||
127620741|NCT01340976|459239242|FG005|Overall Study|Adverse Event|0|||
127620742|NCT03670810|459239251|FG000|Main Study|Adverse Event|37|||
127620743|NCT03670810|459239252|FG001|Main Study|Adverse Event|38|||
127620744|NCT03670810|459239253|FG002|Main Study|Adverse Event|3|||
127620745|NCT03670810|459239254|FG003|Main Study|Adverse Event|4|||
127620746|NCT03670810|459239255|FG004|Main Study|Adverse Event|4|||
127620747|NCT03670810|459239256|FG005|Main Study|Adverse Event|5|||
127620748|NCT03670810|459239257|FG006|Main Study|Adverse Event|0|||
127620749|NCT03670810|459239258|FG007|Main Study|Adverse Event|0|||
127620750|NCT03670810|459239259|FG008|Main Study|Adverse Event|0|||
127620751|NCT03670810|459239251|FG000|Main Study|Lack of Efficacy|8|||
127620752|NCT03670810|459239252|FG001|Main Study|Lack of Efficacy|9|||
127620753|NCT03670810|459239253|FG002|Main Study|Lack of Efficacy|3|||
127620754|NCT03670810|459239254|FG003|Main Study|Lack of Efficacy|4|||
127620755|NCT03670810|459239255|FG004|Main Study|Lack of Efficacy|0|||
127700765|NCT05329220|459533084|FG004|Active Trial Period|Withdrawal by Subject|12|||
127620756|NCT03670810|459239256|FG005|Main Study|Lack of Efficacy|0|||
127620757|NCT03670810|459239257|FG006|Main Study|Lack of Efficacy|0|||
127620758|NCT03670810|459239258|FG007|Main Study|Lack of Efficacy|0|||
127620759|NCT03670810|459239259|FG008|Main Study|Lack of Efficacy|0|||
127620760|NCT03670810|459239251|FG000|Main Study|Lost to Follow-up|9|||
127620761|NCT03670810|459239252|FG001|Main Study|Lost to Follow-up|7|||
127620762|NCT03670810|459239253|FG002|Main Study|Lost to Follow-up|4|||
127620763|NCT03670810|459239254|FG003|Main Study|Lost to Follow-up|6|||
127620764|NCT03670810|459239255|FG004|Main Study|Lost to Follow-up|1|||
127620765|NCT03670810|459239256|FG005|Main Study|Lost to Follow-up|0|||
127620766|NCT03670810|459239257|FG006|Main Study|Lost to Follow-up|0|||
127620767|NCT03670810|459239258|FG007|Main Study|Lost to Follow-up|0|||
127620768|NCT03670810|459239259|FG008|Main Study|Lost to Follow-up|0|||
127620769|NCT03670810|459239251|FG000|Main Study|Non-compliance with Study Drug|0|||
127620770|NCT03670810|459239252|FG001|Main Study|Non-compliance with Study Drug|2|||
127620771|NCT03670810|459239253|FG002|Main Study|Non-compliance with Study Drug|3|||
127620772|NCT03670810|459239254|FG003|Main Study|Non-compliance with Study Drug|0|||
127620773|NCT03670810|459239255|FG004|Main Study|Non-compliance with Study Drug|0|||
127620774|NCT03670810|459239256|FG005|Main Study|Non-compliance with Study Drug|0|||
127620775|NCT03670810|459239257|FG006|Main Study|Non-compliance with Study Drug|0|||
127620776|NCT03670810|459239258|FG007|Main Study|Non-compliance with Study Drug|1|||
127620777|NCT03670810|459239259|FG008|Main Study|Non-compliance with Study Drug|0|||
127620778|NCT03670810|459239251|FG000|Main Study|Physician Decision|3|||
127620779|NCT03670810|459239252|FG001|Main Study|Physician Decision|0|||
127620780|NCT03670810|459239253|FG002|Main Study|Physician Decision|1|||
127620781|NCT03670810|459239254|FG003|Main Study|Physician Decision|0|||
127620782|NCT03670810|459239255|FG004|Main Study|Physician Decision|0|||
127620783|NCT03670810|459239256|FG005|Main Study|Physician Decision|0|||
127620784|NCT03670810|459239257|FG006|Main Study|Physician Decision|1|||
127620785|NCT03670810|459239258|FG007|Main Study|Physician Decision|1|||
127620786|NCT03670810|459239259|FG008|Main Study|Physician Decision|0|||
127620787|NCT03670810|459239251|FG000|Main Study|Pregnancy|1|||
127620788|NCT03670810|459239252|FG001|Main Study|Pregnancy|2|||
127620789|NCT03670810|459239253|FG002|Main Study|Pregnancy|0|||
127620790|NCT03670810|459239254|FG003|Main Study|Pregnancy|0|||
127620791|NCT03670810|459239255|FG004|Main Study|Pregnancy|0|||
127620792|NCT03670810|459239256|FG005|Main Study|Pregnancy|0|||
127620793|NCT03670810|459239257|FG006|Main Study|Pregnancy|0|||
127620794|NCT03670810|459239258|FG007|Main Study|Pregnancy|0|||
127620795|NCT03670810|459239259|FG008|Main Study|Pregnancy|0|||
127620796|NCT03670810|459239251|FG000|Main Study|Protocol Deviation|2|||
127620797|NCT03670810|459239252|FG001|Main Study|Protocol Deviation|12|||
127620798|NCT03670810|459239253|FG002|Main Study|Protocol Deviation|8|||
127620799|NCT03670810|459239254|FG003|Main Study|Protocol Deviation|4|||
127620800|NCT03670810|459239255|FG004|Main Study|Protocol Deviation|0|||
127620801|NCT03670810|459239256|FG005|Main Study|Protocol Deviation|0|||
127620802|NCT03670810|459239257|FG006|Main Study|Protocol Deviation|0|||
127620803|NCT03670810|459239258|FG007|Main Study|Protocol Deviation|0|||
127620804|NCT03670810|459239259|FG008|Main Study|Protocol Deviation|0|||
127620805|NCT03670810|459239251|FG000|Main Study|Withdrawal by Subject|21|||
127620806|NCT03670810|459239252|FG001|Main Study|Withdrawal by Subject|21|||
127620807|NCT03670810|459239253|FG002|Main Study|Withdrawal by Subject|8|||
127620808|NCT03670810|459239254|FG003|Main Study|Withdrawal by Subject|9|||
127620809|NCT03670810|459239255|FG004|Main Study|Withdrawal by Subject|5|||
127620810|NCT03670810|459239256|FG005|Main Study|Withdrawal by Subject|2|||
127620811|NCT03670810|459239257|FG006|Main Study|Withdrawal by Subject|1|||
127620812|NCT03670810|459239258|FG007|Main Study|Withdrawal by Subject|1|||
127620813|NCT03670810|459239259|FG008|Main Study|Withdrawal by Subject|0|||
127620814|NCT03670810|459239251|FG000|Main Study|Participant did not want to take the three other treatments|1|||
127620815|NCT03670810|459239252|FG001|Main Study|Participant did not want to take the three other treatments|0|||
127620816|NCT03670810|459239253|FG002|Main Study|Participant did not want to take the three other treatments|0|||
127620817|NCT03670810|459239254|FG003|Main Study|Participant did not want to take the three other treatments|0|||
127620818|NCT03670810|459239255|FG004|Main Study|Participant did not want to take the three other treatments|0|||
127620819|NCT03670810|459239256|FG005|Main Study|Participant did not want to take the three other treatments|0|||
127620820|NCT03670810|459239257|FG006|Main Study|Participant did not want to take the three other treatments|0|||
127620821|NCT03670810|459239258|FG007|Main Study|Participant did not want to take the three other treatments|0|||
127620822|NCT03670810|459239259|FG008|Main Study|Participant did not want to take the three other treatments|0|||
127791648|NCT01032915|459860713|FG000|Overall Study|Abnormal test procedure result|0|||
127791649|NCT01032915|459860714|FG001|Overall Study|Abnormal test procedure result|0|||
127791650|NCT01032915|459860715|FG002|Overall Study|Abnormal test procedure result|1|||
127791651|NCT01032915|459860716|FG003|Overall Study|Abnormal test procedure result|0|||
127791652|NCT01032915|459860713|FG000|Overall Study|Withdrawal by Subject|0|||
127791653|NCT01032915|459860714|FG001|Overall Study|Withdrawal by Subject|3|||
127791654|NCT01032915|459860715|FG002|Overall Study|Withdrawal by Subject|1|||
127791655|NCT01032915|459860716|FG003|Overall Study|Withdrawal by Subject|1|||
127884708|NCT01783483|460202116|FG001|Overall Study|Death|3|||
127620823|NCT03670810|459239251|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
127620824|NCT03670810|459239252|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
127620825|NCT03670810|459239253|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
127620826|NCT03670810|459239254|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
127620827|NCT03670810|459239255|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
127620828|NCT03670810|459239256|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
127620829|NCT03670810|459239257|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
127620830|NCT03670810|459239258|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
127642609|NCT05554237|459313093|FG008|Part 2 (7 Days)|Adverse Event|0|||
127884709|NCT01783483|460202115|FG000|Overall Study|Lost to Follow-up|14|||
127791656|NCT01032915|459860713|FG000|Overall Study|Administrative reasons|5|||
127791657|NCT01032915|459860714|FG001|Overall Study|Administrative reasons|6|||
127791658|NCT01032915|459860715|FG002|Overall Study|Administrative reasons|4|||
127791659|NCT01032915|459860716|FG003|Overall Study|Administrative reasons|4|||
127791660|NCT01032915|459860713|FG000|Overall Study|Protocol Violation|1|||
127791661|NCT01032915|459860714|FG001|Overall Study|Protocol Violation|0|||
127791662|NCT01032915|459860715|FG002|Overall Study|Protocol Violation|0|||
127791663|NCT01032915|459860716|FG003|Overall Study|Protocol Violation|1|||
127791664|NCT00915681|459860718|FG000|Overall Study|Screening failures|46|||
127791665|NCT00811135|459860719|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
127791666|NCT00811135|459860719|FG000|Overall Study|Death|3|||
127791667|NCT00811135|459860719|FG000|Overall Study|Protocol Violation|2|||
127791668|NCT00811135|459860719|FG000|Overall Study|Violation of Selection Criteria|1|||
127791669|NCT00811135|459860719|FG000|Overall Study|Refused Treatment|1|||
127791670|NCT00811135|459860719|FG000|Overall Study|Withdrawal by Subject|3|||
127791671|NCT00811135|459860719|FG000|Overall Study|Administrative/Other Unspecified|11|||
127791672|NCT00811135|459860719|FG000|Overall Study|Ongoing|59|||
127791673|NCT01118351|459860720|FG000|Overall Study|Adverse Event|3|||
127791674|NCT01118351|459860720|FG000|Overall Study|Withdrawal by Subject|1|||
127791675|NCT00845728|459860734|FG000|Overall Study|Abnormal laboratory value (s)|2|||
127791676|NCT00845728|459860735|FG001|Overall Study|Abnormal laboratory value (s)|2|||
127884710|NCT01783483|460202116|FG001|Overall Study|Lost to Follow-up|10|||
127884711|NCT01783483|460202115|FG000|Overall Study|Withdrawal by Subject|2|||
127884712|NCT01783483|460202116|FG001|Overall Study|Withdrawal by Subject|1|||
127620831|NCT03670810|459239259|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
127620832|NCT03670810|459239251|FG000|Main Study|Travel and Coronavirus issues|0|||
127620833|NCT03670810|459239252|FG001|Main Study|Travel and Coronavirus issues|0|||
127620834|NCT03670810|459239253|FG002|Main Study|Travel and Coronavirus issues|0|||
127620835|NCT03670810|459239254|FG003|Main Study|Travel and Coronavirus issues|1|||
127620836|NCT03670810|459239255|FG004|Main Study|Travel and Coronavirus issues|0|||
127620837|NCT03670810|459239256|FG005|Main Study|Travel and Coronavirus issues|0|||
127620838|NCT03670810|459239257|FG006|Main Study|Travel and Coronavirus issues|0|||
127620839|NCT03670810|459239258|FG007|Main Study|Travel and Coronavirus issues|0|||
127620840|NCT03670810|459239259|FG008|Main Study|Travel and Coronavirus issues|0|||
127620841|NCT03670810|459239251|FG000|Open Label Extension|Protocol Deviation|0|||
127620842|NCT03670810|459239252|FG001|Open Label Extension|Protocol Deviation|0|||
127620843|NCT03670810|459239253|FG002|Open Label Extension|Protocol Deviation|0|||
127620844|NCT03670810|459239254|FG003|Open Label Extension|Protocol Deviation|0|||
127620845|NCT03670810|459239255|FG004|Open Label Extension|Protocol Deviation|0|||
127620846|NCT03670810|459239256|FG005|Open Label Extension|Protocol Deviation|0|||
127620847|NCT03670810|459239257|FG006|Open Label Extension|Protocol Deviation|0|||
127620848|NCT03670810|459239258|FG007|Open Label Extension|Protocol Deviation|0|||
127700766|NCT05329220|459533085|FG005|Active Trial Period|Withdrawal by Subject|13|||
127700767|NCT05329220|459533080|FG000|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
127700768|NCT05329220|459533081|FG001|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
127700769|NCT05329220|459533082|FG002|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
127700770|NCT05329220|459533083|FG003|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
127700771|NCT05329220|459533084|FG004|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
127700772|NCT05329220|459533085|FG005|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|1|||
127700773|NCT05329220|459533080|FG000|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
127700774|NCT05329220|459533081|FG001|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
127700775|NCT05329220|459533082|FG002|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
127700776|NCT05329220|459533083|FG003|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
127700777|NCT05329220|459533084|FG004|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
127700778|NCT05329220|459533085|FG005|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|1|||
127700779|NCT05329220|459533080|FG000|Active Trial Period|SUBJECT WAS OOW|0|||
127791677|NCT00845728|459860734|FG000|Overall Study|Patient's inability to use the device|4|||
127791678|NCT00845728|459860735|FG001|Overall Study|Patient's inability to use the device|6|||
127791679|NCT00845728|459860734|FG000|Overall Study|Abnormal test procedure result (s)|7|||
127620849|NCT03670810|459239259|FG008|Open Label Extension|Protocol Deviation|5|||
127620850|NCT03670810|459239251|FG000|Open Label Extension|Death|0|||
127884713|NCT01783483|460202115|FG000|Overall Study|Physician Decision|1|||
127620851|NCT03670810|459239252|FG001|Open Label Extension|Death|0|||
127620852|NCT03670810|459239253|FG002|Open Label Extension|Death|0|||
127884714|NCT01783483|460202116|FG001|Overall Study|Physician Decision|1|||
127620853|NCT03670810|459239254|FG003|Open Label Extension|Death|0|||
127620854|NCT03670810|459239255|FG004|Open Label Extension|Death|0|||
127620855|NCT03670810|459239256|FG005|Open Label Extension|Death|0|||
127620856|NCT03670810|459239257|FG006|Open Label Extension|Death|0|||
127620857|NCT03670810|459239258|FG007|Open Label Extension|Death|0|||
127620858|NCT03670810|459239259|FG008|Open Label Extension|Death|1|||
127620859|NCT03670810|459239251|FG000|Open Label Extension|COVID-19|0|||
127620860|NCT03670810|459239252|FG001|Open Label Extension|COVID-19|0|||
127620861|NCT03670810|459239253|FG002|Open Label Extension|COVID-19|0|||
127620862|NCT03670810|459239254|FG003|Open Label Extension|COVID-19|0|||
127620863|NCT03670810|459239255|FG004|Open Label Extension|COVID-19|0|||
127620864|NCT03670810|459239256|FG005|Open Label Extension|COVID-19|0|||
127620865|NCT03670810|459239257|FG006|Open Label Extension|COVID-19|0|||
127620866|NCT03670810|459239258|FG007|Open Label Extension|COVID-19|0|||
127620867|NCT03670810|459239259|FG008|Open Label Extension|COVID-19|1|||
127620868|NCT03670810|459239251|FG000|Open Label Extension|Lack of Efficacy|0|||
127620869|NCT03670810|459239252|FG001|Open Label Extension|Lack of Efficacy|0|||
127620870|NCT03670810|459239253|FG002|Open Label Extension|Lack of Efficacy|0|||
127620871|NCT03670810|459239254|FG003|Open Label Extension|Lack of Efficacy|0|||
127620872|NCT03670810|459239255|FG004|Open Label Extension|Lack of Efficacy|0|||
127620873|NCT03670810|459239256|FG005|Open Label Extension|Lack of Efficacy|0|||
127620874|NCT03670810|459239257|FG006|Open Label Extension|Lack of Efficacy|0|||
127620875|NCT03670810|459239258|FG007|Open Label Extension|Lack of Efficacy|0|||
127620876|NCT03670810|459239259|FG008|Open Label Extension|Lack of Efficacy|39|||
127620877|NCT03670810|459239251|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
127620878|NCT03670810|459239252|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
127620879|NCT03670810|459239253|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
127620880|NCT03670810|459239254|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
127620881|NCT03670810|459239255|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
127884715|NCT04130919|460202117|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
127884716|NCT04130919|460202118|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
127620882|NCT03670810|459239256|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
127620883|NCT03670810|459239257|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
127620884|NCT03670810|459239258|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
127620885|NCT03670810|459239259|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
127620886|NCT03670810|459239251|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
127620887|NCT03670810|459239252|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
127620888|NCT03670810|459239253|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
127620889|NCT03670810|459239254|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
127620890|NCT03670810|459239255|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
127620891|NCT03670810|459239256|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
127620892|NCT03670810|459239257|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
127620893|NCT03670810|459239258|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
127620894|NCT03670810|459239259|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
127620895|NCT03670810|459239251|FG000|Open Label Extension|Withdrawal by Subject|0|||
127620896|NCT03670810|459239252|FG001|Open Label Extension|Withdrawal by Subject|0|||
127620897|NCT03670810|459239253|FG002|Open Label Extension|Withdrawal by Subject|0|||
127620898|NCT03670810|459239254|FG003|Open Label Extension|Withdrawal by Subject|0|||
127620899|NCT03670810|459239255|FG004|Open Label Extension|Withdrawal by Subject|0|||
127620900|NCT03670810|459239256|FG005|Open Label Extension|Withdrawal by Subject|0|||
127620901|NCT03670810|459239257|FG006|Open Label Extension|Withdrawal by Subject|0|||
127620902|NCT03670810|459239258|FG007|Open Label Extension|Withdrawal by Subject|0|||
127620903|NCT03670810|459239259|FG008|Open Label Extension|Withdrawal by Subject|46|||
127620904|NCT03670810|459239251|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
127620905|NCT03670810|459239252|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
127620906|NCT03670810|459239253|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
127620907|NCT03670810|459239254|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
127620908|NCT03670810|459239255|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
127620909|NCT03670810|459239256|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
127620910|NCT03670810|459239257|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
127620911|NCT03670810|459239258|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
127620912|NCT03670810|459239259|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
127620913|NCT03670810|459239251|FG000|Open Label Extension|Physician Decision|0|||
127620914|NCT03670810|459239252|FG001|Open Label Extension|Physician Decision|0|||
127620915|NCT03670810|459239253|FG002|Open Label Extension|Physician Decision|0|||
127620916|NCT03670810|459239254|FG003|Open Label Extension|Physician Decision|0|||
127620917|NCT03670810|459239255|FG004|Open Label Extension|Physician Decision|0|||
127620918|NCT03670810|459239256|FG005|Open Label Extension|Physician Decision|0|||
127620919|NCT03670810|459239257|FG006|Open Label Extension|Physician Decision|0|||
127620920|NCT03670810|459239258|FG007|Open Label Extension|Physician Decision|0|||
127620921|NCT03670810|459239259|FG008|Open Label Extension|Physician Decision|2|||
127620922|NCT03670810|459239251|FG000|Open Label Extension|Non-compliance with study drug|0|||
127620923|NCT03670810|459239252|FG001|Open Label Extension|Non-compliance with study drug|0|||
127884717|NCT04130919|460202119|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
127884718|NCT04130919|460202120|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
127884719|NCT04130919|460202121|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
127620924|NCT03670810|459239253|FG002|Open Label Extension|Non-compliance with study drug|0|||
127620925|NCT03670810|459239254|FG003|Open Label Extension|Non-compliance with study drug|0|||
127620926|NCT03670810|459239255|FG004|Open Label Extension|Non-compliance with study drug|0|||
127620927|NCT03670810|459239256|FG005|Open Label Extension|Non-compliance with study drug|0|||
127620928|NCT03670810|459239257|FG006|Open Label Extension|Non-compliance with study drug|0|||
127620929|NCT03670810|459239258|FG007|Open Label Extension|Non-compliance with study drug|0|||
127620930|NCT03670810|459239259|FG008|Open Label Extension|Non-compliance with study drug|5|||
127620931|NCT03670810|459239251|FG000|Open Label Extension|Pregnancy|0|||
127620932|NCT03670810|459239252|FG001|Open Label Extension|Pregnancy|0|||
127620933|NCT03670810|459239253|FG002|Open Label Extension|Pregnancy|0|||
127700780|NCT05329220|459533081|FG001|Active Trial Period|SUBJECT WAS OOW|0|||
127700781|NCT05329220|459533082|FG002|Active Trial Period|SUBJECT WAS OOW|0|||
127700782|NCT05329220|459533083|FG003|Active Trial Period|SUBJECT WAS OOW|0|||
127700783|NCT05329220|459533084|FG004|Active Trial Period|SUBJECT WAS OOW|0|||
127700784|NCT05329220|459533085|FG005|Active Trial Period|SUBJECT WAS OOW|1|||
127700785|NCT05329220|459533080|FG000|Follow-up Period|Adverse Event|0|||
127700786|NCT05329220|459533081|FG001|Follow-up Period|Adverse Event|0|||
127700787|NCT05329220|459533082|FG002|Follow-up Period|Adverse Event|0|||
127700788|NCT05329220|459533083|FG003|Follow-up Period|Adverse Event|0|||
127884720|NCT04130919|460202122|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
127884721|NCT04130919|460202117|FG000|Blinded Treatment Phase|Adverse Event|0|||
127884722|NCT04130919|460202118|FG001|Blinded Treatment Phase|Adverse Event|0|||
127884723|NCT04130919|460202119|FG002|Blinded Treatment Phase|Adverse Event|1|||
127884724|NCT04130919|460202120|FG003|Blinded Treatment Phase|Adverse Event|0|||
127884725|NCT04130919|460202121|FG004|Blinded Treatment Phase|Adverse Event|0|||
127884726|NCT04130919|460202122|FG005|Blinded Treatment Phase|Adverse Event|0|||
127884727|NCT04130919|460202117|FG000|Blinded Treatment Phase|Disease worsening|0|||
127884728|NCT04130919|460202118|FG001|Blinded Treatment Phase|Disease worsening|0|||
127884729|NCT04130919|460202119|FG002|Blinded Treatment Phase|Disease worsening|1|||
127884730|NCT04130919|460202120|FG003|Blinded Treatment Phase|Disease worsening|0|||
127884731|NCT04130919|460202121|FG004|Blinded Treatment Phase|Disease worsening|0|||
127884732|NCT04130919|460202122|FG005|Blinded Treatment Phase|Disease worsening|0|||
127884733|NCT04130919|460202117|FG000|Blinded Treatment Phase|Investigator's decision|0|||
127884734|NCT04130919|460202118|FG001|Blinded Treatment Phase|Investigator's decision|1|||
127884735|NCT04130919|460202119|FG002|Blinded Treatment Phase|Investigator's decision|0|||
127884736|NCT04130919|460202120|FG003|Blinded Treatment Phase|Investigator's decision|0|||
127884737|NCT04130919|460202121|FG004|Blinded Treatment Phase|Investigator's decision|0|||
127884738|NCT04130919|460202122|FG005|Blinded Treatment Phase|Investigator's decision|0|||
127884739|NCT04130919|460202117|FG000|Blinded Treatment Phase|Withdrew consent|1|||
127884740|NCT04130919|460202118|FG001|Blinded Treatment Phase|Withdrew consent|0|||
127884741|NCT04130919|460202119|FG002|Blinded Treatment Phase|Withdrew consent|0|||
127884742|NCT04130919|460202120|FG003|Blinded Treatment Phase|Withdrew consent|0|||
127884743|NCT04130919|460202121|FG004|Blinded Treatment Phase|Withdrew consent|0|||
127620934|NCT03670810|459239254|FG003|Open Label Extension|Pregnancy|0|||
127620935|NCT03670810|459239255|FG004|Open Label Extension|Pregnancy|0|||
127620936|NCT03670810|459239256|FG005|Open Label Extension|Pregnancy|0|||
127884744|NCT04130919|460202122|FG005|Blinded Treatment Phase|Withdrew consent|0|||
127884745|NCT04130919|460202117|FG000|Open-label Treatment Phase|Withdrew consent|0|||
127884746|NCT04130919|460202118|FG001|Open-label Treatment Phase|Withdrew consent|0|||
127884747|NCT04130919|460202119|FG002|Open-label Treatment Phase|Withdrew consent|0|||
127620937|NCT03670810|459239257|FG006|Open Label Extension|Pregnancy|0|||
127620938|NCT03670810|459239258|FG007|Open Label Extension|Pregnancy|0|||
127620939|NCT03670810|459239259|FG008|Open Label Extension|Pregnancy|3|||
127620940|NCT03670810|459239251|FG000|Open Label Extension|Adverse Event|0|||
127620941|NCT03670810|459239252|FG001|Open Label Extension|Adverse Event|0|||
127620942|NCT03670810|459239253|FG002|Open Label Extension|Adverse Event|0|||
127620943|NCT03670810|459239254|FG003|Open Label Extension|Adverse Event|0|||
127620944|NCT03670810|459239255|FG004|Open Label Extension|Adverse Event|0|||
127620945|NCT03670810|459239256|FG005|Open Label Extension|Adverse Event|0|||
127620946|NCT03670810|459239257|FG006|Open Label Extension|Adverse Event|0|||
127620947|NCT03670810|459239258|FG007|Open Label Extension|Adverse Event|0|||
127620948|NCT03670810|459239259|FG008|Open Label Extension|Adverse Event|24|||
127620949|NCT03670810|459239251|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
127620950|NCT03670810|459239252|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
127620951|NCT03670810|459239253|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
127620952|NCT03670810|459239254|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
127620953|NCT03670810|459239255|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
127620954|NCT03670810|459239256|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
127620955|NCT03670810|459239257|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
127620956|NCT03670810|459239258|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
127620957|NCT03670810|459239259|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
127620958|NCT03670810|459239251|FG000|Open Label Extension|Lost to Follow-up|0|||
127620959|NCT03670810|459239252|FG001|Open Label Extension|Lost to Follow-up|0|||
127620960|NCT03670810|459239253|FG002|Open Label Extension|Lost to Follow-up|0|||
127620961|NCT03670810|459239254|FG003|Open Label Extension|Lost to Follow-up|0|||
127620962|NCT03670810|459239255|FG004|Open Label Extension|Lost to Follow-up|0|||
127620963|NCT03670810|459239256|FG005|Open Label Extension|Lost to Follow-up|0|||
127620964|NCT03670810|459239257|FG006|Open Label Extension|Lost to Follow-up|0|||
127620965|NCT03670810|459239258|FG007|Open Label Extension|Lost to Follow-up|0|||
127884748|NCT04130919|460202120|FG003|Open-label Treatment Phase|Withdrew consent|1|||
127884749|NCT04130919|460202121|FG004|Open-label Treatment Phase|Withdrew consent|1|||
127884750|NCT04130919|460202122|FG005|Open-label Treatment Phase|Withdrew consent|1|||
127884751|NCT04130919|460202117|FG000|Open-label Treatment Phase|Disease worsening|0|||
127884752|NCT04130919|460202118|FG001|Open-label Treatment Phase|Disease worsening|0|||
127620966|NCT03670810|459239259|FG008|Open Label Extension|Lost to Follow-up|23|||
127620967|NCT02644967|459239263|FG000|Overall Study|Death|26|||
127884753|NCT04130919|460202119|FG002|Open-label Treatment Phase|Disease worsening|0|||
127884754|NCT04130919|460202120|FG003|Open-label Treatment Phase|Disease worsening|1|||
127884755|NCT04130919|460202121|FG004|Open-label Treatment Phase|Disease worsening|0|||
127884756|NCT04130919|460202122|FG005|Open-label Treatment Phase|Disease worsening|1|||
127620968|NCT02644967|459239263|FG000|Overall Study|Physician Decision|1|||
127700789|NCT05329220|459533084|FG004|Follow-up Period|Adverse Event|2|||
127700790|NCT05329220|459533085|FG005|Follow-up Period|Adverse Event|1|||
127700791|NCT05329220|459533080|FG000|Follow-up Period|Death|0|||
127700792|NCT05329220|459533081|FG001|Follow-up Period|Death|0|||
127700793|NCT05329220|459533082|FG002|Follow-up Period|Death|1|||
127700794|NCT05329220|459533083|FG003|Follow-up Period|Death|1|||
127700795|NCT05329220|459533084|FG004|Follow-up Period|Death|0|||
127700796|NCT05329220|459533085|FG005|Follow-up Period|Death|1|||
127700797|NCT05329220|459533080|FG000|Follow-up Period|Lost to Follow-up|0|||
127700798|NCT05329220|459533081|FG001|Follow-up Period|Lost to Follow-up|1|||
127700799|NCT05329220|459533082|FG002|Follow-up Period|Lost to Follow-up|2|||
127700800|NCT05329220|459533083|FG003|Follow-up Period|Lost to Follow-up|2|||
127700801|NCT05329220|459533084|FG004|Follow-up Period|Lost to Follow-up|113|||
127700802|NCT05329220|459533085|FG005|Follow-up Period|Lost to Follow-up|89|||
127700803|NCT05329220|459533080|FG000|Follow-up Period|Physician Decision|0|||
127700804|NCT05329220|459533081|FG001|Follow-up Period|Physician Decision|0|||
127700805|NCT05329220|459533082|FG002|Follow-up Period|Physician Decision|0|||
127700806|NCT05329220|459533083|FG003|Follow-up Period|Physician Decision|0|||
127700807|NCT05329220|459533084|FG004|Follow-up Period|Physician Decision|2|||
127700808|NCT05329220|459533085|FG005|Follow-up Period|Physician Decision|2|||
127700809|NCT05329220|459533080|FG000|Follow-up Period|Protocol Violation|0|||
127700810|NCT05329220|459533081|FG001|Follow-up Period|Protocol Violation|0|||
127700811|NCT05329220|459533082|FG002|Follow-up Period|Protocol Violation|0|||
127700812|NCT05329220|459533083|FG003|Follow-up Period|Protocol Violation|0|||
127700813|NCT05329220|459533084|FG004|Follow-up Period|Protocol Violation|0|||
127700814|NCT05329220|459533085|FG005|Follow-up Period|Protocol Violation|1|||
127700815|NCT05329220|459533080|FG000|Follow-up Period|Withdrawal by Subject|0|||
127700816|NCT05329220|459533081|FG001|Follow-up Period|Withdrawal by Subject|0|||
127700817|NCT05329220|459533082|FG002|Follow-up Period|Withdrawal by Subject|1|||
127700818|NCT05329220|459533083|FG003|Follow-up Period|Withdrawal by Subject|1|||
127700819|NCT05329220|459533084|FG004|Follow-up Period|Withdrawal by Subject|34|||
127700820|NCT05329220|459533085|FG005|Follow-up Period|Withdrawal by Subject|35|||
127700821|NCT05329220|459533080|FG000|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
127700822|NCT05329220|459533081|FG001|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
127700823|NCT05329220|459533082|FG002|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|1|||
127700824|NCT05329220|459533083|FG003|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
127700825|NCT05329220|459533084|FG004|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
127700826|NCT05329220|459533085|FG005|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
127700827|NCT05329220|459533080|FG000|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
127700828|NCT05329220|459533081|FG001|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
127700829|NCT05329220|459533082|FG002|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
127700830|NCT05329220|459533083|FG003|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
127700831|NCT05329220|459533084|FG004|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|1|||
127884757|NCT04130919|460202117|FG000|Open-label Treatment Phase|Investigator's decision|0|||
127884758|NCT04130919|460202118|FG001|Open-label Treatment Phase|Investigator's decision|0|||
127700832|NCT05329220|459533085|FG005|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
127700833|NCT05329220|459533080|FG000|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
127700834|NCT05329220|459533081|FG001|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
127700835|NCT05329220|459533082|FG002|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
127700836|NCT05329220|459533083|FG003|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
127884759|NCT04130919|460202119|FG002|Open-label Treatment Phase|Investigator's decision|0|||
127884760|NCT04130919|460202120|FG003|Open-label Treatment Phase|Investigator's decision|1|||
127884761|NCT04130919|460202121|FG004|Open-label Treatment Phase|Investigator's decision|0|||
127884762|NCT04130919|460202122|FG005|Open-label Treatment Phase|Investigator's decision|0|||
127884763|NCT04130919|460202117|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
127700837|NCT05329220|459533084|FG004|Follow-up Period|SUBJECT NON-COMPLIANCE|1|||
127700838|NCT05329220|459533085|FG005|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
127700839|NCT05329220|459533080|FG000|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
127700840|NCT05329220|459533081|FG001|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
127700841|NCT05329220|459533082|FG002|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
127700842|NCT05329220|459533083|FG003|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
127700843|NCT05329220|459533084|FG004|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
127700844|NCT05329220|459533085|FG005|Follow-up Period|SUBJECT MOVED OUT OF TOWN|1|||
127700845|NCT05329220|459533080|FG000|Follow-up Period|EARLY TERMINATION|0|||
127620969|NCT02644967|459239263|FG000|Overall Study|Withdrawal by Subject|2|||
127620970|NCT02644967|459239263|FG000|Overall Study|Protocol Violation|1|||
127620971|NCT02644967|459239263|FG000|Overall Study|Progressive Disease|1|||
127620972|NCT02644967|459239263|FG000|Overall Study|Study Terminated by Sponsor|4|||
127620973|NCT03323099|459239265|FG000|Overall Study|Withdrawal by Subject|6|||
127620974|NCT03323099|459239266|FG001|Overall Study|Withdrawal by Subject|12|||
127620975|NCT03323099|459239265|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
127620976|NCT03323099|459239266|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
127620977|NCT05220397|459239271|FG000|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
127620978|NCT05220397|459239272|FG001|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
127620979|NCT05220397|459239273|FG002|Second Janssen Vaccine Administration|Withdrawal by Subject|8|||
127620980|NCT05220397|459239274|FG003|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
127620981|NCT05220397|459239275|FG004|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
127620982|NCT01502644|459239276|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
127620983|NCT01502644|459239277|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
127620984|NCT01502644|459239278|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
127620985|NCT01502644|459239279|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
127620986|NCT01502644|459239276|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
127620987|NCT01502644|459239277|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
127620988|NCT01502644|459239278|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
127620989|NCT01502644|459239279|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
127620990|NCT01502644|459239276|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
127620991|NCT01502644|459239277|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
127620992|NCT01502644|459239278|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
127620993|NCT01502644|459239279|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
127620994|NCT01502644|459239276|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
127620995|NCT01502644|459239277|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
127620996|NCT01502644|459239278|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
127620997|NCT01502644|459239279|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
127620998|NCT01502644|459239276|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
127620999|NCT01502644|459239277|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
127621000|NCT01502644|459239278|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
127621001|NCT01502644|459239279|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
127621002|NCT00637195|459239282|FG000|Overall Study|Lost to Follow-up|1|||
127621003|NCT00637195|459239283|FG001|Overall Study|Lost to Follow-up|0|||
127621004|NCT00637195|459239282|FG000|Overall Study|Other|2|||
127621005|NCT00637195|459239283|FG001|Overall Study|Other|0|||
127621006|NCT00637195|459239282|FG000|Overall Study|Withdrawal by Subject|0|||
127621007|NCT00637195|459239283|FG001|Overall Study|Withdrawal by Subject|1|||
127621008|NCT02388997|459239284|FG000|Overall Study|Adverse Event|1|||
127621009|NCT02388997|459239285|FG001|Overall Study|Adverse Event|2|||
127621010|NCT02388997|459239284|FG000|Overall Study|Withdrawal by Subject|2|||
127621011|NCT02388997|459239285|FG001|Overall Study|Withdrawal by Subject|1|||
127621012|NCT02388997|459239284|FG000|Overall Study|Lung function exclusion criteria|0|||
127621013|NCT02388997|459239285|FG001|Overall Study|Lung function exclusion criteria|2|||
127621014|NCT02388997|459239284|FG000|Overall Study|Tested positive for virus during run-in|0|||
127621015|NCT02388997|459239285|FG001|Overall Study|Tested positive for virus during run-in|1|||
127621016|NCT03025828|459239286|FG000|Overall Study|Lost to Follow-up|1|||
127621017|NCT00207142|459239287|FG000|Induction Phase|Adverse Event|9|||
127621018|NCT00207142|459239288|FG001|Induction Phase|Adverse Event|0|||
127621019|NCT00207142|459239289|FG002|Induction Phase|Adverse Event|0|||
127621020|NCT00207142|459239290|FG003|Induction Phase|Adverse Event|0|||
127621021|NCT00207142|459239287|FG000|Induction Phase|Death|1|||
127621022|NCT00207142|459239288|FG001|Induction Phase|Death|0|||
127621023|NCT00207142|459239289|FG002|Induction Phase|Death|0|||
127621024|NCT00207142|459239290|FG003|Induction Phase|Death|0|||
127621025|NCT00207142|459239287|FG000|Induction Phase|Lack of Efficacy|1|||
127621026|NCT00207142|459239288|FG001|Induction Phase|Lack of Efficacy|0|||
127621027|NCT00207142|459239289|FG002|Induction Phase|Lack of Efficacy|0|||
127621028|NCT00207142|459239290|FG003|Induction Phase|Lack of Efficacy|0|||
127621029|NCT00207142|459239287|FG000|Induction Phase|Lost to Follow-up|5|||
127621030|NCT00207142|459239288|FG001|Induction Phase|Lost to Follow-up|0|||
127621031|NCT00207142|459239289|FG002|Induction Phase|Lost to Follow-up|0|||
127621032|NCT00207142|459239290|FG003|Induction Phase|Lost to Follow-up|0|||
127621033|NCT00207142|459239287|FG000|Induction Phase|Physician Decision|2|||
127621034|NCT00207142|459239288|FG001|Induction Phase|Physician Decision|0|||
127621035|NCT00207142|459239289|FG002|Induction Phase|Physician Decision|0|||
127621036|NCT00207142|459239290|FG003|Induction Phase|Physician Decision|0|||
127621037|NCT00207142|459239287|FG000|Induction Phase|Poor/noncompliance|2|||
127621038|NCT00207142|459239288|FG001|Induction Phase|Poor/noncompliance|0|||
127621039|NCT00207142|459239289|FG002|Induction Phase|Poor/noncompliance|0|||
127621040|NCT00207142|459239290|FG003|Induction Phase|Poor/noncompliance|0|||
127621041|NCT00207142|459239287|FG000|Induction Phase|Pregnancy|1|||
127621042|NCT00207142|459239288|FG001|Induction Phase|Pregnancy|0|||
127621043|NCT00207142|459239289|FG002|Induction Phase|Pregnancy|0|||
127621044|NCT00207142|459239290|FG003|Induction Phase|Pregnancy|0|||
127621045|NCT00207142|459239287|FG000|Induction Phase|Subject no longer meets study criteria|3|||
127621046|NCT00207142|459239288|FG001|Induction Phase|Subject no longer meets study criteria|0|||
127621047|NCT00207142|459239289|FG002|Induction Phase|Subject no longer meets study criteria|0|||
127621048|NCT00207142|459239290|FG003|Induction Phase|Subject no longer meets study criteria|0|||
127621049|NCT00207142|459239287|FG000|Induction Phase|Withdrawal by Subject|4|||
127621050|NCT00207142|459239288|FG001|Induction Phase|Withdrawal by Subject|0|||
127621051|NCT00207142|459239289|FG002|Induction Phase|Withdrawal by Subject|0|||
127621052|NCT00207142|459239290|FG003|Induction Phase|Withdrawal by Subject|0|||
127621053|NCT00207142|459239287|FG000|Induction Phase|Incarceration|1|||
127621054|NCT00207142|459239288|FG001|Induction Phase|Incarceration|0|||
127621055|NCT00207142|459239289|FG002|Induction Phase|Incarceration|0|||
127621056|NCT00207142|459239290|FG003|Induction Phase|Incarceration|0|||
127621057|NCT00207142|459239287|FG000|Induction Phase|Missing lab data|1|||
127621058|NCT00207142|459239288|FG001|Induction Phase|Missing lab data|0|||
127621059|NCT00207142|459239289|FG002|Induction Phase|Missing lab data|0|||
127621060|NCT00207142|459239290|FG003|Induction Phase|Missing lab data|0|||
127621061|NCT00207142|459239287|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
127621062|NCT00207142|459239288|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
127621063|NCT00207142|459239289|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
127621064|NCT00207142|459239290|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
127621065|NCT00207142|459239287|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
127621066|NCT00207142|459239288|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
127621067|NCT00207142|459239289|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
127621068|NCT00207142|459239290|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
127621069|NCT00207142|459239287|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
127621070|NCT00207142|459239288|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
127621071|NCT00207142|459239289|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
127621072|NCT00207142|459239290|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
127621073|NCT00207142|459239287|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
127621074|NCT00207142|459239288|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
127621075|NCT00207142|459239289|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
127621076|NCT00207142|459239290|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
127700846|NCT05329220|459533081|FG001|Follow-up Period|EARLY TERMINATION|0|||
127700847|NCT05329220|459533082|FG002|Follow-up Period|EARLY TERMINATION|0|||
127700848|NCT05329220|459533083|FG003|Follow-up Period|EARLY TERMINATION|0|||
127700849|NCT05329220|459533084|FG004|Follow-up Period|EARLY TERMINATION|0|||
127700850|NCT05329220|459533085|FG005|Follow-up Period|EARLY TERMINATION|1|||
127700851|NCT05329220|459533080|FG000|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
127700852|NCT05329220|459533081|FG001|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
127700853|NCT05329220|459533082|FG002|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
127700854|NCT05329220|459533083|FG003|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
127700855|NCT05329220|459533084|FG004|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
127700856|NCT05329220|459533085|FG005|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|2|||
127700857|NCT05329220|459533080|FG000|Follow-up Period|DROPPED|0|||
127700858|NCT05329220|459533081|FG001|Follow-up Period|DROPPED|0|||
127700859|NCT05329220|459533082|FG002|Follow-up Period|DROPPED|0|||
127700860|NCT05329220|459533083|FG003|Follow-up Period|DROPPED|0|||
127700861|NCT05329220|459533084|FG004|Follow-up Period|DROPPED|0|||
127700862|NCT05329220|459533085|FG005|Follow-up Period|DROPPED|1|||
127700863|NCT05329220|459533080|FG000|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
127700864|NCT05329220|459533081|FG001|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
127700865|NCT05329220|459533082|FG002|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
127700866|NCT05329220|459533083|FG003|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
127700867|NCT05329220|459533084|FG004|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
127700868|NCT05329220|459533085|FG005|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|1|||
127700869|NCT02601313|459533086|FG000|Overall Study|Death|2|||
127700870|NCT02601313|459533087|FG001|Overall Study|Death|41|||
127700871|NCT02601313|459533088|FG002|Overall Study|Death|6|||
127700872|NCT02601313|459533086|FG000|Overall Study|Enrolled but never treated|0|||
127700873|NCT02601313|459533087|FG001|Overall Study|Enrolled but never treated|6|||
127700874|NCT02601313|459533088|FG002|Overall Study|Enrolled but never treated|3|||
127700875|NCT02601313|459533086|FG000|Overall Study|Enrolled, did not initiate AC|4|||
127621077|NCT00207142|459239287|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
127621078|NCT00207142|459239288|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
127884764|NCT04130919|460202118|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
127884765|NCT04130919|460202119|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
127884766|NCT04130919|460202120|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
127884767|NCT04130919|460202121|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
127884768|NCT04130919|460202122|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
127884769|NCT04130919|460202117|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
127884770|NCT04130919|460202118|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
127884771|NCT04130919|460202119|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
127884772|NCT04130919|460202120|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
127884773|NCT04130919|460202121|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
127884774|NCT04130919|460202122|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
127884775|NCT02624518|460202123|FG000|Overall Study|Physician Decision|1|||
127884776|NCT01462695|460202124|FG000|Overall Study|Adverse Event|1|||
127884777|NCT01462695|460202125|FG001|Overall Study|Adverse Event|1|||
127884778|NCT01462695|460202124|FG000|Overall Study|Death|2|||
127884779|NCT01462695|460202125|FG001|Overall Study|Death|0|||
127621079|NCT00207142|459239289|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
127621080|NCT00207142|459239290|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
127621081|NCT00207142|459239287|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
127621082|NCT00207142|459239288|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
127621083|NCT00207142|459239289|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
127621084|NCT00207142|459239290|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
127621085|NCT00207142|459239287|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
127621086|NCT00207142|459239288|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
127621087|NCT00207142|459239289|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
127621088|NCT00207142|459239290|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
127621089|NCT00207142|459239287|FG000|Maintenance Phase/Rescue Phase|Death|0|||
127621090|NCT00207142|459239288|FG001|Maintenance Phase/Rescue Phase|Death|0|||
127621091|NCT00207142|459239289|FG002|Maintenance Phase/Rescue Phase|Death|0|||
127621092|NCT00207142|459239290|FG003|Maintenance Phase/Rescue Phase|Death|1|||
127621093|NCT00207142|459239287|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
127621094|NCT00207142|459239288|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
127621095|NCT00207142|459239289|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
127621096|NCT00207142|459239290|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
127621097|NCT01020019|459239291|FG000|Overall Study|Lost to Follow-up|21|||
127621098|NCT01020019|459239292|FG001|Overall Study|Lost to Follow-up|18|||
127621099|NCT01020019|459239291|FG000|Overall Study|Adverse Event|1|||
127621100|NCT01020019|459239292|FG001|Overall Study|Adverse Event|5|||
127621101|NCT01020019|459239291|FG000|Overall Study|not interested in treatment|4|||
127621102|NCT01020019|459239292|FG001|Overall Study|not interested in treatment|4|||
127621103|NCT01020019|459239291|FG000|Overall Study|moving|0|||
127621104|NCT01020019|459239292|FG001|Overall Study|moving|2|||
127621105|NCT04958109|459239293|FG000|Overall Study|Withdrawal by Subject|0|||
127621106|NCT04958109|459239294|FG001|Overall Study|Withdrawal by Subject|1|||
127621107|NCT04958109|459239293|FG000|Overall Study|Lost to Follow-up|0|||
127621108|NCT04958109|459239294|FG001|Overall Study|Lost to Follow-up|1|||
127621109|NCT02375672|459239295|FG000|Overall Study|remain on follow up|20|||
127621110|NCT01559311|459239296|FG000|Overall Study|Protocol Violation|0|||
127621111|NCT01559311|459239297|FG001|Overall Study|Protocol Violation|0|||
127621112|NCT01559311|459239298|FG002|Overall Study|Protocol Violation|2|||
127621113|NCT01559311|459239296|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
127621114|NCT01559311|459239297|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
127621115|NCT01559311|459239298|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
127621116|NCT01559311|459239296|FG000|Overall Study|Withdrawal by Subject|2|||
127621117|NCT01559311|459239297|FG001|Overall Study|Withdrawal by Subject|1|||
127621118|NCT01559311|459239298|FG002|Overall Study|Withdrawal by Subject|0|||
127621119|NCT01559311|459239296|FG000|Overall Study|Death|0|||
127621120|NCT01559311|459239297|FG001|Overall Study|Death|2|||
127621121|NCT01559311|459239298|FG002|Overall Study|Death|3|||
127621122|NCT01559311|459239296|FG000|Overall Study|Lost to Follow-up|0|||
127621123|NCT01559311|459239297|FG001|Overall Study|Lost to Follow-up|3|||
127621124|NCT01559311|459239298|FG002|Overall Study|Lost to Follow-up|2|||
127621125|NCT01559311|459239296|FG000|Overall Study|Adverse Event|0|||
127621126|NCT01559311|459239297|FG001|Overall Study|Adverse Event|0|||
127621127|NCT01559311|459239298|FG002|Overall Study|Adverse Event|1|||
127621128|NCT02346240|459239301|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
127621129|NCT02346240|459239302|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
127621130|NCT02346240|459239303|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
127884780|NCT01462695|460202124|FG000|Overall Study|Lack of Efficacy|6|||
127884781|NCT01462695|460202125|FG001|Overall Study|Lack of Efficacy|12|||
127621131|NCT02346240|459239304|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
127621132|NCT02346240|459239305|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
127621133|NCT02346240|459239306|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
127621134|NCT02346240|459239307|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
127621135|NCT02346240|459239308|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
127621136|NCT02346240|459239309|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
127621137|NCT02346240|459239310|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
127621138|NCT02346240|459239311|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
127621139|NCT02346240|459239312|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
127621140|NCT02346240|459239313|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
127621141|NCT02346240|459239314|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
127621142|NCT02346240|459239315|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
127621143|NCT02346240|459239316|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
127621144|NCT02346240|459239317|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
127621145|NCT02346240|459239318|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
127621146|NCT02346240|459239319|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
127621147|NCT02346240|459239320|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
127621148|NCT02346240|459239321|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
127621149|NCT02346240|459239322|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
127621150|NCT02346240|459239323|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
127621151|NCT02346240|459239324|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
127621152|NCT02346240|459239301|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
127621153|NCT02346240|459239302|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
127621154|NCT02346240|459239303|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
127621155|NCT02346240|459239304|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
127621156|NCT02346240|459239305|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
127621157|NCT02346240|459239306|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
127621158|NCT02346240|459239307|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
127621159|NCT02346240|459239308|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
127621160|NCT02346240|459239309|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
127621161|NCT02346240|459239310|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
127621162|NCT02346240|459239311|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
127621163|NCT02346240|459239312|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
127621164|NCT02346240|459239313|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
127621165|NCT02346240|459239314|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
127621166|NCT02346240|459239315|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
127621167|NCT02346240|459239316|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
127621168|NCT02346240|459239317|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
127621169|NCT02346240|459239318|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
127621170|NCT02346240|459239319|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
127621171|NCT02346240|459239320|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
127621172|NCT02346240|459239321|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
127621173|NCT02346240|459239322|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
127621174|NCT02346240|459239323|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
127621175|NCT02346240|459239324|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
127791680|NCT00845728|459860735|FG001|Overall Study|Abnormal test procedure result (s)|2|||
127791681|NCT00845728|459860734|FG000|Overall Study|Lost to Follow-up|22|||
127791682|NCT00845728|459860735|FG001|Overall Study|Lost to Follow-up|13|||
127791683|NCT00845728|459860734|FG000|Overall Study|Death|24|||
127791684|NCT00845728|459860735|FG001|Overall Study|Death|26|||
127791685|NCT00845728|459860734|FG000|Overall Study|Administrative Problems|34|||
127791686|NCT00845728|459860735|FG001|Overall Study|Administrative Problems|26|||
127791687|NCT00845728|459860734|FG000|Overall Study|Protocol Violation|36|||
127791688|NCT00845728|459860735|FG001|Overall Study|Protocol Violation|24|||
127791689|NCT00845728|459860734|FG000|Overall Study|Lack of Efficacy|51|||
127791690|NCT00845728|459860735|FG001|Overall Study|Lack of Efficacy|39|||
127791691|NCT00845728|459860734|FG000|Overall Study|Adverse Event|101|||
127791692|NCT00845728|459860735|FG001|Overall Study|Adverse Event|96|||
127791693|NCT00845728|459860734|FG000|Overall Study|Withdrawal by Subject|105|||
127791694|NCT00845728|459860735|FG001|Overall Study|Withdrawal by Subject|108|||
127791695|NCT04951037|459860738|FG000|Overall Study|Lost to Follow-up|16|||
127791696|NCT04951037|459860738|FG000|Overall Study|Withdrawal by Subject|5|||
127791697|NCT04951037|459860738|FG000|Overall Study|Completed study assessments but did not complete the intervention|10|||
127791698|NCT05630937|459860739|FG000|Overall Study|Study terminated by sponsor|1|||
127791699|NCT05630937|459860740|FG001|Overall Study|Study terminated by sponsor|1|||
127791700|NCT05630937|459860741|FG002|Overall Study|Study terminated by sponsor|8|||
127791701|NCT05630937|459860742|FG003|Overall Study|Study terminated by sponsor|0|||
127791702|NCT05630937|459860739|FG000|Overall Study|Lost to Follow-up|0|||
127791703|NCT05630937|459860740|FG001|Overall Study|Lost to Follow-up|0|||
127621176|NCT02346240|459239301|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
127621177|NCT02346240|459239302|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
127621178|NCT02346240|459239303|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
127621179|NCT02346240|459239304|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
127621180|NCT02346240|459239305|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
127621181|NCT02346240|459239306|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
127621182|NCT02346240|459239307|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
127621183|NCT02346240|459239308|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
127621184|NCT02346240|459239309|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
127621185|NCT02346240|459239310|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
127621186|NCT02346240|459239311|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
127621187|NCT02346240|459239312|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
127621188|NCT02346240|459239313|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
127621189|NCT02346240|459239314|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
127621190|NCT02346240|459239315|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
127621191|NCT02346240|459239316|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
127621192|NCT02346240|459239317|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
127621193|NCT02346240|459239318|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
127621194|NCT02346240|459239319|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
127621195|NCT02346240|459239320|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
127621196|NCT02346240|459239321|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
127621197|NCT02346240|459239322|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
127621198|NCT02346240|459239323|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
127621199|NCT02346240|459239324|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
127621200|NCT02346240|459239301|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
127621201|NCT02346240|459239302|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
127621202|NCT02346240|459239303|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
127621203|NCT02346240|459239304|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
127621204|NCT02346240|459239305|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
127621205|NCT02346240|459239306|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
127621206|NCT02346240|459239307|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
127621207|NCT02346240|459239308|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
127621208|NCT02346240|459239309|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
127621209|NCT02346240|459239310|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
127621210|NCT02346240|459239311|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
127621211|NCT02346240|459239312|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
127621212|NCT02346240|459239313|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
127621213|NCT02346240|459239314|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
127621214|NCT02346240|459239315|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
127621215|NCT02346240|459239316|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
127621216|NCT02346240|459239317|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
127621217|NCT02346240|459239318|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
127621218|NCT02346240|459239319|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
127621219|NCT02346240|459239320|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
127621220|NCT02346240|459239321|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
127621221|NCT02346240|459239322|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
127621222|NCT02346240|459239323|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
127621223|NCT02346240|459239324|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
127621224|NCT02346240|459239301|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
127621225|NCT02346240|459239302|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
127621226|NCT02346240|459239303|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
127621227|NCT02346240|459239304|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
127621228|NCT02346240|459239305|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
127621229|NCT02346240|459239306|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
127621230|NCT02346240|459239307|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
127621231|NCT02346240|459239308|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
127621232|NCT02346240|459239309|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
127621233|NCT02346240|459239310|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
127621234|NCT02346240|459239311|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
127621235|NCT02346240|459239312|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
127621236|NCT02346240|459239313|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
127621237|NCT02346240|459239314|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
127621238|NCT02346240|459239315|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
127621239|NCT02346240|459239316|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
127621240|NCT02346240|459239317|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
127621241|NCT02346240|459239318|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
127621242|NCT02346240|459239319|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
127621243|NCT02346240|459239320|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
127621244|NCT02346240|459239321|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
127621245|NCT02346240|459239322|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
127621246|NCT02346240|459239323|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
127621247|NCT02346240|459239324|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
127621248|NCT02346240|459239301|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
127621249|NCT02346240|459239302|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
127621250|NCT02346240|459239303|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
127621251|NCT02346240|459239304|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
127621252|NCT02346240|459239305|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
127621253|NCT02346240|459239306|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
127621254|NCT02346240|459239307|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
127621255|NCT02346240|459239308|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
127621256|NCT02346240|459239309|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
127621257|NCT02346240|459239310|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
127621258|NCT02346240|459239311|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
127621259|NCT02346240|459239312|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
127621260|NCT02346240|459239313|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
127621261|NCT02346240|459239314|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
127621262|NCT02346240|459239315|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
127884782|NCT01462695|460202124|FG000|Overall Study|Physician Decision|5|||
127621263|NCT02346240|459239316|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
127621264|NCT02346240|459239317|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
127621265|NCT02346240|459239318|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
127621266|NCT02346240|459239319|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
127621267|NCT02346240|459239320|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
127621268|NCT02346240|459239321|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
127621269|NCT02346240|459239322|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
127621270|NCT02346240|459239323|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
127621271|NCT02346240|459239324|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
127621272|NCT02346240|459239301|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
127621273|NCT02346240|459239302|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
127621274|NCT02346240|459239303|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
127621275|NCT02346240|459239304|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
127621276|NCT02346240|459239305|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
127621277|NCT02346240|459239306|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
127621278|NCT02346240|459239307|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
127621279|NCT02346240|459239308|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
127621280|NCT02346240|459239309|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
127621281|NCT02346240|459239310|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
127621282|NCT02346240|459239311|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
127621283|NCT02346240|459239312|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
127621284|NCT02346240|459239313|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
127621285|NCT02346240|459239314|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
127621286|NCT02346240|459239315|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
127621287|NCT02346240|459239316|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
127621288|NCT02346240|459239317|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
127621289|NCT02346240|459239318|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
127621290|NCT02346240|459239319|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
127621291|NCT02346240|459239320|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
127621292|NCT02346240|459239321|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
127621293|NCT02346240|459239322|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
127621294|NCT02346240|459239323|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
127621295|NCT02346240|459239324|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
127621296|NCT02346240|459239301|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
127621297|NCT02346240|459239302|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
127621298|NCT02346240|459239303|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
127621299|NCT02346240|459239304|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
127621300|NCT02346240|459239305|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
127621301|NCT02346240|459239306|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
127621302|NCT02346240|459239307|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
127621303|NCT02346240|459239308|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
127621304|NCT02346240|459239309|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
127621305|NCT02346240|459239310|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
127621306|NCT02346240|459239311|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
127621307|NCT02346240|459239312|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
127621308|NCT02346240|459239313|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
127621309|NCT02346240|459239314|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
127621310|NCT02346240|459239315|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
127621311|NCT02346240|459239316|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
127621312|NCT02346240|459239317|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
127621313|NCT02346240|459239318|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
127621314|NCT02346240|459239319|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
127621315|NCT02346240|459239320|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
127621316|NCT02346240|459239321|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
127621317|NCT02346240|459239322|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
127621318|NCT02346240|459239323|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
127621319|NCT02346240|459239324|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
127621320|NCT02346240|459239301|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
127621321|NCT02346240|459239302|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
127621322|NCT02346240|459239303|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
127621323|NCT02346240|459239304|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
127621324|NCT02346240|459239305|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
127621325|NCT02346240|459239306|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
127621326|NCT02346240|459239307|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
127621327|NCT02346240|459239308|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
127621328|NCT02346240|459239309|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
127621329|NCT02346240|459239310|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
127621330|NCT02346240|459239311|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
127621331|NCT02346240|459239312|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
127621332|NCT02346240|459239313|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
127621333|NCT02346240|459239314|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
127621334|NCT02346240|459239315|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
127621335|NCT02346240|459239316|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
127621336|NCT02346240|459239317|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
127621337|NCT02346240|459239318|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
127621338|NCT02346240|459239319|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
127621339|NCT02346240|459239320|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
127621340|NCT02346240|459239321|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
127621341|NCT02346240|459239322|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
127621342|NCT02346240|459239323|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
127621343|NCT02346240|459239324|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
127621344|NCT02346240|459239301|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127621345|NCT02346240|459239302|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127621346|NCT02346240|459239303|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127621347|NCT02346240|459239304|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127621348|NCT02346240|459239305|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127621349|NCT02346240|459239306|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127621350|NCT02346240|459239307|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127621351|NCT02346240|459239308|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127621352|NCT02346240|459239309|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127621353|NCT02346240|459239310|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127621354|NCT02346240|459239311|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127621355|NCT02346240|459239312|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127621356|NCT02346240|459239313|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127621357|NCT02346240|459239314|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127621358|NCT02346240|459239315|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
127621359|NCT02346240|459239316|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127621360|NCT02346240|459239317|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127621361|NCT02346240|459239318|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127621362|NCT02346240|459239319|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127621363|NCT02346240|459239320|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127621364|NCT02346240|459239321|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127621365|NCT02346240|459239322|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127621366|NCT02346240|459239323|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127621367|NCT02346240|459239324|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127621368|NCT02346240|459239301|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
127621369|NCT02346240|459239302|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
127621370|NCT02346240|459239303|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
127621371|NCT02346240|459239304|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
127621372|NCT02346240|459239305|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
127621373|NCT02346240|459239306|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
127621374|NCT02346240|459239307|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
127621375|NCT02346240|459239308|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
127621376|NCT02346240|459239309|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
127621377|NCT02346240|459239310|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
127621378|NCT02346240|459239311|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
127621379|NCT02346240|459239312|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
127700876|NCT02601313|459533087|FG001|Overall Study|Enrolled, did not initiate AC|0|||
127700877|NCT02601313|459533088|FG002|Overall Study|Enrolled, did not initiate AC|0|||
127700878|NCT02601313|459533086|FG000|Overall Study|Full consent withdrawal|0|||
127700879|NCT02601313|459533087|FG001|Overall Study|Full consent withdrawal|3|||
127700880|NCT02601313|459533088|FG002|Overall Study|Full consent withdrawal|2|||
127700881|NCT02601313|459533086|FG000|Overall Study|Lost to Follow-up|0|||
127700882|NCT02601313|459533087|FG001|Overall Study|Lost to Follow-up|1|||
127700883|NCT02601313|459533088|FG002|Overall Study|Lost to Follow-up|1|||
127700884|NCT03766009|459535000|FG000|Usual Care|Death|0|||
127700885|NCT03766009|459535001|FG001|Usual Care|Death|0|||
127700886|NCT03766009|459535002|FG002|Usual Care|Death|0|||
127700887|NCT03766009|459535003|FG003|Usual Care|Death|1|||
127700888|NCT03766009|459535004|FG004|Usual Care|Death|0|||
127700889|NCT03766009|459535005|FG005|Usual Care|Death|0|||
127700890|NCT03766009|459535000|FG000|Usual Care|Lost to Follow-up|0|||
127621380|NCT02346240|459239313|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
127621381|NCT02346240|459239314|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
127621382|NCT02346240|459239315|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
127621383|NCT02346240|459239316|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
127621384|NCT02346240|459239317|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
127621385|NCT02346240|459239318|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
127621386|NCT02346240|459239319|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
127621387|NCT02346240|459239320|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
127621388|NCT02346240|459239321|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
127621389|NCT02346240|459239322|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
127621390|NCT02346240|459239323|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
127621391|NCT02346240|459239324|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
127621392|NCT02346240|459239301|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
127621393|NCT02346240|459239302|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
127621394|NCT02346240|459239303|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
127621395|NCT02346240|459239304|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
127621396|NCT02346240|459239305|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
127621397|NCT02346240|459239306|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
127621398|NCT02346240|459239307|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
127621399|NCT02346240|459239308|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
127621400|NCT02346240|459239309|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
127621401|NCT02346240|459239310|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
127621402|NCT02346240|459239311|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
127621403|NCT02346240|459239312|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
127621404|NCT02346240|459239313|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
127621405|NCT02346240|459239314|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
127621406|NCT02346240|459239315|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
127621407|NCT02346240|459239316|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
127621408|NCT02346240|459239317|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
127621409|NCT02346240|459239318|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
127621410|NCT02346240|459239319|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
127621411|NCT02346240|459239320|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
127621412|NCT02346240|459239321|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
127621413|NCT02346240|459239322|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
127621414|NCT02346240|459239323|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
127621415|NCT02346240|459239324|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
127621416|NCT02346240|459239301|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
127621417|NCT02346240|459239302|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
127621418|NCT02346240|459239303|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
127621419|NCT02346240|459239304|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
127621420|NCT02346240|459239305|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
127621421|NCT02346240|459239306|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
127621422|NCT02346240|459239307|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
127621423|NCT02346240|459239308|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
127621424|NCT02346240|459239309|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
127621425|NCT02346240|459239310|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
127621426|NCT02346240|459239311|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
127621427|NCT02346240|459239312|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
127621428|NCT02346240|459239313|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
127791704|NCT05630937|459860741|FG002|Overall Study|Lost to Follow-up|1|||
127791705|NCT05630937|459860742|FG003|Overall Study|Lost to Follow-up|0|||
127791706|NCT05630937|459860739|FG000|Overall Study|Enrolled but not treated|0|||
127791707|NCT05630937|459860740|FG001|Overall Study|Enrolled but not treated|0|||
127791708|NCT05630937|459860741|FG002|Overall Study|Enrolled but not treated|0|||
127791709|NCT05630937|459860742|FG003|Overall Study|Enrolled but not treated|1|||
127791710|NCT01604265|459860749|FG000|Overall Study|Adverse Event|1|||
127791711|NCT01604265|459860750|FG001|Overall Study|Adverse Event|0|||
127791712|NCT01604265|459860749|FG000|Overall Study|Withdrawal by Subject|1|||
127791713|NCT01604265|459860750|FG001|Overall Study|Withdrawal by Subject|0|||
127791714|NCT02706873|459860751|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
127791715|NCT02706873|459860752|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
127791716|NCT02706873|459860753|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
127791717|NCT02706873|459860754|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
127884783|NCT01462695|460202125|FG001|Overall Study|Physician Decision|0|||
127884784|NCT01462695|460202124|FG000|Overall Study|Withdrawal by Subject|2|||
127884785|NCT01462695|460202125|FG001|Overall Study|Withdrawal by Subject|0|||
127884786|NCT01462695|460202124|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
127884787|NCT01462695|460202125|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
127884788|NCT00068237|460202126|FG000|Overall Study|Ineligible|3|||
127884789|NCT00068237|460202126|FG000|Overall Study|No protocol treatment received|2|||
127884790|NCT01358708|460202127|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
127884791|NCT01358708|460202128|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
127884792|NCT01358708|460202127|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
127884793|NCT01358708|460202128|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
127884794|NCT03056001|460202129|FG000|Overall Study|Death|24|||
127884795|NCT00363129|460202132|FG000|Overall Study|Withdrawal by Subject|11|||
127884796|NCT00363129|460202133|FG001|Overall Study|Withdrawal by Subject|18|||
127884797|NCT00363129|460202132|FG000|Overall Study|Adverse Event|8|||
127884798|NCT00363129|460202133|FG001|Overall Study|Adverse Event|3|||
127884799|NCT00363129|460202132|FG000|Overall Study|Alternate Treatment|2|||
127884800|NCT00363129|460202133|FG001|Overall Study|Alternate Treatment|4|||
127884801|NCT00363129|460202132|FG000|Overall Study|Other Medical Problems|2|||
127884802|NCT00363129|460202133|FG001|Overall Study|Other Medical Problems|4|||
127884803|NCT00363129|460202132|FG000|Overall Study|Death|0|||
127884804|NCT00363129|460202133|FG001|Overall Study|Death|1|||
127884805|NCT00363129|460202132|FG000|Overall Study|Other Reasons|6|||
127884806|NCT00363129|460202133|FG001|Overall Study|Other Reasons|3|||
127884807|NCT03707522|460202134|FG000|Overall Study|Lost to Follow-up|24|||
127884808|NCT03707522|460202135|FG001|Overall Study|Lost to Follow-up|27|||
127884809|NCT03707522|460202136|FG002|Overall Study|Lost to Follow-up|41|||
127884810|NCT03707522|460202137|FG003|Overall Study|Lost to Follow-up|36|||
127884811|NCT04363736|460202138|FG000|Overall Study|Withdrawal by Subject|1|||
127884812|NCT04363736|460202139|FG001|Overall Study|Withdrawal by Subject|0|||
127884813|NCT04363736|460202138|FG000|Overall Study|Lost to Follow-up|10|||
127884814|NCT04363736|460202139|FG001|Overall Study|Lost to Follow-up|7|||
127884815|NCT04363736|460202138|FG000|Overall Study|Death|8|||
127884816|NCT04363736|460202139|FG001|Overall Study|Death|6|||
127884817|NCT03797222|460202140|FG000|Overall Study|Withdrawal by Subject|1|||
127884818|NCT00725725|460202143|FG000|Overall Study|Adverse Event|1|||
127884819|NCT00725725|460202144|FG001|Overall Study|Adverse Event|3|||
127884820|NCT00725725|460202145|FG002|Overall Study|Adverse Event|2|||
127884821|NCT00725725|460202143|FG000|Overall Study|Lost to Follow-up|2|||
127884822|NCT00725725|460202144|FG001|Overall Study|Lost to Follow-up|0|||
127884823|NCT00725725|460202145|FG002|Overall Study|Lost to Follow-up|2|||
127884824|NCT00725725|460202143|FG000|Overall Study|Withdrawal by Subject|1|||
127884825|NCT00725725|460202144|FG001|Overall Study|Withdrawal by Subject|0|||
127884826|NCT00725725|460202145|FG002|Overall Study|Withdrawal by Subject|1|||
127884827|NCT00725725|460202143|FG000|Overall Study|Protocol Violation|0|||
127621429|NCT02346240|459239314|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
127621430|NCT02346240|459239315|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
127621431|NCT02346240|459239316|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
127621432|NCT02346240|459239317|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
127621433|NCT02346240|459239318|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
127621434|NCT02346240|459239319|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
127621435|NCT02346240|459239320|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
127621436|NCT02346240|459239321|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
127621437|NCT02346240|459239322|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
127621438|NCT02346240|459239323|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
127621439|NCT02346240|459239324|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
127621440|NCT02346240|459239301|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
127621441|NCT02346240|459239302|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
127621442|NCT02346240|459239303|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
127621443|NCT02346240|459239304|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
127621444|NCT02346240|459239305|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
127621445|NCT02346240|459239306|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
127621446|NCT02346240|459239307|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
127642610|NCT05554237|459313094|FG009|Part 2 (7 Days)|Adverse Event|1|||
127884828|NCT00725725|460202144|FG001|Overall Study|Protocol Violation|1|||
127884829|NCT00725725|460202145|FG002|Overall Study|Protocol Violation|0|||
127884830|NCT01619085|460202146|FG000|Overall Study|Adverse Event|231|||
127884831|NCT01619085|460202146|FG000|Overall Study|Protocol Violation|4|||
127884832|NCT01619085|460202146|FG000|Overall Study|Lost to Follow-up|3|||
127884833|NCT01619085|460202146|FG000|Overall Study|Withdrawal by Subject|45|||
127884834|NCT01619085|460202146|FG000|Overall Study|Other than specified|96|||
127884835|NCT01619085|460202146|FG000|Overall Study|Not treated|1|||
127884836|NCT01619085|460202146|FG000|Overall Study|Death|145|||
127884837|NCT00990093|460202147|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
127621447|NCT02346240|459239308|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
127621448|NCT02346240|459239309|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
127621449|NCT02346240|459239310|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
127621450|NCT02346240|459239311|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
127621451|NCT02346240|459239312|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
127621452|NCT02346240|459239313|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
127621453|NCT02346240|459239314|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
127621454|NCT02346240|459239315|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
127621455|NCT02346240|459239316|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
127621456|NCT02346240|459239317|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
127621457|NCT02346240|459239318|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
127621458|NCT02346240|459239319|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
127621459|NCT02346240|459239320|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
127621460|NCT02346240|459239321|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
127621461|NCT02346240|459239322|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
127621462|NCT02346240|459239323|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
127621463|NCT02346240|459239324|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
127621464|NCT02346240|459239301|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
127621465|NCT02346240|459239302|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
127621466|NCT02346240|459239303|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
127621467|NCT02346240|459239304|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
127621468|NCT02346240|459239305|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
127621469|NCT02346240|459239306|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
127621470|NCT02346240|459239307|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
127621471|NCT02346240|459239308|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
127621472|NCT02346240|459239309|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
127621473|NCT02346240|459239310|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
127621474|NCT02346240|459239311|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
127621475|NCT02346240|459239312|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
127621476|NCT02346240|459239313|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
127621477|NCT02346240|459239314|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
127621478|NCT02346240|459239315|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
127621479|NCT02346240|459239316|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
127621480|NCT02346240|459239317|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
127621481|NCT02346240|459239318|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
127621482|NCT02346240|459239319|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
127621483|NCT02346240|459239320|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
127621484|NCT02346240|459239321|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
127621485|NCT02346240|459239322|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
127621486|NCT02346240|459239323|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
127621487|NCT02346240|459239324|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
127621488|NCT02346240|459239301|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
127621489|NCT02346240|459239302|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
127621490|NCT02346240|459239303|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
127621491|NCT02346240|459239304|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
127621492|NCT02346240|459239305|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
127621493|NCT02346240|459239306|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
127621494|NCT02346240|459239307|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
127621495|NCT02346240|459239308|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
127621496|NCT02346240|459239309|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
127621497|NCT02346240|459239310|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
127621498|NCT02346240|459239311|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
127621499|NCT02346240|459239312|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
127621500|NCT02346240|459239313|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
127642611|NCT05554237|459313095|FG010|Part 2 (7 Days)|Adverse Event|0|||
127621501|NCT02346240|459239314|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
127884838|NCT00990093|460202148|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
127884839|NCT00990093|460202147|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
127884840|NCT00990093|460202148|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
127884841|NCT00990093|460202147|FG000|Test Period 1 (1-14 Days)|Other|1|||
127884842|NCT00990093|460202148|FG001|Test Period 1 (1-14 Days)|Other|0|||
127884843|NCT00990093|460202147|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
127884844|NCT00990093|460202148|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
127884845|NCT00990093|460202147|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
127884846|NCT00990093|460202148|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
127884847|NCT00990093|460202147|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
127884848|NCT00990093|460202148|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
127884849|NCT00990093|460202147|FG000|Test Period 2 (15-28 Days)|Other|0|||
127884850|NCT00990093|460202148|FG001|Test Period 2 (15-28 Days)|Other|1|||
127884851|NCT04556838|460202149|FG000|Overall Study|Withdrawal by Subject|3|||
127621502|NCT02346240|459239315|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
127621503|NCT02346240|459239316|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
127621504|NCT02346240|459239317|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
127621505|NCT02346240|459239318|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
127621506|NCT02346240|459239319|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
127621507|NCT02346240|459239320|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
127621508|NCT02346240|459239321|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
127621509|NCT02346240|459239322|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
127621510|NCT02346240|459239323|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
127621511|NCT02346240|459239324|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
127621512|NCT02346240|459239301|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
127621513|NCT02346240|459239302|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
127621514|NCT02346240|459239303|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
127621515|NCT02346240|459239304|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
127884852|NCT04556838|460202150|FG001|Overall Study|Withdrawal by Subject|1|||
127884853|NCT04556838|460202151|FG002|Overall Study|Withdrawal by Subject|2|||
127884854|NCT04556838|460202149|FG000|Overall Study|Adverse Event|0|||
127884855|NCT04556838|460202150|FG001|Overall Study|Adverse Event|1|||
127884856|NCT04556838|460202151|FG002|Overall Study|Adverse Event|1|||
127884857|NCT04556838|460202149|FG000|Overall Study|Lost to Follow-up|0|||
127884858|NCT04556838|460202150|FG001|Overall Study|Lost to Follow-up|0|||
127884859|NCT04556838|460202151|FG002|Overall Study|Lost to Follow-up|2|||
127884860|NCT04556838|460202149|FG000|Overall Study|Subject travel|0|||
127884861|NCT04556838|460202150|FG001|Overall Study|Subject travel|1|||
127884862|NCT04556838|460202151|FG002|Overall Study|Subject travel|0|||
127884863|NCT04556838|460202149|FG000|Overall Study|Physician Decision|1|||
127884864|NCT04556838|460202150|FG001|Overall Study|Physician Decision|0|||
127621516|NCT02346240|459239305|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
127621517|NCT02346240|459239306|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
127621518|NCT02346240|459239307|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
127621519|NCT02346240|459239308|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
127621520|NCT02346240|459239309|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
127621521|NCT02346240|459239310|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
127621522|NCT02346240|459239311|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
127621523|NCT02346240|459239312|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
127621524|NCT02346240|459239313|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
127621525|NCT02346240|459239314|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
127621526|NCT02346240|459239315|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
127621527|NCT02346240|459239316|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
127621528|NCT02346240|459239317|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
127621529|NCT02346240|459239318|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
127621530|NCT02346240|459239319|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
127621531|NCT02346240|459239320|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
127621532|NCT02346240|459239321|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
127621533|NCT02346240|459239322|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
127621534|NCT02346240|459239323|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
127621535|NCT02346240|459239324|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
127621536|NCT02346240|459239301|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
127621537|NCT02346240|459239302|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
127621538|NCT02346240|459239303|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
127621539|NCT02346240|459239304|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
127621540|NCT02346240|459239305|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
127621541|NCT02346240|459239306|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
127621542|NCT02346240|459239307|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
127621543|NCT02346240|459239308|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
127621544|NCT02346240|459239309|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
127621545|NCT02346240|459239310|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
127621546|NCT02346240|459239311|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
127791718|NCT02706873|459860751|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
127791719|NCT02706873|459860752|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
127791720|NCT02706873|459860753|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
127791721|NCT02706873|459860754|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
127791722|NCT02706873|459860751|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
127791723|NCT02706873|459860752|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
127791724|NCT02706873|459860753|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
127791725|NCT02706873|459860754|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
127791726|NCT02706873|459860751|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
127791727|NCT02706873|459860752|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
127884865|NCT04556838|460202151|FG002|Overall Study|Physician Decision|0|||
127884866|NCT00995930|460202152|FG000|Overall Study|Protocol deviation|2|||
127884867|NCT00995930|460202153|FG001|Overall Study|Protocol deviation|5|||
127621547|NCT02346240|459239312|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
127621548|NCT02346240|459239313|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
127621549|NCT02346240|459239314|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
127621550|NCT02346240|459239315|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
127621551|NCT02346240|459239316|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
127621552|NCT02346240|459239317|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
127642612|NCT05554237|459313096|FG011|Part 2 (7 Days)|Adverse Event|0|||
127791728|NCT02706873|459860753|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
127791729|NCT02706873|459860754|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
127791730|NCT02706873|459860751|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
127791731|NCT02706873|459860752|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
127791732|NCT02706873|459860753|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
127621553|NCT02346240|459239318|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
127621554|NCT02346240|459239319|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
127621555|NCT02346240|459239320|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
127621556|NCT02346240|459239321|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
127621557|NCT02346240|459239322|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
127621558|NCT02346240|459239323|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
127621559|NCT02346240|459239324|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
127621560|NCT02346240|459239301|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
127621561|NCT02346240|459239302|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
127884868|NCT00995930|460202152|FG000|Overall Study|Death|0|||
127884869|NCT00995930|460202153|FG001|Overall Study|Death|1|||
127884870|NCT00995930|460202152|FG000|Overall Study|Administrative problems|4|||
127884871|NCT00995930|460202153|FG001|Overall Study|Administrative problems|2|||
127884872|NCT00995930|460202152|FG000|Overall Study|Lost to Follow-up|1|||
127884873|NCT00995930|460202153|FG001|Overall Study|Lost to Follow-up|2|||
127884874|NCT00995930|460202152|FG000|Overall Study|Withdrawal by Subject|3|||
127884875|NCT00995930|460202153|FG001|Overall Study|Withdrawal by Subject|4|||
127884876|NCT00995930|460202152|FG000|Overall Study|Adverse Event|11|||
127884877|NCT00995930|460202153|FG001|Overall Study|Adverse Event|14|||
127884878|NCT01458119|460202154|FG000|Overall Study|Physician Decision|4|||
127884879|NCT01458119|460202154|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
127884880|NCT01458119|460202154|FG000|Overall Study|Pregnancy|1|||
127884881|NCT01458119|460202154|FG000|Overall Study|Death|2|||
127884882|NCT01458119|460202154|FG000|Overall Study|Adverse Event|1|||
127884883|NCT01458119|460202154|FG000|Overall Study|Consent Withdrawn by Participant|8|||
127884884|NCT01458119|460202154|FG000|Overall Study|Non-compliance With Study Drug|3|||
127884885|NCT05003167|460202155|FG000|Overall Study|Withdrawal by Subject|1|||
127884886|NCT02367781|460202156|FG000|Overall Study|Withdrawal by Subject|20|||
127884887|NCT02367781|460202157|FG001|Overall Study|Withdrawal by Subject|13|||
127884888|NCT02367781|460202156|FG000|Overall Study|Protocol Violation|0|||
127884889|NCT02367781|460202157|FG001|Overall Study|Protocol Violation|1|||
127884890|NCT02367781|460202156|FG000|Overall Study|Physician Decision|7|||
127884891|NCT02367781|460202157|FG001|Overall Study|Physician Decision|0|||
127884892|NCT02367781|460202156|FG000|Overall Study|Randomized in Error|5|||
127884893|NCT02367781|460202157|FG001|Overall Study|Randomized in Error|4|||
127884894|NCT02367781|460202156|FG000|Overall Study|Non-Compliance|1|||
127884895|NCT02367781|460202157|FG001|Overall Study|Non-Compliance|0|||
127884896|NCT02367781|460202156|FG000|Overall Study|Lost to Follow-up|1|||
127884897|NCT02367781|460202157|FG001|Overall Study|Lost to Follow-up|2|||
127884898|NCT02367781|460202156|FG000|Overall Study|Death|330|||
127884899|NCT02367781|460202157|FG001|Overall Study|Death|176|||
127884900|NCT02367781|460202156|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
127884901|NCT02367781|460202157|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
127884902|NCT02367781|460202156|FG000|Overall Study|Prolonged Hospitalization|1|||
127884903|NCT02367781|460202157|FG001|Overall Study|Prolonged Hospitalization|0|||
127884904|NCT02367781|460202156|FG000|Overall Study|Death Prior First Dose|1|||
127884905|NCT02367781|460202157|FG001|Overall Study|Death Prior First Dose|0|||
127884906|NCT02367781|460202156|FG000|Overall Study|Administrative-Change Facility|1|||
127621562|NCT02346240|459239303|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
127621563|NCT02346240|459239304|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
127621564|NCT02346240|459239305|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
127621565|NCT02346240|459239306|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
127621566|NCT02346240|459239307|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
127621567|NCT02346240|459239308|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
127621568|NCT02346240|459239309|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
127621569|NCT02346240|459239310|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
127621570|NCT02346240|459239311|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
127621571|NCT02346240|459239312|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
127621572|NCT02346240|459239313|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
127621573|NCT02346240|459239314|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
127621574|NCT02346240|459239315|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
127621575|NCT02346240|459239316|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
127621576|NCT02346240|459239317|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
127621577|NCT02346240|459239318|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
127621578|NCT02346240|459239319|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
127621579|NCT02346240|459239320|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
127621580|NCT02346240|459239321|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
127621581|NCT02346240|459239322|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
127621582|NCT02346240|459239323|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
127621583|NCT02346240|459239324|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
127621584|NCT02346240|459239301|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
127621585|NCT02346240|459239302|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
127621586|NCT02346240|459239303|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
127621587|NCT02346240|459239304|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
127621588|NCT02346240|459239305|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
127621589|NCT02346240|459239306|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
127621590|NCT02346240|459239307|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
127621591|NCT02346240|459239308|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
127621592|NCT02346240|459239309|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
127621593|NCT02346240|459239310|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
127621594|NCT02346240|459239311|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
127621595|NCT02346240|459239312|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
127621596|NCT02346240|459239313|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
127621597|NCT02346240|459239314|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
127621598|NCT02346240|459239315|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
127621599|NCT02346240|459239316|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
127621600|NCT02346240|459239317|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
127621601|NCT02346240|459239318|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
127621602|NCT02346240|459239319|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
127621603|NCT02346240|459239320|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
127621604|NCT02346240|459239321|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
127621605|NCT02346240|459239322|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
127621606|NCT02346240|459239323|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
127621607|NCT02346240|459239324|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
127621608|NCT02346240|459239301|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
127621609|NCT02346240|459239302|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
127621610|NCT02346240|459239303|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
127621611|NCT02346240|459239304|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
127621612|NCT02346240|459239305|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
127621613|NCT02346240|459239306|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
127791733|NCT02706873|459860754|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
127791734|NCT02706873|459860751|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
127791735|NCT02706873|459860752|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
127791736|NCT02706873|459860753|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
127791737|NCT02706873|459860754|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
127791738|NCT02706873|459860751|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
127791739|NCT02706873|459860752|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
127791740|NCT02706873|459860753|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
127791741|NCT02706873|459860754|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
127791742|NCT02706873|459860751|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
127791743|NCT02706873|459860752|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
127621614|NCT02346240|459239307|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
127621615|NCT02346240|459239308|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
127621616|NCT02346240|459239309|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
127621617|NCT02346240|459239310|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
127621618|NCT02346240|459239311|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
127621619|NCT02346240|459239312|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
127621620|NCT02346240|459239313|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
127621621|NCT02346240|459239314|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
127621622|NCT02346240|459239315|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
127621623|NCT02346240|459239316|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
127621624|NCT02346240|459239317|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
127621625|NCT02346240|459239318|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
127621626|NCT02346240|459239319|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
127621627|NCT02346240|459239320|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
127621628|NCT02346240|459239321|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
127621629|NCT02346240|459239322|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
127621630|NCT02346240|459239323|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
127621631|NCT02346240|459239324|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
127621632|NCT02346240|459239301|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127621633|NCT02346240|459239302|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127621634|NCT02346240|459239303|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127621635|NCT02346240|459239304|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127621636|NCT02346240|459239305|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127621637|NCT02346240|459239306|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127621638|NCT02346240|459239307|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127621639|NCT02346240|459239308|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127621640|NCT02346240|459239309|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127791744|NCT02706873|459860753|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
127791745|NCT02706873|459860754|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
127791746|NCT02706873|459860751|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
127621641|NCT02346240|459239310|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127621642|NCT02346240|459239311|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127621643|NCT02346240|459239312|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127621644|NCT02346240|459239313|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127621645|NCT02346240|459239314|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127621646|NCT02346240|459239315|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127621647|NCT02346240|459239316|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127621648|NCT02346240|459239317|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127621649|NCT02346240|459239318|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127621650|NCT02346240|459239319|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
127621651|NCT02346240|459239320|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127621652|NCT02346240|459239321|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127621653|NCT02346240|459239322|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
127621654|NCT02346240|459239323|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127621655|NCT02346240|459239324|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127621656|NCT02346240|459239301|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
127621657|NCT02346240|459239302|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
127621658|NCT02346240|459239303|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
127621659|NCT02346240|459239304|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
127621660|NCT02346240|459239305|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
127621661|NCT02346240|459239306|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
127621662|NCT02346240|459239307|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
127621663|NCT02346240|459239308|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
127621664|NCT02346240|459239309|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
127621665|NCT02346240|459239310|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
127621666|NCT02346240|459239311|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
127621667|NCT02346240|459239312|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
127621668|NCT02346240|459239313|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
127621669|NCT02346240|459239314|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
127621670|NCT02346240|459239315|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
127621671|NCT02346240|459239316|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
127791747|NCT02706873|459860752|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
127621672|NCT02346240|459239317|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
127621673|NCT02346240|459239318|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
127791748|NCT02706873|459860753|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
127621674|NCT02346240|459239319|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
127621675|NCT02346240|459239320|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
127621676|NCT02346240|459239321|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
127621677|NCT02346240|459239322|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
127621678|NCT02346240|459239323|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
127621679|NCT02346240|459239324|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
127621680|NCT02346240|459239301|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
127621681|NCT02346240|459239302|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
127621682|NCT02346240|459239303|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
127621683|NCT02346240|459239304|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
127621684|NCT02346240|459239305|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
127621685|NCT02346240|459239306|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
127621686|NCT02346240|459239307|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
127621687|NCT02346240|459239308|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
127621688|NCT02346240|459239309|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
127621689|NCT02346240|459239310|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
127621690|NCT02346240|459239311|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
127621691|NCT02346240|459239312|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
127621692|NCT02346240|459239313|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
127621693|NCT02346240|459239314|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
127621694|NCT02346240|459239315|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
127621695|NCT02346240|459239316|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
127621696|NCT02346240|459239317|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
127621697|NCT02346240|459239318|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
127621698|NCT02346240|459239319|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
127621699|NCT02346240|459239320|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
127621700|NCT02346240|459239321|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
127621701|NCT02346240|459239322|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
127621702|NCT02346240|459239323|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
127621703|NCT02346240|459239324|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
127621704|NCT02346240|459239301|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
127621705|NCT02346240|459239302|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
127621706|NCT02346240|459239303|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
127621707|NCT02346240|459239304|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
127621708|NCT02346240|459239305|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
127621709|NCT02346240|459239306|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
127621710|NCT02346240|459239307|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
127621711|NCT02346240|459239308|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
127621712|NCT02346240|459239309|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
127621713|NCT02346240|459239310|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
127621714|NCT02346240|459239311|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
127621715|NCT02346240|459239312|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
127621716|NCT02346240|459239313|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
127621717|NCT02346240|459239314|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
127621718|NCT02346240|459239315|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
127621719|NCT02346240|459239316|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
127621720|NCT02346240|459239317|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
127621721|NCT02346240|459239318|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
127621722|NCT02346240|459239319|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
127621723|NCT02346240|459239320|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
127621724|NCT02346240|459239321|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
127621725|NCT02346240|459239322|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
127621726|NCT02346240|459239323|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
127621727|NCT02346240|459239324|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
127621728|NCT02346240|459239301|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
127621729|NCT02346240|459239302|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
127621730|NCT02346240|459239303|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
127700891|NCT03766009|459535001|FG001|Usual Care|Lost to Follow-up|0|||
127700892|NCT03766009|459535002|FG002|Usual Care|Lost to Follow-up|0|||
127700893|NCT03766009|459535003|FG003|Usual Care|Lost to Follow-up|1|||
127700894|NCT03766009|459535004|FG004|Usual Care|Lost to Follow-up|0|||
127700895|NCT03766009|459535005|FG005|Usual Care|Lost to Follow-up|0|||
127700896|NCT03766009|459535000|FG000|Usual Care|Treatment goals changed due to metastatic disease|0|||
127700897|NCT03766009|459535001|FG001|Usual Care|Treatment goals changed due to metastatic disease|0|||
127700898|NCT03766009|459535002|FG002|Usual Care|Treatment goals changed due to metastatic disease|2|||
127700899|NCT03766009|459535003|FG003|Usual Care|Treatment goals changed due to metastatic disease|0|||
127700900|NCT03766009|459535004|FG004|Usual Care|Treatment goals changed due to metastatic disease|1|||
127700901|NCT03766009|459535005|FG005|Usual Care|Treatment goals changed due to metastatic disease|0|||
127700902|NCT03766009|459535000|FG000|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
127700903|NCT03766009|459535001|FG001|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
127791749|NCT02706873|459860754|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
127791750|NCT02706873|459860751|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
127791751|NCT02706873|459860752|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
127791752|NCT02706873|459860753|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
127791753|NCT02706873|459860754|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
127791754|NCT02706873|459860751|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
127791755|NCT02706873|459860752|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
127791756|NCT02706873|459860753|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
127791757|NCT02706873|459860754|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
127791758|NCT02706873|459860751|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
127791759|NCT02706873|459860752|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
127791760|NCT02706873|459860753|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
127791761|NCT02706873|459860754|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
127791762|NCT02706873|459860751|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
127791763|NCT02706873|459860752|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
127791764|NCT02706873|459860753|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
127791765|NCT02706873|459860754|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
127791766|NCT02599961|459860758|FG000|Overall Study|Withdrawal by Subject|1|||
127791767|NCT02599961|459860758|FG000|Overall Study|Subject Non-Compliance|2|||
127791768|NCT02599961|459860758|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
127791769|NCT02599961|459860758|FG000|Overall Study|Other, Not Specified|3|||
127791770|NCT00464334|459860761|FG000|Overall Study|Adverse Event|0|||
127791771|NCT00464334|459860762|FG001|Overall Study|Adverse Event|0|||
127791772|NCT00464334|459860763|FG002|Overall Study|Adverse Event|0|||
127791773|NCT00464334|459860764|FG003|Overall Study|Adverse Event|1|||
127791774|NCT00464334|459860765|FG004|Overall Study|Adverse Event|1|||
127791775|NCT00464334|459860766|FG005|Overall Study|Adverse Event|1|||
127791776|NCT00464334|459860767|FG006|Overall Study|Adverse Event|0|||
127791777|NCT00464334|459860768|FG007|Overall Study|Adverse Event|0|||
127791778|NCT00464334|459860769|FG008|Overall Study|Adverse Event|2|||
127791779|NCT00464334|459860770|FG009|Overall Study|Adverse Event|1|||
127791780|NCT00464334|459860771|FG010|Overall Study|Adverse Event|2|||
127791781|NCT00464334|459860761|FG000|Overall Study|Lack of Efficacy|0|||
127791782|NCT00464334|459860762|FG001|Overall Study|Lack of Efficacy|1|||
127791783|NCT00464334|459860763|FG002|Overall Study|Lack of Efficacy|0|||
127791784|NCT00464334|459860764|FG003|Overall Study|Lack of Efficacy|0|||
127791785|NCT00464334|459860765|FG004|Overall Study|Lack of Efficacy|0|||
127791786|NCT00464334|459860766|FG005|Overall Study|Lack of Efficacy|0|||
127791787|NCT00464334|459860767|FG006|Overall Study|Lack of Efficacy|0|||
127791788|NCT00464334|459860768|FG007|Overall Study|Lack of Efficacy|0|||
127791789|NCT00464334|459860769|FG008|Overall Study|Lack of Efficacy|0|||
127791790|NCT00464334|459860770|FG009|Overall Study|Lack of Efficacy|0|||
127791791|NCT00464334|459860771|FG010|Overall Study|Lack of Efficacy|0|||
127791792|NCT00464334|459860761|FG000|Overall Study|Lost to Follow-up|0|||
127791793|NCT00464334|459860762|FG001|Overall Study|Lost to Follow-up|0|||
127791794|NCT00464334|459860763|FG002|Overall Study|Lost to Follow-up|1|||
127791795|NCT00464334|459860764|FG003|Overall Study|Lost to Follow-up|0|||
127791796|NCT00464334|459860765|FG004|Overall Study|Lost to Follow-up|1|||
127791797|NCT00464334|459860766|FG005|Overall Study|Lost to Follow-up|0|||
127791798|NCT00464334|459860767|FG006|Overall Study|Lost to Follow-up|1|||
127791799|NCT00464334|459860768|FG007|Overall Study|Lost to Follow-up|0|||
127791800|NCT00464334|459860769|FG008|Overall Study|Lost to Follow-up|0|||
127791801|NCT00464334|459860770|FG009|Overall Study|Lost to Follow-up|0|||
127791802|NCT00464334|459860771|FG010|Overall Study|Lost to Follow-up|2|||
127791803|NCT00464334|459860761|FG000|Overall Study|Progressive Disease|0|||
127791804|NCT00464334|459860762|FG001|Overall Study|Progressive Disease|0|||
127791805|NCT00464334|459860763|FG002|Overall Study|Progressive Disease|0|||
127791806|NCT00464334|459860764|FG003|Overall Study|Progressive Disease|0|||
127791807|NCT00464334|459860765|FG004|Overall Study|Progressive Disease|0|||
127791808|NCT00464334|459860766|FG005|Overall Study|Progressive Disease|1|||
127791809|NCT00464334|459860767|FG006|Overall Study|Progressive Disease|0|||
127621731|NCT02346240|459239304|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
127621732|NCT02346240|459239305|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
127621733|NCT02346240|459239306|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
127621734|NCT02346240|459239307|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
127621735|NCT02346240|459239308|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
127621736|NCT02346240|459239309|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
127621737|NCT02346240|459239310|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
127621738|NCT02346240|459239311|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
127621739|NCT02346240|459239312|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
127621740|NCT02346240|459239313|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
127621741|NCT02346240|459239314|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
127621742|NCT02346240|459239315|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
127621743|NCT02346240|459239316|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
127621744|NCT02346240|459239317|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
127621745|NCT02346240|459239318|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
127621746|NCT02346240|459239319|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
127621747|NCT02346240|459239320|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
127621748|NCT02346240|459239321|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
127621749|NCT02346240|459239322|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
127621750|NCT02346240|459239323|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
127621751|NCT02346240|459239324|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
127621752|NCT02346240|459239301|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
127621753|NCT02346240|459239302|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
127621754|NCT02346240|459239303|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
127621755|NCT02346240|459239304|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
127621756|NCT02346240|459239305|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
127621757|NCT02346240|459239306|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
127621758|NCT02346240|459239307|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
127621759|NCT02346240|459239308|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
127791810|NCT00464334|459860768|FG007|Overall Study|Progressive Disease|0|||
127791811|NCT00464334|459860769|FG008|Overall Study|Progressive Disease|1|||
127791812|NCT00464334|459860770|FG009|Overall Study|Progressive Disease|0|||
127791813|NCT00464334|459860771|FG010|Overall Study|Progressive Disease|0|||
127791814|NCT00464334|459860761|FG000|Overall Study|Study Terminated by Sponsor|0|||
127791815|NCT00464334|459860762|FG001|Overall Study|Study Terminated by Sponsor|0|||
127621760|NCT02346240|459239309|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
127621761|NCT02346240|459239310|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
127791816|NCT00464334|459860763|FG002|Overall Study|Study Terminated by Sponsor|0|||
127791817|NCT00464334|459860764|FG003|Overall Study|Study Terminated by Sponsor|1|||
127621762|NCT02346240|459239311|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
127621763|NCT02346240|459239312|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
127621764|NCT02346240|459239313|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
127621765|NCT02346240|459239314|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
127621766|NCT02346240|459239315|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
127621767|NCT02346240|459239316|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
127621768|NCT02346240|459239317|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
127700904|NCT03766009|459535002|FG002|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
127700905|NCT03766009|459535003|FG003|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
127700906|NCT03766009|459535004|FG004|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
127700907|NCT03766009|459535005|FG005|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
127700908|NCT03766009|459535000|FG000|Usual Care|No treatment or declined surgery|0|||
127700909|NCT03766009|459535001|FG001|Usual Care|No treatment or declined surgery|0|||
127700910|NCT03766009|459535002|FG002|Usual Care|No treatment or declined surgery|0|||
127700911|NCT03766009|459535003|FG003|Usual Care|No treatment or declined surgery|2|||
127700912|NCT03766009|459535004|FG004|Usual Care|No treatment or declined surgery|0|||
127700913|NCT03766009|459535005|FG005|Usual Care|No treatment or declined surgery|0|||
127884907|NCT02367781|460202157|FG001|Overall Study|Administrative-Change Facility|0|||
127884908|NCT02367781|460202156|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
127700914|NCT03766009|459535000|FG000|Usual Care|No surgery but had lymph node dissection instead|0|||
127700915|NCT03766009|459535001|FG001|Usual Care|No surgery but had lymph node dissection instead|0|||
127700916|NCT03766009|459535002|FG002|Usual Care|No surgery but had lymph node dissection instead|0|||
127700917|NCT03766009|459535003|FG003|Usual Care|No surgery but had lymph node dissection instead|1|||
127700918|NCT03766009|459535004|FG004|Usual Care|No surgery but had lymph node dissection instead|0|||
127700919|NCT03766009|459535005|FG005|Usual Care|No surgery but had lymph node dissection instead|0|||
127700920|NCT03766009|459535000|FG000|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
127700921|NCT03766009|459535001|FG001|Usual Care|No surgery since patient had a good response to endocrine therapy|1|||
127700922|NCT03766009|459535002|FG002|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
127700923|NCT03766009|459535003|FG003|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
127700924|NCT03766009|459535004|FG004|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
127700925|NCT03766009|459535005|FG005|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
127700926|NCT03766009|459535000|FG000|Usual Care|Ineligible|0|||
127700927|NCT03766009|459535001|FG001|Usual Care|Ineligible|1|||
127700928|NCT03766009|459535002|FG002|Usual Care|Ineligible|0|||
127700929|NCT03766009|459535003|FG003|Usual Care|Ineligible|0|||
127700930|NCT03766009|459535004|FG004|Usual Care|Ineligible|0|||
127700931|NCT03766009|459535005|FG005|Usual Care|Ineligible|0|||
127700932|NCT03766009|459535000|FG000|Usual Care|Other: Staff turnover|0|||
127700933|NCT03766009|459535001|FG001|Usual Care|Other: Staff turnover|0|||
127700934|NCT03766009|459535002|FG002|Usual Care|Other: Staff turnover|0|||
127700935|NCT03766009|459535003|FG003|Usual Care|Other: Staff turnover|0|||
127700936|NCT03766009|459535004|FG004|Usual Care|Other: Staff turnover|0|||
127700937|NCT03766009|459535005|FG005|Usual Care|Other: Staff turnover|2|||
127700938|NCT03869866|459535006|FG000|Overall Study|Protocol Violation|1|||
127700939|NCT03869866|459535006|FG000|Overall Study|Withdrawal by Subject|3|||
127700940|NCT03867500|459535007|FG000|Saline Infustion Intervention|Withdrawal by Subject|1|||
127700941|NCT02985957|459535008|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
127700942|NCT02985957|459535009|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
127700943|NCT02985957|459535010|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
127700944|NCT02985957|459535011|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
127700945|NCT02985957|459535012|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
127700946|NCT02985957|459535013|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
127700947|NCT02985957|459535014|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
127621769|NCT02346240|459239318|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
127621770|NCT02346240|459239319|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
127621771|NCT02346240|459239320|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
127621772|NCT02346240|459239321|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
127621773|NCT02346240|459239322|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
127621774|NCT02346240|459239323|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
127621775|NCT02346240|459239324|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
127621776|NCT01573624|459239325|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
127621777|NCT01573624|459239326|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
127621778|NCT01573624|459239327|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
127621779|NCT01573624|459239328|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
127621780|NCT01573624|459239329|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
127621781|NCT01573624|459239330|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
127700948|NCT02985957|459535008|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
127791818|NCT00464334|459860765|FG004|Overall Study|Study Terminated by Sponsor|0|||
127791819|NCT00464334|459860766|FG005|Overall Study|Study Terminated by Sponsor|0|||
127791820|NCT00464334|459860767|FG006|Overall Study|Study Terminated by Sponsor|0|||
127791821|NCT00464334|459860768|FG007|Overall Study|Study Terminated by Sponsor|0|||
127791822|NCT00464334|459860769|FG008|Overall Study|Study Terminated by Sponsor|0|||
127791823|NCT00464334|459860770|FG009|Overall Study|Study Terminated by Sponsor|0|||
127791824|NCT00464334|459860771|FG010|Overall Study|Study Terminated by Sponsor|0|||
127791825|NCT00464334|459860761|FG000|Overall Study|Withdrawal by Subject|1|||
127791826|NCT00464334|459860762|FG001|Overall Study|Withdrawal by Subject|7|||
127791827|NCT00464334|459860763|FG002|Overall Study|Withdrawal by Subject|4|||
127791828|NCT00464334|459860764|FG003|Overall Study|Withdrawal by Subject|2|||
127791829|NCT00464334|459860765|FG004|Overall Study|Withdrawal by Subject|2|||
127791830|NCT00464334|459860766|FG005|Overall Study|Withdrawal by Subject|2|||
127791831|NCT00464334|459860767|FG006|Overall Study|Withdrawal by Subject|2|||
127791832|NCT00464334|459860768|FG007|Overall Study|Withdrawal by Subject|1|||
127791833|NCT00464334|459860769|FG008|Overall Study|Withdrawal by Subject|3|||
127791834|NCT00464334|459860770|FG009|Overall Study|Withdrawal by Subject|0|||
127791835|NCT00464334|459860771|FG010|Overall Study|Withdrawal by Subject|0|||
127791836|NCT00794677|459860780|FG000|First Intervention|Withdrawal by Subject|2|||
127791837|NCT00794677|459860781|FG001|First Intervention|Withdrawal by Subject|0|||
127791838|NCT01422915|459860782|FG000|Overall Study|Adverse Event|1|||
127791839|NCT01152021|459860784|FG000|Overall Study|Adverse Event|4|||
127791840|NCT01152021|459860785|FG001|Overall Study|Adverse Event|4|||
127791841|NCT01152021|459860784|FG000|Overall Study|Study drug had expired|1|||
127791842|NCT01152021|459860785|FG001|Overall Study|Study drug had expired|0|||
127791843|NCT01152021|459860784|FG000|Overall Study|Physician Decision|1|||
127791844|NCT01152021|459860785|FG001|Overall Study|Physician Decision|1|||
127791845|NCT01152021|459860784|FG000|Overall Study|No access to study drug in Pharmacy|0|||
127791846|NCT01152021|459860785|FG001|Overall Study|No access to study drug in Pharmacy|1|||
127791847|NCT00609791|459862192|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
127791848|NCT01394939|459862193|FG000|Overall Study|Adverse Event|1|||
127791849|NCT01394939|459862194|FG001|Overall Study|Adverse Event|3|||
127791850|NCT01394939|459862195|FG002|Overall Study|Adverse Event|0|||
127791851|NCT01394939|459862196|FG003|Overall Study|Adverse Event|2|||
127791852|NCT01394939|459862193|FG000|Overall Study|Death|0|||
127791853|NCT01394939|459862194|FG001|Overall Study|Death|2|||
127791854|NCT01394939|459862195|FG002|Overall Study|Death|0|||
127791855|NCT01394939|459862196|FG003|Overall Study|Death|0|||
127791856|NCT01394939|459862193|FG000|Overall Study|Physician Decision|0|||
127791857|NCT01394939|459862194|FG001|Overall Study|Physician Decision|1|||
127791858|NCT01394939|459862195|FG002|Overall Study|Physician Decision|0|||
127791859|NCT01394939|459862196|FG003|Overall Study|Physician Decision|0|||
127791860|NCT01394939|459862193|FG000|Overall Study|Withdrawal by Subject|0|||
127791861|NCT01394939|459862194|FG001|Overall Study|Withdrawal by Subject|2|||
127791862|NCT01394939|459862195|FG002|Overall Study|Withdrawal by Subject|0|||
127791863|NCT01394939|459862196|FG003|Overall Study|Withdrawal by Subject|2|||
127791864|NCT01394939|459862193|FG000|Overall Study|Others|0|||
127791865|NCT01394939|459862194|FG001|Overall Study|Others|2|||
127791866|NCT01394939|459862195|FG002|Overall Study|Others|0|||
127791867|NCT01394939|459862196|FG003|Overall Study|Others|3|||
127791868|NCT01049035|459862199|FG000|Overall Study|Serious adverse event|0|||
127791869|NCT01049035|459862200|FG001|Overall Study|Serious adverse event|1|||
127791870|NCT01049035|459862201|FG002|Overall Study|Serious adverse event|1|||
127791871|NCT01049035|459862202|FG003|Overall Study|Serious adverse event|2|||
127791872|NCT01049035|459862203|FG004|Overall Study|Serious adverse event|0|||
127791873|NCT01049035|459862204|FG005|Overall Study|Serious adverse event|0|||
127791874|NCT01049035|459862205|FG006|Overall Study|Serious adverse event|0|||
127791875|NCT01049035|459862199|FG000|Overall Study|Other adverse event (AE)|0|||
127791876|NCT01049035|459862200|FG001|Overall Study|Other adverse event (AE)|0|||
127791877|NCT01049035|459862201|FG002|Overall Study|Other adverse event (AE)|0|||
127791878|NCT01049035|459862202|FG003|Overall Study|Other adverse event (AE)|1|||
127791879|NCT01049035|459862203|FG004|Overall Study|Other adverse event (AE)|0|||
127791880|NCT01049035|459862204|FG005|Overall Study|Other adverse event (AE)|0|||
127791881|NCT01049035|459862205|FG006|Overall Study|Other adverse event (AE)|0|||
127791882|NCT01049035|459862199|FG000|Overall Study|Non-compliance with the protocol|12|||
127791883|NCT01049035|459862200|FG001|Overall Study|Non-compliance with the protocol|6|||
127791884|NCT01049035|459862201|FG002|Overall Study|Non-compliance with the protocol|14|||
127791885|NCT01049035|459862202|FG003|Overall Study|Non-compliance with the protocol|5|||
127791886|NCT01049035|459862203|FG004|Overall Study|Non-compliance with the protocol|3|||
127791887|NCT01049035|459862204|FG005|Overall Study|Non-compliance with the protocol|4|||
127791888|NCT01049035|459862205|FG006|Overall Study|Non-compliance with the protocol|10|||
127791889|NCT01049035|459862199|FG000|Overall Study|Lost to Follow-up|5|||
127791890|NCT01049035|459862200|FG001|Overall Study|Lost to Follow-up|4|||
127791891|NCT01049035|459862201|FG002|Overall Study|Lost to Follow-up|4|||
127791892|NCT01049035|459862202|FG003|Overall Study|Lost to Follow-up|1|||
127791893|NCT01049035|459862203|FG004|Overall Study|Lost to Follow-up|0|||
127791894|NCT01049035|459862204|FG005|Overall Study|Lost to Follow-up|3|||
127791895|NCT01049035|459862205|FG006|Overall Study|Lost to Follow-up|3|||
127791896|NCT01049035|459862199|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
127791897|NCT01049035|459862200|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
127791898|NCT01049035|459862201|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
127791899|NCT01049035|459862202|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
127791900|NCT01049035|459862203|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
127791901|NCT01049035|459862204|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
127884909|NCT02367781|460202157|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
127791902|NCT01049035|459862205|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
127791903|NCT02095535|459862206|FG000|Recruitment|Protocol Violation|2|||
127791904|NCT00623480|459862207|FG000|Overall Study|Lost to Follow-up|0|||
127791905|NCT00623480|459862208|FG001|Overall Study|Lost to Follow-up|1|||
127791906|NCT00623480|459862207|FG000|Overall Study|Withdrawal by Subject|2|||
127791907|NCT00623480|459862208|FG001|Overall Study|Withdrawal by Subject|4|||
127791908|NCT00623480|459862207|FG000|Overall Study|Lack of Efficacy|1|||
127791909|NCT00623480|459862208|FG001|Overall Study|Lack of Efficacy|0|||
127791910|NCT00623480|459862207|FG000|Overall Study|Non-compliant with study medication|4|||
127791911|NCT00623480|459862208|FG001|Overall Study|Non-compliant with study medication|0|||
127791912|NCT00623480|459862207|FG000|Overall Study|Protocol Violation|0|||
127791913|NCT00623480|459862208|FG001|Overall Study|Protocol Violation|1|||
127791914|NCT00623480|459862207|FG000|Overall Study|Site closed by sponsor|0|||
127791915|NCT00623480|459862208|FG001|Overall Study|Site closed by sponsor|1|||
127791916|NCT03709654|459862209|FG000|Overall Study|Lost to Follow-up|1|||
127791917|NCT03709654|459862210|FG001|Overall Study|Lost to Follow-up|1|||
127791918|NCT03709654|459862209|FG000|Overall Study|Withdrawal by Subject|1|||
127791919|NCT03709654|459862210|FG001|Overall Study|Withdrawal by Subject|1|||
127791920|NCT03709654|459862209|FG000|Overall Study|Adverse Event|1|||
127791921|NCT03709654|459862210|FG001|Overall Study|Adverse Event|0|||
127791922|NCT01902966|459862211|FG000|Overall Study|Death|1|||
127791923|NCT01902966|459862211|FG000|Overall Study|Physician Decision|1|||
127791924|NCT01902966|459862211|FG000|Overall Study|Withdrawal by Subject|1|||
127791925|NCT02631200|459862214|FG000|First Period|Death|1|||
127791926|NCT02631200|459862215|FG001|First Period|Death|2|||
127791927|NCT02631200|459862214|FG000|First Period|Patient ill-health|2|||
127791928|NCT02631200|459862215|FG001|First Period|Patient ill-health|4|||
127791929|NCT02631200|459862214|FG000|First Period|Withdrawal by Subject|4|||
127791930|NCT02631200|459862215|FG001|First Period|Withdrawal by Subject|1|||
127791931|NCT02631200|459862214|FG000|Deferred Period|Death|0|||
127791932|NCT02631200|459862215|FG001|Deferred Period|Death|1|||
127791933|NCT02631200|459862214|FG000|Deferred Period|Received kidney transplant|0|||
127791934|NCT02631200|459862215|FG001|Deferred Period|Received kidney transplant|1|||
127791935|NCT02631200|459862214|FG000|Deferred Period|Withdrawal by Subject|0|||
127621782|NCT01573624|459239331|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
127791936|NCT02631200|459862215|FG001|Deferred Period|Withdrawal by Subject|2|||
127621783|NCT01573624|459239325|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
127621784|NCT01573624|459239326|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
127621785|NCT01573624|459239327|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
127621786|NCT01573624|459239328|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
127621787|NCT01573624|459239329|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
127621788|NCT01573624|459239330|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
127621789|NCT01573624|459239331|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
127621790|NCT01573624|459239325|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
127621791|NCT01573624|459239326|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
127621792|NCT01573624|459239327|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
127621793|NCT01573624|459239328|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
127621794|NCT01573624|459239329|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
127621795|NCT01573624|459239330|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
127621796|NCT01573624|459239331|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
127621797|NCT01573624|459239325|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
127621798|NCT01573624|459239326|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
127621799|NCT01573624|459239327|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
127621800|NCT01573624|459239328|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
127621801|NCT01573624|459239329|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
127621802|NCT01573624|459239330|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
127621803|NCT01573624|459239331|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
127621804|NCT01573624|459239325|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
127621805|NCT01573624|459239326|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
127621806|NCT01573624|459239327|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
127621807|NCT01573624|459239328|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
127621808|NCT01573624|459239329|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
127621809|NCT01573624|459239330|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
127621810|NCT01573624|459239331|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
127621811|NCT01573624|459239325|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
127621812|NCT01573624|459239326|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
127621813|NCT01573624|459239327|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
127621814|NCT01573624|459239328|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
127621815|NCT01573624|459239329|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
127621816|NCT01573624|459239330|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
127621817|NCT01573624|459239331|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
127621818|NCT01573624|459239325|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
127621819|NCT01573624|459239326|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
127621820|NCT01573624|459239327|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
127621821|NCT01573624|459239328|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
127621822|NCT01573624|459239329|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
127621823|NCT01573624|459239330|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
127621824|NCT01573624|459239331|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
127621825|NCT01573624|459239325|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
127621826|NCT01573624|459239326|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
127621827|NCT01573624|459239327|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
127621828|NCT01573624|459239328|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
127621829|NCT01573624|459239329|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
127700949|NCT02985957|459535009|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
127621830|NCT01573624|459239330|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
127642613|NCT05554237|459313097|FG012|Part 2 (7 Days)|Adverse Event|1|||
127700950|NCT02985957|459535010|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
127642614|NCT05554237|459313098|FG013|Part 2 (7 Days)|Adverse Event|0|||
127700951|NCT02985957|459535011|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
127700952|NCT02985957|459535012|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
127700953|NCT02985957|459535013|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
127700954|NCT02985957|459535014|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
127700955|NCT02985957|459535008|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
127700956|NCT02985957|459535009|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
127700957|NCT02985957|459535010|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
127700958|NCT02985957|459535011|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
127700959|NCT02985957|459535012|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
127700960|NCT02985957|459535013|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
127700961|NCT02985957|459535014|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
127700962|NCT02985957|459535008|FG000|Treatment Period|Death|0|||
127700963|NCT02985957|459535009|FG001|Treatment Period|Death|0|||
127700964|NCT02985957|459535010|FG002|Treatment Period|Death|0|||
127700965|NCT02985957|459535011|FG003|Treatment Period|Death|0|||
127700966|NCT02985957|459535012|FG004|Treatment Period|Death|1|||
127700967|NCT02985957|459535013|FG005|Treatment Period|Death|0|||
127700968|NCT02985957|459535014|FG006|Treatment Period|Death|0|||
127700969|NCT02985957|459535008|FG000|Treatment Period|Participant withdrew consent|0|||
127700970|NCT02985957|459535009|FG001|Treatment Period|Participant withdrew consent|0|||
127700971|NCT02985957|459535010|FG002|Treatment Period|Participant withdrew consent|0|||
127700972|NCT02985957|459535011|FG003|Treatment Period|Participant withdrew consent|1|||
127700973|NCT02985957|459535012|FG004|Treatment Period|Participant withdrew consent|3|||
127700974|NCT02985957|459535013|FG005|Treatment Period|Participant withdrew consent|0|||
127700975|NCT02985957|459535014|FG006|Treatment Period|Participant withdrew consent|1|||
127700976|NCT02985957|459535008|FG000|Treatment Period|Lost to Follow-up|0|||
127700977|NCT02985957|459535009|FG001|Treatment Period|Lost to Follow-up|0|||
127700978|NCT02985957|459535010|FG002|Treatment Period|Lost to Follow-up|0|||
127700979|NCT02985957|459535011|FG003|Treatment Period|Lost to Follow-up|0|||
127700980|NCT02985957|459535012|FG004|Treatment Period|Lost to Follow-up|1|||
127700981|NCT02985957|459535013|FG005|Treatment Period|Lost to Follow-up|0|||
127700982|NCT02985957|459535014|FG006|Treatment Period|Lost to Follow-up|0|||
127700983|NCT02985957|459535008|FG000|Treatment Period|Other reasons|0|||
127700984|NCT02985957|459535009|FG001|Treatment Period|Other reasons|0|||
127700985|NCT02985957|459535010|FG002|Treatment Period|Other reasons|1|||
127700986|NCT02985957|459535011|FG003|Treatment Period|Other reasons|3|||
127700987|NCT02985957|459535012|FG004|Treatment Period|Other reasons|6|||
127700988|NCT02985957|459535013|FG005|Treatment Period|Other reasons|0|||
127700989|NCT02985957|459535014|FG006|Treatment Period|Other reasons|1|||
127700990|NCT02985957|459535008|FG000|Treatment Period|Not reported|0|||
127700991|NCT02985957|459535009|FG001|Treatment Period|Not reported|1|||
127700992|NCT02985957|459535010|FG002|Treatment Period|Not reported|2|||
127700993|NCT02985957|459535011|FG003|Treatment Period|Not reported|5|||
127621831|NCT01573624|459239331|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
127791937|NCT02631200|459862214|FG000|Deferred Period|Lost to Follow-up|0|||
127791938|NCT02631200|459862215|FG001|Deferred Period|Lost to Follow-up|1|||
127791939|NCT01081912|459862216|FG000|Conversion/Titration|Adverse Event|47|||
127791940|NCT01081912|459862217|FG001|Conversion/Titration|Adverse Event|0|||
127791941|NCT01081912|459862218|FG002|Conversion/Titration|Adverse Event|0|||
127791942|NCT01081912|459862216|FG000|Conversion/Titration|Lack of Efficacy|17|||
127791943|NCT01081912|459862217|FG001|Conversion/Titration|Lack of Efficacy|0|||
127791944|NCT01081912|459862218|FG002|Conversion/Titration|Lack of Efficacy|0|||
127791945|NCT01081912|459862216|FG000|Conversion/Titration|Lost to Follow-up|5|||
127791946|NCT01081912|459862217|FG001|Conversion/Titration|Lost to Follow-up|0|||
127791947|NCT01081912|459862218|FG002|Conversion/Titration|Lost to Follow-up|0|||
127791948|NCT01081912|459862216|FG000|Conversion/Titration|Physician Decision|2|||
127791949|NCT01081912|459862217|FG001|Conversion/Titration|Physician Decision|0|||
127791950|NCT01081912|459862218|FG002|Conversion/Titration|Physician Decision|0|||
127791951|NCT01081912|459862216|FG000|Conversion/Titration|Protocol Violation|67|||
127791952|NCT01081912|459862217|FG001|Conversion/Titration|Protocol Violation|0|||
127791953|NCT01081912|459862218|FG002|Conversion/Titration|Protocol Violation|0|||
127791954|NCT01081912|459862216|FG000|Conversion/Titration|Withdrawal by Subject|23|||
127791955|NCT01081912|459862217|FG001|Conversion/Titration|Withdrawal by Subject|0|||
127791956|NCT01081912|459862218|FG002|Conversion/Titration|Withdrawal by Subject|0|||
127791957|NCT01081912|459862216|FG000|Conversion/Titration|Non-Compliance|47|||
127791958|NCT01081912|459862217|FG001|Conversion/Titration|Non-Compliance|0|||
127791959|NCT01081912|459862218|FG002|Conversion/Titration|Non-Compliance|0|||
127791960|NCT01081912|459862216|FG000|Maintenance Treatment|Adverse Event|0|||
127791961|NCT01081912|459862217|FG001|Maintenance Treatment|Adverse Event|2|||
127791962|NCT01081912|459862218|FG002|Maintenance Treatment|Adverse Event|12|||
127791963|NCT01081912|459862216|FG000|Maintenance Treatment|Lack of Efficacy|0|||
127791964|NCT01081912|459862217|FG001|Maintenance Treatment|Lack of Efficacy|14|||
127791965|NCT01081912|459862218|FG002|Maintenance Treatment|Lack of Efficacy|64|||
127791966|NCT01081912|459862216|FG000|Maintenance Treatment|Lost to Follow-up|0|||
127791967|NCT01081912|459862217|FG001|Maintenance Treatment|Lost to Follow-up|1|||
127791968|NCT01081912|459862218|FG002|Maintenance Treatment|Lost to Follow-up|0|||
127791969|NCT01081912|459862216|FG000|Maintenance Treatment|Physician Decision|0|||
127791970|NCT01081912|459862217|FG001|Maintenance Treatment|Physician Decision|0|||
127791971|NCT01081912|459862218|FG002|Maintenance Treatment|Physician Decision|1|||
127791972|NCT01081912|459862216|FG000|Maintenance Treatment|Protocol Violation|0|||
127791973|NCT01081912|459862217|FG001|Maintenance Treatment|Protocol Violation|1|||
127791974|NCT01081912|459862218|FG002|Maintenance Treatment|Protocol Violation|2|||
127791975|NCT01081912|459862216|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
127791976|NCT01081912|459862217|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
127791977|NCT01081912|459862218|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
127791978|NCT01081912|459862216|FG000|Maintenance Treatment|Non-Compliance|0|||
127791979|NCT01081912|459862217|FG001|Maintenance Treatment|Non-Compliance|4|||
127791980|NCT01081912|459862218|FG002|Maintenance Treatment|Non-Compliance|7|||
127791981|NCT01081912|459862216|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
127791982|NCT01081912|459862217|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
127791983|NCT01081912|459862218|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
127791984|NCT03776175|459862220|FG000|Treatment Period (42 Days)|Adverse Event|0|||
127791985|NCT03776175|459862221|FG001|Treatment Period (42 Days)|Adverse Event|1|||
127791986|NCT03776175|459862222|FG002|Treatment Period (42 Days)|Adverse Event|1|||
127791987|NCT03776175|459862223|FG003|Treatment Period (42 Days)|Adverse Event|0|||
127621832|NCT01573624|459239325|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
127621833|NCT01573624|459239326|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
127621834|NCT01573624|459239327|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
127621835|NCT01573624|459239328|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
127621836|NCT01573624|459239329|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
127621837|NCT01573624|459239330|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
127621838|NCT01573624|459239331|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
127621839|NCT01573624|459239325|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
127621840|NCT01573624|459239326|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
127621841|NCT01573624|459239327|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
127621842|NCT01573624|459239328|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
127621843|NCT01573624|459239329|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
127621844|NCT01573624|459239330|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
127621845|NCT01573624|459239331|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
127621846|NCT01573624|459239325|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
127621847|NCT01573624|459239326|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
127621848|NCT01573624|459239327|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
127621849|NCT01573624|459239328|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
127621850|NCT01573624|459239329|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
127621851|NCT01573624|459239330|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
127621852|NCT01573624|459239331|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
127791988|NCT03776175|459862220|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
127621853|NCT01573624|459239325|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
127621854|NCT01573624|459239326|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
127621855|NCT01573624|459239327|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
127621856|NCT01573624|459239328|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
127621857|NCT01573624|459239329|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
127621858|NCT01573624|459239330|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
127621859|NCT01573624|459239331|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
127621860|NCT01573624|459239325|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
127621861|NCT01573624|459239326|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
127621862|NCT01573624|459239327|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
127621863|NCT01573624|459239328|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
127621864|NCT01573624|459239329|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
127621865|NCT01573624|459239330|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
127621866|NCT01573624|459239331|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
127621867|NCT01573624|459239325|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
127621868|NCT01573624|459239326|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
127621869|NCT01573624|459239327|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
127621870|NCT01573624|459239328|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
127621871|NCT01573624|459239329|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
127621872|NCT01573624|459239330|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
127621873|NCT01573624|459239331|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
127621874|NCT01573624|459239325|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
127621875|NCT01573624|459239326|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
127621876|NCT01573624|459239327|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
127621877|NCT01573624|459239328|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
127621878|NCT01573624|459239329|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
127621879|NCT01573624|459239330|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
127621880|NCT01573624|459239331|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
127621881|NCT01573624|459239325|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
127621882|NCT01573624|459239326|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
127621883|NCT01573624|459239327|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
127621884|NCT01573624|459239328|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
127621885|NCT01573624|459239329|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
127621886|NCT01573624|459239330|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
127621887|NCT01573624|459239331|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
127621888|NCT01573624|459239325|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
127621889|NCT01573624|459239326|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
127621890|NCT01573624|459239327|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
127621891|NCT01573624|459239328|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
127621892|NCT01573624|459239329|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
127621893|NCT01573624|459239330|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
127621894|NCT01573624|459239331|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
127621895|NCT01573624|459239325|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
127791989|NCT03776175|459862221|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
127791990|NCT03776175|459862222|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
127791991|NCT03776175|459862223|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
127791992|NCT03776175|459862220|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
127791993|NCT03776175|459862221|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
127791994|NCT03776175|459862222|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
127791995|NCT03776175|459862223|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
127791996|NCT03776175|459862220|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
127791997|NCT03776175|459862221|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
127791998|NCT03776175|459862222|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
127791999|NCT03776175|459862223|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
127792000|NCT03776175|459862220|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
127792001|NCT03776175|459862221|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
127792002|NCT03776175|459862222|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
127621896|NCT01573624|459239326|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
127621897|NCT01573624|459239327|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
127621898|NCT01573624|459239328|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
127621899|NCT01573624|459239329|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
127621900|NCT01573624|459239330|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
127621901|NCT01573624|459239331|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
127621902|NCT01573624|459239325|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
127621903|NCT01573624|459239326|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
127621904|NCT01573624|459239327|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
127621905|NCT01573624|459239328|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
127621906|NCT01573624|459239329|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
127621907|NCT01573624|459239330|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
127700994|NCT02985957|459535012|FG004|Treatment Period|Not reported|0|||
127700995|NCT02985957|459535013|FG005|Treatment Period|Not reported|0|||
127621908|NCT01573624|459239331|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
127700996|NCT02985957|459535014|FG006|Treatment Period|Not reported|0|||
127700997|NCT02985957|459535008|FG000|Treatment Period|Maximum clinical benefit|0|||
127700998|NCT02985957|459535009|FG001|Treatment Period|Maximum clinical benefit|0|||
127700999|NCT02985957|459535010|FG002|Treatment Period|Maximum clinical benefit|1|||
127701000|NCT02985957|459535011|FG003|Treatment Period|Maximum clinical benefit|1|||
127701001|NCT02985957|459535012|FG004|Treatment Period|Maximum clinical benefit|0|||
127701002|NCT02985957|459535013|FG005|Treatment Period|Maximum clinical benefit|0|||
127701003|NCT02985957|459535014|FG006|Treatment Period|Maximum clinical benefit|2|||
127701004|NCT02985957|459535008|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
127701005|NCT02985957|459535009|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
127701006|NCT02985957|459535010|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
127701007|NCT02985957|459535011|FG003|Treatment Period|Adverse event unrelated to study drug|3|||
127701008|NCT02985957|459535012|FG004|Treatment Period|Adverse event unrelated to study drug|7|||
127701009|NCT02985957|459535013|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
127701010|NCT02985957|459535014|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
127701011|NCT02985957|459535008|FG000|Treatment Period|Study drug toxicity|1|||
127701012|NCT02985957|459535009|FG001|Treatment Period|Study drug toxicity|23|||
127701013|NCT02985957|459535010|FG002|Treatment Period|Study drug toxicity|20|||
127701014|NCT02985957|459535011|FG003|Treatment Period|Study drug toxicity|11|||
127701015|NCT02985957|459535012|FG004|Treatment Period|Study drug toxicity|19|||
127701016|NCT02985957|459535013|FG005|Treatment Period|Study drug toxicity|3|||
127701017|NCT02985957|459535014|FG006|Treatment Period|Study drug toxicity|5|||
127701018|NCT02985957|459535008|FG000|Treatment Period|Disease progression|0|||
127701019|NCT02985957|459535009|FG001|Treatment Period|Disease progression|16|||
127701020|NCT02985957|459535010|FG002|Treatment Period|Disease progression|20|||
127701021|NCT02985957|459535011|FG003|Treatment Period|Disease progression|39|||
127701022|NCT02985957|459535012|FG004|Treatment Period|Disease progression|29|||
127621909|NCT01573624|459239325|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
127621910|NCT01573624|459239326|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
127621911|NCT01573624|459239327|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
127621912|NCT01573624|459239328|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
127621913|NCT01573624|459239329|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
127621914|NCT01573624|459239330|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
127621915|NCT01573624|459239331|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
127621916|NCT01573624|459239325|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
127621917|NCT01573624|459239326|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
127621918|NCT01573624|459239327|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
127621919|NCT01573624|459239328|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
127621920|NCT01573624|459239329|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
127621921|NCT01573624|459239330|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
127621922|NCT01573624|459239331|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
127621923|NCT01573624|459239325|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
127621924|NCT01573624|459239326|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
127621925|NCT01573624|459239327|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
127642615|NCT02807558|459313099|FG000|Overall Study|Consent withdrawn by participant|4|||
127642616|NCT02807558|459313100|FG001|Overall Study|Consent withdrawn by participant|0|||
127642617|NCT02807558|459313101|FG002|Overall Study|Consent withdrawn by participant|4|||
127642618|NCT02807558|459313102|FG003|Overall Study|Consent withdrawn by participant|2|||
127642619|NCT02807558|459313103|FG004|Overall Study|Consent withdrawn by participant|1|||
127642620|NCT02807558|459313104|FG005|Overall Study|Consent withdrawn by participant|0|||
127642621|NCT02807558|459313099|FG000|Overall Study|Non-compliance with Study Drug|0|||
127642622|NCT02807558|459313100|FG001|Overall Study|Non-compliance with Study Drug|0|||
127642623|NCT02807558|459313101|FG002|Overall Study|Non-compliance with Study Drug|1|||
127642624|NCT02807558|459313102|FG003|Overall Study|Non-compliance with Study Drug|0|||
127642625|NCT02807558|459313103|FG004|Overall Study|Non-compliance with Study Drug|0|||
127642626|NCT02807558|459313104|FG005|Overall Study|Non-compliance with Study Drug|0|||
127642627|NCT02807558|459313099|FG000|Overall Study|Adverse Event|0|||
127642628|NCT02807558|459313100|FG001|Overall Study|Adverse Event|0|||
127642629|NCT02807558|459313101|FG002|Overall Study|Adverse Event|9|||
127642630|NCT02807558|459313102|FG003|Overall Study|Adverse Event|0|||
127642631|NCT02807558|459313103|FG004|Overall Study|Adverse Event|0|||
127642632|NCT02807558|459313104|FG005|Overall Study|Adverse Event|0|||
127642633|NCT02807558|459313099|FG000|Overall Study|Death|23|||
127642634|NCT02807558|459313100|FG001|Overall Study|Death|2|||
127642635|NCT02807558|459313101|FG002|Overall Study|Death|3|||
127642636|NCT02807558|459313102|FG003|Overall Study|Death|43|||
127642637|NCT02807558|459313103|FG004|Overall Study|Death|24|||
127642638|NCT02807558|459313104|FG005|Overall Study|Death|15|||
127642639|NCT02807558|459313099|FG000|Overall Study|Progressive Disease|0|||
127642640|NCT02807558|459313100|FG001|Overall Study|Progressive Disease|0|||
127642641|NCT02807558|459313101|FG002|Overall Study|Progressive Disease|1|||
127642642|NCT02807558|459313102|FG003|Overall Study|Progressive Disease|0|||
127642643|NCT02807558|459313103|FG004|Overall Study|Progressive Disease|0|||
127642644|NCT02807558|459313104|FG005|Overall Study|Progressive Disease|0|||
127642645|NCT02807558|459313099|FG000|Overall Study|Other than specified|1|||
127642646|NCT02807558|459313100|FG001|Overall Study|Other than specified|0|||
127642647|NCT02807558|459313101|FG002|Overall Study|Other than specified|2|||
127642648|NCT02807558|459313102|FG003|Overall Study|Other than specified|0|||
127642649|NCT02807558|459313103|FG004|Overall Study|Other than specified|1|||
127642650|NCT02807558|459313104|FG005|Overall Study|Other than specified|1|||
127621926|NCT01573624|459239328|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
127621927|NCT01573624|459239329|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
127621928|NCT01573624|459239330|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
127621929|NCT01573624|459239331|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
127621930|NCT01573624|459239325|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
127621931|NCT01573624|459239326|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
127621932|NCT01573624|459239327|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
127621933|NCT01573624|459239328|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
127621934|NCT01573624|459239329|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
127621935|NCT01573624|459239330|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
127621936|NCT01573624|459239331|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
127621937|NCT01573624|459239325|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
127621938|NCT01573624|459239326|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
127621939|NCT01573624|459239327|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
127621940|NCT01573624|459239328|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
127621941|NCT01573624|459239329|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
127621942|NCT01573624|459239330|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
127621943|NCT01573624|459239331|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
127621944|NCT01573624|459239325|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
127621945|NCT01573624|459239326|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
127621946|NCT01573624|459239327|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
127701023|NCT02985957|459535013|FG005|Treatment Period|Disease progression|11|||
127884910|NCT02367781|460202156|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
127884911|NCT02367781|460202157|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
127884912|NCT02367781|460202156|FG000|Overall Study|Study Terminated by Sponsor|3|||
127701024|NCT02985957|459535014|FG006|Treatment Period|Disease progression|28|||
127884913|NCT02367781|460202157|FG001|Overall Study|Study Terminated by Sponsor|1|||
127884914|NCT02367781|460202156|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
127884915|NCT02367781|460202157|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
127884916|NCT02367781|460202156|FG000|Overall Study|Sponsor Decision|2|||
127884917|NCT02367781|460202157|FG001|Overall Study|Sponsor Decision|0|||
127884918|NCT02367781|460202156|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
127884919|NCT02367781|460202157|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
127884920|NCT01133392|460202160|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
127884921|NCT01133392|460202161|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
127884922|NCT01133392|460202160|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
127884923|NCT01133392|460202161|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
127884924|NCT02842086|460202164|FG000|Overall Study|Randomized but Never Treated|6|||
127884925|NCT02842086|460202165|FG001|Overall Study|Randomized but Never Treated|6|||
127884926|NCT02842086|460202164|FG000|Overall Study|Still in Double-Blind Phase|7|||
127884927|NCT02842086|460202165|FG001|Overall Study|Still in Double-Blind Phase|3|||
127884928|NCT02842086|460202164|FG000|Overall Study|Adverse Event|18|||
127884929|NCT02842086|460202165|FG001|Overall Study|Adverse Event|20|||
127884930|NCT02842086|460202164|FG000|Overall Study|Death|3|||
127884931|NCT02842086|460202165|FG001|Overall Study|Death|3|||
127884932|NCT02842086|460202164|FG000|Overall Study|Investigator's Discretion|9|||
127884933|NCT02842086|460202165|FG001|Overall Study|Investigator's Discretion|13|||
127884934|NCT02842086|460202164|FG000|Overall Study|Non-Compliance with Study Drug|9|||
127884935|NCT02842086|460202165|FG001|Overall Study|Non-Compliance with Study Drug|8|||
127884936|NCT02842086|460202164|FG000|Overall Study|Protocol Violation|8|||
127884937|NCT02842086|460202165|FG001|Overall Study|Protocol Violation|4|||
127884938|NCT02842086|460202164|FG000|Overall Study|Withdrew Consent|205|||
127884939|NCT02842086|460202165|FG001|Overall Study|Withdrew Consent|194|||
127884940|NCT02842086|460202164|FG000|Overall Study|Lost to Follow-up|274|||
127884941|NCT02842086|460202165|FG001|Overall Study|Lost to Follow-up|236|||
127884942|NCT02842086|460202164|FG000|Overall Study|HIV-1 Infection|5|||
127884943|NCT02842086|460202165|FG001|Overall Study|HIV-1 Infection|6|||
127884944|NCT03751124|460202166|FG000|Overall Study|Adverse Event|4|||
127884945|NCT03751124|460202167|FG001|Overall Study|Adverse Event|3|||
127884946|NCT03751124|460202166|FG000|Overall Study|Protocol Deviation|0|||
127884947|NCT03751124|460202167|FG001|Overall Study|Protocol Deviation|1|||
127884948|NCT03751124|460202166|FG000|Overall Study|Lost to Follow-up|6|||
127884949|NCT03751124|460202167|FG001|Overall Study|Lost to Follow-up|4|||
127884950|NCT03751124|460202166|FG000|Overall Study|Withdrawal by Subject|6|||
127884951|NCT03751124|460202167|FG001|Overall Study|Withdrawal by Subject|8|||
127884952|NCT03751124|460202166|FG000|Overall Study|Lack of Efficacy|1|||
127884953|NCT03751124|460202167|FG001|Overall Study|Lack of Efficacy|1|||
127884954|NCT03751124|460202166|FG000|Overall Study|Pregnancy|0|||
127884955|NCT03751124|460202167|FG001|Overall Study|Pregnancy|1|||
127884956|NCT03751124|460202166|FG000|Overall Study|Other|9|||
127884957|NCT03751124|460202167|FG001|Overall Study|Other|9|||
127884958|NCT03751124|460202166|FG000|Overall Study|Participants who did not receive any study drug|0|||
127884959|NCT03751124|460202167|FG001|Overall Study|Participants who did not receive any study drug|1|||
127621947|NCT01573624|459239328|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
127621948|NCT01573624|459239329|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
127621949|NCT01573624|459239330|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
127621950|NCT01573624|459239331|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
127621951|NCT01573624|459239325|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
127621952|NCT01573624|459239326|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
127884960|NCT00555399|460202170|FG000|Overall Study|Withdrawal by Subject|0|||
127884961|NCT00555399|460202171|FG001|Overall Study|Withdrawal by Subject|0|||
127621953|NCT01573624|459239327|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
127621954|NCT01573624|459239328|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
127621955|NCT01573624|459239329|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
127621956|NCT01573624|459239330|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
127621957|NCT01573624|459239331|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
127621958|NCT01573624|459239325|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
127621959|NCT01573624|459239326|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
127621960|NCT01573624|459239327|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
127621961|NCT01573624|459239328|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
127621962|NCT01573624|459239329|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
127621963|NCT01573624|459239330|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
127621964|NCT01573624|459239331|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
127621965|NCT03417141|459239333|FG000|Overall Study|Withdrawal by Subject|1|||
127621966|NCT03417141|459239333|FG000|Overall Study|Protocol Violation|3|||
127621967|NCT03706690|459239336|FG000|Overall Study|Withdrawal by Subject|8|||
127621968|NCT03706690|459239337|FG001|Overall Study|Withdrawal by Subject|8|||
127621969|NCT03706690|459239336|FG000|Overall Study|Death|143|||
127621970|NCT03706690|459239337|FG001|Overall Study|Death|75|||
127621971|NCT03706690|459239336|FG000|Overall Study|Ongoing at DCO|121|||
127621972|NCT03706690|459239337|FG001|Overall Study|Ongoing at DCO|52|||
127621973|NCT02098109|459239338|FG000|Overall Study|Protocol Violation|3|||
127621974|NCT02098109|459239339|FG001|Overall Study|Protocol Violation|0|||
127621975|NCT02143843|459239340|FG000|Overall Study|Adverse Event|8|||
127621976|NCT02143843|459239340|FG000|Overall Study|Lack of Efficacy|2|||
127621977|NCT02143843|459239340|FG000|Overall Study|Withdrawal by Subject|2|||
127621978|NCT01822132|459239344|FG000|Overall Study|Lost to Follow-up|4|||
127621979|NCT01822132|459239345|FG001|Overall Study|Lost to Follow-up|2|||
127621980|NCT01247090|459239350|FG000|Overall Study|Physician Decision|1|||
127621981|NCT01247090|459239351|FG001|Overall Study|Physician Decision|0|||
127621982|NCT01247090|459239352|FG002|Overall Study|Physician Decision|0|||
127884962|NCT00555399|460202172|FG002|Overall Study|Withdrawal by Subject|1|||
127884963|NCT00555399|460202173|FG003|Overall Study|Withdrawal by Subject|0|||
127621983|NCT01247090|459239350|FG000|Overall Study|Withdrawal by Subject|0|||
127621984|NCT01247090|459239351|FG001|Overall Study|Withdrawal by Subject|1|||
127621985|NCT01247090|459239352|FG002|Overall Study|Withdrawal by Subject|0|||
127621986|NCT00006916|459239354|FG000|Overall Study|Device not inserted|4|||
127621987|NCT00006916|459239354|FG000|Overall Study|Complication of device insertion|1|||
127621988|NCT03467425|459239358|FG000|Overall Study|Adverse Event|9|||
127621989|NCT03467425|459239359|FG001|Overall Study|Adverse Event|9|||
127621990|NCT03467425|459239358|FG000|Overall Study|Lack of Efficacy|3|||
127621991|NCT03467425|459239359|FG001|Overall Study|Lack of Efficacy|1|||
127621992|NCT03467425|459239358|FG000|Overall Study|Protocol Violation|0|||
127621993|NCT03467425|459239359|FG001|Overall Study|Protocol Violation|1|||
127621994|NCT03467425|459239358|FG000|Overall Study|Lost to Follow-up|18|||
127621995|NCT03467425|459239359|FG001|Overall Study|Lost to Follow-up|25|||
127621996|NCT03467425|459239358|FG000|Overall Study|Physician Decision|2|||
127621997|NCT03467425|459239359|FG001|Overall Study|Physician Decision|1|||
127621998|NCT03467425|459239358|FG000|Overall Study|Withdrawal by Subject|15|||
127621999|NCT03467425|459239359|FG001|Overall Study|Withdrawal by Subject|17|||
127622000|NCT02318693|459239360|FG000|Overall Study|Protocol Violation|0|||
127622001|NCT02318693|459239361|FG001|Overall Study|Protocol Violation|1|||
127622002|NCT00025883|459239362|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
127622003|NCT00025883|459239362|FG000|Overall Study|no baseline data|1|||
127622004|NCT00025883|459239362|FG000|Overall Study|Death|1|||
127622005|NCT00025883|459239362|FG000|Overall Study|Adverse Event|1|||
127622006|NCT00025883|459239362|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
127622007|NCT03080961|459239363|FG000|Overall Study|Withdrawal by Subject|3|||
127622008|NCT04084769|459239372|FG000|Overall Study|Protocol Violation|1|||
127622009|NCT04084769|459239373|FG001|Overall Study|Protocol Violation|3|||
127622010|NCT04084769|459239374|FG002|Overall Study|Protocol Violation|0|||
127622011|NCT04084769|459239375|FG003|Overall Study|Protocol Violation|1|||
127622012|NCT04084769|459239372|FG000|Overall Study|Withdrawal by Subject|0|||
127622013|NCT04084769|459239373|FG001|Overall Study|Withdrawal by Subject|1|||
127622014|NCT04084769|459239374|FG002|Overall Study|Withdrawal by Subject|0|||
127622015|NCT04084769|459239375|FG003|Overall Study|Withdrawal by Subject|0|||
127622016|NCT04084769|459239372|FG000|Overall Study|Withdrawal by parent/guardian|1|||
127622017|NCT04084769|459239373|FG001|Overall Study|Withdrawal by parent/guardian|0|||
127622018|NCT04084769|459239374|FG002|Overall Study|Withdrawal by parent/guardian|0|||
127622019|NCT04084769|459239375|FG003|Overall Study|Withdrawal by parent/guardian|1|||
127622020|NCT04084769|459239372|FG000|Overall Study|Lost to Follow-up|2|||
127622021|NCT04084769|459239373|FG001|Overall Study|Lost to Follow-up|0|||
127622022|NCT04084769|459239374|FG002|Overall Study|Lost to Follow-up|0|||
127622023|NCT04084769|459239375|FG003|Overall Study|Lost to Follow-up|0|||
127622024|NCT03390504|459239376|FG000|Overall Study|Lost to Follow-up|2|||
127622025|NCT03390504|459239377|FG001|Overall Study|Lost to Follow-up|4|||
127622026|NCT03390504|459239378|FG002|Overall Study|Lost to Follow-up|0|||
127622027|NCT03390504|459239379|FG003|Overall Study|Lost to Follow-up|1|||
127622028|NCT03390504|459239376|FG000|Overall Study|Withdrawal by Subject|3|||
127792003|NCT03776175|459862223|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
127792004|NCT03776175|459862220|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
127792005|NCT03776175|459862221|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
127792006|NCT03776175|459862222|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
127792007|NCT03776175|459862223|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
127792008|NCT02412787|459862225|FG000|Overall Study|Withdrawal by Subject|9|||
127792009|NCT02412787|459862225|FG000|Overall Study|Participation Terminated by Investigator|1|||
127792010|NCT02412787|459862225|FG000|Overall Study|Site Terminated by Sponsor|21|||
127792011|NCT02412787|459862225|FG000|Overall Study|Technical Problems|1|||
127792012|NCT02412787|459862225|FG000|Overall Study|Reason Not Specified|1|||
127792013|NCT02311153|459862229|FG000|Overall Study|Lost to Follow-up|5|||
127792014|NCT02311153|459862230|FG001|Overall Study|Lost to Follow-up|7|||
127792015|NCT00414453|459862236|FG000|Overall Study|Abnormal lab work|16|||
127792016|NCT02429414|459862237|FG000|Overall Study|Physician Decision|0|||
127792017|NCT02429414|459862238|FG001|Overall Study|Physician Decision|1|||
127792018|NCT01784861|459862239|FG000|Overall Study|Adverse Event|0|||
127792019|NCT01784861|459862240|FG001|Overall Study|Adverse Event|0|||
127792020|NCT01784861|459862241|FG002|Overall Study|Adverse Event|1|||
127792021|NCT01784861|459862242|FG003|Overall Study|Adverse Event|2|||
127792022|NCT01784861|459862243|FG004|Overall Study|Adverse Event|1|||
127792023|NCT01784861|459862244|FG005|Overall Study|Adverse Event|0|||
127792024|NCT01784861|459862239|FG000|Overall Study|Withdrawal by Subject|0|||
127792025|NCT01784861|459862240|FG001|Overall Study|Withdrawal by Subject|0|||
127792026|NCT01784861|459862241|FG002|Overall Study|Withdrawal by Subject|0|||
127622029|NCT03390504|459239377|FG001|Overall Study|Withdrawal by Subject|15|||
127622030|NCT03390504|459239378|FG002|Overall Study|Withdrawal by Subject|5|||
127622031|NCT03390504|459239379|FG003|Overall Study|Withdrawal by Subject|2|||
127622032|NCT03390504|459239376|FG000|Overall Study|Other|1|||
127622033|NCT03390504|459239377|FG001|Overall Study|Other|2|||
127622034|NCT03390504|459239378|FG002|Overall Study|Other|2|||
127622035|NCT03390504|459239379|FG003|Overall Study|Other|6|||
127622036|NCT03492177|459239380|FG000|Overall Study|Adverse Event|1|||
127622037|NCT03492177|459239381|FG001|Overall Study|Adverse Event|0|||
127622038|NCT03492177|459239382|FG002|Overall Study|Adverse Event|0|||
127622039|NCT03492177|459239380|FG000|Overall Study|Death|3|||
127622040|NCT03492177|459239381|FG001|Overall Study|Death|0|||
127622041|NCT03492177|459239382|FG002|Overall Study|Death|3|||
127622042|NCT03492177|459239380|FG000|Overall Study|Lack of Efficacy|1|||
127622043|NCT03492177|459239381|FG001|Overall Study|Lack of Efficacy|2|||
127622044|NCT03492177|459239382|FG002|Overall Study|Lack of Efficacy|0|||
127622045|NCT03492177|459239380|FG000|Overall Study|Other|1|||
127622046|NCT03492177|459239381|FG001|Overall Study|Other|0|||
127622047|NCT03492177|459239382|FG002|Overall Study|Other|0|||
127622048|NCT03492177|459239380|FG000|Overall Study|Ongoing|16|||
127622049|NCT03492177|459239381|FG001|Overall Study|Ongoing|19|||
127622050|NCT03492177|459239382|FG002|Overall Study|Ongoing|17|||
127622051|NCT04197713|459239383|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|0|||
127622052|NCT04197713|459239384|FG001|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|1|||
127622053|NCT04346615|459240994|FG000|Overall Study|Lost to Follow-up|0|||
127622054|NCT04346615|459240995|FG001|Overall Study|Lost to Follow-up|2|||
127622055|NCT04346615|459240994|FG000|Overall Study|Withdrawal by Subject|1|||
127622056|NCT04346615|459240995|FG001|Overall Study|Withdrawal by Subject|0|||
127622057|NCT04346615|459240994|FG000|Overall Study|Death|5|||
127622058|NCT04346615|459240995|FG001|Overall Study|Death|1|||
127622059|NCT04346615|459240994|FG000|Overall Study|Other|0|||
127622060|NCT04346615|459240995|FG001|Overall Study|Other|2|||
127622061|NCT04346615|459240994|FG000|Overall Study|Randomized not treated|1|||
127622062|NCT04346615|459240995|FG001|Overall Study|Randomized not treated|0|||
127622063|NCT03285646|459241005|FG000|Overall Study|Adverse Event|1|||
127622064|NCT03285646|459241006|FG001|Overall Study|Adverse Event|0|||
127622065|NCT03285646|459241005|FG000|Overall Study|Withdrawal by Subject|10|||
127622066|NCT03285646|459241006|FG001|Overall Study|Withdrawal by Subject|2|||
127622067|NCT03285646|459241005|FG000|Overall Study|Lost to Follow-up|2|||
127622068|NCT03285646|459241006|FG001|Overall Study|Lost to Follow-up|1|||
127622069|NCT03285646|459241005|FG000|Overall Study|Investigator/Sponsor Decision|0|||
127622070|NCT03285646|459241006|FG001|Overall Study|Investigator/Sponsor Decision|1|||
127622071|NCT02610192|459241008|FG000|Overall Study|Received other treatment|8|||
127622072|NCT02610192|459241008|FG000|Overall Study|Physician Decision|1|||
127622073|NCT00503841|459241009|FG000|Overall Study|All screen failures|44|||
127622074|NCT01344057|459241010|FG000|Overall Study|Premature Withdrawal|1|||
127622075|NCT00306592|459241011|FG000|Overall Study|Adverse Event|8|||
127622076|NCT00306592|459241012|FG001|Overall Study|Adverse Event|15|||
127622077|NCT00306592|459241011|FG000|Overall Study|Lost to Follow-up|1|||
127622078|NCT00306592|459241012|FG001|Overall Study|Lost to Follow-up|0|||
127622079|NCT00306592|459241011|FG000|Overall Study|Noncompliance|0|||
127622080|NCT00306592|459241012|FG001|Overall Study|Noncompliance|2|||
127622081|NCT00306592|459241011|FG000|Overall Study|Persistent Antibodies|6|||
127622082|NCT00306592|459241012|FG001|Overall Study|Persistent Antibodies|3|||
127622083|NCT00306592|459241011|FG000|Overall Study|Voluntary|10|||
127622084|NCT00306592|459241012|FG001|Overall Study|Voluntary|6|||
127622085|NCT00306592|459241011|FG000|Overall Study|Other|5|||
127622086|NCT00306592|459241012|FG001|Overall Study|Other|10|||
127622087|NCT00306592|459241011|FG000|Overall Study|Other|1|||
127622088|NCT00306592|459241012|FG001|Overall Study|Other|2|||
127622089|NCT00306592|459241011|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
127622090|NCT00306592|459241012|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
127622091|NCT01440322|459241013|FG000|Overall Study|Discomfort|2|||
127622092|NCT01440322|459241014|FG001|Overall Study|Discomfort|0|||
127622093|NCT01440322|459241013|FG000|Overall Study|Biomicroscopy|1|||
127622094|NCT01440322|459241014|FG001|Overall Study|Biomicroscopy|0|||
127622095|NCT01440322|459241013|FG000|Overall Study|Symptoms and Problems|1|||
127622096|NCT01440322|459241014|FG001|Overall Study|Symptoms and Problems|0|||
127622097|NCT01440322|459241013|FG000|Overall Study|Unacceptable Subjective Vision|1|||
127622098|NCT01440322|459241014|FG001|Overall Study|Unacceptable Subjective Vision|0|||
127622099|NCT01440322|459241013|FG000|Overall Study|Other Product Related|1|||
127622100|NCT01440322|459241014|FG001|Overall Study|Other Product Related|0|||
127622101|NCT01440322|459241013|FG000|Overall Study|Unrelated Medical Problem|0|||
127622102|NCT01440322|459241014|FG001|Overall Study|Unrelated Medical Problem|1|||
127622103|NCT01440322|459241013|FG000|Overall Study|Other Non-Product Related|1|||
127622104|NCT01440322|459241014|FG001|Overall Study|Other Non-Product Related|0|||
127622105|NCT05044234|459241016|FG000|Overall Study|Lost to Follow-up|2|||
127792027|NCT01784861|459862242|FG003|Overall Study|Withdrawal by Subject|1|||
127792028|NCT01784861|459862243|FG004|Overall Study|Withdrawal by Subject|0|||
127792029|NCT01784861|459862244|FG005|Overall Study|Withdrawal by Subject|0|||
127792030|NCT01784861|459862239|FG000|Overall Study|Physician Decision|0|||
127792031|NCT01784861|459862240|FG001|Overall Study|Physician Decision|0|||
127792032|NCT01784861|459862241|FG002|Overall Study|Physician Decision|0|||
127792033|NCT01784861|459862242|FG003|Overall Study|Physician Decision|2|||
127792034|NCT01784861|459862243|FG004|Overall Study|Physician Decision|0|||
127792035|NCT01784861|459862244|FG005|Overall Study|Physician Decision|1|||
127792036|NCT03948178|459862245|FG000|Overall Study|Protocol Violation|1|||
127792037|NCT03948178|459862245|FG000|Overall Study|Lost to Follow-up|2|||
127622106|NCT05044234|459241017|FG001|Overall Study|Lost to Follow-up|1|||
127622107|NCT05044234|459241018|FG002|Overall Study|Lost to Follow-up|1|||
127622108|NCT05044234|459241019|FG003|Overall Study|Lost to Follow-up|2|||
127622109|NCT05044234|459241016|FG000|Overall Study|Withdrawal by Subject|6|||
127622110|NCT05044234|459241017|FG001|Overall Study|Withdrawal by Subject|4|||
127622111|NCT05044234|459241018|FG002|Overall Study|Withdrawal by Subject|5|||
127622112|NCT05044234|459241019|FG003|Overall Study|Withdrawal by Subject|8|||
127622113|NCT05044234|459241016|FG000|Overall Study|Study terminated by Sponsor|21|||
127622114|NCT05044234|459241017|FG001|Overall Study|Study terminated by Sponsor|21|||
127884964|NCT00555399|460202174|FG004|Overall Study|Withdrawal by Subject|0|||
127622115|NCT05044234|459241018|FG002|Overall Study|Study terminated by Sponsor|20|||
127622116|NCT05044234|459241019|FG003|Overall Study|Study terminated by Sponsor|14|||
127622117|NCT05044234|459241016|FG000|Overall Study|Other, not specified|0|||
127622118|NCT05044234|459241017|FG001|Overall Study|Other, not specified|0|||
127622119|NCT05044234|459241018|FG002|Overall Study|Other, not specified|1|||
127622120|NCT05044234|459241019|FG003|Overall Study|Other, not specified|2|||
127622121|NCT05044234|459241016|FG000|Overall Study|Delayed data entry|0|||
127622122|NCT05044234|459241017|FG001|Overall Study|Delayed data entry|0|||
127622123|NCT05044234|459241018|FG002|Overall Study|Delayed data entry|0|||
127622124|NCT05044234|459241019|FG003|Overall Study|Delayed data entry|1|||
127622125|NCT02896127|459241020|FG000|COMPLETED WEEK 52|Adverse Event|9|||
127622126|NCT02896127|459241021|FG001|COMPLETED WEEK 52|Adverse Event|2|||
127622127|NCT02896127|459241020|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
127622128|NCT02896127|459241021|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
127622129|NCT02896127|459241020|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
127622130|NCT02896127|459241021|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
127622131|NCT02896127|459241020|FG000|COMPLETED WEEK 52|Physician Decision|1|||
127792038|NCT03948178|459862245|FG000|Overall Study|Withdrawal by Subject|2|||
127792039|NCT03948178|459862245|FG000|Overall Study|Reason not known|2|||
127792040|NCT03948178|459862245|FG000|Overall Study|Personal reason|14|||
127792041|NCT03948178|459862245|FG000|Overall Study|Disease progression|30|||
127792042|NCT03948178|459862245|FG000|Overall Study|Adverse Event|12|||
127792043|NCT03948178|459862245|FG000|Overall Study|Sponsor terminated study|164|||
127792044|NCT01965262|459862256|FG000|Second Intervention (7 Days)|Discontinued|0|||
127792045|NCT01965262|459862257|FG001|Second Intervention (7 Days)|Discontinued|1|||
127792046|NCT01965262|459862256|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
127792047|NCT01965262|459862257|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
127792048|NCT01965262|459862256|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
127792049|NCT01965262|459862257|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
127792050|NCT00143312|459862258|FG000|Overall Study|Death|11|||
127792051|NCT00143312|459862258|FG000|Overall Study|Adverse Event|2|||
127792052|NCT00143312|459862258|FG000|Overall Study|Lost to Follow-up|1|||
127792053|NCT00143312|459862258|FG000|Overall Study|Other|1|||
127792054|NCT00143312|459862258|FG000|Overall Study|Withdrawal by Subject|1|||
127792055|NCT01029366|459862259|FG000|Overall Study|Withdrawal by Subject|1|||
127792056|NCT01029366|459862260|FG001|Overall Study|Withdrawal by Subject|0|||
127792057|NCT01029366|459862259|FG000|Overall Study|Death|1|||
127792058|NCT01029366|459862260|FG001|Overall Study|Death|1|||
127792059|NCT01029366|459862259|FG000|Overall Study|disease progression|2|||
127792060|NCT01029366|459862260|FG001|Overall Study|disease progression|0|||
127792061|NCT01029366|459862259|FG000|Overall Study|manufacturing failure|0|||
127792062|NCT01029366|459862260|FG001|Overall Study|manufacturing failure|1|||
127792063|NCT00906087|459862266|FG000|Initial Washout|Withdrawal by Subject|1|||
127792064|NCT00906087|459862266|FG000|Initial Washout|Physician Decision|1|||
127792065|NCT00513500|459862279|FG000|Overall Study|Lost to Follow-up|35|||
127792066|NCT00513500|459862280|FG001|Overall Study|Lost to Follow-up|39|||
127792067|NCT00513500|459862279|FG000|Overall Study|Death|2|||
127792068|NCT00513500|459862280|FG001|Overall Study|Death|1|||
127622132|NCT02896127|459241021|FG001|COMPLETED WEEK 52|Physician Decision|1|||
127622133|NCT02896127|459241020|FG000|COMPLETED WEEK 52|Pregnancy|2|||
127622134|NCT02896127|459241021|FG001|COMPLETED WEEK 52|Pregnancy|0|||
127622135|NCT02896127|459241020|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
127622136|NCT02896127|459241021|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
127622137|NCT02896127|459241020|FG000|COMPLETED WEEK 52|Technical problems|1|||
127622138|NCT02896127|459241021|FG001|COMPLETED WEEK 52|Technical problems|0|||
127622139|NCT02896127|459241020|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
127622140|NCT02896127|459241021|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
127622141|NCT02896127|459241020|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
127622142|NCT02896127|459241021|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
127622143|NCT02896127|459241020|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
127622144|NCT02896127|459241021|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
127622145|NCT02896127|459241020|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
127622146|NCT02896127|459241021|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
127622147|NCT02896127|459241020|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
127622148|NCT02896127|459241021|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
127622149|NCT00279708|459241022|FG000|Overall Study|Withdrawal by Subject|2|||
127622150|NCT00279708|459241023|FG001|Overall Study|Withdrawal by Subject|3|||
127622151|NCT00279708|459241022|FG000|Overall Study|Adverse Event|1|||
127622152|NCT00279708|459241023|FG001|Overall Study|Adverse Event|1|||
127622153|NCT03354429|459241024|FG000|Overall Study|Withdrawal by Subject|8|||
127622154|NCT03354429|459241025|FG001|Overall Study|Withdrawal by Subject|7|||
127622155|NCT03354429|459241024|FG000|Overall Study|Lost to Follow-up|1|||
127622156|NCT03354429|459241025|FG001|Overall Study|Lost to Follow-up|0|||
127622157|NCT02488629|459241026|FG000|Overall Study|Lack of Efficacy|3|||
127622158|NCT02488629|459241027|FG001|Overall Study|Lack of Efficacy|1|||
127622159|NCT02488629|459241028|FG002|Overall Study|Lack of Efficacy|0|||
127622160|NCT02488629|459241029|FG003|Overall Study|Lack of Efficacy|0|||
127622161|NCT02488629|459241026|FG000|Overall Study|Withdrawal by Subject|0|||
127622162|NCT02488629|459241027|FG001|Overall Study|Withdrawal by Subject|1|||
127622163|NCT02488629|459241028|FG002|Overall Study|Withdrawal by Subject|0|||
127622164|NCT02488629|459241029|FG003|Overall Study|Withdrawal by Subject|0|||
127622165|NCT02940691|459241030|FG000|Overall Study|Lost to Follow-up|5|||
127622166|NCT02940691|459241030|FG000|Overall Study|Incarceration|1|||
127622167|NCT00654628|459241031|FG000|6-week Active Treatment Period|Adverse Event|9|||
127622168|NCT00654628|459241031|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
127622169|NCT00654628|459241031|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
127622170|NCT00654628|459241031|FG000|6-week Active Treatment Period|Out of window period|1|||
127622171|NCT00654628|459241031|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
127622172|NCT00654628|459241031|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
127622173|NCT01465802|459241034|FG000|Overall Study|Study terminated by sponsor|1|||
127622174|NCT01465802|459241035|FG001|Overall Study|Study terminated by sponsor|0|||
127622175|NCT01465802|459241036|FG002|Overall Study|Study terminated by sponsor|0|||
127622176|NCT01465802|459241037|FG003|Overall Study|Study terminated by sponsor|1|||
127642651|NCT02807558|459313099|FG000|Overall Study|Lack of Efficacy|0|||
127642652|NCT02807558|459313100|FG001|Overall Study|Lack of Efficacy|0|||
127642653|NCT02807558|459313101|FG002|Overall Study|Lack of Efficacy|9|||
127642654|NCT02807558|459313102|FG003|Overall Study|Lack of Efficacy|0|||
127642655|NCT02807558|459313103|FG004|Overall Study|Lack of Efficacy|0|||
127642656|NCT02807558|459313104|FG005|Overall Study|Lack of Efficacy|0|||
127642657|NCT04435366|459313105|FG000|Year 1 (12 Months)|Adverse Event|3|||
127642658|NCT04435366|459313106|FG001|Year 1 (12 Months)|Adverse Event|0|||
127622177|NCT01465802|459241038|FG004|Overall Study|Study terminated by sponsor|7|||
127622178|NCT01465802|459241034|FG000|Overall Study|Withdrawal by Subject|7|||
127622179|NCT01465802|459241035|FG001|Overall Study|Withdrawal by Subject|7|||
127622180|NCT01465802|459241036|FG002|Overall Study|Withdrawal by Subject|0|||
127622181|NCT01465802|459241037|FG003|Overall Study|Withdrawal by Subject|8|||
127622182|NCT01465802|459241038|FG004|Overall Study|Withdrawal by Subject|1|||
127622183|NCT01465802|459241034|FG000|Overall Study|Lost to Follow-up|1|||
127622184|NCT01465802|459241035|FG001|Overall Study|Lost to Follow-up|1|||
127622185|NCT01465802|459241036|FG002|Overall Study|Lost to Follow-up|0|||
127622186|NCT01465802|459241037|FG003|Overall Study|Lost to Follow-up|0|||
127622187|NCT01465802|459241038|FG004|Overall Study|Lost to Follow-up|0|||
127622188|NCT01465802|459241034|FG000|Overall Study|Reason not specified|9|||
127622189|NCT01465802|459241035|FG001|Overall Study|Reason not specified|4|||
127622190|NCT01465802|459241036|FG002|Overall Study|Reason not specified|0|||
127622191|NCT01465802|459241037|FG003|Overall Study|Reason not specified|10|||
127622192|NCT01465802|459241038|FG004|Overall Study|Reason not specified|2|||
127622193|NCT01465802|459241034|FG000|Overall Study|Death|15|||
127622194|NCT01465802|459241035|FG001|Overall Study|Death|12|||
127622195|NCT01465802|459241036|FG002|Overall Study|Death|0|||
127792069|NCT00513500|459862279|FG000|Overall Study|Hospitalized|4|||
127792070|NCT00513500|459862280|FG001|Overall Study|Hospitalized|14|||
127792071|NCT00749996|459862283|FG000|Overall Study|Lost to Follow-up|7|||
127792072|NCT00749996|459862284|FG001|Overall Study|Lost to Follow-up|4|||
127622196|NCT01465802|459241037|FG003|Overall Study|Death|10|||
127622197|NCT01465802|459241038|FG004|Overall Study|Death|2|||
127622198|NCT02331446|459241039|FG000|Overall Study|Lost to Follow-up|2|||
127792073|NCT00749996|459862283|FG000|Overall Study|Withdrawal by Subject|5|||
127622199|NCT02331446|459241040|FG001|Overall Study|Lost to Follow-up|1|||
127622200|NCT02331446|459241041|FG002|Overall Study|Lost to Follow-up|0|||
127792074|NCT00749996|459862284|FG001|Overall Study|Withdrawal by Subject|4|||
127792075|NCT00749996|459862283|FG000|Overall Study|Protocol Violation|2|||
127792076|NCT00749996|459862284|FG001|Overall Study|Protocol Violation|3|||
127792077|NCT00749996|459862283|FG000|Overall Study|Physician Decision|2|||
127792078|NCT00749996|459862284|FG001|Overall Study|Physician Decision|0|||
127792079|NCT00749996|459862283|FG000|Overall Study|Pregnancy|0|||
127792080|NCT00749996|459862284|FG001|Overall Study|Pregnancy|2|||
127792081|NCT00749996|459862283|FG000|Overall Study|Adverse Event|1|||
127622201|NCT02331446|459241042|FG003|Overall Study|Lost to Follow-up|1|||
127622202|NCT02331446|459241039|FG000|Overall Study|Personal Problem|2|||
127622203|NCT02331446|459241040|FG001|Overall Study|Personal Problem|0|||
127622204|NCT02331446|459241041|FG002|Overall Study|Personal Problem|0|||
127622205|NCT02331446|459241042|FG003|Overall Study|Personal Problem|0|||
127622206|NCT02331446|459241039|FG000|Overall Study|Disease|0|||
127622207|NCT02331446|459241040|FG001|Overall Study|Disease|2|||
127622208|NCT02331446|459241041|FG002|Overall Study|Disease|2|||
127622209|NCT02331446|459241042|FG003|Overall Study|Disease|1|||
127622210|NCT02331446|459241039|FG000|Overall Study|Physician Decision|0|||
127622211|NCT02331446|459241040|FG001|Overall Study|Physician Decision|1|||
127622212|NCT02331446|459241041|FG002|Overall Study|Physician Decision|0|||
127622213|NCT02331446|459241042|FG003|Overall Study|Physician Decision|1|||
127622214|NCT02331446|459241039|FG000|Overall Study|Lost before baseline analysis|0|||
127622215|NCT02331446|459241040|FG001|Overall Study|Lost before baseline analysis|1|||
127622216|NCT02331446|459241041|FG002|Overall Study|Lost before baseline analysis|1|||
127701025|NCT02985957|459535008|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
127701026|NCT02985957|459535009|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
127701027|NCT02985957|459535010|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
127701028|NCT02985957|459535011|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
127701029|NCT02985957|459535012|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
127701030|NCT02985957|459535013|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
127701031|NCT02985957|459535014|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
127701032|NCT02985957|459535008|FG000|Treatment Period|Poor/Non-Compliance|0|||
127792082|NCT00749996|459862284|FG001|Overall Study|Adverse Event|0|||
127792083|NCT00749996|459862283|FG000|Overall Study|Death|1|||
127792084|NCT00749996|459862284|FG001|Overall Study|Death|0|||
127792085|NCT00517829|459862285|FG000|Overall Study|Adverse Event|22|||
127792086|NCT00517829|459862286|FG001|Overall Study|Adverse Event|34|||
127792087|NCT00517829|459862285|FG000|Overall Study|Disease Progression|39|||
127792088|NCT00517829|459862286|FG001|Overall Study|Disease Progression|32|||
127792089|NCT00517829|459862285|FG000|Overall Study|Patient Request|6|||
127792090|NCT00517829|459862286|FG001|Overall Study|Patient Request|5|||
127792091|NCT00517829|459862285|FG000|Overall Study|Investigator Request|5|||
127792092|NCT00517829|459862286|FG001|Overall Study|Investigator Request|3|||
127792093|NCT00517829|459862285|FG000|Overall Study|Other|3|||
127792094|NCT00517829|459862286|FG001|Overall Study|Other|1|||
127792095|NCT00606086|459862287|FG000|Overall Study|Adverse Event|1|||
127792096|NCT00606086|459862288|FG001|Overall Study|Adverse Event|1|||
127622217|NCT02331446|459241042|FG003|Overall Study|Lost before baseline analysis|0|||
127622218|NCT02566759|459241043|FG000|All Parts|Withdrawal by Subject|0|||
127622219|NCT02566759|459241044|FG001|All Parts|Withdrawal by Subject|1|||
127622220|NCT02566759|459241045|FG002|All Parts|Withdrawal by Subject|0|||
127622221|NCT02566759|459241046|FG003|All Parts|Withdrawal by Subject|0|||
127622222|NCT02566759|459241047|FG004|All Parts|Withdrawal by Subject|0|||
127792097|NCT00606086|459862287|FG000|Overall Study|Lost to Follow-up|4|||
127792098|NCT00606086|459862288|FG001|Overall Study|Lost to Follow-up|8|||
127792099|NCT00606086|459862287|FG000|Overall Study|Protocol Violation|1|||
127792100|NCT00606086|459862288|FG001|Overall Study|Protocol Violation|0|||
127792101|NCT00606086|459862287|FG000|Overall Study|Withdrawal by Subject|5|||
127792102|NCT00606086|459862288|FG001|Overall Study|Withdrawal by Subject|3|||
127622223|NCT02566759|459241048|FG005|All Parts|Withdrawal by Subject|0|||
127622224|NCT02566759|459241049|FG006|All Parts|Withdrawal by Subject|0|||
127622225|NCT02566759|459241050|FG007|All Parts|Withdrawal by Subject|0|||
127622226|NCT02566759|459241051|FG008|All Parts|Withdrawal by Subject|0|||
127622227|NCT02566759|459241052|FG009|All Parts|Withdrawal by Subject|0|||
127792103|NCT00606086|459862287|FG000|Overall Study|Non-compliance|0|||
127792104|NCT00606086|459862288|FG001|Overall Study|Non-compliance|1|||
127792105|NCT00606086|459862287|FG000|Overall Study|Randomized, not treated|1|||
127884965|NCT00555399|460202175|FG005|Overall Study|Withdrawal by Subject|0|||
127884966|NCT00555399|460202176|FG006|Overall Study|Withdrawal by Subject|0|||
127622228|NCT02566759|459241053|FG010|All Parts|Withdrawal by Subject|0|||
127622229|NCT02566759|459241054|FG011|All Parts|Withdrawal by Subject|0|||
127622230|NCT02566759|459241055|FG012|All Parts|Withdrawal by Subject|0|||
127622231|NCT02566759|459241056|FG013|All Parts|Withdrawal by Subject|0|||
127622232|NCT02566759|459241057|FG014|All Parts|Withdrawal by Subject|0|||
127622233|NCT02566759|459241058|FG015|All Parts|Withdrawal by Subject|0|||
127622234|NCT02566759|459241059|FG016|All Parts|Withdrawal by Subject|0|||
127622235|NCT02566759|459241043|FG000|All Parts|Adverse Event|0|||
127622236|NCT02566759|459241044|FG001|All Parts|Adverse Event|0|||
127622237|NCT02566759|459241045|FG002|All Parts|Adverse Event|0|||
127622238|NCT02566759|459241046|FG003|All Parts|Adverse Event|0|||
127622239|NCT02566759|459241047|FG004|All Parts|Adverse Event|0|||
127622240|NCT02566759|459241048|FG005|All Parts|Adverse Event|0|||
127622241|NCT02566759|459241049|FG006|All Parts|Adverse Event|0|||
127622242|NCT02566759|459241050|FG007|All Parts|Adverse Event|0|||
127622243|NCT02566759|459241051|FG008|All Parts|Adverse Event|0|||
127622244|NCT02566759|459241052|FG009|All Parts|Adverse Event|0|||
127622245|NCT02566759|459241053|FG010|All Parts|Adverse Event|0|||
127622246|NCT02566759|459241054|FG011|All Parts|Adverse Event|0|||
127622247|NCT02566759|459241055|FG012|All Parts|Adverse Event|1|||
127622248|NCT02566759|459241056|FG013|All Parts|Adverse Event|3|||
127622249|NCT02566759|459241057|FG014|All Parts|Adverse Event|0|||
127884967|NCT00555399|460202177|FG007|Overall Study|Withdrawal by Subject|0|||
127622250|NCT02566759|459241058|FG015|All Parts|Adverse Event|0|||
127792106|NCT00606086|459862288|FG001|Overall Study|Randomized, not treated|2|||
127792107|NCT00796315|459862295|FG000|Overall Study|Protocol Violation|0|||
127792108|NCT00796315|459862296|FG001|Overall Study|Protocol Violation|1|||
127792109|NCT00796315|459862297|FG002|Overall Study|Protocol Violation|0|||
127622251|NCT02566759|459241059|FG016|All Parts|Adverse Event|0|||
127792110|NCT01627860|459862298|FG000|Overall Study|Adverse Event|9|||
127884968|NCT00555399|460202178|FG008|Overall Study|Withdrawal by Subject|0|||
127622252|NCT02566759|459241043|FG000|All Parts|Other|0|||
127622253|NCT02566759|459241044|FG001|All Parts|Other|0|||
127622254|NCT02566759|459241045|FG002|All Parts|Other|0|||
127622255|NCT02566759|459241046|FG003|All Parts|Other|0|||
127622256|NCT02566759|459241047|FG004|All Parts|Other|0|||
127792111|NCT01627860|459862299|FG001|Overall Study|Adverse Event|4|||
127792112|NCT01627860|459862298|FG000|Overall Study|Withdrawal by Subject|2|||
127792113|NCT01627860|459862299|FG001|Overall Study|Withdrawal by Subject|1|||
127792114|NCT01627860|459862298|FG000|Overall Study|Seizure frequency doubled|0|||
127792115|NCT01627860|459862299|FG001|Overall Study|Seizure frequency doubled|1|||
127792116|NCT01627860|459862298|FG000|Overall Study|Protocol Violation|1|||
127792117|NCT01627860|459862299|FG001|Overall Study|Protocol Violation|0|||
127792118|NCT00689871|459862304|FG000|Overall Study|Lost to Follow-up|123|||
127792119|NCT00689871|459862305|FG001|Overall Study|Lost to Follow-up|13|||
127792120|NCT00689871|459862306|FG002|Overall Study|Lost to Follow-up|37|||
127792121|NCT00689871|459862307|FG003|Overall Study|Lost to Follow-up|1|||
127792122|NCT00689871|459862304|FG000|Overall Study|Explanted of All Study Devices|36|||
127792123|NCT00689871|459862305|FG001|Overall Study|Explanted of All Study Devices|25|||
127792124|NCT00689871|459862306|FG002|Overall Study|Explanted of All Study Devices|29|||
127792125|NCT00689871|459862307|FG003|Overall Study|Explanted of All Study Devices|3|||
127792126|NCT00689871|459862304|FG000|Overall Study|Withdrawal by Subject|13|||
127792127|NCT00689871|459862305|FG001|Overall Study|Withdrawal by Subject|3|||
127792128|NCT00689871|459862306|FG002|Overall Study|Withdrawal by Subject|4|||
127792129|NCT00689871|459862307|FG003|Overall Study|Withdrawal by Subject|1|||
127792130|NCT00689871|459862304|FG000|Overall Study|Death|1|||
127792131|NCT00689871|459862305|FG001|Overall Study|Death|10|||
127792132|NCT00689871|459862306|FG002|Overall Study|Death|2|||
127792133|NCT00689871|459862307|FG003|Overall Study|Death|2|||
127792134|NCT00689871|459862304|FG000|Overall Study|Physician Decision|2|||
127792135|NCT00689871|459862305|FG001|Overall Study|Physician Decision|1|||
127792136|NCT00689871|459862306|FG002|Overall Study|Physician Decision|1|||
127622257|NCT02566759|459241048|FG005|All Parts|Other|0|||
127622258|NCT02566759|459241049|FG006|All Parts|Other|0|||
127622259|NCT02566759|459241050|FG007|All Parts|Other|0|||
127622260|NCT02566759|459241051|FG008|All Parts|Other|0|||
127622261|NCT02566759|459241052|FG009|All Parts|Other|0|||
127622262|NCT02566759|459241053|FG010|All Parts|Other|0|||
127622263|NCT02566759|459241054|FG011|All Parts|Other|0|||
127622264|NCT02566759|459241055|FG012|All Parts|Other|0|||
127622265|NCT02566759|459241056|FG013|All Parts|Other|2|||
127622266|NCT02566759|459241057|FG014|All Parts|Other|0|||
127622267|NCT02566759|459241058|FG015|All Parts|Other|0|||
127622268|NCT02566759|459241059|FG016|All Parts|Other|0|||
127792137|NCT00689871|459862307|FG003|Overall Study|Physician Decision|0|||
127792138|NCT00889265|459862312|FG000|Overall Study|Adverse Event|1|||
127792139|NCT00889265|459862312|FG000|Overall Study|Lost to Follow-up|5|||
127622269|NCT02566759|459241043|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
127622270|NCT02566759|459241044|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
127622271|NCT02566759|459241045|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
127622272|NCT02566759|459241046|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
127792140|NCT00889265|459862312|FG000|Overall Study|Protocol Violation|1|||
127792141|NCT00250835|459862315|FG000|Overall Study|Withdrawal by Subject|1|||
127701033|NCT02985957|459535009|FG001|Treatment Period|Poor/Non-Compliance|0|||
127701034|NCT02985957|459535010|FG002|Treatment Period|Poor/Non-Compliance|0|||
127701035|NCT02985957|459535011|FG003|Treatment Period|Poor/Non-Compliance|0|||
127701036|NCT02985957|459535012|FG004|Treatment Period|Poor/Non-Compliance|1|||
127701037|NCT02985957|459535013|FG005|Treatment Period|Poor/Non-Compliance|1|||
127701038|NCT02985957|459535014|FG006|Treatment Period|Poor/Non-Compliance|0|||
127701039|NCT02985957|459535008|FG000|Treatment Period|Continuing in Treatment Period|0|||
127701040|NCT02985957|459535009|FG001|Treatment Period|Continuing in Treatment Period|1|||
127701041|NCT02985957|459535010|FG002|Treatment Period|Continuing in Treatment Period|0|||
127701042|NCT02985957|459535011|FG003|Treatment Period|Continuing in Treatment Period|4|||
127701043|NCT02985957|459535012|FG004|Treatment Period|Continuing in Treatment Period|4|||
127701044|NCT02985957|459535013|FG005|Treatment Period|Continuing in Treatment Period|0|||
127701045|NCT02985957|459535014|FG006|Treatment Period|Continuing in Treatment Period|0|||
127701046|NCT04802967|459535021|FG000|Part B|Withdrawal by Subject|0|||
127701047|NCT04802967|459535022|FG001|Part B|Withdrawal by Subject|0|||
127701048|NCT04802967|459535023|FG002|Part B|Withdrawal by Subject|0|||
127701049|NCT04802967|459535024|FG003|Part B|Withdrawal by Subject|0|||
127701050|NCT04802967|459535025|FG004|Part B|Withdrawal by Subject|0|||
127701051|NCT04802967|459535026|FG005|Part B|Withdrawal by Subject|1|||
127701052|NCT04802967|459535027|FG006|Part B|Withdrawal by Subject|0|||
127701053|NCT04802967|459535028|FG007|Part B|Withdrawal by Subject|0|||
127701054|NCT04802967|459535029|FG008|Part B|Withdrawal by Subject|0|||
127701055|NCT04802967|459535030|FG009|Part B|Withdrawal by Subject|0|||
127701056|NCT00085735|459535036|FG000|Overall Study|Adverse Event|1|||
127701057|NCT00085735|459535037|FG001|Overall Study|Adverse Event|0|||
127701058|NCT00085735|459535038|FG002|Overall Study|Adverse Event|0|||
127701059|NCT00085735|459535039|FG003|Overall Study|Adverse Event|0|||
127701060|NCT00085735|459535040|FG004|Overall Study|Adverse Event|0|||
127701061|NCT00085735|459535041|FG005|Overall Study|Adverse Event|0|||
127701062|NCT00085735|459535036|FG000|Overall Study|Lack of Efficacy|2|||
127701063|NCT00085735|459535037|FG001|Overall Study|Lack of Efficacy|4|||
127701064|NCT00085735|459535038|FG002|Overall Study|Lack of Efficacy|6|||
127701065|NCT00085735|459535039|FG003|Overall Study|Lack of Efficacy|3|||
127701066|NCT00085735|459535040|FG004|Overall Study|Lack of Efficacy|4|||
127701067|NCT00085735|459535041|FG005|Overall Study|Lack of Efficacy|3|||
127701068|NCT00085735|459535036|FG000|Overall Study|Lost to Follow-up|0|||
127701069|NCT00085735|459535037|FG001|Overall Study|Lost to Follow-up|1|||
127701070|NCT00085735|459535038|FG002|Overall Study|Lost to Follow-up|0|||
127701071|NCT00085735|459535039|FG003|Overall Study|Lost to Follow-up|0|||
127701072|NCT00085735|459535040|FG004|Overall Study|Lost to Follow-up|1|||
127701073|NCT00085735|459535041|FG005|Overall Study|Lost to Follow-up|0|||
127701074|NCT00085735|459535036|FG000|Overall Study|Physician Decision|2|||
127701075|NCT00085735|459535037|FG001|Overall Study|Physician Decision|3|||
127701076|NCT00085735|459535038|FG002|Overall Study|Physician Decision|2|||
127701077|NCT00085735|459535039|FG003|Overall Study|Physician Decision|3|||
127701078|NCT00085735|459535040|FG004|Overall Study|Physician Decision|11|||
127701079|NCT00085735|459535041|FG005|Overall Study|Physician Decision|8|||
127701080|NCT00085735|459535036|FG000|Overall Study|Protocol Violation|1|||
127792142|NCT00159861|459862316|FG000|Core Study - 16 Weeks|Death|3|||
127792143|NCT00159861|459862317|FG001|Core Study - 16 Weeks|Death|0|||
127792144|NCT00159861|459862316|FG000|Core Study - 16 Weeks|Adverse Event|12|||
127792145|NCT00159861|459862317|FG001|Core Study - 16 Weeks|Adverse Event|6|||
127792146|NCT00159861|459862316|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
127792147|NCT00159861|459862317|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
127792148|NCT00159861|459862316|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
127792149|NCT00159861|459862317|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
127792150|NCT00159861|459862316|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
127792151|NCT00159861|459862317|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
127792152|NCT00159861|459862316|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
127792153|NCT00159861|459862317|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
127792154|NCT00159861|459862316|FG000|Extension Study - up to 3 Years|Death|24|||
127701081|NCT00085735|459535037|FG001|Overall Study|Protocol Violation|0|||
127701082|NCT00085735|459535038|FG002|Overall Study|Protocol Violation|0|||
127701083|NCT00085735|459535039|FG003|Overall Study|Protocol Violation|0|||
127701084|NCT00085735|459535040|FG004|Overall Study|Protocol Violation|0|||
127701085|NCT00085735|459535041|FG005|Overall Study|Protocol Violation|0|||
127701086|NCT00085735|459535036|FG000|Overall Study|Withdrawal by Subject|1|||
127701087|NCT00085735|459535037|FG001|Overall Study|Withdrawal by Subject|0|||
127701088|NCT00085735|459535038|FG002|Overall Study|Withdrawal by Subject|4|||
127701089|NCT00085735|459535039|FG003|Overall Study|Withdrawal by Subject|5|||
127701090|NCT00085735|459535040|FG004|Overall Study|Withdrawal by Subject|7|||
127701091|NCT00085735|459535041|FG005|Overall Study|Withdrawal by Subject|8|||
127701092|NCT00085735|459535036|FG000|Overall Study|Patient ineligible|1|||
127792155|NCT00159861|459862317|FG001|Extension Study - up to 3 Years|Death|28|||
127792156|NCT00159861|459862316|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
127792157|NCT00159861|459862317|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
127792158|NCT00159861|459862316|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
127792159|NCT00159861|459862317|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
127792160|NCT00159861|459862316|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
127792161|NCT00159861|459862317|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
127792162|NCT00159861|459862316|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
127792163|NCT00159861|459862317|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
127792164|NCT04489888|459862318|FG000|Overall Study|Death|75|||
127792165|NCT04489888|459862318|FG000|Overall Study|Sponsor Decision|26|||
127792166|NCT03349099|459862321|FG000|Overall Study|Physician Decision|3|||
127792167|NCT03349099|459862322|FG001|Overall Study|Physician Decision|4|||
127792168|NCT03349099|459862321|FG000|Overall Study|Stone migrated from the kidney|1|||
127792169|NCT03349099|459862322|FG001|Overall Study|Stone migrated from the kidney|0|||
127792170|NCT00278993|459862323|FG000|Overall Study|Adverse Event|24|||
127792171|NCT00278993|459862323|FG000|Overall Study|Withdrawal by Subject|5|||
127792172|NCT00278993|459862323|FG000|Overall Study|Progressive Disease|65|||
127792173|NCT00278993|459862323|FG000|Overall Study|Physician Decision|9|||
127792174|NCT00278993|459862323|FG000|Overall Study|Not Otherwise Specified|4|||
127792175|NCT04194528|459862329|FG000|Overall Study|Adverse Event|1|||
127792176|NCT00333359|459862332|FG000|Overall Study|Adverse Event|29|||
127792177|NCT00333359|459862333|FG001|Overall Study|Adverse Event|35|||
127792178|NCT00333359|459862332|FG000|Overall Study|Withdrawal by Subject|19|||
127792179|NCT00333359|459862333|FG001|Overall Study|Withdrawal by Subject|37|||
127792180|NCT00333359|459862332|FG000|Overall Study|Physician Decision|2|||
127792181|NCT00333359|459862333|FG001|Overall Study|Physician Decision|2|||
127792182|NCT00333359|459862332|FG000|Overall Study|Protocol Non-compliance|2|||
127884969|NCT00555399|460202179|FG009|Overall Study|Withdrawal by Subject|0|||
127622273|NCT02566759|459241047|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
127622274|NCT02566759|459241048|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
127622275|NCT02566759|459241049|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
127622276|NCT02566759|459241050|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
127622277|NCT02566759|459241051|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
127622278|NCT02566759|459241052|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
127622279|NCT02566759|459241053|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
127622280|NCT02566759|459241054|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
127622281|NCT02566759|459241055|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
127622282|NCT02566759|459241056|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
127622283|NCT02566759|459241057|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
127622284|NCT02566759|459241058|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
127622285|NCT02566759|459241059|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
127622286|NCT01126541|459241060|FG000|Overall Study|Adverse Event|0|||
127622287|NCT01126541|459241061|FG001|Overall Study|Adverse Event|2|||
127622288|NCT01126541|459241062|FG002|Overall Study|Adverse Event|4|||
127622289|NCT01126541|459241060|FG000|Overall Study|Death|0|||
127792183|NCT00333359|459862333|FG001|Overall Study|Protocol Non-compliance|8|||
127792184|NCT00333359|459862332|FG000|Overall Study|Lost to Follow-up|15|||
127792185|NCT00333359|459862333|FG001|Overall Study|Lost to Follow-up|25|||
127792186|NCT00333359|459862332|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
127792187|NCT00333359|459862333|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
127792188|NCT00333359|459862332|FG000|Overall Study|Treatment Failure|3|||
127792189|NCT00333359|459862333|FG001|Overall Study|Treatment Failure|8|||
127792190|NCT00333359|459862332|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
127792191|NCT00333359|459862333|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
127792192|NCT04682405|459863541|FG000|Overall Study|Adverse Event|0|||
127792193|NCT04682405|459863542|FG001|Overall Study|Adverse Event|1|||
127792194|NCT00522431|459863543|FG000|Overall Study|Adverse Event|5|||
127622290|NCT01126541|459241061|FG001|Overall Study|Death|1|||
127792195|NCT00522431|459863543|FG000|Overall Study|Protocol Violation|2|||
127792196|NCT00522431|459863543|FG000|Overall Study|Withdrawal by Subject|2|||
127792197|NCT00522431|459863543|FG000|Overall Study|Subject non-compliance|1|||
127792198|NCT00522431|459863543|FG000|Overall Study|Other/unknown|1|||
127792199|NCT01339559|459863546|FG000|Overall Study|Adverse Event|92|||
127792200|NCT01339559|459863546|FG000|Overall Study|Death|5|||
127792201|NCT01339559|459863546|FG000|Overall Study|Lack of Efficacy|164|||
127792202|NCT01339559|459863546|FG000|Overall Study|Lost to Follow-up|22|||
127792203|NCT01339559|459863546|FG000|Overall Study|Subject choice|89|||
127792204|NCT01339559|459863546|FG000|Overall Study|Protocol Violation|15|||
127792205|NCT01339559|459863546|FG000|Overall Study|Study closure at site|1|||
127792206|NCT01339559|459863546|FG000|Overall Study|Incarcerated|2|||
127792207|NCT01339559|459863546|FG000|Overall Study|Epilepsy surgery|1|||
127792208|NCT01339559|459863546|FG000|Overall Study|Pregnancy planned|2|||
127792209|NCT01339559|459863546|FG000|Overall Study|Left the country|1|||
127884970|NCT00555399|460202180|FG010|Overall Study|Withdrawal by Subject|0|||
127622291|NCT01126541|459241062|FG002|Overall Study|Death|0|||
127622292|NCT01126541|459241060|FG000|Overall Study|Lack of Efficacy|6|||
127622293|NCT01126541|459241061|FG001|Overall Study|Lack of Efficacy|1|||
127792210|NCT01339559|459863546|FG000|Overall Study|Investigator decision|2|||
127792211|NCT01339559|459863546|FG000|Overall Study|Patient didn't wish to continue|1|||
127792212|NCT01339559|459863546|FG000|Overall Study|PI decision|1|||
127792213|NCT01137773|459863547|FG000|Overall Study|Death|3|||
127792214|NCT01137773|459863548|FG001|Overall Study|Death|3|||
127792215|NCT01137773|459863547|FG000|Overall Study|Lost to Follow-up|6|||
127792216|NCT01137773|459863548|FG001|Overall Study|Lost to Follow-up|0|||
127701093|NCT00085735|459535037|FG001|Overall Study|Patient ineligible|0|||
127701094|NCT00085735|459535038|FG002|Overall Study|Patient ineligible|3|||
127701095|NCT00085735|459535039|FG003|Overall Study|Patient ineligible|7|||
127701096|NCT00085735|459535040|FG004|Overall Study|Patient ineligible|17|||
127701097|NCT00085735|459535041|FG005|Overall Study|Patient ineligible|8|||
127622294|NCT01126541|459241062|FG002|Overall Study|Lack of Efficacy|11|||
127622295|NCT01126541|459241060|FG000|Overall Study|Lost to Follow-up|1|||
127622296|NCT01126541|459241061|FG001|Overall Study|Lost to Follow-up|2|||
127622297|NCT01126541|459241062|FG002|Overall Study|Lost to Follow-up|2|||
127622298|NCT01126541|459241060|FG000|Overall Study|Withdrawal by Subject|2|||
127622299|NCT01126541|459241061|FG001|Overall Study|Withdrawal by Subject|5|||
127622300|NCT01126541|459241062|FG002|Overall Study|Withdrawal by Subject|6|||
127622301|NCT01126541|459241060|FG000|Overall Study|Protocol Violation|0|||
127622302|NCT01126541|459241061|FG001|Overall Study|Protocol Violation|0|||
127622303|NCT01126541|459241062|FG002|Overall Study|Protocol Violation|1|||
127622304|NCT01126541|459241060|FG000|Overall Study|Administrative reason or other|1|||
127622305|NCT01126541|459241061|FG001|Overall Study|Administrative reason or other|1|||
127622306|NCT01126541|459241062|FG002|Overall Study|Administrative reason or other|2|||
127622307|NCT00226941|459241063|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
127622308|NCT00226941|459241064|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
127622309|NCT00226941|459241065|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
127622310|NCT00226941|459241066|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
127622311|NCT00226941|459241063|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
127622312|NCT00226941|459241064|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
127622313|NCT00226941|459241065|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
127622314|NCT00226941|459241066|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
127622315|NCT01513291|459241067|FG000|Treatment Period|Adverse Event|8|||
127622316|NCT01513291|459241068|FG001|Treatment Period|Adverse Event|4|||
127622317|NCT01513291|459241069|FG002|Treatment Period|Adverse Event|0|||
127622318|NCT01513291|459241070|FG003|Treatment Period|Adverse Event|0|||
127622319|NCT01513291|459241071|FG004|Treatment Period|Adverse Event|0|||
127622320|NCT01513291|459241067|FG000|Treatment Period|Lack of Efficacy|3|||
127622321|NCT01513291|459241068|FG001|Treatment Period|Lack of Efficacy|0|||
127622322|NCT01513291|459241069|FG002|Treatment Period|Lack of Efficacy|0|||
127701098|NCT00085735|459535036|FG000|Overall Study|Excess residual disease|2|||
127701099|NCT00085735|459535037|FG001|Overall Study|Excess residual disease|2|||
127701100|NCT00085735|459535038|FG002|Overall Study|Excess residual disease|1|||
127701101|NCT00085735|459535039|FG003|Overall Study|Excess residual disease|1|||
127701102|NCT00085735|459535040|FG004|Overall Study|Excess residual disease|1|||
127701103|NCT00085735|459535041|FG005|Overall Study|Excess residual disease|4|||
127701104|NCT00085735|459535036|FG000|Overall Study|Reason not documented|1|||
127701105|NCT00085735|459535037|FG001|Overall Study|Reason not documented|0|||
127701106|NCT00085735|459535038|FG002|Overall Study|Reason not documented|1|||
127701107|NCT00085735|459535039|FG003|Overall Study|Reason not documented|0|||
127701108|NCT00085735|459535040|FG004|Overall Study|Reason not documented|1|||
127701109|NCT00085735|459535041|FG005|Overall Study|Reason not documented|0|||
127622323|NCT01513291|459241070|FG003|Treatment Period|Lack of Efficacy|0|||
127701110|NCT00085735|459535036|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
127701111|NCT00085735|459535037|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
127701112|NCT00085735|459535038|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
127701113|NCT00085735|459535039|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
127701114|NCT00085735|459535040|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
127701115|NCT00085735|459535041|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
127701116|NCT04625283|459535042|FG000|Overall Study|post randomization exclusion|28|||
127792217|NCT00290433|459863551|FG000|Overall Study|Disease Progression|13|||
127622324|NCT01513291|459241071|FG004|Treatment Period|Lack of Efficacy|0|||
127622325|NCT01513291|459241067|FG000|Treatment Period|Lost to Follow-up|2|||
127622326|NCT01513291|459241068|FG001|Treatment Period|Lost to Follow-up|3|||
127622327|NCT01513291|459241069|FG002|Treatment Period|Lost to Follow-up|0|||
127622328|NCT01513291|459241070|FG003|Treatment Period|Lost to Follow-up|0|||
127622329|NCT01513291|459241071|FG004|Treatment Period|Lost to Follow-up|0|||
127622330|NCT01513291|459241067|FG000|Treatment Period|Physician Decision|1|||
127622331|NCT01513291|459241068|FG001|Treatment Period|Physician Decision|0|||
127622332|NCT01513291|459241069|FG002|Treatment Period|Physician Decision|0|||
127622333|NCT01513291|459241070|FG003|Treatment Period|Physician Decision|0|||
127622334|NCT01513291|459241071|FG004|Treatment Period|Physician Decision|0|||
127622335|NCT01513291|459241067|FG000|Treatment Period|Protocol Violation|1|||
127622336|NCT01513291|459241068|FG001|Treatment Period|Protocol Violation|2|||
127622337|NCT01513291|459241069|FG002|Treatment Period|Protocol Violation|0|||
127622338|NCT01513291|459241070|FG003|Treatment Period|Protocol Violation|0|||
127622339|NCT01513291|459241071|FG004|Treatment Period|Protocol Violation|0|||
127622340|NCT01513291|459241067|FG000|Treatment Period|Withdrawal by Subject|8|||
127622341|NCT01513291|459241068|FG001|Treatment Period|Withdrawal by Subject|5|||
127622342|NCT01513291|459241069|FG002|Treatment Period|Withdrawal by Subject|0|||
127622343|NCT01513291|459241070|FG003|Treatment Period|Withdrawal by Subject|0|||
127622344|NCT01513291|459241071|FG004|Treatment Period|Withdrawal by Subject|0|||
127622345|NCT01513291|459241067|FG000|Treatment Period|Randomized not treated|0|||
127622346|NCT01513291|459241068|FG001|Treatment Period|Randomized not treated|2|||
127622347|NCT01513291|459241069|FG002|Treatment Period|Randomized not treated|0|||
127622348|NCT01513291|459241070|FG003|Treatment Period|Randomized not treated|0|||
127622349|NCT01513291|459241071|FG004|Treatment Period|Randomized not treated|0|||
127622350|NCT01513291|459241067|FG000|Run-out Period|Lost to Follow-up|0|||
127622351|NCT01513291|459241068|FG001|Run-out Period|Lost to Follow-up|0|||
127622352|NCT01513291|459241069|FG002|Run-out Period|Lost to Follow-up|0|||
127622353|NCT01513291|459241070|FG003|Run-out Period|Lost to Follow-up|1|||
127622354|NCT01513291|459241071|FG004|Run-out Period|Lost to Follow-up|0|||
127622355|NCT01513291|459241067|FG000|Run-out Period|Withdrawal by Subject|0|||
127622356|NCT01513291|459241068|FG001|Run-out Period|Withdrawal by Subject|0|||
127622357|NCT01513291|459241069|FG002|Run-out Period|Withdrawal by Subject|0|||
127622358|NCT01513291|459241070|FG003|Run-out Period|Withdrawal by Subject|1|||
127622359|NCT01513291|459241071|FG004|Run-out Period|Withdrawal by Subject|0|||
127622360|NCT03732638|459241072|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
127622361|NCT03732638|459241073|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
127622362|NCT03732638|459241072|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
127792218|NCT00290433|459863551|FG000|Overall Study|Adverse Event|14|||
127792219|NCT00290433|459863551|FG000|Overall Study|Withdrawal by Subject|1|||
127792220|NCT00290433|459863551|FG000|Overall Study|Non-Compliance|1|||
127622363|NCT03732638|459241073|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
127622364|NCT03732638|459241072|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
127792221|NCT00290433|459863551|FG000|Overall Study|Congestive Heart Failure|1|||
127622365|NCT03732638|459241073|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
127622366|NCT03732638|459241072|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
127622367|NCT03732638|459241073|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
127622368|NCT03732638|459241072|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
127622369|NCT03732638|459241073|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
127622370|NCT03732638|459241072|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
127622371|NCT03732638|459241073|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
127622372|NCT03732638|459241072|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
127622373|NCT03732638|459241073|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
127622374|NCT03732638|459241072|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
127622375|NCT03732638|459241073|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
127622376|NCT03732638|459241072|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
127622377|NCT03732638|459241073|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
127622378|NCT03732638|459241072|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
127622379|NCT03732638|459241073|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
127622380|NCT03732638|459241072|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
127622381|NCT03732638|459241073|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
127622382|NCT03732638|459241072|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
127622383|NCT03732638|459241073|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
127622384|NCT03732638|459241072|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
127884971|NCT00555399|460202181|FG011|Overall Study|Withdrawal by Subject|1|||
127884972|NCT00555399|460202170|FG000|Overall Study|Patient decided not to proceed with treatment|0|||
127884973|NCT00555399|460202171|FG001|Overall Study|Patient decided not to proceed with treatment|0|||
127884974|NCT00555399|460202172|FG002|Overall Study|Patient decided not to proceed with treatment|1|||
127884975|NCT00555399|460202173|FG003|Overall Study|Patient decided not to proceed with treatment|0|||
127884976|NCT00555399|460202174|FG004|Overall Study|Patient decided not to proceed with treatment|0|||
127884977|NCT00555399|460202175|FG005|Overall Study|Patient decided not to proceed with treatment|0|||
127884978|NCT00555399|460202176|FG006|Overall Study|Patient decided not to proceed with treatment|0|||
127884979|NCT00555399|460202177|FG007|Overall Study|Patient decided not to proceed with treatment|0|||
127622385|NCT03732638|459241073|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
127622386|NCT03732638|459241072|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
127884980|NCT00555399|460202178|FG008|Overall Study|Patient decided not to proceed with treatment|0|||
127622387|NCT03732638|459241073|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
127622388|NCT03732638|459241072|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
127622389|NCT03732638|459241073|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
127622390|NCT03732638|459241072|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
127622391|NCT03732638|459241073|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
127622392|NCT03732638|459241072|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
127622393|NCT03732638|459241073|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
127622394|NCT03732638|459241072|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
127622395|NCT03732638|459241073|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
127622396|NCT03732638|459241072|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
127792222|NCT00290433|459863551|FG000|Overall Study|Transplant in CR|5|||
127792223|NCT00290433|459863551|FG000|Overall Study|Unrelated Infection/Death|1|||
127792224|NCT02559687|459863552|FG000|Overall Study|Death|112|||
127792225|NCT02559687|459863552|FG000|Overall Study|Sponsor Decision|5|||
127792226|NCT02559687|459863552|FG000|Overall Study|Withdrawal by Subject|4|||
127792227|NCT03031301|459863556|FG000|Overall Study|Protocol Violation|4|||
127792228|NCT03031301|459863557|FG001|Overall Study|Protocol Violation|8|||
127792229|NCT03031301|459863556|FG000|Overall Study|Withdrawal by Subject|7|||
127792230|NCT03031301|459863557|FG001|Overall Study|Withdrawal by Subject|4|||
127792231|NCT03031301|459863556|FG000|Overall Study|Lost to Follow-up|4|||
127792232|NCT03031301|459863557|FG001|Overall Study|Lost to Follow-up|12|||
127792233|NCT03031301|459863556|FG000|Overall Study|Noncompliance|1|||
127792234|NCT03031301|459863557|FG001|Overall Study|Noncompliance|3|||
127792235|NCT03031301|459863556|FG000|Overall Study|Technical issue|1|||
127792236|NCT03031301|459863557|FG001|Overall Study|Technical issue|1|||
127792237|NCT03031301|459863556|FG000|Overall Study|Adverse Event|1|||
127622397|NCT03732638|459241073|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
127792238|NCT03031301|459863557|FG001|Overall Study|Adverse Event|0|||
127792239|NCT03245450|459863558|FG000|Overall Study|Radiological disease progression|3|||
127792240|NCT03245450|459863559|FG001|Overall Study|Radiological disease progression|3|||
127622398|NCT03732638|459241072|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
127622399|NCT03732638|459241073|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
127622400|NCT03732638|459241072|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
127622401|NCT03732638|459241073|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
127622402|NCT03732638|459241072|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
127622403|NCT03732638|459241073|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
127622404|NCT03732638|459241072|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
127622405|NCT03732638|459241073|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
127622406|NCT03732638|459241072|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
127792241|NCT03245450|459863560|FG002|Overall Study|Radiological disease progression|2|||
127792242|NCT03245450|459863561|FG003|Overall Study|Radiological disease progression|2|||
127792243|NCT03245450|459863562|FG004|Overall Study|Radiological disease progression|7|||
127792244|NCT03245450|459863563|FG005|Overall Study|Radiological disease progression|6|||
127792245|NCT03245450|459863564|FG006|Overall Study|Radiological disease progression|6|||
127792246|NCT03245450|459863558|FG000|Overall Study|Clinical disease progression|0|||
127792247|NCT03245450|459863559|FG001|Overall Study|Clinical disease progression|0|||
127792248|NCT03245450|459863560|FG002|Overall Study|Clinical disease progression|1|||
127792249|NCT03245450|459863561|FG003|Overall Study|Clinical disease progression|0|||
127792250|NCT03245450|459863562|FG004|Overall Study|Clinical disease progression|0|||
127792251|NCT03245450|459863563|FG005|Overall Study|Clinical disease progression|2|||
127792252|NCT03245450|459863564|FG006|Overall Study|Clinical disease progression|0|||
127792253|NCT03245450|459863558|FG000|Overall Study|Other|0|||
127792254|NCT03245450|459863559|FG001|Overall Study|Other|0|||
127792255|NCT03245450|459863560|FG002|Overall Study|Other|0|||
127792256|NCT03245450|459863561|FG003|Overall Study|Other|1|||
127792257|NCT03245450|459863562|FG004|Overall Study|Other|1|||
127792258|NCT03245450|459863563|FG005|Overall Study|Other|1|||
127792259|NCT03245450|459863564|FG006|Overall Study|Other|1|||
127792260|NCT03245450|459863558|FG000|Overall Study|Withdrawal by Subject|0|||
127792261|NCT03245450|459863559|FG001|Overall Study|Withdrawal by Subject|1|||
127622407|NCT03732638|459241073|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
127622408|NCT01358981|459241074|FG000|Period 1|Withdrawal by Subject|0|||
127622409|NCT01358981|459241075|FG001|Period 1|Withdrawal by Subject|0|||
127622410|NCT01358981|459241076|FG002|Period 1|Withdrawal by Subject|0|||
127622411|NCT01358981|459241077|FG003|Period 1|Withdrawal by Subject|1|||
127622412|NCT01358981|459241078|FG004|Period 1|Withdrawal by Subject|0|||
127622413|NCT01358981|459241079|FG005|Period 1|Withdrawal by Subject|0|||
127622414|NCT01358981|459241080|FG006|Period 1|Withdrawal by Subject|0|||
127622415|NCT02519712|459241083|FG000|Overall Study|Disease Relapse|1|||
127622416|NCT02519712|459241083|FG000|Overall Study|Disease Progression|1|||
127622417|NCT02519712|459241083|FG000|Overall Study|Accruals are donors|2|||
127622418|NCT01462357|459241084|FG000|Overall Study|Death|0|||
127622419|NCT01462357|459241085|FG001|Overall Study|Death|0|||
127622420|NCT01462357|459241086|FG002|Overall Study|Death|1|||
127622421|NCT01462357|459241084|FG000|Overall Study|Withdrawal by Subject|3|||
127622422|NCT01462357|459241085|FG001|Overall Study|Withdrawal by Subject|11|||
127622423|NCT01462357|459241086|FG002|Overall Study|Withdrawal by Subject|3|||
127622424|NCT01462357|459241084|FG000|Overall Study|Migrated/moved from study area|2|||
127622425|NCT01462357|459241085|FG001|Overall Study|Migrated/moved from study area|3|||
127622426|NCT01462357|459241086|FG002|Overall Study|Migrated/moved from study area|1|||
127622427|NCT01462357|459241084|FG000|Overall Study|Lost to Follow-up|3|||
127622428|NCT01462357|459241085|FG001|Overall Study|Lost to Follow-up|5|||
127622429|NCT01462357|459241086|FG002|Overall Study|Lost to Follow-up|7|||
127622430|NCT01482767|459241087|FG000|Overall Study|Death|1|||
127622431|NCT01482767|459241088|FG001|Overall Study|Death|1|||
127622432|NCT01482767|459241087|FG000|Overall Study|Withdrawal by Subject|7|||
127622433|NCT01482767|459241088|FG001|Overall Study|Withdrawal by Subject|5|||
127622434|NCT01482767|459241087|FG000|Overall Study|Lost to Follow-up|12|||
127622435|NCT01482767|459241088|FG001|Overall Study|Lost to Follow-up|6|||
127622436|NCT01482767|459241087|FG000|Overall Study|Adverse Event|0|||
127622437|NCT01482767|459241088|FG001|Overall Study|Adverse Event|3|||
127622438|NCT01482767|459241087|FG000|Overall Study|Site closure|22|||
127622439|NCT01482767|459241088|FG001|Overall Study|Site closure|14|||
127622440|NCT01482767|459241087|FG000|Overall Study|Non-adherence to study requirements|4|||
127622441|NCT01482767|459241088|FG001|Overall Study|Non-adherence to study requirements|7|||
127622442|NCT01482767|459241087|FG000|Overall Study|Alternate HCV treatment|7|||
127622443|NCT01482767|459241088|FG001|Overall Study|Alternate HCV treatment|8|||
127622444|NCT01482767|459241087|FG000|Overall Study|Ineligible|0|||
127622445|NCT01482767|459241088|FG001|Overall Study|Ineligible|5|||
127622446|NCT01482767|459241087|FG000|Overall Study|Nurse error|1|||
127622447|NCT01482767|459241088|FG001|Overall Study|Nurse error|0|||
127622448|NCT00806546|459241089|FG000|Overall Study|Enrolled, not treated|35|||
127622449|NCT00806546|459241089|FG000|Overall Study|Lost to Follow-up|32|||
127622450|NCT00806546|459241089|FG000|Overall Study|Adverse Event|74|||
127622451|NCT00806546|459241089|FG000|Overall Study|Withdrawal by Subject|75|||
127622452|NCT00806546|459241089|FG000|Overall Study|Protocol Violation|49|||
127622453|NCT00806546|459241089|FG000|Overall Study|Various|42|||
127622454|NCT03385239|459241092|FG000|Overall Study|Voluntary Withdrawal|2|||
127622455|NCT03385239|459241093|FG001|Overall Study|Voluntary Withdrawal|3|||
127622456|NCT03385239|459241094|FG002|Overall Study|Voluntary Withdrawal|2|||
127701117|NCT04625283|459535043|FG001|Overall Study|post randomization exclusion|20|||
127701118|NCT02817776|459535044|FG000|Overall Study|Excluded|33|||
127701119|NCT02817776|459535044|FG000|Overall Study|Lost to Follow-up|20|||
127701120|NCT02817776|459535044|FG000|Overall Study|Withdrawal by Subject|33|||
127701121|NCT02817776|459535044|FG000|Overall Study|Death|2|||
127701122|NCT02598388|459535045|FG000|Overall Study|Lost to Follow-up|1|||
127792262|NCT03245450|459863560|FG002|Overall Study|Withdrawal by Subject|0|||
127792263|NCT03245450|459863561|FG003|Overall Study|Withdrawal by Subject|0|||
127792264|NCT03245450|459863562|FG004|Overall Study|Withdrawal by Subject|0|||
127622457|NCT03385239|459241095|FG003|Overall Study|Voluntary Withdrawal|3|||
127701123|NCT02598388|459535046|FG001|Overall Study|Lost to Follow-up|0|||
127701124|NCT02598388|459535047|FG002|Overall Study|Lost to Follow-up|1|||
127701125|NCT02598388|459535048|FG003|Overall Study|Lost to Follow-up|0|||
127701126|NCT02598388|459535049|FG004|Overall Study|Lost to Follow-up|5|||
127701127|NCT02598388|459535050|FG005|Overall Study|Lost to Follow-up|1|||
127701128|NCT02598388|459535051|FG006|Overall Study|Lost to Follow-up|2|||
127622458|NCT03385239|459241096|FG004|Overall Study|Voluntary Withdrawal|0|||
127622459|NCT03385239|459241092|FG000|Overall Study|Adverse Event|0|||
127622460|NCT03385239|459241093|FG001|Overall Study|Adverse Event|0|||
127701129|NCT02598388|459535052|FG007|Overall Study|Lost to Follow-up|1|||
127622461|NCT03385239|459241094|FG002|Overall Study|Adverse Event|1|||
127622462|NCT03385239|459241095|FG003|Overall Study|Adverse Event|0|||
127622463|NCT03385239|459241096|FG004|Overall Study|Adverse Event|0|||
127622464|NCT03385239|459241092|FG000|Overall Study|Other|0|||
127622465|NCT03385239|459241093|FG001|Overall Study|Other|0|||
127622466|NCT03385239|459241094|FG002|Overall Study|Other|0|||
127622467|NCT03385239|459241095|FG003|Overall Study|Other|1|||
127701130|NCT02598388|459535053|FG008|Overall Study|Lost to Follow-up|0|||
127622468|NCT03385239|459241096|FG004|Overall Study|Other|0|||
127701131|NCT02598388|459535054|FG009|Overall Study|Lost to Follow-up|0|||
127622469|NCT01574703|459241097|FG000|Overall Study|Adverse Event|0|||
127622470|NCT01574703|459241098|FG001|Overall Study|Adverse Event|2|||
127622471|NCT01574703|459241099|FG002|Overall Study|Adverse Event|1|||
127622472|NCT01574703|459241100|FG003|Overall Study|Adverse Event|1|||
127622473|NCT01574703|459241097|FG000|Overall Study|Protocol Violation|0|||
127622474|NCT01574703|459241098|FG001|Overall Study|Protocol Violation|0|||
127622475|NCT01574703|459241099|FG002|Overall Study|Protocol Violation|0|||
127622476|NCT01574703|459241100|FG003|Overall Study|Protocol Violation|1|||
127622477|NCT01574703|459241097|FG000|Overall Study|Unspecified Reason|27|||
127622478|NCT01574703|459241098|FG001|Overall Study|Unspecified Reason|15|||
127622479|NCT01574703|459241099|FG002|Overall Study|Unspecified Reason|20|||
127622480|NCT01574703|459241100|FG003|Overall Study|Unspecified Reason|16|||
127622481|NCT01574703|459241097|FG000|Overall Study|Withdrawal by Subject|53|||
127622482|NCT01574703|459241098|FG001|Overall Study|Withdrawal by Subject|52|||
127622483|NCT01574703|459241099|FG002|Overall Study|Withdrawal by Subject|36|||
127622484|NCT01574703|459241100|FG003|Overall Study|Withdrawal by Subject|61|||
127622485|NCT01574703|459241097|FG000|Overall Study|Met Withdrawal Criteria|0|||
127622486|NCT01574703|459241098|FG001|Overall Study|Met Withdrawal Criteria|1|||
127622487|NCT01574703|459241099|FG002|Overall Study|Met Withdrawal Criteria|1|||
127622488|NCT01574703|459241100|FG003|Overall Study|Met Withdrawal Criteria|0|||
127622489|NCT01574703|459241097|FG000|Overall Study|Lost to Follow-up|43|||
127622490|NCT01574703|459241098|FG001|Overall Study|Lost to Follow-up|41|||
127622491|NCT01574703|459241099|FG002|Overall Study|Lost to Follow-up|46|||
127622492|NCT01574703|459241100|FG003|Overall Study|Lost to Follow-up|35|||
127622493|NCT01574703|459241097|FG000|Overall Study|Death|2|||
127622494|NCT01574703|459241098|FG001|Overall Study|Death|1|||
127622495|NCT01574703|459241099|FG002|Overall Study|Death|1|||
127622496|NCT01574703|459241100|FG003|Overall Study|Death|0|||
127622497|NCT01524770|459241101|FG000|First Intervention|Withdrawal by Subject|1|||
127622498|NCT01524770|459241102|FG001|First Intervention|Withdrawal by Subject|0|||
127622499|NCT01524770|459241101|FG000|First Intervention|Adverse Event|1|||
127622500|NCT01524770|459241102|FG001|First Intervention|Adverse Event|1|||
127622501|NCT01524770|459241101|FG000|First Intervention|Protocol Violation|1|||
127622502|NCT01524770|459241102|FG001|First Intervention|Protocol Violation|0|||
127622503|NCT02751983|459241103|FG000|Treatment|Stopped ACT, but Remained in study|2|||
127622504|NCT02751983|459241104|FG001|Treatment|Stopped ACT, but Remained in study|0|||
127622505|NCT02751983|459241103|FG000|Treatment|Discharged prior to beginning ACT|2|||
127622506|NCT02751983|459241104|FG001|Treatment|Discharged prior to beginning ACT|0|||
127622507|NCT02751983|459241103|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
127622508|NCT02751983|459241104|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
127622509|NCT02751983|459241103|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
127622510|NCT02751983|459241104|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
127622511|NCT02751983|459241103|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
127622512|NCT02751983|459241104|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
127622513|NCT01282216|459241105|FG000|Overall Study|Graft failure|0|||
127622514|NCT01282216|459241106|FG001|Overall Study|Graft failure|0|||
127622515|NCT01282216|459241107|FG002|Overall Study|Graft failure|3|||
127622516|NCT01282216|459241108|FG003|Overall Study|Graft failure|2|||
127622517|NCT01282216|459241105|FG000|Overall Study|Physician Decision|0|||
127622518|NCT01282216|459241106|FG001|Overall Study|Physician Decision|0|||
127622519|NCT01282216|459241107|FG002|Overall Study|Physician Decision|11|||
127622520|NCT01282216|459241108|FG003|Overall Study|Physician Decision|0|||
127622521|NCT01282216|459241105|FG000|Overall Study|Relapse|0|||
127622522|NCT01282216|459241106|FG001|Overall Study|Relapse|0|||
127622523|NCT01282216|459241107|FG002|Overall Study|Relapse|17|||
127622524|NCT01282216|459241108|FG003|Overall Study|Relapse|6|||
127622525|NCT01282216|459241105|FG000|Overall Study|Death|0|||
127792265|NCT03245450|459863563|FG005|Overall Study|Withdrawal by Subject|0|||
127792266|NCT03245450|459863564|FG006|Overall Study|Withdrawal by Subject|0|||
127792267|NCT03245450|459863558|FG000|Overall Study|Adverse Event|0|||
127792268|NCT03245450|459863559|FG001|Overall Study|Adverse Event|0|||
127792269|NCT03245450|459863560|FG002|Overall Study|Adverse Event|0|||
127622526|NCT01282216|459241106|FG001|Overall Study|Death|0|||
127622527|NCT01282216|459241107|FG002|Overall Study|Death|2|||
127622528|NCT01282216|459241108|FG003|Overall Study|Death|0|||
127622529|NCT01387607|459241110|FG000|Overall Study|Adverse Event|23|||
127622530|NCT01387607|459241111|FG001|Overall Study|Adverse Event|11|||
127622531|NCT01387607|459241110|FG000|Overall Study|Lack of Efficacy|8|||
127622532|NCT01387607|459241111|FG001|Overall Study|Lack of Efficacy|6|||
127622533|NCT01387607|459241110|FG000|Overall Study|Lost to Follow-up|2|||
127792270|NCT03245450|459863561|FG003|Overall Study|Adverse Event|0|||
127792271|NCT03245450|459863562|FG004|Overall Study|Adverse Event|1|||
127622534|NCT01387607|459241111|FG001|Overall Study|Lost to Follow-up|1|||
127622535|NCT01387607|459241110|FG000|Overall Study|No longer meets eligibility criteria|0|||
127622536|NCT01387607|459241111|FG001|Overall Study|No longer meets eligibility criteria|1|||
127622537|NCT01387607|459241110|FG000|Overall Study|Protocol Violation|1|||
127622538|NCT01387607|459241111|FG001|Overall Study|Protocol Violation|5|||
127622539|NCT01387607|459241110|FG000|Overall Study|Withdrawal by Subject|13|||
127622540|NCT01387607|459241111|FG001|Overall Study|Withdrawal by Subject|14|||
127622541|NCT01387607|459241110|FG000|Overall Study|Other|1|||
127622542|NCT01387607|459241111|FG001|Overall Study|Other|1|||
127622543|NCT01387607|459241110|FG000|Overall Study|Randomized, not treated|3|||
127622544|NCT01387607|459241111|FG001|Overall Study|Randomized, not treated|6|||
127622545|NCT02908529|459241112|FG000|Overall Study|Lost to Follow-up|0|||
127622546|NCT02908529|459241113|FG001|Overall Study|Lost to Follow-up|2|||
127622547|NCT03337724|459241114|FG000|Overall Study|Reason not Specified|12|||
127622548|NCT03337724|459241115|FG001|Overall Study|Reason not Specified|21|||
127622549|NCT03337724|459241116|FG002|Overall Study|Reason not Specified|9|||
127622550|NCT03337724|459241117|FG003|Overall Study|Reason not Specified|9|||
127622551|NCT03337724|459241118|FG004|Overall Study|Reason not Specified|29|||
127622552|NCT03337724|459241114|FG000|Overall Study|Withdrawal by Subject|13|||
127622553|NCT03337724|459241115|FG001|Overall Study|Withdrawal by Subject|15|||
127622554|NCT03337724|459241116|FG002|Overall Study|Withdrawal by Subject|4|||
127622555|NCT03337724|459241117|FG003|Overall Study|Withdrawal by Subject|15|||
127622556|NCT03337724|459241118|FG004|Overall Study|Withdrawal by Subject|6|||
127622557|NCT03337724|459241114|FG000|Overall Study|Protocol Deviation|0|||
127622558|NCT03337724|459241115|FG001|Overall Study|Protocol Deviation|1|||
127622559|NCT03337724|459241116|FG002|Overall Study|Protocol Deviation|1|||
127622560|NCT03337724|459241117|FG003|Overall Study|Protocol Deviation|1|||
127622561|NCT03337724|459241118|FG004|Overall Study|Protocol Deviation|0|||
127622562|NCT03337724|459241114|FG000|Overall Study|Adverse Event|1|||
127622563|NCT03337724|459241115|FG001|Overall Study|Adverse Event|1|||
127622564|NCT03337724|459241116|FG002|Overall Study|Adverse Event|0|||
127622565|NCT03337724|459241117|FG003|Overall Study|Adverse Event|1|||
127622566|NCT03337724|459241118|FG004|Overall Study|Adverse Event|0|||
127622567|NCT03337724|459241114|FG000|Overall Study|Death|40|||
127622568|NCT03337724|459241115|FG001|Overall Study|Death|89|||
127622569|NCT03337724|459241116|FG002|Overall Study|Death|43|||
127622570|NCT03337724|459241117|FG003|Overall Study|Death|76|||
127622571|NCT03337724|459241118|FG004|Overall Study|Death|50|||
127622572|NCT03337724|459241114|FG000|Overall Study|Lost to Follow-up|5|||
127622573|NCT03337724|459241115|FG001|Overall Study|Lost to Follow-up|5|||
127622574|NCT03337724|459241116|FG002|Overall Study|Lost to Follow-up|4|||
127622575|NCT03337724|459241117|FG003|Overall Study|Lost to Follow-up|7|||
127622576|NCT03337724|459241118|FG004|Overall Study|Lost to Follow-up|4|||
127622577|NCT03337724|459241114|FG000|Overall Study|Physician Decision|16|||
127622578|NCT03337724|459241115|FG001|Overall Study|Physician Decision|34|||
127622579|NCT03337724|459241116|FG002|Overall Study|Physician Decision|14|||
127622580|NCT03337724|459241117|FG003|Overall Study|Physician Decision|34|||
127622581|NCT03337724|459241118|FG004|Overall Study|Physician Decision|13|||
127622582|NCT03337724|459241114|FG000|Overall Study|Progressive Disease|0|||
127622583|NCT03337724|459241115|FG001|Overall Study|Progressive Disease|2|||
127622584|NCT03337724|459241116|FG002|Overall Study|Progressive Disease|1|||
127622585|NCT03337724|459241117|FG003|Overall Study|Progressive Disease|2|||
127622586|NCT03337724|459241118|FG004|Overall Study|Progressive Disease|0|||
127622587|NCT03337724|459241114|FG000|Overall Study|Symptomatic Deterioration|0|||
127622588|NCT03337724|459241115|FG001|Overall Study|Symptomatic Deterioration|0|||
127622589|NCT03337724|459241116|FG002|Overall Study|Symptomatic Deterioration|0|||
127622590|NCT03337724|459241117|FG003|Overall Study|Symptomatic Deterioration|1|||
127622591|NCT03337724|459241118|FG004|Overall Study|Symptomatic Deterioration|0|||
127622592|NCT05569954|459241121|FG000|Overall Study|Lost to Follow-up|3|||
127622593|NCT05569954|459241122|FG001|Overall Study|Lost to Follow-up|4|||
127622594|NCT05569954|459241121|FG000|Overall Study|Protocol Violation|1|||
127622595|NCT05569954|459241122|FG001|Overall Study|Protocol Violation|2|||
127622596|NCT05569954|459241121|FG000|Overall Study|Withdrawal by Subject|4|||
127701132|NCT02598388|459535055|FG010|Overall Study|Lost to Follow-up|1|||
127701133|NCT02598388|459535056|FG011|Overall Study|Lost to Follow-up|0|||
127701134|NCT02598388|459535045|FG000|Overall Study|Withdrawal by Subject|0|||
127701135|NCT02598388|459535046|FG001|Overall Study|Withdrawal by Subject|0|||
127701136|NCT02598388|459535047|FG002|Overall Study|Withdrawal by Subject|0|||
127701137|NCT02598388|459535048|FG003|Overall Study|Withdrawal by Subject|0|||
127701138|NCT02598388|459535049|FG004|Overall Study|Withdrawal by Subject|2|||
127701139|NCT02598388|459535050|FG005|Overall Study|Withdrawal by Subject|0|||
127701140|NCT02598388|459535051|FG006|Overall Study|Withdrawal by Subject|2|||
127701141|NCT02598388|459535052|FG007|Overall Study|Withdrawal by Subject|0|||
127622597|NCT05569954|459241122|FG001|Overall Study|Withdrawal by Subject|2|||
127622598|NCT01660412|459241123|FG000|Overall Study|Protocol Violation|0|||
127622599|NCT01660412|459241124|FG001|Overall Study|Protocol Violation|3|||
127622600|NCT02239536|459241125|FG000|Overall Study|Non-neoplastic polyp|23|||
127622601|NCT02239536|459241126|FG001|Overall Study|Non-neoplastic polyp|17|||
127622602|NCT01038778|459241127|FG000|Overall Study|Withdrawal by Subject|0|||
127622603|NCT01038778|459241128|FG001|Overall Study|Withdrawal by Subject|2|||
127622604|NCT01038778|459241129|FG002|Overall Study|Withdrawal by Subject|3|||
127701142|NCT02598388|459535053|FG008|Overall Study|Withdrawal by Subject|0|||
127622605|NCT04740034|459241130|FG000|Overall Study|Death|0|||
127622606|NCT04740034|459241131|FG001|Overall Study|Death|1|||
127622607|NCT04740034|459241132|FG002|Overall Study|Death|2|||
127622608|NCT04740034|459241133|FG003|Overall Study|Death|3|||
127622609|NCT04740034|459241134|FG004|Overall Study|Death|4|||
127622610|NCT04740034|459241135|FG005|Overall Study|Death|4|||
127884981|NCT00555399|460202179|FG009|Overall Study|Patient decided not to proceed with treatment|0|||
127884982|NCT00555399|460202180|FG010|Overall Study|Patient decided not to proceed with treatment|0|||
127884983|NCT00555399|460202181|FG011|Overall Study|Patient decided not to proceed with treatment|0|||
127622611|NCT04740034|459241136|FG006|Overall Study|Death|2|||
127622612|NCT04740034|459241137|FG007|Overall Study|Death|2|||
127622613|NCT04740034|459241138|FG008|Overall Study|Death|2|||
127622614|NCT04740034|459241139|FG009|Overall Study|Death|4|||
127622615|NCT04740034|459241140|FG010|Overall Study|Death|0|||
127622616|NCT04740034|459241130|FG000|Overall Study|Lost to Follow-up|0|||
127622617|NCT04740034|459241131|FG001|Overall Study|Lost to Follow-up|0|||
127622618|NCT04740034|459241132|FG002|Overall Study|Lost to Follow-up|0|||
127622619|NCT04740034|459241133|FG003|Overall Study|Lost to Follow-up|1|||
127622620|NCT04740034|459241134|FG004|Overall Study|Lost to Follow-up|2|||
127622621|NCT04740034|459241135|FG005|Overall Study|Lost to Follow-up|2|||
127622622|NCT04740034|459241136|FG006|Overall Study|Lost to Follow-up|0|||
127622623|NCT04740034|459241137|FG007|Overall Study|Lost to Follow-up|0|||
127622624|NCT04740034|459241138|FG008|Overall Study|Lost to Follow-up|0|||
127622625|NCT04740034|459241139|FG009|Overall Study|Lost to Follow-up|1|||
127622626|NCT04740034|459241140|FG010|Overall Study|Lost to Follow-up|0|||
127622627|NCT04740034|459241130|FG000|Overall Study|Withdrawal by Subject|1|||
127622628|NCT04740034|459241131|FG001|Overall Study|Withdrawal by Subject|0|||
127622629|NCT04740034|459241132|FG002|Overall Study|Withdrawal by Subject|0|||
127622630|NCT04740034|459241133|FG003|Overall Study|Withdrawal by Subject|0|||
127622631|NCT04740034|459241134|FG004|Overall Study|Withdrawal by Subject|0|||
127622632|NCT04740034|459241135|FG005|Overall Study|Withdrawal by Subject|0|||
127622633|NCT04740034|459241136|FG006|Overall Study|Withdrawal by Subject|0|||
127622634|NCT04740034|459241137|FG007|Overall Study|Withdrawal by Subject|1|||
127622635|NCT04740034|459241138|FG008|Overall Study|Withdrawal by Subject|0|||
127622636|NCT04740034|459241139|FG009|Overall Study|Withdrawal by Subject|1|||
127622637|NCT04740034|459241140|FG010|Overall Study|Withdrawal by Subject|0|||
127622638|NCT04740034|459241130|FG000|Overall Study|Decision by sponsor|0|||
127622639|NCT04740034|459241131|FG001|Overall Study|Decision by sponsor|0|||
127622640|NCT04740034|459241132|FG002|Overall Study|Decision by sponsor|1|||
127622641|NCT04740034|459241133|FG003|Overall Study|Decision by sponsor|0|||
127622642|NCT04740034|459241134|FG004|Overall Study|Decision by sponsor|0|||
127622643|NCT04740034|459241135|FG005|Overall Study|Decision by sponsor|0|||
127622644|NCT04740034|459241136|FG006|Overall Study|Decision by sponsor|1|||
127622645|NCT04740034|459241137|FG007|Overall Study|Decision by sponsor|2|||
127622646|NCT04740034|459241138|FG008|Overall Study|Decision by sponsor|1|||
127622647|NCT04740034|459241139|FG009|Overall Study|Decision by sponsor|1|||
127622648|NCT04740034|459241140|FG010|Overall Study|Decision by sponsor|2|||
127622649|NCT03728582|459243015|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
127622650|NCT03728582|459243016|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
127622651|NCT03728582|459243015|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
127622652|NCT03728582|459243016|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
127884984|NCT01835470|460203741|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
127884985|NCT01835470|460203741|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
127884986|NCT01272193|460203742|FG000|Overall Study|Adverse Event|1|||
127884987|NCT01272193|460203743|FG001|Overall Study|Adverse Event|1|||
127884988|NCT01272193|460203742|FG000|Overall Study|Lack of Efficacy|0|||
127884989|NCT01272193|460203743|FG001|Overall Study|Lack of Efficacy|3|||
127884990|NCT01272193|460203742|FG000|Overall Study|Withdrawal Criteria|1|||
127884991|NCT01272193|460203743|FG001|Overall Study|Withdrawal Criteria|1|||
127884992|NCT01272193|460203742|FG000|Overall Study|Unclassified|8|||
127884993|NCT01272193|460203743|FG001|Overall Study|Unclassified|7|||
127622653|NCT01034397|459243017|FG000|Overall Study|Lack of compliance|0|||
127622654|NCT01034397|459243018|FG001|Overall Study|Lack of compliance|1|||
127701143|NCT02598388|459535054|FG009|Overall Study|Withdrawal by Subject|1|||
127701144|NCT02598388|459535055|FG010|Overall Study|Withdrawal by Subject|0|||
127622655|NCT01034397|459243017|FG000|Overall Study|Lack of Efficacy|3|||
127622656|NCT01034397|459243018|FG001|Overall Study|Lack of Efficacy|0|||
127622657|NCT01034397|459243017|FG000|Overall Study|Adverse Event|4|||
127622658|NCT01034397|459243018|FG001|Overall Study|Adverse Event|0|||
127884994|NCT01440647|460203744|FG000|Overall Study|Death|2|||
127622659|NCT01034397|459243017|FG000|Overall Study|Other|0|||
127622660|NCT01034397|459243018|FG001|Overall Study|Other|1|||
127622661|NCT01018264|459243019|FG000|Overall Study|Withdrawal by Subject|1|||
127622662|NCT01018264|459243020|FG001|Overall Study|Withdrawal by Subject|0|||
127622663|NCT01018264|459243019|FG000|Overall Study|Lost to Follow-up|0|||
127884995|NCT01440647|460203745|FG001|Overall Study|Death|3|||
127884996|NCT00948025|460203748|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
127622664|NCT01018264|459243020|FG001|Overall Study|Lost to Follow-up|1|||
127622665|NCT01785524|459243021|FG000|Overall Study|Withdrawal by Subject|2|||
127622666|NCT01785524|459243022|FG001|Overall Study|Withdrawal by Subject|2|||
127622667|NCT03217136|459243027|FG000|Overall Study|Lost to Follow-up|2|||
127701145|NCT02598388|459535056|FG011|Overall Study|Withdrawal by Subject|0|||
127701146|NCT02598388|459535045|FG000|Overall Study|Other|0|||
127701147|NCT02598388|459535046|FG001|Overall Study|Other|0|||
127701148|NCT02598388|459535047|FG002|Overall Study|Other|1|||
127701149|NCT02598388|459535048|FG003|Overall Study|Other|0|||
127701150|NCT02598388|459535049|FG004|Overall Study|Other|3|||
127701151|NCT02598388|459535050|FG005|Overall Study|Other|0|||
127701152|NCT02598388|459535051|FG006|Overall Study|Other|1|||
127701153|NCT02598388|459535052|FG007|Overall Study|Other|0|||
127701154|NCT02598388|459535053|FG008|Overall Study|Other|0|||
127701155|NCT02598388|459535054|FG009|Overall Study|Other|0|||
127701156|NCT02598388|459535055|FG010|Overall Study|Other|0|||
127701157|NCT02598388|459535056|FG011|Overall Study|Other|0|||
127701158|NCT04971681|459535075|FG000|Followup|Lost to Follow-up|1|||
127701159|NCT04971681|459535076|FG001|Followup|Lost to Follow-up|0|||
127701160|NCT00686335|459535077|FG000|Run-in Period|Adverse Event|1|||
127701161|NCT00686335|459535077|FG000|Run-in Period|asthma exacerbation|1|||
127701162|NCT00686335|459535077|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
127701163|NCT04149704|459535078|FG000|Three Month Follow-up|Death|2|||
127701164|NCT04149704|459535079|FG001|Three Month Follow-up|Death|0|||
127701165|NCT04149704|459535080|FG002|Three Month Follow-up|Death|0|||
127701166|NCT04149704|459535081|FG003|Three Month Follow-up|Death|0|||
127701167|NCT04149704|459535078|FG000|Three Month Follow-up|Lost to Follow-up|1|||
127701168|NCT04149704|459535079|FG001|Three Month Follow-up|Lost to Follow-up|4|||
127701169|NCT04149704|459535080|FG002|Three Month Follow-up|Lost to Follow-up|5|||
127701170|NCT04149704|459535081|FG003|Three Month Follow-up|Lost to Follow-up|5|||
127701171|NCT04149704|459535078|FG000|Three Month Follow-up|Withdrawal by Subject|1|||
127701172|NCT04149704|459535079|FG001|Three Month Follow-up|Withdrawal by Subject|0|||
127701173|NCT04149704|459535080|FG002|Three Month Follow-up|Withdrawal by Subject|0|||
127701174|NCT04149704|459535081|FG003|Three Month Follow-up|Withdrawal by Subject|0|||
127701175|NCT04149704|459535078|FG000|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
127701176|NCT04149704|459535079|FG001|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
127701177|NCT04149704|459535080|FG002|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
127701178|NCT04149704|459535081|FG003|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
127701179|NCT02677805|459535086|FG000|Double Blind Phase|Lost to Follow-up|8|||
127701180|NCT02677805|459535087|FG001|Double Blind Phase|Lost to Follow-up|3|||
127701181|NCT02677805|459535088|FG002|Double Blind Phase|Lost to Follow-up|0|||
127701182|NCT02677805|459535086|FG000|Double Blind Phase|Withdrawal by Subject|5|||
127701183|NCT02677805|459535087|FG001|Double Blind Phase|Withdrawal by Subject|2|||
127701184|NCT02677805|459535088|FG002|Double Blind Phase|Withdrawal by Subject|0|||
127701185|NCT02677805|459535086|FG000|Open Label Phase|Lost to Follow-up|0|||
127701186|NCT02677805|459535087|FG001|Open Label Phase|Lost to Follow-up|0|||
127701187|NCT02677805|459535088|FG002|Open Label Phase|Lost to Follow-up|10|||
127701188|NCT02677805|459535086|FG000|Open Label Phase|Withdrawal by Subject|0|||
127701189|NCT02677805|459535087|FG001|Open Label Phase|Withdrawal by Subject|0|||
127701190|NCT02677805|459535088|FG002|Open Label Phase|Withdrawal by Subject|6|||
127701191|NCT02268253|459535093|FG000|Stage 1|Withdrawal by Subject|1|||
127701192|NCT02268253|459535094|FG001|Stage 1|Withdrawal by Subject|0|||
127701193|NCT02268253|459535095|FG002|Stage 1|Withdrawal by Subject|0|||
127701194|NCT02268253|459535096|FG003|Stage 1|Withdrawal by Subject|0|||
127701195|NCT02268253|459535097|FG004|Stage 1|Withdrawal by Subject|0|||
127701196|NCT02268253|459535098|FG005|Stage 1|Withdrawal by Subject|0|||
127701197|NCT02268253|459535099|FG006|Stage 1|Withdrawal by Subject|0|||
127701198|NCT02268253|459535093|FG000|Stage 1|Death|0|||
127701199|NCT02268253|459535094|FG001|Stage 1|Death|2|||
127701200|NCT02268253|459535095|FG002|Stage 1|Death|2|||
127701201|NCT02268253|459535096|FG003|Stage 1|Death|2|||
127701202|NCT02268253|459535097|FG004|Stage 1|Death|1|||
127701203|NCT02268253|459535098|FG005|Stage 1|Death|1|||
127701204|NCT02268253|459535099|FG006|Stage 1|Death|0|||
127701205|NCT02268253|459535093|FG000|Stage 2|Disease Recurrence/ Progression|0|||
127701206|NCT02268253|459535094|FG001|Stage 2|Disease Recurrence/ Progression|0|||
127701207|NCT02268253|459535095|FG002|Stage 2|Disease Recurrence/ Progression|1|||
127701208|NCT02268253|459535096|FG003|Stage 2|Disease Recurrence/ Progression|0|||
127701209|NCT02268253|459535097|FG004|Stage 2|Disease Recurrence/ Progression|0|||
127701210|NCT02268253|459535098|FG005|Stage 2|Disease Recurrence/ Progression|0|||
127701211|NCT02268253|459535099|FG006|Stage 2|Disease Recurrence/ Progression|0|||
127701212|NCT02268253|459535093|FG000|Stage 2|Withdrawal by Subject|0|||
127701213|NCT02268253|459535094|FG001|Stage 2|Withdrawal by Subject|0|||
127701214|NCT02268253|459535095|FG002|Stage 2|Withdrawal by Subject|2|||
127701215|NCT02268253|459535096|FG003|Stage 2|Withdrawal by Subject|0|||
127701216|NCT02268253|459535097|FG004|Stage 2|Withdrawal by Subject|0|||
127701217|NCT02268253|459535098|FG005|Stage 2|Withdrawal by Subject|2|||
127701218|NCT02268253|459535099|FG006|Stage 2|Withdrawal by Subject|0|||
127622668|NCT03217136|459243028|FG001|Overall Study|Lost to Follow-up|1|||
127622669|NCT03217136|459243027|FG000|Overall Study|Site Randomized Participant in Error|0|||
127622670|NCT03217136|459243028|FG001|Overall Study|Site Randomized Participant in Error|1|||
127622671|NCT03217136|459243027|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
127622672|NCT03217136|459243028|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
127622673|NCT03217136|459243027|FG000|Overall Study|Dispensing Error|1|||
127622674|NCT03217136|459243028|FG001|Overall Study|Dispensing Error|0|||
127622675|NCT03217136|459243027|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
127622676|NCT03217136|459243028|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
127622677|NCT03192150|459243029|FG000|Overall Study|Adverse Event|14|||
127622678|NCT03192150|459243030|FG001|Overall Study|Adverse Event|12|||
127622679|NCT03192150|459243029|FG000|Overall Study|Lack of Efficacy|23|||
127622680|NCT03192150|459243030|FG001|Overall Study|Lack of Efficacy|30|||
127622681|NCT03192150|459243029|FG000|Overall Study|Lost to Follow-up|1|||
127622682|NCT03192150|459243030|FG001|Overall Study|Lost to Follow-up|1|||
127622683|NCT03192150|459243029|FG000|Overall Study|Withdrawal by Subject|4|||
127622684|NCT03192150|459243030|FG001|Overall Study|Withdrawal by Subject|2|||
127622685|NCT03192150|459243029|FG000|Overall Study|Protocol Violation|5|||
127622686|NCT03192150|459243030|FG001|Overall Study|Protocol Violation|2|||
127622687|NCT03192150|459243029|FG000|Overall Study|Surgery Canceled|6|||
127622688|NCT03192150|459243030|FG001|Overall Study|Surgery Canceled|2|||
127622689|NCT03192150|459243029|FG000|Overall Study|Other-Various Administrative Reasons|2|||
127622690|NCT03192150|459243030|FG001|Overall Study|Other-Various Administrative Reasons|5|||
127622691|NCT02579616|459243031|FG000|Overall Study|Participants did not receive treatment|3|||
127622692|NCT00482391|459243032|FG000|Overall Study|Withdrawal by Subject|1|||
127622693|NCT00482391|459243032|FG000|Overall Study|Adverse Event|1|||
127622694|NCT00482391|459243032|FG000|Overall Study|Death|1|||
127622695|NCT06640829|459243044|FG000|Overall Study|Withdrawal by Subject|1|||
127622696|NCT06640829|459243044|FG000|Overall Study|Lost to Follow-up|1|||
127622697|NCT01350128|459243054|FG000|Overall Study|Withdrawal by Subject|3|||
127622698|NCT01350128|459243054|FG000|Overall Study|Protocol discontinuation criteria|8|||
127622699|NCT01350128|459243054|FG000|Overall Study|Physician Decision|1|||
127622700|NCT01350128|459243054|FG000|Overall Study|Lost to Follow-up|2|||
127622701|NCT00261716|459243056|FG000|Overall Study|Withdrawal by Subject|6|||
127622702|NCT00261716|459243057|FG001|Overall Study|Withdrawal by Subject|8|||
127622703|NCT00261716|459243056|FG000|Overall Study|Lost to Follow-up|0|||
127622704|NCT00261716|459243057|FG001|Overall Study|Lost to Follow-up|2|||
127622705|NCT01611259|459243058|FG000|Overall Study|Physician Decision|1|||
127622706|NCT01611259|459243058|FG000|Overall Study|Lack of Efficacy|2|||
127622707|NCT01611259|459243058|FG000|Overall Study|Adverse Event|4|||
127622708|NCT01611259|459243058|FG000|Overall Study|Withdrawal by Subject|7|||
127622709|NCT04936685|459243059|FG000|Overall Study|Protocol Violation|1|||
127622710|NCT04936685|459243060|FG001|Overall Study|Protocol Violation|0|||
127622711|NCT03969212|459243063|FG000|Overall Study|Adverse Event|1|||
127622712|NCT03969212|459243064|FG001|Overall Study|Adverse Event|0|||
127622713|NCT03969212|459243065|FG002|Overall Study|Adverse Event|0|||
127622714|NCT03969212|459243066|FG003|Overall Study|Adverse Event|0|||
127622715|NCT03969212|459243063|FG000|Overall Study|Lost to Follow-up|2|||
127622716|NCT03969212|459243064|FG001|Overall Study|Lost to Follow-up|2|||
127622717|NCT03969212|459243065|FG002|Overall Study|Lost to Follow-up|2|||
127622718|NCT03969212|459243066|FG003|Overall Study|Lost to Follow-up|2|||
127622719|NCT03969212|459243063|FG000|Overall Study|Protocol Violation|0|||
127622720|NCT03969212|459243064|FG001|Overall Study|Protocol Violation|0|||
127622721|NCT03969212|459243065|FG002|Overall Study|Protocol Violation|0|||
127622722|NCT03969212|459243066|FG003|Overall Study|Protocol Violation|1|||
127622723|NCT03969212|459243063|FG000|Overall Study|Withdrawal by Subject|7|||
127622724|NCT03969212|459243064|FG001|Overall Study|Withdrawal by Subject|13|||
127622725|NCT03969212|459243065|FG002|Overall Study|Withdrawal by Subject|5|||
127622726|NCT03969212|459243066|FG003|Overall Study|Withdrawal by Subject|11|||
127622727|NCT03969212|459243063|FG000|Overall Study|Physician Decision|0|||
127622728|NCT03969212|459243064|FG001|Overall Study|Physician Decision|0|||
127622729|NCT03969212|459243065|FG002|Overall Study|Physician Decision|1|||
127622730|NCT03969212|459243066|FG003|Overall Study|Physician Decision|0|||
127622731|NCT03969212|459243063|FG000|Overall Study|Reason not Specified|22|||
127884997|NCT00948025|460203749|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
127622732|NCT03969212|459243064|FG001|Overall Study|Reason not Specified|23|||
127622733|NCT03969212|459243065|FG002|Overall Study|Reason not Specified|28|||
127622734|NCT03969212|459243066|FG003|Overall Study|Reason not Specified|26|||
127622735|NCT02075320|459243067|FG000|Overall Study|Withdrawal by Subject|2|||
127622736|NCT03773757|459243071|FG000|Overall Study|Withdrawal by Subject|2|||
127622737|NCT03773757|459243072|FG001|Overall Study|Withdrawal by Subject|4|||
127622738|NCT01147653|459243073|FG000|Year 2|Withdrawal by Subject|2|||
127622739|NCT01147653|459243074|FG001|Year 2|Withdrawal by Subject|3|||
127622740|NCT00280566|459243075|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
127622741|NCT00280566|459243076|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
127622742|NCT00280566|459243077|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
127622743|NCT00280566|459243075|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
127622744|NCT00280566|459243076|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
127622745|NCT00280566|459243077|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
127622746|NCT00280566|459243075|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
127622747|NCT00280566|459243076|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
127622748|NCT00280566|459243077|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
127622749|NCT00280566|459243075|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
127622750|NCT00280566|459243076|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
127622751|NCT00280566|459243077|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
127622752|NCT00280566|459243075|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
127622753|NCT00280566|459243076|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
127622754|NCT00280566|459243077|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
127622755|NCT00280566|459243075|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
127622756|NCT00280566|459243076|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
127622757|NCT00280566|459243077|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
127622758|NCT00280566|459243075|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
127622759|NCT00280566|459243076|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
127622760|NCT00280566|459243077|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
127622761|NCT00280566|459243075|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
127622762|NCT00280566|459243076|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
127622763|NCT00280566|459243077|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
127622764|NCT00280566|459243075|FG000|Period 2 Double Blind|Adverse Event|0|||
127622765|NCT00280566|459243076|FG001|Period 2 Double Blind|Adverse Event|11|||
127622766|NCT00280566|459243077|FG002|Period 2 Double Blind|Adverse Event|15|||
127622767|NCT00280566|459243075|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
127622768|NCT00280566|459243076|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
127622769|NCT00280566|459243077|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
127622770|NCT00280566|459243075|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
127622771|NCT00280566|459243076|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
127622772|NCT00280566|459243077|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
127622773|NCT00280566|459243075|FG000|Period 2 Double Blind|miscellaneous|0|||
127622774|NCT00280566|459243076|FG001|Period 2 Double Blind|miscellaneous|10|||
127622775|NCT00280566|459243077|FG002|Period 2 Double Blind|miscellaneous|5|||
127622776|NCT00353366|459243078|FG000|Overall Study|Adverse Event|8|||
127622777|NCT00353366|459243078|FG000|Overall Study|Protocol Violation|12|||
127622778|NCT00353366|459243078|FG000|Overall Study|Withdrawal by Subject|12|||
127622779|NCT00353366|459243078|FG000|Overall Study|Lost to Follow-up|92|||
127622780|NCT00353366|459243078|FG000|Overall Study|Other|19|||
127622781|NCT01109316|459243079|FG000|Study Period 1|Adverse Event|0|||
127622782|NCT01109316|459243080|FG001|Study Period 1|Adverse Event|0|||
127622783|NCT01109316|459243081|FG002|Study Period 1|Adverse Event|1|||
127622784|NCT01109316|459243082|FG003|Study Period 1|Adverse Event|0|||
127622785|NCT01109316|459243083|FG004|Study Period 1|Adverse Event|0|||
127622786|NCT01109316|459243084|FG005|Study Period 1|Adverse Event|0|||
127622787|NCT01109316|459243079|FG000|Study Period 1|Lost to Follow-up|0|||
127622788|NCT01109316|459243080|FG001|Study Period 1|Lost to Follow-up|0|||
127622789|NCT01109316|459243081|FG002|Study Period 1|Lost to Follow-up|1|||
127622790|NCT01109316|459243082|FG003|Study Period 1|Lost to Follow-up|1|||
127622791|NCT01109316|459243083|FG004|Study Period 1|Lost to Follow-up|0|||
127622792|NCT01109316|459243084|FG005|Study Period 1|Lost to Follow-up|0|||
127622793|NCT01109316|459243079|FG000|Study Period 1|Withdrawal by Subject|0|||
127622794|NCT01109316|459243080|FG001|Study Period 1|Withdrawal by Subject|0|||
127622795|NCT01109316|459243081|FG002|Study Period 1|Withdrawal by Subject|1|||
127622796|NCT01109316|459243082|FG003|Study Period 1|Withdrawal by Subject|0|||
127622797|NCT01109316|459243083|FG004|Study Period 1|Withdrawal by Subject|2|||
127622798|NCT01109316|459243084|FG005|Study Period 1|Withdrawal by Subject|0|||
127622799|NCT01109316|459243079|FG000|Study Period 1|Sponsor Decision|0|||
127622800|NCT01109316|459243080|FG001|Study Period 1|Sponsor Decision|0|||
127622801|NCT01109316|459243081|FG002|Study Period 1|Sponsor Decision|0|||
127622802|NCT01109316|459243082|FG003|Study Period 1|Sponsor Decision|0|||
127622803|NCT01109316|459243083|FG004|Study Period 1|Sponsor Decision|0|||
127622804|NCT01109316|459243084|FG005|Study Period 1|Sponsor Decision|2|||
127622805|NCT01109316|459243079|FG000|Study Period 2|Entry Criteria Not Met|0|||
127622806|NCT01109316|459243080|FG001|Study Period 2|Entry Criteria Not Met|1|||
127622807|NCT01109316|459243081|FG002|Study Period 2|Entry Criteria Not Met|0|||
127622808|NCT01109316|459243082|FG003|Study Period 2|Entry Criteria Not Met|0|||
127622809|NCT01109316|459243083|FG004|Study Period 2|Entry Criteria Not Met|0|||
127622810|NCT01109316|459243084|FG005|Study Period 2|Entry Criteria Not Met|0|||
127622811|NCT01109316|459243079|FG000|Study Period 2|Physician Decision|0|||
127622812|NCT01109316|459243080|FG001|Study Period 2|Physician Decision|0|||
127622813|NCT01109316|459243081|FG002|Study Period 2|Physician Decision|0|||
127622814|NCT01109316|459243082|FG003|Study Period 2|Physician Decision|1|||
127622815|NCT01109316|459243083|FG004|Study Period 2|Physician Decision|0|||
127622816|NCT01109316|459243084|FG005|Study Period 2|Physician Decision|0|||
127622817|NCT01109316|459243079|FG000|Study Period 2|Protocol Violation|1|||
127622818|NCT01109316|459243080|FG001|Study Period 2|Protocol Violation|0|||
127622819|NCT01109316|459243081|FG002|Study Period 2|Protocol Violation|0|||
127622820|NCT01109316|459243082|FG003|Study Period 2|Protocol Violation|0|||
127622821|NCT01109316|459243083|FG004|Study Period 2|Protocol Violation|0|||
127622822|NCT01109316|459243084|FG005|Study Period 2|Protocol Violation|0|||
127622823|NCT01109316|459243079|FG000|Study Period 2|Withdrawal by Subject|0|||
127622824|NCT01109316|459243080|FG001|Study Period 2|Withdrawal by Subject|0|||
127622825|NCT01109316|459243081|FG002|Study Period 2|Withdrawal by Subject|1|||
127622826|NCT01109316|459243082|FG003|Study Period 2|Withdrawal by Subject|0|||
127622827|NCT01109316|459243083|FG004|Study Period 2|Withdrawal by Subject|0|||
127622828|NCT01109316|459243084|FG005|Study Period 2|Withdrawal by Subject|1|||
127622829|NCT01109316|459243079|FG000|Study Period 3|Lost to Follow-up|0|||
127622830|NCT01109316|459243080|FG001|Study Period 3|Lost to Follow-up|0|||
127622831|NCT01109316|459243081|FG002|Study Period 3|Lost to Follow-up|0|||
127622832|NCT01109316|459243082|FG003|Study Period 3|Lost to Follow-up|0|||
127622833|NCT01109316|459243083|FG004|Study Period 3|Lost to Follow-up|1|||
127622834|NCT01109316|459243084|FG005|Study Period 3|Lost to Follow-up|0|||
127622835|NCT01109316|459243079|FG000|Study Period 3|Withdrawal by Subject|1|||
127622836|NCT01109316|459243080|FG001|Study Period 3|Withdrawal by Subject|0|||
127622837|NCT01109316|459243081|FG002|Study Period 3|Withdrawal by Subject|0|||
127622838|NCT01109316|459243082|FG003|Study Period 3|Withdrawal by Subject|0|||
127622839|NCT01109316|459243083|FG004|Study Period 3|Withdrawal by Subject|1|||
127622840|NCT01109316|459243084|FG005|Study Period 3|Withdrawal by Subject|0|||
127622841|NCT01302392|459243087|FG000|Overall Study|Lost to Follow-up|1|||
127622842|NCT01302392|459243088|FG001|Overall Study|Lost to Follow-up|0|||
127622843|NCT01302392|459243087|FG000|Overall Study|Withdrawal by Subject|6|||
127622844|NCT01302392|459243088|FG001|Overall Study|Withdrawal by Subject|1|||
127622845|NCT00259857|459243089|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
127622846|NCT00259857|459243090|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
127622847|NCT00259857|459243089|FG000|24 Months Treatment|Lost to Follow-up|0|||
127622848|NCT00259857|459243090|FG001|24 Months Treatment|Lost to Follow-up|3|||
127622849|NCT00670228|459243091|FG000|Overall Study|Adverse Event|1|||
127622850|NCT00670228|459243092|FG001|Overall Study|Adverse Event|0|||
127622851|NCT00670228|459243091|FG000|Overall Study|Death or MACE|0|||
127622852|NCT00670228|459243092|FG001|Overall Study|Death or MACE|1|||
127622853|NCT00670228|459243091|FG000|Overall Study|Not treated|2|||
127622854|NCT00670228|459243092|FG001|Overall Study|Not treated|2|||
127622855|NCT00670228|459243091|FG000|Overall Study|Not meeting the selection criteria|2|||
127622856|NCT00670228|459243092|FG001|Overall Study|Not meeting the selection criteria|0|||
127622857|NCT03049813|459243103|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
127622858|NCT03049813|459243104|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
127622859|NCT03049813|459243105|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
127622860|NCT03049813|459243106|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
127622861|NCT03049813|459243103|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
127622862|NCT03049813|459243104|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
127622863|NCT03049813|459243105|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
127622864|NCT03049813|459243106|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
127622865|NCT03049813|459243103|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
127622866|NCT03049813|459243104|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
127622867|NCT03049813|459243105|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
127622868|NCT03049813|459243106|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
127622869|NCT03049813|459243103|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
127622870|NCT03049813|459243104|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
127622871|NCT03049813|459243105|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
127792272|NCT03245450|459863563|FG005|Overall Study|Adverse Event|0|||
127792273|NCT03245450|459863564|FG006|Overall Study|Adverse Event|2|||
127792274|NCT02432235|459863571|FG000|Overall Study|Death|1|||
127792275|NCT02432235|459863572|FG001|Overall Study|Death|1|||
127792276|NCT02432235|459863573|FG002|Overall Study|Death|2|||
127792277|NCT02432235|459863574|FG003|Overall Study|Death|2|||
127792278|NCT02432235|459863575|FG004|Overall Study|Death|1|||
127792279|NCT02432235|459863576|FG005|Overall Study|Death|3|||
127792280|NCT02432235|459863577|FG006|Overall Study|Death|11|||
127792281|NCT02432235|459863578|FG007|Overall Study|Death|15|||
127792282|NCT02432235|459863579|FG008|Overall Study|Death|15|||
127792283|NCT02432235|459863580|FG009|Overall Study|Death|3|||
127792284|NCT02432235|459863581|FG010|Overall Study|Death|1|||
127792285|NCT02432235|459863582|FG011|Overall Study|Death|0|||
127792286|NCT02432235|459863571|FG000|Overall Study|Withdrawal by Subject|0|||
127884998|NCT00948025|460203748|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
127884999|NCT00948025|460203749|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
127622872|NCT03049813|459243106|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
127622873|NCT01813019|459243107|FG000|Overall Study|Adverse Event|0|||
127622874|NCT01813019|459243108|FG001|Overall Study|Adverse Event|3|||
127792287|NCT02432235|459863572|FG001|Overall Study|Withdrawal by Subject|1|||
127792288|NCT02432235|459863573|FG002|Overall Study|Withdrawal by Subject|0|||
127622875|NCT01813019|459243107|FG000|Overall Study|Withdrawal by Subject|3|||
127622876|NCT01813019|459243108|FG001|Overall Study|Withdrawal by Subject|2|||
127622877|NCT01813019|459243107|FG000|Overall Study|administrative problems|2|||
127622878|NCT01813019|459243108|FG001|Overall Study|administrative problems|0|||
127622879|NCT01813019|459243107|FG000|Overall Study|Protocol Deviation|2|||
127622880|NCT01813019|459243108|FG001|Overall Study|Protocol Deviation|1|||
127622881|NCT02214121|459243120|FG000|Part A|Patient decision|2|||
127622882|NCT02214121|459243121|FG001|Part A|Patient decision|0|||
127622883|NCT02214121|459243122|FG002|Part A|Patient decision|0|||
127622884|NCT02214121|459243120|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
127622885|NCT02214121|459243121|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
127622886|NCT02214121|459243122|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
127622887|NCT02214121|459243120|FG000|Part A|Other|1|||
127622888|NCT02214121|459243121|FG001|Part A|Other|0|||
127622889|NCT02214121|459243122|FG002|Part A|Other|0|||
127622890|NCT02214121|459243120|FG000|Part B|Patient decision|0|||
127622891|NCT02214121|459243121|FG001|Part B|Patient decision|1|||
127622892|NCT02214121|459243122|FG002|Part B|Patient decision|0|||
127622893|NCT02214121|459243120|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
127622894|NCT02214121|459243121|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
127622895|NCT02214121|459243122|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
127622896|NCT02214121|459243120|FG000|Part B|Lost to Follow-up|0|||
127622897|NCT02214121|459243121|FG001|Part B|Lost to Follow-up|0|||
127622898|NCT02214121|459243122|FG002|Part B|Lost to Follow-up|1|||
127622899|NCT00715793|459243123|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
127622900|NCT00715793|459243124|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
127622901|NCT00715793|459243123|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
127622902|NCT00715793|459243124|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
127622903|NCT01849588|459243125|FG000|Overall Study|Lack of Efficacy|3|||
127622904|NCT00094653|459243126|FG000|Overall Study|Death|306|||
127622905|NCT00094653|459243127|FG001|Overall Study|Death|100|||
127622906|NCT00094653|459243128|FG002|Overall Study|Death|119|||
127622907|NCT00094653|459243126|FG000|Overall Study|Subject Withdrew Consent|10|||
127622908|NCT00094653|459243127|FG001|Overall Study|Subject Withdrew Consent|2|||
127622909|NCT00094653|459243128|FG002|Overall Study|Subject Withdrew Consent|3|||
127622910|NCT00094653|459243126|FG000|Overall Study|Other|2|||
127622911|NCT00094653|459243127|FG001|Overall Study|Other|2|||
127622912|NCT00094653|459243128|FG002|Overall Study|Other|2|||
127622913|NCT00094653|459243126|FG000|Overall Study|Lost to Follow-up|3|||
127622914|NCT00094653|459243127|FG001|Overall Study|Lost to Follow-up|2|||
127622915|NCT00094653|459243128|FG002|Overall Study|Lost to Follow-up|1|||
127622916|NCT00094653|459243126|FG000|Overall Study|Protocol Violation|0|||
127622917|NCT00094653|459243127|FG001|Overall Study|Protocol Violation|0|||
127792289|NCT02432235|459863574|FG003|Overall Study|Withdrawal by Subject|0|||
127792290|NCT02432235|459863575|FG004|Overall Study|Withdrawal by Subject|0|||
127792291|NCT02432235|459863576|FG005|Overall Study|Withdrawal by Subject|2|||
127792292|NCT02432235|459863577|FG006|Overall Study|Withdrawal by Subject|5|||
127792293|NCT02432235|459863578|FG007|Overall Study|Withdrawal by Subject|3|||
127792294|NCT02432235|459863579|FG008|Overall Study|Withdrawal by Subject|1|||
127792295|NCT02432235|459863580|FG009|Overall Study|Withdrawal by Subject|0|||
127792296|NCT02432235|459863581|FG010|Overall Study|Withdrawal by Subject|0|||
127792297|NCT02432235|459863582|FG011|Overall Study|Withdrawal by Subject|0|||
127792298|NCT02432235|459863571|FG000|Overall Study|Lost to Follow-up|0|||
127792299|NCT02432235|459863572|FG001|Overall Study|Lost to Follow-up|0|||
127792300|NCT02432235|459863573|FG002|Overall Study|Lost to Follow-up|0|||
127792301|NCT02432235|459863574|FG003|Overall Study|Lost to Follow-up|0|||
127792302|NCT02432235|459863575|FG004|Overall Study|Lost to Follow-up|0|||
127792303|NCT02432235|459863576|FG005|Overall Study|Lost to Follow-up|1|||
127792304|NCT02432235|459863577|FG006|Overall Study|Lost to Follow-up|0|||
127792305|NCT02432235|459863578|FG007|Overall Study|Lost to Follow-up|0|||
127792306|NCT02432235|459863579|FG008|Overall Study|Lost to Follow-up|1|||
127792307|NCT02432235|459863580|FG009|Overall Study|Lost to Follow-up|0|||
127792308|NCT02432235|459863581|FG010|Overall Study|Lost to Follow-up|0|||
127622918|NCT00094653|459243128|FG002|Overall Study|Protocol Violation|1|||
127792309|NCT02432235|459863582|FG011|Overall Study|Lost to Follow-up|0|||
127622919|NCT03921411|459243129|FG000|Overall Study|Withdrawal by Subject|1|||
127622920|NCT03921411|459243129|FG000|Overall Study|Protocol Deviation|2|||
127622921|NCT03921411|459243129|FG000|Overall Study|Enrolled, but never treated|2|||
127622922|NCT03120013|459243133|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
127622923|NCT03120013|459243134|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
127792310|NCT02432235|459863571|FG000|Overall Study|Miscellaneous|0|||
127792311|NCT02432235|459863572|FG001|Overall Study|Miscellaneous|0|||
127792312|NCT02432235|459863573|FG002|Overall Study|Miscellaneous|0|||
127792313|NCT02432235|459863574|FG003|Overall Study|Miscellaneous|0|||
127622924|NCT01541826|459243135|FG000|Overall Study|Lost to Follow-up|2|||
127622925|NCT01541826|459243136|FG001|Overall Study|Lost to Follow-up|3|||
127622926|NCT01541826|459243137|FG002|Overall Study|Lost to Follow-up|0|||
127622927|NCT01541826|459243135|FG000|Overall Study|Withdrawal by Subject|2|||
127792314|NCT02432235|459863575|FG004|Overall Study|Miscellaneous|1|||
127792315|NCT02432235|459863576|FG005|Overall Study|Miscellaneous|6|||
127622928|NCT01541826|459243136|FG001|Overall Study|Withdrawal by Subject|0|||
127622929|NCT01541826|459243137|FG002|Overall Study|Withdrawal by Subject|0|||
127622930|NCT01365273|459243138|FG000|Overall Study|Lost to Follow-up|1|||
127622931|NCT01365273|459243139|FG001|Overall Study|Lost to Follow-up|0|||
127622932|NCT01365273|459243138|FG000|Overall Study|Protocol Violation|0|||
127622933|NCT01365273|459243139|FG001|Overall Study|Protocol Violation|1|||
127622934|NCT01365273|459243138|FG000|Overall Study|Physician Decision|1|||
127622935|NCT01365273|459243139|FG001|Overall Study|Physician Decision|0|||
127622936|NCT01339390|459243142|FG000|Overall Study|Death|32|||
127622937|NCT01339390|459243143|FG001|Overall Study|Death|29|||
127622938|NCT01339390|459243142|FG000|Overall Study|Lost to Follow-up|125|||
127622939|NCT01339390|459243143|FG001|Overall Study|Lost to Follow-up|127|||
127622940|NCT04847674|459243144|FG000|Overall Study|Withdrawal by Subject|0|||
127622941|NCT04847674|459243145|FG001|Overall Study|Withdrawal by Subject|1|||
127622942|NCT04847674|459243146|FG002|Overall Study|Withdrawal by Subject|0|||
127622943|NCT04847674|459243144|FG000|Overall Study|Lost to Follow-up|0|||
127622944|NCT04847674|459243145|FG001|Overall Study|Lost to Follow-up|0|||
127622945|NCT04847674|459243146|FG002|Overall Study|Lost to Follow-up|2|||
127622946|NCT04847674|459243144|FG000|Overall Study|Other than specified|21|||
127622947|NCT04847674|459243145|FG001|Overall Study|Other than specified|20|||
127622948|NCT04847674|459243146|FG002|Overall Study|Other than specified|20|||
127622949|NCT02702401|459243148|FG000|Overall Study|Death|242|||
127622950|NCT02702401|459243149|FG001|Overall Study|Death|125|||
127622951|NCT02702401|459243148|FG000|Overall Study|Withdrawal by Subject|15|||
127622952|NCT02702401|459243149|FG001|Overall Study|Withdrawal by Subject|5|||
127622953|NCT02702401|459243148|FG000|Overall Study|Sponsor Decision|19|||
127622954|NCT02702401|459243149|FG001|Overall Study|Sponsor Decision|3|||
127622955|NCT02702401|459243148|FG000|Overall Study|Physician Decision|1|||
127622956|NCT02702401|459243149|FG001|Overall Study|Physician Decision|2|||
127622957|NCT02702401|459243148|FG000|Overall Study|Lost to Follow-up|1|||
127622958|NCT02702401|459243149|FG001|Overall Study|Lost to Follow-up|0|||
127622959|NCT04292730|459243157|FG000|Overall Study|Lost to Follow-up|8|||
127622960|NCT04292730|459243158|FG001|Overall Study|Lost to Follow-up|12|||
127622961|NCT04292730|459243159|FG002|Overall Study|Lost to Follow-up|12|||
127622962|NCT04292730|459243160|FG003|Overall Study|Lost to Follow-up|48|||
127622963|NCT04292730|459243157|FG000|Overall Study|Death|2|||
127622964|NCT04292730|459243158|FG001|Overall Study|Death|2|||
127622965|NCT04292730|459243159|FG002|Overall Study|Death|4|||
127622966|NCT04292730|459243160|FG003|Overall Study|Death|12|||
127622967|NCT04292730|459243157|FG000|Overall Study|Withdrew Consent|2|||
127622968|NCT04292730|459243158|FG001|Overall Study|Withdrew Consent|2|||
127622969|NCT04292730|459243159|FG002|Overall Study|Withdrew Consent|5|||
127622970|NCT04292730|459243160|FG003|Overall Study|Withdrew Consent|6|||
127622971|NCT04292730|459243157|FG000|Overall Study|Non-Compliance with Study Drug|0|||
127622972|NCT04292730|459243158|FG001|Overall Study|Non-Compliance with Study Drug|1|||
127622973|NCT04292730|459243159|FG002|Overall Study|Non-Compliance with Study Drug|0|||
127622974|NCT04292730|459243160|FG003|Overall Study|Non-Compliance with Study Drug|0|||
127622975|NCT04292730|459243157|FG000|Overall Study|Protocol Violation|0|||
127622976|NCT04292730|459243158|FG001|Overall Study|Protocol Violation|0|||
127622977|NCT04292730|459243159|FG002|Overall Study|Protocol Violation|1|||
127622978|NCT04292730|459243160|FG003|Overall Study|Protocol Violation|0|||
127622979|NCT04292730|459243157|FG000|Overall Study|Randomized but not Treated|8|||
127622980|NCT04292730|459243158|FG001|Overall Study|Randomized but not Treated|4|||
127622981|NCT04292730|459243159|FG002|Overall Study|Randomized but not Treated|0|||
127622982|NCT04292730|459243160|FG003|Overall Study|Randomized but not Treated|14|||
127622983|NCT01527292|459243162|FG000|Overall Study|Physician Decision|0|||
127622984|NCT01527292|459243163|FG001|Overall Study|Physician Decision|3|||
127622985|NCT00096044|459243166|FG000|Overall Study|Withdrawal by Subject|9|||
127622986|NCT00096044|459243166|FG000|Overall Study|Adverse Event|21|||
127622987|NCT00096044|459243166|FG000|Overall Study|Disease Progression|4|||
127622988|NCT02920983|459243167|FG000|Dispense 1|Unacceptable Lens Fit|0|||
127622989|NCT02920983|459243168|FG001|Dispense 1|Unacceptable Lens Fit|0|||
127622990|NCT02920983|459243169|FG002|Dispense 1|Unacceptable Lens Fit|0|||
127622991|NCT02920983|459243170|FG003|Dispense 1|Unacceptable Lens Fit|0|||
127622992|NCT02920983|459243171|FG004|Dispense 1|Unacceptable Lens Fit|1|||
127701219|NCT02268253|459535093|FG000|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
127701220|NCT02268253|459535094|FG001|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
127701221|NCT02268253|459535095|FG002|Stage 2|Completion of 7 or More Cycles of Treatment|2|||
127701222|NCT02268253|459535096|FG003|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
127701223|NCT02268253|459535097|FG004|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
127622993|NCT02920983|459243172|FG005|Dispense 1|Unacceptable Lens Fit|0|||
127622994|NCT02920983|459243167|FG000|Dispense 2|Unscceptable lens fit|1|||
127622995|NCT02920983|459243168|FG001|Dispense 2|Unscceptable lens fit|0|||
127622996|NCT02920983|459243169|FG002|Dispense 2|Unscceptable lens fit|0|||
127622997|NCT02920983|459243170|FG003|Dispense 2|Unscceptable lens fit|0|||
127622998|NCT02920983|459243171|FG004|Dispense 2|Unscceptable lens fit|1|||
127622999|NCT02920983|459243172|FG005|Dispense 2|Unscceptable lens fit|0|||
127623000|NCT02920983|459243167|FG000|Dispense 3|Unacceptable Lens Fit|1|||
127623001|NCT02920983|459243168|FG001|Dispense 3|Unacceptable Lens Fit|1|||
127885000|NCT00948025|460203748|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
127623002|NCT02920983|459243169|FG002|Dispense 3|Unacceptable Lens Fit|0|||
127623003|NCT02920983|459243170|FG003|Dispense 3|Unacceptable Lens Fit|0|||
127623004|NCT02920983|459243171|FG004|Dispense 3|Unacceptable Lens Fit|1|||
127623005|NCT02920983|459243172|FG005|Dispense 3|Unacceptable Lens Fit|0|||
127623006|NCT03851016|459243175|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
127623007|NCT03851016|459243176|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
127623008|NCT03878134|459243177|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
127623009|NCT00586469|459243178|FG000|Overall Study|Adverse Event|0|||
127623010|NCT00586469|459243179|FG001|Overall Study|Adverse Event|1|||
127623011|NCT02553421|459243181|FG000|Overall Study|Lost to Follow-up|21|||
127623012|NCT02553421|459243182|FG001|Overall Study|Lost to Follow-up|1|||
127623013|NCT02553421|459243181|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
127623014|NCT02553421|459243182|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
127623015|NCT02553421|459243181|FG000|Overall Study|Improper Device Placement|3|||
127623016|NCT02553421|459243182|FG001|Overall Study|Improper Device Placement|0|||
127623017|NCT03551210|459243184|FG000|Overall Study|Adverse Event|5|||
127623018|NCT03551210|459243185|FG001|Overall Study|Adverse Event|6|||
127623019|NCT03551210|459243184|FG000|Overall Study|Withdrawal by Subject|1|||
127623020|NCT03551210|459243185|FG001|Overall Study|Withdrawal by Subject|7|||
127623021|NCT03551210|459243184|FG000|Overall Study|Needed in other antibiotic treatment|2|||
127623022|NCT03551210|459243185|FG001|Overall Study|Needed in other antibiotic treatment|5|||
127623023|NCT03551210|459243184|FG000|Overall Study|Lost to Follow-up|1|||
127623024|NCT03551210|459243185|FG001|Overall Study|Lost to Follow-up|1|||
127623025|NCT03551210|459243184|FG000|Overall Study|Absence of visit 4 and 5|1|||
127792316|NCT02432235|459863577|FG006|Overall Study|Miscellaneous|2|||
127792317|NCT02432235|459863578|FG007|Overall Study|Miscellaneous|2|||
127792318|NCT02432235|459863579|FG008|Overall Study|Miscellaneous|4|||
127792319|NCT02432235|459863580|FG009|Overall Study|Miscellaneous|0|||
127792320|NCT02432235|459863581|FG010|Overall Study|Miscellaneous|0|||
127792321|NCT02432235|459863582|FG011|Overall Study|Miscellaneous|1|||
127792322|NCT02970292|459863585|FG000|Overall Study|Physician Decision|1|||
127792323|NCT02970292|459863586|FG001|Overall Study|Physician Decision|1|||
127792324|NCT02970292|459863585|FG000|Overall Study|Withdrawal by Subject|11|||
127792325|NCT02970292|459863586|FG001|Overall Study|Withdrawal by Subject|5|||
127792326|NCT02970292|459863585|FG000|Overall Study|Noncompliance with study drug|2|||
127792327|NCT02970292|459863586|FG001|Overall Study|Noncompliance with study drug|2|||
127792328|NCT02970292|459863585|FG000|Overall Study|Adverse Event|5|||
127792329|NCT02970292|459863586|FG001|Overall Study|Adverse Event|0|||
127792330|NCT02970292|459863585|FG000|Overall Study|Lack of Efficacy|1|||
127792331|NCT02970292|459863586|FG001|Overall Study|Lack of Efficacy|0|||
127792332|NCT02970292|459863585|FG000|Overall Study|Lost to Follow-up|1|||
127792333|NCT02970292|459863586|FG001|Overall Study|Lost to Follow-up|0|||
127792334|NCT02970292|459863585|FG000|Overall Study|Protocol Violation|2|||
127792335|NCT02970292|459863586|FG001|Overall Study|Protocol Violation|0|||
127792336|NCT02970292|459863585|FG000|Overall Study|Other|1|||
127792337|NCT02970292|459863586|FG001|Overall Study|Other|0|||
127792338|NCT03215771|459863591|FG000|Overall Study|Withdrawal by Subject|2|||
127792339|NCT03215771|459863591|FG000|Overall Study|Physician Decision|1|||
127792340|NCT02039375|459863592|FG000|Overall Study|Lost to Follow-up|2|||
127792341|NCT04770389|459863593|FG000|Overall Study|Adverse Event|1|||
127792342|NCT04770389|459863594|FG001|Overall Study|Adverse Event|2|||
127792343|NCT04770389|459863595|FG002|Overall Study|Adverse Event|0|||
127792344|NCT04770389|459863596|FG003|Overall Study|Adverse Event|1|||
127792345|NCT04770389|459863593|FG000|Overall Study|Withdrawal by Subject|0|||
127792346|NCT04770389|459863594|FG001|Overall Study|Withdrawal by Subject|2|||
127792347|NCT04770389|459863595|FG002|Overall Study|Withdrawal by Subject|1|||
127792348|NCT04770389|459863596|FG003|Overall Study|Withdrawal by Subject|0|||
127792349|NCT04770389|459863593|FG000|Overall Study|Failed attempt to draw blood|1|||
127792350|NCT04770389|459863594|FG001|Overall Study|Failed attempt to draw blood|0|||
127792351|NCT04770389|459863595|FG002|Overall Study|Failed attempt to draw blood|0|||
127792352|NCT04770389|459863596|FG003|Overall Study|Failed attempt to draw blood|0|||
127885001|NCT00948025|460203749|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
127623026|NCT03551210|459243185|FG001|Overall Study|Absence of visit 4 and 5|0|||
127623027|NCT03551210|459243184|FG000|Overall Study|No drug for dispensing|0|||
127623028|NCT03551210|459243185|FG001|Overall Study|No drug for dispensing|1|||
127792353|NCT04770389|459863593|FG000|Overall Study|Left the country|0|||
127792354|NCT04770389|459863594|FG001|Overall Study|Left the country|0|||
127792355|NCT04770389|459863595|FG002|Overall Study|Left the country|1|||
127792356|NCT04770389|459863596|FG003|Overall Study|Left the country|2|||
127792357|NCT04770389|459863593|FG000|Overall Study|Randomized in error and did not receive study drug|0|||
127623029|NCT03013491|459243186|FG000|Main Study|Death|2|||
127623030|NCT03013491|459243187|FG001|Main Study|Death|2|||
127623031|NCT03013491|459243188|FG002|Main Study|Death|5|||
127623032|NCT03013491|459243189|FG003|Main Study|Death|3|||
127623033|NCT03013491|459243190|FG004|Main Study|Death|9|||
127623034|NCT03013491|459243191|FG005|Main Study|Death|12|||
127623035|NCT03013491|459243192|FG006|Main Study|Death|3|||
127623036|NCT03013491|459243193|FG007|Main Study|Death|5|||
127623037|NCT03013491|459243194|FG008|Main Study|Death|1|||
127623038|NCT03013491|459243195|FG009|Main Study|Death|2|||
127623039|NCT03013491|459243196|FG010|Main Study|Death|4|||
127623040|NCT03013491|459243197|FG011|Main Study|Death|1|||
127623041|NCT03013491|459243198|FG012|Main Study|Death|1|||
127623042|NCT03013491|459243199|FG013|Main Study|Death|4|||
127623043|NCT03013491|459243200|FG014|Main Study|Death|0|||
127623044|NCT03013491|459243201|FG015|Main Study|Death|3|||
127623045|NCT03013491|459243202|FG016|Main Study|Death|5|||
127623046|NCT03013491|459243203|FG017|Main Study|Death|1|||
127623047|NCT03013491|459243204|FG018|Main Study|Death|47|||
127623048|NCT03013491|459243186|FG000|Main Study|Lost to Follow-up|0|||
127623049|NCT03013491|459243187|FG001|Main Study|Lost to Follow-up|0|||
127623050|NCT03013491|459243188|FG002|Main Study|Lost to Follow-up|1|||
127623051|NCT03013491|459243189|FG003|Main Study|Lost to Follow-up|0|||
127623052|NCT03013491|459243190|FG004|Main Study|Lost to Follow-up|1|||
127623053|NCT03013491|459243191|FG005|Main Study|Lost to Follow-up|0|||
127623054|NCT03013491|459243192|FG006|Main Study|Lost to Follow-up|0|||
127623055|NCT03013491|459243193|FG007|Main Study|Lost to Follow-up|0|||
127623056|NCT03013491|459243194|FG008|Main Study|Lost to Follow-up|0|||
127623057|NCT03013491|459243195|FG009|Main Study|Lost to Follow-up|0|||
127623058|NCT03013491|459243196|FG010|Main Study|Lost to Follow-up|0|||
127623059|NCT03013491|459243197|FG011|Main Study|Lost to Follow-up|0|||
127623060|NCT03013491|459243198|FG012|Main Study|Lost to Follow-up|0|||
127623061|NCT03013491|459243199|FG013|Main Study|Lost to Follow-up|0|||
127623062|NCT03013491|459243200|FG014|Main Study|Lost to Follow-up|0|||
127623063|NCT03013491|459243201|FG015|Main Study|Lost to Follow-up|0|||
127623064|NCT03013491|459243202|FG016|Main Study|Lost to Follow-up|0|||
127623065|NCT03013491|459243203|FG017|Main Study|Lost to Follow-up|0|||
127623066|NCT03013491|459243204|FG018|Main Study|Lost to Follow-up|3|||
127623067|NCT03013491|459243186|FG000|Main Study|Termination of the study by Sponsor|0|||
127623068|NCT03013491|459243187|FG001|Main Study|Termination of the study by Sponsor|0|||
127623069|NCT03013491|459243188|FG002|Main Study|Termination of the study by Sponsor|2|||
127623070|NCT03013491|459243189|FG003|Main Study|Termination of the study by Sponsor|0|||
127623071|NCT03013491|459243190|FG004|Main Study|Termination of the study by Sponsor|1|||
127623072|NCT03013491|459243191|FG005|Main Study|Termination of the study by Sponsor|2|||
127623073|NCT03013491|459243192|FG006|Main Study|Termination of the study by Sponsor|0|||
127623074|NCT03013491|459243193|FG007|Main Study|Termination of the study by Sponsor|0|||
127623075|NCT03013491|459243194|FG008|Main Study|Termination of the study by Sponsor|1|||
127623076|NCT03013491|459243195|FG009|Main Study|Termination of the study by Sponsor|1|||
127623077|NCT03013491|459243196|FG010|Main Study|Termination of the study by Sponsor|1|||
127623078|NCT03013491|459243197|FG011|Main Study|Termination of the study by Sponsor|2|||
127642659|NCT04435366|459313107|FG002|Year 1 (12 Months)|Adverse Event|2|||
127642660|NCT04435366|459313105|FG000|Year 1 (12 Months)|Death|2|||
127642661|NCT04435366|459313106|FG001|Year 1 (12 Months)|Death|0|||
127642662|NCT04435366|459313107|FG002|Year 1 (12 Months)|Death|1|||
127642663|NCT04435366|459313105|FG000|Year 1 (12 Months)|Lost to Follow-up|2|||
127642664|NCT04435366|459313106|FG001|Year 1 (12 Months)|Lost to Follow-up|0|||
127642665|NCT04435366|459313107|FG002|Year 1 (12 Months)|Lost to Follow-up|1|||
127642666|NCT04435366|459313105|FG000|Year 1 (12 Months)|Withdrawal by Subject|17|||
127642667|NCT04435366|459313106|FG001|Year 1 (12 Months)|Withdrawal by Subject|0|||
127642668|NCT04435366|459313107|FG002|Year 1 (12 Months)|Withdrawal by Subject|13|||
127642669|NCT04435366|459313105|FG000|Year 1 (12 Months)|Patient non-compliance|1|||
127642670|NCT04435366|459313106|FG001|Year 1 (12 Months)|Patient non-compliance|0|||
127642671|NCT04435366|459313107|FG002|Year 1 (12 Months)|Patient non-compliance|0|||
127642672|NCT04435366|459313105|FG000|Year 1 (12 Months)|Not treated|0|||
127642673|NCT04435366|459313106|FG001|Year 1 (12 Months)|Not treated|0|||
127642674|NCT04435366|459313107|FG002|Year 1 (12 Months)|Not treated|1|||
127642675|NCT04435366|459313105|FG000|Year 2 (12 Months)|Death|1|||
127642676|NCT04435366|459313106|FG001|Year 2 (12 Months)|Death|4|||
127642677|NCT04435366|459313107|FG002|Year 2 (12 Months)|Death|6|||
127642678|NCT04435366|459313105|FG000|Year 2 (12 Months)|Lost to Follow-up|0|||
127642679|NCT04435366|459313106|FG001|Year 2 (12 Months)|Lost to Follow-up|2|||
127642680|NCT04435366|459313107|FG002|Year 2 (12 Months)|Lost to Follow-up|0|||
127642681|NCT04435366|459313105|FG000|Year 2 (12 Months)|Withdrawal by Subject|4|||
127642682|NCT04435366|459313106|FG001|Year 2 (12 Months)|Withdrawal by Subject|3|||
127642683|NCT04435366|459313107|FG002|Year 2 (12 Months)|Withdrawal by Subject|7|||
127642684|NCT04435366|459313105|FG000|Year 2 (12 Months)|Adverse Event|2|||
127642685|NCT04435366|459313106|FG001|Year 2 (12 Months)|Adverse Event|1|||
127642686|NCT04435366|459313107|FG002|Year 2 (12 Months)|Adverse Event|6|||
127642687|NCT02477111|459313108|FG000|Overall Study|Death|28|||
127642688|NCT02477111|459313108|FG000|Overall Study|Withdrawal by Subject|19|||
127701224|NCT02268253|459535098|FG005|Stage 2|Completion of 7 or More Cycles of Treatment|7|||
127701225|NCT02268253|459535099|FG006|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
127701226|NCT02268253|459535093|FG000|Stage 2|Death|0|||
127701227|NCT02268253|459535094|FG001|Stage 2|Death|0|||
127701228|NCT02268253|459535095|FG002|Stage 2|Death|19|||
127623079|NCT03013491|459243198|FG012|Main Study|Termination of the study by Sponsor|0|||
127701229|NCT02268253|459535096|FG003|Stage 2|Death|0|||
127701230|NCT02268253|459535097|FG004|Stage 2|Death|0|||
127701231|NCT02268253|459535098|FG005|Stage 2|Death|20|||
127701232|NCT02268253|459535099|FG006|Stage 2|Death|1|||
127701233|NCT02268253|459535093|FG000|Stage 2|Lost to Follow-up|0|||
127701234|NCT02268253|459535094|FG001|Stage 2|Lost to Follow-up|0|||
127701235|NCT02268253|459535095|FG002|Stage 2|Lost to Follow-up|0|||
127701236|NCT02268253|459535096|FG003|Stage 2|Lost to Follow-up|0|||
127701237|NCT02268253|459535097|FG004|Stage 2|Lost to Follow-up|0|||
127701238|NCT02268253|459535098|FG005|Stage 2|Lost to Follow-up|4|||
127701239|NCT02268253|459535099|FG006|Stage 2|Lost to Follow-up|0|||
127701240|NCT02268253|459535093|FG000|Stage 2|Transferred to Hospice|0|||
127701241|NCT02268253|459535094|FG001|Stage 2|Transferred to Hospice|0|||
127701242|NCT02268253|459535095|FG002|Stage 2|Transferred to Hospice|0|||
127701243|NCT02268253|459535096|FG003|Stage 2|Transferred to Hospice|0|||
127701244|NCT02268253|459535097|FG004|Stage 2|Transferred to Hospice|0|||
127701245|NCT02268253|459535098|FG005|Stage 2|Transferred to Hospice|2|||
127701246|NCT02268253|459535099|FG006|Stage 2|Transferred to Hospice|0|||
127701247|NCT02268253|459535093|FG000|Stage 3A|Disease Recurrence/ Progression|0|||
127701248|NCT02268253|459535094|FG001|Stage 3A|Disease Recurrence/ Progression|0|||
127701249|NCT02268253|459535095|FG002|Stage 3A|Disease Recurrence/ Progression|1|||
127701250|NCT02268253|459535096|FG003|Stage 3A|Disease Recurrence/ Progression|0|||
127701251|NCT02268253|459535097|FG004|Stage 3A|Disease Recurrence/ Progression|0|||
127701252|NCT02268253|459535098|FG005|Stage 3A|Disease Recurrence/ Progression|0|||
127701253|NCT02268253|459535099|FG006|Stage 3A|Disease Recurrence/ Progression|0|||
127701254|NCT02268253|459535093|FG000|Stage 3A|Withdrawal by Subject|0|||
127701255|NCT02268253|459535094|FG001|Stage 3A|Withdrawal by Subject|0|||
127701256|NCT02268253|459535095|FG002|Stage 3A|Withdrawal by Subject|2|||
127701257|NCT02268253|459535096|FG003|Stage 3A|Withdrawal by Subject|0|||
127701258|NCT02268253|459535097|FG004|Stage 3A|Withdrawal by Subject|0|||
127701259|NCT02268253|459535098|FG005|Stage 3A|Withdrawal by Subject|0|||
127701260|NCT02268253|459535099|FG006|Stage 3A|Withdrawal by Subject|0|||
127701261|NCT02268253|459535093|FG000|Stage 3A|Physician Decision|0|||
127701262|NCT02268253|459535094|FG001|Stage 3A|Physician Decision|0|||
127701263|NCT02268253|459535095|FG002|Stage 3A|Physician Decision|2|||
127701264|NCT02268253|459535096|FG003|Stage 3A|Physician Decision|0|||
127701265|NCT02268253|459535097|FG004|Stage 3A|Physician Decision|0|||
127701266|NCT02268253|459535098|FG005|Stage 3A|Physician Decision|0|||
127701267|NCT02268253|459535099|FG006|Stage 3A|Physician Decision|0|||
127623080|NCT03013491|459243199|FG013|Main Study|Termination of the study by Sponsor|0|||
127623081|NCT03013491|459243200|FG014|Main Study|Termination of the study by Sponsor|0|||
127701268|NCT02268253|459535093|FG000|Stage 3A|Study Terminated by Sponsor|0|||
127701269|NCT02268253|459535094|FG001|Stage 3A|Study Terminated by Sponsor|0|||
127701270|NCT02268253|459535095|FG002|Stage 3A|Study Terminated by Sponsor|2|||
127701271|NCT02268253|459535096|FG003|Stage 3A|Study Terminated by Sponsor|0|||
127623082|NCT03013491|459243201|FG015|Main Study|Termination of the study by Sponsor|0|||
127623083|NCT03013491|459243202|FG016|Main Study|Termination of the study by Sponsor|0|||
127623084|NCT03013491|459243203|FG017|Main Study|Termination of the study by Sponsor|1|||
127623085|NCT03013491|459243204|FG018|Main Study|Termination of the study by Sponsor|13|||
127623086|NCT03013491|459243186|FG000|Main Study|Withdrawal by Subject|0|||
127623087|NCT03013491|459243187|FG001|Main Study|Withdrawal by Subject|0|||
127623088|NCT03013491|459243188|FG002|Main Study|Withdrawal by Subject|0|||
127623089|NCT03013491|459243189|FG003|Main Study|Withdrawal by Subject|4|||
127885002|NCT01637961|460203750|FG000|Overall Study|Ineligible: wrong primary|1|||
127885003|NCT01637961|460203750|FG000|Overall Study|Ineligible: inadequate pathology|1|||
127623090|NCT03013491|459243190|FG004|Main Study|Withdrawal by Subject|2|||
127623091|NCT03013491|459243191|FG005|Main Study|Withdrawal by Subject|1|||
127623092|NCT03013491|459243192|FG006|Main Study|Withdrawal by Subject|0|||
127623093|NCT03013491|459243193|FG007|Main Study|Withdrawal by Subject|0|||
127701272|NCT02268253|459535097|FG004|Stage 3A|Study Terminated by Sponsor|0|||
127701273|NCT02268253|459535098|FG005|Stage 3A|Study Terminated by Sponsor|0|||
127701274|NCT02268253|459535099|FG006|Stage 3A|Study Terminated by Sponsor|0|||
127701275|NCT02268253|459535093|FG000|Stage 3A|Lost to Follow-up|0|||
127701276|NCT02268253|459535094|FG001|Stage 3A|Lost to Follow-up|0|||
127701277|NCT02268253|459535095|FG002|Stage 3A|Lost to Follow-up|1|||
127701278|NCT02268253|459535096|FG003|Stage 3A|Lost to Follow-up|0|||
127701279|NCT02268253|459535097|FG004|Stage 3A|Lost to Follow-up|0|||
127701280|NCT02268253|459535098|FG005|Stage 3A|Lost to Follow-up|0|||
127623094|NCT03013491|459243194|FG008|Main Study|Withdrawal by Subject|0|||
127623095|NCT03013491|459243195|FG009|Main Study|Withdrawal by Subject|0|||
127623096|NCT03013491|459243196|FG010|Main Study|Withdrawal by Subject|1|||
127701281|NCT02268253|459535099|FG006|Stage 3A|Lost to Follow-up|0|||
127701282|NCT02268253|459535093|FG000|Stage 3A|Death|0|||
127701283|NCT02268253|459535094|FG001|Stage 3A|Death|0|||
127885004|NCT02082912|460203757|FG000|Overall Study|Physician Decision|0|||
127885005|NCT02082912|460203758|FG001|Overall Study|Physician Decision|1|||
127885006|NCT00782275|460203773|FG000|Overall Study|Adverse Event|11|||
127885007|NCT00782275|460203773|FG000|Overall Study|Withdrawal by Subject|1|||
127885008|NCT00782275|460203773|FG000|Overall Study|Progressive Disease|21|||
127885009|NCT00782275|460203773|FG000|Overall Study|Physician Decision|4|||
127885010|NCT00782275|460203773|FG000|Overall Study|Not started treatment|1|||
127885011|NCT00782275|460203773|FG000|Overall Study|Other|3|||
127885012|NCT00289731|460203776|FG000|Overall Study|Adverse Event|1|||
127885013|NCT00289731|460203777|FG001|Overall Study|Adverse Event|2|||
127885014|NCT00289731|460203778|FG002|Overall Study|Adverse Event|2|||
127885015|NCT00289731|460203776|FG000|Overall Study|Other|1|||
127885016|NCT00289731|460203777|FG001|Overall Study|Other|0|||
127885017|NCT00289731|460203778|FG002|Overall Study|Other|0|||
127885018|NCT02019979|460203779|FG000|Overall Study|study terminated|14|||
127885019|NCT04023994|460203787|FG000|Overall Study|Lost to Follow-up|0|||
127885020|NCT04023994|460203788|FG001|Overall Study|Lost to Follow-up|1|||
127885021|NCT04023994|460203789|FG002|Overall Study|Lost to Follow-up|2|||
127885022|NCT04023994|460203790|FG003|Overall Study|Lost to Follow-up|0|||
127885023|NCT04023994|460203791|FG004|Overall Study|Lost to Follow-up|0|||
127885024|NCT04023994|460203792|FG005|Overall Study|Lost to Follow-up|0|||
127885025|NCT04023994|460203787|FG000|Overall Study|Withdrawal by Subject|0|||
127885026|NCT04023994|460203788|FG001|Overall Study|Withdrawal by Subject|0|||
127885027|NCT04023994|460203789|FG002|Overall Study|Withdrawal by Subject|0|||
127885028|NCT04023994|460203790|FG003|Overall Study|Withdrawal by Subject|1|||
127885029|NCT04023994|460203791|FG004|Overall Study|Withdrawal by Subject|0|||
127885030|NCT04023994|460203792|FG005|Overall Study|Withdrawal by Subject|0|||
127885031|NCT00923195|460203793|FG000|Overall Study|Death|0|||
127885032|NCT00923195|460203794|FG001|Overall Study|Death|1|||
127623097|NCT03013491|459243197|FG011|Main Study|Withdrawal by Subject|2|||
127623098|NCT03013491|459243198|FG012|Main Study|Withdrawal by Subject|0|||
127623099|NCT03013491|459243199|FG013|Main Study|Withdrawal by Subject|2|||
127623100|NCT03013491|459243200|FG014|Main Study|Withdrawal by Subject|0|||
127623101|NCT03013491|459243201|FG015|Main Study|Withdrawal by Subject|0|||
127623102|NCT03013491|459243202|FG016|Main Study|Withdrawal by Subject|0|||
127623103|NCT03013491|459243203|FG017|Main Study|Withdrawal by Subject|0|||
127623104|NCT03013491|459243204|FG018|Main Study|Withdrawal by Subject|18|||
127623105|NCT03013491|459243186|FG000|Main Study|Disease progression|0|||
127623106|NCT03013491|459243187|FG001|Main Study|Disease progression|0|||
127623107|NCT03013491|459243188|FG002|Main Study|Disease progression|0|||
127623108|NCT03013491|459243189|FG003|Main Study|Disease progression|1|||
127623109|NCT03013491|459243190|FG004|Main Study|Disease progression|0|||
127623110|NCT03013491|459243191|FG005|Main Study|Disease progression|0|||
127623111|NCT03013491|459243192|FG006|Main Study|Disease progression|0|||
127623112|NCT03013491|459243193|FG007|Main Study|Disease progression|0|||
127623113|NCT03013491|459243194|FG008|Main Study|Disease progression|1|||
127623114|NCT03013491|459243195|FG009|Main Study|Disease progression|0|||
127623115|NCT03013491|459243196|FG010|Main Study|Disease progression|1|||
127623116|NCT03013491|459243197|FG011|Main Study|Disease progression|0|||
127623117|NCT03013491|459243198|FG012|Main Study|Disease progression|0|||
127623118|NCT03013491|459243199|FG013|Main Study|Disease progression|0|||
127623119|NCT03013491|459243200|FG014|Main Study|Disease progression|0|||
127623120|NCT03013491|459243201|FG015|Main Study|Disease progression|0|||
127623121|NCT03013491|459243202|FG016|Main Study|Disease progression|0|||
127623122|NCT03013491|459243203|FG017|Main Study|Disease progression|0|||
127623123|NCT03013491|459243204|FG018|Main Study|Disease progression|4|||
127623124|NCT03013491|459243186|FG000|Main Study|Symptomatic deterioration|0|||
127623125|NCT03013491|459243187|FG001|Main Study|Symptomatic deterioration|0|||
127623126|NCT03013491|459243188|FG002|Main Study|Symptomatic deterioration|0|||
127623127|NCT03013491|459243189|FG003|Main Study|Symptomatic deterioration|0|||
127623128|NCT03013491|459243190|FG004|Main Study|Symptomatic deterioration|0|||
127885033|NCT00467818|460203797|FG000|Overall Study|Adverse Event|1|||
127885034|NCT00467818|460203798|FG001|Overall Study|Adverse Event|0|||
127885035|NCT00467818|460203797|FG000|Overall Study|Lost to Follow-up|2|||
127885036|NCT00467818|460203798|FG001|Overall Study|Lost to Follow-up|2|||
127885037|NCT02143947|460203802|FG000|Overall Study|Lost to Follow-up|4|||
127885038|NCT02143947|460203803|FG001|Overall Study|Lost to Follow-up|2|||
127885039|NCT01244815|460203804|FG000|Overall Study|Not Treated|0|||
127885040|NCT01244815|460203805|FG001|Overall Study|Not Treated|1|||
127623129|NCT03013491|459243191|FG005|Main Study|Symptomatic deterioration|1|||
127623130|NCT03013491|459243192|FG006|Main Study|Symptomatic deterioration|0|||
127623131|NCT03013491|459243193|FG007|Main Study|Symptomatic deterioration|0|||
127623132|NCT03013491|459243194|FG008|Main Study|Symptomatic deterioration|0|||
127623133|NCT03013491|459243195|FG009|Main Study|Symptomatic deterioration|0|||
127623134|NCT03013491|459243196|FG010|Main Study|Symptomatic deterioration|0|||
127623135|NCT03013491|459243197|FG011|Main Study|Symptomatic deterioration|0|||
127885041|NCT01244815|460203806|FG002|Overall Study|Not Treated|0|||
127885042|NCT01244815|460203807|FG003|Overall Study|Not Treated|0|||
127885043|NCT01244815|460203804|FG000|Overall Study|Adverse Event|4|||
127885044|NCT01244815|460203805|FG001|Overall Study|Adverse Event|7|||
127885045|NCT01244815|460203806|FG002|Overall Study|Adverse Event|5|||
127885046|NCT01244815|460203807|FG003|Overall Study|Adverse Event|5|||
127885047|NCT01244815|460203804|FG000|Overall Study|Treatment Failure|0|||
127885048|NCT01244815|460203805|FG001|Overall Study|Treatment Failure|0|||
127885049|NCT01244815|460203806|FG002|Overall Study|Treatment Failure|0|||
127885050|NCT01244815|460203807|FG003|Overall Study|Treatment Failure|1|||
127623136|NCT03013491|459243198|FG012|Main Study|Symptomatic deterioration|0|||
127623137|NCT03013491|459243199|FG013|Main Study|Symptomatic deterioration|0|||
127623138|NCT03013491|459243200|FG014|Main Study|Symptomatic deterioration|0|||
127623139|NCT03013491|459243201|FG015|Main Study|Symptomatic deterioration|0|||
127623140|NCT03013491|459243202|FG016|Main Study|Symptomatic deterioration|0|||
127623141|NCT03013491|459243203|FG017|Main Study|Symptomatic deterioration|0|||
127623142|NCT03013491|459243204|FG018|Main Study|Symptomatic deterioration|0|||
127623143|NCT03013491|459243186|FG000|Main Study|Protocol version 8.0 approval|0|||
127623144|NCT03013491|459243187|FG001|Main Study|Protocol version 8.0 approval|0|||
127623145|NCT03013491|459243188|FG002|Main Study|Protocol version 8.0 approval|0|||
127623146|NCT03013491|459243189|FG003|Main Study|Protocol version 8.0 approval|0|||
127623147|NCT03013491|459243190|FG004|Main Study|Protocol version 8.0 approval|0|||
127623148|NCT03013491|459243191|FG005|Main Study|Protocol version 8.0 approval|0|||
127623149|NCT03013491|459243192|FG006|Main Study|Protocol version 8.0 approval|0|||
127623150|NCT03013491|459243193|FG007|Main Study|Protocol version 8.0 approval|0|||
127623151|NCT03013491|459243194|FG008|Main Study|Protocol version 8.0 approval|0|||
127623152|NCT03013491|459243195|FG009|Main Study|Protocol version 8.0 approval|0|||
127623153|NCT03013491|459243196|FG010|Main Study|Protocol version 8.0 approval|1|||
127623154|NCT03013491|459243197|FG011|Main Study|Protocol version 8.0 approval|0|||
127623155|NCT03013491|459243198|FG012|Main Study|Protocol version 8.0 approval|0|||
127623156|NCT03013491|459243199|FG013|Main Study|Protocol version 8.0 approval|0|||
127623157|NCT03013491|459243200|FG014|Main Study|Protocol version 8.0 approval|0|||
127623158|NCT03013491|459243201|FG015|Main Study|Protocol version 8.0 approval|0|||
127623159|NCT03013491|459243202|FG016|Main Study|Protocol version 8.0 approval|0|||
127623160|NCT03013491|459243203|FG017|Main Study|Protocol version 8.0 approval|0|||
127623161|NCT03013491|459243204|FG018|Main Study|Protocol version 8.0 approval|0|||
127623162|NCT03013491|459243186|FG000|Main Study|Partial withdrawal with survival follow-up only|0|||
127623163|NCT03013491|459243187|FG001|Main Study|Partial withdrawal with survival follow-up only|0|||
127623164|NCT03013491|459243188|FG002|Main Study|Partial withdrawal with survival follow-up only|0|||
127623165|NCT03013491|459243189|FG003|Main Study|Partial withdrawal with survival follow-up only|0|||
127623166|NCT03013491|459243190|FG004|Main Study|Partial withdrawal with survival follow-up only|0|||
127885051|NCT01244815|460203804|FG000|Overall Study|Lost to Follow-up|3|||
127623167|NCT03013491|459243191|FG005|Main Study|Partial withdrawal with survival follow-up only|0|||
127623168|NCT03013491|459243192|FG006|Main Study|Partial withdrawal with survival follow-up only|0|||
127623169|NCT03013491|459243193|FG007|Main Study|Partial withdrawal with survival follow-up only|0|||
127623170|NCT03013491|459243194|FG008|Main Study|Partial withdrawal with survival follow-up only|0|||
127623171|NCT03013491|459243195|FG009|Main Study|Partial withdrawal with survival follow-up only|0|||
127623172|NCT03013491|459243196|FG010|Main Study|Partial withdrawal with survival follow-up only|0|||
127623173|NCT03013491|459243197|FG011|Main Study|Partial withdrawal with survival follow-up only|1|||
127623174|NCT03013491|459243198|FG012|Main Study|Partial withdrawal with survival follow-up only|0|||
127623175|NCT03013491|459243199|FG013|Main Study|Partial withdrawal with survival follow-up only|0|||
127623176|NCT03013491|459243200|FG014|Main Study|Partial withdrawal with survival follow-up only|0|||
127623177|NCT03013491|459243201|FG015|Main Study|Partial withdrawal with survival follow-up only|0|||
127885052|NCT01244815|460203805|FG001|Overall Study|Lost to Follow-up|2|||
127885053|NCT01244815|460203806|FG002|Overall Study|Lost to Follow-up|3|||
127885054|NCT01244815|460203807|FG003|Overall Study|Lost to Follow-up|2|||
127885055|NCT01244815|460203804|FG000|Overall Study|Withdrawal by Subject|0|||
127623178|NCT03013491|459243202|FG016|Main Study|Partial withdrawal with survival follow-up only|0|||
127623179|NCT03013491|459243203|FG017|Main Study|Partial withdrawal with survival follow-up only|0|||
127623180|NCT03013491|459243204|FG018|Main Study|Partial withdrawal with survival follow-up only|0|||
127623181|NCT03013491|459243186|FG000|Main Study|Start of new anticancer therapy|0|||
127623182|NCT03013491|459243187|FG001|Main Study|Start of new anticancer therapy|0|||
127623183|NCT03013491|459243188|FG002|Main Study|Start of new anticancer therapy|0|||
127623184|NCT03013491|459243189|FG003|Main Study|Start of new anticancer therapy|0|||
127623185|NCT03013491|459243190|FG004|Main Study|Start of new anticancer therapy|0|||
127623186|NCT03013491|459243191|FG005|Main Study|Start of new anticancer therapy|0|||
127623187|NCT03013491|459243192|FG006|Main Study|Start of new anticancer therapy|0|||
127623188|NCT03013491|459243193|FG007|Main Study|Start of new anticancer therapy|0|||
127623189|NCT03013491|459243194|FG008|Main Study|Start of new anticancer therapy|0|||
127623190|NCT03013491|459243195|FG009|Main Study|Start of new anticancer therapy|0|||
127623191|NCT03013491|459243196|FG010|Main Study|Start of new anticancer therapy|0|||
127623192|NCT03013491|459243197|FG011|Main Study|Start of new anticancer therapy|0|||
127623193|NCT03013491|459243198|FG012|Main Study|Start of new anticancer therapy|0|||
127623194|NCT03013491|459243199|FG013|Main Study|Start of new anticancer therapy|0|||
127623195|NCT03013491|459243200|FG014|Main Study|Start of new anticancer therapy|0|||
127623196|NCT03013491|459243201|FG015|Main Study|Start of new anticancer therapy|0|||
127623197|NCT03013491|459243202|FG016|Main Study|Start of new anticancer therapy|0|||
127623198|NCT03013491|459243203|FG017|Main Study|Start of new anticancer therapy|0|||
127623199|NCT03013491|459243204|FG018|Main Study|Start of new anticancer therapy|2|||
127623200|NCT03013491|459243186|FG000|Long-term Extension|Disease progression|0|||
127623201|NCT03013491|459243187|FG001|Long-term Extension|Disease progression|0|||
127623202|NCT03013491|459243188|FG002|Long-term Extension|Disease progression|0|||
127623203|NCT03013491|459243189|FG003|Long-term Extension|Disease progression|1|||
127623204|NCT03013491|459243190|FG004|Long-term Extension|Disease progression|0|||
127623205|NCT03013491|459243191|FG005|Long-term Extension|Disease progression|0|||
127623206|NCT03013491|459243192|FG006|Long-term Extension|Disease progression|0|||
127623207|NCT03013491|459243193|FG007|Long-term Extension|Disease progression|0|||
127623208|NCT03013491|459243194|FG008|Long-term Extension|Disease progression|0|||
127623209|NCT03013491|459243195|FG009|Long-term Extension|Disease progression|0|||
127701284|NCT02268253|459535095|FG002|Stage 3A|Death|5|||
127701285|NCT02268253|459535096|FG003|Stage 3A|Death|0|||
127701286|NCT02268253|459535097|FG004|Stage 3A|Death|0|||
127701287|NCT02268253|459535098|FG005|Stage 3A|Death|0|||
127701288|NCT02268253|459535099|FG006|Stage 3A|Death|0|||
127701289|NCT05714761|459535100|FG000|Overall Study|Lost to Follow-up|3|||
127701290|NCT05714761|459535100|FG000|Overall Study|Withdrawal by Subject|3|||
127701291|NCT05714761|459535100|FG000|Overall Study|unblinding of sensor data|1|||
127701292|NCT05714761|459535100|FG000|Overall Study|did not complete routine postpartum OGTT|9|||
127701293|NCT05714761|459535100|FG000|Overall Study|did not return second CGM sensor|4|||
127701294|NCT05949788|459535102|FG000|Overall Study|severe birth deformity|2|||
127701295|NCT05949788|459535103|FG001|Overall Study|severe birth deformity|7|||
127701296|NCT05949788|459535102|FG000|Overall Study|twin-twin transfusion syndrome|2|||
127701297|NCT05949788|459535103|FG001|Overall Study|twin-twin transfusion syndrome|7|||
127701298|NCT05949788|459535102|FG000|Overall Study|neonatal hemolytic disease|3|||
127701299|NCT05949788|459535103|FG001|Overall Study|neonatal hemolytic disease|8|||
127701300|NCT05949788|459535102|FG000|Overall Study|death within 14 days after birth|2|||
127701301|NCT05949788|459535103|FG001|Overall Study|death within 14 days after birth|6|||
127701302|NCT05949788|459535102|FG000|Overall Study|transfer to another hospital|2|||
127701303|NCT05949788|459535103|FG001|Overall Study|transfer to another hospital|6|||
127701304|NCT05213390|459535104|FG000|Overall Study|Withdrawal by Subject|2|||
127701305|NCT05213390|459535104|FG000|Overall Study|Lost to Follow-up|12|||
127701306|NCT05213390|459535104|FG000|Overall Study|Protocol Violation|9|||
127701307|NCT01824537|459535105|FG000|Overall Study|Lost to Follow-up|78|||
127701308|NCT01824537|459535106|FG001|Overall Study|Lost to Follow-up|87|||
127701309|NCT05415722|459535120|FG000|Overall Study|Lost to Follow-up|0|||
127701310|NCT05415722|459535121|FG001|Overall Study|Lost to Follow-up|2|||
127701311|NCT05415722|459535122|FG002|Overall Study|Lost to Follow-up|0|||
127701312|NCT05415722|459535123|FG003|Overall Study|Lost to Follow-up|1|||
127701313|NCT05415722|459535124|FG004|Overall Study|Lost to Follow-up|0|||
127701314|NCT05415722|459535125|FG005|Overall Study|Lost to Follow-up|0|||
127701315|NCT05415722|459535126|FG006|Overall Study|Lost to Follow-up|1|||
127623210|NCT03013491|459243196|FG010|Long-term Extension|Disease progression|0|||
127701316|NCT05415722|459535120|FG000|Overall Study|Physician Decision|0|||
127623211|NCT03013491|459243197|FG011|Long-term Extension|Disease progression|0|||
127623212|NCT03013491|459243198|FG012|Long-term Extension|Disease progression|0|||
127623213|NCT03013491|459243199|FG013|Long-term Extension|Disease progression|0|||
127623214|NCT03013491|459243200|FG014|Long-term Extension|Disease progression|0|||
127623215|NCT03013491|459243201|FG015|Long-term Extension|Disease progression|0|||
127701317|NCT05415722|459535121|FG001|Overall Study|Physician Decision|0|||
127701318|NCT05415722|459535122|FG002|Overall Study|Physician Decision|0|||
127701319|NCT05415722|459535123|FG003|Overall Study|Physician Decision|1|||
127623216|NCT03013491|459243202|FG016|Long-term Extension|Disease progression|0|||
127623217|NCT03013491|459243203|FG017|Long-term Extension|Disease progression|0|||
127623218|NCT03013491|459243204|FG018|Long-term Extension|Disease progression|1|||
127623219|NCT03013491|459243186|FG000|Long-term Extension|Withdrawal by Subject|0|||
127623220|NCT03013491|459243187|FG001|Long-term Extension|Withdrawal by Subject|0|||
127623221|NCT03013491|459243188|FG002|Long-term Extension|Withdrawal by Subject|0|||
127623222|NCT03013491|459243189|FG003|Long-term Extension|Withdrawal by Subject|0|||
127623223|NCT03013491|459243190|FG004|Long-term Extension|Withdrawal by Subject|0|||
127623224|NCT03013491|459243191|FG005|Long-term Extension|Withdrawal by Subject|0|||
127623225|NCT03013491|459243192|FG006|Long-term Extension|Withdrawal by Subject|0|||
127623226|NCT03013491|459243193|FG007|Long-term Extension|Withdrawal by Subject|1|||
127623227|NCT03013491|459243194|FG008|Long-term Extension|Withdrawal by Subject|0|||
127623228|NCT03013491|459243195|FG009|Long-term Extension|Withdrawal by Subject|0|||
127623229|NCT03013491|459243196|FG010|Long-term Extension|Withdrawal by Subject|0|||
127623230|NCT03013491|459243197|FG011|Long-term Extension|Withdrawal by Subject|0|||
127623231|NCT03013491|459243198|FG012|Long-term Extension|Withdrawal by Subject|0|||
127623232|NCT03013491|459243199|FG013|Long-term Extension|Withdrawal by Subject|0|||
127623233|NCT03013491|459243200|FG014|Long-term Extension|Withdrawal by Subject|0|||
127623234|NCT03013491|459243201|FG015|Long-term Extension|Withdrawal by Subject|0|||
127623235|NCT03013491|459243202|FG016|Long-term Extension|Withdrawal by Subject|0|||
127623236|NCT03013491|459243203|FG017|Long-term Extension|Withdrawal by Subject|0|||
127623237|NCT03013491|459243204|FG018|Long-term Extension|Withdrawal by Subject|0|||
127623238|NCT03013491|459243186|FG000|Long-term Extension|Adverse Event|0|||
127623239|NCT03013491|459243187|FG001|Long-term Extension|Adverse Event|0|||
127623240|NCT03013491|459243188|FG002|Long-term Extension|Adverse Event|0|||
127623241|NCT03013491|459243189|FG003|Long-term Extension|Adverse Event|0|||
127623242|NCT03013491|459243190|FG004|Long-term Extension|Adverse Event|0|||
127623243|NCT03013491|459243191|FG005|Long-term Extension|Adverse Event|0|||
127623244|NCT03013491|459243192|FG006|Long-term Extension|Adverse Event|0|||
127623245|NCT03013491|459243193|FG007|Long-term Extension|Adverse Event|0|||
127623246|NCT03013491|459243194|FG008|Long-term Extension|Adverse Event|0|||
127623247|NCT03013491|459243195|FG009|Long-term Extension|Adverse Event|0|||
127623248|NCT03013491|459243196|FG010|Long-term Extension|Adverse Event|0|||
127623249|NCT03013491|459243197|FG011|Long-term Extension|Adverse Event|0|||
127623250|NCT03013491|459243198|FG012|Long-term Extension|Adverse Event|0|||
127623251|NCT03013491|459243199|FG013|Long-term Extension|Adverse Event|0|||
127623252|NCT03013491|459243200|FG014|Long-term Extension|Adverse Event|0|||
127623253|NCT03013491|459243201|FG015|Long-term Extension|Adverse Event|0|||
127623254|NCT03013491|459243202|FG016|Long-term Extension|Adverse Event|0|||
127623255|NCT03013491|459243203|FG017|Long-term Extension|Adverse Event|0|||
127623256|NCT03013491|459243204|FG018|Long-term Extension|Adverse Event|1|||
127623257|NCT03013491|459243186|FG000|Long-term Extension|Death|0|||
127623258|NCT03013491|459243187|FG001|Long-term Extension|Death|0|||
127623259|NCT03013491|459243188|FG002|Long-term Extension|Death|0|||
127623260|NCT03013491|459243189|FG003|Long-term Extension|Death|0|||
127623261|NCT03013491|459243190|FG004|Long-term Extension|Death|0|||
127623262|NCT03013491|459243191|FG005|Long-term Extension|Death|0|||
127623263|NCT03013491|459243192|FG006|Long-term Extension|Death|0|||
127623264|NCT03013491|459243193|FG007|Long-term Extension|Death|0|||
127623265|NCT03013491|459243194|FG008|Long-term Extension|Death|0|||
127792358|NCT04770389|459863594|FG001|Overall Study|Randomized in error and did not receive study drug|0|||
127792359|NCT04770389|459863595|FG002|Overall Study|Randomized in error and did not receive study drug|0|||
127792360|NCT04770389|459863596|FG003|Overall Study|Randomized in error and did not receive study drug|1|||
127792361|NCT04770389|459863593|FG000|Overall Study|Lost to Follow-up|0|||
127792362|NCT04770389|459863594|FG001|Overall Study|Lost to Follow-up|0|||
127792363|NCT04770389|459863595|FG002|Overall Study|Lost to Follow-up|0|||
127623266|NCT03013491|459243195|FG009|Long-term Extension|Death|0|||
127623267|NCT03013491|459243196|FG010|Long-term Extension|Death|0|||
127623268|NCT03013491|459243197|FG011|Long-term Extension|Death|0|||
127623269|NCT03013491|459243198|FG012|Long-term Extension|Death|0|||
127623270|NCT03013491|459243199|FG013|Long-term Extension|Death|0|||
127623271|NCT03013491|459243200|FG014|Long-term Extension|Death|0|||
127623272|NCT03013491|459243201|FG015|Long-term Extension|Death|0|||
127623273|NCT03013491|459243202|FG016|Long-term Extension|Death|0|||
127623274|NCT03013491|459243203|FG017|Long-term Extension|Death|0|||
127623275|NCT03013491|459243204|FG018|Long-term Extension|Death|1|||
127623276|NCT03265119|459243205|FG000|Overall Study|Adverse Event|2|||
127623277|NCT03265119|459243206|FG001|Overall Study|Adverse Event|1|||
127623278|NCT03265119|459243205|FG000|Overall Study|Lack of Efficacy|3|||
127623279|NCT03265119|459243206|FG001|Overall Study|Lack of Efficacy|0|||
127623280|NCT03265119|459243205|FG000|Overall Study|Protocol Violation|1|||
127623281|NCT03265119|459243206|FG001|Overall Study|Protocol Violation|2|||
127623282|NCT03265119|459243205|FG000|Overall Study|Withdrawal by Subject|2|||
127623283|NCT03265119|459243206|FG001|Overall Study|Withdrawal by Subject|4|||
127623284|NCT03265119|459243205|FG000|Overall Study|Lost to Follow-up|1|||
127792364|NCT04770389|459863596|FG003|Overall Study|Lost to Follow-up|1|||
127623285|NCT03265119|459243206|FG001|Overall Study|Lost to Follow-up|0|||
127623286|NCT03265119|459243205|FG000|Overall Study|Lack of Compliance|1|||
127623287|NCT03265119|459243206|FG001|Overall Study|Lack of Compliance|0|||
127623288|NCT03238911|459243209|FG000|Overall Study|Withdrawal by Subject|1|||
127623289|NCT03238911|459243210|FG001|Overall Study|Withdrawal by Subject|2|||
127623290|NCT03238911|459243209|FG000|Overall Study|Lost to Follow-up|2|||
127623291|NCT03238911|459243210|FG001|Overall Study|Lost to Follow-up|1|||
127623292|NCT04524403|459244546|FG000|Overall Study|Withdrawal by Subject|10|||
127623293|NCT04524403|459244547|FG001|Overall Study|Withdrawal by Subject|3|||
127623294|NCT04524403|459244548|FG002|Overall Study|Withdrawal by Subject|8|||
127623295|NCT04524403|459244546|FG000|Overall Study|Lost to Follow-up|3|||
127623296|NCT04524403|459244547|FG001|Overall Study|Lost to Follow-up|4|||
127623297|NCT04524403|459244548|FG002|Overall Study|Lost to Follow-up|3|||
127623298|NCT04524403|459244546|FG000|Overall Study|Adverse Event|3|||
127623299|NCT04524403|459244547|FG001|Overall Study|Adverse Event|1|||
127623300|NCT04524403|459244548|FG002|Overall Study|Adverse Event|4|||
127623301|NCT04524403|459244546|FG000|Overall Study|Non-compliant with study drug|1|||
127623302|NCT04524403|459244547|FG001|Overall Study|Non-compliant with study drug|2|||
127623303|NCT04524403|459244548|FG002|Overall Study|Non-compliant with study drug|3|||
127623304|NCT04524403|459244546|FG000|Overall Study|Moved|0|||
127623305|NCT04524403|459244547|FG001|Overall Study|Moved|1|||
127623306|NCT04524403|459244548|FG002|Overall Study|Moved|0|||
127623307|NCT03085927|459244551|FG000|Overall Study|Withdrawal by Subject|1|||
127623308|NCT03085927|459244552|FG001|Overall Study|Withdrawal by Subject|4|||
127623309|NCT03085927|459244551|FG000|Overall Study|Lost to Follow-up|3|||
127623310|NCT03085927|459244552|FG001|Overall Study|Lost to Follow-up|1|||
127623311|NCT03085927|459244551|FG000|Overall Study|Death|1|||
127623312|NCT03085927|459244552|FG001|Overall Study|Death|0|||
127623313|NCT03085927|459244551|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
127623314|NCT03085927|459244552|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
127623315|NCT03085927|459244551|FG000|Overall Study|Dyad Became Ineligible|0|||
127623316|NCT03085927|459244552|FG001|Overall Study|Dyad Became Ineligible|1|||
127623317|NCT02349711|459244554|FG000|Overall Study|Withdrawal by Subject|2|||
127623318|NCT02349711|459244555|FG001|Overall Study|Withdrawal by Subject|1|||
127623319|NCT02349711|459244554|FG000|Overall Study|Lost to Follow-up|1|||
127623320|NCT02349711|459244555|FG001|Overall Study|Lost to Follow-up|1|||
127623321|NCT00194012|459244556|FG000|Randomized Phase|Lack of Efficacy|8|||
127623322|NCT00194012|459244557|FG001|Randomized Phase|Lack of Efficacy|18|||
127623323|NCT00194012|459244556|FG000|Randomized Phase|Study nonadherence|2|||
127623324|NCT00194012|459244557|FG001|Randomized Phase|Study nonadherence|1|||
127623325|NCT00194012|459244556|FG000|Randomized Phase|Withdrawal by Subject|3|||
127623326|NCT00194012|459244557|FG001|Randomized Phase|Withdrawal by Subject|3|||
127623327|NCT00194012|459244556|FG000|Randomized Phase|Adverse Event|2|||
127623328|NCT00194012|459244557|FG001|Randomized Phase|Adverse Event|1|||
127623329|NCT00194012|459244556|FG000|Randomized Phase|Participant reported having a rash|1|||
127623330|NCT00194012|459244557|FG001|Randomized Phase|Participant reported having a rash|0|||
127623331|NCT00194012|459244556|FG000|Randomized Phase|Emesis and enuresis|0|||
127792365|NCT04770389|459863593|FG000|Overall Study|Moved away from study site|0|||
127792366|NCT04770389|459863594|FG001|Overall Study|Moved away from study site|1|||
127792367|NCT04770389|459863595|FG002|Overall Study|Moved away from study site|0|||
127792368|NCT04770389|459863596|FG003|Overall Study|Moved away from study site|0|||
127792369|NCT00542269|459863597|FG000|Overall Study|Adverse Event|10|||
127792370|NCT00542269|459863598|FG001|Overall Study|Adverse Event|4|||
127792371|NCT00542269|459863599|FG002|Overall Study|Adverse Event|5|||
127792372|NCT00542269|459863597|FG000|Overall Study|Protocol Violation|1|||
127792373|NCT00542269|459863598|FG001|Overall Study|Protocol Violation|1|||
127792374|NCT00542269|459863599|FG002|Overall Study|Protocol Violation|0|||
127792375|NCT00542269|459863597|FG000|Overall Study|Withdrawal by Subject|1|||
127792376|NCT00542269|459863598|FG001|Overall Study|Withdrawal by Subject|0|||
127885056|NCT01244815|460203805|FG001|Overall Study|Withdrawal by Subject|2|||
127885057|NCT01244815|460203806|FG002|Overall Study|Withdrawal by Subject|0|||
127623332|NCT00194012|459244557|FG001|Randomized Phase|Emesis and enuresis|1|||
127623333|NCT00194012|459244556|FG000|Randomized Phase|Oral/nasal twitching|0|||
127623334|NCT00194012|459244557|FG001|Randomized Phase|Oral/nasal twitching|1|||
127623335|NCT00194012|459244556|FG000|Open Label Extension (OLE)|Weight Gain|1|||
127623336|NCT00194012|459244557|FG001|Open Label Extension (OLE)|Weight Gain|0|||
127885058|NCT01244815|460203807|FG003|Overall Study|Withdrawal by Subject|3|||
127623337|NCT00194012|459244556|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
127623338|NCT00194012|459244557|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
127623339|NCT00194012|459244556|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
127642689|NCT02477111|459313108|FG000|Overall Study|Lost to Follow-up|4|||
127792377|NCT00542269|459863599|FG002|Overall Study|Withdrawal by Subject|0|||
127792378|NCT00542269|459863597|FG000|Overall Study|Administrative problems|1|||
127885059|NCT01244815|460203804|FG000|Overall Study|Protocol Violation|7|||
127885060|NCT01244815|460203805|FG001|Overall Study|Protocol Violation|4|||
127885061|NCT01244815|460203806|FG002|Overall Study|Protocol Violation|3|||
127885062|NCT01244815|460203807|FG003|Overall Study|Protocol Violation|1|||
127885063|NCT01244815|460203804|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
127885064|NCT01244815|460203805|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
127885065|NCT01244815|460203806|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
127885066|NCT01244815|460203807|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
127885067|NCT00697112|460203809|FG000|Overall Study|Adverse Event|8|||
127623340|NCT00194012|459244557|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
127623341|NCT00194012|459244556|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
127623342|NCT00194012|459244557|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
127623343|NCT01513317|459244563|FG000|Overall Study|Withdrawal by Subject|15|||
127623344|NCT01513317|459244564|FG001|Overall Study|Withdrawal by Subject|4|||
127623345|NCT01513317|459244563|FG000|Overall Study|Death|1|||
127623346|NCT01513317|459244564|FG001|Overall Study|Death|1|||
127623347|NCT01513317|459244563|FG000|Overall Study|Study terminated by sponsor|18|||
127623348|NCT01513317|459244564|FG001|Overall Study|Study terminated by sponsor|18|||
127623349|NCT01513317|459244563|FG000|Overall Study|Other|0|||
127623350|NCT01513317|459244564|FG001|Overall Study|Other|1|||
127623351|NCT02564198|459244565|FG000|Overall Study|Withdrawal by Subject|2|||
127623352|NCT02564198|459244566|FG001|Overall Study|Withdrawal by Subject|4|||
127623353|NCT02564198|459244567|FG002|Overall Study|Withdrawal by Subject|0|||
127623354|NCT02564198|459244565|FG000|Overall Study|Adverse Event|0|||
127623355|NCT02564198|459244566|FG001|Overall Study|Adverse Event|1|||
127623356|NCT02564198|459244567|FG002|Overall Study|Adverse Event|0|||
127623357|NCT02200042|459244568|FG000|Overall Study|Withdrawal by Subject|0|||
127623358|NCT02200042|459244569|FG001|Overall Study|Withdrawal by Subject|1|||
127623359|NCT02097134|459244570|FG000|Overall Study|Physician Decision|4|||
127623360|NCT02097134|459244570|FG000|Overall Study|Non-Protocol Therapy|1|||
127623361|NCT02097134|459244570|FG000|Overall Study|Progressive Disease|3|||
127623362|NCT02097134|459244570|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
127623363|NCT00298896|459244578|FG000|Overall Study|Death|3|||
127623364|NCT00298896|459244578|FG000|Overall Study|Physician Decision|2|||
127623365|NCT00298896|459244578|FG000|Overall Study|Intercurrent Illness|1|||
127623366|NCT00298896|459244578|FG000|Overall Study|Disease Progression|41|||
127623367|NCT00298896|459244578|FG000|Overall Study|Withdrawal by Subject|2|||
127623368|NCT00298896|459244578|FG000|Overall Study|Assigned to treatment in error|1|||
127623369|NCT02649972|459244581|FG000|Overall Study|Not treated|1|||
127623370|NCT03394391|459244584|FG000|Overall Study|Lost to Follow-up|1|||
127623371|NCT03394391|459244585|FG001|Overall Study|Lost to Follow-up|2|||
127623372|NCT01434823|459244588|FG000|Overall Study|Incomplete data in medical record|4|||
127623373|NCT01434823|459244589|FG001|Overall Study|Incomplete data in medical record|7|||
127623374|NCT00519649|459244590|FG000|Overall Study|Withdrawal by Subject|1|||
127623375|NCT04879745|459244591|FG000|Overall Study|Lost to Follow-up|4|||
127623376|NCT04879745|459244592|FG001|Overall Study|Lost to Follow-up|1|||
127623377|NCT00120042|459244593|FG000|Overall Study|all completed protocl|0|||
127623378|NCT00120042|459244594|FG001|Overall Study|all completed protocl|0|||
127623379|NCT00120042|459244595|FG002|Overall Study|all completed protocl|0|||
127623380|NCT03592641|459244598|FG000|Overall Study|Withdrawal by Subject|1|||
127623381|NCT00436280|459244599|FG000|Period 1: Induction|Adverse Event|8|||
127623382|NCT00436280|459244599|FG000|Period 1: Induction|Progressive Disease|12|||
127885068|NCT00697112|460203809|FG000|Overall Study|Lost to Follow-up|1|||
127885069|NCT00697112|460203809|FG000|Overall Study|Did not meet inclusion criteria|1|||
127623383|NCT00436280|459244599|FG000|Period 1: Induction|Stable Disease|6|||
127623384|NCT00436280|459244599|FG000|Period 1: Induction|Withdrawal by Subject|1|||
127623385|NCT00436280|459244599|FG000|Period 1: Induction|Death|1|||
127623386|NCT00436280|459244599|FG000|Period 2: Consolidation|Adverse Event|1|||
127623387|NCT00436280|459244599|FG000|Period 2: Consolidation|Progressive Disease|10|||
127623388|NCT00436280|459244599|FG000|Period 2: Consolidation|Stable Disease|1|||
127623389|NCT00436280|459244599|FG000|Period 2: Consolidation|Physician Decision|2|||
127623390|NCT00436280|459244599|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
127623391|NCT00436280|459244599|FG000|Period 2: Consolidation|Death|1|||
127623392|NCT00436280|459244599|FG000|Period 3: Maintenance|Adverse Event|6|||
127623393|NCT00436280|459244599|FG000|Period 3: Maintenance|Progressive Disease|12|||
127623394|NCT01049919|459244602|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
127623395|NCT01049919|459244603|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
127623396|NCT01049919|459244602|FG000|Overall Study|Withdrawal by Subject|5|||
127623397|NCT01049919|459244603|FG001|Overall Study|Withdrawal by Subject|0|||
127623398|NCT01049919|459244602|FG000|Overall Study|Lost to Follow-up|6|||
127623399|NCT01049919|459244603|FG001|Overall Study|Lost to Follow-up|1|||
127623400|NCT01049919|459244602|FG000|Overall Study|Physician Decision|2|||
127623401|NCT01049919|459244603|FG001|Overall Study|Physician Decision|0|||
127885070|NCT00736333|460203812|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
127623402|NCT01049919|459244602|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
127623403|NCT01049919|459244603|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
127623404|NCT01049919|459244602|FG000|Overall Study|Early study termination by sponsor.|2|||
127623405|NCT01049919|459244603|FG001|Overall Study|Early study termination by sponsor.|0|||
127623406|NCT01532687|459244609|FG000|Overall Study|Death|2|||
127623407|NCT01532687|459244610|FG001|Overall Study|Death|0|||
127623408|NCT01532687|459244609|FG000|Overall Study|Adverse Event|6|||
127623409|NCT01532687|459244610|FG001|Overall Study|Adverse Event|1|||
127623410|NCT01532687|459244609|FG000|Overall Study|Withdrawal by Subject|1|||
127623411|NCT01532687|459244610|FG001|Overall Study|Withdrawal by Subject|0|||
127623412|NCT01532687|459244609|FG000|Overall Study|Physician Decision|2|||
127623413|NCT01532687|459244610|FG001|Overall Study|Physician Decision|1|||
127792379|NCT00542269|459863598|FG001|Overall Study|Administrative problems|1|||
127792380|NCT00542269|459863599|FG002|Overall Study|Administrative problems|1|||
127792381|NCT03873714|459863600|FG000|Overall Study|Six (6) were withdrawn, and one (1) was a Screen Failure|7|||
127792382|NCT03028870|459863601|FG000|Overall Study|Adverse Event|7|||
127792383|NCT03028870|459863602|FG001|Overall Study|Adverse Event|4|||
127792384|NCT03028870|459863603|FG002|Overall Study|Adverse Event|3|||
127792385|NCT03028870|459863604|FG003|Overall Study|Adverse Event|3|||
127792386|NCT03028870|459863601|FG000|Overall Study|Withdrawal by Subject|1|||
127792387|NCT03028870|459863602|FG001|Overall Study|Withdrawal by Subject|1|||
127792388|NCT03028870|459863603|FG002|Overall Study|Withdrawal by Subject|1|||
127792389|NCT03028870|459863604|FG003|Overall Study|Withdrawal by Subject|2|||
127792390|NCT03028870|459863601|FG000|Overall Study|Lost to Follow-up|1|||
127792391|NCT03028870|459863602|FG001|Overall Study|Lost to Follow-up|0|||
127792392|NCT03028870|459863603|FG002|Overall Study|Lost to Follow-up|0|||
127792393|NCT03028870|459863604|FG003|Overall Study|Lost to Follow-up|0|||
127792394|NCT03028870|459863601|FG000|Overall Study|Lack of Efficacy|3|||
127792395|NCT03028870|459863602|FG001|Overall Study|Lack of Efficacy|0|||
127792396|NCT03028870|459863603|FG002|Overall Study|Lack of Efficacy|0|||
127792397|NCT03028870|459863604|FG003|Overall Study|Lack of Efficacy|0|||
127792398|NCT03028870|459863601|FG000|Overall Study|Administrative|5|||
127792399|NCT03028870|459863602|FG001|Overall Study|Administrative|5|||
127792400|NCT03028870|459863603|FG002|Overall Study|Administrative|12|||
127792401|NCT03028870|459863604|FG003|Overall Study|Administrative|4|||
127792402|NCT00708123|459863607|FG000|Period 1|Protocol Violation|0|||
127792403|NCT00708123|459863608|FG001|Period 1|Protocol Violation|1|||
127792404|NCT00708123|459863609|FG002|Period 1|Protocol Violation|0|||
127792405|NCT00708123|459863610|FG003|Period 1|Protocol Violation|1|||
127792406|NCT00708123|459863611|FG004|Period 1|Protocol Violation|0|||
127792407|NCT00708123|459863607|FG000|Period 1|Adverse Event|0|||
127792408|NCT00708123|459863608|FG001|Period 1|Adverse Event|0|||
127792409|NCT00708123|459863609|FG002|Period 1|Adverse Event|1|||
127792410|NCT00708123|459863610|FG003|Period 1|Adverse Event|0|||
127792411|NCT00708123|459863611|FG004|Period 1|Adverse Event|0|||
127792412|NCT00708123|459863607|FG000|Period 2|Protocol Violation|0|||
127792413|NCT00708123|459863608|FG001|Period 2|Protocol Violation|0|||
127792414|NCT00708123|459863609|FG002|Period 2|Protocol Violation|0|||
127792415|NCT00708123|459863610|FG003|Period 2|Protocol Violation|1|||
127792416|NCT00708123|459863611|FG004|Period 2|Protocol Violation|0|||
127792417|NCT00708123|459863607|FG000|Period 2|Other Reason|1|||
127792418|NCT00708123|459863608|FG001|Period 2|Other Reason|0|||
127792419|NCT00708123|459863609|FG002|Period 2|Other Reason|0|||
127792420|NCT00708123|459863610|FG003|Period 2|Other Reason|0|||
127792421|NCT00708123|459863611|FG004|Period 2|Other Reason|0|||
127792422|NCT00708123|459863607|FG000|Period 3|Lost to Follow-up|0|||
127623414|NCT01532687|459244609|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
127623415|NCT01532687|459244610|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
127792423|NCT00708123|459863608|FG001|Period 3|Lost to Follow-up|0|||
127792424|NCT00708123|459863609|FG002|Period 3|Lost to Follow-up|1|||
127792425|NCT00708123|459863610|FG003|Period 3|Lost to Follow-up|1|||
127792426|NCT00708123|459863611|FG004|Period 3|Lost to Follow-up|0|||
127792427|NCT00708123|459863607|FG000|Period 4|Protocol Violation|0|||
127792428|NCT00708123|459863608|FG001|Period 4|Protocol Violation|1|||
127792429|NCT00708123|459863609|FG002|Period 4|Protocol Violation|0|||
127792430|NCT00708123|459863610|FG003|Period 4|Protocol Violation|0|||
127792431|NCT00708123|459863611|FG004|Period 4|Protocol Violation|0|||
127792432|NCT00845650|459863612|FG000|Overall Study|Withdrawal by Subject|0|||
127792433|NCT00845650|459863613|FG001|Overall Study|Withdrawal by Subject|0|||
127623416|NCT03160703|459244611|FG000|Overall Study|Withdrawal by Subject|0|||
127623417|NCT03160703|459244612|FG001|Overall Study|Withdrawal by Subject|0|||
127623418|NCT03160703|459244613|FG002|Overall Study|Withdrawal by Subject|0|||
127623419|NCT03160703|459244614|FG003|Overall Study|Withdrawal by Subject|1|||
127623420|NCT02984995|459244615|FG000|Overall Study|Required stem cell transplant|13|||
127623421|NCT02984995|459244616|FG001|Overall Study|Required stem cell transplant|2|||
127623422|NCT02984995|459244615|FG000|Overall Study|Progressive disease|11|||
127623423|NCT02984995|459244616|FG001|Overall Study|Progressive disease|1|||
127623424|NCT02984995|459244615|FG000|Overall Study|Adverse Event|1|||
127623425|NCT02984995|459244616|FG001|Overall Study|Adverse Event|0|||
127623426|NCT01263873|459244619|FG000|Overall Study|One provider unable to complete numbers|1|||
127623427|NCT01263873|459244620|FG001|Overall Study|One provider unable to complete numbers|1|||
127623428|NCT00047463|459244621|FG000|Overall Study|Withdrawal by Subject|0|||
127623429|NCT00047463|459244622|FG001|Overall Study|Withdrawal by Subject|3|||
127623430|NCT01401530|459244624|FG000|Overall Study|Disease Progression|1|||
127623431|NCT01401530|459244625|FG001|Overall Study|Disease Progression|2|||
127623432|NCT01401530|459244626|FG002|Overall Study|Disease Progression|1|||
127623433|NCT01401530|459244624|FG000|Overall Study|Adverse Event|1|||
127623434|NCT01401530|459244625|FG001|Overall Study|Adverse Event|1|||
127623435|NCT01401530|459244626|FG002|Overall Study|Adverse Event|1|||
127623436|NCT01401530|459244624|FG000|Overall Study|Participant Choice|1|||
127623437|NCT01401530|459244625|FG001|Overall Study|Participant Choice|2|||
127623438|NCT01401530|459244626|FG002|Overall Study|Participant Choice|1|||
127623439|NCT01401530|459244624|FG000|Overall Study|Physician Decision|0|||
127623440|NCT01401530|459244625|FG001|Overall Study|Physician Decision|1|||
127623441|NCT01401530|459244626|FG002|Overall Study|Physician Decision|0|||
127792434|NCT00845650|459863614|FG002|Overall Study|Withdrawal by Subject|0|||
127792435|NCT00845650|459863615|FG003|Overall Study|Withdrawal by Subject|0|||
127792436|NCT00845650|459863616|FG004|Overall Study|Withdrawal by Subject|2|||
127792437|NCT00845650|459863617|FG005|Overall Study|Withdrawal by Subject|0|||
127792438|NCT00845650|459863612|FG000|Overall Study|Lost to Follow-up|0|||
127792439|NCT00845650|459863613|FG001|Overall Study|Lost to Follow-up|0|||
127792440|NCT00845650|459863614|FG002|Overall Study|Lost to Follow-up|3|||
127792441|NCT00845650|459863615|FG003|Overall Study|Lost to Follow-up|1|||
127792442|NCT00845650|459863616|FG004|Overall Study|Lost to Follow-up|0|||
127792443|NCT00845650|459863617|FG005|Overall Study|Lost to Follow-up|1|||
127792444|NCT00845650|459863612|FG000|Overall Study|Sponsor hold on dosing|0|||
127792445|NCT00845650|459863613|FG001|Overall Study|Sponsor hold on dosing|0|||
127792446|NCT00845650|459863614|FG002|Overall Study|Sponsor hold on dosing|0|||
127792447|NCT00845650|459863615|FG003|Overall Study|Sponsor hold on dosing|0|||
127792448|NCT00845650|459863616|FG004|Overall Study|Sponsor hold on dosing|1|||
127792449|NCT00845650|459863617|FG005|Overall Study|Sponsor hold on dosing|1|||
127792450|NCT00845650|459863612|FG000|Overall Study|Unable to access IV line|1|||
127792451|NCT00845650|459863613|FG001|Overall Study|Unable to access IV line|0|||
127885071|NCT00736333|460203812|FG000|Overall Study|Data Missing|2|||
127885072|NCT00736333|460203812|FG000|Overall Study|Tumor Progression|75|||
127885073|NCT00736333|460203812|FG000|Overall Study|Toxicity|6|||
127623442|NCT01448850|459244627|FG000|Overall Study|Death|3|||
127623443|NCT01448850|459244628|FG001|Overall Study|Death|6|||
127623444|NCT01448850|459244627|FG000|Overall Study|Withdrawal by Subject|13|||
127623445|NCT01448850|459244628|FG001|Overall Study|Withdrawal by Subject|21|||
127623446|NCT01448850|459244627|FG000|Overall Study|Lost to Follow-up|3|||
127623447|NCT01448850|459244628|FG001|Overall Study|Lost to Follow-up|1|||
127623448|NCT01448850|459244627|FG000|Overall Study|Other|15|||
127623449|NCT01448850|459244628|FG001|Overall Study|Other|12|||
127623450|NCT02939404|459244629|FG000|Chamber at 24°C, ad Libitum Diet|Adverse Event|2|||
127701320|NCT05415722|459535124|FG004|Overall Study|Physician Decision|0|||
127701321|NCT05415722|459535125|FG005|Overall Study|Physician Decision|0|||
127701322|NCT05415722|459535126|FG006|Overall Study|Physician Decision|1|||
127701323|NCT05415722|459535120|FG000|Overall Study|Protocol Violation|0|||
127701324|NCT05415722|459535121|FG001|Overall Study|Protocol Violation|0|||
127701325|NCT05415722|459535122|FG002|Overall Study|Protocol Violation|0|||
127701326|NCT05415722|459535123|FG003|Overall Study|Protocol Violation|1|||
127701327|NCT05415722|459535124|FG004|Overall Study|Protocol Violation|0|||
127701328|NCT05415722|459535125|FG005|Overall Study|Protocol Violation|0|||
127701329|NCT05415722|459535126|FG006|Overall Study|Protocol Violation|0|||
127701330|NCT05415722|459535120|FG000|Overall Study|Sponsor Discretion|0|||
127701331|NCT05415722|459535121|FG001|Overall Study|Sponsor Discretion|0|||
127701332|NCT05415722|459535122|FG002|Overall Study|Sponsor Discretion|0|||
127701333|NCT05415722|459535123|FG003|Overall Study|Sponsor Discretion|0|||
127701334|NCT05415722|459535124|FG004|Overall Study|Sponsor Discretion|1|||
127701335|NCT05415722|459535125|FG005|Overall Study|Sponsor Discretion|1|||
127701336|NCT05415722|459535126|FG006|Overall Study|Sponsor Discretion|0|||
127701337|NCT05415722|459535120|FG000|Overall Study|Withdrawal by Subject|0|||
127792452|NCT00845650|459863614|FG002|Overall Study|Unable to access IV line|0|||
127792453|NCT00845650|459863615|FG003|Overall Study|Unable to access IV line|0|||
127792454|NCT00845650|459863616|FG004|Overall Study|Unable to access IV line|0|||
127792455|NCT00845650|459863617|FG005|Overall Study|Unable to access IV line|0|||
127885074|NCT00736333|460203812|FG000|Overall Study|Withdrawal by Subject|10|||
127623451|NCT02939404|459244630|FG001|Chamber at 24°C, ad Libitum Diet|Adverse Event|1|||
127623452|NCT02939404|459244629|FG000|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|3|||
127623453|NCT02939404|459244630|FG001|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|2|||
127623454|NCT02606136|459244643|FG000|Main Study (104 Weeks)|Participant/Legal Guardian Decision|5|||
127623455|NCT02606136|459244643|FG000|Main Study (104 Weeks)|Withdrawal by Subject|1|||
127623456|NCT02606136|459244643|FG000|OLE (Up to 208 Weeks)|Participant/Legal Guardian Decision|1|||
127623457|NCT02606136|459244643|FG000|OLE (Up to 208 Weeks)|Sponsor Decision to Terminate Study|14|||
127623458|NCT04112810|459244647|FG000|Overall Study|Only 50 pts are evaluable as 1 pt withdrew before treatment.|1|||
127623459|NCT01859715|459244651|FG000|Overall Study|No 2nd VAS|16|||
127623460|NCT01859715|459244652|FG001|Overall Study|No 2nd VAS|8|||
127623461|NCT01859715|459244653|FG002|Overall Study|No 2nd VAS|23|||
127623462|NCT01252290|459244654|FG000|Overall Study|Withdrawal by Subject|1|||
127623463|NCT02075437|459244655|FG000|Overall Study|Withdrawal by Subject|5|||
127623464|NCT02075437|459244655|FG000|Overall Study|Lost to Follow-up|1|||
127623465|NCT04439240|459244656|FG000|Overall Study|Ineligible|2|||
127623466|NCT04439240|459244656|FG000|Overall Study|Never started treatment|2|||
127623467|NCT04439240|459244656|FG000|Overall Study|Adverse Event|12|||
127623468|NCT04439240|459244656|FG000|Overall Study|Death|2|||
127623469|NCT04439240|459244656|FG000|Overall Study|Disease progression|25|||
127623470|NCT04439240|459244656|FG000|Overall Study|Other diseases|2|||
127623471|NCT04439240|459244656|FG000|Overall Study|Withdrawal by Subject|3|||
127623472|NCT04439240|459244656|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
127623473|NCT04439240|459244656|FG000|Overall Study|Symptomatic decline|1|||
127623474|NCT04439240|459244656|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
127623475|NCT04439240|459244656|FG000|Overall Study|Clinical progression|1|||
127623476|NCT00673452|459244657|FG000|Acute Double-Blind Phase|Adverse Event|41|||
127623477|NCT00673452|459244658|FG001|Acute Double-Blind Phase|Adverse Event|24|||
127623478|NCT00673452|459244657|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
127623479|NCT00673452|459244658|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
127623480|NCT00673452|459244657|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
127623481|NCT00673452|459244658|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
127623482|NCT00673452|459244657|FG000|Acute Double-Blind Phase|Physician Decision|0|||
127623483|NCT00673452|459244658|FG001|Acute Double-Blind Phase|Physician Decision|6|||
127623484|NCT00673452|459244657|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
127623485|NCT00673452|459244658|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
127623486|NCT00673452|459244657|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
127623487|NCT00673452|459244658|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
127623488|NCT00673452|459244657|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
127623489|NCT00673452|459244658|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
127623490|NCT00673452|459244657|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
127623491|NCT00673452|459244658|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
127623492|NCT00673452|459244657|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
127623493|NCT00673452|459244658|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
127623494|NCT00673452|459244657|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
127623495|NCT00673452|459244658|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
127623496|NCT00673452|459244657|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
127623497|NCT00673452|459244658|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
127623498|NCT00673452|459244657|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
127623499|NCT00673452|459244658|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
127623500|NCT00673452|459244657|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
127623501|NCT00673452|459244658|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
127623502|NCT00673452|459244657|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
127623503|NCT00673452|459244658|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
127623504|NCT00673452|459244657|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
127623505|NCT00673452|459244658|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
127623506|NCT00813124|459244659|FG000|Overall Study|Death|2|||
127623507|NCT00813124|459244659|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
127623508|NCT00813124|459244659|FG000|Overall Study|Withdrawal by Subject|1|||
127623509|NCT00767676|459244660|FG000|Overall Study|Investigator error|54|||
127623510|NCT00617240|459244661|FG000|Overall Study|Lack of Efficacy|1|||
127623511|NCT00617240|459244662|FG001|Overall Study|Lack of Efficacy|0|||
127623512|NCT00854581|459244663|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
127623513|NCT00854581|459244663|FG000|Induction (Up to Day 21)|Death|1|||
127623514|NCT00854581|459244663|FG000|Induction (Up to Day 21)|Physician Decision|1|||
127623515|NCT00854581|459244663|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
127623516|NCT03254134|459244664|FG000|Overall Study|Not eligible patients|599|||
127623517|NCT03254134|459244665|FG001|Overall Study|Not eligible patients|3630|||
127623518|NCT02563028|459244666|FG000|Overall Study|Lack of equipment|1|||
127623519|NCT02563028|459244666|FG000|Overall Study|Unable to elicit VEP post induction|1|||
127623520|NCT00378703|459244667|FG000|Overall Study|Disease progression|59|||
127623521|NCT00378703|459244668|FG001|Overall Study|Disease progression|43|||
127623522|NCT00378703|459244669|FG002|Overall Study|Disease progression|48|||
127623523|NCT00378703|459244670|FG003|Overall Study|Disease progression|49|||
127623524|NCT00378703|459244667|FG000|Overall Study|Adverse Event|11|||
127623525|NCT00378703|459244668|FG001|Overall Study|Adverse Event|17|||
127623526|NCT00378703|459244669|FG002|Overall Study|Adverse Event|20|||
127623527|NCT00378703|459244670|FG003|Overall Study|Adverse Event|18|||
127623528|NCT00378703|459244667|FG000|Overall Study|Death|2|||
127623529|NCT00378703|459244668|FG001|Overall Study|Death|2|||
127623530|NCT00378703|459244669|FG002|Overall Study|Death|4|||
127623531|NCT00378703|459244670|FG003|Overall Study|Death|3|||
127623532|NCT00378703|459244667|FG000|Overall Study|Withdrawal by Subject|4|||
127623533|NCT00378703|459244668|FG001|Overall Study|Withdrawal by Subject|8|||
127623534|NCT00378703|459244669|FG002|Overall Study|Withdrawal by Subject|5|||
127623535|NCT00378703|459244670|FG003|Overall Study|Withdrawal by Subject|7|||
127623536|NCT00378703|459244667|FG000|Overall Study|Physician Decision|1|||
127623537|NCT00378703|459244668|FG001|Overall Study|Physician Decision|4|||
127623538|NCT00378703|459244669|FG002|Overall Study|Physician Decision|1|||
127623539|NCT00378703|459244670|FG003|Overall Study|Physician Decision|0|||
127623540|NCT00378703|459244667|FG000|Overall Study|Alternative therapy|4|||
127623541|NCT00378703|459244668|FG001|Overall Study|Alternative therapy|2|||
127623542|NCT00378703|459244669|FG002|Overall Study|Alternative therapy|0|||
127623543|NCT00378703|459244670|FG003|Overall Study|Alternative therapy|0|||
127623544|NCT00378703|459244667|FG000|Overall Study|Other complicated disease|0|||
127623545|NCT00378703|459244668|FG001|Overall Study|Other complicated disease|2|||
127623546|NCT00378703|459244669|FG002|Overall Study|Other complicated disease|2|||
127623547|NCT00378703|459244670|FG003|Overall Study|Other complicated disease|0|||
127623548|NCT00378703|459244667|FG000|Overall Study|Symptomatic deterioration|0|||
127623549|NCT00378703|459244668|FG001|Overall Study|Symptomatic deterioration|1|||
127623550|NCT00378703|459244669|FG002|Overall Study|Symptomatic deterioration|0|||
127623551|NCT00378703|459244670|FG003|Overall Study|Symptomatic deterioration|2|||
127623552|NCT00378703|459244667|FG000|Overall Study|Surgery|1|||
127623553|NCT00378703|459244668|FG001|Overall Study|Surgery|0|||
127623554|NCT00378703|459244669|FG002|Overall Study|Surgery|0|||
127623555|NCT00378703|459244670|FG003|Overall Study|Surgery|1|||
127623556|NCT00378703|459244667|FG000|Overall Study|Joint decision of physician and patient|1|||
127792456|NCT00814892|459863618|FG000|Overall Study|Disease Progression|1|||
127792457|NCT00814892|459863618|FG000|Overall Study|Study Termination|1|||
127792458|NCT04486950|459863619|FG000|Overall Study|Lost to Follow-up|0|||
127792459|NCT04486950|459863620|FG001|Overall Study|Lost to Follow-up|0|||
127792460|NCT04486950|459863621|FG002|Overall Study|Lost to Follow-up|0|||
127792461|NCT04486950|459863622|FG003|Overall Study|Lost to Follow-up|0|||
127792462|NCT04486950|459863623|FG004|Overall Study|Lost to Follow-up|0|||
127623557|NCT00378703|459244668|FG001|Overall Study|Joint decision of physician and patient|0|||
127623558|NCT00378703|459244669|FG002|Overall Study|Joint decision of physician and patient|0|||
127623559|NCT00378703|459244670|FG003|Overall Study|Joint decision of physician and patient|0|||
127623560|NCT00378703|459244667|FG000|Overall Study|Adverse events and progressive disease|0|||
127792463|NCT04486950|459863624|FG005|Overall Study|Lost to Follow-up|1|||
127792464|NCT04486950|459863625|FG006|Overall Study|Lost to Follow-up|0|||
127792465|NCT01119248|459863630|FG000|Overall Study|Physician Decision|5|||
127623561|NCT00378703|459244668|FG001|Overall Study|Adverse events and progressive disease|0|||
127623562|NCT00378703|459244669|FG002|Overall Study|Adverse events and progressive disease|0|||
127623563|NCT00378703|459244670|FG003|Overall Study|Adverse events and progressive disease|1|||
127623564|NCT00378703|459244667|FG000|Overall Study|Relocation|0|||
127623565|NCT00378703|459244668|FG001|Overall Study|Relocation|0|||
127623566|NCT00378703|459244669|FG002|Overall Study|Relocation|1|||
127623567|NCT00378703|459244670|FG003|Overall Study|Relocation|0|||
127623568|NCT00378703|459244667|FG000|Overall Study|Ineligible|4|||
127623569|NCT00378703|459244668|FG001|Overall Study|Ineligible|7|||
127623570|NCT00378703|459244669|FG002|Overall Study|Ineligible|7|||
127623571|NCT00378703|459244670|FG003|Overall Study|Ineligible|7|||
127623572|NCT00378703|459244667|FG000|Overall Study|Never started treatment|1|||
127623573|NCT00378703|459244668|FG001|Overall Study|Never started treatment|4|||
127623574|NCT00378703|459244669|FG002|Overall Study|Never started treatment|0|||
127623575|NCT00378703|459244670|FG003|Overall Study|Never started treatment|0|||
127623576|NCT00378703|459244667|FG000|Overall Study|Other|1|||
127623577|NCT00378703|459244668|FG001|Overall Study|Other|1|||
127623578|NCT00378703|459244669|FG002|Overall Study|Other|2|||
127623579|NCT00378703|459244670|FG003|Overall Study|Other|3|||
127623580|NCT02705820|459244671|FG000|Overall Study|Death|2|||
127623581|NCT02705820|459244671|FG000|Overall Study|Disease Progression|34|||
127623582|NCT02705820|459244671|FG000|Overall Study|Clinical Deterioration|3|||
127623583|NCT01856543|459244675|FG000|Overall Study|Treatment discontinued|6|||
127623584|NCT01856543|459244676|FG001|Overall Study|Treatment discontinued|3|||
127623585|NCT01856543|459244675|FG000|Overall Study|Withdrawn before start|7|||
127623586|NCT01856543|459244676|FG001|Overall Study|Withdrawn before start|3|||
127623587|NCT02457325|459244679|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
127623588|NCT02457325|459244680|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
127623589|NCT01541930|459244681|FG000|Overall Study|Withdrawal by Subject|1|||
127623590|NCT00813358|459244684|FG000|Overall Study|Death|32|||
127623591|NCT00813358|459244684|FG000|Overall Study|Lost to Follow-up|12|||
127623592|NCT00813358|459244684|FG000|Overall Study|other endpoints|5|||
127623593|NCT00813358|459244684|FG000|Overall Study|Withdrawal by Subject|20|||
127623594|NCT00004031|459244685|FG000|Overall Study|Adverse Event|5|||
127623595|NCT00004031|459244686|FG001|Overall Study|Adverse Event|0|||
127623596|NCT00004031|459244685|FG000|Overall Study|Refusal unrelated to adverse events|2|||
127623597|NCT00004031|459244686|FG001|Overall Study|Refusal unrelated to adverse events|11|||
127623598|NCT00004031|459244685|FG000|Overall Study|Progression/relapse|9|||
127623599|NCT00004031|459244686|FG001|Overall Study|Progression/relapse|4|||
127623600|NCT00004031|459244685|FG000|Overall Study|Death|3|||
127623601|NCT00004031|459244686|FG001|Overall Study|Death|1|||
127623602|NCT00004031|459244685|FG000|Overall Study|Other- not protocol specified|3|||
127623603|NCT00004031|459244686|FG001|Overall Study|Other- not protocol specified|3|||
127623604|NCT00004031|459244685|FG000|Overall Study|Reason under review|3|||
127623605|NCT00004031|459244686|FG001|Overall Study|Reason under review|2|||
127623606|NCT03655236|459244690|FG000|Subject Disposition in Part 1 Period|Adverse Event|25|||
127623607|NCT03655236|459244691|FG001|Subject Disposition in Part 1 Period|Adverse Event|55|||
127623608|NCT03655236|459244692|FG002|Subject Disposition in Part 1 Period|Adverse Event|12|||
127623609|NCT03655236|459244690|FG000|Subject Disposition in Part 1 Period|Death|1|||
127623610|NCT03655236|459244691|FG001|Subject Disposition in Part 1 Period|Death|0|||
127623611|NCT03655236|459244692|FG002|Subject Disposition in Part 1 Period|Death|0|||
127623612|NCT03655236|459244690|FG000|Subject Disposition in Part 1 Period|Physician Decision|0|||
127623613|NCT03655236|459244691|FG001|Subject Disposition in Part 1 Period|Physician Decision|3|||
127623614|NCT03655236|459244692|FG002|Subject Disposition in Part 1 Period|Physician Decision|2|||
127623615|NCT03655236|459244690|FG000|Subject Disposition in Part 1 Period|Lost to Follow-up|1|||
127623616|NCT03655236|459244691|FG001|Subject Disposition in Part 1 Period|Lost to Follow-up|3|||
127623617|NCT03655236|459244692|FG002|Subject Disposition in Part 1 Period|Lost to Follow-up|2|||
127623618|NCT03655236|459244690|FG000|Subject Disposition in Part 1 Period|Parkinson's disease progression|2|||
127623619|NCT03655236|459244691|FG001|Subject Disposition in Part 1 Period|Parkinson's disease progression|8|||
127623620|NCT03655236|459244692|FG002|Subject Disposition in Part 1 Period|Parkinson's disease progression|5|||
127623621|NCT03655236|459244690|FG000|Subject Disposition in Part 1 Period|Poor compliance|0|||
127623622|NCT03655236|459244691|FG001|Subject Disposition in Part 1 Period|Poor compliance|2|||
127623623|NCT03655236|459244692|FG002|Subject Disposition in Part 1 Period|Poor compliance|0|||
127623624|NCT03655236|459244690|FG000|Subject Disposition in Part 1 Period|Protocol Violation|1|||
127623625|NCT03655236|459244691|FG001|Subject Disposition in Part 1 Period|Protocol Violation|1|||
127623626|NCT03655236|459244692|FG002|Subject Disposition in Part 1 Period|Protocol Violation|0|||
127623627|NCT03655236|459244690|FG000|Subject Disposition in Part 1 Period|Requires prohibited medication|4|||
127623628|NCT03655236|459244691|FG001|Subject Disposition in Part 1 Period|Requires prohibited medication|5|||
127642690|NCT03492281|459313112|FG000|Overall Study|Withdrawal by Subject|21|||
127642691|NCT03492281|459313113|FG001|Overall Study|Withdrawal by Subject|14|||
127642692|NCT03492281|459313114|FG002|Overall Study|Withdrawal by Subject|13|||
127623629|NCT03655236|459244692|FG002|Subject Disposition in Part 1 Period|Requires prohibited medication|3|||
127623630|NCT03655236|459244690|FG000|Subject Disposition in Part 1 Period|Study terminated by Sponsor|12|||
127623631|NCT03655236|459244691|FG001|Subject Disposition in Part 1 Period|Study terminated by Sponsor|8|||
127623632|NCT03655236|459244692|FG002|Subject Disposition in Part 1 Period|Study terminated by Sponsor|13|||
127623633|NCT03655236|459244690|FG000|Subject Disposition in Part 1 Period|Withdrawal by Subject|0|||
127623634|NCT03655236|459244691|FG001|Subject Disposition in Part 1 Period|Withdrawal by Subject|5|||
127623635|NCT03655236|459244692|FG002|Subject Disposition in Part 1 Period|Withdrawal by Subject|3|||
127623636|NCT03655236|459244690|FG000|Subject Disposition in Part 1 Period|Withdrawal of consent|11|||
127623637|NCT03655236|459244691|FG001|Subject Disposition in Part 1 Period|Withdrawal of consent|16|||
127623638|NCT03655236|459244692|FG002|Subject Disposition in Part 1 Period|Withdrawal of consent|6|||
127623639|NCT03655236|459244690|FG000|Subject Disposition in Part 1 Period|Other|0|||
127623640|NCT03655236|459244691|FG001|Subject Disposition in Part 1 Period|Other|2|||
127623641|NCT03655236|459244692|FG002|Subject Disposition in Part 1 Period|Other|2|||
127623642|NCT03655236|459244690|FG000|Subject Disposition in Part 2 Period|Adverse Event|2|||
127623643|NCT03655236|459244691|FG001|Subject Disposition in Part 2 Period|Adverse Event|5|||
127623644|NCT03655236|459244692|FG002|Subject Disposition in Part 2 Period|Adverse Event|12|||
127623645|NCT03655236|459244690|FG000|Subject Disposition in Part 2 Period|Lost to Follow-up|1|||
127623646|NCT03655236|459244691|FG001|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
127623647|NCT03655236|459244692|FG002|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
127623648|NCT03655236|459244690|FG000|Subject Disposition in Part 2 Period|Parkinson's disease progression|4|||
127623649|NCT03655236|459244691|FG001|Subject Disposition in Part 2 Period|Parkinson's disease progression|0|||
127623650|NCT03655236|459244692|FG002|Subject Disposition in Part 2 Period|Parkinson's disease progression|2|||
127623651|NCT03655236|459244690|FG000|Subject Disposition in Part 2 Period|Protocol Violation|1|||
127623652|NCT03655236|459244691|FG001|Subject Disposition in Part 2 Period|Protocol Violation|0|||
127623653|NCT03655236|459244692|FG002|Subject Disposition in Part 2 Period|Protocol Violation|4|||
127623654|NCT03655236|459244690|FG000|Subject Disposition in Part 2 Period|Requires prohibited medication|3|||
127623655|NCT03655236|459244691|FG001|Subject Disposition in Part 2 Period|Requires prohibited medication|1|||
127623656|NCT03655236|459244692|FG002|Subject Disposition in Part 2 Period|Requires prohibited medication|5|||
127623657|NCT03655236|459244690|FG000|Subject Disposition in Part 2 Period|Study terminated by Sponsor|18|||
127623658|NCT03655236|459244691|FG001|Subject Disposition in Part 2 Period|Study terminated by Sponsor|11|||
127623659|NCT03655236|459244692|FG002|Subject Disposition in Part 2 Period|Study terminated by Sponsor|13|||
127623660|NCT03655236|459244690|FG000|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
127623661|NCT03655236|459244691|FG001|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
127623662|NCT03655236|459244692|FG002|Subject Disposition in Part 2 Period|Withdrawal by Subject|2|||
127623663|NCT03655236|459244690|FG000|Subject Disposition in Part 2 Period|Withdrawal of consent|5|||
127623664|NCT03655236|459244691|FG001|Subject Disposition in Part 2 Period|Withdrawal of consent|1|||
127623665|NCT03655236|459244692|FG002|Subject Disposition in Part 2 Period|Withdrawal of consent|12|||
127623666|NCT03655236|459244690|FG000|Subject Disposition in Part 2 Period|Other|1|||
127623667|NCT03655236|459244691|FG001|Subject Disposition in Part 2 Period|Other|0|||
127623668|NCT03655236|459244692|FG002|Subject Disposition in Part 2 Period|Other|0|||
127623669|NCT00991302|459246400|FG000|Overall Study|Death|0|||
127623670|NCT00991302|459246401|FG001|Overall Study|Death|1|||
127623671|NCT00991302|459246400|FG000|Overall Study|Lost to Follow-up|14|||
127623672|NCT00991302|459246401|FG001|Overall Study|Lost to Follow-up|12|||
127623673|NCT01709318|459246402|FG000|Overall Study|Adverse Event|3|||
127623674|NCT01709318|459246403|FG001|Overall Study|Adverse Event|4|||
127623675|NCT01709318|459246404|FG002|Overall Study|Adverse Event|2|||
127623676|NCT01709318|459246405|FG003|Overall Study|Adverse Event|2|||
127623677|NCT01709318|459246406|FG004|Overall Study|Adverse Event|0|||
127623678|NCT01709318|459246407|FG005|Overall Study|Adverse Event|1|||
127623679|NCT01709318|459246408|FG006|Overall Study|Adverse Event|2|||
127623680|NCT01709318|459246402|FG000|Overall Study|Lost to Follow-up|2|||
127623681|NCT01709318|459246403|FG001|Overall Study|Lost to Follow-up|0|||
127623682|NCT01709318|459246404|FG002|Overall Study|Lost to Follow-up|0|||
127623683|NCT01709318|459246405|FG003|Overall Study|Lost to Follow-up|0|||
127623684|NCT01709318|459246406|FG004|Overall Study|Lost to Follow-up|1|||
127885075|NCT00736333|460203812|FG000|Overall Study|Death|7|||
127885076|NCT00736333|460203812|FG000|Overall Study|Other|4|||
127885077|NCT04126733|460203816|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
127885078|NCT04126733|460203816|FG000|Treatment Period|Adverse Event|8|||
127885079|NCT04126733|460203816|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
127885080|NCT04126733|460203816|FG000|Treatment Period|Physician Decision|5|||
127623685|NCT01709318|459246407|FG005|Overall Study|Lost to Follow-up|1|||
127885081|NCT04126733|460203816|FG000|Treatment Period|Death|1|||
127701338|NCT05415722|459535121|FG001|Overall Study|Withdrawal by Subject|1|||
127701339|NCT05415722|459535122|FG002|Overall Study|Withdrawal by Subject|0|||
127701340|NCT05415722|459535123|FG003|Overall Study|Withdrawal by Subject|1|||
127885082|NCT04126733|460203816|FG000|Treatment Period|Other Reasons|2|||
127623686|NCT01709318|459246408|FG006|Overall Study|Lost to Follow-up|1|||
127623687|NCT01709318|459246402|FG000|Overall Study|Non-compliance with Study Drug|0|||
127623688|NCT01709318|459246403|FG001|Overall Study|Non-compliance with Study Drug|2|||
127623689|NCT01709318|459246404|FG002|Overall Study|Non-compliance with Study Drug|1|||
127623690|NCT01709318|459246405|FG003|Overall Study|Non-compliance with Study Drug|1|||
127623691|NCT01709318|459246406|FG004|Overall Study|Non-compliance with Study Drug|0|||
127623692|NCT01709318|459246407|FG005|Overall Study|Non-compliance with Study Drug|0|||
127623693|NCT01709318|459246408|FG006|Overall Study|Non-compliance with Study Drug|2|||
127792466|NCT00550680|459863631|FG000|Overall Study|Administrative Reasons|1|||
127792467|NCT00550680|459863631|FG000|Overall Study|Adverse Event|5|||
127792468|NCT00550680|459863631|FG000|Overall Study|Death|3|||
127792469|NCT00550680|459863631|FG000|Overall Study|Early Improvement|1|||
127792470|NCT00550680|459863631|FG000|Overall Study|Lost to Follow-up|3|||
127792471|NCT00550680|459863631|FG000|Overall Study|Lack of Efficacy|1|||
127792472|NCT00550680|459863631|FG000|Overall Study|Other|10|||
127792473|NCT00550680|459863631|FG000|Overall Study|Protocol Violation|7|||
127792474|NCT00550680|459863631|FG000|Overall Study|Refused Treatment|19|||
127792475|NCT00550680|459863631|FG000|Overall Study|Screen Failure|6|||
127792476|NCT00562354|459863632|FG000|Overall Study|Physician Decision|0|||
127792477|NCT00562354|459863633|FG001|Overall Study|Physician Decision|1|||
127792478|NCT00562354|459863632|FG000|Overall Study|Lost to Follow-up|0|||
127792479|NCT00562354|459863633|FG001|Overall Study|Lost to Follow-up|1|||
127792480|NCT00317109|459863634|FG000|Overall Study|Withdrawal by Subject|2|||
127623694|NCT01709318|459246402|FG000|Overall Study|Physician Decision|0|||
127623695|NCT01709318|459246403|FG001|Overall Study|Physician Decision|0|||
127623696|NCT01709318|459246404|FG002|Overall Study|Physician Decision|0|||
127623697|NCT01709318|459246405|FG003|Overall Study|Physician Decision|0|||
127623698|NCT01709318|459246406|FG004|Overall Study|Physician Decision|0|||
127792481|NCT00317109|459863635|FG001|Overall Study|Withdrawal by Subject|0|||
127792482|NCT00317109|459863634|FG000|Overall Study|Migated/moved from study area|1|||
127792483|NCT00317109|459863635|FG001|Overall Study|Migated/moved from study area|0|||
127792484|NCT03693625|459863636|FG000|Overall Study|Adverse Event|2|||
127792485|NCT03693625|459863637|FG001|Overall Study|Adverse Event|0|||
127792486|NCT03693625|459863636|FG000|Overall Study|Study Terminated By Sponsor|20|||
127792487|NCT03693625|459863637|FG001|Overall Study|Study Terminated By Sponsor|7|||
127792488|NCT03693625|459863636|FG000|Overall Study|Withdrawal by Subject|1|||
127792489|NCT03693625|459863637|FG001|Overall Study|Withdrawal by Subject|1|||
127792490|NCT01883635|459863638|FG000|Overall Study|Withdrawal by Subject|4|||
127792491|NCT01883635|459863639|FG001|Overall Study|Withdrawal by Subject|0|||
127623699|NCT01709318|459246407|FG005|Overall Study|Physician Decision|0|||
127623700|NCT01709318|459246408|FG006|Overall Study|Physician Decision|1|||
127623701|NCT01709318|459246402|FG000|Overall Study|Pregnancy|0|||
127792492|NCT01187953|459863640|FG000|Overall Study|Death|11|||
127792493|NCT01187953|459863641|FG001|Overall Study|Death|13|||
127792494|NCT01187953|459863640|FG000|Overall Study|Adverse Event|1|||
127623702|NCT01709318|459246403|FG001|Overall Study|Pregnancy|0|||
127623703|NCT01709318|459246404|FG002|Overall Study|Pregnancy|0|||
127623704|NCT01709318|459246405|FG003|Overall Study|Pregnancy|0|||
127623705|NCT01709318|459246406|FG004|Overall Study|Pregnancy|1|||
127623706|NCT01709318|459246407|FG005|Overall Study|Pregnancy|0|||
127623707|NCT01709318|459246408|FG006|Overall Study|Pregnancy|0|||
127623708|NCT01709318|459246402|FG000|Overall Study|Protocol Violation|0|||
127623709|NCT01709318|459246403|FG001|Overall Study|Protocol Violation|0|||
127623710|NCT01709318|459246404|FG002|Overall Study|Protocol Violation|0|||
127623711|NCT01709318|459246405|FG003|Overall Study|Protocol Violation|0|||
127623712|NCT01709318|459246406|FG004|Overall Study|Protocol Violation|2|||
127623713|NCT01709318|459246407|FG005|Overall Study|Protocol Violation|0|||
127623714|NCT01709318|459246408|FG006|Overall Study|Protocol Violation|1|||
127623715|NCT01709318|459246402|FG000|Overall Study|Technical Problems|1|||
127623716|NCT01709318|459246403|FG001|Overall Study|Technical Problems|0|||
127623717|NCT01709318|459246404|FG002|Overall Study|Technical Problems|0|||
127623718|NCT01709318|459246405|FG003|Overall Study|Technical Problems|0|||
127623719|NCT01709318|459246406|FG004|Overall Study|Technical Problems|0|||
127623720|NCT01709318|459246407|FG005|Overall Study|Technical Problems|0|||
127623721|NCT01709318|459246408|FG006|Overall Study|Technical Problems|0|||
127623722|NCT01709318|459246402|FG000|Overall Study|Withdrawal by Subject|3|||
127623723|NCT01709318|459246403|FG001|Overall Study|Withdrawal by Subject|0|||
127623724|NCT01709318|459246404|FG002|Overall Study|Withdrawal by Subject|3|||
127623725|NCT01709318|459246405|FG003|Overall Study|Withdrawal by Subject|3|||
127623726|NCT01709318|459246406|FG004|Overall Study|Withdrawal by Subject|0|||
127623727|NCT01709318|459246407|FG005|Overall Study|Withdrawal by Subject|2|||
127623728|NCT01709318|459246408|FG006|Overall Study|Withdrawal by Subject|4|||
127623729|NCT01709318|459246402|FG000|Overall Study|Other Protocol Specified Criteria|0|||
127623730|NCT01709318|459246403|FG001|Overall Study|Other Protocol Specified Criteria|1|||
127623731|NCT01709318|459246404|FG002|Overall Study|Other Protocol Specified Criteria|0|||
127623732|NCT01709318|459246405|FG003|Overall Study|Other Protocol Specified Criteria|0|||
127623733|NCT01709318|459246406|FG004|Overall Study|Other Protocol Specified Criteria|0|||
127623734|NCT01709318|459246407|FG005|Overall Study|Other Protocol Specified Criteria|0|||
127623735|NCT01709318|459246408|FG006|Overall Study|Other Protocol Specified Criteria|0|||
127623736|NCT02383758|459246409|FG000|Overall Study|Withdrawal by Subject|0|||
127623737|NCT02383758|459246410|FG001|Overall Study|Withdrawal by Subject|2|||
127623738|NCT00600821|459246413|FG000|Overall Study|Death|45|||
127623739|NCT00600821|459246414|FG001|Overall Study|Death|46|||
127623740|NCT00600821|459246413|FG000|Overall Study|Lost to Follow-up|2|||
127623741|NCT00600821|459246414|FG001|Overall Study|Lost to Follow-up|2|||
127623742|NCT00600821|459246413|FG000|Overall Study|Withdrawal by Subject|1|||
127623743|NCT00600821|459246414|FG001|Overall Study|Withdrawal by Subject|1|||
127623744|NCT00600821|459246413|FG000|Overall Study|Terminated by sponsor|8|||
127623745|NCT00600821|459246414|FG001|Overall Study|Terminated by sponsor|6|||
127623746|NCT00600821|459246413|FG000|Overall Study|Objective progression or relapse|0|||
127623747|NCT00600821|459246414|FG001|Overall Study|Objective progression or relapse|1|||
127623748|NCT00600821|459246413|FG000|Overall Study|Randomized but not treated|0|||
127623749|NCT00600821|459246414|FG001|Overall Study|Randomized but not treated|1|||
127623750|NCT00600821|459246413|FG000|Overall Study|Other|2|||
127623751|NCT00600821|459246414|FG001|Overall Study|Other|3|||
127623752|NCT02167035|459246417|FG000|Overall Study|Adverse Event|2|||
127623753|NCT02167035|459246418|FG001|Overall Study|Adverse Event|2|||
127623754|NCT02167035|459246417|FG000|Overall Study|Lost to Follow-up|3|||
127623755|NCT02167035|459246418|FG001|Overall Study|Lost to Follow-up|3|||
127623756|NCT02167035|459246417|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
127623757|NCT02167035|459246418|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
127623758|NCT04304001|459246419|FG000|Overall Study|Lost to Follow-up|13|||
127623759|NCT04304001|459246420|FG001|Overall Study|Lost to Follow-up|9|||
127623760|NCT02664038|459246421|FG000|13 Week|Lost to Follow-up|7|||
127623761|NCT02664038|459246422|FG001|13 Week|Lost to Follow-up|14|||
127701341|NCT05415722|459535124|FG004|Overall Study|Withdrawal by Subject|1|||
127701342|NCT05415722|459535125|FG005|Overall Study|Withdrawal by Subject|0|||
127701343|NCT05415722|459535126|FG006|Overall Study|Withdrawal by Subject|1|||
127701344|NCT02191618|459535133|FG000|Overall Study|Withdrawal by Subject|3|||
127623762|NCT02664038|459246421|FG000|13 Week|Withdrawal by Subject|1|||
127623763|NCT02664038|459246422|FG001|13 Week|Withdrawal by Subject|0|||
127623764|NCT02664038|459246421|FG000|26 Week|Lost to Follow-up|5|||
127623765|NCT02664038|459246422|FG001|26 Week|Lost to Follow-up|4|||
127623766|NCT03296696|459246423|FG000|Overall Study|Started Other Antitumor Therapy|1|||
127623767|NCT03296696|459246424|FG001|Overall Study|Started Other Antitumor Therapy|2|||
127623768|NCT03296696|459246425|FG002|Overall Study|Started Other Antitumor Therapy|1|||
127623769|NCT03296696|459246426|FG003|Overall Study|Started Other Antitumor Therapy|2|||
127623770|NCT03296696|459246427|FG004|Overall Study|Started Other Antitumor Therapy|1|||
127623771|NCT03296696|459246428|FG005|Overall Study|Started Other Antitumor Therapy|1|||
127623772|NCT03296696|459246429|FG006|Overall Study|Started Other Antitumor Therapy|2|||
127701345|NCT02191618|459535133|FG000|Overall Study|Missed Visit|4|||
127623773|NCT03296696|459246430|FG007|Overall Study|Started Other Antitumor Therapy|3|||
127623774|NCT03296696|459246431|FG008|Overall Study|Started Other Antitumor Therapy|1|||
127623775|NCT03296696|459246432|FG009|Overall Study|Started Other Antitumor Therapy|0|||
127623776|NCT03296696|459246423|FG000|Overall Study|Death|0|||
127623777|NCT03296696|459246424|FG001|Overall Study|Death|1|||
127623778|NCT03296696|459246425|FG002|Overall Study|Death|1|||
127623779|NCT03296696|459246426|FG003|Overall Study|Death|2|||
127623780|NCT03296696|459246427|FG004|Overall Study|Death|2|||
127623781|NCT03296696|459246428|FG005|Overall Study|Death|3|||
127623782|NCT03296696|459246429|FG006|Overall Study|Death|1|||
127623783|NCT03296696|459246430|FG007|Overall Study|Death|2|||
127623784|NCT03296696|459246431|FG008|Overall Study|Death|0|||
127623785|NCT03296696|459246432|FG009|Overall Study|Death|0|||
127623786|NCT03296696|459246423|FG000|Overall Study|Withdrawal by Subject|0|||
127623787|NCT03296696|459246424|FG001|Overall Study|Withdrawal by Subject|0|||
127623788|NCT03296696|459246425|FG002|Overall Study|Withdrawal by Subject|1|||
127623789|NCT03296696|459246426|FG003|Overall Study|Withdrawal by Subject|0|||
127623790|NCT03296696|459246427|FG004|Overall Study|Withdrawal by Subject|1|||
127623791|NCT03296696|459246428|FG005|Overall Study|Withdrawal by Subject|0|||
127623792|NCT03296696|459246429|FG006|Overall Study|Withdrawal by Subject|0|||
127623793|NCT03296696|459246430|FG007|Overall Study|Withdrawal by Subject|0|||
127623794|NCT03296696|459246431|FG008|Overall Study|Withdrawal by Subject|0|||
127623795|NCT03296696|459246432|FG009|Overall Study|Withdrawal by Subject|1|||
127623796|NCT04694131|459246433|FG000|Overall Study|Withdrawal by Subject|7|||
127623797|NCT04694131|459246433|FG000|Overall Study|Screen Failure|1|||
127623798|NCT04694131|459246433|FG000|Overall Study|High stimulation threshold|3|||
127623799|NCT04456699|459246434|FG000|Overall Study|Death|48|||
127623800|NCT04456699|459246435|FG001|Overall Study|Death|50|||
127623801|NCT04456699|459246436|FG002|Overall Study|Death|52|||
127623802|NCT04456699|459246434|FG000|Overall Study|Physician Decision|0|||
127623803|NCT04456699|459246435|FG001|Overall Study|Physician Decision|0|||
127623804|NCT04456699|459246436|FG002|Overall Study|Physician Decision|2|||
127623805|NCT04456699|459246434|FG000|Overall Study|Sponsor Decision|55|||
127623806|NCT04456699|459246435|FG001|Overall Study|Sponsor Decision|61|||
127623807|NCT04456699|459246436|FG002|Overall Study|Sponsor Decision|50|||
127623808|NCT04456699|459246434|FG000|Overall Study|Withdrawal by Subject|8|||
127623809|NCT04456699|459246435|FG001|Overall Study|Withdrawal by Subject|4|||
127623810|NCT04456699|459246436|FG002|Overall Study|Withdrawal by Subject|5|||
127623811|NCT00086580|459246441|FG000|Treatment Period|Disease progression|9|||
127623812|NCT00086580|459246442|FG001|Treatment Period|Disease progression|8|||
127623813|NCT00086580|459246441|FG000|Treatment Period|Unable to comply with protocol|3|||
127623814|NCT00086580|459246442|FG001|Treatment Period|Unable to comply with protocol|1|||
127623815|NCT00086580|459246441|FG000|Treatment Period|Withdrawal by Subject|7|||
127623816|NCT00086580|459246442|FG001|Treatment Period|Withdrawal by Subject|8|||
127623817|NCT00086580|459246441|FG000|Treatment Period|Physician Decision|13|||
127623818|NCT00086580|459246442|FG001|Treatment Period|Physician Decision|7|||
127623819|NCT00086580|459246441|FG000|Treatment Period|AE - not treatment related|7|||
127623820|NCT00086580|459246442|FG001|Treatment Period|AE - not treatment related|7|||
127623821|NCT00086580|459246441|FG000|Treatment Period|Toxicity - treatment related|15|||
127623822|NCT00086580|459246442|FG001|Treatment Period|Toxicity - treatment related|15|||
127623823|NCT00086580|459246441|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
127623824|NCT00086580|459246442|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
127623825|NCT00086580|459246441|FG000|Treatment Period|Death|5|||
127623826|NCT00086580|459246442|FG001|Treatment Period|Death|7|||
127623827|NCT00086580|459246441|FG000|Treatment Period|Other|5|||
127623828|NCT00086580|459246442|FG001|Treatment Period|Other|3|||
127623829|NCT00086580|459246441|FG000|Follow-up Period|Disease progression|72|||
127623830|NCT00086580|459246442|FG001|Follow-up Period|Disease progression|99|||
127623831|NCT00086580|459246441|FG000|Follow-up Period|Unable to comply with protocol|5|||
127623832|NCT00086580|459246442|FG001|Follow-up Period|Unable to comply with protocol|0|||
127623833|NCT00086580|459246441|FG000|Follow-up Period|Withdrawal by Subject|6|||
127623834|NCT00086580|459246442|FG001|Follow-up Period|Withdrawal by Subject|6|||
127623835|NCT00086580|459246441|FG000|Follow-up Period|Physician Decision|0|||
127623836|NCT00086580|459246442|FG001|Follow-up Period|Physician Decision|1|||
127623837|NCT00086580|459246441|FG000|Follow-up Period|AE - not related|1|||
127623838|NCT00086580|459246442|FG001|Follow-up Period|AE - not related|0|||
127623839|NCT00086580|459246441|FG000|Follow-up Period|Death|13|||
127623840|NCT00086580|459246442|FG001|Follow-up Period|Death|7|||
127623841|NCT00086580|459246441|FG000|Follow-up Period|Other|7|||
127623842|NCT00086580|459246442|FG001|Follow-up Period|Other|6|||
127623843|NCT00086580|459246441|FG000|Observation Period|Unable to comply with protocol|1|||
127623844|NCT00086580|459246442|FG001|Observation Period|Unable to comply with protocol|1|||
127623845|NCT00086580|459246441|FG000|Observation Period|Withdrawal by Subject|4|||
127623846|NCT00086580|459246442|FG001|Observation Period|Withdrawal by Subject|2|||
127623847|NCT00086580|459246441|FG000|Observation Period|Death|33|||
127623848|NCT00086580|459246442|FG001|Observation Period|Death|55|||
127623849|NCT00086580|459246441|FG000|Observation Period|Other|8|||
127623850|NCT00086580|459246442|FG001|Observation Period|Other|7|||
127623851|NCT02047110|459246446|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
127623852|NCT02047110|459246447|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
127623853|NCT02047110|459246448|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
127623854|NCT02047110|459246449|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
127623855|NCT02047110|459246446|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
127623856|NCT02047110|459246447|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
127623857|NCT02047110|459246448|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
127623858|NCT02047110|459246449|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
127623859|NCT02047110|459246446|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
127623860|NCT02047110|459246447|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
127623861|NCT02047110|459246448|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
127623862|NCT02047110|459246449|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
127623863|NCT02047110|459246446|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
127623864|NCT02047110|459246447|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
127623865|NCT02047110|459246448|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
127623866|NCT02047110|459246449|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
127623867|NCT02047110|459246446|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
127623868|NCT02047110|459246447|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
127623869|NCT02047110|459246448|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
127623870|NCT02047110|459246449|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
127623871|NCT02047110|459246446|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
127623872|NCT02047110|459246447|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
127623873|NCT02047110|459246448|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
127623874|NCT02047110|459246449|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
127623875|NCT02047110|459246446|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
127623876|NCT02047110|459246447|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
127623877|NCT02047110|459246448|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
127623878|NCT02047110|459246449|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
127623879|NCT02047110|459246446|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
127623880|NCT02047110|459246447|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
127623881|NCT02047110|459246448|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
127623882|NCT02047110|459246449|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
127623883|NCT02047110|459246446|FG000|Escape Treatment Period|Adverse Event|1|||
127623884|NCT02047110|459246447|FG001|Escape Treatment Period|Adverse Event|2|||
127623885|NCT02047110|459246448|FG002|Escape Treatment Period|Adverse Event|2|||
127623886|NCT02047110|459246449|FG003|Escape Treatment Period|Adverse Event|0|||
127623887|NCT02047110|459246446|FG000|Escape Treatment Period|Other than specified|1|||
127623888|NCT02047110|459246447|FG001|Escape Treatment Period|Other than specified|2|||
127623889|NCT02047110|459246448|FG002|Escape Treatment Period|Other than specified|0|||
127623890|NCT02047110|459246449|FG003|Escape Treatment Period|Other than specified|1|||
127623891|NCT02047110|459246446|FG000|OLE Treatment Period|Other than specified|0|||
127623892|NCT02047110|459246447|FG001|OLE Treatment Period|Other than specified|0|||
127623893|NCT02047110|459246448|FG002|OLE Treatment Period|Other than specified|1|||
127623894|NCT02047110|459246449|FG003|OLE Treatment Period|Other than specified|0|||
127623895|NCT02247349|459246450|FG000|Overall Study|Disease Progression|7|||
127623896|NCT02247349|459246451|FG001|Overall Study|Disease Progression|4|||
127623897|NCT02247349|459246452|FG002|Overall Study|Disease Progression|26|||
127623898|NCT02247349|459246453|FG003|Overall Study|Disease Progression|31|||
127623899|NCT02247349|459246454|FG004|Overall Study|Disease Progression|16|||
127623900|NCT02247349|459246455|FG005|Overall Study|Disease Progression|6|||
127623901|NCT02247349|459246450|FG000|Overall Study|Study drug toxicity|0|||
127623902|NCT02247349|459246451|FG001|Overall Study|Study drug toxicity|1|||
127623903|NCT02247349|459246452|FG002|Overall Study|Study drug toxicity|1|||
127623904|NCT02247349|459246453|FG003|Overall Study|Study drug toxicity|1|||
127623905|NCT02247349|459246454|FG004|Overall Study|Study drug toxicity|2|||
127623906|NCT02247349|459246455|FG005|Overall Study|Study drug toxicity|2|||
127623907|NCT02247349|459246450|FG000|Overall Study|Death|0|||
127623908|NCT02247349|459246451|FG001|Overall Study|Death|0|||
127623909|NCT02247349|459246452|FG002|Overall Study|Death|0|||
127623910|NCT02247349|459246453|FG003|Overall Study|Death|1|||
127623911|NCT02247349|459246454|FG004|Overall Study|Death|0|||
127623912|NCT02247349|459246455|FG005|Overall Study|Death|0|||
127623913|NCT02247349|459246450|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
127623914|NCT02247349|459246451|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
127623915|NCT02247349|459246452|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
127642693|NCT03492281|459313112|FG000|Overall Study|Lost to Follow-up|14|||
127642694|NCT03492281|459313113|FG001|Overall Study|Lost to Follow-up|15|||
127642695|NCT03492281|459313114|FG002|Overall Study|Lost to Follow-up|10|||
127623916|NCT02247349|459246453|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
127623917|NCT02247349|459246454|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
127623918|NCT02247349|459246455|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
127623919|NCT02247349|459246450|FG000|Overall Study|Participant request to discontinue study treatment|0|||
127623920|NCT02247349|459246451|FG001|Overall Study|Participant request to discontinue study treatment|0|||
127623921|NCT02247349|459246452|FG002|Overall Study|Participant request to discontinue study treatment|1|||
127623922|NCT02247349|459246453|FG003|Overall Study|Participant request to discontinue study treatment|2|||
127623923|NCT02247349|459246454|FG004|Overall Study|Participant request to discontinue study treatment|1|||
127623924|NCT02247349|459246455|FG005|Overall Study|Participant request to discontinue study treatment|0|||
127623925|NCT02247349|459246450|FG000|Overall Study|Withdrawal by Subject|0|||
127623926|NCT02247349|459246451|FG001|Overall Study|Withdrawal by Subject|1|||
127623927|NCT02247349|459246452|FG002|Overall Study|Withdrawal by Subject|0|||
127623928|NCT02247349|459246453|FG003|Overall Study|Withdrawal by Subject|0|||
127623929|NCT02247349|459246454|FG004|Overall Study|Withdrawal by Subject|0|||
127623930|NCT02247349|459246455|FG005|Overall Study|Withdrawal by Subject|0|||
127623931|NCT02247349|459246450|FG000|Overall Study|Administrative reason by sponsor|0|||
127623932|NCT02247349|459246451|FG001|Overall Study|Administrative reason by sponsor|0|||
127623933|NCT02247349|459246452|FG002|Overall Study|Administrative reason by sponsor|0|||
127623934|NCT02247349|459246453|FG003|Overall Study|Administrative reason by sponsor|0|||
127623935|NCT02247349|459246454|FG004|Overall Study|Administrative reason by sponsor|1|||
127623936|NCT02247349|459246455|FG005|Overall Study|Administrative reason by sponsor|0|||
127623937|NCT02247349|459246450|FG000|Overall Study|Other reasons|0|||
127623938|NCT02247349|459246451|FG001|Overall Study|Other reasons|0|||
127623939|NCT02247349|459246452|FG002|Overall Study|Other reasons|1|||
127623940|NCT02247349|459246453|FG003|Overall Study|Other reasons|0|||
127623941|NCT02247349|459246454|FG004|Overall Study|Other reasons|0|||
127623942|NCT02247349|459246455|FG005|Overall Study|Other reasons|0|||
127623943|NCT01959581|459246460|FG000|Overall Study|Lost to Follow-up|5|||
127623944|NCT00079274|459246461|FG000|Overall Study|Withdrawal by Subject|111|||
127623945|NCT00079274|459246462|FG001|Overall Study|Withdrawal by Subject|10|||
127623946|NCT00079274|459246463|FG002|Overall Study|Withdrawal by Subject|12|||
127623947|NCT00079274|459246464|FG003|Overall Study|Withdrawal by Subject|163|||
127623948|NCT00079274|459246465|FG004|Overall Study|Withdrawal by Subject|7|||
127623949|NCT00079274|459246466|FG005|Overall Study|Withdrawal by Subject|8|||
127623950|NCT00079274|459246467|FG006|Overall Study|Withdrawal by Subject|0|||
127623951|NCT00079274|459246461|FG000|Overall Study|Adverse Event|130|||
127623952|NCT00079274|459246462|FG001|Overall Study|Adverse Event|8|||
127623953|NCT00079274|459246463|FG002|Overall Study|Adverse Event|8|||
127623954|NCT00079274|459246464|FG003|Overall Study|Adverse Event|184|||
127623955|NCT00079274|459246465|FG004|Overall Study|Adverse Event|7|||
127623956|NCT00079274|459246466|FG005|Overall Study|Adverse Event|8|||
127623957|NCT00079274|459246467|FG006|Overall Study|Adverse Event|0|||
127792495|NCT01187953|459863641|FG001|Overall Study|Adverse Event|2|||
127792496|NCT01187953|459863640|FG000|Overall Study|Lost to Follow-up|0|||
127623958|NCT00079274|459246461|FG000|Overall Study|Recurrence|21|||
127792497|NCT01187953|459863641|FG001|Overall Study|Lost to Follow-up|3|||
127623959|NCT00079274|459246462|FG001|Overall Study|Recurrence|0|||
127623960|NCT00079274|459246463|FG002|Overall Study|Recurrence|1|||
127623961|NCT00079274|459246464|FG003|Overall Study|Recurrence|15|||
127623962|NCT00079274|459246465|FG004|Overall Study|Recurrence|0|||
127623963|NCT00079274|459246466|FG005|Overall Study|Recurrence|2|||
127792498|NCT01187953|459863640|FG000|Overall Study|Withdrawal by Subject|3|||
127623964|NCT00079274|459246467|FG006|Overall Study|Recurrence|0|||
127623965|NCT00079274|459246461|FG000|Overall Study|Alternate Treatment|6|||
127623966|NCT00079274|459246462|FG001|Overall Study|Alternate Treatment|1|||
127623967|NCT00079274|459246463|FG002|Overall Study|Alternate Treatment|0|||
127623968|NCT00079274|459246464|FG003|Overall Study|Alternate Treatment|3|||
127623969|NCT00079274|459246465|FG004|Overall Study|Alternate Treatment|0|||
127623970|NCT00079274|459246466|FG005|Overall Study|Alternate Treatment|0|||
127623971|NCT00079274|459246467|FG006|Overall Study|Alternate Treatment|0|||
127623972|NCT00079274|459246461|FG000|Overall Study|Other Medical Problems|6|||
127623973|NCT00079274|459246462|FG001|Overall Study|Other Medical Problems|1|||
127623974|NCT00079274|459246463|FG002|Overall Study|Other Medical Problems|0|||
127623975|NCT00079274|459246464|FG003|Overall Study|Other Medical Problems|7|||
127623976|NCT00079274|459246465|FG004|Overall Study|Other Medical Problems|0|||
127623977|NCT00079274|459246466|FG005|Overall Study|Other Medical Problems|0|||
127623978|NCT00079274|459246467|FG006|Overall Study|Other Medical Problems|0|||
127623979|NCT00079274|459246461|FG000|Overall Study|Death|4|||
127623980|NCT00079274|459246462|FG001|Overall Study|Death|0|||
127623981|NCT00079274|459246463|FG002|Overall Study|Death|1|||
127623982|NCT00079274|459246464|FG003|Overall Study|Death|15|||
127623983|NCT00079274|459246465|FG004|Overall Study|Death|0|||
127623984|NCT00079274|459246466|FG005|Overall Study|Death|0|||
127623985|NCT00079274|459246467|FG006|Overall Study|Death|0|||
127623986|NCT00079274|459246461|FG000|Overall Study|Cytogenetic resistance|0|||
127623987|NCT00079274|459246462|FG001|Overall Study|Cytogenetic resistance|0|||
127623988|NCT00079274|459246463|FG002|Overall Study|Cytogenetic resistance|0|||
127623989|NCT00079274|459246464|FG003|Overall Study|Cytogenetic resistance|2|||
127623990|NCT00079274|459246465|FG004|Overall Study|Cytogenetic resistance|0|||
127623991|NCT00079274|459246466|FG005|Overall Study|Cytogenetic resistance|0|||
127623992|NCT00079274|459246467|FG006|Overall Study|Cytogenetic resistance|0|||
127623993|NCT00079274|459246461|FG000|Overall Study|Other|43|||
127623994|NCT00079274|459246462|FG001|Overall Study|Other|7|||
127623995|NCT00079274|459246463|FG002|Overall Study|Other|5|||
127623996|NCT00079274|459246464|FG003|Overall Study|Other|55|||
127623997|NCT00079274|459246465|FG004|Overall Study|Other|1|||
127623998|NCT00079274|459246466|FG005|Overall Study|Other|2|||
127623999|NCT00079274|459246467|FG006|Overall Study|Other|0|||
127624000|NCT04542070|459246469|FG000|Maintenance Period (Day 1 - Month 12)|Adverse Event|10|||
127624001|NCT04542070|459246470|FG001|Maintenance Period (Day 1 - Month 12)|Adverse Event|3|||
127624002|NCT04542070|459246471|FG002|Maintenance Period (Day 1 - Month 12)|Adverse Event|1|||
127624003|NCT04542070|459246472|FG003|Maintenance Period (Day 1 - Month 12)|Adverse Event|0|||
127624004|NCT04542070|459246469|FG000|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|1|||
127624005|NCT04542070|459246470|FG001|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|2|||
127624006|NCT04542070|459246471|FG002|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
127624007|NCT04542070|459246472|FG003|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
127624008|NCT04542070|459246469|FG000|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|3|||
127624009|NCT04542070|459246470|FG001|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|4|||
127624010|NCT04542070|459246471|FG002|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|2|||
127624011|NCT04542070|459246472|FG003|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|0|||
127624012|NCT04542070|459246469|FG000|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
127624013|NCT04542070|459246470|FG001|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
127624014|NCT04542070|459246471|FG002|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
127624015|NCT04542070|459246472|FG003|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
127624016|NCT04542070|459246469|FG000|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|5|||
127624017|NCT04542070|459246470|FG001|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|8|||
127701346|NCT03031470|459535136|FG000|Overall Study|Adverse Event|3|||
127701347|NCT03031470|459535137|FG001|Overall Study|Adverse Event|0|||
127701348|NCT03031470|459535136|FG000|Overall Study|Death|3|||
127701349|NCT03031470|459535137|FG001|Overall Study|Death|1|||
127701350|NCT03031470|459535136|FG000|Overall Study|Lost to Follow-up|1|||
127701351|NCT03031470|459535137|FG001|Overall Study|Lost to Follow-up|1|||
127701352|NCT03031470|459535136|FG000|Overall Study|Withdrawal by Subject|1|||
127701353|NCT03031470|459535137|FG001|Overall Study|Withdrawal by Subject|0|||
127701354|NCT03031470|459535136|FG000|Overall Study|Protocol entry criteria not met|0|||
127701355|NCT03031470|459535137|FG001|Overall Study|Protocol entry criteria not met|1|||
127701356|NCT03031470|459535136|FG000|Overall Study|Cancel the operation|0|||
127701357|NCT03031470|459535137|FG001|Overall Study|Cancel the operation|1|||
127701358|NCT04623671|459535138|FG000|Overall Study|Adverse Event|0|||
127701359|NCT04623671|459535139|FG001|Overall Study|Adverse Event|1|||
127624018|NCT04542070|459246471|FG002|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|9|||
127624019|NCT04542070|459246472|FG003|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|0|||
127624020|NCT04542070|459246469|FG000|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|2|||
127701360|NCT04623671|459535138|FG000|Overall Study|Lost to Follow-up|2|||
127701361|NCT04623671|459535139|FG001|Overall Study|Lost to Follow-up|1|||
127624021|NCT04542070|459246470|FG001|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|6|||
127701362|NCT04623671|459535138|FG000|Overall Study|Death|5|||
127624022|NCT04542070|459246471|FG002|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|1|||
127624023|NCT04542070|459246472|FG003|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|0|||
127624024|NCT04542070|459246469|FG000|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
127624025|NCT04542070|459246470|FG001|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
127624026|NCT04542070|459246471|FG002|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
127885083|NCT04126733|460203816|FG000|Active Follow-up Period|Death|13|||
127885084|NCT04126733|460203816|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
127885085|NCT04126733|460203816|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
127885086|NCT04126733|460203816|FG000|Active Follow-up Period|Other Reasons|1|||
127885087|NCT04126733|460203816|FG000|Long-term Follow-up Period|Death|22|||
127885088|NCT04126733|460203816|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
127885089|NCT04126733|460203816|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
127885090|NCT02629133|460203818|FG000|Overall Study|Lost to Follow-up|3|||
127624027|NCT04542070|459246472|FG003|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
127624028|NCT04542070|459246469|FG000|Maintenance + Extension Period|Adverse Event|10|||
127624029|NCT04542070|459246470|FG001|Maintenance + Extension Period|Adverse Event|2|||
127624030|NCT04542070|459246471|FG002|Maintenance + Extension Period|Adverse Event|0|||
127624031|NCT04542070|459246472|FG003|Maintenance + Extension Period|Adverse Event|0|||
127624032|NCT04542070|459246469|FG000|Maintenance + Extension Period|Lack of Efficacy|2|||
127624033|NCT04542070|459246470|FG001|Maintenance + Extension Period|Lack of Efficacy|2|||
127624034|NCT04542070|459246471|FG002|Maintenance + Extension Period|Lack of Efficacy|0|||
127624035|NCT04542070|459246472|FG003|Maintenance + Extension Period|Lack of Efficacy|0|||
127624036|NCT04542070|459246469|FG000|Maintenance + Extension Period|Lost to Follow-up|3|||
127624037|NCT04542070|459246470|FG001|Maintenance + Extension Period|Lost to Follow-up|4|||
127624038|NCT04542070|459246471|FG002|Maintenance + Extension Period|Lost to Follow-up|0|||
127624039|NCT04542070|459246472|FG003|Maintenance + Extension Period|Lost to Follow-up|0|||
127624040|NCT04542070|459246469|FG000|Maintenance + Extension Period|Physician Decision|1|||
127624041|NCT04542070|459246470|FG001|Maintenance + Extension Period|Physician Decision|1|||
127624042|NCT04542070|459246471|FG002|Maintenance + Extension Period|Physician Decision|0|||
127624043|NCT04542070|459246472|FG003|Maintenance + Extension Period|Physician Decision|0|||
127624044|NCT04542070|459246469|FG000|Maintenance + Extension Period|Protocol Violation|2|||
127624045|NCT04542070|459246470|FG001|Maintenance + Extension Period|Protocol Violation|5|||
127624046|NCT04542070|459246471|FG002|Maintenance + Extension Period|Protocol Violation|0|||
127624047|NCT04542070|459246472|FG003|Maintenance + Extension Period|Protocol Violation|0|||
127624048|NCT04542070|459246469|FG000|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
127624049|NCT04542070|459246470|FG001|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
127624050|NCT04542070|459246471|FG002|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
127624051|NCT04542070|459246472|FG003|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
127624052|NCT04542070|459246469|FG000|Maintenance + Extension Period|Withdrawal by Subject|4|||
127792499|NCT01187953|459863641|FG001|Overall Study|Withdrawal by Subject|3|||
127624053|NCT04542070|459246470|FG001|Maintenance + Extension Period|Withdrawal by Subject|12|||
127624054|NCT04542070|459246471|FG002|Maintenance + Extension Period|Withdrawal by Subject|0|||
127792500|NCT01464307|459863642|FG000|Main Period|Death|0|||
127792501|NCT01464307|459863643|FG001|Main Period|Death|1|||
127792502|NCT01464307|459863642|FG000|Main Period|Adverse Event|6|||
127792503|NCT01464307|459863643|FG001|Main Period|Adverse Event|1|||
127792504|NCT01464307|459863642|FG000|Main Period|Lack of Efficacy|2|||
127792505|NCT01464307|459863643|FG001|Main Period|Lack of Efficacy|0|||
127792506|NCT01464307|459863642|FG000|Main Period|Withdrawal by Subject|5|||
127792507|NCT01464307|459863643|FG001|Main Period|Withdrawal by Subject|2|||
127792508|NCT01464307|459863642|FG000|Main Period|Predefined discontinuation criteria|2|||
127792509|NCT01464307|459863643|FG001|Main Period|Predefined discontinuation criteria|1|||
127792510|NCT01464307|459863642|FG000|Open-Label Extension Period|Adverse Event|15|||
127792511|NCT01464307|459863643|FG001|Open-Label Extension Period|Adverse Event|0|||
127792512|NCT01464307|459863642|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
127885091|NCT02629133|460203819|FG001|Overall Study|Lost to Follow-up|1|||
127885092|NCT02629133|460203818|FG000|Overall Study|Withdrawal by Subject|1|||
127624055|NCT04542070|459246472|FG003|Maintenance + Extension Period|Withdrawal by Subject|0|||
127624056|NCT04542070|459246469|FG000|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
127624057|NCT04542070|459246470|FG001|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
127624058|NCT04542070|459246471|FG002|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
127624059|NCT04542070|459246472|FG003|Extension Period (Month 13 - Month 27)|Adverse Event|4|||
127624060|NCT04542070|459246469|FG000|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
127624061|NCT04542070|459246470|FG001|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
127624062|NCT04542070|459246471|FG002|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
127624063|NCT04542070|459246472|FG003|Extension Period (Month 13 - Month 27)|Lack of Efficacy|1|||
127624064|NCT04542070|459246469|FG000|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
127624065|NCT04542070|459246470|FG001|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
127624066|NCT04542070|459246471|FG002|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
127624067|NCT04542070|459246472|FG003|Extension Period (Month 13 - Month 27)|Lost to Follow-up|1|||
127624068|NCT04542070|459246469|FG000|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
127624069|NCT04542070|459246470|FG001|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
127624070|NCT04542070|459246471|FG002|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
127624071|NCT04542070|459246472|FG003|Extension Period (Month 13 - Month 27)|Physician Decision|2|||
127624072|NCT04542070|459246469|FG000|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
127624073|NCT04542070|459246470|FG001|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
127624074|NCT04542070|459246471|FG002|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
127792513|NCT01464307|459863643|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
127624075|NCT04542070|459246472|FG003|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|5|||
127624076|NCT00550836|459246473|FG000|Overall Study|Withdrawal by Subject|3|||
127792514|NCT01464307|459863642|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
127792515|NCT01464307|459863643|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
127792516|NCT01464307|459863642|FG000|Open-Label Extension Period|Death|1|||
127792517|NCT01464307|459863643|FG001|Open-Label Extension Period|Death|0|||
127792518|NCT01464307|459863642|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
127792519|NCT01464307|459863643|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
127792520|NCT01464307|459863642|FG000|Open-Label Extension Period|Non-compliance|9|||
127792521|NCT01464307|459863643|FG001|Open-Label Extension Period|Non-compliance|0|||
127792522|NCT01464307|459863642|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
127792523|NCT01464307|459863643|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
127792524|NCT02457637|459863646|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
127792525|NCT04942925|459863649|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
127792526|NCT04942925|459863650|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
127792527|NCT04942925|459863649|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
127792528|NCT04942925|459863650|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
127792529|NCT01273883|459863651|FG000|First Intervention|Adverse Event|2|||
127792530|NCT01273883|459863652|FG001|First Intervention|Adverse Event|1|||
127792531|NCT01273883|459863651|FG000|Second Intervention|Lost to Follow-up|1|||
127792532|NCT01273883|459863652|FG001|Second Intervention|Lost to Follow-up|1|||
127792533|NCT01273883|459863651|FG000|Second Intervention|Lack of Efficacy|1|||
127792534|NCT01273883|459863652|FG001|Second Intervention|Lack of Efficacy|0|||
127792535|NCT02043548|459863659|FG000|Overall Study|Lack of Efficacy|1|||
127792536|NCT02043548|459863660|FG001|Overall Study|Lack of Efficacy|0|||
127792537|NCT02043548|459863659|FG000|Overall Study|Adverse Event|0|||
127792538|NCT02043548|459863660|FG001|Overall Study|Adverse Event|1|||
127792539|NCT01430455|459863663|FG000|Overall Study|Withdrawal by Subject|1|||
127792540|NCT01430455|459863663|FG000|Overall Study|Switched to follow-up phase|1|||
127792541|NCT03829657|459863665|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
127792542|NCT03829657|459863666|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
127792543|NCT03829657|459863667|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
127792544|NCT03829657|459863668|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
127792545|NCT03829657|459863669|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
127792546|NCT03829657|459863665|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
127624077|NCT00550836|459246474|FG001|Overall Study|Withdrawal by Subject|9|||
127624078|NCT00179413|459246475|FG000|Overall Study|Adverse Event|38|||
127624079|NCT00179413|459246476|FG001|Overall Study|Adverse Event|20|||
127624080|NCT00179413|459246475|FG000|Overall Study|Withdrawal by Subject|87|||
127624081|NCT00179413|459246476|FG001|Overall Study|Withdrawal by Subject|95|||
127624082|NCT03075644|459246479|FG000|Overall Study|Withdrawal by Subject|1|||
127792547|NCT03829657|459863666|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
127792548|NCT03829657|459863667|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
127792549|NCT03829657|459863668|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
127792550|NCT03829657|459863669|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
127792551|NCT03829657|459863665|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
127792552|NCT03829657|459863666|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
127885093|NCT02629133|460203819|FG001|Overall Study|Withdrawal by Subject|1|||
127885094|NCT03216954|460203820|FG000|Overall Study|Adverse Event|0|||
127885095|NCT03216954|460203821|FG001|Overall Study|Adverse Event|0|||
127885096|NCT03216954|460203822|FG002|Overall Study|Adverse Event|1|||
127885097|NCT03216954|460203823|FG003|Overall Study|Adverse Event|0|||
127885098|NCT03216954|460203824|FG004|Overall Study|Adverse Event|1|||
127885099|NCT03216954|460203820|FG000|Overall Study|Withdrawal by Subject|2|||
127885100|NCT03216954|460203821|FG001|Overall Study|Withdrawal by Subject|0|||
127885101|NCT03216954|460203822|FG002|Overall Study|Withdrawal by Subject|0|||
127885102|NCT03216954|460203823|FG003|Overall Study|Withdrawal by Subject|0|||
127885103|NCT03216954|460203824|FG004|Overall Study|Withdrawal by Subject|0|||
127885104|NCT03216954|460203820|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
127792553|NCT03829657|459863667|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
127792554|NCT03829657|459863668|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
127792555|NCT03829657|459863669|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
127792556|NCT03829657|459863665|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
127792557|NCT03829657|459863666|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
127792558|NCT03829657|459863667|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
127792559|NCT03829657|459863668|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
127792560|NCT03829657|459863669|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
127792561|NCT03829657|459863665|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
127885105|NCT03216954|460203821|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
127885106|NCT03216954|460203822|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
127624083|NCT03075644|459246480|FG001|Overall Study|Withdrawal by Subject|1|||
127624084|NCT01458171|459246481|FG000|Overall Study|Adverse Event|1|||
127624085|NCT01696032|459246482|FG000|Overall Study|Withdrawal by Subject|0|||
127624086|NCT01696032|459246483|FG001|Overall Study|Withdrawal by Subject|0|||
127624087|NCT01696032|459246484|FG002|Overall Study|Withdrawal by Subject|1|||
127624088|NCT01696032|459246485|FG003|Overall Study|Withdrawal by Subject|2|||
127624089|NCT01696032|459246482|FG000|Overall Study|Death|14|||
127624090|NCT01696032|459246483|FG001|Overall Study|Death|4|||
127624091|NCT01696032|459246484|FG002|Overall Study|Death|43|||
127624092|NCT01696032|459246485|FG003|Overall Study|Death|18|||
127624093|NCT01696032|459246482|FG000|Overall Study|Lost to Follow-up|0|||
127624094|NCT01696032|459246483|FG001|Overall Study|Lost to Follow-up|1|||
127624095|NCT01696032|459246484|FG002|Overall Study|Lost to Follow-up|0|||
127624096|NCT01696032|459246485|FG003|Overall Study|Lost to Follow-up|0|||
127624097|NCT01696032|459246482|FG000|Overall Study|Database lock|0|||
127624098|NCT01696032|459246483|FG001|Overall Study|Database lock|1|||
127624099|NCT01696032|459246484|FG002|Overall Study|Database lock|7|||
127624100|NCT01696032|459246485|FG003|Overall Study|Database lock|2|||
127624101|NCT00578565|459246488|FG000|Overall Study|Adverse Event|3|||
127624102|NCT01192152|459246489|FG000|Period 1|left prematurely (while on treatment B)|0|||
127624103|NCT01192152|459246490|FG001|Period 1|left prematurely (while on treatment B)|1|||
127624104|NCT01192152|459246489|FG000|Period 3|family emergency|1|||
127624105|NCT01192152|459246490|FG001|Period 3|family emergency|0|||
127624106|NCT02203591|459246492|FG000|Overall Study|Did not meet treatment day baseline|147|||
127624107|NCT02203591|459246493|FG001|Overall Study|Did not meet treatment day baseline|141|||
127624108|NCT02203591|459246494|FG002|Overall Study|Did not meet treatment day baseline|150|||
127624109|NCT02203591|459246495|FG003|Overall Study|Did not meet treatment day baseline|45|||
127624110|NCT02203591|459246496|FG004|Overall Study|Did not meet treatment day baseline|33|||
127624111|NCT02203591|459246497|FG005|Overall Study|Did not meet treatment day baseline|35|||
127624112|NCT02203591|459246498|FG006|Overall Study|Did not meet treatment day baseline|29|||
127624113|NCT02203591|459246499|FG007|Overall Study|Did not meet treatment day baseline|12|||
127624114|NCT02203591|459246492|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
127624115|NCT02203591|459246493|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
127624116|NCT02203591|459246494|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
127624117|NCT02203591|459246495|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
127624118|NCT02203591|459246496|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
127624119|NCT02203591|459246497|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
127624120|NCT02203591|459246498|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
127624121|NCT02203591|459246499|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
127624122|NCT05013905|459246500|FG000|Overall Study|Adverse Event|1|||
127624123|NCT05013905|459246500|FG000|Overall Study|Lack of Efficacy|1|||
127624124|NCT04666259|459246503|FG000|Treatment Phase|Physician Decision|9|||
127624125|NCT04666259|459246504|FG001|Treatment Phase|Physician Decision|3|||
127624126|NCT04666259|459246505|FG002|Treatment Phase|Physician Decision|3|||
127624127|NCT04666259|459246503|FG000|Treatment Phase|Adverse Event|3|||
127624128|NCT04666259|459246504|FG001|Treatment Phase|Adverse Event|1|||
127885107|NCT03216954|460203823|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
127885108|NCT03216954|460203824|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
127885109|NCT02598193|460203825|FG000|Overall Study|Adverse Event|13|||
127885110|NCT02598193|460203825|FG000|Overall Study|Withdrawal by Subject|1|||
127885111|NCT02598193|460203825|FG000|Overall Study|Listed in active lung transplant list|1|||
127885112|NCT02598193|460203825|FG000|Overall Study|Does not want to take Nintedanib|1|||
127885113|NCT02487979|460203828|FG000|Overall Study|Physician Decision|2|||
127885114|NCT02487979|460203828|FG000|Overall Study|Withdrawal by Subject|2|||
127885115|NCT02487979|460203828|FG000|Overall Study|Progressive Disease|17|||
127885116|NCT00447694|460203829|FG000|Overall Study|Adverse Event|2|||
127885117|NCT00447694|460203829|FG000|Overall Study|Abnormal laboratory value|1|||
127885118|NCT00447694|460203829|FG000|Overall Study|Abnormal test procedure result|1|||
127885119|NCT00447694|460203829|FG000|Overall Study|Withdrawal by Subject|2|||
127885120|NCT02354976|460203834|FG000|Overall Study|Other - reason not specified|1|||
127885121|NCT02354976|460203835|FG001|Overall Study|Other - reason not specified|0|||
127885122|NCT02354976|460203836|FG002|Overall Study|Other - reason not specified|1|||
127885123|NCT02354976|460203834|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
127885124|NCT02354976|460203835|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
127885125|NCT02354976|460203836|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
127885126|NCT02354976|460203834|FG000|Overall Study|Adverse Event|1|||
127885127|NCT02354976|460203835|FG001|Overall Study|Adverse Event|0|||
127885128|NCT02354976|460203836|FG002|Overall Study|Adverse Event|2|||
127885129|NCT00986154|460203837|FG000|Overall Study|Death|136|||
127885130|NCT00986154|460203838|FG001|Overall Study|Death|127|||
127885131|NCT00986154|460203837|FG000|Overall Study|Lost to Follow-up|7|||
127885132|NCT00986154|460203838|FG001|Overall Study|Lost to Follow-up|4|||
127885133|NCT00986154|460203837|FG000|Overall Study|Withdrawal by Subject|32|||
127885134|NCT00986154|460203838|FG001|Overall Study|Withdrawal by Subject|33|||
127885135|NCT00986154|460203837|FG000|Overall Study|investigator/subject decide not continue|6|||
127624129|NCT04666259|459246505|FG002|Treatment Phase|Adverse Event|0|||
127624130|NCT04666259|459246503|FG000|Treatment Phase|Subject decision|1|||
127624131|NCT04666259|459246504|FG001|Treatment Phase|Subject decision|2|||
127624132|NCT04666259|459246505|FG002|Treatment Phase|Subject decision|0|||
127624133|NCT04666259|459246503|FG000|Treatment Phase|Progressive disease|0|||
127624134|NCT04666259|459246504|FG001|Treatment Phase|Progressive disease|1|||
127624135|NCT04666259|459246505|FG002|Treatment Phase|Progressive disease|0|||
127624136|NCT04666259|459246503|FG000|Treatment Phase|Enrolled but not treated and discontinued|1|||
127624137|NCT04666259|459246504|FG001|Treatment Phase|Enrolled but not treated and discontinued|0|||
127624138|NCT04666259|459246505|FG002|Treatment Phase|Enrolled but not treated and discontinued|0|||
127624139|NCT04666259|459246503|FG000|Safety Follow-up Phase|Physician Decision|2|||
127624140|NCT04666259|459246504|FG001|Safety Follow-up Phase|Physician Decision|0|||
127624141|NCT04666259|459246505|FG002|Safety Follow-up Phase|Physician Decision|0|||
127624142|NCT04666259|459246503|FG000|Safety Follow-up Phase|Subject decision|1|||
127624143|NCT04666259|459246504|FG001|Safety Follow-up Phase|Subject decision|0|||
127624144|NCT04666259|459246505|FG002|Safety Follow-up Phase|Subject decision|0|||
127624145|NCT04666259|459246503|FG000|Safety Follow-up Phase|Death|0|||
127624146|NCT04666259|459246504|FG001|Safety Follow-up Phase|Death|1|||
127624147|NCT04666259|459246505|FG002|Safety Follow-up Phase|Death|0|||
127624148|NCT05402995|459246508|FG000|Overall Study|Study terminated due to lack of enrollment and followup.|0|||
127624149|NCT05402995|459246509|FG001|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
127624150|NCT05402995|459246510|FG002|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
127624151|NCT05402995|459246511|FG003|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
127624152|NCT01009099|459246512|FG000|Overall Study|Lost to Follow-up|1|||
127624153|NCT01009099|459246513|FG001|Overall Study|Lost to Follow-up|0|||
127624154|NCT01009099|459246512|FG000|Overall Study|Physician Decision|3|||
127624155|NCT01009099|459246513|FG001|Overall Study|Physician Decision|2|||
127624156|NCT01009099|459246512|FG000|Overall Study|Withdrawal by Subject|1|||
127624157|NCT01009099|459246513|FG001|Overall Study|Withdrawal by Subject|1|||
127624158|NCT01009099|459246512|FG000|Overall Study|Death|0|||
127624159|NCT01009099|459246513|FG001|Overall Study|Death|1|||
127624160|NCT02188485|459246514|FG000|Overall Study|Withdrawal by Subject|2|||
127624161|NCT02188485|459246515|FG001|Overall Study|Withdrawal by Subject|1|||
127624162|NCT02188485|459246514|FG000|Overall Study|PI withdrew, lack of capacity|0|||
127624163|NCT02188485|459246515|FG001|Overall Study|PI withdrew, lack of capacity|2|||
127885136|NCT00986154|460203838|FG001|Overall Study|investigator/subject decide not continue|3|||
127885137|NCT00986154|460203837|FG000|Overall Study|never received study drug|25|||
127885138|NCT00986154|460203838|FG001|Overall Study|never received study drug|27|||
127885139|NCT03726437|460203839|FG000|Overall Study|Lost to Follow-up|85|||
127885140|NCT03726437|460203840|FG001|Overall Study|Lost to Follow-up|76|||
127885141|NCT00068445|460203841|FG000|Randomization|Cancel|1|||
127624164|NCT02501096|459246517|FG000|Overall Study|Lost to Follow-up|0|||
127624165|NCT02501096|459246518|FG001|Overall Study|Lost to Follow-up|0|||
127624166|NCT02501096|459246519|FG002|Overall Study|Lost to Follow-up|0|||
127624167|NCT02501096|459246520|FG003|Overall Study|Lost to Follow-up|0|||
127624168|NCT02501096|459246521|FG004|Overall Study|Lost to Follow-up|1|||
127624169|NCT02501096|459246522|FG005|Overall Study|Lost to Follow-up|1|||
127624170|NCT02501096|459246523|FG006|Overall Study|Lost to Follow-up|3|||
127624171|NCT02501096|459246524|FG007|Overall Study|Lost to Follow-up|0|||
127624172|NCT02501096|459246525|FG008|Overall Study|Lost to Follow-up|0|||
127624173|NCT02501096|459246517|FG000|Overall Study|Withdrawal by Subject|1|||
127624174|NCT02501096|459246518|FG001|Overall Study|Withdrawal by Subject|0|||
127624175|NCT02501096|459246519|FG002|Overall Study|Withdrawal by Subject|7|||
127624176|NCT02501096|459246520|FG003|Overall Study|Withdrawal by Subject|13|||
127624177|NCT02501096|459246521|FG004|Overall Study|Withdrawal by Subject|2|||
127624178|NCT02501096|459246522|FG005|Overall Study|Withdrawal by Subject|2|||
127624179|NCT02501096|459246523|FG006|Overall Study|Withdrawal by Subject|2|||
127624180|NCT02501096|459246524|FG007|Overall Study|Withdrawal by Subject|3|||
127624181|NCT02501096|459246525|FG008|Overall Study|Withdrawal by Subject|0|||
127624182|NCT02501096|459246517|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
127624183|NCT02501096|459246518|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
127624184|NCT02501096|459246519|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
127624185|NCT02501096|459246520|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
127624186|NCT02501096|459246521|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
127624187|NCT02501096|459246522|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
127624188|NCT02501096|459246523|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
127624189|NCT02501096|459246524|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
127624190|NCT02501096|459246525|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
127624191|NCT02501096|459246517|FG000|Overall Study|Death|1|||
127624192|NCT02501096|459246518|FG001|Overall Study|Death|1|||
127624193|NCT02501096|459246519|FG002|Overall Study|Death|88|||
127624194|NCT02501096|459246520|FG003|Overall Study|Death|74|||
127624195|NCT02501096|459246521|FG004|Overall Study|Death|15|||
127624196|NCT02501096|459246522|FG005|Overall Study|Death|16|||
127624197|NCT02501096|459246523|FG006|Overall Study|Death|15|||
127624198|NCT02501096|459246524|FG007|Overall Study|Death|16|||
127624199|NCT02501096|459246525|FG008|Overall Study|Death|1|||
127624200|NCT04187196|459246526|FG000|Overall Study|Screen Failure|2|||
127624201|NCT04187196|459246527|FG001|Overall Study|Screen Failure|0|||
127701363|NCT04623671|459535139|FG001|Overall Study|Death|5|||
127701364|NCT01943409|459535143|FG000|Overall Study|resumed oral/entral|24|||
127624202|NCT03139916|459246530|FG000|Overall Study|Withdrawal by Subject|2|||
127624203|NCT03139916|459246530|FG000|Overall Study|Clinical progression prior to start of study treatment|1|||
127624204|NCT01957475|459246531|FG000|Test Period 1|Withdrawal by Subject|1|||
127624205|NCT01957475|459246532|FG001|Test Period 1|Withdrawal by Subject|0|||
127624206|NCT01957475|459246531|FG000|Test Period 1|Other|1|||
127624207|NCT01957475|459246532|FG001|Test Period 1|Other|0|||
127624208|NCT01957475|459246531|FG000|Test Period 1|Lack of Efficacy|0|||
127624209|NCT01957475|459246532|FG001|Test Period 1|Lack of Efficacy|1|||
127624210|NCT01957475|459246531|FG000|Test Period 2|Adverse Event|1|||
127624211|NCT01957475|459246532|FG001|Test Period 2|Adverse Event|0|||
127624212|NCT04587193|459246533|FG000|Overall Study|Screen failure after consent|3|||
127624213|NCT04587193|459246534|FG001|Overall Study|Screen failure after consent|0|||
127624214|NCT04587193|459246533|FG000|Overall Study|Device broke during study|3|||
127624215|NCT04587193|459246534|FG001|Overall Study|Device broke during study|2|||
127624216|NCT01552772|459246535|FG000|Overall Study|Lost to Follow-up|2|||
127624217|NCT01552772|459246535|FG000|Overall Study|Adverse Event|1|||
127624218|NCT01552772|459246535|FG000|Overall Study|Protocol Deviation|1|||
127624219|NCT00298038|459246541|FG000|Overall Study|Lost to Follow-up|0|||
127624220|NCT00298038|459246542|FG001|Overall Study|Lost to Follow-up|1|||
127624221|NCT00298038|459246541|FG000|Overall Study|Liver Transplant|0|||
127624222|NCT00298038|459246542|FG001|Overall Study|Liver Transplant|1|||
127624223|NCT00298038|459246541|FG000|Overall Study|Protocol Violation|1|||
127624224|NCT00298038|459246542|FG001|Overall Study|Protocol Violation|3|||
127624225|NCT00298038|459246541|FG000|Overall Study|Death|6|||
127624226|NCT00298038|459246542|FG001|Overall Study|Death|3|||
127624227|NCT00298038|459246541|FG000|Overall Study|Withdrawal by Subject|6|||
127624228|NCT00298038|459246542|FG001|Overall Study|Withdrawal by Subject|9|||
127624229|NCT00298038|459246541|FG000|Overall Study|Adverse Event|8|||
127624230|NCT00298038|459246542|FG001|Overall Study|Adverse Event|7|||
127624231|NCT00298038|459246541|FG000|Overall Study|Breakthrough overt HE episode|28|||
127624232|NCT00298038|459246542|FG001|Overall Study|Breakthrough overt HE episode|69|||
127624233|NCT00298038|459246541|FG000|Overall Study|Noncompliance|1|||
127624234|NCT00298038|459246542|FG001|Overall Study|Noncompliance|0|||
127624235|NCT00298038|459246541|FG000|Overall Study|Cocaine Abuse|1|||
127624236|NCT00298038|459246542|FG001|Overall Study|Cocaine Abuse|0|||
127885142|NCT00068445|460203842|FG001|Randomization|Cancel|3|||
127624237|NCT00298038|459246541|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
127624238|NCT00298038|459246542|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
127624239|NCT00773097|459246545|FG000|Overall Study|Withdrawal by Subject|1|||
127624240|NCT00773097|459246545|FG000|Overall Study|Physician Decision|6|||
127624241|NCT02707640|459246546|FG000|Overall Study|Adverse Event|4|||
127624242|NCT02707640|459246547|FG001|Overall Study|Adverse Event|2|||
127624243|NCT02707640|459246546|FG000|Overall Study|Death|1|||
127624244|NCT02707640|459246547|FG001|Overall Study|Death|2|||
127624245|NCT02707640|459246546|FG000|Overall Study|Physician Decision|2|||
127624246|NCT02707640|459246547|FG001|Overall Study|Physician Decision|0|||
127624247|NCT02707640|459246546|FG000|Overall Study|Withdrawal by Subject|0|||
127624248|NCT02707640|459246547|FG001|Overall Study|Withdrawal by Subject|1|||
127624249|NCT02707640|459246546|FG000|Overall Study|Participant's Personal Decision|1|||
127624250|NCT02707640|459246547|FG001|Overall Study|Participant's Personal Decision|2|||
127624251|NCT02707640|459246546|FG000|Overall Study|Sponsor Discretion|1|||
127624252|NCT02707640|459246547|FG001|Overall Study|Sponsor Discretion|0|||
127624253|NCT02517905|459246548|FG000|Overall Study|Lost to Follow-up|4|||
127624254|NCT02517905|459246549|FG001|Overall Study|Lost to Follow-up|0|||
127624255|NCT02517905|459246548|FG000|Overall Study|Withdrawal by Subject|4|||
127624256|NCT02517905|459246549|FG001|Overall Study|Withdrawal by Subject|0|||
127624257|NCT02517905|459246548|FG000|Overall Study|Screen failure|2|||
127624258|NCT02517905|459246549|FG001|Overall Study|Screen failure|2|||
127624259|NCT01755416|459246553|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
127624260|NCT01755416|459246554|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
127624261|NCT02742103|459248272|FG000|Overall Study|Protocol Violation|1|||
127624262|NCT02742103|459248273|FG001|Overall Study|Protocol Violation|0|||
127624263|NCT02742103|459248272|FG000|Overall Study|Death|2|||
127624264|NCT02742103|459248273|FG001|Overall Study|Death|2|||
127624265|NCT02742103|459248272|FG000|Overall Study|Adverse Event|1|||
127624266|NCT02742103|459248273|FG001|Overall Study|Adverse Event|0|||
127624267|NCT02742103|459248272|FG000|Overall Study|Moved to another town|0|||
127624268|NCT02742103|459248273|FG001|Overall Study|Moved to another town|1|||
127624269|NCT02742103|459248272|FG000|Overall Study|Withdrawal by Subject|5|||
127624270|NCT02742103|459248273|FG001|Overall Study|Withdrawal by Subject|2|||
127624271|NCT03042312|459248274|FG000|Overall Study|Administrative Reason|1|||
127624272|NCT03042312|459248275|FG001|Overall Study|Administrative Reason|1|||
127624273|NCT03042312|459248274|FG000|Overall Study|Adverse Event|0|||
127624274|NCT03042312|459248275|FG001|Overall Study|Adverse Event|1|||
127624275|NCT03042312|459248274|FG000|Overall Study|Lost to Follow-up|1|||
127792562|NCT03829657|459863666|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
127792563|NCT03829657|459863667|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
127792564|NCT03829657|459863668|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
127792565|NCT03829657|459863669|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
127792566|NCT03829657|459863665|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
127792567|NCT03829657|459863666|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
127792568|NCT03829657|459863667|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
127792569|NCT03829657|459863668|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
127792570|NCT03829657|459863669|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
127792571|NCT03829657|459863665|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
127792572|NCT03829657|459863666|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
127792573|NCT03829657|459863667|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
127792574|NCT03829657|459863668|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
127792575|NCT03829657|459863669|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
127792576|NCT03829657|459863665|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
127792577|NCT03829657|459863666|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
127792578|NCT03829657|459863667|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
127792579|NCT03829657|459863668|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
127792580|NCT03829657|459863669|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
127792581|NCT03829657|459863665|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
127792582|NCT03829657|459863666|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
127792583|NCT03829657|459863667|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
127792584|NCT03829657|459863668|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
127792585|NCT03829657|459863669|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
127792586|NCT03829657|459863665|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
127792587|NCT03829657|459863666|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
127624276|NCT03042312|459248275|FG001|Overall Study|Lost to Follow-up|3|||
127624277|NCT03042312|459248274|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
127624278|NCT03042312|459248275|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
127624279|NCT03042312|459248274|FG000|Overall Study|Withdrawal by Subject|4|||
127624280|NCT03042312|459248275|FG001|Overall Study|Withdrawal by Subject|5|||
127624281|NCT00646958|459248278|FG000|Overall Study|Lack of Efficacy|1|||
127624282|NCT00646958|459248279|FG001|Overall Study|Lack of Efficacy|0|||
127624283|NCT00646958|459248280|FG002|Overall Study|Lack of Efficacy|0|||
127624284|NCT00646958|459248278|FG000|Overall Study|Adverse Event|4|||
127624285|NCT00646958|459248279|FG001|Overall Study|Adverse Event|0|||
127624286|NCT00646958|459248280|FG002|Overall Study|Adverse Event|0|||
127624287|NCT00646958|459248278|FG000|Overall Study|Lost to Follow-up|1|||
127624288|NCT00646958|459248279|FG001|Overall Study|Lost to Follow-up|5|||
127624289|NCT00646958|459248280|FG002|Overall Study|Lost to Follow-up|7|||
127624290|NCT00646958|459248278|FG000|Overall Study|Protocol Violation|1|||
127624291|NCT00646958|459248279|FG001|Overall Study|Protocol Violation|1|||
127624292|NCT00646958|459248280|FG002|Overall Study|Protocol Violation|0|||
127624293|NCT00646958|459248278|FG000|Overall Study|Abnormal screening lab tests|1|||
127624294|NCT00646958|459248279|FG001|Overall Study|Abnormal screening lab tests|1|||
127624295|NCT00646958|459248280|FG002|Overall Study|Abnormal screening lab tests|0|||
127624296|NCT00646958|459248278|FG000|Overall Study|Withdrawal by Subject|1|||
127624297|NCT00646958|459248279|FG001|Overall Study|Withdrawal by Subject|2|||
127624298|NCT00646958|459248280|FG002|Overall Study|Withdrawal by Subject|0|||
127624299|NCT00646958|459248278|FG000|Overall Study|Did not receive study drug|2|||
127624300|NCT00646958|459248279|FG001|Overall Study|Did not receive study drug|0|||
127624301|NCT00646958|459248280|FG002|Overall Study|Did not receive study drug|2|||
127624302|NCT02573324|459248282|FG000|Overall Study|Withdrawal by Subject|26|||
127624303|NCT02573324|459248283|FG001|Overall Study|Withdrawal by Subject|23|||
127624304|NCT02573324|459248284|FG002|Overall Study|Withdrawal by Subject|3|||
127624305|NCT02573324|459248282|FG000|Overall Study|Lost to Follow-up|4|||
127624306|NCT02573324|459248283|FG001|Overall Study|Lost to Follow-up|5|||
127624307|NCT02573324|459248284|FG002|Overall Study|Lost to Follow-up|0|||
127624308|NCT02573324|459248282|FG000|Overall Study|Study Terminated by Sponsor|107|||
127624309|NCT02573324|459248283|FG001|Overall Study|Study Terminated by Sponsor|89|||
127624310|NCT02573324|459248284|FG002|Overall Study|Study Terminated by Sponsor|2|||
127701365|NCT01943409|459535144|FG001|Overall Study|resumed oral/entral|20|||
127701366|NCT01943409|459535143|FG000|Overall Study|Protocol Violation|14|||
127624311|NCT02573324|459248282|FG000|Overall Study|Death|182|||
127701367|NCT01943409|459535144|FG001|Overall Study|Protocol Violation|24|||
127701368|NCT01943409|459535143|FG000|Overall Study|Death|3|||
127701369|NCT01943409|459535144|FG001|Overall Study|Death|1|||
127701370|NCT01943409|459535143|FG000|Overall Study|Withdrawal by Subject|4|||
127701371|NCT01943409|459535144|FG001|Overall Study|Withdrawal by Subject|3|||
127701372|NCT02310646|459535145|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
127701373|NCT02310646|459535146|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
127701374|NCT02310646|459535145|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
127701375|NCT02310646|459535146|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
127701376|NCT03848065|459535147|FG000|Overall Study|Death|0|||
127701377|NCT03848065|459535148|FG001|Overall Study|Death|1|||
127701378|NCT03848065|459535149|FG002|Overall Study|Death|0|||
127701379|NCT03848065|459535147|FG000|Overall Study|Lost to Follow-up|0|||
127701380|NCT03848065|459535148|FG001|Overall Study|Lost to Follow-up|0|||
127701381|NCT03848065|459535149|FG002|Overall Study|Lost to Follow-up|1|||
127701382|NCT03848065|459535147|FG000|Overall Study|Physician Decision|0|||
127701383|NCT03848065|459535148|FG001|Overall Study|Physician Decision|0|||
127701384|NCT03848065|459535149|FG002|Overall Study|Physician Decision|1|||
127701385|NCT03496168|459535156|FG000|Overall Study|Other Reasons|1|||
127701386|NCT03496168|459535156|FG000|Overall Study|Adverse Event|1|||
127701387|NCT05869383|459535157|FG000|Overall Study|Withdrawal by Subject|2|||
127701388|NCT05869383|459535158|FG001|Overall Study|Withdrawal by Subject|0|||
127701389|NCT04137367|459535159|FG000|Overall Study|Lost to Follow-up|8|||
127701390|NCT04137367|459535160|FG001|Overall Study|Lost to Follow-up|6|||
127701391|NCT04137367|459535161|FG002|Overall Study|Lost to Follow-up|4|||
127701392|NCT03907878|459535162|FG000|Treatment Period|Withdrawal by Subject|5|||
127701393|NCT03907878|459535162|FG000|Treatment Period|Adverse Event|4|||
127624312|NCT02573324|459248283|FG001|Overall Study|Death|200|||
127624313|NCT02573324|459248284|FG002|Overall Study|Death|1|||
127624314|NCT02573324|459248282|FG000|Overall Study|Other, Not Specified|20|||
127624315|NCT02573324|459248283|FG001|Overall Study|Other, Not Specified|27|||
127624316|NCT02573324|459248284|FG002|Overall Study|Other, Not Specified|0|||
127701394|NCT03907878|459535162|FG000|Treatment Period|Lack of Efficacy|1|||
127701395|NCT03907878|459535162|FG000|Treatment Period|Protocol Violation|1|||
127701396|NCT03907878|459535162|FG000|Follow-up Period|Adverse Event|3|||
127701397|NCT03907878|459535162|FG000|Follow-up Period|Withdrawal by Subject|3|||
127701398|NCT04499924|459535163|FG000|Overall Study|Study termination by sponsor|4|||
127701399|NCT04499924|459535164|FG001|Overall Study|Study termination by sponsor|6|||
127792588|NCT03829657|459863667|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
127792589|NCT03829657|459863668|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
127792590|NCT03829657|459863669|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
127792591|NCT01014689|459863670|FG000|Overall Study|Lack of Efficacy|0|||
127792592|NCT01014689|459863671|FG001|Overall Study|Lack of Efficacy|1|||
127792593|NCT01014689|459863670|FG000|Overall Study|Adverse Event|3|||
127792594|NCT01014689|459863671|FG001|Overall Study|Adverse Event|0|||
127792595|NCT01014689|459863670|FG000|Overall Study|Withdrawal by Subject|5|||
127792596|NCT01014689|459863671|FG001|Overall Study|Withdrawal by Subject|4|||
127624317|NCT02573324|459248282|FG000|Overall Study|Unknown Reason|2|||
127624318|NCT02573324|459248283|FG001|Overall Study|Unknown Reason|0|||
127624319|NCT02573324|459248284|FG002|Overall Study|Unknown Reason|0|||
127624320|NCT01607905|459248285|FG000|Overall Study|Withdrawal by participant|7|||
127624321|NCT01607905|459248286|FG001|Overall Study|Withdrawal by participant|2|||
127624322|NCT01607905|459248287|FG002|Overall Study|Withdrawal by participant|4|||
127624323|NCT01607905|459248288|FG003|Overall Study|Withdrawal by participant|6|||
127624324|NCT01607905|459248289|FG004|Overall Study|Withdrawal by participant|0|||
127624325|NCT01607905|459248290|FG005|Overall Study|Withdrawal by participant|4|||
127624326|NCT01607905|459248291|FG006|Overall Study|Withdrawal by participant|12|||
127624327|NCT01607905|459248285|FG000|Overall Study|Incidence or severity of AEs|5|||
127624328|NCT01607905|459248286|FG001|Overall Study|Incidence or severity of AEs|1|||
127624329|NCT01607905|459248287|FG002|Overall Study|Incidence or severity of AEs|1|||
127624330|NCT01607905|459248288|FG003|Overall Study|Incidence or severity of AEs|3|||
127624331|NCT01607905|459248289|FG004|Overall Study|Incidence or severity of AEs|0|||
127624332|NCT01607905|459248290|FG005|Overall Study|Incidence or severity of AEs|2|||
127624333|NCT01607905|459248291|FG006|Overall Study|Incidence or severity of AEs|8|||
127624334|NCT01607905|459248285|FG000|Overall Study|Disease progression|44|||
127624335|NCT01607905|459248286|FG001|Overall Study|Disease progression|16|||
127624336|NCT01607905|459248287|FG002|Overall Study|Disease progression|15|||
127624337|NCT01607905|459248288|FG003|Overall Study|Disease progression|11|||
127624338|NCT01607905|459248289|FG004|Overall Study|Disease progression|6|||
127624339|NCT01607905|459248290|FG005|Overall Study|Disease progression|7|||
127624340|NCT01607905|459248291|FG006|Overall Study|Disease progression|21|||
127624341|NCT01607905|459248285|FG000|Overall Study|Non-compliance with study procedures|0|||
127624342|NCT01607905|459248286|FG001|Overall Study|Non-compliance with study procedures|0|||
127624343|NCT01607905|459248287|FG002|Overall Study|Non-compliance with study procedures|0|||
127624344|NCT01607905|459248288|FG003|Overall Study|Non-compliance with study procedures|0|||
127624345|NCT01607905|459248289|FG004|Overall Study|Non-compliance with study procedures|0|||
127624346|NCT01607905|459248290|FG005|Overall Study|Non-compliance with study procedures|0|||
127624347|NCT01607905|459248291|FG006|Overall Study|Non-compliance with study procedures|1|||
127624348|NCT01607905|459248285|FG000|Overall Study|Death|1|||
127624349|NCT01607905|459248286|FG001|Overall Study|Death|1|||
127624350|NCT01607905|459248287|FG002|Overall Study|Death|1|||
127624351|NCT01607905|459248288|FG003|Overall Study|Death|1|||
127624352|NCT01607905|459248289|FG004|Overall Study|Death|0|||
127624353|NCT01607905|459248290|FG005|Overall Study|Death|0|||
127624354|NCT01607905|459248291|FG006|Overall Study|Death|3|||
127624355|NCT01607905|459248285|FG000|Overall Study|Other treatments become available|1|||
127624356|NCT01607905|459248286|FG001|Overall Study|Other treatments become available|0|||
127624357|NCT01607905|459248287|FG002|Overall Study|Other treatments become available|0|||
127624358|NCT01607905|459248288|FG003|Overall Study|Other treatments become available|0|||
127624359|NCT01607905|459248289|FG004|Overall Study|Other treatments become available|0|||
127624360|NCT01607905|459248290|FG005|Overall Study|Other treatments become available|0|||
127624361|NCT01607905|459248291|FG006|Overall Study|Other treatments become available|1|||
127624362|NCT01607905|459248285|FG000|Overall Study|Investigator discretion|0|||
127624363|NCT01607905|459248286|FG001|Overall Study|Investigator discretion|0|||
127624364|NCT01607905|459248287|FG002|Overall Study|Investigator discretion|0|||
127624365|NCT01607905|459248288|FG003|Overall Study|Investigator discretion|0|||
127624366|NCT01607905|459248289|FG004|Overall Study|Investigator discretion|0|||
127624367|NCT01607905|459248290|FG005|Overall Study|Investigator discretion|1|||
127624368|NCT01607905|459248291|FG006|Overall Study|Investigator discretion|0|||
127624369|NCT01607905|459248285|FG000|Overall Study|Other|1|||
127885143|NCT00068445|460203841|FG000|Randomization|Ineligible|1|||
127624370|NCT01607905|459248286|FG001|Overall Study|Other|0|||
127624371|NCT01607905|459248287|FG002|Overall Study|Other|0|||
127624372|NCT01607905|459248288|FG003|Overall Study|Other|0|||
127624373|NCT01607905|459248289|FG004|Overall Study|Other|0|||
127792597|NCT01014689|459863670|FG000|Overall Study|Protocol Violation|1|||
127885144|NCT00068445|460203842|FG001|Randomization|Ineligible|1|||
127624374|NCT01607905|459248290|FG005|Overall Study|Other|0|||
127624375|NCT01607905|459248291|FG006|Overall Study|Other|1|||
127624376|NCT01607905|459248285|FG000|Overall Study|Randomized but not treated|1|||
127624377|NCT01607905|459248286|FG001|Overall Study|Randomized but not treated|0|||
127792598|NCT01014689|459863671|FG001|Overall Study|Protocol Violation|1|||
127792599|NCT01014689|459863670|FG000|Overall Study|Lost to Follow-up|3|||
127792600|NCT01014689|459863671|FG001|Overall Study|Lost to Follow-up|7|||
127792601|NCT01014689|459863670|FG000|Overall Study|Pregnancy|1|||
127624378|NCT01607905|459248287|FG002|Overall Study|Randomized but not treated|0|||
127624379|NCT01607905|459248288|FG003|Overall Study|Randomized but not treated|0|||
127624380|NCT01607905|459248289|FG004|Overall Study|Randomized but not treated|1|||
127624381|NCT01607905|459248290|FG005|Overall Study|Randomized but not treated|1|||
127624382|NCT01607905|459248291|FG006|Overall Study|Randomized but not treated|0|||
127624383|NCT01105533|459248292|FG000|Overall Study|Death|0|||
127624384|NCT01105533|459248293|FG001|Overall Study|Death|0|||
127624385|NCT01105533|459248294|FG002|Overall Study|Death|0|||
127624386|NCT01105533|459248295|FG003|Overall Study|Death|0|||
127624387|NCT01105533|459248296|FG004|Overall Study|Death|1|||
127624388|NCT01105533|459248297|FG005|Overall Study|Death|0|||
127624389|NCT01105533|459248298|FG006|Overall Study|Death|0|||
127624390|NCT01105533|459248299|FG007|Overall Study|Death|0|||
127624391|NCT01105533|459248300|FG008|Overall Study|Death|0|||
127624392|NCT01105533|459248292|FG000|Overall Study|Lack of Efficacy|1|||
127624393|NCT01105533|459248293|FG001|Overall Study|Lack of Efficacy|1|||
127624394|NCT01105533|459248294|FG002|Overall Study|Lack of Efficacy|3|||
127624395|NCT01105533|459248295|FG003|Overall Study|Lack of Efficacy|3|||
127624396|NCT01105533|459248296|FG004|Overall Study|Lack of Efficacy|4|||
127624397|NCT01105533|459248297|FG005|Overall Study|Lack of Efficacy|5|||
127624398|NCT01105533|459248298|FG006|Overall Study|Lack of Efficacy|3|||
127624399|NCT01105533|459248299|FG007|Overall Study|Lack of Efficacy|2|||
127624400|NCT01105533|459248300|FG008|Overall Study|Lack of Efficacy|9|||
127624401|NCT01105533|459248292|FG000|Overall Study|Adverse Event|0|||
127624402|NCT01105533|459248293|FG001|Overall Study|Adverse Event|0|||
127624403|NCT01105533|459248294|FG002|Overall Study|Adverse Event|0|||
127624404|NCT01105533|459248295|FG003|Overall Study|Adverse Event|0|||
127624405|NCT01105533|459248296|FG004|Overall Study|Adverse Event|1|||
127624406|NCT01105533|459248297|FG005|Overall Study|Adverse Event|2|||
127624407|NCT01105533|459248298|FG006|Overall Study|Adverse Event|2|||
127624408|NCT01105533|459248299|FG007|Overall Study|Adverse Event|0|||
127624409|NCT01105533|459248300|FG008|Overall Study|Adverse Event|1|||
127624410|NCT01105533|459248292|FG000|Overall Study|Other|0|||
127624411|NCT01105533|459248293|FG001|Overall Study|Other|0|||
127624412|NCT01105533|459248294|FG002|Overall Study|Other|0|||
127624413|NCT01105533|459248295|FG003|Overall Study|Other|0|||
127624414|NCT01105533|459248296|FG004|Overall Study|Other|1|||
127624415|NCT01105533|459248297|FG005|Overall Study|Other|0|||
127624416|NCT01105533|459248298|FG006|Overall Study|Other|3|||
127624417|NCT01105533|459248299|FG007|Overall Study|Other|1|||
127792602|NCT01014689|459863671|FG001|Overall Study|Pregnancy|0|||
127792603|NCT02867995|459863674|FG000|Overall Study|Withdrawal by Subject|0|||
127792604|NCT02867995|459863675|FG001|Overall Study|Withdrawal by Subject|1|||
127792605|NCT02867995|459863674|FG000|Overall Study|Lost to Follow-up|0|||
127792606|NCT02867995|459863675|FG001|Overall Study|Lost to Follow-up|2|||
127792607|NCT00150592|459867335|FG000|Overall Study|Adverse Event|4|||
127792608|NCT00150592|459867336|FG001|Overall Study|Adverse Event|1|||
127792609|NCT00150592|459867335|FG000|Overall Study|Protocol Violation|1|||
127792610|NCT00150592|459867336|FG001|Overall Study|Protocol Violation|0|||
127792611|NCT00150592|459867335|FG000|Overall Study|Withdrawal by Subject|1|||
127792612|NCT00150592|459867336|FG001|Overall Study|Withdrawal by Subject|2|||
127792613|NCT00150592|459867335|FG000|Overall Study|Non-compliance|1|||
127792614|NCT00150592|459867336|FG001|Overall Study|Non-compliance|0|||
127792615|NCT00874120|459867341|FG000|First Intervention|Adverse Event|0|||
127792616|NCT00874120|459867342|FG001|First Intervention|Adverse Event|1|||
127624418|NCT01105533|459248300|FG008|Overall Study|Other|2|||
127624419|NCT01105533|459248292|FG000|Overall Study|Physician Decision|0|||
127792617|NCT00874120|459867341|FG000|First Intervention|Withdrawal by Subject|2|||
127792618|NCT00874120|459867342|FG001|First Intervention|Withdrawal by Subject|0|||
127792619|NCT00874120|459867341|FG000|First Intervention|Lost to Follow-up|0|||
127624420|NCT01105533|459248293|FG001|Overall Study|Physician Decision|0|||
127624421|NCT01105533|459248294|FG002|Overall Study|Physician Decision|0|||
127624422|NCT01105533|459248295|FG003|Overall Study|Physician Decision|0|||
127624423|NCT01105533|459248296|FG004|Overall Study|Physician Decision|0|||
127624424|NCT01105533|459248297|FG005|Overall Study|Physician Decision|0|||
127624425|NCT01105533|459248298|FG006|Overall Study|Physician Decision|0|||
127792620|NCT00874120|459867342|FG001|First Intervention|Lost to Follow-up|1|||
127792621|NCT00874120|459867341|FG000|First Intervention|Protocol Violation|3|||
127624426|NCT01105533|459248299|FG007|Overall Study|Physician Decision|1|||
127624427|NCT01105533|459248300|FG008|Overall Study|Physician Decision|0|||
127624428|NCT02096835|459248302|FG000|Overall Study|Withdrawal by Subject|1|||
127624429|NCT02096835|459248303|FG001|Overall Study|Withdrawal by Subject|0|||
127624430|NCT02096835|459248304|FG002|Overall Study|Withdrawal by Subject|0|||
127624431|NCT02096835|459248302|FG000|Overall Study|converted to open procedures|1|||
127624432|NCT02096835|459248303|FG001|Overall Study|converted to open procedures|0|||
127792622|NCT00874120|459867342|FG001|First Intervention|Protocol Violation|0|||
127792623|NCT00874120|459867341|FG000|First Intervention|positive drug test|1|||
127792624|NCT00874120|459867342|FG001|First Intervention|positive drug test|0|||
127624433|NCT02096835|459248304|FG002|Overall Study|converted to open procedures|0|||
127624434|NCT02096835|459248302|FG000|Overall Study|Lost to Follow-up|1|||
127624435|NCT02096835|459248303|FG001|Overall Study|Lost to Follow-up|0|||
127624436|NCT02096835|459248304|FG002|Overall Study|Lost to Follow-up|1|||
127624437|NCT03892889|459248305|FG000|Overall Study|Adverse Event|17|||
127624438|NCT03892889|459248305|FG000|Overall Study|Lack of Efficacy|1|||
127624439|NCT03892889|459248305|FG000|Overall Study|Lost to Follow-up|46|||
127624440|NCT03892889|459248305|FG000|Overall Study|Non-compliance with study drug|22|||
127624441|NCT03892889|459248305|FG000|Overall Study|Pregnancy|1|||
127624442|NCT03892889|459248305|FG000|Overall Study|Protocol Deviation|3|||
127624443|NCT03892889|459248305|FG000|Overall Study|Withdrawal by Subject|50|||
127624444|NCT03892889|459248305|FG000|Overall Study|Withdrawal by Caregiver|1|||
127885145|NCT00068445|460203841|FG000|Treatment|Refused Further Treatment|13|||
127885146|NCT00068445|460203842|FG001|Treatment|Refused Further Treatment|10|||
127885147|NCT00068445|460203841|FG000|Treatment|Adverse Event|7|||
127885148|NCT00068445|460203842|FG001|Treatment|Adverse Event|1|||
127885149|NCT00068445|460203841|FG000|Treatment|Other (Specifics not available)|9|||
127885150|NCT00068445|460203842|FG001|Treatment|Other (Specifics not available)|5|||
127885151|NCT01896700|460203843|FG000|Overall Study|Adverse Event|4|||
127885152|NCT01896700|460203844|FG001|Overall Study|Adverse Event|5|||
127885153|NCT01896700|460203843|FG000|Overall Study|Withdrawal by Subject|0|||
127885154|NCT01896700|460203844|FG001|Overall Study|Withdrawal by Subject|1|||
127885155|NCT00423488|460203845|FG000|Overall Study|No evidence of study drug intake|2|||
127624445|NCT03892889|459248305|FG000|Overall Study|Study Terminated by Sponsor|50|||
127624446|NCT03892889|459248305|FG000|Overall Study|Physician Decision|8|||
127624447|NCT03892889|459248305|FG000|Overall Study|Reason not Specified|5|||
127624448|NCT04260191|459248306|FG000|Overall Study|Decision by Sponsor|0|||
127624449|NCT04260191|459248307|FG001|Overall Study|Decision by Sponsor|1|||
127624450|NCT04260191|459248308|FG002|Overall Study|Decision by Sponsor|0|||
127624451|NCT04260191|459248306|FG000|Overall Study|Withdrawal by Subject|1|||
127624452|NCT04260191|459248307|FG001|Overall Study|Withdrawal by Subject|0|||
127624453|NCT04260191|459248308|FG002|Overall Study|Withdrawal by Subject|3|||
127624454|NCT04260191|459248306|FG000|Overall Study|Death|4|||
127624455|NCT04260191|459248307|FG001|Overall Study|Death|3|||
127624456|NCT04260191|459248308|FG002|Overall Study|Death|2|||
127624457|NCT00659646|459248313|FG000|Overall Study|Protocol Violation|12|||
127624458|NCT00659646|459248314|FG001|Overall Study|Protocol Violation|8|||
127624459|NCT00659646|459248313|FG000|Overall Study|Adverse Event|1|||
127624460|NCT00659646|459248314|FG001|Overall Study|Adverse Event|0|||
127885156|NCT00423488|460203846|FG001|Overall Study|No evidence of study drug intake|1|||
127885157|NCT00423488|460203845|FG000|Overall Study|No post baseline data|3|||
127885158|NCT00423488|460203846|FG001|Overall Study|No post baseline data|0|||
127885159|NCT03118765|460203848|FG000|Overall Study|Withdrawal by Subject|0|||
127885160|NCT03118765|460203849|FG001|Overall Study|Withdrawal by Subject|0|||
127885161|NCT03118765|460203850|FG002|Overall Study|Withdrawal by Subject|1|||
127885162|NCT03118765|460203851|FG003|Overall Study|Withdrawal by Subject|0|||
127885163|NCT03118765|460203852|FG004|Overall Study|Withdrawal by Subject|0|||
127885164|NCT03118765|460203848|FG000|Overall Study|Adverse Event|1|||
127885165|NCT03118765|460203849|FG001|Overall Study|Adverse Event|1|||
127885166|NCT03118765|460203850|FG002|Overall Study|Adverse Event|1|||
127885167|NCT03118765|460203851|FG003|Overall Study|Adverse Event|1|||
127885168|NCT03118765|460203852|FG004|Overall Study|Adverse Event|1|||
127885169|NCT03118765|460203848|FG000|Overall Study|Non compliance with Study Procedures|0|||
127885170|NCT03118765|460203849|FG001|Overall Study|Non compliance with Study Procedures|0|||
127624461|NCT00659646|459248313|FG000|Overall Study|Lost to Follow-up|1|||
127885171|NCT03118765|460203850|FG002|Overall Study|Non compliance with Study Procedures|0|||
127885172|NCT03118765|460203851|FG003|Overall Study|Non compliance with Study Procedures|1|||
127885173|NCT03118765|460203852|FG004|Overall Study|Non compliance with Study Procedures|0|||
127624462|NCT00659646|459248314|FG001|Overall Study|Lost to Follow-up|0|||
127624463|NCT00659646|459248313|FG000|Overall Study|protocol noncompliance after randomized|1|||
127624464|NCT00659646|459248314|FG001|Overall Study|protocol noncompliance after randomized|0|||
127624465|NCT00023673|459248315|FG000|Overall Study|Ineligible / no protocol treatment|0|||
127624466|NCT00023673|459248316|FG001|Overall Study|Ineligible / no protocol treatment|0|||
127624467|NCT00023673|459248317|FG002|Overall Study|Ineligible / no protocol treatment|0|||
127624468|NCT00023673|459248318|FG003|Overall Study|Ineligible / no protocol treatment|1|||
127624469|NCT00023673|459248315|FG000|Overall Study|Patient withdrew consent|0|||
127624470|NCT00023673|459248316|FG001|Overall Study|Patient withdrew consent|0|||
127624471|NCT00023673|459248317|FG002|Overall Study|Patient withdrew consent|0|||
127624472|NCT00023673|459248318|FG003|Overall Study|Patient withdrew consent|1|||
127624473|NCT02453594|459248322|FG000|Overall Study|Protocol Violation|0|||
127624474|NCT02453594|459248323|FG001|Overall Study|Protocol Violation|0|||
127624475|NCT02453594|459248324|FG002|Overall Study|Protocol Violation|1|||
127624476|NCT02453594|459248322|FG000|Overall Study|Cohort Was Closed|17|||
127624477|NCT02453594|459248323|FG001|Overall Study|Cohort Was Closed|21|||
127624478|NCT02453594|459248324|FG002|Overall Study|Cohort Was Closed|14|||
127624479|NCT02453594|459248322|FG000|Overall Study|Death|20|||
127624480|NCT02453594|459248323|FG001|Overall Study|Death|24|||
127624481|NCT02453594|459248324|FG002|Overall Study|Death|16|||
127624482|NCT02453594|459248322|FG000|Overall Study|Lost to Follow-up|6|||
127624483|NCT02453594|459248323|FG001|Overall Study|Lost to Follow-up|14|||
127624484|NCT02453594|459248324|FG002|Overall Study|Lost to Follow-up|2|||
127624485|NCT02453594|459248322|FG000|Overall Study|Physician Decision|2|||
127624486|NCT02453594|459248323|FG001|Overall Study|Physician Decision|4|||
127624487|NCT02453594|459248324|FG002|Overall Study|Physician Decision|0|||
127624488|NCT02453594|459248322|FG000|Overall Study|Site Terminated by Sponsor|1|||
127624489|NCT02453594|459248323|FG001|Overall Study|Site Terminated by Sponsor|0|||
127624490|NCT02453594|459248324|FG002|Overall Study|Site Terminated by Sponsor|1|||
127624491|NCT02453594|459248322|FG000|Overall Study|Transitioned to Extension Study|16|||
127624492|NCT02453594|459248323|FG001|Overall Study|Transitioned to Extension Study|9|||
127624493|NCT02453594|459248324|FG002|Overall Study|Transitioned to Extension Study|16|||
127624494|NCT02453594|459248322|FG000|Overall Study|Withdrawal by Subject|7|||
127624495|NCT02453594|459248323|FG001|Overall Study|Withdrawal by Subject|9|||
127624496|NCT02453594|459248324|FG002|Overall Study|Withdrawal by Subject|11|||
127624497|NCT02086591|459248325|FG000|Overall Study|Adverse Event|1|||
127624498|NCT02086591|459248325|FG000|Overall Study|Withdrawal by Subject|1|||
127624499|NCT02086591|459248325|FG000|Overall Study|protocol terminated|3|||
127624500|NCT02660359|459248330|FG000|Overall Study|Protocol Deviation|0|||
127624501|NCT02660359|459248331|FG001|Overall Study|Protocol Deviation|0|||
127624502|NCT02660359|459248332|FG002|Overall Study|Protocol Deviation|1|||
127624503|NCT02660359|459248330|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
127624504|NCT02660359|459248331|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
127624505|NCT02660359|459248332|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
127624506|NCT02660359|459248330|FG000|Overall Study|Lack of Efficacy|1|||
127624507|NCT02660359|459248331|FG001|Overall Study|Lack of Efficacy|1|||
127624508|NCT02660359|459248332|FG002|Overall Study|Lack of Efficacy|1|||
127624509|NCT02660359|459248330|FG000|Overall Study|Adverse Event|0|||
127624510|NCT02660359|459248331|FG001|Overall Study|Adverse Event|1|||
127792625|NCT00874120|459867341|FG000|Second Intervention|Withdrawal by Subject|1|||
127792626|NCT00874120|459867342|FG001|Second Intervention|Withdrawal by Subject|0|||
127792627|NCT00874120|459867341|FG000|Second Intervention|Protocol Violation|1|||
127792628|NCT00874120|459867342|FG001|Second Intervention|Protocol Violation|0|||
127792629|NCT01823679|459867343|FG000|Overall Study|Death|1|||
127792630|NCT02164981|459867344|FG000|Started|Withdrawal by Subject|2|||
127792631|NCT02164981|459867345|FG001|Started|Withdrawal by Subject|1|||
127792632|NCT02164981|459867346|FG002|Started|Withdrawal by Subject|0|||
127792633|NCT02164981|459867344|FG000|Started|Protocol Violation|2|||
127792634|NCT02164981|459867345|FG001|Started|Protocol Violation|0|||
127792635|NCT02164981|459867346|FG002|Started|Protocol Violation|0|||
127792636|NCT02164981|459867344|FG000|Started|Adverse Event|1|||
127792637|NCT02164981|459867345|FG001|Started|Adverse Event|2|||
127792638|NCT02164981|459867346|FG002|Started|Adverse Event|0|||
127792639|NCT02164981|459867344|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
127624511|NCT02660359|459248332|FG002|Overall Study|Adverse Event|0|||
127624512|NCT02660359|459248330|FG000|Overall Study|Other|2|||
127624513|NCT02660359|459248331|FG001|Overall Study|Other|1|||
127624514|NCT02660359|459248332|FG002|Overall Study|Other|3|||
127792640|NCT02164981|459867345|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
127792641|NCT02164981|459867346|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
127885174|NCT03118765|460203848|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
127624515|NCT02660359|459248330|FG000|Overall Study|Withdrawal by Subject|7|||
127624516|NCT02660359|459248331|FG001|Overall Study|Withdrawal by Subject|5|||
127624517|NCT02660359|459248332|FG002|Overall Study|Withdrawal by Subject|8|||
127624518|NCT02660359|459248330|FG000|Overall Study|Lost to Follow-up|3|||
127624519|NCT02660359|459248331|FG001|Overall Study|Lost to Follow-up|3|||
127624520|NCT02660359|459248332|FG002|Overall Study|Lost to Follow-up|0|||
127642696|NCT03492281|459313112|FG000|Overall Study|Adverse Event|6|||
127792642|NCT02164981|459867344|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
127792643|NCT02164981|459867345|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
127701400|NCT04499924|459535163|FG000|Overall Study|Withdrawal by Subject|1|||
127701401|NCT04499924|459535164|FG001|Overall Study|Withdrawal by Subject|3|||
127701402|NCT05144009|459535165|FG000|Overall Study|Lost to Follow-up|0|||
127701403|NCT05144009|459535166|FG001|Overall Study|Lost to Follow-up|1|||
127701404|NCT05144009|459535165|FG000|Overall Study|Study Termination by the Sponsor|11|||
127701405|NCT05144009|459535166|FG001|Overall Study|Study Termination by the Sponsor|11|||
127701406|NCT05144009|459535165|FG000|Overall Study|Disease Progression|1|||
127701407|NCT05144009|459535166|FG001|Overall Study|Disease Progression|0|||
127701408|NCT05144009|459535165|FG000|Overall Study|Participant Decision|0|||
127701409|NCT05144009|459535166|FG001|Overall Study|Participant Decision|2|||
127701410|NCT05144009|459535165|FG000|Overall Study|Death|5|||
127701411|NCT05144009|459535166|FG001|Overall Study|Death|10|||
127701412|NCT01648023|459535171|FG000|Overall Study|Screen Fail Post Randomization|1|||
127701413|NCT01648023|459535172|FG001|Overall Study|Screen Fail Post Randomization|2|||
127701414|NCT04599062|459535180|FG000|Overall Study|Physician Decision|1|||
127701415|NCT04599062|459535181|FG001|Overall Study|Physician Decision|0|||
127701416|NCT04074759|459535183|FG000|Overall Study|Withdrawal by Subject|0|||
127701417|NCT04074759|459535184|FG001|Overall Study|Withdrawal by Subject|0|||
127701418|NCT04074759|459535185|FG002|Overall Study|Withdrawal by Subject|0|||
127701419|NCT04074759|459535186|FG003|Overall Study|Withdrawal by Subject|0|||
127701420|NCT04074759|459535187|FG004|Overall Study|Withdrawal by Subject|0|||
127701421|NCT04074759|459535188|FG005|Overall Study|Withdrawal by Subject|2|||
127701422|NCT04074759|459535189|FG006|Overall Study|Withdrawal by Subject|0|||
127701423|NCT04074759|459535190|FG007|Overall Study|Withdrawal by Subject|2|||
127701424|NCT04074759|459535191|FG008|Overall Study|Withdrawal by Subject|1|||
127701425|NCT04074759|459535192|FG009|Overall Study|Withdrawal by Subject|2|||
127701426|NCT04074759|459535193|FG010|Overall Study|Withdrawal by Subject|9|||
127701427|NCT04074759|459535194|FG011|Overall Study|Withdrawal by Subject|2|||
127701428|NCT04074759|459535195|FG012|Overall Study|Withdrawal by Subject|1|||
127701429|NCT04074759|459535196|FG013|Overall Study|Withdrawal by Subject|3|||
127701430|NCT04074759|459535197|FG014|Overall Study|Withdrawal by Subject|2|||
127701431|NCT04074759|459535198|FG015|Overall Study|Withdrawal by Subject|0|||
127701432|NCT04074759|459535199|FG016|Overall Study|Withdrawal by Subject|0|||
127701433|NCT04074759|459535200|FG017|Overall Study|Withdrawal by Subject|3|||
127701434|NCT04074759|459535201|FG018|Overall Study|Withdrawal by Subject|1|||
127701435|NCT04074759|459535183|FG000|Overall Study|Death|1|||
127701436|NCT04074759|459535184|FG001|Overall Study|Death|0|||
127701437|NCT04074759|459535185|FG002|Overall Study|Death|1|||
127701438|NCT04074759|459535186|FG003|Overall Study|Death|1|||
127701439|NCT04074759|459535187|FG004|Overall Study|Death|2|||
127701440|NCT04074759|459535188|FG005|Overall Study|Death|0|||
127701441|NCT04074759|459535189|FG006|Overall Study|Death|1|||
127701442|NCT04074759|459535190|FG007|Overall Study|Death|0|||
127701443|NCT04074759|459535191|FG008|Overall Study|Death|3|||
127701444|NCT04074759|459535192|FG009|Overall Study|Death|2|||
127701445|NCT04074759|459535193|FG010|Overall Study|Death|4|||
127701446|NCT04074759|459535194|FG011|Overall Study|Death|1|||
127701447|NCT04074759|459535195|FG012|Overall Study|Death|0|||
127701448|NCT04074759|459535196|FG013|Overall Study|Death|2|||
127701449|NCT04074759|459535197|FG014|Overall Study|Death|1|||
127701450|NCT04074759|459535198|FG015|Overall Study|Death|0|||
127701451|NCT04074759|459535199|FG016|Overall Study|Death|1|||
127701452|NCT04074759|459535200|FG017|Overall Study|Death|0|||
127701453|NCT04074759|459535201|FG018|Overall Study|Death|1|||
127701454|NCT04074759|459535183|FG000|Overall Study|Lost to Follow-up|0|||
127885175|NCT03118765|460203849|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
127885176|NCT03118765|460203850|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
127885177|NCT03118765|460203851|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
127885178|NCT03118765|460203852|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
127885179|NCT03118765|460203848|FG000|Overall Study|COPD Exacerbation|1|||
127885180|NCT03118765|460203849|FG001|Overall Study|COPD Exacerbation|0|||
127885181|NCT03118765|460203850|FG002|Overall Study|COPD Exacerbation|0|||
127701455|NCT04074759|459535184|FG001|Overall Study|Lost to Follow-up|0|||
127701456|NCT04074759|459535185|FG002|Overall Study|Lost to Follow-up|0|||
127701457|NCT04074759|459535186|FG003|Overall Study|Lost to Follow-up|0|||
127701458|NCT04074759|459535187|FG004|Overall Study|Lost to Follow-up|0|||
127701459|NCT04074759|459535188|FG005|Overall Study|Lost to Follow-up|0|||
127701460|NCT04074759|459535189|FG006|Overall Study|Lost to Follow-up|0|||
127701461|NCT04074759|459535190|FG007|Overall Study|Lost to Follow-up|0|||
127701462|NCT04074759|459535191|FG008|Overall Study|Lost to Follow-up|0|||
127701463|NCT04074759|459535192|FG009|Overall Study|Lost to Follow-up|0|||
127701464|NCT04074759|459535193|FG010|Overall Study|Lost to Follow-up|1|||
127701465|NCT04074759|459535194|FG011|Overall Study|Lost to Follow-up|0|||
127701466|NCT04074759|459535195|FG012|Overall Study|Lost to Follow-up|0|||
127701467|NCT04074759|459535196|FG013|Overall Study|Lost to Follow-up|0|||
127701468|NCT04074759|459535197|FG014|Overall Study|Lost to Follow-up|0|||
127792644|NCT02164981|459867346|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
127792645|NCT02164981|459867344|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
127792646|NCT02164981|459867345|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
127792647|NCT02164981|459867346|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
127792648|NCT02404103|459867347|FG000|Overall Study|Adverse Event|1|||
127792649|NCT02404103|459867348|FG001|Overall Study|Adverse Event|0|||
127792650|NCT02404103|459867347|FG000|Overall Study|Lost to Follow-up|3|||
127792651|NCT02404103|459867348|FG001|Overall Study|Lost to Follow-up|3|||
127624521|NCT04101526|459248336|FG000|Overall Study|Did not complete all sleep diary entries|0|||
127624522|NCT04101526|459248337|FG001|Overall Study|Did not complete all sleep diary entries|1|||
127624523|NCT00424372|459248338|FG000|Overall Study|Death|1|||
127624524|NCT00424372|459248338|FG000|Overall Study|Adverse Event|18|||
127624525|NCT00424372|459248338|FG000|Overall Study|Lack of Efficacy|6|||
127624526|NCT00424372|459248338|FG000|Overall Study|Withdrawal by Subject|4|||
127624527|NCT00424372|459248338|FG000|Overall Study|Protocol Violation|1|||
127624528|NCT00424372|459248338|FG000|Overall Study|Health deterioration|1|||
127624529|NCT04622254|459248339|FG000|Main Period (Up to 22 Weeks)|Adverse Event|0|||
127624530|NCT04622254|459248340|FG001|Main Period (Up to 22 Weeks)|Adverse Event|1|||
127624531|NCT04622254|459248341|FG002|Main Period (Up to 22 Weeks)|Adverse Event|0|||
127624532|NCT04622254|459248342|FG003|Main Period (Up to 22 Weeks)|Adverse Event|0|||
127624533|NCT04622254|459248343|FG004|Main Period (Up to 22 Weeks)|Adverse Event|0|||
127624534|NCT04622254|459248344|FG005|Main Period (Up to 22 Weeks)|Adverse Event|0|||
127624535|NCT04622254|459248339|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
127624536|NCT04622254|459248340|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
127624537|NCT04622254|459248341|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
127624538|NCT04622254|459248342|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
127624539|NCT04622254|459248343|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
127624540|NCT04622254|459248344|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
127624541|NCT04622254|459248339|FG000|Main Period (Up to 22 Weeks)|Protocol Violation|1|||
127624542|NCT04622254|459248340|FG001|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
127624543|NCT04622254|459248341|FG002|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
127624544|NCT04622254|459248342|FG003|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
127792652|NCT00328627|459867349|FG000|Overall Study|Hyperglycemic Rescue|41|||
127792653|NCT00328627|459867350|FG001|Overall Study|Hyperglycemic Rescue|18|||
127792654|NCT00328627|459867351|FG002|Overall Study|Hyperglycemic Rescue|16|||
127792655|NCT00328627|459867352|FG003|Overall Study|Hyperglycemic Rescue|13|||
127792656|NCT00328627|459867353|FG004|Overall Study|Hyperglycemic Rescue|6|||
127792657|NCT00328627|459867354|FG005|Overall Study|Hyperglycemic Rescue|5|||
127792658|NCT00328627|459867355|FG006|Overall Study|Hyperglycemic Rescue|19|||
127792659|NCT00328627|459867356|FG007|Overall Study|Hyperglycemic Rescue|6|||
127792660|NCT00328627|459867357|FG008|Overall Study|Hyperglycemic Rescue|6|||
127792661|NCT00328627|459867358|FG009|Overall Study|Hyperglycemic Rescue|11|||
127792662|NCT00328627|459867359|FG010|Overall Study|Hyperglycemic Rescue|3|||
127792663|NCT00328627|459867360|FG011|Overall Study|Hyperglycemic Rescue|2|||
127792664|NCT00328627|459867349|FG000|Overall Study|Adverse Event|3|||
127792665|NCT00328627|459867350|FG001|Overall Study|Adverse Event|1|||
127792666|NCT00328627|459867351|FG002|Overall Study|Adverse Event|2|||
127792667|NCT00328627|459867352|FG003|Overall Study|Adverse Event|3|||
127792668|NCT00328627|459867353|FG004|Overall Study|Adverse Event|1|||
127792669|NCT00328627|459867354|FG005|Overall Study|Adverse Event|2|||
127792670|NCT00328627|459867355|FG006|Overall Study|Adverse Event|1|||
127792671|NCT00328627|459867356|FG007|Overall Study|Adverse Event|2|||
127792672|NCT00328627|459867357|FG008|Overall Study|Adverse Event|0|||
127792673|NCT00328627|459867358|FG009|Overall Study|Adverse Event|7|||
127624545|NCT04622254|459248343|FG004|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
127624546|NCT04622254|459248344|FG005|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
127624547|NCT04622254|459248339|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
127624548|NCT04622254|459248340|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|2|||
127624549|NCT04622254|459248341|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
127624550|NCT04622254|459248342|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
127624551|NCT04622254|459248343|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
127624552|NCT04622254|459248344|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
127624553|NCT04622254|459248339|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
127624554|NCT04622254|459248340|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
127624555|NCT04622254|459248341|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
127624556|NCT04622254|459248342|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|1|||
127624557|NCT04622254|459248343|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
127792674|NCT00328627|459867359|FG010|Overall Study|Adverse Event|5|||
127792675|NCT00328627|459867360|FG011|Overall Study|Adverse Event|4|||
127792676|NCT00328627|459867349|FG000|Overall Study|Protocol Violation|2|||
127792677|NCT00328627|459867350|FG001|Overall Study|Protocol Violation|2|||
127792678|NCT00328627|459867351|FG002|Overall Study|Protocol Violation|2|||
127792679|NCT00328627|459867352|FG003|Overall Study|Protocol Violation|8|||
127792680|NCT00328627|459867353|FG004|Overall Study|Protocol Violation|5|||
127792681|NCT00328627|459867354|FG005|Overall Study|Protocol Violation|5|||
127792682|NCT00328627|459867355|FG006|Overall Study|Protocol Violation|6|||
127792683|NCT00328627|459867356|FG007|Overall Study|Protocol Violation|2|||
127792684|NCT00328627|459867357|FG008|Overall Study|Protocol Violation|1|||
127624558|NCT04622254|459248344|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
127624559|NCT04622254|459248339|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
127624560|NCT04622254|459248340|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
127624561|NCT04622254|459248341|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
127624562|NCT04622254|459248342|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|3|||
127624563|NCT04622254|459248343|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
127624564|NCT04622254|459248344|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
127624565|NCT04622254|459248339|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
127624566|NCT04622254|459248340|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
127624567|NCT04622254|459248341|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
127624568|NCT04622254|459248342|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
127624569|NCT04622254|459248343|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
127624570|NCT04622254|459248344|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
127624571|NCT04622254|459248339|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
127624572|NCT04622254|459248340|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
127624573|NCT04622254|459248341|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
127624574|NCT04622254|459248342|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
127624575|NCT04622254|459248343|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
127624576|NCT04622254|459248344|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
127624577|NCT04622254|459248339|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
127624578|NCT04622254|459248340|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
127624579|NCT04622254|459248341|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
127624580|NCT04622254|459248342|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|1|||
127624581|NCT04622254|459248343|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|9|||
127624582|NCT04622254|459248344|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|3|||
127624583|NCT04622254|459248339|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
127624584|NCT04622254|459248340|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
127624585|NCT04622254|459248341|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
127624586|NCT04622254|459248342|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|1|||
127624587|NCT04622254|459248343|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|5|||
127624588|NCT04622254|459248344|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
127624589|NCT04622254|459248339|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
127624590|NCT04622254|459248340|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
127624591|NCT04622254|459248341|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
127624592|NCT04622254|459248342|FG003|OLEX Period (Up to 39 Weeks)|Other|0|||
127624593|NCT04622254|459248343|FG004|OLEX Period (Up to 39 Weeks)|Other|0|||
127624594|NCT04622254|459248344|FG005|OLEX Period (Up to 39 Weeks)|Other|2|||
127624595|NCT02652624|459248345|FG000|Randomized Phase|Pregnancy|3|||
127624596|NCT02652624|459248346|FG001|Randomized Phase|Pregnancy|1|||
127624597|NCT02652624|459248345|FG000|Randomized Phase|Investigator's Discretion|0|||
127624598|NCT02652624|459248346|FG001|Randomized Phase|Investigator's Discretion|2|||
127624599|NCT02652624|459248345|FG000|Randomized Phase|Death|0|||
127624600|NCT02652624|459248346|FG001|Randomized Phase|Death|1|||
127624601|NCT02652624|459248345|FG000|Randomized Phase|Lost to Follow-up|0|||
127624602|NCT02652624|459248346|FG001|Randomized Phase|Lost to Follow-up|1|||
127624603|NCT02652624|459248345|FG000|Extension Phase|Lost to Follow-up|3|||
127624604|NCT02652624|459248346|FG001|Extension Phase|Lost to Follow-up|1|||
127624605|NCT02652624|459248345|FG000|Extension Phase|Pregnancy|1|||
127624606|NCT02652624|459248346|FG001|Extension Phase|Pregnancy|1|||
127624607|NCT02652624|459248345|FG000|Extension Phase|Adverse Event|0|||
127624608|NCT02652624|459248346|FG001|Extension Phase|Adverse Event|1|||
127624609|NCT02652624|459248345|FG000|Extension Phase|Withdrew Consent|0|||
127624610|NCT02652624|459248346|FG001|Extension Phase|Withdrew Consent|1|||
127624611|NCT01023659|459248347|FG000|Overall Study|Lost to Follow-up|73|||
127624612|NCT01023659|459248348|FG001|Overall Study|Lost to Follow-up|228|||
127624613|NCT01023659|459248349|FG002|Overall Study|Lost to Follow-up|99|||
127624614|NCT00912405|459248350|FG000|Overall Study|Lost to Follow-up|5|||
127624615|NCT01797536|459248353|FG000|Overall Study|Adverse Event|0|||
127624616|NCT01797536|459248354|FG001|Overall Study|Adverse Event|1|||
127624617|NCT01797536|459248355|FG002|Overall Study|Adverse Event|0|||
127624618|NCT01797536|459248356|FG003|Overall Study|Adverse Event|0|||
127792685|NCT00328627|459867358|FG009|Overall Study|Protocol Violation|4|||
127624619|NCT00501540|459248357|FG000|Overall Study|Death|5|||
127624620|NCT00098839|459248358|FG000|Overall Study|Adverse Event|5|||
127624621|NCT00098839|459248359|FG001|Overall Study|Adverse Event|2|||
127624622|NCT00098839|459248358|FG000|Overall Study|Death|1|||
127792686|NCT00328627|459867359|FG010|Overall Study|Protocol Violation|6|||
127624623|NCT00098839|459248359|FG001|Overall Study|Death|2|||
127624624|NCT00098839|459248358|FG000|Overall Study|Physician Decision|4|||
127624625|NCT00098839|459248359|FG001|Overall Study|Physician Decision|14|||
127624626|NCT00098839|459248358|FG000|Overall Study|Withdrawal by Subject|1|||
127624627|NCT00098839|459248359|FG001|Overall Study|Withdrawal by Subject|0|||
127624628|NCT00098839|459248358|FG000|Overall Study|Refusal of further protocol therapy|3|||
127624629|NCT00098839|459248359|FG001|Overall Study|Refusal of further protocol therapy|1|||
127624630|NCT00098839|459248358|FG000|Overall Study|Relapse|6|||
127624631|NCT00098839|459248359|FG001|Overall Study|Relapse|3|||
127624632|NCT00098839|459248358|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
127624633|NCT00098839|459248359|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
127624634|NCT00098839|459248358|FG000|Overall Study|Ineligible|2|||
127624635|NCT00098839|459248359|FG001|Overall Study|Ineligible|0|||
127624636|NCT03228680|459248361|FG000|Overall Study|Adverse Event|13|||
127624637|NCT03228680|459248362|FG001|Overall Study|Adverse Event|18|||
127624638|NCT03228680|459248361|FG000|Overall Study|Randomization failure|0|||
127624639|NCT03228680|459248362|FG001|Overall Study|Randomization failure|1|||
127624640|NCT03228680|459248361|FG000|Overall Study|Withdrawal by Subject|1|||
127624641|NCT03228680|459248362|FG001|Overall Study|Withdrawal by Subject|0|||
127624642|NCT03228680|459248361|FG000|Overall Study|Other|9|||
127624643|NCT03228680|459248362|FG001|Overall Study|Other|16|||
127624644|NCT02148003|459248363|FG000|Overall Study|Failed inclusion criteria|1|||
127624645|NCT02148003|459248364|FG001|Overall Study|Failed inclusion criteria|0|||
127624646|NCT02148003|459248363|FG000|Overall Study|Met exclusion criteria|0|||
127624647|NCT02148003|459248364|FG001|Overall Study|Met exclusion criteria|1|||
127624648|NCT02148003|459248363|FG000|Overall Study|Withdrawal by Subject|0|||
127624649|NCT02148003|459248364|FG001|Overall Study|Withdrawal by Subject|1|||
127624650|NCT02489981|459248365|FG000|Overall Study|Adverse Event|21|||
127624651|NCT02489981|459248365|FG000|Overall Study|Insufficient effectiveness|16|||
127624652|NCT02489981|459248365|FG000|Overall Study|Improved|31|||
127624653|NCT02489981|459248365|FG000|Overall Study|Lost to Follow-up|31|||
127624654|NCT02489981|459248365|FG000|Overall Study|Other than listed|28|||
127624655|NCT00796861|459248366|FG000|Overall Study|Withdrawal by Subject|2|||
127624656|NCT00796861|459248366|FG000|Overall Study|Death|2|||
127624657|NCT03852316|459248369|FG000|Overall Study|Protocol Violation|1|||
127624658|NCT03852316|459248369|FG000|Overall Study|Withdrawal by Subject|2|||
127624659|NCT03852316|459248369|FG000|Overall Study|Enrolled but Device not Utilized|1|||
127624660|NCT03286140|459248371|FG000|Overall Study|Withdrawal by Subject|10|||
127624661|NCT03286140|459248372|FG001|Overall Study|Withdrawal by Subject|5|||
127624662|NCT03286140|459248371|FG000|Overall Study|Lost to Follow-up|5|||
127624663|NCT03286140|459248372|FG001|Overall Study|Lost to Follow-up|10|||
127624664|NCT03286140|459248371|FG000|Overall Study|Failure to comply|0|||
127792687|NCT00328627|459867360|FG011|Overall Study|Protocol Violation|2|||
127792688|NCT00328627|459867349|FG000|Overall Study|Lost to Follow-up|4|||
127792689|NCT00328627|459867350|FG001|Overall Study|Lost to Follow-up|2|||
127792690|NCT00328627|459867351|FG002|Overall Study|Lost to Follow-up|2|||
127792691|NCT00328627|459867352|FG003|Overall Study|Lost to Follow-up|4|||
127792692|NCT00328627|459867353|FG004|Overall Study|Lost to Follow-up|0|||
127792693|NCT00328627|459867354|FG005|Overall Study|Lost to Follow-up|2|||
127792694|NCT00328627|459867355|FG006|Overall Study|Lost to Follow-up|3|||
127792695|NCT00328627|459867356|FG007|Overall Study|Lost to Follow-up|0|||
127792696|NCT00328627|459867357|FG008|Overall Study|Lost to Follow-up|3|||
127792697|NCT00328627|459867358|FG009|Overall Study|Lost to Follow-up|2|||
127792698|NCT00328627|459867359|FG010|Overall Study|Lost to Follow-up|0|||
127792699|NCT00328627|459867360|FG011|Overall Study|Lost to Follow-up|1|||
127792700|NCT00328627|459867349|FG000|Overall Study|Withdrawal by Subject|5|||
127792701|NCT00328627|459867350|FG001|Overall Study|Withdrawal by Subject|4|||
127792702|NCT00328627|459867351|FG002|Overall Study|Withdrawal by Subject|5|||
127792703|NCT00328627|459867352|FG003|Overall Study|Withdrawal by Subject|6|||
127792704|NCT00328627|459867353|FG004|Overall Study|Withdrawal by Subject|2|||
127792705|NCT00328627|459867354|FG005|Overall Study|Withdrawal by Subject|5|||
127792706|NCT00328627|459867355|FG006|Overall Study|Withdrawal by Subject|4|||
127792707|NCT00328627|459867356|FG007|Overall Study|Withdrawal by Subject|4|||
127624665|NCT03286140|459248372|FG001|Overall Study|Failure to comply|1|||
127624666|NCT01565291|459248373|FG000|Overall Study|Withdrawal by Subject|1|||
127624667|NCT01565291|459248374|FG001|Overall Study|Withdrawal by Subject|0|||
127792708|NCT00328627|459867357|FG008|Overall Study|Withdrawal by Subject|4|||
127792709|NCT00328627|459867358|FG009|Overall Study|Withdrawal by Subject|5|||
127792710|NCT00328627|459867359|FG010|Overall Study|Withdrawal by Subject|2|||
127792711|NCT00328627|459867360|FG011|Overall Study|Withdrawal by Subject|7|||
127792712|NCT00328627|459867349|FG000|Overall Study|Pregnancy|0|||
127792713|NCT00328627|459867350|FG001|Overall Study|Pregnancy|1|||
127792714|NCT00328627|459867351|FG002|Overall Study|Pregnancy|0|||
127792715|NCT00328627|459867352|FG003|Overall Study|Pregnancy|0|||
127792716|NCT00328627|459867353|FG004|Overall Study|Pregnancy|0|||
127792717|NCT00328627|459867354|FG005|Overall Study|Pregnancy|0|||
127792718|NCT00328627|459867355|FG006|Overall Study|Pregnancy|0|||
127792719|NCT00328627|459867356|FG007|Overall Study|Pregnancy|0|||
127792720|NCT00328627|459867357|FG008|Overall Study|Pregnancy|0|||
127624668|NCT00515827|459248375|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
127624669|NCT00515827|459248376|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
127624670|NCT00515827|459248375|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
127624671|NCT00515827|459248376|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
127624672|NCT03149237|459248391|FG000|Overall Study|Withdrawal by Subject|4|||
127624673|NCT03149237|459248392|FG001|Overall Study|Withdrawal by Subject|5|||
127624674|NCT01466192|459248393|FG000|Overall Study|Physician Decision|1|||
127624675|NCT01466192|459248393|FG000|Overall Study|Withdrawal by Subject|3|||
127624676|NCT01227512|459248396|FG000|Overall Study|Physician Decision|6|||
127624677|NCT01227512|459248397|FG001|Overall Study|Physician Decision|6|||
127624678|NCT01227512|459248396|FG000|Overall Study|Adverse Event|4|||
127624679|NCT01227512|459248397|FG001|Overall Study|Adverse Event|3|||
127624680|NCT01227512|459248396|FG000|Overall Study|Withdrawal by Subject|3|||
127624681|NCT01227512|459248397|FG001|Overall Study|Withdrawal by Subject|0|||
127624682|NCT01227512|459248396|FG000|Overall Study|Participant met withdrawal criteria|0|||
127624683|NCT01227512|459248397|FG001|Overall Study|Participant met withdrawal criteria|1|||
127624684|NCT04055116|459248398|FG000|First Intervention|Physician Decision|2|||
127624685|NCT04055116|459248399|FG001|First Intervention|Physician Decision|7|||
127624686|NCT02774681|459248406|FG000|Treatment on Study|Progressive Disease|7|||
127624687|NCT02774681|459248406|FG000|Follow-Up for 3 Years|Death|11|||
127624688|NCT02774681|459248406|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
127624689|NCT00512096|459248407|FG000|Overall Study|Adverse Event|2|||
127624690|NCT00512096|459248407|FG000|Overall Study|Withdrawal by Subject|2|||
127624691|NCT00512096|459248407|FG000|Overall Study|Lack of Efficacy|3|||
127624692|NCT01069289|459248408|FG000|Overall Study|Withdrawal by Subject|15|||
127624693|NCT01069289|459248409|FG001|Overall Study|Withdrawal by Subject|26|||
127624694|NCT01069289|459248408|FG000|Overall Study|Adverse Event|21|||
127624695|NCT01069289|459248409|FG001|Overall Study|Adverse Event|28|||
127624696|NCT01069289|459248408|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
127624697|NCT01069289|459248409|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
127624698|NCT01069289|459248408|FG000|Overall Study|Severe non-compliance to protocol|3|||
127624699|NCT01069289|459248409|FG001|Overall Study|Severe non-compliance to protocol|2|||
127624700|NCT01069289|459248408|FG000|Overall Study|Due to deteriorating health condition|1|||
127624701|NCT01069289|459248409|FG001|Overall Study|Due to deteriorating health condition|0|||
127624702|NCT02696096|459248410|FG000|Overall Study|ruled out at screening|1|||
127624703|NCT02696096|459248410|FG000|Overall Study|did not attend second fMRI|1|||
127624704|NCT02047604|459248411|FG000|Overall Study|Withdrawal by Subject|0|||
127624705|NCT02047604|459248412|FG001|Overall Study|Withdrawal by Subject|0|||
127624706|NCT02047604|459248413|FG002|Overall Study|Withdrawal by Subject|0|||
127624707|NCT02047604|459248414|FG003|Overall Study|Withdrawal by Subject|0|||
127624708|NCT02047604|459248415|FG004|Overall Study|Withdrawal by Subject|1|||
127624709|NCT02047604|459248416|FG005|Overall Study|Withdrawal by Subject|1|||
127624710|NCT04035486|459248419|FG000|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|7|||
127624711|NCT04035486|459248420|FG001|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|10|||
127624712|NCT04035486|459248421|FG002|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|197|||
127624713|NCT04035486|459248422|FG003|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|191|||
127624714|NCT04035486|459248419|FG000|Overall Study|Death|6|||
127624715|NCT04035486|459248420|FG001|Overall Study|Death|3|||
127624716|NCT04035486|459248421|FG002|Overall Study|Death|70|||
127624717|NCT04035486|459248422|FG003|Overall Study|Death|77|||
127624718|NCT04035486|459248419|FG000|Overall Study|Screen Failure|0|||
127624719|NCT04035486|459248420|FG001|Overall Study|Screen Failure|0|||
127624720|NCT04035486|459248421|FG002|Overall Study|Screen Failure|1|||
127624721|NCT04035486|459248422|FG003|Overall Study|Screen Failure|1|||
127624722|NCT04035486|459248419|FG000|Overall Study|Withdrawal by Subject|1|||
127624723|NCT04035486|459248420|FG001|Overall Study|Withdrawal by Subject|1|||
127624724|NCT04035486|459248421|FG002|Overall Study|Withdrawal by Subject|11|||
127624725|NCT04035486|459248422|FG003|Overall Study|Withdrawal by Subject|9|||
127624726|NCT02212730|459249899|FG000|Overall Study|Tumor not of the required cell histology|1|||
127624727|NCT02212730|459249900|FG001|Overall Study|Tumor not of the required cell histology|0|||
127624728|NCT02212730|459249899|FG000|Overall Study|Withdrawal by Subject|1|||
127624729|NCT02212730|459249900|FG001|Overall Study|Withdrawal by Subject|0|||
127624730|NCT02212730|459249899|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
127624731|NCT02212730|459249900|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
127624732|NCT02932891|459249901|FG000|Overall Study|Lost to Follow-up|2|||
127624733|NCT02932891|459249901|FG000|Overall Study|HPA Suppress|2|||
127624734|NCT00451282|459249902|FG000|Overall Study|Lost to Follow-up|6|||
127624735|NCT00451282|459249903|FG001|Overall Study|Lost to Follow-up|5|||
127624736|NCT00577122|459249904|FG000|Overall Study|Adverse Event|0|||
127624737|NCT00577122|459249905|FG001|Overall Study|Adverse Event|2|||
127624738|NCT00577122|459249904|FG000|Overall Study|Progression, relapse during active trt|6|||
127624739|NCT00577122|459249905|FG001|Overall Study|Progression, relapse during active trt|8|||
127624740|NCT00577122|459249904|FG000|Overall Study|Prog, refract disease during active trt|8|||
127624741|NCT00577122|459249905|FG001|Overall Study|Prog, refract disease during active trt|5|||
127624742|NCT00577122|459249904|FG000|Overall Study|Alternative Therapy|0|||
127624743|NCT00577122|459249905|FG001|Overall Study|Alternative Therapy|1|||
127624744|NCT00529386|459249914|FG000|Overall Study|Lost to Follow-up|1|||
127624745|NCT04532112|459249915|FG000|Overall Study|Adverse Event|3|||
127624746|NCT04532112|459249916|FG001|Overall Study|Adverse Event|0|||
127624747|NCT03348904|459249917|FG000|Overall Study|Administrative reason by the sponsor|0|||
127624748|NCT03348904|459249918|FG001|Overall Study|Administrative reason by the sponsor|1|||
127624749|NCT03348904|459249919|FG002|Overall Study|Administrative reason by the sponsor|0|||
127624750|NCT02039427|459249925|FG000|Overall Study|Duration of surgery > 3h|1|||
127624751|NCT02039427|459249926|FG001|Overall Study|Duration of surgery > 3h|1|||
127624752|NCT02039427|459249927|FG002|Overall Study|Duration of surgery > 3h|0|||
127624753|NCT02039427|459249928|FG003|Overall Study|Duration of surgery > 3h|0|||
127624754|NCT02039427|459249925|FG000|Overall Study|Withdrawal on concent|0|||
127624755|NCT02039427|459249926|FG001|Overall Study|Withdrawal on concent|0|||
127624756|NCT02039427|459249927|FG002|Overall Study|Withdrawal on concent|0|||
127624757|NCT02039427|459249928|FG003|Overall Study|Withdrawal on concent|1|||
127624758|NCT02039427|459249925|FG000|Overall Study|Cancellation of surgery|0|||
127624759|NCT02039427|459249926|FG001|Overall Study|Cancellation of surgery|0|||
127624760|NCT02039427|459249927|FG002|Overall Study|Cancellation of surgery|1|||
127624761|NCT02039427|459249928|FG003|Overall Study|Cancellation of surgery|0|||
127792721|NCT00328627|459867358|FG009|Overall Study|Pregnancy|0|||
127624762|NCT02039427|459249925|FG000|Overall Study|Loss of follow - up|1|||
127624763|NCT02039427|459249926|FG001|Overall Study|Loss of follow - up|0|||
127624764|NCT02039427|459249927|FG002|Overall Study|Loss of follow - up|2|||
127624765|NCT02039427|459249928|FG003|Overall Study|Loss of follow - up|4|||
127792722|NCT00328627|459867359|FG010|Overall Study|Pregnancy|0|||
127624766|NCT02039427|459249925|FG000|Overall Study|Steroid Use|1|||
127624767|NCT02039427|459249926|FG001|Overall Study|Steroid Use|0|||
127624768|NCT02039427|459249927|FG002|Overall Study|Steroid Use|0|||
127624769|NCT02039427|459249928|FG003|Overall Study|Steroid Use|0|||
127624770|NCT04354831|459249929|FG000|Overall Study|No blood type specific convalescent plasma was available|0|||
127624771|NCT04354831|459249930|FG001|Overall Study|No blood type specific convalescent plasma was available|1|||
127624772|NCT02732847|459249931|FG000|Overall Study|some filled early|42|||
127624773|NCT02732847|459249932|FG001|Overall Study|some filled early|42|||
127624774|NCT02370888|459249933|FG000|Overall Study|disease progression|2|||
127624775|NCT02370888|459249933|FG000|Overall Study|did not meet chimerism criteria|6|||
127624776|NCT04574362|459249934|FG000|Overall Study|Other|0|||
127792723|NCT00328627|459867360|FG011|Overall Study|Pregnancy|0|||
127792724|NCT00328627|459867349|FG000|Overall Study|Physician Decision|4|||
127792725|NCT00328627|459867350|FG001|Overall Study|Physician Decision|3|||
127792726|NCT00328627|459867351|FG002|Overall Study|Physician Decision|1|||
127792727|NCT00328627|459867352|FG003|Overall Study|Physician Decision|2|||
127792728|NCT00328627|459867353|FG004|Overall Study|Physician Decision|1|||
127792729|NCT00328627|459867354|FG005|Overall Study|Physician Decision|1|||
127792730|NCT00328627|459867355|FG006|Overall Study|Physician Decision|1|||
127792731|NCT00328627|459867356|FG007|Overall Study|Physician Decision|0|||
127792732|NCT00328627|459867357|FG008|Overall Study|Physician Decision|3|||
127792733|NCT00328627|459867358|FG009|Overall Study|Physician Decision|2|||
127792734|NCT00328627|459867359|FG010|Overall Study|Physician Decision|1|||
127792735|NCT00328627|459867360|FG011|Overall Study|Physician Decision|0|||
127792736|NCT00328627|459867349|FG000|Overall Study|Other|0|||
127792737|NCT00328627|459867350|FG001|Overall Study|Other|0|||
127792738|NCT00328627|459867351|FG002|Overall Study|Other|0|||
127885182|NCT03118765|460203851|FG003|Overall Study|COPD Exacerbation|1|||
127624777|NCT04574362|459249935|FG001|Overall Study|Other|5|||
127624778|NCT04574362|459249934|FG000|Overall Study|COVID-19|0|||
127792739|NCT00328627|459867352|FG003|Overall Study|Other|1|||
127792740|NCT00328627|459867353|FG004|Overall Study|Other|0|||
127792741|NCT00328627|459867354|FG005|Overall Study|Other|0|||
127885183|NCT03118765|460203852|FG004|Overall Study|COPD Exacerbation|0|||
127792742|NCT00328627|459867355|FG006|Overall Study|Other|1|||
127792743|NCT00328627|459867356|FG007|Overall Study|Other|0|||
127624779|NCT04574362|459249935|FG001|Overall Study|COVID-19|1|||
127624780|NCT04574362|459249934|FG000|Overall Study|Adverse Event|1|||
127624781|NCT04574362|459249935|FG001|Overall Study|Adverse Event|1|||
127624782|NCT04574362|459249934|FG000|Overall Study|Withdrawal by Subject|2|||
127624783|NCT04574362|459249935|FG001|Overall Study|Withdrawal by Subject|4|||
127624784|NCT04574362|459249934|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
127624785|NCT04574362|459249935|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
127792744|NCT00328627|459867357|FG008|Overall Study|Other|0|||
127792745|NCT00328627|459867358|FG009|Overall Study|Other|1|||
127792746|NCT00328627|459867359|FG010|Overall Study|Other|1|||
127792747|NCT00328627|459867360|FG011|Overall Study|Other|0|||
127792748|NCT03311711|459867361|FG000|Overall Study|Death|1|||
127624786|NCT04574362|459249934|FG000|Overall Study|Participant refused to come to the hospital|1|||
127624787|NCT04574362|459249935|FG001|Overall Study|Participant refused to come to the hospital|0|||
127624788|NCT04574362|459249934|FG000|Overall Study|Participant refused the visit|1|||
127624789|NCT04574362|459249935|FG001|Overall Study|Participant refused the visit|0|||
127624790|NCT04574362|459249934|FG000|Overall Study|Participant quit early because of business trip|1|||
127624791|NCT04574362|459249935|FG001|Overall Study|Participant quit early because of business trip|0|||
127624792|NCT01060384|459249936|FG000|Overall Study|Withdrawal by Subject|0|||
127624793|NCT01060384|459249937|FG001|Overall Study|Withdrawal by Subject|1|||
127624794|NCT01060384|459249938|FG002|Overall Study|Withdrawal by Subject|0|||
127624795|NCT01060384|459249939|FG003|Overall Study|Withdrawal by Subject|0|||
127624796|NCT01060384|459249940|FG004|Overall Study|Withdrawal by Subject|0|||
127624797|NCT01060384|459249936|FG000|Overall Study|Death|0|||
127624798|NCT01060384|459249937|FG001|Overall Study|Death|0|||
127624799|NCT01060384|459249938|FG002|Overall Study|Death|0|||
127624800|NCT01060384|459249939|FG003|Overall Study|Death|0|||
127624801|NCT01060384|459249940|FG004|Overall Study|Death|1|||
127624802|NCT01060384|459249936|FG000|Overall Study|Intercurrent illness|0|||
127624803|NCT01060384|459249937|FG001|Overall Study|Intercurrent illness|0|||
127624804|NCT01060384|459249938|FG002|Overall Study|Intercurrent illness|0|||
127624805|NCT01060384|459249939|FG003|Overall Study|Intercurrent illness|0|||
127624806|NCT01060384|459249940|FG004|Overall Study|Intercurrent illness|1|||
127624807|NCT00812929|459249943|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
127624808|NCT00812929|459249944|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
127624809|NCT00812929|459249945|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
127624810|NCT00812929|459249946|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
127624811|NCT00812929|459249947|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
127624812|NCT00812929|459249948|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
127624813|NCT00812929|459249949|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
127624814|NCT00812929|459249950|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
127624815|NCT00812929|459249951|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
127624816|NCT00812929|459249952|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
127624817|NCT00812929|459249943|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
127624818|NCT00812929|459249944|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
127624819|NCT00812929|459249945|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
127624820|NCT00812929|459249946|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
127624821|NCT00812929|459249947|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
127624822|NCT00812929|459249948|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
127624823|NCT00812929|459249949|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
127624824|NCT00812929|459249950|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
127624825|NCT00812929|459249951|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
127624826|NCT00812929|459249952|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
127624827|NCT00812929|459249943|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
127624828|NCT00812929|459249944|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
127624829|NCT00812929|459249945|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
127624830|NCT00812929|459249946|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
127624831|NCT00812929|459249947|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
127624832|NCT00812929|459249948|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
127624833|NCT00812929|459249949|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
127624834|NCT00812929|459249950|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
127624835|NCT00812929|459249951|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
127624836|NCT00812929|459249952|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
127624837|NCT00211081|459249954|FG000|Overall Study|Withdrawal by Subject|2|||
127624838|NCT01332305|459249955|FG000|Overall Study|Adverse Event|1|||
127701469|NCT04074759|459535198|FG015|Overall Study|Lost to Follow-up|0|||
127624839|NCT01332305|459249956|FG001|Overall Study|Adverse Event|4|||
127624840|NCT01332305|459249957|FG002|Overall Study|Adverse Event|6|||
127624841|NCT01332305|459249958|FG003|Overall Study|Adverse Event|3|||
127624842|NCT01332305|459249959|FG004|Overall Study|Adverse Event|5|||
127701470|NCT04074759|459535199|FG016|Overall Study|Lost to Follow-up|1|||
127701471|NCT04074759|459535200|FG017|Overall Study|Lost to Follow-up|0|||
127701472|NCT04074759|459535201|FG018|Overall Study|Lost to Follow-up|1|||
127701473|NCT04074759|459535183|FG000|Overall Study|Other|0|||
127701474|NCT04074759|459535184|FG001|Overall Study|Other|1|||
127701475|NCT04074759|459535185|FG002|Overall Study|Other|1|||
127701476|NCT04074759|459535186|FG003|Overall Study|Other|0|||
127624843|NCT01332305|459249955|FG000|Overall Study|Withdrawal by Subject|6|||
127624844|NCT01332305|459249956|FG001|Overall Study|Withdrawal by Subject|5|||
127624845|NCT01332305|459249957|FG002|Overall Study|Withdrawal by Subject|4|||
127624846|NCT01332305|459249958|FG003|Overall Study|Withdrawal by Subject|1|||
127624847|NCT01332305|459249959|FG004|Overall Study|Withdrawal by Subject|0|||
127624848|NCT01332305|459249955|FG000|Overall Study|Lost to Follow-up|0|||
127624849|NCT01332305|459249956|FG001|Overall Study|Lost to Follow-up|2|||
127624850|NCT01332305|459249957|FG002|Overall Study|Lost to Follow-up|3|||
127701477|NCT04074759|459535187|FG004|Overall Study|Other|2|||
127701478|NCT04074759|459535188|FG005|Overall Study|Other|1|||
127624851|NCT01332305|459249958|FG003|Overall Study|Lost to Follow-up|2|||
127624852|NCT01332305|459249959|FG004|Overall Study|Lost to Follow-up|3|||
127624853|NCT01332305|459249955|FG000|Overall Study|Protocol Violation|1|||
127624854|NCT01332305|459249956|FG001|Overall Study|Protocol Violation|2|||
127624855|NCT01332305|459249957|FG002|Overall Study|Protocol Violation|1|||
127624856|NCT01332305|459249958|FG003|Overall Study|Protocol Violation|0|||
127624857|NCT01332305|459249959|FG004|Overall Study|Protocol Violation|3|||
127624858|NCT01332305|459249955|FG000|Overall Study|Withdrawal by Sponsor|1|||
127624859|NCT01332305|459249956|FG001|Overall Study|Withdrawal by Sponsor|0|||
127624860|NCT01332305|459249957|FG002|Overall Study|Withdrawal by Sponsor|0|||
127624861|NCT01332305|459249958|FG003|Overall Study|Withdrawal by Sponsor|1|||
127624862|NCT01332305|459249959|FG004|Overall Study|Withdrawal by Sponsor|1|||
127624863|NCT01332305|459249955|FG000|Overall Study|Treatment Failure|1|||
127624864|NCT01332305|459249956|FG001|Overall Study|Treatment Failure|1|||
127624865|NCT01332305|459249957|FG002|Overall Study|Treatment Failure|0|||
127624866|NCT01332305|459249958|FG003|Overall Study|Treatment Failure|0|||
127624867|NCT01332305|459249959|FG004|Overall Study|Treatment Failure|0|||
127624868|NCT01332305|459249955|FG000|Overall Study|Physician Decision|0|||
127624869|NCT01332305|459249956|FG001|Overall Study|Physician Decision|0|||
127624870|NCT01332305|459249957|FG002|Overall Study|Physician Decision|0|||
127624871|NCT01332305|459249958|FG003|Overall Study|Physician Decision|1|||
127624872|NCT01332305|459249959|FG004|Overall Study|Physician Decision|0|||
127624873|NCT04027686|459249960|FG000|Overall Study|Lost to Follow-up|2|||
127624874|NCT04027686|459249961|FG001|Overall Study|Lost to Follow-up|0|||
127624875|NCT04027686|459249960|FG000|Overall Study|Withdrawal by Subject|0|||
127624876|NCT04027686|459249961|FG001|Overall Study|Withdrawal by Subject|1|||
127624877|NCT03755765|459249968|FG000|Overall Study|Withdrawal by Subject|2|||
127624878|NCT03755765|459249969|FG001|Overall Study|Withdrawal by Subject|4|||
127624879|NCT03755765|459249970|FG002|Overall Study|Withdrawal by Subject|4|||
127624880|NCT02104557|459249971|FG000|Overall Study|Adverse Event|24|||
127624881|NCT02104557|459249971|FG000|Overall Study|Lost to Follow-up|34|||
127624882|NCT02104557|459249971|FG000|Overall Study|Violated the usage and dosage|14|||
127624883|NCT02104557|459249971|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
127624884|NCT02104557|459249971|FG000|Overall Study|Administered Sayana prior to the contract|1|||
127624885|NCT02104557|459249971|FG000|Overall Study|Other|17|||
127624886|NCT02104557|459249971|FG000|Overall Study|Change to other contraception methods|5|||
127624887|NCT02104557|459249971|FG000|Overall Study|Discontinuation due to no pain|1|||
127624888|NCT02104557|459249971|FG000|Overall Study|Withdrawal consent|2|||
127624889|NCT02104557|459249971|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
127624890|NCT02104557|459249971|FG000|Overall Study|Discontinuation of contraception|9|||
127624891|NCT00111228|459249975|FG000|Overall Study|Withdrawal by Subject|5|||
127624892|NCT00111228|459249976|FG001|Overall Study|Withdrawal by Subject|1|||
127624893|NCT00111228|459249977|FG002|Overall Study|Withdrawal by Subject|0|||
127624894|NCT00678691|459249978|FG000|Overall Study|Adverse Event|6|||
127624895|NCT00678691|459249979|FG001|Overall Study|Adverse Event|4|||
127624896|NCT02178475|459249986|FG000|Overall Study|Withdrawal by Subject|7|||
127624897|NCT02178475|459249986|FG000|Overall Study|Lost to Follow-up|10|||
127624898|NCT02178475|459249986|FG000|Overall Study|Death|13|||
127624899|NCT02178475|459249986|FG000|Overall Study|Protocol-specified Criteria|99|||
127624900|NCT01430585|459249987|FG000|Overall Study|Death|1|||
127624901|NCT01430585|459249987|FG000|Overall Study|Objective Progression or Relapse|3|||
127624902|NCT01430585|459249987|FG000|Overall Study|Study Terminated by Sponsor|3|||
127624903|NCT01430585|459249987|FG000|Overall Study|Other|7|||
127624904|NCT00779766|459249988|FG000|Month 24|Serious Adverse Event|2|||
127624905|NCT00779766|459249989|FG001|Month 24|Serious Adverse Event|3|||
127624906|NCT00779766|459249988|FG000|Month 24|Adverse Event|3|||
127624907|NCT00779766|459249989|FG001|Month 24|Adverse Event|3|||
127624908|NCT00779766|459249988|FG000|Month 24|Protocol Violation|3|||
127624909|NCT00779766|459249989|FG001|Month 24|Protocol Violation|1|||
127624910|NCT00779766|459249988|FG000|Month 24|Withdrawal by Subject|159|||
127624911|NCT00779766|459249989|FG001|Month 24|Withdrawal by Subject|127|||
127624912|NCT00779766|459249988|FG000|Month 24|Migrated/moved from study area|138|||
127624913|NCT00779766|459249989|FG001|Month 24|Migrated/moved from study area|162|||
127624914|NCT00779766|459249988|FG000|Month 24|Lost to Follow-up|9|||
127624915|NCT00779766|459249989|FG001|Month 24|Lost to Follow-up|9|||
127624916|NCT00779766|459249988|FG000|Month 24|Other|18|||
127624917|NCT00779766|459249989|FG001|Month 24|Other|27|||
127624918|NCT00779766|459249988|FG000|Month 48|Withdrawal by Subject|68|||
127624919|NCT00779766|459249989|FG001|Month 48|Withdrawal by Subject|63|||
127624920|NCT00779766|459249988|FG000|Month 48|Migrated/moved from study area|76|||
127624921|NCT00779766|459249989|FG001|Month 48|Migrated/moved from study area|75|||
127624922|NCT00779766|459249988|FG000|Month 48|Lost to Follow-up|29|||
127624923|NCT00779766|459249989|FG001|Month 48|Lost to Follow-up|30|||
127624924|NCT00779766|459249988|FG000|Month 48|Other|1|||
127624925|NCT00779766|459249989|FG001|Month 48|Other|0|||
127624926|NCT00779766|459249988|FG000|Month 72|Withdrawal by Subject|55|||
127624927|NCT00779766|459249989|FG001|Month 72|Withdrawal by Subject|71|||
127624928|NCT00779766|459249988|FG000|Month 72|Migrated/moved from study area|124|||
127624929|NCT00779766|459249989|FG001|Month 72|Migrated/moved from study area|109|||
127624930|NCT00779766|459249988|FG000|Month 72|Lost to Follow-up|6|||
127624931|NCT00779766|459249989|FG001|Month 72|Lost to Follow-up|8|||
127624932|NCT00779766|459249988|FG000|Month 72|Other|0|||
127624933|NCT00779766|459249989|FG001|Month 72|Other|1|||
127624934|NCT01412424|459249992|FG000|Core Treatment Period|Treatment Failure|24|||
127624935|NCT01412424|459249992|FG000|Core Treatment Period|Adverse Event|21|||
127624936|NCT01412424|459249992|FG000|Core Treatment Period|Patient Request|5|||
127624937|NCT01412424|459249992|FG000|Core Treatment Period|Lost to Follow-up|2|||
127624938|NCT01412424|459249992|FG000|Core Treatment Period|Sponsor Request|1|||
127624939|NCT01412424|459249992|FG000|Extension Treatment Period|Adverse Event|2|||
127624940|NCT01412424|459249992|FG000|Extension Treatment Period|Treatment Failure|2|||
127624941|NCT01412424|459249992|FG000|Extension Treatment Period|Patient Request|2|||
127624942|NCT01274637|459249993|FG000|Overall Study|Withdrawal by Subject|0|||
127624943|NCT01274637|459249994|FG001|Overall Study|Withdrawal by Subject|1|||
127624944|NCT01274637|459249993|FG000|Overall Study|Lost to Follow-up|0|||
127624945|NCT01274637|459249994|FG001|Overall Study|Lost to Follow-up|1|||
127624946|NCT02357576|459250002|FG000|Treatment Period|Withdrawal by Subject|0|||
127624947|NCT02357576|459250003|FG001|Treatment Period|Withdrawal by Subject|1|||
127624948|NCT02357576|459250002|FG000|Treatment Period|Physician Decision|0|||
127624949|NCT02357576|459250003|FG001|Treatment Period|Physician Decision|1|||
127624950|NCT02357576|459250002|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
127624951|NCT02357576|459250003|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
127624952|NCT02357576|459250002|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
127624953|NCT02357576|459250003|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
127624954|NCT02357576|459250002|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
127624955|NCT02357576|459250003|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
127624956|NCT02357576|459250002|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
127624957|NCT02357576|459250003|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
127624958|NCT00699699|459250006|FG000|Overall Study|Adverse Event|36|||
127624959|NCT00699699|459250006|FG000|Overall Study|Individual different reasons|21|||
127624960|NCT01632800|459250009|FG000|Overall Study|Subject did not fit in apparatus|1|||
127624961|NCT01000051|459250011|FG000|Overall Study|Withdrawal by Subject|1|||
127624962|NCT01000051|459250012|FG001|Overall Study|Withdrawal by Subject|1|||
127624963|NCT01000051|459250011|FG000|Overall Study|Disease Progression|1|||
127624964|NCT01000051|459250012|FG001|Overall Study|Disease Progression|0|||
127624965|NCT01000051|459250011|FG000|Overall Study|Serious noncompliance|1|||
127624966|NCT01000051|459250012|FG001|Overall Study|Serious noncompliance|0|||
127624967|NCT00414050|459250013|FG000|Overall Study|Adverse Event|1|||
127624968|NCT00414050|459250014|FG001|Overall Study|Adverse Event|1|||
127624969|NCT00414050|459250015|FG002|Overall Study|Adverse Event|1|||
127624970|NCT00414050|459250016|FG003|Overall Study|Adverse Event|1|||
127624971|NCT00414050|459250013|FG000|Overall Study|Lost to Follow-up|2|||
127624972|NCT00414050|459250014|FG001|Overall Study|Lost to Follow-up|2|||
127624973|NCT00414050|459250015|FG002|Overall Study|Lost to Follow-up|1|||
127624974|NCT00414050|459250016|FG003|Overall Study|Lost to Follow-up|1|||
127624975|NCT00414050|459250013|FG000|Overall Study|Withdrawal by Subject|5|||
127624976|NCT00414050|459250014|FG001|Overall Study|Withdrawal by Subject|3|||
127624977|NCT00414050|459250015|FG002|Overall Study|Withdrawal by Subject|2|||
127624978|NCT00414050|459250016|FG003|Overall Study|Withdrawal by Subject|4|||
127624979|NCT00414050|459250013|FG000|Overall Study|Subject discontinued for other reason|1|||
127624980|NCT00414050|459250014|FG001|Overall Study|Subject discontinued for other reason|2|||
127624981|NCT00414050|459250015|FG002|Overall Study|Subject discontinued for other reason|2|||
127624982|NCT00414050|459250016|FG003|Overall Study|Subject discontinued for other reason|1|||
127624983|NCT00414050|459250013|FG000|Overall Study|Subject Moved|0|||
127624984|NCT00414050|459250014|FG001|Overall Study|Subject Moved|0|||
127624985|NCT00414050|459250015|FG002|Overall Study|Subject Moved|0|||
127624986|NCT00414050|459250016|FG003|Overall Study|Subject Moved|1|||
127624987|NCT03495908|459250018|FG000|Overall Study|Withdrawal by Subject|3|||
127624988|NCT03495908|459250019|FG001|Overall Study|Withdrawal by Subject|1|||
127624989|NCT03495908|459250018|FG000|Overall Study|Lost to Follow-up|1|||
127624990|NCT03495908|459250019|FG001|Overall Study|Lost to Follow-up|4|||
127624991|NCT03495908|459250018|FG000|Overall Study|Adverse Event|0|||
127624992|NCT03495908|459250019|FG001|Overall Study|Adverse Event|2|||
127624993|NCT03495908|459250018|FG000|Overall Study|Death|1|||
127624994|NCT03495908|459250019|FG001|Overall Study|Death|0|||
127624995|NCT03495908|459250018|FG000|Overall Study|Physician Decision|5|||
127624996|NCT03495908|459250019|FG001|Overall Study|Physician Decision|4|||
127624997|NCT03495908|459250018|FG000|Overall Study|No documented reason|0|||
127624998|NCT03495908|459250019|FG001|Overall Study|No documented reason|2|||
127624999|NCT03304379|459250024|FG000|Overall Study|Protocol Violation|8|||
127625000|NCT03304379|459250025|FG001|Overall Study|Protocol Violation|10|||
127625001|NCT03304379|459250026|FG002|Overall Study|Protocol Violation|5|||
127885184|NCT03118765|460203848|FG000|Overall Study|Lost to Follow-up|1|||
127885185|NCT03118765|460203849|FG001|Overall Study|Lost to Follow-up|0|||
127885186|NCT03118765|460203850|FG002|Overall Study|Lost to Follow-up|1|||
127885187|NCT03118765|460203851|FG003|Overall Study|Lost to Follow-up|0|||
127885188|NCT03118765|460203852|FG004|Overall Study|Lost to Follow-up|0|||
127885189|NCT03118765|460203848|FG000|Overall Study|Sponsor Decision|1|||
127885190|NCT03118765|460203849|FG001|Overall Study|Sponsor Decision|0|||
127885191|NCT03118765|460203850|FG002|Overall Study|Sponsor Decision|1|||
127885192|NCT03118765|460203851|FG003|Overall Study|Sponsor Decision|0|||
127885193|NCT03118765|460203852|FG004|Overall Study|Sponsor Decision|1|||
127885194|NCT00849524|460203853|FG000|Overall Study|Lack of Efficacy|3|||
127625002|NCT03304379|459250027|FG003|Overall Study|Protocol Violation|0|||
127625003|NCT03304379|459250028|FG004|Overall Study|Protocol Violation|2|||
127625004|NCT03304379|459250024|FG000|Overall Study|Adverse Event|4|||
127625005|NCT03304379|459250025|FG001|Overall Study|Adverse Event|20|||
127625006|NCT03304379|459250026|FG002|Overall Study|Adverse Event|17|||
127625007|NCT03304379|459250027|FG003|Overall Study|Adverse Event|1|||
127625008|NCT03304379|459250028|FG004|Overall Study|Adverse Event|0|||
127625009|NCT03304379|459250024|FG000|Overall Study|Lack of Efficacy|17|||
127625010|NCT03304379|459250025|FG001|Overall Study|Lack of Efficacy|16|||
127625011|NCT03304379|459250026|FG002|Overall Study|Lack of Efficacy|20|||
127625012|NCT03304379|459250027|FG003|Overall Study|Lack of Efficacy|0|||
127625013|NCT03304379|459250028|FG004|Overall Study|Lack of Efficacy|0|||
127625014|NCT03304379|459250024|FG000|Overall Study|Physician Decision|6|||
127625015|NCT03304379|459250025|FG001|Overall Study|Physician Decision|10|||
127625016|NCT03304379|459250026|FG002|Overall Study|Physician Decision|6|||
127625017|NCT03304379|459250027|FG003|Overall Study|Physician Decision|9|||
127625018|NCT03304379|459250028|FG004|Overall Study|Physician Decision|10|||
127625019|NCT03304379|459250024|FG000|Overall Study|Withdrawal by Subject|26|||
127625020|NCT03304379|459250025|FG001|Overall Study|Withdrawal by Subject|58|||
127625021|NCT03304379|459250026|FG002|Overall Study|Withdrawal by Subject|66|||
127625022|NCT03304379|459250027|FG003|Overall Study|Withdrawal by Subject|3|||
127625023|NCT03304379|459250028|FG004|Overall Study|Withdrawal by Subject|5|||
127625024|NCT03304379|459250024|FG000|Overall Study|Lost to Follow-up|8|||
127625025|NCT03304379|459250025|FG001|Overall Study|Lost to Follow-up|24|||
127625026|NCT03304379|459250026|FG002|Overall Study|Lost to Follow-up|35|||
127885195|NCT00527397|460203856|FG000|Overall Study|Adverse Event|3|||
127885196|NCT00527397|460203856|FG000|Overall Study|Lack of Efficacy|1|||
127885197|NCT00527397|460203856|FG000|Overall Study|Protocol Violation|1|||
127885198|NCT00527397|460203856|FG000|Overall Study|Withdrawal by Subject|6|||
127885199|NCT00527397|460203856|FG000|Overall Study|Study terminated by sponsor|13|||
127625027|NCT03304379|459250027|FG003|Overall Study|Lost to Follow-up|4|||
127625028|NCT03304379|459250028|FG004|Overall Study|Lost to Follow-up|0|||
127625029|NCT03304379|459250024|FG000|Overall Study|Death|1|||
127625030|NCT03304379|459250025|FG001|Overall Study|Death|2|||
127625031|NCT03304379|459250026|FG002|Overall Study|Death|0|||
127885200|NCT00879970|460203862|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
127885201|NCT00879970|460203863|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
127625032|NCT03304379|459250027|FG003|Overall Study|Death|0|||
127625033|NCT03304379|459250028|FG004|Overall Study|Death|0|||
127625034|NCT03304379|459250024|FG000|Overall Study|Other|0|||
127625035|NCT03304379|459250025|FG001|Overall Study|Other|1|||
127625036|NCT03304379|459250026|FG002|Overall Study|Other|0|||
127625037|NCT03304379|459250027|FG003|Overall Study|Other|0|||
127625038|NCT03304379|459250028|FG004|Overall Study|Other|0|||
127625039|NCT00057746|459250038|FG000|Overall Study|Withdrawal by Subject|0|||
127625040|NCT00057746|459250039|FG001|Overall Study|Withdrawal by Subject|0|||
127625041|NCT00057746|459250040|FG002|Overall Study|Withdrawal by Subject|1|||
127625042|NCT01469065|459250047|FG000|Overall Study|Lack of Efficacy|0|||
127625043|NCT01469065|459250048|FG001|Overall Study|Lack of Efficacy|0|||
127625044|NCT01469065|459250049|FG002|Overall Study|Lack of Efficacy|0|||
127625045|NCT01469065|459250050|FG003|Overall Study|Lack of Efficacy|0|||
127625046|NCT01469065|459250051|FG004|Overall Study|Lack of Efficacy|1|||
127625047|NCT01469065|459250047|FG000|Overall Study|Other|0|||
127625048|NCT01469065|459250048|FG001|Overall Study|Other|1|||
127625049|NCT01469065|459250049|FG002|Overall Study|Other|0|||
127625050|NCT01469065|459250050|FG003|Overall Study|Other|0|||
127625051|NCT01469065|459250051|FG004|Overall Study|Other|0|||
127625052|NCT00439140|459250052|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
127625053|NCT00439140|459250053|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
127625054|NCT00439140|459250054|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
127625055|NCT00439140|459250052|FG000|Treatment Cycle 1|Personal reasons|0|||
127625056|NCT00439140|459250053|FG001|Treatment Cycle 1|Personal reasons|2|||
127625057|NCT00439140|459250054|FG002|Treatment Cycle 1|Personal reasons|0|||
127625058|NCT00439140|459250052|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
127625059|NCT00439140|459250053|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
127625060|NCT00439140|459250054|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
127625061|NCT00439140|459250052|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
127625062|NCT00439140|459250053|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
127625063|NCT00439140|459250054|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
127625064|NCT00439140|459250052|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
127625065|NCT00439140|459250053|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
127625066|NCT00439140|459250054|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
127625067|NCT00799617|459250060|FG000|Main Testosterone Trial|Randomized in error|1|||
127625068|NCT00799617|459250061|FG001|Main Testosterone Trial|Randomized in error|1|||
127625069|NCT00799617|459250060|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
127625070|NCT00799617|459250061|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
127625071|NCT00799617|459250060|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
127625072|NCT00799617|459250061|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
127625073|NCT00799617|459250060|FG000|Sexual Funtion Trial|No Baseline Data|4|||
127625074|NCT00799617|459250061|FG001|Sexual Funtion Trial|No Baseline Data|7|||
127625075|NCT00799617|459250060|FG000|Physical Function Trial|Lost to Follow-up|6|||
127625076|NCT00799617|459250061|FG001|Physical Function Trial|Lost to Follow-up|11|||
127625077|NCT00799617|459250060|FG000|Vitality Trial|Lost to Follow-up|7|||
127625078|NCT00799617|459250061|FG001|Vitality Trial|Lost to Follow-up|22|||
127625079|NCT00799617|459250060|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
127625080|NCT00799617|459250061|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
127625081|NCT00799617|459250060|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
127625082|NCT00799617|459250061|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
127625083|NCT00799617|459250060|FG000|Bone Trial|Month 12 scan not available|6|||
127625084|NCT00799617|459250061|FG001|Bone Trial|Month 12 scan not available|16|||
127625085|NCT00799617|459250060|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
127625086|NCT00799617|459250061|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
127625087|NCT00799617|459250060|FG000|Anemia Trial|Withdrawal by Subject|3|||
127625088|NCT00799617|459250061|FG001|Anemia Trial|Withdrawal by Subject|3|||
127625089|NCT01848990|459250062|FG000|Overall Study|Adverse Event|6|||
127625090|NCT01848990|459250063|FG001|Overall Study|Adverse Event|2|||
127625091|NCT01848990|459250064|FG002|Overall Study|Adverse Event|0|||
127625092|NCT01848990|459250062|FG000|Overall Study|Lost to Follow-up|6|||
127625093|NCT01848990|459250063|FG001|Overall Study|Lost to Follow-up|2|||
127625094|NCT01848990|459250064|FG002|Overall Study|Lost to Follow-up|2|||
127625095|NCT01848990|459250062|FG000|Overall Study|Protocol Violation|1|||
127625096|NCT01848990|459250063|FG001|Overall Study|Protocol Violation|1|||
127625097|NCT01848990|459250064|FG002|Overall Study|Protocol Violation|0|||
127625098|NCT01848990|459250062|FG000|Overall Study|Withdrawal by Subject|29|||
127625099|NCT01848990|459250063|FG001|Overall Study|Withdrawal by Subject|10|||
127625100|NCT01848990|459250064|FG002|Overall Study|Withdrawal by Subject|11|||
127625101|NCT01848990|459250062|FG000|Overall Study|Physician Decision|1|||
127625102|NCT01848990|459250063|FG001|Overall Study|Physician Decision|1|||
127625103|NCT01848990|459250064|FG002|Overall Study|Physician Decision|0|||
127625104|NCT01848990|459250062|FG000|Overall Study|Non Compliance|1|||
127625105|NCT01848990|459250063|FG001|Overall Study|Non Compliance|0|||
127625106|NCT01848990|459250064|FG002|Overall Study|Non Compliance|0|||
127625107|NCT01848990|459250062|FG000|Overall Study|Death|1|||
127625108|NCT01848990|459250063|FG001|Overall Study|Death|0|||
127625109|NCT01848990|459250064|FG002|Overall Study|Death|1|||
127625110|NCT01848990|459250062|FG000|Overall Study|Other|1|||
127625111|NCT01848990|459250063|FG001|Overall Study|Other|4|||
127625112|NCT01848990|459250064|FG002|Overall Study|Other|2|||
127625113|NCT04497987|459250065|FG000|Overall Study|Adverse Event|1|||
127625114|NCT04497987|459250066|FG001|Overall Study|Adverse Event|0|||
127625115|NCT04497987|459250065|FG000|Overall Study|Death|21|||
127625116|NCT04497987|459250066|FG001|Overall Study|Death|13|||
127625117|NCT04497987|459250065|FG000|Overall Study|Lost to Follow-up|19|||
127625118|NCT04497987|459250066|FG001|Overall Study|Lost to Follow-up|17|||
127625119|NCT04497987|459250065|FG000|Overall Study|Other - as reported by the investigator|22|||
127625120|NCT04497987|459250066|FG001|Overall Study|Other - as reported by the investigator|16|||
127625121|NCT04497987|459250065|FG000|Overall Study|Physician Decision|1|||
127625122|NCT04497987|459250066|FG001|Overall Study|Physician Decision|0|||
127625123|NCT04497987|459250065|FG000|Overall Study|Withdrawal by Subject|35|||
127625124|NCT04497987|459250066|FG001|Overall Study|Withdrawal by Subject|21|||
127625125|NCT01519518|459252618|FG000|Overall Study|Consent not available|7|||
127625126|NCT01519518|459252619|FG001|Overall Study|Consent not available|10|||
127625127|NCT01312909|459252621|FG000|Overall Study|Randomized but not treated|1|||
127625128|NCT01312909|459252622|FG001|Overall Study|Randomized but not treated|3|||
127625129|NCT01312909|459252623|FG002|Overall Study|Randomized but not treated|1|||
127625130|NCT01312909|459252621|FG000|Overall Study|Adverse Event|1|||
127625131|NCT01312909|459252622|FG001|Overall Study|Adverse Event|0|||
127625132|NCT01312909|459252623|FG002|Overall Study|Adverse Event|3|||
127625133|NCT01312909|459252621|FG000|Overall Study|Protocol Violation|2|||
127625134|NCT01312909|459252622|FG001|Overall Study|Protocol Violation|0|||
127625135|NCT01312909|459252623|FG002|Overall Study|Protocol Violation|2|||
127625136|NCT01312909|459252621|FG000|Overall Study|Other|9|||
127625137|NCT01312909|459252622|FG001|Overall Study|Other|6|||
127625138|NCT01312909|459252623|FG002|Overall Study|Other|11|||
127625139|NCT01312909|459252621|FG000|Overall Study|Withdrawal by Subject|8|||
127625140|NCT01312909|459252622|FG001|Overall Study|Withdrawal by Subject|10|||
127625141|NCT01312909|459252623|FG002|Overall Study|Withdrawal by Subject|7|||
127625142|NCT01312909|459252621|FG000|Overall Study|Lost to Follow-up|21|||
127625143|NCT01312909|459252622|FG001|Overall Study|Lost to Follow-up|17|||
127625144|NCT01312909|459252623|FG002|Overall Study|Lost to Follow-up|20|||
127625145|NCT01312909|459252621|FG000|Overall Study|Insufficient clinical response|0|||
127625146|NCT01312909|459252622|FG001|Overall Study|Insufficient clinical response|0|||
127625147|NCT01312909|459252623|FG002|Overall Study|Insufficient clinical response|1|||
127625148|NCT01312909|459252621|FG000|Overall Study|Entrance criteria not met|0|||
127792749|NCT03311711|459867362|FG001|Overall Study|Death|0|||
127792750|NCT03311711|459867363|FG002|Overall Study|Death|0|||
127792751|NCT03311711|459867364|FG003|Overall Study|Death|0|||
127792752|NCT03311711|459867365|FG004|Overall Study|Death|0|||
127792753|NCT03311711|459867366|FG005|Overall Study|Death|0|||
127792754|NCT03311711|459867367|FG006|Overall Study|Death|1|||
127792755|NCT03311711|459867368|FG007|Overall Study|Death|0|||
127792756|NCT03311711|459867369|FG008|Overall Study|Death|1|||
127792757|NCT03311711|459867370|FG009|Overall Study|Death|0|||
127792758|NCT03311711|459867361|FG000|Overall Study|Death of dyad partner|0|||
127792759|NCT03311711|459867362|FG001|Overall Study|Death of dyad partner|1|||
127792760|NCT03311711|459867363|FG002|Overall Study|Death of dyad partner|0|||
127792761|NCT03311711|459867364|FG003|Overall Study|Death of dyad partner|0|||
127792762|NCT03311711|459867365|FG004|Overall Study|Death of dyad partner|0|||
127792763|NCT03311711|459867366|FG005|Overall Study|Death of dyad partner|0|||
127792764|NCT03311711|459867367|FG006|Overall Study|Death of dyad partner|0|||
127792765|NCT03311711|459867368|FG007|Overall Study|Death of dyad partner|1|||
127792766|NCT03311711|459867369|FG008|Overall Study|Death of dyad partner|0|||
127792767|NCT03311711|459867370|FG009|Overall Study|Death of dyad partner|1|||
127792768|NCT03311711|459867361|FG000|Overall Study|Lost to Follow-up|2|||
127792769|NCT03311711|459867362|FG001|Overall Study|Lost to Follow-up|2|||
127792770|NCT03311711|459867363|FG002|Overall Study|Lost to Follow-up|0|||
127792771|NCT03311711|459867364|FG003|Overall Study|Lost to Follow-up|0|||
127792772|NCT03311711|459867365|FG004|Overall Study|Lost to Follow-up|0|||
127792773|NCT03311711|459867366|FG005|Overall Study|Lost to Follow-up|0|||
127792774|NCT03311711|459867367|FG006|Overall Study|Lost to Follow-up|1|||
127792775|NCT03311711|459867368|FG007|Overall Study|Lost to Follow-up|1|||
127792776|NCT03311711|459867369|FG008|Overall Study|Lost to Follow-up|0|||
127792777|NCT03311711|459867370|FG009|Overall Study|Lost to Follow-up|0|||
127625149|NCT01312909|459252622|FG001|Overall Study|Entrance criteria not met|0|||
127625150|NCT01312909|459252623|FG002|Overall Study|Entrance criteria not met|2|||
127625151|NCT00938431|459252627|FG000|Overall Study|Adverse Event|5|||
127792778|NCT03311711|459867361|FG000|Overall Study|Withdrawal by Subject|1|||
127792779|NCT03311711|459867362|FG001|Overall Study|Withdrawal by Subject|1|||
127792780|NCT03311711|459867363|FG002|Overall Study|Withdrawal by Subject|0|||
127792781|NCT03311711|459867364|FG003|Overall Study|Withdrawal by Subject|0|||
127792782|NCT03311711|459867365|FG004|Overall Study|Withdrawal by Subject|0|||
127792783|NCT03311711|459867366|FG005|Overall Study|Withdrawal by Subject|0|||
127792784|NCT03311711|459867367|FG006|Overall Study|Withdrawal by Subject|3|||
127792785|NCT03311711|459867368|FG007|Overall Study|Withdrawal by Subject|3|||
127792786|NCT03311711|459867369|FG008|Overall Study|Withdrawal by Subject|0|||
127792787|NCT03311711|459867370|FG009|Overall Study|Withdrawal by Subject|0|||
127792788|NCT03548051|459867372|FG000|Overall Study|Death|1|||
127792789|NCT03548051|459867373|FG001|Overall Study|Death|1|||
127792790|NCT03548051|459867372|FG000|Overall Study|Withdrawal by Subject|1|||
127792791|NCT03548051|459867373|FG001|Overall Study|Withdrawal by Subject|0|||
127792792|NCT03927105|459867374|FG000|Overall Study|Death|1|||
127792793|NCT03927105|459867374|FG000|Overall Study|In observation for potential re-treatment|2|||
127792794|NCT03927105|459867374|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
127792795|NCT01745146|459867378|FG000|Overall Study|Withdrawal by Subject|1|||
127792796|NCT01745146|459867379|FG001|Overall Study|Withdrawal by Subject|3|||
127792797|NCT01745146|459867378|FG000|Overall Study|Lost to Follow-up|2|||
127792798|NCT01745146|459867379|FG001|Overall Study|Lost to Follow-up|0|||
127792799|NCT05594173|459867380|FG000|Overall Study|Adverse Event|1|||
127792800|NCT05594173|459867380|FG000|Overall Study|COVID-19 Pandemic|2|||
127792801|NCT00647556|459867381|FG000|Overall Study|Adverse Event|0|||
127792802|NCT00647556|459867382|FG001|Overall Study|Adverse Event|1|||
127792803|NCT00647556|459867381|FG000|Overall Study|Lost to Follow-up|1|||
127792804|NCT00647556|459867382|FG001|Overall Study|Lost to Follow-up|0|||
127792805|NCT00647556|459867381|FG000|Overall Study|Protocol Violation|0|||
127792806|NCT00647556|459867382|FG001|Overall Study|Protocol Violation|1|||
127792807|NCT00647556|459867381|FG000|Overall Study|Withdrawal by Subject|1|||
127792808|NCT00647556|459867382|FG001|Overall Study|Withdrawal by Subject|0|||
127792809|NCT00647556|459867381|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
127792810|NCT00647556|459867382|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
127792811|NCT01877187|459867386|FG000|Overall Study|Death|2|||
127792812|NCT01877187|459867386|FG000|Overall Study|Withdrawal by Subject|4|||
127625152|NCT00938431|459252628|FG001|Overall Study|Adverse Event|8|||
127625153|NCT00938431|459252629|FG002|Overall Study|Adverse Event|6|||
127625154|NCT00938431|459252627|FG000|Overall Study|Lack of Efficacy|0|||
127625155|NCT00938431|459252628|FG001|Overall Study|Lack of Efficacy|1|||
127625156|NCT00938431|459252629|FG002|Overall Study|Lack of Efficacy|0|||
127625157|NCT00938431|459252627|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
127625158|NCT00938431|459252628|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
127625159|NCT00938431|459252629|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
127625160|NCT00938431|459252627|FG000|Overall Study|Dosing compliance issue|0|||
127625161|NCT00938431|459252628|FG001|Overall Study|Dosing compliance issue|0|||
127625162|NCT00938431|459252629|FG002|Overall Study|Dosing compliance issue|1|||
127625163|NCT00938431|459252627|FG000|Overall Study|Reached maximum dose early|0|||
127625164|NCT00938431|459252628|FG001|Overall Study|Reached maximum dose early|0|||
127625165|NCT00938431|459252629|FG002|Overall Study|Reached maximum dose early|1|||
127625166|NCT01774903|459252630|FG000|Overall Study|Adverse Event|7|||
127625167|NCT01774903|459252630|FG000|Overall Study|Withdrawal by Subject|2|||
127625168|NCT01774903|459252630|FG000|Overall Study|Lack of Efficacy|1|||
127625169|NCT01774903|459252630|FG000|Overall Study|Ineligible to continue the trial|1|||
127625170|NCT02880371|459252631|FG000|Phase 1b|Lost to Follow-up|1|||
127625171|NCT02880371|459252632|FG001|Phase 1b|Lost to Follow-up|0|||
127625172|NCT02880371|459252633|FG002|Phase 1b|Lost to Follow-up|0|||
127625173|NCT02880371|459252634|FG003|Phase 1b|Lost to Follow-up|0|||
127625174|NCT02880371|459252635|FG004|Phase 1b|Lost to Follow-up|0|||
127625175|NCT02880371|459252636|FG005|Phase 1b|Lost to Follow-up|0|||
127625176|NCT02880371|459252637|FG006|Phase 1b|Lost to Follow-up|0|||
127625177|NCT02880371|459252638|FG007|Phase 1b|Lost to Follow-up|0|||
127625178|NCT02880371|459252631|FG000|Phase 1b|Participants terminated by Sponsor|1|||
127792813|NCT01877187|459867386|FG000|Overall Study|Lost to Follow-up|3|||
127792814|NCT01877187|459867386|FG000|Overall Study|Declining clinical status|11|||
127625179|NCT02880371|459252632|FG001|Phase 1b|Participants terminated by Sponsor|0|||
127625180|NCT02880371|459252633|FG002|Phase 1b|Participants terminated by Sponsor|0|||
127625181|NCT02880371|459252634|FG003|Phase 1b|Participants terminated by Sponsor|0|||
127792815|NCT01877187|459867386|FG000|Overall Study|Liver transplant|2|||
127792816|NCT03548558|459867387|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
127792817|NCT03548558|459867388|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
127792818|NCT03548558|459867389|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
127792819|NCT03548558|459867390|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
127792820|NCT03548558|459867391|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
127792821|NCT03548558|459867392|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
127625182|NCT02880371|459252635|FG004|Phase 1b|Participants terminated by Sponsor|0|||
127625183|NCT02880371|459252636|FG005|Phase 1b|Participants terminated by Sponsor|0|||
127625184|NCT02880371|459252637|FG006|Phase 1b|Participants terminated by Sponsor|0|||
127625185|NCT02880371|459252638|FG007|Phase 1b|Participants terminated by Sponsor|0|||
127625186|NCT02880371|459252631|FG000|Phase 1b|Withdrawal by Subject|0|||
127625187|NCT02880371|459252632|FG001|Phase 1b|Withdrawal by Subject|0|||
127625188|NCT02880371|459252633|FG002|Phase 1b|Withdrawal by Subject|1|||
127625189|NCT02880371|459252634|FG003|Phase 1b|Withdrawal by Subject|0|||
127625190|NCT02880371|459252635|FG004|Phase 1b|Withdrawal by Subject|0|||
127625191|NCT02880371|459252636|FG005|Phase 1b|Withdrawal by Subject|0|||
127625192|NCT02880371|459252637|FG006|Phase 1b|Withdrawal by Subject|0|||
127625193|NCT02880371|459252638|FG007|Phase 1b|Withdrawal by Subject|0|||
127625194|NCT02880371|459252631|FG000|Phase 1b|Death|4|||
127625195|NCT02880371|459252632|FG001|Phase 1b|Death|6|||
127625196|NCT02880371|459252633|FG002|Phase 1b|Death|5|||
127625197|NCT02880371|459252634|FG003|Phase 1b|Death|1|||
127625198|NCT02880371|459252635|FG004|Phase 1b|Death|0|||
127625199|NCT02880371|459252636|FG005|Phase 1b|Death|0|||
127625200|NCT02880371|459252637|FG006|Phase 1b|Death|0|||
127625201|NCT02880371|459252638|FG007|Phase 1b|Death|0|||
127625202|NCT02880371|459252631|FG000|Phase 1b|Enrolled but not Treated|0|||
127625203|NCT02880371|459252632|FG001|Phase 1b|Enrolled but not Treated|1|||
127625204|NCT02880371|459252633|FG002|Phase 1b|Enrolled but not Treated|0|||
127625205|NCT02880371|459252634|FG003|Phase 1b|Enrolled but not Treated|0|||
127625206|NCT02880371|459252635|FG004|Phase 1b|Enrolled but not Treated|0|||
127625207|NCT02880371|459252636|FG005|Phase 1b|Enrolled but not Treated|0|||
127625208|NCT02880371|459252637|FG006|Phase 1b|Enrolled but not Treated|0|||
127625209|NCT02880371|459252638|FG007|Phase 1b|Enrolled but not Treated|0|||
127625210|NCT02880371|459252631|FG000|Phase 2|Enrolled but not Treated|0|||
127625211|NCT02880371|459252632|FG001|Phase 2|Enrolled but not Treated|0|||
127625212|NCT02880371|459252633|FG002|Phase 2|Enrolled but not Treated|0|||
127625213|NCT02880371|459252634|FG003|Phase 2|Enrolled but not Treated|0|||
127625214|NCT02880371|459252635|FG004|Phase 2|Enrolled but not Treated|0|||
127625215|NCT02880371|459252636|FG005|Phase 2|Enrolled but not Treated|1|||
127625216|NCT02880371|459252637|FG006|Phase 2|Enrolled but not Treated|1|||
127625217|NCT02880371|459252638|FG007|Phase 2|Enrolled but not Treated|0|||
127625218|NCT02880371|459252631|FG000|Phase 2|Other|0|||
127625219|NCT02880371|459252632|FG001|Phase 2|Other|0|||
127625220|NCT02880371|459252633|FG002|Phase 2|Other|0|||
127625221|NCT02880371|459252634|FG003|Phase 2|Other|0|||
127625222|NCT02880371|459252635|FG004|Phase 2|Other|0|||
127625223|NCT02880371|459252636|FG005|Phase 2|Other|1|||
127625224|NCT02880371|459252637|FG006|Phase 2|Other|2|||
127792822|NCT03548558|459867393|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
127792823|NCT03548558|459867387|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
127792824|NCT03548558|459867388|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
127792825|NCT03548558|459867389|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
127792826|NCT03548558|459867390|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
127792827|NCT03548558|459867391|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
127792828|NCT03548558|459867392|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
127792829|NCT03548558|459867393|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
127792830|NCT03548558|459867387|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
127792831|NCT03548558|459867388|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
127792832|NCT03548558|459867389|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
127792833|NCT03548558|459867390|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
127792834|NCT03548558|459867391|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
127792835|NCT03548558|459867392|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
127792836|NCT03548558|459867393|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
127792837|NCT03548558|459867387|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
127625225|NCT02880371|459252638|FG007|Phase 2|Other|1|||
127625226|NCT02880371|459252631|FG000|Phase 2|Participants terminated by Sponsor|0|||
127625227|NCT02880371|459252632|FG001|Phase 2|Participants terminated by Sponsor|0|||
127625228|NCT02880371|459252633|FG002|Phase 2|Participants terminated by Sponsor|0|||
127625229|NCT02880371|459252634|FG003|Phase 2|Participants terminated by Sponsor|0|||
127625230|NCT02880371|459252635|FG004|Phase 2|Participants terminated by Sponsor|1|||
127625231|NCT02880371|459252636|FG005|Phase 2|Participants terminated by Sponsor|6|||
127625232|NCT02880371|459252637|FG006|Phase 2|Participants terminated by Sponsor|1|||
127625233|NCT02880371|459252638|FG007|Phase 2|Participants terminated by Sponsor|5|||
127625234|NCT02880371|459252631|FG000|Phase 2|Death|0|||
127625235|NCT02880371|459252632|FG001|Phase 2|Death|0|||
127625236|NCT02880371|459252633|FG002|Phase 2|Death|0|||
127625237|NCT02880371|459252634|FG003|Phase 2|Death|0|||
127625238|NCT02880371|459252635|FG004|Phase 2|Death|1|||
127625239|NCT02880371|459252636|FG005|Phase 2|Death|10|||
127625240|NCT02880371|459252637|FG006|Phase 2|Death|20|||
127625241|NCT02880371|459252638|FG007|Phase 2|Death|5|||
127625242|NCT02880371|459252631|FG000|Phase 2|Lost to Follow-up|0|||
127625243|NCT02880371|459252632|FG001|Phase 2|Lost to Follow-up|0|||
127625244|NCT02880371|459252633|FG002|Phase 2|Lost to Follow-up|0|||
127625245|NCT02880371|459252634|FG003|Phase 2|Lost to Follow-up|0|||
127625246|NCT02880371|459252635|FG004|Phase 2|Lost to Follow-up|0|||
127625247|NCT02880371|459252636|FG005|Phase 2|Lost to Follow-up|0|||
127625248|NCT02880371|459252637|FG006|Phase 2|Lost to Follow-up|3|||
127625249|NCT02880371|459252638|FG007|Phase 2|Lost to Follow-up|0|||
127625250|NCT02880371|459252631|FG000|Phase 2|Withdrawal by Subject|0|||
127625251|NCT02880371|459252632|FG001|Phase 2|Withdrawal by Subject|0|||
127625252|NCT02880371|459252633|FG002|Phase 2|Withdrawal by Subject|0|||
127625253|NCT02880371|459252634|FG003|Phase 2|Withdrawal by Subject|0|||
127625254|NCT02880371|459252635|FG004|Phase 2|Withdrawal by Subject|0|||
127625255|NCT02880371|459252636|FG005|Phase 2|Withdrawal by Subject|1|||
127625256|NCT02880371|459252637|FG006|Phase 2|Withdrawal by Subject|1|||
127625257|NCT02880371|459252638|FG007|Phase 2|Withdrawal by Subject|0|||
127625258|NCT02880371|459252631|FG000|Phase 2|End of Study page not completed by error|0|||
127625259|NCT02880371|459252632|FG001|Phase 2|End of Study page not completed by error|0|||
127625260|NCT02880371|459252633|FG002|Phase 2|End of Study page not completed by error|0|||
127625261|NCT02880371|459252634|FG003|Phase 2|End of Study page not completed by error|0|||
127625262|NCT02880371|459252635|FG004|Phase 2|End of Study page not completed by error|0|||
127625263|NCT02880371|459252636|FG005|Phase 2|End of Study page not completed by error|1|||
127625264|NCT02880371|459252637|FG006|Phase 2|End of Study page not completed by error|0|||
127625265|NCT02880371|459252638|FG007|Phase 2|End of Study page not completed by error|0|||
127625266|NCT01777997|459252641|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
127625267|NCT01777997|459252641|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
127625268|NCT01777997|459252641|FG000|Weeks 48 to 72/96 on ART|Death|1|||
127625269|NCT01777997|459252641|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
127625270|NCT04086472|459252647|FG000|Overall Study|Lost to Follow-up|1|||
127625271|NCT04086472|459252648|FG001|Overall Study|Lost to Follow-up|0|||
127625272|NCT04086472|459252649|FG002|Overall Study|Lost to Follow-up|0|||
127625273|NCT04086472|459252650|FG003|Overall Study|Lost to Follow-up|0|||
127625274|NCT04086472|459252651|FG004|Overall Study|Lost to Follow-up|1|||
127625275|NCT04086472|459252647|FG000|Overall Study|Physician Decision|0|||
127625276|NCT04086472|459252648|FG001|Overall Study|Physician Decision|1|||
127625277|NCT04086472|459252649|FG002|Overall Study|Physician Decision|1|||
127625278|NCT04086472|459252650|FG003|Overall Study|Physician Decision|0|||
127792838|NCT03548558|459867388|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
127792839|NCT03548558|459867389|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
127792840|NCT03548558|459867390|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
127792841|NCT03548558|459867391|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
127792842|NCT03548558|459867392|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
127792843|NCT03548558|459867393|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
127792844|NCT03548558|459867387|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
127792845|NCT03548558|459867388|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
127792846|NCT03548558|459867389|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
127792847|NCT03548558|459867390|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
127792848|NCT03548558|459867391|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
127792849|NCT03548558|459867392|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
127792850|NCT03548558|459867393|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
127792851|NCT03548558|459867387|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
127792852|NCT03548558|459867388|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
127792853|NCT03548558|459867389|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
127792854|NCT03548558|459867390|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
127792855|NCT03548558|459867391|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
127792856|NCT03548558|459867392|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
127792857|NCT03548558|459867393|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
127792858|NCT03273166|459867401|FG000|Overall Study|Withdrawn prior to Completion|31|||
127792859|NCT02669017|459867402|FG000|Overall Study|Death|1|||
127792860|NCT02669017|459867403|FG001|Overall Study|Death|2|||
127792861|NCT02669017|459867404|FG002|Overall Study|Death|2|||
127792862|NCT02669017|459867405|FG003|Overall Study|Death|3|||
127792863|NCT02669017|459867406|FG004|Overall Study|Death|8|||
127792864|NCT02669017|459867407|FG005|Overall Study|Death|18|||
127792865|NCT02669017|459867408|FG006|Overall Study|Death|10|||
127625279|NCT04086472|459252651|FG004|Overall Study|Physician Decision|0|||
127625280|NCT04086472|459252647|FG000|Overall Study|Withdrawal by Subject|1|||
127792866|NCT02669017|459867409|FG007|Overall Study|Death|47|||
127625281|NCT04086472|459252648|FG001|Overall Study|Withdrawal by Subject|1|||
127625282|NCT04086472|459252649|FG002|Overall Study|Withdrawal by Subject|1|||
127625283|NCT04086472|459252650|FG003|Overall Study|Withdrawal by Subject|0|||
127625284|NCT04086472|459252651|FG004|Overall Study|Withdrawal by Subject|0|||
127625285|NCT04086472|459252647|FG000|Overall Study|Various reasons|2|||
127625286|NCT04086472|459252648|FG001|Overall Study|Various reasons|0|||
127885202|NCT00879970|460203864|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
127885203|NCT00879970|460203865|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
127885204|NCT00879970|460203866|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
127885205|NCT00879970|460203862|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
127885206|NCT00879970|460203863|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
127885207|NCT00879970|460203864|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
127885208|NCT00879970|460203865|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
127885209|NCT00879970|460203866|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
127885210|NCT00879970|460203862|FG000|Period 1 TZD Randomization|Death|2|||
127885211|NCT00879970|460203863|FG001|Period 1 TZD Randomization|Death|1|||
127885212|NCT00879970|460203864|FG002|Period 1 TZD Randomization|Death|0|||
127885213|NCT00879970|460203865|FG003|Period 1 TZD Randomization|Death|0|||
127885214|NCT00879970|460203866|FG004|Period 1 TZD Randomization|Death|0|||
127885215|NCT00879970|460203862|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
127885216|NCT00879970|460203863|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
127625287|NCT04086472|459252649|FG002|Overall Study|Various reasons|0|||
127625288|NCT04086472|459252650|FG003|Overall Study|Various reasons|3|||
127625289|NCT04086472|459252651|FG004|Overall Study|Various reasons|1|||
127625290|NCT00048724|459252652|FG000|Overall Study|Adverse Event|53|||
127625291|NCT00048724|459252653|FG001|Overall Study|Adverse Event|12|||
127625292|NCT00048724|459252652|FG000|Overall Study|Withdrawal by Subject|34|||
127625293|NCT00048724|459252653|FG001|Overall Study|Withdrawal by Subject|54|||
127625294|NCT00048724|459252652|FG000|Overall Study|Lost to Follow-up|5|||
127625295|NCT00048724|459252653|FG001|Overall Study|Lost to Follow-up|5|||
127625296|NCT00048724|459252652|FG000|Overall Study|Protocol-defined Clinical Event|17|||
127625297|NCT00048724|459252653|FG001|Overall Study|Protocol-defined Clinical Event|32|||
127625298|NCT00048724|459252652|FG000|Overall Study|Noncompliance With Protocol|4|||
127625299|NCT00048724|459252653|FG001|Overall Study|Noncompliance With Protocol|12|||
127625300|NCT00048724|459252652|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
127625301|NCT00048724|459252653|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
127625302|NCT00048724|459252652|FG000|Overall Study|Administrative|1|||
127625303|NCT00048724|459252653|FG001|Overall Study|Administrative|1|||
127625304|NCT00844545|459252654|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
127625305|NCT00844545|459252654|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
127625306|NCT00844545|459252654|FG000|Extension Treatment Period|Adverse Event|2|||
127625307|NCT00844545|459252654|FG000|Post Treatment Period|Withdrawal by Subject|1|||
127625308|NCT01743092|459252655|FG000|Overall Study|Lost to Follow-up|14|||
127625309|NCT01743092|459252656|FG001|Overall Study|Lost to Follow-up|15|||
127625310|NCT03586869|459252662|FG000|Overall Study|Progressive Disease|3|||
127625311|NCT00403455|459252665|FG000|Overall Study|Withdrawal by Subject|1|||
127625312|NCT02809976|459252672|FG000|Overall Study|Lost to Follow-up|1|||
127625313|NCT02809976|459252672|FG000|Overall Study|Withdrawal by Subject|1|||
127625314|NCT00087568|459252673|FG000|Overall Study|Adverse Event|4|||
127625315|NCT00087568|459252674|FG001|Overall Study|Adverse Event|0|||
127625316|NCT00087568|459252673|FG000|Overall Study|Withdrawal by Subject|1|||
127625317|NCT00087568|459252674|FG001|Overall Study|Withdrawal by Subject|1|||
127625318|NCT00087568|459252673|FG000|Overall Study|Lost to Follow-up|1|||
127625319|NCT00087568|459252674|FG001|Overall Study|Lost to Follow-up|0|||
127625320|NCT00087568|459252673|FG000|Overall Study|Lack of Efficacy|24|||
127625321|NCT00087568|459252674|FG001|Overall Study|Lack of Efficacy|1|||
127625322|NCT04394351|459252675|FG000|Part A (16 Weeks)|Adverse Event|1|||
127625323|NCT04394351|459252676|FG001|Part A (16 Weeks)|Adverse Event|0|||
127625324|NCT04394351|459252677|FG002|Part A (16 Weeks)|Adverse Event|0|||
127625325|NCT04394351|459252678|FG003|Part A (16 Weeks)|Adverse Event|0|||
127625326|NCT04394351|459252679|FG004|Part A (16 Weeks)|Adverse Event|0|||
127625327|NCT04394351|459252680|FG005|Part A (16 Weeks)|Adverse Event|0|||
127625328|NCT04394351|459252681|FG006|Part A (16 Weeks)|Adverse Event|0|||
127625329|NCT04394351|459252682|FG007|Part A (16 Weeks)|Adverse Event|0|||
127625330|NCT04394351|459252675|FG000|Part A (16 Weeks)|Physician Decision|0|||
127625331|NCT04394351|459252676|FG001|Part A (16 Weeks)|Physician Decision|1|||
127625332|NCT04394351|459252677|FG002|Part A (16 Weeks)|Physician Decision|0|||
127625333|NCT04394351|459252678|FG003|Part A (16 Weeks)|Physician Decision|0|||
127625334|NCT04394351|459252679|FG004|Part A (16 Weeks)|Physician Decision|0|||
127625335|NCT04394351|459252680|FG005|Part A (16 Weeks)|Physician Decision|0|||
127625336|NCT04394351|459252681|FG006|Part A (16 Weeks)|Physician Decision|0|||
127625337|NCT04394351|459252682|FG007|Part A (16 Weeks)|Physician Decision|0|||
127625338|NCT04394351|459252675|FG000|Part A (16 Weeks)|Withdrawal by Subject|0|||
127625339|NCT04394351|459252676|FG001|Part A (16 Weeks)|Withdrawal by Subject|1|||
127625340|NCT04394351|459252677|FG002|Part A (16 Weeks)|Withdrawal by Subject|0|||
127625341|NCT04394351|459252678|FG003|Part A (16 Weeks)|Withdrawal by Subject|0|||
127625342|NCT04394351|459252679|FG004|Part A (16 Weeks)|Withdrawal by Subject|0|||
127625343|NCT04394351|459252680|FG005|Part A (16 Weeks)|Withdrawal by Subject|0|||
127625344|NCT04394351|459252681|FG006|Part A (16 Weeks)|Withdrawal by Subject|0|||
127625345|NCT04394351|459252682|FG007|Part A (16 Weeks)|Withdrawal by Subject|0|||
127625346|NCT04394351|459252675|FG000|Part B (36 Weeks)|Adverse Event|0|||
127625347|NCT04394351|459252676|FG001|Part B (36 Weeks)|Adverse Event|0|||
127625348|NCT04394351|459252677|FG002|Part B (36 Weeks)|Adverse Event|0|||
127625349|NCT04394351|459252678|FG003|Part B (36 Weeks)|Adverse Event|0|||
127625350|NCT04394351|459252679|FG004|Part B (36 Weeks)|Adverse Event|0|||
127625351|NCT04394351|459252680|FG005|Part B (36 Weeks)|Adverse Event|0|||
127625352|NCT04394351|459252681|FG006|Part B (36 Weeks)|Adverse Event|1|||
127625353|NCT04394351|459252682|FG007|Part B (36 Weeks)|Adverse Event|0|||
127625354|NCT02992899|459252687|FG000|Overall Study|Withdrawal by Subject|1|||
127625355|NCT02992899|459252688|FG001|Overall Study|Withdrawal by Subject|0|||
127625356|NCT02992899|459252687|FG000|Overall Study|Lost to Follow-up|1|||
127625357|NCT02992899|459252688|FG001|Overall Study|Lost to Follow-up|3|||
127625358|NCT02738775|459252689|FG000|Overall Study|Withdrawal by Subject|0|||
127625359|NCT02738775|459252690|FG001|Overall Study|Withdrawal by Subject|1|||
127625360|NCT02738775|459252691|FG002|Overall Study|Withdrawal by Subject|0|||
127625361|NCT02738775|459252692|FG003|Overall Study|Withdrawal by Subject|0|||
127625362|NCT02738775|459252693|FG004|Overall Study|Withdrawal by Subject|0|||
127625363|NCT02738775|459252694|FG005|Overall Study|Withdrawal by Subject|0|||
127625364|NCT02738775|459252689|FG000|Overall Study|Adverse Event|0|||
127625365|NCT02738775|459252690|FG001|Overall Study|Adverse Event|0|||
127625366|NCT02738775|459252691|FG002|Overall Study|Adverse Event|0|||
127625367|NCT02738775|459252692|FG003|Overall Study|Adverse Event|1|||
127625368|NCT02738775|459252693|FG004|Overall Study|Adverse Event|0|||
127625369|NCT02738775|459252694|FG005|Overall Study|Adverse Event|0|||
127625370|NCT02738775|459252689|FG000|Overall Study|Pregnancy|0|||
127625371|NCT02738775|459252690|FG001|Overall Study|Pregnancy|1|||
127792867|NCT02669017|459867410|FG008|Overall Study|Death|20|||
127792868|NCT02669017|459867402|FG000|Overall Study|Withdrawal by Subject|0|||
127792869|NCT02669017|459867403|FG001|Overall Study|Withdrawal by Subject|0|||
127792870|NCT02669017|459867404|FG002|Overall Study|Withdrawal by Subject|0|||
127792871|NCT02669017|459867405|FG003|Overall Study|Withdrawal by Subject|1|||
127792872|NCT02669017|459867406|FG004|Overall Study|Withdrawal by Subject|2|||
127792873|NCT02669017|459867407|FG005|Overall Study|Withdrawal by Subject|0|||
127792874|NCT02669017|459867408|FG006|Overall Study|Withdrawal by Subject|0|||
127792875|NCT02669017|459867409|FG007|Overall Study|Withdrawal by Subject|2|||
127792876|NCT02669017|459867410|FG008|Overall Study|Withdrawal by Subject|2|||
127792877|NCT02669017|459867402|FG000|Overall Study|Lost to Follow-up|0|||
127625372|NCT02738775|459252691|FG002|Overall Study|Pregnancy|0|||
127625373|NCT02738775|459252692|FG003|Overall Study|Pregnancy|0|||
127625374|NCT02738775|459252693|FG004|Overall Study|Pregnancy|0|||
127625375|NCT02738775|459252694|FG005|Overall Study|Pregnancy|0|||
127625376|NCT02738775|459252689|FG000|Overall Study|Missing|0|||
127625377|NCT02738775|459252690|FG001|Overall Study|Missing|0|||
127625378|NCT02738775|459252691|FG002|Overall Study|Missing|0|||
127792878|NCT02669017|459867403|FG001|Overall Study|Lost to Follow-up|0|||
127885217|NCT00879970|460203864|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
127792879|NCT02669017|459867404|FG002|Overall Study|Lost to Follow-up|0|||
127792880|NCT02669017|459867405|FG003|Overall Study|Lost to Follow-up|0|||
127625379|NCT02738775|459252692|FG003|Overall Study|Missing|0|||
127625380|NCT02738775|459252693|FG004|Overall Study|Missing|0|||
127625381|NCT02738775|459252694|FG005|Overall Study|Missing|1|||
127625382|NCT01600040|459252695|FG000|Overall Study|Withdrawal by Subject|1|||
127625383|NCT00812812|459252699|FG000|Overall Study|Adverse Event|2|||
127625384|NCT00812812|459252700|FG001|Overall Study|Adverse Event|1|||
127625385|NCT00812812|459252699|FG000|Overall Study|Lack of Efficacy|1|||
127625386|NCT00812812|459252700|FG001|Overall Study|Lack of Efficacy|0|||
127625387|NCT00812812|459252699|FG000|Overall Study|Lost to Follow-up|0|||
127625388|NCT00812812|459252700|FG001|Overall Study|Lost to Follow-up|1|||
127625389|NCT00812812|459252699|FG000|Overall Study|Withdrawal by Subject|0|||
127625390|NCT00812812|459252700|FG001|Overall Study|Withdrawal by Subject|2|||
127625391|NCT00720876|459252704|FG000|Overall Study|found to be ineligible after starting tx|2|||
127625392|NCT00684424|459252710|FG000|Overall Study|Adverse Event|1|||
127625393|NCT00684424|459252710|FG000|Overall Study|Lost to Follow-up|2|||
127625394|NCT00684424|459252710|FG000|Overall Study|Other|2|||
127625395|NCT02410811|459252711|FG000|Overall Study|Withdrawal by Subject|0|||
127625396|NCT02410811|459252712|FG001|Overall Study|Withdrawal by Subject|0|||
127625397|NCT02410811|459252713|FG002|Overall Study|Withdrawal by Subject|1|||
127625398|NCT02410811|459252714|FG003|Overall Study|Withdrawal by Subject|0|||
127625399|NCT03511560|459252720|FG000|Overall Study|Death|0|||
127625400|NCT03511560|459252721|FG001|Overall Study|Death|1|||
127625401|NCT03511560|459252720|FG000|Overall Study|Adverse Event|0|||
127625402|NCT03511560|459252721|FG001|Overall Study|Adverse Event|2|||
127625403|NCT03511560|459252720|FG000|Overall Study|Transplant cancelled|0|||
127625404|NCT03511560|459252721|FG001|Overall Study|Transplant cancelled|1|||
127625405|NCT03511560|459252720|FG000|Overall Study|Patient switched to another drug|1|||
127625406|NCT03511560|459252721|FG001|Overall Study|Patient switched to another drug|0|||
127625407|NCT02985736|459252726|FG000|Overall Study|Lost to Follow-up|3|||
127625408|NCT00382733|459252727|FG000|Overall Study|Withdrawal by Subject|0|||
127625409|NCT00382733|459252728|FG001|Overall Study|Withdrawal by Subject|1|||
127625410|NCT00382733|459252729|FG002|Overall Study|Withdrawal by Subject|0|||
127625411|NCT00382733|459252730|FG003|Overall Study|Withdrawal by Subject|0|||
127625412|NCT00382733|459252731|FG004|Overall Study|Withdrawal by Subject|0|||
127625413|NCT01752933|459252736|FG000|Treatment|Disease Progression|3|||
127625414|NCT01752933|459252737|FG001|Treatment|Disease Progression|29|||
127625415|NCT01752933|459252736|FG000|Treatment|Withdrawal by Subject|0|||
127625416|NCT01752933|459252737|FG001|Treatment|Withdrawal by Subject|5|||
127625417|NCT01752933|459252736|FG000|Treatment|Adverse Event|1|||
127625418|NCT01752933|459252737|FG001|Treatment|Adverse Event|4|||
127625419|NCT01752933|459252736|FG000|Treatment|Physician Decision|0|||
127625420|NCT01752933|459252737|FG001|Treatment|Physician Decision|3|||
127625421|NCT01752933|459252736|FG000|Treatment|Death|0|||
127625422|NCT01752933|459252737|FG001|Treatment|Death|2|||
127625423|NCT01752933|459252736|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
127625424|NCT01752933|459252737|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
127625425|NCT01752933|459252736|FG000|Treatment|Patient noncompliant|0|||
127625426|NCT01752933|459252737|FG001|Treatment|Patient noncompliant|1|||
127625427|NCT01752933|459252736|FG000|Treatment|Patient unable to travel to appointments|0|||
127625428|NCT01752933|459252737|FG001|Treatment|Patient unable to travel to appointments|1|||
127625429|NCT01752933|459252736|FG000|Overall Study and Follow-up|Death|4|||
127625430|NCT01752933|459252737|FG001|Overall Study and Follow-up|Death|34|||
127625431|NCT01752933|459252736|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
127625432|NCT01752933|459252737|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
127625433|NCT01752933|459252736|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
127625434|NCT01752933|459252737|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
127625435|NCT01752933|459252736|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
127701479|NCT04074759|459535189|FG006|Overall Study|Other|2|||
127625436|NCT01752933|459252737|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
127642697|NCT03492281|459313113|FG001|Overall Study|Adverse Event|8|||
127642698|NCT03492281|459313114|FG002|Overall Study|Adverse Event|13|||
127642699|NCT03492281|459313112|FG000|Overall Study|Lack of Efficacy|3|||
127642700|NCT03492281|459313113|FG001|Overall Study|Lack of Efficacy|0|||
127642701|NCT03492281|459313114|FG002|Overall Study|Lack of Efficacy|1|||
127642702|NCT03492281|459313112|FG000|Overall Study|Physician Decision|1|||
127642703|NCT03492281|459313113|FG001|Overall Study|Physician Decision|0|||
127642704|NCT03492281|459313114|FG002|Overall Study|Physician Decision|3|||
127642705|NCT03492281|459313112|FG000|Overall Study|Protocol Violation|0|||
127642706|NCT03492281|459313113|FG001|Overall Study|Protocol Violation|2|||
127642707|NCT03492281|459313114|FG002|Overall Study|Protocol Violation|1|||
127642708|NCT03492281|459313112|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
127642709|NCT03492281|459313113|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
127642710|NCT03492281|459313114|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
127642711|NCT03492281|459313112|FG000|Overall Study|Death|0|||
127642712|NCT03492281|459313113|FG001|Overall Study|Death|0|||
127642713|NCT03492281|459313114|FG002|Overall Study|Death|1|||
127642714|NCT03492281|459313112|FG000|Overall Study|Captured as Other in Database|8|||
127642715|NCT03492281|459313113|FG001|Overall Study|Captured as Other in Database|6|||
127642716|NCT03492281|459313114|FG002|Overall Study|Captured as Other in Database|3|||
127642717|NCT01506193|459313115|FG000|Overall Study|Protocol Violation|1|||
127642718|NCT01506193|459313116|FG001|Overall Study|Protocol Violation|0|||
127642719|NCT01506193|459313117|FG002|Overall Study|Protocol Violation|1|||
127642720|NCT01506193|459313115|FG000|Overall Study|Migrated/moved from study area|0|||
127625437|NCT04154631|459252740|FG000|Overall Study|Patients lost to post or 6-month follow-up|42|||
127625438|NCT04154631|459252741|FG001|Overall Study|Patients lost to post or 6-month follow-up|53|||
127625439|NCT02185768|459252742|FG000|Overall Study|Patients were not treated|2|||
127625440|NCT02550652|459252744|FG000|Overall Study|Death|1|||
127625441|NCT02550652|459252745|FG001|Overall Study|Death|4|||
127625442|NCT02550652|459252744|FG000|Overall Study|Lack of Efficacy|1|||
127625443|NCT02550652|459252745|FG001|Overall Study|Lack of Efficacy|0|||
127625444|NCT02550652|459252744|FG000|Overall Study|Withdrawal by Subject|4|||
127625445|NCT02550652|459252745|FG001|Overall Study|Withdrawal by Subject|7|||
127625446|NCT02550652|459252744|FG000|Overall Study|Post Trial Access|1|||
127625447|NCT02550652|459252745|FG001|Overall Study|Post Trial Access|0|||
127625448|NCT02550652|459252744|FG000|Overall Study|Lost to Follow-up|1|||
127625449|NCT02550652|459252745|FG001|Overall Study|Lost to Follow-up|3|||
127625450|NCT02550652|459252744|FG000|Overall Study|Physician Decision|0|||
127625451|NCT02550652|459252745|FG001|Overall Study|Physician Decision|2|||
127625452|NCT02550652|459252744|FG000|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|0|||
127625453|NCT02550652|459252745|FG001|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|2|||
127625454|NCT01706250|459252746|FG000|Overall Study|Lost to Follow-up|2|||
127625455|NCT01858194|459252747|FG000|Overall Study|Total Artificial Heart Implant|0|||
127625456|NCT01858194|459252748|FG001|Overall Study|Total Artificial Heart Implant|1|||
127625457|NCT01858194|459252747|FG000|Overall Study|Lost to Follow-up|0|||
127625458|NCT01858194|459252748|FG001|Overall Study|Lost to Follow-up|1|||
127625459|NCT03181542|459252749|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
127625460|NCT03181542|459252750|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
127625461|NCT04545515|459252751|FG000|Overall Study|Adverse Event|1|||
127625462|NCT04545515|459252751|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
127625463|NCT04545515|459252751|FG000|Overall Study|Commercial drug is available for participant|7|||
127625464|NCT00958880|459252752|FG000|Overall Study|Lost to Follow-up|2|||
127625465|NCT00958880|459252753|FG001|Overall Study|Lost to Follow-up|2|||
127625466|NCT00678561|459252754|FG000|Overall Study|Adverse Event|0|||
127625467|NCT00678561|459252755|FG001|Overall Study|Adverse Event|1|||
127625468|NCT00678561|459252756|FG002|Overall Study|Adverse Event|1|||
127625469|NCT00678561|459252757|FG003|Overall Study|Adverse Event|0|||
127625470|NCT00678561|459252758|FG004|Overall Study|Adverse Event|1|||
127625471|NCT00678561|459252759|FG005|Overall Study|Adverse Event|0|||
127625472|NCT00678561|459252760|FG006|Overall Study|Adverse Event|0|||
127625473|NCT00678561|459252761|FG007|Overall Study|Adverse Event|0|||
127625474|NCT00678561|459252754|FG000|Overall Study|Protocol Violation|0|||
127625475|NCT00678561|459252755|FG001|Overall Study|Protocol Violation|0|||
127625476|NCT00678561|459252756|FG002|Overall Study|Protocol Violation|0|||
127625477|NCT00678561|459252757|FG003|Overall Study|Protocol Violation|0|||
127625478|NCT00678561|459252758|FG004|Overall Study|Protocol Violation|1|||
127625479|NCT00678561|459252759|FG005|Overall Study|Protocol Violation|1|||
127625480|NCT00678561|459252760|FG006|Overall Study|Protocol Violation|0|||
127625481|NCT00678561|459252761|FG007|Overall Study|Protocol Violation|0|||
127625482|NCT00678561|459252754|FG000|Overall Study|Withdrawal by Subject|0|||
127625483|NCT00678561|459252755|FG001|Overall Study|Withdrawal by Subject|0|||
127625484|NCT00678561|459252756|FG002|Overall Study|Withdrawal by Subject|0|||
127625485|NCT00678561|459252757|FG003|Overall Study|Withdrawal by Subject|0|||
127625486|NCT00678561|459252758|FG004|Overall Study|Withdrawal by Subject|0|||
127625487|NCT00678561|459252759|FG005|Overall Study|Withdrawal by Subject|0|||
127625488|NCT00678561|459252760|FG006|Overall Study|Withdrawal by Subject|0|||
127625489|NCT00678561|459252761|FG007|Overall Study|Withdrawal by Subject|1|||
127625490|NCT00437034|459252762|FG000|Overall Study|Adverse Event|1|||
127625491|NCT00437034|459252762|FG000|Overall Study|Disease progression during treatment|5|||
127625492|NCT02460224|459252765|FG000|Overall Study|Adverse Event|0|||
127625493|NCT02460224|459252766|FG001|Overall Study|Adverse Event|0|||
127625494|NCT02460224|459252767|FG002|Overall Study|Adverse Event|0|||
127625495|NCT02460224|459252768|FG003|Overall Study|Adverse Event|0|||
127625496|NCT02460224|459252769|FG004|Overall Study|Adverse Event|0|||
127625497|NCT02460224|459252770|FG005|Overall Study|Adverse Event|0|||
127701480|NCT04074759|459535190|FG007|Overall Study|Other|1|||
127701481|NCT04074759|459535191|FG008|Overall Study|Other|1|||
127701482|NCT04074759|459535192|FG009|Overall Study|Other|4|||
127701483|NCT04074759|459535193|FG010|Overall Study|Other|4|||
127701484|NCT04074759|459535194|FG011|Overall Study|Other|2|||
127701485|NCT04074759|459535195|FG012|Overall Study|Other|0|||
127701486|NCT04074759|459535196|FG013|Overall Study|Other|0|||
127701487|NCT04074759|459535197|FG014|Overall Study|Other|0|||
127701488|NCT04074759|459535198|FG015|Overall Study|Other|1|||
127701489|NCT04074759|459535199|FG016|Overall Study|Other|0|||
127701490|NCT04074759|459535200|FG017|Overall Study|Other|0|||
127701491|NCT04074759|459535201|FG018|Overall Study|Other|0|||
127701492|NCT04074759|459535183|FG000|Overall Study|Missing end of study status|0|||
127701493|NCT04074759|459535184|FG001|Overall Study|Missing end of study status|0|||
127701494|NCT04074759|459535185|FG002|Overall Study|Missing end of study status|0|||
127701495|NCT04074759|459535186|FG003|Overall Study|Missing end of study status|0|||
127792881|NCT02669017|459867406|FG004|Overall Study|Lost to Follow-up|0|||
127792882|NCT02669017|459867407|FG005|Overall Study|Lost to Follow-up|0|||
127625498|NCT02460224|459252771|FG006|Overall Study|Adverse Event|1|||
127625499|NCT02460224|459252772|FG007|Overall Study|Adverse Event|0|||
127625500|NCT02460224|459252773|FG008|Overall Study|Adverse Event|0|||
127625501|NCT02460224|459252774|FG009|Overall Study|Adverse Event|0|||
127625502|NCT02460224|459252775|FG010|Overall Study|Adverse Event|0|||
127625503|NCT02460224|459252776|FG011|Overall Study|Adverse Event|0|||
127625504|NCT02460224|459252777|FG012|Overall Study|Adverse Event|1|||
127625505|NCT02460224|459252778|FG013|Overall Study|Adverse Event|0|||
127625506|NCT02460224|459252779|FG014|Overall Study|Adverse Event|0|||
127625507|NCT02460224|459252780|FG015|Overall Study|Adverse Event|0|||
127625508|NCT02460224|459252781|FG016|Overall Study|Adverse Event|1|||
127625509|NCT02460224|459252782|FG017|Overall Study|Adverse Event|0|||
127625510|NCT02460224|459252783|FG018|Overall Study|Adverse Event|1|||
127625511|NCT02460224|459252784|FG019|Overall Study|Adverse Event|0|||
127625512|NCT02460224|459252785|FG020|Overall Study|Adverse Event|1|||
127625513|NCT02460224|459252786|FG021|Overall Study|Adverse Event|1|||
127625514|NCT02460224|459252787|FG022|Overall Study|Adverse Event|1|||
127625515|NCT02460224|459252788|FG023|Overall Study|Adverse Event|0|||
127625516|NCT02460224|459252789|FG024|Overall Study|Adverse Event|0|||
127625517|NCT02460224|459252790|FG025|Overall Study|Adverse Event|0|||
127625518|NCT02460224|459252791|FG026|Overall Study|Adverse Event|11|||
127625519|NCT02460224|459252792|FG027|Overall Study|Adverse Event|1|||
127625520|NCT02460224|459252793|FG028|Overall Study|Adverse Event|6|||
127625521|NCT02460224|459252765|FG000|Overall Study|Death|0|||
127625522|NCT02460224|459252766|FG001|Overall Study|Death|0|||
127625523|NCT02460224|459252767|FG002|Overall Study|Death|0|||
127625524|NCT02460224|459252768|FG003|Overall Study|Death|0|||
127625525|NCT02460224|459252769|FG004|Overall Study|Death|0|||
127625526|NCT02460224|459252770|FG005|Overall Study|Death|2|||
127625527|NCT02460224|459252771|FG006|Overall Study|Death|1|||
127625528|NCT02460224|459252772|FG007|Overall Study|Death|0|||
127625529|NCT02460224|459252773|FG008|Overall Study|Death|0|||
127625530|NCT02460224|459252774|FG009|Overall Study|Death|1|||
127625531|NCT02460224|459252775|FG010|Overall Study|Death|0|||
127625532|NCT02460224|459252776|FG011|Overall Study|Death|0|||
127625533|NCT02460224|459252777|FG012|Overall Study|Death|0|||
127625534|NCT02460224|459252778|FG013|Overall Study|Death|1|||
127625535|NCT02460224|459252779|FG014|Overall Study|Death|0|||
127625536|NCT02460224|459252780|FG015|Overall Study|Death|0|||
127625537|NCT02460224|459252781|FG016|Overall Study|Death|2|||
127625538|NCT02460224|459252782|FG017|Overall Study|Death|1|||
127625539|NCT02460224|459252783|FG018|Overall Study|Death|0|||
127701496|NCT04074759|459535187|FG004|Overall Study|Missing end of study status|0|||
127701497|NCT04074759|459535188|FG005|Overall Study|Missing end of study status|0|||
127701498|NCT04074759|459535189|FG006|Overall Study|Missing end of study status|0|||
127701499|NCT04074759|459535190|FG007|Overall Study|Missing end of study status|0|||
127701500|NCT04074759|459535191|FG008|Overall Study|Missing end of study status|0|||
127701501|NCT04074759|459535192|FG009|Overall Study|Missing end of study status|0|||
127701502|NCT04074759|459535193|FG010|Overall Study|Missing end of study status|2|||
127701503|NCT04074759|459535194|FG011|Overall Study|Missing end of study status|0|||
127625540|NCT02460224|459252784|FG019|Overall Study|Death|2|||
127625541|NCT02460224|459252785|FG020|Overall Study|Death|0|||
127701504|NCT04074759|459535195|FG012|Overall Study|Missing end of study status|0|||
127625542|NCT02460224|459252786|FG021|Overall Study|Death|0|||
127625543|NCT02460224|459252787|FG022|Overall Study|Death|0|||
127625544|NCT02460224|459252788|FG023|Overall Study|Death|0|||
127625545|NCT02460224|459252789|FG024|Overall Study|Death|1|||
127625546|NCT02460224|459252790|FG025|Overall Study|Death|1|||
127625547|NCT02460224|459252791|FG026|Overall Study|Death|5|||
127625548|NCT02460224|459252792|FG027|Overall Study|Death|0|||
127625549|NCT02460224|459252793|FG028|Overall Study|Death|1|||
127701505|NCT04074759|459535196|FG013|Overall Study|Missing end of study status|0|||
127792883|NCT02669017|459867408|FG006|Overall Study|Lost to Follow-up|0|||
127792884|NCT02669017|459867409|FG007|Overall Study|Lost to Follow-up|0|||
127792885|NCT02669017|459867410|FG008|Overall Study|Lost to Follow-up|1|||
127792886|NCT02669017|459867402|FG000|Overall Study|Miscellaneous|0|||
127792887|NCT02669017|459867403|FG001|Overall Study|Miscellaneous|0|||
127792888|NCT02669017|459867404|FG002|Overall Study|Miscellaneous|0|||
127792889|NCT02669017|459867405|FG003|Overall Study|Miscellaneous|0|||
127792890|NCT02669017|459867406|FG004|Overall Study|Miscellaneous|2|||
127792891|NCT02669017|459867407|FG005|Overall Study|Miscellaneous|1|||
127792892|NCT02669017|459867408|FG006|Overall Study|Miscellaneous|1|||
127792893|NCT02669017|459867409|FG007|Overall Study|Miscellaneous|13|||
127792894|NCT02669017|459867410|FG008|Overall Study|Miscellaneous|2|||
127792895|NCT01289015|459867411|FG000|Overall Study|Protocol Violation|12|||
127792896|NCT01289015|459867412|FG001|Overall Study|Protocol Violation|9|||
127792897|NCT01289015|459867411|FG000|Overall Study|Adverse Event|3|||
127792898|NCT01289015|459867412|FG001|Overall Study|Adverse Event|0|||
127792899|NCT01289015|459867411|FG000|Overall Study|Lost to Follow-up|33|||
127792900|NCT01289015|459867412|FG001|Overall Study|Lost to Follow-up|17|||
127792901|NCT01289015|459867411|FG000|Overall Study|Withdrawal by Subject|17|||
127792902|NCT01289015|459867412|FG001|Overall Study|Withdrawal by Subject|8|||
127792903|NCT01289015|459867411|FG000|Overall Study|Disease progression|1|||
127625550|NCT02460224|459252765|FG000|Overall Study|Lost to Follow-up|0|||
127625551|NCT02460224|459252766|FG001|Overall Study|Lost to Follow-up|0|||
127625552|NCT02460224|459252767|FG002|Overall Study|Lost to Follow-up|0|||
127625553|NCT02460224|459252768|FG003|Overall Study|Lost to Follow-up|0|||
127625554|NCT02460224|459252769|FG004|Overall Study|Lost to Follow-up|0|||
127625555|NCT02460224|459252770|FG005|Overall Study|Lost to Follow-up|0|||
127625556|NCT02460224|459252771|FG006|Overall Study|Lost to Follow-up|0|||
127625557|NCT02460224|459252772|FG007|Overall Study|Lost to Follow-up|0|||
127625558|NCT02460224|459252773|FG008|Overall Study|Lost to Follow-up|0|||
127625559|NCT02460224|459252774|FG009|Overall Study|Lost to Follow-up|0|||
127625560|NCT02460224|459252775|FG010|Overall Study|Lost to Follow-up|0|||
127625561|NCT02460224|459252776|FG011|Overall Study|Lost to Follow-up|0|||
127625562|NCT02460224|459252777|FG012|Overall Study|Lost to Follow-up|0|||
127625563|NCT02460224|459252778|FG013|Overall Study|Lost to Follow-up|0|||
127625564|NCT02460224|459252779|FG014|Overall Study|Lost to Follow-up|0|||
127625565|NCT02460224|459252780|FG015|Overall Study|Lost to Follow-up|0|||
127625566|NCT02460224|459252781|FG016|Overall Study|Lost to Follow-up|0|||
127625567|NCT02460224|459252782|FG017|Overall Study|Lost to Follow-up|0|||
127625568|NCT02460224|459252783|FG018|Overall Study|Lost to Follow-up|0|||
127625569|NCT02460224|459252784|FG019|Overall Study|Lost to Follow-up|0|||
127625570|NCT02460224|459252785|FG020|Overall Study|Lost to Follow-up|0|||
127625571|NCT02460224|459252786|FG021|Overall Study|Lost to Follow-up|0|||
127625572|NCT02460224|459252787|FG022|Overall Study|Lost to Follow-up|1|||
127625573|NCT02460224|459252788|FG023|Overall Study|Lost to Follow-up|0|||
127625574|NCT02460224|459252789|FG024|Overall Study|Lost to Follow-up|0|||
127625575|NCT02460224|459252790|FG025|Overall Study|Lost to Follow-up|0|||
127625576|NCT02460224|459252791|FG026|Overall Study|Lost to Follow-up|0|||
127625577|NCT02460224|459252792|FG027|Overall Study|Lost to Follow-up|0|||
127625578|NCT02460224|459252793|FG028|Overall Study|Lost to Follow-up|0|||
127625579|NCT02460224|459252765|FG000|Overall Study|Physician Decision|0|||
127625580|NCT02460224|459252766|FG001|Overall Study|Physician Decision|1|||
127625581|NCT02460224|459252767|FG002|Overall Study|Physician Decision|0|||
127625582|NCT02460224|459252768|FG003|Overall Study|Physician Decision|0|||
127625583|NCT02460224|459252769|FG004|Overall Study|Physician Decision|1|||
127625584|NCT02460224|459252770|FG005|Overall Study|Physician Decision|0|||
127625585|NCT02460224|459252771|FG006|Overall Study|Physician Decision|0|||
127625586|NCT02460224|459252772|FG007|Overall Study|Physician Decision|1|||
127625587|NCT02460224|459252773|FG008|Overall Study|Physician Decision|0|||
127625588|NCT02460224|459252774|FG009|Overall Study|Physician Decision|0|||
127625589|NCT02460224|459252775|FG010|Overall Study|Physician Decision|0|||
127625590|NCT02460224|459252776|FG011|Overall Study|Physician Decision|1|||
127625591|NCT02460224|459252777|FG012|Overall Study|Physician Decision|0|||
127625592|NCT02460224|459252778|FG013|Overall Study|Physician Decision|1|||
127625593|NCT02460224|459252779|FG014|Overall Study|Physician Decision|0|||
127625594|NCT02460224|459252780|FG015|Overall Study|Physician Decision|0|||
127625595|NCT02460224|459252781|FG016|Overall Study|Physician Decision|2|||
127625596|NCT02460224|459252782|FG017|Overall Study|Physician Decision|1|||
127625597|NCT02460224|459252783|FG018|Overall Study|Physician Decision|1|||
127625598|NCT02460224|459252784|FG019|Overall Study|Physician Decision|2|||
127625599|NCT02460224|459252785|FG020|Overall Study|Physician Decision|1|||
127625600|NCT02460224|459252786|FG021|Overall Study|Physician Decision|1|||
127625601|NCT02460224|459252787|FG022|Overall Study|Physician Decision|0|||
127625602|NCT02460224|459252788|FG023|Overall Study|Physician Decision|0|||
127625603|NCT02460224|459252789|FG024|Overall Study|Physician Decision|1|||
127625604|NCT02460224|459252790|FG025|Overall Study|Physician Decision|0|||
127625605|NCT02460224|459252791|FG026|Overall Study|Physician Decision|14|||
127625606|NCT02460224|459252792|FG027|Overall Study|Physician Decision|1|||
127625607|NCT02460224|459252793|FG028|Overall Study|Physician Decision|6|||
127625608|NCT02460224|459252765|FG000|Overall Study|Progressive disease|15|||
127625609|NCT02460224|459252766|FG001|Overall Study|Progressive disease|11|||
127625610|NCT02460224|459252767|FG002|Overall Study|Progressive disease|5|||
127625611|NCT02460224|459252768|FG003|Overall Study|Progressive disease|6|||
127792904|NCT01289015|459867412|FG001|Overall Study|Disease progression|0|||
127625612|NCT02460224|459252769|FG004|Overall Study|Progressive disease|3|||
127625613|NCT02460224|459252770|FG005|Overall Study|Progressive disease|26|||
127625614|NCT02460224|459252771|FG006|Overall Study|Progressive disease|28|||
127625615|NCT02460224|459252772|FG007|Overall Study|Progressive disease|4|||
127625616|NCT02460224|459252773|FG008|Overall Study|Progressive disease|5|||
127625617|NCT02460224|459252774|FG009|Overall Study|Progressive disease|9|||
127625618|NCT02460224|459252775|FG010|Overall Study|Progressive disease|5|||
127625619|NCT02460224|459252776|FG011|Overall Study|Progressive disease|4|||
127625620|NCT02460224|459252777|FG012|Overall Study|Progressive disease|5|||
127625621|NCT02460224|459252778|FG013|Overall Study|Progressive disease|4|||
127792905|NCT01289015|459867411|FG000|Overall Study|Negative baseline culture and others|33|||
127625622|NCT02460224|459252779|FG014|Overall Study|Progressive disease|5|||
127625623|NCT02460224|459252780|FG015|Overall Study|Progressive disease|5|||
127701506|NCT04074759|459535197|FG014|Overall Study|Missing end of study status|0|||
127701507|NCT04074759|459535198|FG015|Overall Study|Missing end of study status|0|||
127701508|NCT04074759|459535199|FG016|Overall Study|Missing end of study status|1|||
127701509|NCT04074759|459535200|FG017|Overall Study|Missing end of study status|0|||
127701510|NCT04074759|459535201|FG018|Overall Study|Missing end of study status|0|||
127701511|NCT03931174|459535204|FG000|Providers|Staff left organization|26|||
127701512|NCT03931174|459535205|FG001|Providers|Staff left organization|25|||
127701513|NCT03931174|459535204|FG000|Providers|Staff on leave/no longer engaged in implementation initiative|11|||
127701514|NCT03931174|459535205|FG001|Providers|Staff on leave/no longer engaged in implementation initiative|4|||
127701515|NCT03931174|459535204|FG000|Providers|Lost to Follow-up|4|||
127701516|NCT03931174|459535205|FG001|Providers|Lost to Follow-up|4|||
127701517|NCT03931174|459535204|FG000|Patients|Post-consent screening failure|1|||
127701518|NCT03931174|459535205|FG001|Patients|Post-consent screening failure|1|||
127701519|NCT03931174|459535204|FG000|Patients|Death|1|||
127701520|NCT03931174|459535205|FG001|Patients|Death|1|||
127701521|NCT03931174|459535204|FG000|Patients|Lost to Follow-up|60|||
127701522|NCT03931174|459535205|FG001|Patients|Lost to Follow-up|89|||
127701523|NCT03322267|459535206|FG000|Overall Study|Lack of Efficacy|11|||
127701524|NCT03322267|459535206|FG000|Overall Study|Adverse Event|1|||
127701525|NCT03322267|459535206|FG000|Overall Study|Withdrawal by Subject|2|||
127701526|NCT03852472|459535216|FG000|Period 1 - 12 Weeks|Withdrawal by Subject|8|||
127701527|NCT03852472|459535217|FG001|Period 1 - 12 Weeks|Withdrawal by Subject|10|||
127701528|NCT03852472|459535218|FG002|Period 1 - 12 Weeks|Withdrawal by Subject|7|||
127701529|NCT03852472|459535219|FG003|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
127701530|NCT03852472|459535220|FG004|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
127701531|NCT03852472|459535216|FG000|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
127701532|NCT03852472|459535217|FG001|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|1|||
127701533|NCT03852472|459535218|FG002|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|3|||
127701534|NCT03852472|459535219|FG003|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
127701535|NCT03852472|459535220|FG004|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
127701536|NCT03852472|459535216|FG000|Period 1 - 12 Weeks|Lost to Follow-up|5|||
127701537|NCT03852472|459535217|FG001|Period 1 - 12 Weeks|Lost to Follow-up|5|||
127701538|NCT03852472|459535218|FG002|Period 1 - 12 Weeks|Lost to Follow-up|7|||
127701539|NCT03852472|459535219|FG003|Period 1 - 12 Weeks|Lost to Follow-up|0|||
127701540|NCT03852472|459535220|FG004|Period 1 - 12 Weeks|Lost to Follow-up|0|||
127701541|NCT03852472|459535216|FG000|Period 1 - 12 Weeks|Noncompliance with the protocol|2|||
127701542|NCT03852472|459535217|FG001|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
127701543|NCT03852472|459535218|FG002|Period 1 - 12 Weeks|Noncompliance with the protocol|4|||
127701544|NCT03852472|459535219|FG003|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
127701545|NCT03852472|459535220|FG004|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
127701546|NCT03852472|459535216|FG000|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
127705237|NCT01928394|459551571|FG004|Follow-up Period|Participant withdrew consent|0|||
127705238|NCT01928394|459551572|FG005|Follow-up Period|Participant withdrew consent|2|||
127705239|NCT01928394|459551573|FG006|Follow-up Period|Participant withdrew consent|5|||
127705240|NCT01928394|459551574|FG007|Follow-up Period|Participant withdrew consent|1|||
127705241|NCT01928394|459551575|FG008|Follow-up Period|Participant withdrew consent|0|||
127705242|NCT01928394|459551576|FG009|Follow-up Period|Participant withdrew consent|0|||
127705243|NCT01928394|459551577|FG010|Follow-up Period|Participant withdrew consent|5|||
127705244|NCT01928394|459551578|FG011|Follow-up Period|Participant withdrew consent|8|||
127705245|NCT01928394|459551579|FG012|Follow-up Period|Participant withdrew consent|2|||
127705246|NCT01928394|459551580|FG013|Follow-up Period|Participant withdrew consent|12|||
127705247|NCT01928394|459551581|FG014|Follow-up Period|Participant withdrew consent|7|||
127705248|NCT01928394|459551582|FG015|Follow-up Period|Participant withdrew consent|0|||
127705249|NCT01928394|459551583|FG016|Follow-up Period|Participant withdrew consent|5|||
127705250|NCT01928394|459551584|FG017|Follow-up Period|Participant withdrew consent|3|||
127705251|NCT01928394|459551585|FG018|Follow-up Period|Participant withdrew consent|2|||
127705252|NCT01928394|459551586|FG019|Follow-up Period|Participant withdrew consent|7|||
127705253|NCT01928394|459551587|FG020|Follow-up Period|Participant withdrew consent|4|||
127705254|NCT01928394|459551588|FG021|Follow-up Period|Participant withdrew consent|6|||
127705255|NCT01928394|459551589|FG022|Follow-up Period|Participant withdrew consent|2|||
127705256|NCT01928394|459551567|FG000|Follow-up Period|Death|0|||
127705257|NCT01928394|459551568|FG001|Follow-up Period|Death|0|||
127705258|NCT01928394|459551569|FG002|Follow-up Period|Death|2|||
127705259|NCT01928394|459551570|FG003|Follow-up Period|Death|6|||
127705260|NCT01928394|459551571|FG004|Follow-up Period|Death|0|||
127705261|NCT01928394|459551572|FG005|Follow-up Period|Death|6|||
127705262|NCT01928394|459551573|FG006|Follow-up Period|Death|6|||
127705263|NCT01928394|459551574|FG007|Follow-up Period|Death|2|||
127625624|NCT02460224|459252781|FG016|Overall Study|Progressive disease|15|||
127625625|NCT02460224|459252782|FG017|Overall Study|Progressive disease|3|||
127625626|NCT02460224|459252783|FG018|Overall Study|Progressive disease|8|||
127625627|NCT02460224|459252784|FG019|Overall Study|Progressive disease|3|||
127625628|NCT02460224|459252785|FG020|Overall Study|Progressive disease|4|||
127625629|NCT02460224|459252786|FG021|Overall Study|Progressive disease|9|||
127625630|NCT02460224|459252787|FG022|Overall Study|Progressive disease|4|||
127625631|NCT02460224|459252788|FG023|Overall Study|Progressive disease|11|||
127625632|NCT02460224|459252789|FG024|Overall Study|Progressive disease|4|||
127625633|NCT02460224|459252790|FG025|Overall Study|Progressive disease|5|||
127625634|NCT02460224|459252791|FG026|Overall Study|Progressive disease|85|||
127625635|NCT02460224|459252792|FG027|Overall Study|Progressive disease|17|||
127625636|NCT02460224|459252793|FG028|Overall Study|Progressive disease|77|||
127625637|NCT02460224|459252765|FG000|Overall Study|Subject/guardian decision|2|||
127625638|NCT02460224|459252766|FG001|Overall Study|Subject/guardian decision|0|||
127625639|NCT02460224|459252767|FG002|Overall Study|Subject/guardian decision|1|||
127625640|NCT02460224|459252768|FG003|Overall Study|Subject/guardian decision|0|||
127625641|NCT02460224|459252769|FG004|Overall Study|Subject/guardian decision|2|||
127625642|NCT02460224|459252770|FG005|Overall Study|Subject/guardian decision|2|||
127625643|NCT02460224|459252771|FG006|Overall Study|Subject/guardian decision|0|||
127625644|NCT02460224|459252772|FG007|Overall Study|Subject/guardian decision|0|||
127625645|NCT02460224|459252773|FG008|Overall Study|Subject/guardian decision|1|||
127625646|NCT02460224|459252774|FG009|Overall Study|Subject/guardian decision|1|||
127625647|NCT02460224|459252775|FG010|Overall Study|Subject/guardian decision|0|||
127625648|NCT02460224|459252776|FG011|Overall Study|Subject/guardian decision|1|||
127625649|NCT02460224|459252777|FG012|Overall Study|Subject/guardian decision|0|||
127625650|NCT02460224|459252778|FG013|Overall Study|Subject/guardian decision|0|||
127625651|NCT02460224|459252779|FG014|Overall Study|Subject/guardian decision|0|||
127625652|NCT02460224|459252780|FG015|Overall Study|Subject/guardian decision|1|||
127625653|NCT02460224|459252781|FG016|Overall Study|Subject/guardian decision|0|||
127625654|NCT02460224|459252782|FG017|Overall Study|Subject/guardian decision|1|||
127625655|NCT02460224|459252783|FG018|Overall Study|Subject/guardian decision|2|||
127625656|NCT02460224|459252784|FG019|Overall Study|Subject/guardian decision|0|||
127625657|NCT02460224|459252785|FG020|Overall Study|Subject/guardian decision|0|||
127625658|NCT02460224|459252786|FG021|Overall Study|Subject/guardian decision|1|||
127625659|NCT02460224|459252787|FG022|Overall Study|Subject/guardian decision|0|||
127625660|NCT02460224|459252788|FG023|Overall Study|Subject/guardian decision|0|||
127625661|NCT02460224|459252789|FG024|Overall Study|Subject/guardian decision|0|||
127625662|NCT02460224|459252790|FG025|Overall Study|Subject/guardian decision|0|||
127625663|NCT02460224|459252791|FG026|Overall Study|Subject/guardian decision|6|||
127625664|NCT02460224|459252792|FG027|Overall Study|Subject/guardian decision|2|||
127625665|NCT02460224|459252793|FG028|Overall Study|Subject/guardian decision|3|||
127625666|NCT00853658|459252794|FG000|Overall Study|Death|713|||
127625667|NCT00853658|459252795|FG001|Overall Study|Death|768|||
127625668|NCT00853658|459252796|FG002|Overall Study|Death|753|||
127625669|NCT00853658|459252794|FG000|Overall Study|Lost to Follow-up|11|||
127625670|NCT00853658|459252795|FG001|Overall Study|Lost to Follow-up|6|||
127625671|NCT00853658|459252796|FG002|Overall Study|Lost to Follow-up|11|||
127625672|NCT00853658|459252794|FG000|Overall Study|H.A. Request|26|||
127625673|NCT00853658|459252795|FG001|Overall Study|H.A. Request|23|||
127625674|NCT00853658|459252796|FG002|Overall Study|H.A. Request|19|||
127625675|NCT00853658|459252794|FG000|Overall Study|IRB request|0|||
127625676|NCT00853658|459252795|FG001|Overall Study|IRB request|0|||
127625677|NCT00853658|459252796|FG002|Overall Study|IRB request|2|||
127625678|NCT00853658|459252794|FG000|Overall Study|Vital Status known (alive) at study end|2|||
127625679|NCT00853658|459252795|FG001|Overall Study|Vital Status known (alive) at study end|3|||
127625680|NCT00853658|459252796|FG002|Overall Study|Vital Status known (alive) at study end|3|||
127625681|NCT00853658|459252794|FG000|Overall Study|Vital Status unknown at study end|1|||
127625682|NCT00853658|459252795|FG001|Overall Study|Vital Status unknown at study end|1|||
127625683|NCT00853658|459252796|FG002|Overall Study|Vital Status unknown at study end|0|||
127625684|NCT00853658|459252794|FG000|Overall Study|Vital Status at study end N/A|8|||
127625685|NCT00853658|459252795|FG001|Overall Study|Vital Status at study end N/A|10|||
127625686|NCT00853658|459252796|FG002|Overall Study|Vital Status at study end N/A|10|||
127625687|NCT00853658|459252794|FG000|Overall Study|Patient's request|21|||
127625688|NCT00853658|459252795|FG001|Overall Study|Patient's request|17|||
127625689|NCT00853658|459252796|FG002|Overall Study|Patient's request|11|||
127625690|NCT00853658|459252794|FG000|Overall Study|Missing study completion information|5|||
127625691|NCT00853658|459252795|FG001|Overall Study|Missing study completion information|4|||
127625692|NCT00853658|459252796|FG002|Overall Study|Missing study completion information|6|||
127625693|NCT03146650|459252798|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
127625694|NCT03146650|459252798|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
127625695|NCT03146650|459252798|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
127625696|NCT03146650|459252798|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
127625697|NCT03146650|459252798|FG000|2 Year Follow-up|Death|11|||
127625698|NCT03146650|459252798|FG000|2 Year Follow-up|Still in follow-up|7|||
127625699|NCT03146650|459252798|FG000|2 Year Follow-up|Lost to Follow-up|1|||
127625700|NCT03333486|459252801|FG000|Overall Study|Withdrawal by Subject|1|||
127625701|NCT03333486|459252801|FG000|Overall Study|Lost to Follow-up|1|||
127625702|NCT01976845|459252804|FG000|Overall Study|Physician Decision|8|||
127625703|NCT01976845|459252805|FG001|Overall Study|Physician Decision|8|||
127625704|NCT01976845|459252806|FG002|Overall Study|Physician Decision|3|||
127625705|NCT02556710|459254487|FG000|Overall Study|Surgical treatment|3|||
127625706|NCT02556710|459254488|FG001|Overall Study|Surgical treatment|0|||
127625707|NCT02556710|459254487|FG000|Overall Study|Required proscribed pain medication|2|||
127625708|NCT02556710|459254488|FG001|Overall Study|Required proscribed pain medication|1|||
127625709|NCT02556710|459254487|FG000|Overall Study|Lack of Efficacy|1|||
127625710|NCT02556710|459254488|FG001|Overall Study|Lack of Efficacy|0|||
127625711|NCT02556710|459254487|FG000|Overall Study|Worsening osteoarthritis|1|||
127625712|NCT02556710|459254488|FG001|Overall Study|Worsening osteoarthritis|0|||
127625713|NCT02556710|459254487|FG000|Overall Study|Moved out of state|1|||
127625714|NCT02556710|459254488|FG001|Overall Study|Moved out of state|0|||
127625715|NCT02556710|459254487|FG000|Overall Study|Missing reason|3|||
127625716|NCT02556710|459254488|FG001|Overall Study|Missing reason|1|||
127625717|NCT02556710|459254487|FG000|Overall Study|Pain as lack of efficacy|0|||
127625718|NCT02556710|459254488|FG001|Overall Study|Pain as lack of efficacy|4|||
127625719|NCT04258839|459254489|FG000|Overall Study|Adverse Event|2|||
127625720|NCT04258839|459254490|FG001|Overall Study|Adverse Event|4|||
127625721|NCT04258839|459254489|FG000|Overall Study|Lack of Efficacy|0|||
127625722|NCT04258839|459254490|FG001|Overall Study|Lack of Efficacy|2|||
127625723|NCT04258839|459254489|FG000|Overall Study|Lost to Follow-up|2|||
127625724|NCT04258839|459254490|FG001|Overall Study|Lost to Follow-up|0|||
127625725|NCT04258839|459254489|FG000|Overall Study|Withdrawal by Subject|1|||
127625726|NCT04258839|459254490|FG001|Overall Study|Withdrawal by Subject|2|||
127625727|NCT04258839|459254489|FG000|Overall Study|Withdrawal by Caregiver|5|||
127625728|NCT04258839|459254490|FG001|Overall Study|Withdrawal by Caregiver|6|||
127625729|NCT04258839|459254489|FG000|Overall Study|Reason not Specified|0|||
127625730|NCT04258839|459254490|FG001|Overall Study|Reason not Specified|1|||
127625731|NCT02602288|459254495|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
127625732|NCT02602288|459254496|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
127625733|NCT02602288|459254495|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
127625734|NCT02602288|459254496|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
127625735|NCT02602288|459254495|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
127625736|NCT02602288|459254496|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
127625737|NCT02602288|459254495|FG000|12 Month Follow-up|Lost to Follow-up|0|||
127625738|NCT02602288|459254496|FG001|12 Month Follow-up|Lost to Follow-up|4|||
127625739|NCT02602288|459254495|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
127625740|NCT02602288|459254496|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
127625741|NCT01310413|459254497|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
127625742|NCT01310413|459254498|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
127625743|NCT01310413|459254499|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
127705264|NCT01928394|459551575|FG008|Follow-up Period|Death|1|||
127625744|NCT01310413|459254500|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
127625745|NCT01310413|459254501|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
127625746|NCT01310413|459254502|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
127625747|NCT01310413|459254503|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
127625748|NCT01310413|459254497|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
127625749|NCT01310413|459254498|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
127625750|NCT01310413|459254499|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
127625751|NCT01310413|459254500|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
127625752|NCT01310413|459254501|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
127625753|NCT01310413|459254502|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
127625754|NCT01310413|459254503|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
127625755|NCT01310413|459254497|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
127625756|NCT01310413|459254498|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
127625757|NCT01310413|459254499|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
127625758|NCT01310413|459254500|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
127625759|NCT01310413|459254501|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
127625760|NCT01310413|459254502|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
127625761|NCT01310413|459254503|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
127625762|NCT01310413|459254497|FG000|Day 0 to Day 385|Other|1|||
127625763|NCT01310413|459254498|FG001|Day 0 to Day 385|Other|0|||
127625764|NCT01310413|459254499|FG002|Day 0 to Day 385|Other|3|||
127625765|NCT01310413|459254500|FG003|Day 0 to Day 385|Other|0|||
127625766|NCT01310413|459254501|FG004|Day 0 to Day 385|Other|0|||
127625767|NCT01310413|459254502|FG005|Day 0 to Day 385|Other|0|||
127625768|NCT01310413|459254503|FG006|Day 0 to Day 385|Other|0|||
127625769|NCT01310413|459254497|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
127625770|NCT01310413|459254498|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
127625771|NCT01310413|459254499|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
127625772|NCT01310413|459254500|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
127625773|NCT01310413|459254501|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
127625774|NCT01310413|459254502|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
127625775|NCT01310413|459254503|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
127625776|NCT01310413|459254497|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
127625777|NCT01310413|459254498|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
127625778|NCT01310413|459254499|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
127625779|NCT01310413|459254500|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
127625780|NCT01310413|459254501|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
127625781|NCT01310413|459254502|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
127625782|NCT01310413|459254503|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
127625783|NCT00941733|459254504|FG000|Overall Study|Death|24|||
127625784|NCT00941733|459254505|FG001|Overall Study|Death|10|||
127625785|NCT00941733|459254504|FG000|Overall Study|Withdrawal by Subject|14|||
127625786|NCT00941733|459254505|FG001|Overall Study|Withdrawal by Subject|6|||
127625787|NCT00941733|459254504|FG000|Overall Study|Adverse Event|20|||
127625788|NCT00941733|459254505|FG001|Overall Study|Adverse Event|4|||
127625789|NCT00941733|459254504|FG000|Overall Study|Lost to Follow-up|1|||
127625790|NCT00941733|459254505|FG001|Overall Study|Lost to Follow-up|2|||
127625791|NCT00941733|459254504|FG000|Overall Study|Protocol Violation|15|||
127625792|NCT00941733|459254505|FG001|Overall Study|Protocol Violation|6|||
127625793|NCT00612066|459254508|FG000|Overall Study|Adverse Event|1|||
127625794|NCT00630877|459254509|FG000|Overall Study|Adverse Event|11|||
127625795|NCT00630877|459254510|FG001|Overall Study|Adverse Event|8|||
127625796|NCT00630877|459254511|FG002|Overall Study|Adverse Event|7|||
127701547|NCT03852472|459535217|FG001|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|3|||
127625797|NCT00630877|459254509|FG000|Overall Study|Withdrawal by Subject|3|||
127625798|NCT00630877|459254510|FG001|Overall Study|Withdrawal by Subject|4|||
127885218|NCT00879970|460203865|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
127885219|NCT00879970|460203866|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
127885220|NCT00879970|460203862|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
127885221|NCT00879970|460203863|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
127885222|NCT00879970|460203864|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
127885223|NCT00879970|460203865|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
127885224|NCT00879970|460203866|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
127625799|NCT00630877|459254511|FG002|Overall Study|Withdrawal by Subject|0|||
127625800|NCT00630877|459254509|FG000|Overall Study|Lost to Follow-up|2|||
127625801|NCT00630877|459254510|FG001|Overall Study|Lost to Follow-up|0|||
127625802|NCT00630877|459254511|FG002|Overall Study|Lost to Follow-up|0|||
127625803|NCT00630877|459254509|FG000|Overall Study|Noncompliance|2|||
127625804|NCT00630877|459254510|FG001|Overall Study|Noncompliance|3|||
127625805|NCT00630877|459254511|FG002|Overall Study|Noncompliance|1|||
127625806|NCT00630877|459254509|FG000|Overall Study|Protocol violation|1|||
127625807|NCT00630877|459254510|FG001|Overall Study|Protocol violation|0|||
127625808|NCT00630877|459254511|FG002|Overall Study|Protocol violation|1|||
127625809|NCT00630877|459254509|FG000|Overall Study|Personal reasons|0|||
127625810|NCT00630877|459254510|FG001|Overall Study|Personal reasons|0|||
127625811|NCT00630877|459254511|FG002|Overall Study|Personal reasons|1|||
127625812|NCT01643473|459254512|FG000|Overall Study|Lost to Follow-up|1|||
127625813|NCT01643473|459254513|FG001|Overall Study|Lost to Follow-up|0|||
127625814|NCT01913041|459254514|FG000|Overall Study|Protocol Violation|35|||
127625815|NCT01913041|459254514|FG000|Overall Study|Withdrawal by Subject|3|||
127625816|NCT01913041|459254514|FG000|Overall Study|Physician Decision|1|||
127625817|NCT01265953|459254516|FG000|Overall Study|Non compliance|5|||
127625818|NCT01265953|459254517|FG001|Overall Study|Non compliance|3|||
127625819|NCT01610700|459254519|FG000|Overall Study|Adverse Event|3|||
127625820|NCT01610700|459254520|FG001|Overall Study|Adverse Event|1|||
127625821|NCT01610700|459254519|FG000|Overall Study|Withdrawal by Subject|0|||
127625822|NCT01610700|459254520|FG001|Overall Study|Withdrawal by Subject|1|||
127625823|NCT01610700|459254519|FG000|Overall Study|subject took one dose of street cannabis|0|||
127625824|NCT01610700|459254520|FG001|Overall Study|subject took one dose of street cannabis|1|||
127701548|NCT03852472|459535218|FG002|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
127701549|NCT03852472|459535219|FG003|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
127701550|NCT03852472|459535220|FG004|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
127701551|NCT03852472|459535216|FG000|Period 1 - 12 Weeks|Adverse Event|4|||
127701552|NCT03852472|459535217|FG001|Period 1 - 12 Weeks|Adverse Event|6|||
127701553|NCT03852472|459535218|FG002|Period 1 - 12 Weeks|Adverse Event|4|||
127701554|NCT03852472|459535219|FG003|Period 1 - 12 Weeks|Adverse Event|0|||
127701555|NCT03852472|459535220|FG004|Period 1 - 12 Weeks|Adverse Event|0|||
127701556|NCT03852472|459535216|FG000|Period 1 - 12 Weeks|Reason not stated|2|||
127701557|NCT03852472|459535217|FG001|Period 1 - 12 Weeks|Reason not stated|1|||
127701558|NCT03852472|459535218|FG002|Period 1 - 12 Weeks|Reason not stated|0|||
127701559|NCT03852472|459535219|FG003|Period 1 - 12 Weeks|Reason not stated|0|||
127701560|NCT03852472|459535220|FG004|Period 1 - 12 Weeks|Reason not stated|0|||
127701561|NCT03852472|459535216|FG000|Period 2 - Week 44|Withdrawal by Subject|0|||
127701562|NCT03852472|459535217|FG001|Period 2 - Week 44|Withdrawal by Subject|22|||
127701563|NCT03852472|459535218|FG002|Period 2 - Week 44|Withdrawal by Subject|15|||
127701564|NCT03852472|459535219|FG003|Period 2 - Week 44|Withdrawal by Subject|10|||
127701565|NCT03852472|459535220|FG004|Period 2 - Week 44|Withdrawal by Subject|10|||
127701566|NCT03852472|459535216|FG000|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
127701567|NCT03852472|459535217|FG001|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|2|||
127701568|NCT03852472|459535218|FG002|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
127701569|NCT03852472|459535219|FG003|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
127701570|NCT03852472|459535220|FG004|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
127701571|NCT03852472|459535216|FG000|Period 2 - Week 44|Lost to Follow-up|0|||
127701572|NCT03852472|459535217|FG001|Period 2 - Week 44|Lost to Follow-up|8|||
127701573|NCT03852472|459535218|FG002|Period 2 - Week 44|Lost to Follow-up|12|||
127701574|NCT03852472|459535219|FG003|Period 2 - Week 44|Lost to Follow-up|1|||
127701575|NCT03852472|459535220|FG004|Period 2 - Week 44|Lost to Follow-up|2|||
127701576|NCT03852472|459535216|FG000|Period 2 - Week 44|Noncompliance with the protocol|0|||
127701577|NCT03852472|459535217|FG001|Period 2 - Week 44|Noncompliance with the protocol|2|||
127625825|NCT02648698|459254521|FG000|Overall Study|Protocol Violation|1|||
127625826|NCT02648698|459254522|FG001|Overall Study|Protocol Violation|5|||
127625827|NCT01640301|459254523|FG000|Overall Study|Death|0|||
127625828|NCT01640301|459254524|FG001|Overall Study|Death|8|||
127625829|NCT02391948|459254529|FG000|6-month Assessment|Death|0|||
127625830|NCT02391948|459254530|FG001|6-month Assessment|Death|0|||
127625831|NCT02391948|459254531|FG002|6-month Assessment|Death|0|||
127625832|NCT02391948|459254532|FG003|6-month Assessment|Death|0|||
127701578|NCT03852472|459535218|FG002|Period 2 - Week 44|Noncompliance with the protocol|1|||
127701579|NCT03852472|459535219|FG003|Period 2 - Week 44|Noncompliance with the protocol|0|||
127792906|NCT01289015|459867412|FG001|Overall Study|Negative baseline culture and others|20|||
127792907|NCT03509350|459867417|FG000|Overall Study|Withdrawal by Subject|0|||
127792908|NCT03509350|459867418|FG001|Overall Study|Withdrawal by Subject|2|||
127792909|NCT01425203|459867421|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
127625833|NCT02391948|459254533|FG004|6-month Assessment|Death|1|||
127625834|NCT02391948|459254529|FG000|6-month Assessment|Withdrawal by Subject|0|||
127625835|NCT02391948|459254530|FG001|6-month Assessment|Withdrawal by Subject|0|||
127625836|NCT02391948|459254531|FG002|6-month Assessment|Withdrawal by Subject|1|||
127625837|NCT02391948|459254532|FG003|6-month Assessment|Withdrawal by Subject|2|||
127625838|NCT02391948|459254533|FG004|6-month Assessment|Withdrawal by Subject|0|||
127625839|NCT02391948|459254529|FG000|6-month Assessment|Lost to Follow-up|4|||
127625840|NCT02391948|459254530|FG001|6-month Assessment|Lost to Follow-up|5|||
127625841|NCT02391948|459254531|FG002|6-month Assessment|Lost to Follow-up|2|||
127625842|NCT02391948|459254532|FG003|6-month Assessment|Lost to Follow-up|3|||
127625843|NCT02391948|459254533|FG004|6-month Assessment|Lost to Follow-up|1|||
127625844|NCT02391948|459254529|FG000|6-month Assessment|Medical issue/illness|1|||
127625845|NCT02391948|459254530|FG001|6-month Assessment|Medical issue/illness|1|||
127625846|NCT02391948|459254531|FG002|6-month Assessment|Medical issue/illness|0|||
127625847|NCT02391948|459254532|FG003|6-month Assessment|Medical issue/illness|0|||
127625848|NCT02391948|459254533|FG004|6-month Assessment|Medical issue/illness|0|||
127625849|NCT02391948|459254529|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
127625850|NCT02391948|459254530|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
127625851|NCT02391948|459254531|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
127625852|NCT02391948|459254532|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
127625853|NCT02391948|459254533|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
127625854|NCT02391948|459254529|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
127625855|NCT02391948|459254530|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
127625856|NCT02391948|459254531|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
127625857|NCT02391948|459254532|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
127625858|NCT02391948|459254533|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
127625859|NCT02391948|459254529|FG000|12-month Assessment|Death|0|||
127625860|NCT02391948|459254530|FG001|12-month Assessment|Death|0|||
127625861|NCT02391948|459254531|FG002|12-month Assessment|Death|0|||
127625862|NCT02391948|459254532|FG003|12-month Assessment|Death|1|||
127625863|NCT02391948|459254533|FG004|12-month Assessment|Death|0|||
127625864|NCT02391948|459254529|FG000|12-month Assessment|Withdrawal by Subject|1|||
127625865|NCT02391948|459254530|FG001|12-month Assessment|Withdrawal by Subject|0|||
127625866|NCT02391948|459254531|FG002|12-month Assessment|Withdrawal by Subject|0|||
127625867|NCT02391948|459254532|FG003|12-month Assessment|Withdrawal by Subject|1|||
127625868|NCT02391948|459254533|FG004|12-month Assessment|Withdrawal by Subject|0|||
127625869|NCT02391948|459254529|FG000|12-month Assessment|Lost to Follow-up|5|||
127625870|NCT02391948|459254530|FG001|12-month Assessment|Lost to Follow-up|4|||
127625871|NCT02391948|459254531|FG002|12-month Assessment|Lost to Follow-up|4|||
127625872|NCT02391948|459254532|FG003|12-month Assessment|Lost to Follow-up|4|||
127625873|NCT02391948|459254533|FG004|12-month Assessment|Lost to Follow-up|5|||
127625874|NCT02391948|459254529|FG000|12-month Assessment|Medical issue/illness|0|||
127625875|NCT02391948|459254530|FG001|12-month Assessment|Medical issue/illness|1|||
127625876|NCT02391948|459254531|FG002|12-month Assessment|Medical issue/illness|0|||
127625877|NCT02391948|459254532|FG003|12-month Assessment|Medical issue/illness|1|||
127625878|NCT02391948|459254533|FG004|12-month Assessment|Medical issue/illness|0|||
127701580|NCT03852472|459535220|FG004|Period 2 - Week 44|Noncompliance with the protocol|0|||
127701581|NCT03852472|459535216|FG000|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|0|||
127701582|NCT03852472|459535217|FG001|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|1|||
127701583|NCT03852472|459535218|FG002|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
127701584|NCT03852472|459535219|FG003|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|2|||
127701585|NCT03852472|459535220|FG004|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
127701586|NCT03852472|459535216|FG000|Period 2 - Week 44|Adverse Event|0|||
127701587|NCT03852472|459535217|FG001|Period 2 - Week 44|Adverse Event|3|||
127701588|NCT03852472|459535218|FG002|Period 2 - Week 44|Adverse Event|1|||
127701589|NCT03852472|459535219|FG003|Period 2 - Week 44|Adverse Event|2|||
127701590|NCT03852472|459535220|FG004|Period 2 - Week 44|Adverse Event|2|||
127701591|NCT03852472|459535216|FG000|Period 2 - Week 44|COVID-19 Related|0|||
127701592|NCT03852472|459535217|FG001|Period 2 - Week 44|COVID-19 Related|0|||
127701593|NCT03852472|459535218|FG002|Period 2 - Week 44|COVID-19 Related|0|||
127701594|NCT03852472|459535219|FG003|Period 2 - Week 44|COVID-19 Related|1|||
127701595|NCT03852472|459535220|FG004|Period 2 - Week 44|COVID-19 Related|0|||
127701596|NCT03852472|459535216|FG000|Period 2 - Week 44|Reason not stated|0|||
127701597|NCT03852472|459535217|FG001|Period 2 - Week 44|Reason not stated|0|||
127701598|NCT03852472|459535218|FG002|Period 2 - Week 44|Reason not stated|0|||
127701599|NCT03852472|459535219|FG003|Period 2 - Week 44|Reason not stated|0|||
127701600|NCT03852472|459535220|FG004|Period 2 - Week 44|Reason not stated|1|||
127701601|NCT06457802|459535221|FG000|Overall Study|Early termination of study prior to participant completion|2|||
127701602|NCT06457802|459535222|FG001|Overall Study|Early termination of study prior to participant completion|2|||
127701603|NCT01467427|459535223|FG000|Overall Study|Withdrawal by Subject|1|||
127701604|NCT01467427|459535224|FG001|Overall Study|Withdrawal by Subject|0|||
127701605|NCT01467427|459535223|FG000|Overall Study|Not continuing in extension phase|0|||
127701606|NCT01467427|459535224|FG001|Overall Study|Not continuing in extension phase|2|||
127701607|NCT01467427|459535223|FG000|Overall Study|Withdrawal during extension phase,- Non-compliance|0|||
127701608|NCT01467427|459535224|FG001|Overall Study|Withdrawal during extension phase,- Non-compliance|1|||
127701609|NCT01467427|459535223|FG000|Overall Study|Withdrawal during extension phase, Withdrawal criteria|0|||
127701610|NCT01467427|459535224|FG001|Overall Study|Withdrawal during extension phase, Withdrawal criteria|2|||
127701611|NCT01467427|459535223|FG000|Overall Study|Withdrawal during extension phase, Withdrawal of consent|2|||
127701612|NCT01467427|459535224|FG001|Overall Study|Withdrawal during extension phase, Withdrawal of consent|1|||
127701613|NCT01467427|459535223|FG000|Overall Study|Withdrawal during extension phase, Other|3|||
127701614|NCT01467427|459535224|FG001|Overall Study|Withdrawal during extension phase, Other|3|||
127701615|NCT03161028|459535225|FG000|Overall Study|Withdrawal by Subject|6|||
127701616|NCT03161028|459535226|FG001|Overall Study|Withdrawal by Subject|4|||
127701617|NCT03161028|459535225|FG000|Overall Study|Adverse Event|5|||
127701618|NCT03161028|459535226|FG001|Overall Study|Adverse Event|1|||
127701619|NCT03161028|459535225|FG000|Overall Study|Study drug side effects|2|||
127701620|NCT03161028|459535226|FG001|Overall Study|Study drug side effects|2|||
127701621|NCT03161028|459535225|FG000|Overall Study|Administrative PD/UP|4|||
127701622|NCT03161028|459535226|FG001|Overall Study|Administrative PD/UP|2|||
127701623|NCT03161028|459535225|FG000|Overall Study|Lost to Follow-up|2|||
127701624|NCT03161028|459535226|FG001|Overall Study|Lost to Follow-up|0|||
127701625|NCT03161028|459535225|FG000|Overall Study|Unable to comply with procedures|1|||
127701626|NCT03161028|459535226|FG001|Overall Study|Unable to comply with procedures|1|||
127701627|NCT03492216|459535227|FG000|Overall Study|Death|1|||
127701628|NCT03492216|459535228|FG001|Overall Study|Death|0|||
127701629|NCT03492216|459535229|FG002|Overall Study|Death|4|||
127701630|NCT03492216|459535230|FG003|Overall Study|Death|0|||
127701631|NCT03492216|459535227|FG000|Overall Study|Withdrawal by Subject|5|||
127701632|NCT03492216|459535228|FG001|Overall Study|Withdrawal by Subject|3|||
127701633|NCT03492216|459535229|FG002|Overall Study|Withdrawal by Subject|1|||
127701634|NCT03492216|459535230|FG003|Overall Study|Withdrawal by Subject|1|||
127701635|NCT03492216|459535227|FG000|Overall Study|Lost to Follow-up|9|||
127701636|NCT03492216|459535228|FG001|Overall Study|Lost to Follow-up|2|||
127701637|NCT03492216|459535229|FG002|Overall Study|Lost to Follow-up|7|||
127701638|NCT03492216|459535230|FG003|Overall Study|Lost to Follow-up|8|||
127701639|NCT03492216|459535227|FG000|Overall Study|Moved|5|||
127701640|NCT03492216|459535228|FG001|Overall Study|Moved|3|||
127701641|NCT03492216|459535229|FG002|Overall Study|Moved|3|||
127701642|NCT03492216|459535230|FG003|Overall Study|Moved|5|||
127701643|NCT03492216|459535227|FG000|Overall Study|Too ill|0|||
127701644|NCT03492216|459535228|FG001|Overall Study|Too ill|1|||
127701645|NCT03492216|459535229|FG002|Overall Study|Too ill|0|||
127701646|NCT03492216|459535230|FG003|Overall Study|Too ill|0|||
127625879|NCT02391948|459254529|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
127625880|NCT02391948|459254530|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
127625881|NCT02391948|459254531|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
127625882|NCT02391948|459254532|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
127625883|NCT02391948|459254533|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
127625884|NCT02391948|459254529|FG000|18-month Assessment|Death|0|||
127625885|NCT02391948|459254530|FG001|18-month Assessment|Death|0|||
127625886|NCT02391948|459254531|FG002|18-month Assessment|Death|0|||
127701647|NCT03492216|459535227|FG000|Overall Study|Incarcerated|0|||
127701648|NCT03492216|459535228|FG001|Overall Study|Incarcerated|0|||
127701649|NCT03492216|459535229|FG002|Overall Study|Incarcerated|2|||
127701650|NCT03492216|459535230|FG003|Overall Study|Incarcerated|0|||
127701651|NCT00736723|459535231|FG000|Overall Study|Withdrawal by Subject|4|||
127701652|NCT00736723|459535232|FG001|Overall Study|Withdrawal by Subject|3|||
127625887|NCT02391948|459254532|FG003|18-month Assessment|Death|1|||
127625888|NCT02391948|459254533|FG004|18-month Assessment|Death|1|||
127625889|NCT02391948|459254529|FG000|18-month Assessment|Withdrawal by Subject|1|||
127701653|NCT00506519|459537003|FG000|Overall Study|Death|4|||
127701654|NCT00506519|459537004|FG001|Overall Study|Death|6|||
127701655|NCT00506519|459537005|FG002|Overall Study|Death|0|||
127701656|NCT00506519|459537003|FG000|Overall Study|Adverse Event|1|||
127701657|NCT00506519|459537004|FG001|Overall Study|Adverse Event|0|||
127701658|NCT00506519|459537005|FG002|Overall Study|Adverse Event|0|||
127701659|NCT01186367|459537006|FG000|Overall Study|Lost to Follow-up|7|||
127701660|NCT01186367|459537007|FG001|Overall Study|Lost to Follow-up|4|||
127701661|NCT01186367|459537008|FG002|Overall Study|Lost to Follow-up|7|||
127701662|NCT01186367|459537006|FG000|Overall Study|Did not receive study treatment|0|||
127705265|NCT01928394|459551576|FG009|Follow-up Period|Death|2|||
127625890|NCT02391948|459254530|FG001|18-month Assessment|Withdrawal by Subject|0|||
127625891|NCT02391948|459254531|FG002|18-month Assessment|Withdrawal by Subject|0|||
127625892|NCT02391948|459254532|FG003|18-month Assessment|Withdrawal by Subject|1|||
127625893|NCT02391948|459254533|FG004|18-month Assessment|Withdrawal by Subject|0|||
127625894|NCT02391948|459254529|FG000|18-month Assessment|Lost to Follow-up|2|||
127625895|NCT02391948|459254530|FG001|18-month Assessment|Lost to Follow-up|6|||
127625896|NCT02391948|459254531|FG002|18-month Assessment|Lost to Follow-up|2|||
127625897|NCT02391948|459254532|FG003|18-month Assessment|Lost to Follow-up|2|||
127625898|NCT02391948|459254533|FG004|18-month Assessment|Lost to Follow-up|3|||
127625899|NCT02391948|459254529|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
127625900|NCT02391948|459254530|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
127625901|NCT02391948|459254531|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
127625902|NCT02391948|459254532|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
127625903|NCT02391948|459254533|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
127625904|NCT02391948|459254529|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
127625905|NCT02391948|459254530|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
127625906|NCT02391948|459254531|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
127625907|NCT02391948|459254532|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
127625908|NCT02391948|459254533|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
127625909|NCT02391948|459254529|FG000|24-month Assessment|Death|0|||
127625910|NCT02391948|459254530|FG001|24-month Assessment|Death|0|||
127625911|NCT02391948|459254531|FG002|24-month Assessment|Death|0|||
127625912|NCT02391948|459254532|FG003|24-month Assessment|Death|0|||
127625913|NCT02391948|459254533|FG004|24-month Assessment|Death|1|||
127625914|NCT02391948|459254529|FG000|24-month Assessment|Withdrawal by Subject|1|||
127625915|NCT02391948|459254530|FG001|24-month Assessment|Withdrawal by Subject|1|||
127625916|NCT02391948|459254531|FG002|24-month Assessment|Withdrawal by Subject|0|||
127625917|NCT02391948|459254532|FG003|24-month Assessment|Withdrawal by Subject|0|||
127625918|NCT02391948|459254533|FG004|24-month Assessment|Withdrawal by Subject|1|||
127625919|NCT02391948|459254529|FG000|24-month Assessment|Lost to Follow-up|5|||
127625920|NCT02391948|459254530|FG001|24-month Assessment|Lost to Follow-up|4|||
127625921|NCT02391948|459254531|FG002|24-month Assessment|Lost to Follow-up|0|||
127625922|NCT02391948|459254532|FG003|24-month Assessment|Lost to Follow-up|0|||
127625923|NCT02391948|459254533|FG004|24-month Assessment|Lost to Follow-up|0|||
127625924|NCT02391948|459254529|FG000|24-month Assessment|Medical issue/illness|0|||
127625925|NCT02391948|459254530|FG001|24-month Assessment|Medical issue/illness|0|||
127625926|NCT02391948|459254531|FG002|24-month Assessment|Medical issue/illness|1|||
127625927|NCT02391948|459254532|FG003|24-month Assessment|Medical issue/illness|0|||
127625928|NCT02391948|459254533|FG004|24-month Assessment|Medical issue/illness|0|||
127625929|NCT02391948|459254529|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
127625930|NCT02391948|459254530|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
127625931|NCT02391948|459254531|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
127625932|NCT02391948|459254532|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
127625933|NCT02391948|459254533|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
127625934|NCT01529645|459254534|FG000|Overall Study|Lost to Follow-up|0|||
127625935|NCT01529645|459254535|FG001|Overall Study|Lost to Follow-up|1|||
127625936|NCT01529645|459254536|FG002|Overall Study|Lost to Follow-up|1|||
127625937|NCT01529645|459254537|FG003|Overall Study|Lost to Follow-up|1|||
127625938|NCT01529645|459254538|FG004|Overall Study|Lost to Follow-up|1|||
127625939|NCT01529645|459254539|FG005|Overall Study|Lost to Follow-up|0|||
127625940|NCT01529645|459254540|FG006|Overall Study|Lost to Follow-up|2|||
127625941|NCT01529645|459254541|FG007|Overall Study|Lost to Follow-up|0|||
127625942|NCT01529645|459254542|FG008|Overall Study|Lost to Follow-up|1|||
127625943|NCT01529645|459254543|FG009|Overall Study|Lost to Follow-up|0|||
127625944|NCT01529645|459254534|FG000|Overall Study|SAE - Premature contractions|0|||
127625945|NCT01529645|459254535|FG001|Overall Study|SAE - Premature contractions|0|||
127625946|NCT01529645|459254536|FG002|Overall Study|SAE - Premature contractions|1|||
127625947|NCT01529645|459254537|FG003|Overall Study|SAE - Premature contractions|0|||
127625948|NCT01529645|459254538|FG004|Overall Study|SAE - Premature contractions|0|||
127625949|NCT01529645|459254539|FG005|Overall Study|SAE - Premature contractions|0|||
127625950|NCT01529645|459254540|FG006|Overall Study|SAE - Premature contractions|0|||
127625951|NCT01529645|459254541|FG007|Overall Study|SAE - Premature contractions|0|||
127625952|NCT01529645|459254542|FG008|Overall Study|SAE - Premature contractions|0|||
127625953|NCT01529645|459254543|FG009|Overall Study|SAE - Premature contractions|0|||
127625954|NCT01529645|459254534|FG000|Overall Study|Withdrawal by Subject|2|||
127625955|NCT01529645|459254535|FG001|Overall Study|Withdrawal by Subject|0|||
127625956|NCT01529645|459254536|FG002|Overall Study|Withdrawal by Subject|0|||
127625957|NCT01529645|459254537|FG003|Overall Study|Withdrawal by Subject|1|||
127625958|NCT01529645|459254538|FG004|Overall Study|Withdrawal by Subject|1|||
127625959|NCT01529645|459254539|FG005|Overall Study|Withdrawal by Subject|1|||
127625960|NCT01529645|459254540|FG006|Overall Study|Withdrawal by Subject|0|||
127625961|NCT01529645|459254541|FG007|Overall Study|Withdrawal by Subject|0|||
127625962|NCT01529645|459254542|FG008|Overall Study|Withdrawal by Subject|0|||
127625963|NCT01529645|459254543|FG009|Overall Study|Withdrawal by Subject|0|||
127625964|NCT01602315|459254544|FG000|Overall Study|Protocol Violation|0|||
127625965|NCT01602315|459254545|FG001|Overall Study|Protocol Violation|0|||
127625966|NCT01602315|459254546|FG002|Overall Study|Protocol Violation|0|||
127625967|NCT01602315|459254547|FG003|Overall Study|Protocol Violation|0|||
127625968|NCT01602315|459254548|FG004|Overall Study|Protocol Violation|0|||
127625969|NCT01602315|459254549|FG005|Overall Study|Protocol Violation|1|||
127625970|NCT01602315|459254550|FG006|Overall Study|Protocol Violation|0|||
127625971|NCT01602315|459254544|FG000|Overall Study|Physician Decision|2|||
127625972|NCT01602315|459254545|FG001|Overall Study|Physician Decision|0|||
127625973|NCT01602315|459254546|FG002|Overall Study|Physician Decision|0|||
127625974|NCT01602315|459254547|FG003|Overall Study|Physician Decision|0|||
127625975|NCT01602315|459254548|FG004|Overall Study|Physician Decision|2|||
127625976|NCT01602315|459254549|FG005|Overall Study|Physician Decision|1|||
127625977|NCT01602315|459254550|FG006|Overall Study|Physician Decision|1|||
127625978|NCT01602315|459254544|FG000|Overall Study|Disease progression|6|||
127625979|NCT01602315|459254545|FG001|Overall Study|Disease progression|3|||
127625980|NCT01602315|459254546|FG002|Overall Study|Disease progression|10|||
127625981|NCT01602315|459254547|FG003|Overall Study|Disease progression|1|||
127625982|NCT01602315|459254548|FG004|Overall Study|Disease progression|41|||
127625983|NCT01602315|459254549|FG005|Overall Study|Disease progression|12|||
127625984|NCT01602315|459254550|FG006|Overall Study|Disease progression|15|||
127625985|NCT01602315|459254544|FG000|Overall Study|Death|1|||
127625986|NCT01602315|459254545|FG001|Overall Study|Death|1|||
127625987|NCT01602315|459254546|FG002|Overall Study|Death|1|||
127625988|NCT01602315|459254547|FG003|Overall Study|Death|1|||
127625989|NCT01602315|459254548|FG004|Overall Study|Death|7|||
127625990|NCT01602315|459254549|FG005|Overall Study|Death|2|||
127625991|NCT01602315|459254550|FG006|Overall Study|Death|2|||
127625992|NCT01602315|459254544|FG000|Overall Study|Withdrawal by Subject|2|||
127625993|NCT01602315|459254545|FG001|Overall Study|Withdrawal by Subject|0|||
127625994|NCT01602315|459254546|FG002|Overall Study|Withdrawal by Subject|2|||
127625995|NCT01602315|459254547|FG003|Overall Study|Withdrawal by Subject|0|||
127625996|NCT01602315|459254548|FG004|Overall Study|Withdrawal by Subject|6|||
127625997|NCT01602315|459254549|FG005|Overall Study|Withdrawal by Subject|0|||
127625998|NCT01602315|459254550|FG006|Overall Study|Withdrawal by Subject|1|||
127625999|NCT01602315|459254544|FG000|Overall Study|Adverse Event|5|||
127626000|NCT01602315|459254545|FG001|Overall Study|Adverse Event|1|||
127626001|NCT01602315|459254546|FG002|Overall Study|Adverse Event|5|||
127626002|NCT01602315|459254547|FG003|Overall Study|Adverse Event|4|||
127626003|NCT01602315|459254548|FG004|Overall Study|Adverse Event|15|||
127626004|NCT01602315|459254549|FG005|Overall Study|Adverse Event|3|||
127626005|NCT01602315|459254550|FG006|Overall Study|Adverse Event|9|||
127626006|NCT01602315|459254544|FG000|Overall Study|Subject/guardian decision|0|||
127626007|NCT01602315|459254545|FG001|Overall Study|Subject/guardian decision|0|||
127626008|NCT01602315|459254546|FG002|Overall Study|Subject/guardian decision|0|||
127626009|NCT01602315|459254547|FG003|Overall Study|Subject/guardian decision|0|||
127626010|NCT01602315|459254548|FG004|Overall Study|Subject/guardian decision|0|||
127626011|NCT01602315|459254549|FG005|Overall Study|Subject/guardian decision|0|||
127626012|NCT01602315|459254550|FG006|Overall Study|Subject/guardian decision|1|||
127626013|NCT01602315|459254544|FG000|Overall Study|Cross-over patients to combo treatment|0|||
127626014|NCT01602315|459254545|FG001|Overall Study|Cross-over patients to combo treatment|0|||
127626015|NCT01602315|459254546|FG002|Overall Study|Cross-over patients to combo treatment|0|||
127626016|NCT01602315|459254547|FG003|Overall Study|Cross-over patients to combo treatment|0|||
127626017|NCT01602315|459254548|FG004|Overall Study|Cross-over patients to combo treatment|0|||
127626018|NCT01602315|459254549|FG005|Overall Study|Cross-over patients to combo treatment|16|||
127626019|NCT01602315|459254550|FG006|Overall Study|Cross-over patients to combo treatment|0|||
127626020|NCT00440271|459254555|FG000|Overall Study|Protocol Violation|1|||
127626021|NCT00440271|459254556|FG001|Overall Study|Protocol Violation|1|||
127626022|NCT00440271|459254555|FG000|Overall Study|Adverse Event|0|||
127626023|NCT00440271|459254556|FG001|Overall Study|Adverse Event|1|||
127626024|NCT00440271|459254555|FG000|Overall Study|Lost to Follow-up|1|||
127626025|NCT00440271|459254556|FG001|Overall Study|Lost to Follow-up|0|||
127626026|NCT00440271|459254555|FG000|Overall Study|Withdrawal by Subject|0|||
127626027|NCT00440271|459254556|FG001|Overall Study|Withdrawal by Subject|2|||
127626028|NCT00440271|459254555|FG000|Overall Study|Lack of Efficacy|0|||
127626029|NCT00440271|459254556|FG001|Overall Study|Lack of Efficacy|1|||
127626030|NCT00440271|459254555|FG000|Overall Study|Due to closure of trial|8|||
127626031|NCT00440271|459254556|FG001|Overall Study|Due to closure of trial|10|||
127885225|NCT00879970|460203862|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
127626032|NCT00440271|459254555|FG000|Overall Study|Other|2|||
127626033|NCT00440271|459254556|FG001|Overall Study|Other|0|||
127626034|NCT00723801|459254557|FG000|Overall Study|Lost to Follow-up|1|||
127626035|NCT00723801|459254558|FG001|Overall Study|Lost to Follow-up|2|||
127626036|NCT00723801|459254557|FG000|Overall Study|Protocol Violation|2|||
127626037|NCT00723801|459254558|FG001|Overall Study|Protocol Violation|1|||
127626038|NCT01565993|459254566|FG000|Overall Study|Physician Decision|0|||
127792910|NCT01425203|459867422|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
127792911|NCT01425203|459867423|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
127792912|NCT01425203|459867421|FG000|Treatment Phase|Failure at futility timepoint|8|||
127792913|NCT01425203|459867422|FG001|Treatment Phase|Failure at futility timepoint|27|||
127792914|NCT01425203|459867423|FG002|Treatment Phase|Failure at futility timepoint|0|||
127792915|NCT01425203|459867421|FG000|Treatment Phase|Other virologic failure criteria|5|||
127792916|NCT01425203|459867422|FG001|Treatment Phase|Other virologic failure criteria|3|||
127792917|NCT01425203|459867423|FG002|Treatment Phase|Other virologic failure criteria|0|||
127792918|NCT01425203|459867421|FG000|Treatment Phase|Unidentified reasons|11|||
127792919|NCT01425203|459867422|FG001|Treatment Phase|Unidentified reasons|5|||
127792920|NCT01425203|459867423|FG002|Treatment Phase|Unidentified reasons|0|||
127792921|NCT01425203|459867421|FG000|Treatment Phase|Did not receive treatment|0|||
127792922|NCT01425203|459867422|FG001|Treatment Phase|Did not receive treatment|1|||
127792923|NCT01425203|459867423|FG002|Treatment Phase|Did not receive treatment|0|||
127792924|NCT01425203|459867421|FG000|Crossover Phase|Failure at futility timepoint|0|||
127792925|NCT01425203|459867422|FG001|Crossover Phase|Failure at futility timepoint|0|||
127626039|NCT01565993|459254567|FG001|Overall Study|Physician Decision|3|||
127626040|NCT01824303|459254568|FG000|Randomized Study|Withdrawal by Subject|1|||
127626041|NCT01824303|459254569|FG001|Randomized Study|Withdrawal by Subject|1|||
127626042|NCT01824303|459254568|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
127626043|NCT01824303|459254569|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
127626044|NCT04713748|459254570|FG000|Overall Study|Not enough kits allocated|35|||
127626045|NCT00113516|459254571|FG000|Part 1|Adverse Event|6|||
127626046|NCT00113516|459254572|FG001|Part 1|Adverse Event|0|||
127626047|NCT00113516|459254571|FG000|Part 1|Death|3|||
127626048|NCT00113516|459254572|FG001|Part 1|Death|0|||
127626049|NCT00113516|459254571|FG000|Part 1|Other|3|||
127626050|NCT00113516|459254572|FG001|Part 1|Other|0|||
127626051|NCT00113516|459254571|FG000|Part 1|Withdrawal by Subject|2|||
127626052|NCT00113516|459254572|FG001|Part 1|Withdrawal by Subject|0|||
127626053|NCT00113516|459254571|FG000|Part 1|Lack of Efficacy|2|||
127626054|NCT00113516|459254572|FG001|Part 1|Lack of Efficacy|0|||
127626055|NCT00113516|459254571|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
127626056|NCT00113516|459254572|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
127626057|NCT00113516|459254571|FG000|Part 1|Laboratory Abnormality|1|||
127626058|NCT00113516|459254572|FG001|Part 1|Laboratory Abnormality|0|||
127626059|NCT00113516|459254571|FG000|Part 1|Ongoing|1|||
127626060|NCT00113516|459254572|FG001|Part 1|Ongoing|0|||
127626061|NCT00113516|459254571|FG000|Part 1|Missing|65|||
127626062|NCT00113516|459254572|FG001|Part 1|Missing|0|||
127626063|NCT00113516|459254571|FG000|Part 2|Adverse Event|0|||
127626064|NCT00113516|459254572|FG001|Part 2|Adverse Event|16|||
127626065|NCT00113516|459254571|FG000|Part 2|Death|0|||
127626066|NCT00113516|459254572|FG001|Part 2|Death|5|||
127626067|NCT00113516|459254571|FG000|Part 2|Lack of Efficacy|0|||
127626068|NCT00113516|459254572|FG001|Part 2|Lack of Efficacy|37|||
127626069|NCT00113516|459254571|FG000|Part 2|Withdrawal by Subject|0|||
127626070|NCT00113516|459254572|FG001|Part 2|Withdrawal by Subject|3|||
127626071|NCT00113516|459254571|FG000|Part 2|Other|0|||
127626072|NCT00113516|459254572|FG001|Part 2|Other|3|||
127626073|NCT00113516|459254571|FG000|Part 2|Laboratory Abnormality|0|||
127626074|NCT00113516|459254572|FG001|Part 2|Laboratory Abnormality|1|||
127626075|NCT00113516|459254571|FG000|Part 2|Ongoing|0|||
127626076|NCT00113516|459254572|FG001|Part 2|Ongoing|1|||
127626077|NCT03235024|459254573|FG000|Overall Study|Adverse Event|2|||
127626078|NCT03235024|459254574|FG001|Overall Study|Adverse Event|2|||
127626079|NCT03235024|459254573|FG000|Overall Study|Death|1|||
127626080|NCT03235024|459254574|FG001|Overall Study|Death|0|||
127626081|NCT03235024|459254573|FG000|Overall Study|Lost to Follow-up|2|||
127626082|NCT03235024|459254574|FG001|Overall Study|Lost to Follow-up|5|||
127626083|NCT03235024|459254573|FG000|Overall Study|Protocol Violation|1|||
127626084|NCT03235024|459254574|FG001|Overall Study|Protocol Violation|0|||
127626085|NCT03235024|459254573|FG000|Overall Study|Withdrawal by Subject|0|||
127626086|NCT03235024|459254574|FG001|Overall Study|Withdrawal by Subject|3|||
127626087|NCT00705575|459254575|FG000|Overall Study|Abnormal laboratory value(s)|0|||
127626088|NCT00705575|459254576|FG001|Overall Study|Abnormal laboratory value(s)|3|||
127626089|NCT00705575|459254575|FG000|Overall Study|Abnormal test procedure result(s)|2|||
127626090|NCT00705575|459254576|FG001|Overall Study|Abnormal test procedure result(s)|12|||
127626091|NCT00705575|459254575|FG000|Overall Study|Adverse Event|11|||
127626092|NCT00705575|459254576|FG001|Overall Study|Adverse Event|15|||
127885226|NCT00879970|460203863|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
127626093|NCT00705575|459254575|FG000|Overall Study|Lost to Follow-up|3|||
127626094|NCT00705575|459254576|FG001|Overall Study|Lost to Follow-up|4|||
127626095|NCT00705575|459254575|FG000|Overall Study|Protocol Violation|2|||
127626096|NCT00705575|459254576|FG001|Overall Study|Protocol Violation|2|||
127626097|NCT00705575|459254575|FG000|Overall Study|Withdrawal by Subject|5|||
127626098|NCT00705575|459254576|FG001|Overall Study|Withdrawal by Subject|10|||
127626099|NCT02170727|459254577|FG000|Overall Study|Lost to Follow-up|1|||
127626100|NCT02170727|459254578|FG001|Overall Study|Lost to Follow-up|0|||
127626101|NCT02170727|459254577|FG000|Overall Study|Withdrawal by Subject|2|||
127626102|NCT02170727|459254578|FG001|Overall Study|Withdrawal by Subject|0|||
127626103|NCT02520531|459254581|FG000|Overall Study|Revision of study device components|2|||
127626104|NCT02520531|459254582|FG001|Overall Study|Revision of study device components|2|||
127626105|NCT02520531|459254581|FG000|Overall Study|Death|1|||
127626106|NCT02520531|459254582|FG001|Overall Study|Death|2|||
127626107|NCT02520531|459254581|FG000|Overall Study|Lost to Follow-up|1|||
127626108|NCT02520531|459254582|FG001|Overall Study|Lost to Follow-up|1|||
127626109|NCT02520531|459254581|FG000|Overall Study|Meet exclusion criterion|0|||
127626110|NCT02520531|459254582|FG001|Overall Study|Meet exclusion criterion|1|||
127626111|NCT02520531|459254581|FG000|Overall Study|Withdrawal by Subject|1|||
127626112|NCT02520531|459254582|FG001|Overall Study|Withdrawal by Subject|0|||
127626113|NCT02520531|459254581|FG000|Overall Study|Not study device|1|||
127626114|NCT02520531|459254582|FG001|Overall Study|Not study device|0|||
127626115|NCT01193556|459254584|FG000|Overall Study|Study termination|26|||
127626116|NCT01193556|459254585|FG001|Overall Study|Study termination|25|||
127626117|NCT00835406|459254588|FG000|Period: First Intervention|Adverse Event|0|||
127626118|NCT00835406|459254589|FG001|Period: First Intervention|Adverse Event|1|||
127626119|NCT00835406|459254588|FG000|Period: First Intervention|Withdrawal by Subject|2|||
127626120|NCT00835406|459254589|FG001|Period: First Intervention|Withdrawal by Subject|0|||
127626121|NCT00835406|459254588|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
127626122|NCT00835406|459254589|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
127626123|NCT02486406|459254590|FG000|Overall Study|Withdrew consent|1|||
127626124|NCT02486406|459254591|FG001|Overall Study|Withdrew consent|0|||
127626125|NCT02486406|459254592|FG002|Overall Study|Withdrew consent|0|||
127626126|NCT02486406|459254593|FG003|Overall Study|Withdrew consent|1|||
127626127|NCT02486406|459254590|FG000|Overall Study|Lost to Follow-up|1|||
127626128|NCT02486406|459254591|FG001|Overall Study|Lost to Follow-up|3|||
127626129|NCT02486406|459254592|FG002|Overall Study|Lost to Follow-up|1|||
127626130|NCT02486406|459254593|FG003|Overall Study|Lost to Follow-up|3|||
127626131|NCT02486406|459254590|FG000|Overall Study|Other, not specified|0|||
127626132|NCT02486406|459254591|FG001|Overall Study|Other, not specified|0|||
127626133|NCT02486406|459254592|FG002|Overall Study|Other, not specified|1|||
127626134|NCT02486406|459254593|FG003|Overall Study|Other, not specified|0|||
127626135|NCT01826825|459254594|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
127626136|NCT01826825|459254595|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
127626137|NCT02127307|459254596|FG000|Overall Study|Protocol Violation|36|||
127626138|NCT02127307|459254596|FG000|Overall Study|Lost to Follow-up|2|||
127626139|NCT02127307|459254596|FG000|Overall Study|Death|101|||
127626140|NCT02127307|459254596|FG000|Overall Study|Other than specified above|169|||
127626141|NCT03509948|459254597|FG000|Overall Study|Protocol Violation|0|||
127626142|NCT03509948|459254598|FG001|Overall Study|Protocol Violation|1|||
127626143|NCT01071512|459254601|FG000|Overall Study|Adverse Event|1|||
127626144|NCT01071512|459254601|FG000|Overall Study|Development of antibodies to drug|2|||
127626145|NCT01071512|459254601|FG000|Overall Study|positive anti-JC virus antibody test|2|||
127626146|NCT01712984|459254612|FG000|Overall Study|Adverse Event|0|||
127626147|NCT01712984|459254613|FG001|Overall Study|Adverse Event|0|||
127626148|NCT01712984|459254614|FG002|Overall Study|Adverse Event|1|||
127626149|NCT01712984|459254612|FG000|Overall Study|Protocol Violation|2|||
127626150|NCT01712984|459254613|FG001|Overall Study|Protocol Violation|0|||
127626151|NCT01712984|459254614|FG002|Overall Study|Protocol Violation|1|||
127626152|NCT01712984|459254612|FG000|Overall Study|Lost to Follow-up|8|||
127626153|NCT01712984|459254613|FG001|Overall Study|Lost to Follow-up|10|||
127626154|NCT01712984|459254614|FG002|Overall Study|Lost to Follow-up|1|||
127626155|NCT01712984|459254612|FG000|Overall Study|Withdrawal by Subject|6|||
127626156|NCT01712984|459254613|FG001|Overall Study|Withdrawal by Subject|6|||
127626157|NCT01712984|459254614|FG002|Overall Study|Withdrawal by Subject|7|||
127626158|NCT02755831|459254619|FG000|Overall Study|Lost to Follow-up|3|||
127626159|NCT02755831|459254620|FG001|Overall Study|Lost to Follow-up|3|||
127626160|NCT02296112|459254621|FG000|Overall Study|Disease progression|7|||
127626161|NCT02296112|459254621|FG000|Overall Study|Toxicity|1|||
127626162|NCT02296112|459254621|FG000|Overall Study|Began an alternate therapy|1|||
127626163|NCT02442830|459254622|FG000|Overall Study|Technical Failure|0|||
127626164|NCT02442830|459254623|FG001|Overall Study|Technical Failure|1|||
127626165|NCT01516879|459254624|FG000|Overall Study|Withdrawal by Subject|9|||
127626166|NCT01516879|459254625|FG001|Overall Study|Withdrawal by Subject|11|||
127626167|NCT01516879|459254624|FG000|Overall Study|Death|0|||
127626168|NCT01516879|459254625|FG001|Overall Study|Death|2|||
127626169|NCT01516879|459254624|FG000|Overall Study|Lost to Follow-up|2|||
127626170|NCT01516879|459254625|FG001|Overall Study|Lost to Follow-up|11|||
127626171|NCT01516879|459254624|FG000|Overall Study|Other|5|||
127626172|NCT01516879|459254625|FG001|Overall Study|Other|10|||
127626173|NCT00183872|459254626|FG000|Overall Study|Death|3|||
127626174|NCT00183872|459254626|FG000|Overall Study|Adverse Event|9|||
127626175|NCT00183872|459254626|FG000|Overall Study|Withdrawal by Subject|2|||
127626176|NCT00183872|459254626|FG000|Overall Study|Drug delayed more than 28 days|2|||
127626177|NCT01720069|459254627|FG000|Overall Study|Could not use e-diary correctly|0|||
127626178|NCT01720069|459254628|FG001|Overall Study|Could not use e-diary correctly|1|||
127626179|NCT01720069|459254629|FG002|Overall Study|Could not use e-diary correctly|1|||
127626180|NCT01720069|459254627|FG000|Overall Study|Randomised without baseline values|0|||
127626181|NCT01720069|459254628|FG001|Overall Study|Randomised without baseline values|0|||
127626182|NCT01720069|459254629|FG002|Overall Study|Randomised without baseline values|1|||
127626183|NCT01720069|459254627|FG000|Overall Study|Adverse Event|0|||
127626184|NCT01720069|459254628|FG001|Overall Study|Adverse Event|0|||
127626185|NCT01720069|459254629|FG002|Overall Study|Adverse Event|1|||
127626186|NCT01720069|459254627|FG000|Overall Study|Lack of Efficacy|0|||
127626187|NCT01720069|459254628|FG001|Overall Study|Lack of Efficacy|4|||
127626188|NCT01720069|459254629|FG002|Overall Study|Lack of Efficacy|0|||
127626189|NCT01720069|459254627|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
127626190|NCT01720069|459254628|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
127626191|NCT01720069|459254629|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
127626192|NCT01720069|459254627|FG000|Overall Study|Withdrawal by Subject|0|||
127626193|NCT01720069|459254628|FG001|Overall Study|Withdrawal by Subject|2|||
127626194|NCT01720069|459254629|FG002|Overall Study|Withdrawal by Subject|1|||
127626195|NCT01720069|459254627|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
127626196|NCT01720069|459254628|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
127626197|NCT01720069|459254629|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
127626198|NCT01720069|459254627|FG000|Overall Study|Non-compliance on using e-diary|0|||
127626199|NCT01720069|459254628|FG001|Overall Study|Non-compliance on using e-diary|0|||
127626200|NCT01720069|459254629|FG002|Overall Study|Non-compliance on using e-diary|1|||
127626201|NCT01720069|459254627|FG000|Overall Study|Lost to Follow-up|0|||
127626202|NCT01720069|459254628|FG001|Overall Study|Lost to Follow-up|0|||
127626203|NCT01720069|459254629|FG002|Overall Study|Lost to Follow-up|1|||
127701663|NCT01186367|459537007|FG001|Overall Study|Did not receive study treatment|1|||
127701664|NCT01186367|459537008|FG002|Overall Study|Did not receive study treatment|0|||
127701665|NCT02975882|459537009|FG000|Overall Study|Adverse Event|1|||
127701666|NCT02975882|459537010|FG001|Overall Study|Adverse Event|2|||
127701667|NCT02975882|459537011|FG002|Overall Study|Adverse Event|1|||
127701668|NCT02975882|459537012|FG003|Overall Study|Adverse Event|1|||
127701669|NCT02975882|459537009|FG000|Overall Study|Death|0|||
127701670|NCT02975882|459537010|FG001|Overall Study|Death|1|||
127701671|NCT02975882|459537011|FG002|Overall Study|Death|0|||
127701672|NCT02975882|459537012|FG003|Overall Study|Death|0|||
127701673|NCT02975882|459537009|FG000|Overall Study|Lack of Efficacy|3|||
127701674|NCT02975882|459537010|FG001|Overall Study|Lack of Efficacy|7|||
127701675|NCT02975882|459537011|FG002|Overall Study|Lack of Efficacy|4|||
127701676|NCT02975882|459537012|FG003|Overall Study|Lack of Efficacy|3|||
127701677|NCT02975882|459537009|FG000|Overall Study|Physician Decision|0|||
127701678|NCT02975882|459537010|FG001|Overall Study|Physician Decision|2|||
127701679|NCT02975882|459537011|FG002|Overall Study|Physician Decision|4|||
127701680|NCT02975882|459537012|FG003|Overall Study|Physician Decision|2|||
127701681|NCT02975882|459537009|FG000|Overall Study|Ineligible|0|||
127701682|NCT02975882|459537010|FG001|Overall Study|Ineligible|1|||
127701683|NCT02975882|459537011|FG002|Overall Study|Ineligible|0|||
127701684|NCT02975882|459537012|FG003|Overall Study|Ineligible|0|||
127701685|NCT03945292|459537013|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
127701686|NCT03945292|459537014|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
127701687|NCT03945292|459537015|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
127701688|NCT03945292|459537016|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
127701689|NCT03945292|459537017|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
127701690|NCT03945292|459537018|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
127701691|NCT03945292|459537019|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
127701692|NCT03945292|459537020|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
127701693|NCT03945292|459537013|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
127701694|NCT03945292|459537014|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
127701695|NCT03945292|459537015|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|1|||
127701696|NCT03945292|459537016|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
127701697|NCT03945292|459537017|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
127701698|NCT03945292|459537018|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
127701699|NCT03945292|459537019|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
127701700|NCT03945292|459537020|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
127792926|NCT01425203|459867423|FG002|Crossover Phase|Failure at futility timepoint|3|||
127792927|NCT01425203|459867421|FG000|Crossover Phase|Other virologic failure criteria|0|||
127701701|NCT03945292|459537013|FG000|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
127701702|NCT03945292|459537014|FG001|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
127792928|NCT01425203|459867422|FG001|Crossover Phase|Other virologic failure criteria|0|||
127701703|NCT03945292|459537015|FG002|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
127701704|NCT03945292|459537016|FG003|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
127626204|NCT00508742|459254630|FG000|Period 1: Infant Series|Adverse Event|5|||
127626205|NCT00508742|459254631|FG001|Period 1: Infant Series|Adverse Event|4|||
127626206|NCT00508742|459254630|FG000|Period 1: Infant Series|Protocol Violation|1|||
127626207|NCT00508742|459254631|FG001|Period 1: Infant Series|Protocol Violation|0|||
127626208|NCT00508742|459254630|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
127626209|NCT00508742|459254631|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
127626210|NCT00508742|459254630|FG000|Period 1: Infant Series|Physician Decision|1|||
127626211|NCT00508742|459254631|FG001|Period 1: Infant Series|Physician Decision|0|||
127626212|NCT00508742|459254630|FG000|Period 1: Infant Series|Other|4|||
127626213|NCT00508742|459254631|FG001|Period 1: Infant Series|Other|1|||
127626214|NCT00508742|459254630|FG000|Period 2: After Infant Series|Adverse Event|2|||
127626215|NCT00508742|459254631|FG001|Period 2: After Infant Series|Adverse Event|6|||
127626216|NCT00508742|459254630|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
127626217|NCT00508742|459254631|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
127626218|NCT00508742|459254630|FG000|Period 2: After Infant Series|Protocol Violation|1|||
127626219|NCT00508742|459254631|FG001|Period 2: After Infant Series|Protocol Violation|0|||
127626220|NCT00508742|459254630|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
127626221|NCT00508742|459254631|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
127626222|NCT00508742|459254630|FG000|Period 2: After Infant Series|Failed to Return|1|||
127626223|NCT00508742|459254631|FG001|Period 2: After Infant Series|Failed to Return|0|||
127626224|NCT00508742|459254630|FG000|Period 2: After Infant Series|Other|2|||
127626225|NCT00508742|459254631|FG001|Period 2: After Infant Series|Other|1|||
127626226|NCT00508742|459254630|FG000|Period 3: Toddler Dose|Adverse Event|1|||
127626227|NCT00508742|459254631|FG001|Period 3: Toddler Dose|Adverse Event|0|||
127626228|NCT00508742|459254630|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
127626229|NCT00508742|459254631|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
127626230|NCT00508742|459254630|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
127626231|NCT00508742|459254631|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
127626232|NCT00508742|459254630|FG000|Period 3: Toddler Dose|Other|5|||
127626233|NCT00508742|459254631|FG001|Period 3: Toddler Dose|Other|4|||
127626234|NCT04568122|459254632|FG000|Overall Study|Lost to Follow-up|48|||
127626235|NCT04568122|459254633|FG001|Overall Study|Lost to Follow-up|44|||
127626236|NCT04568122|459254634|FG002|Overall Study|Lost to Follow-up|4|||
127626237|NCT04568122|459254635|FG003|Overall Study|Lost to Follow-up|0|||
127626238|NCT04568122|459254636|FG004|Overall Study|Lost to Follow-up|0|||
127626239|NCT00700011|459254642|FG000|Overall Study|Death|0|||
127626240|NCT00700011|459254643|FG001|Overall Study|Death|1|||
127626241|NCT03246529|459254645|FG000|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
127701705|NCT03945292|459537017|FG004|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
127701706|NCT03945292|459537018|FG005|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
127701707|NCT03945292|459537019|FG006|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
127701708|NCT03945292|459537020|FG007|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|1|||
127701709|NCT03524118|459537025|FG000|Overall Study|Lost to Follow-up|0|||
127701710|NCT03524118|459537026|FG001|Overall Study|Lost to Follow-up|0|||
127701711|NCT03524118|459537027|FG002|Overall Study|Lost to Follow-up|0|||
127701712|NCT03524118|459537028|FG003|Overall Study|Lost to Follow-up|0|||
127701713|NCT03524118|459537029|FG004|Overall Study|Lost to Follow-up|1|||
127701714|NCT03524118|459537030|FG005|Overall Study|Lost to Follow-up|0|||
127701715|NCT03524118|459537025|FG000|Overall Study|Other|0|||
127701716|NCT03524118|459537026|FG001|Overall Study|Other|1|||
127701717|NCT03524118|459537027|FG002|Overall Study|Other|0|||
127701718|NCT03524118|459537028|FG003|Overall Study|Other|0|||
127701719|NCT03524118|459537029|FG004|Overall Study|Other|1|||
127701720|NCT03524118|459537030|FG005|Overall Study|Other|1|||
127701721|NCT03524118|459537025|FG000|Overall Study|Physician Decision|0|||
127701722|NCT03524118|459537026|FG001|Overall Study|Physician Decision|0|||
127701723|NCT03524118|459537027|FG002|Overall Study|Physician Decision|0|||
127701724|NCT03524118|459537028|FG003|Overall Study|Physician Decision|0|||
127701725|NCT03524118|459537029|FG004|Overall Study|Physician Decision|1|||
127701726|NCT03524118|459537030|FG005|Overall Study|Physician Decision|0|||
127701727|NCT03524118|459537025|FG000|Overall Study|Protocol Violation|0|||
127701728|NCT03524118|459537026|FG001|Overall Study|Protocol Violation|0|||
127701729|NCT03524118|459537027|FG002|Overall Study|Protocol Violation|1|||
127701730|NCT03524118|459537028|FG003|Overall Study|Protocol Violation|0|||
127701731|NCT03524118|459537029|FG004|Overall Study|Protocol Violation|1|||
127701732|NCT03524118|459537030|FG005|Overall Study|Protocol Violation|0|||
127701733|NCT03524118|459537025|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
127626242|NCT03246529|459254646|FG001|Core Study (Until 100 d Post-transplant)|Adverse Event|2|||
127701734|NCT03524118|459537026|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
127701735|NCT03524118|459537027|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
127626243|NCT03246529|459254647|FG002|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
127626244|NCT03246529|459254645|FG000|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|0|||
127701736|NCT03524118|459537028|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
127701737|NCT03524118|459537029|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
127701738|NCT03524118|459537030|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
127792929|NCT01425203|459867423|FG002|Crossover Phase|Other virologic failure criteria|3|||
127792930|NCT00382993|459867429|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
127792931|NCT00382993|459867430|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
127792932|NCT00382993|459867429|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
127792933|NCT00382993|459867430|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
127792934|NCT00382993|459867429|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
127792935|NCT00382993|459867430|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
127792936|NCT00382993|459867429|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
127792937|NCT00382993|459867430|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
127792938|NCT00382993|459867429|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
127792939|NCT00382993|459867430|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
127792940|NCT00382993|459867429|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
127792941|NCT00382993|459867430|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
127792942|NCT00382993|459867429|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
127792943|NCT00382993|459867430|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
127792944|NCT00382993|459867429|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
127792945|NCT00382993|459867430|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
127792946|NCT00382993|459867429|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
127792947|NCT00382993|459867430|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
127792948|NCT00382993|459867429|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
127792949|NCT00382993|459867430|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
127792950|NCT02898259|459867431|FG000|Overall Study|Adverse Event|0|||
127792951|NCT02898259|459867432|FG001|Overall Study|Adverse Event|0|||
127792952|NCT02898259|459867433|FG002|Overall Study|Adverse Event|1|||
127792953|NCT02898259|459867434|FG003|Overall Study|Adverse Event|0|||
127792954|NCT02898259|459867435|FG004|Overall Study|Adverse Event|0|||
127792955|NCT02898259|459867431|FG000|Overall Study|Lack of Efficacy|1|||
127792956|NCT02898259|459867432|FG001|Overall Study|Lack of Efficacy|1|||
127792957|NCT02898259|459867433|FG002|Overall Study|Lack of Efficacy|3|||
127792958|NCT02898259|459867434|FG003|Overall Study|Lack of Efficacy|0|||
127792959|NCT02898259|459867435|FG004|Overall Study|Lack of Efficacy|0|||
127792960|NCT02898259|459867431|FG000|Overall Study|Lost to Follow-up|0|||
127792961|NCT02898259|459867432|FG001|Overall Study|Lost to Follow-up|0|||
127792962|NCT02898259|459867433|FG002|Overall Study|Lost to Follow-up|1|||
127792963|NCT02898259|459867434|FG003|Overall Study|Lost to Follow-up|0|||
127792964|NCT02898259|459867435|FG004|Overall Study|Lost to Follow-up|0|||
127792965|NCT02898259|459867431|FG000|Overall Study|Transformation before study began|0|||
127792966|NCT02898259|459867432|FG001|Overall Study|Transformation before study began|0|||
127792967|NCT02898259|459867433|FG002|Overall Study|Transformation before study began|0|||
127792968|NCT02898259|459867434|FG003|Overall Study|Transformation before study began|1|||
127792969|NCT02898259|459867435|FG004|Overall Study|Transformation before study began|0|||
127792970|NCT01046877|459867436|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
127792971|NCT01046877|459867436|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
127792972|NCT03016325|459867437|FG000|Treatment Period|Participant withdrew consent|0|||
127792973|NCT03016325|459867438|FG001|Treatment Period|Participant withdrew consent|1|||
127792974|NCT03016325|459867439|FG002|Treatment Period|Participant withdrew consent|0|||
127792975|NCT03016325|459867440|FG003|Treatment Period|Participant withdrew consent|0|||
127792976|NCT03016325|459867441|FG004|Treatment Period|Participant withdrew consent|0|||
127792977|NCT03016325|459867442|FG005|Treatment Period|Participant withdrew consent|0|||
127792978|NCT03016325|459867443|FG006|Treatment Period|Participant withdrew consent|0|||
127792979|NCT03016325|459867444|FG007|Treatment Period|Participant withdrew consent|0|||
127792980|NCT03016325|459867437|FG000|Treatment Period|Death|0|||
127792981|NCT03016325|459867438|FG001|Treatment Period|Death|0|||
127792982|NCT03016325|459867439|FG002|Treatment Period|Death|0|||
127792983|NCT03016325|459867440|FG003|Treatment Period|Death|0|||
127792984|NCT03016325|459867441|FG004|Treatment Period|Death|2|||
127792985|NCT03016325|459867442|FG005|Treatment Period|Death|0|||
127792986|NCT03016325|459867443|FG006|Treatment Period|Death|0|||
127792987|NCT03016325|459867444|FG007|Treatment Period|Death|0|||
127792988|NCT03016325|459867437|FG000|Treatment Period|Participant refuses assessments|0|||
127626245|NCT03246529|459254646|FG001|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
127626246|NCT03246529|459254647|FG002|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
127792989|NCT03016325|459867438|FG001|Treatment Period|Participant refuses assessments|0|||
127792990|NCT03016325|459867439|FG002|Treatment Period|Participant refuses assessments|1|||
127792991|NCT03016325|459867440|FG003|Treatment Period|Participant refuses assessments|0|||
127792992|NCT03016325|459867441|FG004|Treatment Period|Participant refuses assessments|0|||
127792993|NCT03016325|459867442|FG005|Treatment Period|Participant refuses assessments|0|||
127792994|NCT03016325|459867443|FG006|Treatment Period|Participant refuses assessments|0|||
127792995|NCT03016325|459867444|FG007|Treatment Period|Participant refuses assessments|0|||
127792996|NCT03016325|459867437|FG000|32-Day Follow-Up Period|Death|2|||
127885227|NCT00879970|460203864|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
127792997|NCT03016325|459867438|FG001|32-Day Follow-Up Period|Death|0|||
127792998|NCT03016325|459867439|FG002|32-Day Follow-Up Period|Death|5|||
127792999|NCT03016325|459867440|FG003|32-Day Follow-Up Period|Death|6|||
127793000|NCT03016325|459867441|FG004|32-Day Follow-Up Period|Death|3|||
127793001|NCT03016325|459867442|FG005|32-Day Follow-Up Period|Death|0|||
127793002|NCT03016325|459867443|FG006|32-Day Follow-Up Period|Death|0|||
127793003|NCT03016325|459867444|FG007|32-Day Follow-Up Period|Death|0|||
127793004|NCT03016325|459867437|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
127793005|NCT03016325|459867438|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
127793006|NCT03016325|459867439|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
127793007|NCT03016325|459867440|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
127793008|NCT03016325|459867441|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
127793009|NCT03016325|459867442|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
127793010|NCT03016325|459867443|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
127793011|NCT03016325|459867444|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
127793012|NCT03016325|459867437|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
127793013|NCT03016325|459867438|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
127793014|NCT03016325|459867439|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
127793015|NCT03016325|459867440|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
127793016|NCT03016325|459867441|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
127793017|NCT03016325|459867442|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
127793018|NCT03016325|459867443|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
127793019|NCT03016325|459867444|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
127793020|NCT03016325|459867437|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
127793021|NCT03016325|459867438|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
127793022|NCT03016325|459867439|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
127793023|NCT03016325|459867440|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
127793024|NCT03016325|459867441|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
127793025|NCT03016325|459867442|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
127793026|NCT03016325|459867443|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
127793027|NCT03016325|459867444|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
127793028|NCT03016325|459867437|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
127793029|NCT03016325|459867438|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
127793030|NCT03016325|459867439|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
127793031|NCT03016325|459867440|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
127793032|NCT03016325|459867441|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
127793033|NCT03016325|459867442|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
127793034|NCT03016325|459867443|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
127793035|NCT03016325|459867444|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
127793036|NCT03016325|459867437|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
127793037|NCT03016325|459867438|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
127793038|NCT03016325|459867439|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
127793039|NCT03016325|459867440|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
127793040|NCT03016325|459867441|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
127793041|NCT03016325|459867442|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
127793042|NCT03016325|459867443|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
127793043|NCT03016325|459867444|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
127793044|NCT03016325|459867437|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
127793045|NCT03016325|459867438|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
127793046|NCT03016325|459867439|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
127793047|NCT03016325|459867440|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
127793048|NCT03016325|459867441|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
127793049|NCT03016325|459867442|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
127793050|NCT03016325|459867443|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
127793051|NCT03016325|459867444|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
127793052|NCT03016325|459867437|FG000|182-Day Follow-Up Period|Death|3|||
127793053|NCT03016325|459867438|FG001|182-Day Follow-Up Period|Death|3|||
127793054|NCT03016325|459867439|FG002|182-Day Follow-Up Period|Death|11|||
127793055|NCT03016325|459867440|FG003|182-Day Follow-Up Period|Death|12|||
127793056|NCT03016325|459867441|FG004|182-Day Follow-Up Period|Death|9|||
127793057|NCT03016325|459867442|FG005|182-Day Follow-Up Period|Death|0|||
127793058|NCT03016325|459867443|FG006|182-Day Follow-Up Period|Death|0|||
127793059|NCT03016325|459867444|FG007|182-Day Follow-Up Period|Death|1|||
127793060|NCT03016325|459867437|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
127793061|NCT03016325|459867438|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
127626247|NCT03246529|459254645|FG000|Core Study (Until 100 d Post-transplant)|Other Reasons|0|||
127626248|NCT03246529|459254646|FG001|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
127626249|NCT03246529|459254647|FG002|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
127626250|NCT03246529|459254645|FG000|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
127626251|NCT03246529|459254646|FG001|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
127626252|NCT03246529|459254647|FG002|Core Study (Until 100 d Post-transplant)|Physician Decision|1|||
127626253|NCT03246529|459254645|FG000|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|0|||
127626254|NCT03246529|459254646|FG001|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|1|||
127626255|NCT03246529|459254647|FG002|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|4|||
127626256|NCT03246529|459254645|FG000|Follow-up Period at 1 Year FU Completion|Disease progression|2|||
127626257|NCT03246529|459254646|FG001|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
127626258|NCT03246529|459254647|FG002|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
127626259|NCT03246529|459254645|FG000|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|1|||
127626260|NCT03246529|459254646|FG001|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|3|||
127626261|NCT03246529|459254647|FG002|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|0|||
127626262|NCT03246529|459254645|FG000|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
127626263|NCT03246529|459254646|FG001|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|3|||
127626264|NCT03246529|459254647|FG002|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
127626265|NCT03246529|459254645|FG000|Follow-up Period at 1 Year FU Completion|Death|0|||
127626266|NCT03246529|459254646|FG001|Follow-up Period at 1 Year FU Completion|Death|0|||
127626267|NCT03246529|459254647|FG002|Follow-up Period at 1 Year FU Completion|Death|1|||
127626268|NCT01209624|459254648|FG000|Overall Study|Death|2|||
127626269|NCT01209624|459254648|FG000|Overall Study|Adverse Event|13|||
127626270|NCT01209624|459254648|FG000|Overall Study|Lack of Efficacy|17|||
127626271|NCT01209624|459254648|FG000|Overall Study|Lost to Follow-up|290|||
127626272|NCT01209624|459254648|FG000|Overall Study|Other|4|||
127626273|NCT00441337|459254653|FG000|Overall Study|Disease Progression|6|||
127626274|NCT00441337|459254654|FG001|Overall Study|Disease Progression|6|||
127626275|NCT00441337|459254655|FG002|Overall Study|Disease Progression|4|||
127626276|NCT00441337|459254656|FG003|Overall Study|Disease Progression|18|||
127626277|NCT00441337|459254653|FG000|Overall Study|Lost to Follow-up|0|||
127626278|NCT00441337|459254654|FG001|Overall Study|Lost to Follow-up|0|||
127626279|NCT00441337|459254655|FG002|Overall Study|Lost to Follow-up|0|||
127626280|NCT00441337|459254656|FG003|Overall Study|Lost to Follow-up|1|||
127626281|NCT00441337|459254653|FG000|Overall Study|Sponsor Decision|0|||
127626282|NCT00441337|459254654|FG001|Overall Study|Sponsor Decision|0|||
127626283|NCT00441337|459254655|FG002|Overall Study|Sponsor Decision|1|||
127626284|NCT00441337|459254656|FG003|Overall Study|Sponsor Decision|2|||
127626285|NCT00441337|459254653|FG000|Overall Study|Did not meet inclusion criteria|0|||
127626286|NCT00441337|459254654|FG001|Overall Study|Did not meet inclusion criteria|0|||
127626287|NCT00441337|459254655|FG002|Overall Study|Did not meet inclusion criteria|1|||
127626288|NCT00441337|459254656|FG003|Overall Study|Did not meet inclusion criteria|0|||
127626289|NCT06748040|459254657|FG000|Overall Study|Death|3|||
127626290|NCT06748040|459254658|FG001|Overall Study|Death|4|||
127626291|NCT06748040|459254657|FG000|Overall Study|Lost to Follow-up|134|||
127626292|NCT06748040|459254658|FG001|Overall Study|Lost to Follow-up|132|||
127626293|NCT06748040|459254657|FG000|Overall Study|Withdrawal by Subject|3|||
127626294|NCT06748040|459254658|FG001|Overall Study|Withdrawal by Subject|5|||
127626295|NCT01818336|459256338|FG000|Overall Study|Declined retest visit|0|||
127626296|NCT01818336|459256339|FG001|Overall Study|Declined retest visit|11|||
127626297|NCT01818336|459256338|FG000|Overall Study|Lost to Follow-up|0|||
127626298|NCT01818336|459256339|FG001|Overall Study|Lost to Follow-up|1|||
127793062|NCT03016325|459867439|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
127793063|NCT03016325|459867440|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
127793064|NCT03016325|459867441|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
127626299|NCT00827372|459256344|FG000|Overall Study|Adverse Event|5|||
127626300|NCT00827372|459256344|FG000|Overall Study|Lack of Efficacy|3|||
127626301|NCT02293005|459256345|FG000|Overall Study|Adverse Event|2|||
127626302|NCT02293005|459256345|FG000|Overall Study|Death|4|||
127626303|NCT02293005|459256345|FG000|Overall Study|Lost to Follow-up|1|||
127626304|NCT02293005|459256345|FG000|Overall Study|Withdrawal by Subject|2|||
127626305|NCT02293005|459256345|FG000|Overall Study|Progression|17|||
127626306|NCT02139644|459256346|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
127626307|NCT02139644|459256347|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
127626308|NCT02139644|459256348|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
127626309|NCT02139644|459256349|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
127626310|NCT02139644|459256350|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
127626311|NCT02139644|459256351|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
127626312|NCT02139644|459256346|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
127626313|NCT02139644|459256347|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
127626314|NCT02139644|459256348|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
127626315|NCT02139644|459256349|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
127626316|NCT02139644|459256350|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
127626317|NCT02139644|459256351|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
127626318|NCT02139644|459256346|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
127626319|NCT02139644|459256347|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
127626320|NCT02139644|459256348|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
127626321|NCT02139644|459256349|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
127626322|NCT02139644|459256350|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
127626323|NCT02139644|459256351|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
127626324|NCT02139644|459256346|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
127626325|NCT02139644|459256347|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
127626326|NCT02139644|459256348|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
127626327|NCT02139644|459256349|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
127626328|NCT02139644|459256350|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
127793065|NCT03016325|459867442|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
127793066|NCT03016325|459867443|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
127626329|NCT02139644|459256351|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
127626330|NCT02139644|459256346|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
127626331|NCT02139644|459256347|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
127626332|NCT02139644|459256348|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
127626333|NCT02139644|459256349|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
127626334|NCT02139644|459256350|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
127626335|NCT02139644|459256351|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
127626336|NCT02139644|459256346|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
127626337|NCT02139644|459256347|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
127626338|NCT02139644|459256348|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
127626339|NCT02139644|459256349|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
127626340|NCT02139644|459256350|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
127626341|NCT02139644|459256351|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
127626342|NCT02139644|459256346|FG000|Run-In Period (Pre-assignment)|Other|6|||
127626343|NCT02139644|459256347|FG001|Run-In Period (Pre-assignment)|Other|0|||
127793067|NCT03016325|459867444|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
127793068|NCT03016325|459867437|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
127793069|NCT03016325|459867438|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
127793070|NCT03016325|459867439|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
127793071|NCT03016325|459867440|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
127793072|NCT03016325|459867441|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
127793073|NCT03016325|459867442|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
127793074|NCT03016325|459867443|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
127793075|NCT03016325|459867444|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
127793076|NCT03016325|459867437|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
127793077|NCT03016325|459867438|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
127793078|NCT03016325|459867439|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
127793079|NCT03016325|459867440|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
127885228|NCT00879970|460203865|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
127885229|NCT00879970|460203866|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
127626344|NCT02139644|459256348|FG002|Run-In Period (Pre-assignment)|Other|0|||
127626345|NCT02139644|459256349|FG003|Run-In Period (Pre-assignment)|Other|0|||
127626346|NCT02139644|459256350|FG004|Run-In Period (Pre-assignment)|Other|0|||
127626347|NCT02139644|459256351|FG005|Run-In Period (Pre-assignment)|Other|0|||
127626348|NCT02139644|459256346|FG000|Treatment Period|Adverse Event|0|||
127626349|NCT02139644|459256347|FG001|Treatment Period|Adverse Event|0|||
127626350|NCT02139644|459256348|FG002|Treatment Period|Adverse Event|3|||
127626351|NCT02139644|459256349|FG003|Treatment Period|Adverse Event|2|||
127626352|NCT02139644|459256350|FG004|Treatment Period|Adverse Event|1|||
127626353|NCT02139644|459256351|FG005|Treatment Period|Adverse Event|6|||
127626354|NCT02139644|459256346|FG000|Treatment Period|Withdrawal by Subject|0|||
127626355|NCT02139644|459256347|FG001|Treatment Period|Withdrawal by Subject|0|||
127626356|NCT02139644|459256348|FG002|Treatment Period|Withdrawal by Subject|2|||
127626357|NCT02139644|459256349|FG003|Treatment Period|Withdrawal by Subject|2|||
127626358|NCT02139644|459256350|FG004|Treatment Period|Withdrawal by Subject|3|||
127626359|NCT02139644|459256351|FG005|Treatment Period|Withdrawal by Subject|2|||
127626360|NCT02139644|459256346|FG000|Treatment Period|Non-compliance|0|||
127626361|NCT02139644|459256347|FG001|Treatment Period|Non-compliance|0|||
127626362|NCT02139644|459256348|FG002|Treatment Period|Non-compliance|0|||
127626363|NCT02139644|459256349|FG003|Treatment Period|Non-compliance|1|||
127626364|NCT02139644|459256350|FG004|Treatment Period|Non-compliance|0|||
127626365|NCT02139644|459256351|FG005|Treatment Period|Non-compliance|0|||
127626366|NCT02139644|459256346|FG000|Treatment Period|Protocol Violation|0|||
127626367|NCT02139644|459256347|FG001|Treatment Period|Protocol Violation|0|||
127626368|NCT02139644|459256348|FG002|Treatment Period|Protocol Violation|0|||
127626369|NCT02139644|459256349|FG003|Treatment Period|Protocol Violation|1|||
127626370|NCT02139644|459256350|FG004|Treatment Period|Protocol Violation|1|||
127626371|NCT02139644|459256351|FG005|Treatment Period|Protocol Violation|1|||
127626372|NCT02139644|459256346|FG000|Treatment Period|Disease progression|0|||
127626373|NCT02139644|459256347|FG001|Treatment Period|Disease progression|0|||
127626374|NCT02139644|459256348|FG002|Treatment Period|Disease progression|0|||
127626375|NCT02139644|459256349|FG003|Treatment Period|Disease progression|1|||
127626376|NCT02139644|459256350|FG004|Treatment Period|Disease progression|1|||
127626377|NCT02139644|459256351|FG005|Treatment Period|Disease progression|2|||
127626378|NCT02139644|459256346|FG000|Treatment Period|Lost to Follow-up|0|||
127626379|NCT02139644|459256347|FG001|Treatment Period|Lost to Follow-up|0|||
127626380|NCT02139644|459256348|FG002|Treatment Period|Lost to Follow-up|1|||
127626381|NCT02139644|459256349|FG003|Treatment Period|Lost to Follow-up|1|||
127626382|NCT02139644|459256350|FG004|Treatment Period|Lost to Follow-up|1|||
127626383|NCT02139644|459256351|FG005|Treatment Period|Lost to Follow-up|1|||
127626384|NCT02139644|459256346|FG000|Treatment Period|Lack of Efficacy|0|||
127626385|NCT02139644|459256347|FG001|Treatment Period|Lack of Efficacy|0|||
127626386|NCT02139644|459256348|FG002|Treatment Period|Lack of Efficacy|1|||
127626387|NCT02139644|459256349|FG003|Treatment Period|Lack of Efficacy|0|||
127626388|NCT02139644|459256350|FG004|Treatment Period|Lack of Efficacy|1|||
127626389|NCT02139644|459256351|FG005|Treatment Period|Lack of Efficacy|4|||
127626390|NCT02139644|459256346|FG000|Treatment Period|Other|0|||
127626391|NCT02139644|459256347|FG001|Treatment Period|Other|3|||
127626392|NCT02139644|459256348|FG002|Treatment Period|Other|1|||
127626393|NCT02139644|459256349|FG003|Treatment Period|Other|1|||
127626394|NCT02139644|459256350|FG004|Treatment Period|Other|0|||
127626395|NCT02139644|459256351|FG005|Treatment Period|Other|1|||
127626396|NCT03328897|459256352|FG000|Randomized-treatment Epoch|Adverse Event|4|||
127626397|NCT03328897|459256353|FG001|Randomized-treatment Epoch|Adverse Event|1|||
127626398|NCT03328897|459256354|FG002|Randomized-treatment Epoch|Adverse Event|1|||
127626399|NCT03328897|459256352|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
127626400|NCT03328897|459256353|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
127626401|NCT03328897|459256354|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
127626402|NCT03328897|459256352|FG000|Randomized-treatment Epoch|Pregnancy|3|||
127626403|NCT03328897|459256353|FG001|Randomized-treatment Epoch|Pregnancy|0|||
127626404|NCT03328897|459256354|FG002|Randomized-treatment Epoch|Pregnancy|0|||
127626405|NCT03328897|459256352|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
127626406|NCT03328897|459256353|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
127626407|NCT03328897|459256354|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
127626408|NCT03328897|459256352|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
127626409|NCT03328897|459256353|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
127626410|NCT03328897|459256354|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
127626411|NCT03328897|459256352|FG000|Follow-up Epoch|Adverse Event|4|||
127626412|NCT03328897|459256353|FG001|Follow-up Epoch|Adverse Event|0|||
127626413|NCT03328897|459256354|FG002|Follow-up Epoch|Adverse Event|1|||
127626414|NCT03328897|459256352|FG000|Follow-up Epoch|Lack of Efficacy|1|||
127626415|NCT03328897|459256353|FG001|Follow-up Epoch|Lack of Efficacy|1|||
127626416|NCT03328897|459256354|FG002|Follow-up Epoch|Lack of Efficacy|1|||
127626417|NCT03328897|459256352|FG000|Follow-up Epoch|Lost to Follow-up|0|||
127626418|NCT03328897|459256353|FG001|Follow-up Epoch|Lost to Follow-up|1|||
127626419|NCT03328897|459256354|FG002|Follow-up Epoch|Lost to Follow-up|0|||
127626420|NCT03328897|459256352|FG000|Follow-up Epoch|Pregnancy|1|||
127626421|NCT03328897|459256353|FG001|Follow-up Epoch|Pregnancy|0|||
127626422|NCT03328897|459256354|FG002|Follow-up Epoch|Pregnancy|0|||
127626423|NCT03328897|459256352|FG000|Follow-up Epoch|Patient/guardian decision|2|||
127626424|NCT03328897|459256353|FG001|Follow-up Epoch|Patient/guardian decision|1|||
127626425|NCT03328897|459256354|FG002|Follow-up Epoch|Patient/guardian decision|0|||
127626426|NCT00608829|459256356|FG000|Overall Study|Death|6|||
127626427|NCT00608829|459256356|FG000|Overall Study|Withdrawal by Subject|4|||
127705266|NCT01928394|459551577|FG010|Follow-up Period|Death|4|||
127626428|NCT00608829|459256356|FG000|Overall Study|Subject refuses to follow up or return.|5|||
127626429|NCT02564471|459256359|FG000|Overall Study|Adverse Event|1|||
127626430|NCT02564471|459256360|FG001|Overall Study|Adverse Event|0|||
127626431|NCT02564471|459256361|FG002|Overall Study|Adverse Event|0|||
127626432|NCT02564471|459256362|FG003|Overall Study|Adverse Event|0|||
127626433|NCT02564471|459256359|FG000|Overall Study|Withdrawal by Subject|2|||
127626434|NCT02564471|459256360|FG001|Overall Study|Withdrawal by Subject|1|||
127626435|NCT02564471|459256361|FG002|Overall Study|Withdrawal by Subject|3|||
127626436|NCT02564471|459256362|FG003|Overall Study|Withdrawal by Subject|0|||
127626437|NCT02564471|459256359|FG000|Overall Study|Lost to Follow-up|0|||
127626438|NCT02564471|459256360|FG001|Overall Study|Lost to Follow-up|2|||
127626439|NCT02564471|459256361|FG002|Overall Study|Lost to Follow-up|0|||
127626440|NCT02564471|459256362|FG003|Overall Study|Lost to Follow-up|0|||
127626441|NCT02805257|459256363|FG000|Overall Study|Lost to Follow-up|7|||
127626442|NCT02805257|459256364|FG001|Overall Study|Lost to Follow-up|6|||
127626443|NCT02805257|459256363|FG000|Overall Study|Death|0|||
127626444|NCT02805257|459256364|FG001|Overall Study|Death|1|||
127626445|NCT03143829|459256370|FG000|Overall Study|Withdrawal by Subject|2|||
127626446|NCT03143829|459256371|FG001|Overall Study|Withdrawal by Subject|5|||
127626447|NCT03143829|459256370|FG000|Overall Study|Lost to Follow-up|0|||
127626448|NCT03143829|459256371|FG001|Overall Study|Lost to Follow-up|2|||
127626449|NCT03143829|459256370|FG000|Overall Study|Death|1|||
127626450|NCT03143829|459256371|FG001|Overall Study|Death|1|||
127626451|NCT03143829|459256370|FG000|Overall Study|changed treatment, no longer eligible|2|||
127626452|NCT03143829|459256371|FG001|Overall Study|changed treatment, no longer eligible|2|||
127626453|NCT02944578|459256372|FG000|Overall Study|Physician Decision|1|||
127626454|NCT02944578|459256373|FG001|Overall Study|Physician Decision|0|||
127626455|NCT02691455|459256374|FG000|Overall Study|Withdrawal by Subject|1|||
127626456|NCT02691455|459256375|FG001|Overall Study|Withdrawal by Subject|2|||
127626457|NCT02691455|459256374|FG000|Overall Study|Lost to Follow-up|15|||
127626458|NCT02691455|459256375|FG001|Overall Study|Lost to Follow-up|15|||
127626459|NCT01257204|459256376|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
127626460|NCT01257204|459256377|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
127626461|NCT01257204|459256378|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
127626462|NCT01257204|459256376|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
127626463|NCT01257204|459256377|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
127626464|NCT01257204|459256378|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
127626465|NCT01257204|459256376|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
127626466|NCT01257204|459256377|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
127626467|NCT01257204|459256378|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
127626468|NCT01257204|459256376|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
127626469|NCT01257204|459256377|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
127626470|NCT01257204|459256378|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
127626471|NCT01257204|459256376|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
127885230|NCT00879970|460203862|FG000|Period 2 Vitamin D Randomization|Death|0|||
127885231|NCT00879970|460203863|FG001|Period 2 Vitamin D Randomization|Death|0|||
127626472|NCT01257204|459256377|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
127626473|NCT01257204|459256378|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
127626474|NCT01257204|459256376|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
127626475|NCT01257204|459256377|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
127626476|NCT01257204|459256378|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
127626477|NCT01257204|459256376|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
127626478|NCT01257204|459256377|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
127626479|NCT01257204|459256378|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
127626480|NCT01257204|459256376|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
127626481|NCT01257204|459256377|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
127626482|NCT01257204|459256378|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
127626483|NCT01257204|459256376|FG000|Follow-up Period (up to Week 48)|Other|0|||
127626484|NCT01257204|459256377|FG001|Follow-up Period (up to Week 48)|Other|0|||
127626485|NCT01257204|459256378|FG002|Follow-up Period (up to Week 48)|Other|5|||
127626486|NCT01276327|459256381|FG000|Overall Study|Adverse Event|1|||
127626487|NCT01276327|459256382|FG001|Overall Study|Adverse Event|3|||
127626488|NCT01276327|459256381|FG000|Overall Study|Withdrawal by Subject|1|||
127626489|NCT01276327|459256382|FG001|Overall Study|Withdrawal by Subject|0|||
127626490|NCT00807092|459256383|FG000|Overall Study|Adverse Event|0|||
127626491|NCT00807092|459256384|FG001|Overall Study|Adverse Event|1|||
127626492|NCT00807092|459256383|FG000|Overall Study|Protocol Violation|0|||
127626493|NCT00807092|459256384|FG001|Overall Study|Protocol Violation|2|||
127626494|NCT00807092|459256383|FG000|Overall Study|Withdrawal by Subject|1|||
127626495|NCT00807092|459256384|FG001|Overall Study|Withdrawal by Subject|0|||
127626496|NCT00807092|459256383|FG000|Overall Study|CGMS data collection failed|0|||
127626497|NCT00807092|459256384|FG001|Overall Study|CGMS data collection failed|1|||
127626498|NCT04116229|459256385|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
127626499|NCT04116229|459256386|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
127626500|NCT04116229|459256385|FG000|Overall Study|Scheduling not possible.|0|||
127626501|NCT04116229|459256386|FG001|Overall Study|Scheduling not possible.|1|||
127626502|NCT01794949|459256387|FG000|Overall Study|Lost to Follow-up|1|||
127626503|NCT01794949|459256388|FG001|Overall Study|Lost to Follow-up|0|||
127626504|NCT03003676|459256389|FG000|Overall Study|Lack of Efficacy|5|||
127626505|NCT03003676|459256390|FG001|Overall Study|Lack of Efficacy|7|||
127626506|NCT03003676|459256389|FG000|Overall Study|Withdrawal by Subject|0|||
127626507|NCT03003676|459256390|FG001|Overall Study|Withdrawal by Subject|1|||
127626508|NCT03003676|459256389|FG000|Overall Study|Hepatitis B infection|1|||
127626509|NCT03003676|459256390|FG001|Overall Study|Hepatitis B infection|0|||
127626510|NCT03766646|459256399|FG000|Overall Study|Withdrawal by Subject|1|||
127626511|NCT03766646|459256400|FG001|Overall Study|Withdrawal by Subject|0|||
127626512|NCT03766646|459256399|FG000|Overall Study|Protocol Violation|0|||
127626513|NCT03766646|459256400|FG001|Overall Study|Protocol Violation|3|||
127626514|NCT00642304|459256416|FG000|Overall Study|Adverse Event|1|||
127626515|NCT00642304|459256416|FG000|Overall Study|Death|1|||
127626516|NCT00642304|459256416|FG000|Overall Study|Blood transfusion|2|||
127626517|NCT00642304|459256416|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
127626518|NCT00642304|459256416|FG000|Overall Study|Transplantation|1|||
127626519|NCT02863354|459256417|FG000|Year 1|Lost to Follow-up|1|||
127626520|NCT02863354|459256418|FG001|Year 1|Lost to Follow-up|1|||
127626521|NCT02863354|459256417|FG000|Year 1|Withdrawal by Subject|3|||
127626522|NCT02863354|459256418|FG001|Year 1|Withdrawal by Subject|0|||
127626523|NCT02863354|459256417|FG000|Year 1|Death|0|||
127626524|NCT02863354|459256418|FG001|Year 1|Death|1|||
127626525|NCT02863354|459256417|FG000|Year 2|Lost to Follow-up|2|||
127626526|NCT02863354|459256418|FG001|Year 2|Lost to Follow-up|2|||
127626527|NCT01599650|459256422|FG000|Overall Study|Administrative issue|1|||
127626528|NCT01599650|459256423|FG001|Overall Study|Administrative issue|0|||
127626529|NCT01599650|459256424|FG002|Overall Study|Administrative issue|1|||
127626530|NCT01599650|459256422|FG000|Overall Study|Physician Decision|2|||
127626531|NCT01599650|459256423|FG001|Overall Study|Physician Decision|0|||
127626532|NCT01599650|459256424|FG002|Overall Study|Physician Decision|7|||
127626533|NCT01599650|459256422|FG000|Overall Study|Protocol Violation|0|||
127626534|NCT01599650|459256423|FG001|Overall Study|Protocol Violation|3|||
127626535|NCT01599650|459256424|FG002|Overall Study|Protocol Violation|0|||
127626536|NCT01599650|459256422|FG000|Overall Study|Death|2|||
127626537|NCT01599650|459256423|FG001|Overall Study|Death|1|||
127626538|NCT01599650|459256424|FG002|Overall Study|Death|2|||
127626539|NCT01599650|459256422|FG000|Overall Study|Lost to Follow-up|3|||
127626540|NCT01599650|459256423|FG001|Overall Study|Lost to Follow-up|3|||
127626541|NCT01599650|459256424|FG002|Overall Study|Lost to Follow-up|3|||
127626542|NCT01599650|459256422|FG000|Overall Study|Withdrawal by Subject|11|||
127626543|NCT01599650|459256423|FG001|Overall Study|Withdrawal by Subject|11|||
127626544|NCT01599650|459256424|FG002|Overall Study|Withdrawal by Subject|10|||
127626545|NCT01599650|459256422|FG000|Overall Study|Adverse Event|3|||
127626546|NCT01599650|459256423|FG001|Overall Study|Adverse Event|8|||
127626547|NCT01599650|459256424|FG002|Overall Study|Adverse Event|4|||
127626548|NCT02802345|459256425|FG000|Overall Study|Not Treated|0|||
127626549|NCT02802345|459256426|FG001|Overall Study|Not Treated|1|||
127626550|NCT02802345|459256425|FG000|Overall Study|Adverse Event|28|||
127626551|NCT02802345|459256426|FG001|Overall Study|Adverse Event|20|||
127626552|NCT02802345|459256425|FG000|Overall Study|Withdrawal by Subject|3|||
127626553|NCT02802345|459256426|FG001|Overall Study|Withdrawal by Subject|3|||
127626554|NCT02802345|459256425|FG000|Overall Study|Protocol Violation|0|||
127626555|NCT02802345|459256426|FG001|Overall Study|Protocol Violation|1|||
127626556|NCT02802345|459256425|FG000|Overall Study|Other than listed|1|||
127626557|NCT02802345|459256426|FG001|Overall Study|Other than listed|5|||
127626558|NCT05857527|459256429|FG000|Overall Study|Withdrawal by Subject|0|||
127626559|NCT05857527|459256430|FG001|Overall Study|Withdrawal by Subject|1|||
127626560|NCT01748994|459256433|FG000|Overall Study|Lost to Follow-up|8|||
127626561|NCT01748994|459256434|FG001|Overall Study|Lost to Follow-up|6|||
127626562|NCT01723904|459256438|FG000|Overall Study|Noncompliant|3|||
127626563|NCT01723904|459256438|FG000|Overall Study|Adverse Event|5|||
127626564|NCT01723904|459256438|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
127626565|NCT03251924|459256439|FG000|Overall Study|Disease Progression|6|||
127626566|NCT03251924|459256440|FG001|Overall Study|Disease Progression|6|||
127626567|NCT03251924|459256441|FG002|Overall Study|Disease Progression|7|||
127626568|NCT03251924|459256442|FG003|Overall Study|Disease Progression|8|||
127626569|NCT03251924|459256443|FG004|Overall Study|Disease Progression|8|||
127626570|NCT03251924|459256444|FG005|Overall Study|Disease Progression|7|||
127626571|NCT03251924|459256445|FG006|Overall Study|Disease Progression|6|||
127626572|NCT03251924|459256446|FG007|Overall Study|Disease Progression|10|||
127626573|NCT03251924|459256447|FG008|Overall Study|Disease Progression|6|||
127626574|NCT03251924|459256439|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
127626575|NCT03251924|459256440|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
127626576|NCT03251924|459256441|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
127626577|NCT03251924|459256442|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
127626578|NCT03251924|459256443|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
127626579|NCT03251924|459256444|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
127626580|NCT03251924|459256445|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
127626581|NCT03251924|459256446|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
127626582|NCT03251924|459256447|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
127626583|NCT03251924|459256439|FG000|Overall Study|Death|0|||
127626584|NCT03251924|459256440|FG001|Overall Study|Death|1|||
127626585|NCT03251924|459256441|FG002|Overall Study|Death|0|||
127626586|NCT03251924|459256442|FG003|Overall Study|Death|1|||
127626587|NCT03251924|459256443|FG004|Overall Study|Death|1|||
127626588|NCT03251924|459256444|FG005|Overall Study|Death|1|||
127626589|NCT03251924|459256445|FG006|Overall Study|Death|0|||
127793080|NCT03016325|459867441|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
127793081|NCT03016325|459867442|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
127793082|NCT03016325|459867443|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
127793083|NCT03016325|459867444|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
127793084|NCT03016325|459867437|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
127793085|NCT03016325|459867438|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
127626590|NCT03251924|459256446|FG007|Overall Study|Death|0|||
127626591|NCT03251924|459256447|FG008|Overall Study|Death|0|||
127626592|NCT03251924|459256439|FG000|Overall Study|Study Drug Toxicity|0|||
127626593|NCT03251924|459256440|FG001|Overall Study|Study Drug Toxicity|0|||
127626594|NCT03251924|459256441|FG002|Overall Study|Study Drug Toxicity|0|||
127626595|NCT03251924|459256442|FG003|Overall Study|Study Drug Toxicity|1|||
127626596|NCT03251924|459256443|FG004|Overall Study|Study Drug Toxicity|0|||
127626597|NCT03251924|459256444|FG005|Overall Study|Study Drug Toxicity|0|||
127626598|NCT03251924|459256445|FG006|Overall Study|Study Drug Toxicity|0|||
127626599|NCT03251924|459256446|FG007|Overall Study|Study Drug Toxicity|0|||
127793086|NCT03016325|459867439|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
127626600|NCT03251924|459256447|FG008|Overall Study|Study Drug Toxicity|1|||
127626601|NCT03251924|459256439|FG000|Overall Study|Other Reasons|0|||
127626602|NCT03251924|459256440|FG001|Overall Study|Other Reasons|0|||
127626603|NCT03251924|459256441|FG002|Overall Study|Other Reasons|0|||
127626604|NCT03251924|459256442|FG003|Overall Study|Other Reasons|0|||
127626605|NCT03251924|459256443|FG004|Overall Study|Other Reasons|0|||
127626606|NCT03251924|459256444|FG005|Overall Study|Other Reasons|0|||
127626607|NCT03251924|459256445|FG006|Overall Study|Other Reasons|0|||
127626608|NCT03251924|459256446|FG007|Overall Study|Other Reasons|0|||
127626609|NCT03251924|459256447|FG008|Overall Study|Other Reasons|1|||
127626610|NCT03251924|459256439|FG000|Overall Study|Participant request to discontinue study treatment|0|||
127626611|NCT03251924|459256440|FG001|Overall Study|Participant request to discontinue study treatment|0|||
127626612|NCT03251924|459256441|FG002|Overall Study|Participant request to discontinue study treatment|0|||
127626613|NCT03251924|459256442|FG003|Overall Study|Participant request to discontinue study treatment|0|||
127626614|NCT03251924|459256443|FG004|Overall Study|Participant request to discontinue study treatment|0|||
127626615|NCT03251924|459256444|FG005|Overall Study|Participant request to discontinue study treatment|0|||
127626616|NCT03251924|459256445|FG006|Overall Study|Participant request to discontinue study treatment|0|||
127626617|NCT03251924|459256446|FG007|Overall Study|Participant request to discontinue study treatment|1|||
127626618|NCT03251924|459256447|FG008|Overall Study|Participant request to discontinue study treatment|0|||
127626619|NCT02617589|459256456|FG000|Randomization|Request to Discontinue Study Treatment|1|||
127626620|NCT02617589|459256457|FG001|Randomization|Request to Discontinue Study Treatment|3|||
127626621|NCT02617589|459256456|FG000|Randomization|Participant Withdrew Consent|1|||
127626622|NCT02617589|459256457|FG001|Randomization|Participant Withdrew Consent|2|||
127626623|NCT02617589|459256456|FG000|Treatment|Other Reasons|3|||
127626624|NCT02617589|459256457|FG001|Treatment|Other Reasons|3|||
127626625|NCT02617589|459256456|FG000|Treatment|Poor/Non Compliance|1|||
127626626|NCT02617589|459256457|FG001|Treatment|Poor/Non Compliance|1|||
127626627|NCT02617589|459256456|FG000|Treatment|Maximum Clinical Benefit|0|||
127626628|NCT02617589|459256457|FG001|Treatment|Maximum Clinical Benefit|2|||
127626629|NCT02617589|459256456|FG000|Treatment|Participant Withdrew Consent|2|||
127626630|NCT02617589|459256457|FG001|Treatment|Participant Withdrew Consent|6|||
127626631|NCT02617589|459256456|FG000|Treatment|Participant Request to Discontinue|12|||
127626632|NCT02617589|459256457|FG001|Treatment|Participant Request to Discontinue|21|||
127626633|NCT02617589|459256456|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
127626634|NCT02617589|459256457|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
127626635|NCT02617589|459256456|FG000|Treatment|Death|1|||
127626636|NCT02617589|459256457|FG001|Treatment|Death|1|||
127626637|NCT02617589|459256456|FG000|Treatment|Study Drug Toxicity|27|||
127626638|NCT02617589|459256457|FG001|Treatment|Study Drug Toxicity|20|||
127626639|NCT02617589|459256456|FG000|Treatment|Disease Progression|216|||
127626640|NCT02617589|459256457|FG001|Treatment|Disease Progression|136|||
127626641|NCT00179647|459256458|FG000|Overall Study|Adverse Event|294|||
127626642|NCT00179647|459256458|FG000|Overall Study|Lack of Efficacy|478|||
127626643|NCT00179647|459256458|FG000|Overall Study|Withdrawal by Subject|83|||
127626644|NCT00179647|459256458|FG000|Overall Study|Lost to Follow-up|4|||
127626645|NCT00179647|459256458|FG000|Overall Study|Death|94|||
127626646|NCT00179647|459256458|FG000|Overall Study|Other|960|||
127626647|NCT02138214|459256461|FG000|Overall Study|Withdrawal by Subject|0|||
127626648|NCT02138214|459256462|FG001|Overall Study|Withdrawal by Subject|1|||
127626649|NCT02138214|459256463|FG002|Overall Study|Withdrawal by Subject|0|||
127626650|NCT02138214|459256461|FG000|Overall Study|Lost to Follow-up|0|||
127626651|NCT02138214|459256462|FG001|Overall Study|Lost to Follow-up|2|||
127626652|NCT02138214|459256463|FG002|Overall Study|Lost to Follow-up|4|||
127626653|NCT02138214|459256461|FG000|Overall Study|Screen Failure|0|||
127626654|NCT02138214|459256462|FG001|Overall Study|Screen Failure|1|||
127626655|NCT02138214|459256463|FG002|Overall Study|Screen Failure|0|||
127626656|NCT03027466|459256466|FG000|Overall Study|Opting out of the app|1869|||
127626657|NCT03027466|459256467|FG001|Overall Study|Opting out of the app|1819|||
127626658|NCT03027466|459256468|FG002|Overall Study|Opting out of the app|1743|||
127626659|NCT03027466|459256469|FG003|Overall Study|Opting out of the app|1821|||
127626660|NCT02158039|459256474|FG000|Overall Study|Withdrawal by Subject|1|||
127626661|NCT02158039|459256474|FG000|Overall Study|Screen Failure|9|||
127626662|NCT03062891|459256486|FG000|Overall Study|Withdrawal by Subject|2|||
127626663|NCT03062891|459256487|FG001|Overall Study|Withdrawal by Subject|0|||
127626664|NCT03062891|459256486|FG000|Overall Study|Lost to Follow-up|50|||
127626665|NCT03062891|459256487|FG001|Overall Study|Lost to Follow-up|38|||
127626666|NCT03221257|459256488|FG000|Overall Study|Lost to Follow-up|0|||
127626667|NCT03221257|459256489|FG001|Overall Study|Lost to Follow-up|1|||
127626668|NCT03221257|459256488|FG000|Overall Study|Withdrawal by Subject|1|||
127701739|NCT04987320|459537031|FG000|Overall Study|Withdrawal by Subject|0|||
127701740|NCT04987320|459537032|FG001|Overall Study|Withdrawal by Subject|1|||
127701741|NCT01824875|459537033|FG000|Overall Study|Disease progression|22|||
127701742|NCT01824875|459537034|FG001|Overall Study|Disease progression|15|||
127701743|NCT01824875|459537033|FG000|Overall Study|Withdrawal by Subject|5|||
127701744|NCT01824875|459537034|FG001|Overall Study|Withdrawal by Subject|4|||
127701745|NCT01824875|459537033|FG000|Overall Study|Adverse Event|4|||
127701746|NCT01824875|459537034|FG001|Overall Study|Adverse Event|10|||
127701747|NCT01824875|459537033|FG000|Overall Study|Alternative therapy|3|||
127701748|NCT01824875|459537034|FG001|Overall Study|Alternative therapy|0|||
127701749|NCT01824875|459537033|FG000|Overall Study|Complicating disease|1|||
127793087|NCT03016325|459867440|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
127793088|NCT03016325|459867441|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
127793089|NCT03016325|459867442|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
127701750|NCT01824875|459537034|FG001|Overall Study|Complicating disease|0|||
127701751|NCT01824875|459537033|FG000|Overall Study|Physician Decision|0|||
127701752|NCT01824875|459537034|FG001|Overall Study|Physician Decision|1|||
127701753|NCT01824875|459537033|FG000|Overall Study|Non-compliance|1|||
127701754|NCT01824875|459537034|FG001|Overall Study|Non-compliance|1|||
127701755|NCT01824875|459537033|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
127701756|NCT01824875|459537034|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
127701757|NCT01824875|459537033|FG000|Overall Study|Administrative issues|0|||
127701758|NCT01824875|459537034|FG001|Overall Study|Administrative issues|2|||
127701759|NCT01824875|459537033|FG000|Overall Study|Ineligible or never started treatment|9|||
127701760|NCT01824875|459537034|FG001|Overall Study|Ineligible or never started treatment|5|||
127701761|NCT01824875|459537033|FG000|Overall Study|Other|0|||
127701762|NCT01824875|459537034|FG001|Overall Study|Other|2|||
127701763|NCT01098812|459537037|FG000|Overall Study|Death|2|||
127701764|NCT01098812|459537038|FG001|Overall Study|Death|0|||
127701765|NCT01098812|459537039|FG002|Overall Study|Death|1|||
127701766|NCT01098812|459537037|FG000|Overall Study|Lost to Follow-up|0|||
127701767|NCT01098812|459537038|FG001|Overall Study|Lost to Follow-up|1|||
127701768|NCT01098812|459537039|FG002|Overall Study|Lost to Follow-up|0|||
127701769|NCT03462030|459537045|FG000|Overall Study|Withdrawal by Subject|1|||
127701770|NCT03462030|459537046|FG001|Overall Study|Withdrawal by Subject|1|||
127701771|NCT02675751|459537047|FG000|Overall Study|Lost to Follow-up|16|||
127701772|NCT02979327|459537048|FG000|First Intervention|Protocol Violation|1|||
127793090|NCT03016325|459867443|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
127793091|NCT03016325|459867444|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
127793092|NCT03016325|459867437|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
127793093|NCT03016325|459867438|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
127793094|NCT03016325|459867439|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
127793095|NCT03016325|459867440|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
127626669|NCT03221257|459256489|FG001|Overall Study|Withdrawal by Subject|1|||
127626670|NCT01334866|459256491|FG000|Overall Study|Withdrawal by Subject|10|||
127626671|NCT01334866|459256491|FG000|Overall Study|Lost to Follow-up|3|||
127626672|NCT01334866|459256491|FG000|Overall Study|Physician Decision|3|||
127626673|NCT01334866|459256491|FG000|Overall Study|medically necessary prior to procedure|2|||
127626674|NCT01334866|459256491|FG000|Overall Study|medically necessary post-procedure|1|||
127626675|NCT01687166|459256500|FG000|Overall Study|Attempt subject|2|||
127626676|NCT01687166|459256501|FG001|Overall Study|Attempt subject|3|||
127626677|NCT01687166|459256502|FG002|Overall Study|Attempt subject|2|||
127626678|NCT01687166|459256503|FG003|Overall Study|Attempt subject|0|||
127626679|NCT01687166|459256500|FG000|Overall Study|Did not meet eligibility criteria|4|||
127626680|NCT01687166|459256501|FG001|Overall Study|Did not meet eligibility criteria|6|||
127626681|NCT01687166|459256502|FG002|Overall Study|Did not meet eligibility criteria|1|||
127626682|NCT01687166|459256503|FG003|Overall Study|Did not meet eligibility criteria|1|||
127626683|NCT01687166|459256500|FG000|Overall Study|Adverse Event|2|||
127626684|NCT01687166|459256501|FG001|Overall Study|Adverse Event|1|||
127626685|NCT01687166|459256502|FG002|Overall Study|Adverse Event|0|||
127626686|NCT01687166|459256503|FG003|Overall Study|Adverse Event|0|||
127626687|NCT01687166|459256500|FG000|Overall Study|Physician Decision|3|||
127626688|NCT01687166|459256501|FG001|Overall Study|Physician Decision|2|||
127626689|NCT01687166|459256502|FG002|Overall Study|Physician Decision|1|||
127626690|NCT01687166|459256503|FG003|Overall Study|Physician Decision|0|||
127626691|NCT01687166|459256500|FG000|Overall Study|Withdrawal by Subject|11|||
127626692|NCT01687166|459256501|FG001|Overall Study|Withdrawal by Subject|4|||
127626693|NCT01687166|459256502|FG002|Overall Study|Withdrawal by Subject|3|||
127626694|NCT01687166|459256503|FG003|Overall Study|Withdrawal by Subject|0|||
127626695|NCT01687166|459256500|FG000|Overall Study|Lost to Follow-up|2|||
127626696|NCT01687166|459256501|FG001|Overall Study|Lost to Follow-up|5|||
127626697|NCT01687166|459256502|FG002|Overall Study|Lost to Follow-up|1|||
127626698|NCT01687166|459256503|FG003|Overall Study|Lost to Follow-up|0|||
127626699|NCT01687166|459256500|FG000|Overall Study|Equipment/Device Availability|0|||
127626700|NCT01687166|459256501|FG001|Overall Study|Equipment/Device Availability|1|||
127626701|NCT01687166|459256502|FG002|Overall Study|Equipment/Device Availability|0|||
127793096|NCT03016325|459867441|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
127626702|NCT01687166|459256503|FG003|Overall Study|Equipment/Device Availability|0|||
127626703|NCT01687166|459256500|FG000|Overall Study|Death|1|||
127626704|NCT01687166|459256501|FG001|Overall Study|Death|1|||
127626705|NCT01687166|459256502|FG002|Overall Study|Death|0|||
127701773|NCT02979327|459537049|FG001|First Intervention|Protocol Violation|0|||
127701774|NCT05020249|459537050|FG000|Overall Study|Protocol Violation|1|||
127701775|NCT05020249|459537051|FG001|Overall Study|Protocol Violation|0|||
127701776|NCT03474679|459537066|FG000|Overall Study|Death|7|||
127701777|NCT03474679|459537066|FG000|Overall Study|Withdrawal by Subject|1|||
127701778|NCT05499377|459537069|FG000|Overall Study|Withdrawal by Subject|2|||
127626706|NCT01687166|459256503|FG003|Overall Study|Death|0|||
127626707|NCT01687166|459256500|FG000|Overall Study|Protocol Violation|1|||
127626708|NCT01687166|459256501|FG001|Overall Study|Protocol Violation|1|||
127626709|NCT01687166|459256502|FG002|Overall Study|Protocol Violation|1|||
127626710|NCT01687166|459256503|FG003|Overall Study|Protocol Violation|0|||
127626711|NCT01687166|459256500|FG000|Overall Study|Subject moved out of state|0|||
127626712|NCT01687166|459256501|FG001|Overall Study|Subject moved out of state|1|||
127626713|NCT01687166|459256502|FG002|Overall Study|Subject moved out of state|0|||
127626714|NCT01687166|459256503|FG003|Overall Study|Subject moved out of state|0|||
127626715|NCT01687166|459256500|FG000|Overall Study|Patient unable to be compliant|1|||
127626716|NCT01687166|459256501|FG001|Overall Study|Patient unable to be compliant|0|||
127626717|NCT01687166|459256502|FG002|Overall Study|Patient unable to be compliant|0|||
127626718|NCT01687166|459256503|FG003|Overall Study|Patient unable to be compliant|0|||
127626719|NCT01687166|459256500|FG000|Overall Study|Physician choice to use different device|1|||
127626720|NCT01687166|459256501|FG001|Overall Study|Physician choice to use different device|2|||
127626721|NCT01687166|459256502|FG002|Overall Study|Physician choice to use different device|4|||
127626722|NCT01687166|459256503|FG003|Overall Study|Physician choice to use different device|0|||
127626723|NCT01687166|459256500|FG000|Overall Study|Insurance|0|||
127626724|NCT01687166|459256501|FG001|Overall Study|Insurance|0|||
127626725|NCT01687166|459256502|FG002|Overall Study|Insurance|1|||
127626726|NCT01687166|459256503|FG003|Overall Study|Insurance|1|||
127626727|NCT02797262|459256504|FG000|Overall Study|Withdrawal by Subject|5|||
127626728|NCT02797262|459256505|FG001|Overall Study|Withdrawal by Subject|1|||
127626729|NCT02797262|459256504|FG000|Overall Study|Lost to Follow-up|10|||
127626730|NCT02797262|459256505|FG001|Overall Study|Lost to Follow-up|7|||
127626731|NCT02797262|459256504|FG000|Overall Study|Death|1|||
127626732|NCT02797262|459256505|FG001|Overall Study|Death|2|||
127626733|NCT02797262|459256504|FG000|Overall Study|Adverse Event|1|||
127626734|NCT02797262|459256505|FG001|Overall Study|Adverse Event|0|||
127626735|NCT02797262|459256504|FG000|Overall Study|COVID-19|2|||
127626736|NCT02797262|459256505|FG001|Overall Study|COVID-19|1|||
127626737|NCT02797262|459256504|FG000|Overall Study|Out-of-country|1|||
127626738|NCT02797262|459256505|FG001|Overall Study|Out-of-country|0|||
127626739|NCT01600586|459256506|FG000|Overall Study|Physician Decision|3|||
127626740|NCT01600586|459256507|FG001|Overall Study|Physician Decision|3|||
127626741|NCT00983814|459256508|FG000|Open-Label (6 Weeks)|Adverse Event|3|||
127626742|NCT00983814|459256509|FG001|Open-Label (6 Weeks)|Adverse Event|0|||
127626743|NCT00983814|459256510|FG002|Open-Label (6 Weeks)|Adverse Event|0|||
127626744|NCT00983814|459256508|FG000|Open-Label (6 Weeks)|Withdrawal by Subject|2|||
127626745|NCT00983814|459256509|FG001|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
127626746|NCT00983814|459256510|FG002|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
127626747|NCT00983814|459256508|FG000|Open-Label (6 Weeks)|Physician Decision|1|||
127626748|NCT00983814|459256509|FG001|Open-Label (6 Weeks)|Physician Decision|0|||
127626749|NCT00983814|459256510|FG002|Open-Label (6 Weeks)|Physician Decision|0|||
127626750|NCT00983814|459256508|FG000|Open-Label (6 Weeks)|Lost to Follow-up|1|||
127626751|NCT00983814|459256509|FG001|Open-Label (6 Weeks)|Lost to Follow-up|0|||
127626752|NCT00983814|459256510|FG002|Open-Label (6 Weeks)|Lost to Follow-up|0|||
127626753|NCT00983814|459256508|FG000|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
127626754|NCT00983814|459256509|FG001|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
127626755|NCT00983814|459256510|FG002|Double-Blind (2 Weeks)|Withdrawal by Subject|1|||
127626756|NCT00829621|459256511|FG000|Overall Study|Death|1|||
127626757|NCT00829621|459256512|FG001|Overall Study|Death|0|||
127626758|NCT00829621|459256511|FG000|Overall Study|Lost to Follow-up|3|||
127626759|NCT00829621|459256512|FG001|Overall Study|Lost to Follow-up|4|||
127626760|NCT00774995|459256513|FG000|Overall Study|Protocol Violation|0|||
127626761|NCT00774995|459256514|FG001|Overall Study|Protocol Violation|0|||
127626762|NCT00774995|459256515|FG002|Overall Study|Protocol Violation|1|||
127626763|NCT00774995|459256516|FG003|Overall Study|Protocol Violation|0|||
127626764|NCT02766608|459258334|FG000|Overall Study|Adverse Event|27|||
127626765|NCT02766608|459258335|FG001|Overall Study|Adverse Event|22|||
127626766|NCT02766608|459258336|FG002|Overall Study|Adverse Event|17|||
127626767|NCT02766608|459258337|FG003|Overall Study|Adverse Event|13|||
127626768|NCT02766608|459258338|FG004|Overall Study|Adverse Event|12|||
127626769|NCT02766608|459258334|FG000|Overall Study|Withdrawal by Subject|21|||
127626770|NCT02766608|459258335|FG001|Overall Study|Withdrawal by Subject|20|||
127626771|NCT02766608|459258336|FG002|Overall Study|Withdrawal by Subject|24|||
127626772|NCT02766608|459258337|FG003|Overall Study|Withdrawal by Subject|13|||
127626773|NCT02766608|459258338|FG004|Overall Study|Withdrawal by Subject|10|||
127793097|NCT03016325|459867442|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
127626774|NCT02766608|459258334|FG000|Overall Study|Lack of Efficacy|16|||
127626775|NCT02766608|459258335|FG001|Overall Study|Lack of Efficacy|15|||
127626776|NCT02766608|459258336|FG002|Overall Study|Lack of Efficacy|32|||
127626777|NCT02766608|459258337|FG003|Overall Study|Lack of Efficacy|8|||
127626778|NCT02766608|459258338|FG004|Overall Study|Lack of Efficacy|2|||
127626779|NCT02766608|459258334|FG000|Overall Study|Lost to Follow-up|6|||
127626780|NCT02766608|459258335|FG001|Overall Study|Lost to Follow-up|3|||
127626781|NCT02766608|459258336|FG002|Overall Study|Lost to Follow-up|5|||
127626782|NCT02766608|459258337|FG003|Overall Study|Lost to Follow-up|2|||
127626783|NCT02766608|459258338|FG004|Overall Study|Lost to Follow-up|2|||
127626784|NCT02766608|459258334|FG000|Overall Study|Physician Decision|3|||
127626785|NCT02766608|459258335|FG001|Overall Study|Physician Decision|2|||
127626786|NCT02766608|459258336|FG002|Overall Study|Physician Decision|3|||
127626787|NCT02766608|459258337|FG003|Overall Study|Physician Decision|1|||
127626788|NCT02766608|459258338|FG004|Overall Study|Physician Decision|2|||
127626789|NCT02766608|459258334|FG000|Overall Study|Protocol disc criteria|3|||
127626790|NCT02766608|459258335|FG001|Overall Study|Protocol disc criteria|3|||
127626791|NCT02766608|459258336|FG002|Overall Study|Protocol disc criteria|4|||
127626792|NCT02766608|459258337|FG003|Overall Study|Protocol disc criteria|0|||
127626793|NCT02766608|459258338|FG004|Overall Study|Protocol disc criteria|0|||
127626794|NCT02766608|459258334|FG000|Overall Study|Protocol Violation|0|||
127626795|NCT02766608|459258335|FG001|Overall Study|Protocol Violation|4|||
127626796|NCT02766608|459258336|FG002|Overall Study|Protocol Violation|4|||
127626797|NCT02766608|459258337|FG003|Overall Study|Protocol Violation|0|||
127626798|NCT02766608|459258338|FG004|Overall Study|Protocol Violation|1|||
127626799|NCT02766608|459258334|FG000|Overall Study|Administrative Reasons|3|||
127626800|NCT02766608|459258335|FG001|Overall Study|Administrative Reasons|1|||
127626801|NCT02766608|459258336|FG002|Overall Study|Administrative Reasons|1|||
127626802|NCT02766608|459258337|FG003|Overall Study|Administrative Reasons|0|||
127626803|NCT02766608|459258338|FG004|Overall Study|Administrative Reasons|0|||
127626804|NCT02066298|459258339|FG000|Overall Study|Lost to Follow-up|3|||
127626805|NCT02066298|459258340|FG001|Overall Study|Lost to Follow-up|2|||
127626806|NCT02066298|459258341|FG002|Overall Study|Lost to Follow-up|3|||
127626807|NCT02066298|459258342|FG003|Overall Study|Lost to Follow-up|2|||
127626808|NCT02066298|459258343|FG004|Overall Study|Lost to Follow-up|3|||
127626809|NCT02066298|459258344|FG005|Overall Study|Lost to Follow-up|4|||
127626810|NCT02066298|459258339|FG000|Overall Study|Withdrawal by Subject|6|||
127626811|NCT02066298|459258340|FG001|Overall Study|Withdrawal by Subject|6|||
127626812|NCT02066298|459258341|FG002|Overall Study|Withdrawal by Subject|6|||
127626813|NCT02066298|459258342|FG003|Overall Study|Withdrawal by Subject|4|||
127626814|NCT02066298|459258343|FG004|Overall Study|Withdrawal by Subject|5|||
127626815|NCT02066298|459258344|FG005|Overall Study|Withdrawal by Subject|8|||
127626816|NCT02066298|459258339|FG000|Overall Study|Physician Decision|0|||
127626817|NCT02066298|459258340|FG001|Overall Study|Physician Decision|0|||
127626818|NCT02066298|459258341|FG002|Overall Study|Physician Decision|1|||
127626819|NCT02066298|459258342|FG003|Overall Study|Physician Decision|0|||
127626820|NCT02066298|459258343|FG004|Overall Study|Physician Decision|1|||
127626821|NCT02066298|459258344|FG005|Overall Study|Physician Decision|0|||
127626822|NCT02033889|459258345|FG000|Overall Study|Adverse Event|3|||
127626823|NCT02033889|459258346|FG001|Overall Study|Adverse Event|1|||
127626824|NCT02033889|459258347|FG002|Overall Study|Adverse Event|3|||
127626825|NCT02033889|459258345|FG000|Overall Study|Death|3|||
127626826|NCT02033889|459258346|FG001|Overall Study|Death|1|||
127626827|NCT02033889|459258347|FG002|Overall Study|Death|2|||
127626828|NCT02033889|459258345|FG000|Overall Study|Excluded Medication|1|||
127626829|NCT02033889|459258346|FG001|Overall Study|Excluded Medication|1|||
127626830|NCT02033889|459258347|FG002|Overall Study|Excluded Medication|0|||
127626831|NCT02033889|459258345|FG000|Overall Study|Lost to Follow-up|8|||
127626832|NCT02033889|459258346|FG001|Overall Study|Lost to Follow-up|5|||
127626833|NCT02033889|459258347|FG002|Overall Study|Lost to Follow-up|6|||
127626834|NCT02033889|459258345|FG000|Overall Study|Non-Compliance With Study Drug|1|||
127626835|NCT02033889|459258346|FG001|Overall Study|Non-Compliance With Study Drug|0|||
127626836|NCT02033889|459258347|FG002|Overall Study|Non-Compliance With Study Drug|0|||
127626837|NCT02033889|459258345|FG000|Overall Study|Physician Decision|0|||
127793098|NCT03016325|459867443|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
127626838|NCT02033889|459258346|FG001|Overall Study|Physician Decision|1|||
127626839|NCT02033889|459258347|FG002|Overall Study|Physician Decision|1|||
127626840|NCT02033889|459258345|FG000|Overall Study|Participant moved|0|||
127626841|NCT02033889|459258346|FG001|Overall Study|Participant moved|1|||
127626842|NCT02033889|459258347|FG002|Overall Study|Participant moved|0|||
127626843|NCT02033889|459258345|FG000|Overall Study|Withdrawal by Subject|18|||
127626844|NCT02033889|459258346|FG001|Overall Study|Withdrawal by Subject|10|||
127626845|NCT02033889|459258347|FG002|Overall Study|Withdrawal by Subject|13|||
127626846|NCT02348489|459258349|FG000|Overall Study|Death|336|||
127626847|NCT02348489|459258350|FG001|Overall Study|Death|335|||
127626848|NCT02348489|459258349|FG000|Overall Study|Withdrawal by Subject|14|||
127626849|NCT02348489|459258350|FG001|Overall Study|Withdrawal by Subject|27|||
127626850|NCT02348489|459258349|FG000|Overall Study|Lost to Follow-up|3|||
127701779|NCT05499377|459537070|FG001|Overall Study|Withdrawal by Subject|0|||
127701780|NCT05499377|459537069|FG000|Overall Study|Physician Decision|1|||
127701781|NCT05499377|459537070|FG001|Overall Study|Physician Decision|0|||
127701782|NCT02573493|459537071|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
127701783|NCT02573493|459537072|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
127701784|NCT02573493|459537073|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
127701785|NCT02573493|459537074|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
127701786|NCT04332926|459537075|FG000|Overall Study|Withdrawal by Subject|6|||
127701787|NCT04332926|459537075|FG000|Overall Study|Physician Decision|6|||
127701788|NCT05672069|459537079|FG000|Overall Study|Implant removal|1|||
127701789|NCT05672069|459537079|FG000|Overall Study|Lost to Follow-up|2|||
127701790|NCT03808818|459537082|FG000|Overall Study|Death|6|||
127701791|NCT03808818|459537083|FG001|Overall Study|Death|6|||
127701792|NCT03808818|459537082|FG000|Overall Study|Withdrawal by Subject|7|||
127701793|NCT03808818|459537083|FG001|Overall Study|Withdrawal by Subject|18|||
127701794|NCT03808818|459537082|FG000|Overall Study|Lost to Follow-up|31|||
127701795|NCT03808818|459537083|FG001|Overall Study|Lost to Follow-up|33|||
127701796|NCT02231164|459537090|FG000|Overall Study|Adverse Event|1|||
127701797|NCT02231164|459537091|FG001|Overall Study|Adverse Event|1|||
127701798|NCT02231164|459537090|FG000|Overall Study|Lack of Efficacy|4|||
127701799|NCT02231164|459537091|FG001|Overall Study|Lack of Efficacy|3|||
127701800|NCT02231164|459537090|FG000|Overall Study|Withdrawal by Subject|1|||
127701801|NCT02231164|459537091|FG001|Overall Study|Withdrawal by Subject|2|||
127701802|NCT02547363|459537092|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
127701803|NCT02547363|459537093|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
127701804|NCT02547363|459537092|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
127701805|NCT02547363|459537093|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
127701806|NCT02547363|459537092|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
127701807|NCT02547363|459537093|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
127701808|NCT02547363|459537092|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
127701809|NCT02547363|459537093|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
127701810|NCT02547363|459537092|FG000|12-month Follow-up|Withdrawal by Subject|4|||
127701811|NCT02547363|459537093|FG001|12-month Follow-up|Withdrawal by Subject|3|||
127701812|NCT02547363|459537092|FG000|12-month Follow-up|Lost to Follow-up|4|||
127701813|NCT02547363|459537093|FG001|12-month Follow-up|Lost to Follow-up|1|||
127701814|NCT02547363|459537092|FG000|12-month Follow-up|Lack of Efficacy|1|||
127701815|NCT02547363|459537093|FG001|12-month Follow-up|Lack of Efficacy|1|||
127701816|NCT02547363|459537092|FG000|12-month Follow-up|Other|1|||
127701817|NCT02547363|459537093|FG001|12-month Follow-up|Other|0|||
127701818|NCT04436276|459537096|FG000|Overall Study|Adverse Event|0|||
127701819|NCT04436276|459537097|FG001|Overall Study|Adverse Event|0|||
127701820|NCT04436276|459537098|FG002|Overall Study|Adverse Event|0|||
127701821|NCT04436276|459537099|FG003|Overall Study|Adverse Event|0|||
127701822|NCT04436276|459537100|FG004|Overall Study|Adverse Event|0|||
127701823|NCT04436276|459537101|FG005|Overall Study|Adverse Event|0|||
127701824|NCT04436276|459537102|FG006|Overall Study|Adverse Event|0|||
127701825|NCT04436276|459537103|FG007|Overall Study|Adverse Event|0|||
127701826|NCT04436276|459537104|FG008|Overall Study|Adverse Event|0|||
127701827|NCT04436276|459537105|FG009|Overall Study|Adverse Event|0|||
127701828|NCT04436276|459537106|FG010|Overall Study|Adverse Event|0|||
127701829|NCT04436276|459537107|FG011|Overall Study|Adverse Event|0|||
127701830|NCT04436276|459537108|FG012|Overall Study|Adverse Event|0|||
127701831|NCT04436276|459537109|FG013|Overall Study|Adverse Event|0|||
127701832|NCT04436276|459537110|FG014|Overall Study|Adverse Event|0|||
127701833|NCT04436276|459537111|FG015|Overall Study|Adverse Event|0|||
127701834|NCT04436276|459537112|FG016|Overall Study|Adverse Event|1|||
127701835|NCT04436276|459537113|FG017|Overall Study|Adverse Event|0|||
127701836|NCT04436276|459537114|FG018|Overall Study|Adverse Event|0|||
127701837|NCT04436276|459537115|FG019|Overall Study|Adverse Event|0|||
127701838|NCT04436276|459537116|FG020|Overall Study|Adverse Event|0|||
127701839|NCT04436276|459537117|FG021|Overall Study|Adverse Event|0|||
127701840|NCT04436276|459537118|FG022|Overall Study|Adverse Event|0|||
127701841|NCT04436276|459537096|FG000|Overall Study|Death|0|||
127701842|NCT04436276|459537097|FG001|Overall Study|Death|0|||
127885232|NCT00879970|460203864|FG002|Period 2 Vitamin D Randomization|Death|0|||
127701843|NCT04436276|459537098|FG002|Overall Study|Death|0|||
127701844|NCT04436276|459537099|FG003|Overall Study|Death|0|||
127701845|NCT04436276|459537100|FG004|Overall Study|Death|0|||
127701846|NCT04436276|459537101|FG005|Overall Study|Death|0|||
127701847|NCT04436276|459537102|FG006|Overall Study|Death|0|||
127701848|NCT04436276|459537103|FG007|Overall Study|Death|0|||
127701849|NCT04436276|459537104|FG008|Overall Study|Death|0|||
127701850|NCT04436276|459537105|FG009|Overall Study|Death|0|||
127701851|NCT04436276|459537106|FG010|Overall Study|Death|0|||
127701852|NCT04436276|459537107|FG011|Overall Study|Death|0|||
127701853|NCT04436276|459537108|FG012|Overall Study|Death|1|||
127701854|NCT04436276|459537109|FG013|Overall Study|Death|0|||
127626851|NCT02348489|459258350|FG001|Overall Study|Lost to Follow-up|5|||
127626852|NCT01639001|459258351|FG000|Overall Study|Refused further follow-up|9|||
127626853|NCT01639001|459258352|FG001|Overall Study|Refused further follow-up|12|||
127626854|NCT01639001|459258351|FG000|Overall Study|Lost to Follow-up|3|||
127626855|NCT01639001|459258352|FG001|Overall Study|Lost to Follow-up|0|||
127626856|NCT01639001|459258351|FG000|Overall Study|Death|62|||
127626857|NCT01639001|459258352|FG001|Overall Study|Death|61|||
127626858|NCT01639001|459258351|FG000|Overall Study|Randomized but not treated|0|||
127626859|NCT01639001|459258352|FG001|Overall Study|Randomized but not treated|2|||
127626860|NCT01639001|459258351|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
127626861|NCT01639001|459258352|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
127626862|NCT02886572|459258356|FG000|Overall Study|Death|8|||
127626863|NCT01969838|459258358|FG000|Double-blind Phase|Adverse Event|10|||
127626864|NCT01969838|459258359|FG001|Double-blind Phase|Adverse Event|4|||
127626865|NCT01969838|459258360|FG002|Double-blind Phase|Adverse Event|0|||
127626866|NCT01969838|459258361|FG003|Double-blind Phase|Adverse Event|0|||
127626867|NCT01969838|459258358|FG000|Double-blind Phase|Death|5|||
127626868|NCT01969838|459258359|FG001|Double-blind Phase|Death|2|||
127626869|NCT01969838|459258360|FG002|Double-blind Phase|Death|0|||
127626870|NCT01969838|459258361|FG003|Double-blind Phase|Death|0|||
127626871|NCT01969838|459258358|FG000|Double-blind Phase|Physician Decision|5|||
127626872|NCT01969838|459258359|FG001|Double-blind Phase|Physician Decision|1|||
127626873|NCT01969838|459258360|FG002|Double-blind Phase|Physician Decision|0|||
127626874|NCT01969838|459258361|FG003|Double-blind Phase|Physician Decision|0|||
127626875|NCT01969838|459258358|FG000|Double-blind Phase|Subject Decision|4|||
127626876|NCT01969838|459258359|FG001|Double-blind Phase|Subject Decision|2|||
127626877|NCT01969838|459258360|FG002|Double-blind Phase|Subject Decision|0|||
127626878|NCT01969838|459258361|FG003|Double-blind Phase|Subject Decision|0|||
127626879|NCT01969838|459258358|FG000|Double-blind Phase|Disease Progression|2|||
127626880|NCT01969838|459258359|FG001|Double-blind Phase|Disease Progression|0|||
127626881|NCT01969838|459258360|FG002|Double-blind Phase|Disease Progression|0|||
127626882|NCT01969838|459258361|FG003|Double-blind Phase|Disease Progression|0|||
127626883|NCT01969838|459258358|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
127626884|NCT01969838|459258359|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
127626885|NCT01969838|459258360|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
127626886|NCT01969838|459258361|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
127626887|NCT01969838|459258358|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
127626888|NCT01969838|459258359|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
127626889|NCT01969838|459258360|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
127626890|NCT01969838|459258361|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
127626891|NCT01969838|459258358|FG000|Open-label Phase|Adverse Event|0|||
127626892|NCT01969838|459258359|FG001|Open-label Phase|Adverse Event|0|||
127626893|NCT01969838|459258360|FG002|Open-label Phase|Adverse Event|37|||
127626894|NCT01969838|459258361|FG003|Open-label Phase|Adverse Event|49|||
127626895|NCT01969838|459258358|FG000|Open-label Phase|Disease Progression|0|||
127626896|NCT01969838|459258359|FG001|Open-label Phase|Disease Progression|0|||
127626897|NCT01969838|459258360|FG002|Open-label Phase|Disease Progression|26|||
127626898|NCT01969838|459258361|FG003|Open-label Phase|Disease Progression|27|||
127626899|NCT01969838|459258358|FG000|Open-label Phase|Lack of Efficacy|0|||
127626900|NCT01969838|459258359|FG001|Open-label Phase|Lack of Efficacy|0|||
127626901|NCT01969838|459258360|FG002|Open-label Phase|Lack of Efficacy|17|||
127626902|NCT01969838|459258361|FG003|Open-label Phase|Lack of Efficacy|19|||
127626903|NCT01969838|459258358|FG000|Open-label Phase|Subject Decision|0|||
127626904|NCT01969838|459258359|FG001|Open-label Phase|Subject Decision|0|||
127626905|NCT01969838|459258360|FG002|Open-label Phase|Subject Decision|14|||
127626906|NCT01969838|459258361|FG003|Open-label Phase|Subject Decision|15|||
127626907|NCT01969838|459258358|FG000|Open-label Phase|Death|0|||
127626908|NCT01969838|459258359|FG001|Open-label Phase|Death|0|||
127626909|NCT01969838|459258360|FG002|Open-label Phase|Death|13|||
127626910|NCT01969838|459258361|FG003|Open-label Phase|Death|11|||
127626911|NCT01969838|459258358|FG000|Open-label Phase|Physician Decision|0|||
127626912|NCT01969838|459258359|FG001|Open-label Phase|Physician Decision|0|||
127626913|NCT01969838|459258360|FG002|Open-label Phase|Physician Decision|9|||
127626914|NCT01969838|459258361|FG003|Open-label Phase|Physician Decision|14|||
127626915|NCT01969838|459258358|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
127626916|NCT01969838|459258359|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
127626917|NCT01969838|459258360|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
127626918|NCT01969838|459258361|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
127626919|NCT03087591|459258362|FG000|Overall Study|Disease progression before starting treatment, removed from study|1|||
127626920|NCT03087591|459258362|FG000|Overall Study|Withdrawal by Subject|1|||
127626921|NCT00408993|459258365|FG000|Overall Study|Adverse Event|15|||
127626922|NCT00408993|459258366|FG001|Overall Study|Adverse Event|4|||
127626923|NCT00408993|459258365|FG000|Overall Study|Protocol Violation|1|||
127626924|NCT00408993|459258366|FG001|Overall Study|Protocol Violation|6|||
127626925|NCT00408993|459258365|FG000|Overall Study|Lack of Efficacy|1|||
127626926|NCT00408993|459258366|FG001|Overall Study|Lack of Efficacy|4|||
127793099|NCT03016325|459867444|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
127793100|NCT03016325|459867437|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
127793101|NCT03016325|459867438|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
127793102|NCT03016325|459867439|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
127793103|NCT03016325|459867440|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
127793104|NCT03016325|459867441|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
127626927|NCT00408993|459258365|FG000|Overall Study|Withdrawal by Subject|2|||
127626928|NCT00408993|459258366|FG001|Overall Study|Withdrawal by Subject|3|||
127626929|NCT03738865|459258369|FG000|Overall Study|Withdrawal by Subject|3|||
127626930|NCT03738865|459258370|FG001|Overall Study|Withdrawal by Subject|3|||
127626931|NCT03738865|459258369|FG000|Overall Study|Adverse Event|2|||
127626932|NCT03738865|459258370|FG001|Overall Study|Adverse Event|0|||
127626933|NCT03738865|459258369|FG000|Overall Study|Physician Decision|0|||
127626934|NCT03738865|459258370|FG001|Overall Study|Physician Decision|1|||
127626935|NCT02621606|459258371|FG000|Overall Study|Withdrawal by Subject|0|||
127626936|NCT02621606|459258372|FG001|Overall Study|Withdrawal by Subject|1|||
127626937|NCT02621606|459258373|FG002|Overall Study|Withdrawal by Subject|0|||
127626938|NCT00274716|459258374|FG000|Phase A|Other non-reported reason|4|||
127626939|NCT00274716|459258375|FG001|Phase A|Other non-reported reason|2|||
127626940|NCT00274716|459258376|FG002|Phase A|Other non-reported reason|1|||
127626941|NCT00274716|459258377|FG003|Phase A|Other non-reported reason|2|||
127626942|NCT00274716|459258378|FG004|Phase A|Other non-reported reason|0|||
127626943|NCT00274716|459258379|FG005|Phase A|Other non-reported reason|1|||
127626944|NCT00274716|459258374|FG000|Phase A|Participant moved|0|||
127626945|NCT00274716|459258375|FG001|Phase A|Participant moved|0|||
127626946|NCT00274716|459258376|FG002|Phase A|Participant moved|1|||
127626947|NCT00274716|459258377|FG003|Phase A|Participant moved|0|||
127626948|NCT00274716|459258378|FG004|Phase A|Participant moved|0|||
127626949|NCT00274716|459258379|FG005|Phase A|Participant moved|1|||
127626950|NCT00274716|459258374|FG000|Phase A|Site Terminated|0|||
127626951|NCT00274716|459258375|FG001|Phase A|Site Terminated|0|||
127626952|NCT00274716|459258376|FG002|Phase A|Site Terminated|0|||
127626953|NCT00274716|459258377|FG003|Phase A|Site Terminated|1|||
127626954|NCT00274716|459258378|FG004|Phase A|Site Terminated|0|||
127626955|NCT00274716|459258379|FG005|Phase A|Site Terminated|0|||
127626956|NCT00274716|459258374|FG000|Phase A|Protocol Violation|1|||
127626957|NCT00274716|459258375|FG001|Phase A|Protocol Violation|0|||
127626958|NCT00274716|459258376|FG002|Phase A|Protocol Violation|0|||
127626959|NCT00274716|459258377|FG003|Phase A|Protocol Violation|1|||
127626960|NCT00274716|459258378|FG004|Phase A|Protocol Violation|0|||
127626961|NCT00274716|459258379|FG005|Phase A|Protocol Violation|0|||
127626962|NCT00274716|459258374|FG000|Phase A|Met criteria for discontinuation|1|||
127626963|NCT00274716|459258375|FG001|Phase A|Met criteria for discontinuation|1|||
127626964|NCT00274716|459258376|FG002|Phase A|Met criteria for discontinuation|0|||
127626965|NCT00274716|459258377|FG003|Phase A|Met criteria for discontinuation|0|||
127626966|NCT00274716|459258378|FG004|Phase A|Met criteria for discontinuation|0|||
127626967|NCT00274716|459258379|FG005|Phase A|Met criteria for discontinuation|0|||
127626968|NCT00274716|459258374|FG000|Phase A|Withdrawal by Subject|2|||
127626969|NCT00274716|459258375|FG001|Phase A|Withdrawal by Subject|2|||
127626970|NCT00274716|459258376|FG002|Phase A|Withdrawal by Subject|1|||
127626971|NCT00274716|459258377|FG003|Phase A|Withdrawal by Subject|3|||
127626972|NCT00274716|459258378|FG004|Phase A|Withdrawal by Subject|0|||
127626973|NCT00274716|459258379|FG005|Phase A|Withdrawal by Subject|1|||
127626974|NCT00274716|459258374|FG000|Phase A|Adverse Event|2|||
127626975|NCT00274716|459258375|FG001|Phase A|Adverse Event|3|||
127626976|NCT00274716|459258376|FG002|Phase A|Adverse Event|3|||
127626977|NCT00274716|459258377|FG003|Phase A|Adverse Event|0|||
127626978|NCT00274716|459258378|FG004|Phase A|Adverse Event|2|||
127626979|NCT00274716|459258379|FG005|Phase A|Adverse Event|0|||
127793105|NCT03016325|459867442|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
127793106|NCT03016325|459867443|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
127793107|NCT03016325|459867444|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
127793108|NCT03016325|459867437|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
127793109|NCT03016325|459867438|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
127626980|NCT00274716|459258374|FG000|Phase A|Completed but did not enter Phase B|1|||
127626981|NCT00274716|459258375|FG001|Phase A|Completed but did not enter Phase B|2|||
127626982|NCT00274716|459258376|FG002|Phase A|Completed but did not enter Phase B|2|||
127626983|NCT00274716|459258377|FG003|Phase A|Completed but did not enter Phase B|2|||
127626984|NCT00274716|459258378|FG004|Phase A|Completed but did not enter Phase B|1|||
127626985|NCT00274716|459258379|FG005|Phase A|Completed but did not enter Phase B|1|||
127626986|NCT00274716|459258374|FG000|Phase B|Adverse Event|0|||
127626987|NCT00274716|459258375|FG001|Phase B|Adverse Event|0|||
127626988|NCT00274716|459258376|FG002|Phase B|Adverse Event|2|||
127626989|NCT00274716|459258377|FG003|Phase B|Adverse Event|0|||
127626990|NCT00274716|459258378|FG004|Phase B|Adverse Event|0|||
127626991|NCT00274716|459258379|FG005|Phase B|Adverse Event|1|||
127626992|NCT00274716|459258374|FG000|Phase B|Protocol Violation|0|||
127626993|NCT00274716|459258375|FG001|Phase B|Protocol Violation|2|||
127626994|NCT00274716|459258376|FG002|Phase B|Protocol Violation|0|||
127626995|NCT00274716|459258377|FG003|Phase B|Protocol Violation|0|||
127626996|NCT00274716|459258378|FG004|Phase B|Protocol Violation|0|||
127626997|NCT00274716|459258379|FG005|Phase B|Protocol Violation|0|||
127626998|NCT00274716|459258374|FG000|Phase B|Withdrawal by Subject|0|||
127626999|NCT00274716|459258375|FG001|Phase B|Withdrawal by Subject|1|||
127627000|NCT00274716|459258376|FG002|Phase B|Withdrawal by Subject|0|||
127627001|NCT00274716|459258377|FG003|Phase B|Withdrawal by Subject|0|||
127627002|NCT00274716|459258378|FG004|Phase B|Withdrawal by Subject|0|||
127627003|NCT00274716|459258379|FG005|Phase B|Withdrawal by Subject|0|||
127627004|NCT00274716|459258374|FG000|Phase B|Participant moved|1|||
127627005|NCT00274716|459258375|FG001|Phase B|Participant moved|0|||
127627006|NCT00274716|459258376|FG002|Phase B|Participant moved|0|||
127627007|NCT00274716|459258377|FG003|Phase B|Participant moved|0|||
127627008|NCT00274716|459258378|FG004|Phase B|Participant moved|0|||
127627009|NCT00274716|459258379|FG005|Phase B|Participant moved|0|||
127627010|NCT00274716|459258374|FG000|Phase B|Other non-reported reason|0|||
127627011|NCT00274716|459258375|FG001|Phase B|Other non-reported reason|0|||
127627012|NCT00274716|459258376|FG002|Phase B|Other non-reported reason|1|||
127627013|NCT00274716|459258377|FG003|Phase B|Other non-reported reason|1|||
127627014|NCT00274716|459258378|FG004|Phase B|Other non-reported reason|0|||
127627015|NCT00274716|459258379|FG005|Phase B|Other non-reported reason|0|||
127627016|NCT00274716|459258374|FG000|Phase B|Lost to Follow-up|0|||
127627017|NCT00274716|459258375|FG001|Phase B|Lost to Follow-up|1|||
127627018|NCT00274716|459258376|FG002|Phase B|Lost to Follow-up|0|||
127627019|NCT00274716|459258377|FG003|Phase B|Lost to Follow-up|0|||
127627020|NCT00274716|459258378|FG004|Phase B|Lost to Follow-up|0|||
127627021|NCT00274716|459258379|FG005|Phase B|Lost to Follow-up|0|||
127627022|NCT00982319|459258382|FG000|Overall Study|Surgery date change|1|||
127627023|NCT00982319|459258383|FG001|Overall Study|Surgery date change|0|||
127627024|NCT00982319|459258382|FG000|Overall Study|Preop values out of acceptable range|1|||
127627025|NCT00982319|459258383|FG001|Overall Study|Preop values out of acceptable range|1|||
127627026|NCT00982319|459258382|FG000|Overall Study|Pregnancy|0|||
127627027|NCT00982319|459258383|FG001|Overall Study|Pregnancy|1|||
127627028|NCT00975975|459258384|FG000|Overall Study|Death|6|||
127627029|NCT00961259|459258385|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
127627030|NCT00961259|459258386|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
127627031|NCT00961259|459258387|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
127627032|NCT01252251|459258390|FG000|Overall Study|Withdrawal by Subject|1|||
127627033|NCT01324024|459258391|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
127627034|NCT01324024|459258392|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
127627035|NCT01923181|459258393|FG000|Overall Study|Protocol Violation|2|||
127627036|NCT01923181|459258394|FG001|Overall Study|Protocol Violation|2|||
127627037|NCT01923181|459258395|FG002|Overall Study|Protocol Violation|0|||
127627038|NCT01923181|459258396|FG003|Overall Study|Protocol Violation|2|||
127627039|NCT01923181|459258397|FG004|Overall Study|Protocol Violation|2|||
127627040|NCT01923181|459258398|FG005|Overall Study|Protocol Violation|1|||
127627041|NCT01923181|459258399|FG006|Overall Study|Protocol Violation|1|||
127627042|NCT01923181|459258400|FG007|Overall Study|Protocol Violation|2|||
127627043|NCT01923181|459258401|FG008|Overall Study|Protocol Violation|1|||
127701855|NCT04436276|459537110|FG014|Overall Study|Death|1|||
127701856|NCT04436276|459537111|FG015|Overall Study|Death|0|||
127701857|NCT04436276|459537112|FG016|Overall Study|Death|0|||
127701858|NCT04436276|459537113|FG017|Overall Study|Death|0|||
127701859|NCT04436276|459537114|FG018|Overall Study|Death|0|||
127701860|NCT04436276|459537115|FG019|Overall Study|Death|2|||
127701861|NCT04436276|459537116|FG020|Overall Study|Death|0|||
127701862|NCT04436276|459537117|FG021|Overall Study|Death|1|||
127627044|NCT01923181|459258393|FG000|Overall Study|Withdrawal by Subject|0|||
127627045|NCT01923181|459258394|FG001|Overall Study|Withdrawal by Subject|1|||
127627046|NCT01923181|459258395|FG002|Overall Study|Withdrawal by Subject|0|||
127627047|NCT01923181|459258396|FG003|Overall Study|Withdrawal by Subject|1|||
127627048|NCT01923181|459258397|FG004|Overall Study|Withdrawal by Subject|4|||
127627049|NCT01923181|459258398|FG005|Overall Study|Withdrawal by Subject|2|||
127627050|NCT01923181|459258399|FG006|Overall Study|Withdrawal by Subject|4|||
127701863|NCT04436276|459537118|FG022|Overall Study|Death|0|||
127701864|NCT04436276|459537096|FG000|Overall Study|Lost to Follow-up|0|||
127627051|NCT01923181|459258400|FG007|Overall Study|Withdrawal by Subject|3|||
127701865|NCT04436276|459537097|FG001|Overall Study|Lost to Follow-up|2|||
127627052|NCT01923181|459258401|FG008|Overall Study|Withdrawal by Subject|1|||
127627053|NCT01923181|459258393|FG000|Overall Study|Other|1|||
127627054|NCT01923181|459258394|FG001|Overall Study|Other|0|||
127627055|NCT01923181|459258395|FG002|Overall Study|Other|0|||
127701866|NCT04436276|459537098|FG002|Overall Study|Lost to Follow-up|2|||
127627056|NCT01923181|459258396|FG003|Overall Study|Other|1|||
127627057|NCT01923181|459258397|FG004|Overall Study|Other|0|||
127627058|NCT01923181|459258398|FG005|Overall Study|Other|0|||
127627059|NCT01923181|459258399|FG006|Overall Study|Other|0|||
127627060|NCT01923181|459258400|FG007|Overall Study|Other|0|||
127627061|NCT01923181|459258401|FG008|Overall Study|Other|0|||
127627062|NCT01923181|459258393|FG000|Overall Study|Lost to Follow-up|0|||
127627063|NCT01923181|459258394|FG001|Overall Study|Lost to Follow-up|3|||
127627064|NCT01923181|459258395|FG002|Overall Study|Lost to Follow-up|2|||
127627065|NCT01923181|459258396|FG003|Overall Study|Lost to Follow-up|1|||
127627066|NCT01923181|459258397|FG004|Overall Study|Lost to Follow-up|2|||
127627067|NCT01923181|459258398|FG005|Overall Study|Lost to Follow-up|1|||
127627068|NCT01923181|459258399|FG006|Overall Study|Lost to Follow-up|3|||
127627069|NCT01923181|459258400|FG007|Overall Study|Lost to Follow-up|3|||
127627070|NCT01923181|459258401|FG008|Overall Study|Lost to Follow-up|1|||
127627071|NCT01863446|459258407|FG000|Overall Study|Withdrawal by Subject|1|||
127627072|NCT01863446|459258408|FG001|Overall Study|Withdrawal by Subject|0|||
127627073|NCT01863446|459258409|FG002|Overall Study|Withdrawal by Subject|1|||
127627074|NCT01863446|459258410|FG003|Overall Study|Withdrawal by Subject|2|||
127627075|NCT01863446|459258407|FG000|Overall Study|Physician Decision|0|||
127627076|NCT01863446|459258408|FG001|Overall Study|Physician Decision|0|||
127627077|NCT01863446|459258409|FG002|Overall Study|Physician Decision|1|||
127627078|NCT01863446|459258410|FG003|Overall Study|Physician Decision|0|||
127627079|NCT02840877|459258411|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
127627080|NCT02840877|459258411|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
127627081|NCT02840877|459258411|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
127627082|NCT02840877|459258411|FG000|Baseline to 12 Weeks|Death|1|||
127627083|NCT02840877|459258411|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
127627084|NCT02840877|459258411|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
127627085|NCT02840877|459258411|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
127627086|NCT02840877|459258411|FG000|12 Weeks to 6 Months|Treatment failure|1|||
127627087|NCT02840877|459258411|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
127627088|NCT02840877|459258411|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
127627089|NCT02840877|459258411|FG000|12 Weeks to 6 Months|Death|1|||
127627090|NCT02840877|459258411|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
127627091|NCT02840877|459258411|FG000|6 Months to 18 Months|Treatment failure|7|||
127627092|NCT02840877|459258411|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
127627093|NCT02840877|459258411|FG000|6 Months to 18 Months|Moved/transferred out|6|||
127627094|NCT02840877|459258411|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
127627095|NCT02840877|459258411|FG000|6 Months to 18 Months|Death|4|||
127627096|NCT02840877|459258411|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
127627097|NCT02840877|459258411|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
127627098|NCT02840877|459258411|FG000|6 Months to 18 Months|Still in study.|14|||
127627099|NCT02252081|459258414|FG000|Overall Study|Withdrawal by Subject|2|||
127627100|NCT02252081|459258415|FG001|Overall Study|Withdrawal by Subject|1|||
127627101|NCT02252081|459258414|FG000|Overall Study|Adverse Event|4|||
127627102|NCT02252081|459258415|FG001|Overall Study|Adverse Event|1|||
127627103|NCT02252081|459258414|FG000|Overall Study|non compliance & others|0|||
127627104|NCT02252081|459258415|FG001|Overall Study|non compliance & others|2|||
127627105|NCT01168999|459258420|FG000|Overall Study|Lost to Follow-up|2|||
127627106|NCT01168999|459258421|FG001|Overall Study|Lost to Follow-up|1|||
127627107|NCT01168999|459258422|FG002|Overall Study|Lost to Follow-up|0|||
127627108|NCT01168999|459258423|FG003|Overall Study|Lost to Follow-up|0|||
127627109|NCT03603964|459258424|FG000|Overall Study|Death|9|||
127627110|NCT03603964|459258424|FG000|Overall Study|Withdrawal by participant|7|||
127627111|NCT03603964|459258424|FG000|Overall Study|Study terminated by Sponsor|19|||
127627112|NCT04317586|459258425|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
127701867|NCT04436276|459537099|FG003|Overall Study|Lost to Follow-up|1|||
127627113|NCT04317586|459258425|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
127627114|NCT03698773|459258428|FG000|Overall Study|Lost to Follow-up|2|||
127627115|NCT03698773|459258429|FG001|Overall Study|Lost to Follow-up|1|||
127627116|NCT05074433|459258430|FG000|Overall Study|Adverse Event|0|||
127627117|NCT05074433|459258431|FG001|Overall Study|Adverse Event|2|||
127627118|NCT05074433|459258432|FG002|Overall Study|Adverse Event|0|||
127701868|NCT04436276|459537100|FG004|Overall Study|Lost to Follow-up|4|||
127701869|NCT04436276|459537101|FG005|Overall Study|Lost to Follow-up|1|||
127701870|NCT04436276|459537102|FG006|Overall Study|Lost to Follow-up|0|||
127627119|NCT05074433|459258433|FG003|Overall Study|Adverse Event|1|||
127627120|NCT05074433|459258430|FG000|Overall Study|Sponsor Request|0|||
127627121|NCT05074433|459258431|FG001|Overall Study|Sponsor Request|1|||
127627122|NCT05074433|459258432|FG002|Overall Study|Sponsor Request|1|||
127627123|NCT05074433|459258433|FG003|Overall Study|Sponsor Request|0|||
127627124|NCT05074433|459258430|FG000|Overall Study|Death|1|||
127627125|NCT05074433|459258431|FG001|Overall Study|Death|0|||
127627126|NCT05074433|459258432|FG002|Overall Study|Death|0|||
127627127|NCT05074433|459258433|FG003|Overall Study|Death|0|||
127627128|NCT05074433|459258430|FG000|Overall Study|Lost to Follow-up|0|||
127627129|NCT05074433|459258431|FG001|Overall Study|Lost to Follow-up|0|||
127627130|NCT05074433|459258432|FG002|Overall Study|Lost to Follow-up|2|||
127627131|NCT05074433|459258433|FG003|Overall Study|Lost to Follow-up|0|||
127627132|NCT05074433|459258430|FG000|Overall Study|Subject Decision|8|||
127627133|NCT05074433|459258431|FG001|Overall Study|Subject Decision|6|||
127627134|NCT05074433|459258432|FG002|Overall Study|Subject Decision|4|||
127627135|NCT05074433|459258433|FG003|Overall Study|Subject Decision|5|||
127627136|NCT03795922|459258434|FG000|Overall Study|Adverse Event|2|||
127627137|NCT03795922|459258435|FG001|Overall Study|Adverse Event|1|||
127627138|NCT03795922|459258434|FG000|Overall Study|Withdrawal by Subject|5|||
127627139|NCT03795922|459258435|FG001|Overall Study|Withdrawal by Subject|13|||
127627140|NCT03795922|459258434|FG000|Overall Study|Lost to Follow-up|2|||
127627141|NCT03795922|459258435|FG001|Overall Study|Lost to Follow-up|3|||
127627142|NCT03795922|459258434|FG000|Overall Study|Pregnancy|0|||
127627143|NCT03795922|459258435|FG001|Overall Study|Pregnancy|1|||
127627144|NCT03795922|459258434|FG000|Overall Study|Physician Decision|1|||
127627145|NCT03795922|459258435|FG001|Overall Study|Physician Decision|2|||
127627146|NCT03795922|459258434|FG000|Overall Study|Protocol Violation|0|||
127627147|NCT03795922|459258435|FG001|Overall Study|Protocol Violation|1|||
127627148|NCT03795922|459258434|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
127627149|NCT03795922|459258435|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
127627150|NCT02822794|459258436|FG000|Overall Study|Withdrew Consent|1|||
127627151|NCT02822794|459258437|FG001|Overall Study|Withdrew Consent|0|||
127627152|NCT01243944|459258438|FG000|Overall Study|Adverse Event|15|||
127627153|NCT01243944|459258439|FG001|Overall Study|Adverse Event|13|||
127627154|NCT01243944|459258438|FG000|Overall Study|Lost to Follow-up|2|||
127627155|NCT01243944|459258439|FG001|Overall Study|Lost to Follow-up|1|||
127627156|NCT01243944|459258438|FG000|Overall Study|Physician Decision|2|||
127627157|NCT01243944|459258439|FG001|Overall Study|Physician Decision|7|||
127627158|NCT01243944|459258438|FG000|Overall Study|Disease progression|12|||
127627159|NCT01243944|459258439|FG001|Overall Study|Disease progression|11|||
127627160|NCT01243944|459258438|FG000|Overall Study|Protocol deviation|1|||
127627161|NCT01243944|459258439|FG001|Overall Study|Protocol deviation|1|||
127627162|NCT01243944|459258438|FG000|Overall Study|Participant decision|10|||
127627163|NCT01243944|459258439|FG001|Overall Study|Participant decision|15|||
127627164|NCT01243944|459258438|FG000|Overall Study|Death|2|||
127627165|NCT01243944|459258439|FG001|Overall Study|Death|3|||
127627166|NCT01243944|459258438|FG000|Overall Study|Non-compliance with study treatment|1|||
127627167|NCT01243944|459258439|FG001|Overall Study|Non-compliance with study treatment|0|||
127627168|NCT01416805|459258445|FG000|Overall Study|Lost to Follow-up|4|||
127627169|NCT01416805|459258446|FG001|Overall Study|Lost to Follow-up|4|||
127627170|NCT04632940|459258447|FG000|DB Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
127627171|NCT04632940|459258448|FG001|DB Period (52 Weeks)|Participant/Legal Guardian Decision|0|||
127627172|NCT04632940|459258447|FG000|OLE Period (52 Weeks)|Adverse Event|1|||
127627173|NCT04632940|459258448|FG001|OLE Period (52 Weeks)|Adverse Event|0|||
127627174|NCT04632940|459258447|FG000|OLE Period (52 Weeks)|Lost to Follow-up|0|||
127701871|NCT04436276|459537103|FG007|Overall Study|Lost to Follow-up|0|||
127627175|NCT04632940|459258448|FG001|OLE Period (52 Weeks)|Lost to Follow-up|1|||
127627176|NCT04632940|459258447|FG000|OLE Period (52 Weeks)|Physician Decision|1|||
127627177|NCT04632940|459258448|FG001|OLE Period (52 Weeks)|Physician Decision|0|||
127627178|NCT04632940|459258447|FG000|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|11|||
127627179|NCT04632940|459258448|FG001|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|13|||
127627180|NCT04632940|459258447|FG000|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|21|||
127627181|NCT04632940|459258448|FG001|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|19|||
127627182|NCT04632940|459258447|FG000|OLE Period (52 Weeks)|Other than specified|0|||
127627183|NCT04632940|459258448|FG001|OLE Period (52 Weeks)|Other than specified|1|||
127627184|NCT04632940|459258447|FG000|OLE Period (52 Weeks)|Entered into OLE but not treated|0|||
127627185|NCT04632940|459258448|FG001|OLE Period (52 Weeks)|Entered into OLE but not treated|1|||
127627186|NCT02799082|459258449|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
127627187|NCT02799082|459258450|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
127627188|NCT02799082|459258449|FG000|Overall Study|Protocol Violation|0|||
127627189|NCT02799082|459258450|FG001|Overall Study|Protocol Violation|1|||
127627190|NCT00153101|459258457|FG000|Overall Study|Lost to Follow-up|14|||
127627191|NCT00153101|459258458|FG001|Overall Study|Lost to Follow-up|14|||
127627192|NCT00153101|459258459|FG002|Overall Study|Lost to Follow-up|12|||
127627193|NCT00153101|459258460|FG003|Overall Study|Lost to Follow-up|5|||
127627194|NCT00153101|459258461|FG004|Overall Study|Lost to Follow-up|5|||
127627195|NCT00153101|459258457|FG000|Overall Study|Withdrawal by Subject|3|||
127627196|NCT00153101|459258458|FG001|Overall Study|Withdrawal by Subject|4|||
127627197|NCT00153101|459258459|FG002|Overall Study|Withdrawal by Subject|3|||
127627198|NCT00153101|459258460|FG003|Overall Study|Withdrawal by Subject|3|||
127627199|NCT00153101|459258461|FG004|Overall Study|Withdrawal by Subject|5|||
127627200|NCT02610140|459258462|FG000|Randomization and Treatment Period|Radiological progression|23|||
127627201|NCT02610140|459258463|FG001|Randomization and Treatment Period|Radiological progression|15|||
127627202|NCT02610140|459258462|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
127627203|NCT02610140|459258463|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
127627204|NCT02610140|459258462|FG000|Randomization and Treatment Period|Protocol Violation|1|||
127627205|NCT02610140|459258463|FG001|Randomization and Treatment Period|Protocol Violation|0|||
127627206|NCT02610140|459258462|FG000|Randomization and Treatment Period|Physician Decision|0|||
127627207|NCT02610140|459258463|FG001|Randomization and Treatment Period|Physician Decision|1|||
127627208|NCT02610140|459258462|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
127627209|NCT02610140|459258463|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
127627210|NCT02610140|459258462|FG000|Randomization and Treatment Period|Death|7|||
127627211|NCT02610140|459258463|FG001|Randomization and Treatment Period|Death|1|||
127627212|NCT02610140|459258462|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
127627213|NCT02610140|459258463|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
127627214|NCT02610140|459258462|FG000|Randomization and Treatment Period|Adverse Event|44|||
127627215|NCT02610140|459258463|FG001|Randomization and Treatment Period|Adverse Event|13|||
127627216|NCT02610140|459258462|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
127627217|NCT02610140|459258463|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
127627218|NCT02610140|459258462|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
127627219|NCT02610140|459258463|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
127627220|NCT02610140|459258462|FG000|Randomization and Treatment Period|Not treated|3|||
127627221|NCT02610140|459258463|FG001|Randomization and Treatment Period|Not treated|10|||
127627222|NCT02610140|459258462|FG000|Safety Follow-up|Other|0|||
127627223|NCT02610140|459258463|FG001|Safety Follow-up|Other|2|||
127627224|NCT02610140|459258462|FG000|Safety Follow-up|Lost to Follow-up|1|||
127627225|NCT02610140|459258463|FG001|Safety Follow-up|Lost to Follow-up|0|||
127627226|NCT02610140|459258462|FG000|Safety Follow-up|No follow-up|5|||
127627227|NCT02610140|459258463|FG001|Safety Follow-up|No follow-up|3|||
127627228|NCT02610140|459258462|FG000|Safety Follow-up|Death|12|||
127627229|NCT02610140|459258463|FG001|Safety Follow-up|Death|2|||
127627230|NCT02610140|459258462|FG000|Safety Follow-up|Deterioration of general conditions|15|||
127627231|NCT02610140|459258463|FG001|Safety Follow-up|Deterioration of general conditions|5|||
127627232|NCT02610140|459258462|FG000|Safety Follow-up|Withdrawal by Subject|12|||
127627233|NCT02610140|459258463|FG001|Safety Follow-up|Withdrawal by Subject|12|||
127627234|NCT02610140|459258462|FG000|Active Follow-up|Progressive disease - radiological|30|||
127627235|NCT02610140|459258463|FG001|Active Follow-up|Progressive disease - radiological|22|||
127627236|NCT02610140|459258462|FG000|Active Follow-up|Death|8|||
127627237|NCT02610140|459258463|FG001|Active Follow-up|Death|1|||
127701872|NCT04436276|459537104|FG008|Overall Study|Lost to Follow-up|1|||
127701873|NCT04436276|459537105|FG009|Overall Study|Lost to Follow-up|0|||
127701874|NCT04436276|459537106|FG010|Overall Study|Lost to Follow-up|5|||
127627238|NCT02610140|459258462|FG000|Active Follow-up|Withdrawal by Subject|4|||
127627239|NCT02610140|459258463|FG001|Active Follow-up|Withdrawal by Subject|0|||
127627240|NCT02610140|459258462|FG000|Active Follow-up|Progressive disease - clinical|1|||
127627241|NCT02610140|459258463|FG001|Active Follow-up|Progressive disease - clinical|2|||
127627242|NCT02610140|459258462|FG000|Active Follow-up|Deterioration of general conditions|1|||
127627243|NCT02610140|459258463|FG001|Active Follow-up|Deterioration of general conditions|0|||
127627244|NCT02610140|459258462|FG000|Active Follow-up|Ongoing but not completed|4|||
127627245|NCT02610140|459258463|FG001|Active Follow-up|Ongoing but not completed|1|||
127627246|NCT02610140|459258462|FG000|Long-term Follow-up|Death|86|||
127627247|NCT02610140|459258463|FG001|Long-term Follow-up|Death|44|||
127627248|NCT02610140|459258462|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
127627249|NCT02610140|459258463|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
127627250|NCT02610140|459258462|FG000|Long-term Follow-up|Lost to Follow-up|1|||
127627251|NCT02610140|459258463|FG001|Long-term Follow-up|Lost to Follow-up|2|||
127627252|NCT02610140|459258462|FG000|Long-term Follow-up|Ongoing but not completed|30|||
127627253|NCT02610140|459258463|FG001|Long-term Follow-up|Ongoing but not completed|17|||
127627254|NCT03169153|459258464|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
127627255|NCT03169153|459258465|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
127627256|NCT03169153|459258464|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
127627257|NCT03169153|459258465|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
127627258|NCT03169153|459258464|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
127627259|NCT03169153|459258465|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
127627260|NCT03169153|459258464|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
127627261|NCT03169153|459258465|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
127627262|NCT00887341|459258466|FG000|Overall Study|Refused treatment|1|||
127627263|NCT00887341|459258467|FG001|Overall Study|Refused treatment|0|||
127627264|NCT00887341|459258466|FG000|Overall Study|Withdrawal by Subject|1|||
127627265|NCT00887341|459258467|FG001|Overall Study|Withdrawal by Subject|1|||
127627266|NCT00887341|459258466|FG000|Overall Study|Adverse Event|0|||
127627267|NCT00887341|459258467|FG001|Overall Study|Adverse Event|1|||
127627268|NCT00887341|459258466|FG000|Overall Study|Lost to Follow-up|0|||
127627269|NCT00887341|459258467|FG001|Overall Study|Lost to Follow-up|1|||
127627270|NCT01591681|459258470|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
127627271|NCT01591681|459258470|FG000|Overall Study|Failed to use system during run-in|1|||
127627272|NCT01649856|459258473|FG000|Overall Study|Withdrawal by Subject|14|||
127627273|NCT01649856|459258474|FG001|Overall Study|Withdrawal by Subject|14|||
127627274|NCT01649856|459258473|FG000|Overall Study|Protocol Violation|4|||
127627275|NCT01649856|459258474|FG001|Overall Study|Protocol Violation|4|||
127627276|NCT01649856|459258473|FG000|Overall Study|Treatment Failure|1|||
127627277|NCT01649856|459258474|FG001|Overall Study|Treatment Failure|1|||
127627278|NCT01649856|459258473|FG000|Overall Study|Death|69|||
127627279|NCT01649856|459258474|FG001|Overall Study|Death|34|||
127627280|NCT01649856|459258473|FG000|Overall Study|Stable or Progressed Disease|5|||
127627281|NCT01649856|459258474|FG001|Overall Study|Stable or Progressed Disease|3|||
127627282|NCT01649856|459258473|FG000|Overall Study|Lost to Follow-up|20|||
127627283|NCT01649856|459258474|FG001|Overall Study|Lost to Follow-up|16|||
127627284|NCT01649856|459258473|FG000|Overall Study|Lack of Compliance|6|||
127627285|NCT01649856|459258474|FG001|Overall Study|Lack of Compliance|1|||
127627286|NCT01649856|459258473|FG000|Overall Study|Other|20|||
127627287|NCT01649856|459258474|FG001|Overall Study|Other|5|||
127627288|NCT00622635|459258475|FG000|Treatment Period 1|Adverse Event|0|||
127627289|NCT00622635|459258476|FG001|Treatment Period 1|Adverse Event|0|||
127627290|NCT00622635|459258477|FG002|Treatment Period 1|Adverse Event|1|||
127627291|NCT00622635|459258478|FG003|Treatment Period 1|Adverse Event|0|||
127627292|NCT00622635|459258479|FG004|Treatment Period 1|Adverse Event|0|||
127627293|NCT00622635|459258480|FG005|Treatment Period 1|Adverse Event|0|||
127627294|NCT00622635|459258475|FG000|Treatment Period 1|Withdrawal by Subject|0|||
127627295|NCT00622635|459258476|FG001|Treatment Period 1|Withdrawal by Subject|1|||
127701875|NCT04436276|459537107|FG011|Overall Study|Lost to Follow-up|5|||
127701876|NCT04436276|459537108|FG012|Overall Study|Lost to Follow-up|4|||
127701877|NCT04436276|459537109|FG013|Overall Study|Lost to Follow-up|1|||
127701878|NCT04436276|459537110|FG014|Overall Study|Lost to Follow-up|7|||
127701879|NCT04436276|459537111|FG015|Overall Study|Lost to Follow-up|7|||
127701880|NCT04436276|459537112|FG016|Overall Study|Lost to Follow-up|1|||
127701881|NCT04436276|459537113|FG017|Overall Study|Lost to Follow-up|0|||
127701882|NCT04436276|459537114|FG018|Overall Study|Lost to Follow-up|1|||
127701883|NCT04436276|459537115|FG019|Overall Study|Lost to Follow-up|1|||
127701884|NCT04436276|459537116|FG020|Overall Study|Lost to Follow-up|2|||
127701885|NCT04436276|459537117|FG021|Overall Study|Lost to Follow-up|1|||
127701886|NCT04436276|459537118|FG022|Overall Study|Lost to Follow-up|1|||
127701887|NCT04436276|459537096|FG000|Overall Study|Physician Decision|1|||
127701888|NCT04436276|459537097|FG001|Overall Study|Physician Decision|0|||
127701889|NCT04436276|459537098|FG002|Overall Study|Physician Decision|2|||
127701890|NCT04436276|459537099|FG003|Overall Study|Physician Decision|1|||
127701891|NCT04436276|459537100|FG004|Overall Study|Physician Decision|0|||
127701892|NCT04436276|459537101|FG005|Overall Study|Physician Decision|0|||
127701893|NCT04436276|459537102|FG006|Overall Study|Physician Decision|0|||
127701894|NCT04436276|459537103|FG007|Overall Study|Physician Decision|0|||
127701895|NCT04436276|459537104|FG008|Overall Study|Physician Decision|0|||
127701896|NCT04436276|459537105|FG009|Overall Study|Physician Decision|0|||
127701897|NCT04436276|459537106|FG010|Overall Study|Physician Decision|0|||
127701898|NCT04436276|459537107|FG011|Overall Study|Physician Decision|1|||
127701899|NCT04436276|459537108|FG012|Overall Study|Physician Decision|2|||
127701900|NCT04436276|459537109|FG013|Overall Study|Physician Decision|0|||
127701901|NCT04436276|459537110|FG014|Overall Study|Physician Decision|0|||
127627296|NCT00622635|459258477|FG002|Treatment Period 1|Withdrawal by Subject|0|||
127627297|NCT00622635|459258478|FG003|Treatment Period 1|Withdrawal by Subject|0|||
127627298|NCT00622635|459258479|FG004|Treatment Period 1|Withdrawal by Subject|0|||
127627299|NCT00622635|459258480|FG005|Treatment Period 1|Withdrawal by Subject|0|||
127627300|NCT00622635|459258475|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
127627301|NCT00622635|459258476|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
127627302|NCT00622635|459258477|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
127627303|NCT00622635|459258478|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
127627304|NCT00622635|459258479|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
127627305|NCT00622635|459258480|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
127627306|NCT00622635|459258475|FG000|Treatment Period 2|Adverse Event|1|||
127627307|NCT00622635|459258476|FG001|Treatment Period 2|Adverse Event|0|||
127627308|NCT00622635|459258477|FG002|Treatment Period 2|Adverse Event|0|||
127627309|NCT00622635|459258478|FG003|Treatment Period 2|Adverse Event|0|||
127627310|NCT00622635|459258479|FG004|Treatment Period 2|Adverse Event|0|||
127627311|NCT00622635|459258480|FG005|Treatment Period 2|Adverse Event|0|||
127627312|NCT00622635|459258475|FG000|Treatment Period 3|Adverse Event|0|||
127627313|NCT00622635|459258476|FG001|Treatment Period 3|Adverse Event|0|||
127627314|NCT00622635|459258477|FG002|Treatment Period 3|Adverse Event|0|||
127627315|NCT00622635|459258478|FG003|Treatment Period 3|Adverse Event|2|||
127627316|NCT00622635|459258479|FG004|Treatment Period 3|Adverse Event|0|||
127627317|NCT00622635|459258480|FG005|Treatment Period 3|Adverse Event|0|||
127627318|NCT00622635|459258475|FG000|Treatment Period 3|Withdrawal by Subject|0|||
127627319|NCT00622635|459258476|FG001|Treatment Period 3|Withdrawal by Subject|0|||
127627320|NCT00622635|459258477|FG002|Treatment Period 3|Withdrawal by Subject|0|||
127627321|NCT00622635|459258478|FG003|Treatment Period 3|Withdrawal by Subject|1|||
127627322|NCT00622635|459258479|FG004|Treatment Period 3|Withdrawal by Subject|0|||
127627323|NCT00622635|459258480|FG005|Treatment Period 3|Withdrawal by Subject|0|||
127627324|NCT00281840|459258481|FG000|Overall Study|Adverse Event|12|||
127627325|NCT00281840|459258481|FG000|Overall Study|Physician Decision|6|||
127627326|NCT00281840|459258481|FG000|Overall Study|Withdrawal by Subject|3|||
127627327|NCT00281840|459258481|FG000|Overall Study|Disease Progression|2|||
127627328|NCT00281840|459258481|FG000|Overall Study|exceed maximum delay in treatment|1|||
127627329|NCT00281840|459258481|FG000|Overall Study|Complicating Disease|1|||
127627330|NCT01898793|459258491|FG000|Overall Study|Death|2|||
127627331|NCT01898793|459258492|FG001|Overall Study|Death|1|||
127627332|NCT01898793|459258493|FG002|Overall Study|Death|4|||
127627333|NCT01898793|459258494|FG003|Overall Study|Death|0|||
127627334|NCT01898793|459258495|FG004|Overall Study|Death|0|||
127627335|NCT01898793|459258496|FG005|Overall Study|Death|0|||
127627336|NCT01898793|459258497|FG006|Overall Study|Death|0|||
127627337|NCT00931307|459258498|FG000|Overall Study|Lack of Efficacy|12|||
127627338|NCT00931307|459258498|FG000|Overall Study|Biomicroscopy|1|||
127627339|NCT02447991|459258502|FG000|Overall Study|Withdrawn by subject - no data|0|||
127627340|NCT02447991|459258503|FG001|Overall Study|Withdrawn by subject - no data|2|||
127627341|NCT02447991|459258502|FG000|Overall Study|Withdrawn by Subject - with data|4|||
127627342|NCT02447991|459258503|FG001|Overall Study|Withdrawn by Subject - with data|4|||
127627343|NCT02447991|459258502|FG000|Overall Study|Lost to Follow-up - no data|3|||
127627344|NCT02447991|459258503|FG001|Overall Study|Lost to Follow-up - no data|6|||
127627345|NCT02447991|459258502|FG000|Overall Study|Lost to follow-up - with data|0|||
127627346|NCT02447991|459258503|FG001|Overall Study|Lost to follow-up - with data|3|||
127627347|NCT02447991|459258502|FG000|Overall Study|End of study - no treatment results|3|||
127627348|NCT02447991|459258503|FG001|Overall Study|End of study - no treatment results|6|||
127627349|NCT02447991|459258502|FG000|Overall Study|End of study - partial treatment results|0|||
127627350|NCT02447991|459258503|FG001|Overall Study|End of study - partial treatment results|9|||
127627351|NCT00459134|459258504|FG000|Overall Study|Physician Decision|1|||
127627352|NCT00459134|459258505|FG001|Overall Study|Physician Decision|1|||
127627353|NCT00459134|459258504|FG000|Overall Study|Withdrawal by Subject|8|||
127627354|NCT00459134|459258505|FG001|Overall Study|Withdrawal by Subject|7|||
127627355|NCT00459134|459258504|FG000|Overall Study|Lost to Follow-up|6|||
127627356|NCT00459134|459258505|FG001|Overall Study|Lost to Follow-up|7|||
127627357|NCT00459134|459258504|FG000|Overall Study|Surgery|1|||
127627358|NCT00459134|459258505|FG001|Overall Study|Surgery|2|||
127627359|NCT00459134|459258504|FG000|Overall Study|Toxicity|4|||
127627360|NCT00459134|459258505|FG001|Overall Study|Toxicity|5|||
127627361|NCT00459134|459258504|FG000|Overall Study|Progression|1|||
127627362|NCT00459134|459258505|FG001|Overall Study|Progression|0|||
127627363|NCT00459134|459258504|FG000|Overall Study|Multiple Reasons|2|||
127627364|NCT00459134|459258505|FG001|Overall Study|Multiple Reasons|3|||
127627365|NCT03964454|459258508|FG000|Overall Study|Lost to Follow-up|13|||
127627366|NCT03964454|459258509|FG001|Overall Study|Lost to Follow-up|7|||
127627367|NCT03964454|459258508|FG000|Overall Study|Withdrawal by Subject|4|||
127627368|NCT03964454|459258509|FG001|Overall Study|Withdrawal by Subject|11|||
127627369|NCT02343458|459260371|FG000|Overall Study|Adverse Event|15|||
127627370|NCT02343458|459260372|FG001|Overall Study|Adverse Event|14|||
127627371|NCT02343458|459260373|FG002|Overall Study|Adverse Event|15|||
127627372|NCT02343458|459260374|FG003|Overall Study|Adverse Event|3|||
127627373|NCT02343458|459260371|FG000|Overall Study|Lack of Efficacy|3|||
127627374|NCT02343458|459260372|FG001|Overall Study|Lack of Efficacy|8|||
127627375|NCT02343458|459260373|FG002|Overall Study|Lack of Efficacy|4|||
127627376|NCT02343458|459260374|FG003|Overall Study|Lack of Efficacy|8|||
127627377|NCT02343458|459260371|FG000|Overall Study|Withdrawal by Subject|18|||
127627378|NCT02343458|459260372|FG001|Overall Study|Withdrawal by Subject|17|||
127627379|NCT02343458|459260373|FG002|Overall Study|Withdrawal by Subject|23|||
127627380|NCT02343458|459260374|FG003|Overall Study|Withdrawal by Subject|14|||
127627381|NCT02343458|459260371|FG000|Overall Study|Physician Decision|1|||
127627382|NCT02343458|459260372|FG001|Overall Study|Physician Decision|4|||
127627383|NCT02343458|459260373|FG002|Overall Study|Physician Decision|2|||
127627384|NCT02343458|459260374|FG003|Overall Study|Physician Decision|2|||
127627385|NCT02343458|459260371|FG000|Overall Study|Lost to Follow-up|5|||
127627386|NCT02343458|459260372|FG001|Overall Study|Lost to Follow-up|5|||
127627387|NCT02343458|459260373|FG002|Overall Study|Lost to Follow-up|3|||
127627388|NCT02343458|459260374|FG003|Overall Study|Lost to Follow-up|1|||
127627389|NCT02343458|459260371|FG000|Overall Study|Protocol Violation|2|||
127627390|NCT02343458|459260372|FG001|Overall Study|Protocol Violation|5|||
127627391|NCT02343458|459260373|FG002|Overall Study|Protocol Violation|2|||
127627392|NCT02343458|459260374|FG003|Overall Study|Protocol Violation|2|||
127627393|NCT02343458|459260371|FG000|Overall Study|Protocol Specified Criteria|17|||
127627394|NCT02343458|459260372|FG001|Overall Study|Protocol Specified Criteria|13|||
127627395|NCT02343458|459260373|FG002|Overall Study|Protocol Specified Criteria|14|||
127627396|NCT02343458|459260374|FG003|Overall Study|Protocol Specified Criteria|8|||
127627397|NCT02080091|459260375|FG000|Overall Study|Study Terminated|22|||
127627398|NCT02080091|459260375|FG000|Overall Study|Death|1|||
127627399|NCT02080091|459260375|FG000|Overall Study|Withdrawal by Subject|1|||
127627400|NCT02080091|459260375|FG000|Overall Study|Other|1|||
127627401|NCT00672477|459260376|FG000|Overall Study|Adverse Event|10|||
127627402|NCT00672477|459260377|FG001|Overall Study|Adverse Event|7|||
127627403|NCT00672477|459260376|FG000|Overall Study|Death|7|||
127627404|NCT00672477|459260377|FG001|Overall Study|Death|11|||
127627405|NCT00672477|459260376|FG000|Overall Study|Physician Decision|2|||
127627406|NCT00672477|459260377|FG001|Overall Study|Physician Decision|0|||
127627407|NCT00672477|459260376|FG000|Overall Study|Protocol Violation|1|||
127627408|NCT00672477|459260377|FG001|Overall Study|Protocol Violation|1|||
127627409|NCT00672477|459260376|FG000|Overall Study|Withdrawal by Subject|5|||
127627410|NCT00672477|459260377|FG001|Overall Study|Withdrawal by Subject|3|||
127627411|NCT00672477|459260376|FG000|Overall Study|Lack of Efficacy|1|||
127627412|NCT00672477|459260377|FG001|Overall Study|Lack of Efficacy|1|||
127627413|NCT00672477|459260376|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
127627414|NCT00672477|459260377|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
127627415|NCT02866682|459260380|FG000|Overall Study|Death|0|||
127627416|NCT02866682|459260381|FG001|Overall Study|Death|1|||
127627417|NCT02866682|459260380|FG000|Overall Study|Lost to Follow-up|0|||
127627418|NCT02866682|459260381|FG001|Overall Study|Lost to Follow-up|4|||
127627419|NCT02866682|459260380|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
127627420|NCT02866682|459260381|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
127627421|NCT02866682|459260380|FG000|Overall Study|Other|0|||
127627422|NCT02866682|459260381|FG001|Overall Study|Other|1|||
127627423|NCT00201006|459260382|FG000|Overall Study|Withdrawal by Subject|7|||
127627424|NCT00201006|459260383|FG001|Overall Study|Withdrawal by Subject|2|||
127627425|NCT00201006|459260384|FG002|Overall Study|Withdrawal by Subject|3|||
127627426|NCT00201006|459260382|FG000|Overall Study|Adverse Event|1|||
127627427|NCT00201006|459260383|FG001|Overall Study|Adverse Event|0|||
127627428|NCT00201006|459260384|FG002|Overall Study|Adverse Event|1|||
127627429|NCT01750268|459260385|FG000|Overall Study|Lost to Follow-up|0|||
127627430|NCT01750268|459260386|FG001|Overall Study|Lost to Follow-up|2|||
127627431|NCT01750268|459260385|FG000|Overall Study|Physician Decision|0|||
127627432|NCT01750268|459260386|FG001|Overall Study|Physician Decision|3|||
127627433|NCT01750268|459260385|FG000|Overall Study|Withdrawal by Subject|2|||
127627434|NCT01750268|459260386|FG001|Overall Study|Withdrawal by Subject|0|||
127885233|NCT00879970|460203865|FG003|Period 2 Vitamin D Randomization|Death|2|||
127885234|NCT00879970|460203866|FG004|Period 2 Vitamin D Randomization|Death|0|||
127627435|NCT02057757|459260387|FG000|Overall Study|Withdrawal by Subject|3|||
127627436|NCT02057757|459260388|FG001|Overall Study|Withdrawal by Subject|5|||
127627437|NCT02057757|459260387|FG000|Overall Study|Death|2|||
127627438|NCT02057757|459260388|FG001|Overall Study|Death|0|||
127627439|NCT02057757|459260387|FG000|Overall Study|Lost to Follow-up|8|||
127627440|NCT02057757|459260388|FG001|Overall Study|Lost to Follow-up|3|||
127627441|NCT02057757|459260387|FG000|Overall Study|Non-compliance|1|||
127627442|NCT02057757|459260388|FG001|Overall Study|Non-compliance|0|||
127627443|NCT03614793|459260389|FG000|Overall Study|Lost to Follow-up|1|||
127627444|NCT03614793|459260390|FG001|Overall Study|Lost to Follow-up|2|||
127627445|NCT03614793|459260389|FG000|Overall Study|Lack of Efficacy|0|||
127627446|NCT03614793|459260390|FG001|Overall Study|Lack of Efficacy|5|||
127627447|NCT03614793|459260389|FG000|Overall Study|Withdrawal by Subject|0|||
127627448|NCT03614793|459260390|FG001|Overall Study|Withdrawal by Subject|1|||
127701902|NCT04436276|459537111|FG015|Overall Study|Physician Decision|0|||
127627449|NCT03614793|459260389|FG000|Overall Study|Insurance denied coverage of the procedure|0|||
127627450|NCT03614793|459260390|FG001|Overall Study|Insurance denied coverage of the procedure|5|||
127627451|NCT02082522|459260391|FG000|Overall Study|Sponsor termination|5|||
127627452|NCT02082522|459260392|FG001|Overall Study|Sponsor termination|3|||
127627453|NCT02082522|459260391|FG000|Overall Study|Withdrawal by Subject|2|||
127627454|NCT02082522|459260392|FG001|Overall Study|Withdrawal by Subject|4|||
127627455|NCT02082522|459260391|FG000|Overall Study|Death|1|||
127627456|NCT02082522|459260392|FG001|Overall Study|Death|0|||
127627457|NCT02082522|459260391|FG000|Overall Study|Lost to Follow-up|1|||
127627458|NCT02082522|459260392|FG001|Overall Study|Lost to Follow-up|0|||
127627459|NCT02082522|459260391|FG000|Overall Study|Physician Decision|3|||
127627460|NCT02082522|459260392|FG001|Overall Study|Physician Decision|1|||
127627461|NCT02082522|459260391|FG000|Overall Study|Disease progression|2|||
127627462|NCT02082522|459260392|FG001|Overall Study|Disease progression|2|||
127627463|NCT02082522|459260391|FG000|Overall Study|Chemotherapy change|1|||
127627464|NCT02082522|459260392|FG001|Overall Study|Chemotherapy change|3|||
127627465|NCT00456092|459260393|FG000|Extension Phase|Grade 2 or Greater AE|2|||
127627466|NCT00456092|459260394|FG001|Extension Phase|Grade 2 or Greater AE|2|||
127627467|NCT00456092|459260395|FG002|Extension Phase|Grade 2 or Greater AE|0|||
127627468|NCT00456092|459260396|FG003|Extension Phase|Grade 2 or Greater AE|0|||
127627469|NCT00456092|459260397|FG004|Extension Phase|Grade 2 or Greater AE|2|||
127627470|NCT00456092|459260393|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
127627471|NCT00456092|459260394|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
127627472|NCT00456092|459260395|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
127627473|NCT00456092|459260396|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
127627474|NCT00456092|459260397|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
127627475|NCT00456092|459260393|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
127627476|NCT00456092|459260394|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
127627477|NCT00456092|459260395|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
127627478|NCT00456092|459260396|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
127627479|NCT00456092|459260397|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
127627480|NCT00456092|459260393|FG000|Extension Phase|Withdrew Consent|2|||
127627481|NCT00456092|459260394|FG001|Extension Phase|Withdrew Consent|0|||
127627482|NCT00456092|459260395|FG002|Extension Phase|Withdrew Consent|0|||
127627483|NCT00456092|459260396|FG003|Extension Phase|Withdrew Consent|0|||
127627484|NCT00456092|459260397|FG004|Extension Phase|Withdrew Consent|0|||
127627485|NCT00456092|459260393|FG000|Extension Phase|Lost to Follow-up|1|||
127627486|NCT00456092|459260394|FG001|Extension Phase|Lost to Follow-up|1|||
127627487|NCT00456092|459260395|FG002|Extension Phase|Lost to Follow-up|0|||
127627488|NCT00456092|459260396|FG003|Extension Phase|Lost to Follow-up|0|||
127627489|NCT00456092|459260397|FG004|Extension Phase|Lost to Follow-up|1|||
127627490|NCT00456092|459260393|FG000|Extension Phase|Other|2|||
127627491|NCT00456092|459260394|FG001|Extension Phase|Other|0|||
127627492|NCT00456092|459260395|FG002|Extension Phase|Other|0|||
127627493|NCT00456092|459260396|FG003|Extension Phase|Other|1|||
127627494|NCT00456092|459260397|FG004|Extension Phase|Other|1|||
127627495|NCT00456092|459260393|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
127627496|NCT00456092|459260394|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
127627497|NCT00456092|459260395|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
127627498|NCT00456092|459260396|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
127627499|NCT00456092|459260397|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
127627500|NCT00456092|459260393|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
127627501|NCT00456092|459260394|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
127627502|NCT00456092|459260395|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
127627503|NCT00456092|459260396|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
127627504|NCT00456092|459260397|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
127627505|NCT00456092|459260393|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
127627506|NCT00456092|459260394|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
127627507|NCT00456092|459260395|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
127627508|NCT00456092|459260396|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
127627509|NCT00456092|459260397|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
127627510|NCT00456092|459260393|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
127627511|NCT00456092|459260394|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
127627512|NCT00456092|459260395|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
127627513|NCT00456092|459260396|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
127627514|NCT00456092|459260397|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
127627515|NCT00456092|459260393|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
127627516|NCT00456092|459260394|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
127627517|NCT00456092|459260395|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
127885235|NCT01749033|460203868|FG000|Overall Study|Did not receive allocated intervention|3|||
127885236|NCT01749033|460203869|FG001|Overall Study|Did not receive allocated intervention|3|||
127627518|NCT00456092|459260396|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
127627519|NCT00456092|459260397|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
127627520|NCT00456092|459260393|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
127627521|NCT00456092|459260394|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
127627522|NCT00456092|459260395|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
127627523|NCT00456092|459260396|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
127627524|NCT00456092|459260397|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
127627525|NCT00456092|459260393|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
127627526|NCT00456092|459260394|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
127627527|NCT00456092|459260395|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
127627528|NCT00456092|459260396|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
127627529|NCT00456092|459260397|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
127627530|NCT00456092|459260393|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
127627531|NCT00456092|459260394|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
127627532|NCT00456092|459260395|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
127627533|NCT00456092|459260396|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
127627534|NCT00456092|459260397|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
127627535|NCT00456092|459260393|FG000|Treatment Phase (12 Weeks)|Other|1|||
127627536|NCT00456092|459260394|FG001|Treatment Phase (12 Weeks)|Other|0|||
127627537|NCT00456092|459260395|FG002|Treatment Phase (12 Weeks)|Other|1|||
127627538|NCT00456092|459260396|FG003|Treatment Phase (12 Weeks)|Other|0|||
127627539|NCT00456092|459260397|FG004|Treatment Phase (12 Weeks)|Other|0|||
127627540|NCT00563797|459260398|FG000|Overall Study|Lost to Follow-up|7|||
127627541|NCT00563797|459260399|FG001|Overall Study|Lost to Follow-up|2|||
127627542|NCT03224468|459260409|FG000|Overall Study|Did not obtain MM card|53|||
127627543|NCT03224468|459260410|FG001|Overall Study|Did not obtain MM card|0|||
127627544|NCT03224468|459260409|FG000|Overall Study|Lost to Follow-up|4|||
127627545|NCT03224468|459260410|FG001|Overall Study|Lost to Follow-up|11|||
127627546|NCT03224468|459260409|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
127627547|NCT03224468|459260410|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
127627548|NCT02461589|459260411|FG000|Overall Study|Withdrawal by Subject|5|||
127627549|NCT02461589|459260412|FG001|Overall Study|Withdrawal by Subject|1|||
127627550|NCT02461589|459260413|FG002|Overall Study|Withdrawal by Subject|3|||
127627551|NCT02461589|459260414|FG003|Overall Study|Withdrawal by Subject|2|||
127627552|NCT02461589|459260415|FG004|Overall Study|Withdrawal by Subject|1|||
127627553|NCT02461589|459260416|FG005|Overall Study|Withdrawal by Subject|2|||
127627554|NCT02461589|459260417|FG006|Overall Study|Withdrawal by Subject|1|||
127627555|NCT02461589|459260418|FG007|Overall Study|Withdrawal by Subject|3|||
127627556|NCT02461589|459260419|FG008|Overall Study|Withdrawal by Subject|3|||
127627557|NCT02461589|459260420|FG009|Overall Study|Withdrawal by Subject|1|||
127627558|NCT02461589|459260411|FG000|Overall Study|Lost to Follow-up|0|||
127627559|NCT02461589|459260412|FG001|Overall Study|Lost to Follow-up|0|||
127627560|NCT02461589|459260413|FG002|Overall Study|Lost to Follow-up|2|||
127627561|NCT02461589|459260414|FG003|Overall Study|Lost to Follow-up|3|||
127627562|NCT02461589|459260415|FG004|Overall Study|Lost to Follow-up|1|||
127627563|NCT02461589|459260416|FG005|Overall Study|Lost to Follow-up|1|||
127627564|NCT02461589|459260417|FG006|Overall Study|Lost to Follow-up|3|||
127627565|NCT02461589|459260418|FG007|Overall Study|Lost to Follow-up|1|||
127627566|NCT02461589|459260419|FG008|Overall Study|Lost to Follow-up|3|||
127627567|NCT02461589|459260420|FG009|Overall Study|Lost to Follow-up|1|||
127627568|NCT02461589|459260411|FG000|Overall Study|Death|0|||
127627569|NCT02461589|459260412|FG001|Overall Study|Death|0|||
127627570|NCT02461589|459260413|FG002|Overall Study|Death|0|||
127627571|NCT02461589|459260414|FG003|Overall Study|Death|0|||
127627572|NCT02461589|459260415|FG004|Overall Study|Death|0|||
127627573|NCT02461589|459260416|FG005|Overall Study|Death|0|||
127627574|NCT02461589|459260417|FG006|Overall Study|Death|0|||
127627575|NCT02461589|459260418|FG007|Overall Study|Death|1|||
127627576|NCT02461589|459260419|FG008|Overall Study|Death|0|||
127627577|NCT02461589|459260420|FG009|Overall Study|Death|0|||
127627578|NCT02461589|459260411|FG000|Overall Study|Unclassified|0|||
127627579|NCT02461589|459260412|FG001|Overall Study|Unclassified|0|||
127627580|NCT02461589|459260413|FG002|Overall Study|Unclassified|0|||
127793110|NCT03016325|459867439|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
127627581|NCT02461589|459260414|FG003|Overall Study|Unclassified|0|||
127627582|NCT02461589|459260415|FG004|Overall Study|Unclassified|0|||
127627583|NCT02461589|459260416|FG005|Overall Study|Unclassified|0|||
127627584|NCT02461589|459260417|FG006|Overall Study|Unclassified|1|||
127627585|NCT02461589|459260418|FG007|Overall Study|Unclassified|0|||
127627586|NCT02461589|459260419|FG008|Overall Study|Unclassified|0|||
127627587|NCT02461589|459260420|FG009|Overall Study|Unclassified|2|||
127627588|NCT02461589|459260411|FG000|Overall Study|Missing follow-up information|1|||
127627589|NCT02461589|459260412|FG001|Overall Study|Missing follow-up information|1|||
127627590|NCT02461589|459260413|FG002|Overall Study|Missing follow-up information|0|||
127627591|NCT02461589|459260414|FG003|Overall Study|Missing follow-up information|0|||
127627592|NCT02461589|459260415|FG004|Overall Study|Missing follow-up information|0|||
127627593|NCT02461589|459260416|FG005|Overall Study|Missing follow-up information|0|||
127627594|NCT02461589|459260417|FG006|Overall Study|Missing follow-up information|1|||
127627595|NCT02461589|459260418|FG007|Overall Study|Missing follow-up information|0|||
127627596|NCT02461589|459260419|FG008|Overall Study|Missing follow-up information|0|||
127627597|NCT02461589|459260420|FG009|Overall Study|Missing follow-up information|0|||
127627598|NCT02461589|459260411|FG000|Overall Study|Withdrawal from trial before exposure|0|||
127627599|NCT02461589|459260412|FG001|Overall Study|Withdrawal from trial before exposure|0|||
127627600|NCT02461589|459260413|FG002|Overall Study|Withdrawal from trial before exposure|0|||
127627601|NCT02461589|459260414|FG003|Overall Study|Withdrawal from trial before exposure|0|||
127627602|NCT02461589|459260415|FG004|Overall Study|Withdrawal from trial before exposure|0|||
127627603|NCT02461589|459260416|FG005|Overall Study|Withdrawal from trial before exposure|0|||
127627604|NCT02461589|459260417|FG006|Overall Study|Withdrawal from trial before exposure|0|||
127627605|NCT02461589|459260418|FG007|Overall Study|Withdrawal from trial before exposure|0|||
127627606|NCT02461589|459260419|FG008|Overall Study|Withdrawal from trial before exposure|0|||
127627607|NCT02461589|459260420|FG009|Overall Study|Withdrawal from trial before exposure|1|||
127627608|NCT04067141|459260421|FG000|First Intervention|Withdrawal by Subject|0|||
127627609|NCT04067141|459260422|FG001|First Intervention|Withdrawal by Subject|1|||
127627610|NCT04067141|459260421|FG000|Second Intervention|Adverse Event|0|||
127627611|NCT04067141|459260422|FG001|Second Intervention|Adverse Event|2|||
127627612|NCT01038921|459260423|FG000|Overall Study|Withdrawal by Subject|1|||
127627613|NCT01038921|459260424|FG001|Overall Study|Withdrawal by Subject|0|||
127627614|NCT01038921|459260423|FG000|Overall Study|Physician Decision|1|||
127627615|NCT01038921|459260424|FG001|Overall Study|Physician Decision|0|||
127627616|NCT01978119|459260425|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
127627617|NCT01978119|459260426|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
127627618|NCT01978119|459260425|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
127627619|NCT01978119|459260426|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
127627620|NCT01978119|459260425|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
127627621|NCT01978119|459260426|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
127627622|NCT03295201|459260427|FG000|Overall Study|Lost to Follow-up|1|||
127627623|NCT03295201|459260428|FG001|Overall Study|Lost to Follow-up|1|||
127627624|NCT03295201|459260427|FG000|Overall Study|Hospital admission|0|||
127627625|NCT03295201|459260428|FG001|Overall Study|Hospital admission|1|||
127627626|NCT00889421|459260429|FG000|Overall Study|Lack of Efficacy|3|||
127627627|NCT01958918|459260430|FG000|Overall Study|Death|1|||
127627628|NCT01958918|459260431|FG001|Overall Study|Death|3|||
127627629|NCT01958918|459260430|FG000|Overall Study|Lost to Follow-up|4|||
127627630|NCT01958918|459260431|FG001|Overall Study|Lost to Follow-up|7|||
127627631|NCT01958918|459260430|FG000|Overall Study|Withdrawal by Subject|13|||
127627632|NCT01958918|459260431|FG001|Overall Study|Withdrawal by Subject|8|||
127627633|NCT01958918|459260430|FG000|Overall Study|Lack of Efficacy|13|||
127627634|NCT01958918|459260431|FG001|Overall Study|Lack of Efficacy|10|||
127627635|NCT01958918|459260430|FG000|Overall Study|Adverse Event|12|||
127627636|NCT01958918|459260431|FG001|Overall Study|Adverse Event|12|||
127627637|NCT01958918|459260430|FG000|Overall Study|administrative problems|0|||
127627638|NCT01958918|459260431|FG001|Overall Study|administrative problems|2|||
127627639|NCT00659269|459260432|FG000|Overall Study|Physician Decision|1|||
127627640|NCT00659269|459260433|FG001|Overall Study|Physician Decision|1|||
127627641|NCT01158222|459260434|FG000|Overall Study|Not eligible for intermediate phase|17|||
127627642|NCT04327934|459260435|FG000|Overall Study|Did not qualify|7|||
127627643|NCT04327934|459260436|FG001|Overall Study|Did not qualify|4|||
127627644|NCT04327934|459260435|FG000|Overall Study|Physician Decision|0|||
127627645|NCT04327934|459260436|FG001|Overall Study|Physician Decision|1|||
127627646|NCT03095417|459260441|FG000|Overall Study|missed|1|||
127627647|NCT03095417|459260442|FG001|Overall Study|missed|2|||
127627648|NCT03095417|459260443|FG002|Overall Study|missed|0|||
127627649|NCT03095417|459260444|FG003|Overall Study|missed|1|||
127627650|NCT03095417|459260441|FG000|Overall Study|Lost to Follow-up|2|||
127627651|NCT03095417|459260442|FG001|Overall Study|Lost to Follow-up|2|||
127627652|NCT03095417|459260443|FG002|Overall Study|Lost to Follow-up|1|||
127627653|NCT03095417|459260444|FG003|Overall Study|Lost to Follow-up|0|||
127627654|NCT03095417|459260441|FG000|Overall Study|refusal|0|||
127627655|NCT03095417|459260442|FG001|Overall Study|refusal|1|||
127627656|NCT03095417|459260443|FG002|Overall Study|refusal|0|||
127627657|NCT03095417|459260444|FG003|Overall Study|refusal|1|||
127627658|NCT03095417|459260441|FG000|Overall Study|Withdrawal by Subject|8|||
127627659|NCT03095417|459260442|FG001|Overall Study|Withdrawal by Subject|2|||
127627660|NCT03095417|459260443|FG002|Overall Study|Withdrawal by Subject|5|||
127627661|NCT03095417|459260444|FG003|Overall Study|Withdrawal by Subject|4|||
127627662|NCT03095417|459260441|FG000|Overall Study|Physician Decision|1|||
127627663|NCT03095417|459260442|FG001|Overall Study|Physician Decision|2|||
127627664|NCT03095417|459260443|FG002|Overall Study|Physician Decision|2|||
127627665|NCT03095417|459260444|FG003|Overall Study|Physician Decision|2|||
127627666|NCT03095417|459260441|FG000|Overall Study|Death|1|||
127627667|NCT03095417|459260442|FG001|Overall Study|Death|2|||
127627668|NCT03095417|459260443|FG002|Overall Study|Death|1|||
127627669|NCT03095417|459260444|FG003|Overall Study|Death|3|||
127627670|NCT01490060|459260445|FG000|Cycle 1|Change of Treatment|0|||
127627671|NCT01490060|459260446|FG001|Cycle 1|Change of Treatment|1|||
127627672|NCT01490060|459260447|FG002|Cycle 1|Change of Treatment|1|||
127627673|NCT01490060|459260448|FG003|Cycle 1|Change of Treatment|1|||
127627674|NCT01490060|459260445|FG000|Cycle 1|Insurance Denied|0|||
127627675|NCT01490060|459260446|FG001|Cycle 1|Insurance Denied|0|||
127627676|NCT01490060|459260447|FG002|Cycle 1|Insurance Denied|2|||
127627677|NCT01490060|459260448|FG003|Cycle 1|Insurance Denied|0|||
127627678|NCT01490060|459260445|FG000|Cycle 1|Withdrawal by Subject|0|||
127627679|NCT01490060|459260446|FG001|Cycle 1|Withdrawal by Subject|0|||
127627680|NCT01490060|459260447|FG002|Cycle 1|Withdrawal by Subject|0|||
127627681|NCT01490060|459260448|FG003|Cycle 1|Withdrawal by Subject|1|||
127627682|NCT01490060|459260445|FG000|Cycle 1|Treatment at Another Facility|0|||
127627683|NCT01490060|459260446|FG001|Cycle 1|Treatment at Another Facility|0|||
127627684|NCT01490060|459260447|FG002|Cycle 1|Treatment at Another Facility|0|||
127627685|NCT01490060|459260448|FG003|Cycle 1|Treatment at Another Facility|1|||
127627686|NCT01490060|459260445|FG000|Cycle 2|Change of Treatment|1|||
127627687|NCT01490060|459260446|FG001|Cycle 2|Change of Treatment|1|||
127627688|NCT01490060|459260447|FG002|Cycle 2|Change of Treatment|0|||
127627689|NCT01490060|459260448|FG003|Cycle 2|Change of Treatment|0|||
127627690|NCT01490060|459260445|FG000|Cycle 2|Non-Compliance|0|||
127627691|NCT01490060|459260446|FG001|Cycle 2|Non-Compliance|0|||
127627692|NCT01490060|459260447|FG002|Cycle 2|Non-Compliance|1|||
127627693|NCT01490060|459260448|FG003|Cycle 2|Non-Compliance|0|||
127627694|NCT01490060|459260445|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
127627695|NCT01490060|459260446|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
127627696|NCT01490060|459260447|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
127627697|NCT01490060|459260448|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
127627698|NCT01877421|459260449|FG000|Phase 2|Lost to Follow-up|0|||
127627699|NCT01877421|459260450|FG001|Phase 2|Lost to Follow-up|0|||
127627700|NCT01877421|459260451|FG002|Phase 2|Lost to Follow-up|0|||
127627701|NCT01877421|459260452|FG003|Phase 2|Lost to Follow-up|0|||
127627702|NCT01877421|459260453|FG004|Phase 2|Lost to Follow-up|0|||
127627703|NCT01877421|459260454|FG005|Phase 2|Lost to Follow-up|0|||
127627704|NCT01877421|459260455|FG006|Phase 2|Lost to Follow-up|1|||
127627705|NCT01877421|459260456|FG007|Phase 2|Lost to Follow-up|0|||
127627706|NCT01877421|459260457|FG008|Phase 2|Lost to Follow-up|0|||
127627707|NCT01877421|459260458|FG009|Phase 2|Lost to Follow-up|0|||
127627708|NCT01877421|459260459|FG010|Phase 2|Lost to Follow-up|0|||
127627709|NCT01877421|459260460|FG011|Phase 2|Lost to Follow-up|0|||
127627710|NCT01877421|459260461|FG012|Phase 2|Lost to Follow-up|0|||
127627711|NCT01877421|459260462|FG013|Phase 2|Lost to Follow-up|0|||
127627712|NCT01877421|459260463|FG014|Phase 2|Lost to Follow-up|0|||
127627713|NCT01877421|459260464|FG015|Phase 2|Lost to Follow-up|0|||
127627714|NCT01877421|459260465|FG016|Phase 2|Lost to Follow-up|0|||
127627715|NCT01877421|459260466|FG017|Phase 2|Lost to Follow-up|0|||
127627716|NCT01877421|459260449|FG000|Phase 2|Withdrawal by Subject|0|||
127627717|NCT01877421|459260450|FG001|Phase 2|Withdrawal by Subject|0|||
127627718|NCT01877421|459260451|FG002|Phase 2|Withdrawal by Subject|0|||
127627719|NCT01877421|459260452|FG003|Phase 2|Withdrawal by Subject|0|||
127627720|NCT01877421|459260453|FG004|Phase 2|Withdrawal by Subject|0|||
127627721|NCT01877421|459260454|FG005|Phase 2|Withdrawal by Subject|0|||
127627722|NCT01877421|459260455|FG006|Phase 2|Withdrawal by Subject|0|||
127627723|NCT01877421|459260456|FG007|Phase 2|Withdrawal by Subject|0|||
127627724|NCT01877421|459260457|FG008|Phase 2|Withdrawal by Subject|1|||
127627725|NCT01877421|459260458|FG009|Phase 2|Withdrawal by Subject|0|||
127627726|NCT01877421|459260459|FG010|Phase 2|Withdrawal by Subject|1|||
127627727|NCT01877421|459260460|FG011|Phase 2|Withdrawal by Subject|0|||
127627728|NCT01877421|459260461|FG012|Phase 2|Withdrawal by Subject|1|||
127627729|NCT01877421|459260462|FG013|Phase 2|Withdrawal by Subject|0|||
127627730|NCT01877421|459260463|FG014|Phase 2|Withdrawal by Subject|0|||
127627731|NCT01877421|459260464|FG015|Phase 2|Withdrawal by Subject|1|||
127627732|NCT01877421|459260465|FG016|Phase 2|Withdrawal by Subject|0|||
127701903|NCT04436276|459537112|FG016|Overall Study|Physician Decision|0|||
127701904|NCT04436276|459537113|FG017|Overall Study|Physician Decision|0|||
127627733|NCT01877421|459260466|FG017|Phase 2|Withdrawal by Subject|0|||
127701905|NCT04436276|459537114|FG018|Overall Study|Physician Decision|0|||
127627734|NCT01877421|459260449|FG000|Phase 2|Protocol Violation|0|||
127627735|NCT01877421|459260450|FG001|Phase 2|Protocol Violation|0|||
127627736|NCT01877421|459260451|FG002|Phase 2|Protocol Violation|0|||
127627737|NCT01877421|459260452|FG003|Phase 2|Protocol Violation|0|||
127627738|NCT01877421|459260453|FG004|Phase 2|Protocol Violation|0|||
127627739|NCT01877421|459260454|FG005|Phase 2|Protocol Violation|0|||
127627740|NCT01877421|459260455|FG006|Phase 2|Protocol Violation|0|||
127627741|NCT01877421|459260456|FG007|Phase 2|Protocol Violation|0|||
127627742|NCT01877421|459260457|FG008|Phase 2|Protocol Violation|0|||
127701906|NCT04436276|459537115|FG019|Overall Study|Physician Decision|0|||
127627743|NCT01877421|459260458|FG009|Phase 2|Protocol Violation|0|||
127627744|NCT01877421|459260459|FG010|Phase 2|Protocol Violation|1|||
127627745|NCT01877421|459260460|FG011|Phase 2|Protocol Violation|0|||
127627746|NCT01877421|459260461|FG012|Phase 2|Protocol Violation|0|||
127627747|NCT01877421|459260462|FG013|Phase 2|Protocol Violation|0|||
127627748|NCT01877421|459260463|FG014|Phase 2|Protocol Violation|0|||
127627749|NCT01877421|459260464|FG015|Phase 2|Protocol Violation|0|||
127627750|NCT01877421|459260465|FG016|Phase 2|Protocol Violation|0|||
127627751|NCT01877421|459260466|FG017|Phase 2|Protocol Violation|0|||
127627752|NCT01047683|459260467|FG000|Overall Study|Adverse Event|3|||
127627753|NCT01047683|459260468|FG001|Overall Study|Adverse Event|1|||
127627754|NCT01047683|459260469|FG002|Overall Study|Adverse Event|0|||
127627755|NCT01047683|459260467|FG000|Overall Study|Withdrew Consent|1|||
127627756|NCT01047683|459260468|FG001|Overall Study|Withdrew Consent|4|||
127627757|NCT01047683|459260469|FG002|Overall Study|Withdrew Consent|2|||
127627758|NCT01047683|459260467|FG000|Overall Study|Lost to Follow-up|0|||
127627759|NCT01047683|459260468|FG001|Overall Study|Lost to Follow-up|1|||
127627760|NCT01047683|459260469|FG002|Overall Study|Lost to Follow-up|0|||
127627761|NCT01047683|459260467|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
127627762|NCT01047683|459260468|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
127627763|NCT01047683|459260469|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
127627764|NCT00908960|459260471|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
127627765|NCT00908960|459260472|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
127627766|NCT00908960|459260473|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
127627767|NCT01158924|459260475|FG000|Overall Study|Withdrawal by Subject|1|||
127627768|NCT01158924|459260476|FG001|Overall Study|Withdrawal by Subject|2|||
127627769|NCT01158924|459260475|FG000|Overall Study|Lost to Follow-up|0|||
127627770|NCT01158924|459260476|FG001|Overall Study|Lost to Follow-up|1|||
127627771|NCT00724451|459260480|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
127627772|NCT00724451|459260480|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
127627773|NCT00724451|459260480|FG000|Overall Study|Not Eligible for Treatment|431|||
127627774|NCT00724451|459260480|FG000|Overall Study|Participant Refused Treatment|89|||
127627775|NCT00724451|459260480|FG000|Overall Study|Never Started Treatment|89|||
127627776|NCT00724451|459260480|FG000|Overall Study|Unknown; No Data Sources Available|9|||
127627777|NCT00724451|459260480|FG000|Overall Study|Physician Decision|116|||
127627778|NCT00724451|459260480|FG000|Overall Study|Withdrawal by Subject|45|||
127627779|NCT00724451|459260480|FG000|Overall Study|Investigator + Participant Decision|13|||
127627780|NCT01260922|459260482|FG000|First Intervention|Withdrawal by Subject|0|||
127627781|NCT01260922|459260483|FG001|First Intervention|Withdrawal by Subject|1|||
127627782|NCT01260922|459260482|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
127627783|NCT01260922|459260483|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
127627784|NCT01260922|459260482|FG000|Second Intervention|Emesis|0|||
127627785|NCT01260922|459260483|FG001|Second Intervention|Emesis|2|||
127627786|NCT03732248|459260488|FG000|Overall Study|Withdrawal by Subject|1|||
127627787|NCT03732248|459260489|FG001|Overall Study|Withdrawal by Subject|0|||
127627788|NCT00733824|459260490|FG000|Phase I|Withdrawal by Subject|1|||
127627789|NCT00733824|459260491|FG001|Phase I|Withdrawal by Subject|0|||
127627790|NCT00733824|459260492|FG002|Phase I|Withdrawal by Subject|0|||
127627791|NCT00733824|459260493|FG003|Phase I|Withdrawal by Subject|0|||
127627792|NCT00733824|459260494|FG004|Phase I|Withdrawal by Subject|0|||
127627793|NCT01440946|459260496|FG000|Overall Study|Lost to Follow-up|1|||
127627794|NCT01440946|459260497|FG001|Overall Study|Lost to Follow-up|1|||
127627795|NCT01440946|459260496|FG000|Overall Study|Physician Decision|1|||
127627796|NCT01440946|459260497|FG001|Overall Study|Physician Decision|0|||
127627797|NCT01079234|459260505|FG000|Main: Week 0 to 26|Adverse Event|5|||
127627798|NCT01079234|459260506|FG001|Main: Week 0 to 26|Adverse Event|4|||
127627799|NCT01079234|459260507|FG002|Main: Week 0 to 26|Adverse Event|1|||
127627800|NCT01079234|459260508|FG003|Main: Week 0 to 26|Adverse Event|0|||
127627801|NCT01079234|459260505|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
127627802|NCT01079234|459260506|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
127627803|NCT01079234|459260507|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
127627804|NCT01079234|459260508|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
127627805|NCT01079234|459260505|FG000|Main: Week 0 to 26|Protocol Violation|6|||
127627806|NCT01079234|459260506|FG001|Main: Week 0 to 26|Protocol Violation|2|||
127627807|NCT01079234|459260507|FG002|Main: Week 0 to 26|Protocol Violation|4|||
127627808|NCT01079234|459260508|FG003|Main: Week 0 to 26|Protocol Violation|0|||
127627809|NCT01079234|459260505|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
127627810|NCT01079234|459260506|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
127627811|NCT01079234|459260507|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
127627812|NCT01079234|459260508|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
127627813|NCT01079234|459260505|FG000|Main: Week 0 to 26|Unclassified|7|||
127627814|NCT01079234|459260506|FG001|Main: Week 0 to 26|Unclassified|13|||
127627815|NCT01079234|459260507|FG002|Main: Week 0 to 26|Unclassified|4|||
127627816|NCT01079234|459260508|FG003|Main: Week 0 to 26|Unclassified|0|||
127627817|NCT01079234|459260505|FG000|Extension: Week 27 to 52|Adverse Event|0|||
127627818|NCT01079234|459260506|FG001|Extension: Week 27 to 52|Adverse Event|0|||
127701907|NCT04436276|459537116|FG020|Overall Study|Physician Decision|1|||
127627819|NCT01079234|459260507|FG002|Extension: Week 27 to 52|Adverse Event|1|||
127627820|NCT01079234|459260508|FG003|Extension: Week 27 to 52|Adverse Event|0|||
127627821|NCT01079234|459260505|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
127627822|NCT01079234|459260506|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
127627823|NCT01079234|459260507|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
127627824|NCT01079234|459260508|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
127627825|NCT01079234|459260505|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
127627826|NCT01079234|459260506|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
127627827|NCT01079234|459260507|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
127627828|NCT01079234|459260508|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
127627829|NCT01079234|459260505|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
127627830|NCT01079234|459260506|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
127627831|NCT01079234|459260507|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
127627832|NCT01079234|459260508|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
127627833|NCT01079234|459260505|FG000|Extension: Week 27 to 52|Unclassified|0|||
127627834|NCT01079234|459260506|FG001|Extension: Week 27 to 52|Unclassified|0|||
127627835|NCT01079234|459260507|FG002|Extension: Week 27 to 52|Unclassified|4|||
127627836|NCT01079234|459260508|FG003|Extension: Week 27 to 52|Unclassified|7|||
127627837|NCT01312961|459260510|FG000|Overall Study|Adverse Event|3|||
127627838|NCT01312961|459260511|FG001|Overall Study|Adverse Event|3|||
127627839|NCT01312961|459260510|FG000|Overall Study|Lack of Efficacy|11|||
127627840|NCT01312961|459260511|FG001|Overall Study|Lack of Efficacy|1|||
127627841|NCT01312961|459260510|FG000|Overall Study|Poor compliance to protocol|1|||
127627842|NCT01312961|459260511|FG001|Overall Study|Poor compliance to protocol|0|||
127627843|NCT01312961|459260510|FG000|Overall Study|Other than specified above|2|||
127627844|NCT01312961|459260511|FG001|Overall Study|Other than specified above|3|||
127627845|NCT04278417|459260516|FG000|Overall Study|Withdrawal by Subject|20|||
127627846|NCT04278417|459260517|FG001|Overall Study|Withdrawal by Subject|20|||
127627847|NCT04278417|459260516|FG000|Overall Study|Progressive disease|0|||
127627848|NCT04278417|459260517|FG001|Overall Study|Progressive disease|2|||
127627849|NCT04278417|459260516|FG000|Overall Study|Physician Decision|4|||
127627850|NCT04278417|459260517|FG001|Overall Study|Physician Decision|6|||
127627851|NCT04278417|459260516|FG000|Overall Study|Lost to Follow-up|11|||
127627852|NCT04278417|459260517|FG001|Overall Study|Lost to Follow-up|13|||
127627853|NCT04278417|459260516|FG000|Overall Study|Death|8|||
127627854|NCT04278417|459260517|FG001|Overall Study|Death|9|||
127627855|NCT04278417|459260516|FG000|Overall Study|Adverse Event|3|||
127627856|NCT04278417|459260517|FG001|Overall Study|Adverse Event|5|||
127627857|NCT00205712|459260519|FG000|Overall Study|Lost to Follow-up|0|||
127627858|NCT00205712|459260520|FG001|Overall Study|Lost to Follow-up|1|||
127627859|NCT00235989|459260521|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
127627860|NCT00235989|459260522|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
127627861|NCT00235989|459260523|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
127627862|NCT00235989|459260524|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
127627863|NCT00235989|459260525|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
127627864|NCT00235989|459260526|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
127627865|NCT00235989|459260521|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
127627866|NCT00235989|459260522|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
127627867|NCT00235989|459260523|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
127627868|NCT00235989|459260524|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
127627869|NCT00235989|459260525|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
127627870|NCT00235989|459260526|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
127627871|NCT00235989|459260521|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
127627872|NCT00235989|459260522|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
127627873|NCT00235989|459260523|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
127627874|NCT00235989|459260524|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
127627875|NCT00235989|459260525|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
127627876|NCT00235989|459260526|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
127627877|NCT00235989|459260521|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
127627878|NCT00235989|459260522|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
127627879|NCT00235989|459260523|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
127627880|NCT00235989|459260524|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
127627881|NCT00235989|459260525|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
127627882|NCT00235989|459260526|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
127627883|NCT00235989|459260521|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
127627884|NCT00235989|459260522|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
127627885|NCT00235989|459260523|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
127627886|NCT00235989|459260524|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
127627887|NCT00235989|459260525|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
127627888|NCT00235989|459260526|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
127627889|NCT00983580|459260536|FG000|Overall Study|Cancel Prior to treatment|1|||
127627890|NCT00983580|459260537|FG001|Overall Study|Cancel Prior to treatment|3|||
127627891|NCT00983580|459260536|FG000|Overall Study|Protocol Violation|1|||
127627892|NCT00983580|459260537|FG001|Overall Study|Protocol Violation|1|||
127627893|NCT00983580|459260536|FG000|Overall Study|Ineligible|3|||
127627894|NCT00983580|459260537|FG001|Overall Study|Ineligible|0|||
127627895|NCT01652716|459260540|FG000|Overall Study|Loss of glucose control|1|||
127627896|NCT01652716|459260541|FG001|Overall Study|Loss of glucose control|0|||
127627897|NCT01652716|459260540|FG000|Overall Study|Administrative|0|||
127627898|NCT01652716|459260541|FG001|Overall Study|Administrative|2|||
127627899|NCT01652716|459260540|FG000|Overall Study|Investigator decision|1|||
127627900|NCT01652716|459260541|FG001|Overall Study|Investigator decision|4|||
127627901|NCT01652716|459260540|FG000|Overall Study|Lost to Follow-up|12|||
127627902|NCT01652716|459260541|FG001|Overall Study|Lost to Follow-up|11|||
127627903|NCT01652716|459260540|FG000|Overall Study|Protocol Violation|2|||
127627904|NCT01652716|459260541|FG001|Overall Study|Protocol Violation|1|||
127627905|NCT01652716|459260540|FG000|Overall Study|Adverse Event|7|||
127627906|NCT01652716|459260541|FG001|Overall Study|Adverse Event|10|||
127627907|NCT01652716|459260540|FG000|Overall Study|Withdrawal by Subject|33|||
127627908|NCT01652716|459260541|FG001|Overall Study|Withdrawal by Subject|18|||
127627909|NCT01337297|459260542|FG000|Overall Study|They entered to single anodal tDCS|4|||
127627910|NCT01337297|459260543|FG001|Overall Study|They entered to single anodal tDCS|3|||
127627911|NCT01337297|459260542|FG000|Overall Study|Lost to Follow-up|1|||
127627912|NCT01337297|459260543|FG001|Overall Study|Lost to Follow-up|3|||
127627913|NCT02316717|459260544|FG000|Overall Study|Adverse Event|2|||
127627914|NCT02316717|459260545|FG001|Overall Study|Adverse Event|2|||
127627915|NCT02316717|459260546|FG002|Overall Study|Adverse Event|0|||
127627916|NCT02316717|459260544|FG000|Overall Study|Lost to Follow-up|1|||
127627917|NCT02316717|459260545|FG001|Overall Study|Lost to Follow-up|2|||
127627918|NCT02316717|459260546|FG002|Overall Study|Lost to Follow-up|1|||
127627919|NCT02316717|459260544|FG000|Overall Study|Non compliance|3|||
127627920|NCT02316717|459260545|FG001|Overall Study|Non compliance|1|||
127627921|NCT02316717|459260546|FG002|Overall Study|Non compliance|0|||
127627922|NCT02316717|459260544|FG000|Overall Study|Protocol Violation|2|||
127627923|NCT02316717|459260545|FG001|Overall Study|Protocol Violation|0|||
127627924|NCT02316717|459260546|FG002|Overall Study|Protocol Violation|0|||
127627925|NCT02316717|459260544|FG000|Overall Study|Withdrawal by Subject|2|||
127627926|NCT02316717|459260545|FG001|Overall Study|Withdrawal by Subject|1|||
127627927|NCT02316717|459260546|FG002|Overall Study|Withdrawal by Subject|1|||
127627928|NCT02316717|459260544|FG000|Overall Study|Death|0|||
127627929|NCT02316717|459260545|FG001|Overall Study|Death|0|||
127627930|NCT02316717|459260546|FG002|Overall Study|Death|1|||
127627931|NCT02316717|459260544|FG000|Overall Study|Physician Decision|0|||
127627932|NCT02316717|459260545|FG001|Overall Study|Physician Decision|1|||
127627933|NCT02316717|459260546|FG002|Overall Study|Physician Decision|0|||
127627934|NCT02316717|459260544|FG000|Overall Study|TBC|1|||
127627935|NCT02316717|459260545|FG001|Overall Study|TBC|0|||
127627936|NCT02316717|459260546|FG002|Overall Study|TBC|0|||
127627937|NCT02778204|459260547|FG000|Overall Study|Adverse Event|1|||
127627938|NCT02778204|459260548|FG001|Overall Study|Adverse Event|0|||
127627939|NCT02778204|459260549|FG002|Overall Study|Adverse Event|0|||
127627940|NCT02778204|459260550|FG003|Overall Study|Adverse Event|0|||
127627941|NCT02778204|459260547|FG000|Overall Study|Withdrawal by Subject|0|||
127701908|NCT04436276|459537117|FG021|Overall Study|Physician Decision|2|||
127701909|NCT04436276|459537118|FG022|Overall Study|Physician Decision|0|||
127627942|NCT02778204|459260548|FG001|Overall Study|Withdrawal by Subject|0|||
127701910|NCT04436276|459537096|FG000|Overall Study|Protocol Violation|0|||
127701911|NCT04436276|459537097|FG001|Overall Study|Protocol Violation|0|||
127627943|NCT02778204|459260549|FG002|Overall Study|Withdrawal by Subject|1|||
127627944|NCT02778204|459260550|FG003|Overall Study|Withdrawal by Subject|2|||
127627945|NCT02778204|459260547|FG000|Overall Study|Lost to Follow-up|1|||
127627946|NCT02778204|459260548|FG001|Overall Study|Lost to Follow-up|0|||
127627947|NCT02778204|459260549|FG002|Overall Study|Lost to Follow-up|2|||
127627948|NCT02778204|459260550|FG003|Overall Study|Lost to Follow-up|1|||
127627949|NCT02778204|459260547|FG000|Overall Study|Protocol Violation|0|||
127627950|NCT02778204|459260548|FG001|Overall Study|Protocol Violation|0|||
127627951|NCT02778204|459260549|FG002|Overall Study|Protocol Violation|1|||
127627952|NCT02778204|459260550|FG003|Overall Study|Protocol Violation|0|||
127627953|NCT02778204|459260547|FG000|Overall Study|Eligibility Violation|0|||
127627954|NCT02778204|459260548|FG001|Overall Study|Eligibility Violation|0|||
127627955|NCT02778204|459260549|FG002|Overall Study|Eligibility Violation|0|||
127627956|NCT02778204|459260550|FG003|Overall Study|Eligibility Violation|1|||
127627957|NCT00612313|459260567|FG000|Overall Study|Withdrawal by Subject|6|||
127627958|NCT00612313|459260568|FG001|Overall Study|Withdrawal by Subject|9|||
127627959|NCT00612313|459260567|FG000|Overall Study|Lost to Follow-up|11|||
127627960|NCT00612313|459260568|FG001|Overall Study|Lost to Follow-up|4|||
127627961|NCT01694706|459262625|FG000|Overall Study|Adverse Event|0|||
127627962|NCT01694706|459262626|FG001|Overall Study|Adverse Event|1|||
127627963|NCT01694706|459262627|FG002|Overall Study|Adverse Event|0|||
127627964|NCT01694706|459262625|FG000|Overall Study|other reason not defined above|1|||
127627965|NCT01694706|459262626|FG001|Overall Study|other reason not defined above|0|||
127627966|NCT01694706|459262627|FG002|Overall Study|other reason not defined above|0|||
127627967|NCT00530023|459262628|FG000|Overall Study|Withdrawal by Subject|0|||
127627968|NCT00530023|459262629|FG001|Overall Study|Withdrawal by Subject|1|||
127627969|NCT01172938|459262633|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
127627970|NCT01172938|459262634|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
127627971|NCT01172938|459262635|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
127627972|NCT01172938|459262636|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
127627973|NCT01172938|459262637|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
127627974|NCT01172938|459262638|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
127627975|NCT01172938|459262639|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
127627976|NCT01172938|459262640|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
127627977|NCT01172938|459262641|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
127627978|NCT01172938|459262633|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
127627979|NCT01172938|459262634|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
127627980|NCT01172938|459262635|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
127627981|NCT01172938|459262636|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
127627982|NCT01172938|459262637|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
127627983|NCT01172938|459262638|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
127627984|NCT01172938|459262639|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
127627985|NCT01172938|459262640|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
127627986|NCT01172938|459262641|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
127627987|NCT01172938|459262633|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
127627988|NCT01172938|459262634|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
127627989|NCT01172938|459262635|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
127627990|NCT01172938|459262636|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
127627991|NCT01172938|459262637|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
127627992|NCT01172938|459262638|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
127627993|NCT01172938|459262639|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
127627994|NCT01172938|459262640|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
127627995|NCT01172938|459262641|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
127701912|NCT04436276|459537098|FG002|Overall Study|Protocol Violation|0|||
127701913|NCT04436276|459537099|FG003|Overall Study|Protocol Violation|0|||
127701914|NCT04436276|459537100|FG004|Overall Study|Protocol Violation|0|||
127701915|NCT04436276|459537101|FG005|Overall Study|Protocol Violation|0|||
127701916|NCT04436276|459537102|FG006|Overall Study|Protocol Violation|0|||
127701917|NCT04436276|459537103|FG007|Overall Study|Protocol Violation|0|||
127701918|NCT04436276|459537104|FG008|Overall Study|Protocol Violation|0|||
127701919|NCT04436276|459537105|FG009|Overall Study|Protocol Violation|0|||
127701920|NCT04436276|459537106|FG010|Overall Study|Protocol Violation|0|||
127701921|NCT04436276|459537107|FG011|Overall Study|Protocol Violation|0|||
127701922|NCT04436276|459537108|FG012|Overall Study|Protocol Violation|0|||
127701923|NCT04436276|459537109|FG013|Overall Study|Protocol Violation|1|||
127701924|NCT04436276|459537110|FG014|Overall Study|Protocol Violation|0|||
127701925|NCT04436276|459537111|FG015|Overall Study|Protocol Violation|1|||
127701926|NCT04436276|459537112|FG016|Overall Study|Protocol Violation|0|||
127701927|NCT04436276|459537113|FG017|Overall Study|Protocol Violation|0|||
127701928|NCT04436276|459537114|FG018|Overall Study|Protocol Violation|0|||
127701929|NCT04436276|459537115|FG019|Overall Study|Protocol Violation|0|||
127627996|NCT01172938|459262633|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
127627997|NCT01172938|459262634|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
127627998|NCT01172938|459262635|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
127701930|NCT04436276|459537116|FG020|Overall Study|Protocol Violation|0|||
127701931|NCT04436276|459537117|FG021|Overall Study|Protocol Violation|0|||
127793111|NCT03016325|459867440|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
127793112|NCT03016325|459867441|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
127627999|NCT01172938|459262636|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
127701932|NCT04436276|459537118|FG022|Overall Study|Protocol Violation|0|||
127701933|NCT04436276|459537096|FG000|Overall Study|Withdrawal by Subject|25|||
127701934|NCT04436276|459537097|FG001|Overall Study|Withdrawal by Subject|22|||
127701935|NCT04436276|459537098|FG002|Overall Study|Withdrawal by Subject|24|||
127701936|NCT04436276|459537099|FG003|Overall Study|Withdrawal by Subject|23|||
127701937|NCT04436276|459537100|FG004|Overall Study|Withdrawal by Subject|14|||
127628000|NCT01172938|459262637|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
127628001|NCT01172938|459262638|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
127628002|NCT01172938|459262639|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
127628003|NCT01172938|459262640|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
127628004|NCT01172938|459262641|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
127628005|NCT01172938|459262633|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
127628006|NCT01172938|459262634|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
127628007|NCT01172938|459262635|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
127628008|NCT01172938|459262636|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
127628009|NCT01172938|459262637|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
127628010|NCT01172938|459262638|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
127628011|NCT01172938|459262639|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
127628012|NCT01172938|459262640|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
127628013|NCT01172938|459262641|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
127628014|NCT01172938|459262633|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
127628015|NCT01172938|459262634|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
127628016|NCT01172938|459262635|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
127628017|NCT01172938|459262636|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
127628018|NCT01172938|459262637|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
127628019|NCT01172938|459262638|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
127628020|NCT01172938|459262639|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
127628021|NCT01172938|459262640|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
127628022|NCT01172938|459262641|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
127628023|NCT01172938|459262633|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
127628024|NCT01172938|459262634|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
127628025|NCT01172938|459262635|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
127628026|NCT01172938|459262636|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
127628027|NCT01172938|459262637|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
127628028|NCT01172938|459262638|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
127628029|NCT01172938|459262639|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
127628030|NCT01172938|459262640|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
127628031|NCT01172938|459262641|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
127628032|NCT01172938|459262633|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
127628033|NCT01172938|459262634|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
127628034|NCT01172938|459262635|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
127628035|NCT01172938|459262636|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
127628036|NCT01172938|459262637|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
127628037|NCT01172938|459262638|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
127628038|NCT01172938|459262639|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
127628039|NCT01172938|459262640|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
127628040|NCT01172938|459262641|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
127628041|NCT01172938|459262633|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
127628042|NCT01172938|459262634|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
127628043|NCT01172938|459262635|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
127628044|NCT01172938|459262636|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
127628045|NCT01172938|459262637|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
127628046|NCT01172938|459262638|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
127628047|NCT01172938|459262639|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
127628048|NCT01172938|459262640|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
127628049|NCT01172938|459262641|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
127628050|NCT01172938|459262633|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
127628051|NCT01172938|459262634|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
127628052|NCT01172938|459262635|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
127628053|NCT01172938|459262636|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
127628054|NCT01172938|459262637|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
127628055|NCT01172938|459262638|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
127628056|NCT01172938|459262639|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
127628057|NCT01172938|459262640|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
127628058|NCT01172938|459262641|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
127628059|NCT01172938|459262633|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
127628060|NCT01172938|459262634|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
127628061|NCT01172938|459262635|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
127628062|NCT01172938|459262636|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
127628063|NCT01172938|459262637|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
127628064|NCT01172938|459262638|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
127628065|NCT01172938|459262639|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
127628066|NCT01172938|459262640|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
127628067|NCT01172938|459262641|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
127793113|NCT03016325|459867442|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
127701938|NCT04436276|459537101|FG005|Overall Study|Withdrawal by Subject|0|||
127701939|NCT04436276|459537102|FG006|Overall Study|Withdrawal by Subject|0|||
127701940|NCT04436276|459537103|FG007|Overall Study|Withdrawal by Subject|1|||
127701941|NCT04436276|459537104|FG008|Overall Study|Withdrawal by Subject|0|||
127701942|NCT04436276|459537105|FG009|Overall Study|Withdrawal by Subject|1|||
127701943|NCT04436276|459537106|FG010|Overall Study|Withdrawal by Subject|17|||
127701944|NCT04436276|459537107|FG011|Overall Study|Withdrawal by Subject|7|||
127701945|NCT04436276|459537108|FG012|Overall Study|Withdrawal by Subject|10|||
127701946|NCT04436276|459537109|FG013|Overall Study|Withdrawal by Subject|6|||
127628068|NCT01172938|459262633|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
127628069|NCT01172938|459262634|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
127628070|NCT01172938|459262635|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
127628071|NCT01172938|459262636|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
127628072|NCT01172938|459262637|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
127628073|NCT01172938|459262638|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
127628074|NCT01172938|459262639|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
127628075|NCT01172938|459262640|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
127628076|NCT01172938|459262641|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
127628077|NCT01172938|459262633|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
127701947|NCT04436276|459537110|FG014|Overall Study|Withdrawal by Subject|20|||
127701948|NCT04436276|459537111|FG015|Overall Study|Withdrawal by Subject|6|||
127701949|NCT04436276|459537112|FG016|Overall Study|Withdrawal by Subject|11|||
127701950|NCT04436276|459537113|FG017|Overall Study|Withdrawal by Subject|4|||
127701951|NCT04436276|459537114|FG018|Overall Study|Withdrawal by Subject|14|||
127701952|NCT04436276|459537115|FG019|Overall Study|Withdrawal by Subject|24|||
127701953|NCT04436276|459537116|FG020|Overall Study|Withdrawal by Subject|24|||
127701954|NCT04436276|459537117|FG021|Overall Study|Withdrawal by Subject|16|||
127701955|NCT04436276|459537118|FG022|Overall Study|Withdrawal by Subject|14|||
127701956|NCT04436276|459537096|FG000|Overall Study|Other|3|||
127701957|NCT04436276|459537097|FG001|Overall Study|Other|2|||
127701958|NCT04436276|459537098|FG002|Overall Study|Other|5|||
127701959|NCT04436276|459537099|FG003|Overall Study|Other|9|||
127701960|NCT04436276|459537100|FG004|Overall Study|Other|23|||
127701961|NCT04436276|459537101|FG005|Overall Study|Other|1|||
127701962|NCT04436276|459537102|FG006|Overall Study|Other|0|||
127701963|NCT04436276|459537103|FG007|Overall Study|Other|0|||
127701964|NCT04436276|459537104|FG008|Overall Study|Other|0|||
127701965|NCT04436276|459537105|FG009|Overall Study|Other|0|||
127701966|NCT04436276|459537106|FG010|Overall Study|Other|3|||
127701967|NCT04436276|459537107|FG011|Overall Study|Other|1|||
127701968|NCT04436276|459537108|FG012|Overall Study|Other|1|||
127701969|NCT04436276|459537109|FG013|Overall Study|Other|2|||
127701970|NCT04436276|459537110|FG014|Overall Study|Other|3|||
127701971|NCT04436276|459537111|FG015|Overall Study|Other|0|||
127701972|NCT04436276|459537112|FG016|Overall Study|Other|0|||
127701973|NCT04436276|459537113|FG017|Overall Study|Other|6|||
127628078|NCT01172938|459262634|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
127628079|NCT01172938|459262635|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
127701974|NCT04436276|459537114|FG018|Overall Study|Other|1|||
127701975|NCT04436276|459537115|FG019|Overall Study|Other|0|||
127701976|NCT04436276|459537116|FG020|Overall Study|Other|2|||
127701977|NCT04436276|459537117|FG021|Overall Study|Other|2|||
127701978|NCT04436276|459537118|FG022|Overall Study|Other|60|||
127628080|NCT01172938|459262636|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
127628081|NCT01172938|459262637|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
127701979|NCT05281562|459537119|FG000|Overall Study|Ineligible patient|1|||
127701980|NCT05281562|459537120|FG001|Overall Study|Ineligible patient|0|||
127701981|NCT05977530|459537122|FG000|Overall Study|Withdrawal by Subject|1|||
127701982|NCT05977530|459537122|FG000|Overall Study|injury unrelated to research participation. Unable to enter swimming pool to participate in protocol|1|||
127793114|NCT03016325|459867443|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
127701983|NCT04797897|459537129|FG000|Overall Study|Study Termination by Sponsor|1|||
127701984|NCT04797897|459537130|FG001|Overall Study|Study Termination by Sponsor|1|||
127701985|NCT03024437|459537135|FG000|Overall Study|Adverse Event|0|||
127701986|NCT03024437|459537136|FG001|Overall Study|Adverse Event|1|||
127793115|NCT03016325|459867444|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
127701987|NCT03024437|459537137|FG002|Overall Study|Adverse Event|3|||
127701988|NCT03024437|459537138|FG003|Overall Study|Adverse Event|5|||
127701989|NCT03024437|459537139|FG004|Overall Study|Adverse Event|0|||
127701990|NCT03024437|459537135|FG000|Overall Study|Physician Decision|1|||
127628082|NCT01172938|459262638|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
127628083|NCT01172938|459262639|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
127628084|NCT01172938|459262640|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
127628085|NCT01172938|459262641|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
127628086|NCT01172938|459262633|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
127628087|NCT01172938|459262634|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
127628088|NCT01172938|459262635|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
127628089|NCT01172938|459262636|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
127628090|NCT01172938|459262637|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
127628091|NCT01172938|459262638|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
127628092|NCT01172938|459262639|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
127628093|NCT01172938|459262640|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
127628094|NCT01172938|459262641|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
127628095|NCT01172938|459262633|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
127628096|NCT01172938|459262634|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
127628097|NCT01172938|459262635|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
127628098|NCT01172938|459262636|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
127628099|NCT01172938|459262637|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
127628100|NCT01172938|459262638|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
127628101|NCT01172938|459262639|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
127628102|NCT01172938|459262640|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
127628103|NCT01172938|459262641|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
127628104|NCT01172938|459262633|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
127628105|NCT01172938|459262634|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
127628106|NCT01172938|459262635|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
127628107|NCT01172938|459262636|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
127628108|NCT01172938|459262637|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
127628109|NCT01172938|459262638|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
127628110|NCT01172938|459262639|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
127628111|NCT01172938|459262640|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
127628112|NCT01172938|459262641|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
127628113|NCT01172938|459262633|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
127628114|NCT01172938|459262634|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
127628115|NCT01172938|459262635|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
127628116|NCT01172938|459262636|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
127628117|NCT01172938|459262637|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
127628118|NCT01172938|459262638|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
127628119|NCT01172938|459262639|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
127628120|NCT01172938|459262640|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
127628121|NCT01172938|459262641|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
127628122|NCT01172938|459262633|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
127628123|NCT01172938|459262634|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
127628124|NCT01172938|459262635|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
127628125|NCT01172938|459262636|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
127628126|NCT01172938|459262637|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
127628127|NCT01172938|459262638|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
127628128|NCT01172938|459262639|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
127628129|NCT01172938|459262640|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
127628130|NCT01172938|459262641|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
127628131|NCT01172938|459262633|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
127628132|NCT01172938|459262634|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
127628133|NCT01172938|459262635|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
127628134|NCT01172938|459262636|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
127628135|NCT01172938|459262637|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
127628136|NCT01172938|459262638|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
127628137|NCT01172938|459262639|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
127628138|NCT01172938|459262640|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
127628139|NCT01172938|459262641|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
127628140|NCT01172938|459262633|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
127628141|NCT01172938|459262634|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
127628142|NCT01172938|459262635|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
127628143|NCT01172938|459262636|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
127628144|NCT01172938|459262637|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
127628145|NCT01172938|459262638|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
127885237|NCT01749033|460203870|FG002|Overall Study|Did not receive allocated intervention|0|||
127885238|NCT01749033|460203868|FG000|Overall Study|Lost to Follow-up|0|||
127885239|NCT01749033|460203869|FG001|Overall Study|Lost to Follow-up|2|||
127885240|NCT01749033|460203870|FG002|Overall Study|Lost to Follow-up|1|||
127885241|NCT04380701|460203871|FG000|Overall Study|Pregnancy|0|||
127628146|NCT01172938|459262639|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
127628147|NCT01172938|459262640|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
127628148|NCT01172938|459262641|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
127628149|NCT01172938|459262633|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
127628150|NCT01172938|459262634|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
127628151|NCT01172938|459262635|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
127628152|NCT01172938|459262636|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
127628153|NCT01172938|459262637|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
127628154|NCT01172938|459262638|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
127628155|NCT01172938|459262639|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
127628156|NCT01172938|459262640|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
127628157|NCT01172938|459262641|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
127628158|NCT01172938|459262633|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
127628159|NCT01172938|459262634|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
127628160|NCT01172938|459262635|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
127628161|NCT01172938|459262636|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
127628162|NCT01172938|459262637|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
127628163|NCT01172938|459262638|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
127628164|NCT01172938|459262639|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
127628165|NCT01172938|459262640|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
127628166|NCT01172938|459262641|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
127628167|NCT01172938|459262633|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
127628168|NCT01172938|459262634|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
127628169|NCT01172938|459262635|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
127628170|NCT01172938|459262636|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
127628171|NCT01172938|459262637|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
127628172|NCT01172938|459262638|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
127628173|NCT01172938|459262639|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
127628174|NCT01172938|459262640|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
127628175|NCT01172938|459262641|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
127628176|NCT01172938|459262633|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
127628177|NCT01172938|459262634|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
127628178|NCT01172938|459262635|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
127628179|NCT01172938|459262636|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
127628180|NCT01172938|459262637|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
127628181|NCT01172938|459262638|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
127628182|NCT01172938|459262639|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
127628183|NCT01172938|459262640|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
127628184|NCT01172938|459262641|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
127628185|NCT01172938|459262633|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
127628186|NCT01172938|459262634|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
127628187|NCT01172938|459262635|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
127628188|NCT01172938|459262636|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
127628189|NCT01172938|459262637|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
127701991|NCT03024437|459537136|FG001|Overall Study|Physician Decision|0|||
127701992|NCT03024437|459537137|FG002|Overall Study|Physician Decision|0|||
127701993|NCT03024437|459537138|FG003|Overall Study|Physician Decision|1|||
127701994|NCT03024437|459537139|FG004|Overall Study|Physician Decision|0|||
127701995|NCT03024437|459537135|FG000|Overall Study|Disease progression, relapse|1|||
127701996|NCT03024437|459537136|FG001|Overall Study|Disease progression, relapse|0|||
127701997|NCT03024437|459537137|FG002|Overall Study|Disease progression, relapse|0|||
127701998|NCT03024437|459537138|FG003|Overall Study|Disease progression, relapse|3|||
127701999|NCT03024437|459537139|FG004|Overall Study|Disease progression, relapse|0|||
127702000|NCT03024437|459537135|FG000|Overall Study|Disease progression, refractory disease|4|||
127702001|NCT03024437|459537136|FG001|Overall Study|Disease progression, refractory disease|4|||
127702002|NCT03024437|459537137|FG002|Overall Study|Disease progression, refractory disease|2|||
127702003|NCT03024437|459537138|FG003|Overall Study|Disease progression, refractory disease|2|||
127702004|NCT03024437|459537139|FG004|Overall Study|Disease progression, refractory disease|1|||
127702005|NCT03024437|459537135|FG000|Overall Study|Newly diagnosed cancer|0|||
127702006|NCT03024437|459537136|FG001|Overall Study|Newly diagnosed cancer|0|||
127885242|NCT04380701|460203872|FG001|Overall Study|Pregnancy|0|||
127885243|NCT04380701|460203873|FG002|Overall Study|Pregnancy|0|||
127793116|NCT01902290|459867451|FG000|Overall Study|Withdrawal by Subject|19|||
127793117|NCT01902290|459867452|FG001|Overall Study|Withdrawal by Subject|27|||
127793118|NCT01902290|459867451|FG000|Overall Study|Lost to Follow-up|2|||
127793119|NCT01902290|459867452|FG001|Overall Study|Lost to Follow-up|2|||
127793120|NCT01902290|459867451|FG000|Overall Study|Death|1|||
127793121|NCT01902290|459867452|FG001|Overall Study|Death|0|||
127628190|NCT01172938|459262638|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
127628191|NCT01172938|459262639|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
127628192|NCT01172938|459262640|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
127628193|NCT01172938|459262641|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
127628194|NCT01172938|459262633|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
127628195|NCT01172938|459262634|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
127628196|NCT01172938|459262635|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
127628197|NCT01172938|459262636|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
127628198|NCT01172938|459262637|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
127628199|NCT01172938|459262638|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
127628200|NCT01172938|459262639|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
127628201|NCT01172938|459262640|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
127628202|NCT01172938|459262641|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
127628203|NCT01172938|459262633|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
127628204|NCT01172938|459262634|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
127628205|NCT01172938|459262635|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
127628206|NCT01172938|459262636|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
127628207|NCT01172938|459262637|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
127628208|NCT01172938|459262638|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
127628209|NCT01172938|459262639|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
127628210|NCT01172938|459262640|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
127628211|NCT01172938|459262641|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
127628212|NCT01172938|459262633|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
127628213|NCT01172938|459262634|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
127628214|NCT01172938|459262635|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
127628215|NCT01172938|459262636|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
127628216|NCT01172938|459262637|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
127628217|NCT01172938|459262638|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
127628218|NCT01172938|459262639|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
127628219|NCT01172938|459262640|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
127628220|NCT01172938|459262641|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
127628221|NCT01172938|459262633|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
127628222|NCT01172938|459262634|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
127628223|NCT01172938|459262635|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
127628224|NCT01172938|459262636|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
127628225|NCT01172938|459262637|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
127628226|NCT01172938|459262638|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
127628227|NCT01172938|459262639|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
127628228|NCT01172938|459262640|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
127628229|NCT01172938|459262641|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
127628230|NCT01172938|459262633|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
127628231|NCT01172938|459262634|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
127628232|NCT01172938|459262635|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
127628233|NCT01172938|459262636|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
127628234|NCT01172938|459262637|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
127628235|NCT01172938|459262638|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
127628236|NCT01172938|459262639|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
127628237|NCT01172938|459262640|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
127628238|NCT01172938|459262641|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
127628239|NCT01172938|459262633|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
127628240|NCT01172938|459262634|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
127628241|NCT01172938|459262635|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
127628242|NCT01172938|459262636|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
127628243|NCT01172938|459262637|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
127793122|NCT01902290|459867451|FG000|Overall Study|Sponsor Decision|26|||
127793123|NCT01902290|459867452|FG001|Overall Study|Sponsor Decision|24|||
127793124|NCT02250274|459867454|FG000|Overall Study|Insufficient blood draw amount|7|||
127793125|NCT02250274|459867455|FG001|Overall Study|Insufficient blood draw amount|6|||
127885244|NCT04380701|460203874|FG003|Overall Study|Pregnancy|0|||
127885245|NCT04380701|460203875|FG004|Overall Study|Pregnancy|0|||
127885246|NCT04380701|460203876|FG005|Overall Study|Pregnancy|0|||
127885247|NCT04380701|460203877|FG006|Overall Study|Pregnancy|0|||
127793126|NCT01277549|459867456|FG000|Overall Study|Failed to meet eligibility criteria|13|||
127793127|NCT01277549|459867457|FG001|Overall Study|Failed to meet eligibility criteria|9|||
127628244|NCT01172938|459262638|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
127628245|NCT01172938|459262639|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
127628246|NCT01172938|459262640|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
127628247|NCT01172938|459262641|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
127628248|NCT01172938|459262633|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
127628249|NCT01172938|459262634|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
127628250|NCT01172938|459262635|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
127628251|NCT01172938|459262636|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
127628252|NCT01172938|459262637|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
127628253|NCT01172938|459262638|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
127628254|NCT01172938|459262639|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
127628255|NCT01172938|459262640|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
127628256|NCT01172938|459262641|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
127628257|NCT01172938|459262633|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
127628258|NCT01172938|459262634|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
127628259|NCT01172938|459262635|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
127628260|NCT01172938|459262636|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
127628261|NCT01172938|459262637|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
127628262|NCT01172938|459262638|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
127628263|NCT01172938|459262639|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
127628264|NCT01172938|459262640|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
127628265|NCT01172938|459262641|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
127628266|NCT01172938|459262633|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
127628267|NCT01172938|459262634|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
127628268|NCT01172938|459262635|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
127628269|NCT01172938|459262636|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
127628270|NCT01172938|459262637|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
127628271|NCT01172938|459262638|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
127628272|NCT01172938|459262639|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
127628273|NCT01172938|459262640|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
127628274|NCT01172938|459262641|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
127628275|NCT01172938|459262633|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
127628276|NCT01172938|459262634|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
127628277|NCT01172938|459262635|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
127628278|NCT01172938|459262636|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
127628279|NCT01172938|459262637|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
127628280|NCT01172938|459262638|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
127628281|NCT01172938|459262639|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
127628282|NCT01172938|459262640|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
127628283|NCT01172938|459262641|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
127628284|NCT01172938|459262633|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
127628285|NCT01172938|459262634|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
127628286|NCT01172938|459262635|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
127628287|NCT01172938|459262636|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
127628288|NCT01172938|459262637|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
127628289|NCT01172938|459262638|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
127628290|NCT01172938|459262639|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
127628291|NCT01172938|459262640|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
127628292|NCT01172938|459262641|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
127628293|NCT01172938|459262633|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
127628294|NCT01172938|459262634|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
127628295|NCT01172938|459262635|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
127793128|NCT01277549|459867456|FG000|Overall Study|Withdrawal by Subject|1|||
127793129|NCT01277549|459867457|FG001|Overall Study|Withdrawal by Subject|3|||
127793130|NCT01277549|459867456|FG000|Overall Study|Protocol Violation|10|||
127793131|NCT01277549|459867457|FG001|Overall Study|Protocol Violation|1|||
127793132|NCT01277549|459867456|FG000|Overall Study|Physician Decision|2|||
127628296|NCT01172938|459262636|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
127793133|NCT01277549|459867457|FG001|Overall Study|Physician Decision|1|||
127793134|NCT00446511|459867458|FG000|Overall Study|Adverse Event|7|||
127793135|NCT00446511|459867459|FG001|Overall Study|Adverse Event|2|||
127793136|NCT00446511|459867460|FG002|Overall Study|Adverse Event|3|||
127793137|NCT00446511|459867461|FG003|Overall Study|Adverse Event|1|||
127793138|NCT00446511|459867458|FG000|Overall Study|Protocol Violation|0|||
127793139|NCT00446511|459867459|FG001|Overall Study|Protocol Violation|0|||
127793140|NCT00446511|459867460|FG002|Overall Study|Protocol Violation|0|||
127793141|NCT00446511|459867461|FG003|Overall Study|Protocol Violation|1|||
127793142|NCT00446511|459867458|FG000|Overall Study|Withdrawal by Subject|0|||
127793143|NCT00446511|459867459|FG001|Overall Study|Withdrawal by Subject|0|||
127793144|NCT00446511|459867460|FG002|Overall Study|Withdrawal by Subject|0|||
127793145|NCT00446511|459867461|FG003|Overall Study|Withdrawal by Subject|3|||
127793146|NCT00446511|459867458|FG000|Overall Study|Administrative Problems|3|||
127793147|NCT00446511|459867459|FG001|Overall Study|Administrative Problems|0|||
127793148|NCT00446511|459867460|FG002|Overall Study|Administrative Problems|4|||
127793149|NCT00446511|459867461|FG003|Overall Study|Administrative Problems|1|||
127793150|NCT01618214|459867462|FG000|Overall Study|Adverse Event|3|||
127793151|NCT01618214|459867463|FG001|Overall Study|Adverse Event|1|||
127793152|NCT01618214|459867462|FG000|Overall Study|Lack of Efficacy|1|||
127793153|NCT01618214|459867463|FG001|Overall Study|Lack of Efficacy|1|||
127793154|NCT01618214|459867462|FG000|Overall Study|Protocol Violation|1|||
127793155|NCT01618214|459867463|FG001|Overall Study|Protocol Violation|4|||
127793156|NCT01618214|459867462|FG000|Overall Study|Withdrawal Criteria|1|||
127793157|NCT01618214|459867463|FG001|Overall Study|Withdrawal Criteria|2|||
127793158|NCT01618214|459867462|FG000|Overall Study|Unclassified|4|||
127628297|NCT01172938|459262637|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
127628298|NCT01172938|459262638|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
127628299|NCT01172938|459262639|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
127628300|NCT01172938|459262640|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
127628301|NCT01172938|459262641|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
127628302|NCT01172938|459262633|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
127628303|NCT01172938|459262634|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
127628304|NCT01172938|459262635|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
127628305|NCT01172938|459262636|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
127628306|NCT01172938|459262637|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
127628307|NCT01172938|459262638|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
127628308|NCT01172938|459262639|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
127628309|NCT01172938|459262640|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
127628310|NCT01172938|459262641|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
127628311|NCT01172938|459262633|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
127628312|NCT01172938|459262634|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
127628313|NCT01172938|459262635|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
127628314|NCT01172938|459262636|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
127628315|NCT01172938|459262637|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
127628316|NCT01172938|459262638|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
127628317|NCT01172938|459262639|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
127628318|NCT01172938|459262640|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
127628319|NCT01172938|459262641|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
127628320|NCT00003498|459262642|FG000|Overall Study|Not evaluable.|4|||
127628321|NCT05282004|459262646|FG000|Overall Study|Adverse Event|2|||
127628322|NCT03525834|459262647|FG000|Overall Study|Progressive disease|1|||
127628323|NCT02443298|459262648|FG000|Overall Study|Adverse Event|3|||
127628324|NCT02443298|459262649|FG001|Overall Study|Adverse Event|3|||
127628325|NCT02443298|459262648|FG000|Overall Study|Withdrawal by Subject|1|||
127628326|NCT02443298|459262649|FG001|Overall Study|Withdrawal by Subject|2|||
127628327|NCT03586999|459262650|FG000|Overall Study|Lack of Efficacy|2|||
127628328|NCT02464969|459262651|FG000|Main Phase (Day 1 to Day 84)|Adverse Event|7|||
127628329|NCT02464969|459262652|FG001|Main Phase (Day 1 to Day 84)|Adverse Event|0|||
127628330|NCT02464969|459262651|FG000|Main Phase (Day 1 to Day 84)|Death|1|||
127793159|NCT01618214|459867463|FG001|Overall Study|Unclassified|5|||
127793160|NCT04703075|459867467|FG000|Overall Study|Adverse Event|11|||
127793161|NCT04703075|459867468|FG001|Overall Study|Adverse Event|7|||
127793162|NCT04703075|459867467|FG000|Overall Study|Lost to Follow-up|6|||
127628331|NCT02464969|459262652|FG001|Main Phase (Day 1 to Day 84)|Death|1|||
127628332|NCT02464969|459262651|FG000|Main Phase (Day 1 to Day 84)|Lost to Follow-up|3|||
127628333|NCT02464969|459262652|FG001|Main Phase (Day 1 to Day 84)|Lost to Follow-up|0|||
127628334|NCT02464969|459262651|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|0|||
127628335|NCT02464969|459262652|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|4|||
127628336|NCT02464969|459262651|FG000|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|0|||
127628337|NCT02464969|459262652|FG001|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|1|||
127793163|NCT04703075|459867468|FG001|Overall Study|Lost to Follow-up|12|||
127628338|NCT02464969|459262651|FG000|Main Phase (Day 1 to Day 84)|Other Reasons|4|||
127793164|NCT04703075|459867467|FG000|Overall Study|Physician Decision|3|||
127793165|NCT04703075|459867468|FG001|Overall Study|Physician Decision|0|||
127793166|NCT04703075|459867467|FG000|Overall Study|Moved|0|||
127793167|NCT04703075|459867468|FG001|Overall Study|Moved|2|||
127793168|NCT04703075|459867467|FG000|Overall Study|Index INH Resistant|0|||
127793169|NCT04703075|459867468|FG001|Overall Study|Index INH Resistant|1|||
127628339|NCT02464969|459262652|FG001|Main Phase (Day 1 to Day 84)|Other Reasons|2|||
127628340|NCT02464969|459262651|FG000|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
127628341|NCT02464969|459262652|FG001|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
127628342|NCT02464969|459262651|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|1|||
127628343|NCT02464969|459262652|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|0|||
127628344|NCT02464969|459262651|FG000|Extension Phase (Day 85 to Day 168)|Adverse Event|1|||
127628345|NCT02464969|459262652|FG001|Extension Phase (Day 85 to Day 168)|Adverse Event|0|||
127628346|NCT02464969|459262651|FG000|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|1|||
127628347|NCT02464969|459262652|FG001|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|0|||
127628348|NCT02464969|459262651|FG000|Extension Phase (Day 85 to Day 168)|Other Reasons|1|||
127628349|NCT02464969|459262652|FG001|Extension Phase (Day 85 to Day 168)|Other Reasons|0|||
127628350|NCT02399085|459262657|FG000|Overall Study|Adverse Event|16|||
127628351|NCT02399085|459262657|FG000|Overall Study|Death|2|||
127628352|NCT02399085|459262657|FG000|Overall Study|Withdrawal by Subject|8|||
127628353|NCT02399085|459262657|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
127628354|NCT02399085|459262657|FG000|Overall Study|Physician Decision|5|||
127628355|NCT00833924|459262658|FG000|Overall Study|Death|21|||
127628356|NCT00833924|459262658|FG000|Overall Study|Conversion|2|||
127628357|NCT00833924|459262658|FG000|Overall Study|Lost to Follow-up|2|||
127628358|NCT00833924|459262658|FG000|Overall Study|Withdrawal by Subject|13|||
127628359|NCT00833924|459262658|FG000|Overall Study|In study follow-up|71|||
127628360|NCT01485861|459262659|FG000|Phase Ib|Death|1|||
127628361|NCT01485861|459262660|FG001|Phase Ib|Death|0|||
127628362|NCT01485861|459262661|FG002|Phase Ib|Death|0|||
127628363|NCT01485861|459262662|FG003|Phase Ib|Death|0|||
127628364|NCT01485861|459262663|FG004|Phase Ib|Death|0|||
127628365|NCT01485861|459262664|FG005|Phase Ib|Death|0|||
127628366|NCT01485861|459262659|FG000|Phase Ib|Physician Decision|1|||
127628367|NCT01485861|459262660|FG001|Phase Ib|Physician Decision|1|||
127628368|NCT01485861|459262661|FG002|Phase Ib|Physician Decision|0|||
127628369|NCT01485861|459262662|FG003|Phase Ib|Physician Decision|0|||
127628370|NCT01485861|459262663|FG004|Phase Ib|Physician Decision|0|||
127628371|NCT01485861|459262664|FG005|Phase Ib|Physician Decision|0|||
127628372|NCT01485861|459262659|FG000|Phase Ib|Adverse Event|0|||
127628373|NCT01485861|459262660|FG001|Phase Ib|Adverse Event|4|||
127628374|NCT01485861|459262661|FG002|Phase Ib|Adverse Event|0|||
127628375|NCT01485861|459262662|FG003|Phase Ib|Adverse Event|0|||
127628376|NCT01485861|459262663|FG004|Phase Ib|Adverse Event|0|||
127628377|NCT01485861|459262664|FG005|Phase Ib|Adverse Event|0|||
127628378|NCT01485861|459262659|FG000|Phase Ib|Progression of disease|5|||
127628379|NCT01485861|459262660|FG001|Phase Ib|Progression of disease|0|||
127628380|NCT01485861|459262661|FG002|Phase Ib|Progression of disease|0|||
127628381|NCT01485861|459262662|FG003|Phase Ib|Progression of disease|0|||
127628382|NCT01485861|459262663|FG004|Phase Ib|Progression of disease|0|||
127628383|NCT01485861|459262664|FG005|Phase Ib|Progression of disease|0|||
127628384|NCT01485861|459262659|FG000|Phase Ib|Other|3|||
127628385|NCT01485861|459262660|FG001|Phase Ib|Other|0|||
127628386|NCT01485861|459262661|FG002|Phase Ib|Other|0|||
127628387|NCT01485861|459262662|FG003|Phase Ib|Other|0|||
127628388|NCT01485861|459262663|FG004|Phase Ib|Other|0|||
127628389|NCT01485861|459262664|FG005|Phase Ib|Other|0|||
127628390|NCT01485861|459262659|FG000|Phase Ib|Withdrawal by Subject|4|||
127628391|NCT01485861|459262660|FG001|Phase Ib|Withdrawal by Subject|1|||
127628392|NCT01485861|459262661|FG002|Phase Ib|Withdrawal by Subject|0|||
127628393|NCT01485861|459262662|FG003|Phase Ib|Withdrawal by Subject|0|||
127628394|NCT01485861|459262663|FG004|Phase Ib|Withdrawal by Subject|0|||
127628395|NCT01485861|459262664|FG005|Phase Ib|Withdrawal by Subject|0|||
127628396|NCT01485861|459262659|FG000|Phase II|Death|0|||
127628397|NCT01485861|459262660|FG001|Phase II|Death|0|||
127628398|NCT01485861|459262661|FG002|Phase II|Death|67|||
127628399|NCT01485861|459262662|FG003|Phase II|Death|71|||
127793170|NCT04703075|459867467|FG000|Overall Study|Lack of Efficacy|6|||
127628400|NCT01485861|459262663|FG004|Phase II|Death|68|||
127793171|NCT04703075|459867468|FG001|Overall Study|Lack of Efficacy|18|||
127793172|NCT01508702|459867470|FG000|Overall Study|Adverse Event|7|||
127793173|NCT01508702|459867471|FG001|Overall Study|Adverse Event|3|||
127628401|NCT01485861|459262664|FG005|Phase II|Death|0|||
127628402|NCT01485861|459262659|FG000|Phase II|Progression of Disease|0|||
127628403|NCT01485861|459262660|FG001|Phase II|Progression of Disease|0|||
127628404|NCT01485861|459262661|FG002|Phase II|Progression of Disease|1|||
127793174|NCT01508702|459867470|FG000|Overall Study|Gout flare|2|||
127628405|NCT01485861|459262662|FG003|Phase II|Progression of Disease|0|||
127628406|NCT01485861|459262663|FG004|Phase II|Progression of Disease|0|||
127628407|NCT01485861|459262664|FG005|Phase II|Progression of Disease|0|||
127628408|NCT01485861|459262659|FG000|Phase II|Other|0|||
127628409|NCT01485861|459262660|FG001|Phase II|Other|0|||
127628410|NCT01485861|459262661|FG002|Phase II|Other|0|||
127628411|NCT01485861|459262662|FG003|Phase II|Other|1|||
127628412|NCT01485861|459262663|FG004|Phase II|Other|0|||
127628413|NCT01485861|459262664|FG005|Phase II|Other|0|||
127628414|NCT01485861|459262659|FG000|Phase II|Withdrawal by Subject|0|||
127628415|NCT01485861|459262660|FG001|Phase II|Withdrawal by Subject|0|||
127793175|NCT01508702|459867471|FG001|Overall Study|Gout flare|0|||
127628416|NCT01485861|459262661|FG002|Phase II|Withdrawal by Subject|6|||
127628417|NCT01485861|459262662|FG003|Phase II|Withdrawal by Subject|3|||
127628418|NCT01485861|459262663|FG004|Phase II|Withdrawal by Subject|4|||
127628419|NCT01485861|459262664|FG005|Phase II|Withdrawal by Subject|0|||
127628420|NCT01485861|459262659|FG000|Phase II|Lost to Follow-up|0|||
127628421|NCT01485861|459262660|FG001|Phase II|Lost to Follow-up|0|||
127628422|NCT01485861|459262661|FG002|Phase II|Lost to Follow-up|2|||
127628423|NCT01485861|459262662|FG003|Phase II|Lost to Follow-up|3|||
127628424|NCT01485861|459262663|FG004|Phase II|Lost to Follow-up|5|||
127628425|NCT01485861|459262664|FG005|Phase II|Lost to Follow-up|0|||
127628426|NCT01485861|459262659|FG000|Phase II|Study Ended|0|||
127628427|NCT01485861|459262660|FG001|Phase II|Study Ended|0|||
127628428|NCT01485861|459262661|FG002|Phase II|Study Ended|7|||
127628429|NCT01485861|459262662|FG003|Phase II|Study Ended|8|||
127628430|NCT01485861|459262663|FG004|Phase II|Study Ended|6|||
127628431|NCT01485861|459262664|FG005|Phase II|Study Ended|0|||
127628432|NCT01485861|459262659|FG000|Safety Phase|Death|0|||
127628433|NCT01485861|459262660|FG001|Safety Phase|Death|0|||
127628434|NCT01485861|459262661|FG002|Safety Phase|Death|0|||
127628435|NCT01485861|459262662|FG003|Safety Phase|Death|0|||
127628436|NCT01485861|459262663|FG004|Safety Phase|Death|0|||
127628437|NCT01485861|459262664|FG005|Safety Phase|Death|2|||
127628438|NCT01485861|459262659|FG000|Safety Phase|Adverse Event|0|||
127628439|NCT01485861|459262660|FG001|Safety Phase|Adverse Event|0|||
127628440|NCT01485861|459262661|FG002|Safety Phase|Adverse Event|0|||
127628441|NCT01485861|459262662|FG003|Safety Phase|Adverse Event|0|||
127628442|NCT01485861|459262663|FG004|Safety Phase|Adverse Event|0|||
127628443|NCT01485861|459262664|FG005|Safety Phase|Adverse Event|1|||
127628444|NCT01485861|459262659|FG000|Safety Phase|Other|0|||
127628445|NCT01485861|459262660|FG001|Safety Phase|Other|0|||
127628446|NCT01485861|459262661|FG002|Safety Phase|Other|0|||
127628447|NCT01485861|459262662|FG003|Safety Phase|Other|0|||
127628448|NCT01485861|459262663|FG004|Safety Phase|Other|0|||
127628449|NCT01485861|459262664|FG005|Safety Phase|Other|5|||
127628450|NCT01485861|459262659|FG000|Safety Phase|Progression of Disease|0|||
127628451|NCT01485861|459262660|FG001|Safety Phase|Progression of Disease|0|||
127628452|NCT01485861|459262661|FG002|Safety Phase|Progression of Disease|0|||
127628453|NCT01485861|459262662|FG003|Safety Phase|Progression of Disease|0|||
127628454|NCT01485861|459262663|FG004|Safety Phase|Progression of Disease|0|||
127628455|NCT01485861|459262664|FG005|Safety Phase|Progression of Disease|9|||
127628456|NCT01485861|459262659|FG000|Safety Phase|Withdrawal by Subject|0|||
127628457|NCT01485861|459262660|FG001|Safety Phase|Withdrawal by Subject|0|||
127628458|NCT01485861|459262661|FG002|Safety Phase|Withdrawal by Subject|0|||
127628459|NCT01485861|459262662|FG003|Safety Phase|Withdrawal by Subject|0|||
127628460|NCT01485861|459262663|FG004|Safety Phase|Withdrawal by Subject|0|||
127628461|NCT01485861|459262664|FG005|Safety Phase|Withdrawal by Subject|6|||
127628462|NCT01485861|459262659|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
127628463|NCT01485861|459262660|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
127628464|NCT01485861|459262661|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
127628465|NCT01485861|459262662|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
127628466|NCT01485861|459262663|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
127628467|NCT01485861|459262664|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
127628468|NCT01410110|459262665|FG000|Overall Study|Withdrawal by Subject|4|||
127628469|NCT01410110|459262666|FG001|Overall Study|Withdrawal by Subject|2|||
127628470|NCT03653429|459262667|FG000|Overall Study|Physician Decision|4|||
127628471|NCT03653429|459262668|FG001|Overall Study|Physician Decision|10|||
127628472|NCT01525082|459262676|FG000|Overall Study|Death|1|||
127628473|NCT02480621|459262677|FG000|Randomization|Withdrawal by Subject|1|||
127628474|NCT02480621|459262678|FG001|Randomization|Withdrawal by Subject|0|||
127628475|NCT02480621|459262677|FG000|Randomization|Surgeon did not give intervention|0|||
127628476|NCT02480621|459262678|FG001|Randomization|Surgeon did not give intervention|1|||
127628477|NCT02480621|459262677|FG000|Follow Up|Lost to Follow-up|4|||
127628478|NCT02480621|459262678|FG001|Follow Up|Lost to Follow-up|2|||
127628479|NCT03056690|459262682|FG000|Overall Study|Adverse Event|3|||
127628480|NCT03056690|459262683|FG001|Overall Study|Adverse Event|2|||
127628481|NCT03056690|459262682|FG000|Overall Study|Lack of Efficacy|1|||
127628482|NCT03056690|459262683|FG001|Overall Study|Lack of Efficacy|2|||
127628483|NCT03056690|459262682|FG000|Overall Study|Lost to Follow-up|3|||
127793176|NCT01508702|459867470|FG000|Overall Study|Protocol Violation|2|||
127793177|NCT01508702|459867471|FG001|Overall Study|Protocol Violation|1|||
127793178|NCT01508702|459867470|FG000|Overall Study|Lost to Follow-up|1|||
127628484|NCT03056690|459262683|FG001|Overall Study|Lost to Follow-up|2|||
127628485|NCT03056690|459262682|FG000|Overall Study|Protocol Violation|2|||
127628486|NCT03056690|459262683|FG001|Overall Study|Protocol Violation|2|||
127628487|NCT03056690|459262682|FG000|Overall Study|Withdrawal by Subject|3|||
127628488|NCT03056690|459262683|FG001|Overall Study|Withdrawal by Subject|6|||
127628489|NCT03056690|459262682|FG000|Overall Study|Non-compliance with Study Drug|1|||
127628490|NCT03056690|459262683|FG001|Overall Study|Non-compliance with Study Drug|0|||
127628491|NCT03056690|459262682|FG000|Overall Study|Miscellaneous|1|||
127628492|NCT03056690|459262683|FG001|Overall Study|Miscellaneous|2|||
127628493|NCT02543346|459262686|FG000|Second Priming Visit|Withdrawal by Subject|0|||
127628494|NCT02543346|459262687|FG001|Second Priming Visit|Withdrawal by Subject|2|||
127628495|NCT02543346|459262688|FG002|Second Priming Visit|Withdrawal by Subject|2|||
127628496|NCT02543346|459262689|FG003|Second Priming Visit|Withdrawal by Subject|2|||
127628497|NCT02543346|459262686|FG000|Second Priming Visit|Adverse Event|1|||
127628498|NCT02543346|459262687|FG001|Second Priming Visit|Adverse Event|0|||
127628499|NCT02543346|459262688|FG002|Second Priming Visit|Adverse Event|0|||
127628500|NCT02543346|459262689|FG003|Second Priming Visit|Adverse Event|0|||
127628501|NCT01767116|459262690|FG000|Overall Study|Lost to Follow-up|2|||
127628502|NCT01767116|459262691|FG001|Overall Study|Lost to Follow-up|2|||
127628503|NCT02141516|459262696|FG000|Overall Study|Adverse Event|0|||
127628504|NCT02141516|459262697|FG001|Overall Study|Adverse Event|1|||
127628505|NCT02141516|459262698|FG002|Overall Study|Adverse Event|0|||
127628506|NCT02141516|459262696|FG000|Overall Study|Lost to Follow-up|0|||
127628507|NCT02141516|459262697|FG001|Overall Study|Lost to Follow-up|1|||
127628508|NCT02141516|459262698|FG002|Overall Study|Lost to Follow-up|0|||
127628509|NCT02141516|459262696|FG000|Overall Study|Other|0|||
127628510|NCT02141516|459262697|FG001|Overall Study|Other|3|||
127628511|NCT02141516|459262698|FG002|Overall Study|Other|0|||
127628512|NCT01975389|459262699|FG000|Overall Study|Adverse Event|10|||
127628513|NCT01975389|459262700|FG001|Overall Study|Adverse Event|6|||
127628514|NCT01975389|459262699|FG000|Overall Study|Death|61|||
127628515|NCT01975389|459262700|FG001|Overall Study|Death|54|||
127628516|NCT01975389|459262699|FG000|Overall Study|Lost to Follow-up|81|||
127628517|NCT01975389|459262700|FG001|Overall Study|Lost to Follow-up|86|||
127628518|NCT01975389|459262699|FG000|Overall Study|Withdrawal by Subject|90|||
127628519|NCT01975389|459262700|FG001|Overall Study|Withdrawal by Subject|76|||
127628520|NCT01975389|459262699|FG000|Overall Study|Other|6|||
127628521|NCT01975389|459262700|FG001|Overall Study|Other|9|||
127628522|NCT01975389|459262699|FG000|Overall Study|Randomized, not treated|4|||
127628523|NCT01975389|459262700|FG001|Overall Study|Randomized, not treated|5|||
127628524|NCT01072201|459262705|FG000|Overall Study|Lost to Follow-up|0|||
127628525|NCT01072201|459262706|FG001|Overall Study|Lost to Follow-up|1|||
127628526|NCT02052466|459262707|FG000|Overall Study|Withdrawal by Subject|1|||
127628527|NCT02052466|459262707|FG000|Overall Study|Acromial fracture|1|||
127628528|NCT00360334|459262708|FG000|Overall Study|Adverse Event|7|||
127628529|NCT00360334|459262709|FG001|Overall Study|Adverse Event|4|||
127628530|NCT00360334|459262708|FG000|Overall Study|Protocol Violation|1|||
127628531|NCT00360334|459262709|FG001|Overall Study|Protocol Violation|1|||
127628532|NCT00360334|459262708|FG000|Overall Study|Physician Decision|2|||
127628533|NCT00360334|459262709|FG001|Overall Study|Physician Decision|3|||
127628534|NCT00360334|459262708|FG000|Overall Study|Lack of Efficacy|0|||
127628535|NCT00360334|459262709|FG001|Overall Study|Lack of Efficacy|1|||
127628536|NCT00360334|459262708|FG000|Overall Study|Entry criterion not met|1|||
127628537|NCT00360334|459262709|FG001|Overall Study|Entry criterion not met|2|||
127628538|NCT00360334|459262708|FG000|Overall Study|Subject decision|8|||
127628539|NCT00360334|459262709|FG001|Overall Study|Subject decision|2|||
127628540|NCT00595582|459262710|FG000|Overall Study|Pilot study that PI terminated|2|||
127628541|NCT00595582|459262710|FG000|Overall Study|Lost to Follow-up|1|||
127628542|NCT00595582|459262710|FG000|Overall Study|Adverse Event|2|||
127628543|NCT00595582|459262710|FG000|Overall Study|Physician Decision|5|||
127628544|NCT01978184|459262711|FG000|Overall Study|Progressive disease|5|||
127628545|NCT01978184|459262712|FG001|Overall Study|Progressive disease|5|||
127628546|NCT01978184|459262711|FG000|Overall Study|Other than PDA|2|||
127628547|NCT01978184|459262712|FG001|Overall Study|Other than PDA|2|||
127628548|NCT01978184|459262711|FG000|Overall Study|Physician Decision|0|||
127628549|NCT01978184|459262712|FG001|Overall Study|Physician Decision|3|||
127628550|NCT01978184|459262711|FG000|Overall Study|Noncompliance|1|||
127628551|NCT01978184|459262712|FG001|Overall Study|Noncompliance|2|||
127702007|NCT03024437|459537137|FG002|Overall Study|Newly diagnosed cancer|0|||
127702008|NCT03024437|459537138|FG003|Overall Study|Newly diagnosed cancer|1|||
127702009|NCT03024437|459537139|FG004|Overall Study|Newly diagnosed cancer|0|||
127702010|NCT03024437|459537135|FG000|Overall Study|Moved out of state|0|||
127702011|NCT03024437|459537136|FG001|Overall Study|Moved out of state|1|||
127702012|NCT03024437|459537137|FG002|Overall Study|Moved out of state|0|||
127702013|NCT03024437|459537138|FG003|Overall Study|Moved out of state|0|||
127702014|NCT03024437|459537139|FG004|Overall Study|Moved out of state|0|||
127702015|NCT03024437|459537135|FG000|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
127702016|NCT03024437|459537136|FG001|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
127628552|NCT01978184|459262711|FG000|Overall Study|Death|1|||
127628553|NCT01978184|459262712|FG001|Overall Study|Death|0|||
127628554|NCT01978184|459262711|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
127628555|NCT01978184|459262712|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
127628556|NCT00965848|459262717|FG000|Overall Study|Protocol Violation|3|||
127628557|NCT00965848|459262718|FG001|Overall Study|Protocol Violation|0|||
127628558|NCT00965848|459262719|FG002|Overall Study|Protocol Violation|1|||
127628559|NCT00965848|459262717|FG000|Overall Study|Death|11|||
127705267|NCT01928394|459551578|FG011|Follow-up Period|Death|12|||
127793179|NCT01508702|459867471|FG001|Overall Study|Lost to Follow-up|2|||
127793180|NCT01508702|459867470|FG000|Overall Study|Withdrawal by Subject|11|||
127628560|NCT00965848|459262718|FG001|Overall Study|Death|1|||
127628561|NCT00965848|459262719|FG002|Overall Study|Death|5|||
127628562|NCT00965848|459262717|FG000|Overall Study|Lost to Follow-up|0|||
127628563|NCT00965848|459262718|FG001|Overall Study|Lost to Follow-up|0|||
127628564|NCT00965848|459262719|FG002|Overall Study|Lost to Follow-up|1|||
127628565|NCT00965848|459262717|FG000|Overall Study|Withdrawal by Subject|1|||
127628566|NCT00965848|459262718|FG001|Overall Study|Withdrawal by Subject|0|||
127628567|NCT00965848|459262719|FG002|Overall Study|Withdrawal by Subject|0|||
127628568|NCT00965848|459262717|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
127628569|NCT00965848|459262718|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
127628570|NCT00965848|459262719|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
127628571|NCT00965848|459262717|FG000|Overall Study|Not Clinically Evaluable|7|||
127628572|NCT00965848|459262718|FG001|Overall Study|Not Clinically Evaluable|1|||
127628573|NCT00965848|459262719|FG002|Overall Study|Not Clinically Evaluable|1|||
127628574|NCT00965848|459262717|FG000|Overall Study|Other|5|||
127628575|NCT00965848|459262718|FG001|Overall Study|Other|0|||
127628576|NCT00965848|459262719|FG002|Overall Study|Other|1|||
127628577|NCT01328002|459262720|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
127628578|NCT01328002|459262721|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
127628579|NCT01328002|459262720|FG000|Open-Label Period|Adverse Event|8|||
127628580|NCT01328002|459262721|FG001|Open-Label Period|Adverse Event|0|||
127628581|NCT01328002|459262720|FG000|Open-Label Period|Lack of Efficacy|3|||
127628582|NCT01328002|459262721|FG001|Open-Label Period|Lack of Efficacy|0|||
127628583|NCT01328002|459262720|FG000|Open-Label Period|Protocol Violation|2|||
127628584|NCT01328002|459262721|FG001|Open-Label Period|Protocol Violation|0|||
127628585|NCT01328002|459262720|FG000|Open-Label Period|Withdrawal by Subject|9|||
127628586|NCT01328002|459262721|FG001|Open-Label Period|Withdrawal by Subject|0|||
127628587|NCT01328002|459262720|FG000|Open-Label Period|Lost to Follow-up|6|||
127628588|NCT01328002|459262721|FG001|Open-Label Period|Lost to Follow-up|0|||
127628589|NCT01328002|459262720|FG000|Open-Label Period|Other Reason|2|||
127628590|NCT01328002|459262721|FG001|Open-Label Period|Other Reason|0|||
127628591|NCT01328002|459262720|FG000|Double-Blind Period|Adverse Event|1|||
127628592|NCT01328002|459262721|FG001|Double-Blind Period|Adverse Event|0|||
127628593|NCT01328002|459262720|FG000|Double-Blind Period|Lack of Efficacy|1|||
127628594|NCT01328002|459262721|FG001|Double-Blind Period|Lack of Efficacy|0|||
127628595|NCT00813761|459262722|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
127628596|NCT00813761|459262723|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
127628597|NCT00813761|459262724|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
127628598|NCT00813761|459262725|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
127628599|NCT00813761|459262722|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
127628600|NCT00813761|459262723|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
127628601|NCT00813761|459262724|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
127628602|NCT00813761|459262725|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
127628603|NCT00813761|459262722|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
127628604|NCT00813761|459262723|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
127628605|NCT00813761|459262724|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
127628606|NCT00813761|459262725|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
127628607|NCT00813761|459262722|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
127628608|NCT00813761|459262723|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
127628609|NCT00813761|459262724|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
127702017|NCT03024437|459537137|FG002|Overall Study|Needed an alternative therapy prohibited by protocol|1|||
127702018|NCT03024437|459537138|FG003|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
127702019|NCT03024437|459537139|FG004|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
127702020|NCT05239455|459537141|FG000|Overall Study|Adverse Event|1|||
127702021|NCT05239455|459537141|FG000|Overall Study|Sponsor Decision|5|||
127702022|NCT05239455|459537141|FG000|Overall Study|Incomplete Blood Collection|1|||
127702023|NCT01799265|459537142|FG000|Overall Study|Lost to Follow-up|1|||
127702024|NCT01799265|459537143|FG001|Overall Study|Lost to Follow-up|0|||
127702025|NCT01799265|459537142|FG000|Overall Study|Protocol Violation|2|||
127702026|NCT01799265|459537143|FG001|Overall Study|Protocol Violation|1|||
127793181|NCT01508702|459867471|FG001|Overall Study|Withdrawal by Subject|7|||
127628610|NCT00813761|459262725|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
127628611|NCT00813761|459262722|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
127628612|NCT00813761|459262723|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
127628613|NCT00813761|459262724|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
127702027|NCT01799265|459537142|FG000|Overall Study|inadequate sleep study|0|||
127628614|NCT00813761|459262725|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
127628615|NCT00813761|459262722|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
127628616|NCT00813761|459262723|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
127628617|NCT00813761|459262724|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
127628618|NCT00813761|459262725|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
127628619|NCT00813761|459262722|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
127628620|NCT00813761|459262723|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
127628621|NCT00813761|459262724|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
127628622|NCT00813761|459262725|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
127628623|NCT00813761|459262722|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
127628624|NCT00813761|459262723|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
127628625|NCT00813761|459262724|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
127628626|NCT00813761|459262725|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
127628627|NCT00813761|459262722|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
127628628|NCT00813761|459262723|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
127628629|NCT00813761|459262724|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
127628630|NCT00813761|459262725|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
127628631|NCT00813761|459262722|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
127628632|NCT00813761|459262723|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
127628633|NCT00813761|459262724|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
127628634|NCT00813761|459262725|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
127628635|NCT00813761|459262722|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
127628636|NCT00813761|459262723|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
127628637|NCT00813761|459262724|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
127628638|NCT00813761|459262725|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
127628639|NCT00813761|459262722|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
127628640|NCT00813761|459262723|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
127628641|NCT00813761|459262724|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
127628642|NCT00813761|459262725|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
127628643|NCT01208233|459262726|FG000|Overall Study|Adverse Event|0|||
127628644|NCT01208233|459262727|FG001|Overall Study|Adverse Event|1|||
127628645|NCT01208233|459262728|FG002|Overall Study|Adverse Event|2|||
127628646|NCT01208233|459262729|FG003|Overall Study|Adverse Event|0|||
127628647|NCT01208233|459262730|FG004|Overall Study|Adverse Event|3|||
127628648|NCT01208233|459262731|FG005|Overall Study|Adverse Event|5|||
127628649|NCT01208233|459262726|FG000|Overall Study|Death|0|||
127628650|NCT01208233|459262727|FG001|Overall Study|Death|0|||
127628651|NCT01208233|459262728|FG002|Overall Study|Death|0|||
127628652|NCT01208233|459262729|FG003|Overall Study|Death|0|||
127628653|NCT01208233|459262730|FG004|Overall Study|Death|3|||
127628654|NCT01208233|459262731|FG005|Overall Study|Death|5|||
127628655|NCT01208233|459262726|FG000|Overall Study|Did not meet entrance criteria|2|||
127628656|NCT01208233|459262727|FG001|Overall Study|Did not meet entrance criteria|1|||
127628657|NCT01208233|459262728|FG002|Overall Study|Did not meet entrance criteria|1|||
127628658|NCT01208233|459262729|FG003|Overall Study|Did not meet entrance criteria|0|||
127628659|NCT01208233|459262730|FG004|Overall Study|Did not meet entrance criteria|1|||
127628660|NCT01208233|459262731|FG005|Overall Study|Did not meet entrance criteria|0|||
127628661|NCT01208233|459262726|FG000|Overall Study|Medication error without adverse event|0|||
127628662|NCT01208233|459262727|FG001|Overall Study|Medication error without adverse event|0|||
127628663|NCT01208233|459262728|FG002|Overall Study|Medication error without adverse event|0|||
127628664|NCT01208233|459262729|FG003|Overall Study|Medication error without adverse event|0|||
127628665|NCT01208233|459262730|FG004|Overall Study|Medication error without adverse event|0|||
127628666|NCT01208233|459262731|FG005|Overall Study|Medication error without adverse event|1|||
127628667|NCT01208233|459262726|FG000|Overall Study|Study terminated by sponsor|0|||
127628668|NCT01208233|459262727|FG001|Overall Study|Study terminated by sponsor|0|||
127628669|NCT01208233|459262728|FG002|Overall Study|Study terminated by sponsor|0|||
127628670|NCT01208233|459262729|FG003|Overall Study|Study terminated by sponsor|0|||
127628671|NCT01208233|459262730|FG004|Overall Study|Study terminated by sponsor|10|||
127628672|NCT01208233|459262731|FG005|Overall Study|Study terminated by sponsor|7|||
127628673|NCT01208233|459262726|FG000|Overall Study|Protocol Violation|0|||
127628674|NCT01208233|459262727|FG001|Overall Study|Protocol Violation|0|||
127628675|NCT01208233|459262728|FG002|Overall Study|Protocol Violation|0|||
127628676|NCT01208233|459262729|FG003|Overall Study|Protocol Violation|0|||
127628677|NCT01208233|459262730|FG004|Overall Study|Protocol Violation|3|||
127628678|NCT01208233|459262731|FG005|Overall Study|Protocol Violation|0|||
127702028|NCT01799265|459537143|FG001|Overall Study|inadequate sleep study|2|||
127885248|NCT04380701|460203878|FG007|Overall Study|Pregnancy|0|||
127628679|NCT01208233|459262726|FG000|Overall Study|Other|2|||
127628680|NCT01208233|459262727|FG001|Overall Study|Other|1|||
127628681|NCT01208233|459262728|FG002|Overall Study|Other|0|||
127628682|NCT01208233|459262729|FG003|Overall Study|Other|0|||
127702029|NCT03459729|459537144|FG000|Overall Study|Physician Decision|2|||
127628683|NCT01208233|459262730|FG004|Overall Study|Other|0|||
127628684|NCT01208233|459262731|FG005|Overall Study|Other|1|||
127628685|NCT01208233|459262726|FG000|Overall Study|Withdrawal by Subject|1|||
127628686|NCT01208233|459262727|FG001|Overall Study|Withdrawal by Subject|0|||
127628687|NCT01208233|459262728|FG002|Overall Study|Withdrawal by Subject|1|||
127628688|NCT01208233|459262729|FG003|Overall Study|Withdrawal by Subject|1|||
127628689|NCT01208233|459262730|FG004|Overall Study|Withdrawal by Subject|4|||
127628690|NCT01208233|459262731|FG005|Overall Study|Withdrawal by Subject|2|||
127702030|NCT02364557|459537145|FG000|Overall Study|Protocol Violation|3|||
127628691|NCT01181895|459262732|FG000|Overall Study|Adverse Event|3|||
127628692|NCT01181895|459262733|FG001|Overall Study|Adverse Event|1|||
127628693|NCT01181895|459262734|FG002|Overall Study|Adverse Event|1|||
127628694|NCT01181895|459262732|FG000|Overall Study|Lack of Efficacy|8|||
127628695|NCT01181895|459262733|FG001|Overall Study|Lack of Efficacy|9|||
127628696|NCT01181895|459262734|FG002|Overall Study|Lack of Efficacy|9|||
127628697|NCT01181895|459262732|FG000|Overall Study|Protocol Violation|2|||
127628698|NCT01181895|459262733|FG001|Overall Study|Protocol Violation|1|||
127628699|NCT01181895|459262734|FG002|Overall Study|Protocol Violation|0|||
127628700|NCT01181895|459262732|FG000|Overall Study|Lost to Follow-up|0|||
127628701|NCT01181895|459262733|FG001|Overall Study|Lost to Follow-up|1|||
127628702|NCT01181895|459262734|FG002|Overall Study|Lost to Follow-up|2|||
127628703|NCT01181895|459262732|FG000|Overall Study|Investigator Discretion|1|||
127628704|NCT01181895|459262733|FG001|Overall Study|Investigator Discretion|2|||
127628705|NCT01181895|459262734|FG002|Overall Study|Investigator Discretion|1|||
127628706|NCT01181895|459262732|FG000|Overall Study|Withdrawal by Subject|3|||
127628707|NCT01181895|459262733|FG001|Overall Study|Withdrawal by Subject|0|||
127628708|NCT01181895|459262734|FG002|Overall Study|Withdrawal by Subject|5|||
127628709|NCT04028388|459262744|FG000|Overall Study|Evaluations missing|3|||
127628710|NCT04028388|459262745|FG001|Overall Study|Evaluations missing|6|||
127628711|NCT04028388|459262744|FG000|Overall Study|Not started|2|||
127628712|NCT04028388|459262745|FG001|Overall Study|Not started|0|||
127628713|NCT00555438|459262748|FG000|10 Days Post-operative|Death|4|||
127628714|NCT00555438|459262748|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
127628715|NCT00061048|459262749|FG000|Overall Study|Adverse Event|2|||
127628716|NCT00061048|459262749|FG000|Overall Study|disease progression|20|||
127628717|NCT01114516|459262750|FG000|Overall Study|Lost to Follow-up|2|||
127628718|NCT01114516|459262751|FG001|Overall Study|Lost to Follow-up|1|||
127628719|NCT01431508|459262752|FG000|Overall Study|Lack of Efficacy|1|||
127628720|NCT01431508|459262752|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
127628721|NCT00129259|459262754|FG000|Overall Study|Lost to Follow-up|1|||
127628722|NCT00129259|459262755|FG001|Overall Study|Lost to Follow-up|1|||
127628723|NCT00129259|459262754|FG000|Overall Study|Withdrawal by Subject|2|||
127628724|NCT00129259|459262755|FG001|Overall Study|Withdrawal by Subject|1|||
127628725|NCT00129259|459262754|FG000|Overall Study|Only available minimal phone assessments|0|||
127628726|NCT00129259|459262755|FG001|Overall Study|Only available minimal phone assessments|1|||
127628727|NCT01609556|459262759|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
127628728|NCT01609556|459262760|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
127628729|NCT01609556|459262761|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
127628730|NCT01609556|459262762|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
127628731|NCT01609556|459262763|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
127628732|NCT01609556|459262764|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
127628733|NCT01609556|459262765|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
127628734|NCT01609556|459262766|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
127628735|NCT01609556|459262767|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
127628736|NCT01609556|459262768|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
127628737|NCT01609556|459262769|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
127628738|NCT01609556|459262770|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
127628739|NCT01609556|459262771|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
127628740|NCT01609556|459262772|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
127628741|NCT01609556|459262773|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
127628742|NCT01609556|459262774|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
127628743|NCT01609556|459262759|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
127628744|NCT01609556|459262760|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
127628745|NCT01609556|459262761|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
127628746|NCT01609556|459262762|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
127628747|NCT01609556|459262763|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
127628748|NCT01609556|459262764|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
127628749|NCT01609556|459262765|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
127628750|NCT01609556|459262766|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
127628751|NCT01609556|459262767|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
127628752|NCT01609556|459262768|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
127628753|NCT01609556|459262769|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
127628754|NCT01609556|459262770|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
127628755|NCT01609556|459262771|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
127628756|NCT01609556|459262772|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
127628757|NCT01609556|459262773|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
127628758|NCT01609556|459262774|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
127885249|NCT04380701|460203879|FG008|Overall Study|Pregnancy|0|||
127885250|NCT04380701|460203880|FG009|Overall Study|Pregnancy|0|||
127628759|NCT01609556|459262759|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
127628760|NCT01609556|459262760|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
127628761|NCT01609556|459262761|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
127628762|NCT01609556|459262762|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
127628763|NCT01609556|459262763|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
127628764|NCT01609556|459262764|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
127628765|NCT01609556|459262765|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
127628766|NCT01609556|459262766|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
127628767|NCT01609556|459262767|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
127628768|NCT01609556|459262768|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
127628769|NCT01609556|459262769|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
127628770|NCT01609556|459262770|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
127628771|NCT01609556|459262771|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
127628772|NCT01609556|459262772|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
127628773|NCT01609556|459262773|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
127628774|NCT01609556|459262774|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
127628775|NCT01609556|459262759|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
127628776|NCT01609556|459262760|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
127628777|NCT01609556|459262761|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
127628778|NCT01609556|459262762|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
127628779|NCT01609556|459262763|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
127628780|NCT01609556|459262764|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
127628781|NCT01609556|459262765|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
127628782|NCT01609556|459262766|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
127628783|NCT01609556|459262767|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
127628784|NCT01609556|459262768|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
127628785|NCT01609556|459262769|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
127628786|NCT01609556|459262770|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
127628787|NCT01609556|459262771|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
127628788|NCT01609556|459262772|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
127628789|NCT01609556|459262773|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
127628790|NCT01609556|459262774|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
127628791|NCT01609556|459262759|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
127628792|NCT01609556|459262760|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
127628793|NCT01609556|459262761|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
127628794|NCT01609556|459262762|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
127628795|NCT01609556|459262763|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
127628796|NCT01609556|459262764|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
127628797|NCT01609556|459262765|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
127628798|NCT01609556|459262766|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
127628799|NCT01609556|459262767|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
127628800|NCT01609556|459262768|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
127628801|NCT01609556|459262769|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
127628802|NCT01609556|459262770|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
127628803|NCT01609556|459262771|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
127628804|NCT01609556|459262772|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
127628805|NCT01609556|459262773|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
127628806|NCT01609556|459262774|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
127628807|NCT01609556|459262759|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
127628808|NCT01609556|459262760|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
127628809|NCT01609556|459262761|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
127702031|NCT02364557|459537146|FG001|Overall Study|Protocol Violation|1|||
127702032|NCT04200456|459537151|FG000|Overall Study|Physician Decision|0|||
127702033|NCT04200456|459537152|FG001|Overall Study|Physician Decision|1|||
127702034|NCT04200456|459537151|FG000|Overall Study|Withdrawal by Subject|2|||
127702035|NCT04200456|459537152|FG001|Overall Study|Withdrawal by Subject|2|||
127702036|NCT04200456|459537151|FG000|Overall Study|Lack of Efficacy|1|||
127702037|NCT04200456|459537152|FG001|Overall Study|Lack of Efficacy|1|||
127702038|NCT04200456|459537151|FG000|Overall Study|Adverse event, non-fatal|0|||
127702039|NCT04200456|459537152|FG001|Overall Study|Adverse event, non-fatal|1|||
127702040|NCT04200456|459537151|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
127702041|NCT04200456|459537152|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
127705268|NCT01928394|459551579|FG012|Follow-up Period|Death|11|||
127885251|NCT04380701|460203881|FG010|Overall Study|Pregnancy|0|||
127628810|NCT01609556|459262762|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
127628811|NCT01609556|459262763|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
127628812|NCT01609556|459262764|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
127628813|NCT01609556|459262765|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
127628814|NCT01609556|459262766|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
127628815|NCT01609556|459262767|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
127628816|NCT01609556|459262768|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
127628817|NCT01609556|459262769|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
127628818|NCT01609556|459262770|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
127628819|NCT01609556|459262771|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
127628820|NCT01609556|459262772|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
127628821|NCT01609556|459262773|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
127628822|NCT01609556|459262774|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
127628823|NCT01609556|459262759|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
127628824|NCT01609556|459262760|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
127628825|NCT01609556|459262761|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
127628826|NCT01609556|459262762|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
127628827|NCT01609556|459262763|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
127628828|NCT01609556|459262764|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
127628829|NCT01609556|459262765|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
127628830|NCT01609556|459262766|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
127628831|NCT01609556|459262767|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
127628832|NCT01609556|459262768|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
127628833|NCT01609556|459262769|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
127628834|NCT01609556|459262770|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
127628835|NCT01609556|459262771|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
127628836|NCT01609556|459262772|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
127628837|NCT01609556|459262773|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
127628838|NCT01609556|459262774|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
127628839|NCT01609556|459262759|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
127628840|NCT01609556|459262760|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
127628841|NCT01609556|459262761|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
127628842|NCT01609556|459262762|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
127628843|NCT01609556|459262763|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
127628844|NCT01609556|459262764|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
127628845|NCT01609556|459262765|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
127628846|NCT01609556|459262766|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
127628847|NCT01609556|459262767|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
127628848|NCT01609556|459262768|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
127628849|NCT01609556|459262769|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
127628850|NCT01609556|459262770|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
127628851|NCT01609556|459262771|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
127628852|NCT01609556|459262772|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
127628853|NCT01609556|459262773|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
127628854|NCT01609556|459262774|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
127628855|NCT01609556|459262759|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
127702042|NCT04828005|459537153|FG000|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|2|||
127702043|NCT04828005|459537154|FG001|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
127702044|NCT04828005|459537155|FG002|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
127702045|NCT04828005|459537156|FG003|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
127702046|NCT04828005|459537153|FG000|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
127702047|NCT04828005|459537154|FG001|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
127702048|NCT04828005|459537155|FG002|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|2|||
127702049|NCT04828005|459537156|FG003|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|1|||
127702050|NCT04828005|459537153|FG000|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
127702051|NCT04828005|459537154|FG001|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
127702052|NCT04828005|459537155|FG002|Part 2: 1st Treatment (1 Day)|Adverse Event|3|||
127702053|NCT04828005|459537156|FG003|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
127702054|NCT04828005|459537153|FG000|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
127702055|NCT04828005|459537154|FG001|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
127702056|NCT04828005|459537155|FG002|Part 2: 1st Treatment (1 Day)|Protocol Violation|2|||
127702057|NCT04828005|459537156|FG003|Part 2: 1st Treatment (1 Day)|Protocol Violation|1|||
127702058|NCT04828005|459537153|FG000|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
127702059|NCT04828005|459537154|FG001|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
127702060|NCT04828005|459537155|FG002|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
127702061|NCT04828005|459537156|FG003|Part 2: 1st Treatment (1 Day)|Equipment failure|1|||
127628856|NCT01609556|459262760|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
127628857|NCT01609556|459262761|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
127628858|NCT01609556|459262762|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
127628859|NCT01609556|459262763|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
127628860|NCT01609556|459262764|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
127628861|NCT01609556|459262765|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
127628862|NCT01609556|459262766|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
127628863|NCT01609556|459262767|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
127628864|NCT01609556|459262768|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
127628865|NCT01609556|459262769|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
127628866|NCT01609556|459262770|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
127628867|NCT01609556|459262771|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
127628868|NCT01609556|459262772|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
127628869|NCT01609556|459262773|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
127628870|NCT01609556|459262774|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
127628871|NCT01609556|459262759|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
127628872|NCT01609556|459262760|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
127628873|NCT01609556|459262761|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
127628874|NCT01609556|459262762|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
127628875|NCT01609556|459262763|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
127628876|NCT01609556|459262764|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
127628877|NCT01609556|459262765|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
127628878|NCT01609556|459262766|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
127628879|NCT01609556|459262767|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
127628880|NCT01609556|459262768|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
127628881|NCT01609556|459262769|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
127628882|NCT01609556|459262770|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
127628883|NCT01609556|459262771|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
127628884|NCT01609556|459262772|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
127628885|NCT01609556|459262773|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
127628886|NCT01609556|459262774|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
127628887|NCT01609556|459262759|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
127628888|NCT01609556|459262760|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
127628889|NCT01609556|459262761|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
127628890|NCT01609556|459262762|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
127628891|NCT01609556|459262763|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
127628892|NCT01609556|459262764|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
127628893|NCT01609556|459262765|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
127628894|NCT01609556|459262766|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
127628895|NCT01609556|459262767|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
127628896|NCT01609556|459262768|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
127628897|NCT01609556|459262769|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
127628898|NCT01609556|459262770|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
127628899|NCT01609556|459262771|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
127628900|NCT01609556|459262772|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
127628901|NCT01609556|459262773|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
127628902|NCT01609556|459262774|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
127628903|NCT01609556|459262759|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
127628904|NCT01609556|459262760|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
127628905|NCT01609556|459262761|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
127628906|NCT01609556|459262762|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
127628907|NCT01609556|459262763|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
127628908|NCT01609556|459262764|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
127628909|NCT01609556|459262765|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
127628910|NCT01609556|459262766|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
127628911|NCT01609556|459262767|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
127628912|NCT01609556|459262768|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
127628913|NCT01609556|459262769|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
127628914|NCT01609556|459262770|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
127628915|NCT01609556|459262771|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
127628916|NCT01609556|459262772|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
127628917|NCT01609556|459262773|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
127628918|NCT01609556|459262774|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
127628919|NCT01609556|459262759|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
127628920|NCT01609556|459262760|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
127705269|NCT01928394|459551580|FG013|Follow-up Period|Death|25|||
127628921|NCT01609556|459262761|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
127628922|NCT01609556|459262762|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
127628923|NCT01609556|459262763|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
127628924|NCT01609556|459262764|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
127628925|NCT01609556|459262765|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
127628926|NCT01609556|459262766|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
127628927|NCT01609556|459262767|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
127628928|NCT01609556|459262768|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
127628929|NCT01609556|459262769|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
127628930|NCT01609556|459262770|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
127628931|NCT01609556|459262771|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
127628932|NCT01609556|459262772|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
127628933|NCT01609556|459262773|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
127628934|NCT01609556|459262774|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
127628935|NCT01609556|459262759|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
127628936|NCT01609556|459262760|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
127628937|NCT01609556|459262761|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
127628938|NCT01609556|459262762|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
127628939|NCT01609556|459262763|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
127628940|NCT01609556|459262764|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
127628941|NCT01609556|459262765|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
127628942|NCT01609556|459262766|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
127628943|NCT01609556|459262767|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
127628944|NCT01609556|459262768|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
127628945|NCT01609556|459262769|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
127628946|NCT01609556|459262770|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
127628947|NCT01609556|459262771|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
127628948|NCT01609556|459262772|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
127628949|NCT01609556|459262773|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
127628950|NCT01609556|459262774|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
127628951|NCT01609556|459262759|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
127628952|NCT01609556|459262760|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
127628953|NCT01609556|459262761|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
127628954|NCT01609556|459262762|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
127628955|NCT01609556|459262763|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
127628956|NCT01609556|459262764|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
127628957|NCT01609556|459262765|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
127628958|NCT01609556|459262766|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
127628959|NCT01609556|459262767|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
127628960|NCT01609556|459262768|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
127628961|NCT01609556|459262769|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
127628962|NCT01609556|459262770|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
127628963|NCT01609556|459262771|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
127628964|NCT01609556|459262772|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
127628965|NCT01609556|459262773|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
127628966|NCT01609556|459262774|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
127628967|NCT00023452|459262775|FG000|Overall Study|Ineligible for Study|163|||
127628968|NCT00023452|459262776|FG001|Overall Study|Ineligible for Study|159|||
127628969|NCT00023452|459262775|FG000|Overall Study|Out of Window|129|||
127628970|NCT00023452|459262776|FG001|Overall Study|Out of Window|69|||
127628971|NCT00023452|459262775|FG000|Overall Study|Death|2|||
127628972|NCT00023452|459262776|FG001|Overall Study|Death|0|||
127628973|NCT00023452|459262775|FG000|Overall Study|Withdrawal by Subject|66|||
127628974|NCT00023452|459262776|FG001|Overall Study|Withdrawal by Subject|54|||
127628975|NCT00023452|459262775|FG000|Overall Study|Adverse Event|139|||
127628976|NCT00023452|459262776|FG001|Overall Study|Adverse Event|196|||
127628977|NCT00023452|459262775|FG000|Overall Study|Lost to Follow-up|293|||
127628978|NCT00023452|459262776|FG001|Overall Study|Lost to Follow-up|60|||
127628979|NCT00023452|459262775|FG000|Overall Study|Physician Decision|49|||
127628980|NCT00023452|459262776|FG001|Overall Study|Physician Decision|21|||
127628981|NCT00023452|459262775|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
127628982|NCT00023452|459262776|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
127628983|NCT00023452|459262775|FG000|Overall Study|Pregnant|53|||
127628984|NCT00023452|459262776|FG001|Overall Study|Pregnant|20|||
127628985|NCT00023452|459262775|FG000|Overall Study|Other|204|||
127628986|NCT00023452|459262776|FG001|Overall Study|Other|69|||
127628987|NCT05789875|459262777|FG000|Overall Study|Lost to Follow-up|6|||
127628988|NCT01994395|459262778|FG000|Overall Study|Withdrawal by Subject|1|||
127628989|NCT01994395|459262779|FG001|Overall Study|Withdrawal by Subject|2|||
127628990|NCT01940705|459262781|FG000|Overall Study|Lost to Follow-up|1|||
127628991|NCT01940705|459262782|FG001|Overall Study|Lost to Follow-up|3|||
127628992|NCT01940705|459262783|FG002|Overall Study|Lost to Follow-up|2|||
127628993|NCT01940705|459262784|FG003|Overall Study|Lost to Follow-up|2|||
127628994|NCT01940705|459262781|FG000|Overall Study|Withdrawal by Subject|2|||
127628995|NCT01940705|459262782|FG001|Overall Study|Withdrawal by Subject|2|||
127628996|NCT01940705|459262783|FG002|Overall Study|Withdrawal by Subject|3|||
127628997|NCT01940705|459262784|FG003|Overall Study|Withdrawal by Subject|2|||
127628998|NCT01940705|459262781|FG000|Overall Study|Intervention not given|0|||
127628999|NCT01940705|459262782|FG001|Overall Study|Intervention not given|3|||
127629000|NCT01940705|459262783|FG002|Overall Study|Intervention not given|3|||
127629001|NCT01940705|459262784|FG003|Overall Study|Intervention not given|0|||
127629002|NCT01940705|459262781|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
127629003|NCT01940705|459262782|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
127629004|NCT01940705|459262783|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
127629005|NCT01940705|459262784|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
127629006|NCT01632579|459262787|FG000|Washout Period|Adverse Event|1|||
127629007|NCT01632579|459262788|FG001|Washout Period|Adverse Event|0|||
127629008|NCT01632579|459262789|FG002|Washout Period|Adverse Event|0|||
127629009|NCT01632579|459262790|FG003|Washout Period|Adverse Event|0|||
127629010|NCT01632579|459262791|FG004|Washout Period|Adverse Event|0|||
127629011|NCT01632579|459262792|FG005|Washout Period|Adverse Event|0|||
127629012|NCT01632579|459262793|FG006|Washout Period|Adverse Event|0|||
127629013|NCT01632579|459262794|FG007|Washout Period|Adverse Event|0|||
127629014|NCT01632579|459262795|FG008|Washout Period|Adverse Event|0|||
127629015|NCT01632579|459262787|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
127629016|NCT01632579|459262788|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
127629017|NCT01632579|459262789|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
127629018|NCT01632579|459262790|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
127629019|NCT01632579|459262791|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
127629020|NCT01632579|459262792|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
127629021|NCT01632579|459262793|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
127629022|NCT01632579|459262794|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
127629023|NCT01632579|459262795|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
127629024|NCT03779841|459262796|FG000|Randomized Population|Did Not Receive Treatment|3|||
127629025|NCT03779841|459262797|FG001|Randomized Population|Did Not Receive Treatment|1|||
127629026|NCT03779841|459262798|FG002|Randomized Population|Did Not Receive Treatment|0|||
127629027|NCT03779841|459262796|FG000|Treated (Safety) Population|Adverse Event|1|||
127629028|NCT03779841|459262797|FG001|Treated (Safety) Population|Adverse Event|1|||
127629029|NCT03779841|459262798|FG002|Treated (Safety) Population|Adverse Event|0|||
127629030|NCT03779841|459262796|FG000|Treated (Safety) Population|Withdrawal by Subject|4|||
127793182|NCT00761514|459867476|FG000|Overall Study|Adverse Event|1|||
127793183|NCT00761514|459867476|FG000|Overall Study|Withdrawal by Subject|2|||
127793184|NCT00761514|459867476|FG000|Overall Study|Lost to Follow-up|1|||
127793185|NCT00761514|459867476|FG000|Overall Study|Health insurance didn't cover study drug|1|||
127793186|NCT00761514|459867476|FG000|Overall Study|Problem complying with study visit|1|||
127793187|NCT00761514|459867476|FG000|Overall Study|Unable to pay for medications|1|||
127793188|NCT01836783|459867477|FG000|Overall Study|Withdrawal by Subject|0|||
127793189|NCT01836783|459867478|FG001|Overall Study|Withdrawal by Subject|2|||
127793190|NCT02124564|459867483|FG000|Treatment Period|Adverse Event|2|||
127793191|NCT02124564|459867483|FG000|Treatment Period|Lack of Efficacy|3|||
127793192|NCT02124564|459867483|FG000|Treatment Period|Withdrawal by Subject|2|||
127793193|NCT03885089|459867484|FG000|Overall Study|No informed consent for publication of study results|2|||
127793194|NCT01425008|459867491|FG000|Dose Escalation Phase|Progressive Disease|2|||
127885252|NCT04380701|460203882|FG011|Overall Study|Pregnancy|0|||
127885253|NCT04380701|460203883|FG012|Overall Study|Pregnancy|0|||
127885254|NCT04380701|460203884|FG013|Overall Study|Pregnancy|0|||
127885255|NCT04380701|460203885|FG014|Overall Study|Pregnancy|0|||
127885256|NCT04380701|460203886|FG015|Overall Study|Pregnancy|0|||
127885257|NCT04380701|460203887|FG016|Overall Study|Pregnancy|0|||
127885258|NCT04380701|460203888|FG017|Overall Study|Pregnancy|0|||
127885259|NCT04380701|460203889|FG018|Overall Study|Pregnancy|0|||
127885260|NCT04380701|460203890|FG019|Overall Study|Pregnancy|0|||
127885261|NCT04380701|460203891|FG020|Overall Study|Pregnancy|0|||
127885262|NCT04380701|460203892|FG021|Overall Study|Pregnancy|0|||
127885263|NCT04380701|460203893|FG022|Overall Study|Pregnancy|0|||
127629031|NCT03779841|459262797|FG001|Treated (Safety) Population|Withdrawal by Subject|8|||
127885264|NCT04380701|460203894|FG023|Overall Study|Pregnancy|0|||
127629032|NCT03779841|459262798|FG002|Treated (Safety) Population|Withdrawal by Subject|6|||
127629033|NCT03779841|459262796|FG000|Treated (Safety) Population|Lost to Follow-up|5|||
127793195|NCT01425008|459867492|FG001|Dose Escalation Phase|Progressive Disease|3|||
127793196|NCT01425008|459867493|FG002|Dose Escalation Phase|Progressive Disease|2|||
127885265|NCT04380701|460203895|FG024|Overall Study|Pregnancy|0|||
127629034|NCT03779841|459262797|FG001|Treated (Safety) Population|Lost to Follow-up|9|||
127629035|NCT03779841|459262798|FG002|Treated (Safety) Population|Lost to Follow-up|8|||
127629036|NCT03779841|459262796|FG000|Treated (Safety) Population|Death|1|||
127885266|NCT04380701|460203896|FG025|Overall Study|Pregnancy|0|||
127885267|NCT04380701|460203897|FG026|Overall Study|Pregnancy|0|||
127885268|NCT04380701|460203898|FG027|Overall Study|Pregnancy|0|||
127629037|NCT03779841|459262797|FG001|Treated (Safety) Population|Death|0|||
127629038|NCT03779841|459262798|FG002|Treated (Safety) Population|Death|2|||
127629039|NCT00162136|459262799|FG000|Overall Study|Adverse Event|1|||
127629040|NCT00162136|459262799|FG000|Overall Study|Death|1|||
127885269|NCT04380701|460203899|FG028|Overall Study|Pregnancy|0|||
127629041|NCT00162136|459262799|FG000|Overall Study|Disease Progression/Relapse|23|||
127629042|NCT00162136|459262799|FG000|Overall Study|Investigator Request|5|||
127629043|NCT00162136|459262799|FG000|Overall Study|Study Drug Toxicity|4|||
127629044|NCT00162136|459262799|FG000|Overall Study|Withdrawal by Subject|1|||
127629045|NCT02788175|459262800|FG000|Overall Study|Protocol Violation|3|||
127629046|NCT02788175|459262800|FG000|Overall Study|Withdrawal by Subject|4|||
127629047|NCT02788175|459262800|FG000|Overall Study|Ineligible prior to study agent|6|||
127629048|NCT03930745|459262801|FG000|Overall Study|Lost to Follow-up|10|||
127629049|NCT03930745|459262802|FG001|Overall Study|Lost to Follow-up|5|||
127629050|NCT03930745|459262801|FG000|Overall Study|Withdrawal by Subject|1|||
127629051|NCT03930745|459262802|FG001|Overall Study|Withdrawal by Subject|2|||
127629052|NCT03930745|459262801|FG000|Overall Study|Protocol Violation|2|||
127629053|NCT03930745|459262802|FG001|Overall Study|Protocol Violation|2|||
127629054|NCT03930745|459262801|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
127629055|NCT03930745|459262802|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
127629056|NCT03930745|459262801|FG000|Overall Study|Adverse Event|0|||
127629057|NCT03930745|459262802|FG001|Overall Study|Adverse Event|1|||
127629058|NCT03930745|459262801|FG000|Overall Study|Pregnancy|0|||
127629059|NCT03930745|459262802|FG001|Overall Study|Pregnancy|1|||
127629060|NCT00818441|459262807|FG000|Overall Study|Death|69|||
127629061|NCT00818441|459262808|FG001|Overall Study|Death|26|||
127629062|NCT00818441|459262807|FG000|Overall Study|Other|5|||
127629063|NCT00818441|459262808|FG001|Overall Study|Other|0|||
127629064|NCT00818441|459262807|FG000|Overall Study|Lost to Follow-up|2|||
127629065|NCT00818441|459262808|FG001|Overall Study|Lost to Follow-up|1|||
127629066|NCT00818441|459262807|FG000|Overall Study|Withdrawal by Subject|2|||
127629067|NCT00818441|459262808|FG001|Overall Study|Withdrawal by Subject|0|||
127629068|NCT00818441|459262807|FG000|Overall Study|Adverse Event|0|||
127629069|NCT00818441|459262808|FG001|Overall Study|Adverse Event|1|||
127629070|NCT00818441|459262807|FG000|Overall Study|Study terminated by sponsor|11|||
127629071|NCT00818441|459262808|FG001|Overall Study|Study terminated by sponsor|2|||
127629072|NCT03483623|459262810|FG000|Overall Study|43 complete sets achieved|1|||
127629073|NCT02770391|459262811|FG000|Overall Study|Lost to Follow-up|2|||
127629074|NCT02770391|459262811|FG000|Overall Study|Withdrawal by Subject|1|||
127629075|NCT02770391|459262811|FG000|Overall Study|Surgery delayed unevaluable|2|||
127629076|NCT02770391|459262811|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
127629077|NCT01040871|459264471|FG000|Overall Study|Adverse Event|6|||
127629078|NCT01040871|459264472|FG001|Overall Study|Adverse Event|2|||
127629079|NCT01040871|459264471|FG000|Overall Study|Withdrawal by Subject|2|||
127629080|NCT01040871|459264472|FG001|Overall Study|Withdrawal by Subject|0|||
127629081|NCT01040871|459264471|FG000|Overall Study|Death|1|||
127629082|NCT01040871|459264472|FG001|Overall Study|Death|3|||
127629083|NCT01040871|459264471|FG000|Overall Study|Lack of Efficacy|1|||
127629084|NCT01040871|459264472|FG001|Overall Study|Lack of Efficacy|1|||
127629085|NCT01040871|459264471|FG000|Overall Study|drug supply issue|1|||
127629086|NCT01040871|459264472|FG001|Overall Study|drug supply issue|0|||
127629087|NCT01040871|459264471|FG000|Overall Study|Randomized and Not Treated|2|||
127629088|NCT01040871|459264472|FG001|Overall Study|Randomized and Not Treated|1|||
127629089|NCT02696850|459264477|FG000|Overall Study|Withdrawal by Subject|3|||
127629090|NCT02696850|459264478|FG001|Overall Study|Withdrawal by Subject|3|||
127629091|NCT02696850|459264477|FG000|Overall Study|Lost to Follow-up|8|||
127629092|NCT02696850|459264478|FG001|Overall Study|Lost to Follow-up|5|||
127629093|NCT00673049|459264479|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
127702062|NCT04828005|459537153|FG000|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
127702063|NCT04828005|459537154|FG001|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
127702064|NCT04828005|459537155|FG002|Part 2: Washout (4 Days)|Withdrawal by Subject|2|||
127702065|NCT04828005|459537156|FG003|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
127702066|NCT04828005|459537153|FG000|Part 2: Washout (4 Days)|Physician Decision|0|||
127702067|NCT04828005|459537154|FG001|Part 2: Washout (4 Days)|Physician Decision|0|||
127702068|NCT04828005|459537155|FG002|Part 2: Washout (4 Days)|Physician Decision|0|||
127885270|NCT04380701|460203900|FG029|Overall Study|Pregnancy|0|||
127885271|NCT04380701|460203901|FG030|Overall Study|Pregnancy|0|||
127885272|NCT04380701|460203902|FG031|Overall Study|Pregnancy|0|||
127885273|NCT04380701|460203903|FG032|Overall Study|Pregnancy|1|||
127885274|NCT04380701|460203904|FG033|Overall Study|Pregnancy|0|||
127885275|NCT04380701|460203871|FG000|Overall Study|Lost to Follow-up|0|||
127885276|NCT04380701|460203872|FG001|Overall Study|Lost to Follow-up|0|||
127885277|NCT04380701|460203873|FG002|Overall Study|Lost to Follow-up|0|||
127885278|NCT04380701|460203874|FG003|Overall Study|Lost to Follow-up|0|||
127885279|NCT04380701|460203875|FG004|Overall Study|Lost to Follow-up|0|||
127885280|NCT04380701|460203876|FG005|Overall Study|Lost to Follow-up|0|||
127885281|NCT04380701|460203877|FG006|Overall Study|Lost to Follow-up|0|||
127885282|NCT04380701|460203878|FG007|Overall Study|Lost to Follow-up|0|||
127885283|NCT04380701|460203879|FG008|Overall Study|Lost to Follow-up|0|||
127885284|NCT04380701|460203880|FG009|Overall Study|Lost to Follow-up|0|||
127885285|NCT04380701|460203881|FG010|Overall Study|Lost to Follow-up|0|||
127885286|NCT04380701|460203882|FG011|Overall Study|Lost to Follow-up|0|||
127885287|NCT04380701|460203883|FG012|Overall Study|Lost to Follow-up|0|||
127885288|NCT04380701|460203884|FG013|Overall Study|Lost to Follow-up|0|||
127885289|NCT04380701|460203885|FG014|Overall Study|Lost to Follow-up|0|||
127885290|NCT04380701|460203886|FG015|Overall Study|Lost to Follow-up|0|||
127885291|NCT04380701|460203887|FG016|Overall Study|Lost to Follow-up|0|||
127885292|NCT04380701|460203888|FG017|Overall Study|Lost to Follow-up|0|||
127885293|NCT04380701|460203889|FG018|Overall Study|Lost to Follow-up|0|||
127885294|NCT04380701|460203890|FG019|Overall Study|Lost to Follow-up|0|||
127885295|NCT04380701|460203891|FG020|Overall Study|Lost to Follow-up|1|||
127885296|NCT04380701|460203892|FG021|Overall Study|Lost to Follow-up|0|||
127885297|NCT04380701|460203893|FG022|Overall Study|Lost to Follow-up|0|||
127885298|NCT04380701|460203894|FG023|Overall Study|Lost to Follow-up|1|||
127885299|NCT04380701|460203895|FG024|Overall Study|Lost to Follow-up|0|||
127885300|NCT04380701|460203896|FG025|Overall Study|Lost to Follow-up|0|||
127629094|NCT00673049|459264480|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
127629095|NCT00673049|459264481|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
127629096|NCT00673049|459264482|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
127629097|NCT00673049|459264479|FG000|Before Progression on Erlotinib|Death|235|||
127629098|NCT00673049|459264480|FG001|Before Progression on Erlotinib|Death|167|||
127629099|NCT00673049|459264481|FG002|Before Progression on Erlotinib|Death|1|||
127629100|NCT00673049|459264482|FG003|Before Progression on Erlotinib|Death|0|||
127629101|NCT00673049|459264479|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
127629102|NCT00673049|459264480|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
127629103|NCT00673049|459264481|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
127629104|NCT00673049|459264482|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
127629105|NCT00673049|459264479|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
127629106|NCT00673049|459264480|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
127629107|NCT00673049|459264481|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
127629108|NCT00673049|459264482|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
127629109|NCT00673049|459264479|FG000|Before Progression on Erlotinib|Other|1|||
127629110|NCT00673049|459264480|FG001|Before Progression on Erlotinib|Other|2|||
127629111|NCT00673049|459264481|FG002|Before Progression on Erlotinib|Other|0|||
127629112|NCT00673049|459264482|FG003|Before Progression on Erlotinib|Other|0|||
127629113|NCT00673049|459264479|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
127629114|NCT00673049|459264480|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
127629115|NCT00673049|459264481|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
127629116|NCT00673049|459264482|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
127629117|NCT00673049|459264479|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
127629118|NCT00673049|459264480|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
127629119|NCT00673049|459264481|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
127629120|NCT00673049|459264482|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
127702069|NCT04828005|459537156|FG003|Part 2: Washout (4 Days)|Physician Decision|2|||
127705270|NCT01928394|459551581|FG014|Follow-up Period|Death|18|||
127885301|NCT04380701|460203897|FG026|Overall Study|Lost to Follow-up|0|||
127885302|NCT04380701|460203898|FG027|Overall Study|Lost to Follow-up|0|||
127629121|NCT00673049|459264479|FG000|After Progression on Erlotinib|Death|0|||
127629122|NCT00673049|459264480|FG001|After Progression on Erlotinib|Death|0|||
127629123|NCT00673049|459264481|FG002|After Progression on Erlotinib|Death|0|||
127885303|NCT04380701|460203899|FG028|Overall Study|Lost to Follow-up|0|||
127885304|NCT04380701|460203900|FG029|Overall Study|Lost to Follow-up|1|||
127629124|NCT00673049|459264482|FG003|After Progression on Erlotinib|Death|71|||
127629125|NCT00673049|459264479|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
127629126|NCT00673049|459264480|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
127629127|NCT00673049|459264481|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
127629128|NCT00673049|459264482|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
127629129|NCT00673049|459264479|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
127629130|NCT00673049|459264480|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
127629131|NCT00673049|459264481|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
127629132|NCT00673049|459264482|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
127629133|NCT00673049|459264479|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
127629134|NCT00673049|459264480|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
127629135|NCT00673049|459264481|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
127629136|NCT00673049|459264482|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
127629137|NCT01175824|459264483|FG000|Overall Study|Adverse Event|2|||
127629138|NCT01175824|459264484|FG001|Overall Study|Adverse Event|1|||
127629139|NCT01175824|459264483|FG000|Overall Study|Lack of Efficacy|2|||
127629140|NCT01175824|459264484|FG001|Overall Study|Lack of Efficacy|0|||
127629141|NCT01175824|459264483|FG000|Overall Study|Lost to Follow-up|0|||
127629142|NCT01175824|459264484|FG001|Overall Study|Lost to Follow-up|1|||
127629143|NCT01175824|459264483|FG000|Overall Study|Physician Decision|0|||
127629144|NCT01175824|459264484|FG001|Overall Study|Physician Decision|4|||
127629145|NCT01175824|459264483|FG000|Overall Study|Protocol Violation|2|||
127629146|NCT01175824|459264484|FG001|Overall Study|Protocol Violation|5|||
127629147|NCT01175824|459264483|FG000|Overall Study|Withdrawal by Subject|3|||
127629148|NCT01175824|459264484|FG001|Overall Study|Withdrawal by Subject|7|||
127629149|NCT01175824|459264483|FG000|Overall Study|Sponsor Decision|1|||
127629150|NCT01175824|459264484|FG001|Overall Study|Sponsor Decision|0|||
127629151|NCT01175824|459264483|FG000|Overall Study|Entry Criteria Not Met|6|||
127629152|NCT01175824|459264484|FG001|Overall Study|Entry Criteria Not Met|4|||
127629153|NCT00924950|459264485|FG000|Overall Study|Lost to Follow-up|2|||
127629154|NCT04193202|459264486|FG000|Overall Study|Adverse Event|2|||
127629155|NCT04193202|459264487|FG001|Overall Study|Adverse Event|1|||
127629156|NCT04193202|459264486|FG000|Overall Study|Death|0|||
127629157|NCT04193202|459264487|FG001|Overall Study|Death|1|||
127629158|NCT04193202|459264486|FG000|Overall Study|Physician Decision|1|||
127629159|NCT04193202|459264487|FG001|Overall Study|Physician Decision|1|||
127629160|NCT04193202|459264486|FG000|Overall Study|Protocol Violation|2|||
127629161|NCT04193202|459264487|FG001|Overall Study|Protocol Violation|2|||
127629162|NCT04193202|459264486|FG000|Overall Study|Withdrawal by Subject|11|||
127629163|NCT04193202|459264487|FG001|Overall Study|Withdrawal by Subject|5|||
127629164|NCT02979535|459264488|FG000|Overall Study|Non compliance with the protocol|78|||
127629165|NCT02979535|459264489|FG001|Overall Study|Non compliance with the protocol|82|||
127629166|NCT02979535|459264488|FG000|Overall Study|Consent withdrawn by participant|11|||
127629167|NCT02979535|459264489|FG001|Overall Study|Consent withdrawn by participant|18|||
127629168|NCT02979535|459264488|FG000|Overall Study|Lost to Follow-up|6|||
127629169|NCT02979535|459264489|FG001|Overall Study|Lost to Follow-up|1|||
127629170|NCT04820673|459264493|FG000|Overall Study|Adverse Event|6|||
127629171|NCT04820673|459264493|FG000|Overall Study|Due to Lack of Effectiveness|1|||
127629172|NCT04820673|459264493|FG000|Overall Study|Pregnancy|1|||
127629173|NCT04820673|459264493|FG000|Overall Study|Voluntary Withdrawal|20|||
127629174|NCT04820673|459264493|FG000|Overall Study|Lost to Follow-up|10|||
127629175|NCT00767000|459264497|FG000|54-week Study|Adverse Event|4|||
127629176|NCT00767000|459264498|FG001|54-week Study|Adverse Event|6|||
127629177|NCT00767000|459264499|FG002|54-week Study|Adverse Event|6|||
127629178|NCT00767000|459264500|FG003|54-week Study|Adverse Event|8|||
127629179|NCT00767000|459264501|FG004|54-week Study|Adverse Event|4|||
127629180|NCT00767000|459264497|FG000|54-week Study|Creaninine/creatinine clearance|2|||
127702070|NCT04828005|459537153|FG000|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
127702071|NCT04828005|459537154|FG001|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
127629181|NCT00767000|459264498|FG001|54-week Study|Creaninine/creatinine clearance|1|||
127629182|NCT00767000|459264499|FG002|54-week Study|Creaninine/creatinine clearance|2|||
127629183|NCT00767000|459264500|FG003|54-week Study|Creaninine/creatinine clearance|2|||
127629184|NCT00767000|459264501|FG004|54-week Study|Creaninine/creatinine clearance|4|||
127885305|NCT04380701|460203901|FG030|Overall Study|Lost to Follow-up|0|||
127629185|NCT00767000|459264497|FG000|54-week Study|Hyperglycemia|0|||
127629186|NCT00767000|459264498|FG001|54-week Study|Hyperglycemia|0|||
127629187|NCT00767000|459264499|FG002|54-week Study|Hyperglycemia|1|||
127629188|NCT00767000|459264500|FG003|54-week Study|Hyperglycemia|0|||
127629189|NCT00767000|459264501|FG004|54-week Study|Hyperglycemia|1|||
127629190|NCT00767000|459264497|FG000|54-week Study|Hypoglycemia|0|||
127629191|NCT00767000|459264498|FG001|54-week Study|Hypoglycemia|1|||
127629192|NCT00767000|459264499|FG002|54-week Study|Hypoglycemia|0|||
127629193|NCT00767000|459264500|FG003|54-week Study|Hypoglycemia|0|||
127629194|NCT00767000|459264501|FG004|54-week Study|Hypoglycemia|0|||
127629195|NCT00767000|459264497|FG000|54-week Study|Interruption of study medication|0|||
127629196|NCT00767000|459264498|FG001|54-week Study|Interruption of study medication|0|||
127629197|NCT00767000|459264499|FG002|54-week Study|Interruption of study medication|1|||
127629198|NCT00767000|459264500|FG003|54-week Study|Interruption of study medication|0|||
127629199|NCT00767000|459264501|FG004|54-week Study|Interruption of study medication|0|||
127793197|NCT01425008|459867494|FG003|Dose Escalation Phase|Progressive Disease|3|||
127793198|NCT01425008|459867495|FG004|Dose Escalation Phase|Progressive Disease|5|||
127793199|NCT01425008|459867496|FG005|Dose Escalation Phase|Progressive Disease|4|||
127629200|NCT00767000|459264497|FG000|54-week Study|Lack of Efficacy|2|||
127629201|NCT00767000|459264498|FG001|54-week Study|Lack of Efficacy|0|||
127629202|NCT00767000|459264499|FG002|54-week Study|Lack of Efficacy|1|||
127629203|NCT00767000|459264500|FG003|54-week Study|Lack of Efficacy|0|||
127629204|NCT00767000|459264501|FG004|54-week Study|Lack of Efficacy|5|||
127629205|NCT00767000|459264497|FG000|54-week Study|Lost to Follow-up|4|||
127629206|NCT00767000|459264498|FG001|54-week Study|Lost to Follow-up|0|||
127629207|NCT00767000|459264499|FG002|54-week Study|Lost to Follow-up|1|||
127629208|NCT00767000|459264500|FG003|54-week Study|Lost to Follow-up|4|||
127629209|NCT00767000|459264501|FG004|54-week Study|Lost to Follow-up|2|||
127629210|NCT00767000|459264497|FG000|54-week Study|Physician Decision|4|||
127629211|NCT00767000|459264498|FG001|54-week Study|Physician Decision|0|||
127629212|NCT00767000|459264499|FG002|54-week Study|Physician Decision|1|||
127629213|NCT00767000|459264500|FG003|54-week Study|Physician Decision|1|||
127629214|NCT00767000|459264501|FG004|54-week Study|Physician Decision|1|||
127629215|NCT00767000|459264497|FG000|54-week Study|Progressive disease|0|||
127629216|NCT00767000|459264498|FG001|54-week Study|Progressive disease|0|||
127629217|NCT00767000|459264499|FG002|54-week Study|Progressive disease|1|||
127629218|NCT00767000|459264500|FG003|54-week Study|Progressive disease|0|||
127629219|NCT00767000|459264501|FG004|54-week Study|Progressive disease|0|||
127629220|NCT00767000|459264497|FG000|54-week Study|Protocol Violation|0|||
127629221|NCT00767000|459264498|FG001|54-week Study|Protocol Violation|0|||
127629222|NCT00767000|459264499|FG002|54-week Study|Protocol Violation|1|||
127629223|NCT00767000|459264500|FG003|54-week Study|Protocol Violation|2|||
127629224|NCT00767000|459264501|FG004|54-week Study|Protocol Violation|0|||
127629225|NCT00767000|459264497|FG000|54-week Study|Withdrawal by Subject|2|||
127629226|NCT00767000|459264498|FG001|54-week Study|Withdrawal by Subject|3|||
127629227|NCT00767000|459264499|FG002|54-week Study|Withdrawal by Subject|5|||
127629228|NCT00767000|459264500|FG003|54-week Study|Withdrawal by Subject|11|||
127629229|NCT00767000|459264501|FG004|54-week Study|Withdrawal by Subject|13|||
127793200|NCT01425008|459867497|FG006|Dose Escalation Phase|Progressive Disease|0|||
127793201|NCT01425008|459867498|FG007|Dose Escalation Phase|Progressive Disease|2|||
127793202|NCT01425008|459867499|FG008|Dose Escalation Phase|Progressive Disease|6|||
127793203|NCT01425008|459867500|FG009|Dose Escalation Phase|Progressive Disease|2|||
127793204|NCT01425008|459867501|FG010|Dose Escalation Phase|Progressive Disease|0|||
127793205|NCT01425008|459867502|FG011|Dose Escalation Phase|Progressive Disease|0|||
127793206|NCT01425008|459867503|FG012|Dose Escalation Phase|Progressive Disease|0|||
127793207|NCT01425008|459867504|FG013|Dose Escalation Phase|Progressive Disease|0|||
127793208|NCT01425008|459867505|FG014|Dose Escalation Phase|Progressive Disease|0|||
127793209|NCT01425008|459867506|FG015|Dose Escalation Phase|Progressive Disease|0|||
127793210|NCT01425008|459867507|FG016|Dose Escalation Phase|Progressive Disease|0|||
127793211|NCT01425008|459867508|FG017|Dose Escalation Phase|Progressive Disease|0|||
127793212|NCT01425008|459867509|FG018|Dose Escalation Phase|Progressive Disease|0|||
127793213|NCT01425008|459867491|FG000|Dose Escalation Phase|Adverse Event|2|||
127793214|NCT01425008|459867492|FG001|Dose Escalation Phase|Adverse Event|0|||
127629230|NCT00767000|459264497|FG000|54-week Study|Study terminated by sponsor|90|||
127629231|NCT00767000|459264498|FG001|54-week Study|Study terminated by sponsor|102|||
127629232|NCT00767000|459264499|FG002|54-week Study|Study terminated by sponsor|89|||
127629233|NCT00767000|459264500|FG003|54-week Study|Study terminated by sponsor|196|||
127629234|NCT00767000|459264501|FG004|54-week Study|Study terminated by sponsor|194|||
127629235|NCT00767000|459264497|FG000|54-week Study|Reason not reported|0|||
127629236|NCT00767000|459264498|FG001|54-week Study|Reason not reported|0|||
127629237|NCT00767000|459264499|FG002|54-week Study|Reason not reported|0|||
127793215|NCT01425008|459867493|FG002|Dose Escalation Phase|Adverse Event|0|||
127629238|NCT00767000|459264500|FG003|54-week Study|Reason not reported|1|||
127629239|NCT00767000|459264501|FG004|54-week Study|Reason not reported|0|||
127629240|NCT00767000|459264497|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
127629241|NCT00767000|459264498|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
127793216|NCT01425008|459867494|FG003|Dose Escalation Phase|Adverse Event|0|||
127793217|NCT01425008|459867495|FG004|Dose Escalation Phase|Adverse Event|0|||
127793218|NCT01425008|459867496|FG005|Dose Escalation Phase|Adverse Event|2|||
127793219|NCT01425008|459867497|FG006|Dose Escalation Phase|Adverse Event|0|||
127793220|NCT01425008|459867498|FG007|Dose Escalation Phase|Adverse Event|0|||
127793221|NCT01425008|459867499|FG008|Dose Escalation Phase|Adverse Event|2|||
127629242|NCT00767000|459264499|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
127629243|NCT00767000|459264500|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
127629244|NCT00767000|459264501|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
127629245|NCT02039505|459264503|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
127629246|NCT02039505|459264504|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
127629247|NCT02039505|459264505|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
127629248|NCT02039505|459264506|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
127629249|NCT02039505|459264507|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
127629250|NCT02039505|459264508|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
127629251|NCT02039505|459264509|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
127629252|NCT02039505|459264503|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
127629253|NCT02039505|459264504|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
127629254|NCT02039505|459264505|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
127629255|NCT02039505|459264506|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
127629256|NCT02039505|459264507|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
127629257|NCT02039505|459264508|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
127629258|NCT02039505|459264509|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
127629259|NCT02039505|459264503|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
127629260|NCT02039505|459264504|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
127629261|NCT02039505|459264505|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
127629262|NCT02039505|459264506|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
127629263|NCT02039505|459264507|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
127629264|NCT02039505|459264508|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
127629265|NCT02039505|459264509|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
127629266|NCT02039505|459264503|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
127629267|NCT02039505|459264504|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
127629268|NCT02039505|459264505|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
127629269|NCT02039505|459264506|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
127629270|NCT02039505|459264507|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
127629271|NCT02039505|459264508|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
127629272|NCT02039505|459264509|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
127629273|NCT02039505|459264503|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
127629274|NCT02039505|459264504|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
127629275|NCT02039505|459264505|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
127629276|NCT02039505|459264506|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
127629277|NCT02039505|459264507|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
127629278|NCT02039505|459264508|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
127629279|NCT02039505|459264509|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
127629280|NCT02039505|459264503|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
127629281|NCT02039505|459264504|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
127629282|NCT02039505|459264505|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
127629283|NCT02039505|459264506|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
127629284|NCT02039505|459264507|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
127629285|NCT02039505|459264508|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
127629286|NCT02039505|459264509|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
127793222|NCT01425008|459867500|FG009|Dose Escalation Phase|Adverse Event|0|||
127793223|NCT01425008|459867501|FG010|Dose Escalation Phase|Adverse Event|0|||
127629287|NCT02039505|459264503|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
127629288|NCT02039505|459264504|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
127629289|NCT02039505|459264505|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
127629290|NCT02039505|459264506|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
127629291|NCT02039505|459264507|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
127629292|NCT02039505|459264508|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
127629293|NCT02039505|459264509|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
127885306|NCT04380701|460203902|FG031|Overall Study|Lost to Follow-up|0|||
127793224|NCT01425008|459867502|FG011|Dose Escalation Phase|Adverse Event|0|||
127793225|NCT01425008|459867503|FG012|Dose Escalation Phase|Adverse Event|0|||
127793226|NCT01425008|459867504|FG013|Dose Escalation Phase|Adverse Event|0|||
127793227|NCT01425008|459867505|FG014|Dose Escalation Phase|Adverse Event|0|||
127793228|NCT01425008|459867506|FG015|Dose Escalation Phase|Adverse Event|0|||
127793229|NCT01425008|459867507|FG016|Dose Escalation Phase|Adverse Event|0|||
127793230|NCT01425008|459867508|FG017|Dose Escalation Phase|Adverse Event|0|||
127793231|NCT01425008|459867509|FG018|Dose Escalation Phase|Adverse Event|0|||
127793232|NCT01425008|459867491|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
127793233|NCT01425008|459867492|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
127793234|NCT01425008|459867493|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
127793235|NCT01425008|459867494|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
127793236|NCT01425008|459867495|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
127793237|NCT01425008|459867496|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
127793238|NCT01425008|459867497|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
127793239|NCT01425008|459867498|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
127793240|NCT01425008|459867499|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
127793241|NCT01425008|459867500|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
127793242|NCT01425008|459867501|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
127793243|NCT01425008|459867502|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
127793244|NCT01425008|459867503|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
127793245|NCT01425008|459867504|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
127793246|NCT01425008|459867505|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
127793247|NCT01425008|459867506|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
127793248|NCT01425008|459867507|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
127793249|NCT01425008|459867508|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
127793250|NCT01425008|459867509|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
127793251|NCT01425008|459867491|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
127793252|NCT01425008|459867492|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
127793253|NCT01425008|459867493|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
127793254|NCT01425008|459867494|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
127793255|NCT01425008|459867495|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
127793256|NCT01425008|459867496|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
127793257|NCT01425008|459867497|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
127793258|NCT01425008|459867498|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
127793259|NCT01425008|459867499|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
127793260|NCT01425008|459867500|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
127793261|NCT01425008|459867501|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
127793262|NCT01425008|459867502|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
127793263|NCT01425008|459867503|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
127793264|NCT01425008|459867504|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
127793265|NCT01425008|459867505|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
127793266|NCT01425008|459867506|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
127793267|NCT01425008|459867507|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
127793268|NCT01425008|459867508|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
127793269|NCT01425008|459867509|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
127793270|NCT01425008|459867491|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
127793271|NCT01425008|459867492|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
127793272|NCT01425008|459867493|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
127793273|NCT01425008|459867494|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
127793274|NCT01425008|459867495|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
127793275|NCT01425008|459867496|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
127793276|NCT01425008|459867497|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
127793277|NCT01425008|459867498|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
127793278|NCT01425008|459867499|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
127793279|NCT01425008|459867500|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
127793280|NCT01425008|459867501|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
127793281|NCT01425008|459867502|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
127793282|NCT01425008|459867503|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
127793283|NCT01425008|459867504|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
127793284|NCT01425008|459867505|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
127793285|NCT01425008|459867506|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
127793286|NCT01425008|459867507|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
127793287|NCT01425008|459867508|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
127793288|NCT01425008|459867509|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
127793289|NCT01425008|459867491|FG000|Dose Escalation Phase|Other|0|||
127793290|NCT01425008|459867492|FG001|Dose Escalation Phase|Other|0|||
127793291|NCT01425008|459867493|FG002|Dose Escalation Phase|Other|0|||
127793292|NCT01425008|459867494|FG003|Dose Escalation Phase|Other|0|||
127793293|NCT01425008|459867495|FG004|Dose Escalation Phase|Other|0|||
127793294|NCT01425008|459867496|FG005|Dose Escalation Phase|Other|0|||
127793295|NCT01425008|459867497|FG006|Dose Escalation Phase|Other|0|||
127793296|NCT01425008|459867498|FG007|Dose Escalation Phase|Other|0|||
127793297|NCT01425008|459867499|FG008|Dose Escalation Phase|Other|1|||
127793298|NCT01425008|459867500|FG009|Dose Escalation Phase|Other|0|||
127793299|NCT01425008|459867501|FG010|Dose Escalation Phase|Other|0|||
127793300|NCT01425008|459867502|FG011|Dose Escalation Phase|Other|0|||
127793301|NCT01425008|459867503|FG012|Dose Escalation Phase|Other|0|||
127793302|NCT01425008|459867504|FG013|Dose Escalation Phase|Other|0|||
127793303|NCT01425008|459867505|FG014|Dose Escalation Phase|Other|0|||
127629294|NCT02039505|459264503|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
127629295|NCT02039505|459264504|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
127629296|NCT02039505|459264505|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
127629297|NCT02039505|459264506|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
127629298|NCT02039505|459264507|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
127629299|NCT02039505|459264508|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
127629300|NCT02039505|459264509|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
127629301|NCT02039505|459264503|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
127629302|NCT02039505|459264504|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
127629303|NCT02039505|459264505|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
127629304|NCT02039505|459264506|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
127629305|NCT02039505|459264507|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
127629306|NCT02039505|459264508|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
127629307|NCT02039505|459264509|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
127629308|NCT02039505|459264503|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
127629309|NCT02039505|459264504|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
127629310|NCT02039505|459264505|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
127629311|NCT02039505|459264506|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
127629312|NCT02039505|459264507|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
127629313|NCT02039505|459264508|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
127629314|NCT02039505|459264509|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
127629315|NCT02039505|459264503|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
127629316|NCT02039505|459264504|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
127629317|NCT02039505|459264505|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
127629318|NCT02039505|459264506|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
127629319|NCT02039505|459264507|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
127629320|NCT02039505|459264508|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
127629321|NCT02039505|459264509|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
127629322|NCT00097591|459264510|FG000|Overall Study|Withdrawal of consent|342|||
127629323|NCT00097591|459264511|FG001|Overall Study|Withdrawal of consent|323|||
127629324|NCT00097591|459264510|FG000|Overall Study|Less than 6 months on study drug|9|||
127629325|NCT00097591|459264511|FG001|Overall Study|Less than 6 months on study drug|7|||
127629326|NCT00097591|459264510|FG000|Overall Study|Unable to attend termination visit|53|||
127629327|NCT00097591|459264511|FG001|Overall Study|Unable to attend termination visit|51|||
127629328|NCT00097591|459264510|FG000|Overall Study|Lost to follow up|6|||
127629329|NCT00097591|459264511|FG001|Overall Study|Lost to follow up|10|||
127629330|NCT00097591|459264510|FG000|Overall Study|Other|0|||
127629331|NCT00097591|459264511|FG001|Overall Study|Other|3|||
127629332|NCT02530619|459264512|FG000|Registered for Study|Withdrawal by Subject|2|||
127629333|NCT02530619|459264512|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
127629334|NCT02530619|459264512|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
127629335|NCT02530619|459264512|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
127629336|NCT02530619|459264512|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
127629337|NCT02530619|459264512|FG000|Follow-up Period (6 Months)|Death|4|||
127629338|NCT02530619|459264512|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
127629339|NCT02530619|459264512|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
127629340|NCT00009737|459264514|FG000|Overall Study|Adverse Event|112|||
127629341|NCT00009737|459264515|FG001|Overall Study|Adverse Event|75|||
127629342|NCT00009737|459264514|FG000|Overall Study|Death|4|||
127629343|NCT00009737|459264515|FG001|Overall Study|Death|6|||
127793304|NCT01425008|459867506|FG015|Dose Escalation Phase|Other|0|||
127793305|NCT01425008|459867507|FG016|Dose Escalation Phase|Other|0|||
127793306|NCT01425008|459867508|FG017|Dose Escalation Phase|Other|0|||
127793307|NCT01425008|459867509|FG018|Dose Escalation Phase|Other|0|||
127793308|NCT01425008|459867491|FG000|Dose Expansion Phase|Progressive Disease|0|||
127885307|NCT04380701|460203903|FG032|Overall Study|Lost to Follow-up|0|||
127629344|NCT00009737|459264514|FG000|Overall Study|Lack of Efficacy|17|||
127885308|NCT04380701|460203904|FG033|Overall Study|Lost to Follow-up|1|||
127629345|NCT00009737|459264515|FG001|Overall Study|Lack of Efficacy|15|||
127793309|NCT01425008|459867492|FG001|Dose Expansion Phase|Progressive Disease|0|||
127885309|NCT04380701|460203871|FG000|Overall Study|Private reason(s)|0|||
127793310|NCT01425008|459867493|FG002|Dose Expansion Phase|Progressive Disease|0|||
127793311|NCT01425008|459867494|FG003|Dose Expansion Phase|Progressive Disease|0|||
127793312|NCT01425008|459867495|FG004|Dose Expansion Phase|Progressive Disease|0|||
127793313|NCT01425008|459867496|FG005|Dose Expansion Phase|Progressive Disease|0|||
127793314|NCT01425008|459867497|FG006|Dose Expansion Phase|Progressive Disease|0|||
127793315|NCT01425008|459867498|FG007|Dose Expansion Phase|Progressive Disease|0|||
127793316|NCT01425008|459867499|FG008|Dose Expansion Phase|Progressive Disease|0|||
127793317|NCT01425008|459867500|FG009|Dose Expansion Phase|Progressive Disease|0|||
127793318|NCT01425008|459867501|FG010|Dose Expansion Phase|Progressive Disease|10|||
127793319|NCT01425008|459867502|FG011|Dose Expansion Phase|Progressive Disease|4|||
127793320|NCT01425008|459867503|FG012|Dose Expansion Phase|Progressive Disease|12|||
127793321|NCT01425008|459867504|FG013|Dose Expansion Phase|Progressive Disease|1|||
127793322|NCT01425008|459867505|FG014|Dose Expansion Phase|Progressive Disease|5|||
127793323|NCT01425008|459867506|FG015|Dose Expansion Phase|Progressive Disease|8|||
127793324|NCT01425008|459867507|FG016|Dose Expansion Phase|Progressive Disease|9|||
127629346|NCT00009737|459264514|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
127629347|NCT00009737|459264515|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
127629348|NCT00009737|459264514|FG000|Overall Study|Other Protocol Violation|1|||
127629349|NCT00009737|459264515|FG001|Overall Study|Other Protocol Violation|0|||
127629350|NCT00009737|459264514|FG000|Overall Study|Refused Treatment|15|||
127629351|NCT00009737|459264515|FG001|Overall Study|Refused Treatment|16|||
127629352|NCT00009737|459264514|FG000|Overall Study|Lost to Follow-up|1|||
127629353|NCT00009737|459264515|FG001|Overall Study|Lost to Follow-up|1|||
127629354|NCT00009737|459264514|FG000|Overall Study|Administrative/Other Reasons|7|||
127629355|NCT00009737|459264515|FG001|Overall Study|Administrative/Other Reasons|1|||
127629356|NCT01163682|459264519|FG000|Overall Study|Lost to Follow-up|6|||
127629357|NCT01163682|459264520|FG001|Overall Study|Lost to Follow-up|9|||
127629358|NCT00359762|459264526|FG000|Period II|Adverse Event|17|||
127629359|NCT00359762|459264527|FG001|Period II|Adverse Event|0|||
127629360|NCT00359762|459264528|FG002|Period II|Adverse Event|0|||
127629361|NCT00359762|459264529|FG003|Period II|Adverse Event|0|||
127629362|NCT00359762|459264530|FG004|Period II|Adverse Event|49|||
127629363|NCT00359762|459264526|FG000|Period II|Protocol Violation|18|||
127629364|NCT00359762|459264527|FG001|Period II|Protocol Violation|0|||
127629365|NCT00359762|459264528|FG002|Period II|Protocol Violation|0|||
127629366|NCT00359762|459264529|FG003|Period II|Protocol Violation|0|||
127629367|NCT00359762|459264530|FG004|Period II|Protocol Violation|11|||
127629368|NCT00359762|459264526|FG000|Period II|Physician Decision|17|||
127629369|NCT00359762|459264527|FG001|Period II|Physician Decision|0|||
127629370|NCT00359762|459264528|FG002|Period II|Physician Decision|0|||
127793325|NCT01425008|459867508|FG017|Dose Expansion Phase|Progressive Disease|2|||
127793326|NCT01425008|459867509|FG018|Dose Expansion Phase|Progressive Disease|10|||
127793327|NCT01425008|459867491|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
127629371|NCT00359762|459264529|FG003|Period II|Physician Decision|0|||
127629372|NCT00359762|459264530|FG004|Period II|Physician Decision|23|||
127793328|NCT01425008|459867492|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
127793329|NCT01425008|459867493|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
127793330|NCT01425008|459867494|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
127793331|NCT01425008|459867495|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
127793332|NCT01425008|459867496|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
127793333|NCT01425008|459867497|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
127793334|NCT01425008|459867498|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
127793335|NCT01425008|459867499|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
127793336|NCT01425008|459867500|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
127793337|NCT01425008|459867501|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
127793338|NCT01425008|459867502|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
127793339|NCT01425008|459867503|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
127793340|NCT01425008|459867504|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
127629373|NCT00359762|459264526|FG000|Period II|Death|2|||
127629374|NCT00359762|459264527|FG001|Period II|Death|0|||
127793341|NCT01425008|459867505|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
127793342|NCT01425008|459867506|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
127793343|NCT01425008|459867507|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
127793344|NCT01425008|459867508|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
127793345|NCT01425008|459867509|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
127629375|NCT00359762|459264528|FG002|Period II|Death|0|||
127629376|NCT00359762|459264529|FG003|Period II|Death|0|||
127629377|NCT00359762|459264530|FG004|Period II|Death|4|||
127629378|NCT00359762|459264526|FG000|Period II|Lack of Efficacy|11|||
127793346|NCT01425008|459867491|FG000|Dose Expansion Phase|Other|0|||
127793347|NCT01425008|459867492|FG001|Dose Expansion Phase|Other|0|||
127793348|NCT01425008|459867493|FG002|Dose Expansion Phase|Other|0|||
127793349|NCT01425008|459867494|FG003|Dose Expansion Phase|Other|0|||
127793350|NCT01425008|459867495|FG004|Dose Expansion Phase|Other|0|||
127793351|NCT01425008|459867496|FG005|Dose Expansion Phase|Other|0|||
127629379|NCT00359762|459264527|FG001|Period II|Lack of Efficacy|0|||
127629380|NCT00359762|459264528|FG002|Period II|Lack of Efficacy|0|||
127885310|NCT04380701|460203872|FG001|Overall Study|Private reason(s)|0|||
127885311|NCT04380701|460203873|FG002|Overall Study|Private reason(s)|0|||
127629381|NCT00359762|459264529|FG003|Period II|Lack of Efficacy|0|||
127629382|NCT00359762|459264530|FG004|Period II|Lack of Efficacy|8|||
127629383|NCT00359762|459264526|FG000|Period II|Lost to follow up|5|||
127629384|NCT00359762|459264527|FG001|Period II|Lost to follow up|0|||
127629385|NCT00359762|459264528|FG002|Period II|Lost to follow up|0|||
127629386|NCT00359762|459264529|FG003|Period II|Lost to follow up|0|||
127629387|NCT00359762|459264530|FG004|Period II|Lost to follow up|5|||
127629388|NCT00359762|459264526|FG000|Period II|Entry Criteria Not Met|8|||
127629389|NCT00359762|459264527|FG001|Period II|Entry Criteria Not Met|0|||
127629390|NCT00359762|459264528|FG002|Period II|Entry Criteria Not Met|0|||
127629391|NCT00359762|459264529|FG003|Period II|Entry Criteria Not Met|0|||
127629392|NCT00359762|459264530|FG004|Period II|Entry Criteria Not Met|4|||
127629393|NCT00359762|459264526|FG000|Period II|Subject Decision|50|||
127629394|NCT00359762|459264527|FG001|Period II|Subject Decision|0|||
127629395|NCT00359762|459264528|FG002|Period II|Subject Decision|0|||
127629396|NCT00359762|459264529|FG003|Period II|Subject Decision|0|||
127629397|NCT00359762|459264530|FG004|Period II|Subject Decision|70|||
127629398|NCT00359762|459264526|FG000|Period III|Protocol Violation|0|||
127629399|NCT00359762|459264527|FG001|Period III|Protocol Violation|5|||
127629400|NCT00359762|459264528|FG002|Period III|Protocol Violation|3|||
127629401|NCT00359762|459264529|FG003|Period III|Protocol Violation|8|||
127629402|NCT00359762|459264530|FG004|Period III|Protocol Violation|0|||
127629403|NCT00359762|459264526|FG000|Period III|Adverse Event|0|||
127629404|NCT00359762|459264527|FG001|Period III|Adverse Event|3|||
127629405|NCT00359762|459264528|FG002|Period III|Adverse Event|4|||
127629406|NCT00359762|459264529|FG003|Period III|Adverse Event|10|||
127702072|NCT04828005|459537155|FG002|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
127629407|NCT00359762|459264530|FG004|Period III|Adverse Event|0|||
127629408|NCT00359762|459264526|FG000|Period III|Physician Decision|0|||
127629409|NCT00359762|459264527|FG001|Period III|Physician Decision|5|||
127629410|NCT00359762|459264528|FG002|Period III|Physician Decision|9|||
127702073|NCT04828005|459537156|FG003|Part 2: 2nd Treatment (1 Day)|Protocol Violation|2|||
127702074|NCT04828005|459537153|FG000|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
127702075|NCT04828005|459537154|FG001|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
127702076|NCT04828005|459537155|FG002|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
127702077|NCT04828005|459537156|FG003|Part 2: 2nd Treatment (1 Day)|Adverse Event|1|||
127702078|NCT01129102|459538958|FG000|Overall Study|No study drug treatment|2|||
127702079|NCT01129102|459538959|FG001|Overall Study|No study drug treatment|3|||
127629411|NCT00359762|459264529|FG003|Period III|Physician Decision|15|||
127629412|NCT00359762|459264530|FG004|Period III|Physician Decision|0|||
127629413|NCT00359762|459264526|FG000|Period III|Lack of Efficacy|0|||
127629414|NCT00359762|459264527|FG001|Period III|Lack of Efficacy|7|||
127629415|NCT00359762|459264528|FG002|Period III|Lack of Efficacy|5|||
127629416|NCT00359762|459264529|FG003|Period III|Lack of Efficacy|9|||
127629417|NCT00359762|459264530|FG004|Period III|Lack of Efficacy|0|||
127702080|NCT01129102|459538960|FG002|Overall Study|No study drug treatment|1|||
127702081|NCT01129102|459538958|FG000|Overall Study|Withdrawal by Subject|2|||
127702082|NCT01129102|459538959|FG001|Overall Study|Withdrawal by Subject|0|||
127629418|NCT00359762|459264526|FG000|Period III|Lost to follow up|0|||
127629419|NCT00359762|459264527|FG001|Period III|Lost to follow up|1|||
127629420|NCT00359762|459264528|FG002|Period III|Lost to follow up|1|||
127629421|NCT00359762|459264529|FG003|Period III|Lost to follow up|2|||
127629422|NCT00359762|459264530|FG004|Period III|Lost to follow up|0|||
127629423|NCT00359762|459264526|FG000|Period III|Entry Criteria Not Met|0|||
127629424|NCT00359762|459264527|FG001|Period III|Entry Criteria Not Met|1|||
127629425|NCT00359762|459264528|FG002|Period III|Entry Criteria Not Met|0|||
127629426|NCT00359762|459264529|FG003|Period III|Entry Criteria Not Met|1|||
127629427|NCT00359762|459264530|FG004|Period III|Entry Criteria Not Met|0|||
127629428|NCT00359762|459264526|FG000|Period III|Subject Decision|0|||
127629429|NCT00359762|459264527|FG001|Period III|Subject Decision|7|||
127629430|NCT00359762|459264528|FG002|Period III|Subject Decision|8|||
127629431|NCT00359762|459264529|FG003|Period III|Subject Decision|20|||
127629432|NCT00359762|459264530|FG004|Period III|Subject Decision|0|||
127629433|NCT04808609|459264531|FG000|Overall Study|Lost to Follow-up|0|||
127629434|NCT04808609|459264532|FG001|Overall Study|Lost to Follow-up|2|||
127629435|NCT04808609|459264531|FG000|Overall Study|Administrative Withdrawal|0|||
127629436|NCT04808609|459264532|FG001|Overall Study|Administrative Withdrawal|1|||
127629437|NCT01993719|459264536|FG000|First Drug Administration|Not treated|1|||
127629438|NCT01993719|459264537|FG001|First Drug Administration|Not treated|0|||
127629439|NCT01993719|459264538|FG002|First Drug Administration|Not treated|0|||
127629440|NCT01993719|459264539|FG003|First Drug Administration|Not treated|0|||
127629441|NCT01993719|459264540|FG004|First Drug Administration|Not treated|0|||
127629442|NCT04382326|459264544|FG000|Overall Study|Adverse Event, not serious|1|||
127629443|NCT04382326|459264545|FG001|Overall Study|Adverse Event, not serious|2|||
127629444|NCT04382326|459264544|FG000|Overall Study|Other|1|||
127629445|NCT04382326|459264545|FG001|Overall Study|Other|0|||
127629446|NCT04382326|459264544|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
127629447|NCT04382326|459264545|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
127629448|NCT04382326|459264544|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
127629449|NCT04382326|459264545|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
127629450|NCT04382326|459264544|FG000|Overall Study|Protocol Violation|29|||
127629451|NCT04382326|459264545|FG001|Overall Study|Protocol Violation|23|||
127629452|NCT04382326|459264544|FG000|Overall Study|Physician Decision|0|||
127629453|NCT04382326|459264545|FG001|Overall Study|Physician Decision|1|||
127629454|NCT04382326|459264544|FG000|Overall Study|Lost to Follow-up|48|||
127629455|NCT04382326|459264545|FG001|Overall Study|Lost to Follow-up|63|||
127629456|NCT04382326|459264544|FG000|Overall Study|Adverse Event, non-fatal|1|||
127629457|NCT04382326|459264545|FG001|Overall Study|Adverse Event, non-fatal|1|||
127629458|NCT01557946|459264548|FG000|Overall Study|Adverse Event|3|||
127629459|NCT01557946|459264549|FG001|Overall Study|Adverse Event|0|||
127629460|NCT02352493|459264551|FG000|Overall Study|Pregnancy|0|||
127629461|NCT02352493|459264552|FG001|Overall Study|Pregnancy|0|||
127793352|NCT01425008|459867497|FG006|Dose Expansion Phase|Other|0|||
127793353|NCT01425008|459867498|FG007|Dose Expansion Phase|Other|0|||
127793354|NCT01425008|459867499|FG008|Dose Expansion Phase|Other|0|||
127793355|NCT01425008|459867500|FG009|Dose Expansion Phase|Other|0|||
127793356|NCT01425008|459867501|FG010|Dose Expansion Phase|Other|0|||
127793357|NCT01425008|459867502|FG011|Dose Expansion Phase|Other|0|||
127793358|NCT01425008|459867503|FG012|Dose Expansion Phase|Other|1|||
127793359|NCT01425008|459867504|FG013|Dose Expansion Phase|Other|0|||
127793360|NCT01425008|459867505|FG014|Dose Expansion Phase|Other|0|||
127793361|NCT01425008|459867506|FG015|Dose Expansion Phase|Other|0|||
127793362|NCT01425008|459867507|FG016|Dose Expansion Phase|Other|2|||
127793363|NCT01425008|459867508|FG017|Dose Expansion Phase|Other|0|||
127793364|NCT01425008|459867509|FG018|Dose Expansion Phase|Other|4|||
127793365|NCT01425008|459867491|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
127793366|NCT01425008|459867492|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
127793367|NCT01425008|459867493|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
127793368|NCT01425008|459867494|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
127793369|NCT01425008|459867495|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
127793370|NCT01425008|459867496|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
127793371|NCT01425008|459867497|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
127793372|NCT01425008|459867498|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
127793373|NCT01425008|459867499|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
127793374|NCT01425008|459867500|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
127629462|NCT02352493|459264553|FG002|Overall Study|Pregnancy|0|||
127629463|NCT02352493|459264554|FG003|Overall Study|Pregnancy|0|||
127629464|NCT02352493|459264555|FG004|Overall Study|Pregnancy|0|||
127629465|NCT02352493|459264556|FG005|Overall Study|Pregnancy|0|||
127629466|NCT02352493|459264557|FG006|Overall Study|Pregnancy|1|||
127629467|NCT02352493|459264558|FG007|Overall Study|Pregnancy|0|||
127793375|NCT01425008|459867501|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
127629468|NCT02352493|459264559|FG008|Overall Study|Pregnancy|1|||
127629469|NCT02352493|459264560|FG009|Overall Study|Pregnancy|0|||
127629470|NCT02352493|459264561|FG010|Overall Study|Pregnancy|0|||
127629471|NCT02352493|459264562|FG011|Overall Study|Pregnancy|0|||
127629472|NCT02352493|459264563|FG012|Overall Study|Pregnancy|0|||
127629473|NCT02352493|459264564|FG013|Overall Study|Pregnancy|0|||
127793376|NCT01425008|459867502|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
127793377|NCT01425008|459867503|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
127793378|NCT01425008|459867504|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
127793379|NCT01425008|459867505|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
127793380|NCT01425008|459867506|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
127793381|NCT01425008|459867507|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
127793382|NCT01425008|459867508|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
127793383|NCT01425008|459867509|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
127793384|NCT01425008|459867491|FG000|Dose Expansion Phase|Adverse Event|0|||
127793385|NCT01425008|459867492|FG001|Dose Expansion Phase|Adverse Event|0|||
127793386|NCT01425008|459867493|FG002|Dose Expansion Phase|Adverse Event|0|||
127793387|NCT01425008|459867494|FG003|Dose Expansion Phase|Adverse Event|0|||
127793388|NCT01425008|459867495|FG004|Dose Expansion Phase|Adverse Event|0|||
127793389|NCT01425008|459867496|FG005|Dose Expansion Phase|Adverse Event|0|||
127793390|NCT01425008|459867497|FG006|Dose Expansion Phase|Adverse Event|0|||
127793391|NCT01425008|459867498|FG007|Dose Expansion Phase|Adverse Event|0|||
127793392|NCT01425008|459867499|FG008|Dose Expansion Phase|Adverse Event|0|||
127793393|NCT01425008|459867500|FG009|Dose Expansion Phase|Adverse Event|0|||
127793394|NCT01425008|459867501|FG010|Dose Expansion Phase|Adverse Event|2|||
127793395|NCT01425008|459867502|FG011|Dose Expansion Phase|Adverse Event|3|||
127793396|NCT01425008|459867503|FG012|Dose Expansion Phase|Adverse Event|3|||
127793397|NCT01425008|459867504|FG013|Dose Expansion Phase|Adverse Event|0|||
127793398|NCT01425008|459867505|FG014|Dose Expansion Phase|Adverse Event|1|||
127793399|NCT01425008|459867506|FG015|Dose Expansion Phase|Adverse Event|1|||
127793400|NCT01425008|459867507|FG016|Dose Expansion Phase|Adverse Event|5|||
127793401|NCT01425008|459867508|FG017|Dose Expansion Phase|Adverse Event|0|||
127793402|NCT01425008|459867509|FG018|Dose Expansion Phase|Adverse Event|3|||
127793403|NCT01425008|459867491|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
127793404|NCT01425008|459867492|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
127793405|NCT01425008|459867493|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
127629474|NCT02352493|459264565|FG014|Overall Study|Pregnancy|0|||
127629475|NCT02352493|459264566|FG015|Overall Study|Pregnancy|0|||
127793406|NCT01425008|459867494|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
127793407|NCT01425008|459867495|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
127793408|NCT01425008|459867496|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
127793409|NCT01425008|459867497|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
127793410|NCT01425008|459867498|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
127793411|NCT01425008|459867499|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
127793412|NCT01425008|459867500|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
127793413|NCT01425008|459867501|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
127629476|NCT02352493|459264567|FG016|Overall Study|Pregnancy|0|||
127793414|NCT01425008|459867502|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
127793415|NCT01425008|459867503|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
127793416|NCT01425008|459867504|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
127793417|NCT01425008|459867505|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
127793418|NCT01425008|459867506|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
127793419|NCT01425008|459867507|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
127793420|NCT01425008|459867508|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
127793421|NCT01425008|459867509|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
127793422|NCT01425008|459867491|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
127885312|NCT04380701|460203874|FG003|Overall Study|Private reason(s)|0|||
127885313|NCT04380701|460203875|FG004|Overall Study|Private reason(s)|0|||
127885314|NCT04380701|460203876|FG005|Overall Study|Private reason(s)|0|||
127885315|NCT04380701|460203877|FG006|Overall Study|Private reason(s)|1|||
127885316|NCT04380701|460203878|FG007|Overall Study|Private reason(s)|0|||
127885317|NCT04380701|460203879|FG008|Overall Study|Private reason(s)|1|||
127885318|NCT04380701|460203880|FG009|Overall Study|Private reason(s)|1|||
127793423|NCT01425008|459867492|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
127793424|NCT01425008|459867493|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
127793425|NCT01425008|459867494|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
127793426|NCT01425008|459867495|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
127793427|NCT01425008|459867496|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
127793428|NCT01425008|459867497|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
127793429|NCT01425008|459867498|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
127793430|NCT01425008|459867499|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
127793431|NCT01425008|459867500|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
127793432|NCT01425008|459867501|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
127793433|NCT01425008|459867502|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
127793434|NCT01425008|459867503|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
127793435|NCT01425008|459867504|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
127793436|NCT01425008|459867505|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
127793437|NCT01425008|459867506|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
127793438|NCT01425008|459867507|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
127793439|NCT01425008|459867508|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
127793440|NCT01425008|459867509|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
127793441|NCT00805480|459867512|FG000|Overall Study|Withdrawal by Subject|13|||
127793442|NCT00805480|459867513|FG001|Overall Study|Withdrawal by Subject|5|||
127793443|NCT00805480|459867514|FG002|Overall Study|Withdrawal by Subject|11|||
127793444|NCT00805480|459867515|FG003|Overall Study|Withdrawal by Subject|5|||
127793445|NCT00805480|459867512|FG000|Overall Study|Lost to Follow-up|1|||
127793446|NCT00805480|459867513|FG001|Overall Study|Lost to Follow-up|2|||
127793447|NCT00805480|459867514|FG002|Overall Study|Lost to Follow-up|0|||
127629477|NCT02352493|459264568|FG017|Overall Study|Pregnancy|0|||
127629478|NCT02352493|459264551|FG000|Overall Study|Withdrawal by Subject|0|||
127629479|NCT02352493|459264552|FG001|Overall Study|Withdrawal by Subject|0|||
127629480|NCT02352493|459264553|FG002|Overall Study|Withdrawal by Subject|0|||
127629481|NCT02352493|459264554|FG003|Overall Study|Withdrawal by Subject|0|||
127629482|NCT02352493|459264555|FG004|Overall Study|Withdrawal by Subject|0|||
127629483|NCT02352493|459264556|FG005|Overall Study|Withdrawal by Subject|0|||
127629484|NCT02352493|459264557|FG006|Overall Study|Withdrawal by Subject|0|||
127629485|NCT02352493|459264558|FG007|Overall Study|Withdrawal by Subject|0|||
127629486|NCT02352493|459264559|FG008|Overall Study|Withdrawal by Subject|1|||
127629487|NCT02352493|459264560|FG009|Overall Study|Withdrawal by Subject|0|||
127629488|NCT02352493|459264561|FG010|Overall Study|Withdrawal by Subject|0|||
127629489|NCT02352493|459264562|FG011|Overall Study|Withdrawal by Subject|0|||
127629490|NCT02352493|459264563|FG012|Overall Study|Withdrawal by Subject|0|||
127629491|NCT02352493|459264564|FG013|Overall Study|Withdrawal by Subject|0|||
127629492|NCT02352493|459264565|FG014|Overall Study|Withdrawal by Subject|1|||
127629493|NCT02352493|459264566|FG015|Overall Study|Withdrawal by Subject|0|||
127793448|NCT00805480|459867515|FG003|Overall Study|Lost to Follow-up|0|||
127793449|NCT00805480|459867512|FG000|Overall Study|Adverse Event|0|||
127793450|NCT00805480|459867513|FG001|Overall Study|Adverse Event|0|||
127793451|NCT00805480|459867514|FG002|Overall Study|Adverse Event|1|||
127793452|NCT00805480|459867515|FG003|Overall Study|Adverse Event|0|||
127885319|NCT04380701|460203881|FG010|Overall Study|Private reason(s)|0|||
127885320|NCT04380701|460203882|FG011|Overall Study|Private reason(s)|0|||
127885321|NCT04380701|460203883|FG012|Overall Study|Private reason(s)|0|||
127793453|NCT00562588|459867516|FG000|Overall Study|Adverse Event|40|||
127885322|NCT04380701|460203884|FG013|Overall Study|Private reason(s)|0|||
127885323|NCT04380701|460203885|FG014|Overall Study|Private reason(s)|0|||
127629494|NCT02352493|459264567|FG016|Overall Study|Withdrawal by Subject|0|||
127629495|NCT02352493|459264568|FG017|Overall Study|Withdrawal by Subject|0|||
127629496|NCT02352493|459264551|FG000|Overall Study|Lost to Follow-up|0|||
127629497|NCT02352493|459264552|FG001|Overall Study|Lost to Follow-up|0|||
127793454|NCT00562588|459867517|FG001|Overall Study|Adverse Event|58|||
127793455|NCT00562588|459867516|FG000|Overall Study|Protocol Violation|30|||
127793456|NCT00562588|459867517|FG001|Overall Study|Protocol Violation|26|||
127793457|NCT00562588|459867516|FG000|Overall Study|Lost to Follow-up|12|||
127793458|NCT00562588|459867517|FG001|Overall Study|Lost to Follow-up|4|||
127793459|NCT00562588|459867516|FG000|Overall Study|Withdrawal by Subject|10|||
127793460|NCT00562588|459867517|FG001|Overall Study|Withdrawal by Subject|9|||
127793461|NCT00562588|459867516|FG000|Overall Study|Other|0|||
127793462|NCT00562588|459867517|FG001|Overall Study|Other|2|||
127793463|NCT03315871|459867528|FG000|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
127793464|NCT03315871|459867529|FG001|PROSTVAC + CV301 + M7824|Withdrawal by Subject|2|||
127793465|NCT03315871|459867530|FG002|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
127793466|NCT03315871|459867528|FG000|PROSTVAC + CV301 + M7824|Adverse Event|0|||
127793467|NCT03315871|459867529|FG001|PROSTVAC + CV301 + M7824|Adverse Event|2|||
127793468|NCT03315871|459867530|FG002|PROSTVAC + CV301 + M7824|Adverse Event|0|||
127793469|NCT03315871|459867528|FG000|PROSTVAC + CV301 + M7824|Physician Decision|0|||
127793470|NCT03315871|459867529|FG001|PROSTVAC + CV301 + M7824|Physician Decision|1|||
127793471|NCT03315871|459867530|FG002|PROSTVAC + CV301 + M7824|Physician Decision|0|||
127793472|NCT03315871|459867528|FG000|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
127793473|NCT03315871|459867529|FG001|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|1|||
127793474|NCT03315871|459867530|FG002|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
127793475|NCT03315871|459867528|FG000|PROSTVAC + CV301|Progressive disease|0|||
127793476|NCT03315871|459867529|FG001|PROSTVAC + CV301|Progressive disease|0|||
127793477|NCT03315871|459867530|FG002|PROSTVAC + CV301|Progressive disease|1|||
127793478|NCT03315871|459867528|FG000|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
127793479|NCT03315871|459867529|FG001|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
127793480|NCT03315871|459867530|FG002|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|1|||
127793481|NCT04099251|459869331|FG000|Pre-Treatment|Other reasons|1|||
127793482|NCT04099251|459869332|FG001|Pre-Treatment|Other reasons|0|||
127793483|NCT04099251|459869331|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
127793484|NCT04099251|459869332|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
127793485|NCT04099251|459869331|FG000|Blinded Treatment Phase|Other reasons|16|||
127793486|NCT04099251|459869332|FG001|Blinded Treatment Phase|Other reasons|7|||
127793487|NCT04099251|459869331|FG000|Blinded Treatment Phase|Disease recurrence|26|||
127793488|NCT04099251|459869332|FG001|Blinded Treatment Phase|Disease recurrence|41|||
127793489|NCT04099251|459869331|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
127793490|NCT04099251|459869332|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
127793491|NCT04099251|459869331|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
127793492|NCT04099251|459869332|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
127793493|NCT04099251|459869331|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
127793494|NCT04099251|459869332|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
127793495|NCT04099251|459869331|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
127793496|NCT04099251|459869332|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
127793497|NCT04099251|459869331|FG000|Blinded Treatment Phase|Death|6|||
127793498|NCT04099251|459869332|FG001|Blinded Treatment Phase|Death|2|||
127793499|NCT04099251|459869331|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
127793500|NCT04099251|459869332|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
127793501|NCT04099251|459869331|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
127629498|NCT02352493|459264553|FG002|Overall Study|Lost to Follow-up|0|||
127629499|NCT02352493|459264554|FG003|Overall Study|Lost to Follow-up|0|||
127629500|NCT02352493|459264555|FG004|Overall Study|Lost to Follow-up|0|||
127629501|NCT02352493|459264556|FG005|Overall Study|Lost to Follow-up|0|||
127629502|NCT02352493|459264557|FG006|Overall Study|Lost to Follow-up|0|||
127629503|NCT02352493|459264558|FG007|Overall Study|Lost to Follow-up|0|||
127629504|NCT02352493|459264559|FG008|Overall Study|Lost to Follow-up|0|||
127629505|NCT02352493|459264560|FG009|Overall Study|Lost to Follow-up|1|||
127629506|NCT02352493|459264561|FG010|Overall Study|Lost to Follow-up|0|||
127629507|NCT02352493|459264562|FG011|Overall Study|Lost to Follow-up|0|||
127793502|NCT04099251|459869332|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
127793503|NCT04099251|459869331|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
127793504|NCT04099251|459869332|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
127793505|NCT04099251|459869331|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
127793506|NCT04099251|459869332|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
127793507|NCT04099251|459869331|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
127629508|NCT02352493|459264563|FG012|Overall Study|Lost to Follow-up|1|||
127793508|NCT04099251|459869332|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
127885324|NCT04380701|460203886|FG015|Overall Study|Private reason(s)|0|||
127629509|NCT02352493|459264564|FG013|Overall Study|Lost to Follow-up|2|||
127629510|NCT02352493|459264565|FG014|Overall Study|Lost to Follow-up|0|||
127629511|NCT02352493|459264566|FG015|Overall Study|Lost to Follow-up|0|||
127629512|NCT02352493|459264567|FG016|Overall Study|Lost to Follow-up|0|||
127793509|NCT04099251|459869331|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
127793510|NCT04099251|459869332|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
127793511|NCT04099251|459869331|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
127793512|NCT04099251|459869332|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
127793513|NCT04099251|459869331|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
127793514|NCT04099251|459869332|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
127793515|NCT04099251|459869331|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
127793516|NCT04099251|459869332|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
127793517|NCT05032157|459869333|FG000|Overall Study|Adverse Event|12|||
127793518|NCT05032157|459869334|FG001|Overall Study|Adverse Event|7|||
127793519|NCT05032157|459869333|FG000|Overall Study|Pregnancy|0|||
127793520|NCT05032157|459869334|FG001|Overall Study|Pregnancy|2|||
127793521|NCT05032157|459869333|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
127793522|NCT05032157|459869334|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
127793523|NCT05032157|459869333|FG000|Overall Study|Protocol Deviation|8|||
127793524|NCT05032157|459869334|FG001|Overall Study|Protocol Deviation|4|||
127793525|NCT05032157|459869333|FG000|Overall Study|Lost to Follow-up|1|||
127793526|NCT05032157|459869334|FG001|Overall Study|Lost to Follow-up|3|||
127793527|NCT05032157|459869333|FG000|Overall Study|Physician Decision|7|||
127793528|NCT05032157|459869334|FG001|Overall Study|Physician Decision|2|||
127793529|NCT05032157|459869333|FG000|Overall Study|Patient Decision|38|||
127793530|NCT05032157|459869334|FG001|Overall Study|Patient Decision|19|||
127793531|NCT03047980|459869335|FG000|Overall Study|Adverse Event|1|||
127793532|NCT01783678|459869336|FG000|Overall Study|Randomized but Not Treated|0|||
127793533|NCT01783678|459869337|FG001|Overall Study|Randomized but Not Treated|0|||
127793534|NCT01783678|459869338|FG002|Overall Study|Randomized but Not Treated|0|||
127793535|NCT01783678|459869339|FG003|Overall Study|Randomized but Not Treated|1|||
127793536|NCT01783678|459869340|FG004|Overall Study|Randomized but Not Treated|0|||
127793537|NCT01783678|459869341|FG005|Overall Study|Randomized but Not Treated|0|||
127793538|NCT01783678|459869336|FG000|Overall Study|Lack of Efficacy|1|||
127793539|NCT01783678|459869337|FG001|Overall Study|Lack of Efficacy|13|||
127793540|NCT01783678|459869338|FG002|Overall Study|Lack of Efficacy|1|||
127793541|NCT01783678|459869339|FG003|Overall Study|Lack of Efficacy|3|||
127793542|NCT01783678|459869340|FG004|Overall Study|Lack of Efficacy|6|||
127793543|NCT01783678|459869341|FG005|Overall Study|Lack of Efficacy|5|||
127793544|NCT01783678|459869336|FG000|Overall Study|Lost to Follow-up|0|||
127793545|NCT01783678|459869337|FG001|Overall Study|Lost to Follow-up|4|||
127793546|NCT01783678|459869338|FG002|Overall Study|Lost to Follow-up|0|||
127793547|NCT01783678|459869339|FG003|Overall Study|Lost to Follow-up|2|||
127793548|NCT01783678|459869340|FG004|Overall Study|Lost to Follow-up|1|||
127793549|NCT01783678|459869341|FG005|Overall Study|Lost to Follow-up|0|||
127793550|NCT01783678|459869336|FG000|Overall Study|Withdrew Consent|1|||
127793551|NCT01783678|459869337|FG001|Overall Study|Withdrew Consent|1|||
127793552|NCT01783678|459869338|FG002|Overall Study|Withdrew Consent|0|||
127793553|NCT01783678|459869339|FG003|Overall Study|Withdrew Consent|2|||
127793554|NCT01783678|459869340|FG004|Overall Study|Withdrew Consent|0|||
127793555|NCT01783678|459869341|FG005|Overall Study|Withdrew Consent|0|||
127793556|NCT01995071|459869342|FG000|Overall Study|Adverse Event|0|||
127793557|NCT01995071|459869343|FG001|Overall Study|Adverse Event|0|||
127793558|NCT01995071|459869344|FG002|Overall Study|Adverse Event|0|||
127793559|NCT01995071|459869345|FG003|Overall Study|Adverse Event|0|||
127793560|NCT01995071|459869346|FG004|Overall Study|Adverse Event|0|||
127793561|NCT01995071|459869347|FG005|Overall Study|Adverse Event|0|||
127793562|NCT01995071|459869348|FG006|Overall Study|Adverse Event|1|||
127793563|NCT01995071|459869349|FG007|Overall Study|Adverse Event|0|||
127629513|NCT02352493|459264568|FG017|Overall Study|Lost to Follow-up|0|||
127629514|NCT01465334|459264569|FG000|Overall Study|Disease Progression|1|||
127629515|NCT01465334|459264570|FG001|Overall Study|Disease Progression|0|||
127793564|NCT01995071|459869350|FG008|Overall Study|Adverse Event|0|||
127793565|NCT01995071|459869351|FG009|Overall Study|Adverse Event|0|||
127793566|NCT01995071|459869352|FG010|Overall Study|Adverse Event|0|||
127793567|NCT01995071|459869353|FG011|Overall Study|Adverse Event|0|||
127629516|NCT01465334|459264569|FG000|Overall Study|Adverse Event|1|||
127793568|NCT01995071|459869342|FG000|Overall Study|Moved|0|||
127793569|NCT01995071|459869343|FG001|Overall Study|Moved|0|||
127793570|NCT01995071|459869344|FG002|Overall Study|Moved|1|||
127793571|NCT01995071|459869345|FG003|Overall Study|Moved|0|||
127793572|NCT01995071|459869346|FG004|Overall Study|Moved|1|||
127793573|NCT01995071|459869347|FG005|Overall Study|Moved|0|||
127793574|NCT01995071|459869348|FG006|Overall Study|Moved|0|||
127793575|NCT01995071|459869349|FG007|Overall Study|Moved|0|||
127793576|NCT01995071|459869350|FG008|Overall Study|Moved|0|||
127793577|NCT01995071|459869351|FG009|Overall Study|Moved|0|||
127793578|NCT01995071|459869352|FG010|Overall Study|Moved|1|||
127793579|NCT01995071|459869353|FG011|Overall Study|Moved|0|||
127793580|NCT01995071|459869342|FG000|Overall Study|Lost to Follow-up|1|||
127629517|NCT01465334|459264570|FG001|Overall Study|Adverse Event|0|||
127629518|NCT01465334|459264569|FG000|Overall Study|Richter's transformation|0|||
127629519|NCT01465334|459264570|FG001|Overall Study|Richter's transformation|3|||
127629520|NCT01465334|459264569|FG000|Overall Study|Refractory Disease|0|||
127629521|NCT01465334|459264570|FG001|Overall Study|Refractory Disease|3|||
127629522|NCT00572572|459264571|FG000|Overall Study|Withdrawal by Subject|3|||
127629523|NCT00572572|459264572|FG001|Overall Study|Withdrawal by Subject|6|||
127885325|NCT04380701|460203887|FG016|Overall Study|Private reason(s)|0|||
127885326|NCT04380701|460203888|FG017|Overall Study|Private reason(s)|0|||
127885327|NCT04380701|460203889|FG018|Overall Study|Private reason(s)|0|||
127885328|NCT04380701|460203890|FG019|Overall Study|Private reason(s)|0|||
127885329|NCT04380701|460203891|FG020|Overall Study|Private reason(s)|0|||
127885330|NCT04380701|460203892|FG021|Overall Study|Private reason(s)|0|||
127885331|NCT04380701|460203893|FG022|Overall Study|Private reason(s)|0|||
127885332|NCT04380701|460203894|FG023|Overall Study|Private reason(s)|1|||
127885333|NCT04380701|460203895|FG024|Overall Study|Private reason(s)|0|||
127885334|NCT04380701|460203896|FG025|Overall Study|Private reason(s)|0|||
127885335|NCT04380701|460203897|FG026|Overall Study|Private reason(s)|0|||
127885336|NCT04380701|460203898|FG027|Overall Study|Private reason(s)|0|||
127885337|NCT04380701|460203899|FG028|Overall Study|Private reason(s)|0|||
127885338|NCT04380701|460203900|FG029|Overall Study|Private reason(s)|1|||
127885339|NCT04380701|460203901|FG030|Overall Study|Private reason(s)|0|||
127885340|NCT04380701|460203902|FG031|Overall Study|Private reason(s)|0|||
127885341|NCT04380701|460203903|FG032|Overall Study|Private reason(s)|0|||
127885342|NCT04380701|460203904|FG033|Overall Study|Private reason(s)|0|||
127885343|NCT04380701|460203871|FG000|Overall Study|Withdrawal by Subject|0|||
127885344|NCT04380701|460203872|FG001|Overall Study|Withdrawal by Subject|0|||
127885345|NCT04380701|460203873|FG002|Overall Study|Withdrawal by Subject|0|||
127885346|NCT04380701|460203874|FG003|Overall Study|Withdrawal by Subject|0|||
127885347|NCT04380701|460203875|FG004|Overall Study|Withdrawal by Subject|0|||
127885348|NCT04380701|460203876|FG005|Overall Study|Withdrawal by Subject|0|||
127885349|NCT04380701|460203877|FG006|Overall Study|Withdrawal by Subject|1|||
127885350|NCT04380701|460203878|FG007|Overall Study|Withdrawal by Subject|1|||
127885351|NCT04380701|460203879|FG008|Overall Study|Withdrawal by Subject|0|||
127885352|NCT04380701|460203880|FG009|Overall Study|Withdrawal by Subject|0|||
127629524|NCT01831089|459264573|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
127629525|NCT01831089|459264574|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
127702083|NCT01129102|459538960|FG002|Overall Study|Withdrawal by Subject|3|||
127702084|NCT01129102|459538958|FG000|Overall Study|Protocol Violation|0|||
127702085|NCT01129102|459538959|FG001|Overall Study|Protocol Violation|1|||
127702086|NCT01129102|459538960|FG002|Overall Study|Protocol Violation|1|||
127702087|NCT01129102|459538958|FG000|Overall Study|Pregnancy|0|||
127702088|NCT01129102|459538959|FG001|Overall Study|Pregnancy|0|||
127702089|NCT01129102|459538960|FG002|Overall Study|Pregnancy|1|||
127702090|NCT01129102|459538958|FG000|Overall Study|Adverse Event|2|||
127702091|NCT01129102|459538959|FG001|Overall Study|Adverse Event|2|||
127702092|NCT01129102|459538960|FG002|Overall Study|Adverse Event|1|||
127702093|NCT01129102|459538958|FG000|Overall Study|Lost to Follow-up|2|||
127702094|NCT01129102|459538959|FG001|Overall Study|Lost to Follow-up|0|||
127702095|NCT01129102|459538960|FG002|Overall Study|Lost to Follow-up|0|||
127702096|NCT03379675|459538963|FG000|Overall Study|Lost to Follow-up|0|||
127702097|NCT03379675|459538964|FG001|Overall Study|Lost to Follow-up|1|||
127702098|NCT03379675|459538965|FG002|Overall Study|Lost to Follow-up|0|||
127702099|NCT03379675|459538963|FG000|Overall Study|Adverse Event|2|||
127702100|NCT03379675|459538964|FG001|Overall Study|Adverse Event|0|||
127702101|NCT03379675|459538965|FG002|Overall Study|Adverse Event|0|||
127702102|NCT03379675|459538963|FG000|Overall Study|Withdrawal by Subject|2|||
127702103|NCT03379675|459538964|FG001|Overall Study|Withdrawal by Subject|1|||
127702104|NCT03379675|459538965|FG002|Overall Study|Withdrawal by Subject|2|||
127702105|NCT03371381|459538966|FG000|Overall Study|Death|5|||
127702106|NCT03371381|459538966|FG000|Overall Study|Study terminated by sponsor|3|||
127702107|NCT03371381|459538966|FG000|Overall Study|Other|4|||
127702108|NCT03628924|459538967|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
127702109|NCT03628924|459538968|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
127885353|NCT04380701|460203881|FG010|Overall Study|Withdrawal by Subject|0|||
127702110|NCT03628924|459538969|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
127702111|NCT03628924|459538970|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
127702112|NCT03628924|459538971|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
127702113|NCT03628924|459538972|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
127702114|NCT03628924|459538973|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
127702115|NCT03628924|459538967|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
127885354|NCT04380701|460203882|FG011|Overall Study|Withdrawal by Subject|1|||
127885355|NCT04380701|460203883|FG012|Overall Study|Withdrawal by Subject|0|||
127885356|NCT04380701|460203884|FG013|Overall Study|Withdrawal by Subject|1|||
127885357|NCT04380701|460203885|FG014|Overall Study|Withdrawal by Subject|0|||
127885358|NCT04380701|460203886|FG015|Overall Study|Withdrawal by Subject|0|||
127629526|NCT01831089|459264575|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
127629527|NCT01831089|459264576|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
127629528|NCT01831089|459264577|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
127793581|NCT01995071|459869343|FG001|Overall Study|Lost to Follow-up|0|||
127793582|NCT01995071|459869344|FG002|Overall Study|Lost to Follow-up|0|||
127793583|NCT01995071|459869345|FG003|Overall Study|Lost to Follow-up|0|||
127793584|NCT01995071|459869346|FG004|Overall Study|Lost to Follow-up|0|||
127793585|NCT01995071|459869347|FG005|Overall Study|Lost to Follow-up|0|||
127793586|NCT01995071|459869348|FG006|Overall Study|Lost to Follow-up|0|||
127793587|NCT01995071|459869349|FG007|Overall Study|Lost to Follow-up|1|||
127793588|NCT01995071|459869350|FG008|Overall Study|Lost to Follow-up|1|||
127793589|NCT01995071|459869351|FG009|Overall Study|Lost to Follow-up|0|||
127793590|NCT01995071|459869352|FG010|Overall Study|Lost to Follow-up|0|||
127629529|NCT01831089|459264578|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
127629530|NCT01831089|459264573|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
127629531|NCT01831089|459264574|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
127629532|NCT01831089|459264575|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
127629533|NCT01831089|459264576|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
127629534|NCT01831089|459264577|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
127629535|NCT01831089|459264578|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
127629536|NCT01831089|459264573|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
127629537|NCT01831089|459264574|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
127629538|NCT01831089|459264575|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
127629539|NCT01831089|459264576|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
127629540|NCT01831089|459264577|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
127629541|NCT01831089|459264578|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
127629542|NCT01831089|459264573|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
127629543|NCT01831089|459264574|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
127793591|NCT01995071|459869353|FG011|Overall Study|Lost to Follow-up|0|||
127793592|NCT01995071|459869342|FG000|Overall Study|Incarcerated|0|||
127793593|NCT01995071|459869343|FG001|Overall Study|Incarcerated|0|||
127629544|NCT01831089|459264575|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
127629545|NCT01831089|459264576|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
127629546|NCT01831089|459264577|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
127629547|NCT01831089|459264578|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
127629548|NCT01831089|459264573|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
127629549|NCT01831089|459264574|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
127629550|NCT01831089|459264575|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
127629551|NCT01831089|459264576|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
127629552|NCT01831089|459264577|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
127629553|NCT01831089|459264578|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
127629554|NCT01831089|459264573|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
127629555|NCT01831089|459264574|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
127629556|NCT01831089|459264575|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
127629557|NCT01831089|459264576|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
127629558|NCT01831089|459264577|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
127629559|NCT01831089|459264578|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
127629560|NCT01831089|459264573|FG000|Cohort III: Dose Level 3|Global end of study|0|||
127629561|NCT01831089|459264574|FG001|Cohort III: Dose Level 3|Global end of study|0|||
127629562|NCT01831089|459264575|FG002|Cohort III: Dose Level 3|Global end of study|1|||
127629563|NCT01831089|459264576|FG003|Cohort III: Dose Level 3|Global end of study|0|||
127629564|NCT01831089|459264577|FG004|Cohort III: Dose Level 3|Global end of study|0|||
127629565|NCT01831089|459264578|FG005|Cohort III: Dose Level 3|Global end of study|0|||
127629566|NCT01831089|459264573|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
127629567|NCT01831089|459264574|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
127629568|NCT01831089|459264575|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
127629569|NCT01831089|459264576|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
127629570|NCT01831089|459264577|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
127629571|NCT01831089|459264578|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
127793594|NCT01995071|459869344|FG002|Overall Study|Incarcerated|0|||
127793595|NCT01995071|459869345|FG003|Overall Study|Incarcerated|0|||
127793596|NCT01995071|459869346|FG004|Overall Study|Incarcerated|0|||
127793597|NCT01995071|459869347|FG005|Overall Study|Incarcerated|0|||
127793598|NCT01995071|459869348|FG006|Overall Study|Incarcerated|0|||
127793599|NCT01995071|459869349|FG007|Overall Study|Incarcerated|1|||
127793600|NCT01995071|459869350|FG008|Overall Study|Incarcerated|0|||
127629572|NCT01831089|459264573|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
127629573|NCT01831089|459264574|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
127629574|NCT01831089|459264575|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
127629575|NCT01831089|459264576|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
127793601|NCT01995071|459869351|FG009|Overall Study|Incarcerated|0|||
127793602|NCT01995071|459869352|FG010|Overall Study|Incarcerated|0|||
127629576|NCT01831089|459264577|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
127629577|NCT01831089|459264578|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
127629578|NCT01831089|459264573|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
127629579|NCT01831089|459264574|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
127629580|NCT01831089|459264575|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
127629581|NCT01831089|459264576|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
127629582|NCT01831089|459264577|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
127629583|NCT01831089|459264578|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
127629584|NCT01831089|459264573|FG000|Cohort V: Dose Level 5|Death|0|||
127629585|NCT01831089|459264574|FG001|Cohort V: Dose Level 5|Death|0|||
127629586|NCT01831089|459264575|FG002|Cohort V: Dose Level 5|Death|0|||
127629587|NCT01831089|459264576|FG003|Cohort V: Dose Level 5|Death|0|||
127629588|NCT01831089|459264577|FG004|Cohort V: Dose Level 5|Death|1|||
127629589|NCT01831089|459264578|FG005|Cohort V: Dose Level 5|Death|0|||
127629590|NCT01831089|459264573|FG000|Cohort V: Dose Level 5|Global end of study|0|||
127629591|NCT01831089|459264574|FG001|Cohort V: Dose Level 5|Global end of study|0|||
127629592|NCT01831089|459264575|FG002|Cohort V: Dose Level 5|Global end of study|0|||
127629593|NCT01831089|459264576|FG003|Cohort V: Dose Level 5|Global end of study|0|||
127629594|NCT01831089|459264577|FG004|Cohort V: Dose Level 5|Global end of study|2|||
127629595|NCT01831089|459264578|FG005|Cohort V: Dose Level 5|Global end of study|0|||
127629596|NCT01831089|459264573|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
127629597|NCT01831089|459264574|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
127629598|NCT01831089|459264575|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
127629599|NCT01831089|459264576|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
127629600|NCT01831089|459264577|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
127629601|NCT01831089|459264578|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
127629602|NCT01831089|459264573|FG000|Cohort B: Arm B|Progressive disease|0|||
127629603|NCT01831089|459264574|FG001|Cohort B: Arm B|Progressive disease|0|||
127629604|NCT01831089|459264575|FG002|Cohort B: Arm B|Progressive disease|0|||
127629605|NCT01831089|459264576|FG003|Cohort B: Arm B|Progressive disease|0|||
127629606|NCT01831089|459264577|FG004|Cohort B: Arm B|Progressive disease|0|||
127629607|NCT01831089|459264578|FG005|Cohort B: Arm B|Progressive disease|8|||
127629608|NCT01831089|459264573|FG000|Cohort B: Arm B|Physician Decision|0|||
127629609|NCT01831089|459264574|FG001|Cohort B: Arm B|Physician Decision|0|||
127629610|NCT01831089|459264575|FG002|Cohort B: Arm B|Physician Decision|0|||
127629611|NCT01831089|459264576|FG003|Cohort B: Arm B|Physician Decision|0|||
127629612|NCT01831089|459264577|FG004|Cohort B: Arm B|Physician Decision|0|||
127629613|NCT01831089|459264578|FG005|Cohort B: Arm B|Physician Decision|2|||
127629614|NCT01831089|459264573|FG000|Cohort B: Arm B|Never treated|0|||
127793603|NCT01995071|459869353|FG011|Overall Study|Incarcerated|0|||
127793604|NCT00112905|459869354|FG000|Overall Study|Adverse Event|4|||
127793605|NCT00112905|459869354|FG000|Overall Study|Death|1|||
127793606|NCT00112905|459869354|FG000|Overall Study|Ineligibility|5|||
127793607|NCT00112905|459869354|FG000|Overall Study|Alternative treatment|1|||
127793608|NCT00112905|459869354|FG000|Overall Study|performance status was deteiorating|1|||
127793609|NCT01979523|459869355|FG000|Overall Study|Withdrawal by Subject|1|||
127793610|NCT01979523|459869356|FG001|Overall Study|Withdrawal by Subject|0|||
127793611|NCT00488982|459869357|FG000|Course 1|Physician Decision|0|||
127793612|NCT00488982|459869358|FG001|Course 1|Physician Decision|2|||
127793613|NCT00488982|459869359|FG002|Course 1|Physician Decision|4|||
127793614|NCT00488982|459869357|FG000|Course 1|Withdrawal by Subject|0|||
127793615|NCT00488982|459869358|FG001|Course 1|Withdrawal by Subject|8|||
127793616|NCT00488982|459869359|FG002|Course 1|Withdrawal by Subject|2|||
127793617|NCT00488982|459869357|FG000|Course 1|nonprotocol therapy|0|||
127793618|NCT00488982|459869358|FG001|Course 1|nonprotocol therapy|2|||
127793619|NCT00488982|459869359|FG002|Course 1|nonprotocol therapy|2|||
127793620|NCT00488982|459869357|FG000|Course 1|Adverse Event|0|||
127793621|NCT00488982|459869358|FG001|Course 1|Adverse Event|0|||
127793622|NCT00488982|459869359|FG002|Course 1|Adverse Event|6|||
127793623|NCT01709149|459869366|FG000|Open-label Lead-in Phase|Adverse Event|109|||
127793624|NCT01709149|459869367|FG001|Open-label Lead-in Phase|Adverse Event|0|||
127793625|NCT01709149|459869368|FG002|Open-label Lead-in Phase|Adverse Event|0|||
127793626|NCT01709149|459869366|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
127793627|NCT01709149|459869367|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
127793628|NCT01709149|459869368|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
127793629|NCT01709149|459869366|FG000|Open-label Lead-in Phase|Death|1|||
127793630|NCT01709149|459869367|FG001|Open-label Lead-in Phase|Death|0|||
127793631|NCT01709149|459869368|FG002|Open-label Lead-in Phase|Death|0|||
127793632|NCT01709149|459869366|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
127793633|NCT01709149|459869367|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
127793634|NCT01709149|459869368|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
127793635|NCT01709149|459869366|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
127793636|NCT01709149|459869367|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
127793637|NCT01709149|459869368|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
127793638|NCT01709149|459869366|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
127793639|NCT01709149|459869367|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
127793640|NCT01709149|459869368|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
127793641|NCT01709149|459869366|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
127793642|NCT01709149|459869367|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
127793643|NCT01709149|459869368|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
127793644|NCT01709149|459869366|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
127793645|NCT01709149|459869367|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
127793646|NCT01709149|459869368|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
127793647|NCT01709149|459869366|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
127793648|NCT01709149|459869367|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
127793649|NCT01709149|459869368|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
127793650|NCT01709149|459869366|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
127793651|NCT01709149|459869367|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
127793652|NCT01709149|459869368|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
127793653|NCT02192827|459869369|FG000|Overall Study|Lost to Follow-up|25|||
127793654|NCT02192827|459869370|FG001|Overall Study|Lost to Follow-up|27|||
127793655|NCT02192827|459869369|FG000|Overall Study|Given additional steroids with admission|13|||
127793656|NCT02192827|459869370|FG001|Overall Study|Given additional steroids with admission|11|||
127885359|NCT04380701|460203887|FG016|Overall Study|Withdrawal by Subject|1|||
127629615|NCT01831089|459264574|FG001|Cohort B: Arm B|Never treated|0|||
127629616|NCT01831089|459264575|FG002|Cohort B: Arm B|Never treated|0|||
127629617|NCT01831089|459264576|FG003|Cohort B: Arm B|Never treated|0|||
127629618|NCT01831089|459264577|FG004|Cohort B: Arm B|Never treated|0|||
127629619|NCT01831089|459264578|FG005|Cohort B: Arm B|Never treated|2|||
127629620|NCT01831089|459264573|FG000|Cohort B: Arm B|Adverse Event|0|||
127629621|NCT01831089|459264574|FG001|Cohort B: Arm B|Adverse Event|0|||
127629622|NCT01831089|459264575|FG002|Cohort B: Arm B|Adverse Event|0|||
127629623|NCT01831089|459264576|FG003|Cohort B: Arm B|Adverse Event|0|||
127629624|NCT01831089|459264577|FG004|Cohort B: Arm B|Adverse Event|0|||
127793657|NCT00535132|459869371|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
127793658|NCT00535132|459869372|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
127793659|NCT00535132|459869371|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
127793660|NCT00535132|459869372|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
127793661|NCT02590588|459869373|FG000|Overall Study|Adverse Event|1|||
127885360|NCT04380701|460203888|FG017|Overall Study|Withdrawal by Subject|0|||
127629625|NCT01831089|459264578|FG005|Cohort B: Arm B|Adverse Event|1|||
127629626|NCT01831089|459264573|FG000|Cohort B: Arm B|Global end of study|0|||
127629627|NCT01831089|459264574|FG001|Cohort B: Arm B|Global end of study|0|||
127793662|NCT01857869|459869378|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
127793663|NCT01857869|459869379|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
127793664|NCT01857869|459869380|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
127793665|NCT01857869|459869381|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
127793666|NCT01857869|459869382|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
127793667|NCT01857869|459869383|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
127793668|NCT01857869|459869384|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
127793669|NCT01857869|459869385|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
127793670|NCT01857869|459869386|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
127793671|NCT01857869|459869387|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
127793672|NCT01857869|459869378|FG000|Primary/Challenge Phase|Pregnancy|1|||
127793673|NCT01857869|459869379|FG001|Primary/Challenge Phase|Pregnancy|0|||
127793674|NCT01857869|459869380|FG002|Primary/Challenge Phase|Pregnancy|0|||
127793675|NCT01857869|459869381|FG003|Primary/Challenge Phase|Pregnancy|0|||
127793676|NCT01857869|459869382|FG004|Primary/Challenge Phase|Pregnancy|0|||
127793677|NCT01857869|459869383|FG005|Primary/Challenge Phase|Pregnancy|0|||
127793678|NCT01857869|459869384|FG006|Primary/Challenge Phase|Pregnancy|0|||
127793679|NCT01857869|459869385|FG007|Primary/Challenge Phase|Pregnancy|0|||
127793680|NCT01857869|459869386|FG008|Primary/Challenge Phase|Pregnancy|0|||
127793681|NCT01857869|459869387|FG009|Primary/Challenge Phase|Pregnancy|0|||
127793682|NCT01857869|459869378|FG000|Primary/Challenge Phase|Protocol Violation|1|||
127793683|NCT01857869|459869379|FG001|Primary/Challenge Phase|Protocol Violation|0|||
127793684|NCT01857869|459869380|FG002|Primary/Challenge Phase|Protocol Violation|0|||
127793685|NCT01857869|459869381|FG003|Primary/Challenge Phase|Protocol Violation|0|||
127793686|NCT01857869|459869382|FG004|Primary/Challenge Phase|Protocol Violation|0|||
127793687|NCT01857869|459869383|FG005|Primary/Challenge Phase|Protocol Violation|0|||
127793688|NCT01857869|459869384|FG006|Primary/Challenge Phase|Protocol Violation|0|||
127793689|NCT01857869|459869385|FG007|Primary/Challenge Phase|Protocol Violation|0|||
127793690|NCT01857869|459869386|FG008|Primary/Challenge Phase|Protocol Violation|0|||
127793691|NCT01857869|459869387|FG009|Primary/Challenge Phase|Protocol Violation|0|||
127629628|NCT01831089|459264575|FG002|Cohort B: Arm B|Global end of study|0|||
127629629|NCT01831089|459264576|FG003|Cohort B: Arm B|Global end of study|0|||
127629630|NCT01831089|459264577|FG004|Cohort B: Arm B|Global end of study|0|||
127629631|NCT01831089|459264578|FG005|Cohort B: Arm B|Global end of study|1|||
127629632|NCT01925183|459264584|FG000|Overall Study|Adverse Event|1|||
127629633|NCT01925183|459264585|FG001|Overall Study|Adverse Event|0|||
127629634|NCT01046110|459264586|FG000|Overall Study|Adverse Event|9|||
127629635|NCT01046110|459264587|FG001|Overall Study|Adverse Event|2|||
127629636|NCT01046110|459264586|FG000|Overall Study|Lack of Efficacy|0|||
127793692|NCT01857869|459869378|FG000|Primary/Challenge Phase|Other|1|||
127629637|NCT01046110|459264587|FG001|Overall Study|Lack of Efficacy|1|||
127629638|NCT01046110|459264586|FG000|Overall Study|Protocol Violation|7|||
127629639|NCT01046110|459264587|FG001|Overall Study|Protocol Violation|12|||
127793693|NCT01857869|459869379|FG001|Primary/Challenge Phase|Other|1|||
127793694|NCT01857869|459869380|FG002|Primary/Challenge Phase|Other|0|||
127793695|NCT01857869|459869381|FG003|Primary/Challenge Phase|Other|0|||
127629640|NCT01046110|459264586|FG000|Overall Study|Withdrawal Criteria|3|||
127629641|NCT01046110|459264587|FG001|Overall Study|Withdrawal Criteria|5|||
127629642|NCT01046110|459264586|FG000|Overall Study|Unclassified|36|||
127793696|NCT01857869|459869382|FG004|Primary/Challenge Phase|Other|0|||
127793697|NCT01857869|459869383|FG005|Primary/Challenge Phase|Other|0|||
127793698|NCT01857869|459869384|FG006|Primary/Challenge Phase|Other|0|||
127793699|NCT01857869|459869385|FG007|Primary/Challenge Phase|Other|0|||
127793700|NCT01857869|459869386|FG008|Primary/Challenge Phase|Other|0|||
127793701|NCT01857869|459869387|FG009|Primary/Challenge Phase|Other|0|||
127793702|NCT01857869|459869378|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
127793703|NCT01857869|459869379|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
127629643|NCT01046110|459264587|FG001|Overall Study|Unclassified|35|||
127629644|NCT02114892|459264588|FG000|Overall Study|Lost to Follow-up|1|||
127629645|NCT02114892|459264589|FG001|Overall Study|Lost to Follow-up|2|||
127629646|NCT00718042|459264594|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
127629647|NCT00718042|459264595|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
127629648|NCT00718042|459264596|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
127629649|NCT00718042|459264597|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
127629650|NCT00718042|459264598|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
127629651|NCT00718042|459264599|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
127629652|NCT00718042|459264594|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
127629653|NCT00718042|459264595|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
127629654|NCT00718042|459264596|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
127629655|NCT00718042|459264597|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
127629656|NCT00718042|459264598|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
127629657|NCT00718042|459264599|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
127793704|NCT01857869|459869380|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
127793705|NCT01857869|459869381|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
127793706|NCT01857869|459869382|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
127793707|NCT01857869|459869383|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
127793708|NCT01857869|459869384|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
127793709|NCT01857869|459869385|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
127793710|NCT01857869|459869386|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
127793711|NCT01857869|459869387|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
127793712|NCT01857869|459869378|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
127793713|NCT01857869|459869379|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
127793714|NCT01857869|459869380|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
127793715|NCT01857869|459869381|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
127793716|NCT01857869|459869382|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
127793717|NCT01857869|459869383|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
127793718|NCT01857869|459869384|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
127793719|NCT01857869|459869385|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
127793720|NCT01857869|459869386|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
127793721|NCT01857869|459869387|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
127629658|NCT00718042|459264594|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
127629659|NCT00718042|459264595|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
127629660|NCT00718042|459264596|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
127793722|NCT04607733|459869393|FG000|Overall Study|Lost to Follow-up|1|||
127793723|NCT04607733|459869394|FG001|Overall Study|Lost to Follow-up|0|||
127793724|NCT04607733|459869395|FG002|Overall Study|Lost to Follow-up|0|||
127793725|NCT04607733|459869396|FG003|Overall Study|Lost to Follow-up|1|||
127793726|NCT04607733|459869397|FG004|Overall Study|Lost to Follow-up|1|||
127793727|NCT04607733|459869398|FG005|Overall Study|Lost to Follow-up|0|||
127793728|NCT04607733|459869393|FG000|Overall Study|Withdrawal by Subject|0|||
127793729|NCT04607733|459869394|FG001|Overall Study|Withdrawal by Subject|0|||
127793730|NCT04607733|459869395|FG002|Overall Study|Withdrawal by Subject|0|||
127793731|NCT04607733|459869396|FG003|Overall Study|Withdrawal by Subject|0|||
127793732|NCT04607733|459869397|FG004|Overall Study|Withdrawal by Subject|1|||
127793733|NCT04607733|459869398|FG005|Overall Study|Withdrawal by Subject|0|||
127793734|NCT01827670|459869422|FG000|Overall Study|Withdrawal of Consent|3|||
127793735|NCT01827670|459869423|FG001|Overall Study|Withdrawal of Consent|2|||
127793736|NCT01827670|459869422|FG000|Overall Study|Lost to Follow-up|0|||
127793737|NCT01827670|459869423|FG001|Overall Study|Lost to Follow-up|1|||
127793738|NCT02941627|459869430|FG000|Overall Study|Death|1|||
127793739|NCT02941627|459869430|FG000|Overall Study|Surgical failure|1|||
127793740|NCT02941627|459869430|FG000|Overall Study|cholesteatoma prevented implantation|1|||
127793741|NCT03594227|459869431|FG000|Overall Study|Adverse Event|2|||
127793742|NCT03594227|459869432|FG001|Overall Study|Adverse Event|1|||
127793743|NCT03594227|459869433|FG002|Overall Study|Adverse Event|0|||
127793744|NCT03594227|459869434|FG003|Overall Study|Adverse Event|2|||
127793745|NCT03594227|459869431|FG000|Overall Study|Lost to Follow-up|1|||
127793746|NCT03594227|459869432|FG001|Overall Study|Lost to Follow-up|1|||
127793747|NCT03594227|459869433|FG002|Overall Study|Lost to Follow-up|1|||
127793748|NCT03594227|459869434|FG003|Overall Study|Lost to Follow-up|0|||
127793749|NCT03594227|459869431|FG000|Overall Study|Withdrawal by Subject|1|||
127793750|NCT03594227|459869432|FG001|Overall Study|Withdrawal by Subject|1|||
127793751|NCT03594227|459869433|FG002|Overall Study|Withdrawal by Subject|1|||
127793752|NCT03594227|459869434|FG003|Overall Study|Withdrawal by Subject|1|||
127793753|NCT03594227|459869431|FG000|Overall Study|Pregnancy|0|||
127793754|NCT03594227|459869432|FG001|Overall Study|Pregnancy|1|||
127793755|NCT03594227|459869433|FG002|Overall Study|Pregnancy|0|||
127793756|NCT03594227|459869434|FG003|Overall Study|Pregnancy|0|||
127793757|NCT03594227|459869431|FG000|Overall Study|Sponsor Decision|0|||
127793758|NCT03594227|459869432|FG001|Overall Study|Sponsor Decision|0|||
127793759|NCT03594227|459869433|FG002|Overall Study|Sponsor Decision|0|||
127793760|NCT03594227|459869434|FG003|Overall Study|Sponsor Decision|1|||
127793761|NCT03594227|459869431|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
127793762|NCT03594227|459869432|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
127793763|NCT03594227|459869433|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
127793764|NCT03594227|459869434|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
127793765|NCT00790907|459869435|FG000|Overall Study|Adverse Event|9|||
127793766|NCT00790907|459869436|FG001|Overall Study|Adverse Event|7|||
127793767|NCT00790907|459869437|FG002|Overall Study|Adverse Event|6|||
127793768|NCT00790907|459869435|FG000|Overall Study|Physician Decision|304|||
127793769|NCT00790907|459869436|FG001|Overall Study|Physician Decision|271|||
127793770|NCT00790907|459869437|FG002|Overall Study|Physician Decision|255|||
127793771|NCT00790907|459869435|FG000|Overall Study|Withdrawal by Subject|1|||
127793772|NCT00790907|459869436|FG001|Overall Study|Withdrawal by Subject|7|||
127885361|NCT04380701|460203889|FG018|Overall Study|Withdrawal by Subject|0|||
127885362|NCT04380701|460203890|FG019|Overall Study|Withdrawal by Subject|0|||
127793773|NCT00790907|459869437|FG002|Overall Study|Withdrawal by Subject|5|||
127793774|NCT00790907|459869435|FG000|Overall Study|Bleeding Event|11|||
127885363|NCT04380701|460203891|FG020|Overall Study|Withdrawal by Subject|0|||
127885364|NCT04380701|460203892|FG021|Overall Study|Withdrawal by Subject|0|||
127793775|NCT00790907|459869436|FG001|Overall Study|Bleeding Event|16|||
127793776|NCT00790907|459869437|FG002|Overall Study|Bleeding Event|21|||
127793777|NCT00790907|459869435|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
127793778|NCT00790907|459869436|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
127793779|NCT00790907|459869437|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
127793780|NCT00790907|459869435|FG000|Overall Study|Qualifying Condition Not Present|29|||
127793781|NCT00790907|459869436|FG001|Overall Study|Qualifying Condition Not Present|14|||
127885365|NCT04380701|460203893|FG022|Overall Study|Withdrawal by Subject|2|||
127793782|NCT00790907|459869437|FG002|Overall Study|Qualifying Condition Not Present|16|||
127793783|NCT00790907|459869435|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
127793784|NCT00790907|459869436|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
127793785|NCT00790907|459869437|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
127793786|NCT00790907|459869435|FG000|Overall Study|Did Not Receive Study Drug|10|||
127793787|NCT00790907|459869436|FG001|Overall Study|Did Not Receive Study Drug|0|||
127793788|NCT00790907|459869437|FG002|Overall Study|Did Not Receive Study Drug|0|||
127793789|NCT01888640|459869438|FG000|Overall Study|Lost to Follow-up|1|||
127793790|NCT01888640|459869439|FG001|Overall Study|Lost to Follow-up|2|||
127793791|NCT01888640|459869440|FG002|Overall Study|Lost to Follow-up|0|||
127793792|NCT01888640|459869438|FG000|Overall Study|Withdrawal by Subject|15|||
127793793|NCT01888640|459869439|FG001|Overall Study|Withdrawal by Subject|11|||
127793794|NCT01888640|459869440|FG002|Overall Study|Withdrawal by Subject|4|||
127629661|NCT00718042|459264597|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
127629662|NCT00718042|459264598|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
127629663|NCT00718042|459264599|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
127629664|NCT00718042|459264594|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
127629665|NCT00718042|459264595|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
127629666|NCT00718042|459264596|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
127793795|NCT01888640|459869438|FG000|Overall Study|Minimum dose not met|10|||
127793796|NCT01888640|459869439|FG001|Overall Study|Minimum dose not met|16|||
127793797|NCT01888640|459869440|FG002|Overall Study|Minimum dose not met|0|||
127793798|NCT01888640|459869438|FG000|Overall Study|Given wrong unit (placebo)|1|||
127793799|NCT01888640|459869439|FG001|Overall Study|Given wrong unit (placebo)|0|||
127793800|NCT01888640|459869440|FG002|Overall Study|Given wrong unit (placebo)|0|||
127793801|NCT01888640|459869438|FG000|Overall Study|Excluded for prior TENS|0|||
127793802|NCT01888640|459869439|FG001|Overall Study|Excluded for prior TENS|1|||
127793803|NCT01888640|459869440|FG002|Overall Study|Excluded for prior TENS|0|||
127793804|NCT01888640|459869438|FG000|Overall Study|Researcher Termination of Participant|0|||
127793805|NCT01888640|459869439|FG001|Overall Study|Researcher Termination of Participant|1|||
127793806|NCT01888640|459869440|FG002|Overall Study|Researcher Termination of Participant|1|||
127793807|NCT00109707|459869446|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
127793808|NCT00109707|459869447|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
127793809|NCT00109707|459869448|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
127793810|NCT00109707|459869446|FG000|Overall Study|Abnormal laboratory values|1|||
127793811|NCT00109707|459869447|FG001|Overall Study|Abnormal laboratory values|0|||
127793812|NCT00109707|459869448|FG002|Overall Study|Abnormal laboratory values|0|||
127793813|NCT00109707|459869446|FG000|Overall Study|Administrative problems|2|||
127793814|NCT00109707|459869447|FG001|Overall Study|Administrative problems|0|||
127793815|NCT00109707|459869448|FG002|Overall Study|Administrative problems|1|||
127793816|NCT00109707|459869446|FG000|Overall Study|Adverse Event|10|||
127793817|NCT00109707|459869447|FG001|Overall Study|Adverse Event|2|||
127793818|NCT00109707|459869448|FG002|Overall Study|Adverse Event|3|||
127793819|NCT00109707|459869446|FG000|Overall Study|Death|4|||
127793820|NCT00109707|459869447|FG001|Overall Study|Death|0|||
127793821|NCT00109707|459869448|FG002|Overall Study|Death|0|||
127793822|NCT00109707|459869446|FG000|Overall Study|Disease progression|12|||
127793823|NCT00109707|459869447|FG001|Overall Study|Disease progression|4|||
127793824|NCT00109707|459869448|FG002|Overall Study|Disease progression|3|||
127793825|NCT00109707|459869446|FG000|Overall Study|Lost to Follow-up|3|||
127793826|NCT00109707|459869447|FG001|Overall Study|Lost to Follow-up|0|||
127793827|NCT00109707|459869448|FG002|Overall Study|Lost to Follow-up|0|||
127793828|NCT00109707|459869446|FG000|Overall Study|Protocol Violation|1|||
127793829|NCT00109707|459869447|FG001|Overall Study|Protocol Violation|0|||
127793830|NCT00109707|459869448|FG002|Overall Study|Protocol Violation|0|||
127793831|NCT00109707|459869446|FG000|Overall Study|Patient withdrew consent|6|||
127793832|NCT00109707|459869447|FG001|Overall Study|Patient withdrew consent|1|||
127793833|NCT00109707|459869448|FG002|Overall Study|Patient withdrew consent|0|||
127793834|NCT02199080|459869451|FG000|Overall Study|Protocol Violation|12|||
127793835|NCT03436862|459869456|FG000|Overall Study|Adverse Event|4|||
127793836|NCT03436862|459869456|FG000|Overall Study|Progressive Disease|2|||
127793837|NCT02228590|459869458|FG000|Overall Study|Withdrawal by Subject|1|||
127629667|NCT00718042|459264597|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
127629668|NCT00718042|459264598|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
127793838|NCT00391222|459869459|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
127793839|NCT00391222|459869460|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
127793840|NCT00391222|459869461|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
127793841|NCT00391222|459869462|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
127793842|NCT00391222|459869459|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
127793843|NCT00391222|459869460|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
127793844|NCT00391222|459869461|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
127793845|NCT00391222|459869462|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
127793846|NCT00391222|459869459|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
127793847|NCT00391222|459869460|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
127793848|NCT00391222|459869461|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
127793849|NCT00391222|459869462|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
127793850|NCT00391222|459869459|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
127793851|NCT00391222|459869460|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
127793852|NCT00391222|459869461|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
127793853|NCT00391222|459869462|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
127793854|NCT00391222|459869459|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
127793855|NCT00391222|459869460|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
127793856|NCT00391222|459869461|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
127793857|NCT00391222|459869462|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
127793858|NCT00391222|459869459|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
127793859|NCT00391222|459869460|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
127793860|NCT00391222|459869461|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
127793861|NCT00391222|459869462|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
127793862|NCT00391222|459869459|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
127793863|NCT00391222|459869460|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
127793864|NCT00391222|459869461|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
127793865|NCT00391222|459869462|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
127793866|NCT00391222|459869459|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
127793867|NCT00391222|459869460|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
127793868|NCT00391222|459869461|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
127793869|NCT00391222|459869462|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
127793870|NCT00391222|459869459|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
127793871|NCT00391222|459869460|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
127793872|NCT00391222|459869461|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
127793873|NCT00391222|459869462|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
127793874|NCT00391222|459869459|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
127793875|NCT00391222|459869460|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
127793876|NCT00391222|459869461|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
127793877|NCT00391222|459869462|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
127793878|NCT00391222|459869459|FG000|Period III (Double-Blind Treatment)|Other|6|||
127793879|NCT00391222|459869460|FG001|Period III (Double-Blind Treatment)|Other|1|||
127793880|NCT00391222|459869461|FG002|Period III (Double-Blind Treatment)|Other|6|||
127793881|NCT00391222|459869462|FG003|Period III (Double-Blind Treatment)|Other|0|||
127793882|NCT01097863|459869463|FG000|Overall Study|Discomfort|1|||
127793883|NCT01097863|459869464|FG001|Overall Study|Discomfort|0|||
127793884|NCT01097863|459869465|FG002|Overall Study|Discomfort|1|||
127793885|NCT01097863|459869463|FG000|Overall Study|Did not return for final visit|0|||
127793886|NCT01097863|459869464|FG001|Overall Study|Did not return for final visit|0|||
127793887|NCT01097863|459869465|FG002|Overall Study|Did not return for final visit|1|||
127793888|NCT00574275|459869466|FG000|Overall Study|Randomized but not treated|2|||
127793889|NCT00574275|459869467|FG001|Overall Study|Randomized but not treated|3|||
127793890|NCT00574275|459869466|FG000|Overall Study|Adverse Event|32|||
127793891|NCT00574275|459869467|FG001|Overall Study|Adverse Event|76|||
127793892|NCT00574275|459869466|FG000|Overall Study|Disease progression|160|||
127793893|NCT00574275|459869467|FG001|Overall Study|Disease progression|146|||
127793894|NCT00574275|459869466|FG000|Overall Study|Lost to Follow-up|2|||
127793895|NCT00574275|459869467|FG001|Overall Study|Lost to Follow-up|1|||
127793896|NCT00574275|459869466|FG000|Overall Study|Study stopped based on DMC decision|62|||
127793897|NCT00574275|459869467|FG001|Overall Study|Study stopped based on DMC decision|23|||
127793898|NCT00574275|459869466|FG000|Overall Study|Withdrawal by Subject|15|||
127793899|NCT00574275|459869467|FG001|Overall Study|Withdrawal by Subject|17|||
127793900|NCT00574275|459869466|FG000|Overall Study|Error calculating tumor measurement|1|||
127793901|NCT00574275|459869467|FG001|Overall Study|Error calculating tumor measurement|0|||
127793902|NCT00574275|459869466|FG000|Overall Study|Physician Decision|1|||
127793903|NCT00574275|459869467|FG001|Overall Study|Physician Decision|1|||
127793904|NCT00574275|459869466|FG000|Overall Study|Protocol Violation|0|||
127793905|NCT00574275|459869467|FG001|Overall Study|Protocol Violation|1|||
127793906|NCT00574275|459869466|FG000|Overall Study|Patient and Investigator decision|0|||
127793907|NCT00574275|459869467|FG001|Overall Study|Patient and Investigator decision|1|||
127793908|NCT00574275|459869466|FG000|Overall Study|Insurance change|0|||
127793909|NCT00574275|459869467|FG001|Overall Study|Insurance change|1|||
127629669|NCT00718042|459264599|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
127629670|NCT00718042|459264594|FG000|Donor Follow-up|Lost to Follow-up|13|||
127629671|NCT00718042|459264595|FG001|Donor Follow-up|Lost to Follow-up|0|||
127793910|NCT00574275|459869466|FG000|Overall Study|Operation for curative intent|0|||
127793911|NCT00574275|459869467|FG001|Overall Study|Operation for curative intent|1|||
127793912|NCT02703311|459869469|FG000|Overall Study|Death|5|||
127793913|NCT02703311|459869469|FG000|Overall Study|Withdrawal by Subject|3|||
127793914|NCT00960843|459869470|FG000|Overall Study|Lost to Follow-up|2|||
127793915|NCT00960843|459869471|FG001|Overall Study|Lost to Follow-up|0|||
127793916|NCT00960843|459869470|FG000|Overall Study|Protocol Violation|0|||
127793917|NCT00960843|459869471|FG001|Overall Study|Protocol Violation|4|||
127793918|NCT00960843|459869470|FG000|Overall Study|Repeated needle dislodgment|0|||
127793919|NCT00960843|459869471|FG001|Overall Study|Repeated needle dislodgment|1|||
127885366|NCT04380701|460203894|FG023|Overall Study|Withdrawal by Subject|2|||
127885367|NCT04380701|460203895|FG024|Overall Study|Withdrawal by Subject|1|||
127885368|NCT04380701|460203896|FG025|Overall Study|Withdrawal by Subject|1|||
127885369|NCT04380701|460203897|FG026|Overall Study|Withdrawal by Subject|0|||
127885370|NCT04380701|460203898|FG027|Overall Study|Withdrawal by Subject|0|||
127885371|NCT04380701|460203899|FG028|Overall Study|Withdrawal by Subject|0|||
127885372|NCT04380701|460203900|FG029|Overall Study|Withdrawal by Subject|0|||
127885373|NCT04380701|460203901|FG030|Overall Study|Withdrawal by Subject|0|||
127885374|NCT04380701|460203902|FG031|Overall Study|Withdrawal by Subject|0|||
127885375|NCT04380701|460203903|FG032|Overall Study|Withdrawal by Subject|0|||
127885376|NCT04380701|460203904|FG033|Overall Study|Withdrawal by Subject|0|||
127885377|NCT04380701|460203871|FG000|Overall Study|Adverse Event|0|||
127885378|NCT04380701|460203872|FG001|Overall Study|Adverse Event|0|||
127885379|NCT04380701|460203873|FG002|Overall Study|Adverse Event|0|||
127885380|NCT04380701|460203874|FG003|Overall Study|Adverse Event|0|||
127885381|NCT04380701|460203875|FG004|Overall Study|Adverse Event|0|||
127885382|NCT04380701|460203876|FG005|Overall Study|Adverse Event|1|||
127885383|NCT04380701|460203877|FG006|Overall Study|Adverse Event|0|||
127885384|NCT04380701|460203878|FG007|Overall Study|Adverse Event|0|||
127885385|NCT04380701|460203879|FG008|Overall Study|Adverse Event|0|||
127885386|NCT04380701|460203880|FG009|Overall Study|Adverse Event|0|||
127885387|NCT04380701|460203881|FG010|Overall Study|Adverse Event|0|||
127885388|NCT04380701|460203882|FG011|Overall Study|Adverse Event|0|||
127885389|NCT04380701|460203883|FG012|Overall Study|Adverse Event|0|||
127885390|NCT04380701|460203884|FG013|Overall Study|Adverse Event|0|||
127885391|NCT04380701|460203885|FG014|Overall Study|Adverse Event|0|||
127885392|NCT04380701|460203886|FG015|Overall Study|Adverse Event|1|||
127885393|NCT04380701|460203887|FG016|Overall Study|Adverse Event|0|||
127885394|NCT04380701|460203888|FG017|Overall Study|Adverse Event|0|||
127885395|NCT04380701|460203889|FG018|Overall Study|Adverse Event|0|||
127793920|NCT00652366|459869472|FG000|Overall Study|Adverse Event|8|||
127629672|NCT00718042|459264596|FG002|Donor Follow-up|Lost to Follow-up|0|||
127629673|NCT00718042|459264597|FG003|Donor Follow-up|Lost to Follow-up|0|||
127629674|NCT00718042|459264598|FG004|Donor Follow-up|Lost to Follow-up|19|||
127629675|NCT00718042|459264599|FG005|Donor Follow-up|Lost to Follow-up|0|||
127629676|NCT00614939|459264600|FG000|Overall Study|Withdrawal by Subject|10|||
127629677|NCT00614939|459264601|FG001|Overall Study|Withdrawal by Subject|17|||
127629678|NCT00614939|459264600|FG000|Overall Study|Study specific discontinuation criteris|13|||
127629679|NCT00614939|459264601|FG001|Overall Study|Study specific discontinuation criteris|16|||
127629680|NCT00614939|459264600|FG000|Overall Study|Adverse Event|2|||
127793921|NCT00652366|459869473|FG001|Overall Study|Adverse Event|4|||
127793922|NCT00652366|459869474|FG002|Overall Study|Adverse Event|7|||
127793923|NCT00652366|459869475|FG003|Overall Study|Adverse Event|17|||
127793924|NCT00652366|459869476|FG004|Overall Study|Adverse Event|13|||
127793925|NCT00652366|459869472|FG000|Overall Study|Death|5|||
127793926|NCT00652366|459869473|FG001|Overall Study|Death|4|||
127629681|NCT00614939|459264601|FG001|Overall Study|Adverse Event|5|||
127629682|NCT00614939|459264600|FG000|Overall Study|Incorrect enrollment|1|||
127629683|NCT00614939|459264601|FG001|Overall Study|Incorrect enrollment|2|||
127629684|NCT00614939|459264600|FG000|Overall Study|Death|4|||
127629685|NCT00614939|459264601|FG001|Overall Study|Death|3|||
127629686|NCT00614939|459264600|FG000|Overall Study|Poor/non-compliance|4|||
127793927|NCT00652366|459869474|FG002|Overall Study|Death|1|||
127793928|NCT00652366|459869475|FG003|Overall Study|Death|8|||
127793929|NCT00652366|459869476|FG004|Overall Study|Death|5|||
127793930|NCT00652366|459869472|FG000|Overall Study|Lack of Efficacy|84|||
127885396|NCT04380701|460203890|FG019|Overall Study|Adverse Event|1|||
127885397|NCT04380701|460203891|FG020|Overall Study|Adverse Event|0|||
127629687|NCT00614939|459264601|FG001|Overall Study|Poor/non-compliance|0|||
127629688|NCT00614939|459264600|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
127629689|NCT00614939|459264601|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
127629690|NCT00840970|459264602|FG000|Overall Study|Adverse Event|0|||
127793931|NCT00652366|459869473|FG001|Overall Study|Lack of Efficacy|58|||
127793932|NCT00652366|459869474|FG002|Overall Study|Lack of Efficacy|53|||
127793933|NCT00652366|459869475|FG003|Overall Study|Lack of Efficacy|133|||
127793934|NCT00652366|459869476|FG004|Overall Study|Lack of Efficacy|13|||
127885398|NCT04380701|460203892|FG021|Overall Study|Adverse Event|0|||
127793935|NCT00652366|459869472|FG000|Overall Study|Violation of Selection Criteria|0|||
127793936|NCT00652366|459869473|FG001|Overall Study|Violation of Selection Criteria|0|||
127793937|NCT00652366|459869474|FG002|Overall Study|Violation of Selection Criteria|1|||
127793938|NCT00652366|459869475|FG003|Overall Study|Violation of Selection Criteria|0|||
127793939|NCT00652366|459869476|FG004|Overall Study|Violation of Selection Criteria|0|||
127793940|NCT00652366|459869472|FG000|Overall Study|Protocol Violation|1|||
127793941|NCT00652366|459869473|FG001|Overall Study|Protocol Violation|0|||
127793942|NCT00652366|459869474|FG002|Overall Study|Protocol Violation|0|||
127793943|NCT00652366|459869475|FG003|Overall Study|Protocol Violation|0|||
127793944|NCT00652366|459869476|FG004|Overall Study|Protocol Violation|0|||
127793945|NCT00652366|459869472|FG000|Overall Study|Refused treatment|3|||
127793946|NCT00652366|459869473|FG001|Overall Study|Refused treatment|7|||
127793947|NCT00652366|459869474|FG002|Overall Study|Refused treatment|6|||
127793948|NCT00652366|459869475|FG003|Overall Study|Refused treatment|17|||
127793949|NCT00652366|459869476|FG004|Overall Study|Refused treatment|5|||
127793950|NCT00652366|459869472|FG000|Overall Study|Other|5|||
127793951|NCT00652366|459869473|FG001|Overall Study|Other|2|||
127793952|NCT00652366|459869474|FG002|Overall Study|Other|3|||
127793953|NCT00652366|459869475|FG003|Overall Study|Other|4|||
127793954|NCT00652366|459869476|FG004|Overall Study|Other|0|||
127793955|NCT02069899|459869481|FG000|Overall Study|Adverse Event|6|||
127793956|NCT02069899|459869482|FG001|Overall Study|Adverse Event|0|||
127793957|NCT02069899|459869483|FG002|Overall Study|Adverse Event|1|||
127793958|NCT02069899|459869481|FG000|Overall Study|Withdrawal by Participant|2|||
127793959|NCT02069899|459869482|FG001|Overall Study|Withdrawal by Participant|0|||
127793960|NCT02069899|459869483|FG002|Overall Study|Withdrawal by Participant|0|||
127793961|NCT02069899|459869481|FG000|Overall Study|Lost to Follow-up|1|||
127793962|NCT02069899|459869482|FG001|Overall Study|Lost to Follow-up|0|||
127793963|NCT02069899|459869483|FG002|Overall Study|Lost to Follow-up|1|||
127793964|NCT02069899|459869481|FG000|Overall Study|Other|4|||
127793965|NCT02069899|459869482|FG001|Overall Study|Other|0|||
127793966|NCT02069899|459869483|FG002|Overall Study|Other|0|||
127793967|NCT02069899|459869481|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
127793968|NCT02069899|459869482|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
127793969|NCT02069899|459869483|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
127793970|NCT02069899|459869481|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
127793971|NCT02069899|459869482|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
127793972|NCT02069899|459869483|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
127793973|NCT00490451|459869486|FG000|Overall Study|Adverse Event|3|||
127793974|NCT00490451|459869487|FG001|Overall Study|Adverse Event|3|||
127793975|NCT00490451|459869486|FG000|Overall Study|Death|3|||
127793976|NCT00490451|459869487|FG001|Overall Study|Death|1|||
127793977|NCT00490451|459869486|FG000|Overall Study|Withdrawal by Subject|2|||
127793978|NCT00490451|459869487|FG001|Overall Study|Withdrawal by Subject|0|||
127793979|NCT00490451|459869486|FG000|Overall Study|Investigator Decision|1|||
127793980|NCT00490451|459869487|FG001|Overall Study|Investigator Decision|0|||
127793981|NCT00490451|459869486|FG000|Overall Study|Protocol Violation|1|||
127793982|NCT00490451|459869487|FG001|Overall Study|Protocol Violation|0|||
127793983|NCT00490451|459869486|FG000|Overall Study|Progressive Disease|53|||
127793984|NCT00490451|459869487|FG001|Overall Study|Progressive Disease|34|||
127793985|NCT01181011|459869488|FG000|Overall Study|Adverse Event|2|||
127793986|NCT01181011|459869488|FG000|Overall Study|Lost to Follow-up|1|||
127793987|NCT00137111|459869489|FG000|Total Therapy|Death|35|||
127793988|NCT00137111|459869490|FG001|Total Therapy|Death|0|||
127793989|NCT00137111|459869491|FG002|Total Therapy|Death|0|||
127793990|NCT00137111|459869492|FG003|Total Therapy|Death|0|||
127793991|NCT00137111|459869489|FG000|Total Therapy|Non Compliance|5|||
127793992|NCT00137111|459869490|FG001|Total Therapy|Non Compliance|0|||
127793993|NCT00137111|459869491|FG002|Total Therapy|Non Compliance|0|||
127793994|NCT00137111|459869492|FG003|Total Therapy|Non Compliance|0|||
127793995|NCT02788747|459869493|FG000|Overall Study|Adverse Event|1|||
127793996|NCT02788747|459869494|FG001|Overall Study|Adverse Event|0|||
127793997|NCT02788747|459869495|FG002|Overall Study|Adverse Event|0|||
127793998|NCT01967550|459869496|FG000|Overall Study|Withdrawal by Subject|1|||
127793999|NCT01967550|459869497|FG001|Overall Study|Withdrawal by Subject|0|||
127794000|NCT01967550|459869496|FG000|Overall Study|Adverse Event|2|||
127794001|NCT01967550|459869497|FG001|Overall Study|Adverse Event|0|||
127794002|NCT01967550|459869496|FG000|Overall Study|Protocol Violation|2|||
127885399|NCT04380701|460203893|FG022|Overall Study|Adverse Event|0|||
127794003|NCT01967550|459869497|FG001|Overall Study|Protocol Violation|1|||
127794004|NCT01967550|459869496|FG000|Overall Study|Non Compliance|0|||
127794005|NCT01967550|459869497|FG001|Overall Study|Non Compliance|1|||
127794006|NCT00784654|459869500|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
127794007|NCT00784654|459869501|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
127794008|NCT00784654|459869502|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
127794009|NCT00784654|459869500|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
127702116|NCT03628924|459538968|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
127702117|NCT03628924|459538969|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
127702118|NCT03628924|459538970|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
127702119|NCT03628924|459538971|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
127702120|NCT03628924|459538972|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
127702121|NCT03628924|459538973|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
127702122|NCT03628924|459538967|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
127702123|NCT03628924|459538968|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
127702124|NCT03628924|459538969|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
127702125|NCT03628924|459538970|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
127702126|NCT03628924|459538971|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
127702127|NCT03628924|459538972|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
127702128|NCT03628924|459538973|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
127702129|NCT03628924|459538967|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
127702130|NCT03628924|459538968|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
127702131|NCT03628924|459538969|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
127702132|NCT03628924|459538970|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
127705271|NCT01928394|459551582|FG015|Follow-up Period|Death|0|||
127705272|NCT01928394|459551583|FG016|Follow-up Period|Death|6|||
127705273|NCT01928394|459551584|FG017|Follow-up Period|Death|5|||
127705274|NCT01928394|459551585|FG018|Follow-up Period|Death|13|||
127705275|NCT01928394|459551586|FG019|Follow-up Period|Death|13|||
127705276|NCT01928394|459551587|FG020|Follow-up Period|Death|5|||
127705277|NCT01928394|459551588|FG021|Follow-up Period|Death|3|||
127705278|NCT01928394|459551589|FG022|Follow-up Period|Death|2|||
127705279|NCT01928394|459551567|FG000|Follow-up Period|other reason|0|||
127705280|NCT01928394|459551568|FG001|Follow-up Period|other reason|0|||
127705281|NCT01928394|459551569|FG002|Follow-up Period|other reason|0|||
127705282|NCT01928394|459551570|FG003|Follow-up Period|other reason|0|||
127705283|NCT01928394|459551571|FG004|Follow-up Period|other reason|0|||
127705284|NCT01928394|459551572|FG005|Follow-up Period|other reason|0|||
127705285|NCT01928394|459551573|FG006|Follow-up Period|other reason|1|||
127705286|NCT01928394|459551574|FG007|Follow-up Period|other reason|3|||
127705287|NCT01928394|459551575|FG008|Follow-up Period|other reason|0|||
127705288|NCT01928394|459551576|FG009|Follow-up Period|other reason|0|||
127705289|NCT01928394|459551577|FG010|Follow-up Period|other reason|2|||
127705290|NCT01928394|459551578|FG011|Follow-up Period|other reason|1|||
127705291|NCT01928394|459551579|FG012|Follow-up Period|other reason|0|||
127705292|NCT01928394|459551580|FG013|Follow-up Period|other reason|1|||
127705293|NCT01928394|459551581|FG014|Follow-up Period|other reason|4|||
127705294|NCT01928394|459551582|FG015|Follow-up Period|other reason|0|||
127705295|NCT01928394|459551583|FG016|Follow-up Period|other reason|2|||
127705296|NCT01928394|459551584|FG017|Follow-up Period|other reason|0|||
127705297|NCT01928394|459551585|FG018|Follow-up Period|other reason|1|||
127705298|NCT01928394|459551586|FG019|Follow-up Period|other reason|1|||
127705299|NCT01928394|459551587|FG020|Follow-up Period|other reason|0|||
127705300|NCT01928394|459551588|FG021|Follow-up Period|other reason|0|||
127705301|NCT01928394|459551589|FG022|Follow-up Period|other reason|1|||
127705302|NCT01928394|459551567|FG000|Follow-up Period|Lost to Follow-up|0|||
127705303|NCT01928394|459551568|FG001|Follow-up Period|Lost to Follow-up|0|||
127705304|NCT01928394|459551569|FG002|Follow-up Period|Lost to Follow-up|0|||
127705305|NCT01928394|459551570|FG003|Follow-up Period|Lost to Follow-up|0|||
127705306|NCT01928394|459551571|FG004|Follow-up Period|Lost to Follow-up|0|||
127705307|NCT01928394|459551572|FG005|Follow-up Period|Lost to Follow-up|0|||
127705308|NCT01928394|459551573|FG006|Follow-up Period|Lost to Follow-up|0|||
127705309|NCT01928394|459551574|FG007|Follow-up Period|Lost to Follow-up|0|||
127705310|NCT01928394|459551575|FG008|Follow-up Period|Lost to Follow-up|0|||
127705311|NCT01928394|459551576|FG009|Follow-up Period|Lost to Follow-up|0|||
127705312|NCT01928394|459551577|FG010|Follow-up Period|Lost to Follow-up|0|||
127705313|NCT01928394|459551578|FG011|Follow-up Period|Lost to Follow-up|1|||
127705314|NCT01928394|459551579|FG012|Follow-up Period|Lost to Follow-up|1|||
127705315|NCT01928394|459551580|FG013|Follow-up Period|Lost to Follow-up|0|||
127705316|NCT01928394|459551581|FG014|Follow-up Period|Lost to Follow-up|1|||
127705317|NCT01928394|459551582|FG015|Follow-up Period|Lost to Follow-up|0|||
127705318|NCT01928394|459551583|FG016|Follow-up Period|Lost to Follow-up|1|||
127705319|NCT01928394|459551584|FG017|Follow-up Period|Lost to Follow-up|0|||
127705320|NCT01928394|459551585|FG018|Follow-up Period|Lost to Follow-up|0|||
127705321|NCT01928394|459551586|FG019|Follow-up Period|Lost to Follow-up|0|||
127705322|NCT01928394|459551587|FG020|Follow-up Period|Lost to Follow-up|0|||
127705323|NCT01928394|459551588|FG021|Follow-up Period|Lost to Follow-up|0|||
127705324|NCT01928394|459551589|FG022|Follow-up Period|Lost to Follow-up|1|||
127705325|NCT04433208|459551590|FG000|Overall Study|Withdrawal by Subject|0|||
127794010|NCT00784654|459869501|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
127794011|NCT00784654|459869502|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
127794012|NCT00784654|459869500|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
127794013|NCT00784654|459869501|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
127794014|NCT00784654|459869502|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
127794015|NCT00784654|459869500|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
127794016|NCT00784654|459869501|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
127794017|NCT00784654|459869502|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
127629691|NCT00840970|459264603|FG001|Overall Study|Adverse Event|0|||
127629692|NCT00840970|459264604|FG002|Overall Study|Adverse Event|1|||
127629693|NCT04096560|459264605|FG000|Overall Study|Reason not Specified|1|||
127629694|NCT04096560|459264606|FG001|Overall Study|Reason not Specified|0|||
127629695|NCT04096560|459264607|FG002|Overall Study|Reason not Specified|0|||
127629696|NCT04096560|459264608|FG003|Overall Study|Reason not Specified|0|||
127629697|NCT04096560|459264609|FG004|Overall Study|Reason not Specified|1|||
127629698|NCT04096560|459264610|FG005|Overall Study|Reason not Specified|1|||
127629699|NCT04096560|459264611|FG006|Overall Study|Reason not Specified|1|||
127629700|NCT04096560|459264612|FG007|Overall Study|Reason not Specified|0|||
127629701|NCT04096560|459264605|FG000|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
127629702|NCT04096560|459264606|FG001|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
127629703|NCT04096560|459264607|FG002|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
127629704|NCT04096560|459264608|FG003|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
127629705|NCT04096560|459264609|FG004|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
127629706|NCT04096560|459264610|FG005|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
127629707|NCT04096560|459264611|FG006|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
127629708|NCT04096560|459264612|FG007|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
127629709|NCT04096560|459264605|FG000|Overall Study|Study Terminated by Sponsor|0|||
127629710|NCT04096560|459264606|FG001|Overall Study|Study Terminated by Sponsor|0|||
127629711|NCT04096560|459264607|FG002|Overall Study|Study Terminated by Sponsor|0|||
127629712|NCT04096560|459264608|FG003|Overall Study|Study Terminated by Sponsor|5|||
127629713|NCT04096560|459264609|FG004|Overall Study|Study Terminated by Sponsor|6|||
127629714|NCT04096560|459264610|FG005|Overall Study|Study Terminated by Sponsor|4|||
127794018|NCT00784654|459869500|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
127794019|NCT00784654|459869501|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
127794020|NCT00784654|459869502|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
127794021|NCT00784654|459869500|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
127794022|NCT00784654|459869501|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
127794023|NCT00784654|459869502|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
127794024|NCT00784654|459869500|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
127794025|NCT00784654|459869501|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
127794026|NCT00784654|459869502|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
127794027|NCT00784654|459869500|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
127794028|NCT00784654|459869501|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
127794029|NCT00784654|459869502|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
127794030|NCT00784654|459869500|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
127794031|NCT00784654|459869501|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
127794032|NCT00784654|459869502|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
127794033|NCT00784654|459869500|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
127794034|NCT00784654|459869501|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
127794035|NCT00784654|459869502|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
127794036|NCT00784654|459869500|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
127794037|NCT00784654|459869501|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
127794038|NCT00784654|459869502|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
127794039|NCT00784654|459869500|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
127794040|NCT00784654|459869501|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
127794041|NCT00784654|459869502|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
127794042|NCT00784654|459869500|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
127629715|NCT04096560|459264611|FG006|Overall Study|Study Terminated by Sponsor|6|||
127629716|NCT04096560|459264612|FG007|Overall Study|Study Terminated by Sponsor|1|||
127629717|NCT04096560|459264605|FG000|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
127629718|NCT04096560|459264606|FG001|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
127629719|NCT04096560|459264607|FG002|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
127794043|NCT00784654|459869501|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
127794044|NCT00784654|459869502|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
127794045|NCT00784654|459869500|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
127794046|NCT00784654|459869501|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
127794047|NCT00784654|459869502|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
127794048|NCT00784654|459869500|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
127794049|NCT00784654|459869501|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
127794050|NCT00784654|459869502|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
127794051|NCT00784654|459869500|FG000|Randomized Withdrawal Period|Adverse Event|0|||
127794052|NCT00784654|459869501|FG001|Randomized Withdrawal Period|Adverse Event|1|||
127794053|NCT00784654|459869502|FG002|Randomized Withdrawal Period|Adverse Event|1|||
127794054|NCT00784654|459869500|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
127794055|NCT00784654|459869501|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
127794056|NCT00784654|459869502|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
127794057|NCT00784654|459869500|FG000|Randomized Withdrawal Period|Family reasons|0|||
127794058|NCT00784654|459869501|FG001|Randomized Withdrawal Period|Family reasons|0|||
127794059|NCT00784654|459869502|FG002|Randomized Withdrawal Period|Family reasons|1|||
127794060|NCT00262873|459869505|FG000|Overall Study|Adverse Event|3|||
127794061|NCT00262873|459869505|FG000|Overall Study|Withdrawal by Subject|5|||
127794062|NCT00844753|459869506|FG000|Overall Study|Lack of Efficacy|1|||
127794063|NCT00844753|459869507|FG001|Overall Study|Lack of Efficacy|0|||
127794064|NCT00844753|459869508|FG002|Overall Study|Lack of Efficacy|2|||
127794065|NCT00844753|459869509|FG003|Overall Study|Lack of Efficacy|2|||
127794066|NCT00844753|459869506|FG000|Overall Study|Adverse Event|3|||
127794067|NCT00844753|459869507|FG001|Overall Study|Adverse Event|2|||
127794068|NCT00844753|459869508|FG002|Overall Study|Adverse Event|5|||
127794069|NCT00844753|459869509|FG003|Overall Study|Adverse Event|5|||
127794070|NCT00844753|459869506|FG000|Overall Study|Lost to Follow-up|1|||
127794071|NCT00844753|459869507|FG001|Overall Study|Lost to Follow-up|1|||
127794072|NCT00844753|459869508|FG002|Overall Study|Lost to Follow-up|0|||
127794073|NCT00844753|459869509|FG003|Overall Study|Lost to Follow-up|1|||
127794074|NCT00844753|459869506|FG000|Overall Study|could not swallow medication|2|||
127794075|NCT00844753|459869507|FG001|Overall Study|could not swallow medication|0|||
127794076|NCT00844753|459869508|FG002|Overall Study|could not swallow medication|0|||
127794077|NCT00844753|459869509|FG003|Overall Study|could not swallow medication|0|||
127794078|NCT00844753|459869506|FG000|Overall Study|Withdrawal by Subject|1|||
127794079|NCT00844753|459869507|FG001|Overall Study|Withdrawal by Subject|0|||
127794080|NCT00844753|459869508|FG002|Overall Study|Withdrawal by Subject|0|||
127794081|NCT00844753|459869509|FG003|Overall Study|Withdrawal by Subject|3|||
127794082|NCT02425826|459869510|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
127794083|NCT02425826|459869511|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
127794084|NCT02425826|459869512|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
127794085|NCT02425826|459869510|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
127794086|NCT02425826|459869511|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
127629720|NCT04096560|459264608|FG003|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
127629721|NCT04096560|459264609|FG004|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
127629722|NCT04096560|459264610|FG005|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
127629723|NCT04096560|459264611|FG006|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
127629724|NCT04096560|459264612|FG007|Overall Study|Met the Discontinuation Criteria of the Protocol|1|||
127629725|NCT03783923|459264617|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
127629726|NCT03783923|459264618|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
127629727|NCT03783923|459264617|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
127629728|NCT03783923|459264618|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
127629729|NCT03783923|459264617|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
127629730|NCT03783923|459264618|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
127629731|NCT03783923|459264617|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
127629732|NCT03783923|459264618|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
127629733|NCT03783923|459264617|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
127629734|NCT03783923|459264618|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
127629735|NCT01603875|459264621|FG000|Overall Study|Preexisting rabies antibody|3|||
127629736|NCT01603875|459264622|FG001|Overall Study|Preexisting rabies antibody|4|||
127629737|NCT01603875|459264623|FG002|Overall Study|Preexisting rabies antibody|3|||
127629738|NCT01603875|459264621|FG000|Overall Study|Lost to Follow-up|4|||
127629739|NCT01603875|459264622|FG001|Overall Study|Lost to Follow-up|3|||
127629740|NCT01603875|459264623|FG002|Overall Study|Lost to Follow-up|6|||
127629741|NCT01603875|459264621|FG000|Overall Study|Protocol Violation|0|||
127629742|NCT01603875|459264622|FG001|Overall Study|Protocol Violation|1|||
127629743|NCT01603875|459264623|FG002|Overall Study|Protocol Violation|0|||
127629744|NCT01971346|459264624|FG000|Overall Study|Protocol Violation|3|||
127629745|NCT01971346|459264624|FG000|Overall Study|Lost to Follow-up|2|||
127629746|NCT01971346|459264624|FG000|Overall Study|Withdrawal by Subject|2|||
127794087|NCT02425826|459869512|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
127794088|NCT02425826|459869510|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
127794089|NCT02425826|459869511|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
127794090|NCT02425826|459869512|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
127794091|NCT02425826|459869510|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
127794092|NCT02425826|459869511|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
127794093|NCT02425826|459869512|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
127794094|NCT02425826|459869510|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
127794095|NCT02425826|459869511|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
127794096|NCT02425826|459869512|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
127794097|NCT02425826|459869510|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
127794098|NCT02425826|459869511|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
127794099|NCT02425826|459869512|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
127794100|NCT02425826|459869510|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
127794101|NCT02425826|459869511|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
127794102|NCT02425826|459869512|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
127794103|NCT02425826|459869510|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
127794104|NCT02425826|459869511|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
127794105|NCT02425826|459869512|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
127794106|NCT02425826|459869510|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
127794107|NCT02425826|459869511|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
127794108|NCT02425826|459869512|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
127794109|NCT02425826|459869510|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
127794110|NCT02425826|459869511|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
127794111|NCT02425826|459869512|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
127794112|NCT02500121|459869516|FG000|Overall Study|Lost to Follow-up|0|||
127794113|NCT02500121|459869517|FG001|Overall Study|Lost to Follow-up|1|||
127794114|NCT02500121|459869516|FG000|Overall Study|Withdrawal by Subject|1|||
127794115|NCT02500121|459869517|FG001|Overall Study|Withdrawal by Subject|1|||
127794116|NCT02500121|459869516|FG000|Overall Study|Death|26|||
127794117|NCT02500121|459869517|FG001|Overall Study|Death|24|||
127794118|NCT00852995|459869519|FG000|Overall Study|Adverse Event|1|||
127794119|NCT00852995|459869520|FG001|Overall Study|Adverse Event|0|||
127794120|NCT00852995|459869521|FG002|Overall Study|Adverse Event|4|||
127794121|NCT00852995|459869522|FG003|Overall Study|Adverse Event|0|||
127794122|NCT00852995|459869523|FG004|Overall Study|Adverse Event|0|||
127794123|NCT00852995|459869519|FG000|Overall Study|Lost to Follow-up|0|||
127794124|NCT00852995|459869520|FG001|Overall Study|Lost to Follow-up|1|||
127794125|NCT00852995|459869521|FG002|Overall Study|Lost to Follow-up|1|||
127794126|NCT00852995|459869522|FG003|Overall Study|Lost to Follow-up|0|||
127794127|NCT00852995|459869523|FG004|Overall Study|Lost to Follow-up|0|||
127794128|NCT00852995|459869519|FG000|Overall Study|Withdrawal by Subject|4|||
127794129|NCT00852995|459869520|FG001|Overall Study|Withdrawal by Subject|0|||
127794130|NCT00852995|459869521|FG002|Overall Study|Withdrawal by Subject|0|||
127794131|NCT00852995|459869522|FG003|Overall Study|Withdrawal by Subject|1|||
127794132|NCT00852995|459869523|FG004|Overall Study|Withdrawal by Subject|2|||
127794133|NCT00852995|459869519|FG000|Overall Study|Non-Compliance|0|||
127794134|NCT00852995|459869520|FG001|Overall Study|Non-Compliance|0|||
127794135|NCT00852995|459869521|FG002|Overall Study|Non-Compliance|0|||
127794136|NCT00852995|459869522|FG003|Overall Study|Non-Compliance|2|||
127794137|NCT00852995|459869523|FG004|Overall Study|Non-Compliance|0|||
127794138|NCT00852995|459869519|FG000|Overall Study|Progressive Disease|1|||
127794139|NCT00852995|459869520|FG001|Overall Study|Progressive Disease|0|||
127794140|NCT00852995|459869521|FG002|Overall Study|Progressive Disease|0|||
127794141|NCT00852995|459869522|FG003|Overall Study|Progressive Disease|2|||
127794142|NCT00852995|459869523|FG004|Overall Study|Progressive Disease|1|||
127794143|NCT00852995|459869519|FG000|Overall Study|Physician Decision|1|||
127794144|NCT00852995|459869520|FG001|Overall Study|Physician Decision|0|||
127794145|NCT00852995|459869521|FG002|Overall Study|Physician Decision|0|||
127794146|NCT00852995|459869522|FG003|Overall Study|Physician Decision|0|||
127794147|NCT00852995|459869523|FG004|Overall Study|Physician Decision|0|||
127794148|NCT00852995|459869519|FG000|Overall Study|Protocol Violation|0|||
127794149|NCT00852995|459869520|FG001|Overall Study|Protocol Violation|0|||
127794150|NCT00852995|459869521|FG002|Overall Study|Protocol Violation|0|||
127794151|NCT00852995|459869522|FG003|Overall Study|Protocol Violation|0|||
127794152|NCT00852995|459869523|FG004|Overall Study|Protocol Violation|1|||
127794153|NCT00852995|459869519|FG000|Overall Study|Moved Out of Area|1|||
127794154|NCT00852995|459869520|FG001|Overall Study|Moved Out of Area|0|||
127794155|NCT00852995|459869521|FG002|Overall Study|Moved Out of Area|0|||
127794156|NCT00852995|459869522|FG003|Overall Study|Moved Out of Area|0|||
127794157|NCT00852995|459869523|FG004|Overall Study|Moved Out of Area|0|||
127794158|NCT04518462|459869526|FG000|Overall Study|Withdrawal by Subject|0|||
127794159|NCT04518462|459869527|FG001|Overall Study|Withdrawal by Subject|0|||
127794160|NCT04518462|459869528|FG002|Overall Study|Withdrawal by Subject|1|||
127794161|NCT04518462|459869526|FG000|Overall Study|Physician Decision|1|||
127794162|NCT04518462|459869527|FG001|Overall Study|Physician Decision|1|||
127794163|NCT04518462|459869528|FG002|Overall Study|Physician Decision|0|||
127794164|NCT04418076|459869532|FG000|Overall Study|Death|1|||
127794165|NCT04418076|459869533|FG001|Overall Study|Death|0|||
127794166|NCT04418076|459869534|FG002|Overall Study|Death|0|||
127794167|NCT04418076|459869535|FG003|Overall Study|Death|0|||
127794168|NCT04418076|459869532|FG000|Overall Study|Lost to Follow-up|2|||
127794169|NCT04418076|459869533|FG001|Overall Study|Lost to Follow-up|5|||
127794170|NCT04418076|459869534|FG002|Overall Study|Lost to Follow-up|1|||
127794171|NCT04418076|459869535|FG003|Overall Study|Lost to Follow-up|2|||
127794172|NCT04418076|459869532|FG000|Overall Study|Withdrawal by Subject|1|||
127794173|NCT04418076|459869533|FG001|Overall Study|Withdrawal by Subject|0|||
127794174|NCT04418076|459869534|FG002|Overall Study|Withdrawal by Subject|1|||
127794175|NCT04418076|459869535|FG003|Overall Study|Withdrawal by Subject|1|||
127794176|NCT04418076|459869532|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
127794177|NCT04418076|459869533|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
127794178|NCT04418076|459869534|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
127794179|NCT04418076|459869535|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
127794180|NCT01471782|459869536|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
127794181|NCT01471782|459869537|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
127794182|NCT01471782|459869538|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
127794183|NCT01471782|459869539|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
127794184|NCT01471782|459869540|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
127794185|NCT01471782|459869541|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
127794186|NCT01471782|459869536|FG000|Overall Study|Lack of Efficacy|1|||
127794187|NCT01471782|459869537|FG001|Overall Study|Lack of Efficacy|2|||
127794188|NCT01471782|459869538|FG002|Overall Study|Lack of Efficacy|1|||
127794189|NCT01471782|459869539|FG003|Overall Study|Lack of Efficacy|1|||
127794190|NCT01471782|459869540|FG004|Overall Study|Lack of Efficacy|5|||
127794191|NCT01471782|459869541|FG005|Overall Study|Lack of Efficacy|18|||
127794192|NCT01471782|459869536|FG000|Overall Study|Adverse Event|1|||
127794193|NCT01471782|459869537|FG001|Overall Study|Adverse Event|1|||
127794194|NCT01471782|459869538|FG002|Overall Study|Adverse Event|2|||
127794195|NCT01471782|459869539|FG003|Overall Study|Adverse Event|2|||
127794196|NCT01471782|459869540|FG004|Overall Study|Adverse Event|3|||
127794197|NCT01471782|459869541|FG005|Overall Study|Adverse Event|1|||
127794198|NCT01471782|459869536|FG000|Overall Study|Other|0|||
127794199|NCT01471782|459869537|FG001|Overall Study|Other|0|||
127794200|NCT01471782|459869538|FG002|Overall Study|Other|1|||
127794201|NCT01471782|459869539|FG003|Overall Study|Other|1|||
127794202|NCT01471782|459869540|FG004|Overall Study|Other|6|||
127794203|NCT01471782|459869541|FG005|Overall Study|Other|5|||
127794204|NCT01471782|459869536|FG000|Overall Study|Change of Chemotherapy|1|||
127794205|NCT01471782|459869537|FG001|Overall Study|Change of Chemotherapy|1|||
127794206|NCT01471782|459869538|FG002|Overall Study|Change of Chemotherapy|0|||
127794207|NCT01471782|459869539|FG003|Overall Study|Change of Chemotherapy|0|||
127794208|NCT01471782|459869540|FG004|Overall Study|Change of Chemotherapy|1|||
127794209|NCT01471782|459869541|FG005|Overall Study|Change of Chemotherapy|4|||
127794210|NCT01471782|459869536|FG000|Overall Study|Disease Relapse|0|||
127794211|NCT01471782|459869537|FG001|Overall Study|Disease Relapse|0|||
127794212|NCT01471782|459869538|FG002|Overall Study|Disease Relapse|0|||
127794213|NCT01471782|459869539|FG003|Overall Study|Disease Relapse|1|||
127794214|NCT01471782|459869540|FG004|Overall Study|Disease Relapse|2|||
127794215|NCT01471782|459869541|FG005|Overall Study|Disease Relapse|1|||
127629747|NCT01971346|459264624|FG000|Overall Study|Physician Decision|1|||
127794216|NCT01471782|459869536|FG000|Overall Study|Physician Decision|0|||
127794217|NCT01471782|459869537|FG001|Overall Study|Physician Decision|0|||
127794218|NCT01471782|459869538|FG002|Overall Study|Physician Decision|0|||
127794219|NCT01471782|459869539|FG003|Overall Study|Physician Decision|0|||
127794220|NCT01471782|459869540|FG004|Overall Study|Physician Decision|3|||
127794221|NCT01471782|459869541|FG005|Overall Study|Physician Decision|8|||
127794222|NCT01471782|459869536|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
127794223|NCT01471782|459869537|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
127794224|NCT01471782|459869538|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
127794225|NCT01471782|459869539|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
127794226|NCT01471782|459869540|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
127794227|NCT01471782|459869541|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
127794228|NCT01471782|459869536|FG000|Overall Study|Death|0|||
127794229|NCT01471782|459869537|FG001|Overall Study|Death|0|||
127794230|NCT01471782|459869538|FG002|Overall Study|Death|0|||
127794231|NCT01471782|459869539|FG003|Overall Study|Death|0|||
127794232|NCT01471782|459869540|FG004|Overall Study|Death|0|||
127794233|NCT01471782|459869541|FG005|Overall Study|Death|1|||
127794234|NCT01314716|459869542|FG000|Double-Blind Phase|Randomized but not treated|1|||
127794235|NCT01314716|459869543|FG001|Double-Blind Phase|Randomized but not treated|1|||
127794236|NCT01314716|459869542|FG000|Double-Blind Phase|Adverse Event|10|||
127794237|NCT01314716|459869543|FG001|Double-Blind Phase|Adverse Event|4|||
127794238|NCT01314716|459869542|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
127794239|NCT01314716|459869543|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
127794240|NCT01314716|459869542|FG000|Double-Blind Phase|Lost to Follow-up|0|||
127794241|NCT01314716|459869543|FG001|Double-Blind Phase|Lost to Follow-up|1|||
127794242|NCT01314716|459869542|FG000|Double-Blind Phase|Sponsor request|1|||
127794243|NCT01314716|459869543|FG001|Double-Blind Phase|Sponsor request|2|||
127794244|NCT01314716|459869542|FG000|Double-Blind Phase|Physician Decision|0|||
127794245|NCT01314716|459869543|FG001|Double-Blind Phase|Physician Decision|1|||
127794246|NCT01314716|459869542|FG000|Open-Label Phase|Adverse Event|4|||
127794247|NCT01314716|459869543|FG001|Open-Label Phase|Adverse Event|6|||
127794248|NCT01314716|459869542|FG000|Open-Label Phase|Withdrawal by Subject|1|||
127794249|NCT01314716|459869543|FG001|Open-Label Phase|Withdrawal by Subject|2|||
127794250|NCT01314716|459869542|FG000|Open-Label Phase|Physician Decision|5|||
127794251|NCT01314716|459869543|FG001|Open-Label Phase|Physician Decision|4|||
127794252|NCT01452152|459869544|FG000|Overall Study|Study termination by sponsor|5|||
127794253|NCT01452152|459869545|FG001|Overall Study|Study termination by sponsor|0|||
127794254|NCT01452152|459869546|FG002|Overall Study|Study termination by sponsor|4|||
127794255|NCT02627495|459870932|FG000|Overall Study|Withdrawal by Subject|4|||
127794256|NCT00880893|459870933|FG000|Overall Study|Protocol Violation|13|||
127794257|NCT00880893|459870934|FG001|Overall Study|Protocol Violation|1|||
127794258|NCT00880893|459870933|FG000|Overall Study|Withdrawal by Subject|15|||
127794259|NCT00880893|459870934|FG001|Overall Study|Withdrawal by Subject|11|||
127794260|NCT00880893|459870933|FG000|Overall Study|Lost to Follow-up|76|||
127794261|NCT00880893|459870934|FG001|Overall Study|Lost to Follow-up|33|||
127794262|NCT00880893|459870933|FG000|Overall Study|Serious adverse event|3|||
127794263|NCT00880893|459870934|FG001|Overall Study|Serious adverse event|0|||
127794264|NCT02543528|459870937|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
127794265|NCT02543528|459870938|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
127794266|NCT02543528|459870939|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
127794267|NCT02543528|459870940|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
127794268|NCT02543528|459870941|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
127794269|NCT02543528|459870937|FG000|Adaptation Period|Lens Handling Difficultes|0|||
127794270|NCT02543528|459870938|FG001|Adaptation Period|Lens Handling Difficultes|0|||
127794271|NCT02543528|459870939|FG002|Adaptation Period|Lens Handling Difficultes|0|||
127794272|NCT02543528|459870940|FG003|Adaptation Period|Lens Handling Difficultes|0|||
127794273|NCT02543528|459870941|FG004|Adaptation Period|Lens Handling Difficultes|8|||
127794274|NCT02543528|459870937|FG000|Adaptation Period|Lost to Follow-up|0|||
127794275|NCT02543528|459870938|FG001|Adaptation Period|Lost to Follow-up|0|||
127794276|NCT02543528|459870939|FG002|Adaptation Period|Lost to Follow-up|0|||
127794277|NCT02543528|459870940|FG003|Adaptation Period|Lost to Follow-up|0|||
127794278|NCT02543528|459870941|FG004|Adaptation Period|Lost to Follow-up|14|||
127794279|NCT02543528|459870937|FG000|Adaptation Period|Adverse Event|0|||
127794280|NCT02543528|459870938|FG001|Adaptation Period|Adverse Event|0|||
127794281|NCT02543528|459870939|FG002|Adaptation Period|Adverse Event|0|||
127794282|NCT02543528|459870940|FG003|Adaptation Period|Adverse Event|0|||
127794283|NCT02543528|459870941|FG004|Adaptation Period|Adverse Event|2|||
127794284|NCT02543528|459870937|FG000|Extended Wear Period|Adverse Event|17|||
127794285|NCT02543528|459870938|FG001|Extended Wear Period|Adverse Event|11|||
127794286|NCT02543528|459870939|FG002|Extended Wear Period|Adverse Event|16|||
127794287|NCT02543528|459870940|FG003|Extended Wear Period|Adverse Event|3|||
127794288|NCT02543528|459870941|FG004|Extended Wear Period|Adverse Event|0|||
127794289|NCT02543528|459870937|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
127794290|NCT02543528|459870938|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
127794291|NCT02543528|459870939|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
127794292|NCT02543528|459870940|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
127794293|NCT02543528|459870941|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
127794294|NCT02543528|459870937|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
127794295|NCT02543528|459870938|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
127794296|NCT02543528|459870939|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
127794297|NCT02543528|459870940|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
127794298|NCT02543528|459870941|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
127794299|NCT02543528|459870937|FG000|Extended Wear Period|Lost to Follow-up|0|||
127794300|NCT02543528|459870938|FG001|Extended Wear Period|Lost to Follow-up|1|||
127794301|NCT02543528|459870939|FG002|Extended Wear Period|Lost to Follow-up|2|||
127794302|NCT02543528|459870940|FG003|Extended Wear Period|Lost to Follow-up|1|||
127794303|NCT02543528|459870941|FG004|Extended Wear Period|Lost to Follow-up|0|||
127794304|NCT02543528|459870937|FG000|Extended Wear Period|Withdrawal by Subject|10|||
127794305|NCT02543528|459870938|FG001|Extended Wear Period|Withdrawal by Subject|9|||
127794306|NCT02543528|459870939|FG002|Extended Wear Period|Withdrawal by Subject|4|||
127794307|NCT02543528|459870940|FG003|Extended Wear Period|Withdrawal by Subject|5|||
127794308|NCT02543528|459870941|FG004|Extended Wear Period|Withdrawal by Subject|0|||
127794309|NCT02049944|459870942|FG000|Overall Study|Protocol Violation|2|||
127794310|NCT01765673|459870943|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
127794311|NCT01042600|459870944|FG000|Overall Study|Ineligible|1|||
127794312|NCT01042600|459870945|FG001|Overall Study|Ineligible|0|||
127794313|NCT02600507|459870946|FG000|Overall Study|Adverse Event|3|||
127794314|NCT02600507|459870947|FG001|Overall Study|Adverse Event|15|||
127794315|NCT02600507|459870948|FG002|Overall Study|Adverse Event|5|||
127794316|NCT02600507|459870946|FG000|Overall Study|Lack of Efficacy|3|||
127794317|NCT02600507|459870947|FG001|Overall Study|Lack of Efficacy|8|||
127794318|NCT02600507|459870948|FG002|Overall Study|Lack of Efficacy|5|||
127794319|NCT02600507|459870946|FG000|Overall Study|Lost to Follow-up|3|||
127794320|NCT02600507|459870947|FG001|Overall Study|Lost to Follow-up|5|||
127794321|NCT02600507|459870948|FG002|Overall Study|Lost to Follow-up|2|||
127794322|NCT02600507|459870946|FG000|Overall Study|Protocol Violation|12|||
127794323|NCT02600507|459870947|FG001|Overall Study|Protocol Violation|4|||
127794324|NCT02600507|459870948|FG002|Overall Study|Protocol Violation|4|||
127794325|NCT02600507|459870946|FG000|Overall Study|Physician Decision|1|||
127794326|NCT02600507|459870947|FG001|Overall Study|Physician Decision|0|||
127794327|NCT02600507|459870948|FG002|Overall Study|Physician Decision|1|||
127794328|NCT02600507|459870946|FG000|Overall Study|Withdrawal by Subject|7|||
127794329|NCT02600507|459870947|FG001|Overall Study|Withdrawal by Subject|11|||
127794330|NCT02600507|459870948|FG002|Overall Study|Withdrawal by Subject|7|||
127794331|NCT02600507|459870946|FG000|Overall Study|Other|0|||
127794332|NCT02600507|459870947|FG001|Overall Study|Other|1|||
127794333|NCT02600507|459870948|FG002|Overall Study|Other|1|||
127794334|NCT00605085|459870954|FG000|Overall Study|Withdrawal by Subject|8|||
127794335|NCT00605085|459870955|FG001|Overall Study|Withdrawal by Subject|5|||
127794336|NCT00605085|459870954|FG000|Overall Study|Adverse Event|9|||
127794337|NCT00605085|459870955|FG001|Overall Study|Adverse Event|5|||
127794338|NCT00605085|459870954|FG000|Overall Study|Pregnancy|2|||
127794339|NCT00605085|459870955|FG001|Overall Study|Pregnancy|0|||
127794340|NCT00605085|459870954|FG000|Overall Study|Protocol Violation|3|||
127794341|NCT00605085|459870955|FG001|Overall Study|Protocol Violation|2|||
127794342|NCT00605085|459870954|FG000|Overall Study|Lost to Follow-up|10|||
127794343|NCT00605085|459870955|FG001|Overall Study|Lost to Follow-up|5|||
127794344|NCT00605085|459870954|FG000|Overall Study|administrative reasons|18|||
127794345|NCT00605085|459870955|FG001|Overall Study|administrative reasons|8|||
127794346|NCT00621504|459870956|FG000|Overall Study|Adverse Event|1|||
127794347|NCT00621504|459870957|FG001|Overall Study|Adverse Event|3|||
127794348|NCT00621504|459870956|FG000|Overall Study|At the request of sponsor/investigator|1|||
127794349|NCT00621504|459870957|FG001|Overall Study|At the request of sponsor/investigator|0|||
127794350|NCT00621504|459870956|FG000|Overall Study|Withdrew consent|9|||
127794351|NCT00621504|459870957|FG001|Overall Study|Withdrew consent|6|||
127794352|NCT00621504|459870956|FG000|Overall Study|Lost to Follow-up|8|||
127794353|NCT00621504|459870957|FG001|Overall Study|Lost to Follow-up|10|||
127794354|NCT00621504|459870956|FG000|Overall Study|Other|1|||
127794355|NCT00621504|459870957|FG001|Overall Study|Other|0|||
127794356|NCT00621504|459870956|FG000|Overall Study|Death|6|||
127794357|NCT00621504|459870957|FG001|Overall Study|Death|6|||
127794358|NCT03257267|459870962|FG000|Overall Study|Adverse Event|17|||
127794359|NCT03257267|459870963|FG001|Overall Study|Adverse Event|7|||
127794360|NCT03257267|459870962|FG000|Overall Study|Death|96|||
127794361|NCT03257267|459870963|FG001|Overall Study|Death|98|||
127794362|NCT03257267|459870962|FG000|Overall Study|Lost to Follow-up|2|||
127794363|NCT03257267|459870963|FG001|Overall Study|Lost to Follow-up|2|||
127794364|NCT03257267|459870962|FG000|Overall Study|Non-compliance with Study Drug|0|||
127794365|NCT03257267|459870963|FG001|Overall Study|Non-compliance with Study Drug|2|||
127885400|NCT04380701|460203894|FG023|Overall Study|Adverse Event|0|||
127794366|NCT03257267|459870962|FG000|Overall Study|Participant Decision|35|||
127794367|NCT03257267|459870963|FG001|Overall Study|Participant Decision|43|||
127794368|NCT03257267|459870962|FG000|Overall Study|Sponsor Decision|1|||
127794369|NCT03257267|459870963|FG001|Overall Study|Sponsor Decision|0|||
127794370|NCT03257267|459870962|FG000|Overall Study|Physician Decision|1|||
127794371|NCT03257267|459870963|FG001|Overall Study|Physician Decision|3|||
127794372|NCT03257267|459870962|FG000|Overall Study|Disease Progression|109|||
127794373|NCT03257267|459870963|FG001|Overall Study|Disease Progression|121|||
127794374|NCT03257267|459870962|FG000|Overall Study|Withdrawal by Subject|8|||
127794375|NCT03257267|459870963|FG001|Overall Study|Withdrawal by Subject|26|||
127794376|NCT03257267|459870962|FG000|Overall Study|Other|0|||
127794377|NCT03257267|459870963|FG001|Overall Study|Other|2|||
127794378|NCT01623271|459870968|FG000|Overall Study|Withdrawal by Subject|2|||
127794379|NCT00706134|459870969|FG000|Overall Study|Adverse Event|8|||
127794380|NCT00706134|459870970|FG001|Overall Study|Adverse Event|7|||
127794381|NCT00706134|459870971|FG002|Overall Study|Adverse Event|2|||
127794382|NCT00706134|459870972|FG003|Overall Study|Adverse Event|3|||
127794383|NCT00706134|459870969|FG000|Overall Study|Lost to Follow-up|0|||
127794384|NCT00706134|459870970|FG001|Overall Study|Lost to Follow-up|1|||
127794385|NCT00706134|459870971|FG002|Overall Study|Lost to Follow-up|0|||
127794386|NCT00706134|459870972|FG003|Overall Study|Lost to Follow-up|0|||
127794387|NCT00706134|459870969|FG000|Overall Study|Protocol Violation|0|||
127794388|NCT00706134|459870970|FG001|Overall Study|Protocol Violation|6|||
127794389|NCT00706134|459870971|FG002|Overall Study|Protocol Violation|0|||
127794390|NCT00706134|459870972|FG003|Overall Study|Protocol Violation|3|||
127794391|NCT00706134|459870969|FG000|Overall Study|Withdrawal by Subject|1|||
127794392|NCT00706134|459870970|FG001|Overall Study|Withdrawal by Subject|2|||
127794393|NCT00706134|459870971|FG002|Overall Study|Withdrawal by Subject|1|||
127794394|NCT00706134|459870972|FG003|Overall Study|Withdrawal by Subject|0|||
127794395|NCT00706134|459870969|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
127794396|NCT00706134|459870970|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
127794397|NCT00706134|459870971|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
127794398|NCT00706134|459870972|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
127794399|NCT00706134|459870969|FG000|Overall Study|Did not meet study criteria|2|||
127794400|NCT00706134|459870970|FG001|Overall Study|Did not meet study criteria|0|||
127794401|NCT00706134|459870971|FG002|Overall Study|Did not meet study criteria|0|||
127794402|NCT00706134|459870972|FG003|Overall Study|Did not meet study criteria|0|||
127794403|NCT01982292|459870973|FG000|Overall Study|Adverse Event|2|||
127794404|NCT01982292|459870974|FG001|Overall Study|Adverse Event|0|||
127794405|NCT01982292|459870973|FG000|Overall Study|Death|1|||
127794406|NCT01982292|459870974|FG001|Overall Study|Death|0|||
127794407|NCT01982292|459870973|FG000|Overall Study|Lost to Follow-up|2|||
127794408|NCT01982292|459870974|FG001|Overall Study|Lost to Follow-up|0|||
127794409|NCT01982292|459870973|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
127794410|NCT01982292|459870974|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
127794411|NCT01982292|459870973|FG000|Overall Study|Protocol Deviation|1|||
127794412|NCT01982292|459870974|FG001|Overall Study|Protocol Deviation|0|||
127794413|NCT01982292|459870973|FG000|Overall Study|Patient/Guardian Decision|3|||
127629748|NCT04122443|459264627|FG000|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
127629749|NCT04122443|459264628|FG001|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
127629750|NCT04122443|459264629|FG002|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|234|||
127794414|NCT01982292|459870974|FG001|Overall Study|Patient/Guardian Decision|1|||
127794415|NCT01982292|459870973|FG000|Overall Study|Technical Problems|2|||
127794416|NCT01982292|459870974|FG001|Overall Study|Technical Problems|0|||
127794417|NCT00746252|459870977|FG000|Overall Study|weight gain >7.5 %|1|||
127794418|NCT00746252|459870978|FG001|Overall Study|weight gain >7.5 %|2|||
127794419|NCT00082888|459870979|FG000|Overall Study|Ineligible|1|||
127794420|NCT00082888|459870980|FG001|Overall Study|Ineligible|0|||
127794421|NCT00082888|459870981|FG002|Overall Study|Ineligible|0|||
127794422|NCT01659320|459870983|FG000|Overall Study|Withdrawal by Subject|2|||
127794423|NCT01659320|459870983|FG000|Overall Study|Physician Decision|1|||
127794424|NCT01870401|459870984|FG000|Overall Study|Death|48|||
127794425|NCT01870401|459870985|FG001|Overall Study|Death|24|||
127794426|NCT01870401|459870984|FG000|Overall Study|Withdrawal by Subject|39|||
127794427|NCT01870401|459870985|FG001|Overall Study|Withdrawal by Subject|26|||
127794428|NCT01870401|459870984|FG000|Overall Study|Lost to Follow-up|19|||
127794429|NCT01870401|459870985|FG001|Overall Study|Lost to Follow-up|14|||
127794430|NCT01870401|459870984|FG000|Overall Study|Other|9|||
127794431|NCT01870401|459870985|FG001|Overall Study|Other|7|||
127794432|NCT01870401|459870984|FG000|Overall Study|On-going in the Study|35|||
127794433|NCT01870401|459870985|FG001|Overall Study|On-going in the Study|25|||
127794434|NCT02684981|459870986|FG000|Overall Study|Permanently discontinued the treatment|157|||
127794435|NCT02684981|459870987|FG001|Overall Study|Permanently discontinued the treatment|161|||
127794436|NCT02684981|459870988|FG002|Overall Study|Permanently discontinued the treatment|110|||
127794437|NCT02684981|459870986|FG000|Overall Study|Other|83|||
127794438|NCT02684981|459870987|FG001|Overall Study|Other|49|||
127794439|NCT02684981|459870988|FG002|Overall Study|Other|17|||
127794440|NCT04623242|459870989|FG000|Overall Study|Withdrawal by Subject|7|||
127794441|NCT04623242|459870990|FG001|Overall Study|Withdrawal by Subject|12|||
127794442|NCT04623242|459870991|FG002|Overall Study|Withdrawal by Subject|5|||
127794443|NCT04623242|459870992|FG003|Overall Study|Withdrawal by Subject|7|||
127794444|NCT04623242|459870993|FG004|Overall Study|Withdrawal by Subject|0|||
127794445|NCT04623242|459870989|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
127794446|NCT04623242|459870990|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
127794447|NCT04623242|459870991|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
127885401|NCT04380701|460203895|FG024|Overall Study|Adverse Event|0|||
127885402|NCT04380701|460203896|FG025|Overall Study|Adverse Event|0|||
127885403|NCT04380701|460203897|FG026|Overall Study|Adverse Event|0|||
127885404|NCT04380701|460203898|FG027|Overall Study|Adverse Event|0|||
127885405|NCT04380701|460203899|FG028|Overall Study|Adverse Event|0|||
127885406|NCT04380701|460203900|FG029|Overall Study|Adverse Event|0|||
127885407|NCT04380701|460203901|FG030|Overall Study|Adverse Event|0|||
127885408|NCT04380701|460203902|FG031|Overall Study|Adverse Event|0|||
127885409|NCT04380701|460203903|FG032|Overall Study|Adverse Event|0|||
127702133|NCT03628924|459538971|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
127702134|NCT03628924|459538972|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
127702135|NCT03628924|459538973|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
127702136|NCT03628924|459538967|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
127885410|NCT04380701|460203904|FG033|Overall Study|Adverse Event|0|||
127885411|NCT04380701|460203871|FG000|Overall Study|Roll-over into trial BNT162-14|0|||
127885412|NCT04380701|460203872|FG001|Overall Study|Roll-over into trial BNT162-14|0|||
127885413|NCT04380701|460203873|FG002|Overall Study|Roll-over into trial BNT162-14|0|||
127885414|NCT04380701|460203874|FG003|Overall Study|Roll-over into trial BNT162-14|0|||
127885415|NCT04380701|460203875|FG004|Overall Study|Roll-over into trial BNT162-14|0|||
127885416|NCT04380701|460203876|FG005|Overall Study|Roll-over into trial BNT162-14|0|||
127885417|NCT04380701|460203877|FG006|Overall Study|Roll-over into trial BNT162-14|0|||
127885418|NCT04380701|460203878|FG007|Overall Study|Roll-over into trial BNT162-14|0|||
127885419|NCT04380701|460203879|FG008|Overall Study|Roll-over into trial BNT162-14|0|||
127885420|NCT04380701|460203880|FG009|Overall Study|Roll-over into trial BNT162-14|0|||
127885421|NCT04380701|460203881|FG010|Overall Study|Roll-over into trial BNT162-14|0|||
127885422|NCT04380701|460203882|FG011|Overall Study|Roll-over into trial BNT162-14|0|||
127885423|NCT04380701|460203883|FG012|Overall Study|Roll-over into trial BNT162-14|0|||
127885424|NCT04380701|460203884|FG013|Overall Study|Roll-over into trial BNT162-14|0|||
127885425|NCT04380701|460203885|FG014|Overall Study|Roll-over into trial BNT162-14|0|||
127885426|NCT04380701|460203886|FG015|Overall Study|Roll-over into trial BNT162-14|0|||
127885427|NCT04380701|460203887|FG016|Overall Study|Roll-over into trial BNT162-14|0|||
127885428|NCT04380701|460203888|FG017|Overall Study|Roll-over into trial BNT162-14|0|||
127885429|NCT04380701|460203889|FG018|Overall Study|Roll-over into trial BNT162-14|0|||
127885430|NCT04380701|460203890|FG019|Overall Study|Roll-over into trial BNT162-14|0|||
127885431|NCT04380701|460203891|FG020|Overall Study|Roll-over into trial BNT162-14|0|||
127885432|NCT04380701|460203892|FG021|Overall Study|Roll-over into trial BNT162-14|11|||
127885433|NCT04380701|460203893|FG022|Overall Study|Roll-over into trial BNT162-14|11|||
127885434|NCT04380701|460203894|FG023|Overall Study|Roll-over into trial BNT162-14|10|||
127885435|NCT04380701|460203895|FG024|Overall Study|Roll-over into trial BNT162-14|31|||
127885436|NCT04380701|460203896|FG025|Overall Study|Roll-over into trial BNT162-14|0|||
127885437|NCT04380701|460203897|FG026|Overall Study|Roll-over into trial BNT162-14|0|||
127885438|NCT04380701|460203898|FG027|Overall Study|Roll-over into trial BNT162-14|0|||
127885439|NCT04380701|460203899|FG028|Overall Study|Roll-over into trial BNT162-14|0|||
127885440|NCT04380701|460203900|FG029|Overall Study|Roll-over into trial BNT162-14|0|||
127885441|NCT04380701|460203901|FG030|Overall Study|Roll-over into trial BNT162-14|0|||
127885442|NCT04380701|460203902|FG031|Overall Study|Roll-over into trial BNT162-14|0|||
127885443|NCT04380701|460203903|FG032|Overall Study|Roll-over into trial BNT162-14|0|||
127885444|NCT04380701|460203904|FG033|Overall Study|Roll-over into trial BNT162-14|0|||
127885445|NCT04380701|460203871|FG000|Overall Study|Physician Decision|0|||
127885446|NCT04380701|460203872|FG001|Overall Study|Physician Decision|0|||
127702137|NCT03628924|459538968|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
127702138|NCT03628924|459538969|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
127702139|NCT03628924|459538970|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
127702140|NCT03628924|459538971|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
127702141|NCT03628924|459538972|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
127702142|NCT03628924|459538973|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
127702143|NCT03628924|459538967|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
127702144|NCT03628924|459538968|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
127702145|NCT03628924|459538969|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
127702146|NCT03628924|459538970|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
127702147|NCT03628924|459538971|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
127702148|NCT03628924|459538972|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
127702149|NCT03628924|459538973|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
127702150|NCT03628924|459538967|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
127702151|NCT03628924|459538968|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
127885447|NCT04380701|460203873|FG002|Overall Study|Physician Decision|0|||
127885448|NCT04380701|460203874|FG003|Overall Study|Physician Decision|0|||
127794448|NCT04623242|459870992|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
127794449|NCT04623242|459870993|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
127794450|NCT04623242|459870989|FG000|Overall Study|Subject unblinded to mutation status|0|||
127794451|NCT04623242|459870990|FG001|Overall Study|Subject unblinded to mutation status|0|||
127794452|NCT04623242|459870991|FG002|Overall Study|Subject unblinded to mutation status|0|||
127794453|NCT04623242|459870992|FG003|Overall Study|Subject unblinded to mutation status|13|||
127794454|NCT04623242|459870993|FG004|Overall Study|Subject unblinded to mutation status|0|||
127794455|NCT00820898|459870994|FG000|Overall Study|Inelgible - wrong primary site|1|||
127794456|NCT00493870|459870998|FG000|Overall Study|Lost to Follow-up|12|||
127794457|NCT00493870|459870999|FG001|Overall Study|Lost to Follow-up|15|||
127794458|NCT03605680|459871000|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
127794459|NCT03605680|459871001|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
127794460|NCT03605680|459871002|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
127794461|NCT03605680|459871003|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
127794462|NCT03605680|459871000|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
127794463|NCT03605680|459871001|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
127794464|NCT03605680|459871002|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
127794465|NCT03605680|459871003|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
127794466|NCT03605680|459871000|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
127794467|NCT03605680|459871001|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
127794468|NCT03605680|459871002|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
127794469|NCT03605680|459871003|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
127794470|NCT03605680|459871000|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
127794471|NCT03605680|459871001|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
127794472|NCT03605680|459871002|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
127794473|NCT03605680|459871003|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
127794474|NCT03605680|459871000|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
127794475|NCT03605680|459871001|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
127794476|NCT03605680|459871002|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
127794477|NCT03605680|459871003|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
127794478|NCT03605680|459871000|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
127794479|NCT03605680|459871001|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
127794480|NCT03605680|459871002|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
127794481|NCT03605680|459871003|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
127794482|NCT03605680|459871000|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
127794483|NCT03605680|459871001|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
127794484|NCT03605680|459871002|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
127794485|NCT03605680|459871003|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
127794486|NCT03605680|459871000|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
127794487|NCT03605680|459871001|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
127794488|NCT03605680|459871002|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
127794489|NCT03605680|459871003|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
127794490|NCT03605680|459871000|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
127794491|NCT03605680|459871001|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
127794492|NCT03605680|459871002|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
127794493|NCT03605680|459871003|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
127794494|NCT03605680|459871000|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
127794495|NCT03605680|459871001|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
127794496|NCT03605680|459871002|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
127794497|NCT03605680|459871003|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
127794498|NCT03605680|459871000|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
127794499|NCT03605680|459871001|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
127794500|NCT03605680|459871002|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
127794501|NCT03605680|459871003|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
127794502|NCT03605680|459871000|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
127794503|NCT03605680|459871001|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
127794504|NCT03605680|459871002|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
127885449|NCT04380701|460203875|FG004|Overall Study|Physician Decision|0|||
127885450|NCT04380701|460203876|FG005|Overall Study|Physician Decision|0|||
127794505|NCT03605680|459871003|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
127794506|NCT03605680|459871000|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
127794507|NCT03605680|459871001|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
127794508|NCT03605680|459871002|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
127794509|NCT03605680|459871003|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
127794510|NCT03605680|459871000|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
127794511|NCT03605680|459871001|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
127794512|NCT03605680|459871002|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
127794513|NCT03605680|459871003|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
127794514|NCT03605680|459871000|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
127794515|NCT03605680|459871001|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
127794516|NCT03605680|459871002|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
127794517|NCT03605680|459871003|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
127794518|NCT03605680|459871000|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
127794519|NCT03605680|459871001|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
127794520|NCT03605680|459871002|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
127794521|NCT03605680|459871003|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
127794522|NCT03605680|459871000|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
127794523|NCT03605680|459871001|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
127794524|NCT03605680|459871002|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
127794525|NCT03605680|459871003|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
127794526|NCT03605680|459871000|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
127794527|NCT03605680|459871001|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
127794528|NCT03605680|459871002|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
127794529|NCT03605680|459871003|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
127794530|NCT03605680|459871000|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
127794531|NCT03605680|459871001|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
127794532|NCT03605680|459871002|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
127794533|NCT03605680|459871003|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
127794534|NCT01652287|459871004|FG000|Overall Study|Withdrawal by Subject|2|||
127794535|NCT01652287|459871005|FG001|Overall Study|Withdrawal by Subject|0|||
127794536|NCT00527605|459871006|FG000|Overall Study|Adverse Event|3|||
127794537|NCT00527605|459871007|FG001|Overall Study|Adverse Event|0|||
127794538|NCT00527605|459871006|FG000|Overall Study|Withdrawal by Subject|3|||
127794539|NCT00527605|459871007|FG001|Overall Study|Withdrawal by Subject|7|||
127794540|NCT00527605|459871006|FG000|Overall Study|Lost to Follow-up|6|||
127794541|NCT00527605|459871007|FG001|Overall Study|Lost to Follow-up|2|||
127794542|NCT00527605|459871006|FG000|Overall Study|Protocol Violation|1|||
127794543|NCT00527605|459871007|FG001|Overall Study|Protocol Violation|2|||
127794544|NCT00763139|459871008|FG000|Overall Study|Adverse Event|4|||
127794545|NCT00763139|459871009|FG001|Overall Study|Adverse Event|2|||
127794546|NCT00763139|459871008|FG000|Overall Study|Withdrawal by Subject|0|||
127794547|NCT00763139|459871009|FG001|Overall Study|Withdrawal by Subject|1|||
127794548|NCT00763139|459871008|FG000|Overall Study|med change not allowed by protocol|1|||
127794549|NCT00763139|459871009|FG001|Overall Study|med change not allowed by protocol|0|||
127794550|NCT01592760|459871010|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
127794551|NCT01592760|459871011|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
127794552|NCT01592760|459871012|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
127794553|NCT04312009|459871013|FG000|Overall Study|Withdrawal by Subject|2|||
127794554|NCT04312009|459871014|FG001|Overall Study|Withdrawal by Subject|1|||
127794555|NCT00179309|459871020|FG000|Treatment|Toxicity|2|||
127794556|NCT00179309|459871021|FG001|Treatment|Toxicity|3|||
127794557|NCT00179309|459871020|FG000|Treatment|Withdrawal by Subject|1|||
127794558|NCT00179309|459871021|FG001|Treatment|Withdrawal by Subject|2|||
127794559|NCT00179309|459871020|FG000|Treatment|Allergy|1|||
127794560|NCT00179309|459871021|FG001|Treatment|Allergy|0|||
127794561|NCT02797808|459871023|FG000|Overall Study|Withdrawal by Subject|1|||
127794562|NCT02797808|459871024|FG001|Overall Study|Withdrawal by Subject|1|||
127794563|NCT02797808|459871023|FG000|Overall Study|Physician Decision|6|||
127794564|NCT02797808|459871024|FG001|Overall Study|Physician Decision|2|||
127794565|NCT01780831|459871027|FG000|Overall Study|Withdrawal by Subject|0|||
127794566|NCT01780831|459871028|FG001|Overall Study|Withdrawal by Subject|0|||
127629751|NCT04122443|459264627|FG000|Stage 1 - Open Label|Withdrawal by Subject|0|||
127629752|NCT04122443|459264628|FG001|Stage 1 - Open Label|Withdrawal by Subject|0|||
127629753|NCT04122443|459264629|FG002|Stage 1 - Open Label|Withdrawal by Subject|5|||
127629754|NCT00298831|459264630|FG000|Overall Study|Adverse Event|1|||
127629755|NCT00298831|459264630|FG000|Overall Study|Lost to Follow-up|3|||
127629756|NCT00298831|459264630|FG000|Overall Study|Withdrawal by Subject|1|||
127629757|NCT00298831|459264630|FG000|Overall Study|Participants did not receive treatment|27|||
127629758|NCT03149328|459264631|FG000|Overall Study|Withdrawal by Subject|30|||
127629759|NCT03149328|459264632|FG001|Overall Study|Withdrawal by Subject|26|||
127629760|NCT03149328|459264631|FG000|Overall Study|Changed Dialysis Modality|18|||
127629761|NCT03149328|459264632|FG001|Overall Study|Changed Dialysis Modality|1|||
127629762|NCT03149328|459264631|FG000|Overall Study|Transplant|9|||
127629763|NCT03149328|459264632|FG001|Overall Study|Transplant|1|||
127629764|NCT03149328|459264631|FG000|Overall Study|Lost to Follow-up|25|||
127629765|NCT03149328|459264632|FG001|Overall Study|Lost to Follow-up|16|||
127629766|NCT03149328|459264631|FG000|Overall Study|Left Study Site|1|||
127629767|NCT03149328|459264632|FG001|Overall Study|Left Study Site|2|||
127629768|NCT03149328|459264631|FG000|Overall Study|Language Barrier|1|||
127629769|NCT03149328|459264632|FG001|Overall Study|Language Barrier|0|||
127629770|NCT00691210|459264634|FG000|Overall Study|Progression of Disease|0|||
127629771|NCT00691210|459264635|FG001|Overall Study|Progression of Disease|0|||
127629772|NCT00691210|459264636|FG002|Overall Study|Progression of Disease|0|||
127629773|NCT00691210|459264637|FG003|Overall Study|Progression of Disease|2|||
127629774|NCT00691210|459264638|FG004|Overall Study|Progression of Disease|0|||
127629775|NCT00691210|459264639|FG005|Overall Study|Progression of Disease|0|||
127629776|NCT00691210|459264640|FG006|Overall Study|Progression of Disease|0|||
127629777|NCT00691210|459264641|FG007|Overall Study|Progression of Disease|0|||
127702152|NCT03628924|459538969|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
127702153|NCT03628924|459538970|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
127702154|NCT03628924|459538971|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
127702155|NCT03628924|459538972|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
127702156|NCT03628924|459538973|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
127702157|NCT03628924|459538967|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
127702158|NCT03628924|459538968|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
127702159|NCT03628924|459538969|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
127702160|NCT03628924|459538970|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
127702161|NCT03628924|459538971|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
127702162|NCT03628924|459538972|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
127702163|NCT03628924|459538973|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
127702164|NCT03628924|459538967|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
127702165|NCT03628924|459538968|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
127702166|NCT03628924|459538969|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
127702167|NCT03628924|459538970|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
127702168|NCT03628924|459538971|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
127702169|NCT03628924|459538972|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
127702170|NCT03628924|459538973|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
127702171|NCT03628924|459538967|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
127702172|NCT03628924|459538968|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
127702173|NCT03628924|459538969|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
127702174|NCT03628924|459538970|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
127702175|NCT03628924|459538971|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
127702176|NCT03628924|459538972|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
127702177|NCT03628924|459538973|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
127702178|NCT01539083|459538974|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
127702179|NCT01539083|459538975|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
127702180|NCT01539083|459538976|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
127702181|NCT01539083|459538974|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
127702182|NCT01539083|459538975|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
127702183|NCT01539083|459538976|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
127702184|NCT01539083|459538974|FG000|Before Randomization (VCD Induction)|Death|6|||
127702185|NCT01539083|459538975|FG001|Before Randomization (VCD Induction)|Death|0|||
127702186|NCT01539083|459538976|FG002|Before Randomization (VCD Induction)|Death|0|||
127629778|NCT00691210|459264634|FG000|Overall Study|Lack of Efficacy|0|||
127629779|NCT00691210|459264635|FG001|Overall Study|Lack of Efficacy|0|||
127629780|NCT00691210|459264636|FG002|Overall Study|Lack of Efficacy|0|||
127629781|NCT00691210|459264637|FG003|Overall Study|Lack of Efficacy|1|||
127702187|NCT01539083|459538974|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
127629782|NCT00691210|459264638|FG004|Overall Study|Lack of Efficacy|0|||
127629783|NCT00691210|459264639|FG005|Overall Study|Lack of Efficacy|1|||
127629784|NCT00691210|459264640|FG006|Overall Study|Lack of Efficacy|0|||
127794567|NCT01780831|459871029|FG002|Overall Study|Withdrawal by Subject|4|||
127794568|NCT01780831|459871030|FG003|Overall Study|Withdrawal by Subject|0|||
127794569|NCT01780831|459871027|FG000|Overall Study|Lost to Follow-up|0|||
127794570|NCT01780831|459871028|FG001|Overall Study|Lost to Follow-up|0|||
127794571|NCT01780831|459871029|FG002|Overall Study|Lost to Follow-up|0|||
127794572|NCT01780831|459871030|FG003|Overall Study|Lost to Follow-up|1|||
127794573|NCT00267748|459871034|FG000|Non-randomized Period|Progressive disease|10|||
127794574|NCT00267748|459871035|FG001|Non-randomized Period|Progressive disease|0|||
127794575|NCT00267748|459871036|FG002|Non-randomized Period|Progressive disease|0|||
127794576|NCT00267748|459871034|FG000|Non-randomized Period|Adverse Event|8|||
127794577|NCT00267748|459871035|FG001|Non-randomized Period|Adverse Event|0|||
127794578|NCT00267748|459871036|FG002|Non-randomized Period|Adverse Event|0|||
127794579|NCT00267748|459871034|FG000|Non-randomized Period|Death|1|||
127794580|NCT00267748|459871035|FG001|Non-randomized Period|Death|0|||
127794581|NCT00267748|459871036|FG002|Non-randomized Period|Death|0|||
127794582|NCT00267748|459871034|FG000|Non-randomized Period|Participant not willing to participate|1|||
127794583|NCT00267748|459871035|FG001|Non-randomized Period|Participant not willing to participate|0|||
127794584|NCT00267748|459871036|FG002|Non-randomized Period|Participant not willing to participate|0|||
127794585|NCT00267748|459871034|FG000|Non-randomized Period|Other|3|||
127794586|NCT00267748|459871035|FG001|Non-randomized Period|Other|0|||
127794587|NCT00267748|459871036|FG002|Non-randomized Period|Other|0|||
127794588|NCT00267748|459871034|FG000|Randomized Period|Death|0|||
127794589|NCT00267748|459871035|FG001|Randomized Period|Death|2|||
127794590|NCT00267748|459871036|FG002|Randomized Period|Death|3|||
127794591|NCT00267748|459871034|FG000|Randomized Period|Adverse Event|0|||
127794592|NCT00267748|459871035|FG001|Randomized Period|Adverse Event|23|||
127629785|NCT00691210|459264641|FG007|Overall Study|Lack of Efficacy|0|||
127629786|NCT01306617|459264642|FG000|Overall Study|Adverse Event|1|||
127629787|NCT01306617|459264643|FG001|Overall Study|Adverse Event|0|||
127629788|NCT01306617|459264644|FG002|Overall Study|Adverse Event|0|||
127629789|NCT01306617|459264642|FG000|Overall Study|Virologic Failure|0|||
127629790|NCT01306617|459264643|FG001|Overall Study|Virologic Failure|0|||
127629791|NCT01306617|459264644|FG002|Overall Study|Virologic Failure|5|||
127629792|NCT01306617|459264642|FG000|Overall Study|Non-compliance|0|||
127629793|NCT01306617|459264643|FG001|Overall Study|Non-compliance|1|||
127629794|NCT01306617|459264644|FG002|Overall Study|Non-compliance|0|||
127629795|NCT03403634|459264647|FG000|Overall Study|Disease progression|3|||
127629796|NCT03403634|459264647|FG000|Overall Study|Did not meet eligibility criteria|4|||
127629797|NCT01076400|459266241|FG000|Overall Study|Adverse Event|2|||
127629798|NCT01076400|459266242|FG001|Overall Study|Adverse Event|0|||
127629799|NCT01076400|459266243|FG002|Overall Study|Adverse Event|0|||
127629800|NCT01076400|459266241|FG000|Overall Study|Progressive Disease|5|||
127629801|NCT01076400|459266242|FG001|Overall Study|Progressive Disease|0|||
127629802|NCT01076400|459266243|FG002|Overall Study|Progressive Disease|0|||
127629803|NCT03019536|459266245|FG000|Overall Study|Withdrawal by Subject|1|||
127794593|NCT00267748|459871036|FG002|Randomized Period|Adverse Event|25|||
127794594|NCT00267748|459871034|FG000|Randomized Period|Global deterioration of health status|0|||
127794595|NCT00267748|459871035|FG001|Randomized Period|Global deterioration of health status|6|||
127794596|NCT00267748|459871036|FG002|Randomized Period|Global deterioration of health status|7|||
127794597|NCT00267748|459871034|FG000|Randomized Period|Lost to Follow-up|0|||
127794598|NCT00267748|459871035|FG001|Randomized Period|Lost to Follow-up|1|||
127794599|NCT00267748|459871036|FG002|Randomized Period|Lost to Follow-up|0|||
127629804|NCT03019536|459266246|FG001|Overall Study|Withdrawal by Subject|1|||
127629805|NCT03019536|459266247|FG002|Overall Study|Withdrawal by Subject|0|||
127629806|NCT03019536|459266245|FG000|Overall Study|Adverse Event|0|||
127629807|NCT03019536|459266246|FG001|Overall Study|Adverse Event|0|||
127629808|NCT03019536|459266247|FG002|Overall Study|Adverse Event|2|||
127629809|NCT01043874|459266248|FG000|Overall Study|Adverse Event|3|||
127629810|NCT01043874|459266248|FG000|Overall Study|Withdrawal by Subject|1|||
127629811|NCT01043874|459266248|FG000|Overall Study|Lack of Efficacy|1|||
127794600|NCT00267748|459871034|FG000|Randomized Period|Objective progression or relapse|0|||
127794601|NCT00267748|459871035|FG001|Randomized Period|Objective progression or relapse|77|||
127794602|NCT00267748|459871036|FG002|Randomized Period|Objective progression or relapse|86|||
127794603|NCT00267748|459871034|FG000|Randomized Period|Withdrawal by Subject|0|||
127794604|NCT00267748|459871035|FG001|Randomized Period|Withdrawal by Subject|9|||
127794605|NCT00267748|459871036|FG002|Randomized Period|Withdrawal by Subject|2|||
127794606|NCT00267748|459871034|FG000|Randomized Period|Other|0|||
127794607|NCT00267748|459871035|FG001|Randomized Period|Other|9|||
127794608|NCT00267748|459871036|FG002|Randomized Period|Other|6|||
127794609|NCT00267748|459871034|FG000|Randomized Period|randomized but not treated|0|||
127794610|NCT00267748|459871035|FG001|Randomized Period|randomized but not treated|0|||
127794611|NCT00267748|459871036|FG002|Randomized Period|randomized but not treated|3|||
127794612|NCT01294800|459871037|FG000|Overall Study|Adverse Event|7|||
127794613|NCT01294800|459871038|FG001|Overall Study|Adverse Event|6|||
127629812|NCT01043874|459266248|FG000|Overall Study|Administrative Problems|1|||
127794614|NCT01294800|459871039|FG002|Overall Study|Adverse Event|12|||
127794615|NCT01294800|459871040|FG003|Overall Study|Adverse Event|5|||
127629813|NCT00182689|459266256|FG000|Overall Study|Adverse Event|8|||
127794616|NCT01294800|459871037|FG000|Overall Study|Subject Withdrew Consent|2|||
127794617|NCT01294800|459871038|FG001|Overall Study|Subject Withdrew Consent|2|||
127794618|NCT01294800|459871039|FG002|Overall Study|Subject Withdrew Consent|2|||
127794619|NCT01294800|459871040|FG003|Overall Study|Subject Withdrew Consent|11|||
127794620|NCT01294800|459871037|FG000|Overall Study|Lost to Follow-up|0|||
127794621|NCT01294800|459871038|FG001|Overall Study|Lost to Follow-up|0|||
127794622|NCT01294800|459871039|FG002|Overall Study|Lost to Follow-up|1|||
127794623|NCT01294800|459871040|FG003|Overall Study|Lost to Follow-up|0|||
127794624|NCT01294800|459871037|FG000|Overall Study|Non-compliance With Protocol|0|||
127794625|NCT01294800|459871038|FG001|Overall Study|Non-compliance With Protocol|1|||
127794626|NCT01294800|459871039|FG002|Overall Study|Non-compliance With Protocol|1|||
127794627|NCT01294800|459871040|FG003|Overall Study|Non-compliance With Protocol|0|||
127794628|NCT01294800|459871037|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
127794629|NCT01294800|459871038|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
127794630|NCT01294800|459871039|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
127794631|NCT01294800|459871040|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
127794632|NCT05098041|459871041|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
127794633|NCT00797732|459871045|FG000|Overall Study|Withdrawal by Subject|3|||
127794634|NCT00797732|459871046|FG001|Overall Study|Withdrawal by Subject|3|||
127794635|NCT00797732|459871047|FG002|Overall Study|Withdrawal by Subject|0|||
127794636|NCT00797732|459871045|FG000|Overall Study|Lost to Follow-up|1|||
127794637|NCT00797732|459871046|FG001|Overall Study|Lost to Follow-up|0|||
127794638|NCT00797732|459871047|FG002|Overall Study|Lost to Follow-up|0|||
127794639|NCT00797732|459871045|FG000|Overall Study|Death|1|||
127794640|NCT00797732|459871046|FG001|Overall Study|Death|0|||
127629814|NCT00182689|459266257|FG001|Overall Study|Adverse Event|11|||
127794641|NCT00797732|459871047|FG002|Overall Study|Death|0|||
127794642|NCT00797732|459871045|FG000|Overall Study|Not meet inclusion criteria|0|||
127794643|NCT00797732|459871046|FG001|Overall Study|Not meet inclusion criteria|0|||
127794644|NCT00797732|459871047|FG002|Overall Study|Not meet inclusion criteria|7|||
127794645|NCT00797732|459871045|FG000|Overall Study|Excluded due to time constraints|0|||
127794646|NCT00797732|459871046|FG001|Overall Study|Excluded due to time constraints|0|||
127794647|NCT00797732|459871047|FG002|Overall Study|Excluded due to time constraints|24|||
127794648|NCT00797732|459871045|FG000|Overall Study|Refused to Participate|0|||
127794649|NCT00797732|459871046|FG001|Overall Study|Refused to Participate|0|||
127794650|NCT00797732|459871047|FG002|Overall Study|Refused to Participate|123|||
127794651|NCT00401752|459871050|FG000|Overall Study|Adverse Event|2|||
127794652|NCT00401752|459871051|FG001|Overall Study|Adverse Event|5|||
127794653|NCT00401752|459871050|FG000|Overall Study|Withdrawal by Subject|2|||
127794654|NCT00401752|459871051|FG001|Overall Study|Withdrawal by Subject|6|||
127794655|NCT00401752|459871050|FG000|Overall Study|Lost to Follow-up|1|||
127794656|NCT00401752|459871051|FG001|Overall Study|Lost to Follow-up|4|||
127794657|NCT00401752|459871050|FG000|Overall Study|Development of any exclusion criteria|4|||
127794658|NCT00401752|459871051|FG001|Overall Study|Development of any exclusion criteria|2|||
127794659|NCT00401752|459871050|FG000|Overall Study|Physician Decision|1|||
127794660|NCT00401752|459871051|FG001|Overall Study|Physician Decision|1|||
127794661|NCT02275338|459871052|FG000|Overall Study|Adverse Event|15|||
127794662|NCT02275338|459871052|FG000|Overall Study|Lack of Efficacy|3|||
127794663|NCT02275338|459871052|FG000|Overall Study|Withdrawal by Subject|4|||
127794664|NCT02275338|459871052|FG000|Overall Study|Disease progression (death)|1|||
127794665|NCT02275338|459871052|FG000|Overall Study|Ineligible to start Phase 2|4|||
127794666|NCT02275338|459871052|FG000|Overall Study|Reason not specified|5|||
127794667|NCT02275338|459871052|FG000|Overall Study|Does not meet entry criteria|1|||
127794668|NCT00835237|459871055|FG000|Overall Study|Lost to Follow-up|4|||
127794669|NCT00835237|459871056|FG001|Overall Study|Lost to Follow-up|0|||
127794670|NCT00835237|459871055|FG000|Overall Study|Withdrawal by Subject|2|||
127794671|NCT00835237|459871056|FG001|Overall Study|Withdrawal by Subject|0|||
127794672|NCT01265550|459871057|FG000|Pre Randomization|Withdrawal by Subject|0|||
127629815|NCT00182689|459266256|FG000|Overall Study|Withdrawal by Subject|2|||
127629816|NCT00182689|459266257|FG001|Overall Study|Withdrawal by Subject|2|||
127794673|NCT01265550|459871058|FG001|Pre Randomization|Withdrawal by Subject|0|||
127794674|NCT01265550|459871059|FG002|Pre Randomization|Withdrawal by Subject|0|||
127794675|NCT01265550|459871060|FG003|Pre Randomization|Withdrawal by Subject|70|||
127794676|NCT01265550|459871057|FG000|Pre Randomization|Technical Exclusions|0|||
127794677|NCT01265550|459871058|FG001|Pre Randomization|Technical Exclusions|0|||
127794678|NCT01265550|459871059|FG002|Pre Randomization|Technical Exclusions|0|||
127794679|NCT01265550|459871060|FG003|Pre Randomization|Technical Exclusions|54|||
127794680|NCT01265550|459871057|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
127794681|NCT01265550|459871058|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
127794682|NCT01265550|459871059|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
127794683|NCT01265550|459871060|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
127794684|NCT01265550|459871057|FG000|Pre Randomization|Non-GERD organic disorders|0|||
127629817|NCT00182689|459266256|FG000|Overall Study|Progression|27|||
127794685|NCT01265550|459871058|FG001|Pre Randomization|Non-GERD organic disorders|0|||
127794686|NCT01265550|459871059|FG002|Pre Randomization|Non-GERD organic disorders|0|||
127794687|NCT01265550|459871060|FG003|Pre Randomization|Non-GERD organic disorders|23|||
127629818|NCT00182689|459266257|FG001|Overall Study|Progression|29|||
127629819|NCT00182689|459266256|FG000|Overall Study|Death|1|||
127629820|NCT00182689|459266257|FG001|Overall Study|Death|0|||
127629821|NCT00182689|459266256|FG000|Overall Study|not protocol specified|0|||
127629822|NCT00182689|459266257|FG001|Overall Study|not protocol specified|3|||
127629823|NCT00182689|459266256|FG000|Overall Study|Ineligible|1|||
127629824|NCT00182689|459266257|FG001|Overall Study|Ineligible|4|||
127629825|NCT00182689|459266256|FG000|Overall Study|Never received treatment|1|||
127629826|NCT00182689|459266257|FG001|Overall Study|Never received treatment|0|||
127629827|NCT03422003|459266258|FG000|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|7|||
127629828|NCT03422003|459266259|FG001|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|2|||
127629829|NCT03422003|459266258|FG000|6-month Follow-up|Withdrawal by subject, loss to follow-up|26|||
127629830|NCT03422003|459266259|FG001|6-month Follow-up|Withdrawal by subject, loss to follow-up|33|||
127629831|NCT01337089|459266262|FG000|Overall Study|Adverse Event|237|||
127629832|NCT01337089|459266262|FG000|Overall Study|Withdrawal by Subject|129|||
127629833|NCT01337089|459266262|FG000|Overall Study|Withdrawal by Investigator|33|||
127629834|NCT01337089|459266262|FG000|Overall Study|Met Withdrawal Criteria|3|||
127629835|NCT01337089|459266262|FG000|Overall Study|Lost to Follow-up|2|||
127629836|NCT01627249|459266265|FG000|Overall Study|Death|3|||
127629837|NCT01627249|459266266|FG001|Overall Study|Death|5|||
127629838|NCT01627249|459266267|FG002|Overall Study|Death|3|||
127629839|NCT01627249|459266265|FG000|Overall Study|Withdrawal by Subject|12|||
127629840|NCT01627249|459266266|FG001|Overall Study|Withdrawal by Subject|6|||
127629841|NCT01627249|459266267|FG002|Overall Study|Withdrawal by Subject|9|||
127629842|NCT01627249|459266265|FG000|Overall Study|Missed Visit|1|||
127629843|NCT01627249|459266266|FG001|Overall Study|Missed Visit|1|||
127629844|NCT01627249|459266267|FG002|Overall Study|Missed Visit|0|||
127629845|NCT00966940|459266269|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
127629846|NCT00966940|459266270|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
127629847|NCT00966940|459266269|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
127629848|NCT00966940|459266270|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
127629849|NCT02044510|459266271|FG000|Overall Study|Adverse Event|1|||
127629850|NCT02044510|459266272|FG001|Overall Study|Adverse Event|2|||
127629851|NCT03455855|459266273|FG000|Overall Study|Lost to Follow-up|4|||
127629852|NCT03455855|459266274|FG001|Overall Study|Lost to Follow-up|2|||
127629853|NCT00581945|459266277|FG000|Overall Study|Adverse Event|4|||
127629854|NCT00581945|459266278|FG001|Overall Study|Adverse Event|4|||
127629855|NCT00581945|459266277|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
127629856|NCT00581945|459266278|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
127629857|NCT00581945|459266277|FG000|Overall Study|Withdrawal by Subject|2|||
127629858|NCT00581945|459266278|FG001|Overall Study|Withdrawal by Subject|6|||
127629859|NCT00581945|459266277|FG000|Overall Study|Death|1|||
127629860|NCT00581945|459266278|FG001|Overall Study|Death|0|||
127629861|NCT01075321|459266283|FG000|Overall Study|Withdrawal by Subject|0|||
127629862|NCT01075321|459266284|FG001|Overall Study|Withdrawal by Subject|0|||
127629863|NCT01075321|459266285|FG002|Overall Study|Withdrawal by Subject|1|||
127629864|NCT01075321|459266286|FG003|Overall Study|Withdrawal by Subject|1|||
127629865|NCT01075321|459266283|FG000|Overall Study|Protocol Violation|0|||
127629866|NCT01075321|459266284|FG001|Overall Study|Protocol Violation|0|||
127629867|NCT01075321|459266285|FG002|Overall Study|Protocol Violation|1|||
127629868|NCT01075321|459266286|FG003|Overall Study|Protocol Violation|0|||
127629869|NCT01075321|459266283|FG000|Overall Study|Treatment Incomplete due to progression|1|||
127629870|NCT01075321|459266284|FG001|Overall Study|Treatment Incomplete due to progression|0|||
127629871|NCT01075321|459266285|FG002|Overall Study|Treatment Incomplete due to progression|0|||
127629872|NCT01075321|459266286|FG003|Overall Study|Treatment Incomplete due to progression|0|||
127629873|NCT01075321|459266283|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
127629874|NCT01075321|459266284|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
127629875|NCT01075321|459266285|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
127629876|NCT01075321|459266286|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
127629877|NCT01933334|459266290|FG000|Overall Study|Adverse Event|5|||
127629878|NCT01933334|459266291|FG001|Overall Study|Adverse Event|1|||
127629879|NCT01933334|459266290|FG000|Overall Study|Withdrawal by Subject|0|||
127629880|NCT01933334|459266291|FG001|Overall Study|Withdrawal by Subject|1|||
127629881|NCT02013765|459266297|FG000|Overall Study|Trial was terminated by sponsor|1|||
127629882|NCT00575588|459266302|FG000|Overall Study|Adverse Event|11|||
127629883|NCT00575588|459266303|FG001|Overall Study|Adverse Event|13|||
127629884|NCT00575588|459266302|FG000|Overall Study|Withdrawal by Subject|27|||
127629885|NCT00575588|459266303|FG001|Overall Study|Withdrawal by Subject|31|||
127629886|NCT00575588|459266302|FG000|Overall Study|Lost to Follow-up|1|||
127629887|NCT00575588|459266303|FG001|Overall Study|Lost to Follow-up|3|||
127629888|NCT00575588|459266302|FG000|Overall Study|Death|4|||
127794688|NCT01265550|459871057|FG000|Pre Randomization|Functional heartburn|0|||
127794689|NCT01265550|459871058|FG001|Pre Randomization|Functional heartburn|0|||
127794690|NCT01265550|459871059|FG002|Pre Randomization|Functional heartburn|0|||
127794691|NCT01265550|459871060|FG003|Pre Randomization|Functional heartburn|99|||
127794692|NCT00623428|459871063|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
127794693|NCT00623428|459871064|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
127794694|NCT00623428|459871063|FG000|Treatment Period|Death|0|||
127794695|NCT00623428|459871064|FG001|Treatment Period|Death|1|||
127794696|NCT00623428|459871063|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
127794697|NCT00623428|459871064|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
127794698|NCT00623428|459871063|FG000|Treatment Period|Insufficient therapeutic response|0|||
127629889|NCT00575588|459266303|FG001|Overall Study|Death|2|||
127629890|NCT00575588|459266302|FG000|Overall Study|Incorrect enrollment|8|||
127629891|NCT00575588|459266303|FG001|Overall Study|Incorrect enrollment|4|||
127629892|NCT00575588|459266302|FG000|Overall Study|Study specific discontinuation criteria|203|||
127629893|NCT00575588|459266303|FG001|Overall Study|Study specific discontinuation criteria|218|||
127794699|NCT00623428|459871064|FG001|Treatment Period|Insufficient therapeutic response|2|||
127794700|NCT00623428|459871063|FG000|Treatment Period|Other|0|||
127794701|NCT00623428|459871064|FG001|Treatment Period|Other|1|||
127629894|NCT00575588|459266302|FG000|Overall Study|Severe non-compliance to protocol|5|||
127629895|NCT00575588|459266303|FG001|Overall Study|Severe non-compliance to protocol|7|||
127629896|NCT00575588|459266302|FG000|Overall Study|Safety reasons|2|||
127629897|NCT00575588|459266303|FG001|Overall Study|Safety reasons|1|||
127629898|NCT00575588|459266302|FG000|Overall Study|Elevated triglyceride|1|||
127629899|NCT00575588|459266303|FG001|Overall Study|Elevated triglyceride|0|||
127629900|NCT00575588|459266302|FG000|Overall Study|Patient moved|1|||
127629901|NCT00575588|459266303|FG001|Overall Study|Patient moved|3|||
127629902|NCT00575588|459266302|FG000|Overall Study|Impossible to determine HbA1c|0|||
127629903|NCT00575588|459266303|FG001|Overall Study|Impossible to determine HbA1c|1|||
127629904|NCT00504829|459266304|FG000|Overall Study|Protocol Violation|6|||
127629905|NCT00504829|459266305|FG001|Overall Study|Protocol Violation|4|||
127629906|NCT00504829|459266306|FG002|Overall Study|Protocol Violation|10|||
127629907|NCT01854827|459266307|FG000|Overall Study|Death|1|||
127629908|NCT02571452|459266308|FG000|Overall Study Treatment|Protocol Violation|0|||
127629909|NCT02571452|459266309|FG001|Overall Study Treatment|Protocol Violation|1|||
127794702|NCT00623428|459871063|FG000|Treatment Period|Withdrawal by Subject|0|||
127794703|NCT00623428|459871064|FG001|Treatment Period|Withdrawal by Subject|1|||
127794704|NCT00623428|459871063|FG000|Follow-up Period|Relapse post-treatment|11|||
127794705|NCT00623428|459871064|FG001|Follow-up Period|Relapse post-treatment|3|||
127794706|NCT00623428|459871063|FG000|Follow-up Period|Failure to return|10|||
127794707|NCT00623428|459871064|FG001|Follow-up Period|Failure to return|2|||
127794708|NCT00623428|459871063|FG000|Follow-up Period|Patient withdrew consent|5|||
127794709|NCT00623428|459871064|FG001|Follow-up Period|Patient withdrew consent|4|||
127794710|NCT00623428|459871063|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
127794711|NCT00623428|459871064|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
127794712|NCT00623428|459871063|FG000|Follow-up Period|Did not cooperate|0|||
127794713|NCT00623428|459871064|FG001|Follow-up Period|Did not cooperate|3|||
127629910|NCT02571452|459266308|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
127629911|NCT02571452|459266309|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
127629912|NCT02571452|459266308|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
127629913|NCT02571452|459266309|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
127629914|NCT01751568|459266322|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
127629915|NCT01751568|459266323|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
127629916|NCT01751568|459266324|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
127629917|NCT02660944|459266325|FG000|Overall Study|Adverse Event|3|||
127794714|NCT00623428|459871063|FG000|Follow-up Period|Reason not specified|1|||
127794715|NCT00623428|459871064|FG001|Follow-up Period|Reason not specified|1|||
127794716|NCT00623428|459871063|FG000|Follow-up Period|Death|0|||
127794717|NCT00623428|459871064|FG001|Follow-up Period|Death|1|||
127794718|NCT01929408|459871067|FG000|Overall Study|received HCT as initial treatment|8|||
127794719|NCT00293579|459871068|FG000|Overall Study|Withdrawal by Subject|1|||
127794720|NCT01180660|459871069|FG000|Overall Study|Changed to open surgery|1|||
127794721|NCT01180660|459871070|FG001|Overall Study|Changed to open surgery|0|||
127794722|NCT03657043|459872542|FG000|Overall Study|Withdrawal by Subject|1|||
127794723|NCT03657043|459872543|FG001|Overall Study|Withdrawal by Subject|1|||
127794724|NCT03657043|459872544|FG002|Overall Study|Withdrawal by Subject|0|||
127794725|NCT03657043|459872545|FG003|Overall Study|Withdrawal by Subject|0|||
127794726|NCT03657043|459872546|FG004|Overall Study|Withdrawal by Subject|4|||
127794727|NCT03657043|459872542|FG000|Overall Study|Study closure by Sponsor|0|||
127794728|NCT03657043|459872543|FG001|Overall Study|Study closure by Sponsor|2|||
127794729|NCT03657043|459872544|FG002|Overall Study|Study closure by Sponsor|0|||
127794730|NCT03657043|459872545|FG003|Overall Study|Study closure by Sponsor|0|||
127794731|NCT03657043|459872546|FG004|Overall Study|Study closure by Sponsor|17|||
127794732|NCT03657043|459872542|FG000|Overall Study|Lost to Follow-up|0|||
127629918|NCT02660944|459266326|FG001|Overall Study|Adverse Event|4|||
127629919|NCT02660944|459266325|FG000|Overall Study|Physician Decision|3|||
127629920|NCT02660944|459266326|FG001|Overall Study|Physician Decision|1|||
127629921|NCT02660944|459266325|FG000|Overall Study|Withdrawal by Subject|5|||
127629922|NCT02660944|459266326|FG001|Overall Study|Withdrawal by Subject|3|||
127629923|NCT02660944|459266325|FG000|Overall Study|Lost to Follow-up|4|||
127629924|NCT02660944|459266326|FG001|Overall Study|Lost to Follow-up|1|||
127629925|NCT02660944|459266325|FG000|Overall Study|Subject schedule|0|||
127629926|NCT02660944|459266326|FG001|Overall Study|Subject schedule|1|||
127629927|NCT02660944|459266325|FG000|Overall Study|Exclusion criteria met|2|||
127629928|NCT02660944|459266326|FG001|Overall Study|Exclusion criteria met|0|||
127629929|NCT00534352|459266327|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
127629930|NCT00534352|459266327|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
127629931|NCT00534352|459266327|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
127629932|NCT00534352|459266327|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
127629933|NCT00534352|459266327|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
127629934|NCT00534352|459266327|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
127629935|NCT04796610|459266328|FG000|Overall Study|Withdrawal by Subject|1|||
127629936|NCT04796610|459266329|FG001|Overall Study|Withdrawal by Subject|0|||
127629937|NCT04796610|459266330|FG002|Overall Study|Withdrawal by Subject|0|||
127629938|NCT04796610|459266331|FG003|Overall Study|Withdrawal by Subject|0|||
127629939|NCT04796610|459266328|FG000|Overall Study|Lost to Follow-up|2|||
127629940|NCT04796610|459266329|FG001|Overall Study|Lost to Follow-up|0|||
127629941|NCT04796610|459266330|FG002|Overall Study|Lost to Follow-up|1|||
127629942|NCT04796610|459266331|FG003|Overall Study|Lost to Follow-up|1|||
127629943|NCT02059148|459266332|FG000|Treatment 1|Protocol Violation|0|||
127629944|NCT02059148|459266333|FG001|Treatment 1|Protocol Violation|0|||
127629945|NCT02059148|459266334|FG002|Treatment 1|Protocol Violation|0|||
127629946|NCT02059148|459266335|FG003|Treatment 1|Protocol Violation|0|||
127629947|NCT02059148|459266336|FG004|Treatment 1|Protocol Violation|0|||
127629948|NCT02059148|459266337|FG005|Treatment 1|Protocol Violation|1|||
127629949|NCT00403546|459266343|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
127629950|NCT00403546|459266344|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
127629951|NCT00403546|459266345|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
127629952|NCT00403546|459266343|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
127629953|NCT00403546|459266344|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
127629954|NCT00403546|459266345|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
127629955|NCT00403546|459266343|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
127629956|NCT00403546|459266344|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
127629957|NCT00403546|459266345|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
127629958|NCT00403546|459266343|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
127629959|NCT00403546|459266344|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
127629960|NCT00403546|459266345|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
127629961|NCT00403546|459266343|FG000|Screening Phase|Screening Failure|22|||
127629962|NCT00403546|459266344|FG001|Screening Phase|Screening Failure|0|||
127629963|NCT00403546|459266345|FG002|Screening Phase|Screening Failure|0|||
127629964|NCT00403546|459266343|FG000|Screening Phase|Adverse Event|1|||
127629965|NCT00403546|459266344|FG001|Screening Phase|Adverse Event|0|||
127629966|NCT00403546|459266345|FG002|Screening Phase|Adverse Event|0|||
127629967|NCT00403546|459266343|FG000|Screening Phase|Terminated Prior to Randomization|5|||
127629968|NCT00403546|459266344|FG001|Screening Phase|Terminated Prior to Randomization|0|||
127629969|NCT00403546|459266345|FG002|Screening Phase|Terminated Prior to Randomization|0|||
127629970|NCT00403546|459266343|FG000|Randomized Trial|Early Terminations|0|||
127629971|NCT00403546|459266344|FG001|Randomized Trial|Early Terminations|17|||
127629972|NCT00403546|459266345|FG002|Randomized Trial|Early Terminations|16|||
127629973|NCT02673697|459266346|FG000|Overall Study|Adverse Event|2|||
127629974|NCT02673697|459266347|FG001|Overall Study|Adverse Event|0|||
127629975|NCT02673697|459266346|FG000|Overall Study|Death|32|||
127629976|NCT02673697|459266347|FG001|Overall Study|Death|24|||
127629977|NCT02673697|459266346|FG000|Overall Study|Lost to Follow-up|5|||
127629978|NCT02673697|459266347|FG001|Overall Study|Lost to Follow-up|2|||
127629979|NCT02673697|459266346|FG000|Overall Study|Physician Decision|2|||
127629980|NCT02673697|459266347|FG001|Overall Study|Physician Decision|1|||
127629981|NCT02673697|459266346|FG000|Overall Study|Withdrawal by Subject|10|||
127629982|NCT02673697|459266347|FG001|Overall Study|Withdrawal by Subject|7|||
127629983|NCT02673697|459266346|FG000|Overall Study|Change subj medical status|1|||
127629984|NCT02673697|459266347|FG001|Overall Study|Change subj medical status|2|||
127629985|NCT02673697|459266346|FG000|Overall Study|Explant|10|||
127629986|NCT02673697|459266347|FG001|Overall Study|Explant|5|||
127629987|NCT02673697|459266346|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
127629988|NCT02673697|459266347|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
127629989|NCT00437489|459266348|FG000|Overall Study|Study terminated by sponsor|23|||
127629990|NCT00437489|459266349|FG001|Overall Study|Study terminated by sponsor|21|||
127629991|NCT00437489|459266348|FG000|Overall Study|Lost to Follow-up|0|||
127629992|NCT00437489|459266349|FG001|Overall Study|Lost to Follow-up|1|||
127629993|NCT03893448|459266355|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
127629994|NCT03893448|459266356|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
127629995|NCT03893448|459266355|FG000|Overall Study|Physician Decision|8|||
127629996|NCT03893448|459266356|FG001|Overall Study|Physician Decision|14|||
127629997|NCT03893448|459266355|FG000|Overall Study|Lost to Follow-up|34|||
127629998|NCT03893448|459266356|FG001|Overall Study|Lost to Follow-up|27|||
127629999|NCT03893448|459266355|FG000|Overall Study|Death|1|||
127630000|NCT03893448|459266356|FG001|Overall Study|Death|0|||
127630001|NCT05061446|459266364|FG000|Overall Study|Adverse Event|2|||
127630002|NCT05061446|459266365|FG001|Overall Study|Adverse Event|0|||
127630003|NCT05061446|459266366|FG002|Overall Study|Adverse Event|0|||
127630004|NCT05061446|459266364|FG000|Overall Study|Participant no longer available due to personal reason|0|||
127630005|NCT05061446|459266365|FG001|Overall Study|Participant no longer available due to personal reason|1|||
127630006|NCT05061446|459266366|FG002|Overall Study|Participant no longer available due to personal reason|0|||
127630007|NCT03880578|459266367|FG000|Overall Study|Withdrawal by Subject|0|||
127630008|NCT03880578|459266368|FG001|Overall Study|Withdrawal by Subject|3|||
127630009|NCT03880578|459266369|FG002|Overall Study|Withdrawal by Subject|1|||
127630010|NCT03880578|459266367|FG000|Overall Study|Death|0|||
127702188|NCT01539083|459538975|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
127702189|NCT01539083|459538976|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
127702190|NCT01539083|459538974|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
127702191|NCT01539083|459538975|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
127702192|NCT01539083|459538976|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
127702193|NCT01539083|459538974|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
127702194|NCT01539083|459538975|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
127702195|NCT01539083|459538976|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
127702196|NCT01539083|459538974|FG000|Before Randomization (VCD Induction)|Other|5|||
127702197|NCT01539083|459538975|FG001|Before Randomization (VCD Induction)|Other|0|||
127702198|NCT01539083|459538976|FG002|Before Randomization (VCD Induction)|Other|0|||
127702199|NCT01539083|459538974|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
127702200|NCT01539083|459538975|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
127702201|NCT01539083|459538976|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
127702202|NCT01539083|459538974|FG000|After Randomization (TP and VTP)|Other|0|||
127702203|NCT01539083|459538975|FG001|After Randomization (TP and VTP)|Other|1|||
127702204|NCT01539083|459538976|FG002|After Randomization (TP and VTP)|Other|1|||
127702205|NCT01539083|459538974|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
127702206|NCT01539083|459538975|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
127702207|NCT01539083|459538976|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
127702208|NCT01539083|459538974|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
127702209|NCT01539083|459538975|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
127702210|NCT01539083|459538976|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
127702211|NCT01539083|459538974|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
127702212|NCT01539083|459538975|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
127702213|NCT01539083|459538976|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
127702214|NCT01539083|459538974|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
127702215|NCT01539083|459538975|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
127702216|NCT01539083|459538976|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
127702217|NCT01539083|459538974|FG000|After Randomization (TP and VTP)|Death|0|||
127702218|NCT01539083|459538975|FG001|After Randomization (TP and VTP)|Death|6|||
127702219|NCT01539083|459538976|FG002|After Randomization (TP and VTP)|Death|11|||
127702220|NCT06019559|459538977|FG000|Overall Study|Withdrawal by Subject|7|||
127702221|NCT06019559|459538978|FG001|Overall Study|Withdrawal by Subject|6|||
127702222|NCT06019559|459538979|FG002|Overall Study|Withdrawal by Subject|5|||
127702223|NCT06019559|459538977|FG000|Overall Study|Lost to Follow-up|2|||
127702224|NCT06019559|459538978|FG001|Overall Study|Lost to Follow-up|0|||
127702225|NCT06019559|459538979|FG002|Overall Study|Lost to Follow-up|3|||
127702226|NCT06215521|459538980|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
127702227|NCT06215521|459538981|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
127702228|NCT06215521|459538982|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
127702229|NCT06215521|459538983|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
127702230|NCT06215521|459538984|FG004|Treatment Period 1 (Day 1)|Adverse Event|0|||
127702231|NCT06215521|459538985|FG005|Treatment Period 1 (Day 1)|Adverse Event|0|||
127702232|NCT03858634|459538989|FG000|Overall Study|Withdrawal by Subject|1|||
127702233|NCT03858634|459538990|FG001|Overall Study|Withdrawal by Subject|0|||
127702234|NCT03858634|459538989|FG000|Overall Study|Adverse Event|1|||
127794733|NCT03657043|459872543|FG001|Overall Study|Lost to Follow-up|0|||
127630011|NCT03880578|459266368|FG001|Overall Study|Death|1|||
127630012|NCT03880578|459266369|FG002|Overall Study|Death|0|||
127630013|NCT02041429|459266374|FG000|Overall Study|Progressive Disease|2|||
127630014|NCT02041429|459266375|FG001|Overall Study|Progressive Disease|2|||
127702235|NCT03858634|459538990|FG001|Overall Study|Adverse Event|0|||
127702236|NCT03858634|459538989|FG000|Overall Study|Lost to Follow-up|0|||
127630015|NCT02041429|459266376|FG002|Overall Study|Progressive Disease|3|||
127794734|NCT03657043|459872544|FG002|Overall Study|Lost to Follow-up|0|||
127794735|NCT03657043|459872545|FG003|Overall Study|Lost to Follow-up|0|||
127794736|NCT03657043|459872546|FG004|Overall Study|Lost to Follow-up|4|||
127794737|NCT03657043|459872542|FG000|Overall Study|Death|6|||
127794738|NCT03657043|459872543|FG001|Overall Study|Death|5|||
127794739|NCT03657043|459872544|FG002|Overall Study|Death|0|||
127794740|NCT03657043|459872545|FG003|Overall Study|Death|0|||
127794741|NCT03657043|459872546|FG004|Overall Study|Death|53|||
127794742|NCT03657043|459872542|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
127794743|NCT03657043|459872543|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
127794744|NCT03657043|459872544|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
127794745|NCT03657043|459872545|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
127794746|NCT03657043|459872546|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
127794747|NCT03657043|459872542|FG000|Overall Study|Adverse Event|0|||
127794748|NCT03657043|459872543|FG001|Overall Study|Adverse Event|0|||
127794749|NCT03657043|459872544|FG002|Overall Study|Adverse Event|0|||
127794750|NCT03657043|459872545|FG003|Overall Study|Adverse Event|0|||
127794751|NCT03657043|459872546|FG004|Overall Study|Adverse Event|2|||
127794752|NCT03657043|459872542|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
127794753|NCT03657043|459872543|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
127794754|NCT03657043|459872544|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
127794755|NCT03657043|459872545|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
127794756|NCT03657043|459872546|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
127794757|NCT03657043|459872542|FG000|Overall Study|Withdrawal - declined follow-up|0|||
127794758|NCT03657043|459872543|FG001|Overall Study|Withdrawal - declined follow-up|0|||
127794759|NCT03657043|459872544|FG002|Overall Study|Withdrawal - declined follow-up|0|||
127794760|NCT03657043|459872545|FG003|Overall Study|Withdrawal - declined follow-up|0|||
127794761|NCT03657043|459872546|FG004|Overall Study|Withdrawal - declined follow-up|1|||
127794762|NCT01736579|459872547|FG000|Overall Study|Termination of Study by Sponsor|2|||
127794763|NCT01736579|459872548|FG001|Overall Study|Termination of Study by Sponsor|2|||
127794764|NCT05048719|459872554|FG000|Overall Study|Withdrawal by Subject|2|||
127794765|NCT05048719|459872555|FG001|Overall Study|Withdrawal by Subject|1|||
127794766|NCT05048719|459872556|FG002|Overall Study|Withdrawal by Subject|3|||
127794767|NCT05048719|459872557|FG003|Overall Study|Withdrawal by Subject|1|||
127794768|NCT05048719|459872558|FG004|Overall Study|Withdrawal by Subject|0|||
127794769|NCT05048719|459872559|FG005|Overall Study|Withdrawal by Subject|2|||
127630016|NCT02041429|459266377|FG003|Overall Study|Progressive Disease|2|||
127630017|NCT02041429|459266374|FG000|Overall Study|Toxicity|0|||
127630018|NCT02041429|459266375|FG001|Overall Study|Toxicity|1|||
127630019|NCT02041429|459266376|FG002|Overall Study|Toxicity|4|||
127630020|NCT02041429|459266377|FG003|Overall Study|Toxicity|2|||
127630021|NCT02041429|459266374|FG000|Overall Study|Withdrawal by Subject|0|||
127630022|NCT02041429|459266375|FG001|Overall Study|Withdrawal by Subject|1|||
127630023|NCT02041429|459266376|FG002|Overall Study|Withdrawal by Subject|0|||
127794770|NCT05048719|459872560|FG006|Overall Study|Withdrawal by Subject|1|||
127794771|NCT05048719|459872561|FG007|Overall Study|Withdrawal by Subject|1|||
127794772|NCT05048719|459872562|FG008|Overall Study|Withdrawal by Subject|0|||
127630024|NCT02041429|459266377|FG003|Overall Study|Withdrawal by Subject|0|||
127630025|NCT02041429|459266374|FG000|Overall Study|On Maintenance Therapy|1|||
127630026|NCT02041429|459266375|FG001|Overall Study|On Maintenance Therapy|0|||
127630027|NCT02041429|459266376|FG002|Overall Study|On Maintenance Therapy|0|||
127630028|NCT02041429|459266377|FG003|Overall Study|On Maintenance Therapy|2|||
127630029|NCT00861341|459266378|FG000|Overall Study|Withdrawal by Subject|2|||
127630030|NCT03299192|459266379|FG000|Overall Study|Fell before classes started|1|||
127630031|NCT03299192|459266380|FG001|Overall Study|Fell before classes started|0|||
127794773|NCT05048719|459872554|FG000|Overall Study|Death|1|||
127794774|NCT05048719|459872555|FG001|Overall Study|Death|0|||
127630032|NCT03299192|459266381|FG002|Overall Study|Fell before classes started|0|||
127794775|NCT05048719|459872556|FG002|Overall Study|Death|0|||
127794776|NCT05048719|459872557|FG003|Overall Study|Death|0|||
127794777|NCT05048719|459872558|FG004|Overall Study|Death|0|||
127794778|NCT05048719|459872559|FG005|Overall Study|Death|0|||
127794779|NCT05048719|459872560|FG006|Overall Study|Death|0|||
127630033|NCT03299192|459266379|FG000|Overall Study|Other|0|||
127794780|NCT05048719|459872561|FG007|Overall Study|Death|0|||
127794781|NCT05048719|459872562|FG008|Overall Study|Death|0|||
127794782|NCT05048719|459872554|FG000|Overall Study|Adverse Event|0|||
127794783|NCT05048719|459872555|FG001|Overall Study|Adverse Event|1|||
127794784|NCT05048719|459872556|FG002|Overall Study|Adverse Event|2|||
127794785|NCT05048719|459872557|FG003|Overall Study|Adverse Event|0|||
127794786|NCT05048719|459872558|FG004|Overall Study|Adverse Event|1|||
127794787|NCT05048719|459872559|FG005|Overall Study|Adverse Event|0|||
127794788|NCT05048719|459872560|FG006|Overall Study|Adverse Event|0|||
127630034|NCT03299192|459266380|FG001|Overall Study|Other|2|||
127630035|NCT03299192|459266381|FG002|Overall Study|Other|1|||
127630036|NCT01418209|459266382|FG000|Overall Study|Withdrawal by Subject|1|||
127630037|NCT01418209|459266383|FG001|Overall Study|Withdrawal by Subject|0|||
127794789|NCT05048719|459872561|FG007|Overall Study|Adverse Event|0|||
127794790|NCT05048719|459872562|FG008|Overall Study|Adverse Event|0|||
127794791|NCT05048719|459872554|FG000|Overall Study|Lost to Follow-up|0|||
127794792|NCT05048719|459872555|FG001|Overall Study|Lost to Follow-up|0|||
127794793|NCT05048719|459872556|FG002|Overall Study|Lost to Follow-up|1|||
127794794|NCT05048719|459872557|FG003|Overall Study|Lost to Follow-up|3|||
127794795|NCT05048719|459872558|FG004|Overall Study|Lost to Follow-up|1|||
127794796|NCT05048719|459872559|FG005|Overall Study|Lost to Follow-up|1|||
127794797|NCT05048719|459872560|FG006|Overall Study|Lost to Follow-up|1|||
127794798|NCT05048719|459872561|FG007|Overall Study|Lost to Follow-up|1|||
127794799|NCT05048719|459872562|FG008|Overall Study|Lost to Follow-up|0|||
127794800|NCT05048719|459872554|FG000|Overall Study|Physician Decision|0|||
127794801|NCT05048719|459872555|FG001|Overall Study|Physician Decision|0|||
127794802|NCT05048719|459872556|FG002|Overall Study|Physician Decision|0|||
127794803|NCT05048719|459872557|FG003|Overall Study|Physician Decision|0|||
127794804|NCT05048719|459872558|FG004|Overall Study|Physician Decision|0|||
127794805|NCT05048719|459872559|FG005|Overall Study|Physician Decision|0|||
127794806|NCT05048719|459872560|FG006|Overall Study|Physician Decision|0|||
127794807|NCT05048719|459872561|FG007|Overall Study|Physician Decision|1|||
127794808|NCT05048719|459872562|FG008|Overall Study|Physician Decision|1|||
127794809|NCT05048719|459872554|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
127630038|NCT01418209|459266384|FG002|Overall Study|Withdrawal by Subject|1|||
127630039|NCT01418209|459266382|FG000|Overall Study|Did not provide hot flash diary data|1|||
127630040|NCT01418209|459266383|FG001|Overall Study|Did not provide hot flash diary data|3|||
127630041|NCT01418209|459266384|FG002|Overall Study|Did not provide hot flash diary data|3|||
127630042|NCT00766415|459266390|FG000|Overall Study|Withdrawal by Subject|0|||
127630043|NCT00766415|459266391|FG001|Overall Study|Withdrawal by Subject|1|||
127630044|NCT01312467|459266392|FG000|Overall Study|Adverse Event|4|||
127630045|NCT01312467|459266392|FG000|Overall Study|Lost to Follow-up|1|||
127630046|NCT01312467|459266392|FG000|Overall Study|Withdrawal by Subject|2|||
127630047|NCT01312467|459266392|FG000|Overall Study|Deported to country of origin|1|||
127630048|NCT01312467|459266392|FG000|Overall Study|Another medical condition|1|||
127630049|NCT01312467|459266392|FG000|Overall Study|Ineligible|4|||
127630050|NCT02758236|459266393|FG000|Overall Study|Investigator discretion|43|||
127630051|NCT04452344|459266394|FG000|Overall Study|Withdrawal by Subject|3|||
127630052|NCT04452344|459266395|FG001|Overall Study|Withdrawal by Subject|6|||
127630053|NCT04452344|459266394|FG000|Overall Study|Adverse Event|1|||
127630054|NCT04452344|459266395|FG001|Overall Study|Adverse Event|2|||
127630055|NCT04452344|459266394|FG000|Overall Study|Lost to Follow-up|2|||
127630056|NCT04452344|459266395|FG001|Overall Study|Lost to Follow-up|2|||
127630057|NCT04452344|459266394|FG000|Overall Study|No Post-Op Visit|6|||
127630058|NCT04452344|459266395|FG001|Overall Study|No Post-Op Visit|7|||
127630059|NCT04095858|459266399|FG000|Overall Study|Death|1|||
127630060|NCT04095858|459266400|FG001|Overall Study|Death|0|||
127630061|NCT04095858|459266399|FG000|Overall Study|Study terminated by Sponsor|2|||
127630062|NCT04095858|459266400|FG001|Overall Study|Study terminated by Sponsor|4|||
127630063|NCT00560833|459266413|FG000|Overall Study|Adverse Event|16|||
127630064|NCT00560833|459266414|FG001|Overall Study|Adverse Event|10|||
127630065|NCT00560833|459266415|FG002|Overall Study|Adverse Event|25|||
127630066|NCT00560833|459266416|FG003|Overall Study|Adverse Event|23|||
127630067|NCT00560833|459266417|FG004|Overall Study|Adverse Event|35|||
127630068|NCT00560833|459266413|FG000|Overall Study|Lost to Follow-up|0|||
127630069|NCT00560833|459266414|FG001|Overall Study|Lost to Follow-up|0|||
127630070|NCT00560833|459266415|FG002|Overall Study|Lost to Follow-up|1|||
127630071|NCT00560833|459266416|FG003|Overall Study|Lost to Follow-up|0|||
127630072|NCT00560833|459266417|FG004|Overall Study|Lost to Follow-up|0|||
127630073|NCT00560833|459266413|FG000|Overall Study|Lack of Efficacy|22|||
127630074|NCT00560833|459266414|FG001|Overall Study|Lack of Efficacy|9|||
127630075|NCT00560833|459266415|FG002|Overall Study|Lack of Efficacy|6|||
127630076|NCT00560833|459266416|FG003|Overall Study|Lack of Efficacy|4|||
127630077|NCT00560833|459266417|FG004|Overall Study|Lack of Efficacy|4|||
127794810|NCT05048719|459872555|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
127630078|NCT00560833|459266413|FG000|Overall Study|Participant uncooperative|5|||
127630079|NCT00560833|459266414|FG001|Overall Study|Participant uncooperative|5|||
127630080|NCT00560833|459266415|FG002|Overall Study|Participant uncooperative|4|||
127794811|NCT05048719|459872556|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
127794812|NCT05048719|459872557|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
127794813|NCT05048719|459872558|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
127630081|NCT00560833|459266416|FG003|Overall Study|Participant uncooperative|4|||
127630082|NCT00560833|459266417|FG004|Overall Study|Participant uncooperative|2|||
127630083|NCT00560833|459266413|FG000|Overall Study|Other|1|||
127630084|NCT00560833|459266414|FG001|Overall Study|Other|1|||
127630085|NCT00560833|459266415|FG002|Overall Study|Other|3|||
127630086|NCT00560833|459266416|FG003|Overall Study|Other|0|||
127630087|NCT00560833|459266417|FG004|Overall Study|Other|0|||
127630088|NCT00560833|459266413|FG000|Overall Study|Never received drug|0|||
127630089|NCT00560833|459266414|FG001|Overall Study|Never received drug|1|||
127630090|NCT00560833|459266415|FG002|Overall Study|Never received drug|0|||
127794814|NCT05048719|459872559|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
127630091|NCT00560833|459266416|FG003|Overall Study|Never received drug|0|||
127630092|NCT00560833|459266417|FG004|Overall Study|Never received drug|1|||
127630093|NCT00898677|459266422|FG000|Overall Study|Adverse Event|0|||
127630094|NCT00898677|459266423|FG001|Overall Study|Adverse Event|0|||
127885451|NCT04380701|460203877|FG006|Overall Study|Physician Decision|0|||
127885452|NCT04380701|460203878|FG007|Overall Study|Physician Decision|0|||
127885453|NCT04380701|460203879|FG008|Overall Study|Physician Decision|0|||
127885454|NCT04380701|460203880|FG009|Overall Study|Physician Decision|0|||
127885455|NCT04380701|460203881|FG010|Overall Study|Physician Decision|0|||
127885456|NCT04380701|460203882|FG011|Overall Study|Physician Decision|0|||
127885457|NCT04380701|460203883|FG012|Overall Study|Physician Decision|0|||
127885458|NCT04380701|460203884|FG013|Overall Study|Physician Decision|0|||
127630095|NCT00898677|459266424|FG002|Overall Study|Adverse Event|1|||
127630096|NCT00898677|459266425|FG003|Overall Study|Adverse Event|0|||
127630097|NCT00898677|459266422|FG000|Overall Study|Lost to Follow-up|0|||
127630098|NCT00898677|459266423|FG001|Overall Study|Lost to Follow-up|0|||
127630099|NCT00898677|459266424|FG002|Overall Study|Lost to Follow-up|2|||
127630100|NCT00898677|459266425|FG003|Overall Study|Lost to Follow-up|0|||
127630101|NCT00898677|459266422|FG000|Overall Study|Protocol Violation|1|||
127630102|NCT00898677|459266423|FG001|Overall Study|Protocol Violation|1|||
127630103|NCT00898677|459266424|FG002|Overall Study|Protocol Violation|2|||
127702237|NCT03858634|459538990|FG001|Overall Study|Lost to Follow-up|1|||
127702238|NCT03858634|459538989|FG000|Overall Study|Other, Not Specified|1|||
127702239|NCT03858634|459538990|FG001|Overall Study|Other, Not Specified|1|||
127702240|NCT04676763|459538991|FG000|Part 1 (Up to Day 1)|Protocol Violation|0|||
127702241|NCT04676763|459538992|FG001|Part 1 (Up to Day 1)|Protocol Violation|1|||
127702242|NCT04676763|459538993|FG002|Part 1 (Up to Day 1)|Protocol Violation|0|||
127702243|NCT04676763|459538991|FG000|Part 1 (Up to Day 1)|Physician Decision|0|||
127702244|NCT04676763|459538992|FG001|Part 1 (Up to Day 1)|Physician Decision|1|||
127702245|NCT04676763|459538993|FG002|Part 1 (Up to Day 1)|Physician Decision|0|||
127702246|NCT04676763|459538991|FG000|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
127702247|NCT04676763|459538992|FG001|Part 1 (Up to Day 1)|Withdrawal by Subject|1|||
127702248|NCT04676763|459538993|FG002|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
127702249|NCT03150173|459538994|FG000|Overall Study|Lost to Follow-up|13|||
127702250|NCT03150173|459538995|FG001|Overall Study|Lost to Follow-up|5|||
127702251|NCT04016662|459538997|FG000|Run-In Phase|Death|1|||
127702252|NCT04016662|459538997|FG000|Run-In Phase|Withdrawal by Subject|11|||
127702253|NCT04016662|459538997|FG000|Run-In Phase|Not meeting screening eligibility|9|||
127702254|NCT04016662|459538997|FG000|Run-In Phase|Physician Decision|3|||
127702255|NCT04016662|459538997|FG000|HCL (12 Weeks)|Withdrawal by Subject|1|||
127702256|NCT04016662|459538997|FG000|PLGS (12 Weeks)|Death|1|||
127702257|NCT04016662|459538997|FG000|SAP (12 Weeks)|Death|1|||
127702258|NCT01802788|459538998|FG000|Overall Study|Withdrawal by Subject|102|||
127702259|NCT01802788|459538999|FG001|Overall Study|Withdrawal by Subject|5|||
127702260|NCT01802788|459538998|FG000|Overall Study|Death|382|||
127702261|NCT01802788|459538999|FG001|Overall Study|Death|18|||
127702262|NCT01802788|459538998|FG000|Overall Study|Lost to Follow-up|31|||
127702263|NCT01802788|459538999|FG001|Overall Study|Lost to Follow-up|2|||
127702264|NCT01802788|459538998|FG000|Overall Study|Physician Decision|3|||
127702265|NCT01802788|459538999|FG001|Overall Study|Physician Decision|0|||
127702266|NCT01802788|459538998|FG000|Overall Study|Patient Non-Compliance|1|||
127702267|NCT01802788|459538999|FG001|Overall Study|Patient Non-Compliance|0|||
127702268|NCT01802788|459538998|FG000|Overall Study|Study Stopped/Terminated at Site|5|||
127702269|NCT01802788|459538999|FG001|Overall Study|Study Stopped/Terminated at Site|0|||
127702270|NCT01802788|459538998|FG000|Overall Study|Other Reasons|19|||
127702271|NCT01802788|459538999|FG001|Overall Study|Other Reasons|0|||
127630104|NCT00898677|459266425|FG003|Overall Study|Protocol Violation|0|||
127630105|NCT00898677|459266422|FG000|Overall Study|Withdrawal by Subject|0|||
127630106|NCT00898677|459266423|FG001|Overall Study|Withdrawal by Subject|0|||
127630107|NCT00898677|459266424|FG002|Overall Study|Withdrawal by Subject|0|||
127702272|NCT03021096|459539000|FG000|Overall Study|Lost to Follow-up|4|||
127702273|NCT03021096|459539000|FG000|Overall Study|Protocol Violation|2|||
127702274|NCT03904147|459539005|FG000|Overall Study|Death|15|||
127702275|NCT03904147|459539006|FG001|Overall Study|Death|13|||
127702276|NCT03904147|459539007|FG002|Overall Study|Death|15|||
127702277|NCT03904147|459539005|FG000|Overall Study|Withdrawal by Subject|7|||
127702278|NCT03904147|459539006|FG001|Overall Study|Withdrawal by Subject|12|||
127885459|NCT04380701|460203885|FG014|Overall Study|Physician Decision|0|||
127794815|NCT05048719|459872560|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
127794816|NCT05048719|459872561|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
127794817|NCT05048719|459872562|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
127794818|NCT05048719|459872554|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
127794819|NCT05048719|459872555|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
127794820|NCT05048719|459872556|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
127794821|NCT05048719|459872557|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
127794822|NCT05048719|459872558|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
127794823|NCT05048719|459872559|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
127794824|NCT05048719|459872560|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
127794825|NCT05048719|459872561|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
127794826|NCT05048719|459872562|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
127794827|NCT05048719|459872554|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
127794828|NCT05048719|459872555|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
127794829|NCT05048719|459872556|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
127794830|NCT05048719|459872557|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
127794831|NCT05048719|459872558|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
127794832|NCT05048719|459872559|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
127794833|NCT05048719|459872560|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
127794834|NCT05048719|459872561|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
127794835|NCT05048719|459872562|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
127794836|NCT05048719|459872554|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
127794837|NCT05048719|459872555|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
127794838|NCT05048719|459872556|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
127794839|NCT05048719|459872557|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
127794840|NCT05048719|459872558|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
127794841|NCT05048719|459872559|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
127794842|NCT05048719|459872560|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
127794843|NCT05048719|459872561|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
127794844|NCT05048719|459872562|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
127794845|NCT05048719|459872554|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
127794846|NCT05048719|459872555|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
127794847|NCT05048719|459872556|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
127794848|NCT05048719|459872557|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
127794849|NCT05048719|459872558|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
127794850|NCT05048719|459872559|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
127794851|NCT05048719|459872560|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
127794852|NCT05048719|459872561|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
127794853|NCT05048719|459872562|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
127794854|NCT04541004|459872563|FG000|Overall Study|Adverse Event|2|||
127794855|NCT02229552|459872565|FG000|Baseline|Withdrawal by Subject|6|||
127794856|NCT02229552|459872565|FG000|1-year Follow up|Withdrawal by Subject|7|||
127794857|NCT02229552|459872565|FG000|1-year Follow up|Lost to Follow-up|18|||
127794858|NCT02229552|459872565|FG000|2-Year Follow up|Withdrawal by Subject|9|||
127794859|NCT02229552|459872565|FG000|2-Year Follow up|Lost to Follow-up|17|||
127794860|NCT04872101|459872566|FG000|Overall Study|Withdrawal by Subject|10|||
127794861|NCT04872101|459872567|FG001|Overall Study|Withdrawal by Subject|16|||
127794862|NCT04872101|459872566|FG000|Overall Study|Lack of Efficacy|6|||
127794863|NCT04872101|459872567|FG001|Overall Study|Lack of Efficacy|14|||
127794864|NCT04872101|459872566|FG000|Overall Study|Adverse Event|1|||
127794865|NCT04872101|459872567|FG001|Overall Study|Adverse Event|6|||
127794866|NCT04872101|459872566|FG000|Overall Study|Lost to Follow-up|2|||
127794867|NCT04872101|459872567|FG001|Overall Study|Lost to Follow-up|1|||
127794868|NCT04872101|459872566|FG000|Overall Study|Pregnancy|2|||
127794869|NCT04872101|459872567|FG001|Overall Study|Pregnancy|0|||
127794870|NCT04872101|459872566|FG000|Overall Study|Prohibited Medication|1|||
127794871|NCT04872101|459872567|FG001|Overall Study|Prohibited Medication|0|||
127794872|NCT04872101|459872566|FG000|Overall Study|Not dosed|1|||
127794873|NCT04872101|459872567|FG001|Overall Study|Not dosed|0|||
127885460|NCT04380701|460203886|FG015|Overall Study|Physician Decision|0|||
127885461|NCT04380701|460203887|FG016|Overall Study|Physician Decision|0|||
127885462|NCT04380701|460203888|FG017|Overall Study|Physician Decision|0|||
127885463|NCT04380701|460203889|FG018|Overall Study|Physician Decision|0|||
127630108|NCT00898677|459266425|FG003|Overall Study|Withdrawal by Subject|1|||
127630109|NCT00898677|459266422|FG000|Overall Study|Not Treated: Adverse Event|0|||
127630110|NCT00898677|459266423|FG001|Overall Study|Not Treated: Adverse Event|2|||
127630111|NCT00898677|459266424|FG002|Overall Study|Not Treated: Adverse Event|1|||
127630112|NCT00898677|459266425|FG003|Overall Study|Not Treated: Adverse Event|0|||
127630113|NCT00898677|459266422|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
127630114|NCT00898677|459266423|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
127630115|NCT00898677|459266424|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
127630116|NCT00898677|459266425|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
127630117|NCT00898677|459266422|FG000|Overall Study|Not Treated: Pregnancy|0|||
127630118|NCT00898677|459266423|FG001|Overall Study|Not Treated: Pregnancy|0|||
127630119|NCT00898677|459266424|FG002|Overall Study|Not Treated: Pregnancy|1|||
127630120|NCT00898677|459266425|FG003|Overall Study|Not Treated: Pregnancy|0|||
127630121|NCT00898677|459266422|FG000|Overall Study|Not Treated: Protocol Violation|2|||
127630122|NCT00898677|459266423|FG001|Overall Study|Not Treated: Protocol Violation|0|||
127702279|NCT03904147|459539007|FG002|Overall Study|Withdrawal by Subject|1|||
127702280|NCT03904147|459539005|FG000|Overall Study|1Y visit completed after 365 days|1|||
127702281|NCT03904147|459539006|FG001|Overall Study|1Y visit completed after 365 days|1|||
127702282|NCT03904147|459539007|FG002|Overall Study|1Y visit completed after 365 days|0|||
127702283|NCT00764751|459539015|FG000|Overall Study|Adverse Event|1|||
127702284|NCT00764751|459539016|FG001|Overall Study|Adverse Event|1|||
127702285|NCT00764751|459539015|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
127702286|NCT00764751|459539016|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
127702287|NCT03011333|459539022|FG000|Overall Study|Lost to Follow-up|0|||
127702288|NCT03011333|459539023|FG001|Overall Study|Lost to Follow-up|1|||
127702289|NCT03011333|459539024|FG002|Overall Study|Lost to Follow-up|0|||
127702290|NCT03011333|459539025|FG003|Overall Study|Lost to Follow-up|1|||
127702291|NCT03011333|459539026|FG004|Overall Study|Lost to Follow-up|4|||
127702292|NCT03011333|459539027|FG005|Overall Study|Lost to Follow-up|4|||
127702293|NCT03011333|459539028|FG006|Overall Study|Lost to Follow-up|5|||
127702294|NCT02998268|459539032|FG000|Overall Study|Adverse Event|0|||
127702295|NCT02998268|459539033|FG001|Overall Study|Adverse Event|2|||
127702296|NCT02998268|459539032|FG000|Overall Study|Withdrawal by Subject|0|||
127702297|NCT02998268|459539033|FG001|Overall Study|Withdrawal by Subject|1|||
127702298|NCT05269667|459539034|FG000|Overall Study|Study Terminated by Sponsor|4|||
127702299|NCT04413708|459539035|FG000|Overall Study|Lost to Follow-up|1|||
127702300|NCT04413708|459539036|FG001|Overall Study|Lost to Follow-up|2|||
127702301|NCT03133546|459539041|FG000|Overall Study|Death|46|||
127702302|NCT03133546|459539042|FG001|Overall Study|Death|43|||
127702303|NCT03133546|459539041|FG000|Overall Study|Withdrawal/Lost to follow-up|5|||
127702304|NCT03133546|459539042|FG001|Overall Study|Withdrawal/Lost to follow-up|7|||
127702305|NCT05399459|459539045|FG000|Overall Study|Randomized but not treated|29|||
127702306|NCT05399459|459539046|FG001|Overall Study|Randomized but not treated|30|||
127702307|NCT05399459|459539047|FG002|Overall Study|Randomized but not treated|38|||
127702308|NCT05399459|459539045|FG000|Overall Study|Lost to Follow-up|1|||
127702309|NCT05399459|459539046|FG001|Overall Study|Lost to Follow-up|0|||
127702310|NCT05399459|459539047|FG002|Overall Study|Lost to Follow-up|0|||
127702311|NCT06103188|459539048|FG000|Overall Study|Lost to Follow-up|1|||
127702312|NCT06103188|459539049|FG001|Overall Study|Lost to Follow-up|6|||
127702313|NCT06103188|459539050|FG002|Overall Study|Lost to Follow-up|4|||
127702314|NCT01175356|459539055|FG000|Overall Study|Death|1|||
127702315|NCT01175356|459539055|FG000|Overall Study|Lack of Efficacy|12|||
127702316|NCT01175356|459539055|FG000|Overall Study|Lost to Follow-up|1|||
127702317|NCT01175356|459539055|FG000|Overall Study|Physician Decision|23|||
127702318|NCT01175356|459539055|FG000|Overall Study|Ineligible|1|||
127702319|NCT01175356|459539055|FG000|Overall Study|Treatment Slot Not Available|18|||
127702320|NCT01175356|459539055|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
127702321|NCT01175356|459539055|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
127702322|NCT01175356|459539055|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
127702323|NCT01175356|459539055|FG000|Overall Study|Inadequate stem cell for transplant|1|||
127702324|NCT01175356|459539055|FG000|Overall Study|Initiation other tx prior to completion|9|||
127702325|NCT05583578|459539056|FG000|Overall Study|Withdrawal by Subject|2|||
127702326|NCT05583578|459539057|FG001|Overall Study|Withdrawal by Subject|0|||
127702327|NCT05201079|459539070|FG000|Overall Study|Adverse Event|7|||
127702328|NCT05201079|459539071|FG001|Overall Study|Adverse Event|11|||
127702329|NCT05201079|459539070|FG000|Overall Study|Death|1|||
127702330|NCT05201079|459539071|FG001|Overall Study|Death|1|||
127702331|NCT05201079|459539070|FG000|Overall Study|Lack of Efficacy|0|||
127702332|NCT05201079|459539071|FG001|Overall Study|Lack of Efficacy|2|||
127702333|NCT05201079|459539070|FG000|Overall Study|Lost to Follow-up|0|||
127702334|NCT05201079|459539071|FG001|Overall Study|Lost to Follow-up|1|||
127702335|NCT05201079|459539070|FG000|Overall Study|Physician Decision|1|||
127630123|NCT00898677|459266424|FG002|Overall Study|Not Treated: Protocol Violation|2|||
127630124|NCT00898677|459266425|FG003|Overall Study|Not Treated: Protocol Violation|0|||
127702336|NCT05201079|459539071|FG001|Overall Study|Physician Decision|1|||
127702337|NCT05201079|459539070|FG000|Overall Study|Protocol Violation|1|||
127702338|NCT05201079|459539071|FG001|Overall Study|Protocol Violation|0|||
127794874|NCT00971945|459872568|FG000|Overall Study|Progressive Disease|3|||
127794875|NCT00971945|459872568|FG000|Overall Study|Change in treatment policy|1|||
127794876|NCT00971945|459872568|FG000|Overall Study|Other reasons|2|||
127794877|NCT03354663|459872569|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
127794878|NCT03354663|459872569|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
127794879|NCT03354663|459872569|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
127794880|NCT03354663|459872569|FG000|Completed 30-day Visit|Missed Visit|1|||
127794881|NCT03691974|459872570|FG000|Overall Study|Physician Decision|1|||
127794882|NCT03691974|459872571|FG001|Overall Study|Physician Decision|0|||
127794883|NCT03691974|459872570|FG000|Overall Study|Adverse Event|1|||
127794884|NCT03691974|459872571|FG001|Overall Study|Adverse Event|0|||
127794885|NCT03691974|459872570|FG000|Overall Study|Withdrawal by Subject|11|||
127794886|NCT03691974|459872571|FG001|Overall Study|Withdrawal by Subject|9|||
127794887|NCT03691974|459872570|FG000|Overall Study|Protocol Violation|1|||
127794888|NCT03691974|459872571|FG001|Overall Study|Protocol Violation|0|||
127794889|NCT03691974|459872570|FG000|Overall Study|Lost to Follow-up|8|||
127794890|NCT03691974|459872571|FG001|Overall Study|Lost to Follow-up|7|||
127794891|NCT02239939|459872572|FG000|Overall Study|Adverse Event|1|||
127794892|NCT02239939|459872573|FG001|Overall Study|Adverse Event|0|||
127794893|NCT02239939|459872572|FG000|Overall Study|Withdrawal by Subject|1|||
127794894|NCT02239939|459872573|FG001|Overall Study|Withdrawal by Subject|1|||
127794895|NCT02239939|459872572|FG000|Overall Study|Lost to Follow-up|0|||
127794896|NCT02239939|459872573|FG001|Overall Study|Lost to Follow-up|1|||
127794897|NCT03325673|459872582|FG000|Overall Study|Adverse Event|4|||
127794898|NCT03325673|459872583|FG001|Overall Study|Adverse Event|0|||
127885464|NCT04380701|460203890|FG019|Overall Study|Physician Decision|0|||
127885465|NCT04380701|460203891|FG020|Overall Study|Physician Decision|0|||
127885466|NCT04380701|460203892|FG021|Overall Study|Physician Decision|0|||
127885467|NCT04380701|460203893|FG022|Overall Study|Physician Decision|0|||
127885468|NCT04380701|460203894|FG023|Overall Study|Physician Decision|0|||
127885469|NCT04380701|460203895|FG024|Overall Study|Physician Decision|2|||
127885470|NCT04380701|460203896|FG025|Overall Study|Physician Decision|0|||
127885471|NCT04380701|460203897|FG026|Overall Study|Physician Decision|0|||
127885472|NCT04380701|460203898|FG027|Overall Study|Physician Decision|0|||
127885473|NCT04380701|460203899|FG028|Overall Study|Physician Decision|0|||
127885474|NCT04380701|460203900|FG029|Overall Study|Physician Decision|0|||
127885475|NCT04380701|460203901|FG030|Overall Study|Physician Decision|0|||
127885476|NCT04380701|460203902|FG031|Overall Study|Physician Decision|0|||
127885477|NCT04380701|460203903|FG032|Overall Study|Physician Decision|0|||
127885478|NCT04380701|460203904|FG033|Overall Study|Physician Decision|0|||
127885479|NCT04380701|460203871|FG000|Overall Study|Death|0|||
127885480|NCT04380701|460203872|FG001|Overall Study|Death|0|||
127885481|NCT04380701|460203873|FG002|Overall Study|Death|0|||
127885482|NCT04380701|460203874|FG003|Overall Study|Death|0|||
127885483|NCT04380701|460203875|FG004|Overall Study|Death|0|||
127885484|NCT04380701|460203876|FG005|Overall Study|Death|0|||
127885485|NCT04380701|460203877|FG006|Overall Study|Death|0|||
127885486|NCT04380701|460203878|FG007|Overall Study|Death|0|||
127885487|NCT04380701|460203879|FG008|Overall Study|Death|0|||
127885488|NCT04380701|460203880|FG009|Overall Study|Death|0|||
127885489|NCT04380701|460203881|FG010|Overall Study|Death|0|||
127885490|NCT04380701|460203882|FG011|Overall Study|Death|0|||
127885491|NCT04380701|460203883|FG012|Overall Study|Death|0|||
127885492|NCT04380701|460203884|FG013|Overall Study|Death|0|||
127885493|NCT04380701|460203885|FG014|Overall Study|Death|0|||
127885494|NCT04380701|460203886|FG015|Overall Study|Death|0|||
127885495|NCT04380701|460203887|FG016|Overall Study|Death|0|||
127885496|NCT04380701|460203888|FG017|Overall Study|Death|0|||
127885497|NCT04380701|460203889|FG018|Overall Study|Death|0|||
127885498|NCT04380701|460203890|FG019|Overall Study|Death|0|||
127630125|NCT00898677|459266422|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
127794899|NCT01514682|459872584|FG000|Overall Study|Withdrawal by Subject|2|||
127794900|NCT01514682|459872585|FG001|Overall Study|Withdrawal by Subject|3|||
127794901|NCT01514682|459872584|FG000|Overall Study|Physician Decision|4|||
127794902|NCT01514682|459872585|FG001|Overall Study|Physician Decision|3|||
127794903|NCT00590590|459872586|FG000|Overall Study|Lack of Efficacy|1|||
127794904|NCT00590590|459872587|FG001|Overall Study|Lack of Efficacy|2|||
127794905|NCT00590590|459872588|FG002|Overall Study|Lack of Efficacy|0|||
127794906|NCT00590590|459872586|FG000|Overall Study|Adverse Event|1|||
127794907|NCT00590590|459872587|FG001|Overall Study|Adverse Event|0|||
127794908|NCT00590590|459872588|FG002|Overall Study|Adverse Event|0|||
127794909|NCT00590590|459872586|FG000|Overall Study|Protocol Violation|0|||
127794910|NCT00590590|459872587|FG001|Overall Study|Protocol Violation|0|||
127794911|NCT00590590|459872588|FG002|Overall Study|Protocol Violation|2|||
127885499|NCT04380701|460203891|FG020|Overall Study|Death|0|||
127885500|NCT04380701|460203892|FG021|Overall Study|Death|0|||
127885501|NCT04380701|460203893|FG022|Overall Study|Death|0|||
127885502|NCT04380701|460203894|FG023|Overall Study|Death|0|||
127885503|NCT04380701|460203895|FG024|Overall Study|Death|1|||
127885504|NCT04380701|460203896|FG025|Overall Study|Death|0|||
127885505|NCT04380701|460203897|FG026|Overall Study|Death|0|||
127885506|NCT04380701|460203898|FG027|Overall Study|Death|0|||
127794912|NCT00590590|459872586|FG000|Overall Study|Lost to Follow-up|4|||
127794913|NCT00590590|459872587|FG001|Overall Study|Lost to Follow-up|1|||
127794914|NCT00590590|459872588|FG002|Overall Study|Lost to Follow-up|2|||
127794915|NCT00590590|459872586|FG000|Overall Study|Withdrawal by Subject|0|||
127794916|NCT00590590|459872587|FG001|Overall Study|Withdrawal by Subject|1|||
127794917|NCT00590590|459872588|FG002|Overall Study|Withdrawal by Subject|1|||
127794918|NCT00590590|459872586|FG000|Overall Study|Did not complete due to study closure|1|||
127794919|NCT00590590|459872587|FG001|Overall Study|Did not complete due to study closure|1|||
127794920|NCT00590590|459872588|FG002|Overall Study|Did not complete due to study closure|1|||
127794921|NCT00590590|459872586|FG000|Overall Study|Did not complete study|0|||
127794922|NCT00590590|459872587|FG001|Overall Study|Did not complete study|1|||
127794923|NCT00590590|459872588|FG002|Overall Study|Did not complete study|0|||
127794924|NCT02105454|459872591|FG000|Overall Study|Withdrawal by Subject|1|||
127794925|NCT00272038|459872592|FG000|Overall Study|withdrew before they received 2 cycles|7|||
127794926|NCT02721355|459872593|FG000|Overall Study|Lost to Follow-up|6|||
127794927|NCT02721355|459872594|FG001|Overall Study|Lost to Follow-up|1|||
127794928|NCT00356278|459872595|FG000|Overall Study|Withdrawal by Subject|25|||
127794929|NCT00356278|459872596|FG001|Overall Study|Withdrawal by Subject|15|||
127794930|NCT00356278|459872597|FG002|Overall Study|Withdrawal by Subject|19|||
127794931|NCT00883337|459872598|FG000|Core Treatment Period|Adverse Event|9|||
127794932|NCT00883337|459872599|FG001|Core Treatment Period|Adverse Event|12|||
127794933|NCT00883337|459872600|FG002|Core Treatment Period|Adverse Event|22|||
127794934|NCT00883337|459872598|FG000|Core Treatment Period|Lack of Efficacy|7|||
127794935|NCT00883337|459872599|FG001|Core Treatment Period|Lack of Efficacy|4|||
127794936|NCT00883337|459872600|FG002|Core Treatment Period|Lack of Efficacy|2|||
127794937|NCT00883337|459872598|FG000|Core Treatment Period|Lost to Follow-up|1|||
127794938|NCT00883337|459872599|FG001|Core Treatment Period|Lost to Follow-up|1|||
127794939|NCT00883337|459872600|FG002|Core Treatment Period|Lost to Follow-up|0|||
127794940|NCT00883337|459872598|FG000|Core Treatment Period|Withdrawal by Subject|2|||
127794941|NCT00883337|459872599|FG001|Core Treatment Period|Withdrawal by Subject|2|||
127794942|NCT00883337|459872600|FG002|Core Treatment Period|Withdrawal by Subject|6|||
127794943|NCT00883337|459872598|FG000|Core Treatment Period|Wish to be pregnant|1|||
127794944|NCT00883337|459872599|FG001|Core Treatment Period|Wish to be pregnant|2|||
127794945|NCT00883337|459872600|FG002|Core Treatment Period|Wish to be pregnant|1|||
127794946|NCT00883337|459872598|FG000|Core Treatment Period|Poor compliance to protocol|0|||
127794947|NCT00883337|459872599|FG001|Core Treatment Period|Poor compliance to protocol|0|||
127794948|NCT00883337|459872600|FG002|Core Treatment Period|Poor compliance to protocol|1|||
127794949|NCT00883337|459872598|FG000|Core Treatment Period|Other than above|0|||
127794950|NCT00883337|459872599|FG001|Core Treatment Period|Other than above|1|||
127794951|NCT00883337|459872600|FG002|Core Treatment Period|Other than above|1|||
127794952|NCT00883337|459872598|FG000|Extension Treatment Period|Adverse Event|8|||
127794953|NCT00883337|459872599|FG001|Extension Treatment Period|Adverse Event|5|||
127794954|NCT00883337|459872600|FG002|Extension Treatment Period|Adverse Event|5|||
127794955|NCT00883337|459872598|FG000|Extension Treatment Period|Lack of Efficacy|8|||
127794956|NCT00883337|459872599|FG001|Extension Treatment Period|Lack of Efficacy|8|||
127794957|NCT00883337|459872600|FG002|Extension Treatment Period|Lack of Efficacy|8|||
127794958|NCT00883337|459872598|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
127794959|NCT00883337|459872599|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
127794960|NCT00883337|459872600|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
127794961|NCT00883337|459872598|FG000|Extension Treatment Period|Lost to Follow-up|1|||
127794962|NCT00883337|459872599|FG001|Extension Treatment Period|Lost to Follow-up|0|||
127794963|NCT00883337|459872600|FG002|Extension Treatment Period|Lost to Follow-up|0|||
127794964|NCT00883337|459872598|FG000|Extension Treatment Period|Other than above|10|||
127794965|NCT00883337|459872599|FG001|Extension Treatment Period|Other than above|9|||
127794966|NCT00883337|459872600|FG002|Extension Treatment Period|Other than above|5|||
127794967|NCT01678144|459872609|FG000|Stage 1: MAR Classic|Adverse Event|1|||
127794968|NCT02363686|459872610|FG000|Overall Study|Withdrawal by Subject|22|||
127794969|NCT02363686|459872610|FG000|Overall Study|incomplete FEES examinations|13|||
127794970|NCT01485627|459872613|FG000|Overall Study|Patient withdrew|6|||
127794971|NCT01485627|459872614|FG001|Overall Study|Patient withdrew|5|||
127794972|NCT01485627|459872613|FG000|Overall Study|Patient died|3|||
127794973|NCT01485627|459872614|FG001|Overall Study|Patient died|1|||
127794974|NCT01485627|459872613|FG000|Overall Study|Patient lost to followup|0|||
127794975|NCT01485627|459872614|FG001|Overall Study|Patient lost to followup|1|||
127794976|NCT01485627|459872613|FG000|Overall Study|Caregiver withdrew|3|||
127794977|NCT01485627|459872614|FG001|Overall Study|Caregiver withdrew|3|||
127794978|NCT01485627|459872613|FG000|Overall Study|Caregiver lost to follow up|11|||
127794979|NCT01485627|459872614|FG001|Overall Study|Caregiver lost to follow up|12|||
127794980|NCT01485627|459872613|FG000|Overall Study|Caregiver died|1|||
127794981|NCT01485627|459872614|FG001|Overall Study|Caregiver died|0|||
127794982|NCT01485627|459872613|FG000|Overall Study|caregiver was not bereaved|42|||
127794983|NCT01485627|459872614|FG001|Overall Study|caregiver was not bereaved|35|||
127794984|NCT02264990|459872619|FG000|Overall Study|Death|255|||
127794985|NCT02264990|459872620|FG001|Overall Study|Death|250|||
127794986|NCT02264990|459872619|FG000|Overall Study|Withdrawal by Subject|4|||
127794987|NCT02264990|459872620|FG001|Overall Study|Withdrawal by Subject|5|||
127794988|NCT02264990|459872619|FG000|Overall Study|Lost to Follow-up|1|||
127794989|NCT02264990|459872620|FG001|Overall Study|Lost to Follow-up|3|||
127794990|NCT02264990|459872619|FG000|Overall Study|Other|0|||
127794991|NCT02264990|459872620|FG001|Overall Study|Other|1|||
127794992|NCT01662895|459872623|FG000|Overall Study|Lost to Follow-up|0|||
127794993|NCT01662895|459872624|FG001|Overall Study|Lost to Follow-up|1|||
127794994|NCT01895322|459872627|FG000|Overall Study|Adverse Event|1|||
127794995|NCT01895322|459872627|FG000|Overall Study|Withdrawal by Subject|2|||
127794996|NCT01895322|459872627|FG000|Overall Study|Protocol Violation|10|||
127794997|NCT03603496|459872640|FG000|Overall Study|Death|19|||
127794998|NCT03603496|459872641|FG001|Overall Study|Death|24|||
127794999|NCT03603496|459872640|FG000|Overall Study|Lost to Follow-up|141|||
127795000|NCT03603496|459872641|FG001|Overall Study|Lost to Follow-up|141|||
127795001|NCT03603496|459872640|FG000|Overall Study|Withdrawal by Subject|26|||
127795002|NCT03603496|459872641|FG001|Overall Study|Withdrawal by Subject|20|||
127795003|NCT00774345|459872642|FG000|Pre-treatment|Other reasons|2|||
127795004|NCT00774345|459872643|FG001|Pre-treatment|Other reasons|0|||
127795005|NCT00774345|459872642|FG000|Treatment|Adverse Event|61|||
127795006|NCT00774345|459872643|FG001|Treatment|Adverse Event|15|||
127795007|NCT00774345|459872642|FG000|Treatment|Progressive Disease without histologic transformation|51|||
127795008|NCT00774345|459872643|FG001|Treatment|Progressive Disease without histologic transformation|111|||
127795009|NCT00774345|459872642|FG000|Treatment|Progressive Disease with histologic transformation|4|||
127795010|NCT00774345|459872643|FG001|Treatment|Progressive Disease with histologic transformation|2|||
127795011|NCT00774345|459872642|FG000|Treatment|Withdrawal by Subject|5|||
127795012|NCT00774345|459872643|FG001|Treatment|Withdrawal by Subject|2|||
127795013|NCT00774345|459872642|FG000|Treatment|Lost to Follow-up|1|||
127795014|NCT00774345|459872643|FG001|Treatment|Lost to Follow-up|1|||
127795015|NCT00774345|459872642|FG000|Treatment|Death|4|||
127795016|NCT00774345|459872643|FG001|Treatment|Death|0|||
127795017|NCT00774345|459872642|FG000|Treatment|Other Reasons|32|||
127795018|NCT00774345|459872643|FG001|Treatment|Other Reasons|26|||
127795019|NCT00075504|459872644|FG000|Overall Study|Withdrawal by Subject|9|||
127795020|NCT00075504|459872645|FG001|Overall Study|Withdrawal by Subject|7|||
127795021|NCT01692301|459872647|FG000|Overall Study|Adverse Event|15|||
127795022|NCT01692301|459872648|FG001|Overall Study|Adverse Event|12|||
127795023|NCT01692301|459872647|FG000|Overall Study|Death|1|||
127795024|NCT01692301|459872648|FG001|Overall Study|Death|2|||
127795025|NCT01692301|459872647|FG000|Overall Study|Lack of Efficacy|0|||
127795026|NCT01692301|459872648|FG001|Overall Study|Lack of Efficacy|5|||
127795027|NCT01692301|459872647|FG000|Overall Study|Non-compliance with study treatment|1|||
127795028|NCT01692301|459872648|FG001|Overall Study|Non-compliance with study treatment|2|||
127795029|NCT01692301|459872647|FG000|Overall Study|Protocol deviation|9|||
127795030|NCT01692301|459872648|FG001|Overall Study|Protocol deviation|2|||
127795031|NCT01692301|459872647|FG000|Overall Study|Patient/guardian decision|16|||
127795032|NCT01692301|459872648|FG001|Overall Study|Patient/guardian decision|15|||
127795033|NCT01692301|459872647|FG000|Overall Study|Technical problems|0|||
127795034|NCT01692301|459872648|FG001|Overall Study|Technical problems|1|||
127795035|NCT01692301|459872647|FG000|Overall Study|Physician Decision|2|||
127795036|NCT01692301|459872648|FG001|Overall Study|Physician Decision|2|||
127795037|NCT01692301|459872647|FG000|Overall Study|Lost to Follow-up|1|||
127795038|NCT01692301|459872648|FG001|Overall Study|Lost to Follow-up|1|||
127795039|NCT01142726|459872649|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
127630126|NCT00898677|459266423|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
127630127|NCT00898677|459266424|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
127630128|NCT00898677|459266425|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
127795040|NCT01142726|459872650|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
127795041|NCT01142726|459872651|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
127795042|NCT01142726|459872649|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
127795043|NCT01142726|459872650|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
127795044|NCT01142726|459872651|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
127795045|NCT01142726|459872649|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
127795046|NCT01142726|459872650|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
127630129|NCT00898677|459266422|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
127795047|NCT01142726|459872651|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
127795048|NCT01142726|459872649|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
127795049|NCT01142726|459872650|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
127795050|NCT01142726|459872651|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
127630130|NCT00898677|459266423|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
127630131|NCT00898677|459266424|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
127630132|NCT00898677|459266425|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
127795051|NCT01142726|459872649|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
127630133|NCT00898677|459266422|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
127630134|NCT00898677|459266423|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
127630135|NCT00898677|459266424|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
127630136|NCT00898677|459266425|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
127630137|NCT00898677|459266422|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
127630138|NCT00898677|459266423|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
127630139|NCT00898677|459266424|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
127630140|NCT00898677|459266425|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
127630141|NCT00898677|459266422|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
127630142|NCT00898677|459266423|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
127630143|NCT00898677|459266424|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
127630144|NCT00898677|459266425|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
127630145|NCT00898677|459266422|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
127795052|NCT01142726|459872650|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
127795053|NCT01142726|459872651|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
127795054|NCT01142726|459872649|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
127795055|NCT01142726|459872650|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
127795056|NCT01142726|459872651|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
127795057|NCT01142726|459872649|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
127795058|NCT01142726|459872650|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
127795059|NCT01142726|459872651|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
127795060|NCT01142726|459872649|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
127795061|NCT01142726|459872650|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
127795062|NCT01142726|459872651|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
127795063|NCT01142726|459872649|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
127795064|NCT01142726|459872650|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
127795065|NCT01142726|459872651|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
127795066|NCT01142726|459872649|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
127795067|NCT01142726|459872650|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
127795068|NCT01142726|459872651|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
127795069|NCT01142726|459872649|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
127795070|NCT01142726|459872650|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
127795071|NCT01142726|459872651|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
127795072|NCT01142726|459872649|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
127795073|NCT01142726|459872650|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
127795074|NCT01142726|459872651|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
127795075|NCT01142726|459872649|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
127795076|NCT01142726|459872650|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
127795077|NCT01142726|459872651|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
127795078|NCT01142726|459872649|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
127795079|NCT01142726|459872650|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
127795080|NCT01142726|459872651|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
127795081|NCT01142726|459872649|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
127795082|NCT01142726|459872650|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
127795083|NCT01142726|459872651|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
127795084|NCT01142726|459872649|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
127795085|NCT01142726|459872650|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
127795086|NCT01142726|459872651|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
127795087|NCT01568593|459872652|FG000|Overall Study|Lack of Efficacy|4|||
127795088|NCT01568593|459872653|FG001|Overall Study|Lack of Efficacy|1|||
127795089|NCT01568593|459872652|FG000|Overall Study|Adverse Event|3|||
127795090|NCT01568593|459872653|FG001|Overall Study|Adverse Event|2|||
127795091|NCT02109484|459872654|FG000|Overall Study|Lost to Follow-up|0|||
127795092|NCT02109484|459872655|FG001|Overall Study|Lost to Follow-up|0|||
127630146|NCT00898677|459266423|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
127630147|NCT00898677|459266424|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
127795093|NCT02109484|459872656|FG002|Overall Study|Lost to Follow-up|0|||
127795094|NCT02109484|459872657|FG003|Overall Study|Lost to Follow-up|1|||
127795095|NCT02109484|459872658|FG004|Overall Study|Lost to Follow-up|1|||
127795096|NCT02109484|459872659|FG005|Overall Study|Lost to Follow-up|0|||
127795097|NCT02109484|459872660|FG006|Overall Study|Lost to Follow-up|1|||
127630148|NCT00898677|459266425|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
127630149|NCT00898677|459266422|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
127630150|NCT00898677|459266423|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
127630151|NCT00898677|459266424|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
127630152|NCT00898677|459266425|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
127630153|NCT02199691|459266426|FG000|Overall Study|Protocol Violation|3|||
127630154|NCT02199691|459266427|FG001|Overall Study|Protocol Violation|3|||
127630155|NCT02199691|459266428|FG002|Overall Study|Protocol Violation|6|||
127630156|NCT02199691|459266429|FG003|Overall Study|Protocol Violation|7|||
127630157|NCT02199691|459266426|FG000|Overall Study|Withdrawal by Subject|5|||
127630158|NCT02199691|459266427|FG001|Overall Study|Withdrawal by Subject|3|||
127630159|NCT02199691|459266428|FG002|Overall Study|Withdrawal by Subject|12|||
127630160|NCT02199691|459266429|FG003|Overall Study|Withdrawal by Subject|13|||
127630161|NCT02199691|459266426|FG000|Overall Study|Lost to Follow-up|2|||
127630162|NCT02199691|459266427|FG001|Overall Study|Lost to Follow-up|1|||
127630163|NCT02199691|459266428|FG002|Overall Study|Lost to Follow-up|9|||
127630164|NCT02199691|459266429|FG003|Overall Study|Lost to Follow-up|10|||
127630165|NCT00836875|459266432|FG000|Overall Study|Death|3|||
127630166|NCT00836875|459266433|FG001|Overall Study|Death|2|||
127630167|NCT00836875|459266432|FG000|Overall Study|Withdrawal by Subject|0|||
127630168|NCT00836875|459266433|FG001|Overall Study|Withdrawal by Subject|1|||
127630169|NCT00428610|459266434|FG000|Overall Study|Death Due to Adverse Event|3|||
127630170|NCT00428610|459266435|FG001|Overall Study|Death Due to Adverse Event|0|||
127630171|NCT00428610|459266436|FG002|Overall Study|Death Due to Adverse Event|5|||
127630172|NCT00428610|459266434|FG000|Overall Study|Death Due to Progressive Disease|0|||
127630173|NCT00428610|459266435|FG001|Overall Study|Death Due to Progressive Disease|0|||
127630174|NCT00428610|459266436|FG002|Overall Study|Death Due to Progressive Disease|2|||
127630175|NCT00428610|459266434|FG000|Overall Study|Adverse Event|2|||
127630176|NCT00428610|459266435|FG001|Overall Study|Adverse Event|3|||
127630177|NCT00428610|459266436|FG002|Overall Study|Adverse Event|2|||
127630178|NCT00428610|459266434|FG000|Overall Study|Investigator Decision|2|||
127630179|NCT00428610|459266435|FG001|Overall Study|Investigator Decision|1|||
127630180|NCT00428610|459266436|FG002|Overall Study|Investigator Decision|1|||
127630181|NCT00428610|459266434|FG000|Overall Study|Progressive Disease|42|||
127630182|NCT00428610|459266435|FG001|Overall Study|Progressive Disease|14|||
127630183|NCT00428610|459266436|FG002|Overall Study|Progressive Disease|22|||
127630184|NCT00428610|459266434|FG000|Overall Study|Withdrawal by Subject|4|||
127630185|NCT00428610|459266435|FG001|Overall Study|Withdrawal by Subject|0|||
127630186|NCT00428610|459266436|FG002|Overall Study|Withdrawal by Subject|0|||
127795098|NCT02109484|459872661|FG007|Overall Study|Lost to Follow-up|0|||
127630187|NCT03136068|459268275|FG000|Overall Study|Lost to Follow-up|1|||
127630188|NCT03136068|459268276|FG001|Overall Study|Lost to Follow-up|1|||
127630189|NCT03136068|459268275|FG000|Overall Study|Protocol Violation|1|||
127630190|NCT03136068|459268276|FG001|Overall Study|Protocol Violation|0|||
127630191|NCT00432380|459268279|FG000|Overall Study|Migrated/moved from study area|3|||
127630192|NCT00432380|459268280|FG001|Overall Study|Migrated/moved from study area|4|||
127630193|NCT00432380|459268281|FG002|Overall Study|Migrated/moved from study area|1|||
127630194|NCT00432380|459268279|FG000|Overall Study|Adverse Event|1|||
127630195|NCT00432380|459268280|FG001|Overall Study|Adverse Event|0|||
127795099|NCT02109484|459872654|FG000|Overall Study|Withdrawal by Subject|0|||
127795100|NCT02109484|459872655|FG001|Overall Study|Withdrawal by Subject|0|||
127795101|NCT02109484|459872656|FG002|Overall Study|Withdrawal by Subject|0|||
127795102|NCT02109484|459872657|FG003|Overall Study|Withdrawal by Subject|0|||
127795103|NCT02109484|459872658|FG004|Overall Study|Withdrawal by Subject|1|||
127795104|NCT02109484|459872659|FG005|Overall Study|Withdrawal by Subject|1|||
127795105|NCT02109484|459872660|FG006|Overall Study|Withdrawal by Subject|1|||
127795106|NCT02109484|459872661|FG007|Overall Study|Withdrawal by Subject|0|||
127795107|NCT02109484|459872654|FG000|Overall Study|Physician Decision|0|||
127795108|NCT02109484|459872655|FG001|Overall Study|Physician Decision|0|||
127795109|NCT02109484|459872656|FG002|Overall Study|Physician Decision|0|||
127795110|NCT02109484|459872657|FG003|Overall Study|Physician Decision|0|||
127795111|NCT02109484|459872658|FG004|Overall Study|Physician Decision|2|||
127795112|NCT02109484|459872659|FG005|Overall Study|Physician Decision|0|||
127795113|NCT02109484|459872660|FG006|Overall Study|Physician Decision|0|||
127795114|NCT02109484|459872661|FG007|Overall Study|Physician Decision|0|||
127795115|NCT02109484|459872654|FG000|Overall Study|Death|0|||
127795116|NCT02109484|459872655|FG001|Overall Study|Death|0|||
127795117|NCT02109484|459872656|FG002|Overall Study|Death|0|||
127795118|NCT02109484|459872657|FG003|Overall Study|Death|0|||
127795119|NCT02109484|459872658|FG004|Overall Study|Death|0|||
127795120|NCT02109484|459872659|FG005|Overall Study|Death|0|||
127795121|NCT02109484|459872660|FG006|Overall Study|Death|0|||
127795122|NCT02109484|459872661|FG007|Overall Study|Death|2|||
127795123|NCT02109484|459872654|FG000|Overall Study|Moved away from study area|0|||
127795124|NCT02109484|459872655|FG001|Overall Study|Moved away from study area|0|||
127795125|NCT02109484|459872656|FG002|Overall Study|Moved away from study area|0|||
127795126|NCT02109484|459872657|FG003|Overall Study|Moved away from study area|0|||
127795127|NCT02109484|459872658|FG004|Overall Study|Moved away from study area|0|||
127795128|NCT02109484|459872659|FG005|Overall Study|Moved away from study area|0|||
127795129|NCT02109484|459872660|FG006|Overall Study|Moved away from study area|1|||
127795130|NCT02109484|459872661|FG007|Overall Study|Moved away from study area|1|||
127795131|NCT02111993|459872666|FG000|Overall Study|Physician Decision|5|||
127795132|NCT02111993|459872667|FG001|Overall Study|Physician Decision|4|||
127795133|NCT03127384|459872674|FG000|Overall Study|Lost to Follow-up|4|||
127795134|NCT03127384|459872674|FG000|Overall Study|Subject request|2|||
127795135|NCT01026831|459872676|FG000|Overall Study|Adverse Event|4|||
127795136|NCT01026831|459872677|FG001|Overall Study|Adverse Event|3|||
127795137|NCT01026831|459872676|FG000|Overall Study|Lost to Follow-up|2|||
127795138|NCT01026831|459872677|FG001|Overall Study|Lost to Follow-up|0|||
127795139|NCT01026831|459872676|FG000|Overall Study|Physician Decision|1|||
127795140|NCT01026831|459872677|FG001|Overall Study|Physician Decision|1|||
127795141|NCT01026831|459872676|FG000|Overall Study|Protocol Violation|0|||
127795142|NCT01026831|459872677|FG001|Overall Study|Protocol Violation|2|||
127795143|NCT01026831|459872676|FG000|Overall Study|Withdrawal by Subject|7|||
127795144|NCT01026831|459872677|FG001|Overall Study|Withdrawal by Subject|5|||
127795145|NCT04417894|459872678|FG000|Overall Study|Lost to Follow-up|3|||
127795146|NCT04417894|459872679|FG001|Overall Study|Lost to Follow-up|0|||
127795147|NCT04417894|459872678|FG000|Overall Study|Withdrawal by Subject|7|||
127795148|NCT04417894|459872679|FG001|Overall Study|Withdrawal by Subject|6|||
127795149|NCT04417894|459872678|FG000|Overall Study|Lack of Efficacy|3|||
127795150|NCT04417894|459872679|FG001|Overall Study|Lack of Efficacy|1|||
127795151|NCT03440814|459872680|FG000|Overall Study|Adverse Event|2|||
127795152|NCT03440814|459872681|FG001|Overall Study|Adverse Event|1|||
127795153|NCT03440814|459872680|FG000|Overall Study|Lost to Follow-up|2|||
127795154|NCT03440814|459872681|FG001|Overall Study|Lost to Follow-up|0|||
127795155|NCT03440814|459872680|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
127795156|NCT03440814|459872681|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
127630196|NCT00432380|459268281|FG002|Overall Study|Adverse Event|0|||
127630197|NCT01071395|459268282|FG000|Overall Study|Withdrawal by Subject|2|||
127630198|NCT01071395|459268283|FG001|Overall Study|Withdrawal by Subject|1|||
127795157|NCT00879697|459872682|FG000|Overall Study|Physician Decision|2|||
127795158|NCT00879697|459872683|FG001|Overall Study|Physician Decision|2|||
127630199|NCT01071395|459268282|FG000|Overall Study|Adverse Event|3|||
127630200|NCT01071395|459268283|FG001|Overall Study|Adverse Event|1|||
127630201|NCT01539291|459268284|FG000|Study GS-US-312-0116|Adverse Event|9|||
127795159|NCT02751502|459872684|FG000|Overall Study|Lack of funding|4|||
127795160|NCT00088374|459872685|FG000|Overall Study|patient did not receive any 17AAG|1|||
127795161|NCT00088374|459872685|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
127630202|NCT01539291|459268285|FG001|Study GS-US-312-0116|Adverse Event|0|||
127630203|NCT01539291|459268286|FG002|Study GS-US-312-0116|Adverse Event|0|||
127630204|NCT01539291|459268287|FG003|Study GS-US-312-0116|Adverse Event|0|||
127795162|NCT02678390|459872686|FG000|AE (1 Day)|Withdrawal by Subject|0|||
127795163|NCT02678390|459872687|FG001|AE (1 Day)|Withdrawal by Subject|1|||
127795164|NCT00498173|459872688|FG000|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2|||
127795165|NCT00498173|459872689|FG001|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1|||
127795166|NCT00498173|459872690|FG002|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0|||
127795167|NCT01110200|459872691|FG000|Overall Study|Adverse Event|28|||
127795168|NCT01110200|459872692|FG001|Overall Study|Adverse Event|28|||
127795169|NCT01110200|459872691|FG000|Overall Study|Withdrawal by Subject|25|||
127795170|NCT01110200|459872692|FG001|Overall Study|Withdrawal by Subject|32|||
127795171|NCT01110200|459872691|FG000|Overall Study|Lack of Efficacy|16|||
127795172|NCT01110200|459872692|FG001|Overall Study|Lack of Efficacy|25|||
127795173|NCT01110200|459872691|FG000|Overall Study|Protocol Violation|14|||
127795174|NCT01110200|459872692|FG001|Overall Study|Protocol Violation|12|||
127795175|NCT01110200|459872691|FG000|Overall Study|Physician Decision|13|||
127795176|NCT01110200|459872692|FG001|Overall Study|Physician Decision|17|||
127795177|NCT01110200|459872691|FG000|Overall Study|Lost to Follow-up|10|||
127795178|NCT01110200|459872692|FG001|Overall Study|Lost to Follow-up|7|||
127795179|NCT00903175|459872693|FG000|Period 1 - First Line|Adverse Event|36|||
127795180|NCT00903175|459872694|FG001|Period 1 - First Line|Adverse Event|50|||
127795181|NCT00903175|459872693|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
127795182|NCT00903175|459872694|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
127795183|NCT00903175|459872693|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
127795184|NCT00903175|459872694|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
127795185|NCT00903175|459872693|FG000|Period 1 - First Line|Protocol Violation|3|||
127795186|NCT00903175|459872694|FG001|Period 1 - First Line|Protocol Violation|3|||
127630205|NCT01539291|459268284|FG000|Study GS-US-312-0116|Physician Decision|1|||
127630206|NCT01539291|459268285|FG001|Study GS-US-312-0116|Physician Decision|0|||
127630207|NCT01539291|459268286|FG002|Study GS-US-312-0116|Physician Decision|0|||
127795187|NCT00903175|459872693|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
127795188|NCT00903175|459872694|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
127795189|NCT00903175|459872693|FG000|Period 1 - First Line|Administrative problems|12|||
127795190|NCT00903175|459872694|FG001|Period 1 - First Line|Administrative problems|13|||
127795191|NCT00903175|459872693|FG000|Period 1 - First Line|Death|17|||
127795192|NCT00903175|459872694|FG001|Period 1 - First Line|Death|10|||
127795193|NCT00903175|459872693|FG000|Period 2 - Second Line|Missing|1|||
127795194|NCT00903175|459872694|FG001|Period 2 - Second Line|Missing|0|||
127885507|NCT04380701|460203899|FG028|Overall Study|Death|0|||
127885508|NCT04380701|460203900|FG029|Overall Study|Death|0|||
127630208|NCT01539291|459268287|FG003|Study GS-US-312-0116|Physician Decision|0|||
127795195|NCT00903175|459872693|FG000|Period 2 - Second Line|Adverse Event|16|||
127630209|NCT01539291|459268284|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
127795196|NCT00903175|459872694|FG001|Period 2 - Second Line|Adverse Event|20|||
127795197|NCT00903175|459872693|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
127885509|NCT04380701|460203901|FG030|Overall Study|Death|0|||
127630210|NCT01539291|459268285|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
127630211|NCT01539291|459268286|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
127630212|NCT01539291|459268287|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
127630213|NCT01539291|459268284|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
127630214|NCT01539291|459268285|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
127630215|NCT01539291|459268286|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
127630216|NCT01539291|459268287|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
127630217|NCT01539291|459268284|FG000|Study GS-US-312-0116|Other|1|||
127630218|NCT01539291|459268285|FG001|Study GS-US-312-0116|Other|0|||
127630219|NCT01539291|459268286|FG002|Study GS-US-312-0116|Other|0|||
127702339|NCT05201079|459539070|FG000|Overall Study|Withdrawal by Subject|1|||
127702340|NCT05201079|459539071|FG001|Overall Study|Withdrawal by Subject|0|||
127702341|NCT05201079|459539070|FG000|Overall Study|Forbidden medication|9|||
127702342|NCT05201079|459539071|FG001|Overall Study|Forbidden medication|5|||
127702343|NCT05201079|459539070|FG000|Overall Study|Transfer to another hospital|0|||
127702344|NCT05201079|459539071|FG001|Overall Study|Transfer to another hospital|1|||
127702345|NCT05201079|459539070|FG000|Overall Study|Clinical condition|1|||
127702346|NCT05201079|459539071|FG001|Overall Study|Clinical condition|0|||
127702347|NCT05201079|459539070|FG000|Overall Study|SAE and sepsis|1|||
127702348|NCT05201079|459539071|FG001|Overall Study|SAE and sepsis|0|||
127702349|NCT04907851|459539072|FG000|Overall Study|Consent withdrawn|1|||
127702350|NCT04907851|459539073|FG001|Overall Study|Consent withdrawn|2|||
127702351|NCT04907851|459539074|FG002|Overall Study|Consent withdrawn|0|||
127702352|NCT04907851|459539072|FG000|Overall Study|Death|5|||
127702353|NCT04907851|459539073|FG001|Overall Study|Death|15|||
127702354|NCT04907851|459539074|FG002|Overall Study|Death|10|||
127702355|NCT01210807|459539081|FG000|Overall Study|Lost to Follow-up|1|||
127702356|NCT01210807|459539082|FG001|Overall Study|Lost to Follow-up|2|||
127702357|NCT01210807|459539081|FG000|Overall Study|Not implanted bilaterally|2|||
127702358|NCT01210807|459539082|FG001|Overall Study|Not implanted bilaterally|1|||
127702359|NCT05477186|459539087|FG000|Overall Study|Vaccine not administered|0|||
127702360|NCT05477186|459539088|FG001|Overall Study|Vaccine not administered|2|||
127702361|NCT05477186|459539089|FG002|Overall Study|Vaccine not administered|1|||
127702362|NCT05477186|459539090|FG003|Overall Study|Vaccine not administered|0|||
127702363|NCT05477186|459539091|FG004|Overall Study|Vaccine not administered|1|||
127702364|NCT05477186|459539092|FG005|Overall Study|Vaccine not administered|0|||
127702365|NCT05477186|459539093|FG006|Overall Study|Vaccine not administered|0|||
127702366|NCT05477186|459539087|FG000|Overall Study|Withdrawal by Subject|1|||
127702367|NCT05477186|459539088|FG001|Overall Study|Withdrawal by Subject|0|||
127702368|NCT05477186|459539089|FG002|Overall Study|Withdrawal by Subject|0|||
127702369|NCT05477186|459539090|FG003|Overall Study|Withdrawal by Subject|0|||
127702370|NCT05477186|459539091|FG004|Overall Study|Withdrawal by Subject|0|||
127702371|NCT05477186|459539092|FG005|Overall Study|Withdrawal by Subject|1|||
127702372|NCT05477186|459539093|FG006|Overall Study|Withdrawal by Subject|0|||
127702373|NCT05477186|459539087|FG000|Overall Study|Lost to Follow-up|1|||
127702374|NCT05477186|459539088|FG001|Overall Study|Lost to Follow-up|0|||
127702375|NCT05477186|459539089|FG002|Overall Study|Lost to Follow-up|2|||
127702376|NCT05477186|459539090|FG003|Overall Study|Lost to Follow-up|1|||
127702377|NCT05477186|459539091|FG004|Overall Study|Lost to Follow-up|1|||
127702378|NCT05477186|459539092|FG005|Overall Study|Lost to Follow-up|0|||
127702379|NCT05477186|459539093|FG006|Overall Study|Lost to Follow-up|2|||
127702380|NCT00324805|459539094|FG000|Overall Study|Adverse Event|62|||
127702381|NCT00324805|459539095|FG001|Overall Study|Adverse Event|203|||
127702382|NCT00324805|459539094|FG000|Overall Study|Progression|7|||
127702383|NCT00324805|459539095|FG001|Overall Study|Progression|35|||
127702384|NCT00324805|459539094|FG000|Overall Study|Withdrawal by Subject|51|||
127702385|NCT00324805|459539095|FG001|Overall Study|Withdrawal by Subject|174|||
127702386|NCT00324805|459539094|FG000|Overall Study|Death|6|||
127702387|NCT00324805|459539095|FG001|Overall Study|Death|9|||
127702388|NCT00324805|459539094|FG000|Overall Study|Alternative therapy|4|||
127702389|NCT00324805|459539095|FG001|Overall Study|Alternative therapy|8|||
127702390|NCT00324805|459539094|FG000|Overall Study|Other complicating disease|1|||
127702391|NCT00324805|459539095|FG001|Overall Study|Other complicating disease|9|||
127702392|NCT00324805|459539094|FG000|Overall Study|Other reasons|7|||
127702393|NCT00324805|459539095|FG001|Overall Study|Other reasons|26|||
127702394|NCT00324805|459539094|FG000|Overall Study|Other|0|||
127702395|NCT00324805|459539095|FG001|Overall Study|Other|2|||
127702396|NCT00324805|459539094|FG000|Overall Study|Did not start therapy|12|||
127702397|NCT00324805|459539095|FG001|Overall Study|Did not start therapy|17|||
127702398|NCT05792085|459539097|FG000|Overall Study|Death|0|||
127702399|NCT05792085|459539098|FG001|Overall Study|Death|0|||
127702400|NCT05792085|459539099|FG002|Overall Study|Death|0|||
127702401|NCT05792085|459539100|FG003|Overall Study|Death|0|||
127630220|NCT01539291|459268287|FG003|Study GS-US-312-0116|Other|0|||
127885510|NCT04380701|460203902|FG031|Overall Study|Death|0|||
127630221|NCT01539291|459268284|FG000|Study GS-US-312-0117|Adverse Event|22|||
127702402|NCT05792085|459539101|FG004|Overall Study|Death|1|||
127702403|NCT01919554|459539102|FG000|Overall Study|Withdrawal by Subject|0|||
127702404|NCT01919554|459539103|FG001|Overall Study|Withdrawal by Subject|0|||
127702405|NCT01919554|459539104|FG002|Overall Study|Withdrawal by Subject|1|||
127702406|NCT01919554|459539105|FG003|Overall Study|Withdrawal by Subject|1|||
127702407|NCT01544114|459539109|FG000|Overall Study|Withdrawal by Subject|0|||
127702408|NCT01544114|459539110|FG001|Overall Study|Withdrawal by Subject|0|||
127702409|NCT01544114|459539111|FG002|Overall Study|Withdrawal by Subject|3|||
127702410|NCT01544114|459539109|FG000|Overall Study|Lost to Follow-up|0|||
127702411|NCT01544114|459539110|FG001|Overall Study|Lost to Follow-up|2|||
127702412|NCT01544114|459539111|FG002|Overall Study|Lost to Follow-up|0|||
127702413|NCT01544114|459539109|FG000|Overall Study|Adverse Event|1|||
127702414|NCT01544114|459539110|FG001|Overall Study|Adverse Event|1|||
127702415|NCT01544114|459539111|FG002|Overall Study|Adverse Event|2|||
127702416|NCT01544114|459539109|FG000|Overall Study|Protocol Violation|0|||
127702417|NCT01544114|459539110|FG001|Overall Study|Protocol Violation|1|||
127702418|NCT01544114|459539111|FG002|Overall Study|Protocol Violation|0|||
127702419|NCT01733316|459539116|FG000|RP103 Phase|Non-compliance|1|||
127702420|NCT01733316|459539116|FG000|Long Term Extension Phase|Adverse Event|1|||
127702421|NCT01733316|459539116|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
127702422|NCT01733316|459539116|FG000|Long Term Extension Phase|Sponsor Decision|2|||
127702423|NCT03058289|459539123|FG000|Overall Study|Radiographic Deterioration|0|||
127702424|NCT03058289|459539124|FG001|Overall Study|Radiographic Deterioration|3|||
127702425|NCT03058289|459539125|FG002|Overall Study|Radiographic Deterioration|1|||
127702426|NCT03058289|459539126|FG003|Overall Study|Radiographic Deterioration|2|||
127702427|NCT03058289|459539127|FG004|Overall Study|Radiographic Deterioration|6|||
127702428|NCT03058289|459539128|FG005|Overall Study|Radiographic Deterioration|3|||
127702429|NCT03058289|459539129|FG006|Overall Study|Radiographic Deterioration|0|||
127702430|NCT03058289|459539130|FG007|Overall Study|Radiographic Deterioration|4|||
127702431|NCT03058289|459539131|FG008|Overall Study|Radiographic Deterioration|2|||
127702432|NCT03058289|459539123|FG000|Overall Study|Adverse Event|2|||
127702433|NCT03058289|459539124|FG001|Overall Study|Adverse Event|0|||
127702434|NCT03058289|459539125|FG002|Overall Study|Adverse Event|1|||
127702435|NCT03058289|459539126|FG003|Overall Study|Adverse Event|3|||
127702436|NCT03058289|459539127|FG004|Overall Study|Adverse Event|1|||
127702437|NCT03058289|459539128|FG005|Overall Study|Adverse Event|0|||
127702438|NCT03058289|459539129|FG006|Overall Study|Adverse Event|1|||
127702439|NCT03058289|459539130|FG007|Overall Study|Adverse Event|3|||
127702440|NCT03058289|459539131|FG008|Overall Study|Adverse Event|0|||
127702441|NCT03058289|459539123|FG000|Overall Study|Withdrawal by Subject|0|||
127702442|NCT03058289|459539124|FG001|Overall Study|Withdrawal by Subject|0|||
127702443|NCT03058289|459539125|FG002|Overall Study|Withdrawal by Subject|0|||
127702444|NCT03058289|459539126|FG003|Overall Study|Withdrawal by Subject|2|||
127702445|NCT03058289|459539127|FG004|Overall Study|Withdrawal by Subject|0|||
127702446|NCT03058289|459539128|FG005|Overall Study|Withdrawal by Subject|2|||
127702447|NCT03058289|459539129|FG006|Overall Study|Withdrawal by Subject|0|||
127702448|NCT03058289|459539130|FG007|Overall Study|Withdrawal by Subject|4|||
127702449|NCT03058289|459539131|FG008|Overall Study|Withdrawal by Subject|1|||
127702450|NCT03058289|459539123|FG000|Overall Study|Physician Decision|1|||
127702451|NCT03058289|459539124|FG001|Overall Study|Physician Decision|0|||
127702452|NCT03058289|459539125|FG002|Overall Study|Physician Decision|0|||
127702453|NCT03058289|459539126|FG003|Overall Study|Physician Decision|2|||
127702454|NCT03058289|459539127|FG004|Overall Study|Physician Decision|1|||
127702455|NCT03058289|459539128|FG005|Overall Study|Physician Decision|0|||
127702456|NCT03058289|459539129|FG006|Overall Study|Physician Decision|2|||
127702457|NCT03058289|459539130|FG007|Overall Study|Physician Decision|3|||
127702458|NCT03058289|459539131|FG008|Overall Study|Physician Decision|0|||
127702459|NCT03058289|459539123|FG000|Overall Study|Clinical Deterioration|2|||
127702460|NCT03058289|459539124|FG001|Overall Study|Clinical Deterioration|0|||
127795198|NCT00903175|459872694|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
127795199|NCT00903175|459872693|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
127795200|NCT00903175|459872694|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
127795201|NCT00903175|459872693|FG000|Period 2 - Second Line|Administrative problems|19|||
127795202|NCT00903175|459872694|FG001|Period 2 - Second Line|Administrative problems|9|||
127795203|NCT00903175|459872693|FG000|Period 2 - Second Line|Death|5|||
127795204|NCT00903175|459872694|FG001|Period 2 - Second Line|Death|2|||
127795205|NCT03074474|459872699|FG000|Overall Study|Lost to Follow-up|10|||
127795206|NCT03074474|459872699|FG000|Overall Study|Withdrawal by Subject|10|||
127795207|NCT03074474|459872699|FG000|Overall Study|Death|4|||
127795208|NCT03074474|459872699|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
127795209|NCT01318109|459872703|FG000|Overall Study|Adverse Event|0|||
127795210|NCT01318109|459872704|FG001|Overall Study|Adverse Event|2|||
127795211|NCT01318109|459872705|FG002|Overall Study|Adverse Event|0|||
127795212|NCT01318109|459872703|FG000|Overall Study|Withdrawal by Subject|1|||
127795213|NCT01318109|459872704|FG001|Overall Study|Withdrawal by Subject|0|||
127795214|NCT01318109|459872705|FG002|Overall Study|Withdrawal by Subject|0|||
127795215|NCT01318109|459872703|FG000|Overall Study|Schedule Conflict|0|||
127795216|NCT01318109|459872704|FG001|Overall Study|Schedule Conflict|1|||
127795217|NCT01318109|459872705|FG002|Overall Study|Schedule Conflict|0|||
127795218|NCT04042103|459872706|FG000|Overall Study|Lost to Follow-up|1|||
127795219|NCT04042103|459872706|FG000|Overall Study|Withdrawal by Subject|1|||
127795220|NCT02193074|459872707|FG000|Overall Study|Withdrawal by Subject|1|||
127795221|NCT02193074|459872708|FG001|Overall Study|Withdrawal by Subject|2|||
127795222|NCT02193074|459872707|FG000|Overall Study|Adverse Event|16|||
127630222|NCT01539291|459268285|FG001|Study GS-US-312-0117|Adverse Event|1|||
127795223|NCT02193074|459872708|FG001|Overall Study|Adverse Event|13|||
127795224|NCT03124563|459872709|FG000|Overall Study|Lost to Follow-up|1|||
127795225|NCT03124563|459872710|FG001|Overall Study|Lost to Follow-up|1|||
127630223|NCT01539291|459268286|FG002|Study GS-US-312-0117|Adverse Event|9|||
127795226|NCT03124563|459872709|FG000|Overall Study|Withdrawal by Subject|1|||
127795227|NCT03124563|459872710|FG001|Overall Study|Withdrawal by Subject|1|||
127795228|NCT01534533|459872711|FG000|Overall Study|Lost to Follow-up|3|||
127795229|NCT01534533|459872712|FG001|Overall Study|Lost to Follow-up|0|||
127795230|NCT01534533|459872713|FG002|Overall Study|Lost to Follow-up|4|||
127795231|NCT01534533|459872714|FG003|Overall Study|Lost to Follow-up|3|||
127795232|NCT01534533|459872711|FG000|Overall Study|Withdrawal by Subject|5|||
127795233|NCT01534533|459872712|FG001|Overall Study|Withdrawal by Subject|3|||
127795234|NCT01534533|459872713|FG002|Overall Study|Withdrawal by Subject|4|||
127795235|NCT01534533|459872714|FG003|Overall Study|Withdrawal by Subject|1|||
127795236|NCT04311502|459874152|FG000|Overall Study|Death|1|||
127795237|NCT04311502|459874153|FG001|Overall Study|Death|1|||
127795238|NCT04311502|459874154|FG002|Overall Study|Death|1|||
127795239|NCT04311502|459874152|FG000|Overall Study|Lost to Follow-up|2|||
127795240|NCT04311502|459874153|FG001|Overall Study|Lost to Follow-up|3|||
127795241|NCT04311502|459874154|FG002|Overall Study|Lost to Follow-up|0|||
127795242|NCT04311502|459874152|FG000|Overall Study|Participant is in prison|1|||
127795243|NCT04311502|459874153|FG001|Overall Study|Participant is in prison|0|||
127795244|NCT04311502|459874154|FG002|Overall Study|Participant is in prison|0|||
127795245|NCT04311502|459874152|FG000|Overall Study|Participant moved out of country|1|||
127795246|NCT04311502|459874153|FG001|Overall Study|Participant moved out of country|0|||
127795247|NCT04311502|459874154|FG002|Overall Study|Participant moved out of country|0|||
127795248|NCT04311502|459874152|FG000|Overall Study|Withdrawal by Subject|2|||
127795249|NCT04311502|459874153|FG001|Overall Study|Withdrawal by Subject|0|||
127795250|NCT04311502|459874154|FG002|Overall Study|Withdrawal by Subject|0|||
127795251|NCT04311502|459874152|FG000|Overall Study|DSMB Mandated Extension of follow-up|29|||
127795252|NCT04311502|459874153|FG001|Overall Study|DSMB Mandated Extension of follow-up|0|||
127885511|NCT04380701|460203903|FG032|Overall Study|Death|0|||
127885512|NCT04380701|460203904|FG033|Overall Study|Death|0|||
127885513|NCT04380701|460203871|FG000|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
127885514|NCT04380701|460203872|FG001|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
127885515|NCT04380701|460203873|FG002|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
127885516|NCT04380701|460203874|FG003|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
127630224|NCT01539291|459268287|FG003|Study GS-US-312-0117|Adverse Event|12|||
127630225|NCT01539291|459268284|FG000|Study GS-US-312-0117|Physician Decision|9|||
127630226|NCT01539291|459268285|FG001|Study GS-US-312-0117|Physician Decision|0|||
127630227|NCT01539291|459268286|FG002|Study GS-US-312-0117|Physician Decision|6|||
127630228|NCT01539291|459268287|FG003|Study GS-US-312-0117|Physician Decision|4|||
127630229|NCT01539291|459268284|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
127630230|NCT01539291|459268285|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
127630231|NCT01539291|459268286|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
127630232|NCT01539291|459268287|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
127630233|NCT01539291|459268284|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
127630234|NCT01539291|459268285|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
127630235|NCT01539291|459268286|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
127630236|NCT01539291|459268287|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
127630237|NCT01539291|459268284|FG000|Study GS-US-312-0117|Other|2|||
127630238|NCT01539291|459268285|FG001|Study GS-US-312-0117|Other|1|||
127630239|NCT01539291|459268286|FG002|Study GS-US-312-0117|Other|1|||
127630240|NCT01539291|459268287|FG003|Study GS-US-312-0117|Other|1|||
127630241|NCT02239510|459268288|FG000|Overall Study|Lost to Follow-up|2|||
127630242|NCT02239510|459268289|FG001|Overall Study|Lost to Follow-up|1|||
127630243|NCT01782131|459268290|FG000|Overall Study|Death|93|||
127630244|NCT01782131|459268291|FG001|Overall Study|Death|96|||
127630245|NCT01782131|459268290|FG000|Overall Study|Lost to Follow-up|1|||
127630246|NCT01782131|459268291|FG001|Overall Study|Lost to Follow-up|3|||
127630247|NCT01782131|459268290|FG000|Overall Study|Withdrawal by Subject|10|||
127630248|NCT01782131|459268291|FG001|Overall Study|Withdrawal by Subject|10|||
127630249|NCT01782131|459268290|FG000|Overall Study|Randomized but not treated|5|||
127630250|NCT01782131|459268291|FG001|Overall Study|Randomized but not treated|5|||
127630251|NCT01782131|459268290|FG000|Overall Study|Reason not provided|0|||
127630252|NCT01782131|459268291|FG001|Overall Study|Reason not provided|1|||
127630253|NCT02627677|459268292|FG000|Overall Study|Adverse event (not progressive disease)|1|||
127630254|NCT02627677|459268293|FG001|Overall Study|Adverse event (not progressive disease)|4|||
127630255|NCT02627677|459268294|FG002|Overall Study|Adverse event (not progressive disease)|1|||
127630256|NCT02627677|459268292|FG000|Overall Study|Progressive disease|1|||
127630257|NCT02627677|459268293|FG001|Overall Study|Progressive disease|3|||
127630258|NCT02627677|459268294|FG002|Overall Study|Progressive disease|0|||
127630259|NCT02627677|459268292|FG000|Overall Study|Lack of Efficacy|1|||
127795253|NCT04311502|459874154|FG002|Overall Study|DSMB Mandated Extension of follow-up|0|||
127795254|NCT03040999|459874155|FG000|Overall Study|Lost to Follow-up|2|||
127795255|NCT03040999|459874156|FG001|Overall Study|Lost to Follow-up|2|||
127795256|NCT03040999|459874155|FG000|Overall Study|Withdrawal by Subject|12|||
127795257|NCT03040999|459874156|FG001|Overall Study|Withdrawal by Subject|13|||
127795258|NCT03040999|459874155|FG000|Overall Study|Death|155|||
127795259|NCT03040999|459874156|FG001|Overall Study|Death|171|||
127795260|NCT03040999|459874155|FG000|Overall Study|Physician Decision|0|||
127795261|NCT03040999|459874156|FG001|Overall Study|Physician Decision|3|||
127795262|NCT01408147|459874157|FG000|Overall Study|Withdrawal by Subject|0|||
127795263|NCT01408147|459874158|FG001|Overall Study|Withdrawal by Subject|1|||
127795264|NCT01661140|459874159|FG000|Open-Label Period|Adverse Event|44|||
127795265|NCT01661140|459874160|FG001|Open-Label Period|Adverse Event|0|||
127795266|NCT01661140|459874161|FG002|Open-Label Period|Adverse Event|0|||
127795267|NCT01661140|459874159|FG000|Open-Label Period|Protocol Violation|3|||
127795268|NCT01661140|459874160|FG001|Open-Label Period|Protocol Violation|0|||
127795269|NCT01661140|459874161|FG002|Open-Label Period|Protocol Violation|0|||
127795270|NCT01661140|459874159|FG000|Open-Label Period|Withdrawal by Subject|5|||
127795271|NCT01661140|459874160|FG001|Open-Label Period|Withdrawal by Subject|0|||
127795272|NCT01661140|459874161|FG002|Open-Label Period|Withdrawal by Subject|0|||
127630260|NCT02627677|459268293|FG001|Overall Study|Lack of Efficacy|2|||
127630261|NCT02627677|459268294|FG002|Overall Study|Lack of Efficacy|0|||
127630262|NCT02627677|459268292|FG000|Overall Study|Lost to Follow-up|0|||
127795273|NCT01661140|459874159|FG000|Open-Label Period|Investigator Decision|3|||
127795274|NCT01661140|459874160|FG001|Open-Label Period|Investigator Decision|0|||
127795275|NCT01661140|459874161|FG002|Open-Label Period|Investigator Decision|0|||
127795276|NCT01661140|459874159|FG000|Open-Label Period|Death|1|||
127795277|NCT01661140|459874160|FG001|Open-Label Period|Death|0|||
127795278|NCT01661140|459874161|FG002|Open-Label Period|Death|0|||
127795279|NCT01661140|459874159|FG000|Open-Label Period|Administrative/Other|1|||
127630263|NCT02627677|459268293|FG001|Overall Study|Lost to Follow-up|0|||
127630264|NCT02627677|459268294|FG002|Overall Study|Lost to Follow-up|1|||
127630265|NCT02627677|459268292|FG000|Overall Study|Pregnancy|0|||
127630266|NCT02627677|459268293|FG001|Overall Study|Pregnancy|1|||
127630267|NCT02627677|459268294|FG002|Overall Study|Pregnancy|0|||
127630268|NCT02627677|459268292|FG000|Overall Study|Study Terminated by Sponsor|5|||
127630269|NCT02627677|459268293|FG001|Overall Study|Study Terminated by Sponsor|10|||
127630270|NCT02627677|459268294|FG002|Overall Study|Study Terminated by Sponsor|6|||
127630271|NCT02627677|459268292|FG000|Overall Study|Physician Decision|0|||
127630272|NCT02627677|459268293|FG001|Overall Study|Physician Decision|0|||
127630273|NCT02627677|459268294|FG002|Overall Study|Physician Decision|2|||
127630274|NCT02627677|459268292|FG000|Overall Study|Withdrawal by Subject|2|||
127630275|NCT02627677|459268293|FG001|Overall Study|Withdrawal by Subject|1|||
127630276|NCT02627677|459268294|FG002|Overall Study|Withdrawal by Subject|1|||
127630277|NCT02627677|459268292|FG000|Overall Study|Reason not Specified|0|||
127630278|NCT02627677|459268293|FG001|Overall Study|Reason not Specified|0|||
127630279|NCT02627677|459268294|FG002|Overall Study|Reason not Specified|1|||
127630280|NCT02627677|459268292|FG000|Overall Study|Randomized but not Treated|1|||
127630281|NCT02627677|459268293|FG001|Overall Study|Randomized but not Treated|0|||
127630282|NCT02627677|459268294|FG002|Overall Study|Randomized but not Treated|0|||
127630283|NCT00587587|459268299|FG000|Overall Study|Lost to Follow-up|6|||
127630284|NCT00587587|459268300|FG001|Overall Study|Lost to Follow-up|1|||
127630285|NCT02032901|459268301|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
127630286|NCT02032901|459268302|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
127630287|NCT02032901|459268301|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
127630288|NCT02032901|459268302|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
127630289|NCT01722331|459268303|FG000|Part 1|Adverse Event|5|||
127630290|NCT01722331|459268304|FG001|Part 1|Adverse Event|0|||
127630291|NCT01722331|459268305|FG002|Part 1|Adverse Event|0|||
127630292|NCT01722331|459268306|FG003|Part 1|Adverse Event|0|||
127630293|NCT01722331|459268307|FG004|Part 1|Adverse Event|0|||
127630294|NCT01722331|459268308|FG005|Part 1|Adverse Event|0|||
127630295|NCT01722331|459268309|FG006|Part 1|Adverse Event|0|||
127630296|NCT01722331|459268303|FG000|Part 1|Lack of Efficacy|0|||
127630297|NCT01722331|459268304|FG001|Part 1|Lack of Efficacy|0|||
127630298|NCT01722331|459268305|FG002|Part 1|Lack of Efficacy|1|||
127630299|NCT01722331|459268306|FG003|Part 1|Lack of Efficacy|0|||
127630300|NCT01722331|459268307|FG004|Part 1|Lack of Efficacy|2|||
127630301|NCT01722331|459268308|FG005|Part 1|Lack of Efficacy|0|||
127630302|NCT01722331|459268309|FG006|Part 1|Lack of Efficacy|0|||
127630303|NCT01722331|459268303|FG000|Part 1|Lost to Follow-up|1|||
127630304|NCT01722331|459268304|FG001|Part 1|Lost to Follow-up|0|||
127630305|NCT01722331|459268305|FG002|Part 1|Lost to Follow-up|2|||
127630306|NCT01722331|459268306|FG003|Part 1|Lost to Follow-up|0|||
127630307|NCT01722331|459268307|FG004|Part 1|Lost to Follow-up|1|||
127630308|NCT01722331|459268308|FG005|Part 1|Lost to Follow-up|0|||
127630309|NCT01722331|459268309|FG006|Part 1|Lost to Follow-up|0|||
127630310|NCT01722331|459268303|FG000|Part 1|Physician Decision|0|||
127630311|NCT01722331|459268304|FG001|Part 1|Physician Decision|0|||
127630312|NCT01722331|459268305|FG002|Part 1|Physician Decision|3|||
127630313|NCT01722331|459268306|FG003|Part 1|Physician Decision|0|||
127630314|NCT01722331|459268307|FG004|Part 1|Physician Decision|1|||
127630315|NCT01722331|459268308|FG005|Part 1|Physician Decision|0|||
127630316|NCT01722331|459268309|FG006|Part 1|Physician Decision|0|||
127630317|NCT01722331|459268303|FG000|Part 1|Pregnancy|1|||
127630318|NCT01722331|459268304|FG001|Part 1|Pregnancy|0|||
127630319|NCT01722331|459268305|FG002|Part 1|Pregnancy|0|||
127630320|NCT01722331|459268306|FG003|Part 1|Pregnancy|0|||
127630321|NCT01722331|459268307|FG004|Part 1|Pregnancy|0|||
127630322|NCT01722331|459268308|FG005|Part 1|Pregnancy|0|||
127630323|NCT01722331|459268309|FG006|Part 1|Pregnancy|0|||
127630324|NCT01722331|459268303|FG000|Part 1|Progressive Disease|0|||
127630325|NCT01722331|459268304|FG001|Part 1|Progressive Disease|0|||
127630326|NCT01722331|459268305|FG002|Part 1|Progressive Disease|0|||
127630327|NCT01722331|459268306|FG003|Part 1|Progressive Disease|0|||
127630328|NCT01722331|459268307|FG004|Part 1|Progressive Disease|1|||
127630329|NCT01722331|459268308|FG005|Part 1|Progressive Disease|0|||
127630330|NCT01722331|459268309|FG006|Part 1|Progressive Disease|0|||
127630331|NCT01722331|459268303|FG000|Part 1|Protocol Violation|1|||
127795280|NCT01661140|459874160|FG001|Open-Label Period|Administrative/Other|0|||
127630332|NCT01722331|459268304|FG001|Part 1|Protocol Violation|0|||
127630333|NCT01722331|459268305|FG002|Part 1|Protocol Violation|0|||
127630334|NCT01722331|459268306|FG003|Part 1|Protocol Violation|0|||
127630335|NCT01722331|459268307|FG004|Part 1|Protocol Violation|1|||
127630336|NCT01722331|459268308|FG005|Part 1|Protocol Violation|0|||
127630337|NCT01722331|459268309|FG006|Part 1|Protocol Violation|0|||
127630338|NCT01722331|459268303|FG000|Part 1|Withdrawal by Subject|2|||
127630339|NCT01722331|459268304|FG001|Part 1|Withdrawal by Subject|0|||
127630340|NCT01722331|459268305|FG002|Part 1|Withdrawal by Subject|3|||
127630341|NCT01722331|459268306|FG003|Part 1|Withdrawal by Subject|0|||
127630342|NCT01722331|459268307|FG004|Part 1|Withdrawal by Subject|3|||
127630343|NCT01722331|459268308|FG005|Part 1|Withdrawal by Subject|0|||
127630344|NCT01722331|459268309|FG006|Part 1|Withdrawal by Subject|0|||
127630345|NCT01722331|459268303|FG000|Part 2|Adverse Event|3|||
127630346|NCT01722331|459268304|FG001|Part 2|Adverse Event|0|||
127630347|NCT01722331|459268305|FG002|Part 2|Adverse Event|0|||
127630348|NCT01722331|459268306|FG003|Part 2|Adverse Event|0|||
127630349|NCT01722331|459268307|FG004|Part 2|Adverse Event|0|||
127630350|NCT01722331|459268308|FG005|Part 2|Adverse Event|1|||
127630351|NCT01722331|459268309|FG006|Part 2|Adverse Event|0|||
127795281|NCT01661140|459874161|FG002|Open-Label Period|Administrative/Other|0|||
127795282|NCT01661140|459874159|FG000|Open-Label Period|Sponsor termination|16|||
127795283|NCT01661140|459874160|FG001|Open-Label Period|Sponsor termination|0|||
127795284|NCT01661140|459874161|FG002|Open-Label Period|Sponsor termination|0|||
127795285|NCT01661140|459874159|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
127795286|NCT01661140|459874160|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
127630352|NCT01722331|459268303|FG000|Part 2|Lack of Efficacy|3|||
127630353|NCT01722331|459268304|FG001|Part 2|Lack of Efficacy|0|||
127630354|NCT01722331|459268305|FG002|Part 2|Lack of Efficacy|11|||
127630355|NCT01722331|459268306|FG003|Part 2|Lack of Efficacy|0|||
127630356|NCT01722331|459268307|FG004|Part 2|Lack of Efficacy|0|||
127630357|NCT01722331|459268308|FG005|Part 2|Lack of Efficacy|3|||
127630358|NCT01722331|459268309|FG006|Part 2|Lack of Efficacy|3|||
127630359|NCT01722331|459268303|FG000|Part 2|Lost to Follow-up|0|||
127630360|NCT01722331|459268304|FG001|Part 2|Lost to Follow-up|0|||
127630361|NCT01722331|459268305|FG002|Part 2|Lost to Follow-up|3|||
127630362|NCT01722331|459268306|FG003|Part 2|Lost to Follow-up|0|||
127630363|NCT01722331|459268307|FG004|Part 2|Lost to Follow-up|0|||
127630364|NCT01722331|459268308|FG005|Part 2|Lost to Follow-up|1|||
127630365|NCT01722331|459268309|FG006|Part 2|Lost to Follow-up|1|||
127630366|NCT01722331|459268303|FG000|Part 2|Non-Compliance with Study Drug|1|||
127630367|NCT01722331|459268304|FG001|Part 2|Non-Compliance with Study Drug|0|||
127630368|NCT01722331|459268305|FG002|Part 2|Non-Compliance with Study Drug|1|||
127630369|NCT01722331|459268306|FG003|Part 2|Non-Compliance with Study Drug|0|||
127630370|NCT01722331|459268307|FG004|Part 2|Non-Compliance with Study Drug|0|||
127795287|NCT01661140|459874161|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
127795288|NCT01661140|459874159|FG000|Open-Label Period|Lost to Follow-up|2|||
127795289|NCT01661140|459874160|FG001|Open-Label Period|Lost to Follow-up|0|||
127795290|NCT01661140|459874161|FG002|Open-Label Period|Lost to Follow-up|0|||
127795291|NCT01661140|459874159|FG000|Double-Blind Period|Refused Treatment|0|||
127795292|NCT01661140|459874160|FG001|Double-Blind Period|Refused Treatment|0|||
127795293|NCT01661140|459874161|FG002|Double-Blind Period|Refused Treatment|1|||
127795294|NCT01661140|459874159|FG000|Double-Blind Period|Adverse Event|0|||
127795295|NCT01661140|459874160|FG001|Double-Blind Period|Adverse Event|16|||
127795296|NCT01661140|459874161|FG002|Double-Blind Period|Adverse Event|18|||
127795297|NCT01661140|459874159|FG000|Double-Blind Period|Protocol Violation|0|||
127795298|NCT01661140|459874160|FG001|Double-Blind Period|Protocol Violation|2|||
127795299|NCT01661140|459874161|FG002|Double-Blind Period|Protocol Violation|3|||
127795300|NCT01661140|459874159|FG000|Double-Blind Period|Withdrawal by Subject|0|||
127795301|NCT01661140|459874160|FG001|Double-Blind Period|Withdrawal by Subject|1|||
127795302|NCT01661140|459874161|FG002|Double-Blind Period|Withdrawal by Subject|3|||
127795303|NCT01661140|459874159|FG000|Double-Blind Period|Investigator's Decision|0|||
127795304|NCT01661140|459874160|FG001|Double-Blind Period|Investigator's Decision|1|||
127795305|NCT01661140|459874161|FG002|Double-Blind Period|Investigator's Decision|2|||
127795306|NCT01661140|459874159|FG000|Double-Blind Period|Sponsor Termination|0|||
127795307|NCT01661140|459874160|FG001|Double-Blind Period|Sponsor Termination|14|||
127795308|NCT01661140|459874161|FG002|Double-Blind Period|Sponsor Termination|17|||
127795309|NCT01661140|459874159|FG000|Double-Blind Period|Administrative/Other|0|||
127795310|NCT01661140|459874160|FG001|Double-Blind Period|Administrative/Other|7|||
127795311|NCT01661140|459874161|FG002|Double-Blind Period|Administrative/Other|6|||
127795312|NCT01391000|459874162|FG000|Overall Study|Lost to Follow-up|2|||
127795313|NCT01391000|459874163|FG001|Overall Study|Lost to Follow-up|0|||
127795314|NCT00817531|459874164|FG000|Overall Study|Adverse Event|1|||
127795315|NCT00817531|459874164|FG000|Overall Study|Lack of Efficacy|1|||
127795316|NCT00132132|459874168|FG000|Overall Study|Lost to Follow-up|7|||
127795317|NCT00132132|459874169|FG001|Overall Study|Lost to Follow-up|2|||
127795318|NCT00494091|459874172|FG000|Overall Study|Death|5|||
127795319|NCT00494091|459874173|FG001|Overall Study|Death|54|||
127630371|NCT01722331|459268308|FG005|Part 2|Non-Compliance with Study Drug|0|||
127630372|NCT01722331|459268309|FG006|Part 2|Non-Compliance with Study Drug|0|||
127630373|NCT01722331|459268303|FG000|Part 2|Physician Decision|0|||
127630374|NCT01722331|459268304|FG001|Part 2|Physician Decision|0|||
127630375|NCT01722331|459268305|FG002|Part 2|Physician Decision|2|||
127795320|NCT00494091|459874172|FG000|Overall Study|Lost to Follow-up|0|||
127795321|NCT00494091|459874173|FG001|Overall Study|Lost to Follow-up|4|||
127795322|NCT00494091|459874172|FG000|Overall Study|Other|1|||
127795323|NCT00494091|459874173|FG001|Overall Study|Other|11|||
127795324|NCT00494091|459874172|FG000|Overall Study|Withdrawal by Subject|0|||
127795325|NCT00494091|459874173|FG001|Overall Study|Withdrawal by Subject|7|||
127795326|NCT00452699|459874176|FG000|Overall Study|Adverse Event|10|||
127795327|NCT00452699|459874177|FG001|Overall Study|Adverse Event|3|||
127630376|NCT01722331|459268306|FG003|Part 2|Physician Decision|0|||
127630377|NCT01722331|459268307|FG004|Part 2|Physician Decision|0|||
127630378|NCT01722331|459268308|FG005|Part 2|Physician Decision|0|||
127630379|NCT01722331|459268309|FG006|Part 2|Physician Decision|0|||
127630380|NCT01722331|459268303|FG000|Part 2|Pregnancy|0|||
127630381|NCT01722331|459268304|FG001|Part 2|Pregnancy|0|||
127630382|NCT01722331|459268305|FG002|Part 2|Pregnancy|0|||
127795328|NCT00452699|459874176|FG000|Overall Study|Lack of Efficacy|6|||
127795329|NCT00452699|459874177|FG001|Overall Study|Lack of Efficacy|4|||
127795330|NCT00452699|459874176|FG000|Overall Study|Lost to Follow-up|6|||
127795331|NCT00452699|459874177|FG001|Overall Study|Lost to Follow-up|9|||
127795332|NCT00452699|459874176|FG000|Overall Study|Protocol Violation|21|||
127795333|NCT00452699|459874177|FG001|Overall Study|Protocol Violation|25|||
127795334|NCT00452699|459874176|FG000|Overall Study|Withdrawal by Subject|26|||
127795335|NCT00452699|459874177|FG001|Overall Study|Withdrawal by Subject|25|||
127795336|NCT00452699|459874176|FG000|Overall Study|Other|12|||
127795337|NCT00452699|459874177|FG001|Overall Study|Other|7|||
127795338|NCT03847987|459874178|FG000|Overall Study|Lost to Follow-up|1|||
127795339|NCT03847987|459874179|FG001|Overall Study|Lost to Follow-up|0|||
127795340|NCT03847987|459874178|FG000|Overall Study|Adverse Event|2|||
127795341|NCT03847987|459874179|FG001|Overall Study|Adverse Event|0|||
127795342|NCT02111564|459874182|FG000|Overall Study|Death|109|||
127795343|NCT02111564|459874183|FG001|Overall Study|Death|120|||
127795344|NCT02111564|459874182|FG000|Overall Study|Lost to Follow-up|2|||
127795345|NCT02111564|459874183|FG001|Overall Study|Lost to Follow-up|3|||
127795346|NCT02111564|459874182|FG000|Overall Study|Withdrawal by Subject|20|||
127795347|NCT02111564|459874183|FG001|Overall Study|Withdrawal by Subject|20|||
127795348|NCT00687362|459874184|FG000|Overall Study|Protocol Violation|2|||
127795349|NCT00687362|459874184|FG000|Overall Study|Withdrawal by Subject|1|||
127795350|NCT02354703|459874185|FG000|Overall Study|Withdrawal by Subject|1|||
127795351|NCT02354703|459874186|FG001|Overall Study|Withdrawal by Subject|1|||
127795352|NCT02354703|459874187|FG002|Overall Study|Withdrawal by Subject|1|||
127795353|NCT02354703|459874188|FG003|Overall Study|Withdrawal by Subject|1|||
127795354|NCT02354703|459874185|FG000|Overall Study|Lost to Follow-up|2|||
127795355|NCT02354703|459874186|FG001|Overall Study|Lost to Follow-up|7|||
127795356|NCT02354703|459874187|FG002|Overall Study|Lost to Follow-up|9|||
127795357|NCT02354703|459874188|FG003|Overall Study|Lost to Follow-up|2|||
127795358|NCT02354703|459874185|FG000|Overall Study|Adverse Event|0|||
127795359|NCT02354703|459874186|FG001|Overall Study|Adverse Event|0|||
127795360|NCT02354703|459874187|FG002|Overall Study|Adverse Event|1|||
127795361|NCT02354703|459874188|FG003|Overall Study|Adverse Event|0|||
127795362|NCT03468309|459874191|FG000|Overall Study|Lost to Follow-up|4|||
127795363|NCT03468309|459874191|FG000|Overall Study|Withdrawal by Subject|2|||
127795364|NCT01496885|459874195|FG000|Overall Study|Lost to Follow-up|13|||
127795365|NCT01496885|459874195|FG000|Overall Study|Withdrawal by Subject|7|||
127795366|NCT01496885|459874195|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
127795367|NCT01496885|459874195|FG000|Overall Study|Death|1|||
127795368|NCT03446885|459874196|FG000|Overall Study|Lost to Follow-up|1|||
127795369|NCT03446885|459874197|FG001|Overall Study|Lost to Follow-up|0|||
127630383|NCT01722331|459268306|FG003|Part 2|Pregnancy|0|||
127795370|NCT03446885|459874196|FG000|Overall Study|Did not complete entire visit|1|||
127795371|NCT03446885|459874197|FG001|Overall Study|Did not complete entire visit|0|||
127795372|NCT00252057|459874204|FG000|Overall Study|Withdrawal by Subject|2|||
127795373|NCT00252057|459874205|FG001|Overall Study|Withdrawal by Subject|5|||
127795374|NCT00252057|459874204|FG000|Overall Study|Death|1|||
127795375|NCT00252057|459874205|FG001|Overall Study|Death|2|||
127795376|NCT00252057|459874204|FG000|Overall Study|Participant previously enrolled|0|||
127795377|NCT00252057|459874205|FG001|Overall Study|Participant previously enrolled|1|||
127795378|NCT01098071|459874212|FG000|Overall Study|Surgery (adenoidectomy)|2|||
127630384|NCT01722331|459268307|FG004|Part 2|Pregnancy|0|||
127630385|NCT01722331|459268308|FG005|Part 2|Pregnancy|1|||
127630386|NCT01722331|459268309|FG006|Part 2|Pregnancy|0|||
127630387|NCT01722331|459268303|FG000|Part 2|Progressive Disease|0|||
127630388|NCT01722331|459268304|FG001|Part 2|Progressive Disease|0|||
127630389|NCT01722331|459268305|FG002|Part 2|Progressive Disease|1|||
127630390|NCT01722331|459268306|FG003|Part 2|Progressive Disease|0|||
127630391|NCT01722331|459268307|FG004|Part 2|Progressive Disease|0|||
127630392|NCT01722331|459268308|FG005|Part 2|Progressive Disease|0|||
127795379|NCT01098071|459874212|FG000|Overall Study|Lost to Follow-up|13|||
127630393|NCT01722331|459268309|FG006|Part 2|Progressive Disease|0|||
127630394|NCT01722331|459268303|FG000|Part 2|Protocol Violation|1|||
127630395|NCT01722331|459268304|FG001|Part 2|Protocol Violation|0|||
127795380|NCT01081795|459874214|FG000|Overall Study|Adverse Event|18|||
127885517|NCT04380701|460203875|FG004|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
127795381|NCT01081795|459874215|FG001|Overall Study|Adverse Event|23|||
127630396|NCT01722331|459268305|FG002|Part 2|Protocol Violation|0|||
127630397|NCT01722331|459268306|FG003|Part 2|Protocol Violation|0|||
127630398|NCT01722331|459268307|FG004|Part 2|Protocol Violation|0|||
127630399|NCT01722331|459268308|FG005|Part 2|Protocol Violation|0|||
127795382|NCT01081795|459874216|FG002|Overall Study|Adverse Event|6|||
127795383|NCT01081795|459874214|FG000|Overall Study|Lack of Efficacy|7|||
127795384|NCT01081795|459874215|FG001|Overall Study|Lack of Efficacy|5|||
127795385|NCT01081795|459874216|FG002|Overall Study|Lack of Efficacy|19|||
127630400|NCT01722331|459268309|FG006|Part 2|Protocol Violation|0|||
127795386|NCT01081795|459874214|FG000|Overall Study|Subject's schedule|1|||
127795387|NCT01081795|459874215|FG001|Overall Study|Subject's schedule|1|||
127795388|NCT01081795|459874216|FG002|Overall Study|Subject's schedule|2|||
127795389|NCT01081795|459874214|FG000|Overall Study|Revocation of informed consent|2|||
127795390|NCT01081795|459874215|FG001|Overall Study|Revocation of informed consent|0|||
127795391|NCT01081795|459874216|FG002|Overall Study|Revocation of informed consent|0|||
127795392|NCT01081795|459874214|FG000|Overall Study|Ineligible for participation|1|||
127795393|NCT01081795|459874215|FG001|Overall Study|Ineligible for participation|0|||
127795394|NCT01081795|459874216|FG002|Overall Study|Ineligible for participation|0|||
127795395|NCT01081795|459874214|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
127795396|NCT01081795|459874215|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
127795397|NCT01081795|459874216|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
127795398|NCT01081795|459874214|FG000|Overall Study|Using drug with restricted days of use|2|||
127795399|NCT01081795|459874215|FG001|Overall Study|Using drug with restricted days of use|3|||
127795400|NCT01081795|459874216|FG002|Overall Study|Using drug with restricted days of use|2|||
127795401|NCT01081795|459874214|FG000|Overall Study|Other|1|||
127795402|NCT01081795|459874215|FG001|Overall Study|Other|2|||
127795403|NCT01081795|459874216|FG002|Overall Study|Other|0|||
127795404|NCT00661271|459874217|FG000|Overall Study|Lost to Follow-up|28|||
127795405|NCT00661271|459874218|FG001|Overall Study|Lost to Follow-up|25|||
127795406|NCT01707693|459874219|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
127795407|NCT01707693|459874220|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
127795408|NCT01707693|459874219|FG000|Overall Study Allocation|Protocol Violation|4|||
127795409|NCT01707693|459874220|FG001|Overall Study Allocation|Protocol Violation|3|||
127795410|NCT01707693|459874219|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
127795411|NCT01707693|459874220|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
127795412|NCT01707693|459874219|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
127795413|NCT01707693|459874220|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
127795414|NCT00143455|459874221|FG000|Cohort 1|Adverse Event|8|||
127795415|NCT00143455|459874222|FG001|Cohort 1|Adverse Event|4|||
127795416|NCT00143455|459874223|FG002|Cohort 1|Adverse Event|0|||
127795417|NCT00143455|459874224|FG003|Cohort 1|Adverse Event|0|||
127795418|NCT00143455|459874221|FG000|Cohort 1|Death|5|||
127795419|NCT00143455|459874222|FG001|Cohort 1|Death|2|||
127795420|NCT00143455|459874223|FG002|Cohort 1|Death|0|||
127795421|NCT00143455|459874224|FG003|Cohort 1|Death|0|||
127795422|NCT00143455|459874221|FG000|Cohort 1|Progressive Disease|0|||
127795423|NCT00143455|459874222|FG001|Cohort 1|Progressive Disease|6|||
127795424|NCT00143455|459874223|FG002|Cohort 1|Progressive Disease|0|||
127795425|NCT00143455|459874224|FG003|Cohort 1|Progressive Disease|0|||
127795426|NCT00143455|459874221|FG000|Cohort 1|Withdrawal by Subject|1|||
127795427|NCT00143455|459874222|FG001|Cohort 1|Withdrawal by Subject|4|||
127795428|NCT00143455|459874223|FG002|Cohort 1|Withdrawal by Subject|0|||
127795429|NCT00143455|459874224|FG003|Cohort 1|Withdrawal by Subject|0|||
127795430|NCT00143455|459874221|FG000|Cohort 1|Randomized But Not Treated|0|||
127795431|NCT00143455|459874222|FG001|Cohort 1|Randomized But Not Treated|1|||
127795432|NCT00143455|459874223|FG002|Cohort 1|Randomized But Not Treated|0|||
127795433|NCT00143455|459874224|FG003|Cohort 1|Randomized But Not Treated|0|||
127795434|NCT00143455|459874221|FG000|Cohort 2|Adverse Event|0|||
127795435|NCT00143455|459874222|FG001|Cohort 2|Adverse Event|0|||
127795436|NCT00143455|459874223|FG002|Cohort 2|Adverse Event|42|||
127795437|NCT00143455|459874224|FG003|Cohort 2|Adverse Event|30|||
127795438|NCT00143455|459874221|FG000|Cohort 2|No Longer Required Study Treatment|0|||
127795439|NCT00143455|459874222|FG001|Cohort 2|No Longer Required Study Treatment|0|||
127795440|NCT00143455|459874223|FG002|Cohort 2|No Longer Required Study Treatment|1|||
127795441|NCT00143455|459874224|FG003|Cohort 2|No Longer Required Study Treatment|0|||
127795442|NCT00143455|459874221|FG000|Cohort 2|Protocol Violation|0|||
127795443|NCT00143455|459874222|FG001|Cohort 2|Protocol Violation|0|||
127795444|NCT00143455|459874223|FG002|Cohort 2|Protocol Violation|1|||
127795445|NCT00143455|459874224|FG003|Cohort 2|Protocol Violation|1|||
127795446|NCT00143455|459874221|FG000|Cohort 2|Lost to Follow-up|0|||
127630401|NCT01722331|459268303|FG000|Part 2|Withdrawal by Subject|5|||
127795447|NCT00143455|459874222|FG001|Cohort 2|Lost to Follow-up|0|||
127795448|NCT00143455|459874223|FG002|Cohort 2|Lost to Follow-up|1|||
127795449|NCT00143455|459874224|FG003|Cohort 2|Lost to Follow-up|4|||
127795450|NCT00143455|459874221|FG000|Cohort 2|Death|0|||
127795451|NCT00143455|459874222|FG001|Cohort 2|Death|0|||
127795452|NCT00143455|459874223|FG002|Cohort 2|Death|20|||
127795453|NCT00143455|459874224|FG003|Cohort 2|Death|12|||
127795454|NCT00143455|459874221|FG000|Cohort 2|Progressive Disease|0|||
127795455|NCT00143455|459874222|FG001|Cohort 2|Progressive Disease|0|||
127795456|NCT00143455|459874223|FG002|Cohort 2|Progressive Disease|20|||
127795457|NCT00143455|459874224|FG003|Cohort 2|Progressive Disease|27|||
127795458|NCT00143455|459874221|FG000|Cohort 2|Withdrawal by Subject|0|||
127795459|NCT00143455|459874222|FG001|Cohort 2|Withdrawal by Subject|0|||
127795460|NCT00143455|459874223|FG002|Cohort 2|Withdrawal by Subject|13|||
127630402|NCT01722331|459268304|FG001|Part 2|Withdrawal by Subject|0|||
127795461|NCT00143455|459874224|FG003|Cohort 2|Withdrawal by Subject|12|||
127630403|NCT01722331|459268305|FG002|Part 2|Withdrawal by Subject|3|||
127630404|NCT01722331|459268306|FG003|Part 2|Withdrawal by Subject|0|||
127630405|NCT01722331|459268307|FG004|Part 2|Withdrawal by Subject|0|||
127630406|NCT01722331|459268308|FG005|Part 2|Withdrawal by Subject|2|||
127630407|NCT01722331|459268309|FG006|Part 2|Withdrawal by Subject|2|||
127795462|NCT00143455|459874221|FG000|Cohort 2|Other|0|||
127795463|NCT00143455|459874222|FG001|Cohort 2|Other|0|||
127795464|NCT00143455|459874223|FG002|Cohort 2|Other|7|||
127795465|NCT00143455|459874224|FG003|Cohort 2|Other|6|||
127630408|NCT01722331|459268303|FG000|Part 2|Other Protocol Specified Criteria|6|||
127630409|NCT01722331|459268304|FG001|Part 2|Other Protocol Specified Criteria|0|||
127630410|NCT01722331|459268305|FG002|Part 2|Other Protocol Specified Criteria|10|||
127630411|NCT01722331|459268306|FG003|Part 2|Other Protocol Specified Criteria|0|||
127630412|NCT01722331|459268307|FG004|Part 2|Other Protocol Specified Criteria|0|||
127630413|NCT01722331|459268308|FG005|Part 2|Other Protocol Specified Criteria|2|||
127630414|NCT01722331|459268309|FG006|Part 2|Other Protocol Specified Criteria|1|||
127630415|NCT01722331|459268303|FG000|Part 3|Adverse Event|2|||
127795466|NCT00143455|459874221|FG000|Cohort 2|Randomized But Not Treated|0|||
127795467|NCT00143455|459874222|FG001|Cohort 2|Randomized But Not Treated|0|||
127795468|NCT00143455|459874223|FG002|Cohort 2|Randomized But Not Treated|1|||
127795469|NCT00143455|459874224|FG003|Cohort 2|Randomized But Not Treated|1|||
127630416|NCT01722331|459268304|FG001|Part 3|Adverse Event|2|||
127630417|NCT01722331|459268305|FG002|Part 3|Adverse Event|0|||
127630418|NCT01722331|459268306|FG003|Part 3|Adverse Event|1|||
127630419|NCT01722331|459268307|FG004|Part 3|Adverse Event|0|||
127630420|NCT01722331|459268308|FG005|Part 3|Adverse Event|0|||
127630421|NCT01722331|459268309|FG006|Part 3|Adverse Event|0|||
127630422|NCT01722331|459268303|FG000|Part 3|Death|1|||
127630423|NCT01722331|459268304|FG001|Part 3|Death|0|||
127630424|NCT01722331|459268305|FG002|Part 3|Death|0|||
127630425|NCT01722331|459268306|FG003|Part 3|Death|0|||
127630426|NCT01722331|459268307|FG004|Part 3|Death|0|||
127630427|NCT01722331|459268308|FG005|Part 3|Death|0|||
127795470|NCT03713944|459874225|FG000|Study Treatment|Patient non-compliance|1|||
127795471|NCT03713944|459874225|FG000|Study Treatment|Alternative Cancer Therapy|3|||
127795472|NCT03713944|459874225|FG000|Study Treatment|Disease Progression|18|||
127795473|NCT03713944|459874225|FG000|Study Treatment|AE/Side Effects/Complications|2|||
127795474|NCT03713944|459874225|FG000|Study Treatment|Death|2|||
127630428|NCT01722331|459268309|FG006|Part 3|Death|0|||
127630429|NCT01722331|459268303|FG000|Part 3|Lack of Efficacy|1|||
127630430|NCT01722331|459268304|FG001|Part 3|Lack of Efficacy|0|||
127630431|NCT01722331|459268305|FG002|Part 3|Lack of Efficacy|0|||
127630432|NCT01722331|459268306|FG003|Part 3|Lack of Efficacy|0|||
127795475|NCT03713944|459874225|FG000|Study Treatment|Withdrawal by Subject|1|||
127795476|NCT03713944|459874225|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
127795477|NCT03713944|459874225|FG000|Study Treatment|Symptomatic Deterioration|2|||
127795478|NCT03713944|459874225|FG000|Follow up|Withdrawal by Subject|2|||
127795479|NCT03713944|459874225|FG000|Follow up|Death|11|||
127795480|NCT03713944|459874225|FG000|Follow up|Study Terminated|3|||
127795481|NCT00419380|459874228|FG000|Overall Study|Lack of Efficacy|1|||
127795482|NCT00419380|459874229|FG001|Overall Study|Lack of Efficacy|7|||
127795483|NCT00419380|459874228|FG000|Overall Study|Physician Decision|0|||
127795484|NCT00419380|459874229|FG001|Overall Study|Physician Decision|1|||
127795485|NCT00419380|459874228|FG000|Overall Study|Lost to Follow-up|0|||
127795486|NCT00419380|459874229|FG001|Overall Study|Lost to Follow-up|1|||
127795487|NCT00419380|459874228|FG000|Overall Study|Withdrawal by Subject|0|||
127795488|NCT00419380|459874229|FG001|Overall Study|Withdrawal by Subject|1|||
127630433|NCT01722331|459268307|FG004|Part 3|Lack of Efficacy|0|||
127630434|NCT01722331|459268308|FG005|Part 3|Lack of Efficacy|0|||
127795489|NCT03099707|459874230|FG000|Overall Study|Withdrawal by Subject|0|||
127795490|NCT03099707|459874231|FG001|Overall Study|Withdrawal by Subject|3|||
127795491|NCT03099707|459874230|FG000|Overall Study|Lost to Follow-up|0|||
127795492|NCT03099707|459874231|FG001|Overall Study|Lost to Follow-up|1|||
127795493|NCT03861559|459874240|FG000|Overall Study|Adverse Event|0|||
127795494|NCT03861559|459874241|FG001|Overall Study|Adverse Event|2|||
127795495|NCT03861559|459874240|FG000|Overall Study|Treatment failure|0|||
127795496|NCT03861559|459874241|FG001|Overall Study|Treatment failure|2|||
127795497|NCT03861559|459874240|FG000|Overall Study|Noncompliance|1|||
127795498|NCT03861559|459874241|FG001|Overall Study|Noncompliance|1|||
127795499|NCT03861559|459874240|FG000|Overall Study|Did not meet eligibility requirements|1|||
127630435|NCT01722331|459268309|FG006|Part 3|Lack of Efficacy|0|||
127630436|NCT01722331|459268303|FG000|Part 3|Lost to Follow-up|3|||
127630437|NCT01722331|459268304|FG001|Part 3|Lost to Follow-up|4|||
127630438|NCT01722331|459268305|FG002|Part 3|Lost to Follow-up|0|||
127630439|NCT01722331|459268306|FG003|Part 3|Lost to Follow-up|0|||
127630440|NCT01722331|459268307|FG004|Part 3|Lost to Follow-up|0|||
127630441|NCT01722331|459268308|FG005|Part 3|Lost to Follow-up|1|||
127630442|NCT01722331|459268309|FG006|Part 3|Lost to Follow-up|0|||
127630443|NCT01722331|459268303|FG000|Part 3|Non-Compliance with Study Drug|0|||
127630444|NCT01722331|459268304|FG001|Part 3|Non-Compliance with Study Drug|1|||
127795500|NCT03861559|459874241|FG001|Overall Study|Did not meet eligibility requirements|0|||
127795501|NCT03652662|459874242|FG000|Overall Study|Withdrawal by Subject|2|||
127795502|NCT03652662|459874243|FG001|Overall Study|Withdrawal by Subject|1|||
127795503|NCT03652662|459874242|FG000|Overall Study|Lost to Follow-up|1|||
127795504|NCT03652662|459874243|FG001|Overall Study|Lost to Follow-up|0|||
127795505|NCT00487539|459874244|FG000|Overall Study|Adverse Event|3|||
127795506|NCT00487539|459874245|FG001|Overall Study|Adverse Event|2|||
127795507|NCT00487539|459874246|FG002|Overall Study|Adverse Event|1|||
127795508|NCT00487539|459874247|FG003|Overall Study|Adverse Event|1|||
127795509|NCT00487539|459874244|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
127795510|NCT00487539|459874245|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
127795511|NCT00487539|459874246|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
127795512|NCT00487539|459874247|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
127795513|NCT00487539|459874244|FG000|Overall Study|Other|3|||
127795514|NCT00487539|459874245|FG001|Overall Study|Other|1|||
127795515|NCT00487539|459874246|FG002|Overall Study|Other|2|||
127795516|NCT00487539|459874247|FG003|Overall Study|Other|2|||
127795517|NCT01437397|459874248|FG000|Overall Study|Lost to Follow-up|9|||
127795518|NCT01437397|459874249|FG001|Overall Study|Lost to Follow-up|4|||
127795519|NCT01437397|459874250|FG002|Overall Study|Lost to Follow-up|2|||
127795520|NCT01437397|459874251|FG003|Overall Study|Lost to Follow-up|4|||
127795521|NCT01437397|459874252|FG004|Overall Study|Lost to Follow-up|5|||
127795522|NCT01437397|459874248|FG000|Overall Study|Withdrawal by Subject|11|||
127795523|NCT01437397|459874249|FG001|Overall Study|Withdrawal by Subject|12|||
127795524|NCT01437397|459874250|FG002|Overall Study|Withdrawal by Subject|24|||
127795525|NCT01437397|459874251|FG003|Overall Study|Withdrawal by Subject|11|||
127795526|NCT01437397|459874252|FG004|Overall Study|Withdrawal by Subject|22|||
127795527|NCT01437397|459874248|FG000|Overall Study|Protocol Violation|10|||
127795528|NCT01437397|459874249|FG001|Overall Study|Protocol Violation|12|||
127795529|NCT01437397|459874250|FG002|Overall Study|Protocol Violation|13|||
127795530|NCT01437397|459874251|FG003|Overall Study|Protocol Violation|21|||
127795531|NCT01437397|459874252|FG004|Overall Study|Protocol Violation|19|||
127795532|NCT01437397|459874248|FG000|Overall Study|Lack of Efficacy|5|||
127795533|NCT01437397|459874249|FG001|Overall Study|Lack of Efficacy|4|||
127795534|NCT01437397|459874250|FG002|Overall Study|Lack of Efficacy|8|||
127795535|NCT01437397|459874251|FG003|Overall Study|Lack of Efficacy|10|||
127795536|NCT01437397|459874252|FG004|Overall Study|Lack of Efficacy|20|||
127795537|NCT01437397|459874248|FG000|Overall Study|Adverse Event|21|||
127795538|NCT01437397|459874249|FG001|Overall Study|Adverse Event|22|||
127795539|NCT01437397|459874250|FG002|Overall Study|Adverse Event|16|||
127795540|NCT01437397|459874251|FG003|Overall Study|Adverse Event|14|||
127795541|NCT01437397|459874252|FG004|Overall Study|Adverse Event|21|||
127795542|NCT01437397|459874248|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
127795543|NCT01437397|459874249|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
127630445|NCT01722331|459268305|FG002|Part 3|Non-Compliance with Study Drug|0|||
127630446|NCT01722331|459268306|FG003|Part 3|Non-Compliance with Study Drug|0|||
127795544|NCT01437397|459874250|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
127795545|NCT01437397|459874251|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
127795546|NCT01437397|459874252|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
127795547|NCT01687712|459874253|FG000|Cycle 1|Not Biochemically Pregnant|386|||
127795548|NCT01687712|459874254|FG001|Cycle 1|Not Biochemically Pregnant|348|||
127795549|NCT01687712|459874253|FG000|Cycle 1|Early Pregnancy Loss|43|||
127795550|NCT01687712|459874254|FG001|Cycle 1|Early Pregnancy Loss|60|||
127795551|NCT01687712|459874253|FG000|Cycle 1|Ectopic Pregnancy|5|||
127795552|NCT01687712|459874254|FG001|Cycle 1|Ectopic Pregnancy|5|||
127795553|NCT01687712|459874253|FG000|Cycle 1|Heterotropic Pregnancy|1|||
127795554|NCT01687712|459874254|FG001|Cycle 1|Heterotropic Pregnancy|0|||
127795555|NCT01687712|459874253|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
127795556|NCT01687712|459874254|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
127795557|NCT01687712|459874253|FG000|Cycle 1|Abortion|3|||
127795558|NCT01687712|459874254|FG001|Cycle 1|Abortion|0|||
127795559|NCT01687712|459874253|FG000|Cycle 1|Intrauterine Fetal Death|0|||
127795560|NCT01687712|459874254|FG001|Cycle 1|Intrauterine Fetal Death|1|||
127795561|NCT01687712|459874253|FG000|Cycle 1|Lost to Follow-up|1|||
127795562|NCT01687712|459874254|FG001|Cycle 1|Lost to Follow-up|1|||
127795563|NCT01687712|459874253|FG000|Cycle 2|Not Biochemically Pregnant|74|||
127795564|NCT01687712|459874254|FG001|Cycle 2|Not Biochemically Pregnant|77|||
127795565|NCT01687712|459874253|FG000|Cycle 2|Early Pregnancy Loss|18|||
127795566|NCT01687712|459874254|FG001|Cycle 2|Early Pregnancy Loss|16|||
127795567|NCT01687712|459874253|FG000|Cycle 2|Ectopic Pregnancy|0|||
127795568|NCT01687712|459874254|FG001|Cycle 2|Ectopic Pregnancy|1|||
127795569|NCT01687712|459874253|FG000|Cycle 2|Still Birth|1|||
127795570|NCT01687712|459874254|FG001|Cycle 2|Still Birth|0|||
127795571|NCT01687712|459874253|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
127795572|NCT01687712|459874254|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
127795573|NCT01687712|459874253|FG000|Cycle 3|Not Biochemically Pregnant|21|||
127795574|NCT01687712|459874254|FG001|Cycle 3|Not Biochemically Pregnant|22|||
127795575|NCT01687712|459874253|FG000|Cycle 3|Early Pregnancy Loss|1|||
127795576|NCT01687712|459874254|FG001|Cycle 3|Early Pregnancy Loss|2|||
127795577|NCT01687712|459874253|FG000|Cycle 3|Ectopic Pregnancy|1|||
127795578|NCT01687712|459874254|FG001|Cycle 3|Ectopic Pregnancy|0|||
127795579|NCT01687712|459874253|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
127795580|NCT01687712|459874254|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
127795581|NCT00371865|459874255|FG000|Overall Study|Lack of Efficacy|0|||
127795582|NCT00371865|459874256|FG001|Overall Study|Lack of Efficacy|2|||
127795583|NCT00371865|459874255|FG000|Overall Study|Protocol Violation|3|||
127795584|NCT00371865|459874256|FG001|Overall Study|Protocol Violation|2|||
127795585|NCT00371865|459874255|FG000|Overall Study|Withdrawal by Subject|12|||
127795586|NCT00371865|459874256|FG001|Overall Study|Withdrawal by Subject|10|||
127795587|NCT01632566|459874257|FG000|Overall Study|Withdrawal by Subject|0|||
127795588|NCT01632566|459874258|FG001|Overall Study|Withdrawal by Subject|1|||
127795589|NCT01632566|459874259|FG002|Overall Study|Withdrawal by Subject|0|||
127795590|NCT01632566|459874260|FG003|Overall Study|Withdrawal by Subject|0|||
127795591|NCT01632566|459874261|FG004|Overall Study|Withdrawal by Subject|0|||
127795592|NCT01632566|459874257|FG000|Overall Study|Sponsor Decision|0|||
127795593|NCT01632566|459874258|FG001|Overall Study|Sponsor Decision|2|||
127795594|NCT01632566|459874259|FG002|Overall Study|Sponsor Decision|9|||
127795595|NCT01632566|459874260|FG003|Overall Study|Sponsor Decision|2|||
127795596|NCT01632566|459874261|FG004|Overall Study|Sponsor Decision|2|||
127795597|NCT01328951|459874262|FG000|Overall Study|Disease Progression|17|||
127795598|NCT01328951|459874263|FG001|Overall Study|Disease Progression|14|||
127795599|NCT01328951|459874262|FG000|Overall Study|Adverse Event|2|||
127795600|NCT01328951|459874263|FG001|Overall Study|Adverse Event|0|||
127795601|NCT01328951|459874262|FG000|Overall Study|Death|243|||
127795602|NCT01328951|459874263|FG001|Overall Study|Death|258|||
127795603|NCT01328951|459874262|FG000|Overall Study|Lost to Follow-up|6|||
127795604|NCT01328951|459874263|FG001|Overall Study|Lost to Follow-up|7|||
127885518|NCT04380701|460203876|FG005|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
127885519|NCT04380701|460203877|FG006|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
127885520|NCT04380701|460203878|FG007|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
127885521|NCT04380701|460203879|FG008|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
127885522|NCT04380701|460203880|FG009|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
127885523|NCT04380701|460203881|FG010|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
127885524|NCT04380701|460203882|FG011|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
127795605|NCT01328951|459874262|FG000|Overall Study|Withdrawal by Subject|6|||
127795606|NCT01328951|459874263|FG001|Overall Study|Withdrawal by Subject|6|||
127795607|NCT01328951|459874262|FG000|Overall Study|Study Closed by the Sponsor|36|||
127795608|NCT01328951|459874263|FG001|Overall Study|Study Closed by the Sponsor|31|||
127795609|NCT01328951|459874262|FG000|Overall Study|Other|11|||
127795610|NCT01328951|459874263|FG001|Overall Study|Other|6|||
127795611|NCT01003210|459874267|FG000|Overall Study|Lost to Follow-up|1|||
127795612|NCT01003210|459874268|FG001|Overall Study|Lost to Follow-up|3|||
127795613|NCT00271817|459874269|FG000|Part 1|Adverse Event|68|||
127795614|NCT00271817|459874270|FG001|Part 1|Adverse Event|25|||
127795615|NCT00271817|459874271|FG002|Part 1|Adverse Event|156|||
127795616|NCT00271817|459874269|FG000|Part 1|Lost to Follow-up|6|||
127795617|NCT00271817|459874270|FG001|Part 1|Lost to Follow-up|8|||
127795618|NCT00271817|459874271|FG002|Part 1|Lost to Follow-up|24|||
127795619|NCT00271817|459874269|FG000|Part 1|Protocol Violation|5|||
127795620|NCT00271817|459874270|FG001|Part 1|Protocol Violation|4|||
127795621|NCT00271817|459874271|FG002|Part 1|Protocol Violation|7|||
127795622|NCT00271817|459874269|FG000|Part 1|Patient Moved|3|||
127795623|NCT00271817|459874270|FG001|Part 1|Patient Moved|1|||
127795624|NCT00271817|459874271|FG002|Part 1|Patient Moved|5|||
127795625|NCT00271817|459874269|FG000|Part 1|Withdrawal by Subject|23|||
127795626|NCT00271817|459874270|FG001|Part 1|Withdrawal by Subject|17|||
127795627|NCT00271817|459874271|FG002|Part 1|Withdrawal by Subject|45|||
127795628|NCT00271817|459874269|FG000|Part 1|LDL < 50 mg/dL|1|||
127795629|NCT00271817|459874270|FG001|Part 1|LDL < 50 mg/dL|4|||
127795630|NCT00271817|459874271|FG002|Part 1|LDL < 50 mg/dL|48|||
127795631|NCT00271817|459874269|FG000|Part 2|Adverse Event|0|||
127795632|NCT00271817|459874270|FG001|Part 2|Adverse Event|17|||
127795633|NCT00271817|459874271|FG002|Part 2|Adverse Event|33|||
127795634|NCT00271817|459874269|FG000|Part 2|Lack of Efficacy|0|||
127795635|NCT00271817|459874270|FG001|Part 2|Lack of Efficacy|1|||
127795636|NCT00271817|459874271|FG002|Part 2|Lack of Efficacy|6|||
127795637|NCT00271817|459874269|FG000|Part 2|Lost to Follow-up|0|||
127795638|NCT00271817|459874270|FG001|Part 2|Lost to Follow-up|6|||
127795639|NCT00271817|459874271|FG002|Part 2|Lost to Follow-up|18|||
127795640|NCT00271817|459874269|FG000|Part 2|Protocol Violation|0|||
127795641|NCT00271817|459874270|FG001|Part 2|Protocol Violation|3|||
127795642|NCT00271817|459874271|FG002|Part 2|Protocol Violation|5|||
127795643|NCT00271817|459874269|FG000|Part 2|Patient Moved|0|||
127795644|NCT00271817|459874270|FG001|Part 2|Patient Moved|0|||
127795645|NCT00271817|459874271|FG002|Part 2|Patient Moved|5|||
127795646|NCT00271817|459874269|FG000|Part 2|Withdrawal by Subject|0|||
127795647|NCT00271817|459874270|FG001|Part 2|Withdrawal by Subject|2|||
127795648|NCT00271817|459874271|FG002|Part 2|Withdrawal by Subject|13|||
127795649|NCT00271817|459874269|FG000|Part 2|LDL < 50 mg/dL|0|||
127795650|NCT00271817|459874270|FG001|Part 2|LDL < 50 mg/dL|3|||
127795651|NCT00271817|459874271|FG002|Part 2|LDL < 50 mg/dL|4|||
127795652|NCT04153188|459874274|FG000|Overall Study|Lost to Follow-up|1|||
127795653|NCT04153188|459874275|FG001|Overall Study|Lost to Follow-up|1|||
127795654|NCT04153188|459874274|FG000|Overall Study|Withdrawal by Subject|2|||
127795655|NCT04153188|459874275|FG001|Overall Study|Withdrawal by Subject|0|||
127795656|NCT04153188|459874274|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
127795657|NCT04153188|459874275|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
127795658|NCT00264238|459874277|FG000|Overall Study|Protocol Violation|1|||
127630447|NCT01722331|459268307|FG004|Part 3|Non-Compliance with Study Drug|0|||
127630448|NCT01722331|459268308|FG005|Part 3|Non-Compliance with Study Drug|0|||
127630449|NCT01722331|459268309|FG006|Part 3|Non-Compliance with Study Drug|0|||
127795659|NCT00700271|459874278|FG000|Overall Study|Adverse Event|4|||
127795660|NCT00700271|459874279|FG001|Overall Study|Adverse Event|6|||
127795661|NCT00700271|459874278|FG000|Overall Study|Protocol Violation|1|||
127795662|NCT00700271|459874279|FG001|Overall Study|Protocol Violation|0|||
127795663|NCT00700271|459874278|FG000|Overall Study|Administrative Reasons|1|||
127795664|NCT00700271|459874279|FG001|Overall Study|Administrative Reasons|0|||
127795665|NCT00700271|459874278|FG000|Overall Study|Withdrawal by Subject|6|||
127795666|NCT00700271|459874279|FG001|Overall Study|Withdrawal by Subject|4|||
127795667|NCT00700271|459874278|FG000|Overall Study|Lost to Follow-up|2|||
127795668|NCT00700271|459874279|FG001|Overall Study|Lost to Follow-up|2|||
127795669|NCT00861744|459874280|FG000|Overall Study|Adverse Event|0|||
127795670|NCT00861744|459874281|FG001|Overall Study|Adverse Event|0|||
127795671|NCT00861744|459874282|FG002|Overall Study|Adverse Event|0|||
127795672|NCT00861744|459874283|FG003|Overall Study|Adverse Event|1|||
127795673|NCT00861744|459874280|FG000|Overall Study|Lost to Follow-up|7|||
127795674|NCT00861744|459874281|FG001|Overall Study|Lost to Follow-up|19|||
127795675|NCT00861744|459874282|FG002|Overall Study|Lost to Follow-up|17|||
127795676|NCT00861744|459874283|FG003|Overall Study|Lost to Follow-up|12|||
127795677|NCT00861744|459874280|FG000|Overall Study|Withdrawal by Subject|10|||
127795678|NCT00861744|459874281|FG001|Overall Study|Withdrawal by Subject|6|||
127795679|NCT00861744|459874282|FG002|Overall Study|Withdrawal by Subject|6|||
127795680|NCT00861744|459874283|FG003|Overall Study|Withdrawal by Subject|19|||
127795681|NCT00861744|459874280|FG000|Overall Study|Protocol Violation|0|||
127795682|NCT00861744|459874281|FG001|Overall Study|Protocol Violation|1|||
127630450|NCT01722331|459268303|FG000|Part 3|Physician Decision|1|||
127630451|NCT01722331|459268304|FG001|Part 3|Physician Decision|1|||
127630452|NCT01722331|459268305|FG002|Part 3|Physician Decision|0|||
127630453|NCT01722331|459268306|FG003|Part 3|Physician Decision|0|||
127630454|NCT01722331|459268307|FG004|Part 3|Physician Decision|0|||
127630455|NCT01722331|459268308|FG005|Part 3|Physician Decision|0|||
127795683|NCT00861744|459874282|FG002|Overall Study|Protocol Violation|0|||
127795684|NCT00861744|459874283|FG003|Overall Study|Protocol Violation|0|||
127795685|NCT00861744|459874280|FG000|Overall Study|Migration from study area|0|||
127795686|NCT00861744|459874281|FG001|Overall Study|Migration from study area|3|||
127795687|NCT00861744|459874282|FG002|Overall Study|Migration from study area|1|||
127795688|NCT00861744|459874283|FG003|Overall Study|Migration from study area|0|||
127795689|NCT00861744|459874280|FG000|Overall Study|Blood draws|0|||
127795690|NCT00861744|459874281|FG001|Overall Study|Blood draws|0|||
127795691|NCT00861744|459874282|FG002|Overall Study|Blood draws|0|||
127795692|NCT00861744|459874283|FG003|Overall Study|Blood draws|1|||
127795693|NCT05107765|459874284|FG000|Overall Study|Lost to Follow-up|4|||
127795694|NCT05107765|459874285|FG001|Overall Study|Lost to Follow-up|1|||
127795695|NCT05107765|459874284|FG000|Overall Study|Withdrawn by investigator due to non-compliance|1|||
127795696|NCT05107765|459874285|FG001|Overall Study|Withdrawn by investigator due to non-compliance|0|||
127795697|NCT05107765|459874284|FG000|Overall Study|Withdrawal by Subjects due to scheduling issues|6|||
127795698|NCT05107765|459874285|FG001|Overall Study|Withdrawal by Subjects due to scheduling issues|3|||
127795699|NCT01411085|459874288|FG000|Overall Study|Physician Decision|1|||
127795700|NCT01411085|459874288|FG000|Overall Study|Protocol Violation|1|||
127795701|NCT01411085|459874288|FG000|Overall Study|Adverse Event|1|||
127795702|NCT03809611|459874289|FG000|Overall Study|Withdrawal by Subject|1|||
127795703|NCT03809611|459874290|FG001|Overall Study|Withdrawal by Subject|1|||
127795704|NCT02926950|459874291|FG000|Overall Study|Adverse Event|4|||
127795705|NCT02926950|459874292|FG001|Overall Study|Adverse Event|6|||
127795706|NCT02926950|459874291|FG000|Overall Study|At the participant's own request|21|||
127795707|NCT02926950|459874292|FG001|Overall Study|At the participant's own request|25|||
127795708|NCT02926950|459874291|FG000|Overall Study|Reason not Specified|17|||
127795709|NCT02926950|459874292|FG001|Overall Study|Reason not Specified|9|||
127795710|NCT02926950|459874291|FG000|Overall Study|Lost to Follow-up|7|||
127795711|NCT02926950|459874292|FG001|Overall Study|Lost to Follow-up|8|||
127795712|NCT03368170|459875918|FG000|Overall Study|Adverse Event|2|||
127795713|NCT03368170|459875919|FG001|Overall Study|Adverse Event|1|||
127795714|NCT02068547|459875920|FG000|Overall Study|Lost to Follow-up|3|||
127795715|NCT02068547|459875921|FG001|Overall Study|Lost to Follow-up|3|||
127795716|NCT02068547|459875920|FG000|Overall Study|Physician Decision|1|||
127795717|NCT02068547|459875921|FG001|Overall Study|Physician Decision|0|||
127795718|NCT01662440|459875929|FG000|Overall Study|Adverse Event|1|||
127795719|NCT01662440|459875930|FG001|Overall Study|Adverse Event|0|||
127795720|NCT01662440|459875931|FG002|Overall Study|Adverse Event|0|||
127795721|NCT01662440|459875932|FG003|Overall Study|Adverse Event|1|||
127630456|NCT01722331|459268309|FG006|Part 3|Physician Decision|1|||
127630457|NCT01722331|459268303|FG000|Part 3|Protocol Violation|2|||
127630458|NCT01722331|459268304|FG001|Part 3|Protocol Violation|1|||
127630459|NCT01722331|459268305|FG002|Part 3|Protocol Violation|0|||
127630460|NCT01722331|459268306|FG003|Part 3|Protocol Violation|0|||
127630461|NCT01722331|459268307|FG004|Part 3|Protocol Violation|0|||
127630462|NCT01722331|459268308|FG005|Part 3|Protocol Violation|0|||
127630463|NCT01722331|459268309|FG006|Part 3|Protocol Violation|0|||
127630464|NCT01722331|459268303|FG000|Part 3|Withdrawal by Subject|4|||
127630465|NCT01722331|459268304|FG001|Part 3|Withdrawal by Subject|7|||
127630466|NCT01722331|459268305|FG002|Part 3|Withdrawal by Subject|0|||
127630467|NCT01722331|459268306|FG003|Part 3|Withdrawal by Subject|0|||
127630468|NCT01722331|459268307|FG004|Part 3|Withdrawal by Subject|0|||
127630469|NCT01722331|459268308|FG005|Part 3|Withdrawal by Subject|2|||
127630470|NCT01722331|459268309|FG006|Part 3|Withdrawal by Subject|1|||
127630471|NCT01722331|459268303|FG000|Part 3|Other Protocol Specified Criteria|1|||
127630472|NCT01722331|459268304|FG001|Part 3|Other Protocol Specified Criteria|1|||
127630473|NCT01722331|459268305|FG002|Part 3|Other Protocol Specified Criteria|0|||
127795722|NCT01662440|459875929|FG000|Overall Study|Death|0|||
127795723|NCT01662440|459875930|FG001|Overall Study|Death|1|||
127795724|NCT01662440|459875931|FG002|Overall Study|Death|0|||
127795725|NCT01662440|459875932|FG003|Overall Study|Death|0|||
127630474|NCT01722331|459268306|FG003|Part 3|Other Protocol Specified Criteria|0|||
127630475|NCT01722331|459268307|FG004|Part 3|Other Protocol Specified Criteria|0|||
127630476|NCT01722331|459268308|FG005|Part 3|Other Protocol Specified Criteria|0|||
127795726|NCT01662440|459875929|FG000|Overall Study|Lost to Follow-up|2|||
127795727|NCT01662440|459875930|FG001|Overall Study|Lost to Follow-up|2|||
127795728|NCT01662440|459875931|FG002|Overall Study|Lost to Follow-up|4|||
127795729|NCT01662440|459875932|FG003|Overall Study|Lost to Follow-up|1|||
127630477|NCT01722331|459268309|FG006|Part 3|Other Protocol Specified Criteria|0|||
127630478|NCT00262834|459268310|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
127630479|NCT00262834|459268311|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
127630480|NCT00003457|459268312|FG000|Overall Study|Not evaluable|9|||
127795730|NCT01662440|459875929|FG000|Overall Study|Subject moved to another country.|0|||
127630481|NCT02525133|459268318|FG000|Overall Study|Adverse Event|0|||
127630482|NCT02525133|459268319|FG001|Overall Study|Adverse Event|1|||
127630483|NCT02525133|459268318|FG000|Overall Study|Death|0|||
127630484|NCT02525133|459268319|FG001|Overall Study|Death|1|||
127630485|NCT02525133|459268318|FG000|Overall Study|did not meet randomization criteria|1|||
127630486|NCT02525133|459268319|FG001|Overall Study|did not meet randomization criteria|0|||
127630487|NCT02525133|459268318|FG000|Overall Study|Lost to Follow-up|5|||
127630488|NCT02525133|459268319|FG001|Overall Study|Lost to Follow-up|1|||
127630489|NCT02525133|459268318|FG000|Overall Study|randomized not enrolled|3|||
127630490|NCT02525133|459268319|FG001|Overall Study|randomized not enrolled|0|||
127630491|NCT02525133|459268318|FG000|Overall Study|Withdrawal by Subject|1|||
127630492|NCT02525133|459268319|FG001|Overall Study|Withdrawal by Subject|0|||
127630493|NCT04265755|459268320|FG000|Overall Study|Withdrawal by Subject|39|||
127630494|NCT04265755|459268320|FG000|Overall Study|Decision by sponsor|2|||
127630495|NCT04265755|459268320|FG000|Overall Study|Lost to Follow-up|11|||
127630496|NCT04265755|459268320|FG000|Overall Study|Death|1|||
127630497|NCT00633984|459268321|FG000|Overall Study|Lost to Follow-up|0|||
127630498|NCT00633984|459268322|FG001|Overall Study|Lost to Follow-up|6|||
127630499|NCT00633984|459268321|FG000|Overall Study|Withdrawal by Subject|8|||
127630500|NCT00633984|459268322|FG001|Overall Study|Withdrawal by Subject|7|||
127630501|NCT00633984|459268321|FG000|Overall Study|Hospitalized|1|||
127630502|NCT00633984|459268322|FG001|Overall Study|Hospitalized|0|||
127630503|NCT02496884|459268323|FG000|Overall Study|Counted twice as enrolled|2|||
127630504|NCT02496884|459268324|FG001|Overall Study|Counted twice as enrolled|0|||
127630505|NCT02496884|459268325|FG002|Overall Study|Counted twice as enrolled|0|||
127630506|NCT02496884|459268326|FG003|Overall Study|Counted twice as enrolled|0|||
127630507|NCT02496884|459268323|FG000|Overall Study|Withdrawal by Subject|0|||
127630508|NCT02496884|459268324|FG001|Overall Study|Withdrawal by Subject|3|||
127630509|NCT02496884|459268325|FG002|Overall Study|Withdrawal by Subject|0|||
127630510|NCT02496884|459268326|FG003|Overall Study|Withdrawal by Subject|0|||
127630511|NCT01033747|459268327|FG000|Overall Study|Adverse Event|9|||
127630512|NCT01033747|459268328|FG001|Overall Study|Adverse Event|4|||
127630513|NCT01033747|459268327|FG000|Overall Study|Abnormal Laboratory Value|1|||
127630514|NCT01033747|459268328|FG001|Overall Study|Abnormal Laboratory Value|0|||
127630515|NCT01033747|459268327|FG000|Overall Study|Abnormal test procedure|0|||
127630516|NCT01033747|459268328|FG001|Overall Study|Abnormal test procedure|1|||
127630517|NCT01033747|459268327|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
127630518|NCT01033747|459268328|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
127630519|NCT01033747|459268327|FG000|Overall Study|Protocol Violation|1|||
127630520|NCT01033747|459268328|FG001|Overall Study|Protocol Violation|0|||
127630521|NCT01033747|459268327|FG000|Overall Study|Withdrawal by Subject|9|||
127630522|NCT01033747|459268328|FG001|Overall Study|Withdrawal by Subject|6|||
127630523|NCT01033747|459268327|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
127630524|NCT01033747|459268328|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
127630525|NCT01033747|459268327|FG000|Overall Study|Stopped at end of Extension 1|2|||
127630526|NCT01033747|459268328|FG001|Overall Study|Stopped at end of Extension 1|0|||
127630527|NCT02956629|459268329|FG000|Overall Study|Adverse Event|0|||
127630528|NCT02956629|459268330|FG001|Overall Study|Adverse Event|0|||
127630529|NCT02956629|459268331|FG002|Overall Study|Adverse Event|1|||
127630530|NCT02956629|459268332|FG003|Overall Study|Adverse Event|0|||
127630531|NCT02956629|459268333|FG004|Overall Study|Adverse Event|0|||
127630532|NCT02956629|459268334|FG005|Overall Study|Adverse Event|0|||
127630533|NCT02956629|459268329|FG000|Overall Study|Lost to Follow-up|2|||
127630534|NCT02956629|459268330|FG001|Overall Study|Lost to Follow-up|5|||
127630535|NCT02956629|459268331|FG002|Overall Study|Lost to Follow-up|3|||
127630536|NCT02956629|459268332|FG003|Overall Study|Lost to Follow-up|1|||
127630537|NCT02956629|459268333|FG004|Overall Study|Lost to Follow-up|0|||
127630538|NCT02956629|459268334|FG005|Overall Study|Lost to Follow-up|1|||
127630539|NCT02956629|459268329|FG000|Overall Study|Withdrawal by Subject|3|||
127630540|NCT02956629|459268330|FG001|Overall Study|Withdrawal by Subject|1|||
127630541|NCT02956629|459268331|FG002|Overall Study|Withdrawal by Subject|0|||
127630542|NCT02956629|459268332|FG003|Overall Study|Withdrawal by Subject|0|||
127630543|NCT02956629|459268333|FG004|Overall Study|Withdrawal by Subject|0|||
127630544|NCT02956629|459268334|FG005|Overall Study|Withdrawal by Subject|0|||
127630545|NCT00803023|459268339|FG000|Overall Study|Adverse Event|5|||
127630546|NCT00803023|459268340|FG001|Overall Study|Adverse Event|4|||
127630547|NCT00803023|459268341|FG002|Overall Study|Adverse Event|8|||
127630548|NCT00803023|459268342|FG003|Overall Study|Adverse Event|6|||
127630549|NCT00803023|459268339|FG000|Overall Study|Withdrawal by Subject|0|||
127630550|NCT00803023|459268340|FG001|Overall Study|Withdrawal by Subject|2|||
127630551|NCT00803023|459268341|FG002|Overall Study|Withdrawal by Subject|0|||
127630552|NCT00803023|459268342|FG003|Overall Study|Withdrawal by Subject|0|||
127630553|NCT00803023|459268339|FG000|Overall Study|Lost to Follow-up|0|||
127630554|NCT00803023|459268340|FG001|Overall Study|Lost to Follow-up|1|||
127630555|NCT00803023|459268341|FG002|Overall Study|Lost to Follow-up|2|||
127630556|NCT00803023|459268342|FG003|Overall Study|Lost to Follow-up|1|||
127630557|NCT00803023|459268339|FG000|Overall Study|Lack of Efficacy|0|||
127630558|NCT00803023|459268340|FG001|Overall Study|Lack of Efficacy|1|||
127630559|NCT00803023|459268341|FG002|Overall Study|Lack of Efficacy|1|||
127630560|NCT00803023|459268342|FG003|Overall Study|Lack of Efficacy|1|||
127630561|NCT01931839|459268345|FG000|Overall Study|Death|0|||
127630562|NCT01931839|459268346|FG001|Overall Study|Death|1|||
127630563|NCT01931839|459268347|FG002|Overall Study|Death|2|||
127630564|NCT01931839|459268348|FG003|Overall Study|Death|0|||
127630565|NCT01931839|459268349|FG004|Overall Study|Death|0|||
127630566|NCT01931839|459268350|FG005|Overall Study|Death|0|||
127630567|NCT01931839|459268351|FG006|Overall Study|Death|0|||
127630568|NCT01931839|459268345|FG000|Overall Study|Physician Decision|1|||
127630569|NCT01931839|459268346|FG001|Overall Study|Physician Decision|0|||
127630570|NCT01931839|459268347|FG002|Overall Study|Physician Decision|1|||
127630571|NCT01931839|459268348|FG003|Overall Study|Physician Decision|0|||
127630572|NCT01931839|459268349|FG004|Overall Study|Physician Decision|0|||
127630573|NCT01931839|459268350|FG005|Overall Study|Physician Decision|0|||
127630574|NCT01931839|459268351|FG006|Overall Study|Physician Decision|1|||
127630575|NCT01931839|459268345|FG000|Overall Study|Withdrawal of consent|0|||
127630576|NCT01931839|459268346|FG001|Overall Study|Withdrawal of consent|0|||
127630577|NCT01931839|459268347|FG002|Overall Study|Withdrawal of consent|0|||
127630578|NCT01931839|459268348|FG003|Overall Study|Withdrawal of consent|0|||
127630579|NCT01931839|459268349|FG004|Overall Study|Withdrawal of consent|1|||
127630580|NCT01931839|459268350|FG005|Overall Study|Withdrawal of consent|0|||
127630581|NCT01931839|459268351|FG006|Overall Study|Withdrawal of consent|0|||
127630582|NCT01931839|459268345|FG000|Overall Study|Adverse Event|9|||
127630583|NCT01931839|459268346|FG001|Overall Study|Adverse Event|4|||
127630584|NCT01931839|459268347|FG002|Overall Study|Adverse Event|1|||
127630585|NCT01931839|459268348|FG003|Overall Study|Adverse Event|3|||
127630586|NCT01931839|459268349|FG004|Overall Study|Adverse Event|0|||
127630587|NCT01931839|459268350|FG005|Overall Study|Adverse Event|0|||
127630588|NCT01931839|459268351|FG006|Overall Study|Adverse Event|1|||
127630589|NCT01931839|459268345|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
127630590|NCT01931839|459268346|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
127630591|NCT01931839|459268347|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
127630592|NCT01931839|459268348|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
127630593|NCT01931839|459268349|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
127630594|NCT01931839|459268350|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
127630595|NCT01931839|459268351|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
127630596|NCT01931839|459268345|FG000|Overall Study|Other non-compliance|15|||
127630597|NCT01931839|459268346|FG001|Overall Study|Other non-compliance|9|||
127630598|NCT01931839|459268347|FG002|Overall Study|Other non-compliance|12|||
127630599|NCT01931839|459268348|FG003|Overall Study|Other non-compliance|3|||
127630600|NCT01931839|459268349|FG004|Overall Study|Other non-compliance|0|||
127630601|NCT01931839|459268350|FG005|Overall Study|Other non-compliance|3|||
127630602|NCT01931839|459268351|FG006|Overall Study|Other non-compliance|0|||
127630603|NCT01931839|459268345|FG000|Overall Study|Lost to Follow-up|1|||
127630604|NCT01931839|459268346|FG001|Overall Study|Lost to Follow-up|2|||
127630605|NCT01931839|459268347|FG002|Overall Study|Lost to Follow-up|4|||
127630606|NCT01931839|459268348|FG003|Overall Study|Lost to Follow-up|5|||
127630607|NCT01931839|459268349|FG004|Overall Study|Lost to Follow-up|0|||
127630608|NCT01931839|459268350|FG005|Overall Study|Lost to Follow-up|0|||
127630609|NCT01931839|459268351|FG006|Overall Study|Lost to Follow-up|0|||
127630610|NCT01931839|459268345|FG000|Overall Study|Other|4|||
127630611|NCT01931839|459268346|FG001|Overall Study|Other|2|||
127630612|NCT01931839|459268347|FG002|Overall Study|Other|6|||
127630613|NCT01931839|459268348|FG003|Overall Study|Other|0|||
127630614|NCT01931839|459268349|FG004|Overall Study|Other|0|||
127630615|NCT01931839|459268350|FG005|Overall Study|Other|0|||
127630616|NCT01931839|459268351|FG006|Overall Study|Other|0|||
127630617|NCT01762761|459268354|FG000|Overall Study|Adverse Event|15|||
127630618|NCT01762761|459268355|FG001|Overall Study|Adverse Event|17|||
127630619|NCT01762761|459268354|FG000|Overall Study|Lack of Efficacy|9|||
127630620|NCT01762761|459268355|FG001|Overall Study|Lack of Efficacy|25|||
127630621|NCT01762761|459268354|FG000|Overall Study|Protocol Violation|1|||
127630622|NCT01762761|459268355|FG001|Overall Study|Protocol Violation|1|||
127630623|NCT01762761|459268354|FG000|Overall Study|Study closed/terminated|0|||
127630624|NCT01762761|459268355|FG001|Overall Study|Study closed/terminated|2|||
127630625|NCT01762761|459268354|FG000|Overall Study|Lost to Follow-up|3|||
127630626|NCT01762761|459268355|FG001|Overall Study|Lost to Follow-up|6|||
127630627|NCT01762761|459268354|FG000|Overall Study|Physician Decision|4|||
127630628|NCT01762761|459268355|FG001|Overall Study|Physician Decision|6|||
127885525|NCT04380701|460203883|FG012|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
127885526|NCT04380701|460203884|FG013|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
127630629|NCT01762761|459268354|FG000|Overall Study|Withdrawal by Subject|7|||
127630630|NCT01762761|459268355|FG001|Overall Study|Withdrawal by Subject|8|||
127630631|NCT02317575|459268362|FG000|Period 1|Difficulty with venous cannulation|0|||
127630632|NCT02317575|459268363|FG001|Period 1|Difficulty with venous cannulation|1|||
127630633|NCT02317575|459268364|FG002|Period 1|Difficulty with venous cannulation|0|||
127630634|NCT02317575|459268365|FG003|Period 1|Difficulty with venous cannulation|0|||
127630635|NCT02317575|459268366|FG004|Period 1|Difficulty with venous cannulation|0|||
127630636|NCT02317575|459268362|FG000|Period 1|Withdrawal by Subject|1|||
127630637|NCT02317575|459268363|FG001|Period 1|Withdrawal by Subject|0|||
127630638|NCT02317575|459268364|FG002|Period 1|Withdrawal by Subject|0|||
127630639|NCT02317575|459268365|FG003|Period 1|Withdrawal by Subject|0|||
127630640|NCT02317575|459268366|FG004|Period 1|Withdrawal by Subject|0|||
127630641|NCT01114646|459268367|FG000|Overall Study|Withdrawal by Subject|3|||
127630642|NCT01114646|459268368|FG001|Overall Study|Withdrawal by Subject|2|||
127630643|NCT04079933|459268376|FG000|Overall Study|Withdrawal by Subject|3|||
127630644|NCT04079933|459268377|FG001|Overall Study|Withdrawal by Subject|4|||
127630645|NCT04079933|459268376|FG000|Overall Study|Lost to Follow-up|0|||
127630646|NCT04079933|459268377|FG001|Overall Study|Lost to Follow-up|1|||
127630647|NCT01229436|459268378|FG000|Overall Study|Withdrawal by Subject|2|||
127630648|NCT01229436|459268378|FG000|Overall Study|Lost to Follow-up|3|||
127630649|NCT00345579|459268392|FG000|Overall Study|Adverse Event|9|||
127630650|NCT00345579|459268393|FG001|Overall Study|Adverse Event|6|||
127630651|NCT00345579|459268392|FG000|Overall Study|Protocol Violation|14|||
127630652|NCT00345579|459268393|FG001|Overall Study|Protocol Violation|5|||
127630653|NCT00345579|459268392|FG000|Overall Study|Withdrawal by Subject|50|||
127630654|NCT00345579|459268393|FG001|Overall Study|Withdrawal by Subject|17|||
127630655|NCT00345579|459268392|FG000|Overall Study|Lost to Follow-up|82|||
127630656|NCT00345579|459268393|FG001|Overall Study|Lost to Follow-up|36|||
127630657|NCT00345579|459268392|FG000|Overall Study|Other|9|||
127630658|NCT00345579|459268393|FG001|Overall Study|Other|1|||
127630659|NCT01731171|459268394|FG000|Overall Study|Withdrawal by Subject|4|||
127630660|NCT01731171|459268395|FG001|Overall Study|Withdrawal by Subject|1|||
127630661|NCT01731171|459268394|FG000|Overall Study|Lost to Follow-up|3|||
127630662|NCT01731171|459268395|FG001|Overall Study|Lost to Follow-up|2|||
127630663|NCT01731171|459268394|FG000|Overall Study|Moved out of Area|0|||
127630664|NCT01731171|459268395|FG001|Overall Study|Moved out of Area|2|||
127630665|NCT01731171|459268394|FG000|Overall Study|Terminated for Lack of Adherence|0|||
127630666|NCT01731171|459268395|FG001|Overall Study|Terminated for Lack of Adherence|1|||
127630667|NCT01731171|459268394|FG000|Overall Study|Terminated for Safety Reasons|0|||
127630668|NCT01731171|459268395|FG001|Overall Study|Terminated for Safety Reasons|1|||
127630669|NCT00413413|459268396|FG000|Single-Blind|Adverse Event|0|||
127630670|NCT00413413|459268397|FG001|Single-Blind|Adverse Event|9|||
127630671|NCT00413413|459268398|FG002|Single-Blind|Adverse Event|0|||
127630672|NCT00413413|459268396|FG000|Single-Blind|Lack of Efficacy|0|||
127630673|NCT00413413|459268397|FG001|Single-Blind|Lack of Efficacy|5|||
127630674|NCT00413413|459268398|FG002|Single-Blind|Lack of Efficacy|0|||
127630675|NCT00413413|459268396|FG000|Single-Blind|Subject no longer requires study drug|0|||
127630676|NCT00413413|459268397|FG001|Single-Blind|Subject no longer requires study drug|151|||
127630677|NCT00413413|459268398|FG002|Single-Blind|Subject no longer requires study drug|0|||
127630678|NCT00413413|459268396|FG000|Single-Blind|Protocol Violation|0|||
127630679|NCT00413413|459268397|FG001|Single-Blind|Protocol Violation|16|||
127630680|NCT00413413|459268398|FG002|Single-Blind|Protocol Violation|0|||
127630681|NCT00413413|459268396|FG000|Single-Blind|Withdrawal by Subject|0|||
127630682|NCT00413413|459268397|FG001|Single-Blind|Withdrawal by Subject|27|||
127630683|NCT00413413|459268398|FG002|Single-Blind|Withdrawal by Subject|0|||
127630684|NCT00413413|459268396|FG000|Single-Blind|Lost to Follow-up|0|||
127630685|NCT00413413|459268397|FG001|Single-Blind|Lost to Follow-up|8|||
127630686|NCT00413413|459268398|FG002|Single-Blind|Lost to Follow-up|0|||
127630687|NCT00413413|459268396|FG000|Double-Blind|Adverse Event|6|||
127630688|NCT00413413|459268397|FG001|Double-Blind|Adverse Event|0|||
127630689|NCT00413413|459268398|FG002|Double-Blind|Adverse Event|5|||
127630690|NCT00413413|459268396|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
127630691|NCT00413413|459268397|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
127630692|NCT00413413|459268398|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
127630693|NCT00413413|459268396|FG000|Double-Blind|Protocol deviation|1|||
127630694|NCT00413413|459268397|FG001|Double-Blind|Protocol deviation|2|||
127630695|NCT00413413|459268398|FG002|Double-Blind|Protocol deviation|1|||
127630696|NCT00413413|459268396|FG000|Double-Blind|Subject withdrew consent|4|||
127630697|NCT00413413|459268397|FG001|Double-Blind|Subject withdrew consent|6|||
127630698|NCT00413413|459268398|FG002|Double-Blind|Subject withdrew consent|9|||
127630699|NCT00413413|459268396|FG000|Double-Blind|Lost to Follow-up|3|||
127630700|NCT00413413|459268397|FG001|Double-Blind|Lost to Follow-up|4|||
127630701|NCT00413413|459268398|FG002|Double-Blind|Lost to Follow-up|2|||
127630702|NCT03207750|459268401|FG000|Overall Study|Adverse Event|3|||
127630703|NCT03207750|459268402|FG001|Overall Study|Adverse Event|2|||
127630704|NCT03207750|459268401|FG000|Overall Study|Lost to Follow-up|21|||
127630705|NCT03207750|459268402|FG001|Overall Study|Lost to Follow-up|29|||
127630706|NCT03207750|459268401|FG000|Overall Study|Protocol Violation|0|||
127630707|NCT03207750|459268402|FG001|Overall Study|Protocol Violation|1|||
127630708|NCT03207750|459268401|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
127630709|NCT03207750|459268402|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
127630710|NCT03207750|459268401|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
127795731|NCT01662440|459875930|FG001|Overall Study|Subject moved to another country.|1|||
127630711|NCT03207750|459268402|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
127630712|NCT03207750|459268401|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
127630713|NCT03207750|459268402|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
127630714|NCT03207750|459268401|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
127630715|NCT03207750|459268402|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
127630716|NCT03207750|459268401|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
127630717|NCT03207750|459268402|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
127630718|NCT02604589|459268407|FG000|Overall Study|catheter dislodgement|0|||
127630719|NCT02604589|459268408|FG001|Overall Study|catheter dislodgement|0|||
127630720|NCT02604589|459268409|FG002|Overall Study|catheter dislodgement|1|||
127630721|NCT00793910|459268410|FG000|Overall Study|discarded study pills|0|||
127630722|NCT00793910|459268411|FG001|Overall Study|discarded study pills|1|||
127630723|NCT00793910|459268410|FG000|Overall Study|did not pick up medications|1|||
127630724|NCT00793910|459268411|FG001|Overall Study|did not pick up medications|1|||
127630725|NCT00793910|459268410|FG000|Overall Study|ineligible based on entry criteria|2|||
127630726|NCT00793910|459268411|FG001|Overall Study|ineligible based on entry criteria|3|||
127630727|NCT00793910|459268410|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
127630728|NCT00793910|459268411|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
127630729|NCT00793910|459268410|FG000|Overall Study|Withdrawal by Subject|0|||
127630730|NCT00793910|459268411|FG001|Overall Study|Withdrawal by Subject|1|||
127630731|NCT01700946|459268412|FG000|Overall Study|Lost to Follow-up|1|||
127630732|NCT01700946|459268413|FG001|Overall Study|Lost to Follow-up|0|||
127630733|NCT01700946|459268412|FG000|Overall Study|Physician Decision|7|||
127630734|NCT01700946|459268413|FG001|Overall Study|Physician Decision|12|||
127630735|NCT01700946|459268412|FG000|Overall Study|Withdrawal by Subject|0|||
127630736|NCT01700946|459268413|FG001|Overall Study|Withdrawal by Subject|2|||
127630737|NCT01700946|459268412|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
127630738|NCT01700946|459268413|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
127630739|NCT01700946|459268412|FG000|Overall Study|Relapse|2|||
127630740|NCT01700946|459268413|FG001|Overall Study|Relapse|1|||
127630741|NCT01700946|459268412|FG000|Overall Study|Unacceptable toxicity|1|||
127630742|NCT01700946|459268413|FG001|Overall Study|Unacceptable toxicity|0|||
127630743|NCT03321981|459268421|FG000|Overall Study|Progressive Disease (PD)|15|||
127630744|NCT03321981|459268422|FG001|Overall Study|Progressive Disease (PD)|30|||
127630745|NCT03321981|459268423|FG002|Overall Study|Progressive Disease (PD)|47|||
127630746|NCT03321981|459268421|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
127630747|NCT03321981|459268422|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|2|||
127630748|NCT03321981|459268423|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
127630749|NCT03321981|459268421|FG000|Overall Study|Adverse Event|0|||
127630750|NCT03321981|459268422|FG001|Overall Study|Adverse Event|0|||
127630751|NCT03321981|459268423|FG002|Overall Study|Adverse Event|2|||
127630752|NCT03321981|459268421|FG000|Overall Study|symptomatic deterioration|0|||
127630753|NCT03321981|459268422|FG001|Overall Study|symptomatic deterioration|1|||
127630754|NCT03321981|459268423|FG002|Overall Study|symptomatic deterioration|1|||
127630755|NCT03321981|459268421|FG000|Overall Study|Lack of compliance|0|||
127630756|NCT03321981|459268422|FG001|Overall Study|Lack of compliance|1|||
127630757|NCT03321981|459268423|FG002|Overall Study|Lack of compliance|0|||
127630758|NCT03321981|459268421|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
127630759|NCT03321981|459268422|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|1|||
127630760|NCT03321981|459268423|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
127630761|NCT03321981|459268421|FG000|Overall Study|Death|0|||
127630762|NCT03321981|459268422|FG001|Overall Study|Death|1|||
127630763|NCT03321981|459268423|FG002|Overall Study|Death|0|||
127630764|NCT03321981|459268421|FG000|Overall Study|Subject withdrawal of investigational product|0|||
127630765|NCT03321981|459268422|FG001|Overall Study|Subject withdrawal of investigational product|1|||
127630766|NCT03321981|459268423|FG002|Overall Study|Subject withdrawal of investigational product|0|||
127630767|NCT03321981|459268421|FG000|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
127630768|NCT03321981|459268422|FG001|Overall Study|Treating physician decision due to lack of clinical benefit for patient|1|||
127630769|NCT03321981|459268423|FG002|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
127630770|NCT03321981|459268421|FG000|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
127630771|NCT03321981|459268422|FG001|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|1|||
127630772|NCT03321981|459268423|FG002|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
127630773|NCT04934670|459268424|FG000|Overall Study|Death|4|||
127630774|NCT04934670|459268425|FG001|Overall Study|Death|0|||
127630775|NCT04934670|459268424|FG000|Overall Study|Lost to Follow-up|1|||
127630776|NCT04934670|459268425|FG001|Overall Study|Lost to Follow-up|4|||
127630777|NCT00817089|459268426|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
127630778|NCT00817089|459268427|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
127630779|NCT00817089|459268428|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
127630780|NCT00817089|459268429|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
127630781|NCT00817089|459268426|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
127630782|NCT00817089|459268427|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
127630783|NCT00817089|459268428|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
127630784|NCT00817089|459268429|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
127630785|NCT01592708|459268430|FG000|Overall Study|Protocol Violation|3|||
127630786|NCT01592708|459268431|FG001|Overall Study|Protocol Violation|0|||
127630787|NCT01785602|459268432|FG000|Overall Study|Withdrawal by Subject|2|||
127630788|NCT01785602|459268433|FG001|Overall Study|Withdrawal by Subject|0|||
127630789|NCT01785602|459268432|FG000|Overall Study|Lost to Follow-up|1|||
127630790|NCT01785602|459268433|FG001|Overall Study|Lost to Follow-up|1|||
127630791|NCT01785602|459268432|FG000|Overall Study|Adverse Event|3|||
127630792|NCT01785602|459268433|FG001|Overall Study|Adverse Event|5|||
127630793|NCT01785602|459268432|FG000|Overall Study|Administrative problems|7|||
127630794|NCT01785602|459268433|FG001|Overall Study|Administrative problems|3|||
127630795|NCT00101101|459268434|FG000|Overall Study|never received vaccine|20|||
127630796|NCT01916304|459268435|FG000|Overall Study|Screening failure|17|||
127630797|NCT02460198|459268436|FG000|Overall Study|Adverse Event|1|||
127630798|NCT02460198|459268437|FG001|Overall Study|Adverse Event|3|||
127630799|NCT02460198|459268436|FG000|Overall Study|Death|36|||
127630800|NCT02460198|459268437|FG001|Overall Study|Death|28|||
127630801|NCT02460198|459268436|FG000|Overall Study|Lost to Follow-up|1|||
127630802|NCT02460198|459268437|FG001|Overall Study|Lost to Follow-up|1|||
127630803|NCT02460198|459268436|FG000|Overall Study|Transferred to Extension Study|15|||
127630804|NCT02460198|459268437|FG001|Overall Study|Transferred to Extension Study|15|||
127630805|NCT02460198|459268436|FG000|Overall Study|Withdrawal by Subject|2|||
127630806|NCT02460198|459268437|FG001|Overall Study|Withdrawal by Subject|4|||
127630807|NCT02460198|459268436|FG000|Overall Study|Site Terminated By Sponsor|0|||
127630808|NCT02460198|459268437|FG001|Overall Study|Site Terminated By Sponsor|1|||
127630809|NCT02460198|459268436|FG000|Overall Study|Did Not Continue on Extension Study|6|||
127630810|NCT02460198|459268437|FG001|Overall Study|Did Not Continue on Extension Study|11|||
127630811|NCT04382612|459268438|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
127630812|NCT04666441|459268439|FG000|Overall Study|Lost to Follow-up|1|||
127630813|NCT04666441|459268440|FG001|Overall Study|Lost to Follow-up|4|||
127630814|NCT04666441|459268441|FG002|Overall Study|Lost to Follow-up|1|||
127630815|NCT04666441|459268442|FG003|Overall Study|Lost to Follow-up|3|||
127630816|NCT04666441|459268443|FG004|Overall Study|Lost to Follow-up|0|||
127630817|NCT04666441|459268444|FG005|Overall Study|Lost to Follow-up|2|||
127630818|NCT04666441|459268445|FG006|Overall Study|Lost to Follow-up|2|||
127630819|NCT04666441|459268446|FG007|Overall Study|Lost to Follow-up|2|||
127630820|NCT04666441|459268439|FG000|Overall Study|Subject Decision|1|||
127630821|NCT04666441|459268440|FG001|Overall Study|Subject Decision|1|||
127630822|NCT04666441|459268441|FG002|Overall Study|Subject Decision|3|||
127630823|NCT04666441|459268442|FG003|Overall Study|Subject Decision|1|||
127630824|NCT04666441|459268443|FG004|Overall Study|Subject Decision|0|||
127630825|NCT04666441|459268444|FG005|Overall Study|Subject Decision|1|||
127630826|NCT04666441|459268445|FG006|Overall Study|Subject Decision|3|||
127630827|NCT04666441|459268446|FG007|Overall Study|Subject Decision|2|||
127630828|NCT02752048|459268449|FG000|Overall Study|Withdrawal by Subject|0|||
127630829|NCT02752048|459268450|FG001|Overall Study|Withdrawal by Subject|0|||
127630830|NCT02752048|459268451|FG002|Overall Study|Withdrawal by Subject|3|||
127630831|NCT00132769|459268452|FG000|Overall Study|Withdrawal by Subject|1|||
127630832|NCT00132769|459268453|FG001|Overall Study|Withdrawal by Subject|3|||
127630833|NCT00132769|459268452|FG000|Overall Study|Lack of Efficacy|7|||
127630834|NCT00132769|459268453|FG001|Overall Study|Lack of Efficacy|6|||
127630835|NCT00132769|459268452|FG000|Overall Study|Adverse Event|2|||
127630836|NCT00132769|459268453|FG001|Overall Study|Adverse Event|1|||
127630837|NCT00132769|459268452|FG000|Overall Study|Protocol Violation|1|||
127630838|NCT00132769|459268453|FG001|Overall Study|Protocol Violation|1|||
127630839|NCT03285477|459268456|FG000|Treatment and Response Assessment Period|Death|1|||
127630840|NCT03285477|459268457|FG001|Treatment and Response Assessment Period|Death|0|||
127630841|NCT03285477|459268456|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
127630842|NCT03285477|459268457|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
127630843|NCT03285477|459268456|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
127630844|NCT03285477|459268457|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
127630845|NCT03285477|459268456|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
127630846|NCT03285477|459268457|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
127630847|NCT03285477|459268456|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
127630848|NCT03285477|459268457|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
127630849|NCT03823651|459268461|FG000|Overall Study|Death|5|||
127630850|NCT03823651|459268462|FG001|Overall Study|Death|0|||
127630851|NCT03823651|459268461|FG000|Overall Study|Physician Decision|1|||
127630852|NCT03823651|459268462|FG001|Overall Study|Physician Decision|0|||
127630853|NCT03823651|459268461|FG000|Overall Study|Caregiver to patient who died|0|||
127630854|NCT03823651|459268462|FG001|Overall Study|Caregiver to patient who died|5|||
127630855|NCT03823651|459268461|FG000|Overall Study|Caregiver to patient who was withdrawn due to physician decision|0|||
127630856|NCT03823651|459268462|FG001|Overall Study|Caregiver to patient who was withdrawn due to physician decision|1|||
127630857|NCT05350449|459268463|FG000|Overall Study|Withdrawal by Subject|4|||
127630858|NCT05350449|459268464|FG001|Overall Study|Withdrawal by Subject|8|||
127630859|NCT00796718|459270438|FG000|Overall Study|Adverse Event|2|||
127630860|NCT00796718|459270438|FG000|Overall Study|Exclusion Criteria|1|||
127630861|NCT00796718|459270438|FG000|Overall Study|Lost to Follow-up|5|||
127630862|NCT00796718|459270438|FG000|Overall Study|Withdrawal by Informed Consent|1|||
127630863|NCT03266588|459270439|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
127630864|NCT03266588|459270440|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
127630865|NCT03266588|459270441|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
127630866|NCT03266588|459270439|FG000|Observational Period|Withdrawal by Subject|44|||
127630867|NCT03266588|459270440|FG001|Observational Period|Withdrawal by Subject|22|||
127630868|NCT03266588|459270441|FG002|Observational Period|Withdrawal by Subject|13|||
127630869|NCT03266588|459270439|FG000|Observational Period|Non-compliance|18|||
127630870|NCT03266588|459270440|FG001|Observational Period|Non-compliance|12|||
127630871|NCT03266588|459270441|FG002|Observational Period|Non-compliance|10|||
127630872|NCT03266588|459270439|FG000|Observational Period|Lost to Follow-up|8|||
127630873|NCT03266588|459270440|FG001|Observational Period|Lost to Follow-up|12|||
127630874|NCT03266588|459270441|FG002|Observational Period|Lost to Follow-up|4|||
127630875|NCT03266588|459270439|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
127630876|NCT03266588|459270440|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
127630877|NCT03266588|459270441|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
127630878|NCT03266588|459270439|FG000|Observational Period|Protocol Deviation|1|||
127630879|NCT03266588|459270440|FG001|Observational Period|Protocol Deviation|0|||
127630880|NCT03266588|459270441|FG002|Observational Period|Protocol Deviation|0|||
127630881|NCT03266588|459270439|FG000|Observational Period|Other Reasons|3|||
127630882|NCT03266588|459270440|FG001|Observational Period|Other Reasons|0|||
127630883|NCT03266588|459270441|FG002|Observational Period|Other Reasons|1|||
127630884|NCT03266588|459270439|FG000|Long-term Treatment Period|Adverse Event|33|||
127630885|NCT03266588|459270440|FG001|Long-term Treatment Period|Adverse Event|17|||
127630886|NCT03266588|459270441|FG002|Long-term Treatment Period|Adverse Event|8|||
127630887|NCT03266588|459270439|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
127630888|NCT03266588|459270440|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
127630889|NCT03266588|459270441|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
127630890|NCT03266588|459270439|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
127630891|NCT03266588|459270440|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
127630892|NCT03266588|459270441|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
127630893|NCT03266588|459270439|FG000|Long-term Treatment Period|Non-Compliance|126|||
127630894|NCT03266588|459270440|FG001|Long-term Treatment Period|Non-Compliance|57|||
127630895|NCT03266588|459270441|FG002|Long-term Treatment Period|Non-Compliance|7|||
127630896|NCT03266588|459270439|FG000|Long-term Treatment Period|Pregnancy|11|||
127630897|NCT03266588|459270440|FG001|Long-term Treatment Period|Pregnancy|5|||
127630898|NCT03266588|459270441|FG002|Long-term Treatment Period|Pregnancy|0|||
127630899|NCT03266588|459270439|FG000|Long-term Treatment Period|Protocol Deviation|17|||
127630900|NCT03266588|459270440|FG001|Long-term Treatment Period|Protocol Deviation|10|||
127630901|NCT03266588|459270441|FG002|Long-term Treatment Period|Protocol Deviation|4|||
127630902|NCT03266588|459270439|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
127630903|NCT03266588|459270440|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
127630904|NCT03266588|459270441|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
127702461|NCT03058289|459539125|FG002|Overall Study|Clinical Deterioration|0|||
127702462|NCT03058289|459539126|FG003|Overall Study|Clinical Deterioration|2|||
127702463|NCT03058289|459539127|FG004|Overall Study|Clinical Deterioration|1|||
127702464|NCT03058289|459539128|FG005|Overall Study|Clinical Deterioration|1|||
127702465|NCT03058289|459539129|FG006|Overall Study|Clinical Deterioration|0|||
127702466|NCT03058289|459539130|FG007|Overall Study|Clinical Deterioration|3|||
127702467|NCT03058289|459539131|FG008|Overall Study|Clinical Deterioration|2|||
127702468|NCT03058289|459539123|FG000|Overall Study|Lost to Follow-up|0|||
127702469|NCT03058289|459539124|FG001|Overall Study|Lost to Follow-up|0|||
127702470|NCT03058289|459539125|FG002|Overall Study|Lost to Follow-up|0|||
127702471|NCT03058289|459539126|FG003|Overall Study|Lost to Follow-up|0|||
127702472|NCT03058289|459539127|FG004|Overall Study|Lost to Follow-up|1|||
127702473|NCT03058289|459539128|FG005|Overall Study|Lost to Follow-up|0|||
127702474|NCT03058289|459539129|FG006|Overall Study|Lost to Follow-up|0|||
127702475|NCT03058289|459539130|FG007|Overall Study|Lost to Follow-up|0|||
127702476|NCT03058289|459539131|FG008|Overall Study|Lost to Follow-up|0|||
127702477|NCT03058289|459539123|FG000|Overall Study|Refused Further Treatment|0|||
127702478|NCT03058289|459539124|FG001|Overall Study|Refused Further Treatment|0|||
127702479|NCT03058289|459539125|FG002|Overall Study|Refused Further Treatment|1|||
127702480|NCT03058289|459539126|FG003|Overall Study|Refused Further Treatment|0|||
127702481|NCT03058289|459539127|FG004|Overall Study|Refused Further Treatment|1|||
127702482|NCT03058289|459539128|FG005|Overall Study|Refused Further Treatment|0|||
127702483|NCT03058289|459539129|FG006|Overall Study|Refused Further Treatment|0|||
127702484|NCT03058289|459539130|FG007|Overall Study|Refused Further Treatment|0|||
127630905|NCT03266588|459270439|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
127630906|NCT03266588|459270440|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
127630907|NCT03266588|459270441|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
127630908|NCT03266588|459270439|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
127630909|NCT03266588|459270440|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
127630910|NCT03266588|459270441|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
127630911|NCT03266588|459270439|FG000|Long-term Treatment Period|Other Reasons|5|||
127630912|NCT03266588|459270440|FG001|Long-term Treatment Period|Other Reasons|0|||
127630913|NCT03266588|459270441|FG002|Long-term Treatment Period|Other Reasons|0|||
127630914|NCT03266588|459270439|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
127630915|NCT03266588|459270440|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
127630916|NCT03266588|459270441|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
127630917|NCT01073618|459270442|FG000|Overall Study|Death|208|||
127630918|NCT01073618|459270442|FG000|Overall Study|Adverse Event|19|||
127630919|NCT01073618|459270442|FG000|Overall Study|Other|80|||
127630920|NCT00466193|459270443|FG000|Overall Study|Adverse Event|0|||
127702485|NCT03058289|459539131|FG008|Overall Study|Refused Further Treatment|0|||
127702486|NCT03058289|459539123|FG000|Overall Study|Rapid Progression of Disease|0|||
127702487|NCT03058289|459539124|FG001|Overall Study|Rapid Progression of Disease|0|||
127702488|NCT03058289|459539125|FG002|Overall Study|Rapid Progression of Disease|0|||
127702489|NCT03058289|459539126|FG003|Overall Study|Rapid Progression of Disease|1|||
127702490|NCT03058289|459539127|FG004|Overall Study|Rapid Progression of Disease|0|||
127702491|NCT03058289|459539128|FG005|Overall Study|Rapid Progression of Disease|0|||
127702492|NCT03058289|459539129|FG006|Overall Study|Rapid Progression of Disease|0|||
127702493|NCT03058289|459539130|FG007|Overall Study|Rapid Progression of Disease|0|||
127702494|NCT03058289|459539131|FG008|Overall Study|Rapid Progression of Disease|0|||
127702495|NCT00433329|459540507|FG000|Overall Study|Adverse Event|9|||
127702496|NCT00433329|459540507|FG000|Overall Study|Death|4|||
127702497|NCT00433329|459540507|FG000|Overall Study|Withdrew consent|3|||
127702498|NCT00433329|459540507|FG000|Overall Study|Discontinued sildenafil|2|||
127702499|NCT00433329|459540507|FG000|Overall Study|Moved out of state|1|||
127702500|NCT00433329|459540507|FG000|Overall Study|Lost to Follow-up|1|||
127702501|NCT00433329|459540507|FG000|Overall Study|Physician Decision|1|||
127702502|NCT03381196|459540508|FG000|Overall Study|Withdrawal by Subject|7|||
127702503|NCT03381196|459540509|FG001|Overall Study|Withdrawal by Subject|7|||
127702504|NCT03381196|459540508|FG000|Overall Study|Other|0|||
127702505|NCT03381196|459540509|FG001|Overall Study|Other|1|||
127702506|NCT03381196|459540508|FG000|Overall Study|Lost to Follow-up|5|||
127702507|NCT03381196|459540509|FG001|Overall Study|Lost to Follow-up|4|||
127702508|NCT03381196|459540508|FG000|Overall Study|Death|0|||
127702509|NCT03381196|459540509|FG001|Overall Study|Death|1|||
127702510|NCT03381196|459540508|FG000|Overall Study|Adverse Event|1|||
127702511|NCT03381196|459540509|FG001|Overall Study|Adverse Event|0|||
127702512|NCT03381196|459540508|FG000|Overall Study|Randomized, not treated|3|||
127702513|NCT03381196|459540509|FG001|Overall Study|Randomized, not treated|6|||
127702514|NCT04044768|459540511|FG000|Overall Study|Ongoing in Interventional phase at data cut-off|8|||
127702515|NCT04044768|459540512|FG001|Overall Study|Ongoing in Interventional phase at data cut-off|0|||
127702516|NCT01574274|459540513|FG000|Overall Study|Ineligible|0|||
127702517|NCT01574274|459540514|FG001|Overall Study|Ineligible|1|||
127702518|NCT01574274|459540513|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
127702519|NCT01574274|459540514|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
127702520|NCT01574274|459540513|FG000|Overall Study|Ph+ B-ALL|3|||
127702521|NCT01574274|459540514|FG001|Overall Study|Ph+ B-ALL|4|||
127702522|NCT01574274|459540513|FG000|Overall Study|Induction Death|2|||
127702523|NCT01574274|459540514|FG001|Overall Study|Induction Death|0|||
127702524|NCT01574274|459540513|FG000|Overall Study|Induction Failure|4|||
127702525|NCT01574274|459540514|FG001|Overall Study|Induction Failure|1|||
127702526|NCT01574274|459540513|FG000|Overall Study|Adverse Event|16|||
127702527|NCT01574274|459540514|FG001|Overall Study|Adverse Event|13|||
127702528|NCT01574274|459540513|FG000|Overall Study|Remission Death|1|||
127702529|NCT01574274|459540514|FG001|Overall Study|Remission Death|0|||
127702530|NCT01574274|459540513|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
127702531|NCT01574274|459540514|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
127702532|NCT01574274|459540513|FG000|Overall Study|Other, unknown|3|||
127702533|NCT01574274|459540514|FG001|Overall Study|Other, unknown|2|||
127795732|NCT01662440|459875931|FG002|Overall Study|Subject moved to another country.|0|||
127795733|NCT01662440|459875932|FG003|Overall Study|Subject moved to another country.|0|||
127630921|NCT00466193|459270444|FG001|Overall Study|Adverse Event|1|||
127630922|NCT00466193|459270443|FG000|Overall Study|Lost to Follow-up|2|||
127630923|NCT00466193|459270444|FG001|Overall Study|Lost to Follow-up|4|||
127630924|NCT00466193|459270443|FG000|Overall Study|Physician Decision|1|||
127630925|NCT00466193|459270444|FG001|Overall Study|Physician Decision|0|||
127630926|NCT00466193|459270443|FG000|Overall Study|Protocol Violation|1|||
127630927|NCT00466193|459270444|FG001|Overall Study|Protocol Violation|1|||
127630928|NCT00466193|459270443|FG000|Overall Study|Withdrawal by Subject|7|||
127630929|NCT00466193|459270444|FG001|Overall Study|Withdrawal by Subject|2|||
127630930|NCT00466193|459270443|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
127630931|NCT00466193|459270444|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
127630932|NCT02246998|459270445|FG000|Overall Study|Adverse Event|0|||
127630933|NCT02246998|459270446|FG001|Overall Study|Adverse Event|1|||
127630934|NCT02246998|459270447|FG002|Overall Study|Adverse Event|1|||
127630935|NCT02246998|459270448|FG003|Overall Study|Adverse Event|0|||
127630936|NCT02246998|459270445|FG000|Overall Study|Lost to Follow-up|1|||
127630937|NCT02246998|459270446|FG001|Overall Study|Lost to Follow-up|0|||
127795734|NCT01662440|459875929|FG000|Overall Study|Protocol Violation|1|||
127702534|NCT05089019|459540515|FG000|Period 1|Withdrawal by Subject|0|||
127702535|NCT05089019|459540516|FG001|Period 1|Withdrawal by Subject|1|||
127702536|NCT05089019|459540515|FG000|Washout Period|Adverse Event|3|||
127702537|NCT05089019|459540516|FG001|Washout Period|Adverse Event|4|||
127702538|NCT05089019|459540515|FG000|Washout Period|Lost to Follow-up|1|||
127702539|NCT05089019|459540516|FG001|Washout Period|Lost to Follow-up|0|||
127630938|NCT02246998|459270447|FG002|Overall Study|Lost to Follow-up|0|||
127630939|NCT02246998|459270448|FG003|Overall Study|Lost to Follow-up|1|||
127702540|NCT05089019|459540515|FG000|Washout Period|Physician Decision|2|||
127702541|NCT05089019|459540516|FG001|Washout Period|Physician Decision|0|||
127702542|NCT05089019|459540515|FG000|Washout Period|Withdrawal by Subject|6|||
127630940|NCT02246998|459270445|FG000|Overall Study|Randomized but Never Dosed|1|||
127702543|NCT05089019|459540516|FG001|Washout Period|Withdrawal by Subject|3|||
127702544|NCT05089019|459540515|FG000|Period 2|Adverse Event|4|||
127630941|NCT02246998|459270446|FG001|Overall Study|Randomized but Never Dosed|2|||
127630942|NCT02246998|459270447|FG002|Overall Study|Randomized but Never Dosed|2|||
127630943|NCT02246998|459270448|FG003|Overall Study|Randomized but Never Dosed|1|||
127630944|NCT01343082|459270449|FG000|The run-in Period|Not meeting criteria|3|||
127630945|NCT01343082|459270450|FG001|The run-in Period|Not meeting criteria|4|||
127630946|NCT01343082|459270451|FG002|The run-in Period|Not meeting criteria|5|||
127630947|NCT01343082|459270449|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
127630948|NCT01343082|459270450|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
127630949|NCT01343082|459270451|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
127630950|NCT01343082|459270449|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
127630951|NCT01343082|459270450|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
127630952|NCT01343082|459270451|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
127630953|NCT01343082|459270449|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
127630954|NCT01343082|459270450|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
127630955|NCT01343082|459270451|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
127630956|NCT01343082|459270449|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
127630957|NCT01343082|459270450|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
127630958|NCT01343082|459270451|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
127630959|NCT01075074|459270452|FG000|Overall Study|Surgeon changed to open incisional case|1|||
127630960|NCT01075074|459270453|FG001|Overall Study|Surgeon changed to open incisional case|2|||
127630961|NCT01075074|459270454|FG002|Overall Study|Surgeon changed to open incisional case|2|||
127630962|NCT01054729|459270455|FG000|Overall Study|Randomized but Not Treated|0|||
127630963|NCT01054729|459270456|FG001|Overall Study|Randomized but Not Treated|1|||
127630964|NCT01054729|459270457|FG002|Overall Study|Randomized but Not Treated|0|||
127630965|NCT01054729|459270458|FG003|Overall Study|Randomized but Not Treated|0|||
127630966|NCT01054729|459270455|FG000|Overall Study|Adverse Event|1|||
127630967|NCT01054729|459270456|FG001|Overall Study|Adverse Event|1|||
127630968|NCT01054729|459270457|FG002|Overall Study|Adverse Event|2|||
127630969|NCT01054729|459270458|FG003|Overall Study|Adverse Event|1|||
127630970|NCT01054729|459270455|FG000|Overall Study|Withdrawal by Subject|1|||
127630971|NCT01054729|459270456|FG001|Overall Study|Withdrawal by Subject|0|||
127630972|NCT01054729|459270457|FG002|Overall Study|Withdrawal by Subject|1|||
127630973|NCT01054729|459270458|FG003|Overall Study|Withdrawal by Subject|0|||
127630974|NCT01054729|459270455|FG000|Overall Study|Lost to Follow-up|0|||
127630975|NCT01054729|459270456|FG001|Overall Study|Lost to Follow-up|1|||
127630976|NCT01054729|459270457|FG002|Overall Study|Lost to Follow-up|0|||
127630977|NCT01054729|459270458|FG003|Overall Study|Lost to Follow-up|0|||
127630978|NCT01054729|459270455|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
127630979|NCT01054729|459270456|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
127630980|NCT01054729|459270457|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
127630981|NCT01054729|459270458|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
127630982|NCT01054729|459270455|FG000|Overall Study|Non-responder|1|||
127630983|NCT01054729|459270456|FG001|Overall Study|Non-responder|0|||
127630984|NCT01054729|459270457|FG002|Overall Study|Non-responder|1|||
127630985|NCT01054729|459270458|FG003|Overall Study|Non-responder|1|||
127630986|NCT01054729|459270455|FG000|Overall Study|PEG/RBV Non-responder|1|||
127630987|NCT01054729|459270456|FG001|Overall Study|PEG/RBV Non-responder|0|||
127630988|NCT01054729|459270457|FG002|Overall Study|PEG/RBV Non-responder|1|||
127630989|NCT01054729|459270458|FG003|Overall Study|PEG/RBV Non-responder|0|||
127630990|NCT01054729|459270455|FG000|Overall Study|Personal/Obligations|0|||
127630991|NCT01054729|459270456|FG001|Overall Study|Personal/Obligations|1|||
127630992|NCT01054729|459270457|FG002|Overall Study|Personal/Obligations|0|||
127630993|NCT01054729|459270458|FG003|Overall Study|Personal/Obligations|0|||
127630994|NCT01054729|459270455|FG000|Overall Study|Subject moved|0|||
127630995|NCT01054729|459270456|FG001|Overall Study|Subject moved|0|||
127630996|NCT01054729|459270457|FG002|Overall Study|Subject moved|1|||
127630997|NCT01054729|459270458|FG003|Overall Study|Subject moved|0|||
127630998|NCT01054729|459270455|FG000|Overall Study|Lack of Efficacy|0|||
127630999|NCT01054729|459270456|FG001|Overall Study|Lack of Efficacy|0|||
127631000|NCT01054729|459270457|FG002|Overall Study|Lack of Efficacy|0|||
127631001|NCT01054729|459270458|FG003|Overall Study|Lack of Efficacy|1|||
127631002|NCT01575561|459270459|FG000|Overall Study|Adverse Event|9|||
127631003|NCT01575561|459270459|FG000|Overall Study|Lack of Efficacy|8|||
127631004|NCT01575561|459270459|FG000|Overall Study|Lost to Follow-up|6|||
127631005|NCT01575561|459270459|FG000|Overall Study|Protocol Violation|4|||
127631006|NCT01575561|459270459|FG000|Overall Study|Withdrawal by Subject|11|||
127631007|NCT01575561|459270459|FG000|Overall Study|administration|1|||
127631008|NCT00844194|459270460|FG000|Overall Study|Adverse Event|17|||
127631009|NCT00844194|459270461|FG001|Overall Study|Adverse Event|5|||
127631010|NCT00844194|459270460|FG000|Overall Study|Protocol Violation|1|||
127631011|NCT00844194|459270461|FG001|Overall Study|Protocol Violation|1|||
127631012|NCT00844194|459270460|FG000|Overall Study|Lost to Follow-up|1|||
127631013|NCT00844194|459270461|FG001|Overall Study|Lost to Follow-up|1|||
127631014|NCT00844194|459270460|FG000|Overall Study|Withdrawal by Subject|2|||
127631015|NCT00844194|459270461|FG001|Overall Study|Withdrawal by Subject|1|||
127631016|NCT00844194|459270460|FG000|Overall Study|Lack of Efficacy|3|||
127631017|NCT00844194|459270461|FG001|Overall Study|Lack of Efficacy|0|||
127631018|NCT00844194|459270460|FG000|Overall Study|Other reason (not specified)|1|||
127631019|NCT00844194|459270461|FG001|Overall Study|Other reason (not specified)|0|||
127631020|NCT02647658|459270462|FG000|Overall Study|Consent refusal|15|||
127631021|NCT02647658|459270463|FG001|Overall Study|Consent refusal|24|||
127631022|NCT01542528|459270464|FG000|Overall Study|Lost to Follow-up|2|||
127631023|NCT01542528|459270465|FG001|Overall Study|Lost to Follow-up|1|||
127631024|NCT01542528|459270464|FG000|Overall Study|Physician Decision|1|||
127631025|NCT01542528|459270465|FG001|Overall Study|Physician Decision|0|||
127631026|NCT01542528|459270464|FG000|Overall Study|Withdrawal by Subject|9|||
127631027|NCT01542528|459270465|FG001|Overall Study|Withdrawal by Subject|6|||
127631028|NCT01992536|459270466|FG000|Overall Study|Administrative Reason|0|||
127631029|NCT01992536|459270467|FG001|Overall Study|Administrative Reason|0|||
127631030|NCT01992536|459270468|FG002|Overall Study|Administrative Reason|0|||
127631031|NCT01992536|459270469|FG003|Overall Study|Administrative Reason|0|||
127631032|NCT01992536|459270470|FG004|Overall Study|Administrative Reason|0|||
127631033|NCT01992536|459270471|FG005|Overall Study|Administrative Reason|0|||
127631034|NCT01992536|459270472|FG006|Overall Study|Administrative Reason|7|||
127631035|NCT01992536|459270473|FG007|Overall Study|Administrative Reason|0|||
127631036|NCT01992536|459270474|FG008|Overall Study|Administrative Reason|0|||
127631037|NCT01992536|459270475|FG009|Overall Study|Administrative Reason|0|||
127631038|NCT01992536|459270466|FG000|Overall Study|Lost to Follow-up|4|||
127631039|NCT01992536|459270467|FG001|Overall Study|Lost to Follow-up|2|||
127631040|NCT01992536|459270468|FG002|Overall Study|Lost to Follow-up|1|||
127631041|NCT01992536|459270469|FG003|Overall Study|Lost to Follow-up|0|||
127631042|NCT01992536|459270470|FG004|Overall Study|Lost to Follow-up|0|||
127631043|NCT01992536|459270471|FG005|Overall Study|Lost to Follow-up|1|||
127631044|NCT01992536|459270472|FG006|Overall Study|Lost to Follow-up|0|||
127631045|NCT01992536|459270473|FG007|Overall Study|Lost to Follow-up|0|||
127631046|NCT01992536|459270474|FG008|Overall Study|Lost to Follow-up|1|||
127631047|NCT01992536|459270475|FG009|Overall Study|Lost to Follow-up|1|||
127631048|NCT01992536|459270466|FG000|Overall Study|Withdrawal by Subject|0|||
127631049|NCT01992536|459270467|FG001|Overall Study|Withdrawal by Subject|1|||
127631050|NCT01992536|459270468|FG002|Overall Study|Withdrawal by Subject|0|||
127631051|NCT01992536|459270469|FG003|Overall Study|Withdrawal by Subject|2|||
127631052|NCT01992536|459270470|FG004|Overall Study|Withdrawal by Subject|0|||
127631053|NCT01992536|459270471|FG005|Overall Study|Withdrawal by Subject|0|||
127631054|NCT01992536|459270472|FG006|Overall Study|Withdrawal by Subject|0|||
127631055|NCT01992536|459270473|FG007|Overall Study|Withdrawal by Subject|0|||
127631056|NCT01992536|459270474|FG008|Overall Study|Withdrawal by Subject|0|||
127631057|NCT01992536|459270475|FG009|Overall Study|Withdrawal by Subject|0|||
127631058|NCT00406029|459270479|FG000|Overall Study|Adverse Event|12|||
127631059|NCT00406029|459270480|FG001|Overall Study|Adverse Event|2|||
127631060|NCT00406029|459270481|FG002|Overall Study|Adverse Event|5|||
127631061|NCT00406029|459270482|FG003|Overall Study|Adverse Event|10|||
127631062|NCT00406029|459270483|FG004|Overall Study|Adverse Event|7|||
127631063|NCT00406029|459270479|FG000|Overall Study|Withdrawal by Subject|3|||
127631064|NCT00406029|459270480|FG001|Overall Study|Withdrawal by Subject|4|||
127631065|NCT00406029|459270481|FG002|Overall Study|Withdrawal by Subject|2|||
127631066|NCT00406029|459270482|FG003|Overall Study|Withdrawal by Subject|2|||
127631067|NCT00406029|459270483|FG004|Overall Study|Withdrawal by Subject|0|||
127631068|NCT00406029|459270479|FG000|Overall Study|Protocol Violation|1|||
127631069|NCT00406029|459270480|FG001|Overall Study|Protocol Violation|2|||
127631070|NCT00406029|459270481|FG002|Overall Study|Protocol Violation|0|||
127631071|NCT00406029|459270482|FG003|Overall Study|Protocol Violation|2|||
127631072|NCT00406029|459270483|FG004|Overall Study|Protocol Violation|0|||
127631073|NCT00406029|459270479|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
127702545|NCT05089019|459540516|FG001|Period 2|Adverse Event|2|||
127631074|NCT00406029|459270480|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
127631075|NCT00406029|459270481|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
127631076|NCT00406029|459270482|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
127702546|NCT05089019|459540515|FG000|Period 2|Lost to Follow-up|1|||
127702547|NCT05089019|459540516|FG001|Period 2|Lost to Follow-up|0|||
127631077|NCT00406029|459270483|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
127702548|NCT05089019|459540515|FG000|Period 2|Withdrawal by Subject|0|||
127631078|NCT00406029|459270479|FG000|Overall Study|Randomized in Error|0|||
127631079|NCT00406029|459270480|FG001|Overall Study|Randomized in Error|0|||
127631080|NCT00406029|459270481|FG002|Overall Study|Randomized in Error|2|||
127631081|NCT00406029|459270482|FG003|Overall Study|Randomized in Error|3|||
127631082|NCT00406029|459270483|FG004|Overall Study|Randomized in Error|1|||
127631083|NCT01709227|459270484|FG000|Overall Study|Physician Decision|1|||
127631084|NCT01709227|459270485|FG001|Overall Study|Physician Decision|0|||
127631085|NCT01709227|459270484|FG000|Overall Study|Pleural Peritoneal communication|0|||
127631086|NCT01709227|459270485|FG001|Overall Study|Pleural Peritoneal communication|9|||
127631087|NCT03669081|459270487|FG000|Overall Study|Data could not be validated|1|||
127631088|NCT03669081|459270488|FG001|Overall Study|Data could not be validated|1|||
127631089|NCT00389324|459270489|FG000|Run-In Phase|Adverse Event|1|||
127631090|NCT00389324|459270489|FG000|Run-In Phase|Lost to Follow-up|1|||
127631091|NCT00389324|459270489|FG000|Run-In Phase|Withdrawal by Subject|1|||
127631092|NCT00389324|459270489|FG000|Subcutaneous Phase|Adverse Event|2|||
127631093|NCT00389324|459270489|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
127631094|NCT00389324|459270489|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
127631095|NCT00389324|459270489|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
127631096|NCT00795600|459270490|FG000|Overall Study|Adverse Event|1|||
127631097|NCT00795600|459270491|FG001|Overall Study|Adverse Event|1|||
127631098|NCT00795600|459270490|FG000|Overall Study|Protocol Violation|1|||
127631099|NCT00795600|459270491|FG001|Overall Study|Protocol Violation|2|||
127631100|NCT00795600|459270490|FG000|Overall Study|Withdrawal by Subject|1|||
127631101|NCT00795600|459270491|FG001|Overall Study|Withdrawal by Subject|0|||
127631102|NCT00795600|459270490|FG000|Overall Study|Unclassified|1|||
127631103|NCT00795600|459270491|FG001|Overall Study|Unclassified|1|||
127631104|NCT03936244|459270492|FG000|Overall Study|Lost to Follow-up|5|||
127631105|NCT03936244|459270493|FG001|Overall Study|Lost to Follow-up|1|||
127631106|NCT03936244|459270492|FG000|Overall Study|Physician Decision|7|||
127631107|NCT03936244|459270493|FG001|Overall Study|Physician Decision|3|||
127631108|NCT01430130|459270494|FG000|Overall Study|Lost to Follow-up|1|||
127631109|NCT01430130|459270494|FG000|Overall Study|Infection on Control Side of Incision|1|||
127631110|NCT02843568|459270496|FG000|Overall Study|Excluded from Primary Population due to change in treatment|4|||
127631111|NCT02843568|459270497|FG001|Overall Study|Excluded from Primary Population due to change in treatment|2|||
127631112|NCT02843568|459270496|FG000|Overall Study|Death|3|||
127631113|NCT02843568|459270497|FG001|Overall Study|Death|3|||
127631114|NCT02843568|459270496|FG000|Overall Study|Withdrawal by Subject|1|||
127631115|NCT02843568|459270497|FG001|Overall Study|Withdrawal by Subject|1|||
127631116|NCT02843568|459270496|FG000|Overall Study|Lost to Follow-up|2|||
127631117|NCT02843568|459270497|FG001|Overall Study|Lost to Follow-up|0|||
127631118|NCT04788147|459270513|FG000|Overall Study|Screen Failure|3|||
127631119|NCT04788147|459270514|FG001|Overall Study|Screen Failure|10|||
127631120|NCT04788147|459270513|FG000|Overall Study|Incomplete RMRS image session|2|||
127631121|NCT04788147|459270514|FG001|Overall Study|Incomplete RMRS image session|0|||
127631122|NCT05101252|459270515|FG000|Overall Study|Unsatisfactory Test Article|1|||
127631123|NCT05101252|459270516|FG001|Overall Study|Unsatisfactory Test Article|0|||
127631124|NCT05101252|459270515|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
127631125|NCT05101252|459270516|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
127631126|NCT05101252|459270515|FG000|Overall Study|Withdrew Consent during study|0|||
127631127|NCT05101252|459270516|FG001|Overall Study|Withdrew Consent during study|1|||
127631128|NCT05101252|459270515|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
127631129|NCT05101252|459270516|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
127631130|NCT02266381|459270517|FG000|Overall Study|Physician Decision|3|||
127631131|NCT02266381|459270518|FG001|Overall Study|Physician Decision|5|||
127631132|NCT02266381|459270519|FG002|Overall Study|Physician Decision|4|||
127631133|NCT02401672|459270520|FG000|Overall Study|Withdrawal by Subject|1|||
127631134|NCT02401672|459270521|FG001|Overall Study|Withdrawal by Subject|3|||
127631135|NCT01459796|459270522|FG000|Overall Study|Non compliance with protocol|2|||
127631136|NCT01459796|459270523|FG001|Overall Study|Non compliance with protocol|4|||
127631137|NCT01459796|459270522|FG000|Overall Study|Adverse Event|5|||
127631138|NCT01459796|459270523|FG001|Overall Study|Adverse Event|5|||
127631139|NCT01459796|459270522|FG000|Overall Study|Withdrawal by Subject|6|||
127631140|NCT01459796|459270523|FG001|Overall Study|Withdrawal by Subject|3|||
127631141|NCT01459796|459270522|FG000|Overall Study|Lost to Follow-up|5|||
127631142|NCT01459796|459270523|FG001|Overall Study|Lost to Follow-up|4|||
127631143|NCT01459796|459270522|FG000|Overall Study|Reason unspecified|1|||
127631144|NCT01459796|459270523|FG001|Overall Study|Reason unspecified|2|||
127631145|NCT01459796|459270522|FG000|Overall Study|Decision by the sponsor|75|||
127631146|NCT01459796|459270523|FG001|Overall Study|Decision by the sponsor|108|||
127702549|NCT05089019|459540516|FG001|Period 2|Withdrawal by Subject|1|||
127631147|NCT00701051|459270524|FG000|Screening|Failed Screening|40|||
127631148|NCT00701051|459270525|FG001|Screening|Failed Screening|0|||
127631149|NCT00701051|459270526|FG002|Screening|Failed Screening|0|||
127631150|NCT00701051|459270524|FG000|Screening|Time conflicts|19|||
127631151|NCT00701051|459270525|FG001|Screening|Time conflicts|0|||
127631152|NCT00701051|459270526|FG002|Screening|Time conflicts|0|||
127631153|NCT00701051|459270524|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
127631154|NCT00701051|459270525|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
127631155|NCT00701051|459270526|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
127631156|NCT03634579|459270527|FG000|Overall Study|study termination|9|||
127631157|NCT04111497|459270535|FG000|Overall Study|relapse of primary disease|1|||
127631158|NCT04111497|459270535|FG000|Overall Study|toxicity and/or lack of efficacy|13|||
127631159|NCT03321019|459270536|FG000|Overall Study|Withdrawal by Subject|0|||
127631160|NCT03321019|459270537|FG001|Overall Study|Withdrawal by Subject|6|||
127631161|NCT03321019|459270536|FG000|Overall Study|Lost to Follow-up|0|||
127631162|NCT03321019|459270537|FG001|Overall Study|Lost to Follow-up|22|||
127631163|NCT03067441|459270539|FG000|Overall Study|Withdrawal by Subject|16|||
127631164|NCT03067441|459270540|FG001|Overall Study|Withdrawal by Subject|34|||
127631165|NCT03067441|459270539|FG000|Overall Study|Lost to Follow-up|7|||
127631166|NCT03067441|459270540|FG001|Overall Study|Lost to Follow-up|5|||
127631167|NCT03067441|459270539|FG000|Overall Study|Adverse Event|7|||
127631168|NCT03067441|459270540|FG001|Overall Study|Adverse Event|14|||
127631169|NCT03067441|459270539|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
127631170|NCT03067441|459270540|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
127631171|NCT03067441|459270539|FG000|Overall Study|Physician Decision|1|||
127631172|NCT03067441|459270540|FG001|Overall Study|Physician Decision|3|||
127631173|NCT03067441|459270539|FG000|Overall Study|Other|1|||
127631174|NCT03067441|459270540|FG001|Overall Study|Other|1|||
127631175|NCT02056301|459270548|FG000|Overall Study|Protocol Violation|1|||
127631176|NCT02056301|459270549|FG001|Overall Study|Protocol Violation|2|||
127631177|NCT02056301|459270548|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
127631178|NCT02056301|459270549|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
127631179|NCT02056301|459270548|FG000|Overall Study|Withdrawal by Subject|0|||
127631180|NCT02056301|459270549|FG001|Overall Study|Withdrawal by Subject|1|||
127631181|NCT02056301|459270548|FG000|Overall Study|Issues with epidural|0|||
127631182|NCT02056301|459270549|FG001|Overall Study|Issues with epidural|3|||
127631183|NCT03864900|459270552|FG000|Overall Study|Withdrawal by Subject|1|||
127631184|NCT03864900|459270553|FG001|Overall Study|Withdrawal by Subject|1|||
127631185|NCT03864900|459270552|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
127631186|NCT03864900|459270553|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
127631187|NCT03238001|459270555|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
127631188|NCT03238001|459270555|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
127631189|NCT03238001|459270555|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
127631190|NCT03238001|459270555|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
127631191|NCT03238001|459270555|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
127631192|NCT03238001|459270555|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
127631193|NCT03238001|459270555|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
127631194|NCT03238001|459270555|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
127631195|NCT03165045|459270556|FG000|Visit 1|No registration after visit 1|9|||
127631196|NCT03165045|459270556|FG000|Visit 1|No treatment documented|10|||
127631197|NCT03165045|459270556|FG000|Visit 1|No visit 1|10|||
127631198|NCT03165045|459270556|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
127631199|NCT03165045|459270556|FG000|Visit 2|No available total CCQ score at all|29|||
127631200|NCT03165045|459270556|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
127631201|NCT00759109|459270557|FG000|Overall Study|Adverse Event|17|||
127631202|NCT00759109|459270558|FG001|Overall Study|Adverse Event|12|||
127631203|NCT00759109|459270557|FG000|Overall Study|Inability to comply|1|||
127631204|NCT00759109|459270558|FG001|Overall Study|Inability to comply|1|||
127631205|NCT00759109|459270557|FG000|Overall Study|Withdrawal by Subject|9|||
127631206|NCT00759109|459270558|FG001|Overall Study|Withdrawal by Subject|5|||
127631207|NCT00759109|459270557|FG000|Overall Study|Death|4|||
127631208|NCT00759109|459270558|FG001|Overall Study|Death|3|||
127631209|NCT00759109|459270557|FG000|Overall Study|Lost to Follow-up|4|||
127631210|NCT00759109|459270558|FG001|Overall Study|Lost to Follow-up|6|||
127795735|NCT01662440|459875930|FG001|Overall Study|Protocol Violation|0|||
127631211|NCT00759109|459270557|FG000|Overall Study|Started new therapy|2|||
127631212|NCT00759109|459270558|FG001|Overall Study|Started new therapy|6|||
127631213|NCT00759109|459270557|FG000|Overall Study|HCV RNA negative|1|||
127631214|NCT00759109|459270558|FG001|Overall Study|HCV RNA negative|0|||
127631215|NCT00759109|459270557|FG000|Overall Study|Participant moved to a different city|0|||
127631216|NCT00759109|459270558|FG001|Overall Study|Participant moved to a different city|1|||
127631217|NCT00759109|459270557|FG000|Overall Study|Participant had a liver transplant|0|||
127631218|NCT00759109|459270558|FG001|Overall Study|Participant had a liver transplant|1|||
127631219|NCT00759109|459270557|FG000|Overall Study|Lost during study|1|||
127631220|NCT00759109|459270558|FG001|Overall Study|Lost during study|0|||
127631221|NCT01827904|459270559|FG000|Main Study|Withdrawal by Subject|1|||
127631222|NCT01827904|459270560|FG001|Main Study|Withdrawal by Subject|0|||
127631223|NCT01827904|459270561|FG002|Main Study|Withdrawal by Subject|0|||
127631224|NCT01827904|459270559|FG000|Main Study|Adverse Event|1|||
127631225|NCT01827904|459270560|FG001|Main Study|Adverse Event|0|||
127631226|NCT01827904|459270561|FG002|Main Study|Adverse Event|0|||
127631227|NCT01827904|459270559|FG000|Main Continuation / Crossover Phase|Alternative treatment|1|||
127631228|NCT01827904|459270560|FG001|Main Continuation / Crossover Phase|Alternative treatment|0|||
127631229|NCT01827904|459270561|FG002|Main Continuation / Crossover Phase|Alternative treatment|0|||
127631230|NCT01827904|459270559|FG000|Main Continuation / Crossover Phase|Withdrawal by Subject|1|||
127631231|NCT01827904|459270560|FG001|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
127631232|NCT01827904|459270561|FG002|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
127631233|NCT01827904|459270559|FG000|Main Continuation / Crossover Phase|Health reasons unrelated to study|1|||
127631234|NCT01827904|459270560|FG001|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
127631235|NCT01827904|459270561|FG002|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
127631236|NCT01827904|459270559|FG000|Long-term Annual Follow-up|Withdrawal by Subject|11|||
127631237|NCT01827904|459270560|FG001|Long-term Annual Follow-up|Withdrawal by Subject|0|||
127631238|NCT01827904|459270561|FG002|Long-term Annual Follow-up|Withdrawal by Subject|5|||
127631239|NCT01827904|459270559|FG000|Long-term Annual Follow-up|Alternative Treatment|4|||
127631240|NCT01827904|459270560|FG001|Long-term Annual Follow-up|Alternative Treatment|0|||
127631241|NCT01827904|459270561|FG002|Long-term Annual Follow-up|Alternative Treatment|1|||
127631242|NCT01827904|459270559|FG000|Long-term Annual Follow-up|Unrelated Health Reason|2|||
127631243|NCT01827904|459270560|FG001|Long-term Annual Follow-up|Unrelated Health Reason|0|||
127631244|NCT01827904|459270561|FG002|Long-term Annual Follow-up|Unrelated Health Reason|1|||
127631245|NCT01827904|459270559|FG000|Long-term Annual Follow-up|Lost to Follow-up|2|||
127631246|NCT01827904|459270560|FG001|Long-term Annual Follow-up|Lost to Follow-up|0|||
127631247|NCT01827904|459270561|FG002|Long-term Annual Follow-up|Lost to Follow-up|0|||
127631248|NCT01827904|459270559|FG000|Long-term Annual Follow-up|Physician Decision|1|||
127631249|NCT01827904|459270560|FG001|Long-term Annual Follow-up|Physician Decision|0|||
127631250|NCT01827904|459270561|FG002|Long-term Annual Follow-up|Physician Decision|0|||
127631251|NCT01827904|459270559|FG000|Long-term Annual Follow-up|Lack of Efficacy|1|||
127631252|NCT01827904|459270560|FG001|Long-term Annual Follow-up|Lack of Efficacy|0|||
127631253|NCT01827904|459270561|FG002|Long-term Annual Follow-up|Lack of Efficacy|0|||
127631254|NCT01827904|459270559|FG000|Long-term Annual Follow-up|Suboptimal Treatment|1|||
127631255|NCT01827904|459270560|FG001|Long-term Annual Follow-up|Suboptimal Treatment|0|||
127631256|NCT01827904|459270561|FG002|Long-term Annual Follow-up|Suboptimal Treatment|0|||
127631257|NCT01866709|459270565|FG000|Overall Study|Adverse Event|1|||
127631258|NCT01866709|459270566|FG001|Overall Study|Adverse Event|0|||
127631259|NCT03791398|459270567|FG000|Overall Study|Progression of Disease Under Study|2|||
127631260|NCT03791398|459270568|FG001|Overall Study|Progression of Disease Under Study|0|||
127631261|NCT03791398|459270569|FG002|Overall Study|Progression of Disease Under Study|0|||
127631262|NCT02207829|459270570|FG000|Overall Study|Adverse Event|10|||
127631263|NCT02207829|459270571|FG001|Overall Study|Adverse Event|9|||
127631264|NCT02207829|459270570|FG000|Overall Study|Lack of Efficacy|7|||
127631265|NCT02207829|459270571|FG001|Overall Study|Lack of Efficacy|5|||
127631266|NCT02207829|459270570|FG000|Overall Study|Lost to Follow-up|2|||
127631267|NCT02207829|459270571|FG001|Overall Study|Lost to Follow-up|2|||
127631268|NCT02207829|459270570|FG000|Overall Study|Protocol deviation|5|||
127631269|NCT02207829|459270571|FG001|Overall Study|Protocol deviation|4|||
127631270|NCT02207829|459270570|FG000|Overall Study|Withdrew consent|18|||
127631271|NCT02207829|459270571|FG001|Overall Study|Withdrew consent|14|||
127631272|NCT00766376|459270572|FG000|Overall Study|Withdrawal by Subject|27|||
127631273|NCT01800903|459270573|FG000|Second Test Period|unable to catheterise|1|||
127631274|NCT01800903|459270574|FG001|Second Test Period|unable to catheterise|0|||
127631275|NCT01800903|459270575|FG002|Second Test Period|unable to catheterise|0|||
127631276|NCT01800903|459270576|FG003|Second Test Period|unable to catheterise|0|||
127631277|NCT01800903|459270577|FG004|Second Test Period|unable to catheterise|0|||
127702550|NCT01593917|459540521|FG000|Overall Study|Death|67|||
127702551|NCT01593917|459540521|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
127702552|NCT01593917|459540521|FG000|Overall Study|Withdrawal by Subject|23|||
127702553|NCT01593917|459540521|FG000|Overall Study|Lost to Follow-up|12|||
127631278|NCT01800903|459270578|FG005|Second Test Period|unable to catheterise|0|||
127631279|NCT01578551|459270581|FG000|Overall Study|Adverse Event|1|||
127631280|NCT01578551|459270582|FG001|Overall Study|Adverse Event|0|||
127631281|NCT01344460|459270589|FG000|Overall Study|Withdrawal by Subject|1|||
127631282|NCT01344460|459270589|FG000|Overall Study|Lost to Follow-up|2|||
127631283|NCT03283670|459270590|FG000|Placebo Gas|Withdrawal by Subject|2|||
127702554|NCT01593917|459540521|FG000|Overall Study|Protocol Violation|5|||
127702555|NCT01593917|459540521|FG000|Overall Study|Physician Decision|3|||
127702556|NCT02043678|459540526|FG000|Overall Study|Never treated|11|||
127702557|NCT02043678|459540527|FG001|Overall Study|Never treated|9|||
127702558|NCT02043678|459540526|FG000|Overall Study|AE with clinical progressive disease(PD)|20|||
127631284|NCT03283670|459270590|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
127631285|NCT03283670|459270590|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
127631286|NCT00852397|459270592|FG000|Overall Study|Adverse Event|4|||
127631287|NCT00852397|459270593|FG001|Overall Study|Adverse Event|6|||
127631288|NCT00852397|459270594|FG002|Overall Study|Adverse Event|4|||
127631289|NCT00852397|459270592|FG000|Overall Study|Death|0|||
127631290|NCT00852397|459270593|FG001|Overall Study|Death|0|||
127631291|NCT00852397|459270594|FG002|Overall Study|Death|1|||
127631292|NCT00852397|459270592|FG000|Overall Study|Withdrawal by Subject|4|||
127631293|NCT00852397|459270593|FG001|Overall Study|Withdrawal by Subject|1|||
127631294|NCT00852397|459270594|FG002|Overall Study|Withdrawal by Subject|2|||
127631295|NCT00852397|459270592|FG000|Overall Study|Study terminated by sponsor|2|||
127631296|NCT00852397|459270593|FG001|Overall Study|Study terminated by sponsor|1|||
127631297|NCT00852397|459270594|FG002|Overall Study|Study terminated by sponsor|6|||
127631298|NCT00852397|459270592|FG000|Overall Study|Difficulty in study site visit|1|||
127631299|NCT00852397|459270593|FG001|Overall Study|Difficulty in study site visit|0|||
127631300|NCT00852397|459270594|FG002|Overall Study|Difficulty in study site visit|0|||
127631301|NCT00852397|459270592|FG000|Overall Study|Protocol Violation|0|||
127631302|NCT00852397|459270593|FG001|Overall Study|Protocol Violation|0|||
127631303|NCT00852397|459270594|FG002|Overall Study|Protocol Violation|1|||
127631304|NCT01850004|459270601|FG000|Overall Study|Poor/Non-compliance|1|||
127631305|NCT01850004|459270601|FG000|Overall Study|Participant Withdrew Consent|9|||
127631306|NCT01850004|459270601|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
127631307|NCT01850004|459270601|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
127631308|NCT01850004|459270601|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
127631309|NCT01850004|459270601|FG000|Overall Study|Other Reasons|2|||
127631310|NCT01850004|459270601|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
127631311|NCT01850004|459270601|FG000|Overall Study|Maximum Clinical Benefit|4|||
127631312|NCT03859323|459272556|FG000|Overall Study|Lost to Follow-up|0|||
127631313|NCT03859323|459272557|FG001|Overall Study|Lost to Follow-up|0|||
127631314|NCT03859323|459272558|FG002|Overall Study|Lost to Follow-up|0|||
127631315|NCT03859323|459272559|FG003|Overall Study|Lost to Follow-up|0|||
127631316|NCT03859323|459272560|FG004|Overall Study|Lost to Follow-up|0|||
127631317|NCT03859323|459272561|FG005|Overall Study|Lost to Follow-up|0|||
127631318|NCT03859323|459272562|FG006|Overall Study|Lost to Follow-up|1|||
127631319|NCT03859323|459272563|FG007|Overall Study|Lost to Follow-up|0|||
127631320|NCT03859323|459272564|FG008|Overall Study|Lost to Follow-up|0|||
127631321|NCT03859323|459272565|FG009|Overall Study|Lost to Follow-up|0|||
127631322|NCT03859323|459272566|FG010|Overall Study|Lost to Follow-up|0|||
127631323|NCT03859323|459272567|FG011|Overall Study|Lost to Follow-up|0|||
127631324|NCT03859323|459272568|FG012|Overall Study|Lost to Follow-up|0|||
127631325|NCT03859323|459272556|FG000|Overall Study|Withdrawal by Subject|0|||
127631326|NCT03859323|459272557|FG001|Overall Study|Withdrawal by Subject|0|||
127631327|NCT03859323|459272558|FG002|Overall Study|Withdrawal by Subject|1|||
127631328|NCT03859323|459272559|FG003|Overall Study|Withdrawal by Subject|0|||
127631329|NCT03859323|459272560|FG004|Overall Study|Withdrawal by Subject|0|||
127631330|NCT03859323|459272561|FG005|Overall Study|Withdrawal by Subject|1|||
127631331|NCT03859323|459272562|FG006|Overall Study|Withdrawal by Subject|0|||
127631332|NCT03859323|459272563|FG007|Overall Study|Withdrawal by Subject|0|||
127631333|NCT03859323|459272564|FG008|Overall Study|Withdrawal by Subject|0|||
127631334|NCT03859323|459272565|FG009|Overall Study|Withdrawal by Subject|1|||
127631335|NCT03859323|459272566|FG010|Overall Study|Withdrawal by Subject|1|||
127631336|NCT03859323|459272567|FG011|Overall Study|Withdrawal by Subject|2|||
127631337|NCT03859323|459272568|FG012|Overall Study|Withdrawal by Subject|1|||
127631338|NCT03859323|459272556|FG000|Overall Study|Pregnancy|0|||
127631339|NCT03859323|459272557|FG001|Overall Study|Pregnancy|0|||
127631340|NCT03859323|459272558|FG002|Overall Study|Pregnancy|0|||
127631341|NCT03859323|459272559|FG003|Overall Study|Pregnancy|0|||
127631342|NCT03859323|459272560|FG004|Overall Study|Pregnancy|0|||
127631343|NCT03859323|459272561|FG005|Overall Study|Pregnancy|0|||
127631344|NCT03859323|459272562|FG006|Overall Study|Pregnancy|0|||
127631345|NCT03859323|459272563|FG007|Overall Study|Pregnancy|0|||
127631346|NCT03859323|459272564|FG008|Overall Study|Pregnancy|0|||
127631347|NCT03859323|459272565|FG009|Overall Study|Pregnancy|1|||
127631348|NCT03859323|459272566|FG010|Overall Study|Pregnancy|0|||
127631349|NCT03859323|459272567|FG011|Overall Study|Pregnancy|0|||
127631350|NCT03859323|459272568|FG012|Overall Study|Pregnancy|0|||
127631351|NCT01404312|459272571|FG000|Overall Study|Death|21|||
127631352|NCT01404312|459272572|FG001|Overall Study|Death|27|||
127631353|NCT01404312|459272571|FG000|Overall Study|Withdrawal by Subject|15|||
127631354|NCT01404312|459272572|FG001|Overall Study|Withdrawal by Subject|18|||
127631355|NCT01404312|459272571|FG000|Overall Study|Participant Unable to get to clinic|93|||
127631356|NCT01404312|459272572|FG001|Overall Study|Participant Unable to get to clinic|103|||
127631357|NCT01404312|459272571|FG000|Overall Study|Lost to Follow-up|115|||
127631358|NCT01404312|459272572|FG001|Overall Study|Lost to Follow-up|111|||
127631359|NCT01404312|459272571|FG000|Overall Study|Site closed|22|||
127631360|NCT01404312|459272572|FG001|Overall Study|Site closed|21|||
127631361|NCT01404312|459272571|FG000|Overall Study|Participant not willing to adhere to req|31|||
127631362|NCT01404312|459272572|FG001|Overall Study|Participant not willing to adhere to req|29|||
127631363|NCT01404312|459272571|FG000|Overall Study|Severe debilitation, unable to continue|1|||
127631364|NCT01404312|459272572|FG001|Overall Study|Severe debilitation, unable to continue|2|||
127631365|NCT04419493|459272573|FG000|Wash-out After Period 1|Adverse Event|1|||
127631366|NCT04419493|459272574|FG001|Wash-out After Period 1|Adverse Event|2|||
127631367|NCT04419493|459272575|FG002|Wash-out After Period 1|Adverse Event|1|||
127702559|NCT02043678|459540527|FG001|Overall Study|AE with clinical progressive disease(PD)|19|||
127702560|NCT02043678|459540526|FG000|Overall Study|AE without clinical PD|54|||
127702561|NCT02043678|459540527|FG001|Overall Study|AE without clinical PD|36|||
127702562|NCT02043678|459540526|FG000|Overall Study|Lost to Follow-up|1|||
127702563|NCT02043678|459540527|FG001|Overall Study|Lost to Follow-up|1|||
127702564|NCT02043678|459540526|FG000|Overall Study|Other|10|||
127702565|NCT02043678|459540527|FG001|Overall Study|Other|14|||
127702566|NCT02043678|459540526|FG000|Overall Study|Clinical PD|114|||
127631368|NCT04419493|459272576|FG003|Wash-out After Period 1|Adverse Event|0|||
127631369|NCT00524134|459272577|FG000|Overall Study|Withdrawal by Subject|1|||
127631370|NCT00524134|459272577|FG000|Overall Study|Physician Decision|1|||
127631371|NCT03794089|459272578|FG000|Overall Study|Lost to Follow-up|4|||
127631372|NCT03794089|459272579|FG001|Overall Study|Lost to Follow-up|1|||
127631373|NCT03794089|459272578|FG000|Overall Study|Withdrawal by Subject|2|||
127631374|NCT03794089|459272579|FG001|Overall Study|Withdrawal by Subject|0|||
127631375|NCT03985423|459272580|FG000|Overall Study|Adverse Event|1|||
127631376|NCT03985423|459272580|FG000|Overall Study|Death|2|||
127631377|NCT03985423|459272580|FG000|Overall Study|Physician Decision|1|||
127631378|NCT03985423|459272580|FG000|Overall Study|Withdrawal by Subject|2|||
127702567|NCT02043678|459540527|FG001|Overall Study|Clinical PD|148|||
127631379|NCT03985423|459272580|FG000|Overall Study|Lack of insurance and citizenship|1|||
127631380|NCT00129987|459272581|FG000|1st Educational Session|Withdrawal by Subject|141|||
127631381|NCT00129987|459272582|FG001|1st Educational Session|Withdrawal by Subject|109|||
127631382|NCT00129987|459272581|FG000|1 Year|Withdrawal by Subject|32|||
127631383|NCT00129987|459272582|FG001|1 Year|Withdrawal by Subject|21|||
127631384|NCT00982020|459272586|FG000|Overall Study|Adverse Event|19|||
127631385|NCT00982020|459272587|FG001|Overall Study|Adverse Event|15|||
127631386|NCT00982020|459272586|FG000|Overall Study|Withdrawal by Subject|11|||
127631387|NCT00982020|459272587|FG001|Overall Study|Withdrawal by Subject|14|||
127631388|NCT00982020|459272586|FG000|Overall Study|Lost to Follow-up|5|||
127631389|NCT00982020|459272587|FG001|Overall Study|Lost to Follow-up|11|||
127631390|NCT00982020|459272586|FG000|Overall Study|Lack of Efficacy|10|||
127631391|NCT00982020|459272587|FG001|Overall Study|Lack of Efficacy|4|||
127702568|NCT02043678|459540526|FG000|Overall Study|Radiological PD|100|||
127702569|NCT02043678|459540527|FG001|Overall Study|Radiological PD|90|||
127702570|NCT02043678|459540526|FG000|Overall Study|Protocol-driven decision point|59|||
127702571|NCT02043678|459540527|FG001|Overall Study|Protocol-driven decision point|58|||
127702572|NCT02043678|459540526|FG000|Overall Study|Withdrawal by Subject|16|||
127702573|NCT02043678|459540527|FG001|Overall Study|Withdrawal by Subject|20|||
127702574|NCT02043678|459540526|FG000|Overall Study|Protocol Violation|1|||
127702575|NCT02043678|459540527|FG001|Overall Study|Protocol Violation|0|||
127702576|NCT02043678|459540526|FG000|Overall Study|Deterioration of general conditions|1|||
127702577|NCT02043678|459540527|FG001|Overall Study|Deterioration of general conditions|1|||
127702578|NCT02043678|459540526|FG000|Overall Study|Logistical difficulties|2|||
127885527|NCT04380701|460203885|FG014|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
127885528|NCT04380701|460203886|FG015|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
127631392|NCT00982020|459272586|FG000|Overall Study|Parent/Caregiver Decision|5|||
127631393|NCT00982020|459272587|FG001|Overall Study|Parent/Caregiver Decision|5|||
127631394|NCT00982020|459272586|FG000|Overall Study|Treatment Non-compliance|3|||
127631395|NCT00982020|459272587|FG001|Overall Study|Treatment Non-compliance|6|||
127631396|NCT00982020|459272586|FG000|Overall Study|Physician Decision|2|||
127631397|NCT00982020|459272587|FG001|Overall Study|Physician Decision|5|||
127631398|NCT00982020|459272586|FG000|Overall Study|Entry Criteria Not Met|2|||
127631399|NCT00982020|459272587|FG001|Overall Study|Entry Criteria Not Met|1|||
127631400|NCT00982020|459272586|FG000|Overall Study|Protocol Violation|0|||
127631401|NCT00982020|459272587|FG001|Overall Study|Protocol Violation|2|||
127631402|NCT00982020|459272586|FG000|Overall Study|Clinical Relapse|0|||
127631403|NCT00982020|459272587|FG001|Overall Study|Clinical Relapse|1|||
127631404|NCT01854554|459272588|FG000|Overall Study|Denial of Insurance Coverage|12|||
127702579|NCT02043678|459540527|FG001|Overall Study|Logistical difficulties|0|||
127702580|NCT02043678|459540526|FG000|Overall Study|Non-compliance with study drug|3|||
127702581|NCT02043678|459540527|FG001|Overall Study|Non-compliance with study drug|1|||
127885529|NCT04380701|460203887|FG016|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
127631405|NCT01854554|459272589|FG001|Overall Study|Denial of Insurance Coverage|0|||
127631406|NCT01854554|459272588|FG000|Overall Study|Decided to get treatment locally|1|||
127631407|NCT01854554|459272589|FG001|Overall Study|Decided to get treatment locally|5|||
127631408|NCT01854554|459272588|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
127631409|NCT01854554|459272589|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
127631410|NCT01854554|459272588|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
127631411|NCT01854554|459272589|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
127702582|NCT02043678|459540526|FG000|Overall Study|Physician Decision|4|||
127631412|NCT01854554|459272588|FG000|Overall Study|Progression|0|||
127631413|NCT01854554|459272589|FG001|Overall Study|Progression|1|||
127631414|NCT01854554|459272588|FG000|Overall Study|Lost to Follow-up|0|||
127631415|NCT01854554|459272589|FG001|Overall Study|Lost to Follow-up|1|||
127631416|NCT02819726|459272590|FG000|Part A (All Participants)|Lost to Follow-up|0|||
127631417|NCT02819726|459272591|FG001|Part A (All Participants)|Lost to Follow-up|1|||
127631418|NCT02819726|459272592|FG002|Part A (All Participants)|Lost to Follow-up|0|||
127631419|NCT02819726|459272593|FG003|Part A (All Participants)|Lost to Follow-up|0|||
127631420|NCT02819726|459272590|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
127631421|NCT02819726|459272591|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
127631422|NCT02819726|459272592|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
127631423|NCT02819726|459272593|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
127631424|NCT02819726|459272590|FG000|Part A (All Participants)|Protocol non-compliance|3|||
127631425|NCT02819726|459272591|FG001|Part A (All Participants)|Protocol non-compliance|4|||
127631426|NCT02819726|459272592|FG002|Part A (All Participants)|Protocol non-compliance|5|||
127631427|NCT02819726|459272593|FG003|Part A (All Participants)|Protocol non-compliance|0|||
127631428|NCT02819726|459272590|FG000|Part B (All Participants)|Lost to Follow-up|1|||
127631429|NCT02819726|459272591|FG001|Part B (All Participants)|Lost to Follow-up|1|||
127631430|NCT02819726|459272592|FG002|Part B (All Participants)|Lost to Follow-up|2|||
127631431|NCT02819726|459272593|FG003|Part B (All Participants)|Lost to Follow-up|2|||
127631432|NCT02819726|459272590|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
127631433|NCT02819726|459272591|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
127631434|NCT02819726|459272592|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
127631435|NCT02819726|459272593|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
127631436|NCT02819726|459272590|FG000|Part B (All Participants)|Protocol non-compliance|0|||
127631437|NCT02819726|459272591|FG001|Part B (All Participants)|Protocol non-compliance|0|||
127631438|NCT02819726|459272592|FG002|Part B (All Participants)|Protocol non-compliance|1|||
127631439|NCT02819726|459272593|FG003|Part B (All Participants)|Protocol non-compliance|0|||
127631440|NCT02613481|459272594|FG000|Overall Study|Lost to Follow-up|7|||
127631441|NCT02613481|459272594|FG000|Overall Study|Withdrawal by Subject|2|||
127631442|NCT01921348|459272598|FG000|Overall Study|Withdrawal by Subject|1|||
127631443|NCT01921348|459272599|FG001|Overall Study|Withdrawal by Subject|0|||
127631444|NCT01921348|459272598|FG000|Overall Study|Lost to Follow-up|0|||
127631445|NCT01921348|459272599|FG001|Overall Study|Lost to Follow-up|2|||
127631446|NCT01248884|459272605|FG000|Overall Study|Withdrawal by Subject|1|||
127631447|NCT01248884|459272606|FG001|Overall Study|Withdrawal by Subject|3|||
127631448|NCT01248884|459272607|FG002|Overall Study|Withdrawal by Subject|1|||
127631449|NCT01248884|459272605|FG000|Overall Study|Adverse Event|1|||
127631450|NCT01248884|459272606|FG001|Overall Study|Adverse Event|0|||
127631451|NCT01248884|459272607|FG002|Overall Study|Adverse Event|0|||
127631452|NCT02511431|459272608|FG000|Treatment|Lost to Follow-up|0|||
127631453|NCT02511431|459272609|FG001|Treatment|Lost to Follow-up|0|||
127631454|NCT02511431|459272610|FG002|Treatment|Lost to Follow-up|1|||
127631455|NCT02511431|459272611|FG003|Treatment|Lost to Follow-up|0|||
127631456|NCT02511431|459272612|FG004|Treatment|Lost to Follow-up|0|||
127631457|NCT02511431|459272613|FG005|Treatment|Lost to Follow-up|1|||
127631458|NCT04479618|459272614|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
127631459|NCT04479618|459272615|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
127631460|NCT04479618|459272616|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
127631461|NCT04479618|459272614|FG000|Overall Study|Lack of Efficacy|1|||
127631462|NCT04479618|459272615|FG001|Overall Study|Lack of Efficacy|0|||
127631463|NCT04479618|459272616|FG002|Overall Study|Lack of Efficacy|0|||
127631464|NCT04479618|459272614|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
127631465|NCT04479618|459272615|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
127631466|NCT04479618|459272616|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
127631467|NCT04479618|459272614|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
127631468|NCT04479618|459272615|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
127631469|NCT04479618|459272616|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
127631470|NCT04479618|459272614|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
127631471|NCT04479618|459272615|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
127631472|NCT04479618|459272616|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
127631473|NCT04479618|459272614|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
127631474|NCT04479618|459272615|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
127631475|NCT04479618|459272616|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
127631476|NCT02828111|459272623|FG000|Overall Study|Withdrawal by Subject|0|||
127702583|NCT02043678|459540527|FG001|Overall Study|Physician Decision|3|||
127702584|NCT02043678|459540526|FG000|Overall Study|Subject decision|0|||
127702585|NCT02043678|459540527|FG001|Overall Study|Subject decision|1|||
127631477|NCT02828111|459272624|FG001|Overall Study|Withdrawal by Subject|0|||
127631478|NCT02828111|459272625|FG002|Overall Study|Withdrawal by Subject|2|||
127631479|NCT02828111|459272626|FG003|Overall Study|Withdrawal by Subject|0|||
127631480|NCT02828111|459272627|FG004|Overall Study|Withdrawal by Subject|0|||
127631481|NCT02828111|459272623|FG000|Overall Study|Lost to Follow-up|0|||
127631482|NCT02828111|459272624|FG001|Overall Study|Lost to Follow-up|0|||
127631483|NCT02828111|459272625|FG002|Overall Study|Lost to Follow-up|0|||
127631484|NCT02828111|459272626|FG003|Overall Study|Lost to Follow-up|1|||
127631485|NCT02828111|459272627|FG004|Overall Study|Lost to Follow-up|1|||
127631486|NCT03465540|459272630|FG000|Overall Study|Withdrawal by Subject|0|||
127631487|NCT03465540|459272631|FG001|Overall Study|Withdrawal by Subject|0|||
127631488|NCT03465540|459272632|FG002|Overall Study|Withdrawal by Subject|1|||
127631489|NCT03465540|459272633|FG003|Overall Study|Withdrawal by Subject|1|||
127631490|NCT03465540|459272634|FG004|Overall Study|Withdrawal by Subject|1|||
127631491|NCT03465540|459272635|FG005|Overall Study|Withdrawal by Subject|0|||
127631492|NCT03465540|459272630|FG000|Overall Study|Lost to Follow-up|0|||
127631493|NCT03465540|459272631|FG001|Overall Study|Lost to Follow-up|1|||
127631494|NCT03465540|459272632|FG002|Overall Study|Lost to Follow-up|0|||
127631495|NCT03465540|459272633|FG003|Overall Study|Lost to Follow-up|0|||
127631496|NCT03465540|459272634|FG004|Overall Study|Lost to Follow-up|1|||
127631497|NCT03465540|459272635|FG005|Overall Study|Lost to Follow-up|0|||
127631498|NCT03465540|459272630|FG000|Overall Study|Death|1|||
127631499|NCT03465540|459272631|FG001|Overall Study|Death|1|||
127631500|NCT03465540|459272632|FG002|Overall Study|Death|0|||
127631501|NCT03465540|459272633|FG003|Overall Study|Death|2|||
127631502|NCT03465540|459272634|FG004|Overall Study|Death|0|||
127631503|NCT03465540|459272635|FG005|Overall Study|Death|2|||
127631504|NCT03465540|459272630|FG000|Overall Study|Protocol specified criteria|0|||
127631505|NCT03465540|459272631|FG001|Overall Study|Protocol specified criteria|2|||
127631506|NCT03465540|459272632|FG002|Overall Study|Protocol specified criteria|2|||
127631507|NCT03465540|459272633|FG003|Overall Study|Protocol specified criteria|0|||
127631508|NCT03465540|459272634|FG004|Overall Study|Protocol specified criteria|2|||
127631509|NCT03465540|459272635|FG005|Overall Study|Protocol specified criteria|0|||
127631510|NCT02844946|459272636|FG000|Overall Study|Lost to Follow-up|7|||
127631511|NCT02844946|459272637|FG001|Overall Study|Lost to Follow-up|0|||
127631512|NCT02806986|459272638|FG000|Treatment Stage 1|Adverse Event|1|||
127631513|NCT02806986|459272638|FG000|Treatment Stage 2|Adverse Event|3|||
127631514|NCT02806986|459272638|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
127631515|NCT00462384|459272639|FG000|Overall Study|Adverse Event|2|||
127631516|NCT00462384|459272639|FG000|Overall Study|Death|2|||
127631517|NCT00462384|459272639|FG000|Overall Study|Withdrawal by Subject|1|||
127631518|NCT00462384|459272639|FG000|Overall Study|Other|4|||
127631519|NCT02667912|459272640|FG000|Overall Study|Death|3|||
127631520|NCT02667912|459272641|FG001|Overall Study|Death|1|||
127631521|NCT02667912|459272640|FG000|Overall Study|Withdrawal by Subject|1|||
127631522|NCT02667912|459272641|FG001|Overall Study|Withdrawal by Subject|2|||
127631523|NCT02667912|459272640|FG000|Overall Study|Withdrawal by Subject|1|||
127631524|NCT02667912|459272641|FG001|Overall Study|Withdrawal by Subject|0|||
127631525|NCT04443218|459272642|FG000|Overall Study|Exited study for other reasons|9|||
127631526|NCT04443218|459272642|FG000|Overall Study|Withdrawal by Subject|1|||
127631527|NCT04443218|459272642|FG000|Overall Study|Lost to Follow-up|4|||
127631528|NCT04443218|459272642|FG000|Overall Study|Death|19|||
127631529|NCT00022516|459272643|FG000|Overall Study|Adverse Event|0|||
127631530|NCT00022516|459272644|FG001|Overall Study|Adverse Event|59|||
127631531|NCT00022516|459272643|FG000|Overall Study|Lack of Efficacy|0|||
127631532|NCT00022516|459272644|FG001|Overall Study|Lack of Efficacy|27|||
127631533|NCT00022516|459272643|FG000|Overall Study|Physician Decision|0|||
127631534|NCT00022516|459272644|FG001|Overall Study|Physician Decision|1|||
127631535|NCT00022516|459272643|FG000|Overall Study|Protocol Violation|1|||
127631536|NCT00022516|459272644|FG001|Overall Study|Protocol Violation|3|||
127631537|NCT00022516|459272643|FG000|Overall Study|Withdrawal by Subject|2|||
127631538|NCT00022516|459272644|FG001|Overall Study|Withdrawal by Subject|113|||
127631539|NCT00022516|459272643|FG000|Overall Study|Incomplete documentation|0|||
127631540|NCT00022516|459272644|FG001|Overall Study|Incomplete documentation|27|||
127631541|NCT02209324|459272645|FG000|Overall Study|Adverse Event|2|||
127631542|NCT02209324|459272645|FG000|Overall Study|Lack of Efficacy|1|||
127631543|NCT02209324|459272645|FG000|Overall Study|Lost to Follow-up|1|||
127631544|NCT02209324|459272645|FG000|Overall Study|Physician Decision|3|||
127631545|NCT02209324|459272645|FG000|Overall Study|Protocol Violation|14|||
127631546|NCT02209324|459272645|FG000|Overall Study|Withdrawal by Subject|8|||
127631547|NCT02209324|459272645|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|4|||
127631548|NCT02209324|459272645|FG000|Overall Study|Platelet count < LLN in Laboratory test|7|||
127631549|NCT02209324|459272645|FG000|Overall Study|QT interval >-450 ms on measurement of an ECG|5|||
127631550|NCT03433456|459272646|FG000|Overall Study|Death|1|||
127631551|NCT03433456|459272647|FG001|Overall Study|Death|1|||
127631552|NCT03433456|459272646|FG000|Overall Study|Lost to Follow-up|14|||
127631553|NCT03433456|459272647|FG001|Overall Study|Lost to Follow-up|11|||
127631554|NCT03433456|459272646|FG000|Overall Study|Pt in ICU and unable to complete follow-up visit|1|||
127631555|NCT03433456|459272647|FG001|Overall Study|Pt in ICU and unable to complete follow-up visit|0|||
127631556|NCT05799495|459272648|FG000|Treatment (Up to 5 Days)|Adverse Event|0|||
127631557|NCT05799495|459272649|FG001|Treatment (Up to 5 Days)|Adverse Event|1|||
127631558|NCT05799495|459272650|FG002|Treatment (Up to 5 Days)|Adverse Event|1|||
127631559|NCT05799495|459272651|FG003|Treatment (Up to 5 Days)|Adverse Event|0|||
127631560|NCT05799495|459272648|FG000|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
127631561|NCT05799495|459272649|FG001|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
127631562|NCT05799495|459272650|FG002|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
127631563|NCT05799495|459272651|FG003|Treatment (Up to 5 Days)|Non-compliance with study drug|1|||
127631564|NCT05799495|459272648|FG000|Treatment (Up to 5 Days)|Other|0|||
127631565|NCT05799495|459272649|FG001|Treatment (Up to 5 Days)|Other|1|||
127631566|NCT05799495|459272650|FG002|Treatment (Up to 5 Days)|Other|0|||
127631567|NCT05799495|459272651|FG003|Treatment (Up to 5 Days)|Other|0|||
127631568|NCT05799495|459272648|FG000|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
127631569|NCT05799495|459272649|FG001|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
127631570|NCT05799495|459272650|FG002|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
127631571|NCT05799495|459272651|FG003|Treatment (Up to 5 Days)|Withdrawal by Subject|3|||
127631572|NCT05799495|459272648|FG000|Treatment (Up to 5 Days)|Randomized not treated|0|||
127631573|NCT05799495|459272649|FG001|Treatment (Up to 5 Days)|Randomized not treated|1|||
127631574|NCT05799495|459272650|FG002|Treatment (Up to 5 Days)|Randomized not treated|1|||
127631575|NCT05799495|459272651|FG003|Treatment (Up to 5 Days)|Randomized not treated|1|||
127631576|NCT05799495|459272648|FG000|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
127631577|NCT05799495|459272649|FG001|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
127631578|NCT05799495|459272650|FG002|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|1|||
127631579|NCT05799495|459272651|FG003|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
127631580|NCT03105362|459272652|FG000|Overall Study|Withdrawal by Subject|1|||
127631581|NCT03105362|459272652|FG000|Overall Study|Lost to Follow-up|1|||
127631582|NCT01198600|459272653|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
127631583|NCT01198600|459272654|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
127631584|NCT01198600|459272655|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
127631585|NCT01198600|459272656|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
127631586|NCT01198600|459272653|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
127631587|NCT01198600|459272654|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
127631588|NCT01198600|459272655|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
127631589|NCT01198600|459272656|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
127631590|NCT01198600|459272653|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
127631591|NCT01198600|459272654|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
127631592|NCT01198600|459272655|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
127631593|NCT01198600|459272656|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
127631594|NCT01198600|459272653|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
127631595|NCT01198600|459272654|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
127631596|NCT01198600|459272655|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
127631597|NCT01198600|459272656|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
127631598|NCT01198600|459272653|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
127631599|NCT01198600|459272654|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
127631600|NCT01198600|459272655|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
127631601|NCT01198600|459272656|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
127631602|NCT01198600|459272653|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
127631603|NCT01198600|459272654|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
127631604|NCT01198600|459272655|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
127631605|NCT01198600|459272656|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
127631606|NCT01198600|459272653|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
127631607|NCT01198600|459272654|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
127631608|NCT01198600|459272655|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
127631609|NCT01198600|459272656|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
127631610|NCT03694548|459272657|FG000|Part A Survey|Protocol Violation|3|||
127631611|NCT03694548|459272658|FG001|Part A Survey|Protocol Violation|3|||
127631612|NCT03694548|459272659|FG002|Part A Survey|Protocol Violation|0|||
127631613|NCT03694548|459272657|FG000|Part B Yoga Program|Protocol Violation|0|||
127631614|NCT03694548|459272658|FG001|Part B Yoga Program|Protocol Violation|0|||
127631615|NCT03694548|459272659|FG002|Part B Yoga Program|Protocol Violation|3|||
127631616|NCT03694548|459272657|FG000|Part B Yoga Program|Did not attend intervention|0|||
127631617|NCT03694548|459272658|FG001|Part B Yoga Program|Did not attend intervention|0|||
127631618|NCT03694548|459272659|FG002|Part B Yoga Program|Did not attend intervention|8|||
127631619|NCT04177108|459272660|FG000|Overall Study|Withdrawal by Subject|4|||
127631620|NCT04177108|459272661|FG001|Overall Study|Withdrawal by Subject|8|||
127631621|NCT04177108|459272662|FG002|Overall Study|Withdrawal by Subject|9|||
127631622|NCT04177108|459272663|FG003|Overall Study|Withdrawal by Subject|11|||
127631623|NCT04177108|459272664|FG004|Overall Study|Withdrawal by Subject|13|||
127631624|NCT04177108|459272660|FG000|Overall Study|Physician Decision|23|||
127631625|NCT04177108|459272661|FG001|Overall Study|Physician Decision|15|||
127631626|NCT04177108|459272662|FG002|Overall Study|Physician Decision|18|||
127631627|NCT04177108|459272663|FG003|Overall Study|Physician Decision|29|||
127631628|NCT04177108|459272664|FG004|Overall Study|Physician Decision|23|||
127631629|NCT04177108|459272660|FG000|Overall Study|Reason Not Specified|0|||
127631630|NCT04177108|459272661|FG001|Overall Study|Reason Not Specified|1|||
127631631|NCT04177108|459272662|FG002|Overall Study|Reason Not Specified|0|||
127631632|NCT04177108|459272663|FG003|Overall Study|Reason Not Specified|0|||
127631633|NCT04177108|459272664|FG004|Overall Study|Reason Not Specified|2|||
127631634|NCT04177108|459272660|FG000|Overall Study|Lost to Follow-up|0|||
127631635|NCT04177108|459272661|FG001|Overall Study|Lost to Follow-up|0|||
127631636|NCT04177108|459272662|FG002|Overall Study|Lost to Follow-up|1|||
127631637|NCT04177108|459272663|FG003|Overall Study|Lost to Follow-up|1|||
127631638|NCT04177108|459272664|FG004|Overall Study|Lost to Follow-up|1|||
127631639|NCT04177108|459272660|FG000|Overall Study|Death|16|||
127631640|NCT04177108|459272661|FG001|Overall Study|Death|19|||
127631641|NCT04177108|459272662|FG002|Overall Study|Death|13|||
127631642|NCT04177108|459272663|FG003|Overall Study|Death|17|||
127631643|NCT04177108|459272664|FG004|Overall Study|Death|18|||
127631644|NCT04496258|459272668|FG000|Overall Study|Withdrawal by Subject|2|||
127631645|NCT04496258|459272669|FG001|Overall Study|Withdrawal by Subject|1|||
127631646|NCT04102501|459272670|FG000|Overall Study|Withdrawal by Subject|7|||
127631647|NCT04102501|459272671|FG001|Overall Study|Withdrawal by Subject|9|||
127631648|NCT04102501|459272670|FG000|Overall Study|Adverse Event|1|||
127631649|NCT04102501|459272671|FG001|Overall Study|Adverse Event|3|||
127631650|NCT01427712|459272672|FG000|Overall Study|Transfer to a different hospital|2|||
127631651|NCT01427712|459272672|FG000|Overall Study|Lost to Follow-up|1|||
127631652|NCT01427712|459272672|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
127631653|NCT01427712|459272672|FG000|Overall Study|Failure to visit|1|||
127631654|NCT01669343|459272674|FG000|Part A: All Patients|Withdrawal by Subject|7|||
127631655|NCT01669343|459272674|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
127631656|NCT01669343|459272674|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
127631657|NCT01669343|459272674|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
127631658|NCT01669343|459272674|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
127631659|NCT04798586|459272676|FG000|Overall Study|Death|2|||
127631660|NCT00968617|459272677|FG000|Overall Study|Study terminated by sponsor|6|||
127631661|NCT04433767|459272678|FG000|Overall Study|Adverse Event|1|||
127631662|NCT00439777|459272688|FG000|Treatment Period|Death|29|||
127631663|NCT00439777|459272689|FG001|Treatment Period|Death|21|||
127631664|NCT00439777|459272688|FG000|Treatment Period|Study terminated by sponsor|125|||
127631665|NCT00439777|459272689|FG001|Treatment Period|Study terminated by sponsor|132|||
127631666|NCT00439777|459272688|FG000|Treatment Period|Site closed by investigator|0|||
127631667|NCT00439777|459272689|FG001|Treatment Period|Site closed by investigator|1|||
127631668|NCT00439777|459272688|FG000|Treatment Period|Did not take study treatment|7|||
127631669|NCT00439777|459272689|FG001|Treatment Period|Did not take study treatment|8|||
127631670|NCT00439777|459272688|FG000|Treatment Period|Adverse Event|111|||
127631671|NCT00439777|459272689|FG001|Treatment Period|Adverse Event|92|||
127631672|NCT00439777|459272688|FG000|Treatment Period|Protocol Violation|23|||
127631673|NCT00439777|459272689|FG001|Treatment Period|Protocol Violation|30|||
127631674|NCT00439777|459272688|FG000|Treatment Period|Withdrawal by Subject|66|||
127631675|NCT00439777|459272689|FG001|Treatment Period|Withdrawal by Subject|118|||
127631676|NCT00439777|459272688|FG000|Treatment Period|Lack of Efficacy|1|||
127631677|NCT00439777|459272689|FG001|Treatment Period|Lack of Efficacy|4|||
127631678|NCT00439777|459272688|FG000|Treatment Period|Lost to Follow-up|8|||
127631679|NCT00439777|459272689|FG001|Treatment Period|Lost to Follow-up|10|||
127631680|NCT00439777|459272688|FG000|Treatment Period|Protocol driven decision point|1|||
127631681|NCT00439777|459272689|FG001|Treatment Period|Protocol driven decision point|3|||
127631682|NCT00439777|459272688|FG000|Treatment Period|Physician Decision|7|||
127631683|NCT00439777|459272689|FG001|Treatment Period|Physician Decision|18|||
127631684|NCT00439777|459272688|FG000|Treatment Period|Clinical endpoint reached|26|||
127631685|NCT00439777|459272689|FG001|Treatment Period|Clinical endpoint reached|13|||
127631686|NCT00439777|459272688|FG000|Treatment Period|Technical problems|3|||
127631687|NCT00439777|459272689|FG001|Treatment Period|Technical problems|1|||
127631688|NCT00439777|459272688|FG000|Treatment Period|Participant convenience|12|||
127631689|NCT00439777|459272689|FG001|Treatment Period|Participant convenience|8|||
127631690|NCT00439777|459272688|FG000|Observational Period|Protocol Violation|0|||
127631691|NCT00439777|459272689|FG001|Observational Period|Protocol Violation|2|||
127631692|NCT00439777|459272688|FG000|Observational Period|Withdrawal by Subject|9|||
127631693|NCT00439777|459272689|FG001|Observational Period|Withdrawal by Subject|5|||
127631694|NCT00439777|459272688|FG000|Observational Period|Lost to Follow-up|1|||
127631695|NCT00439777|459272689|FG001|Observational Period|Lost to Follow-up|11|||
127631696|NCT00439777|459272688|FG000|Observational Period|Death|27|||
127631697|NCT00439777|459272689|FG001|Observational Period|Death|20|||
127631698|NCT00439777|459272688|FG000|Observational Period|Study terminated by sponsor|3|||
127631699|NCT00439777|459272689|FG001|Observational Period|Study terminated by sponsor|1|||
127631700|NCT00439777|459272688|FG000|Observational Period|Protocol driven decision point|0|||
127631701|NCT00439777|459272689|FG001|Observational Period|Protocol driven decision point|1|||
127631702|NCT00439777|459272688|FG000|Observational Period|Lack of Efficacy|1|||
127885530|NCT04380701|460203888|FG017|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
127631703|NCT00439777|459272689|FG001|Observational Period|Lack of Efficacy|0|||
127631704|NCT00439777|459272688|FG000|Observational Period|Technical problems|0|||
127631705|NCT00439777|459272689|FG001|Observational Period|Technical problems|1|||
127631706|NCT00661492|459272690|FG000|Overall Study|Adverse Event|16|||
127631707|NCT00661492|459272691|FG001|Overall Study|Adverse Event|13|||
127631708|NCT00661492|459272690|FG000|Overall Study|Disease Progression|44|||
127631709|NCT00661492|459272691|FG001|Overall Study|Disease Progression|14|||
127631710|NCT00661492|459272690|FG000|Overall Study|Patient Request|6|||
127631711|NCT00661492|459272691|FG001|Overall Study|Patient Request|1|||
127631712|NCT00661492|459272690|FG000|Overall Study|Investigator Request|1|||
127631713|NCT00661492|459272691|FG001|Overall Study|Investigator Request|0|||
127631714|NCT00661492|459272690|FG000|Overall Study|Lost to Follow-up|0|||
127631715|NCT00661492|459272691|FG001|Overall Study|Lost to Follow-up|1|||
127631716|NCT00661492|459272690|FG000|Overall Study|Other|1|||
127631717|NCT00661492|459272691|FG001|Overall Study|Other|0|||
127631718|NCT01024387|459272692|FG000|Overall Study|Radiographic Progression|29|||
127631719|NCT01024387|459272692|FG000|Overall Study|Symptomatic Progression|10|||
127631720|NCT01024387|459272692|FG000|Overall Study|Physician Decision|5|||
127631721|NCT01024387|459272692|FG000|Overall Study|Withdrawal by Subject|5|||
127631722|NCT01024387|459272692|FG000|Overall Study|Death|2|||
127631723|NCT01024387|459272692|FG000|Overall Study|Prolonged Treatment Delay|1|||
127631724|NCT01024387|459272692|FG000|Overall Study|Adverse Event|3|||
127631725|NCT01024387|459272692|FG000|Overall Study|Other|5|||
127631726|NCT03855189|459272693|FG000|Overall Study|Adverse Event|5|||
127631727|NCT03855189|459272694|FG001|Overall Study|Adverse Event|2|||
127631728|NCT03855189|459272695|FG002|Overall Study|Adverse Event|4|||
127631729|NCT03855189|459272693|FG000|Overall Study|Treatment Failure|1|||
127631730|NCT03855189|459272694|FG001|Overall Study|Treatment Failure|1|||
127631731|NCT03855189|459272695|FG002|Overall Study|Treatment Failure|2|||
127631732|NCT03855189|459272693|FG000|Overall Study|Noncompliance with Protocol|0|||
127631733|NCT03855189|459272694|FG001|Overall Study|Noncompliance with Protocol|1|||
127631734|NCT03855189|459272695|FG002|Overall Study|Noncompliance with Protocol|0|||
127631735|NCT03855189|459272693|FG000|Overall Study|Did Not Return|4|||
127631736|NCT03855189|459272694|FG001|Overall Study|Did Not Return|3|||
127631737|NCT03855189|459272695|FG002|Overall Study|Did Not Return|0|||
127631738|NCT01143259|459272696|FG000|Overall Study|Withdrawal by Subject|3|||
127631739|NCT01143259|459272697|FG001|Overall Study|Withdrawal by Subject|2|||
127631740|NCT01143259|459272696|FG000|Overall Study|Protocol Violation|13|||
127631741|NCT01143259|459272697|FG001|Overall Study|Protocol Violation|9|||
127631742|NCT01143259|459272696|FG000|Overall Study|Screen Failure|7|||
127631743|NCT01143259|459272697|FG001|Overall Study|Screen Failure|9|||
127631744|NCT00099983|459272698|FG000|Overall Study|Lost to Follow-up|2|||
127631745|NCT00099983|459272699|FG001|Overall Study|Lost to Follow-up|3|||
127631746|NCT00099983|459272698|FG000|Overall Study|Missing Source Documents|14|||
127631747|NCT00099983|459272699|FG001|Overall Study|Missing Source Documents|15|||
127631748|NCT00099983|459272698|FG000|Overall Study|Withdrawal by Subject|3|||
127631749|NCT00099983|459272699|FG001|Overall Study|Withdrawal by Subject|2|||
127631750|NCT00099983|459272698|FG000|Overall Study|Adverse Event|1|||
127631751|NCT00099983|459272699|FG001|Overall Study|Adverse Event|1|||
127631752|NCT00099983|459272698|FG000|Overall Study|Lack of Efficacy|0|||
127631753|NCT00099983|459272699|FG001|Overall Study|Lack of Efficacy|1|||
127631754|NCT00099983|459272698|FG000|Overall Study|Unable to return for appointments|1|||
127885531|NCT04380701|460203889|FG018|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
127631755|NCT00099983|459272699|FG001|Overall Study|Unable to return for appointments|1|||
127631756|NCT00099983|459272698|FG000|Overall Study|Moved|1|||
127631757|NCT00099983|459272699|FG001|Overall Study|Moved|0|||
127631758|NCT00099983|459272698|FG000|Overall Study|Other psychiatric problem|1|||
127631759|NCT00099983|459272699|FG001|Overall Study|Other psychiatric problem|0|||
127631760|NCT00099983|459272698|FG000|Overall Study|Incarcerated|0|||
127631761|NCT00099983|459272699|FG001|Overall Study|Incarcerated|1|||
127631762|NCT00099983|459272698|FG000|Overall Study|Intolerant of burden of visits|0|||
127631763|NCT00099983|459272699|FG001|Overall Study|Intolerant of burden of visits|1|||
127631764|NCT00099983|459272698|FG000|Overall Study|Other issue|1|||
127631765|NCT00099983|459272699|FG001|Overall Study|Other issue|0|||
127631766|NCT03191903|459272700|FG000|Overall Study|Withdrawal by Subject|6|||
127631767|NCT03191903|459272701|FG001|Overall Study|Withdrawal by Subject|5|||
127631768|NCT03191903|459272702|FG002|Overall Study|Withdrawal by Subject|4|||
127631769|NCT03191903|459272700|FG000|Overall Study|Adverse Event|1|||
127631770|NCT03191903|459272701|FG001|Overall Study|Adverse Event|0|||
127631771|NCT03191903|459272702|FG002|Overall Study|Adverse Event|0|||
127631772|NCT04369469|459272703|FG000|Overall Study|Lost to Follow-up|2|||
127631773|NCT04369469|459272704|FG001|Overall Study|Lost to Follow-up|4|||
127631774|NCT04369469|459272703|FG000|Overall Study|Physician Decision|2|||
127631775|NCT04369469|459272704|FG001|Overall Study|Physician Decision|1|||
127631776|NCT04369469|459272703|FG000|Overall Study|Withdrawal by Subject|2|||
127631777|NCT04369469|459272704|FG001|Overall Study|Withdrawal by Subject|3|||
127631778|NCT04369469|459272703|FG000|Overall Study|Adverse Event|1|||
127631779|NCT04369469|459272704|FG001|Overall Study|Adverse Event|0|||
127631780|NCT04369469|459272703|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
127631781|NCT04369469|459272704|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
127631782|NCT04369469|459272703|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
127631783|NCT04369469|459272704|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
127631784|NCT04369469|459272703|FG000|Overall Study|Unable to Provide Consent|0|||
127631785|NCT04369469|459272704|FG001|Overall Study|Unable to Provide Consent|1|||
127631786|NCT03099382|459272707|FG000|Overall Study|Protocol Violation|2|||
127631787|NCT03099382|459272708|FG001|Overall Study|Protocol Violation|3|||
127631788|NCT00499369|459272709|FG000|Overall Study|Adverse Event|2|||
127631789|NCT00499369|459272710|FG001|Overall Study|Adverse Event|2|||
127631790|NCT00499369|459272711|FG002|Overall Study|Adverse Event|3|||
127631791|NCT00499369|459272712|FG003|Overall Study|Adverse Event|1|||
127631792|NCT00499369|459272713|FG004|Overall Study|Adverse Event|2|||
127631793|NCT00499369|459272709|FG000|Overall Study|Withdrawal by Subject|0|||
127631794|NCT00499369|459272710|FG001|Overall Study|Withdrawal by Subject|1|||
127631795|NCT00499369|459272711|FG002|Overall Study|Withdrawal by Subject|1|||
127631796|NCT00499369|459272712|FG003|Overall Study|Withdrawal by Subject|0|||
127631797|NCT00499369|459272713|FG004|Overall Study|Withdrawal by Subject|0|||
127631798|NCT00499369|459272709|FG000|Overall Study|Progression|10|||
127631799|NCT00499369|459272710|FG001|Overall Study|Progression|12|||
127631800|NCT00499369|459272711|FG002|Overall Study|Progression|9|||
127631801|NCT00499369|459272712|FG003|Overall Study|Progression|6|||
127631802|NCT00499369|459272713|FG004|Overall Study|Progression|10|||
127631803|NCT00499369|459272709|FG000|Overall Study|Death|0|||
127631804|NCT00499369|459272710|FG001|Overall Study|Death|1|||
127631805|NCT00499369|459272711|FG002|Overall Study|Death|0|||
127631806|NCT00499369|459272712|FG003|Overall Study|Death|0|||
127631807|NCT00499369|459272713|FG004|Overall Study|Death|0|||
127631808|NCT00499369|459272709|FG000|Overall Study|Not protocol specified|2|||
127631809|NCT00499369|459272710|FG001|Overall Study|Not protocol specified|0|||
127631810|NCT00499369|459272711|FG002|Overall Study|Not protocol specified|3|||
127631811|NCT00499369|459272712|FG003|Overall Study|Not protocol specified|1|||
127631812|NCT00499369|459272713|FG004|Overall Study|Not protocol specified|0|||
127631813|NCT00499369|459272709|FG000|Overall Study|Ineligible|2|||
127631814|NCT00499369|459272710|FG001|Overall Study|Ineligible|2|||
127631815|NCT00499369|459272711|FG002|Overall Study|Ineligible|1|||
127631816|NCT00499369|459272712|FG003|Overall Study|Ineligible|1|||
127631817|NCT00499369|459272713|FG004|Overall Study|Ineligible|0|||
127631818|NCT01802411|459272714|FG000|Overall Study|Death|2|||
127631819|NCT01802411|459272715|FG001|Overall Study|Death|1|||
127631820|NCT01802411|459272714|FG000|Overall Study|Adverse Event|2|||
127631821|NCT01802411|459272715|FG001|Overall Study|Adverse Event|7|||
127631822|NCT01802411|459272714|FG000|Overall Study|Lack of Efficacy|8|||
127631823|NCT01802411|459272715|FG001|Overall Study|Lack of Efficacy|10|||
127631824|NCT01802411|459272714|FG000|Overall Study|Withdrawal by Subject|0|||
127702586|NCT02043678|459540526|FG000|Overall Study|Switching to other therapy|3|||
127702587|NCT02043678|459540527|FG001|Overall Study|Switching to other therapy|2|||
127631825|NCT01802411|459272715|FG001|Overall Study|Withdrawal by Subject|2|||
127631826|NCT01802411|459272714|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
127631827|NCT01802411|459272715|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
127631828|NCT01802411|459272714|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
127631829|NCT01802411|459272715|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
127631830|NCT01802411|459272714|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
127631831|NCT01802411|459272715|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
127631832|NCT03864614|459272718|FG000|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|116|||
127631833|NCT03864614|459272719|FG001|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|173|||
127631834|NCT03864614|459272720|FG002|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
127631835|NCT03864614|459272721|FG003|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
127631836|NCT03864614|459272718|FG000|Overall Study|Withdrawal by Subject|72|||
127631837|NCT03864614|459272719|FG001|Overall Study|Withdrawal by Subject|100|||
127631838|NCT03864614|459272720|FG002|Overall Study|Withdrawal by Subject|1|||
127631839|NCT03864614|459272721|FG003|Overall Study|Withdrawal by Subject|21|||
127631840|NCT03864614|459272718|FG000|Overall Study|Lost to Follow-up|45|||
127631841|NCT03864614|459272719|FG001|Overall Study|Lost to Follow-up|54|||
127631842|NCT03864614|459272720|FG002|Overall Study|Lost to Follow-up|0|||
127631843|NCT03864614|459272721|FG003|Overall Study|Lost to Follow-up|9|||
127631844|NCT03864614|459272718|FG000|Overall Study|Adverse Event|42|||
127631845|NCT03864614|459272719|FG001|Overall Study|Adverse Event|30|||
127631846|NCT03864614|459272720|FG002|Overall Study|Adverse Event|1|||
127631847|NCT03864614|459272721|FG003|Overall Study|Adverse Event|9|||
127631848|NCT03864614|459272718|FG000|Overall Study|Protocol Deviation|6|||
127631849|NCT03864614|459272719|FG001|Overall Study|Protocol Deviation|26|||
127631850|NCT03864614|459272720|FG002|Overall Study|Protocol Deviation|0|||
127631851|NCT03864614|459272721|FG003|Overall Study|Protocol Deviation|1|||
127631852|NCT03864614|459272718|FG000|Overall Study|Physician Decision|7|||
127631853|NCT03864614|459272719|FG001|Overall Study|Physician Decision|10|||
127631854|NCT03864614|459272720|FG002|Overall Study|Physician Decision|1|||
127631855|NCT03864614|459272721|FG003|Overall Study|Physician Decision|5|||
127631856|NCT03864614|459272718|FG000|Overall Study|Non-compliance With Investigational Drug|4|||
127631857|NCT03864614|459272719|FG001|Overall Study|Non-compliance With Investigational Drug|4|||
127631858|NCT03864614|459272720|FG002|Overall Study|Non-compliance With Investigational Drug|0|||
127631859|NCT03864614|459272721|FG003|Overall Study|Non-compliance With Investigational Drug|0|||
127631860|NCT03864614|459272718|FG000|Overall Study|Sponsor Decision|1|||
127631861|NCT03864614|459272719|FG001|Overall Study|Sponsor Decision|2|||
127631862|NCT03864614|459272720|FG002|Overall Study|Sponsor Decision|0|||
127631863|NCT03864614|459272721|FG003|Overall Study|Sponsor Decision|0|||
127631864|NCT03864614|459272718|FG000|Overall Study|Pregnancy|0|||
127631865|NCT03864614|459272719|FG001|Overall Study|Pregnancy|1|||
127631866|NCT03864614|459272720|FG002|Overall Study|Pregnancy|0|||
127631867|NCT03864614|459272721|FG003|Overall Study|Pregnancy|0|||
127631868|NCT03864614|459272718|FG000|Overall Study|Other|7|||
127631869|NCT03864614|459272719|FG001|Overall Study|Other|9|||
127631870|NCT03864614|459272720|FG002|Overall Study|Other|1|||
127631871|NCT03864614|459272721|FG003|Overall Study|Other|4|||
127631872|NCT03864614|459272718|FG000|Overall Study|Enrolled but did not receive SAGE-217|0|||
127631873|NCT03864614|459272719|FG001|Overall Study|Enrolled but did not receive SAGE-217|0|||
127631874|NCT03864614|459272720|FG002|Overall Study|Enrolled but did not receive SAGE-217|0|||
127631875|NCT03864614|459272721|FG003|Overall Study|Enrolled but did not receive SAGE-217|159|||
127631876|NCT01045447|459274719|FG000|Overall Study|Adverse Event|0|||
127631877|NCT01045447|459274720|FG001|Overall Study|Adverse Event|1|||
127631878|NCT01045447|459274719|FG000|Overall Study|Lack of Efficacy|3|||
127631879|NCT01045447|459274720|FG001|Overall Study|Lack of Efficacy|1|||
127631880|NCT01045447|459274719|FG000|Overall Study|Protocol Violation|6|||
127631881|NCT01045447|459274720|FG001|Overall Study|Protocol Violation|3|||
127631882|NCT01045447|459274719|FG000|Overall Study|Withdrawal Criteria|10|||
127631883|NCT01045447|459274720|FG001|Overall Study|Withdrawal Criteria|10|||
127702588|NCT02043678|459540526|FG000|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
127702589|NCT02043678|459540527|FG001|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
127702590|NCT02043678|459540526|FG000|Overall Study|Missing|1|||
127702591|NCT02043678|459540527|FG001|Overall Study|Missing|0|||
127631884|NCT01045447|459274719|FG000|Overall Study|Unclassified|17|||
127631885|NCT01045447|459274720|FG001|Overall Study|Unclassified|13|||
127631886|NCT00116805|459274722|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
127631887|NCT00116805|459274723|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
127702592|NCT02043678|459540526|FG000|Overall Study|Adverse Event|0|||
127702593|NCT02043678|459540527|FG001|Overall Study|Adverse Event|1|||
127702594|NCT05543629|459540528|FG000|Overall Study|Death|1|||
127702595|NCT05543629|459540529|FG001|Overall Study|Death|0|||
127702596|NCT05543629|459540530|FG002|Overall Study|Death|1|||
127885532|NCT04380701|460203890|FG019|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
127631888|NCT00116805|459274722|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
127702597|NCT05543629|459540531|FG003|Overall Study|Death|0|||
127702598|NCT05543629|459540532|FG004|Overall Study|Death|0|||
127631889|NCT00116805|459274723|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
127702599|NCT05543629|459540533|FG005|Overall Study|Death|1|||
127885533|NCT04380701|460203891|FG020|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
127631890|NCT00116805|459274722|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
127702600|NCT05543629|459540534|FG006|Overall Study|Death|2|||
127702601|NCT05543629|459540535|FG007|Overall Study|Death|2|||
127631891|NCT00116805|459274723|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
127631892|NCT00116805|459274722|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
127631893|NCT00116805|459274723|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
127631894|NCT00116805|459274722|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
127631895|NCT00116805|459274723|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
127631896|NCT00116805|459274722|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
127631897|NCT00116805|459274723|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
127631898|NCT00116805|459274722|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
127631899|NCT00116805|459274723|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
127631900|NCT00116805|459274722|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
127631901|NCT00116805|459274723|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
127631902|NCT00116805|459274722|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
127631903|NCT00116805|459274723|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
127631904|NCT00116805|459274722|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
127631905|NCT00116805|459274723|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
127631906|NCT00116805|459274722|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
127631907|NCT00116805|459274723|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
127631908|NCT00116805|459274722|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
127631909|NCT00116805|459274723|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
127631910|NCT00116805|459274722|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
127631911|NCT00116805|459274723|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
127631912|NCT00116805|459274722|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
127631913|NCT00116805|459274723|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
127631914|NCT00116805|459274722|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
127631915|NCT00116805|459274723|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
127631916|NCT00116805|459274722|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
127631917|NCT00116805|459274723|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
127702602|NCT05543629|459540528|FG000|Overall Study|Other Reasons|0|||
127631918|NCT00116805|459274722|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
127631919|NCT00116805|459274723|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
127631920|NCT00116805|459274722|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
127631921|NCT00116805|459274723|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
127631922|NCT00116805|459274722|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
127631923|NCT00116805|459274723|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
127631924|NCT00116805|459274722|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
127631925|NCT00116805|459274723|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
127631926|NCT00116805|459274722|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
127631927|NCT00116805|459274723|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
127631928|NCT00116805|459274722|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
127631929|NCT00116805|459274723|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
127631930|NCT00116805|459274722|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
127631931|NCT00116805|459274723|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
127631932|NCT00116805|459274722|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
127631933|NCT00116805|459274723|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
127631934|NCT00116805|459274722|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
127631935|NCT00116805|459274723|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
127631936|NCT00116805|459274722|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
127631937|NCT00116805|459274723|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
127631938|NCT00116805|459274722|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
127631939|NCT00116805|459274723|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
127631940|NCT00116805|459274722|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
127631941|NCT00116805|459274723|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
127631942|NCT00116805|459274722|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
127631943|NCT00116805|459274723|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
127631944|NCT00116805|459274722|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
127631945|NCT00116805|459274723|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
127631946|NCT00116805|459274722|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
127631947|NCT00116805|459274723|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
127631948|NCT00116805|459274722|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
127631949|NCT00116805|459274723|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
127631950|NCT00116805|459274722|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
127631951|NCT00116805|459274723|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
127631952|NCT00116805|459274722|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
127631953|NCT00116805|459274723|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
127631954|NCT00116805|459274722|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
127631955|NCT00116805|459274723|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
127631956|NCT00116805|459274722|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
127631957|NCT00116805|459274723|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
127631958|NCT00116805|459274722|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
127631959|NCT00116805|459274723|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
127631960|NCT00116805|459274722|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
127631961|NCT00116805|459274723|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
127631962|NCT00116805|459274722|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
127631963|NCT00116805|459274723|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
127631964|NCT00116805|459274722|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
127631965|NCT00116805|459274723|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
127631966|NCT00116805|459274722|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
127702603|NCT05543629|459540529|FG001|Overall Study|Other Reasons|0|||
127702604|NCT05543629|459540530|FG002|Overall Study|Other Reasons|0|||
127702605|NCT05543629|459540531|FG003|Overall Study|Other Reasons|0|||
127702606|NCT05543629|459540532|FG004|Overall Study|Other Reasons|1|||
127702607|NCT05543629|459540533|FG005|Overall Study|Other Reasons|0|||
127702608|NCT05543629|459540534|FG006|Overall Study|Other Reasons|0|||
127631967|NCT00116805|459274723|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
127631968|NCT00116805|459274722|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
127631969|NCT00116805|459274723|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
127631970|NCT00116805|459274722|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
127631971|NCT00116805|459274723|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
127631972|NCT00116805|459274722|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
127631973|NCT00116805|459274723|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
127631974|NCT00116805|459274722|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
127631975|NCT00116805|459274723|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
127631976|NCT01760954|459274724|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
127631977|NCT01760954|459274725|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
127631978|NCT01760954|459274726|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
127631979|NCT01760954|459274727|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
127631980|NCT01760954|459274724|FG000|Treatment Period (6 Months)|Adverse Event|5|||
127631981|NCT01760954|459274725|FG001|Treatment Period (6 Months)|Adverse Event|3|||
127631982|NCT01760954|459274726|FG002|Treatment Period (6 Months)|Adverse Event|4|||
127631983|NCT01760954|459274727|FG003|Treatment Period (6 Months)|Adverse Event|10|||
127631984|NCT01760954|459274724|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
127631985|NCT01760954|459274725|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
127631986|NCT01760954|459274726|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
127631987|NCT01760954|459274727|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
127631988|NCT01760954|459274724|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
127631989|NCT01760954|459274725|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
127631990|NCT01760954|459274726|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
127631991|NCT01760954|459274727|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
127631992|NCT01760954|459274724|FG000|Treatment Period (6 Months)|Pregnancy|5|||
127631993|NCT01760954|459274725|FG001|Treatment Period (6 Months)|Pregnancy|0|||
127631994|NCT01760954|459274726|FG002|Treatment Period (6 Months)|Pregnancy|3|||
127631995|NCT01760954|459274727|FG003|Treatment Period (6 Months)|Pregnancy|2|||
127631996|NCT01760954|459274724|FG000|Treatment Period (6 Months)|Non-compliance|1|||
127631997|NCT01760954|459274725|FG001|Treatment Period (6 Months)|Non-compliance|4|||
127631998|NCT01760954|459274726|FG002|Treatment Period (6 Months)|Non-compliance|0|||
127631999|NCT01760954|459274727|FG003|Treatment Period (6 Months)|Non-compliance|3|||
127632000|NCT01760954|459274724|FG000|Treatment Period (6 Months)|Other|0|||
127632001|NCT01760954|459274725|FG001|Treatment Period (6 Months)|Other|3|||
127632002|NCT01760954|459274726|FG002|Treatment Period (6 Months)|Other|3|||
127632003|NCT01760954|459274727|FG003|Treatment Period (6 Months)|Other|1|||
127632004|NCT01760954|459274724|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
127632005|NCT01760954|459274725|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
127632006|NCT01760954|459274726|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
127632007|NCT01760954|459274727|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
127632008|NCT01760954|459274724|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
127632009|NCT01760954|459274725|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
127632010|NCT01760954|459274726|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
127632011|NCT01760954|459274727|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
127632012|NCT01760954|459274724|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
127632013|NCT01760954|459274725|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
127632014|NCT01760954|459274726|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
127632015|NCT01760954|459274727|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
127632016|NCT01760954|459274724|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
127632017|NCT01760954|459274725|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
127632018|NCT01760954|459274726|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
127632019|NCT01760954|459274727|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
127632020|NCT01760954|459274724|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
127632021|NCT01760954|459274725|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
127632022|NCT01760954|459274726|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
127632023|NCT01760954|459274727|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
127632024|NCT01760954|459274724|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
127632025|NCT01760954|459274725|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
127632026|NCT01760954|459274726|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
127632027|NCT01760954|459274727|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
127632028|NCT01760954|459274724|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
127632029|NCT01760954|459274725|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
127632030|NCT01760954|459274726|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
127632031|NCT01760954|459274727|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
127632032|NCT01760954|459274724|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
127702609|NCT05543629|459540535|FG007|Overall Study|Other Reasons|0|||
127702610|NCT05543629|459540528|FG000|Overall Study|Physician Decision|0|||
127702611|NCT05543629|459540529|FG001|Overall Study|Physician Decision|0|||
127702612|NCT05543629|459540530|FG002|Overall Study|Physician Decision|3|||
127885534|NCT04380701|460203892|FG021|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|4|||
127885535|NCT04380701|460203893|FG022|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|2|||
127632033|NCT01760954|459274725|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
127632034|NCT01760954|459274726|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
127632035|NCT01760954|459274727|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
127632036|NCT03320070|459274728|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
127632037|NCT03320070|459274729|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
127632038|NCT03320070|459274728|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
127632039|NCT03320070|459274729|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
127632040|NCT03320070|459274728|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
127632041|NCT03320070|459274729|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
127632042|NCT03320070|459274728|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
127632043|NCT03320070|459274729|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
127632044|NCT03320070|459274728|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
127632045|NCT03320070|459274729|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
127632046|NCT03320070|459274728|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
127632047|NCT03320070|459274729|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
127632048|NCT00317772|459274733|FG000|Overall Study|Adverse Event|0|||
127632049|NCT00317772|459274734|FG001|Overall Study|Adverse Event|0|||
127632050|NCT00317772|459274735|FG002|Overall Study|Adverse Event|0|||
127632051|NCT00317772|459274736|FG003|Overall Study|Adverse Event|2|||
127632052|NCT00317772|459274733|FG000|Overall Study|Disease Progression|2|||
127632053|NCT00317772|459274734|FG001|Overall Study|Disease Progression|2|||
127632054|NCT00317772|459274735|FG002|Overall Study|Disease Progression|1|||
127632055|NCT00317772|459274736|FG003|Overall Study|Disease Progression|7|||
127632056|NCT00353704|459274749|FG000|Overall Study|Protocol Violation|3|||
127632057|NCT00353704|459274750|FG001|Overall Study|Protocol Violation|1|||
127632058|NCT04495374|459274751|FG000|Overall Study|Protocol Violation|2|||
127632059|NCT04495374|459274752|FG001|Overall Study|Protocol Violation|1|||
127632060|NCT02473614|459274753|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
127632061|NCT02473614|459274754|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
127632062|NCT01303627|459274755|FG000|Overall Study|the failure while performing URS|0|||
127632063|NCT01303627|459274756|FG001|Overall Study|the failure while performing URS|1|||
127632064|NCT01054820|459274758|FG000|Overall Study|Withdrawal by Subject|2|||
127632065|NCT01154166|459274759|FG000|Overall Study|Adverse Event|14|||
127632066|NCT01154166|459274760|FG001|Overall Study|Adverse Event|9|||
127632067|NCT01154166|459274759|FG000|Overall Study|Lost to Follow-up|1|||
127632068|NCT01154166|459274760|FG001|Overall Study|Lost to Follow-up|1|||
127632069|NCT01154166|459274759|FG000|Overall Study|Protocol Violation|4|||
127632070|NCT01154166|459274760|FG001|Overall Study|Protocol Violation|1|||
127632071|NCT01154166|459274759|FG000|Overall Study|Withdrawal by Subject|10|||
127632072|NCT01154166|459274760|FG001|Overall Study|Withdrawal by Subject|1|||
127632073|NCT01154166|459274759|FG000|Overall Study|Lack of Efficacy|3|||
127632074|NCT01154166|459274760|FG001|Overall Study|Lack of Efficacy|0|||
127632075|NCT01154166|459274759|FG000|Overall Study|Disease Progression|1|||
127632076|NCT01154166|459274760|FG001|Overall Study|Disease Progression|0|||
127632077|NCT01154166|459274759|FG000|Overall Study|Poor Compliance|1|||
127632078|NCT01154166|459274760|FG001|Overall Study|Poor Compliance|0|||
127632079|NCT00996996|459274761|FG000|Overall Study|Progressive Disease|10|||
127632080|NCT00996996|459274761|FG000|Overall Study|Non-compliance|8|||
127632081|NCT00996996|459274761|FG000|Overall Study|Lost to Follow-up|9|||
127632082|NCT00996996|459274761|FG000|Overall Study|Death|5|||
127632083|NCT00996996|459274761|FG000|Overall Study|Did Not Receive Study Medications|1|||
127632084|NCT01375049|459274764|FG000|Overall Study|Adverse Event|2|||
127632085|NCT01375049|459274764|FG000|Overall Study|Lost to Follow-up|1|||
127632086|NCT01375049|459274764|FG000|Overall Study|Withdrawal by Subject|2|||
127632087|NCT01375049|459274764|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
127632088|NCT01175382|459274767|FG000|Overall Study|Lost to Follow-up|4|||
127632089|NCT01175382|459274768|FG001|Overall Study|Lost to Follow-up|3|||
127632090|NCT01175382|459274769|FG002|Overall Study|Lost to Follow-up|1|||
127632091|NCT01175382|459274767|FG000|Overall Study|Physician Decision|0|||
127632092|NCT01175382|459274768|FG001|Overall Study|Physician Decision|1|||
127632093|NCT01175382|459274769|FG002|Overall Study|Physician Decision|0|||
127632094|NCT01175382|459274767|FG000|Overall Study|Withdrawal by Subject|0|||
127632095|NCT01175382|459274768|FG001|Overall Study|Withdrawal by Subject|0|||
127632096|NCT01175382|459274769|FG002|Overall Study|Withdrawal by Subject|1|||
127632097|NCT01175382|459274767|FG000|Overall Study|No longer having problem|1|||
127632098|NCT01175382|459274768|FG001|Overall Study|No longer having problem|0|||
127632099|NCT01175382|459274769|FG002|Overall Study|No longer having problem|1|||
127632100|NCT01175382|459274767|FG000|Overall Study|Unable/unwilling to attend visits|3|||
127632101|NCT01175382|459274768|FG001|Overall Study|Unable/unwilling to attend visits|1|||
127632102|NCT01175382|459274769|FG002|Overall Study|Unable/unwilling to attend visits|2|||
127632103|NCT01175382|459274767|FG000|Overall Study|Unwilling to follow protocol|0|||
127632104|NCT01175382|459274768|FG001|Overall Study|Unwilling to follow protocol|1|||
127632105|NCT01175382|459274769|FG002|Overall Study|Unwilling to follow protocol|0|||
127632106|NCT01175382|459274767|FG000|Overall Study|Unable to tolerate study meds|0|||
127632107|NCT01175382|459274768|FG001|Overall Study|Unable to tolerate study meds|1|||
127632108|NCT01175382|459274769|FG002|Overall Study|Unable to tolerate study meds|1|||
127632109|NCT00774787|459274770|FG000|Overall Study|Lost to Follow-up|1|||
127632110|NCT02554773|459274771|FG000|Original Dose Regimen (SAS 1)|Physician Decision|1|||
127632111|NCT02554773|459274772|FG001|Original Dose Regimen (SAS 1)|Physician Decision|0|||
127632112|NCT02554773|459274771|FG000|Original Dose Regimen (SAS 1)|Withdrawal by Subject|7|||
127632113|NCT02554773|459274772|FG001|Original Dose Regimen (SAS 1)|Withdrawal by Subject|0|||
127632114|NCT02554773|459274771|FG000|Original Dose Regimen (SAS 1)|Adverse Event|3|||
127632115|NCT02554773|459274772|FG001|Original Dose Regimen (SAS 1)|Adverse Event|0|||
127632116|NCT02554773|459274771|FG000|Original Dose Regimen (SAS 1)|Death|1|||
127632117|NCT02554773|459274772|FG001|Original Dose Regimen (SAS 1)|Death|0|||
127632118|NCT02554773|459274771|FG000|Original Dose Regimen (SAS 1)|Other|4|||
127632119|NCT02554773|459274772|FG001|Original Dose Regimen (SAS 1)|Other|0|||
127632120|NCT02554773|459274771|FG000|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|0|||
127632121|NCT02554773|459274772|FG001|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|1|||
127632122|NCT02554773|459274771|FG000|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|0|||
127632123|NCT02554773|459274772|FG001|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|1|||
127632124|NCT02554773|459274771|FG000|AT-Based Dose Regimen (SAS 2)|Adverse Event|0|||
127632125|NCT02554773|459274772|FG001|AT-Based Dose Regimen (SAS 2)|Adverse Event|1|||
127632126|NCT02554773|459274771|FG000|AT-Based Dose Regimen (SAS 2)|Other|0|||
127632127|NCT02554773|459274772|FG001|AT-Based Dose Regimen (SAS 2)|Other|3|||
127632128|NCT02031276|459274775|FG000|Period 1 Double-blind IV|Adverse Event|6|||
127632129|NCT02031276|459274776|FG001|Period 1 Double-blind IV|Adverse Event|5|||
127632130|NCT02031276|459274777|FG002|Period 1 Double-blind IV|Adverse Event|1|||
127632131|NCT02031276|459274775|FG000|Period 1 Double-blind IV|Other|0|||
127632132|NCT02031276|459274776|FG001|Period 1 Double-blind IV|Other|1|||
127632133|NCT02031276|459274777|FG002|Period 1 Double-blind IV|Other|0|||
127632134|NCT02031276|459274775|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
127632135|NCT02031276|459274776|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
127632136|NCT02031276|459274777|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
127632137|NCT02031276|459274775|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
127632138|NCT02031276|459274776|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
127632139|NCT02031276|459274777|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
127632140|NCT02031276|459274775|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
127632141|NCT02031276|459274776|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
127632142|NCT02031276|459274777|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
127632143|NCT02031276|459274775|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
127632144|NCT02031276|459274776|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
127632145|NCT02031276|459274777|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
127632146|NCT02031276|459274775|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
127632147|NCT02031276|459274776|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
127632148|NCT02031276|459274777|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
127632149|NCT02031276|459274775|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
127632150|NCT02031276|459274776|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
127632151|NCT02031276|459274777|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
127632152|NCT02031276|459274775|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
127632153|NCT02031276|459274776|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
127632154|NCT02031276|459274777|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
127632155|NCT01148810|459274778|FG000|Overall Study|Adverse Event|0|||
127632156|NCT01148810|459274779|FG001|Overall Study|Adverse Event|2|||
127632157|NCT01148810|459274778|FG000|Overall Study|Lack of Efficacy|0|||
127632158|NCT01148810|459274779|FG001|Overall Study|Lack of Efficacy|1|||
127632159|NCT01148810|459274778|FG000|Overall Study|Withdrawal by Subject|0|||
127632160|NCT01148810|459274779|FG001|Overall Study|Withdrawal by Subject|2|||
127632161|NCT01148810|459274778|FG000|Overall Study|Protocol Violation|1|||
127632162|NCT01148810|459274779|FG001|Overall Study|Protocol Violation|0|||
127632163|NCT04408469|459274784|FG000|Overall Study|Lost to Follow-up|6|||
127632164|NCT04408469|459274785|FG001|Overall Study|Lost to Follow-up|9|||
127632165|NCT04408469|459274784|FG000|Overall Study|Withdrawal by Subject|6|||
127632166|NCT04408469|459274785|FG001|Overall Study|Withdrawal by Subject|1|||
127632167|NCT04408469|459274784|FG000|Overall Study|Dismissal due to ineligibility|0|||
127632168|NCT04408469|459274785|FG001|Overall Study|Dismissal due to ineligibility|1|||
127632169|NCT01202773|459274786|FG000|Overall Study|Adverse Event|4|||
127632170|NCT01202773|459274787|FG001|Overall Study|Adverse Event|5|||
127632171|NCT01202773|459274788|FG002|Overall Study|Adverse Event|5|||
127632172|NCT01202773|459274786|FG000|Overall Study|Lack of Efficacy|5|||
127632173|NCT01202773|459274787|FG001|Overall Study|Lack of Efficacy|4|||
127632174|NCT01202773|459274788|FG002|Overall Study|Lack of Efficacy|9|||
127795736|NCT01662440|459875931|FG002|Overall Study|Protocol Violation|0|||
127632175|NCT01202773|459274786|FG000|Overall Study|Entry Criteria Not Met|2|||
127632176|NCT01202773|459274787|FG001|Overall Study|Entry Criteria Not Met|0|||
127795737|NCT01662440|459875932|FG003|Overall Study|Protocol Violation|0|||
127632177|NCT01202773|459274788|FG002|Overall Study|Entry Criteria Not Met|1|||
127632178|NCT01202773|459274786|FG000|Overall Study|Lost to Follow-up|1|||
127632179|NCT01202773|459274787|FG001|Overall Study|Lost to Follow-up|2|||
127632180|NCT01202773|459274788|FG002|Overall Study|Lost to Follow-up|2|||
127632181|NCT01202773|459274786|FG000|Overall Study|Withdrawal by Subject|13|||
127632182|NCT01202773|459274787|FG001|Overall Study|Withdrawal by Subject|6|||
127632183|NCT01202773|459274788|FG002|Overall Study|Withdrawal by Subject|5|||
127632184|NCT01202773|459274786|FG000|Overall Study|Physician Decision|2|||
127632185|NCT01202773|459274787|FG001|Overall Study|Physician Decision|0|||
127632186|NCT01202773|459274788|FG002|Overall Study|Physician Decision|0|||
127632187|NCT01202773|459274786|FG000|Overall Study|Protocol Violation|11|||
127632188|NCT01202773|459274787|FG001|Overall Study|Protocol Violation|6|||
127632189|NCT01202773|459274788|FG002|Overall Study|Protocol Violation|10|||
127702613|NCT05543629|459540531|FG003|Overall Study|Physician Decision|0|||
127632190|NCT01202773|459274786|FG000|Overall Study|Sponsor Decision|19|||
127632191|NCT01202773|459274787|FG001|Overall Study|Sponsor Decision|20|||
127632192|NCT01202773|459274788|FG002|Overall Study|Sponsor Decision|23|||
127702614|NCT05543629|459540532|FG004|Overall Study|Physician Decision|0|||
127702615|NCT05543629|459540533|FG005|Overall Study|Physician Decision|0|||
127632193|NCT00736996|459274794|FG000|Overall Study|Lost to Follow-up|1|||
127632194|NCT00736996|459274795|FG001|Overall Study|Lost to Follow-up|9|||
127632195|NCT00736996|459274796|FG002|Overall Study|Lost to Follow-up|2|||
127632196|NCT00346034|459274797|FG000|Overall Study|Adverse Event|34|||
127632197|NCT00346034|459274797|FG000|Overall Study|Lack of Efficacy|8|||
127702616|NCT05543629|459540534|FG006|Overall Study|Physician Decision|1|||
127632198|NCT00346034|459274797|FG000|Overall Study|Withdrawal by Subject|13|||
127632199|NCT00346034|459274797|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
127632200|NCT00346034|459274797|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
127632201|NCT01255358|459274798|FG000|Overall Study|Adverse Event|2|||
127632202|NCT01255358|459274798|FG000|Overall Study|Protocol Violation|2|||
127632203|NCT00797667|459274799|FG000|Overall Study|Lack of Efficacy|0|||
127632204|NCT00797667|459274800|FG001|Overall Study|Lack of Efficacy|1|||
127632205|NCT00797667|459274801|FG002|Overall Study|Lack of Efficacy|0|||
127632206|NCT00797667|459274799|FG000|Overall Study|Lost to Follow-up|8|||
127632207|NCT00797667|459274800|FG001|Overall Study|Lost to Follow-up|12|||
127632208|NCT00797667|459274801|FG002|Overall Study|Lost to Follow-up|2|||
127632209|NCT00797667|459274799|FG000|Overall Study|Physician Decision|3|||
127632210|NCT00797667|459274800|FG001|Overall Study|Physician Decision|1|||
127632211|NCT00797667|459274801|FG002|Overall Study|Physician Decision|0|||
127632212|NCT00797667|459274799|FG000|Overall Study|Pregnancy|2|||
127632213|NCT00797667|459274800|FG001|Overall Study|Pregnancy|0|||
127632214|NCT00797667|459274801|FG002|Overall Study|Pregnancy|0|||
127632215|NCT00797667|459274799|FG000|Overall Study|Protocol Violation|2|||
127632216|NCT00797667|459274800|FG001|Overall Study|Protocol Violation|7|||
127632217|NCT00797667|459274801|FG002|Overall Study|Protocol Violation|0|||
127632218|NCT00797667|459274799|FG000|Overall Study|Study Terminated by Sponsor|217|||
127632219|NCT00797667|459274800|FG001|Overall Study|Study Terminated by Sponsor|216|||
127632220|NCT00797667|459274801|FG002|Overall Study|Study Terminated by Sponsor|115|||
127632221|NCT00797667|459274799|FG000|Overall Study|Withdrawal by Subject|9|||
127632222|NCT00797667|459274800|FG001|Overall Study|Withdrawal by Subject|14|||
127632223|NCT00797667|459274801|FG002|Overall Study|Withdrawal by Subject|2|||
127632224|NCT00797667|459274799|FG000|Overall Study|Adverse Event|19|||
127632225|NCT00797667|459274800|FG001|Overall Study|Adverse Event|8|||
127632226|NCT00797667|459274801|FG002|Overall Study|Adverse Event|8|||
127632227|NCT01986829|459274802|FG000|Overall Study|Death|1|||
127632228|NCT02504866|459274803|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
127632229|NCT02504866|459274804|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
127632230|NCT02504866|459274805|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
127632231|NCT00781326|459274808|FG000|Phase I|Adverse Event|1|||
127632232|NCT00781326|459274808|FG000|Phase I|Withdrawal by Subject|1|||
127632233|NCT00781326|459274808|FG000|Phase I|Physician Decision|2|||
127632234|NCT00096941|459274809|FG000|Overall Study|disease progression|3|||
127632235|NCT01343056|459274810|FG000|Overall Study|Lost to Follow-up|7|||
127632236|NCT01343056|459274811|FG001|Overall Study|Lost to Follow-up|5|||
127632237|NCT01343056|459274812|FG002|Overall Study|Lost to Follow-up|3|||
127632238|NCT01343056|459274813|FG003|Overall Study|Lost to Follow-up|9|||
127632239|NCT03231371|459274814|FG000|Overall Study|Withdrawal by Subject|1|||
127632240|NCT03231371|459274814|FG000|Overall Study|chose or were ineligible to have MRI|12|||
127632241|NCT03029208|459274815|FG000|Overall Study|Withdrawal by Subject|2|||
127632242|NCT03029208|459274816|FG001|Overall Study|Withdrawal by Subject|3|||
127702617|NCT05543629|459540535|FG007|Overall Study|Physician Decision|0|||
127702618|NCT05543629|459540528|FG000|Overall Study|Study terminated by Sponsor|1|||
127632243|NCT03029208|459274815|FG000|Overall Study|Lost to Follow-up|0|||
127632244|NCT03029208|459274816|FG001|Overall Study|Lost to Follow-up|1|||
127632245|NCT01732835|459274819|FG000|6-month Primary Endpoint|Did not receive device|19|||
127632246|NCT01732835|459274819|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
127632247|NCT01732835|459274819|FG000|6-month Primary Endpoint|Adverse Event|3|||
127632248|NCT01732835|459274819|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
127632249|NCT01732835|459274819|FG000|2-year Extended Follow-up|Adverse Event|3|||
127632250|NCT01732835|459274819|FG000|2-year Extended Follow-up|Death|1|||
127702619|NCT05543629|459540529|FG001|Overall Study|Study terminated by Sponsor|0|||
127632251|NCT02493361|459274820|FG000|Overall Study|Withdrawal by Subject|3|||
127632252|NCT02334748|459274821|FG000|Overall Study|Adverse Event|1|||
127632253|NCT02334748|459274821|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
127632254|NCT02334748|459274821|FG000|Overall Study|Patient no longer required study drug|2|||
127632255|NCT02334748|459274821|FG000|Overall Study|Lack of Efficacy|4|||
127632256|NCT01046643|459274822|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
127632257|NCT01046643|459274823|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
127632258|NCT01046643|459274824|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
127632259|NCT01046643|459274825|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
127632260|NCT00305058|459274832|FG000|Overall Study|Participant too young|1|||
127632261|NCT00305058|459274833|FG001|Overall Study|Participant too young|0|||
127632262|NCT00305058|459274832|FG000|Overall Study|Missing data collection instrument|3|||
127632263|NCT00305058|459274833|FG001|Overall Study|Missing data collection instrument|2|||
127632264|NCT00305058|459274832|FG000|Overall Study|Missing outcome data|3|||
127795738|NCT01662440|459875929|FG000|Overall Study|Withdrawal by Subject|5|||
127702620|NCT05543629|459540530|FG002|Overall Study|Study terminated by Sponsor|0|||
127702621|NCT05543629|459540531|FG003|Overall Study|Study terminated by Sponsor|1|||
127885536|NCT04380701|460203894|FG023|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|16|||
127632265|NCT00305058|459274833|FG001|Overall Study|Missing outcome data|2|||
127632266|NCT02371369|459274834|FG000|Part 1|Physician Decision|0|||
127632267|NCT02371369|459274835|FG001|Part 1|Physician Decision|3|||
127632268|NCT02371369|459274834|FG000|Part 1|Adverse Event|8|||
127632269|NCT02371369|459274835|FG001|Part 1|Adverse Event|0|||
127632270|NCT02371369|459274834|FG000|Part 1|Withdrawal by Subject|1|||
127632271|NCT02371369|459274835|FG001|Part 1|Withdrawal by Subject|6|||
127632272|NCT02371369|459274834|FG000|Part 1|Disease progression|0|||
127632273|NCT02371369|459274835|FG001|Part 1|Disease progression|1|||
127632274|NCT02371369|459274834|FG000|Part 1|Protocol Violation|0|||
127632275|NCT02371369|459274835|FG001|Part 1|Protocol Violation|1|||
127632276|NCT02371369|459274834|FG000|Part 2|Adverse Event|6|||
127632277|NCT02371369|459274835|FG001|Part 2|Adverse Event|5|||
127632278|NCT02371369|459274834|FG000|Part 2|Withdrawal by Subject|16|||
127632279|NCT02371369|459274835|FG001|Part 2|Withdrawal by Subject|6|||
127632280|NCT02371369|459274834|FG000|Part 2|Investigator decision|1|||
127632281|NCT02371369|459274835|FG001|Part 2|Investigator decision|2|||
127632282|NCT02371369|459274834|FG000|Part 2|Death|0|||
127632283|NCT02371369|459274835|FG001|Part 2|Death|1|||
127632284|NCT02371369|459274834|FG000|Part 2|Disease progression|1|||
127632285|NCT02371369|459274835|FG001|Part 2|Disease progression|0|||
127632286|NCT02371369|459274834|FG000|Part 2|Subject Noncompliance|1|||
127632287|NCT02371369|459274835|FG001|Part 2|Subject Noncompliance|0|||
127632288|NCT02371369|459274834|FG000|Part 2|Lost to Follow-up|1|||
127632289|NCT02371369|459274835|FG001|Part 2|Lost to Follow-up|1|||
127632290|NCT02371369|459274834|FG000|Part 2|Subject transitioned to commercial supply|6|||
127795739|NCT01662440|459875930|FG001|Overall Study|Withdrawal by Subject|2|||
127795740|NCT01662440|459875931|FG002|Overall Study|Withdrawal by Subject|2|||
127795741|NCT01662440|459875932|FG003|Overall Study|Withdrawal by Subject|2|||
127795742|NCT00264004|459875933|FG000|Overall Study|Adverse Event|2|||
127795743|NCT00264004|459875934|FG001|Overall Study|Adverse Event|3|||
127795744|NCT00264004|459875935|FG002|Overall Study|Adverse Event|6|||
127795745|NCT00264004|459875936|FG003|Overall Study|Adverse Event|4|||
127795746|NCT00264004|459875933|FG000|Overall Study|Withdrawal by Subject|0|||
127795747|NCT00264004|459875934|FG001|Overall Study|Withdrawal by Subject|1|||
127795748|NCT00264004|459875935|FG002|Overall Study|Withdrawal by Subject|2|||
127795749|NCT00264004|459875936|FG003|Overall Study|Withdrawal by Subject|2|||
127795750|NCT00264004|459875933|FG000|Overall Study|Other|2|||
127795751|NCT00264004|459875934|FG001|Overall Study|Other|2|||
127795752|NCT00264004|459875935|FG002|Overall Study|Other|0|||
127795753|NCT00264004|459875936|FG003|Overall Study|Other|3|||
127795754|NCT00264004|459875933|FG000|Overall Study|Development study specific disc. crit.|1|||
127795755|NCT00264004|459875934|FG001|Overall Study|Development study specific disc. crit.|0|||
127795756|NCT00264004|459875935|FG002|Overall Study|Development study specific disc. crit.|1|||
127795757|NCT00264004|459875936|FG003|Overall Study|Development study specific disc. crit.|0|||
127795758|NCT00264004|459875933|FG000|Overall Study|Cond. under inv. worsened|9|||
127795759|NCT00264004|459875934|FG001|Overall Study|Cond. under inv. worsened|5|||
127795760|NCT00264004|459875935|FG002|Overall Study|Cond. under inv. worsened|3|||
127795761|NCT00264004|459875936|FG003|Overall Study|Cond. under inv. worsened|4|||
127795762|NCT00264004|459875933|FG000|Overall Study|Not treated|3|||
127795763|NCT00264004|459875934|FG001|Overall Study|Not treated|0|||
127795764|NCT00264004|459875935|FG002|Overall Study|Not treated|2|||
127795765|NCT00264004|459875936|FG003|Overall Study|Not treated|2|||
127795766|NCT00691483|459875937|FG000|Overall Study|Adverse Event|14|||
127795767|NCT00691483|459875938|FG001|Overall Study|Adverse Event|6|||
127795768|NCT00691483|459875937|FG000|Overall Study|Lost to Follow-up|17|||
127795769|NCT00691483|459875938|FG001|Overall Study|Lost to Follow-up|10|||
127795770|NCT00691483|459875937|FG000|Overall Study|Withdrawal by Subject|24|||
127795771|NCT00691483|459875938|FG001|Overall Study|Withdrawal by Subject|7|||
127795772|NCT00691483|459875937|FG000|Overall Study|Other known cause|6|||
127795773|NCT00691483|459875938|FG001|Overall Study|Other known cause|1|||
127795774|NCT00691483|459875937|FG000|Overall Study|Randomized by not treated|7|||
127632291|NCT02371369|459274835|FG001|Part 2|Subject transitioned to commercial supply|4|||
127795775|NCT00691483|459875938|FG001|Overall Study|Randomized by not treated|1|||
127795776|NCT00049673|459875940|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
127795777|NCT00049673|459875941|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
127632292|NCT02371369|459274834|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
127795778|NCT02475681|459875942|FG000|Overall Study|Death|16|||
127632293|NCT02371369|459274835|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
127632294|NCT02371369|459274834|FG000|Part 2|Surgical resection of tumor|1|||
127632295|NCT02371369|459274835|FG001|Part 2|Surgical resection of tumor|1|||
127632296|NCT02371369|459274834|FG000|Part 2|Other|0|||
127632297|NCT02371369|459274835|FG001|Part 2|Other|1|||
127632298|NCT02641080|459274836|FG000|Overall Study|Physician Decision|2|||
127632299|NCT02641080|459274837|FG001|Overall Study|Physician Decision|0|||
127632300|NCT02641080|459274836|FG000|Overall Study|Withdrawal by Subject|0|||
127632301|NCT02641080|459274837|FG001|Overall Study|Withdrawal by Subject|1|||
127632302|NCT02641080|459274836|FG000|Overall Study|Rehab Center denied use of pumps|0|||
127632303|NCT02641080|459274837|FG001|Overall Study|Rehab Center denied use of pumps|3|||
127632304|NCT02641080|459274836|FG000|Overall Study|Lost to Follow-up|0|||
127632305|NCT02641080|459274837|FG001|Overall Study|Lost to Follow-up|3|||
127632306|NCT00803634|459274838|FG000|Overall Study|Withdrew Consent|1|||
127632307|NCT00803634|459274839|FG001|Overall Study|Withdrew Consent|0|||
127632308|NCT00803634|459274838|FG000|Overall Study|Lost to Follow-up|2|||
127632309|NCT00803634|459274839|FG001|Overall Study|Lost to Follow-up|3|||
127632310|NCT00803634|459274838|FG000|Overall Study|Death|3|||
127632311|NCT00803634|459274839|FG001|Overall Study|Death|2|||
127632312|NCT04307186|459274842|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
127632313|NCT04307186|459274842|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
127632314|NCT04307186|459274842|FG000|Washout 3-14 Days|Progressive disease|1|||
127632315|NCT04307186|459274842|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
127632316|NCT04307186|459274842|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
127632317|NCT00503685|459274856|FG000|Overall Study|Adverse Event|0|||
127632318|NCT00503685|459274857|FG001|Overall Study|Adverse Event|0|||
127632319|NCT00503685|459274858|FG002|Overall Study|Adverse Event|2|||
127632320|NCT00503685|459274856|FG000|Overall Study|Withdrawal by Subject|0|||
127632321|NCT00503685|459274857|FG001|Overall Study|Withdrawal by Subject|1|||
127632322|NCT00503685|459274858|FG002|Overall Study|Withdrawal by Subject|0|||
127632323|NCT00503685|459274856|FG000|Overall Study|Protocol Violation|0|||
127632324|NCT00503685|459274857|FG001|Overall Study|Protocol Violation|1|||
127632325|NCT00503685|459274858|FG002|Overall Study|Protocol Violation|0|||
127632326|NCT00503685|459274856|FG000|Overall Study|Eligibility Criteria Not Met|0|||
127632327|NCT00503685|459274857|FG001|Overall Study|Eligibility Criteria Not Met|1|||
127632328|NCT00503685|459274858|FG002|Overall Study|Eligibility Criteria Not Met|0|||
127632329|NCT00927927|459274859|FG000|Overall Study|Withdrawal by Subject|0|||
127632330|NCT00927927|459274860|FG001|Overall Study|Withdrawal by Subject|0|||
127632331|NCT00927927|459274861|FG002|Overall Study|Withdrawal by Subject|0|||
127632332|NCT00927927|459274862|FG003|Overall Study|Withdrawal by Subject|0|||
127632333|NCT00927927|459274863|FG004|Overall Study|Withdrawal by Subject|0|||
127632334|NCT00927927|459274864|FG005|Overall Study|Withdrawal by Subject|0|||
127632335|NCT00927927|459274865|FG006|Overall Study|Withdrawal by Subject|0|||
127632336|NCT00927927|459274866|FG007|Overall Study|Withdrawal by Subject|2|||
127632337|NCT00927927|459274867|FG008|Overall Study|Withdrawal by Subject|0|||
127632338|NCT00927927|459274868|FG009|Overall Study|Withdrawal by Subject|0|||
127632339|NCT00927927|459274869|FG010|Overall Study|Withdrawal by Subject|0|||
127632340|NCT00927927|459274870|FG011|Overall Study|Withdrawal by Subject|2|||
127632341|NCT00927927|459274871|FG012|Overall Study|Withdrawal by Subject|0|||
127632342|NCT00927927|459274872|FG013|Overall Study|Withdrawal by Subject|0|||
127632343|NCT00927927|459274873|FG014|Overall Study|Withdrawal by Subject|0|||
127632344|NCT01110239|459274880|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
127632345|NCT01110239|459274881|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
127632346|NCT01110239|459274882|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
127632347|NCT01110239|459274883|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
127632348|NCT01110239|459274880|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
127632349|NCT01110239|459274881|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
127632350|NCT01110239|459274882|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
127632351|NCT01110239|459274883|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
127632352|NCT00080223|459274886|FG000|Overall Study|Adverse Event|23|||
127632353|NCT00080223|459274886|FG000|Overall Study|Death|21|||
127632354|NCT00080223|459274886|FG000|Overall Study|Withdrawal by Subject|13|||
127632355|NCT00080223|459274886|FG000|Overall Study|Lung Transplantation|9|||
127632356|NCT00080223|459274886|FG000|Overall Study|Non-compliance With Study Treatment|7|||
127632357|NCT00080223|459274886|FG000|Overall Study|Participant unwilling to continue|2|||
127632358|NCT00080223|459274886|FG000|Overall Study|Physician Decision|1|||
127632359|NCT05204134|459274889|FG000|Overall Study|Withdrawal by Subject|3|||
127632360|NCT05204134|459274889|FG000|Overall Study|Physician Decision|1|||
127632361|NCT03135522|459274891|FG000|Overall Study|Adverse Event|1|||
127632362|NCT03135522|459274892|FG001|Overall Study|Adverse Event|0|||
127632363|NCT02838017|459274893|FG000|Overall Study|Lost to Follow-up|14|||
127632364|NCT02838017|459274894|FG001|Overall Study|Lost to Follow-up|11|||
127632365|NCT02120924|459274895|FG000|Overall Study|Lack of Efficacy|1|||
127632366|NCT02120924|459274896|FG001|Overall Study|Lack of Efficacy|2|||
127632367|NCT02120924|459274897|FG002|Overall Study|Lack of Efficacy|3|||
127632368|NCT02120924|459274895|FG000|Overall Study|Adverse Event|0|||
127632369|NCT02120924|459274896|FG001|Overall Study|Adverse Event|1|||
127632370|NCT02120924|459274897|FG002|Overall Study|Adverse Event|3|||
127632371|NCT02120924|459274895|FG000|Overall Study|Withdrawal by Subject|16|||
127632372|NCT02120924|459274896|FG001|Overall Study|Withdrawal by Subject|20|||
127632373|NCT02120924|459274897|FG002|Overall Study|Withdrawal by Subject|8|||
127632374|NCT02120924|459274895|FG000|Overall Study|Lost to Follow-up|14|||
127885537|NCT04380701|460203895|FG024|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|55|||
127632375|NCT02120924|459274896|FG001|Overall Study|Lost to Follow-up|14|||
127632376|NCT02120924|459274897|FG002|Overall Study|Lost to Follow-up|11|||
127632377|NCT02120924|459274895|FG000|Overall Study|Pregnancy|2|||
127632378|NCT02120924|459274896|FG001|Overall Study|Pregnancy|0|||
127632379|NCT02120924|459274897|FG002|Overall Study|Pregnancy|0|||
127632380|NCT02120924|459274895|FG000|Overall Study|Protocol Violation|3|||
127632381|NCT02120924|459274896|FG001|Overall Study|Protocol Violation|7|||
127632382|NCT02120924|459274897|FG002|Overall Study|Protocol Violation|2|||
127632383|NCT02120924|459274895|FG000|Overall Study|Physician Decision|0|||
127632384|NCT02120924|459274896|FG001|Overall Study|Physician Decision|1|||
127632385|NCT02120924|459274897|FG002|Overall Study|Physician Decision|1|||
127632386|NCT02120924|459274895|FG000|Overall Study|Death|1|||
127632387|NCT02120924|459274896|FG001|Overall Study|Death|0|||
127632388|NCT02120924|459274897|FG002|Overall Study|Death|0|||
127632389|NCT02120924|459274895|FG000|Overall Study|Compliance with IP|5|||
127632390|NCT02120924|459274896|FG001|Overall Study|Compliance with IP|1|||
127632391|NCT02120924|459274897|FG002|Overall Study|Compliance with IP|1|||
127632392|NCT01884350|459274898|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
127632393|NCT01884350|459274899|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
127795779|NCT02475681|459875943|FG001|Overall Study|Death|6|||
127632394|NCT01884350|459274900|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
127632395|NCT01884350|459274898|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
127632396|NCT01884350|459274899|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
127632397|NCT01884350|459274900|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
127632398|NCT01884350|459274898|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
127632399|NCT01884350|459274899|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
127632400|NCT01884350|459274900|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
127632401|NCT01884350|459274898|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
127632402|NCT01884350|459274899|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
127632403|NCT01884350|459274900|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
127632404|NCT01884350|459274898|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
127632405|NCT01884350|459274899|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
127632406|NCT01884350|459274900|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
127632407|NCT01884350|459274898|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
127632408|NCT01884350|459274899|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
127632409|NCT01884350|459274900|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
127632410|NCT01884350|459274898|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
127632411|NCT01884350|459274899|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
127632412|NCT01884350|459274900|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
127795780|NCT02475681|459875944|FG002|Overall Study|Death|9|||
127795781|NCT02475681|459875942|FG000|Overall Study|Physician Decision|0|||
127795782|NCT02475681|459875943|FG001|Overall Study|Physician Decision|3|||
127795783|NCT02475681|459875944|FG002|Overall Study|Physician Decision|1|||
127795784|NCT02475681|459875942|FG000|Overall Study|Withdrawal by Subject|12|||
127795785|NCT02475681|459875943|FG001|Overall Study|Withdrawal by Subject|6|||
127795786|NCT02475681|459875944|FG002|Overall Study|Withdrawal by Subject|9|||
127795787|NCT02475681|459875942|FG000|Overall Study|Lost to Follow-up|2|||
127795788|NCT02475681|459875943|FG001|Overall Study|Lost to Follow-up|1|||
127795789|NCT02475681|459875944|FG002|Overall Study|Lost to Follow-up|3|||
127795790|NCT02475681|459875942|FG000|Overall Study|Ongoing in Study|0|||
127795791|NCT02475681|459875943|FG001|Overall Study|Ongoing in Study|163|||
127795792|NCT02475681|459875944|FG002|Overall Study|Ongoing in Study|157|||
127795793|NCT02475681|459875942|FG000|Overall Study|Reasons other than above listed|2|||
127795794|NCT02475681|459875943|FG001|Overall Study|Reasons other than above listed|0|||
127795795|NCT02475681|459875944|FG002|Overall Study|Reasons other than above listed|0|||
127795796|NCT01535729|459875945|FG000|Overall Study|Withdrawal by Subject|2|||
127795797|NCT01535729|459875945|FG000|Overall Study|Disease progression|230|||
127795798|NCT01535729|459875945|FG000|Overall Study|Discontinued treatment|25|||
127795799|NCT01535729|459875945|FG000|Overall Study|Lost to Follow-up|8|||
127795800|NCT01535729|459875945|FG000|Overall Study|Death|52|||
127795801|NCT01535729|459875945|FG000|Overall Study|Other|19|||
127795802|NCT01535729|459875945|FG000|Overall Study|Did not sign informed consent|1|||
127795803|NCT01535729|459875945|FG000|Overall Study|No previous chemotherapy|33|||
127795804|NCT01535729|459875945|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
127795805|NCT01535729|459875945|FG000|Overall Study|Protocol Violation|11|||
127795806|NCT01535729|459875945|FG000|Overall Study|Screening failure|1|||
127795807|NCT01535729|459875945|FG000|Overall Study|Not treated|9|||
127795808|NCT01535729|459875945|FG000|Overall Study|No participant record available|5|||
127795809|NCT01262365|459875946|FG000|Overall Study|Lack of Efficacy|35|||
127795810|NCT01262365|459875947|FG001|Overall Study|Lack of Efficacy|30|||
127795811|NCT01262365|459875948|FG002|Overall Study|Lack of Efficacy|47|||
127795812|NCT01262365|459875946|FG000|Overall Study|Protocol Violation|3|||
127795813|NCT01262365|459875947|FG001|Overall Study|Protocol Violation|1|||
127795814|NCT01262365|459875948|FG002|Overall Study|Protocol Violation|1|||
127795815|NCT01262365|459875946|FG000|Overall Study|Lost to Follow-up|3|||
127632413|NCT01884350|459274898|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
127632414|NCT01884350|459274899|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
127632415|NCT01884350|459274900|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
127632416|NCT01884350|459274898|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
127632417|NCT01884350|459274899|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
127632418|NCT01884350|459274900|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
127632419|NCT01884350|459274898|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
127632420|NCT01884350|459274899|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
127632421|NCT01884350|459274900|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
127632422|NCT01884350|459274898|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
127632423|NCT01884350|459274899|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
127632424|NCT01884350|459274900|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
127632425|NCT01884350|459274898|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
127632426|NCT01884350|459274899|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
127632427|NCT01884350|459274900|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
127632428|NCT01884350|459274898|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
127632429|NCT01884350|459274899|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
127632430|NCT01884350|459274900|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
127632431|NCT01884350|459274898|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
127632432|NCT01884350|459274899|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
127632433|NCT01884350|459274900|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
127632434|NCT01884350|459274898|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
127632435|NCT01884350|459274899|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
127632436|NCT01884350|459274900|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
127632437|NCT01884350|459274898|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
127632438|NCT01884350|459274899|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
127795816|NCT01262365|459875947|FG001|Overall Study|Lost to Follow-up|7|||
127632439|NCT01884350|459274900|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
127632440|NCT01884350|459274898|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
127632441|NCT01884350|459274899|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
127632442|NCT01884350|459274900|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
127632443|NCT01884350|459274898|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
127632444|NCT01884350|459274899|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
127632445|NCT01884350|459274900|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
127642721|NCT01506193|459313116|FG001|Overall Study|Migrated/moved from study area|0|||
127885538|NCT04380701|460203896|FG025|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
127885539|NCT04380701|460203897|FG026|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
127632446|NCT01884350|459274898|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
127632447|NCT01884350|459274899|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
127632448|NCT01884350|459274900|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
127632449|NCT01884350|459274898|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
127632450|NCT01884350|459274899|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
127632451|NCT01884350|459274900|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
127632452|NCT01884350|459274898|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
127632453|NCT01884350|459274899|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
127632454|NCT01884350|459274900|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
127632455|NCT01884350|459274898|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
127632456|NCT01884350|459274899|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
127632457|NCT01884350|459274900|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
127632458|NCT01059617|459274901|FG000|Overall Study|Other|7|||
127632459|NCT01059617|459274902|FG001|Overall Study|Other|1|||
127632460|NCT01059617|459274903|FG002|Overall Study|Other|8|||
127632461|NCT01059617|459274904|FG003|Overall Study|Other|6|||
127632462|NCT02345512|459274905|FG000|Overall Study|Adverse Event|1|||
127632463|NCT02345512|459274905|FG000|Overall Study|Withdrawal by Subject|1|||
127632464|NCT01968434|459274908|FG000|Overall Study|Lost to Follow-up|3|||
127885540|NCT04380701|460203898|FG027|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
127632465|NCT01968434|459274909|FG001|Overall Study|Lost to Follow-up|6|||
127632466|NCT00489970|459276643|FG000|Persistence Year 9|Lost to Follow-up|2|||
127632467|NCT00489970|459276644|FG001|Persistence Year 9|Lost to Follow-up|2|||
127632468|NCT00489970|459276645|FG002|Persistence Year 9|Lost to Follow-up|3|||
127632469|NCT00489970|459276643|FG000|Persistence Year 9|Other|1|||
127632470|NCT00489970|459276644|FG001|Persistence Year 9|Other|0|||
127632471|NCT00489970|459276645|FG002|Persistence Year 9|Other|2|||
127632472|NCT02707055|459276652|FG000|Phase 1|Withdrawal by Subject|1|||
127632473|NCT02707055|459276653|FG001|Phase 1|Withdrawal by Subject|2|||
127632474|NCT02707055|459276652|FG000|Phase 1|Physician Decision|0|||
127632475|NCT02707055|459276653|FG001|Phase 1|Physician Decision|1|||
127632476|NCT02707055|459276652|FG000|Phase 2|Adverse Event|1|||
127632477|NCT02707055|459276653|FG001|Phase 2|Adverse Event|2|||
127632478|NCT03564496|459276654|FG000|Overall Study|Withdrawal by Subject|1|||
127632479|NCT03564496|459276655|FG001|Overall Study|Withdrawal by Subject|1|||
127632480|NCT03564496|459276656|FG002|Overall Study|Withdrawal by Subject|0|||
127632481|NCT03564496|459276654|FG000|Overall Study|Screen failure|0|||
127632482|NCT03564496|459276655|FG001|Overall Study|Screen failure|3|||
127632483|NCT03564496|459276656|FG002|Overall Study|Screen failure|0|||
127632484|NCT01159938|459276657|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
127632485|NCT01159938|459276658|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
127632486|NCT01159938|459276659|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
127632487|NCT01159938|459276660|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
127632488|NCT01159938|459276661|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
127632489|NCT02318329|459276665|FG000|Overall Study|Progressive Disease|2|||
127632490|NCT02318329|459276666|FG001|Overall Study|Progressive Disease|3|||
127632491|NCT02318329|459276667|FG002|Overall Study|Progressive Disease|2|||
127632492|NCT02318329|459276668|FG003|Overall Study|Progressive Disease|3|||
127632493|NCT02318329|459276669|FG004|Overall Study|Progressive Disease|3|||
127632494|NCT02318329|459276670|FG005|Overall Study|Progressive Disease|3|||
127632495|NCT02318329|459276671|FG006|Overall Study|Progressive Disease|1|||
127632496|NCT02318329|459276672|FG007|Overall Study|Progressive Disease|1|||
127632497|NCT02318329|459276673|FG008|Overall Study|Progressive Disease|5|||
127632498|NCT02318329|459276674|FG009|Overall Study|Progressive Disease|39|||
127632499|NCT02318329|459276665|FG000|Overall Study|Death|0|||
127632500|NCT02318329|459276666|FG001|Overall Study|Death|0|||
127632501|NCT02318329|459276667|FG002|Overall Study|Death|0|||
127632502|NCT02318329|459276668|FG003|Overall Study|Death|0|||
127632503|NCT02318329|459276669|FG004|Overall Study|Death|0|||
127632504|NCT02318329|459276670|FG005|Overall Study|Death|0|||
127632505|NCT02318329|459276671|FG006|Overall Study|Death|0|||
127632506|NCT02318329|459276672|FG007|Overall Study|Death|0|||
127632507|NCT02318329|459276673|FG008|Overall Study|Death|0|||
127632508|NCT02318329|459276674|FG009|Overall Study|Death|5|||
127632509|NCT02318329|459276665|FG000|Overall Study|Lost to Follow-up|0|||
127632510|NCT02318329|459276666|FG001|Overall Study|Lost to Follow-up|0|||
127632511|NCT02318329|459276667|FG002|Overall Study|Lost to Follow-up|0|||
127632512|NCT02318329|459276668|FG003|Overall Study|Lost to Follow-up|0|||
127632513|NCT02318329|459276669|FG004|Overall Study|Lost to Follow-up|0|||
127632514|NCT02318329|459276670|FG005|Overall Study|Lost to Follow-up|0|||
127632515|NCT02318329|459276671|FG006|Overall Study|Lost to Follow-up|0|||
127632516|NCT02318329|459276672|FG007|Overall Study|Lost to Follow-up|0|||
127632517|NCT02318329|459276673|FG008|Overall Study|Lost to Follow-up|0|||
127632518|NCT02318329|459276674|FG009|Overall Study|Lost to Follow-up|1|||
127632519|NCT02318329|459276665|FG000|Overall Study|Withdrawal by Subject|0|||
127632520|NCT02318329|459276666|FG001|Overall Study|Withdrawal by Subject|0|||
127632521|NCT02318329|459276667|FG002|Overall Study|Withdrawal by Subject|0|||
127632522|NCT02318329|459276668|FG003|Overall Study|Withdrawal by Subject|0|||
127632523|NCT02318329|459276669|FG004|Overall Study|Withdrawal by Subject|0|||
127632524|NCT02318329|459276670|FG005|Overall Study|Withdrawal by Subject|0|||
127632525|NCT02318329|459276671|FG006|Overall Study|Withdrawal by Subject|0|||
127632526|NCT02318329|459276672|FG007|Overall Study|Withdrawal by Subject|0|||
127632527|NCT02318329|459276673|FG008|Overall Study|Withdrawal by Subject|0|||
127632528|NCT02318329|459276674|FG009|Overall Study|Withdrawal by Subject|6|||
127632529|NCT02318329|459276665|FG000|Overall Study|Other|1|||
127632530|NCT02318329|459276666|FG001|Overall Study|Other|1|||
127632531|NCT02318329|459276667|FG002|Overall Study|Other|1|||
127632532|NCT02318329|459276668|FG003|Overall Study|Other|0|||
127632533|NCT02318329|459276669|FG004|Overall Study|Other|0|||
127632534|NCT02318329|459276670|FG005|Overall Study|Other|0|||
127632535|NCT02318329|459276671|FG006|Overall Study|Other|0|||
127632536|NCT02318329|459276672|FG007|Overall Study|Other|0|||
127632537|NCT02318329|459276673|FG008|Overall Study|Other|1|||
127632538|NCT02318329|459276674|FG009|Overall Study|Other|1|||
127632539|NCT00086346|459276675|FG000|Randomization|Did not receive test article|4|||
127632540|NCT00086346|459276676|FG001|Randomization|Did not receive test article|4|||
127632541|NCT00086346|459276675|FG000|Patients Dosed With Test Article|Adverse Event|94|||
127632542|NCT00086346|459276676|FG001|Patients Dosed With Test Article|Adverse Event|11|||
127632543|NCT00086346|459276675|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
127632544|NCT00086346|459276676|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
127632545|NCT00086346|459276675|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
127632546|NCT00086346|459276676|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
127632547|NCT00086346|459276675|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
127632548|NCT00086346|459276676|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
127632549|NCT00086346|459276675|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
127632550|NCT00086346|459276676|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
127632551|NCT00086346|459276675|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
127632552|NCT00086346|459276676|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
127632553|NCT02416791|459276677|FG000|6 Months|Lost to Follow-up|0|||
127632554|NCT02416791|459276678|FG001|6 Months|Lost to Follow-up|0|||
127632555|NCT02416791|459276679|FG002|6 Months|Lost to Follow-up|1|||
127632556|NCT04121962|459276681|FG000|Overall Study|Lost to Follow-up|42|||
127632557|NCT04121962|459276682|FG001|Overall Study|Lost to Follow-up|39|||
127632558|NCT02019719|459276683|FG000|Overall Study|Adverse Event|1|||
127632559|NCT02019719|459276684|FG001|Overall Study|Adverse Event|0|||
127632560|NCT02019719|459276685|FG002|Overall Study|Adverse Event|0|||
127632561|NCT02019719|459276686|FG003|Overall Study|Adverse Event|1|||
127632562|NCT02019719|459276687|FG004|Overall Study|Adverse Event|1|||
127632563|NCT02019719|459276683|FG000|Overall Study|Protocol Violation|1|||
127632564|NCT02019719|459276684|FG001|Overall Study|Protocol Violation|1|||
127632565|NCT02019719|459276685|FG002|Overall Study|Protocol Violation|0|||
127632566|NCT02019719|459276686|FG003|Overall Study|Protocol Violation|0|||
127632567|NCT02019719|459276687|FG004|Overall Study|Protocol Violation|0|||
127632568|NCT02019719|459276683|FG000|Overall Study|Protocol defined stopping criteria|2|||
127632569|NCT02019719|459276684|FG001|Overall Study|Protocol defined stopping criteria|0|||
127632570|NCT02019719|459276685|FG002|Overall Study|Protocol defined stopping criteria|0|||
127632571|NCT02019719|459276686|FG003|Overall Study|Protocol defined stopping criteria|1|||
127632572|NCT02019719|459276687|FG004|Overall Study|Protocol defined stopping criteria|1|||
127632573|NCT02019719|459276683|FG000|Overall Study|Physician Decision|2|||
127632574|NCT02019719|459276684|FG001|Overall Study|Physician Decision|0|||
127632575|NCT02019719|459276685|FG002|Overall Study|Physician Decision|0|||
127632576|NCT02019719|459276686|FG003|Overall Study|Physician Decision|0|||
127632577|NCT02019719|459276687|FG004|Overall Study|Physician Decision|0|||
127632578|NCT04535037|459276688|FG000|Overall Study|Protocol Violation|1|||
127632579|NCT04535037|459276689|FG001|Overall Study|Protocol Violation|0|||
127632580|NCT04535037|459276688|FG000|Overall Study|Withdrawal by Subject|8|||
127632581|NCT04535037|459276689|FG001|Overall Study|Withdrawal by Subject|9|||
127632582|NCT04535037|459276688|FG000|Overall Study|Migrated / moved from the study area|1|||
127632583|NCT04535037|459276689|FG001|Overall Study|Migrated / moved from the study area|4|||
127632584|NCT04535037|459276688|FG000|Overall Study|Other|2|||
127632585|NCT04535037|459276689|FG001|Overall Study|Other|5|||
127632586|NCT02731131|459276697|FG000|Overall Study|Psychiatric Disorder|0|||
127632587|NCT02731131|459276698|FG001|Overall Study|Psychiatric Disorder|1|||
127632588|NCT02731131|459276697|FG000|Overall Study|Refused Therapy|0|||
127632589|NCT02731131|459276698|FG001|Overall Study|Refused Therapy|1|||
127632590|NCT02348216|459276699|FG000|Overall Study|Death|5|||
127632591|NCT02348216|459276700|FG001|Overall Study|Death|53|||
127632592|NCT02348216|459276701|FG002|Overall Study|Death|11|||
127632593|NCT02348216|459276702|FG003|Overall Study|Death|20|||
127632594|NCT02348216|459276703|FG004|Overall Study|Death|16|||
127632595|NCT02348216|459276704|FG005|Overall Study|Death|32|||
127632596|NCT02348216|459276705|FG006|Overall Study|Death|17|||
127632597|NCT02348216|459276699|FG000|Overall Study|Full consent withdrawal|0|||
127632598|NCT02348216|459276700|FG001|Overall Study|Full consent withdrawal|0|||
127632599|NCT02348216|459276701|FG002|Overall Study|Full consent withdrawal|0|||
127632600|NCT02348216|459276702|FG003|Overall Study|Full consent withdrawal|1|||
127632601|NCT02348216|459276703|FG004|Overall Study|Full consent withdrawal|3|||
127632602|NCT02348216|459276704|FG005|Overall Study|Full consent withdrawal|0|||
127632603|NCT02348216|459276705|FG006|Overall Study|Full consent withdrawal|3|||
127632604|NCT02348216|459276699|FG000|Overall Study|Lost to Follow-up|0|||
127632605|NCT02348216|459276700|FG001|Overall Study|Lost to Follow-up|5|||
127632606|NCT02348216|459276701|FG002|Overall Study|Lost to Follow-up|2|||
127632607|NCT02348216|459276702|FG003|Overall Study|Lost to Follow-up|0|||
127632608|NCT02348216|459276703|FG004|Overall Study|Lost to Follow-up|1|||
127632609|NCT02348216|459276704|FG005|Overall Study|Lost to Follow-up|1|||
127632610|NCT02348216|459276705|FG006|Overall Study|Lost to Follow-up|1|||
127632611|NCT02348216|459276699|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
127632612|NCT02348216|459276700|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
127632613|NCT02348216|459276701|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
127795817|NCT01262365|459875948|FG002|Overall Study|Lost to Follow-up|6|||
127632614|NCT02348216|459276702|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
127632615|NCT02348216|459276703|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
127632616|NCT02348216|459276704|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
127795818|NCT01262365|459875946|FG000|Overall Study|Withdrawal by Subject|17|||
127632617|NCT02348216|459276705|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
127632618|NCT02348216|459276699|FG000|Overall Study|Reason not specified|2|||
127632619|NCT02348216|459276700|FG001|Overall Study|Reason not specified|19|||
127632620|NCT02348216|459276701|FG002|Overall Study|Reason not specified|11|||
127632621|NCT02348216|459276702|FG003|Overall Study|Reason not specified|17|||
127632622|NCT02348216|459276703|FG004|Overall Study|Reason not specified|21|||
127632623|NCT02348216|459276704|FG005|Overall Study|Reason not specified|17|||
127632624|NCT02348216|459276705|FG006|Overall Study|Reason not specified|19|||
127632625|NCT01055639|459276706|FG000|Overall Study|Adverse Event|0|||
127632626|NCT01055639|459276707|FG001|Overall Study|Adverse Event|1|||
127632627|NCT01055639|459276706|FG000|Overall Study|Lack of Efficacy|0|||
127885541|NCT04380701|460203899|FG028|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
127632628|NCT01055639|459276707|FG001|Overall Study|Lack of Efficacy|1|||
127632629|NCT01055639|459276706|FG000|Overall Study|Lost to Follow-up|8|||
127632630|NCT01055639|459276707|FG001|Overall Study|Lost to Follow-up|11|||
127885542|NCT04380701|460203900|FG029|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
127885543|NCT04380701|460203901|FG030|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
127885544|NCT04380701|460203902|FG031|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
127632631|NCT01055639|459276706|FG000|Overall Study|Protocol Violation|5|||
127632632|NCT01055639|459276707|FG001|Overall Study|Protocol Violation|5|||
127885545|NCT04380701|460203903|FG032|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
127885546|NCT04380701|460203904|FG033|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
127885547|NCT00383019|460203905|FG000|Overall Study|Adverse Event|5|||
127885548|NCT00383019|460203906|FG001|Overall Study|Adverse Event|1|||
127885549|NCT00383019|460203905|FG000|Overall Study|Withdrawal by Subject|0|||
127885550|NCT00383019|460203906|FG001|Overall Study|Withdrawal by Subject|1|||
127885551|NCT03125915|460203909|FG000|1 Month Follow up|Lost to Follow-up|3|||
127885552|NCT03125915|460203910|FG001|1 Month Follow up|Lost to Follow-up|3|||
127885553|NCT03125915|460203911|FG002|1 Month Follow up|Lost to Follow-up|2|||
127885554|NCT03125915|460203912|FG003|1 Month Follow up|Lost to Follow-up|3|||
127885555|NCT03125915|460203909|FG000|3 Month Follow-up|Lost to Follow-up|6|||
127885556|NCT03125915|460203910|FG001|3 Month Follow-up|Lost to Follow-up|4|||
127885557|NCT03125915|460203911|FG002|3 Month Follow-up|Lost to Follow-up|4|||
127885558|NCT03125915|460203912|FG003|3 Month Follow-up|Lost to Follow-up|2|||
127885559|NCT03125915|460203909|FG000|6 Month Follow-up|Lost to Follow-up|7|||
127885560|NCT03125915|460203910|FG001|6 Month Follow-up|Lost to Follow-up|3|||
127885561|NCT03125915|460203911|FG002|6 Month Follow-up|Lost to Follow-up|6|||
127885562|NCT03125915|460203912|FG003|6 Month Follow-up|Lost to Follow-up|3|||
127885563|NCT01123980|460203913|FG000|Overall Study|Adverse Event|1|||
127885564|NCT01123980|460203914|FG001|Overall Study|Adverse Event|1|||
127885565|NCT01123980|460203913|FG000|Overall Study|Lack of Efficacy|1|||
127885566|NCT01123980|460203914|FG001|Overall Study|Lack of Efficacy|0|||
127885567|NCT01123980|460203913|FG000|Overall Study|Physician Decision|0|||
127885568|NCT01123980|460203914|FG001|Overall Study|Physician Decision|1|||
127885569|NCT01123980|460203913|FG000|Overall Study|Lost to Follow-up|0|||
127885570|NCT01123980|460203914|FG001|Overall Study|Lost to Follow-up|6|||
127885571|NCT01123980|460203913|FG000|Overall Study|Protocol Violation|6|||
127885572|NCT01123980|460203914|FG001|Overall Study|Protocol Violation|6|||
127885573|NCT01123980|460203913|FG000|Overall Study|Withdrawal by Subject|5|||
127885574|NCT01123980|460203914|FG001|Overall Study|Withdrawal by Subject|3|||
127885575|NCT01123980|460203913|FG000|Overall Study|Unclassified|6|||
127885576|NCT01123980|460203914|FG001|Overall Study|Unclassified|7|||
127885577|NCT01225991|460203915|FG000|Overall Study|Withdrawal by Subject|6|||
127885578|NCT00789828|460203916|FG000|Core Period (48 Weeks)|Administrative problems|0|||
127885579|NCT00789828|460203917|FG001|Core Period (48 Weeks)|Administrative problems|1|||
127885580|NCT00789828|460203916|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
127885581|NCT00789828|460203917|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
127885582|NCT00789828|460203916|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
127885583|NCT00789828|460203917|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
127885584|NCT00789828|460203916|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
127885585|NCT00789828|460203917|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
127885586|NCT00789828|460203916|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
127885587|NCT00789828|460203917|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
127885588|NCT00789828|460203916|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
127885589|NCT00789828|460203917|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
127885590|NCT00789828|460203916|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
127632633|NCT01055639|459276706|FG000|Overall Study|Withdrawal by Subject|8|||
127632634|NCT01055639|459276707|FG001|Overall Study|Withdrawal by Subject|11|||
127632635|NCT00562159|459276708|FG000|Overall Study|Adverse Event|11|||
127632636|NCT00562159|459276709|FG001|Overall Study|Adverse Event|8|||
127632637|NCT00562159|459276708|FG000|Overall Study|Lost to Follow-up|5|||
127632638|NCT00562159|459276709|FG001|Overall Study|Lost to Follow-up|4|||
127632639|NCT00562159|459276708|FG000|Overall Study|Withdrawal by Subject|9|||
127632640|NCT00562159|459276709|FG001|Overall Study|Withdrawal by Subject|8|||
127632641|NCT00562159|459276708|FG000|Overall Study|Protocol Violation|12|||
127632642|NCT00562159|459276709|FG001|Overall Study|Protocol Violation|12|||
127632643|NCT00562159|459276708|FG000|Overall Study|Did not meet protocol eligibility|1|||
127632644|NCT00562159|459276709|FG001|Overall Study|Did not meet protocol eligibility|1|||
127632645|NCT00765245|459276710|FG000|Overall Study|disease progression|3|||
127632646|NCT00765245|459276711|FG001|Overall Study|disease progression|2|||
127632647|NCT00765245|459276710|FG000|Overall Study|Withdrawal by Subject|3|||
127632648|NCT00765245|459276711|FG001|Overall Study|Withdrawal by Subject|0|||
127632649|NCT00765245|459276710|FG000|Overall Study|Adverse Event|5|||
127632650|NCT00765245|459276711|FG001|Overall Study|Adverse Event|0|||
127632651|NCT00765245|459276710|FG000|Overall Study|Physician Decision|1|||
127632652|NCT00765245|459276711|FG001|Overall Study|Physician Decision|0|||
127632653|NCT00765245|459276710|FG000|Overall Study|Death|1|||
127632654|NCT00765245|459276711|FG001|Overall Study|Death|0|||
127632655|NCT02417246|459276713|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
127632656|NCT02417246|459276714|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
127632657|NCT02417246|459276713|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
127632658|NCT02417246|459276714|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
127632659|NCT02417246|459276713|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
127632660|NCT02417246|459276714|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
127632661|NCT02417246|459276713|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
127632662|NCT02417246|459276714|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
127632663|NCT01181921|459276717|FG000|Overall Study|Lost to Follow-up|1|||
127632664|NCT04321460|459276718|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
127632665|NCT04321460|459276719|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
127632666|NCT02162810|459276722|FG000|Overall Study|Protocol Violation|1|||
127632667|NCT02162810|459276723|FG001|Overall Study|Protocol Violation|0|||
127632668|NCT02162810|459276722|FG000|Overall Study|patients did not report compliance|4|||
127632669|NCT02162810|459276723|FG001|Overall Study|patients did not report compliance|1|||
127632670|NCT01308749|459276728|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
127632671|NCT01308749|459276729|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
127632672|NCT01308749|459276728|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
127632673|NCT01308749|459276729|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
127632674|NCT01308749|459276728|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
127632675|NCT01308749|459276729|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
127632676|NCT02519504|459276730|FG000|Overall Study|Protocol Violation|6|||
127632677|NCT02519504|459276731|FG001|Overall Study|Protocol Violation|5|||
127632678|NCT02519504|459276730|FG000|Overall Study|Ineligible for direct testing|12|||
127632679|NCT02519504|459276731|FG001|Overall Study|Ineligible for direct testing|12|||
127632680|NCT02519504|459276730|FG000|Overall Study|Did not participate in direct testing|95|||
127632681|NCT02519504|459276731|FG001|Overall Study|Did not participate in direct testing|86|||
127632682|NCT04726709|459276732|FG000|Overall Study|Withdrawal by Subject|2|||
127632683|NCT04726709|459276733|FG001|Overall Study|Withdrawal by Subject|2|||
127885591|NCT00789828|460203917|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
127885592|NCT00789828|460203916|FG000|Open-label Extension Period (4 Years)|Death|1|||
127885593|NCT00789828|460203917|FG001|Open-label Extension Period (4 Years)|Death|0|||
127632684|NCT02546544|459276734|FG000|Overall Study|Disease Progression|14|||
127632685|NCT02546544|459276734|FG000|Overall Study|Adverse Event|1|||
127632686|NCT02546544|459276734|FG000|Overall Study|Withdrawal by Subject|1|||
127632687|NCT02223390|459276735|FG000|Overall Study|Lost to Follow-up|9|||
127632688|NCT02223390|459276736|FG001|Overall Study|Lost to Follow-up|4|||
127632689|NCT02548962|459276738|FG000|Overall Study|Withdrawal by Subject|1|||
127885594|NCT00789828|460203916|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
127885595|NCT00789828|460203917|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
127885596|NCT00789828|460203916|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
127885597|NCT00789828|460203917|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
127885598|NCT02094937|460203918|FG000|8 Weeks in Period 1|Adverse Event|9|||
127885599|NCT02094937|460203919|FG001|8 Weeks in Period 1|Adverse Event|0|||
127632690|NCT02548962|459276739|FG001|Overall Study|Withdrawal by Subject|0|||
127632691|NCT01197950|459276740|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
127632692|NCT01197950|459276741|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
127632693|NCT01197950|459276742|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
127632694|NCT04831736|459276743|FG000|Overall Study|Withdrawal by Subject|0|||
127632695|NCT04831736|459276744|FG001|Overall Study|Withdrawal by Subject|1|||
127632696|NCT01666002|459276747|FG000|Overall Study|Lost to Follow-up|5|||
127632697|NCT01666002|459276748|FG001|Overall Study|Lost to Follow-up|0|||
127632698|NCT01233817|459276749|FG000|Overall Study|Lost to Follow-up|1|||
127632699|NCT01233817|459276749|FG000|Overall Study|Withdrawal by Subject|2|||
127632700|NCT02159482|459276750|FG000|Overall Study|Withdrawal by Subject|2|||
127632701|NCT02159482|459276750|FG000|Overall Study|Physician Decision|3|||
127632702|NCT04000165|459276755|FG000|Overall Study|Physician Decision|1|||
127632703|NCT04000165|459276755|FG000|Overall Study|Withdrawal by Subject|1|||
127632704|NCT00383435|459276756|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
127885600|NCT02094937|460203920|FG002|8 Weeks in Period 1|Adverse Event|0|||
127885601|NCT02094937|460203921|FG003|8 Weeks in Period 1|Adverse Event|0|||
127885602|NCT02094937|460203918|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
127885603|NCT02094937|460203919|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
127885604|NCT02094937|460203920|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
127885605|NCT02094937|460203921|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
127885606|NCT02094937|460203918|FG000|8 Weeks in Period 1|Protocol Violation|2|||
127885607|NCT02094937|460203919|FG001|8 Weeks in Period 1|Protocol Violation|0|||
127885608|NCT02094937|460203920|FG002|8 Weeks in Period 1|Protocol Violation|0|||
127885609|NCT02094937|460203921|FG003|8 Weeks in Period 1|Protocol Violation|0|||
127885610|NCT02094937|460203918|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
127885611|NCT02094937|460203919|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
127885612|NCT02094937|460203920|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
127885613|NCT02094937|460203921|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
127885614|NCT02094937|460203918|FG000|8 Weeks in Period 1|Physician Decision|1|||
127885615|NCT02094937|460203919|FG001|8 Weeks in Period 1|Physician Decision|0|||
127885616|NCT02094937|460203920|FG002|8 Weeks in Period 1|Physician Decision|0|||
127885617|NCT02094937|460203921|FG003|8 Weeks in Period 1|Physician Decision|0|||
127885618|NCT02094937|460203918|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
127885619|NCT02094937|460203919|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
127885620|NCT02094937|460203920|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
127885621|NCT02094937|460203921|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
127885622|NCT02094937|460203918|FG000|12 Weeks in Period 2|Adverse Event|0|||
127885623|NCT02094937|460203919|FG001|12 Weeks in Period 2|Adverse Event|2|||
127885624|NCT02094937|460203920|FG002|12 Weeks in Period 2|Adverse Event|4|||
127885625|NCT02094937|460203921|FG003|12 Weeks in Period 2|Adverse Event|1|||
127885626|NCT02094937|460203918|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
127885627|NCT02094937|460203919|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
127885628|NCT02094937|460203920|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
127885629|NCT02094937|460203921|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
127885630|NCT02094937|460203918|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
127885631|NCT02094937|460203919|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
127885632|NCT02094937|460203920|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
127885633|NCT02094937|460203921|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
127885634|NCT02094937|460203918|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
127885635|NCT02094937|460203919|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
127632705|NCT00383435|459276757|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
127632706|NCT00383435|459276758|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
127632707|NCT00383435|459276759|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
127632708|NCT00383435|459276760|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
127632709|NCT00383435|459276756|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
127632710|NCT00383435|459276757|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
127632711|NCT00383435|459276758|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
127632712|NCT00383435|459276759|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
127632713|NCT00383435|459276760|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
127632714|NCT00383435|459276756|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
127632715|NCT00383435|459276757|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
127632716|NCT00383435|459276758|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
127632717|NCT00383435|459276759|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
127632718|NCT00383435|459276760|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
127632719|NCT00383435|459276756|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
127632720|NCT00383435|459276757|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
127632721|NCT00383435|459276758|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
127632722|NCT00383435|459276759|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
127632723|NCT00383435|459276760|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
127632724|NCT00383435|459276756|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
127632725|NCT00383435|459276757|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
127632726|NCT00383435|459276758|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
127632727|NCT00383435|459276759|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
127632728|NCT00383435|459276760|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
127632729|NCT00383435|459276756|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
127632730|NCT00383435|459276757|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
127632731|NCT00383435|459276758|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
127632732|NCT00383435|459276759|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
127632733|NCT00383435|459276760|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
127632734|NCT00383435|459276756|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
127632735|NCT00383435|459276757|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
127632736|NCT00383435|459276758|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
127632737|NCT00383435|459276759|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
127632738|NCT00383435|459276760|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
127632739|NCT00383435|459276756|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
127632740|NCT00383435|459276757|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
127632741|NCT00383435|459276758|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
127632742|NCT00383435|459276759|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
127632743|NCT00383435|459276760|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
127632744|NCT00383435|459276756|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
127632745|NCT00383435|459276757|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
127632746|NCT00383435|459276758|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
127632747|NCT00383435|459276759|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
127632748|NCT00383435|459276760|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
127632749|NCT00383435|459276756|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
127632750|NCT00383435|459276757|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
127632751|NCT00383435|459276758|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
127632752|NCT00383435|459276759|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
127632753|NCT00383435|459276760|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
127632754|NCT00383435|459276756|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
127632755|NCT00383435|459276757|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
127632756|NCT00383435|459276758|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
127632757|NCT00383435|459276759|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
127632758|NCT00383435|459276760|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
127632759|NCT00383435|459276756|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
127632760|NCT00383435|459276757|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
127632761|NCT00383435|459276758|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
127632762|NCT00383435|459276759|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
127632763|NCT00383435|459276760|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
127632764|NCT00383435|459276756|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
127632765|NCT00383435|459276757|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
127632766|NCT00383435|459276758|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
127632767|NCT00383435|459276759|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
127632768|NCT00383435|459276760|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
127632769|NCT00383435|459276756|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
127632770|NCT00383435|459276757|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
127632771|NCT00383435|459276758|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
127632772|NCT00383435|459276759|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
127632773|NCT00383435|459276760|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
127632774|NCT00383435|459276756|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
127632775|NCT00383435|459276757|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
127632776|NCT00383435|459276758|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
127632777|NCT00383435|459276759|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
127632778|NCT00383435|459276760|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
127632779|NCT00383435|459276756|FG000|26-Week Treatment Safety Extension|Administrative|1|||
127632780|NCT00383435|459276757|FG001|26-Week Treatment Safety Extension|Administrative|1|||
127632781|NCT00383435|459276758|FG002|26-Week Treatment Safety Extension|Administrative|0|||
127632782|NCT00383435|459276759|FG003|26-Week Treatment Safety Extension|Administrative|1|||
127632783|NCT00383435|459276760|FG004|26-Week Treatment Safety Extension|Administrative|0|||
127632784|NCT01753193|459276761|FG000|Overall Study|Withdrawal by Subject|23|||
127632785|NCT01753193|459276761|FG000|Overall Study|Lost to Follow-up|6|||
127632786|NCT01753193|459276761|FG000|Overall Study|Death|1|||
127632787|NCT01753193|459276761|FG000|Overall Study|Other|16|||
127632788|NCT01131312|459276762|FG000|Overall Study|Lost to Follow-up|425|||
127632789|NCT01131312|459276763|FG001|Overall Study|Lost to Follow-up|229|||
127632790|NCT01131312|459276764|FG002|Overall Study|Lost to Follow-up|351|||
127632791|NCT02682264|459276765|FG000|Overall Study|Withdrawal by Subject|56|||
127632792|NCT02682264|459276766|FG001|Overall Study|Withdrawal by Subject|45|||
127632793|NCT02682264|459276765|FG000|Overall Study|Lost to Follow-up|49|||
127632794|NCT02682264|459276766|FG001|Overall Study|Lost to Follow-up|41|||
127632795|NCT02682264|459276765|FG000|Overall Study|Lack of Efficacy|14|||
127632796|NCT02682264|459276766|FG001|Overall Study|Lack of Efficacy|16|||
127632797|NCT02682264|459276765|FG000|Overall Study|Withdrawal by Parent|6|||
127632798|NCT02682264|459276766|FG001|Overall Study|Withdrawal by Parent|7|||
127632799|NCT02682264|459276765|FG000|Overall Study|Adverse Event|9|||
127632800|NCT02682264|459276766|FG001|Overall Study|Adverse Event|0|||
127632801|NCT02682264|459276765|FG000|Overall Study|Noncompliance with study drug|1|||
127632802|NCT02682264|459276766|FG001|Overall Study|Noncompliance with study drug|4|||
127632803|NCT02682264|459276765|FG000|Overall Study|Pregnancy|1|||
127632804|NCT02682264|459276766|FG001|Overall Study|Pregnancy|2|||
127632805|NCT02682264|459276765|FG000|Overall Study|Recovery|1|||
127632806|NCT02682264|459276766|FG001|Overall Study|Recovery|2|||
127632807|NCT02682264|459276765|FG000|Overall Study|Progressive Disease|1|||
127632808|NCT02682264|459276766|FG001|Overall Study|Progressive Disease|0|||
127632809|NCT02682264|459276765|FG000|Overall Study|Technical Problems|0|||
127632810|NCT02682264|459276766|FG001|Overall Study|Technical Problems|1|||
127632811|NCT02682264|459276765|FG000|Overall Study|Moved abroad and unable to continue|0|||
127632812|NCT02682264|459276766|FG001|Overall Study|Moved abroad and unable to continue|3|||
127632813|NCT02682264|459276765|FG000|Overall Study|Stopped test article application|0|||
127632814|NCT02682264|459276766|FG001|Overall Study|Stopped test article application|1|||
127632815|NCT03447769|459276768|FG000|Overall Study|Progressive disease|138|||
127632816|NCT03447769|459276769|FG001|Overall Study|Progressive disease|148|||
127632817|NCT03447769|459276768|FG000|Overall Study|Study terminated by Sponsor|60|||
127632818|NCT03447769|459276769|FG001|Overall Study|Study terminated by Sponsor|44|||
127632819|NCT03447769|459276768|FG000|Overall Study|Adverse Event|34|||
127632820|NCT03447769|459276769|FG001|Overall Study|Adverse Event|31|||
127632821|NCT03447769|459276768|FG000|Overall Study|Patient decision|27|||
127632822|NCT03447769|459276769|FG001|Overall Study|Patient decision|27|||
127632823|NCT03447769|459276768|FG000|Overall Study|Protocol deviation|4|||
127632824|NCT03447769|459276769|FG001|Overall Study|Protocol deviation|6|||
127632825|NCT03447769|459276768|FG000|Overall Study|Death|2|||
127632826|NCT03447769|459276769|FG001|Overall Study|Death|7|||
127632827|NCT03447769|459276768|FG000|Overall Study|Technical problems|1|||
127632828|NCT03447769|459276769|FG001|Overall Study|Technical problems|0|||
127632829|NCT03447769|459276768|FG000|Overall Study|Lost to Follow-up|0|||
127632830|NCT03447769|459276769|FG001|Overall Study|Lost to Follow-up|1|||
127632831|NCT03447769|459276768|FG000|Overall Study|Physician Decision|13|||
127632832|NCT03447769|459276769|FG001|Overall Study|Physician Decision|5|||
127632833|NCT01343407|459276771|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
127632834|NCT01343407|459276772|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
127632835|NCT01343407|459276773|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
127632836|NCT01343407|459276774|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
127632837|NCT01343407|459276775|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
127632838|NCT01343407|459276776|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
127632839|NCT01343407|459276771|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
127632840|NCT01343407|459276772|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
127885636|NCT02094937|460203920|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
127885637|NCT02094937|460203921|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
127632841|NCT01343407|459276773|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
127632842|NCT01343407|459276774|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
127632843|NCT01343407|459276775|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
127632844|NCT01343407|459276776|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
127632845|NCT03950739|459276777|FG000|Treatment Phase|Adverse Event|2|||
127632846|NCT03950739|459276777|FG000|Optional Extension Phase|Death|1|||
127632847|NCT03950739|459276777|FG000|Optional Extension Phase|Progressive Disease|5|||
127632848|NCT03950739|459276777|FG000|Optional Extension Phase|Adverse Event|7|||
127632849|NCT03950739|459276777|FG000|Optional Extension Phase|Lost to Follow-up|2|||
127632850|NCT03950739|459276777|FG000|Optional Extension Phase|Site Closure|2|||
127632851|NCT03950739|459276777|FG000|Optional Extension Phase|Pregnancy|1|||
127632852|NCT03264989|459276781|FG000|Overall Study|Lost to Follow-up|1|||
127885638|NCT02094937|460203918|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
127632853|NCT03264989|459276782|FG001|Overall Study|Lost to Follow-up|0|||
127632854|NCT03264989|459276781|FG000|Overall Study|New Therapy for study Indication|1|||
127632855|NCT03264989|459276782|FG001|Overall Study|New Therapy for study Indication|0|||
127632856|NCT03264989|459276781|FG000|Overall Study|Protocol Violation|0|||
127632857|NCT03264989|459276782|FG001|Overall Study|Protocol Violation|1|||
127632858|NCT03264989|459276781|FG000|Overall Study|Patient decision|13|||
127632859|NCT03264989|459276782|FG001|Overall Study|Patient decision|0|||
127632860|NCT03264989|459276781|FG000|Overall Study|Physician Decision|6|||
127632861|NCT03264989|459276782|FG001|Overall Study|Physician Decision|4|||
127632862|NCT03264989|459276781|FG000|Overall Study|Adverse Event|2|||
127632863|NCT03264989|459276782|FG001|Overall Study|Adverse Event|1|||
127632864|NCT03264989|459276781|FG000|Overall Study|Death|1|||
127632865|NCT03264989|459276782|FG001|Overall Study|Death|1|||
127632866|NCT03264989|459276781|FG000|Overall Study|Pregnancy|2|||
127632867|NCT03264989|459276782|FG001|Overall Study|Pregnancy|0|||
127632868|NCT03264989|459276781|FG000|Overall Study|End of Study|19|||
127632869|NCT03264989|459276782|FG001|Overall Study|End of Study|5|||
127632870|NCT01775137|459276783|FG000|Overall Study|Death|1|||
127632871|NCT01775137|459276783|FG000|Overall Study|Protocol deviation|2|||
127632872|NCT01775137|459276783|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
127632873|NCT01775137|459276783|FG000|Overall Study|Adverse Event|1|||
127632874|NCT01775137|459276783|FG000|Overall Study|Withdrawal by participants|5|||
127632875|NCT01175668|459276788|FG000|Overall Study|Withdrawal by Subject|2|||
127632876|NCT01175668|459276789|FG001|Overall Study|Withdrawal by Subject|0|||
127632877|NCT02328326|459276790|FG000|Overall Study|Withdrawal by Subject|10|||
127632878|NCT02328326|459276791|FG001|Overall Study|Withdrawal by Subject|3|||
127632879|NCT02328326|459276790|FG000|Overall Study|Death|2|||
127885639|NCT02094937|460203919|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
127885640|NCT02094937|460203920|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
127885641|NCT02094937|460203921|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
127885642|NCT03053622|460205212|FG000|Overall Study|Lost to Follow-up|0|||
127885643|NCT03053622|460205213|FG001|Overall Study|Lost to Follow-up|0|||
127885644|NCT03053622|460205214|FG002|Overall Study|Lost to Follow-up|0|||
127885645|NCT03053622|460205215|FG003|Overall Study|Lost to Follow-up|1|||
127885646|NCT01355523|460205219|FG000|Overall Study|Withdrawal by Subject|1|||
127885647|NCT01355523|460205220|FG001|Overall Study|Withdrawal by Subject|4|||
127632880|NCT02328326|459276791|FG001|Overall Study|Death|1|||
127632881|NCT02328326|459276790|FG000|Overall Study|Lost to Follow-up|10|||
127632882|NCT02328326|459276791|FG001|Overall Study|Lost to Follow-up|4|||
127632883|NCT01438541|459276799|FG000|Overall Study|Physician Decision|1|||
127632884|NCT01438541|459276799|FG000|Overall Study|Withdrawal by Subject|1|||
127632885|NCT01438541|459276799|FG000|Overall Study|discharge from the hospital|5|||
127632886|NCT02091167|459276800|FG000|Overall Study|Lost to Follow-up|0|||
127632887|NCT02091167|459276801|FG001|Overall Study|Lost to Follow-up|2|||
127632888|NCT00074282|459278282|FG000|Step 1|Adverse Event|32|||
127632889|NCT00074282|459278283|FG001|Step 1|Adverse Event|0|||
127632890|NCT00074282|459278284|FG002|Step 1|Adverse Event|0|||
127632891|NCT00074282|459278282|FG000|Step 1|Death|6|||
127632892|NCT00074282|459278283|FG001|Step 1|Death|0|||
127632893|NCT00074282|459278284|FG002|Step 1|Death|0|||
127632894|NCT00074282|459278282|FG000|Step 1|Withdrawal by Subject|7|||
127885648|NCT01355523|460205219|FG000|Overall Study|Lost to Follow-up|0|||
127885649|NCT01355523|460205220|FG001|Overall Study|Lost to Follow-up|2|||
127632895|NCT00074282|459278283|FG001|Step 1|Withdrawal by Subject|0|||
127632896|NCT00074282|459278284|FG002|Step 1|Withdrawal by Subject|0|||
127632897|NCT00074282|459278282|FG000|Step 1|Disease progression|2|||
127632898|NCT00074282|459278283|FG001|Step 1|Disease progression|0|||
127632899|NCT00074282|459278284|FG002|Step 1|Disease progression|0|||
127632900|NCT00074282|459278282|FG000|Step 1|Alternative therapy|2|||
127632901|NCT00074282|459278283|FG001|Step 1|Alternative therapy|0|||
127632902|NCT00074282|459278284|FG002|Step 1|Alternative therapy|0|||
127632903|NCT00074282|459278282|FG000|Step 1|Other complicating disease|2|||
127632904|NCT00074282|459278283|FG001|Step 1|Other complicating disease|0|||
127632905|NCT00074282|459278284|FG002|Step 1|Other complicating disease|0|||
127632906|NCT00074282|459278282|FG000|Step 1|Physician Decision|1|||
127632907|NCT00074282|459278283|FG001|Step 1|Physician Decision|0|||
127632908|NCT00074282|459278284|FG002|Step 1|Physician Decision|0|||
127632909|NCT00074282|459278282|FG000|Step 1|Ineligible|4|||
127632910|NCT00074282|459278283|FG001|Step 1|Ineligible|0|||
127632911|NCT00074282|459278284|FG002|Step 1|Ineligible|0|||
127632912|NCT00074282|459278282|FG000|Step 1|Never started treatment|2|||
127632913|NCT00074282|459278283|FG001|Step 1|Never started treatment|0|||
127632914|NCT00074282|459278284|FG002|Step 1|Never started treatment|0|||
127632915|NCT00074282|459278282|FG000|Step 2|Adverse Event|0|||
127632916|NCT00074282|459278283|FG001|Step 2|Adverse Event|2|||
127632917|NCT00074282|459278284|FG002|Step 2|Adverse Event|12|||
127885650|NCT01355523|460205219|FG000|Overall Study|Protocol Violation|0|||
127632918|NCT00074282|459278282|FG000|Step 2|Disease progression|0|||
127632919|NCT00074282|459278283|FG001|Step 2|Disease progression|0|||
127885651|NCT01355523|460205220|FG001|Overall Study|Protocol Violation|2|||
127885652|NCT01355523|460205219|FG000|Overall Study|Adverse Event|0|||
127885653|NCT01355523|460205220|FG001|Overall Study|Adverse Event|2|||
127885654|NCT01011907|460205221|FG000|Overall Study|Withdrawal by Subject|13|||
127885655|NCT01011907|460205222|FG001|Overall Study|Withdrawal by Subject|11|||
127885656|NCT01011907|460205221|FG000|Overall Study|Adverse Event|1|||
127885657|NCT01011907|460205222|FG001|Overall Study|Adverse Event|4|||
127885658|NCT01406873|460205233|FG000|Overall Study|Withdrawal by Subject|1|||
127632920|NCT00074282|459278284|FG002|Step 2|Disease progression|5|||
127632921|NCT00074282|459278282|FG000|Step 2|Death|0|||
127632922|NCT00074282|459278283|FG001|Step 2|Death|0|||
127632923|NCT00074282|459278284|FG002|Step 2|Death|3|||
127632924|NCT00074282|459278282|FG000|Step 2|Withdrawal by Subject|0|||
127632925|NCT00074282|459278283|FG001|Step 2|Withdrawal by Subject|0|||
127632926|NCT00074282|459278284|FG002|Step 2|Withdrawal by Subject|2|||
127632927|NCT00074282|459278282|FG000|Step 2|Physician Decision|0|||
127632928|NCT00074282|459278283|FG001|Step 2|Physician Decision|0|||
127632929|NCT00074282|459278284|FG002|Step 2|Physician Decision|1|||
127632930|NCT00074282|459278282|FG000|Step 2|Ineligible|0|||
127632931|NCT00074282|459278283|FG001|Step 2|Ineligible|0|||
127632932|NCT00074282|459278284|FG002|Step 2|Ineligible|1|||
127632933|NCT00464542|459278285|FG000|Pre-treatment|Withdrawal by Subject|2|||
127632934|NCT01773226|459278286|FG000|Overall Study|Withdrawal by Subject|1|||
127632935|NCT02055352|459278288|FG000|Overall Study|Adverse Event|0|||
127632936|NCT02055352|459278289|FG001|Overall Study|Adverse Event|1|||
127632937|NCT02055352|459278288|FG000|Overall Study|Non-eligible|0|||
127632938|NCT02055352|459278289|FG001|Overall Study|Non-eligible|1|||
127632939|NCT02055352|459278288|FG000|Overall Study|Poor compliance|1|||
127632940|NCT02055352|459278289|FG001|Overall Study|Poor compliance|1|||
127632941|NCT02055352|459278288|FG000|Overall Study|Death|1|||
127632942|NCT02055352|459278289|FG001|Overall Study|Death|2|||
127632943|NCT02055352|459278288|FG000|Overall Study|Patient decision|1|||
127632944|NCT02055352|459278289|FG001|Overall Study|Patient decision|1|||
127632945|NCT02055352|459278288|FG000|Overall Study|Use of prohibited treatment|0|||
127632946|NCT02055352|459278289|FG001|Overall Study|Use of prohibited treatment|3|||
127632947|NCT02055352|459278288|FG000|Overall Study|AE, study drug would be detrimental|1|||
127632948|NCT02055352|459278289|FG001|Overall Study|AE, study drug would be detrimental|3|||
127632949|NCT02055352|459278288|FG000|Overall Study|Withdrawal of informed consent|1|||
127632950|NCT02055352|459278289|FG001|Overall Study|Withdrawal of informed consent|0|||
127632951|NCT02055352|459278288|FG000|Overall Study|Reason unknown|1|||
127632952|NCT02055352|459278289|FG001|Overall Study|Reason unknown|5|||
127632953|NCT02553330|459278294|FG000|Overall Study|Study Terminated by Sponsor|2|||
127632954|NCT02553330|459278295|FG001|Overall Study|Study Terminated by Sponsor|13|||
127632955|NCT02553330|459278296|FG002|Overall Study|Study Terminated by Sponsor|12|||
127632956|NCT02553330|459278294|FG000|Overall Study|Withdrawal by Subject|3|||
127632957|NCT02553330|459278295|FG001|Overall Study|Withdrawal by Subject|19|||
127632958|NCT02553330|459278296|FG002|Overall Study|Withdrawal by Subject|21|||
127632959|NCT02553330|459278294|FG000|Overall Study|Other|0|||
127632960|NCT02553330|459278295|FG001|Overall Study|Other|1|||
127632961|NCT02553330|459278296|FG002|Overall Study|Other|0|||
127632962|NCT02553330|459278294|FG000|Overall Study|Non compliance to study treatment|0|||
127795819|NCT01262365|459875947|FG001|Overall Study|Withdrawal by Subject|22|||
127795820|NCT01262365|459875948|FG002|Overall Study|Withdrawal by Subject|22|||
127632963|NCT02553330|459278295|FG001|Overall Study|Non compliance to study treatment|1|||
127632964|NCT02553330|459278296|FG002|Overall Study|Non compliance to study treatment|0|||
127632965|NCT02553330|459278294|FG000|Overall Study|Adverse Event|0|||
127632966|NCT02553330|459278295|FG001|Overall Study|Adverse Event|1|||
127632967|NCT02553330|459278296|FG002|Overall Study|Adverse Event|0|||
127632968|NCT02553330|459278294|FG000|Overall Study|Lost to Follow-up|0|||
127632969|NCT02553330|459278295|FG001|Overall Study|Lost to Follow-up|4|||
127632970|NCT02553330|459278296|FG002|Overall Study|Lost to Follow-up|4|||
127632971|NCT03551938|459278300|FG000|3-Month Follow Up|Lost to Follow-up|39|||
127632972|NCT03551938|459278301|FG001|3-Month Follow Up|Lost to Follow-up|38|||
127632973|NCT03551938|459278300|FG000|6-Month Follow Up|Lost to Follow-up|46|||
127632974|NCT03551938|459278301|FG001|6-Month Follow Up|Lost to Follow-up|42|||
127632975|NCT03551938|459278300|FG000|9-Month Follow Up|Lost to Follow-up|44|||
127632976|NCT03551938|459278301|FG001|9-Month Follow Up|Lost to Follow-up|43|||
127632977|NCT04137380|459278306|FG000|Overall Study|Physician Decision|0|||
127632978|NCT04137380|459278307|FG001|Overall Study|Physician Decision|0|||
127632979|NCT04137380|459278308|FG002|Overall Study|Physician Decision|0|||
127632980|NCT04137380|459278309|FG003|Overall Study|Physician Decision|1|||
127632981|NCT04137380|459278310|FG004|Overall Study|Physician Decision|0|||
127632982|NCT04137380|459278311|FG005|Overall Study|Physician Decision|0|||
127632983|NCT04137380|459278312|FG006|Overall Study|Physician Decision|0|||
127632984|NCT02265705|459278317|FG000|Treatment Period Week 0-24|Adverse Event|3|||
127632985|NCT02265705|459278318|FG001|Treatment Period Week 0-24|Adverse Event|2|||
127632986|NCT02265705|459278319|FG002|Treatment Period Week 0-24|Adverse Event|0|||
127632987|NCT02265705|459278320|FG003|Treatment Period Week 0-24|Adverse Event|0|||
127632988|NCT02265705|459278321|FG004|Treatment Period Week 0-24|Adverse Event|0|||
127632989|NCT02265705|459278322|FG005|Treatment Period Week 0-24|Adverse Event|0|||
127632990|NCT02265705|459278323|FG006|Treatment Period Week 0-24|Adverse Event|0|||
127795821|NCT01262365|459875946|FG000|Overall Study|Death|1|||
127632991|NCT02265705|459278317|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
127632992|NCT02265705|459278318|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
127632993|NCT02265705|459278319|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
127632994|NCT02265705|459278320|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
127632995|NCT02265705|459278321|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
127632996|NCT02265705|459278322|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
127632997|NCT02265705|459278323|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
127632998|NCT02265705|459278317|FG000|Treatment Period Week 0-24|Physician Decision|1|||
127632999|NCT02265705|459278318|FG001|Treatment Period Week 0-24|Physician Decision|0|||
127795822|NCT01262365|459875947|FG001|Overall Study|Death|2|||
127795823|NCT01262365|459875948|FG002|Overall Study|Death|1|||
127795824|NCT01262365|459875946|FG000|Overall Study|Adverse Event|26|||
127633000|NCT02265705|459278319|FG002|Treatment Period Week 0-24|Physician Decision|0|||
127633001|NCT02265705|459278320|FG003|Treatment Period Week 0-24|Physician Decision|0|||
127633002|NCT02265705|459278321|FG004|Treatment Period Week 0-24|Physician Decision|0|||
127633003|NCT02265705|459278322|FG005|Treatment Period Week 0-24|Physician Decision|0|||
127633004|NCT02265705|459278323|FG006|Treatment Period Week 0-24|Physician Decision|0|||
127633005|NCT02265705|459278317|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
127633006|NCT02265705|459278318|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
127633007|NCT02265705|459278319|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
127633008|NCT02265705|459278320|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
127633009|NCT02265705|459278321|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
127633010|NCT02265705|459278322|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
127633011|NCT02265705|459278323|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
127633012|NCT02265705|459278317|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
127633013|NCT02265705|459278318|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
127633014|NCT02265705|459278319|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
127633015|NCT02265705|459278320|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
127633016|NCT02265705|459278321|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
127633017|NCT02265705|459278322|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
127633018|NCT02265705|459278323|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
127633019|NCT02265705|459278317|FG000|Rescue Period|Withdrawal by Subject|0|||
127633020|NCT02265705|459278318|FG001|Rescue Period|Withdrawal by Subject|0|||
127633021|NCT02265705|459278319|FG002|Rescue Period|Withdrawal by Subject|1|||
127633022|NCT02265705|459278320|FG003|Rescue Period|Withdrawal by Subject|0|||
127633023|NCT02265705|459278321|FG004|Rescue Period|Withdrawal by Subject|0|||
127633024|NCT02265705|459278322|FG005|Rescue Period|Withdrawal by Subject|0|||
127633025|NCT02265705|459278323|FG006|Rescue Period|Withdrawal by Subject|0|||
127633026|NCT02265705|459278317|FG000|Rescue Period|Death|0|||
127633027|NCT02265705|459278318|FG001|Rescue Period|Death|0|||
127633028|NCT02265705|459278319|FG002|Rescue Period|Death|1|||
127633029|NCT02265705|459278320|FG003|Rescue Period|Death|0|||
127633030|NCT02265705|459278321|FG004|Rescue Period|Death|0|||
127633031|NCT02265705|459278322|FG005|Rescue Period|Death|0|||
127633032|NCT02265705|459278323|FG006|Rescue Period|Death|0|||
127633033|NCT02265705|459278317|FG000|Rescue Period|Lack of Efficacy|0|||
127633034|NCT02265705|459278318|FG001|Rescue Period|Lack of Efficacy|0|||
127633035|NCT02265705|459278319|FG002|Rescue Period|Lack of Efficacy|1|||
127633036|NCT02265705|459278320|FG003|Rescue Period|Lack of Efficacy|0|||
127633037|NCT02265705|459278321|FG004|Rescue Period|Lack of Efficacy|0|||
127633038|NCT02265705|459278322|FG005|Rescue Period|Lack of Efficacy|0|||
127633039|NCT02265705|459278323|FG006|Rescue Period|Lack of Efficacy|0|||
127633040|NCT02265705|459278317|FG000|Open Label Period|Adverse Event|0|||
127633041|NCT02265705|459278318|FG001|Open Label Period|Adverse Event|0|||
127633042|NCT02265705|459278319|FG002|Open Label Period|Adverse Event|0|||
127633043|NCT02265705|459278320|FG003|Open Label Period|Adverse Event|2|||
127633044|NCT02265705|459278321|FG004|Open Label Period|Adverse Event|2|||
127633045|NCT02265705|459278322|FG005|Open Label Period|Adverse Event|0|||
127633046|NCT02265705|459278323|FG006|Open Label Period|Adverse Event|0|||
127633047|NCT02265705|459278317|FG000|Open Label Period|Physician Decision|0|||
127633048|NCT02265705|459278318|FG001|Open Label Period|Physician Decision|0|||
127633049|NCT02265705|459278319|FG002|Open Label Period|Physician Decision|0|||
127633050|NCT02265705|459278320|FG003|Open Label Period|Physician Decision|0|||
127633051|NCT02265705|459278321|FG004|Open Label Period|Physician Decision|1|||
127795825|NCT01262365|459875947|FG001|Overall Study|Adverse Event|16|||
127795826|NCT01262365|459875948|FG002|Overall Study|Adverse Event|11|||
127633052|NCT02265705|459278322|FG005|Open Label Period|Physician Decision|0|||
127633053|NCT02265705|459278323|FG006|Open Label Period|Physician Decision|0|||
127633054|NCT02265705|459278317|FG000|Open Label Period|Withdrawal by Subject|0|||
127633055|NCT02265705|459278318|FG001|Open Label Period|Withdrawal by Subject|0|||
127633056|NCT02265705|459278319|FG002|Open Label Period|Withdrawal by Subject|0|||
127633057|NCT02265705|459278320|FG003|Open Label Period|Withdrawal by Subject|0|||
127633058|NCT02265705|459278321|FG004|Open Label Period|Withdrawal by Subject|2|||
127633059|NCT02265705|459278322|FG005|Open Label Period|Withdrawal by Subject|0|||
127633060|NCT02265705|459278323|FG006|Open Label Period|Withdrawal by Subject|0|||
127633061|NCT02265705|459278317|FG000|Follow-up Period|Sponsor Decision|0|||
127633062|NCT02265705|459278318|FG001|Follow-up Period|Sponsor Decision|0|||
127633063|NCT02265705|459278319|FG002|Follow-up Period|Sponsor Decision|0|||
127633064|NCT02265705|459278320|FG003|Follow-up Period|Sponsor Decision|0|||
127633065|NCT02265705|459278321|FG004|Follow-up Period|Sponsor Decision|0|||
127633066|NCT02265705|459278322|FG005|Follow-up Period|Sponsor Decision|1|||
127633067|NCT02265705|459278323|FG006|Follow-up Period|Sponsor Decision|6|||
127633068|NCT02265705|459278317|FG000|Follow-up Period|Adverse Event|0|||
127633069|NCT02265705|459278318|FG001|Follow-up Period|Adverse Event|0|||
127633070|NCT02265705|459278319|FG002|Follow-up Period|Adverse Event|0|||
127633071|NCT02265705|459278320|FG003|Follow-up Period|Adverse Event|0|||
127633072|NCT02265705|459278321|FG004|Follow-up Period|Adverse Event|0|||
127633073|NCT02265705|459278322|FG005|Follow-up Period|Adverse Event|0|||
127633074|NCT02265705|459278323|FG006|Follow-up Period|Adverse Event|3|||
127633075|NCT02265705|459278317|FG000|Follow-up Period|Physician Decision|0|||
127633076|NCT02265705|459278318|FG001|Follow-up Period|Physician Decision|0|||
127633077|NCT02265705|459278319|FG002|Follow-up Period|Physician Decision|0|||
127633078|NCT02265705|459278320|FG003|Follow-up Period|Physician Decision|0|||
127795827|NCT01262365|459875946|FG000|Overall Study|sponsor decision|1|||
127633079|NCT02265705|459278321|FG004|Follow-up Period|Physician Decision|0|||
127633080|NCT02265705|459278322|FG005|Follow-up Period|Physician Decision|0|||
127633081|NCT02265705|459278323|FG006|Follow-up Period|Physician Decision|1|||
127633082|NCT02265705|459278317|FG000|Follow-up Period|Withdrawal by Subject|0|||
127633083|NCT02265705|459278318|FG001|Follow-up Period|Withdrawal by Subject|0|||
127633084|NCT02265705|459278319|FG002|Follow-up Period|Withdrawal by Subject|0|||
127633085|NCT02265705|459278320|FG003|Follow-up Period|Withdrawal by Subject|0|||
127633086|NCT02265705|459278321|FG004|Follow-up Period|Withdrawal by Subject|0|||
127633087|NCT02265705|459278322|FG005|Follow-up Period|Withdrawal by Subject|0|||
127633088|NCT02265705|459278323|FG006|Follow-up Period|Withdrawal by Subject|1|||
127633089|NCT00779246|459278324|FG000|Overall Study|Missing sufficient data for analysis|33|||
127795828|NCT01262365|459875947|FG001|Overall Study|sponsor decision|1|||
127795829|NCT01262365|459875948|FG002|Overall Study|sponsor decision|0|||
127633090|NCT00779246|459278325|FG001|Overall Study|Missing sufficient data for analysis|53|||
127633091|NCT02079805|459278330|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
127633092|NCT02079805|459278331|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
127633093|NCT02079805|459278330|FG000|Overall Study|Voluntary Withdrawal|0|||
127633094|NCT02079805|459278331|FG001|Overall Study|Voluntary Withdrawal|1|||
127633095|NCT00583557|459278333|FG000|Overall Study|Withdrawal by Subject|18|||
127633096|NCT00583557|459278333|FG000|Overall Study|Adverse Event|9|||
127633097|NCT00583557|459278333|FG000|Overall Study|Lack of Efficacy|31|||
127633098|NCT00583557|459278333|FG000|Overall Study|Lack of Compliance|5|||
127633099|NCT00583557|459278333|FG000|Overall Study|Other|5|||
127633100|NCT00583557|459278333|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
127633101|NCT02347761|459278334|FG000|All Collected|Death|1|||
127633102|NCT02347761|459278335|FG001|All Collected|Death|0|||
127633103|NCT02347761|459278336|FG002|All Collected|Death|0|||
127633104|NCT02347761|459278334|FG000|All Collected|Lost to Follow-up|3|||
127633105|NCT02347761|459278335|FG001|All Collected|Lost to Follow-up|2|||
127633106|NCT02347761|459278336|FG002|All Collected|Lost to Follow-up|3|||
127633107|NCT02347761|459278334|FG000|All Collected|Withdrawal by Subject|11|||
127633108|NCT02347761|459278335|FG001|All Collected|Withdrawal by Subject|11|||
127633109|NCT02347761|459278336|FG002|All Collected|Withdrawal by Subject|22|||
127633110|NCT02347761|459278334|FG000|All Collected|invetigator disretion|2|||
127633111|NCT02347761|459278335|FG001|All Collected|invetigator disretion|0|||
127633112|NCT02347761|459278336|FG002|All Collected|invetigator disretion|0|||
127633113|NCT02347761|459278334|FG000|All Collected|instillation site pain|0|||
127633114|NCT02347761|459278335|FG001|All Collected|instillation site pain|0|||
127633115|NCT02347761|459278336|FG002|All Collected|instillation site pain|1|||
127633116|NCT02347761|459278334|FG000|All Collected|exacerbation of COPD|0|||
127633117|NCT02347761|459278335|FG001|All Collected|exacerbation of COPD|0|||
127633118|NCT02347761|459278336|FG002|All Collected|exacerbation of COPD|1|||
127633119|NCT02347761|459278334|FG000|All Collected|moved/travel|0|||
127633120|NCT02347761|459278335|FG001|All Collected|moved/travel|1|||
127633121|NCT02347761|459278336|FG002|All Collected|moved/travel|0|||
127633122|NCT02347761|459278334|FG000|On Study Treatment|Lack of Efficacy|2|||
127633123|NCT02347761|459278335|FG001|On Study Treatment|Lack of Efficacy|3|||
127633124|NCT02347761|459278336|FG002|On Study Treatment|Lack of Efficacy|4|||
127633125|NCT02347761|459278334|FG000|On Study Treatment|non-compliance with study medication|0|||
127633126|NCT02347761|459278335|FG001|On Study Treatment|non-compliance with study medication|0|||
127633127|NCT02347761|459278336|FG002|On Study Treatment|non-compliance with study medication|2|||
127633128|NCT02347761|459278334|FG000|On Study Treatment|Withdrawal by Subject|7|||
127633129|NCT02347761|459278335|FG001|On Study Treatment|Withdrawal by Subject|3|||
127633130|NCT02347761|459278336|FG002|On Study Treatment|Withdrawal by Subject|5|||
127633131|NCT02347761|459278334|FG000|On Study Treatment|move/travel|2|||
127633132|NCT02347761|459278335|FG001|On Study Treatment|move/travel|6|||
127633133|NCT02347761|459278336|FG002|On Study Treatment|move/travel|5|||
127633134|NCT02347761|459278334|FG000|On Study Treatment|dissastisfaction with device|2|||
127633135|NCT02347761|459278335|FG001|On Study Treatment|dissastisfaction with device|1|||
127633136|NCT02347761|459278336|FG002|On Study Treatment|dissastisfaction with device|4|||
127633137|NCT02347761|459278334|FG000|On Study Treatment|Lost to Follow-up|2|||
127633138|NCT02347761|459278335|FG001|On Study Treatment|Lost to Follow-up|1|||
127633139|NCT02347761|459278336|FG002|On Study Treatment|Lost to Follow-up|1|||
127633140|NCT02347761|459278334|FG000|On Study Treatment|investigator discretion|2|||
127633141|NCT02347761|459278335|FG001|On Study Treatment|investigator discretion|0|||
127633142|NCT02347761|459278336|FG002|On Study Treatment|investigator discretion|0|||
127633143|NCT02347761|459278334|FG000|On Study Treatment|durg not working|0|||
127633144|NCT02347761|459278335|FG001|On Study Treatment|durg not working|1|||
127633145|NCT02347761|459278336|FG002|On Study Treatment|durg not working|1|||
127633146|NCT02347761|459278334|FG000|On Study Treatment|Adverse Event|10|||
127633147|NCT02347761|459278335|FG001|On Study Treatment|Adverse Event|8|||
127633148|NCT02347761|459278336|FG002|On Study Treatment|Adverse Event|20|||
127633149|NCT03625570|459278337|FG000|Primary Endpoint - Immediate Post|Withdrawal by Subject|2|||
127633150|NCT03625570|459278338|FG001|Primary Endpoint - Immediate Post|Withdrawal by Subject|1|||
127633151|NCT03625570|459278337|FG000|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|1|||
127633152|NCT03625570|459278338|FG001|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|0|||
127633153|NCT03625570|459278337|FG000|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|0|||
127633154|NCT03625570|459278338|FG001|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|1|||
127633155|NCT01310036|459278346|FG000|Overall Study|Administrative/other|10|||
127633156|NCT01310036|459278346|FG000|Overall Study|Withdrew Consent|11|||
127633157|NCT01310036|459278346|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
127633158|NCT01310036|459278346|FG000|Overall Study|Progression of Disease|164|||
127633159|NCT01310036|459278346|FG000|Overall Study|Death|1|||
127633160|NCT01310036|459278346|FG000|Overall Study|Adverse event or intercurrent illness|12|||
127633161|NCT00553267|459278347|FG000|Overall Study|Adverse Event|8|||
127633162|NCT00553267|459278348|FG001|Overall Study|Adverse Event|10|||
127633163|NCT00553267|459278349|FG002|Overall Study|Adverse Event|5|||
127633164|NCT00553267|459278347|FG000|Overall Study|Non compliant with protocol|3|||
127633165|NCT00553267|459278348|FG001|Overall Study|Non compliant with protocol|3|||
127633166|NCT00553267|459278349|FG002|Overall Study|Non compliant with protocol|2|||
127633167|NCT00553267|459278347|FG000|Overall Study|Lost to Follow-up|0|||
127633168|NCT00553267|459278348|FG001|Overall Study|Lost to Follow-up|0|||
127633169|NCT00553267|459278349|FG002|Overall Study|Lost to Follow-up|1|||
127633170|NCT00553267|459278347|FG000|Overall Study|Consent withdrawn|2|||
127633171|NCT00553267|459278348|FG001|Overall Study|Consent withdrawn|3|||
127633172|NCT00553267|459278349|FG002|Overall Study|Consent withdrawn|1|||
127633173|NCT00553267|459278347|FG000|Overall Study|Specified category|1|||
127633174|NCT00553267|459278348|FG001|Overall Study|Specified category|2|||
127633175|NCT00553267|459278349|FG002|Overall Study|Specified category|1|||
127633176|NCT00096135|459278355|FG000|Overall Study|Physician Decision|20|||
127633177|NCT00096135|459278356|FG001|Overall Study|Physician Decision|4|||
127633178|NCT00096135|459278355|FG000|Overall Study|Refusal of further protocol therapy|4|||
127633179|NCT00096135|459278356|FG001|Overall Study|Refusal of further protocol therapy|1|||
127633180|NCT00096135|459278355|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
127633181|NCT00096135|459278356|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
127633182|NCT00096135|459278355|FG000|Overall Study|Other, specify|15|||
127633183|NCT00096135|459278356|FG001|Overall Study|Other, specify|3|||
127633184|NCT00096135|459278355|FG000|Overall Study|Ineligible|2|||
127633185|NCT00096135|459278356|FG001|Overall Study|Ineligible|0|||
127633186|NCT01568047|459278358|FG000|Overall Study|Ineligibility|1|||
127633187|NCT01568047|459278359|FG001|Overall Study|Ineligibility|0|||
127633188|NCT01568047|459278360|FG002|Overall Study|Ineligibility|0|||
127633189|NCT01568047|459278361|FG003|Overall Study|Ineligibility|0|||
127633190|NCT01568047|459278358|FG000|Overall Study|Withdrawal by Subject|0|||
127633191|NCT01568047|459278359|FG001|Overall Study|Withdrawal by Subject|1|||
127633192|NCT01568047|459278360|FG002|Overall Study|Withdrawal by Subject|0|||
127633193|NCT01568047|459278361|FG003|Overall Study|Withdrawal by Subject|0|||
127633194|NCT01568047|459278358|FG000|Overall Study|Adverse Event|0|||
127633195|NCT01568047|459278359|FG001|Overall Study|Adverse Event|0|||
127633196|NCT01568047|459278360|FG002|Overall Study|Adverse Event|1|||
127633197|NCT01568047|459278361|FG003|Overall Study|Adverse Event|1|||
127633198|NCT00874029|459278362|FG000|Overall Study|Withdrawal by Subject|10|||
127633199|NCT00874029|459278362|FG000|Overall Study|Pregnancy|4|||
127633200|NCT00874029|459278362|FG000|Overall Study|Physician Decision|1|||
127633201|NCT00874029|459278362|FG000|Overall Study|Adverse Event|1|||
127633202|NCT00874029|459278362|FG000|Overall Study|Lost to Follow-up|5|||
127633203|NCT00856583|459278363|FG000|Overall Study|Lack of Efficacy|389|||
127633204|NCT00856583|459278364|FG001|Overall Study|Lack of Efficacy|377|||
127633205|NCT00856583|459278363|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
127633206|NCT00856583|459278364|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
127633207|NCT00856583|459278363|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
127633208|NCT00856583|459278364|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
127633209|NCT00856583|459278363|FG000|Overall Study|Non-compliance|305|||
127633210|NCT00856583|459278364|FG001|Overall Study|Non-compliance|262|||
127633211|NCT00856583|459278363|FG000|Overall Study|Withdrawal by Subject|1092|||
127633212|NCT00856583|459278364|FG001|Overall Study|Withdrawal by Subject|919|||
127633213|NCT00856583|459278363|FG000|Overall Study|Physician Decision|59|||
127633214|NCT00856583|459278364|FG001|Overall Study|Physician Decision|82|||
127633215|NCT00856583|459278363|FG000|Overall Study|Pregnancy|14|||
127633216|NCT00856583|459278364|FG001|Overall Study|Pregnancy|5|||
127633217|NCT00856583|459278363|FG000|Overall Study|Other|92|||
127633218|NCT00856583|459278364|FG001|Overall Study|Other|104|||
127633219|NCT00856583|459278363|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
127633220|NCT00856583|459278364|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
127633221|NCT01944046|459278367|FG000|Randomized to DB|Adverse Event|5|||
127633222|NCT01944046|459278368|FG001|Randomized to DB|Adverse Event|2|||
127633223|NCT01944046|459278367|FG000|Randomized to DB|Clinical Worsening|3|||
127633224|NCT01944046|459278368|FG001|Randomized to DB|Clinical Worsening|2|||
127633225|NCT01944046|459278367|FG000|Randomized to DB|Lost to Follow-up|3|||
127633226|NCT01944046|459278368|FG001|Randomized to DB|Lost to Follow-up|3|||
127633227|NCT01944046|459278367|FG000|Randomized to DB|Withdrawal by Subject|2|||
127633228|NCT01944046|459278368|FG001|Randomized to DB|Withdrawal by Subject|4|||
127633229|NCT01944046|459278367|FG000|Randomized to DB|Physician Decision|1|||
127633230|NCT01944046|459278368|FG001|Randomized to DB|Physician Decision|2|||
127633231|NCT01944046|459278367|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
127633232|NCT01944046|459278368|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
127633233|NCT01944046|459278367|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
127633234|NCT01944046|459278368|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
127633235|NCT01944046|459278367|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
127633236|NCT01944046|459278368|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
127633237|NCT01944046|459278367|FG000|Open Label Eligible and Consented|Adverse Event|6|||
127633238|NCT01944046|459278368|FG001|Open Label Eligible and Consented|Adverse Event|1|||
127633239|NCT01944046|459278367|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
127633240|NCT01944046|459278368|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
127633241|NCT01944046|459278367|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
127633242|NCT01944046|459278368|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
127633243|NCT01618838|459278379|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
127633244|NCT03965052|459278383|FG000|Overall Study|Protocol Violation|1|||
127633245|NCT03965052|459278384|FG001|Overall Study|Protocol Violation|0|||
127633246|NCT00499889|459278394|FG000|Overall Study|Infection prior to treatment|1|||
127633247|NCT00142909|459278398|FG000|Randomization|Various Reasons|7|||
127633248|NCT00142909|459278399|FG001|Randomization|Various Reasons|10|||
127633249|NCT00142909|459278398|FG000|Medications Begin|Protocol Violation|2|||
127633250|NCT00142909|459278399|FG001|Medications Begin|Protocol Violation|0|||
127633251|NCT00142909|459278398|FG000|Medications Begin|Withdrawal by Subject|5|||
127633252|NCT00142909|459278399|FG001|Medications Begin|Withdrawal by Subject|3|||
127633253|NCT00142909|459278398|FG000|Medications Begin|Withdrawal by Subject|2|||
127633254|NCT00142909|459278399|FG001|Medications Begin|Withdrawal by Subject|0|||
127633255|NCT01910519|459278400|FG000|Overall Study|Withdrawal by Subject|2|||
127633256|NCT01910519|459278401|FG001|Overall Study|Withdrawal by Subject|0|||
127633257|NCT01910519|459278400|FG000|Overall Study|Adverse Event|2|||
127633258|NCT01910519|459278401|FG001|Overall Study|Adverse Event|0|||
127633259|NCT04266028|459278402|FG000|Overall Study|Adverse Event|0|||
127633260|NCT04266028|459278403|FG001|Overall Study|Adverse Event|0|||
127633261|NCT04266028|459278404|FG002|Overall Study|Adverse Event|1|||
127633262|NCT04266028|459278405|FG003|Overall Study|Adverse Event|0|||
127633263|NCT04266028|459278406|FG004|Overall Study|Adverse Event|1|||
127633264|NCT04266028|459278407|FG005|Overall Study|Adverse Event|0|||
127633265|NCT04266028|459278408|FG006|Overall Study|Adverse Event|2|||
127633266|NCT04266028|459278409|FG007|Overall Study|Adverse Event|0|||
127633267|NCT04266028|459278402|FG000|Overall Study|temporary halt of the study|0|||
127633268|NCT04266028|459278403|FG001|Overall Study|temporary halt of the study|0|||
127633269|NCT04266028|459278404|FG002|Overall Study|temporary halt of the study|0|||
127633270|NCT04266028|459278405|FG003|Overall Study|temporary halt of the study|0|||
127633271|NCT04266028|459278406|FG004|Overall Study|temporary halt of the study|0|||
127633272|NCT04266028|459278407|FG005|Overall Study|temporary halt of the study|0|||
127633273|NCT04266028|459278408|FG006|Overall Study|temporary halt of the study|2|||
127633274|NCT04266028|459278409|FG007|Overall Study|temporary halt of the study|1|||
127633275|NCT04266028|459278402|FG000|Overall Study|Onset of birch pollen season|0|||
127633276|NCT04266028|459278403|FG001|Overall Study|Onset of birch pollen season|0|||
127633277|NCT04266028|459278404|FG002|Overall Study|Onset of birch pollen season|0|||
127633278|NCT04266028|459278405|FG003|Overall Study|Onset of birch pollen season|0|||
127633279|NCT04266028|459278406|FG004|Overall Study|Onset of birch pollen season|1|||
127633280|NCT04266028|459278407|FG005|Overall Study|Onset of birch pollen season|0|||
127633281|NCT04266028|459278408|FG006|Overall Study|Onset of birch pollen season|0|||
127633282|NCT04266028|459278409|FG007|Overall Study|Onset of birch pollen season|0|||
127633283|NCT01898195|459278410|FG000|Smoking Abstinence|Did not have good measurements|35|||
127633284|NCT01898195|459278411|FG001|Smoking Abstinence|Did not have good measurements|38|||
127633285|NCT01898195|459278412|FG002|Smoking Abstinence|Did not have good measurements|36|||
127633286|NCT02720484|459278417|FG000|Treatment on Study|Adverse Event|1|||
127633287|NCT02720484|459278417|FG000|Treatment on Study|Withdrawal by Subject|1|||
127633288|NCT02720484|459278417|FG000|Treatment on Study|Progressive Disease|4|||
127633289|NCT02720484|459278417|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
127633290|NCT02720484|459278417|FG000|Follow Up for 2 Years|Death|3|||
127633291|NCT02720484|459278417|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
127633292|NCT05070897|459278420|FG000|Overall Study|Protocol Violation|123|||
127633293|NCT05070897|459278421|FG001|Overall Study|Protocol Violation|68|||
127633294|NCT01617629|459278422|FG000|Overall Study|Death|2|||
127633295|NCT01617629|459278422|FG000|Overall Study|Investigator's Clinical Judgement|1|||
127633296|NCT01617629|459278422|FG000|Overall Study|Reason Not Specified|1|||
127633297|NCT01617629|459278422|FG000|Overall Study|Participant Withdrew Consent|2|||
127633298|NCT01663636|459278423|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
127633299|NCT01663636|459278424|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
127633300|NCT03832946|459278425|FG000|Overall Study|Adverse Event|3|||
127633301|NCT03832946|459278426|FG001|Overall Study|Adverse Event|1|||
127633302|NCT03832946|459278425|FG000|Overall Study|Lost to Follow-up|1|||
127633303|NCT03832946|459278426|FG001|Overall Study|Lost to Follow-up|0|||
127633304|NCT03832946|459278425|FG000|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|30|||
127633305|NCT03832946|459278426|FG001|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|22|||
127633306|NCT03832946|459278425|FG000|Overall Study|Lack of Efficacy|1|||
127633307|NCT03832946|459278426|FG001|Overall Study|Lack of Efficacy|0|||
127633308|NCT03832946|459278425|FG000|Overall Study|Withdrawal by Subject|12|||
127633309|NCT03832946|459278426|FG001|Overall Study|Withdrawal by Subject|9|||
127633310|NCT02863991|459278427|FG000|Overall Study|Death|0|||
127633311|NCT02863991|459278428|FG001|Overall Study|Death|3|||
127633312|NCT02863991|459278427|FG000|Overall Study|Lack of Efficacy|0|||
127633313|NCT02863991|459278428|FG001|Overall Study|Lack of Efficacy|1|||
127633314|NCT02863991|459278427|FG000|Overall Study|Study Terminated|2|||
127633315|NCT02863991|459278428|FG001|Overall Study|Study Terminated|8|||
127633316|NCT02663817|459278429|FG000|Overall Study|Screen failure|2|||
127633317|NCT03096782|459278432|FG000|Overall Study|Death|1|||
127633318|NCT03096782|459278432|FG000|Overall Study|Participant Relapsed|1|||
127633319|NCT04401579|459280908|FG000|Overall Study|Death|23|||
127633320|NCT04401579|459280909|FG001|Overall Study|Death|36|||
127633321|NCT04401579|459280908|FG000|Overall Study|Lost to Follow-up|40|||
127633322|NCT04401579|459280909|FG001|Overall Study|Lost to Follow-up|41|||
127633323|NCT04401579|459280908|FG000|Overall Study|Withdrawal by Subject|8|||
127885659|NCT01406873|460205234|FG001|Overall Study|Withdrawal by Subject|1|||
127885660|NCT00207714|460205235|FG000|Overall Study|Adverse Event|6|||
127633324|NCT04401579|459280909|FG001|Overall Study|Withdrawal by Subject|16|||
127633325|NCT04401579|459280908|FG000|Overall Study|Physician Decision|1|||
127633326|NCT04401579|459280909|FG001|Overall Study|Physician Decision|2|||
127633327|NCT04401579|459280908|FG000|Overall Study|Became ineligible after enrollment|1|||
127633328|NCT04401579|459280909|FG001|Overall Study|Became ineligible after enrollment|1|||
127885661|NCT00207714|460205236|FG001|Overall Study|Adverse Event|2|||
127633329|NCT04401579|459280908|FG000|Overall Study|Enrolled but treatment not administered|7|||
127633330|NCT04401579|459280909|FG001|Overall Study|Enrolled but treatment not administered|9|||
127633331|NCT04401579|459280908|FG000|Overall Study|Adverse Event|2|||
127633332|NCT04401579|459280909|FG001|Overall Study|Adverse Event|1|||
127633333|NCT04401579|459280908|FG000|Overall Study|Scheduling error|1|||
127633334|NCT04401579|459280909|FG001|Overall Study|Scheduling error|2|||
127633335|NCT04401579|459280908|FG000|Overall Study|Transferred to another hospital|1|||
127633336|NCT04401579|459280909|FG001|Overall Study|Transferred to another hospital|2|||
127633337|NCT00618514|459280910|FG000|Overall Study|Lost to Follow-up|11|||
127633338|NCT00618514|459280911|FG001|Overall Study|Lost to Follow-up|12|||
127633339|NCT00618514|459280912|FG002|Overall Study|Lost to Follow-up|4|||
127633340|NCT03521635|459280913|FG000|Overall Study|Adverse Event|1|||
127633341|NCT03521635|459280914|FG001|Overall Study|Adverse Event|1|||
127633342|NCT03521635|459280913|FG000|Overall Study|Refused to complete study visit|1|||
127633343|NCT03521635|459280914|FG001|Overall Study|Refused to complete study visit|0|||
127633344|NCT03521635|459280913|FG000|Overall Study|Refused to continue trial medication|2|||
127633345|NCT03521635|459280914|FG001|Overall Study|Refused to continue trial medication|2|||
127633346|NCT03521635|459280913|FG000|Overall Study|Lost to Follow-up|0|||
127633347|NCT03521635|459280914|FG001|Overall Study|Lost to Follow-up|1|||
127633348|NCT03521635|459280913|FG000|Overall Study|Meet exclusion criteria|0|||
127633349|NCT03521635|459280914|FG001|Overall Study|Meet exclusion criteria|1|||
127633350|NCT03521635|459280913|FG000|Overall Study|Patient not taken study medicine|0|||
127633351|NCT03521635|459280914|FG001|Overall Study|Patient not taken study medicine|1|||
127633352|NCT01153633|459280918|FG000|Overall Study|Protocol Violation|1|||
127633353|NCT01153633|459280919|FG001|Overall Study|Protocol Violation|1|||
127633354|NCT01153633|459280918|FG000|Overall Study|Therapeutic failure|3|||
127633355|NCT01153633|459280919|FG001|Overall Study|Therapeutic failure|3|||
127633356|NCT00071487|459280920|FG000|52-Week Double-Blind Period|Adverse Event|5|||
127633357|NCT00071487|459280921|FG001|52-Week Double-Blind Period|Adverse Event|8|||
127633358|NCT00071487|459280922|FG002|52-Week Double-Blind Period|Adverse Event|4|||
127633359|NCT00071487|459280923|FG003|52-Week Double-Blind Period|Adverse Event|8|||
127633360|NCT00071487|459280920|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
127633361|NCT00071487|459280921|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
127633362|NCT00071487|459280922|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
127633363|NCT00071487|459280923|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
127633364|NCT00071487|459280920|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
127633365|NCT00071487|459280921|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
127633366|NCT00071487|459280922|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
127633367|NCT00071487|459280923|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
127633368|NCT00071487|459280920|FG000|52-Week Double-Blind Period|Physician Decision|1|||
127633369|NCT00071487|459280921|FG001|52-Week Double-Blind Period|Physician Decision|0|||
127633370|NCT00071487|459280922|FG002|52-Week Double-Blind Period|Physician Decision|0|||
127633371|NCT00071487|459280923|FG003|52-Week Double-Blind Period|Physician Decision|0|||
127633372|NCT00071487|459280920|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
127633373|NCT00071487|459280921|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
127633374|NCT00071487|459280922|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
127633375|NCT00071487|459280923|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
127633376|NCT00071487|459280920|FG000|52-Week Double-Blind Period|Pregnancy|0|||
127633377|NCT00071487|459280921|FG001|52-Week Double-Blind Period|Pregnancy|1|||
127633378|NCT00071487|459280922|FG002|52-Week Double-Blind Period|Pregnancy|0|||
127633379|NCT00071487|459280923|FG003|52-Week Double-Blind Period|Pregnancy|0|||
127633380|NCT00071487|459280920|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
127633381|NCT00071487|459280921|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
127633382|NCT00071487|459280922|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
127633383|NCT00071487|459280923|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
127633384|NCT00071487|459280920|FG000|52-Week Double-Blind Period|Death|0|||
127633385|NCT00071487|459280921|FG001|52-Week Double-Blind Period|Death|1|||
127633386|NCT00071487|459280922|FG002|52-Week Double-Blind Period|Death|0|||
127633387|NCT00071487|459280923|FG003|52-Week Double-Blind Period|Death|0|||
127633388|NCT00071487|459280920|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
127633389|NCT00071487|459280921|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
127633390|NCT00071487|459280922|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
127633391|NCT00071487|459280923|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
127633392|NCT00071487|459280920|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
127633393|NCT00071487|459280921|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
127633394|NCT00071487|459280922|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
127633395|NCT00071487|459280923|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
127633396|NCT00071487|459280920|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
127633397|NCT00071487|459280921|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
127633398|NCT00071487|459280922|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
127633399|NCT00071487|459280923|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
127633400|NCT00071487|459280920|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
127633401|NCT00071487|459280921|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
127633402|NCT00071487|459280922|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
127633403|NCT00071487|459280923|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
127633404|NCT00071487|459280920|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
127633405|NCT00071487|459280921|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
127633406|NCT00071487|459280922|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
127633407|NCT00071487|459280923|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
127633408|NCT00071487|459280920|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
127633409|NCT00071487|459280921|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
127633410|NCT00071487|459280922|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
127633411|NCT00071487|459280923|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
127633412|NCT00071487|459280920|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
127633413|NCT00071487|459280921|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
127633414|NCT00071487|459280922|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
127633415|NCT00071487|459280923|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
127633416|NCT03725982|459280924|FG000|First Intervention|Withdrawal by Subject|0|||
127633417|NCT03725982|459280925|FG001|First Intervention|Withdrawal by Subject|1|||
127633418|NCT03725982|459280924|FG000|First Intervention|Physician Decision|1|||
127633419|NCT03725982|459280925|FG001|First Intervention|Physician Decision|1|||
127633420|NCT01227889|459280926|FG000|Randomized Phase (RP)|Adverse Event|13|||
127633421|NCT01227889|459280927|FG001|Randomized Phase (RP)|Adverse Event|0|||
127633422|NCT01227889|459280926|FG000|Randomized Phase (RP)|Physician Decision|13|||
127633423|NCT01227889|459280927|FG001|Randomized Phase (RP)|Physician Decision|5|||
127633424|NCT01227889|459280926|FG000|Randomized Phase (RP)|Progressive Disease|135|||
127633425|NCT01227889|459280927|FG001|Randomized Phase (RP)|Progressive Disease|52|||
127633426|NCT01227889|459280926|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
127633427|NCT01227889|459280927|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
127633428|NCT01227889|459280926|FG000|Randomized Phase (RP)|Missing|1|||
127633429|NCT01227889|459280927|FG001|Randomized Phase (RP)|Missing|3|||
127633430|NCT01227889|459280926|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
127633431|NCT01227889|459280927|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
127633432|NCT01227889|459280926|FG000|Crossover Phase|Adverse Event|0|||
127633433|NCT01227889|459280927|FG001|Crossover Phase|Adverse Event|1|||
127633434|NCT01227889|459280926|FG000|Crossover Phase|Physician Decision|0|||
127633435|NCT01227889|459280927|FG001|Crossover Phase|Physician Decision|3|||
127633436|NCT01227889|459280926|FG000|Crossover Phase|Progressive Disease|0|||
127633437|NCT01227889|459280927|FG001|Crossover Phase|Progressive Disease|31|||
127633438|NCT01227889|459280926|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
127633439|NCT01227889|459280927|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
127633440|NCT01227889|459280926|FG000|Crossover Phase|Withdrawal by Subject|0|||
127633441|NCT01227889|459280927|FG001|Crossover Phase|Withdrawal by Subject|1|||
127633442|NCT03268811|459280928|FG000|Overall Study|Adverse Event|0|||
127633443|NCT03268811|459280929|FG001|Overall Study|Adverse Event|1|||
127633444|NCT01205685|459280936|FG000|Overall Study|Disease Progression|10|||
127633445|NCT01205685|459280936|FG000|Overall Study|Withdrawal by Subject|1|||
127633446|NCT04827212|459280940|FG000|Baseline to 16 Weeks|Lost to Follow-up|2|||
127633447|NCT04827212|459280941|FG001|Baseline to 16 Weeks|Lost to Follow-up|2|||
127633448|NCT04827212|459280940|FG000|16 to 24 Weeks|Lost to Follow-up|3|||
127633449|NCT04827212|459280941|FG001|16 to 24 Weeks|Lost to Follow-up|4|||
127633450|NCT03058679|459280942|FG000|Baseline to Week 6|Lost to Follow-up|3|||
127633451|NCT03058679|459280943|FG001|Baseline to Week 6|Lost to Follow-up|2|||
127633452|NCT03058679|459280942|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
127633453|NCT03058679|459280943|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
127633454|NCT03058679|459280942|FG000|Baseline to Week 6|Adverse Event|6|||
127633455|NCT03058679|459280943|FG001|Baseline to Week 6|Adverse Event|6|||
127633456|NCT03058679|459280942|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
127633457|NCT03058679|459280943|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
127633458|NCT03058679|459280942|FG000|Baseline to Week 6|Difficulty following the diet|0|||
127633459|NCT03058679|459280943|FG001|Baseline to Week 6|Difficulty following the diet|2|||
127633460|NCT03058679|459280942|FG000|Baseline to Week 6|Physician Decision|1|||
127633461|NCT03058679|459280943|FG001|Baseline to Week 6|Physician Decision|0|||
127633462|NCT03058679|459280942|FG000|Week 6 to Week 12|Change in medication|5|||
127633463|NCT03058679|459280943|FG001|Week 6 to Week 12|Change in medication|7|||
127633464|NCT03058679|459280942|FG000|Week 6 to Week 12|Adverse Event|4|||
127633465|NCT03058679|459280943|FG001|Week 6 to Week 12|Adverse Event|3|||
127633466|NCT03058679|459280942|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
127633467|NCT03058679|459280943|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
127633468|NCT03058679|459280942|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
127633469|NCT03058679|459280943|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
127633470|NCT00599326|459280948|FG000|Overall Study|Lost to Follow-up|1|||
127633471|NCT00599326|459280948|FG000|Overall Study|Noncompliant|1|||
127633472|NCT00784810|459280951|FG000|Overall Study|Adverse Event|32|||
127633473|NCT00784810|459280952|FG001|Overall Study|Adverse Event|20|||
127633474|NCT00784810|459280951|FG000|Overall Study|Lack of Efficacy|14|||
127633475|NCT00784810|459280952|FG001|Overall Study|Lack of Efficacy|11|||
127633476|NCT00784810|459280951|FG000|Overall Study|Withdrawal by Subject|11|||
127633477|NCT00784810|459280952|FG001|Overall Study|Withdrawal by Subject|9|||
127633478|NCT00784810|459280951|FG000|Overall Study|Administrative|5|||
127633479|NCT00784810|459280952|FG001|Overall Study|Administrative|8|||
127633480|NCT00784810|459280951|FG000|Overall Study|Lost to Follow-up|1|||
127633481|NCT00784810|459280952|FG001|Overall Study|Lost to Follow-up|1|||
127633482|NCT02862106|459280953|FG000|Overall Study|Adverse Event|4|||
127633483|NCT02862106|459280954|FG001|Overall Study|Adverse Event|0|||
127633484|NCT02862106|459280953|FG000|Overall Study|Protocol Violation|16|||
127633485|NCT02862106|459280954|FG001|Overall Study|Protocol Violation|1|||
127633486|NCT02862106|459280953|FG000|Overall Study|Lost to Follow-up|15|||
127633487|NCT02862106|459280954|FG001|Overall Study|Lost to Follow-up|5|||
127633488|NCT02862106|459280953|FG000|Overall Study|Withdrawal by Subject|2|||
127633489|NCT02862106|459280954|FG001|Overall Study|Withdrawal by Subject|0|||
127633490|NCT02862106|459280953|FG000|Overall Study|Subjects moved to other city|1|||
127633491|NCT02862106|459280954|FG001|Overall Study|Subjects moved to other city|0|||
127633492|NCT00563784|459280957|FG000|Overall Study|Withdrawal by Subject|2|||
127633493|NCT00563784|459280957|FG000|Overall Study|Screen Failures|20|||
127633494|NCT03434119|459280960|FG000|Overall Study|Randomized but not treated|1|||
127633495|NCT03434119|459280961|FG001|Overall Study|Randomized but not treated|0|||
127633496|NCT03434119|459280960|FG000|Overall Study|Adverse Event|1|||
127633497|NCT03434119|459280961|FG001|Overall Study|Adverse Event|0|||
127633498|NCT03434119|459280960|FG000|Overall Study|Poor Compliance to Protocol|0|||
127633499|NCT03434119|459280961|FG001|Overall Study|Poor Compliance to Protocol|1|||
127633500|NCT03434119|459280960|FG000|Overall Study|Study Terminated by Sponsor|91|||
127633501|NCT03434119|459280961|FG001|Overall Study|Study Terminated by Sponsor|102|||
127633502|NCT03434119|459280960|FG000|Overall Study|Withdrawal by Subject|7|||
127633503|NCT03434119|459280961|FG001|Overall Study|Withdrawal by Subject|5|||
127633504|NCT03434119|459280960|FG000|Overall Study|Other than specified|7|||
127633505|NCT03434119|459280961|FG001|Overall Study|Other than specified|5|||
127633506|NCT04360824|459280962|FG000|Overall Study|Withdrawal by Subject|2|||
127633507|NCT04360824|459280963|FG001|Overall Study|Withdrawal by Subject|1|||
127633508|NCT04360824|459280962|FG000|Overall Study|Did not receive assigned treatment|1|||
127633509|NCT04360824|459280963|FG001|Overall Study|Did not receive assigned treatment|3|||
127633510|NCT00304070|459280964|FG000|Overall Study|Death|0|||
127633511|NCT00304070|459280965|FG001|Overall Study|Death|0|||
127633512|NCT00304070|459280966|FG002|Overall Study|Death|3|||
127633513|NCT00304070|459280964|FG000|Overall Study|Lost to Follow-up|0|||
127633514|NCT00304070|459280965|FG001|Overall Study|Lost to Follow-up|0|||
127633515|NCT00304070|459280966|FG002|Overall Study|Lost to Follow-up|1|||
127633516|NCT00304070|459280964|FG000|Overall Study|Physician Decision|0|||
127633517|NCT00304070|459280965|FG001|Overall Study|Physician Decision|0|||
127633518|NCT00304070|459280966|FG002|Overall Study|Physician Decision|3|||
127633519|NCT00304070|459280964|FG000|Overall Study|Withdrawal by Subject|0|||
127633520|NCT00304070|459280965|FG001|Overall Study|Withdrawal by Subject|0|||
127633521|NCT00304070|459280966|FG002|Overall Study|Withdrawal by Subject|1|||
127633522|NCT00304070|459280964|FG000|Overall Study|Progressive Disease|3|||
127633523|NCT00304070|459280965|FG001|Overall Study|Progressive Disease|7|||
127633524|NCT00304070|459280966|FG002|Overall Study|Progressive Disease|4|||
127633525|NCT00320216|459280967|FG000|Overall Study|Adverse Event|0|||
127633526|NCT00320216|459280968|FG001|Overall Study|Adverse Event|6|||
127633527|NCT00320216|459280969|FG002|Overall Study|Adverse Event|0|||
127633528|NCT00320216|459280970|FG003|Overall Study|Adverse Event|2|||
127633529|NCT00320216|459280971|FG004|Overall Study|Adverse Event|2|||
127633530|NCT00320216|459280967|FG000|Overall Study|Lack of Efficacy|6|||
127633531|NCT00320216|459280968|FG001|Overall Study|Lack of Efficacy|2|||
127633532|NCT00320216|459280969|FG002|Overall Study|Lack of Efficacy|1|||
127633533|NCT00320216|459280970|FG003|Overall Study|Lack of Efficacy|0|||
127633534|NCT00320216|459280971|FG004|Overall Study|Lack of Efficacy|1|||
127633535|NCT00320216|459280967|FG000|Overall Study|Lost to Follow-up|3|||
127633536|NCT00320216|459280968|FG001|Overall Study|Lost to Follow-up|0|||
127633537|NCT00320216|459280969|FG002|Overall Study|Lost to Follow-up|0|||
127633538|NCT00320216|459280970|FG003|Overall Study|Lost to Follow-up|0|||
127633539|NCT00320216|459280971|FG004|Overall Study|Lost to Follow-up|0|||
127633540|NCT00320216|459280967|FG000|Overall Study|Other|7|||
127633541|NCT00320216|459280968|FG001|Overall Study|Other|2|||
127633542|NCT00320216|459280969|FG002|Overall Study|Other|5|||
127633543|NCT00320216|459280970|FG003|Overall Study|Other|1|||
127633544|NCT00320216|459280971|FG004|Overall Study|Other|3|||
127633545|NCT00377676|459280973|FG000|Overall Study|Adverse Event|498|||
127633546|NCT00377676|459280974|FG001|Overall Study|Adverse Event|107|||
127633547|NCT00377676|459280973|FG000|Overall Study|Protocol Violation|33|||
127633548|NCT00377676|459280974|FG001|Overall Study|Protocol Violation|27|||
127633549|NCT00377676|459280973|FG000|Overall Study|Death|5|||
127633550|NCT00377676|459280974|FG001|Overall Study|Death|2|||
127633551|NCT00377676|459280973|FG000|Overall Study|Withdrawal by Subject|187|||
127633552|NCT00377676|459280974|FG001|Overall Study|Withdrawal by Subject|72|||
127633553|NCT00377676|459280973|FG000|Overall Study|Lost to Follow-up|120|||
127633554|NCT00377676|459280974|FG001|Overall Study|Lost to Follow-up|56|||
127633555|NCT00377676|459280973|FG000|Overall Study|Other|118|||
127633556|NCT00377676|459280974|FG001|Overall Study|Other|58|||
127633557|NCT03579459|459280979|FG000|Overall Study|Adverse Event|7|||
127633558|NCT03579459|459280980|FG001|Overall Study|Adverse Event|6|||
127633559|NCT03579459|459280981|FG002|Overall Study|Adverse Event|2|||
127633560|NCT03579459|459280982|FG003|Overall Study|Adverse Event|6|||
127633561|NCT03579459|459280979|FG000|Overall Study|Death|1|||
127633562|NCT03579459|459280980|FG001|Overall Study|Death|0|||
127633563|NCT03579459|459280981|FG002|Overall Study|Death|1|||
127633564|NCT03579459|459280982|FG003|Overall Study|Death|2|||
127633565|NCT03579459|459280979|FG000|Overall Study|Lost to Follow-up|6|||
127633566|NCT03579459|459280980|FG001|Overall Study|Lost to Follow-up|2|||
127633567|NCT03579459|459280981|FG002|Overall Study|Lost to Follow-up|4|||
127633568|NCT03579459|459280982|FG003|Overall Study|Lost to Follow-up|1|||
127633569|NCT03579459|459280979|FG000|Overall Study|Physician Decision|0|||
127633570|NCT03579459|459280980|FG001|Overall Study|Physician Decision|1|||
127633571|NCT03579459|459280981|FG002|Overall Study|Physician Decision|0|||
127633572|NCT03579459|459280982|FG003|Overall Study|Physician Decision|1|||
127633573|NCT03579459|459280979|FG000|Overall Study|Protocol Violation|1|||
127633574|NCT03579459|459280980|FG001|Overall Study|Protocol Violation|2|||
127633575|NCT03579459|459280981|FG002|Overall Study|Protocol Violation|3|||
127633576|NCT03579459|459280982|FG003|Overall Study|Protocol Violation|5|||
127633577|NCT03579459|459280979|FG000|Overall Study|Withdrawal by Subject|12|||
127633578|NCT03579459|459280980|FG001|Overall Study|Withdrawal by Subject|8|||
127633579|NCT03579459|459280981|FG002|Overall Study|Withdrawal by Subject|11|||
127633580|NCT03579459|459280982|FG003|Overall Study|Withdrawal by Subject|8|||
127633581|NCT03579459|459280979|FG000|Overall Study|Medication error without associated adverse event|2|||
127633582|NCT03579459|459280980|FG001|Overall Study|Medication error without associated adverse event|1|||
127633583|NCT03579459|459280981|FG002|Overall Study|Medication error without associated adverse event|1|||
127633584|NCT03579459|459280982|FG003|Overall Study|Medication error without associated adverse event|0|||
127633585|NCT03579459|459280979|FG000|Overall Study|Other|0|||
127633586|NCT03579459|459280980|FG001|Overall Study|Other|1|||
127633587|NCT03579459|459280981|FG002|Overall Study|Other|1|||
127633588|NCT03579459|459280982|FG003|Overall Study|Other|0|||
127633589|NCT03579459|459280979|FG000|Overall Study|Randomized not vaccinated|0|||
127633590|NCT03579459|459280980|FG001|Overall Study|Randomized not vaccinated|2|||
127633591|NCT03579459|459280981|FG002|Overall Study|Randomized not vaccinated|0|||
127633592|NCT03579459|459280982|FG003|Overall Study|Randomized not vaccinated|1|||
127633593|NCT00148343|459280983|FG000|Overall Study|Withdrawal by Subject|12|||
127633594|NCT00148343|459280984|FG001|Overall Study|Withdrawal by Subject|7|||
127633595|NCT00148343|459280983|FG000|Overall Study|Physician Decision|3|||
127633596|NCT00148343|459280984|FG001|Overall Study|Physician Decision|4|||
127633597|NCT02528214|459280991|FG000|Overall Study|Protocol Violation|0|||
127633598|NCT02528214|459280992|FG001|Overall Study|Protocol Violation|1|||
127633599|NCT02528214|459280991|FG000|Overall Study|Adverse Event|0|||
127633600|NCT02528214|459280992|FG001|Overall Study|Adverse Event|1|||
127633601|NCT02528214|459280991|FG000|Overall Study|Other than specified above|0|||
127633602|NCT02528214|459280992|FG001|Overall Study|Other than specified above|1|||
127633603|NCT00941603|459280996|FG000|Overall Study|Adverse Event|10|||
127633604|NCT00941603|459280997|FG001|Overall Study|Adverse Event|15|||
127633605|NCT00941603|459280998|FG002|Overall Study|Adverse Event|5|||
127633606|NCT00941603|459280999|FG003|Overall Study|Adverse Event|1|||
127633607|NCT00941603|459281000|FG004|Overall Study|Adverse Event|4|||
127633608|NCT00941603|459281001|FG005|Overall Study|Adverse Event|0|||
127633609|NCT00941603|459280996|FG000|Overall Study|Lost to Follow-up|0|||
127633610|NCT00941603|459280997|FG001|Overall Study|Lost to Follow-up|0|||
127633611|NCT00941603|459280998|FG002|Overall Study|Lost to Follow-up|0|||
127633612|NCT00941603|459280999|FG003|Overall Study|Lost to Follow-up|1|||
127633613|NCT00941603|459281000|FG004|Overall Study|Lost to Follow-up|0|||
127633614|NCT00941603|459281001|FG005|Overall Study|Lost to Follow-up|2|||
127633615|NCT00941603|459280996|FG000|Overall Study|Withdrawal by Subject|0|||
127633616|NCT00941603|459280997|FG001|Overall Study|Withdrawal by Subject|0|||
127633617|NCT00941603|459280998|FG002|Overall Study|Withdrawal by Subject|0|||
127633618|NCT00941603|459280999|FG003|Overall Study|Withdrawal by Subject|2|||
127633619|NCT00941603|459281000|FG004|Overall Study|Withdrawal by Subject|0|||
127633620|NCT00941603|459281001|FG005|Overall Study|Withdrawal by Subject|1|||
127633621|NCT00941603|459280996|FG000|Overall Study|Protocol Violation|0|||
127633622|NCT00941603|459280997|FG001|Overall Study|Protocol Violation|1|||
127633623|NCT00941603|459280998|FG002|Overall Study|Protocol Violation|0|||
127633624|NCT00941603|459280999|FG003|Overall Study|Protocol Violation|0|||
127633625|NCT00941603|459281000|FG004|Overall Study|Protocol Violation|0|||
127633626|NCT00941603|459281001|FG005|Overall Study|Protocol Violation|0|||
127633627|NCT00941603|459280996|FG000|Overall Study|Did not meet protocol eligibility|1|||
127633628|NCT00941603|459280997|FG001|Overall Study|Did not meet protocol eligibility|0|||
127633629|NCT00941603|459280998|FG002|Overall Study|Did not meet protocol eligibility|0|||
127633630|NCT00941603|459280999|FG003|Overall Study|Did not meet protocol eligibility|0|||
127633631|NCT00941603|459281000|FG004|Overall Study|Did not meet protocol eligibility|0|||
127633632|NCT00941603|459281001|FG005|Overall Study|Did not meet protocol eligibility|0|||
127633633|NCT02014116|459281002|FG000|Overall Study|Progressive Disease|3|||
127633634|NCT02014116|459281003|FG001|Overall Study|Progressive Disease|4|||
127633635|NCT02014116|459281004|FG002|Overall Study|Progressive Disease|2|||
127633636|NCT02014116|459281005|FG003|Overall Study|Progressive Disease|6|||
127633637|NCT02014116|459281006|FG004|Overall Study|Progressive Disease|1|||
127633638|NCT02014116|459281007|FG005|Overall Study|Progressive Disease|13|||
127633639|NCT02014116|459281008|FG006|Overall Study|Progressive Disease|1|||
127633640|NCT02014116|459281009|FG007|Overall Study|Progressive Disease|3|||
127633641|NCT02014116|459281010|FG008|Overall Study|Progressive Disease|7|||
127633642|NCT02014116|459281002|FG000|Overall Study|Adverse Event|0|||
127633643|NCT02014116|459281003|FG001|Overall Study|Adverse Event|0|||
127633644|NCT02014116|459281004|FG002|Overall Study|Adverse Event|0|||
127633645|NCT02014116|459281005|FG003|Overall Study|Adverse Event|0|||
127633646|NCT02014116|459281006|FG004|Overall Study|Adverse Event|1|||
127633647|NCT02014116|459281007|FG005|Overall Study|Adverse Event|0|||
127633648|NCT02014116|459281008|FG006|Overall Study|Adverse Event|0|||
127633649|NCT02014116|459281009|FG007|Overall Study|Adverse Event|1|||
127885662|NCT00207714|460205237|FG002|Overall Study|Adverse Event|4|||
127633650|NCT02014116|459281010|FG008|Overall Study|Adverse Event|0|||
127633651|NCT02014116|459281002|FG000|Overall Study|Lost to Follow-up|0|||
127633652|NCT02014116|459281003|FG001|Overall Study|Lost to Follow-up|0|||
127633653|NCT02014116|459281004|FG002|Overall Study|Lost to Follow-up|0|||
127633654|NCT02014116|459281005|FG003|Overall Study|Lost to Follow-up|0|||
127633655|NCT02014116|459281006|FG004|Overall Study|Lost to Follow-up|0|||
127885663|NCT00207714|460205238|FG003|Overall Study|Adverse Event|3|||
127633656|NCT02014116|459281007|FG005|Overall Study|Lost to Follow-up|1|||
127633657|NCT02014116|459281008|FG006|Overall Study|Lost to Follow-up|0|||
127633658|NCT02014116|459281009|FG007|Overall Study|Lost to Follow-up|0|||
127633659|NCT02014116|459281010|FG008|Overall Study|Lost to Follow-up|1|||
127633660|NCT02014116|459281002|FG000|Overall Study|Death|0|||
127633661|NCT02014116|459281003|FG001|Overall Study|Death|0|||
127633662|NCT02014116|459281004|FG002|Overall Study|Death|0|||
127885664|NCT00207714|460205239|FG004|Overall Study|Adverse Event|1|||
127633663|NCT02014116|459281005|FG003|Overall Study|Death|0|||
127633664|NCT02014116|459281006|FG004|Overall Study|Death|0|||
127633665|NCT02014116|459281007|FG005|Overall Study|Death|0|||
127633666|NCT02014116|459281008|FG006|Overall Study|Death|0|||
127633667|NCT02014116|459281009|FG007|Overall Study|Death|1|||
127633668|NCT02014116|459281010|FG008|Overall Study|Death|1|||
127633669|NCT02014116|459281002|FG000|Overall Study|Withdrawal by Subject|0|||
127633670|NCT02014116|459281003|FG001|Overall Study|Withdrawal by Subject|0|||
127633671|NCT02014116|459281004|FG002|Overall Study|Withdrawal by Subject|1|||
127633672|NCT02014116|459281005|FG003|Overall Study|Withdrawal by Subject|1|||
127633673|NCT02014116|459281006|FG004|Overall Study|Withdrawal by Subject|0|||
127633674|NCT02014116|459281007|FG005|Overall Study|Withdrawal by Subject|1|||
127633675|NCT02014116|459281008|FG006|Overall Study|Withdrawal by Subject|0|||
127633676|NCT02014116|459281009|FG007|Overall Study|Withdrawal by Subject|0|||
127633677|NCT02014116|459281010|FG008|Overall Study|Withdrawal by Subject|0|||
127633678|NCT02014116|459281002|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
127633679|NCT02014116|459281003|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
127702622|NCT05543629|459540532|FG004|Overall Study|Study terminated by Sponsor|0|||
127633680|NCT02014116|459281004|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
127633681|NCT02014116|459281005|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
127633682|NCT02014116|459281006|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
127633683|NCT02014116|459281007|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
127633684|NCT02014116|459281008|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
127633685|NCT02014116|459281009|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
127633686|NCT02014116|459281010|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
127633687|NCT02014116|459281002|FG000|Overall Study|Physician Decision|0|||
127633688|NCT02014116|459281003|FG001|Overall Study|Physician Decision|0|||
127633689|NCT02014116|459281004|FG002|Overall Study|Physician Decision|0|||
127633690|NCT02014116|459281005|FG003|Overall Study|Physician Decision|0|||
127633691|NCT02014116|459281006|FG004|Overall Study|Physician Decision|0|||
127633692|NCT02014116|459281007|FG005|Overall Study|Physician Decision|0|||
127633693|NCT02014116|459281008|FG006|Overall Study|Physician Decision|0|||
127633694|NCT02014116|459281009|FG007|Overall Study|Physician Decision|0|||
127633695|NCT02014116|459281010|FG008|Overall Study|Physician Decision|1|||
127633696|NCT03879798|459281011|FG000|Overall Study|Adverse Event|0|||
127633697|NCT03879798|459281012|FG001|Overall Study|Adverse Event|0|||
127633698|NCT03879798|459281013|FG002|Overall Study|Adverse Event|0|||
127633699|NCT03879798|459281014|FG003|Overall Study|Adverse Event|0|||
127633700|NCT03879798|459281015|FG004|Overall Study|Adverse Event|0|||
127633701|NCT03879798|459281016|FG005|Overall Study|Adverse Event|1|||
127633702|NCT03879798|459281011|FG000|Overall Study|Lack of Efficacy|0|||
127633703|NCT03879798|459281012|FG001|Overall Study|Lack of Efficacy|0|||
127633704|NCT03879798|459281013|FG002|Overall Study|Lack of Efficacy|0|||
127633705|NCT03879798|459281014|FG003|Overall Study|Lack of Efficacy|0|||
127633706|NCT03879798|459281015|FG004|Overall Study|Lack of Efficacy|0|||
127633707|NCT03879798|459281016|FG005|Overall Study|Lack of Efficacy|1|||
127633708|NCT03879798|459281011|FG000|Overall Study|Withdrawal by Subject|0|||
127633709|NCT03879798|459281012|FG001|Overall Study|Withdrawal by Subject|0|||
127633710|NCT03879798|459281013|FG002|Overall Study|Withdrawal by Subject|0|||
127633711|NCT03879798|459281014|FG003|Overall Study|Withdrawal by Subject|0|||
127633712|NCT03879798|459281015|FG004|Overall Study|Withdrawal by Subject|0|||
127633713|NCT03879798|459281016|FG005|Overall Study|Withdrawal by Subject|1|||
127633714|NCT01040130|459281024|FG000|Overall Study|Adverse Event|1|||
127633715|NCT01040130|459281025|FG001|Overall Study|Adverse Event|1|||
127633716|NCT01040130|459281026|FG002|Overall Study|Adverse Event|0|||
127633717|NCT01040130|459281027|FG003|Overall Study|Adverse Event|5|||
127633718|NCT01040130|459281028|FG004|Overall Study|Adverse Event|0|||
127633719|NCT01040130|459281029|FG005|Overall Study|Adverse Event|3|||
127633720|NCT01040130|459281024|FG000|Overall Study|Protocol Violation|0|||
127633721|NCT01040130|459281025|FG001|Overall Study|Protocol Violation|0|||
127633722|NCT01040130|459281026|FG002|Overall Study|Protocol Violation|2|||
127633723|NCT01040130|459281027|FG003|Overall Study|Protocol Violation|0|||
127633724|NCT01040130|459281028|FG004|Overall Study|Protocol Violation|0|||
127633725|NCT01040130|459281029|FG005|Overall Study|Protocol Violation|0|||
127633726|NCT01040130|459281024|FG000|Overall Study|Withdrawal by Subject|0|||
127633727|NCT01040130|459281025|FG001|Overall Study|Withdrawal by Subject|2|||
127633728|NCT01040130|459281026|FG002|Overall Study|Withdrawal by Subject|0|||
127633729|NCT01040130|459281027|FG003|Overall Study|Withdrawal by Subject|0|||
127633730|NCT01040130|459281028|FG004|Overall Study|Withdrawal by Subject|0|||
127633731|NCT01040130|459281029|FG005|Overall Study|Withdrawal by Subject|1|||
127633732|NCT01040130|459281024|FG000|Overall Study|Other reasons not listed above|2|||
127633733|NCT01040130|459281025|FG001|Overall Study|Other reasons not listed above|0|||
127633734|NCT01040130|459281026|FG002|Overall Study|Other reasons not listed above|0|||
127885665|NCT00207714|460205235|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
127633735|NCT01040130|459281027|FG003|Overall Study|Other reasons not listed above|0|||
127633736|NCT01040130|459281028|FG004|Overall Study|Other reasons not listed above|0|||
127702623|NCT05543629|459540533|FG005|Overall Study|Study terminated by Sponsor|4|||
127702624|NCT05543629|459540534|FG006|Overall Study|Study terminated by Sponsor|1|||
127702625|NCT05543629|459540535|FG007|Overall Study|Study terminated by Sponsor|0|||
127633737|NCT01040130|459281029|FG005|Overall Study|Other reasons not listed above|0|||
127633738|NCT02937545|459281031|FG000|Overall Study|Withdrawal by Subject|1|||
127633739|NCT02937545|459281032|FG001|Overall Study|Withdrawal by Subject|2|||
127633740|NCT02937545|459281033|FG002|Overall Study|Withdrawal by Subject|6|||
127633741|NCT02937545|459281034|FG003|Overall Study|Withdrawal by Subject|7|||
127702626|NCT05543629|459540528|FG000|Overall Study|Withdrawal by Subject|1|||
127702627|NCT05543629|459540529|FG001|Overall Study|Withdrawal by Subject|1|||
127633742|NCT02937545|459281031|FG000|Overall Study|Lost to Follow-up|1|||
127633743|NCT02937545|459281032|FG001|Overall Study|Lost to Follow-up|0|||
127633744|NCT02937545|459281033|FG002|Overall Study|Lost to Follow-up|0|||
127633745|NCT02937545|459281034|FG003|Overall Study|Lost to Follow-up|0|||
127633746|NCT02007577|459281035|FG000|Overall Study|Adverse Event|1|||
127633747|NCT02007577|459281036|FG001|Overall Study|Adverse Event|0|||
127633748|NCT02007577|459281035|FG000|Overall Study|Withdrawal by Subject|0|||
127633749|NCT02007577|459281036|FG001|Overall Study|Withdrawal by Subject|1|||
127633750|NCT02504294|459281037|FG000|Overall Study|Adverse Event|15|||
127633751|NCT02504294|459281038|FG001|Overall Study|Adverse Event|12|||
127633752|NCT02504294|459281037|FG000|Overall Study|Withdrawal by Subject|7|||
127633753|NCT02504294|459281038|FG001|Overall Study|Withdrawal by Subject|1|||
127633754|NCT02504294|459281037|FG000|Overall Study|Protocol Violation|27|||
127633755|NCT02504294|459281038|FG001|Overall Study|Protocol Violation|26|||
127633756|NCT02504294|459281037|FG000|Overall Study|Physician Decision|1|||
127633757|NCT02504294|459281038|FG001|Overall Study|Physician Decision|2|||
127633758|NCT02504294|459281037|FG000|Overall Study|Lost to Follow-up|6|||
127633759|NCT02504294|459281038|FG001|Overall Study|Lost to Follow-up|7|||
127633760|NCT01985126|459281039|FG000|Overall Study|Death|15|||
127633761|NCT01985126|459281040|FG001|Overall Study|Death|69|||
127633762|NCT01985126|459281039|FG000|Overall Study|Lost to Follow-up|0|||
127633763|NCT01985126|459281040|FG001|Overall Study|Lost to Follow-up|8|||
127633764|NCT01985126|459281039|FG000|Overall Study|Study Terminated By Sponsor|1|||
127633765|NCT01985126|459281040|FG001|Overall Study|Study Terminated By Sponsor|22|||
127633766|NCT01985126|459281039|FG000|Overall Study|Withdrawal by Subject|2|||
127633767|NCT01985126|459281040|FG001|Overall Study|Withdrawal by Subject|7|||
127633768|NCT01953926|459281045|FG000|Overall Study|Withdrawal by Subject|23|||
127633769|NCT01953926|459281046|FG001|Overall Study|Withdrawal by Subject|3|||
127633770|NCT01953926|459281047|FG002|Overall Study|Withdrawal by Subject|3|||
127633771|NCT01953926|459281048|FG003|Overall Study|Withdrawal by Subject|5|||
127633772|NCT01953926|459281049|FG004|Overall Study|Withdrawal by Subject|6|||
127633773|NCT01953926|459281050|FG005|Overall Study|Withdrawal by Subject|0|||
127633774|NCT01953926|459281051|FG006|Overall Study|Withdrawal by Subject|1|||
127633775|NCT01953926|459281045|FG000|Overall Study|Physician Decision|1|||
127633776|NCT01953926|459281046|FG001|Overall Study|Physician Decision|0|||
127633777|NCT01953926|459281047|FG002|Overall Study|Physician Decision|0|||
127633778|NCT01953926|459281048|FG003|Overall Study|Physician Decision|0|||
127633779|NCT01953926|459281049|FG004|Overall Study|Physician Decision|2|||
127633780|NCT01953926|459281050|FG005|Overall Study|Physician Decision|0|||
127633781|NCT01953926|459281051|FG006|Overall Study|Physician Decision|0|||
127633782|NCT01953926|459281045|FG000|Overall Study|Lost to Follow-up|18|||
127633783|NCT01953926|459281046|FG001|Overall Study|Lost to Follow-up|3|||
127633784|NCT01953926|459281047|FG002|Overall Study|Lost to Follow-up|0|||
127633785|NCT01953926|459281048|FG003|Overall Study|Lost to Follow-up|5|||
127633786|NCT01953926|459281049|FG004|Overall Study|Lost to Follow-up|3|||
127633787|NCT01953926|459281050|FG005|Overall Study|Lost to Follow-up|0|||
127633788|NCT01953926|459281051|FG006|Overall Study|Lost to Follow-up|0|||
127633789|NCT01953926|459281045|FG000|Overall Study|Protocol Violation|1|||
127633790|NCT01953926|459281046|FG001|Overall Study|Protocol Violation|0|||
127633791|NCT01953926|459281047|FG002|Overall Study|Protocol Violation|0|||
127633792|NCT01953926|459281048|FG003|Overall Study|Protocol Violation|0|||
127633793|NCT01953926|459281049|FG004|Overall Study|Protocol Violation|0|||
127633794|NCT01953926|459281050|FG005|Overall Study|Protocol Violation|0|||
127633795|NCT01953926|459281051|FG006|Overall Study|Protocol Violation|0|||
127633796|NCT01953926|459281045|FG000|Overall Study|Other, Disease progression|2|||
127633797|NCT01953926|459281046|FG001|Overall Study|Other, Disease progression|1|||
127633798|NCT01953926|459281047|FG002|Overall Study|Other, Disease progression|0|||
127633799|NCT01953926|459281048|FG003|Overall Study|Other, Disease progression|0|||
127633800|NCT01953926|459281049|FG004|Overall Study|Other, Disease progression|1|||
127633801|NCT01953926|459281050|FG005|Overall Study|Other, Disease progression|0|||
127633802|NCT01953926|459281051|FG006|Overall Study|Other, Disease progression|0|||
127633803|NCT01953926|459281045|FG000|Overall Study|Discontinuation of study by sponsor|41|||
127633804|NCT01953926|459281046|FG001|Overall Study|Discontinuation of study by sponsor|7|||
127633805|NCT01953926|459281047|FG002|Overall Study|Discontinuation of study by sponsor|5|||
127633806|NCT01953926|459281048|FG003|Overall Study|Discontinuation of study by sponsor|12|||
127633807|NCT01953926|459281049|FG004|Overall Study|Discontinuation of study by sponsor|46|||
127633808|NCT01953926|459281050|FG005|Overall Study|Discontinuation of study by sponsor|5|||
127633809|NCT01953926|459281051|FG006|Overall Study|Discontinuation of study by sponsor|6|||
127633810|NCT01953926|459281045|FG000|Overall Study|Not Treated|1|||
127633811|NCT01953926|459281046|FG001|Overall Study|Not Treated|0|||
127633812|NCT01953926|459281047|FG002|Overall Study|Not Treated|1|||
127633813|NCT01953926|459281048|FG003|Overall Study|Not Treated|0|||
127633814|NCT01953926|459281049|FG004|Overall Study|Not Treated|0|||
127633815|NCT01953926|459281050|FG005|Overall Study|Not Treated|0|||
127633816|NCT01953926|459281051|FG006|Overall Study|Not Treated|0|||
127633817|NCT00784043|459281053|FG000|Overall Study|Withdrawal by Subject|8|||
127633818|NCT00784043|459281054|FG001|Overall Study|Withdrawal by Subject|5|||
127633819|NCT00784043|459281053|FG000|Overall Study|Protocol Terminated|23|||
127633820|NCT00784043|459281054|FG001|Overall Study|Protocol Terminated|1|||
127633821|NCT03585244|459281059|FG000|Overall Study|Withdrawal by Subject|15|||
127633822|NCT06281548|459281061|FG000|Overall Study|Lost to Follow-up|3|||
127633823|NCT03538626|459281062|FG000|Overall Study|Withdrawal by Subject|0|||
127633824|NCT03538626|459281063|FG001|Overall Study|Withdrawal by Subject|1|||
127633825|NCT03538626|459281064|FG002|Overall Study|Withdrawal by Subject|0|||
127633826|NCT03538626|459281065|FG003|Overall Study|Withdrawal by Subject|0|||
127633827|NCT03538626|459281066|FG004|Overall Study|Withdrawal by Subject|0|||
127633828|NCT03538626|459281067|FG005|Overall Study|Withdrawal by Subject|0|||
127633829|NCT03538626|459281068|FG006|Overall Study|Withdrawal by Subject|0|||
127633830|NCT03538626|459281069|FG007|Overall Study|Withdrawal by Subject|0|||
127633831|NCT03538626|459281062|FG000|Overall Study|Lost to Follow-up|0|||
127633832|NCT03538626|459281063|FG001|Overall Study|Lost to Follow-up|0|||
127633833|NCT03538626|459281064|FG002|Overall Study|Lost to Follow-up|0|||
127633834|NCT03538626|459281065|FG003|Overall Study|Lost to Follow-up|0|||
127633835|NCT03538626|459281066|FG004|Overall Study|Lost to Follow-up|0|||
127633836|NCT03538626|459281067|FG005|Overall Study|Lost to Follow-up|0|||
127633837|NCT03538626|459281068|FG006|Overall Study|Lost to Follow-up|1|||
127633838|NCT03538626|459281069|FG007|Overall Study|Lost to Follow-up|0|||
127633839|NCT00288587|459281070|FG000|Overall Study|Death|4|||
127633840|NCT00288587|459281071|FG001|Overall Study|Death|4|||
127633841|NCT00288587|459281070|FG000|Overall Study|Transplant|0|||
127633842|NCT00288587|459281071|FG001|Overall Study|Transplant|3|||
127633843|NCT00288587|459281070|FG000|Overall Study|Adverse Event|0|||
127633844|NCT00288587|459281071|FG001|Overall Study|Adverse Event|1|||
127633845|NCT00288587|459281070|FG000|Overall Study|Physician Decision|0|||
127633846|NCT00288587|459281071|FG001|Overall Study|Physician Decision|2|||
127633847|NCT00288587|459281070|FG000|Overall Study|Severe Aortic Stenosis|1|||
127633848|NCT00288587|459281071|FG001|Overall Study|Severe Aortic Stenosis|0|||
127633849|NCT01434602|459281076|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
127633850|NCT01434602|459281077|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
127633851|NCT01434602|459281078|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
127633852|NCT01434602|459281079|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
127633853|NCT01434602|459281080|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
127633854|NCT01434602|459281076|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
127633855|NCT01434602|459281077|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
127633856|NCT01434602|459281078|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
127633857|NCT01434602|459281079|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
127633858|NCT01434602|459281080|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
127633859|NCT01434602|459281076|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
127633860|NCT01434602|459281077|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
127633861|NCT01434602|459281078|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
127633862|NCT01434602|459281079|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
127633863|NCT01434602|459281080|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
127633864|NCT01434602|459281076|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
127633865|NCT01434602|459281077|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
127633866|NCT01434602|459281078|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
127633867|NCT01434602|459281079|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
127633868|NCT01434602|459281080|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
127633869|NCT01434602|459281076|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
127633870|NCT01434602|459281077|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
127633871|NCT01434602|459281078|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
127795830|NCT01262365|459875946|FG000|Overall Study|Randomization error|1|||
127795831|NCT01262365|459875947|FG001|Overall Study|Randomization error|0|||
127633872|NCT01434602|459281079|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
127633873|NCT01434602|459281080|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
127633874|NCT01434602|459281076|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
127633875|NCT01434602|459281077|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
127633876|NCT01434602|459281078|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
127633877|NCT01434602|459281079|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
127795832|NCT01262365|459875948|FG002|Overall Study|Randomization error|2|||
127795833|NCT01262365|459875946|FG000|Overall Study|Non-compliance|1|||
127795834|NCT01262365|459875947|FG001|Overall Study|Non-compliance|0|||
127795835|NCT01262365|459875948|FG002|Overall Study|Non-compliance|2|||
127795836|NCT01262365|459875946|FG000|Overall Study|Suspected pregnancy|1|||
127795837|NCT01262365|459875947|FG001|Overall Study|Suspected pregnancy|0|||
127795838|NCT01262365|459875948|FG002|Overall Study|Suspected pregnancy|0|||
127795839|NCT01262365|459875946|FG000|Overall Study|Patient pregnant|1|||
127795840|NCT01262365|459875947|FG001|Overall Study|Patient pregnant|0|||
127795841|NCT01262365|459875948|FG002|Overall Study|Patient pregnant|1|||
127795842|NCT01262365|459875946|FG000|Overall Study|Toxicity related to study drug|0|||
127795843|NCT01262365|459875947|FG001|Overall Study|Toxicity related to study drug|1|||
127795844|NCT01262365|459875948|FG002|Overall Study|Toxicity related to study drug|0|||
127633878|NCT01434602|459281080|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
127633879|NCT01434602|459281076|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
127633880|NCT01434602|459281077|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
127633881|NCT01434602|459281078|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
127633882|NCT01434602|459281079|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
127633883|NCT01434602|459281080|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
127633884|NCT01434602|459281076|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
127633885|NCT01434602|459281077|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
127633886|NCT01434602|459281078|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
127633887|NCT01434602|459281079|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
127633888|NCT01434602|459281080|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
127633889|NCT01434602|459281076|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
127633890|NCT01434602|459281077|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
127633891|NCT01434602|459281078|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
127633892|NCT01434602|459281079|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
127633893|NCT01434602|459281080|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
127633894|NCT01434602|459281076|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
127633895|NCT01434602|459281077|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
127633896|NCT01434602|459281078|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
127633897|NCT01434602|459281079|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
127633898|NCT01434602|459281080|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
127633899|NCT00586105|459281087|FG000|Overall Study|Adverse Event|4|||
127633900|NCT00586105|459281087|FG000|Overall Study|Death|2|||
127633901|NCT00586105|459281087|FG000|Overall Study|Protocol Violation|1|||
127633902|NCT00586105|459281087|FG000|Overall Study|Withdrawal by Subject|3|||
127633903|NCT00586105|459281087|FG000|Overall Study|Disease progression|19|||
127633904|NCT00586105|459281087|FG000|Overall Study|Switched to commercial drug|9|||
127633905|NCT00586105|459281087|FG000|Overall Study|Reason not reported|1|||
127633906|NCT03835533|459281090|FG000|Overall Study|Death|5|||
127633907|NCT03835533|459281091|FG001|Overall Study|Death|10|||
127633908|NCT03835533|459281092|FG002|Overall Study|Death|9|||
127633909|NCT03835533|459281090|FG000|Overall Study|Withdrawal by Subject|2|||
127633910|NCT03835533|459281091|FG001|Overall Study|Withdrawal by Subject|2|||
127633911|NCT03835533|459281092|FG002|Overall Study|Withdrawal by Subject|2|||
127633912|NCT03835533|459281090|FG000|Overall Study|Lost to Follow-up|1|||
127633913|NCT03835533|459281091|FG001|Overall Study|Lost to Follow-up|0|||
127633914|NCT03835533|459281092|FG002|Overall Study|Lost to Follow-up|0|||
127633915|NCT01136291|459281093|FG000|Overall Study|Lost to Follow-up|1|||
127633916|NCT01136291|459281094|FG001|Overall Study|Lost to Follow-up|1|||
127795845|NCT01262365|459875946|FG000|Overall Study|Cannot tolerate the protocol|0|||
127795846|NCT01262365|459875947|FG001|Overall Study|Cannot tolerate the protocol|1|||
127633917|NCT02308033|459281098|FG000|Overall Study|Normal Gram stain at Baseline|13|||
127633918|NCT02308033|459281099|FG001|Overall Study|Normal Gram stain at Baseline|10|||
127633919|NCT02308033|459281098|FG000|Overall Study|Positive for STD at Baseline|7|||
127795847|NCT01262365|459875948|FG002|Overall Study|Cannot tolerate the protocol|0|||
127795848|NCT01262365|459875946|FG000|Overall Study|Patient unavailable|0|||
127633920|NCT02308033|459281099|FG001|Overall Study|Positive for STD at Baseline|4|||
127633921|NCT02308033|459281098|FG000|Overall Study|Lost to Follow-up|6|||
127633922|NCT02308033|459281099|FG001|Overall Study|Lost to Follow-up|5|||
127795849|NCT01262365|459875947|FG001|Overall Study|Patient unavailable|0|||
127795850|NCT01262365|459875948|FG002|Overall Study|Patient unavailable|1|||
127795851|NCT00326898|459875949|FG000|Overall Study|Disease progression|52|||
127795852|NCT00326898|459875950|FG001|Overall Study|Disease progression|54|||
127795853|NCT00326898|459875951|FG002|Overall Study|Disease progression|102|||
127795854|NCT00326898|459875949|FG000|Overall Study|Adverse Event|124|||
127795855|NCT00326898|459875950|FG001|Overall Study|Adverse Event|128|||
127795856|NCT00326898|459875951|FG002|Overall Study|Adverse Event|33|||
127795857|NCT00326898|459875949|FG000|Overall Study|Death|2|||
127795858|NCT00326898|459875950|FG001|Overall Study|Death|0|||
127795859|NCT00326898|459875951|FG002|Overall Study|Death|0|||
127795860|NCT00326898|459875949|FG000|Overall Study|Withdrawal by Subject|134|||
127795861|NCT00326898|459875950|FG001|Overall Study|Withdrawal by Subject|128|||
127633923|NCT00345397|459281100|FG000|Overall Study|Death|1|||
127633924|NCT01870843|459281101|FG000|Overall Study|Adverse Event|10|||
127633925|NCT01870843|459281101|FG000|Overall Study|Lost to Follow-up|24|||
127633926|NCT01870843|459281101|FG000|Overall Study|Death|1|||
127633927|NCT01870843|459281101|FG000|Overall Study|Withdrawal by Subject|18|||
127633928|NCT03021187|459281106|FG000|Overall Study|Death|0|||
127633929|NCT03021187|459281107|FG001|Overall Study|Death|0|||
127633930|NCT03021187|459281108|FG002|Overall Study|Death|3|||
127633931|NCT03021187|459281109|FG003|Overall Study|Death|0|||
127633932|NCT03021187|459281106|FG000|Overall Study|Withdrawal by Subject|0|||
127795862|NCT00326898|459875951|FG002|Overall Study|Withdrawal by Subject|32|||
127795863|NCT00326898|459875949|FG000|Overall Study|Alternative therapy|1|||
127795864|NCT00326898|459875950|FG001|Overall Study|Alternative therapy|0|||
127795865|NCT00326898|459875951|FG002|Overall Study|Alternative therapy|0|||
127795866|NCT00326898|459875949|FG000|Overall Study|Other complicating disease|5|||
127633933|NCT03021187|459281107|FG001|Overall Study|Withdrawal by Subject|6|||
127633934|NCT03021187|459281108|FG002|Overall Study|Withdrawal by Subject|2|||
127633935|NCT03021187|459281109|FG003|Overall Study|Withdrawal by Subject|5|||
127633936|NCT03021187|459281106|FG000|Overall Study|Lost to Follow-up|10|||
127633937|NCT03021187|459281107|FG001|Overall Study|Lost to Follow-up|3|||
127633938|NCT03021187|459281108|FG002|Overall Study|Lost to Follow-up|1|||
127633939|NCT03021187|459281109|FG003|Overall Study|Lost to Follow-up|4|||
127633940|NCT01664078|459281110|FG000|Overall Study|Death|9|||
127633941|NCT01664078|459281110|FG000|Overall Study|Withdrawal by Subject|4|||
127633942|NCT01664078|459281110|FG000|Overall Study|Lost to Follow-up|2|||
127633943|NCT01664078|459281110|FG000|Overall Study|missed 5 year visit|1|||
127633944|NCT01664078|459281110|FG000|Overall Study|Other|53|||
127633945|NCT03351049|459281113|FG000|Overall Study|Withdrawal|26|||
127633946|NCT03351049|459281114|FG001|Overall Study|Withdrawal|22|||
127633947|NCT01337245|459281117|FG000|Overall Study|Lost to Follow-up|1|||
127633948|NCT01307501|459281118|FG000|Overall Study|Treatment Failure|1|||
127633949|NCT01307501|459281118|FG000|Overall Study|Death|20|||
127633950|NCT01307501|459281118|FG000|Overall Study|Lost to Follow-up|1|||
127633951|NCT01307501|459281118|FG000|Overall Study|Starting Hospice|1|||
127633952|NCT00558285|459281119|FG000|Overall Study|Adverse Event|1|||
127633953|NCT00558285|459281120|FG001|Overall Study|Adverse Event|1|||
127633954|NCT00558285|459281121|FG002|Overall Study|Adverse Event|4|||
127633955|NCT00558285|459281122|FG003|Overall Study|Adverse Event|1|||
127633956|NCT00558285|459281123|FG004|Overall Study|Adverse Event|2|||
127633957|NCT00558285|459281119|FG000|Overall Study|Abnormal test procedure result(s)|1|||
127633958|NCT00558285|459281120|FG001|Overall Study|Abnormal test procedure result(s)|0|||
127633959|NCT00558285|459281121|FG002|Overall Study|Abnormal test procedure result(s)|0|||
127633960|NCT00558285|459281122|FG003|Overall Study|Abnormal test procedure result(s)|0|||
127633961|NCT00558285|459281123|FG004|Overall Study|Abnormal test procedure result(s)|0|||
127633962|NCT00558285|459281119|FG000|Overall Study|Subject withdrew consent|2|||
127633963|NCT00558285|459281120|FG001|Overall Study|Subject withdrew consent|0|||
127633964|NCT00558285|459281121|FG002|Overall Study|Subject withdrew consent|1|||
127633965|NCT00558285|459281122|FG003|Overall Study|Subject withdrew consent|1|||
127633966|NCT00558285|459281123|FG004|Overall Study|Subject withdrew consent|1|||
127633967|NCT00558285|459281119|FG000|Overall Study|Lost to Follow-up|1|||
127633968|NCT00558285|459281120|FG001|Overall Study|Lost to Follow-up|1|||
127633969|NCT00558285|459281121|FG002|Overall Study|Lost to Follow-up|0|||
127633970|NCT00558285|459281122|FG003|Overall Study|Lost to Follow-up|0|||
127633971|NCT00558285|459281123|FG004|Overall Study|Lost to Follow-up|0|||
127633972|NCT00558285|459281119|FG000|Overall Study|Administrative problems|0|||
127633973|NCT00558285|459281120|FG001|Overall Study|Administrative problems|0|||
127633974|NCT00558285|459281121|FG002|Overall Study|Administrative problems|0|||
127633975|NCT00558285|459281122|FG003|Overall Study|Administrative problems|1|||
127633976|NCT00558285|459281123|FG004|Overall Study|Administrative problems|1|||
127633977|NCT00558285|459281119|FG000|Overall Study|Protocol deviation|1|||
127633978|NCT00558285|459281120|FG001|Overall Study|Protocol deviation|1|||
127633979|NCT00558285|459281121|FG002|Overall Study|Protocol deviation|0|||
127633980|NCT00558285|459281122|FG003|Overall Study|Protocol deviation|1|||
127633981|NCT00558285|459281123|FG004|Overall Study|Protocol deviation|0|||
127795867|NCT00326898|459875950|FG001|Overall Study|Other complicating disease|5|||
127795868|NCT00326898|459875951|FG002|Overall Study|Other complicating disease|4|||
127633982|NCT02730819|459281124|FG000|Overall Study|Lost to Follow-up|9|||
127633983|NCT02121847|459281125|FG000|Overall Study|Administrative Reasons|1|||
127633984|NCT02121847|459281125|FG000|Overall Study|Adverse Event|2|||
127633985|NCT01660906|459281126|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
127633986|NCT03478891|459281127|FG000|Overall Study|Enrolled, but product never administered|0|||
127633987|NCT03478891|459281128|FG001|Overall Study|Enrolled, but product never administered|0|||
127633988|NCT03478891|459281129|FG002|Overall Study|Enrolled, but product never administered|1|||
127633989|NCT03478891|459281127|FG000|Overall Study|Moved from area|0|||
127633990|NCT03478891|459281128|FG001|Overall Study|Moved from area|0|||
127633991|NCT03478891|459281129|FG002|Overall Study|Moved from area|1|||
127633992|NCT03478891|459281127|FG000|Overall Study|Lost to Follow-up|1|||
127633993|NCT03478891|459281128|FG001|Overall Study|Lost to Follow-up|0|||
127633994|NCT03478891|459281129|FG002|Overall Study|Lost to Follow-up|1|||
127633995|NCT03662750|459281130|FG000|Overall Study|Withdrawal by Subject|1|||
127633996|NCT00932893|459281131|FG000|Overall Study|Death|115|||
127633997|NCT00932893|459281132|FG001|Overall Study|Death|24|||
127633998|NCT00932893|459281131|FG000|Overall Study|Lost to Follow-up|8|||
127633999|NCT00932893|459281132|FG001|Overall Study|Lost to Follow-up|0|||
127634000|NCT00932893|459281131|FG000|Overall Study|Withdrawal by Subject|5|||
127634001|NCT00932893|459281132|FG001|Overall Study|Withdrawal by Subject|2|||
127634002|NCT00932893|459281131|FG000|Overall Study|Other|5|||
127634003|NCT00932893|459281132|FG001|Overall Study|Other|144|||
127634004|NCT00136955|459282929|FG000|Overall Study|Adverse Event|8|||
127634005|NCT00136955|459282929|FG000|Overall Study|Lost to Follow-up|1|||
127634006|NCT00136955|459282929|FG000|Overall Study|Withdrawal by Subject|2|||
127795869|NCT00326898|459875949|FG000|Overall Study|Other/Missing/Unknown|33|||
127795870|NCT00326898|459875950|FG001|Overall Study|Other/Missing/Unknown|28|||
127795871|NCT00326898|459875951|FG002|Overall Study|Other/Missing/Unknown|32|||
127795872|NCT03733392|459875955|FG000|Overall Study|Withdrawal by Subject|11|||
127795873|NCT03733392|459875956|FG001|Overall Study|Withdrawal by Subject|1|||
127795874|NCT03733392|459875955|FG000|Overall Study|Death|1|||
127795875|NCT03733392|459875956|FG001|Overall Study|Death|0|||
127795876|NCT03733392|459875955|FG000|Overall Study|Lost to Follow-up|5|||
127795877|NCT03733392|459875956|FG001|Overall Study|Lost to Follow-up|0|||
127795878|NCT03733392|459875955|FG000|Overall Study|Protocol Violation|0|||
127795879|NCT03733392|459875956|FG001|Overall Study|Protocol Violation|1|||
127795880|NCT03733392|459875955|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
127795881|NCT03733392|459875956|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
127795882|NCT03733392|459875955|FG000|Overall Study|Incomplete Ablation or Ablation not done|0|||
127795883|NCT03733392|459875956|FG001|Overall Study|Incomplete Ablation or Ablation not done|5|||
127795884|NCT03733392|459875955|FG000|Overall Study|Patient Non-Compliance|2|||
127795885|NCT03733392|459875956|FG001|Overall Study|Patient Non-Compliance|1|||
127795886|NCT03733392|459875955|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|12|||
127795887|NCT03733392|459875956|FG001|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|0|||
127795888|NCT03733392|459875955|FG000|Overall Study|Withdrawal prior to procedure|5|||
127795889|NCT03733392|459875956|FG001|Overall Study|Withdrawal prior to procedure|2|||
127795890|NCT02615990|459875964|FG000|Overall Study|study terminated|1|||
127795891|NCT02615990|459875965|FG001|Overall Study|study terminated|1|||
127795892|NCT01363986|459875966|FG000|Overall Study|Disease progression|1|||
127795893|NCT01637142|459875967|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
127795894|NCT00925015|459875968|FG000|Overall Study|Adverse Event|1|||
127795895|NCT00925015|459875969|FG001|Overall Study|Adverse Event|2|||
127795896|NCT00925015|459875970|FG002|Overall Study|Adverse Event|1|||
127795897|NCT00925015|459875968|FG000|Overall Study|Physician Decision|0|||
127795898|NCT00925015|459875969|FG001|Overall Study|Physician Decision|1|||
127795899|NCT00925015|459875970|FG002|Overall Study|Physician Decision|0|||
127795900|NCT00925015|459875968|FG000|Overall Study|Progressive Disease|7|||
127795901|NCT00925015|459875969|FG001|Overall Study|Progressive Disease|3|||
127795902|NCT00925015|459875970|FG002|Overall Study|Progressive Disease|4|||
127795903|NCT00925015|459875968|FG000|Overall Study|Withdrawal by Subject|0|||
127795904|NCT00925015|459875969|FG001|Overall Study|Withdrawal by Subject|0|||
127795905|NCT00925015|459875970|FG002|Overall Study|Withdrawal by Subject|1|||
127795906|NCT04986202|459875971|FG000|Overall Study|Death|10|||
127795907|NCT04986202|459875972|FG001|Overall Study|Death|3|||
127634007|NCT00136955|459282929|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
127634008|NCT04450264|459282930|FG000|Overall Study|Incomplete survey|13|||
127634009|NCT04450264|459282931|FG001|Overall Study|Incomplete survey|19|||
127634010|NCT05349617|459282932|FG000|Overall Study|Death|1|||
127634011|NCT05349617|459282933|FG001|Overall Study|Death|1|||
127634012|NCT05349617|459282932|FG000|Overall Study|Lost to Follow-up|3|||
127634013|NCT05349617|459282933|FG001|Overall Study|Lost to Follow-up|8|||
127634014|NCT05349617|459282932|FG000|Overall Study|Withdrawal by Subject|2|||
127634015|NCT05349617|459282933|FG001|Overall Study|Withdrawal by Subject|10|||
127634016|NCT00993447|459282937|FG000|Overall Study|Withdrawal by Subject|23|||
127634017|NCT00993447|459282938|FG001|Overall Study|Withdrawal by Subject|8|||
127634018|NCT00993447|459282937|FG000|Overall Study|Protocol Violation|12|||
127634019|NCT00993447|459282938|FG001|Overall Study|Protocol Violation|8|||
127634020|NCT00993447|459282937|FG000|Overall Study|Lost to Follow-up|1|||
127634021|NCT00993447|459282938|FG001|Overall Study|Lost to Follow-up|3|||
127634022|NCT00993447|459282937|FG000|Overall Study|Adverse Event|1|||
127634023|NCT00993447|459282938|FG001|Overall Study|Adverse Event|0|||
127634024|NCT00970502|459282940|FG000|Overall Study|Withdrawal by Subject|1|||
127795908|NCT04986202|459875973|FG002|Overall Study|Death|10|||
127885666|NCT00207714|460205236|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
127885667|NCT00207714|460205237|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
127634025|NCT03811912|459282941|FG000|Overall Study|Withdrew Consent|4|||
127634026|NCT03811912|459282942|FG001|Overall Study|Withdrew Consent|2|||
127634027|NCT01438411|459282943|FG000|Overall Study|Adverse Event|8|||
127634028|NCT01438411|459282943|FG000|Overall Study|Lost to Follow-up|1|||
127634029|NCT01438411|459282943|FG000|Overall Study|Lack of Efficacy|1|||
127795909|NCT04986202|459875971|FG000|Overall Study|Physician Decision|3|||
127795910|NCT04986202|459875972|FG001|Overall Study|Physician Decision|1|||
127795911|NCT04986202|459875973|FG002|Overall Study|Physician Decision|2|||
127795912|NCT04986202|459875971|FG000|Overall Study|Withdrawal by Subject|4|||
127795913|NCT04986202|459875972|FG001|Overall Study|Withdrawal by Subject|2|||
127795914|NCT04986202|459875973|FG002|Overall Study|Withdrawal by Subject|4|||
127795915|NCT02787863|459875974|FG000|Overall Study|Death|1|||
127795916|NCT02787863|459875975|FG001|Overall Study|Death|0|||
127795917|NCT02787863|459875976|FG002|Overall Study|Death|1|||
127634030|NCT01438411|459282943|FG000|Overall Study|Withdrawal by Subject|3|||
127634031|NCT01863680|459282944|FG000|Overall Study|Adverse Event|17|||
127634032|NCT01863680|459282944|FG000|Overall Study|Risk of OHSS|17|||
127634033|NCT01863680|459282944|FG000|Overall Study|Spontaneous pregnancy|2|||
127634034|NCT01863680|459282944|FG000|Overall Study|Withdrawal by Subject|1|||
127634035|NCT01863680|459282944|FG000|Overall Study|Did not undergo IVF/ET|14|||
127634036|NCT01863680|459282944|FG000|Overall Study|Other|6|||
127634037|NCT00566228|459282945|FG000|Overall Study|Withdrawal by Subject|1|||
127634038|NCT00566228|459282946|FG001|Overall Study|Withdrawal by Subject|0|||
127634039|NCT00566228|459282945|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
127634040|NCT00566228|459282946|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
127634041|NCT00566228|459282945|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
127634042|NCT00566228|459282946|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
127634043|NCT00566228|459282945|FG000|Overall Study|progressed before infusion could occur|0|||
127634044|NCT00566228|459282946|FG001|Overall Study|progressed before infusion could occur|1|||
127634045|NCT02053350|459282947|FG000|Overall Study|Withdrawal by Subject|1|||
127634046|NCT02053350|459282947|FG000|Overall Study|Adverse Event|4|||
127634047|NCT02244944|459282948|FG000|Overall Study|Withdrawal by Subject|1|||
127634048|NCT02244944|459282948|FG000|Overall Study|Study Terminated|1|||
127634049|NCT02367911|459282953|FG000|Overall Study|Withdrawal by Subject|3|||
127634050|NCT02367911|459282954|FG001|Overall Study|Withdrawal by Subject|2|||
127634051|NCT02367911|459282953|FG000|Overall Study|Lost to Follow-up|2|||
127634052|NCT02367911|459282954|FG001|Overall Study|Lost to Follow-up|2|||
127634053|NCT00902304|459282955|FG000|Overall Study|Adverse Event|4|||
127634054|NCT00902304|459282956|FG001|Overall Study|Adverse Event|10|||
127634055|NCT00902304|459282957|FG002|Overall Study|Adverse Event|25|||
127634056|NCT00902304|459282955|FG000|Overall Study|Investigator discretion|3|||
127634057|NCT00902304|459282956|FG001|Overall Study|Investigator discretion|5|||
127634058|NCT00902304|459282957|FG002|Overall Study|Investigator discretion|13|||
127634059|NCT00902304|459282955|FG000|Overall Study|Lost to Follow-up|7|||
127634060|NCT00902304|459282956|FG001|Overall Study|Lost to Follow-up|7|||
127634061|NCT00902304|459282957|FG002|Overall Study|Lost to Follow-up|7|||
127634062|NCT00902304|459282955|FG000|Overall Study|Protocol Violation|9|||
127634063|NCT00902304|459282956|FG001|Overall Study|Protocol Violation|18|||
127634064|NCT00902304|459282957|FG002|Overall Study|Protocol Violation|20|||
127634065|NCT00902304|459282955|FG000|Overall Study|Withdrawal by Subject|32|||
127634066|NCT00902304|459282956|FG001|Overall Study|Withdrawal by Subject|22|||
127634067|NCT00902304|459282957|FG002|Overall Study|Withdrawal by Subject|43|||
127634068|NCT00902304|459282955|FG000|Overall Study|includes pregnancy|3|||
127634069|NCT00902304|459282956|FG001|Overall Study|includes pregnancy|9|||
127634070|NCT00902304|459282957|FG002|Overall Study|includes pregnancy|2|||
127634071|NCT04579757|459282958|FG000|Overall Study|Adverse Event|0|||
127634072|NCT04579757|459282959|FG001|Overall Study|Adverse Event|0|||
127634073|NCT04579757|459282960|FG002|Overall Study|Adverse Event|0|||
127634074|NCT04579757|459282961|FG003|Overall Study|Adverse Event|2|||
127634075|NCT04579757|459282962|FG004|Overall Study|Adverse Event|1|||
127634076|NCT04579757|459282963|FG005|Overall Study|Adverse Event|1|||
127634077|NCT04579757|459282964|FG006|Overall Study|Adverse Event|0|||
127634078|NCT04579757|459282965|FG007|Overall Study|Adverse Event|0|||
127634079|NCT04579757|459282966|FG008|Overall Study|Adverse Event|0|||
127634080|NCT04579757|459282958|FG000|Overall Study|Death|4|||
127634081|NCT04579757|459282959|FG001|Overall Study|Death|1|||
127634082|NCT04579757|459282960|FG002|Overall Study|Death|14|||
127634083|NCT04579757|459282961|FG003|Overall Study|Death|3|||
127634084|NCT04579757|459282962|FG004|Overall Study|Death|2|||
127634085|NCT04579757|459282963|FG005|Overall Study|Death|7|||
127634086|NCT04579757|459282964|FG006|Overall Study|Death|0|||
127795918|NCT02787863|459875977|FG003|Overall Study|Death|0|||
127795919|NCT02787863|459875978|FG004|Overall Study|Death|0|||
127795920|NCT02787863|459875979|FG005|Overall Study|Death|0|||
127634087|NCT04579757|459282965|FG007|Overall Study|Death|1|||
127634088|NCT04579757|459282966|FG008|Overall Study|Death|3|||
127634089|NCT04579757|459282958|FG000|Overall Study|Physician Decision|0|||
127634090|NCT04579757|459282959|FG001|Overall Study|Physician Decision|0|||
127634091|NCT04579757|459282960|FG002|Overall Study|Physician Decision|0|||
127634092|NCT04579757|459282961|FG003|Overall Study|Physician Decision|2|||
127634093|NCT04579757|459282962|FG004|Overall Study|Physician Decision|1|||
127634094|NCT04579757|459282963|FG005|Overall Study|Physician Decision|1|||
127634095|NCT04579757|459282964|FG006|Overall Study|Physician Decision|1|||
127634096|NCT04579757|459282965|FG007|Overall Study|Physician Decision|0|||
127634097|NCT04579757|459282966|FG008|Overall Study|Physician Decision|0|||
127634098|NCT04579757|459282958|FG000|Overall Study|Study Terminated By Sponsor|0|||
127634099|NCT04579757|459282959|FG001|Overall Study|Study Terminated By Sponsor|0|||
127634100|NCT04579757|459282960|FG002|Overall Study|Study Terminated By Sponsor|0|||
127634101|NCT04579757|459282961|FG003|Overall Study|Study Terminated By Sponsor|0|||
127634102|NCT04579757|459282962|FG004|Overall Study|Study Terminated By Sponsor|2|||
127634103|NCT04579757|459282963|FG005|Overall Study|Study Terminated By Sponsor|0|||
127795921|NCT02787863|459875980|FG006|Overall Study|Death|0|||
127795922|NCT02787863|459875981|FG007|Overall Study|Death|0|||
127795923|NCT02787863|459875974|FG000|Overall Study|Withdrawal by Subject|0|||
127795924|NCT02787863|459875975|FG001|Overall Study|Withdrawal by Subject|1|||
127795925|NCT02787863|459875976|FG002|Overall Study|Withdrawal by Subject|1|||
127795926|NCT02787863|459875977|FG003|Overall Study|Withdrawal by Subject|0|||
127795927|NCT02787863|459875978|FG004|Overall Study|Withdrawal by Subject|0|||
127795928|NCT02787863|459875979|FG005|Overall Study|Withdrawal by Subject|0|||
127795929|NCT02787863|459875980|FG006|Overall Study|Withdrawal by Subject|0|||
127795930|NCT02787863|459875981|FG007|Overall Study|Withdrawal by Subject|0|||
127795931|NCT02754726|459875982|FG000|Overall Study|Progressive Disease by RECIST|13|||
127795932|NCT02754726|459875982|FG000|Overall Study|Achieved Best Response and converted to maintenance treatment off study|12|||
127795933|NCT02754726|459875982|FG000|Overall Study|Clinical Disease Progression|5|||
127795934|NCT02754726|459875982|FG000|Overall Study|Adverse Event|3|||
127795935|NCT02754726|459875982|FG000|Overall Study|Withdrawal by Subject|1|||
127795936|NCT02754726|459875982|FG000|Overall Study|Tolerability|1|||
127795937|NCT01885000|459875983|FG000|Overall Study|Adverse Event|1|||
127795938|NCT01885000|459875984|FG001|Overall Study|Adverse Event|0|||
127795939|NCT01885000|459875983|FG000|Overall Study|Withdrawal by Subject|1|||
127795940|NCT01885000|459875984|FG001|Overall Study|Withdrawal by Subject|1|||
127795941|NCT01885000|459875983|FG000|Overall Study|Protocol Violation|0|||
127795942|NCT01885000|459875984|FG001|Overall Study|Protocol Violation|1|||
127795943|NCT03124784|459875985|FG000|Overall Study|Adverse Event|1|||
127795944|NCT03124784|459875985|FG000|Overall Study|Computer/Equip Malfunction|1|||
127795945|NCT01415752|459875996|FG000|Induction (Step 1)|Ineligible|4|||
127795946|NCT01415752|459875997|FG001|Induction (Step 1)|Ineligible|3|||
127795947|NCT01415752|459875998|FG002|Induction (Step 1)|Ineligible|4|||
127795948|NCT01415752|459875999|FG003|Induction (Step 1)|Ineligible|4|||
127795949|NCT01415752|459875996|FG000|Maintenance (Step 2)|Lack of Efficacy|12|||
127795950|NCT01415752|459875997|FG001|Maintenance (Step 2)|Lack of Efficacy|10|||
127795951|NCT01415752|459875998|FG002|Maintenance (Step 2)|Lack of Efficacy|8|||
127795952|NCT01415752|459875999|FG003|Maintenance (Step 2)|Lack of Efficacy|3|||
127795953|NCT01415752|459875996|FG000|Maintenance (Step 2)|Adverse Event|3|||
127795954|NCT01415752|459875997|FG001|Maintenance (Step 2)|Adverse Event|4|||
127885668|NCT00207714|460205238|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
127634104|NCT04579757|459282964|FG006|Overall Study|Study Terminated By Sponsor|0|||
127634105|NCT04579757|459282965|FG007|Overall Study|Study Terminated By Sponsor|2|||
127634106|NCT04579757|459282966|FG008|Overall Study|Study Terminated By Sponsor|0|||
127634107|NCT04579757|459282958|FG000|Overall Study|Withdrawal by Subject|1|||
127634108|NCT04579757|459282959|FG001|Overall Study|Withdrawal by Subject|1|||
127634109|NCT04579757|459282960|FG002|Overall Study|Withdrawal by Subject|0|||
127634110|NCT04579757|459282961|FG003|Overall Study|Withdrawal by Subject|0|||
127634111|NCT04579757|459282962|FG004|Overall Study|Withdrawal by Subject|2|||
127634112|NCT04579757|459282963|FG005|Overall Study|Withdrawal by Subject|1|||
127634113|NCT04579757|459282964|FG006|Overall Study|Withdrawal by Subject|0|||
127634114|NCT04579757|459282965|FG007|Overall Study|Withdrawal by Subject|3|||
127634115|NCT04579757|459282966|FG008|Overall Study|Withdrawal by Subject|0|||
127634116|NCT04579757|459282958|FG000|Overall Study|Radiological or Clinical PD|1|||
127634117|NCT04579757|459282959|FG001|Overall Study|Radiological or Clinical PD|4|||
127634118|NCT04579757|459282960|FG002|Overall Study|Radiological or Clinical PD|1|||
127634119|NCT04579757|459282961|FG003|Overall Study|Radiological or Clinical PD|3|||
127634120|NCT04579757|459282962|FG004|Overall Study|Radiological or Clinical PD|9|||
127634121|NCT04579757|459282963|FG005|Overall Study|Radiological or Clinical PD|4|||
127634122|NCT04579757|459282964|FG006|Overall Study|Radiological or Clinical PD|2|||
127634123|NCT04579757|459282965|FG007|Overall Study|Radiological or Clinical PD|2|||
127634124|NCT04579757|459282966|FG008|Overall Study|Radiological or Clinical PD|0|||
127634125|NCT04579757|459282958|FG000|Overall Study|Start of New Therapy|0|||
127634126|NCT04579757|459282959|FG001|Overall Study|Start of New Therapy|0|||
127634127|NCT04579757|459282960|FG002|Overall Study|Start of New Therapy|0|||
127634128|NCT04579757|459282961|FG003|Overall Study|Start of New Therapy|0|||
127634129|NCT04579757|459282962|FG004|Overall Study|Start of New Therapy|2|||
127634130|NCT04579757|459282963|FG005|Overall Study|Start of New Therapy|1|||
127634131|NCT04579757|459282964|FG006|Overall Study|Start of New Therapy|0|||
127634132|NCT04579757|459282965|FG007|Overall Study|Start of New Therapy|0|||
127634133|NCT04579757|459282966|FG008|Overall Study|Start of New Therapy|0|||
127634134|NCT05706506|459282967|FG000|Overall Study|Adverse Event|1|||
127634135|NCT05706506|459282967|FG000|Overall Study|Withdrawal by Subject|4|||
127795955|NCT01415752|459875998|FG002|Maintenance (Step 2)|Adverse Event|9|||
127795956|NCT01415752|459875999|FG003|Maintenance (Step 2)|Adverse Event|6|||
127795957|NCT01415752|459875996|FG000|Maintenance (Step 2)|Death|1|||
127795958|NCT01415752|459875997|FG001|Maintenance (Step 2)|Death|1|||
127795959|NCT01415752|459875998|FG002|Maintenance (Step 2)|Death|2|||
127795960|NCT01415752|459875999|FG003|Maintenance (Step 2)|Death|0|||
127795961|NCT01415752|459875996|FG000|Maintenance (Step 2)|Withdrawal by Subject|2|||
127885669|NCT00207714|460205239|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
127795962|NCT01415752|459875997|FG001|Maintenance (Step 2)|Withdrawal by Subject|1|||
127795963|NCT01415752|459875998|FG002|Maintenance (Step 2)|Withdrawal by Subject|3|||
127795964|NCT01415752|459875999|FG003|Maintenance (Step 2)|Withdrawal by Subject|3|||
127795965|NCT01415752|459875996|FG000|Maintenance (Step 2)|Alternative therapy|0|||
127795966|NCT01415752|459875997|FG001|Maintenance (Step 2)|Alternative therapy|1|||
127795967|NCT01415752|459875998|FG002|Maintenance (Step 2)|Alternative therapy|0|||
127634136|NCT05706506|459282967|FG000|Overall Study|Lost to Follow-up|2|||
127634137|NCT05706506|459282967|FG000|Overall Study|Inadvertent Enrolment|12|||
127634138|NCT05706506|459282967|FG000|Overall Study|Early Discontinuation Due to Hyperglycemia|1|||
127634139|NCT05706506|459282967|FG000|Overall Study|Participant Moved Out of State|1|||
127634140|NCT00384085|459282968|FG000|Overall Study|Adverse Event|5|||
127634141|NCT00384085|459282969|FG001|Overall Study|Adverse Event|5|||
127634142|NCT00384085|459282970|FG002|Overall Study|Adverse Event|4|||
127634143|NCT00384085|459282968|FG000|Overall Study|Lack of Efficacy|0|||
127634144|NCT00384085|459282969|FG001|Overall Study|Lack of Efficacy|3|||
127634145|NCT00384085|459282970|FG002|Overall Study|Lack of Efficacy|2|||
127634146|NCT00384085|459282968|FG000|Overall Study|No longer Requires Study Treatment|1|||
127634147|NCT00384085|459282969|FG001|Overall Study|No longer Requires Study Treatment|0|||
127634148|NCT00384085|459282970|FG002|Overall Study|No longer Requires Study Treatment|1|||
127634149|NCT00384085|459282968|FG000|Overall Study|Protocol Violation|2|||
127634150|NCT00384085|459282969|FG001|Overall Study|Protocol Violation|2|||
127634151|NCT00384085|459282970|FG002|Overall Study|Protocol Violation|2|||
127634152|NCT00384085|459282968|FG000|Overall Study|Lost to Follow-up|9|||
127634153|NCT00384085|459282969|FG001|Overall Study|Lost to Follow-up|9|||
127634154|NCT00384085|459282970|FG002|Overall Study|Lost to Follow-up|10|||
127634155|NCT00384085|459282968|FG000|Overall Study|Progressive Disease|0|||
127634156|NCT00384085|459282969|FG001|Overall Study|Progressive Disease|1|||
127634157|NCT00384085|459282970|FG002|Overall Study|Progressive Disease|0|||
127634158|NCT00384085|459282968|FG000|Overall Study|Withdrawal by Subject|14|||
127634159|NCT00384085|459282969|FG001|Overall Study|Withdrawal by Subject|19|||
127634160|NCT00384085|459282970|FG002|Overall Study|Withdrawal by Subject|29|||
127634161|NCT00384085|459282968|FG000|Overall Study|Patient non-compliant|4|||
127634162|NCT00384085|459282969|FG001|Overall Study|Patient non-compliant|4|||
127634163|NCT00384085|459282970|FG002|Overall Study|Patient non-compliant|5|||
127634164|NCT00384085|459282968|FG000|Overall Study|Physician Decision|1|||
127634165|NCT00384085|459282969|FG001|Overall Study|Physician Decision|0|||
127634166|NCT00384085|459282970|FG002|Overall Study|Physician Decision|0|||
127634167|NCT00384085|459282968|FG000|Overall Study|Loss of site personnel|1|||
127634168|NCT00384085|459282969|FG001|Overall Study|Loss of site personnel|0|||
127634169|NCT00384085|459282970|FG002|Overall Study|Loss of site personnel|1|||
127634170|NCT00384085|459282968|FG000|Overall Study|Sponsor decision|1|||
127634171|NCT00384085|459282969|FG001|Overall Study|Sponsor decision|2|||
127634172|NCT00384085|459282970|FG002|Overall Study|Sponsor decision|1|||
127634173|NCT00384085|459282968|FG000|Overall Study|Patient moved|1|||
127634174|NCT00384085|459282969|FG001|Overall Study|Patient moved|0|||
127634175|NCT00384085|459282970|FG002|Overall Study|Patient moved|1|||
127634176|NCT00384085|459282968|FG000|Overall Study|Patient required surgery|0|||
127634177|NCT00384085|459282969|FG001|Overall Study|Patient required surgery|1|||
127634178|NCT00384085|459282970|FG002|Overall Study|Patient required surgery|0|||
127634179|NCT00352365|459282973|FG000|Induction Therapy|Adverse Event|7|||
127634180|NCT00352365|459282973|FG000|Induction Therapy|Progression/Relapse|8|||
127634181|NCT00352365|459282973|FG000|Induction Therapy|Death|7|||
127634182|NCT00352365|459282973|FG000|Induction Therapy|Not protocol specified|1|||
127634183|NCT00352365|459282973|FG000|Induction Therapy|Not eligible|3|||
127634184|NCT00352365|459282973|FG000|Induction Therapy|Death before starting protocol therapy|1|||
127634185|NCT00352365|459282973|FG000|Maintenance Therapy|Progression/Relapse|3|||
127634186|NCT00352365|459282973|FG000|Maintenance Therapy|Death|2|||
127634187|NCT00352365|459282973|FG000|Maintenance Therapy|Not protocol specified|3|||
127634188|NCT00352365|459282973|FG000|Maintenance Therapy|Not eligible|4|||
127634189|NCT04743908|459282974|FG000|Overall Study|Death|1|||
127634190|NCT04743908|459282975|FG001|Overall Study|Death|0|||
127634191|NCT04743908|459282974|FG000|Overall Study|Lost to Follow-up|181|||
127634192|NCT04743908|459282975|FG001|Overall Study|Lost to Follow-up|180|||
127634193|NCT04743908|459282974|FG000|Overall Study|Withdrawal by Subject|1|||
127634194|NCT04743908|459282975|FG001|Overall Study|Withdrawal by Subject|2|||
127634195|NCT04837482|459282976|FG000|Period 2|Withdrawal by Subject|0|||
127634196|NCT04837482|459282977|FG001|Period 2|Withdrawal by Subject|1|||
127634197|NCT00987467|459282983|FG000|Overall Study|Lost to Follow-up|2|||
127634198|NCT00512135|459282984|FG000|Overall Study|Not Treated|5|||
127795968|NCT01415752|459875999|FG003|Maintenance (Step 2)|Alternative therapy|0|||
127795969|NCT01415752|459875996|FG000|Maintenance (Step 2)|Other reasons|3|||
127795970|NCT01415752|459875997|FG001|Maintenance (Step 2)|Other reasons|6|||
127634199|NCT00512135|459282984|FG000|Overall Study|Lack of Efficacy|2|||
127634200|NCT00512135|459282984|FG000|Overall Study|Adverse Event|6|||
127634201|NCT00512135|459282984|FG000|Overall Study|Withdrawal by Subject|22|||
127634202|NCT00512135|459282984|FG000|Overall Study|Lost to Follow-up|27|||
127634203|NCT00512135|459282984|FG000|Overall Study|Other|22|||
127634204|NCT02646423|459282985|FG000|Overall Study|Adverse Event|5|||
127795971|NCT01415752|459875998|FG002|Maintenance (Step 2)|Other reasons|4|||
127795972|NCT01415752|459875999|FG003|Maintenance (Step 2)|Other reasons|6|||
127795973|NCT01415752|459875996|FG000|Maintenance (Step 2)|Did not receive treatment|1|||
127795974|NCT01415752|459875997|FG001|Maintenance (Step 2)|Did not receive treatment|0|||
127795975|NCT01415752|459875998|FG002|Maintenance (Step 2)|Did not receive treatment|2|||
127795976|NCT01415752|459875999|FG003|Maintenance (Step 2)|Did not receive treatment|1|||
127795977|NCT01415752|459875996|FG000|Maintenance (Step 2)|ineligible|1|||
127795978|NCT01415752|459875997|FG001|Maintenance (Step 2)|ineligible|1|||
127795979|NCT01415752|459875998|FG002|Maintenance (Step 2)|ineligible|1|||
127795980|NCT01415752|459875999|FG003|Maintenance (Step 2)|ineligible|0|||
127795981|NCT01415752|459875996|FG000|Maintenance (Step 2)|Missing|4|||
127795982|NCT01415752|459875997|FG001|Maintenance (Step 2)|Missing|1|||
127795983|NCT01415752|459875998|FG002|Maintenance (Step 2)|Missing|4|||
127795984|NCT01415752|459875999|FG003|Maintenance (Step 2)|Missing|3|||
127795985|NCT01903837|459876001|FG000|Part A|Withdrawal by Subject|4|||
127795986|NCT01903837|459876002|FG001|Part A|Withdrawal by Subject|9|||
127795987|NCT01903837|459876003|FG002|Part A|Withdrawal by Subject|8|||
127795988|NCT01903837|459876004|FG003|Part A|Withdrawal by Subject|5|||
127795989|NCT01903837|459876001|FG000|Part A|Adverse Event|3|||
127795990|NCT01903837|459876002|FG001|Part A|Adverse Event|6|||
127795991|NCT01903837|459876003|FG002|Part A|Adverse Event|9|||
127795992|NCT01903837|459876004|FG003|Part A|Adverse Event|6|||
127795993|NCT01903837|459876001|FG000|Part A|Lost to Follow-up|9|||
127795994|NCT01903837|459876002|FG001|Part A|Lost to Follow-up|7|||
127795995|NCT01903837|459876003|FG002|Part A|Lost to Follow-up|7|||
127795996|NCT01903837|459876004|FG003|Part A|Lost to Follow-up|2|||
127795997|NCT01903837|459876001|FG000|Part A|Non-compliance with study drug|1|||
127795998|NCT01903837|459876002|FG001|Part A|Non-compliance with study drug|4|||
127795999|NCT01903837|459876003|FG002|Part A|Non-compliance with study drug|4|||
127796000|NCT01903837|459876004|FG003|Part A|Non-compliance with study drug|0|||
127796001|NCT01903837|459876001|FG000|Part A|Physician Decision|1|||
127796002|NCT01903837|459876002|FG001|Part A|Physician Decision|1|||
127796003|NCT01903837|459876003|FG002|Part A|Physician Decision|0|||
127796004|NCT01903837|459876004|FG003|Part A|Physician Decision|0|||
127796005|NCT01903837|459876001|FG000|Part A|Protocol Violation|1|||
127796006|NCT01903837|459876002|FG001|Part A|Protocol Violation|1|||
127796007|NCT01903837|459876003|FG002|Part A|Protocol Violation|0|||
127796008|NCT01903837|459876004|FG003|Part A|Protocol Violation|0|||
127796009|NCT01903837|459876001|FG000|Part B|Lost to Follow-up|0|||
127796010|NCT01903837|459876002|FG001|Part B|Lost to Follow-up|3|||
127796011|NCT01903837|459876003|FG002|Part B|Lost to Follow-up|3|||
127796012|NCT01903837|459876004|FG003|Part B|Lost to Follow-up|4|||
127796013|NCT01903837|459876001|FG000|Part B|Withdrawal by Subject|1|||
127796014|NCT01903837|459876002|FG001|Part B|Withdrawal by Subject|2|||
127796015|NCT01903837|459876003|FG002|Part B|Withdrawal by Subject|0|||
127796016|NCT01903837|459876004|FG003|Part B|Withdrawal by Subject|3|||
127796017|NCT01903837|459876001|FG000|Part B|Adverse Event|3|||
127796018|NCT01903837|459876002|FG001|Part B|Adverse Event|0|||
127796019|NCT01903837|459876003|FG002|Part B|Adverse Event|2|||
127796020|NCT01903837|459876004|FG003|Part B|Adverse Event|0|||
127796021|NCT01903837|459876001|FG000|Part B|Non-compliance with study drug|2|||
127796022|NCT01903837|459876002|FG001|Part B|Non-compliance with study drug|0|||
127796023|NCT01903837|459876003|FG002|Part B|Non-compliance with study drug|0|||
127796024|NCT01903837|459876004|FG003|Part B|Non-compliance with study drug|1|||
127796025|NCT01903837|459876001|FG000|Part B|Incarceration|2|||
127796026|NCT01903837|459876002|FG001|Part B|Incarceration|0|||
127796027|NCT01903837|459876003|FG002|Part B|Incarceration|0|||
127796028|NCT01903837|459876004|FG003|Part B|Incarceration|1|||
127796029|NCT01903837|459876001|FG000|Part B|Physician Decision|1|||
127796030|NCT01903837|459876002|FG001|Part B|Physician Decision|0|||
127796031|NCT01903837|459876003|FG002|Part B|Physician Decision|0|||
127796032|NCT01903837|459876004|FG003|Part B|Physician Decision|2|||
127796033|NCT01903837|459876001|FG000|Part B|Lack of Efficacy|0|||
127796034|NCT01903837|459876002|FG001|Part B|Lack of Efficacy|1|||
127796035|NCT01903837|459876003|FG002|Part B|Lack of Efficacy|0|||
127796036|NCT01903837|459876004|FG003|Part B|Lack of Efficacy|0|||
127796037|NCT00705939|459876006|FG000|Overall Study|Protocol Violation|0|||
127796038|NCT00705939|459876007|FG001|Overall Study|Protocol Violation|0|||
127796039|NCT00705939|459876008|FG002|Overall Study|Protocol Violation|1|||
127796040|NCT00705939|459876006|FG000|Overall Study|Withdrawal by Subject|0|||
127796041|NCT00705939|459876007|FG001|Overall Study|Withdrawal by Subject|1|||
127796042|NCT00705939|459876008|FG002|Overall Study|Withdrawal by Subject|3|||
127796043|NCT00705939|459876006|FG000|Overall Study|Physician Decision|0|||
127796044|NCT00705939|459876007|FG001|Overall Study|Physician Decision|1|||
127796045|NCT00705939|459876008|FG002|Overall Study|Physician Decision|0|||
127796046|NCT05048342|459876009|FG000|Overall Study|Adverse Event|1|||
127796047|NCT05048342|459876009|FG000|Overall Study|Subject decision|2|||
127796048|NCT01441063|459876010|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
127796049|NCT01441063|459876010|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
127796050|NCT04372927|459876014|FG000|Overall Study|Death|1|||
127796051|NCT01665807|459876015|FG000|Overall Study|Withdrawal by Subject|2|||
127796052|NCT01665807|459876016|FG001|Overall Study|Withdrawal by Subject|0|||
127796053|NCT01665807|459876017|FG002|Overall Study|Withdrawal by Subject|1|||
127796054|NCT02728830|459876018|FG000|Overall Study|Exclusionary Surgery|9|||
127796055|NCT02728830|459876018|FG000|Overall Study|Exclusionary Pathology|6|||
127796056|NCT02728830|459876018|FG000|Overall Study|Physician Decision|3|||
127796057|NCT02728830|459876018|FG000|Overall Study|Withdrawal by Subject|2|||
127796058|NCT02728830|459876018|FG000|Overall Study|Lost to Follow-up|1|||
127796059|NCT02728830|459876018|FG000|Overall Study|Exclusionary Lab Values|1|||
127634205|NCT02646423|459282986|FG001|Overall Study|Adverse Event|7|||
127634206|NCT02646423|459282985|FG000|Overall Study|Ineligible|2|||
127634207|NCT02646423|459282986|FG001|Overall Study|Ineligible|1|||
127634208|NCT02807948|459282987|FG000|Overall Study|Physician Decision|1|||
127634209|NCT02807948|459282988|FG001|Overall Study|Physician Decision|0|||
127634210|NCT02624804|459282989|FG000|Overall Study|Screen Failure|5|||
127634211|NCT03073603|459282998|FG000|Overall Study|Noncompliance|3|||
127634212|NCT03073603|459282999|FG001|Overall Study|Noncompliance|1|||
127634213|NCT03073603|459282998|FG000|Overall Study|Adverse Event|5|||
127634214|NCT03073603|459282999|FG001|Overall Study|Adverse Event|3|||
127796060|NCT02728830|459876018|FG000|Overall Study|Contraindicated Illness|1|||
127634215|NCT03073603|459282998|FG000|Overall Study|Physician Decision|1|||
127796061|NCT02728830|459876018|FG000|Overall Study|Language Barrier|1|||
127796062|NCT02462473|459876019|FG000|Overall Study|Death|1|||
127796063|NCT02462473|459876019|FG000|Overall Study|Other|3|||
127796064|NCT01325428|459876022|FG000|Part A|Progressive disease according to RECIST|9|||
127796065|NCT01325428|459876022|FG000|Part A|Clinical signs, symptoms of progression|2|||
127796066|NCT01325428|459876022|FG000|Part A|Other adverse event|1|||
127796067|NCT01325428|459876022|FG000|Part A|Refused continue taking trial medication|2|||
127796068|NCT01325428|459876022|FG000|Part A|Other reason not defined above|2|||
127796069|NCT01325428|459876022|FG000|Part B|Refused continue taking trial medication|2|||
127634216|NCT03073603|459282999|FG001|Overall Study|Physician Decision|2|||
127796070|NCT01325428|459876022|FG000|Part B|Other reason not defined above|1|||
127796071|NCT03847610|459876023|FG000|Overall Study|Withdrawal by Subject|1|||
127796072|NCT03298022|459876024|FG000|Overall Study|Lack of Efficacy|4|||
127796073|NCT03298022|459876024|FG000|Overall Study|Withdrawal by Subject|7|||
127634217|NCT03073603|459282998|FG000|Overall Study|Required treatment not allowed by protocol|1|||
127634218|NCT03073603|459282999|FG001|Overall Study|Required treatment not allowed by protocol|0|||
127634219|NCT03073603|459282998|FG000|Overall Study|Financial or insurance-related|8|||
127796074|NCT03298022|459876024|FG000|Overall Study|Adverse Event|1|||
127796075|NCT03298022|459876024|FG000|Overall Study|disease relapse|1|||
127796076|NCT01445769|459876027|FG000|Overall Study|Consent Withdrawn|2|||
127796077|NCT01445769|459876027|FG000|Overall Study|Disease Progression|1|||
127796078|NCT01445769|459876027|FG000|Overall Study|Lost to Follow-up|5|||
127796079|NCT01400451|459876031|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
127796080|NCT01400451|459876032|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
127796081|NCT01400451|459876033|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
127796082|NCT01400451|459876031|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
127796083|NCT01400451|459876032|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
127796084|NCT01400451|459876033|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
127796085|NCT01400451|459876031|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
127796086|NCT01400451|459876032|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
127796087|NCT01400451|459876033|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
127796088|NCT01400451|459876031|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
127796089|NCT01400451|459876032|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
127796090|NCT01400451|459876033|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
127796091|NCT01400451|459876031|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
127796092|NCT01400451|459876032|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
127796093|NCT01400451|459876033|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
127796094|NCT00343889|459876049|FG000|Overall Study|Lost to Follow-up|2|||
127796095|NCT00343889|459876050|FG001|Overall Study|Lost to Follow-up|0|||
127796096|NCT00343889|459876049|FG000|Overall Study|Withdrawal by Subject|0|||
127796097|NCT00343889|459876050|FG001|Overall Study|Withdrawal by Subject|1|||
127796098|NCT00343889|459876049|FG000|Overall Study|Protocol Violation|1|||
127796099|NCT00343889|459876050|FG001|Overall Study|Protocol Violation|0|||
127796100|NCT01294579|459876053|FG000|Overall Study|Disease progression|12|||
127796101|NCT01294579|459876053|FG000|Overall Study|Adverse Event|11|||
127796102|NCT01294579|459876053|FG000|Overall Study|Study closed/terminated|3|||
127796103|NCT01294579|459876053|FG000|Overall Study|Lost to Follow-up|1|||
127796104|NCT01294579|459876053|FG000|Overall Study|Physician Decision|3|||
127796105|NCT01294579|459876053|FG000|Overall Study|Withdrawal by Subject|5|||
127796106|NCT01967537|459876056|FG000|Overall Study|Withdrawal by Subject|52|||
127796107|NCT01967537|459876056|FG000|Overall Study|Refuse treatment|2|||
127796108|NCT01967537|459876056|FG000|Overall Study|Lost to Follow-up|6|||
127796109|NCT01079182|459876057|FG000|Overall Study|Lost to Follow-up|1634|||
127796110|NCT01079182|459876057|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
127796111|NCT01079182|459876057|FG000|Overall Study|Lack of Efficacy|514|||
127885670|NCT00207714|460205235|FG000|Overall Study|Other|3|||
127796112|NCT01079182|459876057|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
127796113|NCT01079182|459876057|FG000|Overall Study|Reasons not Evaluated|271|||
127796114|NCT05130463|459876058|FG000|Overall Study|Unspecified reasons|2|||
127796115|NCT05130463|459876058|FG000|Overall Study|off-label indication dose|435|||
127796116|NCT03461757|459876059|FG000|Overall Study|Adverse Event|1|||
127885671|NCT00207714|460205236|FG001|Overall Study|Other|2|||
127885672|NCT00207714|460205237|FG002|Overall Study|Other|5|||
127702628|NCT05543629|459540530|FG002|Overall Study|Withdrawal by Subject|0|||
127702629|NCT05543629|459540531|FG003|Overall Study|Withdrawal by Subject|2|||
127702630|NCT05543629|459540532|FG004|Overall Study|Withdrawal by Subject|1|||
127702631|NCT05543629|459540533|FG005|Overall Study|Withdrawal by Subject|1|||
127702632|NCT05543629|459540534|FG006|Overall Study|Withdrawal by Subject|1|||
127702633|NCT05543629|459540535|FG007|Overall Study|Withdrawal by Subject|1|||
127702634|NCT05543629|459540528|FG000|Overall Study|Not Reported|2|||
127702635|NCT05543629|459540529|FG001|Overall Study|Not Reported|2|||
127702636|NCT05543629|459540530|FG002|Overall Study|Not Reported|0|||
127702637|NCT05543629|459540531|FG003|Overall Study|Not Reported|0|||
127702638|NCT05543629|459540532|FG004|Overall Study|Not Reported|1|||
127702639|NCT05543629|459540533|FG005|Overall Study|Not Reported|1|||
127702640|NCT05543629|459540534|FG006|Overall Study|Not Reported|3|||
127702641|NCT05543629|459540535|FG007|Overall Study|Not Reported|0|||
127702642|NCT03216057|459540536|FG000|Overall Study|Lost to Follow-up|2|||
127796117|NCT03461757|459876060|FG001|Overall Study|Adverse Event|0|||
127796118|NCT03461757|459876059|FG000|Overall Study|Lost to Follow-up|13|||
127796119|NCT03461757|459876060|FG001|Overall Study|Lost to Follow-up|7|||
127796120|NCT03461757|459876059|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
127796121|NCT03461757|459876060|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
127702643|NCT03216057|459540537|FG001|Overall Study|Lost to Follow-up|2|||
127702644|NCT04568603|459540538|FG000|Overall Study|Physician Decision|1|||
127796122|NCT03461757|459876059|FG000|Overall Study|Non-compliance with study treatment|0|||
127796123|NCT03461757|459876060|FG001|Overall Study|Non-compliance with study treatment|1|||
127796124|NCT03461757|459876059|FG000|Overall Study|Pregnancy|2|||
127702645|NCT04564742|459540539|FG000|Overall Study|Lost to Follow-up|1|||
127702646|NCT04564742|459540540|FG001|Overall Study|Lost to Follow-up|0|||
127702647|NCT04564742|459540539|FG000|Overall Study|Consent Withdrawal|4|||
127796125|NCT03461757|459876060|FG001|Overall Study|Pregnancy|0|||
127702648|NCT04564742|459540540|FG001|Overall Study|Consent Withdrawal|4|||
127702649|NCT03313076|459540544|FG000|Overall Study|Withdrawal by Subject|2|||
127702650|NCT03313076|459540545|FG001|Overall Study|Withdrawal by Subject|0|||
127702651|NCT03313076|459540546|FG002|Overall Study|Withdrawal by Subject|0|||
127702652|NCT03313076|459540547|FG003|Overall Study|Withdrawal by Subject|0|||
127702653|NCT03313076|459540544|FG000|Overall Study|Lost to Follow-up|0|||
127702654|NCT03313076|459540545|FG001|Overall Study|Lost to Follow-up|2|||
127702655|NCT03313076|459540546|FG002|Overall Study|Lost to Follow-up|2|||
127702656|NCT03313076|459540547|FG003|Overall Study|Lost to Follow-up|2|||
127702657|NCT04307355|459540553|FG000|Overall Study|Non-Compliance|3|||
127702658|NCT04307355|459540554|FG001|Overall Study|Non-Compliance|3|||
127702659|NCT04307355|459540555|FG002|Overall Study|Non-Compliance|0|||
127702660|NCT04225273|459540557|FG000|Overall Study|Lost to Follow-up|3|||
127702661|NCT05270408|459540559|FG000|Started Treatment|Withdrawal by Subject|0|||
127702662|NCT05270408|459540560|FG001|Started Treatment|Withdrawal by Subject|0|||
127702663|NCT05270408|459540561|FG002|Started Treatment|Withdrawal by Subject|3|||
127702664|NCT05270408|459540559|FG000|Started Treatment|Adverse Event|0|||
127702665|NCT05270408|459540560|FG001|Started Treatment|Adverse Event|0|||
127702666|NCT05270408|459540561|FG002|Started Treatment|Adverse Event|1|||
127702667|NCT05270408|459540559|FG000|Follow-Up at 2 Months|Lost to Follow-up|1|||
127702668|NCT05270408|459540560|FG001|Follow-Up at 2 Months|Lost to Follow-up|0|||
127702669|NCT05270408|459540561|FG002|Follow-Up at 2 Months|Lost to Follow-up|0|||
127702670|NCT02465268|459540563|FG000|Overall Study|Withdrawal by Subject|4|||
127702671|NCT02465268|459540564|FG001|Overall Study|Withdrawal by Subject|3|||
127702672|NCT02465268|459540565|FG002|Overall Study|Withdrawal by Subject|1|||
127702673|NCT02465268|459540563|FG000|Overall Study|Not evaluable per protocol criteria|3|||
127702674|NCT02465268|459540564|FG001|Overall Study|Not evaluable per protocol criteria|2|||
127702675|NCT02465268|459540565|FG002|Overall Study|Not evaluable per protocol criteria|1|||
127702676|NCT02465268|459540563|FG000|Overall Study|did not meet eligibility prior to Cycle #1|8|||
127702677|NCT02465268|459540564|FG001|Overall Study|did not meet eligibility prior to Cycle #1|9|||
127702678|NCT02465268|459540565|FG002|Overall Study|did not meet eligibility prior to Cycle #1|9|||
127702679|NCT02465268|459540563|FG000|Overall Study|Study drug did not pass QA/QC|1|||
127702680|NCT02465268|459540564|FG001|Overall Study|Study drug did not pass QA/QC|0|||
127702681|NCT02465268|459540565|FG002|Overall Study|Study drug did not pass QA/QC|0|||
127702682|NCT02465268|459540563|FG000|Overall Study|Adverse Event|0|||
127702683|NCT02465268|459540564|FG001|Overall Study|Adverse Event|1|||
127702684|NCT02465268|459540565|FG002|Overall Study|Adverse Event|0|||
127702685|NCT02465268|459540563|FG000|Overall Study|Physician Decision|0|||
127702686|NCT02465268|459540564|FG001|Overall Study|Physician Decision|1|||
127702687|NCT02465268|459540565|FG002|Overall Study|Physician Decision|0|||
127702688|NCT03020199|459540572|FG000|Treatment Period|Adverse Event|0|||
127702689|NCT03020199|459540573|FG001|Treatment Period|Adverse Event|2|||
127702690|NCT03020199|459540572|FG000|Treatment Period|Lack of Efficacy|1|||
127702691|NCT03020199|459540573|FG001|Treatment Period|Lack of Efficacy|6|||
127702692|NCT03020199|459540572|FG000|Treatment Period|Lost to Follow-up|1|||
127702693|NCT03020199|459540573|FG001|Treatment Period|Lost to Follow-up|6|||
127702694|NCT03020199|459540572|FG000|Treatment Period|Physician Decision|0|||
127702695|NCT03020199|459540573|FG001|Treatment Period|Physician Decision|1|||
127796126|NCT03461757|459876059|FG000|Overall Study|Protocol Violation|1|||
127796127|NCT03461757|459876060|FG001|Overall Study|Protocol Violation|1|||
127796128|NCT03461757|459876059|FG000|Overall Study|Withdrawal by Subject|7|||
127796129|NCT03461757|459876060|FG001|Overall Study|Withdrawal by Subject|7|||
127796130|NCT03461757|459876059|FG000|Overall Study|Other Reasons|1|||
127796131|NCT03461757|459876060|FG001|Overall Study|Other Reasons|4|||
127796132|NCT03499028|459876066|FG000|Overall Study|Lost to Follow-up|12|||
127796133|NCT03499028|459876067|FG001|Overall Study|Lost to Follow-up|9|||
127796134|NCT03499028|459876066|FG000|Overall Study|Withdrawal by Subject|5|||
127796135|NCT03499028|459876067|FG001|Overall Study|Withdrawal by Subject|8|||
127796136|NCT03499028|459876066|FG000|Overall Study|Unplanned SNF discharge|5|||
127796137|NCT03499028|459876067|FG001|Overall Study|Unplanned SNF discharge|8|||
127796138|NCT03595553|459876068|FG000|Overall Study|Withdrawal by Subject|20|||
127796139|NCT03595553|459876069|FG001|Overall Study|Withdrawal by Subject|8|||
127796140|NCT03595553|459876068|FG000|Overall Study|Physician Decision|3|||
127634220|NCT03073603|459282999|FG001|Overall Study|Financial or insurance-related|0|||
127796141|NCT03595553|459876069|FG001|Overall Study|Physician Decision|2|||
127796142|NCT03595553|459876068|FG000|Overall Study|Adverse Event|2|||
127796143|NCT03595553|459876069|FG001|Overall Study|Adverse Event|5|||
127796144|NCT03595553|459876068|FG000|Overall Study|Death|24|||
127796145|NCT03595553|459876069|FG001|Overall Study|Death|22|||
127796146|NCT03595553|459876068|FG000|Overall Study|Lost to Follow-up|6|||
127796147|NCT03595553|459876069|FG001|Overall Study|Lost to Follow-up|7|||
127796148|NCT03595553|459876068|FG000|Overall Study|Other as indicated in CSR|3|||
127796149|NCT03595553|459876069|FG001|Overall Study|Other as indicated in CSR|3|||
127796150|NCT03595553|459876068|FG000|Overall Study|Sponsor Decision|0|||
127796151|NCT03595553|459876069|FG001|Overall Study|Sponsor Decision|1|||
127796152|NCT01035905|459876070|FG000|Overall Study|Lack of Efficacy|1|||
127796153|NCT01035905|459876071|FG001|Overall Study|Lack of Efficacy|1|||
127796154|NCT02508194|459876072|FG000|Overall Study|Death|5|||
127796155|NCT02508194|459876073|FG001|Overall Study|Death|3|||
127796156|NCT02508194|459876072|FG000|Overall Study|Lost to Follow-up|25|||
127796157|NCT02508194|459876073|FG001|Overall Study|Lost to Follow-up|18|||
127796158|NCT02508194|459876072|FG000|Overall Study|Withdrawal by Subject|20|||
127796159|NCT02508194|459876073|FG001|Overall Study|Withdrawal by Subject|18|||
127796160|NCT02508194|459876072|FG000|Overall Study|Error in Randomization|1|||
127634221|NCT03073603|459282998|FG000|Overall Study|Withdrawal by Subject|0|||
127634222|NCT03073603|459282999|FG001|Overall Study|Withdrawal by Subject|1|||
127634223|NCT03073603|459282998|FG000|Overall Study|Discontinued DMT|4|||
127634224|NCT03073603|459282999|FG001|Overall Study|Discontinued DMT|0|||
127634225|NCT03073603|459282998|FG000|Overall Study|Restarted DMT|0|||
127634226|NCT03073603|459282999|FG001|Overall Study|Restarted DMT|1|||
127634227|NCT01659021|459283000|FG000|Main Study|Adverse Event|2|||
127634228|NCT01659021|459283001|FG001|Main Study|Adverse Event|3|||
127634229|NCT01659021|459283000|FG000|Main Study|Lost to Follow-up|1|||
127634230|NCT01659021|459283001|FG001|Main Study|Lost to Follow-up|0|||
127634231|NCT01659021|459283000|FG000|Main Study|Unknown Reasons|2|||
127634232|NCT01659021|459283001|FG001|Main Study|Unknown Reasons|1|||
127634233|NCT01659021|459283000|FG000|Main Study|Physician Decision|34|||
127634234|NCT01659021|459283001|FG001|Main Study|Physician Decision|16|||
127634235|NCT01659021|459283000|FG000|Main Study|Withdrawal by Subject|19|||
127634236|NCT01659021|459283001|FG001|Main Study|Withdrawal by Subject|16|||
127634237|NCT01659021|459283000|FG000|Main Study|Study Terminated by Sponsor|16|||
127634238|NCT01659021|459283001|FG001|Main Study|Study Terminated by Sponsor|1|||
127634239|NCT01659021|459283000|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
127634240|NCT01659021|459283001|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
127634241|NCT01659021|459283000|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
127634242|NCT01659021|459283001|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
127796161|NCT02508194|459876073|FG001|Overall Study|Error in Randomization|3|||
127796162|NCT02508194|459876072|FG000|Overall Study|Principal Investigator Decision|1|||
127796163|NCT02508194|459876073|FG001|Overall Study|Principal Investigator Decision|2|||
127796164|NCT02158091|459876079|FG000|Overall Study|DLT|2|||
127796165|NCT02158091|459876080|FG001|Overall Study|DLT|1|||
127796166|NCT02158091|459876081|FG002|Overall Study|DLT|0|||
127796167|NCT03977467|459876082|FG000|Overall Study|Disease Progression|1|||
127885673|NCT00207714|460205238|FG003|Overall Study|Other|1|||
127634243|NCT00407537|459283002|FG000|Overall Study|Death|5|||
127885674|NCT00207714|460205239|FG004|Overall Study|Other|0|||
127634244|NCT00407537|459283003|FG001|Overall Study|Death|2|||
127796168|NCT03977467|459876083|FG001|Overall Study|Disease Progression|1|||
127885675|NCT03627195|460205240|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
127796169|NCT03977467|459876084|FG002|Overall Study|Disease Progression|30|||
127796170|NCT03977467|459876085|FG003|Overall Study|Disease Progression|0|||
127796171|NCT03977467|459876082|FG000|Overall Study|Adverse Event|0|||
127796172|NCT03977467|459876083|FG001|Overall Study|Adverse Event|1|||
127796173|NCT03977467|459876084|FG002|Overall Study|Adverse Event|0|||
127796174|NCT03977467|459876085|FG003|Overall Study|Adverse Event|0|||
127796175|NCT03977467|459876082|FG000|Overall Study|Death|0|||
127796176|NCT03977467|459876083|FG001|Overall Study|Death|0|||
127796177|NCT03977467|459876084|FG002|Overall Study|Death|3|||
127796178|NCT03977467|459876085|FG003|Overall Study|Death|0|||
127796179|NCT03977467|459876082|FG000|Overall Study|Lack of Efficacy|0|||
127796180|NCT03977467|459876083|FG001|Overall Study|Lack of Efficacy|0|||
127796181|NCT03977467|459876084|FG002|Overall Study|Lack of Efficacy|1|||
127796182|NCT03977467|459876085|FG003|Overall Study|Lack of Efficacy|0|||
127796183|NCT03977467|459876082|FG000|Overall Study|Withdrawal by Subject|2|||
127796184|NCT03977467|459876083|FG001|Overall Study|Withdrawal by Subject|1|||
127796185|NCT03977467|459876084|FG002|Overall Study|Withdrawal by Subject|4|||
127796186|NCT03977467|459876085|FG003|Overall Study|Withdrawal by Subject|0|||
127796187|NCT03977467|459876082|FG000|Overall Study|Study Terminated|1|||
127634245|NCT00407537|459283002|FG000|Overall Study|Adverse Event|36|||
127634246|NCT00407537|459283003|FG001|Overall Study|Adverse Event|0|||
127634247|NCT00407537|459283002|FG000|Overall Study|Lost to Follow-up|12|||
127634248|NCT00407537|459283003|FG001|Overall Study|Lost to Follow-up|19|||
127634249|NCT00407537|459283002|FG000|Overall Study|Other|6|||
127634250|NCT00407537|459283003|FG001|Overall Study|Other|7|||
127634251|NCT00407537|459283002|FG000|Overall Study|Withdrawal by Subject|34|||
127634252|NCT00407537|459283003|FG001|Overall Study|Withdrawal by Subject|16|||
127634253|NCT05348681|459283004|FG000|Overall Study|Study terminated by Sponsor|8|||
127634254|NCT05348681|459283005|FG001|Overall Study|Study terminated by Sponsor|3|||
127634255|NCT05348681|459283004|FG000|Overall Study|Withdrawal by Subject|1|||
127634256|NCT05348681|459283005|FG001|Overall Study|Withdrawal by Subject|1|||
127634257|NCT05348681|459283004|FG000|Overall Study|Lost to Follow-up|1|||
127634258|NCT05348681|459283005|FG001|Overall Study|Lost to Follow-up|1|||
127634259|NCT05348681|459283004|FG000|Overall Study|Adverse Event|1|||
127634260|NCT05348681|459283005|FG001|Overall Study|Adverse Event|0|||
127634261|NCT05348681|459283004|FG000|Overall Study|Other|2|||
127634262|NCT05348681|459283005|FG001|Overall Study|Other|1|||
127634263|NCT00782340|459283006|FG000|Open Label Titration|Adverse Event|12|||
127634264|NCT00782340|459283007|FG001|Open Label Titration|Adverse Event|0|||
127634265|NCT00782340|459283008|FG002|Open Label Titration|Adverse Event|0|||
127634266|NCT00782340|459283006|FG000|Open Label Titration|Treatment failure|50|||
127634267|NCT00782340|459283007|FG001|Open Label Titration|Treatment failure|0|||
127634268|NCT00782340|459283008|FG002|Open Label Titration|Treatment failure|0|||
127634269|NCT00782340|459283006|FG000|Open Label Titration|Protocol Violation|5|||
127796188|NCT03977467|459876083|FG001|Overall Study|Study Terminated|0|||
127796189|NCT03977467|459876084|FG002|Overall Study|Study Terminated|0|||
127796190|NCT03977467|459876085|FG003|Overall Study|Study Terminated|1|||
127634270|NCT00782340|459283007|FG001|Open Label Titration|Protocol Violation|0|||
127634271|NCT00782340|459283008|FG002|Open Label Titration|Protocol Violation|0|||
127634272|NCT00782340|459283006|FG000|Open Label Titration|Withdrawal by Subject|5|||
127634273|NCT00782340|459283007|FG001|Open Label Titration|Withdrawal by Subject|0|||
127634274|NCT00782340|459283008|FG002|Open Label Titration|Withdrawal by Subject|0|||
127634275|NCT00782340|459283006|FG000|Open Label Titration|Enrollment capped|16|||
127634276|NCT00782340|459283007|FG001|Open Label Titration|Enrollment capped|0|||
127634277|NCT00782340|459283008|FG002|Open Label Titration|Enrollment capped|0|||
127634278|NCT00782340|459283006|FG000|Open Label Titration|Did not meet responder criteria|2|||
127796191|NCT05913232|459876086|FG000|Overall Study|Adverse Event|0|||
127796192|NCT05913232|459876087|FG001|Overall Study|Adverse Event|2|||
127796193|NCT05913232|459876088|FG002|Overall Study|Adverse Event|1|||
127634279|NCT00782340|459283007|FG001|Open Label Titration|Did not meet responder criteria|0|||
127634280|NCT00782340|459283008|FG002|Open Label Titration|Did not meet responder criteria|0|||
127634281|NCT00782340|459283006|FG000|Open Label Titration|Lost to Follow-up|5|||
127634282|NCT00782340|459283007|FG001|Open Label Titration|Lost to Follow-up|0|||
127634283|NCT00782340|459283008|FG002|Open Label Titration|Lost to Follow-up|0|||
127634284|NCT00782340|459283006|FG000|Open Label Titration|Randomized in error|6|||
127634285|NCT00782340|459283007|FG001|Open Label Titration|Randomized in error|0|||
127634286|NCT00782340|459283008|FG002|Open Label Titration|Randomized in error|0|||
127634287|NCT03359096|459283009|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
127634288|NCT03359096|459283010|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
127634289|NCT03359096|459283009|FG000|First Intervention (4 Weeks)|Death|1|||
127634290|NCT03359096|459283010|FG001|First Intervention (4 Weeks)|Death|0|||
127634291|NCT03359096|459283009|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
127634292|NCT03359096|459283010|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
127634293|NCT02338362|459283013|FG000|Overall Study|Withdrawal by Subject|1|||
127634294|NCT02338362|459283014|FG001|Overall Study|Withdrawal by Subject|1|||
127634295|NCT01764945|459283016|FG000|Overall Study|Adverse Event|0|||
127634296|NCT01764945|459283017|FG001|Overall Study|Adverse Event|1|||
127634297|NCT01764945|459283018|FG002|Overall Study|Adverse Event|0|||
127634298|NCT01764945|459283019|FG003|Overall Study|Adverse Event|0|||
127634299|NCT01764945|459283020|FG004|Overall Study|Adverse Event|0|||
127634300|NCT01764945|459283021|FG005|Overall Study|Adverse Event|0|||
127634301|NCT01764945|459283022|FG006|Overall Study|Adverse Event|1|||
127634302|NCT01764945|459283023|FG007|Overall Study|Adverse Event|0|||
127634303|NCT05077267|459283024|FG000|Treatment Period|Lost to Follow-up|0|||
127634304|NCT05077267|459283025|FG001|Treatment Period|Lost to Follow-up|1|||
127634305|NCT05077267|459283026|FG002|Treatment Period|Lost to Follow-up|0|||
127634306|NCT05077267|459283024|FG000|Treatment Period|Withdrawal by Subject|0|||
127634307|NCT05077267|459283025|FG001|Treatment Period|Withdrawal by Subject|1|||
127634308|NCT05077267|459283026|FG002|Treatment Period|Withdrawal by Subject|0|||
127634309|NCT05077267|459283024|FG000|Follow-up Period|Lost to Follow-up|0|||
127634310|NCT05077267|459283025|FG001|Follow-up Period|Lost to Follow-up|5|||
127634311|NCT05077267|459283026|FG002|Follow-up Period|Lost to Follow-up|7|||
127634312|NCT05077267|459283024|FG000|Follow-up Period|Withdrawal by Subject|0|||
127634313|NCT05077267|459283025|FG001|Follow-up Period|Withdrawal by Subject|2|||
127634314|NCT05077267|459283026|FG002|Follow-up Period|Withdrawal by Subject|5|||
127634315|NCT05077267|459283024|FG000|Follow-up Period|Study terminated by sponsor|0|||
127634316|NCT05077267|459283025|FG001|Follow-up Period|Study terminated by sponsor|27|||
127634317|NCT05077267|459283026|FG002|Follow-up Period|Study terminated by sponsor|23|||
127634318|NCT05077267|459283024|FG000|Follow-up Period|Received COVID-19 booster outside of trial|0|||
127634319|NCT05077267|459283025|FG001|Follow-up Period|Received COVID-19 booster outside of trial|66|||
127634320|NCT05077267|459283026|FG002|Follow-up Period|Received COVID-19 booster outside of trial|30|||
127634321|NCT05077267|459283024|FG000|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
127634322|NCT05077267|459283025|FG001|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
127634323|NCT05077267|459283026|FG002|Follow-up Period|Patient is busy at work and withdraws the IC|1|||
127634324|NCT02911948|459283027|FG000|Overall Study|Protocol Violation|0|||
127634325|NCT02911948|459283028|FG001|Overall Study|Protocol Violation|1|||
127634326|NCT02911948|459283027|FG000|Overall Study|Withdrawal by Subject|0|||
127634327|NCT02911948|459283028|FG001|Overall Study|Withdrawal by Subject|2|||
127634328|NCT02911948|459283027|FG000|Overall Study|Lack of Efficacy|0|||
127634329|NCT02911948|459283028|FG001|Overall Study|Lack of Efficacy|1|||
127634330|NCT02911948|459283027|FG000|Overall Study|Unclassified|0|||
127634331|NCT02911948|459283028|FG001|Overall Study|Unclassified|3|||
127634332|NCT03867734|459283029|FG000|Overall Study|Lost to Follow-up|2|||
127634333|NCT03738150|459283034|FG000|Base Study|Withdrawal by Subject|1|||
127634334|NCT03738150|459283034|FG000|Extension Study|Withdrawal by Subject|1|||
127634335|NCT02276482|459283041|FG000|Overall Study|Adverse Event|1|||
127634336|NCT02276482|459283042|FG001|Overall Study|Adverse Event|0|||
127634337|NCT02276482|459283041|FG000|Overall Study|Withdrawal by Subject|1|||
127634338|NCT02276482|459283042|FG001|Overall Study|Withdrawal by Subject|0|||
127634339|NCT02276482|459283041|FG000|Overall Study|Gram-negative infection|1|||
127634340|NCT02276482|459283042|FG001|Overall Study|Gram-negative infection|0|||
127634341|NCT02276482|459283041|FG000|Overall Study|Reason not specified|0|||
127634342|NCT02276482|459283042|FG001|Overall Study|Reason not specified|1|||
127796194|NCT05913232|459876089|FG003|Overall Study|Adverse Event|1|||
127796195|NCT01627899|459876090|FG000|Overall Study|Study terminated early by sponsor.|5|||
127634343|NCT01165281|459283050|FG000|Overall Study|Adverse Event|12|||
127634344|NCT01165281|459283051|FG001|Overall Study|Adverse Event|14|||
127634345|NCT01165281|459283050|FG000|Overall Study|Death|3|||
127634346|NCT01165281|459283051|FG001|Overall Study|Death|4|||
127634347|NCT01165281|459283050|FG000|Overall Study|Lack of Efficacy|4|||
127634348|NCT01165281|459283051|FG001|Overall Study|Lack of Efficacy|1|||
127634349|NCT01165281|459283050|FG000|Overall Study|Lost to Follow-up|0|||
127634350|NCT01165281|459283051|FG001|Overall Study|Lost to Follow-up|1|||
127634351|NCT01165281|459283050|FG000|Overall Study|Physician Decision|8|||
127634352|NCT01165281|459283051|FG001|Overall Study|Physician Decision|1|||
127634353|NCT01165281|459283050|FG000|Overall Study|Protocol Violation|6|||
127634354|NCT01165281|459283051|FG001|Overall Study|Protocol Violation|5|||
127634355|NCT01165281|459283050|FG000|Overall Study|Withdrawal by Subject|8|||
127634356|NCT01165281|459283051|FG001|Overall Study|Withdrawal by Subject|7|||
127634357|NCT01165281|459283050|FG000|Overall Study|Noncompliance with Study Drug|1|||
127634358|NCT01165281|459283051|FG001|Overall Study|Noncompliance with Study Drug|4|||
127634359|NCT01165281|459283050|FG000|Overall Study|Progressive Disease|10|||
127634360|NCT01165281|459283051|FG001|Overall Study|Progressive Disease|14|||
127634361|NCT01165281|459283050|FG000|Overall Study|Other|6|||
127634362|NCT01165281|459283051|FG001|Overall Study|Other|0|||
127634363|NCT00364858|459283056|FG000|Overall Study|Adverse Event|1|||
127634364|NCT00364858|459283057|FG001|Overall Study|Adverse Event|5|||
127634365|NCT00364858|459283056|FG000|Overall Study|Withdrawal by Subject|1|||
127634366|NCT00364858|459283057|FG001|Overall Study|Withdrawal by Subject|1|||
127634367|NCT00364858|459283056|FG000|Overall Study|Pregnancy|1|||
127634368|NCT00364858|459283057|FG001|Overall Study|Pregnancy|1|||
127634369|NCT00364858|459283056|FG000|Overall Study|Clinical failure|2|||
127634370|NCT00364858|459283057|FG001|Overall Study|Clinical failure|13|||
127634371|NCT00364858|459283056|FG000|Overall Study|Discontinuation at baseline|1|||
127634372|NCT00364858|459283057|FG001|Overall Study|Discontinuation at baseline|0|||
127634373|NCT00364858|459283056|FG000|Overall Study|Non-compliant|1|||
127634374|NCT00364858|459283057|FG001|Overall Study|Non-compliant|0|||
127634375|NCT00364858|459283056|FG000|Overall Study|Return to Q2 regimen|0|||
127634376|NCT00364858|459283057|FG001|Overall Study|Return to Q2 regimen|1|||
127634377|NCT00364858|459283056|FG000|Overall Study|Clinical baseline issue|0|||
127634378|NCT00364858|459283057|FG001|Overall Study|Clinical baseline issue|1|||
127634379|NCT02005471|459283058|FG000|Main Study|Adverse Event|0|||
127634380|NCT02005471|459283059|FG001|Main Study|Adverse Event|1|||
127634381|NCT02005471|459283060|FG002|Main Study|Adverse Event|0|||
127634382|NCT02005471|459283061|FG003|Main Study|Adverse Event|0|||
127634383|NCT02005471|459283058|FG000|Main Study|Death|83|||
127634384|NCT02005471|459283059|FG001|Main Study|Death|52|||
127634385|NCT02005471|459283060|FG002|Main Study|Death|0|||
127634386|NCT02005471|459283061|FG003|Main Study|Death|0|||
127702696|NCT03020199|459540572|FG000|Treatment Period|Subject/guardian decision|8|||
127702697|NCT03020199|459540573|FG001|Treatment Period|Subject/guardian decision|15|||
127702698|NCT03020199|459540572|FG000|Treatment Period|Subjects not treated|3|||
127702699|NCT03020199|459540573|FG001|Treatment Period|Subjects not treated|4|||
127702700|NCT03020199|459540572|FG000|Follow-up Period|Disease relapse|32|||
127702701|NCT03020199|459540573|FG001|Follow-up Period|Disease relapse|7|||
127702702|NCT03020199|459540572|FG000|Follow-up Period|Lack of Efficacy|1|||
127702703|NCT03020199|459540573|FG001|Follow-up Period|Lack of Efficacy|2|||
127702704|NCT03020199|459540572|FG000|Follow-up Period|Lost to Follow-up|4|||
127702705|NCT03020199|459540573|FG001|Follow-up Period|Lost to Follow-up|6|||
127702706|NCT03020199|459540572|FG000|Follow-up Period|Physician Decision|2|||
127702707|NCT03020199|459540573|FG001|Follow-up Period|Physician Decision|2|||
127702708|NCT03020199|459540572|FG000|Follow-up Period|Protocol Violation|1|||
127702709|NCT03020199|459540573|FG001|Follow-up Period|Protocol Violation|2|||
127702710|NCT03020199|459540572|FG000|Follow-up Period|Study terminated by Sponsor|6|||
127702711|NCT03020199|459540573|FG001|Follow-up Period|Study terminated by Sponsor|3|||
127702712|NCT03020199|459540572|FG000|Follow-up Period|Subject/guardian decision|14|||
127702713|NCT03020199|459540573|FG001|Follow-up Period|Subject/guardian decision|9|||
127702714|NCT04005794|459540574|FG000|Overall Study|Lost to Follow-up|0|||
127702715|NCT04005794|459540575|FG001|Overall Study|Lost to Follow-up|4|||
127702716|NCT04005794|459540576|FG002|Overall Study|Lost to Follow-up|0|||
127702717|NCT04313972|459540579|FG000|Overall Study|Withdrawal by Subject|0|||
127702718|NCT04313972|459540580|FG001|Overall Study|Withdrawal by Subject|1|||
127702719|NCT05386030|459540582|FG000|Overall Study|Death|1|||
127702720|NCT05386030|459540583|FG001|Overall Study|Death|0|||
127702721|NCT05386030|459540582|FG000|Overall Study|Physician Decision|2|||
127702722|NCT05386030|459540583|FG001|Overall Study|Physician Decision|1|||
127702723|NCT05386030|459540582|FG000|Overall Study|Lost to Follow-up|19|||
127702724|NCT05386030|459540583|FG001|Overall Study|Lost to Follow-up|7|||
127702725|NCT05386030|459540582|FG000|Overall Study|Withdrawal by Subject|20|||
127702726|NCT05386030|459540583|FG001|Overall Study|Withdrawal by Subject|10|||
127702727|NCT05386030|459540582|FG000|Overall Study|Eligibility criteria violation|1|||
127702728|NCT05386030|459540583|FG001|Overall Study|Eligibility criteria violation|1|||
127634387|NCT02005471|459283058|FG000|Main Study|Lost to Follow-up|4|||
127634388|NCT02005471|459283059|FG001|Main Study|Lost to Follow-up|5|||
127634389|NCT02005471|459283060|FG002|Main Study|Lost to Follow-up|0|||
127634390|NCT02005471|459283061|FG003|Main Study|Lost to Follow-up|0|||
127634391|NCT02005471|459283058|FG000|Main Study|Physician Decision|3|||
127634392|NCT02005471|459283059|FG001|Main Study|Physician Decision|1|||
127634393|NCT02005471|459283060|FG002|Main Study|Physician Decision|0|||
127702729|NCT05386030|459540582|FG000|Overall Study|Personal Reasons|1|||
127702730|NCT05386030|459540583|FG001|Overall Study|Personal Reasons|0|||
127796196|NCT04341948|459876091|FG000|Overall Study|Adverse Event|0|||
127796197|NCT04341948|459876092|FG001|Overall Study|Adverse Event|1|||
127796198|NCT04341948|459876091|FG000|Overall Study|Lost to Follow-up|6|||
127796199|NCT04341948|459876092|FG001|Overall Study|Lost to Follow-up|1|||
127796200|NCT04341948|459876091|FG000|Overall Study|Physician Decision|1|||
127796201|NCT04341948|459876092|FG001|Overall Study|Physician Decision|2|||
127796202|NCT04341948|459876091|FG000|Overall Study|Withdrawal by Participant|6|||
127796203|NCT04341948|459876092|FG001|Overall Study|Withdrawal by Participant|3|||
127796204|NCT04341948|459876091|FG000|Overall Study|Lack of compliance by Participant|1|||
127796205|NCT04341948|459876092|FG001|Overall Study|Lack of compliance by Participant|0|||
127796206|NCT02787850|459877694|FG000|Overall Study|Withdrawal by Subject|0|||
127796207|NCT02787850|459877695|FG001|Overall Study|Withdrawal by Subject|1|||
127796208|NCT02921971|459877698|FG000|Overall Study|Adverse Event|1|||
127634394|NCT02005471|459283061|FG003|Main Study|Physician Decision|0|||
127634395|NCT02005471|459283058|FG000|Main Study|Withdrawal by Subject|26|||
127634396|NCT02005471|459283059|FG001|Main Study|Withdrawal by Subject|11|||
127634397|NCT02005471|459283060|FG002|Main Study|Withdrawal by Subject|0|||
127634398|NCT02005471|459283061|FG003|Main Study|Withdrawal by Subject|0|||
127634399|NCT02005471|459283058|FG000|Main Study|Reason not Specified|0|||
127634400|NCT02005471|459283059|FG001|Main Study|Reason not Specified|6|||
127634401|NCT02005471|459283060|FG002|Main Study|Reason not Specified|0|||
127634402|NCT02005471|459283061|FG003|Main Study|Reason not Specified|0|||
127634403|NCT02005471|459283058|FG000|Main Study|Randomized but not Dosed|8|||
127634404|NCT02005471|459283059|FG001|Main Study|Randomized but not Dosed|0|||
127634405|NCT02005471|459283060|FG002|Main Study|Randomized but not Dosed|0|||
127634406|NCT02005471|459283061|FG003|Main Study|Randomized but not Dosed|0|||
127634407|NCT02005471|459283058|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
127634408|NCT02005471|459283059|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
127634409|NCT02005471|459283060|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
127634410|NCT02005471|459283061|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
127634411|NCT02005471|459283058|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
127634412|NCT02005471|459283059|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
127634413|NCT02005471|459283060|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
127634414|NCT02005471|459283061|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
127634415|NCT02005471|459283058|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
127634416|NCT02005471|459283059|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
127634417|NCT02005471|459283060|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
127634418|NCT02005471|459283061|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
127634419|NCT00363766|459283062|FG000|Overall Study|Progressive Disease|15|||
127634420|NCT00363766|459283063|FG001|Overall Study|Progressive Disease|9|||
127634421|NCT00363766|459283062|FG000|Overall Study|Adverse Event|10|||
127634422|NCT00363766|459283063|FG001|Overall Study|Adverse Event|2|||
127634423|NCT00363766|459283062|FG000|Overall Study|Disease Related Death|1|||
127634424|NCT00363766|459283063|FG001|Overall Study|Disease Related Death|3|||
127634425|NCT00363766|459283062|FG000|Overall Study|Not Disease Related Death|3|||
127634426|NCT00363766|459283063|FG001|Overall Study|Not Disease Related Death|4|||
127634427|NCT00363766|459283062|FG000|Overall Study|Withdrawal by Subject|2|||
127634428|NCT00363766|459283063|FG001|Overall Study|Withdrawal by Subject|0|||
127634429|NCT00363766|459283062|FG000|Overall Study|Physician Decision|1|||
127634430|NCT00363766|459283063|FG001|Overall Study|Physician Decision|2|||
127634431|NCT00627705|459283064|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
127634432|NCT00627705|459283065|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
127634433|NCT00627705|459283064|FG000|Overall Study|Adverse Event|1|||
127634434|NCT00627705|459283065|FG001|Overall Study|Adverse Event|0|||
127634435|NCT00627705|459283064|FG000|Overall Study|Withdrawal by Subject|0|||
127634436|NCT00627705|459283065|FG001|Overall Study|Withdrawal by Subject|2|||
127634437|NCT00627705|459283064|FG000|Overall Study|Lost to Follow-up|0|||
127634438|NCT00627705|459283065|FG001|Overall Study|Lost to Follow-up|1|||
127634439|NCT01174342|459283072|FG000|Overall Study|Conversion to cesarean section|4|||
127634440|NCT01410448|459283076|FG000|Overall Study|No conversion to everolimus|0|||
127634441|NCT01410448|459283077|FG001|Overall Study|No conversion to everolimus|24|||
127634442|NCT01410448|459283076|FG000|Overall Study|Graft loss|4|||
127634443|NCT01410448|459283077|FG001|Overall Study|Graft loss|1|||
127634444|NCT01410448|459283076|FG000|Overall Study|Administrative issues|2|||
127634445|NCT01410448|459283077|FG001|Overall Study|Administrative issues|1|||
127634446|NCT01410448|459283076|FG000|Overall Study|Lost to Follow-up|1|||
127634447|NCT01410448|459283077|FG001|Overall Study|Lost to Follow-up|0|||
127634448|NCT01410448|459283076|FG000|Overall Study|Withdrawal by Subject|3|||
127796209|NCT02921971|459877699|FG001|Overall Study|Adverse Event|2|||
127796210|NCT02921971|459877698|FG000|Overall Study|Lack of Efficacy|3|||
127634449|NCT01410448|459283077|FG001|Overall Study|Withdrawal by Subject|2|||
127796211|NCT02921971|459877699|FG001|Overall Study|Lack of Efficacy|1|||
127634450|NCT01410448|459283076|FG000|Overall Study|Protocol Violation|0|||
127634451|NCT01410448|459283077|FG001|Overall Study|Protocol Violation|4|||
127634452|NCT01410448|459283076|FG000|Overall Study|Death|2|||
127634453|NCT01410448|459283077|FG001|Overall Study|Death|3|||
127634454|NCT01308580|459283078|FG000|Overall Study|Lost to Follow-up|12|||
127634455|NCT01308580|459283079|FG001|Overall Study|Lost to Follow-up|7|||
127634456|NCT00360529|459283080|FG000|Overall Study|Adverse Event|10|||
127634457|NCT00360529|459283081|FG001|Overall Study|Adverse Event|23|||
127634458|NCT00360529|459283082|FG002|Overall Study|Adverse Event|33|||
127634459|NCT00360529|459283080|FG000|Overall Study|Protocol Violation|3|||
127634460|NCT00360529|459283081|FG001|Overall Study|Protocol Violation|3|||
127634461|NCT00360529|459283082|FG002|Overall Study|Protocol Violation|11|||
127634462|NCT00360529|459283080|FG000|Overall Study|Lost to Follow-up|14|||
127634463|NCT00360529|459283081|FG001|Overall Study|Lost to Follow-up|10|||
127634464|NCT00360529|459283082|FG002|Overall Study|Lost to Follow-up|13|||
127634465|NCT00360529|459283080|FG000|Overall Study|Withdrawal by Subject|22|||
127634466|NCT00360529|459283081|FG001|Overall Study|Withdrawal by Subject|14|||
127634467|NCT00360529|459283082|FG002|Overall Study|Withdrawal by Subject|18|||
127634468|NCT00360529|459283080|FG000|Overall Study|Lack of Efficacy|8|||
127634469|NCT00360529|459283081|FG001|Overall Study|Lack of Efficacy|6|||
127634470|NCT00360529|459283082|FG002|Overall Study|Lack of Efficacy|5|||
127634471|NCT00360529|459283080|FG000|Overall Study|Reason discontinued not explained above|4|||
127634472|NCT00360529|459283081|FG001|Overall Study|Reason discontinued not explained above|9|||
127634473|NCT00360529|459283082|FG002|Overall Study|Reason discontinued not explained above|11|||
127634474|NCT03712917|459283083|FG000|Overall Study|Pregnancy|0|||
127634475|NCT03712917|459283084|FG001|Overall Study|Pregnancy|0|||
127634476|NCT03712917|459283085|FG002|Overall Study|Pregnancy|1|||
127634477|NCT03712917|459283083|FG000|Overall Study|Adverse Event|0|||
127634478|NCT03712917|459283084|FG001|Overall Study|Adverse Event|4|||
127634479|NCT03712917|459283085|FG002|Overall Study|Adverse Event|3|||
127634480|NCT03712917|459283083|FG000|Overall Study|Lost to Follow-up|9|||
127634481|NCT03712917|459283084|FG001|Overall Study|Lost to Follow-up|4|||
127634482|NCT03712917|459283085|FG002|Overall Study|Lost to Follow-up|5|||
127634483|NCT01218438|459283086|FG000|Epoch 1|Physician Decision|2|||
127634484|NCT01218438|459283086|FG000|Epoch 1|Adverse Event|1|||
127634485|NCT01218438|459283086|FG000|Epoch 3|Withdrawal by Subject|3|||
127634486|NCT01218438|459283086|FG000|Epoch 3|Adverse Event|1|||
127634487|NCT01218438|459283086|FG000|Epoch 4|Physician Decision|1|||
127634488|NCT01218438|459283086|FG000|Epoch 4|Withdrawal by Subject|2|||
127634489|NCT01682460|459284642|FG000|Overall Study|Withdrawal by Subject|2|||
127634490|NCT01682460|459284642|FG000|Overall Study|Did not meet inclusion criteria|2|||
127634491|NCT00724282|459284644|FG000|Overall Study|Withdrawal by Subject|3|||
127634492|NCT00724282|459284644|FG000|Overall Study|Physician Decision|1|||
127634493|NCT05732454|459284645|FG000|Part 1: DB Period|Withdrawal by Subject|1|||
127634494|NCT05732454|459284646|FG001|Part 1: DB Period|Withdrawal by Subject|2|||
127634495|NCT05732454|459284645|FG000|Part 1: DB Period|Adverse Event|1|||
127634496|NCT05732454|459284646|FG001|Part 1: DB Period|Adverse Event|0|||
127634497|NCT05732454|459284645|FG000|Part 1: DB Period|Lost to Follow-up|1|||
127634498|NCT05732454|459284646|FG001|Part 1: DB Period|Lost to Follow-up|0|||
127634499|NCT05732454|459284645|FG000|Part 1: DB Period|Protocol Violation|0|||
127634500|NCT05732454|459284646|FG001|Part 1: DB Period|Protocol Violation|1|||
127634501|NCT05732454|459284645|FG000|Part 1: OLE Period|Study Terminated by Sponsor|25|||
127634502|NCT05732454|459284646|FG001|Part 1: OLE Period|Study Terminated by Sponsor|19|||
127634503|NCT05732454|459284645|FG000|Part 1: OLE Period|Withdrawal by Subject|2|||
127634504|NCT05732454|459284646|FG001|Part 1: OLE Period|Withdrawal by Subject|3|||
127634505|NCT05732454|459284645|FG000|Part 1: OLE Period|Adverse Event|0|||
127634506|NCT05732454|459284646|FG001|Part 1: OLE Period|Adverse Event|1|||
127634507|NCT05732454|459284645|FG000|Part 1: OLE Period|Lack of Efficacy|0|||
127634508|NCT05732454|459284646|FG001|Part 1: OLE Period|Lack of Efficacy|1|||
127634509|NCT00838110|459284649|FG000|Overall Study|Death|0|||
127634510|NCT00838110|459284650|FG001|Overall Study|Death|0|||
127634511|NCT00838110|459284651|FG002|Overall Study|Death|1|||
127634512|NCT00838110|459284652|FG003|Overall Study|Death|2|||
127634513|NCT00838110|459284649|FG000|Overall Study|Adverse Event|11|||
127634514|NCT00838110|459284650|FG001|Overall Study|Adverse Event|10|||
127634515|NCT00838110|459284651|FG002|Overall Study|Adverse Event|8|||
127634516|NCT00838110|459284652|FG003|Overall Study|Adverse Event|7|||
127634517|NCT00838110|459284649|FG000|Overall Study|Withdrawal by Subject|5|||
127634518|NCT00838110|459284650|FG001|Overall Study|Withdrawal by Subject|6|||
127634519|NCT00838110|459284651|FG002|Overall Study|Withdrawal by Subject|3|||
127634520|NCT00838110|459284652|FG003|Overall Study|Withdrawal by Subject|4|||
127634521|NCT00838110|459284649|FG000|Overall Study|Other|3|||
127796212|NCT02921971|459877698|FG000|Overall Study|Other than specified above|2|||
127634522|NCT00838110|459284650|FG001|Overall Study|Other|3|||
127634523|NCT00838110|459284651|FG002|Overall Study|Other|3|||
127634524|NCT00838110|459284652|FG003|Overall Study|Other|2|||
127634525|NCT00838110|459284649|FG000|Overall Study|Protocol Violation|0|||
127634526|NCT00838110|459284650|FG001|Overall Study|Protocol Violation|2|||
127634527|NCT00838110|459284651|FG002|Overall Study|Protocol Violation|1|||
127634528|NCT00838110|459284652|FG003|Overall Study|Protocol Violation|1|||
127634529|NCT00838110|459284649|FG000|Overall Study|Lost to Follow-up|3|||
127796213|NCT02921971|459877699|FG001|Overall Study|Other than specified above|1|||
127796214|NCT02322710|459877700|FG000|Overall Study|No efficacy assessment post-baseline|0|||
127796215|NCT02322710|459877701|FG001|Overall Study|No efficacy assessment post-baseline|1|||
127796216|NCT02322710|459877700|FG000|Overall Study|Protocol Violation|20|||
127796217|NCT02322710|459877701|FG001|Overall Study|Protocol Violation|25|||
127796218|NCT04161131|459877702|FG000|Overall Study|Ineligible|2|||
127796219|NCT04161131|459877702|FG000|Overall Study|Lost to Follow-up|4|||
127796220|NCT04316585|459877703|FG000|Overall Study|Adverse Event|2|||
127796221|NCT04316585|459877704|FG001|Overall Study|Adverse Event|1|||
127634530|NCT00838110|459284650|FG001|Overall Study|Lost to Follow-up|0|||
127634531|NCT00838110|459284651|FG002|Overall Study|Lost to Follow-up|0|||
127634532|NCT00838110|459284652|FG003|Overall Study|Lost to Follow-up|0|||
127634533|NCT00838110|459284649|FG000|Overall Study|Did not meet eligibility criteria|0|||
127634534|NCT00838110|459284650|FG001|Overall Study|Did not meet eligibility criteria|0|||
127634535|NCT00838110|459284651|FG002|Overall Study|Did not meet eligibility criteria|1|||
127634536|NCT00838110|459284652|FG003|Overall Study|Did not meet eligibility criteria|2|||
127634537|NCT00838110|459284649|FG000|Overall Study|Randomized but not treated|0|||
127634538|NCT00838110|459284650|FG001|Overall Study|Randomized but not treated|1|||
127634539|NCT00838110|459284651|FG002|Overall Study|Randomized but not treated|0|||
127634540|NCT00838110|459284652|FG003|Overall Study|Randomized but not treated|0|||
127634541|NCT01262651|459284653|FG000|Overall Study|Adverse Event|40|||
127634542|NCT01262651|459284654|FG001|Overall Study|Adverse Event|35|||
127634543|NCT01262651|459284653|FG000|Overall Study|Withdrawal by Subject|15|||
127634544|NCT01262651|459284654|FG001|Overall Study|Withdrawal by Subject|11|||
127634545|NCT01262651|459284653|FG000|Overall Study|Withdrawal by Investigator|2|||
127634546|NCT01262651|459284654|FG001|Overall Study|Withdrawal by Investigator|2|||
127634547|NCT01262651|459284653|FG000|Overall Study|Met Withdrawal Criteria|1|||
127634548|NCT01262651|459284654|FG001|Overall Study|Met Withdrawal Criteria|0|||
127634549|NCT04969783|459284655|FG000|Overall Study|Lost to Follow-up|2|||
127634550|NCT04969783|459284656|FG001|Overall Study|Lost to Follow-up|0|||
127634551|NCT04969783|459284655|FG000|Overall Study|Withdrawal by Subject|4|||
127634552|NCT04969783|459284656|FG001|Overall Study|Withdrawal by Subject|0|||
127634553|NCT04969783|459284655|FG000|Overall Study|Physician Decision|6|||
127634554|NCT04969783|459284656|FG001|Overall Study|Physician Decision|0|||
127634555|NCT00328510|459284657|FG000|Overall Study|Gag disorder, could not use frame|4|||
127634556|NCT00328510|459284658|FG001|Overall Study|Gag disorder, could not use frame|0|||
127634557|NCT00328510|459284657|FG000|Overall Study|Dentition problems, could not use frame|1|||
127634558|NCT00328510|459284658|FG001|Overall Study|Dentition problems, could not use frame|0|||
127634559|NCT00328510|459284657|FG000|Overall Study|Withdrawal by Subject|4|||
127634560|NCT00328510|459284658|FG001|Overall Study|Withdrawal by Subject|2|||
127634561|NCT00328510|459284657|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
127634562|NCT00328510|459284658|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
127634563|NCT00328510|459284657|FG000|Overall Study|Treatment changed to a single fraction|1|||
127634564|NCT00328510|459284658|FG001|Overall Study|Treatment changed to a single fraction|1|||
127634565|NCT03240588|459284659|FG000|Overall Study|Death|3|||
127634566|NCT03240588|459284660|FG001|Overall Study|Death|0|||
127634567|NCT03240588|459284661|FG002|Overall Study|Death|0|||
127634568|NCT03240588|459284659|FG000|Overall Study|Adverse Event|5|||
127634569|NCT03240588|459284660|FG001|Overall Study|Adverse Event|4|||
127634570|NCT03240588|459284661|FG002|Overall Study|Adverse Event|0|||
127634571|NCT03240588|459284659|FG000|Overall Study|Lost to Follow-up|9|||
127634572|NCT03240588|459284660|FG001|Overall Study|Lost to Follow-up|4|||
127634573|NCT03240588|459284661|FG002|Overall Study|Lost to Follow-up|0|||
127634574|NCT03240588|459284659|FG000|Overall Study|Physician Decision|3|||
127634575|NCT03240588|459284660|FG001|Overall Study|Physician Decision|2|||
127634576|NCT03240588|459284661|FG002|Overall Study|Physician Decision|0|||
127634577|NCT03240588|459284659|FG000|Overall Study|Did not meet eligibility criteria|0|||
127634578|NCT03240588|459284660|FG001|Overall Study|Did not meet eligibility criteria|6|||
127634579|NCT03240588|459284661|FG002|Overall Study|Did not meet eligibility criteria|0|||
127796222|NCT04316585|459877703|FG000|Overall Study|Lost to Follow-up|1|||
127796223|NCT04316585|459877704|FG001|Overall Study|Lost to Follow-up|0|||
127634580|NCT03240588|459284659|FG000|Overall Study|No longer meets protocol criteria|12|||
127634581|NCT03240588|459284660|FG001|Overall Study|No longer meets protocol criteria|7|||
127634582|NCT03240588|459284661|FG002|Overall Study|No longer meets protocol criteria|0|||
127634583|NCT03240588|459284659|FG000|Overall Study|Withdrawal by Subject|60|||
127634584|NCT03240588|459284660|FG001|Overall Study|Withdrawal by Subject|52|||
127634585|NCT03240588|459284661|FG002|Overall Study|Withdrawal by Subject|7|||
127634586|NCT03240588|459284659|FG000|Overall Study|Other, additional details not available.|0|||
127634587|NCT03240588|459284660|FG001|Overall Study|Other, additional details not available.|12|||
127634588|NCT03240588|459284661|FG002|Overall Study|Other, additional details not available.|1|||
127634589|NCT03240588|459284659|FG000|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|14|||
127634590|NCT03240588|459284660|FG001|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|3|||
127796224|NCT04316585|459877703|FG000|Overall Study|Withdrawal by Subject|2|||
127634591|NCT03240588|459284661|FG002|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|0|||
127634592|NCT03240588|459284659|FG000|Overall Study|Closure of study|55|||
127634593|NCT03240588|459284660|FG001|Overall Study|Closure of study|3|||
127634594|NCT03240588|459284661|FG002|Overall Study|Closure of study|0|||
127634595|NCT03240588|459284659|FG000|Overall Study|Subject non-compliance|23|||
127634596|NCT03240588|459284660|FG001|Overall Study|Subject non-compliance|2|||
127634597|NCT03240588|459284661|FG002|Overall Study|Subject non-compliance|1|||
127634598|NCT03240588|459284659|FG000|Overall Study|Device Deficiency|1|||
127634599|NCT03240588|459284660|FG001|Overall Study|Device Deficiency|0|||
127634600|NCT03240588|459284661|FG002|Overall Study|Device Deficiency|0|||
127634601|NCT03240588|459284659|FG000|Overall Study|End of study information not provided to determine reason for withdrawal.|0|||
127634602|NCT03240588|459284660|FG001|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
127634603|NCT03240588|459284661|FG002|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
127634604|NCT00377819|459284664|FG000|Overall Study|Adverse Event|2|||
127634605|NCT00377819|459284665|FG001|Overall Study|Adverse Event|3|||
127634606|NCT00377819|459284664|FG000|Overall Study|Withdrawal by Subject|10|||
127634607|NCT00377819|459284665|FG001|Overall Study|Withdrawal by Subject|4|||
127634608|NCT00377819|459284664|FG000|Overall Study|Death|0|||
127634609|NCT00377819|459284665|FG001|Overall Study|Death|1|||
127634610|NCT00377819|459284664|FG000|Overall Study|Lost to Follow-up|0|||
127634611|NCT00377819|459284665|FG001|Overall Study|Lost to Follow-up|1|||
127634612|NCT00377819|459284664|FG000|Overall Study|Protocol Violation|1|||
127634613|NCT00377819|459284665|FG001|Overall Study|Protocol Violation|1|||
127634614|NCT02091726|459284666|FG000|Overall Study|Lost to Follow-up|6|||
127634615|NCT03727750|459284667|FG000|Overall Study|Death|45|||
127634616|NCT03727750|459284667|FG000|Overall Study|Withdrawal by Subject|2|||
127634617|NCT03727750|459284667|FG000|Overall Study|Lost to Follow-up|1|||
127634618|NCT03727750|459284667|FG000|Overall Study|Other|1|||
127634619|NCT01914926|459284675|FG000|Overall Study|Adverse Event|1|||
127634620|NCT01914926|459284676|FG001|Overall Study|Adverse Event|0|||
127634621|NCT01914926|459284675|FG000|Overall Study|uncooperative, agitated and removed|0|||
127634622|NCT01914926|459284676|FG001|Overall Study|uncooperative, agitated and removed|1|||
127634623|NCT00467870|459284677|FG000|Overall Study|Adverse Event|13|||
127634624|NCT00467870|459284678|FG001|Overall Study|Adverse Event|9|||
127634625|NCT00467870|459284679|FG002|Overall Study|Adverse Event|1|||
127634626|NCT00467870|459284680|FG003|Overall Study|Adverse Event|15|||
127634627|NCT00467870|459284681|FG004|Overall Study|Adverse Event|15|||
127634628|NCT00467870|459284682|FG005|Overall Study|Adverse Event|1|||
127634629|NCT00467870|459284677|FG000|Overall Study|Protocol Violation|2|||
127634630|NCT00467870|459284678|FG001|Overall Study|Protocol Violation|1|||
127634631|NCT00467870|459284679|FG002|Overall Study|Protocol Violation|1|||
127634632|NCT00467870|459284680|FG003|Overall Study|Protocol Violation|2|||
127634633|NCT00467870|459284681|FG004|Overall Study|Protocol Violation|0|||
127634634|NCT00467870|459284682|FG005|Overall Study|Protocol Violation|0|||
127634635|NCT00467870|459284677|FG000|Overall Study|Withdrawal by Subject|14|||
127634636|NCT00467870|459284678|FG001|Overall Study|Withdrawal by Subject|21|||
127634637|NCT00467870|459284679|FG002|Overall Study|Withdrawal by Subject|0|||
127702731|NCT04524442|459540584|FG000|Overall Study|Subject Decision|1|||
127702732|NCT04719832|459540585|FG000|Overall Study|Adverse Event|2|||
127702733|NCT04719832|459540586|FG001|Overall Study|Adverse Event|0|||
127702734|NCT04719832|459540585|FG000|Overall Study|Lack of Efficacy|2|||
127702735|NCT04719832|459540586|FG001|Overall Study|Lack of Efficacy|4|||
127702736|NCT04719832|459540585|FG000|Overall Study|Lost to Follow-up|0|||
127702737|NCT04719832|459540586|FG001|Overall Study|Lost to Follow-up|2|||
127702738|NCT04719832|459540585|FG000|Overall Study|Physician Decision|0|||
127702739|NCT04719832|459540586|FG001|Overall Study|Physician Decision|1|||
127702740|NCT04719832|459540585|FG000|Overall Study|Pregnancy|1|||
127702741|NCT04719832|459540586|FG001|Overall Study|Pregnancy|1|||
127702742|NCT04719832|459540585|FG000|Overall Study|Withdrawal by Subject|5|||
127702743|NCT04719832|459540586|FG001|Overall Study|Withdrawal by Subject|5|||
127702744|NCT04719832|459540585|FG000|Overall Study|Randomized, not treated|0|||
127702745|NCT04719832|459540586|FG001|Overall Study|Randomized, not treated|2|||
127702746|NCT04719832|459540585|FG000|Overall Study|GCP violations|4|||
127634638|NCT00467870|459284680|FG003|Overall Study|Withdrawal by Subject|9|||
127634639|NCT00467870|459284681|FG004|Overall Study|Withdrawal by Subject|10|||
127702747|NCT04719832|459540586|FG001|Overall Study|GCP violations|7|||
127702748|NCT05228457|459540587|FG000|Overall Study|Withdrawal by Subject|1|||
127702749|NCT05228457|459540588|FG001|Overall Study|Withdrawal by Subject|1|||
127702750|NCT04880863|459540591|FG000|Overall Study|Adverse Event|1|||
127702751|NCT04880863|459540591|FG000|Overall Study|Patient decision|2|||
127634640|NCT00467870|459284682|FG005|Overall Study|Withdrawal by Subject|1|||
127634641|NCT00467870|459284677|FG000|Overall Study|Lost to Follow-up|5|||
127634642|NCT00467870|459284678|FG001|Overall Study|Lost to Follow-up|3|||
127634643|NCT00467870|459284679|FG002|Overall Study|Lost to Follow-up|1|||
127634644|NCT00467870|459284680|FG003|Overall Study|Lost to Follow-up|1|||
127634645|NCT00467870|459284681|FG004|Overall Study|Lost to Follow-up|3|||
127634646|NCT00467870|459284682|FG005|Overall Study|Lost to Follow-up|0|||
127634647|NCT00467870|459284677|FG000|Overall Study|Subject Non-compliance|3|||
127634648|NCT00467870|459284678|FG001|Overall Study|Subject Non-compliance|4|||
127634649|NCT00467870|459284679|FG002|Overall Study|Subject Non-compliance|0|||
127634650|NCT00467870|459284680|FG003|Overall Study|Subject Non-compliance|1|||
127634651|NCT00467870|459284681|FG004|Overall Study|Subject Non-compliance|5|||
127634652|NCT00467870|459284682|FG005|Overall Study|Subject Non-compliance|0|||
127634653|NCT00467870|459284677|FG000|Overall Study|Other/Unknown|8|||
127634654|NCT00467870|459284678|FG001|Overall Study|Other/Unknown|5|||
127634655|NCT00467870|459284679|FG002|Overall Study|Other/Unknown|1|||
127634656|NCT00467870|459284680|FG003|Overall Study|Other/Unknown|5|||
127634657|NCT00467870|459284681|FG004|Overall Study|Other/Unknown|4|||
127634658|NCT00467870|459284682|FG005|Overall Study|Other/Unknown|0|||
127634659|NCT00321919|459284683|FG000|Overall Study|Adverse Event|17|||
127634660|NCT00321919|459284684|FG001|Overall Study|Adverse Event|10|||
127634661|NCT00321919|459284683|FG000|Overall Study|Death|21|||
127634662|NCT00321919|459284684|FG001|Overall Study|Death|17|||
127634663|NCT00321919|459284683|FG000|Overall Study|Insufficient Therapeutic Response|1|||
127634664|NCT00321919|459284684|FG001|Overall Study|Insufficient Therapeutic Response|0|||
127634665|NCT00321919|459284683|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
127634666|NCT00321919|459284684|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
127634667|NCT00321919|459284683|FG000|Overall Study|Refused Treatment|23|||
127634668|NCT00321919|459284684|FG001|Overall Study|Refused Treatment|14|||
127634669|NCT00321919|459284683|FG000|Overall Study|Other Protocol Violation|2|||
127634670|NCT00321919|459284684|FG001|Overall Study|Other Protocol Violation|3|||
127634671|NCT00321919|459284683|FG000|Overall Study|Failure to Return|3|||
127634672|NCT00321919|459284684|FG001|Overall Study|Failure to Return|1|||
127634673|NCT00321919|459284683|FG000|Overall Study|Other withdrawal reason|7|||
127634674|NCT00321919|459284684|FG001|Overall Study|Other withdrawal reason|6|||
127634675|NCT02261363|459284685|FG000|Overall Study|Lost to Follow-up|21|||
127634676|NCT01517802|459284686|FG000|Overall Study|Death|1|||
127634677|NCT02590354|459284687|FG000|Phase 1|Active hepatitis B or C infection|1|||
127634678|NCT02590354|459284687|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
127634679|NCT02590354|459284687|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
127634680|NCT02590354|459284687|FG000|Phase 1|Subject does not want to participate|20|||
127634681|NCT02590354|459284687|FG000|Phase 1|Lost to Follow-up|1|||
127634682|NCT02590354|459284687|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
127634683|NCT00760929|459284688|FG000|Overall Study|Adverse Event|2|||
127634684|NCT00760929|459284689|FG001|Overall Study|Adverse Event|0|||
127634685|NCT00760929|459284690|FG002|Overall Study|Adverse Event|6|||
127634686|NCT00760929|459284691|FG003|Overall Study|Adverse Event|10|||
127634687|NCT00760929|459284688|FG000|Overall Study|Lack of Efficacy|0|||
127634688|NCT00760929|459284689|FG001|Overall Study|Lack of Efficacy|2|||
127634689|NCT00760929|459284690|FG002|Overall Study|Lack of Efficacy|1|||
127634690|NCT00760929|459284691|FG003|Overall Study|Lack of Efficacy|0|||
127634691|NCT00760929|459284688|FG000|Overall Study|Withdrawal by Subject|1|||
127634692|NCT00760929|459284689|FG001|Overall Study|Withdrawal by Subject|0|||
127634693|NCT00760929|459284690|FG002|Overall Study|Withdrawal by Subject|9|||
127634694|NCT00760929|459284691|FG003|Overall Study|Withdrawal by Subject|1|||
127634695|NCT00760929|459284688|FG000|Overall Study|Lost to Follow-up|0|||
127634696|NCT00760929|459284689|FG001|Overall Study|Lost to Follow-up|0|||
127634697|NCT00760929|459284690|FG002|Overall Study|Lost to Follow-up|1|||
127634698|NCT00760929|459284691|FG003|Overall Study|Lost to Follow-up|0|||
127634699|NCT00760929|459284688|FG000|Overall Study|Progression of Disease|21|||
127634700|NCT00760929|459284689|FG001|Overall Study|Progression of Disease|26|||
127634701|NCT00760929|459284690|FG002|Overall Study|Progression of Disease|38|||
127634702|NCT00760929|459284691|FG003|Overall Study|Progression of Disease|42|||
127634703|NCT00760929|459284688|FG000|Overall Study|Other|2|||
127634704|NCT00760929|459284689|FG001|Overall Study|Other|0|||
127634705|NCT00760929|459284690|FG002|Overall Study|Other|2|||
127634706|NCT00760929|459284691|FG003|Overall Study|Other|1|||
127634707|NCT00760929|459284688|FG000|Overall Study|Death|0|||
127634708|NCT00760929|459284689|FG001|Overall Study|Death|0|||
127634709|NCT00760929|459284690|FG002|Overall Study|Death|1|||
127634710|NCT00760929|459284691|FG003|Overall Study|Death|0|||
127634711|NCT00760929|459284688|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
127634712|NCT00760929|459284689|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
127634713|NCT00760929|459284690|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
127634714|NCT00760929|459284691|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
127634715|NCT02099838|459284692|FG000|Overall Study|Death|1|||
127634716|NCT02099838|459284693|FG001|Overall Study|Death|0|||
127634717|NCT02099838|459284692|FG000|Overall Study|Lost to Follow-up|3|||
127634718|NCT02099838|459284693|FG001|Overall Study|Lost to Follow-up|1|||
127796225|NCT04316585|459877704|FG001|Overall Study|Withdrawal by Subject|3|||
127796226|NCT04316585|459877703|FG000|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
127796227|NCT04316585|459877704|FG001|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
127634719|NCT02099838|459284692|FG000|Overall Study|Withdrawal by Subject|0|||
127634720|NCT02099838|459284693|FG001|Overall Study|Withdrawal by Subject|1|||
127634721|NCT02301143|459284694|FG000|Induction Period|Enrolled But Not Treated|1|||
127634722|NCT02301143|459284695|FG001|Induction Period|Enrolled But Not Treated|0|||
127634723|NCT02301143|459284694|FG000|Induction Period|Death|1|||
127634724|NCT02301143|459284695|FG001|Induction Period|Death|0|||
127634725|NCT02301143|459284694|FG000|Induction Period|Adverse Event|22|||
127634726|NCT02301143|459284695|FG001|Induction Period|Adverse Event|0|||
127634727|NCT02301143|459284694|FG000|Induction Period|Progressive Disease|8|||
127634728|NCT02301143|459284695|FG001|Induction Period|Progressive Disease|0|||
127634729|NCT02301143|459284694|FG000|Induction Period|Withdrawal by Subject|3|||
127634730|NCT02301143|459284695|FG001|Induction Period|Withdrawal by Subject|0|||
127634731|NCT02301143|459284694|FG000|Induction Period|Noncompliance with Study Drug|1|||
127634732|NCT02301143|459284695|FG001|Induction Period|Noncompliance with Study Drug|0|||
127634733|NCT02301143|459284694|FG000|Induction Period|Physician Decision|4|||
127634734|NCT02301143|459284695|FG001|Induction Period|Physician Decision|0|||
127634735|NCT02301143|459284694|FG000|Induction Period|Symptomatic Deterioration|2|||
127634736|NCT02301143|459284695|FG001|Induction Period|Symptomatic Deterioration|0|||
127634737|NCT02301143|459284694|FG000|Induction Period|Protocol Violation|2|||
127634738|NCT02301143|459284695|FG001|Induction Period|Protocol Violation|0|||
127634739|NCT02301143|459284694|FG000|Induction Period|Other|1|||
127634740|NCT02301143|459284695|FG001|Induction Period|Other|0|||
127634741|NCT02301143|459284694|FG000|Investigator's Choice|Adverse Event|0|||
127634742|NCT02301143|459284695|FG001|Investigator's Choice|Adverse Event|3|||
127634743|NCT02301143|459284694|FG000|Investigator's Choice|Progressive Disease|0|||
127634744|NCT02301143|459284695|FG001|Investigator's Choice|Progressive Disease|3|||
127634745|NCT02301143|459284694|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
127634746|NCT02301143|459284695|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
127634747|NCT02301143|459284694|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
127634748|NCT02301143|459284695|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
127634749|NCT02301143|459284694|FG000|Investigator's Choice|Other|0|||
127634750|NCT02301143|459284695|FG001|Investigator's Choice|Other|1|||
127634751|NCT02301143|459284694|FG000|Investigator's Choice|Unresectable Surgery|0|||
127634752|NCT02301143|459284695|FG001|Investigator's Choice|Unresectable Surgery|1|||
127634753|NCT02536508|459284698|FG000|Overall Study|Withdrawal by Subject|18|||
127634754|NCT02536508|459284699|FG001|Overall Study|Withdrawal by Subject|13|||
127634755|NCT02536508|459284700|FG002|Overall Study|Withdrawal by Subject|7|||
127634756|NCT02536508|459284698|FG000|Overall Study|Adverse Event|14|||
127634757|NCT02536508|459284699|FG001|Overall Study|Adverse Event|13|||
127634758|NCT02536508|459284700|FG002|Overall Study|Adverse Event|6|||
127634759|NCT02536508|459284698|FG000|Overall Study|Lost to Follow-up|12|||
127634760|NCT02536508|459284699|FG001|Overall Study|Lost to Follow-up|4|||
127634761|NCT02536508|459284700|FG002|Overall Study|Lost to Follow-up|0|||
127634762|NCT02536508|459284698|FG000|Overall Study|Lack of Efficacy|3|||
127634763|NCT02536508|459284699|FG001|Overall Study|Lack of Efficacy|5|||
127634764|NCT02536508|459284700|FG002|Overall Study|Lack of Efficacy|4|||
127634765|NCT02536508|459284698|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
127634766|NCT02536508|459284699|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
127634767|NCT02536508|459284700|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
127634768|NCT02536508|459284698|FG000|Overall Study|Physician Decision|0|||
127634769|NCT02536508|459284699|FG001|Overall Study|Physician Decision|4|||
127634770|NCT02536508|459284700|FG002|Overall Study|Physician Decision|2|||
127634771|NCT02536508|459284698|FG000|Overall Study|Major Protocol Deviation|2|||
127634772|NCT02536508|459284699|FG001|Overall Study|Major Protocol Deviation|2|||
127634773|NCT02536508|459284700|FG002|Overall Study|Major Protocol Deviation|2|||
127634774|NCT02536508|459284698|FG000|Overall Study|Administrative Reasons|0|||
127634775|NCT02536508|459284699|FG001|Overall Study|Administrative Reasons|1|||
127634776|NCT02536508|459284700|FG002|Overall Study|Administrative Reasons|0|||
127634777|NCT00823719|459284704|FG000|Overall Study|Adverse Event|1|||
127634778|NCT00823719|459284705|FG001|Overall Study|Adverse Event|2|||
127634779|NCT00823719|459284704|FG000|Overall Study|Physician Decision|1|||
127634780|NCT00823719|459284705|FG001|Overall Study|Physician Decision|4|||
127634781|NCT00823719|459284704|FG000|Overall Study|Withdrawal by Subject|0|||
127634782|NCT00823719|459284705|FG001|Overall Study|Withdrawal by Subject|1|||
127634783|NCT00823719|459284704|FG000|Overall Study|Disease Progression|4|||
127634784|NCT00823719|459284705|FG001|Overall Study|Disease Progression|4|||
127634785|NCT04757649|459284707|FG000|Overall Study|Withdrawal by Subject|1|||
127634786|NCT04757649|459284707|FG000|Overall Study|Adverse Event|1|||
127634787|NCT01286779|459284708|FG000|Overall Study|Withdrawal by Subject|9|||
127634788|NCT01286779|459284708|FG000|Overall Study|Protocol Violation|5|||
127634789|NCT01286779|459284708|FG000|Overall Study|Physician Decision|2|||
127796228|NCT04316585|459877703|FG000|Overall Study|INVESTIGATOR DISCRETION|1|||
127634790|NCT01286779|459284708|FG000|Overall Study|Participant had scheduled surgery|1|||
127634791|NCT01286779|459284708|FG000|Overall Study|Participant moved to another country|1|||
127634792|NCT01286779|459284708|FG000|Overall Study|Discontinued by sponsor|1|||
127634793|NCT02896855|459284711|FG000|Overall Study|Death|50|||
127634794|NCT02896855|459284712|FG001|Overall Study|Death|40|||
127634795|NCT02896855|459284711|FG000|Overall Study|Lost to Follow-up|15|||
127634796|NCT02896855|459284712|FG001|Overall Study|Lost to Follow-up|9|||
127634797|NCT02896855|459284711|FG000|Overall Study|Withdrawal by Subject|7|||
127634798|NCT02896855|459284712|FG001|Overall Study|Withdrawal by Subject|4|||
127634799|NCT02508311|459284713|FG000|Overall Study|Withdrawal by Subject|1|||
127634800|NCT02508311|459284714|FG001|Overall Study|Withdrawal by Subject|0|||
127634801|NCT02169674|459284715|FG000|Overall Study|Withdrawal by Subject|2|||
127634802|NCT02169674|459284716|FG001|Overall Study|Withdrawal by Subject|1|||
127634803|NCT02169674|459284715|FG000|Overall Study|Seroprotected|30|||
127634804|NCT02169674|459284716|FG001|Overall Study|Seroprotected|76|||
127634805|NCT02169674|459284715|FG000|Overall Study|Lost to Follow-up|0|||
127634806|NCT02169674|459284716|FG001|Overall Study|Lost to Follow-up|1|||
127634807|NCT00574080|459284721|FG000|Overall Study|Death|10|||
127634808|NCT00574080|459284722|FG001|Overall Study|Death|10|||
127634809|NCT04258020|459284723|FG000|Overall Study|Withdrawal by Subject|1|||
127634810|NCT04258020|459284724|FG001|Overall Study|Withdrawal by Subject|0|||
127634811|NCT01519206|459284725|FG000|Overall Study|Lost to Follow-up|3|||
127634812|NCT01519206|459284725|FG000|Overall Study|Missed Visit|2|||
127634813|NCT01380327|459284726|FG000|Overall Study|Lost to Follow-up|0|||
127634814|NCT01380327|459284727|FG001|Overall Study|Lost to Follow-up|1|||
127634815|NCT01380327|459284728|FG002|Overall Study|Lost to Follow-up|1|||
127634816|NCT01380327|459284726|FG000|Overall Study|Protocol Violation|3|||
127634817|NCT01380327|459284727|FG001|Overall Study|Protocol Violation|2|||
127634818|NCT01380327|459284728|FG002|Overall Study|Protocol Violation|3|||
127634819|NCT01380327|459284726|FG000|Overall Study|Withdrawal by Subject|0|||
127634820|NCT01380327|459284727|FG001|Overall Study|Withdrawal by Subject|0|||
127634821|NCT01380327|459284728|FG002|Overall Study|Withdrawal by Subject|1|||
127634822|NCT01380327|459284726|FG000|Overall Study|Housing situation precluded ability to k|0|||
127634823|NCT01380327|459284727|FG001|Overall Study|Housing situation precluded ability to k|0|||
127634824|NCT01380327|459284728|FG002|Overall Study|Housing situation precluded ability to k|1|||
127634825|NCT01380327|459284726|FG000|Overall Study|Questionable onset of epilepsy|0|||
127634826|NCT01380327|459284727|FG001|Overall Study|Questionable onset of epilepsy|0|||
127634827|NCT01380327|459284728|FG002|Overall Study|Questionable onset of epilepsy|1|||
127634828|NCT04139317|459284729|FG000|Overall Study|Adverse Event|10|||
127634829|NCT04139317|459284730|FG001|Overall Study|Adverse Event|2|||
127634830|NCT04139317|459284729|FG000|Overall Study|Death|6|||
127634831|NCT04139317|459284730|FG001|Overall Study|Death|4|||
127634832|NCT04139317|459284729|FG000|Overall Study|Lost to Follow-up|1|||
127634833|NCT04139317|459284730|FG001|Overall Study|Lost to Follow-up|0|||
127634834|NCT04139317|459284729|FG000|Overall Study|Physician Decision|3|||
127634835|NCT04139317|459284730|FG001|Overall Study|Physician Decision|1|||
127634836|NCT04139317|459284729|FG000|Overall Study|Progressive Disease|19|||
127634837|NCT04139317|459284730|FG001|Overall Study|Progressive Disease|9|||
127634838|NCT04139317|459284729|FG000|Overall Study|Subject Decision|2|||
127634839|NCT04139317|459284730|FG001|Overall Study|Subject Decision|2|||
127634840|NCT06027216|459284733|FG000|Overall Study|Did not qualify|8|||
127634841|NCT03646513|459284737|FG000|Overall Study|Premature study termination|4|||
127634842|NCT02219932|459284742|FG000|Overall Study|Other|5|||
127634843|NCT02219932|459284743|FG001|Overall Study|Other|11|||
127634844|NCT02219932|459284742|FG000|Overall Study|Death|1|||
127634845|NCT02219932|459284743|FG001|Overall Study|Death|1|||
127634846|NCT02219932|459284742|FG000|Overall Study|Investigator Decision|0|||
127634847|NCT02219932|459284743|FG001|Overall Study|Investigator Decision|1|||
127796229|NCT04316585|459877704|FG001|Overall Study|INVESTIGATOR DISCRETION|0|||
127796230|NCT00130832|459877705|FG000|Overall Study|Adverse Event|1|||
127796231|NCT00130832|459877706|FG001|Overall Study|Adverse Event|1|||
127796232|NCT00130832|459877705|FG000|Overall Study|Lost to Follow-up|1|||
127796233|NCT00130832|459877706|FG001|Overall Study|Lost to Follow-up|2|||
127796234|NCT00130832|459877705|FG000|Overall Study|Protocol Violation|6|||
127634848|NCT02219932|459284742|FG000|Overall Study|Consent Withdrawn|11|||
127634849|NCT02219932|459284743|FG001|Overall Study|Consent Withdrawn|7|||
127634850|NCT02219932|459284742|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
127634851|NCT02219932|459284743|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
127634852|NCT02219932|459284742|FG000|Overall Study|Protocol Violation|10|||
127634853|NCT02219932|459284743|FG001|Overall Study|Protocol Violation|6|||
127634854|NCT02219932|459284742|FG000|Overall Study|Pregnancy|1|||
127634855|NCT02219932|459284743|FG001|Overall Study|Pregnancy|0|||
127634856|NCT02219932|459284742|FG000|Overall Study|Lost to Follow-up|4|||
127634857|NCT02219932|459284743|FG001|Overall Study|Lost to Follow-up|2|||
127796235|NCT00130832|459877706|FG001|Overall Study|Protocol Violation|8|||
127796236|NCT00130832|459877705|FG000|Overall Study|Withdrawal by Subject|6|||
127634858|NCT02219932|459284742|FG000|Overall Study|Adverse Event|23|||
127634859|NCT02219932|459284743|FG001|Overall Study|Adverse Event|21|||
127634860|NCT00093145|459284745|FG000|Overall Study|Unacceptable Toxicity Only|2|||
127796237|NCT00130832|459877706|FG001|Overall Study|Withdrawal by Subject|1|||
127796238|NCT00130832|459877705|FG000|Overall Study|Moved|2|||
127796239|NCT00130832|459877706|FG001|Overall Study|Moved|2|||
127634861|NCT00093145|459284745|FG000|Overall Study|Physician Decision|5|||
127634862|NCT00093145|459284745|FG000|Overall Study|Withdrawal by Subject|9|||
127634863|NCT00093145|459284745|FG000|Overall Study|Other|1|||
127634864|NCT04389840|459284746|FG000|Overall Study|Adverse Event|0|||
127634865|NCT04389840|459284747|FG001|Overall Study|Adverse Event|0|||
127634866|NCT04389840|459284748|FG002|Overall Study|Adverse Event|0|||
127634867|NCT04389840|459284749|FG003|Overall Study|Adverse Event|1|||
127634868|NCT04389840|459284750|FG004|Overall Study|Adverse Event|0|||
127634869|NCT04389840|459284751|FG005|Overall Study|Adverse Event|0|||
127634870|NCT04389840|459284746|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
127634871|NCT04389840|459284747|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
127634872|NCT04389840|459284748|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
127634873|NCT04389840|459284749|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
127634874|NCT04389840|459284750|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
127634875|NCT04389840|459284751|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
127634876|NCT04389840|459284746|FG000|Overall Study|Death|0|||
127634877|NCT04389840|459284747|FG001|Overall Study|Death|1|||
127634878|NCT04389840|459284748|FG002|Overall Study|Death|0|||
127634879|NCT04389840|459284749|FG003|Overall Study|Death|0|||
127634880|NCT04389840|459284750|FG004|Overall Study|Death|0|||
127634881|NCT04389840|459284751|FG005|Overall Study|Death|0|||
127634882|NCT02252211|459284752|FG000|Overall Study|Adverse Event|0|||
127634883|NCT02252211|459284753|FG001|Overall Study|Adverse Event|1|||
127634884|NCT02252211|459284754|FG002|Overall Study|Adverse Event|0|||
127634885|NCT02252211|459284752|FG000|Overall Study|Progressive disease|3|||
127634886|NCT02252211|459284753|FG001|Overall Study|Progressive disease|2|||
127634887|NCT02252211|459284754|FG002|Overall Study|Progressive disease|0|||
127634888|NCT02252211|459284752|FG000|Overall Study|Withdrawal by Subject|1|||
127634889|NCT02252211|459284753|FG001|Overall Study|Withdrawal by Subject|0|||
127634890|NCT02252211|459284754|FG002|Overall Study|Withdrawal by Subject|0|||
127634891|NCT02252211|459284752|FG000|Overall Study|Serious Adverse Event During Screening|1|||
127634892|NCT02252211|459284753|FG001|Overall Study|Serious Adverse Event During Screening|0|||
127634893|NCT02252211|459284754|FG002|Overall Study|Serious Adverse Event During Screening|1|||
127634894|NCT00968669|459284755|FG000|Overall Study|Lost to Follow-up|5|||
127634895|NCT00968669|459284756|FG001|Overall Study|Lost to Follow-up|2|||
127634896|NCT00968669|459284757|FG002|Overall Study|Lost to Follow-up|1|||
127634897|NCT00968669|459284758|FG003|Overall Study|Lost to Follow-up|4|||
127634898|NCT00968669|459284755|FG000|Overall Study|Withdrawal by Subject|9|||
127634899|NCT00968669|459284756|FG001|Overall Study|Withdrawal by Subject|7|||
127634900|NCT00968669|459284757|FG002|Overall Study|Withdrawal by Subject|5|||
127634901|NCT00968669|459284758|FG003|Overall Study|Withdrawal by Subject|3|||
127634902|NCT00968669|459284755|FG000|Overall Study|Pregnancy|0|||
127634903|NCT00968669|459284756|FG001|Overall Study|Pregnancy|0|||
127634904|NCT00968669|459284757|FG002|Overall Study|Pregnancy|2|||
127634905|NCT00968669|459284758|FG003|Overall Study|Pregnancy|0|||
127634906|NCT00968669|459284755|FG000|Overall Study|AE|1|||
127634907|NCT00968669|459284756|FG001|Overall Study|AE|0|||
127634908|NCT00968669|459284757|FG002|Overall Study|AE|0|||
127634909|NCT00968669|459284758|FG003|Overall Study|AE|0|||
127634910|NCT00968669|459284755|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
127634911|NCT00968669|459284756|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
127634912|NCT00968669|459284757|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
127634913|NCT00968669|459284758|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
127634914|NCT00968669|459284755|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
127634915|NCT00968669|459284756|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
127634916|NCT00968669|459284757|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
127634917|NCT00968669|459284758|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
127634918|NCT00968669|459284755|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
127634919|NCT00968669|459284756|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
127634920|NCT00968669|459284757|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
127634921|NCT00968669|459284758|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
127634922|NCT00968669|459284755|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
127634923|NCT00968669|459284756|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
127634924|NCT00968669|459284757|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
127634925|NCT00968669|459284758|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
127634926|NCT00968669|459284755|FG000|Overall Study|EARLY WITHDRAWAL|0|||
127634927|NCT00968669|459284756|FG001|Overall Study|EARLY WITHDRAWAL|1|||
127634928|NCT00968669|459284757|FG002|Overall Study|EARLY WITHDRAWAL|0|||
127702752|NCT04880863|459540591|FG000|Overall Study|Confirmed Disease Progression|15|||
127702753|NCT04880863|459540591|FG000|Overall Study|Death|3|||
127702754|NCT04880863|459540591|FG000|Overall Study|Physician Decision|4|||
127702755|NCT04880863|459540591|FG000|Overall Study|Unconfirmed Disease Progression|4|||
127702756|NCT04880863|459540591|FG000|Overall Study|Withdrawal by Subject|2|||
127702757|NCT04880863|459540591|FG000|Overall Study|Study discontinuation by the sponsor|4|||
127702758|NCT04880863|459540591|FG000|Overall Study|Progression disease identified by lumbar puncture|1|||
127702759|NCT04880863|459540591|FG000|Overall Study|Not received study drug NAP|2|||
127702760|NCT03213691|459540592|FG000|Overall Study|Adverse Event|2|||
127702761|NCT03213691|459540592|FG000|Overall Study|Death|3|||
127702762|NCT03213691|459540592|FG000|Overall Study|Physician Decision|1|||
127702763|NCT03213691|459540592|FG000|Overall Study|Progressive Disease|14|||
127702764|NCT03213691|459540592|FG000|Overall Study|Ineligible|1|||
127702765|NCT04898673|459540593|FG000|Overall Study|Screenfail|1|||
127702766|NCT04898673|459540594|FG001|Overall Study|Screenfail|0|||
127702767|NCT01152450|459540599|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
127702768|NCT01152450|459540600|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
127702769|NCT01152450|459540601|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
127702770|NCT01152450|459540602|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
127702771|NCT01152450|459540603|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
127702772|NCT01152450|459540604|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
127702773|NCT01152450|459540599|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
127702774|NCT01152450|459540600|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
127702775|NCT01152450|459540601|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
127702776|NCT01152450|459540602|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
127702777|NCT01152450|459540603|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
127702778|NCT01152450|459540604|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
127702779|NCT01152450|459540599|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
127702780|NCT01152450|459540600|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
127702781|NCT01152450|459540601|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
127702782|NCT01152450|459540602|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
127702783|NCT01152450|459540603|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
127702784|NCT01152450|459540604|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
127702785|NCT05546411|459540605|FG000|Overall Study|Progressive Disease|1|||
127702786|NCT05546411|459540606|FG001|Overall Study|Progressive Disease|0|||
127702787|NCT05546411|459540605|FG000|Overall Study|Adverse Event|0|||
127702788|NCT05546411|459540606|FG001|Overall Study|Adverse Event|1|||
127702789|NCT05546411|459540605|FG000|Overall Study|Metastatic disease|1|||
127702790|NCT05546411|459540606|FG001|Overall Study|Metastatic disease|0|||
127702791|NCT02606422|459540607|FG000|Phase 1: Immediate Follow up|Withdrawal by Subject|2|||
127702792|NCT02606422|459540608|FG001|Phase 1: Immediate Follow up|Withdrawal by Subject|0|||
127702793|NCT02606422|459540607|FG000|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|2|||
127702794|NCT02606422|459540608|FG001|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
127702795|NCT02606422|459540607|FG000|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
127702796|NCT02606422|459540608|FG001|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
127702797|NCT02606422|459540607|FG000|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
127702798|NCT02606422|459540608|FG001|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|1|||
127702799|NCT04625465|459540609|FG000|Overall Study|Lost to Follow-up|2|||
127702800|NCT04625465|459540610|FG001|Overall Study|Lost to Follow-up|2|||
127702801|NCT04625465|459540611|FG002|Overall Study|Lost to Follow-up|1|||
127702802|NCT04625465|459540612|FG003|Overall Study|Lost to Follow-up|0|||
127702803|NCT04625465|459540613|FG004|Overall Study|Lost to Follow-up|0|||
127702804|NCT04625465|459540614|FG005|Overall Study|Lost to Follow-up|2|||
127702805|NCT04625465|459540615|FG006|Overall Study|Lost to Follow-up|0|||
127702806|NCT04625465|459540616|FG007|Overall Study|Lost to Follow-up|0|||
127702807|NCT04625465|459540609|FG000|Overall Study|Death|1|||
127702808|NCT04625465|459540610|FG001|Overall Study|Death|0|||
127702809|NCT04625465|459540611|FG002|Overall Study|Death|0|||
127702810|NCT04625465|459540612|FG003|Overall Study|Death|0|||
127702811|NCT04625465|459540613|FG004|Overall Study|Death|0|||
127702812|NCT04625465|459540614|FG005|Overall Study|Death|0|||
127702813|NCT04625465|459540615|FG006|Overall Study|Death|0|||
127702814|NCT04625465|459540616|FG007|Overall Study|Death|0|||
127702815|NCT04625465|459540609|FG000|Overall Study|Withdrawal by Subject|1|||
127702816|NCT04625465|459540610|FG001|Overall Study|Withdrawal by Subject|0|||
127702817|NCT04625465|459540611|FG002|Overall Study|Withdrawal by Subject|4|||
127702818|NCT04625465|459540612|FG003|Overall Study|Withdrawal by Subject|4|||
127702819|NCT04625465|459540613|FG004|Overall Study|Withdrawal by Subject|4|||
127702820|NCT04625465|459540614|FG005|Overall Study|Withdrawal by Subject|0|||
127702821|NCT04625465|459540615|FG006|Overall Study|Withdrawal by Subject|0|||
127702822|NCT04625465|459540616|FG007|Overall Study|Withdrawal by Subject|0|||
127702823|NCT05566639|459540619|FG000|Overall Study|Adverse Event|1|||
127702824|NCT05566639|459540620|FG001|Overall Study|Adverse Event|1|||
127702825|NCT05566639|459540619|FG000|Overall Study|Serious Adverse Event|1|||
127702826|NCT05566639|459540620|FG001|Overall Study|Serious Adverse Event|3|||
127702827|NCT05566639|459540619|FG000|Overall Study|Death|44|||
127702828|NCT05566639|459540620|FG001|Overall Study|Death|45|||
127702829|NCT05566639|459540619|FG000|Overall Study|Lost to Follow-up|467|||
127796240|NCT00130832|459877705|FG000|Overall Study|Other|0|||
127634929|NCT00968669|459284758|FG003|Overall Study|EARLY WITHDRAWAL|0|||
127634930|NCT00968669|459284755|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
127634931|NCT00968669|459284756|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
127634932|NCT00968669|459284757|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
127634933|NCT00968669|459284758|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
127634934|NCT00968669|459284755|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
127634935|NCT00968669|459284756|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
127634936|NCT00968669|459284757|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
127634937|NCT00968669|459284758|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
127634938|NCT00968669|459284755|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
127634939|NCT00968669|459284756|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
127634940|NCT00968669|459284757|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
127634941|NCT00968669|459284758|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
127634942|NCT00968669|459284755|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
127634943|NCT00968669|459284756|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
127634944|NCT00968669|459284757|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
127634945|NCT00968669|459284758|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
127634946|NCT00968669|459284755|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
127634947|NCT00968669|459284756|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
127634948|NCT00968669|459284757|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
127634949|NCT00968669|459284758|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
127634950|NCT00968669|459284755|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
127634951|NCT00968669|459284756|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
127634952|NCT00968669|459284757|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
127634953|NCT00968669|459284758|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
127634954|NCT00968669|459284755|FG000|Overall Study|SPONSOR DECISION|0|||
127634955|NCT00968669|459284756|FG001|Overall Study|SPONSOR DECISION|1|||
127634956|NCT00968669|459284757|FG002|Overall Study|SPONSOR DECISION|0|||
127634957|NCT00968669|459284758|FG003|Overall Study|SPONSOR DECISION|0|||
127634958|NCT00968669|459284755|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
127634959|NCT00968669|459284756|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
127634960|NCT00968669|459284757|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
127634961|NCT00968669|459284758|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
127634962|NCT00968669|459284755|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
127634963|NCT00968669|459284756|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
127634964|NCT00968669|459284757|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
127634965|NCT00968669|459284758|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
127634966|NCT00968669|459284755|FG000|Overall Study|SUBJECT INCARCERATED|0|||
127634967|NCT00968669|459284756|FG001|Overall Study|SUBJECT INCARCERATED|1|||
127634968|NCT00968669|459284757|FG002|Overall Study|SUBJECT INCARCERATED|0|||
127634969|NCT00968669|459284758|FG003|Overall Study|SUBJECT INCARCERATED|0|||
127634970|NCT00968669|459284755|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
127634971|NCT00968669|459284756|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
127634972|NCT00968669|459284757|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
127634973|NCT00968669|459284758|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
127634974|NCT00968669|459284755|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
127634975|NCT00968669|459284756|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
127634976|NCT00968669|459284757|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
127634977|NCT00968669|459284758|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
127634978|NCT00144339|459284759|FG000|Overall Study|Adverse Event|746|||
127634979|NCT00144339|459284760|FG001|Overall Study|Adverse Event|627|||
127634980|NCT00144339|459284759|FG000|Overall Study|Protocol Violation|75|||
127634981|NCT00144339|459284760|FG001|Overall Study|Protocol Violation|48|||
127634982|NCT00144339|459284759|FG000|Overall Study|Withdrawal by Subject|403|||
127634983|NCT00144339|459284760|FG001|Overall Study|Withdrawal by Subject|300|||
127634984|NCT00144339|459284759|FG000|Overall Study|Lost to Follow-up|76|||
127634985|NCT00144339|459284760|FG001|Overall Study|Lost to Follow-up|64|||
127634986|NCT00144339|459284759|FG000|Overall Study|Other|58|||
127634987|NCT00144339|459284760|FG001|Overall Study|Other|60|||
127634988|NCT01109992|459284761|FG000|Overall Study|Withdrawal by Subject|0|||
127634989|NCT01109992|459284762|FG001|Overall Study|Withdrawal by Subject|1|||
127634990|NCT01109992|459284761|FG000|Overall Study|Movement during rest scan.|0|||
127634991|NCT01109992|459284762|FG001|Overall Study|Movement during rest scan.|1|||
127634992|NCT00690755|459284763|FG000|Overall Study|Physician Decision|2|||
127634993|NCT00690755|459284764|FG001|Overall Study|Physician Decision|0|||
127796241|NCT00130832|459877706|FG001|Overall Study|Other|3|||
127796242|NCT03905863|459877707|FG000|Overall Study|Adverse Event|2|||
127796243|NCT03905863|459877708|FG001|Overall Study|Adverse Event|4|||
127634994|NCT00690755|459284765|FG002|Overall Study|Physician Decision|46|||
127634995|NCT00690755|459284766|FG003|Overall Study|Physician Decision|5|||
127634996|NCT00690755|459284767|FG004|Overall Study|Physician Decision|0|||
127634997|NCT00690755|459284768|FG005|Overall Study|Physician Decision|4|||
127634998|NCT00690755|459284769|FG006|Overall Study|Physician Decision|0|||
127796244|NCT03905863|459877707|FG000|Overall Study|Withdrawal by Subject|2|||
127796245|NCT03905863|459877708|FG001|Overall Study|Withdrawal by Subject|2|||
127796246|NCT03905863|459877707|FG000|Overall Study|Physician Decision|0|||
127796247|NCT03905863|459877708|FG001|Overall Study|Physician Decision|3|||
127796248|NCT03905863|459877707|FG000|Overall Study|Lost to Follow-up|1|||
127796249|NCT03905863|459877708|FG001|Overall Study|Lost to Follow-up|0|||
127796250|NCT03905863|459877707|FG000|Overall Study|Protocol Violation|0|||
127634999|NCT03832192|459284775|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
127635000|NCT03832192|459284776|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
127635001|NCT00809757|459284778|FG000|Overall Study|Adverse Event|2|||
127635002|NCT00809757|459284779|FG001|Overall Study|Adverse Event|3|||
127635003|NCT00809757|459284780|FG002|Overall Study|Adverse Event|3|||
127635004|NCT00809757|459284778|FG000|Overall Study|Lost to Follow-up|0|||
127635005|NCT00809757|459284779|FG001|Overall Study|Lost to Follow-up|0|||
127635006|NCT00809757|459284780|FG002|Overall Study|Lost to Follow-up|1|||
127635007|NCT00809757|459284778|FG000|Overall Study|Protocol Violation|1|||
127635008|NCT00809757|459284779|FG001|Overall Study|Protocol Violation|1|||
127635009|NCT00809757|459284780|FG002|Overall Study|Protocol Violation|1|||
127635010|NCT00809757|459284778|FG000|Overall Study|Withdrawal by Subject|2|||
127635011|NCT00809757|459284779|FG001|Overall Study|Withdrawal by Subject|1|||
127635012|NCT00809757|459284780|FG002|Overall Study|Withdrawal by Subject|3|||
127635013|NCT00809757|459284778|FG000|Overall Study|Subject Uncooperative|1|||
127635014|NCT00809757|459284779|FG001|Overall Study|Subject Uncooperative|0|||
127635015|NCT00809757|459284780|FG002|Overall Study|Subject Uncooperative|2|||
127635016|NCT00809757|459284778|FG000|Overall Study|Noncompliance with Medication|0|||
127635017|NCT00809757|459284779|FG001|Overall Study|Noncompliance with Medication|0|||
127635018|NCT00809757|459284780|FG002|Overall Study|Noncompliance with Medication|1|||
127635019|NCT00253864|459284781|FG000|Overall Study|Lost to Follow-up|5|||
127635020|NCT00253864|459284782|FG001|Overall Study|Lost to Follow-up|8|||
127635021|NCT04295564|459287005|FG000|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|1|||
127635022|NCT04295564|459287006|FG001|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|0|||
127635023|NCT01159691|459287009|FG000|Overall Study|Lost to Follow-up|2|||
127635024|NCT01159691|459287009|FG000|Overall Study|Unknown reasons|1|||
127635025|NCT01159691|459287009|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
127635026|NCT01159691|459287009|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
127635027|NCT01159691|459287009|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
127635028|NCT01159691|459287009|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
127635029|NCT01159691|459287009|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
127635030|NCT01159691|459287009|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
127635031|NCT01928719|459287010|FG000|Overall Study|Lost to Follow-up|26|||
127635032|NCT01928719|459287011|FG001|Overall Study|Lost to Follow-up|11|||
127635033|NCT01928719|459287010|FG000|Overall Study|Withdrawal by Subject|22|||
127635034|NCT01928719|459287011|FG001|Overall Study|Withdrawal by Subject|7|||
127635035|NCT01928719|459287010|FG000|Overall Study|Protocol Violation|3|||
127635036|NCT01928719|459287011|FG001|Overall Study|Protocol Violation|1|||
127635037|NCT01928719|459287010|FG000|Overall Study|Adverse Event|1|||
127635038|NCT01928719|459287011|FG001|Overall Study|Adverse Event|0|||
127635039|NCT02105116|459287017|FG000|Overall Study|not eligible for step 2 of trial|5|||
127635040|NCT02105116|459287017|FG000|Overall Study|Death|1|||
127635041|NCT00773968|459287018|FG000|Overall Study|Adverse Event|2|||
127635042|NCT00773968|459287018|FG000|Overall Study|Death|1|||
127635043|NCT00773968|459287018|FG000|Overall Study|Failure to Return|2|||
127635044|NCT00773968|459287018|FG000|Overall Study|Lack of Efficacy|3|||
127635045|NCT00773968|459287018|FG000|Overall Study|Protocol Violation|1|||
127635046|NCT00773968|459287018|FG000|Overall Study|Withdrawal by Subject|11|||
127796251|NCT03905863|459877708|FG001|Overall Study|Protocol Violation|2|||
127796252|NCT03905863|459877707|FG000|Overall Study|Death|0|||
127796253|NCT03905863|459877708|FG001|Overall Study|Death|1|||
127796254|NCT02944448|459877710|FG000|Overall Study|Adverse Event|37|||
127635047|NCT00773968|459287018|FG000|Overall Study|Screen Failure|17|||
127796255|NCT02944448|459877711|FG001|Overall Study|Adverse Event|6|||
127796256|NCT02944448|459877710|FG000|Overall Study|Lack of Efficacy|8|||
127796257|NCT02944448|459877711|FG001|Overall Study|Lack of Efficacy|5|||
127796258|NCT02944448|459877710|FG000|Overall Study|Lost to Follow-up|3|||
127635048|NCT00773968|459287018|FG000|Overall Study|Other|8|||
127635049|NCT00263666|459287019|FG000|Overall Study|Adverse Event|6|||
127635050|NCT00263666|459287020|FG001|Overall Study|Adverse Event|8|||
127635051|NCT00263666|459287019|FG000|Overall Study|Lost to Follow-up|1|||
127635052|NCT00263666|459287020|FG001|Overall Study|Lost to Follow-up|2|||
127635053|NCT00263666|459287019|FG000|Overall Study|Withdrawal by Subject|0|||
127796259|NCT02944448|459877711|FG001|Overall Study|Lost to Follow-up|1|||
127796260|NCT02944448|459877710|FG000|Overall Study|Protocol Violation|25|||
127796261|NCT02944448|459877711|FG001|Overall Study|Protocol Violation|7|||
127796262|NCT02944448|459877710|FG000|Overall Study|Withdrawal by Subject|14|||
127702830|NCT05566639|459540620|FG001|Overall Study|Lost to Follow-up|461|||
127702831|NCT05566639|459540619|FG000|Overall Study|Physician Decision|45|||
127702832|NCT05566639|459540620|FG001|Overall Study|Physician Decision|44|||
127702833|NCT05566639|459540619|FG000|Overall Study|Protocol Deviation|4|||
127702834|NCT05566639|459540620|FG001|Overall Study|Protocol Deviation|4|||
127702835|NCT05566639|459540619|FG000|Overall Study|Withdrawal by Subject|277|||
127702836|NCT05566639|459540620|FG001|Overall Study|Withdrawal by Subject|271|||
127702837|NCT05566639|459540619|FG000|Overall Study|Other Than Specified|52|||
127702838|NCT05566639|459540620|FG001|Overall Study|Other Than Specified|64|||
127702845|NCT03800654|459540625|FG000|Overall Study|Time constraints|3|||
127702846|NCT03800654|459540626|FG001|Overall Study|Time constraints|3|||
127702847|NCT03800654|459540627|FG002|Overall Study|Time constraints|3|||
127702848|NCT03800654|459540625|FG000|Overall Study|Did Not Meet Inclusion Criteria|1|||
127702849|NCT03800654|459540626|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
127702850|NCT03800654|459540627|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
127702851|NCT03800654|459540625|FG000|Overall Study|Lost to Follow-up|2|||
127702852|NCT03800654|459540626|FG001|Overall Study|Lost to Follow-up|1|||
127702853|NCT03800654|459540627|FG002|Overall Study|Lost to Follow-up|6|||
127702854|NCT03800654|459540625|FG000|Overall Study|Medical Health Issue|0|||
127702855|NCT03800654|459540626|FG001|Overall Study|Medical Health Issue|0|||
127702856|NCT03800654|459540627|FG002|Overall Study|Medical Health Issue|1|||
127702857|NCT03800654|459540625|FG000|Overall Study|Personal Issues|0|||
127702858|NCT03800654|459540626|FG001|Overall Study|Personal Issues|2|||
127702859|NCT03800654|459540627|FG002|Overall Study|Personal Issues|0|||
127702860|NCT03800654|459540625|FG000|Overall Study|Protocol Violation|0|||
127702861|NCT03800654|459540626|FG001|Overall Study|Protocol Violation|1|||
127702862|NCT03800654|459540627|FG002|Overall Study|Protocol Violation|0|||
127702863|NCT04159415|459540628|FG000|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
127702864|NCT04159415|459540629|FG001|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
127702865|NCT04159415|459540630|FG002|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
127702866|NCT04159415|459540631|FG003|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
127702867|NCT04159415|459540632|FG004|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
127635054|NCT00263666|459287020|FG001|Overall Study|Withdrawal by Subject|1|||
127635055|NCT02863926|459287024|FG000|Overall Study|Physician Decision|1|||
127635056|NCT02863926|459287025|FG001|Overall Study|Physician Decision|0|||
127885676|NCT03627195|460205241|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
127885677|NCT03627195|460205242|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
127885678|NCT03627195|460205243|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
127885679|NCT03627195|460205244|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
127885680|NCT03627195|460205245|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
127885681|NCT00736099|460205248|FG000|Overall Study|Adverse Event|61|||
127635057|NCT02863926|459287024|FG000|Overall Study|Lost to Follow-up|1|||
127635058|NCT02863926|459287025|FG001|Overall Study|Lost to Follow-up|1|||
127635059|NCT03422250|459287027|FG000|Intervention|Adverse Event|0|||
127635060|NCT03422250|459287028|FG001|Intervention|Adverse Event|1|||
127635061|NCT03422250|459287029|FG002|Intervention|Adverse Event|0|||
127635062|NCT03422250|459287030|FG003|Intervention|Adverse Event|1|||
127635063|NCT03422250|459287027|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
127635064|NCT03422250|459287028|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
127635065|NCT03422250|459287029|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
127635066|NCT03422250|459287030|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
127635067|NCT03422250|459287027|FG000|Follow-up|Withdrawal by Subject|0|||
127635068|NCT03422250|459287028|FG001|Follow-up|Withdrawal by Subject|0|||
127635069|NCT03422250|459287029|FG002|Follow-up|Withdrawal by Subject|0|||
127635070|NCT03422250|459287030|FG003|Follow-up|Withdrawal by Subject|1|||
127635071|NCT03422250|459287027|FG000|Follow-up|Adverse Event|0|||
127635072|NCT03422250|459287028|FG001|Follow-up|Adverse Event|0|||
127635073|NCT03422250|459287029|FG002|Follow-up|Adverse Event|0|||
127635074|NCT03422250|459287030|FG003|Follow-up|Adverse Event|1|||
127635075|NCT01917526|459287039|FG000|Overall Study|Protocol Violation|1|||
127635076|NCT01917526|459287040|FG001|Overall Study|Protocol Violation|1|||
127702868|NCT04159415|459540633|FG005|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
127702869|NCT04159415|459540634|FG006|Open-Label Treatment Period (OLTP) 4|Ongoing|2|||
127702870|NCT04159415|459540635|FG007|Open-Label Treatment Period (OLTP) 4|Ongoing|2|||
127702871|NCT03691935|459540636|FG000|Overall Study|Physician Decision|2|||
127702872|NCT03691935|459540637|FG001|Overall Study|Physician Decision|1|||
127702873|NCT03691935|459540636|FG000|Overall Study|Adverse Event|3|||
127702874|NCT03691935|459540637|FG001|Overall Study|Adverse Event|0|||
127702875|NCT05576155|459540638|FG000|Overall Study|Withdrawal by Subject|1|||
127702876|NCT05576155|459540639|FG001|Overall Study|Withdrawal by Subject|1|||
127702877|NCT05209152|459540643|FG000|Overall Study|Sponsor decision|1|||
127702878|NCT05209152|459540644|FG001|Overall Study|Sponsor decision|2|||
127702879|NCT05209152|459540643|FG000|Overall Study|Death|3|||
127702880|NCT05209152|459540644|FG001|Overall Study|Death|1|||
127705326|NCT04433208|459551591|FG001|Overall Study|Withdrawal by Subject|1|||
127705327|NCT04433208|459551592|FG002|Overall Study|Withdrawal by Subject|1|||
127705328|NCT04433208|459551593|FG003|Overall Study|Withdrawal by Subject|0|||
127705329|NCT04433208|459551594|FG004|Overall Study|Withdrawal by Subject|2|||
127885682|NCT00736099|460205249|FG001|Overall Study|Adverse Event|18|||
127885683|NCT00736099|460205248|FG000|Overall Study|Protocol Violation|10|||
127796263|NCT02944448|459877711|FG001|Overall Study|Withdrawal by Subject|4|||
127796264|NCT02944448|459877710|FG000|Overall Study|Sponsor did not supply drug in time|0|||
127796265|NCT02944448|459877711|FG001|Overall Study|Sponsor did not supply drug in time|1|||
127796266|NCT02944448|459877710|FG000|Overall Study|Noncompliant with dosing|1|||
127796267|NCT02944448|459877711|FG001|Overall Study|Noncompliant with dosing|0|||
127702881|NCT02696707|459542529|FG000|Per Protocol Population|Physician Decision|2|||
127702882|NCT02696707|459542530|FG001|Per Protocol Population|Physician Decision|1|||
127702883|NCT02696707|459542529|FG000|Per Protocol Population|Participant Decision|0|||
127702884|NCT02696707|459542530|FG001|Per Protocol Population|Participant Decision|2|||
127702885|NCT02696707|459542529|FG000|Completed Study as Planned|Reason = LVEF|2|||
127702886|NCT02696707|459542530|FG001|Completed Study as Planned|Reason = LVEF|2|||
127702887|NCT02696707|459542529|FG000|Completed Study as Planned|Protocol Violation|2|||
127702888|NCT02696707|459542530|FG001|Completed Study as Planned|Protocol Violation|6|||
127702889|NCT02696707|459542529|FG000|Completed Study as Planned|Metastatic disease|3|||
127702890|NCT02696707|459542530|FG001|Completed Study as Planned|Metastatic disease|0|||
127702891|NCT02696707|459542529|FG000|Completed Study as Planned|Location|1|||
127702892|NCT02696707|459542530|FG001|Completed Study as Planned|Location|1|||
127702893|NCT06181227|459542531|FG000|Overall Study|Study terminated by sponsor|7|||
127702894|NCT06181227|459542532|FG001|Overall Study|Study terminated by sponsor|9|||
127702895|NCT03854227|459542536|FG000|Overall Study|Adverse Event|0|||
127702896|NCT03854227|459542537|FG001|Overall Study|Adverse Event|0|||
127702897|NCT03854227|459542538|FG002|Overall Study|Adverse Event|0|||
127702898|NCT03854227|459542539|FG003|Overall Study|Adverse Event|1|||
127702899|NCT03854227|459542540|FG004|Overall Study|Adverse Event|0|||
127702900|NCT03854227|459542541|FG005|Overall Study|Adverse Event|0|||
127702901|NCT03854227|459542542|FG006|Overall Study|Adverse Event|1|||
127702902|NCT03854227|459542543|FG007|Overall Study|Adverse Event|0|||
127702903|NCT03854227|459542544|FG008|Overall Study|Adverse Event|0|||
127702904|NCT03854227|459542545|FG009|Overall Study|Adverse Event|3|||
127702905|NCT03854227|459542546|FG010|Overall Study|Adverse Event|0|||
127702906|NCT03854227|459542547|FG011|Overall Study|Adverse Event|1|||
127702907|NCT03854227|459542536|FG000|Overall Study|Death|0|||
127702908|NCT03854227|459542537|FG001|Overall Study|Death|0|||
127702909|NCT03854227|459542538|FG002|Overall Study|Death|0|||
127702910|NCT03854227|459542539|FG003|Overall Study|Death|0|||
127702911|NCT03854227|459542540|FG004|Overall Study|Death|0|||
127702912|NCT03854227|459542541|FG005|Overall Study|Death|1|||
127702913|NCT03854227|459542542|FG006|Overall Study|Death|0|||
127702914|NCT03854227|459542543|FG007|Overall Study|Death|0|||
127702915|NCT03854227|459542544|FG008|Overall Study|Death|0|||
127702916|NCT03854227|459542545|FG009|Overall Study|Death|1|||
127702917|NCT03854227|459542546|FG010|Overall Study|Death|0|||
127702918|NCT03854227|459542547|FG011|Overall Study|Death|1|||
127796268|NCT02944448|459877710|FG000|Overall Study|Abnormal laboratory values|1|||
127796269|NCT02944448|459877711|FG001|Overall Study|Abnormal laboratory values|0|||
127796270|NCT05499559|459877718|FG000|Overall Study|Lost to Follow-up|467|||
127796271|NCT04681170|459877719|FG000|Stratified Enrolment & run-in|Death|1|||
127796272|NCT04681170|459877720|FG001|Stratified Enrolment & run-in|Death|0|||
127796273|NCT04681170|459877719|FG000|Stratified Enrolment & run-in|Withdrawal by Subject|0|||
127796274|NCT04681170|459877720|FG001|Stratified Enrolment & run-in|Withdrawal by Subject|1|||
127796275|NCT04681170|459877719|FG000|Stratified Enrolment & run-in|Protocol Violation|0|||
127796276|NCT04681170|459877720|FG001|Stratified Enrolment & run-in|Protocol Violation|1|||
127796277|NCT04681170|459877719|FG000|Open Label Efficacy Phase|Adverse Event|0|||
127796278|NCT04681170|459877720|FG001|Open Label Efficacy Phase|Adverse Event|2|||
127796279|NCT04681170|459877719|FG000|Open Label Safety Phase|Withdrawal by Subject|0|||
127796280|NCT04681170|459877720|FG001|Open Label Safety Phase|Withdrawal by Subject|1|||
127796281|NCT04681170|459877719|FG000|Open Label Safety Phase|AEs and none compliance|0|||
127796282|NCT04681170|459877720|FG001|Open Label Safety Phase|AEs and none compliance|1|||
127796283|NCT02468648|459877721|FG000|Overall Study|Death|1|||
127796284|NCT02118792|459877722|FG000|Overall Study|Withdrawal by Subject|6|||
127796285|NCT02118792|459877723|FG001|Overall Study|Withdrawal by Subject|3|||
127796286|NCT02118792|459877722|FG000|Overall Study|Lost to Follow-up|4|||
127796287|NCT02118792|459877723|FG001|Overall Study|Lost to Follow-up|4|||
127796288|NCT02118792|459877722|FG000|Overall Study|Adverse Event|5|||
127796289|NCT02118792|459877723|FG001|Overall Study|Adverse Event|4|||
127796290|NCT02118792|459877722|FG000|Overall Study|Withdrawal by parent/guardian|14|||
127796291|NCT02118792|459877723|FG001|Overall Study|Withdrawal by parent/guardian|20|||
127796292|NCT02118792|459877722|FG000|Overall Study|Other|1|||
127796293|NCT02118792|459877723|FG001|Overall Study|Other|6|||
127796294|NCT02118792|459877722|FG000|Overall Study|Randomised but not treated|1|||
127796295|NCT02118792|459877723|FG001|Overall Study|Randomised but not treated|0|||
127796296|NCT05131204|459877724|FG000|Overall Study|Sponsor request|2|||
127796297|NCT05131204|459877725|FG001|Overall Study|Sponsor request|1|||
127796298|NCT01368835|459877726|FG000|Overall Study|Inclusion criteria/photography quality|22|||
127796299|NCT01368835|459877726|FG000|Overall Study|Lost to Follow-up|11|||
127796300|NCT03118297|459877727|FG000|Overall Study|Lost to Follow-up|0|||
127796301|NCT03118297|459877728|FG001|Overall Study|Lost to Follow-up|2|||
127796302|NCT01777152|459877732|FG000|Overall Study|Withdrawal by Subject|22|||
127796303|NCT01777152|459877733|FG001|Overall Study|Withdrawal by Subject|16|||
127796304|NCT01777152|459877732|FG000|Overall Study|Lost to Follow-up|3|||
127796305|NCT01777152|459877733|FG001|Overall Study|Lost to Follow-up|5|||
127796306|NCT01777152|459877732|FG000|Overall Study|Death|68|||
127796307|NCT01777152|459877733|FG001|Overall Study|Death|89|||
127796308|NCT01777152|459877732|FG000|Overall Study|Not eligible, no study drug received|1|||
127796309|NCT01777152|459877733|FG001|Overall Study|Not eligible, no study drug received|0|||
127796310|NCT01777152|459877732|FG000|Overall Study|Change of diagnosis|1|||
127796311|NCT01777152|459877733|FG001|Overall Study|Change of diagnosis|0|||
127796312|NCT02792842|459877734|FG000|Overall Study|Adverse Event|4|||
127796313|NCT02792842|459877735|FG001|Overall Study|Adverse Event|2|||
127796314|NCT02792842|459877736|FG002|Overall Study|Adverse Event|3|||
127635077|NCT04717596|459287041|FG000|Overall Study|Withdrawal by Subject|4|||
127635078|NCT02460991|459287042|FG000|Overall Study|Withdrawal by Subject|0|||
127635079|NCT02460991|459287043|FG001|Overall Study|Withdrawal by Subject|2|||
127635080|NCT00434057|459287044|FG000|Overall Study|Withdrawal by Subject|1|||
127635081|NCT02473952|459287045|FG000|Overall Study|Adverse Event|2|||
127635082|NCT02473952|459287046|FG001|Overall Study|Adverse Event|2|||
127635083|NCT02473952|459287045|FG000|Overall Study|Withdrawal by Subject|0|||
127635084|NCT02473952|459287046|FG001|Overall Study|Withdrawal by Subject|6|||
127635085|NCT00455195|459287047|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
127635086|NCT00455195|459287048|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
127635087|NCT00455195|459287047|FG000|Double-blind Study AGLU02704|Death|1|||
127635088|NCT00455195|459287048|FG001|Double-blind Study AGLU02704|Death|0|||
127635089|NCT00455195|459287047|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
127635090|NCT00455195|459287048|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
127635091|NCT00455195|459287047|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
127635092|NCT00455195|459287048|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
127635093|NCT02117570|459287049|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
127635094|NCT02117570|459287050|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
127796315|NCT02792842|459877734|FG000|Overall Study|Withdrawal by Subject|0|||
127796316|NCT02792842|459877735|FG001|Overall Study|Withdrawal by Subject|1|||
127796317|NCT02792842|459877736|FG002|Overall Study|Withdrawal by Subject|2|||
127635095|NCT02117570|459287051|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
127796318|NCT02792842|459877734|FG000|Overall Study|Lost to Follow-up|0|||
127635096|NCT02117570|459287049|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
127635097|NCT02117570|459287050|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
127635098|NCT02117570|459287051|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
127635099|NCT02117570|459287049|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
127635100|NCT02117570|459287050|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
127635101|NCT02117570|459287051|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
127635102|NCT02117570|459287049|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
127635103|NCT02117570|459287050|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
127635104|NCT02117570|459287051|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
127635105|NCT02117570|459287049|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
127635106|NCT02117570|459287050|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
127635107|NCT02117570|459287051|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
127635108|NCT02117570|459287049|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
127635109|NCT02117570|459287050|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
127635110|NCT02117570|459287051|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
127635111|NCT02117570|459287049|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
127635112|NCT02117570|459287050|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
127635113|NCT02117570|459287051|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
127635114|NCT03701555|459287052|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
127635115|NCT03701555|459287053|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
127635116|NCT03701555|459287054|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
127635117|NCT03701555|459287055|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
127635118|NCT03701555|459287056|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
127635119|NCT03701555|459287057|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
127635120|NCT03701555|459287058|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
127635121|NCT03701555|459287059|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
127635122|NCT03701555|459287060|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
127635123|NCT03701555|459287061|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
127635124|NCT03701555|459287062|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
127635125|NCT03701555|459287063|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
127635126|NCT03701555|459287064|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
127635127|NCT03701555|459287065|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
127635128|NCT03701555|459287066|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
127635129|NCT03701555|459287067|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
127635130|NCT03701555|459287068|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
127635131|NCT03701555|459287069|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
127635132|NCT03701555|459287070|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
127635133|NCT03701555|459287071|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
127635134|NCT03701555|459287072|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
127635135|NCT03701555|459287073|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
127635136|NCT03701555|459287074|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
127635137|NCT03701555|459287075|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
127635138|NCT03701555|459287076|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
127635139|NCT03701555|459287077|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
127635140|NCT03701555|459287078|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
127635141|NCT03701555|459287079|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
127635142|NCT03701555|459287080|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
127635143|NCT03701555|459287081|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
127635144|NCT03701555|459287082|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
127635145|NCT03701555|459287083|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
127635146|NCT03701555|459287084|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
127635147|NCT03701555|459287085|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
127702919|NCT03854227|459542536|FG000|Overall Study|Physician Decision|0|||
127635148|NCT03701555|459287086|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
127635149|NCT03701555|459287087|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
127635150|NCT03701555|459287052|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
127702920|NCT03854227|459542537|FG001|Overall Study|Physician Decision|0|||
127702921|NCT03854227|459542538|FG002|Overall Study|Physician Decision|0|||
127702922|NCT03854227|459542539|FG003|Overall Study|Physician Decision|0|||
127702923|NCT03854227|459542540|FG004|Overall Study|Physician Decision|0|||
127702924|NCT03854227|459542541|FG005|Overall Study|Physician Decision|1|||
127702925|NCT03854227|459542542|FG006|Overall Study|Physician Decision|0|||
127702926|NCT03854227|459542543|FG007|Overall Study|Physician Decision|0|||
127702927|NCT03854227|459542544|FG008|Overall Study|Physician Decision|1|||
127702928|NCT03854227|459542545|FG009|Overall Study|Physician Decision|1|||
127702929|NCT03854227|459542546|FG010|Overall Study|Physician Decision|0|||
127702930|NCT03854227|459542547|FG011|Overall Study|Physician Decision|1|||
127702931|NCT03854227|459542536|FG000|Overall Study|Progressive disease|1|||
127635151|NCT03701555|459287053|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
127702932|NCT03854227|459542537|FG001|Overall Study|Progressive disease|1|||
127635152|NCT03701555|459287054|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
127702933|NCT03854227|459542538|FG002|Overall Study|Progressive disease|1|||
127702934|NCT03854227|459542539|FG003|Overall Study|Progressive disease|2|||
127702935|NCT03854227|459542540|FG004|Overall Study|Progressive disease|3|||
127635153|NCT03701555|459287055|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
127635154|NCT03701555|459287056|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
127635155|NCT03701555|459287057|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
127635156|NCT03701555|459287058|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
127635157|NCT03701555|459287059|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
127635158|NCT03701555|459287060|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
127635159|NCT03701555|459287061|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
127635160|NCT03701555|459287062|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
127635161|NCT03701555|459287063|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
127635162|NCT03701555|459287064|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
127635163|NCT03701555|459287065|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
127635164|NCT03701555|459287066|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
127635165|NCT03701555|459287067|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
127635166|NCT03701555|459287068|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
127635167|NCT03701555|459287069|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
127635168|NCT03701555|459287070|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
127635169|NCT03701555|459287071|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
127635170|NCT03701555|459287072|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
127635171|NCT03701555|459287073|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
127635172|NCT03701555|459287074|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
127635173|NCT03701555|459287075|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
127635174|NCT03701555|459287076|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
127635175|NCT03701555|459287077|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
127635176|NCT03701555|459287078|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
127635177|NCT03701555|459287079|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
127635178|NCT03701555|459287080|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
127635179|NCT03701555|459287081|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
127635180|NCT03701555|459287082|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
127635181|NCT03701555|459287083|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
127635182|NCT03701555|459287084|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
127635183|NCT03701555|459287085|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
127635184|NCT03701555|459287086|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
127635185|NCT03701555|459287087|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
127635186|NCT03701555|459287052|FG000|Part 2 (Day 1)|Other|0|||
127635187|NCT03701555|459287053|FG001|Part 2 (Day 1)|Other|0|||
127635188|NCT03701555|459287054|FG002|Part 2 (Day 1)|Other|0|||
127635189|NCT03701555|459287055|FG003|Part 2 (Day 1)|Other|0|||
127635190|NCT03701555|459287056|FG004|Part 2 (Day 1)|Other|0|||
127635191|NCT03701555|459287057|FG005|Part 2 (Day 1)|Other|0|||
127635192|NCT03701555|459287058|FG006|Part 2 (Day 1)|Other|0|||
127635193|NCT03701555|459287059|FG007|Part 2 (Day 1)|Other|0|||
127635194|NCT03701555|459287060|FG008|Part 2 (Day 1)|Other|0|||
127635195|NCT03701555|459287061|FG009|Part 2 (Day 1)|Other|0|||
127635196|NCT03701555|459287062|FG010|Part 2 (Day 1)|Other|3|||
127635197|NCT03701555|459287063|FG011|Part 2 (Day 1)|Other|1|||
127635198|NCT03701555|459287064|FG012|Part 2 (Day 1)|Other|0|||
127635199|NCT03701555|459287065|FG013|Part 2 (Day 1)|Other|1|||
127635200|NCT03701555|459287066|FG014|Part 2 (Day 1)|Other|0|||
127635201|NCT03701555|459287067|FG015|Part 2 (Day 1)|Other|2|||
127635202|NCT03701555|459287068|FG016|Part 2 (Day 1)|Other|2|||
127635203|NCT03701555|459287069|FG017|Part 2 (Day 1)|Other|0|||
127635204|NCT03701555|459287070|FG018|Part 2 (Day 1)|Other|0|||
127635205|NCT03701555|459287071|FG019|Part 2 (Day 1)|Other|0|||
127635206|NCT03701555|459287072|FG020|Part 2 (Day 1)|Other|0|||
127635207|NCT03701555|459287073|FG021|Part 2 (Day 1)|Other|0|||
127635208|NCT03701555|459287074|FG022|Part 2 (Day 1)|Other|0|||
127635209|NCT03701555|459287075|FG023|Part 2 (Day 1)|Other|0|||
127635210|NCT03701555|459287076|FG024|Part 2 (Day 1)|Other|0|||
127635211|NCT03701555|459287077|FG025|Part 2 (Day 1)|Other|0|||
127635212|NCT03701555|459287078|FG026|Part 2 (Day 1)|Other|0|||
127635213|NCT03701555|459287079|FG027|Part 2 (Day 1)|Other|0|||
127635214|NCT03701555|459287080|FG028|Part 2 (Day 1)|Other|0|||
127635215|NCT03701555|459287081|FG029|Part 2 (Day 1)|Other|0|||
127635216|NCT03701555|459287082|FG030|Part 2 (Day 1)|Other|0|||
127635217|NCT03701555|459287083|FG031|Part 2 (Day 1)|Other|0|||
127635218|NCT03701555|459287084|FG032|Part 2 (Day 1)|Other|0|||
127635219|NCT03701555|459287085|FG033|Part 2 (Day 1)|Other|0|||
127635220|NCT03701555|459287086|FG034|Part 2 (Day 1)|Other|0|||
127635221|NCT03701555|459287087|FG035|Part 2 (Day 1)|Other|0|||
127635222|NCT03701555|459287052|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
127635223|NCT03701555|459287053|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
127635224|NCT03701555|459287054|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
127635225|NCT03701555|459287055|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
127635226|NCT03701555|459287056|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
127635227|NCT03701555|459287057|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
127635228|NCT03701555|459287058|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
127702936|NCT03854227|459542541|FG005|Overall Study|Progressive disease|1|||
127796319|NCT02792842|459877735|FG001|Overall Study|Lost to Follow-up|0|||
127796320|NCT02792842|459877736|FG002|Overall Study|Lost to Follow-up|1|||
127796321|NCT02792842|459877734|FG000|Overall Study|Schedule delay|0|||
127796322|NCT02792842|459877735|FG001|Overall Study|Schedule delay|1|||
127796323|NCT02792842|459877736|FG002|Overall Study|Schedule delay|1|||
127635229|NCT03701555|459287059|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
127635230|NCT03701555|459287060|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
127635231|NCT03701555|459287061|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
127635232|NCT03701555|459287062|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
127635233|NCT03701555|459287063|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
127635234|NCT03701555|459287064|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
127635235|NCT03701555|459287065|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
127635236|NCT03701555|459287066|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
127635237|NCT03701555|459287067|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
127635238|NCT03701555|459287068|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
127635239|NCT03701555|459287069|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
127635240|NCT03701555|459287070|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
127635241|NCT03701555|459287071|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
127635242|NCT03701555|459287072|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
127635243|NCT03701555|459287073|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
127796324|NCT02926209|459877741|FG000|Study Cohort|Poor Bowel Preparation|1|||
127796325|NCT02926209|459877742|FG001|Study Cohort|Poor Bowel Preparation|0|||
127796326|NCT03345472|459877743|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
127635244|NCT03701555|459287074|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
127635245|NCT03701555|459287075|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
127635246|NCT03701555|459287076|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
127635247|NCT03701555|459287077|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
127796327|NCT03345472|459877743|FG000|Implant to 3 Months|Physician Decision|1|||
127796328|NCT03345472|459877743|FG000|Implant to 3 Months|Adverse Event|1|||
127796329|NCT03345472|459877743|FG000|3 Months to 12 Months|Physician Decision|3|||
127796330|NCT03345472|459877743|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
127796331|NCT03345472|459877743|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
127796332|NCT03345472|459877743|FG000|3 Months to 12 Months|Adverse Event|1|||
127635248|NCT03701555|459287078|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
127635249|NCT03701555|459287079|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
127635250|NCT03701555|459287080|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
127635251|NCT03701555|459287081|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
127635252|NCT03701555|459287082|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
127796333|NCT03345472|459877743|FG000|3 Months to 12 Months|Death|1|||
127796334|NCT01926782|459877744|FG000|Overall Study|Participant moved|2|||
127796335|NCT01926782|459877745|FG001|Overall Study|Participant moved|0|||
127796336|NCT01926782|459877746|FG002|Overall Study|Participant moved|1|||
127796337|NCT01926782|459877747|FG003|Overall Study|Participant moved|1|||
127796338|NCT01926782|459877748|FG004|Overall Study|Participant moved|0|||
127635253|NCT03701555|459287083|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
127635254|NCT03701555|459287084|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
127635255|NCT03701555|459287085|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
127635256|NCT03701555|459287086|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
127796339|NCT01926782|459877749|FG005|Overall Study|Participant moved|3|||
127796340|NCT01926782|459877744|FG000|Overall Study|Physician Decision|0|||
127796341|NCT01926782|459877745|FG001|Overall Study|Physician Decision|2|||
127635257|NCT03701555|459287087|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
127635258|NCT03701555|459287052|FG000|Part 3 (Day 1)|Subject Decision|0|||
127796342|NCT01926782|459877746|FG002|Overall Study|Physician Decision|1|||
127635259|NCT03701555|459287053|FG001|Part 3 (Day 1)|Subject Decision|0|||
127635260|NCT03701555|459287054|FG002|Part 3 (Day 1)|Subject Decision|0|||
127635261|NCT03701555|459287055|FG003|Part 3 (Day 1)|Subject Decision|0|||
127635262|NCT03701555|459287056|FG004|Part 3 (Day 1)|Subject Decision|0|||
127635263|NCT03701555|459287057|FG005|Part 3 (Day 1)|Subject Decision|0|||
127635264|NCT03701555|459287058|FG006|Part 3 (Day 1)|Subject Decision|0|||
127635265|NCT03701555|459287059|FG007|Part 3 (Day 1)|Subject Decision|0|||
127635266|NCT03701555|459287060|FG008|Part 3 (Day 1)|Subject Decision|0|||
127635267|NCT03701555|459287061|FG009|Part 3 (Day 1)|Subject Decision|0|||
127635268|NCT03701555|459287062|FG010|Part 3 (Day 1)|Subject Decision|0|||
127635269|NCT03701555|459287063|FG011|Part 3 (Day 1)|Subject Decision|0|||
127635270|NCT03701555|459287064|FG012|Part 3 (Day 1)|Subject Decision|0|||
127635271|NCT03701555|459287065|FG013|Part 3 (Day 1)|Subject Decision|0|||
127635272|NCT03701555|459287066|FG014|Part 3 (Day 1)|Subject Decision|0|||
127635273|NCT03701555|459287067|FG015|Part 3 (Day 1)|Subject Decision|0|||
127635274|NCT03701555|459287068|FG016|Part 3 (Day 1)|Subject Decision|0|||
127635275|NCT03701555|459287069|FG017|Part 3 (Day 1)|Subject Decision|0|||
127635276|NCT03701555|459287070|FG018|Part 3 (Day 1)|Subject Decision|0|||
127635277|NCT03701555|459287071|FG019|Part 3 (Day 1)|Subject Decision|0|||
127635278|NCT03701555|459287072|FG020|Part 3 (Day 1)|Subject Decision|0|||
127635279|NCT03701555|459287073|FG021|Part 3 (Day 1)|Subject Decision|0|||
127635280|NCT03701555|459287074|FG022|Part 3 (Day 1)|Subject Decision|0|||
127635281|NCT03701555|459287075|FG023|Part 3 (Day 1)|Subject Decision|0|||
127635282|NCT03701555|459287076|FG024|Part 3 (Day 1)|Subject Decision|0|||
127635283|NCT03701555|459287077|FG025|Part 3 (Day 1)|Subject Decision|0|||
127635284|NCT03701555|459287078|FG026|Part 3 (Day 1)|Subject Decision|1|||
127635285|NCT03701555|459287079|FG027|Part 3 (Day 1)|Subject Decision|0|||
127635286|NCT03701555|459287080|FG028|Part 3 (Day 1)|Subject Decision|0|||
127635287|NCT03701555|459287081|FG029|Part 3 (Day 1)|Subject Decision|0|||
127635288|NCT03701555|459287082|FG030|Part 3 (Day 1)|Subject Decision|0|||
127635289|NCT03701555|459287083|FG031|Part 3 (Day 1)|Subject Decision|2|||
127635290|NCT03701555|459287084|FG032|Part 3 (Day 1)|Subject Decision|1|||
127635291|NCT03701555|459287085|FG033|Part 3 (Day 1)|Subject Decision|1|||
127635292|NCT03701555|459287086|FG034|Part 3 (Day 1)|Subject Decision|0|||
127635293|NCT03701555|459287087|FG035|Part 3 (Day 1)|Subject Decision|0|||
127635294|NCT03701555|459287052|FG000|Part 3 (Day 1)|Other|0|||
127635295|NCT03701555|459287053|FG001|Part 3 (Day 1)|Other|0|||
127635296|NCT03701555|459287054|FG002|Part 3 (Day 1)|Other|0|||
127635297|NCT03701555|459287055|FG003|Part 3 (Day 1)|Other|0|||
127635298|NCT03701555|459287056|FG004|Part 3 (Day 1)|Other|0|||
127635299|NCT03701555|459287057|FG005|Part 3 (Day 1)|Other|0|||
127635300|NCT03701555|459287058|FG006|Part 3 (Day 1)|Other|0|||
127635301|NCT03701555|459287059|FG007|Part 3 (Day 1)|Other|0|||
127635302|NCT03701555|459287060|FG008|Part 3 (Day 1)|Other|0|||
127635303|NCT03701555|459287061|FG009|Part 3 (Day 1)|Other|0|||
127635304|NCT03701555|459287062|FG010|Part 3 (Day 1)|Other|0|||
127635305|NCT03701555|459287063|FG011|Part 3 (Day 1)|Other|0|||
127635306|NCT03701555|459287064|FG012|Part 3 (Day 1)|Other|0|||
127635307|NCT03701555|459287065|FG013|Part 3 (Day 1)|Other|0|||
127635308|NCT03701555|459287066|FG014|Part 3 (Day 1)|Other|0|||
127635309|NCT03701555|459287067|FG015|Part 3 (Day 1)|Other|0|||
127635310|NCT03701555|459287068|FG016|Part 3 (Day 1)|Other|0|||
127635311|NCT03701555|459287069|FG017|Part 3 (Day 1)|Other|0|||
127635312|NCT03701555|459287070|FG018|Part 3 (Day 1)|Other|0|||
127635313|NCT03701555|459287071|FG019|Part 3 (Day 1)|Other|0|||
127635314|NCT03701555|459287072|FG020|Part 3 (Day 1)|Other|0|||
127635315|NCT03701555|459287073|FG021|Part 3 (Day 1)|Other|0|||
127635316|NCT03701555|459287074|FG022|Part 3 (Day 1)|Other|0|||
127635317|NCT03701555|459287075|FG023|Part 3 (Day 1)|Other|0|||
127635318|NCT03701555|459287076|FG024|Part 3 (Day 1)|Other|1|||
127635319|NCT03701555|459287077|FG025|Part 3 (Day 1)|Other|1|||
127635320|NCT03701555|459287078|FG026|Part 3 (Day 1)|Other|0|||
127635321|NCT03701555|459287079|FG027|Part 3 (Day 1)|Other|0|||
127796343|NCT01926782|459877747|FG003|Overall Study|Physician Decision|1|||
127796344|NCT01926782|459877748|FG004|Overall Study|Physician Decision|0|||
127796345|NCT01926782|459877749|FG005|Overall Study|Physician Decision|0|||
127635322|NCT03701555|459287080|FG028|Part 3 (Day 1)|Other|0|||
127635323|NCT03701555|459287081|FG029|Part 3 (Day 1)|Other|1|||
127635324|NCT03701555|459287082|FG030|Part 3 (Day 1)|Other|1|||
127635325|NCT03701555|459287083|FG031|Part 3 (Day 1)|Other|0|||
127635326|NCT03701555|459287084|FG032|Part 3 (Day 1)|Other|1|||
127635327|NCT03701555|459287085|FG033|Part 3 (Day 1)|Other|1|||
127635328|NCT03701555|459287086|FG034|Part 3 (Day 1)|Other|0|||
127635329|NCT03701555|459287087|FG035|Part 3 (Day 1)|Other|0|||
127635330|NCT02370602|459287090|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
127635331|NCT02370602|459287091|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
127635332|NCT02370602|459287092|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
127635333|NCT02370602|459287093|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
127635334|NCT02370602|459287094|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
127796346|NCT01926782|459877744|FG000|Overall Study|Other than specified|2|||
127635335|NCT02370602|459287095|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
127635336|NCT03349710|459287096|FG000|Treatment Period|Death|0|||
127635337|NCT03349710|459287097|FG001|Treatment Period|Death|0|||
127635338|NCT03349710|459287098|FG002|Treatment Period|Death|1|||
127635339|NCT03349710|459287099|FG003|Treatment Period|Death|0|||
127635340|NCT03349710|459287096|FG000|Treatment Period|Disease Progression|0|||
127635341|NCT03349710|459287097|FG001|Treatment Period|Disease Progression|2|||
127635342|NCT03349710|459287098|FG002|Treatment Period|Disease Progression|0|||
127635343|NCT03349710|459287099|FG003|Treatment Period|Disease Progression|1|||
127635344|NCT03349710|459287096|FG000|Treatment Period|Study Drug Toxicity|1|||
127635345|NCT03349710|459287097|FG001|Treatment Period|Study Drug Toxicity|0|||
127635346|NCT03349710|459287098|FG002|Treatment Period|Study Drug Toxicity|1|||
127635347|NCT03349710|459287099|FG003|Treatment Period|Study Drug Toxicity|1|||
127635348|NCT03349710|459287096|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
127635349|NCT03349710|459287097|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
127635350|NCT03349710|459287098|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
127635351|NCT03349710|459287099|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
127635352|NCT03349710|459287096|FG000|Treatment Period|admin reason by sponsor|0|||
127635353|NCT03349710|459287097|FG001|Treatment Period|admin reason by sponsor|7|||
127635354|NCT03349710|459287098|FG002|Treatment Period|admin reason by sponsor|0|||
127635355|NCT03349710|459287099|FG003|Treatment Period|admin reason by sponsor|19|||
127635356|NCT03349710|459287096|FG000|Treatment Period|Other Reason|2|||
127635357|NCT03349710|459287097|FG001|Treatment Period|Other Reason|0|||
127635358|NCT03349710|459287098|FG002|Treatment Period|Other Reason|2|||
127635359|NCT03349710|459287099|FG003|Treatment Period|Other Reason|1|||
127635360|NCT03349710|459287096|FG000|Treatment Period|completed|6|||
127635361|NCT03349710|459287097|FG001|Treatment Period|completed|0|||
127635362|NCT03349710|459287098|FG002|Treatment Period|completed|18|||
127635363|NCT03349710|459287099|FG003|Treatment Period|completed|1|||
127635364|NCT03349710|459287096|FG000|Treatment Period|participant request to discontinue|0|||
127635365|NCT03349710|459287097|FG001|Treatment Period|participant request to discontinue|0|||
127635366|NCT03349710|459287098|FG002|Treatment Period|participant request to discontinue|4|||
127635367|NCT03349710|459287099|FG003|Treatment Period|participant request to discontinue|0|||
127635368|NCT03349710|459287096|FG000|Treatment Period|participant withdrew consent|1|||
127635369|NCT03349710|459287097|FG001|Treatment Period|participant withdrew consent|0|||
127635370|NCT03349710|459287098|FG002|Treatment Period|participant withdrew consent|0|||
127635371|NCT03349710|459287099|FG003|Treatment Period|participant withdrew consent|0|||
127635372|NCT01127178|459287100|FG000|Dose Escalation: Treatment Phase|Adverse Event|1|||
127635373|NCT01127178|459287101|FG001|Dose Escalation: Treatment Phase|Adverse Event|0|||
127635374|NCT01127178|459287100|FG000|Dose Escalation: Treatment Phase|Withdrawal by Subject|1|||
127635375|NCT01127178|459287101|FG001|Dose Escalation: Treatment Phase|Withdrawal by Subject|0|||
127635376|NCT01127178|459287100|FG000|Dose Escalation: Treatment Phase|Other|2|||
127635377|NCT01127178|459287101|FG001|Dose Escalation: Treatment Phase|Other|0|||
127635378|NCT01127178|459287100|FG000|Dose Escalation: Extension Phase|Adverse Event|0|||
127635379|NCT01127178|459287101|FG001|Dose Escalation: Extension Phase|Adverse Event|1|||
127635380|NCT01127178|459287100|FG000|Dose Escalation: Extension Phase|Withdrawal by Subject|1|||
127635381|NCT01127178|459287101|FG001|Dose Escalation: Extension Phase|Withdrawal by Subject|0|||
127635382|NCT01127178|459287100|FG000|Dose Escalation: Extension Phase|Other|1|||
127635383|NCT01127178|459287101|FG001|Dose Escalation: Extension Phase|Other|0|||
127635384|NCT02365467|459287102|FG000|Overall Study|Death|3|||
127635385|NCT02043782|459287103|FG000|Period 1|Adverse Event|0|||
127635386|NCT02043782|459287104|FG001|Period 1|Adverse Event|0|||
127635387|NCT02043782|459287105|FG002|Period 1|Adverse Event|1|||
127635388|NCT02043782|459287106|FG003|Period 1|Adverse Event|0|||
127635389|NCT02043782|459287107|FG004|Period 1|Adverse Event|0|||
127635390|NCT02043782|459287108|FG005|Period 1|Adverse Event|0|||
127635391|NCT01306162|459287109|FG000|Period 1|Adverse Event|0|||
127635392|NCT01306162|459287110|FG001|Period 1|Adverse Event|0|||
127635393|NCT01306162|459287111|FG002|Period 1|Adverse Event|0|||
127635394|NCT01306162|459287112|FG003|Period 1|Adverse Event|1|||
127635395|NCT01306162|459287109|FG000|Washout 1|Non-compliance to protocol|0|||
127635396|NCT01306162|459287110|FG001|Washout 1|Non-compliance to protocol|1|||
127635397|NCT01306162|459287111|FG002|Washout 1|Non-compliance to protocol|0|||
127635398|NCT01306162|459287112|FG003|Washout 1|Non-compliance to protocol|0|||
127635399|NCT02959437|459287115|FG000|Overall Study|Death|33|||
127635400|NCT02959437|459287116|FG001|Overall Study|Death|3|||
127635401|NCT02959437|459287117|FG002|Overall Study|Death|0|||
127635402|NCT02959437|459287118|FG003|Overall Study|Death|0|||
127635403|NCT02959437|459287115|FG000|Overall Study|Lost to Follow-up|3|||
127635404|NCT02959437|459287116|FG001|Overall Study|Lost to Follow-up|1|||
127635405|NCT02959437|459287117|FG002|Overall Study|Lost to Follow-up|0|||
127635406|NCT02959437|459287118|FG003|Overall Study|Lost to Follow-up|0|||
127635407|NCT02959437|459287115|FG000|Overall Study|Withdrawal by Subject|11|||
127635408|NCT02959437|459287116|FG001|Overall Study|Withdrawal by Subject|3|||
127635409|NCT02959437|459287117|FG002|Overall Study|Withdrawal by Subject|0|||
127635410|NCT02959437|459287118|FG003|Overall Study|Withdrawal by Subject|0|||
127635411|NCT02959437|459287115|FG000|Overall Study|Progressive Disease|9|||
127635412|NCT02959437|459287116|FG001|Overall Study|Progressive Disease|1|||
127796347|NCT01926782|459877745|FG001|Overall Study|Other than specified|3|||
127796348|NCT01926782|459877746|FG002|Overall Study|Other than specified|5|||
127796349|NCT01926782|459877747|FG003|Overall Study|Other than specified|12|||
127635413|NCT02959437|459287117|FG002|Overall Study|Progressive Disease|0|||
127635414|NCT02959437|459287118|FG003|Overall Study|Progressive Disease|0|||
127635415|NCT02959437|459287115|FG000|Overall Study|Study Terminated by Sponsor|4|||
127635416|NCT02959437|459287116|FG001|Overall Study|Study Terminated by Sponsor|0|||
127635417|NCT02959437|459287117|FG002|Overall Study|Study Terminated by Sponsor|0|||
127635418|NCT02959437|459287118|FG003|Overall Study|Study Terminated by Sponsor|0|||
127635419|NCT02959437|459287115|FG000|Overall Study|Other Unspecified|2|||
127635420|NCT02959437|459287116|FG001|Overall Study|Other Unspecified|0|||
127635421|NCT02959437|459287117|FG002|Overall Study|Other Unspecified|0|||
127635422|NCT02959437|459287118|FG003|Overall Study|Other Unspecified|0|||
127635423|NCT00833989|459287121|FG000|Overall Study|Physician Decision|0|||
127635424|NCT00833989|459287122|FG001|Overall Study|Physician Decision|0|||
127635425|NCT00833989|459287123|FG002|Overall Study|Physician Decision|0|||
127635426|NCT00833989|459287124|FG003|Overall Study|Physician Decision|1|||
127635427|NCT00833989|459287121|FG000|Overall Study|Withdrawal by Subject|3|||
127635428|NCT00833989|459287122|FG001|Overall Study|Withdrawal by Subject|0|||
127635429|NCT00833989|459287123|FG002|Overall Study|Withdrawal by Subject|1|||
127635430|NCT00833989|459287124|FG003|Overall Study|Withdrawal by Subject|1|||
127635431|NCT01949480|459287125|FG000|Overall Study|Physician Decision|5|||
127635432|NCT01949480|459287126|FG001|Overall Study|Physician Decision|8|||
127635433|NCT01272934|459287127|FG000|Overall Study|Adverse Event|0|||
127635434|NCT01272934|459287128|FG001|Overall Study|Adverse Event|1|||
127635435|NCT01272934|459287127|FG000|Overall Study|Abnormal Laboratory Value|0|||
127635436|NCT01272934|459287128|FG001|Overall Study|Abnormal Laboratory Value|1|||
127635437|NCT00214136|459287129|FG000|Overall Study|Death|5|||
127635438|NCT04287920|459287130|FG000|Overall Study|Lost to Follow-up|1|||
127635439|NCT04287920|459287131|FG001|Overall Study|Lost to Follow-up|1|||
127635440|NCT04287920|459287130|FG000|Overall Study|Withdrawal by Subject|0|||
127635441|NCT04287920|459287131|FG001|Overall Study|Withdrawal by Subject|3|||
127635442|NCT04313634|459287132|FG000|Overall Study|Adverse Event|2|||
127635443|NCT04313634|459287133|FG001|Overall Study|Adverse Event|2|||
127635444|NCT04313634|459287134|FG002|Overall Study|Adverse Event|0|||
127635445|NCT04313634|459287132|FG000|Overall Study|Withdrawal by Subject|1|||
127635446|NCT04313634|459287133|FG001|Overall Study|Withdrawal by Subject|0|||
127635447|NCT04313634|459287134|FG002|Overall Study|Withdrawal by Subject|1|||
127702937|NCT03854227|459542542|FG006|Overall Study|Progressive disease|2|||
127702938|NCT03854227|459542543|FG007|Overall Study|Progressive disease|5|||
127702939|NCT03854227|459542544|FG008|Overall Study|Progressive disease|2|||
127702940|NCT03854227|459542545|FG009|Overall Study|Progressive disease|5|||
127702941|NCT03854227|459542546|FG010|Overall Study|Progressive disease|1|||
127702942|NCT03854227|459542547|FG011|Overall Study|Progressive disease|6|||
127702943|NCT03854227|459542536|FG000|Overall Study|Study terminated by sponsor|0|||
127702944|NCT03854227|459542537|FG001|Overall Study|Study terminated by sponsor|0|||
127702945|NCT03854227|459542538|FG002|Overall Study|Study terminated by sponsor|0|||
127702946|NCT03854227|459542539|FG003|Overall Study|Study terminated by sponsor|0|||
127702947|NCT03854227|459542540|FG004|Overall Study|Study terminated by sponsor|0|||
127702948|NCT03854227|459542541|FG005|Overall Study|Study terminated by sponsor|0|||
127702949|NCT03854227|459542542|FG006|Overall Study|Study terminated by sponsor|0|||
127702950|NCT03854227|459542543|FG007|Overall Study|Study terminated by sponsor|0|||
127702951|NCT03854227|459542544|FG008|Overall Study|Study terminated by sponsor|0|||
127702952|NCT03854227|459542545|FG009|Overall Study|Study terminated by sponsor|1|||
127702953|NCT03854227|459542546|FG010|Overall Study|Study terminated by sponsor|0|||
127702954|NCT03854227|459542547|FG011|Overall Study|Study terminated by sponsor|0|||
127702955|NCT03854227|459542536|FG000|Overall Study|Withdrawal by Subject|0|||
127702956|NCT03854227|459542537|FG001|Overall Study|Withdrawal by Subject|0|||
127702957|NCT03854227|459542538|FG002|Overall Study|Withdrawal by Subject|1|||
127702958|NCT03854227|459542539|FG003|Overall Study|Withdrawal by Subject|0|||
127702959|NCT03854227|459542540|FG004|Overall Study|Withdrawal by Subject|0|||
127702960|NCT03854227|459542541|FG005|Overall Study|Withdrawal by Subject|0|||
127702961|NCT03854227|459542542|FG006|Overall Study|Withdrawal by Subject|0|||
127702962|NCT03854227|459542543|FG007|Overall Study|Withdrawal by Subject|0|||
127702963|NCT03854227|459542544|FG008|Overall Study|Withdrawal by Subject|0|||
127702964|NCT03854227|459542545|FG009|Overall Study|Withdrawal by Subject|1|||
127702965|NCT03854227|459542546|FG010|Overall Study|Withdrawal by Subject|1|||
127635448|NCT04313634|459287132|FG000|Overall Study|Protocol Violation|0|||
127796350|NCT01926782|459877748|FG004|Overall Study|Other than specified|4|||
127635449|NCT04313634|459287133|FG001|Overall Study|Protocol Violation|0|||
127635450|NCT04313634|459287134|FG002|Overall Study|Protocol Violation|1|||
127635451|NCT02952924|459287137|FG000|Overall Study|Protocol Violation|0|||
127796351|NCT01926782|459877749|FG005|Overall Study|Other than specified|11|||
127796352|NCT01926782|459877744|FG000|Overall Study|Adverse Event|13|||
127635452|NCT02952924|459287138|FG001|Overall Study|Protocol Violation|0|||
127635453|NCT02952924|459287139|FG002|Overall Study|Protocol Violation|0|||
127635454|NCT02952924|459287140|FG003|Overall Study|Protocol Violation|0|||
127635455|NCT02952924|459287141|FG004|Overall Study|Protocol Violation|0|||
127635456|NCT02952924|459287142|FG005|Overall Study|Protocol Violation|0|||
127635457|NCT02952924|459287143|FG006|Overall Study|Protocol Violation|0|||
127635458|NCT02952924|459287144|FG007|Overall Study|Protocol Violation|0|||
127635459|NCT02952924|459287145|FG008|Overall Study|Protocol Violation|0|||
127635460|NCT02952924|459287146|FG009|Overall Study|Protocol Violation|0|||
127635461|NCT02952924|459287147|FG010|Overall Study|Protocol Violation|0|||
127635462|NCT02952924|459287148|FG011|Overall Study|Protocol Violation|0|||
127635463|NCT02952924|459287149|FG012|Overall Study|Protocol Violation|0|||
127635464|NCT02952924|459287150|FG013|Overall Study|Protocol Violation|0|||
127635465|NCT02952924|459287151|FG014|Overall Study|Protocol Violation|0|||
127635466|NCT02952924|459287152|FG015|Overall Study|Protocol Violation|0|||
127635467|NCT02952924|459287153|FG016|Overall Study|Protocol Violation|0|||
127635468|NCT02952924|459287154|FG017|Overall Study|Protocol Violation|0|||
127635469|NCT02952924|459287155|FG018|Overall Study|Protocol Violation|0|||
127635470|NCT02952924|459287156|FG019|Overall Study|Protocol Violation|1|||
127635471|NCT02952924|459287157|FG020|Overall Study|Protocol Violation|0|||
127635472|NCT02952924|459287158|FG021|Overall Study|Protocol Violation|0|||
127635473|NCT02952924|459287137|FG000|Overall Study|Participant refused to adhere to study protocol|0|||
127635474|NCT02952924|459287138|FG001|Overall Study|Participant refused to adhere to study protocol|0|||
127635475|NCT02952924|459287139|FG002|Overall Study|Participant refused to adhere to study protocol|0|||
127635476|NCT02952924|459287140|FG003|Overall Study|Participant refused to adhere to study protocol|0|||
127635477|NCT02952924|459287141|FG004|Overall Study|Participant refused to adhere to study protocol|0|||
127635478|NCT02952924|459287142|FG005|Overall Study|Participant refused to adhere to study protocol|0|||
127635479|NCT02952924|459287143|FG006|Overall Study|Participant refused to adhere to study protocol|0|||
127635480|NCT02952924|459287144|FG007|Overall Study|Participant refused to adhere to study protocol|0|||
127635481|NCT02952924|459287145|FG008|Overall Study|Participant refused to adhere to study protocol|0|||
127635482|NCT02952924|459287146|FG009|Overall Study|Participant refused to adhere to study protocol|0|||
127635483|NCT02952924|459287147|FG010|Overall Study|Participant refused to adhere to study protocol|0|||
127635484|NCT02952924|459287148|FG011|Overall Study|Participant refused to adhere to study protocol|0|||
127635485|NCT02952924|459287149|FG012|Overall Study|Participant refused to adhere to study protocol|0|||
127635486|NCT02952924|459287150|FG013|Overall Study|Participant refused to adhere to study protocol|0|||
127635487|NCT02952924|459287151|FG014|Overall Study|Participant refused to adhere to study protocol|0|||
127635488|NCT02952924|459287152|FG015|Overall Study|Participant refused to adhere to study protocol|0|||
127635489|NCT02952924|459287153|FG016|Overall Study|Participant refused to adhere to study protocol|0|||
127635490|NCT02952924|459287154|FG017|Overall Study|Participant refused to adhere to study protocol|1|||
127635491|NCT02952924|459287155|FG018|Overall Study|Participant refused to adhere to study protocol|0|||
127635492|NCT02952924|459287156|FG019|Overall Study|Participant refused to adhere to study protocol|0|||
127635493|NCT02952924|459287157|FG020|Overall Study|Participant refused to adhere to study protocol|0|||
127635494|NCT02952924|459287158|FG021|Overall Study|Participant refused to adhere to study protocol|0|||
127635495|NCT02952924|459287137|FG000|Overall Study|Participant unable to adhere to study visit schedule|0|||
127635496|NCT02952924|459287138|FG001|Overall Study|Participant unable to adhere to study visit schedule|0|||
127635497|NCT02952924|459287139|FG002|Overall Study|Participant unable to adhere to study visit schedule|0|||
127635498|NCT02952924|459287140|FG003|Overall Study|Participant unable to adhere to study visit schedule|0|||
127635499|NCT02952924|459287141|FG004|Overall Study|Participant unable to adhere to study visit schedule|0|||
127635500|NCT02952924|459287142|FG005|Overall Study|Participant unable to adhere to study visit schedule|0|||
127635501|NCT02952924|459287143|FG006|Overall Study|Participant unable to adhere to study visit schedule|0|||
127796353|NCT01926782|459877745|FG001|Overall Study|Adverse Event|4|||
127796354|NCT01926782|459877746|FG002|Overall Study|Adverse Event|17|||
127796355|NCT01926782|459877747|FG003|Overall Study|Adverse Event|4|||
127796356|NCT01926782|459877748|FG004|Overall Study|Adverse Event|3|||
127796357|NCT01926782|459877749|FG005|Overall Study|Adverse Event|14|||
127796358|NCT01926782|459877744|FG000|Overall Study|Poor compliance to protocol|5|||
127796359|NCT01926782|459877745|FG001|Overall Study|Poor compliance to protocol|3|||
127796360|NCT01926782|459877746|FG002|Overall Study|Poor compliance to protocol|8|||
127796361|NCT01926782|459877747|FG003|Overall Study|Poor compliance to protocol|0|||
127796362|NCT01926782|459877748|FG004|Overall Study|Poor compliance to protocol|1|||
127796363|NCT01926782|459877749|FG005|Overall Study|Poor compliance to protocol|6|||
127702966|NCT03854227|459542547|FG011|Overall Study|Withdrawal by Subject|0|||
127702967|NCT03854227|459542536|FG000|Overall Study|Disease relapse|0|||
127702968|NCT03854227|459542537|FG001|Overall Study|Disease relapse|0|||
127702969|NCT03854227|459542538|FG002|Overall Study|Disease relapse|0|||
127702970|NCT03854227|459542539|FG003|Overall Study|Disease relapse|0|||
127702971|NCT03854227|459542540|FG004|Overall Study|Disease relapse|0|||
127702972|NCT03854227|459542541|FG005|Overall Study|Disease relapse|0|||
127702973|NCT03854227|459542542|FG006|Overall Study|Disease relapse|0|||
127702974|NCT03854227|459542543|FG007|Overall Study|Disease relapse|0|||
127702975|NCT03854227|459542544|FG008|Overall Study|Disease relapse|1|||
127702976|NCT03854227|459542545|FG009|Overall Study|Disease relapse|0|||
127702977|NCT03854227|459542546|FG010|Overall Study|Disease relapse|0|||
127702978|NCT03854227|459542547|FG011|Overall Study|Disease relapse|0|||
127702979|NCT03854227|459542536|FG000|Overall Study|Global deterioration of health status|0|||
127702980|NCT03854227|459542537|FG001|Overall Study|Global deterioration of health status|0|||
127702981|NCT03854227|459542538|FG002|Overall Study|Global deterioration of health status|0|||
127702982|NCT03854227|459542539|FG003|Overall Study|Global deterioration of health status|0|||
127702983|NCT03854227|459542540|FG004|Overall Study|Global deterioration of health status|0|||
127702984|NCT03854227|459542541|FG005|Overall Study|Global deterioration of health status|1|||
127702985|NCT03854227|459542542|FG006|Overall Study|Global deterioration of health status|0|||
127702986|NCT03854227|459542543|FG007|Overall Study|Global deterioration of health status|1|||
127702987|NCT03854227|459542544|FG008|Overall Study|Global deterioration of health status|0|||
127702988|NCT03854227|459542545|FG009|Overall Study|Global deterioration of health status|0|||
127702989|NCT03854227|459542546|FG010|Overall Study|Global deterioration of health status|0|||
127702990|NCT03854227|459542547|FG011|Overall Study|Global deterioration of health status|0|||
127702991|NCT03854227|459542536|FG000|Overall Study|Refused further treatment|0|||
127702992|NCT03854227|459542537|FG001|Overall Study|Refused further treatment|0|||
127702993|NCT03854227|459542538|FG002|Overall Study|Refused further treatment|0|||
127702994|NCT03854227|459542539|FG003|Overall Study|Refused further treatment|0|||
127702995|NCT03854227|459542540|FG004|Overall Study|Refused further treatment|0|||
127702996|NCT03854227|459542541|FG005|Overall Study|Refused further treatment|0|||
127702997|NCT03854227|459542542|FG006|Overall Study|Refused further treatment|0|||
127702998|NCT03854227|459542543|FG007|Overall Study|Refused further treatment|0|||
127702999|NCT03854227|459542544|FG008|Overall Study|Refused further treatment|0|||
127703000|NCT03854227|459542545|FG009|Overall Study|Refused further treatment|1|||
127703001|NCT03854227|459542546|FG010|Overall Study|Refused further treatment|0|||
127703002|NCT03854227|459542547|FG011|Overall Study|Refused further treatment|1|||
127703003|NCT03854227|459542536|FG000|Overall Study|Other|0|||
127703004|NCT03854227|459542537|FG001|Overall Study|Other|0|||
127703005|NCT03854227|459542538|FG002|Overall Study|Other|0|||
127703006|NCT03854227|459542539|FG003|Overall Study|Other|0|||
127703007|NCT03854227|459542540|FG004|Overall Study|Other|0|||
127703008|NCT03854227|459542541|FG005|Overall Study|Other|0|||
127703009|NCT03854227|459542542|FG006|Overall Study|Other|0|||
127703010|NCT03854227|459542543|FG007|Overall Study|Other|0|||
127703011|NCT03854227|459542544|FG008|Overall Study|Other|1|||
127703012|NCT03854227|459542545|FG009|Overall Study|Other|1|||
127703013|NCT03854227|459542546|FG010|Overall Study|Other|0|||
127703014|NCT03854227|459542547|FG011|Overall Study|Other|0|||
127703015|NCT03668236|459542548|FG000|90-day Follow-up|Withdrawal by Subject|3|||
127703016|NCT03668236|459542549|FG001|90-day Follow-up|Withdrawal by Subject|2|||
127703017|NCT03668236|459542548|FG000|90-day Follow-up|Lost to Follow-up|3|||
127703018|NCT03668236|459542549|FG001|90-day Follow-up|Lost to Follow-up|1|||
127703019|NCT03668236|459542548|FG000|Baseline Characteristics|Lost to Follow-up|9|||
127703020|NCT03668236|459542549|FG001|Baseline Characteristics|Lost to Follow-up|5|||
127703021|NCT03668236|459542548|FG000|1-year Follow-up|Withdrawal by Subject|17|||
127703022|NCT03668236|459542549|FG001|1-year Follow-up|Withdrawal by Subject|15|||
127703023|NCT06132282|459542555|FG000|Overall Study|Lost to Follow-up|31|||
127703024|NCT04376502|459542561|FG000|Overall Study|Deemed ineligible after being enrolled|1|||
127703025|NCT03748953|459542562|FG000|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|0|||
127703026|NCT03748953|459542563|FG001|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|2|||
127703027|NCT03748953|459542562|FG000|Treatment Prior to Amendment 08|Reason not Specified|0|||
127703028|NCT03748953|459542563|FG001|Treatment Prior to Amendment 08|Reason not Specified|2|||
127703029|NCT03748953|459542562|FG000|Treatment Post Amendment 08|Withdrawal by Subject|18|||
127703030|NCT03748953|459542563|FG001|Treatment Post Amendment 08|Withdrawal by Subject|0|||
127703031|NCT03748953|459542562|FG000|Treatment Post Amendment 08|Reason not Specified|16|||
127703032|NCT03748953|459542563|FG001|Treatment Post Amendment 08|Reason not Specified|0|||
127703033|NCT03748953|459542562|FG000|Treatment Post Amendment 08|Lost to Follow-up|1|||
127703034|NCT03748953|459542563|FG001|Treatment Post Amendment 08|Lost to Follow-up|0|||
127703035|NCT04119843|459542564|FG000|Overall Study|Adverse Event|3|||
127703036|NCT04119843|459542564|FG000|Overall Study|Death|1|||
127703037|NCT02841579|459542565|FG000|Overall Study|Death|1|||
127703038|NCT02841579|459542565|FG000|Overall Study|Adverse Event|1|||
127703039|NCT02841579|459542565|FG000|Overall Study|Lack of Efficacy|9|||
127703040|NCT03768505|459542568|FG000|Overall Study|sponsor decision|76|||
127703041|NCT03768505|459542568|FG000|Overall Study|Death|35|||
127703042|NCT03768505|459542568|FG000|Overall Study|Other -Various|30|||
127703043|NCT03768505|459542568|FG000|Overall Study|Withdrawal by Subject|22|||
127703044|NCT03768505|459542568|FG000|Overall Study|Lost to Follow-up|6|||
127635502|NCT02952924|459287144|FG007|Overall Study|Participant unable to adhere to study visit schedule|0|||
127635503|NCT02952924|459287145|FG008|Overall Study|Participant unable to adhere to study visit schedule|0|||
127635504|NCT02952924|459287146|FG009|Overall Study|Participant unable to adhere to study visit schedule|0|||
127635505|NCT02952924|459287147|FG010|Overall Study|Participant unable to adhere to study visit schedule|0|||
127635506|NCT02952924|459287148|FG011|Overall Study|Participant unable to adhere to study visit schedule|0|||
127635507|NCT02952924|459287149|FG012|Overall Study|Participant unable to adhere to study visit schedule|0|||
127635508|NCT02952924|459287150|FG013|Overall Study|Participant unable to adhere to study visit schedule|0|||
127635509|NCT02952924|459287151|FG014|Overall Study|Participant unable to adhere to study visit schedule|0|||
127635510|NCT02952924|459287152|FG015|Overall Study|Participant unable to adhere to study visit schedule|0|||
127635511|NCT02952924|459287153|FG016|Overall Study|Participant unable to adhere to study visit schedule|0|||
127635512|NCT02952924|459287154|FG017|Overall Study|Participant unable to adhere to study visit schedule|0|||
127635513|NCT02952924|459287155|FG018|Overall Study|Participant unable to adhere to study visit schedule|0|||
127635514|NCT02952924|459287156|FG019|Overall Study|Participant unable to adhere to study visit schedule|0|||
127703045|NCT02815566|459542569|FG000|Overall Study|Adverse Event|1|||
127796364|NCT01926782|459877744|FG000|Overall Study|Randomized and not treated|0|||
127635515|NCT02952924|459287157|FG020|Overall Study|Participant unable to adhere to study visit schedule|0|||
127635516|NCT02952924|459287158|FG021|Overall Study|Participant unable to adhere to study visit schedule|1|||
127635517|NCT02952924|459287137|FG000|Overall Study|Noncompliance with study drug|0|||
127635518|NCT02952924|459287138|FG001|Overall Study|Noncompliance with study drug|0|||
127635519|NCT02952924|459287139|FG002|Overall Study|Noncompliance with study drug|0|||
127635520|NCT02952924|459287140|FG003|Overall Study|Noncompliance with study drug|0|||
127635521|NCT02952924|459287141|FG004|Overall Study|Noncompliance with study drug|0|||
127635522|NCT02952924|459287142|FG005|Overall Study|Noncompliance with study drug|0|||
127796365|NCT01926782|459877745|FG001|Overall Study|Randomized and not treated|0|||
127796366|NCT01926782|459877746|FG002|Overall Study|Randomized and not treated|0|||
127635523|NCT02952924|459287143|FG006|Overall Study|Noncompliance with study drug|0|||
127635524|NCT02952924|459287144|FG007|Overall Study|Noncompliance with study drug|0|||
127635525|NCT02952924|459287145|FG008|Overall Study|Noncompliance with study drug|0|||
127635526|NCT02952924|459287146|FG009|Overall Study|Noncompliance with study drug|0|||
127635527|NCT02952924|459287147|FG010|Overall Study|Noncompliance with study drug|0|||
127635528|NCT02952924|459287148|FG011|Overall Study|Noncompliance with study drug|0|||
127635529|NCT02952924|459287149|FG012|Overall Study|Noncompliance with study drug|0|||
127635530|NCT02952924|459287150|FG013|Overall Study|Noncompliance with study drug|0|||
127635531|NCT02952924|459287151|FG014|Overall Study|Noncompliance with study drug|0|||
127635532|NCT02952924|459287152|FG015|Overall Study|Noncompliance with study drug|0|||
127635533|NCT02952924|459287153|FG016|Overall Study|Noncompliance with study drug|0|||
127635534|NCT02952924|459287154|FG017|Overall Study|Noncompliance with study drug|0|||
127635535|NCT02952924|459287155|FG018|Overall Study|Noncompliance with study drug|0|||
127635536|NCT02952924|459287156|FG019|Overall Study|Noncompliance with study drug|0|||
127635537|NCT02952924|459287157|FG020|Overall Study|Noncompliance with study drug|0|||
127635538|NCT02952924|459287158|FG021|Overall Study|Noncompliance with study drug|1|||
127635539|NCT02105948|459287165|FG000|Overall Study|Adverse Event|10|||
127635540|NCT02105948|459287166|FG001|Overall Study|Adverse Event|7|||
127635541|NCT02105948|459287167|FG002|Overall Study|Adverse Event|11|||
127635542|NCT02105948|459287168|FG003|Overall Study|Adverse Event|11|||
127635543|NCT02105948|459287165|FG000|Overall Study|Lack of Efficacy|0|||
127635544|NCT02105948|459287166|FG001|Overall Study|Lack of Efficacy|1|||
127635545|NCT02105948|459287167|FG002|Overall Study|Lack of Efficacy|3|||
127635546|NCT02105948|459287168|FG003|Overall Study|Lack of Efficacy|2|||
127635547|NCT02105948|459287165|FG000|Overall Study|Lost to Follow-up|0|||
127635548|NCT02105948|459287166|FG001|Overall Study|Lost to Follow-up|0|||
127635549|NCT02105948|459287167|FG002|Overall Study|Lost to Follow-up|2|||
127635550|NCT02105948|459287168|FG003|Overall Study|Lost to Follow-up|1|||
127635551|NCT02105948|459287165|FG000|Overall Study|Physician Decision|2|||
127635552|NCT02105948|459287166|FG001|Overall Study|Physician Decision|2|||
127635553|NCT02105948|459287167|FG002|Overall Study|Physician Decision|2|||
127635554|NCT02105948|459287168|FG003|Overall Study|Physician Decision|2|||
127635555|NCT02105948|459287165|FG000|Overall Study|Withdrawal by Subject|15|||
127635556|NCT02105948|459287166|FG001|Overall Study|Withdrawal by Subject|10|||
127635557|NCT02105948|459287167|FG002|Overall Study|Withdrawal by Subject|10|||
127635558|NCT02105948|459287168|FG003|Overall Study|Withdrawal by Subject|11|||
127635559|NCT01934218|459287170|FG000|Double-blind Phase|Adverse Event|8|||
127635560|NCT01934218|459287171|FG001|Double-blind Phase|Adverse Event|8|||
127635561|NCT01934218|459287170|FG000|Double-blind Phase|Lack of Efficacy|6|||
127635562|NCT01934218|459287171|FG001|Double-blind Phase|Lack of Efficacy|7|||
127635563|NCT01934218|459287170|FG000|Double-blind Phase|Lost to Follow-up|7|||
127635564|NCT01934218|459287171|FG001|Double-blind Phase|Lost to Follow-up|14|||
127703046|NCT02815566|459542570|FG001|Overall Study|Adverse Event|1|||
127635565|NCT01934218|459287170|FG000|Double-blind Phase|Physician Decision|1|||
127635566|NCT01934218|459287171|FG001|Double-blind Phase|Physician Decision|2|||
127635567|NCT01934218|459287170|FG000|Double-blind Phase|Protocol Violation|4|||
127703047|NCT02815566|459542569|FG000|Overall Study|Withdrawal by Subject|1|||
127635568|NCT01934218|459287171|FG001|Double-blind Phase|Protocol Violation|0|||
127635569|NCT01934218|459287170|FG000|Double-blind Phase|Withdrawal by Subject|16|||
127635570|NCT01934218|459287171|FG001|Double-blind Phase|Withdrawal by Subject|13|||
127703048|NCT02815566|459542570|FG001|Overall Study|Withdrawal by Subject|0|||
127885684|NCT00736099|460205249|FG001|Overall Study|Protocol Violation|4|||
127885685|NCT00736099|460205248|FG000|Overall Study|Lost to Follow-up|12|||
127796367|NCT01926782|459877747|FG003|Overall Study|Randomized and not treated|1|||
127796368|NCT01926782|459877748|FG004|Overall Study|Randomized and not treated|0|||
127796369|NCT01926782|459877749|FG005|Overall Study|Randomized and not treated|0|||
127796370|NCT01926782|459877744|FG000|Overall Study|Withdrawal by Subject|6|||
127796371|NCT01926782|459877745|FG001|Overall Study|Withdrawal by Subject|1|||
127796372|NCT01926782|459877746|FG002|Overall Study|Withdrawal by Subject|8|||
127796373|NCT01926782|459877747|FG003|Overall Study|Withdrawal by Subject|1|||
127796374|NCT01926782|459877748|FG004|Overall Study|Withdrawal by Subject|0|||
127796375|NCT01926782|459877749|FG005|Overall Study|Withdrawal by Subject|5|||
127796376|NCT01926782|459877744|FG000|Overall Study|Related to study drug administration|0|||
127796377|NCT01926782|459877745|FG001|Overall Study|Related to study drug administration|0|||
127796378|NCT01926782|459877746|FG002|Overall Study|Related to study drug administration|0|||
127796379|NCT01926782|459877747|FG003|Overall Study|Related to study drug administration|0|||
127796380|NCT01926782|459877748|FG004|Overall Study|Related to study drug administration|0|||
127796381|NCT01926782|459877749|FG005|Overall Study|Related to study drug administration|2|||
127796382|NCT00430508|459877752|FG000|Overall Study|Adverse Event|2|||
127796383|NCT00430508|459877753|FG001|Overall Study|Adverse Event|3|||
127796384|NCT00430508|459877754|FG002|Overall Study|Adverse Event|5|||
127796385|NCT00430508|459877755|FG003|Overall Study|Adverse Event|3|||
127796386|NCT00430508|459877752|FG000|Overall Study|Withdrawal by Subject|0|||
127796387|NCT00430508|459877753|FG001|Overall Study|Withdrawal by Subject|1|||
127796388|NCT00430508|459877754|FG002|Overall Study|Withdrawal by Subject|1|||
127796389|NCT00430508|459877755|FG003|Overall Study|Withdrawal by Subject|1|||
127796390|NCT00430508|459877752|FG000|Overall Study|responder at visit 4|0|||
127796391|NCT00430508|459877753|FG001|Overall Study|responder at visit 4|0|||
127796392|NCT00430508|459877754|FG002|Overall Study|responder at visit 4|2|||
127796393|NCT00430508|459877755|FG003|Overall Study|responder at visit 4|0|||
127796394|NCT00430508|459877752|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
127796395|NCT00430508|459877753|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
127796396|NCT00430508|459877754|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
127796397|NCT00430508|459877755|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
127796398|NCT00430508|459877752|FG000|Overall Study|Other|1|||
127796399|NCT00430508|459877753|FG001|Overall Study|Other|1|||
127796400|NCT00430508|459877754|FG002|Overall Study|Other|3|||
127796401|NCT00430508|459877755|FG003|Overall Study|Other|0|||
127796402|NCT04673786|459877760|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
127796403|NCT04673786|459877761|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
127635571|NCT01934218|459287170|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
127796404|NCT04673786|459877762|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
127796405|NCT04673786|459877760|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
127796406|NCT04673786|459877761|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
127796407|NCT04673786|459877762|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
127796408|NCT04673786|459877760|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
127796409|NCT04673786|459877761|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
127796410|NCT04673786|459877762|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
127796411|NCT04673786|459877760|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
127796412|NCT04673786|459877761|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
127796413|NCT04673786|459877762|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
127796414|NCT04673786|459877760|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
127635572|NCT01934218|459287171|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
127635573|NCT01934218|459287170|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
127635574|NCT01934218|459287171|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
127635575|NCT01934218|459287170|FG000|Open-Label Phase|Adverse Event|2|||
127635576|NCT01934218|459287171|FG001|Open-Label Phase|Adverse Event|4|||
127635577|NCT01934218|459287170|FG000|Open-Label Phase|Lack of Efficacy|1|||
127635578|NCT01934218|459287171|FG001|Open-Label Phase|Lack of Efficacy|4|||
127635579|NCT01934218|459287170|FG000|Open-Label Phase|Lost to Follow-up|4|||
127635580|NCT01934218|459287171|FG001|Open-Label Phase|Lost to Follow-up|2|||
127635581|NCT01934218|459287170|FG000|Open-Label Phase|Physician Decision|1|||
127635582|NCT01934218|459287171|FG001|Open-Label Phase|Physician Decision|0|||
127635583|NCT01934218|459287170|FG000|Open-Label Phase|Protocol Violation|1|||
127635584|NCT01934218|459287171|FG001|Open-Label Phase|Protocol Violation|0|||
127635585|NCT01934218|459287170|FG000|Open-Label Phase|Withdrawal by Subject|13|||
127635586|NCT01934218|459287171|FG001|Open-Label Phase|Withdrawal by Subject|11|||
127635587|NCT01934218|459287170|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
127635588|NCT01934218|459287171|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
127635589|NCT01934218|459287170|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
127635590|NCT01934218|459287171|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
127635591|NCT02232893|459287172|FG000|Overall Study|Withdrawal by Subject|4|||
127635592|NCT02232893|459287173|FG001|Overall Study|Withdrawal by Subject|1|||
127635593|NCT02232893|459287172|FG000|Overall Study|Adverse Event|0|||
127635594|NCT02232893|459287173|FG001|Overall Study|Adverse Event|1|||
127635595|NCT02232893|459287172|FG000|Overall Study|Sponsor request early termination|0|||
127635596|NCT02232893|459287173|FG001|Overall Study|Sponsor request early termination|1|||
127635597|NCT02232893|459287172|FG000|Overall Study|Developed exclusion criteria|0|||
127635598|NCT02232893|459287173|FG001|Overall Study|Developed exclusion criteria|1|||
127635599|NCT02232893|459287172|FG000|Overall Study|Other|0|||
127635600|NCT02232893|459287173|FG001|Overall Study|Other|3|||
127635601|NCT01587651|459287177|FG000|Overall Study|Adverse Event|0|||
127635602|NCT01587651|459287178|FG001|Overall Study|Adverse Event|1|||
127635603|NCT01587651|459287179|FG002|Overall Study|Adverse Event|0|||
127635604|NCT01587651|459287177|FG000|Overall Study|Protocol Violation|0|||
127635605|NCT01587651|459287178|FG001|Overall Study|Protocol Violation|1|||
127635606|NCT01587651|459287179|FG002|Overall Study|Protocol Violation|1|||
127635607|NCT01587651|459287177|FG000|Overall Study|Withdrawal by Subject|0|||
127635608|NCT01587651|459287178|FG001|Overall Study|Withdrawal by Subject|1|||
127635609|NCT01587651|459287179|FG002|Overall Study|Withdrawal by Subject|0|||
127635610|NCT04323436|459287180|FG000|Overall Study|Adverse Event|7|||
127635611|NCT04323436|459287181|FG001|Overall Study|Adverse Event|0|||
127635612|NCT04323436|459287182|FG002|Overall Study|Adverse Event|0|||
127635613|NCT04323436|459287180|FG000|Overall Study|Transfer to another clinical study or to other alternative treatment option|8|||
127635614|NCT04323436|459287181|FG001|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
127635615|NCT04323436|459287182|FG002|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
127635616|NCT04323436|459287180|FG000|Overall Study|Death|1|||
127635617|NCT04323436|459287181|FG001|Overall Study|Death|0|||
127635618|NCT04323436|459287182|FG002|Overall Study|Death|0|||
127635619|NCT04323436|459287180|FG000|Overall Study|Physician Decision|2|||
127635620|NCT04323436|459287181|FG001|Overall Study|Physician Decision|0|||
127635621|NCT04323436|459287182|FG002|Overall Study|Physician Decision|0|||
127635622|NCT04323436|459287180|FG000|Overall Study|Progressive disease|10|||
127635623|NCT04323436|459287181|FG001|Overall Study|Progressive disease|0|||
127635624|NCT04323436|459287182|FG002|Overall Study|Progressive disease|0|||
127635625|NCT04323436|459287180|FG000|Overall Study|Subject decision|3|||
127635626|NCT04323436|459287181|FG001|Overall Study|Subject decision|0|||
127635627|NCT04323436|459287182|FG002|Overall Study|Subject decision|0|||
127635628|NCT01660763|459287186|FG000|Overall Study|Lack of Efficacy|45|||
127635629|NCT01660763|459287187|FG001|Overall Study|Lack of Efficacy|50|||
127635630|NCT01660763|459287186|FG000|Overall Study|Adverse Event|22|||
127635631|NCT01660763|459287187|FG001|Overall Study|Adverse Event|7|||
127635632|NCT01660763|459287186|FG000|Overall Study|Protocol Violation|1|||
127635633|NCT01660763|459287187|FG001|Overall Study|Protocol Violation|0|||
127635634|NCT01660763|459287186|FG000|Overall Study|Withdrawal by Subject|4|||
127635635|NCT01660763|459287187|FG001|Overall Study|Withdrawal by Subject|0|||
127635636|NCT01660763|459287186|FG000|Overall Study|Patient ready for early discharge|28|||
127635637|NCT01660763|459287187|FG001|Overall Study|Patient ready for early discharge|4|||
127635638|NCT03325712|459287188|FG000|Overall Study|Protocol Violation|0|||
127635639|NCT03325712|459287189|FG001|Overall Study|Protocol Violation|0|||
127635640|NCT03325712|459287190|FG002|Overall Study|Protocol Violation|0|||
127635641|NCT03325712|459287191|FG003|Overall Study|Protocol Violation|0|||
127635642|NCT03325712|459287192|FG004|Overall Study|Protocol Violation|1|||
127635643|NCT03325712|459287193|FG005|Overall Study|Protocol Violation|0|||
127635644|NCT03325712|459287194|FG006|Overall Study|Protocol Violation|0|||
127635645|NCT03325712|459287195|FG007|Overall Study|Protocol Violation|0|||
127635646|NCT03325712|459287188|FG000|Overall Study|Adverse Event|0|||
127635647|NCT03325712|459287189|FG001|Overall Study|Adverse Event|0|||
127635648|NCT03325712|459287190|FG002|Overall Study|Adverse Event|0|||
127635649|NCT03325712|459287191|FG003|Overall Study|Adverse Event|0|||
127635650|NCT03325712|459287192|FG004|Overall Study|Adverse Event|1|||
127635651|NCT03325712|459287193|FG005|Overall Study|Adverse Event|0|||
127635652|NCT03325712|459287194|FG006|Overall Study|Adverse Event|0|||
127635653|NCT03325712|459287195|FG007|Overall Study|Adverse Event|0|||
127635654|NCT02265237|459287197|FG000|As Treated (Overall Study)|Adverse Event|1|||
127635655|NCT02265237|459287198|FG001|As Treated (Overall Study)|Adverse Event|1|||
127635656|NCT02265237|459287199|FG002|As Treated (Overall Study)|Adverse Event|0|||
127635657|NCT02265237|459287200|FG003|As Treated (Overall Study)|Adverse Event|0|||
127635658|NCT02265237|459287197|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
127635659|NCT02265237|459287198|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
127635660|NCT02265237|459287199|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
127635661|NCT02265237|459287200|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
127635662|NCT02265237|459287197|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
127635663|NCT02265237|459287198|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
127635664|NCT02265237|459287199|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
127635665|NCT02265237|459287200|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
127635666|NCT02265237|459287197|FG000|As Treated (Overall Study)|Other|2|||
127635667|NCT02265237|459287198|FG001|As Treated (Overall Study)|Other|0|||
127635668|NCT02265237|459287199|FG002|As Treated (Overall Study)|Other|3|||
127635669|NCT02265237|459287200|FG003|As Treated (Overall Study)|Other|1|||
127635670|NCT01178853|459287202|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
127635671|NCT01178853|459287203|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
127635672|NCT01178853|459287202|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
127635673|NCT01178853|459287203|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
127635674|NCT01178853|459287202|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
127635675|NCT01178853|459287203|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
127635676|NCT01178853|459287202|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
127635677|NCT01178853|459287203|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
127635678|NCT01178853|459287202|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
127635679|NCT01178853|459287203|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
127635680|NCT03550313|459287204|FG000|Overall Study|Adverse Event|0|||
127635681|NCT03550313|459287205|FG001|Overall Study|Adverse Event|1|||
127635682|NCT03550313|459287206|FG002|Overall Study|Adverse Event|0|||
127635683|NCT03550313|459287204|FG000|Overall Study|Lost to Follow-up|5|||
127635684|NCT03550313|459287205|FG001|Overall Study|Lost to Follow-up|7|||
127635685|NCT03550313|459287206|FG002|Overall Study|Lost to Follow-up|12|||
127635686|NCT03550313|459287204|FG000|Overall Study|Study terminated by sponsor|44|||
127635687|NCT03550313|459287205|FG001|Overall Study|Study terminated by sponsor|37|||
127635688|NCT03550313|459287206|FG002|Overall Study|Study terminated by sponsor|48|||
127635689|NCT03550313|459287204|FG000|Overall Study|No longer met eligibility criteria|3|||
127635690|NCT03550313|459287205|FG001|Overall Study|No longer met eligibility criteria|5|||
127635691|NCT03550313|459287206|FG002|Overall Study|No longer met eligibility criteria|6|||
127635692|NCT03550313|459287204|FG000|Overall Study|Withdrawal by parent/guardian|20|||
127635693|NCT03550313|459287205|FG001|Overall Study|Withdrawal by parent/guardian|18|||
127635694|NCT03550313|459287206|FG002|Overall Study|Withdrawal by parent/guardian|26|||
127635695|NCT03550313|459287204|FG000|Overall Study|Other|4|||
127635696|NCT03550313|459287205|FG001|Overall Study|Other|2|||
127635697|NCT03550313|459287206|FG002|Overall Study|Other|2|||
127635698|NCT03550313|459287204|FG000|Overall Study|Randomized but not vaccinated|3|||
127635699|NCT03550313|459287205|FG001|Overall Study|Randomized but not vaccinated|23|||
127635700|NCT03550313|459287206|FG002|Overall Study|Randomized but not vaccinated|2|||
127635701|NCT03550313|459287204|FG000|Overall Study|Sites terminated due to quality issues|18|||
127635702|NCT03550313|459287205|FG001|Overall Study|Sites terminated due to quality issues|17|||
127635703|NCT03550313|459287206|FG002|Overall Study|Sites terminated due to quality issues|18|||
127635704|NCT00839072|459287207|FG000|First Intervention Period|Withdrawal by Subject|1|||
127635705|NCT00839072|459287208|FG001|First Intervention Period|Withdrawal by Subject|0|||
127635706|NCT00839072|459287207|FG000|First Intervention Period|Adverse Event|1|||
127635707|NCT00839072|459287208|FG001|First Intervention Period|Adverse Event|1|||
127635708|NCT00839072|459287207|FG000|Second Intervention Period|Withdrawal by Subject|1|||
127635709|NCT00839072|459287208|FG001|Second Intervention Period|Withdrawal by Subject|0|||
127635710|NCT00380068|459287210|FG000|Overall Study|Adverse Event|40|||
127635711|NCT00380068|459287210|FG000|Overall Study|Withdrawal by Subject|10|||
127635712|NCT00380068|459287210|FG000|Overall Study|Not compliant|6|||
127635713|NCT00380068|459287210|FG000|Overall Study|Lost to Follow-up|1|||
127703049|NCT02815566|459542569|FG000|Overall Study|Lost to Follow-up|0|||
127703050|NCT02815566|459542570|FG001|Overall Study|Lost to Follow-up|1|||
127703051|NCT04032704|459542573|FG000|Part A|Withdrawal by Subject|0|||
127703052|NCT04032704|459542574|FG001|Part A|Withdrawal by Subject|0|||
127703053|NCT04032704|459542575|FG002|Part A|Withdrawal by Subject|3|||
127703054|NCT04032704|459542576|FG003|Part A|Withdrawal by Subject|0|||
127703055|NCT04032704|459542577|FG004|Part A|Withdrawal by Subject|1|||
127703056|NCT04032704|459542578|FG005|Part A|Withdrawal by Subject|7|||
127703057|NCT04032704|459542579|FG006|Part A|Withdrawal by Subject|0|||
127703058|NCT04032704|459542580|FG007|Part A|Withdrawal by Subject|0|||
127703059|NCT04032704|459542581|FG008|Part A|Withdrawal by Subject|0|||
127703060|NCT04032704|459542582|FG009|Part A|Withdrawal by Subject|0|||
127703061|NCT04032704|459542583|FG010|Part A|Withdrawal by Subject|0|||
127703062|NCT04032704|459542584|FG011|Part A|Withdrawal by Subject|0|||
127703063|NCT04032704|459542585|FG012|Part A|Withdrawal by Subject|0|||
127703064|NCT04032704|459542586|FG013|Part A|Withdrawal by Subject|0|||
127703065|NCT04032704|459542587|FG014|Part A|Withdrawal by Subject|0|||
127635714|NCT00380068|459287210|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
127635715|NCT00380068|459287210|FG000|Overall Study|Lung transplant|3|||
127635716|NCT00380068|459287210|FG000|Overall Study|Physician Decision|2|||
127635717|NCT00380068|459287210|FG000|Overall Study|Partipant moved away|1|||
127635718|NCT00380068|459287210|FG000|Overall Study|Lack of Efficacy|5|||
127635719|NCT01297062|459287211|FG000|Overall Study|Adverse Event|2|||
127635720|NCT01297062|459287212|FG001|Overall Study|Adverse Event|0|||
127635721|NCT01297062|459287213|FG002|Overall Study|Adverse Event|1|||
127635722|NCT01297062|459287214|FG003|Overall Study|Adverse Event|0|||
127635723|NCT01297062|459287215|FG004|Overall Study|Adverse Event|0|||
127635724|NCT01297062|459287216|FG005|Overall Study|Adverse Event|0|||
127635725|NCT01297062|459287217|FG006|Overall Study|Adverse Event|0|||
127635726|NCT01297062|459287211|FG000|Overall Study|Physician Decision|1|||
127635727|NCT01297062|459287212|FG001|Overall Study|Physician Decision|0|||
127635728|NCT01297062|459287213|FG002|Overall Study|Physician Decision|1|||
127635729|NCT01297062|459287214|FG003|Overall Study|Physician Decision|0|||
127635730|NCT01297062|459287215|FG004|Overall Study|Physician Decision|0|||
127635731|NCT01297062|459287216|FG005|Overall Study|Physician Decision|0|||
127635732|NCT01297062|459287217|FG006|Overall Study|Physician Decision|6|||
127635733|NCT01297062|459287211|FG000|Overall Study|Protocol Violation|0|||
127796415|NCT04673786|459877761|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
127796416|NCT04673786|459877762|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
127796417|NCT04673786|459877760|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
127796418|NCT04673786|459877761|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
127796419|NCT04673786|459877762|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
127635734|NCT01297062|459287212|FG001|Overall Study|Protocol Violation|0|||
127635735|NCT01297062|459287213|FG002|Overall Study|Protocol Violation|0|||
127635736|NCT01297062|459287214|FG003|Overall Study|Protocol Violation|0|||
127635737|NCT01297062|459287215|FG004|Overall Study|Protocol Violation|1|||
127635738|NCT01297062|459287216|FG005|Overall Study|Protocol Violation|0|||
127635739|NCT01297062|459287217|FG006|Overall Study|Protocol Violation|0|||
127796420|NCT01422239|459877763|FG000|Overall Study|Lost to Follow-up|4|||
127635740|NCT01297062|459287211|FG000|Overall Study|Subject Decision|1|||
127796421|NCT01422239|459877764|FG001|Overall Study|Lost to Follow-up|3|||
127796422|NCT00720109|459877765|FG000|Induction Period|Did not meet eligibility criteria|3|||
127635741|NCT01297062|459287212|FG001|Overall Study|Subject Decision|1|||
127635742|NCT01297062|459287213|FG002|Overall Study|Subject Decision|0|||
127635743|NCT01297062|459287214|FG003|Overall Study|Subject Decision|1|||
127635744|NCT01297062|459287215|FG004|Overall Study|Subject Decision|1|||
127635745|NCT01297062|459287216|FG005|Overall Study|Subject Decision|1|||
127635746|NCT01297062|459287217|FG006|Overall Study|Subject Decision|2|||
127635747|NCT01458574|459287218|FG000|Overall Study|Adverse Event|5|||
127796423|NCT00720109|459877766|FG001|Induction Period|Did not meet eligibility criteria|0|||
127635748|NCT01458574|459287219|FG001|Overall Study|Adverse Event|9|||
127635749|NCT01458574|459287220|FG002|Overall Study|Adverse Event|7|||
127635750|NCT01458574|459287218|FG000|Overall Study|Lack of Efficacy|70|||
127635751|NCT01458574|459287219|FG001|Overall Study|Lack of Efficacy|53|||
127796424|NCT00720109|459877767|FG002|Induction Period|Did not meet eligibility criteria|0|||
127796425|NCT00720109|459877765|FG000|Induction Period|Bone Marrow Transplant|2|||
127796426|NCT00720109|459877766|FG001|Induction Period|Bone Marrow Transplant|0|||
127796427|NCT00720109|459877767|FG002|Induction Period|Bone Marrow Transplant|0|||
127796428|NCT00720109|459877765|FG000|Induction Period|Physician Decision|1|||
127796429|NCT00720109|459877766|FG001|Induction Period|Physician Decision|0|||
127796430|NCT00720109|459877767|FG002|Induction Period|Physician Decision|0|||
127796431|NCT00720109|459877765|FG000|Risk Stratification Period|Adverse Event|0|||
127796432|NCT00720109|459877766|FG001|Risk Stratification Period|Adverse Event|1|||
127796433|NCT00720109|459877767|FG002|Risk Stratification Period|Adverse Event|0|||
127796434|NCT00720109|459877765|FG000|Risk Stratification Period|Physician Decision|0|||
127796435|NCT00720109|459877766|FG001|Risk Stratification Period|Physician Decision|2|||
127796436|NCT00720109|459877767|FG002|Risk Stratification Period|Physician Decision|1|||
127796437|NCT00720109|459877765|FG000|Risk Stratification Period|Bone marrow transplant|0|||
127796438|NCT00720109|459877766|FG001|Risk Stratification Period|Bone marrow transplant|9|||
127796439|NCT00720109|459877767|FG002|Risk Stratification Period|Bone marrow transplant|7|||
127796440|NCT00720109|459877765|FG000|Risk Stratification Period|Disease progression or relapse|0|||
127796441|NCT00720109|459877766|FG001|Risk Stratification Period|Disease progression or relapse|2|||
127796442|NCT00720109|459877767|FG002|Risk Stratification Period|Disease progression or relapse|0|||
127796443|NCT00720109|459877765|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
127796444|NCT00720109|459877766|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
127885686|NCT00736099|460205249|FG001|Overall Study|Lost to Follow-up|5|||
127885687|NCT00736099|460205248|FG000|Overall Study|Withdrawal by Subject|42|||
127635752|NCT01458574|459287220|FG002|Overall Study|Lack of Efficacy|132|||
127635753|NCT01458574|459287218|FG000|Overall Study|Lost to Follow-up|3|||
127635754|NCT01458574|459287219|FG001|Overall Study|Lost to Follow-up|2|||
127635755|NCT01458574|459287220|FG002|Overall Study|Lost to Follow-up|1|||
127635756|NCT01458574|459287218|FG000|Overall Study|Pregnancy|1|||
127635757|NCT01458574|459287219|FG001|Overall Study|Pregnancy|1|||
127635758|NCT01458574|459287220|FG002|Overall Study|Pregnancy|0|||
127635759|NCT01458574|459287218|FG000|Overall Study|Protocol Violation|0|||
127635760|NCT01458574|459287219|FG001|Overall Study|Protocol Violation|1|||
127635761|NCT01458574|459287220|FG002|Overall Study|Protocol Violation|0|||
127635762|NCT01458574|459287218|FG000|Overall Study|Withdrawal by Subject|6|||
127635763|NCT01458574|459287219|FG001|Overall Study|Withdrawal by Subject|3|||
127635764|NCT01458574|459287220|FG002|Overall Study|Withdrawal by Subject|5|||
127635765|NCT01458574|459287218|FG000|Overall Study|Other|2|||
127635766|NCT01458574|459287219|FG001|Overall Study|Other|1|||
127635767|NCT01458574|459287220|FG002|Overall Study|Other|0|||
127635768|NCT01458574|459287218|FG000|Overall Study|Randomized but not treated|0|||
127635769|NCT01458574|459287219|FG001|Overall Study|Randomized but not treated|1|||
127635770|NCT01458574|459287220|FG002|Overall Study|Randomized but not treated|0|||
127635771|NCT02125786|459287221|FG000|Overall Study|Still in Follow-up|3|||
127635772|NCT02125786|459287221|FG000|Overall Study|Screen Failure|2|||
127635773|NCT02125786|459287221|FG000|Overall Study|Withdrawal by Family before Start of RT|2|||
127635774|NCT02125786|459287221|FG000|Overall Study|Progressive Disease|44|||
127635775|NCT02125786|459287221|FG000|Overall Study|Death|8|||
127635776|NCT04964089|459287222|FG000|Overall Study|Adverse Event|8|||
127635777|NCT04964089|459287223|FG001|Overall Study|Adverse Event|6|||
127635778|NCT04964089|459287222|FG000|Overall Study|Non-compliance with study schedule|1|||
127635779|NCT04964089|459287223|FG001|Overall Study|Non-compliance with study schedule|0|||
127635780|NCT04964089|459287222|FG000|Overall Study|Withdrawal by Subject|6|||
127796445|NCT00720109|459877767|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
127796446|NCT00903929|459877768|FG000|Overall Study|Withdrawal by Subject|0|||
127796447|NCT00903929|459877769|FG001|Overall Study|Withdrawal by Subject|0|||
127796448|NCT00903929|459877770|FG002|Overall Study|Withdrawal by Subject|1|||
127796449|NCT00903929|459877771|FG003|Overall Study|Withdrawal by Subject|2|||
127796450|NCT00903929|459877768|FG000|Overall Study|Adverse Event|0|||
127796451|NCT00903929|459877769|FG001|Overall Study|Adverse Event|0|||
127796452|NCT00903929|459877770|FG002|Overall Study|Adverse Event|0|||
127796453|NCT00903929|459877771|FG003|Overall Study|Adverse Event|1|||
127796454|NCT00512798|459877774|FG000|Overall Study|Death|0|||
127635781|NCT04964089|459287223|FG001|Overall Study|Withdrawal by Subject|5|||
127635782|NCT04964089|459287222|FG000|Overall Study|Lost to Follow-up|1|||
127635783|NCT04964089|459287223|FG001|Overall Study|Lost to Follow-up|1|||
127635784|NCT04964089|459287222|FG000|Overall Study|Progressive disease|4|||
127635785|NCT04964089|459287223|FG001|Overall Study|Progressive disease|0|||
127635786|NCT04964089|459287222|FG000|Overall Study|Physician Decision|1|||
127635787|NCT04964089|459287223|FG001|Overall Study|Physician Decision|0|||
127796455|NCT00512798|459877775|FG001|Overall Study|Death|3|||
127796456|NCT00512798|459877774|FG000|Overall Study|Adverse Event|2|||
127796457|NCT00512798|459877775|FG001|Overall Study|Adverse Event|4|||
127635788|NCT04964089|459287222|FG000|Overall Study|Participant did not want to continue study treatment|1|||
127635789|NCT04964089|459287223|FG001|Overall Study|Participant did not want to continue study treatment|0|||
127796458|NCT00512798|459877774|FG000|Overall Study|Progression of disease|14|||
127796459|NCT00512798|459877775|FG001|Overall Study|Progression of disease|20|||
127796460|NCT00512798|459877774|FG000|Overall Study|Withdrawal by Subject|3|||
127796461|NCT00512798|459877775|FG001|Overall Study|Withdrawal by Subject|0|||
127796462|NCT01358864|459877785|FG000|Overall Study|Adverse Event|0|||
127796463|NCT01358864|459877786|FG001|Overall Study|Adverse Event|6|||
127796464|NCT01358864|459877787|FG002|Overall Study|Adverse Event|9|||
127796465|NCT01358864|459877788|FG003|Overall Study|Adverse Event|0|||
127796466|NCT01358864|459877789|FG004|Overall Study|Adverse Event|4|||
127796467|NCT01358864|459877790|FG005|Overall Study|Adverse Event|8|||
127796468|NCT01358864|459877791|FG006|Overall Study|Adverse Event|12|||
127796469|NCT01358864|459877792|FG007|Overall Study|Adverse Event|7|||
127796470|NCT01358864|459877785|FG000|Overall Study|Lack of Efficacy|26|||
127796471|NCT01358864|459877786|FG001|Overall Study|Lack of Efficacy|3|||
127796472|NCT01358864|459877787|FG002|Overall Study|Lack of Efficacy|4|||
127796473|NCT01358864|459877788|FG003|Overall Study|Lack of Efficacy|19|||
127796474|NCT01358864|459877789|FG004|Overall Study|Lack of Efficacy|7|||
127796475|NCT01358864|459877790|FG005|Overall Study|Lack of Efficacy|4|||
127796476|NCT01358864|459877791|FG006|Overall Study|Lack of Efficacy|49|||
127796477|NCT01358864|459877792|FG007|Overall Study|Lack of Efficacy|44|||
127796478|NCT01358864|459877785|FG000|Overall Study|Lost to Follow-up|0|||
127796479|NCT01358864|459877786|FG001|Overall Study|Lost to Follow-up|0|||
127796480|NCT01358864|459877787|FG002|Overall Study|Lost to Follow-up|1|||
127796481|NCT01358864|459877788|FG003|Overall Study|Lost to Follow-up|0|||
127796482|NCT01358864|459877789|FG004|Overall Study|Lost to Follow-up|0|||
127796483|NCT01358864|459877790|FG005|Overall Study|Lost to Follow-up|0|||
127796484|NCT01358864|459877791|FG006|Overall Study|Lost to Follow-up|0|||
127796485|NCT01358864|459877792|FG007|Overall Study|Lost to Follow-up|1|||
127796486|NCT01358864|459877785|FG000|Overall Study|Withdrawal by Subject|3|||
127796487|NCT01358864|459877786|FG001|Overall Study|Withdrawal by Subject|4|||
127796488|NCT01358864|459877787|FG002|Overall Study|Withdrawal by Subject|2|||
127796489|NCT01358864|459877788|FG003|Overall Study|Withdrawal by Subject|0|||
127635790|NCT04964089|459287222|FG000|Overall Study|Participant moved to different state|1|||
127635791|NCT04964089|459287223|FG001|Overall Study|Participant moved to different state|0|||
127635792|NCT04964089|459287222|FG000|Overall Study|Participant decided to discontinue|0|||
127635793|NCT04964089|459287223|FG001|Overall Study|Participant decided to discontinue|1|||
127635794|NCT01682837|459287224|FG000|Baseline|Withdrawal by Subject|5|||
127635795|NCT00724971|459287229|FG000|Overall Study|Adverse Event|5|||
127635796|NCT00724971|459287229|FG000|Overall Study|Withdrawal by Subject|1|||
127635797|NCT01692197|459287230|FG000|Overall Study|Failed Screening|3|||
127635798|NCT03086447|459287232|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
127635799|NCT03086447|459287233|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
127635800|NCT03086447|459287232|FG000|Overall Study|Lost Lens|2|||
127635801|NCT03086447|459287233|FG001|Overall Study|Lost Lens|5|||
127635802|NCT03086447|459287232|FG000|Overall Study|Product quality complaint|0|||
127635803|NCT03086447|459287233|FG001|Overall Study|Product quality complaint|1|||
127635804|NCT03086447|459287232|FG000|Overall Study|Lens Damage|1|||
127635805|NCT03086447|459287233|FG001|Overall Study|Lens Damage|6|||
127635806|NCT03086447|459287232|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
127635807|NCT03086447|459287233|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
127635808|NCT03086447|459287232|FG000|Overall Study|Test Article No Longer Available|1|||
127635809|NCT03086447|459287233|FG001|Overall Study|Test Article No Longer Available|0|||
127635810|NCT03086447|459287232|FG000|Overall Study|Protocol Violation|2|||
127635811|NCT03086447|459287233|FG001|Overall Study|Protocol Violation|4|||
127635812|NCT03086447|459287232|FG000|Overall Study|Lost to Follow-up|0|||
127635813|NCT03086447|459287233|FG001|Overall Study|Lost to Follow-up|1|||
127635814|NCT03086447|459287232|FG000|Overall Study|Adverse Event|3|||
127635815|NCT03086447|459287233|FG001|Overall Study|Adverse Event|0|||
127635816|NCT03086447|459287232|FG000|Overall Study|Lens Discomfort|2|||
127635817|NCT03086447|459287233|FG001|Overall Study|Lens Discomfort|1|||
127635818|NCT00659334|459287236|FG000|Overall Study|Screen Failure|8|||
127635819|NCT00659334|459287237|FG001|Overall Study|Screen Failure|5|||
127635820|NCT00659334|459287238|FG002|Overall Study|Screen Failure|0|||
127635821|NCT00659334|459287239|FG003|Overall Study|Screen Failure|0|||
127635822|NCT00659334|459287240|FG004|Overall Study|Screen Failure|0|||
127635823|NCT00659334|459287241|FG005|Overall Study|Screen Failure|0|||
127635824|NCT00659334|459287242|FG006|Overall Study|Screen Failure|1|||
127635825|NCT01218646|459287243|FG000|Overall Study|Adverse Event|0|||
127796490|NCT01358864|459877789|FG004|Overall Study|Withdrawal by Subject|0|||
127796491|NCT01358864|459877790|FG005|Overall Study|Withdrawal by Subject|1|||
127885688|NCT00736099|460205249|FG001|Overall Study|Withdrawal by Subject|13|||
127635826|NCT01218646|459287244|FG001|Overall Study|Adverse Event|0|||
127635827|NCT01218646|459287245|FG002|Overall Study|Adverse Event|1|||
127635828|NCT01218646|459287246|FG003|Overall Study|Adverse Event|0|||
127635829|NCT01218646|459287243|FG000|Overall Study|Lost to Follow-up|1|||
127635830|NCT01218646|459287244|FG001|Overall Study|Lost to Follow-up|0|||
127635831|NCT01218646|459287245|FG002|Overall Study|Lost to Follow-up|0|||
127635832|NCT01218646|459287246|FG003|Overall Study|Lost to Follow-up|0|||
127885689|NCT00736099|460205248|FG000|Overall Study|Lack of Efficacy|15|||
127885690|NCT00736099|460205249|FG001|Overall Study|Lack of Efficacy|8|||
127635833|NCT01218646|459287243|FG000|Overall Study|Protocol Violation|0|||
127635834|NCT01218646|459287244|FG001|Overall Study|Protocol Violation|0|||
127635835|NCT01218646|459287245|FG002|Overall Study|Protocol Violation|1|||
127796492|NCT01358864|459877791|FG006|Overall Study|Withdrawal by Subject|1|||
127796493|NCT01358864|459877792|FG007|Overall Study|Withdrawal by Subject|3|||
127796494|NCT01358864|459877785|FG000|Overall Study|Other reason not defined above|2|||
127885691|NCT00736099|460205248|FG000|Overall Study|Other reason|43|||
127796495|NCT01358864|459877786|FG001|Overall Study|Other reason not defined above|0|||
127796496|NCT01358864|459877787|FG002|Overall Study|Other reason not defined above|0|||
127796497|NCT01358864|459877788|FG003|Overall Study|Other reason not defined above|0|||
127796498|NCT01358864|459877789|FG004|Overall Study|Other reason not defined above|0|||
127796499|NCT01358864|459877790|FG005|Overall Study|Other reason not defined above|0|||
127796500|NCT01358864|459877791|FG006|Overall Study|Other reason not defined above|2|||
127796501|NCT01358864|459877792|FG007|Overall Study|Other reason not defined above|0|||
127796502|NCT01358864|459877785|FG000|Overall Study|Not treated|0|||
127796503|NCT01358864|459877786|FG001|Overall Study|Not treated|0|||
127796504|NCT01358864|459877787|FG002|Overall Study|Not treated|0|||
127796505|NCT01358864|459877788|FG003|Overall Study|Not treated|0|||
127796506|NCT01358864|459877789|FG004|Overall Study|Not treated|0|||
127796507|NCT01358864|459877790|FG005|Overall Study|Not treated|0|||
127796508|NCT01358864|459877791|FG006|Overall Study|Not treated|1|||
127796509|NCT01358864|459877792|FG007|Overall Study|Not treated|0|||
127796510|NCT04158648|459877800|FG000|Overall Study|Ongoing in the Study|69|||
127796511|NCT04158648|459877800|FG000|Overall Study|Withdrawal by Subject|4|||
127796512|NCT04209855|459877801|FG000|Overall Study|Death|161|||
127796513|NCT04209855|459877802|FG001|Overall Study|Death|177|||
127635836|NCT01218646|459287246|FG003|Overall Study|Protocol Violation|1|||
127635837|NCT05437510|459287249|FG000|Overall Study|Adverse Event|1|||
127635838|NCT05437510|459287250|FG001|Overall Study|Adverse Event|1|||
127635839|NCT05437510|459287249|FG000|Overall Study|Protocol Deviation|1|||
127635840|NCT05437510|459287250|FG001|Overall Study|Protocol Deviation|6|||
127635841|NCT05437510|459287249|FG000|Overall Study|Withdrawal by Parent/Guardian|23|||
127635842|NCT05437510|459287250|FG001|Overall Study|Withdrawal by Parent/Guardian|22|||
127635843|NCT05437510|459287249|FG000|Overall Study|Lost to Follow-up|219|||
127635844|NCT05437510|459287250|FG001|Overall Study|Lost to Follow-up|289|||
127635845|NCT05437510|459287249|FG000|Overall Study|Ongoing in the Study Extension|1387|||
127635846|NCT05437510|459287250|FG001|Overall Study|Ongoing in the Study Extension|1352|||
127635847|NCT00896168|459289315|FG000|Overall Study|Adverse Event|4|||
127635848|NCT00896168|459289316|FG001|Overall Study|Adverse Event|7|||
127635849|NCT00896168|459289315|FG000|Overall Study|Treatment failure|8|||
127635850|NCT00896168|459289316|FG001|Overall Study|Treatment failure|10|||
127635851|NCT00896168|459289315|FG000|Overall Study|Lost to Follow-up|1|||
127635852|NCT00896168|459289316|FG001|Overall Study|Lost to Follow-up|1|||
127635853|NCT00896168|459289315|FG000|Overall Study|Other|1|||
127635854|NCT00896168|459289316|FG001|Overall Study|Other|1|||
127635855|NCT02492100|459289317|FG000|Overall Study|Death|1|||
127635856|NCT02332720|459289318|FG000|Part A and Part B|Lost to Follow-up|1|||
127635857|NCT02332720|459289319|FG001|Part A and Part B|Lost to Follow-up|0|||
127635858|NCT02332720|459289320|FG002|Part A and Part B|Lost to Follow-up|0|||
127635859|NCT02332720|459289321|FG003|Part A and Part B|Lost to Follow-up|0|||
127635860|NCT02332720|459289322|FG004|Part A and Part B|Lost to Follow-up|0|||
127635861|NCT02332720|459289323|FG005|Part A and Part B|Lost to Follow-up|2|||
127635862|NCT02332720|459289324|FG006|Part A and Part B|Lost to Follow-up|1|||
127635863|NCT02332720|459289325|FG007|Part A and Part B|Lost to Follow-up|1|||
127635864|NCT02332720|459289326|FG008|Part A and Part B|Lost to Follow-up|0|||
127635865|NCT02332720|459289327|FG009|Part A and Part B|Lost to Follow-up|0|||
127635866|NCT02332720|459289328|FG010|Part A and Part B|Lost to Follow-up|0|||
127635867|NCT02332720|459289329|FG011|Part A and Part B|Lost to Follow-up|0|||
127635868|NCT02332720|459289330|FG012|Part A and Part B|Lost to Follow-up|0|||
127635869|NCT02332720|459289331|FG013|Part A and Part B|Lost to Follow-up|0|||
127635870|NCT02332720|459289332|FG014|Part A and Part B|Lost to Follow-up|0|||
127635871|NCT02332720|459289333|FG015|Part A and Part B|Lost to Follow-up|1|||
127635872|NCT02332720|459289334|FG016|Part A and Part B|Lost to Follow-up|0|||
127635873|NCT02332720|459289335|FG017|Part A and Part B|Lost to Follow-up|0|||
127635874|NCT02332720|459289336|FG018|Part A and Part B|Lost to Follow-up|0|||
127635875|NCT02332720|459289337|FG019|Part A and Part B|Lost to Follow-up|0|||
127635876|NCT02332720|459289338|FG020|Part A and Part B|Lost to Follow-up|0|||
127635877|NCT02332720|459289339|FG021|Part A and Part B|Lost to Follow-up|0|||
127635878|NCT02332720|459289340|FG022|Part A and Part B|Lost to Follow-up|0|||
127635879|NCT02332720|459289318|FG000|Part A and Part B|Adverse Event|0|||
127635880|NCT02332720|459289319|FG001|Part A and Part B|Adverse Event|0|||
127635881|NCT02332720|459289320|FG002|Part A and Part B|Adverse Event|0|||
127635882|NCT02332720|459289321|FG003|Part A and Part B|Adverse Event|0|||
127635883|NCT02332720|459289322|FG004|Part A and Part B|Adverse Event|0|||
127635884|NCT02332720|459289323|FG005|Part A and Part B|Adverse Event|0|||
127635885|NCT02332720|459289324|FG006|Part A and Part B|Adverse Event|0|||
127635886|NCT02332720|459289325|FG007|Part A and Part B|Adverse Event|0|||
127635887|NCT02332720|459289326|FG008|Part A and Part B|Adverse Event|0|||
127635888|NCT02332720|459289327|FG009|Part A and Part B|Adverse Event|0|||
127635889|NCT02332720|459289328|FG010|Part A and Part B|Adverse Event|0|||
127635890|NCT02332720|459289329|FG011|Part A and Part B|Adverse Event|0|||
127635891|NCT02332720|459289330|FG012|Part A and Part B|Adverse Event|0|||
127796514|NCT04209855|459877801|FG000|Overall Study|PI Discretion|1|||
127796515|NCT04209855|459877802|FG001|Overall Study|PI Discretion|1|||
127796516|NCT04209855|459877801|FG000|Overall Study|Lost to Follow-up|5|||
127796517|NCT04209855|459877802|FG001|Overall Study|Lost to Follow-up|2|||
127796518|NCT04209855|459877801|FG000|Overall Study|Withdrew consent|10|||
127796519|NCT04209855|459877802|FG001|Overall Study|Withdrew consent|24|||
127796520|NCT04209855|459877801|FG000|Overall Study|Sponsor decision|44|||
127703066|NCT04032704|459542588|FG015|Part A|Withdrawal by Subject|0|||
127703067|NCT04032704|459542589|FG016|Part A|Withdrawal by Subject|0|||
127885692|NCT00736099|460205249|FG001|Overall Study|Other reason|10|||
127703068|NCT04032704|459542590|FG017|Part A|Withdrawal by Subject|0|||
127703069|NCT04032704|459542573|FG000|Part A|Lost to Follow-up|1|||
127703070|NCT04032704|459542574|FG001|Part A|Lost to Follow-up|0|||
127703071|NCT04032704|459542575|FG002|Part A|Lost to Follow-up|0|||
127703072|NCT04032704|459542576|FG003|Part A|Lost to Follow-up|0|||
127703073|NCT04032704|459542577|FG004|Part A|Lost to Follow-up|0|||
127703074|NCT04032704|459542578|FG005|Part A|Lost to Follow-up|0|||
127703075|NCT04032704|459542579|FG006|Part A|Lost to Follow-up|0|||
127703076|NCT04032704|459542580|FG007|Part A|Lost to Follow-up|0|||
127703077|NCT04032704|459542581|FG008|Part A|Lost to Follow-up|0|||
127703078|NCT04032704|459542582|FG009|Part A|Lost to Follow-up|0|||
127703079|NCT04032704|459542583|FG010|Part A|Lost to Follow-up|0|||
127703080|NCT04032704|459542584|FG011|Part A|Lost to Follow-up|0|||
127703081|NCT04032704|459542585|FG012|Part A|Lost to Follow-up|0|||
127703082|NCT04032704|459542586|FG013|Part A|Lost to Follow-up|0|||
127635892|NCT02332720|459289331|FG013|Part A and Part B|Adverse Event|0|||
127635893|NCT02332720|459289332|FG014|Part A and Part B|Adverse Event|0|||
127635894|NCT02332720|459289333|FG015|Part A and Part B|Adverse Event|0|||
127635895|NCT02332720|459289334|FG016|Part A and Part B|Adverse Event|0|||
127635896|NCT02332720|459289335|FG017|Part A and Part B|Adverse Event|1|||
127635897|NCT02332720|459289336|FG018|Part A and Part B|Adverse Event|0|||
127635898|NCT02332720|459289337|FG019|Part A and Part B|Adverse Event|0|||
127635899|NCT02332720|459289338|FG020|Part A and Part B|Adverse Event|0|||
127635900|NCT02332720|459289339|FG021|Part A and Part B|Adverse Event|0|||
127635901|NCT02332720|459289340|FG022|Part A and Part B|Adverse Event|0|||
127635902|NCT02332720|459289318|FG000|Part A and Part B|Physician Decision|0|||
127635903|NCT02332720|459289319|FG001|Part A and Part B|Physician Decision|0|||
127796521|NCT04209855|459877802|FG001|Overall Study|Sponsor decision|18|||
127796522|NCT04209855|459877801|FG000|Overall Study|Other than specified|6|||
127796523|NCT04209855|459877802|FG001|Overall Study|Other than specified|4|||
127796524|NCT01250379|459877805|FG000|Overall Study|Death|141|||
127796525|NCT01250379|459877806|FG001|Overall Study|Death|148|||
127796526|NCT01250379|459877805|FG000|Overall Study|Withdrawal by Subject|32|||
127796527|NCT01250379|459877806|FG001|Overall Study|Withdrawal by Subject|20|||
127796528|NCT01250379|459877805|FG000|Overall Study|Physician Decision|11|||
127796529|NCT01250379|459877806|FG001|Overall Study|Physician Decision|3|||
127635904|NCT02332720|459289320|FG002|Part A and Part B|Physician Decision|0|||
127635905|NCT02332720|459289321|FG003|Part A and Part B|Physician Decision|0|||
127635906|NCT02332720|459289322|FG004|Part A and Part B|Physician Decision|0|||
127635907|NCT02332720|459289323|FG005|Part A and Part B|Physician Decision|0|||
127635908|NCT02332720|459289324|FG006|Part A and Part B|Physician Decision|0|||
127635909|NCT02332720|459289325|FG007|Part A and Part B|Physician Decision|0|||
127635910|NCT02332720|459289326|FG008|Part A and Part B|Physician Decision|0|||
127635911|NCT02332720|459289327|FG009|Part A and Part B|Physician Decision|0|||
127635912|NCT02332720|459289328|FG010|Part A and Part B|Physician Decision|0|||
127635913|NCT02332720|459289329|FG011|Part A and Part B|Physician Decision|0|||
127635914|NCT02332720|459289330|FG012|Part A and Part B|Physician Decision|0|||
127635915|NCT02332720|459289331|FG013|Part A and Part B|Physician Decision|0|||
127635916|NCT02332720|459289332|FG014|Part A and Part B|Physician Decision|0|||
127635917|NCT02332720|459289333|FG015|Part A and Part B|Physician Decision|0|||
127796530|NCT01250379|459877805|FG000|Overall Study|Protocol Violation|2|||
127796531|NCT01250379|459877806|FG001|Overall Study|Protocol Violation|8|||
127796532|NCT01250379|459877805|FG000|Overall Study|Lost to Follow-up|9|||
127796533|NCT01250379|459877806|FG001|Overall Study|Lost to Follow-up|6|||
127796534|NCT01250379|459877805|FG000|Overall Study|Adverse Event|5|||
127796535|NCT01250379|459877806|FG001|Overall Study|Adverse Event|4|||
127796536|NCT01250379|459877805|FG000|Overall Study|Other|0|||
127885693|NCT00833547|460205253|FG000|Overall Study|Withdrawal by Subject|2|||
127885694|NCT00833547|460205254|FG001|Overall Study|Withdrawal by Subject|2|||
127796537|NCT01250379|459877806|FG001|Overall Study|Other|4|||
127885695|NCT00686790|460205259|FG000|Overall Study|Adverse Event|2|||
127885696|NCT00686790|460205259|FG000|Overall Study|Withdrawal by Subject|1|||
127635918|NCT02332720|459289334|FG016|Part A and Part B|Physician Decision|0|||
127635919|NCT02332720|459289335|FG017|Part A and Part B|Physician Decision|0|||
127635920|NCT02332720|459289336|FG018|Part A and Part B|Physician Decision|1|||
127635921|NCT02332720|459289337|FG019|Part A and Part B|Physician Decision|0|||
127635922|NCT02332720|459289338|FG020|Part A and Part B|Physician Decision|0|||
127635923|NCT02332720|459289339|FG021|Part A and Part B|Physician Decision|0|||
127635924|NCT02332720|459289340|FG022|Part A and Part B|Physician Decision|0|||
127635925|NCT02332720|459289318|FG000|Part A and Part B|Withdrawal by Subject|0|||
127635926|NCT02332720|459289319|FG001|Part A and Part B|Withdrawal by Subject|0|||
127635927|NCT02332720|459289320|FG002|Part A and Part B|Withdrawal by Subject|0|||
127635928|NCT02332720|459289321|FG003|Part A and Part B|Withdrawal by Subject|0|||
127635929|NCT02332720|459289322|FG004|Part A and Part B|Withdrawal by Subject|0|||
127635930|NCT02332720|459289323|FG005|Part A and Part B|Withdrawal by Subject|1|||
127796538|NCT01250379|459877805|FG000|Overall Study|Participant noncompliance|2|||
127885697|NCT00686790|460205259|FG000|Overall Study|Death|1|||
127796539|NCT01250379|459877806|FG001|Overall Study|Participant noncompliance|0|||
127796540|NCT05902364|459877807|FG000|Overall Study|Adverse Event|1|||
127796541|NCT05902364|459877808|FG001|Overall Study|Adverse Event|0|||
127796542|NCT01489527|459877810|FG000|Overall Study|Pregnancy|9|||
127796543|NCT01489527|459877811|FG001|Overall Study|Pregnancy|14|||
127796544|NCT01489527|459877810|FG000|Overall Study|Participant moved|6|||
127885698|NCT00686790|460205259|FG000|Overall Study|Lost to Follow-up|12|||
127635931|NCT02332720|459289324|FG006|Part A and Part B|Withdrawal by Subject|0|||
127635932|NCT02332720|459289325|FG007|Part A and Part B|Withdrawal by Subject|0|||
127635933|NCT02332720|459289326|FG008|Part A and Part B|Withdrawal by Subject|0|||
127796545|NCT01489527|459877811|FG001|Overall Study|Participant moved|7|||
127796546|NCT01489527|459877810|FG000|Overall Study|Withdrawal by Subject|0|||
127885699|NCT00096382|460205260|FG000|Overall Study|Not treated|1|||
127796547|NCT01489527|459877811|FG001|Overall Study|Withdrawal by Subject|4|||
127885700|NCT00096382|460205261|FG001|Overall Study|Not treated|0|||
127885701|NCT00096382|460205260|FG000|Overall Study|Death during treatment|1|||
127885702|NCT00096382|460205261|FG001|Overall Study|Death during treatment|0|||
127885703|NCT01326702|460205263|FG000|Overall Study|Other|1|||
127885704|NCT01326702|460205264|FG001|Overall Study|Other|0|||
127885705|NCT01326702|460205265|FG002|Overall Study|Other|0|||
127635934|NCT02332720|459289327|FG009|Part A and Part B|Withdrawal by Subject|0|||
127635935|NCT02332720|459289328|FG010|Part A and Part B|Withdrawal by Subject|0|||
127635936|NCT02332720|459289329|FG011|Part A and Part B|Withdrawal by Subject|0|||
127635937|NCT02332720|459289330|FG012|Part A and Part B|Withdrawal by Subject|0|||
127635938|NCT02332720|459289331|FG013|Part A and Part B|Withdrawal by Subject|0|||
127635939|NCT02332720|459289332|FG014|Part A and Part B|Withdrawal by Subject|0|||
127635940|NCT02332720|459289333|FG015|Part A and Part B|Withdrawal by Subject|0|||
127635941|NCT02332720|459289334|FG016|Part A and Part B|Withdrawal by Subject|0|||
127635942|NCT02332720|459289335|FG017|Part A and Part B|Withdrawal by Subject|0|||
127635943|NCT02332720|459289336|FG018|Part A and Part B|Withdrawal by Subject|0|||
127635944|NCT02332720|459289337|FG019|Part A and Part B|Withdrawal by Subject|1|||
127635945|NCT02332720|459289338|FG020|Part A and Part B|Withdrawal by Subject|0|||
127635946|NCT02332720|459289339|FG021|Part A and Part B|Withdrawal by Subject|0|||
127635947|NCT02332720|459289340|FG022|Part A and Part B|Withdrawal by Subject|0|||
127635948|NCT03832010|459289341|FG000|Overall Study|Withdrawal by Subject|2|||
127635949|NCT03832010|459289342|FG001|Overall Study|Withdrawal by Subject|1|||
127635950|NCT03832010|459289343|FG002|Overall Study|Withdrawal by Subject|0|||
127635951|NCT03832010|459289341|FG000|Overall Study|Lost to Follow-up|2|||
127635952|NCT03832010|459289342|FG001|Overall Study|Lost to Follow-up|1|||
127635953|NCT03832010|459289343|FG002|Overall Study|Lost to Follow-up|1|||
127635954|NCT01003899|459289344|FG000|Overall Study|Other Adverse Event|8|||
127635955|NCT01003899|459289344|FG000|Overall Study|Not entered|4|||
127635956|NCT01003899|459289344|FG000|Overall Study|Not treated|1|||
127635957|NCT01003899|459289344|FG000|Overall Study|Progressive disease|34|||
127635958|NCT03822533|459289346|FG000|3 Month Follow-up|Withdrawal by Subject|3|||
127635959|NCT03822533|459289347|FG001|3 Month Follow-up|Withdrawal by Subject|4|||
127635960|NCT03822533|459289346|FG000|3 Month Follow-up|Lost to Follow-up|2|||
127635961|NCT03822533|459289347|FG001|3 Month Follow-up|Lost to Follow-up|2|||
127635962|NCT03822533|459289346|FG000|6 Month Follow-up|Lost to Follow-up|3|||
127635963|NCT03822533|459289347|FG001|6 Month Follow-up|Lost to Follow-up|0|||
127635964|NCT03822533|459289346|FG000|12 Month Follow-up|Lost to Follow-up|2|||
127635965|NCT03822533|459289347|FG001|12 Month Follow-up|Lost to Follow-up|3|||
127635966|NCT03822533|459289346|FG000|12 Month Follow-up|Pregnancy|0|||
127635967|NCT03822533|459289347|FG001|12 Month Follow-up|Pregnancy|1|||
127635968|NCT03822533|459289346|FG000|12 Month Follow-up|Surgery|2|||
127635969|NCT03822533|459289347|FG001|12 Month Follow-up|Surgery|0|||
127635970|NCT03822533|459289346|FG000|12 Month Follow-up|Wrong address|1|||
127635971|NCT03822533|459289347|FG001|12 Month Follow-up|Wrong address|0|||
127635972|NCT03822533|459289346|FG000|12 Month Follow-up|No symptoms|1|||
127635973|NCT03822533|459289347|FG001|12 Month Follow-up|No symptoms|0|||
127635974|NCT03822533|459289346|FG000|12 Month Follow-up|Changed primary care center|0|||
127635975|NCT03822533|459289347|FG001|12 Month Follow-up|Changed primary care center|1|||
127635976|NCT02489500|459289350|FG000|Overall Study|Death|1|||
127635977|NCT02489500|459289351|FG001|Overall Study|Death|1|||
127635978|NCT02349295|459289353|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
127635979|NCT02349295|459289354|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
127635980|NCT02349295|459289355|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
127635981|NCT02349295|459289356|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
127635982|NCT02349295|459289357|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
127635983|NCT02349295|459289358|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
127635984|NCT02349295|459289359|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
127635985|NCT02349295|459289360|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
127635986|NCT02349295|459289361|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
127635987|NCT02349295|459289362|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
127635988|NCT02349295|459289363|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
127635989|NCT02349295|459289364|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
127885706|NCT01326702|460205266|FG003|Overall Study|Other|0|||
127635990|NCT02349295|459289365|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
127635991|NCT02349295|459289366|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
127635992|NCT02349295|459289353|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
127635993|NCT02349295|459289354|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
127635994|NCT02349295|459289355|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
127635995|NCT02349295|459289356|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
127635996|NCT02349295|459289357|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
127635997|NCT02349295|459289358|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
127635998|NCT02349295|459289359|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
127635999|NCT02349295|459289360|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
127636000|NCT02349295|459289361|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
127636001|NCT02349295|459289362|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
127636002|NCT02349295|459289363|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
127636003|NCT02349295|459289364|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
127636004|NCT02349295|459289365|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
127636005|NCT02349295|459289366|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
127636006|NCT02349295|459289353|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
127636007|NCT02349295|459289354|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
127636008|NCT02349295|459289355|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
127636009|NCT02349295|459289356|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
127636010|NCT02349295|459289357|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
127636011|NCT02349295|459289358|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
127703083|NCT04032704|459542587|FG014|Part A|Lost to Follow-up|0|||
127703084|NCT04032704|459542588|FG015|Part A|Lost to Follow-up|0|||
127703085|NCT04032704|459542589|FG016|Part A|Lost to Follow-up|0|||
127703086|NCT04032704|459542590|FG017|Part A|Lost to Follow-up|0|||
127703087|NCT04032704|459542573|FG000|Part A|Death|9|||
127703088|NCT04032704|459542574|FG001|Part A|Death|2|||
127703089|NCT04032704|459542575|FG002|Part A|Death|10|||
127703090|NCT04032704|459542576|FG003|Part A|Death|7|||
127703091|NCT04032704|459542577|FG004|Part A|Death|4|||
127703092|NCT04032704|459542578|FG005|Part A|Death|5|||
127703093|NCT04032704|459542579|FG006|Part A|Death|0|||
127703094|NCT04032704|459542580|FG007|Part A|Death|0|||
127703095|NCT04032704|459542581|FG008|Part A|Death|0|||
127703096|NCT04032704|459542582|FG009|Part A|Death|0|||
127703097|NCT04032704|459542583|FG010|Part A|Death|0|||
127703098|NCT04032704|459542584|FG011|Part A|Death|0|||
127703099|NCT04032704|459542585|FG012|Part A|Death|0|||
127703100|NCT04032704|459542586|FG013|Part A|Death|0|||
127703101|NCT04032704|459542587|FG014|Part A|Death|0|||
127703102|NCT04032704|459542588|FG015|Part A|Death|0|||
127703103|NCT04032704|459542589|FG016|Part A|Death|0|||
127703104|NCT04032704|459542590|FG017|Part A|Death|0|||
127703105|NCT04032704|459542573|FG000|Part B|Other|0|||
127703106|NCT04032704|459542574|FG001|Part B|Other|0|||
127703107|NCT04032704|459542575|FG002|Part B|Other|0|||
127703108|NCT04032704|459542576|FG003|Part B|Other|0|||
127703109|NCT04032704|459542577|FG004|Part B|Other|0|||
127703110|NCT04032704|459542578|FG005|Part B|Other|0|||
127703111|NCT04032704|459542579|FG006|Part B|Other|0|||
127703112|NCT04032704|459542580|FG007|Part B|Other|1|||
127703113|NCT04032704|459542581|FG008|Part B|Other|2|||
127703114|NCT04032704|459542582|FG009|Part B|Other|1|||
127703115|NCT04032704|459542583|FG010|Part B|Other|1|||
127703116|NCT04032704|459542584|FG011|Part B|Other|1|||
127703117|NCT04032704|459542585|FG012|Part B|Other|5|||
127703118|NCT04032704|459542586|FG013|Part B|Other|13|||
127703119|NCT04032704|459542587|FG014|Part B|Other|0|||
127703120|NCT04032704|459542588|FG015|Part B|Other|0|||
127703121|NCT04032704|459542589|FG016|Part B|Other|0|||
127703122|NCT04032704|459542590|FG017|Part B|Other|0|||
127703123|NCT04032704|459542573|FG000|Part B|Study termination by Sponsor|0|||
127703124|NCT04032704|459542574|FG001|Part B|Study termination by Sponsor|0|||
127703125|NCT04032704|459542575|FG002|Part B|Study termination by Sponsor|0|||
127703126|NCT04032704|459542576|FG003|Part B|Study termination by Sponsor|0|||
127703127|NCT04032704|459542577|FG004|Part B|Study termination by Sponsor|0|||
127703128|NCT04032704|459542578|FG005|Part B|Study termination by Sponsor|0|||
127703129|NCT04032704|459542579|FG006|Part B|Study termination by Sponsor|0|||
127703130|NCT04032704|459542580|FG007|Part B|Study termination by Sponsor|0|||
127703131|NCT04032704|459542581|FG008|Part B|Study termination by Sponsor|1|||
127703132|NCT04032704|459542582|FG009|Part B|Study termination by Sponsor|0|||
127703133|NCT04032704|459542583|FG010|Part B|Study termination by Sponsor|0|||
127703134|NCT04032704|459542584|FG011|Part B|Study termination by Sponsor|0|||
127703135|NCT04032704|459542585|FG012|Part B|Study termination by Sponsor|0|||
127703136|NCT04032704|459542586|FG013|Part B|Study termination by Sponsor|0|||
127703137|NCT04032704|459542587|FG014|Part B|Study termination by Sponsor|0|||
127703138|NCT04032704|459542588|FG015|Part B|Study termination by Sponsor|0|||
127703139|NCT04032704|459542589|FG016|Part B|Study termination by Sponsor|0|||
127703140|NCT04032704|459542590|FG017|Part B|Study termination by Sponsor|0|||
127703141|NCT04032704|459542573|FG000|Part B|Withdrawal by Subject|0|||
127703142|NCT04032704|459542574|FG001|Part B|Withdrawal by Subject|0|||
127703143|NCT04032704|459542575|FG002|Part B|Withdrawal by Subject|0|||
127703144|NCT04032704|459542576|FG003|Part B|Withdrawal by Subject|0|||
127796548|NCT01489527|459877810|FG000|Overall Study|Lost to Follow-up|5|||
127796549|NCT01489527|459877811|FG001|Overall Study|Lost to Follow-up|1|||
127636012|NCT02349295|459289359|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
127636013|NCT02349295|459289360|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
127636014|NCT02349295|459289361|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
127636015|NCT02349295|459289362|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
127636016|NCT02349295|459289363|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
127636017|NCT02349295|459289364|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
127636018|NCT02349295|459289365|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
127636019|NCT02349295|459289366|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
127636020|NCT02349295|459289353|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
127636021|NCT02349295|459289354|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
127636022|NCT02349295|459289355|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
127636023|NCT02349295|459289356|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
127636024|NCT02349295|459289357|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
127636025|NCT02349295|459289358|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
127636026|NCT02349295|459289359|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
127636027|NCT02349295|459289360|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
127636028|NCT02349295|459289361|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
127636029|NCT02349295|459289362|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
127796550|NCT01489527|459877810|FG000|Overall Study|Procedures|1|||
127796551|NCT01489527|459877811|FG001|Overall Study|Procedures|0|||
127796552|NCT01489527|459877810|FG000|Overall Study|Not compliant|1|||
127796553|NCT01489527|459877811|FG001|Overall Study|Not compliant|0|||
127796554|NCT01984268|459877812|FG000|Overall Study|Study Terminated|15|||
127796555|NCT04899232|459877813|FG000|Screening Period|Physician Decision|1|||
127796556|NCT04899232|459877814|FG001|Screening Period|Physician Decision|0|||
127796557|NCT04899232|459877815|FG002|Screening Period|Physician Decision|0|||
127796558|NCT04899232|459877813|FG000|Screening Period|Withdrawal by Subject|1|||
127796559|NCT04899232|459877814|FG001|Screening Period|Withdrawal by Subject|0|||
127796560|NCT04899232|459877815|FG002|Screening Period|Withdrawal by Subject|0|||
127796561|NCT04899232|459877813|FG000|Screening Period|Participant discharged before receiving intervention|3|||
127796562|NCT04899232|459877814|FG001|Screening Period|Participant discharged before receiving intervention|0|||
127796563|NCT04899232|459877815|FG002|Screening Period|Participant discharged before receiving intervention|0|||
127796564|NCT00936208|459877817|FG000|Overall Study|Protocol Violation|37|||
127796565|NCT00936208|459877818|FG001|Overall Study|Protocol Violation|22|||
127796566|NCT01344876|459877821|FG000|Overall Study|Adverse Event|0|||
127796567|NCT01344876|459877822|FG001|Overall Study|Adverse Event|0|||
127796568|NCT01344876|459877823|FG002|Overall Study|Adverse Event|0|||
127796569|NCT01344876|459877824|FG003|Overall Study|Adverse Event|0|||
127796570|NCT01344876|459877825|FG004|Overall Study|Adverse Event|1|||
127796571|NCT01344876|459877821|FG000|Overall Study|Withdrawal by Subject|0|||
127636030|NCT02349295|459289363|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
127796572|NCT01344876|459877822|FG001|Overall Study|Withdrawal by Subject|0|||
127796573|NCT01344876|459877823|FG002|Overall Study|Withdrawal by Subject|1|||
127796574|NCT01344876|459877824|FG003|Overall Study|Withdrawal by Subject|0|||
127796575|NCT01344876|459877825|FG004|Overall Study|Withdrawal by Subject|0|||
127796576|NCT01344876|459877821|FG000|Overall Study|Definite progression of primary disease|1|||
127796577|NCT01344876|459877822|FG001|Overall Study|Definite progression of primary disease|0|||
127636031|NCT02349295|459289364|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
127636032|NCT02349295|459289365|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
127703145|NCT04032704|459542577|FG004|Part B|Withdrawal by Subject|0|||
127703146|NCT04032704|459542578|FG005|Part B|Withdrawal by Subject|0|||
127703147|NCT04032704|459542579|FG006|Part B|Withdrawal by Subject|3|||
127703148|NCT04032704|459542580|FG007|Part B|Withdrawal by Subject|2|||
127703149|NCT04032704|459542581|FG008|Part B|Withdrawal by Subject|2|||
127703150|NCT04032704|459542582|FG009|Part B|Withdrawal by Subject|1|||
127703151|NCT04032704|459542583|FG010|Part B|Withdrawal by Subject|4|||
127703152|NCT04032704|459542584|FG011|Part B|Withdrawal by Subject|6|||
127703153|NCT04032704|459542585|FG012|Part B|Withdrawal by Subject|2|||
127703154|NCT04032704|459542586|FG013|Part B|Withdrawal by Subject|1|||
127703155|NCT04032704|459542587|FG014|Part B|Withdrawal by Subject|0|||
127703156|NCT04032704|459542588|FG015|Part B|Withdrawal by Subject|1|||
127703157|NCT04032704|459542589|FG016|Part B|Withdrawal by Subject|0|||
127703158|NCT04032704|459542590|FG017|Part B|Withdrawal by Subject|0|||
127796578|NCT01344876|459877823|FG002|Overall Study|Definite progression of primary disease|0|||
127796579|NCT01344876|459877824|FG003|Overall Study|Definite progression of primary disease|3|||
127796580|NCT01344876|459877825|FG004|Overall Study|Definite progression of primary disease|0|||
127636033|NCT02349295|459289366|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
127703159|NCT04032704|459542573|FG000|Part B|Lost to Follow-up|0|||
127703160|NCT04032704|459542574|FG001|Part B|Lost to Follow-up|0|||
127703161|NCT04032704|459542575|FG002|Part B|Lost to Follow-up|0|||
127703162|NCT04032704|459542576|FG003|Part B|Lost to Follow-up|0|||
127636034|NCT02349295|459289353|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
127636035|NCT02349295|459289354|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
127636036|NCT02349295|459289355|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
127636037|NCT02349295|459289356|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
127636038|NCT02349295|459289357|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
127636039|NCT02349295|459289358|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
127636040|NCT02349295|459289359|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
127636041|NCT02349295|459289360|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
127636042|NCT02349295|459289361|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
127636043|NCT02349295|459289362|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
127636044|NCT02349295|459289363|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
127636045|NCT02349295|459289364|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
127636046|NCT02349295|459289365|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
127636047|NCT02349295|459289366|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
127636048|NCT02349295|459289353|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
127636049|NCT02349295|459289354|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
127636050|NCT02349295|459289355|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
127636051|NCT02349295|459289356|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
127636052|NCT02349295|459289357|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
127636053|NCT02349295|459289358|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
127636054|NCT02349295|459289359|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
127636055|NCT02349295|459289360|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
127636056|NCT02349295|459289361|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
127636057|NCT02349295|459289362|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
127636058|NCT02349295|459289363|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
127636059|NCT02349295|459289364|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
127636060|NCT02349295|459289365|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
127636061|NCT02349295|459289366|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
127636062|NCT02349295|459289353|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
127636063|NCT02349295|459289354|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
127636064|NCT02349295|459289355|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
127636065|NCT02349295|459289356|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
127636066|NCT02349295|459289357|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
127636067|NCT02349295|459289358|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
127636068|NCT02349295|459289359|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
127636069|NCT02349295|459289360|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
127636070|NCT02349295|459289361|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
127636071|NCT02349295|459289362|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
127636072|NCT02349295|459289363|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
127636073|NCT02349295|459289364|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
127636074|NCT02349295|459289365|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
127636075|NCT02349295|459289366|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
127636076|NCT02349295|459289353|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
127636077|NCT02349295|459289354|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
127636078|NCT02349295|459289355|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
127636079|NCT02349295|459289356|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
127636080|NCT02349295|459289357|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
127636081|NCT02349295|459289358|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
127636082|NCT02349295|459289359|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
127636083|NCT02349295|459289360|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
127703163|NCT04032704|459542577|FG004|Part B|Lost to Follow-up|0|||
127703164|NCT04032704|459542578|FG005|Part B|Lost to Follow-up|0|||
127703165|NCT04032704|459542579|FG006|Part B|Lost to Follow-up|0|||
127703166|NCT04032704|459542580|FG007|Part B|Lost to Follow-up|0|||
127636084|NCT02349295|459289361|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
127636085|NCT02349295|459289362|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
127636086|NCT02349295|459289363|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
127636087|NCT02349295|459289364|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
127636088|NCT02349295|459289365|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
127636089|NCT02349295|459289366|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
127636090|NCT02349295|459289353|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
127636091|NCT02349295|459289354|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
127636092|NCT02349295|459289355|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
127636093|NCT02349295|459289356|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
127636094|NCT02349295|459289357|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
127636095|NCT02349295|459289358|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
127636096|NCT02349295|459289359|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
127636097|NCT02349295|459289360|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
127636098|NCT02349295|459289361|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
127636099|NCT02349295|459289362|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
127636100|NCT02349295|459289363|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
127636101|NCT02349295|459289364|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
127636102|NCT02349295|459289365|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
127636103|NCT02349295|459289366|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
127796581|NCT04428424|459877826|FG000|Overall Study|Does not meet entrance criteria|132|||
127796582|NCT04428424|459877826|FG000|Overall Study|Lost to Follow-up|115|||
127796583|NCT03110224|459877827|FG000|Overall Study|Death|3|||
127796584|NCT03110224|459877827|FG000|Overall Study|Lost to Follow-up|132|||
127796585|NCT03110224|459877827|FG000|Overall Study|Physician Decision|2|||
127796586|NCT03110224|459877827|FG000|Overall Study|Site Closed by Physician|35|||
127796587|NCT03110224|459877827|FG000|Overall Study|Site Closed by Sponsor|202|||
127703167|NCT04032704|459542581|FG008|Part B|Lost to Follow-up|0|||
127703168|NCT04032704|459542582|FG009|Part B|Lost to Follow-up|0|||
127885707|NCT01326702|460205267|FG004|Overall Study|Other|0|||
127885708|NCT01326702|460205268|FG005|Overall Study|Other|1|||
127885709|NCT01326702|460205269|FG006|Overall Study|Other|0|||
127885710|NCT01326702|460205263|FG000|Overall Study|progressive disease|1|||
127885711|NCT01326702|460205264|FG001|Overall Study|progressive disease|1|||
127885712|NCT01326702|460205265|FG002|Overall Study|progressive disease|3|||
127885713|NCT01326702|460205266|FG003|Overall Study|progressive disease|1|||
127885714|NCT01326702|460205267|FG004|Overall Study|progressive disease|3|||
127885715|NCT01326702|460205268|FG005|Overall Study|progressive disease|2|||
127885716|NCT01326702|460205269|FG006|Overall Study|progressive disease|3|||
127885717|NCT01326702|460205263|FG000|Overall Study|Death|0|||
127885718|NCT01326702|460205264|FG001|Overall Study|Death|1|||
127885719|NCT01326702|460205265|FG002|Overall Study|Death|0|||
127885720|NCT01326702|460205266|FG003|Overall Study|Death|0|||
127885721|NCT01326702|460205267|FG004|Overall Study|Death|0|||
127885722|NCT01326702|460205268|FG005|Overall Study|Death|0|||
127885723|NCT01326702|460205269|FG006|Overall Study|Death|0|||
127885724|NCT01326702|460205263|FG000|Overall Study|Adverse Event|0|||
127885725|NCT01326702|460205264|FG001|Overall Study|Adverse Event|0|||
127885726|NCT01326702|460205265|FG002|Overall Study|Adverse Event|1|||
127885727|NCT01326702|460205266|FG003|Overall Study|Adverse Event|1|||
127885728|NCT01326702|460205267|FG004|Overall Study|Adverse Event|0|||
127885729|NCT01326702|460205268|FG005|Overall Study|Adverse Event|3|||
127885730|NCT01326702|460205269|FG006|Overall Study|Adverse Event|1|||
127885731|NCT01326702|460205263|FG000|Overall Study|Withdrawal by Subject|0|||
127703169|NCT04032704|459542583|FG010|Part B|Lost to Follow-up|0|||
127885732|NCT01326702|460205264|FG001|Overall Study|Withdrawal by Subject|0|||
127885733|NCT01326702|460205265|FG002|Overall Study|Withdrawal by Subject|1|||
127885734|NCT01326702|460205266|FG003|Overall Study|Withdrawal by Subject|0|||
127885735|NCT01326702|460205267|FG004|Overall Study|Withdrawal by Subject|1|||
127885736|NCT01326702|460205268|FG005|Overall Study|Withdrawal by Subject|1|||
127885737|NCT01326702|460205269|FG006|Overall Study|Withdrawal by Subject|3|||
127885738|NCT01326702|460205263|FG000|Overall Study|Not Treated|0|||
127885739|NCT01326702|460205264|FG001|Overall Study|Not Treated|0|||
127885740|NCT01326702|460205265|FG002|Overall Study|Not Treated|0|||
127636104|NCT02349295|459289353|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
127636105|NCT02349295|459289354|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
127636106|NCT02349295|459289355|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
127636107|NCT02349295|459289356|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
127636108|NCT02349295|459289357|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
127636109|NCT02349295|459289358|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
127636110|NCT02349295|459289359|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
127636111|NCT02349295|459289360|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
127636112|NCT02349295|459289361|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
127636113|NCT02349295|459289362|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
127636114|NCT02349295|459289363|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
127636115|NCT02349295|459289364|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
127636116|NCT02349295|459289365|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
127636117|NCT02349295|459289366|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
127636118|NCT02349295|459289353|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
127636119|NCT02349295|459289354|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
127636120|NCT02349295|459289355|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
127636121|NCT02349295|459289356|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
127636122|NCT02349295|459289357|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
127636123|NCT02349295|459289358|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
127636124|NCT02349295|459289359|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
127636125|NCT02349295|459289360|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
127636126|NCT02349295|459289361|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
127636127|NCT02349295|459289362|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
127703170|NCT04032704|459542584|FG011|Part B|Lost to Follow-up|1|||
127703171|NCT04032704|459542585|FG012|Part B|Lost to Follow-up|0|||
127636128|NCT02349295|459289363|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
127636129|NCT02349295|459289364|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
127636130|NCT02349295|459289365|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
127636131|NCT02349295|459289366|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
127636132|NCT02349295|459289353|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
127636133|NCT02349295|459289354|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
127636134|NCT02349295|459289355|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
127636135|NCT02349295|459289356|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
127636136|NCT02349295|459289357|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
127636137|NCT02349295|459289358|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
127636138|NCT02349295|459289359|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
127636139|NCT02349295|459289360|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
127636140|NCT02349295|459289361|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
127636141|NCT02349295|459289362|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
127636142|NCT02349295|459289363|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
127636143|NCT02349295|459289364|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
127636144|NCT02349295|459289365|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
127636145|NCT02349295|459289366|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
127636146|NCT02349295|459289353|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
127636147|NCT02349295|459289354|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
127636148|NCT02349295|459289355|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
127636149|NCT02349295|459289356|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
127636150|NCT02349295|459289357|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
127636151|NCT02349295|459289358|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
127636152|NCT02349295|459289359|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
127636153|NCT02349295|459289360|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
127636154|NCT02349295|459289361|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
127636155|NCT02349295|459289362|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
127636156|NCT02349295|459289363|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
127636157|NCT02349295|459289364|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
127636158|NCT02349295|459289365|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
127636159|NCT02349295|459289366|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
127636160|NCT02349295|459289353|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
127636161|NCT02349295|459289354|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
127636162|NCT02349295|459289355|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
127636163|NCT02349295|459289356|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
127636164|NCT02349295|459289357|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
127636165|NCT02349295|459289358|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
127636166|NCT02349295|459289359|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
127636167|NCT02349295|459289360|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
127636168|NCT02349295|459289361|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
127636169|NCT02349295|459289362|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
127636170|NCT02349295|459289363|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
127636171|NCT02349295|459289364|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
127636172|NCT02349295|459289365|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
127636173|NCT02349295|459289366|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
127636174|NCT02349295|459289353|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
127636175|NCT02349295|459289354|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
127636176|NCT02349295|459289355|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
127636177|NCT02349295|459289356|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
127636178|NCT02349295|459289357|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
127636179|NCT02349295|459289358|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
127636180|NCT02349295|459289359|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
127636181|NCT02349295|459289360|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
127703172|NCT04032704|459542586|FG013|Part B|Lost to Follow-up|0|||
127703173|NCT04032704|459542587|FG014|Part B|Lost to Follow-up|0|||
127703174|NCT04032704|459542588|FG015|Part B|Lost to Follow-up|0|||
127703175|NCT04032704|459542589|FG016|Part B|Lost to Follow-up|0|||
127703176|NCT04032704|459542590|FG017|Part B|Lost to Follow-up|0|||
127703177|NCT04032704|459542573|FG000|Part B|Death|0|||
127703178|NCT04032704|459542574|FG001|Part B|Death|0|||
127703179|NCT04032704|459542575|FG002|Part B|Death|0|||
127703180|NCT04032704|459542576|FG003|Part B|Death|0|||
127703181|NCT04032704|459542577|FG004|Part B|Death|0|||
127796588|NCT03110224|459877827|FG000|Overall Study|Withdrawal by Subject|9|||
127796589|NCT04818593|459877828|FG000|Overall Study|Low Oocyte Yield|8|||
127796590|NCT04818593|459877829|FG001|Overall Study|Low Oocyte Yield|8|||
127796591|NCT04818593|459877828|FG000|Overall Study|Not ICSI Insemination|7|||
127796592|NCT04818593|459877829|FG001|Overall Study|Not ICSI Insemination|7|||
127796593|NCT04818593|459877828|FG000|Overall Study|Poor Sperm Quality|2|||
127796594|NCT04818593|459877829|FG001|Overall Study|Poor Sperm Quality|2|||
127796595|NCT04818593|459877828|FG000|Overall Study|Withdrawal by Subject|2|||
127796596|NCT04818593|459877829|FG001|Overall Study|Withdrawal by Subject|2|||
127796597|NCT04818593|459877828|FG000|Overall Study|Conversion to IUI due to low response|1|||
127636182|NCT02349295|459289361|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
127636183|NCT02349295|459289362|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
127636184|NCT02349295|459289363|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
127636185|NCT02349295|459289364|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
127636186|NCT02349295|459289365|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
127636187|NCT02349295|459289366|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
127636188|NCT02349295|459289353|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
127636189|NCT02349295|459289354|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
127636190|NCT02349295|459289355|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
127636191|NCT02349295|459289356|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
127636192|NCT02349295|459289357|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
127636193|NCT02349295|459289358|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
127636194|NCT02349295|459289359|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
127636195|NCT02349295|459289360|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
127636196|NCT02349295|459289361|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
127636197|NCT02349295|459289362|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
127636198|NCT02349295|459289363|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
127636199|NCT02349295|459289364|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
127636200|NCT02349295|459289365|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
127636201|NCT02349295|459289366|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
127636202|NCT02349295|459289353|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
127636203|NCT02349295|459289354|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
127636204|NCT02349295|459289355|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
127636205|NCT02349295|459289356|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
127636206|NCT02349295|459289357|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
127636207|NCT02349295|459289358|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
127636208|NCT02349295|459289359|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
127636209|NCT02349295|459289360|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
127636210|NCT02349295|459289361|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
127636211|NCT02349295|459289362|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
127636212|NCT02349295|459289363|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
127636213|NCT02349295|459289364|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
127636214|NCT02349295|459289365|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
127636215|NCT02349295|459289366|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
127636216|NCT02349295|459289353|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
127636217|NCT02349295|459289354|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
127636218|NCT02349295|459289355|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
127636219|NCT02349295|459289356|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
127636220|NCT02349295|459289357|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
127636221|NCT02349295|459289358|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
127636222|NCT02349295|459289359|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
127796598|NCT04818593|459877829|FG001|Overall Study|Conversion to IUI due to low response|1|||
127796599|NCT01564862|459877830|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
127796600|NCT01564862|459877831|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
127796601|NCT01564862|459877832|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
127796602|NCT01564862|459877830|FG000|Overall Study|Major Protocol Deviation|3|||
127796603|NCT01564862|459877831|FG001|Overall Study|Major Protocol Deviation|3|||
127796604|NCT01564862|459877832|FG002|Overall Study|Major Protocol Deviation|4|||
127796605|NCT01564862|459877830|FG000|Overall Study|Lost to Follow-up|10|||
127796606|NCT01564862|459877831|FG001|Overall Study|Lost to Follow-up|8|||
127796607|NCT01564862|459877832|FG002|Overall Study|Lost to Follow-up|6|||
127796608|NCT01564862|459877830|FG000|Overall Study|Voluntary Withdrawal|9|||
127796609|NCT01564862|459877831|FG001|Overall Study|Voluntary Withdrawal|6|||
127796610|NCT01564862|459877832|FG002|Overall Study|Voluntary Withdrawal|8|||
127796611|NCT01564862|459877830|FG000|Overall Study|Lack of Efficacy|1|||
127796612|NCT01564862|459877831|FG001|Overall Study|Lack of Efficacy|5|||
127796613|NCT01564862|459877832|FG002|Overall Study|Lack of Efficacy|6|||
127796614|NCT01564862|459877830|FG000|Overall Study|Other reason(s)|1|||
127796615|NCT01564862|459877831|FG001|Overall Study|Other reason(s)|0|||
127796616|NCT01564862|459877832|FG002|Overall Study|Other reason(s)|0|||
127796617|NCT04526665|459877833|FG000|Overall Study|Withdrawal by Subject|6|||
127796618|NCT04526665|459877834|FG001|Overall Study|Withdrawal by Subject|3|||
127796619|NCT04526665|459877833|FG000|Overall Study|Adverse Event|4|||
127796620|NCT04526665|459877834|FG001|Overall Study|Adverse Event|1|||
127796621|NCT04526665|459877833|FG000|Overall Study|Physician Decision|2|||
127636223|NCT02349295|459289360|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
127636224|NCT02349295|459289361|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
127636225|NCT02349295|459289362|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
127796622|NCT04526665|459877834|FG001|Overall Study|Physician Decision|2|||
127796623|NCT04526665|459877833|FG000|Overall Study|Death|2|||
127796624|NCT04526665|459877834|FG001|Overall Study|Death|0|||
127796625|NCT04526665|459877833|FG000|Overall Study|Other|0|||
127636226|NCT02349295|459289363|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
127636227|NCT02349295|459289364|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
127636228|NCT02349295|459289365|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
127636229|NCT02349295|459289366|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
127636230|NCT01259713|459289368|FG000|Overall Study|Adverse Event|54|||
127636231|NCT01259713|459289369|FG001|Overall Study|Adverse Event|23|||
127636232|NCT01259713|459289368|FG000|Overall Study|Death Not Related to IFI|8|||
127636233|NCT01259713|459289369|FG001|Overall Study|Death Not Related to IFI|1|||
127636234|NCT01259713|459289368|FG000|Overall Study|Investigators Discretion|14|||
127636235|NCT01259713|459289369|FG001|Overall Study|Investigators Discretion|6|||
127636236|NCT01259713|459289368|FG000|Overall Study|Lack of Efficacy|2|||
127636237|NCT01259713|459289369|FG001|Overall Study|Lack of Efficacy|0|||
127636238|NCT01259713|459289368|FG000|Overall Study|Protocol Violation|5|||
127636239|NCT01259713|459289369|FG001|Overall Study|Protocol Violation|4|||
127636240|NCT01259713|459289368|FG000|Overall Study|Subject Withdrew Consent|12|||
127636241|NCT01259713|459289369|FG001|Overall Study|Subject Withdrew Consent|7|||
127636242|NCT06111742|459289370|FG000|Overall Study|Did not receive intervention|1|||
127636243|NCT06111742|459289371|FG001|Overall Study|Did not receive intervention|0|||
127636244|NCT06111742|459289372|FG002|Overall Study|Did not receive intervention|0|||
127636245|NCT06111742|459289370|FG000|Overall Study|Withdrawal by Subject|2|||
127636246|NCT06111742|459289371|FG001|Overall Study|Withdrawal by Subject|0|||
127636247|NCT06111742|459289372|FG002|Overall Study|Withdrawal by Subject|0|||
127636248|NCT02148250|459289375|FG000|Screening|Withdrawal by Subject|5|||
127636249|NCT02148250|459289376|FG001|Screening|Withdrawal by Subject|0|||
127636250|NCT00695903|459289377|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
127636251|NCT00695903|459289378|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
127636252|NCT00695903|459289377|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
127636253|NCT00695903|459289378|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
127636254|NCT00695903|459289377|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
127636255|NCT00695903|459289378|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
127636256|NCT00695903|459289377|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
127636257|NCT00695903|459289378|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
127636258|NCT00695903|459289377|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
127636259|NCT00695903|459289378|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
127636260|NCT00695903|459289377|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
127636261|NCT00695903|459289378|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
127636262|NCT00695903|459289377|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
127636263|NCT00695903|459289378|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
127636264|NCT00695903|459289377|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
127636265|NCT00695903|459289378|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
127636266|NCT00695903|459289377|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
127636267|NCT00695903|459289378|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
127636268|NCT01296568|459289379|FG000|Continued Access Phase|Lost to Follow-up|1|||
127636269|NCT01296568|459289379|FG000|Continued Access Phase|Withdrawal by Subject|1|||
127636270|NCT01296568|459289379|FG000|Continued Access Phase|Disease Progression|1|||
127636271|NCT00237744|459289380|FG000|Overall Study|Withdrawal by Subject|3|||
127636272|NCT00237744|459289381|FG001|Overall Study|Withdrawal by Subject|1|||
127636273|NCT00237744|459289382|FG002|Overall Study|Withdrawal by Subject|0|||
127636274|NCT03305016|459289383|FG000|Overall Study|Withdrawal by Subject|2|||
127636275|NCT05046795|459289384|FG000|Overall Study|Adverse Event|13|||
127636276|NCT05046795|459289385|FG001|Overall Study|Adverse Event|15|||
127636277|NCT05046795|459289384|FG000|Overall Study|Withdrawal by Subject|4|||
127636278|NCT05046795|459289385|FG001|Overall Study|Withdrawal by Subject|7|||
127636279|NCT05046795|459289384|FG000|Overall Study|Physician Decision|1|||
127636280|NCT05046795|459289385|FG001|Overall Study|Physician Decision|2|||
127636281|NCT05046795|459289384|FG000|Overall Study|Protocol Violation|1|||
127636282|NCT05046795|459289385|FG001|Overall Study|Protocol Violation|2|||
127796626|NCT04526665|459877834|FG001|Overall Study|Other|1|||
127636283|NCT05046795|459289384|FG000|Overall Study|Death|1|||
127636284|NCT05046795|459289385|FG001|Overall Study|Death|0|||
127636285|NCT05046795|459289384|FG000|Overall Study|Public health emergency (COVID-19) restrictions|2|||
127636286|NCT05046795|459289385|FG001|Overall Study|Public health emergency (COVID-19) restrictions|3|||
127636287|NCT05177770|459289386|FG000|Overall Study|Death|4|||
127636288|NCT05177770|459289386|FG000|Overall Study|Withdrawal by Subject|1|||
127636289|NCT05177770|459289386|FG000|Overall Study|Adverse Event prior to dosing|1|||
127796627|NCT02028455|459877835|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
127796628|NCT02028455|459877836|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
127636290|NCT00709722|459289387|FG000|Overall Study|Adverse Event|1|||
127636291|NCT04667117|459289388|FG000|Investigational Period|Lost to Follow-up|0|||
127636292|NCT04667117|459289389|FG001|Investigational Period|Lost to Follow-up|0|||
127636293|NCT04667117|459289390|FG002|Investigational Period|Lost to Follow-up|1|||
127636294|NCT04667117|459289388|FG000|Investigational Period|Protocol Deviation|0|||
127636295|NCT04667117|459289389|FG001|Investigational Period|Protocol Deviation|1|||
127636296|NCT04667117|459289390|FG002|Investigational Period|Protocol Deviation|0|||
127636297|NCT04667117|459289388|FG000|Extension Period|Lost to Follow-up|1|||
127636298|NCT04667117|459289389|FG001|Extension Period|Lost to Follow-up|0|||
127636299|NCT04667117|459289390|FG002|Extension Period|Lost to Follow-up|0|||
127636300|NCT02372396|459289406|FG000|Overall Study|Lost to Follow-up|7|||
127636301|NCT02372396|459289407|FG001|Overall Study|Lost to Follow-up|9|||
127636302|NCT01226745|459289408|FG000|Overall Study|Did not complete schedule of assessments|8|||
127636303|NCT01226745|459289409|FG001|Overall Study|Did not complete schedule of assessments|3|||
127636304|NCT01226745|459289410|FG002|Overall Study|Did not complete schedule of assessments|6|||
127636305|NCT01226745|459289411|FG003|Overall Study|Did not complete schedule of assessments|0|||
127636306|NCT01226745|459289412|FG004|Overall Study|Did not complete schedule of assessments|0|||
127636307|NCT01226745|459289413|FG005|Overall Study|Did not complete schedule of assessments|1|||
127636308|NCT01226745|459289408|FG000|Overall Study|Lost to Follow-up|2|||
127636309|NCT01226745|459289409|FG001|Overall Study|Lost to Follow-up|6|||
127636310|NCT01226745|459289410|FG002|Overall Study|Lost to Follow-up|6|||
127636311|NCT01226745|459289411|FG003|Overall Study|Lost to Follow-up|1|||
127636312|NCT01226745|459289412|FG004|Overall Study|Lost to Follow-up|1|||
127636313|NCT01226745|459289413|FG005|Overall Study|Lost to Follow-up|2|||
127636314|NCT01226745|459289408|FG000|Overall Study|Death|1|||
127636315|NCT01226745|459289409|FG001|Overall Study|Death|0|||
127636316|NCT01226745|459289410|FG002|Overall Study|Death|0|||
127636317|NCT01226745|459289411|FG003|Overall Study|Death|0|||
127636318|NCT01226745|459289412|FG004|Overall Study|Death|0|||
127636319|NCT01226745|459289413|FG005|Overall Study|Death|1|||
127636320|NCT01226745|459289408|FG000|Overall Study|Other|6|||
127636321|NCT01226745|459289409|FG001|Overall Study|Other|7|||
127636322|NCT01226745|459289410|FG002|Overall Study|Other|8|||
127636323|NCT01226745|459289411|FG003|Overall Study|Other|4|||
127636324|NCT01226745|459289412|FG004|Overall Study|Other|3|||
127636325|NCT01226745|459289413|FG005|Overall Study|Other|1|||
127636326|NCT01435577|459289414|FG000|Overall Study|Adverse Event|10|||
127636327|NCT01435577|459289415|FG001|Overall Study|Adverse Event|0|||
127636328|NCT01435577|459289414|FG000|Overall Study|Lack of Efficacy|7|||
127636329|NCT01435577|459289415|FG001|Overall Study|Lack of Efficacy|51|||
127636330|NCT01435577|459289414|FG000|Overall Study|Alternative treatment started|0|||
127636331|NCT01435577|459289415|FG001|Overall Study|Alternative treatment started|1|||
127636332|NCT01196975|459289416|FG000|Overall Study|Adverse Event|2|||
127636333|NCT01196975|459289417|FG001|Overall Study|Adverse Event|2|||
127636334|NCT01196975|459289418|FG002|Overall Study|Adverse Event|0|||
127636335|NCT01196975|459289419|FG003|Overall Study|Adverse Event|0|||
127636336|NCT01196975|459289420|FG004|Overall Study|Adverse Event|2|||
127636337|NCT01196975|459289416|FG000|Overall Study|Withdrawal by Subject|2|||
127636338|NCT01196975|459289417|FG001|Overall Study|Withdrawal by Subject|1|||
127636339|NCT01196975|459289418|FG002|Overall Study|Withdrawal by Subject|0|||
127636340|NCT01196975|459289419|FG003|Overall Study|Withdrawal by Subject|1|||
127636341|NCT01196975|459289420|FG004|Overall Study|Withdrawal by Subject|0|||
127636342|NCT01196975|459289416|FG000|Overall Study|Lost to Follow-up|11|||
127636343|NCT01196975|459289417|FG001|Overall Study|Lost to Follow-up|6|||
127636344|NCT01196975|459289418|FG002|Overall Study|Lost to Follow-up|5|||
127636345|NCT01196975|459289419|FG003|Overall Study|Lost to Follow-up|5|||
127636346|NCT01196975|459289420|FG004|Overall Study|Lost to Follow-up|11|||
127636347|NCT01365494|459289421|FG000|Overall Study|Adverse Event|1|||
127636348|NCT01365494|459289422|FG001|Overall Study|Adverse Event|0|||
127636349|NCT01365494|459289421|FG000|Overall Study|Withdrawal by Subject|0|||
127636350|NCT01365494|459289422|FG001|Overall Study|Withdrawal by Subject|1|||
127636351|NCT01365494|459289421|FG000|Overall Study|Lost to Follow-up|1|||
127636352|NCT01365494|459289422|FG001|Overall Study|Lost to Follow-up|2|||
127636353|NCT04782323|459289423|FG000|Overall Study|Death|1|||
127636354|NCT04782323|459289424|FG001|Overall Study|Death|0|||
127636355|NCT04782323|459289425|FG002|Overall Study|Death|0|||
127636356|NCT04782323|459289426|FG003|Overall Study|Death|0|||
127636357|NCT04782323|459289427|FG004|Overall Study|Death|1|||
127636358|NCT04782323|459289428|FG005|Overall Study|Death|1|||
127636359|NCT04782323|459289429|FG006|Overall Study|Death|1|||
127636360|NCT04782323|459289430|FG007|Overall Study|Death|0|||
127636361|NCT04782323|459289423|FG000|Overall Study|Withdrawal by Subject|0|||
127636362|NCT04782323|459289424|FG001|Overall Study|Withdrawal by Subject|0|||
127636363|NCT04782323|459289425|FG002|Overall Study|Withdrawal by Subject|1|||
127636364|NCT04782323|459289426|FG003|Overall Study|Withdrawal by Subject|0|||
127636365|NCT04782323|459289427|FG004|Overall Study|Withdrawal by Subject|0|||
127636366|NCT04782323|459289428|FG005|Overall Study|Withdrawal by Subject|1|||
127636367|NCT04782323|459289429|FG006|Overall Study|Withdrawal by Subject|0|||
127636368|NCT04782323|459289430|FG007|Overall Study|Withdrawal by Subject|1|||
127636369|NCT04782323|459289423|FG000|Overall Study|Lost to Follow-up|0|||
127636370|NCT04782323|459289424|FG001|Overall Study|Lost to Follow-up|1|||
127885741|NCT01326702|460205266|FG003|Overall Study|Not Treated|1|||
127885742|NCT01326702|460205267|FG004|Overall Study|Not Treated|0|||
127885743|NCT01326702|460205268|FG005|Overall Study|Not Treated|1|||
127885744|NCT01326702|460205269|FG006|Overall Study|Not Treated|0|||
127885745|NCT01835132|460205271|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
127885746|NCT00856778|460205272|FG000|Overall Study|Adverse Event|7|||
127885747|NCT00856778|460205272|FG000|Overall Study|Withdrawal by Subject|10|||
127885748|NCT00856778|460205272|FG000|Overall Study|Study deviation|2|||
127885749|NCT00856778|460205272|FG000|Overall Study|Lost to Follow-up|5|||
127885750|NCT00331773|460205273|FG000|Overall Study|Withdrawal by Subject|6|||
127885751|NCT00331773|460205274|FG001|Overall Study|Withdrawal by Subject|4|||
127885752|NCT00331773|460205273|FG000|Overall Study|Protocol Violation|10|||
127885753|NCT00331773|460205274|FG001|Overall Study|Protocol Violation|3|||
127885754|NCT00525031|460205275|FG000|Overall Study|Disease Progression|1|||
127885755|NCT00525031|460205276|FG001|Overall Study|Disease Progression|1|||
127885756|NCT02140164|460205277|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
127885757|NCT01872689|460205288|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
127885758|NCT01872689|460205289|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
127885759|NCT01872689|460205290|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
127885760|NCT01872689|460205291|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
127885761|NCT01872689|460205288|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
127885762|NCT01872689|460205289|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
127885763|NCT01872689|460205290|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
127885764|NCT01872689|460205291|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
127885765|NCT01872689|460205288|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
127885766|NCT01872689|460205289|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
127885767|NCT01872689|460205290|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
127885768|NCT01872689|460205291|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
127885769|NCT01872689|460205288|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
127885770|NCT01872689|460205289|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
127885771|NCT01872689|460205290|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
127885772|NCT01872689|460205291|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
127885773|NCT01872689|460205288|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
127885774|NCT01872689|460205289|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
127885775|NCT01872689|460205290|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
127885776|NCT01872689|460205291|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
127885777|NCT01872689|460205288|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
127885778|NCT01872689|460205289|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
127885779|NCT01872689|460205290|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
127885780|NCT01872689|460205291|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
127885781|NCT01872689|460205288|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
127885782|NCT01872689|460205289|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
127885783|NCT01872689|460205290|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
127885784|NCT01872689|460205291|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
127885785|NCT01872689|460205288|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
127885786|NCT01872689|460205289|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
127885787|NCT01872689|460205290|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
127885788|NCT01872689|460205291|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
127885789|NCT01872689|460205288|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
127885790|NCT01872689|460205289|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
127885791|NCT01872689|460205290|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
127885792|NCT01872689|460205291|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
127885793|NCT01872689|460205288|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
127885794|NCT01872689|460205289|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
127885795|NCT01872689|460205290|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
127885796|NCT01872689|460205291|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
127885797|NCT01872689|460205288|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
127885798|NCT01872689|460205289|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
127885799|NCT01872689|460205290|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
127885800|NCT01872689|460205291|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
127885801|NCT01872689|460205288|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
127885802|NCT01872689|460205289|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
127885803|NCT01872689|460205290|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
127885804|NCT01872689|460205291|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
127885805|NCT01872689|460205288|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
127885806|NCT01872689|460205289|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
127885807|NCT01872689|460205290|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
127885808|NCT01872689|460205291|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
127885809|NCT01872689|460205288|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
127885810|NCT01872689|460205289|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
127885811|NCT01872689|460205290|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
127885812|NCT01872689|460205291|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
127885813|NCT00686374|460205295|FG000|Overall Study|Lack of Efficacy|10|||
127885814|NCT00686374|460205295|FG000|Overall Study|Adverse Event|8|||
127885815|NCT00686374|460205295|FG000|Overall Study|Withdrew consent|5|||
127796629|NCT02028455|459877837|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
127796630|NCT02028455|459877838|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
127796631|NCT02028455|459877839|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
127796632|NCT02028455|459877840|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
127796633|NCT02028455|459877841|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
127796634|NCT02028455|459877842|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
127796635|NCT02028455|459877835|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
127796636|NCT02028455|459877836|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
127796637|NCT02028455|459877837|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
127796638|NCT02028455|459877838|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
127796639|NCT02028455|459877839|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
127796640|NCT02028455|459877840|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
127796641|NCT02028455|459877841|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
127885816|NCT00686374|460205295|FG000|Overall Study|Lost to Follow-up|1|||
127885817|NCT00686374|460205295|FG000|Overall Study|Missing reason|33|||
127885818|NCT00686374|460205295|FG000|Overall Study|Other, not specified|4|||
127636371|NCT04782323|459289425|FG002|Overall Study|Lost to Follow-up|1|||
127703182|NCT04032704|459542578|FG005|Part B|Death|0|||
127703183|NCT04032704|459542579|FG006|Part B|Death|13|||
127703184|NCT04032704|459542580|FG007|Part B|Death|13|||
127703185|NCT04032704|459542581|FG008|Part B|Death|14|||
127703186|NCT04032704|459542582|FG009|Part B|Death|12|||
127703187|NCT04032704|459542583|FG010|Part B|Death|12|||
127703188|NCT04032704|459542584|FG011|Part B|Death|13|||
127703189|NCT04032704|459542585|FG012|Part B|Death|7|||
127703190|NCT04032704|459542586|FG013|Part B|Death|17|||
127703191|NCT04032704|459542587|FG014|Part B|Death|2|||
127703192|NCT04032704|459542588|FG015|Part B|Death|1|||
127703193|NCT04032704|459542589|FG016|Part B|Death|2|||
127703194|NCT04032704|459542590|FG017|Part B|Death|2|||
127796642|NCT02028455|459877842|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
127796643|NCT02028455|459877835|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
127796644|NCT02028455|459877836|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
127796645|NCT02028455|459877837|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
127796646|NCT02028455|459877838|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
127796647|NCT02028455|459877839|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
127796648|NCT02028455|459877840|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
127796649|NCT02028455|459877841|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
127796650|NCT02028455|459877842|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
127796651|NCT02028455|459877835|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
127796652|NCT02028455|459877836|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
127796653|NCT02028455|459877837|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
127796654|NCT02028455|459877838|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
127796655|NCT02028455|459877839|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
127796656|NCT02028455|459877840|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
127796657|NCT02028455|459877841|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
127796658|NCT02028455|459877842|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
127796659|NCT02396589|459877843|FG000|Intervention|Lost to Follow-up|1|||
127796660|NCT02396589|459877844|FG001|Intervention|Lost to Follow-up|0|||
127796661|NCT02396589|459877843|FG000|6 Month Follow-up|change in health status|0|||
127796662|NCT02396589|459877844|FG001|6 Month Follow-up|change in health status|1|||
127796663|NCT02396589|459877843|FG000|9 Month Follow-up|Death|0|||
127796664|NCT02396589|459877844|FG001|9 Month Follow-up|Death|1|||
127796665|NCT02396589|459877843|FG000|12 Month Follow up|Lost to Follow-up|0|||
127796666|NCT02396589|459877844|FG001|12 Month Follow up|Lost to Follow-up|2|||
127796667|NCT01761266|459878909|FG000|Overall Study|Death|415|||
127796668|NCT01761266|459878910|FG001|Overall Study|Death|402|||
127796669|NCT01761266|459878909|FG000|Overall Study|Lost to Follow-up|8|||
127796670|NCT01761266|459878910|FG001|Overall Study|Lost to Follow-up|12|||
127796671|NCT01761266|459878909|FG000|Overall Study|Withdrawal by Subject|14|||
127796672|NCT01761266|459878910|FG001|Overall Study|Withdrawal by Subject|10|||
127796673|NCT01761266|459878909|FG000|Overall Study|Sponsor Decision|41|||
127796674|NCT01761266|459878910|FG001|Overall Study|Sponsor Decision|52|||
127796675|NCT01284114|459878911|FG000|Overall Study|viral infection|1|||
127796676|NCT01284114|459878911|FG000|Overall Study|From the results of ALLTITUDE study|1|||
127796677|NCT01284114|459878911|FG000|Overall Study|Symptomatic hypotension|1|||
127796678|NCT01284114|459878911|FG000|Overall Study|dizziness|1|||
127796679|NCT03445000|459878913|FG000|Overall Study|Disease progression|8|||
127796680|NCT03445000|459878913|FG000|Overall Study|Adverse Event|3|||
127796681|NCT03445000|459878913|FG000|Overall Study|Death|2|||
127796682|NCT03445000|459878913|FG000|Overall Study|Physician Decision|1|||
127796683|NCT03409744|459878914|FG000|Overall Study|Death|2|||
127796684|NCT03409744|459878914|FG000|Overall Study|Physician Decision|5|||
127796685|NCT03409744|459878914|FG000|Overall Study|Pregnancy|1|||
127796686|NCT03409744|459878914|FG000|Overall Study|Lost to Follow-up|1|||
127796687|NCT03409744|459878914|FG000|Overall Study|Protocol Violation|1|||
127796688|NCT02740478|459878919|FG000|Overall Study|Withdrawal by Subject|1|||
127796689|NCT00699348|459878923|FG000|Overall Study|Death|6|||
127796690|NCT00699348|459878923|FG000|Overall Study|Adverse Event|15|||
127796691|NCT00699348|459878923|FG000|Overall Study|Withdrawal by Subject|11|||
127796692|NCT00699348|459878923|FG000|Overall Study|Protocol Violation|10|||
127796693|NCT00699348|459878923|FG000|Overall Study|Lack of Efficacy|8|||
127796694|NCT00699348|459878923|FG000|Overall Study|Failure to return|1|||
127796695|NCT00699348|459878923|FG000|Overall Study|Blood transfusion|24|||
127796696|NCT00699348|459878923|FG000|Overall Study|Renal transplantation|10|||
127703195|NCT02861300|459542591|FG000|Overall Study|Death|0|||
127703196|NCT02861300|459542592|FG001|Overall Study|Death|0|||
127703197|NCT02861300|459542593|FG002|Overall Study|Death|0|||
127703198|NCT02861300|459542594|FG003|Overall Study|Death|0|||
127703199|NCT02861300|459542595|FG004|Overall Study|Death|0|||
127703200|NCT02861300|459542596|FG005|Overall Study|Death|0|||
127796697|NCT00699348|459878923|FG000|Overall Study|Other|5|||
127796698|NCT03269344|459878924|FG000|Overall Study|Protocol Violation|4|||
127796699|NCT03269344|459878925|FG001|Overall Study|Protocol Violation|3|||
127636372|NCT04782323|459289426|FG003|Overall Study|Lost to Follow-up|0|||
127636373|NCT04782323|459289427|FG004|Overall Study|Lost to Follow-up|0|||
127636374|NCT04782323|459289428|FG005|Overall Study|Lost to Follow-up|1|||
127636375|NCT04782323|459289429|FG006|Overall Study|Lost to Follow-up|1|||
127636376|NCT04782323|459289430|FG007|Overall Study|Lost to Follow-up|2|||
127636377|NCT04782323|459289423|FG000|Overall Study|randomization in error|1|||
127636378|NCT04782323|459289424|FG001|Overall Study|randomization in error|0|||
127636379|NCT04782323|459289425|FG002|Overall Study|randomization in error|0|||
127636380|NCT04782323|459289426|FG003|Overall Study|randomization in error|0|||
127636381|NCT04782323|459289427|FG004|Overall Study|randomization in error|0|||
127636382|NCT04782323|459289428|FG005|Overall Study|randomization in error|0|||
127636383|NCT04782323|459289429|FG006|Overall Study|randomization in error|0|||
127636384|NCT04782323|459289430|FG007|Overall Study|randomization in error|0|||
127636385|NCT00718718|459289431|FG000|Prior to Week 12|Adverse Event|0|||
127636386|NCT00718718|459289432|FG001|Prior to Week 12|Adverse Event|0|||
127636387|NCT00718718|459289433|FG002|Prior to Week 12|Adverse Event|0|||
127636388|NCT00718718|459289434|FG003|Prior to Week 12|Adverse Event|0|||
127636389|NCT00718718|459289435|FG004|Prior to Week 12|Adverse Event|0|||
127636390|NCT00718718|459289436|FG005|Prior to Week 12|Adverse Event|0|||
127636391|NCT00718718|459289437|FG006|Prior to Week 12|Adverse Event|0|||
127636392|NCT00718718|459289438|FG007|Prior to Week 12|Adverse Event|1|||
127636393|NCT00718718|459289439|FG008|Prior to Week 12|Adverse Event|1|||
127636394|NCT00718718|459289440|FG009|Prior to Week 12|Adverse Event|0|||
127636395|NCT00718718|459289431|FG000|Prior to Week 12|Withdrawal by Subject|0|||
127636396|NCT00718718|459289432|FG001|Prior to Week 12|Withdrawal by Subject|0|||
127636397|NCT00718718|459289433|FG002|Prior to Week 12|Withdrawal by Subject|0|||
127636398|NCT00718718|459289434|FG003|Prior to Week 12|Withdrawal by Subject|0|||
127636399|NCT00718718|459289435|FG004|Prior to Week 12|Withdrawal by Subject|3|||
127636400|NCT00718718|459289436|FG005|Prior to Week 12|Withdrawal by Subject|0|||
127636401|NCT00718718|459289437|FG006|Prior to Week 12|Withdrawal by Subject|1|||
127636402|NCT00718718|459289438|FG007|Prior to Week 12|Withdrawal by Subject|1|||
127636403|NCT00718718|459289439|FG008|Prior to Week 12|Withdrawal by Subject|1|||
127636404|NCT00718718|459289440|FG009|Prior to Week 12|Withdrawal by Subject|0|||
127636405|NCT00718718|459289431|FG000|Prior to Week 12|Other|1|||
127636406|NCT00718718|459289432|FG001|Prior to Week 12|Other|0|||
127636407|NCT00718718|459289433|FG002|Prior to Week 12|Other|1|||
127636408|NCT00718718|459289434|FG003|Prior to Week 12|Other|0|||
127636409|NCT00718718|459289435|FG004|Prior to Week 12|Other|0|||
127636410|NCT00718718|459289436|FG005|Prior to Week 12|Other|0|||
127636411|NCT00718718|459289437|FG006|Prior to Week 12|Other|0|||
127636412|NCT00718718|459289438|FG007|Prior to Week 12|Other|0|||
127636413|NCT00718718|459289439|FG008|Prior to Week 12|Other|0|||
127636414|NCT00718718|459289440|FG009|Prior to Week 12|Other|0|||
127636415|NCT00718718|459289431|FG000|Week 12 to End of Study|Adverse Event|0|||
127636416|NCT00718718|459289432|FG001|Week 12 to End of Study|Adverse Event|0|||
127636417|NCT00718718|459289433|FG002|Week 12 to End of Study|Adverse Event|0|||
127636418|NCT00718718|459289434|FG003|Week 12 to End of Study|Adverse Event|0|||
127636419|NCT00718718|459289435|FG004|Week 12 to End of Study|Adverse Event|0|||
127636420|NCT00718718|459289436|FG005|Week 12 to End of Study|Adverse Event|0|||
127636421|NCT00718718|459289437|FG006|Week 12 to End of Study|Adverse Event|0|||
127636422|NCT00718718|459289438|FG007|Week 12 to End of Study|Adverse Event|1|||
127636423|NCT00718718|459289439|FG008|Week 12 to End of Study|Adverse Event|0|||
127636424|NCT00718718|459289440|FG009|Week 12 to End of Study|Adverse Event|0|||
127636425|NCT00718718|459289431|FG000|Week 12 to End of Study|Death|0|||
127636426|NCT00718718|459289432|FG001|Week 12 to End of Study|Death|0|||
127636427|NCT00718718|459289433|FG002|Week 12 to End of Study|Death|0|||
127703201|NCT02861300|459542597|FG006|Overall Study|Death|24|||
127703202|NCT02861300|459542591|FG000|Overall Study|Delay in treatment|0|||
127703203|NCT02861300|459542592|FG001|Overall Study|Delay in treatment|0|||
127703204|NCT02861300|459542593|FG002|Overall Study|Delay in treatment|0|||
127703205|NCT02861300|459542594|FG003|Overall Study|Delay in treatment|0|||
127636428|NCT00718718|459289434|FG003|Week 12 to End of Study|Death|0|||
127636429|NCT00718718|459289435|FG004|Week 12 to End of Study|Death|0|||
127636430|NCT00718718|459289436|FG005|Week 12 to End of Study|Death|1|||
127703206|NCT02861300|459542595|FG004|Overall Study|Delay in treatment|0|||
127636431|NCT00718718|459289437|FG006|Week 12 to End of Study|Death|0|||
127636432|NCT00718718|459289438|FG007|Week 12 to End of Study|Death|0|||
127636433|NCT00718718|459289439|FG008|Week 12 to End of Study|Death|0|||
127636434|NCT00718718|459289440|FG009|Week 12 to End of Study|Death|0|||
127636435|NCT00718718|459289431|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
127636436|NCT00718718|459289432|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
127636437|NCT00718718|459289433|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
127636438|NCT00718718|459289434|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
127636439|NCT00718718|459289435|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
127636440|NCT00718718|459289436|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
127636441|NCT00718718|459289437|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
127636442|NCT00718718|459289438|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
127636443|NCT00718718|459289439|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
127636444|NCT00718718|459289440|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
127636445|NCT00718718|459289431|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
127636446|NCT00718718|459289432|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
127636447|NCT00718718|459289433|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
127636448|NCT00718718|459289434|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
127636449|NCT00718718|459289435|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
127636450|NCT00718718|459289436|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
127636451|NCT00718718|459289437|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
127636452|NCT00718718|459289438|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
127636453|NCT00718718|459289439|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
127636454|NCT00718718|459289440|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
127636455|NCT00718718|459289431|FG000|Week 12 to End of Study|Other|0|||
127636456|NCT00718718|459289432|FG001|Week 12 to End of Study|Other|1|||
127636457|NCT00718718|459289433|FG002|Week 12 to End of Study|Other|0|||
127636458|NCT00718718|459289434|FG003|Week 12 to End of Study|Other|1|||
127636459|NCT00718718|459289435|FG004|Week 12 to End of Study|Other|0|||
127636460|NCT00718718|459289436|FG005|Week 12 to End of Study|Other|0|||
127636461|NCT00718718|459289437|FG006|Week 12 to End of Study|Other|1|||
127636462|NCT00718718|459289438|FG007|Week 12 to End of Study|Other|0|||
127636463|NCT00718718|459289439|FG008|Week 12 to End of Study|Other|0|||
127636464|NCT00718718|459289440|FG009|Week 12 to End of Study|Other|0|||
127636465|NCT04558346|459289449|FG000|Overall Study|Withdrawal by Subject|2|||
127636466|NCT04558346|459289450|FG001|Overall Study|Withdrawal by Subject|0|||
127636467|NCT04558346|459289449|FG000|Overall Study|Lost to Follow-up|0|||
127636468|NCT04558346|459289450|FG001|Overall Study|Lost to Follow-up|1|||
127636469|NCT04558346|459289449|FG000|Overall Study|Adverse Event|0|||
127636470|NCT04558346|459289450|FG001|Overall Study|Adverse Event|1|||
127636471|NCT02715765|459289451|FG000|Overall Study|Study Termination|3|||
127636472|NCT02715765|459289452|FG001|Overall Study|Study Termination|0|||
127636473|NCT02715765|459289453|FG002|Overall Study|Study Termination|0|||
127636474|NCT01462344|459289454|FG000|Overall Study|Withdrawal by Subject|245|||
127636475|NCT01462344|459289455|FG001|Overall Study|Withdrawal by Subject|226|||
127636476|NCT01462344|459289454|FG000|Overall Study|Adverse Event|24|||
127636477|NCT01462344|459289455|FG001|Overall Study|Adverse Event|23|||
127636478|NCT01462344|459289454|FG000|Overall Study|Asthma Exacerbation|34|||
127636479|NCT01462344|459289455|FG001|Overall Study|Asthma Exacerbation|35|||
127636480|NCT01462344|459289454|FG000|Overall Study|Lack of Efficacy|5|||
127636481|NCT01462344|459289455|FG001|Overall Study|Lack of Efficacy|6|||
127636482|NCT01462344|459289454|FG000|Overall Study|Protocol Violation|68|||
127636483|NCT01462344|459289455|FG001|Overall Study|Protocol Violation|53|||
127636484|NCT01462344|459289454|FG000|Overall Study|Lost to Follow-up|7|||
127636485|NCT01462344|459289455|FG001|Overall Study|Lost to Follow-up|7|||
127703207|NCT02861300|459542596|FG005|Overall Study|Delay in treatment|1|||
127885819|NCT03066440|460205296|FG000|Overall Study|Physician Decision|1|||
127885820|NCT03066440|460205297|FG001|Overall Study|Physician Decision|1|||
127885821|NCT03066440|460205296|FG000|Overall Study|Protocol Violation|0|||
127885822|NCT03066440|460205297|FG001|Overall Study|Protocol Violation|2|||
127885823|NCT01106352|460205301|FG000|Overall Study|Subjects untreated|0|||
127885824|NCT01106352|460205302|FG001|Overall Study|Subjects untreated|0|||
127885825|NCT01106352|460205303|FG002|Overall Study|Subjects untreated|0|||
127885826|NCT01106352|460205304|FG003|Overall Study|Subjects untreated|3|||
127885827|NCT01106352|460205305|FG004|Overall Study|Subjects untreated|4|||
127885828|NCT01106352|460205301|FG000|Overall Study|Sponsor Decision|1|||
127885829|NCT01106352|460205302|FG001|Overall Study|Sponsor Decision|0|||
127885830|NCT01106352|460205303|FG002|Overall Study|Sponsor Decision|0|||
127885831|NCT01106352|460205304|FG003|Overall Study|Sponsor Decision|0|||
127636486|NCT01003249|459289458|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
127636487|NCT01003249|459289459|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
127636488|NCT01003249|459289458|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
127636489|NCT01003249|459289459|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
127636490|NCT01003249|459289458|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
127636491|NCT01003249|459289459|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
127636492|NCT01003249|459289458|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
127636493|NCT01003249|459289459|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
127636494|NCT01962974|459289460|FG000|Overall Study|Study termination|7|||
127636495|NCT03394924|459289467|FG000|Overall Study|Adverse Event|0|||
127636496|NCT03394924|459289468|FG001|Overall Study|Adverse Event|5|||
127636497|NCT03394924|459289469|FG002|Overall Study|Adverse Event|0|||
127636498|NCT03394924|459289467|FG000|Overall Study|Withdrawal by Subject|2|||
127636499|NCT03394924|459289468|FG001|Overall Study|Withdrawal by Subject|0|||
127636500|NCT03394924|459289469|FG002|Overall Study|Withdrawal by Subject|0|||
127636501|NCT03394924|459289467|FG000|Overall Study|Lost to Follow-up|0|||
127636502|NCT03394924|459289468|FG001|Overall Study|Lost to Follow-up|1|||
127636503|NCT03394924|459289469|FG002|Overall Study|Lost to Follow-up|0|||
127636504|NCT03394924|459289467|FG000|Overall Study|Did not meet all inclusion criteria|1|||
127636505|NCT03394924|459289468|FG001|Overall Study|Did not meet all inclusion criteria|0|||
127636506|NCT03394924|459289469|FG002|Overall Study|Did not meet all inclusion criteria|0|||
127636507|NCT03588572|459289472|FG000|Visitation 1|Lack of Efficacy|1|||
127636508|NCT03588572|459289473|FG001|Visitation 1|Lack of Efficacy|1|||
127636509|NCT03588572|459289472|FG000|Visitation 2|Lost to Follow-up|1|||
127636510|NCT03588572|459289473|FG001|Visitation 2|Lost to Follow-up|1|||
127636511|NCT03588572|459289472|FG000|Visitation 2|Lack of Efficacy|0|||
127636512|NCT03588572|459289473|FG001|Visitation 2|Lack of Efficacy|1|||
127636513|NCT03588572|459289472|FG000|Visitation 2|Withdrawal by Subject|1|||
127636514|NCT03588572|459289473|FG001|Visitation 2|Withdrawal by Subject|0|||
127636515|NCT03588572|459289472|FG000|Visitation 3|Lost to Follow-up|1|||
127636516|NCT03588572|459289473|FG001|Visitation 3|Lost to Follow-up|1|||
127636517|NCT03588572|459289472|FG000|Visitation 3|Physician Decision|1|||
127636518|NCT03588572|459289473|FG001|Visitation 3|Physician Decision|1|||
127636519|NCT03588572|459289472|FG000|Visitation 3|Withdrawal by Subject|1|||
127636520|NCT03588572|459289473|FG001|Visitation 3|Withdrawal by Subject|0|||
127636521|NCT03387852|459289475|FG000|Overall Study|Adverse event (AE)|3|||
127636522|NCT03387852|459289476|FG001|Overall Study|Adverse event (AE)|0|||
127636523|NCT03387852|459289477|FG002|Overall Study|Adverse event (AE)|2|||
127636524|NCT03387852|459289478|FG003|Overall Study|Adverse event (AE)|0|||
127636525|NCT03387852|459289475|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
127636526|NCT03387852|459289476|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
127636527|NCT03387852|459289477|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
127636528|NCT03387852|459289478|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
127636529|NCT03387852|459289475|FG000|Overall Study|Withdrawal by participant|1|||
127636530|NCT03387852|459289476|FG001|Overall Study|Withdrawal by participant|1|||
127636531|NCT03387852|459289477|FG002|Overall Study|Withdrawal by participant|3|||
127636532|NCT03387852|459289478|FG003|Overall Study|Withdrawal by participant|2|||
127636533|NCT03387852|459289475|FG000|Overall Study|Other- Unspecified|1|||
127885832|NCT01106352|460205305|FG004|Overall Study|Sponsor Decision|0|||
127885833|NCT01106352|460205301|FG000|Overall Study|Too ill to come in for the visit|0|||
127885834|NCT01106352|460205302|FG001|Overall Study|Too ill to come in for the visit|0|||
127636534|NCT03387852|459289476|FG001|Overall Study|Other- Unspecified|1|||
127885835|NCT01106352|460205303|FG002|Overall Study|Too ill to come in for the visit|1|||
127636535|NCT03387852|459289477|FG002|Overall Study|Other- Unspecified|2|||
127636536|NCT03387852|459289478|FG003|Overall Study|Other- Unspecified|1|||
127636537|NCT03387852|459289475|FG000|Overall Study|Poor compliance to protocol|0|||
127636538|NCT03387852|459289476|FG001|Overall Study|Poor compliance to protocol|0|||
127636539|NCT03387852|459289477|FG002|Overall Study|Poor compliance to protocol|0|||
127636540|NCT03387852|459289478|FG003|Overall Study|Poor compliance to protocol|1|||
127885836|NCT01106352|460205304|FG003|Overall Study|Too ill to come in for the visit|0|||
127885837|NCT01106352|460205305|FG004|Overall Study|Too ill to come in for the visit|0|||
127885838|NCT01106352|460205301|FG000|Overall Study|Lost to Follow-up|0|||
127885839|NCT01106352|460205302|FG001|Overall Study|Lost to Follow-up|0|||
127636541|NCT03387852|459289475|FG000|Overall Study|Randomized and not treated|0|||
127636542|NCT03387852|459289476|FG001|Overall Study|Randomized and not treated|0|||
127636543|NCT03387852|459289477|FG002|Overall Study|Randomized and not treated|0|||
127636544|NCT03387852|459289478|FG003|Overall Study|Randomized and not treated|1|||
127636545|NCT02535065|459289487|FG000|Overall Study|Death|13|||
127636546|NCT02535065|459289487|FG000|Overall Study|Lost to Follow-up|1|||
127636547|NCT02535065|459289487|FG000|Overall Study|Withdrawal by Subject|6|||
127636548|NCT00110617|459289489|FG000|Overall Study|Adverse Event|2|||
127636549|NCT00110617|459289490|FG001|Overall Study|Adverse Event|4|||
127636550|NCT00110617|459289489|FG000|Overall Study|Abnormal Laboratory Value|4|||
127636551|NCT00110617|459289490|FG001|Overall Study|Abnormal Laboratory Value|2|||
127636552|NCT00110617|459289489|FG000|Overall Study|Lack of Efficacy|1|||
127636553|NCT00110617|459289490|FG001|Overall Study|Lack of Efficacy|0|||
127636554|NCT00110617|459289489|FG000|Overall Study|Patient no longer requires study drug|1|||
127636555|NCT00110617|459289490|FG001|Overall Study|Patient no longer requires study drug|0|||
127636556|NCT00110617|459289489|FG000|Overall Study|Protocol Violation|5|||
127636557|NCT00110617|459289490|FG001|Overall Study|Protocol Violation|0|||
127636558|NCT00110617|459289489|FG000|Overall Study|Withdrawal by Subject|10|||
127636559|NCT00110617|459289490|FG001|Overall Study|Withdrawal by Subject|4|||
127636560|NCT00110617|459289489|FG000|Overall Study|Lost to Follow-up|9|||
127636561|NCT00110617|459289490|FG001|Overall Study|Lost to Follow-up|1|||
127636562|NCT00110617|459289489|FG000|Overall Study|Administrative problems|6|||
127636563|NCT00110617|459289490|FG001|Overall Study|Administrative problems|5|||
127636564|NCT00110617|459289489|FG000|Overall Study|Death|1|||
127636565|NCT00110617|459289490|FG001|Overall Study|Death|1|||
127636566|NCT00110617|459289489|FG000|Overall Study|Did not receive study drug|0|||
127636567|NCT00110617|459289490|FG001|Overall Study|Did not receive study drug|12|||
127636568|NCT01781572|459289492|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
127636569|NCT01781572|459289493|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
127636570|NCT01781572|459289494|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
127636571|NCT01781572|459289492|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
127636572|NCT01781572|459289493|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
127636573|NCT01781572|459289494|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
127636574|NCT01781572|459289492|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
127636575|NCT01781572|459289493|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
127636576|NCT01781572|459289494|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
127636577|NCT01781572|459289492|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
127636578|NCT01781572|459289493|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
127636579|NCT01781572|459289494|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
127636580|NCT01781572|459289492|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
127636581|NCT01781572|459289493|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
127636582|NCT01781572|459289494|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
127636583|NCT01781572|459289492|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
127636584|NCT01781572|459289493|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
127636585|NCT01781572|459289494|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
127636586|NCT01781572|459289492|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
127636587|NCT01781572|459289493|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
127636588|NCT01781572|459289494|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
127636589|NCT01781572|459289492|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
127636590|NCT01781572|459289493|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
127636591|NCT01781572|459289494|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
127636592|NCT01781572|459289492|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
127636593|NCT01781572|459289493|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
127636594|NCT01781572|459289494|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
127636595|NCT01781572|459289492|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
127636596|NCT01781572|459289493|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
127636597|NCT01781572|459289494|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
127636598|NCT01781572|459289492|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
127636599|NCT01781572|459289493|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
127636600|NCT01781572|459289494|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
127636601|NCT01781572|459289492|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
127636602|NCT01781572|459289493|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
127636603|NCT01781572|459289494|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
127636604|NCT01781572|459289492|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
127636605|NCT01781572|459289493|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
127636606|NCT01781572|459289494|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
127636607|NCT01781572|459289492|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
127636608|NCT01781572|459289493|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
127885840|NCT01106352|460205303|FG002|Overall Study|Lost to Follow-up|0|||
127636609|NCT01781572|459289494|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
127636610|NCT01781572|459289492|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
127636611|NCT01781572|459289493|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
127636612|NCT01781572|459289494|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
127636613|NCT01781572|459289492|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
127636614|NCT01781572|459289493|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
127636615|NCT01781572|459289494|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
127636616|NCT01781572|459289492|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
127636617|NCT01781572|459289493|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
127636618|NCT01781572|459289494|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
127636619|NCT01781572|459289492|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
127636620|NCT01781572|459289493|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
127636621|NCT01781572|459289494|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
127636622|NCT00045110|459289495|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
127636623|NCT00045110|459289496|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
127636624|NCT00045110|459289497|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
127636625|NCT00045110|459289495|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
127636626|NCT00045110|459289496|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
127636627|NCT00045110|459289497|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
127636628|NCT00045110|459289495|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
127636629|NCT00045110|459289496|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
127636630|NCT00045110|459289497|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
127636631|NCT04827576|459291769|FG000|Overall Study|Death|5|||
127636632|NCT04827576|459291770|FG001|Overall Study|Death|17|||
127636633|NCT04827576|459291771|FG002|Overall Study|Death|17|||
127636634|NCT04827576|459291772|FG003|Overall Study|Death|32|||
127636635|NCT04827576|459291769|FG000|Overall Study|Study Terminated by Sponsor|2|||
127636636|NCT04827576|459291770|FG001|Overall Study|Study Terminated by Sponsor|9|||
127636637|NCT04827576|459291771|FG002|Overall Study|Study Terminated by Sponsor|7|||
127636638|NCT04827576|459291772|FG003|Overall Study|Study Terminated by Sponsor|5|||
127636639|NCT04827576|459291769|FG000|Overall Study|Investigator's Discretion|1|||
127636640|NCT04827576|459291770|FG001|Overall Study|Investigator's Discretion|0|||
127636641|NCT04827576|459291771|FG002|Overall Study|Investigator's Discretion|2|||
127636642|NCT04827576|459291772|FG003|Overall Study|Investigator's Discretion|5|||
127636643|NCT04827576|459291769|FG000|Overall Study|Withdrew Consent|0|||
127636644|NCT04827576|459291770|FG001|Overall Study|Withdrew Consent|3|||
127636645|NCT04827576|459291771|FG002|Overall Study|Withdrew Consent|0|||
127636646|NCT04827576|459291772|FG003|Overall Study|Withdrew Consent|0|||
127636647|NCT04827576|459291769|FG000|Overall Study|Lost to Follow-up|1|||
127636648|NCT04827576|459291770|FG001|Overall Study|Lost to Follow-up|0|||
127636649|NCT04827576|459291771|FG002|Overall Study|Lost to Follow-up|0|||
127636650|NCT04827576|459291772|FG003|Overall Study|Lost to Follow-up|0|||
127636651|NCT03069482|459291773|FG000|Overall Study|Lost to Follow-up|0|||
127636652|NCT03069482|459291774|FG001|Overall Study|Lost to Follow-up|1|||
127636653|NCT03069482|459291773|FG000|Overall Study|Physician Decision|1|||
127636654|NCT03069482|459291774|FG001|Overall Study|Physician Decision|0|||
127636655|NCT04537923|459291775|FG000|Overall Study|Adverse Event|2|||
127636656|NCT04537923|459291776|FG001|Overall Study|Adverse Event|1|||
127636657|NCT04537923|459291777|FG002|Overall Study|Adverse Event|2|||
127636658|NCT04537923|459291778|FG003|Overall Study|Adverse Event|4|||
127636659|NCT04537923|459291775|FG000|Overall Study|Death|3|||
127636660|NCT04537923|459291776|FG001|Overall Study|Death|3|||
127636661|NCT04537923|459291777|FG002|Overall Study|Death|1|||
127636662|NCT04537923|459291778|FG003|Overall Study|Death|11|||
127636663|NCT04537923|459291775|FG000|Overall Study|Lost to Follow-up|1|||
127636664|NCT04537923|459291776|FG001|Overall Study|Lost to Follow-up|2|||
127636665|NCT04537923|459291777|FG002|Overall Study|Lost to Follow-up|1|||
127636666|NCT04537923|459291778|FG003|Overall Study|Lost to Follow-up|6|||
127636667|NCT04537923|459291775|FG000|Overall Study|Physician Decision|1|||
127636668|NCT04537923|459291776|FG001|Overall Study|Physician Decision|0|||
127636669|NCT04537923|459291777|FG002|Overall Study|Physician Decision|2|||
127636670|NCT04537923|459291778|FG003|Overall Study|Physician Decision|5|||
127636671|NCT04537923|459291775|FG000|Overall Study|Pregnancy|1|||
127885841|NCT01106352|460205304|FG003|Overall Study|Lost to Follow-up|0|||
127885842|NCT01106352|460205305|FG004|Overall Study|Lost to Follow-up|1|||
127885843|NCT01106352|460205301|FG000|Overall Study|Death|0|||
127885844|NCT01106352|460205302|FG001|Overall Study|Death|0|||
127885845|NCT01106352|460205303|FG002|Overall Study|Death|1|||
127636672|NCT04537923|459291776|FG001|Overall Study|Pregnancy|0|||
127636673|NCT04537923|459291777|FG002|Overall Study|Pregnancy|0|||
127636674|NCT04537923|459291778|FG003|Overall Study|Pregnancy|0|||
127636675|NCT04537923|459291775|FG000|Overall Study|Withdrawal by Subject|4|||
127636676|NCT04537923|459291776|FG001|Overall Study|Withdrawal by Subject|4|||
127636677|NCT04537923|459291777|FG002|Overall Study|Withdrawal by Subject|4|||
127636678|NCT04537923|459291778|FG003|Overall Study|Withdrawal by Subject|58|||
127636679|NCT04537923|459291775|FG000|Overall Study|Missed study visits|2|||
127636680|NCT04537923|459291776|FG001|Overall Study|Missed study visits|0|||
127636681|NCT04537923|459291777|FG002|Overall Study|Missed study visits|0|||
127885846|NCT01106352|460205304|FG003|Overall Study|Death|3|||
127885847|NCT01106352|460205305|FG004|Overall Study|Death|1|||
127885848|NCT01106352|460205301|FG000|Overall Study|Disease progression|0|||
127636682|NCT04537923|459291778|FG003|Overall Study|Missed study visits|3|||
127636683|NCT04537923|459291775|FG000|Overall Study|Sponsor's decision|0|||
127636684|NCT04537923|459291776|FG001|Overall Study|Sponsor's decision|0|||
127636685|NCT04537923|459291777|FG002|Overall Study|Sponsor's decision|1|||
127636686|NCT04537923|459291778|FG003|Overall Study|Sponsor's decision|1|||
127636687|NCT04537923|459291775|FG000|Overall Study|Safety reasons|1|||
127636688|NCT04537923|459291776|FG001|Overall Study|Safety reasons|0|||
127636689|NCT04537923|459291777|FG002|Overall Study|Safety reasons|0|||
127636690|NCT04537923|459291778|FG003|Overall Study|Safety reasons|0|||
127636691|NCT01261611|459291779|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
127636692|NCT01261611|459291780|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
127636693|NCT01261611|459291781|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
127636694|NCT01261611|459291779|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
127636695|NCT01261611|459291780|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
127636696|NCT01261611|459291781|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
127636697|NCT01261611|459291779|FG000|Treatment Cycle 1|Adverse Event|0|||
127636698|NCT01261611|459291780|FG001|Treatment Cycle 1|Adverse Event|1|||
127636699|NCT01261611|459291781|FG002|Treatment Cycle 1|Adverse Event|0|||
127636700|NCT01261611|459291779|FG000|Treatment Cycle 1|Protocol Violation|0|||
127636701|NCT01261611|459291780|FG001|Treatment Cycle 1|Protocol Violation|0|||
127636702|NCT01261611|459291781|FG002|Treatment Cycle 1|Protocol Violation|2|||
127636703|NCT01261611|459291779|FG000|Treatment Cycle 2|Completed study|4|||
127636704|NCT01261611|459291780|FG001|Treatment Cycle 2|Completed study|0|||
127636705|NCT01261611|459291781|FG002|Treatment Cycle 2|Completed study|0|||
127636706|NCT01261611|459291779|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
127636707|NCT01261611|459291780|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
127636708|NCT01261611|459291781|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
127636709|NCT01261611|459291779|FG000|Treatment Cycle 2|Adverse Event|1|||
127636710|NCT01261611|459291780|FG001|Treatment Cycle 2|Adverse Event|0|||
127636711|NCT01261611|459291781|FG002|Treatment Cycle 2|Adverse Event|0|||
127636712|NCT01261611|459291779|FG000|Treatment Cycle 2|Protocol Violation|2|||
127636713|NCT01261611|459291780|FG001|Treatment Cycle 2|Protocol Violation|0|||
127636714|NCT01261611|459291781|FG002|Treatment Cycle 2|Protocol Violation|0|||
127636715|NCT01261611|459291779|FG000|Treatment Cycle 2|Not otherwise specified|2|||
127636716|NCT01261611|459291780|FG001|Treatment Cycle 2|Not otherwise specified|0|||
127636717|NCT01261611|459291781|FG002|Treatment Cycle 2|Not otherwise specified|0|||
127636718|NCT01261611|459291779|FG000|Treatment Cycle 3|Completed study|24|||
127636719|NCT01261611|459291780|FG001|Treatment Cycle 3|Completed study|0|||
127636720|NCT01261611|459291781|FG002|Treatment Cycle 3|Completed study|0|||
127636721|NCT01261611|459291779|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
127636722|NCT01261611|459291780|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
127636723|NCT01261611|459291781|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
127636724|NCT01261611|459291779|FG000|Treatment Cycle 3|Adverse Event|1|||
127636725|NCT01261611|459291780|FG001|Treatment Cycle 3|Adverse Event|0|||
127636726|NCT01261611|459291781|FG002|Treatment Cycle 3|Adverse Event|0|||
127636727|NCT01261611|459291779|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
127636728|NCT01261611|459291780|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
127636729|NCT01261611|459291781|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
127636730|NCT01261611|459291779|FG000|Treatment Cycle 4|Completed study|87|||
127636731|NCT01261611|459291780|FG001|Treatment Cycle 4|Completed study|0|||
127636732|NCT01261611|459291781|FG002|Treatment Cycle 4|Completed study|0|||
127636733|NCT01261611|459291779|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
127636734|NCT01261611|459291780|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
127636735|NCT01261611|459291781|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
127636736|NCT01261611|459291779|FG000|Treatment Cycle 4|Adverse Event|1|||
127636737|NCT01261611|459291780|FG001|Treatment Cycle 4|Adverse Event|0|||
127796700|NCT02597855|459878928|FG000|Overall Study|Lost to Follow-up|2|||
127796701|NCT02597855|459878929|FG001|Overall Study|Lost to Follow-up|1|||
127796702|NCT03704194|459878935|FG000|Overall Study|Withdrawal by Subject|0|||
127796703|NCT03704194|459878936|FG001|Overall Study|Withdrawal by Subject|1|||
127636738|NCT01261611|459291781|FG002|Treatment Cycle 4|Adverse Event|0|||
127636739|NCT01261611|459291779|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
127636740|NCT01261611|459291780|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
127636741|NCT01261611|459291781|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
127636742|NCT01261611|459291779|FG000|Treatment Cycle 4|Not otherwise specified|3|||
127636743|NCT01261611|459291780|FG001|Treatment Cycle 4|Not otherwise specified|0|||
127636744|NCT01261611|459291781|FG002|Treatment Cycle 4|Not otherwise specified|0|||
127636745|NCT01261611|459291779|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
127636746|NCT01261611|459291780|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
127636747|NCT01261611|459291781|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
127796704|NCT02469090|459878940|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
127636748|NCT01261611|459291779|FG000|Treatment Cycle 5|Adverse Event|1|||
127636749|NCT01261611|459291780|FG001|Treatment Cycle 5|Adverse Event|0|||
127636750|NCT01261611|459291781|FG002|Treatment Cycle 5|Adverse Event|0|||
127636751|NCT01261611|459291779|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
127636752|NCT01261611|459291780|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
127636753|NCT01261611|459291781|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
127636754|NCT02527798|459291782|FG000|Overall Study|Physician Decision|1|||
127636755|NCT02527798|459291783|FG001|Overall Study|Physician Decision|0|||
127636756|NCT02527798|459291784|FG002|Overall Study|Physician Decision|1|||
127636757|NCT02527798|459291785|FG003|Overall Study|Physician Decision|1|||
127636758|NCT02527798|459291786|FG004|Overall Study|Physician Decision|0|||
127796705|NCT02469090|459878941|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
127796706|NCT02469090|459878942|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
127796707|NCT02469090|459878940|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
127796708|NCT02469090|459878941|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
127796709|NCT02469090|459878942|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
127636759|NCT02527798|459291787|FG005|Overall Study|Physician Decision|0|||
127636760|NCT02527798|459291782|FG000|Overall Study|Death|0|||
127636761|NCT02527798|459291783|FG001|Overall Study|Death|0|||
127636762|NCT02527798|459291784|FG002|Overall Study|Death|1|||
127636763|NCT02527798|459291785|FG003|Overall Study|Death|0|||
127636764|NCT02527798|459291786|FG004|Overall Study|Death|0|||
127636765|NCT02527798|459291787|FG005|Overall Study|Death|0|||
127636766|NCT02527798|459291782|FG000|Overall Study|Withdrawal by Subject|0|||
127636767|NCT02527798|459291783|FG001|Overall Study|Withdrawal by Subject|1|||
127636768|NCT02527798|459291784|FG002|Overall Study|Withdrawal by Subject|2|||
127636769|NCT02527798|459291785|FG003|Overall Study|Withdrawal by Subject|0|||
127636770|NCT02527798|459291786|FG004|Overall Study|Withdrawal by Subject|0|||
127636771|NCT02527798|459291787|FG005|Overall Study|Withdrawal by Subject|0|||
127636772|NCT02527798|459291782|FG000|Overall Study|Reason undisclosed|1|||
127636773|NCT02527798|459291783|FG001|Overall Study|Reason undisclosed|0|||
127636774|NCT02527798|459291784|FG002|Overall Study|Reason undisclosed|1|||
127636775|NCT02527798|459291785|FG003|Overall Study|Reason undisclosed|0|||
127636776|NCT02527798|459291786|FG004|Overall Study|Reason undisclosed|0|||
127636777|NCT02527798|459291787|FG005|Overall Study|Reason undisclosed|0|||
127636778|NCT02527798|459291782|FG000|Overall Study|Did not receive intervention|1|||
127636779|NCT02527798|459291783|FG001|Overall Study|Did not receive intervention|1|||
127636780|NCT02527798|459291784|FG002|Overall Study|Did not receive intervention|0|||
127636781|NCT02527798|459291785|FG003|Overall Study|Did not receive intervention|0|||
127636782|NCT02527798|459291786|FG004|Overall Study|Did not receive intervention|0|||
127636783|NCT02527798|459291787|FG005|Overall Study|Did not receive intervention|0|||
127636784|NCT04745169|459291792|FG000|Overall Study|Kidney transplantation|1|||
127796710|NCT02469090|459878940|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
127796711|NCT02469090|459878941|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
127796712|NCT02469090|459878942|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
127796713|NCT02469090|459878940|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
127796714|NCT02469090|459878941|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
127796715|NCT02469090|459878942|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
127636785|NCT04745169|459291792|FG000|Overall Study|Participant health problems|3|||
127796716|NCT02469090|459878940|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
127796717|NCT02469090|459878941|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
127796718|NCT02469090|459878942|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
127796719|NCT02469090|459878940|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
127885849|NCT01106352|460205302|FG001|Overall Study|Disease progression|0|||
127885850|NCT01106352|460205303|FG002|Overall Study|Disease progression|0|||
127636786|NCT04745169|459291792|FG000|Overall Study|Physician Decision|2|||
127636787|NCT02891187|459291793|FG000|Overall Study|Lost to Follow-up|1|||
127636788|NCT02891187|459291794|FG001|Overall Study|Lost to Follow-up|2|||
127636789|NCT02041195|459291797|FG000|Overall Study|Adverse Event|1|||
127636790|NCT02041195|459291798|FG001|Overall Study|Adverse Event|2|||
127636791|NCT02041195|459291799|FG002|Overall Study|Adverse Event|0|||
127636792|NCT02041195|459291800|FG003|Overall Study|Adverse Event|0|||
127636793|NCT02041195|459291801|FG004|Overall Study|Adverse Event|0|||
127636794|NCT02041195|459291802|FG005|Overall Study|Adverse Event|0|||
127636795|NCT02041195|459291803|FG006|Overall Study|Adverse Event|3|||
127636796|NCT02041195|459291804|FG007|Overall Study|Adverse Event|0|||
127636797|NCT02041195|459291797|FG000|Overall Study|Withdrawal by Subject|1|||
127636798|NCT02041195|459291798|FG001|Overall Study|Withdrawal by Subject|0|||
127636799|NCT02041195|459291799|FG002|Overall Study|Withdrawal by Subject|0|||
127636800|NCT02041195|459291800|FG003|Overall Study|Withdrawal by Subject|0|||
127636801|NCT02041195|459291801|FG004|Overall Study|Withdrawal by Subject|0|||
127636802|NCT02041195|459291802|FG005|Overall Study|Withdrawal by Subject|0|||
127636803|NCT02041195|459291803|FG006|Overall Study|Withdrawal by Subject|4|||
127636804|NCT02041195|459291804|FG007|Overall Study|Withdrawal by Subject|3|||
127636805|NCT02041195|459291797|FG000|Overall Study|Unable to comply with study visits|0|||
127636806|NCT02041195|459291798|FG001|Overall Study|Unable to comply with study visits|1|||
127636807|NCT02041195|459291799|FG002|Overall Study|Unable to comply with study visits|0|||
127636808|NCT02041195|459291800|FG003|Overall Study|Unable to comply with study visits|0|||
127636809|NCT02041195|459291801|FG004|Overall Study|Unable to comply with study visits|1|||
127636810|NCT02041195|459291802|FG005|Overall Study|Unable to comply with study visits|0|||
127636811|NCT02041195|459291803|FG006|Overall Study|Unable to comply with study visits|0|||
127636812|NCT02041195|459291804|FG007|Overall Study|Unable to comply with study visits|0|||
127636813|NCT02395120|459291805|FG000|Overall Study|Missed follow-up dental exam|57|||
127636814|NCT02395120|459291806|FG001|Overall Study|Missed follow-up dental exam|62|||
127636815|NCT02395120|459291807|FG002|Overall Study|Missed follow-up dental exam|6|||
127636816|NCT02395120|459291808|FG003|Overall Study|Missed follow-up dental exam|6|||
127636817|NCT02395120|459291809|FG004|Overall Study|Missed follow-up dental exam|51|||
127636818|NCT00674986|459291810|FG000|Overall Study|Adverse Event|2|||
127636819|NCT00674986|459291811|FG001|Overall Study|Adverse Event|1|||
127636820|NCT00674986|459291810|FG000|Overall Study|Subject withdrew consent|12|||
127636821|NCT00674986|459291811|FG001|Overall Study|Subject withdrew consent|19|||
127636822|NCT00674986|459291810|FG000|Overall Study|Lost to Follow-up|25|||
127636823|NCT00674986|459291811|FG001|Overall Study|Lost to Follow-up|53|||
127636824|NCT00674986|459291810|FG000|Overall Study|Other reasons|4|||
127636825|NCT00674986|459291811|FG001|Overall Study|Other reasons|8|||
127636826|NCT04546581|459291818|FG000|Overall Study|Adverse Event|9|||
127636827|NCT04546581|459291819|FG001|Overall Study|Adverse Event|3|||
127636828|NCT04546581|459291818|FG000|Overall Study|Physician Decision|0|||
127636829|NCT04546581|459291819|FG001|Overall Study|Physician Decision|1|||
127636830|NCT04546581|459291818|FG000|Overall Study|Protocol Violation|1|||
127636831|NCT04546581|459291819|FG001|Overall Study|Protocol Violation|2|||
127636832|NCT04546581|459291818|FG000|Overall Study|Withdrawal by Subject|3|||
127636833|NCT04546581|459291819|FG001|Overall Study|Withdrawal by Subject|7|||
127636834|NCT02526693|459291820|FG000|Overall Study|Physician Decision|3|||
127636835|NCT02526693|459291821|FG001|Overall Study|Physician Decision|1|||
127636836|NCT01983293|459291822|FG000|Overall Study|Withdrawal by Subject|29|||
127636837|NCT01983293|459291823|FG001|Overall Study|Withdrawal by Subject|15|||
127636838|NCT01983293|459291822|FG000|Overall Study|Missing 12-month visit|3|||
127636839|NCT01983293|459291823|FG001|Overall Study|Missing 12-month visit|3|||
127636840|NCT01983293|459291822|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
127636841|NCT01983293|459291823|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
127636842|NCT01275625|459291824|FG000|Overall Study|Death|1|||
127636843|NCT01275625|459291824|FG000|Overall Study|Lack of Efficacy|2|||
127636844|NCT01275625|459291824|FG000|Overall Study|Lost to Follow-up|1|||
127636845|NCT01275625|459291824|FG000|Overall Study|Withdrawal by Subject|3|||
127636846|NCT01275625|459291824|FG000|Overall Study|Protocol Violation|1|||
127636847|NCT01275625|459291824|FG000|Overall Study|Adverse Event|4|||
127636848|NCT01275625|459291824|FG000|Overall Study|Other|1|||
127636849|NCT01585103|459291826|FG000|Overall Study|Unable to swallow Cytosponge|6|||
127636850|NCT01349569|459291828|FG000|Overall Study|Lack of Efficacy|4|||
127636851|NCT03581305|459291829|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
127636852|NCT03581305|459291830|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
127636853|NCT03581305|459291829|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
127636854|NCT03581305|459291830|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
127636855|NCT03581305|459291829|FG000|Serotonergic Study|Withdrawal by Subject|5|||
127636856|NCT03581305|459291830|FG001|Serotonergic Study|Withdrawal by Subject|1|||
127636857|NCT01747772|459291833|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
127636858|NCT01798927|459291834|FG000|Overall Study|Withdrawal by Subject|1|||
127636859|NCT03750552|459291835|FG000|Overall Study|Adverse Event|5|||
127636860|NCT03750552|459291836|FG001|Overall Study|Adverse Event|1|||
127636861|NCT03750552|459291835|FG000|Overall Study|Withdrawal by Subject|1|||
127636862|NCT03750552|459291836|FG001|Overall Study|Withdrawal by Subject|1|||
127796720|NCT02469090|459878941|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
127796721|NCT02469090|459878942|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
127796722|NCT02469090|459878940|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
127796723|NCT02469090|459878941|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
127636863|NCT03750552|459291835|FG000|Overall Study|Other|2|||
127636864|NCT03750552|459291836|FG001|Overall Study|Other|0|||
127636865|NCT02062632|459291839|FG000|Overall Study|No treatment data|1|||
127636866|NCT00626522|459291840|FG000|Overall Study|Protocol Violation|0|||
127636867|NCT00626522|459291841|FG001|Overall Study|Protocol Violation|0|||
127636868|NCT00626522|459291842|FG002|Overall Study|Protocol Violation|0|||
127636869|NCT00626522|459291843|FG003|Overall Study|Protocol Violation|0|||
127636870|NCT00626522|459291844|FG004|Overall Study|Protocol Violation|1|||
127636871|NCT00626522|459291845|FG005|Overall Study|Protocol Violation|0|||
127636872|NCT00626522|459291840|FG000|Overall Study|Adverse Event|2|||
127636873|NCT00626522|459291841|FG001|Overall Study|Adverse Event|1|||
127636874|NCT00626522|459291842|FG002|Overall Study|Adverse Event|2|||
127636875|NCT00626522|459291843|FG003|Overall Study|Adverse Event|0|||
127636876|NCT00626522|459291844|FG004|Overall Study|Adverse Event|1|||
127636877|NCT00626522|459291845|FG005|Overall Study|Adverse Event|1|||
127636878|NCT00626522|459291840|FG000|Overall Study|Withdrawal by Subject|2|||
127636879|NCT00626522|459291841|FG001|Overall Study|Withdrawal by Subject|5|||
127636880|NCT00626522|459291842|FG002|Overall Study|Withdrawal by Subject|5|||
127636881|NCT00626522|459291843|FG003|Overall Study|Withdrawal by Subject|0|||
127636882|NCT00626522|459291844|FG004|Overall Study|Withdrawal by Subject|4|||
127636883|NCT00626522|459291845|FG005|Overall Study|Withdrawal by Subject|1|||
127636884|NCT00626522|459291840|FG000|Overall Study|COPD exacerbation|0|||
127636885|NCT00626522|459291841|FG001|Overall Study|COPD exacerbation|0|||
127636886|NCT00626522|459291842|FG002|Overall Study|COPD exacerbation|0|||
127636887|NCT00626522|459291843|FG003|Overall Study|COPD exacerbation|1|||
127636888|NCT00626522|459291844|FG004|Overall Study|COPD exacerbation|1|||
127636889|NCT00626522|459291845|FG005|Overall Study|COPD exacerbation|0|||
127636890|NCT00626522|459291840|FG000|Overall Study|Lost to Follow-up|0|||
127796724|NCT02469090|459878942|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
127796725|NCT02469090|459878940|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
127796726|NCT02469090|459878941|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
127796727|NCT02469090|459878942|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
127796728|NCT01391507|459878943|FG000|Overall Study|Death|0|||
127796729|NCT01391507|459878944|FG001|Overall Study|Death|0|||
127796730|NCT01391507|459878945|FG002|Overall Study|Death|0|||
127796731|NCT01391507|459878946|FG003|Overall Study|Death|1|||
127796732|NCT01391507|459878943|FG000|Overall Study|Adverse Event|1|||
127796733|NCT01391507|459878944|FG001|Overall Study|Adverse Event|1|||
127796734|NCT01391507|459878945|FG002|Overall Study|Adverse Event|2|||
127796735|NCT01391507|459878946|FG003|Overall Study|Adverse Event|2|||
127796736|NCT01391507|459878943|FG000|Overall Study|Withdrawal by Subject|1|||
127796737|NCT01391507|459878944|FG001|Overall Study|Withdrawal by Subject|2|||
127796738|NCT01391507|459878945|FG002|Overall Study|Withdrawal by Subject|1|||
127796739|NCT01391507|459878946|FG003|Overall Study|Withdrawal by Subject|1|||
127796740|NCT01391507|459878943|FG000|Overall Study|Lack of Efficacy|0|||
127796741|NCT01391507|459878944|FG001|Overall Study|Lack of Efficacy|0|||
127796742|NCT01391507|459878945|FG002|Overall Study|Lack of Efficacy|0|||
127796743|NCT01391507|459878946|FG003|Overall Study|Lack of Efficacy|1|||
127796744|NCT01391507|459878943|FG000|Overall Study|Protocol Violation|2|||
127796745|NCT01391507|459878944|FG001|Overall Study|Protocol Violation|1|||
127796746|NCT01391507|459878945|FG002|Overall Study|Protocol Violation|1|||
127796747|NCT01391507|459878946|FG003|Overall Study|Protocol Violation|2|||
127796748|NCT00070941|459878955|FG000|Overall Study|Adverse Event|10|||
127796749|NCT00070941|459878956|FG001|Overall Study|Adverse Event|8|||
127796750|NCT00070941|459878957|FG002|Overall Study|Adverse Event|4|||
127796751|NCT00094055|459878958|FG000|Overall Study|Adverse Event|11|||
127796752|NCT00094055|459878958|FG000|Overall Study|Death|4|||
127796753|NCT00094055|459878958|FG000|Overall Study|Lack of Efficacy|17|||
127796754|NCT00094055|459878958|FG000|Overall Study|Lost to Follow-up|2|||
127796755|NCT00094055|459878958|FG000|Overall Study|progressive disease|2|||
127796756|NCT00094055|459878958|FG000|Overall Study|clinical progression|1|||
127796757|NCT00094055|459878958|FG000|Overall Study|roll-over to another study|14|||
127796758|NCT00094055|459878958|FG000|Overall Study|Withdrawal by Subject|9|||
127796759|NCT00411554|459878959|FG000|Overall Study|Adverse Event|2|||
127796760|NCT00411554|459878960|FG001|Overall Study|Adverse Event|4|||
127796761|NCT00411554|459878959|FG000|Overall Study|Lack of Efficacy|2|||
127796762|NCT00411554|459878960|FG001|Overall Study|Lack of Efficacy|5|||
127796763|NCT00411554|459878959|FG000|Overall Study|Withdrawal by Subject|3|||
127796764|NCT00411554|459878960|FG001|Overall Study|Withdrawal by Subject|0|||
127796765|NCT00411554|459878959|FG000|Overall Study|Patient Moved|1|||
127796766|NCT00411554|459878960|FG001|Overall Study|Patient Moved|0|||
127796767|NCT00699907|459878961|FG000|Overall Study|Withdrawal by Subject|2|||
127796768|NCT00699907|459878962|FG001|Overall Study|Withdrawal by Subject|1|||
127796769|NCT00699907|459878963|FG002|Overall Study|Withdrawal by Subject|0|||
127796770|NCT00699907|459878961|FG000|Overall Study|No usable sample|0|||
127796771|NCT00699907|459878962|FG001|Overall Study|No usable sample|9|||
127796772|NCT00699907|459878963|FG002|Overall Study|No usable sample|8|||
127636891|NCT00626522|459291841|FG001|Overall Study|Lost to Follow-up|1|||
127636892|NCT00626522|459291842|FG002|Overall Study|Lost to Follow-up|0|||
127636893|NCT00626522|459291843|FG003|Overall Study|Lost to Follow-up|0|||
127796773|NCT01276236|459878966|FG000|Overall Study|Lack of Efficacy|2|||
127796774|NCT01276236|459878966|FG000|Overall Study|Withdrawal by Subject|4|||
127796775|NCT00044512|459878967|FG000|Follow Up|Lost to Follow-up|2|||
127796776|NCT00357500|459878985|FG000|Overall Study|Adverse Event|3|||
127636894|NCT00626522|459291844|FG004|Overall Study|Lost to Follow-up|0|||
127636895|NCT00626522|459291845|FG005|Overall Study|Lost to Follow-up|0|||
127636896|NCT00626522|459291840|FG000|Overall Study|Inconsistent reason reported|1|||
127636897|NCT00626522|459291841|FG001|Overall Study|Inconsistent reason reported|0|||
127636898|NCT00626522|459291842|FG002|Overall Study|Inconsistent reason reported|0|||
127636899|NCT00626522|459291843|FG003|Overall Study|Inconsistent reason reported|0|||
127636900|NCT00626522|459291844|FG004|Overall Study|Inconsistent reason reported|0|||
127636901|NCT00626522|459291845|FG005|Overall Study|Inconsistent reason reported|0|||
127636902|NCT00626522|459291840|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
127636903|NCT00626522|459291841|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
127636904|NCT00626522|459291842|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
127636905|NCT00626522|459291843|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
127636906|NCT00626522|459291844|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
127636907|NCT00626522|459291845|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
127636908|NCT02280044|459291846|FG000|Overall Study|Planned alternate|0|||
127636909|NCT02280044|459291847|FG001|Overall Study|Planned alternate|2|||
127636910|NCT01490632|459291851|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
127636911|NCT01490632|459291852|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
127636912|NCT01490632|459291853|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
127636913|NCT01490632|459291854|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
127636914|NCT01490632|459291855|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
127636915|NCT01490632|459291856|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
127636916|NCT01490632|459291857|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
127636917|NCT01490632|459291858|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
127636918|NCT01490632|459291859|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
127636919|NCT01490632|459291860|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
127636920|NCT01490632|459291861|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
127636921|NCT01490632|459291862|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
127636922|NCT01490632|459291863|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
127636923|NCT01490632|459291864|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
127636924|NCT01490632|459291865|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
127636925|NCT01490632|459291866|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
127636926|NCT01490632|459291867|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
127636927|NCT01490632|459291868|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
127636928|NCT01490632|459291869|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
127636929|NCT01490632|459291870|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
127636930|NCT01490632|459291851|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
127636931|NCT01490632|459291852|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
127636932|NCT01490632|459291853|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
127636933|NCT01490632|459291854|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
127636934|NCT01490632|459291855|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
127636935|NCT01490632|459291856|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
127636936|NCT01490632|459291857|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
127636937|NCT01490632|459291858|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
127636938|NCT01490632|459291859|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
127636939|NCT01490632|459291860|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
127636940|NCT01490632|459291861|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
127636941|NCT01490632|459291862|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
127636942|NCT01490632|459291863|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
127636943|NCT01490632|459291864|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
127636944|NCT01490632|459291865|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
127636945|NCT01490632|459291866|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
127636946|NCT01490632|459291867|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
127636947|NCT01490632|459291868|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
127636948|NCT01490632|459291869|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
127636949|NCT01490632|459291870|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
127636950|NCT01490632|459291851|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
127636951|NCT01490632|459291852|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
127636952|NCT01490632|459291853|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
127636953|NCT01490632|459291854|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
127636954|NCT01490632|459291855|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
127636955|NCT01490632|459291856|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
127796777|NCT00357500|459878985|FG000|Overall Study|Withdrawal by Subject|5|||
127796778|NCT00357500|459878985|FG000|Overall Study|Progressive Disease|65|||
127796779|NCT00357500|459878985|FG000|Overall Study|Not Started Protocol Therapy|4|||
127796780|NCT02695628|459878986|FG000|Overall Study|Withdrawal by Subject|1|||
127796781|NCT00516737|459878990|FG000|Overall Study|Lost to Follow-up|2|||
127885851|NCT01106352|460205304|FG003|Overall Study|Disease progression|1|||
127885852|NCT01106352|460205305|FG004|Overall Study|Disease progression|0|||
127885853|NCT01106352|460205301|FG000|Overall Study|Withdrawal by Subject|0|||
127885854|NCT01106352|460205302|FG001|Overall Study|Withdrawal by Subject|0|||
127885855|NCT01106352|460205303|FG002|Overall Study|Withdrawal by Subject|0|||
127885856|NCT01106352|460205304|FG003|Overall Study|Withdrawal by Subject|3|||
127885857|NCT01106352|460205305|FG004|Overall Study|Withdrawal by Subject|2|||
127885858|NCT01106352|460205301|FG000|Overall Study|Went on hospice|0|||
127885859|NCT01106352|460205302|FG001|Overall Study|Went on hospice|0|||
127885860|NCT01106352|460205303|FG002|Overall Study|Went on hospice|0|||
127885861|NCT01106352|460205304|FG003|Overall Study|Went on hospice|1|||
127885862|NCT01106352|460205305|FG004|Overall Study|Went on hospice|0|||
127885863|NCT01106352|460205301|FG000|Overall Study|Subject entered hospice|0|||
127885864|NCT01106352|460205302|FG001|Overall Study|Subject entered hospice|0|||
127885865|NCT01106352|460205303|FG002|Overall Study|Subject entered hospice|0|||
127885866|NCT01106352|460205304|FG003|Overall Study|Subject entered hospice|1|||
127885867|NCT01106352|460205305|FG004|Overall Study|Subject entered hospice|0|||
127885868|NCT01106352|460205301|FG000|Overall Study|Home hospice since July 2013|0|||
127885869|NCT01106352|460205302|FG001|Overall Study|Home hospice since July 2013|0|||
127885870|NCT01106352|460205303|FG002|Overall Study|Home hospice since July 2013|0|||
127885871|NCT01106352|460205304|FG003|Overall Study|Home hospice since July 2013|1|||
127885872|NCT01106352|460205305|FG004|Overall Study|Home hospice since July 2013|0|||
127885873|NCT03944707|460205306|FG000|Overall Study|Adverse Event|0|||
127885874|NCT03944707|460205307|FG001|Overall Study|Adverse Event|2|||
127885875|NCT03944707|460205306|FG000|Overall Study|Study terminated by sponsor|12|||
127885876|NCT03944707|460205307|FG001|Overall Study|Study terminated by sponsor|7|||
127885877|NCT03944707|460205306|FG000|Overall Study|Subject decision|0|||
127796782|NCT00516737|459878991|FG001|Overall Study|Lost to Follow-up|0|||
127796783|NCT00516737|459878990|FG000|Overall Study|Physician Decision|0|||
127796784|NCT00516737|459878991|FG001|Overall Study|Physician Decision|1|||
127796785|NCT00516737|459878990|FG000|Overall Study|Withdrawal by Subject|0|||
127796786|NCT00516737|459878991|FG001|Overall Study|Withdrawal by Subject|1|||
127796787|NCT00516737|459878990|FG000|Overall Study|Lack of Qualifying Event|9|||
127796788|NCT00516737|459878991|FG001|Overall Study|Lack of Qualifying Event|6|||
127796789|NCT01844895|459878992|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
127796790|NCT01844895|459878992|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
127796791|NCT01844895|459878992|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
127885878|NCT03944707|460205307|FG001|Overall Study|Subject decision|1|||
127885879|NCT01507831|460205311|FG000|Overall Study|Randomized but not treated|0|||
127885880|NCT01507831|460205312|FG001|Overall Study|Randomized but not treated|3|||
127885881|NCT01507831|460205311|FG000|Overall Study|Adverse Event|48|||
127885882|NCT01507831|460205312|FG001|Overall Study|Adverse Event|113|||
127885883|NCT01507831|460205311|FG000|Overall Study|Death|6|||
127885884|NCT01507831|460205312|FG001|Overall Study|Death|2|||
127885885|NCT01507831|460205311|FG000|Overall Study|Poor compliance to protocol|38|||
127885886|NCT01507831|460205312|FG001|Overall Study|Poor compliance to protocol|60|||
127885887|NCT01507831|460205311|FG000|Overall Study|Physician Decision|0|||
127885888|NCT01507831|460205312|FG001|Overall Study|Physician Decision|4|||
127885889|NCT01507831|460205311|FG000|Overall Study|Participant moved|5|||
127885890|NCT01507831|460205312|FG001|Overall Study|Participant moved|19|||
127885891|NCT01507831|460205311|FG000|Overall Study|Consent withdrawn by participant|34|||
127885892|NCT01507831|460205312|FG001|Overall Study|Consent withdrawn by participant|72|||
127885893|NCT01507831|460205311|FG000|Overall Study|Related to study drug administration|5|||
127885894|NCT01507831|460205312|FG001|Overall Study|Related to study drug administration|14|||
127636956|NCT01490632|459291857|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
127636957|NCT01490632|459291858|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
127636958|NCT01490632|459291859|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
127636959|NCT01490632|459291860|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
127796792|NCT01844895|459878992|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
127636960|NCT01490632|459291861|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
127636961|NCT01490632|459291862|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
127636962|NCT01490632|459291863|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
127636963|NCT01490632|459291864|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
127796793|NCT01844895|459878992|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
127885895|NCT01507831|460205311|FG000|Overall Study|Last visit outside protocol visit window|51|||
127885896|NCT01507831|460205312|FG001|Overall Study|Last visit outside protocol visit window|143|||
127885897|NCT01507831|460205311|FG000|Overall Study|Selection criteria finally not met|0|||
127885898|NCT01507831|460205312|FG001|Overall Study|Selection criteria finally not met|1|||
127885899|NCT01507831|460205311|FG000|Overall Study|Site closure|0|||
127885900|NCT01507831|460205312|FG001|Overall Study|Site closure|3|||
127885901|NCT01507831|460205311|FG000|Overall Study|Potential lost to follow-up|3|||
127885902|NCT01507831|460205312|FG001|Overall Study|Potential lost to follow-up|0|||
127636964|NCT01490632|459291865|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
127636965|NCT01490632|459291866|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
127636966|NCT01490632|459291867|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
127636967|NCT01490632|459291868|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
127636968|NCT01490632|459291869|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
127636969|NCT01490632|459291870|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
127636970|NCT01490632|459291851|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
127636971|NCT01490632|459291852|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
127636972|NCT01490632|459291853|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
127636973|NCT01490632|459291854|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
127636974|NCT01490632|459291855|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
127636975|NCT01490632|459291856|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
127636976|NCT01490632|459291857|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
127636977|NCT01490632|459291858|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
127636978|NCT01490632|459291859|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
127636979|NCT01490632|459291860|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
127636980|NCT01490632|459291861|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
127636981|NCT01490632|459291862|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
127636982|NCT01490632|459291863|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
127636983|NCT01490632|459291864|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
127636984|NCT01490632|459291865|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
127636985|NCT01490632|459291866|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
127636986|NCT01490632|459291867|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
127636987|NCT01490632|459291868|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
127636988|NCT01490632|459291869|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
127636989|NCT01490632|459291870|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
127636990|NCT01490632|459291851|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
127636991|NCT01490632|459291852|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
127636992|NCT01490632|459291853|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
127636993|NCT01490632|459291854|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
127636994|NCT01490632|459291855|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
127636995|NCT01490632|459291856|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
127636996|NCT01490632|459291857|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
127636997|NCT01490632|459291858|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
127636998|NCT01490632|459291859|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
127636999|NCT01490632|459291860|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
127637000|NCT01490632|459291861|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
127637001|NCT01490632|459291862|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
127637002|NCT01490632|459291863|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
127637003|NCT01490632|459291864|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
127637004|NCT01490632|459291865|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
127637005|NCT01490632|459291866|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
127637006|NCT01490632|459291867|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
127637007|NCT01490632|459291868|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
127637008|NCT01490632|459291869|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
127637009|NCT01490632|459291870|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
127637010|NCT01490632|459291851|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
127637011|NCT01490632|459291852|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
127637012|NCT01490632|459291853|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
127637013|NCT01490632|459291854|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
127637014|NCT01490632|459291855|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
127637015|NCT01490632|459291856|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
127637016|NCT01490632|459291857|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
127637017|NCT01490632|459291858|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
127637018|NCT01490632|459291859|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
127637019|NCT01490632|459291860|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
127637020|NCT01490632|459291861|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
127637021|NCT01490632|459291862|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
127637022|NCT01490632|459291863|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
127637023|NCT01490632|459291864|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
127637024|NCT01490632|459291865|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
127637025|NCT01490632|459291866|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
127637026|NCT01490632|459291867|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
127637027|NCT01490632|459291868|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
127637028|NCT01490632|459291869|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
127637029|NCT01490632|459291870|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
127637030|NCT01490632|459291851|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
127796794|NCT01844895|459878992|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
127796795|NCT01844895|459878992|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
127796796|NCT00511355|459878994|FG000|Overall Study|Adverse Event|4|||
127796797|NCT00511355|459878995|FG001|Overall Study|Adverse Event|4|||
127796798|NCT00511355|459878994|FG000|Overall Study|Pregnancy Wish|1|||
127796799|NCT00511355|459878995|FG001|Overall Study|Pregnancy Wish|0|||
127796800|NCT00511355|459878994|FG000|Overall Study|Lost to Follow-up|2|||
127796801|NCT00511355|459878995|FG001|Overall Study|Lost to Follow-up|1|||
127796802|NCT00511355|459878994|FG000|Overall Study|Other Reason|0|||
127796803|NCT00511355|459878995|FG001|Overall Study|Other Reason|1|||
127796804|NCT00511355|459878994|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
127796805|NCT00511355|459878995|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
127796806|NCT00511355|459878994|FG000|Overall Study|Withdrawal of informed consent|0|||
127796807|NCT00511355|459878995|FG001|Overall Study|Withdrawal of informed consent|1|||
127796808|NCT00511355|459878994|FG000|Overall Study|Other reason pre-treatment|0|||
127796809|NCT00511355|459878995|FG001|Overall Study|Other reason pre-treatment|1|||
127796810|NCT00454805|459878998|FG000|Overall Study|Withdrawal by Subject|9|||
127796811|NCT00454805|459878999|FG001|Overall Study|Withdrawal by Subject|2|||
127796812|NCT00454805|459878998|FG000|Overall Study|Death|0|||
127637031|NCT01490632|459291852|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
127637032|NCT01490632|459291853|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
127637033|NCT01490632|459291854|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
127637034|NCT01490632|459291855|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
127637035|NCT01490632|459291856|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
127637036|NCT01490632|459291857|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
127637037|NCT01490632|459291858|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
127637038|NCT01490632|459291859|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
127637039|NCT01490632|459291860|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
127637040|NCT01490632|459291861|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
127637041|NCT01490632|459291862|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
127637042|NCT01490632|459291863|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
127637043|NCT01490632|459291864|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
127637044|NCT01490632|459291865|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
127637045|NCT01490632|459291866|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
127637046|NCT01490632|459291867|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
127637047|NCT01490632|459291868|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
127637048|NCT01490632|459291869|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
127637049|NCT01490632|459291870|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
127637050|NCT01490632|459291851|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
127637051|NCT01490632|459291852|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
127637052|NCT01490632|459291853|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
127637053|NCT01490632|459291854|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
127637054|NCT01490632|459291855|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
127637055|NCT01490632|459291856|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
127637056|NCT01490632|459291857|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
127637057|NCT01490632|459291858|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
127637058|NCT01490632|459291859|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
127637059|NCT01490632|459291860|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
127637060|NCT01490632|459291861|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
127637061|NCT01490632|459291862|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
127637062|NCT01490632|459291863|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
127637063|NCT01490632|459291864|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
127637064|NCT01490632|459291865|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
127637065|NCT01490632|459291866|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
127637066|NCT01490632|459291867|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
127637067|NCT01490632|459291868|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
127637068|NCT01490632|459291869|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
127637069|NCT01490632|459291870|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
127637070|NCT01490632|459291851|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
127637071|NCT01490632|459291852|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
127796813|NCT00454805|459878999|FG001|Overall Study|Death|2|||
127796814|NCT00454805|459878998|FG000|Overall Study|Disease progression|16|||
127637072|NCT01490632|459291853|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
127796815|NCT00454805|459878999|FG001|Overall Study|Disease progression|19|||
127796816|NCT00454805|459878998|FG000|Overall Study|In order to begin radiotherapy|1|||
127796817|NCT00454805|459878999|FG001|Overall Study|In order to begin radiotherapy|0|||
127885903|NCT01507831|460205311|FG000|Overall Study|Other|3|||
127885904|NCT01507831|460205312|FG001|Overall Study|Other|6|||
127885905|NCT01610167|460205313|FG000|Overall Study|Scheduling conflict.|0|||
127885906|NCT01610167|460205314|FG001|Overall Study|Scheduling conflict.|0|||
127885907|NCT01610167|460205315|FG002|Overall Study|Scheduling conflict.|2|||
127885908|NCT03296553|460205317|FG000|Overall Study|Withdrawal by Subject|1|||
127885909|NCT03296553|460205318|FG001|Overall Study|Withdrawal by Subject|1|||
127885910|NCT03296553|460205317|FG000|Overall Study|Death|1|||
127885911|NCT03296553|460205318|FG001|Overall Study|Death|0|||
127885912|NCT02713243|460205319|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
127885913|NCT02713243|460205320|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
127885914|NCT02713243|460205319|FG000|Overall Study|Administrative problems|0|||
127885915|NCT02713243|460205320|FG001|Overall Study|Administrative problems|1|||
127885916|NCT02713243|460205319|FG000|Overall Study|Protocol deviation|0|||
127885917|NCT02713243|460205320|FG001|Overall Study|Protocol deviation|1|||
127885918|NCT01021137|460205321|FG000|Overall Study|Lost to Follow-up|9|||
127885919|NCT01021137|460205322|FG001|Overall Study|Lost to Follow-up|4|||
127885920|NCT01021137|460205323|FG002|Overall Study|Lost to Follow-up|2|||
127885921|NCT01021137|460205324|FG003|Overall Study|Lost to Follow-up|6|||
127885922|NCT01021137|460205321|FG000|Overall Study|Withdrawal by Subject|1|||
127885923|NCT01021137|460205322|FG001|Overall Study|Withdrawal by Subject|0|||
127885924|NCT01021137|460205323|FG002|Overall Study|Withdrawal by Subject|0|||
127885925|NCT01021137|460205324|FG003|Overall Study|Withdrawal by Subject|3|||
127885926|NCT03439293|460205325|FG000|Overall Study|Death|22|||
127885927|NCT03439293|460205325|FG000|Overall Study|Withdrawal by Subject|8|||
127885928|NCT03439293|460205325|FG000|Overall Study|Lost to Follow-up|2|||
127885929|NCT03439293|460205325|FG000|Overall Study|Reason Not Specified|28|||
127885930|NCT03439293|460205325|FG000|Overall Study|Missing|1|||
127885931|NCT02766400|460205328|FG000|Overall Study|Death|1|||
127885932|NCT02766400|460205329|FG001|Overall Study|Death|2|||
127885933|NCT02766400|460205328|FG000|Overall Study|Withdrawal by Subject|1|||
127885934|NCT02766400|460205329|FG001|Overall Study|Withdrawal by Subject|0|||
127885935|NCT03499249|460205336|FG000|Overall Study|Physician Decision|1|||
127885936|NCT00435825|460205337|FG000|Overall Study|Abnormality of Laboratory Test|0|||
127885937|NCT00435825|460205338|FG001|Overall Study|Abnormality of Laboratory Test|1|||
127885938|NCT00435825|460205339|FG002|Overall Study|Abnormality of Laboratory Test|0|||
127885939|NCT00435825|460205340|FG003|Overall Study|Abnormality of Laboratory Test|0|||
127885940|NCT00435825|460205337|FG000|Overall Study|Insufficient Therapeutic Response|3|||
127885941|NCT00435825|460205338|FG001|Overall Study|Insufficient Therapeutic Response|1|||
127885942|NCT00435825|460205339|FG002|Overall Study|Insufficient Therapeutic Response|0|||
127885943|NCT00435825|460205340|FG003|Overall Study|Insufficient Therapeutic Response|3|||
127885944|NCT00435825|460205337|FG000|Overall Study|Other Protocol Violation|1|||
127885945|NCT00435825|460205338|FG001|Overall Study|Other Protocol Violation|0|||
127885946|NCT00435825|460205339|FG002|Overall Study|Other Protocol Violation|0|||
127885947|NCT00435825|460205340|FG003|Overall Study|Other Protocol Violation|0|||
127885948|NCT00435825|460205337|FG000|Overall Study|Refused treatment|2|||
127885949|NCT00435825|460205338|FG001|Overall Study|Refused treatment|0|||
127885950|NCT00435825|460205339|FG002|Overall Study|Refused treatment|0|||
127885951|NCT00435825|460205340|FG003|Overall Study|Refused treatment|5|||
127885952|NCT00435825|460205337|FG000|Overall Study|Failure to return|5|||
127885953|NCT00435825|460205338|FG001|Overall Study|Failure to return|0|||
127885954|NCT00435825|460205339|FG002|Overall Study|Failure to return|4|||
127885955|NCT00435825|460205340|FG003|Overall Study|Failure to return|0|||
127885956|NCT00435825|460205337|FG000|Overall Study|Did not receive study drug|1|||
127885957|NCT00435825|460205338|FG001|Overall Study|Did not receive study drug|0|||
127885958|NCT00435825|460205339|FG002|Overall Study|Did not receive study drug|2|||
127885959|NCT00435825|460205340|FG003|Overall Study|Did not receive study drug|0|||
127885960|NCT00435825|460205337|FG000|Overall Study|Did not enter follow-up|0|||
127796818|NCT03208231|459879010|FG000|Overall Study|Death|1|||
127796819|NCT03208231|459879011|FG001|Overall Study|Death|2|||
127796820|NCT03208231|459879010|FG000|Overall Study|Moved and unable to get to clinic|1|||
127796821|NCT03208231|459879011|FG001|Overall Study|Moved and unable to get to clinic|0|||
127796822|NCT03208231|459879010|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
127796823|NCT03208231|459879011|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
127796824|NCT04347239|459879014|FG000|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|4|||
127796825|NCT04347239|459879015|FG001|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|6|||
127796826|NCT04347239|459879016|FG002|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|0|||
127796827|NCT04347239|459879014|FG000|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
127885961|NCT00435825|460205338|FG001|Overall Study|Did not enter follow-up|4|||
127885962|NCT00435825|460205339|FG002|Overall Study|Did not enter follow-up|1|||
127885963|NCT00435825|460205340|FG003|Overall Study|Did not enter follow-up|3|||
127885964|NCT00435825|460205337|FG000|Overall Study|Did not complete full follow-up period|6|||
127885965|NCT00435825|460205338|FG001|Overall Study|Did not complete full follow-up period|6|||
127885966|NCT00435825|460205339|FG002|Overall Study|Did not complete full follow-up period|4|||
127885967|NCT00435825|460205340|FG003|Overall Study|Did not complete full follow-up period|5|||
127885968|NCT00378482|460205341|FG000|Overall Study|Lost to Follow-up|1|||
127885969|NCT00378482|460205341|FG000|Overall Study|Lack of Efficacy|8|||
127885970|NCT00378482|460205341|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
127885971|NCT00378482|460205341|FG000|Overall Study|Withdrawal by Subject|4|||
127885972|NCT00378482|460205341|FG000|Overall Study|Adverse Event|9|||
127885973|NCT05788237|460205342|FG000|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
127885974|NCT05788237|460205343|FG001|SSA (Approximately 2 Months)|No longer met eligibility criteria|1|||
127885975|NCT05788237|460205344|FG002|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
127885976|NCT05788237|460205345|FG003|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
127885977|NCT05788237|460205342|FG000|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
127885978|NCT05788237|460205343|FG001|SSA (Approximately 2 Months)|Lost to Follow-up|1|||
127885979|NCT05788237|460205344|FG002|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
127885980|NCT05788237|460205345|FG003|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
127885981|NCT05788237|460205342|FG000|SSA (Approximately 2 Months)|Withdrawal by Subject|4|||
127885982|NCT05788237|460205343|FG001|SSA (Approximately 2 Months)|Withdrawal by Subject|8|||
127885983|NCT05788237|460205344|FG002|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
127885984|NCT05788237|460205345|FG003|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
127885985|NCT05788237|460205342|FG000|SSA (Approximately 2 Months)|Adverse Event|1|||
127885986|NCT05788237|460205343|FG001|SSA (Approximately 2 Months)|Adverse Event|2|||
127885987|NCT05788237|460205344|FG002|SSA (Approximately 2 Months)|Adverse Event|0|||
127885988|NCT05788237|460205345|FG003|SSA (Approximately 2 Months)|Adverse Event|0|||
127885989|NCT05788237|460205342|FG000|SSA (Approximately 2 Months)|Death|0|||
127885990|NCT05788237|460205343|FG001|SSA (Approximately 2 Months)|Death|1|||
127885991|NCT05788237|460205344|FG002|SSA (Approximately 2 Months)|Death|0|||
127885992|NCT05788237|460205345|FG003|SSA (Approximately 2 Months)|Death|0|||
127885993|NCT05788237|460205342|FG000|SSB (Approximately 1 Month)|Not Vaccinated|0|||
127885994|NCT05788237|460205343|FG001|SSB (Approximately 1 Month)|Not Vaccinated|0|||
127885995|NCT05788237|460205344|FG002|SSB (Approximately 1 Month)|Not Vaccinated|1|||
127885996|NCT05788237|460205345|FG003|SSB (Approximately 1 Month)|Not Vaccinated|0|||
127885997|NCT05788237|460205342|FG000|SSB (Approximately 1 Month)|Refused further study procedures|0|||
127885998|NCT05788237|460205343|FG001|SSB (Approximately 1 Month)|Refused further study procedures|0|||
127885999|NCT05788237|460205344|FG002|SSB (Approximately 1 Month)|Refused further study procedures|0|||
127796828|NCT04347239|459879015|FG001|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
127796829|NCT04347239|459879016|FG002|Open Label|Pt enrolled but withdrew consent prior to dosing|1|||
127796830|NCT02289950|459879018|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
127796831|NCT02289950|459879019|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
127796832|NCT02289950|459879018|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
127796833|NCT02289950|459879019|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
127796834|NCT02289950|459879018|FG000|Overall Study|Lost to Follow-up|1|||
127796835|NCT02289950|459879019|FG001|Overall Study|Lost to Follow-up|0|||
127796836|NCT02289950|459879018|FG000|Overall Study|Physician Decision|9|||
127796837|NCT02289950|459879019|FG001|Overall Study|Physician Decision|3|||
127796838|NCT02289950|459879018|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
127796839|NCT02289950|459879019|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
127796840|NCT02289950|459879018|FG000|Overall Study|Withdrawal by Subject|1|||
127796841|NCT02289950|459879019|FG001|Overall Study|Withdrawal by Subject|3|||
127796842|NCT02289950|459879018|FG000|Overall Study|Test article held for greater than 28 days|0|||
127886000|NCT05788237|460205345|FG003|SSB (Approximately 1 Month)|Refused further study procedures|1|||
127886001|NCT05788237|460205342|FG000|SSB (Approximately 1 Month)|Other|0|||
127886002|NCT05788237|460205343|FG001|SSB (Approximately 1 Month)|Other|0|||
127886003|NCT05788237|460205344|FG002|SSB (Approximately 1 Month)|Other|0|||
127886004|NCT05788237|460205345|FG003|SSB (Approximately 1 Month)|Other|1|||
127796843|NCT02289950|459879019|FG001|Overall Study|Test article held for greater than 28 days|1|||
127796844|NCT02289950|459879018|FG000|Overall Study|Adverse Event|11|||
127796845|NCT02289950|459879019|FG001|Overall Study|Adverse Event|3|||
127886005|NCT00343642|460206908|FG000|Overall Study|Lost to Follow-up|0|||
127886006|NCT00343642|460206909|FG001|Overall Study|Lost to Follow-up|1|||
127886007|NCT00343642|460206910|FG002|Overall Study|Lost to Follow-up|0|||
127886008|NCT00343642|460206908|FG000|Overall Study|Pregnancy|1|||
127886009|NCT00343642|460206909|FG001|Overall Study|Pregnancy|0|||
127886010|NCT00343642|460206910|FG002|Overall Study|Pregnancy|2|||
127886011|NCT00343642|460206908|FG000|Overall Study|Withdrawal by Subject|2|||
127886012|NCT00343642|460206909|FG001|Overall Study|Withdrawal by Subject|3|||
127886013|NCT00343642|460206910|FG002|Overall Study|Withdrawal by Subject|4|||
127886014|NCT00343642|460206908|FG000|Overall Study|Adverse Event|0|||
127886015|NCT00343642|460206909|FG001|Overall Study|Adverse Event|0|||
127796846|NCT02289950|459879018|FG000|Overall Study|Death|1|||
127796847|NCT02289950|459879019|FG001|Overall Study|Death|1|||
127796848|NCT02289950|459879018|FG000|Overall Study|Other|5|||
127637073|NCT01490632|459291854|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
127637074|NCT01490632|459291855|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
127637075|NCT01490632|459291856|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
127637076|NCT01490632|459291857|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
127637077|NCT01490632|459291858|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
127637078|NCT01490632|459291859|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
127637079|NCT01490632|459291860|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
127637080|NCT01490632|459291861|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
127637081|NCT01490632|459291862|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
127637082|NCT01490632|459291863|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
127637083|NCT01490632|459291864|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
127637084|NCT01490632|459291865|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
127637085|NCT01490632|459291866|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
127637086|NCT01490632|459291867|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
127637087|NCT01490632|459291868|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
127637088|NCT01490632|459291869|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
127637089|NCT01490632|459291870|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
127637090|NCT01490632|459291851|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
127637091|NCT01490632|459291852|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
127637092|NCT01490632|459291853|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
127637093|NCT01490632|459291854|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
127637094|NCT01490632|459291855|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
127637095|NCT01490632|459291856|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
127637096|NCT01490632|459291857|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
127637097|NCT01490632|459291858|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
127637098|NCT01490632|459291859|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
127637099|NCT01490632|459291860|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
127637100|NCT01490632|459291861|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
127637101|NCT01490632|459291862|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
127637102|NCT01490632|459291863|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
127637103|NCT01490632|459291864|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
127637104|NCT01490632|459291865|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
127637105|NCT01490632|459291866|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
127637106|NCT01490632|459291867|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
127637107|NCT01490632|459291868|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
127637108|NCT01490632|459291869|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
127637109|NCT01490632|459291870|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
127637110|NCT01490632|459291851|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
127637111|NCT01490632|459291852|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
127637112|NCT01490632|459291853|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
127637113|NCT01490632|459291854|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
127637114|NCT01490632|459291855|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
127637115|NCT01490632|459291856|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
127637116|NCT01490632|459291857|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
127637117|NCT01490632|459291858|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
127637118|NCT01490632|459291859|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
127637119|NCT01490632|459291860|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
127637120|NCT01490632|459291861|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
127637121|NCT01490632|459291862|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
127637122|NCT01490632|459291863|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
127637123|NCT01490632|459291864|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
127637124|NCT01490632|459291865|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
127637125|NCT01490632|459291866|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
127637126|NCT01490632|459291867|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
127637127|NCT01490632|459291868|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
127637128|NCT01490632|459291869|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
127637129|NCT01490632|459291870|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
127637130|NCT01490632|459291851|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
127637131|NCT01490632|459291852|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
127637132|NCT01490632|459291853|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
127637133|NCT01490632|459291854|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
127637134|NCT01490632|459291855|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
127637135|NCT01490632|459291856|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
127703208|NCT02861300|459542597|FG006|Overall Study|Delay in treatment|0|||
127703209|NCT02861300|459542591|FG000|Overall Study|Disease Progression|0|||
127703210|NCT02861300|459542592|FG001|Overall Study|Disease Progression|1|||
127637136|NCT01490632|459291857|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
127637137|NCT01490632|459291858|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
127637138|NCT01490632|459291859|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
127637139|NCT01490632|459291860|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
127637140|NCT01490632|459291861|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
127637141|NCT01490632|459291862|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
127637142|NCT01490632|459291863|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
127637143|NCT01490632|459291864|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
127637144|NCT01490632|459291865|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
127637145|NCT01490632|459291866|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
127637146|NCT01490632|459291867|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
127637147|NCT01490632|459291868|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
127637148|NCT01490632|459291869|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
127637149|NCT01490632|459291870|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
127637150|NCT01490632|459291851|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
127637151|NCT01490632|459291852|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
127637152|NCT01490632|459291853|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
127637153|NCT01490632|459291854|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
127637154|NCT01490632|459291855|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
127637155|NCT01490632|459291856|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
127637156|NCT01490632|459291857|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
127637157|NCT01490632|459291858|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
127637158|NCT01490632|459291859|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
127637159|NCT01490632|459291860|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
127637160|NCT01490632|459291861|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
127637161|NCT01490632|459291862|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
127637162|NCT01490632|459291863|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
127637163|NCT01490632|459291864|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
127637164|NCT01490632|459291865|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
127637165|NCT01490632|459291866|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
127637166|NCT01490632|459291867|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
127637167|NCT01490632|459291868|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
127637168|NCT01490632|459291869|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
127637169|NCT01490632|459291870|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
127637170|NCT01490632|459291851|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
127637171|NCT01490632|459291852|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
127637172|NCT01490632|459291853|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
127637173|NCT01490632|459291854|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
127637174|NCT01490632|459291855|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
127637175|NCT01490632|459291856|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
127637176|NCT01490632|459291857|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
127637177|NCT01490632|459291858|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
127637178|NCT01490632|459291859|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
127637179|NCT01490632|459291860|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
127637180|NCT01490632|459291861|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
127637181|NCT01490632|459291862|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
127637182|NCT01490632|459291863|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
127637183|NCT01490632|459291864|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
127637184|NCT01490632|459291865|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
127637185|NCT01490632|459291866|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
127637186|NCT01490632|459291867|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
127637187|NCT01490632|459291868|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
127637188|NCT01490632|459291869|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
127637189|NCT01490632|459291870|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
127637190|NCT01490632|459291851|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
127637191|NCT01490632|459291852|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
127637192|NCT01490632|459291853|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
127703211|NCT02861300|459542593|FG002|Overall Study|Disease Progression|0|||
127703212|NCT02861300|459542594|FG003|Overall Study|Disease Progression|0|||
127703213|NCT02861300|459542595|FG004|Overall Study|Disease Progression|0|||
127703214|NCT02861300|459542596|FG005|Overall Study|Disease Progression|0|||
127703215|NCT02861300|459542597|FG006|Overall Study|Disease Progression|2|||
127886016|NCT00343642|460206910|FG002|Overall Study|Adverse Event|1|||
127886017|NCT00343642|460206908|FG000|Overall Study|Flare up|6|||
127886018|NCT00343642|460206909|FG001|Overall Study|Flare up|4|||
127886019|NCT00343642|460206910|FG002|Overall Study|Flare up|0|||
127886020|NCT00860574|460206911|FG000|Overall Study|Death|2|||
127886021|NCT00860574|460206911|FG000|Overall Study|Relapse|1|||
127886022|NCT01246986|460206912|FG000|Overall Study|Lost to Follow-up|0|||
127886023|NCT01246986|460206913|FG001|Overall Study|Lost to Follow-up|1|||
127886024|NCT01246986|460206914|FG002|Overall Study|Lost to Follow-up|3|||
127886025|NCT01246986|460206915|FG003|Overall Study|Lost to Follow-up|0|||
127886026|NCT01246986|460206916|FG004|Overall Study|Lost to Follow-up|0|||
127886027|NCT01246986|460206917|FG005|Overall Study|Lost to Follow-up|1|||
127886028|NCT01246986|460206918|FG006|Overall Study|Lost to Follow-up|0|||
127886029|NCT01246986|460206912|FG000|Overall Study|Withdrawal by Subject|3|||
127637193|NCT01490632|459291854|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
127637194|NCT01490632|459291855|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
127637195|NCT01490632|459291856|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
127637196|NCT01490632|459291857|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
127637197|NCT01490632|459291858|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
127637198|NCT01490632|459291859|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
127637199|NCT01490632|459291860|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
127637200|NCT01490632|459291861|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
127637201|NCT01490632|459291862|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
127637202|NCT01490632|459291863|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
127637203|NCT01490632|459291864|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
127637204|NCT01490632|459291865|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
127637205|NCT01490632|459291866|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
127637206|NCT01490632|459291867|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
127637207|NCT01490632|459291868|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
127637208|NCT01490632|459291869|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
127637209|NCT01490632|459291870|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
127637210|NCT01490632|459291851|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
127637211|NCT01490632|459291852|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
127637212|NCT01490632|459291853|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
127637213|NCT01490632|459291854|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
127637214|NCT01490632|459291855|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
127637215|NCT01490632|459291856|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
127637216|NCT01490632|459291857|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
127637217|NCT01490632|459291858|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
127637218|NCT01490632|459291859|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
127637219|NCT01490632|459291860|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
127637220|NCT01490632|459291861|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
127637221|NCT01490632|459291862|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
127637222|NCT01490632|459291863|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
127637223|NCT01490632|459291864|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
127637224|NCT01490632|459291865|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
127637225|NCT01490632|459291866|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
127637226|NCT01490632|459291867|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
127637227|NCT01490632|459291868|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
127637228|NCT01490632|459291869|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
127637229|NCT01490632|459291870|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
127637230|NCT01490632|459291851|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
127637231|NCT01490632|459291852|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
127637232|NCT01490632|459291853|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
127637233|NCT01490632|459291854|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
127637234|NCT01490632|459291855|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
127637235|NCT01490632|459291856|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
127637236|NCT01490632|459291857|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
127637237|NCT01490632|459291858|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
127637238|NCT01490632|459291859|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
127637239|NCT01490632|459291860|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
127637240|NCT01490632|459291861|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
127886030|NCT01246986|460206913|FG001|Overall Study|Withdrawal by Subject|4|||
127886031|NCT01246986|460206914|FG002|Overall Study|Withdrawal by Subject|3|||
127886032|NCT01246986|460206915|FG003|Overall Study|Withdrawal by Subject|0|||
127637241|NCT01490632|459291862|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
127637242|NCT01490632|459291863|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
127886033|NCT01246986|460206916|FG004|Overall Study|Withdrawal by Subject|4|||
127886034|NCT01246986|460206917|FG005|Overall Study|Withdrawal by Subject|0|||
127886035|NCT01246986|460206918|FG006|Overall Study|Withdrawal by Subject|0|||
127886036|NCT01335399|460206922|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
127637243|NCT01490632|459291864|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
127637244|NCT01490632|459291865|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
127637245|NCT01490632|459291866|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
127637246|NCT01490632|459291867|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
127637247|NCT01490632|459291868|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
127637248|NCT01490632|459291869|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
127637249|NCT01490632|459291870|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
127637250|NCT01490632|459291851|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
127637251|NCT01490632|459291852|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
127637252|NCT01490632|459291853|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
127637253|NCT01490632|459291854|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
127637254|NCT01490632|459291855|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
127637255|NCT01490632|459291856|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
127637256|NCT01490632|459291857|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
127637257|NCT01490632|459291858|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
127637258|NCT01490632|459291859|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
127637259|NCT01490632|459291860|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
127637260|NCT01490632|459291861|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
127637261|NCT01490632|459291862|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
127637262|NCT01490632|459291863|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
127637263|NCT01490632|459291864|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
127637264|NCT01490632|459291865|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
127637265|NCT01490632|459291866|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
127637266|NCT01490632|459291867|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
127637267|NCT01490632|459291868|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
127637268|NCT01490632|459291869|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
127637269|NCT01490632|459291870|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
127637270|NCT01490632|459291851|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
127637271|NCT01490632|459291852|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
127637272|NCT01490632|459291853|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
127637273|NCT01490632|459291854|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
127637274|NCT01490632|459291855|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
127637275|NCT01490632|459291856|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
127637276|NCT01490632|459291857|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
127637277|NCT01490632|459291858|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
127637278|NCT01490632|459291859|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
127637279|NCT01490632|459291860|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
127637280|NCT01490632|459291861|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
127637281|NCT01490632|459291862|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
127637282|NCT01490632|459291863|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
127637283|NCT01490632|459291864|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
127637284|NCT01490632|459291865|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
127637285|NCT01490632|459291866|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
127637286|NCT01490632|459291867|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
127637287|NCT01490632|459291868|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
127637288|NCT01490632|459291869|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
127637289|NCT01490632|459291870|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
127637290|NCT01490632|459291851|FG000|Part D: Re-Treatment Period|Death|0|||
127637291|NCT01490632|459291852|FG001|Part D: Re-Treatment Period|Death|0|||
127637292|NCT01490632|459291853|FG002|Part D: Re-Treatment Period|Death|0|||
127637293|NCT01490632|459291854|FG003|Part D: Re-Treatment Period|Death|0|||
127637294|NCT01490632|459291855|FG004|Part D: Re-Treatment Period|Death|0|||
127637295|NCT01490632|459291856|FG005|Part D: Re-Treatment Period|Death|0|||
127637296|NCT01490632|459291857|FG006|Part D: Re-Treatment Period|Death|0|||
127637297|NCT01490632|459291858|FG007|Part D: Re-Treatment Period|Death|0|||
127637298|NCT01490632|459291859|FG008|Part D: Re-Treatment Period|Death|0|||
127637299|NCT01490632|459291860|FG009|Part D: Re-Treatment Period|Death|0|||
127637300|NCT01490632|459291861|FG010|Part D: Re-Treatment Period|Death|0|||
127637301|NCT01490632|459291862|FG011|Part D: Re-Treatment Period|Death|0|||
127637302|NCT01490632|459291863|FG012|Part D: Re-Treatment Period|Death|0|||
127637303|NCT01490632|459291864|FG013|Part D: Re-Treatment Period|Death|0|||
127637304|NCT01490632|459291865|FG014|Part D: Re-Treatment Period|Death|0|||
127637305|NCT01490632|459291866|FG015|Part D: Re-Treatment Period|Death|0|||
127637306|NCT01490632|459291867|FG016|Part D: Re-Treatment Period|Death|0|||
127637307|NCT01490632|459291868|FG017|Part D: Re-Treatment Period|Death|0|||
127703216|NCT02861300|459542591|FG000|Overall Study|Patient decision/withdrawal/refusal|0|||
127703217|NCT02861300|459542592|FG001|Overall Study|Patient decision/withdrawal/refusal|0|||
127637308|NCT01490632|459291869|FG018|Part D: Re-Treatment Period|Death|1|||
127637309|NCT01490632|459291870|FG019|Part D: Re-Treatment Period|Death|0|||
127637310|NCT01490632|459291851|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
127637311|NCT01490632|459291852|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
127637312|NCT01490632|459291853|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
127637313|NCT01490632|459291854|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
127637314|NCT01490632|459291855|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
127637315|NCT01490632|459291856|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
127637316|NCT01490632|459291857|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
127637317|NCT01490632|459291858|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
127637318|NCT01490632|459291859|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
127637319|NCT01490632|459291860|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
127796849|NCT02289950|459879019|FG001|Overall Study|Other|2|||
127796850|NCT02289950|459879018|FG000|Overall Study|Not Treated|2|||
127796851|NCT02289950|459879019|FG001|Overall Study|Not Treated|1|||
127796852|NCT02270242|459879020|FG000|Overall Study|Withdrawal by Subject|18|||
127796853|NCT02270242|459879021|FG001|Overall Study|Withdrawal by Subject|25|||
127796854|NCT02270242|459879020|FG000|Overall Study|Lost to Follow-up|41|||
127796855|NCT02270242|459879021|FG001|Overall Study|Lost to Follow-up|27|||
127796856|NCT02270242|459879020|FG000|Overall Study|Physician Decision|0|||
127796857|NCT02270242|459879021|FG001|Overall Study|Physician Decision|1|||
127796858|NCT00644787|459879024|FG000|Period 1: Titration Phase|Adverse Event|11|||
127796859|NCT00644787|459879025|FG001|Period 1: Titration Phase|Adverse Event|0|||
127796860|NCT00644787|459879026|FG002|Period 1: Titration Phase|Adverse Event|0|||
127796861|NCT00644787|459879024|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
127796862|NCT00644787|459879025|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
127796863|NCT00644787|459879026|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
127796864|NCT00644787|459879024|FG000|Period 1: Titration Phase|Physician Decision|1|||
127796865|NCT00644787|459879025|FG001|Period 1: Titration Phase|Physician Decision|0|||
127796866|NCT00644787|459879026|FG002|Period 1: Titration Phase|Physician Decision|0|||
127796867|NCT00644787|459879024|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
127796868|NCT00644787|459879025|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
127796869|NCT00644787|459879026|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
127796870|NCT00644787|459879024|FG000|Period 1: Titration Phase|Worsening of complications|1|||
127796871|NCT00644787|459879025|FG001|Period 1: Titration Phase|Worsening of complications|0|||
127796872|NCT00644787|459879026|FG002|Period 1: Titration Phase|Worsening of complications|0|||
127796873|NCT00644787|459879024|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
127637320|NCT01490632|459291861|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
127637321|NCT01490632|459291862|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
127637322|NCT01490632|459291863|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
127703218|NCT02861300|459542593|FG002|Overall Study|Patient decision/withdrawal/refusal|0|||
127703219|NCT02861300|459542594|FG003|Overall Study|Patient decision/withdrawal/refusal|0|||
127703220|NCT02861300|459542595|FG004|Overall Study|Patient decision/withdrawal/refusal|0|||
127703221|NCT02861300|459542596|FG005|Overall Study|Patient decision/withdrawal/refusal|0|||
127703222|NCT02861300|459542597|FG006|Overall Study|Patient decision/withdrawal/refusal|2|||
127703223|NCT02861300|459542591|FG000|Overall Study|Clinical Complications|0|||
127703224|NCT02861300|459542592|FG001|Overall Study|Clinical Complications|0|||
127703225|NCT02861300|459542593|FG002|Overall Study|Clinical Complications|0|||
127703226|NCT02861300|459542594|FG003|Overall Study|Clinical Complications|0|||
127796874|NCT00644787|459879025|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
127637323|NCT01490632|459291864|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
127637324|NCT01490632|459291865|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
127703227|NCT02861300|459542595|FG004|Overall Study|Clinical Complications|0|||
127703228|NCT02861300|459542596|FG005|Overall Study|Clinical Complications|0|||
127637325|NCT01490632|459291866|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
127637326|NCT01490632|459291867|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
127637327|NCT01490632|459291868|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
127637328|NCT01490632|459291869|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
127637329|NCT01490632|459291870|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
127637330|NCT01490632|459291851|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
127637331|NCT01490632|459291852|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
127637332|NCT01490632|459291853|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
127637333|NCT01490632|459291854|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
127637334|NCT01490632|459291855|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
127637335|NCT01490632|459291856|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
127637336|NCT01490632|459291857|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
127637337|NCT01490632|459291858|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
127637338|NCT01490632|459291859|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
127637339|NCT01490632|459291860|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
127637340|NCT01490632|459291861|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
127637341|NCT01490632|459291862|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
127637342|NCT01490632|459291863|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
127637343|NCT01490632|459291864|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
127637344|NCT01490632|459291865|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
127637345|NCT01490632|459291866|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
127637346|NCT01490632|459291867|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
127637347|NCT01490632|459291868|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
127637348|NCT01490632|459291869|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
127637349|NCT01490632|459291870|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
127637350|NCT01490632|459291851|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
127637351|NCT01490632|459291852|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
127637352|NCT01490632|459291853|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
127637353|NCT01490632|459291854|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
127637354|NCT01490632|459291855|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
127637355|NCT01490632|459291856|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
127637356|NCT01490632|459291857|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
127637357|NCT01490632|459291858|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
127637358|NCT01490632|459291859|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
127637359|NCT01490632|459291860|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
127637360|NCT01490632|459291861|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
127637361|NCT01490632|459291862|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
127637362|NCT01490632|459291863|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
127637363|NCT01490632|459291864|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
127637364|NCT01490632|459291865|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
127637365|NCT01490632|459291866|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
127637366|NCT01490632|459291867|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
127637367|NCT01490632|459291868|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
127637368|NCT01490632|459291869|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
127637369|NCT01490632|459291870|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
127637370|NCT01490632|459291851|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
127637371|NCT01490632|459291852|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
127637372|NCT01490632|459291853|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
127637373|NCT01490632|459291854|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
127637374|NCT01490632|459291855|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
127637375|NCT01490632|459291856|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
127637376|NCT01490632|459291857|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
127886037|NCT01335399|460206923|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
127886038|NCT01335399|460206922|FG000|Pre-treatment Period|Participant request to discontinue|0|||
127886039|NCT01335399|460206923|FG001|Pre-treatment Period|Participant request to discontinue|1|||
127637377|NCT01490632|459291858|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
127637378|NCT01490632|459291859|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
127637379|NCT01490632|459291860|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
127637380|NCT01490632|459291861|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
127637381|NCT01490632|459291862|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
127637382|NCT01490632|459291863|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
127637383|NCT01490632|459291864|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
127637384|NCT01490632|459291865|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
127637385|NCT01490632|459291866|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
127703229|NCT02861300|459542597|FG006|Overall Study|Clinical Complications|1|||
127637386|NCT01490632|459291867|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
127637387|NCT01490632|459291868|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
127637388|NCT01490632|459291869|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
127637389|NCT01490632|459291870|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
127703230|NCT03252847|459542598|FG000|Overall Study|Withdrawal by Subject|0|||
127637390|NCT01490632|459291851|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
127637391|NCT01490632|459291852|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
127637392|NCT01490632|459291853|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
127637393|NCT01490632|459291854|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
127637394|NCT01490632|459291855|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
127637395|NCT01490632|459291856|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
127637396|NCT01490632|459291857|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
127637397|NCT01490632|459291858|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
127637398|NCT01490632|459291859|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
127637399|NCT01490632|459291860|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
127637400|NCT01490632|459291861|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
127796875|NCT00644787|459879026|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
127796876|NCT00644787|459879024|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
127796877|NCT00644787|459879025|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
127796878|NCT00644787|459879026|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
127796879|NCT00644787|459879024|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
127796880|NCT00644787|459879025|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
127796881|NCT00644787|459879026|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
127796882|NCT00644787|459879024|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
127796883|NCT00644787|459879025|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
127796884|NCT00644787|459879026|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
127796885|NCT00644787|459879024|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
127796886|NCT00644787|459879025|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
127796887|NCT00644787|459879026|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
127796888|NCT00644787|459879024|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
127796889|NCT00644787|459879025|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
127796890|NCT00644787|459879026|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
127796891|NCT00644787|459879024|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
127796892|NCT00644787|459879025|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
127796893|NCT00644787|459879026|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
127796894|NCT03355300|459879027|FG000|Overall Study|Physician Decision|0|||
127796895|NCT03355300|459879028|FG001|Overall Study|Physician Decision|1|||
127796896|NCT03355300|459879027|FG000|Overall Study|Lack of Efficacy|2|||
127796897|NCT03355300|459879028|FG001|Overall Study|Lack of Efficacy|1|||
127796898|NCT03355300|459879027|FG000|Overall Study|Other reason|1|||
127796899|NCT03355300|459879028|FG001|Overall Study|Other reason|0|||
127796900|NCT03048422|459879029|FG000|Overall Study|Death|1|||
127796901|NCT03048422|459879030|FG001|Overall Study|Death|0|||
127796902|NCT03048422|459879031|FG002|Overall Study|Death|0|||
127796903|NCT03048422|459879029|FG000|Overall Study|Lost to Follow-up|5|||
127796904|NCT03048422|459879030|FG001|Overall Study|Lost to Follow-up|0|||
127796905|NCT03048422|459879031|FG002|Overall Study|Lost to Follow-up|1|||
127796906|NCT03048422|459879029|FG000|Overall Study|Withdrawal by Subject|5|||
127796907|NCT03048422|459879030|FG001|Overall Study|Withdrawal by Subject|7|||
127796908|NCT03048422|459879031|FG002|Overall Study|Withdrawal by Subject|4|||
127796909|NCT03048422|459879029|FG000|Overall Study|Moved|3|||
127796910|NCT03048422|459879030|FG001|Overall Study|Moved|2|||
127796911|NCT03048422|459879031|FG002|Overall Study|Moved|2|||
127796912|NCT03048422|459879029|FG000|Overall Study|Noncompliant with Study Requirements|2|||
127796913|NCT03048422|459879030|FG001|Overall Study|Noncompliant with Study Requirements|1|||
127796914|NCT03048422|459879031|FG002|Overall Study|Noncompliant with Study Requirements|2|||
127796915|NCT03048422|459879029|FG000|Overall Study|Not Able to Get to Clinic|1|||
127796916|NCT03048422|459879030|FG001|Overall Study|Not Able to Get to Clinic|0|||
127796917|NCT03048422|459879031|FG002|Overall Study|Not Able to Get to Clinic|0|||
127796918|NCT05036083|459879035|FG000|Overall Study|Physician Decision|1|||
127796919|NCT05036083|459879035|FG000|Overall Study|Withdrawal by Subject|1|||
127796920|NCT05036083|459879035|FG000|Overall Study|Labs outside instition parameter, eGFR|3|||
127796921|NCT05036083|459879035|FG000|Overall Study|IV not sustainable|1|||
127796922|NCT04622046|459879036|FG000|Intervention Period|Adverse Event|1|||
127796923|NCT04622046|459879036|FG000|Intervention Period|Withdrawal by Subject|2|||
127796924|NCT04622046|459879036|FG000|Extension Period|Ongoing in the Extension Period|21|||
127796925|NCT04647253|459879037|FG000|Overall Study|Death ≤ 365 Days|16|||
127796926|NCT04647253|459879038|FG001|Overall Study|Death ≤ 365 Days|7|||
127796927|NCT04647253|459879037|FG000|Overall Study|Physician Decision|0|||
127796928|NCT04647253|459879038|FG001|Overall Study|Physician Decision|1|||
127637401|NCT01490632|459291862|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
127637402|NCT01490632|459291863|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
127796929|NCT04647253|459879037|FG000|Overall Study|Withdrawal by Subject|7|||
127796930|NCT04647253|459879038|FG001|Overall Study|Withdrawal by Subject|2|||
127796931|NCT04647253|459879037|FG000|Overall Study|Missed 12-Month Visit|9|||
127796932|NCT04647253|459879038|FG001|Overall Study|Missed 12-Month Visit|7|||
127796933|NCT04647253|459879037|FG000|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
127703231|NCT03252847|459542599|FG001|Overall Study|Withdrawal by Subject|0|||
127703232|NCT03252847|459542600|FG002|Overall Study|Withdrawal by Subject|1|||
127703233|NCT03252847|459542601|FG003|Overall Study|Withdrawal by Subject|0|||
127703234|NCT03252847|459542602|FG004|Overall Study|Withdrawal by Subject|0|||
127703235|NCT03252847|459542603|FG005|Overall Study|Withdrawal by Subject|0|||
127703236|NCT03252847|459542604|FG006|Overall Study|Withdrawal by Subject|0|||
127703237|NCT03252847|459542598|FG000|Overall Study|Other: Patient decision|0|||
127703238|NCT03252847|459542599|FG001|Overall Study|Other: Patient decision|0|||
127703239|NCT03252847|459542600|FG002|Overall Study|Other: Patient decision|0|||
127703240|NCT03252847|459542601|FG003|Overall Study|Other: Patient decision|0|||
127703241|NCT03252847|459542602|FG004|Overall Study|Other: Patient decision|1|||
127703242|NCT03252847|459542603|FG005|Overall Study|Other: Patient decision|0|||
127703243|NCT03252847|459542604|FG006|Overall Study|Other: Patient decision|0|||
127703244|NCT01501955|459542605|FG000|Overall Study|Withdrawal by Subject|1|||
127703245|NCT01501955|459542606|FG001|Overall Study|Withdrawal by Subject|0|||
127703246|NCT01501955|459542605|FG000|Overall Study|Adverse Event|1|||
127703247|NCT01501955|459542606|FG001|Overall Study|Adverse Event|3|||
127703248|NCT04992520|459542608|FG000|Part A: First Challenge|Withdrawal by Subject|1|||
127703249|NCT04992520|459542609|FG001|Part A: First Challenge|Withdrawal by Subject|0|||
127703250|NCT04992520|459542610|FG002|Part A: First Challenge|Withdrawal by Subject|0|||
127703251|NCT04992520|459542611|FG003|Part A: First Challenge|Withdrawal by Subject|1|||
127703252|NCT04992520|459542612|FG004|Part A: First Challenge|Withdrawal by Subject|0|||
127703253|NCT04992520|459542613|FG005|Part A: First Challenge|Withdrawal by Subject|0|||
127703254|NCT04992520|459542608|FG000|Part A: First Challenge|Non-compliance|0|||
127703255|NCT04992520|459542609|FG001|Part A: First Challenge|Non-compliance|0|||
127703256|NCT04992520|459542610|FG002|Part A: First Challenge|Non-compliance|0|||
127703257|NCT04992520|459542611|FG003|Part A: First Challenge|Non-compliance|1|||
127703258|NCT04992520|459542612|FG004|Part A: First Challenge|Non-compliance|0|||
127703259|NCT04992520|459542613|FG005|Part A: First Challenge|Non-compliance|0|||
127703260|NCT04992520|459542608|FG000|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
127703261|NCT04992520|459542609|FG001|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
127703262|NCT04992520|459542610|FG002|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
127703263|NCT04992520|459542611|FG003|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
127703264|NCT04992520|459542612|FG004|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
127703265|NCT04992520|459542613|FG005|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
127703266|NCT04992520|459542608|FG000|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
127796934|NCT04647253|459879038|FG001|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
127796935|NCT01844986|459879039|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
127796936|NCT01844986|459879040|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
127796937|NCT01844986|459879039|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
127796938|NCT01844986|459879040|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
127637403|NCT01490632|459291864|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
127637404|NCT01490632|459291865|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
127637405|NCT01490632|459291866|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
127637406|NCT01490632|459291867|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
127637407|NCT01490632|459291868|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
127637408|NCT01490632|459291869|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
127637409|NCT01490632|459291870|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
127637410|NCT01944631|459291879|FG000|Overall Study|Adverse Event|1|||
127637411|NCT01944631|459291880|FG001|Overall Study|Adverse Event|0|||
127637412|NCT01944631|459291879|FG000|Overall Study|Lost to Follow-up|3|||
127637413|NCT01944631|459291880|FG001|Overall Study|Lost to Follow-up|1|||
127637414|NCT01944631|459291879|FG000|Overall Study|Withdrawal by Subject|0|||
127637415|NCT01944631|459291880|FG001|Overall Study|Withdrawal by Subject|1|||
127637416|NCT01412944|459291881|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
127637417|NCT01412944|459291882|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
127637418|NCT01412944|459291883|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
127637419|NCT01412944|459291884|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
127637420|NCT01412944|459291885|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
127637421|NCT01412944|459291886|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
127637422|NCT01412944|459291881|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
127637423|NCT01412944|459291882|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
127637424|NCT01412944|459291883|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
127637425|NCT01412944|459291884|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
127637426|NCT01412944|459291885|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
127637427|NCT01412944|459291886|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
127637428|NCT01412944|459291881|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
127637429|NCT01412944|459291882|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
127637430|NCT01412944|459291883|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
127637431|NCT01412944|459291884|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
127637432|NCT01412944|459291885|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
127637433|NCT01412944|459291886|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
127637434|NCT01412944|459291881|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
127637435|NCT01412944|459291882|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
127637436|NCT01412944|459291883|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
127637437|NCT01412944|459291884|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
127637438|NCT01412944|459291885|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
127637439|NCT01412944|459291886|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
127637440|NCT01412944|459291881|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
127637441|NCT01412944|459291882|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
127637442|NCT01412944|459291883|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
127637443|NCT01412944|459291884|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
127637444|NCT01412944|459291885|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
127637445|NCT01412944|459291886|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
127637446|NCT01412944|459291881|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
127637447|NCT01412944|459291882|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
127637448|NCT01412944|459291883|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
127637449|NCT01412944|459291884|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
127637450|NCT01412944|459291885|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
127637451|NCT01412944|459291886|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
127637452|NCT01412944|459291881|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
127637453|NCT01412944|459291882|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
127637454|NCT01412944|459291883|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
127637455|NCT01412944|459291884|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
127637456|NCT01412944|459291885|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
127637457|NCT01412944|459291886|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
127637458|NCT01412944|459291881|FG000|Entire: IV + Maintenance|Adverse Event|0|||
127637459|NCT01412944|459291882|FG001|Entire: IV + Maintenance|Adverse Event|0|||
127637460|NCT01412944|459291883|FG002|Entire: IV + Maintenance|Adverse Event|0|||
127637461|NCT01412944|459291884|FG003|Entire: IV + Maintenance|Adverse Event|0|||
127637462|NCT01412944|459291885|FG004|Entire: IV + Maintenance|Adverse Event|1|||
127637463|NCT01412944|459291886|FG005|Entire: IV + Maintenance|Adverse Event|0|||
127637464|NCT01412944|459291881|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
127637465|NCT01412944|459291882|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
127637466|NCT01412944|459291883|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
127637467|NCT01412944|459291884|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
127637468|NCT01412944|459291885|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
127637469|NCT01412944|459291886|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
127637470|NCT01412944|459291881|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
127637471|NCT01412944|459291882|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
127637472|NCT01412944|459291883|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
127886040|NCT01335399|460206922|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
127886041|NCT01335399|460206923|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
127886042|NCT01335399|460206922|FG000|Pre-treatment Period|Consent withdrawal|3|||
127886043|NCT01335399|460206923|FG001|Pre-treatment Period|Consent withdrawal|0|||
127886044|NCT01335399|460206922|FG000|Treatment Period|Disease progression|117|||
127886045|NCT01335399|460206923|FG001|Treatment Period|Disease progression|145|||
127886046|NCT01335399|460206922|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
127886047|NCT01335399|460206923|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
127886048|NCT01335399|460206922|FG000|Treatment Period|Study drug toxicity|52|||
127886049|NCT01335399|460206923|FG001|Treatment Period|Study drug toxicity|64|||
127886050|NCT01335399|460206922|FG000|Treatment Period|Participant request to discontinue|30|||
127886051|NCT01335399|460206923|FG001|Treatment Period|Participant request to discontinue|22|||
127886052|NCT01335399|460206922|FG000|Treatment Period|Other reasons|30|||
127886053|NCT01335399|460206923|FG001|Treatment Period|Other reasons|30|||
127886054|NCT01335399|460206922|FG000|Treatment Period|Consent withdrawal|10|||
127886055|NCT01335399|460206923|FG001|Treatment Period|Consent withdrawal|7|||
127886056|NCT01335399|460206922|FG000|Treatment Period|Death|7|||
127886057|NCT01335399|460206923|FG001|Treatment Period|Death|6|||
127886058|NCT01335399|460206922|FG000|Treatment Period|Poor/Non-compliance|3|||
127886059|NCT01335399|460206923|FG001|Treatment Period|Poor/Non-compliance|4|||
127886060|NCT01335399|460206922|FG000|Treatment Period|Lost to Follow-up|2|||
127886061|NCT01335399|460206923|FG001|Treatment Period|Lost to Follow-up|2|||
127886062|NCT01335399|460206922|FG000|Treatment Period|Maximum clinical benefit|1|||
127886063|NCT01335399|460206923|FG001|Treatment Period|Maximum clinical benefit|1|||
127886064|NCT01335399|460206922|FG000|Treatment Period|No longer meet study criteria|1|||
127637473|NCT01412944|459291884|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
127637474|NCT01412944|459291885|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
127637475|NCT01412944|459291886|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
127637476|NCT01412944|459291881|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
127637477|NCT01412944|459291882|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
127637478|NCT01412944|459291883|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
127637479|NCT01412944|459291884|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
127637480|NCT01412944|459291885|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
127637481|NCT01412944|459291886|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
127637482|NCT01412944|459291881|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
127637483|NCT01412944|459291882|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
127637484|NCT01412944|459291883|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
127637485|NCT01412944|459291884|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
127637486|NCT01412944|459291885|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
127637487|NCT01412944|459291886|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
127637488|NCT01412944|459291881|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
127637489|NCT01412944|459291882|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
127637490|NCT01412944|459291883|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
127637491|NCT01412944|459291884|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
127637492|NCT01412944|459291885|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
127637493|NCT01412944|459291886|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
127637494|NCT01412944|459291881|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
127637495|NCT01412944|459291882|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
127637496|NCT01412944|459291883|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
127637497|NCT01412944|459291884|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
127637498|NCT01412944|459291885|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
127637499|NCT01412944|459291886|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
127637500|NCT01412944|459291881|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
127637501|NCT01412944|459291882|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
127637502|NCT01412944|459291883|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
127637503|NCT01412944|459291884|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
127637504|NCT01412944|459291885|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
127637505|NCT01412944|459291886|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
127637506|NCT01412944|459291881|FG000|Entire: IV + Maintenance|Adverse Event|0|||
127637507|NCT01412944|459291882|FG001|Entire: IV + Maintenance|Adverse Event|1|||
127637508|NCT01412944|459291883|FG002|Entire: IV + Maintenance|Adverse Event|0|||
127637509|NCT01412944|459291884|FG003|Entire: IV + Maintenance|Adverse Event|0|||
127886065|NCT01335399|460206923|FG001|Treatment Period|No longer meet study criteria|1|||
127886066|NCT01335399|460206922|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
127886067|NCT01335399|460206923|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
127886068|NCT01416142|460206924|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
127637510|NCT01412944|459291885|FG004|Entire: IV + Maintenance|Adverse Event|0|||
127637511|NCT01412944|459291886|FG005|Entire: IV + Maintenance|Adverse Event|0|||
127637512|NCT01990950|459291887|FG000|Overall Study|Death|3|||
127637513|NCT01990950|459291887|FG000|Overall Study|Lost to Follow-up|2|||
127796939|NCT01844986|459879039|FG000|Overall Study (Global Cohort)|Death|55|||
127796940|NCT01844986|459879040|FG001|Overall Study (Global Cohort)|Death|26|||
127796941|NCT01844986|459879039|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
127796942|NCT01844986|459879040|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
127796943|NCT01844986|459879039|FG000|Overall Study (China Cohort)|Death|10|||
127796944|NCT01844986|459879040|FG001|Overall Study (China Cohort)|Death|6|||
127796945|NCT04705051|459881166|FG000|Overall Study|Enrolled but not treated|1|||
127796946|NCT04705051|459881166|FG000|Overall Study|Study terminated by sponsor|23|||
127796947|NCT02968810|459881167|FG000|Overall Study|Lost to Follow-up|1|||
127796948|NCT02968810|459881168|FG001|Overall Study|Lost to Follow-up|0|||
127796949|NCT02968810|459881167|FG000|Overall Study|Physician Decision|1|||
127637514|NCT01990950|459291887|FG000|Overall Study|Withdrawal by Subject|6|||
127637515|NCT04723576|459291892|FG000|Overall Study|Withdrawal by Subject|2133|||
127637516|NCT04723576|459291893|FG001|Overall Study|Withdrawal by Subject|3234|||
127637517|NCT02097472|459291894|FG000|Received Vaccination 2|Adverse Event|0|||
127637518|NCT02097472|459291895|FG001|Received Vaccination 2|Adverse Event|0|||
127637519|NCT02097472|459291896|FG002|Received Vaccination 2|Adverse Event|0|||
127637520|NCT02097472|459291897|FG003|Received Vaccination 2|Adverse Event|0|||
127637521|NCT02097472|459291898|FG004|Received Vaccination 2|Adverse Event|0|||
127637522|NCT02097472|459291899|FG005|Received Vaccination 2|Adverse Event|0|||
127637523|NCT02097472|459291900|FG006|Received Vaccination 2|Adverse Event|1|||
127637524|NCT02097472|459291901|FG007|Received Vaccination 2|Adverse Event|0|||
127637525|NCT03966157|459291902|FG000|Overall Study|Physician Decision|1|||
127637526|NCT03966157|459291903|FG001|Overall Study|Physician Decision|0|||
127637527|NCT02119416|459291904|FG000|Overall Study|Protocol Violation|1|||
127637528|NCT02119416|459291905|FG001|Overall Study|Protocol Violation|1|||
127637529|NCT02119416|459291906|FG002|Overall Study|Protocol Violation|1|||
127637530|NCT02119416|459291904|FG000|Overall Study|wrong pubertal stage|1|||
127637531|NCT02119416|459291905|FG001|Overall Study|wrong pubertal stage|0|||
127637532|NCT02119416|459291906|FG002|Overall Study|wrong pubertal stage|1|||
127637533|NCT03593655|459291909|FG000|First Product Use Period|Withdrawal by Subject|1|||
127637534|NCT03593655|459291910|FG001|First Product Use Period|Withdrawal by Subject|1|||
127637535|NCT03593655|459291909|FG000|First Product Use Period|Lost to Follow-up|1|||
127637536|NCT03593655|459291910|FG001|First Product Use Period|Lost to Follow-up|3|||
127637537|NCT03593655|459291909|FG000|Second Product Use Period|Withdrawal by Subject|1|||
127637538|NCT03593655|459291910|FG001|Second Product Use Period|Withdrawal by Subject|1|||
127637539|NCT03593655|459291909|FG000|Second Product Use Period|Lost to Follow-up|1|||
127637540|NCT03593655|459291910|FG001|Second Product Use Period|Lost to Follow-up|0|||
127637541|NCT03593655|459291909|FG000|Third Product Use Period|Lost to Follow-up|1|||
127637542|NCT03593655|459291910|FG001|Third Product Use Period|Lost to Follow-up|2|||
127637543|NCT03593655|459291909|FG000|Third Product Use Period|Physician Decision|0|||
127637544|NCT03593655|459291910|FG001|Third Product Use Period|Physician Decision|1|||
127637545|NCT03593655|459291909|FG000|Third Product Use Period|Withdrawal by Subject|0|||
127637546|NCT03593655|459291910|FG001|Third Product Use Period|Withdrawal by Subject|1|||
127637547|NCT03732209|459291911|FG000|Overall Study|Lost to Follow-up|4|||
127637548|NCT03732209|459291912|FG001|Overall Study|Lost to Follow-up|4|||
127637549|NCT03732209|459291911|FG000|Overall Study|Withdrawal by Subject|8|||
127637550|NCT03732209|459291912|FG001|Overall Study|Withdrawal by Subject|9|||
127637551|NCT02864082|459291913|FG000|Overall Study|Adverse Event|1|||
127637552|NCT02864082|459291914|FG001|Overall Study|Adverse Event|1|||
127637553|NCT02864082|459291913|FG000|Overall Study|Lost to Follow-up|0|||
127637554|NCT02864082|459291914|FG001|Overall Study|Lost to Follow-up|1|||
127637555|NCT02864082|459291913|FG000|Overall Study|Withdrawal by Subject|2|||
127637556|NCT02864082|459291914|FG001|Overall Study|Withdrawal by Subject|2|||
127637557|NCT03621696|459291915|FG000|Overall Study|Not eligible|0|||
127637558|NCT03621696|459291916|FG001|Overall Study|Not eligible|0|||
127637559|NCT03621696|459291917|FG002|Overall Study|Not eligible|0|||
127637560|NCT03621696|459291918|FG003|Overall Study|Not eligible|5|||
127637561|NCT03621696|459291915|FG000|Overall Study|Withdrawal by Subject|1|||
127637562|NCT03621696|459291916|FG001|Overall Study|Withdrawal by Subject|1|||
127637563|NCT03621696|459291917|FG002|Overall Study|Withdrawal by Subject|1|||
127637564|NCT03621696|459291918|FG003|Overall Study|Withdrawal by Subject|0|||
127637565|NCT03621696|459291915|FG000|Overall Study|Physician Decision|0|||
127796950|NCT02968810|459881168|FG001|Overall Study|Physician Decision|0|||
127796951|NCT02968810|459881167|FG000|Overall Study|Withdrawal by Subject|1|||
127637566|NCT03621696|459291916|FG001|Overall Study|Physician Decision|0|||
127637567|NCT03621696|459291917|FG002|Overall Study|Physician Decision|1|||
127637568|NCT03621696|459291918|FG003|Overall Study|Physician Decision|0|||
127637569|NCT04349553|459291919|FG000|Overall Study|Withdrawal by Subject|1|||
127637570|NCT04349553|459291920|FG001|Overall Study|Withdrawal by Subject|0|||
127637571|NCT04349553|459291921|FG002|Overall Study|Withdrawal by Subject|1|||
127637572|NCT04349553|459291922|FG003|Overall Study|Withdrawal by Subject|0|||
127637573|NCT02063724|459291923|FG000|Overall Study|Disease progression|1|||
127796952|NCT02968810|459881168|FG001|Overall Study|Withdrawal by Subject|3|||
127637574|NCT01715805|459291924|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
127637575|NCT01715805|459291925|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
127637576|NCT01715805|459291926|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
127637577|NCT01715805|459291927|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
127637578|NCT01715805|459291924|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
127637579|NCT01715805|459291925|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
127637580|NCT01715805|459291926|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
127637581|NCT01715805|459291927|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
127637582|NCT01715805|459291924|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
127637583|NCT01715805|459291925|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
127637584|NCT01715805|459291926|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
127637585|NCT01715805|459291927|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
127637586|NCT01715805|459291924|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
127637587|NCT01715805|459291925|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
127637588|NCT01715805|459291926|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
127637589|NCT01715805|459291927|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
127637590|NCT01715805|459291924|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
127637591|NCT01715805|459291925|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
127637592|NCT01715805|459291926|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
127637593|NCT01715805|459291927|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
127637594|NCT01715805|459291924|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
127637595|NCT01715805|459291925|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
127637596|NCT01715805|459291926|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
127637597|NCT01715805|459291927|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
127637598|NCT01715805|459291924|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
127637599|NCT01715805|459291925|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
127637600|NCT01715805|459291926|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
127637601|NCT01715805|459291927|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
127637602|NCT01715805|459291924|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
127637603|NCT01715805|459291925|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
127637604|NCT01715805|459291926|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
127637605|NCT01715805|459291927|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
127637606|NCT01715805|459291924|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
127637607|NCT01715805|459291925|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
127637608|NCT01715805|459291926|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
127637609|NCT01715805|459291927|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
127637610|NCT01715805|459291924|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
127637611|NCT01715805|459291925|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
127637612|NCT01715805|459291926|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
127637613|NCT01715805|459291927|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
127637614|NCT01715805|459291924|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
127703267|NCT04992520|459542609|FG001|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
127703268|NCT04992520|459542610|FG002|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|1|||
127703269|NCT04992520|459542611|FG003|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
127703270|NCT04992520|459542612|FG004|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
127703271|NCT04992520|459542613|FG005|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
127703272|NCT02714257|459542617|FG000|Overall Study|Withdrawal by Subject|6|||
127703273|NCT02714257|459542618|FG001|Overall Study|Withdrawal by Subject|11|||
127703274|NCT02714257|459542617|FG000|Overall Study|Death|3|||
127703275|NCT02714257|459542618|FG001|Overall Study|Death|4|||
127703276|NCT02714257|459542617|FG000|Overall Study|Lost to Follow-up|1|||
127703277|NCT02714257|459542618|FG001|Overall Study|Lost to Follow-up|6|||
127703278|NCT04103580|459542621|FG000|Phase 1 Active Caregiving|Lost to Follow-up|18|||
127703279|NCT04103580|459542622|FG001|Phase 1 Active Caregiving|Lost to Follow-up|45|||
127703280|NCT04103580|459542621|FG000|Phase 1 Active Caregiving|Withdrawal by Subject|5|||
127703281|NCT04103580|459542622|FG001|Phase 1 Active Caregiving|Withdrawal by Subject|14|||
127703282|NCT04103580|459542621|FG000|Phase 1 Active Caregiving|Decertified from Hospice|3|||
127703283|NCT04103580|459542622|FG001|Phase 1 Active Caregiving|Decertified from Hospice|1|||
127703284|NCT04103580|459542621|FG000|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|41|||
127703285|NCT04103580|459542622|FG001|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|35|||
127703286|NCT04103580|459542621|FG000|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|13|||
127703287|NCT04103580|459542622|FG001|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|19|||
127703288|NCT04103580|459542621|FG000|Phase 1 Active Caregiving|Other|3|||
127703289|NCT04103580|459542622|FG001|Phase 1 Active Caregiving|Other|3|||
127703290|NCT04103580|459542621|FG000|Phase 2 Bereavement|Lost to Follow-up|2|||
127703291|NCT04103580|459542622|FG001|Phase 2 Bereavement|Lost to Follow-up|6|||
127703292|NCT04103580|459542621|FG000|Phase 2 Bereavement|Withdrawal by Subject|1|||
127703293|NCT04103580|459542622|FG001|Phase 2 Bereavement|Withdrawal by Subject|4|||
127703294|NCT04103580|459542621|FG000|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|6|||
127703295|NCT04103580|459542622|FG001|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|7|||
127703296|NCT04103580|459542621|FG000|Phase 2 Bereavement|Other|8|||
127703297|NCT04103580|459542622|FG001|Phase 2 Bereavement|Other|6|||
127703298|NCT04145440|459542623|FG000|Overall Study|Physician Decision|3|||
127703299|NCT04145440|459542624|FG001|Overall Study|Physician Decision|0|||
127703300|NCT04145440|459542623|FG000|Overall Study|Use of prohibited therapy|2|||
127703301|NCT04145440|459542624|FG001|Overall Study|Use of prohibited therapy|3|||
127703302|NCT00104676|459542625|FG000|Overall Study|Death|3|||
127703303|NCT00104676|459542626|FG001|Overall Study|Death|2|||
127703304|NCT00104676|459542625|FG000|Overall Study|Withdrawal by Subject|0|||
127703305|NCT00104676|459542626|FG001|Overall Study|Withdrawal by Subject|2|||
127703306|NCT00104676|459542625|FG000|Overall Study|treatment interruption|4|||
127703307|NCT00104676|459542626|FG001|Overall Study|treatment interruption|10|||
127886069|NCT01416142|460206925|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
127886070|NCT01416142|460206926|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
127886071|NCT02464059|460206927|FG000|Overall Study|Lost to Follow-up|6|||
127886072|NCT00304954|460206930|FG000|Overall Study|Withdrawal by Subject|0|||
127886073|NCT00304954|460206931|FG001|Overall Study|Withdrawal by Subject|0|||
127886074|NCT00304954|460206932|FG002|Overall Study|Withdrawal by Subject|1|||
127886075|NCT00304954|460206933|FG003|Overall Study|Withdrawal by Subject|0|||
127886076|NCT00304954|460206930|FG000|Overall Study|Adverse Event|1|||
127886077|NCT00304954|460206931|FG001|Overall Study|Adverse Event|0|||
127886078|NCT00304954|460206932|FG002|Overall Study|Adverse Event|0|||
127886079|NCT00304954|460206933|FG003|Overall Study|Adverse Event|0|||
127886080|NCT03990389|460206936|FG000|Overall Study|Lost to Follow-up|3|||
127886081|NCT03990389|460206937|FG001|Overall Study|Lost to Follow-up|0|||
127886082|NCT02290028|460206938|FG000|Overall Study|Death|217|||
127886083|NCT02290028|460206938|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
127886084|NCT02290028|460206938|FG000|Overall Study|No longer under care of study physician|76|||
127886085|NCT02290028|460206938|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
127886086|NCT02290028|460206938|FG000|Overall Study|Withdrawal by Subject|52|||
127886087|NCT02290028|460206938|FG000|Overall Study|Study site closure|44|||
127886088|NCT02290028|460206938|FG000|Overall Study|Lost to Follow-up|34|||
127703308|NCT05808257|459542627|FG000|Overall Study|Lost to Follow-up|8|||
127703309|NCT05808257|459542628|FG001|Overall Study|Lost to Follow-up|8|||
127703310|NCT04568486|459542629|FG000|Overall Study|Withdrawal by Subject|26|||
127703311|NCT04568486|459542629|FG000|Overall Study|Lost to Follow-up|7|||
127703312|NCT04042233|459542630|FG000|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|1|||
127703313|NCT04042233|459542631|FG001|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|0|||
127886089|NCT02290028|460206938|FG000|Overall Study|Miscellaneous|10|||
127886090|NCT02290028|460206938|FG000|Overall Study|Transition to EP PASSION|1295|||
127886091|NCT02290028|460206938|FG000|Overall Study|Planned study completion at 12 months|257|||
127886092|NCT03202511|460206939|FG000|Overall Study|Withdrawal by Subject|1|||
127886093|NCT03202511|460206940|FG001|Overall Study|Withdrawal by Subject|0|||
127886094|NCT03208933|460206941|FG000|Overall Study|Death|3|||
127886095|NCT03208933|460206941|FG000|Overall Study|Withdrawal by Subject|3|||
127703314|NCT04042233|459542630|FG000|Overall Study|Protocol Violation|0|||
127703315|NCT04042233|459542631|FG001|Overall Study|Protocol Violation|2|||
127703316|NCT03899259|459542638|FG000|Overall Study|Adverse Event|5|||
127703317|NCT03899259|459542639|FG001|Overall Study|Adverse Event|4|||
127703318|NCT03899259|459542640|FG002|Overall Study|Adverse Event|6|||
127703319|NCT03899259|459542638|FG000|Overall Study|Lack of Efficacy|5|||
127703320|NCT03899259|459542639|FG001|Overall Study|Lack of Efficacy|0|||
127703321|NCT03899259|459542640|FG002|Overall Study|Lack of Efficacy|2|||
127703322|NCT03899259|459542638|FG000|Overall Study|Pregnancy|3|||
127703323|NCT03899259|459542639|FG001|Overall Study|Pregnancy|0|||
127703324|NCT03899259|459542640|FG002|Overall Study|Pregnancy|1|||
127703325|NCT03899259|459542638|FG000|Overall Study|Physician Decision|0|||
127703326|NCT03899259|459542639|FG001|Overall Study|Physician Decision|1|||
127703327|NCT03899259|459542640|FG002|Overall Study|Physician Decision|0|||
127703328|NCT03899259|459542638|FG000|Overall Study|Protocol Deviation|1|||
127703329|NCT03899259|459542639|FG001|Overall Study|Protocol Deviation|1|||
127703330|NCT03899259|459542640|FG002|Overall Study|Protocol Deviation|1|||
127703331|NCT03899259|459542638|FG000|Overall Study|Withdrawal by Subject|8|||
127703332|NCT03899259|459542639|FG001|Overall Study|Withdrawal by Subject|10|||
127703333|NCT03899259|459542640|FG002|Overall Study|Withdrawal by Subject|12|||
127703334|NCT03899259|459542638|FG000|Overall Study|Lost to Follow-up|5|||
127703335|NCT03899259|459542639|FG001|Overall Study|Lost to Follow-up|6|||
127886096|NCT03208933|460206941|FG000|Overall Study|Adverse Event|1|||
127703336|NCT03899259|459542640|FG002|Overall Study|Lost to Follow-up|2|||
127703337|NCT03899259|459542638|FG000|Overall Study|Lack of Adherence|1|||
127703338|NCT03899259|459542639|FG001|Overall Study|Lack of Adherence|0|||
127886097|NCT03208933|460206941|FG000|Overall Study|Lost to Follow-up|2|||
127886098|NCT03208933|460206941|FG000|Overall Study|Physician Decision|3|||
127886099|NCT03208933|460206941|FG000|Overall Study|Protocol Violation|1|||
127637615|NCT01715805|459291925|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
127637616|NCT01715805|459291926|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
127637617|NCT01715805|459291927|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
127637618|NCT01715805|459291924|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
127637619|NCT01715805|459291925|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
127637620|NCT01715805|459291926|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
127637621|NCT01715805|459291927|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
127637622|NCT01715805|459291924|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
127637623|NCT01715805|459291925|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
127637624|NCT01715805|459291926|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
127637625|NCT01715805|459291927|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
127637626|NCT01715805|459291924|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
127637627|NCT01715805|459291925|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
127637628|NCT01715805|459291926|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
127637629|NCT01715805|459291927|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
127637630|NCT02310750|459291934|FG000|HP Period 1|Lost to Follow-up|0|||
127637631|NCT02310750|459291935|FG001|HP Period 1|Lost to Follow-up|0|||
127637632|NCT02310750|459291936|FG002|HP Period 1|Lost to Follow-up|0|||
127637633|NCT02310750|459291937|FG003|HP Period 1|Lost to Follow-up|0|||
127637634|NCT02310750|459291938|FG004|HP Period 1|Lost to Follow-up|0|||
127637635|NCT02310750|459291939|FG005|HP Period 1|Lost to Follow-up|0|||
127637636|NCT02310750|459291940|FG006|HP Period 1|Lost to Follow-up|1|||
127637637|NCT02310750|459291941|FG007|HP Period 1|Lost to Follow-up|0|||
127637638|NCT02310750|459291942|FG008|HP Period 1|Lost to Follow-up|0|||
127637639|NCT02310750|459291943|FG009|HP Period 1|Lost to Follow-up|0|||
127637640|NCT02310750|459291944|FG010|HP Period 1|Lost to Follow-up|0|||
127637641|NCT02310750|459291945|FG011|HP Period 1|Lost to Follow-up|0|||
127637642|NCT02310750|459291946|FG012|HP Period 1|Lost to Follow-up|0|||
127637643|NCT02310750|459291947|FG013|HP Period 1|Lost to Follow-up|0|||
127637644|NCT02310750|459291948|FG014|HP Period 1|Lost to Follow-up|0|||
127637645|NCT02310750|459291949|FG015|HP Period 1|Lost to Follow-up|0|||
127637646|NCT02310750|459291934|FG000|HP Period 1|Withdrawal by Subject|1|||
127637647|NCT02310750|459291935|FG001|HP Period 1|Withdrawal by Subject|0|||
127637648|NCT02310750|459291936|FG002|HP Period 1|Withdrawal by Subject|0|||
127637649|NCT02310750|459291937|FG003|HP Period 1|Withdrawal by Subject|1|||
127637650|NCT02310750|459291938|FG004|HP Period 1|Withdrawal by Subject|0|||
127637651|NCT02310750|459291939|FG005|HP Period 1|Withdrawal by Subject|0|||
127637652|NCT02310750|459291940|FG006|HP Period 1|Withdrawal by Subject|0|||
127637653|NCT02310750|459291941|FG007|HP Period 1|Withdrawal by Subject|0|||
127637654|NCT02310750|459291942|FG008|HP Period 1|Withdrawal by Subject|0|||
127637655|NCT02310750|459291943|FG009|HP Period 1|Withdrawal by Subject|0|||
127637656|NCT02310750|459291944|FG010|HP Period 1|Withdrawal by Subject|0|||
127637657|NCT02310750|459291945|FG011|HP Period 1|Withdrawal by Subject|0|||
127637658|NCT02310750|459291946|FG012|HP Period 1|Withdrawal by Subject|0|||
127637659|NCT02310750|459291947|FG013|HP Period 1|Withdrawal by Subject|0|||
127637660|NCT02310750|459291948|FG014|HP Period 1|Withdrawal by Subject|0|||
127637661|NCT02310750|459291949|FG015|HP Period 1|Withdrawal by Subject|0|||
127637662|NCT02310750|459291934|FG000|HP Washout 1|Lost to Follow-up|0|||
127637663|NCT02310750|459291935|FG001|HP Washout 1|Lost to Follow-up|0|||
127637664|NCT02310750|459291936|FG002|HP Washout 1|Lost to Follow-up|1|||
127637665|NCT02310750|459291937|FG003|HP Washout 1|Lost to Follow-up|1|||
127637666|NCT02310750|459291938|FG004|HP Washout 1|Lost to Follow-up|2|||
127637667|NCT02310750|459291939|FG005|HP Washout 1|Lost to Follow-up|2|||
127637668|NCT02310750|459291940|FG006|HP Washout 1|Lost to Follow-up|3|||
127637669|NCT02310750|459291941|FG007|HP Washout 1|Lost to Follow-up|0|||
127637670|NCT02310750|459291942|FG008|HP Washout 1|Lost to Follow-up|0|||
127637671|NCT02310750|459291943|FG009|HP Washout 1|Lost to Follow-up|0|||
127637672|NCT02310750|459291944|FG010|HP Washout 1|Lost to Follow-up|0|||
127637673|NCT02310750|459291945|FG011|HP Washout 1|Lost to Follow-up|0|||
127637674|NCT02310750|459291946|FG012|HP Washout 1|Lost to Follow-up|0|||
127637675|NCT02310750|459291947|FG013|HP Washout 1|Lost to Follow-up|0|||
127637676|NCT02310750|459291948|FG014|HP Washout 1|Lost to Follow-up|0|||
127637677|NCT02310750|459291949|FG015|HP Washout 1|Lost to Follow-up|0|||
127637678|NCT02310750|459291934|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
127637679|NCT02310750|459291935|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
127637680|NCT02310750|459291936|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
127637681|NCT02310750|459291937|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
127637682|NCT02310750|459291938|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
127637683|NCT02310750|459291939|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
127637684|NCT02310750|459291940|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
127637685|NCT02310750|459291941|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
127637686|NCT02310750|459291942|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
127637687|NCT02310750|459291943|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
127703339|NCT03899259|459542640|FG002|Overall Study|Lack of Adherence|0|||
127703340|NCT03899259|459542638|FG000|Overall Study|Screen Failure|1|||
127703341|NCT03899259|459542639|FG001|Overall Study|Screen Failure|0|||
127703342|NCT03899259|459542640|FG002|Overall Study|Screen Failure|0|||
127703343|NCT03899259|459542638|FG000|Overall Study|Ongoing Study Participation|127|||
127703344|NCT03899259|459542639|FG001|Overall Study|Ongoing Study Participation|134|||
127703345|NCT03899259|459542640|FG002|Overall Study|Ongoing Study Participation|210|||
127703346|NCT05670587|459542641|FG000|Overall Study|Withdrawal by Subject|3|||
127703347|NCT01197378|459542642|FG000|Overall Study|Adverse Event|3|||
127703348|NCT01197378|459542642|FG000|Overall Study|Withdrawal by Subject|1|||
127703349|NCT01197378|459542642|FG000|Overall Study|Physician Decision|1|||
127703350|NCT01197378|459542642|FG000|Overall Study|Other|2|||
127703351|NCT05139810|459542643|FG000|Overall Study|Voluntary Withdrawal|2|||
127703352|NCT05139810|459542644|FG001|Overall Study|Voluntary Withdrawal|1|||
127703353|NCT05139810|459542645|FG002|Overall Study|Voluntary Withdrawal|0|||
127703354|NCT05139810|459542643|FG000|Overall Study|Pregnancy|1|||
127703355|NCT05139810|459542644|FG001|Overall Study|Pregnancy|0|||
127703356|NCT05139810|459542645|FG002|Overall Study|Pregnancy|0|||
127703357|NCT05139810|459542643|FG000|Overall Study|Roll Over to CS7|19|||
127703358|NCT05139810|459542644|FG001|Overall Study|Roll Over to CS7|44|||
127703359|NCT05139810|459542645|FG002|Overall Study|Roll Over to CS7|20|||
127796953|NCT02968810|459881167|FG000|Overall Study|Disease Progression|0|||
127886100|NCT04242186|460206942|FG000|Overall Study|Death|5|||
127886101|NCT00379587|460206943|FG000|Overall Study|Lost to Follow-up|2|||
127886102|NCT00534092|460206944|FG000|Overall Study|Lost to Follow-up|1|||
127886103|NCT00534092|460206945|FG001|Overall Study|Lost to Follow-up|0|||
127886104|NCT00534092|460206944|FG000|Overall Study|personal reasons/family concerns|1|||
127886105|NCT00534092|460206945|FG001|Overall Study|personal reasons/family concerns|0|||
127886106|NCT02323295|460206950|FG000|Overall Study|Adverse Event|0|||
127886107|NCT02323295|460206951|FG001|Overall Study|Adverse Event|1|||
127886108|NCT02323295|460206950|FG000|Overall Study|Withdrawal by Subject|0|||
127886109|NCT02323295|460206951|FG001|Overall Study|Withdrawal by Subject|1|||
127886110|NCT02323295|460206950|FG000|Overall Study|Patient did not have surgery as planned.|0|||
127886111|NCT02323295|460206951|FG001|Overall Study|Patient did not have surgery as planned.|1|||
127886112|NCT00830063|460206952|FG000|Overall Study|Adverse Event|7|||
127886113|NCT00830063|460206953|FG001|Overall Study|Adverse Event|13|||
127886114|NCT00830063|460206954|FG002|Overall Study|Adverse Event|16|||
127886115|NCT00830063|460206955|FG003|Overall Study|Adverse Event|13|||
127886116|NCT00830063|460206952|FG000|Overall Study|Death|1|||
127886117|NCT00830063|460206953|FG001|Overall Study|Death|0|||
127886118|NCT00830063|460206954|FG002|Overall Study|Death|0|||
127886119|NCT00830063|460206955|FG003|Overall Study|Death|0|||
127886120|NCT00830063|460206952|FG000|Overall Study|Lost to Follow-up|0|||
127886121|NCT00830063|460206953|FG001|Overall Study|Lost to Follow-up|0|||
127886122|NCT00830063|460206954|FG002|Overall Study|Lost to Follow-up|3|||
127886123|NCT00830063|460206955|FG003|Overall Study|Lost to Follow-up|1|||
127886124|NCT00830063|460206952|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
127886125|NCT00830063|460206953|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
127886126|NCT00830063|460206954|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
127886127|NCT00830063|460206955|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
127886128|NCT00830063|460206952|FG000|Overall Study|Lack of Efficacy|51|||
127886129|NCT00830063|460206953|FG001|Overall Study|Lack of Efficacy|23|||
127886130|NCT00830063|460206954|FG002|Overall Study|Lack of Efficacy|25|||
127886131|NCT00830063|460206955|FG003|Overall Study|Lack of Efficacy|32|||
127886132|NCT00830063|460206952|FG000|Overall Study|Other|5|||
127886133|NCT00830063|460206953|FG001|Overall Study|Other|5|||
127886134|NCT00830063|460206954|FG002|Overall Study|Other|8|||
127886135|NCT00830063|460206955|FG003|Overall Study|Other|6|||
127886136|NCT00830063|460206952|FG000|Overall Study|Withdrawal by Subject|16|||
127796954|NCT02968810|459881168|FG001|Overall Study|Disease Progression|1|||
127796955|NCT01449708|459881169|FG000|Overall Study|Protocol Violation|0|||
127796956|NCT01449708|459881170|FG001|Overall Study|Protocol Violation|1|||
127796957|NCT01449708|459881169|FG000|Overall Study|surgical complication|1|||
127796958|NCT01449708|459881170|FG001|Overall Study|surgical complication|2|||
127796959|NCT01449708|459881169|FG000|Overall Study|respiratory failure|1|||
127796960|NCT01449708|459881170|FG001|Overall Study|respiratory failure|0|||
127796961|NCT00223496|459881173|FG000|Overall Study|screen failure|9|||
127796962|NCT00223496|459881173|FG000|Overall Study|Lost to Follow-up|4|||
127796963|NCT00223496|459881173|FG000|Overall Study|Lack of Efficacy|6|||
127796964|NCT00223496|459881173|FG000|Overall Study|Withdrawal by Subject|1|||
127796965|NCT00223496|459881173|FG000|Overall Study|Physician Decision|2|||
127886137|NCT00830063|460206953|FG001|Overall Study|Withdrawal by Subject|10|||
127886138|NCT00830063|460206954|FG002|Overall Study|Withdrawal by Subject|16|||
127886139|NCT00830063|460206955|FG003|Overall Study|Withdrawal by Subject|13|||
127796966|NCT00559507|459881174|FG000|Overall Study|Not treated, patient ineligible|3|||
127886140|NCT00830063|460206952|FG000|Overall Study|Protocol Violation|1|||
127886141|NCT00830063|460206953|FG001|Overall Study|Protocol Violation|0|||
127796967|NCT02889796|459881175|FG000|Overall Study|Withdrew Consent|18|||
127796968|NCT02889796|459881176|FG001|Overall Study|Withdrew Consent|29|||
127796969|NCT02889796|459881177|FG002|Overall Study|Withdrew Consent|20|||
127886142|NCT00830063|460206954|FG002|Overall Study|Protocol Violation|3|||
127886143|NCT00830063|460206955|FG003|Overall Study|Protocol Violation|2|||
127886144|NCT00830063|460206952|FG000|Overall Study|Randomized But Not Treated|0|||
127886145|NCT00830063|460206953|FG001|Overall Study|Randomized But Not Treated|2|||
127886146|NCT00830063|460206954|FG002|Overall Study|Randomized But Not Treated|0|||
127886147|NCT00830063|460206955|FG003|Overall Study|Randomized But Not Treated|2|||
127886148|NCT01155063|460206956|FG000|Overall Study|Adverse Event|1|||
127796970|NCT02889796|459881178|FG003|Overall Study|Withdrew Consent|1|||
127637688|NCT02310750|459291944|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
127637689|NCT02310750|459291945|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
127637690|NCT02310750|459291946|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
127637691|NCT02310750|459291947|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
127637692|NCT02310750|459291948|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
127637693|NCT02310750|459291949|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
127637694|NCT02310750|459291934|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
127637695|NCT02310750|459291935|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
127637696|NCT02310750|459291936|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
127637697|NCT02310750|459291937|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
127637698|NCT02310750|459291938|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
127637699|NCT02310750|459291939|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
127637700|NCT02310750|459291940|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
127637701|NCT02310750|459291941|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
127637702|NCT02310750|459291942|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
127637703|NCT02310750|459291943|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
127637704|NCT02310750|459291944|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
127637705|NCT02310750|459291945|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
127637706|NCT02310750|459291946|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
127637707|NCT02310750|459291947|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
127637708|NCT02310750|459291948|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
127637709|NCT02310750|459291949|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
127637710|NCT02310750|459291934|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
127637711|NCT02310750|459291935|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
127637712|NCT02310750|459291936|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
127637713|NCT02310750|459291937|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
127637714|NCT02310750|459291938|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
127637715|NCT02310750|459291939|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
127637716|NCT02310750|459291940|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
127637717|NCT02310750|459291941|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
127637718|NCT02310750|459291942|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
127637719|NCT02310750|459291943|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
127637720|NCT02310750|459291944|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
127637721|NCT02310750|459291945|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
127637722|NCT02310750|459291946|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
127637723|NCT02310750|459291947|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
127637724|NCT02310750|459291948|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
127637725|NCT02310750|459291949|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
127637726|NCT02310750|459291934|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
127637727|NCT02310750|459291935|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
127637728|NCT02310750|459291936|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
127637729|NCT02310750|459291937|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
127637730|NCT02310750|459291938|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
127637731|NCT02310750|459291939|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
127637732|NCT02310750|459291940|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
127637733|NCT02310750|459291941|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
127637734|NCT02310750|459291942|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
127637735|NCT02310750|459291943|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
127637736|NCT02310750|459291944|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
127637737|NCT02310750|459291945|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
127637738|NCT02310750|459291946|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
127637739|NCT02310750|459291947|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
127637740|NCT02310750|459291948|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
127637741|NCT02310750|459291949|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
127637742|NCT02310750|459291934|FG000|HP Washout 2|Lost to Follow-up|0|||
127637743|NCT02310750|459291935|FG001|HP Washout 2|Lost to Follow-up|0|||
127637744|NCT02310750|459291936|FG002|HP Washout 2|Lost to Follow-up|0|||
127637745|NCT02310750|459291937|FG003|HP Washout 2|Lost to Follow-up|0|||
127637746|NCT02310750|459291938|FG004|HP Washout 2|Lost to Follow-up|1|||
127637747|NCT02310750|459291939|FG005|HP Washout 2|Lost to Follow-up|0|||
127637748|NCT02310750|459291940|FG006|HP Washout 2|Lost to Follow-up|7|||
127637749|NCT02310750|459291941|FG007|HP Washout 2|Lost to Follow-up|0|||
127637750|NCT02310750|459291942|FG008|HP Washout 2|Lost to Follow-up|0|||
127637751|NCT02310750|459291943|FG009|HP Washout 2|Lost to Follow-up|0|||
127637752|NCT02310750|459291944|FG010|HP Washout 2|Lost to Follow-up|0|||
127637753|NCT02310750|459291945|FG011|HP Washout 2|Lost to Follow-up|0|||
127637754|NCT02310750|459291946|FG012|HP Washout 2|Lost to Follow-up|0|||
127637755|NCT02310750|459291947|FG013|HP Washout 2|Lost to Follow-up|0|||
127637756|NCT02310750|459291948|FG014|HP Washout 2|Lost to Follow-up|0|||
127637757|NCT02310750|459291949|FG015|HP Washout 2|Lost to Follow-up|0|||
127637758|NCT01220557|459291953|FG000|Overall Study|Lost to Follow-up|5|||
127637759|NCT01220557|459291954|FG001|Overall Study|Lost to Follow-up|3|||
127637760|NCT01220557|459291953|FG000|Overall Study|attended less than 6 lessons|1|||
127637761|NCT01220557|459291954|FG001|Overall Study|attended less than 6 lessons|2|||
127637762|NCT04177758|459291960|FG000|Overall Study|Lost to Follow-up|19|||
127637763|NCT04177758|459291961|FG001|Overall Study|Lost to Follow-up|11|||
127637764|NCT03156023|459291962|FG000|Overall Study|Withdrawal by Subject|1|||
127637765|NCT03156023|459291963|FG001|Overall Study|Withdrawal by Subject|0|||
127637766|NCT03156023|459291964|FG002|Overall Study|Withdrawal by Subject|2|||
127637767|NCT03156023|459291965|FG003|Overall Study|Withdrawal by Subject|1|||
127637768|NCT03156023|459291966|FG004|Overall Study|Withdrawal by Subject|1|||
127637769|NCT03156023|459291962|FG000|Overall Study|Lost to Follow-up|0|||
127637770|NCT03156023|459291963|FG001|Overall Study|Lost to Follow-up|0|||
127637771|NCT03156023|459291964|FG002|Overall Study|Lost to Follow-up|0|||
127637772|NCT03156023|459291965|FG003|Overall Study|Lost to Follow-up|0|||
127637773|NCT03156023|459291966|FG004|Overall Study|Lost to Follow-up|1|||
127637774|NCT00660010|459291967|FG000|Overall Study|Withdrawal by Subject|2|||
127637775|NCT00660010|459291967|FG000|Overall Study|Lost to Follow-up|3|||
127637776|NCT00660010|459291967|FG000|Overall Study|Adverse Event|1|||
127637777|NCT00660010|459291967|FG000|Overall Study|Noncompliance with visit schedule|3|||
127637778|NCT00726752|459291968|FG000|Overall Study|Lack of Efficacy|6|||
127637779|NCT00791765|459293983|FG000|Weeks 1 to 12|Adverse Event|0|||
127637780|NCT00791765|459293984|FG001|Weeks 1 to 12|Adverse Event|1|||
127637781|NCT00791765|459293983|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
127637782|NCT00791765|459293984|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
127637783|NCT00791765|459293983|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
127637784|NCT00791765|459293984|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
127637785|NCT00791765|459293983|FG000|Weeks 1 to 12|Physician Decision|1|||
127637786|NCT00791765|459293984|FG001|Weeks 1 to 12|Physician Decision|0|||
127637787|NCT00791765|459293983|FG000|Weeks 1 to 12|Disease progression|3|||
127637788|NCT00791765|459293984|FG001|Weeks 1 to 12|Disease progression|0|||
127637789|NCT00791765|459293983|FG000|Weeks 1 to 12|Ineligibility determined|0|||
127637790|NCT00791765|459293984|FG001|Weeks 1 to 12|Ineligibility determined|3|||
127637791|NCT00791765|459293983|FG000|Weeks 13 to 24|Protocol deviation|2|||
127637792|NCT00791765|459293984|FG001|Weeks 13 to 24|Protocol deviation|0|||
127637793|NCT00791765|459293983|FG000|Weeks 13 to 24|Adverse Event|0|||
127637794|NCT00791765|459293984|FG001|Weeks 13 to 24|Adverse Event|3|||
127637795|NCT00791765|459293983|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
127637796|NCT00791765|459293984|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
127637797|NCT00791765|459293983|FG000|Weeks 13 to 24|Disease progression|0|||
127637798|NCT00791765|459293984|FG001|Weeks 13 to 24|Disease progression|1|||
127637799|NCT00791765|459293983|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
127637800|NCT00791765|459293984|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
127637801|NCT00791765|459293983|FG000|Weeks 13 to 24|Other|0|||
127637802|NCT00791765|459293984|FG001|Weeks 13 to 24|Other|1|||
127637803|NCT01877408|459293985|FG000|Overall Study|Lost to Follow-up|0|||
127637804|NCT01877408|459293986|FG001|Overall Study|Lost to Follow-up|2|||
127637805|NCT00156065|459293987|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
127637806|NCT00156065|459293988|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
127637807|NCT00156065|459293989|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
127637808|NCT00156065|459293987|FG000|Overall Study|Adverse Event|8|||
127637809|NCT00156065|459293988|FG001|Overall Study|Adverse Event|11|||
127637810|NCT00156065|459293989|FG002|Overall Study|Adverse Event|4|||
127637811|NCT00156065|459293987|FG000|Overall Study|Lack of Efficacy|2|||
127637812|NCT00156065|459293988|FG001|Overall Study|Lack of Efficacy|9|||
127637813|NCT00156065|459293989|FG002|Overall Study|Lack of Efficacy|3|||
127637814|NCT00156065|459293987|FG000|Overall Study|Withdrawal by Subject|13|||
127637815|NCT00156065|459293988|FG001|Overall Study|Withdrawal by Subject|26|||
127637816|NCT00156065|459293989|FG002|Overall Study|Withdrawal by Subject|16|||
127703360|NCT06182033|459542646|FG000|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
127703361|NCT06182033|459542647|FG001|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
127703362|NCT06182033|459542646|FG000|Overall Study|Target child relocation|1|||
127703363|NCT06182033|459542647|FG001|Overall Study|Target child relocation|1|||
127703364|NCT06182033|459542646|FG000|Overall Study|Withdrawal by Subject|1|||
127703365|NCT06182033|459542647|FG001|Overall Study|Withdrawal by Subject|0|||
127703366|NCT05704543|459542648|FG000|Overall Study|Withdrawal by Subject|1|||
127703367|NCT05704543|459542649|FG001|Overall Study|Withdrawal by Subject|1|||
127637817|NCT00156065|459293987|FG000|Overall Study|Lost to Follow-up|5|||
127637818|NCT00156065|459293988|FG001|Overall Study|Lost to Follow-up|7|||
127637819|NCT00156065|459293989|FG002|Overall Study|Lost to Follow-up|1|||
127637820|NCT00156065|459293987|FG000|Overall Study|Other|2|||
127637821|NCT00156065|459293988|FG001|Overall Study|Other|9|||
127637822|NCT00156065|459293989|FG002|Overall Study|Other|3|||
127637823|NCT00920426|459293990|FG000|ITZ111451|Adverse Event|1|||
127637824|NCT00920426|459293991|FG001|ITZ111451|Adverse Event|0|||
127637825|NCT00920426|459293992|FG002|ITZ111451|Adverse Event|0|||
127637826|NCT00920426|459293993|FG003|ITZ111451|Adverse Event|0|||
127637827|NCT01292603|459293994|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
127637828|NCT01292603|459293995|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
127637829|NCT01292603|459293996|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
127637830|NCT01292603|459293997|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
127637831|NCT01292603|459293998|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
127637832|NCT01292603|459293999|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
127637833|NCT01292603|459293994|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
127637834|NCT01292603|459293995|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
127637835|NCT01292603|459293996|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
127637836|NCT01292603|459293997|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
127637837|NCT01292603|459293998|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
127637838|NCT01292603|459293999|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
127637839|NCT01292603|459293994|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
127637840|NCT01292603|459293995|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
127637841|NCT01292603|459293996|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
127637842|NCT01292603|459293997|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
127637843|NCT01292603|459293998|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
127637844|NCT01292603|459293999|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
127637845|NCT01292603|459293994|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
127637846|NCT01292603|459293995|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
127637847|NCT01292603|459293996|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
127637848|NCT01292603|459293997|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
127637849|NCT01292603|459293998|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
127637850|NCT01292603|459293999|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
127637851|NCT01292603|459293994|FG000|Part 1: Regular Follow-Up Period|Death|3|||
127637852|NCT01292603|459293995|FG001|Part 1: Regular Follow-Up Period|Death|1|||
127637853|NCT01292603|459293996|FG002|Part 1: Regular Follow-Up Period|Death|3|||
127637854|NCT01292603|459293997|FG003|Part 1: Regular Follow-Up Period|Death|1|||
127637855|NCT01292603|459293998|FG004|Part 1: Regular Follow-Up Period|Death|0|||
127637856|NCT01292603|459293999|FG005|Part 1: Regular Follow-Up Period|Death|0|||
127637857|NCT01292603|459293994|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
127637858|NCT01292603|459293995|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
127637859|NCT01292603|459293996|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
127637860|NCT01292603|459293997|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
127637861|NCT01292603|459293998|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
127637862|NCT01292603|459293999|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
127637863|NCT01292603|459293994|FG000|Part 2: Dose Confirmation Period|Death|0|||
127637864|NCT01292603|459293995|FG001|Part 2: Dose Confirmation Period|Death|0|||
127637865|NCT01292603|459293996|FG002|Part 2: Dose Confirmation Period|Death|0|||
127637866|NCT01292603|459293997|FG003|Part 2: Dose Confirmation Period|Death|0|||
127637867|NCT01292603|459293998|FG004|Part 2: Dose Confirmation Period|Death|1|||
127637868|NCT01292603|459293999|FG005|Part 2: Dose Confirmation Period|Death|0|||
127637869|NCT01292603|459293994|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
127637870|NCT01292603|459293995|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
127637871|NCT01292603|459293996|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
127637872|NCT01292603|459293997|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
127637873|NCT01292603|459293998|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
127637874|NCT01292603|459293999|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
127637875|NCT01292603|459293994|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
127637876|NCT01292603|459293995|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
127637877|NCT01292603|459293996|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
127637878|NCT01292603|459293997|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
127637879|NCT01292603|459293998|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
127637880|NCT01292603|459293999|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
127637881|NCT01292603|459293994|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
127637882|NCT01292603|459293995|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
127637883|NCT01292603|459293996|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
127637884|NCT01292603|459293997|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
127637885|NCT01292603|459293998|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
127637886|NCT01292603|459293999|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
127637887|NCT01292603|459293994|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
127637888|NCT01292603|459293995|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
127637889|NCT01292603|459293996|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
127637890|NCT01292603|459293997|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
127637891|NCT01292603|459293998|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
127637892|NCT01292603|459293999|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
127637893|NCT01292603|459293994|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
127796971|NCT02889796|459881179|FG004|Overall Study|Withdrew Consent|2|||
127637894|NCT01292603|459293995|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
127637895|NCT01292603|459293996|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
127637896|NCT01292603|459293997|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
127637897|NCT01292603|459293998|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
127637898|NCT01292603|459293999|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
127637899|NCT01292603|459293994|FG000|Part 2: Regular Follow-Up|Death|0|||
127637900|NCT01292603|459293995|FG001|Part 2: Regular Follow-Up|Death|0|||
127637901|NCT01292603|459293996|FG002|Part 2: Regular Follow-Up|Death|0|||
127637902|NCT01292603|459293997|FG003|Part 2: Regular Follow-Up|Death|0|||
127637903|NCT01292603|459293998|FG004|Part 2: Regular Follow-Up|Death|6|||
127637904|NCT01292603|459293999|FG005|Part 2: Regular Follow-Up|Death|3|||
127637905|NCT01292603|459293994|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
127637906|NCT01292603|459293995|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
127637907|NCT01292603|459293996|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
127637908|NCT01292603|459293997|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
127637909|NCT01292603|459293998|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
127637910|NCT01292603|459293999|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
127637911|NCT01292603|459293994|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
127637912|NCT01292603|459293995|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
127637913|NCT01292603|459293996|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
127637914|NCT01292603|459293997|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
127637915|NCT01292603|459293998|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
127637916|NCT01292603|459293999|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
127637917|NCT01292603|459293994|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
127637918|NCT01292603|459293995|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
127637919|NCT01292603|459293996|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
127637920|NCT01292603|459293997|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
127637921|NCT01292603|459293998|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
127637922|NCT01292603|459293999|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
127637923|NCT01292603|459293994|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
127637924|NCT01292603|459293995|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
127637925|NCT01292603|459293996|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
127637926|NCT01292603|459293997|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
127637927|NCT01292603|459293998|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
127637928|NCT01292603|459293999|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
127637929|NCT01292603|459293994|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
127637930|NCT01292603|459293995|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
127637931|NCT01292603|459293996|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
127637932|NCT01292603|459293997|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
127637933|NCT01292603|459293998|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
127637934|NCT01292603|459293999|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
127637935|NCT01292603|459293994|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
127637936|NCT01292603|459293995|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
127637937|NCT01292603|459293996|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
127637938|NCT01292603|459293997|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
127637939|NCT01292603|459293998|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
127637940|NCT01292603|459293999|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
127637941|NCT01292603|459293994|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
127637942|NCT01292603|459293995|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
127637943|NCT01292603|459293996|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
127637944|NCT01292603|459293997|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
127637945|NCT01292603|459293998|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
127637946|NCT01292603|459293999|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
127637947|NCT01292603|459293994|FG000|Overall Survival Status|Death|3|||
127637948|NCT01292603|459293995|FG001|Overall Survival Status|Death|1|||
127637949|NCT01292603|459293996|FG002|Overall Survival Status|Death|3|||
127637950|NCT01292603|459293997|FG003|Overall Survival Status|Death|1|||
127637951|NCT01292603|459293998|FG004|Overall Survival Status|Death|16|||
127637952|NCT01292603|459293999|FG005|Overall Survival Status|Death|10|||
127637953|NCT03870763|459294002|FG000|Overall Study|Study terminated by sponsor|0|||
127637954|NCT03870763|459294003|FG001|Overall Study|Study terminated by sponsor|2|||
127637955|NCT03870763|459294004|FG002|Overall Study|Study terminated by sponsor|0|||
127637956|NCT03870763|459294002|FG000|Overall Study|Withdrawal by Subject|0|||
127637957|NCT03870763|459294003|FG001|Overall Study|Withdrawal by Subject|1|||
127637958|NCT03870763|459294004|FG002|Overall Study|Withdrawal by Subject|0|||
127637959|NCT03870763|459294002|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
127637960|NCT03870763|459294003|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
127637961|NCT03870763|459294004|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
127637962|NCT03586648|459294007|FG000|Period 1|Withdrawal by Subject|0|||
127637963|NCT03586648|459294008|FG001|Period 1|Withdrawal by Subject|1|||
127637964|NCT03586648|459294007|FG000|Period 1|Lost to Follow-up|1|||
127637965|NCT03586648|459294008|FG001|Period 1|Lost to Follow-up|1|||
127637966|NCT03586648|459294007|FG000|Period 1|Adverse Event|1|||
127886149|NCT01155063|460206956|FG000|Overall Study|Withdrawal by Subject|1|||
127886150|NCT01155063|460206956|FG000|Overall Study|Study terminated by sponsor|87|||
127886151|NCT01314703|460206957|FG000|Overall Study|screen failure and closed enrollment|8|||
127886152|NCT00881959|460206960|FG000|Overall Study|Lost to Follow-up|2|||
127886153|NCT00881959|460206961|FG001|Overall Study|Lost to Follow-up|4|||
127886154|NCT01070966|460206964|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
127886155|NCT01070966|460206964|FG000|Participants for Safety Evaluation|Off-label use|9|||
127886156|NCT01070966|460206964|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
127886157|NCT01070966|460206964|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
127886158|NCT01070966|460206964|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
127886159|NCT01070966|460206964|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
127703368|NCT05704543|459542650|FG002|Overall Study|Withdrawal by Subject|0|||
127703369|NCT05704543|459542651|FG003|Overall Study|Withdrawal by Subject|2|||
127703370|NCT05704543|459542648|FG000|Overall Study|Lost to Follow-up|1|||
127703371|NCT05704543|459542649|FG001|Overall Study|Lost to Follow-up|2|||
127703372|NCT05704543|459542650|FG002|Overall Study|Lost to Follow-up|0|||
127703373|NCT05704543|459542651|FG003|Overall Study|Lost to Follow-up|0|||
127703374|NCT02723591|459542655|FG000|Overall Study|Adverse Event|48|||
127637967|NCT03586648|459294008|FG001|Period 1|Adverse Event|0|||
127637968|NCT03586648|459294007|FG000|Period 1|Study related symptoms or complaints|2|||
127637969|NCT03586648|459294008|FG001|Period 1|Study related symptoms or complaints|1|||
127637970|NCT03586648|459294007|FG000|Period 1|Physician Decision|0|||
127637971|NCT03586648|459294008|FG001|Period 1|Physician Decision|1|||
127637972|NCT03586648|459294007|FG000|Period 2|Adverse Event|1|||
127637973|NCT03586648|459294008|FG001|Period 2|Adverse Event|0|||
127637974|NCT00377234|459294010|FG000|Overall Study|Adverse Event|14|||
127637975|NCT00377234|459294011|FG001|Overall Study|Adverse Event|17|||
127637976|NCT00377234|459294010|FG000|Overall Study|Withdrawal by Subject|11|||
127637977|NCT00377234|459294011|FG001|Overall Study|Withdrawal by Subject|9|||
127637978|NCT00377234|459294010|FG000|Overall Study|Lost to Follow-up|4|||
127637979|NCT00377234|459294011|FG001|Overall Study|Lost to Follow-up|2|||
127637980|NCT00377234|459294010|FG000|Overall Study|Administrative|2|||
127637981|NCT00377234|459294011|FG001|Overall Study|Administrative|1|||
127637982|NCT00377234|459294010|FG000|Overall Study|Not assigned|3|||
127637983|NCT00377234|459294011|FG001|Overall Study|Not assigned|2|||
127637984|NCT00907153|459294012|FG000|Overall Study|Lost to Follow-up|1|||
127637985|NCT00907153|459294013|FG001|Overall Study|Lost to Follow-up|1|||
127637986|NCT00907153|459294012|FG000|Overall Study|Withdrawal by Subject|1|||
127637987|NCT00907153|459294013|FG001|Overall Study|Withdrawal by Subject|3|||
127637988|NCT03147248|459294014|FG000|Overall Study|Adverse Event|0|||
127703375|NCT02723591|459542656|FG001|Overall Study|Adverse Event|40|||
127703376|NCT02723591|459542655|FG000|Overall Study|Death|2|||
127703377|NCT02723591|459542656|FG001|Overall Study|Death|2|||
127703378|NCT02723591|459542655|FG000|Overall Study|Lack of Efficacy|4|||
127637989|NCT03147248|459294015|FG001|Overall Study|Adverse Event|2|||
127637990|NCT03147248|459294016|FG002|Overall Study|Adverse Event|2|||
127703379|NCT02723591|459542656|FG001|Overall Study|Lack of Efficacy|3|||
127637991|NCT03147248|459294017|FG003|Overall Study|Adverse Event|2|||
127703380|NCT02723591|459542655|FG000|Overall Study|Lost to Follow-up|1|||
127637992|NCT03147248|459294018|FG004|Overall Study|Adverse Event|6|||
127637993|NCT03147248|459294019|FG005|Overall Study|Adverse Event|11|||
127637994|NCT03147248|459294014|FG000|Overall Study|Disease progression|1|||
127703381|NCT02723591|459542656|FG001|Overall Study|Lost to Follow-up|7|||
127796972|NCT02889796|459881180|FG005|Overall Study|Withdrew Consent|35|||
127796973|NCT02889796|459881175|FG000|Overall Study|Investigator's Discretion|10|||
127796974|NCT02889796|459881176|FG001|Overall Study|Investigator's Discretion|9|||
127796975|NCT02889796|459881177|FG002|Overall Study|Investigator's Discretion|10|||
127637995|NCT03147248|459294015|FG001|Overall Study|Disease progression|0|||
127637996|NCT03147248|459294016|FG002|Overall Study|Disease progression|0|||
127637997|NCT03147248|459294017|FG003|Overall Study|Disease progression|0|||
127637998|NCT03147248|459294018|FG004|Overall Study|Disease progression|0|||
127637999|NCT03147248|459294019|FG005|Overall Study|Disease progression|2|||
127638000|NCT03147248|459294014|FG000|Overall Study|Withdrawal by Subject|0|||
127638001|NCT03147248|459294015|FG001|Overall Study|Withdrawal by Subject|0|||
127638002|NCT03147248|459294016|FG002|Overall Study|Withdrawal by Subject|0|||
127638003|NCT03147248|459294017|FG003|Overall Study|Withdrawal by Subject|0|||
127638004|NCT03147248|459294018|FG004|Overall Study|Withdrawal by Subject|12|||
127638005|NCT03147248|459294019|FG005|Overall Study|Withdrawal by Subject|9|||
127638006|NCT03147248|459294014|FG000|Overall Study|Protocol Violation|0|||
127638007|NCT03147248|459294015|FG001|Overall Study|Protocol Violation|0|||
127638008|NCT03147248|459294016|FG002|Overall Study|Protocol Violation|0|||
127638009|NCT03147248|459294017|FG003|Overall Study|Protocol Violation|0|||
127638010|NCT03147248|459294018|FG004|Overall Study|Protocol Violation|2|||
127638011|NCT03147248|459294019|FG005|Overall Study|Protocol Violation|0|||
127638012|NCT03147248|459294014|FG000|Overall Study|Lost to Follow-up|0|||
127638013|NCT03147248|459294015|FG001|Overall Study|Lost to Follow-up|0|||
127638014|NCT03147248|459294016|FG002|Overall Study|Lost to Follow-up|0|||
127638015|NCT03147248|459294017|FG003|Overall Study|Lost to Follow-up|0|||
127638016|NCT03147248|459294018|FG004|Overall Study|Lost to Follow-up|2|||
127638017|NCT03147248|459294019|FG005|Overall Study|Lost to Follow-up|0|||
127638018|NCT03147248|459294014|FG000|Overall Study|Pregnancy|0|||
127638019|NCT03147248|459294015|FG001|Overall Study|Pregnancy|0|||
127638020|NCT03147248|459294016|FG002|Overall Study|Pregnancy|0|||
127638021|NCT03147248|459294017|FG003|Overall Study|Pregnancy|0|||
127638022|NCT03147248|459294018|FG004|Overall Study|Pregnancy|1|||
127638023|NCT03147248|459294019|FG005|Overall Study|Pregnancy|0|||
127638024|NCT03147248|459294014|FG000|Overall Study|Death|0|||
127638025|NCT03147248|459294015|FG001|Overall Study|Death|0|||
127638026|NCT03147248|459294016|FG002|Overall Study|Death|0|||
127638027|NCT03147248|459294017|FG003|Overall Study|Death|0|||
127638028|NCT03147248|459294018|FG004|Overall Study|Death|0|||
127638029|NCT03147248|459294019|FG005|Overall Study|Death|4|||
127638030|NCT03147248|459294014|FG000|Overall Study|Physician Decision|0|||
127638031|NCT03147248|459294015|FG001|Overall Study|Physician Decision|0|||
127638032|NCT03147248|459294016|FG002|Overall Study|Physician Decision|0|||
127638033|NCT03147248|459294017|FG003|Overall Study|Physician Decision|0|||
127638034|NCT03147248|459294018|FG004|Overall Study|Physician Decision|2|||
127638035|NCT03147248|459294019|FG005|Overall Study|Physician Decision|4|||
127638036|NCT03147248|459294014|FG000|Overall Study|Prolonged Dosing Interval|0|||
127638037|NCT03147248|459294015|FG001|Overall Study|Prolonged Dosing Interval|0|||
127638038|NCT03147248|459294016|FG002|Overall Study|Prolonged Dosing Interval|0|||
127796976|NCT02889796|459881178|FG003|Overall Study|Investigator's Discretion|3|||
127796977|NCT02889796|459881179|FG004|Overall Study|Investigator's Discretion|0|||
127796978|NCT02889796|459881180|FG005|Overall Study|Investigator's Discretion|15|||
127796979|NCT02889796|459881175|FG000|Overall Study|Adverse Event|17|||
127638039|NCT03147248|459294017|FG003|Overall Study|Prolonged Dosing Interval|0|||
127638040|NCT03147248|459294018|FG004|Overall Study|Prolonged Dosing Interval|1|||
127638041|NCT03147248|459294019|FG005|Overall Study|Prolonged Dosing Interval|1|||
127638042|NCT02388724|459294023|FG000|Overall Study|Reason not Specified|0|||
127638043|NCT02388724|459294024|FG001|Overall Study|Reason not Specified|1|||
127638044|NCT02388724|459294023|FG000|Overall Study|Major Protocol Deviation|3|||
127638045|NCT02388724|459294024|FG001|Overall Study|Major Protocol Deviation|3|||
127638046|NCT02388724|459294023|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
127638047|NCT02388724|459294024|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
127638048|NCT02388724|459294023|FG000|Overall Study|Voluntary Withdrawal|6|||
127638049|NCT02388724|459294024|FG001|Overall Study|Voluntary Withdrawal|5|||
127638050|NCT02388724|459294023|FG000|Overall Study|Randomized but not Treated|0|||
127638051|NCT02388724|459294024|FG001|Overall Study|Randomized but not Treated|2|||
127638052|NCT02605954|459294026|FG000|Overall Study|Adverse Event|5|||
127638053|NCT02605954|459294027|FG001|Overall Study|Adverse Event|1|||
127638054|NCT02605954|459294026|FG000|Overall Study|Investigator's Discretion|1|||
127638055|NCT02605954|459294027|FG001|Overall Study|Investigator's Discretion|0|||
127638056|NCT02605954|459294026|FG000|Overall Study|Non-Compliance with Study Drug|1|||
127638057|NCT02605954|459294027|FG001|Overall Study|Non-Compliance with Study Drug|0|||
127796980|NCT02889796|459881176|FG001|Overall Study|Adverse Event|8|||
127796981|NCT02889796|459881177|FG002|Overall Study|Adverse Event|8|||
127638058|NCT02605954|459294026|FG000|Overall Study|Withdrew Consent|2|||
127796982|NCT02889796|459881178|FG003|Overall Study|Adverse Event|4|||
127638059|NCT02605954|459294027|FG001|Overall Study|Withdrew Consent|2|||
127638060|NCT02605954|459294026|FG000|Overall Study|Lost to Follow-up|3|||
127638061|NCT02605954|459294027|FG001|Overall Study|Lost to Follow-up|0|||
127638062|NCT02605954|459294026|FG000|Overall Study|Randomized but not treated|0|||
127638063|NCT02605954|459294027|FG001|Overall Study|Randomized but not treated|1|||
127638064|NCT00856856|459294031|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
127638065|NCT00856856|459294031|FG000|4-year Clinical Follow-up|Missed visit|1|||
127638066|NCT00922428|459294036|FG000|Overall Study|retrospective/extremely implausible data|2|||
127638067|NCT00922428|459294036|FG000|Overall Study|no medication use or questionable use|13|||
127638068|NCT00448539|459294037|FG000|Overall Study|Medication non-compliance|4|||
127638069|NCT00448539|459294038|FG001|Overall Study|Medication non-compliance|1|||
127638070|NCT00448539|459294037|FG000|Overall Study|Protocol Violation|1|||
127638071|NCT00448539|459294038|FG001|Overall Study|Protocol Violation|0|||
127638072|NCT00448539|459294037|FG000|Overall Study|Request of the investigator or sponsor|67|||
127638073|NCT00448539|459294038|FG001|Overall Study|Request of the investigator or sponsor|54|||
127638074|NCT00448539|459294037|FG000|Overall Study|Withdrawal by Subject|20|||
127638075|NCT00448539|459294038|FG001|Overall Study|Withdrawal by Subject|24|||
127638076|NCT00448539|459294037|FG000|Overall Study|Diary non-compliance|1|||
127638077|NCT00448539|459294038|FG001|Overall Study|Diary non-compliance|0|||
127638078|NCT00448539|459294037|FG000|Overall Study|Adverse Event|9|||
127638079|NCT00448539|459294038|FG001|Overall Study|Adverse Event|26|||
127638080|NCT00448539|459294037|FG000|Overall Study|Lack of Efficacy|27|||
127638081|NCT00448539|459294038|FG001|Overall Study|Lack of Efficacy|40|||
127638082|NCT00448539|459294037|FG000|Overall Study|Miscellaneous|2|||
127638083|NCT00448539|459294038|FG001|Overall Study|Miscellaneous|1|||
127638084|NCT00448539|459294037|FG000|Overall Study|Change of meds|2|||
127638085|NCT00448539|459294038|FG001|Overall Study|Change of meds|3|||
127638086|NCT00448539|459294037|FG000|Overall Study|Lost to Follow-up|1|||
127638087|NCT00448539|459294038|FG001|Overall Study|Lost to Follow-up|3|||
127638088|NCT02103439|459294040|FG000|Overall Study|Adverse Event|0|||
127638089|NCT02103439|459294041|FG001|Overall Study|Adverse Event|2|||
127638090|NCT02103439|459294040|FG000|Overall Study|Withdrawal by Subject|3|||
127638091|NCT02103439|459294041|FG001|Overall Study|Withdrawal by Subject|1|||
127638092|NCT02696317|459294042|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
127638093|NCT02696317|459294043|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
127638094|NCT02696317|459294042|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
127638095|NCT02696317|459294043|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
127638096|NCT01343368|459294044|FG000|Overall Study|Death|1|||
127638097|NCT01343368|459294045|FG001|Overall Study|Death|0|||
127638098|NCT01343368|459294044|FG000|Overall Study|Lost to Follow-up|1|||
127638099|NCT01343368|459294045|FG001|Overall Study|Lost to Follow-up|0|||
127638100|NCT04955639|459294046|FG000|Overall Study|Withdrawal by Subject|2|||
127638101|NCT04955639|459294047|FG001|Overall Study|Withdrawal by Subject|2|||
127638102|NCT04955639|459294046|FG000|Overall Study|Week 26 survey not completed|2|||
127638103|NCT04955639|459294047|FG001|Overall Study|Week 26 survey not completed|2|||
127638104|NCT04447404|459294048|FG000|Overall Study|Death|2|||
127638105|NCT04447404|459294049|FG001|Overall Study|Death|0|||
127638106|NCT00321854|459294050|FG000|Overall Study|Adverse Event|41|||
127638107|NCT00321854|459294051|FG001|Overall Study|Adverse Event|43|||
127638108|NCT00321854|459294050|FG000|Overall Study|Lack of Efficacy|9|||
127638109|NCT00321854|459294051|FG001|Overall Study|Lack of Efficacy|14|||
127638110|NCT00321854|459294050|FG000|Overall Study|Protocol Violation|6|||
127638111|NCT00321854|459294051|FG001|Overall Study|Protocol Violation|5|||
127638112|NCT00321854|459294050|FG000|Overall Study|Lost to Follow-up|0|||
127638113|NCT00321854|459294051|FG001|Overall Study|Lost to Follow-up|2|||
127638114|NCT00321854|459294050|FG000|Overall Study|Withdrawal by Subject|6|||
127638115|NCT00321854|459294051|FG001|Overall Study|Withdrawal by Subject|17|||
127638116|NCT00321854|459294050|FG000|Overall Study|Other|1|||
127638117|NCT00321854|459294051|FG001|Overall Study|Other|1|||
127638118|NCT02384759|459294053|FG000|Overall Study|Patients not treated|3|||
127638119|NCT02384759|459294054|FG001|Overall Study|Patients not treated|2|||
127638120|NCT03043664|459294055|FG000|Overall Study|Lost to Follow-up|1|||
127638121|NCT03759873|459294063|FG000|Overall Study|Not appropriate for cardiac rehab|4|||
127638122|NCT03759873|459294064|FG001|Overall Study|Not appropriate for cardiac rehab|4|||
127796983|NCT02889796|459881179|FG004|Overall Study|Adverse Event|1|||
127796984|NCT02889796|459881180|FG005|Overall Study|Adverse Event|7|||
127638123|NCT03759873|459294065|FG002|Overall Study|Not appropriate for cardiac rehab|4|||
127638124|NCT03759873|459294066|FG003|Overall Study|Not appropriate for cardiac rehab|2|||
127638125|NCT03759873|459294063|FG000|Overall Study|Moved outside eligible area|0|||
127638126|NCT03759873|459294064|FG001|Overall Study|Moved outside eligible area|2|||
127638127|NCT03759873|459294065|FG002|Overall Study|Moved outside eligible area|0|||
127638128|NCT03759873|459294066|FG003|Overall Study|Moved outside eligible area|0|||
127638129|NCT03759873|459294063|FG000|Overall Study|Withdrawal by Subject|0|||
127638130|NCT03759873|459294064|FG001|Overall Study|Withdrawal by Subject|0|||
127638131|NCT03759873|459294065|FG002|Overall Study|Withdrawal by Subject|1|||
127796985|NCT02889796|459881175|FG000|Overall Study|Lost to Follow-up|5|||
127638132|NCT03759873|459294066|FG003|Overall Study|Withdrawal by Subject|0|||
127638133|NCT03579563|459294067|FG000|Overall Study|Lost to Follow-up|0|||
127638134|NCT03579563|459294068|FG001|Overall Study|Lost to Follow-up|0|||
127638135|NCT03579563|459294069|FG002|Overall Study|Lost to Follow-up|0|||
127638136|NCT03579563|459294070|FG003|Overall Study|Lost to Follow-up|0|||
127638137|NCT03579563|459294071|FG004|Overall Study|Lost to Follow-up|1|||
127638138|NCT03579563|459294072|FG005|Overall Study|Lost to Follow-up|0|||
127638139|NCT03579563|459294067|FG000|Overall Study|Lack of Efficacy|1|||
127638140|NCT03579563|459294068|FG001|Overall Study|Lack of Efficacy|1|||
127638141|NCT03579563|459294069|FG002|Overall Study|Lack of Efficacy|4|||
127638142|NCT03579563|459294070|FG003|Overall Study|Lack of Efficacy|1|||
127638143|NCT03579563|459294071|FG004|Overall Study|Lack of Efficacy|2|||
127638144|NCT03579563|459294072|FG005|Overall Study|Lack of Efficacy|3|||
127638145|NCT03579563|459294067|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
127638146|NCT03579563|459294068|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
127638147|NCT03579563|459294069|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
127638148|NCT03579563|459294070|FG003|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
127638149|NCT03579563|459294071|FG004|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
127638150|NCT03579563|459294072|FG005|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
127638151|NCT03579563|459294067|FG000|Overall Study|Time/distance concern|0|||
127638152|NCT03579563|459294068|FG001|Overall Study|Time/distance concern|0|||
127638153|NCT03579563|459294069|FG002|Overall Study|Time/distance concern|1|||
127638154|NCT03579563|459294070|FG003|Overall Study|Time/distance concern|0|||
127638155|NCT03579563|459294071|FG004|Overall Study|Time/distance concern|0|||
127638156|NCT03579563|459294072|FG005|Overall Study|Time/distance concern|1|||
127638157|NCT03579563|459294067|FG000|Overall Study|COVID shutdown|2|||
127638158|NCT03579563|459294068|FG001|Overall Study|COVID shutdown|3|||
127638159|NCT03579563|459294069|FG002|Overall Study|COVID shutdown|4|||
127638160|NCT03579563|459294070|FG003|Overall Study|COVID shutdown|3|||
127638161|NCT03579563|459294071|FG004|Overall Study|COVID shutdown|1|||
127638162|NCT03579563|459294072|FG005|Overall Study|COVID shutdown|2|||
127638163|NCT03579563|459294067|FG000|Overall Study|Protocol administration error|1|||
127638164|NCT03579563|459294068|FG001|Overall Study|Protocol administration error|0|||
127638165|NCT03579563|459294069|FG002|Overall Study|Protocol administration error|1|||
127638166|NCT03579563|459294070|FG003|Overall Study|Protocol administration error|0|||
127638167|NCT03579563|459294071|FG004|Overall Study|Protocol administration error|1|||
127638168|NCT03579563|459294072|FG005|Overall Study|Protocol administration error|5|||
127638169|NCT03526250|459294073|FG000|Overall Study|Adverse Event|4|||
127638170|NCT03526250|459294073|FG000|Overall Study|Progressive Disease|16|||
127638171|NCT03526250|459294073|FG000|Overall Study|No Treatment|3|||
127638172|NCT01618864|459294074|FG000|Overall Study|Withdrawal by Subject|2|||
127638173|NCT01618864|459294074|FG000|Overall Study|Lost to Follow-up|2|||
127638174|NCT02513563|459294075|FG000|Overall Study|Death|4|||
127638175|NCT02513563|459294075|FG000|Overall Study|Withdrawal by Subject|4|||
127638176|NCT02513563|459294075|FG000|Overall Study|Physician Decision|1|||
127638177|NCT01650259|459294085|FG000|Overall Study|Improvement|105|||
127638178|NCT01650259|459294086|FG001|Overall Study|Improvement|0|||
127638179|NCT01650259|459294085|FG000|Overall Study|Adverse Event|127|||
127638180|NCT01650259|459294086|FG001|Overall Study|Adverse Event|0|||
127638181|NCT01650259|459294085|FG000|Overall Study|Lack of Efficacy|143|||
127638182|NCT01650259|459294086|FG001|Overall Study|Lack of Efficacy|0|||
127638183|NCT01650259|459294085|FG000|Overall Study|Lost to Follow-up|435|||
127638184|NCT01650259|459294086|FG001|Overall Study|Lost to Follow-up|0|||
127638185|NCT01650259|459294085|FG000|Overall Study|Patients had no visit after entry|70|||
127638186|NCT01650259|459294086|FG001|Overall Study|Patients had no visit after entry|0|||
127703382|NCT02723591|459542655|FG000|Overall Study|Protocol Violation|20|||
127703383|NCT02723591|459542656|FG001|Overall Study|Protocol Violation|23|||
127703384|NCT02723591|459542655|FG000|Overall Study|Withdrawal by Subject|4|||
127703385|NCT02723591|459542656|FG001|Overall Study|Withdrawal by Subject|8|||
127703386|NCT02723591|459542655|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
127703387|NCT02723591|459542656|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
127703388|NCT02723591|459542655|FG000|Overall Study|Miscellaneous|5|||
127703389|NCT02723591|459542656|FG001|Overall Study|Miscellaneous|6|||
127703390|NCT02151981|459542661|FG000|Overall Study|Death|184|||
127638187|NCT01650259|459294085|FG000|Overall Study|CRF not collected|98|||
127638188|NCT01650259|459294086|FG001|Overall Study|CRF not collected|82|||
127638189|NCT01650259|459294085|FG000|Overall Study|Not treated|1|||
127638190|NCT01650259|459294086|FG001|Overall Study|Not treated|7|||
127638191|NCT01650259|459294085|FG000|Overall Study|Other than listed|64|||
127638192|NCT01650259|459294086|FG001|Overall Study|Other than listed|146|||
127638193|NCT00355082|459294087|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
127638194|NCT00355082|459294088|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
127638195|NCT00355082|459294089|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
127703391|NCT02151981|459542662|FG001|Overall Study|Death|88|||
127796986|NCT02889796|459881176|FG001|Overall Study|Lost to Follow-up|7|||
127796987|NCT02889796|459881177|FG002|Overall Study|Lost to Follow-up|2|||
127638196|NCT00355082|459294087|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
127638197|NCT00355082|459294088|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
127638198|NCT00355082|459294089|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
127638199|NCT00355082|459294087|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
127638200|NCT00355082|459294088|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
127638201|NCT00355082|459294089|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
127638202|NCT00355082|459294087|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
127638203|NCT00355082|459294088|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
127638204|NCT00355082|459294089|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
127638205|NCT00355082|459294087|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
127638206|NCT00355082|459294088|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
127638207|NCT00355082|459294089|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
127638208|NCT00355082|459294087|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
127638209|NCT00355082|459294088|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
127638210|NCT00355082|459294089|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
127638211|NCT00355082|459294087|FG000|Continuation Phase|Adverse Event|2|||
127638212|NCT00355082|459294088|FG001|Continuation Phase|Adverse Event|0|||
127638213|NCT00355082|459294089|FG002|Continuation Phase|Adverse Event|1|||
127638214|NCT00355082|459294087|FG000|Continuation Phase|Lost to Follow-up|2|||
127638215|NCT00355082|459294088|FG001|Continuation Phase|Lost to Follow-up|0|||
127638216|NCT00355082|459294089|FG002|Continuation Phase|Lost to Follow-up|1|||
127638217|NCT00355082|459294087|FG000|Continuation Phase|Protocol Violation|1|||
127638218|NCT00355082|459294088|FG001|Continuation Phase|Protocol Violation|0|||
127638219|NCT00355082|459294089|FG002|Continuation Phase|Protocol Violation|1|||
127638220|NCT00355082|459294087|FG000|Continuation Phase|Withdrawal by Subject|4|||
127638221|NCT00355082|459294088|FG001|Continuation Phase|Withdrawal by Subject|0|||
127638222|NCT00355082|459294089|FG002|Continuation Phase|Withdrawal by Subject|0|||
127638223|NCT00355082|459294087|FG000|Continuation Phase|Lack of Efficacy|5|||
127638224|NCT00355082|459294088|FG001|Continuation Phase|Lack of Efficacy|0|||
127638225|NCT00355082|459294089|FG002|Continuation Phase|Lack of Efficacy|0|||
127638226|NCT00355082|459294087|FG000|Continuation Phase|Site Closed by Sponsor|8|||
127638227|NCT00355082|459294088|FG001|Continuation Phase|Site Closed by Sponsor|0|||
127638228|NCT00355082|459294089|FG002|Continuation Phase|Site Closed by Sponsor|0|||
127638229|NCT00355082|459294087|FG000|Continuation Phase|Scheduling Error|1|||
127638230|NCT00355082|459294088|FG001|Continuation Phase|Scheduling Error|0|||
127638231|NCT00355082|459294089|FG002|Continuation Phase|Scheduling Error|0|||
127638232|NCT00355082|459294087|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
127638233|NCT00355082|459294088|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
127638234|NCT00355082|459294089|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
127638235|NCT02663128|459294098|FG000|Period 2|Physician Decision|0|||
127638236|NCT02663128|459294099|FG001|Period 2|Physician Decision|0|||
127638237|NCT02663128|459294100|FG002|Period 2|Physician Decision|0|||
127638238|NCT02663128|459294101|FG003|Period 2|Physician Decision|0|||
127638239|NCT02663128|459294102|FG004|Period 2|Physician Decision|1|||
127638240|NCT02663128|459294103|FG005|Period 2|Physician Decision|0|||
127638241|NCT01358526|459294104|FG000|Open-label Titration Period|Adverse Event|95|||
127638242|NCT01358526|459294105|FG001|Open-label Titration Period|Adverse Event|0|||
127638243|NCT01358526|459294106|FG002|Open-label Titration Period|Adverse Event|0|||
127638244|NCT01358526|459294104|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
127638245|NCT01358526|459294105|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
127638246|NCT01358526|459294106|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
127638247|NCT01358526|459294104|FG000|Open-label Titration Period|Lost to Follow-up|25|||
127638248|NCT01358526|459294105|FG001|Open-label Titration Period|Lost to Follow-up|0|||
127638249|NCT01358526|459294106|FG002|Open-label Titration Period|Lost to Follow-up|0|||
127638250|NCT01358526|459294104|FG000|Open-label Titration Period|Lack of Efficacy|107|||
127638251|NCT01358526|459294105|FG001|Open-label Titration Period|Lack of Efficacy|0|||
127638252|NCT01358526|459294106|FG002|Open-label Titration Period|Lack of Efficacy|0|||
127638253|NCT01358526|459294104|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
127638254|NCT01358526|459294105|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
127638255|NCT01358526|459294106|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
127638256|NCT01358526|459294104|FG000|Open-label Titration Period|Administrative|8|||
127638257|NCT01358526|459294105|FG001|Open-label Titration Period|Administrative|0|||
127638258|NCT01358526|459294106|FG002|Open-label Titration Period|Administrative|0|||
127638259|NCT01358526|459294104|FG000|Open-label Titration Period|Did not qualify|178|||
127638260|NCT01358526|459294105|FG001|Open-label Titration Period|Did not qualify|0|||
127638261|NCT01358526|459294106|FG002|Open-label Titration Period|Did not qualify|0|||
127638262|NCT01358526|459294104|FG000|Double-blind Phase|Adverse Event|0|||
127638263|NCT01358526|459294105|FG001|Double-blind Phase|Adverse Event|24|||
127638264|NCT01358526|459294106|FG002|Double-blind Phase|Adverse Event|23|||
127638265|NCT01358526|459294104|FG000|Double-blind Phase|Withdrawal by Subject|0|||
127638266|NCT01358526|459294105|FG001|Double-blind Phase|Withdrawal by Subject|10|||
127638267|NCT01358526|459294106|FG002|Double-blind Phase|Withdrawal by Subject|8|||
127638268|NCT01358526|459294104|FG000|Double-blind Phase|Lost to Follow-up|0|||
127638269|NCT01358526|459294105|FG001|Double-blind Phase|Lost to Follow-up|4|||
127638270|NCT01358526|459294106|FG002|Double-blind Phase|Lost to Follow-up|1|||
127638271|NCT01358526|459294104|FG000|Double-blind Phase|Lack of Efficacy|0|||
127638272|NCT01358526|459294105|FG001|Double-blind Phase|Lack of Efficacy|31|||
127638273|NCT01358526|459294106|FG002|Double-blind Phase|Lack of Efficacy|73|||
127638274|NCT01358526|459294104|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
127638275|NCT01358526|459294105|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
127638276|NCT01358526|459294106|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
127638277|NCT01358526|459294104|FG000|Double-blind Phase|Administrative|0|||
127638278|NCT01358526|459294105|FG001|Double-blind Phase|Administrative|6|||
127638279|NCT01358526|459294106|FG002|Double-blind Phase|Administrative|10|||
127638280|NCT03277313|459294123|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
127638281|NCT03277313|459294124|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
127638282|NCT03277313|459294123|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
127638283|NCT03277313|459294124|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
127638284|NCT03277313|459294123|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
127638285|NCT03277313|459294124|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
127638286|NCT03277313|459294123|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
127638287|NCT03277313|459294124|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
127638288|NCT03277313|459294123|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
127638289|NCT03277313|459294124|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
127638290|NCT02132611|459294125|FG000|Overall Study|Death|2|||
127638291|NCT02194621|459294127|FG000|Overall Study|6 withdrew prior to randomization|2|||
127638292|NCT02194621|459294128|FG001|Overall Study|6 withdrew prior to randomization|2|||
127638293|NCT02194621|459294129|FG002|Overall Study|6 withdrew prior to randomization|2|||
127638294|NCT02194621|459294127|FG000|Overall Study|Withdrawal by Subject|4|||
127638295|NCT02194621|459294128|FG001|Overall Study|Withdrawal by Subject|4|||
127638296|NCT02194621|459294129|FG002|Overall Study|Withdrawal by Subject|7|||
127638297|NCT02763384|459294137|FG000|Overall Study|Physician Decision|1|||
127638298|NCT02763384|459294137|FG000|Overall Study|Rapid decline - went on hospice|1|||
127638299|NCT02493127|459294138|FG000|Overall Study|Lost to Follow-up|1|||
127638300|NCT02493127|459294139|FG001|Overall Study|Lost to Follow-up|1|||
127638301|NCT03034577|459294141|FG000|Overall Study|Withdrawal by Subject|6|||
127638302|NCT03034577|459294142|FG001|Overall Study|Withdrawal by Subject|9|||
127638303|NCT03034577|459294141|FG000|Overall Study|Lost to Follow-up|25|||
127638304|NCT03034577|459294142|FG001|Overall Study|Lost to Follow-up|26|||
127638305|NCT01432366|459295404|FG000|Overall Study|Non-Responder|7|||
127638306|NCT01432366|459295404|FG000|Overall Study|Adverse Event|8|||
127638307|NCT01432366|459295404|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
127638308|NCT01432366|459295404|FG000|Overall Study|Pregnancy|1|||
127638309|NCT01432366|459295404|FG000|Overall Study|Lost to Follow-up|13|||
127638310|NCT01432366|459295404|FG000|Overall Study|Lack of Efficacy|1|||
127638311|NCT01432366|459295404|FG000|Overall Study|Site Closed|20|||
127638312|NCT01432366|459295404|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
127638313|NCT01432366|459295404|FG000|Overall Study|Other|14|||
127638314|NCT01808690|459295405|FG000|Overall Study|Withdrawal by Subject|1|||
127638315|NCT01808690|459295406|FG001|Overall Study|Withdrawal by Subject|2|||
127638316|NCT01880424|459295410|FG000|Overall Study|Adverse Event|7|||
127638317|NCT01880424|459295411|FG001|Overall Study|Adverse Event|6|||
127638318|NCT01880424|459295410|FG000|Overall Study|Lack of Efficacy|1|||
127638319|NCT01880424|459295411|FG001|Overall Study|Lack of Efficacy|4|||
127638320|NCT01880424|459295410|FG000|Overall Study|Lost to Follow-up|3|||
127638321|NCT01880424|459295411|FG001|Overall Study|Lost to Follow-up|2|||
127638322|NCT01880424|459295410|FG000|Overall Study|Protocol Violation|11|||
127638323|NCT01880424|459295411|FG001|Overall Study|Protocol Violation|13|||
127638324|NCT01880424|459295410|FG000|Overall Study|Withdrawal by Subject|10|||
127638325|NCT01880424|459295411|FG001|Overall Study|Withdrawal by Subject|30|||
127638326|NCT01880424|459295410|FG000|Overall Study|Other|1|||
127638327|NCT01880424|459295411|FG001|Overall Study|Other|0|||
127638328|NCT04969250|459295412|FG000|Overall Study|Protocol Violation|0|||
127638329|NCT04969250|459295413|FG001|Overall Study|Protocol Violation|2|||
127638330|NCT04969250|459295414|FG002|Overall Study|Protocol Violation|3|||
127638331|NCT04969250|459295415|FG003|Overall Study|Protocol Violation|8|||
127703392|NCT02151981|459542661|FG000|Overall Study|Lost to Follow-up|7|||
127703393|NCT02151981|459542662|FG001|Overall Study|Lost to Follow-up|1|||
127703394|NCT02151981|459542661|FG000|Overall Study|Withdrawal by Subject|27|||
127703395|NCT02151981|459542662|FG001|Overall Study|Withdrawal by Subject|21|||
127703396|NCT02151981|459542661|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
127703397|NCT02151981|459542662|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
127703398|NCT02151981|459542661|FG000|Overall Study|Other reasons|1|||
127703399|NCT02151981|459542662|FG001|Overall Study|Other reasons|2|||
127703400|NCT01946789|459542670|FG000|Overall Study|Death|0|||
127703401|NCT01946789|459542671|FG001|Overall Study|Death|2|||
127638332|NCT04969250|459295412|FG000|Overall Study|Withdrawal by Subject|0|||
127638333|NCT04969250|459295413|FG001|Overall Study|Withdrawal by Subject|1|||
127638334|NCT04969250|459295414|FG002|Overall Study|Withdrawal by Subject|0|||
127638335|NCT04969250|459295415|FG003|Overall Study|Withdrawal by Subject|0|||
127638336|NCT00130533|459295418|FG000|Overall Study|Withdrawal by Subject|33|||
127638337|NCT00130533|459295419|FG001|Overall Study|Withdrawal by Subject|6|||
127638338|NCT00130533|459295418|FG000|Overall Study|Adverse Event|34|||
127638339|NCT00130533|459295419|FG001|Overall Study|Adverse Event|1|||
127638340|NCT00130533|459295418|FG000|Overall Study|Disease relapse|9|||
127638341|NCT00130533|459295419|FG001|Overall Study|Disease relapse|13|||
127638342|NCT00130533|459295418|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
127638343|NCT00130533|459295419|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
127638344|NCT00130533|459295418|FG000|Overall Study|Death|4|||
127638345|NCT00130533|459295419|FG001|Overall Study|Death|2|||
127638346|NCT00130533|459295418|FG000|Overall Study|Protocol Violation|5|||
127638347|NCT00130533|459295419|FG001|Overall Study|Protocol Violation|1|||
127638348|NCT00130533|459295418|FG000|Overall Study|Lost to Follow-up|1|||
127638349|NCT00130533|459295419|FG001|Overall Study|Lost to Follow-up|1|||
127638350|NCT00130533|459295418|FG000|Overall Study|Sponsor´s decision|2|||
127638351|NCT00130533|459295419|FG001|Overall Study|Sponsor´s decision|0|||
127638352|NCT00130533|459295418|FG000|Overall Study|Second Primary Malignancy|0|||
127638353|NCT00130533|459295419|FG001|Overall Study|Second Primary Malignancy|1|||
127638354|NCT00130533|459295418|FG000|Overall Study|Other|12|||
127638355|NCT00130533|459295419|FG001|Overall Study|Other|5|||
127638356|NCT01059565|459295420|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
127638357|NCT01059565|459295421|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
127638358|NCT01059565|459295420|FG000|24-Week Randomized Phase|Adverse Event|5|||
127638359|NCT01059565|459295421|FG001|24-Week Randomized Phase|Adverse Event|0|||
127638360|NCT01059565|459295420|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
127638361|NCT01059565|459295421|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
127638362|NCT01059565|459295420|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
127638363|NCT01059565|459295421|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
127638364|NCT01059565|459295420|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
127638365|NCT01059565|459295421|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
127638366|NCT01059565|459295420|FG000|24-Week Open-Label Phase|Adverse Event|2|||
127638367|NCT01059565|459295421|FG001|24-Week Open-Label Phase|Adverse Event|0|||
127638368|NCT01059565|459295420|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
127638369|NCT01059565|459295421|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
127638370|NCT01059565|459295420|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
127638371|NCT01059565|459295421|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
127638372|NCT01059565|459295420|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
127638373|NCT01059565|459295421|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
127638374|NCT01059565|459295420|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
127638375|NCT01059565|459295421|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
127638376|NCT01059565|459295420|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
127638377|NCT01059565|459295421|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
127638378|NCT03263429|459295426|FG000|Overall Study|Withdrawal by Subject|0|||
127638379|NCT03263429|459295427|FG001|Overall Study|Withdrawal by Subject|1|||
127638380|NCT03263429|459295428|FG002|Overall Study|Withdrawal by Subject|0|||
127638381|NCT03263429|459295426|FG000|Overall Study|Follow-Up Period Completed|0|||
127638382|NCT03263429|459295427|FG001|Overall Study|Follow-Up Period Completed|2|||
127638383|NCT03263429|459295428|FG002|Overall Study|Follow-Up Period Completed|0|||
127638384|NCT03263429|459295426|FG000|Overall Study|Death|3|||
127638385|NCT03263429|459295427|FG001|Overall Study|Death|5|||
127638386|NCT03263429|459295428|FG002|Overall Study|Death|16|||
127638387|NCT03263429|459295426|FG000|Overall Study|Participant unable to return|0|||
127638388|NCT03263429|459295427|FG001|Overall Study|Participant unable to return|0|||
127638389|NCT03263429|459295428|FG002|Overall Study|Participant unable to return|1|||
127638390|NCT03263429|459295426|FG000|Overall Study|Study Closed|0|||
127638391|NCT03263429|459295427|FG001|Overall Study|Study Closed|0|||
127703402|NCT01946789|459542672|FG002|Overall Study|Death|1|||
127703403|NCT01946789|459542673|FG003|Overall Study|Death|1|||
127703404|NCT01946789|459542674|FG004|Overall Study|Death|1|||
127703405|NCT01946789|459542675|FG005|Overall Study|Death|1|||
127703406|NCT01946789|459542676|FG006|Overall Study|Death|3|||
127703407|NCT01946789|459542677|FG007|Overall Study|Death|1|||
127703408|NCT01946789|459542678|FG008|Overall Study|Death|2|||
127703409|NCT01946789|459542670|FG000|Overall Study|Progressive Disease|0|||
127703410|NCT01946789|459542671|FG001|Overall Study|Progressive Disease|0|||
127703411|NCT01946789|459542672|FG002|Overall Study|Progressive Disease|1|||
127703412|NCT01946789|459542673|FG003|Overall Study|Progressive Disease|0|||
127638392|NCT03263429|459295428|FG002|Overall Study|Study Closed|1|||
127638393|NCT01605617|459295429|FG000|First Intervention|Adverse Event|0|||
127703413|NCT01946789|459542674|FG004|Overall Study|Progressive Disease|0|||
127703414|NCT01946789|459542675|FG005|Overall Study|Progressive Disease|2|||
127638394|NCT01605617|459295430|FG001|First Intervention|Adverse Event|1|||
127638395|NCT01605617|459295429|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
127638396|NCT01605617|459295430|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
127638397|NCT03638141|459295431|FG000|Overall Study|1 subject was removed from the study due to non compliance and was never treated.|1|||
127638398|NCT02647359|459295435|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
127638399|NCT02647359|459295436|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
127638400|NCT02647359|459295435|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
127638401|NCT02647359|459295436|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
127638402|NCT02647359|459295435|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
127638403|NCT02647359|459295436|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
127638404|NCT02647359|459295435|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
127638405|NCT02647359|459295436|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
127638406|NCT02647359|459295435|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
127638407|NCT02647359|459295436|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
127638408|NCT02647359|459295435|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
127638409|NCT02647359|459295436|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
127638410|NCT04818346|459295441|FG000|24-Week Placebo-controlled Period|Adverse Event|1|||
127638411|NCT04818346|459295442|FG001|24-Week Placebo-controlled Period|Adverse Event|2|||
127638412|NCT04818346|459295443|FG002|24-Week Placebo-controlled Period|Adverse Event|0|||
127638413|NCT04818346|459295444|FG003|24-Week Placebo-controlled Period|Adverse Event|3|||
127638414|NCT04818346|459295441|FG000|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
127638415|NCT04818346|459295442|FG001|24-Week Placebo-controlled Period|Lost to Follow-up|2|||
127638416|NCT04818346|459295443|FG002|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
127638417|NCT04818346|459295444|FG003|24-Week Placebo-controlled Period|Lost to Follow-up|1|||
127638418|NCT04818346|459295441|FG000|24-Week Placebo-controlled Period|Physician Decision|1|||
127638419|NCT04818346|459295442|FG001|24-Week Placebo-controlled Period|Physician Decision|0|||
127638420|NCT04818346|459295443|FG002|24-Week Placebo-controlled Period|Physician Decision|0|||
127638421|NCT04818346|459295444|FG003|24-Week Placebo-controlled Period|Physician Decision|0|||
127638422|NCT04818346|459295441|FG000|24-Week Placebo-controlled Period|Protocol Violation|0|||
127638423|NCT04818346|459295442|FG001|24-Week Placebo-controlled Period|Protocol Violation|0|||
127638424|NCT04818346|459295443|FG002|24-Week Placebo-controlled Period|Protocol Violation|1|||
127638425|NCT04818346|459295444|FG003|24-Week Placebo-controlled Period|Protocol Violation|1|||
127638426|NCT04818346|459295441|FG000|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
127638427|NCT04818346|459295442|FG001|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
127638428|NCT04818346|459295443|FG002|24-Week Placebo-controlled Period|Withdrawal by Subject|6|||
127638429|NCT04818346|459295444|FG003|24-Week Placebo-controlled Period|Withdrawal by Subject|2|||
127638430|NCT04818346|459295441|FG000|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|1|||
127638431|NCT04818346|459295442|FG001|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
127638432|NCT04818346|459295443|FG002|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
127638433|NCT04818346|459295444|FG003|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
127638434|NCT04818346|459295441|FG000|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
127638435|NCT04818346|459295442|FG001|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
127638436|NCT04818346|459295443|FG002|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
127638437|NCT04818346|459295444|FG003|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
127638438|NCT04818346|459295441|FG000|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
127638439|NCT04818346|459295442|FG001|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
127638440|NCT04818346|459295443|FG002|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|1|||
127638441|NCT04818346|459295444|FG003|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
127638442|NCT04818346|459295441|FG000|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
127638443|NCT04818346|459295442|FG001|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
127638444|NCT04818346|459295443|FG002|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
127638445|NCT04818346|459295444|FG003|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
127638446|NCT04818346|459295441|FG000|28-Week Double-blind Extension Period|Adverse Event|1|||
127638447|NCT04818346|459295442|FG001|28-Week Double-blind Extension Period|Adverse Event|0|||
127638448|NCT04818346|459295443|FG002|28-Week Double-blind Extension Period|Adverse Event|1|||
127638449|NCT04818346|459295444|FG003|28-Week Double-blind Extension Period|Adverse Event|1|||
127638450|NCT04818346|459295441|FG000|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
127638451|NCT04818346|459295442|FG001|28-Week Double-blind Extension Period|Lost to Follow-up|2|||
127638452|NCT04818346|459295443|FG002|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
127638453|NCT04818346|459295444|FG003|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
127638454|NCT04818346|459295441|FG000|28-Week Double-blind Extension Period|Withdrawal by Subject|0|||
127638455|NCT04818346|459295442|FG001|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
127638456|NCT04818346|459295443|FG002|28-Week Double-blind Extension Period|Withdrawal by Subject|4|||
127638457|NCT04818346|459295444|FG003|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
127638458|NCT04818346|459295441|FG000|28-Week Double-blind Extension Period|Non-compliance|0|||
127638459|NCT04818346|459295442|FG001|28-Week Double-blind Extension Period|Non-compliance|1|||
127638460|NCT04818346|459295443|FG002|28-Week Double-blind Extension Period|Non-compliance|0|||
127638461|NCT04818346|459295444|FG003|28-Week Double-blind Extension Period|Non-compliance|0|||
127638462|NCT04818346|459295441|FG000|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
127638463|NCT04818346|459295442|FG001|28-Week Double-blind Extension Period|Non-compliance with Study Drug|1|||
127638464|NCT04818346|459295443|FG002|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
127638465|NCT04818346|459295444|FG003|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
127638466|NCT04818346|459295441|FG000|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
127638467|NCT04818346|459295442|FG001|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
127638468|NCT04818346|459295443|FG002|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
127638469|NCT04818346|459295444|FG003|28-Week Double-blind Extension Period|Scheduling Conflicts|1|||
127638470|NCT01672801|459295445|FG000|Overall Study|Screen Failure|0|||
127638471|NCT01672801|459295446|FG001|Overall Study|Screen Failure|1|||
127638472|NCT01362140|459295447|FG000|Overall Study|Noncompliance|1|||
127638473|NCT01362140|459295448|FG001|Overall Study|Noncompliance|0|||
127638474|NCT01362140|459295447|FG000|Overall Study|Adverse Event|2|||
127638475|NCT01362140|459295448|FG001|Overall Study|Adverse Event|2|||
127638476|NCT01362140|459295447|FG000|Overall Study|Withdrawal by Subject|3|||
127638477|NCT01362140|459295448|FG001|Overall Study|Withdrawal by Subject|3|||
127638478|NCT01362140|459295447|FG000|Overall Study|Administrative Decision|0|||
127638479|NCT01362140|459295448|FG001|Overall Study|Administrative Decision|1|||
127638480|NCT01362140|459295447|FG000|Overall Study|Death|2|||
127638481|NCT01362140|459295448|FG001|Overall Study|Death|1|||
127638482|NCT01362140|459295447|FG000|Overall Study|Other|1|||
127638483|NCT01362140|459295448|FG001|Overall Study|Other|1|||
127638484|NCT01362140|459295447|FG000|Overall Study|Protocol-specified Criteria|1|||
127638485|NCT01362140|459295448|FG001|Overall Study|Protocol-specified Criteria|2|||
127638486|NCT01362140|459295447|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
127638487|NCT01362140|459295448|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
127638488|NCT00492284|459295450|FG000|Overall Study|Adverse Event|0|||
127638489|NCT00492284|459295451|FG001|Overall Study|Adverse Event|1|||
127638490|NCT00492284|459295452|FG002|Overall Study|Adverse Event|1|||
127638491|NCT00492284|459295453|FG003|Overall Study|Adverse Event|2|||
127638492|NCT00492284|459295450|FG000|Overall Study|Lost to Follow-up|0|||
127638493|NCT00492284|459295451|FG001|Overall Study|Lost to Follow-up|0|||
127638494|NCT00492284|459295452|FG002|Overall Study|Lost to Follow-up|3|||
127638495|NCT00492284|459295453|FG003|Overall Study|Lost to Follow-up|1|||
127638496|NCT00492284|459295450|FG000|Overall Study|Death|0|||
127638497|NCT00492284|459295451|FG001|Overall Study|Death|3|||
127638498|NCT00492284|459295452|FG002|Overall Study|Death|2|||
127638499|NCT00492284|459295453|FG003|Overall Study|Death|5|||
127638500|NCT00492284|459295450|FG000|Overall Study|Withdrawal by Subject|1|||
127638501|NCT00492284|459295451|FG001|Overall Study|Withdrawal by Subject|0|||
127638502|NCT00492284|459295452|FG002|Overall Study|Withdrawal by Subject|0|||
127638503|NCT00492284|459295453|FG003|Overall Study|Withdrawal by Subject|2|||
127638504|NCT06476366|459295454|FG000|Overall Study|Lost to Follow-up|1|||
127638505|NCT06476366|459295455|FG001|Overall Study|Lost to Follow-up|3|||
127638506|NCT06476366|459295454|FG000|Overall Study|Adverse Event|1|||
127638507|NCT06476366|459295455|FG001|Overall Study|Adverse Event|0|||
127638508|NCT03150056|459295456|FG000|Overall Study|Withdrawal by Subject|0|||
127638509|NCT03150056|459295457|FG001|Overall Study|Withdrawal by Subject|0|||
127638510|NCT03150056|459295458|FG002|Overall Study|Withdrawal by Subject|0|||
127638511|NCT03150056|459295459|FG003|Overall Study|Withdrawal by Subject|0|||
127638512|NCT03150056|459295460|FG004|Overall Study|Withdrawal by Subject|0|||
127638513|NCT03150056|459295461|FG005|Overall Study|Withdrawal by Subject|2|||
127638514|NCT03150056|459295456|FG000|Overall Study|Study terminated by Sponsor|1|||
127638515|NCT03150056|459295457|FG001|Overall Study|Study terminated by Sponsor|3|||
127703415|NCT01946789|459542676|FG006|Overall Study|Progressive Disease|0|||
127703416|NCT01946789|459542677|FG007|Overall Study|Progressive Disease|0|||
127703417|NCT01946789|459542678|FG008|Overall Study|Progressive Disease|0|||
127703418|NCT01946789|459542670|FG000|Overall Study|Withdrawal by Subject|0|||
127703419|NCT01946789|459542671|FG001|Overall Study|Withdrawal by Subject|0|||
127703420|NCT01946789|459542672|FG002|Overall Study|Withdrawal by Subject|0|||
127703421|NCT01946789|459542673|FG003|Overall Study|Withdrawal by Subject|2|||
127703422|NCT01946789|459542674|FG004|Overall Study|Withdrawal by Subject|1|||
127703423|NCT01946789|459542675|FG005|Overall Study|Withdrawal by Subject|0|||
127703424|NCT01946789|459542676|FG006|Overall Study|Withdrawal by Subject|1|||
127703425|NCT01946789|459542677|FG007|Overall Study|Withdrawal by Subject|0|||
127638516|NCT03150056|459295458|FG002|Overall Study|Study terminated by Sponsor|1|||
127638517|NCT03150056|459295459|FG003|Overall Study|Study terminated by Sponsor|1|||
127638518|NCT03150056|459295460|FG004|Overall Study|Study terminated by Sponsor|5|||
127638519|NCT03150056|459295461|FG005|Overall Study|Study terminated by Sponsor|6|||
127638520|NCT03150056|459295456|FG000|Overall Study|Death|9|||
127638521|NCT03150056|459295457|FG001|Overall Study|Death|2|||
127638522|NCT03150056|459295458|FG002|Overall Study|Death|2|||
127638523|NCT03150056|459295459|FG003|Overall Study|Death|7|||
127638524|NCT03150056|459295460|FG004|Overall Study|Death|8|||
127638525|NCT03150056|459295461|FG005|Overall Study|Death|10|||
127638526|NCT00965523|459295462|FG000|Study 221|Progressive Disease|4|||
127638527|NCT00965523|459295462|FG000|Study 221|Physician Decision|3|||
127638528|NCT00965523|459295462|FG000|Study 224|Progressive Disease|5|||
127638529|NCT00965523|459295462|FG000|Study 224|Physician Decision|1|||
127638530|NCT01581281|459295463|FG000|Overall Study|Early Study Closure|15|||
127638531|NCT01581281|459295464|FG001|Overall Study|Early Study Closure|6|||
127638532|NCT01581281|459295465|FG002|Overall Study|Early Study Closure|12|||
127638533|NCT01939028|459295468|FG000|Overall Study|Withdrawal by Subject|5|||
127638534|NCT01939028|459295468|FG000|Overall Study|Physician Decision|7|||
127638535|NCT00700401|459295479|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
127638536|NCT00700401|459295479|FG000|Overall Study|Adverse Event|5|||
127638537|NCT00700401|459295479|FG000|Overall Study|Refused Treatment|2|||
127638538|NCT00700401|459295479|FG000|Overall Study|Lost to Follow-up|1|||
127638539|NCT00700401|459295479|FG000|Overall Study|Treatment never started|1|||
127638540|NCT00700401|459295479|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
127638541|NCT00700401|459295479|FG000|Overall Study|Withdrawal by Subject|2|||
127638542|NCT03273946|459295480|FG000|Overall Study|Withdrawal by Subject|5|||
127638543|NCT03273946|459295480|FG000|Overall Study|Unwillingness of the guardian|1|||
127638544|NCT03273946|459295480|FG000|Overall Study|Participant refused to use the drug|2|||
127638545|NCT03273946|459295480|FG000|Overall Study|Participant relative refused to use drug|1|||
127638546|NCT00092131|459295481|FG000|Treatment Period I|Adverse Event|1|||
127638547|NCT00092131|459295482|FG001|Treatment Period I|Adverse Event|0|||
127638548|NCT00092131|459295481|FG000|Treatment Period II|Adverse Event|0|||
127638549|NCT00092131|459295482|FG001|Treatment Period II|Adverse Event|1|||
127638550|NCT02576067|459295483|FG000|Overall Study|Death|0|||
127638551|NCT02576067|459295484|FG001|Overall Study|Death|1|||
127638552|NCT02576067|459295483|FG000|Overall Study|Lack of Efficacy|1|||
127638553|NCT02576067|459295484|FG001|Overall Study|Lack of Efficacy|0|||
127638554|NCT02576067|459295483|FG000|Overall Study|Lost to Follow-up|11|||
127638555|NCT02576067|459295484|FG001|Overall Study|Lost to Follow-up|0|||
127638556|NCT02576067|459295483|FG000|Overall Study|Withdrawal by Subject|11|||
127638557|NCT02576067|459295484|FG001|Overall Study|Withdrawal by Subject|2|||
127638558|NCT02576067|459295483|FG000|Overall Study|study closure of main CIRT trial)|0|||
127638559|NCT02576067|459295484|FG001|Overall Study|study closure of main CIRT trial)|8|||
127638560|NCT02576067|459295483|FG000|Overall Study|not randomized, failed run-in|7|||
127638561|NCT02576067|459295484|FG001|Overall Study|not randomized, failed run-in|0|||
127638562|NCT02576067|459295483|FG000|Overall Study|screen failure/ re-enrolled|0|||
127638563|NCT02576067|459295484|FG001|Overall Study|screen failure/ re-enrolled|25|||
127638564|NCT02576067|459295483|FG000|Overall Study|Physician Decision|4|||
127638565|NCT02576067|459295484|FG001|Overall Study|Physician Decision|0|||
127638566|NCT02372409|459295485|FG000|Overall Study|Lost to Follow-up|1|||
127638567|NCT02372409|459295486|FG001|Overall Study|Lost to Follow-up|0|||
127638568|NCT02372409|459295485|FG000|Overall Study|Disease progression|1|||
127638569|NCT02372409|459295486|FG001|Overall Study|Disease progression|1|||
127638570|NCT04598152|459295489|FG000|Overall Study|Lost to Follow-up|0|||
127638571|NCT04598152|459295490|FG001|Overall Study|Lost to Follow-up|1|||
127638572|NCT03346759|459295491|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
127638573|NCT03346759|459295492|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
127638574|NCT03346759|459295491|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
127638575|NCT03346759|459295492|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
127638576|NCT03346759|459295491|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
127638577|NCT03346759|459295492|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
127638578|NCT03674177|459295494|FG000|Overall Study|Lost to Follow-up|2|||
127638579|NCT03674177|459295495|FG001|Overall Study|Lost to Follow-up|1|||
127638580|NCT03674177|459295496|FG002|Overall Study|Lost to Follow-up|0|||
127638581|NCT03674177|459295497|FG003|Overall Study|Lost to Follow-up|2|||
127638582|NCT02096900|459295498|FG000|Overall Study|Did not receive medication|3|||
127638583|NCT02096900|459295499|FG001|Overall Study|Did not receive medication|1|||
127638584|NCT02096900|459295498|FG000|Overall Study|Surgery cancelled- medication received|1|||
127638585|NCT02096900|459295499|FG001|Overall Study|Surgery cancelled- medication received|1|||
127638586|NCT01128413|459295503|FG000|Overall Study|Withdrawal by Subject|1|||
127638587|NCT01128413|459295504|FG001|Overall Study|Withdrawal by Subject|0|||
127638588|NCT01128413|459295503|FG000|Overall Study|NICOM Monitor Problems|2|||
127638589|NCT01128413|459295504|FG001|Overall Study|NICOM Monitor Problems|1|||
127638590|NCT01128413|459295503|FG000|Overall Study|Pt made DNR|1|||
127638591|NCT01128413|459295504|FG001|Overall Study|Pt made DNR|0|||
127638592|NCT00722761|459295505|FG000|Overall Study|Lost to Follow-up|1|||
127638593|NCT00722761|459295506|FG001|Overall Study|Lost to Follow-up|4|||
127796988|NCT02889796|459881178|FG003|Overall Study|Lost to Follow-up|0|||
127796989|NCT02889796|459881179|FG004|Overall Study|Lost to Follow-up|2|||
127796990|NCT02889796|459881180|FG005|Overall Study|Lost to Follow-up|6|||
127796991|NCT02889796|459881175|FG000|Overall Study|Protocol Violation|0|||
127796992|NCT02889796|459881176|FG001|Overall Study|Protocol Violation|1|||
127796993|NCT02889796|459881177|FG002|Overall Study|Protocol Violation|3|||
127796994|NCT02889796|459881178|FG003|Overall Study|Protocol Violation|0|||
127796995|NCT02889796|459881179|FG004|Overall Study|Protocol Violation|0|||
127796996|NCT02889796|459881180|FG005|Overall Study|Protocol Violation|4|||
127796997|NCT02889796|459881175|FG000|Overall Study|Non-compliance With Study Drug|0|||
127796998|NCT02889796|459881176|FG001|Overall Study|Non-compliance With Study Drug|2|||
127796999|NCT02889796|459881177|FG002|Overall Study|Non-compliance With Study Drug|0|||
127797000|NCT02889796|459881178|FG003|Overall Study|Non-compliance With Study Drug|0|||
127797001|NCT02889796|459881179|FG004|Overall Study|Non-compliance With Study Drug|1|||
127797002|NCT02889796|459881180|FG005|Overall Study|Non-compliance With Study Drug|2|||
127797003|NCT02889796|459881175|FG000|Overall Study|Death|1|||
127797004|NCT02889796|459881176|FG001|Overall Study|Death|1|||
127797005|NCT02889796|459881177|FG002|Overall Study|Death|0|||
127638594|NCT00722761|459295505|FG000|Overall Study|Withdrawal by Subject|5|||
127638595|NCT00722761|459295506|FG001|Overall Study|Withdrawal by Subject|2|||
127638596|NCT02075593|459295508|FG000|Overall Study|Withdrawal by Subject|1|||
127638597|NCT02010060|459295510|FG000|Overall Study|Lost to Follow-up|1|||
127638598|NCT02010060|459295511|FG001|Overall Study|Lost to Follow-up|2|||
127638599|NCT02010060|459295512|FG002|Overall Study|Lost to Follow-up|2|||
127638600|NCT02010060|459295510|FG000|Overall Study|Injury|0|||
127638601|NCT02010060|459295511|FG001|Overall Study|Injury|1|||
127638602|NCT02010060|459295512|FG002|Overall Study|Injury|0|||
127638603|NCT05819749|459295513|FG000|Overall Study|Lost to Follow-up|1|||
127638604|NCT00680407|459295514|FG000|Overall Study|Lost to Follow-up|3|||
127638605|NCT00680407|459295515|FG001|Overall Study|Lost to Follow-up|3|||
127638606|NCT00680407|459295516|FG002|Overall Study|Lost to Follow-up|1|||
127638607|NCT00680407|459295514|FG000|Overall Study|Withdrawal by Subject|5|||
127638608|NCT00680407|459295515|FG001|Overall Study|Withdrawal by Subject|2|||
127638609|NCT00680407|459295516|FG002|Overall Study|Withdrawal by Subject|2|||
127638610|NCT06167031|459295517|FG000|Overall Study|Lost to Follow-up|5|||
127638611|NCT06167031|459295518|FG001|Overall Study|Lost to Follow-up|1|||
127638612|NCT03214367|459297901|FG000|Lead-in Period|Withdrawal by Subject|50|||
127638613|NCT03214367|459297902|FG001|Lead-in Period|Withdrawal by Subject|0|||
127638614|NCT03214367|459297903|FG002|Lead-in Period|Withdrawal by Subject|0|||
127638615|NCT03214367|459297904|FG003|Lead-in Period|Withdrawal by Subject|0|||
127638616|NCT03214367|459297905|FG004|Lead-in Period|Withdrawal by Subject|2|||
127638617|NCT03214367|459297906|FG005|Lead-in Period|Withdrawal by Subject|0|||
127638618|NCT03214367|459297907|FG006|Lead-in Period|Withdrawal by Subject|0|||
127638619|NCT03214367|459297908|FG007|Lead-in Period|Withdrawal by Subject|0|||
127638620|NCT03214367|459297901|FG000|Lead-in Period|Adverse Event|3|||
127638621|NCT03214367|459297902|FG001|Lead-in Period|Adverse Event|0|||
127638622|NCT03214367|459297903|FG002|Lead-in Period|Adverse Event|0|||
127638623|NCT03214367|459297904|FG003|Lead-in Period|Adverse Event|0|||
127638624|NCT03214367|459297905|FG004|Lead-in Period|Adverse Event|0|||
127638625|NCT03214367|459297906|FG005|Lead-in Period|Adverse Event|0|||
127638626|NCT03214367|459297907|FG006|Lead-in Period|Adverse Event|0|||
127638627|NCT03214367|459297908|FG007|Lead-in Period|Adverse Event|0|||
127638628|NCT03214367|459297901|FG000|Lead-in Period|Lost to Follow-up|12|||
127638629|NCT03214367|459297902|FG001|Lead-in Period|Lost to Follow-up|0|||
127638630|NCT03214367|459297903|FG002|Lead-in Period|Lost to Follow-up|0|||
127638631|NCT03214367|459297904|FG003|Lead-in Period|Lost to Follow-up|0|||
127638632|NCT03214367|459297905|FG004|Lead-in Period|Lost to Follow-up|0|||
127638633|NCT03214367|459297906|FG005|Lead-in Period|Lost to Follow-up|0|||
127638634|NCT03214367|459297907|FG006|Lead-in Period|Lost to Follow-up|0|||
127638635|NCT03214367|459297908|FG007|Lead-in Period|Lost to Follow-up|0|||
127638636|NCT03214367|459297901|FG000|Lead-in Period|Sponsor Decision|11|||
127638637|NCT03214367|459297902|FG001|Lead-in Period|Sponsor Decision|0|||
127638638|NCT03214367|459297903|FG002|Lead-in Period|Sponsor Decision|0|||
127638639|NCT03214367|459297904|FG003|Lead-in Period|Sponsor Decision|0|||
127638640|NCT03214367|459297905|FG004|Lead-in Period|Sponsor Decision|0|||
127638641|NCT03214367|459297906|FG005|Lead-in Period|Sponsor Decision|0|||
127638642|NCT03214367|459297907|FG006|Lead-in Period|Sponsor Decision|0|||
127638643|NCT03214367|459297908|FG007|Lead-in Period|Sponsor Decision|0|||
127638644|NCT03214367|459297901|FG000|Lead-in Period|Physician Decision|12|||
127638645|NCT03214367|459297902|FG001|Lead-in Period|Physician Decision|0|||
127638646|NCT03214367|459297903|FG002|Lead-in Period|Physician Decision|0|||
127638647|NCT03214367|459297904|FG003|Lead-in Period|Physician Decision|0|||
127638648|NCT03214367|459297905|FG004|Lead-in Period|Physician Decision|0|||
127638649|NCT03214367|459297906|FG005|Lead-in Period|Physician Decision|0|||
127638650|NCT03214367|459297907|FG006|Lead-in Period|Physician Decision|0|||
127638651|NCT03214367|459297908|FG007|Lead-in Period|Physician Decision|0|||
127638652|NCT03214367|459297901|FG000|Lead-in Period|Protocol Violation|5|||
127638653|NCT03214367|459297902|FG001|Lead-in Period|Protocol Violation|0|||
127638654|NCT03214367|459297903|FG002|Lead-in Period|Protocol Violation|0|||
127638655|NCT03214367|459297904|FG003|Lead-in Period|Protocol Violation|0|||
127638656|NCT03214367|459297905|FG004|Lead-in Period|Protocol Violation|0|||
127638657|NCT03214367|459297906|FG005|Lead-in Period|Protocol Violation|0|||
127638658|NCT03214367|459297907|FG006|Lead-in Period|Protocol Violation|0|||
127638659|NCT03214367|459297908|FG007|Lead-in Period|Protocol Violation|0|||
127638660|NCT03214367|459297901|FG000|Lead-in Period|Treatment Interruption|1|||
127638661|NCT03214367|459297902|FG001|Lead-in Period|Treatment Interruption|0|||
127638662|NCT03214367|459297903|FG002|Lead-in Period|Treatment Interruption|0|||
127638663|NCT03214367|459297904|FG003|Lead-in Period|Treatment Interruption|0|||
127638664|NCT03214367|459297905|FG004|Lead-in Period|Treatment Interruption|0|||
127638665|NCT03214367|459297906|FG005|Lead-in Period|Treatment Interruption|0|||
127638666|NCT03214367|459297907|FG006|Lead-in Period|Treatment Interruption|0|||
127638667|NCT03214367|459297908|FG007|Lead-in Period|Treatment Interruption|0|||
127638668|NCT03214367|459297901|FG000|Treatment Period|Adverse Event|0|||
127638669|NCT03214367|459297902|FG001|Treatment Period|Adverse Event|1|||
127638670|NCT03214367|459297903|FG002|Treatment Period|Adverse Event|4|||
127638671|NCT03214367|459297904|FG003|Treatment Period|Adverse Event|2|||
127638672|NCT03214367|459297905|FG004|Treatment Period|Adverse Event|0|||
127638673|NCT03214367|459297906|FG005|Treatment Period|Adverse Event|0|||
127638674|NCT03214367|459297907|FG006|Treatment Period|Adverse Event|0|||
127638675|NCT03214367|459297908|FG007|Treatment Period|Adverse Event|0|||
127638676|NCT03214367|459297901|FG000|Treatment Period|Death|0|||
127638677|NCT03214367|459297902|FG001|Treatment Period|Death|1|||
127638678|NCT03214367|459297903|FG002|Treatment Period|Death|1|||
127638679|NCT03214367|459297904|FG003|Treatment Period|Death|1|||
127638680|NCT03214367|459297905|FG004|Treatment Period|Death|0|||
127638681|NCT03214367|459297906|FG005|Treatment Period|Death|0|||
127638682|NCT03214367|459297907|FG006|Treatment Period|Death|0|||
127638683|NCT03214367|459297908|FG007|Treatment Period|Death|0|||
127638684|NCT03214367|459297901|FG000|Treatment Period|Lost to Follow-up|0|||
127638685|NCT03214367|459297902|FG001|Treatment Period|Lost to Follow-up|5|||
127638686|NCT03214367|459297903|FG002|Treatment Period|Lost to Follow-up|3|||
127638687|NCT03214367|459297904|FG003|Treatment Period|Lost to Follow-up|2|||
127638688|NCT03214367|459297905|FG004|Treatment Period|Lost to Follow-up|0|||
127638689|NCT03214367|459297906|FG005|Treatment Period|Lost to Follow-up|2|||
127638690|NCT03214367|459297907|FG006|Treatment Period|Lost to Follow-up|1|||
127638691|NCT03214367|459297908|FG007|Treatment Period|Lost to Follow-up|0|||
127638692|NCT03214367|459297901|FG000|Treatment Period|Sponsor Decision|0|||
127638693|NCT03214367|459297902|FG001|Treatment Period|Sponsor Decision|3|||
127638694|NCT03214367|459297903|FG002|Treatment Period|Sponsor Decision|0|||
127638695|NCT03214367|459297904|FG003|Treatment Period|Sponsor Decision|0|||
127638696|NCT03214367|459297905|FG004|Treatment Period|Sponsor Decision|0|||
127638697|NCT03214367|459297906|FG005|Treatment Period|Sponsor Decision|0|||
127638698|NCT03214367|459297907|FG006|Treatment Period|Sponsor Decision|0|||
127638699|NCT03214367|459297908|FG007|Treatment Period|Sponsor Decision|0|||
127638700|NCT03214367|459297901|FG000|Treatment Period|Physician Decision|0|||
127638701|NCT03214367|459297902|FG001|Treatment Period|Physician Decision|1|||
127638702|NCT03214367|459297903|FG002|Treatment Period|Physician Decision|2|||
127638703|NCT03214367|459297904|FG003|Treatment Period|Physician Decision|0|||
127638704|NCT03214367|459297905|FG004|Treatment Period|Physician Decision|0|||
127638705|NCT03214367|459297906|FG005|Treatment Period|Physician Decision|0|||
127638706|NCT03214367|459297907|FG006|Treatment Period|Physician Decision|0|||
127638707|NCT03214367|459297908|FG007|Treatment Period|Physician Decision|0|||
127638708|NCT03214367|459297901|FG000|Treatment Period|Protocol Violation|0|||
127638709|NCT03214367|459297902|FG001|Treatment Period|Protocol Violation|3|||
127638710|NCT03214367|459297903|FG002|Treatment Period|Protocol Violation|0|||
127638711|NCT03214367|459297904|FG003|Treatment Period|Protocol Violation|0|||
127638712|NCT03214367|459297905|FG004|Treatment Period|Protocol Violation|0|||
127638713|NCT03214367|459297906|FG005|Treatment Period|Protocol Violation|0|||
127638714|NCT03214367|459297907|FG006|Treatment Period|Protocol Violation|0|||
127638715|NCT03214367|459297908|FG007|Treatment Period|Protocol Violation|0|||
127638716|NCT03214367|459297901|FG000|Treatment Period|Withdrawal by Subject|0|||
127638717|NCT03214367|459297902|FG001|Treatment Period|Withdrawal by Subject|20|||
127638718|NCT03214367|459297903|FG002|Treatment Period|Withdrawal by Subject|23|||
127638719|NCT03214367|459297904|FG003|Treatment Period|Withdrawal by Subject|14|||
127638720|NCT03214367|459297905|FG004|Treatment Period|Withdrawal by Subject|0|||
127638721|NCT03214367|459297906|FG005|Treatment Period|Withdrawal by Subject|1|||
127638722|NCT03214367|459297907|FG006|Treatment Period|Withdrawal by Subject|1|||
127797006|NCT02889796|459881178|FG003|Overall Study|Death|1|||
127638723|NCT03214367|459297908|FG007|Treatment Period|Withdrawal by Subject|1|||
127638724|NCT03508843|459297909|FG000|Overall Study|Withdrawal by Subject|1|||
127638725|NCT03508843|459297909|FG000|Overall Study|technical difficulties|2|||
127638726|NCT00765843|459297910|FG000|Overall Study|Lost to Follow-up|1|||
127638727|NCT00765843|459297911|FG001|Overall Study|Lost to Follow-up|3|||
127638728|NCT00765843|459297912|FG002|Overall Study|Lost to Follow-up|2|||
127638729|NCT00765843|459297910|FG000|Overall Study|did not return to receive intervention|0|||
127638730|NCT00765843|459297911|FG001|Overall Study|did not return to receive intervention|1|||
127638731|NCT00765843|459297912|FG002|Overall Study|did not return to receive intervention|0|||
127638732|NCT00765843|459297910|FG000|Overall Study|Adverse Event|0|||
127638733|NCT00765843|459297911|FG001|Overall Study|Adverse Event|0|||
127638734|NCT00765843|459297912|FG002|Overall Study|Adverse Event|1|||
127638735|NCT03555396|459297913|FG000|Overall Study|Death|3|||
127638736|NCT03555396|459297914|FG001|Overall Study|Death|1|||
127638737|NCT03555396|459297913|FG000|Overall Study|Lost to Follow-up|0|||
127638738|NCT03555396|459297914|FG001|Overall Study|Lost to Follow-up|2|||
127638739|NCT01369342|459297922|FG000|Overall Study|Withdrawal by Subject|7|||
127638740|NCT01369342|459297923|FG001|Overall Study|Withdrawal by Subject|7|||
127638741|NCT01369342|459297924|FG002|Overall Study|Withdrawal by Subject|2|||
127638742|NCT01369342|459297922|FG000|Overall Study|Lost to Follow-up|5|||
127638743|NCT01369342|459297923|FG001|Overall Study|Lost to Follow-up|2|||
127638744|NCT01369342|459297924|FG002|Overall Study|Lost to Follow-up|1|||
127638745|NCT01369342|459297922|FG000|Overall Study|Not Treated|1|||
127638746|NCT01369342|459297923|FG001|Overall Study|Not Treated|0|||
127638747|NCT01369342|459297924|FG002|Overall Study|Not Treated|0|||
127638748|NCT01816594|459297925|FG000|Overall Study|Local Progress|0|||
127638749|NCT01816594|459297926|FG001|Overall Study|Local Progress|2|||
127638750|NCT01816594|459297925|FG000|Overall Study|Adverse Event|9|||
127638751|NCT01816594|459297926|FG001|Overall Study|Adverse Event|0|||
127638752|NCT01816594|459297925|FG000|Overall Study|Withdrawal by Subject|1|||
127638753|NCT01816594|459297926|FG001|Overall Study|Withdrawal by Subject|0|||
127638754|NCT01816594|459297925|FG000|Overall Study|Physician Decision|1|||
127638755|NCT01816594|459297926|FG001|Overall Study|Physician Decision|0|||
127638756|NCT03905655|459297927|FG000|Overall Study|Adverse Event|1|||
127638757|NCT03905655|459297928|FG001|Overall Study|Adverse Event|0|||
127638758|NCT03905655|459297929|FG002|Overall Study|Adverse Event|1|||
127638759|NCT03905655|459297930|FG003|Overall Study|Adverse Event|1|||
127638760|NCT02566031|459297931|FG000|Overall Study|Patient/guardian decision|14|||
127638761|NCT02566031|459297932|FG001|Overall Study|Patient/guardian decision|7|||
127638762|NCT02566031|459297931|FG000|Overall Study|Protocol deviation|2|||
127638763|NCT02566031|459297932|FG001|Overall Study|Protocol deviation|3|||
127638764|NCT02566031|459297931|FG000|Overall Study|Adverse Event|3|||
127638765|NCT02566031|459297932|FG001|Overall Study|Adverse Event|1|||
127638766|NCT02566031|459297931|FG000|Overall Study|Lost to Follow-up|1|||
127638767|NCT02566031|459297932|FG001|Overall Study|Lost to Follow-up|1|||
127638768|NCT00413153|459297933|FG000|Overall Study|Withdrawal by Subject|1|||
127638769|NCT00413153|459297934|FG001|Overall Study|Withdrawal by Subject|1|||
127638770|NCT00413153|459297933|FG000|Overall Study|Adverse Event|1|||
127638771|NCT00413153|459297934|FG001|Overall Study|Adverse Event|0|||
127638772|NCT03204279|459297935|FG000|Overall Study|Withdrawal by Subject|0|||
127638773|NCT03204279|459297936|FG001|Overall Study|Withdrawal by Subject|1|||
127638774|NCT02277106|459297937|FG000|Stage 2|Adverse Event|0|||
127638775|NCT02277106|459297938|FG001|Stage 2|Adverse Event|0|||
127638776|NCT02277106|459297939|FG002|Stage 2|Adverse Event|1|||
127638777|NCT01064739|459297940|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
127638778|NCT02479412|459297945|FG000|Overall Study|Adverse Event|0|||
127638779|NCT02479412|459297946|FG001|Overall Study|Adverse Event|0|||
127638780|NCT02479412|459297947|FG002|Overall Study|Adverse Event|1|||
127638781|NCT02479412|459297948|FG003|Overall Study|Adverse Event|0|||
127638782|NCT02479412|459297949|FG004|Overall Study|Adverse Event|0|||
127638783|NCT02479412|459297950|FG005|Overall Study|Adverse Event|0|||
127638784|NCT02479412|459297951|FG006|Overall Study|Adverse Event|0|||
127638785|NCT02479412|459297952|FG007|Overall Study|Adverse Event|0|||
127638786|NCT02479412|459297953|FG008|Overall Study|Adverse Event|0|||
127638787|NCT02479412|459297945|FG000|Overall Study|Study-specific withdrawal criteria|0|||
127638788|NCT02479412|459297946|FG001|Overall Study|Study-specific withdrawal criteria|0|||
127638789|NCT02479412|459297947|FG002|Overall Study|Study-specific withdrawal criteria|1|||
127638790|NCT02479412|459297948|FG003|Overall Study|Study-specific withdrawal criteria|1|||
127638791|NCT02479412|459297949|FG004|Overall Study|Study-specific withdrawal criteria|0|||
127638792|NCT02479412|459297950|FG005|Overall Study|Study-specific withdrawal criteria|0|||
127638793|NCT02479412|459297951|FG006|Overall Study|Study-specific withdrawal criteria|0|||
127638794|NCT02479412|459297952|FG007|Overall Study|Study-specific withdrawal criteria|1|||
127638795|NCT02479412|459297953|FG008|Overall Study|Study-specific withdrawal criteria|1|||
127638796|NCT02479412|459297945|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
127638797|NCT02479412|459297946|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
127638798|NCT02479412|459297947|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
127638799|NCT02479412|459297948|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
127638800|NCT02479412|459297949|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
127638801|NCT02479412|459297950|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
127638802|NCT02479412|459297951|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
127797007|NCT02889796|459881179|FG004|Overall Study|Death|0|||
127797008|NCT02889796|459881180|FG005|Overall Study|Death|1|||
127797009|NCT02889796|459881175|FG000|Overall Study|Pregnancy|0|||
127797010|NCT02889796|459881176|FG001|Overall Study|Pregnancy|1|||
127886160|NCT01070966|460206964|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
127886161|NCT01070966|460206964|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
127886162|NCT02770716|460206965|FG000|Overall Study|Death|101|||
127886163|NCT02770716|460206966|FG001|Overall Study|Death|45|||
127886164|NCT02770716|460206965|FG000|Overall Study|Withdrawal by Subject|4|||
127886165|NCT02770716|460206966|FG001|Overall Study|Withdrawal by Subject|2|||
127886166|NCT02770716|460206965|FG000|Overall Study|Lost to Follow-up|1|||
127886167|NCT02770716|460206966|FG001|Overall Study|Lost to Follow-up|0|||
127886168|NCT02770716|460206965|FG000|Overall Study|Various reasons|6|||
127886169|NCT02770716|460206966|FG001|Overall Study|Various reasons|2|||
127886170|NCT01725113|460206967|FG000|Overall Study|Kidney Transplant|1|||
127886171|NCT01725113|460206968|FG001|Overall Study|Kidney Transplant|1|||
127886172|NCT01725113|460206967|FG000|Overall Study|Withdrawal by Subject|0|||
127886173|NCT01725113|460206968|FG001|Overall Study|Withdrawal by Subject|1|||
127886174|NCT03989115|460206969|FG000|Overall Study|Withdrawal by Subject|2|||
127886175|NCT03989115|460206970|FG001|Overall Study|Withdrawal by Subject|1|||
127886176|NCT03989115|460206971|FG002|Overall Study|Withdrawal by Subject|3|||
127886177|NCT03989115|460206972|FG003|Overall Study|Withdrawal by Subject|0|||
127886178|NCT03989115|460206973|FG004|Overall Study|Withdrawal by Subject|17|||
127886179|NCT03989115|460206974|FG005|Overall Study|Withdrawal by Subject|1|||
127886180|NCT03989115|460206975|FG006|Overall Study|Withdrawal by Subject|0|||
127886181|NCT03989115|460206976|FG007|Overall Study|Withdrawal by Subject|0|||
127886182|NCT03989115|460206969|FG000|Overall Study|Sponsor decision to terminate the study|1|||
127886183|NCT03989115|460206970|FG001|Overall Study|Sponsor decision to terminate the study|1|||
127886184|NCT03989115|460206971|FG002|Overall Study|Sponsor decision to terminate the study|0|||
127886185|NCT03989115|460206972|FG003|Overall Study|Sponsor decision to terminate the study|1|||
127886186|NCT03989115|460206973|FG004|Overall Study|Sponsor decision to terminate the study|11|||
127886187|NCT03989115|460206974|FG005|Overall Study|Sponsor decision to terminate the study|0|||
127886188|NCT03989115|460206975|FG006|Overall Study|Sponsor decision to terminate the study|2|||
127886189|NCT03989115|460206976|FG007|Overall Study|Sponsor decision to terminate the study|1|||
127886190|NCT03989115|460206969|FG000|Overall Study|Lost to Follow-up|2|||
127886191|NCT03989115|460206970|FG001|Overall Study|Lost to Follow-up|0|||
127886192|NCT03989115|460206971|FG002|Overall Study|Lost to Follow-up|0|||
127886193|NCT03989115|460206972|FG003|Overall Study|Lost to Follow-up|0|||
127886194|NCT03989115|460206973|FG004|Overall Study|Lost to Follow-up|1|||
127886195|NCT03989115|460206974|FG005|Overall Study|Lost to Follow-up|0|||
127886196|NCT03989115|460206975|FG006|Overall Study|Lost to Follow-up|0|||
127886197|NCT03989115|460206976|FG007|Overall Study|Lost to Follow-up|0|||
127886198|NCT03989115|460206969|FG000|Overall Study|Death|2|||
127886199|NCT03989115|460206970|FG001|Overall Study|Death|2|||
127886200|NCT03989115|460206971|FG002|Overall Study|Death|9|||
127886201|NCT03989115|460206972|FG003|Overall Study|Death|6|||
127886202|NCT03989115|460206973|FG004|Overall Study|Death|31|||
127886203|NCT03989115|460206974|FG005|Overall Study|Death|6|||
127886204|NCT03989115|460206975|FG006|Overall Study|Death|2|||
127886205|NCT03989115|460206976|FG007|Overall Study|Death|3|||
127886206|NCT03989115|460206969|FG000|Overall Study|Other|1|||
127886207|NCT03989115|460206970|FG001|Overall Study|Other|2|||
127886208|NCT03989115|460206971|FG002|Overall Study|Other|0|||
127886209|NCT03989115|460206972|FG003|Overall Study|Other|0|||
127886210|NCT03989115|460206973|FG004|Overall Study|Other|5|||
127886211|NCT03989115|460206974|FG005|Overall Study|Other|0|||
127703426|NCT01946789|459542678|FG008|Overall Study|Withdrawal by Subject|0|||
127703427|NCT05374798|459542679|FG000|Overall Study|Lost to Follow-up|2|||
127703428|NCT05374798|459542679|FG000|Overall Study|Withdrawal by Subject|2|||
127703429|NCT05374798|459542679|FG000|Overall Study|Withdrawn by Principal Investigator.|2|||
127703430|NCT01275677|459542684|FG000|Overall Study|Not at risk for recurrence.|1|||
127703431|NCT01275677|459542685|FG001|Overall Study|Not at risk for recurrence.|1|||
127703432|NCT01275677|459542684|FG000|Overall Study|No follow-up|26|||
127703433|NCT01275677|459542685|FG001|Overall Study|No follow-up|37|||
127703434|NCT01275677|459542684|FG000|Overall Study|No clinical follow up.|1|||
127886212|NCT03989115|460206975|FG006|Overall Study|Other|0|||
127886213|NCT03989115|460206976|FG007|Overall Study|Other|0|||
127886214|NCT01808209|460206980|FG000|Overall Study|Lost to Follow-up|0|||
127886215|NCT01808209|460206981|FG001|Overall Study|Lost to Follow-up|1|||
127886216|NCT00751998|460206994|FG000|Overall Study|Lost to Follow-up|7|||
127886217|NCT00751998|460206994|FG000|Overall Study|Death|11|||
127886218|NCT00751998|460206994|FG000|Overall Study|Withdrawal by Subject|2|||
127886219|NCT01965535|460206995|FG000|Overall Study|Lack of Efficacy|2|||
127886220|NCT01965535|460206996|FG001|Overall Study|Lack of Efficacy|1|||
127886221|NCT02983227|460206997|FG000|Overall Study|Adverse Event|21|||
127886222|NCT02983227|460206998|FG001|Overall Study|Adverse Event|3|||
127886223|NCT02983227|460206997|FG000|Overall Study|Death|3|||
127886224|NCT02983227|460206998|FG001|Overall Study|Death|0|||
127886225|NCT02983227|460206997|FG000|Overall Study|Lack of Efficacy|8|||
127886226|NCT02983227|460206998|FG001|Overall Study|Lack of Efficacy|1|||
127703435|NCT01275677|459542685|FG001|Overall Study|No clinical follow up.|4|||
127703436|NCT04409353|459542694|FG000|Overall Study|Discontinued intervention prior to end of follow-up|4|||
127703437|NCT04409353|459542695|FG001|Overall Study|Discontinued intervention prior to end of follow-up|11|||
127886227|NCT02983227|460206997|FG000|Overall Study|Lost to Follow-up|3|||
127886228|NCT02983227|460206998|FG001|Overall Study|Lost to Follow-up|0|||
127886229|NCT02983227|460206997|FG000|Overall Study|Multiple Reasons|2|||
127886230|NCT02983227|460206998|FG001|Overall Study|Multiple Reasons|1|||
127886231|NCT02983227|460206997|FG000|Overall Study|Physician Decision|3|||
127703438|NCT04409353|459542696|FG002|Overall Study|Discontinued intervention prior to end of follow-up|6|||
127703439|NCT04409353|459542694|FG000|Overall Study|Lost to Follow-up|6|||
127703440|NCT04409353|459542695|FG001|Overall Study|Lost to Follow-up|8|||
127703441|NCT04409353|459542696|FG002|Overall Study|Lost to Follow-up|7|||
127703442|NCT04409353|459542694|FG000|Overall Study|Major surgery during participation window|4|||
127703443|NCT04409353|459542695|FG001|Overall Study|Major surgery during participation window|3|||
127703444|NCT04409353|459542696|FG002|Overall Study|Major surgery during participation window|3|||
127703445|NCT04409353|459542694|FG000|Overall Study|Life event occurred during participation window|3|||
127703446|NCT04409353|459542695|FG001|Overall Study|Life event occurred during participation window|2|||
127703447|NCT04409353|459542696|FG002|Overall Study|Life event occurred during participation window|4|||
127703448|NCT04409353|459542694|FG000|Overall Study|Lack of Efficacy|4|||
127797011|NCT02889796|459881177|FG002|Overall Study|Pregnancy|1|||
127797012|NCT02889796|459881178|FG003|Overall Study|Pregnancy|0|||
127797013|NCT02889796|459881179|FG004|Overall Study|Pregnancy|0|||
127797014|NCT02889796|459881180|FG005|Overall Study|Pregnancy|0|||
127797015|NCT02889796|459881175|FG000|Overall Study|Randomized but not Dosed|2|||
127797016|NCT02889796|459881176|FG001|Overall Study|Randomized but not Dosed|0|||
127797017|NCT02889796|459881177|FG002|Overall Study|Randomized but not Dosed|0|||
127797018|NCT02889796|459881178|FG003|Overall Study|Randomized but not Dosed|0|||
127797019|NCT02889796|459881179|FG004|Overall Study|Randomized but not Dosed|0|||
127797020|NCT02889796|459881180|FG005|Overall Study|Randomized but not Dosed|2|||
127797021|NCT01407926|459881186|FG000|Overall Study|Lost to Follow-up|55|||
127797022|NCT02814565|459881187|FG000|Overall Study|Lack of Efficacy|0|||
127797023|NCT02814565|459881188|FG001|Overall Study|Lack of Efficacy|1|||
127797024|NCT02814565|459881187|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
127797025|NCT02814565|459881188|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
127797026|NCT04656652|459881189|FG000|Overall Study|Lost to Follow-up|2|||
127797027|NCT04656652|459881190|FG001|Overall Study|Lost to Follow-up|2|||
127797028|NCT04656652|459881189|FG000|Overall Study|Death|213|||
127797029|NCT04656652|459881190|FG001|Overall Study|Death|212|||
127797030|NCT04656652|459881189|FG000|Overall Study|Other|1|||
127797031|NCT04656652|459881190|FG001|Overall Study|Other|0|||
127797032|NCT04656652|459881189|FG000|Overall Study|Withdrawal by Subject|15|||
127797033|NCT04656652|459881190|FG001|Overall Study|Withdrawal by Subject|29|||
127797034|NCT01414257|459881193|FG000|Overall Study|No Visit After First Day of Treatment|12|||
127797035|NCT01414257|459881193|FG000|Overall Study|Protocol Violation|10|||
127797036|NCT02479802|459881194|FG000|Overall Study|Lost to Follow-up|1|||
127797037|NCT02479802|459881194|FG000|Overall Study|Adverse Event|1|||
127797038|NCT01882907|459881195|FG000|Overall Study|Adverse Event|3|||
127797039|NCT01882907|459881196|FG001|Overall Study|Adverse Event|1|||
127797040|NCT01882907|459881195|FG000|Overall Study|Lack of Efficacy|0|||
127797041|NCT01882907|459881196|FG001|Overall Study|Lack of Efficacy|3|||
127797042|NCT01882907|459881195|FG000|Overall Study|Lost to Follow-up|1|||
127797043|NCT01882907|459881196|FG001|Overall Study|Lost to Follow-up|4|||
127797044|NCT01882907|459881195|FG000|Overall Study|Protocol Violation|10|||
127797045|NCT01882907|459881196|FG001|Overall Study|Protocol Violation|14|||
127797046|NCT01882907|459881195|FG000|Overall Study|Withdrawal by Subject|0|||
127797047|NCT01882907|459881196|FG001|Overall Study|Withdrawal by Subject|6|||
127797048|NCT01978093|459881197|FG000|Overall Study|Death|1|||
127797049|NCT01978093|459881198|FG001|Overall Study|Death|0|||
127797050|NCT01978093|459881197|FG000|Overall Study|Adverse Event|0|||
127797051|NCT01978093|459881198|FG001|Overall Study|Adverse Event|5|||
127797052|NCT01978093|459881197|FG000|Overall Study|Protocol Violation|8|||
127797053|NCT01978093|459881198|FG001|Overall Study|Protocol Violation|2|||
127797054|NCT01978093|459881197|FG000|Overall Study|Withdrawal by Subject|29|||
127797055|NCT01978093|459881198|FG001|Overall Study|Withdrawal by Subject|25|||
127797056|NCT01978093|459881197|FG000|Overall Study|Lost to Follow-up|11|||
127797057|NCT01978093|459881198|FG001|Overall Study|Lost to Follow-up|15|||
127797058|NCT01978093|459881197|FG000|Overall Study|Migrated/moved from study area|11|||
127797059|NCT01978093|459881198|FG001|Overall Study|Migrated/moved from study area|13|||
127797060|NCT01978093|459881197|FG000|Overall Study|Loss of kaiser coverage|4|||
127797061|NCT01978093|459881198|FG001|Overall Study|Loss of kaiser coverage|10|||
127797062|NCT01978093|459881197|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
127797063|NCT01978093|459881198|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
127797064|NCT01978093|459881197|FG000|Overall Study|Mother lost custody of child|0|||
127886232|NCT02983227|460206998|FG001|Overall Study|Physician Decision|1|||
127797065|NCT01978093|459881198|FG001|Overall Study|Mother lost custody of child|1|||
127886233|NCT02983227|460206997|FG000|Overall Study|Withdrawal by Subject|19|||
127703449|NCT04409353|459542695|FG001|Overall Study|Lack of Efficacy|1|||
127703450|NCT04409353|459542696|FG002|Overall Study|Lack of Efficacy|3|||
127886234|NCT02983227|460206998|FG001|Overall Study|Withdrawal by Subject|8|||
127886235|NCT01493531|460207001|FG000|Overall Study|Adverse Event|4|||
127886236|NCT01493531|460207002|FG001|Overall Study|Adverse Event|12|||
127886237|NCT01493531|460207003|FG002|Overall Study|Adverse Event|9|||
127886238|NCT01493531|460207001|FG000|Overall Study|Gout flare|3|||
127886239|NCT01493531|460207002|FG001|Overall Study|Gout flare|0|||
127886240|NCT01493531|460207003|FG002|Overall Study|Gout flare|2|||
127886241|NCT01493531|460207001|FG000|Overall Study|Protocol Violation|8|||
127886242|NCT01493531|460207002|FG001|Overall Study|Protocol Violation|15|||
127886243|NCT01493531|460207003|FG002|Overall Study|Protocol Violation|12|||
127886244|NCT01493531|460207001|FG000|Overall Study|Sponsor terminated study|5|||
127886245|NCT01493531|460207002|FG001|Overall Study|Sponsor terminated study|2|||
127886246|NCT01493531|460207003|FG002|Overall Study|Sponsor terminated study|3|||
127886247|NCT01493531|460207001|FG000|Overall Study|Lost to Follow-up|5|||
127886248|NCT01493531|460207002|FG001|Overall Study|Lost to Follow-up|7|||
127886249|NCT01493531|460207003|FG002|Overall Study|Lost to Follow-up|11|||
127886250|NCT01493531|460207001|FG000|Overall Study|Withdrawal by Subject|16|||
127886251|NCT01493531|460207002|FG001|Overall Study|Withdrawal by Subject|13|||
127886252|NCT01493531|460207003|FG002|Overall Study|Withdrawal by Subject|11|||
127886253|NCT01493531|460207001|FG000|Overall Study|Death|0|||
127886254|NCT01493531|460207002|FG001|Overall Study|Death|1|||
127886255|NCT01493531|460207003|FG002|Overall Study|Death|0|||
127886256|NCT01946282|460207004|FG000|Year 1|Did not return FIT kit|4186|||
127886257|NCT01946282|460207005|FG001|Year 1|Did not return FIT kit|608|||
127886258|NCT01946282|460207006|FG002|Year 1|Did not return FIT kit|654|||
127886259|NCT01946282|460207004|FG000|Year 2|Did not return FIT kit|803|||
127886260|NCT01946282|460207005|FG001|Year 2|Did not return FIT kit|131|||
127886261|NCT01946282|460207006|FG002|Year 2|Did not return FIT kit|115|||
127886262|NCT01946282|460207004|FG000|Year 3|Did not return FIT kit|288|||
127886263|NCT01946282|460207005|FG001|Year 3|Did not return FIT kit|43|||
127886264|NCT01946282|460207006|FG002|Year 3|Did not return FIT kit|30|||
127886265|NCT00845026|460207009|FG000|Study Period III|Adverse Event|23|||
127886266|NCT00845026|460207010|FG001|Study Period III|Adverse Event|19|||
127886267|NCT00845026|460207009|FG000|Study Period III|Perceived lack of efficacy|27|||
127886268|NCT00845026|460207010|FG001|Study Period III|Perceived lack of efficacy|15|||
127886269|NCT00845026|460207009|FG000|Study Period III|Withdrawal by Subject|19|||
127886270|NCT00845026|460207010|FG001|Study Period III|Withdrawal by Subject|15|||
127886271|NCT00845026|460207009|FG000|Study Period III|Entry Criteria not met|8|||
127886272|NCT00845026|460207010|FG001|Study Period III|Entry Criteria not met|11|||
127886273|NCT00845026|460207009|FG000|Study Period III|Lost to Follow-up|4|||
127886274|NCT00845026|460207010|FG001|Study Period III|Lost to Follow-up|5|||
127886275|NCT00845026|460207009|FG000|Study Period III|Protocol Violation|8|||
127886276|NCT00845026|460207010|FG001|Study Period III|Protocol Violation|1|||
127886277|NCT00845026|460207009|FG000|Study Period III|Scheduled conflict|3|||
127886278|NCT00845026|460207010|FG001|Study Period III|Scheduled conflict|1|||
127886279|NCT00845026|460207009|FG000|Study Period III|Subject is moving or has moved|2|||
127886280|NCT00845026|460207010|FG001|Study Period III|Subject is moving or has moved|4|||
127886281|NCT00845026|460207009|FG000|Study Period III|Transportation issues|1|||
127886282|NCT00845026|460207010|FG001|Study Period III|Transportation issues|1|||
127886283|NCT00845026|460207009|FG000|Study Period IV|Adverse Event|4|||
127886284|NCT00845026|460207010|FG001|Study Period IV|Adverse Event|0|||
127886285|NCT00845026|460207009|FG000|Study Period IV|Perceived lack of efficacy|2|||
127886286|NCT00845026|460207010|FG001|Study Period IV|Perceived lack of efficacy|1|||
127886287|NCT00845026|460207009|FG000|Study Period IV|Protocol Violation|3|||
127886288|NCT00845026|460207010|FG001|Study Period IV|Protocol Violation|1|||
127886289|NCT00845026|460207009|FG000|Study Period IV|Lost to Follow-up|1|||
127886290|NCT00845026|460207010|FG001|Study Period IV|Lost to Follow-up|0|||
127886291|NCT00845026|460207009|FG000|Study Period IV|Withdrawal by Subject|4|||
127703451|NCT04409353|459542694|FG000|Overall Study|Adverse Event|2|||
127703452|NCT04409353|459542695|FG001|Overall Study|Adverse Event|1|||
127703453|NCT04409353|459542696|FG002|Overall Study|Adverse Event|1|||
127703454|NCT04409353|459542694|FG000|Overall Study|Disease burden - unable to participate|0|||
127703455|NCT04409353|459542695|FG001|Overall Study|Disease burden - unable to participate|1|||
127703456|NCT04409353|459542696|FG002|Overall Study|Disease burden - unable to participate|1|||
127886292|NCT00845026|460207010|FG001|Study Period IV|Withdrawal by Subject|1|||
127886293|NCT00845026|460207009|FG000|Study Period IV|Entry Criteria Not Met|1|||
127886294|NCT00845026|460207010|FG001|Study Period IV|Entry Criteria Not Met|0|||
127886295|NCT00845026|460207009|FG000|Study Period IV|Subject is moving or has moved|0|||
127886296|NCT00845026|460207010|FG001|Study Period IV|Subject is moving or has moved|1|||
127886297|NCT00845026|460207009|FG000|Study Period IV|Scheduling conflict|1|||
127886298|NCT00845026|460207010|FG001|Study Period IV|Scheduling conflict|0|||
127886299|NCT01325532|460207011|FG000|Overall Study|Withdrawal by Subject|2|||
127886300|NCT01325532|460207012|FG001|Overall Study|Withdrawal by Subject|0|||
127703457|NCT04409353|459542694|FG000|Overall Study|Intervention too complicated|1|||
127703458|NCT04409353|459542695|FG001|Overall Study|Intervention too complicated|0|||
127638803|NCT02479412|459297952|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
127638804|NCT02479412|459297953|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
127638805|NCT01571362|459297954|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
127638806|NCT01571362|459297955|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
127638807|NCT01571362|459297956|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
127638808|NCT01571362|459297954|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
127638809|NCT01571362|459297955|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
127638810|NCT01571362|459297956|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
127638811|NCT01571362|459297954|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
127638812|NCT01571362|459297955|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
127638813|NCT01571362|459297956|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
127638814|NCT01571362|459297954|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
127638815|NCT01571362|459297955|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
127638816|NCT01571362|459297956|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
127638817|NCT01571362|459297954|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
127638818|NCT01571362|459297955|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
127638819|NCT01571362|459297956|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
127638820|NCT01571362|459297954|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
127638821|NCT01571362|459297955|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
127638822|NCT01571362|459297956|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
127638823|NCT01571362|459297954|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
127638824|NCT01571362|459297955|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
127638825|NCT01571362|459297956|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
127638826|NCT01571362|459297954|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
127638827|NCT01571362|459297955|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
127638828|NCT01571362|459297956|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
127638829|NCT01571362|459297954|FG000|Double-Blind Treatment Period|Adverse Event|0|||
127638830|NCT01571362|459297955|FG001|Double-Blind Treatment Period|Adverse Event|9|||
127638831|NCT01571362|459297956|FG002|Double-Blind Treatment Period|Adverse Event|14|||
127638832|NCT01571362|459297954|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
127638833|NCT01571362|459297955|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
127638834|NCT01571362|459297956|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
127638835|NCT01571362|459297954|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
127638836|NCT01571362|459297955|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
127638837|NCT01571362|459297956|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
127638838|NCT01571362|459297954|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
127638839|NCT01571362|459297955|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
127638840|NCT01571362|459297956|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
127638841|NCT01669629|459297958|FG000|Period 1|protocol deviation|1|||
127638842|NCT01669629|459297959|FG001|Period 1|protocol deviation|2|||
127638843|NCT01221597|459297960|FG000|Overall Study|Adverse Event|4|||
127638844|NCT01221597|459297961|FG001|Overall Study|Adverse Event|1|||
127638845|NCT01221597|459297960|FG000|Overall Study|Withdrawal by Subject|20|||
127638846|NCT01221597|459297961|FG001|Overall Study|Withdrawal by Subject|6|||
127638847|NCT01221597|459297960|FG000|Overall Study|Lost to Follow-up|6|||
127638848|NCT01221597|459297961|FG001|Overall Study|Lost to Follow-up|5|||
127638849|NCT01221597|459297960|FG000|Overall Study|Protocol Violation|1|||
127638850|NCT01221597|459297961|FG001|Overall Study|Protocol Violation|0|||
127638851|NCT01221597|459297960|FG000|Overall Study|Other|3|||
127638852|NCT01221597|459297961|FG001|Overall Study|Other|4|||
127638853|NCT01221597|459297960|FG000|Overall Study|Death|2|||
127638854|NCT01221597|459297961|FG001|Overall Study|Death|0|||
127638855|NCT03667053|459297963|FG000|Overall Study|Withdrawal by Subject|1|||
127638856|NCT03667053|459297964|FG001|Overall Study|Withdrawal by Subject|0|||
127638857|NCT03667053|459297965|FG002|Overall Study|Withdrawal by Subject|0|||
127638858|NCT00487162|459297966|FG000|Overall Study|Adverse Event|0|||
127638859|NCT00487162|459297967|FG001|Overall Study|Adverse Event|1|||
127638860|NCT00487162|459297966|FG000|Overall Study|Physician Decision|0|||
127638861|NCT00487162|459297967|FG001|Overall Study|Physician Decision|1|||
127638862|NCT00487162|459297966|FG000|Overall Study|Withdrawal by Subject|2|||
127638863|NCT00487162|459297967|FG001|Overall Study|Withdrawal by Subject|3|||
127638864|NCT02278328|459297969|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
127638865|NCT02278328|459297970|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
127638866|NCT02278328|459297971|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
127638867|NCT02278328|459297969|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
127638868|NCT02278328|459297970|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
127638869|NCT02278328|459297971|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
127703459|NCT04409353|459542696|FG002|Overall Study|Intervention too complicated|1|||
127703460|NCT04081103|459542697|FG000|Overall Study|Adverse Event|1|||
127703461|NCT04081103|459542698|FG001|Overall Study|Adverse Event|1|||
127638870|NCT02278328|459297969|FG000|Neuropsych Screening|incomplete consent|0|||
127638871|NCT02278328|459297970|FG001|Neuropsych Screening|incomplete consent|0|||
127638872|NCT02278328|459297971|FG002|Neuropsych Screening|incomplete consent|2|||
127638873|NCT03834779|459297976|FG000|Overall Study|Death|1|||
127638874|NCT03834779|459297977|FG001|Overall Study|Death|2|||
127638875|NCT03834779|459297976|FG000|Overall Study|Lost to Follow-up|6|||
127638876|NCT03834779|459297977|FG001|Overall Study|Lost to Follow-up|4|||
127638877|NCT01292928|459297982|FG000|Overall Study|Death|8|||
127638878|NCT01292928|459297982|FG000|Overall Study|Withdrawal by Subject|8|||
127638879|NCT01292928|459297982|FG000|Overall Study|Lost to Follow-up|6|||
127638880|NCT01292928|459297982|FG000|Overall Study|Physician Decision|2|||
127638881|NCT03280121|459297985|FG000|Overall Study|Physician Decision|1|||
127638882|NCT03280121|459297985|FG000|Overall Study|Lost to Follow-up|1|||
127638883|NCT03280121|459297985|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
127638884|NCT04420221|459297991|FG000|Overall Study|Withdrawal by Subject|0|||
127638885|NCT04420221|459297992|FG001|Overall Study|Withdrawal by Subject|0|||
127638886|NCT04420221|459297993|FG002|Overall Study|Withdrawal by Subject|0|||
127638887|NCT04420221|459297994|FG003|Overall Study|Withdrawal by Subject|0|||
127638888|NCT04420221|459297995|FG004|Overall Study|Withdrawal by Subject|0|||
127638889|NCT04420221|459297996|FG005|Overall Study|Withdrawal by Subject|20|||
127638890|NCT04420221|459297997|FG006|Overall Study|Withdrawal by Subject|5|||
127638891|NCT04420221|459297991|FG000|Overall Study|Other|0|||
127638892|NCT04420221|459297992|FG001|Overall Study|Other|0|||
127638893|NCT04420221|459297993|FG002|Overall Study|Other|0|||
127638894|NCT04420221|459297994|FG003|Overall Study|Other|0|||
127638895|NCT04420221|459297995|FG004|Overall Study|Other|0|||
127638896|NCT04420221|459297996|FG005|Overall Study|Other|1|||
127638897|NCT04420221|459297997|FG006|Overall Study|Other|1|||
127638898|NCT04420221|459297991|FG000|Overall Study|Lost to Follow-up|0|||
127638899|NCT04420221|459297992|FG001|Overall Study|Lost to Follow-up|0|||
127638900|NCT04420221|459297993|FG002|Overall Study|Lost to Follow-up|0|||
127638901|NCT04420221|459297994|FG003|Overall Study|Lost to Follow-up|0|||
127638902|NCT04420221|459297995|FG004|Overall Study|Lost to Follow-up|0|||
127638903|NCT04420221|459297996|FG005|Overall Study|Lost to Follow-up|3|||
127638904|NCT04420221|459297997|FG006|Overall Study|Lost to Follow-up|2|||
127638905|NCT04420221|459297991|FG000|Overall Study|Migrated / Moved from the Study Area|0|||
127638906|NCT04420221|459297992|FG001|Overall Study|Migrated / Moved from the Study Area|0|||
127638907|NCT04420221|459297993|FG002|Overall Study|Migrated / Moved from the Study Area|0|||
127638908|NCT04420221|459297994|FG003|Overall Study|Migrated / Moved from the Study Area|0|||
127638909|NCT04420221|459297995|FG004|Overall Study|Migrated / Moved from the Study Area|0|||
127638910|NCT04420221|459297996|FG005|Overall Study|Migrated / Moved from the Study Area|1|||
127638911|NCT04420221|459297997|FG006|Overall Study|Migrated / Moved from the Study Area|2|||
127638912|NCT00511004|459297998|FG000|Overall Study|Lost to Follow-up|0|||
127638913|NCT00511004|459297999|FG001|Overall Study|Lost to Follow-up|0|||
127638914|NCT00511004|459298000|FG002|Overall Study|Lost to Follow-up|4|||
127638915|NCT00990652|459298001|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
127638916|NCT00990652|459298001|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
127638917|NCT02085408|459298003|FG000|Step 1: Induction|Disease Progression|19|||
127638918|NCT02085408|459298004|FG001|Step 1: Induction|Disease Progression|19|||
127638919|NCT02085408|459298003|FG000|Step 1: Induction|Adverse Event|18|||
127638920|NCT02085408|459298004|FG001|Step 1: Induction|Adverse Event|17|||
127638921|NCT02085408|459298003|FG000|Step 1: Induction|Death|33|||
127638922|NCT02085408|459298004|FG001|Step 1: Induction|Death|30|||
127638923|NCT02085408|459298003|FG000|Step 1: Induction|Withdrawal by Subject|16|||
127638924|NCT02085408|459298004|FG001|Step 1: Induction|Withdrawal by Subject|8|||
127638925|NCT02085408|459298003|FG000|Step 1: Induction|Alternative Therapy|15|||
127638926|NCT02085408|459298004|FG001|Step 1: Induction|Alternative Therapy|19|||
127638927|NCT02085408|459298003|FG000|Step 1: Induction|Complicating Disease|2|||
127638928|NCT02085408|459298004|FG001|Step 1: Induction|Complicating Disease|3|||
127638929|NCT02085408|459298003|FG000|Step 1: Induction|Other|27|||
127638930|NCT02085408|459298004|FG001|Step 1: Induction|Other|39|||
127638931|NCT02085408|459298003|FG000|Step 1: Induction|Never started treatment|6|||
127638932|NCT02085408|459298004|FG001|Step 1: Induction|Never started treatment|4|||
127638933|NCT02085408|459298003|FG000|Step 2: Consolidation|Disease Progression|5|||
127638934|NCT02085408|459298004|FG001|Step 2: Consolidation|Disease Progression|20|||
127638935|NCT02085408|459298003|FG000|Step 2: Consolidation|Adverse Event|9|||
127638936|NCT02085408|459298004|FG001|Step 2: Consolidation|Adverse Event|8|||
127638937|NCT02085408|459298003|FG000|Step 2: Consolidation|Death|4|||
127638938|NCT02085408|459298004|FG001|Step 2: Consolidation|Death|3|||
127638939|NCT02085408|459298003|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
127638940|NCT02085408|459298004|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
127638941|NCT02085408|459298003|FG000|Step 2: Consolidation|Alternative Therapy|9|||
127638942|NCT02085408|459298004|FG001|Step 2: Consolidation|Alternative Therapy|3|||
127638943|NCT02085408|459298003|FG000|Step 2: Consolidation|Complicating Disease|0|||
127638944|NCT02085408|459298004|FG001|Step 2: Consolidation|Complicating Disease|2|||
127638945|NCT02085408|459298003|FG000|Step 2: Consolidation|Other|6|||
127638946|NCT02085408|459298004|FG001|Step 2: Consolidation|Other|6|||
127638947|NCT02085408|459298003|FG000|Step 2: Consolidation|Never started treatment|4|||
127638948|NCT02085408|459298004|FG001|Step 2: Consolidation|Never started treatment|3|||
127638949|NCT02085408|459298003|FG000|Step 3: Maintenance|Disease Progression|13|||
127638950|NCT02085408|459298004|FG001|Step 3: Maintenance|Disease Progression|11|||
127638951|NCT02085408|459298003|FG000|Step 3: Maintenance|Adverse Event|2|||
127638952|NCT02085408|459298004|FG001|Step 3: Maintenance|Adverse Event|4|||
127638953|NCT02085408|459298003|FG000|Step 3: Maintenance|Death|1|||
127638954|NCT02085408|459298004|FG001|Step 3: Maintenance|Death|2|||
127638955|NCT02085408|459298003|FG000|Step 3: Maintenance|Alternative Therapy|1|||
127638956|NCT02085408|459298004|FG001|Step 3: Maintenance|Alternative Therapy|1|||
127638957|NCT02085408|459298003|FG000|Step 3: Maintenance|Complicating Disease|0|||
127638958|NCT02085408|459298004|FG001|Step 3: Maintenance|Complicating Disease|1|||
127638959|NCT02085408|459298003|FG000|Step 3: Maintenance|Other|3|||
127638960|NCT02085408|459298004|FG001|Step 3: Maintenance|Other|2|||
127638961|NCT02085408|459298003|FG000|Step 3: Maintenance|Never started treatment|5|||
127638962|NCT02085408|459298004|FG001|Step 3: Maintenance|Never started treatment|1|||
127638963|NCT01556438|459298007|FG000|Overall Study|Adverse Event|4|||
127638964|NCT01556438|459298008|FG001|Overall Study|Adverse Event|2|||
127638965|NCT01556438|459298007|FG000|Overall Study|Sponsor Decision|0|||
127638966|NCT01556438|459298008|FG001|Overall Study|Sponsor Decision|2|||
127638967|NCT01556438|459298007|FG000|Overall Study|Progressive Disease|0|||
127638968|NCT01556438|459298008|FG001|Overall Study|Progressive Disease|6|||
127638969|NCT01556438|459298007|FG000|Overall Study|Death|0|||
127638970|NCT01556438|459298008|FG001|Overall Study|Death|1|||
127638971|NCT03695172|459298009|FG000|Overall Study|Withdrawal by Subject|1|||
127638972|NCT03695172|459298010|FG001|Overall Study|Withdrawal by Subject|1|||
127638973|NCT03695172|459298011|FG002|Overall Study|Withdrawal by Subject|0|||
127638974|NCT02734212|459298013|FG000|Overall Study|Lost to Follow-up|5|||
127638975|NCT02734212|459298014|FG001|Overall Study|Lost to Follow-up|10|||
127638976|NCT00688636|459298015|FG000|Overall Study|Adverse Event|2|||
127638977|NCT00688636|459298016|FG001|Overall Study|Adverse Event|1|||
127638978|NCT01910129|459298021|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
127638979|NCT01910129|459298022|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
127638980|NCT01910129|459298023|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
127638981|NCT01910129|459298021|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
127638982|NCT01910129|459298022|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
127638983|NCT01910129|459298023|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
127638984|NCT00319098|459298024|FG000|Overall Study|Serious adverse event|3|||
127638985|NCT00319098|459298025|FG001|Overall Study|Serious adverse event|0|||
127638986|NCT00319098|459298024|FG000|Overall Study|Adverse Event|20|||
127638987|NCT00319098|459298025|FG001|Overall Study|Adverse Event|1|||
127886301|NCT03012815|460207013|FG000|Overall Study|Lost to Follow-up|1|||
127886302|NCT03012815|460207014|FG001|Overall Study|Lost to Follow-up|0|||
127886303|NCT03012815|460207013|FG000|Overall Study|Physician Decision|3|||
127886304|NCT03012815|460207014|FG001|Overall Study|Physician Decision|2|||
127886305|NCT03012815|460207013|FG000|Overall Study|Adverse Event|1|||
127886306|NCT03012815|460207014|FG001|Overall Study|Adverse Event|0|||
127886307|NCT01252238|460207015|FG000|Overall Study|Sponsor terminated study|4|||
127886308|NCT01252238|460207016|FG001|Overall Study|Sponsor terminated study|4|||
127886309|NCT01252238|460207017|FG002|Overall Study|Sponsor terminated study|4|||
127886310|NCT02295280|460207018|FG000|Overall Study|Adverse Event|0|||
127886311|NCT02295280|460207019|FG001|Overall Study|Adverse Event|1|||
127886312|NCT00558519|460207020|FG000|Overall Study|Ph+|20|||
127703462|NCT04081103|459542699|FG002|Overall Study|Adverse Event|1|||
127703463|NCT04081103|459542697|FG000|Overall Study|Physician Decision|0|||
127703464|NCT04081103|459542698|FG001|Overall Study|Physician Decision|0|||
127703465|NCT04081103|459542699|FG002|Overall Study|Physician Decision|1|||
127703466|NCT03034356|459542700|FG000|Baseline|Lost to Follow-up|2|||
127703467|NCT03034356|459542701|FG001|Baseline|Lost to Follow-up|4|||
127703468|NCT03034356|459542700|FG000|Baseline|Withdrawal by Subject|2|||
127703469|NCT03034356|459542701|FG001|Baseline|Withdrawal by Subject|0|||
127703470|NCT03034356|459542700|FG000|Baseline|Physician Decision|0|||
127703471|NCT03034356|459542701|FG001|Baseline|Physician Decision|1|||
127703472|NCT03034356|459542700|FG000|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
127703473|NCT03034356|459542701|FG001|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
127703474|NCT03034356|459542700|FG000|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|1|||
127703475|NCT03034356|459542701|FG001|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|2|||
127703476|NCT03034356|459542700|FG000|Post-Intervention 1 (4 Weeks)|Physician Decision|1|||
127703477|NCT03034356|459542701|FG001|Post-Intervention 1 (4 Weeks)|Physician Decision|0|||
127886313|NCT00558519|460207020|FG000|Overall Study|Ineligible|1|||
127886314|NCT00558519|460207020|FG000|Overall Study|Insufficient data|1|||
127886315|NCT00558519|460207020|FG000|Overall Study|Never received treatment|1|||
127886316|NCT00124449|460207023|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
127886317|NCT00124449|460207024|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
127703478|NCT03034356|459542700|FG000|Post-Washout (4 Weeks)|Withdrawal by Subject|2|||
127703479|NCT03034356|459542701|FG001|Post-Washout (4 Weeks)|Withdrawal by Subject|0|||
127886318|NCT00124449|460207023|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
127886319|NCT00124449|460207024|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
127886320|NCT00124449|460207023|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
127886321|NCT00124449|460207024|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
127703480|NCT05309291|459542702|FG000|Overall Study|Adverse Event|0|||
127703481|NCT05309291|459542703|FG001|Overall Study|Adverse Event|1|||
127703482|NCT03221426|459542704|FG000|Overall Study|Ongoing in study|212|||
127703483|NCT03221426|459542705|FG001|Overall Study|Ongoing in study|193|||
127886322|NCT00124449|460207023|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
127886323|NCT00124449|460207024|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
127886324|NCT00124449|460207023|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
127886325|NCT00124449|460207024|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
127886326|NCT00124449|460207023|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
127886327|NCT00124449|460207024|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
127886328|NCT00124449|460207023|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
127886329|NCT00124449|460207024|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
127886330|NCT00124449|460207023|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
127886331|NCT00124449|460207024|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
127886332|NCT00124449|460207023|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
127886333|NCT00124449|460207024|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
127886334|NCT00124449|460207023|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
127886335|NCT00124449|460207024|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
127886336|NCT00124449|460207023|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
127886337|NCT00124449|460207024|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
127886338|NCT00124449|460207023|FG000|18-Month Untreated Observation Period|Relocated|1|||
127886339|NCT00124449|460207024|FG001|18-Month Untreated Observation Period|Relocated|0|||
127886340|NCT01254045|460207025|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
127886341|NCT01254045|460207026|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
127703484|NCT03221426|459542706|FG002|Overall Study|Ongoing in study|61|||
127703485|NCT03221426|459542707|FG003|Overall Study|Ongoing in study|55|||
127886342|NCT01254045|460207027|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
127886343|NCT01254045|460207028|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
127886344|NCT01254045|460207029|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
127886345|NCT01254045|460207030|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
127886346|NCT02971605|460207031|FG000|Overall Study|Withdrawal by Subject|1|||
127703486|NCT03221426|459542704|FG000|Overall Study|Withdrawal by Subject|12|||
127703487|NCT03221426|459542705|FG001|Overall Study|Withdrawal by Subject|4|||
127886347|NCT00869089|460207038|FG000|Overall Study|Lost to Follow-up|1|||
127886348|NCT00869089|460207038|FG000|Overall Study|Withdrawal by Subject|1|||
127886349|NCT00869089|460207038|FG000|Overall Study|Screen Fail|1|||
127886350|NCT01559818|460207043|FG000|Overall Study|Physician Decision|1|||
127886351|NCT01559818|460207043|FG000|Overall Study|Pregnancy|1|||
127886352|NCT01559818|460207043|FG000|Overall Study|Study terminated by Sponsor|4|||
127886353|NCT01559818|460207043|FG000|Overall Study|Withdrawal by Subject|1|||
127886354|NCT04071626|460207047|FG000|Overall Study|Withdrawal by Subject|1|||
127886355|NCT04071626|460207048|FG001|Overall Study|Withdrawal by Subject|1|||
127886356|NCT04071626|460207047|FG000|Overall Study|Protocol Violation|0|||
127886357|NCT04071626|460207048|FG001|Overall Study|Protocol Violation|1|||
127886358|NCT01374906|460207049|FG000|Overall Study|Abnormal laboratory value(s)|0|||
127886359|NCT01374906|460207050|FG001|Overall Study|Abnormal laboratory value(s)|3|||
127886360|NCT01374906|460207049|FG000|Overall Study|Administrative problems|2|||
127886361|NCT01374906|460207050|FG001|Overall Study|Administrative problems|2|||
127886362|NCT01374906|460207049|FG000|Overall Study|Adverse Event|10|||
127886363|NCT01374906|460207050|FG001|Overall Study|Adverse Event|11|||
127886364|NCT01374906|460207049|FG000|Overall Study|Death|0|||
127886365|NCT01374906|460207050|FG001|Overall Study|Death|2|||
127886366|NCT01374906|460207049|FG000|Overall Study|Protocol Violation|2|||
127886367|NCT01374906|460207050|FG001|Overall Study|Protocol Violation|2|||
127886368|NCT01374906|460207049|FG000|Overall Study|Withdrawal by Subject|15|||
127886369|NCT01374906|460207050|FG001|Overall Study|Withdrawal by Subject|9|||
127886370|NCT01374906|460207049|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
127886371|NCT01374906|460207050|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
127886372|NCT02475980|460207051|FG000|Overall Study|Lost to Follow-up|4|||
127886373|NCT02475980|460207051|FG000|Overall Study|Withdrawal by Subject|1|||
127797066|NCT01978093|459881197|FG000|Overall Study|Child was in care of grandmother|0|||
127797067|NCT01978093|459881198|FG001|Overall Study|Child was in care of grandmother|1|||
127797068|NCT01978093|459881197|FG000|Overall Study|N/A for vaccine administration|0|||
127797069|NCT01978093|459881198|FG001|Overall Study|N/A for vaccine administration|1|||
127797070|NCT01784965|459881202|FG000|Overall Study|Withdrawal by Subject|6|||
127638988|NCT00319098|459298024|FG000|Overall Study|Withdrawal by Subject|37|||
127638989|NCT00319098|459298025|FG001|Overall Study|Withdrawal by Subject|8|||
127638990|NCT00319098|459298024|FG000|Overall Study|Migrated/moved from study area|2|||
127638991|NCT00319098|459298025|FG001|Overall Study|Migrated/moved from study area|1|||
127638992|NCT00319098|459298024|FG000|Overall Study|Lost to Follow-up|37|||
127638993|NCT00319098|459298025|FG001|Overall Study|Lost to Follow-up|13|||
127797071|NCT01784965|459881203|FG001|Overall Study|Withdrawal by Subject|3|||
127797072|NCT01784965|459881202|FG000|Overall Study|Adverse Event|0|||
127797073|NCT01784965|459881203|FG001|Overall Study|Adverse Event|8|||
127797074|NCT01491178|459881204|FG000|Overall Study|Adverse Event|1016|||
127797075|NCT01491178|459881204|FG000|Overall Study|Improvement of NVAF|210|||
127797076|NCT01491178|459881204|FG000|Overall Study|To conduct invasive treatment|59|||
127797077|NCT01491178|459881204|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
127797078|NCT01491178|459881204|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
127797079|NCT01491178|459881204|FG000|Overall Study|To take a contraindication|20|||
127797080|NCT01491178|459881204|FG000|Overall Study|Other than specified above|657|||
127797081|NCT05689047|459881205|FG000|Overall Study|Lost to Follow-up|0|||
127797082|NCT05689047|459881206|FG001|Overall Study|Lost to Follow-up|1|||
127797083|NCT05689047|459881205|FG000|Overall Study|Protocol Deviation|1|||
127797084|NCT05689047|459881206|FG001|Overall Study|Protocol Deviation|0|||
127797085|NCT01604512|459881207|FG000|Overall Study|Withdrawal by Subject|3|||
127797086|NCT01604512|459881207|FG000|Overall Study|Not treated|4|||
127797087|NCT03286842|459881210|FG000|Overall Study|Patients rolled over to another study|80|||
127797088|NCT03178487|459881211|FG000|Period 1|Adverse Event|1|||
127797089|NCT03178487|459881212|FG001|Period 1|Adverse Event|2|||
127797090|NCT03178487|459881211|FG000|Period 1|Withdrawal by Subject|2|||
127797091|NCT03178487|459881212|FG001|Period 1|Withdrawal by Subject|1|||
127797092|NCT03178487|459881211|FG000|Period 1|Lost to Follow-up|1|||
127797093|NCT03178487|459881212|FG001|Period 1|Lost to Follow-up|0|||
127797094|NCT03178487|459881211|FG000|Period 1|Other|0|||
127797095|NCT03178487|459881212|FG001|Period 1|Other|1|||
127797096|NCT03178487|459881211|FG000|Period 2|Adverse Event|4|||
127797097|NCT03178487|459881212|FG001|Period 2|Adverse Event|4|||
127797098|NCT03178487|459881211|FG000|Period 2|Withdrawal by Subject|6|||
127797099|NCT03178487|459881212|FG001|Period 2|Withdrawal by Subject|6|||
127797100|NCT03178487|459881211|FG000|Period 2|Lost to Follow-up|2|||
127797101|NCT03178487|459881212|FG001|Period 2|Lost to Follow-up|2|||
127886374|NCT00665626|460207055|FG000|Overall Study|Lack of Efficacy|8|||
127886375|NCT00665626|460207056|FG001|Overall Study|Lack of Efficacy|5|||
127886376|NCT00665626|460207055|FG000|Overall Study|Lost to Follow-up|0|||
127886377|NCT00665626|460207056|FG001|Overall Study|Lost to Follow-up|2|||
127886378|NCT00665626|460207055|FG000|Overall Study|Withdrawal by Subject|0|||
127797102|NCT03178487|459881211|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
127797103|NCT03178487|459881212|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
127886379|NCT00665626|460207056|FG001|Overall Study|Withdrawal by Subject|1|||
127886380|NCT00665626|460207055|FG000|Overall Study|Protocol Violation|0|||
127886381|NCT00665626|460207056|FG001|Overall Study|Protocol Violation|2|||
127886382|NCT00665626|460207055|FG000|Overall Study|Adverse Event|1|||
127886383|NCT00665626|460207056|FG001|Overall Study|Adverse Event|9|||
127886384|NCT00665626|460207055|FG000|Overall Study|Due to exclusion criteria|0|||
127886385|NCT00665626|460207056|FG001|Overall Study|Due to exclusion criteria|1|||
127886386|NCT00665626|460207055|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
127886387|NCT00665626|460207056|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
127886388|NCT00665626|460207055|FG000|Overall Study|Unably to comply with dosing regimen|0|||
127886389|NCT00665626|460207056|FG001|Overall Study|Unably to comply with dosing regimen|1|||
127886390|NCT00665626|460207055|FG000|Overall Study|Death|1|||
127886391|NCT00665626|460207056|FG001|Overall Study|Death|0|||
127886392|NCT04147611|460207057|FG000|Overall Study|Physician Decision|0|||
127886393|NCT04147611|460207058|FG001|Overall Study|Physician Decision|1|||
127886394|NCT01629693|460207061|FG000|Overall Study|Lost to Follow-up|2|||
127886395|NCT01629693|460207062|FG001|Overall Study|Lost to Follow-up|4|||
127886396|NCT01629693|460207061|FG000|Overall Study|Withdrawal by Subject|2|||
127886397|NCT01629693|460207062|FG001|Overall Study|Withdrawal by Subject|2|||
127886398|NCT01629693|460207061|FG000|Overall Study|Adverse Event|1|||
127886399|NCT01629693|460207062|FG001|Overall Study|Adverse Event|0|||
127886400|NCT01629693|460207061|FG000|Overall Study|Investigator decision|0|||
127886401|NCT01629693|460207062|FG001|Overall Study|Investigator decision|1|||
127886402|NCT01629693|460207061|FG000|Overall Study|Poor comfort of study lenses|0|||
127886403|NCT01629693|460207062|FG001|Overall Study|Poor comfort of study lenses|2|||
127886404|NCT01629693|460207061|FG000|Overall Study|Subject decision unrelated to AE|0|||
127886405|NCT01629693|460207062|FG001|Overall Study|Subject decision unrelated to AE|1|||
127886406|NCT01529749|460207063|FG000|Overall Study|Lost to Follow-up|0|||
127886407|NCT01529749|460207064|FG001|Overall Study|Lost to Follow-up|1|||
127886408|NCT01529749|460207065|FG002|Overall Study|Lost to Follow-up|1|||
127886409|NCT01529749|460207066|FG003|Overall Study|Lost to Follow-up|0|||
127886410|NCT01529749|460207063|FG000|Overall Study|Physician Decision|0|||
127886411|NCT01529749|460207064|FG001|Overall Study|Physician Decision|0|||
127886412|NCT01529749|460207065|FG002|Overall Study|Physician Decision|0|||
127886413|NCT01529749|460207066|FG003|Overall Study|Physician Decision|1|||
127886414|NCT01529749|460207063|FG000|Overall Study|Withdrawal by Subject|0|||
127886415|NCT01529749|460207064|FG001|Overall Study|Withdrawal by Subject|1|||
127886416|NCT01529749|460207065|FG002|Overall Study|Withdrawal by Subject|1|||
127886417|NCT01529749|460207066|FG003|Overall Study|Withdrawal by Subject|0|||
127886418|NCT01529749|460207063|FG000|Overall Study|Protocol Violation|0|||
127886419|NCT01529749|460207064|FG001|Overall Study|Protocol Violation|0|||
127886420|NCT01529749|460207065|FG002|Overall Study|Protocol Violation|0|||
127886421|NCT01529749|460207066|FG003|Overall Study|Protocol Violation|1|||
127703488|NCT03221426|459542706|FG002|Overall Study|Withdrawal by Subject|2|||
127703489|NCT03221426|459542707|FG003|Overall Study|Withdrawal by Subject|3|||
127703490|NCT03221426|459542704|FG000|Overall Study|Lost to Follow-up|4|||
127703491|NCT03221426|459542705|FG001|Overall Study|Lost to Follow-up|1|||
127703492|NCT03221426|459542706|FG002|Overall Study|Lost to Follow-up|1|||
127703493|NCT03221426|459542707|FG003|Overall Study|Lost to Follow-up|0|||
127703494|NCT03221426|459542704|FG000|Overall Study|Death|174|||
127703495|NCT03221426|459542705|FG001|Overall Study|Death|204|||
127703496|NCT03221426|459542706|FG002|Overall Study|Death|36|||
127703497|NCT03221426|459542707|FG003|Overall Study|Death|45|||
127886422|NCT04385199|460207067|FG000|Overall Study|Withdrawal by Subject|1|||
127886423|NCT04385199|460207068|FG001|Overall Study|Withdrawal by Subject|0|||
127886424|NCT00265083|460208554|FG000|Overall Study|Adverse Event|5|||
127886425|NCT00265083|460208555|FG001|Overall Study|Adverse Event|13|||
127886426|NCT00265083|460208556|FG002|Overall Study|Adverse Event|15|||
127886427|NCT00265083|460208554|FG000|Overall Study|Lost to Follow-up|3|||
127703498|NCT05809453|459544613|FG000|Overall Study|Withdrawal by Subject|1|||
127703499|NCT05809453|459544614|FG001|Overall Study|Withdrawal by Subject|0|||
127703500|NCT05809453|459544615|FG002|Overall Study|Withdrawal by Subject|0|||
127703501|NCT05809453|459544616|FG003|Overall Study|Withdrawal by Subject|0|||
127703502|NCT03287817|459544617|FG000|Overall Study|Progressive disease|4|||
127703503|NCT03287817|459544618|FG001|Overall Study|Progressive disease|2|||
127703504|NCT03287817|459544619|FG002|Overall Study|Progressive disease|3|||
127703505|NCT03287817|459544620|FG003|Overall Study|Progressive disease|10|||
127703506|NCT03287817|459544621|FG004|Overall Study|Progressive disease|8|||
127703507|NCT03287817|459544617|FG000|Overall Study|Death|0|||
127703508|NCT03287817|459544618|FG001|Overall Study|Death|0|||
127703509|NCT03287817|459544619|FG002|Overall Study|Death|2|||
127703510|NCT03287817|459544620|FG003|Overall Study|Death|3|||
127703511|NCT03287817|459544621|FG004|Overall Study|Death|4|||
127703512|NCT03287817|459544617|FG000|Overall Study|Physician Decision|0|||
127703513|NCT03287817|459544618|FG001|Overall Study|Physician Decision|0|||
127703514|NCT03287817|459544619|FG002|Overall Study|Physician Decision|0|||
127703515|NCT03287817|459544620|FG003|Overall Study|Physician Decision|1|||
127703516|NCT03287817|459544621|FG004|Overall Study|Physician Decision|0|||
127703517|NCT03287817|459544617|FG000|Overall Study|Withdrawal by Subject|0|||
127703518|NCT03287817|459544618|FG001|Overall Study|Withdrawal by Subject|0|||
127703519|NCT03287817|459544619|FG002|Overall Study|Withdrawal by Subject|0|||
127797104|NCT03178487|459881211|FG000|Period 2|Other|8|||
127797105|NCT03178487|459881212|FG001|Period 2|Other|7|||
127797106|NCT01453855|459881213|FG000|Overall Study|Adverse Event|3|||
127797107|NCT01453855|459881214|FG001|Overall Study|Adverse Event|4|||
127797108|NCT01453855|459881213|FG000|Overall Study|Lost to Follow-up|2|||
127797109|NCT01453855|459881214|FG001|Overall Study|Lost to Follow-up|1|||
127797110|NCT01453855|459881213|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
127797111|NCT01453855|459881214|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
127797112|NCT01453855|459881213|FG000|Overall Study|Noncompliance|1|||
127797113|NCT01453855|459881214|FG001|Overall Study|Noncompliance|0|||
127797114|NCT01453855|459881213|FG000|Overall Study|Inadequate Control of IOP|1|||
127797115|NCT01453855|459881214|FG001|Overall Study|Inadequate Control of IOP|5|||
127797116|NCT01453855|459881213|FG000|Overall Study|Other|0|||
127638994|NCT00319098|459298024|FG000|Overall Study|Others|33|||
127638995|NCT00319098|459298025|FG001|Overall Study|Others|8|||
127638996|NCT00319098|459298024|FG000|Overall Study|Protocol Violation|3|||
127638997|NCT00319098|459298025|FG001|Overall Study|Protocol Violation|1|||
127638998|NCT02187991|459298026|FG000|Overall Study|Adverse Event|13|||
127638999|NCT02187991|459298027|FG001|Overall Study|Adverse Event|14|||
127639000|NCT02187991|459298028|FG002|Overall Study|Adverse Event|3|||
127639001|NCT02187991|459298029|FG003|Overall Study|Adverse Event|2|||
127639002|NCT02187991|459298026|FG000|Overall Study|Withdrawal by Subject|9|||
127639003|NCT02187991|459298027|FG001|Overall Study|Withdrawal by Subject|6|||
127639004|NCT02187991|459298028|FG002|Overall Study|Withdrawal by Subject|3|||
127639005|NCT02187991|459298029|FG003|Overall Study|Withdrawal by Subject|2|||
127639006|NCT02187991|459298026|FG000|Overall Study|Physician Decision|4|||
127639007|NCT02187991|459298027|FG001|Overall Study|Physician Decision|4|||
127639008|NCT02187991|459298028|FG002|Overall Study|Physician Decision|0|||
127639009|NCT02187991|459298029|FG003|Overall Study|Physician Decision|2|||
127639010|NCT02187991|459298026|FG000|Overall Study|Other, unrelated complication|7|||
127639011|NCT02187991|459298027|FG001|Overall Study|Other, unrelated complication|1|||
127639012|NCT02187991|459298028|FG002|Overall Study|Other, unrelated complication|1|||
127639013|NCT02187991|459298029|FG003|Overall Study|Other, unrelated complication|2|||
127639014|NCT02187991|459298026|FG000|Overall Study|Death|1|||
127639015|NCT02187991|459298027|FG001|Overall Study|Death|3|||
127639016|NCT02187991|459298028|FG002|Overall Study|Death|0|||
127639017|NCT02187991|459298029|FG003|Overall Study|Death|0|||
127639018|NCT01392560|459298030|FG000|Overall Study|Adverse Event|2|||
127639019|NCT01392560|459298030|FG000|Overall Study|not entered|8|||
127639020|NCT01392560|459298030|FG000|Overall Study|discontinued during placebo run-in|2|||
127639021|NCT02199028|459298033|FG000|Week 1|Adverse Event|1|||
127639022|NCT02199028|459298034|FG001|Week 1|Adverse Event|0|||
127639023|NCT02199028|459298033|FG000|Week 3|Adverse Event|1|||
127639024|NCT02199028|459298034|FG001|Week 3|Adverse Event|0|||
127639025|NCT01881126|459298035|FG000|Overall Study|Non-compliance|1|||
127639026|NCT01881126|459298036|FG001|Overall Study|Non-compliance|1|||
127639027|NCT01881126|459298035|FG000|Overall Study|Adverse Event|0|||
127639028|NCT01881126|459298036|FG001|Overall Study|Adverse Event|1|||
127639029|NCT00522275|459298037|FG000|Overall Study|Adverse Event|35|||
127703520|NCT03287817|459544620|FG003|Overall Study|Withdrawal by Subject|0|||
127703521|NCT03287817|459544621|FG004|Overall Study|Withdrawal by Subject|4|||
127703522|NCT05251909|459544626|FG000|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
127703523|NCT05251909|459544627|FG001|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
127703524|NCT05543915|459544628|FG000|Overall Study|Lost to Follow-up|0|||
127703525|NCT05543915|459544629|FG001|Overall Study|Lost to Follow-up|1|||
127703526|NCT02993159|459544632|FG000|Overall Study|Withdrawal by Subject|1|||
127703527|NCT02993159|459544633|FG001|Overall Study|Withdrawal by Subject|3|||
127703528|NCT02993159|459544632|FG000|Overall Study|Protocol Violation|1|||
127703529|NCT02993159|459544633|FG001|Overall Study|Protocol Violation|0|||
127703530|NCT02993159|459544632|FG000|Overall Study|Opted out of surgery|2|||
127703531|NCT02993159|459544633|FG001|Overall Study|Opted out of surgery|0|||
127703532|NCT02993159|459544632|FG000|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
127703533|NCT02993159|459544633|FG001|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
127797117|NCT01453855|459881214|FG001|Overall Study|Other|1|||
127797118|NCT01562548|459881219|FG000|Overall Study|Lost to Follow-up|0|||
127797119|NCT01562548|459881220|FG001|Overall Study|Lost to Follow-up|0|||
127797120|NCT01562548|459881221|FG002|Overall Study|Lost to Follow-up|1|||
127797121|NCT01562548|459881222|FG003|Overall Study|Lost to Follow-up|0|||
127797122|NCT01496066|459881223|FG000|Overall Study|Lost to Follow-up|8|||
127797123|NCT01496066|459881224|FG001|Overall Study|Lost to Follow-up|5|||
127797124|NCT01496066|459881223|FG000|Overall Study|Explant|3|||
127639030|NCT00522275|459298037|FG000|Overall Study|Lack of Efficacy|80|||
127639031|NCT00522275|459298037|FG000|Overall Study|Subject withdrew consent|16|||
127639032|NCT00522275|459298037|FG000|Overall Study|Protocol deviation|1|||
127703534|NCT02993159|459544632|FG000|Overall Study|Physician Decision|0|||
127703535|NCT02993159|459544633|FG001|Overall Study|Physician Decision|1|||
127703536|NCT05034328|459544634|FG000|Overall Study|Protocol Violation|1|||
127703537|NCT05034328|459544635|FG001|Overall Study|Protocol Violation|0|||
127703538|NCT05034328|459544634|FG000|Overall Study|Lost to Follow-up|0|||
127703539|NCT05034328|459544635|FG001|Overall Study|Lost to Follow-up|10|||
127703540|NCT03625167|459544638|FG000|Overall Study|Protocol Violation|5|||
127703541|NCT02969707|459544641|FG000|Overall Study|Withdrawal by Subject|6|||
127703542|NCT02969707|459544642|FG001|Overall Study|Withdrawal by Subject|5|||
127703543|NCT02969707|459544641|FG000|Overall Study|Severe anxiety|0|||
127703544|NCT02969707|459544642|FG001|Overall Study|Severe anxiety|1|||
127703545|NCT02969707|459544641|FG000|Overall Study|Positive toxicology screen|0|||
127703546|NCT02969707|459544642|FG001|Overall Study|Positive toxicology screen|2|||
127703547|NCT02969707|459544641|FG000|Overall Study|Claustrophobia|2|||
127703548|NCT02969707|459544642|FG001|Overall Study|Claustrophobia|2|||
127703549|NCT02969707|459544641|FG000|Overall Study|Non-compliance|1|||
127703550|NCT02969707|459544642|FG001|Overall Study|Non-compliance|2|||
127703551|NCT04314713|459544643|FG000|Overall Study|Lost to Follow-up|0|||
127703552|NCT04314713|459544644|FG001|Overall Study|Lost to Follow-up|0|||
127703553|NCT04314713|459544645|FG002|Overall Study|Lost to Follow-up|0|||
127703554|NCT04314713|459544646|FG003|Overall Study|Lost to Follow-up|1|||
127703555|NCT04314713|459544647|FG004|Overall Study|Lost to Follow-up|0|||
127703556|NCT04314713|459544648|FG005|Overall Study|Lost to Follow-up|0|||
127703557|NCT00248287|459544653|FG000|Overall Study|Adverse Event|11|||
127703558|NCT00248287|459544654|FG001|Overall Study|Adverse Event|10|||
127703559|NCT00248287|459544653|FG000|Overall Study|Death|1|||
127703560|NCT00248287|459544654|FG001|Overall Study|Death|0|||
127703561|NCT00248287|459544653|FG000|Overall Study|Lost to Follow-up|0|||
127703562|NCT00248287|459544654|FG001|Overall Study|Lost to Follow-up|1|||
127703563|NCT00248287|459544653|FG000|Overall Study|Investigator Request|4|||
127703564|NCT00248287|459544654|FG001|Overall Study|Investigator Request|3|||
127886428|NCT00265083|460208555|FG001|Overall Study|Lost to Follow-up|4|||
127886429|NCT00265083|460208556|FG002|Overall Study|Lost to Follow-up|4|||
127886430|NCT00265083|460208554|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
127703565|NCT00248287|459544653|FG000|Overall Study|Patient Request|5|||
127703566|NCT00248287|459544654|FG001|Overall Study|Patient Request|3|||
127703567|NCT00248287|459544653|FG000|Overall Study|Other|3|||
127703568|NCT00248287|459544654|FG001|Overall Study|Other|2|||
127703569|NCT03766685|459544674|FG000|Overall Study|Lost to Follow-up|1|||
127703570|NCT03766685|459544675|FG001|Overall Study|Lost to Follow-up|1|||
127703571|NCT03766685|459544676|FG002|Overall Study|Lost to Follow-up|0|||
127703572|NCT03766685|459544677|FG003|Overall Study|Lost to Follow-up|0|||
127703573|NCT03766685|459544674|FG000|Overall Study|Adverse Event, not fatal|0|||
127703574|NCT03766685|459544675|FG001|Overall Study|Adverse Event, not fatal|1|||
127703575|NCT03766685|459544676|FG002|Overall Study|Adverse Event, not fatal|0|||
127703576|NCT03766685|459544677|FG003|Overall Study|Adverse Event, not fatal|1|||
127703577|NCT03766685|459544674|FG000|Overall Study|Withdrawal by Subject|0|||
127703578|NCT03766685|459544675|FG001|Overall Study|Withdrawal by Subject|2|||
127703579|NCT03766685|459544676|FG002|Overall Study|Withdrawal by Subject|0|||
127703580|NCT03766685|459544677|FG003|Overall Study|Withdrawal by Subject|0|||
127703581|NCT03766685|459544674|FG000|Overall Study|Protocol Violation|0|||
127703582|NCT03766685|459544675|FG001|Overall Study|Protocol Violation|1|||
127703583|NCT03766685|459544676|FG002|Overall Study|Protocol Violation|0|||
127703584|NCT03766685|459544677|FG003|Overall Study|Protocol Violation|0|||
127703585|NCT03766685|459544674|FG000|Overall Study|Non-compliance|0|||
127703586|NCT03766685|459544675|FG001|Overall Study|Non-compliance|2|||
127703587|NCT03766685|459544676|FG002|Overall Study|Non-compliance|0|||
127703588|NCT03766685|459544677|FG003|Overall Study|Non-compliance|0|||
127703589|NCT05297565|459544680|FG000|Overall Study|Other Reasons|0|||
127703590|NCT05297565|459544681|FG001|Overall Study|Other Reasons|1|||
127703591|NCT05297565|459544680|FG000|Overall Study|Physician Decision|0|||
127703592|NCT05297565|459544681|FG001|Overall Study|Physician Decision|1|||
127703593|NCT05297565|459544680|FG000|Overall Study|Disease recurrence|1|||
127703594|NCT05297565|459544681|FG001|Overall Study|Disease recurrence|0|||
127703595|NCT05940194|459544695|FG000|Overall Study|Adverse Event|0|||
127703596|NCT05940194|459544696|FG001|Overall Study|Adverse Event|1|||
127703597|NCT05940194|459544697|FG002|Overall Study|Adverse Event|0|||
127703598|NCT05940194|459544695|FG000|Overall Study|Migrated/Moved from the study area|2|||
127703599|NCT05940194|459544696|FG001|Overall Study|Migrated/Moved from the study area|2|||
127703600|NCT05940194|459544697|FG002|Overall Study|Migrated/Moved from the study area|4|||
127703601|NCT01959607|459544698|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
127703602|NCT01959607|459544699|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
127703603|NCT01959607|459544700|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
127703604|NCT01959607|459544701|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
127703605|NCT04054193|459544713|FG000|Cycle 1|Physician Decision|1|||
127703606|NCT04054193|459544713|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
127703607|NCT04054193|459544713|FG000|Cycle 1|Allocated but not treated|3|||
127703608|NCT04054193|459544713|FG000|Cycles 2-3|Physician Decision|2|||
127886431|NCT00265083|460208555|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
127639033|NCT00522275|459298037|FG000|Overall Study|Unsatisfactory compliance|11|||
127639034|NCT00522275|459298037|FG000|Overall Study|Lost to Follow-up|8|||
127639035|NCT00522275|459298037|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
127639036|NCT00522275|459298037|FG000|Overall Study|Other: Subject is pregnant|2|||
127639037|NCT00522275|459298037|FG000|Overall Study|Other: Subject relocated|2|||
127639038|NCT00522275|459298037|FG000|Overall Study|Other: Subject arrested|1|||
127639039|NCT00522275|459298037|FG000|Overall Study|Other: Site / clinic closed|4|||
127639040|NCT00522275|459298037|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
127639041|NCT00522275|459298037|FG000|Overall Study|Other: Sponsor request|2|||
127639042|NCT00522275|459298037|FG000|Overall Study|Other: Subject ran out of medication|1|||
127639043|NCT00522275|459298037|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
127639044|NCT02341417|459298038|FG000|Overall Study|Withdrawal by Subject|0|||
127639045|NCT02341417|459298039|FG001|Overall Study|Withdrawal by Subject|2|||
127639046|NCT02341417|459298040|FG002|Overall Study|Withdrawal by Subject|0|||
127639047|NCT02341417|459298038|FG000|Overall Study|Decision by sponsor|2|||
127639048|NCT02341417|459298039|FG001|Overall Study|Decision by sponsor|0|||
127639049|NCT02341417|459298040|FG002|Overall Study|Decision by sponsor|0|||
127639050|NCT02341417|459298038|FG000|Overall Study|Death|0|||
127639051|NCT02341417|459298039|FG001|Overall Study|Death|0|||
127639052|NCT02341417|459298040|FG002|Overall Study|Death|1|||
127639053|NCT04773587|459298043|FG000|Overall Study|Lost to Follow-up|11|||
127639054|NCT04773587|459298044|FG001|Overall Study|Lost to Follow-up|3|||
127639055|NCT04773587|459298043|FG000|Overall Study|Adverse Event|6|||
127639056|NCT04773587|459298044|FG001|Overall Study|Adverse Event|3|||
127639057|NCT04773587|459298043|FG000|Overall Study|Lack of Efficacy|5|||
127639058|NCT04773587|459298044|FG001|Overall Study|Lack of Efficacy|2|||
127639059|NCT04773587|459298043|FG000|Overall Study|Withdrawal by Subject|4|||
127639060|NCT04773587|459298044|FG001|Overall Study|Withdrawal by Subject|5|||
127639061|NCT04773587|459298043|FG000|Overall Study|Noncompliance|1|||
127639062|NCT04773587|459298044|FG001|Overall Study|Noncompliance|0|||
127639063|NCT04773587|459298043|FG000|Overall Study|Protocol Violation|1|||
127639064|NCT04773587|459298044|FG001|Overall Study|Protocol Violation|0|||
127639065|NCT04773587|459298043|FG000|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|1|||
127797125|NCT01496066|459881224|FG001|Overall Study|Explant|0|||
127797126|NCT01496066|459881223|FG000|Overall Study|Death|1|||
127797127|NCT01496066|459881224|FG001|Overall Study|Death|4|||
127797128|NCT00493038|459881225|FG000|Treatment|Adverse Event|8|||
127797129|NCT00493038|459881226|FG001|Treatment|Adverse Event|4|||
127797130|NCT00493038|459881225|FG000|Treatment|Lost to Follow-up|5|||
127797131|NCT00493038|459881226|FG001|Treatment|Lost to Follow-up|3|||
127797132|NCT00493038|459881225|FG000|Treatment|Withdrawal by Subject|11|||
127797133|NCT00493038|459881226|FG001|Treatment|Withdrawal by Subject|12|||
127797134|NCT00493038|459881225|FG000|Treatment|Other|0|||
127797135|NCT00493038|459881226|FG001|Treatment|Other|1|||
127797136|NCT00493038|459881225|FG000|Follow-up|Lost to Follow-up|1|||
127797137|NCT00493038|459881226|FG001|Follow-up|Lost to Follow-up|0|||
127797138|NCT01847885|459881228|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
127797139|NCT01847885|459881229|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
127797140|NCT01847885|459881230|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
127797141|NCT01847885|459881228|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
127797142|NCT01847885|459881229|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
127797143|NCT01847885|459881230|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
127797144|NCT01847885|459881228|FG000|Initial Enrollment (Consented)|Screen failure|39|||
127797145|NCT01847885|459881229|FG001|Initial Enrollment (Consented)|Screen failure|0|||
127797146|NCT01847885|459881230|FG002|Initial Enrollment (Consented)|Screen failure|0|||
127797147|NCT01847885|459881228|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
127797148|NCT01847885|459881229|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
127797149|NCT01847885|459881230|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
127797150|NCT01847885|459881228|FG000|Randomization|Protocol Violation|0|||
127797151|NCT01847885|459881229|FG001|Randomization|Protocol Violation|1|||
127797152|NCT01847885|459881230|FG002|Randomization|Protocol Violation|0|||
127639066|NCT04773587|459298044|FG001|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|0|||
127797153|NCT01847885|459881228|FG000|Randomization|Withdrawal by Subject|0|||
127797154|NCT01847885|459881229|FG001|Randomization|Withdrawal by Subject|0|||
127797155|NCT01847885|459881230|FG002|Randomization|Withdrawal by Subject|2|||
127797156|NCT01847885|459881228|FG000|Randomization|Screen Failure|0|||
127797157|NCT01847885|459881229|FG001|Randomization|Screen Failure|3|||
127797158|NCT01847885|459881230|FG002|Randomization|Screen Failure|0|||
127797159|NCT02161211|459881234|FG000|Overall Study|Lost to Follow-up|21|||
127797160|NCT02161211|459881235|FG001|Overall Study|Lost to Follow-up|27|||
127639067|NCT01808313|459298045|FG000|Overall Study|Adverse Event|5|||
127797161|NCT02161211|459881236|FG002|Overall Study|Lost to Follow-up|21|||
127797162|NCT02161211|459881234|FG000|Overall Study|Dropped|12|||
127797163|NCT02161211|459881235|FG001|Overall Study|Dropped|5|||
127886432|NCT00265083|460208556|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
127797164|NCT02161211|459881236|FG002|Overall Study|Dropped|9|||
127797165|NCT03728309|459881237|FG000|Overall Study|Randomized but not Treated|0|||
127797166|NCT03728309|459881238|FG001|Overall Study|Randomized but not Treated|1|||
127639068|NCT01808313|459298045|FG000|Overall Study|Protocol Violation|2|||
127639069|NCT01808313|459298045|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
127639070|NCT01808313|459298045|FG000|Overall Study|Lost to Follow-up|1|||
127639071|NCT01808313|459298045|FG000|Overall Study|Physician Decision|1|||
127639072|NCT04656847|459298047|FG000|3 Month After Inclusion|lack of data on myocardial infarction and/or data by visits|23|||
127639073|NCT03301051|459298048|FG000|Overall Study|Adverse Event|0|||
127639074|NCT03301051|459298049|FG001|Overall Study|Adverse Event|4|||
127639075|NCT03301051|459298048|FG000|Overall Study|Withdrawal by Subject|59|||
127639076|NCT03301051|459298049|FG001|Overall Study|Withdrawal by Subject|65|||
127639077|NCT03301051|459298048|FG000|Overall Study|Lost to Follow-up|263|||
127639078|NCT03301051|459298049|FG001|Overall Study|Lost to Follow-up|282|||
127639079|NCT03301051|459298048|FG000|Overall Study|Protocol Violation|1|||
127639080|NCT03301051|459298049|FG001|Overall Study|Protocol Violation|3|||
127639081|NCT03301051|459298048|FG000|Overall Study|Physician Decision|1|||
127639082|NCT03301051|459298049|FG001|Overall Study|Physician Decision|3|||
127639083|NCT03301051|459298048|FG000|Overall Study|Death|1|||
127639084|NCT03301051|459298049|FG001|Overall Study|Death|1|||
127639085|NCT03301051|459298048|FG000|Overall Study|Miscellaneous|8|||
127639086|NCT03301051|459298049|FG001|Overall Study|Miscellaneous|4|||
127639087|NCT03301051|459298048|FG000|Overall Study|Randomized, not vaccinated|13|||
127639088|NCT03301051|459298049|FG001|Overall Study|Randomized, not vaccinated|10|||
127639089|NCT00047879|459298050|FG000|Overall Study|Progressive disease|4|||
127639090|NCT00047879|459298051|FG001|Overall Study|Progressive disease|3|||
127639091|NCT00622167|459298052|FG000|Overall Study|Did not meet angiographic criteria|20|||
127639092|NCT01954017|459298055|FG000|Overall Study|Adverse Event|0|||
127639093|NCT01954017|459298056|FG001|Overall Study|Adverse Event|0|||
127639094|NCT01954017|459298057|FG002|Overall Study|Adverse Event|1|||
127639095|NCT01954017|459298055|FG000|Overall Study|Death|2|||
127639096|NCT01954017|459298056|FG001|Overall Study|Death|1|||
127639097|NCT01954017|459298057|FG002|Overall Study|Death|1|||
127639098|NCT01954017|459298055|FG000|Overall Study|Withdrawal by Subject|0|||
127639099|NCT01954017|459298056|FG001|Overall Study|Withdrawal by Subject|1|||
127639100|NCT01954017|459298057|FG002|Overall Study|Withdrawal by Subject|0|||
127639101|NCT01954017|459298055|FG000|Overall Study|Protocol Violation|0|||
127639102|NCT01954017|459298056|FG001|Overall Study|Protocol Violation|3|||
127797167|NCT03728309|459881237|FG000|Overall Study|Adverse Event|0|||
127797168|NCT03728309|459881238|FG001|Overall Study|Adverse Event|1|||
127797169|NCT03728309|459881237|FG000|Overall Study|Withdrawal by Subject|2|||
127797170|NCT03728309|459881238|FG001|Overall Study|Withdrawal by Subject|8|||
127639103|NCT01954017|459298057|FG002|Overall Study|Protocol Violation|2|||
127639104|NCT01954017|459298055|FG000|Overall Study|Necrotizing enterocolitis|1|||
127639105|NCT01954017|459298056|FG001|Overall Study|Necrotizing enterocolitis|0|||
127639106|NCT01954017|459298057|FG002|Overall Study|Necrotizing enterocolitis|1|||
127797171|NCT03728309|459881237|FG000|Overall Study|Lost to Follow-up|9|||
127639107|NCT01954017|459298055|FG000|Overall Study|Enteral intake stopped >7 days|0|||
127639108|NCT01954017|459298056|FG001|Overall Study|Enteral intake stopped >7 days|1|||
127639109|NCT01954017|459298057|FG002|Overall Study|Enteral intake stopped >7 days|1|||
127639110|NCT01954017|459298055|FG000|Overall Study|All other reasons|2|||
127639111|NCT01954017|459298056|FG001|Overall Study|All other reasons|2|||
127639112|NCT01954017|459298057|FG002|Overall Study|All other reasons|7|||
127639113|NCT00714168|459298064|FG000|Overall Study|Pregnancy|5|||
127639114|NCT00714168|459298065|FG001|Overall Study|Pregnancy|4|||
127639115|NCT00714168|459298064|FG000|Overall Study|Lost to Follow-up|32|||
127639116|NCT00714168|459298065|FG001|Overall Study|Lost to Follow-up|50|||
127639117|NCT00714168|459298064|FG000|Overall Study|Relocation|4|||
127639118|NCT00714168|459298065|FG001|Overall Study|Relocation|3|||
127639119|NCT00714168|459298064|FG000|Overall Study|Non-study medical condition|3|||
127639120|NCT00714168|459298065|FG001|Overall Study|Non-study medical condition|2|||
127639121|NCT02653482|459298070|FG000|Overall Study|Death|1|||
127639122|NCT02653482|459298071|FG001|Overall Study|Death|1|||
127639123|NCT03230916|459298074|FG000|Overall Study|Withdrawal by Subject|0|||
127639124|NCT03230916|459298075|FG001|Overall Study|Withdrawal by Subject|0|||
127639125|NCT03230916|459298076|FG002|Overall Study|Withdrawal by Subject|0|||
127639126|NCT03230916|459298077|FG003|Overall Study|Withdrawal by Subject|0|||
127639127|NCT03230916|459298078|FG004|Overall Study|Withdrawal by Subject|0|||
127639128|NCT03230916|459298079|FG005|Overall Study|Withdrawal by Subject|1|||
127639129|NCT03230916|459298080|FG006|Overall Study|Withdrawal by Subject|0|||
127639130|NCT03230916|459298081|FG007|Overall Study|Withdrawal by Subject|0|||
127639131|NCT03230916|459298082|FG008|Overall Study|Withdrawal by Subject|0|||
127639132|NCT03230916|459298083|FG009|Overall Study|Withdrawal by Subject|0|||
127639133|NCT03230916|459298084|FG010|Overall Study|Withdrawal by Subject|0|||
127639134|NCT04370054|459298085|FG000|Treatment Phase|Lost to Follow-up|1|||
127639135|NCT04370054|459298085|FG000|Treatment Phase|Withdrawal by Subject|1|||
127639136|NCT04370054|459298085|FG000|Follow-Up Phase|Ongoing|75|||
127639137|NCT06273774|459298086|FG000|Overall Study|Participant was out of state.|0|||
127639138|NCT06273774|459298087|FG001|Overall Study|Participant was out of state.|0|||
127639139|NCT06273774|459298088|FG002|Overall Study|Participant was out of state.|0|||
127639140|NCT06273774|459298089|FG003|Overall Study|Participant was out of state.|0|||
127639141|NCT06273774|459298090|FG004|Overall Study|Participant was out of state.|0|||
127639142|NCT06273774|459298091|FG005|Overall Study|Participant was out of state.|1|||
127639143|NCT06273774|459298086|FG000|Overall Study|Lost to Follow-up|0|||
127639144|NCT06273774|459298087|FG001|Overall Study|Lost to Follow-up|0|||
127639145|NCT06273774|459298088|FG002|Overall Study|Lost to Follow-up|0|||
127639146|NCT06273774|459298089|FG003|Overall Study|Lost to Follow-up|0|||
127639147|NCT06273774|459298090|FG004|Overall Study|Lost to Follow-up|1|||
127639148|NCT06273774|459298091|FG005|Overall Study|Lost to Follow-up|0|||
127639149|NCT01625897|459300409|FG000|Overall Study|Adverse Event|27|||
127639150|NCT01625897|459300410|FG001|Overall Study|Adverse Event|10|||
127639151|NCT01625897|459300409|FG000|Overall Study|Physician Decision|0|||
127639152|NCT01625897|459300410|FG001|Overall Study|Physician Decision|1|||
127639153|NCT01625897|459300409|FG000|Overall Study|Withdrawal by Subject|25|||
127639154|NCT01625897|459300410|FG001|Overall Study|Withdrawal by Subject|3|||
127639155|NCT01912612|459300413|FG000|Overall Study|Adverse Event|4|||
127639156|NCT01912612|459300414|FG001|Overall Study|Adverse Event|0|||
127639157|NCT01912612|459300415|FG002|Overall Study|Adverse Event|0|||
127639158|NCT01912612|459300413|FG000|Overall Study|Withdrew consent|1|||
127639159|NCT01912612|459300414|FG001|Overall Study|Withdrew consent|0|||
127639160|NCT01912612|459300415|FG002|Overall Study|Withdrew consent|0|||
127639161|NCT01912612|459300413|FG000|Overall Study|Study design change|0|||
127639162|NCT01912612|459300414|FG001|Overall Study|Study design change|0|||
127639163|NCT01912612|459300415|FG002|Overall Study|Study design change|3|||
127639164|NCT01588184|459300416|FG000|Overall Study|Death|1|||
127639165|NCT01588184|459300417|FG001|Overall Study|Death|0|||
127639166|NCT01588184|459300418|FG002|Overall Study|Death|0|||
127797172|NCT03728309|459881238|FG001|Overall Study|Lost to Follow-up|10|||
127797173|NCT03728309|459881237|FG000|Overall Study|Protocol Deviation|0|||
127797174|NCT03728309|459881238|FG001|Overall Study|Protocol Deviation|1|||
127797175|NCT03728309|459881237|FG000|Overall Study|Due to COVID|1|||
127797176|NCT03728309|459881238|FG001|Overall Study|Due to COVID|3|||
127797177|NCT00953758|459881241|FG000|Overall Study|Death|2|||
127639167|NCT01588184|459300419|FG003|Overall Study|Death|1|||
127797178|NCT00953758|459881242|FG001|Overall Study|Death|0|||
127797179|NCT00953758|459881243|FG002|Overall Study|Death|1|||
127797180|NCT00953758|459881244|FG003|Overall Study|Death|1|||
127797181|NCT00953758|459881245|FG004|Overall Study|Death|1|||
127797182|NCT00953758|459881246|FG005|Overall Study|Death|1|||
127639168|NCT01588184|459300420|FG004|Overall Study|Death|1|||
127639169|NCT01588184|459300421|FG005|Overall Study|Death|1|||
127639170|NCT01588184|459300416|FG000|Overall Study|Withdrawal by Subject|2|||
127639171|NCT01588184|459300417|FG001|Overall Study|Withdrawal by Subject|4|||
127639172|NCT01588184|459300418|FG002|Overall Study|Withdrawal by Subject|0|||
127639173|NCT01588184|459300419|FG003|Overall Study|Withdrawal by Subject|1|||
127639174|NCT01588184|459300420|FG004|Overall Study|Withdrawal by Subject|0|||
127639175|NCT01588184|459300421|FG005|Overall Study|Withdrawal by Subject|0|||
127797183|NCT00953758|459881247|FG006|Overall Study|Death|1|||
127703609|NCT04054193|459544713|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
127703610|NCT04054193|459544713|FG000|Cycles 2-3|Various reasons|17|||
127703611|NCT02966873|459544714|FG000|Overall Study|Lost to Follow-up|16|||
127703612|NCT02966873|459544715|FG001|Overall Study|Lost to Follow-up|15|||
127703613|NCT03084536|459544716|FG000|Overall Study|Determined to be ineligible|0|||
127703614|NCT03084536|459544717|FG001|Overall Study|Determined to be ineligible|0|||
127703615|NCT03084536|459544718|FG002|Overall Study|Determined to be ineligible|16|||
127703616|NCT03084536|459544716|FG000|Overall Study|Withdrawal by Subject|0|||
127703617|NCT03084536|459544717|FG001|Overall Study|Withdrawal by Subject|0|||
127703618|NCT03084536|459544718|FG002|Overall Study|Withdrawal by Subject|4|||
127703619|NCT03084536|459544716|FG000|Overall Study|Physician Decision|0|||
127703620|NCT03084536|459544717|FG001|Overall Study|Physician Decision|0|||
127703621|NCT03084536|459544718|FG002|Overall Study|Physician Decision|3|||
127703622|NCT03084536|459544716|FG000|Overall Study|Death|0|||
127703623|NCT03084536|459544717|FG001|Overall Study|Death|0|||
127703624|NCT03084536|459544718|FG002|Overall Study|Death|1|||
127703625|NCT03084536|459544716|FG000|Overall Study|Lost to Follow-up|0|||
127703626|NCT03084536|459544717|FG001|Overall Study|Lost to Follow-up|0|||
127703627|NCT03084536|459544718|FG002|Overall Study|Lost to Follow-up|1|||
127703628|NCT03084536|459544716|FG000|Overall Study|Protocol Violation|0|||
127703629|NCT03084536|459544717|FG001|Overall Study|Protocol Violation|0|||
127703630|NCT03084536|459544718|FG002|Overall Study|Protocol Violation|1|||
127703631|NCT03084536|459544716|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
127703632|NCT03084536|459544717|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
127703633|NCT03084536|459544718|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
127639176|NCT01588184|459300416|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
127639177|NCT01588184|459300417|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
127639178|NCT01588184|459300418|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
127639179|NCT01588184|459300419|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
127639180|NCT01588184|459300420|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
127639181|NCT01588184|459300421|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
127639182|NCT01588184|459300416|FG000|Overall Study|multiple reasons|0|||
127639183|NCT01588184|459300417|FG001|Overall Study|multiple reasons|3|||
127639184|NCT01588184|459300418|FG002|Overall Study|multiple reasons|0|||
127639185|NCT01588184|459300419|FG003|Overall Study|multiple reasons|1|||
127639186|NCT01588184|459300420|FG004|Overall Study|multiple reasons|0|||
127639187|NCT01588184|459300421|FG005|Overall Study|multiple reasons|0|||
127639188|NCT02008890|459300423|FG000|Period 1|Withdrawal by Subject|7|||
127639189|NCT02008890|459300424|FG001|Period 1|Withdrawal by Subject|7|||
127639190|NCT02008890|459300425|FG002|Period 1|Withdrawal by Subject|5|||
127639191|NCT02008890|459300426|FG003|Period 1|Withdrawal by Subject|0|||
127639192|NCT02008890|459300427|FG004|Period 1|Withdrawal by Subject|0|||
127639193|NCT02008890|459300423|FG000|Period 1|Pregnancy|1|||
127639194|NCT02008890|459300424|FG001|Period 1|Pregnancy|0|||
127639195|NCT02008890|459300425|FG002|Period 1|Pregnancy|0|||
127639196|NCT02008890|459300426|FG003|Period 1|Pregnancy|0|||
127639197|NCT02008890|459300427|FG004|Period 1|Pregnancy|0|||
127639198|NCT02008890|459300423|FG000|Period 1|Physician Decision|1|||
127639199|NCT02008890|459300424|FG001|Period 1|Physician Decision|0|||
127639200|NCT02008890|459300425|FG002|Period 1|Physician Decision|1|||
127639201|NCT02008890|459300426|FG003|Period 1|Physician Decision|0|||
127639202|NCT02008890|459300427|FG004|Period 1|Physician Decision|0|||
127639203|NCT02008890|459300423|FG000|Period 1|Adverse Event|6|||
127639204|NCT02008890|459300424|FG001|Period 1|Adverse Event|8|||
127639205|NCT02008890|459300425|FG002|Period 1|Adverse Event|6|||
127639206|NCT02008890|459300426|FG003|Period 1|Adverse Event|0|||
127703634|NCT03235544|459544729|FG000|Overall Study|Death|11|||
127703635|NCT03235544|459544730|FG001|Overall Study|Death|31|||
127703636|NCT03235544|459544731|FG002|Overall Study|Death|19|||
127703637|NCT03235544|459544732|FG003|Overall Study|Death|34|||
127703638|NCT03235544|459544729|FG000|Overall Study|Lost to Follow-up|0|||
127639207|NCT02008890|459300427|FG004|Period 1|Adverse Event|0|||
127639208|NCT02008890|459300423|FG000|Period 2|Adverse Event|12|||
127703639|NCT03235544|459544730|FG001|Overall Study|Lost to Follow-up|1|||
127703640|NCT03235544|459544731|FG002|Overall Study|Lost to Follow-up|1|||
127703641|NCT03235544|459544732|FG003|Overall Study|Lost to Follow-up|1|||
127703642|NCT03235544|459544729|FG000|Overall Study|Withdrawal by Subject|0|||
127639209|NCT02008890|459300424|FG001|Period 2|Adverse Event|7|||
127639210|NCT02008890|459300425|FG002|Period 2|Adverse Event|0|||
127639211|NCT02008890|459300426|FG003|Period 2|Adverse Event|5|||
127639212|NCT02008890|459300427|FG004|Period 2|Adverse Event|5|||
127639213|NCT02008890|459300423|FG000|Period 2|Withdrawal by Subject|11|||
127703643|NCT03235544|459544730|FG001|Overall Study|Withdrawal by Subject|3|||
127703644|NCT03235544|459544731|FG002|Overall Study|Withdrawal by Subject|1|||
127639214|NCT02008890|459300424|FG001|Period 2|Withdrawal by Subject|8|||
127639215|NCT02008890|459300425|FG002|Period 2|Withdrawal by Subject|0|||
127639216|NCT02008890|459300426|FG003|Period 2|Withdrawal by Subject|7|||
127639217|NCT02008890|459300427|FG004|Period 2|Withdrawal by Subject|2|||
127639218|NCT02008890|459300423|FG000|Period 2|Physician Decision|4|||
127639219|NCT02008890|459300424|FG001|Period 2|Physician Decision|0|||
127639220|NCT02008890|459300425|FG002|Period 2|Physician Decision|0|||
127639221|NCT02008890|459300426|FG003|Period 2|Physician Decision|2|||
127639222|NCT02008890|459300427|FG004|Period 2|Physician Decision|1|||
127639223|NCT02008890|459300423|FG000|Period 2|Lost to Follow-up|0|||
127639224|NCT02008890|459300424|FG001|Period 2|Lost to Follow-up|0|||
127639225|NCT02008890|459300425|FG002|Period 2|Lost to Follow-up|1|||
127639226|NCT02008890|459300426|FG003|Period 2|Lost to Follow-up|0|||
127639227|NCT02008890|459300427|FG004|Period 2|Lost to Follow-up|0|||
127639228|NCT02008890|459300423|FG000|Extension Period|Withdrawal by Subject|3|||
127639229|NCT02008890|459300424|FG001|Extension Period|Withdrawal by Subject|2|||
127639230|NCT02008890|459300425|FG002|Extension Period|Withdrawal by Subject|0|||
127639231|NCT02008890|459300426|FG003|Extension Period|Withdrawal by Subject|4|||
127639232|NCT02008890|459300427|FG004|Extension Period|Withdrawal by Subject|2|||
127639233|NCT02008890|459300423|FG000|Extension Period|Lost to Follow-up|1|||
127639234|NCT02008890|459300424|FG001|Extension Period|Lost to Follow-up|0|||
127639235|NCT02008890|459300425|FG002|Extension Period|Lost to Follow-up|0|||
127639236|NCT02008890|459300426|FG003|Extension Period|Lost to Follow-up|0|||
127639237|NCT02008890|459300427|FG004|Extension Period|Lost to Follow-up|0|||
127639238|NCT02008890|459300423|FG000|Extension Period|Adverse Event|1|||
127639239|NCT02008890|459300424|FG001|Extension Period|Adverse Event|3|||
127639240|NCT02008890|459300425|FG002|Extension Period|Adverse Event|0|||
127639241|NCT02008890|459300426|FG003|Extension Period|Adverse Event|0|||
127639242|NCT02008890|459300427|FG004|Extension Period|Adverse Event|2|||
127639243|NCT02207816|459300428|FG000|Overall Study|Serious Adverse Event|0|||
127639244|NCT02207816|459300429|FG001|Overall Study|Serious Adverse Event|5|||
127639245|NCT02207816|459300430|FG002|Overall Study|Serious Adverse Event|2|||
127639246|NCT02207816|459300428|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
127639247|NCT02207816|459300429|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
127639248|NCT02207816|459300430|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
127639249|NCT02207816|459300428|FG000|Overall Study|Withdrawal by Subject|4|||
127639250|NCT02207816|459300429|FG001|Overall Study|Withdrawal by Subject|9|||
127639251|NCT02207816|459300430|FG002|Overall Study|Withdrawal by Subject|7|||
127639252|NCT02207816|459300428|FG000|Overall Study|Migrated/Moved From Study Area|41|||
127639253|NCT02207816|459300429|FG001|Overall Study|Migrated/Moved From Study Area|60|||
127639254|NCT02207816|459300430|FG002|Overall Study|Migrated/Moved From Study Area|51|||
127639255|NCT02207816|459300428|FG000|Overall Study|Lost to Follow-up|3|||
127639256|NCT02207816|459300429|FG001|Overall Study|Lost to Follow-up|9|||
127639257|NCT02207816|459300430|FG002|Overall Study|Lost to Follow-up|1|||
127639258|NCT02207816|459300428|FG000|Overall Study|Other|1|||
127639259|NCT02207816|459300429|FG001|Overall Study|Other|2|||
127639260|NCT02207816|459300430|FG002|Overall Study|Other|4|||
127639261|NCT05912400|459300431|FG000|Overall Study|Lost to Follow-up|1|||
127639262|NCT05912400|459300432|FG001|Overall Study|Lost to Follow-up|0|||
127639263|NCT05912400|459300431|FG000|Overall Study|Physician Decision|6|||
127639264|NCT05912400|459300432|FG001|Overall Study|Physician Decision|0|||
127639265|NCT05912400|459300431|FG000|Overall Study|Withdrawal by Subject|1|||
127639266|NCT05912400|459300432|FG001|Overall Study|Withdrawal by Subject|0|||
127639267|NCT02522494|459300435|FG000|Overall Study|Lost to Follow-up|6|||
127639268|NCT02522494|459300436|FG001|Overall Study|Lost to Follow-up|2|||
127639269|NCT02522494|459300435|FG000|Overall Study|Withdrawal by Subject|1|||
127639270|NCT02522494|459300436|FG001|Overall Study|Withdrawal by Subject|0|||
127639271|NCT02522494|459300435|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
127639272|NCT02522494|459300436|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
127639273|NCT02522494|459300435|FG000|Overall Study|Participant did not watch the video|1|||
127639274|NCT02522494|459300436|FG001|Overall Study|Participant did not watch the video|0|||
127639275|NCT02522494|459300435|FG000|Overall Study|Death|0|||
127639276|NCT02522494|459300436|FG001|Overall Study|Death|1|||
127639277|NCT03461003|459300439|FG000|Overall Study|Lost to Follow-up|2|||
127639278|NCT03461003|459300440|FG001|Overall Study|Lost to Follow-up|2|||
127639279|NCT03461003|459300439|FG000|Overall Study|Withdrawal by Subject|3|||
127639280|NCT03461003|459300440|FG001|Overall Study|Withdrawal by Subject|1|||
127639281|NCT03489304|459300441|FG000|Overall Study|Lost to Follow-up|4|||
127639282|NCT02239679|459300445|FG000|Overall Study|Lost to Follow-up|1|||
127639283|NCT02239679|459300446|FG001|Overall Study|Lost to Follow-up|0|||
127703645|NCT03235544|459544732|FG003|Overall Study|Withdrawal by Subject|5|||
127703646|NCT03235544|459544729|FG000|Overall Study|Disease Progression|0|||
127703647|NCT03235544|459544730|FG001|Overall Study|Disease Progression|1|||
127703648|NCT03235544|459544731|FG002|Overall Study|Disease Progression|0|||
127639284|NCT02239679|459300447|FG002|Overall Study|Lost to Follow-up|0|||
127639285|NCT02239679|459300445|FG000|Overall Study|Withdrawal by Subject|2|||
127703649|NCT03235544|459544732|FG003|Overall Study|Disease Progression|2|||
127639286|NCT02239679|459300446|FG001|Overall Study|Withdrawal by Subject|3|||
127639287|NCT02239679|459300447|FG002|Overall Study|Withdrawal by Subject|1|||
127639288|NCT02047045|459300448|FG000|Baseline|Withdrawal by Subject|3|||
127639289|NCT02047045|459300449|FG001|Baseline|Withdrawal by Subject|2|||
127639290|NCT02047045|459300448|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
127639291|NCT02047045|459300449|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
127639292|NCT02047045|459300448|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
127639293|NCT02047045|459300449|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
127639294|NCT02047045|459300448|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
127639295|NCT02047045|459300449|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
127639296|NCT02047045|459300448|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
127639297|NCT02047045|459300449|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
127639298|NCT02047045|459300448|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
127639299|NCT02047045|459300449|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
127639300|NCT02047045|459300448|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
127639301|NCT02047045|459300449|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
127639302|NCT02047045|459300448|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
127639303|NCT02047045|459300449|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
127639304|NCT02047045|459300448|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
127639305|NCT02047045|459300449|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
127639306|NCT02564523|459300450|FG000|Overall Study|Withdrawal by Subject|3|||
127639307|NCT02564523|459300451|FG001|Overall Study|Withdrawal by Subject|0|||
127639308|NCT02564523|459300452|FG002|Overall Study|Withdrawal by Subject|1|||
127639309|NCT02564523|459300453|FG003|Overall Study|Withdrawal by Subject|0|||
127639310|NCT02564523|459300454|FG004|Overall Study|Withdrawal by Subject|1|||
127639311|NCT02564523|459300455|FG005|Overall Study|Withdrawal by Subject|0|||
127639312|NCT02564523|459300456|FG006|Overall Study|Withdrawal by Subject|1|||
127639313|NCT02564523|459300457|FG007|Overall Study|Withdrawal by Subject|0|||
127639314|NCT02564523|459300458|FG008|Overall Study|Withdrawal by Subject|0|||
127639315|NCT02564523|459300459|FG009|Overall Study|Withdrawal by Subject|0|||
127639316|NCT02564523|459300460|FG010|Overall Study|Withdrawal by Subject|1|||
127639317|NCT02564523|459300461|FG011|Overall Study|Withdrawal by Subject|0|||
127639318|NCT02564523|459300462|FG012|Overall Study|Withdrawal by Subject|1|||
127639319|NCT02564523|459300463|FG013|Overall Study|Withdrawal by Subject|0|||
127639320|NCT02564523|459300464|FG014|Overall Study|Withdrawal by Subject|0|||
127639321|NCT02564523|459300465|FG015|Overall Study|Withdrawal by Subject|0|||
127639322|NCT02564523|459300466|FG016|Overall Study|Withdrawal by Subject|0|||
127639323|NCT02564523|459300467|FG017|Overall Study|Withdrawal by Subject|0|||
127639324|NCT02564523|459300450|FG000|Overall Study|Adverse Event|0|||
127639325|NCT02564523|459300451|FG001|Overall Study|Adverse Event|0|||
127639326|NCT02564523|459300452|FG002|Overall Study|Adverse Event|0|||
127639327|NCT02564523|459300453|FG003|Overall Study|Adverse Event|0|||
127639328|NCT02564523|459300454|FG004|Overall Study|Adverse Event|0|||
127639329|NCT02564523|459300455|FG005|Overall Study|Adverse Event|0|||
127639330|NCT02564523|459300456|FG006|Overall Study|Adverse Event|0|||
127639331|NCT02564523|459300457|FG007|Overall Study|Adverse Event|0|||
127639332|NCT02564523|459300458|FG008|Overall Study|Adverse Event|0|||
127639333|NCT02564523|459300459|FG009|Overall Study|Adverse Event|0|||
127639334|NCT02564523|459300460|FG010|Overall Study|Adverse Event|0|||
127639335|NCT02564523|459300461|FG011|Overall Study|Adverse Event|0|||
127639336|NCT02564523|459300462|FG012|Overall Study|Adverse Event|0|||
127639337|NCT02564523|459300463|FG013|Overall Study|Adverse Event|0|||
127639338|NCT02564523|459300464|FG014|Overall Study|Adverse Event|0|||
127639339|NCT02564523|459300465|FG015|Overall Study|Adverse Event|0|||
127639340|NCT02564523|459300466|FG016|Overall Study|Adverse Event|0|||
127639341|NCT02564523|459300467|FG017|Overall Study|Adverse Event|1|||
127703650|NCT03235544|459544729|FG000|Overall Study|Participant Transitioned to Rollover Protocol|0|||
127703651|NCT03235544|459544730|FG001|Overall Study|Participant Transitioned to Rollover Protocol|0|||
127703652|NCT03235544|459544731|FG002|Overall Study|Participant Transitioned to Rollover Protocol|2|||
127703653|NCT03235544|459544732|FG003|Overall Study|Participant Transitioned to Rollover Protocol|5|||
127639342|NCT02564523|459300450|FG000|Overall Study|Death|0|||
127639343|NCT02564523|459300451|FG001|Overall Study|Death|0|||
127639344|NCT02564523|459300452|FG002|Overall Study|Death|0|||
127639345|NCT02564523|459300453|FG003|Overall Study|Death|0|||
127639346|NCT02564523|459300454|FG004|Overall Study|Death|0|||
127639347|NCT02564523|459300455|FG005|Overall Study|Death|0|||
127639348|NCT02564523|459300456|FG006|Overall Study|Death|1|||
127639349|NCT02564523|459300457|FG007|Overall Study|Death|0|||
127639350|NCT02564523|459300458|FG008|Overall Study|Death|0|||
127639351|NCT02564523|459300459|FG009|Overall Study|Death|0|||
127639352|NCT02564523|459300460|FG010|Overall Study|Death|1|||
127639353|NCT02564523|459300461|FG011|Overall Study|Death|0|||
127639354|NCT02564523|459300462|FG012|Overall Study|Death|0|||
127639355|NCT02564523|459300463|FG013|Overall Study|Death|0|||
127639356|NCT02564523|459300464|FG014|Overall Study|Death|0|||
127639357|NCT02564523|459300465|FG015|Overall Study|Death|0|||
127703654|NCT03235544|459544729|FG000|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
127703655|NCT03235544|459544730|FG001|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
127703656|NCT03235544|459544731|FG002|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
127703657|NCT03235544|459544732|FG003|Overall Study|Discomfort, Pain, and Radiographic Advancement|1|||
127703658|NCT04830800|459544733|FG000|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|2|||
127703659|NCT04830800|459544734|FG001|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
127703660|NCT04830800|459544735|FG002|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
127703661|NCT04830800|459544736|FG003|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
127703662|NCT04830800|459544737|FG004|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
127703663|NCT03816332|459544740|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
127703664|NCT03816332|459544740|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
127703665|NCT01456949|459544741|FG000|Enrollment|PI death- incomplete data|6|||
127703666|NCT01456949|459544741|FG000|Enrollment|Death|1|||
127703667|NCT01456949|459544741|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
127703668|NCT01456949|459544741|FG000|Enrollment|Physician Decision|10|||
127703669|NCT01456949|459544741|FG000|Enrollment|Withdrawal by Subject|7|||
127703670|NCT01456949|459544741|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
127703671|NCT01456949|459544741|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
127703672|NCT01456949|459544741|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
127703673|NCT01456949|459544741|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
127703674|NCT01456949|459544741|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
127703675|NCT01456949|459544741|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
127703676|NCT01456949|459544741|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
127703677|NCT01456949|459544741|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
127703678|NCT03710603|459544742|FG000|Overall Study|Adverse Event|1|||
127703679|NCT03710603|459544743|FG001|Overall Study|Adverse Event|0|||
127703680|NCT03710603|459544742|FG000|Overall Study|Death|44|||
127703681|NCT03710603|459544743|FG001|Overall Study|Death|34|||
127703682|NCT03710603|459544742|FG000|Overall Study|Lost to Follow-up|3|||
127703683|NCT03710603|459544743|FG001|Overall Study|Lost to Follow-up|5|||
127703684|NCT03710603|459544742|FG000|Overall Study|Withdrawal by Subject|11|||
127703685|NCT03710603|459544743|FG001|Overall Study|Withdrawal by Subject|10|||
127703686|NCT02626533|459544744|FG000|Overall Study|Protocol Violation|14|||
127703687|NCT02626533|459544744|FG000|Overall Study|Patients were found have meet criteria under the exclusion criterion|2|||
127703688|NCT02626533|459544744|FG000|Overall Study|Withdrawal by Subject|1|||
127703689|NCT04753697|459544745|FG000|Induction Phase|Withdrawal by Subject|12|||
127703690|NCT04753697|459544746|FG001|Induction Phase|Withdrawal by Subject|5|||
127703691|NCT04753697|459544747|FG002|Induction Phase|Withdrawal by Subject|6|||
127703692|NCT04753697|459544745|FG000|Induction Phase|Physician Decision|1|||
127703693|NCT04753697|459544746|FG001|Induction Phase|Physician Decision|0|||
127703694|NCT04753697|459544747|FG002|Induction Phase|Physician Decision|0|||
127703695|NCT04753697|459544745|FG000|Induction Phase|Lost to Follow-up|2|||
127703696|NCT04753697|459544746|FG001|Induction Phase|Lost to Follow-up|2|||
127703697|NCT04753697|459544747|FG002|Induction Phase|Lost to Follow-up|1|||
127703698|NCT04753697|459544745|FG000|Induction Phase|Lack of Efficacy|1|||
127703699|NCT04753697|459544746|FG001|Induction Phase|Lack of Efficacy|0|||
127703700|NCT04753697|459544747|FG002|Induction Phase|Lack of Efficacy|0|||
127703701|NCT04753697|459544745|FG000|Maintenance Phase|Physician Decision|0|||
127703702|NCT04753697|459544746|FG001|Maintenance Phase|Physician Decision|0|||
127703703|NCT04753697|459544747|FG002|Maintenance Phase|Physician Decision|1|||
127703704|NCT04753697|459544745|FG000|Maintenance Phase|Withdrawal by Subject|3|||
127703705|NCT04753697|459544746|FG001|Maintenance Phase|Withdrawal by Subject|4|||
127703706|NCT04753697|459544747|FG002|Maintenance Phase|Withdrawal by Subject|6|||
127703707|NCT04753697|459544745|FG000|Maintenance Phase|Lost to Follow-up|2|||
127703708|NCT04753697|459544746|FG001|Maintenance Phase|Lost to Follow-up|2|||
127703709|NCT04753697|459544747|FG002|Maintenance Phase|Lost to Follow-up|0|||
127703710|NCT04753697|459544745|FG000|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|1|||
127703711|NCT04753697|459544746|FG001|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
127703712|NCT04753697|459544747|FG002|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
127703713|NCT04753697|459544745|FG000|Maintenance Phase|Adverse Event|0|||
127703714|NCT04753697|459544746|FG001|Maintenance Phase|Adverse Event|1|||
127703715|NCT04753697|459544747|FG002|Maintenance Phase|Adverse Event|1|||
127703716|NCT04753697|459544745|FG000|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|1|||
127703717|NCT04753697|459544746|FG001|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
127703718|NCT04753697|459544747|FG002|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
127703719|NCT03701763|459544748|FG000|Placebo-controlled Phase|Adverse Event|1|||
127703720|NCT03701763|459544749|FG001|Placebo-controlled Phase|Adverse Event|5|||
127703721|NCT03701763|459544750|FG002|Placebo-controlled Phase|Adverse Event|0|||
127703722|NCT03701763|459544751|FG003|Placebo-controlled Phase|Adverse Event|0|||
127703723|NCT03701763|459544748|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
127639358|NCT02564523|459300466|FG016|Overall Study|Death|0|||
127639359|NCT02564523|459300467|FG017|Overall Study|Death|0|||
127639360|NCT02564523|459300450|FG000|Overall Study|Lost to Follow-up|2|||
127639361|NCT02564523|459300451|FG001|Overall Study|Lost to Follow-up|1|||
127639362|NCT02564523|459300452|FG002|Overall Study|Lost to Follow-up|4|||
127639363|NCT02564523|459300453|FG003|Overall Study|Lost to Follow-up|0|||
127639364|NCT02564523|459300454|FG004|Overall Study|Lost to Follow-up|1|||
127639365|NCT02564523|459300455|FG005|Overall Study|Lost to Follow-up|0|||
127639366|NCT02564523|459300456|FG006|Overall Study|Lost to Follow-up|1|||
127639367|NCT02564523|459300457|FG007|Overall Study|Lost to Follow-up|0|||
127639368|NCT02564523|459300458|FG008|Overall Study|Lost to Follow-up|0|||
127639369|NCT02564523|459300459|FG009|Overall Study|Lost to Follow-up|0|||
127639370|NCT02564523|459300460|FG010|Overall Study|Lost to Follow-up|0|||
127639371|NCT02564523|459300461|FG011|Overall Study|Lost to Follow-up|1|||
127639372|NCT02564523|459300462|FG012|Overall Study|Lost to Follow-up|1|||
127639373|NCT02564523|459300463|FG013|Overall Study|Lost to Follow-up|0|||
127639374|NCT02564523|459300464|FG014|Overall Study|Lost to Follow-up|0|||
127639375|NCT02564523|459300465|FG015|Overall Study|Lost to Follow-up|0|||
127639376|NCT02564523|459300466|FG016|Overall Study|Lost to Follow-up|0|||
127639377|NCT02564523|459300467|FG017|Overall Study|Lost to Follow-up|0|||
127639378|NCT02564523|459300450|FG000|Overall Study|Physician Decision|0|||
127639379|NCT02564523|459300451|FG001|Overall Study|Physician Decision|0|||
127639380|NCT02564523|459300452|FG002|Overall Study|Physician Decision|0|||
127639381|NCT02564523|459300453|FG003|Overall Study|Physician Decision|0|||
127639382|NCT02564523|459300454|FG004|Overall Study|Physician Decision|1|||
127639383|NCT02564523|459300455|FG005|Overall Study|Physician Decision|0|||
127639384|NCT02564523|459300456|FG006|Overall Study|Physician Decision|0|||
127639385|NCT02564523|459300457|FG007|Overall Study|Physician Decision|0|||
127639386|NCT02564523|459300458|FG008|Overall Study|Physician Decision|0|||
127639387|NCT02564523|459300459|FG009|Overall Study|Physician Decision|0|||
127639388|NCT02564523|459300460|FG010|Overall Study|Physician Decision|1|||
127639389|NCT02564523|459300461|FG011|Overall Study|Physician Decision|0|||
127639390|NCT02564523|459300462|FG012|Overall Study|Physician Decision|0|||
127639391|NCT02564523|459300463|FG013|Overall Study|Physician Decision|0|||
127639392|NCT02564523|459300464|FG014|Overall Study|Physician Decision|0|||
127639393|NCT02564523|459300465|FG015|Overall Study|Physician Decision|0|||
127639394|NCT02564523|459300466|FG016|Overall Study|Physician Decision|0|||
127639395|NCT02564523|459300467|FG017|Overall Study|Physician Decision|0|||
127639396|NCT02564523|459300450|FG000|Overall Study|Protocol Violation|2|||
127639397|NCT02564523|459300451|FG001|Overall Study|Protocol Violation|2|||
127639398|NCT02564523|459300452|FG002|Overall Study|Protocol Violation|5|||
127639399|NCT02564523|459300453|FG003|Overall Study|Protocol Violation|0|||
127639400|NCT02564523|459300454|FG004|Overall Study|Protocol Violation|1|||
127639401|NCT02564523|459300455|FG005|Overall Study|Protocol Violation|0|||
127639402|NCT02564523|459300456|FG006|Overall Study|Protocol Violation|0|||
127639403|NCT02564523|459300457|FG007|Overall Study|Protocol Violation|0|||
127639404|NCT02564523|459300458|FG008|Overall Study|Protocol Violation|0|||
127639405|NCT02564523|459300459|FG009|Overall Study|Protocol Violation|0|||
127639406|NCT02564523|459300460|FG010|Overall Study|Protocol Violation|0|||
127639407|NCT02564523|459300461|FG011|Overall Study|Protocol Violation|0|||
127639408|NCT02564523|459300462|FG012|Overall Study|Protocol Violation|0|||
127639409|NCT02564523|459300463|FG013|Overall Study|Protocol Violation|0|||
127639410|NCT02564523|459300464|FG014|Overall Study|Protocol Violation|0|||
127639411|NCT02564523|459300465|FG015|Overall Study|Protocol Violation|0|||
127639412|NCT02564523|459300466|FG016|Overall Study|Protocol Violation|0|||
127639413|NCT02564523|459300467|FG017|Overall Study|Protocol Violation|0|||
127639414|NCT02564523|459300450|FG000|Overall Study|Other|3|||
127639415|NCT02564523|459300451|FG001|Overall Study|Other|0|||
127639416|NCT02564523|459300452|FG002|Overall Study|Other|0|||
127639417|NCT02564523|459300453|FG003|Overall Study|Other|1|||
127639418|NCT02564523|459300454|FG004|Overall Study|Other|0|||
127639419|NCT02564523|459300455|FG005|Overall Study|Other|0|||
127639420|NCT02564523|459300456|FG006|Overall Study|Other|0|||
127639421|NCT02564523|459300457|FG007|Overall Study|Other|0|||
127639422|NCT02564523|459300458|FG008|Overall Study|Other|0|||
127639423|NCT02564523|459300459|FG009|Overall Study|Other|0|||
127639424|NCT02564523|459300460|FG010|Overall Study|Other|0|||
127639425|NCT02564523|459300461|FG011|Overall Study|Other|0|||
127639426|NCT02564523|459300462|FG012|Overall Study|Other|0|||
127639427|NCT02564523|459300463|FG013|Overall Study|Other|0|||
127639428|NCT02564523|459300464|FG014|Overall Study|Other|0|||
127639429|NCT02564523|459300465|FG015|Overall Study|Other|0|||
127639430|NCT02564523|459300466|FG016|Overall Study|Other|0|||
127639431|NCT02564523|459300467|FG017|Overall Study|Other|0|||
127639432|NCT04862143|459300471|FG000|Overall Study|Adverse Event|1|||
127639433|NCT04862143|459300471|FG000|Overall Study|Study terminated by sponsor|1|||
127639434|NCT03031938|459300472|FG000|Overall Study|Death|1|||
127639435|NCT03031938|459300473|FG001|Overall Study|Death|0|||
127639436|NCT01491854|459300477|FG000|Overall Study|mainly due to premature termination|93|||
127639437|NCT01491854|459300477|FG000|Overall Study|Death|1|||
127639438|NCT01491854|459300477|FG000|Overall Study|Withdrawal by Subject|3|||
127639439|NCT01491854|459300477|FG000|Overall Study|Lost to Follow-up|33|||
127639440|NCT00121238|459300478|FG000|Overall Study|disease progression before intervention|1|||
127639441|NCT00121238|459300478|FG000|Overall Study|Protocol Violation|2|||
127639442|NCT01026974|459300487|FG000|Overall Study|Withdrawal by Subject|0|||
127639443|NCT01026974|459300488|FG001|Overall Study|Withdrawal by Subject|1|||
127639444|NCT01026974|459300489|FG002|Overall Study|Withdrawal by Subject|7|||
127639445|NCT01026974|459300490|FG003|Overall Study|Withdrawal by Subject|2|||
127639446|NCT01026974|459300487|FG000|Overall Study|Lost to Follow-up|1|||
127639447|NCT01026974|459300488|FG001|Overall Study|Lost to Follow-up|1|||
127639448|NCT01026974|459300489|FG002|Overall Study|Lost to Follow-up|4|||
127639449|NCT01026974|459300490|FG003|Overall Study|Lost to Follow-up|0|||
127639450|NCT01026974|459300487|FG000|Overall Study|Adverse Event|0|||
127639451|NCT01026974|459300488|FG001|Overall Study|Adverse Event|0|||
127639452|NCT01026974|459300489|FG002|Overall Study|Adverse Event|0|||
127639453|NCT01026974|459300490|FG003|Overall Study|Adverse Event|1|||
127639454|NCT01026974|459300487|FG000|Overall Study|Inappropriate enrollment|0|||
127639455|NCT01026974|459300488|FG001|Overall Study|Inappropriate enrollment|0|||
127639456|NCT01026974|459300489|FG002|Overall Study|Inappropriate enrollment|1|||
127639457|NCT01026974|459300490|FG003|Overall Study|Inappropriate enrollment|0|||
127639458|NCT00325468|459300491|FG000|Overall Study|Adverse Event|1|||
127639459|NCT00325468|459300492|FG001|Overall Study|Adverse Event|1|||
127639460|NCT00325468|459300493|FG002|Overall Study|Adverse Event|0|||
127639461|NCT00325468|459300494|FG003|Overall Study|Adverse Event|5|||
127639462|NCT00325468|459300495|FG004|Overall Study|Adverse Event|1|||
127639463|NCT00325468|459300491|FG000|Overall Study|Death|2|||
127639464|NCT00325468|459300492|FG001|Overall Study|Death|0|||
127639465|NCT00325468|459300493|FG002|Overall Study|Death|2|||
127639466|NCT00325468|459300494|FG003|Overall Study|Death|4|||
127639467|NCT00325468|459300495|FG004|Overall Study|Death|0|||
127639468|NCT00325468|459300491|FG000|Overall Study|Lost to Follow-up|0|||
127639469|NCT00325468|459300492|FG001|Overall Study|Lost to Follow-up|0|||
127639470|NCT00325468|459300493|FG002|Overall Study|Lost to Follow-up|1|||
127639471|NCT00325468|459300494|FG003|Overall Study|Lost to Follow-up|2|||
127639472|NCT00325468|459300495|FG004|Overall Study|Lost to Follow-up|2|||
127639473|NCT00325468|459300491|FG000|Overall Study|Physician Decision|1|||
127639474|NCT00325468|459300492|FG001|Overall Study|Physician Decision|1|||
127639475|NCT00325468|459300493|FG002|Overall Study|Physician Decision|0|||
127639476|NCT00325468|459300494|FG003|Overall Study|Physician Decision|1|||
127639477|NCT00325468|459300495|FG004|Overall Study|Physician Decision|0|||
127639478|NCT00325468|459300491|FG000|Overall Study|Withdrawal by Subject|3|||
127639479|NCT00325468|459300492|FG001|Overall Study|Withdrawal by Subject|1|||
127639480|NCT00325468|459300493|FG002|Overall Study|Withdrawal by Subject|0|||
127639481|NCT00325468|459300494|FG003|Overall Study|Withdrawal by Subject|14|||
127639482|NCT00325468|459300495|FG004|Overall Study|Withdrawal by Subject|4|||
127639483|NCT00325468|459300491|FG000|Overall Study|site closure etc|4|||
127639484|NCT00325468|459300492|FG001|Overall Study|site closure etc|2|||
127639485|NCT00325468|459300493|FG002|Overall Study|site closure etc|1|||
127639486|NCT00325468|459300494|FG003|Overall Study|site closure etc|8|||
127639487|NCT00325468|459300495|FG004|Overall Study|site closure etc|1|||
127639488|NCT01314118|459300498|FG000|Overall Study|Adverse Event|9|||
127639489|NCT01314118|459300498|FG000|Overall Study|Progressive disease|27|||
127639490|NCT01314118|459300498|FG000|Overall Study|Physician Decision|11|||
127639491|NCT01314118|459300498|FG000|Overall Study|Death|4|||
127639492|NCT01314118|459300498|FG000|Overall Study|Protocol Violation|5|||
127639493|NCT01314118|459300498|FG000|Overall Study|Withdrawal by Subject|11|||
127639494|NCT01314118|459300498|FG000|Overall Study|Other|2|||
127639495|NCT01314118|459300498|FG000|Overall Study|Ongoing|62|||
127639496|NCT05545072|459300504|FG000|Overall Study|Lost to Follow-up|1|||
127639497|NCT05545072|459300505|FG001|Overall Study|Lost to Follow-up|0|||
127703724|NCT03701763|459544749|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
127703725|NCT03701763|459544750|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
127703726|NCT03701763|459544751|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
127703727|NCT03701763|459544748|FG000|Placebo-controlled Phase|Miscellaneous|2|||
127703728|NCT03701763|459544749|FG001|Placebo-controlled Phase|Miscellaneous|0|||
127703729|NCT03701763|459544750|FG002|Placebo-controlled Phase|Miscellaneous|0|||
127703730|NCT03701763|459544751|FG003|Placebo-controlled Phase|Miscellaneous|0|||
127703731|NCT03701763|459544748|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
127703732|NCT03701763|459544749|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
127703733|NCT03701763|459544750|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
127797184|NCT00953758|459881248|FG007|Overall Study|Death|3|||
127639498|NCT05545072|459300504|FG000|Overall Study|Study ended prematurely due to funding|2|||
127639499|NCT05545072|459300505|FG001|Overall Study|Study ended prematurely due to funding|2|||
127639500|NCT05585307|459300506|FG000|Overall Study|Lost to Follow-up|0|||
127639501|NCT05585307|459300507|FG001|Overall Study|Lost to Follow-up|0|||
127639502|NCT05585307|459300508|FG002|Overall Study|Lost to Follow-up|0|||
127639503|NCT05585307|459300509|FG003|Overall Study|Lost to Follow-up|0|||
127639504|NCT05585307|459300510|FG004|Overall Study|Lost to Follow-up|0|||
127639505|NCT05585307|459300511|FG005|Overall Study|Lost to Follow-up|0|||
127639506|NCT05585307|459300512|FG006|Overall Study|Lost to Follow-up|1|||
127639507|NCT05585307|459300513|FG007|Overall Study|Lost to Follow-up|0|||
127639508|NCT04642638|459300514|FG000|Overall Study|Withdrawal by Subject|23|||
127639509|NCT04642638|459300515|FG001|Overall Study|Withdrawal by Subject|29|||
127639510|NCT04642638|459300516|FG002|Overall Study|Withdrawal by Subject|9|||
127639511|NCT04642638|459300517|FG003|Overall Study|Withdrawal by Subject|7|||
127639512|NCT04642638|459300518|FG004|Overall Study|Withdrawal by Subject|61|||
127639513|NCT04642638|459300519|FG005|Overall Study|Withdrawal by Subject|27|||
127639514|NCT04642638|459300514|FG000|Overall Study|Lost to Follow-up|17|||
127639515|NCT04642638|459300515|FG001|Overall Study|Lost to Follow-up|18|||
127639516|NCT04642638|459300516|FG002|Overall Study|Lost to Follow-up|5|||
127639517|NCT04642638|459300517|FG003|Overall Study|Lost to Follow-up|5|||
127639518|NCT04642638|459300518|FG004|Overall Study|Lost to Follow-up|6|||
127639519|NCT04642638|459300519|FG005|Overall Study|Lost to Follow-up|3|||
127639520|NCT04642638|459300514|FG000|Overall Study|Adverse Event|0|||
127639521|NCT04642638|459300515|FG001|Overall Study|Adverse Event|0|||
127639522|NCT04642638|459300516|FG002|Overall Study|Adverse Event|1|||
127639523|NCT04642638|459300517|FG003|Overall Study|Adverse Event|0|||
127639524|NCT04642638|459300518|FG004|Overall Study|Adverse Event|10|||
127639525|NCT04642638|459300519|FG005|Overall Study|Adverse Event|3|||
127639526|NCT04642638|459300514|FG000|Overall Study|Reason Not Specified|1|||
127639527|NCT04642638|459300515|FG001|Overall Study|Reason Not Specified|4|||
127639528|NCT04642638|459300516|FG002|Overall Study|Reason Not Specified|0|||
127639529|NCT04642638|459300517|FG003|Overall Study|Reason Not Specified|0|||
127639530|NCT04642638|459300518|FG004|Overall Study|Reason Not Specified|38|||
127639531|NCT04642638|459300519|FG005|Overall Study|Reason Not Specified|16|||
127639532|NCT04642638|459300514|FG000|Overall Study|Physician Decision|0|||
127639533|NCT04642638|459300515|FG001|Overall Study|Physician Decision|0|||
127639534|NCT04642638|459300516|FG002|Overall Study|Physician Decision|0|||
127639535|NCT04642638|459300517|FG003|Overall Study|Physician Decision|0|||
127639536|NCT04642638|459300518|FG004|Overall Study|Physician Decision|2|||
127639537|NCT04642638|459300519|FG005|Overall Study|Physician Decision|1|||
127639538|NCT04642638|459300514|FG000|Overall Study|Protocol Deviation|0|||
127639539|NCT04642638|459300515|FG001|Overall Study|Protocol Deviation|0|||
127639540|NCT04642638|459300516|FG002|Overall Study|Protocol Deviation|0|||
127639541|NCT04642638|459300517|FG003|Overall Study|Protocol Deviation|0|||
127639542|NCT04642638|459300518|FG004|Overall Study|Protocol Deviation|1|||
127639543|NCT04642638|459300519|FG005|Overall Study|Protocol Deviation|3|||
127639544|NCT04642638|459300514|FG000|Overall Study|Study Terminated|0|||
127639545|NCT04642638|459300515|FG001|Overall Study|Study Terminated|0|||
127639546|NCT04642638|459300516|FG002|Overall Study|Study Terminated|0|||
127639547|NCT04642638|459300517|FG003|Overall Study|Study Terminated|0|||
127639548|NCT04642638|459300518|FG004|Overall Study|Study Terminated|484|||
127639549|NCT04642638|459300519|FG005|Overall Study|Study Terminated|250|||
127639550|NCT04642638|459300514|FG000|Overall Study|Pregnancy|0|||
127639551|NCT04642638|459300515|FG001|Overall Study|Pregnancy|0|||
127639552|NCT04642638|459300516|FG002|Overall Study|Pregnancy|0|||
127639553|NCT04642638|459300517|FG003|Overall Study|Pregnancy|0|||
127639554|NCT04642638|459300518|FG004|Overall Study|Pregnancy|1|||
127639555|NCT04642638|459300519|FG005|Overall Study|Pregnancy|0|||
127639556|NCT04053764|459300525|FG000|Overall Study|Withdrawal by Subject|6|||
127639557|NCT04053764|459300526|FG001|Overall Study|Withdrawal by Subject|2|||
127639558|NCT04053764|459300525|FG000|Overall Study|Physician Decision|2|||
127639559|NCT04053764|459300526|FG001|Overall Study|Physician Decision|1|||
127639560|NCT04053764|459300525|FG000|Overall Study|Adverse Event|1|||
127639561|NCT04053764|459300526|FG001|Overall Study|Adverse Event|0|||
127703734|NCT03701763|459544751|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
127703735|NCT03701763|459544748|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
127703736|NCT03701763|459544749|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
127703737|NCT03701763|459544750|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
127703738|NCT03701763|459544751|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
127703739|NCT03701763|459544748|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
127703740|NCT03701763|459544749|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
127703741|NCT03701763|459544750|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
127703742|NCT03701763|459544751|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
127703743|NCT03701763|459544748|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
127703744|NCT03701763|459544749|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
127639562|NCT04053764|459300525|FG000|Overall Study|Pregnancy|1|||
127639563|NCT04053764|459300526|FG001|Overall Study|Pregnancy|0|||
127703745|NCT03701763|459544750|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
127703746|NCT03701763|459544751|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
127639564|NCT02384954|459300530|FG000|Phase 1|Progressive Disease|2|||
127639565|NCT02384954|459300531|FG001|Phase 1|Progressive Disease|0|||
127639566|NCT02384954|459300532|FG002|Phase 1|Progressive Disease|1|||
127639567|NCT02384954|459300533|FG003|Phase 1|Progressive Disease|1|||
127639568|NCT02384954|459300534|FG004|Phase 1|Progressive Disease|0|||
127703747|NCT03701763|459544748|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
127639569|NCT02384954|459300535|FG005|Phase 1|Progressive Disease|0|||
127639570|NCT02384954|459300536|FG006|Phase 1|Progressive Disease|0|||
127639571|NCT02384954|459300537|FG007|Phase 1|Progressive Disease|0|||
127639572|NCT02384954|459300538|FG008|Phase 1|Progressive Disease|0|||
127639573|NCT02384954|459300530|FG000|Phase 1|Adverse Event|0|||
127639574|NCT02384954|459300531|FG001|Phase 1|Adverse Event|0|||
127639575|NCT02384954|459300532|FG002|Phase 1|Adverse Event|1|||
127639576|NCT02384954|459300533|FG003|Phase 1|Adverse Event|0|||
127639577|NCT02384954|459300534|FG004|Phase 1|Adverse Event|0|||
127639578|NCT02384954|459300535|FG005|Phase 1|Adverse Event|0|||
127639579|NCT02384954|459300536|FG006|Phase 1|Adverse Event|0|||
127639580|NCT02384954|459300537|FG007|Phase 1|Adverse Event|0|||
127639581|NCT02384954|459300538|FG008|Phase 1|Adverse Event|0|||
127639582|NCT02384954|459300530|FG000|Phase 2|Progressive Disease|0|||
127639583|NCT02384954|459300531|FG001|Phase 2|Progressive Disease|0|||
127639584|NCT02384954|459300532|FG002|Phase 2|Progressive Disease|0|||
127639585|NCT02384954|459300533|FG003|Phase 2|Progressive Disease|0|||
127639586|NCT02384954|459300534|FG004|Phase 2|Progressive Disease|0|||
127639587|NCT02384954|459300535|FG005|Phase 2|Progressive Disease|0|||
127639588|NCT02384954|459300536|FG006|Phase 2|Progressive Disease|0|||
127639589|NCT02384954|459300537|FG007|Phase 2|Progressive Disease|1|||
127639590|NCT02384954|459300538|FG008|Phase 2|Progressive Disease|2|||
127639591|NCT02384954|459300530|FG000|Phase 2|Adverse Event|0|||
127639592|NCT02384954|459300531|FG001|Phase 2|Adverse Event|0|||
127639593|NCT02384954|459300532|FG002|Phase 2|Adverse Event|0|||
127639594|NCT02384954|459300533|FG003|Phase 2|Adverse Event|0|||
127639595|NCT02384954|459300534|FG004|Phase 2|Adverse Event|0|||
127639596|NCT02384954|459300535|FG005|Phase 2|Adverse Event|0|||
127639597|NCT02384954|459300536|FG006|Phase 2|Adverse Event|0|||
127639598|NCT02384954|459300537|FG007|Phase 2|Adverse Event|1|||
127639599|NCT02384954|459300538|FG008|Phase 2|Adverse Event|1|||
127639600|NCT02384954|459300530|FG000|Phase 2|Failure to meet continuation criteria|0|||
127639601|NCT02384954|459300531|FG001|Phase 2|Failure to meet continuation criteria|0|||
127639602|NCT02384954|459300532|FG002|Phase 2|Failure to meet continuation criteria|0|||
127639603|NCT02384954|459300533|FG003|Phase 2|Failure to meet continuation criteria|0|||
127639604|NCT02384954|459300534|FG004|Phase 2|Failure to meet continuation criteria|0|||
127639605|NCT02384954|459300535|FG005|Phase 2|Failure to meet continuation criteria|0|||
127639606|NCT02384954|459300536|FG006|Phase 2|Failure to meet continuation criteria|0|||
127639607|NCT02384954|459300537|FG007|Phase 2|Failure to meet continuation criteria|1|||
127639608|NCT02384954|459300538|FG008|Phase 2|Failure to meet continuation criteria|0|||
127639609|NCT04732286|459300539|FG000|Overall Study|Progressive Disease|2|||
127639610|NCT04732286|459300539|FG000|Overall Study|Physician Decision|1|||
127639611|NCT04732286|459300539|FG000|Overall Study|Study Terminated by Sponsor|31|||
127639612|NCT04732286|459300539|FG000|Overall Study|Withdrawal by Subject|10|||
127639613|NCT04732286|459300539|FG000|Overall Study|Non-compliance With Study Drug|1|||
127639614|NCT04732286|459300539|FG000|Overall Study|Lost to Follow-up|4|||
127639615|NCT04732286|459300539|FG000|Overall Study|Death|51|||
127639616|NCT01474681|459300540|FG000|Overall Study|Death|0|||
127639617|NCT01474681|459300541|FG001|Overall Study|Death|3|||
127639618|NCT01474681|459300542|FG002|Overall Study|Death|2|||
127639619|NCT01474681|459300543|FG003|Overall Study|Death|6|||
127639620|NCT03595904|459300550|FG000|Overall Study|Protocol Violation|3|||
127639621|NCT03595904|459300551|FG001|Overall Study|Protocol Violation|1|||
127639622|NCT03595904|459300550|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
127639623|NCT03595904|459300551|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
127639624|NCT03595904|459300550|FG000|Overall Study|Insurance complications|1|||
127639625|NCT03595904|459300551|FG001|Overall Study|Insurance complications|0|||
127639626|NCT03595904|459300550|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
127639627|NCT03595904|459300551|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
127639628|NCT02081846|459300554|FG000|Overall Study|Withdrawal by Subject|1|||
127639629|NCT02081846|459300555|FG001|Overall Study|Withdrawal by Subject|0|||
127639630|NCT02081846|459300554|FG000|Overall Study|invalid consent|1|||
127886433|NCT00265083|460208554|FG000|Overall Study|Other|1|||
127886434|NCT00265083|460208555|FG001|Overall Study|Other|12|||
127886435|NCT00265083|460208556|FG002|Overall Study|Other|9|||
127886436|NCT02919475|460208558|FG000|Overall Study|Adverse Event|3|||
127886437|NCT02919475|460208559|FG001|Overall Study|Adverse Event|3|||
127886438|NCT02919475|460208560|FG002|Overall Study|Adverse Event|3|||
127639631|NCT02081846|459300555|FG001|Overall Study|invalid consent|0|||
127639632|NCT03282227|459300556|FG000|Overall Study|Exposure Goals Achieved|60|||
127639633|NCT03282227|459300556|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
127639634|NCT03282227|459300556|FG000|Overall Study|Adverse Event|15|||
127639635|NCT03282227|459300556|FG000|Overall Study|Lost to Follow-up|21|||
127639636|NCT03282227|459300556|FG000|Overall Study|Withdrawal by Subject|20|||
127639637|NCT03282227|459300556|FG000|Overall Study|Lack of Efficacy|12|||
127639638|NCT03282227|459300556|FG000|Overall Study|Sponsor decision|3|||
127639639|NCT03282227|459300556|FG000|Overall Study|Physician Decision|2|||
127639640|NCT03282227|459300556|FG000|Overall Study|Pregnancy|2|||
127639641|NCT03282227|459300556|FG000|Overall Study|Other|1|||
127886439|NCT02919475|460208561|FG003|Overall Study|Adverse Event|9|||
127886440|NCT02919475|460208562|FG004|Overall Study|Adverse Event|2|||
127639642|NCT02576678|459300557|FG000|Overall Study|Adverse Event|0|||
127639643|NCT02576678|459300558|FG001|Overall Study|Adverse Event|0|||
127639644|NCT02576678|459300559|FG002|Overall Study|Adverse Event|2|||
127639645|NCT02576678|459300557|FG000|Overall Study|Withdrawal by Subject|3|||
127639646|NCT02576678|459300558|FG001|Overall Study|Withdrawal by Subject|1|||
127639647|NCT02576678|459300559|FG002|Overall Study|Withdrawal by Subject|2|||
127639648|NCT02576678|459300557|FG000|Overall Study|Lost to Follow-up|0|||
127639649|NCT02576678|459300558|FG001|Overall Study|Lost to Follow-up|0|||
127639650|NCT02576678|459300559|FG002|Overall Study|Lost to Follow-up|1|||
127639651|NCT02576678|459300557|FG000|Overall Study|Miscellaneous|2|||
127639652|NCT02576678|459300558|FG001|Overall Study|Miscellaneous|0|||
127639653|NCT02576678|459300559|FG002|Overall Study|Miscellaneous|0|||
127639654|NCT02251990|459300563|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
127639655|NCT02251990|459300564|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
127639656|NCT02251990|459300563|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
127639657|NCT02251990|459300564|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
127639658|NCT02251990|459300563|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
127639659|NCT02251990|459300564|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
127639660|NCT02251990|459300563|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
127639661|NCT02251990|459300564|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
127639662|NCT02251990|459300563|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
127639663|NCT02251990|459300564|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
127639664|NCT02251990|459300563|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
127639665|NCT02251990|459300564|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
127639666|NCT00295750|459300568|FG000|Overall Study|Adverse Event|19|||
127639667|NCT00295750|459300569|FG001|Overall Study|Adverse Event|15|||
127639668|NCT00295750|459300570|FG002|Overall Study|Adverse Event|12|||
127639669|NCT00295750|459300568|FG000|Overall Study|Lack of Efficacy|1|||
127639670|NCT00295750|459300569|FG001|Overall Study|Lack of Efficacy|1|||
127639671|NCT00295750|459300570|FG002|Overall Study|Lack of Efficacy|0|||
127639672|NCT00295750|459300568|FG000|Overall Study|Lost to Follow-up|1|||
127639673|NCT00295750|459300569|FG001|Overall Study|Lost to Follow-up|4|||
127639674|NCT00295750|459300570|FG002|Overall Study|Lost to Follow-up|1|||
127639675|NCT00295750|459300568|FG000|Overall Study|Taking prohibited therapy|2|||
127639676|NCT00295750|459300569|FG001|Overall Study|Taking prohibited therapy|3|||
127797185|NCT00953758|459881249|FG008|Overall Study|Death|1|||
127639677|NCT00295750|459300570|FG002|Overall Study|Taking prohibited therapy|2|||
127639678|NCT00295750|459300568|FG000|Overall Study|Administrative errors|2|||
127639679|NCT00295750|459300569|FG001|Overall Study|Administrative errors|4|||
127639680|NCT00295750|459300570|FG002|Overall Study|Administrative errors|5|||
127797186|NCT00953758|459881250|FG009|Overall Study|Death|0|||
127703748|NCT03701763|459544749|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
127703749|NCT03701763|459544750|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
127703750|NCT03701763|459544751|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
127703751|NCT03701763|459544748|FG000|Apremilast Extension Phase|Adverse Event|0|||
127703752|NCT03701763|459544749|FG001|Apremilast Extension Phase|Adverse Event|0|||
127703753|NCT03701763|459544750|FG002|Apremilast Extension Phase|Adverse Event|3|||
127703754|NCT03701763|459544751|FG003|Apremilast Extension Phase|Adverse Event|1|||
127703755|NCT03701763|459544748|FG000|Apremilast Extension Phase|Miscellaneous|0|||
127797187|NCT00953758|459881241|FG000|Overall Study|Participant refused further follow-up|0|||
127797188|NCT00953758|459881242|FG001|Overall Study|Participant refused further follow-up|0|||
127797189|NCT00953758|459881243|FG002|Overall Study|Participant refused further follow-up|1|||
127797190|NCT00953758|459881244|FG003|Overall Study|Participant refused further follow-up|0|||
127797191|NCT00953758|459881245|FG004|Overall Study|Participant refused further follow-up|3|||
127797192|NCT00953758|459881246|FG005|Overall Study|Participant refused further follow-up|0|||
127797193|NCT00953758|459881247|FG006|Overall Study|Participant refused further follow-up|0|||
127797194|NCT00953758|459881248|FG007|Overall Study|Participant refused further follow-up|0|||
127797195|NCT00953758|459881249|FG008|Overall Study|Participant refused further follow-up|1|||
127797196|NCT00953758|459881250|FG009|Overall Study|Participant refused further follow-up|0|||
127797197|NCT00953758|459881241|FG000|Overall Study|Lost to Follow-up|0|||
127639681|NCT00295750|459300568|FG000|Overall Study|Trial drug errors|1|||
127639682|NCT00295750|459300569|FG001|Overall Study|Trial drug errors|1|||
127639683|NCT00295750|459300570|FG002|Overall Study|Trial drug errors|0|||
127639684|NCT00295750|459300568|FG000|Overall Study|Disease progression|2|||
127639685|NCT00295750|459300569|FG001|Overall Study|Disease progression|1|||
127639686|NCT00295750|459300570|FG002|Overall Study|Disease progression|0|||
127639687|NCT00295750|459300568|FG000|Overall Study|Personal reasons|0|||
127639688|NCT00295750|459300569|FG001|Overall Study|Personal reasons|1|||
127639689|NCT00295750|459300570|FG002|Overall Study|Personal reasons|0|||
127639690|NCT00295750|459300568|FG000|Overall Study|Randomized but never received trial drug|4|||
127639691|NCT00295750|459300569|FG001|Overall Study|Randomized but never received trial drug|3|||
127639692|NCT00295750|459300570|FG002|Overall Study|Randomized but never received trial drug|3|||
127639693|NCT00295750|459300568|FG000|Overall Study|Withdrawal by Subject|9|||
127639694|NCT00295750|459300569|FG001|Overall Study|Withdrawal by Subject|4|||
127639695|NCT00295750|459300570|FG002|Overall Study|Withdrawal by Subject|7|||
127639696|NCT00295750|459300568|FG000|Overall Study|Protocol Violation|2|||
127639697|NCT00295750|459300569|FG001|Overall Study|Protocol Violation|4|||
127639698|NCT00295750|459300570|FG002|Overall Study|Protocol Violation|2|||
127639699|NCT01857531|459300586|FG000|Overall Study|Withdrawal by Subject|4|||
127639700|NCT00744653|459300590|FG000|Overall Study|antineoplastic treatment|11|||
127639701|NCT00744653|459300590|FG000|Overall Study|Death|1|||
127639702|NCT00744653|459300590|FG000|Overall Study|Lost to Follow-up|1|||
127639703|NCT00744653|459300590|FG000|Overall Study|Physician Decision|3|||
127639704|NCT04764396|459300593|FG000|Overall Study|Physician Decision|1|||
127639705|NCT04764396|459300594|FG001|Overall Study|Physician Decision|0|||
127639706|NCT01864564|459300598|FG000|Overall Study|Lost to Follow-up|17|||
127639707|NCT01864564|459300599|FG001|Overall Study|Lost to Follow-up|23|||
127639708|NCT01864564|459300598|FG000|Overall Study|Withdrawal by Subject|20|||
127639709|NCT01864564|459300599|FG001|Overall Study|Withdrawal by Subject|11|||
127639710|NCT01864564|459300598|FG000|Overall Study|Protocol Violation|0|||
127639711|NCT01864564|459300599|FG001|Overall Study|Protocol Violation|27|||
127639712|NCT01864564|459300598|FG000|Overall Study|not reported|0|||
127639713|NCT01864564|459300599|FG001|Overall Study|not reported|34|||
127639714|NCT03077724|459300600|FG000|Overall Study|Lost to Follow-up|5|||
127639715|NCT03077724|459300601|FG001|Overall Study|Lost to Follow-up|1|||
127639716|NCT03077724|459300600|FG000|Overall Study|Withdrawal by Subject|3|||
127639717|NCT03077724|459300601|FG001|Overall Study|Withdrawal by Subject|1|||
127703756|NCT03701763|459544749|FG001|Apremilast Extension Phase|Miscellaneous|0|||
127703757|NCT03701763|459544750|FG002|Apremilast Extension Phase|Miscellaneous|2|||
127703758|NCT03701763|459544751|FG003|Apremilast Extension Phase|Miscellaneous|1|||
127797198|NCT00953758|459881242|FG001|Overall Study|Lost to Follow-up|0|||
127797199|NCT00953758|459881243|FG002|Overall Study|Lost to Follow-up|0|||
127797200|NCT00953758|459881244|FG003|Overall Study|Lost to Follow-up|1|||
127639718|NCT02269670|459300602|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
127639719|NCT04657211|459300605|FG000|Overall Study|Withdrawal by Subject|21|||
127639720|NCT04657211|459300605|FG000|Overall Study|Lost to Follow-up|113|||
127639721|NCT04657211|459300605|FG000|Overall Study|Death|47|||
127639722|NCT04657211|459300605|FG000|Overall Study|Transfer to another institution|21|||
127639723|NCT04657211|459300605|FG000|Overall Study|Other|29|||
127639724|NCT02693665|459300606|FG000|Overall Study|Death|3|||
127639725|NCT02693665|459300607|FG001|Overall Study|Death|2|||
127639726|NCT02693665|459300606|FG000|Overall Study|Lost to Follow-up|7|||
127639727|NCT02693665|459300607|FG001|Overall Study|Lost to Follow-up|3|||
127639728|NCT02693665|459300606|FG000|Overall Study|Protocol Violation|1|||
127703759|NCT03701763|459544748|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
127797201|NCT00953758|459881245|FG004|Overall Study|Lost to Follow-up|0|||
127639729|NCT02693665|459300607|FG001|Overall Study|Protocol Violation|0|||
127639730|NCT02693665|459300606|FG000|Overall Study|Withdrawal by Subject|2|||
127639731|NCT02693665|459300607|FG001|Overall Study|Withdrawal by Subject|0|||
127639732|NCT02693665|459300606|FG000|Overall Study|patient wanted to leave it behind|1|||
127639733|NCT02693665|459300607|FG001|Overall Study|patient wanted to leave it behind|0|||
127639734|NCT02693665|459300606|FG000|Overall Study|anxiety|1|||
127639735|NCT02693665|459300607|FG001|Overall Study|anxiety|0|||
127639736|NCT02693665|459300606|FG000|Overall Study|family issues|1|||
127639737|NCT02693665|459300607|FG001|Overall Study|family issues|0|||
127639738|NCT02693665|459300606|FG000|Overall Study|no reason given|1|||
127639739|NCT02693665|459300607|FG001|Overall Study|no reason given|0|||
127639740|NCT00710424|459300612|FG000|Overall Study|Adverse Event|30|||
127639741|NCT00710424|459300613|FG001|Overall Study|Adverse Event|12|||
127639742|NCT00710424|459300612|FG000|Overall Study|Lack of Efficacy|4|||
127639743|NCT00710424|459300613|FG001|Overall Study|Lack of Efficacy|5|||
127639744|NCT00710424|459300612|FG000|Overall Study|Withdrawal by Subject|5|||
127639745|NCT00710424|459300613|FG001|Overall Study|Withdrawal by Subject|3|||
127639746|NCT00710424|459300612|FG000|Overall Study|Lost to Follow-up|0|||
127639747|NCT00710424|459300613|FG001|Overall Study|Lost to Follow-up|1|||
127639748|NCT00710424|459300612|FG000|Overall Study|Refused medication, no side effects|1|||
127639749|NCT00710424|459300613|FG001|Overall Study|Refused medication, no side effects|0|||
127639750|NCT00710424|459300612|FG000|Overall Study|Non-compliance with stable analgesia|1|||
127639751|NCT00710424|459300613|FG001|Overall Study|Non-compliance with stable analgesia|0|||
127639752|NCT00710424|459300612|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
127639753|NCT00710424|459300613|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
127639754|NCT00710424|459300612|FG000|Overall Study|Subject thought medication changed|1|||
127639755|NCT00710424|459300613|FG001|Overall Study|Subject thought medication changed|0|||
127639756|NCT00710424|459300612|FG000|Overall Study|Ceased treatment due to travel|1|||
127639757|NCT00710424|459300613|FG001|Overall Study|Ceased treatment due to travel|0|||
127639758|NCT00710424|459300612|FG000|Overall Study|Subject preferred paracetamol|0|||
127639759|NCT00710424|459300613|FG001|Overall Study|Subject preferred paracetamol|1|||
127639760|NCT00710424|459300612|FG000|Overall Study|Felt good so stopped treatment|0|||
127639761|NCT00710424|459300613|FG001|Overall Study|Felt good so stopped treatment|1|||
127639762|NCT01962493|459300614|FG000|Overall Study|Adverse Event|1|||
127639763|NCT01962493|459300615|FG001|Overall Study|Adverse Event|2|||
127639764|NCT01962493|459300614|FG000|Overall Study|Protocol Violation|0|||
127639765|NCT01962493|459300615|FG001|Overall Study|Protocol Violation|1|||
127639766|NCT01962493|459300614|FG000|Overall Study|Withdrawal by Subject|4|||
127639767|NCT01962493|459300615|FG001|Overall Study|Withdrawal by Subject|2|||
127639768|NCT03776136|459300616|FG000|Overall Study|Death|85|||
127639769|NCT03776136|459300616|FG000|Overall Study|Withdrawal by Subject|3|||
127639770|NCT03776136|459300616|FG000|Overall Study|Sponsor Decision|15|||
127639771|NCT04414696|459300617|FG000|3-month Follow up|Withdrawal by Subject|1|||
127639772|NCT04414696|459300618|FG001|3-month Follow up|Withdrawal by Subject|0|||
127639773|NCT04414696|459300617|FG000|3-month Follow up|Lost to Follow-up|22|||
127639774|NCT04414696|459300618|FG001|3-month Follow up|Lost to Follow-up|23|||
127639775|NCT04414696|459300617|FG000|6-month Follow up|Withdrawal by Subject|1|||
127639776|NCT04414696|459300618|FG001|6-month Follow up|Withdrawal by Subject|2|||
127639777|NCT04414696|459300617|FG000|6-month Follow up|Lost to Follow-up|5|||
127639778|NCT04414696|459300618|FG001|6-month Follow up|Lost to Follow-up|2|||
127639779|NCT00924287|459302338|FG000|Overall Study|Death|1|||
127639780|NCT02621931|459302339|FG000|Overall Study|Death|0|||
127639781|NCT02621931|459302340|FG001|Overall Study|Death|1|||
127639782|NCT02621931|459302341|FG002|Overall Study|Death|0|||
127639783|NCT02621931|459302339|FG000|Overall Study|Adverse Event|8|||
127639784|NCT02621931|459302340|FG001|Overall Study|Adverse Event|5|||
127639785|NCT02621931|459302341|FG002|Overall Study|Adverse Event|7|||
127639786|NCT02621931|459302339|FG000|Overall Study|Withdrawal by Subject|12|||
127639787|NCT02621931|459302340|FG001|Overall Study|Withdrawal by Subject|10|||
127639788|NCT02621931|459302341|FG002|Overall Study|Withdrawal by Subject|11|||
127639789|NCT02621931|459302339|FG000|Overall Study|Protocol Violation|2|||
127639790|NCT02621931|459302340|FG001|Overall Study|Protocol Violation|2|||
127639791|NCT02621931|459302341|FG002|Overall Study|Protocol Violation|2|||
127639792|NCT02621931|459302339|FG000|Overall Study|Pregnancy|2|||
127639793|NCT02621931|459302340|FG001|Overall Study|Pregnancy|0|||
127639794|NCT02621931|459302341|FG002|Overall Study|Pregnancy|0|||
127639795|NCT02621931|459302339|FG000|Overall Study|Noncompliance to study procedures|0|||
127639796|NCT02621931|459302340|FG001|Overall Study|Noncompliance to study procedures|1|||
127639797|NCT02621931|459302341|FG002|Overall Study|Noncompliance to study procedures|2|||
127639798|NCT02621931|459302339|FG000|Overall Study|Lost to Follow-up|8|||
127703760|NCT03701763|459544749|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
127703761|NCT03701763|459544750|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
127639799|NCT02621931|459302340|FG001|Overall Study|Lost to Follow-up|7|||
127639800|NCT02621931|459302341|FG002|Overall Study|Lost to Follow-up|10|||
127639801|NCT02621931|459302339|FG000|Overall Study|Lack of Efficacy|0|||
127639802|NCT02621931|459302340|FG001|Overall Study|Lack of Efficacy|0|||
127639803|NCT02621931|459302341|FG002|Overall Study|Lack of Efficacy|1|||
127639804|NCT02621931|459302339|FG000|Overall Study|Other|1|||
127703762|NCT03701763|459544751|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
127703763|NCT03701763|459544748|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
127703764|NCT03701763|459544749|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
127703765|NCT03701763|459544750|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
127703766|NCT03701763|459544751|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
127703767|NCT03701763|459544748|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
127703768|NCT03701763|459544749|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
127703769|NCT03701763|459544750|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
127703770|NCT03701763|459544751|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
127703771|NCT03701763|459544748|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
127703772|NCT03701763|459544749|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
127703773|NCT03701763|459544750|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
127703774|NCT03701763|459544751|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
127703775|NCT03701763|459544748|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
127703776|NCT03701763|459544749|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
127703777|NCT03701763|459544750|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
127703778|NCT03701763|459544751|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
127703779|NCT03701763|459544748|FG000|14-Week Observational Follow-up Phase|Other|0|||
127703780|NCT03701763|459544749|FG001|14-Week Observational Follow-up Phase|Other|0|||
127703781|NCT03701763|459544750|FG002|14-Week Observational Follow-up Phase|Other|1|||
127703782|NCT03701763|459544751|FG003|14-Week Observational Follow-up Phase|Other|0|||
127703783|NCT03701763|459544748|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
127703784|NCT03701763|459544749|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
127703785|NCT03701763|459544750|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
127703786|NCT03701763|459544751|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
127703787|NCT03701763|459544748|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
127703788|NCT03701763|459544749|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
127703789|NCT03701763|459544750|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
127703790|NCT03701763|459544751|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
127703791|NCT03785964|459544753|FG000|Overall Study|Adverse Event|14|||
127703792|NCT03785964|459544754|FG001|Overall Study|Adverse Event|1|||
127703793|NCT03785964|459544753|FG000|Overall Study|Unqualified Clinical Progression|1|||
127703794|NCT03785964|459544754|FG001|Overall Study|Unqualified Clinical Progression|1|||
127703795|NCT03785964|459544753|FG000|Overall Study|Participant non-compliance|1|||
127703796|NCT03785964|459544754|FG001|Overall Study|Participant non-compliance|1|||
127703797|NCT03785964|459544753|FG000|Overall Study|Not treated|1|||
127703798|NCT03785964|459544754|FG001|Overall Study|Not treated|0|||
127703799|NCT03785964|459544753|FG000|Overall Study|Other reason|5|||
127703800|NCT03785964|459544754|FG001|Overall Study|Other reason|11|||
127703801|NCT03785964|459544753|FG000|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|36|||
127703802|NCT03785964|459544754|FG001|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|23|||
127703803|NCT04117347|459544761|FG000|Overall Study|Adverse Event|0|||
127703804|NCT04117347|459544762|FG001|Overall Study|Adverse Event|0|||
127703805|NCT04117347|459544763|FG002|Overall Study|Adverse Event|1|||
127703806|NCT04117347|459544761|FG000|Overall Study|No time for study|0|||
127703807|NCT04117347|459544762|FG001|Overall Study|No time for study|2|||
127703808|NCT04117347|459544763|FG002|Overall Study|No time for study|0|||
127703809|NCT04117347|459544761|FG000|Overall Study|Family emergency|1|||
127703810|NCT04117347|459544762|FG001|Overall Study|Family emergency|0|||
127703811|NCT04117347|459544763|FG002|Overall Study|Family emergency|0|||
127886441|NCT02919475|460208558|FG000|Overall Study|Death|0|||
127703812|NCT03687086|459544764|FG000|Overall Study|Withdrawal by Subject|3|||
127703813|NCT03687086|459544765|FG001|Overall Study|Withdrawal by Subject|4|||
127703814|NCT03687086|459544764|FG000|Overall Study|Lost to Follow-up|1|||
127703815|NCT03687086|459544765|FG001|Overall Study|Lost to Follow-up|1|||
127703816|NCT03687086|459544764|FG000|Overall Study|Death|1|||
127703817|NCT03687086|459544765|FG001|Overall Study|Death|0|||
127703818|NCT03687086|459544764|FG000|Overall Study|Incomplete assessment|0|||
127703819|NCT03687086|459544765|FG001|Overall Study|Incomplete assessment|2|||
127703820|NCT02505984|459544766|FG000|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|1|||
127703821|NCT02505984|459544767|FG001|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|0|||
127703822|NCT02505984|459544766|FG000|Overall Study|Unreliable self-report data|1|||
127703823|NCT02505984|459544767|FG001|Overall Study|Unreliable self-report data|0|||
127703824|NCT02505984|459544766|FG000|Overall Study|Study blind opened during assessment|0|||
127703825|NCT02505984|459544767|FG001|Overall Study|Study blind opened during assessment|1|||
127703826|NCT02505984|459544766|FG000|Overall Study|Noncompliance with study protocol|0|||
127703827|NCT02505984|459544767|FG001|Overall Study|Noncompliance with study protocol|1|||
127703828|NCT05194956|459544768|FG000|Washout Period|Withdrawal by Subject|0|||
127703829|NCT05194956|459544769|FG001|Washout Period|Withdrawal by Subject|2|||
127797202|NCT00953758|459881246|FG005|Overall Study|Lost to Follow-up|0|||
127797203|NCT00953758|459881247|FG006|Overall Study|Lost to Follow-up|0|||
127797204|NCT00953758|459881248|FG007|Overall Study|Lost to Follow-up|1|||
127797205|NCT00953758|459881249|FG008|Overall Study|Lost to Follow-up|0|||
127639805|NCT02621931|459302340|FG001|Overall Study|Other|1|||
127639806|NCT02621931|459302341|FG002|Overall Study|Other|3|||
127639807|NCT02811861|459302342|FG000|Overall Study|Radiological Disease Progression|123|||
127639808|NCT02811861|459302343|FG001|Overall Study|Radiological Disease Progression|97|||
127639809|NCT02811861|459302344|FG002|Overall Study|Radiological Disease Progression|174|||
127639810|NCT02811861|459302342|FG000|Overall Study|Clinical Disease Progression|20|||
127639811|NCT02811861|459302343|FG001|Overall Study|Clinical Disease Progression|19|||
127639812|NCT02811861|459302344|FG002|Overall Study|Clinical Disease Progression|22|||
127639813|NCT02811861|459302342|FG000|Overall Study|Adverse Event|63|||
127639814|NCT02811861|459302343|FG001|Overall Study|Adverse Event|60|||
127639815|NCT02811861|459302344|FG002|Overall Study|Adverse Event|41|||
127639816|NCT02811861|459302342|FG000|Overall Study|Lost to Follow-up|0|||
127639817|NCT02811861|459302343|FG001|Overall Study|Lost to Follow-up|0|||
127639818|NCT02811861|459302344|FG002|Overall Study|Lost to Follow-up|1|||
127639819|NCT02811861|459302342|FG000|Overall Study|Subject Choice|29|||
127639820|NCT02811861|459302343|FG001|Overall Study|Subject Choice|17|||
127639821|NCT02811861|459302344|FG002|Overall Study|Subject Choice|23|||
127639822|NCT02811861|459302342|FG000|Overall Study|Withdrawal by Subject|4|||
127639823|NCT02811861|459302343|FG001|Overall Study|Withdrawal by Subject|4|||
127639824|NCT02811861|459302344|FG002|Overall Study|Withdrawal by Subject|9|||
127639825|NCT02811861|459302342|FG000|Overall Study|Other|4|||
127639826|NCT02811861|459302343|FG001|Overall Study|Other|13|||
127639827|NCT02811861|459302344|FG002|Overall Study|Other|3|||
127639828|NCT02811861|459302342|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
127639829|NCT02811861|459302343|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
127639830|NCT02811861|459302344|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
127639831|NCT02811861|459302342|FG000|Overall Study|Randomized but not treated|2|||
127639832|NCT02811861|459302343|FG001|Overall Study|Randomized but not treated|3|||
127639833|NCT02811861|459302344|FG002|Overall Study|Randomized but not treated|17|||
127639834|NCT02925455|459302345|FG000|Overall Study|Withdrawal by Subject|2|||
127639835|NCT02925455|459302346|FG001|Overall Study|Withdrawal by Subject|0|||
127639836|NCT00360308|459302347|FG000|Overall Study|Adverse Event|15|||
127639837|NCT00360308|459302348|FG001|Overall Study|Adverse Event|14|||
127639838|NCT00360308|459302349|FG002|Overall Study|Adverse Event|25|||
127639839|NCT00360308|459302347|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
127639840|NCT00360308|459302348|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
127639841|NCT00360308|459302349|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
127639842|NCT00360308|459302347|FG000|Overall Study|Protocol Violation|2|||
127639843|NCT00360308|459302348|FG001|Overall Study|Protocol Violation|1|||
127639844|NCT00360308|459302349|FG002|Overall Study|Protocol Violation|2|||
127639845|NCT00360308|459302347|FG000|Overall Study|Withdrawal by Subject|11|||
127639846|NCT00360308|459302348|FG001|Overall Study|Withdrawal by Subject|7|||
127639847|NCT00360308|459302349|FG002|Overall Study|Withdrawal by Subject|14|||
127797206|NCT00953758|459881250|FG009|Overall Study|Lost to Follow-up|1|||
127797207|NCT00953758|459881241|FG000|Overall Study|Physician Decision|0|||
127797208|NCT00953758|459881242|FG001|Overall Study|Physician Decision|0|||
127797209|NCT00953758|459881243|FG002|Overall Study|Physician Decision|0|||
127797210|NCT00953758|459881244|FG003|Overall Study|Physician Decision|0|||
127797211|NCT00953758|459881245|FG004|Overall Study|Physician Decision|1|||
127797212|NCT00953758|459881246|FG005|Overall Study|Physician Decision|0|||
127797213|NCT00953758|459881247|FG006|Overall Study|Physician Decision|0|||
127797214|NCT00953758|459881248|FG007|Overall Study|Physician Decision|0|||
127797215|NCT00953758|459881249|FG008|Overall Study|Physician Decision|0|||
127797216|NCT00953758|459881250|FG009|Overall Study|Physician Decision|0|||
127639848|NCT00360308|459302347|FG000|Overall Study|Lack of Efficacy|3|||
127639849|NCT00360308|459302348|FG001|Overall Study|Lack of Efficacy|0|||
127639850|NCT00360308|459302349|FG002|Overall Study|Lack of Efficacy|2|||
127639851|NCT00360308|459302347|FG000|Overall Study|Other|2|||
127639852|NCT00360308|459302348|FG001|Overall Study|Other|1|||
127639853|NCT00360308|459302349|FG002|Overall Study|Other|1|||
127639854|NCT00360308|459302347|FG000|Overall Study|Study termination by sponsor|43|||
127639855|NCT00360308|459302348|FG001|Overall Study|Study termination by sponsor|55|||
127797217|NCT00953758|459881241|FG000|Overall Study|Disease progression|0|||
127797218|NCT00953758|459881242|FG001|Overall Study|Disease progression|0|||
127797219|NCT00953758|459881243|FG002|Overall Study|Disease progression|0|||
127639856|NCT00360308|459302349|FG002|Overall Study|Study termination by sponsor|44|||
127639857|NCT01217073|459302350|FG000|Base Period|Adverse Event|1|||
127639858|NCT01217073|459302351|FG001|Base Period|Adverse Event|0|||
127639859|NCT01217073|459302352|FG002|Base Period|Adverse Event|1|||
127639860|NCT01217073|459302353|FG003|Base Period|Adverse Event|0|||
127639861|NCT01217073|459302354|FG004|Base Period|Adverse Event|4|||
127639862|NCT01217073|459302355|FG005|Base Period|Adverse Event|1|||
127639863|NCT01217073|459302356|FG006|Base Period|Adverse Event|0|||
127797220|NCT00953758|459881244|FG003|Overall Study|Disease progression|0|||
127639864|NCT01217073|459302357|FG007|Base Period|Adverse Event|0|||
127639865|NCT01217073|459302350|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
127639866|NCT01217073|459302351|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
127639867|NCT01217073|459302352|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
127639868|NCT01217073|459302353|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
127639869|NCT01217073|459302354|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
127639870|NCT01217073|459302355|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
127639871|NCT01217073|459302356|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
127639872|NCT01217073|459302357|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
127639873|NCT01217073|459302350|FG000|Base Period|Excluded medication|0|||
127639874|NCT01217073|459302351|FG001|Base Period|Excluded medication|0|||
127639875|NCT01217073|459302352|FG002|Base Period|Excluded medication|0|||
127639876|NCT01217073|459302353|FG003|Base Period|Excluded medication|0|||
127639877|NCT01217073|459302354|FG004|Base Period|Excluded medication|1|||
127639878|NCT01217073|459302355|FG005|Base Period|Excluded medication|0|||
127639879|NCT01217073|459302356|FG006|Base Period|Excluded medication|0|||
127639880|NCT01217073|459302357|FG007|Base Period|Excluded medication|0|||
127639881|NCT01217073|459302350|FG000|Base Period|Lack of Efficacy|0|||
127639882|NCT01217073|459302351|FG001|Base Period|Lack of Efficacy|0|||
127639883|NCT01217073|459302352|FG002|Base Period|Lack of Efficacy|0|||
127639884|NCT01217073|459302353|FG003|Base Period|Lack of Efficacy|0|||
127639885|NCT01217073|459302354|FG004|Base Period|Lack of Efficacy|0|||
127639886|NCT01217073|459302355|FG005|Base Period|Lack of Efficacy|1|||
127639887|NCT01217073|459302356|FG006|Base Period|Lack of Efficacy|0|||
127639888|NCT01217073|459302357|FG007|Base Period|Lack of Efficacy|0|||
127639889|NCT01217073|459302350|FG000|Base Period|Lost to Follow-up|0|||
127639890|NCT01217073|459302351|FG001|Base Period|Lost to Follow-up|0|||
127639891|NCT01217073|459302352|FG002|Base Period|Lost to Follow-up|1|||
127639892|NCT01217073|459302353|FG003|Base Period|Lost to Follow-up|1|||
127639893|NCT01217073|459302354|FG004|Base Period|Lost to Follow-up|3|||
127639894|NCT01217073|459302355|FG005|Base Period|Lost to Follow-up|0|||
127639895|NCT01217073|459302356|FG006|Base Period|Lost to Follow-up|0|||
127797221|NCT00953758|459881245|FG004|Overall Study|Disease progression|1|||
127797222|NCT00953758|459881246|FG005|Overall Study|Disease progression|0|||
127797223|NCT00953758|459881247|FG006|Overall Study|Disease progression|0|||
127797224|NCT00953758|459881248|FG007|Overall Study|Disease progression|0|||
127797225|NCT00953758|459881249|FG008|Overall Study|Disease progression|0|||
127797226|NCT00953758|459881250|FG009|Overall Study|Disease progression|0|||
127797227|NCT00953758|459881241|FG000|Overall Study|Participant went for transplant|0|||
127797228|NCT00953758|459881242|FG001|Overall Study|Participant went for transplant|0|||
127797229|NCT00953758|459881243|FG002|Overall Study|Participant went for transplant|0|||
127797230|NCT00953758|459881244|FG003|Overall Study|Participant went for transplant|0|||
127797231|NCT00953758|459881245|FG004|Overall Study|Participant went for transplant|0|||
127797232|NCT00953758|459881246|FG005|Overall Study|Participant went for transplant|0|||
127797233|NCT00953758|459881247|FG006|Overall Study|Participant went for transplant|0|||
127797234|NCT00953758|459881248|FG007|Overall Study|Participant went for transplant|0|||
127797235|NCT00953758|459881249|FG008|Overall Study|Participant went for transplant|1|||
127797236|NCT00953758|459881250|FG009|Overall Study|Participant went for transplant|0|||
127797237|NCT01536860|459881251|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
127797238|NCT01536860|459881252|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
127797239|NCT01536860|459881253|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
127797240|NCT01164722|459881254|FG000|Overall Study|Adverse Event|0|||
127797241|NCT01164722|459881255|FG001|Overall Study|Adverse Event|1|||
127797242|NCT01164722|459881254|FG000|Overall Study|Withdrawal by Subject|3|||
127797243|NCT01164722|459881255|FG001|Overall Study|Withdrawal by Subject|4|||
127797244|NCT01164722|459881254|FG000|Overall Study|Lost to Follow-up|3|||
127797245|NCT01164722|459881255|FG001|Overall Study|Lost to Follow-up|6|||
127639896|NCT01217073|459302357|FG007|Base Period|Lost to Follow-up|0|||
127639897|NCT01217073|459302350|FG000|Base Period|Physician Decision|0|||
127639898|NCT01217073|459302351|FG001|Base Period|Physician Decision|0|||
127639899|NCT01217073|459302352|FG002|Base Period|Physician Decision|0|||
127639900|NCT01217073|459302353|FG003|Base Period|Physician Decision|0|||
127797246|NCT01164722|459881254|FG000|Overall Study|met protocol criteria for non-treatment|11|||
127797247|NCT01164722|459881255|FG001|Overall Study|met protocol criteria for non-treatment|1|||
127797248|NCT01164722|459881254|FG000|Overall Study|enrolled on other study, concomitant med|1|||
127797249|NCT01164722|459881255|FG001|Overall Study|enrolled on other study, concomitant med|3|||
127797250|NCT00999908|459881256|FG000|Treatment Period 1|Subject withdrew consent|2|||
127797251|NCT00999908|459881257|FG001|Treatment Period 1|Subject withdrew consent|0|||
127639901|NCT01217073|459302354|FG004|Base Period|Physician Decision|1|||
127639902|NCT01217073|459302355|FG005|Base Period|Physician Decision|0|||
127639903|NCT01217073|459302356|FG006|Base Period|Physician Decision|0|||
127639904|NCT01217073|459302357|FG007|Base Period|Physician Decision|0|||
127639905|NCT01217073|459302350|FG000|Base Period|Protocol Violation|1|||
127639906|NCT01217073|459302351|FG001|Base Period|Protocol Violation|0|||
127639907|NCT01217073|459302352|FG002|Base Period|Protocol Violation|0|||
127639908|NCT01217073|459302353|FG003|Base Period|Protocol Violation|0|||
127639909|NCT01217073|459302354|FG004|Base Period|Protocol Violation|1|||
127797252|NCT00999908|459881258|FG002|Treatment Period 1|Subject withdrew consent|0|||
127797253|NCT00999908|459881256|FG000|Treatment Period 2|Protocol Violation|1|||
127797254|NCT00999908|459881257|FG001|Treatment Period 2|Protocol Violation|0|||
127797255|NCT00999908|459881258|FG002|Treatment Period 2|Protocol Violation|0|||
127797256|NCT01290692|459881263|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
127797257|NCT00993031|459881267|FG000|Overall Study|Death|0|||
127797258|NCT00993031|459881268|FG001|Overall Study|Death|1|||
127797259|NCT00993031|459881267|FG000|Overall Study|Physician Decision|0|||
127797260|NCT00993031|459881268|FG001|Overall Study|Physician Decision|2|||
127797261|NCT00993031|459881267|FG000|Overall Study|Withdrawal by Subject|3|||
127797262|NCT00993031|459881268|FG001|Overall Study|Withdrawal by Subject|3|||
127797263|NCT00993031|459881267|FG000|Overall Study|Lost to Follow-up|19|||
127797264|NCT00993031|459881268|FG001|Overall Study|Lost to Follow-up|13|||
127797265|NCT01543087|459881270|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
127797266|NCT01543087|459881271|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
127797267|NCT01543087|459881272|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
127797268|NCT01543087|459881273|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
127797269|NCT01543087|459881274|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
127797270|NCT01543087|459881275|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
127797271|NCT01543087|459881270|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
127797272|NCT01543087|459881271|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
127797273|NCT01543087|459881272|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
127797274|NCT01543087|459881273|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
127797275|NCT01543087|459881274|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
127797276|NCT01543087|459881275|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
127797277|NCT01543087|459881270|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
127797278|NCT01543087|459881271|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
127797279|NCT01543087|459881272|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
127797280|NCT01543087|459881273|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
127797281|NCT01543087|459881274|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
127797282|NCT01543087|459881275|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
127797283|NCT01543087|459881270|FG000|Stage 1 (48 Months)|Other than specified|5|||
127797284|NCT01543087|459881271|FG001|Stage 1 (48 Months)|Other than specified|0|||
127797285|NCT01543087|459881272|FG002|Stage 1 (48 Months)|Other than specified|9|||
127797286|NCT01543087|459881273|FG003|Stage 1 (48 Months)|Other than specified|0|||
127797287|NCT01543087|459881274|FG004|Stage 1 (48 Months)|Other than specified|0|||
127797288|NCT01543087|459881275|FG005|Stage 1 (48 Months)|Other than specified|0|||
127797289|NCT01543087|459881270|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
127797290|NCT01543087|459881271|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
127797291|NCT01543087|459881272|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
127797292|NCT01543087|459881273|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
127797293|NCT01543087|459881274|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
127639910|NCT01217073|459302355|FG005|Base Period|Protocol Violation|2|||
127797294|NCT01543087|459881275|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
127797295|NCT01543087|459881270|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
127797296|NCT01543087|459881271|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
127797297|NCT01543087|459881272|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
127797298|NCT01543087|459881273|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
127797299|NCT01543087|459881274|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
127797300|NCT01543087|459881275|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
127797301|NCT01543087|459881270|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
127797302|NCT01543087|459881271|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
127797303|NCT01543087|459881272|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
127797304|NCT01543087|459881273|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
127797305|NCT01543087|459881274|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
127797306|NCT01543087|459881275|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
127797307|NCT00706030|459881276|FG000|Overall Study|Disease Progression|4|||
127797308|NCT00706030|459881277|FG001|Overall Study|Disease Progression|6|||
127797309|NCT00706030|459881278|FG002|Overall Study|Disease Progression|46|||
127797310|NCT00706030|459881279|FG003|Overall Study|Disease Progression|12|||
127797311|NCT00706030|459881276|FG000|Overall Study|Adverse Event|1|||
127797312|NCT00706030|459881277|FG001|Overall Study|Adverse Event|0|||
127797313|NCT00706030|459881278|FG002|Overall Study|Adverse Event|4|||
127797314|NCT00706030|459881279|FG003|Overall Study|Adverse Event|2|||
127797315|NCT00706030|459881276|FG000|Overall Study|Withdrawal by Subject|1|||
127797316|NCT00706030|459881277|FG001|Overall Study|Withdrawal by Subject|0|||
127797317|NCT00706030|459881278|FG002|Overall Study|Withdrawal by Subject|2|||
127797318|NCT00706030|459881279|FG003|Overall Study|Withdrawal by Subject|0|||
127797319|NCT00706030|459881276|FG000|Overall Study|Physician Decision|0|||
127797320|NCT00706030|459881277|FG001|Overall Study|Physician Decision|0|||
127797321|NCT00706030|459881278|FG002|Overall Study|Physician Decision|2|||
127797322|NCT00706030|459881279|FG003|Overall Study|Physician Decision|0|||
127797323|NCT00706030|459881276|FG000|Overall Study|Not recorded|0|||
127797324|NCT00706030|459881277|FG001|Overall Study|Not recorded|0|||
127797325|NCT00706030|459881278|FG002|Overall Study|Not recorded|2|||
127797326|NCT00706030|459881279|FG003|Overall Study|Not recorded|0|||
127797327|NCT00706030|459881276|FG000|Overall Study|Protocol Violation|0|||
127797328|NCT00706030|459881277|FG001|Overall Study|Protocol Violation|0|||
127797329|NCT00706030|459881278|FG002|Overall Study|Protocol Violation|1|||
127797330|NCT00706030|459881279|FG003|Overall Study|Protocol Violation|1|||
127797331|NCT00706030|459881276|FG000|Overall Study|Failed to return|0|||
127797332|NCT00706030|459881277|FG001|Overall Study|Failed to return|0|||
127797333|NCT00706030|459881278|FG002|Overall Study|Failed to return|1|||
127797334|NCT00706030|459881279|FG003|Overall Study|Failed to return|0|||
127797335|NCT00706030|459881276|FG000|Overall Study|Symptomatic Deterioration|0|||
127797336|NCT00706030|459881277|FG001|Overall Study|Symptomatic Deterioration|0|||
127797337|NCT00706030|459881278|FG002|Overall Study|Symptomatic Deterioration|1|||
127797338|NCT00706030|459881279|FG003|Overall Study|Symptomatic Deterioration|0|||
127797339|NCT00706030|459881276|FG000|Overall Study|No treatment received|0|||
127797340|NCT00706030|459881277|FG001|Overall Study|No treatment received|0|||
127797341|NCT00706030|459881278|FG002|Overall Study|No treatment received|0|||
127797342|NCT00706030|459881279|FG003|Overall Study|No treatment received|1|||
127797343|NCT00706030|459881276|FG000|Overall Study|Death|0|||
127797344|NCT00706030|459881277|FG001|Overall Study|Death|0|||
127797345|NCT00706030|459881278|FG002|Overall Study|Death|1|||
127797346|NCT00706030|459881279|FG003|Overall Study|Death|0|||
127797347|NCT02682901|459881280|FG000|Overall Study|Adverse Event|10|||
127797348|NCT02682901|459881281|FG001|Overall Study|Adverse Event|3|||
127797349|NCT02682901|459881280|FG000|Overall Study|Lack of Efficacy|0|||
127797350|NCT02682901|459881281|FG001|Overall Study|Lack of Efficacy|1|||
127797351|NCT03870555|459881282|FG000|Period 3 (2 Days)|Adverse Event|1|||
127797352|NCT03870555|459881283|FG001|Period 3 (2 Days)|Adverse Event|0|||
127797353|NCT03870555|459881284|FG002|Period 3 (2 Days)|Adverse Event|0|||
127797354|NCT03167073|459881287|FG000|Overall Study|Stillbirth|1|||
127797355|NCT03167073|459881288|FG001|Overall Study|Stillbirth|0|||
127797356|NCT02573155|459881289|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
127797357|NCT02573155|459881290|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
127797358|NCT02573155|459881289|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
127797359|NCT02573155|459881290|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
127797360|NCT02573155|459881289|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
127797361|NCT02573155|459881290|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
127797362|NCT02573155|459881289|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
127797363|NCT02573155|459881290|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
127797364|NCT02573155|459881289|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
127797365|NCT02573155|459881290|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
127797366|NCT02573155|459881289|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
127797367|NCT02573155|459881290|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
127797368|NCT02573155|459881289|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
127797369|NCT02573155|459881290|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
127797370|NCT02573155|459881289|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
127797371|NCT02573155|459881290|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
127797372|NCT01681433|459881291|FG000|Overall Study|Lack of Efficacy|23|||
127797373|NCT01681433|459881292|FG001|Overall Study|Lack of Efficacy|23|||
127797374|NCT01681433|459881291|FG000|Overall Study|Withdrawal by Subject|5|||
127797375|NCT01681433|459881292|FG001|Overall Study|Withdrawal by Subject|5|||
127797376|NCT01681433|459881291|FG000|Overall Study|Protocol Violation|2|||
127797377|NCT01681433|459881292|FG001|Overall Study|Protocol Violation|0|||
127797378|NCT01681433|459881291|FG000|Overall Study|Adverse Event|2|||
127797379|NCT01681433|459881292|FG001|Overall Study|Adverse Event|4|||
127797380|NCT01681433|459881291|FG000|Overall Study|Lost to Follow-up|0|||
127797381|NCT01681433|459881292|FG001|Overall Study|Lost to Follow-up|1|||
127797382|NCT02301403|459881293|FG000|Overall Study|Withdrawal by Subject|28|||
127797383|NCT02301403|459881294|FG001|Overall Study|Withdrawal by Subject|41|||
127797384|NCT03434977|459881295|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
127797385|NCT03434977|459881296|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
127797386|NCT03064841|459881297|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
127797387|NCT03064841|459881297|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
127797388|NCT03064841|459881297|FG000|Overall Study|Screen failure|2|||
127797389|NCT00217087|459881298|FG000|Overall Study|decided to have esophagectomy|1|||
127797390|NCT00217087|459881299|FG001|Overall Study|decided to have esophagectomy|2|||
127797391|NCT00217087|459881298|FG000|Overall Study|completed less than 12 months return|10|||
127797392|NCT00217087|459881299|FG001|Overall Study|completed less than 12 months return|18|||
127797393|NCT03920670|459881300|FG000|Overall Study|Protocol Violation|2|||
127797394|NCT03920670|459881301|FG001|Overall Study|Protocol Violation|2|||
127797395|NCT03920670|459881300|FG000|Overall Study|Adverse Event|1|||
127797396|NCT03920670|459881301|FG001|Overall Study|Adverse Event|0|||
127797397|NCT04770779|459881318|FG000|Overall Study|Randomized, never treated|0|||
127639911|NCT01217073|459302356|FG006|Base Period|Protocol Violation|0|||
127639912|NCT01217073|459302357|FG007|Base Period|Protocol Violation|0|||
127639913|NCT01217073|459302350|FG000|Base Period|Withdrawal by Subject|4|||
127639914|NCT01217073|459302351|FG001|Base Period|Withdrawal by Subject|5|||
127639915|NCT01217073|459302352|FG002|Base Period|Withdrawal by Subject|5|||
127797398|NCT04770779|459881319|FG001|Overall Study|Randomized, never treated|1|||
127797399|NCT04770779|459881318|FG000|Overall Study|Adverse Event|9|||
127797400|NCT04770779|459881319|FG001|Overall Study|Adverse Event|1|||
127797401|NCT04770779|459881318|FG000|Overall Study|Withdrawal by Subject|7|||
127797402|NCT04770779|459881319|FG001|Overall Study|Withdrawal by Subject|1|||
127797403|NCT04770779|459881318|FG000|Overall Study|Pregnancy|0|||
127797404|NCT04770779|459881319|FG001|Overall Study|Pregnancy|1|||
127797405|NCT02321436|459881320|FG000|Overall Study|Withdrawal by Subject|1|||
127797406|NCT02321436|459881321|FG001|Overall Study|Withdrawal by Subject|0|||
127797407|NCT02321436|459881320|FG000|Overall Study|Lost to Follow-up|0|||
127797408|NCT02321436|459881321|FG001|Overall Study|Lost to Follow-up|1|||
127797409|NCT04137887|459883399|FG000|Overall Study|Death|102|||
127797410|NCT04137887|459883400|FG001|Overall Study|Death|92|||
127797411|NCT04137887|459883399|FG000|Overall Study|Withdrawal by Subject|2|||
127797412|NCT04137887|459883400|FG001|Overall Study|Withdrawal by Subject|3|||
127797413|NCT04137887|459883399|FG000|Overall Study|Randomized but not treated|0|||
127797414|NCT04137887|459883400|FG001|Overall Study|Randomized but not treated|1|||
127797415|NCT01790503|459883403|FG000|Overall Study|Adverse Event|1|||
127797416|NCT01790503|459883404|FG001|Overall Study|Adverse Event|0|||
127797417|NCT01790503|459883405|FG002|Overall Study|Adverse Event|0|||
127797418|NCT01790503|459883406|FG003|Overall Study|Adverse Event|0|||
127797419|NCT01790503|459883407|FG004|Overall Study|Adverse Event|0|||
127797420|NCT01790503|459883408|FG005|Overall Study|Adverse Event|2|||
127797421|NCT01790503|459883409|FG006|Overall Study|Adverse Event|0|||
127797422|NCT01790503|459883410|FG007|Overall Study|Adverse Event|0|||
127797423|NCT01790503|459883411|FG008|Overall Study|Adverse Event|2|||
127797424|NCT01790503|459883412|FG009|Overall Study|Adverse Event|4|||
127797425|NCT01790503|459883413|FG010|Overall Study|Adverse Event|7|||
127797426|NCT01790503|459883403|FG000|Overall Study|Withdrawal by Subject|0|||
127797427|NCT01790503|459883404|FG001|Overall Study|Withdrawal by Subject|0|||
127797428|NCT01790503|459883405|FG002|Overall Study|Withdrawal by Subject|1|||
127797429|NCT01790503|459883406|FG003|Overall Study|Withdrawal by Subject|1|||
127797430|NCT01790503|459883407|FG004|Overall Study|Withdrawal by Subject|1|||
127797431|NCT01790503|459883408|FG005|Overall Study|Withdrawal by Subject|2|||
127797432|NCT01790503|459883409|FG006|Overall Study|Withdrawal by Subject|1|||
127639916|NCT01217073|459302353|FG003|Base Period|Withdrawal by Subject|1|||
127797433|NCT01790503|459883410|FG007|Overall Study|Withdrawal by Subject|0|||
127797434|NCT01790503|459883411|FG008|Overall Study|Withdrawal by Subject|0|||
127797435|NCT01790503|459883412|FG009|Overall Study|Withdrawal by Subject|0|||
127797436|NCT01790503|459883413|FG010|Overall Study|Withdrawal by Subject|1|||
127797437|NCT01790503|459883403|FG000|Overall Study|Disease progression|2|||
127639917|NCT01217073|459302354|FG004|Base Period|Withdrawal by Subject|5|||
127797438|NCT01790503|459883404|FG001|Overall Study|Disease progression|1|||
127797439|NCT01790503|459883405|FG002|Overall Study|Disease progression|0|||
127797440|NCT01790503|459883406|FG003|Overall Study|Disease progression|1|||
127797441|NCT01790503|459883407|FG004|Overall Study|Disease progression|2|||
127797442|NCT01790503|459883408|FG005|Overall Study|Disease progression|1|||
127797443|NCT01790503|459883409|FG006|Overall Study|Disease progression|0|||
127797444|NCT01790503|459883410|FG007|Overall Study|Disease progression|1|||
127797445|NCT01790503|459883411|FG008|Overall Study|Disease progression|0|||
127797446|NCT01790503|459883412|FG009|Overall Study|Disease progression|17|||
127797447|NCT01790503|459883413|FG010|Overall Study|Disease progression|7|||
127797448|NCT01790503|459883403|FG000|Overall Study|Protocol Violation|0|||
127797449|NCT01790503|459883404|FG001|Overall Study|Protocol Violation|0|||
127797450|NCT01790503|459883405|FG002|Overall Study|Protocol Violation|0|||
127797451|NCT01790503|459883406|FG003|Overall Study|Protocol Violation|0|||
127797452|NCT01790503|459883407|FG004|Overall Study|Protocol Violation|0|||
127797453|NCT01790503|459883408|FG005|Overall Study|Protocol Violation|0|||
127797454|NCT01790503|459883409|FG006|Overall Study|Protocol Violation|0|||
127797455|NCT01790503|459883410|FG007|Overall Study|Protocol Violation|0|||
127797456|NCT01790503|459883411|FG008|Overall Study|Protocol Violation|0|||
127797457|NCT01790503|459883412|FG009|Overall Study|Protocol Violation|1|||
127797458|NCT01790503|459883413|FG010|Overall Study|Protocol Violation|0|||
127797459|NCT01790503|459883403|FG000|Overall Study|Physician Decision|0|||
127797460|NCT01790503|459883404|FG001|Overall Study|Physician Decision|0|||
127797461|NCT01790503|459883405|FG002|Overall Study|Physician Decision|0|||
127797462|NCT01790503|459883406|FG003|Overall Study|Physician Decision|0|||
127797463|NCT01790503|459883407|FG004|Overall Study|Physician Decision|0|||
127797464|NCT01790503|459883408|FG005|Overall Study|Physician Decision|0|||
127797465|NCT01790503|459883409|FG006|Overall Study|Physician Decision|0|||
127797466|NCT01790503|459883410|FG007|Overall Study|Physician Decision|0|||
127797467|NCT01790503|459883411|FG008|Overall Study|Physician Decision|0|||
127797468|NCT01790503|459883412|FG009|Overall Study|Physician Decision|1|||
127797469|NCT01790503|459883413|FG010|Overall Study|Physician Decision|1|||
127797470|NCT01790503|459883403|FG000|Overall Study|Death|0|||
127797471|NCT01790503|459883404|FG001|Overall Study|Death|0|||
127797472|NCT01790503|459883405|FG002|Overall Study|Death|0|||
127797473|NCT01790503|459883406|FG003|Overall Study|Death|0|||
127797474|NCT01790503|459883407|FG004|Overall Study|Death|0|||
127797475|NCT01790503|459883408|FG005|Overall Study|Death|0|||
127797476|NCT01790503|459883409|FG006|Overall Study|Death|0|||
127797477|NCT01790503|459883410|FG007|Overall Study|Death|0|||
127797478|NCT01790503|459883411|FG008|Overall Study|Death|0|||
127797479|NCT01790503|459883412|FG009|Overall Study|Death|1|||
127797480|NCT01790503|459883413|FG010|Overall Study|Death|0|||
127797481|NCT01790503|459883403|FG000|Overall Study|Non Compliance|0|||
127797482|NCT01790503|459883404|FG001|Overall Study|Non Compliance|0|||
127797483|NCT01790503|459883405|FG002|Overall Study|Non Compliance|0|||
127797484|NCT01790503|459883406|FG003|Overall Study|Non Compliance|0|||
127797485|NCT01790503|459883407|FG004|Overall Study|Non Compliance|1|||
127797486|NCT01790503|459883408|FG005|Overall Study|Non Compliance|0|||
127797487|NCT01790503|459883409|FG006|Overall Study|Non Compliance|0|||
127797488|NCT01790503|459883410|FG007|Overall Study|Non Compliance|0|||
127797489|NCT01790503|459883411|FG008|Overall Study|Non Compliance|0|||
127797490|NCT01790503|459883412|FG009|Overall Study|Non Compliance|0|||
127797491|NCT01790503|459883413|FG010|Overall Study|Non Compliance|0|||
127797492|NCT01790503|459883403|FG000|Overall Study|Other|0|||
127797493|NCT01790503|459883404|FG001|Overall Study|Other|0|||
127797494|NCT01790503|459883405|FG002|Overall Study|Other|0|||
127797495|NCT01790503|459883406|FG003|Overall Study|Other|0|||
127797496|NCT01790503|459883407|FG004|Overall Study|Other|1|||
127797497|NCT01790503|459883408|FG005|Overall Study|Other|0|||
127797498|NCT01790503|459883409|FG006|Overall Study|Other|0|||
127639918|NCT01217073|459302355|FG005|Base Period|Withdrawal by Subject|5|||
127639919|NCT01217073|459302356|FG006|Base Period|Withdrawal by Subject|0|||
127639920|NCT01217073|459302357|FG007|Base Period|Withdrawal by Subject|0|||
127797499|NCT01790503|459883410|FG007|Overall Study|Other|0|||
127797500|NCT01790503|459883411|FG008|Overall Study|Other|1|||
127797501|NCT01790503|459883412|FG009|Overall Study|Other|2|||
127639921|NCT01217073|459302350|FG000|Extension Period|Adverse Event|0|||
127639922|NCT01217073|459302351|FG001|Extension Period|Adverse Event|0|||
127639923|NCT01217073|459302352|FG002|Extension Period|Adverse Event|0|||
127797502|NCT01790503|459883413|FG010|Overall Study|Other|0|||
127797503|NCT00984204|459883425|FG000|Overall Study|Death|1|||
127797504|NCT00984204|459883425|FG000|Overall Study|Lost to Follow-up|4|||
127797505|NCT00984204|459883425|FG000|Overall Study|Lack of Efficacy|10|||
127797506|NCT01268293|459883427|FG000|Overall Study|Disease progression|7|||
127797507|NCT01268293|459883427|FG000|Overall Study|Adverse Event|1|||
127797508|NCT01268293|459883427|FG000|Overall Study|Subject choice|1|||
127797509|NCT05702515|459883428|FG000|Overall Study|7 patients were excluded due to the inability to complete a chest radiograph.|7|||
127797510|NCT01396005|459883429|FG000|Overall Study|Withdrawal by Subject|0|||
127797511|NCT01396005|459883430|FG001|Overall Study|Withdrawal by Subject|1|||
127797512|NCT01396005|459883429|FG000|Overall Study|Non-compliance with protocol|0|||
127797513|NCT01396005|459883430|FG001|Overall Study|Non-compliance with protocol|1|||
127797514|NCT00424827|459883431|FG000|Overall Study|Adverse Event|1|||
127797515|NCT03757988|459883432|FG000|Overall Study|Withdrawal by Subject|1|||
127797516|NCT03237065|459883435|FG000|Overall Study|Adverse Event|0|||
127797517|NCT03237065|459883436|FG001|Overall Study|Adverse Event|2|||
127797518|NCT03237065|459883435|FG000|Overall Study|Protocol Violation|0|||
127797519|NCT03237065|459883436|FG001|Overall Study|Protocol Violation|1|||
127797520|NCT03237065|459883435|FG000|Overall Study|Withdrawal by Subject|3|||
127797521|NCT03237065|459883436|FG001|Overall Study|Withdrawal by Subject|0|||
127797522|NCT03237065|459883435|FG000|Overall Study|Lost to Follow-up|1|||
127797523|NCT03237065|459883436|FG001|Overall Study|Lost to Follow-up|0|||
127797524|NCT03237065|459883435|FG000|Overall Study|Unable to obtain venous access|0|||
127797525|NCT03237065|459883436|FG001|Overall Study|Unable to obtain venous access|1|||
127797526|NCT00209339|459883437|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
127797527|NCT00209339|459883437|FG000|At 12 Months Follow-up|Death|1|||
127797528|NCT00209339|459883437|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
127797529|NCT00209339|459883437|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
127797530|NCT00209339|459883437|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
127797531|NCT00209339|459883437|FG000|At 24 Months Follow-up|Death|1|||
127797532|NCT00209339|459883437|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
127797533|NCT00209339|459883437|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
127797534|NCT00209339|459883437|FG000|At 4 Years Follow-up|Death|1|||
127797535|NCT00209339|459883437|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
127797536|NCT00209339|459883437|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
127797537|NCT00209339|459883437|FG000|At 5 Years Follow-up|Death|1|||
127797538|NCT01764633|459883438|FG000|Overall Study|Withdrawal by Subject|105|||
127797539|NCT01764633|459883439|FG001|Overall Study|Withdrawal by Subject|88|||
127797540|NCT01764633|459883438|FG000|Overall Study|Lost to Follow-up|13|||
127797541|NCT01764633|459883439|FG001|Overall Study|Lost to Follow-up|5|||
127797542|NCT02268058|459883440|FG000|Overall Study|Protocol Violation|1|||
127797543|NCT02268058|459883441|FG001|Overall Study|Protocol Violation|0|||
127797544|NCT02268058|459883442|FG002|Overall Study|Protocol Violation|0|||
127797545|NCT02268058|459883443|FG003|Overall Study|Protocol Violation|0|||
127797546|NCT04418765|459883444|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
127797547|NCT04418765|459883445|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
127797548|NCT04418765|459883446|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
127797549|NCT04418765|459883444|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
127797550|NCT04418765|459883445|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
127797551|NCT04418765|459883446|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
127797552|NCT04418765|459883444|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
127797553|NCT04418765|459883445|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
127797554|NCT04418765|459883446|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
127797555|NCT04418765|459883444|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
127797556|NCT04418765|459883445|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
127797557|NCT04418765|459883446|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
127797558|NCT04418765|459883444|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
127797559|NCT04418765|459883445|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
127797560|NCT04418765|459883446|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
127797561|NCT04418765|459883444|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
127797562|NCT04418765|459883445|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
127797563|NCT04418765|459883446|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
127797564|NCT04418765|459883444|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
127797565|NCT04418765|459883445|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
127797566|NCT04418765|459883446|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
127797567|NCT04418765|459883444|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
127797568|NCT04418765|459883445|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
127797569|NCT04418765|459883446|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
127797570|NCT04418765|459883444|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
127797571|NCT04418765|459883445|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
127797572|NCT04418765|459883446|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
127797573|NCT04418765|459883444|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
127797574|NCT04418765|459883445|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
127797575|NCT04418765|459883446|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
127797576|NCT04418765|459883444|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
127797577|NCT04418765|459883445|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
127797578|NCT04418765|459883446|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
127797579|NCT04418765|459883444|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
127797580|NCT04418765|459883445|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
127797581|NCT04418765|459883446|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
127797582|NCT04418765|459883444|FG000|Extension Period (48 Weeks)|Other than specified|0|||
127797583|NCT04418765|459883445|FG001|Extension Period (48 Weeks)|Other than specified|5|||
127797584|NCT04418765|459883446|FG002|Extension Period (48 Weeks)|Other than specified|2|||
127797585|NCT01121393|459883447|FG000|Overall Study|Progressive disease|201|||
127797586|NCT01121393|459883448|FG001|Overall Study|Progressive disease|20|||
127797587|NCT01121393|459883447|FG000|Overall Study|Other Adverse events|24|||
127797588|NCT01121393|459883448|FG001|Overall Study|Other Adverse events|45|||
127797589|NCT01121393|459883447|FG000|Overall Study|Non-compliant with protocol|0|||
127797590|NCT01121393|459883448|FG001|Overall Study|Non-compliant with protocol|3|||
127797591|NCT01121393|459883447|FG000|Overall Study|Lost to Follow-up|1|||
127797592|NCT01121393|459883448|FG001|Overall Study|Lost to Follow-up|0|||
127797593|NCT01121393|459883447|FG000|Overall Study|Refused cont. medication|7|||
127797594|NCT01121393|459883448|FG001|Overall Study|Refused cont. medication|7|||
127797595|NCT01121393|459883447|FG000|Overall Study|Not treated|3|||
127797596|NCT01121393|459883448|FG001|Overall Study|Not treated|9|||
127797597|NCT01121393|459883447|FG000|Overall Study|Other than listed|6|||
127797598|NCT01121393|459883448|FG001|Overall Study|Other than listed|0|||
127797599|NCT01100944|459883449|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
127797600|NCT01100944|459883450|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
127797601|NCT01100944|459883451|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
127797602|NCT01100944|459883449|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
127797603|NCT01100944|459883450|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
127797604|NCT01100944|459883451|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
127797605|NCT01100944|459883449|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
127797606|NCT01100944|459883450|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
127797607|NCT01100944|459883451|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
127797608|NCT01100944|459883449|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
127797609|NCT01100944|459883450|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
127797610|NCT01100944|459883451|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
127797611|NCT00577993|459883452|FG000|Overall Study|Adverse Event|1|||
127797612|NCT00577993|459883453|FG001|Overall Study|Adverse Event|0|||
127797613|NCT00577993|459883454|FG002|Overall Study|Adverse Event|0|||
127797614|NCT00577993|459883452|FG000|Overall Study|Death|0|||
127797615|NCT00577993|459883453|FG001|Overall Study|Death|1|||
127797616|NCT00577993|459883454|FG002|Overall Study|Death|1|||
127797617|NCT00577993|459883452|FG000|Overall Study|Lack of Efficacy|0|||
127797618|NCT00577993|459883453|FG001|Overall Study|Lack of Efficacy|1|||
127797619|NCT00577993|459883454|FG002|Overall Study|Lack of Efficacy|0|||
127797620|NCT00577993|459883452|FG000|Overall Study|Protocol Violation|2|||
127797621|NCT00577993|459883453|FG001|Overall Study|Protocol Violation|3|||
127797622|NCT00577993|459883454|FG002|Overall Study|Protocol Violation|0|||
127797623|NCT00577993|459883452|FG000|Overall Study|Withdrawal by Subject|1|||
127797624|NCT00577993|459883453|FG001|Overall Study|Withdrawal by Subject|0|||
127797625|NCT00577993|459883454|FG002|Overall Study|Withdrawal by Subject|2|||
127797626|NCT00577993|459883452|FG000|Overall Study|Conversion|2|||
127797627|NCT00577993|459883453|FG001|Overall Study|Conversion|5|||
127797628|NCT00577993|459883454|FG002|Overall Study|Conversion|0|||
127797629|NCT00577993|459883452|FG000|Overall Study|Uninsured|1|||
127797630|NCT00577993|459883453|FG001|Overall Study|Uninsured|0|||
127797631|NCT00577993|459883454|FG002|Overall Study|Uninsured|0|||
127797632|NCT02296242|459883457|FG000|Overall Study|Death|1|||
127797633|NCT02296242|459883458|FG001|Overall Study|Death|1|||
127797634|NCT02296242|459883459|FG002|Overall Study|Death|1|||
127797635|NCT02296242|459883460|FG003|Overall Study|Death|1|||
127797636|NCT02296242|459883461|FG004|Overall Study|Death|1|||
127797637|NCT02296242|459883457|FG000|Overall Study|Withdrawal by Subject|0|||
127797638|NCT02296242|459883458|FG001|Overall Study|Withdrawal by Subject|0|||
127797639|NCT02296242|459883459|FG002|Overall Study|Withdrawal by Subject|1|||
127797640|NCT02296242|459883460|FG003|Overall Study|Withdrawal by Subject|1|||
127797641|NCT02296242|459883461|FG004|Overall Study|Withdrawal by Subject|3|||
127797642|NCT02296242|459883457|FG000|Overall Study|Disease Progression|1|||
127797643|NCT02296242|459883458|FG001|Overall Study|Disease Progression|3|||
127797644|NCT02296242|459883459|FG002|Overall Study|Disease Progression|2|||
127797645|NCT02296242|459883460|FG003|Overall Study|Disease Progression|8|||
127797646|NCT02296242|459883461|FG004|Overall Study|Disease Progression|11|||
127797647|NCT02296242|459883457|FG000|Overall Study|Unacceptable Toxicity|0|||
127797648|NCT02296242|459883458|FG001|Overall Study|Unacceptable Toxicity|0|||
127797649|NCT02296242|459883459|FG002|Overall Study|Unacceptable Toxicity|0|||
127797650|NCT02296242|459883460|FG003|Overall Study|Unacceptable Toxicity|0|||
127797651|NCT02296242|459883461|FG004|Overall Study|Unacceptable Toxicity|1|||
127797652|NCT02296242|459883457|FG000|Overall Study|Patient Condition Changed|0|||
127886442|NCT02919475|460208559|FG001|Overall Study|Death|1|||
127797653|NCT02296242|459883458|FG001|Overall Study|Patient Condition Changed|0|||
127797654|NCT02296242|459883459|FG002|Overall Study|Patient Condition Changed|2|||
127797655|NCT02296242|459883460|FG003|Overall Study|Patient Condition Changed|0|||
127797656|NCT02296242|459883461|FG004|Overall Study|Patient Condition Changed|1|||
127797657|NCT02296242|459883457|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
127797658|NCT02296242|459883458|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
127797659|NCT02296242|459883459|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
127886443|NCT02919475|460208560|FG002|Overall Study|Death|0|||
127797660|NCT02296242|459883460|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
127797661|NCT02296242|459883461|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
127797662|NCT02296242|459883457|FG000|Overall Study|Lost to Follow-up|1|||
127797663|NCT02296242|459883458|FG001|Overall Study|Lost to Follow-up|0|||
127797664|NCT02296242|459883459|FG002|Overall Study|Lost to Follow-up|0|||
127797665|NCT02296242|459883460|FG003|Overall Study|Lost to Follow-up|0|||
127797666|NCT02296242|459883461|FG004|Overall Study|Lost to Follow-up|0|||
127797667|NCT02296242|459883457|FG000|Overall Study|Need for Hydroxyurea|2|||
127797668|NCT02296242|459883458|FG001|Overall Study|Need for Hydroxyurea|0|||
127797669|NCT02296242|459883459|FG002|Overall Study|Need for Hydroxyurea|0|||
127797670|NCT02296242|459883460|FG003|Overall Study|Need for Hydroxyurea|0|||
127797671|NCT02296242|459883461|FG004|Overall Study|Need for Hydroxyurea|0|||
127797672|NCT02296242|459883457|FG000|Overall Study|Screened for Other Protocol|0|||
127797673|NCT02296242|459883458|FG001|Overall Study|Screened for Other Protocol|1|||
127797674|NCT02296242|459883459|FG002|Overall Study|Screened for Other Protocol|0|||
127797675|NCT02296242|459883460|FG003|Overall Study|Screened for Other Protocol|0|||
127797676|NCT02296242|459883461|FG004|Overall Study|Screened for Other Protocol|0|||
127797677|NCT02296242|459883457|FG000|Overall Study|Physician Decision|0|||
127797678|NCT02296242|459883458|FG001|Overall Study|Physician Decision|1|||
127797679|NCT02296242|459883459|FG002|Overall Study|Physician Decision|0|||
127797680|NCT02296242|459883460|FG003|Overall Study|Physician Decision|1|||
127797681|NCT02296242|459883461|FG004|Overall Study|Physician Decision|0|||
127797682|NCT02296242|459883457|FG000|Overall Study|Alternative Treatment|0|||
127797683|NCT02296242|459883458|FG001|Overall Study|Alternative Treatment|0|||
127797684|NCT02296242|459883459|FG002|Overall Study|Alternative Treatment|0|||
127797685|NCT02296242|459883460|FG003|Overall Study|Alternative Treatment|1|||
127797686|NCT02296242|459883461|FG004|Overall Study|Alternative Treatment|0|||
127797687|NCT02296242|459883457|FG000|Overall Study|Adverse Event|0|||
127797688|NCT02296242|459883458|FG001|Overall Study|Adverse Event|0|||
127797689|NCT02296242|459883459|FG002|Overall Study|Adverse Event|0|||
127797690|NCT02296242|459883460|FG003|Overall Study|Adverse Event|1|||
127797691|NCT02296242|459883461|FG004|Overall Study|Adverse Event|0|||
127797692|NCT02296242|459883457|FG000|Overall Study|Lack of Efficacy|0|||
127797693|NCT02296242|459883458|FG001|Overall Study|Lack of Efficacy|0|||
127797694|NCT02296242|459883459|FG002|Overall Study|Lack of Efficacy|0|||
127797695|NCT02296242|459883460|FG003|Overall Study|Lack of Efficacy|0|||
127797696|NCT02296242|459883461|FG004|Overall Study|Lack of Efficacy|3|||
127797697|NCT02217566|459883462|FG000|Overall Study|Lost to Follow-up|2|||
127797698|NCT02217566|459883462|FG000|Overall Study|Death|3|||
127797699|NCT02217566|459883462|FG000|Overall Study|Early study termination|6|||
127797700|NCT02574637|459883470|FG000|Double-blind Period|Adverse Event|1|||
127797701|NCT02574637|459883471|FG001|Double-blind Period|Adverse Event|0|||
127797702|NCT02574637|459883472|FG002|Double-blind Period|Adverse Event|0|||
127797703|NCT02574637|459883473|FG003|Double-blind Period|Adverse Event|0|||
127797704|NCT02574637|459883474|FG004|Double-blind Period|Adverse Event|0|||
127797705|NCT02574637|459883475|FG005|Double-blind Period|Adverse Event|0|||
127639924|NCT01217073|459302353|FG003|Extension Period|Adverse Event|0|||
127639925|NCT01217073|459302354|FG004|Extension Period|Adverse Event|0|||
127639926|NCT01217073|459302355|FG005|Extension Period|Adverse Event|0|||
127639927|NCT01217073|459302356|FG006|Extension Period|Adverse Event|19|||
127639928|NCT01217073|459302357|FG007|Extension Period|Adverse Event|5|||
127639929|NCT01217073|459302350|FG000|Extension Period|ALT/AST|0|||
127639930|NCT01217073|459302351|FG001|Extension Period|ALT/AST|0|||
127639931|NCT01217073|459302352|FG002|Extension Period|ALT/AST|0|||
127639932|NCT01217073|459302353|FG003|Extension Period|ALT/AST|0|||
127639933|NCT01217073|459302354|FG004|Extension Period|ALT/AST|0|||
127639934|NCT01217073|459302355|FG005|Extension Period|ALT/AST|0|||
127639935|NCT01217073|459302356|FG006|Extension Period|ALT/AST|2|||
127639936|NCT01217073|459302357|FG007|Extension Period|ALT/AST|0|||
127639937|NCT01217073|459302350|FG000|Extension Period|Contraindication to study medication|0|||
127639938|NCT01217073|459302351|FG001|Extension Period|Contraindication to study medication|0|||
127639939|NCT01217073|459302352|FG002|Extension Period|Contraindication to study medication|0|||
127639940|NCT01217073|459302353|FG003|Extension Period|Contraindication to study medication|0|||
127639941|NCT01217073|459302354|FG004|Extension Period|Contraindication to study medication|0|||
127639942|NCT01217073|459302355|FG005|Extension Period|Contraindication to study medication|0|||
127639943|NCT01217073|459302356|FG006|Extension Period|Contraindication to study medication|1|||
127639944|NCT01217073|459302357|FG007|Extension Period|Contraindication to study medication|0|||
127639945|NCT01217073|459302350|FG000|Extension Period|Creatinine/eGFR|0|||
127639946|NCT01217073|459302351|FG001|Extension Period|Creatinine/eGFR|0|||
127639947|NCT01217073|459302352|FG002|Extension Period|Creatinine/eGFR|0|||
127797706|NCT02574637|459883476|FG006|Double-blind Period|Adverse Event|0|||
127797707|NCT02574637|459883477|FG007|Double-blind Period|Adverse Event|0|||
127797708|NCT02574637|459883478|FG008|Double-blind Period|Adverse Event|0|||
127797709|NCT02574637|459883479|FG009|Double-blind Period|Adverse Event|0|||
127797710|NCT02574637|459883470|FG000|Double-blind Period|Lack of Efficacy|0|||
127797711|NCT02574637|459883471|FG001|Double-blind Period|Lack of Efficacy|0|||
127797712|NCT02574637|459883472|FG002|Double-blind Period|Lack of Efficacy|2|||
127797713|NCT02574637|459883473|FG003|Double-blind Period|Lack of Efficacy|0|||
127797714|NCT02574637|459883474|FG004|Double-blind Period|Lack of Efficacy|0|||
127797715|NCT02574637|459883475|FG005|Double-blind Period|Lack of Efficacy|0|||
127797716|NCT02574637|459883476|FG006|Double-blind Period|Lack of Efficacy|0|||
127797717|NCT02574637|459883477|FG007|Double-blind Period|Lack of Efficacy|0|||
127797718|NCT02574637|459883478|FG008|Double-blind Period|Lack of Efficacy|0|||
127797719|NCT02574637|459883479|FG009|Double-blind Period|Lack of Efficacy|0|||
127797720|NCT02574637|459883470|FG000|Double-blind Period|Protocol Deviation|1|||
127797721|NCT02574637|459883471|FG001|Double-blind Period|Protocol Deviation|0|||
127797722|NCT02574637|459883472|FG002|Double-blind Period|Protocol Deviation|0|||
127797723|NCT02574637|459883473|FG003|Double-blind Period|Protocol Deviation|0|||
127797724|NCT02574637|459883474|FG004|Double-blind Period|Protocol Deviation|0|||
127797725|NCT02574637|459883475|FG005|Double-blind Period|Protocol Deviation|0|||
127797726|NCT02574637|459883476|FG006|Double-blind Period|Protocol Deviation|0|||
127797727|NCT02574637|459883477|FG007|Double-blind Period|Protocol Deviation|0|||
127797728|NCT02574637|459883478|FG008|Double-blind Period|Protocol Deviation|0|||
127797729|NCT02574637|459883479|FG009|Double-blind Period|Protocol Deviation|0|||
127797730|NCT02574637|459883470|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
127797731|NCT02574637|459883471|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
127797732|NCT02574637|459883472|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
127797733|NCT02574637|459883473|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
127797734|NCT02574637|459883474|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
127797735|NCT02574637|459883475|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
127797736|NCT02574637|459883476|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
127797737|NCT02574637|459883477|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
127639948|NCT01217073|459302353|FG003|Extension Period|Creatinine/eGFR|0|||
127639949|NCT01217073|459302354|FG004|Extension Period|Creatinine/eGFR|0|||
127639950|NCT01217073|459302355|FG005|Extension Period|Creatinine/eGFR|0|||
127639951|NCT01217073|459302356|FG006|Extension Period|Creatinine/eGFR|11|||
127639952|NCT01217073|459302357|FG007|Extension Period|Creatinine/eGFR|1|||
127639953|NCT01217073|459302350|FG000|Extension Period|Death|0|||
127639954|NCT01217073|459302351|FG001|Extension Period|Death|0|||
127639955|NCT01217073|459302352|FG002|Extension Period|Death|0|||
127639956|NCT01217073|459302353|FG003|Extension Period|Death|0|||
127639957|NCT01217073|459302354|FG004|Extension Period|Death|0|||
127639958|NCT01217073|459302355|FG005|Extension Period|Death|0|||
127639959|NCT01217073|459302356|FG006|Extension Period|Death|1|||
127639960|NCT01217073|459302357|FG007|Extension Period|Death|0|||
127639961|NCT01217073|459302350|FG000|Extension Period|Excluded medication|0|||
127639962|NCT01217073|459302351|FG001|Extension Period|Excluded medication|0|||
127639963|NCT01217073|459302352|FG002|Extension Period|Excluded medication|0|||
127639964|NCT01217073|459302353|FG003|Extension Period|Excluded medication|0|||
127797738|NCT02574637|459883478|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
127797739|NCT02574637|459883479|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
127797740|NCT02574637|459883470|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
127797741|NCT02574637|459883471|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
127797742|NCT02574637|459883472|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
127797743|NCT02574637|459883473|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
127797744|NCT02574637|459883474|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
127797745|NCT02574637|459883475|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
127797746|NCT02574637|459883476|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
127797747|NCT02574637|459883477|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
127797748|NCT02574637|459883478|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
127797749|NCT02574637|459883479|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
127797750|NCT02574637|459883470|FG000|Double-blind Period|Reason Not Specified|0|||
127797751|NCT02574637|459883471|FG001|Double-blind Period|Reason Not Specified|0|||
127797752|NCT02574637|459883472|FG002|Double-blind Period|Reason Not Specified|0|||
127797753|NCT02574637|459883473|FG003|Double-blind Period|Reason Not Specified|1|||
127797754|NCT02574637|459883474|FG004|Double-blind Period|Reason Not Specified|0|||
127797755|NCT02574637|459883475|FG005|Double-blind Period|Reason Not Specified|0|||
127797756|NCT02574637|459883476|FG006|Double-blind Period|Reason Not Specified|0|||
127797757|NCT02574637|459883477|FG007|Double-blind Period|Reason Not Specified|0|||
127797758|NCT02574637|459883478|FG008|Double-blind Period|Reason Not Specified|0|||
127797759|NCT02574637|459883479|FG009|Double-blind Period|Reason Not Specified|0|||
127797760|NCT02574637|459883470|FG000|Open-label (OL) Period|Adverse Event|0|||
127797761|NCT02574637|459883471|FG001|Open-label (OL) Period|Adverse Event|0|||
127797762|NCT02574637|459883472|FG002|Open-label (OL) Period|Adverse Event|0|||
127797763|NCT02574637|459883473|FG003|Open-label (OL) Period|Adverse Event|0|||
127797764|NCT02574637|459883474|FG004|Open-label (OL) Period|Adverse Event|0|||
127797765|NCT02574637|459883475|FG005|Open-label (OL) Period|Adverse Event|0|||
127797766|NCT02574637|459883476|FG006|Open-label (OL) Period|Adverse Event|0|||
127886444|NCT02919475|460208561|FG003|Overall Study|Death|0|||
127886445|NCT02919475|460208562|FG004|Overall Study|Death|0|||
127886446|NCT02919475|460208558|FG000|Overall Study|Lost to Follow-up|0|||
127886447|NCT02919475|460208559|FG001|Overall Study|Lost to Follow-up|0|||
127886448|NCT02919475|460208560|FG002|Overall Study|Lost to Follow-up|0|||
127886449|NCT02919475|460208561|FG003|Overall Study|Lost to Follow-up|1|||
127886450|NCT02919475|460208562|FG004|Overall Study|Lost to Follow-up|0|||
127886451|NCT02919475|460208558|FG000|Overall Study|Withdrawal by Subject|2|||
127639965|NCT01217073|459302354|FG004|Extension Period|Excluded medication|0|||
127639966|NCT01217073|459302355|FG005|Extension Period|Excluded medication|0|||
127639967|NCT01217073|459302356|FG006|Extension Period|Excluded medication|2|||
127639968|NCT01217073|459302357|FG007|Extension Period|Excluded medication|0|||
127639969|NCT01217073|459302350|FG000|Extension Period|Lack of Efficacy|0|||
127639970|NCT01217073|459302351|FG001|Extension Period|Lack of Efficacy|0|||
127639971|NCT01217073|459302352|FG002|Extension Period|Lack of Efficacy|0|||
127797767|NCT02574637|459883477|FG007|Open-label (OL) Period|Adverse Event|0|||
127797768|NCT02574637|459883478|FG008|Open-label (OL) Period|Adverse Event|1|||
127797769|NCT02574637|459883479|FG009|Open-label (OL) Period|Adverse Event|0|||
127886452|NCT02919475|460208559|FG001|Overall Study|Withdrawal by Subject|3|||
127639972|NCT01217073|459302353|FG003|Extension Period|Lack of Efficacy|0|||
127639973|NCT01217073|459302354|FG004|Extension Period|Lack of Efficacy|0|||
127639974|NCT01217073|459302355|FG005|Extension Period|Lack of Efficacy|0|||
127797770|NCT02574637|459883470|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
127886453|NCT02919475|460208560|FG002|Overall Study|Withdrawal by Subject|1|||
127797771|NCT02574637|459883471|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
127797772|NCT02574637|459883472|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
127639975|NCT01217073|459302356|FG006|Extension Period|Lack of Efficacy|3|||
127639976|NCT01217073|459302357|FG007|Extension Period|Lack of Efficacy|0|||
127639977|NCT01217073|459302350|FG000|Extension Period|Lost to Follow-up|0|||
127639978|NCT01217073|459302351|FG001|Extension Period|Lost to Follow-up|0|||
127797773|NCT02574637|459883473|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
127797774|NCT02574637|459883474|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
127797775|NCT02574637|459883475|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
127797776|NCT02574637|459883476|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
127797777|NCT02574637|459883477|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
127797778|NCT02574637|459883478|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
127797779|NCT02574637|459883479|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
127797780|NCT02574637|459883470|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
127797781|NCT02574637|459883471|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
127797782|NCT02574637|459883472|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
127797783|NCT02574637|459883473|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
127797784|NCT02574637|459883474|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
127797785|NCT02574637|459883475|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
127797786|NCT02574637|459883476|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
127797787|NCT02574637|459883477|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
127797788|NCT02574637|459883478|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
127797789|NCT02574637|459883479|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
127797790|NCT04016311|459883480|FG000|Overall Study|Withdrawal by Subject|1|||
127797791|NCT04016311|459883481|FG001|Overall Study|Withdrawal by Subject|0|||
127797792|NCT04029519|459883484|FG000|Overall Study|Protocol Violation|1|||
127797793|NCT04029519|459883484|FG000|Overall Study|Withdrawal by Subject|3|||
127797794|NCT04029519|459883484|FG000|Overall Study|Lost to Follow-up|1|||
127797795|NCT02064387|459883485|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
127639979|NCT01217073|459302352|FG002|Extension Period|Lost to Follow-up|0|||
127639980|NCT01217073|459302353|FG003|Extension Period|Lost to Follow-up|0|||
127639981|NCT01217073|459302354|FG004|Extension Period|Lost to Follow-up|0|||
127639982|NCT01217073|459302355|FG005|Extension Period|Lost to Follow-up|0|||
127639983|NCT01217073|459302356|FG006|Extension Period|Lost to Follow-up|9|||
127639984|NCT01217073|459302357|FG007|Extension Period|Lost to Follow-up|1|||
127639985|NCT01217073|459302350|FG000|Extension Period|Non-compliance with study drug|0|||
127639986|NCT01217073|459302351|FG001|Extension Period|Non-compliance with study drug|0|||
127639987|NCT01217073|459302352|FG002|Extension Period|Non-compliance with study drug|0|||
127639988|NCT01217073|459302353|FG003|Extension Period|Non-compliance with study drug|0|||
127639989|NCT01217073|459302354|FG004|Extension Period|Non-compliance with study drug|0|||
127639990|NCT01217073|459302355|FG005|Extension Period|Non-compliance with study drug|0|||
127639991|NCT01217073|459302356|FG006|Extension Period|Non-compliance with study drug|0|||
127639992|NCT01217073|459302357|FG007|Extension Period|Non-compliance with study drug|1|||
127639993|NCT01217073|459302350|FG000|Extension Period|Physician Decision|0|||
127639994|NCT01217073|459302351|FG001|Extension Period|Physician Decision|0|||
127639995|NCT01217073|459302352|FG002|Extension Period|Physician Decision|0|||
127639996|NCT01217073|459302353|FG003|Extension Period|Physician Decision|0|||
127639997|NCT01217073|459302354|FG004|Extension Period|Physician Decision|0|||
127639998|NCT01217073|459302355|FG005|Extension Period|Physician Decision|0|||
127639999|NCT01217073|459302356|FG006|Extension Period|Physician Decision|4|||
127640000|NCT01217073|459302357|FG007|Extension Period|Physician Decision|1|||
127640001|NCT01217073|459302350|FG000|Extension Period|Protocol Violation|0|||
127640002|NCT01217073|459302351|FG001|Extension Period|Protocol Violation|0|||
127640003|NCT01217073|459302352|FG002|Extension Period|Protocol Violation|0|||
127640004|NCT01217073|459302353|FG003|Extension Period|Protocol Violation|0|||
127797796|NCT02064387|459883486|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
127797797|NCT02064387|459883487|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
127797798|NCT02064387|459883488|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
127797799|NCT02064387|459883489|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
127797800|NCT02064387|459883490|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
127797801|NCT02064387|459883491|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
127797802|NCT02064387|459883492|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
127640005|NCT01217073|459302354|FG004|Extension Period|Protocol Violation|0|||
127640006|NCT01217073|459302355|FG005|Extension Period|Protocol Violation|0|||
127640007|NCT01217073|459302356|FG006|Extension Period|Protocol Violation|2|||
127640008|NCT01217073|459302357|FG007|Extension Period|Protocol Violation|1|||
127640009|NCT01217073|459302350|FG000|Extension Period|Site discontinued study participation|0|||
127640010|NCT01217073|459302351|FG001|Extension Period|Site discontinued study participation|0|||
127640011|NCT01217073|459302352|FG002|Extension Period|Site discontinued study participation|0|||
127640012|NCT01217073|459302353|FG003|Extension Period|Site discontinued study participation|0|||
127640013|NCT01217073|459302354|FG004|Extension Period|Site discontinued study participation|0|||
127640014|NCT01217073|459302355|FG005|Extension Period|Site discontinued study participation|0|||
127640015|NCT01217073|459302356|FG006|Extension Period|Site discontinued study participation|7|||
127640016|NCT01217073|459302357|FG007|Extension Period|Site discontinued study participation|2|||
127640017|NCT01217073|459302350|FG000|Extension Period|Withdrawal by Subject|0|||
127640018|NCT01217073|459302351|FG001|Extension Period|Withdrawal by Subject|0|||
127640019|NCT01217073|459302352|FG002|Extension Period|Withdrawal by Subject|0|||
127640020|NCT01217073|459302353|FG003|Extension Period|Withdrawal by Subject|0|||
127640021|NCT01217073|459302354|FG004|Extension Period|Withdrawal by Subject|0|||
127640022|NCT01217073|459302355|FG005|Extension Period|Withdrawal by Subject|0|||
127640023|NCT01217073|459302356|FG006|Extension Period|Withdrawal by Subject|30|||
127640024|NCT01217073|459302357|FG007|Extension Period|Withdrawal by Subject|8|||
127640025|NCT00454051|459302371|FG000|Overall Study|Adverse Event|1|||
127640026|NCT00454051|459302372|FG001|Overall Study|Adverse Event|2|||
127640027|NCT00454051|459302371|FG000|Overall Study|Withdrawal by Subject|1|||
127640028|NCT00454051|459302372|FG001|Overall Study|Withdrawal by Subject|0|||
127640029|NCT00454051|459302371|FG000|Overall Study|Protocol Violation|1|||
127640030|NCT00454051|459302372|FG001|Overall Study|Protocol Violation|1|||
127640031|NCT02015676|459302382|FG000|Overall Study|Adverse Event|2|||
127640032|NCT02015676|459302383|FG001|Overall Study|Adverse Event|18|||
127640033|NCT02015676|459302384|FG002|Overall Study|Adverse Event|0|||
127640034|NCT02015676|459302382|FG000|Overall Study|Lack of Efficacy|2|||
127640035|NCT02015676|459302383|FG001|Overall Study|Lack of Efficacy|4|||
127640036|NCT02015676|459302384|FG002|Overall Study|Lack of Efficacy|0|||
127640037|NCT02015676|459302382|FG000|Overall Study|Protocol Violation|1|||
127640038|NCT02015676|459302383|FG001|Overall Study|Protocol Violation|0|||
127640039|NCT02015676|459302384|FG002|Overall Study|Protocol Violation|0|||
127640040|NCT02015676|459302382|FG000|Overall Study|Withdrawal by Subject|1|||
127640041|NCT02015676|459302383|FG001|Overall Study|Withdrawal by Subject|7|||
127640042|NCT02015676|459302384|FG002|Overall Study|Withdrawal by Subject|1|||
127640043|NCT02015676|459302382|FG000|Overall Study|Administrative reasons|0|||
127640044|NCT02015676|459302383|FG001|Overall Study|Administrative reasons|3|||
127640045|NCT02015676|459302384|FG002|Overall Study|Administrative reasons|1|||
127640046|NCT02015676|459302382|FG000|Overall Study|Death|0|||
127640047|NCT02015676|459302383|FG001|Overall Study|Death|1|||
127640048|NCT02015676|459302384|FG002|Overall Study|Death|0|||
127640049|NCT02015676|459302382|FG000|Overall Study|Disease progression|3|||
127640050|NCT02015676|459302383|FG001|Overall Study|Disease progression|1|||
127640051|NCT02015676|459302384|FG002|Overall Study|Disease progression|1|||
127640052|NCT01270347|459302391|FG000|Core Phase|Adverse Event|1|||
127640053|NCT01270347|459302392|FG001|Core Phase|Adverse Event|6|||
127640054|NCT01270347|459302391|FG000|Core Phase|Withdrawal by Subject|1|||
127640055|NCT01270347|459302392|FG001|Core Phase|Withdrawal by Subject|2|||
127640056|NCT01270347|459302391|FG000|Core Phase|Lost to Follow-up|0|||
127640057|NCT01270347|459302392|FG001|Core Phase|Lost to Follow-up|1|||
127640058|NCT01270347|459302391|FG000|Core Phase|Miscellaneous|8|||
127640059|NCT01270347|459302392|FG001|Core Phase|Miscellaneous|14|||
127640060|NCT01270347|459302391|FG000|Extension Phase|Adverse Event|1|||
127640061|NCT01270347|459302392|FG001|Extension Phase|Adverse Event|3|||
127640062|NCT01270347|459302391|FG000|Extension Phase|Withdrawal by Subject|3|||
127640063|NCT01270347|459302392|FG001|Extension Phase|Withdrawal by Subject|4|||
127640064|NCT01270347|459302391|FG000|Extension Phase|Miscellaneous|2|||
127640065|NCT01270347|459302392|FG001|Extension Phase|Miscellaneous|2|||
127640066|NCT02189798|459302393|FG000|Extended Use Phase|Withdrawal by Subject|0|||
127640067|NCT02189798|459302394|FG001|Extended Use Phase|Withdrawal by Subject|4|||
127640068|NCT02189798|459302393|FG000|Extended Use Phase|Physician Decision|1|||
127640069|NCT02189798|459302394|FG001|Extended Use Phase|Physician Decision|0|||
127640070|NCT02189798|459302393|FG000|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|11|||
127640071|NCT02189798|459302394|FG001|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|1|||
127640072|NCT02189798|459302393|FG000|Extended Use Phase|Explanted prior to 24 month visit|1|||
127640073|NCT02189798|459302394|FG001|Extended Use Phase|Explanted prior to 24 month visit|0|||
127640074|NCT02189798|459302393|FG000|Extended Use Phase|Travel Issues|2|||
127640075|NCT02189798|459302394|FG001|Extended Use Phase|Travel Issues|1|||
127640076|NCT02189798|459302393|FG000|Extended Use Phase|No longer perceiving a benefit from acoustic component|0|||
127640077|NCT02189798|459302394|FG001|Extended Use Phase|No longer perceiving a benefit from acoustic component|3|||
127640078|NCT02273141|459302395|FG000|Overall Study|Adverse Event|0|||
127640079|NCT02273141|459302396|FG001|Overall Study|Adverse Event|1|||
127640080|NCT02273141|459302395|FG000|Overall Study|Lost to Follow-up|1|||
127640081|NCT02273141|459302396|FG001|Overall Study|Lost to Follow-up|3|||
127640082|NCT02273141|459302395|FG000|Overall Study|Withdrawal by Subject|10|||
127640083|NCT02273141|459302396|FG001|Overall Study|Withdrawal by Subject|15|||
127640084|NCT02273141|459302395|FG000|Overall Study|Various|6|||
127640085|NCT02273141|459302396|FG001|Overall Study|Various|6|||
127640086|NCT00529399|459302397|FG000|Overall Study|Lost to Follow-up|1|||
127640087|NCT00529399|459302398|FG001|Overall Study|Lost to Follow-up|0|||
127640088|NCT00529399|459302399|FG002|Overall Study|Lost to Follow-up|1|||
127640089|NCT00529399|459302397|FG000|Overall Study|Withdrawal by Subject|1|||
127640090|NCT00529399|459302398|FG001|Overall Study|Withdrawal by Subject|0|||
127640091|NCT00529399|459302399|FG002|Overall Study|Withdrawal by Subject|1|||
127640092|NCT00529399|459302397|FG000|Overall Study|Non-compliant|0|||
127640093|NCT00529399|459302398|FG001|Overall Study|Non-compliant|1|||
127640094|NCT00529399|459302399|FG002|Overall Study|Non-compliant|0|||
127640095|NCT04313881|459302406|FG000|Overall Study|Death|138|||
127640096|NCT04313881|459302407|FG001|Overall Study|Death|126|||
127640097|NCT04313881|459302406|FG000|Overall Study|Study terminated by sponsor|108|||
127640098|NCT04313881|459302407|FG001|Overall Study|Study terminated by sponsor|129|||
127640099|NCT04313881|459302406|FG000|Overall Study|Consent withdrawn|19|||
127640100|NCT04313881|459302407|FG001|Overall Study|Consent withdrawn|15|||
127640101|NCT04313881|459302406|FG000|Overall Study|Reason not Specified|3|||
127640102|NCT04313881|459302407|FG001|Overall Study|Reason not Specified|1|||
127640103|NCT01572727|459302408|FG000|Overall Study|Adverse Event|43|||
127640104|NCT01572727|459302409|FG001|Overall Study|Adverse Event|15|||
127640105|NCT01572727|459302408|FG000|Overall Study|Lost to Follow-up|1|||
127640106|NCT01572727|459302409|FG001|Overall Study|Lost to Follow-up|1|||
127640107|NCT01572727|459302408|FG000|Overall Study|Physician Decision|23|||
127640108|NCT01572727|459302409|FG001|Overall Study|Physician Decision|9|||
127640109|NCT01572727|459302408|FG000|Overall Study|Progressive disease|59|||
127640110|NCT01572727|459302409|FG001|Overall Study|Progressive disease|82|||
127640111|NCT01572727|459302408|FG000|Overall Study|Protocol Violation|0|||
127640112|NCT01572727|459302409|FG001|Overall Study|Protocol Violation|1|||
127640113|NCT01572727|459302408|FG000|Overall Study|Study terminated by sponsor|61|||
127640114|NCT01572727|459302409|FG001|Overall Study|Study terminated by sponsor|83|||
127640115|NCT01572727|459302408|FG000|Overall Study|Parent/guardian decision|14|||
127640116|NCT01572727|459302409|FG001|Overall Study|Parent/guardian decision|9|||
127640117|NCT01572727|459302408|FG000|Overall Study|Death|2|||
127640118|NCT01572727|459302409|FG001|Overall Study|Death|2|||
127640119|NCT01572727|459302408|FG000|Overall Study|Untreated|4|||
127640120|NCT01572727|459302409|FG001|Overall Study|Untreated|7|||
127640121|NCT03998618|459302410|FG000|Overall Study|Death|7|||
127640122|NCT03998618|459302411|FG001|Overall Study|Death|11|||
127640123|NCT03998618|459302410|FG000|Overall Study|hospice enrollment|3|||
127640124|NCT03998618|459302411|FG001|Overall Study|hospice enrollment|3|||
127640125|NCT03998618|459302410|FG000|Overall Study|Not feeling well/health problems|3|||
127640126|NCT03998618|459302411|FG001|Overall Study|Not feeling well/health problems|5|||
127640127|NCT03998618|459302410|FG000|Overall Study|Lost to Follow-up|6|||
127640128|NCT03998618|459302411|FG001|Overall Study|Lost to Follow-up|6|||
127640129|NCT03998618|459302410|FG000|Overall Study|Withdrawal by Subject|0|||
127640130|NCT03998618|459302411|FG001|Overall Study|Withdrawal by Subject|4|||
127640131|NCT02834780|459302412|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
127703830|NCT04201262|459544774|FG000|Overall Study|Adverse Event|1|||
127640132|NCT02834780|459302413|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
127640133|NCT02834780|459302414|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
127640134|NCT02834780|459302415|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
127640135|NCT02834780|459302416|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
127703831|NCT04201262|459544775|FG001|Overall Study|Adverse Event|2|||
127703832|NCT04201262|459544774|FG000|Overall Study|Continuing in the study|57|||
127703833|NCT04201262|459544775|FG001|Overall Study|Continuing in the study|0|||
127703834|NCT04201262|459544774|FG000|Overall Study|Withdrawal by Subject|0|||
127703835|NCT04201262|459544775|FG001|Overall Study|Withdrawal by Subject|1|||
127703836|NCT05446168|459544776|FG000|Overall Study|Physician Decision|0|||
127703837|NCT05446168|459544777|FG001|Overall Study|Physician Decision|1|||
127703838|NCT03511664|459544779|FG000|Overall Study|Death|457|||
127703839|NCT03511664|459544780|FG001|Overall Study|Death|201|||
127703840|NCT03511664|459544781|FG002|Overall Study|Death|21|||
127703841|NCT03511664|459544779|FG000|Overall Study|Withdrew consent|40|||
127703842|NCT03511664|459544780|FG001|Overall Study|Withdrew consent|63|||
127703843|NCT03511664|459544781|FG002|Overall Study|Withdrew consent|3|||
127703844|NCT03511664|459544779|FG000|Overall Study|Other protocol pre-specified reasons for discontinuation|15|||
127703845|NCT03511664|459544780|FG001|Overall Study|Other protocol pre-specified reasons for discontinuation|4|||
127703846|NCT03511664|459544781|FG002|Overall Study|Other protocol pre-specified reasons for discontinuation|2|||
127703847|NCT03511664|459544779|FG000|Overall Study|Lost to Follow-up|8|||
127703848|NCT03511664|459544780|FG001|Overall Study|Lost to Follow-up|5|||
127703849|NCT03511664|459544781|FG002|Overall Study|Lost to Follow-up|0|||
127703850|NCT03511664|459544779|FG000|Overall Study|Physician Decision|2|||
127703851|NCT03511664|459544780|FG001|Overall Study|Physician Decision|1|||
127703852|NCT03511664|459544781|FG002|Overall Study|Physician Decision|0|||
127703853|NCT03511664|459544779|FG000|Overall Study|Patient non-compliance|1|||
127703854|NCT03511664|459544780|FG001|Overall Study|Patient non-compliance|0|||
127703855|NCT03511664|459544781|FG002|Overall Study|Patient non-compliance|0|||
127703856|NCT02823145|459544784|FG000|Enrollment|Other|1|||
127797803|NCT02064387|459883493|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
127797804|NCT02064387|459883494|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
127703857|NCT02823145|459544785|FG001|Enrollment|Other|0|||
127703858|NCT02823145|459544784|FG000|Treatment|Adverse Event|0|||
127703859|NCT02823145|459544785|FG001|Treatment|Adverse Event|11|||
127703860|NCT02823145|459544784|FG000|Treatment|Death|0|||
127640136|NCT02834780|459302417|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
127640137|NCT02834780|459302418|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
127640138|NCT02834780|459302419|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
127640139|NCT02834780|459302420|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
127640140|NCT02834780|459302421|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
127640141|NCT02834780|459302422|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
127640142|NCT02834780|459302423|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
127640143|NCT02834780|459302424|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
127797805|NCT02064387|459883495|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
127797806|NCT02064387|459883496|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
127797807|NCT02064387|459883485|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
127797808|NCT02064387|459883486|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
127797809|NCT02064387|459883487|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
127797810|NCT02064387|459883488|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
127797811|NCT02064387|459883489|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
127797812|NCT02064387|459883490|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
127797813|NCT02064387|459883491|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
127797814|NCT02064387|459883492|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
127797815|NCT02064387|459883493|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
127797816|NCT02064387|459883494|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
127797817|NCT02064387|459883495|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
127797818|NCT02064387|459883496|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
127797819|NCT02064387|459883485|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
127640144|NCT02834780|459302412|FG000|Overall Study|Withdrawal by Subject|0|||
127640145|NCT02834780|459302413|FG001|Overall Study|Withdrawal by Subject|0|||
127640146|NCT02834780|459302414|FG002|Overall Study|Withdrawal by Subject|1|||
127640147|NCT02834780|459302415|FG003|Overall Study|Withdrawal by Subject|0|||
127640148|NCT02834780|459302416|FG004|Overall Study|Withdrawal by Subject|0|||
127640149|NCT02834780|459302417|FG005|Overall Study|Withdrawal by Subject|0|||
127640150|NCT02834780|459302418|FG006|Overall Study|Withdrawal by Subject|0|||
127640151|NCT02834780|459302419|FG007|Overall Study|Withdrawal by Subject|0|||
127640152|NCT02834780|459302420|FG008|Overall Study|Withdrawal by Subject|0|||
127640153|NCT02834780|459302421|FG009|Overall Study|Withdrawal by Subject|0|||
127640154|NCT02834780|459302422|FG010|Overall Study|Withdrawal by Subject|1|||
127640155|NCT02834780|459302423|FG011|Overall Study|Withdrawal by Subject|0|||
127640156|NCT02834780|459302424|FG012|Overall Study|Withdrawal by Subject|0|||
127640157|NCT02834780|459302412|FG000|Overall Study|Adverse Event|0|||
127640158|NCT02834780|459302413|FG001|Overall Study|Adverse Event|0|||
127640159|NCT02834780|459302414|FG002|Overall Study|Adverse Event|0|||
127640160|NCT02834780|459302415|FG003|Overall Study|Adverse Event|0|||
127640161|NCT02834780|459302416|FG004|Overall Study|Adverse Event|1|||
127640162|NCT02834780|459302417|FG005|Overall Study|Adverse Event|0|||
127640163|NCT02834780|459302418|FG006|Overall Study|Adverse Event|1|||
127640164|NCT02834780|459302419|FG007|Overall Study|Adverse Event|1|||
127640165|NCT02834780|459302420|FG008|Overall Study|Adverse Event|0|||
127640166|NCT02834780|459302421|FG009|Overall Study|Adverse Event|2|||
127640167|NCT02834780|459302422|FG010|Overall Study|Adverse Event|0|||
127640168|NCT02834780|459302423|FG011|Overall Study|Adverse Event|3|||
127886454|NCT02919475|460208561|FG003|Overall Study|Withdrawal by Subject|2|||
127886455|NCT02919475|460208562|FG004|Overall Study|Withdrawal by Subject|2|||
127886456|NCT02919475|460208558|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
127886457|NCT02919475|460208559|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
127886458|NCT02919475|460208560|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
127886459|NCT02919475|460208561|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
127886460|NCT02919475|460208562|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
127886461|NCT00775983|460208566|FG000|Overall Study|Protocol Violation|1|||
127886462|NCT00775983|460208567|FG001|Overall Study|Protocol Violation|2|||
127886463|NCT02762565|460208570|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
127886464|NCT00623623|460208571|FG000|Overall Study|Previous enrolment into this study|1|||
127886465|NCT00623623|460208572|FG001|Overall Study|Previous enrolment into this study|1|||
127886466|NCT02499354|460208573|FG000|Overall Study|Withdrawal by Subject|1|||
127640169|NCT02834780|459302424|FG012|Overall Study|Adverse Event|2|||
127640170|NCT02834780|459302412|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
127797820|NCT02064387|459883486|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
127640171|NCT02834780|459302413|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
127640172|NCT02834780|459302414|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
127640173|NCT02834780|459302415|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
127640174|NCT02834780|459302416|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
127797821|NCT02064387|459883487|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
127640175|NCT02834780|459302417|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
127640176|NCT02834780|459302418|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
127640177|NCT02834780|459302419|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
127640178|NCT02834780|459302420|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
127640179|NCT02834780|459302421|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
127640180|NCT02834780|459302422|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
127640181|NCT02834780|459302423|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
127640182|NCT02834780|459302424|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
127640183|NCT02834780|459302412|FG000|Overall Study|Other|1|||
127640184|NCT02834780|459302413|FG001|Overall Study|Other|0|||
127640185|NCT02834780|459302414|FG002|Overall Study|Other|1|||
127640186|NCT02834780|459302415|FG003|Overall Study|Other|2|||
127640187|NCT02834780|459302416|FG004|Overall Study|Other|0|||
127886467|NCT02499354|460208574|FG001|Overall Study|Withdrawal by Subject|0|||
127886468|NCT01759381|460208575|FG000|Overall Study|Death|1|||
127886469|NCT01759381|460208576|FG001|Overall Study|Death|0|||
127886470|NCT00447603|460208578|FG000|Screening|Withdrawal by Subject|1|||
127886471|NCT00447603|460208579|FG001|Screening|Withdrawal by Subject|0|||
127886472|NCT00447603|460208580|FG002|Screening|Withdrawal by Subject|0|||
127886473|NCT00447603|460208578|FG000|Screening|Protocol Violation|1|||
127886474|NCT00447603|460208579|FG001|Screening|Protocol Violation|0|||
127886475|NCT00447603|460208580|FG002|Screening|Protocol Violation|0|||
127886476|NCT00447603|460208578|FG000|Screening|Screen Failure|4|||
127640188|NCT02834780|459302417|FG005|Overall Study|Other|0|||
127640189|NCT02834780|459302418|FG006|Overall Study|Other|0|||
127640190|NCT02834780|459302419|FG007|Overall Study|Other|0|||
127640191|NCT02834780|459302420|FG008|Overall Study|Other|0|||
127640192|NCT02834780|459302421|FG009|Overall Study|Other|0|||
127640193|NCT02834780|459302422|FG010|Overall Study|Other|0|||
127640194|NCT02834780|459302423|FG011|Overall Study|Other|0|||
127640195|NCT02834780|459302424|FG012|Overall Study|Other|1|||
127640196|NCT02415400|459302425|FG000|Overall Study|Adverse Event|0|||
127640197|NCT02415400|459302426|FG001|Overall Study|Adverse Event|1|||
127640198|NCT02415400|459302427|FG002|Overall Study|Adverse Event|1|||
127640199|NCT02415400|459302428|FG003|Overall Study|Adverse Event|2|||
127640200|NCT02415400|459302425|FG000|Overall Study|Participant request to stop therapy|4|||
127640201|NCT02415400|459302426|FG001|Overall Study|Participant request to stop therapy|3|||
127640202|NCT02415400|459302427|FG002|Overall Study|Participant request to stop therapy|8|||
127640203|NCT02415400|459302428|FG003|Overall Study|Participant request to stop therapy|6|||
127640204|NCT02415400|459302425|FG000|Overall Study|Participant withdrew consent|14|||
127640205|NCT02415400|459302426|FG001|Overall Study|Participant withdrew consent|12|||
127640206|NCT02415400|459302427|FG002|Overall Study|Participant withdrew consent|30|||
127640207|NCT02415400|459302428|FG003|Overall Study|Participant withdrew consent|21|||
127640208|NCT02415400|459302425|FG000|Overall Study|Death|39|||
127640209|NCT02415400|459302426|FG001|Overall Study|Death|41|||
127886477|NCT00447603|460208579|FG001|Screening|Screen Failure|0|||
127886478|NCT00447603|460208580|FG002|Screening|Screen Failure|0|||
127886479|NCT00447603|460208578|FG000|Screening|Study Terminated by Sponsor|15|||
127886480|NCT00447603|460208579|FG001|Screening|Study Terminated by Sponsor|0|||
127640210|NCT02415400|459302427|FG002|Overall Study|Death|35|||
127640211|NCT02415400|459302428|FG003|Overall Study|Death|42|||
127640212|NCT02415400|459302425|FG000|Overall Study|Lost to Follow-up|3|||
127640213|NCT02415400|459302426|FG001|Overall Study|Lost to Follow-up|3|||
127703861|NCT02823145|459544785|FG001|Treatment|Death|3|||
127703862|NCT02823145|459544784|FG000|Treatment|Family Decision|0|||
127703863|NCT02823145|459544785|FG001|Treatment|Family Decision|1|||
127703864|NCT02823145|459544784|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
127703865|NCT02823145|459544785|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
127703866|NCT02823145|459544784|FG000|Treatment|Lack of Efficacy|0|||
127703867|NCT02823145|459544785|FG001|Treatment|Lack of Efficacy|48|||
127703868|NCT02823145|459544784|FG000|Treatment|Non-Compliance With E-Diary|0|||
127703869|NCT02823145|459544785|FG001|Treatment|Non-Compliance With E-Diary|1|||
127703870|NCT02823145|459544784|FG000|Treatment|Physician Decision|0|||
127703871|NCT02823145|459544785|FG001|Treatment|Physician Decision|2|||
127703872|NCT02823145|459544784|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
127703873|NCT02823145|459544785|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
127703874|NCT02823145|459544784|FG000|Treatment|Subject needed to take prohibited medication|0|||
127703875|NCT02823145|459544785|FG001|Treatment|Subject needed to take prohibited medication|1|||
127703876|NCT02823145|459544784|FG000|Treatment|Subject transferred to direct access programme|0|||
127703877|NCT02823145|459544785|FG001|Treatment|Subject transferred to direct access programme|1|||
127886481|NCT00447603|460208580|FG002|Screening|Study Terminated by Sponsor|0|||
127886482|NCT00447603|460208578|FG000|Filter Period|Adverse Event|0|||
127886483|NCT00447603|460208579|FG001|Filter Period|Adverse Event|0|||
127640214|NCT02415400|459302427|FG002|Overall Study|Lost to Follow-up|2|||
127703878|NCT02823145|459544784|FG000|Treatment|Switching to commercially available drug|0|||
127703879|NCT02823145|459544785|FG001|Treatment|Switching to commercially available drug|11|||
127640215|NCT02415400|459302428|FG003|Overall Study|Lost to Follow-up|5|||
127640216|NCT02415400|459302425|FG000|Overall Study|Poor/Non-Compliance|0|||
127640217|NCT02415400|459302426|FG001|Overall Study|Poor/Non-Compliance|1|||
127640218|NCT02415400|459302427|FG002|Overall Study|Poor/Non-Compliance|3|||
127640219|NCT02415400|459302428|FG003|Overall Study|Poor/Non-Compliance|4|||
127640220|NCT02415400|459302425|FG000|Overall Study|Participant no longer meets criteria|2|||
127640221|NCT02415400|459302426|FG001|Overall Study|Participant no longer meets criteria|0|||
127640222|NCT02415400|459302427|FG002|Overall Study|Participant no longer meets criteria|0|||
127640223|NCT02415400|459302428|FG003|Overall Study|Participant no longer meets criteria|1|||
127640224|NCT02415400|459302425|FG000|Overall Study|Participant doesn't answer phone|1|||
127640225|NCT02415400|459302426|FG001|Overall Study|Participant doesn't answer phone|0|||
127640226|NCT02415400|459302427|FG002|Overall Study|Participant doesn't answer phone|0|||
127640227|NCT02415400|459302428|FG003|Overall Study|Participant doesn't answer phone|0|||
127640228|NCT02415400|459302425|FG000|Overall Study|Participant wanted home visits|1|||
127640229|NCT02415400|459302426|FG001|Overall Study|Participant wanted home visits|0|||
127640230|NCT02415400|459302427|FG002|Overall Study|Participant wanted home visits|0|||
127640231|NCT02415400|459302428|FG003|Overall Study|Participant wanted home visits|0|||
127640232|NCT02415400|459302425|FG000|Overall Study|Randomized in error|2|||
127640233|NCT02415400|459302426|FG001|Overall Study|Randomized in error|0|||
127640234|NCT02415400|459302427|FG002|Overall Study|Randomized in error|0|||
127640235|NCT02415400|459302428|FG003|Overall Study|Randomized in error|0|||
127640236|NCT02415400|459302425|FG000|Overall Study|No study drug on site|0|||
127640237|NCT02415400|459302426|FG001|Overall Study|No study drug on site|1|||
127640238|NCT02415400|459302427|FG002|Overall Study|No study drug on site|0|||
127640239|NCT02415400|459302428|FG003|Overall Study|No study drug on site|0|||
127640240|NCT02415400|459302425|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
127640241|NCT02415400|459302426|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
127640242|NCT02415400|459302427|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
127640243|NCT02415400|459302428|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
127640244|NCT02415400|459302425|FG000|Overall Study|Coagulation values cannot be set|0|||
127640245|NCT02415400|459302426|FG001|Overall Study|Coagulation values cannot be set|0|||
127640246|NCT02415400|459302427|FG002|Overall Study|Coagulation values cannot be set|1|||
127640247|NCT02415400|459302428|FG003|Overall Study|Coagulation values cannot be set|0|||
127640248|NCT02415400|459302425|FG000|Overall Study|State regulations prevent participation|0|||
127640249|NCT02415400|459302426|FG001|Overall Study|State regulations prevent participation|0|||
127640250|NCT02415400|459302427|FG002|Overall Study|State regulations prevent participation|1|||
127640251|NCT02415400|459302428|FG003|Overall Study|State regulations prevent participation|0|||
127640252|NCT02415400|459302425|FG000|Overall Study|Poor treatment monitoring|0|||
127640253|NCT02415400|459302426|FG001|Overall Study|Poor treatment monitoring|0|||
127640254|NCT02415400|459302427|FG002|Overall Study|Poor treatment monitoring|1|||
127640255|NCT02415400|459302428|FG003|Overall Study|Poor treatment monitoring|0|||
127640256|NCT02415400|459302425|FG000|Overall Study|Participant in jail|0|||
127640257|NCT02415400|459302426|FG001|Overall Study|Participant in jail|0|||
127640258|NCT02415400|459302427|FG002|Overall Study|Participant in jail|1|||
127640259|NCT02415400|459302428|FG003|Overall Study|Participant in jail|0|||
127640260|NCT02415400|459302425|FG000|Overall Study|Investigator decision|0|||
127640261|NCT02415400|459302426|FG001|Overall Study|Investigator decision|0|||
127640262|NCT02415400|459302427|FG002|Overall Study|Investigator decision|1|||
127640263|NCT02415400|459302428|FG003|Overall Study|Investigator decision|1|||
127640264|NCT02415400|459302425|FG000|Overall Study|Site closure; participant won't transfer|0|||
127640265|NCT02415400|459302426|FG001|Overall Study|Site closure; participant won't transfer|0|||
127640266|NCT02415400|459302427|FG002|Overall Study|Site closure; participant won't transfer|0|||
127640267|NCT02415400|459302428|FG003|Overall Study|Site closure; participant won't transfer|1|||
127640268|NCT02270450|459302429|FG000|Overall Study|Refusal unrelated to adverse event|3|||
127640269|NCT02270450|459302430|FG001|Overall Study|Refusal unrelated to adverse event|1|||
127640270|NCT02270450|459302431|FG002|Overall Study|Refusal unrelated to adverse event|5|||
127640271|NCT02270450|459302432|FG003|Overall Study|Refusal unrelated to adverse event|14|||
127640272|NCT02270450|459302429|FG000|Overall Study|Progression/relapse|1|||
127640273|NCT02270450|459302430|FG001|Overall Study|Progression/relapse|2|||
127640274|NCT02270450|459302431|FG002|Overall Study|Progression/relapse|4|||
127640275|NCT02270450|459302432|FG003|Overall Study|Progression/relapse|9|||
127640276|NCT02270450|459302429|FG000|Overall Study|Death|19|||
127703880|NCT02823145|459544784|FG000|Treatment|Transitioned to commercial supply of medication|0|||
127703881|NCT02823145|459544785|FG001|Treatment|Transitioned to commercial supply of medication|1|||
127703882|NCT02823145|459544784|FG000|Treatment|Withdrawal By Caregiver|0|||
127703883|NCT02823145|459544785|FG001|Treatment|Withdrawal By Caregiver|1|||
127703884|NCT02823145|459544784|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
127703885|NCT02823145|459544785|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
127703886|NCT02823145|459544784|FG000|Treatment|Withdrawal by Subject|0|||
127703887|NCT02823145|459544785|FG001|Treatment|Withdrawal by Subject|16|||
127703888|NCT02823145|459544784|FG000|Treatment|Reason unknown|0|||
127703889|NCT02823145|459544785|FG001|Treatment|Reason unknown|1|||
127640277|NCT02270450|459302430|FG001|Overall Study|Death|19|||
127640278|NCT02270450|459302431|FG002|Overall Study|Death|31|||
127640279|NCT02270450|459302432|FG003|Overall Study|Death|59|||
127640280|NCT02363738|459302433|FG000|Overall Study|Adverse Event|5|||
127640281|NCT02363738|459302434|FG001|Overall Study|Adverse Event|2|||
127640282|NCT02363738|459302433|FG000|Overall Study|Lack of Efficacy|1|||
127640283|NCT02363738|459302434|FG001|Overall Study|Lack of Efficacy|2|||
127640284|NCT02363738|459302433|FG000|Overall Study|Lost to Follow-up|2|||
127640285|NCT02363738|459302434|FG001|Overall Study|Lost to Follow-up|1|||
127640286|NCT03265600|459302439|FG000|Overall Study|Lost to Follow-up|17|||
127640287|NCT03265600|459302440|FG001|Overall Study|Lost to Follow-up|5|||
127640288|NCT03265600|459302439|FG000|Overall Study|Withdrawal by Subject|4|||
127640289|NCT03265600|459302440|FG001|Overall Study|Withdrawal by Subject|2|||
127640290|NCT03265600|459302439|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
127640291|NCT03265600|459302440|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
127640292|NCT04330638|459302441|FG000|Overall Study|Adverse Event|9|||
127640293|NCT04330638|459302442|FG001|Overall Study|Adverse Event|10|||
127640294|NCT04330638|459302443|FG002|Overall Study|Adverse Event|15|||
127640295|NCT04330638|459302444|FG003|Overall Study|Adverse Event|6|||
127640296|NCT04330638|459302445|FG004|Overall Study|Adverse Event|10|||
127640297|NCT04330638|459302446|FG005|Overall Study|Adverse Event|5|||
127640298|NCT04330638|459302441|FG000|Overall Study|Other|2|||
127640299|NCT04330638|459302442|FG001|Overall Study|Other|2|||
127640300|NCT04330638|459302443|FG002|Overall Study|Other|5|||
127640301|NCT04330638|459302444|FG003|Overall Study|Other|1|||
127640302|NCT04330638|459302445|FG004|Overall Study|Other|3|||
127640303|NCT04330638|459302446|FG005|Overall Study|Other|2|||
127640304|NCT04330638|459302441|FG000|Overall Study|Withdrawal by Subject|4|||
127640305|NCT04330638|459302442|FG001|Overall Study|Withdrawal by Subject|0|||
127640306|NCT04330638|459302443|FG002|Overall Study|Withdrawal by Subject|0|||
127640307|NCT04330638|459302444|FG003|Overall Study|Withdrawal by Subject|0|||
127640308|NCT04330638|459302445|FG004|Overall Study|Withdrawal by Subject|0|||
127640309|NCT04330638|459302446|FG005|Overall Study|Withdrawal by Subject|0|||
127640310|NCT04330638|459302441|FG000|Overall Study|Lost to Follow-up|3|||
127640311|NCT04330638|459302442|FG001|Overall Study|Lost to Follow-up|2|||
127640312|NCT04330638|459302443|FG002|Overall Study|Lost to Follow-up|3|||
127640313|NCT04330638|459302444|FG003|Overall Study|Lost to Follow-up|2|||
127640314|NCT04330638|459302445|FG004|Overall Study|Lost to Follow-up|3|||
127640315|NCT04330638|459302446|FG005|Overall Study|Lost to Follow-up|0|||
127640316|NCT02293538|459302447|FG000|Overall Study|Adverse Event|0|||
127640317|NCT02293538|459302448|FG001|Overall Study|Adverse Event|1|||
127640318|NCT02293538|459302447|FG000|Overall Study|Lost to Follow-up|1|||
127640319|NCT02293538|459302448|FG001|Overall Study|Lost to Follow-up|0|||
127640320|NCT02293538|459302447|FG000|Overall Study|Withdrawal by Subject|0|||
127640321|NCT02293538|459302448|FG001|Overall Study|Withdrawal by Subject|1|||
127640322|NCT00322348|459302449|FG000|Overall Study|Adverse Event|0|||
127640323|NCT00322348|459302450|FG001|Overall Study|Adverse Event|1|||
127640324|NCT00322348|459302449|FG000|Overall Study|Withdrawal by Subject|1|||
127640325|NCT00322348|459302450|FG001|Overall Study|Withdrawal by Subject|4|||
127640326|NCT00322348|459302449|FG000|Overall Study|Lost to Follow-up|1|||
127640327|NCT00322348|459302450|FG001|Overall Study|Lost to Follow-up|0|||
127640328|NCT00322348|459302449|FG000|Overall Study|Death|0|||
127640329|NCT00322348|459302450|FG001|Overall Study|Death|2|||
127797822|NCT02064387|459883488|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
127797823|NCT02064387|459883489|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
127797824|NCT02064387|459883490|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
127797825|NCT02064387|459883491|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
127797826|NCT02064387|459883492|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
127797827|NCT02064387|459883493|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
127797828|NCT02064387|459883494|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
127886484|NCT00447603|460208580|FG002|Filter Period|Adverse Event|1|||
127640330|NCT00322348|459302449|FG000|Overall Study|Disease Progression|30|||
127640331|NCT00322348|459302450|FG001|Overall Study|Disease Progression|25|||
127640332|NCT00322348|459302449|FG000|Overall Study|Reasons not specified|5|||
127640333|NCT00322348|459302450|FG001|Overall Study|Reasons not specified|1|||
127640334|NCT00695669|459302453|FG000|Overall Study|Adverse Event|0|||
127640335|NCT00695669|459302454|FG001|Overall Study|Adverse Event|0|||
127640336|NCT00695669|459302455|FG002|Overall Study|Adverse Event|2|||
127640337|NCT00695669|459302456|FG003|Overall Study|Adverse Event|0|||
127640338|NCT00695669|459302453|FG000|Overall Study|Lost to Follow-up|4|||
127640339|NCT00695669|459302454|FG001|Overall Study|Lost to Follow-up|4|||
127640340|NCT00695669|459302455|FG002|Overall Study|Lost to Follow-up|1|||
127640341|NCT00695669|459302456|FG003|Overall Study|Lost to Follow-up|4|||
127640342|NCT05045625|459302457|FG000|Overall Study|Lost to Follow-up|3|||
127640343|NCT01022762|459302469|FG000|Overall Study|Adverse Event|3|||
127640344|NCT01022762|459302470|FG001|Overall Study|Adverse Event|1|||
127640345|NCT01022762|459302469|FG000|Overall Study|Lack of Efficacy|0|||
127640346|NCT01022762|459302470|FG001|Overall Study|Lack of Efficacy|1|||
127640347|NCT01022762|459302469|FG000|Overall Study|Protocol Violation|7|||
127640348|NCT01022762|459302470|FG001|Overall Study|Protocol Violation|6|||
127640349|NCT01022762|459302469|FG000|Overall Study|Unclassified|12|||
127640350|NCT01022762|459302470|FG001|Overall Study|Unclassified|20|||
127640351|NCT00435370|459302471|FG000|Overall Study|Adverse Event|8|||
127640352|NCT00435370|459302472|FG001|Overall Study|Adverse Event|8|||
127640353|NCT00435370|459302471|FG000|Overall Study|Withdrawal by Subject|10|||
127640354|NCT00435370|459302472|FG001|Overall Study|Withdrawal by Subject|10|||
127640355|NCT00435370|459302471|FG000|Overall Study|Antipsychotic medication changed|4|||
127640356|NCT00435370|459302472|FG001|Overall Study|Antipsychotic medication changed|2|||
127640357|NCT01965834|459302473|FG000|Overall Study|Lack of Efficacy|4|||
127640358|NCT03943095|459302474|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
127640359|NCT03943095|459302475|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
127640360|NCT03943095|459302474|FG000|Overall Study|Withdrawal by Subject|1|||
127640361|NCT03943095|459302475|FG001|Overall Study|Withdrawal by Subject|0|||
127640362|NCT03826667|459302477|FG000|Overall Study|Protocol deviation|21|||
127640363|NCT00617344|459302478|FG000|Overall Study|Serious adverse event|1|||
127640364|NCT00617344|459302479|FG001|Overall Study|Serious adverse event|0|||
127640365|NCT00617344|459302480|FG002|Overall Study|Serious adverse event|0|||
127640366|NCT00617344|459302478|FG000|Overall Study|Other Adverse Event|1|||
127640367|NCT00617344|459302479|FG001|Overall Study|Other Adverse Event|1|||
127640368|NCT00617344|459302480|FG002|Overall Study|Other Adverse Event|0|||
127640369|NCT00617344|459302478|FG000|Overall Study|Protocol Violation|10|||
127640370|NCT00617344|459302479|FG001|Overall Study|Protocol Violation|8|||
127640371|NCT00617344|459302480|FG002|Overall Study|Protocol Violation|5|||
127640372|NCT00617344|459302478|FG000|Overall Study|Lost to Follow-up|5|||
127640373|NCT00617344|459302479|FG001|Overall Study|Lost to Follow-up|4|||
127640374|NCT00617344|459302480|FG002|Overall Study|Lost to Follow-up|1|||
127640375|NCT00617344|459302478|FG000|Overall Study|Withdrawal by Subject|8|||
127640376|NCT00617344|459302479|FG001|Overall Study|Withdrawal by Subject|9|||
127640377|NCT00617344|459302480|FG002|Overall Study|Withdrawal by Subject|2|||
127640378|NCT02298192|459302481|FG000|Overall Study|Unclassified|3|||
127640379|NCT02298192|459302482|FG001|Overall Study|Unclassified|2|||
127640380|NCT02298192|459302481|FG000|Overall Study|Withdrawal criteria|2|||
127640381|NCT02298192|459302482|FG001|Overall Study|Withdrawal criteria|0|||
127640382|NCT02298192|459302481|FG000|Overall Study|Withdrawal by Subject|6|||
127640383|NCT02298192|459302482|FG001|Overall Study|Withdrawal by Subject|1|||
127640384|NCT02298192|459302481|FG000|Overall Study|Lost to Follow-up|2|||
127640385|NCT02298192|459302482|FG001|Overall Study|Lost to Follow-up|1|||
127640386|NCT02298192|459302481|FG000|Overall Study|Adverse Event|6|||
127640387|NCT02298192|459302482|FG001|Overall Study|Adverse Event|2|||
127640388|NCT00679939|459302485|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
127640389|NCT00679939|459302486|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
127640390|NCT00679939|459302485|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
127640391|NCT00679939|459302486|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
127640392|NCT00679939|459302485|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
127640393|NCT00679939|459302486|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
127640394|NCT00679939|459302485|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
127640395|NCT00679939|459302486|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
127640396|NCT00679939|459302485|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
127640397|NCT00679939|459302486|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
127640398|NCT00679939|459302485|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
127640399|NCT00679939|459302486|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
127640400|NCT00679939|459302485|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
127640401|NCT00679939|459302486|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
127640402|NCT00679939|459302485|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
127640403|NCT00679939|459302486|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
127640404|NCT00679939|459302485|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
127640405|NCT00679939|459302486|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
127640406|NCT00679939|459302485|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
127640407|NCT00679939|459302486|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
127640408|NCT00941330|459302491|FG000|Overall Study|Other|1|||
127640409|NCT00941330|459302492|FG001|Overall Study|Other|0|||
127640410|NCT00941330|459302491|FG000|Overall Study|Physician Decision|0|||
127640411|NCT00941330|459302492|FG001|Overall Study|Physician Decision|2|||
127640412|NCT00613951|459302493|FG000|Overall Study|Adverse Event|1|||
127640413|NCT00613951|459302494|FG001|Overall Study|Adverse Event|0|||
127640414|NCT00613951|459302495|FG002|Overall Study|Adverse Event|1|||
127640415|NCT00613951|459302493|FG000|Overall Study|Lack of Efficacy|0|||
127640416|NCT00613951|459302494|FG001|Overall Study|Lack of Efficacy|1|||
127640417|NCT00613951|459302495|FG002|Overall Study|Lack of Efficacy|1|||
127640418|NCT00613951|459302493|FG000|Overall Study|Protocol Violation|1|||
127886485|NCT00447603|460208578|FG000|Filter Period|Screen Failure|0|||
127886486|NCT00447603|460208579|FG001|Filter Period|Screen Failure|3|||
127886487|NCT00447603|460208580|FG002|Filter Period|Screen Failure|4|||
127886488|NCT00447603|460208578|FG000|Filter Period|Study terminated by Sponsor|0|||
127886489|NCT00447603|460208579|FG001|Filter Period|Study terminated by Sponsor|1|||
127886490|NCT00447603|460208580|FG002|Filter Period|Study terminated by Sponsor|10|||
127886491|NCT01427920|460208583|FG000|Overall Study|Adverse Event|1|||
127886492|NCT01427920|460208584|FG001|Overall Study|Adverse Event|2|||
127886493|NCT01427920|460208583|FG000|Overall Study|Lack of Efficacy|1|||
127886494|NCT01427920|460208584|FG001|Overall Study|Lack of Efficacy|0|||
127886495|NCT01427920|460208583|FG000|Overall Study|Protocol Violation|1|||
127886496|NCT01427920|460208584|FG001|Overall Study|Protocol Violation|3|||
127886497|NCT01427920|460208583|FG000|Overall Study|Withdrawal Criteria|4|||
127886498|NCT01427920|460208584|FG001|Overall Study|Withdrawal Criteria|4|||
127886499|NCT01427920|460208583|FG000|Overall Study|Unclassified|2|||
127886500|NCT01427920|460208584|FG001|Overall Study|Unclassified|8|||
127886501|NCT02732561|460208586|FG000|Overall Study|Lost to Follow-up|1|||
127886502|NCT02732561|460208587|FG001|Overall Study|Lost to Follow-up|1|||
127886503|NCT02732561|460208586|FG000|Overall Study|Withdrawal by Subject|1|||
127886504|NCT02732561|460208587|FG001|Overall Study|Withdrawal by Subject|0|||
127886505|NCT02410837|460208594|FG000|Overall Study|Death|387|||
127886506|NCT02410837|460208594|FG000|Overall Study|Lost to Follow-up|50|||
127886507|NCT02410837|460208594|FG000|Overall Study|Withdrawal by Subject|44|||
127886508|NCT02410837|460208594|FG000|Overall Study|Physician Decision|6|||
127886509|NCT02410837|460208594|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
127886510|NCT00837577|460208595|FG000|Double-blind Period|Clinical Adverse Event|1|||
127886511|NCT00837577|460208596|FG001|Double-blind Period|Clinical Adverse Event|0|||
127886512|NCT00837577|460208595|FG000|Double-blind Period|Withdrawal by Subject|1|||
127886513|NCT00837577|460208596|FG001|Double-blind Period|Withdrawal by Subject|0|||
127886514|NCT00837577|460208595|FG000|Open-label Period|Clinical Adverse Event|2|||
127886515|NCT00837577|460208596|FG001|Open-label Period|Clinical Adverse Event|2|||
127886516|NCT00837577|460208595|FG000|Open-label Period|Laboratory Adverse Event|0|||
127886517|NCT00837577|460208596|FG001|Open-label Period|Laboratory Adverse Event|1|||
127886518|NCT00837577|460208595|FG000|Open-label Period|Lack of Efficacy|4|||
127886519|NCT00837577|460208596|FG001|Open-label Period|Lack of Efficacy|3|||
127886520|NCT00837577|460208595|FG000|Open-label Period|Withdrawal by Subject|1|||
127886521|NCT00837577|460208596|FG001|Open-label Period|Withdrawal by Subject|2|||
127886522|NCT00837577|460208595|FG000|Open-label Period|Other Reason|1|||
127886523|NCT00837577|460208596|FG001|Open-label Period|Other Reason|1|||
127886524|NCT03031431|460208601|FG000|Overall Study|Infant removed by maternal request|1|||
127886525|NCT01205529|460208602|FG000|Overall Study|Procedure Cancelled|4|||
127886526|NCT01205529|460208602|FG000|Overall Study|Withdrawal by Subject|2|||
127640419|NCT00613951|459302494|FG001|Overall Study|Protocol Violation|1|||
127640420|NCT00613951|459302495|FG002|Overall Study|Protocol Violation|1|||
127640421|NCT00613951|459302493|FG000|Overall Study|Unclassified|5|||
127640422|NCT00613951|459302494|FG001|Overall Study|Unclassified|3|||
127640423|NCT00613951|459302495|FG002|Overall Study|Unclassified|2|||
127640424|NCT00127608|459302496|FG000|Overall Study|VZV DNA negative|1|||
127640425|NCT01329029|459302497|FG000|Overall Study|Withdrawal by Subject|117|||
127640426|NCT01329029|459302498|FG001|Overall Study|Withdrawal by Subject|87|||
127640427|NCT01329029|459302497|FG000|Overall Study|Adverse Event|82|||
127640428|NCT01329029|459302498|FG001|Overall Study|Adverse Event|29|||
127640429|NCT01329029|459302497|FG000|Overall Study|Death|16|||
127640430|NCT01329029|459302498|FG001|Overall Study|Death|19|||
127886527|NCT01205529|460208602|FG000|Overall Study|Physician Decision|4|||
127640431|NCT01329029|459302497|FG000|Overall Study|Other|14|||
127886528|NCT01205529|460208602|FG000|Overall Study|Unstable post op|15|||
127886529|NCT01205529|460208602|FG000|Overall Study|No longer met criteria|30|||
127886530|NCT01027884|460208606|FG000|Overall Study|Adverse Event|2|||
127886531|NCT01027884|460208607|FG001|Overall Study|Adverse Event|1|||
127886532|NCT01027884|460208606|FG000|Overall Study|Protocol Violation|1|||
127886533|NCT01027884|460208607|FG001|Overall Study|Protocol Violation|0|||
127886534|NCT01027884|460208606|FG000|Overall Study|Non-compliance|1|||
127886535|NCT01027884|460208607|FG001|Overall Study|Non-compliance|1|||
127640432|NCT01329029|459302498|FG001|Overall Study|Other|20|||
127640433|NCT01329029|459302497|FG000|Overall Study|COPD Exacerbation|11|||
127640434|NCT01329029|459302498|FG001|Overall Study|COPD Exacerbation|18|||
127886536|NCT01027884|460208606|FG000|Overall Study|Withdrawal by Subject|0|||
127886537|NCT01027884|460208607|FG001|Overall Study|Withdrawal by Subject|1|||
127886538|NCT01027884|460208606|FG000|Overall Study|Lost to Follow-up|0|||
127886539|NCT01027884|460208607|FG001|Overall Study|Lost to Follow-up|1|||
127886540|NCT01027884|460208606|FG000|Overall Study|Spinal fixation surgery|0|||
127886541|NCT01027884|460208607|FG001|Overall Study|Spinal fixation surgery|3|||
127886542|NCT03670537|460208609|FG000|Overall Study|Protocol Violation|1|||
127640435|NCT01329029|459302497|FG000|Overall Study|Physician Decision|16|||
127640436|NCT01329029|459302498|FG001|Overall Study|Physician Decision|13|||
127640437|NCT01329029|459302497|FG000|Overall Study|Lost to Follow-up|8|||
127640438|NCT01329029|459302498|FG001|Overall Study|Lost to Follow-up|5|||
127886543|NCT02059187|460208610|FG000|Overall Study|Adverse Event|0|||
127640439|NCT01329029|459302497|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
127640440|NCT01329029|459302498|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
127640441|NCT00506493|459302504|FG000|Overall Study|Death|6|||
127640442|NCT00506493|459302504|FG000|Overall Study|Withdrawal by Subject|5|||
127640443|NCT01266642|459302505|FG000|Overall Study|Protocol Violation|0|||
127640444|NCT01266642|459302506|FG001|Overall Study|Protocol Violation|1|||
127640445|NCT02985866|459304516|FG000|Overall Study|Poor CGM data|1|||
127640446|NCT02985866|459304517|FG001|Overall Study|Poor CGM data|1|||
127640447|NCT04066114|459304518|FG000|Overall Study|Adverse Event|1|||
127640448|NCT04066114|459304519|FG001|Overall Study|Adverse Event|0|||
127640449|NCT04066114|459304520|FG002|Overall Study|Adverse Event|0|||
127640450|NCT04066114|459304518|FG000|Overall Study|Withdrawal by Subject|1|||
127640451|NCT04066114|459304519|FG001|Overall Study|Withdrawal by Subject|0|||
127640452|NCT04066114|459304520|FG002|Overall Study|Withdrawal by Subject|0|||
127640453|NCT04066114|459304518|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
127640454|NCT04066114|459304519|FG001|Overall Study|Did Not Meet Eligibility Criteria|7|||
127640455|NCT04066114|459304520|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
127703890|NCT05292391|459544786|FG000|Overall Study|Lost to Follow-up|0|||
127703891|NCT05292391|459544787|FG001|Overall Study|Lost to Follow-up|0|||
127703892|NCT05292391|459544788|FG002|Overall Study|Lost to Follow-up|0|||
127703893|NCT05292391|459544789|FG003|Overall Study|Lost to Follow-up|1|||
127703894|NCT05292391|459544790|FG004|Overall Study|Lost to Follow-up|0|||
127640456|NCT03117738|459304521|FG000|Overall Study|Withdrawal by Subject|3|||
127640457|NCT03117738|459304522|FG001|Overall Study|Withdrawal by Subject|1|||
127640458|NCT03117738|459304521|FG000|Overall Study|Lost to Follow-up|1|||
127640459|NCT03117738|459304522|FG001|Overall Study|Lost to Follow-up|4|||
127640460|NCT04004611|459304523|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
127703895|NCT04857723|459544791|FG000|Overall Study|Withdrawal by Subject|2|||
127703896|NCT02276885|459546636|FG000|Overall Study|Withdrawal by Subject|2|||
127703897|NCT02276885|459546637|FG001|Overall Study|Withdrawal by Subject|0|||
127703898|NCT02276885|459546636|FG000|Overall Study|Lost to Follow-up|5|||
127703899|NCT02276885|459546637|FG001|Overall Study|Lost to Follow-up|2|||
127703900|NCT04171141|459546641|FG000|Overall Study|Adverse Event|0|||
127703901|NCT04171141|459546642|FG001|Overall Study|Adverse Event|0|||
127703902|NCT04171141|459546643|FG002|Overall Study|Adverse Event|2|||
127703903|NCT04171141|459546644|FG003|Overall Study|Adverse Event|0|||
127703904|NCT04171141|459546645|FG004|Overall Study|Adverse Event|0|||
127703905|NCT04171141|459546646|FG005|Overall Study|Adverse Event|0|||
127703906|NCT04171141|459546647|FG006|Overall Study|Adverse Event|0|||
127703907|NCT04171141|459546648|FG007|Overall Study|Adverse Event|0|||
127703908|NCT04171141|459546649|FG008|Overall Study|Adverse Event|0|||
127703909|NCT04171141|459546650|FG009|Overall Study|Adverse Event|0|||
127703910|NCT04171141|459546651|FG010|Overall Study|Adverse Event|0|||
127703911|NCT04171141|459546652|FG011|Overall Study|Adverse Event|0|||
127703912|NCT04171141|459546653|FG012|Overall Study|Adverse Event|0|||
127703913|NCT04171141|459546654|FG013|Overall Study|Adverse Event|2|||
127703914|NCT04171141|459546655|FG014|Overall Study|Adverse Event|0|||
127703915|NCT04171141|459546656|FG015|Overall Study|Adverse Event|0|||
127703916|NCT04171141|459546641|FG000|Overall Study|Physician Decision|0|||
127703917|NCT04171141|459546642|FG001|Overall Study|Physician Decision|0|||
127703918|NCT04171141|459546643|FG002|Overall Study|Physician Decision|0|||
127703919|NCT04171141|459546644|FG003|Overall Study|Physician Decision|0|||
127703920|NCT04171141|459546645|FG004|Overall Study|Physician Decision|1|||
127703921|NCT04171141|459546646|FG005|Overall Study|Physician Decision|0|||
127703922|NCT04171141|459546647|FG006|Overall Study|Physician Decision|0|||
127640461|NCT04004611|459304524|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
127640462|NCT04004611|459304525|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
127797829|NCT02064387|459883495|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
127797830|NCT02064387|459883496|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
127640463|NCT04004611|459304526|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
127640464|NCT04004611|459304527|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
127640465|NCT04004611|459304528|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
127640466|NCT04004611|459304529|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
127640467|NCT04004611|459304530|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
127640468|NCT04004611|459304531|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
127640469|NCT04004611|459304523|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
127640470|NCT04004611|459304524|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
127640471|NCT04004611|459304525|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
127640472|NCT04004611|459304526|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
127640473|NCT04004611|459304527|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
127640474|NCT04004611|459304528|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
127640475|NCT04004611|459304529|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
127640476|NCT04004611|459304530|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
127640477|NCT04004611|459304531|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
127640478|NCT04004611|459304523|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
127640479|NCT04004611|459304524|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
127640480|NCT04004611|459304525|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
127640481|NCT04004611|459304526|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
127640482|NCT04004611|459304527|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
127797831|NCT02064387|459883485|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
127797832|NCT02064387|459883486|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
127797833|NCT02064387|459883487|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
127797834|NCT02064387|459883488|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
127797835|NCT02064387|459883489|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
127797836|NCT02064387|459883490|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
127797837|NCT02064387|459883491|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
127640483|NCT04004611|459304528|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
127640484|NCT04004611|459304529|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
127640485|NCT04004611|459304530|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
127640486|NCT04004611|459304531|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
127640487|NCT04004611|459304523|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
127640488|NCT04004611|459304524|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
127640489|NCT04004611|459304525|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
127640490|NCT04004611|459304526|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
127640491|NCT04004611|459304527|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
127797838|NCT02064387|459883492|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
127797839|NCT02064387|459883493|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
127797840|NCT02064387|459883494|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
127797841|NCT02064387|459883495|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
127797842|NCT02064387|459883496|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
127797843|NCT02064387|459883485|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
127640492|NCT04004611|459304528|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
127886544|NCT02059187|460208611|FG001|Overall Study|Adverse Event|3|||
127886545|NCT02059187|460208610|FG000|Overall Study|Death|1|||
127886546|NCT02059187|460208611|FG001|Overall Study|Death|1|||
127886547|NCT02059187|460208610|FG000|Overall Study|Lost to Follow-up|9|||
127886548|NCT02059187|460208611|FG001|Overall Study|Lost to Follow-up|8|||
127640493|NCT04004611|459304529|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
127640494|NCT04004611|459304530|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
127640495|NCT04004611|459304531|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
127640496|NCT04004611|459304523|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
127640497|NCT04004611|459304524|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
127640498|NCT04004611|459304525|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
127640499|NCT04004611|459304526|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
127640500|NCT04004611|459304527|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
127886549|NCT02059187|460208610|FG000|Overall Study|Non-compliance with study drug|1|||
127886550|NCT02059187|460208611|FG001|Overall Study|Non-compliance with study drug|0|||
127886551|NCT02059187|460208610|FG000|Overall Study|Physician Decision|1|||
127886552|NCT02059187|460208611|FG001|Overall Study|Physician Decision|2|||
127886553|NCT02059187|460208610|FG000|Overall Study|Protocol Violation|1|||
127886554|NCT02059187|460208611|FG001|Overall Study|Protocol Violation|0|||
127886555|NCT02059187|460208610|FG000|Overall Study|Withdrawal by Subject|12|||
127886556|NCT02059187|460208611|FG001|Overall Study|Withdrawal by Subject|8|||
127886557|NCT03070431|460208612|FG000|Overall Study|Withdrawal by Subject|2|||
127886558|NCT03070431|460208612|FG000|Overall Study|Lost to Follow-up|2|||
127886559|NCT01889862|460208613|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
127886560|NCT01889862|460208614|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
127886561|NCT01889862|460208615|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
127886562|NCT01889862|460208616|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
127886563|NCT01889862|460208617|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
127886564|NCT01889862|460208613|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
127886565|NCT01889862|460208614|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
127886566|NCT01889862|460208615|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
127886567|NCT01889862|460208616|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
127886568|NCT01889862|460208617|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
127640501|NCT04004611|459304528|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
127640502|NCT04004611|459304529|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
127886569|NCT01889862|460208613|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
127886570|NCT01889862|460208614|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
127886571|NCT01889862|460208615|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
127886572|NCT01889862|460208616|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
127886573|NCT01889862|460208617|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
127886574|NCT01889862|460208613|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
127886575|NCT01889862|460208614|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
127886576|NCT01889862|460208615|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
127886577|NCT01889862|460208616|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
127886578|NCT01889862|460208617|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
127886579|NCT01889862|460208613|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
127886580|NCT01889862|460208614|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
127886581|NCT01889862|460208615|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
127886582|NCT01889862|460208616|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
127886583|NCT01889862|460208617|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
127886584|NCT01889862|460208613|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
127886585|NCT01889862|460208614|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
127886586|NCT01889862|460208615|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
127886587|NCT01889862|460208616|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
127886588|NCT01889862|460208617|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
127886589|NCT01889862|460208613|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
127886590|NCT01889862|460208614|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
127886591|NCT01889862|460208615|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
127886592|NCT01889862|460208616|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
127640503|NCT04004611|459304530|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
127640504|NCT04004611|459304531|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
127640505|NCT04004611|459304523|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
127886593|NCT01889862|460208617|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
127640506|NCT04004611|459304524|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
127640507|NCT04004611|459304525|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
127640508|NCT04004611|459304526|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
127640509|NCT04004611|459304527|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
127640510|NCT04004611|459304528|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
127640511|NCT04004611|459304529|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
127886594|NCT01889862|460208613|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
127886595|NCT01889862|460208614|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
127886596|NCT01889862|460208615|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
127886597|NCT01889862|460208616|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
127886598|NCT01889862|460208617|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
127886599|NCT01889862|460208613|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
127886600|NCT01889862|460208614|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
127886601|NCT01889862|460208615|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
127886602|NCT01889862|460208616|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
127886603|NCT01889862|460208617|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
127886604|NCT01889862|460208613|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
127886605|NCT01889862|460208614|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
127886606|NCT01889862|460208615|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
127886607|NCT01889862|460208616|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
127886608|NCT01889862|460208617|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
127886609|NCT02065791|460208618|FG000|Overall Study|Closed Site|1|||
127886610|NCT02065791|460208619|FG001|Overall Study|Closed Site|1|||
127886611|NCT02065791|460208618|FG000|Overall Study|Withdrawal by Subject|11|||
127886612|NCT02065791|460208619|FG001|Overall Study|Withdrawal by Subject|5|||
127886613|NCT02065791|460208618|FG000|Overall Study|Lost to Follow-up|13|||
127640512|NCT04004611|459304530|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
127640513|NCT04004611|459304531|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
127640514|NCT04420689|459304532|FG000|Overall Study|COVID-19 related hospitalization|0|||
127640515|NCT04420689|459304533|FG001|Overall Study|COVID-19 related hospitalization|0|||
127640516|NCT04420689|459304534|FG002|Overall Study|COVID-19 related hospitalization|0|||
127640517|NCT04420689|459304535|FG003|Overall Study|COVID-19 related hospitalization|0|||
127640518|NCT04420689|459304536|FG004|Overall Study|COVID-19 related hospitalization|1|||
127886614|NCT02065791|460208619|FG001|Overall Study|Lost to Follow-up|9|||
127886615|NCT00272961|460208620|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
127886616|NCT00272961|460208621|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
127886617|NCT00272961|460208622|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
127886618|NCT00272961|460208623|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
127886619|NCT00272961|460208624|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
127886620|NCT00272961|460208620|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
127886621|NCT00272961|460208621|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
127886622|NCT00272961|460208622|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
127886623|NCT00272961|460208623|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
127886624|NCT00272961|460208624|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
127886625|NCT00272961|460208620|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
127886626|NCT00272961|460208621|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
127886627|NCT00272961|460208622|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
127640519|NCT04420689|459304537|FG005|Overall Study|COVID-19 related hospitalization|0|||
127640520|NCT04420689|459304538|FG006|Overall Study|COVID-19 related hospitalization|0|||
127640521|NCT04420689|459304532|FG000|Overall Study|Physician Decision|0|||
127640522|NCT04420689|459304533|FG001|Overall Study|Physician Decision|0|||
127886628|NCT00272961|460208623|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
127886629|NCT00272961|460208624|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
127886630|NCT00272961|460208620|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
127886631|NCT00272961|460208621|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
127886632|NCT00272961|460208622|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
127886633|NCT00272961|460208623|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
127640523|NCT04420689|459304534|FG002|Overall Study|Physician Decision|0|||
127640524|NCT04420689|459304535|FG003|Overall Study|Physician Decision|0|||
127640525|NCT04420689|459304536|FG004|Overall Study|Physician Decision|0|||
127640526|NCT04420689|459304537|FG005|Overall Study|Physician Decision|1|||
127640527|NCT04420689|459304538|FG006|Overall Study|Physician Decision|0|||
127703923|NCT04171141|459546648|FG007|Overall Study|Physician Decision|0|||
127703924|NCT04171141|459546649|FG008|Overall Study|Physician Decision|0|||
127703925|NCT04171141|459546650|FG009|Overall Study|Physician Decision|0|||
127703926|NCT04171141|459546651|FG010|Overall Study|Physician Decision|0|||
127703927|NCT04171141|459546652|FG011|Overall Study|Physician Decision|0|||
127703928|NCT04171141|459546653|FG012|Overall Study|Physician Decision|0|||
127703929|NCT04171141|459546654|FG013|Overall Study|Physician Decision|0|||
127703930|NCT04171141|459546655|FG014|Overall Study|Physician Decision|0|||
127703931|NCT04171141|459546656|FG015|Overall Study|Physician Decision|1|||
127703932|NCT04171141|459546641|FG000|Overall Study|Progressive disease|2|||
127703933|NCT04171141|459546642|FG001|Overall Study|Progressive disease|3|||
127703934|NCT04171141|459546643|FG002|Overall Study|Progressive disease|4|||
127703935|NCT04171141|459546644|FG003|Overall Study|Progressive disease|7|||
127703936|NCT04171141|459546645|FG004|Overall Study|Progressive disease|1|||
127703937|NCT04171141|459546646|FG005|Overall Study|Progressive disease|8|||
127703938|NCT04171141|459546647|FG006|Overall Study|Progressive disease|4|||
127703939|NCT04171141|459546648|FG007|Overall Study|Progressive disease|6|||
127703940|NCT04171141|459546649|FG008|Overall Study|Progressive disease|7|||
127703941|NCT04171141|459546650|FG009|Overall Study|Progressive disease|3|||
127703942|NCT04171141|459546651|FG010|Overall Study|Progressive disease|4|||
127703943|NCT04171141|459546652|FG011|Overall Study|Progressive disease|3|||
127703944|NCT04171141|459546653|FG012|Overall Study|Progressive disease|4|||
127703945|NCT04171141|459546654|FG013|Overall Study|Progressive disease|2|||
127703946|NCT04171141|459546655|FG014|Overall Study|Progressive disease|4|||
127703947|NCT04171141|459546656|FG015|Overall Study|Progressive disease|1|||
127703948|NCT04171141|459546641|FG000|Overall Study|Withdrawal by Subject|0|||
127703949|NCT04171141|459546642|FG001|Overall Study|Withdrawal by Subject|0|||
127703950|NCT04171141|459546643|FG002|Overall Study|Withdrawal by Subject|0|||
127703951|NCT04171141|459546644|FG003|Overall Study|Withdrawal by Subject|1|||
127703952|NCT04171141|459546645|FG004|Overall Study|Withdrawal by Subject|0|||
127703953|NCT04171141|459546646|FG005|Overall Study|Withdrawal by Subject|0|||
127703954|NCT04171141|459546647|FG006|Overall Study|Withdrawal by Subject|1|||
127703955|NCT04171141|459546648|FG007|Overall Study|Withdrawal by Subject|0|||
127703956|NCT04171141|459546649|FG008|Overall Study|Withdrawal by Subject|0|||
127703957|NCT04171141|459546650|FG009|Overall Study|Withdrawal by Subject|1|||
127703958|NCT04171141|459546651|FG010|Overall Study|Withdrawal by Subject|0|||
127703959|NCT04171141|459546652|FG011|Overall Study|Withdrawal by Subject|0|||
127703960|NCT04171141|459546653|FG012|Overall Study|Withdrawal by Subject|0|||
127703961|NCT04171141|459546654|FG013|Overall Study|Withdrawal by Subject|0|||
127703962|NCT04171141|459546655|FG014|Overall Study|Withdrawal by Subject|0|||
127640528|NCT00515502|459304539|FG000|Treatment Period 1|Adverse Event|0|||
127640529|NCT00515502|459304540|FG001|Treatment Period 1|Adverse Event|0|||
127703963|NCT04171141|459546656|FG015|Overall Study|Withdrawal by Subject|0|||
127703964|NCT04171141|459546641|FG000|Overall Study|Global deterioration of health status|0|||
127703965|NCT04171141|459546642|FG001|Overall Study|Global deterioration of health status|0|||
127703966|NCT04171141|459546643|FG002|Overall Study|Global deterioration of health status|0|||
127703967|NCT04171141|459546644|FG003|Overall Study|Global deterioration of health status|1|||
127703968|NCT04171141|459546645|FG004|Overall Study|Global deterioration of health status|0|||
127703969|NCT04171141|459546646|FG005|Overall Study|Global deterioration of health status|2|||
127797844|NCT02064387|459883486|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
127797845|NCT02064387|459883487|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
127797846|NCT02064387|459883488|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
127797847|NCT02064387|459883489|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
127797848|NCT02064387|459883490|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
127797849|NCT02064387|459883491|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
127797850|NCT02064387|459883492|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
127797851|NCT02064387|459883493|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
127797852|NCT02064387|459883494|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
127797853|NCT02064387|459883495|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
127797854|NCT02064387|459883496|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
127797855|NCT02706730|459883497|FG000|Overall Study|Adverse Event|3|||
127797856|NCT02706730|459883497|FG000|Overall Study|Lack of Efficacy|5|||
127797857|NCT02706730|459883497|FG000|Overall Study|Withdrawal by Subject|11|||
127797858|NCT02706730|459883497|FG000|Overall Study|Study Terminated by Sponsor|11|||
127797859|NCT02706730|459883497|FG000|Overall Study|Subject chose not to receive injection|3|||
127797860|NCT02499029|459883498|FG000|Overall Study|Lost to Follow-up|2|||
127797861|NCT02499029|459883499|FG001|Overall Study|Lost to Follow-up|2|||
127797862|NCT02499029|459883498|FG000|Overall Study|Physician Decision|2|||
127797863|NCT02499029|459883499|FG001|Overall Study|Physician Decision|1|||
127797864|NCT02499029|459883498|FG000|Overall Study|Death|1|||
127797865|NCT02499029|459883499|FG001|Overall Study|Death|0|||
127797866|NCT01999582|459883500|FG000|Overall Study|Withdrawal by Subject|0|||
127797867|NCT01999582|459883501|FG001|Overall Study|Withdrawal by Subject|0|||
127797868|NCT01999582|459883502|FG002|Overall Study|Withdrawal by Subject|0|||
127797869|NCT01999582|459883503|FG003|Overall Study|Withdrawal by Subject|1|||
127797870|NCT01999582|459883504|FG004|Overall Study|Withdrawal by Subject|0|||
127797871|NCT01999582|459883505|FG005|Overall Study|Withdrawal by Subject|0|||
127797872|NCT01999582|459883500|FG000|Overall Study|Adverse Event|0|||
127797873|NCT01999582|459883501|FG001|Overall Study|Adverse Event|0|||
127797874|NCT01999582|459883502|FG002|Overall Study|Adverse Event|3|||
127797875|NCT01999582|459883503|FG003|Overall Study|Adverse Event|0|||
127797876|NCT01999582|459883504|FG004|Overall Study|Adverse Event|1|||
127797877|NCT01999582|459883505|FG005|Overall Study|Adverse Event|0|||
127797878|NCT01999582|459883500|FG000|Overall Study|Other Reasons|1|||
127797879|NCT01999582|459883501|FG001|Overall Study|Other Reasons|0|||
127797880|NCT01999582|459883502|FG002|Overall Study|Other Reasons|3|||
127797881|NCT01999582|459883503|FG003|Overall Study|Other Reasons|1|||
127797882|NCT01999582|459883504|FG004|Overall Study|Other Reasons|1|||
127797883|NCT01999582|459883505|FG005|Overall Study|Other Reasons|2|||
127797884|NCT01999582|459883500|FG000|Overall Study|Protocol Violation|1|||
127797885|NCT01999582|459883501|FG001|Overall Study|Protocol Violation|0|||
127797886|NCT01999582|459883502|FG002|Overall Study|Protocol Violation|0|||
127797887|NCT01999582|459883503|FG003|Overall Study|Protocol Violation|0|||
127797888|NCT01999582|459883504|FG004|Overall Study|Protocol Violation|0|||
127797889|NCT01999582|459883505|FG005|Overall Study|Protocol Violation|1|||
127797890|NCT01999582|459883500|FG000|Overall Study|Lack of Efficacy|1|||
127797891|NCT01999582|459883501|FG001|Overall Study|Lack of Efficacy|3|||
127797892|NCT01999582|459883502|FG002|Overall Study|Lack of Efficacy|0|||
127797893|NCT01999582|459883503|FG003|Overall Study|Lack of Efficacy|1|||
127797894|NCT01999582|459883504|FG004|Overall Study|Lack of Efficacy|0|||
127797895|NCT01999582|459883505|FG005|Overall Study|Lack of Efficacy|0|||
127797896|NCT03889639|459883508|FG000|Overall Study|Withdrawal by Subject|0|||
127797897|NCT03889639|459883509|FG001|Overall Study|Withdrawal by Subject|0|||
127797898|NCT03889639|459883510|FG002|Overall Study|Withdrawal by Subject|0|||
127797899|NCT03889639|459883511|FG003|Overall Study|Withdrawal by Subject|0|||
127797900|NCT03889639|459883512|FG004|Overall Study|Withdrawal by Subject|0|||
127797901|NCT03889639|459883513|FG005|Overall Study|Withdrawal by Subject|0|||
127797902|NCT03889639|459883514|FG006|Overall Study|Withdrawal by Subject|0|||
127703970|NCT04171141|459546647|FG006|Overall Study|Global deterioration of health status|1|||
127703971|NCT04171141|459546648|FG007|Overall Study|Global deterioration of health status|0|||
127703972|NCT04171141|459546649|FG008|Overall Study|Global deterioration of health status|1|||
127797903|NCT03889639|459883515|FG007|Overall Study|Withdrawal by Subject|1|||
127797904|NCT01703858|459883516|FG000|Overall Study|Withdrawal by Subject|0|||
127797905|NCT01703858|459883517|FG001|Overall Study|Withdrawal by Subject|1|||
127797906|NCT01703858|459883518|FG002|Overall Study|Withdrawal by Subject|0|||
127797907|NCT00927095|459883519|FG000|Overall Study|Adverse Event|3|||
127797908|NCT00927095|459883520|FG001|Overall Study|Adverse Event|1|||
127886634|NCT00272961|460208624|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
127886635|NCT00272961|460208620|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
127886636|NCT00272961|460208621|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
127886637|NCT00272961|460208622|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
127886638|NCT00272961|460208623|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
127886639|NCT00272961|460208624|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
127886640|NCT00272961|460208620|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
127886641|NCT00272961|460208621|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
127886642|NCT00272961|460208622|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
127886643|NCT00272961|460208623|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
127886644|NCT00272961|460208624|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
127886645|NCT00272961|460208620|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
127886646|NCT00272961|460208621|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
127886647|NCT00272961|460208622|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
127886648|NCT00272961|460208623|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
127886649|NCT00272961|460208624|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
127886650|NCT00272961|460208620|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
127886651|NCT00272961|460208621|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
127886652|NCT00272961|460208622|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
127886653|NCT00272961|460208623|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
127886654|NCT00272961|460208624|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
127886655|NCT00106028|460208634|FG000|Overall Study|Adverse Event|3|||
127886656|NCT00106028|460208635|FG001|Overall Study|Adverse Event|2|||
127640530|NCT00515502|459304541|FG002|Treatment Period 1|Adverse Event|0|||
127640531|NCT00515502|459304542|FG003|Treatment Period 1|Adverse Event|0|||
127640532|NCT00515502|459304543|FG004|Treatment Period 1|Adverse Event|0|||
127886657|NCT00106028|460208634|FG000|Overall Study|Protocol Violation|1|||
127886658|NCT00106028|460208635|FG001|Overall Study|Protocol Violation|1|||
127886659|NCT00106028|460208634|FG000|Overall Study|Withdrawal by Subject|2|||
127640533|NCT00515502|459304544|FG005|Treatment Period 1|Adverse Event|0|||
127640534|NCT00515502|459304545|FG006|Treatment Period 1|Adverse Event|1|||
127640535|NCT00515502|459304546|FG007|Treatment Period 1|Adverse Event|0|||
127886660|NCT00106028|460208635|FG001|Overall Study|Withdrawal by Subject|8|||
127886661|NCT00106028|460208634|FG000|Overall Study|Lost to Follow-up|0|||
127886662|NCT00106028|460208635|FG001|Overall Study|Lost to Follow-up|1|||
127886663|NCT01280981|460208636|FG000|Overall Study|Withdrawal by Subject|11|||
127886664|NCT01280981|460208636|FG000|Overall Study|Protocol Violation|2|||
127640536|NCT00515502|459304547|FG008|Treatment Period 1|Adverse Event|1|||
127640537|NCT00515502|459304548|FG009|Treatment Period 1|Adverse Event|0|||
127640538|NCT00515502|459304549|FG010|Treatment Period 1|Adverse Event|0|||
127640539|NCT00515502|459304550|FG011|Treatment Period 1|Adverse Event|1|||
127640540|NCT00515502|459304539|FG000|Treatment Period 2|Adverse Event|0|||
127640541|NCT00515502|459304540|FG001|Treatment Period 2|Adverse Event|1|||
127640542|NCT00515502|459304541|FG002|Treatment Period 2|Adverse Event|0|||
127640543|NCT00515502|459304542|FG003|Treatment Period 2|Adverse Event|0|||
127640544|NCT00515502|459304543|FG004|Treatment Period 2|Adverse Event|0|||
127640545|NCT00515502|459304544|FG005|Treatment Period 2|Adverse Event|0|||
127640546|NCT00515502|459304545|FG006|Treatment Period 2|Adverse Event|0|||
127640547|NCT00515502|459304546|FG007|Treatment Period 2|Adverse Event|0|||
127640548|NCT00515502|459304547|FG008|Treatment Period 2|Adverse Event|0|||
127640549|NCT00515502|459304548|FG009|Treatment Period 2|Adverse Event|0|||
127640550|NCT00515502|459304549|FG010|Treatment Period 2|Adverse Event|0|||
127640551|NCT00515502|459304550|FG011|Treatment Period 2|Adverse Event|0|||
127640552|NCT02732938|459304554|FG000|Overall Study|Death|0|||
127640553|NCT02732938|459304555|FG001|Overall Study|Death|11|||
127640554|NCT02732938|459304556|FG002|Overall Study|Death|0|||
127640555|NCT02732938|459304554|FG000|Overall Study|Randomized but did not receive treatment|0|||
127640556|NCT02732938|459304555|FG001|Overall Study|Randomized but did not receive treatment|1|||
127640557|NCT02732938|459304556|FG002|Overall Study|Randomized but did not receive treatment|0|||
127640558|NCT02732938|459304554|FG000|Overall Study|Refused further follow-up|1|||
127640559|NCT02732938|459304555|FG001|Overall Study|Refused further follow-up|0|||
127640560|NCT02732938|459304556|FG002|Overall Study|Refused further follow-up|0|||
127640561|NCT02732938|459304554|FG000|Overall Study|Study terminated by sponsor|3|||
127640562|NCT02732938|459304555|FG001|Overall Study|Study terminated by sponsor|6|||
127640563|NCT02732938|459304556|FG002|Overall Study|Study terminated by sponsor|0|||
127640564|NCT03927950|459304557|FG000|Overall Study|Adverse Event|9|||
127703973|NCT04171141|459546650|FG009|Overall Study|Global deterioration of health status|0|||
127640565|NCT03647501|459304558|FG000|Overall Study|Lost to Follow-up|1|||
127640566|NCT03647501|459304559|FG001|Overall Study|Lost to Follow-up|1|||
127640567|NCT03647501|459304558|FG000|Overall Study|Withdrawal by Subject|0|||
127640568|NCT03647501|459304559|FG001|Overall Study|Withdrawal by Subject|1|||
127640569|NCT04530448|459304560|FG000|Overall Study|Physician Decision|3|||
127640570|NCT04530448|459304561|FG001|Overall Study|Physician Decision|0|||
127640571|NCT01613248|459304562|FG000|Overall Study|Adverse Event|0|||
127640572|NCT01613248|459304563|FG001|Overall Study|Adverse Event|0|||
127640573|NCT01613248|459304564|FG002|Overall Study|Adverse Event|0|||
127640574|NCT01613248|459304565|FG003|Overall Study|Adverse Event|1|||
127640575|NCT01613248|459304566|FG004|Overall Study|Adverse Event|0|||
127640576|NCT01613248|459304567|FG005|Overall Study|Adverse Event|0|||
127640577|NCT01613248|459304562|FG000|Overall Study|Withdrawal by Subject|3|||
127640578|NCT01613248|459304563|FG001|Overall Study|Withdrawal by Subject|2|||
127640579|NCT01613248|459304564|FG002|Overall Study|Withdrawal by Subject|2|||
127640580|NCT01613248|459304565|FG003|Overall Study|Withdrawal by Subject|5|||
127797909|NCT00927095|459883521|FG002|Overall Study|Adverse Event|0|||
127797910|NCT00927095|459883519|FG000|Overall Study|Withdrawal by Subject|2|||
127797911|NCT00927095|459883520|FG001|Overall Study|Withdrawal by Subject|1|||
127797912|NCT00927095|459883521|FG002|Overall Study|Withdrawal by Subject|1|||
127797913|NCT00927095|459883519|FG000|Overall Study|Physician Decision|1|||
127797914|NCT00927095|459883520|FG001|Overall Study|Physician Decision|2|||
127797915|NCT00927095|459883521|FG002|Overall Study|Physician Decision|1|||
127797916|NCT02556255|459883522|FG000|Overall Study|Lost to Follow-up|4|||
127797917|NCT03115151|459883523|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
127797918|NCT03115151|459883524|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
127797919|NCT03115151|459883523|FG000|Overall Study|Epidural catheter removal|1|||
127797920|NCT03115151|459883524|FG001|Overall Study|Epidural catheter removal|0|||
127797921|NCT03115151|459883523|FG000|Overall Study|Withdrawal by Subject|0|||
127797922|NCT03115151|459883524|FG001|Overall Study|Withdrawal by Subject|1|||
127797923|NCT03115151|459883523|FG000|Overall Study|Intervention not received according to the protocol.|1|||
127797924|NCT03115151|459883524|FG001|Overall Study|Intervention not received according to the protocol.|1|||
127797925|NCT03115151|459883523|FG000|Overall Study|Physician Decision|1|||
127797926|NCT03115151|459883524|FG001|Overall Study|Physician Decision|0|||
127797927|NCT03115151|459883523|FG000|Overall Study|Randomization not applied|1|||
127797928|NCT03115151|459883524|FG001|Overall Study|Randomization not applied|1|||
127797929|NCT05779072|459883530|FG000|Overall Study|Lost to Follow-up|0|||
127797930|NCT05779072|459883531|FG001|Overall Study|Lost to Follow-up|1|||
127797931|NCT05779072|459883530|FG000|Overall Study|Withdrawal by Subject|1|||
127797932|NCT05779072|459883531|FG001|Overall Study|Withdrawal by Subject|5|||
127797933|NCT03694925|459883532|FG000|Overall Study|Inadequate laboratory testing|0|||
127797934|NCT03694925|459883533|FG001|Overall Study|Inadequate laboratory testing|3|||
127797935|NCT03694925|459883534|FG002|Overall Study|Inadequate laboratory testing|0|||
127797936|NCT02799069|459883537|FG000|Overall Study|Adverse Event|0|||
127797937|NCT02799069|459883538|FG001|Overall Study|Adverse Event|2|||
127797938|NCT02799069|459883539|FG002|Overall Study|Adverse Event|2|||
127797939|NCT02799069|459883537|FG000|Overall Study|Lack of Efficacy|2|||
127797940|NCT02799069|459883538|FG001|Overall Study|Lack of Efficacy|0|||
127640581|NCT01613248|459304566|FG004|Overall Study|Withdrawal by Subject|0|||
127797941|NCT02799069|459883539|FG002|Overall Study|Lack of Efficacy|0|||
127797942|NCT02799069|459883537|FG000|Overall Study|Lost to Follow-up|1|||
127797943|NCT02799069|459883538|FG001|Overall Study|Lost to Follow-up|1|||
127797944|NCT02799069|459883539|FG002|Overall Study|Lost to Follow-up|0|||
127797945|NCT02799069|459883537|FG000|Overall Study|Withdrawal by Subject|4|||
127797946|NCT02799069|459883538|FG001|Overall Study|Withdrawal by Subject|4|||
127797947|NCT02799069|459883539|FG002|Overall Study|Withdrawal by Subject|3|||
127797948|NCT02799069|459883537|FG000|Overall Study|Protocol Violation|1|||
127797949|NCT02799069|459883538|FG001|Overall Study|Protocol Violation|0|||
127797950|NCT02799069|459883539|FG002|Overall Study|Protocol Violation|2|||
127797951|NCT03033875|459883540|FG000|Overall Study|Withdrawal by Subject|5|||
127797952|NCT03033875|459883541|FG001|Overall Study|Withdrawal by Subject|9|||
127797953|NCT03033875|459883542|FG002|Overall Study|Withdrawal by Subject|4|||
127797954|NCT03033875|459883540|FG000|Overall Study|Other|14|||
127797955|NCT03033875|459883541|FG001|Overall Study|Other|15|||
127797956|NCT03033875|459883542|FG002|Overall Study|Other|8|||
127797957|NCT00730639|459883547|FG000|Overall Study|Adverse Event|3|||
127797958|NCT00730639|459883548|FG001|Overall Study|Adverse Event|0|||
127797959|NCT00730639|459883549|FG002|Overall Study|Adverse Event|9|||
127797960|NCT00730639|459883550|FG003|Overall Study|Adverse Event|8|||
127797961|NCT00730639|459883551|FG004|Overall Study|Adverse Event|23|||
127797962|NCT00730639|459883547|FG000|Overall Study|Complete Response|0|||
127640582|NCT01613248|459304567|FG005|Overall Study|Withdrawal by Subject|1|||
127640583|NCT01613248|459304562|FG000|Overall Study|Lost to Follow-up|5|||
127640584|NCT01613248|459304563|FG001|Overall Study|Lost to Follow-up|7|||
127640585|NCT01613248|459304564|FG002|Overall Study|Lost to Follow-up|4|||
127797963|NCT00730639|459883548|FG001|Overall Study|Complete Response|0|||
127640586|NCT01613248|459304565|FG003|Overall Study|Lost to Follow-up|8|||
127797964|NCT00730639|459883549|FG002|Overall Study|Complete Response|2|||
127797965|NCT00730639|459883550|FG003|Overall Study|Complete Response|2|||
127797966|NCT00730639|459883551|FG004|Overall Study|Complete Response|1|||
127797967|NCT00730639|459883547|FG000|Overall Study|Completed Maximum Cycles|0|||
127797968|NCT00730639|459883548|FG001|Overall Study|Completed Maximum Cycles|0|||
127797969|NCT00730639|459883549|FG002|Overall Study|Completed Maximum Cycles|11|||
127797970|NCT00730639|459883550|FG003|Overall Study|Completed Maximum Cycles|3|||
127640587|NCT01613248|459304566|FG004|Overall Study|Lost to Follow-up|4|||
127886665|NCT01280981|460208636|FG000|Overall Study|Lack of Efficacy|13|||
127886666|NCT01280981|460208636|FG000|Overall Study|Lost to Follow-up|3|||
127886667|NCT01280981|460208636|FG000|Overall Study|Adverse Event|6|||
127886668|NCT01280981|460208636|FG000|Overall Study|Irregular or discontinued menses|3|||
127886669|NCT01280981|460208636|FG000|Overall Study|Failed to return|45|||
127886670|NCT01280981|460208636|FG000|Overall Study|Non-compliance with protocol|3|||
127886671|NCT01280981|460208636|FG000|Overall Study|Withdrawal of consent|3|||
127886672|NCT01280981|460208636|FG000|Overall Study|Elective surgery|2|||
127886673|NCT01280981|460208636|FG000|Overall Study|Study site closure|1|||
127886674|NCT06371079|460208638|FG000|Overall Study|Missing data|88|||
127886675|NCT06371079|460208639|FG001|Overall Study|Missing data|247|||
127886676|NCT01256398|460208640|FG000|Overall Study|Withdrawal by Subject|1|||
127886677|NCT00411762|460208642|FG000|Overall Study|Withdrawal by Subject|5|||
127886678|NCT03276962|460208643|FG000|Overall Study|Serious Adverse Event And/Or Pimd|2|||
127886679|NCT03276962|460208644|FG001|Overall Study|Serious Adverse Event And/Or Pimd|1|||
127886680|NCT03276962|460208645|FG002|Overall Study|Serious Adverse Event And/Or Pimd|0|||
127886681|NCT03276962|460208646|FG003|Overall Study|Serious Adverse Event And/Or Pimd|4|||
127886682|NCT03276962|460208647|FG004|Overall Study|Serious Adverse Event And/Or Pimd|1|||
127886683|NCT03276962|460208643|FG000|Overall Study|Protocol Deviation|2|||
127886684|NCT03276962|460208644|FG001|Overall Study|Protocol Deviation|0|||
127886685|NCT03276962|460208645|FG002|Overall Study|Protocol Deviation|1|||
127886686|NCT03276962|460208646|FG003|Overall Study|Protocol Deviation|2|||
127886687|NCT03276962|460208647|FG004|Overall Study|Protocol Deviation|1|||
127886688|NCT03276962|460208643|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
127886689|NCT03276962|460208644|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
127886690|NCT03276962|460208645|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
127886691|NCT03276962|460208646|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
127886692|NCT03276962|460208647|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
127886693|NCT03276962|460208643|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
127886694|NCT03276962|460208644|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
127886695|NCT03276962|460208645|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
127886696|NCT03276962|460208646|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
127886697|NCT03276962|460208647|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
127886698|NCT03276962|460208643|FG000|Overall Study|Lost to Follow-up|10|||
127886699|NCT03276962|460208644|FG001|Overall Study|Lost to Follow-up|10|||
127886700|NCT03276962|460208645|FG002|Overall Study|Lost to Follow-up|4|||
127886701|NCT03276962|460208646|FG003|Overall Study|Lost to Follow-up|6|||
127886702|NCT03276962|460208647|FG004|Overall Study|Lost to Follow-up|10|||
127886703|NCT03276962|460208643|FG000|Overall Study|Other|0|||
127886704|NCT03276962|460208644|FG001|Overall Study|Other|2|||
127886705|NCT03276962|460208645|FG002|Overall Study|Other|0|||
127886706|NCT03276962|460208646|FG003|Overall Study|Other|2|||
127886707|NCT03276962|460208647|FG004|Overall Study|Other|1|||
127886708|NCT01238211|460208648|FG000|Overall Study|Continues active treatment|31|||
127640588|NCT01613248|459304567|FG005|Overall Study|Lost to Follow-up|2|||
127640589|NCT01613248|459304562|FG000|Overall Study|Study Terminated by Sponsor|4|||
127640590|NCT01613248|459304563|FG001|Overall Study|Study Terminated by Sponsor|6|||
127797971|NCT00730639|459883551|FG004|Overall Study|Completed Maximum Cycles|6|||
127797972|NCT00730639|459883547|FG000|Overall Study|Death|0|||
127797973|NCT00730639|459883548|FG001|Overall Study|Death|0|||
127797974|NCT00730639|459883549|FG002|Overall Study|Death|0|||
127797975|NCT00730639|459883550|FG003|Overall Study|Death|0|||
127797976|NCT00730639|459883551|FG004|Overall Study|Death|2|||
127797977|NCT00730639|459883547|FG000|Overall Study|Disease Progression|12|||
127797978|NCT00730639|459883548|FG001|Overall Study|Disease Progression|13|||
127797979|NCT00730639|459883549|FG002|Overall Study|Disease Progression|48|||
127797980|NCT00730639|459883550|FG003|Overall Study|Disease Progression|32|||
127797981|NCT00730639|459883551|FG004|Overall Study|Disease Progression|88|||
127797982|NCT00730639|459883547|FG000|Overall Study|non-specified|0|||
127797983|NCT00730639|459883548|FG001|Overall Study|non-specified|0|||
127797984|NCT00730639|459883549|FG002|Overall Study|non-specified|4|||
127797985|NCT00730639|459883550|FG003|Overall Study|non-specified|2|||
127797986|NCT00730639|459883551|FG004|Overall Study|non-specified|3|||
127797987|NCT00730639|459883547|FG000|Overall Study|Protocol Violation|0|||
127797988|NCT00730639|459883548|FG001|Overall Study|Protocol Violation|0|||
127797989|NCT00730639|459883549|FG002|Overall Study|Protocol Violation|1|||
127797990|NCT00730639|459883550|FG003|Overall Study|Protocol Violation|0|||
127797991|NCT00730639|459883551|FG004|Overall Study|Protocol Violation|0|||
127797992|NCT00730639|459883547|FG000|Overall Study|Withdrawal by Subject|0|||
127886709|NCT01238211|460208648|FG000|Overall Study|Adverse Event|7|||
127886710|NCT01238211|460208648|FG000|Overall Study|Death|4|||
127886711|NCT01238211|460208648|FG000|Overall Study|Relapse/Progression|2|||
127797993|NCT00730639|459883548|FG001|Overall Study|Withdrawal by Subject|0|||
127886712|NCT01238211|460208648|FG000|Overall Study|Withdrawal by Subject|7|||
127886713|NCT01238211|460208648|FG000|Overall Study|Non-protocol treatment|4|||
127886714|NCT01238211|460208648|FG000|Overall Study|Investigator/Patient Decision|3|||
127886715|NCT04428502|460208649|FG000|Overall Study|Did not meet entrance criteria|14|||
127886716|NCT00449930|460208655|FG000|Overall Study|Adverse Event|9|||
127886717|NCT00449930|460208656|FG001|Overall Study|Adverse Event|19|||
127886718|NCT00449930|460208655|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
127886719|NCT00449930|460208656|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
127886720|NCT00449930|460208655|FG000|Overall Study|Lack of Efficacy|10|||
127886721|NCT00449930|460208656|FG001|Overall Study|Lack of Efficacy|1|||
127886722|NCT00449930|460208655|FG000|Overall Study|Lost to Follow-up|9|||
127886723|NCT00449930|460208656|FG001|Overall Study|Lost to Follow-up|14|||
127886724|NCT00449930|460208655|FG000|Overall Study|Physician Decision|1|||
127886725|NCT00449930|460208656|FG001|Overall Study|Physician Decision|2|||
127886726|NCT00449930|460208655|FG000|Overall Study|Protocol Violation|14|||
127886727|NCT00449930|460208656|FG001|Overall Study|Protocol Violation|15|||
127886728|NCT00449930|460208655|FG000|Overall Study|Withdrawal by Subject|16|||
127886729|NCT00449930|460208656|FG001|Overall Study|Withdrawal by Subject|23|||
127886730|NCT00449930|460208655|FG000|Overall Study|Glycemic discontinuation criteria|1|||
127886731|NCT00449930|460208656|FG001|Overall Study|Glycemic discontinuation criteria|1|||
127886732|NCT03550794|460208657|FG000|Overall Study|No longer met inclusion criteria|1|||
127886733|NCT03550794|460208658|FG001|Overall Study|No longer met inclusion criteria|2|||
127886734|NCT03550794|460208657|FG000|Overall Study|Goals of care changed|1|||
127886735|NCT03550794|460208658|FG001|Overall Study|Goals of care changed|0|||
127886736|NCT03550794|460208657|FG000|Overall Study|Withdrawal by Subject|2|||
127886737|NCT03550794|460208658|FG001|Overall Study|Withdrawal by Subject|0|||
127886738|NCT03550794|460208657|FG000|Overall Study|Death|0|||
127886739|NCT03550794|460208658|FG001|Overall Study|Death|1|||
127886740|NCT03712228|460208659|FG000|Treatment Period 1|Lack of Efficacy|0|||
127886741|NCT03712228|460208660|FG001|Treatment Period 1|Lack of Efficacy|0|||
127886742|NCT03712228|460208661|FG002|Treatment Period 1|Lack of Efficacy|0|||
127886743|NCT03712228|460208662|FG003|Treatment Period 1|Lack of Efficacy|0|||
127886744|NCT03712228|460208663|FG004|Treatment Period 1|Lack of Efficacy|0|||
127886745|NCT03712228|460208664|FG005|Treatment Period 1|Lack of Efficacy|1|||
127886746|NCT03712228|460208659|FG000|Treatment Period 2|Pregnancy|0|||
127886747|NCT03712228|460208660|FG001|Treatment Period 2|Pregnancy|0|||
127886748|NCT03712228|460208661|FG002|Treatment Period 2|Pregnancy|0|||
127886749|NCT03712228|460208662|FG003|Treatment Period 2|Pregnancy|1|||
127886750|NCT03712228|460208663|FG004|Treatment Period 2|Pregnancy|0|||
127886751|NCT03712228|460208664|FG005|Treatment Period 2|Pregnancy|0|||
127886752|NCT03712228|460208659|FG000|Treatment Period 2|Withdrawal by Subject|0|||
127886753|NCT03712228|460208660|FG001|Treatment Period 2|Withdrawal by Subject|0|||
127886754|NCT03712228|460208661|FG002|Treatment Period 2|Withdrawal by Subject|0|||
127886755|NCT03712228|460208662|FG003|Treatment Period 2|Withdrawal by Subject|1|||
127886756|NCT03712228|460208663|FG004|Treatment Period 2|Withdrawal by Subject|0|||
127886757|NCT03712228|460208664|FG005|Treatment Period 2|Withdrawal by Subject|0|||
127886758|NCT01964105|460208665|FG000|Overall Study|Lost to Follow-up|2|||
127886759|NCT01964105|460208666|FG001|Overall Study|Lost to Follow-up|13|||
127886760|NCT01964105|460208667|FG002|Overall Study|Lost to Follow-up|0|||
127886761|NCT03001011|460208668|FG000|Overall Study|Adverse Event|9|||
127886762|NCT03001011|460208669|FG001|Overall Study|Adverse Event|3|||
127886763|NCT03001011|460208668|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
127886764|NCT03001011|460208669|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
127886765|NCT03001011|460208668|FG000|Overall Study|Other than specified above|3|||
127886766|NCT03001011|460208669|FG001|Overall Study|Other than specified above|8|||
127886767|NCT02875067|460208670|FG000|Overall Study|Withdrawal by Subject|1|||
127886768|NCT02875067|460208670|FG000|Overall Study|Withdrawal by Termination of Study|5|||
127886769|NCT00065065|460208671|FG000|Overall Study|Adverse Event|3|||
127886770|NCT00065065|460208672|FG001|Overall Study|Adverse Event|2|||
127886771|NCT00065065|460208671|FG000|Overall Study|Withdrawal by Subject|1|||
127886772|NCT00065065|460208672|FG001|Overall Study|Withdrawal by Subject|5|||
127886773|NCT00065065|460208671|FG000|Overall Study|Lack of Efficacy|4|||
127886774|NCT00065065|460208672|FG001|Overall Study|Lack of Efficacy|11|||
127886775|NCT00065065|460208671|FG000|Overall Study|Other|2|||
127886776|NCT00065065|460208672|FG001|Overall Study|Other|2|||
127886777|NCT05288673|460208674|FG000|Overall Study|Consent withdrawn by subject|0|||
127886778|NCT05288673|460208675|FG001|Overall Study|Consent withdrawn by subject|0|||
127886779|NCT05288673|460208676|FG002|Overall Study|Consent withdrawn by subject|1|||
127886780|NCT01050673|460208677|FG000|Overall Study|Physician Decision|4|||
127886781|NCT01050673|460208678|FG001|Overall Study|Physician Decision|5|||
127886782|NCT03056352|460208679|FG000|Overall Study|Lost to Follow-up|1|||
127886783|NCT00597207|460208684|FG000|Overall Study|Lost to Follow-up|5|||
127886784|NCT00597207|460208685|FG001|Overall Study|Lost to Follow-up|7|||
127886785|NCT00520351|460208686|FG000|First Intervention|Withdrawal by Subject|1|||
127886786|NCT00520351|460208687|FG001|First Intervention|Withdrawal by Subject|1|||
127886787|NCT02278952|460208688|FG000|Overall Study|Insufficient Sample|6|||
127886788|NCT01010230|460208693|FG000|Overall Study|Withdrawal by Subject|6|||
127886789|NCT01010230|460208694|FG001|Overall Study|Withdrawal by Subject|5|||
127886790|NCT01010230|460208693|FG000|Overall Study|Lost to Follow-up|4|||
127797994|NCT00730639|459883549|FG002|Overall Study|Withdrawal by Subject|6|||
127797995|NCT00730639|459883550|FG003|Overall Study|Withdrawal by Subject|3|||
127797996|NCT00730639|459883551|FG004|Overall Study|Withdrawal by Subject|4|||
127797997|NCT00730639|459883547|FG000|Overall Study|Treatment on-going|2|||
127797998|NCT00730639|459883548|FG001|Overall Study|Treatment on-going|5|||
127797999|NCT00730639|459883549|FG002|Overall Study|Treatment on-going|5|||
127798000|NCT00730639|459883550|FG003|Overall Study|Treatment on-going|4|||
127798001|NCT00730639|459883551|FG004|Overall Study|Treatment on-going|4|||
127798002|NCT02665286|459883552|FG000|Overall Study|Lost to Follow-up|3|||
127798003|NCT02665286|459883553|FG001|Overall Study|Lost to Follow-up|2|||
127798004|NCT02665286|459883554|FG002|Overall Study|Lost to Follow-up|1|||
127798005|NCT01972074|459883562|FG000|Overall Study|Adverse Event|4|||
127798006|NCT01972074|459883563|FG001|Overall Study|Adverse Event|1|||
127798007|NCT01972074|459883564|FG002|Overall Study|Adverse Event|0|||
127798008|NCT01972074|459883562|FG000|Overall Study|Lack of Efficacy|1|||
127798009|NCT01972074|459883563|FG001|Overall Study|Lack of Efficacy|1|||
127798010|NCT01972074|459883564|FG002|Overall Study|Lack of Efficacy|0|||
127798011|NCT01972074|459883562|FG000|Overall Study|Lost to Follow-up|0|||
127798012|NCT01972074|459883563|FG001|Overall Study|Lost to Follow-up|1|||
127798013|NCT01972074|459883564|FG002|Overall Study|Lost to Follow-up|1|||
127798014|NCT01972074|459883562|FG000|Overall Study|Withdrawal by Subject|1|||
127798015|NCT01972074|459883563|FG001|Overall Study|Withdrawal by Subject|1|||
127798016|NCT01972074|459883564|FG002|Overall Study|Withdrawal by Subject|1|||
127798017|NCT01972074|459883562|FG000|Overall Study|Scanner Unavailable|0|||
127798018|NCT01972074|459883563|FG001|Overall Study|Scanner Unavailable|0|||
127798019|NCT01972074|459883564|FG002|Overall Study|Scanner Unavailable|1|||
127798020|NCT05574062|459883565|FG000|Pre Run-In|Screening failure|3|||
127798021|NCT05574062|459883566|FG001|Pre Run-In|Screening failure|0|||
127798022|NCT05574062|459883567|FG002|Pre Run-In|Screening failure|0|||
127798023|NCT05574062|459883568|FG003|Pre Run-In|Screening failure|0|||
127798024|NCT05574062|459883569|FG004|Pre Run-In|Screening failure|0|||
127798025|NCT05574062|459883565|FG000|Study Phase Period 1|Withdrawal by Subject|0|||
127798026|NCT05574062|459883566|FG001|Study Phase Period 1|Withdrawal by Subject|1|||
127798027|NCT05574062|459883567|FG002|Study Phase Period 1|Withdrawal by Subject|0|||
127798028|NCT05574062|459883568|FG003|Study Phase Period 1|Withdrawal by Subject|0|||
127798029|NCT05574062|459883569|FG004|Study Phase Period 1|Withdrawal by Subject|0|||
127798030|NCT05574062|459883565|FG000|Study Phase Period 2|Withdrawal by Subject|0|||
127798031|NCT05574062|459883566|FG001|Study Phase Period 2|Withdrawal by Subject|1|||
127798032|NCT05574062|459883567|FG002|Study Phase Period 2|Withdrawal by Subject|0|||
127798033|NCT05574062|459883568|FG003|Study Phase Period 2|Withdrawal by Subject|0|||
127798034|NCT05574062|459883569|FG004|Study Phase Period 2|Withdrawal by Subject|0|||
127798035|NCT05574062|459883565|FG000|Continuation Phase Period 1|Physician Decision|1|||
127798036|NCT05574062|459883566|FG001|Continuation Phase Period 1|Physician Decision|0|||
127798037|NCT05574062|459883567|FG002|Continuation Phase Period 1|Physician Decision|0|||
127798038|NCT05574062|459883568|FG003|Continuation Phase Period 1|Physician Decision|0|||
127798039|NCT05574062|459883569|FG004|Continuation Phase Period 1|Physician Decision|0|||
127798040|NCT05574062|459883565|FG000|Continuation Phase Period 1|Withdrawal by Subject|1|||
127798041|NCT05574062|459883566|FG001|Continuation Phase Period 1|Withdrawal by Subject|0|||
127798042|NCT05574062|459883567|FG002|Continuation Phase Period 1|Withdrawal by Subject|0|||
127798043|NCT05574062|459883568|FG003|Continuation Phase Period 1|Withdrawal by Subject|0|||
127798044|NCT05574062|459883569|FG004|Continuation Phase Period 1|Withdrawal by Subject|0|||
127798045|NCT05574062|459883565|FG000|Continuation Phase Period 1|Adverse Event|1|||
127798046|NCT05574062|459883566|FG001|Continuation Phase Period 1|Adverse Event|0|||
127798047|NCT05574062|459883567|FG002|Continuation Phase Period 1|Adverse Event|0|||
127798048|NCT05574062|459883568|FG003|Continuation Phase Period 1|Adverse Event|0|||
127798049|NCT05574062|459883569|FG004|Continuation Phase Period 1|Adverse Event|0|||
127798050|NCT05574062|459883565|FG000|Continuation Phase Period 1|Death|1|||
127798051|NCT05574062|459883566|FG001|Continuation Phase Period 1|Death|0|||
127798052|NCT05574062|459883567|FG002|Continuation Phase Period 1|Death|0|||
127798053|NCT05574062|459883568|FG003|Continuation Phase Period 1|Death|0|||
127798054|NCT05574062|459883569|FG004|Continuation Phase Period 1|Death|0|||
127798055|NCT05574062|459883565|FG000|Continuation Phase Period 2|Withdrawal by Subject|0|||
127798056|NCT05574062|459883566|FG001|Continuation Phase Period 2|Withdrawal by Subject|0|||
127798057|NCT05574062|459883567|FG002|Continuation Phase Period 2|Withdrawal by Subject|0|||
127798058|NCT05574062|459883568|FG003|Continuation Phase Period 2|Withdrawal by Subject|1|||
127798059|NCT05574062|459883569|FG004|Continuation Phase Period 2|Withdrawal by Subject|0|||
127798060|NCT04820309|459883572|FG000|Overall Study|Adverse Event|96|||
127798061|NCT04820309|459883572|FG000|Overall Study|ineligible for further treatment according to inclusion/exclusion criteria|1|||
127798062|NCT04820309|459883572|FG000|Overall Study|Consent Withdrawn|93|||
127798063|NCT04820309|459883572|FG000|Overall Study|failure to adhere to protocol|32|||
127798064|NCT04820309|459883572|FG000|Overall Study|alcohol or drug use|6|||
127798065|NCT04820309|459883572|FG000|Overall Study|Lost to Follow-up|46|||
127798066|NCT04820309|459883572|FG000|Overall Study|Death|2|||
127798067|NCT04820309|459883572|FG000|Overall Study|Pregnancy|1|||
127798068|NCT04820309|459883572|FG000|Overall Study|Other reasons|12|||
127640591|NCT01613248|459304564|FG002|Overall Study|Study Terminated by Sponsor|8|||
127640592|NCT01613248|459304565|FG003|Overall Study|Study Terminated by Sponsor|8|||
127640593|NCT01613248|459304566|FG004|Overall Study|Study Terminated by Sponsor|9|||
127640594|NCT01613248|459304567|FG005|Overall Study|Study Terminated by Sponsor|11|||
127640595|NCT01613248|459304562|FG000|Overall Study|Physician Decision|8|||
127640596|NCT01613248|459304563|FG001|Overall Study|Physician Decision|8|||
127640597|NCT01613248|459304564|FG002|Overall Study|Physician Decision|9|||
127640598|NCT01613248|459304565|FG003|Overall Study|Physician Decision|4|||
127640599|NCT01613248|459304566|FG004|Overall Study|Physician Decision|7|||
127640600|NCT01613248|459304567|FG005|Overall Study|Physician Decision|6|||
127640601|NCT01613248|459304562|FG000|Overall Study|Lack of Qualifying Event|9|||
127640602|NCT01613248|459304563|FG001|Overall Study|Lack of Qualifying Event|11|||
127640603|NCT01613248|459304564|FG002|Overall Study|Lack of Qualifying Event|10|||
127640604|NCT01613248|459304565|FG003|Overall Study|Lack of Qualifying Event|11|||
127640605|NCT01613248|459304566|FG004|Overall Study|Lack of Qualifying Event|15|||
127640606|NCT01613248|459304567|FG005|Overall Study|Lack of Qualifying Event|18|||
127640607|NCT01613248|459304562|FG000|Overall Study|Pregnancy|0|||
127640608|NCT01613248|459304563|FG001|Overall Study|Pregnancy|0|||
127640609|NCT01613248|459304564|FG002|Overall Study|Pregnancy|0|||
127640610|NCT01613248|459304565|FG003|Overall Study|Pregnancy|1|||
127640611|NCT01613248|459304566|FG004|Overall Study|Pregnancy|0|||
127640612|NCT01613248|459304567|FG005|Overall Study|Pregnancy|0|||
127640613|NCT01433354|459304568|FG000|Overall Study|Adverse Event|6|||
127640614|NCT01433354|459304568|FG000|Overall Study|Lost to Follow-up|1|||
127640615|NCT01433354|459304568|FG000|Overall Study|Administrative problems|90|||
127640616|NCT01433354|459304568|FG000|Overall Study|Protocol Violation|2|||
127640617|NCT01433354|459304568|FG000|Overall Study|Lack of Efficacy|17|||
127640618|NCT01433354|459304568|FG000|Overall Study|Subject Withdrew Consent|3|||
127640619|NCT02013622|459304574|FG000|Overall Study|Lost to Follow-up|10|||
127640620|NCT02013622|459304574|FG000|Overall Study|Adverse Event|3|||
127640621|NCT02013622|459304574|FG000|Overall Study|Met Withdrawal Criteria|3|||
127640622|NCT02013622|459304574|FG000|Overall Study|Withdrawal by Subject|6|||
127640623|NCT02013622|459304574|FG000|Overall Study|Protocol Deviation|1|||
127640624|NCT02013622|459304574|FG000|Overall Study|Lack of Efficacy|1|||
127640625|NCT04307004|459304582|FG000|Randomization 1|Withdrawal by Subject|25|||
127640626|NCT04307004|459304583|FG001|Randomization 1|Withdrawal by Subject|26|||
127640627|NCT04307004|459304584|FG002|Randomization 1|Withdrawal by Subject|0|||
127640628|NCT04307004|459304585|FG003|Randomization 1|Withdrawal by Subject|0|||
127640629|NCT04307004|459304582|FG000|Randomization 2|Withdrawal by Subject|0|||
127640630|NCT04307004|459304583|FG001|Randomization 2|Withdrawal by Subject|0|||
127640631|NCT04307004|459304584|FG002|Randomization 2|Withdrawal by Subject|28|||
127640632|NCT04307004|459304585|FG003|Randomization 2|Withdrawal by Subject|23|||
127640633|NCT04391023|459304586|FG000|Overall Study|Withdrawal by Subject|2|||
127640634|NCT04391023|459304587|FG001|Overall Study|Withdrawal by Subject|2|||
127640635|NCT01381692|459304588|FG000|Overall Study|Adverse Event|1|||
127640636|NCT01381692|459304589|FG001|Overall Study|Adverse Event|0|||
127640637|NCT01381692|459304590|FG002|Overall Study|Adverse Event|0|||
127640638|NCT01381692|459304591|FG003|Overall Study|Adverse Event|0|||
127640639|NCT01381692|459304592|FG004|Overall Study|Adverse Event|0|||
127640640|NCT01381692|459304593|FG005|Overall Study|Adverse Event|0|||
127640641|NCT00727272|459304596|FG000|Washout Period A|Adverse Event|0|||
127640642|NCT00727272|459304597|FG001|Washout Period A|Adverse Event|0|||
127640643|NCT00727272|459304598|FG002|Washout Period A|Adverse Event|1|||
127640644|NCT00727272|459304596|FG000|Washout Period B|Withdrawal by Subject|0|||
127640645|NCT00727272|459304597|FG001|Washout Period B|Withdrawal by Subject|0|||
127640646|NCT00727272|459304598|FG002|Washout Period B|Withdrawal by Subject|1|||
127640647|NCT00651664|459304599|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
127640648|NCT00651664|459304600|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
127640649|NCT00651664|459304601|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
127640650|NCT00651664|459304602|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
127640651|NCT00651664|459304603|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
127640652|NCT00651664|459304604|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
127640653|NCT00651664|459304605|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
127640654|NCT00651664|459304606|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
127640655|NCT00651664|459304607|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
127640656|NCT00651664|459304608|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
127640657|NCT00651664|459304599|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
127640658|NCT00651664|459304600|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
127640659|NCT00651664|459304601|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
127640660|NCT00651664|459304602|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
127640661|NCT00651664|459304603|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
127640662|NCT00651664|459304604|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
127640663|NCT00651664|459304605|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
127640664|NCT00651664|459304606|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
127798069|NCT03692052|459883573|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
127798070|NCT03692052|459883573|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
127798071|NCT03692052|459883573|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
127798072|NCT03692052|459883573|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
127640665|NCT00651664|459304607|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
127640666|NCT00651664|459304608|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
127640667|NCT00651664|459304599|FG000|Overall Study|Progressive Disease|3|||
127640668|NCT00651664|459304600|FG001|Overall Study|Progressive Disease|3|||
127640669|NCT00651664|459304601|FG002|Overall Study|Progressive Disease|3|||
127640670|NCT00651664|459304602|FG003|Overall Study|Progressive Disease|12|||
127640671|NCT00651664|459304603|FG004|Overall Study|Progressive Disease|4|||
127640672|NCT00651664|459304604|FG005|Overall Study|Progressive Disease|1|||
127640673|NCT00651664|459304605|FG006|Overall Study|Progressive Disease|3|||
127640674|NCT00651664|459304606|FG007|Overall Study|Progressive Disease|6|||
127640675|NCT00651664|459304607|FG008|Overall Study|Progressive Disease|5|||
127640676|NCT00651664|459304608|FG009|Overall Study|Progressive Disease|5|||
127640677|NCT00651664|459304599|FG000|Overall Study|Patient Declined Further Treatment|0|||
127640678|NCT00651664|459304600|FG001|Overall Study|Patient Declined Further Treatment|0|||
127640679|NCT00651664|459304601|FG002|Overall Study|Patient Declined Further Treatment|0|||
127640680|NCT00651664|459304602|FG003|Overall Study|Patient Declined Further Treatment|1|||
127640681|NCT00651664|459304603|FG004|Overall Study|Patient Declined Further Treatment|1|||
127640682|NCT00651664|459304604|FG005|Overall Study|Patient Declined Further Treatment|1|||
127640683|NCT00651664|459304605|FG006|Overall Study|Patient Declined Further Treatment|0|||
127798073|NCT05600309|459883576|FG000|Overall Study|Death|41|||
127798074|NCT05600309|459883577|FG001|Overall Study|Death|38|||
127798075|NCT05600309|459883576|FG000|Overall Study|Sponsor Decision|9|||
127798076|NCT05600309|459883577|FG001|Overall Study|Sponsor Decision|6|||
127798077|NCT00980538|459883582|FG000|Overall Study|Lost to Follow-up|20|||
127798078|NCT00980538|459883582|FG000|Overall Study|Sponsor's Decision|4|||
127798079|NCT00980538|459883582|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
127798080|NCT00980538|459883582|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
127798081|NCT00980538|459883582|FG000|Overall Study|Switch to Commercially Available Medication|25|||
127798082|NCT00980538|459883582|FG000|Overall Study|Participant Non-Compliant|9|||
127798083|NCT00980538|459883582|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
127798084|NCT00980538|459883582|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
127798085|NCT00980538|459883582|FG000|Overall Study|Other|60|||
127798086|NCT00980538|459883582|FG000|Overall Study|Other|1|||
127798087|NCT02482129|459883583|FG000|Overall Study|Adverse Event-prior to treatment|0|||
127798088|NCT02482129|459883584|FG001|Overall Study|Adverse Event-prior to treatment|1|||
127798089|NCT02482129|459883583|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
127798090|NCT02482129|459883584|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
127798091|NCT02482129|459883583|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
127798092|NCT02482129|459883584|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
127798093|NCT02482129|459883583|FG000|Overall Study|Criteria not met-prior to treatment|1|||
127798094|NCT02482129|459883584|FG001|Overall Study|Criteria not met-prior to treatment|0|||
127798095|NCT02482129|459883583|FG000|Overall Study|Adverse Event|1|||
127798096|NCT02482129|459883584|FG001|Overall Study|Adverse Event|0|||
127798097|NCT02482129|459883583|FG000|Overall Study|Withdrawal by Subject|2|||
127798098|NCT02482129|459883584|FG001|Overall Study|Withdrawal by Subject|0|||
127798099|NCT02482129|459883583|FG000|Overall Study|Criteria not met|1|||
127798100|NCT02482129|459883584|FG001|Overall Study|Criteria not met|0|||
127798101|NCT03505021|459883585|FG000|Overall Study|Protocol Violation|1|||
127798102|NCT03505021|459883586|FG001|Overall Study|Protocol Violation|0|||
127640684|NCT00651664|459304606|FG007|Overall Study|Patient Declined Further Treatment|0|||
127640685|NCT00651664|459304607|FG008|Overall Study|Patient Declined Further Treatment|0|||
127640686|NCT00651664|459304608|FG009|Overall Study|Patient Declined Further Treatment|1|||
127640687|NCT00651664|459304599|FG000|Overall Study|Symptomatic Deterioration|0|||
127640688|NCT00651664|459304600|FG001|Overall Study|Symptomatic Deterioration|0|||
127640689|NCT00651664|459304601|FG002|Overall Study|Symptomatic Deterioration|0|||
127640690|NCT00651664|459304602|FG003|Overall Study|Symptomatic Deterioration|1|||
127640691|NCT00651664|459304603|FG004|Overall Study|Symptomatic Deterioration|0|||
127798103|NCT03505021|459883585|FG000|Overall Study|Death|9|||
127798104|NCT03505021|459883586|FG001|Overall Study|Death|8|||
127640692|NCT00651664|459304604|FG005|Overall Study|Symptomatic Deterioration|0|||
127640693|NCT00651664|459304605|FG006|Overall Study|Symptomatic Deterioration|1|||
127640694|NCT00651664|459304606|FG007|Overall Study|Symptomatic Deterioration|0|||
127798105|NCT03505021|459883585|FG000|Overall Study|Consent withdrawn by subject|6|||
127798106|NCT03505021|459883586|FG001|Overall Study|Consent withdrawn by subject|1|||
127798107|NCT03505021|459883585|FG000|Overall Study|Lost to Follow-up|5|||
127798108|NCT03505021|459883586|FG001|Overall Study|Lost to Follow-up|3|||
127798109|NCT03505021|459883585|FG000|Overall Study|Adverse Event|26|||
127798110|NCT03505021|459883586|FG001|Overall Study|Adverse Event|9|||
127798111|NCT03505021|459883585|FG000|Overall Study|Disease progression|33|||
127798112|NCT03505021|459883586|FG001|Overall Study|Disease progression|17|||
127798113|NCT03505021|459883585|FG000|Overall Study|Other|11|||
127798114|NCT03505021|459883586|FG001|Overall Study|Other|5|||
127798115|NCT03505021|459883585|FG000|Overall Study|Personal reason|21|||
127798116|NCT03505021|459883586|FG001|Overall Study|Personal reason|12|||
127798117|NCT03087955|459885505|FG000|Overall Study|Death|4|||
127798118|NCT03087955|459885506|FG001|Overall Study|Death|0|||
127798119|NCT03087955|459885505|FG000|Overall Study|Lack of Efficacy|2|||
127798120|NCT03087955|459885506|FG001|Overall Study|Lack of Efficacy|0|||
127798121|NCT03087955|459885505|FG000|Overall Study|Lost to Follow-up|1|||
127798122|NCT03087955|459885506|FG001|Overall Study|Lost to Follow-up|0|||
127886791|NCT01010230|460208694|FG001|Overall Study|Lost to Follow-up|2|||
127886792|NCT00530439|460208695|FG000|Overall Study|GDM|9|||
127798123|NCT02392429|459885507|FG000|Screening|Screen failure|15|||
127886793|NCT00530439|460208696|FG001|Overall Study|GDM|3|||
127886794|NCT00530439|460208695|FG000|Overall Study|Withdraw|18|||
127798124|NCT02392429|459885507|FG000|Enrolled Participants|Ineligible due to disease|3|||
127886795|NCT00530439|460208696|FG001|Overall Study|Withdraw|14|||
127886796|NCT00530439|460208695|FG000|Overall Study|Missed abortion|1|||
127640695|NCT00651664|459304607|FG008|Overall Study|Symptomatic Deterioration|1|||
127640696|NCT00651664|459304608|FG009|Overall Study|Symptomatic Deterioration|0|||
127640697|NCT00651664|459304599|FG000|Overall Study|Reason not Specified|0|||
127640698|NCT00651664|459304600|FG001|Overall Study|Reason not Specified|0|||
127640699|NCT00651664|459304601|FG002|Overall Study|Reason not Specified|0|||
127640700|NCT00651664|459304602|FG003|Overall Study|Reason not Specified|0|||
127640701|NCT00651664|459304603|FG004|Overall Study|Reason not Specified|0|||
127640702|NCT00651664|459304604|FG005|Overall Study|Reason not Specified|0|||
127640703|NCT00651664|459304605|FG006|Overall Study|Reason not Specified|1|||
127640704|NCT00651664|459304606|FG007|Overall Study|Reason not Specified|0|||
127640705|NCT00651664|459304607|FG008|Overall Study|Reason not Specified|0|||
127640706|NCT00651664|459304608|FG009|Overall Study|Reason not Specified|0|||
127640707|NCT02195986|459304611|FG000|Overall Study|Adverse Event|3|||
127640708|NCT02195986|459304612|FG001|Overall Study|Adverse Event|0|||
127640709|NCT02195986|459304613|FG002|Overall Study|Adverse Event|0|||
127640710|NCT02195986|459304611|FG000|Overall Study|Withdrawal by Subject|0|||
127640711|NCT02195986|459304612|FG001|Overall Study|Withdrawal by Subject|3|||
127640712|NCT02195986|459304613|FG002|Overall Study|Withdrawal by Subject|0|||
127640713|NCT02195986|459304611|FG000|Overall Study|Family Emergency|0|||
127640714|NCT02195986|459304612|FG001|Overall Study|Family Emergency|0|||
127640715|NCT02195986|459304613|FG002|Overall Study|Family Emergency|1|||
127640716|NCT02195986|459304611|FG000|Overall Study|Protocol Violation|0|||
127640717|NCT02195986|459304612|FG001|Overall Study|Protocol Violation|1|||
127640718|NCT02195986|459304613|FG002|Overall Study|Protocol Violation|1|||
127640719|NCT02195986|459304611|FG000|Overall Study|Non-compliance|0|||
127640720|NCT02195986|459304612|FG001|Overall Study|Non-compliance|1|||
127640721|NCT02195986|459304613|FG002|Overall Study|Non-compliance|0|||
127640722|NCT03449030|459304616|FG000|Overall Study|Withdrawal by Subject|0|||
127640723|NCT03449030|459304617|FG001|Overall Study|Withdrawal by Subject|0|||
127640724|NCT03449030|459304618|FG002|Overall Study|Withdrawal by Subject|0|||
127640725|NCT03449030|459304619|FG003|Overall Study|Withdrawal by Subject|1|||
127640726|NCT03449030|459304620|FG004|Overall Study|Withdrawal by Subject|1|||
127640727|NCT03449030|459304621|FG005|Overall Study|Withdrawal by Subject|1|||
127640728|NCT03449030|459304622|FG006|Overall Study|Withdrawal by Subject|1|||
127640729|NCT03449030|459304623|FG007|Overall Study|Withdrawal by Subject|2|||
127640730|NCT03449030|459304624|FG008|Overall Study|Withdrawal by Subject|0|||
127640731|NCT03449030|459304625|FG009|Overall Study|Withdrawal by Subject|0|||
127640732|NCT03449030|459304616|FG000|Overall Study|Symptomatic Deterioration|0|||
127640733|NCT03449030|459304617|FG001|Overall Study|Symptomatic Deterioration|1|||
127640734|NCT03449030|459304618|FG002|Overall Study|Symptomatic Deterioration|0|||
127640735|NCT03449030|459304619|FG003|Overall Study|Symptomatic Deterioration|0|||
127640736|NCT03449030|459304620|FG004|Overall Study|Symptomatic Deterioration|0|||
127640737|NCT03449030|459304621|FG005|Overall Study|Symptomatic Deterioration|1|||
127640738|NCT03449030|459304622|FG006|Overall Study|Symptomatic Deterioration|1|||
127640739|NCT03449030|459304623|FG007|Overall Study|Symptomatic Deterioration|0|||
127640740|NCT03449030|459304624|FG008|Overall Study|Symptomatic Deterioration|2|||
127640741|NCT03449030|459304625|FG009|Overall Study|Symptomatic Deterioration|0|||
127640742|NCT03449030|459304616|FG000|Overall Study|Progressive Disease|1|||
127640743|NCT03449030|459304617|FG001|Overall Study|Progressive Disease|0|||
127640744|NCT03449030|459304618|FG002|Overall Study|Progressive Disease|1|||
127640745|NCT03449030|459304619|FG003|Overall Study|Progressive Disease|4|||
127640746|NCT03449030|459304620|FG004|Overall Study|Progressive Disease|5|||
127640747|NCT03449030|459304621|FG005|Overall Study|Progressive Disease|3|||
127640748|NCT03449030|459304622|FG006|Overall Study|Progressive Disease|0|||
127640749|NCT03449030|459304623|FG007|Overall Study|Progressive Disease|1|||
127640750|NCT03449030|459304624|FG008|Overall Study|Progressive Disease|1|||
127640751|NCT03449030|459304625|FG009|Overall Study|Progressive Disease|1|||
127640752|NCT03449030|459304616|FG000|Overall Study|Adverse Event|0|||
127640753|NCT03449030|459304617|FG001|Overall Study|Adverse Event|0|||
127640754|NCT03449030|459304618|FG002|Overall Study|Adverse Event|0|||
127640755|NCT03449030|459304619|FG003|Overall Study|Adverse Event|0|||
127640756|NCT03449030|459304620|FG004|Overall Study|Adverse Event|0|||
127640757|NCT03449030|459304621|FG005|Overall Study|Adverse Event|2|||
127640758|NCT03449030|459304622|FG006|Overall Study|Adverse Event|0|||
127640759|NCT03449030|459304623|FG007|Overall Study|Adverse Event|0|||
127640760|NCT03449030|459304624|FG008|Overall Study|Adverse Event|0|||
127640761|NCT03449030|459304625|FG009|Overall Study|Adverse Event|0|||
127640762|NCT03449030|459304616|FG000|Overall Study|Death|0|||
127640763|NCT03449030|459304617|FG001|Overall Study|Death|0|||
127640764|NCT03449030|459304618|FG002|Overall Study|Death|0|||
127640765|NCT03449030|459304619|FG003|Overall Study|Death|0|||
127640766|NCT03449030|459304620|FG004|Overall Study|Death|1|||
127640767|NCT03449030|459304621|FG005|Overall Study|Death|0|||
127640768|NCT03449030|459304622|FG006|Overall Study|Death|0|||
127640769|NCT03449030|459304623|FG007|Overall Study|Death|0|||
127640770|NCT03449030|459304624|FG008|Overall Study|Death|0|||
127640771|NCT03449030|459304625|FG009|Overall Study|Death|0|||
127640772|NCT02491671|459304632|FG000|Overall Study|Adverse Event|6|||
127640773|NCT02491671|459304633|FG001|Overall Study|Adverse Event|8|||
127640774|NCT02491671|459304632|FG000|Overall Study|Death|0|||
127640775|NCT02491671|459304633|FG001|Overall Study|Death|2|||
127640776|NCT02491671|459304632|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
127640777|NCT02491671|459304633|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
127703974|NCT04171141|459546651|FG010|Overall Study|Global deterioration of health status|0|||
127703975|NCT04171141|459546652|FG011|Overall Study|Global deterioration of health status|0|||
127640778|NCT00535730|459304634|FG000|Overall Study|Adverse Event|1|||
127640779|NCT00535730|459304635|FG001|Overall Study|Adverse Event|1|||
127640780|NCT00535730|459304634|FG000|Overall Study|Lost to Follow-up|0|||
127640781|NCT00535730|459304635|FG001|Overall Study|Lost to Follow-up|1|||
127640782|NCT00535730|459304634|FG000|Overall Study|Physician Decision|0|||
127640783|NCT00535730|459304635|FG001|Overall Study|Physician Decision|1|||
127640784|NCT00535730|459304634|FG000|Overall Study|Protocol Violation|1|||
127640785|NCT00535730|459304635|FG001|Overall Study|Protocol Violation|0|||
127640786|NCT00535730|459304634|FG000|Overall Study|Withdrawal by Subject|0|||
127640787|NCT00535730|459304635|FG001|Overall Study|Withdrawal by Subject|4|||
127640788|NCT00936858|459304636|FG000|Overall Study|Death|3|||
127640789|NCT00936858|459304636|FG000|Overall Study|Progression|29|||
127640790|NCT00936858|459304636|FG000|Overall Study|Withdrawal by Subject|5|||
127640791|NCT00936858|459304636|FG000|Overall Study|Adverse Event|1|||
127640792|NCT00936858|459304636|FG000|Overall Study|Physician Decision|7|||
127640793|NCT00936858|459304636|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
127640794|NCT00936858|459304636|FG000|Overall Study|Lost to Follow-up|1|||
127640795|NCT01090453|459304647|FG000|Overall Study|Withdrawal by Subject|1|||
127640796|NCT01090453|459304648|FG001|Overall Study|Withdrawal by Subject|2|||
127640797|NCT01090453|459304647|FG000|Overall Study|Lost to Follow-up|7|||
127640798|NCT01090453|459304648|FG001|Overall Study|Lost to Follow-up|7|||
127640799|NCT01090453|459304647|FG000|Overall Study|Non serious AEs|1|||
127640800|NCT01090453|459304648|FG001|Overall Study|Non serious AEs|0|||
127640801|NCT01090453|459304647|FG000|Overall Study|Protocol Violation|2|||
127640802|NCT01090453|459304648|FG001|Overall Study|Protocol Violation|0|||
127640803|NCT01090453|459304647|FG000|Overall Study|Other|2|||
127640804|NCT01090453|459304648|FG001|Overall Study|Other|4|||
127640805|NCT01090453|459304647|FG000|Overall Study|Eligibility Criteria|0|||
127640806|NCT01090453|459304648|FG001|Overall Study|Eligibility Criteria|1|||
127640807|NCT04072159|459304649|FG000|Overall Study|Lost to Follow-up|6|||
127640808|NCT04072159|459304650|FG001|Overall Study|Lost to Follow-up|6|||
127640809|NCT04072159|459304649|FG000|Overall Study|Withdrawal by Subject|2|||
127640810|NCT04072159|459304650|FG001|Overall Study|Withdrawal by Subject|0|||
127640811|NCT00989287|459304656|FG000|Overall Study|Adverse Event|1|||
127640812|NCT00989287|459304657|FG001|Overall Study|Adverse Event|0|||
127640813|NCT00989287|459304656|FG000|Overall Study|Lost to Follow-up|0|||
127640814|NCT00989287|459304657|FG001|Overall Study|Lost to Follow-up|1|||
127640815|NCT00729833|459304658|FG000|Overall Study|Death|5|||
127640816|NCT00729833|459304659|FG001|Overall Study|Death|1|||
127798125|NCT02392429|459885507|FG000|Enrolled Participants|Withdrawal by Subject|4|||
127798126|NCT02392429|459885507|FG000|Enrolled Participants|Post-treatment FLT PET/CT scan not completed|9|||
127798127|NCT02392429|459885507|FG000|Evaluable|Death|5|||
127798128|NCT02392429|459885507|FG000|Evaluable|Withdrawal by Subject|1|||
127798129|NCT02392429|459885507|FG000|Evaluable|Adverse Event|1|||
127798130|NCT02392429|459885507|FG000|Evaluable|remission bone marrow biopsy|3|||
127798131|NCT03266016|459885511|FG000|Acute Phase (0 to 28 Days)|Withdrawal by Subject|1|||
127798132|NCT03266016|459885512|FG001|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
127640817|NCT00729833|459304660|FG002|Overall Study|Death|3|||
127640818|NCT00729833|459304661|FG003|Overall Study|Death|5|||
127640819|NCT00729833|459304658|FG000|Overall Study|Study Terminated by Sponsor|0|||
127640820|NCT00729833|459304659|FG001|Overall Study|Study Terminated by Sponsor|0|||
127640821|NCT00729833|459304660|FG002|Overall Study|Study Terminated by Sponsor|1|||
127640822|NCT00729833|459304661|FG003|Overall Study|Study Terminated by Sponsor|0|||
127640823|NCT00729833|459304658|FG000|Overall Study|Lost to Follow-up|1|||
127640824|NCT00729833|459304659|FG001|Overall Study|Lost to Follow-up|0|||
127640825|NCT00729833|459304660|FG002|Overall Study|Lost to Follow-up|0|||
127640826|NCT00729833|459304661|FG003|Overall Study|Lost to Follow-up|0|||
127640827|NCT00729833|459304658|FG000|Overall Study|Withdrawal by Subject|3|||
127640828|NCT00729833|459304659|FG001|Overall Study|Withdrawal by Subject|1|||
127640829|NCT00729833|459304660|FG002|Overall Study|Withdrawal by Subject|3|||
127640830|NCT00729833|459304661|FG003|Overall Study|Withdrawal by Subject|0|||
127640831|NCT00729833|459304658|FG000|Overall Study|Unspecified Reasons|11|||
127640832|NCT00729833|459304659|FG001|Overall Study|Unspecified Reasons|5|||
127640833|NCT00729833|459304660|FG002|Overall Study|Unspecified Reasons|5|||
127640834|NCT00729833|459304661|FG003|Overall Study|Unspecified Reasons|1|||
127640835|NCT00417079|459304662|FG000|Overall Study|Disease progression|267|||
127640836|NCT00417079|459304663|FG001|Overall Study|Disease progression|180|||
127640837|NCT00417079|459304662|FG000|Overall Study|Adverse Event|32|||
127640838|NCT00417079|459304663|FG001|Overall Study|Adverse Event|67|||
127640839|NCT00417079|459304662|FG000|Overall Study|Non-compliance to protocol|0|||
127798133|NCT03266016|459885513|FG002|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
127798134|NCT03266016|459885514|FG003|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
127640840|NCT00417079|459304663|FG001|Overall Study|Non-compliance to protocol|1|||
127640841|NCT00417079|459304662|FG000|Overall Study|Lost to Follow-up|2|||
127640842|NCT00417079|459304663|FG001|Overall Study|Lost to Follow-up|0|||
127640843|NCT00417079|459304662|FG000|Overall Study|Withdrawal by Subject|17|||
127640844|NCT00417079|459304663|FG001|Overall Study|Withdrawal by Subject|8|||
127640845|NCT00417079|459304662|FG000|Overall Study|Not treated|6|||
127640846|NCT00417079|459304663|FG001|Overall Study|Not treated|7|||
127640847|NCT00417079|459304662|FG000|Overall Study|Screened failure|2|||
127798135|NCT03266016|459885511|FG000|Acute Phase (0 to 28 Days)|Completed study at acute phase.|75|||
127640848|NCT00417079|459304663|FG001|Overall Study|Screened failure|1|||
127640849|NCT00417079|459304662|FG000|Overall Study|Investigator's decision|1|||
127640850|NCT00417079|459304663|FG001|Overall Study|Investigator's decision|4|||
127640851|NCT00417079|459304662|FG000|Overall Study|Non-confirmed Disease progression|1|||
127640852|NCT00417079|459304663|FG001|Overall Study|Non-confirmed Disease progression|1|||
127640853|NCT00417079|459304662|FG000|Overall Study|Clinical deterioration|1|||
127640854|NCT00417079|459304663|FG001|Overall Study|Clinical deterioration|0|||
127640855|NCT00417079|459304662|FG000|Overall Study|Screening error|2|||
127640856|NCT00417079|459304663|FG001|Overall Study|Screening error|1|||
127640857|NCT00417079|459304662|FG000|Overall Study|Withdrawal by subject's family|0|||
127640858|NCT00417079|459304663|FG001|Overall Study|Withdrawal by subject's family|1|||
127640859|NCT00417079|459304662|FG000|Overall Study|Patient unable to come to the clinic|0|||
127640860|NCT00417079|459304663|FG001|Overall Study|Patient unable to come to the clinic|1|||
127640861|NCT00417079|459304662|FG000|Overall Study|abnormal liver function tests|0|||
127640862|NCT00417079|459304663|FG001|Overall Study|abnormal liver function tests|1|||
127640863|NCT04403698|459304665|FG000|Overall Study|Adverse Event|1|||
127640864|NCT04403698|459304666|FG001|Overall Study|Adverse Event|1|||
127640865|NCT04403698|459304665|FG000|Overall Study|Lost to Follow-up|1|||
127640866|NCT04403698|459304666|FG001|Overall Study|Lost to Follow-up|0|||
127640867|NCT04403698|459304665|FG000|Overall Study|Protocol Violation|0|||
127640868|NCT04403698|459304666|FG001|Overall Study|Protocol Violation|1|||
127640869|NCT03152552|459304667|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
127640870|NCT03152552|459304668|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
127640871|NCT03152552|459304669|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
127640872|NCT03152552|459304670|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
127640873|NCT03152552|459304671|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
127640874|NCT03152552|459304667|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
127640875|NCT03152552|459304668|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
127640876|NCT03152552|459304669|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
127640877|NCT03152552|459304670|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
127640878|NCT03152552|459304671|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
127640879|NCT03152552|459304667|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
127640880|NCT03152552|459304668|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
127640881|NCT03152552|459304669|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
127640882|NCT03152552|459304670|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
127640883|NCT03152552|459304671|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
127640884|NCT03152552|459304667|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
127703976|NCT04171141|459546653|FG012|Overall Study|Global deterioration of health status|0|||
127703977|NCT04171141|459546654|FG013|Overall Study|Global deterioration of health status|0|||
127703978|NCT04171141|459546655|FG014|Overall Study|Global deterioration of health status|1|||
127703979|NCT04171141|459546656|FG015|Overall Study|Global deterioration of health status|1|||
127703980|NCT04858451|459546659|FG000|Part 0 (Protocol Version 3.0)|Discontinued|4|||
127703981|NCT04858451|459546660|FG001|Part 0 (Protocol Version 3.0)|Discontinued|0|||
127703982|NCT04858451|459546661|FG002|Part 0 (Protocol Version 3.0)|Discontinued|0|||
127703983|NCT04858451|459546662|FG003|Part 0 (Protocol Version 3.0)|Discontinued|0|||
127703984|NCT04858451|459546663|FG004|Part 0 (Protocol Version 3.0)|Discontinued|0|||
127703985|NCT04858451|459546664|FG005|Part 0 (Protocol Version 3.0)|Discontinued|0|||
127703986|NCT04858451|459546665|FG006|Part 0 (Protocol Version 3.0)|Discontinued|0|||
127703987|NCT04858451|459546666|FG007|Part 0 (Protocol Version 3.0)|Discontinued|0|||
127703988|NCT04858451|459546667|FG008|Part 0 (Protocol Version 3.0)|Discontinued|0|||
127703989|NCT04858451|459546659|FG000|Part 2|Discontinued|0|||
127886797|NCT00530439|460208696|FG001|Overall Study|Missed abortion|4|||
127640885|NCT03152552|459304668|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
127640886|NCT03152552|459304669|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
127640887|NCT03152552|459304670|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
127640888|NCT03152552|459304671|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
127640889|NCT03152552|459304667|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
127640890|NCT03152552|459304668|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
127640891|NCT03152552|459304669|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
127640892|NCT03152552|459304670|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
127640893|NCT03152552|459304671|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
127640894|NCT03152552|459304667|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
127640895|NCT03152552|459304668|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
127640896|NCT03152552|459304669|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
127640897|NCT03152552|459304670|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
127640898|NCT03152552|459304671|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
127640899|NCT03152552|459304667|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
127640900|NCT03152552|459304668|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
127640901|NCT03152552|459304669|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
127640902|NCT03152552|459304670|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
127640903|NCT03152552|459304671|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
127640904|NCT04899349|459304674|FG000|Overall Study|Study terminated by Sponsor|2|||
127640905|NCT04899349|459304675|FG001|Overall Study|Study terminated by Sponsor|0|||
127640906|NCT03570619|459304676|FG000|Overall Study|Adverse Event|2|||
127640907|NCT03570619|459304677|FG001|Overall Study|Adverse Event|0|||
127640908|NCT03570619|459304678|FG002|Overall Study|Adverse Event|1|||
127640909|NCT03570619|459304676|FG000|Overall Study|new diagnosis of new malignancy|1|||
127640910|NCT03570619|459304677|FG001|Overall Study|new diagnosis of new malignancy|0|||
127640911|NCT03570619|459304678|FG002|Overall Study|new diagnosis of new malignancy|0|||
127640912|NCT03570619|459304676|FG000|Overall Study|Physician Decision|1|||
127640913|NCT03570619|459304677|FG001|Overall Study|Physician Decision|1|||
127640914|NCT03570619|459304678|FG002|Overall Study|Physician Decision|0|||
127640915|NCT03570619|459304676|FG000|Overall Study|Withdrawal by Subject|0|||
127798136|NCT03266016|459885512|FG001|Acute Phase (0 to 28 Days)|Completed study at acute phase.|56|||
127798137|NCT03266016|459885513|FG002|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
127798138|NCT03266016|459885514|FG003|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
127798139|NCT00482014|459885515|FG000|Overall Study|Withdrawal by Subject|1|||
127798140|NCT00482014|459885516|FG001|Overall Study|Withdrawal by Subject|2|||
127798141|NCT00482014|459885517|FG002|Overall Study|Withdrawal by Subject|3|||
127798142|NCT00482014|459885518|FG003|Overall Study|Withdrawal by Subject|4|||
127798143|NCT00482014|459885515|FG000|Overall Study|Adverse Event|3|||
127798144|NCT00482014|459885516|FG001|Overall Study|Adverse Event|0|||
127798145|NCT00482014|459885517|FG002|Overall Study|Adverse Event|2|||
127798146|NCT00482014|459885518|FG003|Overall Study|Adverse Event|8|||
127798147|NCT00482014|459885515|FG000|Overall Study|Death|1|||
127798148|NCT00482014|459885516|FG001|Overall Study|Death|2|||
127798149|NCT00482014|459885517|FG002|Overall Study|Death|1|||
127798150|NCT00482014|459885518|FG003|Overall Study|Death|4|||
127798151|NCT00482014|459885515|FG000|Overall Study|Lack of Efficacy|1|||
127798152|NCT00482014|459885516|FG001|Overall Study|Lack of Efficacy|0|||
127798153|NCT00482014|459885517|FG002|Overall Study|Lack of Efficacy|4|||
127798154|NCT00482014|459885518|FG003|Overall Study|Lack of Efficacy|6|||
127798155|NCT00482014|459885515|FG000|Overall Study|Sponsor Decision|1|||
127798156|NCT00482014|459885516|FG001|Overall Study|Sponsor Decision|2|||
127798157|NCT00482014|459885517|FG002|Overall Study|Sponsor Decision|1|||
127798158|NCT00482014|459885518|FG003|Overall Study|Sponsor Decision|1|||
127798159|NCT03686397|459885519|FG000|Overall Study|Lack of Efficacy|3|||
127798160|NCT03686397|459885520|FG001|Overall Study|Lack of Efficacy|5|||
127798161|NCT03686397|459885519|FG000|Overall Study|Adverse Event|0|||
127798162|NCT03686397|459885520|FG001|Overall Study|Adverse Event|1|||
127798163|NCT03686397|459885519|FG000|Overall Study|Protocol Violation|0|||
127798164|NCT03686397|459885520|FG001|Overall Study|Protocol Violation|1|||
127798165|NCT03686397|459885519|FG000|Overall Study|Withdrawal by Subject|0|||
127798166|NCT03686397|459885520|FG001|Overall Study|Withdrawal by Subject|1|||
127798167|NCT03686397|459885519|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
127798168|NCT03686397|459885520|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
127798169|NCT01178138|459885523|FG000|Overall Study|Lost to Follow-up|8|||
127798170|NCT01178138|459885523|FG000|Overall Study|Withdrawal by Subject|7|||
127798171|NCT01178138|459885523|FG000|Overall Study|Physician Decision|8|||
127798172|NCT01241708|459885524|FG000|Overall Study|Withdrawal by Subject|6|||
127798173|NCT01241708|459885524|FG000|Overall Study|Screen Failure|6|||
127798174|NCT01241708|459885524|FG000|Overall Study|Did not move forward with 2nd Transplant|39|||
127798175|NCT01241708|459885524|FG000|Overall Study|Lost to Follow-up|5|||
127798176|NCT04183335|459885525|FG000|Overall Study|Adverse Event|1|||
127640916|NCT03570619|459304677|FG001|Overall Study|Withdrawal by Subject|2|||
127640917|NCT03570619|459304678|FG002|Overall Study|Withdrawal by Subject|0|||
127640918|NCT01302119|459304679|FG000|Overall Study|Withdrawal by Subject|30|||
127640919|NCT01302119|459304680|FG001|Overall Study|Withdrawal by Subject|20|||
127640920|NCT01302119|459304679|FG000|Overall Study|Lost to Follow-up|10|||
127640921|NCT01302119|459304680|FG001|Overall Study|Lost to Follow-up|4|||
127640922|NCT01302119|459304679|FG000|Overall Study|Adverse Event|2|||
127640923|NCT01302119|459304680|FG001|Overall Study|Adverse Event|1|||
127640924|NCT01302119|459304679|FG000|Overall Study|Non-compliance|4|||
127640925|NCT01302119|459304680|FG001|Overall Study|Non-compliance|2|||
127640926|NCT01302119|459304679|FG000|Overall Study|Non-specific|4|||
127640927|NCT01302119|459304680|FG001|Overall Study|Non-specific|1|||
127640928|NCT04084314|459304681|FG000|Overall Study|Subject/guardian decision|91|||
127640929|NCT04084314|459304681|FG000|Overall Study|Adverse Event|24|||
127640930|NCT04084314|459304681|FG000|Overall Study|Lost to Follow-up|19|||
127640931|NCT04084314|459304681|FG000|Overall Study|New therapy for study indication|9|||
127640932|NCT04084314|459304681|FG000|Overall Study|Pregnancy|9|||
127640933|NCT04084314|459304681|FG000|Overall Study|Withdrawal of informed consent|8|||
127640934|NCT04084314|459304681|FG000|Overall Study|Physician Decision|4|||
127640935|NCT04084314|459304681|FG000|Overall Study|Protocol Deviation|3|||
127640936|NCT00802074|459304685|FG000|Overall Study|Adverse Event|1|||
127703990|NCT04858451|459546660|FG001|Part 2|Discontinued|0|||
127703991|NCT04858451|459546661|FG002|Part 2|Discontinued|0|||
127703992|NCT04858451|459546662|FG003|Part 2|Discontinued|0|||
127703993|NCT04858451|459546663|FG004|Part 2|Discontinued|0|||
127703994|NCT04858451|459546664|FG005|Part 2|Discontinued|0|||
127703995|NCT04858451|459546665|FG006|Part 2|Discontinued|0|||
127703996|NCT04858451|459546666|FG007|Part 2|Discontinued|0|||
127703997|NCT04858451|459546667|FG008|Part 2|Discontinued|63|||
127703998|NCT03314454|459546668|FG000|Overall Study|Protocol Violation|1|||
127703999|NCT04233216|459546670|FG000|Overall Study|Lost to Follow-up|1|||
127704000|NCT04233216|459546671|FG001|Overall Study|Lost to Follow-up|0|||
127704001|NCT04233216|459546672|FG002|Overall Study|Lost to Follow-up|2|||
127704002|NCT04233216|459546673|FG003|Overall Study|Lost to Follow-up|0|||
127704003|NCT04233216|459546670|FG000|Overall Study|Physician Decision|0|||
127704004|NCT04233216|459546671|FG001|Overall Study|Physician Decision|3|||
127704005|NCT04233216|459546672|FG002|Overall Study|Physician Decision|0|||
127704006|NCT04233216|459546673|FG003|Overall Study|Physician Decision|2|||
127704007|NCT04233216|459546670|FG000|Overall Study|Withdrawal by Subject|0|||
127704008|NCT04233216|459546671|FG001|Overall Study|Withdrawal by Subject|2|||
127704009|NCT04233216|459546672|FG002|Overall Study|Withdrawal by Subject|1|||
127704010|NCT04233216|459546673|FG003|Overall Study|Withdrawal by Subject|0|||
127704011|NCT03652389|459546674|FG000|Overall Study|Lost to Follow-up|1|||
127704012|NCT03652389|459546675|FG001|Overall Study|Lost to Follow-up|5|||
127704013|NCT03652389|459546674|FG000|Overall Study|Withdrawal by Subject|5|||
127704014|NCT03652389|459546675|FG001|Overall Study|Withdrawal by Subject|1|||
127704015|NCT03652389|459546674|FG000|Overall Study|New diagnosis|2|||
127704016|NCT03652389|459546675|FG001|Overall Study|New diagnosis|0|||
127704017|NCT04979442|459546680|FG000|Overall Study|Death|43|||
127704018|NCT04979442|459546681|FG001|Overall Study|Death|30|||
127640937|NCT00802074|459304686|FG001|Overall Study|Adverse Event|1|||
127704019|NCT04979442|459546680|FG000|Overall Study|Withdrawal by Subject|8|||
127704020|NCT04979442|459546681|FG001|Overall Study|Withdrawal by Subject|13|||
127704021|NCT04979442|459546680|FG000|Overall Study|Physician Decision|1|||
127704022|NCT04979442|459546681|FG001|Overall Study|Physician Decision|1|||
127704023|NCT04979442|459546680|FG000|Overall Study|Lost to Follow-up|0|||
127704024|NCT04979442|459546681|FG001|Overall Study|Lost to Follow-up|2|||
127640938|NCT00802074|459304687|FG002|Overall Study|Adverse Event|1|||
127640939|NCT00802074|459304688|FG003|Overall Study|Adverse Event|0|||
127640940|NCT00802074|459304689|FG004|Overall Study|Adverse Event|0|||
127640941|NCT00802074|459304690|FG005|Overall Study|Adverse Event|0|||
127640942|NCT00802074|459304685|FG000|Overall Study|Withdrawal by Subject|1|||
127640943|NCT00802074|459304686|FG001|Overall Study|Withdrawal by Subject|0|||
127640944|NCT00802074|459304687|FG002|Overall Study|Withdrawal by Subject|0|||
127640945|NCT00802074|459304688|FG003|Overall Study|Withdrawal by Subject|0|||
127798177|NCT04183335|459885526|FG001|Overall Study|Adverse Event|0|||
127886798|NCT00530439|460208695|FG000|Overall Study|Misclassification|2|||
127886799|NCT00530439|460208696|FG001|Overall Study|Misclassification|0|||
127886800|NCT00530439|460208695|FG000|Overall Study|Twin pregnancy|0|||
127886801|NCT00530439|460208696|FG001|Overall Study|Twin pregnancy|2|||
127886802|NCT00530439|460208695|FG000|Overall Study|Severe malformation/abortion|0|||
127886803|NCT00530439|460208696|FG001|Overall Study|Severe malformation/abortion|3|||
127886804|NCT03705169|460208701|FG000|Overall Study|Lost to Follow-up|0|||
127886805|NCT03705169|460208702|FG001|Overall Study|Lost to Follow-up|0|||
127886806|NCT03705169|460208703|FG002|Overall Study|Lost to Follow-up|0|||
127886807|NCT03705169|460208704|FG003|Overall Study|Lost to Follow-up|2|||
127886808|NCT03705169|460208705|FG004|Overall Study|Lost to Follow-up|0|||
127886809|NCT03705169|460208706|FG005|Overall Study|Lost to Follow-up|2|||
127886810|NCT03705169|460208707|FG006|Overall Study|Lost to Follow-up|1|||
127886811|NCT03705169|460208708|FG007|Overall Study|Lost to Follow-up|0|||
127886812|NCT03705169|460208709|FG008|Overall Study|Lost to Follow-up|0|||
127886813|NCT03705169|460208710|FG009|Overall Study|Lost to Follow-up|1|||
127886814|NCT03705169|460208701|FG000|Overall Study|Adverse Event|0|||
127886815|NCT03705169|460208702|FG001|Overall Study|Adverse Event|0|||
127886816|NCT03705169|460208703|FG002|Overall Study|Adverse Event|0|||
127886817|NCT03705169|460208704|FG003|Overall Study|Adverse Event|1|||
127886818|NCT03705169|460208705|FG004|Overall Study|Adverse Event|0|||
127886819|NCT03705169|460208706|FG005|Overall Study|Adverse Event|0|||
127886820|NCT03705169|460208707|FG006|Overall Study|Adverse Event|0|||
127886821|NCT03705169|460208708|FG007|Overall Study|Adverse Event|0|||
127886822|NCT03705169|460208709|FG008|Overall Study|Adverse Event|0|||
127886823|NCT03705169|460208710|FG009|Overall Study|Adverse Event|0|||
127886824|NCT03705169|460208701|FG000|Overall Study|Site Closure|0|||
127886825|NCT03705169|460208702|FG001|Overall Study|Site Closure|0|||
127886826|NCT03705169|460208703|FG002|Overall Study|Site Closure|0|||
127886827|NCT03705169|460208704|FG003|Overall Study|Site Closure|1|||
127640946|NCT00802074|459304689|FG004|Overall Study|Withdrawal by Subject|0|||
127640947|NCT00802074|459304690|FG005|Overall Study|Withdrawal by Subject|0|||
127640948|NCT03336619|459304691|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
127886828|NCT03705169|460208705|FG004|Overall Study|Site Closure|0|||
127886829|NCT03705169|460208706|FG005|Overall Study|Site Closure|0|||
127886830|NCT03705169|460208707|FG006|Overall Study|Site Closure|0|||
127886831|NCT03705169|460208708|FG007|Overall Study|Site Closure|0|||
127886832|NCT03705169|460208709|FG008|Overall Study|Site Closure|0|||
127640949|NCT03336619|459304692|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
127886833|NCT03705169|460208710|FG009|Overall Study|Site Closure|0|||
127886834|NCT03705169|460208701|FG000|Overall Study|Did not receive study treatment|0|||
127886835|NCT03705169|460208702|FG001|Overall Study|Did not receive study treatment|0|||
127886836|NCT03705169|460208703|FG002|Overall Study|Did not receive study treatment|0|||
127886837|NCT03705169|460208704|FG003|Overall Study|Did not receive study treatment|1|||
127886838|NCT03705169|460208705|FG004|Overall Study|Did not receive study treatment|0|||
127886839|NCT03705169|460208706|FG005|Overall Study|Did not receive study treatment|0|||
127886840|NCT03705169|460208707|FG006|Overall Study|Did not receive study treatment|0|||
127886841|NCT03705169|460208708|FG007|Overall Study|Did not receive study treatment|0|||
127886842|NCT03705169|460208709|FG008|Overall Study|Did not receive study treatment|0|||
127886843|NCT03705169|460208710|FG009|Overall Study|Did not receive study treatment|0|||
127886844|NCT03705169|460208701|FG000|Overall Study|Concerns about study visit compliance|0|||
127886845|NCT03705169|460208702|FG001|Overall Study|Concerns about study visit compliance|0|||
127886846|NCT03705169|460208703|FG002|Overall Study|Concerns about study visit compliance|0|||
127886847|NCT03705169|460208704|FG003|Overall Study|Concerns about study visit compliance|1|||
127886848|NCT03705169|460208705|FG004|Overall Study|Concerns about study visit compliance|0|||
127886849|NCT03705169|460208706|FG005|Overall Study|Concerns about study visit compliance|0|||
127886850|NCT03705169|460208707|FG006|Overall Study|Concerns about study visit compliance|0|||
127886851|NCT03705169|460208708|FG007|Overall Study|Concerns about study visit compliance|0|||
127886852|NCT03705169|460208709|FG008|Overall Study|Concerns about study visit compliance|0|||
127886853|NCT03705169|460208710|FG009|Overall Study|Concerns about study visit compliance|0|||
127886854|NCT01963676|460210391|FG000|Overall Study|Withdrawal by Subject|1|||
127886855|NCT01963676|460210392|FG001|Overall Study|Withdrawal by Subject|0|||
127886856|NCT01246973|460210393|FG000|Overall Study|Other|38|||
127886857|NCT01246973|460210394|FG001|Overall Study|Other|25|||
127886858|NCT01246973|460210393|FG000|Overall Study|Adverse Event|16|||
127886859|NCT01246973|460210394|FG001|Overall Study|Adverse Event|9|||
127886860|NCT01246973|460210393|FG000|Overall Study|Withdrawal by Subject|7|||
127886861|NCT01246973|460210394|FG001|Overall Study|Withdrawal by Subject|13|||
127886862|NCT00766506|460210395|FG000|Overall Study|Use rescue medication after 3 hours|3|||
127886863|NCT00766506|460210396|FG001|Overall Study|Use rescue medication after 3 hours|0|||
127886864|NCT00766506|460210395|FG000|Overall Study|Other|2|||
127886865|NCT00766506|460210396|FG001|Overall Study|Other|2|||
127886866|NCT02496221|460210397|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
127886867|NCT02496221|460210398|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
127886868|NCT02496221|460210397|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
127886869|NCT02496221|460210398|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
127886870|NCT02496221|460210397|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
127886871|NCT02496221|460210398|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
127886872|NCT03262233|460210399|FG000|Overall Study|Withdrawal by Subject|12|||
127886873|NCT03262233|460210400|FG001|Overall Study|Withdrawal by Subject|8|||
127886874|NCT03262233|460210401|FG002|Overall Study|Withdrawal by Subject|21|||
127886875|NCT03262233|460210402|FG003|Overall Study|Withdrawal by Subject|13|||
127886876|NCT03262233|460210399|FG000|Overall Study|Declined due to shock|1|||
127886877|NCT03262233|460210400|FG001|Overall Study|Declined due to shock|2|||
127886878|NCT03262233|460210401|FG002|Overall Study|Declined due to shock|2|||
127886879|NCT03262233|460210402|FG003|Overall Study|Declined due to shock|3|||
127640950|NCT03336619|459304691|FG000|Overall Study|Withdrawal by Subject|17|||
127640951|NCT03336619|459304692|FG001|Overall Study|Withdrawal by Subject|16|||
127640952|NCT03336619|459304691|FG000|Overall Study|Adverse Event|2|||
127886880|NCT03262233|460210399|FG000|Overall Study|Protocol Violation|5|||
127886881|NCT03262233|460210400|FG001|Overall Study|Protocol Violation|10|||
127886882|NCT03262233|460210401|FG002|Overall Study|Protocol Violation|2|||
127886883|NCT03262233|460210402|FG003|Overall Study|Protocol Violation|13|||
127886884|NCT03262233|460210399|FG000|Overall Study|data collection artifact|0|||
127640953|NCT03336619|459304692|FG001|Overall Study|Adverse Event|5|||
127886885|NCT03262233|460210400|FG001|Overall Study|data collection artifact|1|||
127640954|NCT03336619|459304691|FG000|Overall Study|Physician Decision|3|||
127704025|NCT04979442|459546680|FG000|Overall Study|do not want to continue|0|||
127704026|NCT04979442|459546681|FG001|Overall Study|do not want to continue|1|||
127704027|NCT02427464|459546684|FG000|Overall Study|Adverse Event|6|||
127704028|NCT02427464|459546685|FG001|Overall Study|Adverse Event|1|||
127704029|NCT02427464|459546684|FG000|Overall Study|Lost to Follow-up|16|||
127704030|NCT02427464|459546685|FG001|Overall Study|Lost to Follow-up|5|||
127704031|NCT02427464|459546684|FG000|Overall Study|Physician Decision|2|||
127704032|NCT02427464|459546685|FG001|Overall Study|Physician Decision|0|||
127704033|NCT02427464|459546684|FG000|Overall Study|Withdrawal by Subject|10|||
127704034|NCT02427464|459546685|FG001|Overall Study|Withdrawal by Subject|8|||
127704035|NCT02427464|459546684|FG000|Overall Study|Noncompliance|16|||
127704036|NCT02427464|459546685|FG001|Overall Study|Noncompliance|10|||
127704037|NCT02927236|459546688|FG000|Characterization Phase|Physician Decision|0|||
127704038|NCT02927236|459546689|FG001|Characterization Phase|Physician Decision|3|||
127704039|NCT02927236|459546690|FG002|Characterization Phase|Physician Decision|0|||
127704040|NCT02927236|459546691|FG003|Characterization Phase|Physician Decision|2|||
127704041|NCT02927236|459546688|FG000|Characterization Phase|Lost to Follow-up|0|||
127704042|NCT02927236|459546689|FG001|Characterization Phase|Lost to Follow-up|0|||
127704043|NCT02927236|459546690|FG002|Characterization Phase|Lost to Follow-up|0|||
127704044|NCT02927236|459546691|FG003|Characterization Phase|Lost to Follow-up|3|||
127704045|NCT02927236|459546688|FG000|Characterization Phase|Withdrawal by Subject|1|||
127704046|NCT02927236|459546689|FG001|Characterization Phase|Withdrawal by Subject|0|||
127704047|NCT02927236|459546690|FG002|Characterization Phase|Withdrawal by Subject|0|||
127704048|NCT02927236|459546691|FG003|Characterization Phase|Withdrawal by Subject|1|||
127704049|NCT02927236|459546688|FG000|Treatment Phase|Adverse Event|1|||
127704050|NCT02927236|459546689|FG001|Treatment Phase|Adverse Event|0|||
127704051|NCT02927236|459546690|FG002|Treatment Phase|Adverse Event|1|||
127704052|NCT02927236|459546691|FG003|Treatment Phase|Adverse Event|1|||
127704053|NCT02927236|459546688|FG000|Treatment Phase|Protocol Violation|3|||
127704054|NCT02927236|459546689|FG001|Treatment Phase|Protocol Violation|0|||
127704055|NCT02927236|459546690|FG002|Treatment Phase|Protocol Violation|0|||
127704056|NCT02927236|459546691|FG003|Treatment Phase|Protocol Violation|1|||
127704057|NCT02927236|459546688|FG000|Treatment Phase|Lost to Follow-up|1|||
127704058|NCT02927236|459546689|FG001|Treatment Phase|Lost to Follow-up|0|||
127704059|NCT02927236|459546690|FG002|Treatment Phase|Lost to Follow-up|0|||
127704060|NCT02927236|459546691|FG003|Treatment Phase|Lost to Follow-up|0|||
127704061|NCT02927236|459546688|FG000|Follow-up Phase|Lost to Follow-up|1|||
127704062|NCT02927236|459546689|FG001|Follow-up Phase|Lost to Follow-up|0|||
127704063|NCT02927236|459546690|FG002|Follow-up Phase|Lost to Follow-up|1|||
127704064|NCT02927236|459546691|FG003|Follow-up Phase|Lost to Follow-up|0|||
127704065|NCT05496231|459546695|FG000|Overall Study|Adverse Event|1|||
127704066|NCT05496231|459546696|FG001|Overall Study|Adverse Event|1|||
127704067|NCT05496231|459546697|FG002|Overall Study|Adverse Event|0|||
127704068|NCT05496231|459546698|FG003|Overall Study|Adverse Event|4|||
127704069|NCT05496231|459546695|FG000|Overall Study|Withdrawal by Subject|5|||
127704070|NCT05496231|459546696|FG001|Overall Study|Withdrawal by Subject|5|||
127704071|NCT05496231|459546697|FG002|Overall Study|Withdrawal by Subject|4|||
127704072|NCT05496231|459546698|FG003|Overall Study|Withdrawal by Subject|11|||
127704073|NCT05496231|459546695|FG000|Overall Study|Migrated/moved from the study area|3|||
127704074|NCT05496231|459546696|FG001|Overall Study|Migrated/moved from the study area|5|||
127704075|NCT05496231|459546697|FG002|Overall Study|Migrated/moved from the study area|3|||
127704076|NCT05496231|459546698|FG003|Overall Study|Migrated/moved from the study area|3|||
127704077|NCT05496231|459546695|FG000|Overall Study|Lost to Follow-up|13|||
127704078|NCT05496231|459546696|FG001|Overall Study|Lost to Follow-up|6|||
127704079|NCT05496231|459546697|FG002|Overall Study|Lost to Follow-up|11|||
127704080|NCT05496231|459546698|FG003|Overall Study|Lost to Follow-up|6|||
127704081|NCT05496231|459546695|FG000|Overall Study|Other|9|||
127704082|NCT05496231|459546696|FG001|Overall Study|Other|7|||
127704083|NCT05496231|459546697|FG002|Overall Study|Other|7|||
127704084|NCT05496231|459546698|FG003|Overall Study|Other|8|||
127704085|NCT05029622|459546703|FG000|Overall Study|Lost to Follow-up|1|||
127704086|NCT03974178|459546705|FG000|Overall Study|Death|0|||
127798178|NCT04183335|459885525|FG000|Overall Study|Withdrawal by Subject|12|||
127704087|NCT03974178|459546706|FG001|Overall Study|Death|1|||
127704088|NCT04508309|459546710|FG000|Overall Study|Death|0|||
127704089|NCT04508309|459546711|FG001|Overall Study|Death|0|||
127704090|NCT04508309|459546712|FG002|Overall Study|Death|0|||
127886886|NCT03262233|460210401|FG002|Overall Study|data collection artifact|0|||
127886887|NCT03262233|460210402|FG003|Overall Study|data collection artifact|0|||
127886888|NCT01120600|460210405|FG000|Overall Study|Adverse Event|7|||
127886889|NCT01120600|460210406|FG001|Overall Study|Adverse Event|7|||
127886890|NCT01120600|460210405|FG000|Overall Study|Excessive Bone Loss|0|||
127886891|NCT01120600|460210406|FG001|Overall Study|Excessive Bone Loss|4|||
127886892|NCT01120600|460210405|FG000|Overall Study|Lost to Follow-up|1|||
127886893|NCT01120600|460210406|FG001|Overall Study|Lost to Follow-up|3|||
127886894|NCT01120600|460210405|FG000|Overall Study|Physician Decision|1|||
127886895|NCT01120600|460210406|FG001|Overall Study|Physician Decision|3|||
127886896|NCT01120600|460210405|FG000|Overall Study|Protocol Violation|0|||
127886897|NCT01120600|460210406|FG001|Overall Study|Protocol Violation|4|||
127886898|NCT01120600|460210405|FG000|Overall Study|Withdrawal by Subject|10|||
127886899|NCT01120600|460210406|FG001|Overall Study|Withdrawal by Subject|11|||
127886900|NCT01165242|460210407|FG000|Overall Study|Unreachable Subjects|1|||
127886901|NCT01165242|460210408|FG001|Overall Study|Unreachable Subjects|0|||
127886902|NCT01165242|460210409|FG002|Overall Study|Unreachable Subjects|0|||
127886903|NCT01165242|460210407|FG000|Overall Study|Incarcerated Subjects|0|||
127886904|NCT01165242|460210408|FG001|Overall Study|Incarcerated Subjects|1|||
127886905|NCT01165242|460210409|FG002|Overall Study|Incarcerated Subjects|0|||
127886906|NCT01165242|460210407|FG000|Overall Study|Visit 2 Declined by Subject|0|||
127886907|NCT01165242|460210408|FG001|Overall Study|Visit 2 Declined by Subject|0|||
127886908|NCT01165242|460210409|FG002|Overall Study|Visit 2 Declined by Subject|1|||
127886909|NCT01165242|460210407|FG000|Overall Study|Withdrawal by Subject|0|||
127886910|NCT01165242|460210408|FG001|Overall Study|Withdrawal by Subject|2|||
127886911|NCT01165242|460210409|FG002|Overall Study|Withdrawal by Subject|2|||
127886912|NCT01165242|460210407|FG000|Overall Study|Extended Holiday|0|||
127886913|NCT01165242|460210408|FG001|Overall Study|Extended Holiday|0|||
127886914|NCT01165242|460210409|FG002|Overall Study|Extended Holiday|1|||
127886915|NCT01165242|460210407|FG000|Overall Study|Lost to Follow-up|9|||
127886916|NCT01165242|460210408|FG001|Overall Study|Lost to Follow-up|7|||
127886917|NCT01165242|460210409|FG002|Overall Study|Lost to Follow-up|10|||
127886918|NCT03770000|460210410|FG000|Overall Study|Premature discontinuation due to PD|0|||
127886919|NCT03770000|460210411|FG001|Overall Study|Premature discontinuation due to PD|0|||
127886920|NCT03770000|460210412|FG002|Overall Study|Premature discontinuation due to PD|1|||
127886921|NCT03770000|460210413|FG003|Overall Study|Premature discontinuation due to PD|3|||
127886922|NCT03770000|460210414|FG004|Overall Study|Premature discontinuation due to PD|2|||
127886923|NCT03877237|460210415|FG000|Overall Study|Adverse Event|1|||
127886924|NCT03877237|460210416|FG001|Overall Study|Adverse Event|2|||
127886925|NCT03877237|460210415|FG000|Overall Study|Death|3|||
127886926|NCT03877237|460210416|FG001|Overall Study|Death|2|||
127886927|NCT03877237|460210415|FG000|Overall Study|Physician Decision|1|||
127886928|NCT03877237|460210416|FG001|Overall Study|Physician Decision|0|||
127886929|NCT03877237|460210415|FG000|Overall Study|Withdrawal by Subject|0|||
127886930|NCT03877237|460210416|FG001|Overall Study|Withdrawal by Subject|2|||
127886931|NCT00566098|460210419|FG000|Collection of MILs|Withdrawal by Subject|1|||
127886932|NCT00566098|460210419|FG000|Collection of MILs|Relapsed|1|||
127886933|NCT00566098|460210419|FG000|Generation of MILs Product|Relapsed|1|||
127886934|NCT00566098|460210419|FG000|Administration of ASCT+MILs|Death|10|||
127886935|NCT00566098|460210419|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
127886936|NCT01690520|460210422|FG000|Overall Study|Death|25|||
127798179|NCT04183335|459885526|FG001|Overall Study|Withdrawal by Subject|3|||
127798180|NCT02605642|459885527|FG000|Overall Study|Other|11|||
127798181|NCT02605642|459885528|FG001|Overall Study|Other|1|||
127798182|NCT02605642|459885527|FG000|Overall Study|Participant non-compliance|2|||
127798183|NCT02605642|459885528|FG001|Overall Study|Participant non-compliance|4|||
127798184|NCT02605642|459885527|FG000|Overall Study|Physician Decision|10|||
127798185|NCT02605642|459885528|FG001|Overall Study|Physician Decision|0|||
127798186|NCT02605642|459885527|FG000|Overall Study|Lost to Follow-up|12|||
127798187|NCT02605642|459885528|FG001|Overall Study|Lost to Follow-up|1|||
127798188|NCT02605642|459885527|FG000|Overall Study|Adverse Event|14|||
127886937|NCT01690520|460210423|FG001|Overall Study|Death|21|||
127886938|NCT01690520|460210422|FG000|Overall Study|Lost to Follow-up|2|||
127886939|NCT01690520|460210423|FG001|Overall Study|Lost to Follow-up|3|||
127886940|NCT01690520|460210422|FG000|Overall Study|Withdrawal by Subject|2|||
127886941|NCT01690520|460210423|FG001|Overall Study|Withdrawal by Subject|0|||
127886942|NCT01690520|460210422|FG000|Overall Study|Relapse|0|||
127886943|NCT01690520|460210423|FG001|Overall Study|Relapse|1|||
127886944|NCT01690520|460210422|FG000|Overall Study|Other|0|||
127886945|NCT01690520|460210423|FG001|Overall Study|Other|1|||
127886946|NCT01690520|460210422|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
127886947|NCT01690520|460210423|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
127886948|NCT02236754|460210424|FG000|Overall Study|Withdrawal by Subject|1|||
127886949|NCT02236754|460210425|FG001|Overall Study|Withdrawal by Subject|0|||
127886950|NCT04006847|460210426|FG000|Overall Study|Product issue|1|||
127640955|NCT03336619|459304692|FG001|Overall Study|Physician Decision|0|||
127640956|NCT03743038|459304693|FG000|Overall Study|Physician Decision|1|||
127640957|NCT01300546|459304694|FG000|Overall Study|Withdrawal by Subject|1|||
127640958|NCT01300546|459304695|FG001|Overall Study|Withdrawal by Subject|0|||
127640959|NCT01300546|459304694|FG000|Overall Study|Lost to Follow-up|0|||
127798189|NCT02605642|459885528|FG001|Overall Study|Adverse Event|2|||
127798190|NCT02605642|459885527|FG000|Overall Study|Withdrawal by Subject|23|||
127798191|NCT02605642|459885528|FG001|Overall Study|Withdrawal by Subject|2|||
127798192|NCT02605642|459885527|FG000|Overall Study|Lack of response|24|||
127798193|NCT02605642|459885528|FG001|Overall Study|Lack of response|11|||
127798194|NCT00618748|459885538|FG000|Overall Study|Adverse Event|4|||
127798195|NCT00618748|459885539|FG001|Overall Study|Adverse Event|3|||
127798196|NCT00618748|459885540|FG002|Overall Study|Adverse Event|8|||
127798197|NCT00618748|459885538|FG000|Overall Study|Physician Decision|3|||
127798198|NCT00618748|459885539|FG001|Overall Study|Physician Decision|1|||
127798199|NCT00618748|459885540|FG002|Overall Study|Physician Decision|1|||
127798200|NCT00618748|459885538|FG000|Overall Study|Withdrawal by Subject|4|||
127798201|NCT00618748|459885539|FG001|Overall Study|Withdrawal by Subject|1|||
127798202|NCT00618748|459885540|FG002|Overall Study|Withdrawal by Subject|5|||
127798203|NCT03806127|459885545|FG000|Overall Study|Withdrawal by Subject|4|||
127798204|NCT03806127|459885546|FG001|Overall Study|Withdrawal by Subject|5|||
127798205|NCT03806127|459885545|FG000|Overall Study|Protocol Violation|3|||
127886951|NCT00382291|460210427|FG000|Overall Study|Adverse Event|1|||
127886952|NCT00382291|460210428|FG001|Overall Study|Adverse Event|2|||
127640960|NCT01300546|459304695|FG001|Overall Study|Lost to Follow-up|2|||
127640961|NCT01300546|459304694|FG000|Overall Study|Lack of Efficacy|0|||
127640962|NCT01300546|459304695|FG001|Overall Study|Lack of Efficacy|3|||
127886953|NCT00382291|460210429|FG002|Overall Study|Adverse Event|2|||
127886954|NCT00382291|460210427|FG000|Overall Study|Protocol Violation|1|||
127886955|NCT00382291|460210428|FG001|Overall Study|Protocol Violation|0|||
127886956|NCT00382291|460210429|FG002|Overall Study|Protocol Violation|0|||
127886957|NCT00382291|460210427|FG000|Overall Study|Temporary study suspension|2|||
127886958|NCT00382291|460210428|FG001|Overall Study|Temporary study suspension|2|||
127886959|NCT00382291|460210429|FG002|Overall Study|Temporary study suspension|5|||
127886960|NCT00382291|460210427|FG000|Overall Study|Withdrawal by Subject|0|||
127886961|NCT00382291|460210428|FG001|Overall Study|Withdrawal by Subject|2|||
127886962|NCT00382291|460210429|FG002|Overall Study|Withdrawal by Subject|0|||
127886963|NCT00382291|460210427|FG000|Overall Study|Physician Decision|0|||
127886964|NCT00382291|460210428|FG001|Overall Study|Physician Decision|1|||
127886965|NCT00382291|460210429|FG002|Overall Study|Physician Decision|0|||
127886966|NCT00382291|460210427|FG000|Overall Study|Lack of Efficacy|0|||
127886967|NCT00382291|460210428|FG001|Overall Study|Lack of Efficacy|0|||
127886968|NCT00382291|460210429|FG002|Overall Study|Lack of Efficacy|1|||
127886969|NCT01375010|460210430|FG000|Overall Study|Lost to Follow-up|8|||
127886970|NCT01375010|460210431|FG001|Overall Study|Lost to Follow-up|2|||
127886971|NCT01375010|460210430|FG000|Overall Study|Withdrawal by Subject|4|||
127886972|NCT01375010|460210431|FG001|Overall Study|Withdrawal by Subject|2|||
127886973|NCT02614703|460210432|FG000|Overall Study|Withdrawal by Subject|7|||
127886974|NCT02614703|460210433|FG001|Overall Study|Withdrawal by Subject|1|||
127886975|NCT02402933|460210434|FG000|Overall Study|Withdrawal by Subject|4|||
127886976|NCT02402933|460210434|FG000|Overall Study|Discontinued; Site Termination|10|||
127886977|NCT01681771|460210439|FG000|Overall Study|Lost to Follow-up|4|||
127886978|NCT01681771|460210440|FG001|Overall Study|Lost to Follow-up|2|||
127886979|NCT00660790|460210447|FG000|Baseline to 3 Months|Death|1|||
127886980|NCT00660790|460210447|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
127886981|NCT00660790|460210447|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
127886982|NCT02791659|460210448|FG000|Overall Study|Protocol Violation|0|||
127886983|NCT02791659|460210449|FG001|Overall Study|Protocol Violation|1|||
127886984|NCT03840811|460210450|FG000|Overall Study|Lost to Follow-up|0|||
127886985|NCT03840811|460210451|FG001|Overall Study|Lost to Follow-up|0|||
127886986|NCT03840811|460210452|FG002|Overall Study|Lost to Follow-up|1|||
127886987|NCT01625845|460210453|FG000|Overall Study|Adverse Event|1|||
127886988|NCT01625845|460210454|FG001|Overall Study|Adverse Event|2|||
127886989|NCT01625845|460210453|FG000|Overall Study|Lost to Follow-up|2|||
127886990|NCT01625845|460210454|FG001|Overall Study|Lost to Follow-up|1|||
127886991|NCT01625845|460210453|FG000|Overall Study|Withdrawal by Subject|2|||
127886992|NCT01625845|460210454|FG001|Overall Study|Withdrawal by Subject|0|||
127886993|NCT02853929|460210455|FG000|Overall Study|Lost to Follow-up|3|||
127886994|NCT02853929|460210456|FG001|Overall Study|Lost to Follow-up|0|||
127886995|NCT02853929|460210455|FG000|Overall Study|Withdrawal by Subject|1|||
127886996|NCT02853929|460210456|FG001|Overall Study|Withdrawal by Subject|0|||
127886997|NCT02853929|460210455|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
127886998|NCT02853929|460210456|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
127886999|NCT01078623|460210457|FG000|Treatment Period 1|Adverse Event|1|||
127887000|NCT01078623|460210458|FG001|Treatment Period 1|Adverse Event|1|||
127887001|NCT01078623|460210459|FG002|Treatment Period 1|Adverse Event|1|||
127887002|NCT01078623|460210460|FG003|Treatment Period 1|Adverse Event|0|||
127887003|NCT01078623|460210461|FG004|Treatment Period 1|Adverse Event|0|||
127887004|NCT01078623|460210462|FG005|Treatment Period 1|Adverse Event|0|||
127887005|NCT01078623|460210463|FG006|Treatment Period 1|Adverse Event|1|||
127887006|NCT01078623|460210464|FG007|Treatment Period 1|Adverse Event|0|||
127887007|NCT01078623|460210465|FG008|Treatment Period 1|Adverse Event|1|||
127887008|NCT01078623|460210466|FG009|Treatment Period 1|Adverse Event|1|||
127887009|NCT01078623|460210467|FG010|Treatment Period 1|Adverse Event|0|||
127887010|NCT01078623|460210468|FG011|Treatment Period 1|Adverse Event|0|||
127887011|NCT01078623|460210469|FG012|Treatment Period 1|Adverse Event|0|||
127887012|NCT01078623|460210470|FG013|Treatment Period 1|Adverse Event|0|||
127887013|NCT01078623|460210471|FG014|Treatment Period 1|Adverse Event|0|||
127887014|NCT01078623|460210472|FG015|Treatment Period 1|Adverse Event|0|||
127887015|NCT01078623|460210473|FG016|Treatment Period 1|Adverse Event|0|||
127887016|NCT01078623|460210474|FG017|Treatment Period 1|Adverse Event|0|||
127887017|NCT01078623|460210475|FG018|Treatment Period 1|Adverse Event|0|||
127887018|NCT01078623|460210476|FG019|Treatment Period 1|Adverse Event|0|||
127887019|NCT01078623|460210457|FG000|Treatment Period 1|Withdrawal by Subject|0|||
127887020|NCT01078623|460210458|FG001|Treatment Period 1|Withdrawal by Subject|0|||
127887021|NCT01078623|460210459|FG002|Treatment Period 1|Withdrawal by Subject|0|||
127887022|NCT01078623|460210460|FG003|Treatment Period 1|Withdrawal by Subject|0|||
127887023|NCT01078623|460210461|FG004|Treatment Period 1|Withdrawal by Subject|0|||
127887024|NCT01078623|460210462|FG005|Treatment Period 1|Withdrawal by Subject|0|||
127887025|NCT01078623|460210463|FG006|Treatment Period 1|Withdrawal by Subject|0|||
127887026|NCT01078623|460210464|FG007|Treatment Period 1|Withdrawal by Subject|1|||
127887027|NCT01078623|460210465|FG008|Treatment Period 1|Withdrawal by Subject|0|||
127887028|NCT01078623|460210466|FG009|Treatment Period 1|Withdrawal by Subject|0|||
127887029|NCT01078623|460210467|FG010|Treatment Period 1|Withdrawal by Subject|1|||
127887030|NCT01078623|460210468|FG011|Treatment Period 1|Withdrawal by Subject|0|||
127887031|NCT01078623|460210469|FG012|Treatment Period 1|Withdrawal by Subject|0|||
127887032|NCT01078623|460210470|FG013|Treatment Period 1|Withdrawal by Subject|0|||
127887033|NCT01078623|460210471|FG014|Treatment Period 1|Withdrawal by Subject|0|||
127887034|NCT01078623|460210472|FG015|Treatment Period 1|Withdrawal by Subject|0|||
127887035|NCT01078623|460210473|FG016|Treatment Period 1|Withdrawal by Subject|0|||
127887036|NCT01078623|460210474|FG017|Treatment Period 1|Withdrawal by Subject|0|||
127887037|NCT01078623|460210475|FG018|Treatment Period 1|Withdrawal by Subject|0|||
127887038|NCT01078623|460210476|FG019|Treatment Period 1|Withdrawal by Subject|0|||
127887039|NCT01078623|460210457|FG000|Treatment Period 1|Protocol Violation|0|||
127887040|NCT01078623|460210458|FG001|Treatment Period 1|Protocol Violation|0|||
127887041|NCT01078623|460210459|FG002|Treatment Period 1|Protocol Violation|0|||
127887042|NCT01078623|460210460|FG003|Treatment Period 1|Protocol Violation|0|||
127887043|NCT01078623|460210461|FG004|Treatment Period 1|Protocol Violation|0|||
127887044|NCT01078623|460210462|FG005|Treatment Period 1|Protocol Violation|1|||
127887045|NCT01078623|460210463|FG006|Treatment Period 1|Protocol Violation|0|||
127887046|NCT01078623|460210464|FG007|Treatment Period 1|Protocol Violation|0|||
127887047|NCT01078623|460210465|FG008|Treatment Period 1|Protocol Violation|0|||
127887048|NCT01078623|460210466|FG009|Treatment Period 1|Protocol Violation|0|||
127887049|NCT01078623|460210467|FG010|Treatment Period 1|Protocol Violation|0|||
127887050|NCT01078623|460210468|FG011|Treatment Period 1|Protocol Violation|0|||
127887051|NCT01078623|460210469|FG012|Treatment Period 1|Protocol Violation|0|||
127887052|NCT01078623|460210470|FG013|Treatment Period 1|Protocol Violation|0|||
127640963|NCT01300546|459304694|FG000|Overall Study|Adverse Event|0|||
127640964|NCT01300546|459304695|FG001|Overall Study|Adverse Event|1|||
127887053|NCT01078623|460210471|FG014|Treatment Period 1|Protocol Violation|0|||
127887054|NCT01078623|460210472|FG015|Treatment Period 1|Protocol Violation|0|||
127887055|NCT01078623|460210473|FG016|Treatment Period 1|Protocol Violation|0|||
127887056|NCT01078623|460210474|FG017|Treatment Period 1|Protocol Violation|0|||
127887057|NCT01078623|460210475|FG018|Treatment Period 1|Protocol Violation|0|||
127887058|NCT01078623|460210476|FG019|Treatment Period 1|Protocol Violation|0|||
127887059|NCT01078623|460210457|FG000|Treatment Period 2|Adverse Event|0|||
127887060|NCT01078623|460210458|FG001|Treatment Period 2|Adverse Event|0|||
127887061|NCT01078623|460210459|FG002|Treatment Period 2|Adverse Event|0|||
127887062|NCT01078623|460210460|FG003|Treatment Period 2|Adverse Event|0|||
127887063|NCT01078623|460210461|FG004|Treatment Period 2|Adverse Event|0|||
127887064|NCT01078623|460210462|FG005|Treatment Period 2|Adverse Event|0|||
127640965|NCT02820623|459304696|FG000|Overall Study|Withdrawal by Subject|1|||
127798206|NCT03806127|459885546|FG001|Overall Study|Protocol Violation|1|||
127798207|NCT03806127|459885545|FG000|Overall Study|Adverse Event|3|||
127798208|NCT03806127|459885546|FG001|Overall Study|Adverse Event|0|||
127640966|NCT02820623|459304697|FG001|Overall Study|Withdrawal by Subject|3|||
127640967|NCT02820623|459304698|FG002|Overall Study|Withdrawal by Subject|3|||
127640968|NCT02820623|459304696|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
127640969|NCT02820623|459304697|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
127640970|NCT02820623|459304698|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
127640971|NCT02820623|459304696|FG000|Overall Study|Therapist unable to enroll clients|1|||
127640972|NCT02820623|459304697|FG001|Overall Study|Therapist unable to enroll clients|1|||
127798209|NCT03806127|459885545|FG000|Overall Study|Unable to Complete Procedures|0|||
127640973|NCT02820623|459304698|FG002|Overall Study|Therapist unable to enroll clients|3|||
127640974|NCT02820623|459304696|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
127640975|NCT02820623|459304697|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
127640976|NCT02820623|459304698|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
127640977|NCT01371851|459304705|FG000|Overall Study|Lost to Follow-up|5|||
127640978|NCT01371851|459304706|FG001|Overall Study|Lost to Follow-up|8|||
127640979|NCT01371851|459304705|FG000|Overall Study|was arrested and put in jail|0|||
127640980|NCT01371851|459304706|FG001|Overall Study|was arrested and put in jail|1|||
127640981|NCT01371851|459304705|FG000|Overall Study|non study related adverse event|1|||
127640982|NCT01371851|459304706|FG001|Overall Study|non study related adverse event|0|||
127640983|NCT01371851|459304705|FG000|Overall Study|Blood Pressure outside study parameters|2|||
127640984|NCT01371851|459304706|FG001|Overall Study|Blood Pressure outside study parameters|0|||
127640985|NCT00833638|459304707|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
127640986|NCT00833638|459304708|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
127640987|NCT00833638|459304709|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
127640988|NCT00833638|459304707|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
127640989|NCT00833638|459304708|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
127640990|NCT00833638|459304709|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
127640991|NCT00833638|459304707|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
127640992|NCT00833638|459304708|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
127640993|NCT00833638|459304709|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
127640994|NCT00833638|459304707|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
127640995|NCT00833638|459304708|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
127640996|NCT00833638|459304709|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
127640997|NCT00833638|459304707|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
127640998|NCT00833638|459304708|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
127704091|NCT04508309|459546713|FG003|Overall Study|Death|0|||
127704092|NCT04508309|459546714|FG004|Overall Study|Death|1|||
127640999|NCT00833638|459304709|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
127704093|NCT04508309|459546710|FG000|Overall Study|Lost to Follow-up|0|||
127704094|NCT04508309|459546711|FG001|Overall Study|Lost to Follow-up|0|||
127704095|NCT04508309|459546712|FG002|Overall Study|Lost to Follow-up|1|||
127704096|NCT04508309|459546713|FG003|Overall Study|Lost to Follow-up|1|||
127704097|NCT04508309|459546714|FG004|Overall Study|Lost to Follow-up|0|||
127704098|NCT04508309|459546710|FG000|Overall Study|Withdrawal by Subject|0|||
127704099|NCT04508309|459546711|FG001|Overall Study|Withdrawal by Subject|0|||
127704100|NCT04508309|459546712|FG002|Overall Study|Withdrawal by Subject|0|||
127704101|NCT04508309|459546713|FG003|Overall Study|Withdrawal by Subject|0|||
127704102|NCT04508309|459546714|FG004|Overall Study|Withdrawal by Subject|1|||
127704103|NCT05526430|459546715|FG000|Overall Study|Withdrawal by Subject|0|||
127704104|NCT05526430|459546716|FG001|Overall Study|Withdrawal by Subject|2|||
127704105|NCT05526430|459546717|FG002|Overall Study|Withdrawal by Subject|0|||
127704106|NCT05526430|459546718|FG003|Overall Study|Withdrawal by Subject|0|||
127704107|NCT03085810|459546722|FG000|Main Study|Withdrawal by Subject|77|||
127704108|NCT03085810|459546723|FG001|Main Study|Withdrawal by Subject|0|||
127704109|NCT03085810|459546724|FG002|Main Study|Withdrawal by Subject|0|||
127704110|NCT03085810|459546722|FG000|Main Study|Terminated By Sponsor|14|||
127704111|NCT03085810|459546723|FG001|Main Study|Terminated By Sponsor|0|||
127704112|NCT03085810|459546724|FG002|Main Study|Terminated By Sponsor|0|||
127704113|NCT03085810|459546722|FG000|Main Study|Protocol Violation|15|||
127704114|NCT03085810|459546723|FG001|Main Study|Protocol Violation|0|||
127704115|NCT03085810|459546724|FG002|Main Study|Protocol Violation|0|||
127704116|NCT03085810|459546722|FG000|Main Study|Physician Decision|13|||
127704117|NCT03085810|459546723|FG001|Main Study|Physician Decision|0|||
127704118|NCT03085810|459546724|FG002|Main Study|Physician Decision|0|||
127704119|NCT03085810|459546722|FG000|Main Study|Lost to Follow-up|17|||
127704120|NCT03085810|459546723|FG001|Main Study|Lost to Follow-up|0|||
127704121|NCT03085810|459546724|FG002|Main Study|Lost to Follow-up|0|||
127704122|NCT03085810|459546722|FG000|Main Study|Adverse Event|25|||
127704123|NCT03085810|459546723|FG001|Main Study|Adverse Event|0|||
127704124|NCT03085810|459546724|FG002|Main Study|Adverse Event|0|||
127704125|NCT03085810|459546722|FG000|Main Study|Pregnancy|7|||
127704126|NCT03085810|459546723|FG001|Main Study|Pregnancy|0|||
127704127|NCT03085810|459546724|FG002|Main Study|Pregnancy|0|||
127704128|NCT03085810|459546722|FG000|Main Study|Changed to Commercial Ocrelizumab|4|||
127704129|NCT03085810|459546723|FG001|Main Study|Changed to Commercial Ocrelizumab|0|||
127704130|NCT03085810|459546724|FG002|Main Study|Changed to Commercial Ocrelizumab|0|||
127704131|NCT03085810|459546722|FG000|Main Study|Lack of Efficacy|10|||
127704132|NCT03085810|459546723|FG001|Main Study|Lack of Efficacy|0|||
127704133|NCT03085810|459546724|FG002|Main Study|Lack of Efficacy|0|||
127704134|NCT03085810|459546722|FG000|Main Study|Death|12|||
127704135|NCT03085810|459546723|FG001|Main Study|Death|0|||
127704136|NCT03085810|459546724|FG002|Main Study|Death|0|||
127704137|NCT03085810|459546722|FG000|Main Study|Disease progression|1|||
127704138|NCT03085810|459546723|FG001|Main Study|Disease progression|0|||
127704139|NCT03085810|459546724|FG002|Main Study|Disease progression|0|||
127704140|NCT03085810|459546722|FG000|Main Study|Site Closure|3|||
127704141|NCT03085810|459546723|FG001|Main Study|Site Closure|0|||
127704142|NCT03085810|459546724|FG002|Main Study|Site Closure|0|||
127704143|NCT03085810|459546722|FG000|Main Study|Planned pregnancy|17|||
127704144|NCT03085810|459546723|FG001|Main Study|Planned pregnancy|0|||
127704145|NCT03085810|459546724|FG002|Main Study|Planned pregnancy|0|||
127704146|NCT03085810|459546722|FG000|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
127704147|NCT03085810|459546723|FG001|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
127704148|NCT03085810|459546724|FG002|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|3|||
127704149|NCT03085810|459546722|FG000|Substudy (Week 24 to Week 144)|Withdrawal by Subject|0|||
127704150|NCT03085810|459546723|FG001|Substudy (Week 24 to Week 144)|Withdrawal by Subject|5|||
127704151|NCT03085810|459546724|FG002|Substudy (Week 24 to Week 144)|Withdrawal by Subject|7|||
127704152|NCT03085810|459546722|FG000|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|0|||
127704153|NCT03085810|459546723|FG001|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|355|||
127704154|NCT03085810|459546724|FG002|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|352|||
127704155|NCT03085810|459546722|FG000|Substudy (Week 24 to Week 144)|Reason Not Specified|0|||
127704156|NCT03085810|459546723|FG001|Substudy (Week 24 to Week 144)|Reason Not Specified|13|||
127704157|NCT03085810|459546724|FG002|Substudy (Week 24 to Week 144)|Reason Not Specified|8|||
127704158|NCT05200403|459546727|FG000|Overall Study|Withdrawal by Subject|4|||
127704159|NCT05200403|459546728|FG001|Overall Study|Withdrawal by Subject|2|||
127704160|NCT05200403|459546729|FG002|Overall Study|Withdrawal by Subject|6|||
127704161|NCT05073458|459546731|FG000|24-week Double-blind Period|Adverse Event|1|||
127704162|NCT05073458|459546732|FG001|24-week Double-blind Period|Adverse Event|0|||
127798210|NCT03806127|459885546|FG001|Overall Study|Unable to Complete Procedures|1|||
127798211|NCT03806127|459885545|FG000|Overall Study|Pregnancy|0|||
127798212|NCT03806127|459885546|FG001|Overall Study|Pregnancy|1|||
127798213|NCT03806127|459885545|FG000|Overall Study|Lost to Follow-up|5|||
127798214|NCT03806127|459885546|FG001|Overall Study|Lost to Follow-up|1|||
127798215|NCT03806127|459885545|FG000|Overall Study|Physician Decision|1|||
127798216|NCT03806127|459885546|FG001|Overall Study|Physician Decision|1|||
127798217|NCT03806127|459885545|FG000|Overall Study|Could Not Come Due to Covid|1|||
127798218|NCT03806127|459885546|FG001|Overall Study|Could Not Come Due to Covid|0|||
127798219|NCT03806127|459885545|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
127704163|NCT05073458|459546731|FG000|24-week Double-blind Period|Physician Decision|1|||
127704164|NCT05073458|459546732|FG001|24-week Double-blind Period|Physician Decision|0|||
127704165|NCT05073458|459546731|FG000|24-week Double-blind Period|Study Terminated by Sponsor|1|||
127704166|NCT05073458|459546732|FG001|24-week Double-blind Period|Study Terminated by Sponsor|1|||
127704167|NCT05073458|459546731|FG000|24-week Double-blind Period|Withdrawal by Subject|0|||
127704168|NCT05073458|459546732|FG001|24-week Double-blind Period|Withdrawal by Subject|1|||
127704169|NCT05073458|459546731|FG000|24-week Open-label Period|Withdrawal by Subject|1|||
127704170|NCT05073458|459546732|FG001|24-week Open-label Period|Withdrawal by Subject|0|||
127704171|NCT05073458|459546731|FG000|24-week Open-label Period|Adverse Event|1|||
127704172|NCT05073458|459546732|FG001|24-week Open-label Period|Adverse Event|2|||
127704173|NCT00950742|459546733|FG000|Overall Study|Other Adverse Event|1|||
127887065|NCT01078623|460210463|FG006|Treatment Period 2|Adverse Event|1|||
127887066|NCT01078623|460210464|FG007|Treatment Period 2|Adverse Event|0|||
127887067|NCT01078623|460210465|FG008|Treatment Period 2|Adverse Event|0|||
127887068|NCT01078623|460210466|FG009|Treatment Period 2|Adverse Event|0|||
127887069|NCT01078623|460210467|FG010|Treatment Period 2|Adverse Event|0|||
127887070|NCT01078623|460210468|FG011|Treatment Period 2|Adverse Event|0|||
127887071|NCT01078623|460210469|FG012|Treatment Period 2|Adverse Event|0|||
127887072|NCT01078623|460210470|FG013|Treatment Period 2|Adverse Event|0|||
127887073|NCT01078623|460210471|FG014|Treatment Period 2|Adverse Event|0|||
127887074|NCT01078623|460210472|FG015|Treatment Period 2|Adverse Event|0|||
127887075|NCT01078623|460210473|FG016|Treatment Period 2|Adverse Event|0|||
127887076|NCT01078623|460210474|FG017|Treatment Period 2|Adverse Event|0|||
127887077|NCT01078623|460210475|FG018|Treatment Period 2|Adverse Event|1|||
127887078|NCT01078623|460210476|FG019|Treatment Period 2|Adverse Event|0|||
127887079|NCT01078623|460210457|FG000|Treatment Period 2|Withdrawal by Subject|0|||
127887080|NCT01078623|460210458|FG001|Treatment Period 2|Withdrawal by Subject|0|||
127887081|NCT01078623|460210459|FG002|Treatment Period 2|Withdrawal by Subject|0|||
127887082|NCT01078623|460210460|FG003|Treatment Period 2|Withdrawal by Subject|0|||
127887083|NCT01078623|460210461|FG004|Treatment Period 2|Withdrawal by Subject|0|||
127887084|NCT01078623|460210462|FG005|Treatment Period 2|Withdrawal by Subject|1|||
127704174|NCT00950742|459546734|FG001|Overall Study|Other Adverse Event|0|||
127704175|NCT00950742|459546733|FG000|Overall Study|Withdrawal by Subject|3|||
127704176|NCT00950742|459546734|FG001|Overall Study|Withdrawal by Subject|0|||
127704177|NCT00950742|459546733|FG000|Overall Study|Progressive Disease|6|||
127704178|NCT00950742|459546734|FG001|Overall Study|Progressive Disease|2|||
127704179|NCT00950742|459546733|FG000|Overall Study|Dose limiting toxicity|6|||
127704180|NCT00950742|459546734|FG001|Overall Study|Dose limiting toxicity|0|||
127704181|NCT00592852|459546738|FG000|Overall Study|Non-compliance|1|||
127798220|NCT03806127|459885546|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
127798221|NCT03806127|459885545|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
127798222|NCT03806127|459885546|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
127798223|NCT03806127|459885545|FG000|Overall Study|Covid 19 Restrictions|2|||
127798224|NCT03806127|459885546|FG001|Overall Study|Covid 19 Restrictions|0|||
127798225|NCT03806127|459885545|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
127798226|NCT03806127|459885546|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
127798227|NCT03806127|459885545|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
127798228|NCT03806127|459885546|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
127798229|NCT01467492|459885549|FG000|Overall Study|Withdrawal by Subject|6|||
127798230|NCT01467492|459885550|FG001|Overall Study|Withdrawal by Subject|4|||
127798231|NCT01467492|459885549|FG000|Overall Study|Study Terminated by Sponsor|6|||
127798232|NCT01467492|459885550|FG001|Overall Study|Study Terminated by Sponsor|4|||
127798233|NCT01467492|459885549|FG000|Overall Study|Adverse Event|4|||
127798234|NCT01467492|459885550|FG001|Overall Study|Adverse Event|3|||
127798235|NCT01467492|459885549|FG000|Overall Study|Lost to Follow-up|3|||
127798236|NCT01467492|459885550|FG001|Overall Study|Lost to Follow-up|2|||
127798237|NCT01467492|459885549|FG000|Overall Study|Undefined|2|||
127798238|NCT01467492|459885550|FG001|Overall Study|Undefined|0|||
127704182|NCT00592852|459546738|FG000|Overall Study|Adverse Event|3|||
127704183|NCT00592852|459546738|FG000|Overall Study|Found ineligible|1|||
127704184|NCT00592852|459546738|FG000|Overall Study|Withdrawal by Subject|1|||
127704185|NCT05002088|459546740|FG000|Overall Study|Withdrawal by Subject|9|||
127704186|NCT05002088|459546741|FG001|Overall Study|Withdrawal by Subject|0|||
127798239|NCT01467492|459885549|FG000|Overall Study|Enrolled But Not Treated|1|||
127798240|NCT01467492|459885550|FG001|Overall Study|Enrolled But Not Treated|0|||
127798241|NCT03823391|459885552|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
127798242|NCT03823391|459885553|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
127887085|NCT01078623|460210463|FG006|Treatment Period 2|Withdrawal by Subject|0|||
127887086|NCT01078623|460210464|FG007|Treatment Period 2|Withdrawal by Subject|0|||
127887087|NCT01078623|460210465|FG008|Treatment Period 2|Withdrawal by Subject|0|||
127704187|NCT05002088|459546740|FG000|Overall Study|Lost to Follow-up|0|||
127704188|NCT05002088|459546741|FG001|Overall Study|Lost to Follow-up|1|||
127887088|NCT01078623|460210466|FG009|Treatment Period 2|Withdrawal by Subject|0|||
127887089|NCT01078623|460210467|FG010|Treatment Period 2|Withdrawal by Subject|0|||
127704189|NCT05002088|459546740|FG000|Overall Study|Death|16|||
127704190|NCT05002088|459546741|FG001|Overall Study|Death|2|||
127641000|NCT00833638|459304707|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
127641001|NCT00833638|459304708|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
127798243|NCT03823391|459885552|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
127798244|NCT03823391|459885553|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
127798245|NCT02450487|459885554|FG000|Overall Study|Lost to Follow-up|3|||
127798246|NCT01790048|459885555|FG000|Overall Study|Incorrect Age|9|||
127798247|NCT01790048|459885556|FG001|Overall Study|Incorrect Age|14|||
127798248|NCT01790048|459885555|FG000|Overall Study|data entry error|0|||
127798249|NCT01790048|459885556|FG001|Overall Study|data entry error|1|||
127798250|NCT01790048|459885555|FG000|Overall Study|Other|0|||
127798251|NCT01790048|459885556|FG001|Overall Study|Other|2|||
127798252|NCT01790048|459885555|FG000|Overall Study|SAM at Enrollment|2|||
127798253|NCT01790048|459885556|FG001|Overall Study|SAM at Enrollment|0|||
127798254|NCT01790048|459885555|FG000|Overall Study|Measurement error|1|||
127798255|NCT01790048|459885556|FG001|Overall Study|Measurement error|0|||
127798256|NCT00159432|459885557|FG000|Overall Study|Adverse Event|1|||
127798257|NCT00159432|459885557|FG000|Overall Study|Death|1|||
127798258|NCT00159432|459885557|FG000|Overall Study|Lack of Efficacy|8|||
127798259|NCT05218499|459885560|FG000|Overall Study|Not treated|1|||
127798260|NCT05218499|459885561|FG001|Overall Study|Not treated|1|||
127798261|NCT05218499|459885562|FG002|Overall Study|Not treated|8|||
127798262|NCT05218499|459885560|FG000|Overall Study|Death|2|||
127798263|NCT05218499|459885561|FG001|Overall Study|Death|0|||
127798264|NCT05218499|459885562|FG002|Overall Study|Death|0|||
127798265|NCT05218499|459885560|FG000|Overall Study|Other than listed|3|||
127798266|NCT05218499|459885561|FG001|Overall Study|Other than listed|7|||
127798267|NCT05218499|459885562|FG002|Overall Study|Other than listed|10|||
127798268|NCT05218499|459885560|FG000|Overall Study|Protocol deviation|5|||
127798269|NCT05218499|459885561|FG001|Overall Study|Protocol deviation|6|||
127798270|NCT05218499|459885562|FG002|Overall Study|Protocol deviation|4|||
127798271|NCT05218499|459885560|FG000|Overall Study|Technical problems|0|||
127798272|NCT05218499|459885561|FG001|Overall Study|Technical problems|1|||
127798273|NCT05218499|459885562|FG002|Overall Study|Technical problems|0|||
127798274|NCT05218499|459885560|FG000|Overall Study|Burden of trial procedures|0|||
127798275|NCT05218499|459885561|FG001|Overall Study|Burden of trial procedures|1|||
127798276|NCT05218499|459885562|FG002|Overall Study|Burden of trial procedures|2|||
127798277|NCT05218499|459885560|FG000|Overall Study|Clinical disease progression|6|||
127798278|NCT05218499|459885561|FG001|Overall Study|Clinical disease progression|6|||
127798279|NCT05218499|459885562|FG002|Overall Study|Clinical disease progression|11|||
127798280|NCT05218499|459885560|FG000|Overall Study|Objective disease progression|44|||
127798281|NCT05218499|459885561|FG001|Overall Study|Objective disease progression|61|||
127798282|NCT05218499|459885562|FG002|Overall Study|Objective disease progression|42|||
127798283|NCT05218499|459885560|FG000|Overall Study|Adverse Event|11|||
127798284|NCT05218499|459885561|FG001|Overall Study|Adverse Event|36|||
127798285|NCT05218499|459885562|FG002|Overall Study|Adverse Event|9|||
127798286|NCT05218499|459885560|FG000|Overall Study|On treatment at time of snapshot|18|||
127798287|NCT05218499|459885561|FG001|Overall Study|On treatment at time of snapshot|29|||
127798288|NCT05218499|459885562|FG002|Overall Study|On treatment at time of snapshot|0|||
127798289|NCT03946670|459885563|FG000|Overall Study|Progressive Disease|26|||
127798290|NCT03946670|459885564|FG001|Overall Study|Progressive Disease|23|||
127798291|NCT03946670|459885563|FG000|Overall Study|Adverse Event|7|||
127798292|NCT03946670|459885564|FG001|Overall Study|Adverse Event|9|||
127798293|NCT03946670|459885563|FG000|Overall Study|Death|5|||
127798294|NCT03946670|459885564|FG001|Overall Study|Death|6|||
127798295|NCT03946670|459885563|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
127798296|NCT03946670|459885564|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
127798297|NCT03946670|459885563|FG000|Overall Study|Subject Decision|4|||
127798298|NCT03946670|459885564|FG001|Overall Study|Subject Decision|4|||
127798299|NCT03946670|459885563|FG000|Overall Study|Physician Decision|3|||
127798300|NCT03946670|459885564|FG001|Overall Study|Physician Decision|3|||
127798301|NCT03946670|459885563|FG000|Overall Study|New Therapy for Study Indication|1|||
127798302|NCT03946670|459885564|FG001|Overall Study|New Therapy for Study Indication|0|||
127798303|NCT03946670|459885563|FG000|Overall Study|Not treated|1|||
127798304|NCT03946670|459885564|FG001|Overall Study|Not treated|1|||
127798305|NCT03132636|459885565|FG000|Overall Study|Adverse Event|1|||
127798306|NCT03132636|459885566|FG001|Overall Study|Adverse Event|2|||
127798307|NCT03132636|459885565|FG000|Overall Study|Death|4|||
127798308|NCT03132636|459885566|FG001|Overall Study|Death|7|||
127798309|NCT03132636|459885565|FG000|Overall Study|Lost to Follow-up|3|||
127798310|NCT03132636|459885566|FG001|Overall Study|Lost to Follow-up|2|||
127798311|NCT03132636|459885565|FG000|Overall Study|Non compliance with protocol by participant|1|||
127798312|NCT03132636|459885566|FG001|Overall Study|Non compliance with protocol by participant|1|||
127798313|NCT03132636|459885565|FG000|Overall Study|Subject decision|1|||
127798314|NCT03132636|459885566|FG001|Overall Study|Subject decision|9|||
127798315|NCT03132636|459885565|FG000|Overall Study|Sponsor decision|0|||
127798316|NCT03132636|459885566|FG001|Overall Study|Sponsor decision|1|||
127798317|NCT03132636|459885565|FG000|Overall Study|Physician Decision|1|||
127798318|NCT03132636|459885566|FG001|Overall Study|Physician Decision|0|||
127641002|NCT00833638|459304709|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
127641003|NCT00833638|459304707|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
127641004|NCT00833638|459304708|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
127704191|NCT05002088|459546740|FG000|Overall Study|Protocol Violation|25|||
127704192|NCT05002088|459546741|FG001|Overall Study|Protocol Violation|7|||
127704193|NCT04068181|459546742|FG000|Overall Study|Death|17|||
127704194|NCT04068181|459546743|FG001|Overall Study|Death|12|||
127704195|NCT04068181|459546744|FG002|Overall Study|Death|4|||
127704196|NCT04068181|459546745|FG003|Overall Study|Death|7|||
127704197|NCT04068181|459546742|FG000|Overall Study|Lost to Follow-up|1|||
127704198|NCT04068181|459546743|FG001|Overall Study|Lost to Follow-up|0|||
127704199|NCT04068181|459546744|FG002|Overall Study|Lost to Follow-up|0|||
127704200|NCT04068181|459546745|FG003|Overall Study|Lost to Follow-up|0|||
127704201|NCT04068181|459546742|FG000|Overall Study|Withdrawal of consent from study|3|||
127704202|NCT04068181|459546743|FG001|Overall Study|Withdrawal of consent from study|0|||
127704203|NCT04068181|459546744|FG002|Overall Study|Withdrawal of consent from study|0|||
127704204|NCT04068181|459546745|FG003|Overall Study|Withdrawal of consent from study|0|||
127704205|NCT04909801|459546746|FG000|Overall Study|Lack of Efficacy|2|||
127704206|NCT04909801|459546747|FG001|Overall Study|Lack of Efficacy|1|||
127704207|NCT04909801|459546746|FG000|Overall Study|Adverse Event|1|||
127704208|NCT04909801|459546747|FG001|Overall Study|Adverse Event|2|||
127704209|NCT04909801|459546746|FG000|Overall Study|Participant request to discontinue study treatment|1|||
127704210|NCT04909801|459546747|FG001|Overall Study|Participant request to discontinue study treatment|2|||
127704211|NCT04909801|459546746|FG000|Overall Study|Withdrawal by Subject|2|||
127704212|NCT04909801|459546747|FG001|Overall Study|Withdrawal by Subject|1|||
127704213|NCT04909801|459546746|FG000|Overall Study|other reasons|1|||
127704214|NCT04909801|459546747|FG001|Overall Study|other reasons|1|||
127704215|NCT04515849|459546759|FG000|Overall Study|Adverse Event|0|||
127704216|NCT04515849|459546760|FG001|Overall Study|Adverse Event|0|||
127704217|NCT04515849|459546761|FG002|Overall Study|Adverse Event|0|||
127704218|NCT04515849|459546762|FG003|Overall Study|Adverse Event|1|||
127704219|NCT04515849|459546763|FG004|Overall Study|Adverse Event|2|||
127704220|NCT04515849|459546759|FG000|Overall Study|Death|2|||
127704221|NCT04515849|459546760|FG001|Overall Study|Death|0|||
127704222|NCT04515849|459546761|FG002|Overall Study|Death|0|||
127704223|NCT04515849|459546762|FG003|Overall Study|Death|0|||
127704224|NCT04515849|459546763|FG004|Overall Study|Death|0|||
127704225|NCT04515849|459546759|FG000|Overall Study|Other:family emergency|0|||
127704226|NCT04515849|459546760|FG001|Overall Study|Other:family emergency|0|||
127704227|NCT04515849|459546761|FG002|Overall Study|Other:family emergency|0|||
127704228|NCT04515849|459546762|FG003|Overall Study|Other:family emergency|1|||
127704229|NCT04515849|459546763|FG004|Overall Study|Other:family emergency|0|||
127704230|NCT04515849|459546759|FG000|Overall Study|Other:randomised by error|0|||
127704231|NCT04515849|459546760|FG001|Overall Study|Other:randomised by error|1|||
127704232|NCT04515849|459546761|FG002|Overall Study|Other:randomised by error|0|||
127704233|NCT04515849|459546762|FG003|Overall Study|Other:randomised by error|0|||
127704234|NCT04515849|459546763|FG004|Overall Study|Other:randomised by error|0|||
127704235|NCT04515849|459546759|FG000|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
127704236|NCT04515849|459546760|FG001|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
127704237|NCT04515849|459546761|FG002|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
127704238|NCT04515849|459546762|FG003|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|1|||
127704239|NCT04515849|459546763|FG004|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
127704240|NCT04515849|459546759|FG000|Overall Study|Physician Decision|0|||
127704241|NCT04515849|459546760|FG001|Overall Study|Physician Decision|1|||
127704242|NCT04515849|459546761|FG002|Overall Study|Physician Decision|0|||
127704243|NCT04515849|459546762|FG003|Overall Study|Physician Decision|0|||
127704244|NCT04515849|459546763|FG004|Overall Study|Physician Decision|0|||
127704245|NCT04515849|459546759|FG000|Overall Study|Withdrawal by Subject|1|||
127704246|NCT04515849|459546760|FG001|Overall Study|Withdrawal by Subject|2|||
127704247|NCT04515849|459546761|FG002|Overall Study|Withdrawal by Subject|1|||
127704248|NCT04515849|459546762|FG003|Overall Study|Withdrawal by Subject|0|||
127704249|NCT04515849|459546763|FG004|Overall Study|Withdrawal by Subject|0|||
127704250|NCT04577963|459546769|FG000|Part 2|Death|0|||
127704251|NCT04577963|459546770|FG001|Part 2|Death|1|||
127704252|NCT04577963|459546771|FG002|Part 2|Death|8|||
127704253|NCT04577963|459546772|FG003|Part 2|Death|0|||
127704254|NCT04577963|459546773|FG004|Part 2|Death|20|||
127704255|NCT04577963|459546769|FG000|Part 2|Lost to Follow-up|0|||
127704256|NCT04577963|459546770|FG001|Part 2|Lost to Follow-up|0|||
127704257|NCT04577963|459546771|FG002|Part 2|Lost to Follow-up|0|||
127641005|NCT00833638|459304709|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
127704258|NCT04577963|459546772|FG003|Part 2|Lost to Follow-up|0|||
127704259|NCT04577963|459546773|FG004|Part 2|Lost to Follow-up|2|||
127704260|NCT04577963|459546769|FG000|Part 2|Withdrawal by Subject|0|||
127704261|NCT04577963|459546770|FG001|Part 2|Withdrawal by Subject|0|||
127641006|NCT00833638|459304707|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
127641007|NCT00833638|459304708|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
127641008|NCT00833638|459304709|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
127641009|NCT00833638|459304707|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
127641010|NCT00833638|459304708|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
127641011|NCT00833638|459304709|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
127641012|NCT04439110|459304712|FG000|Overall Study|Ineligible|2|||
127641013|NCT04439110|459304712|FG000|Overall Study|Adverse Event|4|||
127641014|NCT04439110|459304712|FG000|Overall Study|Death|2|||
127641015|NCT04439110|459304712|FG000|Overall Study|Disease proression|25|||
127641016|NCT04439110|459304712|FG000|Overall Study|Withdrawal by Subject|1|||
127641017|NCT04439110|459304712|FG000|Overall Study|Alternative therapy|1|||
127641018|NCT04439110|459304712|FG000|Overall Study|Other complicating disease|1|||
127641019|NCT04439110|459304712|FG000|Overall Study|Personal reasons|1|||
127641020|NCT04439110|459304712|FG000|Overall Study|Still on treatment|1|||
127641021|NCT05245864|459304713|FG000|Overall Study|Withdrawal by Subject|1|||
127641022|NCT05245864|459304714|FG001|Overall Study|Withdrawal by Subject|1|||
127641023|NCT02119260|459306078|FG000|Overall Study|Adverse Event|1|||
127641024|NCT02119260|459306079|FG001|Overall Study|Adverse Event|0|||
127641025|NCT02119260|459306080|FG002|Overall Study|Adverse Event|0|||
127641026|NCT02119260|459306081|FG003|Overall Study|Adverse Event|0|||
127641027|NCT02119260|459306082|FG004|Overall Study|Adverse Event|0|||
127641028|NCT02119260|459306083|FG005|Overall Study|Adverse Event|0|||
127641029|NCT02119260|459306084|FG006|Overall Study|Adverse Event|0|||
127641030|NCT02119260|459306078|FG000|Overall Study|Withdrew consent|0|||
127704262|NCT04577963|459546771|FG002|Part 2|Withdrawal by Subject|0|||
127704263|NCT04577963|459546772|FG003|Part 2|Withdrawal by Subject|0|||
127704264|NCT04577963|459546773|FG004|Part 2|Withdrawal by Subject|10|||
127704265|NCT04577963|459546769|FG000|Part 2|Progressive disease|0|||
127704266|NCT04577963|459546770|FG001|Part 2|Progressive disease|0|||
127704267|NCT04577963|459546771|FG002|Part 2|Progressive disease|0|||
127704268|NCT04577963|459546772|FG003|Part 2|Progressive disease|0|||
127704269|NCT04577963|459546773|FG004|Part 2|Progressive disease|2|||
127704270|NCT04577963|459546769|FG000|Part 2|Investigator decision|0|||
127704271|NCT04577963|459546770|FG001|Part 2|Investigator decision|0|||
127704272|NCT04577963|459546771|FG002|Part 2|Investigator decision|0|||
127704273|NCT04577963|459546772|FG003|Part 2|Investigator decision|0|||
127704274|NCT04577963|459546773|FG004|Part 2|Investigator decision|1|||
127704275|NCT04577963|459546769|FG000|Part 2|Sponsor terminated study|0|||
127704276|NCT04577963|459546770|FG001|Part 2|Sponsor terminated study|0|||
127704277|NCT04577963|459546771|FG002|Part 2|Sponsor terminated study|3|||
127704278|NCT04577963|459546772|FG003|Part 2|Sponsor terminated study|1|||
127704279|NCT04577963|459546773|FG004|Part 2|Sponsor terminated study|4|||
127704280|NCT03257410|459548768|FG000|Overall Study|Adverse Event|2|||
127704281|NCT03257410|459548769|FG001|Overall Study|Adverse Event|3|||
127704282|NCT03257410|459548768|FG000|Overall Study|Protocol Violation|1|||
127704283|NCT03257410|459548769|FG001|Overall Study|Protocol Violation|2|||
127704284|NCT03257410|459548768|FG000|Overall Study|Lost to Follow-up|1|||
127704285|NCT03257410|459548769|FG001|Overall Study|Lost to Follow-up|0|||
127704286|NCT03257410|459548768|FG000|Overall Study|Withdrawal by Subject|1|||
127704287|NCT03257410|459548769|FG001|Overall Study|Withdrawal by Subject|2|||
127704288|NCT03257410|459548768|FG000|Overall Study|Physician Decision|1|||
127704289|NCT03257410|459548769|FG001|Overall Study|Physician Decision|1|||
127704290|NCT03257410|459548768|FG000|Overall Study|Renal transplantation|2|||
127704291|NCT03257410|459548769|FG001|Overall Study|Renal transplantation|0|||
127704292|NCT03257410|459548768|FG000|Overall Study|Switch to peritoneal dialysis|1|||
127704293|NCT03257410|459548769|FG001|Overall Study|Switch to peritoneal dialysis|0|||
127704294|NCT03257410|459548768|FG000|Overall Study|Death|3|||
127704295|NCT03257410|459548769|FG001|Overall Study|Death|2|||
127704296|NCT03257410|459548768|FG000|Overall Study|Change to another dialysis center|2|||
127704297|NCT03257410|459548769|FG001|Overall Study|Change to another dialysis center|2|||
127704298|NCT03257410|459548768|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
127704299|NCT03257410|459548769|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
127704300|NCT03257410|459548768|FG000|Overall Study|Miscellaneous|2|||
127704301|NCT03257410|459548769|FG001|Overall Study|Miscellaneous|2|||
127704302|NCT03257410|459548768|FG000|Overall Study|Other|0|||
127704303|NCT03257410|459548769|FG001|Overall Study|Other|1|||
127704304|NCT02561247|459548770|FG000|Overall Study|Protocol Violation|1|||
127704305|NCT02561247|459548770|FG000|Overall Study|Withdrawal by Subject|1|||
127704306|NCT02561247|459548770|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
127704307|NCT04231149|459548771|FG000|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
127704308|NCT04231149|459548772|FG001|Washout (Minimum 5 Days)|Withdrawal by Subject|1|||
127704309|NCT04231149|459548773|FG002|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
127704310|NCT04231149|459548774|FG003|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
127704311|NCT04231149|459548775|FG004|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
127704312|NCT04298983|459548777|FG000|Overall Study|Adverse Event|4|||
127704313|NCT04298983|459548777|FG000|Overall Study|Lack of Efficacy|3|||
127798319|NCT03132636|459885565|FG000|Overall Study|Progressive disease|33|||
127798320|NCT03132636|459885566|FG001|Overall Study|Progressive disease|36|||
127704314|NCT02116530|459548778|FG000|Overall Study|Withdrawal by Subject|1|||
127704315|NCT02116530|459548779|FG001|Overall Study|Withdrawal by Subject|2|||
127704316|NCT02116530|459548778|FG000|Overall Study|Adverse Event|4|||
127704317|NCT02116530|459548779|FG001|Overall Study|Adverse Event|0|||
127704318|NCT02116530|459548778|FG000|Overall Study|Physician Decision|1|||
127704319|NCT02116530|459548779|FG001|Overall Study|Physician Decision|0|||
127704320|NCT02116530|459548778|FG000|Overall Study|Lost to Follow-up|1|||
127704321|NCT02116530|459548779|FG001|Overall Study|Lost to Follow-up|0|||
127704322|NCT02116530|459548778|FG000|Overall Study|Other Medical Problems|2|||
127704323|NCT02116530|459548779|FG001|Overall Study|Other Medical Problems|2|||
127704324|NCT03656510|459548781|FG000|Overall Study|Lost to Follow-up|1|||
127704325|NCT03656510|459548782|FG001|Overall Study|Lost to Follow-up|0|||
127704326|NCT03656510|459548783|FG002|Overall Study|Lost to Follow-up|0|||
127704327|NCT03656510|459548784|FG003|Overall Study|Lost to Follow-up|0|||
127704328|NCT03656510|459548785|FG004|Overall Study|Lost to Follow-up|0|||
127704329|NCT03656510|459548786|FG005|Overall Study|Lost to Follow-up|0|||
127704330|NCT03656510|459548781|FG000|Overall Study|Withdrawal by Subject|1|||
127704331|NCT03656510|459548782|FG001|Overall Study|Withdrawal by Subject|1|||
127704332|NCT03656510|459548783|FG002|Overall Study|Withdrawal by Subject|0|||
127704333|NCT03656510|459548784|FG003|Overall Study|Withdrawal by Subject|1|||
127704334|NCT03656510|459548785|FG004|Overall Study|Withdrawal by Subject|0|||
127704335|NCT03656510|459548786|FG005|Overall Study|Withdrawal by Subject|0|||
127704336|NCT05671653|459548787|FG000|Cohort 1 Period 6 - Treatment|Other|0|||
127704337|NCT05671653|459548788|FG001|Cohort 1 Period 6 - Treatment|Other|0|||
127704338|NCT05671653|459548789|FG002|Cohort 1 Period 6 - Treatment|Other|0|||
127704339|NCT05671653|459548790|FG003|Cohort 1 Period 6 - Treatment|Other|0|||
127704340|NCT05671653|459548791|FG004|Cohort 1 Period 6 - Treatment|Other|0|||
127704341|NCT05671653|459548792|FG005|Cohort 1 Period 6 - Treatment|Other|1|||
127704342|NCT05671653|459548793|FG006|Cohort 1 Period 6 - Treatment|Other|0|||
127704343|NCT05671653|459548794|FG007|Cohort 1 Period 6 - Treatment|Other|0|||
127704344|NCT05671653|459548795|FG008|Cohort 1 Period 6 - Treatment|Other|0|||
127704345|NCT05671653|459548796|FG009|Cohort 1 Period 6 - Treatment|Other|0|||
127704346|NCT05671653|459548797|FG010|Cohort 1 Period 6 - Treatment|Other|0|||
127704347|NCT05671653|459548798|FG011|Cohort 1 Period 6 - Treatment|Other|0|||
127704348|NCT05671653|459548799|FG012|Cohort 1 Period 6 - Treatment|Other|0|||
127704349|NCT05671653|459548787|FG000|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
127704350|NCT05671653|459548788|FG001|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
127704351|NCT05671653|459548789|FG002|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
127704352|NCT05671653|459548790|FG003|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
127704353|NCT05671653|459548791|FG004|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
127704354|NCT05671653|459548792|FG005|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|5|||
127704355|NCT05671653|459548793|FG006|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
127704356|NCT05671653|459548794|FG007|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
127704357|NCT05671653|459548795|FG008|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
127704358|NCT05671653|459548796|FG009|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
127704359|NCT05671653|459548797|FG010|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
127704360|NCT05671653|459548798|FG011|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
127704361|NCT05671653|459548799|FG012|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
127704362|NCT05671653|459548787|FG000|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
127704363|NCT05671653|459548788|FG001|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
127704364|NCT05671653|459548789|FG002|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
127704365|NCT05671653|459548790|FG003|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
127704366|NCT05671653|459548791|FG004|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
127704367|NCT05671653|459548792|FG005|Cohort 1 Period 6 - Treatment|Adverse Event|2|||
127704368|NCT05671653|459548793|FG006|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
127704369|NCT05671653|459548794|FG007|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
127704370|NCT05671653|459548795|FG008|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
127704371|NCT05671653|459548796|FG009|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
127704372|NCT05671653|459548797|FG010|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
127704373|NCT05671653|459548798|FG011|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
127704374|NCT05671653|459548799|FG012|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
127704375|NCT05671653|459548787|FG000|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
127704376|NCT05671653|459548788|FG001|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
127704377|NCT05671653|459548789|FG002|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
127704378|NCT05671653|459548790|FG003|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
127704379|NCT05671653|459548791|FG004|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
127704380|NCT05671653|459548792|FG005|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
127704381|NCT05671653|459548793|FG006|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
127704382|NCT05671653|459548794|FG007|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
127704383|NCT05671653|459548795|FG008|Cohort 1 Period 9 - Treatment|Adverse Event|1|||
127704384|NCT05671653|459548796|FG009|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
127704385|NCT05671653|459548797|FG010|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
127704386|NCT05671653|459548798|FG011|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
127704387|NCT05671653|459548799|FG012|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
127704388|NCT05671653|459548787|FG000|Cohort 2 Period 2|Adverse Event|0|||
127704389|NCT05671653|459548788|FG001|Cohort 2 Period 2|Adverse Event|0|||
127704390|NCT05671653|459548789|FG002|Cohort 2 Period 2|Adverse Event|0|||
127704391|NCT05671653|459548790|FG003|Cohort 2 Period 2|Adverse Event|0|||
127704392|NCT05671653|459548791|FG004|Cohort 2 Period 2|Adverse Event|0|||
127704393|NCT05671653|459548792|FG005|Cohort 2 Period 2|Adverse Event|0|||
127704394|NCT05671653|459548793|FG006|Cohort 2 Period 2|Adverse Event|0|||
127704395|NCT05671653|459548794|FG007|Cohort 2 Period 2|Adverse Event|0|||
127704396|NCT05671653|459548795|FG008|Cohort 2 Period 2|Adverse Event|0|||
127704397|NCT05671653|459548796|FG009|Cohort 2 Period 2|Adverse Event|0|||
127704398|NCT05671653|459548797|FG010|Cohort 2 Period 2|Adverse Event|1|||
127704399|NCT05671653|459548798|FG011|Cohort 2 Period 2|Adverse Event|0|||
127704400|NCT05671653|459548799|FG012|Cohort 2 Period 2|Adverse Event|0|||
127704401|NCT05671653|459548787|FG000|Cohort 2 Period 2|Lost to Follow-up|0|||
127704402|NCT05671653|459548788|FG001|Cohort 2 Period 2|Lost to Follow-up|0|||
127704403|NCT05671653|459548789|FG002|Cohort 2 Period 2|Lost to Follow-up|0|||
127704404|NCT05671653|459548790|FG003|Cohort 2 Period 2|Lost to Follow-up|0|||
127704405|NCT05671653|459548791|FG004|Cohort 2 Period 2|Lost to Follow-up|0|||
127704406|NCT05671653|459548792|FG005|Cohort 2 Period 2|Lost to Follow-up|0|||
127704407|NCT05671653|459548793|FG006|Cohort 2 Period 2|Lost to Follow-up|0|||
127704408|NCT05671653|459548794|FG007|Cohort 2 Period 2|Lost to Follow-up|0|||
127704409|NCT05671653|459548795|FG008|Cohort 2 Period 2|Lost to Follow-up|0|||
127704410|NCT05671653|459548796|FG009|Cohort 2 Period 2|Lost to Follow-up|0|||
127704411|NCT05671653|459548797|FG010|Cohort 2 Period 2|Lost to Follow-up|1|||
127704412|NCT05671653|459548798|FG011|Cohort 2 Period 2|Lost to Follow-up|0|||
127704413|NCT05671653|459548799|FG012|Cohort 2 Period 2|Lost to Follow-up|0|||
127704414|NCT05671653|459548787|FG000|Cohort 2 Period 2|Pregnancy|0|||
127704415|NCT05671653|459548788|FG001|Cohort 2 Period 2|Pregnancy|0|||
127887090|NCT01078623|460210468|FG011|Treatment Period 2|Withdrawal by Subject|0|||
127887091|NCT01078623|460210469|FG012|Treatment Period 2|Withdrawal by Subject|0|||
127887092|NCT01078623|460210470|FG013|Treatment Period 2|Withdrawal by Subject|0|||
127887093|NCT01078623|460210471|FG014|Treatment Period 2|Withdrawal by Subject|0|||
127887094|NCT01078623|460210472|FG015|Treatment Period 2|Withdrawal by Subject|0|||
127887095|NCT01078623|460210473|FG016|Treatment Period 2|Withdrawal by Subject|0|||
127887096|NCT01078623|460210474|FG017|Treatment Period 2|Withdrawal by Subject|0|||
127887097|NCT01078623|460210475|FG018|Treatment Period 2|Withdrawal by Subject|0|||
127704416|NCT05671653|459548789|FG002|Cohort 2 Period 2|Pregnancy|0|||
127704417|NCT05671653|459548790|FG003|Cohort 2 Period 2|Pregnancy|0|||
127704418|NCT05671653|459548791|FG004|Cohort 2 Period 2|Pregnancy|0|||
127704419|NCT05671653|459548792|FG005|Cohort 2 Period 2|Pregnancy|0|||
127704420|NCT05671653|459548793|FG006|Cohort 2 Period 2|Pregnancy|0|||
127704421|NCT05671653|459548794|FG007|Cohort 2 Period 2|Pregnancy|0|||
127704422|NCT05671653|459548795|FG008|Cohort 2 Period 2|Pregnancy|0|||
127704423|NCT05671653|459548796|FG009|Cohort 2 Period 2|Pregnancy|0|||
127704424|NCT05671653|459548797|FG010|Cohort 2 Period 2|Pregnancy|1|||
127704425|NCT05671653|459548798|FG011|Cohort 2 Period 2|Pregnancy|0|||
127704426|NCT05671653|459548799|FG012|Cohort 2 Period 2|Pregnancy|0|||
127704427|NCT05671653|459548787|FG000|Cohort 2 Period 2|Withdrawal by Subject|0|||
127704428|NCT05671653|459548788|FG001|Cohort 2 Period 2|Withdrawal by Subject|0|||
127704429|NCT05671653|459548789|FG002|Cohort 2 Period 2|Withdrawal by Subject|0|||
127704430|NCT05671653|459548790|FG003|Cohort 2 Period 2|Withdrawal by Subject|0|||
127704431|NCT05671653|459548791|FG004|Cohort 2 Period 2|Withdrawal by Subject|0|||
127704432|NCT05671653|459548792|FG005|Cohort 2 Period 2|Withdrawal by Subject|0|||
127704433|NCT05671653|459548793|FG006|Cohort 2 Period 2|Withdrawal by Subject|0|||
127704434|NCT05671653|459548794|FG007|Cohort 2 Period 2|Withdrawal by Subject|0|||
127704435|NCT05671653|459548795|FG008|Cohort 2 Period 2|Withdrawal by Subject|0|||
127704436|NCT05671653|459548796|FG009|Cohort 2 Period 2|Withdrawal by Subject|0|||
127704437|NCT05671653|459548797|FG010|Cohort 2 Period 2|Withdrawal by Subject|1|||
127704438|NCT05671653|459548798|FG011|Cohort 2 Period 2|Withdrawal by Subject|0|||
127704439|NCT05671653|459548799|FG012|Cohort 2 Period 2|Withdrawal by Subject|0|||
127704440|NCT05671653|459548787|FG000|Cohort 2 Period 2|Other|0|||
127887098|NCT01078623|460210476|FG019|Treatment Period 2|Withdrawal by Subject|0|||
127887099|NCT01078623|460210457|FG000|Treatment Period 3|Adverse Event|0|||
127887100|NCT01078623|460210458|FG001|Treatment Period 3|Adverse Event|0|||
127887101|NCT01078623|460210459|FG002|Treatment Period 3|Adverse Event|0|||
127887102|NCT01078623|460210460|FG003|Treatment Period 3|Adverse Event|0|||
127704441|NCT05671653|459548788|FG001|Cohort 2 Period 2|Other|0|||
127704442|NCT05671653|459548789|FG002|Cohort 2 Period 2|Other|0|||
127704443|NCT05671653|459548790|FG003|Cohort 2 Period 2|Other|0|||
127704444|NCT05671653|459548791|FG004|Cohort 2 Period 2|Other|0|||
127887103|NCT01078623|460210461|FG004|Treatment Period 3|Adverse Event|1|||
127887104|NCT01078623|460210462|FG005|Treatment Period 3|Adverse Event|0|||
127887105|NCT01078623|460210463|FG006|Treatment Period 3|Adverse Event|0|||
127887106|NCT01078623|460210464|FG007|Treatment Period 3|Adverse Event|0|||
127887107|NCT01078623|460210465|FG008|Treatment Period 3|Adverse Event|0|||
127704445|NCT05671653|459548792|FG005|Cohort 2 Period 2|Other|0|||
127704446|NCT05671653|459548793|FG006|Cohort 2 Period 2|Other|0|||
127704447|NCT05671653|459548794|FG007|Cohort 2 Period 2|Other|0|||
127704448|NCT05671653|459548795|FG008|Cohort 2 Period 2|Other|0|||
127704449|NCT05671653|459548796|FG009|Cohort 2 Period 2|Other|0|||
127704450|NCT05671653|459548797|FG010|Cohort 2 Period 2|Other|1|||
127704451|NCT05671653|459548798|FG011|Cohort 2 Period 2|Other|0|||
127704452|NCT05671653|459548799|FG012|Cohort 2 Period 2|Other|0|||
127704453|NCT05671653|459548787|FG000|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
127704454|NCT05671653|459548788|FG001|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
127704455|NCT05671653|459548789|FG002|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
127704456|NCT05671653|459548790|FG003|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
127704457|NCT05671653|459548791|FG004|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
127704458|NCT05671653|459548792|FG005|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
127704459|NCT05671653|459548793|FG006|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
127704460|NCT05671653|459548794|FG007|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
127704461|NCT05671653|459548795|FG008|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
127704462|NCT05671653|459548796|FG009|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
127704463|NCT05671653|459548797|FG010|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
127704464|NCT05671653|459548798|FG011|Cohort 2 Period 3 - Treatment|Adverse Event|1|||
127704465|NCT05671653|459548799|FG012|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
127704466|NCT02305888|459548800|FG000|Overall Study|Lost to Follow-up|0|||
127704467|NCT02305888|459548801|FG001|Overall Study|Lost to Follow-up|0|||
127704468|NCT02305888|459548802|FG002|Overall Study|Lost to Follow-up|1|||
127704469|NCT02305888|459548800|FG000|Overall Study|Adverse Event|0|||
127704470|NCT02305888|459548801|FG001|Overall Study|Adverse Event|1|||
127704471|NCT02305888|459548802|FG002|Overall Study|Adverse Event|0|||
127704472|NCT06232590|459548803|FG000|Period 2: Second Intervention|Unable to attend study visit|1|||
127704473|NCT06232590|459548804|FG001|Period 2: Second Intervention|Unable to attend study visit|0|||
127704474|NCT04914676|459548805|FG000|Overall Study|Study termination|3|||
127704475|NCT04914676|459548806|FG001|Overall Study|Study termination|0|||
127704476|NCT05436262|459548808|FG000|Pre-Randomization|Withdrawal by Subject|1|||
127704477|NCT05436262|459548809|FG001|Pre-Randomization|Withdrawal by Subject|0|||
127704478|NCT05436262|459548810|FG002|Pre-Randomization|Withdrawal by Subject|0|||
127704479|NCT05436262|459548808|FG000|Randomization|Withdrawal by Subject|0|||
127704480|NCT05436262|459548809|FG001|Randomization|Withdrawal by Subject|1|||
127704481|NCT05436262|459548810|FG002|Randomization|Withdrawal by Subject|0|||
127704482|NCT05299073|459548811|FG000|Overall Study|Withdrawal by Subject|0|||
127704483|NCT05299073|459548812|FG001|Overall Study|Withdrawal by Subject|0|||
127704484|NCT05299073|459548813|FG002|Overall Study|Withdrawal by Subject|1|||
127704485|NCT05299073|459548811|FG000|Overall Study|Adverse Event|0|||
127704486|NCT05299073|459548812|FG001|Overall Study|Adverse Event|1|||
127704487|NCT05299073|459548813|FG002|Overall Study|Adverse Event|0|||
127704488|NCT05299073|459548811|FG000|Overall Study|Lost to Follow-up|0|||
127704489|NCT05299073|459548812|FG001|Overall Study|Lost to Follow-up|1|||
127704490|NCT05299073|459548813|FG002|Overall Study|Lost to Follow-up|0|||
127704491|NCT04850898|459548814|FG000|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
127704492|NCT04850898|459548815|FG001|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
127704493|NCT04770402|459548822|FG000|Overall Study|Lost to Follow-up|1|||
127704494|NCT04770402|459548823|FG001|Overall Study|Lost to Follow-up|2|||
127704495|NCT04770402|459548822|FG000|Overall Study|Non-compliance|1|||
127704496|NCT04770402|459548823|FG001|Overall Study|Non-compliance|0|||
127704497|NCT04770402|459548822|FG000|Overall Study|Withdrawal by Subject|0|||
127704498|NCT04770402|459548823|FG001|Overall Study|Withdrawal by Subject|1|||
127704499|NCT03599661|459548825|FG000|Overall Study|Lost to Follow-up|9|||
127704500|NCT04550221|459548828|FG000|Overall Study|Lost to Follow-up|0|||
127704501|NCT04550221|459548829|FG001|Overall Study|Lost to Follow-up|4|||
127704502|NCT04550221|459548828|FG000|Overall Study|Withdrawn|3|||
127704503|NCT04550221|459548829|FG001|Overall Study|Withdrawn|0|||
127704504|NCT04550221|459548828|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
127704505|NCT04550221|459548829|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
127704506|NCT04811040|459548830|FG000|Overall Study|Lost to Follow-up|2|||
127704507|NCT04811040|459548831|FG001|Overall Study|Lost to Follow-up|0|||
127704508|NCT04811040|459548832|FG002|Overall Study|Lost to Follow-up|0|||
127704509|NCT04811040|459548833|FG003|Overall Study|Lost to Follow-up|0|||
127704510|NCT04811040|459548830|FG000|Overall Study|Withdrew consent|1|||
127887108|NCT01078623|460210466|FG009|Treatment Period 3|Adverse Event|0|||
127704511|NCT04811040|459548831|FG001|Overall Study|Withdrew consent|1|||
127704512|NCT04811040|459548832|FG002|Overall Study|Withdrew consent|0|||
127704513|NCT04811040|459548833|FG003|Overall Study|Withdrew consent|0|||
127704514|NCT05274074|459548834|FG000|Overall Study|Lost to Follow-up|2|||
127704515|NCT05274074|459548835|FG001|Overall Study|Lost to Follow-up|3|||
127704516|NCT05274074|459548834|FG000|Overall Study|Withdrawal by Subject|1|||
127704517|NCT05274074|459548835|FG001|Overall Study|Withdrawal by Subject|2|||
127704518|NCT01828099|459548837|FG000|Treatment Period|Adverse Event|24|||
127704519|NCT01828099|459548838|FG001|Treatment Period|Adverse Event|23|||
127704520|NCT01828099|459548837|FG000|Treatment Period|Death|10|||
127704521|NCT01828099|459548838|FG001|Treatment Period|Death|12|||
127704522|NCT01828099|459548837|FG000|Treatment Period|Lost to Follow-up|2|||
127704523|NCT01828099|459548838|FG001|Treatment Period|Lost to Follow-up|1|||
127704524|NCT01828099|459548837|FG000|Treatment Period|Non-compliance with study treatment|1|||
127887109|NCT01078623|460210467|FG010|Treatment Period 3|Adverse Event|0|||
127704525|NCT01828099|459548838|FG001|Treatment Period|Non-compliance with study treatment|0|||
127704526|NCT01828099|459548837|FG000|Treatment Period|Physician Decision|17|||
127704527|NCT01828099|459548838|FG001|Treatment Period|Physician Decision|16|||
127704528|NCT01828099|459548837|FG000|Treatment Period|Progressive disease|99|||
127704529|NCT01828099|459548838|FG001|Treatment Period|Progressive disease|107|||
127704530|NCT01828099|459548837|FG000|Treatment Period|Subject/guardian decision|22|||
127704531|NCT01828099|459548838|FG001|Treatment Period|Subject/guardian decision|26|||
127704532|NCT01828099|459548837|FG000|Treatment Period|Study terminated by Sponsor|13|||
127704533|NCT01828099|459548838|FG001|Treatment Period|Study terminated by Sponsor|1|||
127704534|NCT01828099|459548837|FG000|Treatment Period|Protocol deviation|1|||
127704535|NCT01828099|459548838|FG001|Treatment Period|Protocol deviation|0|||
127704536|NCT01828099|459548837|FG000|Treatment Period|No longer requires treatment|0|||
127704537|NCT01828099|459548838|FG001|Treatment Period|No longer requires treatment|1|||
127704538|NCT01828099|459548837|FG000|Extension-treatment Phase|Adverse Event|0|||
127704539|NCT01828099|459548838|FG001|Extension-treatment Phase|Adverse Event|17|||
127704540|NCT01828099|459548837|FG000|Extension-treatment Phase|Death|0|||
127704541|NCT01828099|459548838|FG001|Extension-treatment Phase|Death|11|||
127704542|NCT01828099|459548837|FG000|Extension-treatment Phase|Physician Decision|0|||
127704543|NCT01828099|459548838|FG001|Extension-treatment Phase|Physician Decision|5|||
127704544|NCT01828099|459548837|FG000|Extension-treatment Phase|Progressive disease|0|||
127704545|NCT01828099|459548838|FG001|Extension-treatment Phase|Progressive disease|54|||
127704546|NCT01828099|459548837|FG000|Extension-treatment Phase|Study terminated by sponsor|0|||
127704547|NCT01828099|459548838|FG001|Extension-treatment Phase|Study terminated by sponsor|5|||
127704548|NCT01828099|459548837|FG000|Extension-treatment Phase|Subject/guardian decision|0|||
127704549|NCT01828099|459548838|FG001|Extension-treatment Phase|Subject/guardian decision|10|||
127704550|NCT04362254|459548845|FG000|Overall Study|Adverse Event|1|||
127704551|NCT04362254|459548845|FG000|Overall Study|Protocol Violation|1|||
127704552|NCT04362254|459548845|FG000|Overall Study|Due to early termination of the trial|10|||
127704553|NCT04568434|459548848|FG000|Overall Study|Voluntary Withdrawal|0|||
127704554|NCT04568434|459548849|FG001|Overall Study|Voluntary Withdrawal|1|||
127704555|NCT04568434|459548850|FG002|Overall Study|Voluntary Withdrawal|1|||
127704556|NCT04568434|459548848|FG000|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|0|||
127704557|NCT04568434|459548849|FG001|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|1|||
127798321|NCT03132636|459885565|FG000|Overall Study|Withdrawal of consent|2|||
127798322|NCT03132636|459885566|FG001|Overall Study|Withdrawal of consent|5|||
127798323|NCT03132636|459885565|FG000|Overall Study|Did not re-consent|1|||
127798324|NCT03132636|459885566|FG001|Overall Study|Did not re-consent|0|||
127798325|NCT03132636|459885565|FG000|Overall Study|Lost insurance coverage|1|||
127798326|NCT03132636|459885566|FG001|Overall Study|Lost insurance coverage|0|||
127798327|NCT03132636|459885565|FG000|Overall Study|Related to radiological outcomes|0|||
127798328|NCT03132636|459885566|FG001|Overall Study|Related to radiological outcomes|1|||
127798329|NCT03132636|459885565|FG000|Overall Study|Unable to come to site for continued visits|0|||
127798330|NCT03132636|459885566|FG001|Overall Study|Unable to come to site for continued visits|1|||
127798331|NCT04537208|459885571|FG000|Overall Study|Adverse Event|0|||
127798332|NCT04537208|459885572|FG001|Overall Study|Adverse Event|0|||
127704558|NCT04568434|459548850|FG002|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|2|||
127704559|NCT04568434|459548848|FG000|Overall Study|Investigator Judgement|1|||
127704560|NCT04568434|459548849|FG001|Overall Study|Investigator Judgement|0|||
127704561|NCT04568434|459548850|FG002|Overall Study|Investigator Judgement|0|||
127704562|NCT05469464|459548851|FG000|Overall Study|Withdrawal by Subject|8|||
127704563|NCT05469464|459548852|FG001|Overall Study|Withdrawal by Subject|7|||
127704564|NCT05469464|459548853|FG002|Overall Study|Withdrawal by Subject|4|||
127704565|NCT05469464|459548854|FG003|Overall Study|Withdrawal by Subject|5|||
127887110|NCT01078623|460210468|FG011|Treatment Period 3|Adverse Event|0|||
127887111|NCT01078623|460210469|FG012|Treatment Period 3|Adverse Event|0|||
127704566|NCT05469464|459548851|FG000|Overall Study|Adverse Event|8|||
127704567|NCT05469464|459548852|FG001|Overall Study|Adverse Event|14|||
127704568|NCT05469464|459548853|FG002|Overall Study|Adverse Event|13|||
127704569|NCT05469464|459548854|FG003|Overall Study|Adverse Event|2|||
127704570|NCT05469464|459548851|FG000|Overall Study|Lost to Follow-up|2|||
127704571|NCT05469464|459548852|FG001|Overall Study|Lost to Follow-up|5|||
127704572|NCT05469464|459548853|FG002|Overall Study|Lost to Follow-up|3|||
127887112|NCT01078623|460210470|FG013|Treatment Period 3|Adverse Event|1|||
127887113|NCT01078623|460210471|FG014|Treatment Period 3|Adverse Event|0|||
127887114|NCT01078623|460210472|FG015|Treatment Period 3|Adverse Event|0|||
127887115|NCT01078623|460210473|FG016|Treatment Period 3|Adverse Event|0|||
127887116|NCT01078623|460210474|FG017|Treatment Period 3|Adverse Event|0|||
127887117|NCT01078623|460210475|FG018|Treatment Period 3|Adverse Event|0|||
127887118|NCT01078623|460210476|FG019|Treatment Period 3|Adverse Event|0|||
127887119|NCT01078623|460210457|FG000|Treatment Period 4|Adverse Event|0|||
127887120|NCT01078623|460210458|FG001|Treatment Period 4|Adverse Event|0|||
127887121|NCT01078623|460210459|FG002|Treatment Period 4|Adverse Event|1|||
127887122|NCT01078623|460210460|FG003|Treatment Period 4|Adverse Event|0|||
127887123|NCT01078623|460210461|FG004|Treatment Period 4|Adverse Event|0|||
127887124|NCT01078623|460210462|FG005|Treatment Period 4|Adverse Event|0|||
127887125|NCT01078623|460210463|FG006|Treatment Period 4|Adverse Event|0|||
127887126|NCT01078623|460210464|FG007|Treatment Period 4|Adverse Event|0|||
127887127|NCT01078623|460210465|FG008|Treatment Period 4|Adverse Event|0|||
127887128|NCT01078623|460210466|FG009|Treatment Period 4|Adverse Event|0|||
127887129|NCT01078623|460210467|FG010|Treatment Period 4|Adverse Event|0|||
127887130|NCT01078623|460210468|FG011|Treatment Period 4|Adverse Event|0|||
127887131|NCT01078623|460210469|FG012|Treatment Period 4|Adverse Event|0|||
127887132|NCT01078623|460210470|FG013|Treatment Period 4|Adverse Event|0|||
127887133|NCT01078623|460210471|FG014|Treatment Period 4|Adverse Event|0|||
127887134|NCT01078623|460210472|FG015|Treatment Period 4|Adverse Event|0|||
127887135|NCT01078623|460210473|FG016|Treatment Period 4|Adverse Event|0|||
127887136|NCT01078623|460210474|FG017|Treatment Period 4|Adverse Event|0|||
127887137|NCT01078623|460210475|FG018|Treatment Period 4|Adverse Event|0|||
127887138|NCT01078623|460210476|FG019|Treatment Period 4|Adverse Event|0|||
127887139|NCT01078623|460210457|FG000|Treatment Period 4|Withdrawal by Subject|0|||
127887140|NCT01078623|460210458|FG001|Treatment Period 4|Withdrawal by Subject|0|||
127887141|NCT01078623|460210459|FG002|Treatment Period 4|Withdrawal by Subject|0|||
127887142|NCT01078623|460210460|FG003|Treatment Period 4|Withdrawal by Subject|0|||
127887143|NCT01078623|460210461|FG004|Treatment Period 4|Withdrawal by Subject|0|||
127887144|NCT01078623|460210462|FG005|Treatment Period 4|Withdrawal by Subject|0|||
127887145|NCT01078623|460210463|FG006|Treatment Period 4|Withdrawal by Subject|0|||
127887146|NCT01078623|460210464|FG007|Treatment Period 4|Withdrawal by Subject|0|||
127887147|NCT01078623|460210465|FG008|Treatment Period 4|Withdrawal by Subject|0|||
127887148|NCT01078623|460210466|FG009|Treatment Period 4|Withdrawal by Subject|0|||
127887149|NCT01078623|460210467|FG010|Treatment Period 4|Withdrawal by Subject|0|||
127887150|NCT01078623|460210468|FG011|Treatment Period 4|Withdrawal by Subject|0|||
127887151|NCT01078623|460210469|FG012|Treatment Period 4|Withdrawal by Subject|0|||
127887152|NCT01078623|460210470|FG013|Treatment Period 4|Withdrawal by Subject|0|||
127887153|NCT01078623|460210471|FG014|Treatment Period 4|Withdrawal by Subject|0|||
127887154|NCT01078623|460210472|FG015|Treatment Period 4|Withdrawal by Subject|1|||
127887155|NCT01078623|460210473|FG016|Treatment Period 4|Withdrawal by Subject|0|||
127887156|NCT01078623|460210474|FG017|Treatment Period 4|Withdrawal by Subject|0|||
127887157|NCT01078623|460210475|FG018|Treatment Period 4|Withdrawal by Subject|0|||
127887158|NCT01078623|460210476|FG019|Treatment Period 4|Withdrawal by Subject|0|||
127887159|NCT00463866|460210477|FG000|Overall Study|Adverse Event|70|||
127887160|NCT00463866|460210478|FG001|Overall Study|Adverse Event|93|||
127887161|NCT00463866|460210477|FG000|Overall Study|Withdrawal by Subject|81|||
127887162|NCT00463866|460210478|FG001|Overall Study|Withdrawal by Subject|79|||
127887163|NCT00463866|460210477|FG000|Overall Study|Lost to Follow-up|46|||
127887164|NCT00463866|460210478|FG001|Overall Study|Lost to Follow-up|55|||
127887165|NCT00463866|460210477|FG000|Overall Study|Incorrect Enrolment|64|||
127887166|NCT00463866|460210478|FG001|Overall Study|Incorrect Enrolment|66|||
127887167|NCT00463866|460210477|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
127887168|NCT00463866|460210478|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
127887169|NCT00463866|460210477|FG000|Overall Study|Safety Reason|1|||
127887170|NCT00463866|460210478|FG001|Overall Study|Safety Reason|3|||
127887171|NCT00463866|460210477|FG000|Overall Study|Mis-Randomization of subject|0|||
127887172|NCT00463866|460210478|FG001|Overall Study|Mis-Randomization of subject|1|||
127887173|NCT00463866|460210477|FG000|Overall Study|Other|22|||
127887174|NCT00463866|460210478|FG001|Overall Study|Other|22|||
127887175|NCT02265952|460210480|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
127887176|NCT02265952|460210481|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
127887177|NCT02265952|460210480|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
127887178|NCT02265952|460210481|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
127887179|NCT01042977|460210482|FG000|Overall Study|Adverse Event|4|||
127887180|NCT01042977|460210483|FG001|Overall Study|Adverse Event|12|||
127887181|NCT01042977|460210482|FG000|Overall Study|Death|2|||
127887182|NCT01042977|460210483|FG001|Overall Study|Death|1|||
127887183|NCT01042977|460210482|FG000|Overall Study|Withdrawal by Subject|8|||
127887184|NCT01042977|460210483|FG001|Overall Study|Withdrawal by Subject|16|||
127887185|NCT01042977|460210482|FG000|Overall Study|Lost to Follow-up|0|||
127887186|NCT01042977|460210483|FG001|Overall Study|Lost to Follow-up|2|||
127887187|NCT01042977|460210482|FG000|Overall Study|Poor/non-compliance|3|||
127887188|NCT01042977|460210483|FG001|Overall Study|Poor/non-compliance|4|||
127887189|NCT01042977|460210482|FG000|Overall Study|Subject no longer meets study criteria|15|||
127704573|NCT05469464|459548854|FG003|Overall Study|Lost to Follow-up|3|||
127704574|NCT05469464|459548851|FG000|Overall Study|Lack of Efficacy|4|||
127704575|NCT05469464|459548852|FG001|Overall Study|Lack of Efficacy|1|||
127704576|NCT05469464|459548853|FG002|Overall Study|Lack of Efficacy|2|||
127704577|NCT05469464|459548854|FG003|Overall Study|Lack of Efficacy|2|||
127704578|NCT05469464|459548851|FG000|Overall Study|Physician Decision|0|||
127704579|NCT05469464|459548852|FG001|Overall Study|Physician Decision|0|||
127704580|NCT05469464|459548853|FG002|Overall Study|Physician Decision|0|||
127704581|NCT05469464|459548854|FG003|Overall Study|Physician Decision|1|||
127704582|NCT03905798|459548855|FG000|Overall Study|No informed consent for notification/publication of study results|94|||
127704583|NCT06473662|459548856|FG000|Overall Study|Withdrawal by Subject|1|||
127704584|NCT06473662|459548857|FG001|Overall Study|Withdrawal by Subject|6|||
127704585|NCT06473662|459548858|FG002|Overall Study|Withdrawal by Subject|5|||
127704586|NCT06473662|459548856|FG000|Overall Study|Uncontrolled hyperglycaemia|1|||
127704587|NCT06473662|459548857|FG001|Overall Study|Uncontrolled hyperglycaemia|2|||
127704588|NCT06473662|459548858|FG002|Overall Study|Uncontrolled hyperglycaemia|2|||
127704589|NCT06473662|459548856|FG000|Overall Study|Starting HbA1c below 7%|0|||
127704590|NCT06473662|459548857|FG001|Overall Study|Starting HbA1c below 7%|1|||
127704591|NCT06473662|459548858|FG002|Overall Study|Starting HbA1c below 7%|1|||
127704592|NCT06473662|459548856|FG000|Overall Study|No data from Central lab (protocol violation)|14|||
127704593|NCT06473662|459548857|FG001|Overall Study|No data from Central lab (protocol violation)|9|||
127704594|NCT06473662|459548858|FG002|Overall Study|No data from Central lab (protocol violation)|4|||
127704595|NCT06473662|459548856|FG000|Overall Study|Did not take medication|2|||
127704596|NCT06473662|459548857|FG001|Overall Study|Did not take medication|3|||
127704597|NCT06473662|459548858|FG002|Overall Study|Did not take medication|2|||
127704598|NCT05485779|459548859|FG000|Treatment Period 1 (Fasted)|Adverse Event|0|||
127704599|NCT05485779|459548860|FG001|Treatment Period 1 (Fasted)|Adverse Event|0|||
127704600|NCT05485779|459548861|FG002|Treatment Period 1 (Fasted)|Adverse Event|0|||
127704601|NCT05485779|459548862|FG003|Treatment Period 1 (Fasted)|Adverse Event|0|||
127704602|NCT05485779|459548863|FG004|Treatment Period 1 (Fasted)|Adverse Event|0|||
127704603|NCT05485779|459548864|FG005|Treatment Period 1 (Fasted)|Adverse Event|0|||
127704604|NCT05485779|459548865|FG006|Treatment Period 1 (Fasted)|Adverse Event|0|||
127704605|NCT05485779|459548866|FG007|Treatment Period 1 (Fasted)|Adverse Event|1|||
127704606|NCT05485779|459548867|FG008|Treatment Period 1 (Fasted)|Adverse Event|1|||
127704607|NCT05485779|459548868|FG009|Treatment Period 1 (Fasted)|Adverse Event|0|||
127704608|NCT05485779|459548869|FG010|Treatment Period 1 (Fasted)|Adverse Event|0|||
127704609|NCT05485779|459548859|FG000|Treatment Period 1 (Fasted)|Physician Decision|0|||
127704610|NCT05485779|459548860|FG001|Treatment Period 1 (Fasted)|Physician Decision|0|||
127704611|NCT05485779|459548861|FG002|Treatment Period 1 (Fasted)|Physician Decision|0|||
127704612|NCT05485779|459548862|FG003|Treatment Period 1 (Fasted)|Physician Decision|0|||
127704613|NCT05485779|459548863|FG004|Treatment Period 1 (Fasted)|Physician Decision|0|||
127704614|NCT05485779|459548864|FG005|Treatment Period 1 (Fasted)|Physician Decision|0|||
127704615|NCT05485779|459548865|FG006|Treatment Period 1 (Fasted)|Physician Decision|0|||
127704616|NCT05485779|459548866|FG007|Treatment Period 1 (Fasted)|Physician Decision|0|||
127704617|NCT05485779|459548867|FG008|Treatment Period 1 (Fasted)|Physician Decision|0|||
127704618|NCT05485779|459548868|FG009|Treatment Period 1 (Fasted)|Physician Decision|0|||
127704619|NCT05485779|459548869|FG010|Treatment Period 1 (Fasted)|Physician Decision|1|||
127704620|NCT05485779|459548859|FG000|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
127704621|NCT05485779|459548860|FG001|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
127704622|NCT05485779|459548861|FG002|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
127704623|NCT05485779|459548862|FG003|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|1|||
127704624|NCT05485779|459548863|FG004|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
127704625|NCT05485779|459548864|FG005|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
127704626|NCT05485779|459548865|FG006|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
127704627|NCT05485779|459548866|FG007|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
127704628|NCT05485779|459548867|FG008|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
127704629|NCT05485779|459548868|FG009|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
127704630|NCT05485779|459548869|FG010|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
127704631|NCT03463044|459548870|FG000|Overall Study|Lost to Follow-up|0|||
127704632|NCT03463044|459548871|FG001|Overall Study|Lost to Follow-up|0|||
127798333|NCT04537208|459885573|FG002|Overall Study|Adverse Event|0|||
127798334|NCT04537208|459885574|FG003|Overall Study|Adverse Event|0|||
127798335|NCT04537208|459885575|FG004|Overall Study|Adverse Event|0|||
127798336|NCT04537208|459885576|FG005|Overall Study|Adverse Event|0|||
127704633|NCT03463044|459548872|FG002|Overall Study|Lost to Follow-up|0|||
127704634|NCT03463044|459548873|FG003|Overall Study|Lost to Follow-up|0|||
127641031|NCT02119260|459306079|FG001|Overall Study|Withdrew consent|1|||
127641032|NCT02119260|459306080|FG002|Overall Study|Withdrew consent|1|||
127641033|NCT02119260|459306081|FG003|Overall Study|Withdrew consent|0|||
127641034|NCT02119260|459306082|FG004|Overall Study|Withdrew consent|0|||
127641035|NCT02119260|459306083|FG005|Overall Study|Withdrew consent|0|||
127641036|NCT02119260|459306084|FG006|Overall Study|Withdrew consent|0|||
127641037|NCT00857207|459306085|FG000|Overall Study|Withdrawal by Subject|13|||
127641038|NCT00857207|459306086|FG001|Overall Study|Withdrawal by Subject|0|||
127641039|NCT00857207|459306085|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
127798337|NCT04537208|459885577|FG006|Overall Study|Adverse Event|0|||
127798338|NCT04537208|459885578|FG007|Overall Study|Adverse Event|0|||
127798339|NCT04537208|459885579|FG008|Overall Study|Adverse Event|1|||
127798340|NCT04537208|459885580|FG009|Overall Study|Adverse Event|0|||
127798341|NCT04537208|459885581|FG010|Overall Study|Adverse Event|0|||
127798342|NCT04537208|459885571|FG000|Overall Study|Protocol deviation|0|||
127798343|NCT04537208|459885572|FG001|Overall Study|Protocol deviation|0|||
127798344|NCT04537208|459885573|FG002|Overall Study|Protocol deviation|2|||
127798345|NCT04537208|459885574|FG003|Overall Study|Protocol deviation|0|||
127887190|NCT01042977|460210483|FG001|Overall Study|Subject no longer meets study criteria|13|||
127887191|NCT01042977|460210482|FG000|Overall Study|Incorrect enrollment|6|||
127641040|NCT00857207|459306086|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
127641041|NCT00857207|459306085|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
127641042|NCT00857207|459306086|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
127641043|NCT00440531|459306090|FG000|Overall Study|Adverse Event|1|||
127641044|NCT00440531|459306091|FG001|Overall Study|Adverse Event|0|||
127641045|NCT00440531|459306092|FG002|Overall Study|Adverse Event|2|||
127641046|NCT00440531|459306090|FG000|Overall Study|Withdrawal by Subject|2|||
127641047|NCT00440531|459306091|FG001|Overall Study|Withdrawal by Subject|0|||
127641048|NCT00440531|459306092|FG002|Overall Study|Withdrawal by Subject|0|||
127641049|NCT00440531|459306090|FG000|Overall Study|Protocol Violation|1|||
127641050|NCT00440531|459306091|FG001|Overall Study|Protocol Violation|2|||
127641051|NCT00440531|459306092|FG002|Overall Study|Protocol Violation|0|||
127641052|NCT00440531|459306090|FG000|Overall Study|Lost to Follow-up|4|||
127641053|NCT00440531|459306091|FG001|Overall Study|Lost to Follow-up|3|||
127641054|NCT00440531|459306092|FG002|Overall Study|Lost to Follow-up|5|||
127641055|NCT00440531|459306090|FG000|Overall Study|see pre-assignment details|2|||
127641056|NCT00440531|459306091|FG001|Overall Study|see pre-assignment details|0|||
127641057|NCT00440531|459306092|FG002|Overall Study|see pre-assignment details|0|||
127641058|NCT00686166|459306102|FG000|Overall Study|Adverse Event|7|||
127641059|NCT00686166|459306102|FG000|Overall Study|Withdrawal by Subject|1|||
127641060|NCT00686166|459306102|FG000|Overall Study|Progression/Relapse|1|||
127641061|NCT00686166|459306102|FG000|Overall Study|Death|1|||
127641062|NCT00686166|459306102|FG000|Overall Study|Not Protocol Specified|1|||
127641063|NCT00686166|459306102|FG000|Overall Study|Ineligible|5|||
127641064|NCT00686166|459306102|FG000|Overall Study|Did not begin protocol therapy|4|||
127641065|NCT03912259|459306105|FG000|Overall Study|Adverse Event (AE)|2|||
127641066|NCT03912259|459306106|FG001|Overall Study|Adverse Event (AE)|4|||
127641067|NCT03912259|459306105|FG000|Overall Study|Lack of Efficacy|4|||
127641068|NCT03912259|459306106|FG001|Overall Study|Lack of Efficacy|1|||
127641069|NCT03912259|459306105|FG000|Overall Study|Withdrawal by Subject|11|||
127641070|NCT03912259|459306106|FG001|Overall Study|Withdrawal by Subject|1|||
127641071|NCT01549613|459306107|FG000|Overall Study|Lost to Follow-up|11|||
127641072|NCT01549613|459306108|FG001|Overall Study|Lost to Follow-up|11|||
127641073|NCT02216123|459306109|FG000|Overall Study|Lost to Follow-up|4|||
127641074|NCT02216123|459306110|FG001|Overall Study|Lost to Follow-up|2|||
127641075|NCT02216123|459306109|FG000|Overall Study|Withdrawal by Subject|2|||
127641076|NCT02216123|459306110|FG001|Overall Study|Withdrawal by Subject|0|||
127641077|NCT02131272|459306111|FG000|Overall Study|Withdrawal by parent|0|||
127641078|NCT02131272|459306112|FG001|Overall Study|Withdrawal by parent|1|||
127641079|NCT02131272|459306111|FG000|Overall Study|Withdrawal by Subject|0|||
127641080|NCT02131272|459306112|FG001|Overall Study|Withdrawal by Subject|1|||
127641081|NCT02131272|459306111|FG000|Overall Study|Withdrawal Criteria|1|||
127641082|NCT02131272|459306112|FG001|Overall Study|Withdrawal Criteria|0|||
127641083|NCT00254982|459306114|FG000|Overall Study|Other|2|||
127641084|NCT00254982|459306115|FG001|Overall Study|Other|1|||
127641085|NCT00254982|459306114|FG000|Overall Study|Lack of Efficacy|5|||
127641086|NCT00254982|459306115|FG001|Overall Study|Lack of Efficacy|3|||
127798346|NCT04537208|459885575|FG004|Overall Study|Protocol deviation|0|||
127798347|NCT04537208|459885576|FG005|Overall Study|Protocol deviation|2|||
127798348|NCT04537208|459885577|FG006|Overall Study|Protocol deviation|4|||
127798349|NCT04537208|459885578|FG007|Overall Study|Protocol deviation|0|||
127798350|NCT04537208|459885579|FG008|Overall Study|Protocol deviation|1|||
127798351|NCT04537208|459885580|FG009|Overall Study|Protocol deviation|0|||
127798352|NCT04537208|459885581|FG010|Overall Study|Protocol deviation|2|||
127798353|NCT04537208|459885571|FG000|Overall Study|Withdrawal by Subject|4|||
127798354|NCT04537208|459885572|FG001|Overall Study|Withdrawal by Subject|2|||
127798355|NCT04537208|459885573|FG002|Overall Study|Withdrawal by Subject|1|||
127798356|NCT04537208|459885574|FG003|Overall Study|Withdrawal by Subject|3|||
127798357|NCT04537208|459885575|FG004|Overall Study|Withdrawal by Subject|5|||
127798358|NCT04537208|459885576|FG005|Overall Study|Withdrawal by Subject|1|||
127641087|NCT00254982|459306114|FG000|Overall Study|Lost to Follow-up|5|||
127641088|NCT00254982|459306115|FG001|Overall Study|Lost to Follow-up|3|||
127641089|NCT00254982|459306114|FG000|Overall Study|Adverse Event|18|||
127641090|NCT00254982|459306115|FG001|Overall Study|Adverse Event|16|||
127641091|NCT00254982|459306114|FG000|Overall Study|Withdrawal by Subject|1|||
127641092|NCT00254982|459306115|FG001|Overall Study|Withdrawal by Subject|1|||
127887192|NCT01042977|460210483|FG001|Overall Study|Incorrect enrollment|4|||
127887193|NCT01042977|460210482|FG000|Overall Study|Safety|0|||
127641093|NCT00254982|459306114|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
127641094|NCT00254982|459306115|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
127641095|NCT00254982|459306114|FG000|Overall Study|Protocol deviation|1|||
127641096|NCT00254982|459306115|FG001|Overall Study|Protocol deviation|1|||
127798359|NCT04537208|459885577|FG006|Overall Study|Withdrawal by Subject|6|||
127641097|NCT00254982|459306114|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
127704635|NCT03463044|459548874|FG004|Overall Study|Lost to Follow-up|0|||
127704636|NCT03463044|459548875|FG005|Overall Study|Lost to Follow-up|0|||
127704637|NCT03463044|459548876|FG006|Overall Study|Lost to Follow-up|0|||
127704638|NCT03463044|459548877|FG007|Overall Study|Lost to Follow-up|1|||
127704639|NCT03463044|459548878|FG008|Overall Study|Lost to Follow-up|0|||
127704640|NCT05192109|459548879|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
127704641|NCT05192109|459548880|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
127704642|NCT05192109|459548881|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
127704643|NCT05192109|459548882|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
127704644|NCT05192109|459548879|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
127704645|NCT05192109|459548880|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
127704646|NCT05192109|459548881|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
127704647|NCT05192109|459548882|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
127704648|NCT04498390|459548883|FG000|Overall Study|Adverse Event|0|||
127704649|NCT04498390|459548884|FG001|Overall Study|Adverse Event|0|||
127704650|NCT04498390|459548885|FG002|Overall Study|Adverse Event|1|||
127704651|NCT04498390|459548886|FG003|Overall Study|Adverse Event|0|||
127704652|NCT04498390|459548887|FG004|Overall Study|Adverse Event|0|||
127704653|NCT04498390|459548883|FG000|Overall Study|Withdrawal by Subject|0|||
127704654|NCT04498390|459548884|FG001|Overall Study|Withdrawal by Subject|0|||
127704655|NCT04498390|459548885|FG002|Overall Study|Withdrawal by Subject|0|||
127704656|NCT04498390|459548886|FG003|Overall Study|Withdrawal by Subject|1|||
127704657|NCT04498390|459548887|FG004|Overall Study|Withdrawal by Subject|0|||
127704658|NCT05370040|459548888|FG000|Overall Study|Lost to Follow-up|0|||
127704659|NCT05370040|459548889|FG001|Overall Study|Lost to Follow-up|0|||
127704660|NCT05370040|459548890|FG002|Overall Study|Lost to Follow-up|1|||
127704661|NCT05370040|459548891|FG003|Overall Study|Lost to Follow-up|0|||
127704662|NCT05370040|459548892|FG004|Overall Study|Lost to Follow-up|1|||
127704663|NCT05370040|459548893|FG005|Overall Study|Lost to Follow-up|0|||
127704664|NCT05170841|459548894|FG000|Single Dose Phase|Adverse Event|1|||
127704665|NCT05170841|459548895|FG001|Single Dose Phase|Adverse Event|2|||
127704666|NCT05170841|459548896|FG002|Single Dose Phase|Adverse Event|0|||
127704667|NCT05170841|459548897|FG003|Single Dose Phase|Adverse Event|2|||
127704668|NCT05170841|459548894|FG000|Multiple Dose Phase|Adverse Event|1|||
127704669|NCT05170841|459548895|FG001|Multiple Dose Phase|Adverse Event|2|||
127704670|NCT05170841|459548896|FG002|Multiple Dose Phase|Adverse Event|1|||
127704671|NCT05170841|459548897|FG003|Multiple Dose Phase|Adverse Event|4|||
127704672|NCT05170841|459548894|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
127704673|NCT05170841|459548895|FG001|Multiple Dose Phase|Withdrawal by Subject|1|||
127704674|NCT05170841|459548896|FG002|Multiple Dose Phase|Withdrawal by Subject|0|||
127704675|NCT05170841|459548897|FG003|Multiple Dose Phase|Withdrawal by Subject|0|||
127704676|NCT04865289|459548898|FG000|Overall Study|Participant ongoing in study|47|||
127704677|NCT04865289|459548899|FG001|Overall Study|Participant ongoing in study|35|||
127704678|NCT04865289|459548898|FG000|Overall Study|Death|27|||
127704679|NCT04865289|459548899|FG001|Overall Study|Death|21|||
127704680|NCT02733159|459548902|FG000|Overall Study|Adverse Event|1|||
127704681|NCT02733159|459548902|FG000|Overall Study|Lack of disease progression|1|||
127704682|NCT06122194|459548903|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
127704683|NCT06122194|459548904|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
127704684|NCT06122194|459548905|FG002|Treatment Period 1 (3 Days)|Adverse Event|1|||
127704685|NCT06122194|459548906|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
127704686|NCT02709161|459548917|FG000|Overall Study|Withdrawal by Subject|1|||
127704687|NCT02709161|459548918|FG001|Overall Study|Withdrawal by Subject|0|||
127704688|NCT03626220|459548919|FG000|Overall Study|Withdrawal by Subject|2|||
127704689|NCT03626220|459548920|FG001|Overall Study|Withdrawal by Subject|0|||
127704690|NCT03663569|459550216|FG000|Overall Study|Discontinuation of study|11|||
127704691|NCT03663569|459550216|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
127704692|NCT03663569|459550216|FG000|Overall Study|Deceased patient|6|||
127704693|NCT03663569|459550216|FG000|Overall Study|Lost to Follow-up|18|||
127704694|NCT03663569|459550216|FG000|Overall Study|Withdrawal of consent|5|||
127704695|NCT03663569|459550216|FG000|Overall Study|Patient's request|11|||
127704696|NCT03663569|459550216|FG000|Overall Study|Adverse Event|4|||
127704697|NCT03663569|459550216|FG000|Overall Study|Not come to second visit|3|||
127704698|NCT03663569|459550216|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
127704699|NCT03663569|459550216|FG000|Overall Study|Serious adverse event|1|||
127704700|NCT05877976|459550217|FG000|Overall Study|Lost to Follow-up|31|||
127704701|NCT04248725|459550218|FG000|Post-Treatment|Lost to Follow-up|6|||
127704702|NCT04248725|459550219|FG001|Post-Treatment|Lost to Follow-up|5|||
127704703|NCT04248725|459550218|FG000|6-Month Follow Up|Lost to Follow-up|9|||
127704704|NCT04248725|459550219|FG001|6-Month Follow Up|Lost to Follow-up|8|||
127704705|NCT05622812|459550220|FG000|Overall Study|Withdrawal by Subject|1|||
127704706|NCT05622812|459550221|FG001|Overall Study|Withdrawal by Subject|4|||
127704707|NCT05622812|459550220|FG000|Overall Study|Lost to Follow-up|2|||
127704708|NCT05622812|459550221|FG001|Overall Study|Lost to Follow-up|1|||
127704709|NCT03916185|459550222|FG000|Overall Study|Lost to Follow-up|0|||
127704710|NCT03916185|459550223|FG001|Overall Study|Lost to Follow-up|1|||
127704711|NCT03916185|459550224|FG002|Overall Study|Lost to Follow-up|0|||
127641098|NCT00254982|459306115|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
127641099|NCT00254982|459306114|FG000|Overall Study|Malignancy|0|||
127641100|NCT00254982|459306115|FG001|Overall Study|Malignancy|2|||
127641101|NCT00254982|459306114|FG000|Overall Study|Opportunistic infection|1|||
127641102|NCT00254982|459306115|FG001|Overall Study|Opportunistic infection|0|||
127641103|NCT00254982|459306114|FG000|Overall Study|Abnormal liver function tests|2|||
127641104|NCT00254982|459306115|FG001|Overall Study|Abnormal liver function tests|1|||
127641105|NCT01540851|459306117|FG000|Overall Study|Lost to Follow-up|14|||
127641106|NCT01540851|459306118|FG001|Overall Study|Lost to Follow-up|15|||
127641107|NCT01540851|459306117|FG000|Overall Study|Withdrawal by Subject|7|||
127641108|NCT01540851|459306118|FG001|Overall Study|Withdrawal by Subject|3|||
127641109|NCT00224874|459306121|FG000|Overall Study|Withdrawal by Subject|0|||
127641110|NCT00224874|459306122|FG001|Overall Study|Withdrawal by Subject|0|||
127641111|NCT00224874|459306123|FG002|Overall Study|Withdrawal by Subject|1|||
127641112|NCT00224874|459306124|FG003|Overall Study|Withdrawal by Subject|0|||
127641113|NCT02633137|459306125|FG000|Overall Study|Adverse Event|1|||
127641114|NCT02633137|459306125|FG000|Overall Study|Lack of Efficacy|2|||
127641115|NCT02633137|459306125|FG000|Overall Study|Withdrawal by Subject|1|||
127641116|NCT01324271|459306126|FG000|Overall Study|Lost to Follow-up|3|||
127641117|NCT01324271|459306127|FG001|Overall Study|Lost to Follow-up|0|||
127641118|NCT01324271|459306126|FG000|Overall Study|Physician Decision|1|||
127641119|NCT01324271|459306127|FG001|Overall Study|Physician Decision|0|||
127641120|NCT05130970|459306128|FG000|Overall Study|Adverse Event|1|||
127704712|NCT03916185|459550225|FG003|Overall Study|Lost to Follow-up|0|||
127704713|NCT03916185|459550222|FG000|Overall Study|Moved|1|||
127704714|NCT03916185|459550223|FG001|Overall Study|Moved|0|||
127704715|NCT03916185|459550224|FG002|Overall Study|Moved|0|||
127704716|NCT03916185|459550225|FG003|Overall Study|Moved|1|||
127704717|NCT03916185|459550222|FG000|Overall Study|Not Able to Get to Clinic|1|||
127704718|NCT03916185|459550223|FG001|Overall Study|Not Able to Get to Clinic|0|||
127704719|NCT03916185|459550224|FG002|Overall Study|Not Able to Get to Clinic|0|||
127704720|NCT03916185|459550225|FG003|Overall Study|Not Able to Get to Clinic|0|||
127704721|NCT02844465|459550232|FG000|Overall Study|Screen Failure|36|||
127704722|NCT02844465|459550232|FG000|Overall Study|Withdrawal Prior to Procedure|17|||
127704723|NCT02844465|459550232|FG000|Overall Study|Withdrawal by Subject|5|||
127704724|NCT02844465|459550232|FG000|Overall Study|Lost to Follow-up|1|||
127704725|NCT02844465|459550232|FG000|Overall Study|Retreatment|1|||
127704726|NCT03819153|459550233|FG000|Overall Study|Withdrawal by Subject|20|||
127704727|NCT03819153|459550234|FG001|Overall Study|Withdrawal by Subject|28|||
127704728|NCT03819153|459550233|FG000|Overall Study|Lost to Follow-up|23|||
127704729|NCT03819153|459550234|FG001|Overall Study|Lost to Follow-up|30|||
127704730|NCT03240016|459550241|FG000|Overall Study|Adverse Event|9|||
127704731|NCT03240016|459550241|FG000|Overall Study|Withdrawal by Subject|7|||
127704732|NCT03240016|459550241|FG000|Overall Study|Death|1|||
127887194|NCT01042977|460210483|FG001|Overall Study|Safety|2|||
127887195|NCT01042977|460210482|FG000|Overall Study|Administrative reason by sponsor|0|||
127887196|NCT01042977|460210483|FG001|Overall Study|Administrative reason by sponsor|1|||
127887197|NCT01042977|460210482|FG000|Overall Study|Various|3|||
127887198|NCT01042977|460210483|FG001|Overall Study|Various|0|||
127887199|NCT02424565|460210486|FG000|Period 1 (D0)|Protocol Violation|0|||
127887200|NCT02424565|460210487|FG001|Period 1 (D0)|Protocol Violation|1|||
127887201|NCT03650400|460210488|FG000|Overall Study|Study terminated by sponsor|0|||
127887202|NCT03650400|460210489|FG001|Overall Study|Study terminated by sponsor|5|||
127887203|NCT04228302|460210497|FG000|Overall Study|Adverse Event|0|||
127887204|NCT04228302|460210498|FG001|Overall Study|Adverse Event|0|||
127887205|NCT04228302|460210499|FG002|Overall Study|Adverse Event|0|||
127887206|NCT04228302|460210500|FG003|Overall Study|Adverse Event|0|||
127887207|NCT04228302|460210501|FG004|Overall Study|Adverse Event|1|||
127887208|NCT04228302|460210502|FG005|Overall Study|Adverse Event|0|||
127887209|NCT01886300|460210509|FG000|Overall Study|Trial terminated by sponsor|16|||
127887210|NCT02008721|460210510|FG000|Overall Study|Withdrawal by Subject|5|||
127887211|NCT02008721|460210511|FG001|Overall Study|Withdrawal by Subject|1|||
127887212|NCT02008721|460210510|FG000|Overall Study|Death|4|||
127887213|NCT02008721|460210511|FG001|Overall Study|Death|2|||
127887214|NCT02008721|460210510|FG000|Overall Study|Adverse Event|3|||
127641121|NCT05130970|459306129|FG001|Overall Study|Adverse Event|1|||
127641122|NCT05130970|459306128|FG000|Overall Study|Death|0|||
127641123|NCT05130970|459306129|FG001|Overall Study|Death|1|||
127641124|NCT05130970|459306128|FG000|Overall Study|Lost to Follow-up|0|||
127641125|NCT05130970|459306129|FG001|Overall Study|Lost to Follow-up|1|||
127641126|NCT05130970|459306128|FG000|Overall Study|Physician Decision|0|||
127641127|NCT05130970|459306129|FG001|Overall Study|Physician Decision|1|||
127641128|NCT05130970|459306128|FG000|Overall Study|Withdrawal by Subject|1|||
127641129|NCT05130970|459306129|FG001|Overall Study|Withdrawal by Subject|1|||
127641130|NCT03996473|459306130|FG000|Treatment Assignment|Withdrawal by Subject|1|||
127641131|NCT03996473|459306130|FG000|Treatment Assignment|Progressive disease|6|||
127641132|NCT03996473|459306130|FG000|Treatment Assignment|Study drug never administered|1|||
127641133|NCT03996473|459306130|FG000|Active Follow-up|Death|1|||
127641134|NCT03996473|459306130|FG000|Long-term Follow-up|Death|5|||
127641135|NCT06116591|459306131|FG000|Overall Study|No longer met eligibility criteria|0|||
127641136|NCT06116591|459306132|FG001|Overall Study|No longer met eligibility criteria|1|||
127641137|NCT06116591|459306131|FG000|Overall Study|Other: Change in life situation|0|||
127641138|NCT06116591|459306132|FG001|Overall Study|Other: Change in life situation|1|||
127641139|NCT03644186|459306133|FG000|Overall Study|Withdrawal by Subject|1|||
127641140|NCT03644186|459306134|FG001|Overall Study|Withdrawal by Subject|1|||
127641141|NCT02701985|459306135|FG000|Overall Study|Withdrawal by Subject|1|||
127641142|NCT02701985|459306136|FG001|Overall Study|Withdrawal by Subject|1|||
127641143|NCT02701985|459306135|FG000|Overall Study|Lost to Follow-up|1|||
127641144|NCT02701985|459306136|FG001|Overall Study|Lost to Follow-up|0|||
127641145|NCT02701985|459306135|FG000|Overall Study|Death|1|||
127641146|NCT02701985|459306136|FG001|Overall Study|Death|0|||
127641147|NCT02701985|459306135|FG000|Overall Study|Adverse Event|0|||
127641148|NCT02701985|459306136|FG001|Overall Study|Adverse Event|5|||
127641149|NCT01640808|459306138|FG000|Overall Study|Unable to continue dynamic CT|14|||
127641150|NCT01640808|459306139|FG001|Overall Study|Unable to continue dynamic CT|4|||
127641151|NCT01640808|459306138|FG000|Overall Study|Withdrawal by Subject|12|||
127641152|NCT01640808|459306139|FG001|Overall Study|Withdrawal by Subject|4|||
127641153|NCT01640808|459306138|FG000|Overall Study|Lost to Follow-up|4|||
127641154|NCT01640808|459306139|FG001|Overall Study|Lost to Follow-up|0|||
127641155|NCT01640808|459306138|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
127641156|NCT01640808|459306139|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
127641157|NCT01640808|459306138|FG000|Overall Study|Administration of anticancer drugs|2|||
127641158|NCT01640808|459306139|FG001|Overall Study|Administration of anticancer drugs|1|||
127641159|NCT01640808|459306138|FG000|Overall Study|Physician Decision|19|||
127641160|NCT01640808|459306139|FG001|Overall Study|Physician Decision|5|||
127704733|NCT03240016|459550241|FG000|Overall Study|Physician Decision|2|||
127887215|NCT02008721|460210511|FG001|Overall Study|Adverse Event|5|||
127887216|NCT02008721|460210510|FG000|Overall Study|Protocol Violation|3|||
127641161|NCT01640808|459306138|FG000|Overall Study|Randomized but not treated|4|||
127641162|NCT01640808|459306139|FG001|Overall Study|Randomized but not treated|2|||
127641163|NCT01869491|459306140|FG000|Overall Study|Adverse Event|3|||
127641164|NCT01869491|459306141|FG001|Overall Study|Adverse Event|5|||
127641165|NCT01869491|459306140|FG000|Overall Study|Lack of Efficacy|0|||
127887217|NCT02008721|460210511|FG001|Overall Study|Protocol Violation|2|||
127641166|NCT01869491|459306141|FG001|Overall Study|Lack of Efficacy|3|||
127704734|NCT03913442|459550242|FG000|Overall Study|Adverse Event|0|||
127798360|NCT04537208|459885578|FG007|Overall Study|Withdrawal by Subject|1|||
127798361|NCT04537208|459885579|FG008|Overall Study|Withdrawal by Subject|7|||
127798362|NCT04537208|459885580|FG009|Overall Study|Withdrawal by Subject|2|||
127798363|NCT04537208|459885581|FG010|Overall Study|Withdrawal by Subject|4|||
127798364|NCT04537208|459885571|FG000|Overall Study|Lost to Follow-up|4|||
127798365|NCT04537208|459885572|FG001|Overall Study|Lost to Follow-up|1|||
127798366|NCT04537208|459885573|FG002|Overall Study|Lost to Follow-up|3|||
127798367|NCT04537208|459885574|FG003|Overall Study|Lost to Follow-up|4|||
127798368|NCT04537208|459885575|FG004|Overall Study|Lost to Follow-up|3|||
127798369|NCT04537208|459885576|FG005|Overall Study|Lost to Follow-up|2|||
127798370|NCT04537208|459885577|FG006|Overall Study|Lost to Follow-up|3|||
127641167|NCT01869491|459306140|FG000|Overall Study|Withdrawal by Subject|6|||
127641168|NCT01869491|459306141|FG001|Overall Study|Withdrawal by Subject|7|||
127641169|NCT01869491|459306140|FG000|Overall Study|Lost to Follow-up|11|||
127641170|NCT01869491|459306141|FG001|Overall Study|Lost to Follow-up|9|||
127641171|NCT01869491|459306140|FG000|Overall Study|No further need of investigational product|1|||
127641172|NCT01869491|459306141|FG001|Overall Study|No further need of investigational product|0|||
127641173|NCT04009291|459306142|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
127641174|NCT04009291|459306143|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
127641175|NCT04009291|459306144|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
127641176|NCT04009291|459306145|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
127641177|NCT04009291|459306146|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
127641178|NCT04009291|459306142|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
127641179|NCT04009291|459306143|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
127641180|NCT04009291|459306144|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
127641181|NCT04009291|459306145|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
127641182|NCT04009291|459306146|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
127641183|NCT05553808|459306147|FG000|Overall Study|Death|25|||
127641184|NCT05553808|459306148|FG001|Overall Study|Death|62|||
127641185|NCT05553808|459306147|FG000|Overall Study|Site Closed|6|||
127641186|NCT05553808|459306148|FG001|Overall Study|Site Closed|6|||
127641187|NCT05553808|459306147|FG000|Overall Study|Lost to Follow-up|1|||
127641188|NCT05553808|459306148|FG001|Overall Study|Lost to Follow-up|0|||
127641189|NCT05553808|459306147|FG000|Overall Study|Withdrawal by Subject|3|||
127641190|NCT05553808|459306148|FG001|Overall Study|Withdrawal by Subject|2|||
127641191|NCT00808808|459306157|FG000|Overall Study|Vaccinated; survey not completed|131|||
127641192|NCT00808808|459306158|FG001|Overall Study|Vaccinated; survey not completed|169|||
127641193|NCT00808808|459306159|FG002|Overall Study|Vaccinated; survey not completed|302|||
127641194|NCT00808808|459306157|FG000|Overall Study|Employee was not vaccinated.|2686|||
127641195|NCT00808808|459306158|FG001|Overall Study|Employee was not vaccinated.|2268|||
127641196|NCT00808808|459306159|FG002|Overall Study|Employee was not vaccinated.|2255|||
127641197|NCT00490646|459306161|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
127641198|NCT00490646|459306162|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
127641199|NCT00490646|459306161|FG000|Overall Study|Never Treated (had an adverse event)|1|||
127641200|NCT00490646|459306162|FG001|Overall Study|Never Treated (had an adverse event)|0|||
127641201|NCT00490646|459306161|FG000|Overall Study|Never Treated (withdrew consent)|0|||
127641202|NCT00490646|459306162|FG001|Overall Study|Never Treated (withdrew consent)|1|||
127704735|NCT03913442|459550243|FG001|Overall Study|Adverse Event|3|||
127704736|NCT03913442|459550242|FG000|Overall Study|Withdrawal by Subject|5|||
127704737|NCT03913442|459550243|FG001|Overall Study|Withdrawal by Subject|5|||
127704738|NCT03913442|459550242|FG000|Overall Study|Terminations|2|||
127704739|NCT03913442|459550243|FG001|Overall Study|Terminations|1|||
127704740|NCT03913442|459550242|FG000|Overall Study|Lost to Follow-up|2|||
127704741|NCT03913442|459550243|FG001|Overall Study|Lost to Follow-up|2|||
127798371|NCT04537208|459885578|FG007|Overall Study|Lost to Follow-up|2|||
127798372|NCT04537208|459885579|FG008|Overall Study|Lost to Follow-up|7|||
127798373|NCT04537208|459885580|FG009|Overall Study|Lost to Follow-up|2|||
127798374|NCT04537208|459885581|FG010|Overall Study|Lost to Follow-up|2|||
127798375|NCT05030311|459885582|FG000|Overall Study|Technical problems|0|||
127798376|NCT05030311|459885583|FG001|Overall Study|Technical problems|1|||
127798377|NCT05030311|459885582|FG000|Overall Study|Withdrawal by Subject|31|||
127798378|NCT05030311|459885583|FG001|Overall Study|Withdrawal by Subject|17|||
127798379|NCT05030311|459885582|FG000|Overall Study|Adverse Event|13|||
127798380|NCT05030311|459885583|FG001|Overall Study|Adverse Event|5|||
127798381|NCT05030311|459885582|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
127641203|NCT05608629|459306163|FG000|Overall Study|Lost to Follow-up|2|||
127641204|NCT01453595|459306164|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
127641205|NCT01453595|459306165|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
127704742|NCT02460458|459550244|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analysis|31|||
127704743|NCT02460458|459550244|FG000|Confirmatory Phase|Lack of sample to analyse|19|||
127798382|NCT05030311|459885583|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
127704744|NCT02460458|459550244|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|5|||
127704745|NCT02460458|459550244|FG000|First Prospective Phase|Lost to Follow-up|84|||
127704746|NCT02460458|459550244|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|34|||
127704747|NCT03952338|459550245|FG000|Overall Study|Lost to Follow-up|11|||
127704748|NCT03952338|459550246|FG001|Overall Study|Lost to Follow-up|17|||
127704749|NCT03952338|459550245|FG000|Overall Study|Withdrawal by Subject|1|||
127704750|NCT03952338|459550246|FG001|Overall Study|Withdrawal by Subject|1|||
127704751|NCT03952338|459550245|FG000|Overall Study|Protocol Violation|1|||
127704752|NCT03952338|459550246|FG001|Overall Study|Protocol Violation|0|||
127704753|NCT05070728|459550249|FG000|Overall Study|Sponsor decided to stop study enrollment and terminate the study|0|||
127704754|NCT05070728|459550250|FG001|Overall Study|Sponsor decided to stop study enrollment and terminate the study|6|||
127704755|NCT02589795|459550252|FG000|Overall Study|Lost to Follow-up|1|||
127704756|NCT02589795|459550253|FG001|Overall Study|Lost to Follow-up|0|||
127704757|NCT02589795|459550254|FG002|Overall Study|Lost to Follow-up|0|||
127704758|NCT02589795|459550252|FG000|Overall Study|Withdrawal by Subject|0|||
127704759|NCT02589795|459550253|FG001|Overall Study|Withdrawal by Subject|0|||
127704760|NCT02589795|459550254|FG002|Overall Study|Withdrawal by Subject|2|||
127704761|NCT02589795|459550252|FG000|Overall Study|Protocol Violation|0|||
127641206|NCT01453595|459306166|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
127641207|NCT00983073|459306167|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
127641208|NCT00983073|459306167|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
127641209|NCT00983073|459306167|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
127641210|NCT00983073|459306167|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
127641211|NCT00983073|459306167|FG000|Titration and Optimal Dose Period|Other reason|4|||
127641212|NCT00983073|459306167|FG000|Maintenance Period|Adverse Event|5|||
127641213|NCT00983073|459306167|FG000|Maintenance Period|Withdrawal by Subject|2|||
127641214|NCT00983073|459306167|FG000|Maintenance Period|Lack of Efficacy|2|||
127641215|NCT00983073|459306167|FG000|Maintenance Period|Other Reason|7|||
127641216|NCT02962908|459306170|FG000|Overall Study|Lost to Follow-up|0|||
127641217|NCT02962908|459306171|FG001|Overall Study|Lost to Follow-up|3|||
127641218|NCT02962908|459306172|FG002|Overall Study|Lost to Follow-up|0|||
127641219|NCT02962908|459306173|FG003|Overall Study|Lost to Follow-up|1|||
127641220|NCT02962908|459306170|FG000|Overall Study|Withdrawal by Subject|0|||
127641221|NCT02962908|459306171|FG001|Overall Study|Withdrawal by Subject|3|||
127641222|NCT02962908|459306172|FG002|Overall Study|Withdrawal by Subject|0|||
127641223|NCT02962908|459306173|FG003|Overall Study|Withdrawal by Subject|2|||
127641224|NCT02962908|459306170|FG000|Overall Study|Protocol Violation|0|||
127641225|NCT02962908|459306171|FG001|Overall Study|Protocol Violation|1|||
127641226|NCT02962908|459306172|FG002|Overall Study|Protocol Violation|0|||
127641227|NCT02962908|459306173|FG003|Overall Study|Protocol Violation|0|||
127641228|NCT02962908|459306170|FG000|Overall Study|Physician Decision|0|||
127641229|NCT02962908|459306171|FG001|Overall Study|Physician Decision|1|||
127641230|NCT02962908|459306172|FG002|Overall Study|Physician Decision|0|||
127641231|NCT02962908|459306173|FG003|Overall Study|Physician Decision|0|||
127641232|NCT03543254|459306174|FG000|Overall Study|Lost to Follow-up|1|||
127641233|NCT01261338|459306175|FG000|Overall Study|Withdrawal by Subject|3|||
127641234|NCT01261338|459306176|FG001|Overall Study|Withdrawal by Subject|2|||
127641235|NCT02313428|459306177|FG000|Overall Study|Lost to Follow-up|1|||
127641236|NCT02313428|459306178|FG001|Overall Study|Lost to Follow-up|1|||
127641237|NCT05374421|459306179|FG000|Overall Study|Withdrawal by Subject|3|||
127641238|NCT05374421|459306180|FG001|Overall Study|Withdrawal by Subject|4|||
127641239|NCT02899728|459306181|FG000|Overall Study|Withdrawal by Subject|1|||
127641240|NCT02899728|459306182|FG001|Overall Study|Withdrawal by Subject|1|||
127641241|NCT05557942|459306183|FG000|Overall Study|Death|0|||
127704762|NCT02589795|459550253|FG001|Overall Study|Protocol Violation|0|||
127704763|NCT02589795|459550254|FG002|Overall Study|Protocol Violation|1|||
127704764|NCT04707625|459550277|FG000|Overall Study|IRB Required Early Termination Due to Safety Concerns|17|||
127704765|NCT00321048|459550278|FG000|Overall Study|Withdrawal by Subject|6|||
127704766|NCT00321048|459550279|FG001|Overall Study|Withdrawal by Subject|8|||
127704767|NCT04471246|459550282|FG000|Overall Study|Lost to Follow-up|2|||
127704768|NCT04471246|459550283|FG001|Overall Study|Lost to Follow-up|2|||
127704769|NCT05764525|459550284|FG000|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|1|||
127704770|NCT05764525|459550285|FG001|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|0|||
127641242|NCT05557942|459306184|FG001|Overall Study|Death|0|||
127641243|NCT05557942|459306185|FG002|Overall Study|Death|0|||
127641244|NCT05557942|459306186|FG003|Overall Study|Death|2|||
127641245|NCT05557942|459306187|FG004|Overall Study|Death|1|||
127641246|NCT05557942|459306188|FG005|Overall Study|Death|1|||
127641247|NCT05557942|459306183|FG000|Overall Study|Physician Decision|1|||
127704771|NCT05764525|459550284|FG000|Overall Study|Withdrawal by Subject|4|||
127704772|NCT05764525|459550285|FG001|Overall Study|Withdrawal by Subject|8|||
127704773|NCT05764525|459550284|FG000|Overall Study|Physician Decision|1|||
127704774|NCT05764525|459550285|FG001|Overall Study|Physician Decision|0|||
127798383|NCT05030311|459885582|FG000|Overall Study|Physician Decision|5|||
127798384|NCT05030311|459885583|FG001|Overall Study|Physician Decision|2|||
127887218|NCT00373685|460210514|FG000|Overall Study|Death|2|||
127641248|NCT05557942|459306184|FG001|Overall Study|Physician Decision|1|||
127641249|NCT05557942|459306185|FG002|Overall Study|Physician Decision|2|||
127641250|NCT05557942|459306186|FG003|Overall Study|Physician Decision|3|||
127641251|NCT05557942|459306187|FG004|Overall Study|Physician Decision|0|||
127641252|NCT05557942|459306188|FG005|Overall Study|Physician Decision|2|||
127641253|NCT05557942|459306183|FG000|Overall Study|Study terminated by sponsor|17|||
127641254|NCT05557942|459306184|FG001|Overall Study|Study terminated by sponsor|17|||
127641255|NCT05557942|459306185|FG002|Overall Study|Study terminated by sponsor|14|||
127641256|NCT05557942|459306186|FG003|Overall Study|Study terminated by sponsor|40|||
127641257|NCT05557942|459306187|FG004|Overall Study|Study terminated by sponsor|45|||
127641258|NCT05557942|459306188|FG005|Overall Study|Study terminated by sponsor|37|||
127641259|NCT05557942|459306183|FG000|Overall Study|Protocol Violation|0|||
127641260|NCT05557942|459306184|FG001|Overall Study|Protocol Violation|0|||
127641261|NCT05557942|459306185|FG002|Overall Study|Protocol Violation|0|||
127641262|NCT05557942|459306186|FG003|Overall Study|Protocol Violation|0|||
127641263|NCT05557942|459306187|FG004|Overall Study|Protocol Violation|0|||
127641264|NCT05557942|459306188|FG005|Overall Study|Protocol Violation|1|||
127641265|NCT05557942|459306183|FG000|Overall Study|Withdrawal by Subject|0|||
127641266|NCT05557942|459306184|FG001|Overall Study|Withdrawal by Subject|0|||
127641267|NCT05557942|459306185|FG002|Overall Study|Withdrawal by Subject|0|||
127641268|NCT05557942|459306186|FG003|Overall Study|Withdrawal by Subject|0|||
127641269|NCT05557942|459306187|FG004|Overall Study|Withdrawal by Subject|2|||
127641270|NCT05557942|459306188|FG005|Overall Study|Withdrawal by Subject|0|||
127641271|NCT02477618|459306189|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
127641272|NCT02477618|459306190|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
127641273|NCT02477618|459306189|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
127641274|NCT02477618|459306190|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
127641275|NCT02477618|459306189|FG000|Overall Study|Adverse Event|1|||
127641276|NCT02477618|459306190|FG001|Overall Study|Adverse Event|1|||
127641277|NCT02477618|459306189|FG000|Overall Study|Transferred Away from Study Site|1|||
127641278|NCT02477618|459306190|FG001|Overall Study|Transferred Away from Study Site|0|||
127641279|NCT02477618|459306189|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
127641280|NCT02477618|459306190|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
127641281|NCT00655980|459306194|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
127641282|NCT00655980|459306195|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
127641283|NCT00655980|459306196|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
127641284|NCT05540522|459306197|FG000|Overall Study|Adverse Event|1|||
127641285|NCT05540522|459306198|FG001|Overall Study|Adverse Event|0|||
127641286|NCT05540522|459306199|FG002|Overall Study|Adverse Event|2|||
127641287|NCT05540522|459306200|FG003|Overall Study|Adverse Event|5|||
127641288|NCT05540522|459306197|FG000|Overall Study|Lost to Follow-up|487|||
127641289|NCT05540522|459306198|FG001|Overall Study|Lost to Follow-up|427|||
127641290|NCT05540522|459306199|FG002|Overall Study|Lost to Follow-up|146|||
127641291|NCT05540522|459306200|FG003|Overall Study|Lost to Follow-up|166|||
127641292|NCT05540522|459306197|FG000|Overall Study|Physician Decision|11|||
127641293|NCT05540522|459306198|FG001|Overall Study|Physician Decision|19|||
127641294|NCT05540522|459306199|FG002|Overall Study|Physician Decision|8|||
127641295|NCT05540522|459306200|FG003|Overall Study|Physician Decision|13|||
127641296|NCT05540522|459306197|FG000|Overall Study|Pregnancy|1|||
127641297|NCT05540522|459306198|FG001|Overall Study|Pregnancy|0|||
127641298|NCT05540522|459306199|FG002|Overall Study|Pregnancy|0|||
127641299|NCT05540522|459306200|FG003|Overall Study|Pregnancy|0|||
127641300|NCT05540522|459306197|FG000|Overall Study|Protocol Violation|3|||
127641301|NCT05540522|459306198|FG001|Overall Study|Protocol Violation|1|||
127641302|NCT05540522|459306199|FG002|Overall Study|Protocol Violation|9|||
127641303|NCT05540522|459306200|FG003|Overall Study|Protocol Violation|7|||
127641304|NCT05540522|459306197|FG000|Overall Study|Withdrawal by Subject|168|||
127641305|NCT05540522|459306198|FG001|Overall Study|Withdrawal by Subject|134|||
127641306|NCT05540522|459306199|FG002|Overall Study|Withdrawal by Subject|331|||
127641307|NCT05540522|459306200|FG003|Overall Study|Withdrawal by Subject|322|||
127641308|NCT05540522|459306197|FG000|Overall Study|Death|7|||
127641309|NCT05540522|459306198|FG001|Overall Study|Death|9|||
127641310|NCT05540522|459306199|FG002|Overall Study|Death|49|||
127641311|NCT05540522|459306200|FG003|Overall Study|Death|46|||
127641312|NCT05540522|459306197|FG000|Overall Study|Not vaccinated|34|||
127641313|NCT05540522|459306198|FG001|Overall Study|Not vaccinated|53|||
127641314|NCT05540522|459306199|FG002|Overall Study|Not vaccinated|57|||
127641315|NCT05540522|459306200|FG003|Overall Study|Not vaccinated|50|||
127641316|NCT05540522|459306197|FG000|Overall Study|No longer meets eligibility criteria|0|||
127641317|NCT05540522|459306198|FG001|Overall Study|No longer meets eligibility criteria|0|||
127641318|NCT05540522|459306199|FG002|Overall Study|No longer meets eligibility criteria|3|||
127641319|NCT05540522|459306200|FG003|Overall Study|No longer meets eligibility criteria|2|||
127641320|NCT05540522|459306197|FG000|Overall Study|Other (Unspecified)|8|||
127641321|NCT05540522|459306198|FG001|Overall Study|Other (Unspecified)|10|||
127641322|NCT05540522|459306199|FG002|Overall Study|Other (Unspecified)|4|||
127887219|NCT00373685|460210515|FG001|Overall Study|Death|1|||
127641323|NCT05540522|459306200|FG003|Overall Study|Other (Unspecified)|2|||
127641324|NCT03754803|459306201|FG000|Overall Study|Withdrawal by Subject|2|||
127641325|NCT05239039|459306202|FG000|Overall Study|Withdrawal by Subject|0|||
127641326|NCT05239039|459306203|FG001|Overall Study|Withdrawal by Subject|1|||
127641327|NCT00936390|459306206|FG000|Overall Study|Protocol Violation|21|||
127641328|NCT00936390|459306207|FG001|Overall Study|Protocol Violation|25|||
127641329|NCT04348604|459306208|FG000|Week 8|Withdrawal by Subject|1|||
127641330|NCT04348604|459306209|FG001|Week 8|Withdrawal by Subject|1|||
127641331|NCT04348604|459306208|FG000|Week 8|Lost to Follow-up|1|||
127641332|NCT04348604|459306209|FG001|Week 8|Lost to Follow-up|2|||
127641333|NCT04348604|459306208|FG000|Week 8|Suspended|0|||
127641334|NCT04348604|459306209|FG001|Week 8|Suspended|1|||
127641335|NCT04348604|459306208|FG000|Week 12|Lost to Follow-up|1|||
127641336|NCT04348604|459306209|FG001|Week 12|Lost to Follow-up|2|||
127641337|NCT04348604|459306208|FG000|Week 12|Withdrawal by Subject|1|||
127641338|NCT04348604|459306209|FG001|Week 12|Withdrawal by Subject|0|||
127641339|NCT04348604|459306208|FG000|Week 24|Lost to Follow-up|2|||
127641340|NCT04348604|459306209|FG001|Week 24|Lost to Follow-up|1|||
127641341|NCT02097108|459306210|FG000|Overall Study|Adverse Event|1|||
127641342|NCT02097108|459306210|FG000|Overall Study|patient was abroad for 6 months|1|||
127641343|NCT00955357|459308182|FG000|Titration Phase|Adverse Event|9|||
127641344|NCT00955357|459308183|FG001|Titration Phase|Adverse Event|46|||
127641345|NCT00955357|459308182|FG000|Titration Phase|Lack of Efficacy|0|||
127641346|NCT00955357|459308183|FG001|Titration Phase|Lack of Efficacy|2|||
127641347|NCT00955357|459308182|FG000|Titration Phase|Protocol Violation|3|||
127641348|NCT00955357|459308183|FG001|Titration Phase|Protocol Violation|7|||
127641349|NCT00955357|459308182|FG000|Titration Phase|Lost to Follow-up|1|||
127641350|NCT00955357|459308183|FG001|Titration Phase|Lost to Follow-up|3|||
127641351|NCT00955357|459308182|FG000|Titration Phase|Withdrawal by Subject|3|||
127641352|NCT00955357|459308183|FG001|Titration Phase|Withdrawal by Subject|5|||
127641353|NCT00955357|459308182|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
127641354|NCT00955357|459308183|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
127641355|NCT00955357|459308182|FG000|Titration Phase|Study medication not tolerated|0|||
127641356|NCT00955357|459308183|FG001|Titration Phase|Study medication not tolerated|1|||
127641357|NCT00955357|459308182|FG000|Titration Phase|Non compliance to study procedures|0|||
127641358|NCT00955357|459308183|FG001|Titration Phase|Non compliance to study procedures|1|||
127641359|NCT00955357|459308182|FG000|Maintenance Phase|Adverse Event|3|||
127641360|NCT00955357|459308183|FG001|Maintenance Phase|Adverse Event|23|||
127641361|NCT00955357|459308182|FG000|Maintenance Phase|Lack of Efficacy|0|||
127641362|NCT00955357|459308183|FG001|Maintenance Phase|Lack of Efficacy|4|||
127641363|NCT00955357|459308182|FG000|Maintenance Phase|Protocol Violation|2|||
127641364|NCT00955357|459308183|FG001|Maintenance Phase|Protocol Violation|6|||
127641365|NCT00955357|459308182|FG000|Maintenance Phase|Lost to Follow-up|2|||
127641366|NCT00955357|459308183|FG001|Maintenance Phase|Lost to Follow-up|7|||
127641367|NCT00955357|459308182|FG000|Maintenance Phase|Withdrawal by Subject|4|||
127641368|NCT00955357|459308183|FG001|Maintenance Phase|Withdrawal by Subject|4|||
127641369|NCT00955357|459308182|FG000|Maintenance Phase|Patient moving out of area|0|||
127641370|NCT00955357|459308183|FG001|Maintenance Phase|Patient moving out of area|1|||
127641371|NCT00955357|459308182|FG000|Maintenance Phase|Non compliance to study procedures|1|||
127641372|NCT00955357|459308183|FG001|Maintenance Phase|Non compliance to study procedures|0|||
127641373|NCT01258608|459308184|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
127641374|NCT01258608|459308185|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
127641375|NCT01258608|459308184|FG000|Overall Study|Clinical progression|1|||
127641376|NCT01258608|459308185|FG001|Overall Study|Clinical progression|0|||
127641377|NCT01258608|459308184|FG000|Overall Study|Sponsor decision|0|||
127641378|NCT01258608|459308185|FG001|Overall Study|Sponsor decision|1|||
127641379|NCT01258608|459308184|FG000|Overall Study|Physician Decision|6|||
127641380|NCT01258608|459308185|FG001|Overall Study|Physician Decision|1|||
127641381|NCT01258608|459308184|FG000|Overall Study|Lost to Follow-up|0|||
127641382|NCT01258608|459308185|FG001|Overall Study|Lost to Follow-up|1|||
127641383|NCT01258608|459308184|FG000|Overall Study|Lack of compliance|1|||
127641384|NCT01258608|459308185|FG001|Overall Study|Lack of compliance|0|||
127641385|NCT01258608|459308184|FG000|Overall Study|Lack of Efficacy|0|||
127641386|NCT01258608|459308185|FG001|Overall Study|Lack of Efficacy|1|||
127641387|NCT01258608|459308184|FG000|Overall Study|Adverse Event|6|||
127641388|NCT01258608|459308185|FG001|Overall Study|Adverse Event|10|||
127641389|NCT01258608|459308184|FG000|Overall Study|Withdrawal by Subject|6|||
127641390|NCT01258608|459308185|FG001|Overall Study|Withdrawal by Subject|5|||
127641391|NCT02943408|459308187|FG000|Overall Study|Lost to Follow-up|7|||
127641392|NCT02943408|459308188|FG001|Overall Study|Lost to Follow-up|1|||
127641393|NCT02943408|459308187|FG000|Overall Study|Withdrawal by Subject|0|||
127641394|NCT02943408|459308188|FG001|Overall Study|Withdrawal by Subject|1|||
127641395|NCT02181803|459308189|FG000|Overall Study|Withdrawal by Subject|0|||
127641396|NCT02181803|459308190|FG001|Overall Study|Withdrawal by Subject|2|||
127641397|NCT02181803|459308191|FG002|Overall Study|Withdrawal by Subject|0|||
127641398|NCT02181803|459308192|FG003|Overall Study|Withdrawal by Subject|0|||
127641399|NCT02181803|459308193|FG004|Overall Study|Withdrawal by Subject|0|||
127641400|NCT02181803|459308194|FG005|Overall Study|Withdrawal by Subject|0|||
127641401|NCT02181803|459308195|FG006|Overall Study|Withdrawal by Subject|0|||
127641402|NCT02181803|459308196|FG007|Overall Study|Withdrawal by Subject|0|||
127641403|NCT02181803|459308197|FG008|Overall Study|Withdrawal by Subject|0|||
127641404|NCT02181803|459308189|FG000|Overall Study|Physician Decision|0|||
127641405|NCT02181803|459308190|FG001|Overall Study|Physician Decision|0|||
127641406|NCT02181803|459308191|FG002|Overall Study|Physician Decision|0|||
127641407|NCT02181803|459308192|FG003|Overall Study|Physician Decision|1|||
127641408|NCT02181803|459308193|FG004|Overall Study|Physician Decision|0|||
127641409|NCT02181803|459308194|FG005|Overall Study|Physician Decision|0|||
127641410|NCT02181803|459308195|FG006|Overall Study|Physician Decision|0|||
127641411|NCT02181803|459308196|FG007|Overall Study|Physician Decision|1|||
127641412|NCT02181803|459308197|FG008|Overall Study|Physician Decision|0|||
127641413|NCT02181803|459308189|FG000|Overall Study|Adverse Event|0|||
127641414|NCT02181803|459308190|FG001|Overall Study|Adverse Event|2|||
127641415|NCT02181803|459308191|FG002|Overall Study|Adverse Event|0|||
127641416|NCT02181803|459308192|FG003|Overall Study|Adverse Event|1|||
127641417|NCT02181803|459308193|FG004|Overall Study|Adverse Event|0|||
127641418|NCT02181803|459308194|FG005|Overall Study|Adverse Event|0|||
127641419|NCT02181803|459308195|FG006|Overall Study|Adverse Event|1|||
127641420|NCT02181803|459308196|FG007|Overall Study|Adverse Event|0|||
127641421|NCT02181803|459308197|FG008|Overall Study|Adverse Event|0|||
127641422|NCT03151005|459308198|FG000|Overall Study|Lost to Follow-up|5|||
127641423|NCT03151005|459308199|FG001|Overall Study|Lost to Follow-up|5|||
127641424|NCT04786444|459308200|FG000|Overall Study|Withdrawal by Subject|4|||
127641425|NCT04786444|459308201|FG001|Overall Study|Withdrawal by Subject|7|||
127641426|NCT04786444|459308202|FG002|Overall Study|Withdrawal by Subject|2|||
127641427|NCT04786444|459308200|FG000|Overall Study|Lost to Follow-up|11|||
127641428|NCT04786444|459308201|FG001|Overall Study|Lost to Follow-up|9|||
127641429|NCT04786444|459308202|FG002|Overall Study|Lost to Follow-up|10|||
127641430|NCT04786444|459308200|FG000|Overall Study|Subject would like to become pregnant|0|||
127641431|NCT04786444|459308201|FG001|Overall Study|Subject would like to become pregnant|1|||
127641432|NCT04786444|459308202|FG002|Overall Study|Subject would like to become pregnant|0|||
127641433|NCT02462876|459308203|FG000|Overall Study|Death|3|||
127641434|NCT02462876|459308203|FG000|Overall Study|Lost to Follow-up|7|||
127641435|NCT02462876|459308203|FG000|Overall Study|Surgical Bypass|9|||
127641436|NCT02462876|459308203|FG000|Overall Study|Amputation Above the Metatarsals|1|||
127641437|NCT02462876|459308203|FG000|Overall Study|36 months follow-up visit missed|1|||
127641438|NCT02462876|459308203|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
127641439|NCT02462876|459308203|FG000|Overall Study|Patient did not come back to the vascular department|1|||
127641440|NCT02462876|459308203|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
127641441|NCT02462876|459308203|FG000|Overall Study|Patient refused to come back|1|||
127641442|NCT02462876|459308203|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
127641443|NCT02462876|459308203|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
127641444|NCT01786512|459308208|FG000|Overall Study|Lost to Follow-up|0|||
127641445|NCT01786512|459308209|FG001|Overall Study|Lost to Follow-up|0|||
127641446|NCT01786512|459308210|FG002|Overall Study|Lost to Follow-up|0|||
127641447|NCT01786512|459308211|FG003|Overall Study|Lost to Follow-up|0|||
127641448|NCT01786512|459308212|FG004|Overall Study|Lost to Follow-up|0|||
127641449|NCT01786512|459308213|FG005|Overall Study|Lost to Follow-up|0|||
127641450|NCT01786512|459308214|FG006|Overall Study|Lost to Follow-up|0|||
127641451|NCT01786512|459308215|FG007|Overall Study|Lost to Follow-up|0|||
127641452|NCT01786512|459308216|FG008|Overall Study|Lost to Follow-up|0|||
127641453|NCT01786512|459308217|FG009|Overall Study|Lost to Follow-up|1|||
127641454|NCT01786512|459308218|FG010|Overall Study|Lost to Follow-up|0|||
127641455|NCT01786512|459308208|FG000|Overall Study|Decision by sponsor|0|||
127641456|NCT01786512|459308209|FG001|Overall Study|Decision by sponsor|0|||
127641457|NCT01786512|459308210|FG002|Overall Study|Decision by sponsor|0|||
127641458|NCT01786512|459308211|FG003|Overall Study|Decision by sponsor|0|||
127641459|NCT01786512|459308212|FG004|Overall Study|Decision by sponsor|0|||
127641460|NCT01786512|459308213|FG005|Overall Study|Decision by sponsor|0|||
127641461|NCT01786512|459308214|FG006|Overall Study|Decision by sponsor|0|||
127641462|NCT01786512|459308215|FG007|Overall Study|Decision by sponsor|0|||
127641463|NCT01786512|459308216|FG008|Overall Study|Decision by sponsor|0|||
127641464|NCT01786512|459308217|FG009|Overall Study|Decision by sponsor|0|||
127641465|NCT01786512|459308218|FG010|Overall Study|Decision by sponsor|2|||
127641466|NCT01786512|459308208|FG000|Overall Study|Withdrawal by Subject|0|||
127641467|NCT01786512|459308209|FG001|Overall Study|Withdrawal by Subject|1|||
127641468|NCT01786512|459308210|FG002|Overall Study|Withdrawal by Subject|0|||
127641469|NCT01786512|459308211|FG003|Overall Study|Withdrawal by Subject|0|||
127641470|NCT01786512|459308212|FG004|Overall Study|Withdrawal by Subject|0|||
127641471|NCT01786512|459308213|FG005|Overall Study|Withdrawal by Subject|0|||
127641472|NCT01786512|459308214|FG006|Overall Study|Withdrawal by Subject|1|||
127641473|NCT01786512|459308215|FG007|Overall Study|Withdrawal by Subject|0|||
127641474|NCT01786512|459308216|FG008|Overall Study|Withdrawal by Subject|0|||
127641475|NCT01786512|459308217|FG009|Overall Study|Withdrawal by Subject|3|||
127641476|NCT01786512|459308218|FG010|Overall Study|Withdrawal by Subject|7|||
127641477|NCT01786512|459308208|FG000|Overall Study|Death|0|||
127641478|NCT01786512|459308209|FG001|Overall Study|Death|0|||
127641479|NCT01786512|459308210|FG002|Overall Study|Death|0|||
127641480|NCT01786512|459308211|FG003|Overall Study|Death|0|||
127641481|NCT01786512|459308212|FG004|Overall Study|Death|0|||
127641482|NCT01786512|459308213|FG005|Overall Study|Death|0|||
127641483|NCT01786512|459308214|FG006|Overall Study|Death|0|||
127641484|NCT01786512|459308215|FG007|Overall Study|Death|0|||
127641485|NCT01786512|459308216|FG008|Overall Study|Death|4|||
127641486|NCT01786512|459308217|FG009|Overall Study|Death|1|||
127641487|NCT01786512|459308218|FG010|Overall Study|Death|3|||
127641488|NCT03166618|459308219|FG000|Overall Study|Study was Terminated|0|||
127641489|NCT03166618|459308220|FG001|Overall Study|Study was Terminated|1|||
127641490|NCT01925950|459308221|FG000|Part 2|Withdrawal by Subject|1|||
127641491|NCT01925950|459308222|FG001|Part 2|Withdrawal by Subject|0|||
127641492|NCT00605293|459308225|FG000|Overall Study|Death|2|||
127641493|NCT00605293|459308226|FG001|Overall Study|Death|1|||
127641494|NCT00605293|459308225|FG000|Overall Study|Insufficient Therapeutic Response|2|||
127641495|NCT00605293|459308226|FG001|Overall Study|Insufficient Therapeutic Response|0|||
127641496|NCT00605293|459308225|FG000|Overall Study|Adverse Event|1|||
127641497|NCT00605293|459308226|FG001|Overall Study|Adverse Event|0|||
127641498|NCT00605293|459308225|FG000|Overall Study|Holidays Dialysis Out|1|||
127641499|NCT00605293|459308226|FG001|Overall Study|Holidays Dialysis Out|0|||
127641500|NCT00605293|459308225|FG000|Overall Study|Blood Transfusion|7|||
127641501|NCT00605293|459308226|FG001|Overall Study|Blood Transfusion|1|||
127641502|NCT00605293|459308225|FG000|Overall Study|Renal Transplantation|3|||
127641503|NCT00605293|459308226|FG001|Overall Study|Renal Transplantation|1|||
127641504|NCT00605293|459308225|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
127641505|NCT00605293|459308226|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
127641506|NCT00605293|459308225|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
127641507|NCT00605293|459308226|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
127641508|NCT00605293|459308225|FG000|Overall Study|Principal Investigator Decision|0|||
127641509|NCT00605293|459308226|FG001|Overall Study|Principal Investigator Decision|1|||
127641510|NCT00381940|459308227|FG000|Overall Study|Lack of Efficacy|3|||
127641511|NCT00381940|459308227|FG000|Overall Study|Protocol Violation|1|||
127641512|NCT00381940|459308227|FG000|Overall Study|Ineligible|1|||
127641513|NCT03162224|459308228|FG000|Overall Study|Death|4|||
127641514|NCT03162224|459308229|FG001|Overall Study|Death|5|||
127641515|NCT03162224|459308230|FG002|Overall Study|Death|8|||
127641516|NCT03162224|459308228|FG000|Overall Study|Withdrawal by Subject|1|||
127641517|NCT03162224|459308229|FG001|Overall Study|Withdrawal by Subject|0|||
127641518|NCT03162224|459308230|FG002|Overall Study|Withdrawal by Subject|1|||
127641519|NCT03162224|459308228|FG000|Overall Study|Lost to Follow-up|0|||
127641520|NCT03162224|459308229|FG001|Overall Study|Lost to Follow-up|1|||
127641521|NCT03162224|459308230|FG002|Overall Study|Lost to Follow-up|0|||
127641522|NCT03162224|459308228|FG000|Overall Study|Other|6|||
127641523|NCT03162224|459308229|FG001|Overall Study|Other|2|||
127641524|NCT03162224|459308230|FG002|Overall Study|Other|1|||
127704775|NCT03334630|459550286|FG000|Overall Study|Withdrawal by Subject|7|||
127704776|NCT03334630|459550287|FG001|Overall Study|Withdrawal by Subject|7|||
127704777|NCT03334630|459550286|FG000|Overall Study|Lost to Follow-up|3|||
127704778|NCT03334630|459550287|FG001|Overall Study|Lost to Follow-up|1|||
127641525|NCT03137303|459308232|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
127704779|NCT03334630|459550286|FG000|Overall Study|Adverse Event|0|||
127704780|NCT03334630|459550287|FG001|Overall Study|Adverse Event|1|||
127641526|NCT03137303|459308233|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
127641527|NCT03137303|459308232|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
127641528|NCT03137303|459308233|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
127641529|NCT03137303|459308232|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
127641530|NCT03137303|459308233|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
127641531|NCT03137303|459308232|FG000|T3: 9-month Follow-up|Death|1|||
127641532|NCT03137303|459308233|FG001|T3: 9-month Follow-up|Death|0|||
127641533|NCT03137303|459308232|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
127641534|NCT03137303|459308233|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
127641535|NCT03137303|459308232|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
127641536|NCT03137303|459308233|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
127641537|NCT03137303|459308232|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
127641538|NCT03137303|459308233|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
127704781|NCT03334630|459550286|FG000|Overall Study|Physician Decision|1|||
127798385|NCT05030311|459885582|FG000|Overall Study|Lost to Follow-up|5|||
127798386|NCT05030311|459885583|FG001|Overall Study|Lost to Follow-up|1|||
127798387|NCT05030311|459885582|FG000|Overall Study|Protocol Violation|4|||
127798388|NCT05030311|459885583|FG001|Overall Study|Protocol Violation|4|||
127798389|NCT03042468|459885585|FG000|Overall Study|Death|0|||
127798390|NCT03042468|459885586|FG001|Overall Study|Death|1|||
127798391|NCT03042468|459885587|FG002|Overall Study|Death|1|||
127641539|NCT03561090|459308236|FG000|Overall Study|Adverse Event|11|||
127641540|NCT03561090|459308237|FG001|Overall Study|Adverse Event|7|||
127641541|NCT03561090|459308236|FG000|Overall Study|Non-Compliance With Study Drug|2|||
127641542|NCT03561090|459308237|FG001|Overall Study|Non-Compliance With Study Drug|0|||
127641543|NCT03561090|459308236|FG000|Overall Study|Protocol Violation|2|||
127641544|NCT03561090|459308237|FG001|Overall Study|Protocol Violation|2|||
127641545|NCT03561090|459308236|FG000|Overall Study|Withdrawal by Subject|7|||
127641546|NCT03561090|459308237|FG001|Overall Study|Withdrawal by Subject|7|||
127641547|NCT03561090|459308236|FG000|Overall Study|Lost to Follow-up|7|||
127641548|NCT03561090|459308237|FG001|Overall Study|Lost to Follow-up|2|||
127641549|NCT03561090|459308236|FG000|Overall Study|Study Terminated by Sponsor|10|||
127641550|NCT03561090|459308237|FG001|Overall Study|Study Terminated by Sponsor|15|||
127641551|NCT03561090|459308236|FG000|Overall Study|Randomized by Mistake|1|||
127641552|NCT03561090|459308237|FG001|Overall Study|Randomized by Mistake|1|||
127641553|NCT03561090|459308236|FG000|Overall Study|Other Not Specified|0|||
127641554|NCT03561090|459308237|FG001|Overall Study|Other Not Specified|2|||
127641555|NCT04162769|459308238|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
127641556|NCT04162769|459308239|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
127641557|NCT04162769|459308240|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
127641558|NCT04162769|459308241|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
127641559|NCT04162769|459308238|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
127641560|NCT04162769|459308239|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
127641561|NCT04162769|459308240|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
127641562|NCT04162769|459308241|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
127641563|NCT04162769|459308238|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
127641564|NCT04162769|459308239|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
127641565|NCT04162769|459308240|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
127641566|NCT04162769|459308241|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
127641567|NCT04162769|459308238|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
127641568|NCT04162769|459308239|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
127641569|NCT04162769|459308240|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
127641570|NCT04162769|459308241|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
127641571|NCT04162769|459308238|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
127641572|NCT04162769|459308239|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
127641573|NCT04162769|459308240|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
127641574|NCT04162769|459308241|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
127641575|NCT04162769|459308238|FG000|Double-blind Treatment (12-Week)|Other|0|||
127641576|NCT04162769|459308239|FG001|Double-blind Treatment (12-Week)|Other|1|||
127641577|NCT04162769|459308240|FG002|Double-blind Treatment (12-Week)|Other|1|||
127641578|NCT04162769|459308241|FG003|Double-blind Treatment (12-Week)|Other|0|||
127641579|NCT04162769|459308238|FG000|OLE Period (52-Week)|Adverse Event|0|||
127641580|NCT04162769|459308239|FG001|OLE Period (52-Week)|Adverse Event|0|||
127641581|NCT04162769|459308240|FG002|OLE Period (52-Week)|Adverse Event|0|||
127641582|NCT04162769|459308241|FG003|OLE Period (52-Week)|Adverse Event|5|||
127641583|NCT04162769|459308238|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
127641584|NCT04162769|459308239|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
127641585|NCT04162769|459308240|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
127641586|NCT04162769|459308241|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
127641587|NCT04162769|459308238|FG000|OLE Period (52-Week)|Physician Decision|0|||
127641588|NCT04162769|459308239|FG001|OLE Period (52-Week)|Physician Decision|0|||
127641589|NCT04162769|459308240|FG002|OLE Period (52-Week)|Physician Decision|0|||
127641590|NCT04162769|459308241|FG003|OLE Period (52-Week)|Physician Decision|1|||
127641591|NCT04162769|459308238|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
127641592|NCT04162769|459308239|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
127641593|NCT04162769|459308240|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
127641594|NCT04162769|459308241|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
127641595|NCT04162769|459308238|FG000|OLE Period (52-Week)|Protocol deviation|0|||
127641596|NCT04162769|459308239|FG001|OLE Period (52-Week)|Protocol deviation|0|||
127641597|NCT04162769|459308240|FG002|OLE Period (52-Week)|Protocol deviation|0|||
127641598|NCT04162769|459308241|FG003|OLE Period (52-Week)|Protocol deviation|2|||
127641599|NCT00725452|459308244|FG000|Overall Study|Adverse Event|3|||
127641600|NCT00725452|459308244|FG000|Overall Study|Lack of Efficacy|2|||
127641601|NCT00725452|459308244|FG000|Overall Study|Reason not specified|1|||
127798392|NCT03042468|459885588|FG003|Overall Study|Death|0|||
127798393|NCT03042468|459885589|FG004|Overall Study|Death|0|||
127641602|NCT00725452|459308244|FG000|Overall Study|Physician Decision|1|||
127798394|NCT03042468|459885590|FG005|Overall Study|Death|0|||
127641603|NCT00725452|459308244|FG000|Overall Study|Withdrawal by Subject|3|||
127641604|NCT00725452|459308244|FG000|Overall Study|Lost to Follow-up|1|||
127641605|NCT00620750|459308246|FG000|Overall Study|Lost to Follow-up|25|||
127641606|NCT02163733|459308247|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
127641607|NCT02163733|459308248|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
127641608|NCT02163733|459308249|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
127641609|NCT02163733|459308247|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
127641610|NCT02163733|459308248|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
127641611|NCT02163733|459308249|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
127641612|NCT04477187|459308250|FG000|Overall Study|Lost to Follow-up|2|||
127641613|NCT02633800|459308251|FG000|Overall Study|Death|3|||
127641614|NCT02633800|459308252|FG001|Overall Study|Death|3|||
127641615|NCT02633800|459308251|FG000|Overall Study|Reason not provided|1|||
127641616|NCT02633800|459308252|FG001|Overall Study|Reason not provided|0|||
127641617|NCT02633800|459308251|FG000|Overall Study|Radiologic(al) progression|23|||
127641618|NCT02633800|459308252|FG001|Overall Study|Radiologic(al) progression|23|||
127641619|NCT02633800|459308251|FG000|Overall Study|Clinical progression|3|||
127641620|NCT02633800|459308252|FG001|Overall Study|Clinical progression|6|||
127641621|NCT02633800|459308251|FG000|Overall Study|Study terminated by sponsor|6|||
127641622|NCT02633800|459308252|FG001|Overall Study|Study terminated by sponsor|5|||
127641623|NCT02633800|459308251|FG000|Overall Study|Adverse event, non-fatal|7|||
127641624|NCT02633800|459308252|FG001|Overall Study|Adverse event, non-fatal|2|||
127641625|NCT02633800|459308251|FG000|Overall Study|Withdrawal by Subject|0|||
127641626|NCT02633800|459308252|FG001|Overall Study|Withdrawal by Subject|3|||
127641627|NCT02633800|459308251|FG000|Overall Study|Patient Request|1|||
127641628|NCT02633800|459308252|FG001|Overall Study|Patient Request|1|||
127641629|NCT00746590|459308253|FG000|Overall Study|Death|1|||
127641630|NCT00464815|459308255|FG000|Overall Study|Withdrawal by Subject|6|||
127641631|NCT00464815|459308256|FG001|Overall Study|Withdrawal by Subject|3|||
127641632|NCT04402866|459308259|FG000|Overall Study|Discontinued Prior to Treatment|0|||
127641633|NCT04402866|459308260|FG001|Overall Study|Discontinued Prior to Treatment|0|||
127641634|NCT04402866|459308261|FG002|Overall Study|Discontinued Prior to Treatment|0|||
127641635|NCT04402866|459308262|FG003|Overall Study|Discontinued Prior to Treatment|0|||
127641636|NCT04402866|459308263|FG004|Overall Study|Discontinued Prior to Treatment|2|||
127641637|NCT04402866|459308264|FG005|Overall Study|Discontinued Prior to Treatment|3|||
127641638|NCT04402866|459308259|FG000|Overall Study|Adverse Event|2|||
127641639|NCT04402866|459308260|FG001|Overall Study|Adverse Event|1|||
127641640|NCT04402866|459308261|FG002|Overall Study|Adverse Event|0|||
127641641|NCT04402866|459308262|FG003|Overall Study|Adverse Event|0|||
127641642|NCT04402866|459308263|FG004|Overall Study|Adverse Event|13|||
127641643|NCT04402866|459308264|FG005|Overall Study|Adverse Event|8|||
127641644|NCT04402866|459308259|FG000|Overall Study|Miscellaneous|0|||
127641645|NCT04402866|459308260|FG001|Overall Study|Miscellaneous|0|||
127641646|NCT04402866|459308261|FG002|Overall Study|Miscellaneous|1|||
127641647|NCT04402866|459308262|FG003|Overall Study|Miscellaneous|0|||
127641648|NCT04402866|459308263|FG004|Overall Study|Miscellaneous|0|||
127641649|NCT04402866|459308264|FG005|Overall Study|Miscellaneous|0|||
127641650|NCT04402866|459308259|FG000|Overall Study|Lost to Follow-up|0|||
127641651|NCT04402866|459308260|FG001|Overall Study|Lost to Follow-up|0|||
127641652|NCT04402866|459308261|FG002|Overall Study|Lost to Follow-up|0|||
127641653|NCT04402866|459308262|FG003|Overall Study|Lost to Follow-up|0|||
127641654|NCT04402866|459308263|FG004|Overall Study|Lost to Follow-up|0|||
127641655|NCT04402866|459308264|FG005|Overall Study|Lost to Follow-up|1|||
127641656|NCT04402866|459308259|FG000|Overall Study|Withdrawal by Subject|0|||
127641657|NCT04402866|459308260|FG001|Overall Study|Withdrawal by Subject|0|||
127641658|NCT04402866|459308261|FG002|Overall Study|Withdrawal by Subject|0|||
127641659|NCT04402866|459308262|FG003|Overall Study|Withdrawal by Subject|0|||
127641660|NCT04402866|459308263|FG004|Overall Study|Withdrawal by Subject|0|||
127704782|NCT03334630|459550287|FG001|Overall Study|Physician Decision|1|||
127704783|NCT03334630|459550286|FG000|Overall Study|Enrollment closed|2|||
127704784|NCT03334630|459550287|FG001|Overall Study|Enrollment closed|1|||
127704785|NCT03334630|459550286|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
127704786|NCT03334630|459550287|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
127641661|NCT04402866|459308264|FG005|Overall Study|Withdrawal by Subject|2|||
127641662|NCT00868439|459308268|FG000|Overall Study|Adverse Event|4|||
127641663|NCT00868439|459308269|FG001|Overall Study|Adverse Event|3|||
127641664|NCT00868439|459308268|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
127641665|NCT00868439|459308269|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
127641666|NCT00868439|459308268|FG000|Overall Study|Death|0|||
127641667|NCT00868439|459308269|FG001|Overall Study|Death|1|||
127641668|NCT00868439|459308268|FG000|Overall Study|Protocol Violation|1|||
127641669|NCT00868439|459308269|FG001|Overall Study|Protocol Violation|1|||
127641670|NCT00868439|459308268|FG000|Overall Study|Physician Decision|1|||
127641671|NCT00868439|459308269|FG001|Overall Study|Physician Decision|0|||
127641672|NCT00868439|459308268|FG000|Overall Study|Withdrawal by Subject|0|||
127704787|NCT03334630|459550286|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
127641673|NCT00868439|459308269|FG001|Overall Study|Withdrawal by Subject|1|||
127641674|NCT00476476|459308270|FG000|Overall Study|Adverse Event|2|||
127641675|NCT00476476|459308271|FG001|Overall Study|Adverse Event|7|||
127641676|NCT00476476|459308270|FG000|Overall Study|Progressive Disease|0|||
127641677|NCT00476476|459308271|FG001|Overall Study|Progressive Disease|17|||
127641678|NCT00971048|459308279|FG000|Overall Study|Protocol Violation|1|||
127641679|NCT00971048|459308280|FG001|Overall Study|Protocol Violation|2|||
127641680|NCT00971048|459308281|FG002|Overall Study|Protocol Violation|0|||
127641681|NCT00971048|459308282|FG003|Overall Study|Protocol Violation|1|||
127641682|NCT00971048|459308279|FG000|Overall Study|Adverse Event|0|||
127887220|NCT00373685|460210514|FG000|Overall Study|Adverse Event|278|||
127887221|NCT00373685|460210515|FG001|Overall Study|Adverse Event|253|||
127641683|NCT00971048|459308280|FG001|Overall Study|Adverse Event|0|||
127641684|NCT00971048|459308281|FG002|Overall Study|Adverse Event|1|||
127641685|NCT00971048|459308282|FG003|Overall Study|Adverse Event|0|||
127641686|NCT00971048|459308279|FG000|Overall Study|Physician Decision|0|||
127641687|NCT00971048|459308280|FG001|Overall Study|Physician Decision|0|||
127641688|NCT00971048|459308281|FG002|Overall Study|Physician Decision|0|||
127641689|NCT00971048|459308282|FG003|Overall Study|Physician Decision|1|||
127641690|NCT03321396|459308285|FG000|Overall Study|Physician Decision|1|||
127641691|NCT01654549|459308288|FG000|Overall Study|H.pylori eradication not successful|0|||
127641692|NCT01654549|459308289|FG001|Overall Study|H.pylori eradication not successful|1|||
127641693|NCT00937924|459308290|FG000|Overall Study|Lost to Follow-up|44|||
127641694|NCT00937924|459308291|FG001|Overall Study|Lost to Follow-up|44|||
127641695|NCT00937924|459308292|FG002|Overall Study|Lost to Follow-up|41|||
127641696|NCT05072080|459308295|FG000|Overall Study|Death|0|||
127641697|NCT05072080|459308296|FG001|Overall Study|Death|0|||
127641698|NCT05072080|459308297|FG002|Overall Study|Death|1|||
127641699|NCT05072080|459308298|FG003|Overall Study|Death|0|||
127641700|NCT05072080|459308295|FG000|Overall Study|Lost to Follow-up|65|||
127641701|NCT05072080|459308296|FG001|Overall Study|Lost to Follow-up|70|||
127641702|NCT05072080|459308297|FG002|Overall Study|Lost to Follow-up|58|||
127641703|NCT05072080|459308298|FG003|Overall Study|Lost to Follow-up|23|||
127641704|NCT05072080|459308295|FG000|Overall Study|Physician Decision|2|||
127641705|NCT05072080|459308296|FG001|Overall Study|Physician Decision|1|||
127641706|NCT05072080|459308297|FG002|Overall Study|Physician Decision|1|||
127641707|NCT05072080|459308298|FG003|Overall Study|Physician Decision|0|||
127641708|NCT05072080|459308295|FG000|Overall Study|Withdrawal by Subject|45|||
127641709|NCT05072080|459308296|FG001|Overall Study|Withdrawal by Subject|30|||
127641710|NCT05072080|459308297|FG002|Overall Study|Withdrawal by Subject|27|||
127641711|NCT05072080|459308298|FG003|Overall Study|Withdrawal by Subject|7|||
127641712|NCT05072080|459308295|FG000|Overall Study|Sponsor Decision|0|||
127641713|NCT05072080|459308296|FG001|Overall Study|Sponsor Decision|1|||
127641714|NCT05072080|459308297|FG002|Overall Study|Sponsor Decision|0|||
127641715|NCT05072080|459308298|FG003|Overall Study|Sponsor Decision|0|||
127641716|NCT05072080|459308295|FG000|Overall Study|Subject moved|1|||
127641717|NCT05072080|459308296|FG001|Overall Study|Subject moved|3|||
127641718|NCT05072080|459308297|FG002|Overall Study|Subject moved|5|||
127641719|NCT05072080|459308298|FG003|Overall Study|Subject moved|2|||
127641720|NCT05072080|459308295|FG000|Overall Study|Withdrawal by parent|0|||
127641721|NCT05072080|459308296|FG001|Overall Study|Withdrawal by parent|0|||
127641722|NCT05072080|459308297|FG002|Overall Study|Withdrawal by parent|1|||
127641723|NCT05072080|459308298|FG003|Overall Study|Withdrawal by parent|0|||
127641724|NCT05072080|459308295|FG000|Overall Study|Subject was deployed|0|||
127641725|NCT05072080|459308296|FG001|Overall Study|Subject was deployed|1|||
127641726|NCT05072080|459308297|FG002|Overall Study|Subject was deployed|0|||
127641727|NCT05072080|459308298|FG003|Overall Study|Subject was deployed|0|||
127887222|NCT00373685|460210514|FG000|Overall Study|Insufficient clinical response|169|||
127887223|NCT00373685|460210515|FG001|Overall Study|Insufficient clinical response|119|||
127704788|NCT03334630|459550287|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
127704789|NCT03030261|459550289|FG000|Overall Study|Still receiving continuation therapy|5|||
127704790|NCT04971109|459550293|FG000|Overall Study|Adverse Event|4|||
127704791|NCT04971109|459550294|FG001|Overall Study|Adverse Event|3|||
127704792|NCT04971109|459550293|FG000|Overall Study|Failure to Meet Cont. Criteria|7|||
127704793|NCT04971109|459550294|FG001|Overall Study|Failure to Meet Cont. Criteria|0|||
127704794|NCT04971109|459550293|FG000|Overall Study|Lost to Follow-up|8|||
127704795|NCT04971109|459550294|FG001|Overall Study|Lost to Follow-up|2|||
127704796|NCT04971109|459550293|FG000|Overall Study|Physician Decision|5|||
127704797|NCT04971109|459550294|FG001|Overall Study|Physician Decision|0|||
127704798|NCT04971109|459550293|FG000|Overall Study|Protocol Violation|0|||
127704799|NCT04971109|459550294|FG001|Overall Study|Protocol Violation|1|||
127704800|NCT04971109|459550293|FG000|Overall Study|Withdrawal by Subject|18|||
127704801|NCT04971109|459550294|FG001|Overall Study|Withdrawal by Subject|3|||
127704802|NCT04971109|459550293|FG000|Overall Study|Subject was randomized in error|1|||
127704803|NCT04971109|459550294|FG001|Overall Study|Subject was randomized in error|0|||
127704804|NCT03910478|459550295|FG000|Overall Study|Death|13|||
127704805|NCT03910478|459550296|FG001|Overall Study|Death|6|||
127704806|NCT03910478|459550295|FG000|Overall Study|Withdrawal by Subject|23|||
127704807|NCT03910478|459550296|FG001|Overall Study|Withdrawal by Subject|2|||
127704808|NCT03910478|459550295|FG000|Overall Study|Physician Decision|5|||
127704809|NCT03910478|459550296|FG001|Overall Study|Physician Decision|0|||
127704810|NCT03910478|459550295|FG000|Overall Study|Protocol Violation|1|||
127704811|NCT03910478|459550296|FG001|Overall Study|Protocol Violation|0|||
127704812|NCT03910478|459550295|FG000|Overall Study|Failure to meet continuation criteria|2|||
127704813|NCT03910478|459550296|FG001|Overall Study|Failure to meet continuation criteria|0|||
127704814|NCT03910478|459550295|FG000|Overall Study|Wouldn't proceed DBS portion, data collection only|1|||
127704815|NCT03910478|459550296|FG001|Overall Study|Wouldn't proceed DBS portion, data collection only|0|||
127704816|NCT05293171|459550298|FG000|Washout 5 to 7 Days|Adverse Event|1|||
127704817|NCT05293171|459550299|FG001|Washout 5 to 7 Days|Adverse Event|1|||
127704818|NCT05293171|459550300|FG002|Washout 5 to 7 Days|Adverse Event|0|||
127704819|NCT05293171|459550301|FG003|Washout 5 to 7 Days|Adverse Event|0|||
127704820|NCT05293171|459550302|FG004|Washout 5 to 7 Days|Adverse Event|0|||
127704821|NCT05293171|459550303|FG005|Washout 5 to 7 Days|Adverse Event|0|||
127704822|NCT05293171|459550304|FG006|Washout 5 to 7 Days|Adverse Event|0|||
127704823|NCT05293171|459550305|FG007|Washout 5 to 7 Days|Adverse Event|0|||
127704824|NCT05293171|459550306|FG008|Washout 5 to 7 Days|Adverse Event|0|||
127704825|NCT05293171|459550307|FG009|Washout 5 to 7 Days|Adverse Event|0|||
127704826|NCT05293171|459550308|FG010|Washout 5 to 7 Days|Adverse Event|0|||
127704827|NCT05293171|459550309|FG011|Washout 5 to 7 Days|Adverse Event|0|||
127704828|NCT05293171|459550298|FG000|Washout 5 to 7 Days|Adverse Event|0|||
127704829|NCT05293171|459550299|FG001|Washout 5 to 7 Days|Adverse Event|0|||
127704830|NCT05293171|459550300|FG002|Washout 5 to 7 Days|Adverse Event|0|||
127704831|NCT05293171|459550301|FG003|Washout 5 to 7 Days|Adverse Event|0|||
127704832|NCT05293171|459550302|FG004|Washout 5 to 7 Days|Adverse Event|0|||
127704833|NCT05293171|459550303|FG005|Washout 5 to 7 Days|Adverse Event|1|||
127704834|NCT05293171|459550304|FG006|Washout 5 to 7 Days|Adverse Event|0|||
127704835|NCT05293171|459550305|FG007|Washout 5 to 7 Days|Adverse Event|0|||
127704836|NCT05293171|459550306|FG008|Washout 5 to 7 Days|Adverse Event|0|||
127704837|NCT05293171|459550307|FG009|Washout 5 to 7 Days|Adverse Event|0|||
127704838|NCT05293171|459550308|FG010|Washout 5 to 7 Days|Adverse Event|0|||
127704839|NCT05293171|459550309|FG011|Washout 5 to 7 Days|Adverse Event|0|||
127704840|NCT04066205|459550312|FG000|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|5|||
127704841|NCT04066205|459550313|FG001|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|3|||
127704842|NCT04066205|459550312|FG000|T2 Immediate Post-Intervention|did not respond|5|||
127704843|NCT04066205|459550313|FG001|T2 Immediate Post-Intervention|did not respond|3|||
127704844|NCT01712490|459550317|FG000|Overall Study|Ongoing|601|||
127704845|NCT01712490|459550318|FG001|Overall Study|Ongoing|586|||
127704846|NCT01712490|459550317|FG000|Overall Study|Other|11|||
127704847|NCT01712490|459550318|FG001|Overall Study|Other|11|||
127704848|NCT01712490|459550317|FG000|Overall Study|Withdrawal by Subject|36|||
127704849|NCT01712490|459550318|FG001|Overall Study|Withdrawal by Subject|44|||
127704850|NCT01712490|459550317|FG000|Overall Study|Lost to Follow-up|16|||
127704851|NCT01712490|459550318|FG001|Overall Study|Lost to Follow-up|29|||
127704852|NCT03987022|459550321|FG000|Overall Study|Lost to Follow-up|2|||
127704853|NCT03987022|459550322|FG001|Overall Study|Lost to Follow-up|2|||
127704854|NCT03987022|459550321|FG000|Overall Study|Withdrawal by Subject|1|||
127704855|NCT03987022|459550322|FG001|Overall Study|Withdrawal by Subject|0|||
127704856|NCT03478956|459550323|FG000|Randomized Treatment Period|Adverse Event|1|||
127704857|NCT03478956|459550324|FG001|Randomized Treatment Period|Adverse Event|0|||
127798395|NCT03042468|459885585|FG000|Overall Study|Withdrawal by Subject|0|||
127704858|NCT03478956|459550325|FG002|Randomized Treatment Period|Adverse Event|0|||
127704859|NCT03478956|459550326|FG003|Randomized Treatment Period|Adverse Event|0|||
127704860|NCT03478956|459550323|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
127704861|NCT03478956|459550324|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
127704862|NCT03478956|459550325|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
127641728|NCT05072080|459308295|FG000|Overall Study|Subject left site without receiving dose|0|||
127641729|NCT05072080|459308296|FG001|Overall Study|Subject left site without receiving dose|1|||
127641730|NCT05072080|459308297|FG002|Overall Study|Subject left site without receiving dose|0|||
127641731|NCT05072080|459308298|FG003|Overall Study|Subject left site without receiving dose|0|||
127641732|NCT05072080|459308295|FG000|Overall Study|Subject incarcerated|0|||
127641733|NCT05072080|459308296|FG001|Overall Study|Subject incarcerated|1|||
127641734|NCT05072080|459308297|FG002|Overall Study|Subject incarcerated|0|||
127641735|NCT05072080|459308298|FG003|Overall Study|Subject incarcerated|1|||
127641736|NCT05072080|459308295|FG000|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|0|||
127641737|NCT05072080|459308296|FG001|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|2|||
127641738|NCT05072080|459308297|FG002|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
127641739|NCT05072080|459308298|FG003|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
127641740|NCT05072080|459308295|FG000|Overall Study|Subject missed last visit (Day 183)|3|||
127641741|NCT05072080|459308296|FG001|Overall Study|Subject missed last visit (Day 183)|1|||
127641742|NCT05072080|459308297|FG002|Overall Study|Subject missed last visit (Day 183)|1|||
127641743|NCT05072080|459308298|FG003|Overall Study|Subject missed last visit (Day 183)|0|||
127641744|NCT01972841|459308305|FG000|Overall Study|Randomized but Never Received Treatment|2|||
127641745|NCT01972841|459308306|FG001|Overall Study|Randomized but Never Received Treatment|5|||
127641746|NCT01972841|459308307|FG002|Overall Study|Randomized but Never Received Treatment|4|||
127641747|NCT01972841|459308308|FG003|Overall Study|Randomized but Never Received Treatment|2|||
127641748|NCT01972841|459308309|FG004|Overall Study|Randomized but Never Received Treatment|6|||
127641749|NCT01972841|459308310|FG005|Overall Study|Randomized but Never Received Treatment|13|||
127641750|NCT01972841|459308305|FG000|Overall Study|Adverse Event|13|||
127641751|NCT01972841|459308306|FG001|Overall Study|Adverse Event|8|||
127798396|NCT03042468|459885586|FG001|Overall Study|Withdrawal by Subject|0|||
127641752|NCT01972841|459308307|FG002|Overall Study|Adverse Event|12|||
127641753|NCT01972841|459308308|FG003|Overall Study|Adverse Event|9|||
127641754|NCT01972841|459308309|FG004|Overall Study|Adverse Event|21|||
127641755|NCT01972841|459308310|FG005|Overall Study|Adverse Event|26|||
127798397|NCT03042468|459885587|FG002|Overall Study|Withdrawal by Subject|0|||
127887224|NCT00373685|460210514|FG000|Overall Study|Did not meet entrance criteria|167|||
127704863|NCT03478956|459550326|FG003|Randomized Treatment Period|Withdrawal by Subject|0|||
127704864|NCT03478956|459550323|FG000|Open Label Extension Period|Adverse Event|0|||
127704865|NCT03478956|459550324|FG001|Open Label Extension Period|Adverse Event|0|||
127704866|NCT03478956|459550325|FG002|Open Label Extension Period|Adverse Event|4|||
127704867|NCT03478956|459550326|FG003|Open Label Extension Period|Adverse Event|0|||
127704868|NCT03478956|459550323|FG000|Open Label Extension Period|Lack of Efficacy|0|||
127704869|NCT03478956|459550324|FG001|Open Label Extension Period|Lack of Efficacy|0|||
127704870|NCT03478956|459550325|FG002|Open Label Extension Period|Lack of Efficacy|8|||
127704871|NCT03478956|459550326|FG003|Open Label Extension Period|Lack of Efficacy|0|||
127704872|NCT03478956|459550323|FG000|Open Label Extension Period|Reason Not Provided|0|||
127704873|NCT03478956|459550324|FG001|Open Label Extension Period|Reason Not Provided|0|||
127704874|NCT03478956|459550325|FG002|Open Label Extension Period|Reason Not Provided|1|||
127704875|NCT03478956|459550326|FG003|Open Label Extension Period|Reason Not Provided|0|||
127704876|NCT03478956|459550323|FG000|Open Label Extension Period|Study Terminated by Sponsor|0|||
127704877|NCT03478956|459550324|FG001|Open Label Extension Period|Study Terminated by Sponsor|0|||
127704878|NCT03478956|459550325|FG002|Open Label Extension Period|Study Terminated by Sponsor|6|||
127704879|NCT03478956|459550326|FG003|Open Label Extension Period|Study Terminated by Sponsor|0|||
127704880|NCT03478956|459550323|FG000|Open Label Extension Period|Withdrawal by Subject|0|||
127704881|NCT03478956|459550324|FG001|Open Label Extension Period|Withdrawal by Subject|0|||
127704882|NCT03478956|459550325|FG002|Open Label Extension Period|Withdrawal by Subject|2|||
127704883|NCT03478956|459550326|FG003|Open Label Extension Period|Withdrawal by Subject|0|||
127704884|NCT03478956|459550323|FG000|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
127704885|NCT03478956|459550324|FG001|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
127704886|NCT03478956|459550325|FG002|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
127704887|NCT03478956|459550326|FG003|PML Safety Monitoring Period|Study Terminated by Sponsor|9|||
127704888|NCT04800211|459550327|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|4|||
127704889|NCT04800211|459550328|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|1|||
127704890|NCT04800211|459550329|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|0|||
127704891|NCT04800211|459550327|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|1|||
127704892|NCT04800211|459550328|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
127704893|NCT04800211|459550329|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
127704894|NCT04800211|459550327|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
127704895|NCT04800211|459550328|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
127704896|NCT04800211|459550329|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|2|||
127704897|NCT04800211|459550327|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|8|||
127704898|NCT04800211|459550328|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|7|||
127704899|NCT04800211|459550329|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|2|||
127887225|NCT00373685|460210515|FG001|Overall Study|Did not meet entrance criteria|184|||
127887226|NCT00373685|460210514|FG000|Overall Study|Lost to follow up|83|||
127887227|NCT00373685|460210515|FG001|Overall Study|Lost to follow up|103|||
127887228|NCT00373685|460210514|FG000|Overall Study|No longer willing to participate|337|||
127887229|NCT00373685|460210515|FG001|Overall Study|No longer willing to participate|352|||
127887230|NCT00373685|460210514|FG000|Overall Study|Other|149|||
127887231|NCT00373685|460210515|FG001|Overall Study|Other|146|||
127641756|NCT01972841|459308305|FG000|Overall Study|Lack of Efficacy|1|||
127641757|NCT01972841|459308306|FG001|Overall Study|Lack of Efficacy|0|||
127641758|NCT01972841|459308307|FG002|Overall Study|Lack of Efficacy|0|||
127641759|NCT01972841|459308308|FG003|Overall Study|Lack of Efficacy|2|||
127641760|NCT01972841|459308309|FG004|Overall Study|Lack of Efficacy|4|||
127641761|NCT01972841|459308310|FG005|Overall Study|Lack of Efficacy|1|||
127641762|NCT01972841|459308305|FG000|Overall Study|Lost to Follow-up|4|||
127641763|NCT01972841|459308306|FG001|Overall Study|Lost to Follow-up|2|||
127641764|NCT01972841|459308307|FG002|Overall Study|Lost to Follow-up|4|||
127641765|NCT01972841|459308308|FG003|Overall Study|Lost to Follow-up|2|||
127641766|NCT01972841|459308309|FG004|Overall Study|Lost to Follow-up|9|||
127641767|NCT01972841|459308310|FG005|Overall Study|Lost to Follow-up|3|||
127641768|NCT01972841|459308305|FG000|Overall Study|Protocol Violation|2|||
127641769|NCT01972841|459308306|FG001|Overall Study|Protocol Violation|2|||
127641770|NCT01972841|459308307|FG002|Overall Study|Protocol Violation|3|||
127641771|NCT01972841|459308308|FG003|Overall Study|Protocol Violation|5|||
127641772|NCT01972841|459308309|FG004|Overall Study|Protocol Violation|9|||
127641773|NCT01972841|459308310|FG005|Overall Study|Protocol Violation|4|||
127641774|NCT01972841|459308305|FG000|Overall Study|Withdrawal by participants|21|||
127641775|NCT01972841|459308306|FG001|Overall Study|Withdrawal by participants|27|||
127641776|NCT01972841|459308307|FG002|Overall Study|Withdrawal by participants|23|||
127641777|NCT01972841|459308308|FG003|Overall Study|Withdrawal by participants|16|||
127641778|NCT01972841|459308309|FG004|Overall Study|Withdrawal by participants|33|||
127641779|NCT01972841|459308310|FG005|Overall Study|Withdrawal by participants|34|||
127641780|NCT01972841|459308305|FG000|Overall Study|Miscellaneous|0|||
127641781|NCT01972841|459308306|FG001|Overall Study|Miscellaneous|0|||
127641782|NCT01972841|459308307|FG002|Overall Study|Miscellaneous|4|||
127641783|NCT01972841|459308308|FG003|Overall Study|Miscellaneous|1|||
127704900|NCT04800211|459550327|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Other|1|||
127704901|NCT04800211|459550328|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
127704902|NCT04800211|459550329|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
127704903|NCT04800211|459550327|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
127704904|NCT04800211|459550328|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
127704905|NCT04800211|459550329|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|1|||
127704906|NCT04800211|459550327|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
127704907|NCT04800211|459550328|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
127704908|NCT04800211|459550329|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|1|||
127704909|NCT04800211|459550327|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|8|||
127704910|NCT04800211|459550328|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|7|||
127704911|NCT04800211|459550329|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|5|||
127704912|NCT04800211|459550327|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
127704913|NCT04800211|459550328|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
127704914|NCT04800211|459550329|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|1|||
127704915|NCT04800211|459550327|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
127704916|NCT04800211|459550328|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
127704917|NCT04800211|459550329|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Other|2|||
127704918|NCT04800211|459550327|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|1|||
127704919|NCT04800211|459550328|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
127704920|NCT04800211|459550329|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
127704921|NCT05123586|459550332|FG000|Overall Study|Physician Decision|1|||
127704922|NCT05123586|459550333|FG001|Overall Study|Physician Decision|1|||
127704923|NCT05123586|459550332|FG000|Overall Study|Withdrawal by Subject|0|||
127704924|NCT05123586|459550333|FG001|Overall Study|Withdrawal by Subject|3|||
127704925|NCT03734679|459550339|FG000|Overall Study|Missed Visit|1|||
127704926|NCT02887521|459550347|FG000|Overall Study|Withdrawal by Subject|0|||
127704927|NCT02887521|459550348|FG001|Overall Study|Withdrawal by Subject|3|||
127704928|NCT05299723|459551537|FG000|Overall Study|Withdrawal by Subject|0|||
127704929|NCT05299723|459551538|FG001|Overall Study|Withdrawal by Subject|2|||
127704930|NCT05299723|459551539|FG002|Overall Study|Withdrawal by Subject|0|||
127704931|NCT03220035|459551540|FG000|Overall Study|Adverse Event|1|||
127704932|NCT03220035|459551540|FG000|Overall Study|Protocol Violation|1|||
127704933|NCT03220035|459551540|FG000|Overall Study|Progressive Disease|2|||
127704934|NCT02593773|459551546|FG000|Overall Study|Voluntary Withdrawal|3|||
127704935|NCT02593773|459551546|FG000|Overall Study|Study Terminated by Sponsor|31|||
127704936|NCT02593773|459551546|FG000|Overall Study|Death|1|||
127704937|NCT05452460|459551550|FG000|Overall Study|Lost to Follow-up|3|||
127704938|NCT05452460|459551551|FG001|Overall Study|Lost to Follow-up|3|||
127704939|NCT05452460|459551550|FG000|Overall Study|Did not receive intervention|1|||
127704940|NCT05452460|459551551|FG001|Overall Study|Did not receive intervention|0|||
127704941|NCT05934942|459551554|FG000|Run-in Period|Not treated|1|||
127704942|NCT05934942|459551554|FG000|Run-in Period|Withdrawal by Subject|1|||
127704943|NCT04447040|459551555|FG000|Overall Study|Lost to Follow-up|2|||
127704944|NCT04447040|459551556|FG001|Overall Study|Lost to Follow-up|1|||
127704945|NCT04447040|459551557|FG002|Overall Study|Lost to Follow-up|3|||
127704946|NCT04447040|459551558|FG003|Overall Study|Lost to Follow-up|3|||
127798398|NCT03042468|459885588|FG003|Overall Study|Withdrawal by Subject|0|||
127798399|NCT03042468|459885589|FG004|Overall Study|Withdrawal by Subject|0|||
127798400|NCT03042468|459885590|FG005|Overall Study|Withdrawal by Subject|1|||
127798401|NCT03042468|459885585|FG000|Overall Study|Lost to Follow-up|0|||
127641784|NCT01972841|459308309|FG004|Overall Study|Miscellaneous|0|||
127641785|NCT01972841|459308310|FG005|Overall Study|Miscellaneous|4|||
127641786|NCT01972841|459308305|FG000|Overall Study|Did not have end of treatment page|0|||
127641787|NCT01972841|459308306|FG001|Overall Study|Did not have end of treatment page|0|||
127641788|NCT01972841|459308307|FG002|Overall Study|Did not have end of treatment page|0|||
127641789|NCT01972841|459308308|FG003|Overall Study|Did not have end of treatment page|0|||
127641790|NCT01972841|459308309|FG004|Overall Study|Did not have end of treatment page|1|||
127641791|NCT01972841|459308310|FG005|Overall Study|Did not have end of treatment page|0|||
127641792|NCT04969198|459308313|FG000|Overall Study|Withdrawal by Subject|20|||
127641793|NCT04969198|459308313|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
127641794|NCT04969198|459308313|FG000|Overall Study|Lost to Follow-up|20|||
127641795|NCT02308748|459308324|FG000|Period 1|Withdrawal by Subject|0|||
127641796|NCT02308748|459308325|FG001|Period 1|Withdrawal by Subject|0|||
127641797|NCT02308748|459308326|FG002|Period 1|Withdrawal by Subject|1|||
127641798|NCT02308748|459308327|FG003|Period 1|Withdrawal by Subject|0|||
127641799|NCT02308748|459308328|FG004|Period 1|Withdrawal by Subject|0|||
127641800|NCT02308748|459308329|FG005|Period 1|Withdrawal by Subject|0|||
127641801|NCT02308748|459308330|FG006|Period 1|Withdrawal by Subject|0|||
127641802|NCT02308748|459308331|FG007|Period 1|Withdrawal by Subject|0|||
127641803|NCT02308748|459308332|FG008|Period 1|Withdrawal by Subject|0|||
127641804|NCT02308748|459308333|FG009|Period 1|Withdrawal by Subject|0|||
127641805|NCT02308748|459308324|FG000|Period 2|Adverse Event|0|||
127641806|NCT02308748|459308325|FG001|Period 2|Adverse Event|0|||
127641807|NCT02308748|459308326|FG002|Period 2|Adverse Event|0|||
127641808|NCT02308748|459308327|FG003|Period 2|Adverse Event|0|||
127641809|NCT02308748|459308328|FG004|Period 2|Adverse Event|0|||
127641810|NCT02308748|459308329|FG005|Period 2|Adverse Event|0|||
127641811|NCT02308748|459308330|FG006|Period 2|Adverse Event|0|||
127641812|NCT02308748|459308331|FG007|Period 2|Adverse Event|1|||
127641813|NCT02308748|459308332|FG008|Period 2|Adverse Event|0|||
127641814|NCT02308748|459308333|FG009|Period 2|Adverse Event|0|||
127641815|NCT02308748|459308324|FG000|Period 3|Protocol Violation|0|||
127641816|NCT02308748|459308325|FG001|Period 3|Protocol Violation|0|||
127641817|NCT02308748|459308326|FG002|Period 3|Protocol Violation|0|||
127641818|NCT02308748|459308327|FG003|Period 3|Protocol Violation|0|||
127641819|NCT02308748|459308328|FG004|Period 3|Protocol Violation|0|||
127641820|NCT02308748|459308329|FG005|Period 3|Protocol Violation|0|||
127641821|NCT02308748|459308330|FG006|Period 3|Protocol Violation|0|||
127641822|NCT02308748|459308331|FG007|Period 3|Protocol Violation|0|||
127641823|NCT02308748|459308332|FG008|Period 3|Protocol Violation|0|||
127641824|NCT02308748|459308333|FG009|Period 3|Protocol Violation|1|||
127641825|NCT02308748|459308324|FG000|Period 5|Adverse Event|1|||
127641826|NCT02308748|459308325|FG001|Period 5|Adverse Event|0|||
127641827|NCT02308748|459308326|FG002|Period 5|Adverse Event|0|||
127641828|NCT02308748|459308327|FG003|Period 5|Adverse Event|0|||
127641829|NCT02308748|459308328|FG004|Period 5|Adverse Event|0|||
127641830|NCT02308748|459308329|FG005|Period 5|Adverse Event|0|||
127641831|NCT02308748|459308330|FG006|Period 5|Adverse Event|0|||
127641832|NCT02308748|459308331|FG007|Period 5|Adverse Event|0|||
127641833|NCT02308748|459308332|FG008|Period 5|Adverse Event|1|||
127641834|NCT02308748|459308333|FG009|Period 5|Adverse Event|0|||
127641835|NCT01041638|459308334|FG000|Overall Study|Adverse Event|4|||
127641836|NCT01041638|459308334|FG000|Overall Study|Death|1|||
127641837|NCT01041638|459308334|FG000|Overall Study|Lack of Efficacy|7|||
127641838|NCT01041638|459308334|FG000|Overall Study|Physician Decision|4|||
127641839|NCT01041638|459308334|FG000|Overall Study|Withdrawal by Subject|11|||
127641840|NCT01687257|459308336|FG000|Overall Study|Efficacy Failure|6|||
127641841|NCT01687257|459308337|FG001|Overall Study|Efficacy Failure|0|||
127641842|NCT01687257|459308338|FG002|Overall Study|Efficacy Failure|5|||
127641843|NCT01687257|459308336|FG000|Overall Study|Subject Withdrew Consent|1|||
127641844|NCT01687257|459308337|FG001|Overall Study|Subject Withdrew Consent|1|||
127641845|NCT01687257|459308338|FG002|Overall Study|Subject Withdrew Consent|1|||
127641846|NCT01687257|459308336|FG000|Overall Study|Adverse Event|1|||
127641847|NCT01687257|459308337|FG001|Overall Study|Adverse Event|0|||
127641848|NCT01687257|459308338|FG002|Overall Study|Adverse Event|0|||
127641849|NCT01687257|459308336|FG000|Overall Study|Investigator's Discretion|0|||
127641850|NCT01687257|459308337|FG001|Overall Study|Investigator's Discretion|3|||
127641851|NCT01687257|459308338|FG002|Overall Study|Investigator's Discretion|0|||
127641852|NCT01565707|459308340|FG000|Overall Study|Adverse Event|1|||
127641853|NCT01565707|459308341|FG001|Overall Study|Adverse Event|6|||
127641854|NCT01565707|459308342|FG002|Overall Study|Adverse Event|2|||
127641855|NCT01565707|459308343|FG003|Overall Study|Adverse Event|1|||
127641856|NCT01565707|459308340|FG000|Overall Study|Lost to Follow-up|1|||
127641857|NCT01565707|459308341|FG001|Overall Study|Lost to Follow-up|0|||
127641858|NCT01565707|459308342|FG002|Overall Study|Lost to Follow-up|0|||
127641859|NCT01565707|459308343|FG003|Overall Study|Lost to Follow-up|0|||
127641860|NCT01565707|459308340|FG000|Overall Study|Protocol Violation|1|||
127641861|NCT01565707|459308341|FG001|Overall Study|Protocol Violation|0|||
127641862|NCT01565707|459308342|FG002|Overall Study|Protocol Violation|0|||
127641863|NCT01565707|459308343|FG003|Overall Study|Protocol Violation|1|||
127641864|NCT01565707|459308340|FG000|Overall Study|Withdrawal by Subject|3|||
127641865|NCT01565707|459308341|FG001|Overall Study|Withdrawal by Subject|1|||
127641866|NCT01565707|459308342|FG002|Overall Study|Withdrawal by Subject|1|||
127641867|NCT01565707|459308343|FG003|Overall Study|Withdrawal by Subject|1|||
127641868|NCT01565707|459308340|FG000|Overall Study|Randomized but not evaluable|2|||
127641869|NCT01565707|459308341|FG001|Overall Study|Randomized but not evaluable|0|||
127641870|NCT01565707|459308342|FG002|Overall Study|Randomized but not evaluable|0|||
127641871|NCT01565707|459308343|FG003|Overall Study|Randomized but not evaluable|0|||
127641872|NCT01565707|459308340|FG000|Overall Study|Miscellaneous|1|||
127641873|NCT01565707|459308341|FG001|Overall Study|Miscellaneous|1|||
127641874|NCT01565707|459308342|FG002|Overall Study|Miscellaneous|0|||
127641875|NCT01565707|459308343|FG003|Overall Study|Miscellaneous|2|||
127641876|NCT05207813|459308344|FG000|Overall Study|Lost to Follow-up|2|||
127641877|NCT04988308|459308348|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
127641878|NCT04988308|459308349|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
127641879|NCT04988308|459308350|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
127641880|NCT04988308|459308351|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
127641881|NCT04988308|459308352|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
127641882|NCT04988308|459308353|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
127641883|NCT04988308|459308348|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
127641884|NCT04988308|459308349|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
127641885|NCT04988308|459308350|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
127641886|NCT04988308|459308351|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
127641887|NCT04988308|459308352|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
127641888|NCT04988308|459308353|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
127641889|NCT04988308|459308348|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
127641890|NCT04988308|459308349|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
127641891|NCT04988308|459308350|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
127641892|NCT04988308|459308351|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
127641893|NCT04988308|459308352|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
127641894|NCT04988308|459308353|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
127641895|NCT04988308|459308348|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
127641896|NCT04988308|459308349|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
127641897|NCT04988308|459308350|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
127641898|NCT04988308|459308351|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
127641899|NCT04988308|459308352|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
127641900|NCT04988308|459308353|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
127641901|NCT04988308|459308348|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
127641902|NCT04988308|459308349|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
127641903|NCT04988308|459308350|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
127641904|NCT04988308|459308351|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
127641905|NCT04988308|459308352|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
127641906|NCT04988308|459308353|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
127641907|NCT04988308|459308348|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
127641908|NCT04988308|459308349|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
127641909|NCT04988308|459308350|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
127641910|NCT04988308|459308351|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
127641911|NCT04988308|459308352|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
127641912|NCT04988308|459308353|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
127641913|NCT04988308|459308348|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
127641914|NCT04988308|459308349|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
127641915|NCT04988308|459308350|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
127641916|NCT04988308|459308351|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
127641917|NCT04988308|459308352|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
127704947|NCT04447040|459551559|FG004|Overall Study|Lost to Follow-up|1|||
127704948|NCT04447040|459551560|FG005|Overall Study|Lost to Follow-up|3|||
127704949|NCT04447040|459551555|FG000|Overall Study|Withdrawal by Subject|0|||
127704950|NCT04447040|459551556|FG001|Overall Study|Withdrawal by Subject|1|||
127704951|NCT04447040|459551557|FG002|Overall Study|Withdrawal by Subject|1|||
127704952|NCT04447040|459551558|FG003|Overall Study|Withdrawal by Subject|1|||
127704953|NCT04447040|459551559|FG004|Overall Study|Withdrawal by Subject|0|||
127704954|NCT04447040|459551560|FG005|Overall Study|Withdrawal by Subject|0|||
127641918|NCT04988308|459308353|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
127704955|NCT01208662|459551561|FG000|Induction and Consolidation|Disease Progression|23|||
127641919|NCT04988308|459308348|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
127641920|NCT04988308|459308349|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
127641921|NCT04988308|459308350|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
127641922|NCT04988308|459308351|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
127641923|NCT04988308|459308352|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
127641924|NCT04988308|459308353|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
127641925|NCT04988308|459308348|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
127641926|NCT04988308|459308349|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
127641927|NCT04988308|459308350|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
127641928|NCT04988308|459308351|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
127641929|NCT04988308|459308352|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
127641930|NCT04988308|459308353|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
127641931|NCT02625623|459308355|FG000|Overall Study|Participants randomized but not treated|9|||
127641932|NCT02625623|459308356|FG001|Overall Study|Participants randomized but not treated|1|||
127641933|NCT02352948|459308357|FG000|Overall Study|Death|47|||
127641934|NCT02352948|459308358|FG001|Overall Study|Death|48|||
127641935|NCT02352948|459308359|FG002|Overall Study|Death|114|||
127641936|NCT02352948|459308360|FG003|Overall Study|Death|74|||
127641937|NCT02352948|459308361|FG004|Overall Study|Death|77|||
127641938|NCT02352948|459308362|FG005|Overall Study|Death|44|||
127641939|NCT02352948|459308357|FG000|Overall Study|Lost to Follow-up|1|||
127641940|NCT02352948|459308358|FG001|Overall Study|Lost to Follow-up|0|||
127641941|NCT02352948|459308359|FG002|Overall Study|Lost to Follow-up|2|||
127641942|NCT02352948|459308360|FG003|Overall Study|Lost to Follow-up|1|||
127641943|NCT02352948|459308361|FG004|Overall Study|Lost to Follow-up|2|||
127641944|NCT02352948|459308362|FG005|Overall Study|Lost to Follow-up|1|||
127641945|NCT02352948|459308357|FG000|Overall Study|Withdrawal by Subject|1|||
127641946|NCT02352948|459308358|FG001|Overall Study|Withdrawal by Subject|10|||
127641947|NCT02352948|459308359|FG002|Overall Study|Withdrawal by Subject|11|||
127641948|NCT02352948|459308360|FG003|Overall Study|Withdrawal by Subject|23|||
127641949|NCT02352948|459308361|FG004|Overall Study|Withdrawal by Subject|9|||
127641950|NCT02352948|459308362|FG005|Overall Study|Withdrawal by Subject|4|||
127641951|NCT02352948|459308357|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
127641952|NCT02352948|459308358|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
127641953|NCT02352948|459308359|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
127641954|NCT02352948|459308360|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
127641955|NCT02352948|459308361|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
127641956|NCT02352948|459308362|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
127641957|NCT02352948|459308357|FG000|Overall Study|Other|0|||
127641958|NCT02352948|459308358|FG001|Overall Study|Other|0|||
127641959|NCT02352948|459308359|FG002|Overall Study|Other|2|||
127641960|NCT02352948|459308360|FG003|Overall Study|Other|0|||
127641961|NCT02352948|459308361|FG004|Overall Study|Other|0|||
127641962|NCT02352948|459308362|FG005|Overall Study|Other|0|||
127641963|NCT01178086|459308363|FG000|Overall Study|Participant refusal|7|||
127641964|NCT01178086|459308363|FG000|Overall Study|Physician Decision|44|||
127641965|NCT01178086|459308363|FG000|Overall Study|Switch to other CLL therapy|113|||
127641966|NCT01178086|459308363|FG000|Overall Study|Death|59|||
127641967|NCT01178086|459308363|FG000|Overall Study|Other unspecified|89|||
127641968|NCT01178086|459308363|FG000|Overall Study|Excluded from EAS|20|||
127641969|NCT00234065|459308364|FG000|Overall Study|Adverse Event|268|||
127641970|NCT00234065|459308365|FG001|Overall Study|Adverse Event|166|||
127641971|NCT00234065|459308364|FG000|Overall Study|Withdrawal by Subject|73|||
127641972|NCT00234065|459308365|FG001|Overall Study|Withdrawal by Subject|56|||
127641973|NCT00234065|459308364|FG000|Overall Study|Physician Decision|23|||
127641974|NCT00234065|459308365|FG001|Overall Study|Physician Decision|22|||
127641975|NCT00234065|459308364|FG000|Overall Study|Not Classified|111|||
127641976|NCT00234065|459308365|FG001|Overall Study|Not Classified|112|||
127641977|NCT00126438|459308366|FG000|Overall Study|Withdrawal due to adverse event|1|||
127641978|NCT00126438|459308367|FG001|Overall Study|Withdrawal due to adverse event|0|||
127641979|NCT00126438|459308366|FG000|Overall Study|Lost to Follow-up|22|||
127641980|NCT00126438|459308367|FG001|Overall Study|Lost to Follow-up|0|||
127641981|NCT00126438|459308366|FG000|Overall Study|Protocol Violation|8|||
127641982|NCT00126438|459308367|FG001|Overall Study|Protocol Violation|8|||
127641983|NCT00126438|459308366|FG000|Overall Study|Withdrawal by Subject|3|||
127641984|NCT00126438|459308367|FG001|Overall Study|Withdrawal by Subject|2|||
127641985|NCT02057874|459309975|FG000|Overall Study|participant did not return for scan|1|||
127798402|NCT03042468|459885586|FG001|Overall Study|Lost to Follow-up|0|||
127641986|NCT01738984|459309976|FG000|Overall Study|Pregnancy|4|||
127641987|NCT01738984|459309977|FG001|Overall Study|Pregnancy|0|||
127641988|NCT01738984|459309976|FG000|Overall Study|Withdrawal by Subject|1|||
127641989|NCT01738984|459309977|FG001|Overall Study|Withdrawal by Subject|0|||
127641990|NCT01738984|459309976|FG000|Overall Study|Lost to Follow-up|59|||
127641991|NCT01738984|459309977|FG001|Overall Study|Lost to Follow-up|39|||
127641992|NCT01621126|459309984|FG000|Overall Study|Physician Decision|6|||
127798403|NCT03042468|459885587|FG002|Overall Study|Lost to Follow-up|0|||
127641993|NCT00886340|459309985|FG000|Overall Study|Withdrawal by Subject|0|||
127641994|NCT00886340|459309986|FG001|Overall Study|Withdrawal by Subject|7|||
127641995|NCT01949311|459309988|FG000|Overall Study|Lost to Follow-up|73|||
127641996|NCT01949311|459309988|FG000|Overall Study|Terminated by Sponsor|708|||
127641997|NCT01949311|459309988|FG000|Overall Study|Withdrawal by Subject|375|||
127641998|NCT01949311|459309988|FG000|Overall Study|Lack of Efficacy|50|||
127641999|NCT01949311|459309988|FG000|Overall Study|Protocol Deviation|34|||
127642000|NCT01949311|459309988|FG000|Overall Study|Pregnancy|20|||
127642001|NCT01949311|459309988|FG000|Overall Study|Physician Decision|9|||
127642002|NCT01949311|459309988|FG000|Overall Study|Other|4|||
127642003|NCT01949311|459309988|FG000|Overall Study|Adverse Event|107|||
127642004|NCT02338154|459309989|FG000|Overall Study|Death|46|||
127642005|NCT02338154|459309989|FG000|Overall Study|Valve Implant Failure|17|||
127642006|NCT02338154|459309989|FG000|Overall Study|Valve Explant|11|||
127642007|NCT02338154|459309989|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
127642008|NCT02338154|459309989|FG000|Overall Study|Lost to Follow-up|8|||
127642009|NCT02338154|459309989|FG000|Overall Study|Other Reason|3|||
127642010|NCT02338154|459309989|FG000|Overall Study|Patients Without Exit Form|47|||
127642011|NCT02338154|459309989|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
127642012|NCT02120027|459309992|FG000|Overall Study|Adverse Event|4|||
127642013|NCT02120027|459309993|FG001|Overall Study|Adverse Event|5|||
127642014|NCT02120027|459309992|FG000|Overall Study|Lack of Efficacy|3|||
127642015|NCT02120027|459309993|FG001|Overall Study|Lack of Efficacy|5|||
127642016|NCT02120027|459309992|FG000|Overall Study|Lost to Follow-up|5|||
127642017|NCT02120027|459309993|FG001|Overall Study|Lost to Follow-up|13|||
127642018|NCT02120027|459309992|FG000|Overall Study|Other|4|||
127642019|NCT02120027|459309993|FG001|Overall Study|Other|0|||
127642020|NCT02120027|459309992|FG000|Overall Study|Physician Decision|4|||
127642021|NCT02120027|459309993|FG001|Overall Study|Physician Decision|3|||
127642022|NCT02120027|459309992|FG000|Overall Study|Protocol Violation|18|||
127642023|NCT02120027|459309993|FG001|Overall Study|Protocol Violation|21|||
127642024|NCT02120027|459309992|FG000|Overall Study|Study terminated by Sponsor|45|||
127642025|NCT02120027|459309993|FG001|Overall Study|Study terminated by Sponsor|47|||
127642026|NCT02120027|459309992|FG000|Overall Study|Withdrawal by Subject|33|||
127642027|NCT02120027|459309993|FG001|Overall Study|Withdrawal by Subject|25|||
127642028|NCT00447057|459309998|FG000|Overall Study|Adverse Event|4|||
127642029|NCT00447057|459309999|FG001|Overall Study|Adverse Event|10|||
127642030|NCT00447057|459310000|FG002|Overall Study|Adverse Event|0|||
127642031|NCT00447057|459310001|FG003|Overall Study|Adverse Event|3|||
127642032|NCT00447057|459309998|FG000|Overall Study|Death due to study disease|6|||
127642033|NCT00447057|459309999|FG001|Overall Study|Death due to study disease|4|||
127642034|NCT00447057|459310000|FG002|Overall Study|Death due to study disease|1|||
127642035|NCT00447057|459310001|FG003|Overall Study|Death due to study disease|1|||
127642036|NCT00447057|459309998|FG000|Overall Study|Lost to Follow-up|0|||
127642037|NCT00447057|459309999|FG001|Overall Study|Lost to Follow-up|1|||
127642038|NCT00447057|459310000|FG002|Overall Study|Lost to Follow-up|0|||
127642039|NCT00447057|459310001|FG003|Overall Study|Lost to Follow-up|0|||
127642040|NCT00447057|459309998|FG000|Overall Study|Entry criteria not met|1|||
127642041|NCT00447057|459309999|FG001|Overall Study|Entry criteria not met|1|||
127642042|NCT00447057|459310000|FG002|Overall Study|Entry criteria not met|0|||
127642043|NCT00447057|459310001|FG003|Overall Study|Entry criteria not met|0|||
127642044|NCT00447057|459309998|FG000|Overall Study|Protocol Violation|0|||
127642045|NCT00447057|459309999|FG001|Overall Study|Protocol Violation|1|||
127642046|NCT00447057|459310000|FG002|Overall Study|Protocol Violation|0|||
127642047|NCT00447057|459310001|FG003|Overall Study|Protocol Violation|0|||
127642048|NCT00447057|459309998|FG000|Overall Study|Withdrawal by Subject|4|||
127642049|NCT00447057|459309999|FG001|Overall Study|Withdrawal by Subject|5|||
127642050|NCT00447057|459310000|FG002|Overall Study|Withdrawal by Subject|1|||
127642051|NCT00447057|459310001|FG003|Overall Study|Withdrawal by Subject|1|||
127642052|NCT00447057|459309998|FG000|Overall Study|Physician Decision|9|||
127642053|NCT00447057|459309999|FG001|Overall Study|Physician Decision|6|||
127642054|NCT00447057|459310000|FG002|Overall Study|Physician Decision|3|||
127642055|NCT00447057|459310001|FG003|Overall Study|Physician Decision|1|||
127642056|NCT00447057|459309998|FG000|Overall Study|Sponsor decision|1|||
127642057|NCT00447057|459309999|FG001|Overall Study|Sponsor decision|1|||
127642058|NCT00447057|459310000|FG002|Overall Study|Sponsor decision|0|||
127642059|NCT00447057|459310001|FG003|Overall Study|Sponsor decision|0|||
127642060|NCT00447057|459309998|FG000|Overall Study|Progressive disease|58|||
127642061|NCT00447057|459309999|FG001|Overall Study|Progressive disease|43|||
127642062|NCT00447057|459310000|FG002|Overall Study|Progressive disease|13|||
127642063|NCT00447057|459310001|FG003|Overall Study|Progressive disease|18|||
127642064|NCT00447057|459309998|FG000|Overall Study|Death due to adverse event|0|||
127642065|NCT00447057|459309999|FG001|Overall Study|Death due to adverse event|0|||
127642066|NCT00447057|459310000|FG002|Overall Study|Death due to adverse event|1|||
127642067|NCT00447057|459310001|FG003|Overall Study|Death due to adverse event|2|||
127642068|NCT00447057|459309998|FG000|Overall Study|Death, study drug related|0|||
127798404|NCT03042468|459885588|FG003|Overall Study|Lost to Follow-up|0|||
127798405|NCT03042468|459885589|FG004|Overall Study|Lost to Follow-up|1|||
127798406|NCT03042468|459885590|FG005|Overall Study|Lost to Follow-up|1|||
127642069|NCT00447057|459309999|FG001|Overall Study|Death, study drug related|1|||
127642070|NCT00447057|459310000|FG002|Overall Study|Death, study drug related|0|||
127642071|NCT00447057|459310001|FG003|Overall Study|Death, study drug related|0|||
127642072|NCT01843192|459310002|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
127642073|NCT01843192|459310003|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
127642074|NCT01843192|459310004|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
127642075|NCT01471054|459310005|FG000|Overall Study|Study terminated prematurely|4|||
127642076|NCT01471054|459310006|FG001|Overall Study|Study terminated prematurely|0|||
127642077|NCT04493216|459310007|FG000|Overall Study|Study terminated by sponsor|30|||
127642078|NCT04493216|459310008|FG001|Overall Study|Study terminated by sponsor|33|||
127642079|NCT04493216|459310009|FG002|Overall Study|Study terminated by sponsor|28|||
127642080|NCT04493216|459310010|FG003|Overall Study|Study terminated by sponsor|27|||
127887232|NCT00373685|460210514|FG000|Overall Study|Protocol Violation|191|||
127887233|NCT00373685|460210515|FG001|Overall Study|Protocol Violation|182|||
127887234|NCT00373685|460210514|FG000|Overall Study|Final Status Unknown|12|||
127642081|NCT04493216|459310007|FG000|Overall Study|Withdrawal by Subject|2|||
127887235|NCT00373685|460210515|FG001|Overall Study|Final Status Unknown|4|||
127887236|NCT00373685|460210514|FG000|Overall Study|Randomized, not treated|51|||
127642082|NCT04493216|459310008|FG001|Overall Study|Withdrawal by Subject|1|||
127642083|NCT04493216|459310009|FG002|Overall Study|Withdrawal by Subject|1|||
127642084|NCT04493216|459310010|FG003|Overall Study|Withdrawal by Subject|2|||
127642085|NCT04493216|459310007|FG000|Overall Study|Protocol Violation|1|||
127642086|NCT04493216|459310008|FG001|Overall Study|Protocol Violation|2|||
127642087|NCT04493216|459310009|FG002|Overall Study|Protocol Violation|0|||
127642088|NCT04493216|459310010|FG003|Overall Study|Protocol Violation|2|||
127642089|NCT04493216|459310007|FG000|Overall Study|Physician Decision|0|||
127642090|NCT04493216|459310008|FG001|Overall Study|Physician Decision|0|||
127642091|NCT04493216|459310009|FG002|Overall Study|Physician Decision|1|||
127642092|NCT04493216|459310010|FG003|Overall Study|Physician Decision|0|||
127642093|NCT04493216|459310007|FG000|Overall Study|Lost to Follow-up|2|||
127642094|NCT04493216|459310008|FG001|Overall Study|Lost to Follow-up|1|||
127642095|NCT04493216|459310009|FG002|Overall Study|Lost to Follow-up|0|||
127642096|NCT04493216|459310010|FG003|Overall Study|Lost to Follow-up|1|||
127642097|NCT04493216|459310007|FG000|Overall Study|Adverse Event|1|||
127642098|NCT04493216|459310008|FG001|Overall Study|Adverse Event|4|||
127642099|NCT04493216|459310009|FG002|Overall Study|Adverse Event|5|||
127642100|NCT04493216|459310010|FG003|Overall Study|Adverse Event|2|||
127642101|NCT04493216|459310007|FG000|Overall Study|Subject reached protocol-defined stopping criteria|4|||
127642102|NCT04493216|459310008|FG001|Overall Study|Subject reached protocol-defined stopping criteria|2|||
127642103|NCT04493216|459310009|FG002|Overall Study|Subject reached protocol-defined stopping criteria|7|||
127642104|NCT04493216|459310010|FG003|Overall Study|Subject reached protocol-defined stopping criteria|2|||
127642105|NCT01559844|459310011|FG000|Overall Study|Consent Withdrawn|7|||
127642106|NCT01559844|459310011|FG000|Overall Study|Death|5|||
127642107|NCT01559844|459310011|FG000|Overall Study|Efficacy Failure|10|||
127642108|NCT01559844|459310011|FG000|Overall Study|No Longer A Transplant Candidate|3|||
127642109|NCT00951041|459310012|FG000|Overall Study|Withdrawal by Subject|1|||
127642110|NCT00951041|459310013|FG001|Overall Study|Withdrawal by Subject|1|||
127642111|NCT00951041|459310012|FG000|Overall Study|Lost to Follow-up|1|||
127642112|NCT00951041|459310013|FG001|Overall Study|Lost to Follow-up|0|||
127642113|NCT00951041|459310012|FG000|Overall Study|Other|3|||
127642114|NCT00951041|459310013|FG001|Overall Study|Other|0|||
127642115|NCT01514448|459310014|FG000|Overall Study|Death|7|||
127642116|NCT01514448|459310015|FG001|Overall Study|Death|8|||
127642117|NCT01514448|459310014|FG000|Overall Study|Withdrawal by Subject|2|||
127642118|NCT01514448|459310015|FG001|Overall Study|Withdrawal by Subject|0|||
127642119|NCT01514448|459310014|FG000|Overall Study|Lost to Follow-up|2|||
127642120|NCT01514448|459310015|FG001|Overall Study|Lost to Follow-up|0|||
127642121|NCT01514448|459310014|FG000|Overall Study|New Cancer Therapy|1|||
127642122|NCT01514448|459310015|FG001|Overall Study|New Cancer Therapy|0|||
127642123|NCT02314624|459310016|FG000|Overall Study|No participating patient|16|||
127642124|NCT02314624|459310017|FG001|Overall Study|No participating patient|13|||
127642125|NCT02314624|459310016|FG000|Overall Study|Participant withdrew|7|||
127642126|NCT02314624|459310017|FG001|Overall Study|Participant withdrew|2|||
127642127|NCT02314624|459310016|FG000|Overall Study|Lost to Follow-up|2|||
127642128|NCT02314624|459310017|FG001|Overall Study|Lost to Follow-up|5|||
127642129|NCT02314624|459310016|FG000|Overall Study|Dropped/Excluded by PI|6|||
127642130|NCT02314624|459310017|FG001|Overall Study|Dropped/Excluded by PI|6|||
127642131|NCT00713648|459310026|FG000|Overall Study|Adverse Event|1|||
127642132|NCT00713648|459310026|FG000|Overall Study|Unclassified|2|||
127642133|NCT00713648|459310026|FG000|Overall Study|According to Protocol|2|||
127642134|NCT00713648|459310026|FG000|Overall Study|Development of antibodies|3|||
127642135|NCT00082173|459310027|FG000|Overall Study|Withdrawal by Subject|3|||
127642136|NCT00082173|459310028|FG001|Overall Study|Withdrawal by Subject|5|||
127642137|NCT00082173|459310027|FG000|Overall Study|Lost to Follow-up|1|||
127642138|NCT00082173|459310028|FG001|Overall Study|Lost to Follow-up|0|||
127642139|NCT00082173|459310027|FG000|Overall Study|Adverse Event|1|||
127704956|NCT01208662|459551562|FG001|Induction and Consolidation|Disease Progression|13|||
127704957|NCT01208662|459551563|FG002|Induction and Consolidation|Disease Progression|0|||
127704958|NCT01208662|459551561|FG000|Induction and Consolidation|Adverse Event|16|||
127704959|NCT01208662|459551562|FG001|Induction and Consolidation|Adverse Event|18|||
127704960|NCT01208662|459551563|FG002|Induction and Consolidation|Adverse Event|2|||
127704961|NCT01208662|459551561|FG000|Induction and Consolidation|MD or Participant Decision|16|||
127704962|NCT01208662|459551562|FG001|Induction and Consolidation|MD or Participant Decision|34|||
127704963|NCT01208662|459551563|FG002|Induction and Consolidation|MD or Participant Decision|4|||
127704964|NCT01208662|459551561|FG000|Induction and Consolidation|Death|1|||
127704965|NCT01208662|459551562|FG001|Induction and Consolidation|Death|3|||
127704966|NCT01208662|459551563|FG002|Induction and Consolidation|Death|1|||
127704967|NCT01208662|459551561|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
127704968|NCT01208662|459551562|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
127704969|NCT01208662|459551563|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
127704970|NCT01208662|459551561|FG000|Maintenance|Disease Progression|156|||
127704971|NCT01208662|459551562|FG001|Maintenance|Disease Progression|102|||
127642140|NCT00082173|459310028|FG001|Overall Study|Adverse Event|0|||
127642141|NCT00082173|459310027|FG000|Overall Study|Culture negative or resistant at baselin|5|||
127642142|NCT00082173|459310028|FG001|Overall Study|Culture negative or resistant at baselin|6|||
127642143|NCT01733732|459310029|FG000|Overall Study|Adverse Event|1|||
127642144|NCT01733732|459310030|FG001|Overall Study|Adverse Event|0|||
127642145|NCT01733732|459310029|FG000|Overall Study|Did not attend all study visits|1|||
127642146|NCT01733732|459310030|FG001|Overall Study|Did not attend all study visits|0|||
127642147|NCT01260350|459310041|FG000|Overall Study|Lack of Efficacy|0|||
127642148|NCT01260350|459310042|FG001|Overall Study|Lack of Efficacy|0|||
127642149|NCT01260350|459310043|FG002|Overall Study|Lack of Efficacy|0|||
127642150|NCT01260350|459310044|FG003|Overall Study|Lack of Efficacy|0|||
127642151|NCT01260350|459310045|FG004|Overall Study|Lack of Efficacy|0|||
127642152|NCT01260350|459310046|FG005|Overall Study|Lack of Efficacy|0|||
127642153|NCT01260350|459310047|FG006|Overall Study|Lack of Efficacy|0|||
127642154|NCT01260350|459310048|FG007|Overall Study|Lack of Efficacy|0|||
127642155|NCT01260350|459310049|FG008|Overall Study|Lack of Efficacy|0|||
127642156|NCT01260350|459310050|FG009|Overall Study|Lack of Efficacy|0|||
127642157|NCT01260350|459310051|FG010|Overall Study|Lack of Efficacy|0|||
127642158|NCT01260350|459310052|FG011|Overall Study|Lack of Efficacy|0|||
127642159|NCT01260350|459310053|FG012|Overall Study|Lack of Efficacy|0|||
127642160|NCT01260350|459310054|FG013|Overall Study|Lack of Efficacy|0|||
127642161|NCT01260350|459310055|FG014|Overall Study|Lack of Efficacy|0|||
127642162|NCT01260350|459310056|FG015|Overall Study|Lack of Efficacy|0|||
127642163|NCT01260350|459310057|FG016|Overall Study|Lack of Efficacy|0|||
127642164|NCT01260350|459310058|FG017|Overall Study|Lack of Efficacy|1|||
127642165|NCT01260350|459310059|FG018|Overall Study|Lack of Efficacy|0|||
127642166|NCT01260350|459310060|FG019|Overall Study|Lack of Efficacy|0|||
127642167|NCT01260350|459310061|FG020|Overall Study|Lack of Efficacy|3|||
127642168|NCT01260350|459310062|FG021|Overall Study|Lack of Efficacy|0|||
127642169|NCT01260350|459310041|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
127642170|NCT01260350|459310042|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
127642171|NCT01260350|459310043|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
127642172|NCT01260350|459310044|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
127642173|NCT01260350|459310045|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
127642174|NCT01260350|459310046|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
127642175|NCT01260350|459310047|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
127642176|NCT01260350|459310048|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
127642177|NCT01260350|459310049|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
127642178|NCT01260350|459310050|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
127642179|NCT01260350|459310051|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
127642180|NCT01260350|459310052|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
127642181|NCT01260350|459310053|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
127642182|NCT01260350|459310054|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
127642183|NCT01260350|459310055|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
127642184|NCT01260350|459310056|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
127642185|NCT01260350|459310057|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
127642186|NCT01260350|459310058|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
127642187|NCT01260350|459310059|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
127642188|NCT01260350|459310060|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
127642189|NCT01260350|459310061|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
127642190|NCT01260350|459310062|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
127642191|NCT01358968|459310065|FG000|Period 2|Adverse Event|0|||
127642192|NCT01358968|459310066|FG001|Period 2|Adverse Event|1|||
127642193|NCT01358968|459310067|FG002|Period 2|Adverse Event|0|||
127642194|NCT01358968|459310068|FG003|Period 2|Adverse Event|0|||
127642195|NCT01358968|459310065|FG000|Continued Access Phase|Progression of Disease|0|||
127642196|NCT01358968|459310066|FG001|Continued Access Phase|Progression of Disease|0|||
127642197|NCT01358968|459310067|FG002|Continued Access Phase|Progression of Disease|8|||
127642198|NCT01358968|459310068|FG003|Continued Access Phase|Progression of Disease|4|||
127642199|NCT01358968|459310065|FG000|Continued Access Phase|Protocol Violation|0|||
127642200|NCT01358968|459310066|FG001|Continued Access Phase|Protocol Violation|0|||
127642201|NCT01358968|459310067|FG002|Continued Access Phase|Protocol Violation|0|||
127642202|NCT01358968|459310068|FG003|Continued Access Phase|Protocol Violation|2|||
127642203|NCT01358968|459310065|FG000|Continued Access Phase|Withdrawal by Subject|0|||
127642204|NCT01358968|459310066|FG001|Continued Access Phase|Withdrawal by Subject|0|||
127704972|NCT01208662|459551563|FG002|Maintenance|Disease Progression|0|||
127704973|NCT01208662|459551561|FG000|Maintenance|Adverse Event|12|||
127704974|NCT01208662|459551562|FG001|Maintenance|Adverse Event|28|||
127704975|NCT01208662|459551563|FG002|Maintenance|Adverse Event|0|||
127704976|NCT01208662|459551561|FG000|Maintenance|MD or Participant Decision|24|||
127704977|NCT01208662|459551562|FG001|Maintenance|MD or Participant Decision|36|||
127704978|NCT01208662|459551563|FG002|Maintenance|MD or Participant Decision|0|||
127704979|NCT01208662|459551561|FG000|Maintenance|Death|0|||
127704980|NCT01208662|459551562|FG001|Maintenance|Death|3|||
127704981|NCT01208662|459551563|FG002|Maintenance|Death|0|||
127704982|NCT01208662|459551561|FG000|Maintenance|Discontinued for other reasons|21|||
127704983|NCT01208662|459551562|FG001|Maintenance|Discontinued for other reasons|31|||
127704984|NCT01208662|459551563|FG002|Maintenance|Discontinued for other reasons|0|||
127704985|NCT01208662|459551561|FG000|Maintenance|Still on Treatment|78|||
127704986|NCT01208662|459551562|FG001|Maintenance|Still on Treatment|89|||
127704987|NCT01208662|459551563|FG002|Maintenance|Still on Treatment|0|||
127704988|NCT04076618|459551564|FG000|Overall Study|Lost to Follow-up|2|||
127704989|NCT04076618|459551565|FG001|Overall Study|Lost to Follow-up|1|||
127704990|NCT04076618|459551566|FG002|Overall Study|Lost to Follow-up|3|||
127704991|NCT04076618|459551564|FG000|Overall Study|Withdrawal by Subject|3|||
127704992|NCT04076618|459551565|FG001|Overall Study|Withdrawal by Subject|1|||
127704993|NCT04076618|459551566|FG002|Overall Study|Withdrawal by Subject|2|||
127704994|NCT04076618|459551564|FG000|Overall Study|Relocated out of state|0|||
127704995|NCT04076618|459551565|FG001|Overall Study|Relocated out of state|2|||
127704996|NCT04076618|459551566|FG002|Overall Study|Relocated out of state|0|||
127704997|NCT04076618|459551564|FG000|Overall Study|COVID concerns|0|||
127704998|NCT04076618|459551565|FG001|Overall Study|COVID concerns|1|||
127704999|NCT04076618|459551566|FG002|Overall Study|COVID concerns|0|||
127705000|NCT04076618|459551564|FG000|Overall Study|Adverse Event|0|||
127705001|NCT04076618|459551565|FG001|Overall Study|Adverse Event|0|||
127705002|NCT04076618|459551566|FG002|Overall Study|Adverse Event|2|||
127705003|NCT01928394|459551567|FG000|Treatment Period|Disease progression|17|||
127705004|NCT01928394|459551568|FG001|Treatment Period|Disease progression|2|||
127705005|NCT01928394|459551569|FG002|Treatment Period|Disease progression|12|||
127705006|NCT01928394|459551570|FG003|Treatment Period|Disease progression|48|||
127705007|NCT01928394|459551571|FG004|Treatment Period|Disease progression|3|||
127705008|NCT01928394|459551572|FG005|Treatment Period|Disease progression|25|||
127705009|NCT01928394|459551573|FG006|Treatment Period|Disease progression|38|||
127705010|NCT01928394|459551574|FG007|Treatment Period|Disease progression|16|||
127705011|NCT01928394|459551575|FG008|Treatment Period|Disease progression|3|||
127705012|NCT01928394|459551576|FG009|Treatment Period|Disease progression|11|||
127705013|NCT01928394|459551577|FG010|Treatment Period|Disease progression|22|||
127705014|NCT01928394|459551578|FG011|Treatment Period|Disease progression|73|||
127705015|NCT01928394|459551579|FG012|Treatment Period|Disease progression|38|||
127705016|NCT01928394|459551580|FG013|Treatment Period|Disease progression|118|||
127705017|NCT01928394|459551581|FG014|Treatment Period|Disease progression|59|||
127705018|NCT01928394|459551582|FG015|Treatment Period|Disease progression|1|||
127705019|NCT01928394|459551583|FG016|Treatment Period|Disease progression|43|||
127705020|NCT01928394|459551584|FG017|Treatment Period|Disease progression|56|||
127705021|NCT01928394|459551585|FG018|Treatment Period|Disease progression|50|||
127705022|NCT01928394|459551586|FG019|Treatment Period|Disease progression|71|||
127705023|NCT01928394|459551587|FG020|Treatment Period|Disease progression|30|||
127705024|NCT01928394|459551588|FG021|Treatment Period|Disease progression|31|||
127705025|NCT01928394|459551589|FG022|Treatment Period|Disease progression|31|||
127705026|NCT01928394|459551567|FG000|Treatment Period|Study drug toxicity|1|||
127705027|NCT01928394|459551568|FG001|Treatment Period|Study drug toxicity|1|||
127705028|NCT01928394|459551569|FG002|Treatment Period|Study drug toxicity|3|||
127705029|NCT01928394|459551570|FG003|Treatment Period|Study drug toxicity|3|||
127705030|NCT01928394|459551571|FG004|Treatment Period|Study drug toxicity|0|||
127705031|NCT01928394|459551572|FG005|Treatment Period|Study drug toxicity|9|||
127705032|NCT01928394|459551573|FG006|Treatment Period|Study drug toxicity|7|||
127705033|NCT01928394|459551574|FG007|Treatment Period|Study drug toxicity|1|||
127705034|NCT01928394|459551575|FG008|Treatment Period|Study drug toxicity|0|||
127705035|NCT01928394|459551576|FG009|Treatment Period|Study drug toxicity|5|||
127705036|NCT01928394|459551577|FG010|Treatment Period|Study drug toxicity|2|||
127705037|NCT01928394|459551578|FG011|Treatment Period|Study drug toxicity|3|||
127705038|NCT01928394|459551579|FG012|Treatment Period|Study drug toxicity|7|||
127705039|NCT01928394|459551580|FG013|Treatment Period|Study drug toxicity|5|||
127705040|NCT01928394|459551581|FG014|Treatment Period|Study drug toxicity|12|||
127705041|NCT01928394|459551582|FG015|Treatment Period|Study drug toxicity|0|||
127705042|NCT01928394|459551583|FG016|Treatment Period|Study drug toxicity|3|||
127705043|NCT01928394|459551584|FG017|Treatment Period|Study drug toxicity|3|||
127705044|NCT01928394|459551585|FG018|Treatment Period|Study drug toxicity|12|||
127705045|NCT01928394|459551586|FG019|Treatment Period|Study drug toxicity|15|||
127705046|NCT01928394|459551587|FG020|Treatment Period|Study drug toxicity|4|||
127705047|NCT01928394|459551588|FG021|Treatment Period|Study drug toxicity|7|||
127705048|NCT01928394|459551589|FG022|Treatment Period|Study drug toxicity|4|||
127705049|NCT01928394|459551567|FG000|Treatment Period|AE unrelated to study drug|0|||
127705050|NCT01928394|459551568|FG001|Treatment Period|AE unrelated to study drug|0|||
127705051|NCT01928394|459551569|FG002|Treatment Period|AE unrelated to study drug|2|||
127705052|NCT01928394|459551570|FG003|Treatment Period|AE unrelated to study drug|3|||
127705053|NCT01928394|459551571|FG004|Treatment Period|AE unrelated to study drug|0|||
127705054|NCT01928394|459551572|FG005|Treatment Period|AE unrelated to study drug|5|||
127705055|NCT01928394|459551573|FG006|Treatment Period|AE unrelated to study drug|1|||
127705056|NCT01928394|459551574|FG007|Treatment Period|AE unrelated to study drug|0|||
127705057|NCT01928394|459551575|FG008|Treatment Period|AE unrelated to study drug|0|||
127642205|NCT01358968|459310067|FG002|Continued Access Phase|Withdrawal by Subject|3|||
127642206|NCT01358968|459310068|FG003|Continued Access Phase|Withdrawal by Subject|0|||
127642207|NCT01358968|459310065|FG000|Continued Access Phase|Death|0|||
127642208|NCT01358968|459310066|FG001|Continued Access Phase|Death|0|||
127642209|NCT01358968|459310067|FG002|Continued Access Phase|Death|1|||
127642210|NCT01358968|459310068|FG003|Continued Access Phase|Death|1|||
127642211|NCT01814371|459310072|FG000|Overall Study|Lost to Follow-up|30|||
127642212|NCT01814371|459310073|FG001|Overall Study|Lost to Follow-up|27|||
127642213|NCT02794285|459310074|FG000|Overall Study|Adverse Event|11|||
127642214|NCT02794285|459310075|FG001|Overall Study|Adverse Event|4|||
127642215|NCT02794285|459310076|FG002|Overall Study|Adverse Event|5|||
127642216|NCT02794285|459310077|FG003|Overall Study|Adverse Event|8|||
127642217|NCT02794285|459310074|FG000|Overall Study|Condition Under Investigation Improved|1|||
127642218|NCT02794285|459310075|FG001|Overall Study|Condition Under Investigation Improved|0|||
127642219|NCT02794285|459310076|FG002|Overall Study|Condition Under Investigation Improved|0|||
127642220|NCT02794285|459310077|FG003|Overall Study|Condition Under Investigation Improved|0|||
127642221|NCT02794285|459310074|FG000|Overall Study|Condition Under Investigation Worsened|0|||
127642222|NCT02794285|459310075|FG001|Overall Study|Condition Under Investigation Worsened|2|||
127642223|NCT02794285|459310076|FG002|Overall Study|Condition Under Investigation Worsened|1|||
127642224|NCT02794285|459310077|FG003|Overall Study|Condition Under Investigation Worsened|0|||
127642225|NCT02794285|459310074|FG000|Overall Study|Death|2|||
127642226|NCT02794285|459310075|FG001|Overall Study|Death|1|||
127642227|NCT02794285|459310076|FG002|Overall Study|Death|2|||
127642228|NCT02794285|459310077|FG003|Overall Study|Death|0|||
127642229|NCT02794285|459310074|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
127642230|NCT02794285|459310075|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
127642231|NCT02794285|459310076|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
127642232|NCT02794285|459310077|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
127642233|NCT02794285|459310074|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
127642234|NCT02794285|459310075|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
127642235|NCT02794285|459310076|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
127705058|NCT01928394|459551576|FG009|Treatment Period|AE unrelated to study drug|2|||
127705059|NCT01928394|459551577|FG010|Treatment Period|AE unrelated to study drug|0|||
127705060|NCT01928394|459551578|FG011|Treatment Period|AE unrelated to study drug|12|||
127705061|NCT01928394|459551579|FG012|Treatment Period|AE unrelated to study drug|6|||
127705062|NCT01928394|459551580|FG013|Treatment Period|AE unrelated to study drug|13|||
127705063|NCT01928394|459551581|FG014|Treatment Period|AE unrelated to study drug|6|||
127705064|NCT01928394|459551582|FG015|Treatment Period|AE unrelated to study drug|1|||
127705065|NCT01928394|459551583|FG016|Treatment Period|AE unrelated to study drug|1|||
127642236|NCT02794285|459310077|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
127642237|NCT02794285|459310074|FG000|Overall Study|Lack of Efficacy|10|||
127642238|NCT02794285|459310075|FG001|Overall Study|Lack of Efficacy|6|||
127642239|NCT02794285|459310076|FG002|Overall Study|Lack of Efficacy|3|||
127798407|NCT03083886|459885591|FG000|Overall Study|Withdrawal by Subject|51|||
127798408|NCT03083886|459885592|FG001|Overall Study|Withdrawal by Subject|73|||
127798409|NCT03083886|459885593|FG002|Overall Study|Withdrawal by Subject|104|||
127798410|NCT03083886|459885591|FG000|Overall Study|Missing Baseline data|43|||
127798411|NCT03083886|459885592|FG001|Overall Study|Missing Baseline data|42|||
127798412|NCT03083886|459885593|FG002|Overall Study|Missing Baseline data|31|||
127798413|NCT03083886|459885591|FG000|Overall Study|Investigator terminated|1|||
127798414|NCT03083886|459885592|FG001|Overall Study|Investigator terminated|6|||
127798415|NCT03083886|459885593|FG002|Overall Study|Investigator terminated|3|||
127798416|NCT04161495|459885594|FG000|Overall Study|Withdrawal by Subject|3|||
127798417|NCT04161495|459885595|FG001|Overall Study|Withdrawal by Subject|0|||
127798418|NCT04161495|459885594|FG000|Overall Study|Protocol Violation|1|||
127798419|NCT04161495|459885595|FG001|Overall Study|Protocol Violation|0|||
127798420|NCT04161495|459885594|FG000|Overall Study|Prohibited concomitant medication|3|||
127798421|NCT04161495|459885595|FG001|Overall Study|Prohibited concomitant medication|0|||
127798422|NCT04161495|459885594|FG000|Overall Study|Adverse Event|1|||
127798423|NCT04161495|459885595|FG001|Overall Study|Adverse Event|0|||
127798424|NCT04161495|459885594|FG000|Overall Study|Other - Unspecified|1|||
127798425|NCT04161495|459885595|FG001|Overall Study|Other - Unspecified|0|||
127798426|NCT04161495|459885594|FG000|Overall Study|Death|0|||
127798427|NCT04161495|459885595|FG001|Overall Study|Death|1|||
127798428|NCT03655756|459885596|FG000|Overall Study|Death|1|||
127798429|NCT00253630|459885597|FG000|Overall Study|ineligible|2|||
127798430|NCT00429858|459885598|FG000|Overall Study|Withdrawal by Subject|1|||
127798431|NCT00429858|459885598|FG000|Overall Study|Study Termination|1|||
127798432|NCT01587079|459885599|FG000|Overall Study|Protocol-specified criteria|9|||
127798433|NCT01587079|459885599|FG000|Overall Study|Protocol Violation|5|||
127798434|NCT01587079|459885599|FG000|Overall Study|Lost to Follow-up|2|||
127798435|NCT01587079|459885599|FG000|Overall Study|Physician Decision|2|||
127798436|NCT01587079|459885599|FG000|Overall Study|Withdrawal by Subject|7|||
127798437|NCT01587079|459885599|FG000|Overall Study|Adverse Event|14|||
127798438|NCT01239160|459885601|FG000|Overall Study|Lost to Follow-up|3|||
127798439|NCT01239160|459885602|FG001|Overall Study|Lost to Follow-up|5|||
127798440|NCT01239160|459885603|FG002|Overall Study|Lost to Follow-up|0|||
127798441|NCT01239160|459885601|FG000|Overall Study|Withdrawal by Subject|17|||
127798442|NCT01239160|459885602|FG001|Overall Study|Withdrawal by Subject|6|||
127798443|NCT01239160|459885603|FG002|Overall Study|Withdrawal by Subject|2|||
127798444|NCT01239160|459885601|FG000|Overall Study|Physician Decision|5|||
127798445|NCT01239160|459885602|FG001|Overall Study|Physician Decision|7|||
127798446|NCT01239160|459885603|FG002|Overall Study|Physician Decision|2|||
127642240|NCT02794285|459310077|FG003|Overall Study|Lack of Efficacy|3|||
127642241|NCT02794285|459310074|FG000|Overall Study|Lost to Follow-up|5|||
127642242|NCT02794285|459310075|FG001|Overall Study|Lost to Follow-up|6|||
127642243|NCT02794285|459310076|FG002|Overall Study|Lost to Follow-up|3|||
127642244|NCT02794285|459310077|FG003|Overall Study|Lost to Follow-up|1|||
127642245|NCT02794285|459310074|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
127642246|NCT02794285|459310075|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
127642247|NCT02794285|459310076|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
127642248|NCT02794285|459310077|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
127642249|NCT02794285|459310074|FG000|Overall Study|Withdrawal by Subject|38|||
127642250|NCT02794285|459310075|FG001|Overall Study|Withdrawal by Subject|29|||
127642251|NCT02794285|459310076|FG002|Overall Study|Withdrawal by Subject|20|||
127798447|NCT01239160|459885601|FG000|Overall Study|Early Termination Due to Study Closure|0|||
127798448|NCT01239160|459885602|FG001|Overall Study|Early Termination Due to Study Closure|1|||
127798449|NCT01239160|459885603|FG002|Overall Study|Early Termination Due to Study Closure|6|||
127798450|NCT00704964|459885609|FG000|Overall Study|Not completed on time|328|||
127798451|NCT04781816|459885610|FG000|Overall Study|Adverse Event|0|||
127798452|NCT04781816|459885611|FG001|Overall Study|Adverse Event|1|||
127798453|NCT04781816|459885610|FG000|Overall Study|Withdrawal by Subject|1|||
127798454|NCT04781816|459885611|FG001|Overall Study|Withdrawal by Subject|1|||
127798455|NCT04781816|459885610|FG000|Overall Study|Not Related to Coronavirus Disease 2019|1|||
127798456|NCT04781816|459885611|FG001|Overall Study|Not Related to Coronavirus Disease 2019|1|||
127798457|NCT02062658|459885612|FG000|Overall Study|Withdrawal by Subject|1|||
127642252|NCT02794285|459310077|FG003|Overall Study|Withdrawal by Subject|12|||
127642253|NCT02794285|459310074|FG000|Overall Study|Missing|1|||
127705066|NCT01928394|459551584|FG017|Treatment Period|AE unrelated to study drug|6|||
127705067|NCT01928394|459551585|FG018|Treatment Period|AE unrelated to study drug|3|||
127705068|NCT01928394|459551586|FG019|Treatment Period|AE unrelated to study drug|5|||
127705069|NCT01928394|459551587|FG020|Treatment Period|AE unrelated to study drug|1|||
127705070|NCT01928394|459551588|FG021|Treatment Period|AE unrelated to study drug|1|||
127705071|NCT01928394|459551589|FG022|Treatment Period|AE unrelated to study drug|0|||
127705072|NCT01928394|459551567|FG000|Treatment Period|Participant request to stop therapy|0|||
127705073|NCT01928394|459551568|FG001|Treatment Period|Participant request to stop therapy|0|||
127705074|NCT01928394|459551569|FG002|Treatment Period|Participant request to stop therapy|0|||
127705075|NCT01928394|459551570|FG003|Treatment Period|Participant request to stop therapy|0|||
127705076|NCT01928394|459551571|FG004|Treatment Period|Participant request to stop therapy|0|||
127705077|NCT01928394|459551572|FG005|Treatment Period|Participant request to stop therapy|3|||
127705078|NCT01928394|459551573|FG006|Treatment Period|Participant request to stop therapy|3|||
127705079|NCT01928394|459551574|FG007|Treatment Period|Participant request to stop therapy|0|||
127705080|NCT01928394|459551575|FG008|Treatment Period|Participant request to stop therapy|0|||
127705081|NCT01928394|459551576|FG009|Treatment Period|Participant request to stop therapy|0|||
127705082|NCT01928394|459551577|FG010|Treatment Period|Participant request to stop therapy|3|||
127705083|NCT01928394|459551578|FG011|Treatment Period|Participant request to stop therapy|2|||
127705084|NCT01928394|459551579|FG012|Treatment Period|Participant request to stop therapy|1|||
127705085|NCT01928394|459551580|FG013|Treatment Period|Participant request to stop therapy|2|||
127705086|NCT01928394|459551581|FG014|Treatment Period|Participant request to stop therapy|4|||
127705087|NCT01928394|459551582|FG015|Treatment Period|Participant request to stop therapy|0|||
127705088|NCT01928394|459551583|FG016|Treatment Period|Participant request to stop therapy|1|||
127705089|NCT01928394|459551584|FG017|Treatment Period|Participant request to stop therapy|3|||
127705090|NCT01928394|459551585|FG018|Treatment Period|Participant request to stop therapy|1|||
127705091|NCT01928394|459551586|FG019|Treatment Period|Participant request to stop therapy|1|||
127705092|NCT01928394|459551587|FG020|Treatment Period|Participant request to stop therapy|3|||
127705093|NCT01928394|459551588|FG021|Treatment Period|Participant request to stop therapy|1|||
127705094|NCT01928394|459551589|FG022|Treatment Period|Participant request to stop therapy|3|||
127705095|NCT01928394|459551567|FG000|Treatment Period|Participant withdrew consent|0|||
127705096|NCT01928394|459551568|FG001|Treatment Period|Participant withdrew consent|0|||
127705097|NCT01928394|459551569|FG002|Treatment Period|Participant withdrew consent|1|||
127705098|NCT01928394|459551570|FG003|Treatment Period|Participant withdrew consent|1|||
127705099|NCT01928394|459551571|FG004|Treatment Period|Participant withdrew consent|0|||
127705100|NCT01928394|459551572|FG005|Treatment Period|Participant withdrew consent|1|||
127705101|NCT01928394|459551573|FG006|Treatment Period|Participant withdrew consent|0|||
127705102|NCT01928394|459551574|FG007|Treatment Period|Participant withdrew consent|1|||
127705103|NCT01928394|459551575|FG008|Treatment Period|Participant withdrew consent|0|||
127705104|NCT01928394|459551576|FG009|Treatment Period|Participant withdrew consent|0|||
127705105|NCT01928394|459551577|FG010|Treatment Period|Participant withdrew consent|1|||
127705106|NCT01928394|459551578|FG011|Treatment Period|Participant withdrew consent|1|||
127705107|NCT01928394|459551579|FG012|Treatment Period|Participant withdrew consent|1|||
127705108|NCT01928394|459551580|FG013|Treatment Period|Participant withdrew consent|0|||
127705109|NCT01928394|459551581|FG014|Treatment Period|Participant withdrew consent|2|||
127705110|NCT01928394|459551582|FG015|Treatment Period|Participant withdrew consent|0|||
127705111|NCT01928394|459551583|FG016|Treatment Period|Participant withdrew consent|2|||
127705112|NCT01928394|459551584|FG017|Treatment Period|Participant withdrew consent|1|||
127705113|NCT01928394|459551585|FG018|Treatment Period|Participant withdrew consent|1|||
127705114|NCT01928394|459551586|FG019|Treatment Period|Participant withdrew consent|1|||
127705115|NCT01928394|459551587|FG020|Treatment Period|Participant withdrew consent|0|||
127705116|NCT01928394|459551588|FG021|Treatment Period|Participant withdrew consent|2|||
127705117|NCT01928394|459551589|FG022|Treatment Period|Participant withdrew consent|0|||
127705118|NCT01928394|459551567|FG000|Treatment Period|Poor/non-compliance|0|||
127705119|NCT01928394|459551568|FG001|Treatment Period|Poor/non-compliance|0|||
127705120|NCT01928394|459551569|FG002|Treatment Period|Poor/non-compliance|0|||
127705121|NCT01928394|459551570|FG003|Treatment Period|Poor/non-compliance|1|||
127705122|NCT01928394|459551571|FG004|Treatment Period|Poor/non-compliance|0|||
127705123|NCT01928394|459551572|FG005|Treatment Period|Poor/non-compliance|0|||
127798458|NCT02062658|459885612|FG000|Overall Study|Lack of Efficacy|1|||
127798459|NCT01789970|459885613|FG000|Open-label Titration Period|Adverse Event|68|||
127798460|NCT01789970|459885614|FG001|Open-label Titration Period|Adverse Event|0|||
127798461|NCT01789970|459885615|FG002|Open-label Titration Period|Adverse Event|0|||
127705124|NCT01928394|459551573|FG006|Treatment Period|Poor/non-compliance|0|||
127705125|NCT01928394|459551574|FG007|Treatment Period|Poor/non-compliance|0|||
127705126|NCT01928394|459551575|FG008|Treatment Period|Poor/non-compliance|0|||
127705127|NCT01928394|459551576|FG009|Treatment Period|Poor/non-compliance|0|||
127705128|NCT01928394|459551577|FG010|Treatment Period|Poor/non-compliance|0|||
127705129|NCT01928394|459551578|FG011|Treatment Period|Poor/non-compliance|0|||
127798462|NCT01789970|459885613|FG000|Open-label Titration Period|Lack of Efficacy|31|||
127798463|NCT01789970|459885614|FG001|Open-label Titration Period|Lack of Efficacy|0|||
127798464|NCT01789970|459885615|FG002|Open-label Titration Period|Lack of Efficacy|0|||
127798465|NCT01789970|459885613|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
127798466|NCT01789970|459885614|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
127887327|NCT04128696|460210582|FG000|Overall Study|Withdrawal by Subject|12|||
127887328|NCT04128696|460210583|FG001|Overall Study|Withdrawal by Subject|11|||
127887329|NCT04128696|460210582|FG000|Overall Study|Study Closed/Terminated|26|||
127887330|NCT04128696|460210583|FG001|Overall Study|Study Closed/Terminated|38|||
127887331|NCT04128696|460210582|FG000|Overall Study|Physician Decision|2|||
127887332|NCT04128696|460210583|FG001|Overall Study|Physician Decision|3|||
127887333|NCT00585039|460210584|FG000|Overall Study|medication spilled|2|||
127887334|NCT00585039|460210585|FG001|Overall Study|medication spilled|0|||
127887335|NCT01585831|460210588|FG000|Overall Study|Physician Decision|0|||
127887336|NCT01585831|460210589|FG001|Overall Study|Physician Decision|1|||
127887337|NCT01585831|460210588|FG000|Overall Study|Withdrawal by Subject|2|||
127887338|NCT01585831|460210589|FG001|Overall Study|Withdrawal by Subject|1|||
127887339|NCT02046369|460210590|FG000|Overall Study|Adverse Event|3|||
127887340|NCT02046369|460210591|FG001|Overall Study|Adverse Event|3|||
127887341|NCT02046369|460210590|FG000|Overall Study|Lack of Efficacy|3|||
127887342|NCT02046369|460210591|FG001|Overall Study|Lack of Efficacy|3|||
127887343|NCT02046369|460210590|FG000|Overall Study|Lost to Follow-up|3|||
127887344|NCT02046369|460210591|FG001|Overall Study|Lost to Follow-up|3|||
127887345|NCT02046369|460210590|FG000|Overall Study|Protocol Violation|1|||
127887346|NCT02046369|460210591|FG001|Overall Study|Protocol Violation|2|||
127887347|NCT02046369|460210590|FG000|Overall Study|Withdrawal by Subject|3|||
127887348|NCT02046369|460210591|FG001|Overall Study|Withdrawal by Subject|6|||
127887349|NCT02046369|460210590|FG000|Overall Study|never received study drug|0|||
127887350|NCT02046369|460210591|FG001|Overall Study|never received study drug|1|||
127887351|NCT02046369|460210590|FG000|Overall Study|non compliance|1|||
127887352|NCT02046369|460210591|FG001|Overall Study|non compliance|0|||
127887353|NCT03120520|460210592|FG000|Overall Study|Lost to Follow-up|1|||
127887354|NCT03120520|460210593|FG001|Overall Study|Lost to Follow-up|1|||
127887355|NCT03120520|460210594|FG002|Overall Study|Lost to Follow-up|1|||
127642874|NCT01292239|459313204|FG001|Overall Study|Withdrawal by Subject|6|||
127642875|NCT00262821|459313205|FG000|Overall Study|Ineligible - wrong stage|0|||
127642876|NCT00262821|459313206|FG001|Overall Study|Ineligible - wrong stage|3|||
127642877|NCT00262821|459313205|FG000|Overall Study|Ineligible - wrong cell type|2|||
127642878|NCT00262821|459313206|FG001|Overall Study|Ineligible - wrong cell type|2|||
127642879|NCT00262821|459313205|FG000|Overall Study|Ineligible - wrong primary|0|||
127642880|NCT00262821|459313206|FG001|Overall Study|Ineligible - wrong primary|1|||
127642881|NCT00262821|459313205|FG000|Overall Study|Ineligible - inadequate pathology|1|||
127642882|NCT00262821|459313206|FG001|Overall Study|Ineligible - inadequate pathology|3|||
127642883|NCT00262821|459313205|FG000|Overall Study|Ineligible - elevated creatinine|0|||
127642884|NCT00262821|459313206|FG001|Overall Study|Ineligible - elevated creatinine|2|||
127642885|NCT00262821|459313205|FG000|Overall Study|Ineligible - required test not done|1|||
127642886|NCT00262821|459313206|FG001|Overall Study|Ineligible - required test not done|4|||
127642887|NCT00262821|459313205|FG000|Overall Study|Inevaluable - inadequate data|0|||
127642888|NCT00262821|459313206|FG001|Overall Study|Inevaluable - inadequate data|4|||
127642889|NCT01988779|459313208|FG000|Overall Study|Withdrawal by Subject|2|||
127642890|NCT01988779|459313209|FG001|Overall Study|Withdrawal by Subject|2|||
127642891|NCT01988779|459313208|FG000|Overall Study|Protocol Violation|1|||
127642892|NCT01988779|459313209|FG001|Overall Study|Protocol Violation|0|||
127642893|NCT00377403|459313211|FG000|Overall Study|Unable to contact for telephone intervie|4|||
127642894|NCT00377403|459313212|FG001|Overall Study|Unable to contact for telephone intervie|7|||
127642895|NCT00736645|459313213|FG000|Overall Study|Adverse Event|0|||
127642896|NCT00736645|459313214|FG001|Overall Study|Adverse Event|2|||
127642897|NCT00736645|459313215|FG002|Overall Study|Adverse Event|0|||
127642898|NCT00736645|459313216|FG003|Overall Study|Adverse Event|0|||
127642899|NCT00295022|459313219|FG000|Overall Study|Adverse Event|1|||
127642900|NCT00295022|459313220|FG001|Overall Study|Adverse Event|1|||
127642901|NCT00295022|459313221|FG002|Overall Study|Adverse Event|2|||
127642902|NCT00295022|459313219|FG000|Overall Study|Lost to Follow-up|0|||
127642903|NCT00295022|459313220|FG001|Overall Study|Lost to Follow-up|0|||
127642904|NCT00295022|459313221|FG002|Overall Study|Lost to Follow-up|1|||
127642905|NCT00295022|459313219|FG000|Overall Study|Withdrawal by Subject|0|||
127642906|NCT00295022|459313220|FG001|Overall Study|Withdrawal by Subject|0|||
127642907|NCT00295022|459313221|FG002|Overall Study|Withdrawal by Subject|2|||
127642908|NCT00734630|459313222|FG000|Overall Study|Lack of Efficacy|4|||
127642909|NCT00734630|459313223|FG001|Overall Study|Lack of Efficacy|4|||
127887356|NCT03120520|460210595|FG003|Overall Study|Lost to Follow-up|1|||
127642910|NCT00734630|459313222|FG000|Overall Study|Withdrawal by Subject|7|||
127642911|NCT00734630|459313223|FG001|Overall Study|Withdrawal by Subject|9|||
127642912|NCT00734630|459313222|FG000|Overall Study|Lost to Follow-up|13|||
127642913|NCT00734630|459313223|FG001|Overall Study|Lost to Follow-up|7|||
127887357|NCT03120520|460210592|FG000|Overall Study|Withdrawal by Subject|3|||
127642914|NCT00734630|459313222|FG000|Overall Study|Protocol Violation|0|||
127642915|NCT00734630|459313223|FG001|Overall Study|Protocol Violation|3|||
127642916|NCT00734630|459313222|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
127887358|NCT03120520|460210593|FG001|Overall Study|Withdrawal by Subject|2|||
127887359|NCT03120520|460210594|FG002|Overall Study|Withdrawal by Subject|3|||
127887360|NCT03120520|460210595|FG003|Overall Study|Withdrawal by Subject|2|||
127705330|NCT04433208|459551595|FG005|Overall Study|Withdrawal by Subject|1|||
127705331|NCT04433208|459551590|FG000|Overall Study|Lost to Follow-up|0|||
127705332|NCT04433208|459551591|FG001|Overall Study|Lost to Follow-up|0|||
127705333|NCT04433208|459551592|FG002|Overall Study|Lost to Follow-up|0|||
127705334|NCT04433208|459551593|FG003|Overall Study|Lost to Follow-up|0|||
127705335|NCT04433208|459551594|FG004|Overall Study|Lost to Follow-up|0|||
127705336|NCT04433208|459551595|FG005|Overall Study|Lost to Follow-up|1|||
127705337|NCT03386578|459551600|FG000|PK Component|Lost to Follow-up|0|||
127705338|NCT03386578|459551601|FG001|PK Component|Lost to Follow-up|1|||
127705339|NCT03386578|459551602|FG002|PK Component|Lost to Follow-up|0|||
127705340|NCT03386578|459551603|FG003|PK Component|Lost to Follow-up|0|||
127705341|NCT03386578|459551604|FG004|PK Component|Lost to Follow-up|0|||
127705342|NCT03386578|459551605|FG005|PK Component|Lost to Follow-up|0|||
127705343|NCT03386578|459551606|FG006|PK Component|Lost to Follow-up|1|||
127705344|NCT03386578|459551607|FG007|PK Component|Lost to Follow-up|0|||
127705345|NCT03386578|459551608|FG008|PK Component|Lost to Follow-up|0|||
127705346|NCT03386578|459551609|FG009|PK Component|Lost to Follow-up|0|||
127705347|NCT03386578|459551600|FG000|PK Component|Stillbirth/Abortion|0|||
127705348|NCT03386578|459551601|FG001|PK Component|Stillbirth/Abortion|0|||
127705349|NCT03386578|459551602|FG002|PK Component|Stillbirth/Abortion|0|||
127705350|NCT03386578|459551603|FG003|PK Component|Stillbirth/Abortion|0|||
127705351|NCT03386578|459551604|FG004|PK Component|Stillbirth/Abortion|0|||
127705352|NCT03386578|459551605|FG005|PK Component|Stillbirth/Abortion|2|||
127705353|NCT03386578|459551606|FG006|PK Component|Stillbirth/Abortion|0|||
127705354|NCT03386578|459551607|FG007|PK Component|Stillbirth/Abortion|0|||
127705355|NCT03386578|459551608|FG008|PK Component|Stillbirth/Abortion|0|||
127705356|NCT03386578|459551609|FG009|PK Component|Stillbirth/Abortion|0|||
127705357|NCT03386578|459551600|FG000|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
127705358|NCT03386578|459551601|FG001|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
127705359|NCT03386578|459551602|FG002|PrEP Comparison Component Step 1|Lost to Follow-up|17|||
127705360|NCT03386578|459551603|FG003|PrEP Comparison Component Step 1|Lost to Follow-up|9|||
127705361|NCT03386578|459551604|FG004|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
127705362|NCT03386578|459551605|FG005|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
127705363|NCT03386578|459551606|FG006|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
127705364|NCT03386578|459551607|FG007|PrEP Comparison Component Step 1|Lost to Follow-up|7|||
127705365|NCT03386578|459551608|FG008|PrEP Comparison Component Step 1|Lost to Follow-up|5|||
127705366|NCT03386578|459551609|FG009|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
127705367|NCT03386578|459551600|FG000|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
127705368|NCT03386578|459551601|FG001|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
127705369|NCT03386578|459551602|FG002|PrEP Comparison Component Step 1|Withdrawal by Subject|9|||
127705370|NCT03386578|459551603|FG003|PrEP Comparison Component Step 1|Withdrawal by Subject|4|||
127705371|NCT03386578|459551604|FG004|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
127705372|NCT03386578|459551605|FG005|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
127705373|NCT03386578|459551606|FG006|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
127705374|NCT03386578|459551607|FG007|PrEP Comparison Component Step 1|Withdrawal by Subject|5|||
127705375|NCT03386578|459551608|FG008|PrEP Comparison Component Step 1|Withdrawal by Subject|1|||
127705376|NCT03386578|459551609|FG009|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
127705377|NCT03386578|459551600|FG000|PrEP Comparison Component Step 1|Death|0|||
127705378|NCT03386578|459551601|FG001|PrEP Comparison Component Step 1|Death|0|||
127705379|NCT03386578|459551602|FG002|PrEP Comparison Component Step 1|Death|1|||
127705380|NCT03386578|459551603|FG003|PrEP Comparison Component Step 1|Death|0|||
127887361|NCT03120520|460210592|FG000|Overall Study|Other|0|||
127705381|NCT03386578|459551604|FG004|PrEP Comparison Component Step 1|Death|0|||
127705382|NCT03386578|459551605|FG005|PrEP Comparison Component Step 1|Death|0|||
127705383|NCT03386578|459551606|FG006|PrEP Comparison Component Step 1|Death|0|||
127887362|NCT03120520|460210593|FG001|Overall Study|Other|1|||
127705384|NCT03386578|459551607|FG007|PrEP Comparison Component Step 1|Death|9|||
127705385|NCT03386578|459551608|FG008|PrEP Comparison Component Step 1|Death|5|||
127887363|NCT03120520|460210594|FG002|Overall Study|Other|0|||
127705386|NCT03386578|459551609|FG009|PrEP Comparison Component Step 1|Death|0|||
127705387|NCT03386578|459551600|FG000|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
127705388|NCT03386578|459551601|FG001|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
127705389|NCT03386578|459551602|FG002|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
127705390|NCT03386578|459551603|FG003|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
127705391|NCT03386578|459551604|FG004|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
127705392|NCT03386578|459551605|FG005|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
127705393|NCT03386578|459551606|FG006|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
127705394|NCT03386578|459551607|FG007|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
127705395|NCT03386578|459551608|FG008|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
127705396|NCT03386578|459551609|FG009|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
127705397|NCT03386578|459551600|FG000|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
127705398|NCT03386578|459551601|FG001|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
127705399|NCT03386578|459551602|FG002|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
127705400|NCT03386578|459551603|FG003|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
127887364|NCT03120520|460210595|FG003|Overall Study|Other|0|||
127887365|NCT02133352|460210599|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
127887366|NCT00579254|460210600|FG000|Overall Study|Lost to Follow-up|39|||
127887367|NCT00579254|460210600|FG000|Overall Study|Discontinued when study terminated|73|||
127887368|NCT02557672|460210601|FG000|Overall Study|Withdrawal by Subject|4|||
127887369|NCT02557672|460210602|FG001|Overall Study|Withdrawal by Subject|2|||
127887370|NCT00420290|460210603|FG000|Overall Study|Adverse Event|3|||
127887371|NCT00420290|460210604|FG001|Overall Study|Adverse Event|1|||
127887372|NCT00420290|460210603|FG000|Overall Study|Withdrawal by Subject|0|||
127887373|NCT00420290|460210604|FG001|Overall Study|Withdrawal by Subject|2|||
127887374|NCT00420290|460210603|FG000|Overall Study|did not meet inclusion/exclusion|1|||
127887375|NCT00420290|460210604|FG001|Overall Study|did not meet inclusion/exclusion|1|||
127887376|NCT02092961|460211832|FG000|Overall Study|Not reported|1|||
127887377|NCT02092961|460211833|FG001|Overall Study|Not reported|0|||
127887378|NCT02092961|460211834|FG002|Overall Study|Not reported|1|||
127887379|NCT02092961|460211832|FG000|Overall Study|Study stopped|13|||
127705401|NCT03386578|459551604|FG004|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
127705402|NCT03386578|459551605|FG005|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
127705403|NCT03386578|459551606|FG006|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
127705404|NCT03386578|459551607|FG007|PrEP Comparison Component Step 1|Stillbirth/Abortion|2|||
127705405|NCT03386578|459551608|FG008|PrEP Comparison Component Step 1|Stillbirth/Abortion|4|||
127705406|NCT03386578|459551609|FG009|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
127705407|NCT03386578|459551600|FG000|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
127705408|NCT03386578|459551601|FG001|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
127705409|NCT03386578|459551602|FG002|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
127705410|NCT03386578|459551603|FG003|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
127705411|NCT03386578|459551604|FG004|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
127705412|NCT03386578|459551605|FG005|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
127705413|NCT03386578|459551606|FG006|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
127705414|NCT03386578|459551607|FG007|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|10|||
127705415|NCT03386578|459551608|FG008|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|5|||
127705416|NCT03386578|459551609|FG009|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
127705417|NCT05093842|459551612|FG000|Overall Study|Pregnancy loss|1|||
127887380|NCT02092961|460211833|FG001|Overall Study|Study stopped|9|||
127887381|NCT02092961|460211834|FG002|Overall Study|Study stopped|12|||
127887382|NCT02092961|460211832|FG000|Overall Study|Lack of therapeutic response|2|||
127887383|NCT02092961|460211833|FG001|Overall Study|Lack of therapeutic response|1|||
127705418|NCT05093842|459551613|FG001|Overall Study|Pregnancy loss|1|||
127705419|NCT05093842|459551612|FG000|Overall Study|Lost to Follow-up|6|||
127705420|NCT05093842|459551613|FG001|Overall Study|Lost to Follow-up|0|||
127705421|NCT05093842|459551612|FG000|Overall Study|Physician Decision|0|||
127705422|NCT05093842|459551613|FG001|Overall Study|Physician Decision|1|||
127705423|NCT02724969|459551614|FG000|Overall Study|Lost to Follow-up|12|||
127705424|NCT02724969|459551615|FG001|Overall Study|Lost to Follow-up|6|||
127705425|NCT02724969|459551614|FG000|Overall Study|Withdrawal by Subject|3|||
127705426|NCT02724969|459551615|FG001|Overall Study|Withdrawal by Subject|3|||
127705427|NCT02724969|459551614|FG000|Overall Study|Infant demise|0|||
127705428|NCT02724969|459551615|FG001|Overall Study|Infant demise|2|||
127705429|NCT05147116|459551616|FG000|Overall Study|Withdrawal by Subject|0|||
127705430|NCT05147116|459551617|FG001|Overall Study|Withdrawal by Subject|1|||
127705431|NCT03672916|459551618|FG000|Overall Study|Death|6|||
127705432|NCT03672916|459551618|FG000|Overall Study|Lost to Follow-up|29|||
127705433|NCT03672916|459551618|FG000|Overall Study|Adverse Event|6|||
127705434|NCT03672916|459551618|FG000|Overall Study|Withdrawal by Subject|11|||
127705435|NCT04197336|459551619|FG000|Overall Study|Withdrawal by Subject|1|||
127705436|NCT04585815|459551620|FG000|Sub-study A- Treatment Phase|Adverse Event|0|||
127705437|NCT04585815|459551621|FG001|Sub-study A- Treatment Phase|Adverse Event|1|||
127705438|NCT04585815|459551622|FG002|Sub-study A- Treatment Phase|Adverse Event|0|||
127705439|NCT04585815|459551623|FG003|Sub-study A- Treatment Phase|Adverse Event|0|||
127705440|NCT04585815|459551624|FG004|Sub-study A- Treatment Phase|Adverse Event|0|||
127705441|NCT04585815|459551625|FG005|Sub-study A- Treatment Phase|Adverse Event|0|||
127705442|NCT04585815|459551626|FG006|Sub-study A- Treatment Phase|Adverse Event|0|||
127705443|NCT04585815|459551620|FG000|Sub-study A- Treatment Phase|Death|0|||
127705444|NCT04585815|459551621|FG001|Sub-study A- Treatment Phase|Death|1|||
127705445|NCT04585815|459551622|FG002|Sub-study A- Treatment Phase|Death|0|||
127705446|NCT04585815|459551623|FG003|Sub-study A- Treatment Phase|Death|0|||
127705447|NCT04585815|459551624|FG004|Sub-study A- Treatment Phase|Death|0|||
127705448|NCT04585815|459551625|FG005|Sub-study A- Treatment Phase|Death|0|||
127705449|NCT04585815|459551626|FG006|Sub-study A- Treatment Phase|Death|0|||
127705450|NCT04585815|459551620|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
127705451|NCT04585815|459551621|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
127705452|NCT04585815|459551622|FG002|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
127705453|NCT04585815|459551623|FG003|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
127705454|NCT04585815|459551624|FG004|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
127705455|NCT04585815|459551625|FG005|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
127705456|NCT04585815|459551626|FG006|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
127705457|NCT04585815|459551620|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
127705458|NCT04585815|459551621|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
127705459|NCT04585815|459551622|FG002|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
127705460|NCT04585815|459551623|FG003|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
127705461|NCT04585815|459551624|FG004|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
127705462|NCT04585815|459551625|FG005|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
127705463|NCT04585815|459551626|FG006|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
127705464|NCT04585815|459551620|FG000|Sub-study A- Treatment Phase|Other|1|||
127705465|NCT04585815|459551621|FG001|Sub-study A- Treatment Phase|Other|0|||
127705466|NCT04585815|459551622|FG002|Sub-study A- Treatment Phase|Other|0|||
127705467|NCT04585815|459551623|FG003|Sub-study A- Treatment Phase|Other|0|||
127705468|NCT04585815|459551624|FG004|Sub-study A- Treatment Phase|Other|0|||
127705469|NCT04585815|459551625|FG005|Sub-study A- Treatment Phase|Other|0|||
127705470|NCT04585815|459551626|FG006|Sub-study A- Treatment Phase|Other|0|||
127705471|NCT04585815|459551620|FG000|Sub-study A- Treatment Phase|Ongoing treatment|2|||
127705472|NCT04585815|459551621|FG001|Sub-study A- Treatment Phase|Ongoing treatment|6|||
127705473|NCT04585815|459551622|FG002|Sub-study A- Treatment Phase|Ongoing treatment|0|||
127705474|NCT04585815|459551623|FG003|Sub-study A- Treatment Phase|Ongoing treatment|0|||
127705475|NCT04585815|459551624|FG004|Sub-study A- Treatment Phase|Ongoing treatment|0|||
127705476|NCT04585815|459551625|FG005|Sub-study A- Treatment Phase|Ongoing treatment|0|||
127705477|NCT04585815|459551626|FG006|Sub-study A- Treatment Phase|Ongoing treatment|0|||
127705478|NCT04585815|459551620|FG000|Sub-study A- Follow-up Phase|Ongoing in study|0|||
127705479|NCT04585815|459551621|FG001|Sub-study A- Follow-up Phase|Ongoing in study|1|||
127705480|NCT04585815|459551622|FG002|Sub-study A- Follow-up Phase|Ongoing in study|0|||
127705481|NCT04585815|459551623|FG003|Sub-study A- Follow-up Phase|Ongoing in study|0|||
127705482|NCT04585815|459551624|FG004|Sub-study A- Follow-up Phase|Ongoing in study|0|||
127705483|NCT04585815|459551625|FG005|Sub-study A- Follow-up Phase|Ongoing in study|0|||
127705484|NCT04585815|459551626|FG006|Sub-study A- Follow-up Phase|Ongoing in study|0|||
127705485|NCT04585815|459551620|FG000|Sub-study B- Treatment Phase|Adverse Event|0|||
127705486|NCT04585815|459551621|FG001|Sub-study B- Treatment Phase|Adverse Event|0|||
127705487|NCT04585815|459551622|FG002|Sub-study B- Treatment Phase|Adverse Event|0|||
127705488|NCT04585815|459551623|FG003|Sub-study B- Treatment Phase|Adverse Event|0|||
127705489|NCT04585815|459551624|FG004|Sub-study B- Treatment Phase|Adverse Event|0|||
127705490|NCT04585815|459551625|FG005|Sub-study B- Treatment Phase|Adverse Event|0|||
127705491|NCT04585815|459551626|FG006|Sub-study B- Treatment Phase|Adverse Event|2|||
127705492|NCT04585815|459551620|FG000|Sub-study B- Treatment Phase|Death|0|||
127705493|NCT04585815|459551621|FG001|Sub-study B- Treatment Phase|Death|0|||
127798506|NCT01789970|459885615|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
127798507|NCT01789970|459885613|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
127798508|NCT01789970|459885614|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
127798509|NCT01789970|459885615|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
127798510|NCT01789970|459885613|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
127798511|NCT01789970|459885614|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
127798512|NCT01789970|459885615|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
127887384|NCT02092961|460211834|FG002|Overall Study|Lack of therapeutic response|3|||
127887385|NCT02092961|460211832|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
127705494|NCT04585815|459551622|FG002|Sub-study B- Treatment Phase|Death|0|||
127705495|NCT04585815|459551623|FG003|Sub-study B- Treatment Phase|Death|1|||
127705496|NCT04585815|459551624|FG004|Sub-study B- Treatment Phase|Death|0|||
127705497|NCT04585815|459551625|FG005|Sub-study B- Treatment Phase|Death|0|||
127705498|NCT04585815|459551626|FG006|Sub-study B- Treatment Phase|Death|0|||
127705499|NCT04585815|459551620|FG000|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
127705500|NCT04585815|459551621|FG001|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
127705501|NCT04585815|459551622|FG002|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
127705502|NCT04585815|459551623|FG003|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
127705503|NCT04585815|459551624|FG004|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
127705504|NCT04585815|459551625|FG005|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
127705505|NCT04585815|459551626|FG006|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
127705506|NCT04585815|459551620|FG000|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
127705507|NCT04585815|459551621|FG001|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
127705508|NCT04585815|459551622|FG002|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
127705509|NCT04585815|459551623|FG003|Sub-study B- Treatment Phase|Global deterioration of health status|1|||
127705510|NCT04585815|459551624|FG004|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
127705511|NCT04585815|459551625|FG005|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
127705512|NCT04585815|459551626|FG006|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
127705513|NCT04585815|459551620|FG000|Sub-study B- Treatment Phase|Ongoing treatment|0|||
127705514|NCT04585815|459551621|FG001|Sub-study B- Treatment Phase|Ongoing treatment|0|||
127705515|NCT04585815|459551622|FG002|Sub-study B- Treatment Phase|Ongoing treatment|0|||
127705516|NCT04585815|459551623|FG003|Sub-study B- Treatment Phase|Ongoing treatment|0|||
127705517|NCT04585815|459551624|FG004|Sub-study B- Treatment Phase|Ongoing treatment|0|||
127705518|NCT04585815|459551625|FG005|Sub-study B- Treatment Phase|Ongoing treatment|0|||
127705519|NCT04585815|459551626|FG006|Sub-study B- Treatment Phase|Ongoing treatment|1|||
127705520|NCT04585815|459551620|FG000|Sub-study B- Treatment Phase|Progressive disease|0|||
127705521|NCT04585815|459551621|FG001|Sub-study B- Treatment Phase|Progressive disease|0|||
127705522|NCT04585815|459551622|FG002|Sub-study B- Treatment Phase|Progressive disease|3|||
127705523|NCT04585815|459551623|FG003|Sub-study B- Treatment Phase|Progressive disease|2|||
127705524|NCT04585815|459551624|FG004|Sub-study B- Treatment Phase|Progressive disease|2|||
127705525|NCT04585815|459551625|FG005|Sub-study B- Treatment Phase|Progressive disease|0|||
127705526|NCT04585815|459551626|FG006|Sub-study B- Treatment Phase|Progressive disease|4|||
127705527|NCT04585815|459551620|FG000|Sub-study B- Treatment Phase|Physician Decision|0|||
127705528|NCT04585815|459551621|FG001|Sub-study B- Treatment Phase|Physician Decision|0|||
127705529|NCT04585815|459551622|FG002|Sub-study B- Treatment Phase|Physician Decision|0|||
127705530|NCT04585815|459551623|FG003|Sub-study B- Treatment Phase|Physician Decision|1|||
127705531|NCT04585815|459551624|FG004|Sub-study B- Treatment Phase|Physician Decision|1|||
127705532|NCT04585815|459551625|FG005|Sub-study B- Treatment Phase|Physician Decision|1|||
127705533|NCT04585815|459551626|FG006|Sub-study B- Treatment Phase|Physician Decision|0|||
127705534|NCT04585815|459551620|FG000|Sub-study B- Follow-up Phase|Ongoing in study|0|||
127705535|NCT04585815|459551621|FG001|Sub-study B- Follow-up Phase|Ongoing in study|0|||
127798513|NCT01789970|459885613|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
127798514|NCT01789970|459885614|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
127798515|NCT01789970|459885615|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
127798516|NCT01789970|459885613|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
127798517|NCT01789970|459885614|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
127798518|NCT01789970|459885615|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
127798519|NCT01789970|459885613|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
127798520|NCT01789970|459885614|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
127798521|NCT01789970|459885615|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
127798522|NCT02161562|459885616|FG000|Overall Study|Withdrawal by Subject|5|||
127798523|NCT02161562|459885617|FG001|Overall Study|Withdrawal by Subject|8|||
127798524|NCT02161562|459885616|FG000|Overall Study|Protocol Violation|9|||
127798525|NCT02161562|459885617|FG001|Overall Study|Protocol Violation|4|||
127798526|NCT02161562|459885616|FG000|Overall Study|Pregnancy|1|||
127798527|NCT02161562|459885617|FG001|Overall Study|Pregnancy|2|||
127798528|NCT02161562|459885616|FG000|Overall Study|Lost to Follow-up|3|||
127798529|NCT02161562|459885617|FG001|Overall Study|Lost to Follow-up|1|||
127798530|NCT02161562|459885616|FG000|Overall Study|Lack of Efficacy|4|||
127798531|NCT02161562|459885617|FG001|Overall Study|Lack of Efficacy|1|||
127798532|NCT02161562|459885616|FG000|Overall Study|Adverse Event|1|||
127798533|NCT02161562|459885617|FG001|Overall Study|Adverse Event|1|||
127798534|NCT02161562|459885616|FG000|Overall Study|Participant moved back to home country|1|||
127798535|NCT02161562|459885617|FG001|Overall Study|Participant moved back to home country|0|||
127798536|NCT02161562|459885616|FG000|Overall Study|Withdrew due to being out of the country|1|||
127798537|NCT02161562|459885617|FG001|Overall Study|Withdrew due to being out of the country|0|||
127887386|NCT02092961|460211833|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
127887387|NCT02092961|460211834|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
127887388|NCT02092961|460211832|FG000|Overall Study|Adverse Event|2|||
127887389|NCT02092961|460211833|FG001|Overall Study|Adverse Event|4|||
127705536|NCT04585815|459551622|FG002|Sub-study B- Follow-up Phase|Ongoing in study|0|||
127705537|NCT04585815|459551623|FG003|Sub-study B- Follow-up Phase|Ongoing in study|0|||
127705538|NCT04585815|459551624|FG004|Sub-study B- Follow-up Phase|Ongoing in study|1|||
127705539|NCT04585815|459551625|FG005|Sub-study B- Follow-up Phase|Ongoing in study|1|||
127705540|NCT04585815|459551626|FG006|Sub-study B- Follow-up Phase|Ongoing in study|3|||
127705541|NCT04585815|459551620|FG000|Sub-study B- Follow-up Phase|Death|0|||
127705542|NCT04585815|459551621|FG001|Sub-study B- Follow-up Phase|Death|0|||
127705543|NCT04585815|459551622|FG002|Sub-study B- Follow-up Phase|Death|1|||
127705544|NCT04585815|459551623|FG003|Sub-study B- Follow-up Phase|Death|3|||
127705545|NCT04585815|459551624|FG004|Sub-study B- Follow-up Phase|Death|0|||
127705546|NCT04585815|459551625|FG005|Sub-study B- Follow-up Phase|Death|0|||
127705547|NCT04585815|459551626|FG006|Sub-study B- Follow-up Phase|Death|1|||
127705548|NCT04295512|459551634|FG000|Overall Study|Lack of family response to schedule assessment|0|||
127705549|NCT04295512|459551635|FG001|Overall Study|Lack of family response to schedule assessment|0|||
127705550|NCT04295512|459551636|FG002|Overall Study|Lack of family response to schedule assessment|0|||
127705551|NCT04295512|459551637|FG003|Overall Study|Lack of family response to schedule assessment|2|||
127705552|NCT04295512|459551634|FG000|Overall Study|Therapist did not refer eligible family|7|||
127705553|NCT04295512|459551635|FG001|Overall Study|Therapist did not refer eligible family|7|||
127705554|NCT04295512|459551636|FG002|Overall Study|Therapist did not refer eligible family|0|||
127705555|NCT04295512|459551637|FG003|Overall Study|Therapist did not refer eligible family|0|||
127705556|NCT04587453|459551642|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
127705557|NCT04587453|459551643|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
127705558|NCT03571581|459551646|FG000|Overall Study|Death|2|||
127705559|NCT03571581|459551646|FG000|Overall Study|Withdrawal by Subject|2|||
127705560|NCT01309672|459551648|FG000|Overall Study|Lack of Efficacy|20|||
127705561|NCT01309672|459551648|FG000|Overall Study|Other|9|||
127705562|NCT01309672|459551648|FG000|Overall Study|Adverse Event|5|||
127705563|NCT01309672|459551648|FG000|Overall Study|Withdrawal by Subject|3|||
127705564|NCT05623228|459551649|FG000|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|1|||
127705565|NCT05623228|459551650|FG001|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
127705566|NCT05623228|459551651|FG002|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
127705567|NCT05623228|459551652|FG003|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
127705568|NCT05623228|459551653|FG004|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
127705569|NCT05623228|459551654|FG005|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
127705570|NCT05623228|459551655|FG006|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
127705571|NCT05623228|459551656|FG007|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
127887390|NCT02092961|460211834|FG002|Overall Study|Adverse Event|0|||
127887391|NCT01792284|460211835|FG000|Lead-in Period|Adverse Event|15|||
127705572|NCT05623228|459551649|FG000|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
127705573|NCT05623228|459551650|FG001|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
127705574|NCT05623228|459551651|FG002|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
127705575|NCT05623228|459551652|FG003|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
127798538|NCT02161562|459885616|FG000|Overall Study|Participant moved out of province|1|||
127798539|NCT02161562|459885617|FG001|Overall Study|Participant moved out of province|0|||
127798540|NCT01639833|459885623|FG000|Overall Study|Death|4|||
127798541|NCT01639833|459885624|FG001|Overall Study|Death|2|||
127798542|NCT01639833|459885623|FG000|Overall Study|Withdrawal by Subject|2|||
127798543|NCT01639833|459885624|FG001|Overall Study|Withdrawal by Subject|2|||
127798544|NCT02436876|459885636|FG000|Overall Study|Lost to Follow-up|0|||
127798545|NCT02436876|459885637|FG001|Overall Study|Lost to Follow-up|1|||
127798546|NCT02436876|459885638|FG002|Overall Study|Lost to Follow-up|1|||
127798547|NCT02436876|459885639|FG003|Overall Study|Lost to Follow-up|1|||
127798548|NCT02436876|459885636|FG000|Overall Study|Withdrawal by Subject|1|||
127798549|NCT02436876|459885637|FG001|Overall Study|Withdrawal by Subject|0|||
127798550|NCT02436876|459885638|FG002|Overall Study|Withdrawal by Subject|0|||
127798551|NCT02436876|459885639|FG003|Overall Study|Withdrawal by Subject|1|||
127798552|NCT02436876|459885636|FG000|Overall Study|Physician Decision|0|||
127798553|NCT02436876|459885637|FG001|Overall Study|Physician Decision|2|||
127798554|NCT02436876|459885638|FG002|Overall Study|Physician Decision|1|||
127798555|NCT02436876|459885639|FG003|Overall Study|Physician Decision|0|||
127798556|NCT02436876|459885636|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
127887392|NCT01792284|460211836|FG001|Lead-in Period|Adverse Event|0|||
127887393|NCT01792284|460211837|FG002|Lead-in Period|Adverse Event|0|||
127887394|NCT01792284|460211835|FG000|Lead-in Period|Lost to Follow-up|2|||
127705576|NCT05623228|459551653|FG004|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
127705577|NCT05623228|459551654|FG005|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
127705578|NCT05623228|459551655|FG006|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
127798557|NCT02436876|459885637|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
127798558|NCT02436876|459885638|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
127887395|NCT01792284|460211836|FG001|Lead-in Period|Lost to Follow-up|0|||
127705579|NCT05623228|459551656|FG007|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
127705580|NCT04141891|459551658|FG000|6 Month Follow-up (Drivers Only)|Missed interview|3|||
127705581|NCT04141891|459551659|FG001|6 Month Follow-up (Drivers Only)|Missed interview|8|||
127705582|NCT04141891|459551658|FG000|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
127705583|NCT04141891|459551659|FG001|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
127705584|NCT04141891|459551658|FG000|12 Month Follow-up (Drivers + SPs)|Missed interview|9|||
127705585|NCT04141891|459551659|FG001|12 Month Follow-up (Drivers + SPs)|Missed interview|20|||
127705586|NCT04141891|459551658|FG000|12 Month Follow-up (Drivers + SPs)|Death|1|||
127705587|NCT04141891|459551659|FG001|12 Month Follow-up (Drivers + SPs)|Death|4|||
127705588|NCT04141891|459551658|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|11|||
127705589|NCT04141891|459551659|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|8|||
127705590|NCT04141891|459551658|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|0|||
127705591|NCT04141891|459551659|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|2|||
127705592|NCT04141891|459551658|FG000|18 Month Follow-up (Drivers Only)|Missed interview|12|||
127705593|NCT04141891|459551659|FG001|18 Month Follow-up (Drivers Only)|Missed interview|14|||
127705594|NCT04141891|459551658|FG000|18 Month Follow-up (Drivers Only)|Death|1|||
127705595|NCT04141891|459551659|FG001|18 Month Follow-up (Drivers Only)|Death|2|||
127705596|NCT04141891|459551658|FG000|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|1|||
127705597|NCT04141891|459551659|FG001|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|3|||
127705598|NCT04141891|459551658|FG000|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|0|||
127705599|NCT04141891|459551659|FG001|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|1|||
127705600|NCT04141891|459551658|FG000|24 Month Follow-up (Drivers and SPs)|Missed interview|22|||
127705601|NCT04141891|459551659|FG001|24 Month Follow-up (Drivers and SPs)|Missed interview|18|||
127705602|NCT04141891|459551658|FG000|24 Month Follow-up (Drivers and SPs)|Death|2|||
127705603|NCT04141891|459551659|FG001|24 Month Follow-up (Drivers and SPs)|Death|3|||
127705604|NCT04141891|459551658|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|5|||
127705605|NCT04141891|459551659|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|6|||
127705606|NCT04141891|459551658|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|2|||
127705607|NCT04141891|459551659|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|0|||
127705608|NCT04737330|459551660|FG000|Treatment Period (Baseline to Week 16)|Lost to Follow-up|1|||
127705609|NCT04737330|459551661|FG001|Treatment Period (Baseline to Week 16)|Lost to Follow-up|0|||
127705610|NCT04737330|459551660|FG000|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|1|||
127705611|NCT04737330|459551661|FG001|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|2|||
127705612|NCT04737330|459551660|FG000|Follow-up Period (Week 16 to Week 108)|Not satisfied|1|||
127705613|NCT04737330|459551661|FG001|Follow-up Period (Week 16 to Week 108)|Not satisfied|0|||
127705614|NCT04737330|459551660|FG000|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|3|||
127705615|NCT04737330|459551661|FG001|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|1|||
127705616|NCT04737330|459551660|FG000|Follow-up Period (Week 16 to Week 108)|No benefit IMP|0|||
127705617|NCT04737330|459551661|FG001|Follow-up Period (Week 16 to Week 108)|No benefit IMP|1|||
127705618|NCT04737330|459551660|FG000|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|0|||
127705619|NCT04737330|459551661|FG001|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|1|||
127705620|NCT04625725|459551662|FG000|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|1|||
127705621|NCT04625725|459551663|FG001|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
127705622|NCT04625725|459551664|FG002|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
127705623|NCT04625725|459551665|FG003|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
127705624|NCT04625725|459551666|FG004|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
127705625|NCT04625725|459551667|FG005|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
127705626|NCT04625725|459551662|FG000|Provent Main Study|Withdrawal by Subject|242|||
127705627|NCT04625725|459551663|FG001|Provent Main Study|Withdrawal by Subject|144|||
127705628|NCT04625725|459551664|FG002|Provent Main Study|Withdrawal by Subject|0|||
127705629|NCT04625725|459551665|FG003|Provent Main Study|Withdrawal by Subject|0|||
127705630|NCT04625725|459551666|FG004|Provent Main Study|Withdrawal by Subject|0|||
127705631|NCT04625725|459551667|FG005|Provent Main Study|Withdrawal by Subject|0|||
127705632|NCT04625725|459551662|FG000|Provent Main Study|Physician Decision|5|||
127705633|NCT04625725|459551663|FG001|Provent Main Study|Physician Decision|0|||
127642917|NCT00734630|459313223|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
127642918|NCT00734630|459313222|FG000|Overall Study|Adverse Event|3|||
127642919|NCT00734630|459313223|FG001|Overall Study|Adverse Event|6|||
127642920|NCT00734630|459313222|FG000|Overall Study|Randomized in Error|0|||
127642921|NCT00734630|459313223|FG001|Overall Study|Randomized in Error|1|||
127642922|NCT00734630|459313222|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
127642923|NCT00734630|459313223|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
127642924|NCT00734630|459313222|FG000|Overall Study|Poor Compliance|1|||
127642925|NCT00734630|459313223|FG001|Overall Study|Poor Compliance|1|||
127642926|NCT03792126|459313224|FG000|Overall Study|Adverse Event|1|||
127642927|NCT03792126|459313225|FG001|Overall Study|Adverse Event|2|||
127642928|NCT03792126|459313224|FG000|Overall Study|Death|0|||
127642929|NCT03792126|459313225|FG001|Overall Study|Death|1|||
127642930|NCT03792126|459313224|FG000|Overall Study|Lost to Follow-up|1|||
127642931|NCT03792126|459313225|FG001|Overall Study|Lost to Follow-up|0|||
127642932|NCT03792126|459313224|FG000|Overall Study|Withdrawal by Subject|0|||
127642933|NCT03792126|459313225|FG001|Overall Study|Withdrawal by Subject|1|||
127642934|NCT03792126|459313224|FG000|Overall Study|COVID-19 Restrictions|1|||
127642935|NCT03792126|459313225|FG001|Overall Study|COVID-19 Restrictions|3|||
127642936|NCT03792126|459313224|FG000|Overall Study|Symptoms resolved|0|||
127642937|NCT03792126|459313225|FG001|Overall Study|Symptoms resolved|3|||
127642938|NCT02238379|459313226|FG000|Overall Study|Lost to Follow-up|1|||
127642939|NCT02238379|459313227|FG001|Overall Study|Lost to Follow-up|0|||
127642940|NCT04123067|459313228|FG000|Overall Study|Lost to Follow-up|0|||
127642941|NCT04123067|459313229|FG001|Overall Study|Lost to Follow-up|1|||
127642942|NCT01441102|459313230|FG000|Overall Study|Adverse Event|1|||
127642943|NCT01441102|459313230|FG000|Overall Study|Withdrawal by Subject|2|||
127642944|NCT01775904|459313231|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
127642945|NCT01775904|459313231|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
127642946|NCT00518115|459313232|FG000|Overall Study|Adverse Event|6|||
127642947|NCT00518115|459313233|FG001|Overall Study|Adverse Event|1|||
127642948|NCT00518115|459313234|FG002|Overall Study|Adverse Event|5|||
127642949|NCT00518115|459313235|FG003|Overall Study|Adverse Event|6|||
127642950|NCT00518115|459313236|FG004|Overall Study|Adverse Event|5|||
127642951|NCT00518115|459313237|FG005|Overall Study|Adverse Event|5|||
127642952|NCT00518115|459313238|FG006|Overall Study|Adverse Event|5|||
127642953|NCT00518115|459313239|FG007|Overall Study|Adverse Event|10|||
127642954|NCT00518115|459313240|FG008|Overall Study|Adverse Event|2|||
127642955|NCT00518115|459313241|FG009|Overall Study|Adverse Event|9|||
127642956|NCT00518115|459313232|FG000|Overall Study|Lost to Follow-up|0|||
127642957|NCT00518115|459313233|FG001|Overall Study|Lost to Follow-up|0|||
127642958|NCT00518115|459313234|FG002|Overall Study|Lost to Follow-up|2|||
127642959|NCT00518115|459313235|FG003|Overall Study|Lost to Follow-up|3|||
127642960|NCT00518115|459313236|FG004|Overall Study|Lost to Follow-up|1|||
127642961|NCT00518115|459313237|FG005|Overall Study|Lost to Follow-up|3|||
127642962|NCT00518115|459313238|FG006|Overall Study|Lost to Follow-up|0|||
127642963|NCT00518115|459313239|FG007|Overall Study|Lost to Follow-up|1|||
127642964|NCT00518115|459313240|FG008|Overall Study|Lost to Follow-up|1|||
127642965|NCT00518115|459313241|FG009|Overall Study|Lost to Follow-up|1|||
127642966|NCT00518115|459313232|FG000|Overall Study|Protocol Violation|1|||
127642967|NCT00518115|459313233|FG001|Overall Study|Protocol Violation|3|||
127705634|NCT04625725|459551664|FG002|Provent Main Study|Physician Decision|0|||
127887396|NCT01792284|460211837|FG002|Lead-in Period|Lost to Follow-up|0|||
127887397|NCT01792284|460211835|FG000|Lead-in Period|Protocol Violation|1|||
127887398|NCT01792284|460211836|FG001|Lead-in Period|Protocol Violation|0|||
127887399|NCT01792284|460211837|FG002|Lead-in Period|Protocol Violation|0|||
127887400|NCT01792284|460211835|FG000|Lead-in Period|Withdrawal by Subject|10|||
127887401|NCT01792284|460211836|FG001|Lead-in Period|Withdrawal by Subject|0|||
127887402|NCT01792284|460211837|FG002|Lead-in Period|Withdrawal by Subject|0|||
127887403|NCT01792284|460211835|FG000|Lead-in Period|Physician Decision|1|||
127887404|NCT01792284|460211836|FG001|Lead-in Period|Physician Decision|0|||
127887405|NCT01792284|460211837|FG002|Lead-in Period|Physician Decision|0|||
127887406|NCT01792284|460211835|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
127887407|NCT01792284|460211836|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
127887408|NCT01792284|460211837|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
127887409|NCT01792284|460211835|FG000|Randomization Period 1|Withdrawal by Subject|0|||
127642968|NCT00518115|459313234|FG002|Overall Study|Protocol Violation|1|||
127642969|NCT00518115|459313235|FG003|Overall Study|Protocol Violation|0|||
127642970|NCT00518115|459313236|FG004|Overall Study|Protocol Violation|0|||
127642971|NCT00518115|459313237|FG005|Overall Study|Protocol Violation|0|||
127642972|NCT00518115|459313238|FG006|Overall Study|Protocol Violation|0|||
127642973|NCT00518115|459313239|FG007|Overall Study|Protocol Violation|0|||
127642974|NCT00518115|459313240|FG008|Overall Study|Protocol Violation|0|||
127642975|NCT00518115|459313241|FG009|Overall Study|Protocol Violation|0|||
127642976|NCT00518115|459313232|FG000|Overall Study|Withdrawal by Subject|1|||
127642977|NCT00518115|459313233|FG001|Overall Study|Withdrawal by Subject|1|||
127642978|NCT00518115|459313234|FG002|Overall Study|Withdrawal by Subject|5|||
127642979|NCT00518115|459313235|FG003|Overall Study|Withdrawal by Subject|0|||
127642980|NCT00518115|459313236|FG004|Overall Study|Withdrawal by Subject|2|||
127887410|NCT01792284|460211836|FG001|Randomization Period 1|Withdrawal by Subject|1|||
127887411|NCT01792284|460211837|FG002|Randomization Period 1|Withdrawal by Subject|1|||
127887412|NCT01792284|460211835|FG000|Randomization Period 1|Physician Decision|0|||
127705635|NCT04625725|459551665|FG003|Provent Main Study|Physician Decision|0|||
127705636|NCT04625725|459551666|FG004|Provent Main Study|Physician Decision|0|||
127705637|NCT04625725|459551667|FG005|Provent Main Study|Physician Decision|0|||
127705638|NCT04625725|459551662|FG000|Provent Main Study|Protocol Violation|1|||
127705639|NCT04625725|459551663|FG001|Provent Main Study|Protocol Violation|0|||
127705640|NCT04625725|459551664|FG002|Provent Main Study|Protocol Violation|0|||
127705641|NCT04625725|459551665|FG003|Provent Main Study|Protocol Violation|0|||
127705642|NCT04625725|459551666|FG004|Provent Main Study|Protocol Violation|0|||
127705643|NCT04625725|459551667|FG005|Provent Main Study|Protocol Violation|0|||
127705644|NCT04625725|459551662|FG000|Provent Main Study|Lost to Follow-up|357|||
127705645|NCT04625725|459551663|FG001|Provent Main Study|Lost to Follow-up|200|||
127705646|NCT04625725|459551664|FG002|Provent Main Study|Lost to Follow-up|0|||
127705647|NCT04625725|459551665|FG003|Provent Main Study|Lost to Follow-up|0|||
127705648|NCT04625725|459551666|FG004|Provent Main Study|Lost to Follow-up|0|||
127705649|NCT04625725|459551667|FG005|Provent Main Study|Lost to Follow-up|0|||
127705650|NCT04625725|459551662|FG000|Provent Main Study|Death|22|||
127705651|NCT04625725|459551663|FG001|Provent Main Study|Death|10|||
127705652|NCT04625725|459551664|FG002|Provent Main Study|Death|0|||
127705653|NCT04625725|459551665|FG003|Provent Main Study|Death|0|||
127705654|NCT04625725|459551666|FG004|Provent Main Study|Death|0|||
127705655|NCT04625725|459551667|FG005|Provent Main Study|Death|0|||
127705656|NCT04625725|459551662|FG000|Provent Main Study|Adverse Event|2|||
127705657|NCT04625725|459551663|FG001|Provent Main Study|Adverse Event|1|||
127705658|NCT04625725|459551664|FG002|Provent Main Study|Adverse Event|0|||
127705659|NCT04625725|459551665|FG003|Provent Main Study|Adverse Event|0|||
127705660|NCT04625725|459551666|FG004|Provent Main Study|Adverse Event|0|||
127705661|NCT04625725|459551667|FG005|Provent Main Study|Adverse Event|0|||
127705662|NCT04625725|459551662|FG000|Provent Main Study|Participants dosed in sub-study|310|||
127705663|NCT04625725|459551663|FG001|Provent Main Study|Participants dosed in sub-study|193|||
127705664|NCT04625725|459551664|FG002|Provent Main Study|Participants dosed in sub-study|0|||
127705665|NCT04625725|459551665|FG003|Provent Main Study|Participants dosed in sub-study|0|||
127705666|NCT04625725|459551666|FG004|Provent Main Study|Participants dosed in sub-study|0|||
127705667|NCT04625725|459551667|FG005|Provent Main Study|Participants dosed in sub-study|0|||
127705668|NCT04625725|459551662|FG000|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
127705669|NCT04625725|459551663|FG001|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
127705670|NCT04625725|459551664|FG002|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
127705671|NCT04625725|459551665|FG003|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
127705672|NCT04625725|459551666|FG004|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
127705673|NCT04625725|459551667|FG005|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
127705674|NCT04625725|459551662|FG000|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|14|||
127705675|NCT04625725|459551663|FG001|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|2|||
127705676|NCT04625725|459551664|FG002|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
127705677|NCT04625725|459551665|FG003|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
127705678|NCT04625725|459551666|FG004|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
127705679|NCT04625725|459551667|FG005|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
127705680|NCT04625725|459551662|FG000|Provent Main Study|INCARCERATION|3|||
127705681|NCT04625725|459551663|FG001|Provent Main Study|INCARCERATION|0|||
127705682|NCT04625725|459551664|FG002|Provent Main Study|INCARCERATION|0|||
127705683|NCT04625725|459551665|FG003|Provent Main Study|INCARCERATION|0|||
127705684|NCT04625725|459551666|FG004|Provent Main Study|INCARCERATION|0|||
127705685|NCT04625725|459551667|FG005|Provent Main Study|INCARCERATION|0|||
127705686|NCT04625725|459551662|FG000|Provent Main Study|WITHDRAWAL OF CONSENT|3|||
127705687|NCT04625725|459551663|FG001|Provent Main Study|WITHDRAWAL OF CONSENT|2|||
127705688|NCT04625725|459551664|FG002|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
127705689|NCT04625725|459551665|FG003|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
127705690|NCT04625725|459551666|FG004|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
127705691|NCT04625725|459551667|FG005|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
127705692|NCT04625725|459551662|FG000|Provent Main Study|MOVED ABROAD / LOCATION|7|||
127705693|NCT04625725|459551663|FG001|Provent Main Study|MOVED ABROAD / LOCATION|2|||
127705694|NCT04625725|459551664|FG002|Provent Main Study|MOVED ABROAD / LOCATION|0|||
127705695|NCT04625725|459551665|FG003|Provent Main Study|MOVED ABROAD / LOCATION|0|||
127705696|NCT04625725|459551666|FG004|Provent Main Study|MOVED ABROAD / LOCATION|0|||
127705697|NCT04625725|459551667|FG005|Provent Main Study|MOVED ABROAD / LOCATION|0|||
127705698|NCT04625725|459551662|FG000|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
127705699|NCT04625725|459551663|FG001|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
127705700|NCT04625725|459551664|FG002|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
127705701|NCT04625725|459551665|FG003|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
127705702|NCT04625725|459551666|FG004|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
127705703|NCT04625725|459551667|FG005|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
127705704|NCT04625725|459551662|FG000|Provent Main Study|MISSING REASON|0|||
127705705|NCT04625725|459551663|FG001|Provent Main Study|MISSING REASON|1|||
127705706|NCT04625725|459551664|FG002|Provent Main Study|MISSING REASON|0|||
127705707|NCT04625725|459551665|FG003|Provent Main Study|MISSING REASON|0|||
127642981|NCT00518115|459313237|FG005|Overall Study|Withdrawal by Subject|1|||
127642982|NCT00518115|459313238|FG006|Overall Study|Withdrawal by Subject|0|||
127642983|NCT00518115|459313239|FG007|Overall Study|Withdrawal by Subject|2|||
127642984|NCT00518115|459313240|FG008|Overall Study|Withdrawal by Subject|1|||
127642985|NCT00518115|459313241|FG009|Overall Study|Withdrawal by Subject|3|||
127642986|NCT00518115|459313232|FG000|Overall Study|Lack of Efficacy|1|||
127642987|NCT00518115|459313233|FG001|Overall Study|Lack of Efficacy|0|||
127642988|NCT00518115|459313234|FG002|Overall Study|Lack of Efficacy|1|||
127642989|NCT00518115|459313235|FG003|Overall Study|Lack of Efficacy|1|||
127642990|NCT00518115|459313236|FG004|Overall Study|Lack of Efficacy|0|||
127642991|NCT00518115|459313237|FG005|Overall Study|Lack of Efficacy|0|||
127642992|NCT00518115|459313238|FG006|Overall Study|Lack of Efficacy|0|||
127642993|NCT00518115|459313239|FG007|Overall Study|Lack of Efficacy|1|||
127642994|NCT00518115|459313240|FG008|Overall Study|Lack of Efficacy|0|||
127642995|NCT00518115|459313241|FG009|Overall Study|Lack of Efficacy|0|||
127642996|NCT00518115|459313232|FG000|Overall Study|Non-Compliance|1|||
127642997|NCT00518115|459313233|FG001|Overall Study|Non-Compliance|0|||
127642998|NCT00518115|459313234|FG002|Overall Study|Non-Compliance|1|||
127642999|NCT00518115|459313235|FG003|Overall Study|Non-Compliance|0|||
127643000|NCT00518115|459313236|FG004|Overall Study|Non-Compliance|1|||
127643001|NCT00518115|459313237|FG005|Overall Study|Non-Compliance|1|||
127643002|NCT00518115|459313238|FG006|Overall Study|Non-Compliance|1|||
127643003|NCT00518115|459313239|FG007|Overall Study|Non-Compliance|1|||
127643004|NCT00518115|459313240|FG008|Overall Study|Non-Compliance|0|||
127643005|NCT00518115|459313241|FG009|Overall Study|Non-Compliance|1|||
127643006|NCT00518115|459313232|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
127643007|NCT00518115|459313233|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
127643008|NCT00518115|459313234|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
127643009|NCT00518115|459313235|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
127643010|NCT00518115|459313236|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
127643011|NCT00518115|459313237|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
127643012|NCT00518115|459313238|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
127705708|NCT04625725|459551666|FG004|Provent Main Study|MISSING REASON|0|||
127705709|NCT04625725|459551667|FG005|Provent Main Study|MISSING REASON|0|||
127705710|NCT04625725|459551662|FG000|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
127705711|NCT04625725|459551663|FG001|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
127705712|NCT04625725|459551664|FG002|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
127705713|NCT04625725|459551665|FG003|Provent Sub Study|SUBJECT MOVED OUT OF AREA|1|||
127705714|NCT04625725|459551666|FG004|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
127705715|NCT04625725|459551667|FG005|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
127705716|NCT04625725|459551662|FG000|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
127705717|NCT04625725|459551663|FG001|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
127705718|NCT04625725|459551664|FG002|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|1|||
127705719|NCT04625725|459551665|FG003|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
127705720|NCT04625725|459551666|FG004|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
127705721|NCT04625725|459551667|FG005|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
127705722|NCT04625725|459551662|FG000|Provent Sub Study|Lost to Follow-up|0|||
127705723|NCT04625725|459551663|FG001|Provent Sub Study|Lost to Follow-up|0|||
127705724|NCT04625725|459551664|FG002|Provent Sub Study|Lost to Follow-up|20|||
127705725|NCT04625725|459551665|FG003|Provent Sub Study|Lost to Follow-up|10|||
127887413|NCT01792284|460211836|FG001|Randomization Period 1|Physician Decision|1|||
127887414|NCT01792284|460211837|FG002|Randomization Period 1|Physician Decision|1|||
127887415|NCT01792284|460211835|FG000|Randomization Period 1|Adverse Event|0|||
127887416|NCT01792284|460211836|FG001|Randomization Period 1|Adverse Event|0|||
127887417|NCT01792284|460211837|FG002|Randomization Period 1|Adverse Event|2|||
127887418|NCT01792284|460211835|FG000|Randomization Period 1|Lost to Follow-up|0|||
127887419|NCT01792284|460211836|FG001|Randomization Period 1|Lost to Follow-up|0|||
127887420|NCT01792284|460211837|FG002|Randomization Period 1|Lost to Follow-up|1|||
127887421|NCT01792284|460211835|FG000|Randomization Period 2|Protocol Violation|0|||
127887422|NCT01792284|460211836|FG001|Randomization Period 2|Protocol Violation|1|||
127643013|NCT00518115|459313239|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
127643014|NCT00518115|459313240|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
127643015|NCT00518115|459313241|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
127705726|NCT04625725|459551666|FG004|Provent Sub Study|Lost to Follow-up|6|||
127705727|NCT04625725|459551667|FG005|Provent Sub Study|Lost to Follow-up|4|||
127887423|NCT01792284|460211837|FG002|Randomization Period 2|Protocol Violation|0|||
127887424|NCT01792284|460211835|FG000|Randomization Period 2|Withdrawal by Subject|0|||
127887425|NCT01792284|460211836|FG001|Randomization Period 2|Withdrawal by Subject|2|||
127643016|NCT00518115|459313232|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
127643017|NCT00518115|459313233|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
127705728|NCT04625725|459551662|FG000|Provent Sub Study|Death|0|||
127705729|NCT04625725|459551663|FG001|Provent Sub Study|Death|0|||
127705730|NCT04625725|459551664|FG002|Provent Sub Study|Death|8|||
127705731|NCT04625725|459551665|FG003|Provent Sub Study|Death|5|||
127705732|NCT04625725|459551666|FG004|Provent Sub Study|Death|0|||
127705733|NCT04625725|459551667|FG005|Provent Sub Study|Death|1|||
127887426|NCT01792284|460211837|FG002|Randomization Period 2|Withdrawal by Subject|0|||
127887427|NCT01169649|460211838|FG000|Overall Study|Patient Not Treated|3|||
127887428|NCT01847313|460211839|FG000|Overall Study|Death|0|||
127705734|NCT04625725|459551662|FG000|Provent Sub Study|Adverse Event|0|||
127705735|NCT04625725|459551663|FG001|Provent Sub Study|Adverse Event|0|||
127705736|NCT04625725|459551664|FG002|Provent Sub Study|Adverse Event|0|||
127705737|NCT04625725|459551665|FG003|Provent Sub Study|Adverse Event|0|||
127705738|NCT04625725|459551666|FG004|Provent Sub Study|Adverse Event|0|||
127705739|NCT04625725|459551667|FG005|Provent Sub Study|Adverse Event|1|||
127705740|NCT04625725|459551662|FG000|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
127705741|NCT04625725|459551663|FG001|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
127705742|NCT04625725|459551664|FG002|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
127705743|NCT04625725|459551665|FG003|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
127705744|NCT04625725|459551666|FG004|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|1|||
127705745|NCT04625725|459551667|FG005|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
127705746|NCT04625725|459551662|FG000|Provent Sub Study|Withdrawal by Subject|0|||
127705747|NCT04625725|459551663|FG001|Provent Sub Study|Withdrawal by Subject|0|||
127705748|NCT04625725|459551664|FG002|Provent Sub Study|Withdrawal by Subject|11|||
127705749|NCT04625725|459551665|FG003|Provent Sub Study|Withdrawal by Subject|13|||
127705750|NCT04625725|459551666|FG004|Provent Sub Study|Withdrawal by Subject|5|||
127705751|NCT04625725|459551667|FG005|Provent Sub Study|Withdrawal by Subject|6|||
127705752|NCT04625725|459551662|FG000|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
127705753|NCT04625725|459551663|FG001|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
127705754|NCT04625725|459551664|FG002|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
127705755|NCT04625725|459551665|FG003|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
127705756|NCT04625725|459551666|FG004|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
127705757|NCT04625725|459551667|FG005|Provent Sub Study|NON COMPLIANCE BY SUBJECT|1|||
127705758|NCT03298451|459551671|FG000|Overall Study|Death|275|||
127705759|NCT03298451|459551672|FG001|Overall Study|Death|260|||
127705760|NCT03298451|459551673|FG002|Overall Study|Death|122|||
127705761|NCT03298451|459551674|FG003|Overall Study|Death|280|||
127705762|NCT03298451|459551671|FG000|Overall Study|Lost to Follow-up|1|||
127705763|NCT03298451|459551672|FG001|Overall Study|Lost to Follow-up|1|||
127705764|NCT03298451|459551673|FG002|Overall Study|Lost to Follow-up|0|||
127705765|NCT03298451|459551674|FG003|Overall Study|Lost to Follow-up|7|||
127705766|NCT03298451|459551671|FG000|Overall Study|Withdrawal by Subject|9|||
127705767|NCT03298451|459551672|FG001|Overall Study|Withdrawal by Subject|7|||
127705768|NCT03298451|459551673|FG002|Overall Study|Withdrawal by Subject|1|||
127705769|NCT03298451|459551674|FG003|Overall Study|Withdrawal by Subject|20|||
127705770|NCT04032847|459551679|FG000|Overall Study|Study termination by sponsor|8|||
127887429|NCT01847313|460211840|FG001|Overall Study|Death|1|||
127887430|NCT01847313|460211839|FG000|Overall Study|Withdrawal by Subject|0|||
127705771|NCT04032847|459551680|FG001|Overall Study|Study termination by sponsor|0|||
127705772|NCT04032847|459551681|FG002|Overall Study|Study termination by sponsor|4|||
127705773|NCT04032847|459551679|FG000|Overall Study|Death|12|||
127705774|NCT04032847|459551680|FG001|Overall Study|Death|0|||
127705775|NCT04032847|459551681|FG002|Overall Study|Death|0|||
127705776|NCT04032847|459551679|FG000|Overall Study|Progressive disease|2|||
127705777|NCT04032847|459551680|FG001|Overall Study|Progressive disease|0|||
127705778|NCT04032847|459551681|FG002|Overall Study|Progressive disease|1|||
127705779|NCT05873556|459551682|FG000|Overall Study|Lost to Follow-up|4|||
127705780|NCT05873556|459551683|FG001|Overall Study|Lost to Follow-up|1|||
127705781|NCT03381586|459551684|FG000|Overall Study|Adverse Event|1|||
127705782|NCT03381586|459551685|FG001|Overall Study|Adverse Event|1|||
127705783|NCT03381586|459551684|FG000|Overall Study|Protocol Violation|1|||
127705784|NCT03381586|459551685|FG001|Overall Study|Protocol Violation|0|||
127705785|NCT03381586|459551684|FG000|Overall Study|Withdrawal by Subject|1|||
127705786|NCT03381586|459551685|FG001|Overall Study|Withdrawal by Subject|2|||
127705787|NCT00696111|459553101|FG000|Overall Study|Withdrawal by Subject|17|||
127705788|NCT02433379|459553102|FG000|Overall Study|Screen Failures|55|||
127705789|NCT02433379|459553102|FG000|Overall Study|Death|57|||
127705790|NCT02433379|459553102|FG000|Overall Study|Total Withdrawals|209|||
127705791|NCT02038777|459553107|FG000|Overall Study|Death|0|||
127705792|NCT02038777|459553108|FG001|Overall Study|Death|2|||
127705793|NCT02038777|459553109|FG002|Overall Study|Death|0|||
127705794|NCT02038777|459553110|FG003|Overall Study|Death|1|||
127705795|NCT02038777|459553111|FG004|Overall Study|Death|2|||
127705796|NCT02038777|459553112|FG005|Overall Study|Death|4|||
127705797|NCT02038777|459553113|FG006|Overall Study|Death|0|||
127705798|NCT02038777|459553114|FG007|Overall Study|Death|11|||
127705799|NCT02038777|459553107|FG000|Overall Study|Lost to Follow-up|0|||
127705800|NCT02038777|459553108|FG001|Overall Study|Lost to Follow-up|0|||
127705801|NCT02038777|459553109|FG002|Overall Study|Lost to Follow-up|0|||
127705802|NCT02038777|459553110|FG003|Overall Study|Lost to Follow-up|1|||
127705803|NCT02038777|459553111|FG004|Overall Study|Lost to Follow-up|0|||
127705804|NCT02038777|459553112|FG005|Overall Study|Lost to Follow-up|0|||
127705805|NCT02038777|459553113|FG006|Overall Study|Lost to Follow-up|0|||
127705806|NCT02038777|459553114|FG007|Overall Study|Lost to Follow-up|0|||
127705807|NCT02038777|459553107|FG000|Overall Study|Other|0|||
127705808|NCT02038777|459553108|FG001|Overall Study|Other|1|||
127705809|NCT02038777|459553109|FG002|Overall Study|Other|0|||
127705810|NCT02038777|459553110|FG003|Overall Study|Other|2|||
127705811|NCT02038777|459553111|FG004|Overall Study|Other|1|||
127705812|NCT02038777|459553112|FG005|Overall Study|Other|0|||
127705813|NCT02038777|459553113|FG006|Overall Study|Other|0|||
127705814|NCT02038777|459553114|FG007|Overall Study|Other|0|||
127705815|NCT02038777|459553107|FG000|Overall Study|Randomized but not treated|0|||
127705816|NCT02038777|459553108|FG001|Overall Study|Randomized but not treated|1|||
127705817|NCT02038777|459553109|FG002|Overall Study|Randomized but not treated|0|||
127705818|NCT02038777|459553110|FG003|Overall Study|Randomized but not treated|0|||
127705819|NCT02038777|459553111|FG004|Overall Study|Randomized but not treated|0|||
127705820|NCT02038777|459553112|FG005|Overall Study|Randomized but not treated|0|||
127705821|NCT02038777|459553113|FG006|Overall Study|Randomized but not treated|0|||
127705822|NCT02038777|459553114|FG007|Overall Study|Randomized but not treated|0|||
127705823|NCT02038777|459553107|FG000|Overall Study|Started Chemotherapy|1|||
127705824|NCT02038777|459553108|FG001|Overall Study|Started Chemotherapy|0|||
127705825|NCT02038777|459553109|FG002|Overall Study|Started Chemotherapy|3|||
127705826|NCT02038777|459553110|FG003|Overall Study|Started Chemotherapy|0|||
127705827|NCT02038777|459553111|FG004|Overall Study|Started Chemotherapy|0|||
127705828|NCT02038777|459553112|FG005|Overall Study|Started Chemotherapy|0|||
127705829|NCT02038777|459553113|FG006|Overall Study|Started Chemotherapy|0|||
127705830|NCT02038777|459553114|FG007|Overall Study|Started Chemotherapy|0|||
127705831|NCT02038777|459553107|FG000|Overall Study|participation terminated by sponsor|0|||
127798559|NCT02436876|459885639|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
127798560|NCT03403205|459885640|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|4|||
127798561|NCT03403205|459885641|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
127798562|NCT03403205|459885642|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
127798563|NCT03403205|459885643|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
127798564|NCT03403205|459885644|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
127798565|NCT03403205|459885645|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
127705832|NCT02038777|459553108|FG001|Overall Study|participation terminated by sponsor|0|||
127705833|NCT02038777|459553109|FG002|Overall Study|participation terminated by sponsor|0|||
127705834|NCT02038777|459553110|FG003|Overall Study|participation terminated by sponsor|0|||
127705835|NCT02038777|459553111|FG004|Overall Study|participation terminated by sponsor|0|||
127705836|NCT02038777|459553112|FG005|Overall Study|participation terminated by sponsor|0|||
127705837|NCT02038777|459553113|FG006|Overall Study|participation terminated by sponsor|1|||
127705838|NCT02038777|459553114|FG007|Overall Study|participation terminated by sponsor|1|||
127705839|NCT04299464|459553115|FG000|Overall Study|Adverse Event|1|||
127887431|NCT01847313|460211840|FG001|Overall Study|Withdrawal by Subject|1|||
127887432|NCT02962882|460211842|FG000|Overall Study|Adverse Event|2|||
127887433|NCT02962882|460211842|FG000|Overall Study|Withdrawal by Subject|2|||
127887434|NCT02962882|460211842|FG000|Overall Study|Transfer from ICU|32|||
127887435|NCT01312779|460211843|FG000|Overall Study|Withdrawal by Subject|2|||
127887436|NCT01312779|460211843|FG000|Overall Study|Death|3|||
127887437|NCT01312779|460211843|FG000|Overall Study|Not Implanted with Device|27|||
127887438|NCT01663714|460211846|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
127887439|NCT01663714|460211846|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
127887440|NCT01663714|460211846|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
127887441|NCT01663714|460211846|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
127887442|NCT01663714|460211846|FG000|Long-Term Follow-Up|Death|4|||
127887443|NCT01663714|460211846|FG000|Long-Term Follow-Up|Non-compliance|1|||
127887444|NCT00597584|460211847|FG000|Overall Study|Adverse Event|4|||
127887445|NCT00597584|460211848|FG001|Overall Study|Adverse Event|2|||
127887446|NCT00597584|460211847|FG000|Overall Study|Death|53|||
127887447|NCT00597584|460211848|FG001|Overall Study|Death|30|||
127887448|NCT00597584|460211847|FG000|Overall Study|Lack of Efficacy|1|||
127887449|NCT00597584|460211848|FG001|Overall Study|Lack of Efficacy|0|||
127887450|NCT00597584|460211847|FG000|Overall Study|Lost to Follow-up|2|||
127887451|NCT00597584|460211848|FG001|Overall Study|Lost to Follow-up|4|||
127887452|NCT00597584|460211847|FG000|Overall Study|Physician Decision|3|||
127887453|NCT00597584|460211848|FG001|Overall Study|Physician Decision|0|||
127887454|NCT00597584|460211847|FG000|Overall Study|Pregnancy|2|||
127887455|NCT00597584|460211848|FG001|Overall Study|Pregnancy|0|||
127887456|NCT00597584|460211847|FG000|Overall Study|Withdrawal by Subject|44|||
127887457|NCT00597584|460211848|FG001|Overall Study|Withdrawal by Subject|12|||
127887458|NCT00597584|460211847|FG000|Overall Study|Discontinued Dialysis|0|||
127643018|NCT00518115|459313234|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
127643019|NCT00518115|459313235|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
127643020|NCT00518115|459313236|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
127643021|NCT00518115|459313237|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
127643022|NCT00518115|459313238|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
127643023|NCT00518115|459313239|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
127643024|NCT00518115|459313240|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
127643025|NCT00518115|459313241|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
127643026|NCT00518115|459313232|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
127643027|NCT00518115|459313233|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
127643028|NCT00518115|459313234|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
127643029|NCT00518115|459313235|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
127643030|NCT00518115|459313236|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
127643031|NCT00518115|459313237|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
127643032|NCT00518115|459313238|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
127643033|NCT00518115|459313239|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
127643034|NCT00518115|459313240|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
127643035|NCT00518115|459313241|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
127643036|NCT00518115|459313232|FG000|Overall Study|Wrong Monotherapy Administered|0|||
127643037|NCT00518115|459313233|FG001|Overall Study|Wrong Monotherapy Administered|0|||
127643038|NCT00518115|459313234|FG002|Overall Study|Wrong Monotherapy Administered|1|||
127643039|NCT00518115|459313235|FG003|Overall Study|Wrong Monotherapy Administered|0|||
127643040|NCT00518115|459313236|FG004|Overall Study|Wrong Monotherapy Administered|0|||
127643041|NCT00518115|459313237|FG005|Overall Study|Wrong Monotherapy Administered|0|||
127643042|NCT00518115|459313238|FG006|Overall Study|Wrong Monotherapy Administered|1|||
127643043|NCT00518115|459313239|FG007|Overall Study|Wrong Monotherapy Administered|0|||
127643044|NCT00518115|459313240|FG008|Overall Study|Wrong Monotherapy Administered|0|||
127643045|NCT00518115|459313241|FG009|Overall Study|Wrong Monotherapy Administered|0|||
127643046|NCT00518115|459313232|FG000|Overall Study|Violation of Exclusion Criteria|0|||
127643047|NCT00518115|459313233|FG001|Overall Study|Violation of Exclusion Criteria|0|||
127643048|NCT00518115|459313234|FG002|Overall Study|Violation of Exclusion Criteria|0|||
127643049|NCT00518115|459313235|FG003|Overall Study|Violation of Exclusion Criteria|1|||
127887459|NCT00597584|460211848|FG001|Overall Study|Discontinued Dialysis|1|||
127643050|NCT00518115|459313236|FG004|Overall Study|Violation of Exclusion Criteria|0|||
127643051|NCT00518115|459313237|FG005|Overall Study|Violation of Exclusion Criteria|0|||
127643052|NCT00518115|459313238|FG006|Overall Study|Violation of Exclusion Criteria|1|||
127643053|NCT00518115|459313239|FG007|Overall Study|Violation of Exclusion Criteria|0|||
127887460|NCT00597584|460211847|FG000|Overall Study|Lost ability to consent|1|||
127887461|NCT00597584|460211848|FG001|Overall Study|Lost ability to consent|1|||
127887462|NCT00597584|460211847|FG000|Overall Study|Never dosed|1|||
127887463|NCT00597584|460211848|FG001|Overall Study|Never dosed|0|||
127887464|NCT00597584|460211847|FG000|Overall Study|Relocation|8|||
127887465|NCT00597584|460211848|FG001|Overall Study|Relocation|6|||
127887466|NCT00597584|460211847|FG000|Overall Study|Renal transplant|9|||
127887467|NCT00597584|460211848|FG001|Overall Study|Renal transplant|7|||
127887468|NCT00515073|460211849|FG000|Overall Study|Withdrawal by Subject|1|||
127705840|NCT04299464|459553116|FG001|Overall Study|Adverse Event|0|||
127705841|NCT04299464|459553117|FG002|Overall Study|Adverse Event|2|||
127705842|NCT04299464|459553115|FG000|Overall Study|Non-compliance with Study Drug|1|||
127705843|NCT04299464|459553116|FG001|Overall Study|Non-compliance with Study Drug|0|||
127705844|NCT04299464|459553117|FG002|Overall Study|Non-compliance with Study Drug|0|||
127705845|NCT04299464|459553115|FG000|Overall Study|Reason not Specified|0|||
127705846|NCT04299464|459553116|FG001|Overall Study|Reason not Specified|1|||
127705847|NCT04299464|459553117|FG002|Overall Study|Reason not Specified|3|||
127705848|NCT04299464|459553115|FG000|Overall Study|Physician Decision|0|||
127705849|NCT04299464|459553116|FG001|Overall Study|Physician Decision|1|||
127705850|NCT04299464|459553117|FG002|Overall Study|Physician Decision|1|||
127705851|NCT04299464|459553115|FG000|Overall Study|Withdrawal by Subject|0|||
127705852|NCT04299464|459553116|FG001|Overall Study|Withdrawal by Subject|2|||
127705853|NCT04299464|459553117|FG002|Overall Study|Withdrawal by Subject|1|||
127705854|NCT03676192|459553118|FG000|Induction Study Period|Adverse Event|21|||
127705855|NCT03676192|459553119|FG001|Induction Study Period|Adverse Event|20|||
127705856|NCT03676192|459553118|FG000|Induction Study Period|Death|23|||
127705857|NCT03676192|459553119|FG001|Induction Study Period|Death|20|||
127705858|NCT03676192|459553118|FG000|Induction Study Period|Lost to Follow-up|3|||
127705859|NCT03676192|459553119|FG001|Induction Study Period|Lost to Follow-up|3|||
127705860|NCT03676192|459553118|FG000|Induction Study Period|Physician Decision|6|||
127705861|NCT03676192|459553119|FG001|Induction Study Period|Physician Decision|3|||
127705862|NCT03676192|459553118|FG000|Induction Study Period|Progressive Disease|32|||
127705863|NCT03676192|459553119|FG001|Induction Study Period|Progressive Disease|21|||
127705864|NCT03676192|459553118|FG000|Induction Study Period|Protocol Violation|1|||
127705865|NCT03676192|459553119|FG001|Induction Study Period|Protocol Violation|2|||
127705866|NCT03676192|459553118|FG000|Induction Study Period|Withdrawal by Subject|20|||
127705867|NCT03676192|459553119|FG001|Induction Study Period|Withdrawal by Subject|15|||
127705868|NCT05907174|459553120|FG000|3-Month Assessment|Withdrawal by Subject|0|||
127705869|NCT05907174|459553121|FG001|3-Month Assessment|Withdrawal by Subject|0|||
127705870|NCT05907174|459553122|FG002|3-Month Assessment|Withdrawal by Subject|0|||
127705871|NCT05907174|459553123|FG003|3-Month Assessment|Withdrawal by Subject|1|||
127705872|NCT05907174|459553120|FG000|3-Month Assessment|Lost to Follow-up|1|||
127705873|NCT05907174|459553121|FG001|3-Month Assessment|Lost to Follow-up|1|||
127705874|NCT05907174|459553122|FG002|3-Month Assessment|Lost to Follow-up|1|||
127705875|NCT05907174|459553123|FG003|3-Month Assessment|Lost to Follow-up|1|||
127705876|NCT05907174|459553120|FG000|6-Month Assessment|Death|0|||
127705877|NCT05907174|459553121|FG001|6-Month Assessment|Death|0|||
127705878|NCT05907174|459553122|FG002|6-Month Assessment|Death|3|||
127705879|NCT05907174|459553123|FG003|6-Month Assessment|Death|0|||
127705880|NCT05907174|459553120|FG000|6-Month Assessment|Withdrawal by Subject|0|||
127705881|NCT05907174|459553121|FG001|6-Month Assessment|Withdrawal by Subject|0|||
127705882|NCT05907174|459553122|FG002|6-Month Assessment|Withdrawal by Subject|1|||
127705883|NCT05907174|459553123|FG003|6-Month Assessment|Withdrawal by Subject|1|||
127705884|NCT05907174|459553120|FG000|6-Month Assessment|Lost to Follow-up|0|||
127705885|NCT05907174|459553121|FG001|6-Month Assessment|Lost to Follow-up|1|||
127705886|NCT05907174|459553122|FG002|6-Month Assessment|Lost to Follow-up|1|||
127705887|NCT05907174|459553123|FG003|6-Month Assessment|Lost to Follow-up|1|||
127705888|NCT05906784|459553124|FG000|Overall Study|Lost to Follow-up|2|||
127705889|NCT05906784|459553125|FG001|Overall Study|Lost to Follow-up|1|||
127705890|NCT05906784|459553126|FG002|Overall Study|Lost to Follow-up|1|||
127705891|NCT05906784|459553127|FG003|Overall Study|Lost to Follow-up|1|||
127705892|NCT03249090|459553131|FG000|Enrollment|Excluded after randomization for ineligibility|4|||
127705893|NCT03249090|459553132|FG001|Enrollment|Excluded after randomization for ineligibility|2|||
127705894|NCT03249090|459553131|FG000|3 Month Time Point|Death, hospice, discontinued therapy|41|||
127705895|NCT03249090|459553132|FG001|3 Month Time Point|Death, hospice, discontinued therapy|37|||
127705896|NCT03249090|459553131|FG000|3 Month Time Point|Voluntary withdrawal|6|||
127705897|NCT03249090|459553132|FG001|3 Month Time Point|Voluntary withdrawal|3|||
127705898|NCT03249090|459553131|FG000|3 Month Time Point|Changed oncology practice|4|||
127798566|NCT03403205|459885640|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|4|||
127798567|NCT03403205|459885641|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
127798568|NCT03403205|459885642|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
127798569|NCT03403205|459885643|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
127705899|NCT03249090|459553132|FG001|3 Month Time Point|Changed oncology practice|2|||
127705900|NCT03249090|459553131|FG000|12 Month Time Point|Death, hospice, discontinued therapy|172|||
127798570|NCT03403205|459885644|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
127798571|NCT03403205|459885645|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
127705901|NCT03249090|459553132|FG001|12 Month Time Point|Death, hospice, discontinued therapy|175|||
127705902|NCT03249090|459553131|FG000|12 Month Time Point|Voluntary withdrawal|35|||
127705903|NCT03249090|459553132|FG001|12 Month Time Point|Voluntary withdrawal|4|||
127705904|NCT03249090|459553131|FG000|12 Month Time Point|Changed oncology practice|20|||
127705905|NCT03249090|459553132|FG001|12 Month Time Point|Changed oncology practice|9|||
127705906|NCT04685135|459553133|FG000|Overall Study|Death|126|||
127705907|NCT04685135|459553134|FG001|Overall Study|Death|53|||
127705908|NCT04685135|459553133|FG000|Overall Study|Withdrawal by Subject|12|||
127705909|NCT04685135|459553134|FG001|Overall Study|Withdrawal by Subject|16|||
127705910|NCT03476343|459553136|FG000|Overall Study|Clinical exam moved to another scanner|7|||
127705911|NCT03476343|459553136|FG000|Overall Study|Clinical order cancelled|4|||
127705912|NCT03476343|459553136|FG000|Overall Study|Neonate did not settle down for the scan|1|||
127705913|NCT03088878|459553139|FG000|Overall Study|Adverse Event|0|||
127705914|NCT03088878|459553140|FG001|Overall Study|Adverse Event|0|||
127705915|NCT03088878|459553141|FG002|Overall Study|Adverse Event|0|||
127705916|NCT03088878|459553142|FG003|Overall Study|Adverse Event|0|||
127705917|NCT03088878|459553143|FG004|Overall Study|Adverse Event|4|||
127705918|NCT03088878|459553144|FG005|Overall Study|Adverse Event|2|||
127705919|NCT03088878|459553145|FG006|Overall Study|Adverse Event|1|||
127705920|NCT03088878|459553146|FG007|Overall Study|Adverse Event|0|||
127705921|NCT03088878|459553147|FG008|Overall Study|Adverse Event|0|||
127705922|NCT03088878|459553148|FG009|Overall Study|Adverse Event|0|||
127705923|NCT03088878|459553149|FG010|Overall Study|Adverse Event|0|||
127705924|NCT03088878|459553150|FG011|Overall Study|Adverse Event|0|||
127705925|NCT03088878|459553151|FG012|Overall Study|Adverse Event|5|||
127705926|NCT03088878|459553152|FG013|Overall Study|Adverse Event|3|||
127705927|NCT03088878|459553139|FG000|Overall Study|Clinical Progression|0|||
127705928|NCT03088878|459553140|FG001|Overall Study|Clinical Progression|0|||
127705929|NCT03088878|459553141|FG002|Overall Study|Clinical Progression|0|||
127705930|NCT03088878|459553142|FG003|Overall Study|Clinical Progression|0|||
127705931|NCT03088878|459553143|FG004|Overall Study|Clinical Progression|2|||
127705932|NCT03088878|459553144|FG005|Overall Study|Clinical Progression|0|||
127705933|NCT03088878|459553145|FG006|Overall Study|Clinical Progression|0|||
127705934|NCT03088878|459553146|FG007|Overall Study|Clinical Progression|0|||
127705935|NCT03088878|459553147|FG008|Overall Study|Clinical Progression|0|||
127705936|NCT03088878|459553148|FG009|Overall Study|Clinical Progression|0|||
127705937|NCT03088878|459553149|FG010|Overall Study|Clinical Progression|0|||
127705938|NCT03088878|459553150|FG011|Overall Study|Clinical Progression|0|||
127705939|NCT03088878|459553151|FG012|Overall Study|Clinical Progression|0|||
127705940|NCT03088878|459553152|FG013|Overall Study|Clinical Progression|0|||
127705941|NCT03088878|459553139|FG000|Overall Study|Death|0|||
127705942|NCT03088878|459553140|FG001|Overall Study|Death|0|||
127705943|NCT03088878|459553141|FG002|Overall Study|Death|0|||
127705944|NCT03088878|459553142|FG003|Overall Study|Death|0|||
127705945|NCT03088878|459553143|FG004|Overall Study|Death|2|||
127705946|NCT03088878|459553144|FG005|Overall Study|Death|0|||
127705947|NCT03088878|459553145|FG006|Overall Study|Death|0|||
127705948|NCT03088878|459553146|FG007|Overall Study|Death|0|||
127705949|NCT03088878|459553147|FG008|Overall Study|Death|0|||
127705950|NCT03088878|459553148|FG009|Overall Study|Death|0|||
127705951|NCT03088878|459553149|FG010|Overall Study|Death|0|||
127705952|NCT03088878|459553150|FG011|Overall Study|Death|1|||
127705953|NCT03088878|459553151|FG012|Overall Study|Death|0|||
127705954|NCT03088878|459553152|FG013|Overall Study|Death|0|||
127705955|NCT03088878|459553139|FG000|Overall Study|Disease Progression|1|||
127705956|NCT03088878|459553140|FG001|Overall Study|Disease Progression|2|||
127705957|NCT03088878|459553141|FG002|Overall Study|Disease Progression|3|||
127705958|NCT03088878|459553142|FG003|Overall Study|Disease Progression|0|||
127705959|NCT03088878|459553143|FG004|Overall Study|Disease Progression|3|||
127705960|NCT03088878|459553144|FG005|Overall Study|Disease Progression|0|||
127705961|NCT03088878|459553145|FG006|Overall Study|Disease Progression|0|||
127705962|NCT03088878|459553146|FG007|Overall Study|Disease Progression|0|||
127705963|NCT03088878|459553147|FG008|Overall Study|Disease Progression|0|||
127705964|NCT03088878|459553148|FG009|Overall Study|Disease Progression|0|||
127705965|NCT03088878|459553149|FG010|Overall Study|Disease Progression|0|||
127798572|NCT03403205|459885640|FG000|Primary Evaluation Period (48 Weeks)|Death|1|||
127798573|NCT03403205|459885641|FG001|Primary Evaluation Period (48 Weeks)|Death|0|||
127705966|NCT03088878|459553150|FG011|Overall Study|Disease Progression|0|||
127705967|NCT03088878|459553151|FG012|Overall Study|Disease Progression|1|||
127705968|NCT03088878|459553152|FG013|Overall Study|Disease Progression|1|||
127705969|NCT03088878|459553139|FG000|Overall Study|Initiation of Alternative Treatment|0|||
127705970|NCT03088878|459553140|FG001|Overall Study|Initiation of Alternative Treatment|0|||
127705971|NCT03088878|459553141|FG002|Overall Study|Initiation of Alternative Treatment|0|||
127705972|NCT03088878|459553142|FG003|Overall Study|Initiation of Alternative Treatment|1|||
127705973|NCT03088878|459553143|FG004|Overall Study|Initiation of Alternative Treatment|0|||
127705974|NCT03088878|459553144|FG005|Overall Study|Initiation of Alternative Treatment|0|||
127705975|NCT03088878|459553145|FG006|Overall Study|Initiation of Alternative Treatment|0|||
127705976|NCT03088878|459553146|FG007|Overall Study|Initiation of Alternative Treatment|1|||
127705977|NCT03088878|459553147|FG008|Overall Study|Initiation of Alternative Treatment|1|||
127705978|NCT03088878|459553148|FG009|Overall Study|Initiation of Alternative Treatment|0|||
127705979|NCT03088878|459553149|FG010|Overall Study|Initiation of Alternative Treatment|0|||
127705980|NCT03088878|459553150|FG011|Overall Study|Initiation of Alternative Treatment|0|||
127887469|NCT00515073|460211849|FG000|Overall Study|Physician Decision|1|||
127887470|NCT01456052|460211850|FG000|Overall Study|Adverse Event|1|||
127887471|NCT01456052|460211851|FG001|Overall Study|Adverse Event|1|||
127887472|NCT01456052|460211852|FG002|Overall Study|Adverse Event|2|||
127887473|NCT01456052|460211850|FG000|Overall Study|Consent withdrawn|0|||
127887474|NCT01456052|460211851|FG001|Overall Study|Consent withdrawn|2|||
127887475|NCT01456052|460211852|FG002|Overall Study|Consent withdrawn|1|||
127887476|NCT01456052|460211850|FG000|Overall Study|Protocol Violation|0|||
127887477|NCT01456052|460211851|FG001|Overall Study|Protocol Violation|1|||
127887478|NCT01456052|460211852|FG002|Overall Study|Protocol Violation|0|||
127887479|NCT01456052|460211850|FG000|Overall Study|Physician Decision|1|||
127887480|NCT01456052|460211851|FG001|Overall Study|Physician Decision|0|||
127887481|NCT01456052|460211852|FG002|Overall Study|Physician Decision|1|||
127887482|NCT01456052|460211850|FG000|Overall Study|Treatment Failure|0|||
127887483|NCT01456052|460211851|FG001|Overall Study|Treatment Failure|1|||
127887484|NCT01456052|460211852|FG002|Overall Study|Treatment Failure|1|||
127887485|NCT01904383|460211853|FG000|Overall Study|CRF not collected|117|||
127887486|NCT01904383|460211853|FG000|Overall Study|Reason not listed|147|||
127887487|NCT01904383|460211853|FG000|Overall Study|Lost to Follow-up|674|||
127887488|NCT01904383|460211853|FG000|Overall Study|Lack of Efficacy|370|||
127887489|NCT01904383|460211853|FG000|Overall Study|Improvement|141|||
127887490|NCT01904383|460211853|FG000|Overall Study|Adverse Event|271|||
127887491|NCT01904383|460211853|FG000|Overall Study|No patient visit after entry|54|||
127887492|NCT01294592|460211854|FG000|Overall Study|Adverse Event|28|||
127887493|NCT01294592|460211855|FG001|Overall Study|Adverse Event|13|||
127887494|NCT01294592|460211854|FG000|Overall Study|Lack of Efficacy|7|||
127887495|NCT01294592|460211855|FG001|Overall Study|Lack of Efficacy|5|||
127887496|NCT01294592|460211854|FG000|Overall Study|Protocol Violation|1|||
127887497|NCT01294592|460211855|FG001|Overall Study|Protocol Violation|7|||
127887498|NCT01294592|460211854|FG000|Overall Study|Lost to Follow-up|7|||
127887499|NCT01294592|460211855|FG001|Overall Study|Lost to Follow-up|9|||
127887500|NCT01294592|460211854|FG000|Overall Study|Physician Decision|6|||
127887501|NCT01294592|460211855|FG001|Overall Study|Physician Decision|11|||
127887502|NCT01294592|460211854|FG000|Overall Study|Withdrawal by Subject|28|||
127887503|NCT01294592|460211855|FG001|Overall Study|Withdrawal by Subject|28|||
127887504|NCT03549130|460211856|FG000|Overall Study|Adverse Event|0|||
127887505|NCT03549130|460211857|FG001|Overall Study|Adverse Event|1|||
127643054|NCT00518115|459313240|FG008|Overall Study|Violation of Exclusion Criteria|0|||
127643055|NCT00518115|459313241|FG009|Overall Study|Violation of Exclusion Criteria|0|||
127643056|NCT00518115|459313232|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
127643057|NCT00518115|459313233|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
127643058|NCT00518115|459313234|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
127643059|NCT00518115|459313235|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
127643060|NCT00518115|459313236|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
127643061|NCT00518115|459313237|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
127643062|NCT00518115|459313238|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
127643063|NCT00518115|459313239|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
127643064|NCT00518115|459313240|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
127643065|NCT00518115|459313241|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
127643066|NCT00518115|459313232|FG000|Overall Study|Withdrew Consent|0|||
127643067|NCT00518115|459313233|FG001|Overall Study|Withdrew Consent|0|||
127643068|NCT00518115|459313234|FG002|Overall Study|Withdrew Consent|0|||
127643069|NCT00518115|459313235|FG003|Overall Study|Withdrew Consent|0|||
127643070|NCT00518115|459313236|FG004|Overall Study|Withdrew Consent|0|||
127643071|NCT00518115|459313237|FG005|Overall Study|Withdrew Consent|1|||
127643072|NCT00518115|459313238|FG006|Overall Study|Withdrew Consent|0|||
127643073|NCT00518115|459313239|FG007|Overall Study|Withdrew Consent|0|||
127643074|NCT00518115|459313240|FG008|Overall Study|Withdrew Consent|0|||
127643075|NCT00518115|459313241|FG009|Overall Study|Withdrew Consent|0|||
127643076|NCT00518115|459313232|FG000|Overall Study|Moved Out of State|0|||
127643077|NCT00518115|459313233|FG001|Overall Study|Moved Out of State|0|||
127643078|NCT00518115|459313234|FG002|Overall Study|Moved Out of State|0|||
127887506|NCT03549130|460211856|FG000|Overall Study|Lost to Follow-up|0|||
127887507|NCT03549130|460211857|FG001|Overall Study|Lost to Follow-up|1|||
127887508|NCT01113710|460211858|FG000|Overall Study|Adverse Event|64|||
127887509|NCT01113710|460211858|FG000|Overall Study|Lack of Efficacy|41|||
127887510|NCT01113710|460211858|FG000|Overall Study|No Information Available|40|||
127887511|NCT01113710|460211858|FG000|Overall Study|Withdrawal by Subject|28|||
127887512|NCT01113710|460211858|FG000|Overall Study|Lost to Follow-up|20|||
127887513|NCT01113710|460211858|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
127887514|NCT01113710|460211858|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
127887515|NCT01113710|460211858|FG000|Overall Study|Lack of Patient's Compliance|8|||
127887516|NCT01113710|460211858|FG000|Overall Study|Other|7|||
127643079|NCT00518115|459313235|FG003|Overall Study|Moved Out of State|0|||
127643080|NCT00518115|459313236|FG004|Overall Study|Moved Out of State|0|||
127643081|NCT00518115|459313237|FG005|Overall Study|Moved Out of State|0|||
127643082|NCT00518115|459313238|FG006|Overall Study|Moved Out of State|0|||
127643083|NCT00518115|459313239|FG007|Overall Study|Moved Out of State|0|||
127643084|NCT00518115|459313240|FG008|Overall Study|Moved Out of State|0|||
127643085|NCT00518115|459313241|FG009|Overall Study|Moved Out of State|1|||
127643086|NCT04891419|459313242|FG000|Overall Study|Withdrawal by Subject|4|||
127643087|NCT04891419|459313243|FG001|Overall Study|Withdrawal by Subject|0|||
127643088|NCT04891419|459313242|FG000|Overall Study|Lost to Follow-up|1|||
127643089|NCT04891419|459313243|FG001|Overall Study|Lost to Follow-up|3|||
127643090|NCT00827918|459313244|FG000|Overall Study|Adverse Event|4|||
127643091|NCT00827918|459313245|FG001|Overall Study|Adverse Event|0|||
127643092|NCT00827918|459313246|FG002|Overall Study|Adverse Event|0|||
127643093|NCT00827918|459313244|FG000|Overall Study|Lack of Efficacy|16|||
127643094|NCT00827918|459313245|FG001|Overall Study|Lack of Efficacy|4|||
127643095|NCT00827918|459313246|FG002|Overall Study|Lack of Efficacy|15|||
127643096|NCT00827918|459313244|FG000|Overall Study|Physician Decision|1|||
127643097|NCT00827918|459313245|FG001|Overall Study|Physician Decision|0|||
127643098|NCT00827918|459313246|FG002|Overall Study|Physician Decision|0|||
127643099|NCT00827918|459313244|FG000|Overall Study|Pregnancy|0|||
127643100|NCT00827918|459313245|FG001|Overall Study|Pregnancy|1|||
127643101|NCT00827918|459313246|FG002|Overall Study|Pregnancy|0|||
127643102|NCT00827918|459313244|FG000|Overall Study|Progressive Disease|1|||
127643103|NCT00827918|459313245|FG001|Overall Study|Progressive Disease|1|||
127643104|NCT00827918|459313246|FG002|Overall Study|Progressive Disease|0|||
127643105|NCT00827918|459313244|FG000|Overall Study|Protocol Violation|0|||
127643106|NCT00827918|459313245|FG001|Overall Study|Protocol Violation|1|||
127643107|NCT00827918|459313246|FG002|Overall Study|Protocol Violation|0|||
127643108|NCT00827918|459313244|FG000|Overall Study|Withdrawal by Subject|6|||
127643109|NCT00827918|459313245|FG001|Overall Study|Withdrawal by Subject|2|||
127643110|NCT00827918|459313246|FG002|Overall Study|Withdrawal by Subject|6|||
127643111|NCT00843167|459313247|FG000|Treatment Period|Adverse Event|1|||
127643112|NCT00843167|459313248|FG001|Treatment Period|Adverse Event|5|||
127643113|NCT00843167|459313247|FG000|Treatment Period|Withdrawal by Subject|2|||
127643114|NCT00843167|459313248|FG001|Treatment Period|Withdrawal by Subject|3|||
127643115|NCT02291614|459313249|FG000|Overall Study|Lost to Follow-up|0|||
127643116|NCT02291614|459313250|FG001|Overall Study|Lost to Follow-up|0|||
127643117|NCT02291614|459313251|FG002|Overall Study|Lost to Follow-up|0|||
127643118|NCT02291614|459313252|FG003|Overall Study|Lost to Follow-up|0|||
127643119|NCT02291614|459313253|FG004|Overall Study|Lost to Follow-up|0|||
127643120|NCT02291614|459313254|FG005|Overall Study|Lost to Follow-up|0|||
127643121|NCT02291614|459313255|FG006|Overall Study|Lost to Follow-up|0|||
127643122|NCT02291614|459313256|FG007|Overall Study|Lost to Follow-up|1|||
127643123|NCT02291614|459313257|FG008|Overall Study|Lost to Follow-up|0|||
127643124|NCT02291614|459313258|FG009|Overall Study|Lost to Follow-up|0|||
127643125|NCT02291614|459313259|FG010|Overall Study|Lost to Follow-up|0|||
127643126|NCT02291614|459313249|FG000|Overall Study|Withdrawal by Subject|0|||
127643127|NCT02291614|459313250|FG001|Overall Study|Withdrawal by Subject|1|||
127643128|NCT02291614|459313251|FG002|Overall Study|Withdrawal by Subject|0|||
127643129|NCT02291614|459313252|FG003|Overall Study|Withdrawal by Subject|0|||
127643130|NCT02291614|459313253|FG004|Overall Study|Withdrawal by Subject|0|||
127643131|NCT02291614|459313254|FG005|Overall Study|Withdrawal by Subject|0|||
127643132|NCT02291614|459313255|FG006|Overall Study|Withdrawal by Subject|0|||
127643133|NCT02291614|459313256|FG007|Overall Study|Withdrawal by Subject|0|||
127643134|NCT02291614|459313257|FG008|Overall Study|Withdrawal by Subject|0|||
127643135|NCT02291614|459313258|FG009|Overall Study|Withdrawal by Subject|2|||
127643136|NCT02291614|459313259|FG010|Overall Study|Withdrawal by Subject|2|||
127643137|NCT02291614|459313249|FG000|Overall Study|Decision by sponsor|0|||
127643138|NCT02291614|459313250|FG001|Overall Study|Decision by sponsor|0|||
127643139|NCT02291614|459313251|FG002|Overall Study|Decision by sponsor|0|||
127643140|NCT02291614|459313252|FG003|Overall Study|Decision by sponsor|1|||
127643141|NCT02291614|459313253|FG004|Overall Study|Decision by sponsor|0|||
127643142|NCT02291614|459313254|FG005|Overall Study|Decision by sponsor|0|||
127643143|NCT02291614|459313255|FG006|Overall Study|Decision by sponsor|0|||
127643144|NCT02291614|459313256|FG007|Overall Study|Decision by sponsor|0|||
127643145|NCT02291614|459313257|FG008|Overall Study|Decision by sponsor|0|||
127643146|NCT02291614|459313258|FG009|Overall Study|Decision by sponsor|0|||
127643147|NCT02291614|459313259|FG010|Overall Study|Decision by sponsor|0|||
127643148|NCT02291614|459313249|FG000|Overall Study|Death|0|||
127643149|NCT02291614|459313250|FG001|Overall Study|Death|0|||
127643150|NCT02291614|459313251|FG002|Overall Study|Death|1|||
127643151|NCT02291614|459313252|FG003|Overall Study|Death|0|||
127643152|NCT02291614|459313253|FG004|Overall Study|Death|1|||
127643153|NCT02291614|459313254|FG005|Overall Study|Death|1|||
127643154|NCT02291614|459313255|FG006|Overall Study|Death|1|||
127643155|NCT02291614|459313256|FG007|Overall Study|Death|0|||
127887517|NCT01113710|460211858|FG000|Overall Study|Adverse Event/Other|5|||
127887518|NCT01113710|460211858|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
127887519|NCT01113710|460211858|FG000|Overall Study|Lack of Efficacy/Other|4|||
127887520|NCT01113710|460211858|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
127887521|NCT01113710|460211858|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
127887522|NCT01113710|460211858|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
127887523|NCT01113710|460211858|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
127887524|NCT01113710|460211858|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
127887525|NCT01113710|460211858|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
127887526|NCT01113710|460211858|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
127643156|NCT02291614|459313257|FG008|Overall Study|Death|0|||
127643157|NCT02291614|459313258|FG009|Overall Study|Death|0|||
127643158|NCT02291614|459313259|FG010|Overall Study|Death|0|||
127643159|NCT00127101|459313260|FG000|Base Protocol|Adverse Event|0|||
127643160|NCT00127101|459313261|FG001|Base Protocol|Adverse Event|2|||
127643161|NCT00127101|459313262|FG002|Base Protocol|Adverse Event|1|||
127887527|NCT01113710|460211858|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
127887528|NCT01113710|460211858|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
127887529|NCT01113710|460211858|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
127887530|NCT01113710|460211858|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
127887531|NCT01113710|460211858|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
127887532|NCT01113710|460211858|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
127887533|NCT04356573|460211859|FG000|Overall Study|Didn't Qualify|1|||
127887534|NCT04356573|460211860|FG001|Overall Study|Didn't Qualify|0|||
127643162|NCT00127101|459313263|FG003|Base Protocol|Adverse Event|0|||
127643163|NCT00127101|459313264|FG004|Base Protocol|Adverse Event|0|||
127643164|NCT00127101|459313265|FG005|Base Protocol|Adverse Event|0|||
127643165|NCT00127101|459313260|FG000|Base Protocol|Lack of Efficacy|1|||
127643166|NCT00127101|459313261|FG001|Base Protocol|Lack of Efficacy|0|||
127643167|NCT00127101|459313262|FG002|Base Protocol|Lack of Efficacy|0|||
127643168|NCT00127101|459313263|FG003|Base Protocol|Lack of Efficacy|0|||
127643169|NCT00127101|459313264|FG004|Base Protocol|Lack of Efficacy|2|||
127643170|NCT00127101|459313265|FG005|Base Protocol|Lack of Efficacy|0|||
127643171|NCT00127101|459313260|FG000|Base Protocol|Withdrawal by Subject|1|||
127643172|NCT00127101|459313261|FG001|Base Protocol|Withdrawal by Subject|2|||
127643173|NCT00127101|459313262|FG002|Base Protocol|Withdrawal by Subject|1|||
127643174|NCT00127101|459313263|FG003|Base Protocol|Withdrawal by Subject|0|||
127643175|NCT00127101|459313264|FG004|Base Protocol|Withdrawal by Subject|0|||
127643176|NCT00127101|459313265|FG005|Base Protocol|Withdrawal by Subject|1|||
127643177|NCT00127101|459313260|FG000|Continuation Phase|Adverse Event|0|||
127643178|NCT00127101|459313261|FG001|Continuation Phase|Adverse Event|0|||
127643179|NCT00127101|459313262|FG002|Continuation Phase|Adverse Event|0|||
127643180|NCT00127101|459313263|FG003|Continuation Phase|Adverse Event|0|||
127643181|NCT00127101|459313264|FG004|Continuation Phase|Adverse Event|1|||
127643182|NCT00127101|459313265|FG005|Continuation Phase|Adverse Event|1|||
127705981|NCT03088878|459553151|FG012|Overall Study|Initiation of Alternative Treatment|0|||
127705982|NCT03088878|459553152|FG013|Overall Study|Initiation of Alternative Treatment|0|||
127705983|NCT03088878|459553139|FG000|Overall Study|Withdrawal by Subject|0|||
127705984|NCT03088878|459553140|FG001|Overall Study|Withdrawal by Subject|0|||
127705985|NCT03088878|459553141|FG002|Overall Study|Withdrawal by Subject|0|||
127705986|NCT03088878|459553142|FG003|Overall Study|Withdrawal by Subject|1|||
127705987|NCT03088878|459553143|FG004|Overall Study|Withdrawal by Subject|4|||
127705988|NCT03088878|459553144|FG005|Overall Study|Withdrawal by Subject|1|||
127705989|NCT03088878|459553145|FG006|Overall Study|Withdrawal by Subject|1|||
127705990|NCT03088878|459553146|FG007|Overall Study|Withdrawal by Subject|0|||
127705991|NCT03088878|459553147|FG008|Overall Study|Withdrawal by Subject|1|||
127705992|NCT03088878|459553148|FG009|Overall Study|Withdrawal by Subject|2|||
127705993|NCT03088878|459553149|FG010|Overall Study|Withdrawal by Subject|0|||
127705994|NCT03088878|459553150|FG011|Overall Study|Withdrawal by Subject|2|||
127887535|NCT03568500|460211861|FG000|Overall Study|Lost to Follow-up|1|||
127705995|NCT03088878|459553151|FG012|Overall Study|Withdrawal by Subject|1|||
127705996|NCT03088878|459553152|FG013|Overall Study|Withdrawal by Subject|0|||
127705997|NCT03088878|459553139|FG000|Overall Study|Terminated by Sponsor|2|||
127705998|NCT03088878|459553140|FG001|Overall Study|Terminated by Sponsor|1|||
127705999|NCT03088878|459553141|FG002|Overall Study|Terminated by Sponsor|0|||
127706000|NCT03088878|459553142|FG003|Overall Study|Terminated by Sponsor|1|||
127706001|NCT03088878|459553143|FG004|Overall Study|Terminated by Sponsor|6|||
127887536|NCT03568500|460211862|FG001|Overall Study|Lost to Follow-up|1|||
127643183|NCT00127101|459313260|FG000|Continuation Phase|Lack of Efficacy|0|||
127643184|NCT00127101|459313261|FG001|Continuation Phase|Lack of Efficacy|0|||
127643185|NCT00127101|459313262|FG002|Continuation Phase|Lack of Efficacy|0|||
127643186|NCT00127101|459313263|FG003|Continuation Phase|Lack of Efficacy|0|||
127643187|NCT00127101|459313264|FG004|Continuation Phase|Lack of Efficacy|0|||
127643188|NCT00127101|459313265|FG005|Continuation Phase|Lack of Efficacy|1|||
127643189|NCT00127101|459313260|FG000|Continuation Phase|Withdrawal by Subject|0|||
127643190|NCT00127101|459313261|FG001|Continuation Phase|Withdrawal by Subject|0|||
127643191|NCT00127101|459313262|FG002|Continuation Phase|Withdrawal by Subject|1|||
127643192|NCT00127101|459313263|FG003|Continuation Phase|Withdrawal by Subject|0|||
127643193|NCT00127101|459313264|FG004|Continuation Phase|Withdrawal by Subject|2|||
127643194|NCT00127101|459313265|FG005|Continuation Phase|Withdrawal by Subject|1|||
127643195|NCT02137369|459313268|FG000|Overall Study|Withdrawal by Subject|3|||
127643196|NCT02137369|459313269|FG001|Overall Study|Withdrawal by Subject|2|||
127643197|NCT02137369|459313268|FG000|Overall Study|Adverse Event|2|||
127643198|NCT02137369|459313269|FG001|Overall Study|Adverse Event|0|||
127643199|NCT02137369|459313268|FG000|Overall Study|Lost to Follow-up|1|||
127643200|NCT02137369|459313269|FG001|Overall Study|Lost to Follow-up|0|||
127643201|NCT02137369|459313268|FG000|Overall Study|Moved away|2|||
127643202|NCT02137369|459313269|FG001|Overall Study|Moved away|0|||
127643203|NCT02160314|459315190|FG000|Overall Study|Adverse Event|0|||
127643204|NCT02160314|459315191|FG001|Overall Study|Adverse Event|6|||
127643205|NCT02160314|459315190|FG000|Overall Study|Protocol Violation|0|||
127643206|NCT02160314|459315191|FG001|Overall Study|Protocol Violation|4|||
127643207|NCT02160314|459315190|FG000|Overall Study|Withdrawal by Subject|1|||
127643208|NCT02160314|459315191|FG001|Overall Study|Withdrawal by Subject|2|||
127643209|NCT02160314|459315190|FG000|Overall Study|Lost to Follow-up|0|||
127643210|NCT02160314|459315191|FG001|Overall Study|Lost to Follow-up|1|||
127643211|NCT00593567|459315195|FG000|Overall Study|Adverse Event|2|||
127643212|NCT00593567|459315196|FG001|Overall Study|Adverse Event|0|||
127643213|NCT00593567|459315195|FG000|Overall Study|Physician Decision|2|||
127643214|NCT00593567|459315196|FG001|Overall Study|Physician Decision|0|||
127643215|NCT00593567|459315195|FG000|Overall Study|Protocol Violation|13|||
127643216|NCT00593567|459315196|FG001|Overall Study|Protocol Violation|7|||
127643217|NCT00593567|459315195|FG000|Overall Study|Lack of Efficacy|2|||
127643218|NCT00593567|459315196|FG001|Overall Study|Lack of Efficacy|1|||
127643219|NCT00593567|459315195|FG000|Overall Study|Withdrawal by Subject|1|||
127643220|NCT00593567|459315196|FG001|Overall Study|Withdrawal by Subject|2|||
127643221|NCT00785291|459315197|FG000|Overall Study|Never began treatment|8|||
127643222|NCT00785291|459315198|FG001|Overall Study|Never began treatment|4|||
127643223|NCT00785291|459315199|FG002|Overall Study|Never began treatment|4|||
127643224|NCT00785291|459315197|FG000|Overall Study|Adverse Event|39|||
127643225|NCT00785291|459315198|FG001|Overall Study|Adverse Event|70|||
127643226|NCT00785291|459315199|FG002|Overall Study|Adverse Event|56|||
127643227|NCT00785291|459315197|FG000|Overall Study|Death|7|||
127643228|NCT00785291|459315198|FG001|Overall Study|Death|4|||
127643229|NCT00785291|459315199|FG002|Overall Study|Death|3|||
127643230|NCT00785291|459315197|FG000|Overall Study|Withdrawal by Subject|35|||
127643231|NCT00785291|459315198|FG001|Overall Study|Withdrawal by Subject|36|||
127643232|NCT00785291|459315199|FG002|Overall Study|Withdrawal by Subject|17|||
127643233|NCT00785291|459315197|FG000|Overall Study|Alternative Therapy|12|||
127643234|NCT00785291|459315198|FG001|Overall Study|Alternative Therapy|6|||
127643235|NCT00785291|459315199|FG002|Overall Study|Alternative Therapy|7|||
127643236|NCT00785291|459315197|FG000|Overall Study|Complicating illness|6|||
127643237|NCT00785291|459315198|FG001|Overall Study|Complicating illness|4|||
127643238|NCT00785291|459315199|FG002|Overall Study|Complicating illness|4|||
127643239|NCT00785291|459315197|FG000|Overall Study|Other Medical Reasons|29|||
127643240|NCT00785291|459315198|FG001|Overall Study|Other Medical Reasons|25|||
127643241|NCT00785291|459315199|FG002|Overall Study|Other Medical Reasons|15|||
127643242|NCT00570674|459315200|FG000|Overall Study|Withdrawal by Subject|0|||
127643243|NCT00570674|459315201|FG001|Overall Study|Withdrawal by Subject|0|||
127643244|NCT00570674|459315202|FG002|Overall Study|Withdrawal by Subject|1|||
127643245|NCT00570674|459315203|FG003|Overall Study|Withdrawal by Subject|0|||
127643246|NCT00570674|459315204|FG004|Overall Study|Withdrawal by Subject|0|||
127706002|NCT03088878|459553144|FG005|Overall Study|Terminated by Sponsor|0|||
127643247|NCT00570674|459315205|FG005|Overall Study|Withdrawal by Subject|0|||
127643248|NCT00570674|459315206|FG006|Overall Study|Withdrawal by Subject|0|||
127643249|NCT02979639|459315207|FG000|Overall Study|Withdrawal based on medical judgement|1|||
127706003|NCT03088878|459553145|FG006|Overall Study|Terminated by Sponsor|0|||
127643250|NCT02979639|459315207|FG000|Overall Study|Lost to Follow-up|8|||
127643251|NCT02979639|459315207|FG000|Overall Study|Withdrawal by Subject|3|||
127643252|NCT02979639|459315207|FG000|Overall Study|Adverse Event|2|||
127643253|NCT04050865|459315210|FG000|Overall Study|Adverse Event|1|||
127643254|NCT04050865|459315211|FG001|Overall Study|Adverse Event|0|||
127643255|NCT04050865|459315210|FG000|Overall Study|no insert|1|||
127643256|NCT04050865|459315211|FG001|Overall Study|no insert|0|||
127706004|NCT03088878|459553146|FG007|Overall Study|Terminated by Sponsor|0|||
127706005|NCT03088878|459553147|FG008|Overall Study|Terminated by Sponsor|0|||
127706006|NCT03088878|459553148|FG009|Overall Study|Terminated by Sponsor|0|||
127706007|NCT03088878|459553149|FG010|Overall Study|Terminated by Sponsor|3|||
127706008|NCT03088878|459553150|FG011|Overall Study|Terminated by Sponsor|13|||
127706009|NCT03088878|459553151|FG012|Overall Study|Terminated by Sponsor|2|||
127706010|NCT03088878|459553152|FG013|Overall Study|Terminated by Sponsor|1|||
127706011|NCT03088878|459553139|FG000|Overall Study|Completed 2 years of Treatment|0|||
127706012|NCT03088878|459553140|FG001|Overall Study|Completed 2 years of Treatment|0|||
127706013|NCT03088878|459553141|FG002|Overall Study|Completed 2 years of Treatment|0|||
127706014|NCT03088878|459553142|FG003|Overall Study|Completed 2 years of Treatment|0|||
127706015|NCT03088878|459553143|FG004|Overall Study|Completed 2 years of Treatment|0|||
127706016|NCT03088878|459553144|FG005|Overall Study|Completed 2 years of Treatment|0|||
127706017|NCT03088878|459553145|FG006|Overall Study|Completed 2 years of Treatment|1|||
127706018|NCT03088878|459553146|FG007|Overall Study|Completed 2 years of Treatment|0|||
127706019|NCT03088878|459553147|FG008|Overall Study|Completed 2 years of Treatment|0|||
127706020|NCT03088878|459553148|FG009|Overall Study|Completed 2 years of Treatment|1|||
127706021|NCT03088878|459553149|FG010|Overall Study|Completed 2 years of Treatment|0|||
127706022|NCT03088878|459553150|FG011|Overall Study|Completed 2 years of Treatment|0|||
127706023|NCT03088878|459553151|FG012|Overall Study|Completed 2 years of Treatment|8|||
127706024|NCT03088878|459553152|FG013|Overall Study|Completed 2 years of Treatment|3|||
127706025|NCT03088878|459553139|FG000|Overall Study|Physician Decision|0|||
127706026|NCT03088878|459553140|FG001|Overall Study|Physician Decision|0|||
127706027|NCT03088878|459553141|FG002|Overall Study|Physician Decision|0|||
127706028|NCT03088878|459553142|FG003|Overall Study|Physician Decision|0|||
127706029|NCT03088878|459553143|FG004|Overall Study|Physician Decision|0|||
127706030|NCT03088878|459553144|FG005|Overall Study|Physician Decision|0|||
127798574|NCT03403205|459885642|FG002|Primary Evaluation Period (48 Weeks)|Death|1|||
127798575|NCT03403205|459885643|FG003|Primary Evaluation Period (48 Weeks)|Death|0|||
127798576|NCT03403205|459885644|FG004|Primary Evaluation Period (48 Weeks)|Death|0|||
127798577|NCT03403205|459885645|FG005|Primary Evaluation Period (48 Weeks)|Death|0|||
127798578|NCT03403205|459885640|FG000|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
127798579|NCT03403205|459885641|FG001|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
127798580|NCT03403205|459885642|FG002|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
127798581|NCT03403205|459885643|FG003|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
127798582|NCT03403205|459885644|FG004|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
127798583|NCT03403205|459885645|FG005|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
127798584|NCT03403205|459885640|FG000|Primary Evaluation Period (48 Weeks)|Pregnancy|1|||
127798585|NCT03403205|459885641|FG001|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
127798586|NCT03403205|459885642|FG002|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
127798587|NCT03403205|459885643|FG003|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
127798588|NCT03403205|459885644|FG004|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
127798589|NCT03403205|459885645|FG005|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
127798590|NCT03403205|459885640|FG000|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
127798591|NCT03403205|459885641|FG001|Primary Evaluation Period (48 Weeks)|Protocol Deviation|1|||
127798592|NCT03403205|459885642|FG002|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
127798593|NCT03403205|459885643|FG003|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
127798594|NCT03403205|459885644|FG004|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
127798595|NCT03403205|459885645|FG005|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
127798596|NCT03403205|459885640|FG000|Primary Evaluation Period (48 Weeks)|Randomized but not treated|1|||
127798597|NCT03403205|459885641|FG001|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
127798598|NCT03403205|459885642|FG002|Primary Evaluation Period (48 Weeks)|Randomized but not treated|4|||
127798599|NCT03403205|459885643|FG003|Primary Evaluation Period (48 Weeks)|Randomized but not treated|2|||
127798600|NCT03403205|459885644|FG004|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
127798601|NCT03403205|459885645|FG005|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
127798602|NCT03403205|459885640|FG000|Extension Period (Up to 60 Months)|Withdrawal by Subject|6|||
127798603|NCT03403205|459885641|FG001|Extension Period (Up to 60 Months)|Withdrawal by Subject|7|||
127798604|NCT03403205|459885642|FG002|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
127706031|NCT03088878|459553145|FG006|Overall Study|Physician Decision|0|||
127706032|NCT03088878|459553146|FG007|Overall Study|Physician Decision|2|||
127706033|NCT03088878|459553147|FG008|Overall Study|Physician Decision|1|||
127706034|NCT03088878|459553148|FG009|Overall Study|Physician Decision|0|||
127706035|NCT03088878|459553149|FG010|Overall Study|Physician Decision|0|||
127706036|NCT03088878|459553150|FG011|Overall Study|Physician Decision|0|||
127706037|NCT03088878|459553151|FG012|Overall Study|Physician Decision|0|||
127706038|NCT03088878|459553152|FG013|Overall Study|Physician Decision|1|||
127706039|NCT03088878|459553139|FG000|Overall Study|COVID Related noncompliance|0|||
127706040|NCT03088878|459553140|FG001|Overall Study|COVID Related noncompliance|0|||
127706041|NCT03088878|459553141|FG002|Overall Study|COVID Related noncompliance|0|||
127706042|NCT03088878|459553142|FG003|Overall Study|COVID Related noncompliance|0|||
127706043|NCT03088878|459553143|FG004|Overall Study|COVID Related noncompliance|0|||
127706044|NCT03088878|459553144|FG005|Overall Study|COVID Related noncompliance|0|||
127706045|NCT03088878|459553145|FG006|Overall Study|COVID Related noncompliance|0|||
127706046|NCT03088878|459553146|FG007|Overall Study|COVID Related noncompliance|0|||
127706047|NCT03088878|459553147|FG008|Overall Study|COVID Related noncompliance|0|||
127706048|NCT03088878|459553148|FG009|Overall Study|COVID Related noncompliance|0|||
127706049|NCT03088878|459553149|FG010|Overall Study|COVID Related noncompliance|0|||
127706050|NCT03088878|459553150|FG011|Overall Study|COVID Related noncompliance|0|||
127706051|NCT03088878|459553151|FG012|Overall Study|COVID Related noncompliance|0|||
127706052|NCT03088878|459553152|FG013|Overall Study|COVID Related noncompliance|1|||
127706053|NCT03088878|459553139|FG000|Overall Study|Drug or Study Noncompliance|0|||
127706054|NCT03088878|459553140|FG001|Overall Study|Drug or Study Noncompliance|0|||
127706055|NCT03088878|459553141|FG002|Overall Study|Drug or Study Noncompliance|0|||
127706056|NCT03088878|459553142|FG003|Overall Study|Drug or Study Noncompliance|0|||
127706057|NCT03088878|459553143|FG004|Overall Study|Drug or Study Noncompliance|0|||
127706058|NCT03088878|459553144|FG005|Overall Study|Drug or Study Noncompliance|0|||
127706059|NCT03088878|459553145|FG006|Overall Study|Drug or Study Noncompliance|0|||
127706060|NCT03088878|459553146|FG007|Overall Study|Drug or Study Noncompliance|0|||
127706061|NCT03088878|459553147|FG008|Overall Study|Drug or Study Noncompliance|0|||
127706062|NCT03088878|459553148|FG009|Overall Study|Drug or Study Noncompliance|0|||
127798605|NCT03403205|459885643|FG003|Extension Period (Up to 60 Months)|Withdrawal by Subject|1|||
127798606|NCT03403205|459885644|FG004|Extension Period (Up to 60 Months)|Withdrawal by Subject|0|||
127798607|NCT03403205|459885645|FG005|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
127798608|NCT03403205|459885640|FG000|Extension Period (Up to 60 Months)|Adverse Event|6|||
127798609|NCT03403205|459885641|FG001|Extension Period (Up to 60 Months)|Adverse Event|3|||
127798610|NCT03403205|459885642|FG002|Extension Period (Up to 60 Months)|Adverse Event|1|||
127798611|NCT03403205|459885643|FG003|Extension Period (Up to 60 Months)|Adverse Event|1|||
127798612|NCT03403205|459885644|FG004|Extension Period (Up to 60 Months)|Adverse Event|0|||
127798613|NCT03403205|459885645|FG005|Extension Period (Up to 60 Months)|Adverse Event|0|||
127798614|NCT03403205|459885640|FG000|Extension Period (Up to 60 Months)|Death|1|||
127798615|NCT03403205|459885641|FG001|Extension Period (Up to 60 Months)|Death|0|||
127798616|NCT03403205|459885642|FG002|Extension Period (Up to 60 Months)|Death|0|||
127798617|NCT03403205|459885643|FG003|Extension Period (Up to 60 Months)|Death|0|||
127798618|NCT03403205|459885644|FG004|Extension Period (Up to 60 Months)|Death|0|||
127798619|NCT03403205|459885645|FG005|Extension Period (Up to 60 Months)|Death|0|||
127798620|NCT03403205|459885640|FG000|Extension Period (Up to 60 Months)|Lost to Follow-up|1|||
127798621|NCT03403205|459885641|FG001|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
127798622|NCT03403205|459885642|FG002|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
127798623|NCT03403205|459885643|FG003|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
127798624|NCT03403205|459885644|FG004|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
127798625|NCT03403205|459885645|FG005|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
127798626|NCT03403205|459885640|FG000|Extension Period (Up to 60 Months)|Pregnancy|1|||
127798627|NCT03403205|459885641|FG001|Extension Period (Up to 60 Months)|Pregnancy|1|||
127798628|NCT03403205|459885642|FG002|Extension Period (Up to 60 Months)|Pregnancy|0|||
127798629|NCT03403205|459885643|FG003|Extension Period (Up to 60 Months)|Pregnancy|0|||
127798630|NCT03403205|459885644|FG004|Extension Period (Up to 60 Months)|Pregnancy|0|||
127798631|NCT03403205|459885645|FG005|Extension Period (Up to 60 Months)|Pregnancy|0|||
127798632|NCT03403205|459885640|FG000|Extension Period (Up to 60 Months)|Protocol Deviation|1|||
127798633|NCT03403205|459885641|FG001|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
127798634|NCT03403205|459885642|FG002|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
127798635|NCT03403205|459885643|FG003|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
127798636|NCT03403205|459885644|FG004|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
127798637|NCT03403205|459885645|FG005|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
127887537|NCT03568500|460211863|FG002|Overall Study|Lost to Follow-up|2|||
127706063|NCT03088878|459553149|FG010|Overall Study|Drug or Study Noncompliance|0|||
127706064|NCT03088878|459553150|FG011|Overall Study|Drug or Study Noncompliance|0|||
127706065|NCT03088878|459553151|FG012|Overall Study|Drug or Study Noncompliance|1|||
127706066|NCT03088878|459553152|FG013|Overall Study|Drug or Study Noncompliance|0|||
127706067|NCT01346540|459553164|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
127643257|NCT04050865|459315210|FG000|Overall Study|Only 1 insert|2|||
127643258|NCT04050865|459315211|FG001|Overall Study|Only 1 insert|3|||
127643259|NCT04050865|459315210|FG000|Overall Study|Physician Decision|0|||
127643260|NCT04050865|459315211|FG001|Overall Study|Physician Decision|1|||
127643261|NCT04050865|459315210|FG000|Overall Study|Withdrawal by Subject|0|||
127643262|NCT04050865|459315211|FG001|Overall Study|Withdrawal by Subject|1|||
127643263|NCT04205630|459315216|FG000|Overall Study|Disease progression per RECIST 1.1|37|||
127643264|NCT04205630|459315216|FG000|Overall Study|Disease clinical progression|7|||
127643265|NCT04205630|459315216|FG000|Overall Study|Withdrawal by Subject|2|||
127643266|NCT04205630|459315216|FG000|Overall Study|Adverse Event|17|||
127643267|NCT04205630|459315216|FG000|Overall Study|Other|1|||
127643268|NCT01597050|459315220|FG000|Overall Study|Withdrawal by Subject|1|||
127643269|NCT01597050|459315221|FG001|Overall Study|Withdrawal by Subject|0|||
127643270|NCT00483184|459315222|FG000|Overall Study|Withdrawal by Subject|2|||
127643271|NCT00483184|459315223|FG001|Overall Study|Withdrawal by Subject|2|||
127643272|NCT00483184|459315224|FG002|Overall Study|Withdrawal by Subject|0|||
127643273|NCT00483184|459315222|FG000|Overall Study|Lost to Follow-up|1|||
127643274|NCT00483184|459315223|FG001|Overall Study|Lost to Follow-up|0|||
127643275|NCT00483184|459315224|FG002|Overall Study|Lost to Follow-up|0|||
127643276|NCT00483184|459315222|FG000|Overall Study|Adverse Event|1|||
127643277|NCT00483184|459315223|FG001|Overall Study|Adverse Event|2|||
127643278|NCT00483184|459315224|FG002|Overall Study|Adverse Event|2|||
127643279|NCT00483184|459315222|FG000|Overall Study|Protocol Violation|1|||
127643280|NCT00483184|459315223|FG001|Overall Study|Protocol Violation|0|||
127643281|NCT00483184|459315224|FG002|Overall Study|Protocol Violation|1|||
127643282|NCT00558428|459315225|FG000|Overall Study|Adverse Event|6|||
127643283|NCT00558428|459315226|FG001|Overall Study|Adverse Event|22|||
127643284|NCT00558428|459315227|FG002|Overall Study|Adverse Event|3|||
127643285|NCT00558428|459315228|FG003|Overall Study|Adverse Event|4|||
127643286|NCT00558428|459315225|FG000|Overall Study|Lost to Follow-up|0|||
127643287|NCT00558428|459315226|FG001|Overall Study|Lost to Follow-up|1|||
127643288|NCT00558428|459315227|FG002|Overall Study|Lost to Follow-up|0|||
127643289|NCT00558428|459315228|FG003|Overall Study|Lost to Follow-up|0|||
127643290|NCT00558428|459315225|FG000|Overall Study|Lack of Efficacy|0|||
127643291|NCT00558428|459315226|FG001|Overall Study|Lack of Efficacy|0|||
127643292|NCT00558428|459315227|FG002|Overall Study|Lack of Efficacy|1|||
127643293|NCT00558428|459315228|FG003|Overall Study|Lack of Efficacy|2|||
127643294|NCT00558428|459315225|FG000|Overall Study|Non compliant with protocol|1|||
127643295|NCT00558428|459315226|FG001|Overall Study|Non compliant with protocol|0|||
127643296|NCT00558428|459315227|FG002|Overall Study|Non compliant with protocol|0|||
127643297|NCT00558428|459315228|FG003|Overall Study|Non compliant with protocol|3|||
127643298|NCT00558428|459315225|FG000|Overall Study|Consent withdrawn|2|||
127643299|NCT00558428|459315226|FG001|Overall Study|Consent withdrawn|1|||
127643300|NCT00558428|459315227|FG002|Overall Study|Consent withdrawn|0|||
127643301|NCT00558428|459315228|FG003|Overall Study|Consent withdrawn|1|||
127643302|NCT00558428|459315225|FG000|Overall Study|Other|3|||
127643303|NCT00558428|459315226|FG001|Overall Study|Other|0|||
127643304|NCT00558428|459315227|FG002|Overall Study|Other|0|||
127643305|NCT00558428|459315228|FG003|Overall Study|Other|1|||
127643306|NCT00815295|459315229|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
127643307|NCT00815295|459315230|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
127643308|NCT00815295|459315231|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
127643309|NCT00530855|459315232|FG000|Overall Study|Lack of Efficacy|20|||
127643310|NCT00530855|459315232|FG000|Overall Study|Withdrawal by Subject|30|||
127643311|NCT00530855|459315232|FG000|Overall Study|Fatal Serious AE|3|||
127643312|NCT00530855|459315232|FG000|Overall Study|Non Fatal Serious AE|7|||
127643313|NCT00530855|459315232|FG000|Overall Study|Non Fatal Non Serious AE|12|||
127643314|NCT00530855|459315232|FG000|Overall Study|Protocol Violation|3|||
127643315|NCT00530855|459315232|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
127706068|NCT01346540|459553165|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
127706069|NCT01346540|459553164|FG000|Overall Study|Adverse Event|0|||
127706070|NCT01346540|459553165|FG001|Overall Study|Adverse Event|4|||
127706071|NCT03362476|459553170|FG000|Overall Study|Withdrawal by Subject|0|||
127706072|NCT03362476|459553171|FG001|Overall Study|Withdrawal by Subject|1|||
127706073|NCT05974501|459553172|FG000|Overall Study|Physician Decision|0|||
127706074|NCT05974501|459553173|FG001|Overall Study|Physician Decision|1|||
127706075|NCT04270942|459553175|FG000|Overall Study|Death|1|||
127798638|NCT03403205|459885640|FG000|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|66|||
127643316|NCT00530855|459315232|FG000|Overall Study|Lost to Follow-up|9|||
127643317|NCT00530855|459315232|FG000|Overall Study|Other reason for premature termination|17|||
127643318|NCT05224050|459315233|FG000|Overall Study|Withdrawal by Subject|9|||
127643319|NCT05224050|459315233|FG000|Overall Study|Lost to Follow-up|3|||
127643320|NCT01292876|459315234|FG000|Overall Study|Physician Decision|4|||
127643321|NCT01627327|459315235|FG000|Overall Study|Adverse Event|6|||
127643322|NCT01627327|459315236|FG001|Overall Study|Adverse Event|12|||
127643323|NCT01627327|459315235|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
127643324|NCT01627327|459315236|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
127706076|NCT01221948|459553188|FG000|Overall Study|Physician Decision|5|||
127643325|NCT01627327|459315235|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
127643326|NCT01627327|459315236|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
127643327|NCT01627327|459315235|FG000|Overall Study|Protocol Violation|4|||
127643328|NCT01627327|459315236|FG001|Overall Study|Protocol Violation|10|||
127643329|NCT01627327|459315235|FG000|Overall Study|Lost to Follow-up|1|||
127643330|NCT01627327|459315236|FG001|Overall Study|Lost to Follow-up|3|||
127643331|NCT01627327|459315235|FG000|Overall Study|Physician Decision|1|||
127643332|NCT01627327|459315236|FG001|Overall Study|Physician Decision|0|||
127643333|NCT01627327|459315235|FG000|Overall Study|Withdrawal by Subject|3|||
127643334|NCT01627327|459315236|FG001|Overall Study|Withdrawal by Subject|3|||
127643335|NCT01137474|459315242|FG000|Overall Study|Adverse Event|3|||
127643336|NCT01137474|459315243|FG001|Overall Study|Adverse Event|5|||
127643337|NCT01137474|459315244|FG002|Overall Study|Adverse Event|1|||
127643338|NCT01137474|459315245|FG003|Overall Study|Adverse Event|3|||
127643339|NCT01137474|459315242|FG000|Overall Study|Withdrawal by Subject|7|||
127643340|NCT01137474|459315243|FG001|Overall Study|Withdrawal by Subject|2|||
127643341|NCT01137474|459315244|FG002|Overall Study|Withdrawal by Subject|6|||
127643342|NCT01137474|459315245|FG003|Overall Study|Withdrawal by Subject|9|||
127643343|NCT01137474|459315242|FG000|Overall Study|No longer met study criteria|6|||
127643344|NCT01137474|459315243|FG001|Overall Study|No longer met study criteria|1|||
127643345|NCT01137474|459315244|FG002|Overall Study|No longer met study criteria|0|||
127643346|NCT01137474|459315245|FG003|Overall Study|No longer met study criteria|5|||
127643347|NCT01137474|459315242|FG000|Overall Study|Lost to Follow-up|5|||
127643348|NCT01137474|459315243|FG001|Overall Study|Lost to Follow-up|1|||
127643349|NCT01137474|459315244|FG002|Overall Study|Lost to Follow-up|0|||
127643350|NCT01137474|459315245|FG003|Overall Study|Lost to Follow-up|2|||
127643351|NCT01137474|459315242|FG000|Overall Study|Lack of Efficacy|0|||
127643352|NCT01137474|459315243|FG001|Overall Study|Lack of Efficacy|0|||
127643353|NCT01137474|459315244|FG002|Overall Study|Lack of Efficacy|0|||
127643354|NCT01137474|459315245|FG003|Overall Study|Lack of Efficacy|2|||
127643355|NCT01137474|459315242|FG000|Overall Study|Other|3|||
127643356|NCT01137474|459315243|FG001|Overall Study|Other|1|||
127643357|NCT01137474|459315244|FG002|Overall Study|Other|0|||
127643358|NCT01137474|459315245|FG003|Overall Study|Other|0|||
127643359|NCT01137474|459315242|FG000|Overall Study|Pregnancy|0|||
127643360|NCT01137474|459315243|FG001|Overall Study|Pregnancy|1|||
127643361|NCT01137474|459315244|FG002|Overall Study|Pregnancy|0|||
127643362|NCT01137474|459315245|FG003|Overall Study|Pregnancy|0|||
127643363|NCT01137474|459315242|FG000|Overall Study|Administrative reason by sponsor|0|||
127643364|NCT01137474|459315243|FG001|Overall Study|Administrative reason by sponsor|1|||
127643365|NCT01137474|459315244|FG002|Overall Study|Administrative reason by sponsor|0|||
127643366|NCT01137474|459315245|FG003|Overall Study|Administrative reason by sponsor|0|||
127643367|NCT04794803|459315246|FG000|Overall Study|Death|1|||
127643368|NCT04794803|459315247|FG001|Overall Study|Death|3|||
127643369|NCT04794803|459315246|FG000|Overall Study|Lost to Follow-up|2|||
127643370|NCT04794803|459315247|FG001|Overall Study|Lost to Follow-up|2|||
127643371|NCT04794803|459315246|FG000|Overall Study|Withdrawal by Subject|1|||
127643372|NCT04794803|459315247|FG001|Overall Study|Withdrawal by Subject|0|||
127643373|NCT04794803|459315246|FG000|Overall Study|Physician Decision|1|||
127643374|NCT04794803|459315247|FG001|Overall Study|Physician Decision|1|||
127643375|NCT04794803|459315246|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
127643376|NCT04794803|459315247|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
127643377|NCT04794803|459315246|FG000|Overall Study|Refused to continue the treatment|1|||
127643378|NCT04794803|459315247|FG001|Overall Study|Refused to continue the treatment|0|||
127643379|NCT04794803|459315246|FG000|Overall Study|Patient admitted to ICU|0|||
127643380|NCT04794803|459315247|FG001|Overall Study|Patient admitted to ICU|1|||
127643381|NCT00911534|459315248|FG000|Overall Study|Adverse Event|4|||
127643382|NCT00911534|459315249|FG001|Overall Study|Adverse Event|4|||
127643383|NCT00911534|459315248|FG000|Overall Study|Lost to Follow-up|2|||
127643384|NCT00911534|459315249|FG001|Overall Study|Lost to Follow-up|4|||
127643385|NCT00911534|459315248|FG000|Overall Study|Withdrawal by Subject|2|||
127643386|NCT00911534|459315249|FG001|Overall Study|Withdrawal by Subject|1|||
127643387|NCT00911534|459315248|FG000|Overall Study|Lack of Efficacy|4|||
127643388|NCT00911534|459315249|FG001|Overall Study|Lack of Efficacy|1|||
127643389|NCT00911534|459315248|FG000|Overall Study|Withdrawal of consent|1|||
127643390|NCT00911534|459315249|FG001|Overall Study|Withdrawal of consent|4|||
127643391|NCT00911534|459315248|FG000|Overall Study|Other|2|||
127643392|NCT00911534|459315249|FG001|Overall Study|Other|2|||
127643393|NCT04040751|459315250|FG000|Overall Study|Withdrawal by Subject|2|||
127643394|NCT04040751|459315251|FG001|Overall Study|Withdrawal by Subject|0|||
127643395|NCT04040751|459315252|FG002|Overall Study|Withdrawal by Subject|2|||
127643396|NCT04040751|459315253|FG003|Overall Study|Withdrawal by Subject|0|||
127643397|NCT03896035|459315254|FG000|Overall Study|Lost to Follow-up|2|||
127643398|NCT03896035|459315255|FG001|Overall Study|Lost to Follow-up|6|||
127643399|NCT03896035|459315254|FG000|Overall Study|Withdrawal by Subject|0|||
127643400|NCT03896035|459315255|FG001|Overall Study|Withdrawal by Subject|1|||
127643401|NCT03896035|459315254|FG000|Overall Study|Health/family health issues during COVID|0|||
127706077|NCT01221948|459553188|FG000|Overall Study|Withdrawal by Subject|2|||
127706078|NCT01221948|459553188|FG000|Overall Study|not disclosed|2|||
127706079|NCT01221948|459553188|FG000|Overall Study|Death|1|||
127706080|NCT01221948|459553188|FG000|Overall Study|Protocol Violation|4|||
127706081|NCT00746096|459553189|FG000|Overall Study|Adverse Event|1|||
127706082|NCT00746096|459553190|FG001|Overall Study|Adverse Event|0|||
127706083|NCT00746096|459553189|FG000|Overall Study|Withdrawal by Subject|5|||
127706084|NCT00746096|459553190|FG001|Overall Study|Withdrawal by Subject|1|||
127706085|NCT00746096|459553189|FG000|Overall Study|Lost to Follow-up|2|||
127706086|NCT00746096|459553190|FG001|Overall Study|Lost to Follow-up|1|||
127706087|NCT00746096|459553189|FG000|Overall Study|Protocol Violation|1|||
127706088|NCT00746096|459553190|FG001|Overall Study|Protocol Violation|0|||
127706089|NCT00746096|459553189|FG000|Overall Study|No study drug treatment|1|||
127706090|NCT00746096|459553190|FG001|Overall Study|No study drug treatment|1|||
127706091|NCT04059185|459553191|FG000|Longitudinal Assessment-Adults Only|Lost to Follow-up|187|||
127706092|NCT04059185|459553192|FG001|Longitudinal Assessment-Adults Only|Lost to Follow-up|195|||
127706093|NCT04059185|459553193|FG002|Longitudinal Assessment-Adults Only|Lost to Follow-up|177|||
127706094|NCT04059185|459553191|FG000|Longitudinal Assessment-Adults Only|Protocol Violation|11|||
127706095|NCT04059185|459553192|FG001|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
127706096|NCT04059185|459553193|FG002|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
127706097|NCT04059185|459553191|FG000|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
127706098|NCT04059185|459553192|FG001|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
127706099|NCT04059185|459553193|FG002|Longitudinal Assessment-Adults Only|Withdrawal by Subject|1|||
127706100|NCT04059185|459553191|FG000|Longitudinal Assessment-Adults Only|Baseline survey incomplete|4|||
127706101|NCT04059185|459553192|FG001|Longitudinal Assessment-Adults Only|Baseline survey incomplete|8|||
127706102|NCT04059185|459553193|FG002|Longitudinal Assessment-Adults Only|Baseline survey incomplete|3|||
127706103|NCT04059185|459553191|FG000|Longitudinal Assessment-Adults Only|Death|4|||
127706104|NCT04059185|459553192|FG001|Longitudinal Assessment-Adults Only|Death|4|||
127706105|NCT04059185|459553193|FG002|Longitudinal Assessment-Adults Only|Death|3|||
127706106|NCT03756662|459553194|FG000|Overall Study|due to an SAE that was not related to the medical device or medical procedure.|1|||
127706107|NCT03295721|459553204|FG000|Overall Study|Adverse Event|1|||
127706108|NCT03295721|459553205|FG001|Overall Study|Adverse Event|0|||
127706109|NCT03295721|459553206|FG002|Overall Study|Adverse Event|0|||
127706110|NCT03295721|459553204|FG000|Overall Study|Lost to Follow-up|1|||
127706111|NCT03295721|459553205|FG001|Overall Study|Lost to Follow-up|1|||
127706112|NCT03295721|459553206|FG002|Overall Study|Lost to Follow-up|1|||
127706113|NCT03295721|459553204|FG000|Overall Study|Withdrawal by Subject|1|||
127706114|NCT03295721|459553205|FG001|Overall Study|Withdrawal by Subject|0|||
127706115|NCT03295721|459553206|FG002|Overall Study|Withdrawal by Subject|1|||
127706116|NCT03295721|459553204|FG000|Overall Study|Death|0|||
127706117|NCT03295721|459553205|FG001|Overall Study|Death|0|||
127706118|NCT03295721|459553206|FG002|Overall Study|Death|1|||
127706119|NCT01651403|459553210|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
127706120|NCT01651403|459553211|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
127706121|NCT01651403|459553210|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
127706122|NCT01651403|459553211|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
127706123|NCT01651403|459553210|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
127706124|NCT01651403|459553211|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
127706125|NCT01651403|459553210|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
127706126|NCT01651403|459553211|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
127706127|NCT01651403|459553210|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
127706128|NCT01651403|459553211|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
127706129|NCT01651403|459553210|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
127706130|NCT01651403|459553211|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
127706131|NCT05090683|459553214|FG000|Overall Study|Lost to Follow-up|10|||
127706132|NCT05090683|459553215|FG001|Overall Study|Lost to Follow-up|2|||
127706133|NCT05090683|459553214|FG000|Overall Study|Withdrawal by Subject|15|||
127706134|NCT05090683|459553215|FG001|Overall Study|Withdrawal by Subject|0|||
127706135|NCT03213665|459553218|FG000|Overall Study|Adverse Event|1|||
127706136|NCT03213665|459553218|FG000|Overall Study|Physician Decision|2|||
127798639|NCT03403205|459885641|FG001|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|32|||
127798640|NCT03403205|459885642|FG002|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|21|||
127798641|NCT03403205|459885643|FG003|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|10|||
127798642|NCT03403205|459885644|FG004|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|7|||
127798643|NCT03403205|459885645|FG005|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|8|||
127798644|NCT03403205|459885640|FG000|Extension Period (Up to 60 Months)|Other than specified|5|||
127798645|NCT03403205|459885641|FG001|Extension Period (Up to 60 Months)|Other than specified|5|||
127798646|NCT03403205|459885642|FG002|Extension Period (Up to 60 Months)|Other than specified|3|||
127798647|NCT03403205|459885643|FG003|Extension Period (Up to 60 Months)|Other than specified|0|||
127798648|NCT03403205|459885644|FG004|Extension Period (Up to 60 Months)|Other than specified|1|||
127798649|NCT03403205|459885645|FG005|Extension Period (Up to 60 Months)|Other than specified|0|||
127798650|NCT03403205|459885640|FG000|Extension Period (Up to 60 Months)|Physician Decision|2|||
127798651|NCT03403205|459885641|FG001|Extension Period (Up to 60 Months)|Physician Decision|1|||
127798652|NCT03403205|459885642|FG002|Extension Period (Up to 60 Months)|Physician Decision|1|||
127798653|NCT03403205|459885643|FG003|Extension Period (Up to 60 Months)|Physician Decision|0|||
127798654|NCT03403205|459885644|FG004|Extension Period (Up to 60 Months)|Physician Decision|0|||
127798655|NCT03403205|459885645|FG005|Extension Period (Up to 60 Months)|Physician Decision|0|||
127798656|NCT01834729|459885648|FG000|Overall Study|Did not return bowel diaries|0|||
127798657|NCT01834729|459885649|FG001|Overall Study|Did not return bowel diaries|0|||
127798658|NCT01834729|459885650|FG002|Overall Study|Did not return bowel diaries|3|||
127798659|NCT01834729|459885651|FG003|Overall Study|Did not return bowel diaries|0|||
127798660|NCT01834729|459885648|FG000|Overall Study|Withdrawal by Subject|1|||
127798661|NCT01834729|459885649|FG001|Overall Study|Withdrawal by Subject|1|||
127798662|NCT01834729|459885650|FG002|Overall Study|Withdrawal by Subject|0|||
127798663|NCT01834729|459885651|FG003|Overall Study|Withdrawal by Subject|0|||
127798664|NCT01834729|459885648|FG000|Overall Study|Adverse Event|0|||
127798665|NCT01834729|459885649|FG001|Overall Study|Adverse Event|0|||
127798666|NCT01834729|459885650|FG002|Overall Study|Adverse Event|0|||
127798667|NCT01834729|459885651|FG003|Overall Study|Adverse Event|2|||
127798668|NCT02971670|459885652|FG000|Overall Study|Withdrawal by Subject|4|||
127798669|NCT02971670|459885653|FG001|Overall Study|Withdrawal by Subject|1|||
127798670|NCT02971670|459885654|FG002|Overall Study|Withdrawal by Subject|1|||
127798671|NCT02971670|459885655|FG003|Overall Study|Withdrawal by Subject|2|||
127798672|NCT00288080|459885656|FG000|Overall Study|Withdrawal by Subject|1|||
127798673|NCT00288080|459885657|FG001|Overall Study|Withdrawal by Subject|3|||
127798674|NCT00288080|459885656|FG000|Overall Study|Protocol Violation|25|||
127798675|NCT00288080|459885657|FG001|Overall Study|Protocol Violation|20|||
127798676|NCT02387580|459885661|FG000|Overall Study|Withdrawal by Subject|0|||
127798677|NCT02387580|459885662|FG001|Overall Study|Withdrawal by Subject|0|||
127887538|NCT03568500|460211861|FG000|Overall Study|Adverse Event|1|||
127887539|NCT03568500|460211862|FG001|Overall Study|Adverse Event|1|||
127887540|NCT03568500|460211863|FG002|Overall Study|Adverse Event|2|||
127887541|NCT03568500|460211861|FG000|Overall Study|Physician Decision|1|||
127887542|NCT03568500|460211862|FG001|Overall Study|Physician Decision|0|||
127887543|NCT03568500|460211863|FG002|Overall Study|Physician Decision|0|||
127887544|NCT03568500|460211861|FG000|Overall Study|Withdrawal by Subject|4|||
127887545|NCT03568500|460211862|FG001|Overall Study|Withdrawal by Subject|2|||
127887546|NCT03568500|460211863|FG002|Overall Study|Withdrawal by Subject|0|||
127887547|NCT03568500|460211861|FG000|Overall Study|Technical Problems|2|||
127887548|NCT03568500|460211862|FG001|Overall Study|Technical Problems|1|||
127887549|NCT03568500|460211863|FG002|Overall Study|Technical Problems|0|||
127887550|NCT03568500|460211861|FG000|Overall Study|Participant Noncompliance|1|||
127887551|NCT03568500|460211862|FG001|Overall Study|Participant Noncompliance|1|||
127887552|NCT03568500|460211863|FG002|Overall Study|Participant Noncompliance|0|||
127887553|NCT04132232|460211871|FG000|Overall Study|Randomized but met exclusion criteria.|1|||
127887554|NCT04132232|460211872|FG001|Overall Study|Randomized but met exclusion criteria.|1|||
127798678|NCT02387580|459885663|FG002|Overall Study|Withdrawal by Subject|0|||
127798679|NCT02387580|459885664|FG003|Overall Study|Withdrawal by Subject|1|||
127887555|NCT04132232|460211871|FG000|Overall Study|Lost to Follow-up|6|||
127706137|NCT03213665|459553218|FG000|Overall Study|Withdrawal by Subject|3|||
127706138|NCT03213665|459553218|FG000|Overall Study|Progressive Disease|13|||
127706139|NCT03325985|459553219|FG000|Overall Study|Lost to Follow-up|122|||
127706140|NCT03325985|459553220|FG001|Overall Study|Lost to Follow-up|26|||
127706141|NCT03325985|459553221|FG002|Overall Study|Lost to Follow-up|141|||
127706142|NCT03325985|459553222|FG003|Overall Study|Lost to Follow-up|28|||
127706143|NCT03325985|459553219|FG000|Overall Study|Death|99|||
127706144|NCT03325985|459553220|FG001|Overall Study|Death|36|||
127706145|NCT03325985|459553221|FG002|Overall Study|Death|94|||
127706146|NCT03325985|459553222|FG003|Overall Study|Death|32|||
127706147|NCT03056573|459553223|FG000|Overall Study|Death|2|||
127706148|NCT03056573|459553224|FG001|Overall Study|Death|4|||
127706149|NCT03056573|459553223|FG000|Overall Study|Withdrawal by Subject|2|||
127706150|NCT03056573|459553224|FG001|Overall Study|Withdrawal by Subject|0|||
127706151|NCT03056573|459553223|FG000|Overall Study|Lost to Follow-up|1|||
127706152|NCT03056573|459553224|FG001|Overall Study|Lost to Follow-up|1|||
127706153|NCT04689256|459553225|FG000|Overall Study|Participants declined to participate in the interventions per protocol|2|||
127706154|NCT04689256|459553226|FG001|Overall Study|Participants declined to participate in the interventions per protocol|0|||
127706155|NCT05104463|459553227|FG000|Overall Study|Adverse Event|1|||
127706156|NCT05104463|459553228|FG001|Overall Study|Adverse Event|1|||
127706157|NCT05104463|459553227|FG000|Overall Study|Lost to Follow-up|1|||
127706158|NCT05104463|459553228|FG001|Overall Study|Lost to Follow-up|1|||
127706159|NCT05104463|459553227|FG000|Overall Study|Physician Decision|1|||
127706160|NCT05104463|459553228|FG001|Overall Study|Physician Decision|0|||
127706161|NCT05104463|459553227|FG000|Overall Study|Protocol Violation|0|||
127706162|NCT05104463|459553228|FG001|Overall Study|Protocol Violation|2|||
127706163|NCT05104463|459553227|FG000|Overall Study|Withdrawal by Subject|1|||
127706164|NCT05104463|459553228|FG001|Overall Study|Withdrawal by Subject|1|||
127706165|NCT05267470|459553230|FG000|Overall Study|Decision by sponsor|0|||
127706166|NCT05267470|459553231|FG001|Overall Study|Decision by sponsor|3|||
127706167|NCT05267470|459553232|FG002|Overall Study|Decision by sponsor|19|||
127706168|NCT05267470|459553233|FG003|Overall Study|Decision by sponsor|7|||
127706169|NCT05267470|459553234|FG004|Overall Study|Decision by sponsor|3|||
127706170|NCT05267470|459553230|FG000|Overall Study|Withdrawal by Subject|1|||
127706171|NCT05267470|459553231|FG001|Overall Study|Withdrawal by Subject|1|||
127706172|NCT05267470|459553232|FG002|Overall Study|Withdrawal by Subject|2|||
127706173|NCT05267470|459553233|FG003|Overall Study|Withdrawal by Subject|2|||
127706174|NCT05267470|459553234|FG004|Overall Study|Withdrawal by Subject|0|||
127706175|NCT05267470|459553230|FG000|Overall Study|Death|3|||
127706176|NCT05267470|459553231|FG001|Overall Study|Death|5|||
127706177|NCT05267470|459553232|FG002|Overall Study|Death|8|||
127706178|NCT05267470|459553233|FG003|Overall Study|Death|18|||
127706179|NCT05267470|459553234|FG004|Overall Study|Death|1|||
127706180|NCT05267470|459553230|FG000|Overall Study|Lost to Follow-up|0|||
127706181|NCT05267470|459553231|FG001|Overall Study|Lost to Follow-up|0|||
127706182|NCT05267470|459553232|FG002|Overall Study|Lost to Follow-up|0|||
127706183|NCT05267470|459553233|FG003|Overall Study|Lost to Follow-up|1|||
127706184|NCT05267470|459553234|FG004|Overall Study|Lost to Follow-up|0|||
127706185|NCT04230681|459553241|FG000|Overall Study|Physician Decision|2|||
127706186|NCT04230681|459553242|FG001|Overall Study|Physician Decision|3|||
127706187|NCT04230681|459553241|FG000|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
127706188|NCT04230681|459553242|FG001|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
127706189|NCT04230681|459553241|FG000|Overall Study|IV inadvertently removed|0|||
127706190|NCT04230681|459553242|FG001|Overall Study|IV inadvertently removed|1|||
127706191|NCT04079218|459555349|FG000|Overall Study|Death|1|||
127706192|NCT04079218|459555350|FG001|Overall Study|Death|0|||
127706193|NCT04079218|459555349|FG000|Overall Study|Withdrawal by Subject|3|||
127706194|NCT04079218|459555350|FG001|Overall Study|Withdrawal by Subject|0|||
127706195|NCT04079218|459555349|FG000|Overall Study|Physician Decision|4|||
127706196|NCT04079218|459555350|FG001|Overall Study|Physician Decision|0|||
127706197|NCT04079218|459555349|FG000|Overall Study|Lost to Follow-up|0|||
127706198|NCT04079218|459555350|FG001|Overall Study|Lost to Follow-up|1|||
127706199|NCT02052882|459555354|FG000|Overall Study|Not treated|11|||
127887556|NCT04132232|460211872|FG001|Overall Study|Lost to Follow-up|7|||
127706200|NCT02052882|459555354|FG000|Overall Study|Protocol Violation|1|||
127706201|NCT02052882|459555354|FG000|Overall Study|Inadequate testing|1|||
127706202|NCT04766892|459555355|FG000|Overall Study|Withdrawal by Subject|1|||
127706203|NCT04766892|459555355|FG000|Overall Study|Lost to Follow-up|1|||
127706204|NCT04766892|459555355|FG000|Overall Study|Adverse Event|3|||
127706205|NCT04766892|459555355|FG000|Overall Study|Left ventricular ejection fraction (LVEF) Criteria Met|1|||
127706206|NCT04778397|459555356|FG000|Overall Study|Death|59|||
127706207|NCT04778397|459555357|FG001|Overall Study|Death|54|||
127706208|NCT04778397|459555358|FG002|Overall Study|Death|11|||
127706209|NCT04778397|459555359|FG003|Overall Study|Death|9|||
127643402|NCT03896035|459315255|FG001|Overall Study|Health/family health issues during COVID|4|||
127643403|NCT01388816|459315256|FG000|Overall Study|Adverse Event|0|||
127643404|NCT01388816|459315257|FG001|Overall Study|Adverse Event|2|||
127643405|NCT01388816|459315258|FG002|Overall Study|Adverse Event|0|||
127643406|NCT01388816|459315259|FG003|Overall Study|Adverse Event|0|||
127643407|NCT01388816|459315256|FG000|Overall Study|Lost to Follow-up|0|||
127643408|NCT01388816|459315257|FG001|Overall Study|Lost to Follow-up|1|||
127643409|NCT01388816|459315258|FG002|Overall Study|Lost to Follow-up|0|||
127643410|NCT01388816|459315259|FG003|Overall Study|Lost to Follow-up|0|||
127643411|NCT01388816|459315256|FG000|Overall Study|Withdrawal by Subject|2|||
127643412|NCT01388816|459315257|FG001|Overall Study|Withdrawal by Subject|1|||
127643413|NCT01388816|459315258|FG002|Overall Study|Withdrawal by Subject|1|||
127643414|NCT01388816|459315259|FG003|Overall Study|Withdrawal by Subject|0|||
127643415|NCT01388816|459315256|FG000|Overall Study|Protocol Violation|0|||
127643416|NCT01388816|459315257|FG001|Overall Study|Protocol Violation|0|||
127643417|NCT01388816|459315258|FG002|Overall Study|Protocol Violation|2|||
127643418|NCT01388816|459315259|FG003|Overall Study|Protocol Violation|0|||
127643419|NCT00743366|459315260|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
127643420|NCT00743366|459315261|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
127643421|NCT03206203|459315262|FG000|Treatment|Death|38|||
127643422|NCT03206203|459315263|FG001|Treatment|Death|26|||
127643423|NCT03206203|459315264|FG002|Treatment|Death|0|||
127643424|NCT03206203|459315262|FG000|Treatment|Withdrawal by Subject|1|||
127643425|NCT03206203|459315263|FG001|Treatment|Withdrawal by Subject|0|||
127643426|NCT03206203|459315264|FG002|Treatment|Withdrawal by Subject|0|||
127643427|NCT03206203|459315262|FG000|Treatment|Lost to Follow-up|4|||
127643428|NCT03206203|459315263|FG001|Treatment|Lost to Follow-up|0|||
127643429|NCT03206203|459315264|FG002|Treatment|Lost to Follow-up|0|||
127643430|NCT03206203|459315262|FG000|Treatment|N/A in Follow-Up|8|||
127643431|NCT03206203|459315263|FG001|Treatment|N/A in Follow-Up|1|||
127643432|NCT03206203|459315264|FG002|Treatment|N/A in Follow-Up|0|||
127643433|NCT03206203|459315262|FG000|Treatment|Disease progression|0|||
127643434|NCT03206203|459315263|FG001|Treatment|Disease progression|1|||
127643435|NCT03206203|459315264|FG002|Treatment|Disease progression|0|||
127643436|NCT03206203|459315262|FG000|Treatment|Refused follow-up|0|||
127643437|NCT03206203|459315263|FG001|Treatment|Refused follow-up|1|||
127643438|NCT03206203|459315264|FG002|Treatment|Refused follow-up|0|||
127643439|NCT03206203|459315262|FG000|Treatment|Cross over to Arm 1|0|||
127643440|NCT03206203|459315263|FG001|Treatment|Cross over to Arm 1|19|||
127643441|NCT03206203|459315264|FG002|Treatment|Cross over to Arm 1|0|||
127643442|NCT03206203|459315262|FG000|Optional Cross-Over|Death|0|||
127643443|NCT03206203|459315263|FG001|Optional Cross-Over|Death|0|||
127643444|NCT03206203|459315264|FG002|Optional Cross-Over|Death|14|||
127643445|NCT03206203|459315262|FG000|Optional Cross-Over|Refused follow-up|0|||
127643446|NCT03206203|459315263|FG001|Optional Cross-Over|Refused follow-up|0|||
127643447|NCT03206203|459315264|FG002|Optional Cross-Over|Refused follow-up|2|||
127643448|NCT00335322|459315265|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
127643449|NCT00335322|459315266|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
127643450|NCT00335322|459315267|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
127643451|NCT01152580|459315268|FG000|Overall Study|Withdrawal by Subject|0|||
127643452|NCT01152580|459315269|FG001|Overall Study|Withdrawal by Subject|1|||
127643453|NCT03364751|459315272|FG000|Overall Study|Withdrawal by Subject|1|||
127643454|NCT03364751|459315273|FG001|Overall Study|Withdrawal by Subject|0|||
127643455|NCT03364751|459315274|FG002|Overall Study|Withdrawal by Subject|0|||
127643456|NCT03364751|459315275|FG003|Overall Study|Withdrawal by Subject|0|||
127643457|NCT03364751|459315272|FG000|Overall Study|Lost to Follow-up|0|||
127643458|NCT03364751|459315273|FG001|Overall Study|Lost to Follow-up|1|||
127643459|NCT03364751|459315274|FG002|Overall Study|Lost to Follow-up|0|||
127643460|NCT03364751|459315275|FG003|Overall Study|Lost to Follow-up|0|||
127643461|NCT00675766|459315276|FG000|Overall Study|Lost to Follow-up|6|||
127643462|NCT00675766|459315277|FG001|Overall Study|Lost to Follow-up|5|||
127643463|NCT00675766|459315278|FG002|Overall Study|Lost to Follow-up|21|||
127643464|NCT00675766|459315279|FG003|Overall Study|Lost to Follow-up|26|||
127643465|NCT02275065|459315281|FG000|Overall Study|Randomized but not treated|1|||
127643466|NCT02275065|459315282|FG001|Overall Study|Randomized but not treated|0|||
127643467|NCT02275065|459315283|FG002|Overall Study|Randomized but not treated|1|||
127706210|NCT04778397|459555356|FG000|Overall Study|Study Terminated by Sponsor|34|||
127706211|NCT04778397|459555357|FG001|Overall Study|Study Terminated by Sponsor|42|||
127706212|NCT04778397|459555358|FG002|Overall Study|Study Terminated by Sponsor|15|||
127643468|NCT02275065|459315284|FG003|Overall Study|Randomized but not treated|1|||
127643469|NCT02275065|459315285|FG004|Overall Study|Randomized but not treated|0|||
127643470|NCT03015402|459315286|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
127643471|NCT03015402|459315287|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|2|||
127643472|NCT03015402|459315286|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
127643473|NCT03015402|459315287|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
127643474|NCT03213158|459315288|FG000|Overall Study|Withdrawal by Subject|1|||
127643475|NCT03213158|459315288|FG000|Overall Study|Physician Decision|2|||
127643476|NCT01995461|459315291|FG000|Overall Study|Death|1|||
127706213|NCT04778397|459555359|FG003|Overall Study|Study Terminated by Sponsor|12|||
127706214|NCT04778397|459555356|FG000|Overall Study|Withdrew Consent|5|||
127706215|NCT04778397|459555357|FG001|Overall Study|Withdrew Consent|4|||
127706216|NCT04778397|459555358|FG002|Overall Study|Withdrew Consent|1|||
127706217|NCT04778397|459555359|FG003|Overall Study|Withdrew Consent|1|||
127706218|NCT04778397|459555356|FG000|Overall Study|Reason Not Specified|1|||
127706219|NCT04778397|459555357|FG001|Overall Study|Reason Not Specified|3|||
127706220|NCT04778397|459555358|FG002|Overall Study|Reason Not Specified|0|||
127706221|NCT04778397|459555359|FG003|Overall Study|Reason Not Specified|2|||
127706222|NCT04778397|459555356|FG000|Overall Study|Lost to Follow-up|2|||
127706223|NCT04778397|459555357|FG001|Overall Study|Lost to Follow-up|1|||
127706224|NCT04778397|459555358|FG002|Overall Study|Lost to Follow-up|0|||
127706225|NCT04778397|459555359|FG003|Overall Study|Lost to Follow-up|1|||
127706226|NCT04294641|459555360|FG000|Overall Study|Screen failure|4|||
127706227|NCT02668692|459555362|FG000|Overall Study|Adverse Event|1|||
127706228|NCT02668692|459555363|FG001|Overall Study|Adverse Event|0|||
127706229|NCT01627574|459555366|FG000|Overall Study|Withdrawal by Subject|8|||
127706230|NCT01627574|459555367|FG001|Overall Study|Withdrawal by Subject|5|||
127706231|NCT01627574|459555366|FG000|Overall Study|Lost to Follow-up|13|||
127706232|NCT01627574|459555367|FG001|Overall Study|Lost to Follow-up|13|||
127706233|NCT04730739|459555368|FG000|Overall Study|Death|1|||
127706234|NCT03308877|459555370|FG000|Overall Study|Lost to Follow-up|32|||
127706235|NCT03308877|459555371|FG001|Overall Study|Lost to Follow-up|28|||
127706236|NCT04677738|459555387|FG000|Overall Study|Withdrawal by Subject|4|||
127706237|NCT04677738|459555388|FG001|Overall Study|Withdrawal by Subject|2|||
127706238|NCT04707469|459555389|FG000|Overall Study|Site closure|0|||
127706239|NCT04707469|459555390|FG001|Overall Study|Site closure|2|||
127706240|NCT04707469|459555391|FG002|Overall Study|Site closure|0|||
127706241|NCT04707469|459555389|FG000|Overall Study|Physician Decision|2|||
127706242|NCT04707469|459555390|FG001|Overall Study|Physician Decision|2|||
127706243|NCT04707469|459555391|FG002|Overall Study|Physician Decision|2|||
127706244|NCT04707469|459555389|FG000|Overall Study|Death|1|||
127706245|NCT04707469|459555390|FG001|Overall Study|Death|6|||
127706246|NCT04707469|459555391|FG002|Overall Study|Death|2|||
127706247|NCT04707469|459555389|FG000|Overall Study|Lost to Follow-up|9|||
127706248|NCT04707469|459555390|FG001|Overall Study|Lost to Follow-up|19|||
127706249|NCT04707469|459555391|FG002|Overall Study|Lost to Follow-up|14|||
127706250|NCT04707469|459555389|FG000|Overall Study|Withdrawal by Subject|17|||
127706251|NCT04707469|459555390|FG001|Overall Study|Withdrawal by Subject|16|||
127706252|NCT04707469|459555391|FG002|Overall Study|Withdrawal by Subject|12|||
127706253|NCT04359654|459555401|FG000|Overall Study|Withdrawal by Subject|1|||
127706254|NCT04359654|459555402|FG001|Overall Study|Withdrawal by Subject|0|||
127706255|NCT04359654|459555401|FG000|Overall Study|Adverse Event|0|||
127706256|NCT04359654|459555402|FG001|Overall Study|Adverse Event|1|||
127706257|NCT04314778|459555404|FG000|Overall Study|Lost to Follow-up|5|||
127706258|NCT04314778|459555405|FG001|Overall Study|Lost to Follow-up|3|||
127706259|NCT03523572|459555406|FG000|Dose Escalation|Progressive disease|1|||
127706260|NCT03523572|459555407|FG001|Dose Escalation|Progressive disease|0|||
127706261|NCT03523572|459555408|FG002|Dose Escalation|Progressive disease|0|||
127706262|NCT03523572|459555409|FG003|Dose Escalation|Progressive disease|0|||
127706263|NCT03523572|459555410|FG004|Dose Escalation|Progressive disease|0|||
127706264|NCT03523572|459555411|FG005|Dose Escalation|Progressive disease|0|||
127706265|NCT03523572|459555406|FG000|Dose Escalation|Clinical Progression|0|||
127706266|NCT03523572|459555407|FG001|Dose Escalation|Clinical Progression|1|||
127706267|NCT03523572|459555408|FG002|Dose Escalation|Clinical Progression|0|||
127706268|NCT03523572|459555409|FG003|Dose Escalation|Clinical Progression|0|||
127798680|NCT02387580|459885665|FG004|Overall Study|Withdrawal by Subject|0|||
127706269|NCT03523572|459555410|FG004|Dose Escalation|Clinical Progression|0|||
127706270|NCT03523572|459555411|FG005|Dose Escalation|Clinical Progression|0|||
127706271|NCT03523572|459555406|FG000|Dose Escalation|Adverse Event|2|||
127706272|NCT03523572|459555407|FG001|Dose Escalation|Adverse Event|0|||
127706273|NCT03523572|459555408|FG002|Dose Escalation|Adverse Event|0|||
127706274|NCT03523572|459555409|FG003|Dose Escalation|Adverse Event|0|||
127706275|NCT03523572|459555410|FG004|Dose Escalation|Adverse Event|0|||
127706276|NCT03523572|459555411|FG005|Dose Escalation|Adverse Event|0|||
127706277|NCT03523572|459555406|FG000|Dose Escalation|Physician Decision|1|||
127706278|NCT03523572|459555407|FG001|Dose Escalation|Physician Decision|1|||
127706279|NCT03523572|459555408|FG002|Dose Escalation|Physician Decision|0|||
127706280|NCT03523572|459555409|FG003|Dose Escalation|Physician Decision|0|||
127706281|NCT03523572|459555410|FG004|Dose Escalation|Physician Decision|0|||
127706282|NCT03523572|459555411|FG005|Dose Escalation|Physician Decision|0|||
127706283|NCT03523572|459555406|FG000|Dose Expansion|Progressive Disease|0|||
127798681|NCT02387580|459885666|FG005|Overall Study|Withdrawal by Subject|0|||
127643477|NCT01995461|459315291|FG000|Overall Study|Lost to Follow-up|2|||
127643478|NCT01995461|459315291|FG000|Overall Study|Withdrawal by Subject|2|||
127643479|NCT03240692|459315299|FG000|Overall Study|Physician Decision|1|||
127643480|NCT03240692|459315299|FG000|Overall Study|Withdrawal by Subject|1|||
127643481|NCT02300220|459315300|FG000|Overall Study|Lost to Follow-up|1|||
127643482|NCT02300220|459315301|FG001|Overall Study|Lost to Follow-up|2|||
127643483|NCT02300220|459315300|FG000|Overall Study|Death|1|||
127643484|NCT02300220|459315301|FG001|Overall Study|Death|1|||
127643485|NCT02300220|459315300|FG000|Overall Study|Adverse Event|1|||
127643486|NCT02300220|459315301|FG001|Overall Study|Adverse Event|1|||
127643487|NCT02300220|459315300|FG000|Overall Study|Protocol Violation|1|||
127643488|NCT02300220|459315301|FG001|Overall Study|Protocol Violation|0|||
127643489|NCT02300220|459315300|FG000|Overall Study|Withdrawal by Subject|0|||
127643490|NCT02300220|459315301|FG001|Overall Study|Withdrawal by Subject|2|||
127643491|NCT02300220|459315300|FG000|Overall Study|Did not tolerate IMP|0|||
127643492|NCT02300220|459315301|FG001|Overall Study|Did not tolerate IMP|1|||
127643493|NCT04322682|459315302|FG000|Overall Study|Withdrawal by Subject|33|||
127643494|NCT04322682|459315303|FG001|Overall Study|Withdrawal by Subject|47|||
127643495|NCT04322682|459315302|FG000|Overall Study|Death|5|||
127643496|NCT04322682|459315303|FG001|Overall Study|Death|9|||
127643497|NCT04322682|459315302|FG000|Overall Study|Lost to Follow-up|4|||
127643498|NCT04322682|459315303|FG001|Overall Study|Lost to Follow-up|8|||
127643499|NCT04322682|459315302|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
127643500|NCT04322682|459315303|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
127643501|NCT00441090|459315305|FG000|Overall Study|Adverse Event|0|||
127643502|NCT00441090|459315306|FG001|Overall Study|Adverse Event|1|||
127643503|NCT00441090|459315307|FG002|Overall Study|Adverse Event|1|||
127643504|NCT00441090|459315308|FG003|Overall Study|Adverse Event|0|||
127643505|NCT00441090|459315309|FG004|Overall Study|Adverse Event|0|||
127643506|NCT00441090|459315305|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
127643507|NCT00441090|459315306|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
127643508|NCT00441090|459315307|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
127643509|NCT00441090|459315308|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
127643510|NCT00441090|459315309|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
127643511|NCT00441090|459315305|FG000|Overall Study|Withdrawal by Subject|1|||
127643512|NCT00441090|459315306|FG001|Overall Study|Withdrawal by Subject|0|||
127643513|NCT00441090|459315307|FG002|Overall Study|Withdrawal by Subject|1|||
127643514|NCT00441090|459315308|FG003|Overall Study|Withdrawal by Subject|0|||
127643515|NCT00441090|459315309|FG004|Overall Study|Withdrawal by Subject|0|||
127643516|NCT00441090|459315305|FG000|Overall Study|Lack of Efficacy|1|||
127643517|NCT00441090|459315306|FG001|Overall Study|Lack of Efficacy|0|||
127643518|NCT00441090|459315307|FG002|Overall Study|Lack of Efficacy|0|||
127643519|NCT00441090|459315308|FG003|Overall Study|Lack of Efficacy|0|||
127643520|NCT00441090|459315309|FG004|Overall Study|Lack of Efficacy|0|||
127643521|NCT03085485|459315310|FG000|Overall Study|Death|1|||
127643522|NCT03085485|459315311|FG001|Overall Study|Death|0|||
127643523|NCT03085485|459315310|FG000|Overall Study|Lost to Follow-up|1|||
127643524|NCT03085485|459315311|FG001|Overall Study|Lost to Follow-up|0|||
127643525|NCT00605280|459315312|FG000|Year 1|Protocol Violation|0|||
127643526|NCT00605280|459315313|FG001|Year 1|Protocol Violation|0|||
127643527|NCT00605280|459315314|FG002|Year 1|Protocol Violation|0|||
127643528|NCT00605280|459315315|FG003|Year 1|Protocol Violation|1|||
127643529|NCT00605280|459315312|FG000|Year 1|Adverse Event|3|||
127643530|NCT00605280|459315313|FG001|Year 1|Adverse Event|1|||
127643531|NCT00605280|459315314|FG002|Year 1|Adverse Event|1|||
127643532|NCT00605280|459315315|FG003|Year 1|Adverse Event|5|||
127643533|NCT00605280|459315312|FG000|Year 1|Physician Decision|7|||
127643534|NCT00605280|459315313|FG001|Year 1|Physician Decision|4|||
127643535|NCT00605280|459315314|FG002|Year 1|Physician Decision|0|||
127643536|NCT00605280|459315315|FG003|Year 1|Physician Decision|6|||
127643537|NCT00605280|459315312|FG000|Year 1|Withdrawal by Subject|2|||
127643538|NCT00605280|459315313|FG001|Year 1|Withdrawal by Subject|4|||
127643539|NCT00605280|459315314|FG002|Year 1|Withdrawal by Subject|0|||
127643540|NCT00605280|459315315|FG003|Year 1|Withdrawal by Subject|4|||
127643541|NCT00605280|459315312|FG000|Year 1|Other|2|||
127643542|NCT00605280|459315313|FG001|Year 1|Other|1|||
127643543|NCT00605280|459315314|FG002|Year 1|Other|0|||
127643544|NCT00605280|459315315|FG003|Year 1|Other|1|||
127643545|NCT00605280|459315312|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
127643546|NCT00605280|459315313|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
127643547|NCT00605280|459315314|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
127887557|NCT00368537|460211873|FG000|Randomization|No study drug dosed|13|||
127643548|NCT00605280|459315315|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
127643549|NCT00605280|459315312|FG000|Year 2|Adverse Event|4|||
127643550|NCT00605280|459315313|FG001|Year 2|Adverse Event|0|||
127643551|NCT00605280|459315314|FG002|Year 2|Adverse Event|2|||
127643552|NCT00605280|459315315|FG003|Year 2|Adverse Event|4|||
127643553|NCT00605280|459315312|FG000|Year 2|Physician Decision|11|||
127643554|NCT00605280|459315313|FG001|Year 2|Physician Decision|6|||
127643555|NCT00605280|459315314|FG002|Year 2|Physician Decision|4|||
127643556|NCT00605280|459315315|FG003|Year 2|Physician Decision|11|||
127643557|NCT00605280|459315312|FG000|Year 2|Withdrawal by Subject|4|||
127643558|NCT00605280|459315313|FG001|Year 2|Withdrawal by Subject|0|||
127643559|NCT00605280|459315314|FG002|Year 2|Withdrawal by Subject|0|||
127706284|NCT03523572|459555407|FG001|Dose Expansion|Progressive Disease|0|||
127643560|NCT00605280|459315315|FG003|Year 2|Withdrawal by Subject|4|||
127643561|NCT00605280|459315312|FG000|Year 2|Other|1|||
127643562|NCT00605280|459315313|FG001|Year 2|Other|0|||
127706285|NCT03523572|459555408|FG002|Dose Expansion|Progressive Disease|9|||
127706286|NCT03523572|459555409|FG003|Dose Expansion|Progressive Disease|11|||
127706287|NCT03523572|459555410|FG004|Dose Expansion|Progressive Disease|15|||
127706288|NCT03523572|459555411|FG005|Dose Expansion|Progressive Disease|2|||
127706289|NCT03523572|459555406|FG000|Dose Expansion|Clinical Progression|0|||
127706290|NCT03523572|459555407|FG001|Dose Expansion|Clinical Progression|0|||
127706291|NCT03523572|459555408|FG002|Dose Expansion|Clinical Progression|2|||
127706292|NCT03523572|459555409|FG003|Dose Expansion|Clinical Progression|2|||
127706293|NCT03523572|459555410|FG004|Dose Expansion|Clinical Progression|2|||
127706294|NCT03523572|459555411|FG005|Dose Expansion|Clinical Progression|0|||
127706295|NCT03523572|459555406|FG000|Dose Expansion|Adverse Event|0|||
127706296|NCT03523572|459555407|FG001|Dose Expansion|Adverse Event|0|||
127706297|NCT03523572|459555408|FG002|Dose Expansion|Adverse Event|10|||
127706298|NCT03523572|459555409|FG003|Dose Expansion|Adverse Event|1|||
127706299|NCT03523572|459555410|FG004|Dose Expansion|Adverse Event|5|||
127706300|NCT03523572|459555411|FG005|Dose Expansion|Adverse Event|2|||
127706301|NCT03523572|459555406|FG000|Dose Expansion|Withdrawal by Subject|0|||
127706302|NCT03523572|459555407|FG001|Dose Expansion|Withdrawal by Subject|0|||
127643563|NCT00605280|459315314|FG002|Year 2|Other|0|||
127643564|NCT00605280|459315315|FG003|Year 2|Other|1|||
127643565|NCT00605280|459315312|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
127706303|NCT03523572|459555408|FG002|Dose Expansion|Withdrawal by Subject|1|||
127706304|NCT03523572|459555409|FG003|Dose Expansion|Withdrawal by Subject|1|||
127706305|NCT03523572|459555410|FG004|Dose Expansion|Withdrawal by Subject|0|||
127706306|NCT03523572|459555411|FG005|Dose Expansion|Withdrawal by Subject|0|||
127643566|NCT00605280|459315313|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
127643567|NCT00605280|459315314|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
127643568|NCT00605280|459315315|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
127643569|NCT00605280|459315312|FG000|Year 3 Extension|Adverse Event|2|||
127643570|NCT00605280|459315313|FG001|Year 3 Extension|Adverse Event|0|||
127643571|NCT00605280|459315314|FG002|Year 3 Extension|Adverse Event|0|||
127643572|NCT00605280|459315315|FG003|Year 3 Extension|Adverse Event|2|||
127798682|NCT06098729|459885671|FG000|Overall Study|Withdrawal by Subject|1|||
127798683|NCT04925752|459885677|FG000|Overall Study|Still on Study|1826|||
127798684|NCT04925752|459885678|FG001|Overall Study|Still on Study|926|||
127798685|NCT04925752|459885677|FG000|Overall Study|Withdrew Consent|128|||
127798686|NCT04925752|459885678|FG001|Overall Study|Withdrew Consent|59|||
127798687|NCT04925752|459885677|FG000|Overall Study|Lost to Follow-up|73|||
127798688|NCT04925752|459885678|FG001|Overall Study|Lost to Follow-up|47|||
127798689|NCT04925752|459885677|FG000|Overall Study|Randomized but Never Treated|12|||
127798690|NCT04925752|459885678|FG001|Overall Study|Randomized but Never Treated|9|||
127798691|NCT04925752|459885677|FG000|Overall Study|Hiv-1 Infection|6|||
127798692|NCT04925752|459885678|FG001|Overall Study|Hiv-1 Infection|7|||
127798693|NCT04925752|459885677|FG000|Overall Study|Investigator's discretion|8|||
127798694|NCT04925752|459885678|FG001|Overall Study|Investigator's discretion|5|||
127798695|NCT04925752|459885677|FG000|Overall Study|Non-compliance with Study Drug|8|||
127798696|NCT04925752|459885678|FG001|Overall Study|Non-compliance with Study Drug|5|||
127798697|NCT04925752|459885677|FG000|Overall Study|Adverse Event|5|||
127798698|NCT04925752|459885678|FG001|Overall Study|Adverse Event|2|||
127798699|NCT04925752|459885677|FG000|Overall Study|Death|4|||
127798700|NCT04925752|459885678|FG001|Overall Study|Death|2|||
127798701|NCT04925752|459885677|FG000|Overall Study|Protocol Violation|1|||
127798702|NCT04925752|459885678|FG001|Overall Study|Protocol Violation|3|||
127798703|NCT04925752|459885677|FG000|Overall Study|Withdrew Assent|1|||
127798704|NCT04925752|459885678|FG001|Overall Study|Withdrew Assent|0|||
127798705|NCT03864653|459885681|FG000|Overall Study|Withdrawal by Subject|1|||
127798706|NCT00546052|459885682|FG000|Overall Study|Adverse Event|47|||
127887558|NCT00368537|460211874|FG001|Randomization|No study drug dosed|6|||
127887559|NCT00368537|460211873|FG000|Baseline Participants|Lost to Follow-up|16|||
127887560|NCT00368537|460211874|FG001|Baseline Participants|Lost to Follow-up|17|||
127887561|NCT00368537|460211873|FG000|Baseline Participants|Withdrawal by Subject|6|||
127887562|NCT00368537|460211874|FG001|Baseline Participants|Withdrawal by Subject|4|||
127887563|NCT00368537|460211873|FG000|Baseline Participants|Death|1|||
127887564|NCT00368537|460211874|FG001|Baseline Participants|Death|2|||
127887565|NCT00368537|460211873|FG000|Baseline Participants|No susceptibility|1|||
127887566|NCT00368537|460211874|FG001|Baseline Participants|No susceptibility|0|||
127887567|NCT00368537|460211873|FG000|Baseline Participants|Patient uncompliant|0|||
127887568|NCT00368537|460211874|FG001|Baseline Participants|Patient uncompliant|1|||
127887569|NCT01368276|460211884|FG000|Overall Study|Death|1|||
127887570|NCT01368276|460211885|FG001|Overall Study|Death|10|||
127887571|NCT00267007|460211886|FG000|Overall Study|Withdrawal by Subject|6|||
127887572|NCT00267007|460211887|FG001|Overall Study|Withdrawal by Subject|0|||
127887573|NCT00267007|460211886|FG000|Overall Study|Lost to Follow-up|1|||
127887574|NCT00267007|460211887|FG001|Overall Study|Lost to Follow-up|0|||
127887575|NCT00267007|460211886|FG000|Overall Study|Non-compliance|0|||
127887576|NCT00267007|460211887|FG001|Overall Study|Non-compliance|1|||
127887577|NCT00267007|460211886|FG000|Overall Study|Adverse Event|1|||
127887578|NCT00267007|460211887|FG001|Overall Study|Adverse Event|0|||
127887579|NCT01825876|460211889|FG000|Period 2|Withdrawal by Subject|0|||
127887580|NCT01825876|460211890|FG001|Period 2|Withdrawal by Subject|1|||
127887581|NCT04133519|460211895|FG000|Overall Study|Withdrawal by Subject|5|||
127887582|NCT04133519|460211896|FG001|Overall Study|Withdrawal by Subject|4|||
127887583|NCT04133519|460211895|FG000|Overall Study|Protocol Violation|0|||
127887584|NCT04133519|460211896|FG001|Overall Study|Protocol Violation|1|||
127887585|NCT04133519|460211895|FG000|Overall Study|Never started treatment|1|||
127887586|NCT04133519|460211896|FG001|Overall Study|Never started treatment|1|||
127887587|NCT02436135|460211897|FG000|Overall Study|Progressive Disease|3|||
127887588|NCT02436135|460211898|FG001|Overall Study|Progressive Disease|1|||
127643573|NCT00605280|459315312|FG000|Year 3 Extension|Physician Decision|0|||
127643574|NCT00605280|459315313|FG001|Year 3 Extension|Physician Decision|0|||
127643575|NCT00605280|459315314|FG002|Year 3 Extension|Physician Decision|0|||
127798707|NCT00546052|459885682|FG000|Overall Study|Lost to Follow-up|144|||
127798708|NCT00546052|459885682|FG000|Overall Study|Protocol Violation|9|||
127798709|NCT00546052|459885682|FG000|Overall Study|Withdrawal by Subject|20|||
127798710|NCT00546052|459885682|FG000|Overall Study|Non Compliance|7|||
127798711|NCT01928381|459885685|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
127798712|NCT01928381|459885686|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
127887589|NCT02436135|460211897|FG000|Overall Study|Investigator Discretion|1|||
127887590|NCT02436135|460211898|FG001|Overall Study|Investigator Discretion|2|||
127887591|NCT02436135|460211897|FG000|Overall Study|Adverse Event|1|||
127887592|NCT02436135|460211898|FG001|Overall Study|Adverse Event|0|||
127887593|NCT02436135|460211897|FG000|Overall Study|Withdrawal by Participant|1|||
127887594|NCT02436135|460211898|FG001|Overall Study|Withdrawal by Participant|0|||
127706307|NCT03523572|459555406|FG000|Dose Expansion|Physician Decision|0|||
127706308|NCT03523572|459555407|FG001|Dose Expansion|Physician Decision|0|||
127706309|NCT03523572|459555408|FG002|Dose Expansion|Physician Decision|1|||
127706310|NCT03523572|459555409|FG003|Dose Expansion|Physician Decision|0|||
127706311|NCT03523572|459555410|FG004|Dose Expansion|Physician Decision|1|||
127706312|NCT03523572|459555411|FG005|Dose Expansion|Physician Decision|0|||
127706313|NCT03523572|459555406|FG000|Dose Expansion|Miscellaneous|0|||
127706314|NCT03523572|459555407|FG001|Dose Expansion|Miscellaneous|0|||
127706315|NCT03523572|459555408|FG002|Dose Expansion|Miscellaneous|0|||
127706316|NCT03523572|459555409|FG003|Dose Expansion|Miscellaneous|0|||
127706317|NCT03523572|459555410|FG004|Dose Expansion|Miscellaneous|3|||
127706318|NCT03523572|459555411|FG005|Dose Expansion|Miscellaneous|0|||
127887595|NCT02436135|460211897|FG000|Overall Study|Study Terminated By Sponsor|0|||
127887596|NCT02436135|460211898|FG001|Overall Study|Study Terminated By Sponsor|1|||
127887597|NCT00475852|460211901|FG000|Overall Study|Death|444|||
127887598|NCT00475852|460211902|FG001|Overall Study|Death|456|||
127887599|NCT00475852|460211901|FG000|Overall Study|Withdrawal by Subject|19|||
127887600|NCT00475852|460211902|FG001|Overall Study|Withdrawal by Subject|24|||
127887601|NCT00475852|460211901|FG000|Overall Study|Lost to Follow-up|54|||
127887602|NCT00475852|460211902|FG001|Overall Study|Lost to Follow-up|68|||
127887603|NCT00297479|460211904|FG000|Overall Study|Lost to Follow-up|37|||
127887604|NCT00297479|460211905|FG001|Overall Study|Lost to Follow-up|54|||
127887605|NCT00297479|460211906|FG002|Overall Study|Lost to Follow-up|51|||
127887606|NCT01664494|460211909|FG000|Overall Study|Withdrawal by Subject|27|||
127887607|NCT01664494|460211909|FG000|Overall Study|Death|18|||
127887608|NCT01664494|460211909|FG000|Overall Study|Other|49|||
127887609|NCT01664494|460211909|FG000|Overall Study|Lost to Follow-up|99|||
127887610|NCT03196791|460211910|FG000|Overall Study|Protocol Violation|7|||
127887611|NCT03196791|460211911|FG001|Overall Study|Protocol Violation|3|||
127887612|NCT03196791|460211910|FG000|Overall Study|Withdrawal by Subject|3|||
127887613|NCT03196791|460211911|FG001|Overall Study|Withdrawal by Subject|2|||
127887614|NCT03063632|460211916|FG000|Overall Study|Death|4|||
127887615|NCT03063632|460211917|FG001|Overall Study|Death|6|||
127887616|NCT03063632|460211916|FG000|Overall Study|Lost to Follow-up|0|||
127887617|NCT03063632|460211917|FG001|Overall Study|Lost to Follow-up|1|||
127887618|NCT03063632|460211916|FG000|Overall Study|Withdrawal by Subject|0|||
127887619|NCT03063632|460211917|FG001|Overall Study|Withdrawal by Subject|2|||
127887620|NCT03063632|460211916|FG000|Overall Study|Physician Decision|2|||
127887621|NCT03063632|460211917|FG001|Overall Study|Physician Decision|0|||
127887622|NCT03063632|460211916|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
127887623|NCT03063632|460211917|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
127887624|NCT02570165|460211920|FG000|Overall Study|Adverse Event|1|||
127887625|NCT02570165|460211921|FG001|Overall Study|Adverse Event|0|||
127887626|NCT02570165|460211922|FG002|Overall Study|Adverse Event|2|||
127887627|NCT02570165|460211923|FG003|Overall Study|Adverse Event|0|||
127887628|NCT02570165|460211924|FG004|Overall Study|Adverse Event|0|||
127887629|NCT02570165|460211925|FG005|Overall Study|Adverse Event|0|||
127887630|NCT02570165|460211926|FG006|Overall Study|Adverse Event|0|||
127887631|NCT02570165|460211920|FG000|Overall Study|Lack of Efficacy|0|||
127887632|NCT02570165|460211921|FG001|Overall Study|Lack of Efficacy|1|||
127887633|NCT02570165|460211922|FG002|Overall Study|Lack of Efficacy|0|||
127887634|NCT02570165|460211923|FG003|Overall Study|Lack of Efficacy|0|||
127887635|NCT02570165|460211924|FG004|Overall Study|Lack of Efficacy|4|||
127887636|NCT02570165|460211925|FG005|Overall Study|Lack of Efficacy|0|||
127887637|NCT02570165|460211926|FG006|Overall Study|Lack of Efficacy|0|||
127887638|NCT02570165|460211920|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
127887639|NCT02570165|460211921|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
127887640|NCT02570165|460211922|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
127887641|NCT02570165|460211923|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
127887642|NCT02570165|460211924|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
127887643|NCT02570165|460211925|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
127887644|NCT02570165|460211926|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
127887645|NCT02570165|460211920|FG000|Overall Study|Lost to Follow-up|0|||
127887646|NCT02570165|460211921|FG001|Overall Study|Lost to Follow-up|0|||
127887647|NCT02570165|460211922|FG002|Overall Study|Lost to Follow-up|1|||
127887648|NCT02570165|460211923|FG003|Overall Study|Lost to Follow-up|1|||
127887649|NCT02570165|460211924|FG004|Overall Study|Lost to Follow-up|0|||
127887650|NCT02570165|460211925|FG005|Overall Study|Lost to Follow-up|0|||
127887651|NCT02570165|460211926|FG006|Overall Study|Lost to Follow-up|0|||
127887652|NCT02570165|460211920|FG000|Overall Study|Physician Decision|0|||
127706319|NCT02240238|459555427|FG000|Phase 1|Adverse Event|0|||
127706320|NCT02240238|459555428|FG001|Phase 1|Adverse Event|0|||
127706321|NCT02240238|459555429|FG002|Phase 1|Adverse Event|0|||
127887653|NCT02570165|460211921|FG001|Overall Study|Physician Decision|1|||
127887654|NCT02570165|460211922|FG002|Overall Study|Physician Decision|0|||
127887655|NCT02570165|460211923|FG003|Overall Study|Physician Decision|0|||
127887656|NCT02570165|460211924|FG004|Overall Study|Physician Decision|0|||
127887657|NCT02570165|460211925|FG005|Overall Study|Physician Decision|0|||
127887658|NCT02570165|460211926|FG006|Overall Study|Physician Decision|0|||
127706322|NCT02240238|459555430|FG003|Phase 1|Adverse Event|0|||
127706323|NCT02240238|459555431|FG004|Phase 1|Adverse Event|0|||
127706324|NCT02240238|459555432|FG005|Phase 1|Adverse Event|0|||
127706325|NCT02240238|459555433|FG006|Phase 1|Adverse Event|3|||
127706326|NCT02240238|459555434|FG007|Phase 1|Adverse Event|1|||
127706327|NCT02240238|459555435|FG008|Phase 1|Adverse Event|0|||
127706328|NCT02240238|459555436|FG009|Phase 1|Adverse Event|0|||
127798713|NCT01928381|459885687|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
127798714|NCT01928381|459885688|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
127798715|NCT01928381|459885689|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
127798716|NCT01928381|459885690|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
127798717|NCT01928381|459885691|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
127798718|NCT01928381|459885685|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
127798719|NCT01928381|459885686|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
127798720|NCT01928381|459885687|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
127706329|NCT02240238|459555437|FG010|Phase 1|Adverse Event|0|||
127706330|NCT02240238|459555438|FG011|Phase 1|Adverse Event|0|||
127706331|NCT02240238|459555427|FG000|Phase 1|Death|0|||
127706332|NCT02240238|459555428|FG001|Phase 1|Death|0|||
127706333|NCT02240238|459555429|FG002|Phase 1|Death|0|||
127706334|NCT02240238|459555430|FG003|Phase 1|Death|0|||
127706335|NCT02240238|459555431|FG004|Phase 1|Death|0|||
127706336|NCT02240238|459555432|FG005|Phase 1|Death|1|||
127798721|NCT01928381|459885688|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
127798722|NCT01928381|459885689|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
127798723|NCT01928381|459885690|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
127798724|NCT01928381|459885691|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
127798725|NCT01928381|459885685|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
127798726|NCT01928381|459885686|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
127798727|NCT01928381|459885687|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
127798728|NCT01928381|459885688|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
127798729|NCT01928381|459885689|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
127798730|NCT01928381|459885690|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
127798731|NCT01928381|459885691|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
127887659|NCT02570165|460211920|FG000|Overall Study|Withdrawal by Subject|0|||
127706337|NCT02240238|459555433|FG006|Phase 1|Death|0|||
127706338|NCT02240238|459555434|FG007|Phase 1|Death|0|||
127706339|NCT02240238|459555435|FG008|Phase 1|Death|0|||
127706340|NCT02240238|459555436|FG009|Phase 1|Death|0|||
127706341|NCT02240238|459555437|FG010|Phase 1|Death|0|||
127798732|NCT01928381|459885685|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
127887660|NCT02570165|460211921|FG001|Overall Study|Withdrawal by Subject|0|||
127887661|NCT02570165|460211922|FG002|Overall Study|Withdrawal by Subject|0|||
127887662|NCT02570165|460211923|FG003|Overall Study|Withdrawal by Subject|2|||
127887663|NCT02570165|460211924|FG004|Overall Study|Withdrawal by Subject|1|||
127887664|NCT02570165|460211925|FG005|Overall Study|Withdrawal by Subject|0|||
127887665|NCT02570165|460211926|FG006|Overall Study|Withdrawal by Subject|0|||
127887666|NCT02570165|460211920|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
127887667|NCT02570165|460211921|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
127887668|NCT02570165|460211922|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
127887669|NCT02570165|460211923|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
127887670|NCT02570165|460211924|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
127887671|NCT02570165|460211925|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
127887672|NCT02570165|460211926|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
127887673|NCT02570165|460211920|FG000|Overall Study|Withdrawal Request by GSK|0|||
127887674|NCT02570165|460211921|FG001|Overall Study|Withdrawal Request by GSK|0|||
127887675|NCT02570165|460211922|FG002|Overall Study|Withdrawal Request by GSK|2|||
127887676|NCT02570165|460211923|FG003|Overall Study|Withdrawal Request by GSK|0|||
127887677|NCT02570165|460211924|FG004|Overall Study|Withdrawal Request by GSK|0|||
127887678|NCT02570165|460211925|FG005|Overall Study|Withdrawal Request by GSK|0|||
127887679|NCT02570165|460211926|FG006|Overall Study|Withdrawal Request by GSK|0|||
127887680|NCT01789281|460211927|FG000|Overall Study|Disease progression|15|||
127887681|NCT01789281|460211928|FG001|Overall Study|Disease progression|4|||
127887682|NCT01789281|460211927|FG000|Overall Study|Adverse Event|5|||
127887683|NCT01789281|460211928|FG001|Overall Study|Adverse Event|5|||
127887684|NCT01789281|460211927|FG000|Overall Study|Withdrawal by Subject|1|||
127887685|NCT01789281|460211928|FG001|Overall Study|Withdrawal by Subject|0|||
127887686|NCT01789281|460211927|FG000|Overall Study|Lost to Follow-up|1|||
127887687|NCT01789281|460211928|FG001|Overall Study|Lost to Follow-up|0|||
127887688|NCT01789281|460211927|FG000|Overall Study|Administrative problems|0|||
127887689|NCT01789281|460211928|FG001|Overall Study|Administrative problems|1|||
127887690|NCT04304950|460211937|FG000|Overall Study|Lost to Follow-up|1|||
127887691|NCT04304950|460211938|FG001|Overall Study|Lost to Follow-up|1|||
127887692|NCT02418910|460211939|FG000|Overall Study|Lost to Follow-up|3|||
127887693|NCT02418910|460211939|FG000|Overall Study|Withdrawal by Subject|4|||
127887694|NCT03634488|460211941|FG000|Overall Study|Death|1|||
127887695|NCT03634488|460211942|FG001|Overall Study|Death|0|||
127887696|NCT03634488|460211943|FG002|Overall Study|Death|0|||
127887697|NCT03634488|460211941|FG000|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|1|||
127887698|NCT03634488|460211942|FG001|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
127887699|NCT03634488|460211943|FG002|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
127887700|NCT03182686|460211944|FG000|Overall Study|Lost to Follow-up|2|||
127887701|NCT03182686|460211945|FG001|Overall Study|Lost to Follow-up|0|||
127887702|NCT03182686|460211944|FG000|Overall Study|Adverse Event|2|||
127887703|NCT03182686|460211945|FG001|Overall Study|Adverse Event|0|||
127887704|NCT03182686|460211944|FG000|Overall Study|Withdrawal by Subject|3|||
127887705|NCT03182686|460211945|FG001|Overall Study|Withdrawal by Subject|0|||
127887706|NCT01154127|460211946|FG000|Period 1 (21 Days)|Adverse Event|3|||
127887707|NCT01154127|460211947|FG001|Period 1 (21 Days)|Adverse Event|4|||
127887708|NCT01154127|460211946|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
127887709|NCT01154127|460211947|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
127887710|NCT01154127|460211946|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
127706342|NCT02240238|459555438|FG011|Phase 1|Death|0|||
127706343|NCT02240238|459555427|FG000|Phase 1|Sponsor termination|0|||
127706344|NCT02240238|459555428|FG001|Phase 1|Sponsor termination|0|||
127706345|NCT02240238|459555429|FG002|Phase 1|Sponsor termination|0|||
127706346|NCT02240238|459555430|FG003|Phase 1|Sponsor termination|0|||
127706347|NCT02240238|459555431|FG004|Phase 1|Sponsor termination|0|||
127706348|NCT02240238|459555432|FG005|Phase 1|Sponsor termination|1|||
127643576|NCT00605280|459315315|FG003|Year 3 Extension|Physician Decision|2|||
127643577|NCT00605280|459315312|FG000|Year 3 Extension|Withdrawal by Subject|2|||
127643578|NCT00605280|459315313|FG001|Year 3 Extension|Withdrawal by Subject|0|||
127643579|NCT00605280|459315314|FG002|Year 3 Extension|Withdrawal by Subject|0|||
127643580|NCT00605280|459315315|FG003|Year 3 Extension|Withdrawal by Subject|5|||
127643581|NCT00605280|459315312|FG000|Year 3 Extension|Other|2|||
127643582|NCT00605280|459315313|FG001|Year 3 Extension|Other|0|||
127643583|NCT00605280|459315314|FG002|Year 3 Extension|Other|0|||
127643584|NCT00605280|459315315|FG003|Year 3 Extension|Other|0|||
127643585|NCT00605280|459315312|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
127643586|NCT00605280|459315313|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
127643587|NCT00605280|459315314|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
127643588|NCT00605280|459315315|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
127643589|NCT01662310|459315319|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
127643590|NCT01662310|459315320|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
127643591|NCT01662310|459315321|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
127643592|NCT01662310|459315322|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
127643593|NCT01662310|459315323|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
127643594|NCT01662310|459315319|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
127643595|NCT01662310|459315320|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
127643596|NCT01662310|459315321|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
127643597|NCT01662310|459315322|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
127643598|NCT01662310|459315323|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
127643599|NCT01662310|459315319|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
127643600|NCT01662310|459315320|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
127643601|NCT01662310|459315321|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
127643602|NCT01662310|459315322|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
127643603|NCT01662310|459315323|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
127643604|NCT01662310|459315319|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
127643605|NCT01662310|459315320|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
127643606|NCT01662310|459315321|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
127643607|NCT01662310|459315322|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
127643608|NCT01662310|459315323|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
127643609|NCT01662310|459315319|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
127643610|NCT01662310|459315320|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
127643611|NCT01662310|459315321|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
127643612|NCT01662310|459315322|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
127643613|NCT01662310|459315323|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
127643614|NCT01662310|459315319|FG000|Run-In or Stabilization Phase|Other|1|||
127643615|NCT01662310|459315320|FG001|Run-In or Stabilization Phase|Other|0|||
127643616|NCT01662310|459315321|FG002|Run-In or Stabilization Phase|Other|0|||
127643617|NCT01662310|459315322|FG003|Run-In or Stabilization Phase|Other|0|||
127643618|NCT01662310|459315323|FG004|Run-In or Stabilization Phase|Other|0|||
127643619|NCT01662310|459315319|FG000|Double-Blind Phase|Adverse Event|0|||
127643620|NCT01662310|459315320|FG001|Double-Blind Phase|Adverse Event|0|||
127643621|NCT01662310|459315321|FG002|Double-Blind Phase|Adverse Event|1|||
127643622|NCT01662310|459315322|FG003|Double-Blind Phase|Adverse Event|0|||
127643623|NCT01662310|459315323|FG004|Double-Blind Phase|Adverse Event|0|||
127643624|NCT01662310|459315319|FG000|Double-Blind Phase|Lost to Follow-up|0|||
127643625|NCT01662310|459315320|FG001|Double-Blind Phase|Lost to Follow-up|3|||
127643626|NCT01662310|459315321|FG002|Double-Blind Phase|Lost to Follow-up|0|||
127643627|NCT01662310|459315322|FG003|Double-Blind Phase|Lost to Follow-up|0|||
127643628|NCT01662310|459315323|FG004|Double-Blind Phase|Lost to Follow-up|0|||
127643629|NCT01662310|459315319|FG000|Double-Blind Phase|Pregnancy|0|||
127643630|NCT01662310|459315320|FG001|Double-Blind Phase|Pregnancy|2|||
127643631|NCT01662310|459315321|FG002|Double-Blind Phase|Pregnancy|0|||
127643632|NCT01662310|459315322|FG003|Double-Blind Phase|Pregnancy|0|||
127643633|NCT01662310|459315323|FG004|Double-Blind Phase|Pregnancy|0|||
127706349|NCT02240238|459555433|FG006|Phase 1|Sponsor termination|0|||
127643634|NCT01662310|459315319|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
127643635|NCT01662310|459315320|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
127643636|NCT01662310|459315321|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
127643637|NCT01662310|459315322|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
127643638|NCT01662310|459315323|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
127706350|NCT02240238|459555434|FG007|Phase 1|Sponsor termination|0|||
127706351|NCT02240238|459555435|FG008|Phase 1|Sponsor termination|0|||
127706352|NCT02240238|459555436|FG009|Phase 1|Sponsor termination|0|||
127706353|NCT02240238|459555437|FG010|Phase 1|Sponsor termination|0|||
127706354|NCT02240238|459555438|FG011|Phase 1|Sponsor termination|0|||
127706355|NCT02240238|459555427|FG000|Phase 1|Withdrawal by Subject|0|||
127706356|NCT02240238|459555428|FG001|Phase 1|Withdrawal by Subject|0|||
127706357|NCT02240238|459555429|FG002|Phase 1|Withdrawal by Subject|0|||
127798733|NCT01928381|459885686|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
127706358|NCT02240238|459555430|FG003|Phase 1|Withdrawal by Subject|0|||
127706359|NCT02240238|459555431|FG004|Phase 1|Withdrawal by Subject|0|||
127706360|NCT02240238|459555432|FG005|Phase 1|Withdrawal by Subject|2|||
127706361|NCT02240238|459555433|FG006|Phase 1|Withdrawal by Subject|0|||
127798734|NCT01928381|459885687|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
127798735|NCT01928381|459885688|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
127798736|NCT01928381|459885689|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
127798737|NCT01928381|459885690|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
127798738|NCT01928381|459885691|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
127798739|NCT01928381|459885685|FG000|Part 1 - Pain Training|Protocol Violation|1|||
127798740|NCT01928381|459885686|FG001|Part 1 - Pain Training|Protocol Violation|0|||
127798741|NCT01928381|459885687|FG002|Part 1 - Pain Training|Protocol Violation|0|||
127798742|NCT01928381|459885688|FG003|Part 1 - Pain Training|Protocol Violation|0|||
127798743|NCT01928381|459885689|FG004|Part 1 - Pain Training|Protocol Violation|0|||
127798744|NCT01928381|459885690|FG005|Part 1 - Pain Training|Protocol Violation|0|||
127798745|NCT01928381|459885691|FG006|Part 1 - Pain Training|Protocol Violation|0|||
127798746|NCT01928381|459885685|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
127798747|NCT01928381|459885686|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
127798748|NCT01928381|459885687|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
127798749|NCT01928381|459885688|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
127798750|NCT01928381|459885689|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
127798751|NCT01928381|459885690|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
127798752|NCT01928381|459885691|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
127798753|NCT01928381|459885685|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
127798754|NCT01928381|459885686|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
127706362|NCT02240238|459555434|FG007|Phase 1|Withdrawal by Subject|0|||
127798755|NCT01928381|459885687|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
127706363|NCT02240238|459555435|FG008|Phase 1|Withdrawal by Subject|0|||
127706364|NCT02240238|459555436|FG009|Phase 1|Withdrawal by Subject|0|||
127706365|NCT02240238|459555437|FG010|Phase 1|Withdrawal by Subject|0|||
127706366|NCT02240238|459555438|FG011|Phase 1|Withdrawal by Subject|0|||
127706367|NCT02240238|459555427|FG000|Phase 1|Physician Decision|0|||
127706368|NCT02240238|459555428|FG001|Phase 1|Physician Decision|0|||
127706369|NCT02240238|459555429|FG002|Phase 1|Physician Decision|0|||
127706370|NCT02240238|459555430|FG003|Phase 1|Physician Decision|0|||
127706371|NCT02240238|459555431|FG004|Phase 1|Physician Decision|0|||
127706372|NCT02240238|459555432|FG005|Phase 1|Physician Decision|2|||
127706373|NCT02240238|459555433|FG006|Phase 1|Physician Decision|0|||
127798756|NCT01928381|459885688|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
127798757|NCT01928381|459885689|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
127706374|NCT02240238|459555434|FG007|Phase 1|Physician Decision|0|||
127706375|NCT02240238|459555435|FG008|Phase 1|Physician Decision|0|||
127706376|NCT02240238|459555436|FG009|Phase 1|Physician Decision|0|||
127706377|NCT02240238|459555437|FG010|Phase 1|Physician Decision|0|||
127706378|NCT02240238|459555438|FG011|Phase 1|Physician Decision|0|||
127706379|NCT02240238|459555427|FG000|Phase 2|Adverse Event|0|||
127706380|NCT02240238|459555428|FG001|Phase 2|Adverse Event|0|||
127706381|NCT02240238|459555429|FG002|Phase 2|Adverse Event|0|||
127706382|NCT02240238|459555430|FG003|Phase 2|Adverse Event|0|||
127643639|NCT01662310|459315319|FG000|Double-Blind Phase|Other|0|||
127643640|NCT01662310|459315320|FG001|Double-Blind Phase|Other|0|||
127643641|NCT01662310|459315321|FG002|Double-Blind Phase|Other|1|||
127643642|NCT01662310|459315322|FG003|Double-Blind Phase|Other|0|||
127643643|NCT01662310|459315323|FG004|Double-Blind Phase|Other|0|||
127643644|NCT01662310|459315319|FG000|Double-Blind Phase|Randomized but not treated|0|||
127643645|NCT01662310|459315320|FG001|Double-Blind Phase|Randomized but not treated|1|||
127643646|NCT01662310|459315321|FG002|Double-Blind Phase|Randomized but not treated|0|||
127643647|NCT01662310|459315322|FG003|Double-Blind Phase|Randomized but not treated|0|||
127643648|NCT01662310|459315323|FG004|Double-Blind Phase|Randomized but not treated|0|||
127643649|NCT01662310|459315319|FG000|Open-Label Extension Phase|Adverse Event|0|||
127643650|NCT01662310|459315320|FG001|Open-Label Extension Phase|Adverse Event|0|||
127643651|NCT01662310|459315321|FG002|Open-Label Extension Phase|Adverse Event|0|||
127643652|NCT01662310|459315322|FG003|Open-Label Extension Phase|Adverse Event|3|||
127643653|NCT01662310|459315323|FG004|Open-Label Extension Phase|Adverse Event|0|||
127643654|NCT01662310|459315319|FG000|Open-Label Extension Phase|Death|0|||
127643655|NCT01662310|459315320|FG001|Open-Label Extension Phase|Death|0|||
127643656|NCT01662310|459315321|FG002|Open-Label Extension Phase|Death|0|||
127643657|NCT01662310|459315322|FG003|Open-Label Extension Phase|Death|1|||
127643658|NCT01662310|459315323|FG004|Open-Label Extension Phase|Death|0|||
127643659|NCT01662310|459315319|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
127643660|NCT01662310|459315320|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
127643661|NCT01662310|459315321|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
127643662|NCT01662310|459315322|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
127643663|NCT01662310|459315323|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
127643664|NCT01662310|459315319|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
127643665|NCT01662310|459315320|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
127643666|NCT01662310|459315321|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
127643667|NCT01662310|459315322|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
127643668|NCT01662310|459315323|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
127643669|NCT01662310|459315319|FG000|Open-Label Extension Phase|Pregnancy|0|||
127643670|NCT01662310|459315320|FG001|Open-Label Extension Phase|Pregnancy|0|||
127643671|NCT01662310|459315321|FG002|Open-Label Extension Phase|Pregnancy|0|||
127643672|NCT01662310|459315322|FG003|Open-Label Extension Phase|Pregnancy|1|||
127643673|NCT01662310|459315323|FG004|Open-Label Extension Phase|Pregnancy|0|||
127643674|NCT01662310|459315319|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
127643675|NCT01662310|459315320|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
127643676|NCT01662310|459315321|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
127706383|NCT02240238|459555431|FG004|Phase 2|Adverse Event|0|||
127643677|NCT01662310|459315322|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
127643678|NCT01662310|459315323|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
127706384|NCT02240238|459555432|FG005|Phase 2|Adverse Event|0|||
127643679|NCT01302847|459315327|FG000|Overall Study|Death|0|||
127643680|NCT01302847|459315328|FG001|Overall Study|Death|1|||
127643681|NCT01302847|459315329|FG002|Overall Study|Death|0|||
127643682|NCT01302847|459315330|FG003|Overall Study|Death|0|||
127643683|NCT01302847|459315331|FG004|Overall Study|Death|0|||
127643684|NCT01302847|459315332|FG005|Overall Study|Death|1|||
127643685|NCT01302847|459315333|FG006|Overall Study|Death|1|||
127706385|NCT02240238|459555433|FG006|Phase 2|Adverse Event|0|||
127643686|NCT01302847|459315334|FG007|Overall Study|Death|0|||
127798758|NCT01928381|459885690|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
127706386|NCT02240238|459555434|FG007|Phase 2|Adverse Event|0|||
127706387|NCT02240238|459555435|FG008|Phase 2|Adverse Event|0|||
127798759|NCT01928381|459885691|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
127798760|NCT01928381|459885685|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
127798761|NCT01928381|459885686|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
127798762|NCT01928381|459885687|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
127798763|NCT01928381|459885688|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
127798764|NCT01928381|459885689|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
127798765|NCT01928381|459885690|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
127798766|NCT01928381|459885691|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
127798767|NCT01928381|459885685|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
127798768|NCT01928381|459885686|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
127798769|NCT01928381|459885687|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
127798770|NCT01928381|459885688|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
127798771|NCT01928381|459885689|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
127798772|NCT01928381|459885690|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
127798773|NCT01928381|459885691|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
127798774|NCT01928381|459885685|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
127798775|NCT01928381|459885686|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
127798776|NCT01928381|459885687|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
127798777|NCT01928381|459885688|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
127798778|NCT01928381|459885689|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
127798779|NCT01928381|459885690|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
127798780|NCT01928381|459885691|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
127798781|NCT01928381|459885685|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
127798782|NCT01928381|459885686|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
127798783|NCT01928381|459885687|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
127798784|NCT01928381|459885688|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
127798785|NCT01928381|459885689|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
127798786|NCT01928381|459885690|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
127798787|NCT01928381|459885691|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
127798788|NCT01928381|459885685|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
127798789|NCT01928381|459885686|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
127798790|NCT01928381|459885687|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
127798791|NCT01928381|459885688|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
127798792|NCT01928381|459885689|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
127798793|NCT01928381|459885690|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
127798794|NCT01928381|459885691|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
127798795|NCT01928381|459885685|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
127798796|NCT01928381|459885686|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
127798797|NCT01928381|459885687|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
127798798|NCT01928381|459885688|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
127798799|NCT01928381|459885689|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
127798800|NCT01928381|459885690|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
127798801|NCT01928381|459885691|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
127798802|NCT01928381|459885685|FG000|Washout First Intervention|Protocol Violation|0|||
127798803|NCT01928381|459885686|FG001|Washout First Intervention|Protocol Violation|0|||
127798804|NCT01928381|459885687|FG002|Washout First Intervention|Protocol Violation|0|||
127798805|NCT01928381|459885688|FG003|Washout First Intervention|Protocol Violation|0|||
127798806|NCT01928381|459885689|FG004|Washout First Intervention|Protocol Violation|1|||
127798807|NCT01928381|459885690|FG005|Washout First Intervention|Protocol Violation|0|||
127798808|NCT01928381|459885691|FG006|Washout First Intervention|Protocol Violation|0|||
127798809|NCT01928381|459885685|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
127798810|NCT01928381|459885686|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
127887711|NCT01154127|460211947|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
127798811|NCT01928381|459885687|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
127798812|NCT01928381|459885688|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
127798813|NCT01928381|459885689|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
127798814|NCT01928381|459885690|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
127798815|NCT01928381|459885691|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
127798816|NCT01928381|459885685|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
127798817|NCT01928381|459885686|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
127798818|NCT01928381|459885687|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
127798819|NCT01928381|459885688|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
127643687|NCT01302847|459315327|FG000|Overall Study|Pregnancy|2|||
127643688|NCT01302847|459315328|FG001|Overall Study|Pregnancy|0|||
127643689|NCT01302847|459315329|FG002|Overall Study|Pregnancy|0|||
127643690|NCT01302847|459315330|FG003|Overall Study|Pregnancy|0|||
127643691|NCT01302847|459315331|FG004|Overall Study|Pregnancy|0|||
127643692|NCT01302847|459315332|FG005|Overall Study|Pregnancy|0|||
127643693|NCT01302847|459315333|FG006|Overall Study|Pregnancy|0|||
127643694|NCT01302847|459315334|FG007|Overall Study|Pregnancy|0|||
127643695|NCT01302847|459315327|FG000|Overall Study|Virologic failure|0|||
127643696|NCT01302847|459315328|FG001|Overall Study|Virologic failure|2|||
127643697|NCT01302847|459315329|FG002|Overall Study|Virologic failure|0|||
127643698|NCT01302847|459315330|FG003|Overall Study|Virologic failure|2|||
127643699|NCT01302847|459315331|FG004|Overall Study|Virologic failure|1|||
127643700|NCT01302847|459315332|FG005|Overall Study|Virologic failure|3|||
127643701|NCT01302847|459315333|FG006|Overall Study|Virologic failure|1|||
127643702|NCT01302847|459315334|FG007|Overall Study|Virologic failure|2|||
127643703|NCT01302847|459315327|FG000|Overall Study|Severe debilitation, unable to continue|0|||
127643704|NCT01302847|459315328|FG001|Overall Study|Severe debilitation, unable to continue|0|||
127643705|NCT01302847|459315329|FG002|Overall Study|Severe debilitation, unable to continue|0|||
127643706|NCT01302847|459315330|FG003|Overall Study|Severe debilitation, unable to continue|0|||
127643707|NCT01302847|459315331|FG004|Overall Study|Severe debilitation, unable to continue|0|||
127643708|NCT01302847|459315332|FG005|Overall Study|Severe debilitation, unable to continue|1|||
127643709|NCT01302847|459315333|FG006|Overall Study|Severe debilitation, unable to continue|1|||
127643710|NCT01302847|459315334|FG007|Overall Study|Severe debilitation, unable to continue|0|||
127643711|NCT01302847|459315327|FG000|Overall Study|Not able to get to clinic|1|||
127643712|NCT01302847|459315328|FG001|Overall Study|Not able to get to clinic|1|||
127643713|NCT01302847|459315329|FG002|Overall Study|Not able to get to clinic|0|||
127643714|NCT01302847|459315330|FG003|Overall Study|Not able to get to clinic|0|||
127643715|NCT01302847|459315331|FG004|Overall Study|Not able to get to clinic|0|||
127643716|NCT01302847|459315332|FG005|Overall Study|Not able to get to clinic|0|||
127643717|NCT01302847|459315333|FG006|Overall Study|Not able to get to clinic|0|||
127643718|NCT01302847|459315334|FG007|Overall Study|Not able to get to clinic|0|||
127643719|NCT01302847|459315327|FG000|Overall Study|Site closing|2|||
127798820|NCT01928381|459885689|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
127798821|NCT01928381|459885690|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
127798822|NCT01928381|459885691|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
127798823|NCT04441905|459887908|FG000|Overall Study|Lost to Follow-up|1|||
127798824|NCT04441905|459887909|FG001|Overall Study|Lost to Follow-up|0|||
127798825|NCT04441905|459887910|FG002|Overall Study|Lost to Follow-up|0|||
127798826|NCT04441905|459887911|FG003|Overall Study|Lost to Follow-up|0|||
127798827|NCT04441905|459887912|FG004|Overall Study|Lost to Follow-up|0|||
127798828|NCT04441905|459887913|FG005|Overall Study|Lost to Follow-up|0|||
127798829|NCT04441905|459887908|FG000|Overall Study|Enrolled but treatment not administered|0|||
127798830|NCT04441905|459887909|FG001|Overall Study|Enrolled but treatment not administered|1|||
127798831|NCT04441905|459887910|FG002|Overall Study|Enrolled but treatment not administered|0|||
127798832|NCT04441905|459887911|FG003|Overall Study|Enrolled but treatment not administered|0|||
127798833|NCT04441905|459887912|FG004|Overall Study|Enrolled but treatment not administered|0|||
127798834|NCT04441905|459887913|FG005|Overall Study|Enrolled but treatment not administered|0|||
127643720|NCT01302847|459315328|FG001|Overall Study|Site closing|2|||
127798835|NCT04441905|459887908|FG000|Overall Study|Became ineligible after enrollment|0|||
127643721|NCT01302847|459315329|FG002|Overall Study|Site closing|0|||
127643722|NCT01302847|459315330|FG003|Overall Study|Site closing|0|||
127643723|NCT01302847|459315331|FG004|Overall Study|Site closing|0|||
127643724|NCT01302847|459315332|FG005|Overall Study|Site closing|0|||
127643725|NCT01302847|459315333|FG006|Overall Study|Site closing|0|||
127643726|NCT01302847|459315334|FG007|Overall Study|Site closing|0|||
127643727|NCT01302847|459315327|FG000|Overall Study|Withdrawal by Subject|1|||
127798836|NCT04441905|459887909|FG001|Overall Study|Became ineligible after enrollment|0|||
127798837|NCT04441905|459887910|FG002|Overall Study|Became ineligible after enrollment|0|||
127798838|NCT04441905|459887911|FG003|Overall Study|Became ineligible after enrollment|0|||
127798839|NCT04441905|459887912|FG004|Overall Study|Became ineligible after enrollment|1|||
127798840|NCT04441905|459887913|FG005|Overall Study|Became ineligible after enrollment|0|||
127798841|NCT04770753|459887914|FG000|Overall Study|Randomized, never treated|1|||
127798842|NCT04770753|459887915|FG001|Overall Study|Randomized, never treated|1|||
127798843|NCT04770753|459887914|FG000|Overall Study|Withdrawal by Subject|3|||
127798844|NCT04770753|459887915|FG001|Overall Study|Withdrawal by Subject|1|||
127798845|NCT04770753|459887914|FG000|Overall Study|Adverse Event|2|||
127798846|NCT04770753|459887915|FG001|Overall Study|Adverse Event|0|||
127798847|NCT04770753|459887914|FG000|Overall Study|Pregnancy|1|||
127643728|NCT01302847|459315328|FG001|Overall Study|Withdrawal by Subject|0|||
127643729|NCT01302847|459315329|FG002|Overall Study|Withdrawal by Subject|0|||
127643730|NCT01302847|459315330|FG003|Overall Study|Withdrawal by Subject|0|||
127643731|NCT01302847|459315331|FG004|Overall Study|Withdrawal by Subject|1|||
127643732|NCT01302847|459315332|FG005|Overall Study|Withdrawal by Subject|0|||
127643733|NCT01302847|459315333|FG006|Overall Study|Withdrawal by Subject|0|||
127798848|NCT04770753|459887915|FG001|Overall Study|Pregnancy|0|||
127798849|NCT04770753|459887914|FG000|Overall Study|Other un-specified|1|||
127798850|NCT04770753|459887915|FG001|Overall Study|Other un-specified|0|||
127798851|NCT02775851|459887916|FG000|Overall Study|Adverse Event|1|||
127798852|NCT02775851|459887917|FG001|Overall Study|Adverse Event|10|||
127798853|NCT02775851|459887916|FG000|Overall Study|Refusal Unrelated to Adverse Event|0|||
127643734|NCT01302847|459315334|FG007|Overall Study|Withdrawal by Subject|1|||
127643735|NCT01302847|459315327|FG000|Overall Study|Not willing to adhere to requirements|5|||
127643736|NCT01302847|459315328|FG001|Overall Study|Not willing to adhere to requirements|0|||
127643737|NCT01302847|459315329|FG002|Overall Study|Not willing to adhere to requirements|1|||
127643738|NCT01302847|459315330|FG003|Overall Study|Not willing to adhere to requirements|0|||
127643739|NCT01302847|459315331|FG004|Overall Study|Not willing to adhere to requirements|0|||
127798854|NCT02775851|459887917|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
127643740|NCT01302847|459315332|FG005|Overall Study|Not willing to adhere to requirements|0|||
127643741|NCT01302847|459315333|FG006|Overall Study|Not willing to adhere to requirements|0|||
127643742|NCT01302847|459315334|FG007|Overall Study|Not willing to adhere to requirements|2|||
127643743|NCT01302847|459315327|FG000|Overall Study|Site unable to contact participant|2|||
127643744|NCT01302847|459315328|FG001|Overall Study|Site unable to contact participant|1|||
127643745|NCT01302847|459315329|FG002|Overall Study|Site unable to contact participant|0|||
127643746|NCT01302847|459315330|FG003|Overall Study|Site unable to contact participant|0|||
127643747|NCT01302847|459315331|FG004|Overall Study|Site unable to contact participant|0|||
127706388|NCT02240238|459555436|FG009|Phase 2|Adverse Event|7|||
127706389|NCT02240238|459555437|FG010|Phase 2|Adverse Event|14|||
127706390|NCT02240238|459555438|FG011|Phase 2|Adverse Event|2|||
127706391|NCT02240238|459555427|FG000|Phase 2|Death|0|||
127706392|NCT02240238|459555428|FG001|Phase 2|Death|0|||
127706393|NCT02240238|459555429|FG002|Phase 2|Death|0|||
127706394|NCT02240238|459555430|FG003|Phase 2|Death|0|||
127706395|NCT02240238|459555431|FG004|Phase 2|Death|0|||
127706396|NCT02240238|459555432|FG005|Phase 2|Death|0|||
127706397|NCT02240238|459555433|FG006|Phase 2|Death|0|||
127706398|NCT02240238|459555434|FG007|Phase 2|Death|0|||
127798855|NCT02775851|459887916|FG000|Overall Study|Progression/Relapse|0|||
127798856|NCT02775851|459887917|FG001|Overall Study|Progression/Relapse|4|||
127798857|NCT02775851|459887916|FG000|Overall Study|Other - Not Protocol Specified|0|||
127798858|NCT02775851|459887917|FG001|Overall Study|Other - Not Protocol Specified|7|||
127798859|NCT02775851|459887916|FG000|Overall Study|Withdrawal by Subject|1|||
127798860|NCT02775851|459887917|FG001|Overall Study|Withdrawal by Subject|0|||
127798861|NCT03718143|459887922|FG000|Overall Study|Death|1|||
127798862|NCT03718143|459887923|FG001|Overall Study|Death|0|||
127798863|NCT03718143|459887924|FG002|Overall Study|Death|0|||
127798864|NCT03718143|459887922|FG000|Overall Study|Progression of Disease|1|||
127798865|NCT03718143|459887923|FG001|Overall Study|Progression of Disease|0|||
127798866|NCT03718143|459887924|FG002|Overall Study|Progression of Disease|0|||
127798867|NCT03718143|459887922|FG000|Overall Study|Withdrawal of Informed Consent|1|||
127706399|NCT02240238|459555435|FG008|Phase 2|Death|0|||
127706400|NCT02240238|459555436|FG009|Phase 2|Death|3|||
127706401|NCT02240238|459555437|FG010|Phase 2|Death|2|||
127706402|NCT02240238|459555438|FG011|Phase 2|Death|1|||
127706403|NCT02240238|459555427|FG000|Phase 2|Disease progression|0|||
127706404|NCT02240238|459555428|FG001|Phase 2|Disease progression|0|||
127798868|NCT03718143|459887923|FG001|Overall Study|Withdrawal of Informed Consent|2|||
127798869|NCT03718143|459887924|FG002|Overall Study|Withdrawal of Informed Consent|1|||
127706405|NCT02240238|459555429|FG002|Phase 2|Disease progression|0|||
127706406|NCT02240238|459555430|FG003|Phase 2|Disease progression|0|||
127706407|NCT02240238|459555431|FG004|Phase 2|Disease progression|0|||
127798870|NCT05064059|459887925|FG000|Overall Study|Death|199|||
127706408|NCT02240238|459555432|FG005|Phase 2|Disease progression|0|||
127706409|NCT02240238|459555433|FG006|Phase 2|Disease progression|0|||
127706410|NCT02240238|459555434|FG007|Phase 2|Disease progression|0|||
127706411|NCT02240238|459555435|FG008|Phase 2|Disease progression|0|||
127706412|NCT02240238|459555436|FG009|Phase 2|Disease progression|5|||
127706413|NCT02240238|459555437|FG010|Phase 2|Disease progression|11|||
127706414|NCT02240238|459555438|FG011|Phase 2|Disease progression|1|||
127706415|NCT02240238|459555427|FG000|Phase 2|Withdrawal by Subject|0|||
127706416|NCT02240238|459555428|FG001|Phase 2|Withdrawal by Subject|0|||
127706417|NCT02240238|459555429|FG002|Phase 2|Withdrawal by Subject|0|||
127706418|NCT02240238|459555430|FG003|Phase 2|Withdrawal by Subject|0|||
127706419|NCT02240238|459555431|FG004|Phase 2|Withdrawal by Subject|0|||
127706420|NCT02240238|459555432|FG005|Phase 2|Withdrawal by Subject|0|||
127706421|NCT02240238|459555433|FG006|Phase 2|Withdrawal by Subject|0|||
127706422|NCT02240238|459555434|FG007|Phase 2|Withdrawal by Subject|0|||
127706423|NCT02240238|459555435|FG008|Phase 2|Withdrawal by Subject|0|||
127706424|NCT02240238|459555436|FG009|Phase 2|Withdrawal by Subject|1|||
127706425|NCT02240238|459555437|FG010|Phase 2|Withdrawal by Subject|1|||
127706426|NCT02240238|459555438|FG011|Phase 2|Withdrawal by Subject|0|||
127706427|NCT02240238|459555427|FG000|Phase 2|Physician Decision|0|||
127706428|NCT02240238|459555428|FG001|Phase 2|Physician Decision|0|||
127706429|NCT02240238|459555429|FG002|Phase 2|Physician Decision|0|||
127706430|NCT02240238|459555430|FG003|Phase 2|Physician Decision|0|||
127706431|NCT02240238|459555431|FG004|Phase 2|Physician Decision|0|||
127706432|NCT02240238|459555432|FG005|Phase 2|Physician Decision|0|||
127706433|NCT02240238|459555433|FG006|Phase 2|Physician Decision|0|||
127706434|NCT02240238|459555434|FG007|Phase 2|Physician Decision|0|||
127706435|NCT02240238|459555435|FG008|Phase 2|Physician Decision|0|||
127706436|NCT02240238|459555436|FG009|Phase 2|Physician Decision|1|||
127706437|NCT02240238|459555437|FG010|Phase 2|Physician Decision|3|||
127706438|NCT02240238|459555438|FG011|Phase 2|Physician Decision|0|||
127706439|NCT02240238|459555427|FG000|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
127706440|NCT02240238|459555428|FG001|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
127706441|NCT02240238|459555429|FG002|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
127706442|NCT02240238|459555430|FG003|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
127706443|NCT02240238|459555431|FG004|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
127706444|NCT02240238|459555432|FG005|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
127798871|NCT05064059|459887926|FG001|Overall Study|Death|196|||
127643748|NCT01302847|459315332|FG005|Overall Study|Site unable to contact participant|0|||
127643749|NCT01302847|459315333|FG006|Overall Study|Site unable to contact participant|2|||
127643750|NCT01302847|459315334|FG007|Overall Study|Site unable to contact participant|0|||
127643751|NCT04302350|459315337|FG000|Overall Study|Physician Decision|1|||
127643752|NCT04302350|459315338|FG001|Overall Study|Physician Decision|1|||
127643753|NCT04302350|459315339|FG002|Overall Study|Physician Decision|2|||
127643754|NCT04302350|459315337|FG000|Overall Study|Lack of Efficacy|1|||
127643755|NCT04302350|459315338|FG001|Overall Study|Lack of Efficacy|1|||
127643756|NCT04302350|459315339|FG002|Overall Study|Lack of Efficacy|4|||
127643757|NCT04302350|459315337|FG000|Overall Study|Adverse Event|0|||
127643758|NCT04302350|459315338|FG001|Overall Study|Adverse Event|1|||
127643759|NCT04302350|459315339|FG002|Overall Study|Adverse Event|2|||
127643760|NCT00374322|459315342|FG000|Overall Study|Lost to Follow-up|92|||
127643761|NCT00374322|459315343|FG001|Overall Study|Lost to Follow-up|90|||
127643762|NCT00374322|459315342|FG000|Overall Study|Protocol Violation|8|||
127643763|NCT00374322|459315343|FG001|Overall Study|Protocol Violation|3|||
127643764|NCT00374322|459315342|FG000|Overall Study|Withdrawal by Subject|235|||
127643765|NCT00374322|459315343|FG001|Overall Study|Withdrawal by Subject|167|||
127643766|NCT00374322|459315342|FG000|Overall Study|Sponsor Terminated Study|866|||
127643767|NCT00374322|459315343|FG001|Overall Study|Sponsor Terminated Study|990|||
127643768|NCT00374322|459315342|FG000|Overall Study|Physician Decision|36|||
127643769|NCT00374322|459315343|FG001|Overall Study|Physician Decision|32|||
127643770|NCT00374322|459315342|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
127643771|NCT00374322|459315343|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
127798872|NCT05064059|459887925|FG000|Overall Study|Physician Decision|4|||
127643772|NCT00374322|459315342|FG000|Overall Study|Sponsor Decision|2|||
127643773|NCT00374322|459315343|FG001|Overall Study|Sponsor Decision|3|||
127643774|NCT00374322|459315342|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
127643775|NCT00374322|459315343|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
127643776|NCT00374322|459315342|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
127643777|NCT00374322|459315343|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
127643778|NCT00374322|459315342|FG000|Overall Study|Severe Toxicity|1|||
127643779|NCT00374322|459315343|FG001|Overall Study|Severe Toxicity|0|||
127643780|NCT00374322|459315342|FG000|Overall Study|Site Closed|2|||
127643781|NCT00374322|459315343|FG001|Overall Study|Site Closed|2|||
127643782|NCT00374322|459315342|FG000|Overall Study|Participant Changed Physician|1|||
127643783|NCT00374322|459315343|FG001|Overall Study|Participant Changed Physician|0|||
127643784|NCT00374322|459315342|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
127643785|NCT00374322|459315343|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
127643786|NCT00374322|459315342|FG000|Overall Study|Noncompliance with Study Requirements|0|||
127643787|NCT00374322|459315343|FG001|Overall Study|Noncompliance with Study Requirements|1|||
127643788|NCT00374322|459315342|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
127643789|NCT00374322|459315343|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
127643790|NCT00374322|459315342|FG000|Overall Study|Did Not Receive Study Medication|8|||
127643791|NCT00374322|459315343|FG001|Overall Study|Did Not Receive Study Medication|6|||
127643792|NCT02012491|459315344|FG000|Overall Study|Lost to Follow-up|1|||
127643793|NCT02012491|459315345|FG001|Overall Study|Lost to Follow-up|0|||
127643794|NCT02012491|459315344|FG000|Overall Study|Protocol Violation|0|||
127643795|NCT02012491|459315345|FG001|Overall Study|Protocol Violation|1|||
127643796|NCT02012491|459315344|FG000|Overall Study|Withdrawal by Subject|1|||
127643797|NCT02012491|459315345|FG001|Overall Study|Withdrawal by Subject|0|||
127643798|NCT00450411|459315346|FG000|Overall Study|Protocol Violation|6|||
127643799|NCT00450411|459315346|FG000|Overall Study|No protocol treatment|2|||
127643800|NCT03969719|459315357|FG000|Overall Study|Other reasons not specified|1|||
127643801|NCT03969719|459315358|FG001|Overall Study|Other reasons not specified|1|||
127643802|NCT03969719|459315359|FG002|Overall Study|Other reasons not specified|3|||
127643803|NCT03969719|459315357|FG000|Overall Study|Withdrawal by Subject|2|||
127643804|NCT03969719|459315358|FG001|Overall Study|Withdrawal by Subject|3|||
127643805|NCT03969719|459315359|FG002|Overall Study|Withdrawal by Subject|2|||
127643806|NCT03969719|459315357|FG000|Overall Study|Protocol Violation|1|||
127643807|NCT03969719|459315358|FG001|Overall Study|Protocol Violation|2|||
127643808|NCT03969719|459315359|FG002|Overall Study|Protocol Violation|0|||
127643809|NCT03969719|459315357|FG000|Overall Study|Adverse Event|0|||
127643810|NCT03969719|459315358|FG001|Overall Study|Adverse Event|2|||
127643811|NCT03969719|459315359|FG002|Overall Study|Adverse Event|0|||
127798873|NCT05064059|459887926|FG001|Overall Study|Physician Decision|2|||
127643812|NCT03969719|459315357|FG000|Overall Study|Lost to Follow-up|0|||
127643813|NCT03969719|459315358|FG001|Overall Study|Lost to Follow-up|1|||
127643814|NCT03969719|459315359|FG002|Overall Study|Lost to Follow-up|0|||
127643815|NCT02130193|459315363|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
127643816|NCT02130193|459315364|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
127643817|NCT02130193|459315365|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
127643818|NCT02130193|459315363|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
127643819|NCT02130193|459315364|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
127643820|NCT02130193|459315365|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
127643821|NCT02130193|459315363|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
127643822|NCT02130193|459315364|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
127887712|NCT01154127|460211946|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
127887713|NCT01154127|460211947|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
127887714|NCT01154127|460211946|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
127887715|NCT01154127|460211947|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
127887716|NCT01697449|460211948|FG000|Overall Study|Disease progression|47|||
127887717|NCT01697449|460211948|FG000|Overall Study|Adverse Event|7|||
127887718|NCT01697449|460211948|FG000|Overall Study|Lost to Follow-up|5|||
127887719|NCT01697449|460211948|FG000|Overall Study|Withdrawal by Subject|2|||
127887720|NCT01697449|460211948|FG000|Overall Study|Physician Decision|1|||
127887721|NCT01697449|460211948|FG000|Overall Study|Death|2|||
127887722|NCT01697449|460211948|FG000|Overall Study|Other|1|||
127887723|NCT01697449|460211948|FG000|Overall Study|Missing|25|||
127887724|NCT02390219|460211949|FG000|Overall Study|Death|1|||
127887725|NCT02390219|460211949|FG000|Overall Study|Physician Decision|1|||
127887726|NCT02390219|460211949|FG000|Overall Study|Adverse Event|6|||
127887727|NCT02390219|460211949|FG000|Overall Study|Withdrawal by Subject|1|||
127643823|NCT02130193|459315365|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
127643824|NCT02130193|459315363|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
127643825|NCT02130193|459315364|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
127643826|NCT02130193|459315365|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
127643827|NCT01297959|459315366|FG000|Overall Study|Adverse Event|0|||
127643828|NCT01297959|459315367|FG001|Overall Study|Adverse Event|1|||
127643829|NCT01297959|459315366|FG000|Overall Study|Protocol Violation|2|||
127643830|NCT01297959|459315367|FG001|Overall Study|Protocol Violation|1|||
127643831|NCT01297959|459315366|FG000|Overall Study|Withdrawal by Subject|5|||
127643832|NCT01297959|459315367|FG001|Overall Study|Withdrawal by Subject|4|||
127643833|NCT01297959|459315366|FG000|Overall Study|Physician Decision|0|||
127643834|NCT01297959|459315367|FG001|Overall Study|Physician Decision|1|||
127643835|NCT01297959|459315366|FG000|Overall Study|Unrelated medical illness / complication|0|||
127643836|NCT01297959|459315367|FG001|Overall Study|Unrelated medical illness / complication|2|||
127643837|NCT01297959|459315366|FG000|Overall Study|Other|13|||
127643838|NCT01297959|459315367|FG001|Overall Study|Other|7|||
127643839|NCT01667432|459315368|FG000|Overall Study|Premature Study Termination|26|||
127643840|NCT01667432|459315368|FG000|Overall Study|Failure to Return|10|||
127643841|NCT01667432|459315368|FG000|Overall Study|Moved to Another Center|3|||
127643842|NCT01667432|459315368|FG000|Overall Study|Lost to Follow-up|3|||
127643843|NCT01667432|459315368|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
127643844|NCT01667432|459315368|FG000|Overall Study|Insufficient Therapeutic Response|4|||
127643845|NCT01667432|459315368|FG000|Overall Study|Adverse Event|1|||
127643846|NCT01667432|459315368|FG000|Overall Study|Protocol Deviation|2|||
127643847|NCT01667432|459315368|FG000|Overall Study|Principal Investigator Decision|1|||
127643848|NCT01667432|459315368|FG000|Overall Study|Reason Not Specified|2|||
127643849|NCT01667432|459315368|FG000|Overall Study|Missing Information|4|||
127643850|NCT02077166|459315369|FG000|Overall Study|Death|6|||
127643851|NCT02077166|459315370|FG001|Overall Study|Death|7|||
127643852|NCT02077166|459315371|FG002|Overall Study|Death|5|||
127643853|NCT02077166|459315372|FG003|Overall Study|Death|6|||
127643854|NCT02077166|459315373|FG004|Overall Study|Death|4|||
127706445|NCT02240238|459555433|FG006|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
127706446|NCT02240238|459555434|FG007|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
127643855|NCT02077166|459315374|FG005|Overall Study|Death|32|||
127643856|NCT02077166|459315375|FG006|Overall Study|Death|22|||
127643857|NCT02077166|459315369|FG000|Overall Study|Study Closure by Sponsor|3|||
127643858|NCT02077166|459315370|FG001|Overall Study|Study Closure by Sponsor|0|||
127706447|NCT02240238|459555435|FG008|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
127706448|NCT02240238|459555436|FG009|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|1|||
127706449|NCT02240238|459555437|FG010|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
127643859|NCT02077166|459315371|FG002|Overall Study|Study Closure by Sponsor|2|||
127706450|NCT02240238|459555438|FG011|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
127706451|NCT02240238|459555427|FG000|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
127706452|NCT02240238|459555428|FG001|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
127706453|NCT02240238|459555429|FG002|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
127706454|NCT02240238|459555430|FG003|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
127706455|NCT02240238|459555431|FG004|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
127706456|NCT02240238|459555432|FG005|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
127706457|NCT02240238|459555433|FG006|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
127706458|NCT02240238|459555434|FG007|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
127706459|NCT02240238|459555435|FG008|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
127706460|NCT02240238|459555436|FG009|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|1|||
127706461|NCT02240238|459555437|FG010|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
127706462|NCT02240238|459555438|FG011|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
127706463|NCT02240238|459555427|FG000|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
127706464|NCT02240238|459555428|FG001|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
127706465|NCT02240238|459555429|FG002|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
127706466|NCT02240238|459555430|FG003|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
127706467|NCT02240238|459555431|FG004|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
127706468|NCT02240238|459555432|FG005|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
127706469|NCT02240238|459555433|FG006|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
127706470|NCT02240238|459555434|FG007|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
127706471|NCT02240238|459555435|FG008|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
127706472|NCT02240238|459555436|FG009|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
127643860|NCT02077166|459315372|FG003|Overall Study|Study Closure by Sponsor|2|||
127643861|NCT02077166|459315373|FG004|Overall Study|Study Closure by Sponsor|2|||
127643862|NCT02077166|459315374|FG005|Overall Study|Study Closure by Sponsor|12|||
127643863|NCT02077166|459315375|FG006|Overall Study|Study Closure by Sponsor|4|||
127643864|NCT02077166|459315369|FG000|Overall Study|Lost to Follow-up|0|||
127643865|NCT02077166|459315370|FG001|Overall Study|Lost to Follow-up|0|||
127643866|NCT02077166|459315371|FG002|Overall Study|Lost to Follow-up|0|||
127643867|NCT02077166|459315372|FG003|Overall Study|Lost to Follow-up|0|||
127643868|NCT02077166|459315373|FG004|Overall Study|Lost to Follow-up|0|||
127643869|NCT02077166|459315374|FG005|Overall Study|Lost to Follow-up|1|||
127643870|NCT02077166|459315375|FG006|Overall Study|Lost to Follow-up|0|||
127643871|NCT02077166|459315369|FG000|Overall Study|Withdrawal by Subject|3|||
127643872|NCT02077166|459315370|FG001|Overall Study|Withdrawal by Subject|0|||
127643873|NCT02077166|459315371|FG002|Overall Study|Withdrawal by Subject|1|||
127643874|NCT02077166|459315372|FG003|Overall Study|Withdrawal by Subject|1|||
127643875|NCT02077166|459315373|FG004|Overall Study|Withdrawal by Subject|1|||
127643876|NCT02077166|459315374|FG005|Overall Study|Withdrawal by Subject|3|||
127643877|NCT02077166|459315375|FG006|Overall Study|Withdrawal by Subject|0|||
127643878|NCT02077166|459315369|FG000|Overall Study|Other, Not Specified|0|||
127643879|NCT02077166|459315370|FG001|Overall Study|Other, Not Specified|0|||
127643880|NCT02077166|459315371|FG002|Overall Study|Other, Not Specified|1|||
127643881|NCT02077166|459315372|FG003|Overall Study|Other, Not Specified|0|||
127643882|NCT02077166|459315373|FG004|Overall Study|Other, Not Specified|1|||
127643883|NCT02077166|459315374|FG005|Overall Study|Other, Not Specified|7|||
127643884|NCT02077166|459315375|FG006|Overall Study|Other, Not Specified|8|||
127643885|NCT00707031|459315376|FG000|Overall Study|Adverse Event|45|||
127643886|NCT00707031|459315377|FG001|Overall Study|Adverse Event|45|||
127643887|NCT00707031|459315376|FG000|Overall Study|Lack of Efficacy|19|||
127643888|NCT00707031|459315377|FG001|Overall Study|Lack of Efficacy|6|||
127643889|NCT00707031|459315376|FG000|Overall Study|Lost to Follow-up|2|||
127643890|NCT00707031|459315377|FG001|Overall Study|Lost to Follow-up|1|||
127643891|NCT00707031|459315376|FG000|Overall Study|Protocol Violation|1|||
127643892|NCT00707031|459315377|FG001|Overall Study|Protocol Violation|0|||
127643893|NCT00707031|459315376|FG000|Overall Study|Withdrawal by Subject|7|||
127643894|NCT00707031|459315377|FG001|Overall Study|Withdrawal by Subject|8|||
127643895|NCT00707031|459315376|FG000|Overall Study|Poor Compliance to Protocol|7|||
127887728|NCT02390219|460211949|FG000|Overall Study|Lost to Follow-up|2|||
127887729|NCT02390219|460211949|FG000|Overall Study|Other|2|||
127643896|NCT00707031|459315377|FG001|Overall Study|Poor Compliance to Protocol|13|||
127643897|NCT00707031|459315376|FG000|Overall Study|Familial or Personal Reasons|12|||
127643898|NCT00707031|459315377|FG001|Overall Study|Familial or Personal Reasons|15|||
127643899|NCT00707031|459315376|FG000|Overall Study|Serious Noncompliance|2|||
127643900|NCT00707031|459315377|FG001|Overall Study|Serious Noncompliance|3|||
127643901|NCT00707031|459315376|FG000|Overall Study|Sponsor Decision|9|||
127643902|NCT00707031|459315377|FG001|Overall Study|Sponsor Decision|8|||
127706473|NCT02240238|459555437|FG010|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|1|||
127706474|NCT02240238|459555438|FG011|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
127706475|NCT02240238|459555427|FG000|Phase 2|TREATMENT DELAY >14 DAYS|0|||
127706476|NCT02240238|459555428|FG001|Phase 2|TREATMENT DELAY >14 DAYS|0|||
127706477|NCT02240238|459555429|FG002|Phase 2|TREATMENT DELAY >14 DAYS|0|||
127706478|NCT02240238|459555430|FG003|Phase 2|TREATMENT DELAY >14 DAYS|0|||
127706479|NCT02240238|459555431|FG004|Phase 2|TREATMENT DELAY >14 DAYS|0|||
127706480|NCT02240238|459555432|FG005|Phase 2|TREATMENT DELAY >14 DAYS|0|||
127706481|NCT02240238|459555433|FG006|Phase 2|TREATMENT DELAY >14 DAYS|0|||
127706482|NCT02240238|459555434|FG007|Phase 2|TREATMENT DELAY >14 DAYS|0|||
127706483|NCT02240238|459555435|FG008|Phase 2|TREATMENT DELAY >14 DAYS|0|||
127706484|NCT02240238|459555436|FG009|Phase 2|TREATMENT DELAY >14 DAYS|0|||
127887730|NCT01169844|460211950|FG000|Overall Study|Adverse Event|0|||
127887731|NCT01169844|460211951|FG001|Overall Study|Adverse Event|1|||
127706485|NCT02240238|459555437|FG010|Phase 2|TREATMENT DELAY >14 DAYS|1|||
127798874|NCT05064059|459887925|FG000|Overall Study|Sponsor Decision|14|||
127798875|NCT05064059|459887926|FG001|Overall Study|Sponsor Decision|11|||
127798876|NCT05064059|459887925|FG000|Overall Study|Withdrawal by Subject|4|||
127798877|NCT05064059|459887926|FG001|Overall Study|Withdrawal by Subject|11|||
127798878|NCT01934140|459887927|FG000|Persistence Phase (Year 6-10)|Other|24|||
127798879|NCT01934140|459887928|FG001|Persistence Phase (Year 6-10)|Other|6|||
127798880|NCT01934140|459887927|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
127798881|NCT01934140|459887928|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
127798882|NCT01934140|459887927|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
127798883|NCT01934140|459887928|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
127798884|NCT01934140|459887927|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
127798885|NCT01934140|459887928|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
127798886|NCT01934140|459887927|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
127798887|NCT01934140|459887928|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
127798888|NCT01934140|459887927|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
127798889|NCT01934140|459887928|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
127798890|NCT01934140|459887927|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
127798891|NCT01934140|459887928|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
127798892|NCT01934140|459887927|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
127798893|NCT01934140|459887928|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
127798894|NCT00805740|459887929|FG000|Overall Study|Death|7|||
127798895|NCT00805740|459887930|FG001|Overall Study|Death|4|||
127798896|NCT00805740|459887929|FG000|Overall Study|Withdrawal by Subject|1|||
127798897|NCT00805740|459887930|FG001|Overall Study|Withdrawal by Subject|0|||
127887732|NCT01169844|460211950|FG000|Overall Study|Patient withdrew consent|4|||
127887733|NCT01169844|460211951|FG001|Overall Study|Patient withdrew consent|0|||
127643903|NCT01389973|459315383|FG000|Overall Study|Lost to Follow-up|1|||
127643904|NCT01389973|459315383|FG000|Overall Study|Trial Stopped by Sponsor|9|||
127643905|NCT01389973|459315383|FG000|Overall Study|Other|10|||
127643906|NCT02626780|459315384|FG000|Overall Study|Withdrawal by Subject|3|||
127643907|NCT03456700|459315385|FG000|Overall Study|Withdrawal by Subject|1|||
127643908|NCT04154787|459315386|FG000|Overall Study|Adverse Event|0|||
127643909|NCT04154787|459315387|FG001|Overall Study|Adverse Event|1|||
127643910|NCT04154787|459315388|FG002|Overall Study|Adverse Event|0|||
127643911|NCT04154787|459315386|FG000|Overall Study|Patient Requires Other Treatment|0|||
127643912|NCT04154787|459315387|FG001|Overall Study|Patient Requires Other Treatment|1|||
127643913|NCT04154787|459315388|FG002|Overall Study|Patient Requires Other Treatment|0|||
127643914|NCT04154787|459315386|FG000|Overall Study|Study Terminated By Sponsor|0|||
127643915|NCT04154787|459315387|FG001|Overall Study|Study Terminated By Sponsor|6|||
127643916|NCT04154787|459315388|FG002|Overall Study|Study Terminated By Sponsor|1|||
127643917|NCT04154787|459315386|FG000|Overall Study|Subject Decision|0|||
127643918|NCT04154787|459315387|FG001|Overall Study|Subject Decision|1|||
127643919|NCT04154787|459315388|FG002|Overall Study|Subject Decision|0|||
127643920|NCT04154787|459315386|FG000|Overall Study|Suspected Lack Of Efficacy|0|||
127643921|NCT04154787|459315387|FG001|Overall Study|Suspected Lack Of Efficacy|1|||
127643922|NCT04154787|459315388|FG002|Overall Study|Suspected Lack Of Efficacy|0|||
127643923|NCT00003508|459317193|FG000|Overall Study|Not evaluable|5|||
127643924|NCT04918784|459317194|FG000|Overall Study|Amputation - no longer eligible|1|||
127643925|NCT04918784|459317195|FG001|Overall Study|Amputation - no longer eligible|2|||
127643926|NCT04918784|459317194|FG000|Overall Study|Death|1|||
127643927|NCT04918784|459317195|FG001|Overall Study|Death|0|||
127643928|NCT04918784|459317194|FG000|Overall Study|patient non-compliance|3|||
127643929|NCT04918784|459317195|FG001|Overall Study|patient non-compliance|1|||
127643930|NCT04918784|459317194|FG000|Overall Study|Adverse Event|1|||
127643931|NCT04918784|459317195|FG001|Overall Study|Adverse Event|0|||
127643932|NCT01712009|459317196|FG000|Overall Study|Withdrawal by Subject|24|||
127643933|NCT01712009|459317197|FG001|Overall Study|Withdrawal by Subject|15|||
127643934|NCT01712009|459317198|FG002|Overall Study|Withdrawal by Subject|8|||
127643935|NCT01712009|459317196|FG000|Overall Study|Lost to Follow-up|2|||
127643936|NCT01712009|459317197|FG001|Overall Study|Lost to Follow-up|0|||
127643937|NCT01712009|459317198|FG002|Overall Study|Lost to Follow-up|1|||
127643938|NCT01712009|459317196|FG000|Overall Study|Decision by Sponsor|12|||
127643939|NCT01712009|459317197|FG001|Overall Study|Decision by Sponsor|14|||
127643940|NCT01712009|459317198|FG002|Overall Study|Decision by Sponsor|12|||
127643941|NCT01377480|459317199|FG000|Overall Study|Protocol Violation|0|||
127643942|NCT01377480|459317200|FG001|Overall Study|Protocol Violation|0|||
127643943|NCT01377480|459317201|FG002|Overall Study|Protocol Violation|0|||
127643944|NCT01377480|459317202|FG003|Overall Study|Protocol Violation|4|||
127643945|NCT01377480|459317199|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
127643946|NCT01377480|459317200|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
127643947|NCT01377480|459317201|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
127643948|NCT01377480|459317202|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
127643949|NCT01377480|459317199|FG000|Overall Study|Withdrawal by Subject|0|||
127643950|NCT01377480|459317200|FG001|Overall Study|Withdrawal by Subject|0|||
127643951|NCT01377480|459317201|FG002|Overall Study|Withdrawal by Subject|1|||
127643952|NCT01377480|459317202|FG003|Overall Study|Withdrawal by Subject|0|||
127643953|NCT01377480|459317199|FG000|Overall Study|Serious adverse event|0|||
127643954|NCT01377480|459317200|FG001|Overall Study|Serious adverse event|0|||
127643955|NCT01377480|459317201|FG002|Overall Study|Serious adverse event|1|||
127643956|NCT01377480|459317202|FG003|Overall Study|Serious adverse event|1|||
127643957|NCT01377480|459317199|FG000|Overall Study|Other|0|||
127643958|NCT01377480|459317200|FG001|Overall Study|Other|0|||
127643959|NCT01377480|459317201|FG002|Overall Study|Other|7|||
127643960|NCT01377480|459317202|FG003|Overall Study|Other|6|||
127643961|NCT03576768|459317206|FG000|Overall Study|Lost to Follow-up|3|||
127643962|NCT03576768|459317207|FG001|Overall Study|Lost to Follow-up|3|||
127643963|NCT03576768|459317208|FG002|Overall Study|Lost to Follow-up|0|||
127643964|NCT03576768|459317209|FG003|Overall Study|Lost to Follow-up|0|||
127643965|NCT00590902|459317210|FG000|Overall Study|Death|1|||
127643966|NCT01986881|459317214|FG000|Overall Study|Death|228|||
127643967|NCT01986881|459317215|FG001|Overall Study|Death|233|||
127643968|NCT01986881|459317216|FG002|Overall Study|Death|247|||
127643969|NCT01986881|459317214|FG000|Overall Study|Lost to Follow-up|51|||
127643970|NCT01986881|459317215|FG001|Overall Study|Lost to Follow-up|44|||
127643971|NCT01986881|459317216|FG002|Overall Study|Lost to Follow-up|55|||
127643972|NCT01986881|459317214|FG000|Overall Study|Physician Decision|7|||
127643973|NCT01986881|459317215|FG001|Overall Study|Physician Decision|4|||
127643974|NCT01986881|459317216|FG002|Overall Study|Physician Decision|6|||
127643975|NCT01986881|459317214|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
127643976|NCT01986881|459317215|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
127643977|NCT01986881|459317216|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
127643978|NCT01986881|459317214|FG000|Overall Study|Withdrawal by Subject|41|||
127643979|NCT01986881|459317215|FG001|Overall Study|Withdrawal by Subject|60|||
127643980|NCT01986881|459317216|FG002|Overall Study|Withdrawal by Subject|45|||
127643981|NCT01986881|459317214|FG000|Overall Study|Subject Moved|0|||
127643982|NCT01986881|459317215|FG001|Overall Study|Subject Moved|1|||
127643983|NCT01986881|459317216|FG002|Overall Study|Subject Moved|0|||
127643984|NCT01986881|459317214|FG000|Overall Study|Other|1|||
127643985|NCT01986881|459317215|FG001|Overall Study|Other|2|||
127643986|NCT01986881|459317216|FG002|Overall Study|Other|2|||
127643987|NCT02586025|459317226|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
127643988|NCT02586025|459317227|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
127643989|NCT02586025|459317226|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
127643990|NCT02586025|459317227|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
127706486|NCT02240238|459555438|FG011|Phase 2|TREATMENT DELAY >14 DAYS|0|||
127706487|NCT02240238|459555427|FG000|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
127706488|NCT02240238|459555428|FG001|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
127643991|NCT02586025|459317226|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
127706489|NCT02240238|459555429|FG002|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
127643992|NCT02586025|459317227|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
127643993|NCT02586025|459317226|FG000|Neoadjuvant Treatment|Death|1|||
127643994|NCT02586025|459317227|FG001|Neoadjuvant Treatment|Death|0|||
127643995|NCT02586025|459317226|FG000|Neoadjuvant Treatment|Adverse Event|1|||
127643996|NCT02586025|459317227|FG001|Neoadjuvant Treatment|Adverse Event|0|||
127643997|NCT02586025|459317226|FG000|Neoadjuvant Treatment|Physician Decision|2|||
127643998|NCT02586025|459317227|FG001|Neoadjuvant Treatment|Physician Decision|1|||
127643999|NCT02586025|459317226|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
127644000|NCT02586025|459317227|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
127644001|NCT02586025|459317226|FG000|Adjuvant Treatment|Recurrent Disease|4|||
127644002|NCT02586025|459317227|FG001|Adjuvant Treatment|Recurrent Disease|5|||
127644003|NCT02586025|459317226|FG000|Adjuvant Treatment|Physician Decision|0|||
127644004|NCT02586025|459317227|FG001|Adjuvant Treatment|Physician Decision|1|||
127644005|NCT02586025|459317226|FG000|Adjuvant Treatment|Pregnancy|1|||
127887734|NCT01169844|460211950|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
127887735|NCT01169844|460211951|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
127887736|NCT05037409|460211952|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
127644006|NCT02586025|459317227|FG001|Adjuvant Treatment|Pregnancy|0|||
127644007|NCT02586025|459317226|FG000|Treatment-Free Follow-Up|Death|11|||
127644008|NCT02586025|459317227|FG001|Treatment-Free Follow-Up|Death|11|||
127644009|NCT02586025|459317226|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
127798898|NCT00805740|459887929|FG000|Overall Study|Lost to Follow-up|1|||
127887737|NCT05037409|460211953|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
127887738|NCT05037409|460211954|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
127887739|NCT00529568|460211955|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
127887740|NCT00529568|460211956|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
127887741|NCT00529568|460211957|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
127887742|NCT00529568|460211955|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
127887743|NCT00529568|460211956|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
127887744|NCT00529568|460211957|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
127887745|NCT00529568|460211955|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
127887746|NCT00529568|460211956|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
127887747|NCT00529568|460211957|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
127887748|NCT00529568|460211955|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
127887749|NCT00529568|460211956|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
127887750|NCT00529568|460211957|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
127706490|NCT02240238|459555430|FG003|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
127706491|NCT02240238|459555431|FG004|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
127706492|NCT02240238|459555432|FG005|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
127706493|NCT02240238|459555433|FG006|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
127706494|NCT02240238|459555434|FG007|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
127706495|NCT02240238|459555435|FG008|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
127706496|NCT02240238|459555436|FG009|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
127706497|NCT02240238|459555437|FG010|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|1|||
127706498|NCT02240238|459555438|FG011|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
127706499|NCT02240238|459555427|FG000|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
127706500|NCT02240238|459555428|FG001|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
127706501|NCT02240238|459555429|FG002|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
127706502|NCT02240238|459555430|FG003|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
127706503|NCT02240238|459555431|FG004|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
127706504|NCT02240238|459555432|FG005|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
127706505|NCT02240238|459555433|FG006|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
127706506|NCT02240238|459555434|FG007|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
127706507|NCT02240238|459555435|FG008|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
127706508|NCT02240238|459555436|FG009|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
127706509|NCT02240238|459555437|FG010|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|1|||
127798899|NCT00805740|459887930|FG001|Overall Study|Lost to Follow-up|0|||
127798900|NCT00805740|459887929|FG000|Overall Study|Randomized, but not treated|2|||
127798901|NCT00805740|459887930|FG001|Overall Study|Randomized, but not treated|0|||
127644010|NCT02586025|459317227|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
127644011|NCT02586025|459317226|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
127644012|NCT02586025|459317227|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
127644013|NCT02586025|459317226|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
127644014|NCT02586025|459317227|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
127644015|NCT02586025|459317226|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
127644016|NCT02586025|459317227|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
127644017|NCT00175825|459317228|FG000|Overall Study|Adverse Event|3|||
127644018|NCT00175825|459317229|FG001|Overall Study|Adverse Event|2|||
127644019|NCT00175825|459317230|FG002|Overall Study|Adverse Event|1|||
127644020|NCT00175825|459317231|FG003|Overall Study|Adverse Event|1|||
127644021|NCT00175825|459317228|FG000|Overall Study|Lost to Follow-up|1|||
127644022|NCT00175825|459317229|FG001|Overall Study|Lost to Follow-up|2|||
127644023|NCT00175825|459317230|FG002|Overall Study|Lost to Follow-up|0|||
127644024|NCT00175825|459317231|FG003|Overall Study|Lost to Follow-up|0|||
127644025|NCT00175825|459317228|FG000|Overall Study|Withdrawal by Subject|1|||
127644026|NCT00175825|459317229|FG001|Overall Study|Withdrawal by Subject|0|||
127644027|NCT00175825|459317230|FG002|Overall Study|Withdrawal by Subject|0|||
127644028|NCT00175825|459317231|FG003|Overall Study|Withdrawal by Subject|0|||
127644029|NCT02030015|459317232|FG000|Overall Study|Withdrawal by Subject|3|||
127644030|NCT02030015|459317232|FG000|Overall Study|Death|13|||
127644031|NCT00608582|459317234|FG000|Overall Study|Lost to Follow-up|2|||
127644032|NCT00608582|459317235|FG001|Overall Study|Lost to Follow-up|0|||
127644033|NCT00608582|459317234|FG000|Overall Study|No Best Response in Phase 1 located|1|||
127644034|NCT00608582|459317235|FG001|Overall Study|No Best Response in Phase 1 located|1|||
127644035|NCT00608582|459317234|FG000|Overall Study|Illicit Drug Use|1|||
127644036|NCT00608582|459317235|FG001|Overall Study|Illicit Drug Use|0|||
127644037|NCT00608582|459317234|FG000|Overall Study|Early stage Design Change|0|||
127644038|NCT00608582|459317235|FG001|Overall Study|Early stage Design Change|3|||
127644039|NCT04279314|459317247|FG000|Overall Study|Adverse Event|55|||
127644040|NCT04279314|459317247|FG000|Overall Study|Withdrawal by Subject|5|||
127644041|NCT04279314|459317247|FG000|Overall Study|Lack of Efficacy|5|||
127644042|NCT04279314|459317247|FG000|Overall Study|Protocol Violation|3|||
127644043|NCT04279314|459317247|FG000|Overall Study|Other (not COVID-19 related)|2|||
127644044|NCT00160680|459317248|FG000|Overall Study|Adverse Event|0|||
127644045|NCT00160680|459317249|FG001|Overall Study|Adverse Event|1|||
127644046|NCT00160680|459317248|FG000|Overall Study|Lack of Efficacy|2|||
127644047|NCT00160680|459317249|FG001|Overall Study|Lack of Efficacy|1|||
127644048|NCT00160680|459317248|FG000|Overall Study|Lost to Follow-up|3|||
127644049|NCT00160680|459317249|FG001|Overall Study|Lost to Follow-up|2|||
127644050|NCT00160680|459317248|FG000|Overall Study|Withdrawal by Subject|4|||
127644051|NCT00160680|459317249|FG001|Overall Study|Withdrawal by Subject|9|||
127644052|NCT02450331|459317255|FG000|Overall Study|Death|162|||
127644053|NCT02450331|459317256|FG001|Overall Study|Death|171|||
127644054|NCT02450331|459317255|FG000|Overall Study|Lost to Follow-up|14|||
127644055|NCT02450331|459317256|FG001|Overall Study|Lost to Follow-up|12|||
127644056|NCT02450331|459317255|FG000|Overall Study|Withdrawal by Subject|55|||
127644057|NCT02450331|459317256|FG001|Overall Study|Withdrawal by Subject|44|||
127644058|NCT02450331|459317255|FG000|Overall Study|Non-specified other|1|||
127644059|NCT02450331|459317256|FG001|Overall Study|Non-specified other|1|||
127644060|NCT02723864|459317257|FG000|Overall Study|Refused further treatment|1|||
127644061|NCT02723864|459317258|FG001|Overall Study|Refused further treatment|0|||
127644062|NCT02723864|459317259|FG002|Overall Study|Refused further treatment|0|||
127644063|NCT02723864|459317260|FG003|Overall Study|Refused further treatment|0|||
127644064|NCT02723864|459317261|FG004|Overall Study|Refused further treatment|1|||
127644065|NCT02723864|459317262|FG005|Overall Study|Refused further treatment|2|||
127644066|NCT02723864|459317263|FG006|Overall Study|Refused further treatment|0|||
127706510|NCT02240238|459555438|FG011|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
127644067|NCT02723864|459317257|FG000|Overall Study|Exceed treatment hold time|0|||
127644068|NCT02723864|459317258|FG001|Overall Study|Exceed treatment hold time|1|||
127644069|NCT02723864|459317259|FG002|Overall Study|Exceed treatment hold time|0|||
127644070|NCT02723864|459317260|FG003|Overall Study|Exceed treatment hold time|0|||
127644071|NCT02723864|459317261|FG004|Overall Study|Exceed treatment hold time|0|||
127644072|NCT02723864|459317262|FG005|Overall Study|Exceed treatment hold time|0|||
127644073|NCT02723864|459317263|FG006|Overall Study|Exceed treatment hold time|0|||
127644074|NCT02723864|459317257|FG000|Overall Study|Clinical progression|0|||
127644075|NCT02723864|459317258|FG001|Overall Study|Clinical progression|0|||
127644076|NCT02723864|459317259|FG002|Overall Study|Clinical progression|1|||
127644077|NCT02723864|459317260|FG003|Overall Study|Clinical progression|0|||
127644078|NCT02723864|459317261|FG004|Overall Study|Clinical progression|0|||
127644079|NCT02723864|459317262|FG005|Overall Study|Clinical progression|3|||
127644080|NCT02723864|459317263|FG006|Overall Study|Clinical progression|1|||
127644081|NCT02723864|459317257|FG000|Overall Study|Physician Decision|0|||
127644082|NCT02723864|459317258|FG001|Overall Study|Physician Decision|0|||
127644083|NCT02723864|459317259|FG002|Overall Study|Physician Decision|0|||
127644084|NCT02723864|459317260|FG003|Overall Study|Physician Decision|0|||
127644085|NCT02723864|459317261|FG004|Overall Study|Physician Decision|0|||
127644086|NCT02723864|459317262|FG005|Overall Study|Physician Decision|0|||
127644087|NCT02723864|459317263|FG006|Overall Study|Physician Decision|1|||
127644088|NCT02723864|459317257|FG000|Overall Study|Changes in patient condition|0|||
127644089|NCT02723864|459317258|FG001|Overall Study|Changes in patient condition|0|||
127644090|NCT02723864|459317259|FG002|Overall Study|Changes in patient condition|0|||
127644091|NCT02723864|459317260|FG003|Overall Study|Changes in patient condition|0|||
127644092|NCT02723864|459317261|FG004|Overall Study|Changes in patient condition|0|||
127644093|NCT02723864|459317262|FG005|Overall Study|Changes in patient condition|1|||
127644094|NCT02723864|459317263|FG006|Overall Study|Changes in patient condition|0|||
127644095|NCT02723864|459317257|FG000|Overall Study|Patient choice|0|||
127644096|NCT02723864|459317258|FG001|Overall Study|Patient choice|0|||
127644097|NCT02723864|459317259|FG002|Overall Study|Patient choice|0|||
127644098|NCT02723864|459317260|FG003|Overall Study|Patient choice|0|||
127644099|NCT02723864|459317261|FG004|Overall Study|Patient choice|0|||
127644100|NCT02723864|459317262|FG005|Overall Study|Patient choice|1|||
127644101|NCT02723864|459317263|FG006|Overall Study|Patient choice|0|||
127644102|NCT02723864|459317257|FG000|Overall Study|Adverse Event|0|||
127644103|NCT02723864|459317258|FG001|Overall Study|Adverse Event|0|||
127644104|NCT02723864|459317259|FG002|Overall Study|Adverse Event|0|||
127644105|NCT02723864|459317260|FG003|Overall Study|Adverse Event|0|||
127644106|NCT02723864|459317261|FG004|Overall Study|Adverse Event|0|||
127644107|NCT02723864|459317262|FG005|Overall Study|Adverse Event|1|||
127644108|NCT02723864|459317263|FG006|Overall Study|Adverse Event|0|||
127644109|NCT02723864|459317257|FG000|Overall Study|Started new treatment|0|||
127644110|NCT02723864|459317258|FG001|Overall Study|Started new treatment|0|||
127644111|NCT02723864|459317259|FG002|Overall Study|Started new treatment|0|||
127644112|NCT02723864|459317260|FG003|Overall Study|Started new treatment|0|||
127644113|NCT02723864|459317261|FG004|Overall Study|Started new treatment|0|||
127644114|NCT02723864|459317262|FG005|Overall Study|Started new treatment|1|||
127644115|NCT02723864|459317263|FG006|Overall Study|Started new treatment|0|||
127644116|NCT02723864|459317257|FG000|Overall Study|Switched to alternative treatment|0|||
127644117|NCT02723864|459317258|FG001|Overall Study|Switched to alternative treatment|0|||
127644118|NCT02723864|459317259|FG002|Overall Study|Switched to alternative treatment|0|||
127644119|NCT02723864|459317260|FG003|Overall Study|Switched to alternative treatment|0|||
127644120|NCT02723864|459317261|FG004|Overall Study|Switched to alternative treatment|0|||
127644121|NCT02723864|459317262|FG005|Overall Study|Switched to alternative treatment|1|||
127644122|NCT02723864|459317263|FG006|Overall Study|Switched to alternative treatment|0|||
127644123|NCT02723864|459317257|FG000|Overall Study|Late determination of ineligibility|0|||
127644124|NCT02723864|459317258|FG001|Overall Study|Late determination of ineligibility|0|||
127644125|NCT02723864|459317259|FG002|Overall Study|Late determination of ineligibility|0|||
127644126|NCT02723864|459317260|FG003|Overall Study|Late determination of ineligibility|0|||
127644127|NCT02723864|459317261|FG004|Overall Study|Late determination of ineligibility|0|||
127644128|NCT02723864|459317262|FG005|Overall Study|Late determination of ineligibility|1|||
127644129|NCT02723864|459317263|FG006|Overall Study|Late determination of ineligibility|0|||
127644130|NCT03232983|459317266|FG000|Period 1|Physician Decision|0|||
127644131|NCT03232983|459317267|FG001|Period 1|Physician Decision|0|||
127644132|NCT03232983|459317268|FG002|Period 1|Physician Decision|1|||
127644133|NCT03232983|459317269|FG003|Period 1|Physician Decision|0|||
127644134|NCT03232983|459317266|FG000|Washout Period 2|Physician Decision|0|||
127644135|NCT03232983|459317267|FG001|Washout Period 2|Physician Decision|0|||
127644136|NCT03232983|459317268|FG002|Washout Period 2|Physician Decision|1|||
127644137|NCT03232983|459317269|FG003|Washout Period 2|Physician Decision|0|||
127644138|NCT03232983|459317266|FG000|Washout Period 2|Withdrawal by Subject|0|||
127644139|NCT03232983|459317267|FG001|Washout Period 2|Withdrawal by Subject|0|||
127644140|NCT03232983|459317268|FG002|Washout Period 2|Withdrawal by Subject|0|||
127644141|NCT03232983|459317269|FG003|Washout Period 2|Withdrawal by Subject|1|||
127644142|NCT03232983|459317266|FG000|Period 4|Withdrawal by Subject|1|||
127644143|NCT03232983|459317267|FG001|Period 4|Withdrawal by Subject|0|||
127644144|NCT03232983|459317268|FG002|Period 4|Withdrawal by Subject|0|||
127644145|NCT03232983|459317269|FG003|Period 4|Withdrawal by Subject|0|||
127644146|NCT02548455|459317272|FG000|Overall Study|Withdrawal by Subject|27|||
127644147|NCT02548455|459317272|FG000|Overall Study|Death|26|||
127644148|NCT02548455|459317272|FG000|Overall Study|Lost to Follow-up|14|||
127644149|NCT02548455|459317272|FG000|Overall Study|Visit not completed|173|||
127644150|NCT02261493|459317277|FG000|Overall Study|Noncompliance|0|||
127706511|NCT02240238|459555427|FG000|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
127706512|NCT02240238|459555428|FG001|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
127644151|NCT02261493|459317278|FG001|Overall Study|Noncompliance|0|||
127644152|NCT02261493|459317279|FG002|Overall Study|Noncompliance|2|||
127644153|NCT02261493|459317277|FG000|Overall Study|Physician Decision|0|||
127644154|NCT02261493|459317278|FG001|Overall Study|Physician Decision|1|||
127644155|NCT02261493|459317279|FG002|Overall Study|Physician Decision|0|||
127644156|NCT02261493|459317277|FG000|Overall Study|Undisclosed alcohol abuse|0|||
127644157|NCT02261493|459317278|FG001|Overall Study|Undisclosed alcohol abuse|1|||
127644158|NCT02261493|459317279|FG002|Overall Study|Undisclosed alcohol abuse|0|||
127644159|NCT02261493|459317277|FG000|Overall Study|Protocol Violation|1|||
127644160|NCT02261493|459317278|FG001|Overall Study|Protocol Violation|0|||
127644161|NCT02261493|459317279|FG002|Overall Study|Protocol Violation|0|||
127644162|NCT02261493|459317277|FG000|Overall Study|Personal Reasons|14|||
127644163|NCT02261493|459317278|FG001|Overall Study|Personal Reasons|14|||
127644164|NCT02261493|459317279|FG002|Overall Study|Personal Reasons|16|||
127644165|NCT02261493|459317277|FG000|Overall Study|Lost to Follow-up|14|||
127644166|NCT02261493|459317278|FG001|Overall Study|Lost to Follow-up|27|||
127644167|NCT02261493|459317279|FG002|Overall Study|Lost to Follow-up|8|||
127644168|NCT02261493|459317277|FG000|Overall Study|Pregnancy|1|||
127644169|NCT02261493|459317278|FG001|Overall Study|Pregnancy|2|||
127644170|NCT02261493|459317279|FG002|Overall Study|Pregnancy|0|||
127644171|NCT02261493|459317277|FG000|Overall Study|Lack of Efficacy|0|||
127644172|NCT02261493|459317278|FG001|Overall Study|Lack of Efficacy|1|||
127644173|NCT02261493|459317279|FG002|Overall Study|Lack of Efficacy|0|||
127644174|NCT02261493|459317277|FG000|Overall Study|Adverse Event|0|||
127644175|NCT02261493|459317278|FG001|Overall Study|Adverse Event|1|||
127644176|NCT02261493|459317279|FG002|Overall Study|Adverse Event|0|||
127644177|NCT02436330|459317281|FG000|Cohort 1|Lost to Follow-up|5|||
127644178|NCT02436330|459317282|FG001|Cohort 1|Lost to Follow-up|2|||
127644179|NCT02436330|459317281|FG000|Cohort 1|Withdrawal by Subject|0|||
127644180|NCT02436330|459317282|FG001|Cohort 1|Withdrawal by Subject|1|||
127644181|NCT02436330|459317281|FG000|Cohort 2|Lost to Follow-up|2|||
127644182|NCT02436330|459317282|FG001|Cohort 2|Lost to Follow-up|0|||
127644183|NCT02436330|459317281|FG000|Cohort 2|Withdrawal by Subject|2|||
127644184|NCT02436330|459317282|FG001|Cohort 2|Withdrawal by Subject|3|||
127644185|NCT02436330|459317281|FG000|Cohort 3|Lost to Follow-up|1|||
127644186|NCT02436330|459317282|FG001|Cohort 3|Lost to Follow-up|0|||
127644187|NCT02436330|459317281|FG000|Cohort 3|Withdrawal by Subject|4|||
127644188|NCT02436330|459317282|FG001|Cohort 3|Withdrawal by Subject|0|||
127644189|NCT02436330|459317281|FG000|Cohort 4|Lost to Follow-up|1|||
127644190|NCT02436330|459317282|FG001|Cohort 4|Lost to Follow-up|0|||
127644191|NCT02436330|459317281|FG000|Cohort 4|Withdrawal by Subject|1|||
127706513|NCT02240238|459555429|FG002|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
127706514|NCT02240238|459555430|FG003|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
127706515|NCT02240238|459555431|FG004|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
127706516|NCT02240238|459555432|FG005|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
127706517|NCT02240238|459555433|FG006|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
127706518|NCT02240238|459555434|FG007|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
127798902|NCT00200850|459887931|FG000|Overall Study|relocation|1|||
127644192|NCT02436330|459317282|FG001|Cohort 4|Withdrawal by Subject|0|||
127644193|NCT02436330|459317281|FG000|Cohort 5|Lost to Follow-up|3|||
127644194|NCT02436330|459317282|FG001|Cohort 5|Lost to Follow-up|2|||
127644195|NCT02436330|459317281|FG000|Cohort 5|Withdrawal by Subject|3|||
127644196|NCT02436330|459317282|FG001|Cohort 5|Withdrawal by Subject|2|||
127644197|NCT02436330|459317281|FG000|Cohort 6|Lost to Follow-up|2|||
127644198|NCT02436330|459317282|FG001|Cohort 6|Lost to Follow-up|0|||
127644199|NCT02436330|459317281|FG000|Cohort 6|Withdrawal by Subject|1|||
127644200|NCT02436330|459317282|FG001|Cohort 6|Withdrawal by Subject|1|||
127644201|NCT00162370|459317287|FG000|Efficacy Population|Lost to Follow-up|51|||
127644202|NCT04575051|459317288|FG000|Time Period 0|Discontinued due to death or moving to higher level of care|15|||
127706519|NCT02240238|459555435|FG008|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
127706520|NCT02240238|459555436|FG009|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
127706521|NCT02240238|459555437|FG010|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|1|||
127706522|NCT02240238|459555438|FG011|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
127706523|NCT02240238|459555427|FG000|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
127706524|NCT02240238|459555428|FG001|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
127706525|NCT02240238|459555429|FG002|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
127706526|NCT02240238|459555430|FG003|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
127706527|NCT02240238|459555431|FG004|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
127706528|NCT02240238|459555432|FG005|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
127706529|NCT02240238|459555433|FG006|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
127706530|NCT02240238|459555434|FG007|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
127706531|NCT02240238|459555435|FG008|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
127706532|NCT02240238|459555436|FG009|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
127706533|NCT02240238|459555437|FG010|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
127706534|NCT02240238|459555438|FG011|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|1|||
127706535|NCT03519178|459555439|FG000|PF-06873600 Treatment|Adverse Event|0|||
127706536|NCT03519178|459555440|FG001|PF-06873600 Treatment|Adverse Event|0|||
127706537|NCT03519178|459555441|FG002|PF-06873600 Treatment|Adverse Event|0|||
127706538|NCT03519178|459555442|FG003|PF-06873600 Treatment|Adverse Event|0|||
127706539|NCT03519178|459555443|FG004|PF-06873600 Treatment|Adverse Event|0|||
127706540|NCT03519178|459555444|FG005|PF-06873600 Treatment|Adverse Event|0|||
127706541|NCT03519178|459555445|FG006|PF-06873600 Treatment|Adverse Event|0|||
127706542|NCT03519178|459555446|FG007|PF-06873600 Treatment|Adverse Event|2|||
127706543|NCT03519178|459555447|FG008|PF-06873600 Treatment|Adverse Event|1|||
127706544|NCT03519178|459555448|FG009|PF-06873600 Treatment|Adverse Event|0|||
127706545|NCT03519178|459555449|FG010|PF-06873600 Treatment|Adverse Event|0|||
127706546|NCT03519178|459555450|FG011|PF-06873600 Treatment|Adverse Event|0|||
127706547|NCT03519178|459555451|FG012|PF-06873600 Treatment|Adverse Event|1|||
127706548|NCT03519178|459555452|FG013|PF-06873600 Treatment|Adverse Event|3|||
127706549|NCT03519178|459555453|FG014|PF-06873600 Treatment|Adverse Event|2|||
127706550|NCT03519178|459555439|FG000|PF-06873600 Treatment|Death|0|||
127706551|NCT03519178|459555440|FG001|PF-06873600 Treatment|Death|0|||
127706552|NCT03519178|459555441|FG002|PF-06873600 Treatment|Death|0|||
127706553|NCT03519178|459555442|FG003|PF-06873600 Treatment|Death|0|||
127706554|NCT03519178|459555443|FG004|PF-06873600 Treatment|Death|0|||
127706555|NCT03519178|459555444|FG005|PF-06873600 Treatment|Death|0|||
127706556|NCT03519178|459555445|FG006|PF-06873600 Treatment|Death|0|||
127706557|NCT03519178|459555446|FG007|PF-06873600 Treatment|Death|0|||
127706558|NCT03519178|459555447|FG008|PF-06873600 Treatment|Death|1|||
127706559|NCT03519178|459555448|FG009|PF-06873600 Treatment|Death|1|||
127706560|NCT03519178|459555449|FG010|PF-06873600 Treatment|Death|0|||
127706561|NCT03519178|459555450|FG011|PF-06873600 Treatment|Death|0|||
127706562|NCT03519178|459555451|FG012|PF-06873600 Treatment|Death|0|||
127887751|NCT00529568|460211955|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
127706563|NCT03519178|459555452|FG013|PF-06873600 Treatment|Death|0|||
127706564|NCT03519178|459555453|FG014|PF-06873600 Treatment|Death|1|||
127706565|NCT03519178|459555439|FG000|PF-06873600 Treatment|Physician Decision|0|||
127706566|NCT03519178|459555440|FG001|PF-06873600 Treatment|Physician Decision|0|||
127706567|NCT03519178|459555441|FG002|PF-06873600 Treatment|Physician Decision|0|||
127798903|NCT00200850|459887932|FG001|Overall Study|relocation|0|||
127798904|NCT00200850|459887933|FG002|Overall Study|relocation|1|||
127798905|NCT00200850|459887931|FG000|Overall Study|too busy|1|||
127798906|NCT00200850|459887932|FG001|Overall Study|too busy|0|||
127798907|NCT00200850|459887933|FG002|Overall Study|too busy|0|||
127798908|NCT00200850|459887931|FG000|Overall Study|Pregnancy|0|||
127798909|NCT00200850|459887932|FG001|Overall Study|Pregnancy|0|||
127798910|NCT00200850|459887933|FG002|Overall Study|Pregnancy|1|||
127798911|NCT00200850|459887931|FG000|Overall Study|Poor adherence|0|||
127798912|NCT00200850|459887932|FG001|Overall Study|Poor adherence|0|||
127798913|NCT00200850|459887933|FG002|Overall Study|Poor adherence|1|||
127798914|NCT00200850|459887931|FG000|Overall Study|optic neuritis|0|||
127798915|NCT00200850|459887932|FG001|Overall Study|optic neuritis|0|||
127798916|NCT00200850|459887933|FG002|Overall Study|optic neuritis|1|||
127798917|NCT00200850|459887931|FG000|Overall Study|Adverse Event|1|||
127798918|NCT00200850|459887932|FG001|Overall Study|Adverse Event|1|||
127798919|NCT00200850|459887933|FG002|Overall Study|Adverse Event|2|||
127798920|NCT02595879|459887934|FG000|Expansion Cohort|Did not complete treatment regimen|1|||
127798921|NCT02595879|459887935|FG001|Expansion Cohort|Did not complete treatment regimen|0|||
127798922|NCT04294459|459887936|FG000|Overall Study|Adverse Event|0|||
127798923|NCT04294459|459887937|FG001|Overall Study|Adverse Event|1|||
127798924|NCT01534676|459887938|FG000|Overall Study|Study closed due to poor enrollment|2|||
127798925|NCT01534676|459887939|FG001|Overall Study|Study closed due to poor enrollment|1|||
127644203|NCT04575051|459317289|FG001|Time Period 0|Discontinued due to death or moving to higher level of care|6|||
127644204|NCT04575051|459317290|FG002|Time Period 0|Discontinued due to death or moving to higher level of care|19|||
127644205|NCT04575051|459317291|FG003|Time Period 0|Discontinued due to death or moving to higher level of care|9|||
127644206|NCT04575051|459317292|FG004|Time Period 0|Discontinued due to death or moving to higher level of care|8|||
127644207|NCT04575051|459317288|FG000|Time Period 1|Missing follow up|1|||
127644208|NCT04575051|459317289|FG001|Time Period 1|Missing follow up|3|||
127644209|NCT04575051|459317290|FG002|Time Period 1|Missing follow up|1|||
127644210|NCT04575051|459317291|FG003|Time Period 1|Missing follow up|3|||
127644211|NCT04575051|459317292|FG004|Time Period 1|Missing follow up|2|||
127644212|NCT04575051|459317288|FG000|Time Period 1|Discontinued due to death or moving to higher level of care|13|||
127644213|NCT04575051|459317289|FG001|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
127644214|NCT04575051|459317290|FG002|Time Period 1|Discontinued due to death or moving to higher level of care|9|||
127644215|NCT04575051|459317291|FG003|Time Period 1|Discontinued due to death or moving to higher level of care|15|||
127644216|NCT04575051|459317292|FG004|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
127644217|NCT04575051|459317288|FG000|Time Period 2|Missing follow up|1|||
127644218|NCT04575051|459317289|FG001|Time Period 2|Missing follow up|8|||
127644219|NCT04575051|459317290|FG002|Time Period 2|Missing follow up|7|||
127644220|NCT04575051|459317291|FG003|Time Period 2|Missing follow up|0|||
127644221|NCT04575051|459317292|FG004|Time Period 2|Missing follow up|1|||
127644222|NCT04575051|459317288|FG000|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
127644223|NCT04575051|459317289|FG001|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
127644224|NCT04575051|459317290|FG002|Time Period 2|Discontinued due to death or moved to higher level of care|20|||
127644225|NCT04575051|459317291|FG003|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
127644226|NCT04575051|459317292|FG004|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
127644227|NCT04575051|459317288|FG000|Time Period 3|Missing follow up|8|||
127644228|NCT04575051|459317289|FG001|Time Period 3|Missing follow up|6|||
127644229|NCT04575051|459317290|FG002|Time Period 3|Missing follow up|4|||
127798926|NCT02908880|459887941|FG000|Overall Study|Lost to Follow-up|4|||
127798927|NCT02908880|459887941|FG000|Overall Study|Explantation of the device|1|||
127798928|NCT02908880|459887941|FG000|Overall Study|Withdrawal by Subject|17|||
127798929|NCT02908880|459887941|FG000|Overall Study|Death|5|||
127644230|NCT04575051|459317291|FG003|Time Period 3|Missing follow up|3|||
127798930|NCT02421887|459887942|FG000|Overall Study|Lost to Follow-up|5|||
127798931|NCT02421887|459887943|FG001|Overall Study|Lost to Follow-up|0|||
127798932|NCT02421887|459887942|FG000|Overall Study|Withdrawal by Subject|8|||
127706568|NCT03519178|459555442|FG003|PF-06873600 Treatment|Physician Decision|0|||
127706569|NCT03519178|459555443|FG004|PF-06873600 Treatment|Physician Decision|0|||
127706570|NCT03519178|459555444|FG005|PF-06873600 Treatment|Physician Decision|0|||
127706571|NCT03519178|459555445|FG006|PF-06873600 Treatment|Physician Decision|0|||
127706572|NCT03519178|459555446|FG007|PF-06873600 Treatment|Physician Decision|1|||
127706573|NCT03519178|459555447|FG008|PF-06873600 Treatment|Physician Decision|0|||
127706574|NCT03519178|459555448|FG009|PF-06873600 Treatment|Physician Decision|0|||
127706575|NCT03519178|459555449|FG010|PF-06873600 Treatment|Physician Decision|1|||
127706576|NCT03519178|459555450|FG011|PF-06873600 Treatment|Physician Decision|0|||
127706577|NCT03519178|459555451|FG012|PF-06873600 Treatment|Physician Decision|0|||
127706578|NCT03519178|459555452|FG013|PF-06873600 Treatment|Physician Decision|4|||
127644231|NCT04575051|459317292|FG004|Time Period 3|Missing follow up|0|||
127644232|NCT04575051|459317288|FG000|Time Period 3|Discontinued due to death or moved to higher level of care|5|||
127644233|NCT04575051|459317289|FG001|Time Period 3|Discontinued due to death or moved to higher level of care|4|||
127644234|NCT04575051|459317290|FG002|Time Period 3|Discontinued due to death or moved to higher level of care|11|||
127644235|NCT04575051|459317291|FG003|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
127644236|NCT04575051|459317292|FG004|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
127644237|NCT04575051|459317288|FG000|Time Period 4|Missing follow up|17|||
127644238|NCT04575051|459317289|FG001|Time Period 4|Missing follow up|3|||
127644239|NCT04575051|459317290|FG002|Time Period 4|Missing follow up|4|||
127644240|NCT04575051|459317291|FG003|Time Period 4|Missing follow up|2|||
127644241|NCT04575051|459317292|FG004|Time Period 4|Missing follow up|1|||
127644242|NCT04575051|459317288|FG000|Time Period 4|Discontinued due to death or moved to higher level of care|2|||
127644243|NCT04575051|459317289|FG001|Time Period 4|Discontinued due to death or moved to higher level of care|3|||
127644244|NCT04575051|459317290|FG002|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
127644245|NCT04575051|459317291|FG003|Time Period 4|Discontinued due to death or moved to higher level of care|1|||
127644246|NCT04575051|459317292|FG004|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
127644247|NCT04575051|459317288|FG000|Time Period 5|Missing follow up|11|||
127644248|NCT04575051|459317289|FG001|Time Period 5|Missing follow up|8|||
127644249|NCT04575051|459317290|FG002|Time Period 5|Missing follow up|12|||
127644250|NCT04575051|459317291|FG003|Time Period 5|Missing follow up|3|||
127644251|NCT04575051|459317292|FG004|Time Period 5|Missing follow up|11|||
127644252|NCT03624504|459317293|FG000|Overall Study|Unsuccessful Implant|1|||
127644253|NCT02862457|459317294|FG000|Overall Study|Death|1|||
127644254|NCT02862457|459317295|FG001|Overall Study|Death|3|||
127644255|NCT02862457|459317296|FG002|Overall Study|Death|2|||
127644256|NCT02862457|459317297|FG003|Overall Study|Death|3|||
127644257|NCT02862457|459317298|FG004|Overall Study|Death|0|||
127644258|NCT02862457|459317299|FG005|Overall Study|Death|2|||
127644259|NCT02862457|459317300|FG006|Overall Study|Death|1|||
127644260|NCT02862457|459317294|FG000|Overall Study|Lost to Follow-up|1|||
127644261|NCT02862457|459317295|FG001|Overall Study|Lost to Follow-up|0|||
127644262|NCT02862457|459317296|FG002|Overall Study|Lost to Follow-up|0|||
127644263|NCT02862457|459317297|FG003|Overall Study|Lost to Follow-up|1|||
127706579|NCT03519178|459555453|FG014|PF-06873600 Treatment|Physician Decision|1|||
127706580|NCT03519178|459555439|FG000|PF-06873600 Treatment|Progressive disease|1|||
127706581|NCT03519178|459555440|FG001|PF-06873600 Treatment|Progressive disease|1|||
127706582|NCT03519178|459555441|FG002|PF-06873600 Treatment|Progressive disease|1|||
127706583|NCT03519178|459555442|FG003|PF-06873600 Treatment|Progressive disease|1|||
127706584|NCT03519178|459555443|FG004|PF-06873600 Treatment|Progressive disease|6|||
127706585|NCT03519178|459555444|FG005|PF-06873600 Treatment|Progressive disease|7|||
127706586|NCT03519178|459555445|FG006|PF-06873600 Treatment|Progressive disease|3|||
127706587|NCT03519178|459555446|FG007|PF-06873600 Treatment|Progressive disease|7|||
127706588|NCT03519178|459555447|FG008|PF-06873600 Treatment|Progressive disease|3|||
127706589|NCT03519178|459555448|FG009|PF-06873600 Treatment|Progressive disease|5|||
127706590|NCT03519178|459555449|FG010|PF-06873600 Treatment|Progressive disease|4|||
127706591|NCT03519178|459555450|FG011|PF-06873600 Treatment|Progressive disease|3|||
127706592|NCT03519178|459555451|FG012|PF-06873600 Treatment|Progressive disease|4|||
127706593|NCT03519178|459555452|FG013|PF-06873600 Treatment|Progressive disease|28|||
127706594|NCT03519178|459555453|FG014|PF-06873600 Treatment|Progressive disease|7|||
127706595|NCT03519178|459555439|FG000|PF-06873600 Treatment|Withdrawal by Subject|0|||
127706596|NCT03519178|459555440|FG001|PF-06873600 Treatment|Withdrawal by Subject|0|||
127706597|NCT03519178|459555441|FG002|PF-06873600 Treatment|Withdrawal by Subject|1|||
127706598|NCT03519178|459555442|FG003|PF-06873600 Treatment|Withdrawal by Subject|0|||
127706599|NCT03519178|459555443|FG004|PF-06873600 Treatment|Withdrawal by Subject|2|||
127706600|NCT03519178|459555444|FG005|PF-06873600 Treatment|Withdrawal by Subject|0|||
127706601|NCT03519178|459555445|FG006|PF-06873600 Treatment|Withdrawal by Subject|0|||
127706602|NCT03519178|459555446|FG007|PF-06873600 Treatment|Withdrawal by Subject|1|||
127706603|NCT03519178|459555447|FG008|PF-06873600 Treatment|Withdrawal by Subject|3|||
127798933|NCT02421887|459887943|FG001|Overall Study|Withdrawal by Subject|5|||
127798934|NCT02421887|459887942|FG000|Overall Study|Physician Decision|2|||
127644264|NCT02862457|459317298|FG004|Overall Study|Lost to Follow-up|0|||
127644265|NCT02862457|459317299|FG005|Overall Study|Lost to Follow-up|0|||
127887752|NCT00529568|460211956|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
127887753|NCT00529568|460211957|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
127887754|NCT00529568|460211955|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
127887755|NCT00529568|460211956|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
127887756|NCT00529568|460211957|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
127887757|NCT00529568|460211955|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
127887758|NCT00529568|460211956|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
127887759|NCT00529568|460211957|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
127887760|NCT00529568|460211955|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
127887761|NCT00529568|460211956|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
127887762|NCT00529568|460211957|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
127887763|NCT00529568|460211955|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
127887764|NCT00529568|460211956|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
127887765|NCT00529568|460211957|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
127887766|NCT00529568|460211955|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
127887767|NCT00529568|460211956|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
127887768|NCT00529568|460211957|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
127887769|NCT00529568|460211955|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
127644266|NCT02862457|459317300|FG006|Overall Study|Lost to Follow-up|0|||
127706604|NCT03519178|459555448|FG009|PF-06873600 Treatment|Withdrawal by Subject|2|||
127706605|NCT03519178|459555449|FG010|PF-06873600 Treatment|Withdrawal by Subject|0|||
127706606|NCT03519178|459555450|FG011|PF-06873600 Treatment|Withdrawal by Subject|2|||
127706607|NCT03519178|459555451|FG012|PF-06873600 Treatment|Withdrawal by Subject|1|||
127706608|NCT03519178|459555452|FG013|PF-06873600 Treatment|Withdrawal by Subject|1|||
127706609|NCT03519178|459555453|FG014|PF-06873600 Treatment|Withdrawal by Subject|2|||
127706610|NCT03519178|459555439|FG000|PF-06873600 Treatment|Global deterioration of health status|0|||
127706611|NCT03519178|459555440|FG001|PF-06873600 Treatment|Global deterioration of health status|0|||
127706612|NCT03519178|459555441|FG002|PF-06873600 Treatment|Global deterioration of health status|0|||
127706613|NCT03519178|459555442|FG003|PF-06873600 Treatment|Global deterioration of health status|2|||
127706614|NCT03519178|459555443|FG004|PF-06873600 Treatment|Global deterioration of health status|0|||
127706615|NCT03519178|459555444|FG005|PF-06873600 Treatment|Global deterioration of health status|0|||
127706616|NCT03519178|459555445|FG006|PF-06873600 Treatment|Global deterioration of health status|1|||
127706617|NCT03519178|459555446|FG007|PF-06873600 Treatment|Global deterioration of health status|2|||
127706618|NCT03519178|459555447|FG008|PF-06873600 Treatment|Global deterioration of health status|1|||
127706619|NCT03519178|459555448|FG009|PF-06873600 Treatment|Global deterioration of health status|1|||
127706620|NCT03519178|459555449|FG010|PF-06873600 Treatment|Global deterioration of health status|2|||
127706621|NCT03519178|459555450|FG011|PF-06873600 Treatment|Global deterioration of health status|0|||
127706622|NCT03519178|459555451|FG012|PF-06873600 Treatment|Global deterioration of health status|0|||
127706623|NCT03519178|459555452|FG013|PF-06873600 Treatment|Global deterioration of health status|3|||
127706624|NCT03519178|459555453|FG014|PF-06873600 Treatment|Global deterioration of health status|0|||
127706625|NCT03519178|459555439|FG000|PF-06873600 Treatment|Refused further treatment|0|||
127706626|NCT03519178|459555440|FG001|PF-06873600 Treatment|Refused further treatment|1|||
127706627|NCT03519178|459555441|FG002|PF-06873600 Treatment|Refused further treatment|0|||
127706628|NCT03519178|459555442|FG003|PF-06873600 Treatment|Refused further treatment|0|||
127706629|NCT03519178|459555443|FG004|PF-06873600 Treatment|Refused further treatment|1|||
127706630|NCT03519178|459555444|FG005|PF-06873600 Treatment|Refused further treatment|0|||
127706631|NCT03519178|459555445|FG006|PF-06873600 Treatment|Refused further treatment|0|||
127887770|NCT00529568|460211956|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
127887771|NCT00529568|460211957|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
127644267|NCT02862457|459317294|FG000|Overall Study|Withdrawal by Subject|0|||
127644268|NCT02862457|459317295|FG001|Overall Study|Withdrawal by Subject|0|||
127644269|NCT02862457|459317296|FG002|Overall Study|Withdrawal by Subject|1|||
127644270|NCT02862457|459317297|FG003|Overall Study|Withdrawal by Subject|0|||
127644271|NCT02862457|459317298|FG004|Overall Study|Withdrawal by Subject|0|||
127644272|NCT02862457|459317299|FG005|Overall Study|Withdrawal by Subject|1|||
127644273|NCT02862457|459317300|FG006|Overall Study|Withdrawal by Subject|0|||
127644274|NCT01328080|459317303|FG000|Overall Study|Lost to Follow-up|5|||
127644275|NCT00862134|459317304|FG000|Overall Study|Death|1|||
127644276|NCT00862134|459317305|FG001|Overall Study|Death|0|||
127644277|NCT00862134|459317304|FG000|Overall Study|Physician Decision|0|||
127644278|NCT00862134|459317305|FG001|Overall Study|Physician Decision|1|||
127644279|NCT00862134|459317304|FG000|Overall Study|Withdrawal by Subject|1|||
127644280|NCT00862134|459317305|FG001|Overall Study|Withdrawal by Subject|2|||
127644281|NCT00862134|459317304|FG000|Overall Study|Sponsor terminated study|5|||
127644282|NCT00862134|459317305|FG001|Overall Study|Sponsor terminated study|7|||
127706632|NCT03519178|459555446|FG007|PF-06873600 Treatment|Refused further treatment|0|||
127887772|NCT01201356|460211958|FG000|Overall Study|Adverse Event|170|||
127644283|NCT00862134|459317304|FG000|Overall Study|Adverse Event|2|||
127887773|NCT01201356|460211958|FG000|Overall Study|Abnormal laboratory value(s)|51|||
127887774|NCT01201356|460211958|FG000|Overall Study|Abnormal test procedure result(s)|3|||
127887775|NCT01201356|460211958|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
127887776|NCT01201356|460211958|FG000|Overall Study|Condition no longer requires study drug|12|||
127887777|NCT01201356|460211958|FG000|Overall Study|Withdrawal by Subject|144|||
127887778|NCT01201356|460211958|FG000|Overall Study|Lost to Follow-up|50|||
127887779|NCT01201356|460211958|FG000|Overall Study|administrative problems|74|||
127887780|NCT01201356|460211958|FG000|Overall Study|Death|16|||
127887781|NCT01201356|460211958|FG000|Overall Study|Protocol Violation|12|||
127887782|NCT00931385|460211959|FG000|Overall Study|Adverse Event|2|||
127887783|NCT00931385|460211960|FG001|Overall Study|Adverse Event|1|||
127887784|NCT00931385|460211961|FG002|Overall Study|Adverse Event|0|||
127887785|NCT00931385|460211962|FG003|Overall Study|Adverse Event|3|||
127887786|NCT00931385|460211959|FG000|Overall Study|Protocol Violation|0|||
127887787|NCT00931385|460211960|FG001|Overall Study|Protocol Violation|0|||
127887788|NCT00931385|460211961|FG002|Overall Study|Protocol Violation|1|||
127887789|NCT00931385|460211962|FG003|Overall Study|Protocol Violation|0|||
127887790|NCT00931385|460211959|FG000|Overall Study|Withdrawal by Subject|0|||
127887791|NCT00931385|460211960|FG001|Overall Study|Withdrawal by Subject|1|||
127887792|NCT00931385|460211961|FG002|Overall Study|Withdrawal by Subject|0|||
127644284|NCT00862134|459317305|FG001|Overall Study|Adverse Event|2|||
127644285|NCT00862134|459317304|FG000|Overall Study|Withdrew prior to dosing|2|||
127644286|NCT00862134|459317305|FG001|Overall Study|Withdrew prior to dosing|0|||
127644287|NCT02191267|459317306|FG000|Overall Study|Withdrawal by Subject|1|||
127644288|NCT02191267|459317307|FG001|Overall Study|Withdrawal by Subject|0|||
127644289|NCT02191267|459317308|FG002|Overall Study|Withdrawal by Subject|0|||
127644290|NCT00765674|459317309|FG000|Overall Study|Adverse Event|7|||
127644291|NCT00765674|459317310|FG001|Overall Study|Adverse Event|2|||
127644292|NCT00765674|459317311|FG002|Overall Study|Adverse Event|8|||
127644293|NCT00765674|459317312|FG003|Overall Study|Adverse Event|11|||
127644294|NCT00765674|459317309|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
127644295|NCT00765674|459317310|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
127644296|NCT00765674|459317311|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
127644297|NCT00765674|459317312|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
127644298|NCT00765674|459317309|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
127644299|NCT00765674|459317310|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
127644300|NCT00765674|459317311|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
127644301|NCT00765674|459317312|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
127644302|NCT00765674|459317309|FG000|Overall Study|Lack of Efficacy|2|||
127644303|NCT00765674|459317310|FG001|Overall Study|Lack of Efficacy|3|||
127644304|NCT00765674|459317311|FG002|Overall Study|Lack of Efficacy|1|||
127644305|NCT00765674|459317312|FG003|Overall Study|Lack of Efficacy|2|||
127644306|NCT00765674|459317309|FG000|Overall Study|Protocol Violation|2|||
127644307|NCT00765674|459317310|FG001|Overall Study|Protocol Violation|0|||
127644308|NCT00765674|459317311|FG002|Overall Study|Protocol Violation|1|||
127644309|NCT00765674|459317312|FG003|Overall Study|Protocol Violation|0|||
127644310|NCT00765674|459317309|FG000|Overall Study|Withdrawal by Subject|5|||
127644311|NCT00765674|459317310|FG001|Overall Study|Withdrawal by Subject|7|||
127644312|NCT00765674|459317311|FG002|Overall Study|Withdrawal by Subject|3|||
127644313|NCT00765674|459317312|FG003|Overall Study|Withdrawal by Subject|8|||
127644314|NCT00765674|459317309|FG000|Overall Study|Lost to Follow-up|4|||
127644315|NCT00765674|459317310|FG001|Overall Study|Lost to Follow-up|6|||
127644316|NCT00765674|459317311|FG002|Overall Study|Lost to Follow-up|2|||
127644317|NCT00765674|459317312|FG003|Overall Study|Lost to Follow-up|1|||
127644318|NCT00765674|459317309|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
127644319|NCT00765674|459317310|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
127644320|NCT00765674|459317311|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
127644321|NCT00765674|459317312|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
127644322|NCT01813474|459317313|FG000|Overall Study|Withdrawal by Subject|0|||
127644323|NCT01813474|459317314|FG001|Overall Study|Withdrawal by Subject|0|||
127644324|NCT01813474|459317315|FG002|Overall Study|Withdrawal by Subject|1|||
127644325|NCT01813474|459317313|FG000|Overall Study|Adverse Event|1|||
127644326|NCT01813474|459317314|FG001|Overall Study|Adverse Event|1|||
127644327|NCT01813474|459317315|FG002|Overall Study|Adverse Event|0|||
127644328|NCT01813474|459317313|FG000|Overall Study|Lack of Efficacy|2|||
127798935|NCT02421887|459887943|FG001|Overall Study|Physician Decision|4|||
127798936|NCT02421887|459887942|FG000|Overall Study|Adverse Event|2|||
127798937|NCT02421887|459887943|FG001|Overall Study|Adverse Event|0|||
127798938|NCT00257010|459887951|FG000|Overall Study|Lack of Efficacy|11|||
127798939|NCT00257010|459887951|FG000|Overall Study|Lost to Follow-up|53|||
127798940|NCT00257010|459887951|FG000|Overall Study|Withdrawal by Subject|34|||
127798941|NCT00257010|459887951|FG000|Overall Study|Adverse Event|10|||
127798942|NCT00257010|459887951|FG000|Overall Study|various|11|||
127798943|NCT00257010|459887951|FG000|Overall Study|no headache reported|9|||
127798944|NCT00608985|459887954|FG000|Overall Study|Adverse Event|2|||
127798945|NCT00608985|459887955|FG001|Overall Study|Adverse Event|7|||
127798946|NCT00608985|459887956|FG002|Overall Study|Adverse Event|4|||
127798947|NCT00608985|459887957|FG003|Overall Study|Adverse Event|6|||
127798948|NCT00608985|459887954|FG000|Overall Study|Administrative/Other|7|||
127798949|NCT00608985|459887955|FG001|Overall Study|Administrative/Other|4|||
127798950|NCT00608985|459887956|FG002|Overall Study|Administrative/Other|1|||
127798951|NCT00608985|459887957|FG003|Overall Study|Administrative/Other|2|||
127798952|NCT00608985|459887954|FG000|Overall Study|Withdrawal of Consent|5|||
127798953|NCT00608985|459887955|FG001|Overall Study|Withdrawal of Consent|1|||
127798954|NCT00608985|459887956|FG002|Overall Study|Withdrawal of Consent|1|||
127798955|NCT00608985|459887957|FG003|Overall Study|Withdrawal of Consent|1|||
127644329|NCT01813474|459317314|FG001|Overall Study|Lack of Efficacy|6|||
127798956|NCT00608985|459887954|FG000|Overall Study|Lost to Follow-up|2|||
127644330|NCT01813474|459317315|FG002|Overall Study|Lack of Efficacy|9|||
127644331|NCT01813474|459317313|FG000|Overall Study|Death|0|||
127644332|NCT01813474|459317314|FG001|Overall Study|Death|0|||
127644333|NCT01813474|459317315|FG002|Overall Study|Death|1|||
127798957|NCT00608985|459887955|FG001|Overall Study|Lost to Follow-up|1|||
127798958|NCT00608985|459887956|FG002|Overall Study|Lost to Follow-up|0|||
127798959|NCT00608985|459887957|FG003|Overall Study|Lost to Follow-up|0|||
127644334|NCT00316082|459317318|FG000|Overall Study|Lack of Efficacy|2|||
127644335|NCT00316082|459317319|FG001|Overall Study|Lack of Efficacy|3|||
127644336|NCT00316082|459317320|FG002|Overall Study|Lack of Efficacy|3|||
127644337|NCT00316082|459317321|FG003|Overall Study|Lack of Efficacy|4|||
127644338|NCT00316082|459317322|FG004|Overall Study|Lack of Efficacy|6|||
127644339|NCT00316082|459317318|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
127644340|NCT00316082|459317319|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
127644341|NCT00316082|459317320|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
127644342|NCT00316082|459317321|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
127644343|NCT00316082|459317322|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
127644344|NCT00316082|459317318|FG000|Overall Study|Lost to Follow-up|7|||
127644345|NCT00316082|459317319|FG001|Overall Study|Lost to Follow-up|6|||
127644346|NCT00316082|459317320|FG002|Overall Study|Lost to Follow-up|7|||
127644347|NCT00316082|459317321|FG003|Overall Study|Lost to Follow-up|8|||
127644348|NCT00316082|459317322|FG004|Overall Study|Lost to Follow-up|6|||
127644349|NCT00316082|459317318|FG000|Overall Study|Poor/noncompliance|6|||
127644350|NCT00316082|459317319|FG001|Overall Study|Poor/noncompliance|1|||
127644351|NCT00316082|459317320|FG002|Overall Study|Poor/noncompliance|4|||
127644352|NCT00316082|459317321|FG003|Overall Study|Poor/noncompliance|1|||
127644353|NCT00316082|459317322|FG004|Overall Study|Poor/noncompliance|4|||
127644354|NCT00316082|459317318|FG000|Overall Study|Adverse Event|4|||
127644355|NCT00316082|459317319|FG001|Overall Study|Adverse Event|2|||
127644356|NCT00316082|459317320|FG002|Overall Study|Adverse Event|5|||
127644357|NCT00316082|459317321|FG003|Overall Study|Adverse Event|1|||
127644358|NCT00316082|459317322|FG004|Overall Study|Adverse Event|3|||
127644359|NCT00316082|459317318|FG000|Overall Study|Subject no longer meets study criteria|3|||
127644360|NCT00316082|459317319|FG001|Overall Study|Subject no longer meets study criteria|1|||
127644361|NCT00316082|459317320|FG002|Overall Study|Subject no longer meets study criteria|2|||
127644362|NCT00316082|459317321|FG003|Overall Study|Subject no longer meets study criteria|2|||
127644363|NCT00316082|459317322|FG004|Overall Study|Subject no longer meets study criteria|1|||
127644364|NCT00316082|459317318|FG000|Overall Study|Physician Decision|1|||
127644365|NCT00316082|459317319|FG001|Overall Study|Physician Decision|1|||
127644366|NCT00316082|459317320|FG002|Overall Study|Physician Decision|2|||
127644367|NCT00316082|459317321|FG003|Overall Study|Physician Decision|1|||
127644368|NCT00316082|459317322|FG004|Overall Study|Physician Decision|1|||
127644369|NCT00316082|459317318|FG000|Overall Study|Death|0|||
127644370|NCT00316082|459317319|FG001|Overall Study|Death|0|||
127644371|NCT00316082|459317320|FG002|Overall Study|Death|1|||
127644372|NCT00316082|459317321|FG003|Overall Study|Death|0|||
127644373|NCT00316082|459317322|FG004|Overall Study|Death|0|||
127798960|NCT03033745|459887958|FG000|Overall Study|Protocol Violation|0|||
127798961|NCT03033745|459887959|FG001|Overall Study|Protocol Violation|0|||
127644374|NCT00316082|459317318|FG000|Overall Study|Administrative reason by sponsor|0|||
127644375|NCT00316082|459317319|FG001|Overall Study|Administrative reason by sponsor|0|||
127706633|NCT03519178|459555447|FG008|PF-06873600 Treatment|Refused further treatment|0|||
127706634|NCT03519178|459555448|FG009|PF-06873600 Treatment|Refused further treatment|0|||
127706635|NCT03519178|459555449|FG010|PF-06873600 Treatment|Refused further treatment|0|||
127706636|NCT03519178|459555450|FG011|PF-06873600 Treatment|Refused further treatment|0|||
127706637|NCT03519178|459555451|FG012|PF-06873600 Treatment|Refused further treatment|0|||
127706638|NCT03519178|459555452|FG013|PF-06873600 Treatment|Refused further treatment|0|||
127706639|NCT03519178|459555453|FG014|PF-06873600 Treatment|Refused further treatment|1|||
127706640|NCT03519178|459555439|FG000|PF-06873600 Treatment|Other|0|||
127706641|NCT03519178|459555440|FG001|PF-06873600 Treatment|Other|0|||
127706642|NCT03519178|459555441|FG002|PF-06873600 Treatment|Other|0|||
127706643|NCT03519178|459555442|FG003|PF-06873600 Treatment|Other|0|||
127706644|NCT03519178|459555443|FG004|PF-06873600 Treatment|Other|0|||
127706645|NCT03519178|459555444|FG005|PF-06873600 Treatment|Other|0|||
127706646|NCT03519178|459555445|FG006|PF-06873600 Treatment|Other|0|||
127706647|NCT03519178|459555446|FG007|PF-06873600 Treatment|Other|0|||
127706648|NCT03519178|459555447|FG008|PF-06873600 Treatment|Other|1|||
127706649|NCT03519178|459555448|FG009|PF-06873600 Treatment|Other|0|||
127706650|NCT03519178|459555449|FG010|PF-06873600 Treatment|Other|0|||
127706651|NCT03519178|459555450|FG011|PF-06873600 Treatment|Other|0|||
127706652|NCT03519178|459555451|FG012|PF-06873600 Treatment|Other|0|||
127706653|NCT03519178|459555452|FG013|PF-06873600 Treatment|Other|1|||
127706654|NCT03519178|459555453|FG014|PF-06873600 Treatment|Other|3|||
127706655|NCT03519178|459555439|FG000|PF-06873600 Treatment|Lost to Follow-up|0|||
127706656|NCT03519178|459555440|FG001|PF-06873600 Treatment|Lost to Follow-up|0|||
127706657|NCT03519178|459555441|FG002|PF-06873600 Treatment|Lost to Follow-up|0|||
127706658|NCT03519178|459555442|FG003|PF-06873600 Treatment|Lost to Follow-up|0|||
127706659|NCT03519178|459555443|FG004|PF-06873600 Treatment|Lost to Follow-up|0|||
127706660|NCT03519178|459555444|FG005|PF-06873600 Treatment|Lost to Follow-up|0|||
127706661|NCT03519178|459555445|FG006|PF-06873600 Treatment|Lost to Follow-up|0|||
127706662|NCT03519178|459555446|FG007|PF-06873600 Treatment|Lost to Follow-up|0|||
127706663|NCT03519178|459555447|FG008|PF-06873600 Treatment|Lost to Follow-up|0|||
127706664|NCT03519178|459555448|FG009|PF-06873600 Treatment|Lost to Follow-up|0|||
127706665|NCT03519178|459555449|FG010|PF-06873600 Treatment|Lost to Follow-up|0|||
127706666|NCT03519178|459555450|FG011|PF-06873600 Treatment|Lost to Follow-up|0|||
127706667|NCT03519178|459555451|FG012|PF-06873600 Treatment|Lost to Follow-up|0|||
127706668|NCT03519178|459555452|FG013|PF-06873600 Treatment|Lost to Follow-up|0|||
127706669|NCT03519178|459555453|FG014|PF-06873600 Treatment|Lost to Follow-up|1|||
127706670|NCT03519178|459555439|FG000|PF-06873600 Treatment|Study terminated by sponsor|0|||
127706671|NCT03519178|459555440|FG001|PF-06873600 Treatment|Study terminated by sponsor|0|||
127706672|NCT03519178|459555441|FG002|PF-06873600 Treatment|Study terminated by sponsor|0|||
127706673|NCT03519178|459555442|FG003|PF-06873600 Treatment|Study terminated by sponsor|0|||
127706674|NCT03519178|459555443|FG004|PF-06873600 Treatment|Study terminated by sponsor|0|||
127706675|NCT03519178|459555444|FG005|PF-06873600 Treatment|Study terminated by sponsor|0|||
127706676|NCT03519178|459555445|FG006|PF-06873600 Treatment|Study terminated by sponsor|0|||
127706677|NCT03519178|459555446|FG007|PF-06873600 Treatment|Study terminated by sponsor|0|||
127706678|NCT03519178|459555447|FG008|PF-06873600 Treatment|Study terminated by sponsor|0|||
127706679|NCT03519178|459555448|FG009|PF-06873600 Treatment|Study terminated by sponsor|0|||
127706680|NCT03519178|459555449|FG010|PF-06873600 Treatment|Study terminated by sponsor|0|||
127706681|NCT03519178|459555450|FG011|PF-06873600 Treatment|Study terminated by sponsor|0|||
127706682|NCT03519178|459555451|FG012|PF-06873600 Treatment|Study terminated by sponsor|0|||
127706683|NCT03519178|459555452|FG013|PF-06873600 Treatment|Study terminated by sponsor|4|||
127706684|NCT03519178|459555453|FG014|PF-06873600 Treatment|Study terminated by sponsor|4|||
127706685|NCT03519178|459555439|FG000|PF-06873600 Treatment|Ongoing|0|||
127706686|NCT03519178|459555440|FG001|PF-06873600 Treatment|Ongoing|0|||
127706687|NCT03519178|459555441|FG002|PF-06873600 Treatment|Ongoing|0|||
127706688|NCT03519178|459555442|FG003|PF-06873600 Treatment|Ongoing|0|||
127706689|NCT03519178|459555443|FG004|PF-06873600 Treatment|Ongoing|0|||
127798962|NCT03033745|459887960|FG002|Overall Study|Protocol Violation|1|||
127798963|NCT03033745|459887958|FG000|Overall Study|Adverse Event|1|||
127798964|NCT03033745|459887959|FG001|Overall Study|Adverse Event|0|||
127798965|NCT03033745|459887960|FG002|Overall Study|Adverse Event|1|||
127798966|NCT03033745|459887958|FG000|Overall Study|Withdrawal by Subject|0|||
127798967|NCT03033745|459887959|FG001|Overall Study|Withdrawal by Subject|1|||
127798968|NCT03033745|459887960|FG002|Overall Study|Withdrawal by Subject|0|||
127706690|NCT03519178|459555444|FG005|PF-06873600 Treatment|Ongoing|0|||
127706691|NCT03519178|459555445|FG006|PF-06873600 Treatment|Ongoing|0|||
127706692|NCT03519178|459555446|FG007|PF-06873600 Treatment|Ongoing|0|||
127706693|NCT03519178|459555447|FG008|PF-06873600 Treatment|Ongoing|0|||
127706694|NCT03519178|459555448|FG009|PF-06873600 Treatment|Ongoing|0|||
127706695|NCT03519178|459555449|FG010|PF-06873600 Treatment|Ongoing|0|||
127706696|NCT03519178|459555450|FG011|PF-06873600 Treatment|Ongoing|0|||
127706697|NCT03519178|459555451|FG012|PF-06873600 Treatment|Ongoing|0|||
127706698|NCT03519178|459555452|FG013|PF-06873600 Treatment|Ongoing|1|||
127706699|NCT03519178|459555453|FG014|PF-06873600 Treatment|Ongoing|6|||
127706700|NCT03519178|459555439|FG000|Disposition for Fluvestrant Treatment|Adverse Event|0|||
127798969|NCT00323557|459887961|FG000|Overall Study|Physician Decision|1|||
127798970|NCT00323557|459887962|FG001|Overall Study|Physician Decision|0|||
127798971|NCT02450578|459887963|FG000|Overall Study|ECG abnormality so not treated|1|||
127798972|NCT02450578|459887964|FG001|Overall Study|ECG abnormality so not treated|0|||
127798973|NCT02450578|459887965|FG002|Overall Study|ECG abnormality so not treated|0|||
127798974|NCT02450578|459887966|FG003|Overall Study|ECG abnormality so not treated|0|||
127798975|NCT00662792|459887967|FG000|Period 1|Personal Reasons|0|||
127798976|NCT00662792|459887968|FG001|Period 1|Personal Reasons|0|||
127798977|NCT00662792|459887969|FG002|Period 1|Personal Reasons|1|||
127798978|NCT00662792|459887970|FG003|Period 1|Personal Reasons|0|||
127798979|NCT00662792|459887967|FG000|Period 1|Refused continuing medication|0|||
127798980|NCT00662792|459887968|FG001|Period 1|Refused continuing medication|1|||
127798981|NCT00662792|459887969|FG002|Period 1|Refused continuing medication|1|||
127798982|NCT00662792|459887970|FG003|Period 1|Refused continuing medication|0|||
127798983|NCT00662792|459887967|FG000|Period 1|Lost to Follow-up|1|||
127798984|NCT00662792|459887968|FG001|Period 1|Lost to Follow-up|0|||
127798985|NCT00662792|459887969|FG002|Period 1|Lost to Follow-up|0|||
127798986|NCT00662792|459887970|FG003|Period 1|Lost to Follow-up|0|||
127798987|NCT00662792|459887967|FG000|Period 1|Other adverse event (AE)|0|||
127798988|NCT00662792|459887968|FG001|Period 1|Other adverse event (AE)|2|||
127798989|NCT00662792|459887969|FG002|Period 1|Other adverse event (AE)|0|||
127798990|NCT00662792|459887970|FG003|Period 1|Other adverse event (AE)|0|||
127798991|NCT00662792|459887967|FG000|Period 1|Worsening of disease under study (AE)|1|||
127706701|NCT03519178|459555440|FG001|Disposition for Fluvestrant Treatment|Adverse Event|0|||
127706702|NCT03519178|459555441|FG002|Disposition for Fluvestrant Treatment|Adverse Event|0|||
127706703|NCT03519178|459555442|FG003|Disposition for Fluvestrant Treatment|Adverse Event|0|||
127706704|NCT03519178|459555443|FG004|Disposition for Fluvestrant Treatment|Adverse Event|0|||
127706705|NCT03519178|459555444|FG005|Disposition for Fluvestrant Treatment|Adverse Event|0|||
127706706|NCT03519178|459555445|FG006|Disposition for Fluvestrant Treatment|Adverse Event|0|||
127706707|NCT03519178|459555446|FG007|Disposition for Fluvestrant Treatment|Adverse Event|0|||
127706708|NCT03519178|459555447|FG008|Disposition for Fluvestrant Treatment|Adverse Event|0|||
127706709|NCT03519178|459555448|FG009|Disposition for Fluvestrant Treatment|Adverse Event|0|||
127706710|NCT03519178|459555449|FG010|Disposition for Fluvestrant Treatment|Adverse Event|0|||
127706711|NCT03519178|459555450|FG011|Disposition for Fluvestrant Treatment|Adverse Event|0|||
127706712|NCT03519178|459555451|FG012|Disposition for Fluvestrant Treatment|Adverse Event|0|||
127706713|NCT03519178|459555452|FG013|Disposition for Fluvestrant Treatment|Adverse Event|1|||
127706714|NCT03519178|459555453|FG014|Disposition for Fluvestrant Treatment|Adverse Event|0|||
127706715|NCT03519178|459555439|FG000|Disposition for Fluvestrant Treatment|Death|0|||
127706716|NCT03519178|459555440|FG001|Disposition for Fluvestrant Treatment|Death|0|||
127798992|NCT00662792|459887968|FG001|Period 1|Worsening of disease under study (AE)|3|||
127798993|NCT00662792|459887969|FG002|Period 1|Worsening of disease under study (AE)|2|||
127798994|NCT00662792|459887970|FG003|Period 1|Worsening of disease under study (AE)|0|||
127798995|NCT00662792|459887967|FG000|Period 1|Not treated|0|||
127798996|NCT00662792|459887968|FG001|Period 1|Not treated|1|||
127798997|NCT00662792|459887969|FG002|Period 1|Not treated|0|||
127798998|NCT00662792|459887970|FG003|Period 1|Not treated|0|||
127798999|NCT00662792|459887967|FG000|Period 2|Worsening of disease under study|1|||
127799000|NCT00662792|459887968|FG001|Period 2|Worsening of disease under study|0|||
127799001|NCT00662792|459887969|FG002|Period 2|Worsening of disease under study|0|||
127799002|NCT00662792|459887970|FG003|Period 2|Worsening of disease under study|3|||
127799003|NCT00662792|459887967|FG000|Period 3|Refused continuing medication|1|||
127799004|NCT00662792|459887968|FG001|Period 3|Refused continuing medication|0|||
127799005|NCT00662792|459887969|FG002|Period 3|Refused continuing medication|1|||
127799006|NCT00662792|459887970|FG003|Period 3|Refused continuing medication|0|||
127799007|NCT00662792|459887967|FG000|Period 3|Other adverse event (AE)|0|||
127799008|NCT00662792|459887968|FG001|Period 3|Other adverse event (AE)|0|||
127799009|NCT00662792|459887969|FG002|Period 3|Other adverse event (AE)|1|||
127799010|NCT00662792|459887970|FG003|Period 3|Other adverse event (AE)|1|||
127799011|NCT00662792|459887967|FG000|Period 4|Refused continuing medication|0|||
127799012|NCT00662792|459887968|FG001|Period 4|Refused continuing medication|1|||
127799013|NCT00662792|459887969|FG002|Period 4|Refused continuing medication|0|||
127799014|NCT00662792|459887970|FG003|Period 4|Refused continuing medication|0|||
127799015|NCT00662792|459887967|FG000|Period 4|Other adverse event (AE)|1|||
127799016|NCT00662792|459887968|FG001|Period 4|Other adverse event (AE)|0|||
127799017|NCT00662792|459887969|FG002|Period 4|Other adverse event (AE)|0|||
127799018|NCT00662792|459887970|FG003|Period 4|Other adverse event (AE)|0|||
127799019|NCT00662792|459887967|FG000|Period 4|Worsening of disease under study (AE)|0|||
127799020|NCT00662792|459887968|FG001|Period 4|Worsening of disease under study (AE)|0|||
127799021|NCT00662792|459887969|FG002|Period 4|Worsening of disease under study (AE)|0|||
127799022|NCT00662792|459887970|FG003|Period 4|Worsening of disease under study (AE)|1|||
127799023|NCT00090545|459887973|FG000|Overall Study|Disease progression on study|21|||
127799024|NCT00090545|459887974|FG001|Overall Study|Disease progression on study|17|||
127799025|NCT00090545|459887973|FG000|Overall Study|Refused further treatment|1|||
127799026|NCT00090545|459887974|FG001|Overall Study|Refused further treatment|4|||
127799027|NCT00090545|459887973|FG000|Overall Study|Death|0|||
127799028|NCT00090545|459887974|FG001|Overall Study|Death|1|||
127706717|NCT03519178|459555441|FG002|Disposition for Fluvestrant Treatment|Death|0|||
127706718|NCT03519178|459555442|FG003|Disposition for Fluvestrant Treatment|Death|0|||
127706719|NCT03519178|459555443|FG004|Disposition for Fluvestrant Treatment|Death|0|||
127706720|NCT03519178|459555444|FG005|Disposition for Fluvestrant Treatment|Death|0|||
127706721|NCT03519178|459555445|FG006|Disposition for Fluvestrant Treatment|Death|0|||
127706722|NCT03519178|459555446|FG007|Disposition for Fluvestrant Treatment|Death|0|||
127706723|NCT03519178|459555447|FG008|Disposition for Fluvestrant Treatment|Death|0|||
127706724|NCT03519178|459555448|FG009|Disposition for Fluvestrant Treatment|Death|1|||
127706725|NCT03519178|459555449|FG010|Disposition for Fluvestrant Treatment|Death|0|||
127706726|NCT03519178|459555450|FG011|Disposition for Fluvestrant Treatment|Death|0|||
127706727|NCT03519178|459555451|FG012|Disposition for Fluvestrant Treatment|Death|0|||
127706728|NCT03519178|459555452|FG013|Disposition for Fluvestrant Treatment|Death|0|||
127706729|NCT03519178|459555453|FG014|Disposition for Fluvestrant Treatment|Death|1|||
127706730|NCT03519178|459555439|FG000|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
127706731|NCT03519178|459555440|FG001|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
127706732|NCT03519178|459555441|FG002|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
127706733|NCT03519178|459555442|FG003|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
127706734|NCT03519178|459555443|FG004|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
127706735|NCT03519178|459555444|FG005|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
127706736|NCT03519178|459555445|FG006|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
127706737|NCT03519178|459555446|FG007|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
127706738|NCT03519178|459555447|FG008|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
127706739|NCT03519178|459555448|FG009|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
127706740|NCT03519178|459555449|FG010|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
127706741|NCT03519178|459555450|FG011|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
127706742|NCT03519178|459555451|FG012|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
127706743|NCT03519178|459555452|FG013|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
127706744|NCT03519178|459555453|FG014|Disposition for Fluvestrant Treatment|Lost to Follow-up|1|||
127706745|NCT03519178|459555439|FG000|Disposition for Fluvestrant Treatment|Physician Decision|0|||
127706746|NCT03519178|459555440|FG001|Disposition for Fluvestrant Treatment|Physician Decision|0|||
127706747|NCT03519178|459555441|FG002|Disposition for Fluvestrant Treatment|Physician Decision|0|||
127706748|NCT03519178|459555442|FG003|Disposition for Fluvestrant Treatment|Physician Decision|0|||
127706749|NCT03519178|459555443|FG004|Disposition for Fluvestrant Treatment|Physician Decision|0|||
127706750|NCT03519178|459555444|FG005|Disposition for Fluvestrant Treatment|Physician Decision|0|||
127706751|NCT03519178|459555445|FG006|Disposition for Fluvestrant Treatment|Physician Decision|0|||
127706752|NCT03519178|459555446|FG007|Disposition for Fluvestrant Treatment|Physician Decision|0|||
127706753|NCT03519178|459555447|FG008|Disposition for Fluvestrant Treatment|Physician Decision|0|||
127706754|NCT03519178|459555448|FG009|Disposition for Fluvestrant Treatment|Physician Decision|0|||
127706755|NCT03519178|459555449|FG010|Disposition for Fluvestrant Treatment|Physician Decision|0|||
127706756|NCT03519178|459555450|FG011|Disposition for Fluvestrant Treatment|Physician Decision|0|||
127706757|NCT03519178|459555451|FG012|Disposition for Fluvestrant Treatment|Physician Decision|0|||
127706758|NCT03519178|459555452|FG013|Disposition for Fluvestrant Treatment|Physician Decision|4|||
127706759|NCT03519178|459555453|FG014|Disposition for Fluvestrant Treatment|Physician Decision|2|||
127706760|NCT03519178|459555439|FG000|Disposition for Fluvestrant Treatment|Progressive disease|0|||
127706761|NCT03519178|459555440|FG001|Disposition for Fluvestrant Treatment|Progressive disease|0|||
127706762|NCT03519178|459555441|FG002|Disposition for Fluvestrant Treatment|Progressive disease|0|||
127706763|NCT03519178|459555442|FG003|Disposition for Fluvestrant Treatment|Progressive disease|0|||
127706764|NCT03519178|459555443|FG004|Disposition for Fluvestrant Treatment|Progressive disease|0|||
127706765|NCT03519178|459555444|FG005|Disposition for Fluvestrant Treatment|Progressive disease|0|||
127706766|NCT03519178|459555445|FG006|Disposition for Fluvestrant Treatment|Progressive disease|0|||
127706767|NCT03519178|459555446|FG007|Disposition for Fluvestrant Treatment|Progressive disease|0|||
127706768|NCT03519178|459555447|FG008|Disposition for Fluvestrant Treatment|Progressive disease|0|||
127706769|NCT03519178|459555448|FG009|Disposition for Fluvestrant Treatment|Progressive disease|5|||
127706770|NCT03519178|459555449|FG010|Disposition for Fluvestrant Treatment|Progressive disease|0|||
127706771|NCT03519178|459555450|FG011|Disposition for Fluvestrant Treatment|Progressive disease|0|||
127706772|NCT03519178|459555451|FG012|Disposition for Fluvestrant Treatment|Progressive disease|0|||
127706773|NCT03519178|459555452|FG013|Disposition for Fluvestrant Treatment|Progressive disease|30|||
127706774|NCT03519178|459555453|FG014|Disposition for Fluvestrant Treatment|Progressive disease|7|||
127706775|NCT03519178|459555439|FG000|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
127706776|NCT03519178|459555440|FG001|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
127706777|NCT03519178|459555441|FG002|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
127706778|NCT03519178|459555442|FG003|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
127644376|NCT00316082|459317320|FG002|Overall Study|Administrative reason by sponsor|1|||
127644377|NCT00316082|459317321|FG003|Overall Study|Administrative reason by sponsor|0|||
127644378|NCT00316082|459317322|FG004|Overall Study|Administrative reason by sponsor|0|||
127644379|NCT00528775|459317325|FG000|Overall Study|Other not specified|1|||
127644380|NCT01207102|459317329|FG000|Overall Study|Withdrawal by Subject|5|||
127644381|NCT01207102|459317329|FG000|Overall Study|Adverse Event|2|||
127644382|NCT01207102|459317329|FG000|Overall Study|progression|2|||
127644383|NCT01207102|459317329|FG000|Overall Study|Withdrawal by Treating Physician|1|||
127644384|NCT01239030|459317330|FG000|Double Blind|Adverse Event|0|||
127644385|NCT01239030|459317331|FG001|Double Blind|Adverse Event|1|||
127644386|NCT01239030|459317332|FG002|Double Blind|Adverse Event|0|||
127644387|NCT01239030|459317333|FG003|Double Blind|Adverse Event|2|||
127644388|NCT01239030|459317334|FG004|Double Blind|Adverse Event|0|||
127644389|NCT01239030|459317330|FG000|Double Blind|Withdrawal by Subject|0|||
127644390|NCT01239030|459317331|FG001|Double Blind|Withdrawal by Subject|1|||
127644391|NCT01239030|459317332|FG002|Double Blind|Withdrawal by Subject|1|||
127644392|NCT01239030|459317333|FG003|Double Blind|Withdrawal by Subject|0|||
127644393|NCT01239030|459317334|FG004|Double Blind|Withdrawal by Subject|1|||
127644394|NCT01239030|459317330|FG000|Double Blind|Lost to Follow-up|1|||
127644395|NCT01239030|459317331|FG001|Double Blind|Lost to Follow-up|1|||
127644396|NCT01239030|459317332|FG002|Double Blind|Lost to Follow-up|0|||
127644397|NCT01239030|459317333|FG003|Double Blind|Lost to Follow-up|0|||
127644398|NCT01239030|459317334|FG004|Double Blind|Lost to Follow-up|0|||
127644399|NCT01239030|459317330|FG000|Double Blind|Physician Decision|0|||
127644400|NCT01239030|459317331|FG001|Double Blind|Physician Decision|1|||
127644401|NCT01239030|459317332|FG002|Double Blind|Physician Decision|0|||
127644402|NCT01239030|459317333|FG003|Double Blind|Physician Decision|0|||
127644403|NCT01239030|459317334|FG004|Double Blind|Physician Decision|0|||
127644404|NCT01239030|459317330|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
127644405|NCT01239030|459317331|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
127644406|NCT01239030|459317332|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
127644407|NCT01239030|459317333|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
127644408|NCT01239030|459317334|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
127644409|NCT01239030|459317330|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
127644410|NCT01239030|459317331|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
127644411|NCT01239030|459317332|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
127644412|NCT01239030|459317333|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
127644413|NCT01239030|459317334|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
127644414|NCT01239030|459317330|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
127644415|NCT01239030|459317331|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
127644416|NCT01239030|459317332|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
127644417|NCT01239030|459317333|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
127644418|NCT01239030|459317334|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
127644419|NCT01239030|459317330|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
127644420|NCT01239030|459317331|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
127644421|NCT01239030|459317332|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
127644422|NCT01239030|459317333|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
127644423|NCT01239030|459317334|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
127644424|NCT00829387|459317335|FG000|Overall Study|Withdrawal by Subject|2|||
127644425|NCT00829387|459317336|FG001|Overall Study|Withdrawal by Subject|3|||
127644426|NCT00829387|459317335|FG000|Overall Study|Disqualified by PI|1|||
127644427|NCT00829387|459317336|FG001|Overall Study|Disqualified by PI|0|||
127644428|NCT01112579|459317337|FG000|Overall Study|Missed Visit|1|||
127644429|NCT01112579|459317338|FG001|Overall Study|Missed Visit|1|||
127644430|NCT01112579|459317337|FG000|Overall Study|Death|0|||
127644431|NCT01112579|459317338|FG001|Overall Study|Death|2|||
127644432|NCT00818753|459317339|FG000|Overall Study|Protocol Violation|1|||
127644433|NCT00818753|459317340|FG001|Overall Study|Protocol Violation|0|||
127644434|NCT00818753|459317341|FG002|Overall Study|Protocol Violation|0|||
127644435|NCT00818753|459317339|FG000|Overall Study|Other reason (not specified)|0|||
127644436|NCT00818753|459317340|FG001|Overall Study|Other reason (not specified)|0|||
127644437|NCT00818753|459317341|FG002|Overall Study|Other reason (not specified)|1|||
127644438|NCT00818753|459317339|FG000|Overall Study|Randomised and not treated|2|||
127887793|NCT00931385|460211962|FG003|Overall Study|Withdrawal by Subject|1|||
127644439|NCT00818753|459317340|FG001|Overall Study|Randomised and not treated|0|||
127644440|NCT00818753|459317341|FG002|Overall Study|Randomised and not treated|0|||
127644441|NCT04304833|459317342|FG000|Overall Study|Due to the pandemic in person visits were not allowed|4|||
127644442|NCT04304833|459317343|FG001|Overall Study|Due to the pandemic in person visits were not allowed|2|||
127644443|NCT01951625|459317344|FG000|Treatment Period|Protocol Violation|2|||
127644444|NCT01951625|459317345|FG001|Treatment Period|Protocol Violation|0|||
127644445|NCT01951625|459317346|FG002|Treatment Period|Protocol Violation|1|||
127644446|NCT01951625|459317347|FG003|Treatment Period|Protocol Violation|3|||
127644447|NCT01951625|459317348|FG004|Treatment Period|Protocol Violation|2|||
127644448|NCT01951625|459317344|FG000|Treatment Period|Physician Decision|0|||
127644449|NCT01951625|459317345|FG001|Treatment Period|Physician Decision|0|||
127644450|NCT01951625|459317346|FG002|Treatment Period|Physician Decision|0|||
127644451|NCT01951625|459317347|FG003|Treatment Period|Physician Decision|0|||
127644452|NCT01951625|459317348|FG004|Treatment Period|Physician Decision|1|||
127644453|NCT01951625|459317344|FG000|Treatment Period|Protocol driven decision point|0|||
127644454|NCT01951625|459317345|FG001|Treatment Period|Protocol driven decision point|5|||
127644455|NCT01951625|459317346|FG002|Treatment Period|Protocol driven decision point|0|||
127644456|NCT01951625|459317347|FG003|Treatment Period|Protocol driven decision point|2|||
127644457|NCT01951625|459317348|FG004|Treatment Period|Protocol driven decision point|1|||
127644458|NCT01951625|459317344|FG000|Treatment Period|Non compliance with study drug|1|||
127644459|NCT01951625|459317345|FG001|Treatment Period|Non compliance with study drug|2|||
127644460|NCT01951625|459317346|FG002|Treatment Period|Non compliance with study drug|2|||
127644461|NCT01951625|459317347|FG003|Treatment Period|Non compliance with study drug|0|||
127644462|NCT01951625|459317348|FG004|Treatment Period|Non compliance with study drug|0|||
127644463|NCT01951625|459317344|FG000|Treatment Period|Death|3|||
127644464|NCT01951625|459317345|FG001|Treatment Period|Death|2|||
127644465|NCT01951625|459317346|FG002|Treatment Period|Death|2|||
127644466|NCT01951625|459317347|FG003|Treatment Period|Death|1|||
127706779|NCT03519178|459555443|FG004|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
127706780|NCT03519178|459555444|FG005|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
127706781|NCT03519178|459555445|FG006|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
127706782|NCT03519178|459555446|FG007|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
127706783|NCT03519178|459555447|FG008|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
127706784|NCT03519178|459555448|FG009|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
127706785|NCT03519178|459555449|FG010|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
127706786|NCT03519178|459555450|FG011|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
127706787|NCT03519178|459555451|FG012|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
127706788|NCT03519178|459555452|FG013|Disposition for Fluvestrant Treatment|Study terminated by sponsor|4|||
127706789|NCT03519178|459555453|FG014|Disposition for Fluvestrant Treatment|Study terminated by sponsor|4|||
127706790|NCT03519178|459555439|FG000|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
127706791|NCT03519178|459555440|FG001|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
127706792|NCT03519178|459555441|FG002|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
127706793|NCT03519178|459555442|FG003|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
127706794|NCT03519178|459555443|FG004|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
127706795|NCT03519178|459555444|FG005|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
127706796|NCT03519178|459555445|FG006|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
127706797|NCT03519178|459555446|FG007|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
127706798|NCT03519178|459555447|FG008|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
127706799|NCT03519178|459555448|FG009|Disposition for Fluvestrant Treatment|Withdrawal by Subject|2|||
127706800|NCT03519178|459555449|FG010|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
127706801|NCT03519178|459555450|FG011|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
127706802|NCT03519178|459555451|FG012|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
127706803|NCT03519178|459555452|FG013|Disposition for Fluvestrant Treatment|Withdrawal by Subject|1|||
127706804|NCT03519178|459555453|FG014|Disposition for Fluvestrant Treatment|Withdrawal by Subject|2|||
127706805|NCT03519178|459555439|FG000|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
127706806|NCT03519178|459555440|FG001|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
127706807|NCT03519178|459555441|FG002|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
127706808|NCT03519178|459555442|FG003|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
127706809|NCT03519178|459555443|FG004|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
127706810|NCT03519178|459555444|FG005|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
127799029|NCT00090545|459887973|FG000|Overall Study|Adverse Event|0|||
127799030|NCT00090545|459887974|FG001|Overall Study|Adverse Event|2|||
127799031|NCT00441545|459887975|FG000|First Intervention|Adverse Event|6|||
127799032|NCT00441545|459887976|FG001|First Intervention|Adverse Event|5|||
127799033|NCT00441545|459887975|FG000|First Intervention|Protocol Violation|2|||
127799034|NCT00441545|459887976|FG001|First Intervention|Protocol Violation|2|||
127799035|NCT00441545|459887975|FG000|First Intervention|Withdrawal by Subject|3|||
127799036|NCT00441545|459887976|FG001|First Intervention|Withdrawal by Subject|3|||
127799037|NCT00441545|459887975|FG000|First Intervention|Kidney transplant|1|||
127644467|NCT01951625|459317348|FG004|Treatment Period|Death|2|||
127644468|NCT01951625|459317344|FG000|Treatment Period|Adverse Event|7|||
127644469|NCT01951625|459317345|FG001|Treatment Period|Adverse Event|10|||
127644470|NCT01951625|459317346|FG002|Treatment Period|Adverse Event|9|||
127644471|NCT01951625|459317347|FG003|Treatment Period|Adverse Event|8|||
127644472|NCT01951625|459317348|FG004|Treatment Period|Adverse Event|8|||
127644473|NCT01951625|459317344|FG000|Treatment Period|Withdrawal by Subject|5|||
127644474|NCT01951625|459317345|FG001|Treatment Period|Withdrawal by Subject|2|||
127644475|NCT01951625|459317346|FG002|Treatment Period|Withdrawal by Subject|1|||
127644476|NCT01951625|459317347|FG003|Treatment Period|Withdrawal by Subject|7|||
127644477|NCT01951625|459317348|FG004|Treatment Period|Withdrawal by Subject|3|||
127644478|NCT01951625|459317344|FG000|Treatment Period|Lost to Follow-up|1|||
127644479|NCT01951625|459317345|FG001|Treatment Period|Lost to Follow-up|0|||
127644480|NCT01951625|459317346|FG002|Treatment Period|Lost to Follow-up|0|||
127644481|NCT01951625|459317347|FG003|Treatment Period|Lost to Follow-up|1|||
127644482|NCT01951625|459317348|FG004|Treatment Period|Lost to Follow-up|0|||
127644483|NCT01951625|459317344|FG000|Follow Up Period|Non-compliance with study drug|1|||
127644484|NCT01951625|459317345|FG001|Follow Up Period|Non-compliance with study drug|0|||
127644485|NCT01951625|459317346|FG002|Follow Up Period|Non-compliance with study drug|0|||
127644486|NCT01951625|459317347|FG003|Follow Up Period|Non-compliance with study drug|0|||
127644487|NCT01951625|459317348|FG004|Follow Up Period|Non-compliance with study drug|0|||
127644488|NCT01951625|459317344|FG000|Follow Up Period|Death|1|||
127644489|NCT01951625|459317345|FG001|Follow Up Period|Death|3|||
127644490|NCT01951625|459317346|FG002|Follow Up Period|Death|2|||
127644491|NCT01951625|459317347|FG003|Follow Up Period|Death|2|||
127644492|NCT01951625|459317348|FG004|Follow Up Period|Death|1|||
127644493|NCT01951625|459317344|FG000|Follow Up Period|Logistical difficulties|1|||
127644494|NCT01951625|459317345|FG001|Follow Up Period|Logistical difficulties|2|||
127644495|NCT01951625|459317346|FG002|Follow Up Period|Logistical difficulties|0|||
127644496|NCT01951625|459317347|FG003|Follow Up Period|Logistical difficulties|0|||
127644497|NCT01951625|459317348|FG004|Follow Up Period|Logistical difficulties|0|||
127644498|NCT01951625|459317344|FG000|Follow Up Period|Adverse Event|0|||
127644499|NCT01951625|459317345|FG001|Follow Up Period|Adverse Event|3|||
127644500|NCT01951625|459317346|FG002|Follow Up Period|Adverse Event|2|||
127644501|NCT01951625|459317347|FG003|Follow Up Period|Adverse Event|3|||
127644502|NCT01951625|459317348|FG004|Follow Up Period|Adverse Event|5|||
127644503|NCT01951625|459317344|FG000|Follow Up Period|Withdrawal by Subject|4|||
127644504|NCT01951625|459317345|FG001|Follow Up Period|Withdrawal by Subject|1|||
127644505|NCT01951625|459317346|FG002|Follow Up Period|Withdrawal by Subject|0|||
127644506|NCT01951625|459317347|FG003|Follow Up Period|Withdrawal by Subject|5|||
127644507|NCT01951625|459317348|FG004|Follow Up Period|Withdrawal by Subject|3|||
127644508|NCT01951625|459317344|FG000|Follow Up Period|Lost to Follow-up|1|||
127644509|NCT01951625|459317345|FG001|Follow Up Period|Lost to Follow-up|0|||
127644510|NCT01951625|459317346|FG002|Follow Up Period|Lost to Follow-up|0|||
127644511|NCT01951625|459317347|FG003|Follow Up Period|Lost to Follow-up|1|||
127644512|NCT01951625|459317348|FG004|Follow Up Period|Lost to Follow-up|1|||
127644513|NCT02459574|459317351|FG000|Overall Study|Withdrawal by Subject|6|||
127644514|NCT02459574|459317352|FG001|Overall Study|Withdrawal by Subject|6|||
127644515|NCT02459574|459317353|FG002|Overall Study|Withdrawal by Subject|2|||
127644516|NCT02459574|459317351|FG000|Overall Study|Lost to Follow-up|1|||
127644517|NCT02459574|459317352|FG001|Overall Study|Lost to Follow-up|1|||
127644518|NCT02459574|459317353|FG002|Overall Study|Lost to Follow-up|0|||
127644519|NCT02459574|459317351|FG000|Overall Study|Death|0|||
127644520|NCT02459574|459317352|FG001|Overall Study|Death|1|||
127644521|NCT02459574|459317353|FG002|Overall Study|Death|0|||
127644522|NCT00251745|459317354|FG000|Overall Study|Adverse Event|7|||
127644523|NCT00251745|459317355|FG001|Overall Study|Adverse Event|9|||
127644524|NCT00251745|459317356|FG002|Overall Study|Adverse Event|11|||
127644525|NCT00251745|459317354|FG000|Overall Study|Lost to Follow-up|4|||
127644526|NCT00251745|459317355|FG001|Overall Study|Lost to Follow-up|2|||
127644527|NCT00251745|459317356|FG002|Overall Study|Lost to Follow-up|5|||
127644528|NCT00251745|459317354|FG000|Overall Study|Withdrawal by Subject|13|||
127644529|NCT00251745|459317355|FG001|Overall Study|Withdrawal by Subject|7|||
127644530|NCT00251745|459317356|FG002|Overall Study|Withdrawal by Subject|3|||
127644531|NCT00251745|459317354|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
127644532|NCT00251745|459317355|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
127644533|NCT00251745|459317356|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
127644534|NCT00251745|459317354|FG000|Overall Study|Lack of Efficacy|3|||
127644535|NCT00251745|459317355|FG001|Overall Study|Lack of Efficacy|0|||
127644536|NCT00251745|459317356|FG002|Overall Study|Lack of Efficacy|0|||
127644537|NCT00251745|459317354|FG000|Overall Study|Noncompliant|0|||
127799038|NCT00441545|459887976|FG001|First Intervention|Kidney transplant|1|||
127644538|NCT00251745|459317355|FG001|Overall Study|Noncompliant|2|||
127644539|NCT00251745|459317356|FG002|Overall Study|Noncompliant|2|||
127644540|NCT00251745|459317354|FG000|Overall Study|Pregnancy|0|||
127644541|NCT00251745|459317355|FG001|Overall Study|Pregnancy|1|||
127644542|NCT00251745|459317356|FG002|Overall Study|Pregnancy|0|||
127644543|NCT00251745|459317354|FG000|Overall Study|Per Subject Request|0|||
127644544|NCT00251745|459317355|FG001|Overall Study|Per Subject Request|0|||
127644545|NCT00251745|459317356|FG002|Overall Study|Per Subject Request|1|||
127799039|NCT00441545|459887975|FG000|First Intervention|Lack of Efficacy|2|||
127799040|NCT00441545|459887976|FG001|First Intervention|Lack of Efficacy|0|||
127799041|NCT00441545|459887975|FG000|First Intervention|Subject exceeded safety criteria|0|||
127799042|NCT00441545|459887976|FG001|First Intervention|Subject exceeded safety criteria|1|||
127799043|NCT00441545|459887975|FG000|First Intervention|Subject met an exclusionary criteria|1|||
127799044|NCT00441545|459887976|FG001|First Intervention|Subject met an exclusionary criteria|0|||
127799045|NCT00441545|459887975|FG000|First Intervention|Extended hospitalization|1|||
127799046|NCT00441545|459887976|FG001|First Intervention|Extended hospitalization|0|||
127799047|NCT00441545|459887975|FG000|First Intervention|Site error|1|||
127799048|NCT00441545|459887976|FG001|First Intervention|Site error|0|||
127799049|NCT00441545|459887975|FG000|First Intervention|Sponsor's request|1|||
127799050|NCT00441545|459887976|FG001|First Intervention|Sponsor's request|0|||
127799051|NCT00441545|459887975|FG000|Second Intervention|Adverse Event|5|||
127799052|NCT00441545|459887976|FG001|Second Intervention|Adverse Event|2|||
127799053|NCT00441545|459887975|FG000|Second Intervention|Protocol Violation|4|||
127799054|NCT00441545|459887976|FG001|Second Intervention|Protocol Violation|1|||
127799055|NCT00441545|459887975|FG000|Second Intervention|Withdrawal by Subject|1|||
127799056|NCT00441545|459887976|FG001|Second Intervention|Withdrawal by Subject|1|||
127799057|NCT00441545|459887975|FG000|Second Intervention|Kidney Transplant|1|||
127799058|NCT00441545|459887976|FG001|Second Intervention|Kidney Transplant|1|||
127799059|NCT00441545|459887975|FG000|Second Intervention|Lack of Efficacy|0|||
127799060|NCT00441545|459887976|FG001|Second Intervention|Lack of Efficacy|1|||
127644546|NCT00251745|459317354|FG000|Overall Study|Per Investigator Request|1|||
127644547|NCT00251745|459317355|FG001|Overall Study|Per Investigator Request|0|||
127644548|NCT00251745|459317356|FG002|Overall Study|Per Investigator Request|0|||
127644549|NCT04866017|459317359|FG000|Overall Study|Study Terminated by Sponsor|13|||
127644550|NCT04866017|459317360|FG001|Overall Study|Study Terminated by Sponsor|14|||
127644551|NCT04866017|459317361|FG002|Overall Study|Study Terminated by Sponsor|13|||
127644552|NCT04866017|459317359|FG000|Overall Study|Death|8|||
127644553|NCT04866017|459317360|FG001|Overall Study|Death|4|||
127644554|NCT04866017|459317361|FG002|Overall Study|Death|8|||
127644555|NCT04866017|459317359|FG000|Overall Study|Withdrawal by Subject|1|||
127644556|NCT04866017|459317360|FG001|Overall Study|Withdrawal by Subject|0|||
127644557|NCT04866017|459317361|FG002|Overall Study|Withdrawal by Subject|1|||
127644558|NCT04866017|459317359|FG000|Overall Study|Physician Decision|0|||
127644559|NCT04866017|459317360|FG001|Overall Study|Physician Decision|1|||
127644560|NCT04866017|459317361|FG002|Overall Study|Physician Decision|0|||
127644561|NCT01475136|459317362|FG000|Overall Study|Sponsor Decision|0|||
127644562|NCT01475136|459317363|FG001|Overall Study|Sponsor Decision|1|||
127644563|NCT01475136|459317364|FG002|Overall Study|Sponsor Decision|0|||
127644564|NCT01475136|459317365|FG003|Overall Study|Sponsor Decision|0|||
127644565|NCT01475136|459317362|FG000|Overall Study|Entry Criteria Not Met|0|||
127644566|NCT01475136|459317363|FG001|Overall Study|Entry Criteria Not Met|2|||
127644567|NCT01475136|459317364|FG002|Overall Study|Entry Criteria Not Met|3|||
127644568|NCT01475136|459317365|FG003|Overall Study|Entry Criteria Not Met|1|||
127644569|NCT01475136|459317362|FG000|Overall Study|Withdrawal by Subject|0|||
127644570|NCT01475136|459317363|FG001|Overall Study|Withdrawal by Subject|0|||
127644571|NCT01475136|459317364|FG002|Overall Study|Withdrawal by Subject|0|||
127644572|NCT01475136|459317365|FG003|Overall Study|Withdrawal by Subject|2|||
127644573|NCT01475136|459317362|FG000|Overall Study|Adverse Event|1|||
127644574|NCT01475136|459317363|FG001|Overall Study|Adverse Event|0|||
127644575|NCT01475136|459317364|FG002|Overall Study|Adverse Event|0|||
127644576|NCT01475136|459317365|FG003|Overall Study|Adverse Event|1|||
127644577|NCT01475136|459317362|FG000|Overall Study|Death|0|||
127644578|NCT01475136|459317363|FG001|Overall Study|Death|0|||
127644579|NCT01475136|459317364|FG002|Overall Study|Death|0|||
127644580|NCT01475136|459317365|FG003|Overall Study|Death|1|||
127644581|NCT03355326|459317366|FG000|Overall Study|Protocol Violation|3|||
127644582|NCT03355326|459317367|FG001|Overall Study|Protocol Violation|3|||
127644583|NCT04179175|459319084|FG000|Overall Study|Ongoing at the time of the data cut-off date|94|||
127799061|NCT00441545|459887975|FG000|Second Intervention|Subject exceeded safety criteria|1|||
127799062|NCT00441545|459887976|FG001|Second Intervention|Subject exceeded safety criteria|0|||
127799063|NCT00441545|459887975|FG000|Second Intervention|Subject moved|0|||
127799064|NCT00441545|459887976|FG001|Second Intervention|Subject moved|1|||
127644584|NCT04179175|459319085|FG001|Overall Study|Ongoing at the time of the data cut-off date|54|||
127644585|NCT04179175|459319086|FG002|Overall Study|Ongoing at the time of the data cut-off date|95|||
127799065|NCT02347176|459887977|FG000|Overall Study|Lost to Follow-up|2|||
127799066|NCT02347176|459887978|FG001|Overall Study|Lost to Follow-up|3|||
127887794|NCT00931385|460211959|FG000|Overall Study|Lost to Follow-up|0|||
127644586|NCT04179175|459319087|FG003|Overall Study|Ongoing at the time of the data cut-off date|43|||
127644587|NCT04179175|459319088|FG004|Overall Study|Ongoing at the time of the data cut-off date|98|||
127644588|NCT04179175|459319089|FG005|Overall Study|Ongoing at the time of the data cut-off date|105|||
127644589|NCT04179175|459319084|FG000|Overall Study|Adverse Event|5|||
127799067|NCT02347176|459887979|FG002|Overall Study|Lost to Follow-up|1|||
127799068|NCT02347176|459887980|FG003|Overall Study|Lost to Follow-up|1|||
127706811|NCT03519178|459555445|FG006|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
127706812|NCT03519178|459555446|FG007|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
127706813|NCT03519178|459555447|FG008|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
127706814|NCT03519178|459555448|FG009|Disposition for Fluvestrant Treatment|Global deterioration of health status|1|||
127706815|NCT03519178|459555449|FG010|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
127706816|NCT03519178|459555450|FG011|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
127706817|NCT03519178|459555451|FG012|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
127706818|NCT03519178|459555452|FG013|Disposition for Fluvestrant Treatment|Global deterioration of health status|3|||
127706819|NCT03519178|459555453|FG014|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
127706820|NCT03519178|459555439|FG000|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
127706821|NCT03519178|459555440|FG001|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
127706822|NCT03519178|459555441|FG002|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
127799069|NCT02347176|459887977|FG000|Overall Study|Withdrawal by Subject|9|||
127799070|NCT02347176|459887978|FG001|Overall Study|Withdrawal by Subject|5|||
127799071|NCT02347176|459887979|FG002|Overall Study|Withdrawal by Subject|5|||
127799072|NCT02347176|459887980|FG003|Overall Study|Withdrawal by Subject|3|||
127799073|NCT02347176|459887977|FG000|Overall Study|Other|1|||
127799074|NCT02347176|459887978|FG001|Overall Study|Other|2|||
127799075|NCT02347176|459887979|FG002|Overall Study|Other|2|||
127799076|NCT02347176|459887980|FG003|Overall Study|Other|0|||
127799077|NCT02809833|459887985|FG000|Overall Study|Death|3|||
127799078|NCT02809833|459887985|FG000|Overall Study|Intolerance|54|||
127799079|NCT02809833|459887985|FG000|Overall Study|Lack of Efficacy|89|||
127799080|NCT02809833|459887985|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
127799081|NCT02809833|459887985|FG000|Overall Study|Noncompliance|1|||
127799082|NCT02809833|459887985|FG000|Overall Study|Withdrawal by Subject|34|||
127799083|NCT02809833|459887985|FG000|Overall Study|Lost to Follow-up|35|||
127799084|NCT02809833|459887985|FG000|Overall Study|Adverse Event (AE)|24|||
127799085|NCT02809833|459887985|FG000|Overall Study|Other|5|||
127799086|NCT02809833|459887985|FG000|Overall Study|Missing Information|52|||
127799087|NCT00523991|459887986|FG000|Overall Study|Adverse Event|6|||
127799088|NCT00523991|459887987|FG001|Overall Study|Adverse Event|5|||
127799089|NCT00523991|459887986|FG000|Overall Study|Protocol Violation|1|||
127799090|NCT00523991|459887987|FG001|Overall Study|Protocol Violation|4|||
127799091|NCT00523991|459887986|FG000|Overall Study|Lost to Follow-up|4|||
127799092|NCT00523991|459887987|FG001|Overall Study|Lost to Follow-up|1|||
127799093|NCT00523991|459887986|FG000|Overall Study|Withdrawal by Subject|7|||
127799094|NCT00523991|459887987|FG001|Overall Study|Withdrawal by Subject|17|||
127799095|NCT00523991|459887986|FG000|Overall Study|Other reason (not specified)|3|||
127799096|NCT00523991|459887987|FG001|Overall Study|Other reason (not specified)|0|||
127799097|NCT00193063|459887989|FG000|Overall Study|Lack of Efficacy|3|||
127799098|NCT00193063|459887989|FG000|Overall Study|Adverse Event|1|||
127799099|NCT00744874|459887990|FG000|Overall Study|Lost to Follow-up|1|||
127799100|NCT00744874|459887990|FG000|Overall Study|Withdrawal by Subject|1|||
127799101|NCT00744874|459887990|FG000|Overall Study|Study Device not available at procedure|1|||
127799102|NCT00744874|459887990|FG000|Overall Study|Unable to accomodate schedule|1|||
127799103|NCT01064167|459887991|FG000|Overall Study|Protocol Violation|14|||
127799104|NCT01064167|459887992|FG001|Overall Study|Protocol Violation|15|||
127799105|NCT00725075|459887993|FG000|Overall Study|Use of Excluded Medication|0|||
127799106|NCT00725075|459887994|FG001|Overall Study|Use of Excluded Medication|1|||
127799107|NCT00725075|459887995|FG002|Overall Study|Use of Excluded Medication|0|||
127799108|NCT00725075|459887993|FG000|Overall Study|Protocol Violation|0|||
127799109|NCT00725075|459887994|FG001|Overall Study|Protocol Violation|0|||
127799110|NCT00725075|459887995|FG002|Overall Study|Protocol Violation|1|||
127799111|NCT00725075|459887993|FG000|Overall Study|Lost to Follow-up|1|||
127799112|NCT00725075|459887994|FG001|Overall Study|Lost to Follow-up|0|||
127799113|NCT00725075|459887995|FG002|Overall Study|Lost to Follow-up|0|||
127799114|NCT00725075|459887993|FG000|Overall Study|Withdrawal by Subject|4|||
127799115|NCT00725075|459887994|FG001|Overall Study|Withdrawal by Subject|5|||
127799116|NCT00725075|459887995|FG002|Overall Study|Withdrawal by Subject|4|||
127799117|NCT00725075|459887993|FG000|Overall Study|Adverse Event|2|||
127799118|NCT00725075|459887994|FG001|Overall Study|Adverse Event|1|||
127799119|NCT00725075|459887995|FG002|Overall Study|Adverse Event|1|||
127799120|NCT00725075|459887993|FG000|Overall Study|Worsening of Disease|2|||
127799121|NCT00725075|459887994|FG001|Overall Study|Worsening of Disease|1|||
127799122|NCT00725075|459887995|FG002|Overall Study|Worsening of Disease|2|||
127799123|NCT00725075|459887993|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
127799124|NCT00725075|459887994|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
127799125|NCT00725075|459887995|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
127799126|NCT00725075|459887993|FG000|Overall Study|Other|1|||
127887795|NCT00931385|460211960|FG001|Overall Study|Lost to Follow-up|0|||
127887796|NCT00931385|460211961|FG002|Overall Study|Lost to Follow-up|0|||
127887797|NCT00931385|460211962|FG003|Overall Study|Lost to Follow-up|1|||
127706823|NCT03519178|459555442|FG003|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
127706824|NCT03519178|459555443|FG004|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
127706825|NCT03519178|459555444|FG005|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
127706826|NCT03519178|459555445|FG006|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
127706827|NCT03519178|459555446|FG007|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
127706828|NCT03519178|459555447|FG008|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
127706829|NCT03519178|459555448|FG009|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
127706830|NCT03519178|459555449|FG010|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
127706831|NCT03519178|459555450|FG011|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
127706832|NCT03519178|459555451|FG012|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
127706833|NCT03519178|459555452|FG013|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
127706834|NCT03519178|459555453|FG014|Disposition for Fluvestrant Treatment|Refused further treatment|2|||
127706835|NCT03519178|459555439|FG000|Disposition for Fluvestrant Treatment|Other|0|||
127706836|NCT03519178|459555440|FG001|Disposition for Fluvestrant Treatment|Other|0|||
127706837|NCT03519178|459555441|FG002|Disposition for Fluvestrant Treatment|Other|0|||
127706838|NCT03519178|459555442|FG003|Disposition for Fluvestrant Treatment|Other|0|||
127706839|NCT03519178|459555443|FG004|Disposition for Fluvestrant Treatment|Other|0|||
127706840|NCT03519178|459555444|FG005|Disposition for Fluvestrant Treatment|Other|0|||
127706841|NCT03519178|459555445|FG006|Disposition for Fluvestrant Treatment|Other|0|||
127706842|NCT03519178|459555446|FG007|Disposition for Fluvestrant Treatment|Other|0|||
127706843|NCT03519178|459555447|FG008|Disposition for Fluvestrant Treatment|Other|0|||
127706844|NCT03519178|459555448|FG009|Disposition for Fluvestrant Treatment|Other|0|||
127706845|NCT03519178|459555449|FG010|Disposition for Fluvestrant Treatment|Other|0|||
127706846|NCT03519178|459555450|FG011|Disposition for Fluvestrant Treatment|Other|0|||
127706847|NCT03519178|459555451|FG012|Disposition for Fluvestrant Treatment|Other|0|||
127706848|NCT03519178|459555452|FG013|Disposition for Fluvestrant Treatment|Other|1|||
127706849|NCT03519178|459555453|FG014|Disposition for Fluvestrant Treatment|Other|3|||
127706850|NCT03519178|459555439|FG000|Disposition for Fluvestrant Treatment|Ongoing|0|||
127706851|NCT03519178|459555440|FG001|Disposition for Fluvestrant Treatment|Ongoing|0|||
127706852|NCT03519178|459555441|FG002|Disposition for Fluvestrant Treatment|Ongoing|0|||
127706853|NCT03519178|459555442|FG003|Disposition for Fluvestrant Treatment|Ongoing|0|||
127706854|NCT03519178|459555443|FG004|Disposition for Fluvestrant Treatment|Ongoing|0|||
127706855|NCT03519178|459555444|FG005|Disposition for Fluvestrant Treatment|Ongoing|0|||
127706856|NCT03519178|459555445|FG006|Disposition for Fluvestrant Treatment|Ongoing|0|||
127706857|NCT03519178|459555446|FG007|Disposition for Fluvestrant Treatment|Ongoing|0|||
127706858|NCT03519178|459555447|FG008|Disposition for Fluvestrant Treatment|Ongoing|0|||
127706859|NCT03519178|459555448|FG009|Disposition for Fluvestrant Treatment|Ongoing|0|||
127706860|NCT03519178|459555449|FG010|Disposition for Fluvestrant Treatment|Ongoing|0|||
127706861|NCT03519178|459555450|FG011|Disposition for Fluvestrant Treatment|Ongoing|0|||
127706862|NCT03519178|459555451|FG012|Disposition for Fluvestrant Treatment|Ongoing|0|||
127706863|NCT03519178|459555452|FG013|Disposition for Fluvestrant Treatment|Ongoing|1|||
127706864|NCT03519178|459555453|FG014|Disposition for Fluvestrant Treatment|Ongoing|6|||
127706865|NCT03519178|459555439|FG000|Disposition for Letrozole Treatment|Physician Decision|0|||
127706866|NCT03519178|459555440|FG001|Disposition for Letrozole Treatment|Physician Decision|0|||
127706867|NCT03519178|459555441|FG002|Disposition for Letrozole Treatment|Physician Decision|0|||
127706868|NCT03519178|459555442|FG003|Disposition for Letrozole Treatment|Physician Decision|0|||
127706869|NCT03519178|459555443|FG004|Disposition for Letrozole Treatment|Physician Decision|0|||
127706870|NCT03519178|459555444|FG005|Disposition for Letrozole Treatment|Physician Decision|0|||
127706871|NCT03519178|459555445|FG006|Disposition for Letrozole Treatment|Physician Decision|0|||
127706872|NCT03519178|459555446|FG007|Disposition for Letrozole Treatment|Physician Decision|0|||
127706873|NCT03519178|459555447|FG008|Disposition for Letrozole Treatment|Physician Decision|0|||
127887798|NCT00811070|460211964|FG000|Overall Study|Death|0|||
127706874|NCT03519178|459555448|FG009|Disposition for Letrozole Treatment|Physician Decision|0|||
127887799|NCT00811070|460211965|FG001|Overall Study|Death|0|||
127799127|NCT00725075|459887994|FG001|Overall Study|Other|0|||
127644590|NCT04179175|459319085|FG001|Overall Study|Adverse Event|3|||
127644591|NCT04179175|459319086|FG002|Overall Study|Adverse Event|3|||
127644592|NCT04179175|459319087|FG003|Overall Study|Adverse Event|4|||
127644593|NCT04179175|459319088|FG004|Overall Study|Adverse Event|6|||
127644594|NCT04179175|459319089|FG005|Overall Study|Adverse Event|6|||
127644595|NCT04179175|459319084|FG000|Overall Study|Lack of Efficacy|5|||
127644596|NCT04179175|459319085|FG001|Overall Study|Lack of Efficacy|1|||
127644597|NCT04179175|459319086|FG002|Overall Study|Lack of Efficacy|3|||
127644598|NCT04179175|459319087|FG003|Overall Study|Lack of Efficacy|2|||
127644599|NCT04179175|459319088|FG004|Overall Study|Lack of Efficacy|18|||
127644600|NCT04179175|459319089|FG005|Overall Study|Lack of Efficacy|7|||
127644601|NCT04179175|459319084|FG000|Overall Study|Lost to Follow-up|5|||
127644602|NCT04179175|459319085|FG001|Overall Study|Lost to Follow-up|3|||
127644603|NCT04179175|459319086|FG002|Overall Study|Lost to Follow-up|2|||
127644604|NCT04179175|459319087|FG003|Overall Study|Lost to Follow-up|2|||
127644605|NCT04179175|459319088|FG004|Overall Study|Lost to Follow-up|4|||
127644606|NCT04179175|459319089|FG005|Overall Study|Lost to Follow-up|5|||
127644607|NCT04179175|459319084|FG000|Overall Study|Physician Decision|2|||
127644608|NCT04179175|459319085|FG001|Overall Study|Physician Decision|0|||
127644609|NCT04179175|459319086|FG002|Overall Study|Physician Decision|2|||
127644610|NCT04179175|459319087|FG003|Overall Study|Physician Decision|3|||
127644611|NCT04179175|459319088|FG004|Overall Study|Physician Decision|1|||
127644612|NCT04179175|459319089|FG005|Overall Study|Physician Decision|1|||
127644613|NCT04179175|459319084|FG000|Overall Study|Pregnancy|3|||
127644614|NCT04179175|459319085|FG001|Overall Study|Pregnancy|0|||
127644615|NCT04179175|459319086|FG002|Overall Study|Pregnancy|3|||
127644616|NCT04179175|459319087|FG003|Overall Study|Pregnancy|0|||
127644617|NCT04179175|459319088|FG004|Overall Study|Pregnancy|1|||
127644618|NCT04179175|459319089|FG005|Overall Study|Pregnancy|2|||
127644619|NCT04179175|459319084|FG000|Overall Study|Withdrawal by Subject|22|||
127644620|NCT04179175|459319085|FG001|Overall Study|Withdrawal by Subject|10|||
127644621|NCT04179175|459319086|FG002|Overall Study|Withdrawal by Subject|12|||
127644622|NCT04179175|459319087|FG003|Overall Study|Withdrawal by Subject|8|||
127644623|NCT04179175|459319088|FG004|Overall Study|Withdrawal by Subject|23|||
127644624|NCT04179175|459319089|FG005|Overall Study|Withdrawal by Subject|31|||
127644625|NCT04179175|459319084|FG000|Overall Study|Technical problems|0|||
127644626|NCT04179175|459319085|FG001|Overall Study|Technical problems|0|||
127644627|NCT04179175|459319086|FG002|Overall Study|Technical problems|1|||
127644628|NCT04179175|459319087|FG003|Overall Study|Technical problems|1|||
127644629|NCT04179175|459319088|FG004|Overall Study|Technical problems|0|||
127644630|NCT04179175|459319089|FG005|Overall Study|Technical problems|0|||
127644631|NCT03014674|459319093|FG000|Overall Study|Withdrawal by Subject|1|||
127644632|NCT03014674|459319094|FG001|Overall Study|Withdrawal by Subject|0|||
127644633|NCT03014674|459319095|FG002|Overall Study|Withdrawal by Subject|0|||
127644634|NCT03224182|459319099|FG000|Overall Study|Study Drug Not Instilled|6|||
127644635|NCT03224182|459319100|FG001|Overall Study|Study Drug Not Instilled|1|||
127644636|NCT03224182|459319099|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
127644637|NCT03224182|459319100|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
127644638|NCT03224182|459319099|FG000|Overall Study|Withdrew of Consent|4|||
127644639|NCT03224182|459319100|FG001|Overall Study|Withdrew of Consent|2|||
127644640|NCT03224182|459319099|FG000|Overall Study|Investigator Decision|3|||
127644641|NCT03224182|459319100|FG001|Overall Study|Investigator Decision|1|||
127644642|NCT03224182|459319099|FG000|Overall Study|Sponsor Decision|26|||
127644643|NCT03224182|459319100|FG001|Overall Study|Sponsor Decision|12|||
127644644|NCT03224182|459319099|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
127644645|NCT03224182|459319100|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
127644646|NCT03224182|459319099|FG000|Overall Study|Lost to Follow-up|1|||
127644647|NCT03224182|459319100|FG001|Overall Study|Lost to Follow-up|0|||
127644648|NCT03224182|459319099|FG000|Overall Study|Participant Had Recurrence|11|||
127644649|NCT03224182|459319100|FG001|Overall Study|Participant Had Recurrence|5|||
127644650|NCT03224182|459319099|FG000|Overall Study|Death|0|||
127644651|NCT03224182|459319100|FG001|Overall Study|Death|1|||
127644652|NCT03224182|459319099|FG000|Overall Study|Reason not Specified|3|||
127644653|NCT03224182|459319100|FG001|Overall Study|Reason not Specified|3|||
127644654|NCT03224182|459319099|FG000|Overall Study|Other|1|||
127644655|NCT03224182|459319100|FG001|Overall Study|Other|0|||
127644656|NCT02822222|459319101|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
127644657|NCT02822222|459319102|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
127644658|NCT02481310|459319103|FG000|Follow up|Still in follow up|0|||
127644659|NCT02481310|459319104|FG001|Follow up|Still in follow up|3|||
127644660|NCT02481310|459319105|FG002|Follow up|Still in follow up|0|||
127644661|NCT00833560|459319106|FG000|Overall Study|Toxicity|13|||
127644662|NCT00833560|459319106|FG000|Overall Study|Adverse Event|11|||
127644663|NCT00833560|459319106|FG000|Overall Study|Protocol Violation|6|||
127644664|NCT00833560|459319106|FG000|Overall Study|Lack of Efficacy|4|||
127706875|NCT03519178|459555449|FG010|Disposition for Letrozole Treatment|Physician Decision|1|||
127706876|NCT03519178|459555450|FG011|Disposition for Letrozole Treatment|Physician Decision|0|||
127706877|NCT03519178|459555451|FG012|Disposition for Letrozole Treatment|Physician Decision|0|||
127706878|NCT03519178|459555452|FG013|Disposition for Letrozole Treatment|Physician Decision|0|||
127706879|NCT03519178|459555453|FG014|Disposition for Letrozole Treatment|Physician Decision|0|||
127706880|NCT03519178|459555439|FG000|Disposition for Letrozole Treatment|Progressive disease|0|||
127706881|NCT03519178|459555440|FG001|Disposition for Letrozole Treatment|Progressive disease|0|||
127706882|NCT03519178|459555441|FG002|Disposition for Letrozole Treatment|Progressive disease|0|||
127706883|NCT03519178|459555442|FG003|Disposition for Letrozole Treatment|Progressive disease|0|||
127706884|NCT03519178|459555443|FG004|Disposition for Letrozole Treatment|Progressive disease|0|||
127706885|NCT03519178|459555444|FG005|Disposition for Letrozole Treatment|Progressive disease|0|||
127706886|NCT03519178|459555445|FG006|Disposition for Letrozole Treatment|Progressive disease|0|||
127706887|NCT03519178|459555446|FG007|Disposition for Letrozole Treatment|Progressive disease|0|||
127706888|NCT03519178|459555447|FG008|Disposition for Letrozole Treatment|Progressive disease|0|||
127706889|NCT03519178|459555448|FG009|Disposition for Letrozole Treatment|Progressive disease|0|||
127706890|NCT03519178|459555449|FG010|Disposition for Letrozole Treatment|Progressive disease|4|||
127706891|NCT03519178|459555450|FG011|Disposition for Letrozole Treatment|Progressive disease|0|||
127706892|NCT03519178|459555451|FG012|Disposition for Letrozole Treatment|Progressive disease|0|||
127706893|NCT03519178|459555452|FG013|Disposition for Letrozole Treatment|Progressive disease|0|||
127706894|NCT03519178|459555453|FG014|Disposition for Letrozole Treatment|Progressive disease|0|||
127706895|NCT03519178|459555439|FG000|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
127706896|NCT03519178|459555440|FG001|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
127706897|NCT03519178|459555441|FG002|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
127706898|NCT03519178|459555442|FG003|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
127706899|NCT03519178|459555443|FG004|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
127706900|NCT03519178|459555444|FG005|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
127706901|NCT03519178|459555445|FG006|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
127706902|NCT03519178|459555446|FG007|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
127706903|NCT03519178|459555447|FG008|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
127706904|NCT03519178|459555448|FG009|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
127706905|NCT03519178|459555449|FG010|Disposition for Letrozole Treatment|Global deterioration of health status|2|||
127706906|NCT03519178|459555450|FG011|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
127706907|NCT03519178|459555451|FG012|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
127706908|NCT03519178|459555452|FG013|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
127706909|NCT03519178|459555453|FG014|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
127706910|NCT03519178|459555439|FG000|Follow-Up|Death|0|||
127706911|NCT03519178|459555440|FG001|Follow-Up|Death|0|||
127706912|NCT03519178|459555441|FG002|Follow-Up|Death|1|||
127706913|NCT03519178|459555442|FG003|Follow-Up|Death|0|||
127706914|NCT03519178|459555443|FG004|Follow-Up|Death|0|||
127706915|NCT03519178|459555444|FG005|Follow-Up|Death|0|||
127706916|NCT03519178|459555445|FG006|Follow-Up|Death|0|||
127706917|NCT03519178|459555446|FG007|Follow-Up|Death|0|||
127706918|NCT03519178|459555447|FG008|Follow-Up|Death|3|||
127706919|NCT03519178|459555448|FG009|Follow-Up|Death|1|||
127706920|NCT03519178|459555449|FG010|Follow-Up|Death|0|||
127706921|NCT03519178|459555450|FG011|Follow-Up|Death|0|||
127706922|NCT03519178|459555451|FG012|Follow-Up|Death|2|||
127706923|NCT03519178|459555452|FG013|Follow-Up|Death|0|||
127706924|NCT03519178|459555453|FG014|Follow-Up|Death|0|||
127706925|NCT03519178|459555439|FG000|Follow-Up|Lost to Follow-up|0|||
127799128|NCT00725075|459887995|FG002|Overall Study|Other|0|||
127799129|NCT03984305|459887997|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
127799130|NCT03984305|459887998|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
127706926|NCT03519178|459555440|FG001|Follow-Up|Lost to Follow-up|0|||
127706927|NCT03519178|459555441|FG002|Follow-Up|Lost to Follow-up|0|||
127706928|NCT03519178|459555442|FG003|Follow-Up|Lost to Follow-up|0|||
127706929|NCT03519178|459555443|FG004|Follow-Up|Lost to Follow-up|0|||
127706930|NCT03519178|459555444|FG005|Follow-Up|Lost to Follow-up|3|||
127706931|NCT03519178|459555445|FG006|Follow-Up|Lost to Follow-up|1|||
127706932|NCT03519178|459555446|FG007|Follow-Up|Lost to Follow-up|4|||
127706933|NCT03519178|459555447|FG008|Follow-Up|Lost to Follow-up|1|||
127799131|NCT03984305|459887997|FG000|Overall Study|Withdrawal by Subject|3|||
127799132|NCT03984305|459887998|FG001|Overall Study|Withdrawal by Subject|3|||
127706934|NCT03519178|459555448|FG009|Follow-Up|Lost to Follow-up|0|||
127706935|NCT03519178|459555449|FG010|Follow-Up|Lost to Follow-up|0|||
127706936|NCT03519178|459555450|FG011|Follow-Up|Lost to Follow-up|0|||
127706937|NCT03519178|459555451|FG012|Follow-Up|Lost to Follow-up|0|||
127706938|NCT03519178|459555452|FG013|Follow-Up|Lost to Follow-up|0|||
127706939|NCT03519178|459555453|FG014|Follow-Up|Lost to Follow-up|0|||
127887800|NCT00811070|460211966|FG002|Overall Study|Death|0|||
127887801|NCT00811070|460211967|FG003|Overall Study|Death|2|||
127887802|NCT00811070|460211968|FG004|Overall Study|Death|5|||
127887803|NCT00811070|460211969|FG005|Overall Study|Death|0|||
127887804|NCT00811070|460211964|FG000|Overall Study|Other|1|||
127887805|NCT00811070|460211965|FG001|Overall Study|Other|0|||
127887806|NCT00811070|460211966|FG002|Overall Study|Other|0|||
127887807|NCT00811070|460211967|FG003|Overall Study|Other|0|||
127887808|NCT00811070|460211968|FG004|Overall Study|Other|0|||
127887809|NCT00811070|460211969|FG005|Overall Study|Other|0|||
127887810|NCT00811070|460211964|FG000|Overall Study|Withdrawal by Subject|0|||
127887811|NCT00811070|460211965|FG001|Overall Study|Withdrawal by Subject|1|||
127887812|NCT00811070|460211966|FG002|Overall Study|Withdrawal by Subject|0|||
127887813|NCT00811070|460211967|FG003|Overall Study|Withdrawal by Subject|0|||
127887814|NCT00811070|460211968|FG004|Overall Study|Withdrawal by Subject|0|||
127887815|NCT00811070|460211969|FG005|Overall Study|Withdrawal by Subject|0|||
127887816|NCT00811070|460211964|FG000|Overall Study|Physician Decision|0|||
127887817|NCT00811070|460211965|FG001|Overall Study|Physician Decision|0|||
127887818|NCT00811070|460211966|FG002|Overall Study|Physician Decision|0|||
127887819|NCT00811070|460211967|FG003|Overall Study|Physician Decision|0|||
127887820|NCT00811070|460211968|FG004|Overall Study|Physician Decision|0|||
127887821|NCT00811070|460211969|FG005|Overall Study|Physician Decision|1|||
127887822|NCT04444752|460211973|FG000|Overall Study|Adverse Event|1|||
127887823|NCT04444752|460211974|FG001|Overall Study|Adverse Event|0|||
127887824|NCT04444752|460211975|FG002|Overall Study|Adverse Event|0|||
127887825|NCT04444752|460211976|FG003|Overall Study|Adverse Event|2|||
127887826|NCT04444752|460211973|FG000|Overall Study|Lost to Follow-up|2|||
127887827|NCT04444752|460211974|FG001|Overall Study|Lost to Follow-up|6|||
127887828|NCT04444752|460211975|FG002|Overall Study|Lost to Follow-up|2|||
127887829|NCT04444752|460211976|FG003|Overall Study|Lost to Follow-up|5|||
127887830|NCT04444752|460211973|FG000|Overall Study|Physician Decision|0|||
127887831|NCT04444752|460211974|FG001|Overall Study|Physician Decision|0|||
127887832|NCT04444752|460211975|FG002|Overall Study|Physician Decision|0|||
127887833|NCT04444752|460211976|FG003|Overall Study|Physician Decision|2|||
127887834|NCT04444752|460211973|FG000|Overall Study|Pregnancy|0|||
127887835|NCT04444752|460211974|FG001|Overall Study|Pregnancy|0|||
127887836|NCT04444752|460211975|FG002|Overall Study|Pregnancy|0|||
127887837|NCT04444752|460211976|FG003|Overall Study|Pregnancy|1|||
127887838|NCT04444752|460211973|FG000|Overall Study|Withdrawal by Subject|6|||
127887839|NCT04444752|460211974|FG001|Overall Study|Withdrawal by Subject|5|||
127887840|NCT04444752|460211975|FG002|Overall Study|Withdrawal by Subject|3|||
127887841|NCT04444752|460211976|FG003|Overall Study|Withdrawal by Subject|4|||
127887842|NCT04444752|460211973|FG000|Overall Study|Protocol Violation|1|||
127887843|NCT04444752|460211974|FG001|Overall Study|Protocol Violation|1|||
127887844|NCT04444752|460211975|FG002|Overall Study|Protocol Violation|0|||
127887845|NCT04444752|460211976|FG003|Overall Study|Protocol Violation|0|||
127887846|NCT04444752|460211973|FG000|Overall Study|Patient moving out of town|1|||
127887847|NCT04444752|460211974|FG001|Overall Study|Patient moving out of town|0|||
127887848|NCT04444752|460211975|FG002|Overall Study|Patient moving out of town|0|||
127887849|NCT04444752|460211976|FG003|Overall Study|Patient moving out of town|1|||
127644665|NCT00833560|459319106|FG000|Overall Study|Death|2|||
127644666|NCT00833560|459319106|FG000|Overall Study|Pregression of other disease|1|||
127644667|NCT00833560|459319106|FG000|Overall Study|Other|5|||
127644668|NCT00643916|459319107|FG000|Overall Study|Protocol Violation|0|||
127644669|NCT00643916|459319108|FG001|Overall Study|Protocol Violation|1|||
127644670|NCT00643916|459319109|FG002|Overall Study|Protocol Violation|1|||
127644671|NCT00643916|459319110|FG003|Overall Study|Protocol Violation|1|||
127644672|NCT00643916|459319111|FG004|Overall Study|Protocol Violation|0|||
127644673|NCT00643916|459319112|FG005|Overall Study|Protocol Violation|0|||
127644674|NCT00643916|459319107|FG000|Overall Study|Lost to Follow-up|0|||
127644675|NCT00643916|459319108|FG001|Overall Study|Lost to Follow-up|1|||
127644676|NCT00643916|459319109|FG002|Overall Study|Lost to Follow-up|0|||
127644677|NCT00643916|459319110|FG003|Overall Study|Lost to Follow-up|0|||
127644678|NCT00643916|459319111|FG004|Overall Study|Lost to Follow-up|0|||
127644679|NCT00643916|459319112|FG005|Overall Study|Lost to Follow-up|0|||
127644680|NCT00643916|459319107|FG000|Overall Study|Withdrawal by Subject|2|||
127644681|NCT00643916|459319108|FG001|Overall Study|Withdrawal by Subject|2|||
127644682|NCT00643916|459319109|FG002|Overall Study|Withdrawal by Subject|2|||
127644683|NCT00643916|459319110|FG003|Overall Study|Withdrawal by Subject|1|||
127644684|NCT00643916|459319111|FG004|Overall Study|Withdrawal by Subject|0|||
127644685|NCT00643916|459319112|FG005|Overall Study|Withdrawal by Subject|1|||
127644686|NCT00643916|459319107|FG000|Overall Study|Not Vaccinated|2|||
127644687|NCT00643916|459319108|FG001|Overall Study|Not Vaccinated|2|||
127644688|NCT00643916|459319109|FG002|Overall Study|Not Vaccinated|3|||
127887850|NCT04444752|460211973|FG000|Overall Study|Lack of Efficacy|0|||
127887851|NCT04444752|460211974|FG001|Overall Study|Lack of Efficacy|0|||
127887852|NCT04444752|460211975|FG002|Overall Study|Lack of Efficacy|0|||
127887853|NCT04444752|460211976|FG003|Overall Study|Lack of Efficacy|1|||
127706940|NCT03519178|459555439|FG000|Follow-Up|Withdrawal by Subject|1|||
127706941|NCT03519178|459555440|FG001|Follow-Up|Withdrawal by Subject|2|||
127706942|NCT03519178|459555441|FG002|Follow-Up|Withdrawal by Subject|2|||
127706943|NCT03519178|459555442|FG003|Follow-Up|Withdrawal by Subject|3|||
127706944|NCT03519178|459555443|FG004|Follow-Up|Withdrawal by Subject|5|||
127706945|NCT03519178|459555444|FG005|Follow-Up|Withdrawal by Subject|1|||
127706946|NCT03519178|459555445|FG006|Follow-Up|Withdrawal by Subject|2|||
127706947|NCT03519178|459555446|FG007|Follow-Up|Withdrawal by Subject|6|||
127706948|NCT03519178|459555447|FG008|Follow-Up|Withdrawal by Subject|5|||
127706949|NCT03519178|459555448|FG009|Follow-Up|Withdrawal by Subject|2|||
127706950|NCT03519178|459555449|FG010|Follow-Up|Withdrawal by Subject|3|||
127706951|NCT03519178|459555450|FG011|Follow-Up|Withdrawal by Subject|5|||
127706952|NCT03519178|459555451|FG012|Follow-Up|Withdrawal by Subject|2|||
127706953|NCT03519178|459555452|FG013|Follow-Up|Withdrawal by Subject|0|||
127706954|NCT03519178|459555453|FG014|Follow-Up|Withdrawal by Subject|0|||
127706955|NCT03519178|459555439|FG000|Follow-Up|Other|0|||
127706956|NCT03519178|459555440|FG001|Follow-Up|Other|0|||
127706957|NCT03519178|459555441|FG002|Follow-Up|Other|0|||
127706958|NCT03519178|459555442|FG003|Follow-Up|Other|0|||
127799133|NCT03984305|459887997|FG000|Overall Study|Lost to Follow-up|1|||
127706959|NCT03519178|459555443|FG004|Follow-Up|Other|0|||
127706960|NCT03519178|459555444|FG005|Follow-Up|Other|0|||
127706961|NCT03519178|459555445|FG006|Follow-Up|Other|0|||
127799134|NCT03984305|459887998|FG001|Overall Study|Lost to Follow-up|0|||
127799135|NCT02340663|459887999|FG000|Overall Study|Lost to Follow-up|1|||
127799136|NCT02340663|459888000|FG001|Overall Study|Lost to Follow-up|0|||
127799137|NCT02340663|459887999|FG000|Overall Study|Protocol Violation|1|||
127799138|NCT02340663|459888000|FG001|Overall Study|Protocol Violation|0|||
127799139|NCT02340663|459887999|FG000|Overall Study|Withdrawal by Subject|3|||
127799140|NCT02340663|459888000|FG001|Overall Study|Withdrawal by Subject|1|||
127799141|NCT02979431|459888001|FG000|Overall Study|Parent/guardian withdrew consent|2|||
127799142|NCT02979431|459888002|FG001|Overall Study|Parent/guardian withdrew consent|1|||
127799143|NCT02979431|459888003|FG002|Overall Study|Parent/guardian withdrew consent|1|||
127799144|NCT02979431|459888004|FG003|Overall Study|Parent/guardian withdrew consent|1|||
127799145|NCT02979431|459888001|FG000|Overall Study|Randomized but received no study drug|1|||
127799146|NCT02979431|459888002|FG001|Overall Study|Randomized but received no study drug|1|||
127799147|NCT02979431|459888003|FG002|Overall Study|Randomized but received no study drug|0|||
127799148|NCT02979431|459888004|FG003|Overall Study|Randomized but received no study drug|0|||
127799149|NCT02979431|459888001|FG000|Overall Study|Adverse Event|0|||
127799150|NCT02979431|459888002|FG001|Overall Study|Adverse Event|0|||
127799151|NCT02979431|459888003|FG002|Overall Study|Adverse Event|1|||
127706962|NCT03519178|459555446|FG007|Follow-Up|Other|1|||
127706963|NCT03519178|459555447|FG008|Follow-Up|Other|0|||
127706964|NCT03519178|459555448|FG009|Follow-Up|Other|0|||
127706965|NCT03519178|459555449|FG010|Follow-Up|Other|0|||
127706966|NCT03519178|459555450|FG011|Follow-Up|Other|0|||
127706967|NCT03519178|459555451|FG012|Follow-Up|Other|0|||
127706968|NCT03519178|459555452|FG013|Follow-Up|Other|0|||
127706969|NCT03519178|459555453|FG014|Follow-Up|Other|0|||
127799152|NCT02979431|459888004|FG003|Overall Study|Adverse Event|0|||
127799153|NCT02979431|459888001|FG000|Overall Study|Subject left country after Day14|1|||
127799154|NCT02979431|459888002|FG001|Overall Study|Subject left country after Day14|0|||
127644689|NCT00643916|459319110|FG003|Overall Study|Not Vaccinated|0|||
127644690|NCT00643916|459319111|FG004|Overall Study|Not Vaccinated|2|||
127644691|NCT00643916|459319112|FG005|Overall Study|Not Vaccinated|0|||
127644692|NCT00499031|459319113|FG000|Overall Study|Improper pre-protocol treatment|1|||
127644693|NCT00499031|459319113|FG000|Overall Study|Required test not done|1|||
127644694|NCT00499031|459319113|FG000|Overall Study|Never treated|1|||
127644695|NCT02606279|459319123|FG000|Overall Study|Lost to Follow-up|0|||
127644696|NCT02606279|459319124|FG001|Overall Study|Lost to Follow-up|1|||
127644697|NCT02184611|459319125|FG000|Overall Study|Lack of Efficacy|11|||
127644698|NCT02184611|459319126|FG001|Overall Study|Lack of Efficacy|15|||
127644699|NCT02184611|459319125|FG000|Overall Study|Withdrawal by Subject|5|||
127644700|NCT02184611|459319126|FG001|Overall Study|Withdrawal by Subject|6|||
127644701|NCT02184611|459319125|FG000|Overall Study|Adverse Event|4|||
127644702|NCT02184611|459319126|FG001|Overall Study|Adverse Event|5|||
127644703|NCT02184611|459319125|FG000|Overall Study|Protocol Violation|1|||
127644704|NCT02184611|459319126|FG001|Overall Study|Protocol Violation|1|||
127644705|NCT02184611|459319125|FG000|Overall Study|Protocol defined stopping criteria|0|||
127644706|NCT02184611|459319126|FG001|Overall Study|Protocol defined stopping criteria|1|||
127644707|NCT00985725|459319129|FG000|Overall Study|Adverse Event|4|||
127644708|NCT00985725|459319130|FG001|Overall Study|Adverse Event|1|||
127644709|NCT00985725|459319129|FG000|Overall Study|Protocol Violation|1|||
127644710|NCT00985725|459319130|FG001|Overall Study|Protocol Violation|3|||
127644711|NCT00985725|459319129|FG000|Overall Study|Withdrawal by Subject|4|||
127644712|NCT00985725|459319130|FG001|Overall Study|Withdrawal by Subject|4|||
127644713|NCT00985725|459319129|FG000|Overall Study|Lost to Follow-up|1|||
127644714|NCT00985725|459319130|FG001|Overall Study|Lost to Follow-up|1|||
127644715|NCT00985725|459319129|FG000|Overall Study|Lack of Efficacy|0|||
127644716|NCT00985725|459319130|FG001|Overall Study|Lack of Efficacy|1|||
127644717|NCT00985725|459319129|FG000|Overall Study|Non-compliance|1|||
127644718|NCT00985725|459319130|FG001|Overall Study|Non-compliance|2|||
127644719|NCT00985725|459319129|FG000|Overall Study|Out-of-window visits|0|||
127644720|NCT00985725|459319130|FG001|Overall Study|Out-of-window visits|1|||
127644721|NCT03563716|459319131|FG000|Overall Study|Death|20|||
127644722|NCT03563716|459319132|FG001|Overall Study|Death|14|||
127644723|NCT03563716|459319131|FG000|Overall Study|Withdrawal by Subject|3|||
127644724|NCT03563716|459319132|FG001|Overall Study|Withdrawal by Subject|3|||
127644725|NCT03563716|459319131|FG000|Overall Study|Still on Study|45|||
127644726|NCT03563716|459319132|FG001|Overall Study|Still on Study|50|||
127644727|NCT02583425|459319133|FG000|Screening|Did not meet entry criteria|12|||
127644728|NCT02583425|459319133|FG000|Baseline|Did not meet continued criteria|5|||
127644729|NCT02583425|459319133|FG000|Treatment Period|Adverse Event|1|||
127644730|NCT02428296|459319136|FG000|Overall Study|Adverse Event|7|||
127644731|NCT02428296|459319136|FG000|Overall Study|Withdrawal by Subject|2|||
127644732|NCT02230956|459319137|FG000|Overall Study|Adverse Event|1|||
127644733|NCT02230956|459319138|FG001|Overall Study|Adverse Event|1|||
127644734|NCT02230956|459319139|FG002|Overall Study|Adverse Event|0|||
127644735|NCT02230956|459319137|FG000|Overall Study|Lack of Efficacy|1|||
127644736|NCT02230956|459319138|FG001|Overall Study|Lack of Efficacy|1|||
127644737|NCT02230956|459319139|FG002|Overall Study|Lack of Efficacy|1|||
127644738|NCT02230956|459319137|FG000|Overall Study|Lost to Follow-up|1|||
127644739|NCT02230956|459319138|FG001|Overall Study|Lost to Follow-up|1|||
127644740|NCT02230956|459319139|FG002|Overall Study|Lost to Follow-up|2|||
127644741|NCT02230956|459319137|FG000|Overall Study|Personal Reasons|2|||
127644742|NCT02230956|459319138|FG001|Overall Study|Personal Reasons|1|||
127644743|NCT02230956|459319139|FG002|Overall Study|Personal Reasons|1|||
127644744|NCT02230956|459319137|FG000|Overall Study|Protocol Violation|0|||
127644745|NCT02230956|459319138|FG001|Overall Study|Protocol Violation|1|||
127644746|NCT02230956|459319139|FG002|Overall Study|Protocol Violation|1|||
127644747|NCT02230956|459319137|FG000|Overall Study|Other Miscellaneous Reason|0|||
127644748|NCT02230956|459319138|FG001|Overall Study|Other Miscellaneous Reason|1|||
127644749|NCT02230956|459319139|FG002|Overall Study|Other Miscellaneous Reason|2|||
127644750|NCT00338884|459319140|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
127644751|NCT00338884|459319140|FG000|Overall Study|Adverse Event|14|||
127644752|NCT00338884|459319140|FG000|Overall Study|Death|8|||
127644753|NCT00338884|459319140|FG000|Overall Study|Other|4|||
127644754|NCT00338884|459319140|FG000|Overall Study|Global Deterioration of Health Status|3|||
127644755|NCT00338884|459319140|FG000|Overall Study|Withdrawal by Subject|3|||
127644756|NCT00338884|459319140|FG000|Overall Study|Lost to Follow-up|1|||
127706970|NCT03519178|459555439|FG000|Long-term Follow-up|Death|0|||
127706971|NCT03519178|459555440|FG001|Long-term Follow-up|Death|0|||
127706972|NCT03519178|459555441|FG002|Long-term Follow-up|Death|0|||
127706973|NCT03519178|459555442|FG003|Long-term Follow-up|Death|0|||
127706974|NCT03519178|459555443|FG004|Long-term Follow-up|Death|0|||
127706975|NCT03519178|459555444|FG005|Long-term Follow-up|Death|0|||
127706976|NCT03519178|459555445|FG006|Long-term Follow-up|Death|0|||
127706977|NCT03519178|459555446|FG007|Long-term Follow-up|Death|0|||
127706978|NCT03519178|459555447|FG008|Long-term Follow-up|Death|0|||
127644757|NCT00338884|459319140|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
127644758|NCT01970982|459319142|FG000|Overall Study|Withdrawal by Subject|0|||
127644759|NCT01970982|459319143|FG001|Overall Study|Withdrawal by Subject|0|||
127644760|NCT01970982|459319144|FG002|Overall Study|Withdrawal by Subject|2|||
127644761|NCT05711641|459319146|FG000|Washout (2 Weeks)|Lost to Follow-up|2|||
127644762|NCT05711641|459319147|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
127644763|NCT05711641|459319146|FG000|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|1|||
127644764|NCT05711641|459319147|FG001|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|0|||
127644765|NCT00951483|459319148|FG000|Overall Study|Physician Decision|4|||
127644766|NCT00951483|459319149|FG001|Overall Study|Physician Decision|0|||
127644767|NCT00951483|459319148|FG000|Overall Study|Withdrawal by Subject|15|||
127644768|NCT00951483|459319149|FG001|Overall Study|Withdrawal by Subject|0|||
127644769|NCT03583554|459319150|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
127644770|NCT03583554|459319151|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
127644771|NCT03583554|459319152|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
127644772|NCT03178266|459319153|FG000|Overall Study|Death|0|||
127644773|NCT03178266|459319154|FG001|Overall Study|Death|1|||
127644774|NCT03178266|459319153|FG000|Overall Study|Disont. Early|0|||
127644775|NCT03178266|459319154|FG001|Overall Study|Disont. Early|1|||
127644776|NCT03178266|459319153|FG000|Overall Study|Withdrawal by Subject|0|||
127644777|NCT03178266|459319154|FG001|Overall Study|Withdrawal by Subject|2|||
127644778|NCT02342886|459319155|FG000|Overall Study|Treatment non-compliance|1|||
127644779|NCT02342886|459319156|FG001|Overall Study|Treatment non-compliance|0|||
127644780|NCT02342886|459319157|FG002|Overall Study|Treatment non-compliance|0|||
127644781|NCT02342886|459319158|FG003|Overall Study|Treatment non-compliance|1|||
127644782|NCT02342886|459319159|FG004|Overall Study|Treatment non-compliance|0|||
127644783|NCT02342886|459319155|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
127644784|NCT02342886|459319156|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
127644785|NCT02342886|459319157|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
127644786|NCT02342886|459319158|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
127644787|NCT02342886|459319159|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
127644788|NCT02342886|459319155|FG000|Overall Study|Adverse event/specific toxicity|4|||
127644789|NCT02342886|459319156|FG001|Overall Study|Adverse event/specific toxicity|3|||
127644790|NCT02342886|459319157|FG002|Overall Study|Adverse event/specific toxicity|11|||
127644791|NCT02342886|459319158|FG003|Overall Study|Adverse event/specific toxicity|2|||
127644792|NCT02342886|459319159|FG004|Overall Study|Adverse event/specific toxicity|1|||
127644793|NCT02342886|459319155|FG000|Overall Study|Lost to Follow-up|1|||
127644794|NCT02342886|459319156|FG001|Overall Study|Lost to Follow-up|0|||
127644795|NCT02342886|459319157|FG002|Overall Study|Lost to Follow-up|0|||
127644796|NCT02342886|459319158|FG003|Overall Study|Lost to Follow-up|0|||
127644797|NCT02342886|459319159|FG004|Overall Study|Lost to Follow-up|0|||
127644798|NCT02342886|459319155|FG000|Overall Study|Death|1|||
127644799|NCT02342886|459319156|FG001|Overall Study|Death|2|||
127644800|NCT02342886|459319157|FG002|Overall Study|Death|1|||
127644801|NCT02342886|459319158|FG003|Overall Study|Death|0|||
127644802|NCT02342886|459319159|FG004|Overall Study|Death|1|||
127644803|NCT02342886|459319155|FG000|Overall Study|Withdrawal by Subject|0|||
127644804|NCT02342886|459319156|FG001|Overall Study|Withdrawal by Subject|1|||
127644805|NCT02342886|459319157|FG002|Overall Study|Withdrawal by Subject|0|||
127644806|NCT02342886|459319158|FG003|Overall Study|Withdrawal by Subject|1|||
127644807|NCT02342886|459319159|FG004|Overall Study|Withdrawal by Subject|0|||
127644808|NCT02342886|459319155|FG000|Overall Study|Investigator/sponsor decision|0|||
127644809|NCT02342886|459319156|FG001|Overall Study|Investigator/sponsor decision|2|||
127644810|NCT02342886|459319157|FG002|Overall Study|Investigator/sponsor decision|0|||
127644811|NCT02342886|459319158|FG003|Overall Study|Investigator/sponsor decision|3|||
127644812|NCT02342886|459319159|FG004|Overall Study|Investigator/sponsor decision|1|||
127644813|NCT02342886|459319155|FG000|Overall Study|Pregnancy|0|||
127644814|NCT02342886|459319156|FG001|Overall Study|Pregnancy|0|||
127644815|NCT02342886|459319157|FG002|Overall Study|Pregnancy|2|||
127644816|NCT02342886|459319158|FG003|Overall Study|Pregnancy|0|||
127644817|NCT02342886|459319159|FG004|Overall Study|Pregnancy|0|||
127644818|NCT02342886|459319155|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
127644819|NCT02342886|459319156|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
127644820|NCT02342886|459319157|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
127644821|NCT02342886|459319158|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
127706979|NCT03519178|459555448|FG009|Long-term Follow-up|Death|0|||
127706980|NCT03519178|459555449|FG010|Long-term Follow-up|Death|0|||
127706981|NCT03519178|459555450|FG011|Long-term Follow-up|Death|0|||
127706982|NCT03519178|459555451|FG012|Long-term Follow-up|Death|0|||
127706983|NCT03519178|459555452|FG013|Long-term Follow-up|Death|4|||
127706984|NCT03519178|459555453|FG014|Long-term Follow-up|Death|4|||
127706985|NCT03519178|459555439|FG000|Long-term Follow-up|Lost to Follow-up|0|||
127706986|NCT03519178|459555440|FG001|Long-term Follow-up|Lost to Follow-up|0|||
127706987|NCT03519178|459555441|FG002|Long-term Follow-up|Lost to Follow-up|0|||
127706988|NCT03519178|459555442|FG003|Long-term Follow-up|Lost to Follow-up|0|||
127644822|NCT02342886|459319159|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
127644823|NCT02342886|459319155|FG000|Overall Study|Protocol Violation|0|||
127644824|NCT02342886|459319156|FG001|Overall Study|Protocol Violation|0|||
127644825|NCT02342886|459319157|FG002|Overall Study|Protocol Violation|0|||
127644826|NCT02342886|459319158|FG003|Overall Study|Protocol Violation|2|||
127644827|NCT02342886|459319159|FG004|Overall Study|Protocol Violation|0|||
127644828|NCT00587964|459319160|FG000|Overall Study|Withdrawal by Subject|1|||
127644829|NCT00587964|459319160|FG000|Overall Study|Lost to Follow-up|1|||
127644830|NCT00587964|459319160|FG000|Overall Study|Patient found to be ineligible|1|||
127644831|NCT00587964|459319160|FG000|Overall Study|Patient did not receive intervention|5|||
127644832|NCT00587964|459319160|FG000|Overall Study|Progression of Disease|4|||
127644833|NCT00540124|459319161|FG000|Overall Study|Adverse Event|0|||
127644834|NCT00540124|459319162|FG001|Overall Study|Adverse Event|2|||
127644835|NCT00540124|459319163|FG002|Overall Study|Adverse Event|1|||
127644836|NCT00540124|459319161|FG000|Overall Study|Entry Criteria Not Met|2|||
127644837|NCT00540124|459319162|FG001|Overall Study|Entry Criteria Not Met|0|||
127644838|NCT00540124|459319163|FG002|Overall Study|Entry Criteria Not Met|0|||
127644839|NCT00540124|459319161|FG000|Overall Study|Lack of Efficacy|1|||
127644840|NCT00540124|459319162|FG001|Overall Study|Lack of Efficacy|0|||
127644841|NCT00540124|459319163|FG002|Overall Study|Lack of Efficacy|0|||
127644842|NCT00540124|459319161|FG000|Overall Study|Withdrawal by Subject|1|||
127644843|NCT00540124|459319162|FG001|Overall Study|Withdrawal by Subject|1|||
127644844|NCT00540124|459319163|FG002|Overall Study|Withdrawal by Subject|0|||
127644845|NCT01569438|459319169|FG000|Overall Study|Lack of Efficacy|1|||
127644846|NCT01569438|459319170|FG001|Overall Study|Lack of Efficacy|2|||
127644847|NCT01569438|459319169|FG000|Overall Study|Withdrawal by Subject|0|||
127644848|NCT01569438|459319170|FG001|Overall Study|Withdrawal by Subject|3|||
127644849|NCT01569438|459319169|FG000|Overall Study|Adverse Event|2|||
127644850|NCT01569438|459319170|FG001|Overall Study|Adverse Event|15|||
127644851|NCT01569438|459319169|FG000|Overall Study|Protocol Violation|2|||
127644852|NCT01569438|459319170|FG001|Overall Study|Protocol Violation|0|||
127644853|NCT01569438|459319169|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
127644854|NCT01569438|459319170|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
127644855|NCT01569438|459319169|FG000|Overall Study|Sponsor/Physician decision|1|||
127644856|NCT01569438|459319170|FG001|Overall Study|Sponsor/Physician decision|1|||
127644857|NCT01569438|459319169|FG000|Overall Study|Unable to adhere to study schedule|0|||
127644858|NCT01569438|459319170|FG001|Overall Study|Unable to adhere to study schedule|1|||
127644859|NCT01777854|459319173|FG000|Overall Study|Physician Decision|3|||
127644860|NCT01777854|459319174|FG001|Overall Study|Physician Decision|3|||
127644861|NCT03649230|459319176|FG000|Overall Study|Adverse Event|12|||
127644862|NCT03649230|459319176|FG000|Overall Study|Death|8|||
127644863|NCT03649230|459319176|FG000|Overall Study|Withdrawal by Subject|6|||
127644864|NCT03649230|459319176|FG000|Overall Study|Physician Decision|5|||
127644865|NCT03649230|459319176|FG000|Overall Study|Disease progression|5|||
127644866|NCT03649230|459319176|FG000|Overall Study|Switched to non-HEC|5|||
127644867|NCT03649230|459319176|FG000|Overall Study|Chemotherapy discontinued|4|||
127644868|NCT03649230|459319176|FG000|Overall Study|Received only 3 HEC cycles|4|||
127644869|NCT03649230|459319176|FG000|Overall Study|Screen Failure|3|||
127644870|NCT03649230|459319176|FG000|Overall Study|Patient stopped treatment|2|||
127644871|NCT03649230|459319176|FG000|Overall Study|Protocol Violation|1|||
127644872|NCT03649230|459319176|FG000|Overall Study|Non-compliance|1|||
127644873|NCT03649230|459319176|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
127644874|NCT01693068|459319181|FG000|Randomization Period|On-study|2|||
127644875|NCT01693068|459319182|FG001|Randomization Period|On-study|5|||
127644876|NCT01693068|459319183|FG002|Randomization Period|On-study|0|||
127644877|NCT01693068|459319181|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
127644878|NCT01693068|459319182|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
127644879|NCT01693068|459319183|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
127644880|NCT00977665|459319189|FG000|Overall Study|Withdrawal by Subject|1|||
127644881|NCT00977665|459319190|FG001|Overall Study|Withdrawal by Subject|3|||
127644882|NCT00977665|459319189|FG000|Overall Study|Physician Decision|2|||
127799155|NCT02979431|459888003|FG002|Overall Study|Subject left country after Day14|0|||
127799156|NCT02979431|459888004|FG003|Overall Study|Subject left country after Day14|0|||
127799157|NCT01656434|459888005|FG000|Overall Study|Adverse Event|199|||
127799158|NCT01656434|459888006|FG001|Overall Study|Adverse Event|63|||
127644883|NCT00977665|459319190|FG001|Overall Study|Physician Decision|1|||
127644884|NCT00977665|459319189|FG000|Overall Study|Sponsor requested withdrawal|0|||
127644885|NCT00977665|459319190|FG001|Overall Study|Sponsor requested withdrawal|1|||
127644886|NCT00977665|459319189|FG000|Overall Study|Lost to Follow-up|1|||
127644887|NCT00977665|459319190|FG001|Overall Study|Lost to Follow-up|0|||
127644888|NCT00977665|459319189|FG000|Overall Study|Death|3|||
127644889|NCT00977665|459319190|FG001|Overall Study|Death|2|||
127644890|NCT00977665|459319189|FG000|Overall Study|Adverse Event|14|||
127644891|NCT00977665|459319190|FG001|Overall Study|Adverse Event|7|||
127887854|NCT04444752|460211973|FG000|Overall Study|Death|0|||
127887855|NCT04444752|460211974|FG001|Overall Study|Death|0|||
127887856|NCT04444752|460211975|FG002|Overall Study|Death|1|||
127887857|NCT04444752|460211976|FG003|Overall Study|Death|0|||
127887858|NCT01759537|460211977|FG000|Overall Study|Death|1|||
127887859|NCT01759537|460211978|FG001|Overall Study|Death|1|||
127887860|NCT01759537|460211977|FG000|Overall Study|Pregnancy|1|||
127887861|NCT01759537|460211978|FG001|Overall Study|Pregnancy|1|||
127887862|NCT01759537|460211977|FG000|Overall Study|Lost to Follow-up|9|||
127887863|NCT01759537|460211978|FG001|Overall Study|Lost to Follow-up|9|||
127887864|NCT01759537|460211977|FG000|Overall Study|Accident involving jaw fracture|1|||
127887865|NCT01759537|460211978|FG001|Overall Study|Accident involving jaw fracture|1|||
127887866|NCT01759537|460211977|FG000|Overall Study|Subcrestal implant too coronal|1|||
127887867|NCT01759537|460211978|FG001|Overall Study|Subcrestal implant too coronal|1|||
127887868|NCT02270983|460213881|FG000|Overall Study|Adverse Event|3|||
127887869|NCT02270983|460213882|FG001|Overall Study|Adverse Event|2|||
127887870|NCT02270983|460213883|FG002|Overall Study|Adverse Event|6|||
127887871|NCT02270983|460213881|FG000|Overall Study|Lack of Efficacy|2|||
127887872|NCT02270983|460213882|FG001|Overall Study|Lack of Efficacy|1|||
127887873|NCT02270983|460213883|FG002|Overall Study|Lack of Efficacy|1|||
127887874|NCT02270983|460213881|FG000|Overall Study|Withdrawal by Subject|1|||
127887875|NCT02270983|460213882|FG001|Overall Study|Withdrawal by Subject|0|||
127887876|NCT02270983|460213883|FG002|Overall Study|Withdrawal by Subject|2|||
127887877|NCT02270983|460213881|FG000|Overall Study|Lost to Follow-up|1|||
127887878|NCT02270983|460213882|FG001|Overall Study|Lost to Follow-up|1|||
127887879|NCT02270983|460213883|FG002|Overall Study|Lost to Follow-up|2|||
127887880|NCT02270983|460213881|FG000|Overall Study|Protocol Violation|1|||
127887881|NCT02270983|460213882|FG001|Overall Study|Protocol Violation|1|||
127887882|NCT02270983|460213883|FG002|Overall Study|Protocol Violation|1|||
127887883|NCT02270983|460213881|FG000|Overall Study|family emergency|0|||
127887884|NCT02270983|460213882|FG001|Overall Study|family emergency|1|||
127887885|NCT02270983|460213883|FG002|Overall Study|family emergency|0|||
127887886|NCT02270983|460213881|FG000|Overall Study|study procedure non-compliance|1|||
127887887|NCT02270983|460213882|FG001|Overall Study|study procedure non-compliance|0|||
127887888|NCT02270983|460213883|FG002|Overall Study|study procedure non-compliance|0|||
127887889|NCT02270983|460213881|FG000|Overall Study|moved away from study site|0|||
127887890|NCT02270983|460213882|FG001|Overall Study|moved away from study site|1|||
127887891|NCT02270983|460213883|FG002|Overall Study|moved away from study site|0|||
127887892|NCT00854620|460213886|FG000|Overall Study|Adverse Event|1|||
127887893|NCT01623830|460213890|FG000|Overall Study|Withdrawal by Subject|6|||
127887894|NCT01623830|460213891|FG001|Overall Study|Withdrawal by Subject|7|||
127887895|NCT01623830|460213890|FG000|Overall Study|Exclusion from Study|1|||
127887896|NCT01623830|460213891|FG001|Overall Study|Exclusion from Study|2|||
127887897|NCT00928252|460213892|FG000|Overall Study|Physician Decision|3|||
127887898|NCT01605461|460213895|FG000|Overall Study|Lost to Follow-up|3|||
127887899|NCT01605461|460213895|FG000|Overall Study|Withdrawal by Subject|1|||
127887900|NCT02024698|460213896|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
127887901|NCT02024698|460213897|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
127887902|NCT02370784|460213901|FG000|Overall Study|Patient started prohibited medication|0|||
127887903|NCT02370784|460213902|FG001|Overall Study|Patient started prohibited medication|1|||
127887904|NCT00693784|460213905|FG000|Overall Study|Lost to Follow-up|2|||
127887905|NCT00693784|460213905|FG000|Overall Study|Withdrawal by Subject|2|||
127887906|NCT00326885|460213907|FG000|Overall Study|Adverse Event|1|||
127887907|NCT00326885|460213907|FG000|Overall Study|Withdrawal by Subject|3|||
127887908|NCT00326885|460213907|FG000|Overall Study|Physician Decision|1|||
127887909|NCT00326885|460213907|FG000|Overall Study|Hospice withdrew consent|2|||
127887910|NCT01473758|460213908|FG000|Cycle 1|Adverse Event|10|||
127887911|NCT01473758|460213909|FG001|Cycle 1|Adverse Event|2|||
127887912|NCT01473758|460213910|FG002|Cycle 1|Adverse Event|0|||
127887913|NCT01473758|460213911|FG003|Cycle 1|Adverse Event|0|||
127887914|NCT01473758|460213908|FG000|Cycle 1|Withdrawal by Subject|1|||
127644892|NCT00977665|459319189|FG000|Overall Study|Treatment failure|0|||
127644893|NCT00977665|459319190|FG001|Overall Study|Treatment failure|1|||
127887915|NCT01473758|460213909|FG001|Cycle 1|Withdrawal by Subject|1|||
127887916|NCT01473758|460213910|FG002|Cycle 1|Withdrawal by Subject|0|||
127887917|NCT01473758|460213911|FG003|Cycle 1|Withdrawal by Subject|0|||
127887918|NCT01473758|460213908|FG000|Cycle 2|Adverse Event|0|||
127887919|NCT01473758|460213909|FG001|Cycle 2|Adverse Event|0|||
127887920|NCT01473758|460213910|FG002|Cycle 2|Adverse Event|5|||
127887921|NCT01473758|460213911|FG003|Cycle 2|Adverse Event|0|||
127887922|NCT01677910|460213912|FG000|Double-Blind Treatment Period|Adverse Event|6|||
127887923|NCT01677910|460213913|FG001|Double-Blind Treatment Period|Adverse Event|2|||
127887924|NCT01677910|460213914|FG002|Double-Blind Treatment Period|Adverse Event|3|||
127887925|NCT01677910|460213915|FG003|Double-Blind Treatment Period|Adverse Event|0|||
127887926|NCT01677910|460213912|FG000|Double-Blind Treatment Period|Physician Decision|0|||
127887927|NCT01677910|460213913|FG001|Double-Blind Treatment Period|Physician Decision|0|||
127644894|NCT02432105|459319195|FG000|Overall Study|Lost to Follow-up|1|||
127644895|NCT02432105|459319196|FG001|Overall Study|Lost to Follow-up|1|||
127644896|NCT02432105|459319197|FG002|Overall Study|Lost to Follow-up|0|||
127644897|NCT02432105|459319195|FG000|Overall Study|Withdrawal by Subject|1|||
127644898|NCT02432105|459319196|FG001|Overall Study|Withdrawal by Subject|0|||
127644899|NCT02432105|459319197|FG002|Overall Study|Withdrawal by Subject|1|||
127644900|NCT02432105|459319195|FG000|Overall Study|Culture positive for yeast|0|||
127644901|NCT02432105|459319196|FG001|Overall Study|Culture positive for yeast|1|||
127644902|NCT02432105|459319197|FG002|Overall Study|Culture positive for yeast|0|||
127644903|NCT02432105|459319195|FG000|Overall Study|Randomized in error|0|||
127644904|NCT02432105|459319196|FG001|Overall Study|Randomized in error|0|||
127644905|NCT02432105|459319197|FG002|Overall Study|Randomized in error|2|||
127706989|NCT03519178|459555443|FG004|Long-term Follow-up|Lost to Follow-up|0|||
127706990|NCT03519178|459555444|FG005|Long-term Follow-up|Lost to Follow-up|0|||
127706991|NCT03519178|459555445|FG006|Long-term Follow-up|Lost to Follow-up|0|||
127706992|NCT03519178|459555446|FG007|Long-term Follow-up|Lost to Follow-up|0|||
127706993|NCT03519178|459555447|FG008|Long-term Follow-up|Lost to Follow-up|0|||
127706994|NCT03519178|459555448|FG009|Long-term Follow-up|Lost to Follow-up|0|||
127706995|NCT03519178|459555449|FG010|Long-term Follow-up|Lost to Follow-up|0|||
127706996|NCT03519178|459555450|FG011|Long-term Follow-up|Lost to Follow-up|0|||
127706997|NCT03519178|459555451|FG012|Long-term Follow-up|Lost to Follow-up|0|||
127706998|NCT03519178|459555452|FG013|Long-term Follow-up|Lost to Follow-up|1|||
127706999|NCT03519178|459555453|FG014|Long-term Follow-up|Lost to Follow-up|1|||
127707000|NCT03519178|459555439|FG000|Long-term Follow-up|Study terminated by sponsor|0|||
127707001|NCT03519178|459555440|FG001|Long-term Follow-up|Study terminated by sponsor|0|||
127707002|NCT03519178|459555441|FG002|Long-term Follow-up|Study terminated by sponsor|0|||
127707003|NCT03519178|459555442|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
127707004|NCT03519178|459555443|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
127707005|NCT03519178|459555444|FG005|Long-term Follow-up|Study terminated by sponsor|0|||
127707006|NCT03519178|459555445|FG006|Long-term Follow-up|Study terminated by sponsor|0|||
127707007|NCT03519178|459555446|FG007|Long-term Follow-up|Study terminated by sponsor|0|||
127707008|NCT03519178|459555447|FG008|Long-term Follow-up|Study terminated by sponsor|0|||
127707009|NCT03519178|459555448|FG009|Long-term Follow-up|Study terminated by sponsor|0|||
127707010|NCT03519178|459555449|FG010|Long-term Follow-up|Study terminated by sponsor|0|||
127707011|NCT03519178|459555450|FG011|Long-term Follow-up|Study terminated by sponsor|0|||
127707012|NCT03519178|459555451|FG012|Long-term Follow-up|Study terminated by sponsor|0|||
127707013|NCT03519178|459555452|FG013|Long-term Follow-up|Study terminated by sponsor|31|||
127707014|NCT03519178|459555453|FG014|Long-term Follow-up|Study terminated by sponsor|13|||
127707015|NCT03519178|459555439|FG000|Long-term Follow-up|Withdrawal by Subject|0|||
127707016|NCT03519178|459555440|FG001|Long-term Follow-up|Withdrawal by Subject|0|||
127707017|NCT03519178|459555441|FG002|Long-term Follow-up|Withdrawal by Subject|0|||
127707018|NCT03519178|459555442|FG003|Long-term Follow-up|Withdrawal by Subject|0|||
127707019|NCT03519178|459555443|FG004|Long-term Follow-up|Withdrawal by Subject|0|||
127707020|NCT03519178|459555444|FG005|Long-term Follow-up|Withdrawal by Subject|0|||
127707021|NCT03519178|459555445|FG006|Long-term Follow-up|Withdrawal by Subject|0|||
127707022|NCT03519178|459555446|FG007|Long-term Follow-up|Withdrawal by Subject|0|||
127707023|NCT03519178|459555447|FG008|Long-term Follow-up|Withdrawal by Subject|0|||
127644906|NCT01400503|459319198|FG000|Overall Study|Withdrawal by Subject|1|||
127644907|NCT01400503|459319198|FG000|Overall Study|Study Terminated by Sponsor|58|||
127644908|NCT01400503|459319198|FG000|Overall Study|Other|1|||
127707024|NCT03519178|459555448|FG009|Long-term Follow-up|Withdrawal by Subject|0|||
127707025|NCT03519178|459555449|FG010|Long-term Follow-up|Withdrawal by Subject|0|||
127707026|NCT03519178|459555450|FG011|Long-term Follow-up|Withdrawal by Subject|0|||
127707027|NCT03519178|459555451|FG012|Long-term Follow-up|Withdrawal by Subject|0|||
127707028|NCT03519178|459555452|FG013|Long-term Follow-up|Withdrawal by Subject|7|||
127707029|NCT03519178|459555453|FG014|Long-term Follow-up|Withdrawal by Subject|3|||
127707030|NCT03519178|459555439|FG000|Long-term Follow-up|Other|0|||
127799159|NCT01656434|459888005|FG000|Overall Study|Enrollment terminated at trial site|2|||
127799160|NCT01656434|459888006|FG001|Overall Study|Enrollment terminated at trial site|0|||
127799161|NCT01656434|459888005|FG000|Overall Study|Lost to Follow-up|309|||
127799162|NCT01656434|459888006|FG001|Overall Study|Lost to Follow-up|76|||
127799163|NCT01656434|459888005|FG000|Overall Study|Site discontinued study participation|24|||
127799164|NCT01656434|459888006|FG001|Overall Study|Site discontinued study participation|9|||
127799165|NCT01656434|459888005|FG000|Overall Study|Screen failure|2|||
127799166|NCT01656434|459888006|FG001|Overall Study|Screen failure|0|||
127799167|NCT01656434|459888005|FG000|Overall Study|Protocol Violation|7|||
127644909|NCT00058123|459319199|FG000|Overall Study|Wrong histology|9|||
127644910|NCT00058123|459319199|FG000|Overall Study|Received >3 prior treatments|1|||
127644911|NCT01212770|459319200|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
127707031|NCT03519178|459555440|FG001|Long-term Follow-up|Other|0|||
127707032|NCT03519178|459555441|FG002|Long-term Follow-up|Other|0|||
127707033|NCT03519178|459555442|FG003|Long-term Follow-up|Other|0|||
127799168|NCT01656434|459888006|FG001|Overall Study|Protocol Violation|0|||
127799169|NCT01656434|459888005|FG000|Overall Study|Pregnancy wish|18|||
127799170|NCT01656434|459888006|FG001|Overall Study|Pregnancy wish|6|||
127644912|NCT01212770|459319201|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
127644913|NCT01212770|459319202|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
127644914|NCT01212770|459319203|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
127644915|NCT01212770|459319204|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
127644916|NCT01212770|459319205|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
127644917|NCT01212770|459319206|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
127644918|NCT01212770|459319207|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
127644919|NCT01212770|459319208|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
127644920|NCT01212770|459319200|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
127644921|NCT01212770|459319201|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
127644922|NCT01212770|459319202|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
127644923|NCT01212770|459319203|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
127644924|NCT01212770|459319204|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
127644925|NCT01212770|459319205|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
127644926|NCT01212770|459319206|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
127644927|NCT01212770|459319207|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
127644928|NCT01212770|459319208|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
127644929|NCT01212770|459319200|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
127644930|NCT01212770|459319201|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
127644931|NCT01212770|459319202|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
127644932|NCT01212770|459319203|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
127644933|NCT01212770|459319204|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
127644934|NCT01212770|459319205|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
127644935|NCT01212770|459319206|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
127644936|NCT01212770|459319207|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
127644937|NCT01212770|459319208|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
127644938|NCT01212770|459319200|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
127644939|NCT01212770|459319201|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
127644940|NCT01212770|459319202|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
127644941|NCT01212770|459319203|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
127644942|NCT01212770|459319204|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
127644943|NCT01212770|459319205|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
127644944|NCT01212770|459319206|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
127644945|NCT01212770|459319207|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
127644946|NCT01212770|459319208|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
127644947|NCT01212770|459319200|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
127644948|NCT01212770|459319201|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
127644949|NCT01212770|459319202|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
127644950|NCT01212770|459319203|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
127644951|NCT01212770|459319204|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
127644952|NCT01212770|459319205|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
127644953|NCT01212770|459319206|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
127644954|NCT01212770|459319207|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
127644955|NCT01212770|459319208|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
127644956|NCT01212770|459319200|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
127644957|NCT01212770|459319201|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
127644958|NCT01212770|459319202|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
127644959|NCT01212770|459319203|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
127644960|NCT01212770|459319204|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
127707034|NCT03519178|459555443|FG004|Long-term Follow-up|Other|0|||
127707035|NCT03519178|459555444|FG005|Long-term Follow-up|Other|0|||
127707036|NCT03519178|459555445|FG006|Long-term Follow-up|Other|0|||
127707037|NCT03519178|459555446|FG007|Long-term Follow-up|Other|0|||
127707038|NCT03519178|459555447|FG008|Long-term Follow-up|Other|0|||
127707039|NCT03519178|459555448|FG009|Long-term Follow-up|Other|0|||
127707040|NCT03519178|459555449|FG010|Long-term Follow-up|Other|0|||
127707041|NCT03519178|459555450|FG011|Long-term Follow-up|Other|0|||
127707042|NCT03519178|459555451|FG012|Long-term Follow-up|Other|0|||
127707043|NCT03519178|459555452|FG013|Long-term Follow-up|Other|0|||
127707044|NCT03519178|459555453|FG014|Long-term Follow-up|Other|1|||
127707045|NCT03519178|459555439|FG000|Long-term Follow-up|Ongoing|0|||
127707046|NCT03519178|459555440|FG001|Long-term Follow-up|Ongoing|0|||
127707047|NCT03519178|459555441|FG002|Long-term Follow-up|Ongoing|0|||
127707048|NCT03519178|459555442|FG003|Long-term Follow-up|Ongoing|0|||
127707049|NCT03519178|459555443|FG004|Long-term Follow-up|Ongoing|0|||
127707050|NCT03519178|459555444|FG005|Long-term Follow-up|Ongoing|0|||
127707051|NCT03519178|459555445|FG006|Long-term Follow-up|Ongoing|0|||
127707052|NCT03519178|459555446|FG007|Long-term Follow-up|Ongoing|0|||
127707053|NCT03519178|459555447|FG008|Long-term Follow-up|Ongoing|0|||
127707054|NCT03519178|459555448|FG009|Long-term Follow-up|Ongoing|0|||
127707055|NCT03519178|459555449|FG010|Long-term Follow-up|Ongoing|0|||
127707056|NCT03519178|459555450|FG011|Long-term Follow-up|Ongoing|0|||
127707057|NCT03519178|459555451|FG012|Long-term Follow-up|Ongoing|0|||
127707058|NCT03519178|459555452|FG013|Long-term Follow-up|Ongoing|1|||
127707059|NCT03519178|459555453|FG014|Long-term Follow-up|Ongoing|0|||
127707060|NCT02315703|459555454|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
127707061|NCT02315703|459555455|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
127707062|NCT02315703|459555456|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
127707063|NCT02315703|459555457|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
127707064|NCT02315703|459555458|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
127707065|NCT02315703|459555459|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
127707066|NCT02315703|459555460|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
127707067|NCT02315703|459555461|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
127707068|NCT02315703|459555454|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
127707069|NCT02315703|459555455|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
127707070|NCT02315703|459555456|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
127707071|NCT02315703|459555457|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
127707072|NCT02315703|459555458|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
127707073|NCT02315703|459555459|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
127707074|NCT02315703|459555460|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
127707075|NCT02315703|459555461|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
127707076|NCT02315703|459555454|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
127707077|NCT02315703|459555455|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
127707078|NCT02315703|459555456|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
127707079|NCT02315703|459555457|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
127707080|NCT02315703|459555458|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
127707081|NCT02315703|459555459|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
127707082|NCT02315703|459555460|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
127707083|NCT02315703|459555461|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
127707084|NCT02315703|459555454|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
127707085|NCT02315703|459555455|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
127707086|NCT02315703|459555456|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
127707087|NCT02315703|459555457|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
127707088|NCT02315703|459555458|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
127707089|NCT02315703|459555459|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
127707090|NCT02315703|459555460|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
127707091|NCT02315703|459555461|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
127707092|NCT02315703|459555454|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
127707093|NCT02315703|459555455|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
127707094|NCT02315703|459555456|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
127707095|NCT02315703|459555457|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
127707096|NCT02315703|459555458|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
127707097|NCT02315703|459555459|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
127707098|NCT02315703|459555460|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
127707099|NCT02315703|459555461|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
127707100|NCT02315703|459555454|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
127707101|NCT02315703|459555455|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
127707102|NCT02315703|459555456|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
127707103|NCT02315703|459555457|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
127707104|NCT02315703|459555458|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
127707105|NCT02315703|459555459|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
127707106|NCT02315703|459555460|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
127707107|NCT02315703|459555461|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
127707108|NCT02315703|459555454|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
127707109|NCT02315703|459555455|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
127707110|NCT02315703|459555456|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
127707111|NCT02315703|459555457|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
127707112|NCT02315703|459555458|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
127644961|NCT01212770|459319205|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
127644962|NCT01212770|459319206|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
127644963|NCT01212770|459319207|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
127644964|NCT01212770|459319208|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
127644965|NCT01212770|459319200|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
127644966|NCT01212770|459319201|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
127644967|NCT01212770|459319202|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
127644968|NCT01212770|459319203|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
127644969|NCT01212770|459319204|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
127644970|NCT01212770|459319205|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
127644971|NCT01212770|459319206|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
127644972|NCT01212770|459319207|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
127644973|NCT01212770|459319208|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
127644974|NCT01212770|459319200|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
127644975|NCT01212770|459319201|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
127644976|NCT01212770|459319202|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
127644977|NCT01212770|459319203|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
127644978|NCT01212770|459319204|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
127644979|NCT01212770|459319205|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
127644980|NCT01212770|459319206|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
127644981|NCT01212770|459319207|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
127644982|NCT01212770|459319208|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
127644983|NCT01212770|459319200|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
127644984|NCT01212770|459319201|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
127644985|NCT01212770|459319202|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
127644986|NCT01212770|459319203|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
127644987|NCT01212770|459319204|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
127644988|NCT01212770|459319205|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
127644989|NCT01212770|459319206|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
127644990|NCT01212770|459319207|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
127644991|NCT01212770|459319208|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
127644992|NCT01212770|459319200|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
127644993|NCT01212770|459319201|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
127644994|NCT01212770|459319202|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
127644995|NCT01212770|459319203|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
127644996|NCT01212770|459319204|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
127644997|NCT01212770|459319205|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
127644998|NCT01212770|459319206|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
127799171|NCT01656434|459888005|FG000|Overall Study|Pregnancy|45|||
127799172|NCT01656434|459888006|FG001|Overall Study|Pregnancy|10|||
127799173|NCT01656434|459888005|FG000|Overall Study|Physician Decision|7|||
127799174|NCT01656434|459888006|FG001|Overall Study|Physician Decision|2|||
127799175|NCT01656434|459888005|FG000|Overall Study|Non-compliance with study drug|48|||
127887928|NCT01677910|460213914|FG002|Double-Blind Treatment Period|Physician Decision|1|||
127887929|NCT01677910|460213915|FG003|Double-Blind Treatment Period|Physician Decision|0|||
127887930|NCT01677910|460213912|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
127887931|NCT01677910|460213913|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
127799176|NCT01656434|459888006|FG001|Overall Study|Non-compliance with study drug|9|||
127799177|NCT01656434|459888005|FG000|Overall Study|Study terminated by sponsor|1501|||
127799178|NCT01656434|459888006|FG001|Overall Study|Study terminated by sponsor|348|||
127799179|NCT01656434|459888005|FG000|Overall Study|Participant discontinued; drug related|13|||
127799180|NCT01656434|459888006|FG001|Overall Study|Participant discontinued; drug related|4|||
127887932|NCT01677910|460213914|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
127887933|NCT01677910|460213915|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
127887934|NCT01677910|460213912|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
127887935|NCT01677910|460213913|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
127887936|NCT01677910|460213914|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
127887937|NCT01677910|460213915|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
127887938|NCT01677910|460213912|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
127887939|NCT01677910|460213913|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
127887940|NCT01677910|460213914|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
127644999|NCT01212770|459319207|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
127645000|NCT01212770|459319208|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
127799181|NCT01656434|459888005|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
127799182|NCT01656434|459888006|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
127887941|NCT01677910|460213915|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
127645001|NCT01212770|459319200|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
127645002|NCT01212770|459319201|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
127645003|NCT01212770|459319202|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
127645004|NCT01212770|459319203|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
127645005|NCT01212770|459319204|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
127645006|NCT01212770|459319205|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
127645007|NCT01212770|459319206|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
127645008|NCT01212770|459319207|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
127645009|NCT01212770|459319208|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
127645010|NCT01212770|459319200|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
127645011|NCT01212770|459319201|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
127645012|NCT01212770|459319202|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
127645013|NCT01212770|459319203|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
127645014|NCT01212770|459319204|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
127645015|NCT01212770|459319205|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
127645016|NCT01212770|459319206|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
127645017|NCT01212770|459319207|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
127645018|NCT01212770|459319208|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
127645019|NCT01212770|459319200|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
127645020|NCT01212770|459319201|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
127645021|NCT01212770|459319202|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
127645022|NCT01212770|459319203|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
127645023|NCT01212770|459319204|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
127645024|NCT01212770|459319205|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
127645025|NCT01212770|459319206|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
127645026|NCT01212770|459319207|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
127645027|NCT01212770|459319208|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
127645028|NCT01212770|459319200|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
127645029|NCT01212770|459319201|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
127645030|NCT01212770|459319202|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
127645031|NCT01212770|459319203|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
127645032|NCT01212770|459319204|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
127645033|NCT01212770|459319205|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
127645034|NCT01212770|459319206|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
127645035|NCT01212770|459319207|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
127645036|NCT01212770|459319208|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
127645037|NCT01212770|459319200|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
127645038|NCT01212770|459319201|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
127645039|NCT01212770|459319202|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
127645040|NCT01212770|459319203|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
127645041|NCT01212770|459319204|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
127645042|NCT01212770|459319205|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
127645043|NCT01212770|459319206|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
127645044|NCT01212770|459319207|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
127645045|NCT01212770|459319208|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
127645046|NCT01212770|459319200|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
127645047|NCT01212770|459319201|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
127645048|NCT01212770|459319202|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
127645049|NCT01212770|459319203|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
127645050|NCT01212770|459319204|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
127645051|NCT01212770|459319205|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
127645052|NCT01212770|459319206|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
127645053|NCT01212770|459319207|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
127645054|NCT01212770|459319208|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
127645055|NCT01212770|459319200|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
127645056|NCT01212770|459319201|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
127645057|NCT01212770|459319202|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
127645058|NCT01212770|459319203|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
127645059|NCT01212770|459319204|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
127645060|NCT01212770|459319205|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
127645061|NCT01212770|459319206|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
127645062|NCT01212770|459319207|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
127645063|NCT01212770|459319208|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
127887942|NCT01677910|460213912|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
127887943|NCT01677910|460213913|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
127887944|NCT01677910|460213914|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
127887945|NCT01677910|460213915|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
127887946|NCT01677910|460213912|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
127887947|NCT01677910|460213913|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
127887948|NCT01677910|460213914|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
127887949|NCT01677910|460213915|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
127887950|NCT01677910|460213912|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
127887951|NCT01677910|460213913|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
127887952|NCT01677910|460213914|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
127887953|NCT01677910|460213915|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
127887954|NCT01677910|460213912|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
127887955|NCT01677910|460213913|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
127887956|NCT01677910|460213914|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
127887957|NCT01677910|460213915|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
127887958|NCT01677910|460213912|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
127887959|NCT01677910|460213913|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
127887960|NCT01677910|460213914|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
127887961|NCT01677910|460213915|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
127887962|NCT03341273|460213918|FG000|Overall Study|Lost to Follow-up|7|||
127887963|NCT03341273|460213919|FG001|Overall Study|Lost to Follow-up|7|||
127887964|NCT03341273|460213918|FG000|Overall Study|Withdrawal by Subject|4|||
127887965|NCT03341273|460213919|FG001|Overall Study|Withdrawal by Subject|2|||
127887966|NCT03341273|460213918|FG000|Overall Study|Physician Decision|1|||
127887967|NCT03341273|460213919|FG001|Overall Study|Physician Decision|0|||
127887968|NCT03341273|460213918|FG000|Overall Study|Protocol Violation|0|||
127887969|NCT03341273|460213919|FG001|Overall Study|Protocol Violation|1|||
127887970|NCT03341273|460213918|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
127887971|NCT03341273|460213919|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
127887972|NCT03341273|460213918|FG000|Overall Study|Became ineligible after enrollment|1|||
127887973|NCT03341273|460213919|FG001|Overall Study|Became ineligible after enrollment|0|||
127887974|NCT03341273|460213918|FG000|Overall Study|Not Eligible at Enrollment|0|||
127887975|NCT03341273|460213919|FG001|Overall Study|Not Eligible at Enrollment|1|||
127887976|NCT03341273|460213918|FG000|Overall Study|Participant incarcerated|1|||
127887977|NCT03341273|460213919|FG001|Overall Study|Participant incarcerated|0|||
127887978|NCT00685919|460213920|FG000|Overall Study|Withdrawal by Subject|0|||
127887979|NCT00685919|460213921|FG001|Overall Study|Withdrawal by Subject|0|||
127887980|NCT00685919|460213922|FG002|Overall Study|Withdrawal by Subject|1|||
127887981|NCT00685919|460213923|FG003|Overall Study|Withdrawal by Subject|0|||
127887982|NCT00685919|460213920|FG000|Overall Study|Physician Decision|1|||
127887983|NCT00685919|460213921|FG001|Overall Study|Physician Decision|0|||
127887984|NCT00685919|460213922|FG002|Overall Study|Physician Decision|0|||
127887985|NCT00685919|460213923|FG003|Overall Study|Physician Decision|0|||
127887986|NCT01717456|460213924|FG000|End of Treatment|Physician Decision|0|||
127887987|NCT01717456|460213925|FG001|End of Treatment|Physician Decision|1|||
127887988|NCT01717456|460213924|FG000|End of Treatment|Lost to Follow-up|0|||
127887989|NCT01717456|460213925|FG001|End of Treatment|Lost to Follow-up|1|||
127645064|NCT01212770|459319200|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
127645065|NCT01212770|459319201|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
127645066|NCT01212770|459319202|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
127645067|NCT01212770|459319203|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
127645068|NCT01212770|459319204|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
127887990|NCT01717456|460213924|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
127887991|NCT01717456|460213925|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
127887992|NCT03870997|460213928|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
127887993|NCT03870997|460213929|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
127887994|NCT03870997|460213930|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
127887995|NCT03870997|460213931|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
127887996|NCT03870997|460213932|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
127887997|NCT03870997|460213933|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
127645069|NCT01212770|459319205|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
127645070|NCT01212770|459319206|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
127645071|NCT01212770|459319207|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
127645072|NCT01212770|459319208|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
127645073|NCT01212770|459319200|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
127645074|NCT01212770|459319201|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
127645075|NCT01212770|459319202|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
127645076|NCT01212770|459319203|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
127645077|NCT01212770|459319204|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
127645078|NCT01212770|459319205|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
127645079|NCT01212770|459319206|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
127645080|NCT01212770|459319207|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
127645081|NCT01212770|459319208|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
127645082|NCT01212770|459319200|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
127645083|NCT01212770|459319201|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
127645084|NCT01212770|459319202|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
127645085|NCT01212770|459319203|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
127645086|NCT01212770|459319204|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
127645087|NCT01212770|459319205|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
127645088|NCT01212770|459319206|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
127645089|NCT01212770|459319207|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
127645090|NCT01212770|459319208|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
127645091|NCT01212770|459319200|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
127645092|NCT01212770|459319201|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
127645093|NCT01212770|459319202|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
127645094|NCT01212770|459319203|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
127645095|NCT01212770|459319204|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
127645096|NCT01212770|459319205|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
127645097|NCT01212770|459319206|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
127645098|NCT01212770|459319207|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
127645099|NCT01212770|459319208|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
127645100|NCT01212770|459319200|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
127645101|NCT01212770|459319201|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
127645102|NCT01212770|459319202|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
127645103|NCT01212770|459319203|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
127645104|NCT01212770|459319204|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
127645105|NCT01212770|459319205|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
127645106|NCT01212770|459319206|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
127645107|NCT01212770|459319207|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
127645108|NCT01212770|459319208|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
127645109|NCT01212770|459319200|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
127645110|NCT01212770|459319201|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
127645111|NCT01212770|459319202|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
127645112|NCT01212770|459319203|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
127645113|NCT01212770|459319204|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
127645114|NCT01212770|459319205|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
127645115|NCT01212770|459319206|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
127645116|NCT01212770|459319207|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
127645117|NCT01212770|459319208|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
127645118|NCT01212770|459319200|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
127645119|NCT01212770|459319201|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
127645120|NCT01212770|459319202|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
127645121|NCT01212770|459319203|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
127645122|NCT01212770|459319204|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
127645123|NCT01212770|459319205|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
127645124|NCT01212770|459319206|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
127645125|NCT01212770|459319207|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
127645126|NCT01212770|459319208|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
127645127|NCT01212770|459319200|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
127645128|NCT01212770|459319201|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
127645129|NCT01212770|459319202|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
127645130|NCT01212770|459319203|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
127645131|NCT01212770|459319204|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
127645132|NCT01212770|459319205|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
127645133|NCT01212770|459319206|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
127645134|NCT01212770|459319207|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
127645135|NCT01212770|459319208|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
127645136|NCT01212770|459319200|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
127645137|NCT01212770|459319201|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
127707113|NCT02315703|459555459|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
127707114|NCT02315703|459555460|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
127707115|NCT02315703|459555461|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
127707116|NCT02315703|459555454|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
127707117|NCT02315703|459555455|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
127707118|NCT02315703|459555456|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
127707119|NCT02315703|459555457|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
127707120|NCT02315703|459555458|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
127799183|NCT01656434|459888005|FG000|Overall Study|Non-compliance with protocol|39|||
127799184|NCT01656434|459888006|FG001|Overall Study|Non-compliance with protocol|15|||
127799185|NCT01656434|459888005|FG000|Overall Study|Participant moved|40|||
127799186|NCT01656434|459888006|FG001|Overall Study|Participant moved|12|||
127799187|NCT01656434|459888005|FG000|Overall Study|Participant withdrew consent|28|||
127799188|NCT01656434|459888006|FG001|Overall Study|Participant withdrew consent|9|||
127799189|NCT01656434|459888005|FG000|Overall Study|Withdrawal by Subject|64|||
127799190|NCT01656434|459888006|FG001|Overall Study|Withdrawal by Subject|7|||
127799191|NCT01235962|459888007|FG000|Overall Study|Withdrawal by Subject|20|||
127799192|NCT01235962|459888008|FG001|Overall Study|Withdrawal by Subject|19|||
127799193|NCT01235962|459888009|FG002|Overall Study|Withdrawal by Subject|62|||
127799194|NCT01235962|459888010|FG003|Overall Study|Withdrawal by Subject|49|||
127799195|NCT01235962|459888007|FG000|Overall Study|Lost to Follow-up|21|||
127799196|NCT01235962|459888008|FG001|Overall Study|Lost to Follow-up|16|||
127799197|NCT01235962|459888009|FG002|Overall Study|Lost to Follow-up|47|||
127799198|NCT01235962|459888010|FG003|Overall Study|Lost to Follow-up|32|||
127799199|NCT01235962|459888007|FG000|Overall Study|Physician Decision|5|||
127799200|NCT01235962|459888008|FG001|Overall Study|Physician Decision|0|||
127799201|NCT01235962|459888009|FG002|Overall Study|Physician Decision|9|||
127799202|NCT01235962|459888010|FG003|Overall Study|Physician Decision|5|||
127799203|NCT00087646|459888011|FG000|Overall Study|Adverse Event|37|||
127799204|NCT00087646|459888012|FG001|Overall Study|Adverse Event|6|||
127799205|NCT00087646|459888013|FG002|Overall Study|Adverse Event|18|||
127799206|NCT00087646|459888014|FG003|Overall Study|Adverse Event|20|||
127799207|NCT00087646|459888011|FG000|Overall Study|Death|0|||
127799208|NCT00087646|459888012|FG001|Overall Study|Death|1|||
127799209|NCT00087646|459888013|FG002|Overall Study|Death|0|||
127799210|NCT00087646|459888014|FG003|Overall Study|Death|0|||
127799211|NCT00087646|459888011|FG000|Overall Study|Withdrawal by Subject|6|||
127799212|NCT00087646|459888012|FG001|Overall Study|Withdrawal by Subject|1|||
127799213|NCT00087646|459888013|FG002|Overall Study|Withdrawal by Subject|2|||
127799214|NCT00087646|459888014|FG003|Overall Study|Withdrawal by Subject|2|||
127799215|NCT00087646|459888011|FG000|Overall Study|Insufficient therapeutic response|64|||
127799216|NCT00087646|459888012|FG001|Overall Study|Insufficient therapeutic response|24|||
127799217|NCT00087646|459888013|FG002|Overall Study|Insufficient therapeutic response|38|||
127799218|NCT00087646|459888014|FG003|Overall Study|Insufficient therapeutic response|51|||
127799219|NCT00087646|459888011|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
127799220|NCT00087646|459888012|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
127799221|NCT00087646|459888013|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
127799222|NCT00087646|459888014|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
127799223|NCT00087646|459888011|FG000|Overall Study|Failure to Return|5|||
127799224|NCT00087646|459888012|FG001|Overall Study|Failure to Return|2|||
127799225|NCT00087646|459888013|FG002|Overall Study|Failure to Return|2|||
127799226|NCT00087646|459888014|FG003|Overall Study|Failure to Return|3|||
127799227|NCT00087646|459888011|FG000|Overall Study|Administrative/Other|6|||
127799228|NCT00087646|459888012|FG001|Overall Study|Administrative/Other|1|||
127799229|NCT00087646|459888013|FG002|Overall Study|Administrative/Other|1|||
127799230|NCT00087646|459888014|FG003|Overall Study|Administrative/Other|2|||
127799231|NCT00087646|459888011|FG000|Overall Study|Other Protocol Violation|3|||
127799232|NCT00087646|459888012|FG001|Overall Study|Other Protocol Violation|1|||
127799233|NCT00087646|459888013|FG002|Overall Study|Other Protocol Violation|0|||
127799234|NCT00087646|459888014|FG003|Overall Study|Other Protocol Violation|0|||
127799235|NCT00087646|459888011|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
127799236|NCT00087646|459888012|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
127799237|NCT00087646|459888013|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
127799238|NCT00087646|459888014|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
127799239|NCT01580397|459888017|FG000|Overall Study|Lack of Efficacy|14|||
127799240|NCT02902120|459888018|FG000|Overall Study|Lack of Efficacy|1|||
127799241|NCT02004873|459888020|FG000|Overall Study|Implant unsuccessful|6|||
127799242|NCT02004873|459888020|FG000|Overall Study|Awaiting 6-month visit|390|||
127799243|NCT02004873|459888020|FG000|Overall Study|Missed 6-month visit|4|||
127799244|NCT02004873|459888020|FG000|Overall Study|Death|23|||
127799245|NCT02004873|459888020|FG000|Overall Study|Withdrawal by Subject|1|||
127799246|NCT01353703|459888021|FG000|Overall Study|Migrated/moved from study area|1|||
127799247|NCT01353703|459888022|FG001|Overall Study|Migrated/moved from study area|0|||
127799248|NCT03467958|459888039|FG000|Overall Study|Adverse Event|20|||
127799249|NCT03467958|459888040|FG001|Overall Study|Adverse Event|32|||
127887998|NCT03751020|460213936|FG000|Overall Study|Withdrawal by Subject|2|||
127887999|NCT03751020|460213937|FG001|Overall Study|Withdrawal by Subject|0|||
127645138|NCT01212770|459319202|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
127645139|NCT01212770|459319203|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
127645140|NCT01212770|459319204|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
127645141|NCT01212770|459319205|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
127645142|NCT01212770|459319206|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
127645143|NCT01212770|459319207|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
127645144|NCT01212770|459319208|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
127645145|NCT01212770|459319200|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
127645146|NCT01212770|459319201|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
127645147|NCT01212770|459319202|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
127645148|NCT01212770|459319203|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
127645149|NCT01212770|459319204|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
127645150|NCT01212770|459319205|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
127645151|NCT01212770|459319206|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
127645152|NCT01212770|459319207|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
127645153|NCT01212770|459319208|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
127645154|NCT01212770|459319200|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
127645155|NCT01212770|459319201|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
127645156|NCT01212770|459319202|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
127645157|NCT01212770|459319203|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
127645158|NCT01212770|459319204|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
127645159|NCT01212770|459319205|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
127645160|NCT01212770|459319206|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
127645161|NCT01212770|459319207|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
127645162|NCT01212770|459319208|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
127645163|NCT01212770|459319200|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
127645164|NCT01212770|459319201|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
127645165|NCT01212770|459319202|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
127645166|NCT01212770|459319203|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
127645167|NCT01212770|459319204|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
127645168|NCT01212770|459319205|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
127645169|NCT01212770|459319206|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
127645170|NCT01212770|459319207|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
127645171|NCT01212770|459319208|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
127645172|NCT01212770|459319200|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
127645173|NCT01212770|459319201|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
127645174|NCT01212770|459319202|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
127645175|NCT01212770|459319203|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
127645176|NCT01212770|459319204|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
127645177|NCT01212770|459319205|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
127645178|NCT01212770|459319206|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
127645179|NCT01212770|459319207|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
127645180|NCT01212770|459319208|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
127645181|NCT01212770|459319200|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
127645182|NCT01212770|459319201|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
127645183|NCT01212770|459319202|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
127645184|NCT01212770|459319203|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
127645185|NCT01212770|459319204|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
127645186|NCT01212770|459319205|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
127645187|NCT01212770|459319206|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
127645188|NCT01212770|459319207|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
127645189|NCT01212770|459319208|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
127645190|NCT01212770|459319200|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
127645191|NCT01212770|459319201|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
127645192|NCT01212770|459319202|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
127645193|NCT01212770|459319203|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
127645194|NCT01212770|459319204|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
127645195|NCT01212770|459319205|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
127645196|NCT01212770|459319206|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
127645197|NCT01212770|459319207|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
127645198|NCT01212770|459319208|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
127645199|NCT01212770|459319200|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
127645200|NCT01212770|459319201|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
127645201|NCT01212770|459319202|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
127645202|NCT01212770|459319203|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
127888000|NCT03751020|460213938|FG002|Overall Study|Withdrawal by Subject|0|||
127888001|NCT03751020|460213936|FG000|Overall Study|Lost to Follow-up|7|||
127707121|NCT02315703|459555459|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
127707122|NCT02315703|459555460|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
127707123|NCT02315703|459555461|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
127707124|NCT02315703|459555454|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
127707125|NCT02315703|459555455|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
127707126|NCT02315703|459555456|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
127707127|NCT02315703|459555457|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
127707128|NCT02315703|459555458|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
127707129|NCT02315703|459555459|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
127707130|NCT02315703|459555460|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
127707131|NCT02315703|459555461|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
127707132|NCT05216406|459555473|FG000|Overall Study|Lost to Follow-up|8|||
127707133|NCT05216406|459555474|FG001|Overall Study|Lost to Follow-up|9|||
127707134|NCT04690582|459555475|FG000|Overall Study|Withdrawal by Subject|6|||
127707135|NCT04690582|459555476|FG001|Overall Study|Withdrawal by Subject|4|||
127707136|NCT03711474|459555477|FG000|Overall Study|Physician Decision|2|||
127707137|NCT03711474|459555478|FG001|Overall Study|Physician Decision|0|||
127707138|NCT03625115|459555481|FG000|Overall Study|Withdrawal by Subject|4|||
127707139|NCT03625115|459555482|FG001|Overall Study|Withdrawal by Subject|7|||
127707140|NCT03625115|459555481|FG000|Overall Study|Lost to Follow-up|17|||
127707141|NCT03625115|459555482|FG001|Overall Study|Lost to Follow-up|24|||
127707142|NCT04101357|459555484|FG000|Overall Study|Death|1|||
127707143|NCT04101357|459555485|FG001|Overall Study|Death|1|||
127707144|NCT04101357|459555486|FG002|Overall Study|Death|1|||
127888002|NCT03751020|460213937|FG001|Overall Study|Lost to Follow-up|4|||
127888003|NCT03751020|460213938|FG002|Overall Study|Lost to Follow-up|10|||
127888004|NCT00033631|460213939|FG000|Overall Study|Protocol Violation|14|||
127707145|NCT04101357|459555487|FG003|Overall Study|Death|2|||
127707146|NCT04101357|459555488|FG004|Overall Study|Death|4|||
127707147|NCT04101357|459555489|FG005|Overall Study|Death|11|||
127707148|NCT04101357|459555490|FG006|Overall Study|Death|4|||
127707149|NCT04101357|459555491|FG007|Overall Study|Death|4|||
127707150|NCT04101357|459555492|FG008|Overall Study|Death|5|||
127888005|NCT00033631|460213940|FG001|Overall Study|Protocol Violation|11|||
127888006|NCT00033631|460213939|FG000|Overall Study|Withdrawal by Subject|4|||
127707151|NCT04101357|459555493|FG009|Overall Study|Death|2|||
127707152|NCT04101357|459555494|FG010|Overall Study|Death|3|||
127707153|NCT04101357|459555484|FG000|Overall Study|Trial closure|0|||
127707154|NCT04101357|459555485|FG001|Overall Study|Trial closure|0|||
127707155|NCT04101357|459555486|FG002|Overall Study|Trial closure|0|||
127707156|NCT04101357|459555487|FG003|Overall Study|Trial closure|0|||
127707157|NCT04101357|459555488|FG004|Overall Study|Trial closure|0|||
127707158|NCT04101357|459555489|FG005|Overall Study|Trial closure|2|||
127707159|NCT04101357|459555490|FG006|Overall Study|Trial closure|2|||
127707160|NCT04101357|459555491|FG007|Overall Study|Trial closure|0|||
127707161|NCT04101357|459555492|FG008|Overall Study|Trial closure|0|||
127707162|NCT04101357|459555493|FG009|Overall Study|Trial closure|0|||
127799250|NCT03467958|459888041|FG002|Overall Study|Adverse Event|5|||
127799251|NCT03467958|459888042|FG003|Overall Study|Adverse Event|3|||
127799252|NCT03467958|459888043|FG004|Overall Study|Adverse Event|3|||
127799253|NCT03467958|459888044|FG005|Overall Study|Adverse Event|3|||
127799254|NCT03467958|459888045|FG006|Overall Study|Adverse Event|6|||
127799255|NCT03467958|459888046|FG007|Overall Study|Adverse Event|5|||
127799256|NCT03467958|459888047|FG008|Overall Study|Adverse Event|0|||
127799257|NCT03467958|459888039|FG000|Overall Study|Lack of Efficacy|59|||
127799258|NCT03467958|459888040|FG001|Overall Study|Lack of Efficacy|120|||
127799259|NCT03467958|459888041|FG002|Overall Study|Lack of Efficacy|6|||
127799260|NCT03467958|459888042|FG003|Overall Study|Lack of Efficacy|9|||
127799261|NCT03467958|459888043|FG004|Overall Study|Lack of Efficacy|8|||
127799262|NCT03467958|459888044|FG005|Overall Study|Lack of Efficacy|9|||
127799263|NCT03467958|459888045|FG006|Overall Study|Lack of Efficacy|11|||
127799264|NCT03467958|459888046|FG007|Overall Study|Lack of Efficacy|9|||
127799265|NCT03467958|459888047|FG008|Overall Study|Lack of Efficacy|3|||
127799266|NCT03467958|459888039|FG000|Overall Study|Lost to Follow-up|1|||
127799267|NCT03467958|459888040|FG001|Overall Study|Lost to Follow-up|2|||
127799268|NCT03467958|459888041|FG002|Overall Study|Lost to Follow-up|1|||
127799269|NCT03467958|459888042|FG003|Overall Study|Lost to Follow-up|0|||
127799270|NCT03467958|459888043|FG004|Overall Study|Lost to Follow-up|4|||
127799271|NCT03467958|459888044|FG005|Overall Study|Lost to Follow-up|0|||
127888007|NCT00033631|460213940|FG001|Overall Study|Withdrawal by Subject|4|||
127888008|NCT00528879|460213941|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
127799272|NCT03467958|459888045|FG006|Overall Study|Lost to Follow-up|0|||
127707163|NCT04101357|459555494|FG010|Overall Study|Trial closure|1|||
127707164|NCT04101357|459555484|FG000|Overall Study|Lost to Follow-up|0|||
127707165|NCT04101357|459555485|FG001|Overall Study|Lost to Follow-up|0|||
127707166|NCT04101357|459555486|FG002|Overall Study|Lost to Follow-up|0|||
127707167|NCT04101357|459555487|FG003|Overall Study|Lost to Follow-up|1|||
127707168|NCT04101357|459555488|FG004|Overall Study|Lost to Follow-up|0|||
127707169|NCT04101357|459555489|FG005|Overall Study|Lost to Follow-up|0|||
127707170|NCT04101357|459555490|FG006|Overall Study|Lost to Follow-up|0|||
127707171|NCT04101357|459555491|FG007|Overall Study|Lost to Follow-up|1|||
127707172|NCT04101357|459555492|FG008|Overall Study|Lost to Follow-up|0|||
127707173|NCT04101357|459555493|FG009|Overall Study|Lost to Follow-up|0|||
127707174|NCT04101357|459555494|FG010|Overall Study|Lost to Follow-up|0|||
127707175|NCT04101357|459555484|FG000|Overall Study|Withdrawal by Subject|1|||
127707176|NCT04101357|459555485|FG001|Overall Study|Withdrawal by Subject|0|||
127707177|NCT04101357|459555486|FG002|Overall Study|Withdrawal by Subject|0|||
127707178|NCT04101357|459555487|FG003|Overall Study|Withdrawal by Subject|0|||
127707179|NCT04101357|459555488|FG004|Overall Study|Withdrawal by Subject|0|||
127707180|NCT04101357|459555489|FG005|Overall Study|Withdrawal by Subject|0|||
127707181|NCT04101357|459555490|FG006|Overall Study|Withdrawal by Subject|0|||
127707182|NCT04101357|459555491|FG007|Overall Study|Withdrawal by Subject|0|||
127707183|NCT04101357|459555492|FG008|Overall Study|Withdrawal by Subject|1|||
127707184|NCT04101357|459555493|FG009|Overall Study|Withdrawal by Subject|1|||
127707185|NCT04101357|459555494|FG010|Overall Study|Withdrawal by Subject|0|||
127707186|NCT04101357|459555484|FG000|Overall Study|Other|0|||
127707187|NCT04101357|459555485|FG001|Overall Study|Other|0|||
127707188|NCT04101357|459555486|FG002|Overall Study|Other|0|||
127707189|NCT04101357|459555487|FG003|Overall Study|Other|0|||
127707190|NCT04101357|459555488|FG004|Overall Study|Other|0|||
127707191|NCT04101357|459555489|FG005|Overall Study|Other|1|||
127707192|NCT04101357|459555490|FG006|Overall Study|Other|2|||
127707193|NCT04101357|459555491|FG007|Overall Study|Other|1|||
127707194|NCT04101357|459555492|FG008|Overall Study|Other|0|||
127707195|NCT04101357|459555493|FG009|Overall Study|Other|0|||
127707196|NCT04101357|459555494|FG010|Overall Study|Other|0|||
127707197|NCT04101357|459555484|FG000|Overall Study|Enrolled but not treated|0|||
127707198|NCT04101357|459555485|FG001|Overall Study|Enrolled but not treated|0|||
127707199|NCT04101357|459555486|FG002|Overall Study|Enrolled but not treated|0|||
127707200|NCT04101357|459555487|FG003|Overall Study|Enrolled but not treated|0|||
127707201|NCT04101357|459555488|FG004|Overall Study|Enrolled but not treated|0|||
127707202|NCT04101357|459555489|FG005|Overall Study|Enrolled but not treated|1|||
127707203|NCT04101357|459555490|FG006|Overall Study|Enrolled but not treated|1|||
127707204|NCT04101357|459555491|FG007|Overall Study|Enrolled but not treated|0|||
127707205|NCT04101357|459555492|FG008|Overall Study|Enrolled but not treated|0|||
127707206|NCT04101357|459555493|FG009|Overall Study|Enrolled but not treated|0|||
127707207|NCT04101357|459555494|FG010|Overall Study|Enrolled but not treated|0|||
127707208|NCT05868382|459555495|FG000|Overall Study|Lost to Follow-up|5|||
127707209|NCT05868382|459555496|FG001|Overall Study|Lost to Follow-up|0|||
127707210|NCT05868382|459555497|FG002|Overall Study|Lost to Follow-up|6|||
127707211|NCT05868382|459555498|FG003|Overall Study|Lost to Follow-up|4|||
127707212|NCT05868382|459555499|FG004|Overall Study|Lost to Follow-up|2|||
127707213|NCT05868382|459555500|FG005|Overall Study|Lost to Follow-up|6|||
127707214|NCT05868382|459555495|FG000|Overall Study|Withdrawal by Subject|1|||
127707215|NCT05868382|459555496|FG001|Overall Study|Withdrawal by Subject|0|||
127707216|NCT05868382|459555497|FG002|Overall Study|Withdrawal by Subject|0|||
127707217|NCT05868382|459555498|FG003|Overall Study|Withdrawal by Subject|0|||
127707218|NCT05868382|459555499|FG004|Overall Study|Withdrawal by Subject|1|||
127707219|NCT05868382|459555500|FG005|Overall Study|Withdrawal by Subject|0|||
127799273|NCT03467958|459888046|FG007|Overall Study|Lost to Follow-up|0|||
127799274|NCT03467958|459888047|FG008|Overall Study|Lost to Follow-up|0|||
127799275|NCT03467958|459888039|FG000|Overall Study|Other reasons|8|||
127799276|NCT03467958|459888040|FG001|Overall Study|Other reasons|14|||
127799277|NCT03467958|459888041|FG002|Overall Study|Other reasons|2|||
127799278|NCT03467958|459888042|FG003|Overall Study|Other reasons|1|||
127799279|NCT03467958|459888043|FG004|Overall Study|Other reasons|4|||
127799280|NCT03467958|459888044|FG005|Overall Study|Other reasons|0|||
127799281|NCT03467958|459888045|FG006|Overall Study|Other reasons|1|||
127707220|NCT02497950|459555501|FG000|Overall Study|Death|209|||
127707221|NCT02497950|459555501|FG000|Overall Study|Transplanted|85|||
127707222|NCT02497950|459555501|FG000|Overall Study|Explanted|8|||
127707223|NCT02497950|459555501|FG000|Overall Study|Device Permanently Deactivated|4|||
127707224|NCT02497950|459555501|FG000|Overall Study|Implanted/Exchanged to an LVAD other than HM3|1|||
127707225|NCT02497950|459555501|FG000|Overall Study|Lost to Follow-up|6|||
127707226|NCT02497950|459555501|FG000|Overall Study|Withdrawal by Subject|2|||
127799282|NCT03467958|459888046|FG007|Overall Study|Other reasons|0|||
127799283|NCT03467958|459888047|FG008|Overall Study|Other reasons|1|||
127707227|NCT02497950|459555501|FG000|Overall Study|Center Did Not Participate in Long-Term FU|4|||
127707228|NCT02497950|459555501|FG000|Overall Study|Refused Consent to Long-Term FU|13|||
127707229|NCT01236781|459555502|FG000|Overall Study|Ineligible|2|||
127707230|NCT01236781|459555503|FG001|Overall Study|Ineligible|1|||
127645203|NCT01212770|459319204|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
127645204|NCT01212770|459319205|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
127645205|NCT01212770|459319206|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
127645206|NCT01212770|459319207|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
127645207|NCT01212770|459319208|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
127645208|NCT01212770|459319200|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
127645209|NCT01212770|459319201|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
127645210|NCT01212770|459319202|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
127645211|NCT01212770|459319203|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
127645212|NCT01212770|459319204|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
127645213|NCT01212770|459319205|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
127645214|NCT01212770|459319206|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
127645215|NCT01212770|459319207|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
127645216|NCT01212770|459319208|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
127645217|NCT01212770|459319200|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
127645218|NCT01212770|459319201|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
127645219|NCT01212770|459319202|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
127645220|NCT01212770|459319203|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
127645221|NCT01212770|459319204|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
127645222|NCT01212770|459319205|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
127645223|NCT01212770|459319206|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
127645224|NCT01212770|459319207|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
127645225|NCT01212770|459319208|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
127645226|NCT01212770|459319200|FG000|Long-term Safety Phase (Year 5)|Death|0|||
127645227|NCT01212770|459319201|FG001|Long-term Safety Phase (Year 5)|Death|0|||
127645228|NCT01212770|459319202|FG002|Long-term Safety Phase (Year 5)|Death|0|||
127645229|NCT01212770|459319203|FG003|Long-term Safety Phase (Year 5)|Death|0|||
127645230|NCT01212770|459319204|FG004|Long-term Safety Phase (Year 5)|Death|0|||
127645231|NCT01212770|459319205|FG005|Long-term Safety Phase (Year 5)|Death|0|||
127645232|NCT01212770|459319206|FG006|Long-term Safety Phase (Year 5)|Death|0|||
127645233|NCT01212770|459319207|FG007|Long-term Safety Phase (Year 5)|Death|1|||
127645234|NCT01212770|459319208|FG008|Long-term Safety Phase (Year 5)|Death|0|||
127645235|NCT03519854|459319220|FG000|Overall Study|Technical Error|0|||
127645236|NCT03519854|459319221|FG001|Overall Study|Technical Error|0|||
127645237|NCT03519854|459319222|FG002|Overall Study|Technical Error|1|||
127645238|NCT03519854|459319223|FG003|Overall Study|Technical Error|0|||
127645239|NCT03519854|459319224|FG004|Overall Study|Technical Error|0|||
127645240|NCT03519854|459319225|FG005|Overall Study|Technical Error|0|||
127645241|NCT03519854|459319226|FG006|Overall Study|Technical Error|0|||
127645242|NCT03519854|459319227|FG007|Overall Study|Technical Error|0|||
127645243|NCT03519854|459319228|FG008|Overall Study|Technical Error|0|||
127645244|NCT03519854|459319229|FG009|Overall Study|Technical Error|0|||
127645245|NCT03519854|459319230|FG010|Overall Study|Technical Error|0|||
127645246|NCT03519854|459319231|FG011|Overall Study|Technical Error|0|||
127645247|NCT03519854|459319232|FG012|Overall Study|Technical Error|0|||
127645248|NCT03519854|459319233|FG013|Overall Study|Technical Error|0|||
127645249|NCT03519854|459319234|FG014|Overall Study|Technical Error|0|||
127645250|NCT03519854|459319235|FG015|Overall Study|Technical Error|0|||
127645251|NCT03519854|459319236|FG016|Overall Study|Technical Error|0|||
127645252|NCT03519854|459319237|FG017|Overall Study|Technical Error|0|||
127645253|NCT02747238|459319242|FG000|Overall Study|Lack of Efficacy|0|||
127645254|NCT02747238|459319243|FG001|Overall Study|Lack of Efficacy|1|||
127645255|NCT02747238|459319242|FG000|Overall Study|Data lost|3|||
127645256|NCT02747238|459319243|FG001|Overall Study|Data lost|5|||
127645257|NCT02085252|459319246|FG000|Overall Study|Withdrawal of Consent|1|||
127645258|NCT02085252|459319247|FG001|Overall Study|Withdrawal of Consent|0|||
127645259|NCT02085252|459319246|FG000|Overall Study|Adverse Event|0|||
127645260|NCT02085252|459319247|FG001|Overall Study|Adverse Event|1|||
127645261|NCT02085252|459319246|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
127645262|NCT02085252|459319247|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
127645263|NCT02085252|459319246|FG000|Overall Study|Reason Not Specified|0|||
127645264|NCT02085252|459319247|FG001|Overall Study|Reason Not Specified|1|||
127645265|NCT02085252|459319246|FG000|Overall Study|Reason Unknown|0|||
127645266|NCT02085252|459319247|FG001|Overall Study|Reason Unknown|1|||
127645267|NCT00951275|459319248|FG000|Overall Study|Administrative Reason|1|||
127645268|NCT00951275|459319248|FG000|Overall Study|Adverse Event|7|||
127645269|NCT00951275|459319248|FG000|Overall Study|Withdrawal by Subject|4|||
127645270|NCT00951275|459319248|FG000|Overall Study|Protocol Violation|1|||
127645271|NCT03053050|459319253|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
127799284|NCT03467958|459888039|FG000|Overall Study|Pregnancy|1|||
127799285|NCT03467958|459888040|FG001|Overall Study|Pregnancy|0|||
127799286|NCT03467958|459888041|FG002|Overall Study|Pregnancy|0|||
127799287|NCT03467958|459888042|FG003|Overall Study|Pregnancy|0|||
127799288|NCT03467958|459888043|FG004|Overall Study|Pregnancy|0|||
127707231|NCT01236781|459555502|FG000|Overall Study|Did not complete study imaging|5|||
127707232|NCT01236781|459555503|FG001|Overall Study|Did not complete study imaging|0|||
127707233|NCT01009788|459555516|FG000|Overall Study|Withdrawal by Subject|1|||
127707234|NCT01009788|459555517|FG001|Overall Study|Withdrawal by Subject|0|||
127707235|NCT04308681|459555518|FG000|Pre-Treatment|Not reported|1|||
127707236|NCT04308681|459555519|FG001|Pre-Treatment|Not reported|1|||
127707237|NCT04308681|459555520|FG002|Pre-Treatment|Not reported|0|||
127707238|NCT04308681|459555521|FG003|Pre-Treatment|Not reported|0|||
127707239|NCT04308681|459555522|FG004|Pre-Treatment|Not reported|0|||
127707240|NCT04308681|459555523|FG005|Pre-Treatment|Not reported|2|||
127707241|NCT04308681|459555524|FG006|Pre-Treatment|Not reported|0|||
127707242|NCT04308681|459555525|FG007|Pre-Treatment|Not reported|0|||
127707243|NCT04308681|459555518|FG000|Treatment up to Week 26|Withdrawal by participant|2|||
127707244|NCT04308681|459555519|FG001|Treatment up to Week 26|Withdrawal by participant|1|||
127707245|NCT04308681|459555520|FG002|Treatment up to Week 26|Withdrawal by participant|1|||
127707246|NCT04308681|459555521|FG003|Treatment up to Week 26|Withdrawal by participant|0|||
127707247|NCT04308681|459555522|FG004|Treatment up to Week 26|Withdrawal by participant|0|||
127707248|NCT04308681|459555523|FG005|Treatment up to Week 26|Withdrawal by participant|1|||
127707249|NCT04308681|459555524|FG006|Treatment up to Week 26|Withdrawal by participant|1|||
127707250|NCT04308681|459555525|FG007|Treatment up to Week 26|Withdrawal by participant|0|||
127707251|NCT04308681|459555518|FG000|Treatment up to Week 26|Other reasons|2|||
127707252|NCT04308681|459555519|FG001|Treatment up to Week 26|Other reasons|0|||
127707253|NCT04308681|459555520|FG002|Treatment up to Week 26|Other reasons|0|||
127707254|NCT04308681|459555521|FG003|Treatment up to Week 26|Other reasons|0|||
127707255|NCT04308681|459555522|FG004|Treatment up to Week 26|Other reasons|1|||
127707256|NCT04308681|459555523|FG005|Treatment up to Week 26|Other reasons|1|||
127707257|NCT04308681|459555524|FG006|Treatment up to Week 26|Other reasons|0|||
127707258|NCT04308681|459555525|FG007|Treatment up to Week 26|Other reasons|0|||
127707259|NCT04308681|459555518|FG000|Treatment up to Week 26|Participant no longer meets study criteria|0|||
127707260|NCT04308681|459555519|FG001|Treatment up to Week 26|Participant no longer meets study criteria|1|||
127707261|NCT04308681|459555520|FG002|Treatment up to Week 26|Participant no longer meets study criteria|2|||
127707262|NCT04308681|459555521|FG003|Treatment up to Week 26|Participant no longer meets study criteria|0|||
127707263|NCT04308681|459555522|FG004|Treatment up to Week 26|Participant no longer meets study criteria|1|||
127707264|NCT04308681|459555523|FG005|Treatment up to Week 26|Participant no longer meets study criteria|0|||
127707265|NCT04308681|459555524|FG006|Treatment up to Week 26|Participant no longer meets study criteria|1|||
127707266|NCT04308681|459555525|FG007|Treatment up to Week 26|Participant no longer meets study criteria|0|||
127707267|NCT04308681|459555518|FG000|Treatment up to Week 26|Adverse Event|6|||
127707268|NCT04308681|459555519|FG001|Treatment up to Week 26|Adverse Event|5|||
127707269|NCT04308681|459555520|FG002|Treatment up to Week 26|Adverse Event|5|||
127707270|NCT04308681|459555521|FG003|Treatment up to Week 26|Adverse Event|0|||
127707271|NCT04308681|459555522|FG004|Treatment up to Week 26|Adverse Event|6|||
127707272|NCT04308681|459555523|FG005|Treatment up to Week 26|Adverse Event|1|||
127707273|NCT04308681|459555524|FG006|Treatment up to Week 26|Adverse Event|0|||
127707274|NCT04308681|459555525|FG007|Treatment up to Week 26|Adverse Event|0|||
127707275|NCT04308681|459555518|FG000|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
127707276|NCT04308681|459555519|FG001|Treatment up to Week 26|Adverse event unrelated to study drug|2|||
127707277|NCT04308681|459555520|FG002|Treatment up to Week 26|Adverse event unrelated to study drug|1|||
127707278|NCT04308681|459555521|FG003|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
127707279|NCT04308681|459555522|FG004|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
127707280|NCT04308681|459555523|FG005|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
127799289|NCT03467958|459888044|FG005|Overall Study|Pregnancy|1|||
127799290|NCT03467958|459888045|FG006|Overall Study|Pregnancy|0|||
127799291|NCT03467958|459888046|FG007|Overall Study|Pregnancy|0|||
127799292|NCT03467958|459888047|FG008|Overall Study|Pregnancy|0|||
127799293|NCT03467958|459888039|FG000|Overall Study|Study terminated by sponsor|65|||
127799294|NCT03467958|459888040|FG001|Overall Study|Study terminated by sponsor|117|||
127799295|NCT03467958|459888041|FG002|Overall Study|Study terminated by sponsor|45|||
127799296|NCT03467958|459888042|FG003|Overall Study|Study terminated by sponsor|64|||
127799297|NCT03467958|459888043|FG004|Overall Study|Study terminated by sponsor|66|||
127799298|NCT03467958|459888044|FG005|Overall Study|Study terminated by sponsor|17|||
127799299|NCT03467958|459888045|FG006|Overall Study|Study terminated by sponsor|11|||
127799300|NCT03467958|459888046|FG007|Overall Study|Study terminated by sponsor|5|||
127707281|NCT04308681|459555524|FG006|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
127707282|NCT04308681|459555525|FG007|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
127707283|NCT04308681|459555518|FG000|OTE - 26 Weeks|Withdrawal by participant|0|||
127799301|NCT03467958|459888047|FG008|Overall Study|Study terminated by sponsor|5|||
127799302|NCT03467958|459888039|FG000|Overall Study|Withdrawal by Subject|25|||
127707284|NCT04308681|459555519|FG001|OTE - 26 Weeks|Withdrawal by participant|0|||
127645272|NCT03053050|459319254|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
127645273|NCT03053050|459319255|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
127645274|NCT03053050|459319256|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
127645275|NCT03053050|459319253|FG000|Randomized Phase|Withdrew Consent|16|||
127645276|NCT03053050|459319254|FG001|Randomized Phase|Withdrew Consent|8|||
127645277|NCT03053050|459319255|FG002|Randomized Phase|Withdrew Consent|9|||
127645278|NCT03053050|459319256|FG003|Randomized Phase|Withdrew Consent|0|||
127645279|NCT03053050|459319253|FG000|Randomized Phase|Investigator's Discretion|6|||
127645280|NCT03053050|459319254|FG001|Randomized Phase|Investigator's Discretion|6|||
127645281|NCT03053050|459319255|FG002|Randomized Phase|Investigator's Discretion|3|||
127645282|NCT03053050|459319256|FG003|Randomized Phase|Investigator's Discretion|0|||
127645283|NCT03053050|459319253|FG000|Randomized Phase|Lost to Follow-up|5|||
127645284|NCT03053050|459319254|FG001|Randomized Phase|Lost to Follow-up|1|||
127645285|NCT03053050|459319255|FG002|Randomized Phase|Lost to Follow-up|1|||
127645286|NCT03053050|459319256|FG003|Randomized Phase|Lost to Follow-up|0|||
127645287|NCT03053050|459319253|FG000|Randomized Phase|Adverse Event|0|||
127645288|NCT03053050|459319254|FG001|Randomized Phase|Adverse Event|1|||
127645289|NCT03053050|459319255|FG002|Randomized Phase|Adverse Event|0|||
127645290|NCT03053050|459319256|FG003|Randomized Phase|Adverse Event|0|||
127645291|NCT03053050|459319253|FG000|Randomized Phase|Randomized but Never Treated|2|||
127645292|NCT03053050|459319254|FG001|Randomized Phase|Randomized but Never Treated|2|||
127645293|NCT03053050|459319255|FG002|Randomized Phase|Randomized but Never Treated|2|||
127645294|NCT03053050|459319256|FG003|Randomized Phase|Randomized but Never Treated|0|||
127645295|NCT03053050|459319253|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
127645296|NCT03053050|459319254|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
127645297|NCT03053050|459319255|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
127645298|NCT03053050|459319256|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
127645299|NCT03053050|459319253|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
127645300|NCT03053050|459319254|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
127645301|NCT03053050|459319255|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
127645302|NCT03053050|459319256|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
127645303|NCT03053050|459319253|FG000|Open-label Phase|Withdrew Consent|0|||
127645304|NCT03053050|459319254|FG001|Open-label Phase|Withdrew Consent|0|||
127645305|NCT03053050|459319255|FG002|Open-label Phase|Withdrew Consent|0|||
127645306|NCT03053050|459319256|FG003|Open-label Phase|Withdrew Consent|6|||
127645307|NCT03053050|459319253|FG000|Open-label Phase|Investigator's Discretion|0|||
127645308|NCT03053050|459319254|FG001|Open-label Phase|Investigator's Discretion|0|||
127645309|NCT03053050|459319255|FG002|Open-label Phase|Investigator's Discretion|0|||
127645310|NCT03053050|459319256|FG003|Open-label Phase|Investigator's Discretion|4|||
127645311|NCT03703466|459319257|FG000|Overall Study|Death|2|||
127645312|NCT03703466|459319258|FG001|Overall Study|Death|1|||
127645313|NCT03703466|459319259|FG002|Overall Study|Death|0|||
127645314|NCT03703466|459319257|FG000|Overall Study|Withdrawal by Subject|0|||
127645315|NCT03703466|459319258|FG001|Overall Study|Withdrawal by Subject|3|||
127645316|NCT03703466|459319259|FG002|Overall Study|Withdrawal by Subject|0|||
127645317|NCT03703466|459319257|FG000|Overall Study|Completed < 3 Cycles|2|||
127645318|NCT03703466|459319258|FG001|Overall Study|Completed < 3 Cycles|2|||
127645319|NCT03703466|459319259|FG002|Overall Study|Completed < 3 Cycles|2|||
127645320|NCT05338333|459319260|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
127645321|NCT05338333|459319261|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
127645322|NCT03409666|459320960|FG000|Overall Study|Physician Decision|0|||
127645323|NCT03409666|459320961|FG001|Overall Study|Physician Decision|1|||
127645324|NCT03409666|459320960|FG000|Overall Study|Protocol Violation|0|||
127645325|NCT03409666|459320961|FG001|Overall Study|Protocol Violation|3|||
127645326|NCT01791725|459320962|FG000|Overall Study|Withdrawal by Subject|0|||
127645327|NCT01791725|459320963|FG001|Overall Study|Withdrawal by Subject|1|||
127707285|NCT04308681|459555520|FG002|OTE - 26 Weeks|Withdrawal by participant|4|||
127707286|NCT04308681|459555521|FG003|OTE - 26 Weeks|Withdrawal by participant|0|||
127645328|NCT01791725|459320964|FG002|Overall Study|Withdrawal by Subject|0|||
127645329|NCT00512148|459320965|FG000|Primay Study Period|Withdrawal by Subject|1|||
127707287|NCT04308681|459555522|FG004|OTE - 26 Weeks|Withdrawal by participant|0|||
127707288|NCT04308681|459555523|FG005|OTE - 26 Weeks|Withdrawal by participant|0|||
127645330|NCT00677833|459320966|FG000|Overall Study|Withdrawal by Subject|4|||
127645331|NCT00677833|459320967|FG001|Overall Study|Withdrawal by Subject|0|||
127645332|NCT00677833|459320968|FG002|Overall Study|Withdrawal by Subject|1|||
127645333|NCT00677833|459320969|FG003|Overall Study|Withdrawal by Subject|3|||
127645334|NCT00677833|459320966|FG000|Overall Study|Lost to Follow-up|0|||
127707289|NCT04308681|459555524|FG006|OTE - 26 Weeks|Withdrawal by participant|1|||
127707290|NCT04308681|459555525|FG007|OTE - 26 Weeks|Withdrawal by participant|0|||
127707291|NCT04308681|459555518|FG000|OTE - 26 Weeks|Death|0|||
127707292|NCT04308681|459555519|FG001|OTE - 26 Weeks|Death|1|||
127707293|NCT04308681|459555520|FG002|OTE - 26 Weeks|Death|0|||
127707294|NCT04308681|459555521|FG003|OTE - 26 Weeks|Death|0|||
127707295|NCT04308681|459555522|FG004|OTE - 26 Weeks|Death|0|||
127707296|NCT04308681|459555523|FG005|OTE - 26 Weeks|Death|0|||
127707297|NCT04308681|459555524|FG006|OTE - 26 Weeks|Death|1|||
127707298|NCT04308681|459555525|FG007|OTE - 26 Weeks|Death|0|||
127707299|NCT04308681|459555518|FG000|OTE - 26 Weeks|Adverse Event|0|||
127707300|NCT04308681|459555519|FG001|OTE - 26 Weeks|Adverse Event|2|||
127707301|NCT04308681|459555520|FG002|OTE - 26 Weeks|Adverse Event|8|||
127707302|NCT04308681|459555521|FG003|OTE - 26 Weeks|Adverse Event|3|||
127707303|NCT04308681|459555522|FG004|OTE - 26 Weeks|Adverse Event|0|||
127707304|NCT04308681|459555523|FG005|OTE - 26 Weeks|Adverse Event|1|||
127707305|NCT04308681|459555524|FG006|OTE - 26 Weeks|Adverse Event|2|||
127707306|NCT04308681|459555525|FG007|OTE - 26 Weeks|Adverse Event|0|||
127707307|NCT04308681|459555518|FG000|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
127707308|NCT04308681|459555519|FG001|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
127707309|NCT04308681|459555520|FG002|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
127707310|NCT04308681|459555521|FG003|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
127707311|NCT04308681|459555522|FG004|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
127707312|NCT04308681|459555523|FG005|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
127707313|NCT04308681|459555524|FG006|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
127707314|NCT04308681|459555525|FG007|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
127707315|NCT05565820|459555526|FG000|7 Day Treatment Effectiveness|Withdrawal by Subject|2|||
127707316|NCT05565820|459555527|FG001|7 Day Treatment Effectiveness|Withdrawal by Subject|0|||
127707317|NCT05565820|459555526|FG000|14 Day Treatment Effectiveness|Withdrawal by Subject|2|||
127707318|NCT05565820|459555527|FG001|14 Day Treatment Effectiveness|Withdrawal by Subject|0|||
127707319|NCT02684227|459555530|FG000|Overall Study|Adverse Event|1|||
127707320|NCT02684227|459555531|FG001|Overall Study|Adverse Event|7|||
127707321|NCT02684227|459555530|FG000|Overall Study|Death|0|||
127707322|NCT02684227|459555531|FG001|Overall Study|Death|2|||
127707323|NCT02684227|459555530|FG000|Overall Study|Withdrawal by Subject|0|||
127707324|NCT02684227|459555531|FG001|Overall Study|Withdrawal by Subject|1|||
127707325|NCT02684227|459555530|FG000|Overall Study|Progressive Disease|0|||
127707326|NCT02684227|459555531|FG001|Overall Study|Progressive Disease|2|||
127707327|NCT03606408|459555532|FG000|Overall Study|Adverse Event|13|||
127707328|NCT03606408|459555532|FG000|Overall Study|Withdrawal by Subject|7|||
127707329|NCT03606408|459555532|FG000|Overall Study|Physician Decision|4|||
127707330|NCT03606408|459555532|FG000|Overall Study|Lack of Efficacy|2|||
127707331|NCT03606408|459555532|FG000|Overall Study|Death|1|||
127707332|NCT03606408|459555532|FG000|Overall Study|new therapy for study indication|1|||
127707333|NCT03556293|459555533|FG000|Overall Study|Ineligible for analysis|1904|||
127707334|NCT03556293|459555534|FG001|Overall Study|Ineligible for analysis|1471|||
127707335|NCT03556293|459555535|FG002|Overall Study|Ineligible for analysis|1091|||
127707336|NCT03556293|459555536|FG003|Overall Study|Ineligible for analysis|1269|||
127707337|NCT02424617|459556796|FG000|Overall Study|Adverse Event|0|||
127707338|NCT02424617|459556797|FG001|Overall Study|Adverse Event|1|||
127707339|NCT02424617|459556798|FG002|Overall Study|Adverse Event|0|||
127707340|NCT02424617|459556799|FG003|Overall Study|Adverse Event|0|||
127707341|NCT02424617|459556796|FG000|Overall Study|Investigator Decision|0|||
127707342|NCT02424617|459556797|FG001|Overall Study|Investigator Decision|0|||
127707343|NCT02424617|459556798|FG002|Overall Study|Investigator Decision|0|||
127707344|NCT02424617|459556799|FG003|Overall Study|Investigator Decision|1|||
127707345|NCT02424617|459556796|FG000|Overall Study|Withdrawal by Subject|1|||
127707346|NCT02424617|459556797|FG001|Overall Study|Withdrawal by Subject|1|||
127707347|NCT02424617|459556798|FG002|Overall Study|Withdrawal by Subject|0|||
127707348|NCT02424617|459556799|FG003|Overall Study|Withdrawal by Subject|1|||
127707349|NCT02424617|459556796|FG000|Overall Study|Progressive Disease|7|||
127707350|NCT02424617|459556797|FG001|Overall Study|Progressive Disease|6|||
127707351|NCT02424617|459556798|FG002|Overall Study|Progressive Disease|11|||
127888009|NCT00528879|460213942|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
127707352|NCT02424617|459556799|FG003|Overall Study|Progressive Disease|10|||
127707353|NCT02424617|459556796|FG000|Overall Study|Other|0|||
127707354|NCT02424617|459556797|FG001|Overall Study|Other|0|||
127707355|NCT02424617|459556798|FG002|Overall Study|Other|0|||
127707356|NCT02424617|459556799|FG003|Overall Study|Other|1|||
127707357|NCT02694822|459556800|FG000|Phase 1|Death|2|||
127888010|NCT00528879|460213943|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
127707358|NCT02694822|459556801|FG001|Phase 1|Death|1|||
127707359|NCT02694822|459556802|FG002|Phase 1|Death|6|||
127707360|NCT02694822|459556803|FG003|Phase 1|Death|6|||
127707361|NCT02694822|459556804|FG004|Phase 1|Death|3|||
127707362|NCT02694822|459556805|FG005|Phase 1|Death|0|||
127707363|NCT02694822|459556800|FG000|Phase 1|Withdrawal by Subject|2|||
127645335|NCT00677833|459320967|FG001|Overall Study|Lost to Follow-up|0|||
127645336|NCT00677833|459320968|FG002|Overall Study|Lost to Follow-up|1|||
127645337|NCT00677833|459320969|FG003|Overall Study|Lost to Follow-up|0|||
127645338|NCT02001194|459320971|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
127645339|NCT02001194|459320972|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
127645340|NCT02001194|459320973|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
127645341|NCT02001194|459320974|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
127645342|NCT02001194|459320971|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
127645343|NCT02001194|459320972|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
127645344|NCT02001194|459320973|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
127645345|NCT02001194|459320974|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
127645346|NCT02690974|459320975|FG000|Overall Study|Adverse Event|16|||
127645347|NCT02690974|459320975|FG000|Overall Study|Death|9|||
127645348|NCT02690974|459320975|FG000|Overall Study|Subject/guardian decision|4|||
127645349|NCT02690974|459320975|FG000|Overall Study|Lost to Follow-up|3|||
127645350|NCT02690974|459320975|FG000|Overall Study|Withdrawal of Informed Consent|3|||
127645351|NCT02690974|459320975|FG000|Overall Study|Physician Decision|2|||
127645352|NCT02690974|459320975|FG000|Overall Study|Non-compliance with study treatment|1|||
127645353|NCT02690974|459320975|FG000|Overall Study|Protocol-defined stopping criteria|1|||
127645354|NCT02690974|459320975|FG000|Overall Study|Protocol Deviation|1|||
127645355|NCT00522301|459320981|FG000|Overall Study|Withdrawal by Subject|1|||
127645356|NCT00522301|459320981|FG000|Overall Study|Adverse Event|5|||
127645357|NCT01666951|459320982|FG000|Overall Study|Not dosed|1|||
127645358|NCT01666951|459320983|FG001|Overall Study|Not dosed|1|||
127645359|NCT02366910|459320987|FG000|Overall Study|Withdrawal by Subject|2|||
127645360|NCT02366910|459320987|FG000|Overall Study|Screen Failure|3|||
127645361|NCT02623322|459320991|FG000|Overall Study|Lost to Follow-up|2|||
127645362|NCT02623322|459320992|FG001|Overall Study|Lost to Follow-up|1|||
127645363|NCT02623322|459320993|FG002|Overall Study|Lost to Follow-up|0|||
127645364|NCT01690130|459320997|FG000|Overall Study|Subject have cancelled visit.|1|||
127645365|NCT01690130|459320998|FG001|Overall Study|Subject have cancelled visit.|0|||
127645366|NCT05159622|459320999|FG000|Overall Study|Lost to Follow-up|4|||
127645367|NCT05159622|459321000|FG001|Overall Study|Lost to Follow-up|5|||
127645368|NCT03318523|459321001|FG000|PC Period: Up to Year 1|Adverse Event|1|||
127645369|NCT03318523|459321002|FG001|PC Period: Up to Year 1|Adverse Event|0|||
127645370|NCT03318523|459321003|FG002|PC Period: Up to Year 1|Adverse Event|2|||
127645371|NCT03318523|459321004|FG003|PC Period: Up to Year 1|Adverse Event|0|||
127645372|NCT03318523|459321005|FG004|PC Period: Up to Year 1|Adverse Event|0|||
127645373|NCT03318523|459321006|FG005|PC Period: Up to Year 1|Adverse Event|0|||
127645374|NCT03318523|459321007|FG006|PC Period: Up to Year 1|Adverse Event|0|||
127645375|NCT03318523|459321008|FG007|PC Period: Up to Year 1|Adverse Event|0|||
127645376|NCT03318523|459321009|FG008|PC Period: Up to Year 1|Adverse Event|0|||
127645377|NCT03318523|459321010|FG009|PC Period: Up to Year 1|Adverse Event|0|||
127645378|NCT03318523|459321001|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
127645379|NCT03318523|459321002|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
127645380|NCT03318523|459321003|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
127645381|NCT03318523|459321004|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
127645382|NCT03318523|459321005|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
127645383|NCT03318523|459321006|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
127645384|NCT03318523|459321007|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
127645385|NCT03318523|459321008|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
127645386|NCT03318523|459321009|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
127645387|NCT03318523|459321010|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
127645388|NCT03318523|459321001|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
127645389|NCT03318523|459321002|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
127645390|NCT03318523|459321003|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
127645391|NCT03318523|459321004|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
127645392|NCT03318523|459321005|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
127645393|NCT03318523|459321006|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
127645394|NCT03318523|459321007|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
127645395|NCT03318523|459321008|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
127645396|NCT03318523|459321009|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
127645397|NCT03318523|459321010|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
127645398|NCT03318523|459321001|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
127645399|NCT03318523|459321002|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
127645400|NCT03318523|459321003|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
127645401|NCT03318523|459321004|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
127645402|NCT03318523|459321005|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
127645403|NCT03318523|459321006|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
127645404|NCT03318523|459321007|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
127707364|NCT02694822|459556801|FG001|Phase 1|Withdrawal by Subject|2|||
127707365|NCT02694822|459556802|FG002|Phase 1|Withdrawal by Subject|4|||
127645405|NCT03318523|459321008|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
127645406|NCT03318523|459321009|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
127645407|NCT03318523|459321010|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
127645408|NCT03318523|459321001|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
127645409|NCT03318523|459321002|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
127645410|NCT03318523|459321003|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
127645411|NCT03318523|459321004|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
127645412|NCT03318523|459321005|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
127645413|NCT03318523|459321006|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
127645414|NCT03318523|459321007|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
127645415|NCT03318523|459321008|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
127645416|NCT03318523|459321009|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
127645417|NCT03318523|459321010|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
127645418|NCT03318523|459321001|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
127645419|NCT03318523|459321002|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
127645420|NCT03318523|459321003|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
127645421|NCT03318523|459321004|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
127645422|NCT03318523|459321005|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
127645423|NCT03318523|459321006|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
127645424|NCT03318523|459321007|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
127645425|NCT03318523|459321008|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
127645426|NCT03318523|459321009|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
127645427|NCT03318523|459321010|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
127645428|NCT03318523|459321001|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
127645429|NCT03318523|459321002|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
127645430|NCT03318523|459321003|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
127645431|NCT03318523|459321004|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
127645432|NCT03318523|459321005|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
127645433|NCT03318523|459321006|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
127645434|NCT03318523|459321007|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
127645435|NCT03318523|459321008|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
127645436|NCT03318523|459321009|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
127645437|NCT03318523|459321010|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
127645438|NCT03318523|459321001|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
127645439|NCT03318523|459321002|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
127645440|NCT03318523|459321003|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
127645441|NCT03318523|459321004|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
127645442|NCT03318523|459321005|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
127645443|NCT03318523|459321006|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
127799303|NCT03467958|459888040|FG001|Overall Study|Withdrawal by Subject|44|||
127799304|NCT03467958|459888041|FG002|Overall Study|Withdrawal by Subject|7|||
127799305|NCT03467958|459888042|FG003|Overall Study|Withdrawal by Subject|8|||
127799306|NCT03467958|459888043|FG004|Overall Study|Withdrawal by Subject|6|||
127799307|NCT03467958|459888044|FG005|Overall Study|Withdrawal by Subject|8|||
127799308|NCT03467958|459888045|FG006|Overall Study|Withdrawal by Subject|4|||
127799309|NCT03467958|459888046|FG007|Overall Study|Withdrawal by Subject|1|||
127799310|NCT03467958|459888047|FG008|Overall Study|Withdrawal by Subject|4|||
127799311|NCT02925156|459888050|FG000|Overall Study|Lost to Follow-up|27|||
127799312|NCT02925156|459888051|FG001|Overall Study|Lost to Follow-up|53|||
127799313|NCT02925156|459888052|FG002|Overall Study|Lost to Follow-up|51|||
127799314|NCT02925156|459888053|FG003|Overall Study|Lost to Follow-up|59|||
127799315|NCT02925156|459888054|FG004|Overall Study|Lost to Follow-up|89|||
127799316|NCT02925156|459888055|FG005|Overall Study|Lost to Follow-up|107|||
127799317|NCT02925156|459888056|FG006|Overall Study|Lost to Follow-up|34|||
127799318|NCT02925156|459888057|FG007|Overall Study|Lost to Follow-up|36|||
127799319|NCT02925156|459888058|FG008|Overall Study|Lost to Follow-up|73|||
127799320|NCT02925156|459888059|FG009|Overall Study|Lost to Follow-up|34|||
127799321|NCT00866307|459888060|FG000|Induction|Adverse Event|5|||
127799322|NCT00866307|459888061|FG001|Induction|Adverse Event|0|||
127645444|NCT03318523|459321007|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
127799323|NCT00866307|459888062|FG002|Induction|Adverse Event|0|||
127799324|NCT00866307|459888060|FG000|Induction|Death|2|||
127799325|NCT00866307|459888061|FG001|Induction|Death|0|||
127799326|NCT00866307|459888062|FG002|Induction|Death|0|||
127799327|NCT00866307|459888060|FG000|Induction|Physician Decision|5|||
127799328|NCT00866307|459888061|FG001|Induction|Physician Decision|0|||
127799329|NCT00866307|459888062|FG002|Induction|Physician Decision|0|||
127799330|NCT00866307|459888060|FG000|Induction|Progressive Disease|1|||
127799331|NCT00866307|459888061|FG001|Induction|Progressive Disease|0|||
127799332|NCT00866307|459888062|FG002|Induction|Progressive Disease|0|||
127799333|NCT00866307|459888060|FG000|Induction|Identification of Patients with Day 29 M|3|||
127799334|NCT00866307|459888061|FG001|Induction|Identification of Patients with Day 29 M|0|||
127799335|NCT00866307|459888062|FG002|Induction|Identification of Patients with Day 29 M|0|||
127799336|NCT00866307|459888060|FG000|Induction|Inadequate cytognetic samples th|1|||
127799337|NCT00866307|459888061|FG001|Induction|Inadequate cytognetic samples th|0|||
127799338|NCT00866307|459888062|FG002|Induction|Inadequate cytognetic samples th|0|||
127799339|NCT00866307|459888060|FG000|Induction|Improper post-induction consent|2|||
127799340|NCT00866307|459888061|FG001|Induction|Improper post-induction consent|0|||
127799341|NCT00866307|459888062|FG002|Induction|Improper post-induction consent|0|||
127799342|NCT00866307|459888060|FG000|Induction|Study was closed at the time|1|||
127799343|NCT00866307|459888061|FG001|Induction|Study was closed at the time|0|||
127799344|NCT00866307|459888062|FG002|Induction|Study was closed at the time|0|||
127799345|NCT00866307|459888060|FG000|Consolidation/Maintenance|Adverse Event|0|||
127799346|NCT00866307|459888061|FG001|Consolidation/Maintenance|Adverse Event|0|||
127799347|NCT00866307|459888062|FG002|Consolidation/Maintenance|Adverse Event|8|||
127799348|NCT00866307|459888060|FG000|Consolidation/Maintenance|Death|0|||
127799349|NCT00866307|459888061|FG001|Consolidation/Maintenance|Death|0|||
127799350|NCT00866307|459888062|FG002|Consolidation/Maintenance|Death|1|||
127799351|NCT00866307|459888060|FG000|Consolidation/Maintenance|Physician Decision|0|||
127799352|NCT00866307|459888061|FG001|Consolidation/Maintenance|Physician Decision|3|||
127799353|NCT00866307|459888062|FG002|Consolidation/Maintenance|Physician Decision|2|||
127799354|NCT00866307|459888060|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
127799355|NCT00866307|459888061|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
127799356|NCT00866307|459888062|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
127799357|NCT00866307|459888060|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
127799358|NCT00866307|459888061|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
127799359|NCT00866307|459888062|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
127799360|NCT00866307|459888060|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
127799361|NCT00866307|459888061|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
127799362|NCT00866307|459888062|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
127799363|NCT00866307|459888060|FG000|Consolidation/Maintenance|Therapy error|0|||
127799364|NCT00866307|459888061|FG001|Consolidation/Maintenance|Therapy error|1|||
127799365|NCT00866307|459888062|FG002|Consolidation/Maintenance|Therapy error|0|||
127799366|NCT00866307|459888060|FG000|Consolidation/Maintenance|Non-compliance|0|||
127799367|NCT00866307|459888061|FG001|Consolidation/Maintenance|Non-compliance|0|||
127799368|NCT00866307|459888062|FG002|Consolidation/Maintenance|Non-compliance|1|||
127799369|NCT00866307|459888060|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
127799370|NCT00866307|459888061|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
127799371|NCT00866307|459888062|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
127799372|NCT02286947|459888063|FG000|Overall Study|Withdrawal by Subject|2|||
127799373|NCT01060059|459888066|FG000|Overall Study|Adverse Event|1|||
127799374|NCT01060059|459888067|FG001|Overall Study|Adverse Event|1|||
127799375|NCT01060059|459888066|FG000|Overall Study|Death|2|||
127799376|NCT01060059|459888067|FG001|Overall Study|Death|3|||
127799377|NCT01060059|459888066|FG000|Overall Study|Lost to Follow-up|18|||
127799378|NCT01060059|459888067|FG001|Overall Study|Lost to Follow-up|34|||
127799379|NCT01060059|459888066|FG000|Overall Study|entry criteria not met|4|||
127799380|NCT01060059|459888067|FG001|Overall Study|entry criteria not met|3|||
127799381|NCT01060059|459888066|FG000|Overall Study|Withdrawal by Subject|35|||
127799382|NCT01060059|459888067|FG001|Overall Study|Withdrawal by Subject|23|||
127799383|NCT01060059|459888066|FG000|Overall Study|lack of glycemic control|2|||
127799384|NCT01060059|459888067|FG001|Overall Study|lack of glycemic control|1|||
127799385|NCT01060059|459888066|FG000|Overall Study|lack of compliance|5|||
127799386|NCT01060059|459888067|FG001|Overall Study|lack of compliance|2|||
127799387|NCT01614093|459888068|FG000|Overall Study|Withdrawal by Subject|1|||
127799388|NCT00848354|459888069|FG000|Phase 1|Adverse Event|5|||
127799389|NCT00848354|459888070|FG001|Phase 1|Adverse Event|4|||
127799390|NCT00848354|459888069|FG000|Phase 1|Discontinuation of study by sponsor|2|||
127799391|NCT00848354|459888070|FG001|Phase 1|Discontinuation of study by sponsor|1|||
127799392|NCT00848354|459888069|FG000|Phase 1|Failed to return|0|||
127799393|NCT00848354|459888070|FG001|Phase 1|Failed to return|1|||
127799394|NCT00848354|459888069|FG000|Phase 1|Lost to Follow-up|1|||
127799395|NCT00848354|459888070|FG001|Phase 1|Lost to Follow-up|1|||
127707366|NCT02694822|459556803|FG003|Phase 1|Withdrawal by Subject|8|||
127707367|NCT02694822|459556804|FG004|Phase 1|Withdrawal by Subject|1|||
127707368|NCT02694822|459556805|FG005|Phase 1|Withdrawal by Subject|0|||
127707369|NCT02694822|459556800|FG000|Phase 2|Death|0|||
127707370|NCT02694822|459556801|FG001|Phase 2|Death|0|||
127707371|NCT02694822|459556802|FG002|Phase 2|Death|0|||
127707372|NCT02694822|459556803|FG003|Phase 2|Death|0|||
127707373|NCT02694822|459556804|FG004|Phase 2|Death|0|||
127707374|NCT02694822|459556805|FG005|Phase 2|Death|26|||
127707375|NCT02694822|459556800|FG000|Phase 2|Withdrawal by Subject|0|||
127707376|NCT02694822|459556801|FG001|Phase 2|Withdrawal by Subject|0|||
127707377|NCT02694822|459556802|FG002|Phase 2|Withdrawal by Subject|0|||
127707378|NCT02694822|459556803|FG003|Phase 2|Withdrawal by Subject|0|||
127707379|NCT02694822|459556804|FG004|Phase 2|Withdrawal by Subject|0|||
127707380|NCT02694822|459556805|FG005|Phase 2|Withdrawal by Subject|13|||
127707381|NCT02694822|459556800|FG000|Phase 2|Administrative Study Closure|0|||
127707382|NCT02694822|459556801|FG001|Phase 2|Administrative Study Closure|0|||
127707383|NCT02694822|459556802|FG002|Phase 2|Administrative Study Closure|0|||
127707384|NCT02694822|459556803|FG003|Phase 2|Administrative Study Closure|0|||
127707385|NCT02694822|459556804|FG004|Phase 2|Administrative Study Closure|0|||
127707386|NCT02694822|459556805|FG005|Phase 2|Administrative Study Closure|2|||
127707387|NCT02694822|459556800|FG000|Phase 2|Lost to Follow-up|0|||
127707388|NCT02694822|459556801|FG001|Phase 2|Lost to Follow-up|0|||
127707389|NCT02694822|459556802|FG002|Phase 2|Lost to Follow-up|0|||
127707390|NCT02694822|459556803|FG003|Phase 2|Lost to Follow-up|0|||
127707391|NCT02694822|459556804|FG004|Phase 2|Lost to Follow-up|0|||
127707392|NCT02694822|459556805|FG005|Phase 2|Lost to Follow-up|1|||
127707393|NCT02694822|459556800|FG000|Phase 2|Participant Transferred to Another Site|0|||
127707394|NCT02694822|459556801|FG001|Phase 2|Participant Transferred to Another Site|0|||
127707395|NCT02694822|459556802|FG002|Phase 2|Participant Transferred to Another Site|0|||
127707396|NCT02694822|459556803|FG003|Phase 2|Participant Transferred to Another Site|0|||
127707397|NCT02694822|459556804|FG004|Phase 2|Participant Transferred to Another Site|0|||
127707398|NCT02694822|459556805|FG005|Phase 2|Participant Transferred to Another Site|1|||
127707399|NCT01868997|459556806|FG000|Overall Study|Adverse Event|2|||
127707400|NCT01868997|459556807|FG001|Overall Study|Adverse Event|5|||
127707401|NCT01868997|459556806|FG000|Overall Study|Lack of Efficacy|2|||
127707402|NCT01868997|459556807|FG001|Overall Study|Lack of Efficacy|0|||
127707403|NCT01868997|459556806|FG000|Overall Study|Other|3|||
127707404|NCT01868997|459556807|FG001|Overall Study|Other|1|||
127707405|NCT03209973|459556810|FG000|Overall Study|Withdrawal by Subject|7|||
127707406|NCT03209973|459556810|FG000|Overall Study|Lost to Follow-up|2|||
127707407|NCT03209973|459556810|FG000|Overall Study|Death|8|||
127707408|NCT03209973|459556810|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
127707409|NCT03209973|459556810|FG000|Overall Study|Sponsor Decision|18|||
127707410|NCT03209973|459556810|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
127707411|NCT03209973|459556810|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
127707412|NCT04024020|459556816|FG000|Overall Study|Withdrawal by Subject|2|||
127707413|NCT04024020|459556817|FG001|Overall Study|Withdrawal by Subject|2|||
127707414|NCT05646355|459556818|FG000|Overall Study|Lost to Follow-up|1|||
127707415|NCT05646355|459556819|FG001|Overall Study|Lost to Follow-up|0|||
127707416|NCT05646355|459556818|FG000|Overall Study|translated materials not available for pilot|2|||
127707417|NCT05646355|459556819|FG001|Overall Study|translated materials not available for pilot|0|||
127707418|NCT05646355|459556818|FG000|Overall Study|no longer screen eligible (completed screening prior to intervention)|6|||
127707419|NCT05646355|459556819|FG001|Overall Study|no longer screen eligible (completed screening prior to intervention)|0|||
127707420|NCT05269966|459556822|FG000|Overall Study|Adverse Event|4|||
127707421|NCT05269966|459556822|FG000|Overall Study|Withdrawal by Subject|1|||
127707422|NCT05269966|459556822|FG000|Overall Study|Lost to Follow-up|4|||
127707423|NCT05269966|459556822|FG000|Overall Study|Physician Decision|1|||
127707424|NCT05863156|459556823|FG000|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
127707425|NCT05863156|459556824|FG001|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
127707426|NCT05863156|459556825|FG002|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|23|||
127707427|NCT04797195|459556826|FG000|Overall Study|Death|8|||
127707428|NCT04797195|459556827|FG001|Overall Study|Death|15|||
127707429|NCT04797195|459556826|FG000|Overall Study|Change from PD|15|||
127707430|NCT04797195|459556827|FG001|Overall Study|Change from PD|15|||
127707431|NCT04797195|459556826|FG000|Overall Study|Withdrawal by Subject|3|||
127707432|NCT04797195|459556827|FG001|Overall Study|Withdrawal by Subject|2|||
127707433|NCT02296684|459556828|FG000|Overall Study|Withdrawal by Subject|0|||
127707434|NCT02296684|459556829|FG001|Overall Study|Withdrawal by Subject|1|||
127799396|NCT00848354|459888069|FG000|Phase 1|Unspecified Reason|1|||
127799397|NCT00848354|459888070|FG001|Phase 1|Unspecified Reason|1|||
127707435|NCT02296684|459556830|FG002|Overall Study|Withdrawal by Subject|1|||
127707436|NCT02296684|459556828|FG000|Overall Study|Death|2|||
127707437|NCT02296684|459556829|FG001|Overall Study|Death|0|||
127707438|NCT02296684|459556830|FG002|Overall Study|Death|0|||
127707439|NCT00429364|459556833|FG000|Overall Study|Withdrawal by Subject|11|||
127707440|NCT00429364|459556834|FG001|Overall Study|Withdrawal by Subject|5|||
127707441|NCT00429364|459556833|FG000|Overall Study|Physician Decision|4|||
127707442|NCT00429364|459556834|FG001|Overall Study|Physician Decision|2|||
127707443|NCT00429364|459556833|FG000|Overall Study|Lost to Follow-up|7|||
127707444|NCT00429364|459556834|FG001|Overall Study|Lost to Follow-up|6|||
127707445|NCT00429364|459556833|FG000|Overall Study|Death|0|||
127707446|NCT00429364|459556834|FG001|Overall Study|Death|1|||
127707447|NCT00429364|459556833|FG000|Overall Study|Underwent aortic root surgery|10|||
127707448|NCT00429364|459556834|FG001|Overall Study|Underwent aortic root surgery|18|||
127707449|NCT00429364|459556833|FG000|Overall Study|Pregnancy|0|||
127707450|NCT00429364|459556834|FG001|Overall Study|Pregnancy|1|||
127707451|NCT04871529|459556835|FG000|Overall Study|Withdrawal by Subject|0|||
127707452|NCT04871529|459556836|FG001|Overall Study|Withdrawal by Subject|1|||
127707453|NCT04871529|459556835|FG000|Overall Study|Death|0|||
127707454|NCT04871529|459556836|FG001|Overall Study|Death|1|||
127707455|NCT04871529|459556835|FG000|Overall Study|Not protocol specified|0|||
127707456|NCT04871529|459556836|FG001|Overall Study|Not protocol specified|1|||
127707457|NCT04786119|459556837|FG000|Overall Study|Withdrawal by Subject|2|||
127707458|NCT05828017|459556844|FG000|Review of Intake and Hearing Test Result|Removed by Investigator due to hearing loss change and no longer meeting study criteria.|1|||
127707459|NCT05012163|459556845|FG000|Overall Study|Protocol Violation|0|||
127707460|NCT05012163|459556846|FG001|Overall Study|Protocol Violation|0|||
127707461|NCT05012163|459556847|FG002|Overall Study|Protocol Violation|1|||
127707462|NCT05012163|459556848|FG003|Overall Study|Protocol Violation|1|||
127707463|NCT05076266|459556849|FG000|Overall Study|Survey not complete - Participant refusal|2|||
127707464|NCT05076266|459556850|FG001|Overall Study|Survey not complete - Participant refusal|0|||
127707465|NCT04003246|459556853|FG000|Overall Study|Death|9|||
127707466|NCT04132518|459556859|FG000|Overall Study|Prematurely withdrawn from the study|0|||
127707467|NCT04132518|459556860|FG001|Overall Study|Prematurely withdrawn from the study|9|||
127707468|NCT04132518|459556861|FG002|Overall Study|Prematurely withdrawn from the study|1|||
127707469|NCT05524402|459556863|FG000|Overall Study|Withdrawal by Subject|3|||
127707470|NCT05524402|459556864|FG001|Overall Study|Withdrawal by Subject|1|||
127707471|NCT05524402|459556863|FG000|Overall Study|Lost to Follow-up|2|||
127707472|NCT05524402|459556864|FG001|Overall Study|Lost to Follow-up|1|||
127707473|NCT03213873|459556867|FG000|Overall Study|Withdrawal by Subject|8|||
127707474|NCT03213873|459556868|FG001|Overall Study|Withdrawal by Subject|9|||
127707475|NCT03213873|459556867|FG000|Overall Study|Diagnosed w atypical PD after randomization|0|||
127707476|NCT03213873|459556868|FG001|Overall Study|Diagnosed w atypical PD after randomization|1|||
127707477|NCT03213873|459556867|FG000|Overall Study|Lost to Follow-up|0|||
127707478|NCT03213873|459556868|FG001|Overall Study|Lost to Follow-up|2|||
127707479|NCT02361216|459556874|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
127707480|NCT02361216|459556875|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
127707481|NCT02361216|459556874|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
127707482|NCT02361216|459556875|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
127707483|NCT02361216|459556874|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
127707484|NCT02361216|459556875|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
127707485|NCT02361216|459556874|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
127707486|NCT02361216|459556875|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
127707487|NCT02361216|459556874|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
127707488|NCT02361216|459556875|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
127707489|NCT02361216|459556874|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
127707490|NCT02361216|459556875|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
127707491|NCT02852655|459556883|FG000|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
127707492|NCT02852655|459556884|FG001|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
127707493|NCT02852655|459556885|FG002|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|1|||
127707494|NCT02852655|459556883|FG000|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
127707495|NCT02852655|459556884|FG001|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
127707496|NCT02852655|459556885|FG002|Registered and Ready to Initiate Tx|Withdrawal by Subject|2|||
127707497|NCT02852655|459556883|FG000|Eligible to Initiate Adjuvant MK3475|Disease Progression|1|||
127707498|NCT02852655|459556884|FG001|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
127707499|NCT02852655|459556885|FG002|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
127707500|NCT02852655|459556883|FG000|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
127707501|NCT02852655|459556884|FG001|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|1|||
127707502|NCT02852655|459556885|FG002|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
127707503|NCT02852655|459556883|FG000|Adjuvant MK3475 Therapy|Disease Progression|13|||
127707504|NCT02852655|459556884|FG001|Adjuvant MK3475 Therapy|Disease Progression|21|||
127707505|NCT02852655|459556885|FG002|Adjuvant MK3475 Therapy|Disease Progression|12|||
127707506|NCT02852655|459556883|FG000|Adjuvant MK3475 Therapy|Adverse Event|1|||
127888011|NCT00528879|460213944|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
127888012|NCT00528879|460213941|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
127888013|NCT00528879|460213942|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
127707507|NCT02852655|459556884|FG001|Adjuvant MK3475 Therapy|Adverse Event|0|||
127707508|NCT02852655|459556885|FG002|Adjuvant MK3475 Therapy|Adverse Event|0|||
127707509|NCT02852655|459556883|FG000|Adjuvant MK3475 Therapy|Withdrawal by Subject|0|||
127707510|NCT02852655|459556884|FG001|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
127707511|NCT02852655|459556885|FG002|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
127707512|NCT02852655|459556883|FG000|Adjuvant MK3475 Therapy|Still on Active Study Therapy|1|||
127888014|NCT00528879|460213943|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
127888015|NCT00528879|460213944|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
127888016|NCT00528879|460213941|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
127888017|NCT00528879|460213942|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
127888018|NCT00528879|460213943|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
127888019|NCT00528879|460213944|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
127888020|NCT00528879|460213941|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
127888021|NCT00528879|460213942|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
127888022|NCT00528879|460213943|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
127645445|NCT03318523|459321008|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
127707513|NCT02852655|459556884|FG001|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
127707514|NCT02852655|459556885|FG002|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
127707515|NCT02852655|459556883|FG000|Adjuvant MK3475 Therapy|Physician Decision|0|||
127707516|NCT02852655|459556884|FG001|Adjuvant MK3475 Therapy|Physician Decision|0|||
127707517|NCT02852655|459556885|FG002|Adjuvant MK3475 Therapy|Physician Decision|1|||
127645446|NCT03318523|459321009|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
127645447|NCT03318523|459321010|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
127645448|NCT03581981|459321014|FG000|Overall Study|Withdrawal by Subject|12|||
127645449|NCT03581981|459321015|FG001|Overall Study|Withdrawal by Subject|13|||
127645450|NCT03581981|459321014|FG000|Overall Study|Physician Decision|1|||
127645451|NCT03581981|459321015|FG001|Overall Study|Physician Decision|2|||
127645452|NCT03581981|459321014|FG000|Overall Study|Lost to Follow-up|0|||
127645453|NCT03581981|459321015|FG001|Overall Study|Lost to Follow-up|4|||
127645454|NCT02080871|459321016|FG000|Overall Study|Death|1|||
127645455|NCT02080871|459321016|FG000|Overall Study|Lost to Follow-up|1|||
127645456|NCT00234052|459321017|FG000|Treatment|Withdrawal by Subject|3|||
127645457|NCT00234052|459321017|FG000|Treatment|Adverse Event|5|||
127645458|NCT00234052|459321017|FG000|Treatment|Death|2|||
127645459|NCT00234052|459321017|FG000|Treatment|Progressive Disease|11|||
127645460|NCT00234052|459321017|FG000|Follow-up for 5 Years|Death|41|||
127645461|NCT00234052|459321017|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
127645462|NCT00234052|459321017|FG000|Follow-up for 5 Years|Other|7|||
127645463|NCT01410474|459321018|FG000|Overall Study|Withdrawal by Subject|0|||
127645464|NCT01410474|459321019|FG001|Overall Study|Withdrawal by Subject|1|||
127645465|NCT00828984|459321021|FG000|Overall Study|Adverse Event|2|||
127645466|NCT00828984|459321022|FG001|Overall Study|Adverse Event|3|||
127645467|NCT00828984|459321023|FG002|Overall Study|Adverse Event|0|||
127645468|NCT00828984|459321021|FG000|Overall Study|Lost to Follow-up|5|||
127645469|NCT00828984|459321022|FG001|Overall Study|Lost to Follow-up|3|||
127645470|NCT00828984|459321023|FG002|Overall Study|Lost to Follow-up|1|||
127645471|NCT00828984|459321021|FG000|Overall Study|Withdrawal by Subject|4|||
127707518|NCT04544007|459556890|FG000|Overall Study|Withdrawal by Subject|1|||
127707519|NCT04544007|459556890|FG000|Overall Study|Confirmed Progressive Disease|1|||
127707520|NCT02988661|459556891|FG000|Overall Study|Death|2|||
127707521|NCT02988661|459556892|FG001|Overall Study|Death|18|||
127707522|NCT02988661|459556891|FG000|Overall Study|Lost to Follow-up|0|||
127707523|NCT02988661|459556892|FG001|Overall Study|Lost to Follow-up|33|||
127707524|NCT02988661|459556891|FG000|Overall Study|Withdrawal by Subject|0|||
127707525|NCT02988661|459556892|FG001|Overall Study|Withdrawal by Subject|6|||
127707526|NCT02988661|459556891|FG000|Overall Study|Unable to complete the 18-month survey|1|||
127707527|NCT02988661|459556892|FG001|Overall Study|Unable to complete the 18-month survey|27|||
127707528|NCT02413489|459556908|FG000|Overall Study|Death|11|||
127707529|NCT02413489|459556909|FG001|Overall Study|Death|3|||
127707530|NCT02413489|459556910|FG002|Overall Study|Death|4|||
127707531|NCT02413489|459556908|FG000|Overall Study|Withdrawal by Subject|2|||
127707532|NCT02413489|459556909|FG001|Overall Study|Withdrawal by Subject|0|||
127645472|NCT00828984|459321022|FG001|Overall Study|Withdrawal by Subject|4|||
127645473|NCT00828984|459321023|FG002|Overall Study|Withdrawal by Subject|4|||
127645474|NCT00828984|459321021|FG000|Overall Study|Ineligable|1|||
127645475|NCT00828984|459321022|FG001|Overall Study|Ineligable|2|||
127707533|NCT02413489|459556910|FG002|Overall Study|Withdrawal by Subject|0|||
127707534|NCT02413489|459556908|FG000|Overall Study|Study Terminated By Sponsor|2|||
127799398|NCT00848354|459888069|FG000|Phase 1|Protocol Violation|1|||
127799399|NCT00848354|459888070|FG001|Phase 1|Protocol Violation|1|||
127799400|NCT00848354|459888069|FG000|Phase 1|Withdrawal by Subject|2|||
127799401|NCT00848354|459888070|FG001|Phase 1|Withdrawal by Subject|4|||
127799402|NCT00848354|459888069|FG000|Phase 1|Lack of Efficacy|0|||
127799403|NCT00848354|459888070|FG001|Phase 1|Lack of Efficacy|1|||
127799404|NCT00848354|459888069|FG000|Phase 2 Year 1|Adverse Event|7|||
127799405|NCT00848354|459888070|FG001|Phase 2 Year 1|Adverse Event|2|||
127799406|NCT00848354|459888069|FG000|Phase 2 Year 1|Death|1|||
127799407|NCT00848354|459888070|FG001|Phase 2 Year 1|Death|0|||
127799408|NCT00848354|459888069|FG000|Phase 2 Year 1|Failed to Return|1|||
127799409|NCT00848354|459888070|FG001|Phase 2 Year 1|Failed to Return|1|||
127799410|NCT00848354|459888069|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
127799411|NCT00848354|459888070|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
127645476|NCT00828984|459321023|FG002|Overall Study|Ineligable|0|||
127645477|NCT00828984|459321021|FG000|Overall Study|Medical Contraindication|0|||
127645478|NCT00828984|459321022|FG001|Overall Study|Medical Contraindication|1|||
127645479|NCT00828984|459321023|FG002|Overall Study|Medical Contraindication|0|||
127645480|NCT00828984|459321021|FG000|Overall Study|Noncompliant|1|||
127645481|NCT00828984|459321022|FG001|Overall Study|Noncompliant|2|||
127799412|NCT00848354|459888069|FG000|Phase 2 Year 1|Unspecified Reason|3|||
127799413|NCT00848354|459888070|FG001|Phase 2 Year 1|Unspecified Reason|0|||
127799414|NCT00848354|459888069|FG000|Phase 2 Year 1|Protocol Violation|4|||
127799415|NCT00848354|459888070|FG001|Phase 2 Year 1|Protocol Violation|1|||
127799416|NCT00848354|459888069|FG000|Phase 2 Year 1|Subject Request|1|||
127799417|NCT00848354|459888070|FG001|Phase 2 Year 1|Subject Request|2|||
127799418|NCT00848354|459888069|FG000|Phase 2 Year 2|Adverse Event|12|||
127799419|NCT00848354|459888070|FG001|Phase 2 Year 2|Adverse Event|2|||
127799420|NCT00848354|459888069|FG000|Phase 2 Year 2|Death|2|||
127799421|NCT00848354|459888070|FG001|Phase 2 Year 2|Death|0|||
127799422|NCT00848354|459888069|FG000|Phase 2 Year 2|Failed to return|3|||
127645482|NCT00828984|459321023|FG002|Overall Study|Noncompliant|3|||
127645483|NCT00828984|459321021|FG000|Overall Study|ConMed|1|||
127645484|NCT00828984|459321022|FG001|Overall Study|ConMed|1|||
127645485|NCT00828984|459321023|FG002|Overall Study|ConMed|1|||
127645486|NCT01615328|459321027|FG000|Overall Study|Lost to Follow-up|3|||
127645487|NCT01615328|459321028|FG001|Overall Study|Lost to Follow-up|5|||
127645488|NCT03338894|459321029|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
127645489|NCT00863655|459321030|FG000|Overall Study|Protocol Violation|4|||
127645490|NCT00863655|459321031|FG001|Overall Study|Protocol Violation|0|||
127645491|NCT00863655|459321030|FG000|Overall Study|Adverse Event|52|||
127645492|NCT00863655|459321031|FG001|Overall Study|Adverse Event|8|||
127645493|NCT00863655|459321030|FG000|Overall Study|Withdrawal by Subject|47|||
127645494|NCT00863655|459321031|FG001|Overall Study|Withdrawal by Subject|7|||
127645495|NCT00863655|459321030|FG000|Overall Study|Administrative problems|1|||
127645496|NCT00863655|459321031|FG001|Overall Study|Administrative problems|0|||
127645497|NCT00863655|459321030|FG000|Overall Study|Death|7|||
127645498|NCT00863655|459321031|FG001|Overall Study|Death|1|||
127645499|NCT00863655|459321030|FG000|Overall Study|New cancer therapy|5|||
127645500|NCT00863655|459321031|FG001|Overall Study|New cancer therapy|1|||
127645501|NCT00863655|459321030|FG000|Overall Study|Disease progression|364|||
127645502|NCT00863655|459321031|FG001|Overall Study|Disease progression|221|||
127645503|NCT00863655|459321030|FG000|Overall Study|Treatment completed as per protocol|5|||
127645504|NCT00863655|459321031|FG001|Overall Study|Treatment completed as per protocol|1|||
127645505|NCT04465357|459321032|FG000|Overall Study|Adverse Event|2|||
127645506|NCT04465357|459321032|FG000|Overall Study|Lack of Efficacy|1|||
127645507|NCT04465357|459321032|FG000|Overall Study|Lost to Follow-up|2|||
127645508|NCT04465357|459321032|FG000|Overall Study|Withdrawal by Subject|6|||
127645509|NCT04465357|459321032|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
127645510|NCT02157779|459321035|FG000|Overall Study|Logistical|9|||
127645511|NCT02157779|459321036|FG001|Overall Study|Logistical|3|||
127645512|NCT02157779|459321035|FG000|Overall Study|Stopped attending, reason unknown|11|||
127799423|NCT00848354|459888070|FG001|Phase 2 Year 2|Failed to return|0|||
127799424|NCT00848354|459888069|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
127799425|NCT00848354|459888070|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
127799426|NCT00848354|459888069|FG000|Phase 2 Year 2|Unspecified Reason|1|||
127799427|NCT00848354|459888070|FG001|Phase 2 Year 2|Unspecified Reason|0|||
127645513|NCT02157779|459321036|FG001|Overall Study|Stopped attending, reason unknown|7|||
127645514|NCT02157779|459321035|FG000|Overall Study|No response to outreach after Baseline|1|||
127645515|NCT02157779|459321036|FG001|Overall Study|No response to outreach after Baseline|1|||
127799428|NCT00848354|459888069|FG000|Phase 2 Year 2|Protocol Violation|1|||
127645516|NCT02157779|459321035|FG000|Overall Study|Moved|1|||
127645517|NCT02157779|459321036|FG001|Overall Study|Moved|0|||
127645518|NCT02157779|459321035|FG000|Overall Study|Medical|1|||
127799429|NCT00848354|459888070|FG001|Phase 2 Year 2|Protocol Violation|1|||
127799430|NCT00848354|459888069|FG000|Phase 2 Year 2|Subject Request|1|||
127799431|NCT00848354|459888070|FG001|Phase 2 Year 2|Subject Request|1|||
127707535|NCT02413489|459556909|FG001|Overall Study|Study Terminated By Sponsor|13|||
127707536|NCT02413489|459556910|FG002|Overall Study|Study Terminated By Sponsor|1|||
127707537|NCT02575950|459556911|FG000|Overall Study|Withdrawal by Subject|0|||
127707538|NCT02575950|459556912|FG001|Overall Study|Withdrawal by Subject|0|||
127707539|NCT02575950|459556913|FG002|Overall Study|Withdrawal by Subject|0|||
127707540|NCT02575950|459556914|FG003|Overall Study|Withdrawal by Subject|2|||
127707541|NCT02575950|459556911|FG000|Overall Study|Lost to Follow-up|0|||
127707542|NCT02575950|459556912|FG001|Overall Study|Lost to Follow-up|1|||
127707543|NCT02575950|459556913|FG002|Overall Study|Lost to Follow-up|0|||
127707544|NCT02575950|459556914|FG003|Overall Study|Lost to Follow-up|3|||
127707545|NCT05645757|459559023|FG000|Overall Study|Enrolled but treatment not administered|0|||
127707546|NCT05645757|459559024|FG001|Overall Study|Enrolled but treatment not administered|0|||
127707547|NCT05645757|459559025|FG002|Overall Study|Enrolled but treatment not administered|0|||
127707548|NCT05645757|459559026|FG003|Overall Study|Enrolled but treatment not administered|0|||
127707549|NCT05645757|459559027|FG004|Overall Study|Enrolled but treatment not administered|1|||
127707550|NCT05645757|459559028|FG005|Overall Study|Enrolled but treatment not administered|1|||
127707551|NCT05645757|459559029|FG006|Overall Study|Enrolled but treatment not administered|0|||
127707552|NCT05645757|459559030|FG007|Overall Study|Enrolled but treatment not administered|0|||
127707553|NCT03924635|459559031|FG000|Overall Study|Withdrawal by Subject|2|||
127707554|NCT03924635|459559032|FG001|Overall Study|Withdrawal by Subject|4|||
127707555|NCT00539591|459559033|FG000|Overall Study|Toxicity|3|||
127707556|NCT00539591|459559034|FG001|Overall Study|Toxicity|0|||
127707557|NCT00539591|459559035|FG002|Overall Study|Toxicity|0|||
127707558|NCT00539591|459559033|FG000|Overall Study|Disease progression|2|||
127707559|NCT00539591|459559034|FG001|Overall Study|Disease progression|2|||
127707560|NCT00539591|459559035|FG002|Overall Study|Disease progression|3|||
127707561|NCT01960452|459559036|FG000|Overall Study|Withdrawal by Subject|2|||
127799432|NCT00848354|459888069|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
127799433|NCT00848354|459888070|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
127799434|NCT01777581|459888071|FG000|Overall Study|Lost to Follow-up|1|||
127799435|NCT01777581|459888072|FG001|Overall Study|Lost to Follow-up|1|||
127799436|NCT01777581|459888071|FG000|Overall Study|Adverse Event|2|||
127799437|NCT01777581|459888072|FG001|Overall Study|Adverse Event|0|||
127799438|NCT01777581|459888071|FG000|Overall Study|Lack of Efficacy|0|||
127799439|NCT01777581|459888072|FG001|Overall Study|Lack of Efficacy|1|||
127799440|NCT04202679|459888075|FG000|Overall Study|Adverse Event|2|||
127799441|NCT04202679|459888076|FG001|Overall Study|Adverse Event|0|||
127799442|NCT04202679|459888075|FG000|Overall Study|Poor compliance to protocol|1|||
127799443|NCT04202679|459888076|FG001|Overall Study|Poor compliance to protocol|0|||
127799444|NCT04202679|459888075|FG000|Overall Study|Withdrawal by Subject|23|||
127799445|NCT04202679|459888076|FG001|Overall Study|Withdrawal by Subject|6|||
127799446|NCT03406897|459888077|FG000|Overall Study|Lost to Follow-up|1|||
127799447|NCT03406897|459888078|FG001|Overall Study|Lost to Follow-up|2|||
127799448|NCT03406897|459888077|FG000|Overall Study|Withdrawal by Subject|4|||
127799449|NCT03406897|459888078|FG001|Overall Study|Withdrawal by Subject|4|||
127799450|NCT03406897|459888077|FG000|Overall Study|Physician Decision|0|||
127799451|NCT03406897|459888078|FG001|Overall Study|Physician Decision|1|||
127799452|NCT00598975|459889672|FG000|Overall Study|Adverse Event|1|||
127799453|NCT00598975|459889673|FG001|Overall Study|Adverse Event|1|||
127799454|NCT00598975|459889672|FG000|Overall Study|Brain metastases|1|||
127799455|NCT00598975|459889673|FG001|Overall Study|Brain metastases|0|||
127799456|NCT00598975|459889672|FG000|Overall Study|Withdrawal by Subject|1|||
127799457|NCT00598975|459889673|FG001|Overall Study|Withdrawal by Subject|1|||
127799458|NCT00598975|459889672|FG000|Overall Study|Withdrawal of consent|0|||
127799459|NCT00598975|459889673|FG001|Overall Study|Withdrawal of consent|1|||
127888023|NCT00528879|460213944|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
127888024|NCT00528879|460213941|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
127888025|NCT00528879|460213942|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
127707562|NCT01960452|459559037|FG001|Overall Study|Withdrawal by Subject|1|||
127707563|NCT01960452|459559036|FG000|Overall Study|Sleep apnea in Night 1|1|||
127707564|NCT01960452|459559037|FG001|Overall Study|Sleep apnea in Night 1|0|||
127707565|NCT01960452|459559036|FG000|Overall Study|Poor Sleep in Night 1|0|||
127799460|NCT00598975|459889672|FG000|Overall Study|Disease progression|8|||
127799461|NCT00598975|459889673|FG001|Overall Study|Disease progression|3|||
127799462|NCT00598975|459889672|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
127799463|NCT00598975|459889673|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
127799464|NCT05227690|459889683|FG000|Overall Study|Adverse Event|5|||
127799465|NCT05227690|459889684|FG001|Overall Study|Adverse Event|6|||
127799466|NCT05227690|459889685|FG002|Overall Study|Adverse Event|10|||
127799467|NCT05227690|459889683|FG000|Overall Study|Lack of Efficacy|2|||
127799468|NCT05227690|459889684|FG001|Overall Study|Lack of Efficacy|4|||
127799469|NCT05227690|459889685|FG002|Overall Study|Lack of Efficacy|1|||
127707566|NCT01960452|459559037|FG001|Overall Study|Poor Sleep in Night 1|2|||
127707567|NCT01960452|459559036|FG000|Overall Study|No Sex/Age Match Night 1|1|||
127707568|NCT01960452|459559037|FG001|Overall Study|No Sex/Age Match Night 1|0|||
127707569|NCT01960452|459559036|FG000|Overall Study|No Sex/Age Match Night 2|0|||
127707570|NCT01960452|459559037|FG001|Overall Study|No Sex/Age Match Night 2|2|||
127707571|NCT01960452|459559036|FG000|Overall Study|Technical Difficulties Night 2|2|||
127707572|NCT01960452|459559037|FG001|Overall Study|Technical Difficulties Night 2|0|||
127707573|NCT04660539|459559048|FG000|Overall Study|Adverse Event|10|||
127707574|NCT04660539|459559048|FG000|Overall Study|Lack of Efficacy|4|||
127707575|NCT04660539|459559048|FG000|Overall Study|Lost to Follow-up|5|||
127707576|NCT04660539|459559048|FG000|Overall Study|Non-Compliance With Study Drug|3|||
127707577|NCT04660539|459559048|FG000|Overall Study|Reason not Specified|12|||
127707578|NCT04660539|459559048|FG000|Overall Study|Pregnancy|2|||
127707579|NCT04660539|459559048|FG000|Overall Study|Protocol Violation|2|||
127707580|NCT04660539|459559048|FG000|Overall Study|Switch To Commercial Satralizumab|1|||
127707581|NCT04660539|459559048|FG000|Overall Study|Withdrawal by Subject|21|||
127707582|NCT03655028|459559051|FG000|12-weeks Follow up|Death|1|||
127707583|NCT03655028|459559052|FG001|12-weeks Follow up|Death|0|||
127707584|NCT03655028|459559051|FG000|12-weeks Follow up|Physician Decision|3|||
127707585|NCT03655028|459559052|FG001|12-weeks Follow up|Physician Decision|3|||
127707586|NCT03655028|459559051|FG000|12-weeks Follow up|Withdrawal by Subject|2|||
127707587|NCT03655028|459559052|FG001|12-weeks Follow up|Withdrawal by Subject|0|||
127707588|NCT03655028|459559051|FG000|12-weeks Follow up|Lost to Follow-up|4|||
127707589|NCT03655028|459559052|FG001|12-weeks Follow up|Lost to Follow-up|4|||
127707590|NCT03655028|459559051|FG000|24-weeks|Lost to Follow-up|1|||
127707591|NCT03655028|459559052|FG001|24-weeks|Lost to Follow-up|1|||
127707592|NCT03655028|459559051|FG000|24-weeks|Death|0|||
127707593|NCT03655028|459559052|FG001|24-weeks|Death|1|||
127707594|NCT03513302|459559053|FG000|First Intervention (14 Days)|Screen failure|15|||
127707595|NCT03513302|459559054|FG001|First Intervention (14 Days)|Screen failure|16|||
127707596|NCT05256654|459559055|FG000|Overall Study|Adverse Event|0|||
127707597|NCT05256654|459559056|FG001|Overall Study|Adverse Event|0|||
127707598|NCT05256654|459559057|FG002|Overall Study|Adverse Event|1|||
127707599|NCT05256654|459559058|FG003|Overall Study|Adverse Event|0|||
127707600|NCT05256654|459559055|FG000|Overall Study|Lost to Follow-up|0|||
127707601|NCT05256654|459559056|FG001|Overall Study|Lost to Follow-up|0|||
127707602|NCT05256654|459559057|FG002|Overall Study|Lost to Follow-up|0|||
127707603|NCT05256654|459559058|FG003|Overall Study|Lost to Follow-up|1|||
127707604|NCT05256654|459559055|FG000|Overall Study|Withdrawal by Subject|1|||
127707605|NCT05256654|459559056|FG001|Overall Study|Withdrawal by Subject|2|||
127707606|NCT05256654|459559057|FG002|Overall Study|Withdrawal by Subject|1|||
127707607|NCT05256654|459559058|FG003|Overall Study|Withdrawal by Subject|3|||
127707608|NCT05256654|459559055|FG000|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
127707609|NCT05256654|459559056|FG001|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
127707610|NCT05256654|459559057|FG002|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
127707611|NCT05256654|459559058|FG003|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
127707612|NCT05256654|459559055|FG000|Overall Study|Other|0|||
127707613|NCT05256654|459559056|FG001|Overall Study|Other|0|||
127707614|NCT05256654|459559057|FG002|Overall Study|Other|0|||
127707615|NCT05256654|459559058|FG003|Overall Study|Other|1|||
127799470|NCT05227690|459889683|FG000|Overall Study|Physician Decision|6|||
127799471|NCT05227690|459889684|FG001|Overall Study|Physician Decision|0|||
127799472|NCT05227690|459889685|FG002|Overall Study|Physician Decision|4|||
127799473|NCT05227690|459889683|FG000|Overall Study|Withdrawal of consent|28|||
127799474|NCT05227690|459889684|FG001|Overall Study|Withdrawal of consent|27|||
127799475|NCT05227690|459889685|FG002|Overall Study|Withdrawal of consent|21|||
127799476|NCT05227690|459889683|FG000|Overall Study|Other, not specified|2|||
127799477|NCT05227690|459889684|FG001|Overall Study|Other, not specified|2|||
127799478|NCT05227690|459889685|FG002|Overall Study|Other, not specified|1|||
127799479|NCT04033367|459889686|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
127799480|NCT04033367|459889687|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
127799481|NCT04033367|459889686|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
127799482|NCT04033367|459889687|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
127707616|NCT05167864|459559059|FG000|Overall Study|Lost to Follow-up|7|||
127707617|NCT05167864|459559060|FG001|Overall Study|Lost to Follow-up|6|||
127707618|NCT05167864|459559061|FG002|Overall Study|Lost to Follow-up|7|||
127707619|NCT05167864|459559062|FG003|Overall Study|Lost to Follow-up|9|||
127707620|NCT05207956|459559077|FG000|Overall Study|Lost to follow up|1|||
127707621|NCT05207956|459559078|FG001|Overall Study|Lost to follow up|2|||
127799483|NCT04033367|459889686|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
127799484|NCT04033367|459889687|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
127799485|NCT04033367|459889686|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
127799486|NCT04033367|459889687|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
127799487|NCT02723201|459889688|FG000|Second Intervention Period|Protocol Violation|1|||
127799488|NCT02723201|459889689|FG001|Second Intervention Period|Protocol Violation|0|||
127707622|NCT01254864|459559079|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|4|||
127707623|NCT01254864|459559080|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
127707624|NCT01254864|459559081|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
127707625|NCT01254864|459559079|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Death|1|||
127707626|NCT01254864|459559080|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
127707627|NCT01254864|459559081|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
127707628|NCT01254864|459559079|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|24|||
127707629|NCT01254864|459559080|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
127707630|NCT01254864|459559081|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
127707631|NCT01254864|459559079|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|9|||
127707632|NCT01254864|459559080|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
127707633|NCT01254864|459559081|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
127707634|NCT01254864|459559079|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|2|||
127707635|NCT01254864|459559080|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
127707636|NCT01254864|459559081|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
127707637|NCT01254864|459559079|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|7|||
127707638|NCT01254864|459559080|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
127707639|NCT01254864|459559081|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
127707640|NCT01254864|459559079|FG000|Randomization Phase|Adverse Event|0|||
127707641|NCT01254864|459559080|FG001|Randomization Phase|Adverse Event|5|||
127707642|NCT01254864|459559081|FG002|Randomization Phase|Adverse Event|17|||
127707643|NCT01254864|459559079|FG000|Randomization Phase|Death|0|||
127707644|NCT01254864|459559080|FG001|Randomization Phase|Death|1|||
127707645|NCT01254864|459559081|FG002|Randomization Phase|Death|0|||
127707646|NCT01254864|459559079|FG000|Randomization Phase|Lost to Follow-up|0|||
127707647|NCT01254864|459559080|FG001|Randomization Phase|Lost to Follow-up|0|||
127707648|NCT01254864|459559081|FG002|Randomization Phase|Lost to Follow-up|1|||
127707649|NCT01254864|459559079|FG000|Randomization Phase|Physician Decision|0|||
127707650|NCT01254864|459559080|FG001|Randomization Phase|Physician Decision|20|||
127707651|NCT01254864|459559081|FG002|Randomization Phase|Physician Decision|25|||
127707652|NCT01254864|459559079|FG000|Randomization Phase|Withdrawal by Subject|0|||
127707653|NCT01254864|459559080|FG001|Randomization Phase|Withdrawal by Subject|4|||
127707654|NCT01254864|459559081|FG002|Randomization Phase|Withdrawal by Subject|2|||
127707655|NCT01254864|459559079|FG000|Randomization Phase|Non-Compliance|0|||
127707656|NCT01254864|459559080|FG001|Randomization Phase|Non-Compliance|1|||
127707657|NCT01254864|459559081|FG002|Randomization Phase|Non-Compliance|0|||
127707658|NCT01254864|459559079|FG000|Randomization Phase|Comorbidities|0|||
127707659|NCT01254864|459559080|FG001|Randomization Phase|Comorbidities|2|||
127707660|NCT01254864|459559081|FG002|Randomization Phase|Comorbidities|1|||
127707661|NCT01828112|459559086|FG000|Treatment Phase|Adverse Event|7|||
127707662|NCT01828112|459559087|FG001|Treatment Phase|Adverse Event|8|||
127707663|NCT01828112|459559088|FG002|Treatment Phase|Adverse Event|0|||
127707664|NCT01828112|459559086|FG000|Treatment Phase|Death|9|||
127707665|NCT01828112|459559087|FG001|Treatment Phase|Death|5|||
127707666|NCT01828112|459559088|FG002|Treatment Phase|Death|0|||
127707667|NCT01828112|459559086|FG000|Treatment Phase|No longer required treatment|0|||
127707668|NCT01828112|459559087|FG001|Treatment Phase|No longer required treatment|1|||
127707669|NCT01828112|459559088|FG002|Treatment Phase|No longer required treatment|0|||
127707670|NCT01828112|459559086|FG000|Treatment Phase|Physician Decision|6|||
127707671|NCT01828112|459559087|FG001|Treatment Phase|Physician Decision|7|||
127707672|NCT01828112|459559088|FG002|Treatment Phase|Physician Decision|0|||
127707673|NCT01828112|459559086|FG000|Treatment Phase|Pregnancy|1|||
127707674|NCT01828112|459559087|FG001|Treatment Phase|Pregnancy|0|||
127707675|NCT01828112|459559088|FG002|Treatment Phase|Pregnancy|0|||
127707676|NCT01828112|459559086|FG000|Treatment Phase|Progressive disease|79|||
127707677|NCT01828112|459559087|FG001|Treatment Phase|Progressive disease|87|||
127707678|NCT01828112|459559088|FG002|Treatment Phase|Progressive disease|0|||
127707679|NCT01828112|459559086|FG000|Treatment Phase|Study terminated by sponsor|1|||
127707680|NCT01828112|459559087|FG001|Treatment Phase|Study terminated by sponsor|0|||
127707681|NCT01828112|459559088|FG002|Treatment Phase|Study terminated by sponsor|0|||
127707682|NCT01828112|459559086|FG000|Treatment Phase|Subject/guardian decision|12|||
127707683|NCT01828112|459559087|FG001|Treatment Phase|Subject/guardian decision|8|||
127707684|NCT01828112|459559088|FG002|Treatment Phase|Subject/guardian decision|0|||
127707685|NCT01828112|459559086|FG000|Extension Treatment Phase|Adverse Event|0|||
127707686|NCT01828112|459559087|FG001|Extension Treatment Phase|Adverse Event|0|||
127707687|NCT01828112|459559088|FG002|Extension Treatment Phase|Adverse Event|6|||
127707688|NCT01828112|459559086|FG000|Extension Treatment Phase|Death|0|||
127707689|NCT01828112|459559087|FG001|Extension Treatment Phase|Death|0|||
127707690|NCT01828112|459559088|FG002|Extension Treatment Phase|Death|17|||
127707691|NCT01828112|459559086|FG000|Extension Treatment Phase|Physician Decision|0|||
127645519|NCT02157779|459321036|FG001|Overall Study|Medical|0|||
127645520|NCT02157779|459321035|FG000|Overall Study|Legal issue|1|||
127645521|NCT02157779|459321036|FG001|Overall Study|Legal issue|0|||
127645522|NCT00002558|459321041|FG000|Overall Study|Withdrawal by Subject|0|||
127645523|NCT00002558|459321042|FG001|Overall Study|Withdrawal by Subject|1|||
127645524|NCT02065336|459321043|FG000|Extension Phase|Study Terminated by Sponsor|0|||
127645525|NCT02065336|459321044|FG001|Extension Phase|Study Terminated by Sponsor|0|||
127645526|NCT02065336|459321045|FG002|Extension Phase|Study Terminated by Sponsor|0|||
127645527|NCT02065336|459321046|FG003|Extension Phase|Study Terminated by Sponsor|0|||
127645528|NCT02065336|459321047|FG004|Extension Phase|Study Terminated by Sponsor|0|||
127645529|NCT02065336|459321048|FG005|Extension Phase|Study Terminated by Sponsor|0|||
127645530|NCT02065336|459321049|FG006|Extension Phase|Study Terminated by Sponsor|0|||
127645531|NCT02065336|459321050|FG007|Extension Phase|Study Terminated by Sponsor|0|||
127645532|NCT02065336|459321051|FG008|Extension Phase|Study Terminated by Sponsor|2|||
127645533|NCT02065336|459321052|FG009|Extension Phase|Study Terminated by Sponsor|8|||
127645534|NCT00626028|459321053|FG000|Overall Study|Adverse Event|1|||
127645535|NCT00626028|459321054|FG001|Overall Study|Adverse Event|1|||
127645536|NCT00626028|459321053|FG000|Overall Study|Device Failure|0|||
127645537|NCT00626028|459321054|FG001|Overall Study|Device Failure|1|||
127799489|NCT02723201|459889690|FG002|Second Intervention Period|Protocol Violation|0|||
127799490|NCT02723201|459889688|FG000|Second Intervention Period|Adverse Event|1|||
127799491|NCT02723201|459889689|FG001|Second Intervention Period|Adverse Event|0|||
127799492|NCT02723201|459889690|FG002|Second Intervention Period|Adverse Event|0|||
127799493|NCT03472560|459889691|FG000|Overall Study|Subject transfer to continuation protocol|0|||
127799494|NCT03472560|459889692|FG001|Overall Study|Subject transfer to continuation protocol|1|||
127799495|NCT03472560|459889691|FG000|Overall Study|Withdrawal by Subject|4|||
127799496|NCT03472560|459889692|FG001|Overall Study|Withdrawal by Subject|0|||
127799497|NCT03472560|459889691|FG000|Overall Study|Progressive disease|24|||
127799498|NCT03472560|459889692|FG001|Overall Study|Progressive disease|8|||
127645538|NCT00626028|459321053|FG000|Overall Study|Physician Decision|2|||
127645539|NCT00626028|459321054|FG001|Overall Study|Physician Decision|1|||
127645540|NCT00626028|459321053|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
127645541|NCT00626028|459321054|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
127645542|NCT00831779|459321055|FG000|Overall Study|Lost to Follow-up|1|||
127645543|NCT00831779|459321056|FG001|Overall Study|Lost to Follow-up|0|||
127645544|NCT00831779|459321055|FG000|Overall Study|No longer met criteria|0|||
127645545|NCT00831779|459321056|FG001|Overall Study|No longer met criteria|1|||
127645546|NCT01984684|459321058|FG000|Overall Study|Lost to Follow-up|25|||
127645547|NCT01984684|459321059|FG001|Overall Study|Lost to Follow-up|24|||
127645548|NCT01984684|459321058|FG000|Overall Study|Adverse Event|8|||
127645549|NCT01984684|459321059|FG001|Overall Study|Adverse Event|12|||
127645550|NCT01984684|459321058|FG000|Overall Study|Withdrawal by Subject|9|||
127645551|NCT01984684|459321059|FG001|Overall Study|Withdrawal by Subject|9|||
127645552|NCT01984684|459321058|FG000|Overall Study|Lack of Efficacy|3|||
127645553|NCT01984684|459321059|FG001|Overall Study|Lack of Efficacy|6|||
127645554|NCT01984684|459321058|FG000|Overall Study|Physician Decision|4|||
127645555|NCT01984684|459321059|FG001|Overall Study|Physician Decision|2|||
127799499|NCT03472560|459889691|FG000|Overall Study|Physician Decision|1|||
127799500|NCT03472560|459889692|FG001|Overall Study|Physician Decision|0|||
127799501|NCT03472560|459889691|FG000|Overall Study|Death|7|||
127799502|NCT03472560|459889692|FG001|Overall Study|Death|4|||
127799503|NCT03472560|459889691|FG000|Overall Study|Adverse Event|5|||
127799504|NCT03472560|459889692|FG001|Overall Study|Adverse Event|3|||
127799505|NCT03472560|459889691|FG000|Overall Study|Global deterioration of health status|0|||
127799506|NCT03472560|459889692|FG001|Overall Study|Global deterioration of health status|4|||
127799507|NCT00491179|459889693|FG000|Overall Study|Adverse Event|5|||
127799508|NCT00491179|459889694|FG001|Overall Study|Adverse Event|1|||
127799509|NCT00491179|459889693|FG000|Overall Study|Withdrawal by Subject|2|||
127799510|NCT00491179|459889694|FG001|Overall Study|Withdrawal by Subject|1|||
127799511|NCT04269395|459889695|FG000|Overall Study|Lost to Follow-up|1|||
127799512|NCT04269395|459889696|FG001|Overall Study|Lost to Follow-up|0|||
127799513|NCT04269395|459889695|FG000|Overall Study|Study terminated by Sponsor|13|||
127799514|NCT04269395|459889696|FG001|Overall Study|Study terminated by Sponsor|10|||
127799515|NCT03529773|459889697|FG000|Overall Study|Adverse Event|0|||
127799516|NCT03529773|459889698|FG001|Overall Study|Adverse Event|0|||
127799517|NCT03529773|459889699|FG002|Overall Study|Adverse Event|0|||
127799518|NCT03529773|459889700|FG003|Overall Study|Adverse Event|0|||
127645556|NCT01984684|459321058|FG000|Overall Study|Protocol Violation|4|||
127645557|NCT01984684|459321059|FG001|Overall Study|Protocol Violation|2|||
127645558|NCT01984684|459321058|FG000|Overall Study|Death|0|||
127645559|NCT01984684|459321059|FG001|Overall Study|Death|1|||
127645560|NCT01984684|459321058|FG000|Overall Study|Noncompliance with study drug|2|||
127799519|NCT03529773|459889701|FG004|Overall Study|Adverse Event|0|||
127799520|NCT03529773|459889702|FG005|Overall Study|Adverse Event|0|||
127799521|NCT03529773|459889703|FG006|Overall Study|Adverse Event|0|||
127799522|NCT03529773|459889704|FG007|Overall Study|Adverse Event|0|||
127707692|NCT01828112|459559087|FG001|Extension Treatment Phase|Physician Decision|0|||
127707693|NCT01828112|459559088|FG002|Extension Treatment Phase|Physician Decision|5|||
127707694|NCT01828112|459559086|FG000|Extension Treatment Phase|Progressive disease|0|||
127707695|NCT01828112|459559087|FG001|Extension Treatment Phase|Progressive disease|0|||
127707696|NCT01828112|459559088|FG002|Extension Treatment Phase|Progressive disease|46|||
127707697|NCT01828112|459559086|FG000|Extension Treatment Phase|Study terminated by sponsor|0|||
127707698|NCT01828112|459559087|FG001|Extension Treatment Phase|Study terminated by sponsor|0|||
127707699|NCT01828112|459559088|FG002|Extension Treatment Phase|Study terminated by sponsor|1|||
127707700|NCT01828112|459559086|FG000|Extension Treatment Phase|Subject/guardian decision|0|||
127707701|NCT01828112|459559087|FG001|Extension Treatment Phase|Subject/guardian decision|0|||
127707702|NCT01828112|459559088|FG002|Extension Treatment Phase|Subject/guardian decision|4|||
127707703|NCT05184452|459559096|FG000|Overall Study|Lost to Follow-up|0|||
127707704|NCT05184452|459559097|FG001|Overall Study|Lost to Follow-up|0|||
127707705|NCT05184452|459559098|FG002|Overall Study|Lost to Follow-up|0|||
127707706|NCT05184452|459559099|FG003|Overall Study|Lost to Follow-up|0|||
127707707|NCT05184452|459559100|FG004|Overall Study|Lost to Follow-up|0|||
127707708|NCT05184452|459559101|FG005|Overall Study|Lost to Follow-up|2|||
127707709|NCT05184452|459559102|FG006|Overall Study|Lost to Follow-up|0|||
127707710|NCT05184452|459559103|FG007|Overall Study|Lost to Follow-up|0|||
127707711|NCT05184452|459559104|FG008|Overall Study|Lost to Follow-up|0|||
127707712|NCT05184452|459559105|FG009|Overall Study|Lost to Follow-up|1|||
127707713|NCT05184452|459559096|FG000|Overall Study|Withdrawal by Subject|0|||
127707714|NCT05184452|459559097|FG001|Overall Study|Withdrawal by Subject|0|||
127707715|NCT05184452|459559098|FG002|Overall Study|Withdrawal by Subject|0|||
127799523|NCT03529773|459889705|FG008|Overall Study|Adverse Event|0|||
127799524|NCT03529773|459889706|FG009|Overall Study|Adverse Event|0|||
127799525|NCT03529773|459889707|FG010|Overall Study|Adverse Event|0|||
127799526|NCT03529773|459889708|FG011|Overall Study|Adverse Event|0|||
127799527|NCT03529773|459889709|FG012|Overall Study|Adverse Event|0|||
127799528|NCT03529773|459889710|FG013|Overall Study|Adverse Event|0|||
127799529|NCT03529773|459889711|FG014|Overall Study|Adverse Event|0|||
127799530|NCT03529773|459889712|FG015|Overall Study|Adverse Event|0|||
127799531|NCT03529773|459889713|FG016|Overall Study|Adverse Event|0|||
127799532|NCT03529773|459889714|FG017|Overall Study|Adverse Event|0|||
127799533|NCT03529773|459889715|FG018|Overall Study|Adverse Event|0|||
127799534|NCT03529773|459889716|FG019|Overall Study|Adverse Event|0|||
127799535|NCT03529773|459889717|FG020|Overall Study|Adverse Event|0|||
127799536|NCT03529773|459889718|FG021|Overall Study|Adverse Event|0|||
127799537|NCT03529773|459889719|FG022|Overall Study|Adverse Event|0|||
127799538|NCT03529773|459889720|FG023|Overall Study|Adverse Event|0|||
127799539|NCT03529773|459889721|FG024|Overall Study|Adverse Event|0|||
127799540|NCT03529773|459889722|FG025|Overall Study|Adverse Event|0|||
127799541|NCT03529773|459889723|FG026|Overall Study|Adverse Event|0|||
127799542|NCT03529773|459889724|FG027|Overall Study|Adverse Event|0|||
127799543|NCT03529773|459889725|FG028|Overall Study|Adverse Event|0|||
127799544|NCT03529773|459889726|FG029|Overall Study|Adverse Event|0|||
127799545|NCT03529773|459889727|FG030|Overall Study|Adverse Event|1|||
127799546|NCT03529773|459889728|FG031|Overall Study|Adverse Event|0|||
127799547|NCT03529773|459889729|FG032|Overall Study|Adverse Event|0|||
127799548|NCT03529773|459889730|FG033|Overall Study|Adverse Event|0|||
127799549|NCT03529773|459889731|FG034|Overall Study|Adverse Event|0|||
127799550|NCT03529773|459889732|FG035|Overall Study|Adverse Event|1|||
127799551|NCT03529773|459889733|FG036|Overall Study|Adverse Event|0|||
127799552|NCT03529773|459889734|FG037|Overall Study|Adverse Event|0|||
127799553|NCT03529773|459889735|FG038|Overall Study|Adverse Event|1|||
127799554|NCT03529773|459889736|FG039|Overall Study|Adverse Event|1|||
127799555|NCT03529773|459889697|FG000|Overall Study|Death|0|||
127707716|NCT05184452|459559099|FG003|Overall Study|Withdrawal by Subject|0|||
127707717|NCT05184452|459559100|FG004|Overall Study|Withdrawal by Subject|0|||
127707718|NCT05184452|459559101|FG005|Overall Study|Withdrawal by Subject|1|||
127799556|NCT03529773|459889698|FG001|Overall Study|Death|0|||
127799557|NCT03529773|459889699|FG002|Overall Study|Death|0|||
127799558|NCT03529773|459889700|FG003|Overall Study|Death|0|||
127976278|NCT00325156|460533170|FG000|Overall Study|Migrated/moved from study area|12|||
127707719|NCT05184452|459559102|FG006|Overall Study|Withdrawal by Subject|0|||
127707720|NCT05184452|459559103|FG007|Overall Study|Withdrawal by Subject|0|||
127799559|NCT03529773|459889701|FG004|Overall Study|Death|0|||
127799560|NCT03529773|459889702|FG005|Overall Study|Death|0|||
127799561|NCT03529773|459889703|FG006|Overall Study|Death|0|||
127799562|NCT03529773|459889704|FG007|Overall Study|Death|0|||
127799563|NCT03529773|459889705|FG008|Overall Study|Death|0|||
127799564|NCT03529773|459889706|FG009|Overall Study|Death|0|||
127799565|NCT03529773|459889707|FG010|Overall Study|Death|0|||
127799566|NCT03529773|459889708|FG011|Overall Study|Death|0|||
127645561|NCT01984684|459321059|FG001|Overall Study|Noncompliance with study drug|1|||
127645562|NCT01984684|459321058|FG000|Overall Study|Subject incarcerated|1|||
127645563|NCT01984684|459321059|FG001|Overall Study|Subject incarcerated|0|||
127645564|NCT01984684|459321058|FG000|Overall Study|Study drug not available at site|1|||
127645565|NCT01984684|459321059|FG001|Overall Study|Study drug not available at site|1|||
127645566|NCT01984684|459321058|FG000|Overall Study|Subject had inadequate IV access|0|||
127645567|NCT01984684|459321059|FG001|Overall Study|Subject had inadequate IV access|1|||
127645568|NCT01375114|459321060|FG000|Overall Study|Lost to Follow-up|1|||
127645569|NCT01375114|459321061|FG001|Overall Study|Lost to Follow-up|0|||
127645570|NCT01375114|459321062|FG002|Overall Study|Lost to Follow-up|1|||
127645571|NCT01375114|459321060|FG000|Overall Study|Disease Progression|3|||
127645572|NCT01375114|459321061|FG001|Overall Study|Disease Progression|2|||
127645573|NCT01375114|459321062|FG002|Overall Study|Disease Progression|2|||
127645574|NCT01375114|459321060|FG000|Overall Study|Patient Changed Mind|0|||
127645575|NCT01375114|459321061|FG001|Overall Study|Patient Changed Mind|0|||
127645576|NCT01375114|459321062|FG002|Overall Study|Patient Changed Mind|2|||
127645577|NCT01375114|459321060|FG000|Overall Study|Pruritus|0|||
127645578|NCT01375114|459321061|FG001|Overall Study|Pruritus|0|||
127645579|NCT01375114|459321062|FG002|Overall Study|Pruritus|1|||
127707721|NCT05184452|459559104|FG008|Overall Study|Withdrawal by Subject|0|||
127707722|NCT05184452|459559105|FG009|Overall Study|Withdrawal by Subject|1|||
127707723|NCT05586490|459559106|FG000|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
127707724|NCT05586490|459559107|FG001|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
127707725|NCT05586490|459559108|FG002|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|1|||
127707726|NCT05586490|459559109|FG003|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
127707727|NCT05586490|459559110|FG004|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
127707728|NCT05586490|459559106|FG000|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|1|||
127707729|NCT05586490|459559107|FG001|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
127707730|NCT05586490|459559108|FG002|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
127707731|NCT05586490|459559109|FG003|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
127707732|NCT05586490|459559110|FG004|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
127707733|NCT05586490|459559106|FG000|Completed Aim 3 - No Device Arm|Withdrawal by Subject|1|||
127707734|NCT05586490|459559107|FG001|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
127707735|NCT05586490|459559108|FG002|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
127707736|NCT05586490|459559109|FG003|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
127707737|NCT05586490|459559110|FG004|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
127707738|NCT05425420|459559118|FG000|Overall Study|Physician Decision|1|||
127707739|NCT05425420|459559118|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
127707740|NCT04428203|459559119|FG000|Overall Study|Adverse Event|1|||
127707741|NCT04428203|459559120|FG001|Overall Study|Adverse Event|0|||
127707742|NCT04428203|459559121|FG002|Overall Study|Adverse Event|0|||
127707743|NCT04428203|459559119|FG000|Overall Study|Withdrawal by Subject|1|||
127707744|NCT04428203|459559120|FG001|Overall Study|Withdrawal by Subject|0|||
127707745|NCT04428203|459559121|FG002|Overall Study|Withdrawal by Subject|1|||
127707746|NCT05280574|459559122|FG000|Overall Study|Withdrawal by Subject|0|||
127707747|NCT05280574|459559123|FG001|Overall Study|Withdrawal by Subject|2|||
127707748|NCT05280574|459559124|FG002|Overall Study|Withdrawal by Subject|0|||
127707749|NCT05237284|459559129|FG000|Part A (Double-blind Period: 24 Weeks)|Other|0|||
127707750|NCT05237284|459559130|FG001|Part A (Double-blind Period: 24 Weeks)|Other|2|||
127707751|NCT05237284|459559131|FG002|Part A (Double-blind Period: 24 Weeks)|Other|0|||
127707752|NCT05237284|459559132|FG003|Part A (Double-blind Period: 24 Weeks)|Other|0|||
127707753|NCT05237284|459559129|FG000|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|8|||
127707754|NCT05237284|459559130|FG001|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|13|||
127707755|NCT05237284|459559131|FG002|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
127799567|NCT03529773|459889709|FG012|Overall Study|Death|1|||
127799568|NCT03529773|459889710|FG013|Overall Study|Death|0|||
127799569|NCT03529773|459889711|FG014|Overall Study|Death|0|||
127645580|NCT01375114|459321060|FG000|Overall Study|Restlessness|0|||
127799570|NCT03529773|459889712|FG015|Overall Study|Death|0|||
127645581|NCT01375114|459321061|FG001|Overall Study|Restlessness|0|||
127645582|NCT01375114|459321062|FG002|Overall Study|Restlessness|1|||
127799571|NCT03529773|459889713|FG016|Overall Study|Death|0|||
127799572|NCT03529773|459889714|FG017|Overall Study|Death|0|||
127799573|NCT03529773|459889715|FG018|Overall Study|Death|0|||
127799574|NCT03529773|459889716|FG019|Overall Study|Death|1|||
127799575|NCT03529773|459889717|FG020|Overall Study|Death|0|||
127799576|NCT03529773|459889718|FG021|Overall Study|Death|0|||
127799577|NCT03529773|459889719|FG022|Overall Study|Death|1|||
127799578|NCT03529773|459889720|FG023|Overall Study|Death|0|||
127799579|NCT03529773|459889721|FG024|Overall Study|Death|0|||
127799580|NCT03529773|459889722|FG025|Overall Study|Death|0|||
127799581|NCT03529773|459889723|FG026|Overall Study|Death|0|||
127799582|NCT03529773|459889724|FG027|Overall Study|Death|0|||
127799583|NCT03529773|459889725|FG028|Overall Study|Death|0|||
127707756|NCT05237284|459559132|FG003|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
127707757|NCT05237284|459559129|FG000|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
127707758|NCT05237284|459559130|FG001|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|1|||
127707759|NCT05237284|459559131|FG002|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
127707760|NCT05237284|459559132|FG003|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
127707761|NCT05237284|459559129|FG000|Part A (Double-blind Period: 24 Weeks)|Adverse Event|6|||
127707762|NCT05237284|459559130|FG001|Part A (Double-blind Period: 24 Weeks)|Adverse Event|20|||
127707763|NCT05237284|459559131|FG002|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
127707764|NCT05237284|459559132|FG003|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
127707765|NCT05237284|459559129|FG000|Part B (Open-label Period: 80 Weeks)|Other|0|||
127707766|NCT05237284|459559130|FG001|Part B (Open-label Period: 80 Weeks)|Other|0|||
127707767|NCT05237284|459559131|FG002|Part B (Open-label Period: 80 Weeks)|Other|0|||
127707768|NCT05237284|459559132|FG003|Part B (Open-label Period: 80 Weeks)|Other|3|||
127707769|NCT05237284|459559129|FG000|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
127707770|NCT05237284|459559130|FG001|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
127707771|NCT05237284|459559131|FG002|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|64|||
127707772|NCT05237284|459559132|FG003|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|126|||
127707773|NCT05237284|459559129|FG000|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
127707774|NCT05237284|459559130|FG001|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
127707775|NCT05237284|459559131|FG002|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|11|||
127707776|NCT05237284|459559132|FG003|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|21|||
127707777|NCT05237284|459559129|FG000|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
127707778|NCT05237284|459559130|FG001|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
127707779|NCT05237284|459559131|FG002|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
127707780|NCT05237284|459559132|FG003|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|1|||
127707781|NCT05237284|459559129|FG000|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
127707782|NCT05237284|459559130|FG001|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
127707783|NCT05237284|459559131|FG002|Part B (Open-label Period: 80 Weeks)|Adverse Event|13|||
127707784|NCT05237284|459559132|FG003|Part B (Open-label Period: 80 Weeks)|Adverse Event|16|||
127707785|NCT04056611|459559134|FG000|Overall Study|Physician Decision|1|||
127707786|NCT03733925|459559137|FG000|Overall Study|Lost to Follow-up|1|||
127707787|NCT03733925|459559137|FG000|Overall Study|Withdrawal by Subject|2|||
127707788|NCT03733925|459559137|FG000|Overall Study|Adverse Event|2|||
127707789|NCT03733925|459559137|FG000|Overall Study|Non-Compliance with Study Drug|1|||
127707790|NCT02631746|459559138|FG000|Overall Study|Lack of Efficacy|3|||
127707791|NCT04571619|459559139|FG000|Phase 1|Death|22|||
127707792|NCT04571619|459559140|FG001|Phase 1|Death|18|||
127707793|NCT04571619|459559139|FG000|Phase 1|Withdrawal by Subject|7|||
127707794|NCT04571619|459559140|FG001|Phase 1|Withdrawal by Subject|2|||
127707795|NCT04571619|459559139|FG000|Phase 2|Death|13|||
127707796|NCT04571619|459559140|FG001|Phase 2|Death|16|||
127707797|NCT04571619|459559139|FG000|Phase 2|Withdrawal by Subject|6|||
127707798|NCT04571619|459559140|FG001|Phase 2|Withdrawal by Subject|4|||
127707799|NCT02224144|459559141|FG000|Overall Study|Lost to Follow-up|3|||
127707800|NCT02224144|459559142|FG001|Overall Study|Lost to Follow-up|1|||
127707801|NCT02224144|459559141|FG000|Overall Study|Death|2|||
127707802|NCT02224144|459559142|FG001|Overall Study|Death|0|||
127707803|NCT02224144|459559141|FG000|Overall Study|Withdrawal by Subject|0|||
127707804|NCT02224144|459559142|FG001|Overall Study|Withdrawal by Subject|1|||
127707805|NCT02780700|459559152|FG000|Overall Study|Progressive disease|1|||
127707806|NCT04820322|459559157|FG000|Overall Study|Adverse Event|1|||
127707807|NCT04820322|459559158|FG001|Overall Study|Adverse Event|0|||
127707808|NCT02834390|459559163|FG000|Induction Phase|Progressive disease|0|||
127707809|NCT02834390|459559164|FG001|Induction Phase|Progressive disease|1|||
127707810|NCT02834390|459559163|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
127707811|NCT02834390|459559164|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
127799584|NCT03529773|459889726|FG029|Overall Study|Death|0|||
127799585|NCT03529773|459889727|FG030|Overall Study|Death|0|||
127799586|NCT03529773|459889728|FG031|Overall Study|Death|0|||
127799587|NCT03529773|459889729|FG032|Overall Study|Death|0|||
127799588|NCT03529773|459889730|FG033|Overall Study|Death|1|||
127799589|NCT03529773|459889731|FG034|Overall Study|Death|1|||
127799590|NCT03529773|459889732|FG035|Overall Study|Death|0|||
127707812|NCT02834390|459559163|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
127707813|NCT02834390|459559164|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
127707814|NCT02834390|459559163|FG000|Consolidation Phase|Physician Decision|1|||
127707815|NCT02834390|459559164|FG001|Consolidation Phase|Physician Decision|1|||
127707816|NCT02998528|459559165|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
127707817|NCT02998528|459559166|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
127707818|NCT02998528|459559167|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
127707819|NCT02998528|459559165|FG000|Randomization Period|Participant withdrew consent|0|||
127707820|NCT02998528|459559166|FG001|Randomization Period|Participant withdrew consent|3|||
127707821|NCT02998528|459559167|FG002|Randomization Period|Participant withdrew consent|0|||
127799591|NCT03529773|459889733|FG036|Overall Study|Death|1|||
127707822|NCT02998528|459559165|FG000|Randomization Period|Participant no longer meets study criteria|1|||
127707823|NCT02998528|459559166|FG001|Randomization Period|Participant no longer meets study criteria|3|||
127707824|NCT02998528|459559167|FG002|Randomization Period|Participant no longer meets study criteria|2|||
127707825|NCT02998528|459559165|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
127707826|NCT02998528|459559166|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
127707827|NCT02998528|459559167|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
127707828|NCT02998528|459559165|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
127707829|NCT02998528|459559166|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
127707830|NCT02998528|459559167|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
127707831|NCT02998528|459559165|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
127707832|NCT02998528|459559166|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
127707833|NCT02998528|459559167|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
127707834|NCT02998528|459559165|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
127707835|NCT02998528|459559166|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
127707836|NCT02998528|459559167|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
127707837|NCT02998528|459559165|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
127707838|NCT02998528|459559166|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
127707839|NCT02998528|459559167|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
127707840|NCT02998528|459559165|FG000|Neoadjuvant Treatment Period|Death|1|||
127707841|NCT02998528|459559166|FG001|Neoadjuvant Treatment Period|Death|0|||
127707842|NCT02998528|459559167|FG002|Neoadjuvant Treatment Period|Death|0|||
127707843|NCT02998528|459559165|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
127707844|NCT02998528|459559166|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
127707845|NCT02998528|459559167|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
127707846|NCT02998528|459559165|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
127707847|NCT02998528|459559166|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
127707848|NCT02998528|459559167|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
127707849|NCT02998528|459559165|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
127707850|NCT02998528|459559166|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
127707851|NCT02998528|459559167|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
127707852|NCT02998528|459559165|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
127707853|NCT02998528|459559166|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
127799592|NCT03529773|459889734|FG037|Overall Study|Death|0|||
127799593|NCT03529773|459889735|FG038|Overall Study|Death|0|||
127707854|NCT02998528|459559167|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
127707855|NCT02998528|459559165|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
127799594|NCT03529773|459889736|FG039|Overall Study|Death|0|||
127799595|NCT03529773|459889697|FG000|Overall Study|Lost to Follow-up|0|||
127799596|NCT03529773|459889698|FG001|Overall Study|Lost to Follow-up|0|||
127799597|NCT03529773|459889699|FG002|Overall Study|Lost to Follow-up|1|||
127645583|NCT01375114|459321060|FG000|Overall Study|Diarrhea|0|||
127645584|NCT01375114|459321061|FG001|Overall Study|Diarrhea|0|||
127645585|NCT01375114|459321062|FG002|Overall Study|Diarrhea|1|||
127645586|NCT01375114|459321060|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
127645587|NCT01375114|459321061|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
127645588|NCT01375114|459321062|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
127645589|NCT01375114|459321060|FG000|Overall Study|Nausea|0|||
127645590|NCT01375114|459321061|FG001|Overall Study|Nausea|1|||
127645591|NCT01375114|459321062|FG002|Overall Study|Nausea|0|||
127645592|NCT01375114|459321060|FG000|Overall Study|Increased AST/ALT|0|||
127645593|NCT01375114|459321061|FG001|Overall Study|Increased AST/ALT|1|||
127645594|NCT01375114|459321062|FG002|Overall Study|Increased AST/ALT|0|||
127645595|NCT01375114|459321060|FG000|Overall Study|Vaginal Hemorrhage|0|||
127645596|NCT01375114|459321061|FG001|Overall Study|Vaginal Hemorrhage|1|||
127645597|NCT01375114|459321062|FG002|Overall Study|Vaginal Hemorrhage|0|||
127645598|NCT01375114|459321060|FG000|Overall Study|Family problem|0|||
127645599|NCT01375114|459321061|FG001|Overall Study|Family problem|1|||
127645600|NCT01375114|459321062|FG002|Overall Study|Family problem|0|||
127645601|NCT01375114|459321060|FG000|Overall Study|Protocol Violation|2|||
127645602|NCT01375114|459321061|FG001|Overall Study|Protocol Violation|0|||
127645603|NCT01375114|459321062|FG002|Overall Study|Protocol Violation|0|||
127645604|NCT03311373|459321069|FG000|Overall Study|Adverse Event|1|||
127645605|NCT03311373|459321069|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
127645606|NCT03311373|459321069|FG000|Overall Study|Lost to Follow-up|1|||
127645607|NCT03311373|459321069|FG000|Overall Study|Physician Decision|1|||
127645608|NCT03311373|459321069|FG000|Overall Study|Withdrawal by Subject|3|||
127645609|NCT01256567|459321070|FG000|Overall Study|Withdrawal by Subject|1|||
127645610|NCT02925676|459321075|FG000|Overall Study|Withdrawal by Subject|1|||
127645611|NCT03260868|459321076|FG000|Overall Study|Poor Compliance to Protocol|0|||
127645612|NCT03260868|459321077|FG001|Overall Study|Poor Compliance to Protocol|2|||
127645613|NCT03260868|459321076|FG000|Overall Study|Study Terminated By Sponsor|2|||
127645614|NCT03260868|459321077|FG001|Overall Study|Study Terminated By Sponsor|1|||
127645615|NCT03260868|459321076|FG000|Overall Study|Other than specified above|1|||
127645616|NCT03260868|459321077|FG001|Overall Study|Other than specified above|0|||
127645617|NCT00541450|459321078|FG000|Phase A|Adverse Event|3|||
127645618|NCT00541450|459321079|FG001|Phase A|Adverse Event|0|||
127645619|NCT00541450|459321078|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
127645620|NCT00541450|459321079|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
127645621|NCT00541450|459321078|FG000|Phase A|Hyperglycemia|0|||
127645622|NCT00541450|459321079|FG001|Phase A|Hyperglycemia|1|||
127645623|NCT00541450|459321078|FG000|Phase A|Lost to Follow-up|6|||
127645624|NCT00541450|459321079|FG001|Phase A|Lost to Follow-up|4|||
127645625|NCT00541450|459321078|FG000|Phase A|Physician Decision|2|||
127645626|NCT00541450|459321079|FG001|Phase A|Physician Decision|0|||
127645627|NCT00541450|459321078|FG000|Phase A|Protocol Violation|2|||
127645628|NCT00541450|459321079|FG001|Phase A|Protocol Violation|3|||
127645629|NCT00541450|459321078|FG000|Phase A|Withdrawal by Subject|7|||
127645630|NCT00541450|459321079|FG001|Phase A|Withdrawal by Subject|7|||
127645631|NCT00541450|459321078|FG000|Phase B|Adverse Event|6|||
127645632|NCT00541450|459321079|FG001|Phase B|Adverse Event|6|||
127645633|NCT00541450|459321078|FG000|Phase B|Hyperglycemia|10|||
127645634|NCT00541450|459321079|FG001|Phase B|Hyperglycemia|9|||
127645635|NCT00541450|459321078|FG000|Phase B|Lost to Follow-up|6|||
127645636|NCT00541450|459321079|FG001|Phase B|Lost to Follow-up|4|||
127645637|NCT00541450|459321078|FG000|Phase B|Physician Decision|4|||
127645638|NCT00541450|459321079|FG001|Phase B|Physician Decision|2|||
127645639|NCT00541450|459321078|FG000|Phase B|Pregnancy|0|||
127645640|NCT00541450|459321079|FG001|Phase B|Pregnancy|1|||
127645641|NCT00541450|459321078|FG000|Phase B|Protocol Violation|3|||
127645642|NCT00541450|459321079|FG001|Phase B|Protocol Violation|3|||
127645643|NCT00541450|459321078|FG000|Phase B|Withdrawal by Subject|8|||
127645644|NCT00541450|459321079|FG001|Phase B|Withdrawal by Subject|6|||
127645645|NCT01298999|459321080|FG000|Overall Study|Physician Decision|0|||
127645646|NCT01298999|459321081|FG001|Overall Study|Physician Decision|1|||
127645647|NCT01298999|459321080|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
127645648|NCT01298999|459321081|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
127645649|NCT01169675|459321082|FG000|Overall Study|Progressive disease|13|||
127645650|NCT01169675|459321083|FG001|Overall Study|Progressive disease|2|||
127645651|NCT01169675|459321084|FG002|Overall Study|Progressive disease|5|||
127645652|NCT01169675|459321085|FG003|Overall Study|Progressive disease|15|||
127645653|NCT01169675|459321086|FG004|Overall Study|Progressive disease|1|||
127645654|NCT01169675|459321082|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
127645655|NCT01169675|459321083|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
127645656|NCT01169675|459321084|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
127645657|NCT01169675|459321085|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
127645658|NCT01169675|459321086|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
127645659|NCT01169675|459321082|FG000|Overall Study|Adverse Event|5|||
127645660|NCT01169675|459321083|FG001|Overall Study|Adverse Event|1|||
127645661|NCT01169675|459321084|FG002|Overall Study|Adverse Event|2|||
127707856|NCT02998528|459559166|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
127707857|NCT02998528|459559167|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
127707858|NCT02998528|459559165|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
127707859|NCT02998528|459559166|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
127707860|NCT02998528|459559167|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
127707861|NCT03213678|459559174|FG000|Overall Study|Death|1|||
127707862|NCT03213678|459559174|FG000|Overall Study|Physician Decision|1|||
127707863|NCT03213678|459559174|FG000|Overall Study|Progressive disease|16|||
127707864|NCT04218851|459559175|FG000|Overall Study|Death|1|||
127707865|NCT04218851|459559176|FG001|Overall Study|Death|3|||
127799598|NCT03529773|459889700|FG003|Overall Study|Lost to Follow-up|0|||
127799599|NCT03529773|459889701|FG004|Overall Study|Lost to Follow-up|1|||
127799600|NCT03529773|459889702|FG005|Overall Study|Lost to Follow-up|1|||
127799601|NCT03529773|459889703|FG006|Overall Study|Lost to Follow-up|0|||
127799602|NCT03529773|459889704|FG007|Overall Study|Lost to Follow-up|0|||
127799603|NCT03529773|459889705|FG008|Overall Study|Lost to Follow-up|0|||
127799604|NCT03529773|459889706|FG009|Overall Study|Lost to Follow-up|0|||
127799605|NCT03529773|459889707|FG010|Overall Study|Lost to Follow-up|0|||
127799606|NCT03529773|459889708|FG011|Overall Study|Lost to Follow-up|0|||
127799607|NCT03529773|459889709|FG012|Overall Study|Lost to Follow-up|0|||
127799608|NCT03529773|459889710|FG013|Overall Study|Lost to Follow-up|1|||
127799609|NCT03529773|459889711|FG014|Overall Study|Lost to Follow-up|4|||
127799610|NCT03529773|459889712|FG015|Overall Study|Lost to Follow-up|1|||
127799611|NCT03529773|459889713|FG016|Overall Study|Lost to Follow-up|1|||
127799612|NCT03529773|459889714|FG017|Overall Study|Lost to Follow-up|0|||
127799613|NCT03529773|459889715|FG018|Overall Study|Lost to Follow-up|1|||
127799614|NCT03529773|459889716|FG019|Overall Study|Lost to Follow-up|1|||
127799615|NCT03529773|459889717|FG020|Overall Study|Lost to Follow-up|2|||
127799616|NCT03529773|459889718|FG021|Overall Study|Lost to Follow-up|4|||
127799617|NCT03529773|459889719|FG022|Overall Study|Lost to Follow-up|3|||
127799618|NCT03529773|459889720|FG023|Overall Study|Lost to Follow-up|4|||
127799619|NCT03529773|459889721|FG024|Overall Study|Lost to Follow-up|3|||
127799620|NCT03529773|459889722|FG025|Overall Study|Lost to Follow-up|5|||
127799621|NCT03529773|459889723|FG026|Overall Study|Lost to Follow-up|5|||
127799622|NCT03529773|459889724|FG027|Overall Study|Lost to Follow-up|0|||
127799623|NCT03529773|459889725|FG028|Overall Study|Lost to Follow-up|0|||
127799624|NCT03529773|459889726|FG029|Overall Study|Lost to Follow-up|0|||
127799625|NCT03529773|459889727|FG030|Overall Study|Lost to Follow-up|1|||
127799626|NCT03529773|459889728|FG031|Overall Study|Lost to Follow-up|0|||
127799627|NCT03529773|459889729|FG032|Overall Study|Lost to Follow-up|0|||
127799628|NCT03529773|459889730|FG033|Overall Study|Lost to Follow-up|1|||
127799629|NCT03529773|459889731|FG034|Overall Study|Lost to Follow-up|1|||
127799630|NCT03529773|459889732|FG035|Overall Study|Lost to Follow-up|0|||
127799631|NCT03529773|459889733|FG036|Overall Study|Lost to Follow-up|0|||
127799632|NCT03529773|459889734|FG037|Overall Study|Lost to Follow-up|3|||
127799633|NCT03529773|459889735|FG038|Overall Study|Lost to Follow-up|1|||
127799634|NCT03529773|459889736|FG039|Overall Study|Lost to Follow-up|1|||
127799635|NCT03529773|459889697|FG000|Overall Study|No longer meets eligibility criteria|0|||
127799636|NCT03529773|459889698|FG001|Overall Study|No longer meets eligibility criteria|0|||
127799637|NCT03529773|459889699|FG002|Overall Study|No longer meets eligibility criteria|0|||
127799638|NCT03529773|459889700|FG003|Overall Study|No longer meets eligibility criteria|0|||
127799639|NCT03529773|459889701|FG004|Overall Study|No longer meets eligibility criteria|0|||
127799640|NCT03529773|459889702|FG005|Overall Study|No longer meets eligibility criteria|0|||
127799641|NCT03529773|459889703|FG006|Overall Study|No longer meets eligibility criteria|0|||
127799642|NCT03529773|459889704|FG007|Overall Study|No longer meets eligibility criteria|0|||
127799643|NCT03529773|459889705|FG008|Overall Study|No longer meets eligibility criteria|0|||
127799644|NCT03529773|459889706|FG009|Overall Study|No longer meets eligibility criteria|0|||
127799645|NCT03529773|459889707|FG010|Overall Study|No longer meets eligibility criteria|0|||
127707866|NCT03174275|459559177|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
127707867|NCT03174275|459559177|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
127707868|NCT03174275|459559177|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
127707869|NCT03174275|459559177|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
127799646|NCT03529773|459889708|FG011|Overall Study|No longer meets eligibility criteria|0|||
127799647|NCT03529773|459889709|FG012|Overall Study|No longer meets eligibility criteria|0|||
127707870|NCT03174275|459559177|FG000|Adjuvant Chemotherapy|Progression|1|||
127799648|NCT03529773|459889710|FG013|Overall Study|No longer meets eligibility criteria|0|||
127799649|NCT03529773|459889711|FG014|Overall Study|No longer meets eligibility criteria|0|||
127799650|NCT03529773|459889712|FG015|Overall Study|No longer meets eligibility criteria|0|||
127799651|NCT03529773|459889713|FG016|Overall Study|No longer meets eligibility criteria|0|||
127799652|NCT03529773|459889714|FG017|Overall Study|No longer meets eligibility criteria|0|||
127799653|NCT03529773|459889715|FG018|Overall Study|No longer meets eligibility criteria|0|||
127799654|NCT03529773|459889716|FG019|Overall Study|No longer meets eligibility criteria|0|||
127799655|NCT03529773|459889717|FG020|Overall Study|No longer meets eligibility criteria|0|||
127707871|NCT03174275|459559177|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
127888026|NCT00528879|460213943|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
127888027|NCT00528879|460213944|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
127888028|NCT00528879|460213941|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
127707872|NCT03174275|459559177|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
127707873|NCT03174275|459559177|FG000|Adjuvant Durvalumab|Progression|1|||
127707874|NCT03174275|459559177|FG000|Adjuvant Durvalumab|Adverse Event|3|||
127707875|NCT03174275|459559177|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
127707876|NCT03174275|459559177|FG000|Adjuvant Radiotherapy|Progression|1|||
127707877|NCT03174275|459559177|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
127707878|NCT04456296|459559178|FG000|Overall Study|Withdrawal by Subject|14|||
127707879|NCT04456296|459559179|FG001|Overall Study|Withdrawal by Subject|21|||
127707880|NCT04456296|459559180|FG002|Overall Study|Withdrawal by Subject|21|||
127707881|NCT04456296|459559178|FG000|Overall Study|Adverse Event|2|||
127707882|NCT04456296|459559179|FG001|Overall Study|Adverse Event|2|||
127707883|NCT04456296|459559180|FG002|Overall Study|Adverse Event|2|||
127707884|NCT04456296|459559178|FG000|Overall Study|Death|1|||
127707885|NCT04456296|459559179|FG001|Overall Study|Death|0|||
127707886|NCT04456296|459559180|FG002|Overall Study|Death|0|||
127707887|NCT04456296|459559178|FG000|Overall Study|Lost to Follow-up|3|||
127707888|NCT04456296|459559179|FG001|Overall Study|Lost to Follow-up|5|||
127707889|NCT04456296|459559180|FG002|Overall Study|Lost to Follow-up|6|||
127707890|NCT04456296|459559178|FG000|Overall Study|Other than specified|0|||
127707891|NCT04456296|459559179|FG001|Overall Study|Other than specified|1|||
127707892|NCT04456296|459559180|FG002|Overall Study|Other than specified|4|||
127707893|NCT04456296|459559178|FG000|Overall Study|Randomized, not treated|2|||
127707894|NCT04456296|459559179|FG001|Overall Study|Randomized, not treated|1|||
127707895|NCT04456296|459559180|FG002|Overall Study|Randomized, not treated|0|||
127707896|NCT04247802|459559181|FG000|Overall Study|Withdrawal by Subject|1|||
127707897|NCT04247802|459559182|FG001|Overall Study|Withdrawal by Subject|3|||
127707898|NCT04247802|459559181|FG000|Overall Study|LTFU COVID lockdown restrictions|10|||
127707899|NCT04247802|459559182|FG001|Overall Study|LTFU COVID lockdown restrictions|7|||
127707900|NCT04271046|459559183|FG000|Overall Study|Death|0|||
127707901|NCT04271046|459559184|FG001|Overall Study|Death|2|||
127707902|NCT04271046|459559185|FG002|Overall Study|Death|0|||
127707903|NCT04271046|459559186|FG003|Overall Study|Death|2|||
127707904|NCT04271046|459559183|FG000|Overall Study|Lost to Follow-up|12|||
127707905|NCT04271046|459559184|FG001|Overall Study|Lost to Follow-up|12|||
127707906|NCT04271046|459559185|FG002|Overall Study|Lost to Follow-up|11|||
127707907|NCT04271046|459559186|FG003|Overall Study|Lost to Follow-up|11|||
127707908|NCT04271046|459559183|FG000|Overall Study|Patient with Dementia Died|2|||
127707909|NCT04271046|459559184|FG001|Overall Study|Patient with Dementia Died|0|||
127707910|NCT04271046|459559185|FG002|Overall Study|Patient with Dementia Died|2|||
127707911|NCT04271046|459559186|FG003|Overall Study|Patient with Dementia Died|0|||
127707912|NCT04271046|459559183|FG000|Overall Study|Patient with dementia were not administered surveys|0|||
127707913|NCT04271046|459559184|FG001|Overall Study|Patient with dementia were not administered surveys|18|||
127707914|NCT04271046|459559185|FG002|Overall Study|Patient with dementia were not administered surveys|0|||
127707915|NCT04271046|459559186|FG003|Overall Study|Patient with dementia were not administered surveys|22|||
127707916|NCT04826471|459561257|FG000|Overall Study|Lost to Follow-up|2|||
127707917|NCT04826471|459561257|FG000|Overall Study|Protocol Violation|3|||
127707918|NCT04826471|459561257|FG000|Overall Study|Withdrawal by Subject|1|||
127707919|NCT04414722|459561258|FG000|Overall Study|Lost to Follow-up|3|||
127707920|NCT04414722|459561259|FG001|Overall Study|Lost to Follow-up|4|||
127707921|NCT04414722|459561260|FG002|Overall Study|Lost to Follow-up|3|||
127707922|NCT04414722|459561261|FG003|Overall Study|Lost to Follow-up|2|||
127707923|NCT04414722|459561262|FG004|Overall Study|Lost to Follow-up|3|||
127707924|NCT04414722|459561258|FG000|Overall Study|Withdrawal by Subject|6|||
127707925|NCT04414722|459561259|FG001|Overall Study|Withdrawal by Subject|3|||
127707926|NCT04414722|459561260|FG002|Overall Study|Withdrawal by Subject|1|||
127707927|NCT04414722|459561261|FG003|Overall Study|Withdrawal by Subject|5|||
127707928|NCT04414722|459561262|FG004|Overall Study|Withdrawal by Subject|1|||
127707929|NCT04414722|459561258|FG000|Overall Study|Physician Decision|0|||
127707930|NCT04414722|459561259|FG001|Overall Study|Physician Decision|1|||
127707931|NCT04414722|459561260|FG002|Overall Study|Physician Decision|2|||
127707932|NCT04414722|459561261|FG003|Overall Study|Physician Decision|0|||
127707933|NCT04414722|459561262|FG004|Overall Study|Physician Decision|0|||
127707934|NCT04414722|459561258|FG000|Overall Study|Non-participatory|0|||
127707935|NCT04414722|459561259|FG001|Overall Study|Non-participatory|1|||
127707936|NCT04414722|459561260|FG002|Overall Study|Non-participatory|1|||
127707937|NCT04414722|459561261|FG003|Overall Study|Non-participatory|0|||
127707938|NCT04414722|459561262|FG004|Overall Study|Non-participatory|0|||
127707939|NCT05218096|459561264|FG000|Primary Evaluation|Withdrawal by Subject|0|||
127707940|NCT05218096|459561265|FG001|Primary Evaluation|Withdrawal by Subject|0|||
127707941|NCT05218096|459561266|FG002|Primary Evaluation|Withdrawal by Subject|2|||
127707942|NCT05218096|459561267|FG003|Primary Evaluation|Withdrawal by Subject|0|||
127707943|NCT05218096|459561268|FG004|Primary Evaluation|Withdrawal by Subject|0|||
127707944|NCT05218096|459561264|FG000|Primary Evaluation|Physician Decision|1|||
127707945|NCT05218096|459561265|FG001|Primary Evaluation|Physician Decision|0|||
127707946|NCT05218096|459561266|FG002|Primary Evaluation|Physician Decision|0|||
127707947|NCT05218096|459561267|FG003|Primary Evaluation|Physician Decision|0|||
127707948|NCT05218096|459561268|FG004|Primary Evaluation|Physician Decision|0|||
127707949|NCT05218096|459561264|FG000|Extended Treatment|Clinical Deterioration|1|||
127707950|NCT05218096|459561265|FG001|Extended Treatment|Clinical Deterioration|1|||
127707951|NCT05218096|459561266|FG002|Extended Treatment|Clinical Deterioration|0|||
127707952|NCT05218096|459561267|FG003|Extended Treatment|Clinical Deterioration|0|||
127707953|NCT05218096|459561268|FG004|Extended Treatment|Clinical Deterioration|0|||
127707954|NCT05218096|459561264|FG000|Extended Treatment|Study Terminated by Sponsor|6|||
127707955|NCT05218096|459561265|FG001|Extended Treatment|Study Terminated by Sponsor|3|||
127707956|NCT05218096|459561266|FG002|Extended Treatment|Study Terminated by Sponsor|0|||
127707957|NCT05218096|459561267|FG003|Extended Treatment|Study Terminated by Sponsor|3|||
127707958|NCT05218096|459561268|FG004|Extended Treatment|Study Terminated by Sponsor|2|||
127707959|NCT05218096|459561264|FG000|Extended Treatment|Withdrawal by Subject|1|||
127707960|NCT05218096|459561265|FG001|Extended Treatment|Withdrawal by Subject|3|||
127707961|NCT05218096|459561266|FG002|Extended Treatment|Withdrawal by Subject|0|||
127707962|NCT05218096|459561267|FG003|Extended Treatment|Withdrawal by Subject|2|||
127707963|NCT05218096|459561268|FG004|Extended Treatment|Withdrawal by Subject|2|||
127707964|NCT05218096|459561264|FG000|Extended Treatment|Lack of Efficacy|3|||
127707965|NCT05218096|459561265|FG001|Extended Treatment|Lack of Efficacy|0|||
127707966|NCT05218096|459561266|FG002|Extended Treatment|Lack of Efficacy|0|||
127707967|NCT05218096|459561267|FG003|Extended Treatment|Lack of Efficacy|0|||
127707968|NCT05218096|459561268|FG004|Extended Treatment|Lack of Efficacy|0|||
127707969|NCT05218096|459561264|FG000|Extended Treatment|Physician Decision|0|||
127707970|NCT05218096|459561265|FG001|Extended Treatment|Physician Decision|1|||
127707971|NCT05218096|459561266|FG002|Extended Treatment|Physician Decision|0|||
127707972|NCT05218096|459561267|FG003|Extended Treatment|Physician Decision|0|||
127707973|NCT05218096|459561268|FG004|Extended Treatment|Physician Decision|0|||
127707974|NCT05218096|459561264|FG000|Open-label Extension|Adverse Event|1|||
127799656|NCT03529773|459889718|FG021|Overall Study|No longer meets eligibility criteria|0|||
127799657|NCT03529773|459889719|FG022|Overall Study|No longer meets eligibility criteria|1|||
127799658|NCT03529773|459889720|FG023|Overall Study|No longer meets eligibility criteria|0|||
127799659|NCT03529773|459889721|FG024|Overall Study|No longer meets eligibility criteria|0|||
127799660|NCT03529773|459889722|FG025|Overall Study|No longer meets eligibility criteria|0|||
127799661|NCT03529773|459889723|FG026|Overall Study|No longer meets eligibility criteria|0|||
127799662|NCT03529773|459889724|FG027|Overall Study|No longer meets eligibility criteria|0|||
127799663|NCT03529773|459889725|FG028|Overall Study|No longer meets eligibility criteria|0|||
127799664|NCT03529773|459889726|FG029|Overall Study|No longer meets eligibility criteria|0|||
127799665|NCT03529773|459889727|FG030|Overall Study|No longer meets eligibility criteria|0|||
127799666|NCT03529773|459889728|FG031|Overall Study|No longer meets eligibility criteria|0|||
127799667|NCT03529773|459889729|FG032|Overall Study|No longer meets eligibility criteria|0|||
127799668|NCT03529773|459889730|FG033|Overall Study|No longer meets eligibility criteria|0|||
127799669|NCT03529773|459889731|FG034|Overall Study|No longer meets eligibility criteria|0|||
127799670|NCT03529773|459889732|FG035|Overall Study|No longer meets eligibility criteria|0|||
127799671|NCT03529773|459889733|FG036|Overall Study|No longer meets eligibility criteria|0|||
127799672|NCT03529773|459889734|FG037|Overall Study|No longer meets eligibility criteria|0|||
127799673|NCT03529773|459889735|FG038|Overall Study|No longer meets eligibility criteria|1|||
127799674|NCT03529773|459889736|FG039|Overall Study|No longer meets eligibility criteria|0|||
127799675|NCT03529773|459889697|FG000|Overall Study|Other|0|||
127799676|NCT03529773|459889698|FG001|Overall Study|Other|0|||
127799677|NCT03529773|459889699|FG002|Overall Study|Other|0|||
127799678|NCT03529773|459889700|FG003|Overall Study|Other|0|||
127799679|NCT03529773|459889701|FG004|Overall Study|Other|0|||
127799680|NCT03529773|459889702|FG005|Overall Study|Other|0|||
127799681|NCT03529773|459889703|FG006|Overall Study|Other|0|||
127799682|NCT03529773|459889704|FG007|Overall Study|Other|0|||
127799683|NCT03529773|459889705|FG008|Overall Study|Other|0|||
127799684|NCT03529773|459889706|FG009|Overall Study|Other|0|||
127799685|NCT03529773|459889707|FG010|Overall Study|Other|0|||
127799686|NCT03529773|459889708|FG011|Overall Study|Other|0|||
127799687|NCT03529773|459889709|FG012|Overall Study|Other|1|||
127799688|NCT03529773|459889710|FG013|Overall Study|Other|0|||
127799689|NCT03529773|459889711|FG014|Overall Study|Other|2|||
127799690|NCT03529773|459889712|FG015|Overall Study|Other|0|||
127976279|NCT00325156|460533170|FG000|Overall Study|Adverse event, non-fatal|3|||
127799691|NCT03529773|459889713|FG016|Overall Study|Other|0|||
127799692|NCT03529773|459889714|FG017|Overall Study|Other|3|||
127799693|NCT03529773|459889715|FG018|Overall Study|Other|0|||
127707975|NCT05218096|459561265|FG001|Open-label Extension|Adverse Event|0|||
127707976|NCT05218096|459561266|FG002|Open-label Extension|Adverse Event|0|||
127707977|NCT05218096|459561267|FG003|Open-label Extension|Adverse Event|0|||
127707978|NCT05218096|459561268|FG004|Open-label Extension|Adverse Event|1|||
127707979|NCT05218096|459561264|FG000|Open-label Extension|Pregnancy|0|||
127707980|NCT05218096|459561265|FG001|Open-label Extension|Pregnancy|0|||
127707981|NCT05218096|459561266|FG002|Open-label Extension|Pregnancy|0|||
127707982|NCT05218096|459561267|FG003|Open-label Extension|Pregnancy|0|||
127707983|NCT05218096|459561268|FG004|Open-label Extension|Pregnancy|1|||
127707984|NCT05218096|459561264|FG000|Open-label Extension|Lack of Efficacy|1|||
127707985|NCT05218096|459561265|FG001|Open-label Extension|Lack of Efficacy|2|||
127707986|NCT05218096|459561266|FG002|Open-label Extension|Lack of Efficacy|0|||
127707987|NCT05218096|459561267|FG003|Open-label Extension|Lack of Efficacy|0|||
127707988|NCT05218096|459561268|FG004|Open-label Extension|Lack of Efficacy|0|||
127707989|NCT05218096|459561264|FG000|Open-label Extension|Lost to Follow-up|1|||
127707990|NCT05218096|459561265|FG001|Open-label Extension|Lost to Follow-up|0|||
127707991|NCT05218096|459561266|FG002|Open-label Extension|Lost to Follow-up|0|||
127707992|NCT05218096|459561267|FG003|Open-label Extension|Lost to Follow-up|0|||
127707993|NCT05218096|459561268|FG004|Open-label Extension|Lost to Follow-up|0|||
127707994|NCT05218096|459561264|FG000|Open-label Extension|Death|0|||
127707995|NCT05218096|459561265|FG001|Open-label Extension|Death|0|||
127707996|NCT05218096|459561266|FG002|Open-label Extension|Death|0|||
127707997|NCT05218096|459561267|FG003|Open-label Extension|Death|1|||
127707998|NCT05218096|459561268|FG004|Open-label Extension|Death|0|||
127707999|NCT05218096|459561264|FG000|Open-label Extension|Study Terminated by Sponsor|13|||
127708000|NCT05218096|459561265|FG001|Open-label Extension|Study Terminated by Sponsor|4|||
127708001|NCT05218096|459561266|FG002|Open-label Extension|Study Terminated by Sponsor|0|||
127708002|NCT05218096|459561267|FG003|Open-label Extension|Study Terminated by Sponsor|7|||
127708003|NCT05218096|459561268|FG004|Open-label Extension|Study Terminated by Sponsor|7|||
127708004|NCT04304144|459561274|FG000|DLT Observation Period|Physician Decision|0|||
127708005|NCT04304144|459561275|FG001|DLT Observation Period|Physician Decision|1|||
127708006|NCT04304144|459561276|FG002|DLT Observation Period|Physician Decision|0|||
127708007|NCT04304144|459561277|FG003|DLT Observation Period|Physician Decision|0|||
127708008|NCT04304144|459561274|FG000|Continued Treatment Period|Adverse Event|0|||
127708009|NCT04304144|459561275|FG001|Continued Treatment Period|Adverse Event|1|||
127708010|NCT04304144|459561276|FG002|Continued Treatment Period|Adverse Event|0|||
127708011|NCT04304144|459561277|FG003|Continued Treatment Period|Adverse Event|0|||
127708012|NCT04304144|459561274|FG000|Continued Treatment Period|Death|0|||
127708013|NCT04304144|459561275|FG001|Continued Treatment Period|Death|0|||
127708014|NCT04304144|459561276|FG002|Continued Treatment Period|Death|1|||
127708015|NCT04304144|459561277|FG003|Continued Treatment Period|Death|2|||
127708016|NCT04304144|459561274|FG000|Continued Treatment Period|Withdrawal by Subject|1|||
127708017|NCT04304144|459561275|FG001|Continued Treatment Period|Withdrawal by Subject|0|||
127708018|NCT04304144|459561276|FG002|Continued Treatment Period|Withdrawal by Subject|0|||
127708019|NCT04304144|459561277|FG003|Continued Treatment Period|Withdrawal by Subject|3|||
127708020|NCT04304144|459561274|FG000|Continued Treatment Period|Other than specified|2|||
127708021|NCT04304144|459561275|FG001|Continued Treatment Period|Other than specified|0|||
127708022|NCT04304144|459561276|FG002|Continued Treatment Period|Other than specified|1|||
127708023|NCT04304144|459561277|FG003|Continued Treatment Period|Other than specified|1|||
127708024|NCT05618587|459561278|FG000|Overall Study|Lost to Follow-up|2|||
127708025|NCT05618587|459561279|FG001|Overall Study|Lost to Follow-up|0|||
127708026|NCT04862416|459561286|FG000|Overall Study|Withdrawal by Subject|0|||
127708027|NCT04862416|459561287|FG001|Overall Study|Withdrawal by Subject|1|||
127708028|NCT04862416|459561288|FG002|Overall Study|Withdrawal by Subject|0|||
127708029|NCT04862416|459561289|FG003|Overall Study|Withdrawal by Subject|1|||
127708030|NCT04862416|459561290|FG004|Overall Study|Withdrawal by Subject|0|||
127708031|NCT04862416|459561291|FG005|Overall Study|Withdrawal by Subject|0|||
127799694|NCT03529773|459889716|FG019|Overall Study|Other|0|||
127799695|NCT03529773|459889717|FG020|Overall Study|Other|1|||
127799696|NCT03529773|459889718|FG021|Overall Study|Other|0|||
127799697|NCT03529773|459889719|FG022|Overall Study|Other|1|||
127799698|NCT03529773|459889720|FG023|Overall Study|Other|0|||
127799699|NCT03529773|459889721|FG024|Overall Study|Other|3|||
127799700|NCT03529773|459889722|FG025|Overall Study|Other|2|||
127708032|NCT04862416|459561292|FG006|Overall Study|Withdrawal by Subject|0|||
127708033|NCT04862416|459561293|FG007|Overall Study|Withdrawal by Subject|0|||
127888029|NCT00528879|460213942|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
127708034|NCT03442309|459561294|FG000|Overall Study|Lost to Follow-up|1676|||
127708035|NCT03442309|459561295|FG001|Overall Study|Lost to Follow-up|1642|||
127708036|NCT03852550|459561296|FG000|Overall Study|Lost to Follow-up|4|||
127708037|NCT03852550|459561297|FG001|Overall Study|Lost to Follow-up|3|||
127708038|NCT03852550|459561296|FG000|Overall Study|Only parent outcomes completed|0|||
127708039|NCT03852550|459561297|FG001|Overall Study|Only parent outcomes completed|1|||
127708040|NCT03852550|459561296|FG000|Overall Study|Withdrawal by Subject|1|||
127708041|NCT03852550|459561297|FG001|Overall Study|Withdrawal by Subject|0|||
127708042|NCT05204654|459561298|FG000|Overall Study|Study terminated due to time restraint|2|||
127799701|NCT03529773|459889723|FG026|Overall Study|Other|2|||
127799702|NCT03529773|459889724|FG027|Overall Study|Other|0|||
127708043|NCT05204654|459561299|FG001|Overall Study|Study terminated due to time restraint|2|||
127799703|NCT03529773|459889725|FG028|Overall Study|Other|0|||
127799704|NCT03529773|459889726|FG029|Overall Study|Other|0|||
127799705|NCT03529773|459889727|FG030|Overall Study|Other|0|||
127799706|NCT03529773|459889728|FG031|Overall Study|Other|0|||
127799707|NCT03529773|459889729|FG032|Overall Study|Other|0|||
127799708|NCT03529773|459889730|FG033|Overall Study|Other|0|||
127799709|NCT03529773|459889731|FG034|Overall Study|Other|1|||
127799710|NCT03529773|459889732|FG035|Overall Study|Other|1|||
127799711|NCT03529773|459889733|FG036|Overall Study|Other|0|||
127799712|NCT03529773|459889734|FG037|Overall Study|Other|0|||
127799713|NCT03529773|459889735|FG038|Overall Study|Other|0|||
127799714|NCT03529773|459889736|FG039|Overall Study|Other|0|||
127799715|NCT03529773|459889697|FG000|Overall Study|Physician Decision|0|||
127799716|NCT03529773|459889698|FG001|Overall Study|Physician Decision|0|||
127799717|NCT03529773|459889699|FG002|Overall Study|Physician Decision|0|||
127799718|NCT03529773|459889700|FG003|Overall Study|Physician Decision|0|||
127799719|NCT03529773|459889701|FG004|Overall Study|Physician Decision|0|||
127799720|NCT03529773|459889702|FG005|Overall Study|Physician Decision|0|||
127799721|NCT03529773|459889703|FG006|Overall Study|Physician Decision|0|||
127799722|NCT03529773|459889704|FG007|Overall Study|Physician Decision|0|||
127799723|NCT03529773|459889705|FG008|Overall Study|Physician Decision|0|||
127799724|NCT03529773|459889706|FG009|Overall Study|Physician Decision|0|||
127888030|NCT00528879|460213943|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
127888031|NCT00528879|460213944|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
127645662|NCT01169675|459321085|FG003|Overall Study|Adverse Event|0|||
127645663|NCT01169675|459321086|FG004|Overall Study|Adverse Event|0|||
127645664|NCT01169675|459321082|FG000|Overall Study|Withdrawal by Subject|1|||
127645665|NCT01169675|459321083|FG001|Overall Study|Withdrawal by Subject|0|||
127645666|NCT01169675|459321084|FG002|Overall Study|Withdrawal by Subject|0|||
127645667|NCT01169675|459321085|FG003|Overall Study|Withdrawal by Subject|1|||
127645668|NCT01169675|459321086|FG004|Overall Study|Withdrawal by Subject|2|||
127645669|NCT01169675|459321082|FG000|Overall Study|Other Reason Not Defined Above|0|||
127645670|NCT01169675|459321083|FG001|Overall Study|Other Reason Not Defined Above|0|||
127645671|NCT01169675|459321084|FG002|Overall Study|Other Reason Not Defined Above|0|||
127645672|NCT01169675|459321085|FG003|Overall Study|Other Reason Not Defined Above|1|||
127645673|NCT01169675|459321086|FG004|Overall Study|Other Reason Not Defined Above|1|||
127645674|NCT00803452|459321087|FG000|Overall Study|Adverse Event|0|||
127645675|NCT00803452|459321088|FG001|Overall Study|Adverse Event|2|||
127645676|NCT00803452|459321087|FG000|Overall Study|Lost to Follow-up|0|||
127645677|NCT00803452|459321088|FG001|Overall Study|Lost to Follow-up|3|||
127645678|NCT04839965|459321089|FG000|Overall Study|Death|6|||
127645679|NCT04839965|459321090|FG001|Overall Study|Death|6|||
127645680|NCT04839965|459321089|FG000|Overall Study|Lost to Follow-up|1|||
127645681|NCT04839965|459321090|FG001|Overall Study|Lost to Follow-up|0|||
127645682|NCT02816138|459321091|FG000|Overall Study|Adverse Event|1|||
127645683|NCT02365519|459321092|FG000|Randomized and Treated|Adverse Event|0|||
127645684|NCT02365519|459321093|FG001|Randomized and Treated|Adverse Event|1|||
127645685|NCT02365519|459321094|FG002|Randomized and Treated|Adverse Event|0|||
127645686|NCT02365519|459321092|FG000|Randomized and Treated|Withdrawal by Subject|0|||
127645687|NCT02365519|459321093|FG001|Randomized and Treated|Withdrawal by Subject|1|||
127645688|NCT02365519|459321094|FG002|Randomized and Treated|Withdrawal by Subject|1|||
127645689|NCT02291679|459321095|FG000|Overall Study|Adverse Event|2|||
127645690|NCT02291679|459321096|FG001|Overall Study|Adverse Event|12|||
127645691|NCT02291679|459321097|FG002|Overall Study|Adverse Event|19|||
127645692|NCT02291679|459321095|FG000|Overall Study|Protocol Violation|5|||
127645693|NCT02291679|459321096|FG001|Overall Study|Protocol Violation|1|||
127645694|NCT02291679|459321097|FG002|Overall Study|Protocol Violation|7|||
127645695|NCT02291679|459321095|FG000|Overall Study|Withdrew Consent|18|||
127645696|NCT02291679|459321096|FG001|Overall Study|Withdrew Consent|10|||
127645697|NCT02291679|459321097|FG002|Overall Study|Withdrew Consent|15|||
127645698|NCT02291679|459321095|FG000|Overall Study|Lost to Follow-up|12|||
127645699|NCT02291679|459321096|FG001|Overall Study|Lost to Follow-up|10|||
127645700|NCT02291679|459321097|FG002|Overall Study|Lost to Follow-up|9|||
127645701|NCT02291679|459321095|FG000|Overall Study|Insufficient Therapeutic Response|5|||
127645702|NCT02291679|459321096|FG001|Overall Study|Insufficient Therapeutic Response|5|||
127645703|NCT02291679|459321097|FG002|Overall Study|Insufficient Therapeutic Response|7|||
127645704|NCT02291679|459321095|FG000|Overall Study|Other|2|||
127645705|NCT02291679|459321096|FG001|Overall Study|Other|4|||
127799725|NCT03529773|459889707|FG010|Overall Study|Physician Decision|0|||
127799726|NCT03529773|459889708|FG011|Overall Study|Physician Decision|0|||
127799727|NCT03529773|459889709|FG012|Overall Study|Physician Decision|0|||
127799728|NCT03529773|459889710|FG013|Overall Study|Physician Decision|0|||
127799729|NCT03529773|459889711|FG014|Overall Study|Physician Decision|0|||
127799730|NCT03529773|459889712|FG015|Overall Study|Physician Decision|0|||
127799731|NCT03529773|459889713|FG016|Overall Study|Physician Decision|0|||
127799732|NCT03529773|459889714|FG017|Overall Study|Physician Decision|0|||
127799733|NCT03529773|459889715|FG018|Overall Study|Physician Decision|0|||
127799734|NCT03529773|459889716|FG019|Overall Study|Physician Decision|1|||
127799735|NCT03529773|459889717|FG020|Overall Study|Physician Decision|1|||
127799736|NCT03529773|459889718|FG021|Overall Study|Physician Decision|0|||
127799737|NCT03529773|459889719|FG022|Overall Study|Physician Decision|0|||
127799738|NCT03529773|459889720|FG023|Overall Study|Physician Decision|0|||
127799739|NCT03529773|459889721|FG024|Overall Study|Physician Decision|0|||
127799740|NCT03529773|459889722|FG025|Overall Study|Physician Decision|0|||
127799741|NCT03529773|459889723|FG026|Overall Study|Physician Decision|0|||
127799742|NCT03529773|459889724|FG027|Overall Study|Physician Decision|0|||
127799743|NCT03529773|459889725|FG028|Overall Study|Physician Decision|0|||
127799744|NCT03529773|459889726|FG029|Overall Study|Physician Decision|0|||
127799745|NCT03529773|459889727|FG030|Overall Study|Physician Decision|0|||
127799746|NCT03529773|459889728|FG031|Overall Study|Physician Decision|0|||
127799747|NCT03529773|459889729|FG032|Overall Study|Physician Decision|0|||
127799748|NCT03529773|459889730|FG033|Overall Study|Physician Decision|0|||
127799749|NCT03529773|459889731|FG034|Overall Study|Physician Decision|0|||
127799750|NCT03529773|459889732|FG035|Overall Study|Physician Decision|0|||
127799751|NCT03529773|459889733|FG036|Overall Study|Physician Decision|0|||
127799752|NCT03529773|459889734|FG037|Overall Study|Physician Decision|0|||
127799753|NCT03529773|459889735|FG038|Overall Study|Physician Decision|0|||
127799754|NCT03529773|459889736|FG039|Overall Study|Physician Decision|0|||
127799755|NCT03529773|459889697|FG000|Overall Study|Protocol Violation|0|||
127799756|NCT03529773|459889698|FG001|Overall Study|Protocol Violation|0|||
127799757|NCT03529773|459889699|FG002|Overall Study|Protocol Violation|0|||
127799758|NCT03529773|459889700|FG003|Overall Study|Protocol Violation|0|||
127799759|NCT03529773|459889701|FG004|Overall Study|Protocol Violation|0|||
127799760|NCT03529773|459889702|FG005|Overall Study|Protocol Violation|0|||
127799761|NCT03529773|459889703|FG006|Overall Study|Protocol Violation|0|||
127799762|NCT03529773|459889704|FG007|Overall Study|Protocol Violation|0|||
127799763|NCT03529773|459889705|FG008|Overall Study|Protocol Violation|0|||
127799764|NCT03529773|459889706|FG009|Overall Study|Protocol Violation|0|||
127799765|NCT03529773|459889707|FG010|Overall Study|Protocol Violation|0|||
127799766|NCT03529773|459889708|FG011|Overall Study|Protocol Violation|0|||
127799767|NCT03529773|459889709|FG012|Overall Study|Protocol Violation|0|||
127799768|NCT03529773|459889710|FG013|Overall Study|Protocol Violation|0|||
127799769|NCT03529773|459889711|FG014|Overall Study|Protocol Violation|0|||
127799770|NCT03529773|459889712|FG015|Overall Study|Protocol Violation|0|||
127799771|NCT03529773|459889713|FG016|Overall Study|Protocol Violation|0|||
127799772|NCT03529773|459889714|FG017|Overall Study|Protocol Violation|0|||
127799773|NCT03529773|459889715|FG018|Overall Study|Protocol Violation|0|||
127799774|NCT03529773|459889716|FG019|Overall Study|Protocol Violation|0|||
127799775|NCT03529773|459889717|FG020|Overall Study|Protocol Violation|0|||
127799776|NCT03529773|459889718|FG021|Overall Study|Protocol Violation|0|||
127799777|NCT03529773|459889719|FG022|Overall Study|Protocol Violation|0|||
127799778|NCT03529773|459889720|FG023|Overall Study|Protocol Violation|0|||
127799779|NCT03529773|459889721|FG024|Overall Study|Protocol Violation|0|||
127799780|NCT03529773|459889722|FG025|Overall Study|Protocol Violation|0|||
127799781|NCT03529773|459889723|FG026|Overall Study|Protocol Violation|0|||
127799782|NCT03529773|459889724|FG027|Overall Study|Protocol Violation|0|||
127799783|NCT03529773|459889725|FG028|Overall Study|Protocol Violation|0|||
127799784|NCT03529773|459889726|FG029|Overall Study|Protocol Violation|0|||
127799785|NCT03529773|459889727|FG030|Overall Study|Protocol Violation|1|||
127799786|NCT03529773|459889728|FG031|Overall Study|Protocol Violation|0|||
127799787|NCT03529773|459889729|FG032|Overall Study|Protocol Violation|0|||
127799788|NCT03529773|459889730|FG033|Overall Study|Protocol Violation|0|||
127799789|NCT03529773|459889731|FG034|Overall Study|Protocol Violation|0|||
127799790|NCT03529773|459889732|FG035|Overall Study|Protocol Violation|0|||
127799791|NCT03529773|459889733|FG036|Overall Study|Protocol Violation|0|||
127799792|NCT03529773|459889734|FG037|Overall Study|Protocol Violation|0|||
127799793|NCT03529773|459889735|FG038|Overall Study|Protocol Violation|0|||
127799794|NCT03529773|459889736|FG039|Overall Study|Protocol Violation|0|||
127799795|NCT03529773|459889697|FG000|Overall Study|Withdrawal by Subject|0|||
127799796|NCT03529773|459889698|FG001|Overall Study|Withdrawal by Subject|0|||
127799797|NCT03529773|459889699|FG002|Overall Study|Withdrawal by Subject|0|||
127799798|NCT03529773|459889700|FG003|Overall Study|Withdrawal by Subject|0|||
127799799|NCT03529773|459889701|FG004|Overall Study|Withdrawal by Subject|0|||
127799800|NCT03529773|459889702|FG005|Overall Study|Withdrawal by Subject|0|||
127799801|NCT03529773|459889703|FG006|Overall Study|Withdrawal by Subject|0|||
127799802|NCT03529773|459889704|FG007|Overall Study|Withdrawal by Subject|1|||
127799803|NCT03529773|459889705|FG008|Overall Study|Withdrawal by Subject|0|||
127799804|NCT03529773|459889706|FG009|Overall Study|Withdrawal by Subject|1|||
127799805|NCT03529773|459889707|FG010|Overall Study|Withdrawal by Subject|1|||
127799806|NCT03529773|459889708|FG011|Overall Study|Withdrawal by Subject|0|||
127799807|NCT03529773|459889709|FG012|Overall Study|Withdrawal by Subject|0|||
127799808|NCT03529773|459889710|FG013|Overall Study|Withdrawal by Subject|0|||
127799809|NCT03529773|459889711|FG014|Overall Study|Withdrawal by Subject|0|||
127799810|NCT03529773|459889712|FG015|Overall Study|Withdrawal by Subject|3|||
127708044|NCT02446236|459561300|FG000|Overall Study|Screen Failure|1|||
127708045|NCT02446236|459561301|FG001|Overall Study|Screen Failure|0|||
127708046|NCT02446236|459561302|FG002|Overall Study|Screen Failure|1|||
127708047|NCT02446236|459561300|FG000|Overall Study|Actively Receiving Therapy|0|||
127708048|NCT02446236|459561301|FG001|Overall Study|Actively Receiving Therapy|0|||
127708049|NCT02446236|459561302|FG002|Overall Study|Actively Receiving Therapy|1|||
127708050|NCT04862234|459561303|FG000|Overall Study|Surgery cancellation|1|||
127708051|NCT04862234|459561304|FG001|Overall Study|Surgery cancellation|2|||
127708052|NCT04862234|459561303|FG000|Overall Study|Early discharge (<48 hours) - no CGM data collected|0|||
127708053|NCT04862234|459561304|FG001|Overall Study|Early discharge (<48 hours) - no CGM data collected|1|||
127708054|NCT04862234|459561303|FG000|Overall Study|Early discharge (<48 hours) - CGM data collected|0|||
127708055|NCT04862234|459561304|FG001|Overall Study|Early discharge (<48 hours) - CGM data collected|1|||
127708056|NCT03292484|459561305|FG000|Overall Study|Participants did not have Disposition - Study Exit forms|415|||
127708057|NCT03292484|459561305|FG000|Overall Study|Withdrew consent (unrelated to adverse event [AE])|86|||
127708058|NCT03292484|459561305|FG000|Overall Study|Protocol Violation|2|||
127708059|NCT03292484|459561305|FG000|Overall Study|Investigator decision (unrelated to AE)|13|||
127708060|NCT03292484|459561305|FG000|Overall Study|Sponsor decision|349|||
127708061|NCT03292484|459561305|FG000|Overall Study|Lost to Follow-up|7|||
127708062|NCT03292484|459561305|FG000|Overall Study|Coronavirus Disease 2019|1|||
127708063|NCT03292484|459561305|FG000|Overall Study|Other|20|||
127708064|NCT05290493|459561306|FG000|Overall Study|Withdrawal by Subject|2|||
127708065|NCT05290493|459561307|FG001|Overall Study|Withdrawal by Subject|2|||
127708066|NCT05290493|459561306|FG000|Overall Study|Adverse Event|1|||
127708067|NCT05290493|459561307|FG001|Overall Study|Adverse Event|0|||
127708068|NCT04615273|459561313|FG000|Overall Study|Withdrawal by Subject|3|||
127708069|NCT04615273|459561314|FG001|Overall Study|Withdrawal by Subject|1|||
127708070|NCT04615273|459561315|FG002|Overall Study|Withdrawal by Subject|2|||
127708071|NCT04615273|459561313|FG000|Overall Study|Adverse Event|1|||
127708072|NCT04615273|459561314|FG001|Overall Study|Adverse Event|0|||
127708073|NCT04615273|459561315|FG002|Overall Study|Adverse Event|1|||
127708074|NCT04615273|459561313|FG000|Overall Study|Lost to Follow-up|0|||
127708075|NCT04615273|459561314|FG001|Overall Study|Lost to Follow-up|1|||
127708076|NCT04615273|459561315|FG002|Overall Study|Lost to Follow-up|0|||
127708077|NCT04615273|459561313|FG000|Overall Study|Physician Decision|0|||
127708078|NCT04615273|459561314|FG001|Overall Study|Physician Decision|0|||
127708079|NCT04615273|459561315|FG002|Overall Study|Physician Decision|1|||
127708080|NCT04615273|459561313|FG000|Overall Study|Other|0|||
127708081|NCT04615273|459561314|FG001|Overall Study|Other|1|||
127708082|NCT04615273|459561315|FG002|Overall Study|Other|0|||
127708083|NCT04615273|459561313|FG000|Overall Study|Randomized but not treated|1|||
127708084|NCT04615273|459561314|FG001|Overall Study|Randomized but not treated|3|||
127708085|NCT04615273|459561315|FG002|Overall Study|Randomized but not treated|1|||
127708086|NCT03677141|459561316|FG000|Overall Study|Death|2|||
127708087|NCT03677141|459561317|FG001|Overall Study|Death|1|||
127708088|NCT03677141|459561318|FG002|Overall Study|Death|6|||
127708089|NCT03677141|459561319|FG003|Overall Study|Death|9|||
127708090|NCT03677141|459561320|FG004|Overall Study|Death|5|||
127708091|NCT03677141|459561321|FG005|Overall Study|Death|3|||
127708092|NCT03677141|459561316|FG000|Overall Study|Lost to Follow-up|0|||
127708093|NCT03677141|459561317|FG001|Overall Study|Lost to Follow-up|0|||
127708094|NCT03677141|459561318|FG002|Overall Study|Lost to Follow-up|0|||
127708095|NCT03677141|459561319|FG003|Overall Study|Lost to Follow-up|2|||
127708096|NCT03677141|459561320|FG004|Overall Study|Lost to Follow-up|0|||
127708097|NCT03677141|459561321|FG005|Overall Study|Lost to Follow-up|0|||
127708098|NCT03677141|459561316|FG000|Overall Study|Screen failure or enrolled in error|0|||
127708099|NCT03677141|459561317|FG001|Overall Study|Screen failure or enrolled in error|0|||
127708100|NCT03677141|459561318|FG002|Overall Study|Screen failure or enrolled in error|0|||
127708101|NCT03677141|459561319|FG003|Overall Study|Screen failure or enrolled in error|0|||
127708102|NCT03677141|459561320|FG004|Overall Study|Screen failure or enrolled in error|2|||
127708103|NCT03677141|459561321|FG005|Overall Study|Screen failure or enrolled in error|0|||
127708104|NCT03677141|459561316|FG000|Overall Study|Physician Decision|0|||
127708105|NCT03677141|459561317|FG001|Overall Study|Physician Decision|0|||
127708106|NCT03677141|459561318|FG002|Overall Study|Physician Decision|0|||
127708107|NCT03677141|459561319|FG003|Overall Study|Physician Decision|0|||
127708108|NCT03677141|459561320|FG004|Overall Study|Physician Decision|1|||
127799811|NCT03529773|459889713|FG016|Overall Study|Withdrawal by Subject|0|||
127799812|NCT03529773|459889714|FG017|Overall Study|Withdrawal by Subject|2|||
127708109|NCT03677141|459561321|FG005|Overall Study|Physician Decision|0|||
127799813|NCT03529773|459889715|FG018|Overall Study|Withdrawal by Subject|3|||
127799814|NCT03529773|459889716|FG019|Overall Study|Withdrawal by Subject|1|||
127708110|NCT03677141|459561316|FG000|Overall Study|Withdrawal by Subject|0|||
127708111|NCT03677141|459561317|FG001|Overall Study|Withdrawal by Subject|0|||
127708112|NCT03677141|459561318|FG002|Overall Study|Withdrawal by Subject|1|||
127708113|NCT03677141|459561319|FG003|Overall Study|Withdrawal by Subject|1|||
127708114|NCT03677141|459561320|FG004|Overall Study|Withdrawal by Subject|1|||
127708115|NCT03677141|459561321|FG005|Overall Study|Withdrawal by Subject|0|||
127708116|NCT05838027|459561327|FG000|Overall Study|Lost to Follow-up|5|||
127799815|NCT03529773|459889717|FG020|Overall Study|Withdrawal by Subject|3|||
127799816|NCT03529773|459889718|FG021|Overall Study|Withdrawal by Subject|1|||
127799817|NCT03529773|459889719|FG022|Overall Study|Withdrawal by Subject|1|||
127799818|NCT03529773|459889720|FG023|Overall Study|Withdrawal by Subject|2|||
127799819|NCT03529773|459889721|FG024|Overall Study|Withdrawal by Subject|2|||
127799820|NCT03529773|459889722|FG025|Overall Study|Withdrawal by Subject|4|||
127799821|NCT03529773|459889723|FG026|Overall Study|Withdrawal by Subject|2|||
127799822|NCT03529773|459889724|FG027|Overall Study|Withdrawal by Subject|1|||
127799823|NCT03529773|459889725|FG028|Overall Study|Withdrawal by Subject|1|||
127799824|NCT03529773|459889726|FG029|Overall Study|Withdrawal by Subject|0|||
127799825|NCT03529773|459889727|FG030|Overall Study|Withdrawal by Subject|0|||
127799826|NCT03529773|459889728|FG031|Overall Study|Withdrawal by Subject|0|||
127799827|NCT03529773|459889729|FG032|Overall Study|Withdrawal by Subject|0|||
127799828|NCT03529773|459889730|FG033|Overall Study|Withdrawal by Subject|0|||
127799829|NCT03529773|459889731|FG034|Overall Study|Withdrawal by Subject|1|||
127799830|NCT03529773|459889732|FG035|Overall Study|Withdrawal by Subject|2|||
127799831|NCT03529773|459889733|FG036|Overall Study|Withdrawal by Subject|0|||
127799832|NCT03529773|459889734|FG037|Overall Study|Withdrawal by Subject|2|||
127799833|NCT03529773|459889735|FG038|Overall Study|Withdrawal by Subject|1|||
127799834|NCT03529773|459889736|FG039|Overall Study|Withdrawal by Subject|1|||
127799835|NCT03529773|459889697|FG000|Overall Study|Screen Failure|0|||
127799836|NCT03529773|459889698|FG001|Overall Study|Screen Failure|0|||
127799837|NCT03529773|459889699|FG002|Overall Study|Screen Failure|0|||
127799838|NCT03529773|459889700|FG003|Overall Study|Screen Failure|0|||
127799839|NCT03529773|459889701|FG004|Overall Study|Screen Failure|0|||
127799840|NCT03529773|459889702|FG005|Overall Study|Screen Failure|0|||
127799841|NCT03529773|459889703|FG006|Overall Study|Screen Failure|0|||
127799842|NCT03529773|459889704|FG007|Overall Study|Screen Failure|0|||
127799843|NCT03529773|459889705|FG008|Overall Study|Screen Failure|0|||
127799844|NCT03529773|459889706|FG009|Overall Study|Screen Failure|0|||
127799845|NCT03529773|459889707|FG010|Overall Study|Screen Failure|0|||
127799846|NCT03529773|459889708|FG011|Overall Study|Screen Failure|0|||
127799847|NCT03529773|459889709|FG012|Overall Study|Screen Failure|0|||
127799848|NCT03529773|459889710|FG013|Overall Study|Screen Failure|0|||
127799849|NCT03529773|459889711|FG014|Overall Study|Screen Failure|0|||
127799850|NCT03529773|459889712|FG015|Overall Study|Screen Failure|0|||
127799851|NCT03529773|459889713|FG016|Overall Study|Screen Failure|0|||
127799852|NCT03529773|459889714|FG017|Overall Study|Screen Failure|0|||
127799853|NCT03529773|459889715|FG018|Overall Study|Screen Failure|0|||
127799854|NCT03529773|459889716|FG019|Overall Study|Screen Failure|0|||
127799855|NCT03529773|459889717|FG020|Overall Study|Screen Failure|0|||
127799856|NCT03529773|459889718|FG021|Overall Study|Screen Failure|0|||
127799857|NCT03529773|459889719|FG022|Overall Study|Screen Failure|0|||
127799858|NCT03529773|459889720|FG023|Overall Study|Screen Failure|0|||
127799859|NCT03529773|459889721|FG024|Overall Study|Screen Failure|0|||
127799860|NCT03529773|459889722|FG025|Overall Study|Screen Failure|0|||
127645706|NCT02291679|459321097|FG002|Overall Study|Other|2|||
127645707|NCT00981084|459321098|FG000|Post Intervention (Data Analysis)|poor effort|1|||
127645708|NCT00981084|459321099|FG001|Post Intervention (Data Analysis)|poor effort|1|||
127645709|NCT00981084|459321098|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
127645710|NCT00981084|459321099|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
127645711|NCT02048072|459321100|FG000|Overall Study|Adverse Event|3|||
127645712|NCT02048072|459321100|FG000|Overall Study|Lost to Follow-up|1|||
127645713|NCT00725296|459321101|FG000|Overall Study|Adverse Event|11|||
127645714|NCT00725296|459321101|FG000|Overall Study|Lack of Efficacy|7|||
127645715|NCT00725296|459321101|FG000|Overall Study|Withdrawal by Subject|3|||
127645716|NCT00725296|459321101|FG000|Overall Study|Non-Compliance|2|||
127645717|NCT00725296|459321101|FG000|Overall Study|Lost to Follow-up|1|||
127645718|NCT00725296|459321101|FG000|Overall Study|Other|38|||
127645719|NCT03360942|459321103|FG000|Overall Study|Device explanted|2|||
127645720|NCT03360942|459321103|FG000|Overall Study|Study closure|1|||
127645721|NCT03360942|459321103|FG000|Overall Study|Withdrawal by Subject|2|||
127645722|NCT01592370|459321109|FG000|Overall Study|Disease Progression|62|||
127645723|NCT01592370|459321110|FG001|Overall Study|Disease Progression|16|||
127645724|NCT01592370|459321111|FG002|Overall Study|Disease Progression|52|||
127645725|NCT01592370|459321112|FG003|Overall Study|Disease Progression|3|||
127645726|NCT01592370|459321113|FG004|Overall Study|Disease Progression|3|||
127645727|NCT01592370|459321114|FG005|Overall Study|Disease Progression|31|||
127645728|NCT01592370|459321115|FG006|Overall Study|Disease Progression|14|||
127645729|NCT01592370|459321109|FG000|Overall Study|Study Drug Toxicity|14|||
127645730|NCT01592370|459321110|FG001|Overall Study|Study Drug Toxicity|3|||
127645731|NCT01592370|459321111|FG002|Overall Study|Study Drug Toxicity|0|||
127645732|NCT01592370|459321112|FG003|Overall Study|Study Drug Toxicity|0|||
127645733|NCT01592370|459321113|FG004|Overall Study|Study Drug Toxicity|0|||
127645734|NCT01592370|459321114|FG005|Overall Study|Study Drug Toxicity|0|||
127799861|NCT03529773|459889723|FG026|Overall Study|Screen Failure|0|||
127799862|NCT03529773|459889724|FG027|Overall Study|Screen Failure|0|||
127799863|NCT03529773|459889725|FG028|Overall Study|Screen Failure|0|||
127799864|NCT03529773|459889726|FG029|Overall Study|Screen Failure|0|||
127799865|NCT03529773|459889727|FG030|Overall Study|Screen Failure|0|||
127799866|NCT03529773|459889728|FG031|Overall Study|Screen Failure|0|||
127799867|NCT03529773|459889729|FG032|Overall Study|Screen Failure|0|||
127799868|NCT03529773|459889730|FG033|Overall Study|Screen Failure|0|||
127799869|NCT03529773|459889731|FG034|Overall Study|Screen Failure|0|||
127799870|NCT03529773|459889732|FG035|Overall Study|Screen Failure|0|||
127799871|NCT03529773|459889733|FG036|Overall Study|Screen Failure|1|||
127799872|NCT03529773|459889734|FG037|Overall Study|Screen Failure|1|||
127799873|NCT03529773|459889735|FG038|Overall Study|Screen Failure|0|||
127799874|NCT03529773|459889736|FG039|Overall Study|Screen Failure|1|||
127799875|NCT03529773|459889697|FG000|Overall Study|Randomized but not vaccinated|0|||
127799876|NCT03529773|459889698|FG001|Overall Study|Randomized but not vaccinated|0|||
127799877|NCT03529773|459889699|FG002|Overall Study|Randomized but not vaccinated|0|||
127799878|NCT03529773|459889700|FG003|Overall Study|Randomized but not vaccinated|0|||
127799879|NCT03529773|459889701|FG004|Overall Study|Randomized but not vaccinated|0|||
127799880|NCT03529773|459889702|FG005|Overall Study|Randomized but not vaccinated|0|||
127799881|NCT03529773|459889703|FG006|Overall Study|Randomized but not vaccinated|0|||
127799882|NCT03529773|459889704|FG007|Overall Study|Randomized but not vaccinated|0|||
127799883|NCT03529773|459889705|FG008|Overall Study|Randomized but not vaccinated|0|||
127799884|NCT03529773|459889706|FG009|Overall Study|Randomized but not vaccinated|0|||
127799885|NCT03529773|459889707|FG010|Overall Study|Randomized but not vaccinated|0|||
127888032|NCT00528879|460213941|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
127799886|NCT03529773|459889708|FG011|Overall Study|Randomized but not vaccinated|0|||
127799887|NCT03529773|459889709|FG012|Overall Study|Randomized but not vaccinated|0|||
127799888|NCT03529773|459889710|FG013|Overall Study|Randomized but not vaccinated|0|||
127799889|NCT03529773|459889711|FG014|Overall Study|Randomized but not vaccinated|0|||
127799890|NCT03529773|459889712|FG015|Overall Study|Randomized but not vaccinated|0|||
127799891|NCT03529773|459889713|FG016|Overall Study|Randomized but not vaccinated|0|||
127799892|NCT03529773|459889714|FG017|Overall Study|Randomized but not vaccinated|1|||
127799893|NCT03529773|459889715|FG018|Overall Study|Randomized but not vaccinated|0|||
127799894|NCT03529773|459889716|FG019|Overall Study|Randomized but not vaccinated|0|||
127799895|NCT03529773|459889717|FG020|Overall Study|Randomized but not vaccinated|0|||
127799896|NCT03529773|459889718|FG021|Overall Study|Randomized but not vaccinated|0|||
127799897|NCT03529773|459889719|FG022|Overall Study|Randomized but not vaccinated|0|||
127799898|NCT03529773|459889720|FG023|Overall Study|Randomized but not vaccinated|0|||
127799899|NCT03529773|459889721|FG024|Overall Study|Randomized but not vaccinated|0|||
127799900|NCT03529773|459889722|FG025|Overall Study|Randomized but not vaccinated|0|||
127888033|NCT00528879|460213942|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
127888034|NCT00528879|460213943|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
127888035|NCT00528879|460213944|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
127888036|NCT00528879|460213941|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
127888037|NCT00528879|460213942|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
127888038|NCT00528879|460213943|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
127888039|NCT00528879|460213944|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
127888040|NCT00528879|460213941|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
127888041|NCT00528879|460213942|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
127888042|NCT00528879|460213943|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
127888043|NCT00528879|460213944|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
127888044|NCT00528879|460213941|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
127888045|NCT00528879|460213942|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
127888046|NCT00528879|460213943|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
127888047|NCT00528879|460213944|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
127888048|NCT00528879|460213941|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
127888049|NCT00528879|460213942|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
127888050|NCT00528879|460213943|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
127888051|NCT00528879|460213944|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
127888052|NCT00528879|460213941|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
127888053|NCT00528879|460213942|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
127799901|NCT03529773|459889723|FG026|Overall Study|Randomized but not vaccinated|0|||
127799902|NCT03529773|459889724|FG027|Overall Study|Randomized but not vaccinated|1|||
127799903|NCT03529773|459889725|FG028|Overall Study|Randomized but not vaccinated|0|||
127799904|NCT03529773|459889726|FG029|Overall Study|Randomized but not vaccinated|0|||
127888054|NCT00528879|460213943|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
127888055|NCT00528879|460213944|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
127799905|NCT03529773|459889727|FG030|Overall Study|Randomized but not vaccinated|0|||
127799906|NCT03529773|459889728|FG031|Overall Study|Randomized but not vaccinated|0|||
127799907|NCT03529773|459889729|FG032|Overall Study|Randomized but not vaccinated|0|||
127799908|NCT03529773|459889730|FG033|Overall Study|Randomized but not vaccinated|0|||
127708117|NCT05838027|459561328|FG001|Overall Study|Lost to Follow-up|1|||
127708118|NCT05838027|459561327|FG000|Overall Study|Withdrawal by Subject|1|||
127708119|NCT05838027|459561328|FG001|Overall Study|Withdrawal by Subject|0|||
127708120|NCT04599634|459561329|FG000|Overall Study|Dose limiting toxicity|0|||
127708121|NCT04599634|459561330|FG001|Overall Study|Dose limiting toxicity|0|||
127708122|NCT04599634|459561331|FG002|Overall Study|Dose limiting toxicity|2|||
127708123|NCT04599634|459561332|FG003|Overall Study|Dose limiting toxicity|0|||
127708124|NCT03714815|459561333|FG000|Overall Study|Physician Decision|2|||
127708125|NCT03714815|459561333|FG000|Overall Study|Withdrawal by Subject|2|||
127799909|NCT03529773|459889731|FG034|Overall Study|Randomized but not vaccinated|0|||
127799910|NCT03529773|459889732|FG035|Overall Study|Randomized but not vaccinated|0|||
127799911|NCT03529773|459889733|FG036|Overall Study|Randomized but not vaccinated|0|||
127799912|NCT03529773|459889734|FG037|Overall Study|Randomized but not vaccinated|0|||
127799913|NCT03529773|459889735|FG038|Overall Study|Randomized but not vaccinated|0|||
127799914|NCT03529773|459889736|FG039|Overall Study|Randomized but not vaccinated|0|||
127799915|NCT01537211|459889737|FG000|Overall Study|Lost to Follow-up|0|||
127799916|NCT01537211|459889738|FG001|Overall Study|Lost to Follow-up|1|||
127799917|NCT02475655|459889740|FG000|Overall Study|Lost to Follow-up|0|||
127799918|NCT02475655|459889741|FG001|Overall Study|Lost to Follow-up|1|||
127799919|NCT00197054|459889746|FG000|Overall Study|Withdrawal by Subject|9|||
127799920|NCT00197054|459889747|FG001|Overall Study|Withdrawal by Subject|3|||
127799921|NCT00197054|459889748|FG002|Overall Study|Withdrawal by Subject|3|||
127799922|NCT00197054|459889746|FG000|Overall Study|Moved from area|7|||
127799923|NCT00197054|459889747|FG001|Overall Study|Moved from area|14|||
127799924|NCT00197054|459889748|FG002|Overall Study|Moved from area|9|||
127799925|NCT00197054|459889746|FG000|Overall Study|Lost to Follow-up|1|||
127799926|NCT00197054|459889747|FG001|Overall Study|Lost to Follow-up|4|||
127799927|NCT00197054|459889748|FG002|Overall Study|Lost to Follow-up|0|||
127799928|NCT01699087|459889752|FG000|Overall Study|Lost to Follow-up|7|||
127799929|NCT01699087|459889752|FG000|Overall Study|Screen failure (prior to treatment)|15|||
127799930|NCT01699087|459889752|FG000|Overall Study|Unable to make future visits|2|||
127799931|NCT03021642|459889753|FG000|Washout Period (21 Days)|Adverse Event|1|||
127799932|NCT03021642|459889754|FG001|Washout Period (21 Days)|Adverse Event|1|||
127799933|NCT02474082|459889755|FG000|Overall Study|Adverse Event|2|||
127799934|NCT02474082|459889756|FG001|Overall Study|Adverse Event|32|||
127799935|NCT02474082|459889755|FG000|Overall Study|Withdrawal of informed consent|1|||
127799936|NCT02474082|459889756|FG001|Overall Study|Withdrawal of informed consent|11|||
127799937|NCT02474082|459889755|FG000|Overall Study|Lost to Follow-up|2|||
127799938|NCT02474082|459889756|FG001|Overall Study|Lost to Follow-up|2|||
127799939|NCT02474082|459889755|FG000|Overall Study|Dose tapering not achieved|0|||
127799940|NCT02474082|459889756|FG001|Overall Study|Dose tapering not achieved|4|||
127799941|NCT02474082|459889755|FG000|Overall Study|Participant/guardian decision|1|||
127799942|NCT02474082|459889756|FG001|Overall Study|Participant/guardian decision|2|||
127799943|NCT02474082|459889755|FG000|Overall Study|Non-compliance with study treatment|0|||
127799944|NCT02474082|459889756|FG001|Overall Study|Non-compliance with study treatment|2|||
127799945|NCT02474082|459889755|FG000|Overall Study|Protocol deviation|0|||
127799946|NCT02474082|459889756|FG001|Overall Study|Protocol deviation|1|||
127799947|NCT00379795|459889762|FG000|Overall Study|Death|31|||
127799948|NCT00379795|459889763|FG001|Overall Study|Death|8|||
127799949|NCT00379795|459889764|FG002|Overall Study|Death|6|||
127799950|NCT00379795|459889765|FG003|Overall Study|Death|4|||
127799951|NCT00379795|459889766|FG004|Overall Study|Death|7|||
127799952|NCT00379795|459889762|FG000|Overall Study|Adverse Event|17|||
127799953|NCT00379795|459889763|FG001|Overall Study|Adverse Event|3|||
127799954|NCT00379795|459889764|FG002|Overall Study|Adverse Event|3|||
127799955|NCT00379795|459889765|FG003|Overall Study|Adverse Event|1|||
127799956|NCT00379795|459889766|FG004|Overall Study|Adverse Event|4|||
127799957|NCT00379795|459889762|FG000|Overall Study|Lost to Follow-up|8|||
127799958|NCT00379795|459889763|FG001|Overall Study|Lost to Follow-up|1|||
127799959|NCT00379795|459889764|FG002|Overall Study|Lost to Follow-up|2|||
127799960|NCT00379795|459889765|FG003|Overall Study|Lost to Follow-up|1|||
127799961|NCT00379795|459889766|FG004|Overall Study|Lost to Follow-up|4|||
127799962|NCT00379795|459889762|FG000|Overall Study|Physician Decision|25|||
127799963|NCT00379795|459889763|FG001|Overall Study|Physician Decision|0|||
127799964|NCT00379795|459889764|FG002|Overall Study|Physician Decision|2|||
127799965|NCT00379795|459889765|FG003|Overall Study|Physician Decision|2|||
127799966|NCT00379795|459889766|FG004|Overall Study|Physician Decision|2|||
127799967|NCT00379795|459889762|FG000|Overall Study|Withdrawal by Subject|94|||
127799968|NCT00379795|459889763|FG001|Overall Study|Withdrawal by Subject|11|||
127799969|NCT00379795|459889764|FG002|Overall Study|Withdrawal by Subject|19|||
127799970|NCT00379795|459889765|FG003|Overall Study|Withdrawal by Subject|7|||
127708126|NCT03714815|459561333|FG000|Overall Study|Death|11|||
127799971|NCT00379795|459889766|FG004|Overall Study|Withdrawal by Subject|14|||
127799972|NCT00379795|459889762|FG000|Overall Study|Subject non-compliance|7|||
127799973|NCT00379795|459889763|FG001|Overall Study|Subject non-compliance|2|||
127799974|NCT00379795|459889764|FG002|Overall Study|Subject non-compliance|0|||
127799975|NCT00379795|459889765|FG003|Overall Study|Subject non-compliance|0|||
127799976|NCT00379795|459889766|FG004|Overall Study|Subject non-compliance|1|||
127799977|NCT00379795|459889762|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
127799978|NCT00379795|459889763|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
127799979|NCT00379795|459889764|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
127799980|NCT00379795|459889765|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
127799981|NCT00379795|459889766|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
127799982|NCT00379795|459889762|FG000|Overall Study|Subjects condition mandated intervention|34|||
127799983|NCT00379795|459889763|FG001|Overall Study|Subjects condition mandated intervention|9|||
127799984|NCT00379795|459889764|FG002|Overall Study|Subjects condition mandated intervention|7|||
127799985|NCT00379795|459889765|FG003|Overall Study|Subjects condition mandated intervention|5|||
127799986|NCT00379795|459889766|FG004|Overall Study|Subjects condition mandated intervention|7|||
127799987|NCT00379795|459889762|FG000|Overall Study|Sponsor's decision|257|||
127799988|NCT00379795|459889763|FG001|Overall Study|Sponsor's decision|17|||
127799989|NCT00379795|459889764|FG002|Overall Study|Sponsor's decision|54|||
127799990|NCT00379795|459889765|FG003|Overall Study|Sponsor's decision|47|||
127799991|NCT00379795|459889766|FG004|Overall Study|Sponsor's decision|10|||
127799992|NCT01127165|459889767|FG000|Overall Study|Adverse Event|2|||
127799993|NCT01127165|459889768|FG001|Overall Study|Adverse Event|2|||
127799994|NCT01127165|459889767|FG000|Overall Study|Lack of Efficacy|10|||
127799995|NCT01127165|459889768|FG001|Overall Study|Lack of Efficacy|8|||
127799996|NCT01127165|459889767|FG000|Overall Study|Lost to Follow-up|3|||
127799997|NCT01127165|459889768|FG001|Overall Study|Lost to Follow-up|5|||
127799998|NCT01127165|459889767|FG000|Overall Study|Withdrawal by Subject|1|||
127799999|NCT01127165|459889768|FG001|Overall Study|Withdrawal by Subject|3|||
127800000|NCT01127165|459889767|FG000|Overall Study|Protocol Violation|0|||
127800001|NCT01127165|459889768|FG001|Overall Study|Protocol Violation|1|||
127800002|NCT00763321|459889769|FG000|Open-label Period|Adverse Event|24|||
127800003|NCT00763321|459889770|FG001|Open-label Period|Adverse Event|0|||
127800004|NCT00763321|459889771|FG002|Open-label Period|Adverse Event|0|||
127800005|NCT00763321|459889769|FG000|Open-label Period|Lost to Follow-up|14|||
127800006|NCT00763321|459889770|FG001|Open-label Period|Lost to Follow-up|0|||
127800007|NCT00763321|459889771|FG002|Open-label Period|Lost to Follow-up|0|||
127800008|NCT00763321|459889769|FG000|Open-label Period|Withdrawal by Subject|7|||
127800009|NCT00763321|459889770|FG001|Open-label Period|Withdrawal by Subject|0|||
127800010|NCT00763321|459889771|FG002|Open-label Period|Withdrawal by Subject|0|||
127800011|NCT00763321|459889769|FG000|Open-label Period|Subject noncompliant|7|||
127800012|NCT00763321|459889770|FG001|Open-label Period|Subject noncompliant|0|||
127800013|NCT00763321|459889771|FG002|Open-label Period|Subject noncompliant|0|||
127800014|NCT00763321|459889769|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
127800015|NCT00763321|459889770|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
127800016|NCT00763321|459889771|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
127800017|NCT00763321|459889769|FG000|Open-label Period|Lack of Efficacy|2|||
127800018|NCT00763321|459889770|FG001|Open-label Period|Lack of Efficacy|0|||
127800019|NCT00763321|459889771|FG002|Open-label Period|Lack of Efficacy|0|||
127800020|NCT00763321|459889769|FG000|Open-label Period|Other|4|||
127800021|NCT00763321|459889770|FG001|Open-label Period|Other|0|||
127800022|NCT00763321|459889771|FG002|Open-label Period|Other|0|||
127800023|NCT00763321|459889769|FG000|Double-blind Period|Lack of Efficacy|0|||
127800024|NCT00763321|459889770|FG001|Double-blind Period|Lack of Efficacy|9|||
127800025|NCT00763321|459889771|FG002|Double-blind Period|Lack of Efficacy|17|||
127800026|NCT00763321|459889769|FG000|Double-blind Period|Adverse Event|0|||
127800027|NCT00763321|459889770|FG001|Double-blind Period|Adverse Event|4|||
127800028|NCT00763321|459889771|FG002|Double-blind Period|Adverse Event|4|||
127800029|NCT00763321|459889769|FG000|Double-blind Period|Lost to Follow-up|0|||
127800030|NCT00763321|459889770|FG001|Double-blind Period|Lost to Follow-up|4|||
127800031|NCT00763321|459889771|FG002|Double-blind Period|Lost to Follow-up|2|||
127800032|NCT00763321|459889769|FG000|Double-blind Period|Withdrawal by Subject|0|||
127800033|NCT00763321|459889770|FG001|Double-blind Period|Withdrawal by Subject|2|||
127800034|NCT00763321|459889771|FG002|Double-blind Period|Withdrawal by Subject|3|||
127800035|NCT00763321|459889769|FG000|Double-blind Period|Other|0|||
127800036|NCT00763321|459889770|FG001|Double-blind Period|Other|2|||
127800037|NCT00763321|459889771|FG002|Double-blind Period|Other|3|||
127800038|NCT03175549|459889772|FG000|Overall Study|Lost to Follow-up|2|||
127800039|NCT03175549|459889773|FG001|Overall Study|Lost to Follow-up|2|||
127800040|NCT03175549|459889772|FG000|Overall Study|Medication non-compliance|2|||
127800041|NCT03175549|459889773|FG001|Overall Study|Medication non-compliance|2|||
127800042|NCT02435849|459889774|FG000|Overall Study|Death|23|||
127800043|NCT02435849|459889775|FG001|Overall Study|Death|0|||
127800044|NCT02435849|459889774|FG000|Overall Study|Lack of Efficacy|10|||
127645735|NCT01592370|459321115|FG006|Overall Study|Study Drug Toxicity|1|||
127645736|NCT01592370|459321109|FG000|Overall Study|AE unrelated to study drug|4|||
127645737|NCT01592370|459321110|FG001|Overall Study|AE unrelated to study drug|3|||
127645738|NCT01592370|459321111|FG002|Overall Study|AE unrelated to study drug|0|||
127645739|NCT01592370|459321112|FG003|Overall Study|AE unrelated to study drug|0|||
127645740|NCT01592370|459321113|FG004|Overall Study|AE unrelated to study drug|0|||
127645741|NCT01592370|459321114|FG005|Overall Study|AE unrelated to study drug|0|||
127645742|NCT01592370|459321115|FG006|Overall Study|AE unrelated to study drug|1|||
127645743|NCT01592370|459321109|FG000|Overall Study|Request to discontinue study treatment|5|||
127645744|NCT01592370|459321110|FG001|Overall Study|Request to discontinue study treatment|0|||
127645745|NCT01592370|459321111|FG002|Overall Study|Request to discontinue study treatment|2|||
127645746|NCT01592370|459321112|FG003|Overall Study|Request to discontinue study treatment|0|||
127645747|NCT01592370|459321113|FG004|Overall Study|Request to discontinue study treatment|1|||
127645748|NCT01592370|459321114|FG005|Overall Study|Request to discontinue study treatment|2|||
127645749|NCT01592370|459321115|FG006|Overall Study|Request to discontinue study treatment|0|||
127645750|NCT01592370|459321109|FG000|Overall Study|Withdrew consent|1|||
127645751|NCT01592370|459321110|FG001|Overall Study|Withdrew consent|2|||
127645752|NCT01592370|459321111|FG002|Overall Study|Withdrew consent|1|||
127645753|NCT01592370|459321112|FG003|Overall Study|Withdrew consent|1|||
127645754|NCT01592370|459321113|FG004|Overall Study|Withdrew consent|0|||
127645755|NCT01592370|459321114|FG005|Overall Study|Withdrew consent|0|||
127645756|NCT01592370|459321115|FG006|Overall Study|Withdrew consent|0|||
127645757|NCT01592370|459321109|FG000|Overall Study|Maximum clinical benefit|11|||
127645758|NCT01592370|459321110|FG001|Overall Study|Maximum clinical benefit|1|||
127645759|NCT01592370|459321111|FG002|Overall Study|Maximum clinical benefit|7|||
127645760|NCT01592370|459321112|FG003|Overall Study|Maximum clinical benefit|1|||
127645761|NCT01592370|459321113|FG004|Overall Study|Maximum clinical benefit|0|||
127645762|NCT01592370|459321114|FG005|Overall Study|Maximum clinical benefit|0|||
127645763|NCT01592370|459321115|FG006|Overall Study|Maximum clinical benefit|0|||
127645764|NCT01592370|459321109|FG000|Overall Study|No longer meets study criteria|1|||
127645765|NCT01592370|459321110|FG001|Overall Study|No longer meets study criteria|0|||
127645766|NCT01592370|459321111|FG002|Overall Study|No longer meets study criteria|0|||
127645767|NCT01592370|459321112|FG003|Overall Study|No longer meets study criteria|0|||
127645768|NCT01592370|459321113|FG004|Overall Study|No longer meets study criteria|0|||
127645769|NCT01592370|459321114|FG005|Overall Study|No longer meets study criteria|0|||
127645770|NCT01592370|459321115|FG006|Overall Study|No longer meets study criteria|0|||
127645771|NCT01592370|459321109|FG000|Overall Study|Other Reasons|6|||
127645772|NCT01592370|459321110|FG001|Overall Study|Other Reasons|0|||
127645773|NCT01592370|459321111|FG002|Overall Study|Other Reasons|10|||
127645774|NCT01592370|459321112|FG003|Overall Study|Other Reasons|0|||
127645775|NCT01592370|459321113|FG004|Overall Study|Other Reasons|0|||
127645776|NCT01592370|459321114|FG005|Overall Study|Other Reasons|1|||
127645777|NCT01592370|459321115|FG006|Overall Study|Other Reasons|0|||
127645778|NCT05073133|459321117|FG000|Overall Study|Death|2|||
127645779|NCT04508699|459321122|FG000|Overall Study|Lack of Efficacy|2|||
127645780|NCT04508699|459321123|FG001|Overall Study|Lack of Efficacy|15|||
127645781|NCT04508699|459321122|FG000|Overall Study|Withdrawal by Subject|0|||
127645782|NCT04508699|459321123|FG001|Overall Study|Withdrawal by Subject|2|||
127645783|NCT00289887|459322622|FG000|Overall Study|Adverse Event|3|||
127645784|NCT00289887|459322623|FG001|Overall Study|Adverse Event|3|||
127645785|NCT00289887|459322622|FG000|Overall Study|Lack of Efficacy|3|||
127645786|NCT00289887|459322623|FG001|Overall Study|Lack of Efficacy|11|||
127645787|NCT00289887|459322622|FG000|Overall Study|Lost to Follow-up|3|||
127645788|NCT00289887|459322623|FG001|Overall Study|Lost to Follow-up|3|||
127645789|NCT00289887|459322622|FG000|Overall Study|Protocol Violation|3|||
127645790|NCT00289887|459322623|FG001|Overall Study|Protocol Violation|1|||
127645791|NCT00289887|459322622|FG000|Overall Study|Withdrawal by Subject|3|||
127645792|NCT00289887|459322623|FG001|Overall Study|Withdrawal by Subject|8|||
127645793|NCT00289887|459322622|FG000|Overall Study|Other|7|||
127645794|NCT00289887|459322623|FG001|Overall Study|Other|3|||
127645795|NCT01266850|459322624|FG000|Overall Study|Lost to Follow-up|19|||
127645796|NCT01266850|459322625|FG001|Overall Study|Lost to Follow-up|19|||
127645797|NCT01266850|459322626|FG002|Overall Study|Lost to Follow-up|13|||
127645798|NCT01266850|459322627|FG003|Overall Study|Lost to Follow-up|13|||
127645799|NCT01266850|459322628|FG004|Overall Study|Lost to Follow-up|12|||
127645800|NCT01266850|459322624|FG000|Overall Study|Withdrawal by Subject|8|||
127645801|NCT01266850|459322625|FG001|Overall Study|Withdrawal by Subject|9|||
127645802|NCT01266850|459322626|FG002|Overall Study|Withdrawal by Subject|6|||
127645803|NCT01266850|459322627|FG003|Overall Study|Withdrawal by Subject|9|||
127888056|NCT00528879|460213941|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
127888057|NCT00528879|460213942|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
127888058|NCT00528879|460213943|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
127708127|NCT03505008|459561335|FG000|Before Week 24 Randomization|Withdrawal by Subject|24|||
127708128|NCT03505008|459561336|FG001|Before Week 24 Randomization|Withdrawal by Subject|0|||
127708129|NCT03505008|459561337|FG002|Before Week 24 Randomization|Withdrawal by Subject|0|||
127708130|NCT03505008|459561338|FG003|Before Week 24 Randomization|Withdrawal by Subject|0|||
127708131|NCT03505008|459561335|FG000|Before Week 24 Randomization|Adverse Event|10|||
127708132|NCT03505008|459561336|FG001|Before Week 24 Randomization|Adverse Event|0|||
127708133|NCT03505008|459561337|FG002|Before Week 24 Randomization|Adverse Event|0|||
127708134|NCT03505008|459561338|FG003|Before Week 24 Randomization|Adverse Event|0|||
127708135|NCT03505008|459561335|FG000|Before Week 24 Randomization|Lack of Efficacy|8|||
127708136|NCT03505008|459561336|FG001|Before Week 24 Randomization|Lack of Efficacy|0|||
127708137|NCT03505008|459561337|FG002|Before Week 24 Randomization|Lack of Efficacy|0|||
127708138|NCT03505008|459561338|FG003|Before Week 24 Randomization|Lack of Efficacy|0|||
127708139|NCT03505008|459561335|FG000|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|5|||
127708140|NCT03505008|459561336|FG001|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
127708141|NCT03505008|459561337|FG002|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
127708142|NCT03505008|459561338|FG003|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
127708143|NCT03505008|459561335|FG000|Before Week 24 Randomization|Physician Decision|2|||
127708144|NCT03505008|459561336|FG001|Before Week 24 Randomization|Physician Decision|0|||
127708145|NCT03505008|459561337|FG002|Before Week 24 Randomization|Physician Decision|0|||
127708146|NCT03505008|459561338|FG003|Before Week 24 Randomization|Physician Decision|0|||
127708147|NCT03505008|459561335|FG000|Before Week 24 Randomization|Lost to Follow-up|1|||
127708148|NCT03505008|459561336|FG001|Before Week 24 Randomization|Lost to Follow-up|0|||
127708149|NCT03505008|459561337|FG002|Before Week 24 Randomization|Lost to Follow-up|0|||
127708150|NCT03505008|459561338|FG003|Before Week 24 Randomization|Lost to Follow-up|0|||
127708151|NCT03505008|459561335|FG000|Before Week 24 Randomization|Inadequate Methotrexate Adherence|1|||
127708152|NCT03505008|459561336|FG001|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
127708153|NCT03505008|459561337|FG002|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
127708154|NCT03505008|459561338|FG003|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
127708155|NCT03505008|459561335|FG000|Before Week 24 Randomization|Complication|1|||
127708156|NCT03505008|459561336|FG001|Before Week 24 Randomization|Complication|0|||
127708157|NCT03505008|459561337|FG002|Before Week 24 Randomization|Complication|0|||
127708158|NCT03505008|459561338|FG003|Before Week 24 Randomization|Complication|0|||
127708159|NCT03505008|459561335|FG000|After Week 24 Randomization|Withdrawal by Subject|0|||
127708160|NCT03505008|459561336|FG001|After Week 24 Randomization|Withdrawal by Subject|0|||
127708161|NCT03505008|459561337|FG002|After Week 24 Randomization|Withdrawal by Subject|3|||
127708162|NCT03505008|459561338|FG003|After Week 24 Randomization|Withdrawal by Subject|3|||
127708163|NCT03505008|459561335|FG000|After Week 24 Randomization|Lack of Efficacy|0|||
127708164|NCT03505008|459561336|FG001|After Week 24 Randomization|Lack of Efficacy|2|||
127708165|NCT03505008|459561337|FG002|After Week 24 Randomization|Lack of Efficacy|3|||
127708166|NCT03505008|459561338|FG003|After Week 24 Randomization|Lack of Efficacy|1|||
127708167|NCT03505008|459561335|FG000|After Week 24 Randomization|Adverse Event|0|||
127708168|NCT03505008|459561336|FG001|After Week 24 Randomization|Adverse Event|1|||
127708169|NCT03505008|459561337|FG002|After Week 24 Randomization|Adverse Event|2|||
127708170|NCT03505008|459561338|FG003|After Week 24 Randomization|Adverse Event|2|||
127708171|NCT03505008|459561335|FG000|After Week 24 Randomization|Lost to Follow-up|0|||
127708172|NCT03505008|459561336|FG001|After Week 24 Randomization|Lost to Follow-up|1|||
127800045|NCT02435849|459889775|FG001|Overall Study|Lack of Efficacy|0|||
127800046|NCT02435849|459889774|FG000|Overall Study|New therapy for study indication|8|||
127800047|NCT02435849|459889775|FG001|Overall Study|New therapy for study indication|0|||
127800048|NCT02435849|459889774|FG000|Overall Study|Subject/guardian decision|5|||
127800049|NCT02435849|459889775|FG001|Overall Study|Subject/guardian decision|1|||
127800050|NCT02435849|459889774|FG000|Overall Study|Lost to Follow-up|1|||
127800051|NCT02435849|459889775|FG001|Overall Study|Lost to Follow-up|0|||
127800052|NCT02435849|459889774|FG000|Overall Study|Physician Decision|1|||
127800053|NCT02435849|459889775|FG001|Overall Study|Physician Decision|0|||
127800054|NCT02486757|459889776|FG000|Overall Study|Lost to Follow-up|1|||
127800055|NCT01017952|459889777|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
127800056|NCT01017952|459889778|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
127800057|NCT01017952|459889779|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
127800058|NCT01017952|459889780|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
127800059|NCT01017952|459889781|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
127708173|NCT03505008|459561337|FG002|After Week 24 Randomization|Lost to Follow-up|0|||
127708174|NCT03505008|459561338|FG003|After Week 24 Randomization|Lost to Follow-up|2|||
127708175|NCT03505008|459561335|FG000|After Week 24 Randomization|Protocol Violation|0|||
127708176|NCT03505008|459561336|FG001|After Week 24 Randomization|Protocol Violation|0|||
127708177|NCT03505008|459561337|FG002|After Week 24 Randomization|Protocol Violation|1|||
127708178|NCT03505008|459561338|FG003|After Week 24 Randomization|Protocol Violation|0|||
127708179|NCT02962076|459561341|FG000|Overall Study|MHED tracer not available|5|||
127708180|NCT02962076|459561341|FG000|Overall Study|Protocol Violation|1|||
127708181|NCT02962076|459561341|FG000|Overall Study|Physician Decision|1|||
127708182|NCT04741776|459561342|FG000|Overall Study|Withdrawal by Subject|7|||
127708183|NCT04741776|459561343|FG001|Overall Study|Withdrawal by Subject|10|||
127708184|NCT04741776|459561344|FG002|Overall Study|Withdrawal by Subject|10|||
127708185|NCT04741776|459561345|FG003|Overall Study|Withdrawal by Subject|17|||
127708186|NCT04741776|459561342|FG000|Overall Study|Death|0|||
127708187|NCT04741776|459561343|FG001|Overall Study|Death|0|||
127708188|NCT04741776|459561344|FG002|Overall Study|Death|1|||
127708189|NCT04741776|459561345|FG003|Overall Study|Death|0|||
127708190|NCT04089865|459561346|FG000|Overall Study|Withdrawal by Subject|2|||
127708191|NCT04089865|459561347|FG001|Overall Study|Withdrawal by Subject|2|||
127708192|NCT04089865|459561348|FG002|Overall Study|Withdrawal by Subject|7|||
127708193|NCT04089865|459561349|FG003|Overall Study|Withdrawal by Subject|2|||
127708194|NCT03824366|459561355|FG000|Overall Study|Death|1|||
127708195|NCT03824366|459561355|FG000|Overall Study|Previously unidentified metal artifact|1|||
127708196|NCT03824366|459561355|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
127708197|NCT03824366|459561355|FG000|Overall Study|Withdrawal by Subject|1|||
127708198|NCT05069896|459561356|FG000|Overall Study|Adverse Event|0|||
127708199|NCT05069896|459561357|FG001|Overall Study|Adverse Event|1|||
127708200|NCT05069896|459561358|FG002|Overall Study|Adverse Event|1|||
127708201|NCT05069896|459561359|FG003|Overall Study|Adverse Event|0|||
127708202|NCT05069896|459561360|FG004|Overall Study|Adverse Event|0|||
127708203|NCT05069896|459561361|FG005|Overall Study|Adverse Event|0|||
127708204|NCT05069896|459561356|FG000|Overall Study|Lost to Follow-up|0|||
127708205|NCT05069896|459561357|FG001|Overall Study|Lost to Follow-up|0|||
127708206|NCT05069896|459561358|FG002|Overall Study|Lost to Follow-up|1|||
127708207|NCT05069896|459561359|FG003|Overall Study|Lost to Follow-up|0|||
127708208|NCT05069896|459561360|FG004|Overall Study|Lost to Follow-up|1|||
127708209|NCT05069896|459561361|FG005|Overall Study|Lost to Follow-up|2|||
127708210|NCT04068831|459561362|FG000|Overall Study|Disease Progression|10|||
127708211|NCT04068831|459561363|FG001|Overall Study|Disease Progression|8|||
127708212|NCT00323856|459561364|FG000|Overall Study|Withdrawal by Subject|1|||
127708213|NCT00323856|459561364|FG000|Overall Study|Was uncooperative and noncompliant|1|||
127708214|NCT00323856|459561364|FG000|Overall Study|Reason not specified|1|||
127708215|NCT00323856|459561364|FG000|Overall Study|Missing|2|||
127708216|NCT03156465|459561365|FG000|Overall Study|Withdrawal by Subject|2|||
127708217|NCT04086121|459561374|FG000|Overall Study|Other than listed|8|||
127708218|NCT04086121|459561374|FG000|Overall Study|Withdrawal by Subject|3|||
127888059|NCT00528879|460213944|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
127888060|NCT00528879|460213941|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
127888061|NCT00528879|460213942|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
127888062|NCT00528879|460213943|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
127888063|NCT00528879|460213944|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
127708219|NCT04086121|459561374|FG000|Overall Study|Lost to Follow-up|2|||
127708220|NCT04086121|459561374|FG000|Overall Study|Adverse Event|1|||
127708221|NCT04580914|459561377|FG000|Overall Study|Withdrawal by Subject|6|||
127708222|NCT04580914|459561377|FG000|Overall Study|Lost to Follow-up|2|||
127708223|NCT03580356|459561379|FG000|Treatment Period|Withdrawal by Subject|13|||
127708224|NCT03580356|459561380|FG001|Treatment Period|Withdrawal by Subject|0|||
127708225|NCT03580356|459561381|FG002|Treatment Period|Withdrawal by Subject|13|||
127708226|NCT03580356|459561382|FG003|Treatment Period|Withdrawal by Subject|1|||
127708227|NCT03580356|459561383|FG004|Treatment Period|Withdrawal by Subject|17|||
127708228|NCT03580356|459561384|FG005|Treatment Period|Withdrawal by Subject|0|||
127708229|NCT03580356|459561385|FG006|Treatment Period|Withdrawal by Subject|5|||
127708230|NCT03580356|459561386|FG007|Treatment Period|Withdrawal by Subject|0|||
127708231|NCT03580356|459561379|FG000|Treatment Period|Adverse Event|10|||
127708232|NCT03580356|459561380|FG001|Treatment Period|Adverse Event|0|||
127708233|NCT03580356|459561381|FG002|Treatment Period|Adverse Event|13|||
127708234|NCT03580356|459561382|FG003|Treatment Period|Adverse Event|0|||
127708235|NCT03580356|459561383|FG004|Treatment Period|Adverse Event|5|||
127708236|NCT03580356|459561384|FG005|Treatment Period|Adverse Event|0|||
127708237|NCT03580356|459561385|FG006|Treatment Period|Adverse Event|8|||
127888064|NCT00528879|460213941|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
127708238|NCT03580356|459561386|FG007|Treatment Period|Adverse Event|0|||
127708239|NCT03580356|459561379|FG000|Treatment Period|Protocol Violation|5|||
127708240|NCT03580356|459561380|FG001|Treatment Period|Protocol Violation|0|||
127708241|NCT03580356|459561381|FG002|Treatment Period|Protocol Violation|6|||
127708242|NCT03580356|459561382|FG003|Treatment Period|Protocol Violation|1|||
127888065|NCT00528879|460213942|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
127888066|NCT00528879|460213943|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
127888067|NCT00528879|460213944|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
127888068|NCT00528879|460213941|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
127888069|NCT00528879|460213942|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
127888070|NCT00528879|460213943|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
127888071|NCT00528879|460213944|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
127888072|NCT00078819|460213945|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
127888073|NCT00078819|460213946|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
127888074|NCT00078819|460213947|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
127888075|NCT00078819|460213948|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
127888076|NCT00078819|460213945|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
127888077|NCT00078819|460213946|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
127888078|NCT00078819|460213947|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
127888079|NCT00078819|460213948|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
127888080|NCT00078819|460213945|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
127888081|NCT00078819|460213946|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
127888082|NCT00078819|460213947|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
127888083|NCT00078819|460213948|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
127888084|NCT00078819|460213945|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
127888085|NCT00078819|460213946|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
127888086|NCT00078819|460213947|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
127888087|NCT00078819|460213948|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
127888088|NCT00078819|460213945|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
127888089|NCT00078819|460213946|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
127888090|NCT00078819|460213947|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
127888091|NCT00078819|460213948|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
127888092|NCT00078819|460213945|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
127888093|NCT00078819|460213946|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
127888094|NCT00078819|460213947|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
127888095|NCT00078819|460213948|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
127888096|NCT00078819|460213945|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
127888097|NCT00078819|460213946|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
127708243|NCT03580356|459561383|FG004|Treatment Period|Protocol Violation|9|||
127708244|NCT03580356|459561384|FG005|Treatment Period|Protocol Violation|1|||
127708245|NCT03580356|459561385|FG006|Treatment Period|Protocol Violation|1|||
127708246|NCT03580356|459561386|FG007|Treatment Period|Protocol Violation|0|||
127708247|NCT03580356|459561379|FG000|Treatment Period|Lack of Efficacy|6|||
127708248|NCT03580356|459561380|FG001|Treatment Period|Lack of Efficacy|0|||
127708249|NCT03580356|459561381|FG002|Treatment Period|Lack of Efficacy|2|||
127708250|NCT03580356|459561382|FG003|Treatment Period|Lack of Efficacy|0|||
127708251|NCT03580356|459561383|FG004|Treatment Period|Lack of Efficacy|3|||
127708252|NCT03580356|459561384|FG005|Treatment Period|Lack of Efficacy|0|||
127708253|NCT03580356|459561385|FG006|Treatment Period|Lack of Efficacy|3|||
127708254|NCT03580356|459561386|FG007|Treatment Period|Lack of Efficacy|0|||
127708255|NCT03580356|459561379|FG000|Treatment Period|Pregnancy|1|||
127708256|NCT03580356|459561380|FG001|Treatment Period|Pregnancy|0|||
127708257|NCT03580356|459561381|FG002|Treatment Period|Pregnancy|7|||
127708258|NCT03580356|459561382|FG003|Treatment Period|Pregnancy|0|||
127708259|NCT03580356|459561383|FG004|Treatment Period|Pregnancy|2|||
127708260|NCT03580356|459561384|FG005|Treatment Period|Pregnancy|0|||
127708261|NCT03580356|459561385|FG006|Treatment Period|Pregnancy|1|||
127708262|NCT03580356|459561386|FG007|Treatment Period|Pregnancy|0|||
127708263|NCT03580356|459561379|FG000|Treatment Period|Physician Decision|2|||
127708264|NCT03580356|459561380|FG001|Treatment Period|Physician Decision|0|||
127708265|NCT03580356|459561381|FG002|Treatment Period|Physician Decision|1|||
127708266|NCT03580356|459561382|FG003|Treatment Period|Physician Decision|0|||
127708267|NCT03580356|459561383|FG004|Treatment Period|Physician Decision|4|||
127708268|NCT03580356|459561384|FG005|Treatment Period|Physician Decision|0|||
127708269|NCT03580356|459561385|FG006|Treatment Period|Physician Decision|2|||
127708270|NCT03580356|459561386|FG007|Treatment Period|Physician Decision|0|||
127708271|NCT03580356|459561379|FG000|Treatment Period|Lost to Follow-up|1|||
127708272|NCT03580356|459561380|FG001|Treatment Period|Lost to Follow-up|1|||
127708273|NCT03580356|459561381|FG002|Treatment Period|Lost to Follow-up|1|||
127708274|NCT03580356|459561382|FG003|Treatment Period|Lost to Follow-up|0|||
127708275|NCT03580356|459561383|FG004|Treatment Period|Lost to Follow-up|3|||
127708276|NCT03580356|459561384|FG005|Treatment Period|Lost to Follow-up|0|||
127708277|NCT03580356|459561385|FG006|Treatment Period|Lost to Follow-up|1|||
127708278|NCT03580356|459561386|FG007|Treatment Period|Lost to Follow-up|0|||
127708279|NCT03580356|459561379|FG000|Treatment Period|Death|0|||
127708280|NCT03580356|459561380|FG001|Treatment Period|Death|0|||
127708281|NCT03580356|459561381|FG002|Treatment Period|Death|1|||
127708282|NCT03580356|459561382|FG003|Treatment Period|Death|0|||
127708283|NCT03580356|459561383|FG004|Treatment Period|Death|0|||
127708284|NCT03580356|459561384|FG005|Treatment Period|Death|0|||
127708285|NCT03580356|459561385|FG006|Treatment Period|Death|0|||
127708286|NCT03580356|459561386|FG007|Treatment Period|Death|0|||
127708287|NCT03580356|459561379|FG000|Treatment Period|Technical problems|0|||
127708288|NCT03580356|459561380|FG001|Treatment Period|Technical problems|0|||
127708289|NCT03580356|459561381|FG002|Treatment Period|Technical problems|0|||
127708290|NCT03580356|459561382|FG003|Treatment Period|Technical problems|0|||
127708291|NCT03580356|459561383|FG004|Treatment Period|Technical problems|1|||
127708292|NCT03580356|459561384|FG005|Treatment Period|Technical problems|0|||
127708293|NCT03580356|459561385|FG006|Treatment Period|Technical problems|0|||
127708294|NCT03580356|459561386|FG007|Treatment Period|Technical problems|0|||
127708295|NCT03580356|459561379|FG000|Treatment Period|Misrandomized, no treatment|0|||
127708296|NCT03580356|459561380|FG001|Treatment Period|Misrandomized, no treatment|0|||
127708297|NCT03580356|459561381|FG002|Treatment Period|Misrandomized, no treatment|1|||
127708298|NCT03580356|459561382|FG003|Treatment Period|Misrandomized, no treatment|0|||
127708299|NCT03580356|459561383|FG004|Treatment Period|Misrandomized, no treatment|2|||
127708300|NCT03580356|459561384|FG005|Treatment Period|Misrandomized, no treatment|0|||
127708301|NCT03580356|459561385|FG006|Treatment Period|Misrandomized, no treatment|0|||
127708302|NCT03580356|459561386|FG007|Treatment Period|Misrandomized, no treatment|0|||
127708303|NCT03580356|459561379|FG000|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
127708304|NCT03580356|459561380|FG001|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
127708305|NCT03580356|459561381|FG002|Post-treatment Follow Up Period|Withdrawal by Subject|12|||
127800060|NCT01017952|459889777|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
127800061|NCT01017952|459889778|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
127800062|NCT01017952|459889779|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
127800063|NCT01017952|459889780|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
127800064|NCT01017952|459889781|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
127800065|NCT01017952|459889777|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
127800066|NCT01017952|459889778|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
127800067|NCT01017952|459889779|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
127800068|NCT01017952|459889780|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
127800069|NCT01017952|459889781|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
127800070|NCT01017952|459889777|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
127800071|NCT01017952|459889778|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
127800072|NCT01017952|459889779|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
127800073|NCT01017952|459889780|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
127800074|NCT01017952|459889781|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
127800075|NCT01017952|459889777|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
127800076|NCT01017952|459889778|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
127800077|NCT01017952|459889779|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
127800078|NCT01017952|459889780|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
127800079|NCT01017952|459889781|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
127800080|NCT01017952|459889777|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
127800081|NCT01017952|459889778|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
127708306|NCT03580356|459561382|FG003|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
127708307|NCT03580356|459561383|FG004|Post-treatment Follow Up Period|Withdrawal by Subject|4|||
127888098|NCT00078819|460213947|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
127888099|NCT00078819|460213948|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
127888100|NCT00078819|460213945|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
127888101|NCT00078819|460213946|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
127645804|NCT01266850|459322628|FG004|Overall Study|Withdrawal by Subject|12|||
127645805|NCT01266850|459322624|FG000|Overall Study|Physician Decision|3|||
127645806|NCT01266850|459322625|FG001|Overall Study|Physician Decision|6|||
127645807|NCT01266850|459322626|FG002|Overall Study|Physician Decision|4|||
127645808|NCT01266850|459322627|FG003|Overall Study|Physician Decision|4|||
127645809|NCT01266850|459322628|FG004|Overall Study|Physician Decision|3|||
127645810|NCT01266850|459322624|FG000|Overall Study|Protocol Violation|0|||
127645811|NCT01266850|459322625|FG001|Overall Study|Protocol Violation|1|||
127645812|NCT01266850|459322626|FG002|Overall Study|Protocol Violation|0|||
127645813|NCT01266850|459322627|FG003|Overall Study|Protocol Violation|1|||
127645814|NCT01266850|459322628|FG004|Overall Study|Protocol Violation|2|||
127645815|NCT01266850|459322624|FG000|Overall Study|Adverse Event|0|||
127645816|NCT01266850|459322625|FG001|Overall Study|Adverse Event|0|||
127645817|NCT01266850|459322626|FG002|Overall Study|Adverse Event|0|||
127645818|NCT01266850|459322627|FG003|Overall Study|Adverse Event|0|||
127645819|NCT01266850|459322628|FG004|Overall Study|Adverse Event|1|||
127645820|NCT01266850|459322624|FG000|Overall Study|Site Closure|0|||
127645821|NCT01266850|459322625|FG001|Overall Study|Site Closure|1|||
127645822|NCT01266850|459322626|FG002|Overall Study|Site Closure|1|||
127645823|NCT01266850|459322627|FG003|Overall Study|Site Closure|1|||
127645824|NCT01266850|459322628|FG004|Overall Study|Site Closure|0|||
127645825|NCT00437645|459322630|FG000|Overall Study|Adverse Event|15|||
127645826|NCT00437645|459322631|FG001|Overall Study|Adverse Event|84|||
127645827|NCT00437645|459322630|FG000|Overall Study|Withdrawal by Subject|10|||
127645828|NCT00437645|459322631|FG001|Overall Study|Withdrawal by Subject|22|||
127645829|NCT00437645|459322630|FG000|Overall Study|Protocol Violation|3|||
127645830|NCT00437645|459322631|FG001|Overall Study|Protocol Violation|3|||
127645831|NCT00437645|459322630|FG000|Overall Study|Lost to Follow-up|2|||
127645832|NCT00437645|459322631|FG001|Overall Study|Lost to Follow-up|3|||
127645833|NCT00437645|459322630|FG000|Overall Study|Administrative problems|2|||
127645834|NCT00437645|459322631|FG001|Overall Study|Administrative problems|1|||
127645835|NCT00437645|459322630|FG000|Overall Study|Lack of Efficacy|2|||
127645836|NCT00437645|459322631|FG001|Overall Study|Lack of Efficacy|1|||
127645837|NCT00437645|459322630|FG000|Overall Study|Condition no longer requires study drug|1|||
127645838|NCT00437645|459322631|FG001|Overall Study|Condition no longer requires study drug|1|||
127800082|NCT01017952|459889779|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
127800083|NCT01017952|459889780|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
127800084|NCT01017952|459889781|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
127800085|NCT01017952|459889777|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
127800086|NCT01017952|459889778|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
127800087|NCT01017952|459889779|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
127800088|NCT01017952|459889780|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
127800089|NCT01017952|459889781|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
127800090|NCT01017952|459889777|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
127800091|NCT01017952|459889778|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
127800092|NCT01017952|459889779|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
127800093|NCT01017952|459889780|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
127800094|NCT01017952|459889781|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
127800095|NCT01017952|459889777|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
127800096|NCT01017952|459889778|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
127800097|NCT01017952|459889779|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
127645839|NCT03751631|459322632|FG000|Overall Study|Withdrawal by Subject|0|||
127800098|NCT01017952|459889780|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
127888102|NCT00078819|460213947|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
127645840|NCT03751631|459322633|FG001|Overall Study|Withdrawal by Subject|0|||
127645841|NCT03751631|459322634|FG002|Overall Study|Withdrawal by Subject|1|||
127800099|NCT01017952|459889781|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
127645842|NCT03751631|459322635|FG003|Overall Study|Withdrawal by Subject|1|||
127645843|NCT03751631|459322636|FG004|Overall Study|Withdrawal by Subject|0|||
127645844|NCT03751631|459322637|FG005|Overall Study|Withdrawal by Subject|0|||
127645845|NCT03382782|459322642|FG000|Cohort 1|Withdrawal by Subject|11|||
127645846|NCT03382782|459322643|FG001|Cohort 1|Withdrawal by Subject|5|||
127800100|NCT01017952|459889777|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
127800101|NCT01017952|459889778|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
127800102|NCT01017952|459889779|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
127800103|NCT01017952|459889780|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
127800104|NCT01017952|459889781|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
127800105|NCT01017952|459889777|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
127800106|NCT01017952|459889778|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
127800107|NCT01017952|459889779|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
127800108|NCT01017952|459889780|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
127800109|NCT01017952|459889781|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
127800110|NCT01017952|459889777|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
127800111|NCT01017952|459889778|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
127800112|NCT01017952|459889779|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
127800113|NCT01017952|459889780|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
127800114|NCT01017952|459889781|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
127800115|NCT01017952|459889777|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
127645847|NCT03382782|459322644|FG002|Cohort 1|Withdrawal by Subject|0|||
127800116|NCT01017952|459889778|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
127800117|NCT01017952|459889779|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
127800118|NCT01017952|459889780|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
127800119|NCT01017952|459889781|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
127800120|NCT01017952|459889777|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
127800121|NCT01017952|459889778|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
127800122|NCT01017952|459889779|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
127800123|NCT01017952|459889780|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
127800124|NCT01017952|459889781|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
127645848|NCT03382782|459322642|FG000|Cohort 2|Withdrawal by Subject|1|||
127645849|NCT03382782|459322643|FG001|Cohort 2|Withdrawal by Subject|1|||
127800125|NCT04849780|459889782|FG000|Period 1|Covid-19 Related|1|||
127800126|NCT04849780|459889783|FG001|Period 1|Covid-19 Related|0|||
127800127|NCT04849780|459889782|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
127800128|NCT04849780|459889783|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
127800129|NCT04849780|459889782|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
127800130|NCT04849780|459889783|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
127800131|NCT01665144|459889785|FG000|Core Part|Withdrawal by Subject|96|||
127800132|NCT01665144|459889786|FG001|Core Part|Withdrawal by Subject|77|||
127800133|NCT01665144|459889787|FG002|Core Part|Withdrawal by Subject|0|||
127645850|NCT03382782|459322644|FG002|Cohort 2|Withdrawal by Subject|0|||
127645851|NCT03382782|459322642|FG000|Cohort 3|Withdrawal by Subject|1|||
127645852|NCT03382782|459322643|FG001|Cohort 3|Withdrawal by Subject|2|||
127645853|NCT03382782|459322644|FG002|Cohort 3|Withdrawal by Subject|0|||
127645854|NCT00428090|459322647|FG000|Overall Study|Adverse Event|10|||
127645855|NCT00428090|459322648|FG001|Overall Study|Adverse Event|8|||
127645856|NCT00428090|459322649|FG002|Overall Study|Adverse Event|10|||
127645857|NCT00428090|459322650|FG003|Overall Study|Adverse Event|11|||
127645858|NCT00428090|459322647|FG000|Overall Study|Lost to Follow-up|3|||
127645859|NCT00428090|459322648|FG001|Overall Study|Lost to Follow-up|6|||
127645860|NCT00428090|459322649|FG002|Overall Study|Lost to Follow-up|1|||
127645861|NCT00428090|459322650|FG003|Overall Study|Lost to Follow-up|4|||
127645862|NCT00428090|459322647|FG000|Overall Study|Protocol Violation|3|||
127645863|NCT00428090|459322648|FG001|Overall Study|Protocol Violation|1|||
127645864|NCT00428090|459322649|FG002|Overall Study|Protocol Violation|3|||
127645865|NCT00428090|459322650|FG003|Overall Study|Protocol Violation|3|||
127645866|NCT00428090|459322647|FG000|Overall Study|Withdrawal by Subject|10|||
127645867|NCT00428090|459322648|FG001|Overall Study|Withdrawal by Subject|12|||
127645868|NCT00428090|459322649|FG002|Overall Study|Withdrawal by Subject|15|||
127645869|NCT00428090|459322650|FG003|Overall Study|Withdrawal by Subject|5|||
127645870|NCT00428090|459322647|FG000|Overall Study|Sponsor terminated study|0|||
127645871|NCT00428090|459322648|FG001|Overall Study|Sponsor terminated study|1|||
127645872|NCT00428090|459322649|FG002|Overall Study|Sponsor terminated study|0|||
127800134|NCT01665144|459889785|FG000|Core Part|Adverse Event|45|||
127800135|NCT01665144|459889786|FG001|Core Part|Adverse Event|18|||
127800136|NCT01665144|459889787|FG002|Core Part|Adverse Event|0|||
127645873|NCT00428090|459322650|FG003|Overall Study|Sponsor terminated study|0|||
127800137|NCT01665144|459889785|FG000|Core Part|Lack of Efficacy|16|||
127800138|NCT01665144|459889786|FG001|Core Part|Lack of Efficacy|11|||
127645874|NCT00428090|459322647|FG000|Overall Study|Non-compliance|4|||
127645875|NCT00428090|459322648|FG001|Overall Study|Non-compliance|0|||
127645876|NCT00428090|459322649|FG002|Overall Study|Non-compliance|1|||
127645877|NCT00428090|459322650|FG003|Overall Study|Non-compliance|3|||
127708308|NCT03580356|459561384|FG005|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
127708309|NCT03580356|459561385|FG006|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
127708310|NCT03580356|459561386|FG007|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
127708311|NCT03580356|459561379|FG000|Post-treatment Follow Up Period|Lost to Follow-up|3|||
127708312|NCT03580356|459561380|FG001|Post-treatment Follow Up Period|Lost to Follow-up|0|||
127708313|NCT03580356|459561381|FG002|Post-treatment Follow Up Period|Lost to Follow-up|2|||
127708314|NCT03580356|459561382|FG003|Post-treatment Follow Up Period|Lost to Follow-up|0|||
127708315|NCT03580356|459561383|FG004|Post-treatment Follow Up Period|Lost to Follow-up|1|||
127708316|NCT03580356|459561384|FG005|Post-treatment Follow Up Period|Lost to Follow-up|0|||
127708317|NCT03580356|459561385|FG006|Post-treatment Follow Up Period|Lost to Follow-up|0|||
127708318|NCT03580356|459561386|FG007|Post-treatment Follow Up Period|Lost to Follow-up|0|||
127708319|NCT03580356|459561379|FG000|Post-treatment Follow Up Period|Adverse Event|1|||
127708320|NCT03580356|459561380|FG001|Post-treatment Follow Up Period|Adverse Event|0|||
127708321|NCT03580356|459561381|FG002|Post-treatment Follow Up Period|Adverse Event|3|||
127708322|NCT03580356|459561382|FG003|Post-treatment Follow Up Period|Adverse Event|0|||
127708323|NCT03580356|459561383|FG004|Post-treatment Follow Up Period|Adverse Event|0|||
127708324|NCT03580356|459561384|FG005|Post-treatment Follow Up Period|Adverse Event|0|||
127708325|NCT03580356|459561385|FG006|Post-treatment Follow Up Period|Adverse Event|0|||
127708326|NCT03580356|459561386|FG007|Post-treatment Follow Up Period|Adverse Event|0|||
127708327|NCT03580356|459561379|FG000|Post-treatment Follow Up Period|Lack of Efficacy|0|||
127708328|NCT03580356|459561380|FG001|Post-treatment Follow Up Period|Lack of Efficacy|0|||
127708329|NCT03580356|459561381|FG002|Post-treatment Follow Up Period|Lack of Efficacy|1|||
127708330|NCT03580356|459561382|FG003|Post-treatment Follow Up Period|Lack of Efficacy|0|||
127708331|NCT03580356|459561383|FG004|Post-treatment Follow Up Period|Lack of Efficacy|1|||
127708332|NCT03580356|459561384|FG005|Post-treatment Follow Up Period|Lack of Efficacy|0|||
127708333|NCT03580356|459561385|FG006|Post-treatment Follow Up Period|Lack of Efficacy|0|||
127708334|NCT03580356|459561386|FG007|Post-treatment Follow Up Period|Lack of Efficacy|0|||
127708335|NCT03580356|459561379|FG000|Post-treatment Follow Up Period|Protocol Violation|1|||
127708336|NCT03580356|459561380|FG001|Post-treatment Follow Up Period|Protocol Violation|0|||
127708337|NCT03580356|459561381|FG002|Post-treatment Follow Up Period|Protocol Violation|1|||
127708338|NCT03580356|459561382|FG003|Post-treatment Follow Up Period|Protocol Violation|0|||
127708339|NCT03580356|459561383|FG004|Post-treatment Follow Up Period|Protocol Violation|0|||
127708340|NCT03580356|459561384|FG005|Post-treatment Follow Up Period|Protocol Violation|0|||
127708341|NCT03580356|459561385|FG006|Post-treatment Follow Up Period|Protocol Violation|0|||
127708342|NCT03580356|459561386|FG007|Post-treatment Follow Up Period|Protocol Violation|0|||
127708343|NCT03580356|459561379|FG000|Post-treatment Follow Up Period|Physician Decision|0|||
127708344|NCT03580356|459561380|FG001|Post-treatment Follow Up Period|Physician Decision|0|||
127708345|NCT03580356|459561381|FG002|Post-treatment Follow Up Period|Physician Decision|0|||
127708346|NCT03580356|459561382|FG003|Post-treatment Follow Up Period|Physician Decision|0|||
127708347|NCT03580356|459561383|FG004|Post-treatment Follow Up Period|Physician Decision|0|||
127708348|NCT03580356|459561384|FG005|Post-treatment Follow Up Period|Physician Decision|0|||
127708349|NCT03580356|459561385|FG006|Post-treatment Follow Up Period|Physician Decision|1|||
127708350|NCT03580356|459561386|FG007|Post-treatment Follow Up Period|Physician Decision|0|||
127708351|NCT03580356|459561379|FG000|Post-treatment Follow Up Period|Pregnancy|1|||
127708352|NCT03580356|459561380|FG001|Post-treatment Follow Up Period|Pregnancy|0|||
127708353|NCT03580356|459561381|FG002|Post-treatment Follow Up Period|Pregnancy|0|||
127708354|NCT03580356|459561382|FG003|Post-treatment Follow Up Period|Pregnancy|0|||
127708355|NCT03580356|459561383|FG004|Post-treatment Follow Up Period|Pregnancy|0|||
127708356|NCT03580356|459561384|FG005|Post-treatment Follow Up Period|Pregnancy|0|||
127708357|NCT03580356|459561385|FG006|Post-treatment Follow Up Period|Pregnancy|0|||
127708358|NCT03580356|459561386|FG007|Post-treatment Follow Up Period|Pregnancy|0|||
127708359|NCT05715528|459561387|FG000|Overall Study|Randomized but never treated|11|||
127708360|NCT05715528|459561388|FG001|Overall Study|Randomized but never treated|13|||
127708361|NCT05715528|459561387|FG000|Overall Study|Withdrew consent|7|||
127708362|NCT05715528|459561388|FG001|Overall Study|Withdrew consent|15|||
127708363|NCT05715528|459561387|FG000|Overall Study|Lost to Follow-up|5|||
127708364|NCT05715528|459561388|FG001|Overall Study|Lost to Follow-up|13|||
127708365|NCT05715528|459561387|FG000|Overall Study|Investigator's discretion|3|||
127708366|NCT05715528|459561388|FG001|Overall Study|Investigator's discretion|1|||
127708367|NCT05715528|459561387|FG000|Overall Study|Protocol Violation|2|||
127708368|NCT05715528|459561388|FG001|Overall Study|Protocol Violation|0|||
127708369|NCT05715528|459561387|FG000|Overall Study|Non-compliance with study drug|0|||
127708370|NCT05715528|459561388|FG001|Overall Study|Non-compliance with study drug|1|||
127645878|NCT00428090|459322647|FG000|Overall Study|Par. did not returned to visit|1|||
127645879|NCT00428090|459322648|FG001|Overall Study|Par. did not returned to visit|0|||
127645880|NCT00428090|459322649|FG002|Overall Study|Par. did not returned to visit|0|||
127645881|NCT00428090|459322650|FG003|Overall Study|Par. did not returned to visit|1|||
127645882|NCT00428090|459322647|FG000|Overall Study|Follow-Up visit not possible|1|||
127645883|NCT00428090|459322648|FG001|Overall Study|Follow-Up visit not possible|0|||
127645884|NCT00428090|459322649|FG002|Overall Study|Follow-Up visit not possible|0|||
127645885|NCT00428090|459322650|FG003|Overall Study|Follow-Up visit not possible|0|||
127645886|NCT00428090|459322647|FG000|Overall Study|Prohibited medication used for SAE|1|||
127645887|NCT00428090|459322648|FG001|Overall Study|Prohibited medication used for SAE|0|||
127645888|NCT00428090|459322649|FG002|Overall Study|Prohibited medication used for SAE|0|||
127645889|NCT00428090|459322650|FG003|Overall Study|Prohibited medication used for SAE|0|||
127645890|NCT00428090|459322647|FG000|Overall Study|Death of par.|1|||
127645891|NCT00428090|459322648|FG001|Overall Study|Death of par.|0|||
127645892|NCT00428090|459322649|FG002|Overall Study|Death of par.|1|||
127645893|NCT00428090|459322650|FG003|Overall Study|Death of par.|0|||
127645894|NCT00428090|459322647|FG000|Overall Study|Visit 7 exceed the visit window|0|||
127645895|NCT00428090|459322648|FG001|Overall Study|Visit 7 exceed the visit window|1|||
127645896|NCT00428090|459322649|FG002|Overall Study|Visit 7 exceed the visit window|0|||
127645897|NCT00428090|459322650|FG003|Overall Study|Visit 7 exceed the visit window|0|||
127645898|NCT00428090|459322647|FG000|Overall Study|Medical monitor terminated par.|0|||
127645899|NCT00428090|459322648|FG001|Overall Study|Medical monitor terminated par.|1|||
127645900|NCT00428090|459322649|FG002|Overall Study|Medical monitor terminated par.|0|||
127645901|NCT00428090|459322650|FG003|Overall Study|Medical monitor terminated par.|0|||
127645902|NCT00428090|459322647|FG000|Overall Study|Mental status of par. was|0|||
127645903|NCT00428090|459322648|FG001|Overall Study|Mental status of par. was|1|||
127645904|NCT00428090|459322649|FG002|Overall Study|Mental status of par. was|0|||
127645905|NCT00428090|459322650|FG003|Overall Study|Mental status of par. was|0|||
127645906|NCT00428090|459322647|FG000|Overall Study|Worsening of AD|0|||
127645907|NCT00428090|459322648|FG001|Overall Study|Worsening of AD|0|||
127645908|NCT00428090|459322649|FG002|Overall Study|Worsening of AD|1|||
127645909|NCT00428090|459322650|FG003|Overall Study|Worsening of AD|0|||
127645910|NCT00428090|459322647|FG000|Overall Study|Excluded for concerning QTc value|0|||
127645911|NCT00428090|459322648|FG001|Overall Study|Excluded for concerning QTc value|0|||
127645912|NCT00428090|459322649|FG002|Overall Study|Excluded for concerning QTc value|1|||
127645913|NCT00428090|459322650|FG003|Overall Study|Excluded for concerning QTc value|0|||
127645914|NCT00428090|459322647|FG000|Overall Study|Insufficient AD documentation|0|||
127708371|NCT03118518|459561389|FG000|Overall Study|Early Exit after treatment|2|||
127708372|NCT03118518|459561390|FG001|Overall Study|Early Exit after treatment|8|||
127708373|NCT03118518|459561389|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
127708374|NCT03118518|459561390|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
127708375|NCT03536884|459561396|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|8|||
127708376|NCT03536884|459561397|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|6|||
127708377|NCT03536884|459561398|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
127708378|NCT03536884|459561399|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
127708379|NCT03536884|459561400|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
127800139|NCT01665144|459889787|FG002|Core Part|Lack of Efficacy|0|||
127800140|NCT01665144|459889785|FG000|Core Part|Lost to Follow-up|9|||
127800141|NCT01665144|459889786|FG001|Core Part|Lost to Follow-up|8|||
127800142|NCT01665144|459889787|FG002|Core Part|Lost to Follow-up|0|||
127645915|NCT00428090|459322648|FG001|Overall Study|Insufficient AD documentation|0|||
127708380|NCT03536884|459561401|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
127708381|NCT03536884|459561402|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
127708382|NCT03536884|459561403|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
127708383|NCT03536884|459561404|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
127708384|NCT03536884|459561405|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
127708385|NCT03536884|459561406|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
127708386|NCT03536884|459561407|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
127708387|NCT03536884|459561396|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
127708388|NCT03536884|459561397|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|3|||
127708389|NCT03536884|459561398|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
127708390|NCT03536884|459561399|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
127800143|NCT01665144|459889785|FG000|Core Part|Physician Decision|13|||
127800144|NCT01665144|459889786|FG001|Core Part|Physician Decision|1|||
127645916|NCT00428090|459322649|FG002|Overall Study|Insufficient AD documentation|1|||
127645917|NCT00428090|459322650|FG003|Overall Study|Insufficient AD documentation|0|||
127645918|NCT00428090|459322647|FG000|Overall Study|High MMSE scores|0|||
127645919|NCT00428090|459322648|FG001|Overall Study|High MMSE scores|0|||
127645920|NCT00428090|459322649|FG002|Overall Study|High MMSE scores|1|||
127645921|NCT00428090|459322650|FG003|Overall Study|High MMSE scores|0|||
127645922|NCT00428090|459322647|FG000|Overall Study|Deterioration of cognitive status|0|||
127645923|NCT00428090|459322648|FG001|Overall Study|Deterioration of cognitive status|0|||
127645924|NCT00428090|459322649|FG002|Overall Study|Deterioration of cognitive status|1|||
127645925|NCT00428090|459322650|FG003|Overall Study|Deterioration of cognitive status|0|||
127645926|NCT00428090|459322647|FG000|Overall Study|Serious adverse event|0|||
127645927|NCT00428090|459322648|FG001|Overall Study|Serious adverse event|0|||
127645928|NCT00428090|459322649|FG002|Overall Study|Serious adverse event|1|||
127645929|NCT00428090|459322650|FG003|Overall Study|Serious adverse event|0|||
127645930|NCT00428090|459322647|FG000|Overall Study|Excluded for heart insufficiency|0|||
127645931|NCT00428090|459322648|FG001|Overall Study|Excluded for heart insufficiency|0|||
127645932|NCT00428090|459322649|FG002|Overall Study|Excluded for heart insufficiency|1|||
127645933|NCT00428090|459322650|FG003|Overall Study|Excluded for heart insufficiency|0|||
127645934|NCT00428090|459322647|FG000|Overall Study|Raised Creatinine Value|0|||
127645935|NCT00428090|459322648|FG001|Overall Study|Raised Creatinine Value|0|||
127645936|NCT00428090|459322649|FG002|Overall Study|Raised Creatinine Value|0|||
127645937|NCT00428090|459322650|FG003|Overall Study|Raised Creatinine Value|1|||
127645938|NCT03255824|459322654|FG000|Overall Study|Under-sedation|2|||
127645939|NCT03255824|459322655|FG001|Overall Study|Under-sedation|1|||
127645940|NCT00337272|459322658|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
127645941|NCT00337272|459322659|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
127645942|NCT00337272|459322658|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
127645943|NCT00337272|459322659|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
127645944|NCT00337272|459322658|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
127645945|NCT00337272|459322659|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
127645946|NCT00337272|459322658|FG000|Treatment Period|Non-compliance|1|||
127645947|NCT00337272|459322659|FG001|Treatment Period|Non-compliance|1|||
127645948|NCT00337272|459322658|FG000|Treatment Period|Withdrawal by Subject|0|||
127645949|NCT00337272|459322659|FG001|Treatment Period|Withdrawal by Subject|1|||
127645950|NCT00337272|459322658|FG000|Withdrawal Period|Non-compliance|0|||
127645951|NCT00337272|459322659|FG001|Withdrawal Period|Non-compliance|1|||
127645952|NCT04605978|459322663|FG000|Overall Study|Adverse Event|2|||
127645953|NCT04605978|459322664|FG001|Overall Study|Adverse Event|1|||
127645954|NCT04605978|459322663|FG000|Overall Study|Withdrawal nonmedical reason|1|||
127708391|NCT03536884|459561400|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
127708392|NCT03536884|459561401|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
127708393|NCT03536884|459561402|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
127708394|NCT03536884|459561403|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
127708395|NCT03536884|459561404|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
127708396|NCT03536884|459561405|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
127708397|NCT03536884|459561406|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
127708398|NCT03536884|459561407|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
127708399|NCT03536884|459561396|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|3|||
127708400|NCT03536884|459561397|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|4|||
127708401|NCT03536884|459561398|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
127708402|NCT03536884|459561399|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
127708403|NCT03536884|459561400|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
127708404|NCT03536884|459561401|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
127708405|NCT03536884|459561402|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
127708406|NCT03536884|459561403|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
127708407|NCT03536884|459561404|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
127708408|NCT03536884|459561405|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
127708409|NCT03536884|459561406|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
127708410|NCT03536884|459561407|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
127708411|NCT03536884|459561396|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
127645955|NCT04605978|459322664|FG001|Overall Study|Withdrawal nonmedical reason|1|||
127645956|NCT03813238|459322665|FG000|Overall Study|Adverse Event|0|||
127645957|NCT03813238|459322666|FG001|Overall Study|Adverse Event|6|||
127645958|NCT03813238|459322665|FG000|Overall Study|Withdrawal by parent/guardian|0|||
127645959|NCT03813238|459322666|FG001|Overall Study|Withdrawal by parent/guardian|2|||
127645960|NCT03813238|459322665|FG000|Overall Study|Lost to Follow-up|0|||
127645961|NCT03813238|459322666|FG001|Overall Study|Lost to Follow-up|1|||
127888103|NCT00078819|460213948|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
127888104|NCT00667719|460213949|FG000|Overall Study|Adverse Event|39|||
127888105|NCT00667719|460213949|FG000|Overall Study|Abnormal Test Procedure|1|||
127888106|NCT00667719|460213949|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
127888107|NCT00667719|460213949|FG000|Overall Study|Protocol Violation|3|||
127888108|NCT00667719|460213949|FG000|Overall Study|Withdrawal by Subject|17|||
127888109|NCT00667719|460213949|FG000|Overall Study|Lost to Follow-up|8|||
127888110|NCT00323609|460213950|FG000|Overall Study|Death|16|||
127888111|NCT00323609|460213951|FG001|Overall Study|Death|21|||
127888112|NCT00323609|460213952|FG002|Overall Study|Death|0|||
127888113|NCT00323609|460213953|FG003|Overall Study|Death|0|||
127888114|NCT00323609|460213950|FG000|Overall Study|Lost to Follow-up|9|||
127888115|NCT00323609|460213951|FG001|Overall Study|Lost to Follow-up|10|||
127888116|NCT00323609|460213952|FG002|Overall Study|Lost to Follow-up|0|||
127888117|NCT00323609|460213953|FG003|Overall Study|Lost to Follow-up|0|||
127888118|NCT00323609|460213950|FG000|Overall Study|Physician Decision|2|||
127888119|NCT00323609|460213951|FG001|Overall Study|Physician Decision|0|||
127888120|NCT00323609|460213952|FG002|Overall Study|Physician Decision|0|||
127888121|NCT00323609|460213953|FG003|Overall Study|Physician Decision|1|||
127888122|NCT00323609|460213950|FG000|Overall Study|Withdrawal by Subject|11|||
127888123|NCT00323609|460213951|FG001|Overall Study|Withdrawal by Subject|23|||
127888124|NCT00323609|460213952|FG002|Overall Study|Withdrawal by Subject|4|||
127888125|NCT00323609|460213953|FG003|Overall Study|Withdrawal by Subject|4|||
127888126|NCT00323609|460213950|FG000|Overall Study|Other non-VCF-related medical condition|3|||
127888127|NCT00323609|460213951|FG001|Overall Study|Other non-VCF-related medical condition|2|||
127888128|NCT00323609|460213952|FG002|Overall Study|Other non-VCF-related medical condition|0|||
127888129|NCT00323609|460213953|FG003|Overall Study|Other non-VCF-related medical condition|0|||
127888130|NCT00323609|460213950|FG000|Overall Study|Sponsor discontinued trial|29|||
127888131|NCT00323609|460213951|FG001|Overall Study|Sponsor discontinued trial|29|||
127888132|NCT00323609|460213952|FG002|Overall Study|Sponsor discontinued trial|0|||
127888133|NCT00323609|460213953|FG003|Overall Study|Sponsor discontinued trial|0|||
127708412|NCT03536884|459561397|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|1|||
127708413|NCT03536884|459561398|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
127708414|NCT03536884|459561399|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
127708415|NCT03536884|459561400|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
127708416|NCT03536884|459561401|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
127708417|NCT03536884|459561402|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
127708418|NCT03536884|459561403|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
127708419|NCT03536884|459561404|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
127708420|NCT03536884|459561405|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
127708421|NCT03536884|459561406|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
127708422|NCT03536884|459561407|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
127708423|NCT03536884|459561396|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
127800145|NCT01665144|459889787|FG002|Core Part|Physician Decision|0|||
127800146|NCT01665144|459889785|FG000|Core Part|Progressive disease|8|||
127800147|NCT01665144|459889786|FG001|Core Part|Progressive disease|4|||
127800148|NCT01665144|459889787|FG002|Core Part|Progressive disease|0|||
127800149|NCT01665144|459889785|FG000|Core Part|Non-compliance with study treatment|5|||
127800150|NCT01665144|459889786|FG001|Core Part|Non-compliance with study treatment|0|||
127800151|NCT01665144|459889787|FG002|Core Part|Non-compliance with study treatment|0|||
127800152|NCT01665144|459889785|FG000|Core Part|Death|3|||
127800153|NCT01665144|459889786|FG001|Core Part|Death|1|||
127800154|NCT01665144|459889787|FG002|Core Part|Death|0|||
127800155|NCT01665144|459889785|FG000|Core Part|Protocol deviation|3|||
127800156|NCT01665144|459889786|FG001|Core Part|Protocol deviation|1|||
127800157|NCT01665144|459889787|FG002|Core Part|Protocol deviation|0|||
127800158|NCT01665144|459889785|FG000|Core Part|New therapy for study indication|2|||
127800159|NCT01665144|459889786|FG001|Core Part|New therapy for study indication|1|||
127800160|NCT01665144|459889787|FG002|Core Part|New therapy for study indication|0|||
127888134|NCT00323609|460213950|FG000|Overall Study|Unrelenting or severe back pain|1|||
127888135|NCT00323609|460213951|FG001|Overall Study|Unrelenting or severe back pain|1|||
127888136|NCT00323609|460213952|FG002|Overall Study|Unrelenting or severe back pain|0|||
127888137|NCT00323609|460213953|FG003|Overall Study|Unrelenting or severe back pain|0|||
127888138|NCT00323609|460213950|FG000|Overall Study|Logistical withdrawal|9|||
127888139|NCT00323609|460213951|FG001|Overall Study|Logistical withdrawal|5|||
127888140|NCT00323609|460213952|FG002|Overall Study|Logistical withdrawal|0|||
127888141|NCT00323609|460213953|FG003|Overall Study|Logistical withdrawal|1|||
127800161|NCT01665144|459889785|FG000|Core Part|Technical problems|2|||
127800162|NCT01665144|459889786|FG001|Core Part|Technical problems|0|||
127800163|NCT01665144|459889787|FG002|Core Part|Technical problems|0|||
127800164|NCT01665144|459889785|FG000|Extension Part|Patient/guardian decision|180|||
127800165|NCT01665144|459889786|FG001|Extension Part|Patient/guardian decision|0|||
127800166|NCT01665144|459889787|FG002|Extension Part|Patient/guardian decision|98|||
127800167|NCT01665144|459889785|FG000|Extension Part|Adverse Event|104|||
127800168|NCT01665144|459889786|FG001|Extension Part|Adverse Event|0|||
127645962|NCT03813238|459322665|FG000|Overall Study|Other than specified|1|||
127645963|NCT03813238|459322666|FG001|Overall Study|Other than specified|2|||
127645964|NCT01644734|459322667|FG000|Overall Study|Adverse Event|4|||
127645965|NCT01644734|459322667|FG000|Overall Study|Lost to Follow-up|17|||
127645966|NCT01644734|459322667|FG000|Overall Study|Reasons other than stated above|7|||
127645967|NCT01644734|459322667|FG000|Overall Study|Missing documentation|238|||
127645968|NCT04393441|459322669|FG000|Overall Study|Adverse Event|0|||
127645969|NCT04393441|459322670|FG001|Overall Study|Adverse Event|3|||
127645970|NCT04393441|459322669|FG000|Overall Study|Withdrawal by Subject|5|||
127645971|NCT04393441|459322670|FG001|Overall Study|Withdrawal by Subject|7|||
127645972|NCT04393441|459322669|FG000|Overall Study|Lost to Follow-up|0|||
127645973|NCT04393441|459322670|FG001|Overall Study|Lost to Follow-up|2|||
127645974|NCT04393441|459322669|FG000|Overall Study|Protocol Deviation|2|||
127645975|NCT04393441|459322670|FG001|Overall Study|Protocol Deviation|1|||
127645976|NCT04393441|459322669|FG000|Overall Study|Reason not Specified|1|||
127645977|NCT04393441|459322670|FG001|Overall Study|Reason not Specified|1|||
127645978|NCT02472964|459322673|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
127645979|NCT02472964|459322674|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
127645980|NCT02472964|459322673|FG000|Part 1 (up to Week 24)|disease progression|58|||
127645981|NCT02472964|459322674|FG001|Part 1 (up to Week 24)|disease progression|47|||
127645982|NCT02472964|459322673|FG000|Part 1 (up to Week 24)|Death|3|||
127645983|NCT02472964|459322674|FG001|Part 1 (up to Week 24)|Death|6|||
127645984|NCT02472964|459322673|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
127645985|NCT02472964|459322674|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
127645986|NCT02472964|459322673|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
127645987|NCT02472964|459322674|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
127645988|NCT02472964|459322673|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
127645989|NCT02472964|459322674|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
127645990|NCT02472964|459322673|FG000|Part 1 (up to Week 24)|Other|2|||
127645991|NCT02472964|459322674|FG001|Part 1 (up to Week 24)|Other|1|||
127645992|NCT02472964|459322673|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
127645993|NCT02472964|459322674|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
127645994|NCT02472964|459322673|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
127645995|NCT02472964|459322674|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
127645996|NCT02472964|459322673|FG000|Part 2 (Week 24-week 48)|Death|0|||
127645997|NCT02472964|459322674|FG001|Part 2 (Week 24-week 48)|Death|1|||
127645998|NCT02472964|459322673|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
127645999|NCT02472964|459322674|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
127646000|NCT02472964|459322673|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
127646001|NCT02472964|459322674|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
127646002|NCT02472964|459322673|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
127646003|NCT02472964|459322674|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
127646004|NCT02472964|459322673|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
127646005|NCT02472964|459322674|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
127646006|NCT00689221|459322680|FG000|Overall Study|Ongoing at cut-off date|39|||
127646007|NCT00689221|459322681|FG001|Overall Study|Ongoing at cut-off date|36|||
127646008|NCT01749982|459322682|FG000|Overall Study|Physician Decision|0|||
127646009|NCT01749982|459322683|FG001|Overall Study|Physician Decision|0|||
127646010|NCT01749982|459322684|FG002|Overall Study|Physician Decision|0|||
127646011|NCT01749982|459322685|FG003|Overall Study|Physician Decision|1|||
127646012|NCT01749982|459322682|FG000|Overall Study|Lost to Follow-up|0|||
127800169|NCT01665144|459889787|FG002|Extension Part|Adverse Event|59|||
127646013|NCT01749982|459322683|FG001|Overall Study|Lost to Follow-up|0|||
127646014|NCT01749982|459322684|FG002|Overall Study|Lost to Follow-up|0|||
127646015|NCT01749982|459322685|FG003|Overall Study|Lost to Follow-up|1|||
127646016|NCT01749982|459322682|FG000|Overall Study|Withdrawal by Subject|0|||
127646017|NCT01749982|459322683|FG001|Overall Study|Withdrawal by Subject|0|||
127646018|NCT01749982|459322684|FG002|Overall Study|Withdrawal by Subject|0|||
127800170|NCT01665144|459889785|FG000|Extension Part|Study closed early|42|||
127800171|NCT01665144|459889786|FG001|Extension Part|Study closed early|0|||
127800172|NCT01665144|459889787|FG002|Extension Part|Study closed early|19|||
127800173|NCT01665144|459889785|FG000|Extension Part|Progressive disease|36|||
127800174|NCT01665144|459889786|FG001|Extension Part|Progressive disease|0|||
127800175|NCT01665144|459889787|FG002|Extension Part|Progressive disease|14|||
127800176|NCT01665144|459889785|FG000|Extension Part|Lack of Efficacy|37|||
127800177|NCT01665144|459889786|FG001|Extension Part|Lack of Efficacy|0|||
127800178|NCT01665144|459889787|FG002|Extension Part|Lack of Efficacy|12|||
127800179|NCT01665144|459889785|FG000|Extension Part|Physician Decision|29|||
127800180|NCT01665144|459889786|FG001|Extension Part|Physician Decision|0|||
127800181|NCT01665144|459889787|FG002|Extension Part|Physician Decision|13|||
127800182|NCT01665144|459889785|FG000|Extension Part|Technical problems|20|||
127800183|NCT01665144|459889786|FG001|Extension Part|Technical problems|0|||
127800184|NCT01665144|459889787|FG002|Extension Part|Technical problems|8|||
127800185|NCT01665144|459889785|FG000|Extension Part|Death|20|||
127800186|NCT01665144|459889786|FG001|Extension Part|Death|0|||
127800187|NCT01665144|459889787|FG002|Extension Part|Death|4|||
127800188|NCT01665144|459889785|FG000|Extension Part|Missing|12|||
127800189|NCT01665144|459889786|FG001|Extension Part|Missing|0|||
127800190|NCT01665144|459889787|FG002|Extension Part|Missing|6|||
127800191|NCT01665144|459889785|FG000|Extension Part|Lost to Follow-up|9|||
127800192|NCT01665144|459889786|FG001|Extension Part|Lost to Follow-up|0|||
127800193|NCT01665144|459889787|FG002|Extension Part|Lost to Follow-up|5|||
127800194|NCT01665144|459889785|FG000|Extension Part|New therapy for study indication|3|||
127800195|NCT01665144|459889786|FG001|Extension Part|New therapy for study indication|0|||
127800196|NCT01665144|459889787|FG002|Extension Part|New therapy for study indication|2|||
127800197|NCT01665144|459889785|FG000|Extension Part|Protocol deviation|3|||
127800198|NCT01665144|459889786|FG001|Extension Part|Protocol deviation|0|||
127800199|NCT01665144|459889787|FG002|Extension Part|Protocol deviation|0|||
127800200|NCT01913483|459889792|FG000|Overall Study|Withdrawal by Subject|1|||
127800201|NCT01913483|459889793|FG001|Overall Study|Withdrawal by Subject|2|||
127800202|NCT01913483|459889792|FG000|Overall Study|Lost to Follow-up|6|||
127800203|NCT01913483|459889793|FG001|Overall Study|Lost to Follow-up|3|||
127800204|NCT01913483|459889792|FG000|Overall Study|Death|14|||
127800205|NCT01913483|459889793|FG001|Overall Study|Death|17|||
127800206|NCT02302963|459889794|FG000|Overall Study|Withdrawal by Subject|2|||
127800207|NCT02302963|459889795|FG001|Overall Study|Withdrawal by Subject|1|||
127800208|NCT02302963|459889794|FG000|Overall Study|Steroid injection|0|||
127800209|NCT02302963|459889795|FG001|Overall Study|Steroid injection|1|||
127800210|NCT02302963|459889794|FG000|Overall Study|Physician Decision|1|||
127800211|NCT02302963|459889795|FG001|Overall Study|Physician Decision|0|||
127800212|NCT01816243|459889796|FG000|Overall Study|Adverse Event|6|||
127800213|NCT01816243|459889796|FG000|Overall Study|Lost to Follow-up|1|||
127800214|NCT01816243|459889796|FG000|Overall Study|Lack of Efficacy|1|||
127800215|NCT01816243|459889796|FG000|Overall Study|Not eligible for the study|1|||
127800216|NCT01816243|459889796|FG000|Overall Study|Amputation|3|||
127888142|NCT00323609|460213950|FG000|Overall Study|Other reason|11|||
127800217|NCT00915343|459889797|FG000|Part B - Open Label Period|Treatment switch|0|||
127800218|NCT00915343|459889798|FG001|Part B - Open Label Period|Treatment switch|0|||
127800219|NCT00915343|459889799|FG002|Part B - Open Label Period|Treatment switch|1|||
127800220|NCT00915343|459889797|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
127800221|NCT00915343|459889798|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
127800222|NCT00915343|459889799|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
127800223|NCT01920711|459889800|FG000|Overall Study|Death|347|||
127800224|NCT01920711|459889801|FG001|Overall Study|Death|356|||
127800225|NCT01920711|459889800|FG000|Overall Study|Lost to Follow-up|13|||
127800226|NCT01920711|459889801|FG001|Overall Study|Lost to Follow-up|14|||
127800227|NCT01920711|459889800|FG000|Overall Study|Withdrawal by Subject|4|||
127800228|NCT01920711|459889801|FG001|Overall Study|Withdrawal by Subject|3|||
127800229|NCT01145066|459889802|FG000|Overall Study|To resume NSAIDs|2|||
127800230|NCT01145066|459889803|FG001|Overall Study|To resume NSAIDs|2|||
127800231|NCT01145066|459889804|FG002|Overall Study|To resume NSAIDs|1|||
127800232|NCT01145066|459889802|FG000|Overall Study|Non-related surgery|0|||
127800233|NCT01145066|459889803|FG001|Overall Study|Non-related surgery|0|||
127800234|NCT01145066|459889804|FG002|Overall Study|Non-related surgery|1|||
127800235|NCT01145066|459889802|FG000|Overall Study|Withdrawal by Subject|0|||
127800236|NCT01145066|459889803|FG001|Overall Study|Withdrawal by Subject|0|||
127800237|NCT01145066|459889804|FG002|Overall Study|Withdrawal by Subject|2|||
127800238|NCT01145066|459889802|FG000|Overall Study|To start new med|1|||
127800239|NCT01145066|459889803|FG001|Overall Study|To start new med|0|||
127800240|NCT01145066|459889804|FG002|Overall Study|To start new med|0|||
127800241|NCT01145066|459889802|FG000|Overall Study|problems swallowing capsule|1|||
127800242|NCT01145066|459889803|FG001|Overall Study|problems swallowing capsule|0|||
127800243|NCT01145066|459889804|FG002|Overall Study|problems swallowing capsule|0|||
127800244|NCT01145066|459889802|FG000|Overall Study|Abdominal discomfort|0|||
127800245|NCT01145066|459889803|FG001|Overall Study|Abdominal discomfort|1|||
127800246|NCT01145066|459889804|FG002|Overall Study|Abdominal discomfort|0|||
127800247|NCT01145066|459889802|FG000|Overall Study|Low platelet count|0|||
127800248|NCT01145066|459889803|FG001|Overall Study|Low platelet count|1|||
127708424|NCT03536884|459561397|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|1|||
127708425|NCT03536884|459561398|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
127708426|NCT03536884|459561399|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
127708427|NCT03536884|459561400|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
127708428|NCT03536884|459561401|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
127708429|NCT03536884|459561402|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
127708430|NCT03536884|459561403|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
127708431|NCT03536884|459561404|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
127708432|NCT03536884|459561405|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
127708433|NCT03536884|459561406|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
127708434|NCT03536884|459561407|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
127708435|NCT03536884|459561396|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
127708436|NCT03536884|459561397|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|1|||
127708437|NCT03536884|459561398|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
127708438|NCT03536884|459561399|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
127708439|NCT03536884|459561400|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
127708440|NCT03536884|459561401|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
127708441|NCT03536884|459561402|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
127708442|NCT03536884|459561403|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
127708443|NCT03536884|459561404|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
127708444|NCT03536884|459561405|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
127708445|NCT03536884|459561406|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
127708446|NCT03536884|459561407|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
127708447|NCT03536884|459561396|FG000|Double-Blind Period: MTP Wk 16-48|Death|0|||
127708448|NCT03536884|459561397|FG001|Double-Blind Period: MTP Wk 16-48|Death|0|||
127708449|NCT03536884|459561398|FG002|Double-Blind Period: MTP Wk 16-48|Death|1|||
127708450|NCT03536884|459561399|FG003|Double-Blind Period: MTP Wk 16-48|Death|0|||
127708451|NCT03536884|459561400|FG004|Double-Blind Period: MTP Wk 16-48|Death|1|||
127708452|NCT03536884|459561401|FG005|Double-Blind Period: MTP Wk 16-48|Death|0|||
127708453|NCT03536884|459561402|FG006|Double-Blind Period: MTP Wk 16-48|Death|0|||
127708454|NCT03536884|459561403|FG007|Double-Blind Period: MTP Wk 16-48|Death|0|||
127708455|NCT03536884|459561404|FG008|Double-Blind Period: MTP Wk 16-48|Death|0|||
127708456|NCT03536884|459561405|FG009|Double-Blind Period: MTP Wk 16-48|Death|0|||
127708457|NCT03536884|459561406|FG010|Double-Blind Period: MTP Wk 16-48|Death|0|||
127708458|NCT03536884|459561407|FG011|Double-Blind Period: MTP Wk 16-48|Death|0|||
127708459|NCT03536884|459561396|FG000|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
127708460|NCT03536884|459561397|FG001|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
127708461|NCT03536884|459561398|FG002|Double-Blind Period: MTP Wk 16-48|Adverse Event|1|||
127708462|NCT03536884|459561399|FG003|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
127708463|NCT03536884|459561400|FG004|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
127708464|NCT03536884|459561401|FG005|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
127708465|NCT03536884|459561402|FG006|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
127708466|NCT03536884|459561403|FG007|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
127708467|NCT03536884|459561404|FG008|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
127708468|NCT03536884|459561405|FG009|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
127708469|NCT03536884|459561406|FG010|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
127708470|NCT03536884|459561407|FG011|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
127708471|NCT03536884|459561396|FG000|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
127708472|NCT03536884|459561397|FG001|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
127708473|NCT03536884|459561398|FG002|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
127708474|NCT03536884|459561399|FG003|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|1|||
127708475|NCT03536884|459561400|FG004|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|4|||
127708476|NCT03536884|459561401|FG005|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
127708477|NCT03536884|459561402|FG006|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
127708478|NCT03536884|459561403|FG007|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
127708479|NCT03536884|459561404|FG008|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
127708480|NCT03536884|459561405|FG009|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
127708481|NCT03536884|459561406|FG010|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
127708482|NCT03536884|459561407|FG011|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
127800249|NCT01145066|459889804|FG002|Overall Study|Low platelet count|0|||
127800250|NCT03687502|459889809|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
127708483|NCT03536884|459561396|FG000|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
127708484|NCT03536884|459561397|FG001|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
127708485|NCT03536884|459561398|FG002|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|1|||
127708486|NCT03536884|459561399|FG003|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|2|||
127708487|NCT03536884|459561400|FG004|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|9|||
127708488|NCT03536884|459561401|FG005|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
127708489|NCT03536884|459561402|FG006|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
127708490|NCT03536884|459561403|FG007|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
127708491|NCT03536884|459561404|FG008|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
127708492|NCT03536884|459561405|FG009|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
127708493|NCT03536884|459561406|FG010|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
127708494|NCT03536884|459561407|FG011|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
127708495|NCT03536884|459561396|FG000|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
127708496|NCT03536884|459561397|FG001|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
127708497|NCT03536884|459561398|FG002|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|7|||
127708498|NCT03536884|459561399|FG003|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|3|||
127708499|NCT03536884|459561400|FG004|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|12|||
127708500|NCT03536884|459561401|FG005|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
127708501|NCT03536884|459561402|FG006|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
127708502|NCT03536884|459561403|FG007|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
127708503|NCT03536884|459561404|FG008|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
127708504|NCT03536884|459561405|FG009|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
127708505|NCT03536884|459561406|FG010|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
127708506|NCT03536884|459561407|FG011|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
127708507|NCT03536884|459561396|FG000|OLE Period: Wk48-Wk144|Adverse Event|0|||
127708508|NCT03536884|459561397|FG001|OLE Period: Wk48-Wk144|Adverse Event|0|||
127708509|NCT03536884|459561398|FG002|OLE Period: Wk48-Wk144|Adverse Event|0|||
127708510|NCT03536884|459561399|FG003|OLE Period: Wk48-Wk144|Adverse Event|0|||
127708511|NCT03536884|459561400|FG004|OLE Period: Wk48-Wk144|Adverse Event|0|||
127708512|NCT03536884|459561401|FG005|OLE Period: Wk48-Wk144|Adverse Event|10|||
127708513|NCT03536884|459561402|FG006|OLE Period: Wk48-Wk144|Adverse Event|8|||
127708514|NCT03536884|459561403|FG007|OLE Period: Wk48-Wk144|Adverse Event|6|||
127708515|NCT03536884|459561404|FG008|OLE Period: Wk48-Wk144|Adverse Event|13|||
127708516|NCT03536884|459561405|FG009|OLE Period: Wk48-Wk144|Adverse Event|0|||
127708517|NCT03536884|459561406|FG010|OLE Period: Wk48-Wk144|Adverse Event|0|||
127708518|NCT03536884|459561407|FG011|OLE Period: Wk48-Wk144|Adverse Event|0|||
127708519|NCT03536884|459561396|FG000|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
127708520|NCT03536884|459561397|FG001|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
127708521|NCT03536884|459561398|FG002|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
127708522|NCT03536884|459561399|FG003|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
127708523|NCT03536884|459561400|FG004|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
127708524|NCT03536884|459561401|FG005|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
127708525|NCT03536884|459561402|FG006|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
127708526|NCT03536884|459561403|FG007|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
127708527|NCT03536884|459561404|FG008|OLE Period: Wk48-Wk144|Lack of Efficacy|4|||
127708528|NCT03536884|459561405|FG009|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
127708529|NCT03536884|459561406|FG010|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
127708530|NCT03536884|459561407|FG011|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
127708531|NCT03536884|459561396|FG000|OLE Period: Wk48-Wk144|Protocol Violation|0|||
127708532|NCT03536884|459561397|FG001|OLE Period: Wk48-Wk144|Protocol Violation|0|||
127708533|NCT03536884|459561398|FG002|OLE Period: Wk48-Wk144|Protocol Violation|0|||
127800251|NCT03687502|459889809|FG000|Overall Study|Lumason not available|1|||
127800252|NCT01724528|459889813|FG000|Overall Study|Death|3|||
127800253|NCT01724528|459889814|FG001|Overall Study|Death|0|||
127800254|NCT01724528|459889813|FG000|Overall Study|Withdrawal by Subject|0|||
127800255|NCT01724528|459889814|FG001|Overall Study|Withdrawal by Subject|2|||
127800256|NCT01724528|459889813|FG000|Overall Study|Protocol Violation|0|||
127800257|NCT01724528|459889814|FG001|Overall Study|Protocol Violation|1|||
127708534|NCT03536884|459561399|FG003|OLE Period: Wk48-Wk144|Protocol Violation|0|||
127708535|NCT03536884|459561400|FG004|OLE Period: Wk48-Wk144|Protocol Violation|0|||
127708536|NCT03536884|459561401|FG005|OLE Period: Wk48-Wk144|Protocol Violation|1|||
127708537|NCT03536884|459561402|FG006|OLE Period: Wk48-Wk144|Protocol Violation|0|||
127708538|NCT03536884|459561403|FG007|OLE Period: Wk48-Wk144|Protocol Violation|2|||
127800258|NCT01724528|459889813|FG000|Overall Study|Patient refused to attend last visit|1|||
127800259|NCT01724528|459889814|FG001|Overall Study|Patient refused to attend last visit|0|||
127800260|NCT01634555|459889820|FG000|Overall Study|Adverse Event|3|||
127800261|NCT01634555|459889820|FG000|Overall Study|Physician Decision|1|||
127800262|NCT06228586|459889821|FG000|Overall Study|Withdrawal by Participant or Parent/Guardian|3|||
127800263|NCT06228586|459889822|FG001|Overall Study|Withdrawal by Participant or Parent/Guardian|1|||
127800264|NCT01299766|459891357|FG000|Overall Study|Death|5|||
127708539|NCT03536884|459561404|FG008|OLE Period: Wk48-Wk144|Protocol Violation|0|||
127708540|NCT03536884|459561405|FG009|OLE Period: Wk48-Wk144|Protocol Violation|0|||
127708541|NCT03536884|459561406|FG010|OLE Period: Wk48-Wk144|Protocol Violation|0|||
127708542|NCT03536884|459561407|FG011|OLE Period: Wk48-Wk144|Protocol Violation|0|||
127708543|NCT03536884|459561396|FG000|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
127708544|NCT03536884|459561397|FG001|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
127708545|NCT03536884|459561398|FG002|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
127708546|NCT03536884|459561399|FG003|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
127708547|NCT03536884|459561400|FG004|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
127708548|NCT03536884|459561401|FG005|OLE Period: Wk48-Wk144|Lost to Follow-up|7|||
127708549|NCT03536884|459561402|FG006|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
127708550|NCT03536884|459561403|FG007|OLE Period: Wk48-Wk144|Lost to Follow-up|1|||
127708551|NCT03536884|459561404|FG008|OLE Period: Wk48-Wk144|Lost to Follow-up|5|||
127708552|NCT03536884|459561405|FG009|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
127708553|NCT03536884|459561406|FG010|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
127708554|NCT03536884|459561407|FG011|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
127708555|NCT03536884|459561396|FG000|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
127708556|NCT03536884|459561397|FG001|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
127708557|NCT03536884|459561398|FG002|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
127708558|NCT03536884|459561399|FG003|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
127708559|NCT03536884|459561400|FG004|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
127708560|NCT03536884|459561401|FG005|OLE Period: Wk48-Wk144|Withdrawal by Subject|12|||
127708561|NCT03536884|459561402|FG006|OLE Period: Wk48-Wk144|Withdrawal by Subject|7|||
127708562|NCT03536884|459561403|FG007|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
127708563|NCT03536884|459561404|FG008|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
127708564|NCT03536884|459561405|FG009|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
127708565|NCT03536884|459561406|FG010|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
127708566|NCT03536884|459561407|FG011|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
127708567|NCT03536884|459561396|FG000|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
127708568|NCT03536884|459561397|FG001|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
127708569|NCT03536884|459561398|FG002|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
127708570|NCT03536884|459561399|FG003|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
127708571|NCT03536884|459561400|FG004|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
127708572|NCT03536884|459561401|FG005|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|1|||
127708573|NCT03536884|459561402|FG006|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
127708574|NCT03536884|459561403|FG007|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
127708575|NCT03536884|459561404|FG008|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
127708576|NCT03536884|459561405|FG009|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
127708577|NCT03536884|459561406|FG010|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
127708578|NCT03536884|459561407|FG011|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
127708579|NCT03536884|459561396|FG000|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
127708580|NCT03536884|459561397|FG001|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
127708581|NCT03536884|459561398|FG002|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
127708582|NCT03536884|459561399|FG003|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
127708583|NCT03536884|459561400|FG004|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
127708584|NCT03536884|459561401|FG005|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
127708585|NCT03536884|459561402|FG006|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|1|||
127708586|NCT03536884|459561403|FG007|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
127708587|NCT03536884|459561404|FG008|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
127708588|NCT03536884|459561405|FG009|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
127708589|NCT03536884|459561406|FG010|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
127708590|NCT03536884|459561407|FG011|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
127708591|NCT03536884|459561396|FG000|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
127708592|NCT03536884|459561397|FG001|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
127708593|NCT03536884|459561398|FG002|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
127708594|NCT03536884|459561399|FG003|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
127708595|NCT03536884|459561400|FG004|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
127708596|NCT03536884|459561401|FG005|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
127708597|NCT03536884|459561402|FG006|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|1|||
127708598|NCT03536884|459561403|FG007|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
127708599|NCT03536884|459561404|FG008|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
127708600|NCT03536884|459561405|FG009|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
127708601|NCT03536884|459561406|FG010|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
127708602|NCT03536884|459561407|FG011|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
127708603|NCT03536884|459561396|FG000|OLE Period: Wk48-Wk144|Non-compliance|0|||
127708604|NCT03536884|459561397|FG001|OLE Period: Wk48-Wk144|Non-compliance|0|||
127708605|NCT03536884|459561398|FG002|OLE Period: Wk48-Wk144|Non-compliance|0|||
127708606|NCT03536884|459561399|FG003|OLE Period: Wk48-Wk144|Non-compliance|0|||
127708607|NCT03536884|459561400|FG004|OLE Period: Wk48-Wk144|Non-compliance|0|||
127708608|NCT03536884|459561401|FG005|OLE Period: Wk48-Wk144|Non-compliance|1|||
127708609|NCT03536884|459561402|FG006|OLE Period: Wk48-Wk144|Non-compliance|0|||
127708610|NCT03536884|459561403|FG007|OLE Period: Wk48-Wk144|Non-compliance|0|||
127708611|NCT03536884|459561404|FG008|OLE Period: Wk48-Wk144|Non-compliance|0|||
127708612|NCT03536884|459561405|FG009|OLE Period: Wk48-Wk144|Non-compliance|0|||
127708613|NCT03536884|459561406|FG010|OLE Period: Wk48-Wk144|Non-compliance|0|||
127800265|NCT01299766|459891358|FG001|Overall Study|Death|4|||
127800266|NCT01299766|459891357|FG000|Overall Study|Withdrawal by Subject|29|||
127800267|NCT01299766|459891358|FG001|Overall Study|Withdrawal by Subject|19|||
127800268|NCT00403260|459891361|FG000|Overall Study|Adverse Event|5|||
127800269|NCT00403260|459891362|FG001|Overall Study|Adverse Event|4|||
127800270|NCT00403260|459891361|FG000|Overall Study|Withdrawal by Subject|5|||
127800271|NCT00403260|459891362|FG001|Overall Study|Withdrawal by Subject|6|||
127800272|NCT00403260|459891361|FG000|Overall Study|Lost to Follow-up|49|||
127800273|NCT00403260|459891362|FG001|Overall Study|Lost to Follow-up|25|||
127800274|NCT00403260|459891361|FG000|Overall Study|Re-appearance of P. falciparum|34|||
127800275|NCT00403260|459891362|FG001|Overall Study|Re-appearance of P. falciparum|25|||
127800276|NCT00403260|459891361|FG000|Overall Study|P. vivax infection|26|||
127800277|NCT00403260|459891362|FG001|Overall Study|P. vivax infection|4|||
127800278|NCT00403260|459891361|FG000|Overall Study|Mixed infection with P. vivax|2|||
127800279|NCT00403260|459891362|FG001|Overall Study|Mixed infection with P. vivax|0|||
127800280|NCT00403260|459891361|FG000|Overall Study|Mixed infection with P. falciparum|1|||
127800281|NCT00403260|459891362|FG001|Overall Study|Mixed infection with P. falciparum|0|||
127800282|NCT00403260|459891361|FG000|Overall Study|P. vivax infection at screening|1|||
127800283|NCT00403260|459891362|FG001|Overall Study|P. vivax infection at screening|0|||
127888143|NCT00323609|460213951|FG001|Overall Study|Other reason|8|||
127888144|NCT00323609|460213952|FG002|Overall Study|Other reason|4|||
127888145|NCT00323609|460213953|FG003|Overall Study|Other reason|9|||
127888146|NCT02217345|460213954|FG000|Overall Study|Lost to Follow-up|2|||
127708614|NCT03536884|459561407|FG011|OLE Period: Wk48-Wk144|Non-compliance|0|||
127708615|NCT03536884|459561396|FG000|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
127888147|NCT02217345|460213955|FG001|Overall Study|Lost to Follow-up|1|||
127888148|NCT02217345|460213954|FG000|Overall Study|Withdrawal by Subject|3|||
127888149|NCT02217345|460213955|FG001|Overall Study|Withdrawal by Subject|2|||
127888150|NCT02217345|460213954|FG000|Overall Study|Adverse Event|2|||
127888151|NCT02217345|460213955|FG001|Overall Study|Adverse Event|1|||
127888152|NCT02217345|460213954|FG000|Overall Study|Physician Decision|0|||
127888153|NCT02217345|460213955|FG001|Overall Study|Physician Decision|1|||
127888154|NCT00950599|460213959|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
127888155|NCT00950599|460213960|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
127888156|NCT00950599|460213961|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
127888157|NCT00950599|460213962|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
127888158|NCT00950599|460213963|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
127888159|NCT00950599|460213964|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
127888160|NCT00950599|460213965|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
127888161|NCT00950599|460213966|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
127888162|NCT00950599|460213967|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
127888163|NCT00950599|460213968|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
127888164|NCT00950599|460213959|FG000|Double-Blind Treatment Period|Adverse Event|0|||
127888165|NCT00950599|460213960|FG001|Double-Blind Treatment Period|Adverse Event|1|||
127888166|NCT00950599|460213961|FG002|Double-Blind Treatment Period|Adverse Event|1|||
127888167|NCT00950599|460213962|FG003|Double-Blind Treatment Period|Adverse Event|1|||
127888168|NCT00950599|460213963|FG004|Double-Blind Treatment Period|Adverse Event|1|||
127888169|NCT00950599|460213964|FG005|Double-Blind Treatment Period|Adverse Event|1|||
127888170|NCT00950599|460213965|FG006|Double-Blind Treatment Period|Adverse Event|0|||
127888171|NCT00950599|460213966|FG007|Double-Blind Treatment Period|Adverse Event|0|||
127888172|NCT00950599|460213967|FG008|Double-Blind Treatment Period|Adverse Event|0|||
127888173|NCT00950599|460213968|FG009|Double-Blind Treatment Period|Adverse Event|0|||
127888174|NCT00950599|460213959|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
127888175|NCT00950599|460213960|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
127708616|NCT03536884|459561397|FG001|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
127708617|NCT03536884|459561398|FG002|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
127708618|NCT03536884|459561399|FG003|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
127708619|NCT03536884|459561400|FG004|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
127708620|NCT03536884|459561401|FG005|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
127708621|NCT03536884|459561402|FG006|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
127708622|NCT03536884|459561403|FG007|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
127800284|NCT00403260|459891361|FG000|Overall Study|P. ovale infection|1|||
127800285|NCT00403260|459891362|FG001|Overall Study|P. ovale infection|0|||
127800286|NCT00403260|459891361|FG000|Overall Study|Gametocyte re-appearance|1|||
127800287|NCT00403260|459891362|FG001|Overall Study|Gametocyte re-appearance|1|||
127800288|NCT00403260|459891361|FG000|Overall Study|Withdrawn from study accidentally|0|||
127800289|NCT00403260|459891362|FG001|Overall Study|Withdrawn from study accidentally|1|||
127800290|NCT01354028|459891363|FG000|Overall Study|Physician Decision|0|||
127800291|NCT01354028|459891364|FG001|Overall Study|Physician Decision|2|||
127800292|NCT01354028|459891363|FG000|Overall Study|Discharged before study start|2|||
127800293|NCT01354028|459891364|FG001|Overall Study|Discharged before study start|2|||
127800294|NCT01354028|459891363|FG000|Overall Study|No quiet alert state|0|||
127800295|NCT01354028|459891364|FG001|Overall Study|No quiet alert state|1|||
127800296|NCT00935883|459891367|FG000|Treatment Period|Physician Decision|1|||
127800297|NCT00935883|459891368|FG001|Treatment Period|Physician Decision|0|||
127888176|NCT00950599|460213961|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
127888177|NCT00950599|460213962|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
127888178|NCT00950599|460213963|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
127888179|NCT00950599|460213964|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
127800298|NCT00935883|459891367|FG000|Treatment Period|Withdrawal by Subject|0|||
127800299|NCT00935883|459891368|FG001|Treatment Period|Withdrawal by Subject|2|||
127800300|NCT02770326|459891373|FG000|Overall Study|Death|3|||
127800301|NCT02770326|459891373|FG000|Overall Study|Lost to Follow-up|1|||
127800302|NCT02971202|459891374|FG000|Overall Study|Pregnancy|1|||
127800303|NCT02971202|459891375|FG001|Overall Study|Pregnancy|0|||
127800304|NCT02971202|459891376|FG002|Overall Study|Pregnancy|0|||
127800305|NCT02971202|459891374|FG000|Overall Study|screen fail after consent|1|||
127800306|NCT02971202|459891375|FG001|Overall Study|screen fail after consent|0|||
127800307|NCT02971202|459891376|FG002|Overall Study|screen fail after consent|1|||
127800308|NCT01946178|459891377|FG000|Overall Study|Pregnancy|1|||
127888180|NCT00950599|460213965|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
127800309|NCT01946178|459891377|FG000|Overall Study|Lost to Follow-up|1|||
127800310|NCT02634580|459891378|FG000|Double-blind Treatment Period|Subject Request|1|||
127800311|NCT02634580|459891379|FG001|Double-blind Treatment Period|Subject Request|0|||
127800312|NCT02634580|459891380|FG002|Double-blind Treatment Period|Subject Request|1|||
127800313|NCT02634580|459891381|FG003|Double-blind Treatment Period|Subject Request|1|||
127800314|NCT02634580|459891378|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
127800315|NCT02634580|459891379|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
127800316|NCT02634580|459891380|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
127800317|NCT02634580|459891381|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
127800318|NCT01505894|459891382|FG000|Overall Study|Adverse Event|1|||
127800319|NCT01505894|459891383|FG001|Overall Study|Adverse Event|0|||
127800320|NCT01505894|459891384|FG002|Overall Study|Adverse Event|0|||
127800321|NCT01505894|459891385|FG003|Overall Study|Adverse Event|0|||
127800322|NCT01505894|459891386|FG004|Overall Study|Adverse Event|0|||
127800323|NCT01505894|459891387|FG005|Overall Study|Adverse Event|0|||
127800324|NCT01505894|459891388|FG006|Overall Study|Adverse Event|0|||
127800325|NCT01505894|459891389|FG007|Overall Study|Adverse Event|0|||
127800326|NCT01505894|459891390|FG008|Overall Study|Adverse Event|0|||
127800327|NCT01505894|459891382|FG000|Overall Study|Other than specified|0|||
127800328|NCT01505894|459891383|FG001|Overall Study|Other than specified|0|||
127800329|NCT01505894|459891384|FG002|Overall Study|Other than specified|0|||
127800330|NCT01505894|459891385|FG003|Overall Study|Other than specified|0|||
127800331|NCT01505894|459891386|FG004|Overall Study|Other than specified|1|||
127800332|NCT01505894|459891387|FG005|Overall Study|Other than specified|0|||
127800333|NCT01505894|459891388|FG006|Overall Study|Other than specified|0|||
127800334|NCT01505894|459891389|FG007|Overall Study|Other than specified|0|||
127800335|NCT01505894|459891390|FG008|Overall Study|Other than specified|0|||
127800336|NCT01622569|459891391|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
127800337|NCT01622569|459891392|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
127800338|NCT01622569|459891393|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
127800339|NCT01622569|459891394|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
127800340|NCT01622569|459891391|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
127800341|NCT01622569|459891392|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
127800342|NCT01622569|459891393|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
127800343|NCT01622569|459891394|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
127800344|NCT01622569|459891391|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
127800345|NCT01622569|459891392|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
127800346|NCT01622569|459891393|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
127800347|NCT01622569|459891394|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
127800348|NCT01622569|459891391|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
127800349|NCT01622569|459891392|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
127800350|NCT01622569|459891393|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
127800351|NCT01622569|459891394|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
127800352|NCT01622569|459891391|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
127800353|NCT01622569|459891392|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
127800354|NCT01622569|459891393|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
127800355|NCT01622569|459891394|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
127800356|NCT01622569|459891391|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
127800357|NCT01622569|459891392|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
127800358|NCT01622569|459891393|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
127800359|NCT01622569|459891394|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
127800360|NCT01622569|459891391|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
127800361|NCT01622569|459891392|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
127800362|NCT01622569|459891393|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
127888181|NCT00950599|460213966|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
127888182|NCT00950599|460213967|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
127888183|NCT00950599|460213968|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
127646019|NCT01749982|459322685|FG003|Overall Study|Withdrawal by Subject|1|||
127646020|NCT01812655|459322686|FG000|Overall Study|Protocol Violation|1|||
127646021|NCT01812655|459322687|FG001|Overall Study|Protocol Violation|1|||
127646022|NCT01812655|459322688|FG002|Overall Study|Protocol Violation|0|||
127646023|NCT01596582|459322690|FG000|Overall Study|Deemed ineligible after study visit|3|||
127646024|NCT01596582|459322691|FG001|Overall Study|Deemed ineligible after study visit|6|||
127646025|NCT01596582|459322690|FG000|Overall Study|Missing all outcome data|1|||
127646026|NCT01596582|459322691|FG001|Overall Study|Missing all outcome data|1|||
127646027|NCT04672941|459322692|FG000|Overall Study|Investigator decision|1|||
127646028|NCT04672941|459322692|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
127646029|NCT04672941|459322692|FG000|Overall Study|COVID-19 related but no adverse event|1|||
127646030|NCT04672941|459322692|FG000|Overall Study|Adverse Event|2|||
127646031|NCT04672941|459322692|FG000|Overall Study|Lost to Follow-up|2|||
127646032|NCT04435665|459322693|FG000|Overall Study|Lost to Follow-up|0|||
127646033|NCT04435665|459322694|FG001|Overall Study|Lost to Follow-up|0|||
127646034|NCT04435665|459322695|FG002|Overall Study|Lost to Follow-up|0|||
127646035|NCT04435665|459322696|FG003|Overall Study|Lost to Follow-up|1|||
127646036|NCT00765388|459322698|FG000|Period 1|Lack of Efficacy|1|||
127646037|NCT00765388|459322699|FG001|Period 1|Lack of Efficacy|2|||
127646038|NCT00765388|459322698|FG000|Period 1|Lost to Follow-up|0|||
127646039|NCT00765388|459322699|FG001|Period 1|Lost to Follow-up|1|||
127646040|NCT00765388|459322698|FG000|Period 1|Herpes Zoster|0|||
127646041|NCT00765388|459322699|FG001|Period 1|Herpes Zoster|1|||
127646042|NCT00765388|459322698|FG000|Period 1|Hip operation|0|||
127646043|NCT00765388|459322699|FG001|Period 1|Hip operation|1|||
127646044|NCT03923933|459322700|FG000|Overall Study|Lost to Follow-up|1|||
127888184|NCT00950599|460213959|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
127800363|NCT01622569|459891394|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
127646045|NCT03923933|459322701|FG001|Overall Study|Lost to Follow-up|0|||
127646046|NCT03923933|459322700|FG000|Overall Study|Withdrawal by Subject|0|||
127646047|NCT03923933|459322701|FG001|Overall Study|Withdrawal by Subject|1|||
127646048|NCT00419263|459322702|FG000|Overall Study|Lost to Follow-up|2|||
127646049|NCT00419263|459322703|FG001|Overall Study|Lost to Follow-up|1|||
127646050|NCT00419263|459322704|FG002|Overall Study|Lost to Follow-up|1|||
127800364|NCT01622569|459891391|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
127800365|NCT01622569|459891392|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
127800366|NCT01622569|459891393|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
127800367|NCT01622569|459891394|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
127800368|NCT01001702|459891395|FG000|Overall Study|Lost to Follow-up|7|||
127800369|NCT01001702|459891395|FG000|Overall Study|Adverse Event|7|||
127800370|NCT01001702|459891395|FG000|Overall Study|Sponsor Discontinued Study|4|||
127800371|NCT01001702|459891395|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
127800372|NCT01001702|459891395|FG000|Overall Study|Investigator withdrew Subject|10|||
127800373|NCT01001702|459891395|FG000|Overall Study|Withdrawal by Subject|19|||
127800374|NCT01001702|459891395|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
127800375|NCT00584233|459891398|FG000|Overall Study|Withdrawal by Subject|5|||
127800376|NCT00584233|459891398|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
127800377|NCT02222714|459891399|FG000|Overall Study|Death|0|||
127800378|NCT02222714|459891400|FG001|Overall Study|Death|2|||
127800379|NCT02222714|459891401|FG002|Overall Study|Death|3|||
127800380|NCT02222714|459891402|FG003|Overall Study|Death|4|||
127800381|NCT02222714|459891403|FG004|Overall Study|Death|6|||
127800382|NCT02222714|459891399|FG000|Overall Study|Withdrawal by Subject|0|||
127800383|NCT02222714|459891400|FG001|Overall Study|Withdrawal by Subject|0|||
127800384|NCT02222714|459891401|FG002|Overall Study|Withdrawal by Subject|1|||
127800385|NCT02222714|459891402|FG003|Overall Study|Withdrawal by Subject|0|||
127800386|NCT02222714|459891403|FG004|Overall Study|Withdrawal by Subject|1|||
127800387|NCT01940484|459891404|FG000|Overall Study|Withdrawal by Subject|3|||
127800388|NCT01940484|459891404|FG000|Overall Study|Underwent transplantation|4|||
127800389|NCT01940484|459891404|FG000|Overall Study|Death|2|||
127800390|NCT01940484|459891404|FG000|Overall Study|Adverse Event|1|||
127800391|NCT01285908|459891405|FG000|Baseline Measurement|unable to insert catheter|1|||
127800392|NCT01285908|459891406|FG001|Baseline Measurement|unable to insert catheter|0|||
127800393|NCT01285908|459891407|FG002|Baseline Measurement|unable to insert catheter|0|||
127800394|NCT01285908|459891405|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
127800395|NCT01285908|459891406|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
127800396|NCT01285908|459891407|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
127800397|NCT01285908|459891405|FG000|Baseline Measurement|unable to tolerate procedure|1|||
127800398|NCT01285908|459891406|FG001|Baseline Measurement|unable to tolerate procedure|0|||
127800399|NCT01285908|459891407|FG002|Baseline Measurement|unable to tolerate procedure|0|||
127800400|NCT01340209|459891408|FG000|Overall Study|Adverse Event|1|||
127800401|NCT01340209|459891409|FG001|Overall Study|Adverse Event|1|||
127800402|NCT01340209|459891410|FG002|Overall Study|Adverse Event|2|||
127800403|NCT01340209|459891408|FG000|Overall Study|Protocol Violation|1|||
127800404|NCT01340209|459891409|FG001|Overall Study|Protocol Violation|2|||
127800405|NCT01340209|459891410|FG002|Overall Study|Protocol Violation|1|||
127800406|NCT01340209|459891408|FG000|Overall Study|Withdrawal by Subject|0|||
127800407|NCT01340209|459891409|FG001|Overall Study|Withdrawal by Subject|0|||
127800408|NCT01340209|459891410|FG002|Overall Study|Withdrawal by Subject|1|||
127800409|NCT01340209|459891408|FG000|Overall Study|Other reason not defined above|3|||
127800410|NCT01340209|459891409|FG001|Overall Study|Other reason not defined above|5|||
127800411|NCT01340209|459891410|FG002|Overall Study|Other reason not defined above|4|||
127800412|NCT04142983|459891413|FG000|Overall Study|Lost to Follow-up|73|||
127800413|NCT04142983|459891413|FG000|Overall Study|Withdrawal by Subject|10|||
127800414|NCT04142983|459891413|FG000|Overall Study|Physician Decision|1|||
127800415|NCT04142983|459891413|FG000|Overall Study|Adverse Event|1|||
127800416|NCT04142983|459891413|FG000|Overall Study|No longer eligible|4|||
127800417|NCT04142983|459891413|FG000|Overall Study|Screen Failure|10|||
127800418|NCT00643994|459891417|FG000|Overall Study|Death|24|||
127800419|NCT00643994|459891417|FG000|Overall Study|Lost to Follow-up|72|||
127800420|NCT01212185|459891430|FG000|Overall Study|Protocol Violation|2|||
127800421|NCT01212185|459891431|FG001|Overall Study|Protocol Violation|1|||
127800422|NCT00094757|459891432|FG000|Overall Study|Adverse Event|11|||
127800423|NCT00094757|459891433|FG001|Overall Study|Adverse Event|9|||
127800424|NCT00094757|459891434|FG002|Overall Study|Adverse Event|6|||
127800425|NCT00094757|459891432|FG000|Overall Study|Lack of Efficacy|11|||
127800426|NCT00094757|459891433|FG001|Overall Study|Lack of Efficacy|15|||
127800427|NCT00094757|459891434|FG002|Overall Study|Lack of Efficacy|8|||
127800428|NCT00094757|459891432|FG000|Overall Study|Lost to Follow-up|3|||
127800429|NCT00094757|459891433|FG001|Overall Study|Lost to Follow-up|5|||
127800430|NCT00094757|459891434|FG002|Overall Study|Lost to Follow-up|6|||
127800431|NCT00094757|459891432|FG000|Overall Study|Patient Moved|2|||
127800432|NCT00094757|459891433|FG001|Overall Study|Patient Moved|1|||
127800433|NCT00094757|459891434|FG002|Overall Study|Patient Moved|1|||
127800434|NCT00094757|459891432|FG000|Overall Study|Protocol Violation|8|||
127800435|NCT00094757|459891433|FG001|Overall Study|Protocol Violation|5|||
127800436|NCT00094757|459891434|FG002|Overall Study|Protocol Violation|3|||
127800437|NCT00094757|459891432|FG000|Overall Study|Withdrawal by Subject|14|||
127800438|NCT00094757|459891433|FG001|Overall Study|Withdrawal by Subject|21|||
127888185|NCT00950599|460213960|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
127888186|NCT00950599|460213961|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
127888187|NCT00950599|460213962|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
127888188|NCT00950599|460213963|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
127888189|NCT00950599|460213964|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
127888190|NCT00950599|460213965|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
127888191|NCT00950599|460213966|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
127888192|NCT00950599|460213967|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
127888193|NCT00950599|460213968|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
127888194|NCT00950599|460213959|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
127888195|NCT00950599|460213960|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
127888196|NCT00950599|460213961|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
127888197|NCT00950599|460213962|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
127888198|NCT00950599|460213963|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
127888199|NCT00950599|460213964|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
127888200|NCT00950599|460213965|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
127888201|NCT00950599|460213966|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
127888202|NCT00950599|460213967|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
127888203|NCT00950599|460213968|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
127888204|NCT00950599|460213959|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
127888205|NCT00950599|460213960|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
127888206|NCT00950599|460213961|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
127888207|NCT00950599|460213962|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
127888208|NCT00950599|460213963|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
127888209|NCT00950599|460213964|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
127888210|NCT00950599|460213965|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
127888211|NCT00950599|460213966|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
127888212|NCT00950599|460213967|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
127888213|NCT00950599|460213968|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
127888214|NCT00950599|460213959|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
127888215|NCT00950599|460213960|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
127646051|NCT00419263|459322702|FG000|Overall Study|Randomized in Error, Not Treated|1|||
127646052|NCT00419263|459322703|FG001|Overall Study|Randomized in Error, Not Treated|1|||
127646053|NCT00419263|459322704|FG002|Overall Study|Randomized in Error, Not Treated|0|||
127800439|NCT00094757|459891434|FG002|Overall Study|Withdrawal by Subject|5|||
127800440|NCT00094757|459891432|FG000|Overall Study|Other|3|||
127800441|NCT00094757|459891433|FG001|Overall Study|Other|3|||
127800442|NCT00094757|459891434|FG002|Overall Study|Other|1|||
127800443|NCT00094757|459891432|FG000|Overall Study|Protocol specified discontinuation|1|||
127800444|NCT00094757|459891433|FG001|Overall Study|Protocol specified discontinuation|3|||
127800445|NCT00094757|459891434|FG002|Overall Study|Protocol specified discontinuation|0|||
127800446|NCT00756938|459891435|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
127800447|NCT00756938|459891436|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
127800448|NCT00756938|459891437|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
127800449|NCT00756938|459891438|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
127800450|NCT00756938|459891435|FG000|12-week Base Study|Protocol Violation|0|||
127800451|NCT00756938|459891436|FG001|12-week Base Study|Protocol Violation|0|||
127800452|NCT00756938|459891437|FG002|12-week Base Study|Protocol Violation|1|||
127800453|NCT00756938|459891438|FG003|12-week Base Study|Protocol Violation|0|||
127800454|NCT00756938|459891435|FG000|12-week Base Study|Lost to Follow-up|1|||
127800455|NCT00756938|459891436|FG001|12-week Base Study|Lost to Follow-up|0|||
127800456|NCT00756938|459891437|FG002|12-week Base Study|Lost to Follow-up|0|||
127800457|NCT00756938|459891438|FG003|12-week Base Study|Lost to Follow-up|0|||
127800458|NCT00756938|459891435|FG000|Optional Extension|Lack of Efficacy|0|||
127800459|NCT00756938|459891436|FG001|Optional Extension|Lack of Efficacy|0|||
127800460|NCT00756938|459891437|FG002|Optional Extension|Lack of Efficacy|0|||
127800461|NCT00756938|459891438|FG003|Optional Extension|Lack of Efficacy|1|||
127800462|NCT00756938|459891435|FG000|Optional Extension|End of Study|0|||
127800463|NCT00756938|459891436|FG001|Optional Extension|End of Study|0|||
127800464|NCT00756938|459891437|FG002|Optional Extension|End of Study|0|||
127888216|NCT00950599|460213961|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
127888217|NCT00950599|460213962|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
127800465|NCT00756938|459891438|FG003|Optional Extension|End of Study|11|||
127646054|NCT00419263|459322702|FG000|Overall Study|Adverse Event|0|||
127646055|NCT00419263|459322703|FG001|Overall Study|Adverse Event|0|||
127800466|NCT00756938|459891435|FG000|Optional Extension|Protocol-specific criteria met|0|||
127646056|NCT00419263|459322704|FG002|Overall Study|Adverse Event|1|||
127646057|NCT00419263|459322702|FG000|Overall Study|Withdrawal by Subject|0|||
127646058|NCT00419263|459322703|FG001|Overall Study|Withdrawal by Subject|0|||
127646059|NCT00419263|459322704|FG002|Overall Study|Withdrawal by Subject|1|||
127646060|NCT01563536|459322715|FG000|Overall Study|Withdrawal by Subject|0|||
127646061|NCT01563536|459322716|FG001|Overall Study|Withdrawal by Subject|2|||
127646062|NCT01563536|459322715|FG000|Overall Study|Lost to Follow-up|1|||
127646063|NCT01563536|459322716|FG001|Overall Study|Lost to Follow-up|0|||
127646064|NCT00538590|459322722|FG000|Overall Study|Death|1|||
127646065|NCT00538590|459322723|FG001|Overall Study|Death|0|||
127646066|NCT00671931|459322727|FG000|Overall Study|Physician Decision|1|||
127646067|NCT00671931|459322728|FG001|Overall Study|Physician Decision|0|||
127646068|NCT00671931|459322729|FG002|Overall Study|Physician Decision|0|||
127646069|NCT00671931|459322730|FG003|Overall Study|Physician Decision|2|||
127646070|NCT00671931|459322731|FG004|Overall Study|Physician Decision|1|||
127646071|NCT02151266|459322735|FG000|Overall Study|Lost to Follow-up|1|||
127646072|NCT02151266|459322736|FG001|Overall Study|Lost to Follow-up|4|||
127646073|NCT02151266|459322737|FG002|Overall Study|Lost to Follow-up|1|||
127646074|NCT02151266|459322735|FG000|Overall Study|Did NOT receive intervention|3|||
127708623|NCT03536884|459561404|FG008|OLE Period: Wk48-Wk144|She wants to be pregnant|1|||
127708624|NCT03536884|459561405|FG009|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
127708625|NCT03536884|459561406|FG010|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
127708626|NCT03536884|459561407|FG011|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
127708627|NCT03536884|459561396|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
127708628|NCT03536884|459561397|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
127708629|NCT03536884|459561398|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
127708630|NCT03536884|459561399|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
127708631|NCT03536884|459561400|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
127708632|NCT03536884|459561401|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
127708633|NCT03536884|459561402|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
127708634|NCT03536884|459561403|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
127708635|NCT03536884|459561404|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
127708636|NCT03536884|459561405|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
127708637|NCT03536884|459561406|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
127708638|NCT03536884|459561407|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
127708639|NCT03536884|459561396|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
127708640|NCT03536884|459561397|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
127708641|NCT03536884|459561398|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
127708642|NCT03536884|459561399|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
127708643|NCT03536884|459561400|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
127708644|NCT03536884|459561401|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
127708645|NCT03536884|459561402|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
127708646|NCT03536884|459561403|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
127708647|NCT03536884|459561404|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
127708648|NCT03536884|459561405|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
127708649|NCT03536884|459561406|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
127708650|NCT03536884|459561407|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
127708651|NCT03536884|459561396|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
127708652|NCT03536884|459561397|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
127708653|NCT03536884|459561398|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
127708654|NCT03536884|459561399|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
127708655|NCT03536884|459561400|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
127708656|NCT03536884|459561401|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
127708657|NCT03536884|459561402|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
127708658|NCT03536884|459561403|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
127708659|NCT03536884|459561404|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
127708660|NCT03536884|459561405|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
127708661|NCT03536884|459561406|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|1|||
127708662|NCT03536884|459561407|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
127708663|NCT03536884|459561396|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
127708664|NCT03536884|459561397|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
127708665|NCT03536884|459561398|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
127708666|NCT03536884|459561399|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
127708667|NCT03536884|459561400|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
127646075|NCT02151266|459322736|FG001|Overall Study|Did NOT receive intervention|6|||
127888218|NCT00950599|460213963|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
127888219|NCT00950599|460213964|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
127888220|NCT00950599|460213965|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
127888221|NCT00950599|460213966|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
127888222|NCT00950599|460213967|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
127888223|NCT00950599|460213968|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
127888224|NCT00950599|460213959|FG000|Follow-Up Period|Adverse Event|0|||
127888225|NCT00950599|460213960|FG001|Follow-Up Period|Adverse Event|0|||
127888226|NCT00950599|460213961|FG002|Follow-Up Period|Adverse Event|0|||
127888227|NCT00950599|460213962|FG003|Follow-Up Period|Adverse Event|0|||
127888228|NCT00950599|460213963|FG004|Follow-Up Period|Adverse Event|0|||
127888229|NCT00950599|460213964|FG005|Follow-Up Period|Adverse Event|0|||
127888230|NCT00950599|460213965|FG006|Follow-Up Period|Adverse Event|0|||
127888231|NCT00950599|460213966|FG007|Follow-Up Period|Adverse Event|0|||
127888232|NCT00950599|460213967|FG008|Follow-Up Period|Adverse Event|1|||
127888233|NCT00950599|460213968|FG009|Follow-Up Period|Adverse Event|0|||
127646076|NCT02151266|459322737|FG002|Overall Study|Did NOT receive intervention|2|||
127646077|NCT02151266|459322735|FG000|Overall Study|Not able to exercise|4|||
127646078|NCT02151266|459322736|FG001|Overall Study|Not able to exercise|5|||
127646079|NCT02151266|459322737|FG002|Overall Study|Not able to exercise|4|||
127646080|NCT02355028|459322743|FG000|Overall Study|Adverse Event|2|||
127646081|NCT02355028|459322744|FG001|Overall Study|Adverse Event|0|||
127646082|NCT02355028|459322743|FG000|Overall Study|Withdrawal by Subject|1|||
127646083|NCT02355028|459322744|FG001|Overall Study|Withdrawal by Subject|1|||
127646084|NCT02355028|459322743|FG000|Overall Study|Deemed ineligible after randomization|8|||
127646085|NCT02355028|459322744|FG001|Overall Study|Deemed ineligible after randomization|4|||
127646086|NCT02276222|459322745|FG000|Overall Study|Adverse Event|62|||
127646087|NCT02276222|459322746|FG001|Overall Study|Adverse Event|11|||
127646088|NCT02276222|459322745|FG000|Overall Study|Death|3|||
127646089|NCT02276222|459322746|FG001|Overall Study|Death|4|||
127646090|NCT02276222|459322745|FG000|Overall Study|Lack of Efficacy|13|||
127646091|NCT02276222|459322746|FG001|Overall Study|Lack of Efficacy|3|||
127646092|NCT02276222|459322745|FG000|Overall Study|Protocol Violation|3|||
127646093|NCT02276222|459322746|FG001|Overall Study|Protocol Violation|2|||
127646094|NCT02276222|459322745|FG000|Overall Study|Withdrawal by Subject|79|||
127646095|NCT02276222|459322746|FG001|Overall Study|Withdrawal by Subject|33|||
127646096|NCT02276222|459322745|FG000|Overall Study|non compliance with study medication|6|||
127646097|NCT02276222|459322746|FG001|Overall Study|non compliance with study medication|2|||
127646098|NCT02276222|459322745|FG000|Overall Study|sponsor decision|0|||
127646099|NCT02276222|459322746|FG001|Overall Study|sponsor decision|3|||
127646100|NCT02276222|459322745|FG000|Overall Study|Lost to Follow-up|15|||
127646101|NCT02276222|459322746|FG001|Overall Study|Lost to Follow-up|5|||
127646102|NCT02276222|459322745|FG000|Overall Study|Physician Decision|2|||
127646103|NCT02276222|459322746|FG001|Overall Study|Physician Decision|1|||
127646104|NCT02276222|459322745|FG000|Overall Study|sheduling conflict|1|||
127646105|NCT02276222|459322746|FG001|Overall Study|sheduling conflict|0|||
127646106|NCT02276222|459322745|FG000|Overall Study|subject withdrew after randomization|1|||
127646107|NCT02276222|459322746|FG001|Overall Study|subject withdrew after randomization|0|||
127646108|NCT01971723|459322747|FG000|Overall Study|Withdrawal by Subject|1|||
127646109|NCT01971723|459322748|FG001|Overall Study|Withdrawal by Subject|1|||
127646110|NCT01971723|459322747|FG000|Overall Study|Protocol Violation|1|||
127646111|NCT01971723|459322748|FG001|Overall Study|Protocol Violation|2|||
127646112|NCT05899686|459322749|FG000|Overall Study|Protocol Violation|1|||
127646113|NCT03645759|459322750|FG000|Overall Study|Lost to Follow-up|3|||
127646114|NCT03645759|459322751|FG001|Overall Study|Lost to Follow-up|2|||
127646115|NCT01648270|459322752|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
127646116|NCT00902694|459322753|FG000|Overall Study|Death|1|||
127708668|NCT03536884|459561401|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
127888234|NCT00950599|460213959|FG000|Follow-Up Period|Lack of Efficacy|0|||
127888235|NCT00950599|460213960|FG001|Follow-Up Period|Lack of Efficacy|0|||
127888236|NCT00950599|460213961|FG002|Follow-Up Period|Lack of Efficacy|0|||
127888237|NCT00950599|460213962|FG003|Follow-Up Period|Lack of Efficacy|0|||
127888238|NCT00950599|460213963|FG004|Follow-Up Period|Lack of Efficacy|0|||
127646117|NCT00902694|459322754|FG001|Overall Study|Death|3|||
127646118|NCT00902694|459322753|FG000|Overall Study|Lost to Follow-up|1|||
127646119|NCT00902694|459322754|FG001|Overall Study|Lost to Follow-up|0|||
127646120|NCT00902694|459322753|FG000|Overall Study|Censored per protocol|3|||
127646121|NCT00902694|459322754|FG001|Overall Study|Censored per protocol|1|||
127646122|NCT00902694|459322753|FG000|Overall Study|Pregnancy|1|||
127646123|NCT00902694|459322754|FG001|Overall Study|Pregnancy|1|||
127646124|NCT00902694|459322753|FG000|Overall Study|Incarceration|1|||
127646125|NCT00902694|459322754|FG001|Overall Study|Incarceration|0|||
127646126|NCT04969263|459322755|FG000|Overall Study|Death|1|||
127646127|NCT04969263|459322755|FG000|Overall Study|Lost to Follow-up|2|||
127646128|NCT04969263|459322755|FG000|Overall Study|Withdrawal by Subject|5|||
127888239|NCT00950599|460213964|FG005|Follow-Up Period|Lack of Efficacy|0|||
127888240|NCT00950599|460213965|FG006|Follow-Up Period|Lack of Efficacy|0|||
127888241|NCT00950599|460213966|FG007|Follow-Up Period|Lack of Efficacy|0|||
127888242|NCT00950599|460213967|FG008|Follow-Up Period|Lack of Efficacy|3|||
127888243|NCT00950599|460213968|FG009|Follow-Up Period|Lack of Efficacy|0|||
127888244|NCT00950599|460213959|FG000|Follow-Up Period|Lost to Follow-up|0|||
127888245|NCT00950599|460213960|FG001|Follow-Up Period|Lost to Follow-up|0|||
127888246|NCT00950599|460213961|FG002|Follow-Up Period|Lost to Follow-up|0|||
127888247|NCT00950599|460213962|FG003|Follow-Up Period|Lost to Follow-up|0|||
127888248|NCT00950599|460213963|FG004|Follow-Up Period|Lost to Follow-up|0|||
127888249|NCT00950599|460213964|FG005|Follow-Up Period|Lost to Follow-up|0|||
127888250|NCT00950599|460213965|FG006|Follow-Up Period|Lost to Follow-up|0|||
127888251|NCT00950599|460213966|FG007|Follow-Up Period|Lost to Follow-up|0|||
127888252|NCT00950599|460213967|FG008|Follow-Up Period|Lost to Follow-up|5|||
127888253|NCT00950599|460213968|FG009|Follow-Up Period|Lost to Follow-up|1|||
127888254|NCT00950599|460213959|FG000|Follow-Up Period|Physician Decision|0|||
127888255|NCT00950599|460213960|FG001|Follow-Up Period|Physician Decision|0|||
127888256|NCT00950599|460213961|FG002|Follow-Up Period|Physician Decision|0|||
127888257|NCT00950599|460213962|FG003|Follow-Up Period|Physician Decision|0|||
127888258|NCT00950599|460213963|FG004|Follow-Up Period|Physician Decision|0|||
127888259|NCT00950599|460213964|FG005|Follow-Up Period|Physician Decision|0|||
127888260|NCT00950599|460213965|FG006|Follow-Up Period|Physician Decision|0|||
127888261|NCT00950599|460213966|FG007|Follow-Up Period|Physician Decision|0|||
127888262|NCT00950599|460213967|FG008|Follow-Up Period|Physician Decision|1|||
127888263|NCT00950599|460213968|FG009|Follow-Up Period|Physician Decision|0|||
127888264|NCT00950599|460213959|FG000|Follow-Up Period|Poor/Noncompliance|0|||
127888265|NCT00950599|460213960|FG001|Follow-Up Period|Poor/Noncompliance|0|||
127888266|NCT00950599|460213961|FG002|Follow-Up Period|Poor/Noncompliance|0|||
127888267|NCT00950599|460213962|FG003|Follow-Up Period|Poor/Noncompliance|0|||
127888268|NCT00950599|460213963|FG004|Follow-Up Period|Poor/Noncompliance|0|||
127888269|NCT00950599|460213964|FG005|Follow-Up Period|Poor/Noncompliance|0|||
127888270|NCT00950599|460213965|FG006|Follow-Up Period|Poor/Noncompliance|0|||
127888271|NCT00950599|460213966|FG007|Follow-Up Period|Poor/Noncompliance|0|||
127888272|NCT00950599|460213967|FG008|Follow-Up Period|Poor/Noncompliance|1|||
127888273|NCT00950599|460213968|FG009|Follow-Up Period|Poor/Noncompliance|0|||
127888274|NCT00950599|460213959|FG000|Follow-Up Period|Subject withdrew Consent|0|||
127888275|NCT00950599|460213960|FG001|Follow-Up Period|Subject withdrew Consent|0|||
127888276|NCT00950599|460213961|FG002|Follow-Up Period|Subject withdrew Consent|0|||
127888277|NCT00950599|460213962|FG003|Follow-Up Period|Subject withdrew Consent|0|||
127888278|NCT00950599|460213963|FG004|Follow-Up Period|Subject withdrew Consent|0|||
127888279|NCT00950599|460213964|FG005|Follow-Up Period|Subject withdrew Consent|0|||
127888280|NCT00950599|460213965|FG006|Follow-Up Period|Subject withdrew Consent|0|||
127888281|NCT00950599|460213966|FG007|Follow-Up Period|Subject withdrew Consent|0|||
127888282|NCT00950599|460213967|FG008|Follow-Up Period|Subject withdrew Consent|2|||
127888283|NCT00950599|460213968|FG009|Follow-Up Period|Subject withdrew Consent|1|||
127888284|NCT00971204|460213970|FG000|Overall Study|Did not meet all criteria-not treated|14|||
127888285|NCT00971204|460213970|FG000|Overall Study|Lost to Follow-up|10|||
127888286|NCT02729194|460213971|FG000|Overall Study|Withdrawal by Subject|3|||
127888287|NCT01401478|460213974|FG000|Overall Study|Study drug not available|6|||
127888288|NCT01401478|460213974|FG000|Overall Study|Adverse Event|5|||
127888289|NCT01401478|460213974|FG000|Overall Study|Hyperphosphatemia|5|||
127888290|NCT01401478|460213974|FG000|Overall Study|Lost to Follow-up|5|||
127888291|NCT01401478|460213974|FG000|Overall Study|Kidney transplantation|3|||
127888292|NCT01401478|460213974|FG000|Overall Study|Withdrawal by Subject|3|||
127888293|NCT01401478|460213974|FG000|Overall Study|Blood samples not available|1|||
127646129|NCT04969263|459322755|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
127646130|NCT03657277|459322757|FG000|Overall Study|Physician Decision|2|||
127646131|NCT03657277|459322757|FG000|Overall Study|Lost to Follow-up|1|||
127646132|NCT03657277|459322757|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
127646133|NCT02693743|459322758|FG000|Overall Study|Physician Decision|1|||
127646134|NCT02693743|459322759|FG001|Overall Study|Physician Decision|0|||
127888294|NCT01401478|460213974|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
127888295|NCT01401478|460213974|FG000|Overall Study|Low intact parathyroid hormone|1|||
127888296|NCT01401478|460213974|FG000|Overall Study|Serious adverse event|1|||
127888297|NCT01684722|460213975|FG000|Overall Study|Lost to Follow-up|78|||
127888298|NCT01684722|460213976|FG001|Overall Study|Lost to Follow-up|56|||
127888299|NCT01684722|460213977|FG002|Overall Study|Lost to Follow-up|75|||
127888300|NCT01684722|460213978|FG003|Overall Study|Lost to Follow-up|89|||
127888301|NCT01684722|460213975|FG000|Overall Study|Death|19|||
127888302|NCT01684722|460213976|FG001|Overall Study|Death|21|||
127888303|NCT01684722|460213977|FG002|Overall Study|Death|19|||
127646135|NCT01024608|459322760|FG000|Overall Study|Adverse Event|1|||
127646136|NCT01024608|459322761|FG001|Overall Study|Adverse Event|0|||
127646137|NCT01024608|459322760|FG000|Overall Study|Withdrawal by Subject|1|||
127888304|NCT01684722|460213978|FG003|Overall Study|Death|21|||
127800467|NCT00756938|459891436|FG001|Optional Extension|Protocol-specific criteria met|0|||
127800468|NCT00756938|459891437|FG002|Optional Extension|Protocol-specific criteria met|0|||
127800469|NCT00756938|459891438|FG003|Optional Extension|Protocol-specific criteria met|9|||
127800470|NCT00756938|459891435|FG000|Optional Extension|Physician Decision|0|||
127800471|NCT00756938|459891436|FG001|Optional Extension|Physician Decision|0|||
127800472|NCT00756938|459891437|FG002|Optional Extension|Physician Decision|0|||
127800473|NCT00756938|459891438|FG003|Optional Extension|Physician Decision|3|||
127800474|NCT00756938|459891435|FG000|Optional Extension|Lost to Follow-up|0|||
127800475|NCT00756938|459891436|FG001|Optional Extension|Lost to Follow-up|0|||
127800476|NCT00756938|459891437|FG002|Optional Extension|Lost to Follow-up|0|||
127800477|NCT00756938|459891438|FG003|Optional Extension|Lost to Follow-up|1|||
127800478|NCT00756938|459891435|FG000|Optional Extension|Protocol Violation|0|||
127800479|NCT00756938|459891436|FG001|Optional Extension|Protocol Violation|0|||
127800480|NCT00756938|459891437|FG002|Optional Extension|Protocol Violation|0|||
127800481|NCT00756938|459891438|FG003|Optional Extension|Protocol Violation|1|||
127800482|NCT00756938|459891435|FG000|Optional Extension|Withdrawal by Subject|0|||
127800483|NCT00756938|459891436|FG001|Optional Extension|Withdrawal by Subject|0|||
127800484|NCT00756938|459891437|FG002|Optional Extension|Withdrawal by Subject|0|||
127800485|NCT00756938|459891438|FG003|Optional Extension|Withdrawal by Subject|10|||
127800486|NCT00756938|459891435|FG000|Optional Extension|Adverse Event|0|||
127800487|NCT00756938|459891436|FG001|Optional Extension|Adverse Event|0|||
127800488|NCT00756938|459891437|FG002|Optional Extension|Adverse Event|0|||
127800489|NCT00756938|459891438|FG003|Optional Extension|Adverse Event|1|||
127800490|NCT04317274|459891439|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
127800491|NCT04317274|459891440|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
127800492|NCT04317274|459891441|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
127800493|NCT04317274|459891442|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
127800494|NCT00797823|459891444|FG000|First Period (Initial Randomization)|Physician Decision|1|||
127800495|NCT00797823|459891445|FG001|First Period (Initial Randomization)|Physician Decision|0|||
127800496|NCT00797823|459891446|FG002|First Period (Initial Randomization)|Physician Decision|0|||
127800497|NCT02568046|459891447|FG000|Overall Study|Adverse Event|0|||
127800498|NCT02568046|459891448|FG001|Overall Study|Adverse Event|1|||
127800499|NCT02568046|459891447|FG000|Overall Study|Death|2|||
127800500|NCT02568046|459891448|FG001|Overall Study|Death|0|||
127800501|NCT02568046|459891447|FG000|Overall Study|Progressive Disease|1|||
127800502|NCT02568046|459891448|FG001|Overall Study|Progressive Disease|0|||
127800503|NCT02568046|459891447|FG000|Overall Study|Withdrawal by Subject|2|||
127800504|NCT02568046|459891448|FG001|Overall Study|Withdrawal by Subject|1|||
127800505|NCT02568046|459891447|FG000|Overall Study|Other Events|0|||
127800506|NCT02568046|459891448|FG001|Overall Study|Other Events|1|||
127800507|NCT03403192|459891451|FG000|Overall Study|Lost to Follow-up|1|||
127800508|NCT03403192|459891452|FG001|Overall Study|Lost to Follow-up|2|||
127800509|NCT03403192|459891453|FG002|Overall Study|Lost to Follow-up|0|||
127800510|NCT03403192|459891454|FG003|Overall Study|Lost to Follow-up|0|||
127800511|NCT03403192|459891451|FG000|Overall Study|Unable to respond|0|||
127800512|NCT03403192|459891452|FG001|Overall Study|Unable to respond|1|||
127800513|NCT03403192|459891453|FG002|Overall Study|Unable to respond|0|||
127800514|NCT03403192|459891454|FG003|Overall Study|Unable to respond|0|||
127800515|NCT03403192|459891451|FG000|Overall Study|Incomplete|3|||
127800516|NCT03403192|459891452|FG001|Overall Study|Incomplete|1|||
127800517|NCT03403192|459891453|FG002|Overall Study|Incomplete|3|||
127646138|NCT01024608|459322761|FG001|Overall Study|Withdrawal by Subject|0|||
127646139|NCT01024608|459322760|FG000|Overall Study|Lost to Follow-up|0|||
127646140|NCT01024608|459322761|FG001|Overall Study|Lost to Follow-up|1|||
127646141|NCT01024608|459322760|FG000|Overall Study|Protocol Violation|0|||
127646142|NCT01024608|459322761|FG001|Overall Study|Protocol Violation|3|||
127646143|NCT01024608|459322760|FG000|Overall Study|Never received study treatment|2|||
127800518|NCT03403192|459891454|FG003|Overall Study|Incomplete|6|||
127800519|NCT01298492|459891455|FG000|Overall Study|Death|2|||
127800520|NCT01298492|459891455|FG000|Overall Study|Insufficient Clinical Response|22|||
127800521|NCT01298492|459891455|FG000|Overall Study|Lost to Follow-up|12|||
127800522|NCT01298492|459891455|FG000|Overall Study|Withdrawal by Subject|47|||
127646144|NCT01024608|459322761|FG001|Overall Study|Never received study treatment|0|||
127646145|NCT00657618|459322768|FG000|Overall Study|Adverse Event|32|||
127646146|NCT00657618|459322768|FG000|Overall Study|Withdrawal by Subject|8|||
127800523|NCT01298492|459891455|FG000|Overall Study|Other (Unspecified)|7|||
127800524|NCT01298492|459891455|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
127800525|NCT01298492|459891455|FG000|Overall Study|Protocol Violation|2|||
127800526|NCT01298492|459891455|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
127888305|NCT03412019|460213979|FG000|Overall Study|Withdrawal by Subject|1|||
127888306|NCT03412019|460213980|FG001|Overall Study|Withdrawal by Subject|1|||
127888307|NCT00947011|460213982|FG000|Overall Study|Study was terminated,PI left institution|12|||
127646147|NCT00657618|459322768|FG000|Overall Study|negative for leishmaniasis|2|||
127646148|NCT00657618|459322768|FG000|Overall Study|didn't start due to schedule conflicts|1|||
127646149|NCT04922554|459322779|FG000|Overall Study|Adverse Event|4|||
127646150|NCT04922554|459322780|FG001|Overall Study|Adverse Event|0|||
127646151|NCT04922554|459322779|FG000|Overall Study|Withdrawal by Subject|1|||
127646152|NCT04922554|459322780|FG001|Overall Study|Withdrawal by Subject|0|||
127646153|NCT03432364|459324350|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
127646154|NCT03320018|459324351|FG000|Treatment Period|Withdrawal by Subject|1|||
127646155|NCT03320018|459324352|FG001|Treatment Period|Withdrawal by Subject|0|||
127646156|NCT03320018|459324351|FG000|Day 90 Follow up|Death|0|||
127646157|NCT03320018|459324352|FG001|Day 90 Follow up|Death|1|||
127646158|NCT03284788|459324353|FG000|Overall Study|Withdrawal by Subject|2|||
127646159|NCT03104699|459324360|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
127646160|NCT03104699|459324361|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
127646161|NCT03104699|459324362|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
127646162|NCT03104699|459324363|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|8|||
127646163|NCT03104699|459324364|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
127646164|NCT03104699|459324365|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
127646165|NCT03104699|459324360|FG000|Phase 1: Dose Escalation|Physician Decision|0|||
127646166|NCT03104699|459324361|FG001|Phase 1: Dose Escalation|Physician Decision|0|||
127646167|NCT03104699|459324362|FG002|Phase 1: Dose Escalation|Physician Decision|2|||
127646168|NCT03104699|459324363|FG003|Phase 1: Dose Escalation|Physician Decision|1|||
127646169|NCT03104699|459324364|FG004|Phase 1: Dose Escalation|Physician Decision|0|||
127646170|NCT03104699|459324365|FG005|Phase 1: Dose Escalation|Physician Decision|0|||
127646171|NCT03104699|459324360|FG000|Phase 1: Dose Escalation|Death|6|||
127646172|NCT03104699|459324361|FG001|Phase 1: Dose Escalation|Death|3|||
127646173|NCT03104699|459324362|FG002|Phase 1: Dose Escalation|Death|0|||
127646174|NCT03104699|459324363|FG003|Phase 1: Dose Escalation|Death|1|||
127646175|NCT03104699|459324364|FG004|Phase 1: Dose Escalation|Death|1|||
127646176|NCT03104699|459324365|FG005|Phase 1: Dose Escalation|Death|0|||
127646177|NCT03104699|459324360|FG000|Phase 1: Dose Escalation|Completed Follow Up|2|||
127646178|NCT03104699|459324361|FG001|Phase 1: Dose Escalation|Completed Follow Up|2|||
127646179|NCT03104699|459324362|FG002|Phase 1: Dose Escalation|Completed Follow Up|1|||
127646180|NCT03104699|459324363|FG003|Phase 1: Dose Escalation|Completed Follow Up|0|||
127646181|NCT03104699|459324364|FG004|Phase 1: Dose Escalation|Completed Follow Up|2|||
127708669|NCT03536884|459561402|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
127708670|NCT03536884|459561403|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
127708671|NCT03536884|459561404|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
127708672|NCT03536884|459561405|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
127708673|NCT03536884|459561406|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
127708674|NCT03536884|459561407|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|3|||
127708675|NCT03536884|459561396|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
127708676|NCT03536884|459561397|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
127708677|NCT03536884|459561398|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
127708678|NCT03536884|459561399|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
127708679|NCT03536884|459561400|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
127708680|NCT03536884|459561401|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
127708681|NCT03536884|459561402|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
127708682|NCT03536884|459561403|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
127708683|NCT03536884|459561404|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
127708684|NCT03536884|459561405|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
127708685|NCT03536884|459561406|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
127646182|NCT03104699|459324365|FG005|Phase 1: Dose Escalation|Completed Follow Up|0|||
127646183|NCT03104699|459324360|FG000|Phase 1: Dose Escalation|Lost to Follow-up|0|||
127646184|NCT03104699|459324361|FG001|Phase 1: Dose Escalation|Lost to Follow-up|1|||
127646185|NCT03104699|459324362|FG002|Phase 1: Dose Escalation|Lost to Follow-up|1|||
127646186|NCT03104699|459324363|FG003|Phase 1: Dose Escalation|Lost to Follow-up|0|||
127646187|NCT03104699|459324364|FG004|Phase 1: Dose Escalation|Lost to Follow-up|0|||
127646188|NCT03104699|459324365|FG005|Phase 1: Dose Escalation|Lost to Follow-up|0|||
127888308|NCT00479401|460213986|FG000|Overall Study|Adverse Event|24|||
127888309|NCT00479401|460213987|FG001|Overall Study|Adverse Event|20|||
127888310|NCT00479401|460213988|FG002|Overall Study|Adverse Event|4|||
127888311|NCT00479401|460213986|FG000|Overall Study|Lack of Efficacy|2|||
127888312|NCT00479401|460213987|FG001|Overall Study|Lack of Efficacy|2|||
127888313|NCT00479401|460213988|FG002|Overall Study|Lack of Efficacy|4|||
127888314|NCT00479401|460213986|FG000|Overall Study|Protocol Violation|2|||
127888315|NCT00479401|460213987|FG001|Overall Study|Protocol Violation|1|||
127888316|NCT00479401|460213988|FG002|Overall Study|Protocol Violation|1|||
127888317|NCT00479401|460213986|FG000|Overall Study|Lost to Follow-up|1|||
127888318|NCT00479401|460213987|FG001|Overall Study|Lost to Follow-up|1|||
127888319|NCT00479401|460213988|FG002|Overall Study|Lost to Follow-up|1|||
127646189|NCT03104699|459324360|FG000|Phase 1: Dose Escalation|Progressive Disease|0|||
127646190|NCT03104699|459324361|FG001|Phase 1: Dose Escalation|Progressive Disease|0|||
127646191|NCT03104699|459324362|FG002|Phase 1: Dose Escalation|Progressive Disease|0|||
127646192|NCT03104699|459324363|FG003|Phase 1: Dose Escalation|Progressive Disease|0|||
127646193|NCT03104699|459324364|FG004|Phase 1: Dose Escalation|Progressive Disease|1|||
127646194|NCT03104699|459324365|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
127646195|NCT03104699|459324360|FG000|Phase 1: Dose Escalation|Disease Progression|0|||
127646196|NCT03104699|459324361|FG001|Phase 1: Dose Escalation|Disease Progression|2|||
127646197|NCT03104699|459324362|FG002|Phase 1: Dose Escalation|Disease Progression|0|||
127646198|NCT03104699|459324363|FG003|Phase 1: Dose Escalation|Disease Progression|0|||
127646199|NCT03104699|459324364|FG004|Phase 1: Dose Escalation|Disease Progression|0|||
127646200|NCT03104699|459324365|FG005|Phase 1: Dose Escalation|Disease Progression|0|||
127646201|NCT03104699|459324360|FG000|Phase 1: Dose Escalation|Protocol Violation|0|||
127646202|NCT03104699|459324361|FG001|Phase 1: Dose Escalation|Protocol Violation|0|||
127646203|NCT03104699|459324362|FG002|Phase 1: Dose Escalation|Protocol Violation|0|||
127646204|NCT03104699|459324363|FG003|Phase 1: Dose Escalation|Protocol Violation|0|||
127646205|NCT03104699|459324364|FG004|Phase 1: Dose Escalation|Protocol Violation|2|||
127646206|NCT03104699|459324365|FG005|Phase 1: Dose Escalation|Protocol Violation|0|||
127646207|NCT03104699|459324360|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
127646208|NCT03104699|459324361|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
127646209|NCT03104699|459324362|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
127708686|NCT03536884|459561407|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|1|||
127708687|NCT03485729|459561412|FG000|Overall Study|Withdrawal by Subject|0|||
127708688|NCT03485729|459561413|FG001|Overall Study|Withdrawal by Subject|0|||
127708689|NCT03485729|459561414|FG002|Overall Study|Withdrawal by Subject|1|||
127708690|NCT03485729|459561412|FG000|Overall Study|Disease progression|8|||
127708691|NCT03485729|459561413|FG001|Overall Study|Disease progression|13|||
127708692|NCT03485729|459561414|FG002|Overall Study|Disease progression|1|||
127708693|NCT03485729|459561412|FG000|Overall Study|Hospice care|1|||
127708694|NCT03485729|459561413|FG001|Overall Study|Hospice care|0|||
127708695|NCT03485729|459561414|FG002|Overall Study|Hospice care|0|||
127708696|NCT03485729|459561412|FG000|Overall Study|Poor performance status|1|||
127708697|NCT03485729|459561413|FG001|Overall Study|Poor performance status|0|||
127708698|NCT03485729|459561414|FG002|Overall Study|Poor performance status|0|||
127708699|NCT03485729|459561412|FG000|Overall Study|Illness|0|||
127708700|NCT03485729|459561413|FG001|Overall Study|Illness|1|||
127708701|NCT03485729|459561414|FG002|Overall Study|Illness|0|||
127708702|NCT05035654|459561416|FG000|Overall Study|Physician Decision|0|||
127708703|NCT05035654|459561417|FG001|Overall Study|Physician Decision|1|||
127708704|NCT05035654|459561418|FG002|Overall Study|Physician Decision|0|||
127708705|NCT05035654|459561416|FG000|Overall Study|Adverse Event|0|||
127708706|NCT05035654|459561417|FG001|Overall Study|Adverse Event|1|||
127708707|NCT05035654|459561418|FG002|Overall Study|Adverse Event|0|||
127708708|NCT05035654|459561416|FG000|Overall Study|Withdrawal by Subject|0|||
127708709|NCT05035654|459561417|FG001|Overall Study|Withdrawal by Subject|0|||
127708710|NCT05035654|459561418|FG002|Overall Study|Withdrawal by Subject|4|||
127708711|NCT05035654|459561416|FG000|Overall Study|Bilateral Dislodgement|1|||
127708712|NCT05035654|459561417|FG001|Overall Study|Bilateral Dislodgement|0|||
127708713|NCT05035654|459561418|FG002|Overall Study|Bilateral Dislodgement|0|||
127708714|NCT02367040|459561423|FG000|Overall Study|Lost to Follow-up|1|||
127708715|NCT02367040|459561424|FG001|Overall Study|Lost to Follow-up|1|||
127708716|NCT02367040|459561423|FG000|Overall Study|Lack of Efficacy|1|||
127708717|NCT02367040|459561424|FG001|Overall Study|Lack of Efficacy|0|||
127708718|NCT02367040|459561423|FG000|Overall Study|Additional primary malignancy|0|||
127888320|NCT00479401|460213986|FG000|Overall Study|Withdrawal by Subject|16|||
127708719|NCT02367040|459561424|FG001|Overall Study|Additional primary malignancy|1|||
127708720|NCT02367040|459561423|FG000|Overall Study|AE not associated with clinical disease progression|114|||
127708721|NCT02367040|459561424|FG001|Overall Study|AE not associated with clinical disease progression|11|||
127708722|NCT02367040|459561423|FG000|Overall Study|AE associated with clinical disease progression|1|||
127888321|NCT00479401|460213987|FG001|Overall Study|Withdrawal by Subject|10|||
127888322|NCT00479401|460213988|FG002|Overall Study|Withdrawal by Subject|2|||
127646210|NCT03104699|459324363|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
127646211|NCT03104699|459324364|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
127800527|NCT01298492|459891455|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
127800528|NCT00352105|459891456|FG000|Overall Study|Death|5|||
127800529|NCT00352105|459891456|FG000|Overall Study|Withdrawal by Subject|5|||
127800530|NCT00352105|459891456|FG000|Overall Study|Lack of Efficacy|9|||
127800531|NCT00352105|459891456|FG000|Overall Study|Adverse Event|19|||
127800532|NCT00352105|459891456|FG000|Overall Study|Protocol Violation|2|||
127800533|NCT02551159|459891459|FG000|Overall Study|Death|352|||
127800534|NCT02551159|459891460|FG001|Overall Study|Death|174|||
127800535|NCT02551159|459891461|FG002|Overall Study|Death|161|||
127800536|NCT02551159|459891459|FG000|Overall Study|Withdrawal by Subject|8|||
127800537|NCT02551159|459891460|FG001|Overall Study|Withdrawal by Subject|5|||
127800538|NCT02551159|459891461|FG002|Overall Study|Withdrawal by Subject|16|||
127800539|NCT02551159|459891459|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
127800540|NCT02551159|459891460|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
127800541|NCT02551159|459891461|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
127800542|NCT02175680|459891462|FG000|Overall Study|non-compliance|1|||
127800543|NCT02175680|459891462|FG000|Overall Study|other non-medical reason|1|||
127800544|NCT00911989|459891465|FG000|Overall Study|Adverse Event|1|||
127646212|NCT03104699|459324365|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|6|||
127646213|NCT03104699|459324360|FG000|Phase 2: Dose Expansion|Death|0|||
127646214|NCT03104699|459324361|FG001|Phase 2: Dose Expansion|Death|0|||
127646215|NCT03104699|459324362|FG002|Phase 2: Dose Expansion|Death|0|||
127646216|NCT03104699|459324363|FG003|Phase 2: Dose Expansion|Death|0|||
127646217|NCT03104699|459324364|FG004|Phase 2: Dose Expansion|Death|0|||
127646218|NCT03104699|459324365|FG005|Phase 2: Dose Expansion|Death|107|||
127646219|NCT03104699|459324360|FG000|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
127646220|NCT03104699|459324361|FG001|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
127646221|NCT03104699|459324362|FG002|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
127646222|NCT03104699|459324363|FG003|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
127646223|NCT03104699|459324364|FG004|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
127646224|NCT03104699|459324365|FG005|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|1|||
127646225|NCT03104699|459324360|FG000|Phase 2: Dose Expansion|Administrative Study Closure|0|||
127646226|NCT03104699|459324361|FG001|Phase 2: Dose Expansion|Administrative Study Closure|0|||
127646227|NCT03104699|459324362|FG002|Phase 2: Dose Expansion|Administrative Study Closure|0|||
127646228|NCT03104699|459324363|FG003|Phase 2: Dose Expansion|Administrative Study Closure|0|||
127646229|NCT03104699|459324364|FG004|Phase 2: Dose Expansion|Administrative Study Closure|0|||
127646230|NCT03104699|459324365|FG005|Phase 2: Dose Expansion|Administrative Study Closure|13|||
127646231|NCT03104699|459324360|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
127646232|NCT03104699|459324361|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
127708723|NCT02367040|459561424|FG001|Overall Study|AE associated with clinical disease progression|3|||
127708724|NCT02367040|459561423|FG000|Overall Study|Physician Decision|2|||
127708725|NCT02367040|459561424|FG001|Overall Study|Physician Decision|8|||
127708726|NCT02367040|459561423|FG000|Overall Study|Non-compliance with study drug|1|||
127708727|NCT02367040|459561424|FG001|Overall Study|Non-compliance with study drug|0|||
127708728|NCT02367040|459561423|FG000|Overall Study|Failure to meet continuation criteria|1|||
127708729|NCT02367040|459561424|FG001|Overall Study|Failure to meet continuation criteria|0|||
127708730|NCT02367040|459561423|FG000|Overall Study|Switching to other therapy|2|||
127708731|NCT02367040|459561424|FG001|Overall Study|Switching to other therapy|0|||
127708732|NCT02367040|459561423|FG000|Overall Study|Withdrawal by Subject|46|||
127708733|NCT02367040|459561424|FG001|Overall Study|Withdrawal by Subject|16|||
127708734|NCT02367040|459561423|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
127708735|NCT02367040|459561424|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
127708736|NCT02367040|459561423|FG000|Overall Study|Patient decision|39|||
127708737|NCT02367040|459561424|FG001|Overall Study|Patient decision|14|||
127708738|NCT02367040|459561423|FG000|Overall Study|Required procedure failed|1|||
127708739|NCT02367040|459561424|FG001|Overall Study|Required procedure failed|0|||
127708740|NCT02367040|459561423|FG000|Overall Study|Randomized by mistake with study treatment|1|||
127708741|NCT02367040|459561424|FG001|Overall Study|Randomized by mistake with study treatment|0|||
127708742|NCT02367040|459561423|FG000|Overall Study|Protocol Violation|1|||
127708743|NCT02367040|459561424|FG001|Overall Study|Protocol Violation|0|||
127708744|NCT02367040|459561423|FG000|Overall Study|Progressive disease - radiological progression|51|||
127708745|NCT02367040|459561424|FG001|Overall Study|Progressive disease - radiological progression|78|||
127708746|NCT02367040|459561423|FG000|Overall Study|Progressive disease - clinical progression|6|||
127708747|NCT02367040|459561424|FG001|Overall Study|Progressive disease - clinical progression|6|||
127708748|NCT02367040|459561423|FG000|Overall Study|Drug not administered|3|||
127708749|NCT02367040|459561424|FG001|Overall Study|Drug not administered|2|||
127708750|NCT02367040|459561423|FG000|Overall Study|Progressive disease|0|||
127708751|NCT02367040|459561424|FG001|Overall Study|Progressive disease|1|||
127800545|NCT04949841|459891469|FG000|Overall Study|Adverse Event|7|||
127800546|NCT04949841|459891469|FG000|Overall Study|Death|1|||
127800547|NCT04949841|459891469|FG000|Overall Study|Withdrawal by Subject|52|||
127800548|NCT04949841|459891469|FG000|Overall Study|Pregnancy|4|||
127800549|NCT04949841|459891469|FG000|Overall Study|Lost to Follow-up|9|||
127800550|NCT04949841|459891469|FG000|Overall Study|Lack of Efficacy|55|||
127800551|NCT04949841|459891469|FG000|Overall Study|Various reasons|9|||
127800552|NCT03179436|459891470|FG000|Overall Study|Withdrawal by Subject|1|||
127800553|NCT03179436|459891471|FG001|Overall Study|Withdrawal by Subject|0|||
127800554|NCT03179436|459891472|FG002|Overall Study|Withdrawal by Subject|0|||
127800555|NCT03179436|459891473|FG003|Overall Study|Withdrawal by Subject|4|||
127800556|NCT03179436|459891474|FG004|Overall Study|Withdrawal by Subject|2|||
127800557|NCT03179436|459891475|FG005|Overall Study|Withdrawal by Subject|2|||
127800558|NCT03179436|459891476|FG006|Overall Study|Withdrawal by Subject|5|||
127800559|NCT03179436|459891477|FG007|Overall Study|Withdrawal by Subject|0|||
127800560|NCT03179436|459891478|FG008|Overall Study|Withdrawal by Subject|3|||
127800561|NCT03179436|459891479|FG009|Overall Study|Withdrawal by Subject|0|||
127800562|NCT03179436|459891480|FG010|Overall Study|Withdrawal by Subject|0|||
127800563|NCT03179436|459891481|FG011|Overall Study|Withdrawal by Subject|0|||
127800564|NCT03179436|459891470|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
127800565|NCT03179436|459891471|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
127800566|NCT03179436|459891472|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
127800567|NCT03179436|459891473|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
127800568|NCT03179436|459891474|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
127800569|NCT03179436|459891475|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
127800570|NCT03179436|459891476|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
127800571|NCT03179436|459891477|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
127800572|NCT03179436|459891478|FG008|Overall Study|Withdrawal by Parent/Guardian|0|||
127800573|NCT03179436|459891479|FG009|Overall Study|Withdrawal by Parent/Guardian|0|||
127800574|NCT03179436|459891480|FG010|Overall Study|Withdrawal by Parent/Guardian|0|||
127800575|NCT03179436|459891481|FG011|Overall Study|Withdrawal by Parent/Guardian|0|||
127800576|NCT03179436|459891470|FG000|Overall Study|Sponsor Decision|0|||
127800577|NCT03179436|459891471|FG001|Overall Study|Sponsor Decision|0|||
127800578|NCT03179436|459891472|FG002|Overall Study|Sponsor Decision|1|||
127800579|NCT03179436|459891473|FG003|Overall Study|Sponsor Decision|3|||
127800580|NCT03179436|459891474|FG004|Overall Study|Sponsor Decision|9|||
127800581|NCT03179436|459891475|FG005|Overall Study|Sponsor Decision|7|||
127800582|NCT03179436|459891476|FG006|Overall Study|Sponsor Decision|2|||
127800583|NCT03179436|459891477|FG007|Overall Study|Sponsor Decision|4|||
127800584|NCT03179436|459891478|FG008|Overall Study|Sponsor Decision|23|||
127800585|NCT03179436|459891479|FG009|Overall Study|Sponsor Decision|6|||
127800586|NCT03179436|459891480|FG010|Overall Study|Sponsor Decision|7|||
127800587|NCT03179436|459891481|FG011|Overall Study|Sponsor Decision|5|||
127800588|NCT03179436|459891470|FG000|Overall Study|Randomized by Mistake without Study Treatment|0|||
127800589|NCT03179436|459891471|FG001|Overall Study|Randomized by Mistake without Study Treatment|1|||
127800590|NCT03179436|459891472|FG002|Overall Study|Randomized by Mistake without Study Treatment|0|||
127800591|NCT03179436|459891473|FG003|Overall Study|Randomized by Mistake without Study Treatment|0|||
127800592|NCT03179436|459891474|FG004|Overall Study|Randomized by Mistake without Study Treatment|0|||
127800593|NCT03179436|459891475|FG005|Overall Study|Randomized by Mistake without Study Treatment|1|||
127800594|NCT03179436|459891476|FG006|Overall Study|Randomized by Mistake without Study Treatment|0|||
127800595|NCT03179436|459891477|FG007|Overall Study|Randomized by Mistake without Study Treatment|0|||
127800596|NCT03179436|459891478|FG008|Overall Study|Randomized by Mistake without Study Treatment|0|||
127800597|NCT03179436|459891479|FG009|Overall Study|Randomized by Mistake without Study Treatment|0|||
127800598|NCT03179436|459891480|FG010|Overall Study|Randomized by Mistake without Study Treatment|0|||
127800599|NCT03179436|459891481|FG011|Overall Study|Randomized by Mistake without Study Treatment|0|||
127800600|NCT03179436|459891470|FG000|Overall Study|Lost to Follow-up|1|||
127800601|NCT03179436|459891471|FG001|Overall Study|Lost to Follow-up|0|||
127800602|NCT03179436|459891472|FG002|Overall Study|Lost to Follow-up|0|||
127800603|NCT03179436|459891473|FG003|Overall Study|Lost to Follow-up|1|||
127800604|NCT03179436|459891474|FG004|Overall Study|Lost to Follow-up|0|||
127800605|NCT03179436|459891475|FG005|Overall Study|Lost to Follow-up|1|||
127800606|NCT03179436|459891476|FG006|Overall Study|Lost to Follow-up|0|||
127800607|NCT03179436|459891477|FG007|Overall Study|Lost to Follow-up|0|||
127800608|NCT03179436|459891478|FG008|Overall Study|Lost to Follow-up|1|||
127800609|NCT03179436|459891479|FG009|Overall Study|Lost to Follow-up|1|||
127800610|NCT03179436|459891480|FG010|Overall Study|Lost to Follow-up|0|||
127800611|NCT03179436|459891481|FG011|Overall Study|Lost to Follow-up|0|||
127800612|NCT03179436|459891470|FG000|Overall Study|Death|12|||
127800613|NCT03179436|459891471|FG001|Overall Study|Death|17|||
127800614|NCT03179436|459891472|FG002|Overall Study|Death|7|||
127800615|NCT03179436|459891473|FG003|Overall Study|Death|32|||
127800616|NCT03179436|459891474|FG004|Overall Study|Death|29|||
127646233|NCT03104699|459324362|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
127800617|NCT03179436|459891475|FG005|Overall Study|Death|30|||
127800618|NCT03179436|459891476|FG006|Overall Study|Death|33|||
127800619|NCT03179436|459891477|FG007|Overall Study|Death|9|||
127800620|NCT03179436|459891478|FG008|Overall Study|Death|84|||
127800621|NCT03179436|459891479|FG009|Overall Study|Death|33|||
127888323|NCT00479401|460213986|FG000|Overall Study|Exclusion criteria, relocation|4|||
127888324|NCT00479401|460213987|FG001|Overall Study|Exclusion criteria, relocation|3|||
127646234|NCT03104699|459324363|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
127646235|NCT03104699|459324364|FG004|Phase 2: Dose Expansion|Lost to Follow-up|0|||
127646236|NCT03104699|459324365|FG005|Phase 2: Dose Expansion|Lost to Follow-up|5|||
127646237|NCT03104699|459324360|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
127646238|NCT03104699|459324361|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
127646239|NCT03104699|459324362|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
127646240|NCT03104699|459324363|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
127646241|NCT03104699|459324364|FG004|Phase 2: Dose Expansion|Progressive Disease|0|||
127646242|NCT03104699|459324365|FG005|Phase 2: Dose Expansion|Progressive Disease|1|||
127646243|NCT00152464|459324366|FG000|Overall Study|Adverse Event|3|||
127646244|NCT00152464|459324367|FG001|Overall Study|Adverse Event|6|||
127646245|NCT00152464|459324366|FG000|Overall Study|Lost to Follow-up|8|||
127646246|NCT00152464|459324367|FG001|Overall Study|Lost to Follow-up|4|||
127646247|NCT00152464|459324366|FG000|Overall Study|Protocol Violation|3|||
127646248|NCT00152464|459324367|FG001|Overall Study|Protocol Violation|1|||
127646249|NCT00152464|459324366|FG000|Overall Study|Withdrawal by Subject|21|||
127646250|NCT00152464|459324367|FG001|Overall Study|Withdrawal by Subject|22|||
127646251|NCT00152464|459324366|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
127646252|NCT00152464|459324367|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
127646253|NCT00152464|459324366|FG000|Overall Study|Eczema deterioration|0|||
127646254|NCT00152464|459324367|FG001|Overall Study|Eczema deterioration|1|||
127646255|NCT00152464|459324366|FG000|Overall Study|Parent decision|1|||
127646256|NCT00152464|459324367|FG001|Overall Study|Parent decision|1|||
127646257|NCT00152464|459324366|FG000|Overall Study|Investigator decision|1|||
127646258|NCT00152464|459324367|FG001|Overall Study|Investigator decision|0|||
127646259|NCT00152464|459324366|FG000|Overall Study|Lack of Efficacy|1|||
127646260|NCT00152464|459324367|FG001|Overall Study|Lack of Efficacy|0|||
127646261|NCT00152464|459324366|FG000|Overall Study|Eczema poorly controlled|1|||
127646262|NCT00152464|459324367|FG001|Overall Study|Eczema poorly controlled|0|||
127646263|NCT00152464|459324366|FG000|Overall Study|Patient relocated|1|||
127646264|NCT00152464|459324367|FG001|Overall Study|Patient relocated|0|||
127646265|NCT00420199|459324368|FG000|Overall Study|Participant no longer met study criteria|1|||
127646266|NCT00420199|459324369|FG001|Overall Study|Participant no longer met study criteria|0|||
127646267|NCT00430248|459324370|FG000|Overall Study|Adverse Event|49|||
127646268|NCT00430248|459324371|FG001|Overall Study|Adverse Event|61|||
127646269|NCT00430248|459324372|FG002|Overall Study|Adverse Event|64|||
127646270|NCT00430248|459324370|FG000|Overall Study|Protocol Violation|10|||
127646271|NCT00430248|459324371|FG001|Overall Study|Protocol Violation|2|||
127646272|NCT00430248|459324372|FG002|Overall Study|Protocol Violation|4|||
127646273|NCT00430248|459324370|FG000|Overall Study|Personal Reasons|12|||
127646274|NCT00430248|459324371|FG001|Overall Study|Personal Reasons|24|||
127646275|NCT00430248|459324372|FG002|Overall Study|Personal Reasons|9|||
127646276|NCT00430248|459324370|FG000|Overall Study|Lost to Follow-up|28|||
127646277|NCT00430248|459324371|FG001|Overall Study|Lost to Follow-up|33|||
127708752|NCT02367040|459561423|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
127708753|NCT02367040|459561424|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
127708754|NCT02367040|459561423|FG000|Overall Study|Death|2|||
127708755|NCT02367040|459561424|FG001|Overall Study|Death|0|||
127708756|NCT05856435|459561436|FG000|Overall Study|Lost to Follow-up|6|||
127708757|NCT02323880|459561437|FG000|Overall Study|Adverse Event|2|||
127708758|NCT02323880|459561438|FG001|Overall Study|Adverse Event|0|||
127708759|NCT02323880|459561439|FG002|Overall Study|Adverse Event|1|||
127708760|NCT02323880|459561440|FG003|Overall Study|Adverse Event|1|||
127708761|NCT02323880|459561441|FG004|Overall Study|Adverse Event|1|||
127646278|NCT00430248|459324372|FG002|Overall Study|Lost to Follow-up|28|||
127646279|NCT00430248|459324370|FG000|Overall Study|Therapeutic Failure|1|||
127646280|NCT00430248|459324371|FG001|Overall Study|Therapeutic Failure|1|||
127646281|NCT00430248|459324372|FG002|Overall Study|Therapeutic Failure|1|||
127646282|NCT00430248|459324370|FG000|Overall Study|Withdrawal by Subject|14|||
127646283|NCT00430248|459324371|FG001|Overall Study|Withdrawal by Subject|20|||
127646284|NCT00430248|459324372|FG002|Overall Study|Withdrawal by Subject|16|||
127646285|NCT00430248|459324370|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
127646286|NCT00430248|459324371|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
127888325|NCT00479401|460213988|FG002|Overall Study|Exclusion criteria, relocation|0|||
127646287|NCT00430248|459324372|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
127708762|NCT02323880|459561442|FG005|Overall Study|Adverse Event|0|||
127800622|NCT03179436|459891480|FG010|Overall Study|Death|22|||
127800623|NCT03179436|459891481|FG011|Overall Study|Death|15|||
127888326|NCT01430104|460213991|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
127888327|NCT01571635|460213992|FG000|Overall Study|Adverse Event|3|||
127888328|NCT01571635|460213993|FG001|Overall Study|Adverse Event|0|||
127888329|NCT01571635|460213994|FG002|Overall Study|Adverse Event|2|||
127888330|NCT01571635|460213995|FG003|Overall Study|Adverse Event|3|||
127888331|NCT01571635|460213996|FG004|Overall Study|Adverse Event|5|||
127800624|NCT05168267|459891482|FG000|Overall Study|Withdrawal by Subject|2|||
127800625|NCT05168267|459891483|FG001|Overall Study|Withdrawal by Subject|1|||
127800626|NCT05168267|459891482|FG000|Overall Study|Withdrawn by Therapist|1|||
127800627|NCT05168267|459891483|FG001|Overall Study|Withdrawn by Therapist|1|||
127800628|NCT05168267|459891482|FG000|Overall Study|Left Facility|1|||
127800629|NCT05168267|459891483|FG001|Overall Study|Left Facility|0|||
127800630|NCT04811716|459891485|FG000|Overall Study|Withdrawal by Subject|2|||
127800631|NCT04811716|459891486|FG001|Overall Study|Withdrawal by Subject|0|||
127800632|NCT00500682|459891492|FG000|Overall Study|Adverse Event|37|||
127800633|NCT00500682|459891493|FG001|Overall Study|Adverse Event|29|||
127800634|NCT00500682|459891492|FG000|Overall Study|Death|25|||
127800635|NCT00500682|459891493|FG001|Overall Study|Death|16|||
127800636|NCT00500682|459891492|FG000|Overall Study|Lost to Follow-up|11|||
127800637|NCT00500682|459891493|FG001|Overall Study|Lost to Follow-up|11|||
127800638|NCT00500682|459891492|FG000|Overall Study|Physician Decision|6|||
127800639|NCT00500682|459891493|FG001|Overall Study|Physician Decision|10|||
127800640|NCT00500682|459891492|FG000|Overall Study|Pregnancy|2|||
127800641|NCT00500682|459891493|FG001|Overall Study|Pregnancy|0|||
127800642|NCT00500682|459891492|FG000|Overall Study|Protocol Violation|1|||
127800643|NCT00500682|459891493|FG001|Overall Study|Protocol Violation|3|||
127800644|NCT00500682|459891492|FG000|Overall Study|Withdrawal by Subject|80|||
127800645|NCT00500682|459891493|FG001|Overall Study|Withdrawal by Subject|74|||
127800646|NCT00500682|459891492|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
127800647|NCT00500682|459891493|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
127800648|NCT00429585|459891494|FG000|Overall Study|Death|1|||
127800649|NCT00429585|459891495|FG001|Overall Study|Death|0|||
127800650|NCT00429585|459891494|FG000|Overall Study|Lost to Follow-up|27|||
127800651|NCT00429585|459891495|FG001|Overall Study|Lost to Follow-up|20|||
127646288|NCT00430248|459324370|FG000|Overall Study|Gout Flare|3|||
127646289|NCT00430248|459324371|FG001|Overall Study|Gout Flare|7|||
127646290|NCT00430248|459324372|FG002|Overall Study|Gout Flare|2|||
127646291|NCT00430248|459324370|FG000|Overall Study|Reason Not Specified|8|||
127646292|NCT00430248|459324371|FG001|Overall Study|Reason Not Specified|8|||
127646293|NCT00430248|459324372|FG002|Overall Study|Reason Not Specified|11|||
127646294|NCT01754467|459324376|FG000|Overall Study|Lost to Follow-up|1|||
127646295|NCT01970462|459324377|FG000|Overall Study|Lost to Follow-up|0|||
127646296|NCT01970462|459324378|FG001|Overall Study|Lost to Follow-up|2|||
127646297|NCT04020341|459324381|FG000|Overall Study|Adverse Event|8|||
127646298|NCT04020341|459324382|FG001|Overall Study|Adverse Event|6|||
127646299|NCT04020341|459324381|FG000|Overall Study|Lost to Follow-up|8|||
127646300|NCT04020341|459324382|FG001|Overall Study|Lost to Follow-up|2|||
127646301|NCT04020341|459324381|FG000|Overall Study|Withdrawal by Subject|16|||
127646302|NCT04020341|459324382|FG001|Overall Study|Withdrawal by Subject|16|||
127646303|NCT04020341|459324381|FG000|Overall Study|Participant not able to swallow the tablet|1|||
127646304|NCT04020341|459324382|FG001|Overall Study|Participant not able to swallow the tablet|0|||
127646305|NCT04020341|459324381|FG000|Overall Study|Physician Decision|0|||
127646306|NCT04020341|459324382|FG001|Overall Study|Physician Decision|2|||
127646307|NCT04020341|459324381|FG000|Overall Study|Protocol Deviation|0|||
127646308|NCT04020341|459324382|FG001|Overall Study|Protocol Deviation|2|||
127646309|NCT05763628|459324383|FG000|Period 1: First Intervention, 2 Weeks|Protocol Violation|0|||
127646310|NCT05763628|459324384|FG001|Period 1: First Intervention, 2 Weeks|Protocol Violation|1|||
127646311|NCT05763628|459324383|FG000|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|0|||
127646312|NCT05763628|459324384|FG001|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|1|||
127646313|NCT05763628|459324383|FG000|Period 2: Second Intervention, 2 Weeks|Protocol Violation|1|||
127646314|NCT05763628|459324384|FG001|Period 2: Second Intervention, 2 Weeks|Protocol Violation|0|||
127800652|NCT00429585|459891494|FG000|Overall Study|Physician Decision|2|||
127800653|NCT00429585|459891495|FG001|Overall Study|Physician Decision|0|||
127800654|NCT01582308|459891496|FG000|Period 1|Withdrawal by Subject|0|||
127800655|NCT01582308|459891497|FG001|Period 1|Withdrawal by Subject|0|||
127800656|NCT01582308|459891498|FG002|Period 1|Withdrawal by Subject|0|||
127800657|NCT01582308|459891499|FG003|Period 1|Withdrawal by Subject|0|||
127800658|NCT01582308|459891500|FG004|Period 1|Withdrawal by Subject|0|||
127800659|NCT01582308|459891501|FG005|Period 1|Withdrawal by Subject|0|||
127800660|NCT01582308|459891502|FG006|Period 1|Withdrawal by Subject|1|||
127800661|NCT01582308|459891503|FG007|Period 1|Withdrawal by Subject|0|||
127646315|NCT04683926|459324385|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
127646316|NCT04683926|459324386|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
127800662|NCT01582308|459891504|FG008|Period 1|Withdrawal by Subject|0|||
127800663|NCT01582308|459891505|FG009|Period 1|Withdrawal by Subject|0|||
127800664|NCT01582308|459891496|FG000|10-day Washout Following Period 1|Physician Decision|0|||
127708763|NCT02323880|459561443|FG006|Overall Study|Adverse Event|1|||
127708764|NCT02323880|459561444|FG007|Overall Study|Adverse Event|0|||
127708765|NCT02323880|459561437|FG000|Overall Study|Death|0|||
127708766|NCT02323880|459561438|FG001|Overall Study|Death|0|||
127708767|NCT02323880|459561439|FG002|Overall Study|Death|0|||
127708768|NCT02323880|459561440|FG003|Overall Study|Death|0|||
127800665|NCT01582308|459891497|FG001|10-day Washout Following Period 1|Physician Decision|0|||
127800666|NCT01582308|459891498|FG002|10-day Washout Following Period 1|Physician Decision|0|||
127800667|NCT01582308|459891499|FG003|10-day Washout Following Period 1|Physician Decision|0|||
127800668|NCT01582308|459891500|FG004|10-day Washout Following Period 1|Physician Decision|1|||
127800669|NCT01582308|459891501|FG005|10-day Washout Following Period 1|Physician Decision|0|||
127800670|NCT01582308|459891502|FG006|10-day Washout Following Period 1|Physician Decision|0|||
127800671|NCT01582308|459891503|FG007|10-day Washout Following Period 1|Physician Decision|0|||
127800672|NCT01582308|459891504|FG008|10-day Washout Following Period 1|Physician Decision|0|||
127800673|NCT01582308|459891505|FG009|10-day Washout Following Period 1|Physician Decision|0|||
127800674|NCT01582308|459891496|FG000|Period 4|Physician Decision|1|||
127800675|NCT01582308|459891497|FG001|Period 4|Physician Decision|0|||
127800676|NCT01582308|459891498|FG002|Period 4|Physician Decision|0|||
127800677|NCT01582308|459891499|FG003|Period 4|Physician Decision|0|||
127800678|NCT01582308|459891500|FG004|Period 4|Physician Decision|0|||
127800679|NCT01582308|459891501|FG005|Period 4|Physician Decision|1|||
127800680|NCT01582308|459891502|FG006|Period 4|Physician Decision|0|||
127800681|NCT01582308|459891503|FG007|Period 4|Physician Decision|0|||
127800682|NCT01582308|459891504|FG008|Period 4|Physician Decision|0|||
127800683|NCT01582308|459891505|FG009|Period 4|Physician Decision|1|||
127800684|NCT01182428|459891508|FG000|Overall Study|Physician Decision|1|||
127800685|NCT01182428|459891509|FG001|Overall Study|Physician Decision|0|||
127800686|NCT01182428|459891508|FG000|Overall Study|Lost to Follow-up|9|||
127800687|NCT01182428|459891509|FG001|Overall Study|Lost to Follow-up|1|||
127800688|NCT01182428|459891508|FG000|Overall Study|Withdrawal by Subject|1|||
127800689|NCT01182428|459891509|FG001|Overall Study|Withdrawal by Subject|0|||
127708769|NCT02323880|459561441|FG004|Overall Study|Death|0|||
127708770|NCT02323880|459561442|FG005|Overall Study|Death|1|||
127708771|NCT02323880|459561443|FG006|Overall Study|Death|0|||
127708772|NCT02323880|459561444|FG007|Overall Study|Death|0|||
127708773|NCT02323880|459561437|FG000|Overall Study|Lack of Efficacy|4|||
127708774|NCT02323880|459561438|FG001|Overall Study|Lack of Efficacy|11|||
127708775|NCT02323880|459561439|FG002|Overall Study|Lack of Efficacy|5|||
127708776|NCT02323880|459561440|FG003|Overall Study|Lack of Efficacy|5|||
127708777|NCT02323880|459561441|FG004|Overall Study|Lack of Efficacy|4|||
127708778|NCT02323880|459561442|FG005|Overall Study|Lack of Efficacy|8|||
127708779|NCT02323880|459561443|FG006|Overall Study|Lack of Efficacy|4|||
127708780|NCT02323880|459561444|FG007|Overall Study|Lack of Efficacy|6|||
127708781|NCT02323880|459561437|FG000|Overall Study|Physician Decision|0|||
127708782|NCT02323880|459561438|FG001|Overall Study|Physician Decision|0|||
127708783|NCT02323880|459561439|FG002|Overall Study|Physician Decision|0|||
127708784|NCT02323880|459561440|FG003|Overall Study|Physician Decision|0|||
127708785|NCT02323880|459561441|FG004|Overall Study|Physician Decision|1|||
127708786|NCT02323880|459561442|FG005|Overall Study|Physician Decision|1|||
127708787|NCT02323880|459561443|FG006|Overall Study|Physician Decision|1|||
127708788|NCT02323880|459561444|FG007|Overall Study|Physician Decision|0|||
127708789|NCT02323880|459561437|FG000|Overall Study|Withdrawal by Subject|0|||
127708790|NCT02323880|459561438|FG001|Overall Study|Withdrawal by Subject|2|||
127708791|NCT02323880|459561439|FG002|Overall Study|Withdrawal by Subject|0|||
127800690|NCT01227902|459893210|FG000|Overall Study|Adverse Event|12|||
127800691|NCT01227902|459893211|FG001|Overall Study|Adverse Event|8|||
127800692|NCT01227902|459893212|FG002|Overall Study|Adverse Event|11|||
127800693|NCT01227902|459893213|FG003|Overall Study|Adverse Event|4|||
127800694|NCT01227902|459893210|FG000|Overall Study|Lack of Efficacy|1|||
127800695|NCT01227902|459893211|FG001|Overall Study|Lack of Efficacy|2|||
127800696|NCT01227902|459893212|FG002|Overall Study|Lack of Efficacy|2|||
127800697|NCT01227902|459893213|FG003|Overall Study|Lack of Efficacy|1|||
127800698|NCT01227902|459893210|FG000|Overall Study|Protocol Violation|1|||
127800699|NCT01227902|459893211|FG001|Overall Study|Protocol Violation|0|||
127800700|NCT01227902|459893212|FG002|Overall Study|Protocol Violation|0|||
127800701|NCT01227902|459893213|FG003|Overall Study|Protocol Violation|0|||
127708792|NCT02323880|459561440|FG003|Overall Study|Withdrawal by Subject|0|||
127708793|NCT02323880|459561441|FG004|Overall Study|Withdrawal by Subject|0|||
127708794|NCT02323880|459561442|FG005|Overall Study|Withdrawal by Subject|0|||
127708795|NCT02323880|459561443|FG006|Overall Study|Withdrawal by Subject|0|||
127708796|NCT02323880|459561444|FG007|Overall Study|Withdrawal by Subject|0|||
127708797|NCT04934072|459561446|FG000|Day 0 to Week 52|Withdrawal by Subject|17|||
127800702|NCT01227902|459893210|FG000|Overall Study|Lost to Follow-up|0|||
127708798|NCT04934072|459561447|FG001|Day 0 to Week 52|Withdrawal by Subject|22|||
127800703|NCT01227902|459893211|FG001|Overall Study|Lost to Follow-up|0|||
127800704|NCT01227902|459893212|FG002|Overall Study|Lost to Follow-up|1|||
127800705|NCT01227902|459893213|FG003|Overall Study|Lost to Follow-up|2|||
127800706|NCT01227902|459893210|FG000|Overall Study|Physician Decision|0|||
127800707|NCT01227902|459893211|FG001|Overall Study|Physician Decision|1|||
127646317|NCT04683926|459324387|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
127646318|NCT04683926|459324388|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
127646319|NCT02123108|459324391|FG000|Overall Study|Death|2|||
127646320|NCT02123108|459324392|FG001|Overall Study|Death|3|||
127646321|NCT00716092|459324393|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
127646322|NCT00716092|459324394|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
127646323|NCT00716092|459324395|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
127708799|NCT04934072|459561448|FG002|Day 0 to Week 52|Withdrawal by Subject|0|||
127708800|NCT04934072|459561449|FG003|Day 0 to Week 52|Withdrawal by Subject|0|||
127708801|NCT04934072|459561450|FG004|Day 0 to Week 52|Withdrawal by Subject|0|||
127708802|NCT04934072|459561446|FG000|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|4|||
127708803|NCT04934072|459561447|FG001|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|1|||
127708804|NCT04934072|459561448|FG002|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
127708805|NCT04934072|459561449|FG003|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
127708806|NCT04934072|459561450|FG004|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
127708807|NCT04934072|459561446|FG000|Day 0 to Week 52|Other|3|||
127708808|NCT04934072|459561447|FG001|Day 0 to Week 52|Other|1|||
127708809|NCT04934072|459561448|FG002|Day 0 to Week 52|Other|0|||
127708810|NCT04934072|459561449|FG003|Day 0 to Week 52|Other|0|||
127708811|NCT04934072|459561450|FG004|Day 0 to Week 52|Other|0|||
127708812|NCT04934072|459561446|FG000|Day 0 to Week 52|Adverse Event|1|||
127708813|NCT04934072|459561447|FG001|Day 0 to Week 52|Adverse Event|3|||
127708814|NCT04934072|459561448|FG002|Day 0 to Week 52|Adverse Event|0|||
127708815|NCT04934072|459561449|FG003|Day 0 to Week 52|Adverse Event|0|||
127708816|NCT04934072|459561450|FG004|Day 0 to Week 52|Adverse Event|0|||
127708817|NCT04934072|459561446|FG000|Week 52 to Week 78|Adverse Event|0|||
127708818|NCT04934072|459561447|FG001|Week 52 to Week 78|Adverse Event|0|||
127708819|NCT04934072|459561448|FG002|Week 52 to Week 78|Adverse Event|0|||
127800708|NCT01227902|459893212|FG002|Overall Study|Physician Decision|1|||
127800709|NCT01227902|459893213|FG003|Overall Study|Physician Decision|0|||
127800710|NCT01227902|459893210|FG000|Overall Study|Withdrawal by Subject|4|||
127800711|NCT01227902|459893211|FG001|Overall Study|Withdrawal by Subject|2|||
127800712|NCT01227902|459893212|FG002|Overall Study|Withdrawal by Subject|4|||
127646324|NCT01132326|459324396|FG000|Overall Study|Lack of Efficacy|25|||
127646325|NCT01132326|459324396|FG000|Overall Study|Adverse Event|37|||
127646326|NCT01132326|459324396|FG000|Overall Study|Protocol Violation|1|||
127646327|NCT01132326|459324396|FG000|Overall Study|Lost to Follow-up|16|||
127646328|NCT01132326|459324396|FG000|Overall Study|Withdrawal by Subject|40|||
127646329|NCT01132326|459324396|FG000|Overall Study|Physician Decision|10|||
127646330|NCT01132326|459324396|FG000|Overall Study|Study Termination|80|||
127646331|NCT01132326|459324396|FG000|Overall Study|Declining Health|1|||
127646332|NCT01132326|459324396|FG000|Overall Study|Pregnancy|1|||
127646333|NCT01132326|459324396|FG000|Overall Study|Caregiver Withdrew Consent|1|||
127646334|NCT01132326|459324396|FG000|Overall Study|Death|5|||
127646335|NCT01132326|459324396|FG000|Overall Study|Subject Unable to Come To Visits|1|||
127646336|NCT00677235|459324397|FG000|Overall Study|Withdrawal by Subject|1|||
127646337|NCT00677235|459324398|FG001|Overall Study|Withdrawal by Subject|1|||
127646338|NCT00677235|459324397|FG000|Overall Study|Lost to Follow-up|2|||
127646339|NCT00677235|459324398|FG001|Overall Study|Lost to Follow-up|1|||
127646340|NCT00677235|459324397|FG000|Overall Study|Death|37|||
127646341|NCT00677235|459324398|FG001|Overall Study|Death|36|||
127646342|NCT00677235|459324397|FG000|Overall Study|Adverse Experience|1|||
127646343|NCT00677235|459324398|FG001|Overall Study|Adverse Experience|0|||
127646344|NCT00952367|459324399|FG000|Overall Study|Withdrawal by Subject|2|||
127646345|NCT00952367|459324399|FG000|Overall Study|Noncoordination|1|||
127646346|NCT00952367|459324399|FG000|Overall Study|Protocol Violation|3|||
127646347|NCT01040260|459324400|FG000|Overall Study|Withdrawal by Subject|12|||
127646348|NCT01040260|459324401|FG001|Overall Study|Withdrawal by Subject|6|||
127708820|NCT04934072|459561449|FG003|Week 52 to Week 78|Adverse Event|1|||
127708821|NCT04934072|459561450|FG004|Week 52 to Week 78|Adverse Event|1|||
127708822|NCT04934072|459561446|FG000|Week 52 to Week 78|Withdrawal by Subject|0|||
127800713|NCT01227902|459893213|FG003|Overall Study|Withdrawal by Subject|3|||
127800714|NCT05280756|459893214|FG000|Overall Study|Lost to Follow-up|1|||
127800715|NCT05280756|459893215|FG001|Overall Study|Lost to Follow-up|1|||
127800716|NCT02527707|459893220|FG000|Overall Study|Adverse Event|1|||
127708823|NCT04934072|459561447|FG001|Week 52 to Week 78|Withdrawal by Subject|0|||
127708824|NCT04934072|459561448|FG002|Week 52 to Week 78|Withdrawal by Subject|6|||
127708825|NCT04934072|459561449|FG003|Week 52 to Week 78|Withdrawal by Subject|1|||
127708826|NCT04934072|459561450|FG004|Week 52 to Week 78|Withdrawal by Subject|2|||
127800717|NCT02527707|459893220|FG000|Overall Study|Adverse Event|1|||
127646349|NCT01040260|459324400|FG000|Overall Study|Lost to Follow-up|3|||
127646350|NCT01040260|459324401|FG001|Overall Study|Lost to Follow-up|5|||
127646351|NCT04570436|459324405|FG000|Overall Study|Adverse Event|0|||
127646352|NCT04570436|459324406|FG001|Overall Study|Adverse Event|0|||
127646353|NCT04570436|459324407|FG002|Overall Study|Adverse Event|1|||
127646354|NCT04570436|459324408|FG003|Overall Study|Adverse Event|0|||
127646355|NCT04570436|459324409|FG004|Overall Study|Adverse Event|0|||
127708827|NCT04934072|459561446|FG000|Week 52 to Week 78|Other|0|||
127800718|NCT00930059|459893221|FG000|Overall Study|Death|1|||
127646356|NCT04570436|459324410|FG005|Overall Study|Adverse Event|0|||
127646357|NCT04570436|459324411|FG006|Overall Study|Adverse Event|0|||
127646358|NCT04570436|459324412|FG007|Overall Study|Adverse Event|0|||
127646359|NCT04570436|459324413|FG008|Overall Study|Adverse Event|0|||
127646360|NCT04570436|459324414|FG009|Overall Study|Adverse Event|0|||
127646361|NCT04570436|459324405|FG000|Overall Study|Physician Decision|1|||
127646362|NCT04570436|459324406|FG001|Overall Study|Physician Decision|0|||
127646363|NCT04570436|459324407|FG002|Overall Study|Physician Decision|0|||
127646364|NCT04570436|459324408|FG003|Overall Study|Physician Decision|0|||
127646365|NCT04570436|459324409|FG004|Overall Study|Physician Decision|0|||
127646366|NCT04570436|459324410|FG005|Overall Study|Physician Decision|0|||
127646367|NCT04570436|459324411|FG006|Overall Study|Physician Decision|0|||
127646368|NCT04570436|459324412|FG007|Overall Study|Physician Decision|0|||
127646369|NCT04570436|459324413|FG008|Overall Study|Physician Decision|0|||
127646370|NCT04570436|459324414|FG009|Overall Study|Physician Decision|0|||
127646371|NCT00781391|459324415|FG000|Overall Study|never received study drug|24|||
127646372|NCT00781391|459324416|FG001|Overall Study|never received study drug|23|||
127646373|NCT00781391|459324417|FG002|Overall Study|never received study drug|32|||
127646374|NCT00781391|459324415|FG000|Overall Study|Protocol Violation|19|||
127646375|NCT00781391|459324416|FG001|Overall Study|Protocol Violation|17|||
127646376|NCT00781391|459324417|FG002|Overall Study|Protocol Violation|20|||
127646377|NCT00781391|459324415|FG000|Overall Study|Death|789|||
127646378|NCT00781391|459324416|FG001|Overall Study|Death|730|||
127646379|NCT00781391|459324417|FG002|Overall Study|Death|706|||
127646380|NCT00781391|459324415|FG000|Overall Study|Withdrawal by Subject|47|||
127646381|NCT00781391|459324416|FG001|Overall Study|Withdrawal by Subject|37|||
127646382|NCT00781391|459324417|FG002|Overall Study|Withdrawal by Subject|25|||
127646383|NCT00781391|459324415|FG000|Overall Study|Lost to Follow-up|0|||
127646384|NCT00781391|459324416|FG001|Overall Study|Lost to Follow-up|0|||
127646385|NCT00781391|459324417|FG002|Overall Study|Lost to Follow-up|1|||
127646386|NCT00929162|459324420|FG000|Overall Study|Adverse Event|8|||
127646387|NCT00929162|459324421|FG001|Overall Study|Adverse Event|5|||
127646388|NCT00929162|459324420|FG000|Overall Study|Withdrawal by Subject|3|||
127646389|NCT00929162|459324421|FG001|Overall Study|Withdrawal by Subject|1|||
127646390|NCT00929162|459324420|FG000|Overall Study|Protocol Violation|32|||
127646391|NCT00929162|459324421|FG001|Overall Study|Protocol Violation|30|||
127646392|NCT00929162|459324420|FG000|Overall Study|Other termination reason|5|||
127646393|NCT00929162|459324421|FG001|Overall Study|Other termination reason|6|||
127646394|NCT01822587|459324422|FG000|Overall Study|Lost to Follow-up|7|||
127646395|NCT01822587|459324423|FG001|Overall Study|Lost to Follow-up|9|||
127708828|NCT04934072|459561447|FG001|Week 52 to Week 78|Other|0|||
127708829|NCT04934072|459561448|FG002|Week 52 to Week 78|Other|1|||
127646396|NCT01822587|459324424|FG002|Overall Study|Lost to Follow-up|12|||
127646397|NCT01822587|459324422|FG000|Overall Study|Physician Decision|9|||
127646398|NCT01822587|459324423|FG001|Overall Study|Physician Decision|6|||
127646399|NCT01822587|459324424|FG002|Overall Study|Physician Decision|6|||
127646400|NCT01274182|459324425|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
127646401|NCT01274182|459324426|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
127708830|NCT04934072|459561449|FG003|Week 52 to Week 78|Other|0|||
127708831|NCT04934072|459561450|FG004|Week 52 to Week 78|Other|0|||
127708832|NCT05660434|459561452|FG000|Overall Study|Never obtained study materials|2|||
127708833|NCT05660434|459561453|FG001|Overall Study|Never obtained study materials|1|||
127708834|NCT01820611|459561462|FG000|Overall Study|Death|8|||
127708835|NCT01820611|459561462|FG000|Overall Study|Adverse Event|1|||
127708836|NCT01820611|459561462|FG000|Overall Study|Withdrawal by Subject|9|||
127708837|NCT05736458|459561463|FG000|Baseline MRI and Assessments|Lost to Follow-up|0|||
127708838|NCT05736458|459561464|FG001|Baseline MRI and Assessments|Lost to Follow-up|0|||
127708839|NCT05736458|459561465|FG002|Baseline MRI and Assessments|Lost to Follow-up|4|||
127708840|NCT05736458|459561463|FG000|Baseline MRI and Assessments|Withdrawal by Subject|2|||
127708841|NCT05736458|459561464|FG001|Baseline MRI and Assessments|Withdrawal by Subject|0|||
127708842|NCT05736458|459561465|FG002|Baseline MRI and Assessments|Withdrawal by Subject|0|||
127708843|NCT05736458|459561463|FG000|TMS/fMRI #1|Physician Decision|0|||
127708844|NCT05736458|459561464|FG001|TMS/fMRI #1|Physician Decision|0|||
127708845|NCT05736458|459561465|FG002|TMS/fMRI #1|Physician Decision|2|||
127708846|NCT05736458|459561463|FG000|Washout (at Least 7 Days)|Lost to Follow-up|0|||
127708847|NCT05736458|459561464|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
127708848|NCT05736458|459561465|FG002|Washout (at Least 7 Days)|Lost to Follow-up|0|||
127708849|NCT02990338|459561466|FG000|Overall Study|Randomized and not treated|4|||
127708850|NCT02990338|459561467|FG001|Overall Study|Randomized and not treated|2|||
127708851|NCT02990338|459561466|FG000|Overall Study|Adverse Event|23|||
127708852|NCT02990338|459561467|FG001|Overall Study|Adverse Event|22|||
127708853|NCT02990338|459561466|FG000|Overall Study|Progressive disease|118|||
127708854|NCT02990338|459561467|FG001|Overall Study|Progressive disease|107|||
127708855|NCT02990338|459561466|FG000|Overall Study|Poor compliance to protocol|0|||
127708856|NCT02990338|459561467|FG001|Overall Study|Poor compliance to protocol|1|||
127708857|NCT02990338|459561466|FG000|Overall Study|Withdrawal by Subject|6|||
127708858|NCT02990338|459561467|FG001|Overall Study|Withdrawal by Subject|8|||
127708859|NCT02990338|459561466|FG000|Overall Study|Physician's decision|2|||
127708860|NCT02990338|459561467|FG001|Overall Study|Physician's decision|6|||
127708861|NCT02990338|459561466|FG000|Overall Study|Treatment extension study|0|||
127708862|NCT02990338|459561467|FG001|Overall Study|Treatment extension study|6|||
127708863|NCT02990338|459561466|FG000|Overall Study|Unconfirmed disease progression per investigator|0|||
127708864|NCT02990338|459561467|FG001|Overall Study|Unconfirmed disease progression per investigator|1|||
127708865|NCT02990338|459561466|FG000|Overall Study|Continue with therapy available commercially|0|||
127708866|NCT02990338|459561467|FG001|Overall Study|Continue with therapy available commercially|1|||
127708867|NCT05900154|459561468|FG000|Follow-Up Period|Lost to Follow-up|1|||
127708868|NCT05900154|459561469|FG001|Follow-Up Period|Lost to Follow-up|2|||
127708869|NCT05900154|459561470|FG002|Follow-Up Period|Lost to Follow-up|1|||
127708870|NCT05900154|459561471|FG003|Follow-Up Period|Lost to Follow-up|0|||
127708871|NCT05900154|459561472|FG004|Follow-Up Period|Lost to Follow-up|1|||
127708872|NCT05900154|459561473|FG005|Follow-Up Period|Lost to Follow-up|1|||
127708873|NCT02865538|459561477|FG000|Overall Study|Withdrawal by Subject|0|||
127708874|NCT02865538|459561478|FG001|Overall Study|Withdrawal by Subject|0|||
127708875|NCT02865538|459561479|FG002|Overall Study|Withdrawal by Subject|1|||
127708876|NCT02865538|459561480|FG003|Overall Study|Withdrawal by Subject|0|||
127708877|NCT02865538|459561481|FG004|Overall Study|Withdrawal by Subject|0|||
127708878|NCT02865538|459561477|FG000|Overall Study|Lost to Follow-up|1|||
127708879|NCT02865538|459561478|FG001|Overall Study|Lost to Follow-up|0|||
127708880|NCT02865538|459561479|FG002|Overall Study|Lost to Follow-up|0|||
127708881|NCT02865538|459561480|FG003|Overall Study|Lost to Follow-up|0|||
127708882|NCT02865538|459561481|FG004|Overall Study|Lost to Follow-up|0|||
127708883|NCT03106740|459563218|FG000|Overall Study|Lost to Follow-up|2|||
127708884|NCT03106740|459563219|FG001|Overall Study|Lost to Follow-up|2|||
127708885|NCT03106740|459563218|FG000|Overall Study|Withdrawal by Subject|2|||
127708886|NCT03106740|459563219|FG001|Overall Study|Withdrawal by Subject|4|||
127708887|NCT03106740|459563218|FG000|Overall Study|Physician Decision|0|||
127708888|NCT03106740|459563219|FG001|Overall Study|Physician Decision|1|||
127708889|NCT03106740|459563218|FG000|Overall Study|Partial data|1|||
127708890|NCT03106740|459563219|FG001|Overall Study|Partial data|0|||
127708891|NCT04565990|459563220|FG000|Overall Study|Death|5|||
127708892|NCT04565990|459563220|FG000|Overall Study|Lost to Follow-up|1|||
127708893|NCT04565990|459563220|FG000|Overall Study|Withdrawal by Subject|1|||
127708894|NCT04797858|459563221|FG000|Overall Study|Withdrawal by Subject|0|||
127708895|NCT04797858|459563222|FG001|Overall Study|Withdrawal by Subject|1|||
127708896|NCT04797858|459563221|FG000|Overall Study|Excluded due to administrative error|7|||
127708897|NCT04797858|459563222|FG001|Overall Study|Excluded due to administrative error|8|||
127708898|NCT05363163|459563232|FG000|Overall Study|Withdrawal by Subject|13|||
127708899|NCT03673501|459563233|FG000|Overall Study|Participants ongoing.|36|||
127708900|NCT03673501|459563234|FG001|Overall Study|Participants ongoing.|24|||
127708901|NCT04709419|459563238|FG000|Overall Study|Physician Decision|1|||
127708902|NCT04709419|459563239|FG001|Overall Study|Physician Decision|0|||
127708903|NCT05683340|459563240|FG000|Overall Study|Adverse Event|1|||
127708904|NCT05683340|459563241|FG001|Overall Study|Adverse Event|1|||
127708905|NCT05683340|459563240|FG000|Overall Study|Protocol Violation|1|||
127708906|NCT05683340|459563241|FG001|Overall Study|Protocol Violation|0|||
127708907|NCT05683340|459563240|FG000|Overall Study|Withdrawal by Subject|0|||
127708908|NCT05683340|459563241|FG001|Overall Study|Withdrawal by Subject|2|||
127708909|NCT01314105|459563245|FG000|Overall Study|Progressive Disease|6|||
127708910|NCT01314105|459563246|FG001|Overall Study|Progressive Disease|10|||
127708911|NCT01314105|459563245|FG000|Overall Study|Refused to continue taking medication|0|||
127708912|NCT01314105|459563246|FG001|Overall Study|Refused to continue taking medication|1|||
127708913|NCT01314105|459563245|FG000|Overall Study|Other Adverse Event|1|||
127708914|NCT01314105|459563246|FG001|Overall Study|Other Adverse Event|1|||
127708915|NCT02056834|459563247|FG000|Overall Study|Lost to Follow-up|7|||
127708916|NCT06106022|459563248|FG000|Overall Study|Lost to Follow-up|1|||
127708917|NCT06106022|459563249|FG001|Overall Study|Lost to Follow-up|0|||
127708918|NCT06106022|459563248|FG000|Overall Study|Voluntary Withdrawal|0|||
127708919|NCT06106022|459563249|FG001|Overall Study|Voluntary Withdrawal|2|||
127708920|NCT03276676|459563251|FG000|Overall Study|Withdrawal by Subject|2|||
127708921|NCT03276676|459563252|FG001|Overall Study|Withdrawal by Subject|1|||
127708922|NCT03583333|459563255|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
127708923|NCT03583333|459563256|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
127708924|NCT03583333|459563255|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
127708925|NCT03583333|459563256|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
127708926|NCT03583333|459563255|FG000|Overall Study|Withdrawal by Subject|9|||
127708927|NCT03583333|459563256|FG001|Overall Study|Withdrawal by Subject|5|||
127708928|NCT03583333|459563255|FG000|Overall Study|Physician Decision|3|||
127708929|NCT03583333|459563256|FG001|Overall Study|Physician Decision|2|||
127708930|NCT03583333|459563255|FG000|Overall Study|Death|12|||
127708931|NCT03583333|459563256|FG001|Overall Study|Death|7|||
127708932|NCT03926130|459563257|FG000|Overall Study|Adverse Event|9|||
127708933|NCT03926130|459563258|FG001|Overall Study|Adverse Event|11|||
127708934|NCT03926130|459563259|FG002|Overall Study|Adverse Event|2|||
127708935|NCT03926130|459563260|FG003|Overall Study|Adverse Event|0|||
127708936|NCT03926130|459563257|FG000|Overall Study|Death|2|||
127708937|NCT03926130|459563258|FG001|Overall Study|Death|0|||
127708938|NCT03926130|459563259|FG002|Overall Study|Death|1|||
127708939|NCT03926130|459563260|FG003|Overall Study|Death|0|||
127708940|NCT03926130|459563257|FG000|Overall Study|Lack of Efficacy|14|||
127708941|NCT03926130|459563258|FG001|Overall Study|Lack of Efficacy|11|||
127708942|NCT03926130|459563259|FG002|Overall Study|Lack of Efficacy|7|||
127708943|NCT03926130|459563260|FG003|Overall Study|Lack of Efficacy|1|||
127708944|NCT03926130|459563257|FG000|Overall Study|Lost to Follow-up|0|||
127708945|NCT03926130|459563258|FG001|Overall Study|Lost to Follow-up|7|||
127708946|NCT03926130|459563259|FG002|Overall Study|Lost to Follow-up|1|||
127708947|NCT03926130|459563260|FG003|Overall Study|Lost to Follow-up|0|||
127708948|NCT03926130|459563257|FG000|Overall Study|As Reported by Investigator|2|||
127708949|NCT03926130|459563258|FG001|Overall Study|As Reported by Investigator|6|||
127708950|NCT03926130|459563259|FG002|Overall Study|As Reported by Investigator|6|||
127708951|NCT03926130|459563260|FG003|Overall Study|As Reported by Investigator|0|||
127708952|NCT03926130|459563257|FG000|Overall Study|Physician Decision|3|||
127708953|NCT03926130|459563258|FG001|Overall Study|Physician Decision|2|||
127708954|NCT03926130|459563259|FG002|Overall Study|Physician Decision|1|||
127708955|NCT03926130|459563260|FG003|Overall Study|Physician Decision|0|||
127708956|NCT03926130|459563257|FG000|Overall Study|Pregnancy|2|||
127708957|NCT03926130|459563258|FG001|Overall Study|Pregnancy|2|||
127708958|NCT03926130|459563259|FG002|Overall Study|Pregnancy|1|||
127708959|NCT03926130|459563260|FG003|Overall Study|Pregnancy|0|||
127708960|NCT03926130|459563257|FG000|Overall Study|Withdrawal by Subject|20|||
127708961|NCT03926130|459563258|FG001|Overall Study|Withdrawal by Subject|28|||
127708962|NCT03926130|459563259|FG002|Overall Study|Withdrawal by Subject|18|||
127708963|NCT03926130|459563260|FG003|Overall Study|Withdrawal by Subject|1|||
127708964|NCT03926130|459563257|FG000|Overall Study|Non-Compliance|1|||
127708965|NCT03926130|459563258|FG001|Overall Study|Non-Compliance|1|||
127708966|NCT03926130|459563259|FG002|Overall Study|Non-Compliance|0|||
127708967|NCT03926130|459563260|FG003|Overall Study|Non-Compliance|0|||
127708968|NCT03926130|459563257|FG000|Overall Study|Disposition Not Captured|0|||
127708969|NCT03926130|459563258|FG001|Overall Study|Disposition Not Captured|2|||
127708970|NCT03926130|459563259|FG002|Overall Study|Disposition Not Captured|1|||
127708971|NCT03926130|459563260|FG003|Overall Study|Disposition Not Captured|0|||
127708972|NCT01730937|459563261|FG000|Overall Study|Protocol Violation|5|||
127708973|NCT01730937|459563262|FG001|Overall Study|Protocol Violation|11|||
127708974|NCT04469270|459563273|FG000|Overall Study|Adverse Event|2|||
127708975|NCT04469270|459563274|FG001|Overall Study|Adverse Event|0|||
127708976|NCT04469270|459563273|FG000|Overall Study|Lost to Follow-up|4|||
127708977|NCT04469270|459563274|FG001|Overall Study|Lost to Follow-up|3|||
127708978|NCT04469270|459563273|FG000|Overall Study|Withdrawal by Subject|7|||
127708979|NCT04469270|459563274|FG001|Overall Study|Withdrawal by Subject|3|||
127646402|NCT01274182|459324427|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
127646403|NCT01274182|459324425|FG000|Overall Study|Adverse Event|4|||
127646404|NCT01274182|459324426|FG001|Overall Study|Adverse Event|5|||
127646405|NCT01274182|459324427|FG002|Overall Study|Adverse Event|3|||
127646406|NCT01274182|459324425|FG000|Overall Study|Withdrawal by Subject|5|||
127646407|NCT01274182|459324426|FG001|Overall Study|Withdrawal by Subject|5|||
127646408|NCT01274182|459324427|FG002|Overall Study|Withdrawal by Subject|3|||
127646409|NCT01274182|459324425|FG000|Overall Study|Lost to Follow-up|2|||
127646410|NCT01274182|459324426|FG001|Overall Study|Lost to Follow-up|3|||
127646411|NCT01274182|459324427|FG002|Overall Study|Lost to Follow-up|1|||
127646412|NCT01274182|459324425|FG000|Overall Study|Protocol Violation|3|||
127646413|NCT01274182|459324426|FG001|Overall Study|Protocol Violation|2|||
127646414|NCT01274182|459324427|FG002|Overall Study|Protocol Violation|0|||
127646415|NCT01274182|459324425|FG000|Overall Study|Death|1|||
127646416|NCT01274182|459324426|FG001|Overall Study|Death|0|||
127646417|NCT01274182|459324427|FG002|Overall Study|Death|1|||
127646418|NCT02355002|459324428|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
127646419|NCT02355002|459324429|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
127646420|NCT02355002|459324428|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
127646421|NCT02355002|459324429|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
127646422|NCT02355002|459324428|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
127646423|NCT02355002|459324429|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
127646424|NCT02355002|459324428|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
127646425|NCT02355002|459324429|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
127646426|NCT02355002|459324428|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
127646427|NCT02355002|459324429|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
127646428|NCT02355002|459324428|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
127646429|NCT02355002|459324429|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
127646430|NCT02355002|459324428|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
127646431|NCT02355002|459324429|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
127646432|NCT00708916|459324430|FG000|Overall Study|Subject Noncompliance|2|||
127646433|NCT00708916|459324430|FG000|Overall Study|Adverse Event|2|||
127646434|NCT03205371|459324440|FG000|Overall Study|Withdrawal by Subject|4|||
127646435|NCT03205371|459324441|FG001|Overall Study|Withdrawal by Subject|1|||
127646436|NCT03205371|459324442|FG002|Overall Study|Withdrawal by Subject|0|||
127646437|NCT03205371|459324443|FG003|Overall Study|Withdrawal by Subject|0|||
127646438|NCT03205371|459324444|FG004|Overall Study|Withdrawal by Subject|0|||
127646439|NCT03205371|459324445|FG005|Overall Study|Withdrawal by Subject|0|||
127646440|NCT03205371|459324446|FG006|Overall Study|Withdrawal by Subject|4|||
127646441|NCT03205371|459324447|FG007|Overall Study|Withdrawal by Subject|0|||
127646442|NCT03205371|459324448|FG008|Overall Study|Withdrawal by Subject|2|||
127646443|NCT03205371|459324449|FG009|Overall Study|Withdrawal by Subject|0|||
127646444|NCT03205371|459324450|FG010|Overall Study|Withdrawal by Subject|0|||
127646445|NCT03205371|459324451|FG011|Overall Study|Withdrawal by Subject|1|||
127646446|NCT03205371|459324440|FG000|Overall Study|Lost to Follow-up|0|||
127646447|NCT03205371|459324441|FG001|Overall Study|Lost to Follow-up|0|||
127646448|NCT03205371|459324442|FG002|Overall Study|Lost to Follow-up|0|||
127646449|NCT03205371|459324443|FG003|Overall Study|Lost to Follow-up|0|||
127646450|NCT03205371|459324444|FG004|Overall Study|Lost to Follow-up|0|||
127646451|NCT03205371|459324445|FG005|Overall Study|Lost to Follow-up|0|||
127646452|NCT03205371|459324446|FG006|Overall Study|Lost to Follow-up|5|||
127646453|NCT03205371|459324447|FG007|Overall Study|Lost to Follow-up|2|||
127646454|NCT03205371|459324448|FG008|Overall Study|Lost to Follow-up|3|||
127646455|NCT03205371|459324449|FG009|Overall Study|Lost to Follow-up|0|||
127646456|NCT03205371|459324450|FG010|Overall Study|Lost to Follow-up|0|||
127646457|NCT03205371|459324451|FG011|Overall Study|Lost to Follow-up|0|||
127646458|NCT03205371|459324440|FG000|Overall Study|Protocol Violation|0|||
127646459|NCT03205371|459324441|FG001|Overall Study|Protocol Violation|0|||
127646460|NCT03205371|459324442|FG002|Overall Study|Protocol Violation|0|||
127646461|NCT03205371|459324443|FG003|Overall Study|Protocol Violation|0|||
127646462|NCT03205371|459324444|FG004|Overall Study|Protocol Violation|0|||
127646463|NCT03205371|459324445|FG005|Overall Study|Protocol Violation|0|||
127646464|NCT03205371|459324446|FG006|Overall Study|Protocol Violation|1|||
127888332|NCT01571635|460213992|FG000|Overall Study|Other reasons|2|||
127800719|NCT00930059|459893222|FG001|Overall Study|Death|0|||
127800720|NCT00930059|459893221|FG000|Overall Study|Did not meet entrance criteria|1|||
127800721|NCT00930059|459893222|FG001|Overall Study|Did not meet entrance criteria|1|||
127800722|NCT00930059|459893221|FG000|Overall Study|Withdrawal by Subject|3|||
127800723|NCT00930059|459893222|FG001|Overall Study|Withdrawal by Subject|4|||
127800724|NCT00930059|459893221|FG000|Overall Study|Other|1|||
127800725|NCT00930059|459893222|FG001|Overall Study|Other|0|||
127800726|NCT00930059|459893221|FG000|Overall Study|1 site terminated by sponsor|1|||
127800727|NCT00930059|459893222|FG001|Overall Study|1 site terminated by sponsor|1|||
127800728|NCT00930059|459893221|FG000|Overall Study|Adverse Event|1|||
127800729|NCT00930059|459893222|FG001|Overall Study|Adverse Event|6|||
127800730|NCT04002310|459893225|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
127800731|NCT04002310|459893226|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
127800732|NCT04002310|459893227|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
127800733|NCT04002310|459893228|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
127800734|NCT04002310|459893229|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
127800735|NCT00542997|459893230|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
127800736|NCT00542997|459893230|FG000|Wash in / Wash Out Period|Adverse Event|3|||
127800737|NCT00542997|459893230|FG000|Efficacy Period|Adverse Event|3|||
127800738|NCT02949128|459893233|FG000|Initial Evaluation Period (26 Weeks)|Failed to Meet Eligibility Criteria|2|||
127800739|NCT02949128|459893233|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|3|||
127800740|NCT02949128|459893233|FG000|Initial Evaluation Period (26 Weeks)|Death|2|||
127646465|NCT03205371|459324447|FG007|Overall Study|Protocol Violation|0|||
127646466|NCT03205371|459324448|FG008|Overall Study|Protocol Violation|0|||
127646467|NCT03205371|459324449|FG009|Overall Study|Protocol Violation|0|||
127646468|NCT03205371|459324450|FG010|Overall Study|Protocol Violation|0|||
127646469|NCT03205371|459324451|FG011|Overall Study|Protocol Violation|0|||
127646470|NCT03205371|459324440|FG000|Overall Study|Adverse Event|0|||
127646471|NCT03205371|459324441|FG001|Overall Study|Adverse Event|0|||
127646472|NCT03205371|459324442|FG002|Overall Study|Adverse Event|0|||
127646473|NCT03205371|459324443|FG003|Overall Study|Adverse Event|0|||
127646474|NCT03205371|459324444|FG004|Overall Study|Adverse Event|0|||
127646475|NCT03205371|459324445|FG005|Overall Study|Adverse Event|0|||
127646476|NCT03205371|459324446|FG006|Overall Study|Adverse Event|0|||
127646477|NCT03205371|459324447|FG007|Overall Study|Adverse Event|1|||
127646478|NCT03205371|459324448|FG008|Overall Study|Adverse Event|0|||
127646479|NCT03205371|459324449|FG009|Overall Study|Adverse Event|0|||
127646480|NCT03205371|459324450|FG010|Overall Study|Adverse Event|0|||
127646481|NCT03205371|459324451|FG011|Overall Study|Adverse Event|0|||
127646482|NCT02835339|459324455|FG000|Overall Study|Did not receive allocated intervention|13|||
127646483|NCT02835339|459324456|FG001|Overall Study|Did not receive allocated intervention|16|||
127646484|NCT01077544|459324457|FG000|Overall Study|New Cancer Therapy|3|||
127646485|NCT01077544|459324458|FG001|Overall Study|New Cancer Therapy|3|||
127646486|NCT01077544|459324457|FG000|Overall Study|Adverse Event|0|||
127646487|NCT01077544|459324458|FG001|Overall Study|Adverse Event|1|||
127646488|NCT01077544|459324457|FG000|Overall Study|Disease Progression|0|||
127646489|NCT01077544|459324458|FG001|Overall Study|Disease Progression|1|||
127646490|NCT03923959|459324459|FG000|Overall Study|Death|16|||
127646491|NCT03923959|459324460|FG001|Overall Study|Death|12|||
127646492|NCT03923959|459324459|FG000|Overall Study|Lost to Follow-up|56|||
127646493|NCT03923959|459324460|FG001|Overall Study|Lost to Follow-up|56|||
127646494|NCT03923959|459324459|FG000|Overall Study|Withdrawal by Subject|1|||
127646495|NCT03923959|459324460|FG001|Overall Study|Withdrawal by Subject|1|||
127646496|NCT03923959|459324459|FG000|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|0|||
127646497|NCT03923959|459324460|FG001|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|1|||
127646498|NCT04918147|459324461|FG000|Overall Study|Disease flare as defined in protocol|0|||
127646499|NCT04918147|459324462|FG001|Overall Study|Disease flare as defined in protocol|2|||
127646500|NCT02954354|459324464|FG000|Overall Study|Adverse Event|2|||
127646501|NCT02954354|459324465|FG001|Overall Study|Adverse Event|2|||
127646502|NCT02954354|459324466|FG002|Overall Study|Adverse Event|4|||
127646503|NCT02954354|459324464|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
127646504|NCT02954354|459324465|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
127646505|NCT02954354|459324466|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
127646506|NCT02954354|459324464|FG000|Overall Study|Lack of Efficacy|0|||
127646507|NCT02954354|459324465|FG001|Overall Study|Lack of Efficacy|2|||
127646508|NCT02954354|459324466|FG002|Overall Study|Lack of Efficacy|0|||
127646509|NCT02954354|459324464|FG000|Overall Study|Withdrawal by Subject|17|||
127646510|NCT02954354|459324465|FG001|Overall Study|Withdrawal by Subject|9|||
127646511|NCT02954354|459324466|FG002|Overall Study|Withdrawal by Subject|11|||
127646512|NCT02954354|459324464|FG000|Overall Study|Lost to Follow-up|12|||
127800741|NCT02949128|459893233|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
127800742|NCT02949128|459893233|FG000|Initial Evaluation Period (26 Weeks)|Protocol Violation|1|||
127800743|NCT02949128|459893233|FG000|Extension Period (Up to 4.5 Years)|Death|1|||
127800744|NCT02949128|459893233|FG000|Extension Period (Up to 4.5 Years)|Physician Decision|5|||
127800745|NCT02949128|459893233|FG000|Extension Period (Up to 4.5 Years)|Protocol Violation|1|||
127800746|NCT02949128|459893233|FG000|Extension Period (Up to 4.5 Years)|Withdrawal by Subject|9|||
127800747|NCT02949128|459893233|FG000|Extension Period (Up to 4.5 Years)|Other than specified|5|||
127800748|NCT03064763|459893237|FG000|Overall Study|Lost to Follow-up|1|||
127800749|NCT03064763|459893237|FG000|Overall Study|Death|8|||
127646513|NCT02954354|459324465|FG001|Overall Study|Lost to Follow-up|5|||
127646514|NCT02954354|459324466|FG002|Overall Study|Lost to Follow-up|0|||
127646515|NCT02954354|459324464|FG000|Overall Study|Miscellaneous|2|||
127646516|NCT02954354|459324465|FG001|Overall Study|Miscellaneous|2|||
127646517|NCT02954354|459324466|FG002|Overall Study|Miscellaneous|1|||
127646518|NCT03338829|459324467|FG000|Overall Study|Lost to Follow-up|4|||
127646519|NCT03338829|459324468|FG001|Overall Study|Lost to Follow-up|2|||
127646520|NCT03338829|459324469|FG002|Overall Study|Lost to Follow-up|4|||
127646521|NCT03338829|459324467|FG000|Overall Study|Pregnancy loss|1|||
127646522|NCT03338829|459324468|FG001|Overall Study|Pregnancy loss|1|||
127646523|NCT03338829|459324469|FG002|Overall Study|Pregnancy loss|0|||
127646524|NCT03338829|459324467|FG000|Overall Study|Protocol Violation|0|||
127646525|NCT03338829|459324468|FG001|Overall Study|Protocol Violation|1|||
127646526|NCT03338829|459324469|FG002|Overall Study|Protocol Violation|0|||
127646527|NCT03575325|459324470|FG000|Overall Study|Death|1|||
127646528|NCT02618967|459324474|FG000|Overall Study|Lost to Follow-up|0|||
127646529|NCT02618967|459324475|FG001|Overall Study|Lost to Follow-up|0|||
127646530|NCT02618967|459324476|FG002|Overall Study|Lost to Follow-up|1|||
127646531|NCT02618967|459324477|FG003|Overall Study|Lost to Follow-up|0|||
127646532|NCT02618967|459324478|FG004|Overall Study|Lost to Follow-up|2|||
127646533|NCT02618967|459324479|FG005|Overall Study|Lost to Follow-up|0|||
127646534|NCT02618967|459324480|FG006|Overall Study|Lost to Follow-up|0|||
127800750|NCT00808444|459893247|FG000|Overall Study|Withdrawal by Subject|1|||
127800751|NCT00808444|459893248|FG001|Overall Study|Withdrawal by Subject|0|||
127800752|NCT00808444|459893247|FG000|Overall Study|Lost to Follow-up|0|||
127800753|NCT00808444|459893248|FG001|Overall Study|Lost to Follow-up|1|||
127800754|NCT01461044|459893249|FG000|Overall Study|Death|58|||
127800755|NCT01461044|459893250|FG001|Overall Study|Death|35|||
127800756|NCT01461044|459893249|FG000|Overall Study|Lost to Follow-up|12|||
127800757|NCT01461044|459893250|FG001|Overall Study|Lost to Follow-up|5|||
127800758|NCT00716976|459893251|FG000|Overall Study|Adverse Event|2|||
127800759|NCT00716976|459893252|FG001|Overall Study|Adverse Event|0|||
127800760|NCT00716976|459893251|FG000|Overall Study|Death|1|||
127800761|NCT00716976|459893252|FG001|Overall Study|Death|0|||
127800762|NCT00716976|459893251|FG000|Overall Study|Physician Decision|2|||
127800763|NCT00716976|459893252|FG001|Overall Study|Physician Decision|2|||
127800764|NCT00716976|459893251|FG000|Overall Study|Withdrawal by Subject|5|||
127800765|NCT00716976|459893252|FG001|Overall Study|Withdrawal by Subject|1|||
127800766|NCT00716976|459893251|FG000|Overall Study|Premature discontinuation cisplatin|5|||
127800767|NCT00716976|459893252|FG001|Overall Study|Premature discontinuation cisplatin|4|||
127800768|NCT00716976|459893251|FG000|Overall Study|Radiation during protocol|1|||
127800769|NCT00716976|459893252|FG001|Overall Study|Radiation during protocol|0|||
127800770|NCT00716976|459893251|FG000|Overall Study|Ineligibles|4|||
127800771|NCT00716976|459893252|FG001|Overall Study|Ineligibles|2|||
127800772|NCT00122135|459893253|FG000|Overall Study|Withdrawal by Subject|3|||
127800773|NCT00122135|459893254|FG001|Overall Study|Withdrawal by Subject|0|||
127800774|NCT03068325|459893260|FG000|Overall Study|Lost to Follow-up|5|||
127800775|NCT00975156|459893261|FG000|Overall Study|Protocol Violation|0|||
127800776|NCT00975156|459893262|FG001|Overall Study|Protocol Violation|1|||
127800777|NCT00454779|459893267|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
127800778|NCT00454779|459893268|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
127800779|NCT00454779|459893267|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
127800780|NCT00454779|459893268|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
127800781|NCT00454779|459893267|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
127888333|NCT01571635|460213993|FG001|Overall Study|Other reasons|1|||
127646535|NCT02618967|459324481|FG007|Overall Study|Lost to Follow-up|0|||
127646536|NCT02618967|459324474|FG000|Overall Study|Withdrawal by Subject|1|||
127646537|NCT02618967|459324475|FG001|Overall Study|Withdrawal by Subject|0|||
127646538|NCT02618967|459324476|FG002|Overall Study|Withdrawal by Subject|0|||
127800782|NCT00454779|459893268|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
127800783|NCT00454779|459893267|FG000|First-line Treatment Phase|Protocol Violation|0|||
127800784|NCT00454779|459893268|FG001|First-line Treatment Phase|Protocol Violation|1|||
127800785|NCT00454779|459893267|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
127800786|NCT00454779|459893268|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
127800787|NCT00454779|459893267|FG000|First-line Treatment Phase|Ongoing|1|||
127800788|NCT00454779|459893268|FG001|First-line Treatment Phase|Ongoing|0|||
127800789|NCT00454779|459893267|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
127646539|NCT02618967|459324477|FG003|Overall Study|Withdrawal by Subject|0|||
127708980|NCT04469270|459563273|FG000|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|2|||
127708981|NCT04469270|459563274|FG001|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|0|||
127708982|NCT04469270|459563273|FG000|Overall Study|missing|1|||
127708983|NCT04469270|459563274|FG001|Overall Study|missing|0|||
127708984|NCT04880733|459563298|FG000|Participants in the RCT (Overall Study)|Data collection issue|3|||
127708985|NCT04880733|459563299|FG001|Participants in the RCT (Overall Study)|Data collection issue|5|||
127708986|NCT04880733|459563300|FG002|Participants in the RCT (Overall Study)|Data collection issue|0|||
127708987|NCT04880733|459563298|FG000|Participants in the RCT (Overall Study)|Withdrawal by Subject|3|||
127708988|NCT04880733|459563299|FG001|Participants in the RCT (Overall Study)|Withdrawal by Subject|1|||
127708989|NCT04880733|459563300|FG002|Participants in the RCT (Overall Study)|Withdrawal by Subject|0|||
127708990|NCT04880733|459563298|FG000|Participants in the RCT (Overall Study)|Delay due to ED imaging|1|||
127708991|NCT04880733|459563299|FG001|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
127708992|NCT04880733|459563300|FG002|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
127708993|NCT04880733|459563298|FG000|Participants in the RCT (Overall Study)|Early discharge|0|||
127708994|NCT04880733|459563299|FG001|Participants in the RCT (Overall Study)|Early discharge|1|||
127708995|NCT04880733|459563300|FG002|Participants in the RCT (Overall Study)|Early discharge|0|||
127708996|NCT04880733|459563298|FG000|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
127708997|NCT04880733|459563299|FG001|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
127708998|NCT04880733|459563300|FG002|ED Staff/Providers 6 Month Assessment|Skipped question 2|1|||
127708999|NCT05424380|459563303|FG000|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|1|||
127709000|NCT05424380|459563304|FG001|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
127709001|NCT05424380|459563305|FG002|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
127709002|NCT05424380|459563306|FG003|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
127709003|NCT05424380|459563307|FG004|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
127709004|NCT05424380|459563308|FG005|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
127709005|NCT05424380|459563303|FG000|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|1|||
127709006|NCT05424380|459563304|FG001|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
127709007|NCT05424380|459563305|FG002|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
127709008|NCT05424380|459563306|FG003|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
127709009|NCT05424380|459563307|FG004|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
127709010|NCT05424380|459563308|FG005|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
127709011|NCT05424380|459563303|FG000|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|1|||
127709012|NCT05424380|459563304|FG001|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
127709013|NCT05424380|459563305|FG002|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
127709014|NCT05424380|459563306|FG003|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
127709015|NCT05424380|459563307|FG004|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
127709016|NCT05424380|459563308|FG005|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
127709017|NCT05424380|459563303|FG000|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
127709018|NCT05424380|459563304|FG001|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|1|||
127709019|NCT05424380|459563305|FG002|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
127709020|NCT05424380|459563306|FG003|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
127709021|NCT05424380|459563307|FG004|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
127709022|NCT05424380|459563308|FG005|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
127709023|NCT05424380|459563303|FG000|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
127709024|NCT05424380|459563304|FG001|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|1|||
127709025|NCT05424380|459563305|FG002|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
127709026|NCT05424380|459563306|FG003|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
127709027|NCT05424380|459563307|FG004|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
127709028|NCT05424380|459563308|FG005|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
127709029|NCT05424380|459563303|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
127709030|NCT05424380|459563304|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
127709031|NCT05424380|459563305|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|1|||
127709032|NCT05424380|459563306|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
127709033|NCT05424380|459563307|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
127709034|NCT05424380|459563308|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
127709035|NCT05424380|459563303|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
127709036|NCT05424380|459563304|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
127709037|NCT05424380|459563305|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|1|||
127709038|NCT05424380|459563306|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
127709039|NCT05424380|459563307|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
127709040|NCT05424380|459563308|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
127709041|NCT05424380|459563303|FG000|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
127709042|NCT05424380|459563304|FG001|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
127709043|NCT05424380|459563305|FG002|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|1|||
127709044|NCT05424380|459563306|FG003|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
127646540|NCT02618967|459324478|FG004|Overall Study|Withdrawal by Subject|0|||
127646541|NCT02618967|459324479|FG005|Overall Study|Withdrawal by Subject|0|||
127646542|NCT02618967|459324480|FG006|Overall Study|Withdrawal by Subject|0|||
127646543|NCT02618967|459324481|FG007|Overall Study|Withdrawal by Subject|0|||
127646544|NCT01368965|459324482|FG000|Overall Study|Lost to Follow-up|12|||
127646545|NCT02612311|459324483|FG000|Overall Study|Adverse Event|16|||
127646546|NCT02612311|459324484|FG001|Overall Study|Adverse Event|12|||
127646547|NCT02612311|459324485|FG002|Overall Study|Adverse Event|7|||
127646548|NCT02612311|459324486|FG003|Overall Study|Adverse Event|13|||
127646549|NCT02612311|459324483|FG000|Overall Study|Death|29|||
127646550|NCT02612311|459324484|FG001|Overall Study|Death|10|||
127646551|NCT02612311|459324485|FG002|Overall Study|Death|11|||
127646552|NCT02612311|459324486|FG003|Overall Study|Death|11|||
127646553|NCT02612311|459324483|FG000|Overall Study|Initiation of Non-protocol Intervention|5|||
127646554|NCT02612311|459324484|FG001|Overall Study|Initiation of Non-protocol Intervention|3|||
127646555|NCT02612311|459324485|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
127646556|NCT02612311|459324486|FG003|Overall Study|Initiation of Non-protocol Intervention|0|||
127646557|NCT02612311|459324483|FG000|Overall Study|Investigator's Decision|11|||
127646558|NCT02612311|459324484|FG001|Overall Study|Investigator's Decision|15|||
127646559|NCT02612311|459324485|FG002|Overall Study|Investigator's Decision|6|||
127646560|NCT02612311|459324486|FG003|Overall Study|Investigator's Decision|6|||
127646561|NCT02612311|459324483|FG000|Overall Study|Lack of Efficacy|0|||
127646562|NCT02612311|459324484|FG001|Overall Study|Lack of Efficacy|0|||
127646563|NCT02612311|459324485|FG002|Overall Study|Lack of Efficacy|1|||
127646564|NCT02612311|459324486|FG003|Overall Study|Lack of Efficacy|1|||
127646565|NCT02612311|459324483|FG000|Overall Study|Lost to Follow-up|2|||
127646566|NCT02612311|459324484|FG001|Overall Study|Lost to Follow-up|2|||
127646567|NCT02612311|459324485|FG002|Overall Study|Lost to Follow-up|1|||
127646568|NCT02612311|459324486|FG003|Overall Study|Lost to Follow-up|2|||
127646569|NCT02612311|459324483|FG000|Overall Study|Progressive Disease Confirmed by Central Radiology|75|||
127646570|NCT02612311|459324484|FG001|Overall Study|Progressive Disease Confirmed by Central Radiology|113|||
127646571|NCT02612311|459324485|FG002|Overall Study|Progressive Disease Confirmed by Central Radiology|38|||
127646572|NCT02612311|459324486|FG003|Overall Study|Progressive Disease Confirmed by Central Radiology|43|||
127646573|NCT02612311|459324483|FG000|Overall Study|Site Terminated by Sponsor|29|||
127646574|NCT02612311|459324484|FG001|Overall Study|Site Terminated by Sponsor|12|||
127646575|NCT02612311|459324485|FG002|Overall Study|Site Terminated by Sponsor|13|||
127646576|NCT02612311|459324486|FG003|Overall Study|Site Terminated by Sponsor|5|||
127646577|NCT02612311|459324483|FG000|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|29|||
127646578|NCT02612311|459324484|FG001|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|24|||
127646579|NCT02612311|459324485|FG002|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|6|||
127646580|NCT02612311|459324486|FG003|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|5|||
127646581|NCT02612311|459324483|FG000|Overall Study|Reason Not Specified|3|||
127646582|NCT02612311|459324484|FG001|Overall Study|Reason Not Specified|7|||
127646583|NCT02612311|459324485|FG002|Overall Study|Reason Not Specified|4|||
127646584|NCT02612311|459324486|FG003|Overall Study|Reason Not Specified|5|||
127646585|NCT02612311|459324483|FG000|Overall Study|Unknown/Missing|10|||
127646586|NCT02612311|459324484|FG001|Overall Study|Unknown/Missing|13|||
127646587|NCT02612311|459324485|FG002|Overall Study|Unknown/Missing|4|||
127646588|NCT02612311|459324486|FG003|Overall Study|Unknown/Missing|0|||
127646589|NCT02612311|459324483|FG000|Overall Study|Non-Compliance with Study|1|||
127646590|NCT02612311|459324484|FG001|Overall Study|Non-Compliance with Study|0|||
127646591|NCT02612311|459324485|FG002|Overall Study|Non-Compliance with Study|0|||
127646592|NCT02612311|459324486|FG003|Overall Study|Non-Compliance with Study|0|||
127646593|NCT00514735|459324487|FG000|Overall Study|Withdrawal by Subject|13|||
127646594|NCT00514735|459324488|FG001|Overall Study|Withdrawal by Subject|5|||
127646595|NCT00514735|459324487|FG000|Overall Study|Death|1|||
127646596|NCT00514735|459324488|FG001|Overall Study|Death|0|||
127646597|NCT00514735|459324487|FG000|Overall Study|Lost to Follow-up|0|||
127646598|NCT00514735|459324488|FG001|Overall Study|Lost to Follow-up|1|||
127646599|NCT00553696|459324496|FG000|Overall Study|Adverse Event|2|||
127646600|NCT00553696|459324497|FG001|Overall Study|Adverse Event|4|||
127646601|NCT00553696|459324498|FG002|Overall Study|Adverse Event|0|||
127646602|NCT00553696|459324499|FG003|Overall Study|Adverse Event|1|||
127646603|NCT00553696|459324496|FG000|Overall Study|Global deterioration of health status|0|||
127646604|NCT00553696|459324497|FG001|Overall Study|Global deterioration of health status|2|||
127646605|NCT00553696|459324498|FG002|Overall Study|Global deterioration of health status|0|||
127646606|NCT00553696|459324499|FG003|Overall Study|Global deterioration of health status|0|||
127646607|NCT00553696|459324496|FG000|Overall Study|Objective progression or relapse|2|||
127888334|NCT01571635|460213994|FG002|Overall Study|Other reasons|2|||
127888335|NCT01571635|460213995|FG003|Overall Study|Other reasons|2|||
127888336|NCT01571635|460213996|FG004|Overall Study|Other reasons|1|||
127888337|NCT01571635|460213992|FG000|Overall Study|Study terminated by sponsor|0|||
127888338|NCT01571635|460213993|FG001|Overall Study|Study terminated by sponsor|4|||
127888339|NCT01571635|460213994|FG002|Overall Study|Study terminated by sponsor|1|||
127888340|NCT01571635|460213995|FG003|Overall Study|Study terminated by sponsor|3|||
127888341|NCT01571635|460213996|FG004|Overall Study|Study terminated by sponsor|1|||
127888342|NCT01571635|460213992|FG000|Overall Study|Withdrew consent|1|||
127888343|NCT01571635|460213993|FG001|Overall Study|Withdrew consent|1|||
127888344|NCT01571635|460213994|FG002|Overall Study|Withdrew consent|2|||
127888345|NCT01571635|460213995|FG003|Overall Study|Withdrew consent|3|||
127888346|NCT01571635|460213996|FG004|Overall Study|Withdrew consent|0|||
127646608|NCT00553696|459324497|FG001|Overall Study|Objective progression or relapse|9|||
127646609|NCT00553696|459324498|FG002|Overall Study|Objective progression or relapse|6|||
127646610|NCT00553696|459324499|FG003|Overall Study|Objective progression or relapse|0|||
127646611|NCT00553696|459324496|FG000|Overall Study|Withdrawal by Subject|0|||
127646612|NCT00553696|459324497|FG001|Overall Study|Withdrawal by Subject|1|||
127646613|NCT00553696|459324498|FG002|Overall Study|Withdrawal by Subject|0|||
127646614|NCT00553696|459324499|FG003|Overall Study|Withdrawal by Subject|0|||
127646615|NCT00686881|459324500|FG000|Overall Study|Withdrawal by Subject|11|||
127646616|NCT00686881|459324501|FG001|Overall Study|Withdrawal by Subject|18|||
127646617|NCT00686881|459324500|FG000|Overall Study|Lost to Follow-up|0|||
127646618|NCT00686881|459324501|FG001|Overall Study|Lost to Follow-up|1|||
127646619|NCT00686881|459324500|FG000|Overall Study|Treatment-related adverse event|10|||
127646620|NCT00686881|459324501|FG001|Overall Study|Treatment-related adverse event|9|||
127646621|NCT00686881|459324500|FG000|Overall Study|Met discontinuation criteria|5|||
127646622|NCT00686881|459324501|FG001|Overall Study|Met discontinuation criteria|0|||
127646623|NCT00686881|459324500|FG000|Overall Study|Onset of malignant tumor|11|||
127646624|NCT00686881|459324501|FG001|Overall Study|Onset of malignant tumor|11|||
127646625|NCT00686881|459324500|FG000|Overall Study|Lack of Efficacy|4|||
127646626|NCT00686881|459324501|FG001|Overall Study|Lack of Efficacy|3|||
127646627|NCT00686881|459324500|FG000|Overall Study|Physician Decision|1|||
127646628|NCT00686881|459324501|FG001|Overall Study|Physician Decision|0|||
127646629|NCT00686881|459324500|FG000|Overall Study|Circumstances of site|1|||
127646630|NCT00686881|459324501|FG001|Overall Study|Circumstances of site|1|||
127646631|NCT00686881|459324500|FG000|Overall Study|Did not meet protocol eligibility|1|||
127646632|NCT00686881|459324501|FG001|Overall Study|Did not meet protocol eligibility|0|||
127646633|NCT00686881|459324500|FG000|Overall Study|Irregular visits|1|||
127646634|NCT00686881|459324501|FG001|Overall Study|Irregular visits|0|||
127646635|NCT00686881|459324500|FG000|Overall Study|Study discontinuation|35|||
127646636|NCT00686881|459324501|FG001|Overall Study|Study discontinuation|32|||
127646637|NCT00686881|459324500|FG000|Overall Study|Never received study drug|2|||
127646638|NCT00686881|459324501|FG001|Overall Study|Never received study drug|6|||
127646639|NCT02170025|459324502|FG000|Overall Study|Adverse Event|2|||
127646640|NCT02170025|459324503|FG001|Overall Study|Adverse Event|0|||
127646641|NCT00572195|459324504|FG000|Overall Study|Withdrawal by Subject|50|||
127646642|NCT00572195|459324504|FG000|Overall Study|Death|9|||
127646643|NCT00572195|459324504|FG000|Overall Study|Adverse Event|4|||
127646644|NCT00572195|459324504|FG000|Overall Study|Lost to Follow-up|5|||
127646645|NCT02412137|459324505|FG000|Overall Study|Withdrawal by Subject|2|||
127646646|NCT02412137|459324506|FG001|Overall Study|Withdrawal by Subject|0|||
127646647|NCT02412137|459324505|FG000|Overall Study|Lost to Follow-up|21|||
127646648|NCT02412137|459324506|FG001|Overall Study|Lost to Follow-up|14|||
127646649|NCT02412137|459324505|FG000|Overall Study|Physician Decision|28|||
127646650|NCT02412137|459324506|FG001|Overall Study|Physician Decision|9|||
127646651|NCT04981678|459324507|FG000|Overall Study|Lost to Follow-up|0|||
127646652|NCT04981678|459324508|FG001|Overall Study|Lost to Follow-up|1|||
127646653|NCT01323530|459326410|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
127646654|NCT01323530|459326411|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
127646655|NCT01323530|459326412|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
127888347|NCT01571635|460213992|FG000|Overall Study|Lack of Efficacy|0|||
127646656|NCT01323530|459326413|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
127646657|NCT01323530|459326414|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
127646658|NCT01323530|459326415|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
127646659|NCT01323530|459326416|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
127646660|NCT01323530|459326410|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
127888348|NCT01571635|460213993|FG001|Overall Study|Lack of Efficacy|2|||
127646661|NCT01323530|459326411|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
127646662|NCT01323530|459326412|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
127646663|NCT01323530|459326413|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
127888349|NCT01571635|460213994|FG002|Overall Study|Lack of Efficacy|0|||
127888350|NCT01571635|460213995|FG003|Overall Study|Lack of Efficacy|1|||
127888351|NCT01571635|460213996|FG004|Overall Study|Lack of Efficacy|2|||
127888352|NCT01722266|460213997|FG000|Overall Study|Withdrawal by Subject|1|||
127888353|NCT01722266|460213998|FG001|Overall Study|Withdrawal by Subject|2|||
127888354|NCT01722266|460213999|FG002|Overall Study|Withdrawal by Subject|0|||
127888355|NCT01722266|460214000|FG003|Overall Study|Withdrawal by Subject|0|||
127888356|NCT01722266|460213997|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
127888357|NCT01722266|460213998|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
127888358|NCT01722266|460213999|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
127888359|NCT01722266|460214000|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
127888360|NCT01722266|460213997|FG000|Overall Study|Dropped out due to Nausea|0|||
127888361|NCT01722266|460213998|FG001|Overall Study|Dropped out due to Nausea|0|||
127888362|NCT01722266|460213999|FG002|Overall Study|Dropped out due to Nausea|2|||
127888363|NCT01722266|460214000|FG003|Overall Study|Dropped out due to Nausea|0|||
127646664|NCT01323530|459326414|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
127646665|NCT01323530|459326415|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
127646666|NCT01323530|459326416|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
127646667|NCT01323530|459326410|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
127646668|NCT01323530|459326411|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
127646669|NCT01323530|459326412|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
127646670|NCT01323530|459326413|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
127646671|NCT01323530|459326414|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
127646672|NCT01323530|459326415|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
127646673|NCT01323530|459326416|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
127646674|NCT01323530|459326410|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
127646675|NCT01323530|459326411|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
127646676|NCT01323530|459326412|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
127646677|NCT01323530|459326413|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
127646678|NCT01323530|459326414|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
127646679|NCT01323530|459326415|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
127646680|NCT01323530|459326416|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
127646681|NCT01323530|459326410|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
127646682|NCT01323530|459326411|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
127646683|NCT01323530|459326412|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
127646684|NCT01323530|459326413|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
127646685|NCT01323530|459326414|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
127646686|NCT01323530|459326415|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
127646687|NCT01323530|459326416|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
127646688|NCT01323530|459326410|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
127646689|NCT01323530|459326411|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
127646690|NCT01323530|459326412|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
127646691|NCT01323530|459326413|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
127646692|NCT01323530|459326414|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
127646693|NCT01323530|459326415|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
127646694|NCT01323530|459326416|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
127646695|NCT01323530|459326410|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
127646696|NCT01323530|459326411|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
127646697|NCT01323530|459326412|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
127646698|NCT01323530|459326413|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
127646699|NCT01323530|459326414|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
127646700|NCT01323530|459326415|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
127646701|NCT01323530|459326416|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
127646702|NCT01323530|459326410|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
127646703|NCT01323530|459326411|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
127646704|NCT01323530|459326412|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
127646705|NCT01323530|459326413|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
127646706|NCT01323530|459326414|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
127646707|NCT01323530|459326415|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
127646708|NCT01323530|459326416|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
127646709|NCT01735201|459326417|FG000|Overall Study|Adverse Event|1|||
127646710|NCT01735201|459326418|FG001|Overall Study|Adverse Event|1|||
127646711|NCT01735201|459326419|FG002|Overall Study|Adverse Event|0|||
127646712|NCT01735201|459326420|FG003|Overall Study|Adverse Event|1|||
127646713|NCT01735201|459326421|FG004|Overall Study|Adverse Event|1|||
127646714|NCT01735201|459326422|FG005|Overall Study|Adverse Event|3|||
127888364|NCT02862535|460214001|FG000|Overall Study|Death|7|||
127709045|NCT05424380|459563307|FG004|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
127709046|NCT05424380|459563308|FG005|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
127709047|NCT05424380|459563303|FG000|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
127709048|NCT05424380|459563304|FG001|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
127709049|NCT05424380|459563305|FG002|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
127709050|NCT05424380|459563306|FG003|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|1|||
127709051|NCT05424380|459563307|FG004|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
127709052|NCT05424380|459563308|FG005|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
127709053|NCT05424380|459563303|FG000|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
127800790|NCT00454779|459893268|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
127800791|NCT00454779|459893267|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
127800792|NCT00454779|459893268|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
127800793|NCT00454779|459893267|FG000|Second-line Treatment Phase|Ongoing|0|||
127800794|NCT00454779|459893268|FG001|Second-line Treatment Phase|Ongoing|1|||
127800795|NCT05425563|459893269|FG000|Overall Study|Withdrawal by Subject|17|||
127800796|NCT03106779|459893275|FG000|Overall Study|Lack of Efficacy|33|||
127800797|NCT03106779|459893276|FG001|Overall Study|Lack of Efficacy|24|||
127800798|NCT03106779|459893275|FG000|Overall Study|Adverse Event|8|||
127800799|NCT03106779|459893276|FG001|Overall Study|Adverse Event|16|||
127800800|NCT03106779|459893275|FG000|Overall Study|Physician Decision|10|||
127800801|NCT03106779|459893276|FG001|Overall Study|Physician Decision|6|||
127800802|NCT03106779|459893275|FG000|Overall Study|Patient/guardian decision|4|||
127800803|NCT03106779|459893276|FG001|Overall Study|Patient/guardian decision|3|||
127800804|NCT03106779|459893275|FG000|Overall Study|Progressive disease|1|||
127800805|NCT03106779|459893276|FG001|Overall Study|Progressive disease|3|||
127800806|NCT03106779|459893275|FG000|Overall Study|Lost to Follow-up|1|||
127800807|NCT03106779|459893276|FG001|Overall Study|Lost to Follow-up|2|||
127800808|NCT03106779|459893275|FG000|Overall Study|Death|1|||
127800809|NCT03106779|459893276|FG001|Overall Study|Death|0|||
127800810|NCT03106779|459893275|FG000|Overall Study|Protocol Violation|1|||
127800811|NCT03106779|459893276|FG001|Overall Study|Protocol Violation|0|||
127800812|NCT03106779|459893275|FG000|Overall Study|Not treated|1|||
127800813|NCT03106779|459893276|FG001|Overall Study|Not treated|0|||
127800814|NCT02288247|459893277|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|52|||
127800815|NCT02288247|459893278|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|0|||
127800816|NCT02288247|459893277|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Death|35|||
127800817|NCT02288247|459893278|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Death|0|||
127800818|NCT02288247|459893277|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|1|||
127800819|NCT02288247|459893278|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|0|||
127800820|NCT02288247|459893277|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|393|||
127800821|NCT02288247|459893278|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|0|||
127800822|NCT02288247|459893277|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|9|||
127800823|NCT02288247|459893278|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|0|||
127800824|NCT02288247|459893277|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|54|||
127800825|NCT02288247|459893278|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|0|||
127800826|NCT02288247|459893277|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Other|142|||
127800827|NCT02288247|459893278|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Other|0|||
127800828|NCT02288247|459893277|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|2|||
127800829|NCT02288247|459893278|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|0|||
127800830|NCT02288247|459893277|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
127800831|NCT02288247|459893278|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
127800832|NCT02288247|459893277|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
127800833|NCT02288247|459893278|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
127800834|NCT02288247|459893277|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
127800835|NCT02288247|459893278|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
127800836|NCT02288247|459893277|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
127800837|NCT02288247|459893278|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
127800838|NCT02288247|459893277|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
127800839|NCT02288247|459893278|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
127800840|NCT02288247|459893277|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
127800841|NCT02288247|459893278|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
127800842|NCT02288247|459893277|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
127800843|NCT02288247|459893278|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
127800844|NCT02288247|459893277|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
127800845|NCT02288247|459893278|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
127709054|NCT05424380|459563304|FG001|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
127709055|NCT05424380|459563305|FG002|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
127709056|NCT05424380|459563306|FG003|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|1|||
127709057|NCT05424380|459563307|FG004|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
127709058|NCT05424380|459563308|FG005|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
127709059|NCT05424380|459563303|FG000|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
127709060|NCT05424380|459563304|FG001|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
127709061|NCT05424380|459563305|FG002|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
127709062|NCT05424380|459563306|FG003|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|1|||
127709063|NCT05424380|459563307|FG004|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
127709064|NCT05424380|459563308|FG005|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
127709065|NCT05424380|459563303|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
127709066|NCT05424380|459563304|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
127709067|NCT05424380|459563305|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
127709068|NCT05424380|459563306|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
127709069|NCT05424380|459563307|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|3|||
127709070|NCT05424380|459563308|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
127709071|NCT05424380|459563303|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
127709072|NCT05424380|459563304|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
127709073|NCT05424380|459563305|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
127709074|NCT05424380|459563306|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
127709075|NCT05424380|459563307|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|1|||
127709076|NCT05424380|459563308|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
127646715|NCT01735201|459326423|FG006|Overall Study|Adverse Event|2|||
127646716|NCT01735201|459326424|FG007|Overall Study|Adverse Event|1|||
127646717|NCT01735201|459326417|FG000|Overall Study|Personal Reasons|1|||
127646718|NCT01735201|459326418|FG001|Overall Study|Personal Reasons|0|||
127646719|NCT01735201|459326419|FG002|Overall Study|Personal Reasons|0|||
127646720|NCT01735201|459326420|FG003|Overall Study|Personal Reasons|0|||
127646721|NCT01735201|459326421|FG004|Overall Study|Personal Reasons|0|||
127646722|NCT01735201|459326422|FG005|Overall Study|Personal Reasons|0|||
127646723|NCT01735201|459326423|FG006|Overall Study|Personal Reasons|0|||
127646724|NCT01735201|459326424|FG007|Overall Study|Personal Reasons|0|||
127646725|NCT01735201|459326417|FG000|Overall Study|Protocol Violation|1|||
127646726|NCT01735201|459326418|FG001|Overall Study|Protocol Violation|0|||
127646727|NCT01735201|459326419|FG002|Overall Study|Protocol Violation|0|||
127646728|NCT01735201|459326420|FG003|Overall Study|Protocol Violation|0|||
127646729|NCT01735201|459326421|FG004|Overall Study|Protocol Violation|0|||
127646730|NCT01735201|459326422|FG005|Overall Study|Protocol Violation|0|||
127646731|NCT01735201|459326423|FG006|Overall Study|Protocol Violation|0|||
127646732|NCT01735201|459326424|FG007|Overall Study|Protocol Violation|0|||
127646733|NCT01735201|459326417|FG000|Overall Study|Other Miscellaneous Reasons|0|||
127646734|NCT01735201|459326418|FG001|Overall Study|Other Miscellaneous Reasons|0|||
127646735|NCT01735201|459326419|FG002|Overall Study|Other Miscellaneous Reasons|0|||
127646736|NCT01735201|459326420|FG003|Overall Study|Other Miscellaneous Reasons|1|||
127646737|NCT01735201|459326421|FG004|Overall Study|Other Miscellaneous Reasons|0|||
127646738|NCT01735201|459326422|FG005|Overall Study|Other Miscellaneous Reasons|2|||
127646739|NCT01735201|459326423|FG006|Overall Study|Other Miscellaneous Reasons|1|||
127646740|NCT01735201|459326424|FG007|Overall Study|Other Miscellaneous Reasons|1|||
127646741|NCT01553318|459326425|FG000|Overall Study|Protocol Violation|3|||
127646742|NCT01553318|459326426|FG001|Overall Study|Protocol Violation|2|||
127646743|NCT02127372|459326433|FG000|Overall Study|Withdrawal by Subject|1|||
127646744|NCT02127372|459326434|FG001|Overall Study|Withdrawal by Subject|0|||
127709077|NCT05424380|459563303|FG000|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
127800846|NCT04093531|459893279|FG000|Overall Study|failed screening|4|||
127800847|NCT00272987|459893280|FG000|Overall Study|Adverse Event|1|||
127646745|NCT03597568|459326435|FG000|Overall Study|Withdrawal by Subject|1|||
127646746|NCT03597568|459326436|FG001|Overall Study|Withdrawal by Subject|1|||
127800848|NCT00272987|459893281|FG001|Overall Study|Adverse Event|0|||
127800849|NCT00272987|459893282|FG002|Overall Study|Adverse Event|0|||
127646747|NCT03597568|459326435|FG000|Overall Study|Unable to analyze vascular data|1|||
127646748|NCT03597568|459326436|FG001|Overall Study|Unable to analyze vascular data|1|||
127800850|NCT00272987|459893280|FG000|Overall Study|Lost to Follow-up|3|||
127800851|NCT00272987|459893281|FG001|Overall Study|Lost to Follow-up|1|||
127800852|NCT00272987|459893282|FG002|Overall Study|Lost to Follow-up|1|||
127800853|NCT00272987|459893280|FG000|Overall Study|Withdrawal by Subject|1|||
127646749|NCT02565914|459326442|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
127646750|NCT02565914|459326442|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
127709078|NCT05424380|459563304|FG001|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
127709079|NCT05424380|459563305|FG002|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
127709080|NCT05424380|459563306|FG003|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
127709081|NCT05424380|459563307|FG004|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|1|||
127709082|NCT05424380|459563308|FG005|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
127709083|NCT02909686|459563309|FG000|Overall Study|Physician Decision|3|||
127709084|NCT02909686|459563309|FG000|Overall Study|Withdrawal by Subject|2|||
127709085|NCT03858517|459563310|FG000|Overall Study|Adverse Event|1|||
127709086|NCT03858517|459563310|FG000|Overall Study|Lost to Follow-up|1|||
127709087|NCT03858517|459563310|FG000|Overall Study|removed for being incarcerated|1|||
127709088|NCT03858517|459563310|FG000|Overall Study|Sponsor Closure|48|||
127709089|NCT06037668|459563311|FG000|Overall Study|Lost to Follow-up|1|||
127709090|NCT06037668|459563312|FG001|Overall Study|Lost to Follow-up|1|||
127709091|NCT06037668|459563311|FG000|Overall Study|Protocol Violation|1|||
127709092|NCT06037668|459563312|FG001|Overall Study|Protocol Violation|0|||
127709093|NCT06037668|459563311|FG000|Overall Study|Withdrawal by Subject|1|||
127709094|NCT06037668|459563312|FG001|Overall Study|Withdrawal by Subject|0|||
127709095|NCT06037668|459563311|FG000|Overall Study|Other Study Discontinuation Reason|1|||
127709096|NCT06037668|459563312|FG001|Overall Study|Other Study Discontinuation Reason|0|||
127709097|NCT05285137|459563314|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
127709098|NCT05285137|459563315|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
127709099|NCT05285137|459563316|FG002|Overall Study|Failure to Meet Continuation Criteria|0|||
127709100|NCT05285137|459563317|FG003|Overall Study|Failure to Meet Continuation Criteria|0|||
127709101|NCT05285137|459563318|FG004|Overall Study|Failure to Meet Continuation Criteria|0|||
127709102|NCT05285137|459563319|FG005|Overall Study|Failure to Meet Continuation Criteria|0|||
127709103|NCT05285137|459563320|FG006|Overall Study|Failure to Meet Continuation Criteria|2|||
127709104|NCT05285137|459563321|FG007|Overall Study|Failure to Meet Continuation Criteria|0|||
127709105|NCT05285137|459563322|FG008|Overall Study|Failure to Meet Continuation Criteria|1|||
127709106|NCT05285137|459563314|FG000|Overall Study|Lost to Follow-up|0|||
127709107|NCT05285137|459563315|FG001|Overall Study|Lost to Follow-up|0|||
127709108|NCT05285137|459563316|FG002|Overall Study|Lost to Follow-up|1|||
127709109|NCT05285137|459563317|FG003|Overall Study|Lost to Follow-up|3|||
127709110|NCT05285137|459563318|FG004|Overall Study|Lost to Follow-up|0|||
127709111|NCT05285137|459563319|FG005|Overall Study|Lost to Follow-up|0|||
127709112|NCT05285137|459563320|FG006|Overall Study|Lost to Follow-up|1|||
127709113|NCT05285137|459563321|FG007|Overall Study|Lost to Follow-up|0|||
127709114|NCT05285137|459563322|FG008|Overall Study|Lost to Follow-up|0|||
127709115|NCT05285137|459563314|FG000|Overall Study|Physician Decision|0|||
127709116|NCT05285137|459563315|FG001|Overall Study|Physician Decision|1|||
127709117|NCT05285137|459563316|FG002|Overall Study|Physician Decision|0|||
127709118|NCT05285137|459563317|FG003|Overall Study|Physician Decision|0|||
127709119|NCT05285137|459563318|FG004|Overall Study|Physician Decision|0|||
127709120|NCT05285137|459563319|FG005|Overall Study|Physician Decision|0|||
127709121|NCT05285137|459563320|FG006|Overall Study|Physician Decision|0|||
127709122|NCT05285137|459563321|FG007|Overall Study|Physician Decision|0|||
127709123|NCT05285137|459563322|FG008|Overall Study|Physician Decision|0|||
127709124|NCT05285137|459563314|FG000|Overall Study|Pregnancy|0|||
127709125|NCT05285137|459563315|FG001|Overall Study|Pregnancy|0|||
127709126|NCT05285137|459563316|FG002|Overall Study|Pregnancy|0|||
127709127|NCT05285137|459563317|FG003|Overall Study|Pregnancy|0|||
127709128|NCT05285137|459563318|FG004|Overall Study|Pregnancy|0|||
127709129|NCT05285137|459563319|FG005|Overall Study|Pregnancy|0|||
127709130|NCT05285137|459563320|FG006|Overall Study|Pregnancy|1|||
127709131|NCT05285137|459563321|FG007|Overall Study|Pregnancy|0|||
127709132|NCT05285137|459563322|FG008|Overall Study|Pregnancy|0|||
127709133|NCT05285137|459563314|FG000|Overall Study|Withdrawal by Subject|0|||
127709134|NCT05285137|459563315|FG001|Overall Study|Withdrawal by Subject|1|||
127800854|NCT00272987|459893281|FG001|Overall Study|Withdrawal by Subject|0|||
127800855|NCT00272987|459893282|FG002|Overall Study|Withdrawal by Subject|3|||
127709135|NCT05285137|459563316|FG002|Overall Study|Withdrawal by Subject|2|||
127709136|NCT05285137|459563317|FG003|Overall Study|Withdrawal by Subject|1|||
127709137|NCT05285137|459563318|FG004|Overall Study|Withdrawal by Subject|0|||
127709138|NCT05285137|459563319|FG005|Overall Study|Withdrawal by Subject|0|||
127709139|NCT05285137|459563320|FG006|Overall Study|Withdrawal by Subject|0|||
127709140|NCT05285137|459563321|FG007|Overall Study|Withdrawal by Subject|0|||
127709141|NCT05285137|459563322|FG008|Overall Study|Withdrawal by Subject|1|||
127709142|NCT03717935|459563323|FG000|Overall Study|Withdrawal by Subject|0|||
127800856|NCT00272987|459893280|FG000|Overall Study|Sponsor Terminated study|0|||
127800857|NCT00272987|459893281|FG001|Overall Study|Sponsor Terminated study|1|||
127800858|NCT00272987|459893282|FG002|Overall Study|Sponsor Terminated study|1|||
127709143|NCT03717935|459563324|FG001|Overall Study|Withdrawal by Subject|2|||
127709144|NCT03484819|459563329|FG000|Overall Study|Death|2|||
127709145|NCT03484819|459563329|FG000|Overall Study|Adverse Event|2|||
127709146|NCT03484819|459563329|FG000|Overall Study|Physician Decision|1|||
127709147|NCT03484819|459563329|FG000|Overall Study|Withdrawal by Subject|2|||
127709148|NCT03484819|459563329|FG000|Overall Study|Disease Progression|4|||
127709149|NCT03484819|459563329|FG000|Overall Study|Complicating Condition|1|||
127800859|NCT00272987|459893280|FG000|Overall Study|Disease progression|1|||
127800860|NCT00272987|459893281|FG001|Overall Study|Disease progression|1|||
127800861|NCT00272987|459893282|FG002|Overall Study|Disease progression|2|||
127800862|NCT00272987|459893280|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
127800863|NCT00272987|459893281|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
127800864|NCT00272987|459893282|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
127800865|NCT00272987|459893280|FG000|Overall Study|Death|1|||
127800866|NCT00272987|459893281|FG001|Overall Study|Death|0|||
127800867|NCT00272987|459893282|FG002|Overall Study|Death|0|||
127800868|NCT01163786|459893283|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
127800869|NCT01163786|459893283|FG000|Treatment With Bortezomib|Adverse Event|2|||
127800870|NCT01163786|459893283|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
127800871|NCT00634569|459893284|FG000|Overall Study|Withdrawal by Subject|0|||
127800872|NCT00634569|459893285|FG001|Overall Study|Withdrawal by Subject|4|||
127800873|NCT00634569|459893284|FG000|Overall Study|Physician Decision|0|||
127800874|NCT00634569|459893285|FG001|Overall Study|Physician Decision|1|||
127800875|NCT02918019|459893286|FG000|Overall Study|Death|0|||
127646751|NCT02565914|459326442|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
127646752|NCT02565914|459326442|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
127646753|NCT02565914|459326442|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
127646754|NCT02565914|459326442|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
127646755|NCT02565914|459326442|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
127646756|NCT02565914|459326442|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
127646757|NCT02565914|459326442|FG000|Part A (Up to 96 Weeks)|Other|18|||
127646758|NCT02565914|459326442|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
127646759|NCT02565914|459326442|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
127646760|NCT02565914|459326442|FG000|Part B (Up to 96 Weeks)|Other|1|||
127646761|NCT02565914|459326442|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
127646762|NCT02565914|459326442|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
127646763|NCT02565914|459326442|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
127646764|NCT02565914|459326442|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
127646765|NCT02565914|459326442|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
127646766|NCT02565914|459326442|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
127646767|NCT02565914|459326442|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
127646768|NCT02565914|459326442|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
127646769|NCT02565914|459326442|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
127646770|NCT02565914|459326442|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
127646771|NCT02565914|459326442|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
127646772|NCT02565914|459326442|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
127646773|NCT04493931|459326444|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
127646774|NCT04493931|459326445|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
127646775|NCT04493931|459326446|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
127646776|NCT04493931|459326447|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
127646777|NCT04493931|459326448|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
127646778|NCT04493931|459326449|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
127646779|NCT04493931|459326450|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
127646780|NCT04493931|459326444|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
127800876|NCT02918019|459893287|FG001|Overall Study|Death|0|||
127800877|NCT02918019|459893288|FG002|Overall Study|Death|1|||
127800878|NCT02918019|459893289|FG003|Overall Study|Death|0|||
127800879|NCT02918019|459893286|FG000|Overall Study|Lost to Follow-up|1|||
127800880|NCT02918019|459893287|FG001|Overall Study|Lost to Follow-up|1|||
127800881|NCT02918019|459893288|FG002|Overall Study|Lost to Follow-up|0|||
127800882|NCT02918019|459893289|FG003|Overall Study|Lost to Follow-up|1|||
127800883|NCT02918019|459893286|FG000|Overall Study|Principal investigator request|0|||
127800884|NCT02918019|459893287|FG001|Overall Study|Principal investigator request|0|||
127800885|NCT02918019|459893288|FG002|Overall Study|Principal investigator request|0|||
127800886|NCT02918019|459893289|FG003|Overall Study|Principal investigator request|1|||
127800887|NCT02918019|459893286|FG000|Overall Study|Physician Decision|1|||
127646781|NCT04493931|459326445|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
127800888|NCT02918019|459893287|FG001|Overall Study|Physician Decision|3|||
127800889|NCT02918019|459893288|FG002|Overall Study|Physician Decision|2|||
127646782|NCT04493931|459326446|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
127800890|NCT02918019|459893289|FG003|Overall Study|Physician Decision|0|||
127800891|NCT02918019|459893286|FG000|Overall Study|Protocol deviation|1|||
127800892|NCT02918019|459893287|FG001|Overall Study|Protocol deviation|1|||
127800893|NCT02918019|459893288|FG002|Overall Study|Protocol deviation|0|||
127709150|NCT04479761|459563330|FG000|Overall Study|could not perform the balance tasks|1|||
127709151|NCT04479761|459563331|FG001|Overall Study|could not perform the balance tasks|0|||
127709152|NCT04479761|459563332|FG002|Overall Study|could not perform the balance tasks|0|||
127709153|NCT04479761|459563330|FG000|Overall Study|Adverse Event|1|||
127709154|NCT04479761|459563331|FG001|Overall Study|Adverse Event|0|||
127709155|NCT04479761|459563332|FG002|Overall Study|Adverse Event|0|||
127709156|NCT04479761|459563330|FG000|Overall Study|one control did not meet screening criteria|0|||
127709157|NCT04479761|459563331|FG001|Overall Study|one control did not meet screening criteria|0|||
127709158|NCT04479761|459563332|FG002|Overall Study|one control did not meet screening criteria|1|||
127709159|NCT04479761|459563330|FG000|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
127709160|NCT04479761|459563331|FG001|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|3|||
127709161|NCT04479761|459563332|FG002|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
127709162|NCT02997202|459563336|FG000|Overall Study|Miscellaneous|2|||
127709163|NCT02997202|459563337|FG001|Overall Study|Miscellaneous|2|||
127709164|NCT02997202|459563336|FG000|Overall Study|Withdrawal by Subject|8|||
127709165|NCT02997202|459563337|FG001|Overall Study|Withdrawal by Subject|12|||
127709166|NCT02997202|459563336|FG000|Overall Study|Lost to Follow-up|5|||
127709167|NCT02997202|459563337|FG001|Overall Study|Lost to Follow-up|3|||
127709168|NCT02997202|459563336|FG000|Overall Study|Death|41|||
127709169|NCT02997202|459563337|FG001|Overall Study|Death|45|||
127709170|NCT00303459|459563343|FG000|Overall Study|Death|33|||
127709171|NCT00303459|459563344|FG001|Overall Study|Death|44|||
127709172|NCT00303459|459563343|FG000|Overall Study|Withdrawal of consent|32|||
127709173|NCT00303459|459563344|FG001|Overall Study|Withdrawal of consent|26|||
127709174|NCT00303459|459563343|FG000|Overall Study|Lost to Follow-up|5|||
127709175|NCT00303459|459563344|FG001|Overall Study|Lost to Follow-up|4|||
127709176|NCT00303459|459563343|FG000|Overall Study|Administrative reason|7|||
127709177|NCT00303459|459563344|FG001|Overall Study|Administrative reason|7|||
127888365|NCT02862535|460214002|FG001|Overall Study|Death|3|||
127888366|NCT02862535|460214003|FG002|Overall Study|Death|2|||
127888367|NCT02862535|460214004|FG003|Overall Study|Death|5|||
127888368|NCT02862535|460214001|FG000|Overall Study|Study Terminated by Sponsor|1|||
127888369|NCT02862535|460214002|FG001|Overall Study|Study Terminated by Sponsor|3|||
127888370|NCT02862535|460214003|FG002|Overall Study|Study Terminated by Sponsor|8|||
127888371|NCT02862535|460214004|FG003|Overall Study|Study Terminated by Sponsor|5|||
127888372|NCT02862535|460214001|FG000|Overall Study|Enrolled, not Treated|1|||
127888373|NCT02862535|460214002|FG001|Overall Study|Enrolled, not Treated|0|||
127888374|NCT02862535|460214003|FG002|Overall Study|Enrolled, not Treated|0|||
127888375|NCT02862535|460214004|FG003|Overall Study|Enrolled, not Treated|1|||
127888376|NCT05478603|460214010|FG000|Overall Study|Withdrawal by Subject|0|||
127888377|NCT05478603|460214011|FG001|Overall Study|Withdrawal by Subject|1|||
127888378|NCT05478603|460214012|FG002|Overall Study|Withdrawal by Subject|0|||
127888379|NCT05478603|460214013|FG003|Overall Study|Withdrawal by Subject|0|||
127888380|NCT02472977|460214014|FG000|Overall Study|Disease progression|4|||
127888381|NCT02472977|460214015|FG001|Overall Study|Disease progression|25|||
127888382|NCT02472977|460214016|FG002|Overall Study|Disease progression|6|||
127888383|NCT02472977|460214014|FG000|Overall Study|Withdrawal by Subject|0|||
127888384|NCT02472977|460214015|FG001|Overall Study|Withdrawal by Subject|1|||
127888385|NCT02472977|460214016|FG002|Overall Study|Withdrawal by Subject|0|||
127646783|NCT04493931|459326447|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
127646784|NCT04493931|459326448|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
127646785|NCT04493931|459326449|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
127646786|NCT04493931|459326450|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
127646787|NCT04493931|459326444|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
127646788|NCT04493931|459326445|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
127646789|NCT04493931|459326446|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
127646790|NCT04493931|459326447|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
127646791|NCT04493931|459326448|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
127646792|NCT04493931|459326449|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
127709178|NCT00303459|459563343|FG000|Overall Study|Decision by the investigator|5|||
127709179|NCT00303459|459563344|FG001|Overall Study|Decision by the investigator|7|||
127709180|NCT00303459|459563343|FG000|Overall Study|Lung transplantation|1|||
127888386|NCT02472977|460214014|FG000|Overall Study|Study drug toxicity|2|||
127888387|NCT02472977|460214015|FG001|Overall Study|Study drug toxicity|0|||
127709181|NCT00303459|459563344|FG001|Overall Study|Lung transplantation|1|||
127709182|NCT04129554|459563345|FG000|Overall Study|Withdrawal by Subject|4|||
127709183|NCT04129554|459563346|FG001|Overall Study|Withdrawal by Subject|3|||
127888388|NCT02472977|460214016|FG002|Overall Study|Study drug toxicity|2|||
127888389|NCT02472977|460214014|FG000|Overall Study|Subject request to discontinue treatment|0|||
127888390|NCT02472977|460214015|FG001|Overall Study|Subject request to discontinue treatment|1|||
127888391|NCT02472977|460214016|FG002|Overall Study|Subject request to discontinue treatment|0|||
127646793|NCT04493931|459326450|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
127646794|NCT04493931|459326444|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
127646795|NCT04493931|459326445|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
127646796|NCT04493931|459326446|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
127646797|NCT04493931|459326447|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
127646798|NCT04493931|459326448|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
127646799|NCT04493931|459326449|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
127646800|NCT04493931|459326450|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
127646801|NCT01197508|459326457|FG000|Overall Study|Withdrawal by Subject|8|||
127646802|NCT01197508|459326458|FG001|Overall Study|Withdrawal by Subject|7|||
127646803|NCT01197508|459326459|FG002|Overall Study|Withdrawal by Subject|15|||
127646804|NCT01197508|459326460|FG003|Overall Study|Withdrawal by Subject|4|||
127646805|NCT01197508|459326457|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
127646806|NCT01197508|459326458|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
127646807|NCT01197508|459326459|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
127646808|NCT01197508|459326460|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
127646809|NCT01197508|459326457|FG000|Overall Study|Adverse Event|10|||
127646810|NCT01197508|459326458|FG001|Overall Study|Adverse Event|13|||
127646811|NCT01197508|459326459|FG002|Overall Study|Adverse Event|23|||
127646812|NCT01197508|459326460|FG003|Overall Study|Adverse Event|3|||
127646813|NCT01197508|459326457|FG000|Overall Study|Severe non-compliance to protocol|0|||
127646814|NCT01197508|459326458|FG001|Overall Study|Severe non-compliance to protocol|3|||
127646815|NCT01197508|459326459|FG002|Overall Study|Severe non-compliance to protocol|1|||
127646816|NCT01197508|459326460|FG003|Overall Study|Severe non-compliance to protocol|3|||
127646817|NCT01197508|459326457|FG000|Overall Study|Condition under investigation worsened|1|||
127646818|NCT01197508|459326458|FG001|Overall Study|Condition under investigation worsened|1|||
127646819|NCT01197508|459326459|FG002|Overall Study|Condition under investigation worsened|1|||
127646820|NCT01197508|459326460|FG003|Overall Study|Condition under investigation worsened|1|||
127646821|NCT01197508|459326457|FG000|Overall Study|Lack of Efficacy|1|||
127646822|NCT01197508|459326458|FG001|Overall Study|Lack of Efficacy|2|||
127646823|NCT01197508|459326459|FG002|Overall Study|Lack of Efficacy|2|||
127646824|NCT01197508|459326460|FG003|Overall Study|Lack of Efficacy|1|||
127646825|NCT01197508|459326457|FG000|Overall Study|Study-specific withdrawal criteria|0|||
127646826|NCT01197508|459326458|FG001|Overall Study|Study-specific withdrawal criteria|0|||
127646827|NCT01197508|459326459|FG002|Overall Study|Study-specific withdrawal criteria|1|||
127646828|NCT01197508|459326460|FG003|Overall Study|Study-specific withdrawal criteria|2|||
127646829|NCT01197508|459326457|FG000|Overall Study|Lost to Follow-up|1|||
127646830|NCT01197508|459326458|FG001|Overall Study|Lost to Follow-up|1|||
127646831|NCT01197508|459326459|FG002|Overall Study|Lost to Follow-up|2|||
127646832|NCT01197508|459326460|FG003|Overall Study|Lost to Follow-up|0|||
127646833|NCT01197508|459326457|FG000|Overall Study|Other|2|||
127646834|NCT01197508|459326458|FG001|Overall Study|Other|3|||
127646835|NCT01197508|459326459|FG002|Overall Study|Other|2|||
127646836|NCT01197508|459326460|FG003|Overall Study|Other|2|||
127646837|NCT00266825|459326462|FG000|Completed Follow-Up|Lost to Follow-up|14|||
127800894|NCT02918019|459893289|FG003|Overall Study|Protocol deviation|2|||
127646838|NCT00266825|459326463|FG001|Completed Follow-Up|Lost to Follow-up|19|||
127646839|NCT00266825|459326462|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
127646840|NCT00266825|459326463|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
127646841|NCT01301391|459326466|FG000|Overall Study|Death|13|||
127646842|NCT01301391|459326466|FG000|Overall Study|Lost to Follow-up|3|||
127646843|NCT01301391|459326466|FG000|Overall Study|Physician Decision|2|||
127646844|NCT01301391|459326466|FG000|Overall Study|Sponsor's decision|8|||
127646845|NCT02799784|459326470|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
127646846|NCT02799784|459326471|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
127646847|NCT02799784|459326470|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
127646848|NCT02799784|459326471|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
127646849|NCT02799784|459326470|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
127646850|NCT02799784|459326471|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
127646851|NCT02799784|459326470|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
127646852|NCT02799784|459326471|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
127646853|NCT02799784|459326470|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
127646854|NCT02799784|459326471|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
127646855|NCT02799784|459326470|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
127646856|NCT02799784|459326471|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
127646857|NCT03466086|459326474|FG000|Period 1|Sponsor decision due to study timeline|1|||
127646858|NCT03466086|459326475|FG001|Period 1|Sponsor decision due to study timeline|0|||
127646859|NCT03466086|459326474|FG000|Period 1|Withdrawal by Subject|1|||
127646860|NCT03466086|459326475|FG001|Period 1|Withdrawal by Subject|0|||
127646861|NCT00595504|459326476|FG000|Overall Study|Withdrawal by Subject|1|||
127646862|NCT00595504|459326477|FG001|Overall Study|Withdrawal by Subject|3|||
127709184|NCT04129554|459563345|FG000|Overall Study|Other|0|||
127709185|NCT04129554|459563346|FG001|Overall Study|Other|2|||
127709186|NCT01570361|459563347|FG000|Overall Study|Subject discontinued|1|||
127709187|NCT01570361|459563348|FG001|Overall Study|Subject discontinued|2|||
127709188|NCT01570361|459563347|FG000|Overall Study|Sponsor closing the study|51|||
127709189|NCT01570361|459563348|FG001|Overall Study|Sponsor closing the study|50|||
127709190|NCT01570361|459563347|FG000|Overall Study|Subject excluded|5|||
127709191|NCT01570361|459563348|FG001|Overall Study|Subject excluded|3|||
127709192|NCT01570361|459563347|FG000|Overall Study|Subject withdrew consent|14|||
127709193|NCT01570361|459563348|FG001|Overall Study|Subject withdrew consent|9|||
127709194|NCT01570361|459563347|FG000|Overall Study|Adverse Event|2|||
127709195|NCT01570361|459563348|FG001|Overall Study|Adverse Event|1|||
127709196|NCT01570361|459563347|FG000|Overall Study|Lost to Follow-up|4|||
127709197|NCT01570361|459563348|FG001|Overall Study|Lost to Follow-up|4|||
127709198|NCT01570361|459563347|FG000|Overall Study|Death|5|||
127709199|NCT01570361|459563348|FG001|Overall Study|Death|4|||
127709200|NCT01570361|459563347|FG000|Overall Study|Other|0|||
127709201|NCT01570361|459563348|FG001|Overall Study|Other|2|||
127709202|NCT02846545|459563351|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
127709203|NCT02846545|459563352|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
127709204|NCT02846545|459563351|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
127709205|NCT02846545|459563352|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
127709206|NCT02846545|459563351|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
127709207|NCT02846545|459563352|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
127709208|NCT02846545|459563351|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
127709209|NCT02846545|459563352|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
127709210|NCT02846545|459563351|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
127709211|NCT02846545|459563352|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
127709212|NCT03691298|459563355|FG000|Overall Study|Lost to Follow-up|8|||
127709213|NCT03691298|459563355|FG000|Overall Study|Sponsor terminated study|2|||
127709214|NCT02492711|459563359|FG000|Overall Study|Adverse Event|9|||
127709215|NCT02492711|459563360|FG001|Overall Study|Adverse Event|9|||
127709216|NCT02492711|459563361|FG002|Overall Study|Adverse Event|2|||
127709217|NCT02492711|459563359|FG000|Overall Study|Death|3|||
127709218|NCT02492711|459563360|FG001|Overall Study|Death|3|||
127709219|NCT02492711|459563361|FG002|Overall Study|Death|0|||
127709220|NCT02492711|459563359|FG000|Overall Study|Withdrawal by Subject|10|||
127709221|NCT02492711|459563360|FG001|Overall Study|Withdrawal by Subject|16|||
127709222|NCT02492711|459563361|FG002|Overall Study|Withdrawal by Subject|5|||
127709223|NCT02492711|459563359|FG000|Overall Study|Physician Decision|10|||
127709224|NCT02492711|459563360|FG001|Overall Study|Physician Decision|6|||
127709225|NCT02492711|459563361|FG002|Overall Study|Physician Decision|4|||
127709226|NCT02492711|459563359|FG000|Overall Study|Lost to Follow-up|0|||
127709227|NCT02492711|459563360|FG001|Overall Study|Lost to Follow-up|0|||
127709228|NCT02492711|459563361|FG002|Overall Study|Lost to Follow-up|1|||
127709229|NCT02492711|459563359|FG000|Overall Study|study treatment delay|2|||
127709230|NCT02492711|459563360|FG001|Overall Study|study treatment delay|1|||
127709231|NCT02492711|459563361|FG002|Overall Study|study treatment delay|0|||
127709232|NCT02492711|459563359|FG000|Overall Study|change in chemotherapy|0|||
127709233|NCT02492711|459563360|FG001|Overall Study|change in chemotherapy|1|||
127709234|NCT02492711|459563361|FG002|Overall Study|change in chemotherapy|0|||
127709235|NCT02492711|459563359|FG000|Overall Study|never treated|2|||
127709236|NCT02492711|459563360|FG001|Overall Study|never treated|4|||
127709237|NCT02492711|459563361|FG002|Overall Study|never treated|0|||
127709238|NCT02492711|459563359|FG000|Overall Study|Other|0|||
127800895|NCT02918019|459893286|FG000|Overall Study|Withdrawal by Subject|3|||
127709239|NCT02492711|459563360|FG001|Overall Study|Other|0|||
127709240|NCT02492711|459563361|FG002|Overall Study|Other|1|||
127709241|NCT03993392|459563366|FG000|Overall Study|Withdrawal by Subject|3|||
127709242|NCT03993392|459563366|FG000|Overall Study|Lost to Follow-up|2|||
127709243|NCT03993392|459563366|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
127646863|NCT00595504|459326476|FG000|Overall Study|Physician Decision|1|||
127646864|NCT00595504|459326477|FG001|Overall Study|Physician Decision|0|||
127646865|NCT01949870|459326479|FG000|Overall Study|Lack of Efficacy|2|||
127646866|NCT01949870|459326479|FG000|Overall Study|Adverse Event|1|||
127646867|NCT01949870|459326479|FG000|Overall Study|Study termination|1|||
127646868|NCT01949870|459326479|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
127646869|NCT02570126|459326483|FG000|Overall Study|Lost to Follow-up|2|||
127646870|NCT02570126|459326484|FG001|Overall Study|Lost to Follow-up|0|||
127646871|NCT02570126|459326483|FG000|Overall Study|Unable To Arrange Visit 3|1|||
127646872|NCT02570126|459326484|FG001|Overall Study|Unable To Arrange Visit 3|0|||
127646873|NCT02570126|459326483|FG000|Overall Study|Violation Of Procedures GSK|0|||
127646874|NCT02570126|459326484|FG001|Overall Study|Violation Of Procedures GSK|1|||
127646875|NCT02570126|459326483|FG000|Overall Study|Protocol Violation|0|||
127646876|NCT02570126|459326484|FG001|Overall Study|Protocol Violation|1|||
127646877|NCT02570126|459326483|FG000|Overall Study|Withdrawal by Subject|3|||
127646878|NCT02570126|459326484|FG001|Overall Study|Withdrawal by Subject|7|||
127646879|NCT00917579|459326485|FG000|Washout >= 2 Weeks|Adverse Event|1|||
127646880|NCT00917579|459326486|FG001|Washout >= 2 Weeks|Adverse Event|0|||
127646881|NCT00917579|459326485|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
127646882|NCT00917579|459326486|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
127646883|NCT00754338|459326487|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
127646884|NCT00754338|459326488|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
127646885|NCT00754338|459326489|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
127646886|NCT00754338|459326490|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
127646887|NCT00754338|459326487|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
127646888|NCT00754338|459326488|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
127646889|NCT00754338|459326489|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
127646890|NCT00754338|459326490|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
127646891|NCT00677352|459326491|FG000|Treatment Phase|Adverse Event|14|||
127646892|NCT00677352|459326492|FG001|Treatment Phase|Adverse Event|22|||
127646893|NCT00677352|459326491|FG000|Treatment Phase|Lack of Efficacy|2|||
127646894|NCT00677352|459326492|FG001|Treatment Phase|Lack of Efficacy|3|||
127646895|NCT00677352|459326491|FG000|Treatment Phase|Lost to Follow-up|0|||
127646896|NCT00677352|459326492|FG001|Treatment Phase|Lost to Follow-up|1|||
127646897|NCT00677352|459326491|FG000|Treatment Phase|Withdrawal by Subject|7|||
127646898|NCT00677352|459326492|FG001|Treatment Phase|Withdrawal by Subject|7|||
127646899|NCT00677352|459326491|FG000|Treatment Phase|Physician Decision|1|||
127646900|NCT00677352|459326492|FG001|Treatment Phase|Physician Decision|0|||
127646901|NCT00677352|459326491|FG000|Treatment Phase|Pregnancy|0|||
127646902|NCT00677352|459326492|FG001|Treatment Phase|Pregnancy|1|||
127646903|NCT00677352|459326491|FG000|Treatment Phase|Protocol Violation|1|||
127646904|NCT00677352|459326492|FG001|Treatment Phase|Protocol Violation|1|||
127646905|NCT00677352|459326491|FG000|Treatment Phase|Transference or work related matter|0|||
127646906|NCT00677352|459326492|FG001|Treatment Phase|Transference or work related matter|5|||
127646907|NCT00677352|459326491|FG000|Treatment Phase|Not treated|0|||
127646908|NCT00677352|459326492|FG001|Treatment Phase|Not treated|2|||
127646909|NCT00677352|459326491|FG000|Tapering Phase|Adverse Event|1|||
127646910|NCT00677352|459326492|FG001|Tapering Phase|Adverse Event|5|||
127646911|NCT00677352|459326491|FG000|Tapering Phase|Withdrawal by Subject|5|||
127646912|NCT00677352|459326492|FG001|Tapering Phase|Withdrawal by Subject|3|||
127646913|NCT00677352|459326491|FG000|Tapering Phase|Pregnancy|0|||
127646914|NCT00677352|459326492|FG001|Tapering Phase|Pregnancy|1|||
127646915|NCT00677352|459326491|FG000|Tapering Phase|Job transfer|0|||
127646916|NCT00677352|459326492|FG001|Tapering Phase|Job transfer|1|||
127646917|NCT02182973|459326500|FG000|Overall Study|Withdrawal by Subject|3|||
127646918|NCT02182973|459326501|FG001|Overall Study|Withdrawal by Subject|0|||
127646919|NCT04385368|459326503|FG000|Overall Study|Death|5|||
127646920|NCT04385368|459326504|FG001|Overall Study|Death|5|||
127646921|NCT04385368|459326503|FG000|Overall Study|Physician Decision|3|||
127646922|NCT04385368|459326504|FG001|Overall Study|Physician Decision|0|||
127646923|NCT04385368|459326503|FG000|Overall Study|Withdrawal by Subject|4|||
127646924|NCT04385368|459326504|FG001|Overall Study|Withdrawal by Subject|3|||
127646925|NCT01235546|459326505|FG000|Overall Study|Staff error, medication not administered|1|||
127646926|NCT01235546|459326506|FG001|Overall Study|Staff error, medication not administered|0|||
127709244|NCT05962814|459563371|FG000|Overall Study|failed eligibility|1|||
127709245|NCT04999111|459564422|FG000|Overall Study|Lost to Follow-up|21|||
127709246|NCT04999111|459564423|FG001|Overall Study|Lost to Follow-up|16|||
127709247|NCT04999111|459564424|FG002|Overall Study|Lost to Follow-up|2|||
127709248|NCT04999111|459564425|FG003|Overall Study|Lost to Follow-up|26|||
127709249|NCT04999111|459564426|FG004|Overall Study|Lost to Follow-up|30|||
127709250|NCT04999111|459564427|FG005|Overall Study|Lost to Follow-up|6|||
127709251|NCT04999111|459564422|FG000|Overall Study|Physician Decision|1|||
127646927|NCT01235546|459326505|FG000|Overall Study|Protocol Violation|1|||
127709252|NCT04999111|459564423|FG001|Overall Study|Physician Decision|3|||
127646928|NCT01235546|459326506|FG001|Overall Study|Protocol Violation|1|||
127646929|NCT01123382|459326507|FG000|Overall Study|Withdrawal by Subject|1|||
127709253|NCT04999111|459564424|FG002|Overall Study|Physician Decision|0|||
127709254|NCT04999111|459564425|FG003|Overall Study|Physician Decision|1|||
127709255|NCT04999111|459564426|FG004|Overall Study|Physician Decision|2|||
127709256|NCT04999111|459564427|FG005|Overall Study|Physician Decision|0|||
127709257|NCT04999111|459564422|FG000|Overall Study|Withdrawal by Subject|23|||
127709258|NCT04999111|459564423|FG001|Overall Study|Withdrawal by Subject|29|||
127709259|NCT04999111|459564424|FG002|Overall Study|Withdrawal by Subject|15|||
127709260|NCT04999111|459564425|FG003|Overall Study|Withdrawal by Subject|30|||
127709261|NCT04999111|459564426|FG004|Overall Study|Withdrawal by Subject|35|||
127709262|NCT04999111|459564427|FG005|Overall Study|Withdrawal by Subject|10|||
127709263|NCT04999111|459564422|FG000|Overall Study|Other|6|||
127709264|NCT04999111|459564423|FG001|Overall Study|Other|6|||
127709265|NCT04999111|459564424|FG002|Overall Study|Other|3|||
127709266|NCT04999111|459564425|FG003|Overall Study|Other|8|||
127709267|NCT04999111|459564426|FG004|Overall Study|Other|8|||
127709268|NCT04999111|459564427|FG005|Overall Study|Other|5|||
127709269|NCT04999111|459564422|FG000|Overall Study|Non-compliance with study schedule|1|||
127709270|NCT04999111|459564423|FG001|Overall Study|Non-compliance with study schedule|0|||
127709271|NCT04999111|459564424|FG002|Overall Study|Non-compliance with study schedule|0|||
127709272|NCT04999111|459564425|FG003|Overall Study|Non-compliance with study schedule|1|||
127709273|NCT04999111|459564426|FG004|Overall Study|Non-compliance with study schedule|1|||
127709274|NCT04999111|459564427|FG005|Overall Study|Non-compliance with study schedule|1|||
127709275|NCT04999111|459564422|FG000|Overall Study|Randomized but not vaccinated|1|||
127709276|NCT04999111|459564423|FG001|Overall Study|Randomized but not vaccinated|2|||
127709277|NCT04999111|459564424|FG002|Overall Study|Randomized but not vaccinated|0|||
127709278|NCT04999111|459564425|FG003|Overall Study|Randomized but not vaccinated|3|||
127709279|NCT04999111|459564426|FG004|Overall Study|Randomized but not vaccinated|3|||
127709280|NCT04999111|459564427|FG005|Overall Study|Randomized but not vaccinated|0|||
127709281|NCT04999111|459564422|FG000|Overall Study|Adverse Event|1|||
127709282|NCT04999111|459564423|FG001|Overall Study|Adverse Event|1|||
127709283|NCT04999111|459564424|FG002|Overall Study|Adverse Event|0|||
127709284|NCT04999111|459564425|FG003|Overall Study|Adverse Event|0|||
127709285|NCT04999111|459564426|FG004|Overall Study|Adverse Event|0|||
127709286|NCT04999111|459564427|FG005|Overall Study|Adverse Event|0|||
127709287|NCT04999111|459564422|FG000|Overall Study|Initiated prohibited medication|0|||
127709288|NCT04999111|459564423|FG001|Overall Study|Initiated prohibited medication|0|||
127709289|NCT04999111|459564424|FG002|Overall Study|Initiated prohibited medication|0|||
127709290|NCT04999111|459564425|FG003|Overall Study|Initiated prohibited medication|0|||
127709291|NCT04999111|459564426|FG004|Overall Study|Initiated prohibited medication|1|||
127709292|NCT04999111|459564427|FG005|Overall Study|Initiated prohibited medication|0|||
127709293|NCT02437136|459564431|FG000|Dose Escalation/Confirmation (Phase 1b)|Death|4|||
127709294|NCT02437136|459564432|FG001|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
127709295|NCT02437136|459564433|FG002|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
127709296|NCT02437136|459564434|FG003|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
127709297|NCT02437136|459564435|FG004|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
127709298|NCT02437136|459564436|FG005|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
127709299|NCT02437136|459564437|FG006|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
127709300|NCT02437136|459564431|FG000|Expansion (Phase 2)|Death|0|||
127709301|NCT02437136|459564432|FG001|Expansion (Phase 2)|Death|0|||
127709302|NCT02437136|459564433|FG002|Expansion (Phase 2)|Death|0|||
127709303|NCT02437136|459564434|FG003|Expansion (Phase 2)|Death|6|||
127800896|NCT02918019|459893287|FG001|Overall Study|Withdrawal by Subject|4|||
127800897|NCT02918019|459893288|FG002|Overall Study|Withdrawal by Subject|6|||
127800898|NCT02918019|459893289|FG003|Overall Study|Withdrawal by Subject|4|||
127800899|NCT02918019|459893286|FG000|Overall Study|Adverse Event|0|||
127800900|NCT02918019|459893287|FG001|Overall Study|Adverse Event|1|||
127800901|NCT02918019|459893288|FG002|Overall Study|Adverse Event|0|||
127800902|NCT02918019|459893289|FG003|Overall Study|Adverse Event|1|||
127800903|NCT03222349|459893290|FG000|Overall Study|Treatment B not done|5|||
127800904|NCT03222349|459893291|FG001|Overall Study|Treatment B not done|0|||
127800905|NCT03222349|459893290|FG000|Overall Study|Lost to Follow-up|1|||
127800906|NCT03222349|459893291|FG001|Overall Study|Lost to Follow-up|2|||
127709304|NCT02437136|459564435|FG004|Expansion (Phase 2)|Death|37|||
127709305|NCT02437136|459564436|FG005|Expansion (Phase 2)|Death|29|||
127709306|NCT02437136|459564437|FG006|Expansion (Phase 2)|Death|24|||
127709307|NCT02437136|459564431|FG000|Expansion (Phase 2)|Withdrawal by Subject|0|||
127709308|NCT02437136|459564432|FG001|Expansion (Phase 2)|Withdrawal by Subject|0|||
127709309|NCT02437136|459564433|FG002|Expansion (Phase 2)|Withdrawal by Subject|0|||
127709310|NCT02437136|459564434|FG003|Expansion (Phase 2)|Withdrawal by Subject|7|||
127709311|NCT02437136|459564435|FG004|Expansion (Phase 2)|Withdrawal by Subject|25|||
127709312|NCT02437136|459564436|FG005|Expansion (Phase 2)|Withdrawal by Subject|4|||
127709313|NCT02437136|459564437|FG006|Expansion (Phase 2)|Withdrawal by Subject|2|||
127709314|NCT02437136|459564431|FG000|Expansion (Phase 2)|Lost to Follow-up|0|||
127800907|NCT03222349|459893290|FG000|Overall Study|Withdrawal by Subject|1|||
127800908|NCT03222349|459893291|FG001|Overall Study|Withdrawal by Subject|0|||
127709315|NCT02437136|459564432|FG001|Expansion (Phase 2)|Lost to Follow-up|0|||
127709316|NCT02437136|459564433|FG002|Expansion (Phase 2)|Lost to Follow-up|0|||
127709317|NCT02437136|459564434|FG003|Expansion (Phase 2)|Lost to Follow-up|0|||
127709318|NCT02437136|459564435|FG004|Expansion (Phase 2)|Lost to Follow-up|3|||
127709319|NCT02437136|459564436|FG005|Expansion (Phase 2)|Lost to Follow-up|3|||
127709320|NCT02437136|459564437|FG006|Expansion (Phase 2)|Lost to Follow-up|2|||
127709321|NCT05524116|459564443|FG000|Baseline to Postintervention (Week 8)|Brain tumor flare up|0|||
127709322|NCT05524116|459564444|FG001|Baseline to Postintervention (Week 8)|Brain tumor flare up|1|||
127709323|NCT05524116|459564443|FG000|Baseline to Postintervention (Week 8)|concussion|0|||
127709324|NCT05524116|459564444|FG001|Baseline to Postintervention (Week 8)|concussion|1|||
127709325|NCT05524116|459564443|FG000|Baseline to Postintervention (Week 8)|hernia surgery|0|||
127709326|NCT05524116|459564444|FG001|Baseline to Postintervention (Week 8)|hernia surgery|1|||
127709327|NCT05524116|459564443|FG000|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|1|||
127709328|NCT05524116|459564444|FG001|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|0|||
127709329|NCT05524116|459564443|FG000|Week 8 to Follow-up (Week 14)|Lost to Follow-up|0|||
127709330|NCT05524116|459564444|FG001|Week 8 to Follow-up (Week 14)|Lost to Follow-up|1|||
127709331|NCT05405985|459564448|FG000|Overall Study|Withdrawal by Subject|1|||
127709332|NCT05405985|459564449|FG001|Overall Study|Withdrawal by Subject|0|||
127709333|NCT02839265|459564450|FG000|Overall Study|Screen Failure|2|||
127709334|NCT02839265|459564450|FG000|Overall Study|Death|1|||
127709335|NCT02839265|459564450|FG000|Overall Study|Progression of SVC syndrome prior to treatment initiation|1|||
127709336|NCT05533190|459564453|FG000|Overall Study|Lost to Follow-up|19|||
127709337|NCT05533190|459564454|FG001|Overall Study|Lost to Follow-up|7|||
127709338|NCT05533190|459564453|FG000|Overall Study|Failed to download app|1|||
127709339|NCT05533190|459564454|FG001|Overall Study|Failed to download app|0|||
127709340|NCT05533190|459564453|FG000|Overall Study|Thought app was a scam|1|||
127709341|NCT05533190|459564454|FG001|Overall Study|Thought app was a scam|0|||
127709342|NCT05533190|459564453|FG000|Overall Study|Withdrawal by Subject|2|||
127709343|NCT05533190|459564454|FG001|Overall Study|Withdrawal by Subject|0|||
127709344|NCT05552508|459564455|FG000|Overall Study|Adverse Event|3|||
127709345|NCT01917084|459564458|FG000|Overall Study|Withdrawal by Subject|1|||
127709346|NCT04451772|459564466|FG000|Overall Study|Adverse Event|1|||
127709347|NCT04451772|459564467|FG001|Overall Study|Adverse Event|0|||
127709348|NCT04451772|459564468|FG002|Overall Study|Adverse Event|1|||
127709349|NCT04451772|459564469|FG003|Overall Study|Adverse Event|1|||
127709350|NCT04451772|459564470|FG004|Overall Study|Adverse Event|0|||
127709351|NCT04451772|459564471|FG005|Overall Study|Adverse Event|3|||
127709352|NCT04451772|459564466|FG000|Overall Study|Withdrawal by Subject|2|||
127709353|NCT04451772|459564467|FG001|Overall Study|Withdrawal by Subject|7|||
127709354|NCT04451772|459564468|FG002|Overall Study|Withdrawal by Subject|2|||
127709355|NCT04451772|459564469|FG003|Overall Study|Withdrawal by Subject|1|||
127709356|NCT04451772|459564470|FG004|Overall Study|Withdrawal by Subject|1|||
127709357|NCT04451772|459564471|FG005|Overall Study|Withdrawal by Subject|0|||
127709358|NCT04451772|459564466|FG000|Overall Study|Other, not specified|1|||
127709359|NCT04451772|459564467|FG001|Overall Study|Other, not specified|2|||
127709360|NCT04451772|459564468|FG002|Overall Study|Other, not specified|1|||
127709361|NCT04451772|459564469|FG003|Overall Study|Other, not specified|0|||
127709362|NCT04451772|459564470|FG004|Overall Study|Other, not specified|0|||
127709363|NCT04451772|459564471|FG005|Overall Study|Other, not specified|1|||
127709364|NCT04451772|459564466|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
127709365|NCT04451772|459564467|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
127709366|NCT04451772|459564468|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
127709367|NCT04451772|459564469|FG003|Overall Study|Sponsor decision based on interim analysis data review|11|||
127709368|NCT04451772|459564470|FG004|Overall Study|Sponsor decision based on interim analysis data review|23|||
127800909|NCT03222349|459893290|FG000|Overall Study|Treatment A not done|0|||
127800910|NCT03222349|459893291|FG001|Overall Study|Treatment A not done|5|||
127800911|NCT03222349|459893290|FG000|Overall Study|Study terminated by sponsor|1|||
127800912|NCT03222349|459893291|FG001|Overall Study|Study terminated by sponsor|0|||
127800913|NCT01808612|459893298|FG000|Treatment Period|Adverse Event|8|||
127800914|NCT01808612|459893299|FG001|Treatment Period|Adverse Event|4|||
127800915|NCT01808612|459893300|FG002|Treatment Period|Adverse Event|3|||
127709369|NCT04451772|459564471|FG005|Overall Study|Sponsor decision based on interim analysis data review|9|||
127709370|NCT02828358|459564475|FG000|Overall Study|Physician Decision|7|||
127709371|NCT02828358|459564476|FG001|Overall Study|Physician Decision|1|||
127709372|NCT02828358|459564475|FG000|Overall Study|Treatment Failure|6|||
127709373|NCT02828358|459564476|FG001|Overall Study|Treatment Failure|0|||
127709374|NCT02828358|459564475|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
127709375|NCT02828358|459564476|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
127709376|NCT02828358|459564475|FG000|Overall Study|Refusal of further protocol therapy|2|||
127709377|NCT02828358|459564476|FG001|Overall Study|Refusal of further protocol therapy|0|||
127709378|NCT02828358|459564475|FG000|Overall Study|Relapse|25|||
127800916|NCT01808612|459893298|FG000|Treatment Period|Lost to Follow-up|2|||
127800917|NCT01808612|459893299|FG001|Treatment Period|Lost to Follow-up|2|||
127800918|NCT01808612|459893300|FG002|Treatment Period|Lost to Follow-up|1|||
127800919|NCT01808612|459893298|FG000|Treatment Period|Protocol Violation|1|||
127646930|NCT01123382|459326508|FG001|Overall Study|Withdrawal by Subject|4|||
127646931|NCT01123382|459326507|FG000|Overall Study|Lost to Follow-up|1|||
127646932|NCT01123382|459326508|FG001|Overall Study|Lost to Follow-up|2|||
127646933|NCT01256411|459326509|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
127646934|NCT01256411|459326510|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
127646935|NCT01256411|459326511|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
127646936|NCT01256411|459326512|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
127646937|NCT01256411|459326513|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
127646938|NCT01256411|459326514|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
127646939|NCT01256411|459326509|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
127646940|NCT01256411|459326510|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
127646941|NCT01256411|459326511|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
127646942|NCT01256411|459326512|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
127646943|NCT01256411|459326513|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
127646944|NCT01256411|459326514|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
127646945|NCT01256411|459326509|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
127646946|NCT01256411|459326510|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
127646947|NCT01256411|459326511|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
127646948|NCT01256411|459326512|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
127646949|NCT01256411|459326513|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
127646950|NCT01256411|459326514|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
127646951|NCT01256411|459326509|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
127646952|NCT01256411|459326510|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
127646953|NCT01256411|459326511|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
127646954|NCT01256411|459326512|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
127646955|NCT01256411|459326513|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
127646956|NCT01256411|459326514|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
127646957|NCT01256411|459326509|FG000|Extension by Maximum Treatment|Adverse Event|4|||
127646958|NCT01256411|459326510|FG001|Extension by Maximum Treatment|Adverse Event|2|||
127646959|NCT01256411|459326511|FG002|Extension by Maximum Treatment|Adverse Event|1|||
127646960|NCT01256411|459326512|FG003|Extension by Maximum Treatment|Adverse Event|0|||
127646961|NCT01256411|459326513|FG004|Extension by Maximum Treatment|Adverse Event|0|||
127646962|NCT01256411|459326514|FG005|Extension by Maximum Treatment|Adverse Event|0|||
127646963|NCT01256411|459326509|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
127646964|NCT01256411|459326510|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
127646965|NCT01256411|459326511|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
127646966|NCT01256411|459326512|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
127646967|NCT01256411|459326513|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
127646968|NCT01256411|459326514|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
127646969|NCT01256411|459326509|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
127646970|NCT01256411|459326510|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
127646971|NCT01256411|459326511|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
127646972|NCT01256411|459326512|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
127646973|NCT01256411|459326513|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
127646974|NCT01256411|459326514|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
127646975|NCT01256411|459326509|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
127646976|NCT01256411|459326510|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
127646977|NCT01256411|459326511|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
127800920|NCT01808612|459893299|FG001|Treatment Period|Protocol Violation|0|||
127800921|NCT01808612|459893300|FG002|Treatment Period|Protocol Violation|0|||
127646978|NCT01256411|459326512|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
127646979|NCT01256411|459326513|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
127646980|NCT01256411|459326514|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
127646981|NCT01256411|459326509|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
127646982|NCT01256411|459326510|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
127646983|NCT01256411|459326511|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
127646984|NCT01256411|459326512|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
127646985|NCT01256411|459326513|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
127800922|NCT01808612|459893298|FG000|Treatment Period|Withdrawal by Subject|1|||
127800923|NCT01808612|459893299|FG001|Treatment Period|Withdrawal by Subject|0|||
127800924|NCT01808612|459893300|FG002|Treatment Period|Withdrawal by Subject|4|||
127800925|NCT01808612|459893298|FG000|Treatment Period|Physician Decision|1|||
127646986|NCT01256411|459326514|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
127646987|NCT01256411|459326509|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
127800926|NCT01808612|459893299|FG001|Treatment Period|Physician Decision|0|||
127800927|NCT01808612|459893300|FG002|Treatment Period|Physician Decision|4|||
127709379|NCT02828358|459564476|FG001|Overall Study|Relapse|0|||
127709380|NCT02828358|459564475|FG000|Overall Study|Still on therapy|5|||
127709381|NCT02828358|459564476|FG001|Overall Study|Still on therapy|0|||
127709382|NCT04804540|459564479|FG000|Overall Study|Adverse Event|26|||
127709383|NCT04804540|459564480|FG001|Overall Study|Adverse Event|13|||
127709384|NCT05172232|459564481|FG000|Overall Study|Lost to Follow-up|3|||
127709385|NCT01828021|459564482|FG000|Overall Study|Adverse Event|5|||
127709386|NCT01828021|459564482|FG000|Overall Study|Lack of Efficacy|17|||
127709387|NCT01828021|459564482|FG000|Overall Study|Withdrawal by Subject|2|||
127709388|NCT01828021|459564482|FG000|Overall Study|Ileal obstruction, unrelated|1|||
127709389|NCT04186819|459564484|FG000|Overall Study|Adverse Event|1|||
127709390|NCT04186819|459564484|FG000|Overall Study|Lost to Follow-up|1|||
127709391|NCT04186819|459564484|FG000|Overall Study|Opted for EBRT|1|||
127709392|NCT04186819|459564484|FG000|Overall Study|Opted SBRT|1|||
127709393|NCT04186819|459564484|FG000|Overall Study|Patient decided to have focal ablation and not surgery|2|||
127709394|NCT04186819|459564484|FG000|Overall Study|Physician Decision|1|||
127709395|NCT04186819|459564484|FG000|Overall Study|RP Delayed|1|||
127709396|NCT04186819|459564484|FG000|Overall Study|Sponsor Decision: Outdated FU Timeline|1|||
127709397|NCT04186819|459564484|FG000|Overall Study|Subject declined for financial reasons|1|||
127709398|NCT04186819|459564484|FG000|Overall Study|The subject declined any biopsy or surgery due to COVID-19 pandemic|1|||
127709399|NCT04186819|459564484|FG000|Overall Study|The subject declined for any biopsy or other imaging|2|||
127709400|NCT04186819|459564484|FG000|Overall Study|The subject opted for other treatment option|2|||
127709401|NCT04186819|459564484|FG000|Overall Study|The subject opted for other treatment options|1|||
127709402|NCT04186819|459564484|FG000|Overall Study|Withdrawal by Subject|3|||
127709403|NCT04186819|459564484|FG000|Overall Study|Reason not specified|1|||
127709404|NCT01199133|459564486|FG000|Year 1|Adverse Event|16|||
127709405|NCT01199133|459564487|FG001|Year 1|Adverse Event|4|||
127709406|NCT01199133|459564486|FG000|Year 1|Withdrawal by Subject|8|||
127709407|NCT01199133|459564487|FG001|Year 1|Withdrawal by Subject|4|||
127709408|NCT01199133|459564486|FG000|Year 1|Any other reason not above-mentioned|6|||
127709409|NCT01199133|459564487|FG001|Year 1|Any other reason not above-mentioned|7|||
127709410|NCT01199133|459564486|FG000|Year 2|Adverse Event|1|||
127709411|NCT01199133|459564487|FG001|Year 2|Adverse Event|0|||
127709412|NCT01199133|459564486|FG000|Year 2|Withdrawal by Subject|1|||
127709413|NCT01199133|459564487|FG001|Year 2|Withdrawal by Subject|1|||
127709414|NCT01199133|459564486|FG000|Year 2|Any other reason not above-mentioned|1|||
127709415|NCT01199133|459564487|FG001|Year 2|Any other reason not above-mentioned|2|||
127709416|NCT05013385|459564489|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
127709417|NCT01447719|459564490|FG000|Overall Study|Image acquisition failure|2|||
127709418|NCT01447719|459564490|FG000|Overall Study|Invalid image or not imaged|3|||
127709419|NCT01447719|459564490|FG000|Overall Study|Subject still living at end of study|79|||
127709420|NCT01447719|459564490|FG000|Overall Study|Withdrawal by Subject|2|||
127709421|NCT01447719|459564490|FG000|Overall Study|Family withdrew autopsy consent|7|||
127709422|NCT05100628|459564491|FG000|Overall Study|Progressive Disease|1|||
127709423|NCT05100628|459564492|FG001|Overall Study|Progressive Disease|0|||
127709424|NCT05100628|459564493|FG002|Overall Study|Progressive Disease|0|||
127709425|NCT05100628|459564494|FG003|Overall Study|Progressive Disease|0|||
127709426|NCT05100628|459564491|FG000|Overall Study|Study Terminated by Sponsor|0|||
127709427|NCT05100628|459564492|FG001|Overall Study|Study Terminated by Sponsor|0|||
127709428|NCT05100628|459564493|FG002|Overall Study|Study Terminated by Sponsor|3|||
127709429|NCT05100628|459564494|FG003|Overall Study|Study Terminated by Sponsor|0|||
127709430|NCT05100628|459564491|FG000|Overall Study|unkown|0|||
127709431|NCT05100628|459564492|FG001|Overall Study|unkown|1|||
127709432|NCT05100628|459564493|FG002|Overall Study|unkown|0|||
127709433|NCT05100628|459564494|FG003|Overall Study|unkown|0|||
127709434|NCT03252288|459564497|FG000|Overall Study|Death|1|||
127709435|NCT03252288|459564498|FG001|Overall Study|Death|0|||
127709436|NCT03252288|459564499|FG002|Overall Study|Death|0|||
127709437|NCT03252288|459564497|FG000|Overall Study|Death|11|||
127709438|NCT03252288|459564498|FG001|Overall Study|Death|0|||
127709439|NCT03252288|459564499|FG002|Overall Study|Death|0|||
127709440|NCT03252288|459564497|FG000|Overall Study|Withdrawal by Subject|2|||
127709441|NCT03252288|459564498|FG001|Overall Study|Withdrawal by Subject|0|||
127709442|NCT03252288|459564499|FG002|Overall Study|Withdrawal by Subject|0|||
127709443|NCT03252288|459564497|FG000|Overall Study|Lost to Follow-up|79|||
127709444|NCT03252288|459564498|FG001|Overall Study|Lost to Follow-up|0|||
127709445|NCT03252288|459564499|FG002|Overall Study|Lost to Follow-up|0|||
127709446|NCT03252288|459564497|FG000|Overall Study|Loss of baseline data on tablets|6|||
127709447|NCT03252288|459564498|FG001|Overall Study|Loss of baseline data on tablets|0|||
127709448|NCT03252288|459564499|FG002|Overall Study|Loss of baseline data on tablets|0|||
127709449|NCT02938923|459564510|FG000|Overall Study|Death|1|||
127709450|NCT02938923|459564511|FG001|Overall Study|Death|0|||
127709451|NCT02938923|459564512|FG002|Overall Study|Death|0|||
127709452|NCT02938923|459564510|FG000|Overall Study|Physician Decision|0|||
127709453|NCT02938923|459564511|FG001|Overall Study|Physician Decision|2|||
127709454|NCT02938923|459564512|FG002|Overall Study|Physician Decision|0|||
127709455|NCT02938923|459564510|FG000|Overall Study|Withdrawal by Subject|0|||
127800928|NCT01808612|459893298|FG000|Treatment Period|Sponsor Decision|1|||
127800929|NCT01808612|459893299|FG001|Treatment Period|Sponsor Decision|0|||
127800930|NCT01808612|459893300|FG002|Treatment Period|Sponsor Decision|0|||
127800931|NCT01808612|459893298|FG000|Treatment Period|Lack of Efficacy|1|||
127800932|NCT01808612|459893299|FG001|Treatment Period|Lack of Efficacy|1|||
127800933|NCT01808612|459893300|FG002|Treatment Period|Lack of Efficacy|2|||
127800934|NCT01808612|459893298|FG000|Discontinuation Period|Adverse Event|1|||
127800935|NCT01808612|459893299|FG001|Discontinuation Period|Adverse Event|0|||
127800936|NCT01808612|459893300|FG002|Discontinuation Period|Adverse Event|0|||
127800937|NCT01808612|459893298|FG000|Discontinuation Period|Physician Decision|1|||
127800938|NCT01808612|459893299|FG001|Discontinuation Period|Physician Decision|0|||
127800939|NCT01808612|459893300|FG002|Discontinuation Period|Physician Decision|0|||
127800940|NCT01808612|459893298|FG000|Discontinuation Period|Lost to Follow-up|0|||
127800941|NCT01808612|459893299|FG001|Discontinuation Period|Lost to Follow-up|1|||
127800942|NCT01808612|459893300|FG002|Discontinuation Period|Lost to Follow-up|0|||
127800943|NCT04823949|459893301|FG000|Overall Study|Withdrawal by Subject|0|||
127800944|NCT04823949|459893302|FG001|Overall Study|Withdrawal by Subject|4|||
127800945|NCT04823949|459893301|FG000|Overall Study|Physician Decision|0|||
127800946|NCT04823949|459893302|FG001|Overall Study|Physician Decision|1|||
127800947|NCT01700192|459893304|FG000|Overall Study|Adverse Event|73|||
127800948|NCT01700192|459893305|FG001|Overall Study|Adverse Event|18|||
127800949|NCT01700192|459893304|FG000|Overall Study|Lack of Efficacy|1|||
127800950|NCT01700192|459893305|FG001|Overall Study|Lack of Efficacy|0|||
127800951|NCT01700192|459893304|FG000|Overall Study|Lost to Follow-up|42|||
127800952|NCT01700192|459893305|FG001|Overall Study|Lost to Follow-up|29|||
127800953|NCT01700192|459893304|FG000|Overall Study|Noncompliance with study drug|0|||
127800954|NCT01700192|459893305|FG001|Overall Study|Noncompliance with study drug|5|||
127800955|NCT01700192|459893304|FG000|Overall Study|Physician Decision|2|||
127800956|NCT01700192|459893305|FG001|Overall Study|Physician Decision|3|||
127800957|NCT01700192|459893304|FG000|Overall Study|Pregnancy|1|||
127800958|NCT01700192|459893305|FG001|Overall Study|Pregnancy|4|||
127800959|NCT01700192|459893304|FG000|Overall Study|Progressive disease|1|||
127800960|NCT01700192|459893305|FG001|Overall Study|Progressive disease|0|||
127800961|NCT01700192|459893304|FG000|Overall Study|Protocol Violation|3|||
127800962|NCT01700192|459893305|FG001|Overall Study|Protocol Violation|4|||
127800963|NCT01700192|459893304|FG000|Overall Study|Technical problems|0|||
127800964|NCT01700192|459893305|FG001|Overall Study|Technical problems|1|||
127800965|NCT01700192|459893304|FG000|Overall Study|Withdrawal by Subject|56|||
127800966|NCT01700192|459893305|FG001|Overall Study|Withdrawal by Subject|64|||
127800967|NCT01700192|459893304|FG000|Overall Study|Never received study drug|1|||
127800968|NCT01700192|459893305|FG001|Overall Study|Never received study drug|0|||
127800969|NCT02793232|459893308|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
127800970|NCT02793232|459893309|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
127800971|NCT02793232|459893310|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
127800972|NCT02793232|459893311|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
127646988|NCT01256411|459326510|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
127646989|NCT01256411|459326511|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
127646990|NCT01256411|459326512|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
127646991|NCT01256411|459326513|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
127646992|NCT01256411|459326514|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
127646993|NCT02740049|459326515|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
127646994|NCT02316769|459326516|FG000|Overall Study|Physician Decision|1|||
127646995|NCT02316769|459326517|FG001|Overall Study|Physician Decision|0|||
127646996|NCT02316769|459326516|FG000|Overall Study|Withdrawal by Subject|1|||
127646997|NCT02316769|459326517|FG001|Overall Study|Withdrawal by Subject|0|||
127646998|NCT04721925|459326518|FG000|2-Month Assessment|Lost to Follow-up|5|||
127646999|NCT04721925|459326519|FG001|2-Month Assessment|Lost to Follow-up|3|||
127647000|NCT04721925|459326518|FG000|4-Month Assessment|Lost to Follow-up|3|||
127647001|NCT04721925|459326519|FG001|4-Month Assessment|Lost to Follow-up|6|||
127647002|NCT04535947|459326523|FG000|Overall Study|Adverse Event|1|||
127647003|NCT04535947|459326524|FG001|Overall Study|Adverse Event|4|||
127647004|NCT04535947|459326523|FG000|Overall Study|Other reasons not specified|2|||
127647005|NCT04535947|459326524|FG001|Overall Study|Other reasons not specified|0|||
127647006|NCT04535947|459326523|FG000|Overall Study|Withdrawal by Subject|1|||
127647007|NCT04535947|459326524|FG001|Overall Study|Withdrawal by Subject|1|||
127647008|NCT03802123|459326525|FG000|Overall Study|Withdrawal by Subject|3|||
127800973|NCT02793232|459893312|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
127800974|NCT02793232|459893313|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
127800975|NCT02793232|459893314|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
127800976|NCT02793232|459893315|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
127800977|NCT02793232|459893316|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
127647009|NCT03802123|459326525|FG000|Overall Study|Physician Decision|1|||
127647010|NCT03802123|459326525|FG000|Overall Study|Subject moved to hospice care|1|||
127647011|NCT03802123|459326525|FG000|Overall Study|technician error|1|||
127647012|NCT03802123|459326525|FG000|Overall Study|Death|3|||
127647013|NCT02684006|459326527|FG000|Overall Study|Other|18|||
127647014|NCT02684006|459326528|FG001|Overall Study|Other|6|||
127647015|NCT02684006|459326527|FG000|Overall Study|Protocol Violation|2|||
127647016|NCT02684006|459326528|FG001|Overall Study|Protocol Violation|1|||
127647017|NCT02684006|459326527|FG000|Overall Study|Non-compliance with study drug|1|||
127647018|NCT02684006|459326528|FG001|Overall Study|Non-compliance with study drug|1|||
127647019|NCT02684006|459326527|FG000|Overall Study|No longer met eligibility criteria|6|||
127647020|NCT02684006|459326528|FG001|Overall Study|No longer met eligibility criteria|2|||
127647021|NCT02684006|459326527|FG000|Overall Study|Lost to Follow-up|0|||
127647022|NCT02684006|459326528|FG001|Overall Study|Lost to Follow-up|1|||
127647023|NCT02684006|459326527|FG000|Overall Study|Death|25|||
127647024|NCT02684006|459326528|FG001|Overall Study|Death|22|||
127647025|NCT02684006|459326527|FG000|Overall Study|Global deterioration of health status|18|||
127647026|NCT02684006|459326528|FG001|Overall Study|Global deterioration of health status|20|||
127647027|NCT02684006|459326527|FG000|Overall Study|Physician Decision|15|||
127647028|NCT02684006|459326528|FG001|Overall Study|Physician Decision|8|||
127647029|NCT02684006|459326527|FG000|Overall Study|Adverse Event|86|||
127647030|NCT02684006|459326528|FG001|Overall Study|Adverse Event|65|||
127647031|NCT02684006|459326527|FG000|Overall Study|Withdrawal by Subject|29|||
127647032|NCT02684006|459326528|FG001|Overall Study|Withdrawal by Subject|43|||
127647033|NCT02684006|459326527|FG000|Overall Study|Progressive disease|236|||
127647034|NCT02684006|459326528|FG001|Overall Study|Progressive disease|266|||
127647035|NCT02684006|459326527|FG000|Overall Study|Participation terminated by sponsor|6|||
127647036|NCT02684006|459326528|FG001|Overall Study|Participation terminated by sponsor|9|||
127647037|NCT04495179|459326529|FG000|Overall Study|Lost to Follow-up|0|||
127647038|NCT04495179|459326530|FG001|Overall Study|Lost to Follow-up|1|||
127647039|NCT04495179|459326529|FG000|Overall Study|Withdrawal by Subject|2|||
127647040|NCT04495179|459326530|FG001|Overall Study|Withdrawal by Subject|4|||
127647041|NCT04495179|459326529|FG000|Overall Study|Study terminated by sponsor|0|||
127647042|NCT04495179|459326530|FG001|Overall Study|Study terminated by sponsor|18|||
127647043|NCT04495179|459326529|FG000|Overall Study|Death|0|||
127647044|NCT04495179|459326530|FG001|Overall Study|Death|4|||
127647045|NCT04495179|459326529|FG000|Overall Study|Adverse Event|0|||
127709456|NCT02938923|459564511|FG001|Overall Study|Withdrawal by Subject|1|||
127709457|NCT02938923|459564512|FG002|Overall Study|Withdrawal by Subject|1|||
127709458|NCT00721149|459564513|FG000|Overall Study|Physician Decision|1|||
127709459|NCT02518048|459564524|FG000|Overall Study|Withdrawal by Subject|1|||
127709460|NCT04505410|459564525|FG000|Overall Study|Adverse Event|2|||
127709461|NCT04505410|459564526|FG001|Overall Study|Adverse Event|0|||
127709462|NCT04505410|459564525|FG000|Overall Study|abdominal pain after starting tofacitinib|1|||
127647046|NCT04495179|459326530|FG001|Overall Study|Adverse Event|1|||
127647047|NCT02355743|459326541|FG000|Overall Study|Withdrawal by Subject|1|||
127647048|NCT02355743|459326541|FG000|Overall Study|Lost to Follow-up|1|||
127647049|NCT04212091|459326542|FG000|Overall Study|Lost to Follow-up|0|||
127647050|NCT04212091|459326543|FG001|Overall Study|Lost to Follow-up|0|||
127647051|NCT04212091|459326544|FG002|Overall Study|Lost to Follow-up|0|||
127647052|NCT04212091|459326545|FG003|Overall Study|Lost to Follow-up|0|||
127647053|NCT04212091|459326546|FG004|Overall Study|Lost to Follow-up|1|||
127647054|NCT04212091|459326547|FG005|Overall Study|Lost to Follow-up|1|||
127647055|NCT04212091|459326542|FG000|Overall Study|Participant unable to adhere to visit|0|||
127647056|NCT04212091|459326543|FG001|Overall Study|Participant unable to adhere to visit|0|||
127709463|NCT04505410|459564526|FG001|Overall Study|abdominal pain after starting tofacitinib|1|||
127709464|NCT04505410|459564525|FG000|Overall Study|did not want to follow diet|1|||
127709465|NCT04505410|459564526|FG001|Overall Study|did not want to follow diet|0|||
127647057|NCT04212091|459326544|FG002|Overall Study|Participant unable to adhere to visit|0|||
127647058|NCT04212091|459326545|FG003|Overall Study|Participant unable to adhere to visit|0|||
127647059|NCT04212091|459326546|FG004|Overall Study|Participant unable to adhere to visit|1|||
127647060|NCT04212091|459326547|FG005|Overall Study|Participant unable to adhere to visit|0|||
127647061|NCT00715429|459326548|FG000|Overall Study|Did not complete the study diary|0|||
127647062|NCT00715429|459326549|FG001|Overall Study|Did not complete the study diary|1|||
127800978|NCT02883244|459893317|FG000|Overall Study|Lost to Follow-up|0|||
127800979|NCT02883244|459893318|FG001|Overall Study|Lost to Follow-up|1|||
127800980|NCT02435914|459893319|FG000|Overall Study|Ocular Adverse Event|1|||
127800981|NCT02435914|459893320|FG001|Overall Study|Ocular Adverse Event|0|||
127800982|NCT02435914|459893321|FG002|Overall Study|Ocular Adverse Event|0|||
127800983|NCT02435914|459893322|FG003|Overall Study|Ocular Adverse Event|0|||
127800984|NCT02435914|459893319|FG000|Overall Study|Withdrawal by Subject|0|||
127647063|NCT04085328|459326550|FG000|Overall Study|Witihdrew Consent|16|||
127647064|NCT04085328|459326551|FG001|Overall Study|Witihdrew Consent|16|||
127647065|NCT04085328|459326550|FG000|Overall Study|Adverse Event|8|||
127647066|NCT04085328|459326551|FG001|Overall Study|Adverse Event|7|||
127800985|NCT02435914|459893320|FG001|Overall Study|Withdrawal by Subject|1|||
127800986|NCT02435914|459893321|FG002|Overall Study|Withdrawal by Subject|0|||
127800987|NCT02435914|459893322|FG003|Overall Study|Withdrawal by Subject|0|||
127800988|NCT02435914|459893319|FG000|Overall Study|Other Miscellaneous Reason|0|||
127800989|NCT02435914|459893320|FG001|Overall Study|Other Miscellaneous Reason|0|||
127800990|NCT02435914|459893321|FG002|Overall Study|Other Miscellaneous Reason|1|||
127800991|NCT02435914|459893322|FG003|Overall Study|Other Miscellaneous Reason|0|||
127800992|NCT01405053|459893323|FG000|Overall Study|Adverse Event|3|||
127800993|NCT01405053|459893324|FG001|Overall Study|Adverse Event|0|||
127800994|NCT01405053|459893323|FG000|Overall Study|Lost to Follow-up|0|||
127800995|NCT01405053|459893324|FG001|Overall Study|Lost to Follow-up|1|||
127800996|NCT01405053|459893323|FG000|Overall Study|Participant choice|2|||
127800997|NCT01405053|459893324|FG001|Overall Study|Participant choice|1|||
127800998|NCT01405053|459893323|FG000|Overall Study|Inadequate therapeutic effect|2|||
127800999|NCT01405053|459893324|FG001|Overall Study|Inadequate therapeutic effect|1|||
127647067|NCT04085328|459326550|FG000|Overall Study|Lost to Follow-up|7|||
127647068|NCT04085328|459326551|FG001|Overall Study|Lost to Follow-up|2|||
127647069|NCT04085328|459326550|FG000|Overall Study|Physician Decision|0|||
127647070|NCT04085328|459326551|FG001|Overall Study|Physician Decision|1|||
127647071|NCT04085328|459326550|FG000|Overall Study|Pregnancy|0|||
127647072|NCT04085328|459326551|FG001|Overall Study|Pregnancy|1|||
127647073|NCT04085328|459326550|FG000|Overall Study|Reasons Related to COVID-19|5|||
127647074|NCT04085328|459326551|FG001|Overall Study|Reasons Related to COVID-19|8|||
127647075|NCT04085328|459326550|FG000|Overall Study|Did not meet inclusion criteria|1|||
127647076|NCT04085328|459326551|FG001|Overall Study|Did not meet inclusion criteria|1|||
127647077|NCT04085328|459326550|FG000|Overall Study|Early termination|1|||
127647078|NCT04085328|459326551|FG001|Overall Study|Early termination|0|||
127647079|NCT03804710|459326560|FG000|Overall Study|Adverse Event|0|||
127647080|NCT03804710|459326561|FG001|Overall Study|Adverse Event|3|||
127647081|NCT03804710|459326560|FG000|Overall Study|Withdrawal by Subject|2|||
127647082|NCT03804710|459326561|FG001|Overall Study|Withdrawal by Subject|1|||
127647083|NCT03804710|459326560|FG000|Overall Study|Other|0|||
127647084|NCT03804710|459326561|FG001|Overall Study|Other|1|||
127647085|NCT04542018|459326562|FG000|Overall Study|Withdrawal by Subject|0|||
127647086|NCT04542018|459326563|FG001|Overall Study|Withdrawal by Subject|0|||
127647087|NCT04542018|459326564|FG002|Overall Study|Withdrawal by Subject|4|||
127647088|NCT04542018|459326562|FG000|Overall Study|Protocol Violation|0|||
127801000|NCT01405053|459893323|FG000|Overall Study|Withdrawal by Subject|3|||
127801001|NCT01405053|459893324|FG001|Overall Study|Withdrawal by Subject|4|||
127801002|NCT01405053|459893323|FG000|Overall Study|Other|0|||
127801003|NCT01405053|459893324|FG001|Overall Study|Other|1|||
127801004|NCT00268242|459893327|FG000|Overall Study|Death|1|||
127801005|NCT00993928|459893328|FG000|Overall Study|Withdrawal by Subject|4|||
127801006|NCT00993928|459893329|FG001|Overall Study|Withdrawal by Subject|7|||
127801007|NCT00993928|459893328|FG000|Overall Study|ineligible|1|||
127801008|NCT00993928|459893329|FG001|Overall Study|ineligible|0|||
127647089|NCT04542018|459326563|FG001|Overall Study|Protocol Violation|0|||
127647090|NCT04542018|459326564|FG002|Overall Study|Protocol Violation|2|||
127647091|NCT01428076|459326568|FG000|Overall Study|Adverse Event|0|||
127647092|NCT01428076|459326569|FG001|Overall Study|Adverse Event|1|||
127647093|NCT02454101|459326570|FG000|Overall Study|Adverse Event|2|||
127801009|NCT04871711|459893330|FG000|Overall Study|Withdrawal by Subject|11|||
127801010|NCT04871711|459893331|FG001|Overall Study|Withdrawal by Subject|5|||
127709466|NCT04505410|459564525|FG000|Overall Study|flare up of ulcerative colitis|0|||
127709467|NCT04505410|459564526|FG001|Overall Study|flare up of ulcerative colitis|1|||
127709468|NCT04505410|459564525|FG000|Overall Study|Lost to Follow-up|0|||
127709469|NCT04505410|459564526|FG001|Overall Study|Lost to Follow-up|2|||
127709470|NCT04505410|459564525|FG000|Overall Study|Lost to Follow-up|1|||
127709471|NCT04505410|459564526|FG001|Overall Study|Lost to Follow-up|0|||
127709472|NCT04505410|459564525|FG000|Overall Study|initiated another diet on their own|0|||
127647094|NCT02454101|459326571|FG001|Overall Study|Adverse Event|3|||
127647095|NCT02454101|459326570|FG000|Overall Study|Lost to Follow-up|3|||
127647096|NCT02454101|459326571|FG001|Overall Study|Lost to Follow-up|4|||
127647097|NCT02216773|459326572|FG000|Overall Study|Disease progression|4|||
127647098|NCT02216773|459326573|FG001|Overall Study|Disease progression|2|||
127647099|NCT02216773|459326572|FG000|Overall Study|Insufficient FLRV|4|||
127647100|NCT02216773|459326573|FG001|Overall Study|Insufficient FLRV|0|||
127647101|NCT02216773|459326572|FG000|Overall Study|Abandoned|4|||
127647102|NCT02216773|459326573|FG001|Overall Study|Abandoned|3|||
127647103|NCT04274894|459326574|FG000|Overall Study|Adverse Event|7|||
127647104|NCT04274894|459326574|FG000|Overall Study|Withdrew consent|5|||
127647105|NCT04274894|459326574|FG000|Overall Study|Lost to Follow-up|9|||
127647106|NCT04274894|459326574|FG000|Overall Study|COVID-19 infection|1|||
127647107|NCT04274894|459326574|FG000|Overall Study|Other, not specified|20|||
127647108|NCT01936857|459326575|FG000|Overall Study|Sent to prison or 06 center|11|||
127647109|NCT01936857|459326576|FG001|Overall Study|Sent to prison or 06 center|12|||
127647110|NCT01936857|459326575|FG000|Overall Study|Lost to Follow-up|10|||
127647111|NCT01936857|459326576|FG001|Overall Study|Lost to Follow-up|7|||
127647112|NCT01936857|459326575|FG000|Overall Study|Death|7|||
127647113|NCT01936857|459326576|FG001|Overall Study|Death|3|||
127647114|NCT01936857|459326575|FG000|Overall Study|Moved|2|||
127647115|NCT01936857|459326576|FG001|Overall Study|Moved|1|||
127647116|NCT01936857|459326575|FG000|Overall Study|Withdrawal by Subject|1|||
127647117|NCT01936857|459326576|FG001|Overall Study|Withdrawal by Subject|0|||
127647118|NCT01936857|459326575|FG000|Overall Study|Side effect of medication|1|||
127647119|NCT01936857|459326576|FG001|Overall Study|Side effect of medication|0|||
127647120|NCT01936857|459326575|FG000|Overall Study|Other|2|||
127647121|NCT01936857|459326576|FG001|Overall Study|Other|2|||
127647122|NCT02279043|459326577|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
127647123|NCT02279043|459326578|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
127647124|NCT02279043|459326579|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
127647125|NCT02279043|459326577|FG000|Overall Study|Lost to Follow-up|46|||
127647126|NCT02279043|459326578|FG001|Overall Study|Lost to Follow-up|88|||
127647127|NCT02279043|459326579|FG002|Overall Study|Lost to Follow-up|0|||
127647128|NCT02124265|459326580|FG000|Overall Study|Adverse Event|1|||
127647129|NCT00490282|459326581|FG000|Overall Study|Withdrawal by Subject|3|||
127647130|NCT04510675|459326582|FG000|Overall Study|Withdrawal by Subject|5|||
127647131|NCT04198805|459326583|FG000|Overall Study|Death|0|||
127647132|NCT04198805|459326584|FG001|Overall Study|Death|0|||
127647133|NCT04198805|459326585|FG002|Overall Study|Death|0|||
127647134|NCT04198805|459326586|FG003|Overall Study|Death|1|||
127647135|NCT04198805|459326583|FG000|Overall Study|Early Termination|8|||
127647136|NCT04198805|459326584|FG001|Overall Study|Early Termination|4|||
127647137|NCT04198805|459326585|FG002|Overall Study|Early Termination|6|||
127647138|NCT04198805|459326586|FG003|Overall Study|Early Termination|9|||
127647139|NCT01330433|459326587|FG000|Overall Study|Death|1|||
127647140|NCT01330433|459326588|FG001|Overall Study|Death|3|||
127647141|NCT01330433|459326587|FG000|Overall Study|Lost to Follow-up|1|||
127647142|NCT01330433|459326588|FG001|Overall Study|Lost to Follow-up|0|||
127647143|NCT01499082|459326589|FG000|Overall Study|Randomized but not Treated|0|||
127647144|NCT01499082|459326590|FG001|Overall Study|Randomized but not Treated|1|||
127647145|NCT01499082|459326589|FG000|Overall Study|Adverse Event|12|||
127647146|NCT01499082|459326590|FG001|Overall Study|Adverse Event|16|||
127647147|NCT01499082|459326589|FG000|Overall Study|Lack of Efficacy|1|||
127647148|NCT01499082|459326590|FG001|Overall Study|Lack of Efficacy|1|||
127647149|NCT01499082|459326589|FG000|Overall Study|Protocol Violation|6|||
127647150|NCT01499082|459326590|FG001|Overall Study|Protocol Violation|8|||
127647151|NCT01499082|459326589|FG000|Overall Study|Diverse Reasons|18|||
127647152|NCT01499082|459326590|FG001|Overall Study|Diverse Reasons|14|||
127647153|NCT01499082|459326589|FG000|Overall Study|Site Closure for Noncompliance|5|||
127647154|NCT01499082|459326590|FG001|Overall Study|Site Closure for Noncompliance|2|||
127647155|NCT01499082|459326589|FG000|Overall Study|Hypoglycemia|2|||
127647156|NCT01499082|459326590|FG001|Overall Study|Hypoglycemia|3|||
127647157|NCT01499082|459326589|FG000|Overall Study|Lost to Follow-up|1|||
127647158|NCT01499082|459326590|FG001|Overall Study|Lost to Follow-up|3|||
127647159|NCT03599349|459326591|FG000|Overall Study|Lost to Follow-up|1|||
127647160|NCT01830127|459326597|FG000|Overall Study|Adverse Event|1|||
127647161|NCT01830127|459326598|FG001|Overall Study|Adverse Event|6|||
127647162|NCT01830127|459326597|FG000|Overall Study|Lack of Efficacy|3|||
127647163|NCT01830127|459326598|FG001|Overall Study|Lack of Efficacy|0|||
127647164|NCT01830127|459326597|FG000|Overall Study|Withdrawal by Subject|1|||
127647165|NCT01830127|459326598|FG001|Overall Study|Withdrawal by Subject|1|||
127647166|NCT01830127|459326597|FG000|Overall Study|Other reason not defined above|0|||
127647167|NCT01830127|459326598|FG001|Overall Study|Other reason not defined above|2|||
127647168|NCT00567190|459326604|FG000|Overall Study|Death|235|||
127647169|NCT00567190|459326605|FG001|Overall Study|Death|280|||
127647170|NCT00567190|459326604|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
127647171|NCT00567190|459326605|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
127709473|NCT04505410|459564526|FG001|Overall Study|initiated another diet on their own|2|||
127709474|NCT01586910|459565515|FG000|Overall Study|Death|4|||
127709475|NCT01586910|459565516|FG001|Overall Study|Death|4|||
127709476|NCT01586910|459565515|FG000|Overall Study|Withdrawal by Subject|6|||
127709477|NCT01586910|459565516|FG001|Overall Study|Withdrawal by Subject|43|||
127709478|NCT01586910|459565515|FG000|Overall Study|Physician withdrew Subject|5|||
127709479|NCT01586910|459565516|FG001|Overall Study|Physician withdrew Subject|24|||
127709480|NCT03640286|459565521|FG000|Overall Study|Adverse Event|6|||
127709481|NCT03640286|459565522|FG001|Overall Study|Adverse Event|6|||
127709482|NCT03640286|459565521|FG000|Overall Study|Lost to Follow-up|3|||
127709483|NCT03640286|459565522|FG001|Overall Study|Lost to Follow-up|6|||
127709484|NCT03640286|459565521|FG000|Overall Study|Pregnancy|1|||
127709485|NCT03640286|459565522|FG001|Overall Study|Pregnancy|0|||
127709486|NCT03640286|459565521|FG000|Overall Study|Withdrawal by Subject|10|||
127709487|NCT03640286|459565522|FG001|Overall Study|Withdrawal by Subject|10|||
127709488|NCT03640286|459565521|FG000|Overall Study|Non-compliance|4|||
127709489|NCT03640286|459565522|FG001|Overall Study|Non-compliance|10|||
127709490|NCT03640286|459565521|FG000|Overall Study|Medication change|1|||
127709491|NCT03640286|459565522|FG001|Overall Study|Medication change|0|||
127709492|NCT03640286|459565521|FG000|Overall Study|Other|1|||
127709493|NCT03640286|459565522|FG001|Overall Study|Other|2|||
127709494|NCT03640286|459565521|FG000|Overall Study|Joined another lifestyle program|0|||
127709495|NCT03640286|459565522|FG001|Overall Study|Joined another lifestyle program|1|||
127709496|NCT03181516|459565523|FG000|Overall Study|Withdrawal by Subject|14|||
127709497|NCT03181516|459565524|FG001|Overall Study|Withdrawal by Subject|7|||
127709498|NCT03181516|459565523|FG000|Overall Study|Lost to Follow-up|2|||
127709499|NCT03181516|459565524|FG001|Overall Study|Lost to Follow-up|2|||
127709500|NCT03635424|459565525|FG000|Overall Study|Adverse Event|1|||
127709501|NCT03635424|459565525|FG000|Overall Study|Death|1|||
127709502|NCT03635424|459565525|FG000|Overall Study|Device not implanted|1|||
127709503|NCT02278211|459565526|FG000|Overall Study|Unable to analyse PET scan|2|||
127709504|NCT04167553|459565527|FG000|Overall Study|Withdrawal by Subject|1|||
127709505|NCT04167553|459565528|FG001|Overall Study|Withdrawal by Subject|0|||
127709506|NCT04167553|459565529|FG002|Overall Study|Withdrawal by Subject|1|||
127709507|NCT04167553|459565530|FG003|Overall Study|Withdrawal by Subject|2|||
127709508|NCT04167553|459565531|FG004|Overall Study|Withdrawal by Subject|1|||
127709509|NCT04167553|459565532|FG005|Overall Study|Withdrawal by Subject|0|||
127709510|NCT04167553|459565533|FG006|Overall Study|Withdrawal by Subject|0|||
127801011|NCT04871711|459893330|FG000|Overall Study|Lack of Efficacy|5|||
127801012|NCT04871711|459893331|FG001|Overall Study|Lack of Efficacy|7|||
127801013|NCT04871711|459893330|FG000|Overall Study|Adverse Event|2|||
127801014|NCT04871711|459893331|FG001|Overall Study|Adverse Event|6|||
127801015|NCT04871711|459893330|FG000|Overall Study|Various reasons|2|||
127801016|NCT04871711|459893331|FG001|Overall Study|Various reasons|1|||
127801017|NCT04871711|459893330|FG000|Overall Study|Lost to Follow-up|0|||
127801018|NCT04871711|459893331|FG001|Overall Study|Lost to Follow-up|2|||
127801019|NCT03979274|459893332|FG000|Treatment Period 2|Withdrawal by Subject|0|||
127801020|NCT03979274|459893333|FG001|Treatment Period 2|Withdrawal by Subject|1|||
127801021|NCT03551743|459893341|FG000|Overall Study|Adverse Event|1|||
127801022|NCT03551743|459893342|FG001|Overall Study|Adverse Event|0|||
127801023|NCT03551743|459893343|FG002|Overall Study|Adverse Event|0|||
127888392|NCT00738920|460214023|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
127709511|NCT04167553|459565527|FG000|Overall Study|Physician Decision|0|||
127709512|NCT04167553|459565528|FG001|Overall Study|Physician Decision|0|||
127801024|NCT03551743|459893344|FG003|Overall Study|Adverse Event|0|||
127801025|NCT03551743|459893341|FG000|Overall Study|Withdrawal by Subject|1|||
127801026|NCT03551743|459893342|FG001|Overall Study|Withdrawal by Subject|0|||
127801027|NCT03551743|459893343|FG002|Overall Study|Withdrawal by Subject|0|||
127801028|NCT03551743|459893344|FG003|Overall Study|Withdrawal by Subject|0|||
127801029|NCT02319044|459893345|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
127801030|NCT02319044|459893346|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
127647172|NCT00344461|459326611|FG000|Overall Study|Adverse Event|6|||
127647173|NCT00344461|459326611|FG000|Overall Study|Death|1|||
127647174|NCT00344461|459326611|FG000|Overall Study|Lack of Efficacy|2|||
127709513|NCT04167553|459565529|FG002|Overall Study|Physician Decision|0|||
127709514|NCT04167553|459565530|FG003|Overall Study|Physician Decision|0|||
127709515|NCT04167553|459565531|FG004|Overall Study|Physician Decision|2|||
127709516|NCT04167553|459565532|FG005|Overall Study|Physician Decision|2|||
127647175|NCT00344461|459326611|FG000|Overall Study|Lost to Follow-up|2|||
127647176|NCT00344461|459326611|FG000|Overall Study|Physician Decision|2|||
127647177|NCT00344461|459326611|FG000|Overall Study|Protocol Violation|6|||
127647178|NCT00344461|459326611|FG000|Overall Study|Withdrawal by Subject|2|||
127647179|NCT00636610|459326614|FG000|Overall Study|Adverse Event|4|||
127647180|NCT00636610|459326615|FG001|Overall Study|Adverse Event|4|||
127647181|NCT00636610|459326614|FG000|Overall Study|Death|6|||
127647182|NCT00636610|459326615|FG001|Overall Study|Death|3|||
127647183|NCT00636610|459326614|FG000|Overall Study|Physician decision to withdraw patient|15|||
127647184|NCT00636610|459326615|FG001|Overall Study|Physician decision to withdraw patient|9|||
127647185|NCT00636610|459326614|FG000|Overall Study|Subject decision to withdraw|15|||
127647186|NCT00636610|459326615|FG001|Overall Study|Subject decision to withdraw|11|||
127647187|NCT00636610|459326614|FG000|Overall Study|Disease progression - radiographic|41|||
127647188|NCT00636610|459326615|FG001|Overall Study|Disease progression - radiographic|51|||
127647189|NCT00636610|459326614|FG000|Overall Study|Disease progression - clinical|8|||
127647190|NCT00636610|459326615|FG001|Overall Study|Disease progression - clinical|3|||
127647191|NCT00636610|459326614|FG000|Overall Study|Reason for discontinuation not available|3|||
127647192|NCT00636610|459326615|FG001|Overall Study|Reason for discontinuation not available|2|||
127709517|NCT04167553|459565533|FG006|Overall Study|Physician Decision|0|||
127709518|NCT04167553|459565527|FG000|Overall Study|Lost to Follow-up|0|||
127709519|NCT04167553|459565528|FG001|Overall Study|Lost to Follow-up|0|||
127709520|NCT04167553|459565529|FG002|Overall Study|Lost to Follow-up|2|||
127709521|NCT04167553|459565530|FG003|Overall Study|Lost to Follow-up|0|||
127709522|NCT04167553|459565531|FG004|Overall Study|Lost to Follow-up|0|||
127709523|NCT04167553|459565532|FG005|Overall Study|Lost to Follow-up|0|||
127709524|NCT04167553|459565533|FG006|Overall Study|Lost to Follow-up|0|||
127709525|NCT05224544|459565536|FG000|V2, Catheterization and Visualization|Adverse Event|2|||
127709526|NCT05224544|459565537|FG001|V2, Catheterization and Visualization|Adverse Event|1|||
127709527|NCT00844415|459565538|FG000|Overall Study|Withdrawal by Subject|1|||
127709528|NCT02473445|459565539|FG000|Overall Study|Withdrawal by Subject|2|||
127709529|NCT02473445|459565539|FG000|Overall Study|Sponsor Decision|20|||
127709530|NCT03015532|459565540|FG000|Overall Study|Adverse Event|0|||
127709531|NCT03015532|459565541|FG001|Overall Study|Adverse Event|0|||
127709532|NCT03015532|459565542|FG002|Overall Study|Adverse Event|0|||
127709533|NCT03015532|459565543|FG003|Overall Study|Adverse Event|0|||
127709534|NCT03015532|459565544|FG004|Overall Study|Adverse Event|0|||
127709535|NCT03015532|459565545|FG005|Overall Study|Adverse Event|2|||
127709536|NCT03015532|459565546|FG006|Overall Study|Adverse Event|1|||
127709537|NCT03015532|459565547|FG007|Overall Study|Adverse Event|0|||
127709538|NCT03015532|459565540|FG000|Overall Study|Withdrawal by Subject|0|||
127709539|NCT03015532|459565541|FG001|Overall Study|Withdrawal by Subject|0|||
127709540|NCT03015532|459565542|FG002|Overall Study|Withdrawal by Subject|0|||
127709541|NCT03015532|459565543|FG003|Overall Study|Withdrawal by Subject|0|||
127709542|NCT03015532|459565544|FG004|Overall Study|Withdrawal by Subject|0|||
127709543|NCT03015532|459565545|FG005|Overall Study|Withdrawal by Subject|0|||
127709544|NCT03015532|459565546|FG006|Overall Study|Withdrawal by Subject|1|||
127709545|NCT03015532|459565547|FG007|Overall Study|Withdrawal by Subject|0|||
127709546|NCT05970861|459565548|FG000|Overall Study|Physician Decision|4|||
127709547|NCT05970861|459565549|FG001|Overall Study|Physician Decision|4|||
127709548|NCT05970861|459565548|FG000|Overall Study|Lost to Follow-up|4|||
127709549|NCT05970861|459565549|FG001|Overall Study|Lost to Follow-up|3|||
127709550|NCT03988621|459565553|FG000|Overall Study|Lost to Follow-up|16|||
127709551|NCT03988621|459565554|FG001|Overall Study|Lost to Follow-up|17|||
127709552|NCT03988621|459565553|FG000|Overall Study|Withdrawal by Subject|14|||
127709553|NCT03988621|459565554|FG001|Overall Study|Withdrawal by Subject|7|||
127709554|NCT03988621|459565553|FG000|Overall Study|Patient Lost to Follow Up|15|||
127709555|NCT03988621|459565554|FG001|Overall Study|Patient Lost to Follow Up|15|||
127709556|NCT03988621|459565553|FG000|Overall Study|Patient death|1|||
127709557|NCT03988621|459565554|FG001|Overall Study|Patient death|5|||
127709558|NCT04629339|459565555|FG000|Overall Study|Death|1|||
127709559|NCT04629339|459565556|FG001|Overall Study|Death|0|||
127709560|NCT04629339|459565557|FG002|Overall Study|Death|2|||
127709561|NCT04629339|459565558|FG003|Overall Study|Death|2|||
127709562|NCT04629339|459565559|FG004|Overall Study|Death|0|||
127709563|NCT04629339|459565555|FG000|Overall Study|Disease Progression|0|||
127709564|NCT04629339|459565556|FG001|Overall Study|Disease Progression|0|||
127709565|NCT04629339|459565557|FG002|Overall Study|Disease Progression|1|||
127709566|NCT04629339|459565558|FG003|Overall Study|Disease Progression|1|||
127709567|NCT04629339|459565559|FG004|Overall Study|Disease Progression|0|||
127709568|NCT04629339|459565555|FG000|Overall Study|Lost to Follow-up|0|||
127709569|NCT04629339|459565556|FG001|Overall Study|Lost to Follow-up|0|||
127709570|NCT04629339|459565557|FG002|Overall Study|Lost to Follow-up|0|||
127709571|NCT04629339|459565558|FG003|Overall Study|Lost to Follow-up|1|||
127709572|NCT04629339|459565559|FG004|Overall Study|Lost to Follow-up|0|||
127709573|NCT04629339|459565555|FG000|Overall Study|Physician Decision|0|||
127709574|NCT04629339|459565556|FG001|Overall Study|Physician Decision|1|||
127709575|NCT04629339|459565557|FG002|Overall Study|Physician Decision|0|||
127709576|NCT04629339|459565558|FG003|Overall Study|Physician Decision|0|||
127709577|NCT04629339|459565559|FG004|Overall Study|Physician Decision|0|||
127709578|NCT04629339|459565555|FG000|Overall Study|Study Terminated by Sponsor|0|||
127709579|NCT04629339|459565556|FG001|Overall Study|Study Terminated by Sponsor|0|||
127709580|NCT04629339|459565557|FG002|Overall Study|Study Terminated by Sponsor|0|||
127709581|NCT04629339|459565558|FG003|Overall Study|Study Terminated by Sponsor|1|||
127709582|NCT04629339|459565559|FG004|Overall Study|Study Terminated by Sponsor|0|||
127709583|NCT04629339|459565555|FG000|Overall Study|Withdrawal by Subject|0|||
127709584|NCT04629339|459565556|FG001|Overall Study|Withdrawal by Subject|0|||
127709585|NCT04629339|459565557|FG002|Overall Study|Withdrawal by Subject|2|||
127709586|NCT04629339|459565558|FG003|Overall Study|Withdrawal by Subject|2|||
127709587|NCT04629339|459565559|FG004|Overall Study|Withdrawal by Subject|0|||
127709588|NCT04158739|459565562|FG000|Overall Study|Adverse Event|1|||
127709589|NCT04158739|459565563|FG001|Overall Study|Adverse Event|0|||
127709590|NCT04158739|459565562|FG000|Overall Study|Death|0|||
127709591|NCT04158739|459565563|FG001|Overall Study|Death|1|||
127709592|NCT04158739|459565562|FG000|Overall Study|Lack of Efficacy|3|||
127709593|NCT04158739|459565563|FG001|Overall Study|Lack of Efficacy|7|||
127709594|NCT04158739|459565562|FG000|Overall Study|Physician Decision|0|||
127709595|NCT04158739|459565563|FG001|Overall Study|Physician Decision|1|||
127709596|NCT04158739|459565562|FG000|Overall Study|Withdrawal by Subject|3|||
127709597|NCT04158739|459565563|FG001|Overall Study|Withdrawal by Subject|0|||
127709598|NCT03914469|459565564|FG000|Overall Study|Lost to Follow-up|1|||
127709599|NCT03914469|459565565|FG001|Overall Study|Lost to Follow-up|4|||
127709600|NCT04778410|459565566|FG000|Safety Run-in Period|Death|5|||
127709601|NCT04778410|459565567|FG001|Safety Run-in Period|Death|6|||
127709602|NCT04778410|459565568|FG002|Safety Run-in Period|Death|0|||
127709603|NCT04778410|459565569|FG003|Safety Run-in Period|Death|0|||
127709604|NCT04778410|459565570|FG004|Safety Run-in Period|Death|0|||
127709605|NCT04778410|459565571|FG005|Safety Run-in Period|Death|0|||
127709606|NCT04778410|459565566|FG000|Phase 2 Period|Death|0|||
127709607|NCT04778410|459565567|FG001|Phase 2 Period|Death|0|||
127709608|NCT04778410|459565568|FG002|Phase 2 Period|Death|0|||
127709609|NCT04778410|459565569|FG003|Phase 2 Period|Death|5|||
127709610|NCT04778410|459565570|FG004|Phase 2 Period|Death|18|||
127709611|NCT04778410|459565571|FG005|Phase 2 Period|Death|0|||
127709612|NCT04778410|459565566|FG000|Phase 2 Period|Lost to Follow-up|0|||
127709613|NCT04778410|459565567|FG001|Phase 2 Period|Lost to Follow-up|0|||
127709614|NCT04778410|459565568|FG002|Phase 2 Period|Lost to Follow-up|0|||
127709615|NCT04778410|459565569|FG003|Phase 2 Period|Lost to Follow-up|1|||
127709616|NCT04778410|459565570|FG004|Phase 2 Period|Lost to Follow-up|1|||
127709617|NCT04778410|459565571|FG005|Phase 2 Period|Lost to Follow-up|0|||
127709618|NCT04778410|459565566|FG000|Phase 2 Period|Study Terminated By Sponsor|0|||
127709619|NCT04778410|459565567|FG001|Phase 2 Period|Study Terminated By Sponsor|0|||
127709620|NCT04778410|459565568|FG002|Phase 2 Period|Study Terminated By Sponsor|0|||
127709621|NCT04778410|459565569|FG003|Phase 2 Period|Study Terminated By Sponsor|1|||
127709622|NCT04778410|459565570|FG004|Phase 2 Period|Study Terminated By Sponsor|0|||
127709623|NCT04778410|459565571|FG005|Phase 2 Period|Study Terminated By Sponsor|0|||
127709624|NCT04778410|459565566|FG000|Phase 2 Period|Withdrew Consent|0|||
127709625|NCT04778410|459565567|FG001|Phase 2 Period|Withdrew Consent|0|||
127709626|NCT04778410|459565568|FG002|Phase 2 Period|Withdrew Consent|0|||
127709627|NCT04778410|459565569|FG003|Phase 2 Period|Withdrew Consent|0|||
127709628|NCT04778410|459565570|FG004|Phase 2 Period|Withdrew Consent|2|||
127709629|NCT04778410|459565571|FG005|Phase 2 Period|Withdrew Consent|0|||
127709630|NCT00677365|459565578|FG000|Overall Study|Adverse Event|2|||
127709631|NCT00677365|459565579|FG001|Overall Study|Adverse Event|1|||
127709632|NCT00677365|459565580|FG002|Overall Study|Adverse Event|1|||
127709633|NCT00677365|459565581|FG003|Overall Study|Adverse Event|2|||
127709634|NCT00677365|459565578|FG000|Overall Study|Withdrawal by Subject|0|||
127709635|NCT00677365|459565579|FG001|Overall Study|Withdrawal by Subject|0|||
127709636|NCT00677365|459565580|FG002|Overall Study|Withdrawal by Subject|1|||
127709637|NCT00677365|459565581|FG003|Overall Study|Withdrawal by Subject|0|||
127709638|NCT00677365|459565578|FG000|Overall Study|Other reason|0|||
127709639|NCT00677365|459565579|FG001|Overall Study|Other reason|0|||
127709640|NCT00677365|459565580|FG002|Overall Study|Other reason|0|||
127709641|NCT00677365|459565581|FG003|Overall Study|Other reason|1|||
127709642|NCT01121588|459565583|FG000|Overall Study|Death|5|||
127709643|NCT01121588|459565584|FG001|Overall Study|Death|3|||
127709644|NCT01121588|459565585|FG002|Overall Study|Death|13|||
127709645|NCT01121588|459565583|FG000|Overall Study|Study Terminated by Sponsor|1|||
127709646|NCT01121588|459565584|FG001|Overall Study|Study Terminated by Sponsor|1|||
127709647|NCT01121588|459565585|FG002|Overall Study|Study Terminated by Sponsor|0|||
127709648|NCT01121588|459565583|FG000|Overall Study|Participant Refused Further Followup|2|||
127709649|NCT01121588|459565584|FG001|Overall Study|Participant Refused Further Followup|0|||
127709650|NCT01121588|459565585|FG002|Overall Study|Participant Refused Further Followup|2|||
127709651|NCT01121588|459565583|FG000|Overall Study|Lost to Follow-up|0|||
127709652|NCT01121588|459565584|FG001|Overall Study|Lost to Follow-up|1|||
127709653|NCT01121588|459565585|FG002|Overall Study|Lost to Follow-up|1|||
127709654|NCT01121588|459565583|FG000|Overall Study|Non-Specified Reasons|9|||
127709655|NCT01121588|459565584|FG001|Overall Study|Non-Specified Reasons|4|||
127709656|NCT01121588|459565585|FG002|Overall Study|Non-Specified Reasons|2|||
127709657|NCT02944968|459565587|FG000|Overall Study|Subject excluded before study procedure|1|||
127709658|NCT02944968|459565587|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
127709659|NCT02542631|459565588|FG000|Overall Study|Adverse Event|1|||
127709660|NCT02542631|459565589|FG001|Overall Study|Adverse Event|1|||
127709661|NCT02542631|459565588|FG000|Overall Study|Sponsor Termination|1|||
127709662|NCT02542631|459565589|FG001|Overall Study|Sponsor Termination|0|||
127709663|NCT02542631|459565588|FG000|Overall Study|Withdrawal by Subject|11|||
127709664|NCT02542631|459565589|FG001|Overall Study|Withdrawal by Subject|16|||
127709665|NCT02542631|459565588|FG000|Overall Study|Protocol Violation|1|||
127709666|NCT02542631|459565589|FG001|Overall Study|Protocol Violation|1|||
127709667|NCT02542631|459565588|FG000|Overall Study|Physician Decision|6|||
127709668|NCT02542631|459565589|FG001|Overall Study|Physician Decision|4|||
127709669|NCT02542631|459565588|FG000|Overall Study|Lost to Follow-up|6|||
127709670|NCT02542631|459565589|FG001|Overall Study|Lost to Follow-up|5|||
127709671|NCT02542631|459565588|FG000|Overall Study|Death|1|||
127709672|NCT02542631|459565589|FG001|Overall Study|Death|2|||
127709673|NCT02542631|459565588|FG000|Overall Study|Other|2|||
127709674|NCT02542631|459565589|FG001|Overall Study|Other|1|||
127709675|NCT02542631|459565588|FG000|Overall Study|Used Prohibited Medication|2|||
127709676|NCT02542631|459565589|FG001|Overall Study|Used Prohibited Medication|1|||
127709677|NCT04583280|459565591|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
127709678|NCT04583280|459565592|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
127709679|NCT00631475|459565593|FG000|Overall Study|Death|18|||
127709680|NCT00631475|459565593|FG000|Overall Study|Adverse Event|14|||
127709681|NCT00631475|459565593|FG000|Overall Study|Withdrew consent|5|||
127709682|NCT00631475|459565593|FG000|Overall Study|Preparation for lung transplant|8|||
127709683|NCT05158504|459565594|FG000|Overall Study|Lost to Follow-up|2|||
127709684|NCT05158504|459565595|FG001|Overall Study|Lost to Follow-up|3|||
127709685|NCT03606512|459565596|FG000|Overall Study|Lost to Follow-up|0|||
127709686|NCT03606512|459565597|FG001|Overall Study|Lost to Follow-up|1|||
127709687|NCT03606512|459565596|FG000|Overall Study|'moved from study area|0|||
127709688|NCT03606512|459565597|FG001|Overall Study|'moved from study area|1|||
127709689|NCT05513937|459565598|FG000|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
127709690|NCT05513937|459565599|FG001|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|1|||
127709691|NCT05513937|459565600|FG002|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
127709692|NCT05513937|459565601|FG003|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
127709693|NCT05513937|459565598|FG000|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|2|||
127709694|NCT05513937|459565599|FG001|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|5|||
127709695|NCT05513937|459565600|FG002|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
127709696|NCT05513937|459565601|FG003|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
127709697|NCT05513937|459565598|FG000|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|1|||
127709698|NCT05513937|459565599|FG001|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
127709699|NCT05513937|459565600|FG002|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
127709700|NCT05513937|459565601|FG003|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
127709701|NCT05513937|459565598|FG000|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|1|||
127709702|NCT05513937|459565599|FG001|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
127709703|NCT05513937|459565600|FG002|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
127709704|NCT05513937|459565601|FG003|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
127709705|NCT05513937|459565598|FG000|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
127709706|NCT05513937|459565599|FG001|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
127709707|NCT05513937|459565600|FG002|Combination Therapy (4 to 8 Weeks)|Adverse Event|2|||
127709708|NCT05513937|459565601|FG003|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
127709709|NCT05513937|459565598|FG000|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
127709710|NCT05513937|459565599|FG001|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
127709711|NCT05513937|459565600|FG002|Combination Therapy (4 to 8 Weeks)|Protocol Violation|1|||
127709712|NCT05513937|459565601|FG003|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
127709713|NCT02577354|459565602|FG000|Overall Study|Lack of Efficacy|4|||
127709714|NCT02577354|459565603|FG001|Overall Study|Lack of Efficacy|4|||
127709715|NCT02577354|459565602|FG000|Overall Study|Lost to Follow-up|3|||
127709716|NCT02577354|459565603|FG001|Overall Study|Lost to Follow-up|1|||
127709717|NCT02577354|459565602|FG000|Overall Study|Missed Visit|4|||
127709718|NCT02577354|459565603|FG001|Overall Study|Missed Visit|3|||
127709719|NCT02577354|459565602|FG000|Overall Study|Adverse Event|4|||
127709720|NCT02577354|459565603|FG001|Overall Study|Adverse Event|5|||
127709721|NCT03245840|459565604|FG000|Overall Study|Adverse Event|6|||
127709722|NCT03245840|459565605|FG001|Overall Study|Adverse Event|0|||
127801031|NCT02319044|459893347|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
127801032|NCT02319044|459893345|FG000|Overall Study|Withdrawal by Subject|3|||
127801033|NCT02319044|459893346|FG001|Overall Study|Withdrawal by Subject|3|||
127801034|NCT02319044|459893347|FG002|Overall Study|Withdrawal by Subject|6|||
127801035|NCT02319044|459893345|FG000|Overall Study|Condition under investigation worsened|100|||
127801036|NCT02319044|459893346|FG001|Overall Study|Condition under investigation worsened|50|||
127801037|NCT02319044|459893347|FG002|Overall Study|Condition under investigation worsened|46|||
127801038|NCT02319044|459893345|FG000|Overall Study|Adverse Event|17|||
127801039|NCT02319044|459893346|FG001|Overall Study|Adverse Event|2|||
127801040|NCT02319044|459893347|FG002|Overall Study|Adverse Event|8|||
127801041|NCT02319044|459893345|FG000|Overall Study|Study specific discontinuation criteria|2|||
127801042|NCT02319044|459893346|FG001|Overall Study|Study specific discontinuation criteria|2|||
127801043|NCT02319044|459893347|FG002|Overall Study|Study specific discontinuation criteria|1|||
127801044|NCT02319044|459893345|FG000|Overall Study|Not treated|0|||
127801045|NCT02319044|459893346|FG001|Overall Study|Not treated|2|||
127801046|NCT02319044|459893347|FG002|Overall Study|Not treated|2|||
127801047|NCT02317562|459893348|FG000|Overall Study|Physician Decision|1|||
127801048|NCT02317562|459893348|FG000|Overall Study|early termination of the study|8|||
127801049|NCT02317562|459893348|FG000|Overall Study|Lack of Efficacy|4|||
127801050|NCT02317562|459893348|FG000|Overall Study|Withdrawal by Subject|1|||
127709723|NCT03245840|459565604|FG000|Overall Study|Death|2|||
127709724|NCT03245840|459565605|FG001|Overall Study|Death|0|||
127709725|NCT03245840|459565604|FG000|Overall Study|Withdrawal by Subject|31|||
127709726|NCT03245840|459565605|FG001|Overall Study|Withdrawal by Subject|1|||
127709727|NCT03245840|459565604|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
127709728|NCT03245840|459565605|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
127709729|NCT03245840|459565604|FG000|Overall Study|Physician Decision|4|||
127709730|NCT03245840|459565605|FG001|Overall Study|Physician Decision|1|||
127709731|NCT03245840|459565604|FG000|Overall Study|Study Terminated by Sponsor|56|||
127709732|NCT03245840|459565605|FG001|Overall Study|Study Terminated by Sponsor|6|||
127709733|NCT03245840|459565604|FG000|Overall Study|Site Terminated by Sponsor|4|||
127709734|NCT03245840|459565605|FG001|Overall Study|Site Terminated by Sponsor|0|||
127709735|NCT03245840|459565604|FG000|Overall Study|Lost to Follow-up|12|||
127709736|NCT03245840|459565605|FG001|Overall Study|Lost to Follow-up|2|||
127709737|NCT03245840|459565604|FG000|Overall Study|Pregnancy|2|||
127709738|NCT03245840|459565605|FG001|Overall Study|Pregnancy|0|||
127709739|NCT03245840|459565604|FG000|Overall Study|Non-Compliance with Study Drug|2|||
127709740|NCT03245840|459565605|FG001|Overall Study|Non-Compliance with Study Drug|0|||
127709741|NCT03245840|459565604|FG000|Overall Study|Not treated|1|||
127709742|NCT03245840|459565605|FG001|Overall Study|Not treated|1|||
127709743|NCT04109066|459565606|FG000|Pre-treatment|Participant withdrew consent|2|||
127709744|NCT04109066|459565607|FG001|Pre-treatment|Participant withdrew consent|0|||
127709745|NCT04109066|459565606|FG000|Pre-treatment|Participant no longer meets study criteria|1|||
127709746|NCT04109066|459565607|FG001|Pre-treatment|Participant no longer meets study criteria|1|||
127709747|NCT04109066|459565606|FG000|Treatment|Lack of Efficacy|2|||
127709748|NCT04109066|459565607|FG001|Treatment|Lack of Efficacy|4|||
127709749|NCT04109066|459565606|FG000|Treatment|Adverse Event|23|||
127709750|NCT04109066|459565607|FG001|Treatment|Adverse Event|7|||
127709751|NCT04109066|459565606|FG000|Treatment|Participant request to discontinue Study treatment|15|||
127709752|NCT04109066|459565607|FG001|Treatment|Participant request to discontinue Study treatment|14|||
127709753|NCT04109066|459565606|FG000|Treatment|Withdrawal by Subject|8|||
127709754|NCT04109066|459565607|FG001|Treatment|Withdrawal by Subject|8|||
127709755|NCT04109066|459565606|FG000|Treatment|Death|3|||
127709756|NCT04109066|459565607|FG001|Treatment|Death|0|||
127709757|NCT04109066|459565606|FG000|Treatment|Participant no longer meets study criteria|2|||
127709758|NCT04109066|459565607|FG001|Treatment|Participant no longer meets study criteria|2|||
127709759|NCT04109066|459565606|FG000|Treatment|Administrative reasons by sponsor|2|||
127709760|NCT04109066|459565607|FG001|Treatment|Administrative reasons by sponsor|3|||
127709761|NCT04109066|459565606|FG000|Treatment|Other reasons|17|||
127709762|NCT04109066|459565607|FG001|Treatment|Other reasons|23|||
127709763|NCT04109066|459565606|FG000|Treatment|Disease Progression|4|||
127709764|NCT04109066|459565607|FG001|Treatment|Disease Progression|7|||
127709765|NCT04109066|459565606|FG000|Treatment|Study drug toxicity|12|||
127709766|NCT04109066|459565607|FG001|Treatment|Study drug toxicity|5|||
127709767|NCT04109066|459565606|FG000|Treatment|Adverse Event unrelated to Study drug|1|||
127709768|NCT04109066|459565607|FG001|Treatment|Adverse Event unrelated to Study drug|0|||
127709769|NCT04109066|459565606|FG000|Treatment|Disease Recurrence|0|||
127709770|NCT04109066|459565607|FG001|Treatment|Disease Recurrence|2|||
127801051|NCT00626093|459893349|FG000|Overall Study|Lost to Follow-up|5|||
127801052|NCT00626093|459893349|FG000|Overall Study|Death|1|||
127801053|NCT00626093|459893349|FG000|Overall Study|Physician Decision|4|||
127801054|NCT00626093|459893349|FG000|Overall Study|Withdrawal by Subject|6|||
127801055|NCT00626093|459893349|FG000|Overall Study|Protocol Violation|1|||
127709771|NCT04109066|459565606|FG000|Treatment|Not reported|4|||
127709772|NCT04109066|459565607|FG001|Treatment|Not reported|8|||
127709773|NCT04078152|459565608|FG000|Overall Study|Other|83|||
127709774|NCT04078152|459565609|FG001|Overall Study|Other|22|||
127709775|NCT04078152|459565610|FG002|Overall Study|Other|25|||
127709776|NCT04078152|459565608|FG000|Overall Study|Development of study specific withdrawal criteria|1|||
127709777|NCT04078152|459565609|FG001|Overall Study|Development of study specific withdrawal criteria|1|||
127709778|NCT04078152|459565610|FG002|Overall Study|Development of study specific withdrawal criteria|0|||
127709779|NCT04078152|459565608|FG000|Overall Study|Withdrawal by Subject|5|||
127709780|NCT04078152|459565609|FG001|Overall Study|Withdrawal by Subject|0|||
127709781|NCT04078152|459565610|FG002|Overall Study|Withdrawal by Subject|1|||
127709782|NCT04078152|459565608|FG000|Overall Study|Death|10|||
127709783|NCT04078152|459565609|FG001|Overall Study|Death|2|||
127709784|NCT04078152|459565610|FG002|Overall Study|Death|12|||
127709785|NCT04078152|459565608|FG000|Overall Study|Adverse Event|1|||
127709786|NCT04078152|459565609|FG001|Overall Study|Adverse Event|0|||
127709787|NCT04078152|459565610|FG002|Overall Study|Adverse Event|0|||
127709788|NCT02510235|459565611|FG000|Overall Study|Withdrawal by Subject|1|||
127709789|NCT02510235|459565612|FG001|Overall Study|Withdrawal by Subject|0|||
127709790|NCT03367156|459566740|FG000|Overall Study|Lack of interest|3|||
127709791|NCT03367156|459566741|FG001|Overall Study|Lack of interest|1|||
127709792|NCT03367156|459566740|FG000|Overall Study|Death|2|||
127709793|NCT03367156|459566741|FG001|Overall Study|Death|0|||
127709794|NCT03367156|459566740|FG000|Overall Study|Lost to Follow-up|2|||
127709795|NCT03367156|459566741|FG001|Overall Study|Lost to Follow-up|1|||
127709796|NCT03367156|459566740|FG000|Overall Study|Became ineligible|1|||
127709797|NCT03367156|459566741|FG001|Overall Study|Became ineligible|2|||
127709798|NCT03367156|459566740|FG000|Overall Study|Hospitalization|1|||
127709799|NCT03367156|459566741|FG001|Overall Study|Hospitalization|0|||
127709800|NCT03367156|459566740|FG000|Overall Study|Concerned about Treatment|11|||
127709801|NCT03367156|459566741|FG001|Overall Study|Concerned about Treatment|3|||
127709802|NCT03367156|459566740|FG000|Overall Study|Started new treatment|4|||
127709803|NCT03367156|459566741|FG001|Overall Study|Started new treatment|1|||
127709804|NCT05507437|459566742|FG000|Overall Study|Withdrawal by Subject|1|||
127709805|NCT05507437|459566743|FG001|Overall Study|Withdrawal by Subject|1|||
127709806|NCT05507437|459566742|FG000|Overall Study|Death|3|||
127709807|NCT05507437|459566743|FG001|Overall Study|Death|0|||
127709808|NCT04282980|459566745|FG000|Overall Study|Remained on treatment|6|||
127709809|NCT04282980|459566745|FG000|Overall Study|Survival follow-up|11|||
127709810|NCT04282980|459566745|FG000|Overall Study|Withdrawal of informed consent|1|||
127709811|NCT04282980|459566745|FG000|Overall Study|Lost to Follow-up|1|||
127709812|NCT03571386|459566747|FG000|Overall Study|scheduling conflict|4|||
127709813|NCT03571386|459566748|FG001|Overall Study|scheduling conflict|0|||
127709814|NCT03571386|459566747|FG000|Overall Study|Withdrawal by Subject|15|||
127709815|NCT03571386|459566748|FG001|Overall Study|Withdrawal by Subject|5|||
127709816|NCT04311632|459566749|FG000|Overall Study|Withdrawal by Subject|0|||
127709817|NCT04311632|459566750|FG001|Overall Study|Withdrawal by Subject|0|||
127709818|NCT04311632|459566751|FG002|Overall Study|Withdrawal by Subject|1|||
127709819|NCT04605159|459566752|FG000|Overall Study|Adverse Event|6|||
127709820|NCT04605159|459566753|FG001|Overall Study|Adverse Event|3|||
127709821|NCT04605159|459566754|FG002|Overall Study|Adverse Event|21|||
127709822|NCT04605159|459566755|FG003|Overall Study|Adverse Event|4|||
127709823|NCT04605159|459566752|FG000|Overall Study|Lost to Follow-up|74|||
127709824|NCT04605159|459566753|FG001|Overall Study|Lost to Follow-up|45|||
127709825|NCT04605159|459566754|FG002|Overall Study|Lost to Follow-up|119|||
127709826|NCT04605159|459566755|FG003|Overall Study|Lost to Follow-up|80|||
127709827|NCT04605159|459566752|FG000|Overall Study|Protocol Violation|4|||
127709828|NCT04605159|459566753|FG001|Overall Study|Protocol Violation|5|||
127709829|NCT04605159|459566754|FG002|Overall Study|Protocol Violation|2|||
127709830|NCT04605159|459566755|FG003|Overall Study|Protocol Violation|0|||
127709831|NCT04605159|459566752|FG000|Overall Study|Withdrawal by Subject|66|||
127709832|NCT04605159|459566753|FG001|Overall Study|Withdrawal by Subject|37|||
127709833|NCT04605159|459566754|FG002|Overall Study|Withdrawal by Subject|68|||
127709834|NCT04605159|459566755|FG003|Overall Study|Withdrawal by Subject|50|||
127709835|NCT04605159|459566752|FG000|Overall Study|Migrated / moved from the study area|32|||
127709836|NCT04605159|459566753|FG001|Overall Study|Migrated / moved from the study area|22|||
127709837|NCT04605159|459566754|FG002|Overall Study|Migrated / moved from the study area|41|||
127709838|NCT04605159|459566755|FG003|Overall Study|Migrated / moved from the study area|21|||
127709839|NCT04605159|459566752|FG000|Overall Study|Other|1|||
127709840|NCT04605159|459566753|FG001|Overall Study|Other|2|||
127709841|NCT04605159|459566754|FG002|Overall Study|Other|7|||
127709842|NCT04605159|459566755|FG003|Overall Study|Other|3|||
127709843|NCT04881461|459566756|FG000|Overall Study|Adverse Event|2|||
127801056|NCT00626093|459893349|FG000|Overall Study|One of the required devices not implante|6|||
127801057|NCT03434379|459893350|FG000|Global Period|Lost to Follow-up|3|||
127709844|NCT04881461|459566757|FG001|Overall Study|Adverse Event|4|||
127709845|NCT04881461|459566756|FG000|Overall Study|Withdrawal by Subject|19|||
127709846|NCT04881461|459566757|FG001|Overall Study|Withdrawal by Subject|19|||
127709847|NCT04881461|459566756|FG000|Overall Study|Lost to Follow-up|4|||
127709848|NCT04881461|459566757|FG001|Overall Study|Lost to Follow-up|4|||
127709849|NCT04881461|459566756|FG000|Overall Study|Lack of Efficacy|1|||
127709850|NCT04881461|459566757|FG001|Overall Study|Lack of Efficacy|0|||
127709851|NCT04881461|459566756|FG000|Overall Study|"Reason stated as other in CRF"|1|||
127709852|NCT04881461|459566757|FG001|Overall Study|"Reason stated as other in CRF"|2|||
127709853|NCT05422885|459566762|FG000|Overall Study|Lost to Follow-up|1|||
127709854|NCT05422885|459566762|FG000|Overall Study|Withdrawal by Subject|2|||
127709855|NCT04084574|459566763|FG000|Overall Study|Lost to Follow-up|1|||
127709856|NCT04084574|459566764|FG001|Overall Study|Lost to Follow-up|0|||
127709857|NCT04084574|459566763|FG000|Overall Study|Physician Decision|1|||
127709858|NCT04084574|459566764|FG001|Overall Study|Physician Decision|0|||
127709859|NCT04084574|459566763|FG000|Overall Study|Relocated out of state|1|||
127709860|NCT04084574|459566764|FG001|Overall Study|Relocated out of state|0|||
127709861|NCT02641730|459566765|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
127709862|NCT02641730|459566766|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
127709863|NCT02641730|459566767|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
127709864|NCT02641730|459566768|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
127709865|NCT02641730|459566769|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
127801058|NCT03434379|459893351|FG001|Global Period|Lost to Follow-up|6|||
127801059|NCT03434379|459893352|FG002|Global Period|Lost to Follow-up|0|||
127801060|NCT03434379|459893353|FG003|Global Period|Lost to Follow-up|0|||
127801061|NCT03434379|459893350|FG000|Global Period|Death|115|||
127801062|NCT03434379|459893351|FG001|Global Period|Death|228|||
127801063|NCT03434379|459893352|FG002|Global Period|Death|0|||
127801064|NCT03434379|459893353|FG003|Global Period|Death|0|||
127801065|NCT03434379|459893350|FG000|Global Period|Withdrawal by Subject|20|||
127801066|NCT03434379|459893351|FG001|Global Period|Withdrawal by Subject|21|||
127801067|NCT03434379|459893352|FG002|Global Period|Withdrawal by Subject|0|||
127801068|NCT03434379|459893353|FG003|Global Period|Withdrawal by Subject|0|||
127801069|NCT03434379|459893350|FG000|Global Period|Reason Unspecified|0|||
127801070|NCT03434379|459893351|FG001|Global Period|Reason Unspecified|1|||
127801071|NCT03434379|459893352|FG002|Global Period|Reason Unspecified|0|||
127801072|NCT03434379|459893353|FG003|Global Period|Reason Unspecified|0|||
127801073|NCT03434379|459893350|FG000|Global Period|Study Ended by Sponsor|26|||
127801074|NCT03434379|459893351|FG001|Global Period|Study Ended by Sponsor|80|||
127801075|NCT03434379|459893352|FG002|Global Period|Study Ended by Sponsor|0|||
127801076|NCT03434379|459893353|FG003|Global Period|Study Ended by Sponsor|0|||
127801077|NCT03434379|459893350|FG000|Global Period|Physician Decision|1|||
127801078|NCT03434379|459893351|FG001|Global Period|Physician Decision|0|||
127801079|NCT03434379|459893352|FG002|Global Period|Physician Decision|0|||
127801080|NCT03434379|459893353|FG003|Global Period|Physician Decision|0|||
127801081|NCT03434379|459893350|FG000|China Extension Period|Lost to Follow-up|0|||
127801082|NCT03434379|459893351|FG001|China Extension Period|Lost to Follow-up|0|||
127888393|NCT00738920|460214024|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
127888394|NCT00738920|460214025|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
127709866|NCT02641730|459566765|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
127709867|NCT02641730|459566766|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
127709868|NCT02641730|459566767|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
127709869|NCT02641730|459566768|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
127709870|NCT02641730|459566769|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
127709871|NCT02641730|459566765|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
127709872|NCT02641730|459566766|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
127709873|NCT02641730|459566767|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
127709874|NCT02641730|459566768|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
127709875|NCT02641730|459566769|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
127709876|NCT02641730|459566765|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
127709877|NCT02641730|459566766|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
127709878|NCT02641730|459566767|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
127709879|NCT02641730|459566768|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
127709880|NCT02641730|459566769|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
127709881|NCT02641730|459566765|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
127709882|NCT02641730|459566766|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
127709883|NCT02641730|459566767|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
127709884|NCT02641730|459566768|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
127709885|NCT02641730|459566769|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
127709886|NCT02641730|459566765|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
127709887|NCT02641730|459566766|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
127801083|NCT03434379|459893352|FG002|China Extension Period|Lost to Follow-up|2|||
127801084|NCT03434379|459893353|FG003|China Extension Period|Lost to Follow-up|3|||
127801085|NCT03434379|459893350|FG000|China Extension Period|Death|0|||
127801086|NCT03434379|459893351|FG001|China Extension Period|Death|0|||
127888395|NCT00738920|460214023|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
127709888|NCT02641730|459566767|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
127709889|NCT02641730|459566768|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
127801087|NCT03434379|459893352|FG002|China Extension Period|Death|46|||
127801088|NCT03434379|459893353|FG003|China Extension Period|Death|88|||
127801089|NCT03434379|459893350|FG000|China Extension Period|Withdrawal by Subject|0|||
127801090|NCT03434379|459893351|FG001|China Extension Period|Withdrawal by Subject|0|||
127801091|NCT03434379|459893352|FG002|China Extension Period|Withdrawal by Subject|8|||
127801092|NCT03434379|459893353|FG003|China Extension Period|Withdrawal by Subject|6|||
127801093|NCT03434379|459893350|FG000|China Extension Period|Study Ended by Sponsor|0|||
127801094|NCT03434379|459893351|FG001|China Extension Period|Study Ended by Sponsor|0|||
127801095|NCT03434379|459893352|FG002|China Extension Period|Study Ended by Sponsor|5|||
127801096|NCT03434379|459893353|FG003|China Extension Period|Study Ended by Sponsor|36|||
127801097|NCT04556617|459893356|FG000|Overall Study|progressive disease|0|||
127801098|NCT04556617|459893357|FG001|Overall Study|progressive disease|2|||
127801099|NCT04556617|459893358|FG002|Overall Study|progressive disease|2|||
127709890|NCT02641730|459566769|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
127709891|NCT04614948|459566772|FG000|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|5|||
127709892|NCT04614948|459566773|FG001|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|10|||
127709893|NCT04614948|459566774|FG002|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|0|||
127709894|NCT04614948|459566772|FG000|DB Phase (Day 1 up to 7.2 Months)|Death|6|||
127709895|NCT04614948|459566773|FG001|DB Phase (Day 1 up to 7.2 Months)|Death|13|||
127709896|NCT04614948|459566774|FG002|DB Phase (Day 1 up to 7.2 Months)|Death|0|||
127709897|NCT04614948|459566772|FG000|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|170|||
127709898|NCT04614948|459566773|FG001|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|219|||
127709899|NCT04614948|459566774|FG002|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|0|||
127709900|NCT04614948|459566772|FG000|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|15|||
127709901|NCT04614948|459566773|FG001|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|6|||
127709902|NCT04614948|459566774|FG002|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|0|||
127709903|NCT04614948|459566772|FG000|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
127709904|NCT04614948|459566773|FG001|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|1|||
127709905|NCT04614948|459566774|FG002|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
127709906|NCT04614948|459566772|FG000|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|1|||
127709907|NCT04614948|459566773|FG001|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|7|||
127709908|NCT04614948|459566774|FG002|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|0|||
127709909|NCT04614948|459566772|FG000|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|468|||
127709910|NCT04614948|459566773|FG001|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|1273|||
127709911|NCT04614948|459566774|FG002|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|0|||
127709912|NCT04614948|459566772|FG000|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|10|||
127709913|NCT04614948|459566773|FG001|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|75|||
127709914|NCT04614948|459566774|FG002|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|0|||
127709915|NCT04614948|459566772|FG000|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
127709916|NCT04614948|459566773|FG001|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|3|||
127709917|NCT04614948|459566774|FG002|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
127709918|NCT04614948|459566772|FG000|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
127709919|NCT04614948|459566773|FG001|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|2|||
127709920|NCT04614948|459566774|FG002|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
127709921|NCT04614948|459566772|FG000|DB Phase (Day 1 up to 7.2 Months)|Other|26|||
127709922|NCT04614948|459566773|FG001|DB Phase (Day 1 up to 7.2 Months)|Other|149|||
127709923|NCT04614948|459566774|FG002|DB Phase (Day 1 up to 7.2 Months)|Other|0|||
127709924|NCT04614948|459566772|FG000|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
127709925|NCT04614948|459566773|FG001|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
127709926|NCT04614948|459566774|FG002|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|14|||
127709927|NCT04614948|459566772|FG000|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
127709928|NCT04614948|459566773|FG001|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
127709929|NCT04614948|459566774|FG002|DB + Open-label Phase (2 Years 6 Months)|Death|131|||
127709930|NCT04614948|459566772|FG000|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
127709931|NCT04614948|459566773|FG001|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
127709932|NCT04614948|459566774|FG002|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|3796|||
127709933|NCT04614948|459566772|FG000|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
127709934|NCT04614948|459566773|FG001|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
127709935|NCT04614948|459566774|FG002|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|178|||
127801100|NCT04556617|459893359|FG003|Overall Study|progressive disease|1|||
127801101|NCT04556617|459893360|FG004|Overall Study|progressive disease|1|||
127801102|NCT04556617|459893356|FG000|Overall Study|Physician Decision|0|||
127801103|NCT04556617|459893357|FG001|Overall Study|Physician Decision|0|||
127709936|NCT04614948|459566772|FG000|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
127709937|NCT04614948|459566773|FG001|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
127709938|NCT04614948|459566774|FG002|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|2|||
127709939|NCT04614948|459566772|FG000|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
127801104|NCT04556617|459893358|FG002|Overall Study|Physician Decision|2|||
127801105|NCT04556617|459893359|FG003|Overall Study|Physician Decision|0|||
127801106|NCT04556617|459893360|FG004|Overall Study|Physician Decision|0|||
127801107|NCT04556617|459893356|FG000|Overall Study|Adverse Event|0|||
127801108|NCT04556617|459893357|FG001|Overall Study|Adverse Event|0|||
127801109|NCT04556617|459893358|FG002|Overall Study|Adverse Event|2|||
127801110|NCT04556617|459893359|FG003|Overall Study|Adverse Event|3|||
127801111|NCT04556617|459893360|FG004|Overall Study|Adverse Event|0|||
127801112|NCT04556617|459893356|FG000|Overall Study|Withdrawal by Subject|0|||
127801113|NCT04556617|459893357|FG001|Overall Study|Withdrawal by Subject|2|||
127801114|NCT04556617|459893358|FG002|Overall Study|Withdrawal by Subject|1|||
127801115|NCT04556617|459893359|FG003|Overall Study|Withdrawal by Subject|1|||
127801116|NCT04556617|459893360|FG004|Overall Study|Withdrawal by Subject|0|||
127801117|NCT04556617|459893356|FG000|Overall Study|PSA increase|0|||
127801118|NCT04556617|459893357|FG001|Overall Study|PSA increase|1|||
127801119|NCT04556617|459893358|FG002|Overall Study|PSA increase|0|||
127801120|NCT04556617|459893359|FG003|Overall Study|PSA increase|0|||
127801121|NCT04556617|459893360|FG004|Overall Study|PSA increase|0|||
127801122|NCT04556617|459893356|FG000|Overall Study|Sponsor study termination|1|||
127801123|NCT04556617|459893357|FG001|Overall Study|Sponsor study termination|0|||
127801124|NCT04556617|459893358|FG002|Overall Study|Sponsor study termination|0|||
127801125|NCT04556617|459893359|FG003|Overall Study|Sponsor study termination|0|||
127801126|NCT04556617|459893360|FG004|Overall Study|Sponsor study termination|0|||
127801127|NCT05702736|459893361|FG000|Overall Study|2 patients didn't participate in the study voluntarily.|2|||
127801128|NCT05702736|459893362|FG001|Overall Study|2 patients didn't participate in the study voluntarily.|0|||
127801129|NCT05702736|459893361|FG000|Overall Study|2 patients didn't complete 6 interviews.|2|||
127801130|NCT05702736|459893362|FG001|Overall Study|2 patients didn't complete 6 interviews.|0|||
127801131|NCT02937350|459893365|FG000|Overall Study|Withdrawal by Subject|0|||
127801132|NCT02937350|459893366|FG001|Overall Study|Withdrawal by Subject|1|||
127801133|NCT02937350|459893367|FG002|Overall Study|Withdrawal by Subject|0|||
127801134|NCT01877083|459893368|FG000|Treatment Phase|Disease Progression|10|||
127801135|NCT01877083|459893368|FG000|Treatment Phase|Clinical Progression|1|||
127801136|NCT01877083|459893368|FG000|Treatment Phase|Adverse Event|6|||
127801137|NCT01877083|459893368|FG000|Treatment Phase|Withdrawal by Subject|2|||
127709940|NCT04614948|459566773|FG001|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
127709941|NCT04614948|459566774|FG002|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|9|||
127709942|NCT04614948|459566772|FG000|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
127709943|NCT04614948|459566773|FG001|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
127709944|NCT04614948|459566774|FG002|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|5922|||
127709945|NCT04614948|459566772|FG000|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
127709946|NCT04614948|459566773|FG001|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
127709947|NCT04614948|459566774|FG002|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|92|||
127709948|NCT04614948|459566772|FG000|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
127709949|NCT04614948|459566773|FG001|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
127709950|NCT04614948|459566774|FG002|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|48|||
127709951|NCT04614948|459566772|FG000|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
127709952|NCT04614948|459566773|FG001|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
127709953|NCT04614948|459566774|FG002|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|17|||
127709954|NCT04614948|459566772|FG000|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
127801138|NCT01877083|459893368|FG000|Treatment Phase|Lost to Follow-up|1|||
127801139|NCT01877083|459893368|FG000|Extension Phase|Disease Progression|3|||
127801140|NCT01877083|459893368|FG000|Extension Phase|Adverse Event|2|||
127801141|NCT02363478|459894913|FG000|Overall Study|Lost to Follow-up|4|||
127801142|NCT02363478|459894913|FG000|Overall Study|Adverse Event|4|||
127801143|NCT00768898|459894914|FG000|Overall Study|Unrelated injury|1|||
127801144|NCT00768898|459894914|FG000|Overall Study|Headache|1|||
127801145|NCT03160560|459894915|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
127801146|NCT03160560|459894916|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
127801147|NCT03160560|459894917|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
127801148|NCT03160560|459894918|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
127801149|NCT03160560|459894915|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
127801150|NCT03160560|459894916|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
127801151|NCT03160560|459894917|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
127801152|NCT03160560|459894918|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
127801153|NCT00667576|459894921|FG000|Overall Study|Withdrawal by Subject|1|||
127709955|NCT04614948|459566773|FG001|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
127709956|NCT04614948|459566774|FG002|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|1|||
127709957|NCT04614948|459566772|FG000|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
127709958|NCT04614948|459566773|FG001|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
127709959|NCT04614948|459566774|FG002|DB + Open-label Phase (2 Years 6 Months)|Other|477|||
127709960|NCT03663205|459566775|FG000|Overall Study|Death|144|||
127709961|NCT03663205|459566776|FG001|Overall Study|Death|69|||
127709962|NCT03663205|459566775|FG000|Overall Study|Sponsor decision|53|||
127709963|NCT03663205|459566776|FG001|Overall Study|Sponsor decision|19|||
127709964|NCT03663205|459566775|FG000|Overall Study|Withdrawal by Subject|8|||
127709965|NCT03663205|459566776|FG001|Overall Study|Withdrawal by Subject|11|||
127709966|NCT03663205|459566775|FG000|Overall Study|Lost to Follow-up|7|||
127709967|NCT03663205|459566776|FG001|Overall Study|Lost to Follow-up|9|||
127709968|NCT03663205|459566775|FG000|Overall Study|Transferred to long term extension study|11|||
127709969|NCT03663205|459566776|FG001|Overall Study|Transferred to long term extension study|3|||
127709970|NCT02326974|459566777|FG000|Overall Study|Withdrawal by Subject|2|||
127709971|NCT02326974|459566777|FG000|Overall Study|failed heterogenity evaluation|5|||
127709972|NCT04924400|459566785|FG000|Overall Study|Lost to Follow-up|3|||
127709973|NCT04924400|459566786|FG001|Overall Study|Lost to Follow-up|0|||
127709974|NCT04424316|459566787|FG000|Overall Study|Adverse Event|0|||
127709975|NCT04424316|459566788|FG001|Overall Study|Adverse Event|1|||
127709976|NCT04424316|459566789|FG002|Overall Study|Adverse Event|0|||
127709977|NCT04424316|459566790|FG003|Overall Study|Adverse Event|0|||
127709978|NCT04424316|459566787|FG000|Overall Study|Death|1|||
127709979|NCT04424316|459566788|FG001|Overall Study|Death|0|||
127709980|NCT04424316|459566789|FG002|Overall Study|Death|8|||
127709981|NCT04424316|459566790|FG003|Overall Study|Death|14|||
127709982|NCT04424316|459566787|FG000|Overall Study|Lost to Follow-up|93|||
127709983|NCT04424316|459566788|FG001|Overall Study|Lost to Follow-up|88|||
127709984|NCT04424316|459566789|FG002|Overall Study|Lost to Follow-up|224|||
127709985|NCT04424316|459566790|FG003|Overall Study|Lost to Follow-up|211|||
127709986|NCT04424316|459566787|FG000|Overall Study|No longer met eligibility criteria|1|||
127709987|NCT04424316|459566788|FG001|Overall Study|No longer met eligibility criteria|0|||
127709988|NCT04424316|459566789|FG002|Overall Study|No longer met eligibility criteria|0|||
127709989|NCT04424316|459566790|FG003|Overall Study|No longer met eligibility criteria|0|||
127709990|NCT04424316|459566787|FG000|Overall Study|Other|15|||
127709991|NCT04424316|459566788|FG001|Overall Study|Other|11|||
127709992|NCT04424316|459566789|FG002|Overall Study|Other|34|||
127709993|NCT04424316|459566790|FG003|Overall Study|Other|45|||
127709994|NCT04424316|459566787|FG000|Overall Study|Physician Decision|1|||
127709995|NCT04424316|459566788|FG001|Overall Study|Physician Decision|0|||
127709996|NCT04424316|459566789|FG002|Overall Study|Physician Decision|1|||
127709997|NCT04424316|459566790|FG003|Overall Study|Physician Decision|1|||
127709998|NCT04424316|459566787|FG000|Overall Study|Protocol Violation|0|||
127709999|NCT04424316|459566788|FG001|Overall Study|Protocol Violation|1|||
127710000|NCT04424316|459566789|FG002|Overall Study|Protocol Violation|0|||
127710001|NCT04424316|459566790|FG003|Overall Study|Protocol Violation|0|||
127710002|NCT04424316|459566787|FG000|Overall Study|Withdrawal by Subject|71|||
127710003|NCT04424316|459566788|FG001|Overall Study|Withdrawal by Subject|77|||
127710004|NCT04424316|459566789|FG002|Overall Study|Withdrawal by Subject|0|||
127710005|NCT04424316|459566790|FG003|Overall Study|Withdrawal by Subject|0|||
127710006|NCT04424316|459566787|FG000|Overall Study|Withdrawal by parent/guardian|0|||
127710007|NCT04424316|459566788|FG001|Overall Study|Withdrawal by parent/guardian|0|||
127710008|NCT04424316|459566789|FG002|Overall Study|Withdrawal by parent/guardian|74|||
127710009|NCT04424316|459566790|FG003|Overall Study|Withdrawal by parent/guardian|81|||
127710010|NCT04424316|459566787|FG000|Overall Study|Randomized but not vaccinated|13|||
127710011|NCT04424316|459566788|FG001|Overall Study|Randomized but not vaccinated|21|||
127710012|NCT04424316|459566789|FG002|Overall Study|Randomized but not vaccinated|0|||
127710013|NCT04424316|459566790|FG003|Overall Study|Randomized but not vaccinated|0|||
127710014|NCT04424316|459566787|FG000|Overall Study|Mother vaccinated but unblinded during study|1|||
127710015|NCT04424316|459566788|FG001|Overall Study|Mother vaccinated but unblinded during study|0|||
127710016|NCT04424316|459566789|FG002|Overall Study|Mother vaccinated but unblinded during study|2|||
127710017|NCT04424316|459566790|FG003|Overall Study|Mother vaccinated but unblinded during study|0|||
127710018|NCT00412607|459566793|FG000|Overall Study|Withdrawal by Subject|9|||
127710019|NCT00412607|459566793|FG000|Overall Study|Lost to Follow-up|19|||
127710020|NCT00412607|459566793|FG000|Overall Study|Death|61|||
127710021|NCT00412607|459566793|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
127710022|NCT05652010|459566796|FG000|First Intervention|Withdrawal by Subject|0|||
127710023|NCT05652010|459566797|FG001|First Intervention|Withdrawal by Subject|1|||
127710024|NCT05652010|459566796|FG000|Second Intervention|Withdrawal by Subject|1|||
127710025|NCT05652010|459566797|FG001|Second Intervention|Withdrawal by Subject|0|||
127710026|NCT05741294|459566799|FG000|Overall Study|Lost to Follow-up|3|||
127710027|NCT05741294|459566799|FG000|Overall Study|Protocol deviation|3|||
127710028|NCT05741294|459566799|FG000|Overall Study|Withdrawal by Subject|1|||
127801154|NCT00667576|459894922|FG001|Overall Study|Withdrawal by Subject|0|||
127801155|NCT00667576|459894923|FG002|Overall Study|Withdrawal by Subject|1|||
127801156|NCT00667576|459894924|FG003|Overall Study|Withdrawal by Subject|1|||
127801157|NCT00667576|459894925|FG004|Overall Study|Withdrawal by Subject|1|||
127801158|NCT00667576|459894921|FG000|Overall Study|Adverse Event|1|||
127801159|NCT00667576|459894922|FG001|Overall Study|Adverse Event|1|||
127801160|NCT00667576|459894923|FG002|Overall Study|Adverse Event|0|||
127801161|NCT00667576|459894924|FG003|Overall Study|Adverse Event|0|||
127801162|NCT00667576|459894925|FG004|Overall Study|Adverse Event|0|||
127801163|NCT00667576|459894921|FG000|Overall Study|Lost to Follow-up|0|||
127801164|NCT00667576|459894922|FG001|Overall Study|Lost to Follow-up|0|||
127801165|NCT00667576|459894923|FG002|Overall Study|Lost to Follow-up|1|||
127801166|NCT00667576|459894924|FG003|Overall Study|Lost to Follow-up|0|||
127801167|NCT00667576|459894925|FG004|Overall Study|Lost to Follow-up|0|||
127801168|NCT00667576|459894921|FG000|Overall Study|Protocol Violation|0|||
127801169|NCT00667576|459894922|FG001|Overall Study|Protocol Violation|0|||
127801170|NCT00667576|459894923|FG002|Overall Study|Protocol Violation|0|||
127801171|NCT00667576|459894924|FG003|Overall Study|Protocol Violation|1|||
127801172|NCT00667576|459894925|FG004|Overall Study|Protocol Violation|0|||
127801173|NCT00667576|459894921|FG000|Overall Study|Physician Decision|0|||
127801174|NCT00667576|459894922|FG001|Overall Study|Physician Decision|0|||
127801175|NCT00667576|459894923|FG002|Overall Study|Physician Decision|0|||
127801176|NCT00667576|459894924|FG003|Overall Study|Physician Decision|1|||
127801177|NCT00667576|459894925|FG004|Overall Study|Physician Decision|0|||
127801178|NCT00667576|459894921|FG000|Overall Study|Missed Visit|0|||
127801179|NCT00667576|459894922|FG001|Overall Study|Missed Visit|0|||
127801180|NCT00667576|459894923|FG002|Overall Study|Missed Visit|0|||
127801181|NCT00667576|459894924|FG003|Overall Study|Missed Visit|1|||
127801182|NCT00667576|459894925|FG004|Overall Study|Missed Visit|0|||
127801183|NCT01390389|459894926|FG000|Overall Study|Withdrawal by Subject|2|||
127801184|NCT01390389|459894927|FG001|Overall Study|Withdrawal by Subject|0|||
127801185|NCT01390389|459894926|FG000|Overall Study|Screen Fail|2|||
127710029|NCT04707768|459566800|FG000|Overall Study|Adverse Event|9|||
127710030|NCT04707768|459566801|FG001|Overall Study|Adverse Event|18|||
127710031|NCT04707768|459566802|FG002|Overall Study|Adverse Event|3|||
127710032|NCT04707768|459566800|FG000|Overall Study|Investigator's Discretion|8|||
127710033|NCT04707768|459566801|FG001|Overall Study|Investigator's Discretion|4|||
127710034|NCT04707768|459566802|FG002|Overall Study|Investigator's Discretion|3|||
127710035|NCT04707768|459566800|FG000|Overall Study|Withdrawal by Subject|6|||
127710036|NCT04707768|459566801|FG001|Overall Study|Withdrawal by Subject|8|||
127710037|NCT04707768|459566802|FG002|Overall Study|Withdrawal by Subject|2|||
127710038|NCT04707768|459566800|FG000|Overall Study|Lack of Efficacy|1|||
127710039|NCT04707768|459566801|FG001|Overall Study|Lack of Efficacy|3|||
127710040|NCT04707768|459566802|FG002|Overall Study|Lack of Efficacy|0|||
127710041|NCT04707768|459566800|FG000|Overall Study|Lost to Follow-up|0|||
127710042|NCT04707768|459566801|FG001|Overall Study|Lost to Follow-up|0|||
127710043|NCT04707768|459566802|FG002|Overall Study|Lost to Follow-up|3|||
127710044|NCT04707768|459566800|FG000|Overall Study|Death|13|||
127710045|NCT04707768|459566801|FG001|Overall Study|Death|11|||
127710046|NCT04707768|459566802|FG002|Overall Study|Death|13|||
127801186|NCT01390389|459894927|FG001|Overall Study|Screen Fail|1|||
127801187|NCT02002975|459894930|FG000|Overall Study|Case Report Forms Uncollected|135|||
127801188|NCT02002975|459894930|FG000|Overall Study|Protocol Deviation|437|||
127801189|NCT01430442|459894931|FG000|Overall Study|Subject Withdrew Consent|3|||
127801190|NCT01430442|459894932|FG001|Overall Study|Subject Withdrew Consent|0|||
127801191|NCT01430442|459894933|FG002|Overall Study|Subject Withdrew Consent|1|||
127801192|NCT01430442|459894934|FG003|Overall Study|Subject Withdrew Consent|0|||
127801193|NCT01430442|459894935|FG004|Overall Study|Subject Withdrew Consent|2|||
127801194|NCT01430442|459894936|FG005|Overall Study|Subject Withdrew Consent|1|||
127801195|NCT01430442|459894937|FG006|Overall Study|Subject Withdrew Consent|5|||
127801196|NCT01430442|459894938|FG007|Overall Study|Subject Withdrew Consent|2|||
127801197|NCT01430442|459894931|FG000|Overall Study|Lost to Follow-up|2|||
127801198|NCT01430442|459894932|FG001|Overall Study|Lost to Follow-up|0|||
127801199|NCT01430442|459894933|FG002|Overall Study|Lost to Follow-up|1|||
127710047|NCT04707768|459566800|FG000|Overall Study|Protocol Violation|2|||
127710048|NCT04707768|459566801|FG001|Overall Study|Protocol Violation|1|||
127710049|NCT04707768|459566802|FG002|Overall Study|Protocol Violation|0|||
127710050|NCT04707768|459566800|FG000|Overall Study|Non Compliance with Study Drug|1|||
127801200|NCT01430442|459894934|FG003|Overall Study|Lost to Follow-up|2|||
127710051|NCT04707768|459566801|FG001|Overall Study|Non Compliance with Study Drug|0|||
127710052|NCT04707768|459566802|FG002|Overall Study|Non Compliance with Study Drug|0|||
127801201|NCT01430442|459894935|FG004|Overall Study|Lost to Follow-up|2|||
127801202|NCT01430442|459894936|FG005|Overall Study|Lost to Follow-up|1|||
127801203|NCT01430442|459894937|FG006|Overall Study|Lost to Follow-up|5|||
127801204|NCT01430442|459894938|FG007|Overall Study|Lost to Follow-up|1|||
127801205|NCT01430442|459894931|FG000|Overall Study|Pregnancy|1|||
127801206|NCT01430442|459894932|FG001|Overall Study|Pregnancy|0|||
127801207|NCT01430442|459894933|FG002|Overall Study|Pregnancy|0|||
127801208|NCT01430442|459894934|FG003|Overall Study|Pregnancy|0|||
127801209|NCT01430442|459894935|FG004|Overall Study|Pregnancy|0|||
127888396|NCT00738920|460214024|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
127888397|NCT00738920|460214025|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
127888398|NCT00738920|460214023|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
127888399|NCT00738920|460214024|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
127888400|NCT00738920|460214025|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
127888401|NCT00738920|460214023|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
127710053|NCT04707768|459566800|FG000|Overall Study|Transplant|4|||
127710054|NCT04707768|459566801|FG001|Overall Study|Transplant|4|||
127710055|NCT04707768|459566802|FG002|Overall Study|Transplant|8|||
127710056|NCT04707768|459566800|FG000|Overall Study|Other|9|||
127710057|NCT04707768|459566801|FG001|Overall Study|Other|5|||
127710058|NCT04707768|459566802|FG002|Overall Study|Other|2|||
127710059|NCT05890105|459566803|FG000|Overall Study|Adverse Event|1|||
127710060|NCT05890105|459566804|FG001|Overall Study|Adverse Event|0|||
127710061|NCT05890105|459566805|FG002|Overall Study|Adverse Event|0|||
127710062|NCT05890105|459566803|FG000|Overall Study|Other|1|||
127710063|NCT05890105|459566804|FG001|Overall Study|Other|2|||
127710064|NCT05890105|459566805|FG002|Overall Study|Other|0|||
127710065|NCT00450216|459566806|FG000|Overall Study|Adverse Event|38|||
127710066|NCT00450216|459566807|FG001|Overall Study|Adverse Event|23|||
127710067|NCT00450216|459566806|FG000|Overall Study|Withdrawal by Subject|48|||
127710068|NCT00450216|459566807|FG001|Overall Study|Withdrawal by Subject|26|||
127710069|NCT00450216|459566806|FG000|Overall Study|Lost to Follow-up|16|||
127710070|NCT00450216|459566807|FG001|Overall Study|Lost to Follow-up|9|||
127710071|NCT00450216|459566806|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
127710072|NCT00450216|459566807|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
127710073|NCT00450216|459566806|FG000|Overall Study|misc|21|||
127710074|NCT00450216|459566807|FG001|Overall Study|misc|20|||
127710075|NCT04206787|459566808|FG000|Overall Study|Other than listed|2|||
127710076|NCT04206787|459566808|FG000|Overall Study|Investigator decision|1|||
127710077|NCT04206787|459566808|FG000|Overall Study|Death|25|||
127710078|NCT04206787|459566808|FG000|Overall Study|Lost to Follow-up|9|||
127710079|NCT04206787|459566808|FG000|Overall Study|Withdrawal of consent|9|||
127710080|NCT03011034|459566810|FG000|Overall Study|Adverse Event|1|||
127710081|NCT03011034|459566811|FG001|Overall Study|Adverse Event|0|||
127710082|NCT04678856|459566816|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
127710083|NCT04678856|459566817|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|0|||
127710084|NCT04678856|459566816|FG000|Overall Study|Withdrawal by Subject|5|||
127710085|NCT04678856|459566817|FG001|Overall Study|Withdrawal by Subject|1|||
127710086|NCT00942877|459568206|FG000|Overall Study|Refused further treatment|1|||
127710087|NCT00942877|459568207|FG001|Overall Study|Refused further treatment|1|||
127710088|NCT00942877|459568206|FG000|Overall Study|Patient was not treated|1|||
127710089|NCT00942877|459568207|FG001|Overall Study|Patient was not treated|0|||
127710090|NCT00942877|459568206|FG000|Overall Study|Adverse Event|1|||
127710091|NCT00942877|459568207|FG001|Overall Study|Adverse Event|0|||
127710092|NCT00942877|459568206|FG000|Overall Study|Progressive disease|42|||
127710093|NCT00942877|459568207|FG001|Overall Study|Progressive disease|3|||
127710094|NCT02905331|459568210|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
127710095|NCT02905331|459568211|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
127710096|NCT02905331|459568212|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
127710097|NCT02905331|459568210|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
127710098|NCT02905331|459568211|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
127710099|NCT02905331|459568212|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
127710100|NCT02905331|459568210|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
127710101|NCT02905331|459568211|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
127710102|NCT02905331|459568212|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
127710103|NCT02905331|459568210|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
127710104|NCT02905331|459568211|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
127710105|NCT02905331|459568212|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
127710106|NCT02905331|459568210|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
127710107|NCT02905331|459568211|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
127710108|NCT02905331|459568212|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
127710109|NCT01385202|459568213|FG000|Overall Study|Lost to Follow-up|6|||
127710110|NCT01385202|459568213|FG000|Overall Study|Not Eligible|11|||
127710111|NCT01385202|459568213|FG000|Overall Study|Withdrawn|1|||
127710112|NCT03681262|459568214|FG000|Overall Study|Continuing on study|3|||
127710113|NCT03681262|459568215|FG001|Overall Study|Continuing on study|3|||
127710114|NCT03681262|459568214|FG000|Overall Study|Lost to Follow-up|1|||
127710115|NCT03681262|459568215|FG001|Overall Study|Lost to Follow-up|0|||
127710116|NCT04102111|459568217|FG000|Overall Study|Withdrawal by Subject|2|||
127710117|NCT04102111|459568218|FG001|Overall Study|Withdrawal by Subject|3|||
127710118|NCT04102111|459568217|FG000|Overall Study|Adverse Event|1|||
127710119|NCT04102111|459568218|FG001|Overall Study|Adverse Event|1|||
127710120|NCT04102111|459568217|FG000|Overall Study|Study terminated by sponsor|1|||
127710121|NCT04102111|459568218|FG001|Overall Study|Study terminated by sponsor|3|||
127710122|NCT00887198|459568219|FG000|Randomized Period|Ongoing|42|||
127710123|NCT00887198|459568220|FG001|Randomized Period|Ongoing|0|||
127710124|NCT00887198|459568221|FG002|Randomized Period|Ongoing|0|||
127710125|NCT00887198|459568219|FG000|Randomized Period|Adverse Event|50|||
127710126|NCT00887198|459568220|FG001|Randomized Period|Adverse Event|33|||
127710127|NCT00887198|459568221|FG002|Randomized Period|Adverse Event|0|||
127710128|NCT00887198|459568219|FG000|Randomized Period|Lost to Follow-up|1|||
127710129|NCT00887198|459568220|FG001|Randomized Period|Lost to Follow-up|0|||
127710130|NCT00887198|459568221|FG002|Randomized Period|Lost to Follow-up|0|||
127710131|NCT00887198|459568219|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
127710132|NCT00887198|459568220|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
127710133|NCT00887198|459568221|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
127710134|NCT00887198|459568219|FG000|Randomized Period|Withdrawal by Subject|41|||
127710135|NCT00887198|459568220|FG001|Randomized Period|Withdrawal by Subject|56|||
127710136|NCT00887198|459568221|FG002|Randomized Period|Withdrawal by Subject|0|||
127710137|NCT00887198|459568219|FG000|Randomized Period|Progressive disease|366|||
127710138|NCT00887198|459568220|FG001|Randomized Period|Progressive disease|370|||
127710139|NCT00887198|459568221|FG002|Randomized Period|Progressive disease|0|||
127710140|NCT00887198|459568219|FG000|Randomized Period|Other|42|||
127710141|NCT00887198|459568220|FG001|Randomized Period|Other|30|||
127710142|NCT00887198|459568221|FG002|Randomized Period|Other|0|||
127710143|NCT00887198|459568219|FG000|Randomized Period|Randomized, Not treated|4|||
127710144|NCT00887198|459568220|FG001|Randomized Period|Randomized, Not treated|2|||
127710145|NCT00887198|459568221|FG002|Randomized Period|Randomized, Not treated|0|||
127710146|NCT00887198|459568219|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
127710147|NCT00887198|459568220|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
127710148|NCT00887198|459568221|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
127710149|NCT00887198|459568219|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
127710150|NCT00887198|459568220|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
127710151|NCT00887198|459568221|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
127710152|NCT00887198|459568219|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
127710153|NCT00887198|459568220|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
127710154|NCT00887198|459568221|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
127710155|NCT00887198|459568219|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
127710156|NCT00887198|459568220|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
127710157|NCT00887198|459568221|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
127710158|NCT00887198|459568219|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
127710159|NCT00887198|459568220|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
127710160|NCT00887198|459568221|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
127710161|NCT00887198|459568219|FG000|Cross Over (Placebo to AA)|Other|0|||
127710162|NCT00887198|459568220|FG001|Cross Over (Placebo to AA)|Other|0|||
127710163|NCT00887198|459568221|FG002|Cross Over (Placebo to AA)|Other|19|||
127710164|NCT02782676|459568222|FG000|Overall Study|Lost to Follow-up|0|||
127710165|NCT02782676|459568223|FG001|Overall Study|Lost to Follow-up|1|||
127710166|NCT03334695|459568224|FG000|Overall Study|Lost to Follow-up|3|||
127710167|NCT03334695|459568225|FG001|Overall Study|Lost to Follow-up|3|||
127710168|NCT03334695|459568224|FG000|Overall Study|Physician Decision|1|||
127710169|NCT03334695|459568225|FG001|Overall Study|Physician Decision|2|||
127710170|NCT03334695|459568224|FG000|Overall Study|Protocol Violation|0|||
127801210|NCT01430442|459894936|FG005|Overall Study|Pregnancy|1|||
127801211|NCT01430442|459894937|FG006|Overall Study|Pregnancy|0|||
127801212|NCT01430442|459894938|FG007|Overall Study|Pregnancy|0|||
127801213|NCT01430442|459894931|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
127801214|NCT01430442|459894932|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
127710171|NCT03334695|459568225|FG001|Overall Study|Protocol Violation|1|||
127710172|NCT00319046|459568226|FG000|Overall Study|withdrawal of subject's consent|7|||
127710173|NCT00319046|459568226|FG000|Overall Study|administrative reason|1|||
127710174|NCT02874742|459568227|FG000|Overall Study|Death|0|||
127710175|NCT02874742|459568228|FG001|Overall Study|Death|1|||
127710176|NCT02874742|459568229|FG002|Overall Study|Death|0|||
127710177|NCT02874742|459568227|FG000|Overall Study|Lost to Follow-up|5|||
127710178|NCT02874742|459568228|FG001|Overall Study|Lost to Follow-up|4|||
127710179|NCT02874742|459568229|FG002|Overall Study|Lost to Follow-up|1|||
127710180|NCT02874742|459568227|FG000|Overall Study|Withdrawal by Subject|17|||
127710181|NCT02874742|459568228|FG001|Overall Study|Withdrawal by Subject|8|||
127710182|NCT02874742|459568229|FG002|Overall Study|Withdrawal by Subject|0|||
127710183|NCT02874742|459568227|FG000|Overall Study|Other|4|||
127710184|NCT02874742|459568228|FG001|Overall Study|Other|1|||
127710185|NCT02874742|459568229|FG002|Overall Study|Other|0|||
127710186|NCT02874742|459568227|FG000|Overall Study|Progressive Disease|1|||
127710187|NCT02874742|459568228|FG001|Overall Study|Progressive Disease|0|||
127801215|NCT01430442|459894933|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
127801216|NCT01430442|459894934|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
127801217|NCT01430442|459894935|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
127801218|NCT01430442|459894936|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
127801219|NCT01430442|459894937|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
127801220|NCT01430442|459894938|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
127801221|NCT01641939|459894939|FG000|Overall Study|Death|90|||
127801222|NCT01641939|459894940|FG001|Overall Study|Death|187|||
127801223|NCT01641939|459894941|FG002|Overall Study|Death|61|||
127801224|NCT01641939|459894939|FG000|Overall Study|Lost to Follow-up|3|||
127801225|NCT01641939|459894940|FG001|Overall Study|Lost to Follow-up|2|||
127801226|NCT01641939|459894941|FG002|Overall Study|Lost to Follow-up|1|||
127801227|NCT01641939|459894939|FG000|Overall Study|Withdrawal by Subject|14|||
127801228|NCT01641939|459894940|FG001|Overall Study|Withdrawal by Subject|11|||
127801229|NCT01641939|459894941|FG002|Overall Study|Withdrawal by Subject|5|||
127801230|NCT01641939|459894939|FG000|Overall Study|Study Terminated by Sponsor|10|||
127801231|NCT01641939|459894940|FG001|Overall Study|Study Terminated by Sponsor|28|||
127801232|NCT01641939|459894941|FG002|Overall Study|Study Terminated by Sponsor|3|||
127801233|NCT00772629|459894942|FG000|Overall Study|Subject was not vaccinated|1|||
127801234|NCT00772629|459894943|FG001|Overall Study|Subject was not vaccinated|0|||
127801235|NCT05162066|459894947|FG000|Overall Study|Adverse Event|1|||
127801236|NCT05162066|459894948|FG001|Overall Study|Adverse Event|0|||
127801237|NCT05162066|459894949|FG002|Overall Study|Adverse Event|0|||
127801238|NCT05162066|459894947|FG000|Overall Study|Perceived lack of efficacy|1|||
127801239|NCT05162066|459894948|FG001|Overall Study|Perceived lack of efficacy|0|||
127801240|NCT05162066|459894949|FG002|Overall Study|Perceived lack of efficacy|0|||
127801241|NCT01072344|459894950|FG000|Overall Study|Relasped-reached end point|7|||
127888402|NCT00738920|460214024|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
127710188|NCT02874742|459568229|FG002|Overall Study|Progressive Disease|0|||
127710189|NCT02874742|459568227|FG000|Overall Study|Screen Failure|0|||
127710190|NCT02874742|459568228|FG001|Overall Study|Screen Failure|2|||
127710191|NCT02874742|459568229|FG002|Overall Study|Screen Failure|0|||
127710192|NCT00964392|459568233|FG000|Overall Study|Withdrawal by Subject|4|||
127710193|NCT00964392|459568234|FG001|Overall Study|Withdrawal by Subject|6|||
127710194|NCT00964392|459568233|FG000|Overall Study|Lost to Follow-up|4|||
127710195|NCT00964392|459568234|FG001|Overall Study|Lost to Follow-up|10|||
127710196|NCT00964392|459568233|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
127710197|NCT00964392|459568234|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
127710198|NCT00964392|459568233|FG000|Overall Study|Not completed|44|||
127710199|NCT00964392|459568234|FG001|Overall Study|Not completed|168|||
127710200|NCT04055012|459568235|FG000|Overall Study|Withdrawal by Subject|1|||
127710201|NCT04055012|459568236|FG001|Overall Study|Withdrawal by Subject|3|||
127710202|NCT04055012|459568237|FG002|Overall Study|Withdrawal by Subject|1|||
127710203|NCT04055012|459568238|FG003|Overall Study|Withdrawal by Subject|0|||
127710204|NCT04055012|459568235|FG000|Overall Study|Metformin Recall|1|||
127710205|NCT04055012|459568236|FG001|Overall Study|Metformin Recall|1|||
127710206|NCT04055012|459568237|FG002|Overall Study|Metformin Recall|1|||
127710207|NCT04055012|459568238|FG003|Overall Study|Metformin Recall|0|||
127710208|NCT04173247|459568247|FG000|Overall Study|Withdrawal by Subject|0|||
127710209|NCT04173247|459568248|FG001|Overall Study|Withdrawal by Subject|2|||
127710210|NCT04173247|459568247|FG000|Overall Study|Death|1|||
127710211|NCT04173247|459568248|FG001|Overall Study|Death|0|||
127710212|NCT04173247|459568247|FG000|Overall Study|Physician Decision|1|||
127710213|NCT04173247|459568248|FG001|Overall Study|Physician Decision|0|||
127710214|NCT05070741|459568249|FG000|Overall Study|Failed initial laboratory testing and was unable to progress to heat therapy treatment.|1|||
127710215|NCT03582033|459568250|FG000|Part A|Other|0|||
127710216|NCT03582033|459568251|FG001|Part A|Other|0|||
127710217|NCT03582033|459568252|FG002|Part A|Other|0|||
127710218|NCT03582033|459568253|FG003|Part A|Other|0|||
127710219|NCT03582033|459568254|FG004|Part A|Other|2|||
127710220|NCT03582033|459568255|FG005|Part A|Other|0|||
127710221|NCT03582033|459568256|FG006|Part A|Other|0|||
127801242|NCT01072344|459894951|FG001|Overall Study|Relasped-reached end point|12|||
127801243|NCT01072344|459894950|FG000|Overall Study|Protocol Violation|1|||
127801244|NCT01072344|459894951|FG001|Overall Study|Protocol Violation|2|||
127801245|NCT01072344|459894950|FG000|Overall Study|Lost to Follow-up|3|||
127801246|NCT01072344|459894951|FG001|Overall Study|Lost to Follow-up|4|||
127710222|NCT03582033|459568257|FG007|Part A|Other|0|||
127710223|NCT03582033|459568258|FG008|Part A|Other|0|||
127710224|NCT03582033|459568259|FG009|Part A|Other|0|||
127710225|NCT03582033|459568250|FG000|Part A|Death|1|||
127710226|NCT03582033|459568251|FG001|Part A|Death|1|||
127710227|NCT03582033|459568252|FG002|Part A|Death|2|||
127801247|NCT01871090|459894952|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
127801248|NCT01871090|459894953|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
127801249|NCT01871090|459894952|FG000|Overall Study|Interrogation not completed correctly|1|||
127801250|NCT01871090|459894953|FG001|Overall Study|Interrogation not completed correctly|0|||
127801251|NCT01871090|459894952|FG000|Overall Study|Subject Non-Compliance|0|||
127801252|NCT01871090|459894953|FG001|Overall Study|Subject Non-Compliance|1|||
127801253|NCT00168831|459894966|FG000|Overall Study|Adverse Event|36|||
127801254|NCT00168831|459894967|FG001|Overall Study|Adverse Event|47|||
127801255|NCT00168831|459894968|FG002|Overall Study|Adverse Event|74|||
127801256|NCT00168831|459894966|FG000|Overall Study|Lost to Follow-up|5|||
127801257|NCT00168831|459894967|FG001|Overall Study|Lost to Follow-up|6|||
127801258|NCT00168831|459894968|FG002|Overall Study|Lost to Follow-up|4|||
127801259|NCT00168831|459894966|FG000|Overall Study|Withdrawal by Subject|7|||
127801260|NCT00168831|459894967|FG001|Overall Study|Withdrawal by Subject|14|||
127801261|NCT00168831|459894968|FG002|Overall Study|Withdrawal by Subject|19|||
127801262|NCT00168831|459894966|FG000|Overall Study|Protocol Violation|6|||
127801263|NCT00168831|459894967|FG001|Overall Study|Protocol Violation|11|||
127801264|NCT00168831|459894968|FG002|Overall Study|Protocol Violation|11|||
127801265|NCT00168831|459894966|FG000|Overall Study|Other|6|||
127801266|NCT00168831|459894967|FG001|Overall Study|Other|3|||
127801267|NCT00168831|459894968|FG002|Overall Study|Other|6|||
127801268|NCT02009878|459894970|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
127801269|NCT02009878|459894971|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
127801270|NCT02009878|459894972|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
127801271|NCT04652804|459894975|FG000|Overall Study|Ineligible post randomization|1|||
127801272|NCT04652804|459894976|FG001|Overall Study|Ineligible post randomization|0|||
127801273|NCT04652804|459894977|FG002|Overall Study|Ineligible post randomization|1|||
127801274|NCT04652804|459894978|FG003|Overall Study|Ineligible post randomization|0|||
127801275|NCT04652804|459894979|FG004|Overall Study|Ineligible post randomization|1|||
127710228|NCT03582033|459568253|FG003|Part A|Death|4|||
127710229|NCT03582033|459568254|FG004|Part A|Death|11|||
127710230|NCT03582033|459568255|FG005|Part A|Death|0|||
127710231|NCT03582033|459568256|FG006|Part A|Death|0|||
127710232|NCT03582033|459568257|FG007|Part A|Death|0|||
127710233|NCT03582033|459568258|FG008|Part A|Death|0|||
127710234|NCT03582033|459568259|FG009|Part A|Death|0|||
127710235|NCT03582033|459568250|FG000|Part A|Lost to Follow-up|0|||
127710236|NCT03582033|459568251|FG001|Part A|Lost to Follow-up|0|||
127710237|NCT03582033|459568252|FG002|Part A|Lost to Follow-up|0|||
127710238|NCT03582033|459568253|FG003|Part A|Lost to Follow-up|0|||
127710239|NCT03582033|459568254|FG004|Part A|Lost to Follow-up|1|||
127710240|NCT03582033|459568255|FG005|Part A|Lost to Follow-up|0|||
127710241|NCT03582033|459568256|FG006|Part A|Lost to Follow-up|0|||
127710242|NCT03582033|459568257|FG007|Part A|Lost to Follow-up|0|||
127710243|NCT03582033|459568258|FG008|Part A|Lost to Follow-up|0|||
127710244|NCT03582033|459568259|FG009|Part A|Lost to Follow-up|0|||
127710245|NCT03582033|459568250|FG000|Part A|Study terminated by sponsor|0|||
127710246|NCT03582033|459568251|FG001|Part A|Study terminated by sponsor|0|||
127710247|NCT03582033|459568252|FG002|Part A|Study terminated by sponsor|0|||
127710248|NCT03582033|459568253|FG003|Part A|Study terminated by sponsor|2|||
127801276|NCT04652804|459894980|FG005|Overall Study|Ineligible post randomization|1|||
127801277|NCT04652804|459894975|FG000|Overall Study|Missing SVR lab results|2|||
127801278|NCT04652804|459894976|FG001|Overall Study|Missing SVR lab results|0|||
127801279|NCT04652804|459894977|FG002|Overall Study|Missing SVR lab results|0|||
127801280|NCT04652804|459894978|FG003|Overall Study|Missing SVR lab results|0|||
127801281|NCT04652804|459894979|FG004|Overall Study|Missing SVR lab results|0|||
127710249|NCT03582033|459568254|FG004|Part A|Study terminated by sponsor|1|||
127710250|NCT03582033|459568255|FG005|Part A|Study terminated by sponsor|0|||
127710251|NCT03582033|459568256|FG006|Part A|Study terminated by sponsor|0|||
127710252|NCT03582033|459568257|FG007|Part A|Study terminated by sponsor|0|||
127710253|NCT03582033|459568258|FG008|Part A|Study terminated by sponsor|0|||
127801282|NCT04652804|459894980|FG005|Overall Study|Missing SVR lab results|0|||
127801283|NCT03634800|459894981|FG000|Overall Study|Adverse Event|1|||
127801284|NCT03634800|459894981|FG000|Overall Study|Disease Progression|4|||
127801285|NCT03634800|459894981|FG000|Overall Study|Withdrawal by Subject|1|||
127801286|NCT00343512|459894988|FG000|Overall Study|Withdrawal by Subject|2|||
127801287|NCT00191451|459894991|FG000|Overall Study|Withdrawal by Subject|2|||
127801288|NCT00191451|459894992|FG001|Overall Study|Withdrawal by Subject|3|||
127801289|NCT00191451|459894993|FG002|Overall Study|Withdrawal by Subject|5|||
127801290|NCT00191451|459894991|FG000|Overall Study|Physician Decision|2|||
127801291|NCT00191451|459894992|FG001|Overall Study|Physician Decision|9|||
127801292|NCT00191451|459894993|FG002|Overall Study|Physician Decision|6|||
127801293|NCT00191451|459894991|FG000|Overall Study|Sponsor Decision|1|||
127801294|NCT00191451|459894992|FG001|Overall Study|Sponsor Decision|0|||
127801295|NCT00191451|459894993|FG002|Overall Study|Sponsor Decision|0|||
127801296|NCT00191451|459894991|FG000|Overall Study|Ineligible|0|||
127801297|NCT00191451|459894992|FG001|Overall Study|Ineligible|1|||
127801298|NCT00191451|459894993|FG002|Overall Study|Ineligible|0|||
127801299|NCT00191451|459894991|FG000|Overall Study|Reason Not Specified|2|||
127801300|NCT00191451|459894992|FG001|Overall Study|Reason Not Specified|1|||
127801301|NCT00191451|459894993|FG002|Overall Study|Reason Not Specified|3|||
127801302|NCT00684515|459894994|FG000|Overall Study|Adverse Event|3|||
127801303|NCT00684515|459894995|FG001|Overall Study|Adverse Event|3|||
127801304|NCT00684515|459894996|FG002|Overall Study|Adverse Event|1|||
127710254|NCT03582033|459568259|FG009|Part A|Study terminated by sponsor|0|||
127710255|NCT03582033|459568250|FG000|Part A|Withdrawal by Subject|1|||
127710256|NCT03582033|459568251|FG001|Part A|Withdrawal by Subject|1|||
127710257|NCT03582033|459568252|FG002|Part A|Withdrawal by Subject|0|||
127710258|NCT03582033|459568253|FG003|Part A|Withdrawal by Subject|1|||
127710259|NCT03582033|459568254|FG004|Part A|Withdrawal by Subject|7|||
127710260|NCT03582033|459568255|FG005|Part A|Withdrawal by Subject|0|||
127710261|NCT03582033|459568256|FG006|Part A|Withdrawal by Subject|0|||
127710262|NCT03582033|459568257|FG007|Part A|Withdrawal by Subject|0|||
127710263|NCT03582033|459568258|FG008|Part A|Withdrawal by Subject|0|||
127710264|NCT03582033|459568259|FG009|Part A|Withdrawal by Subject|0|||
127710265|NCT03582033|459568250|FG000|Part B|Death|0|||
127710266|NCT03582033|459568251|FG001|Part B|Death|0|||
127710267|NCT03582033|459568252|FG002|Part B|Death|0|||
127710268|NCT03582033|459568253|FG003|Part B|Death|0|||
127710269|NCT03582033|459568254|FG004|Part B|Death|0|||
127710270|NCT03582033|459568255|FG005|Part B|Death|2|||
127710271|NCT03582033|459568256|FG006|Part B|Death|0|||
127710272|NCT03582033|459568257|FG007|Part B|Death|0|||
127710273|NCT03582033|459568258|FG008|Part B|Death|0|||
127710274|NCT03582033|459568259|FG009|Part B|Death|0|||
127710275|NCT03582033|459568250|FG000|Part B|Study terminated by sponsor|0|||
127710276|NCT03582033|459568251|FG001|Part B|Study terminated by sponsor|0|||
127710277|NCT03582033|459568252|FG002|Part B|Study terminated by sponsor|0|||
127710278|NCT03582033|459568253|FG003|Part B|Study terminated by sponsor|0|||
127710279|NCT03582033|459568254|FG004|Part B|Study terminated by sponsor|0|||
127710280|NCT03582033|459568255|FG005|Part B|Study terminated by sponsor|12|||
127710281|NCT03582033|459568256|FG006|Part B|Study terminated by sponsor|0|||
127710282|NCT03582033|459568257|FG007|Part B|Study terminated by sponsor|0|||
127710283|NCT03582033|459568258|FG008|Part B|Study terminated by sponsor|0|||
127710284|NCT03582033|459568259|FG009|Part B|Study terminated by sponsor|0|||
127710285|NCT03582033|459568250|FG000|Part B|Withdrawal by Subject|0|||
127710286|NCT03582033|459568251|FG001|Part B|Withdrawal by Subject|0|||
127801305|NCT00684515|459894994|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
127801306|NCT00684515|459894995|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
127801307|NCT00684515|459894996|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
127801308|NCT04428411|459894997|FG000|Overall Study|Lost to Follow-up|114|||
127801309|NCT00880256|459895002|FG000|Overall Study|Lost to Follow-up|28|||
127710287|NCT03582033|459568252|FG002|Part B|Withdrawal by Subject|0|||
127710288|NCT03582033|459568253|FG003|Part B|Withdrawal by Subject|0|||
127710289|NCT03582033|459568254|FG004|Part B|Withdrawal by Subject|0|||
127801310|NCT00603915|459895007|FG000|Overall Study|Physician Decision|1|||
127801311|NCT03891901|459895008|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
127801312|NCT03891901|459895009|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
127801313|NCT03891901|459895010|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
127801314|NCT03891901|459895011|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
127801315|NCT03891901|459895012|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
127710290|NCT03582033|459568255|FG005|Part B|Withdrawal by Subject|6|||
127710291|NCT03582033|459568256|FG006|Part B|Withdrawal by Subject|0|||
127710292|NCT03582033|459568257|FG007|Part B|Withdrawal by Subject|0|||
127710293|NCT03582033|459568258|FG008|Part B|Withdrawal by Subject|0|||
127710294|NCT03582033|459568259|FG009|Part B|Withdrawal by Subject|0|||
127710295|NCT03582033|459568250|FG000|Part C|Other|0|||
127710296|NCT03582033|459568251|FG001|Part C|Other|0|||
127710297|NCT03582033|459568252|FG002|Part C|Other|0|||
127710298|NCT03582033|459568253|FG003|Part C|Other|0|||
127710299|NCT03582033|459568254|FG004|Part C|Other|0|||
127710300|NCT03582033|459568255|FG005|Part C|Other|0|||
127710301|NCT03582033|459568256|FG006|Part C|Other|2|||
127710302|NCT03582033|459568257|FG007|Part C|Other|0|||
127710303|NCT03582033|459568258|FG008|Part C|Other|0|||
127710304|NCT03582033|459568259|FG009|Part C|Other|0|||
127801316|NCT03891901|459895013|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
127801317|NCT03891901|459895014|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
127710305|NCT03582033|459568250|FG000|Part C|Death|0|||
127710306|NCT03582033|459568251|FG001|Part C|Death|0|||
127710307|NCT03582033|459568252|FG002|Part C|Death|0|||
127710308|NCT03582033|459568253|FG003|Part C|Death|0|||
127710309|NCT03582033|459568254|FG004|Part C|Death|0|||
127710310|NCT03582033|459568255|FG005|Part C|Death|0|||
127710311|NCT03582033|459568256|FG006|Part C|Death|6|||
127710312|NCT03582033|459568257|FG007|Part C|Death|1|||
127710313|NCT03582033|459568258|FG008|Part C|Death|2|||
127710314|NCT03582033|459568259|FG009|Part C|Death|0|||
127710315|NCT03582033|459568250|FG000|Part C|Study terminated by sponsor|0|||
127710316|NCT03582033|459568251|FG001|Part C|Study terminated by sponsor|0|||
127710317|NCT03582033|459568252|FG002|Part C|Study terminated by sponsor|0|||
127710318|NCT03582033|459568253|FG003|Part C|Study terminated by sponsor|0|||
127710319|NCT03582033|459568254|FG004|Part C|Study terminated by sponsor|0|||
127710320|NCT03582033|459568255|FG005|Part C|Study terminated by sponsor|0|||
127710321|NCT03582033|459568256|FG006|Part C|Study terminated by sponsor|3|||
127710322|NCT03582033|459568257|FG007|Part C|Study terminated by sponsor|3|||
127710323|NCT03582033|459568258|FG008|Part C|Study terminated by sponsor|2|||
127710324|NCT03582033|459568259|FG009|Part C|Study terminated by sponsor|0|||
127710325|NCT03582033|459568250|FG000|Part C|Withdrawal by Subject|0|||
127710326|NCT03582033|459568251|FG001|Part C|Withdrawal by Subject|0|||
127710327|NCT03582033|459568252|FG002|Part C|Withdrawal by Subject|0|||
127710328|NCT03582033|459568253|FG003|Part C|Withdrawal by Subject|0|||
127710329|NCT03582033|459568254|FG004|Part C|Withdrawal by Subject|0|||
127710330|NCT03582033|459568255|FG005|Part C|Withdrawal by Subject|0|||
127710331|NCT03582033|459568256|FG006|Part C|Withdrawal by Subject|1|||
127710332|NCT03582033|459568257|FG007|Part C|Withdrawal by Subject|2|||
127710333|NCT03582033|459568258|FG008|Part C|Withdrawal by Subject|1|||
127710334|NCT03582033|459568259|FG009|Part C|Withdrawal by Subject|0|||
127710335|NCT03582033|459568250|FG000|Part D|Death|0|||
127710336|NCT03582033|459568251|FG001|Part D|Death|0|||
127710337|NCT03582033|459568252|FG002|Part D|Death|0|||
127710338|NCT03582033|459568253|FG003|Part D|Death|0|||
127710339|NCT03582033|459568254|FG004|Part D|Death|0|||
127710340|NCT03582033|459568255|FG005|Part D|Death|0|||
127710341|NCT03582033|459568256|FG006|Part D|Death|0|||
127710342|NCT03582033|459568257|FG007|Part D|Death|0|||
127710343|NCT03582033|459568258|FG008|Part D|Death|0|||
127710344|NCT03582033|459568259|FG009|Part D|Death|1|||
127710345|NCT03582033|459568250|FG000|Part D|Study terminated by sponsor|0|||
127710346|NCT03582033|459568251|FG001|Part D|Study terminated by sponsor|0|||
127710347|NCT03582033|459568252|FG002|Part D|Study terminated by sponsor|0|||
127710348|NCT03582033|459568253|FG003|Part D|Study terminated by sponsor|0|||
127710349|NCT03582033|459568254|FG004|Part D|Study terminated by sponsor|0|||
127710350|NCT03582033|459568255|FG005|Part D|Study terminated by sponsor|0|||
127710351|NCT03582033|459568256|FG006|Part D|Study terminated by sponsor|0|||
127710352|NCT03582033|459568257|FG007|Part D|Study terminated by sponsor|0|||
127710353|NCT03582033|459568258|FG008|Part D|Study terminated by sponsor|0|||
127710354|NCT03582033|459568259|FG009|Part D|Study terminated by sponsor|4|||
127710355|NCT03812614|459568262|FG000|Intervention|Withdrawal by Subject|7|||
127710356|NCT03812614|459568263|FG001|Intervention|Withdrawal by Subject|2|||
127710357|NCT03812614|459568264|FG002|Intervention|Withdrawal by Subject|7|||
127710358|NCT03812614|459568265|FG003|Intervention|Withdrawal by Subject|2|||
127710359|NCT03812614|459568262|FG000|Intervention|Patient declined to participate in the introductory session intervention|1|||
127710360|NCT03812614|459568263|FG001|Intervention|Patient declined to participate in the introductory session intervention|5|||
127710361|NCT03812614|459568264|FG002|Intervention|Patient declined to participate in the introductory session intervention|11|||
127710362|NCT03812614|459568265|FG003|Intervention|Patient declined to participate in the introductory session intervention|86|||
127710363|NCT03812614|459568262|FG000|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|23|||
127710364|NCT03812614|459568263|FG001|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|20|||
127710365|NCT03812614|459568264|FG002|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
127710366|NCT03812614|459568265|FG003|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
127710367|NCT03812614|459568262|FG000|6-month Follow-up|Lost to Follow-up|0|||
127710368|NCT03812614|459568263|FG001|6-month Follow-up|Lost to Follow-up|0|||
127710369|NCT03812614|459568264|FG002|6-month Follow-up|Lost to Follow-up|12|||
127710370|NCT03812614|459568265|FG003|6-month Follow-up|Lost to Follow-up|8|||
127710371|NCT03812614|459568262|FG000|12-month Follow-up|Lost to Follow-up|18|||
127710372|NCT03812614|459568263|FG001|12-month Follow-up|Lost to Follow-up|17|||
127710373|NCT03812614|459568264|FG002|12-month Follow-up|Lost to Follow-up|5|||
127710374|NCT03812614|459568265|FG003|12-month Follow-up|Lost to Follow-up|2|||
127710375|NCT05205161|459568266|FG000|Overall Study|Study terminated by sponsor|3|||
127710376|NCT05205161|459568267|FG001|Overall Study|Study terminated by sponsor|3|||
127710377|NCT05205161|459568268|FG002|Overall Study|Study terminated by sponsor|1|||
127710378|NCT04675034|459568275|FG000|Overall Study|Lost to Follow-up|1|||
127710379|NCT04675034|459568276|FG001|Overall Study|Lost to Follow-up|1|||
127710380|NCT04675034|459568277|FG002|Overall Study|Lost to Follow-up|0|||
127710381|NCT04675034|459568278|FG003|Overall Study|Lost to Follow-up|2|||
127710382|NCT04675034|459568279|FG004|Overall Study|Lost to Follow-up|0|||
127710383|NCT04675034|459568275|FG000|Overall Study|Protocol Violation|1|||
127710384|NCT04675034|459568276|FG001|Overall Study|Protocol Violation|0|||
127710385|NCT04675034|459568277|FG002|Overall Study|Protocol Violation|0|||
127710386|NCT04675034|459568278|FG003|Overall Study|Protocol Violation|1|||
127710387|NCT04675034|459568279|FG004|Overall Study|Protocol Violation|3|||
127710388|NCT04675034|459568275|FG000|Overall Study|Withdrawal by Subject|9|||
127710389|NCT04675034|459568276|FG001|Overall Study|Withdrawal by Subject|3|||
127710390|NCT04675034|459568277|FG002|Overall Study|Withdrawal by Subject|4|||
127710391|NCT04675034|459568278|FG003|Overall Study|Withdrawal by Subject|8|||
127710392|NCT04675034|459568279|FG004|Overall Study|Withdrawal by Subject|6|||
127710393|NCT04163991|459568280|FG000|Overall Study|Adverse Event|0|||
127710394|NCT04163991|459568281|FG001|Overall Study|Adverse Event|0|||
127710395|NCT04163991|459568282|FG002|Overall Study|Adverse Event|0|||
127710396|NCT04163991|459568283|FG003|Overall Study|Adverse Event|1|||
127710397|NCT04163991|459568284|FG004|Overall Study|Adverse Event|0|||
127710398|NCT04163991|459568280|FG000|Overall Study|Death|0|||
127710399|NCT04163991|459568281|FG001|Overall Study|Death|0|||
127710400|NCT04163991|459568282|FG002|Overall Study|Death|1|||
127710401|NCT04163991|459568283|FG003|Overall Study|Death|0|||
127710402|NCT04163991|459568284|FG004|Overall Study|Death|0|||
127710403|NCT04163991|459568280|FG000|Overall Study|Lost to Follow-up|0|||
127710404|NCT04163991|459568281|FG001|Overall Study|Lost to Follow-up|1|||
127710405|NCT04163991|459568282|FG002|Overall Study|Lost to Follow-up|0|||
127710406|NCT04163991|459568283|FG003|Overall Study|Lost to Follow-up|0|||
127710407|NCT04163991|459568284|FG004|Overall Study|Lost to Follow-up|0|||
127710408|NCT04163991|459568280|FG000|Overall Study|Withdrawal by Subject|1|||
127710409|NCT04163991|459568281|FG001|Overall Study|Withdrawal by Subject|1|||
127710410|NCT04163991|459568282|FG002|Overall Study|Withdrawal by Subject|3|||
127710411|NCT04163991|459568283|FG003|Overall Study|Withdrawal by Subject|1|||
127710412|NCT04163991|459568284|FG004|Overall Study|Withdrawal by Subject|1|||
127710413|NCT04163991|459568280|FG000|Overall Study|Other, Not Specified|0|||
127710414|NCT04163991|459568281|FG001|Overall Study|Other, Not Specified|1|||
127710415|NCT04163991|459568282|FG002|Overall Study|Other, Not Specified|1|||
127710416|NCT04163991|459568283|FG003|Overall Study|Other, Not Specified|1|||
127710417|NCT04163991|459568284|FG004|Overall Study|Other, Not Specified|0|||
127710418|NCT04214418|459568285|FG000|Overall Study|Withdrawal by Subject|1|||
127710419|NCT04214418|459568286|FG001|Overall Study|Withdrawal by Subject|0|||
127710420|NCT04214418|459568287|FG002|Overall Study|Withdrawal by Subject|0|||
127710421|NCT04214418|459568288|FG003|Overall Study|Withdrawal by Subject|0|||
127710422|NCT04214418|459568289|FG004|Overall Study|Withdrawal by Subject|0|||
127710423|NCT04214418|459568290|FG005|Overall Study|Withdrawal by Subject|0|||
127710424|NCT04214418|459568285|FG000|Overall Study|Adverse Event|0|||
127710425|NCT04214418|459568286|FG001|Overall Study|Adverse Event|2|||
127710426|NCT04214418|459568287|FG002|Overall Study|Adverse Event|0|||
127710427|NCT04214418|459568288|FG003|Overall Study|Adverse Event|0|||
127710428|NCT04214418|459568289|FG004|Overall Study|Adverse Event|0|||
127710429|NCT04214418|459568290|FG005|Overall Study|Adverse Event|0|||
127710430|NCT04214418|459568285|FG000|Overall Study|Death|1|||
127710431|NCT04214418|459568286|FG001|Overall Study|Death|0|||
127710432|NCT04214418|459568287|FG002|Overall Study|Death|0|||
127710433|NCT04214418|459568288|FG003|Overall Study|Death|0|||
127710434|NCT04214418|459568289|FG004|Overall Study|Death|0|||
127710435|NCT04214418|459568290|FG005|Overall Study|Death|0|||
127710436|NCT05008055|459568294|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|3|||
127710437|NCT05008055|459568295|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
127710438|NCT05008055|459568296|FG002|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
127710439|NCT04635059|459568297|FG000|Overall Study|Study terminated early.|4|||
127710440|NCT03248479|459568301|FG000|Overall Study|Death|12|||
127710441|NCT03248479|459568302|FG001|Overall Study|Death|44|||
127710442|NCT03248479|459568303|FG002|Overall Study|Death|1|||
127710443|NCT03248479|459568304|FG003|Overall Study|Death|72|||
127710444|NCT03248479|459568305|FG004|Overall Study|Death|17|||
127710445|NCT03248479|459568306|FG005|Overall Study|Death|6|||
127710446|NCT03248479|459568307|FG006|Overall Study|Death|1|||
127710447|NCT03248479|459568308|FG007|Overall Study|Death|14|||
127710448|NCT03248479|459568309|FG008|Overall Study|Death|3|||
127710449|NCT03248479|459568310|FG009|Overall Study|Death|7|||
127710450|NCT03248479|459568311|FG010|Overall Study|Death|3|||
127710451|NCT03248479|459568312|FG011|Overall Study|Death|1|||
127710452|NCT03248479|459568313|FG012|Overall Study|Death|1|||
127710453|NCT03248479|459568301|FG000|Overall Study|Study terminated by sponsor|12|||
127710454|NCT03248479|459568302|FG001|Overall Study|Study terminated by sponsor|15|||
127710455|NCT03248479|459568303|FG002|Overall Study|Study terminated by sponsor|0|||
127710456|NCT03248479|459568304|FG003|Overall Study|Study terminated by sponsor|5|||
127710457|NCT03248479|459568305|FG004|Overall Study|Study terminated by sponsor|0|||
127710458|NCT03248479|459568306|FG005|Overall Study|Study terminated by sponsor|0|||
127710459|NCT03248479|459568307|FG006|Overall Study|Study terminated by sponsor|0|||
127710460|NCT03248479|459568308|FG007|Overall Study|Study terminated by sponsor|1|||
127710461|NCT03248479|459568309|FG008|Overall Study|Study terminated by sponsor|1|||
127710462|NCT03248479|459568310|FG009|Overall Study|Study terminated by sponsor|0|||
127710463|NCT03248479|459568311|FG010|Overall Study|Study terminated by sponsor|5|||
127710464|NCT03248479|459568312|FG011|Overall Study|Study terminated by sponsor|4|||
127710465|NCT03248479|459568313|FG012|Overall Study|Study terminated by sponsor|0|||
127710466|NCT03248479|459568301|FG000|Overall Study|Consent withdrawn|6|||
127710467|NCT03248479|459568302|FG001|Overall Study|Consent withdrawn|3|||
127710468|NCT03248479|459568303|FG002|Overall Study|Consent withdrawn|0|||
127710469|NCT03248479|459568304|FG003|Overall Study|Consent withdrawn|9|||
127710470|NCT03248479|459568305|FG004|Overall Study|Consent withdrawn|1|||
127710471|NCT03248479|459568306|FG005|Overall Study|Consent withdrawn|0|||
127710472|NCT03248479|459568307|FG006|Overall Study|Consent withdrawn|0|||
127710473|NCT03248479|459568308|FG007|Overall Study|Consent withdrawn|1|||
127710474|NCT03248479|459568309|FG008|Overall Study|Consent withdrawn|0|||
127710475|NCT03248479|459568310|FG009|Overall Study|Consent withdrawn|3|||
127710476|NCT03248479|459568311|FG010|Overall Study|Consent withdrawn|1|||
127710477|NCT03248479|459568312|FG011|Overall Study|Consent withdrawn|0|||
127710478|NCT03248479|459568313|FG012|Overall Study|Consent withdrawn|1|||
127710479|NCT03248479|459568301|FG000|Overall Study|Lost to Follow-up|2|||
127710480|NCT03248479|459568302|FG001|Overall Study|Lost to Follow-up|1|||
127710481|NCT03248479|459568303|FG002|Overall Study|Lost to Follow-up|0|||
127710482|NCT03248479|459568304|FG003|Overall Study|Lost to Follow-up|0|||
127710483|NCT03248479|459568305|FG004|Overall Study|Lost to Follow-up|0|||
127710484|NCT03248479|459568306|FG005|Overall Study|Lost to Follow-up|0|||
127710485|NCT03248479|459568307|FG006|Overall Study|Lost to Follow-up|0|||
127710486|NCT03248479|459568308|FG007|Overall Study|Lost to Follow-up|0|||
127710487|NCT03248479|459568309|FG008|Overall Study|Lost to Follow-up|0|||
127710488|NCT03248479|459568310|FG009|Overall Study|Lost to Follow-up|0|||
127710489|NCT03248479|459568311|FG010|Overall Study|Lost to Follow-up|0|||
127710490|NCT03248479|459568312|FG011|Overall Study|Lost to Follow-up|0|||
127710491|NCT03248479|459568313|FG012|Overall Study|Lost to Follow-up|1|||
127710492|NCT03248479|459568301|FG000|Overall Study|Not reported|0|||
127710493|NCT03248479|459568302|FG001|Overall Study|Not reported|0|||
127710494|NCT03248479|459568303|FG002|Overall Study|Not reported|0|||
127710495|NCT03248479|459568304|FG003|Overall Study|Not reported|1|||
127710496|NCT03248479|459568305|FG004|Overall Study|Not reported|1|||
127710497|NCT03248479|459568306|FG005|Overall Study|Not reported|0|||
127710498|NCT03248479|459568307|FG006|Overall Study|Not reported|0|||
127710499|NCT03248479|459568308|FG007|Overall Study|Not reported|1|||
127710500|NCT03248479|459568309|FG008|Overall Study|Not reported|1|||
127710501|NCT03248479|459568310|FG009|Overall Study|Not reported|0|||
127710502|NCT03248479|459568311|FG010|Overall Study|Not reported|0|||
127710503|NCT03248479|459568312|FG011|Overall Study|Not reported|0|||
127710504|NCT03248479|459568313|FG012|Overall Study|Not reported|0|||
127710505|NCT03735979|459568314|FG000|Overall Study|Lost to Follow-up|1|||
127710506|NCT03735979|459568315|FG001|Overall Study|Lost to Follow-up|12|||
127710507|NCT03735979|459568316|FG002|Overall Study|Lost to Follow-up|14|||
127710508|NCT03735979|459568314|FG000|Overall Study|Withdrawal by Subject|1|||
127710509|NCT03735979|459568315|FG001|Overall Study|Withdrawal by Subject|5|||
127710510|NCT03735979|459568316|FG002|Overall Study|Withdrawal by Subject|2|||
127710511|NCT03735979|459568314|FG000|Overall Study|Not due to the above reasons|1|||
127710512|NCT03735979|459568315|FG001|Overall Study|Not due to the above reasons|0|||
127710513|NCT03735979|459568316|FG002|Overall Study|Not due to the above reasons|0|||
127710514|NCT00319111|459568319|FG000|Overall Study|Adverse Event|20|||
127710515|NCT00319111|459568319|FG000|Overall Study|Withdrawal of consent|11|||
127710516|NCT00319111|459568319|FG000|Overall Study|Death|9|||
127710517|NCT00319111|459568319|FG000|Overall Study|Lack of clinical improvement|4|||
127710518|NCT00319111|459568319|FG000|Overall Study|Administrative|2|||
127710519|NCT00319111|459568319|FG000|Overall Study|Treatment failure|1|||
127710520|NCT05654662|459568320|FG000|Overall Study|Withdrawal by Subject|1|||
127710521|NCT05654662|459568321|FG001|Overall Study|Withdrawal by Subject|0|||
127710522|NCT05654662|459568320|FG000|Overall Study|A death in the family|1|||
127710523|NCT05654662|459568321|FG001|Overall Study|A death in the family|0|||
127710524|NCT03165955|459568322|FG000|Treatment|Withdrawal by Subject|3|||
127710525|NCT03165955|459568322|FG000|Treatment|Death|1|||
127710526|NCT03165955|459568322|FG000|Treatment|Adverse Event|1|||
127710527|NCT03165955|459568322|FG000|Treatment|Progressive disease|3|||
127710528|NCT04499521|459568325|FG000|Overall Study|Disease Progression|1|||
127710529|NCT04499521|459568326|FG001|Overall Study|Disease Progression|0|||
127710530|NCT05525104|459568327|FG000|Overall Study|Failed caudal analgesia|1|||
127710531|NCT05525104|459568328|FG001|Overall Study|Failed caudal analgesia|3|||
127888403|NCT00738920|460214025|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
127710532|NCT05525104|459568327|FG000|Overall Study|Premedication needed|0|||
127710533|NCT05525104|459568328|FG001|Overall Study|Premedication needed|1|||
127710534|NCT05525104|459568327|FG000|Overall Study|Protocol Violation|10|||
127710535|NCT05525104|459568328|FG001|Overall Study|Protocol Violation|0|||
127710536|NCT05525104|459568327|FG000|Overall Study|Cancelled operation|1|||
127710537|NCT05525104|459568328|FG001|Overall Study|Cancelled operation|0|||
127710538|NCT03990883|459568329|FG000|Blinded Treatment Phase|Adverse Event|1|||
127710539|NCT03990883|459568330|FG001|Blinded Treatment Phase|Adverse Event|1|||
127710540|NCT03990883|459568331|FG002|Blinded Treatment Phase|Adverse Event|0|||
127710541|NCT03990883|459568329|FG000|Blinded Treatment Phase|Lost to Follow-up|7|||
127710542|NCT03990883|459568330|FG001|Blinded Treatment Phase|Lost to Follow-up|10|||
127710543|NCT03990883|459568331|FG002|Blinded Treatment Phase|Lost to Follow-up|0|||
127710544|NCT03990883|459568329|FG000|Blinded Treatment Phase|Physician Decision|1|||
127710545|NCT03990883|459568330|FG001|Blinded Treatment Phase|Physician Decision|0|||
127710546|NCT03990883|459568331|FG002|Blinded Treatment Phase|Physician Decision|0|||
127710547|NCT03990883|459568329|FG000|Blinded Treatment Phase|Withdrawal by Subject|2|||
127710548|NCT03990883|459568330|FG001|Blinded Treatment Phase|Withdrawal by Subject|5|||
127710549|NCT03990883|459568331|FG002|Blinded Treatment Phase|Withdrawal by Subject|0|||
127710550|NCT03990883|459568329|FG000|Blinded Treatment Phase|COVID-19|3|||
127710551|NCT03990883|459568330|FG001|Blinded Treatment Phase|COVID-19|2|||
127710552|NCT03990883|459568331|FG002|Blinded Treatment Phase|COVID-19|0|||
127710553|NCT03990883|459568329|FG000|Blinded Treatment Phase|Personal Reasons|6|||
127710554|NCT03990883|459568330|FG001|Blinded Treatment Phase|Personal Reasons|3|||
127710555|NCT03990883|459568331|FG002|Blinded Treatment Phase|Personal Reasons|0|||
127710556|NCT03990883|459568329|FG000|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|3|||
127710557|NCT03990883|459568330|FG001|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|2|||
127710558|NCT03990883|459568331|FG002|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|0|||
127710559|NCT03990883|459568329|FG000|Open Label Extension Phase|Lost to Follow-up|0|||
127710560|NCT03990883|459568330|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
127710561|NCT03990883|459568331|FG002|Open Label Extension Phase|Lost to Follow-up|1|||
127710562|NCT03990883|459568329|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
127710563|NCT03990883|459568330|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
127710564|NCT03990883|459568331|FG002|Open Label Extension Phase|Withdrawal by Subject|1|||
127710565|NCT04427007|459569783|FG000|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|0|||
127710566|NCT04427007|459569784|FG001|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|1|||
127710567|NCT04633278|459569785|FG000|Overall Study|Adverse Event|1|||
127710568|NCT04633278|459569786|FG001|Overall Study|Adverse Event|0|||
127710569|NCT04633278|459569785|FG000|Overall Study|Withdrawal by Subject|1|||
127710570|NCT04633278|459569786|FG001|Overall Study|Withdrawal by Subject|0|||
127710571|NCT04633278|459569785|FG000|Overall Study|Death|11|||
127710572|NCT04633278|459569786|FG001|Overall Study|Death|7|||
127710573|NCT04633278|459569785|FG000|Overall Study|Sponsor Decision|3|||
127710574|NCT04633278|459569786|FG001|Overall Study|Sponsor Decision|0|||
127710575|NCT04633278|459569785|FG000|Overall Study|Not Listed|1|||
127710576|NCT04633278|459569786|FG001|Overall Study|Not Listed|0|||
127710577|NCT05247034|459569787|FG000|Overall Study|Lost to Follow-up|3|||
127710578|NCT05247034|459569788|FG001|Overall Study|Lost to Follow-up|2|||
127710579|NCT05247034|459569787|FG000|Overall Study|Organizational problems when attending appointments|1|||
127710580|NCT05247034|459569788|FG001|Overall Study|Organizational problems when attending appointments|0|||
127710581|NCT04464564|459569791|FG000|Period A (Placebo lead-in)|Other|5|||
127710582|NCT04464564|459569792|FG001|Period A (Placebo lead-in)|Other|0|||
127710583|NCT04464564|459569793|FG002|Period A (Placebo lead-in)|Other|0|||
127710584|NCT04464564|459569794|FG003|Period A (Placebo lead-in)|Other|0|||
127710585|NCT04464564|459569791|FG000|Period B (Randomization Period)|Adverse Event|0|||
127710586|NCT04464564|459569792|FG001|Period B (Randomization Period)|Adverse Event|1|||
127710587|NCT04464564|459569793|FG002|Period B (Randomization Period)|Adverse Event|2|||
127710588|NCT04464564|459569794|FG003|Period B (Randomization Period)|Adverse Event|8|||
127710589|NCT04464564|459569791|FG000|Period B (Randomization Period)|Lack of Efficacy|0|||
127710590|NCT04464564|459569792|FG001|Period B (Randomization Period)|Lack of Efficacy|1|||
127710591|NCT04464564|459569793|FG002|Period B (Randomization Period)|Lack of Efficacy|0|||
127710592|NCT04464564|459569794|FG003|Period B (Randomization Period)|Lack of Efficacy|0|||
127710593|NCT04464564|459569791|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
127710594|NCT04464564|459569792|FG001|Period B (Randomization Period)|Lost to Follow-up|0|||
127710595|NCT04464564|459569793|FG002|Period B (Randomization Period)|Lost to Follow-up|0|||
127710596|NCT04464564|459569794|FG003|Period B (Randomization Period)|Lost to Follow-up|1|||
127710597|NCT04464564|459569791|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
127710598|NCT04464564|459569792|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
127710599|NCT04464564|459569793|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
127710600|NCT04464564|459569794|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|5|||
127710601|NCT04464564|459569791|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
127710602|NCT04464564|459569792|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
127710603|NCT04464564|459569793|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
127710604|NCT04464564|459569794|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|7|||
127710605|NCT04464564|459569791|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
127710606|NCT04464564|459569792|FG001|Period B (Randomization Period)|Withdrawal by Subject|2|||
127710607|NCT04464564|459569793|FG002|Period B (Randomization Period)|Withdrawal by Subject|4|||
127710608|NCT04464564|459569794|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
127710609|NCT04464564|459569791|FG000|Period B (Randomization Period)|Reason not Specified|0|||
127710610|NCT04464564|459569792|FG001|Period B (Randomization Period)|Reason not Specified|3|||
127710611|NCT04464564|459569793|FG002|Period B (Randomization Period)|Reason not Specified|3|||
127710612|NCT04464564|459569794|FG003|Period B (Randomization Period)|Reason not Specified|3|||
127710613|NCT03505710|459569795|FG000|Overall Study|Progressive Disease|24|||
127710614|NCT03505710|459569796|FG001|Overall Study|Progressive Disease|17|||
127710615|NCT03505710|459569797|FG002|Overall Study|Progressive Disease|43|||
127710616|NCT03505710|459569795|FG000|Overall Study|Clinical Progression|6|||
127710617|NCT03505710|459569796|FG001|Overall Study|Clinical Progression|8|||
127710618|NCT03505710|459569797|FG002|Overall Study|Clinical Progression|3|||
127710619|NCT03505710|459569795|FG000|Overall Study|Adverse Event|12|||
127710620|NCT03505710|459569796|FG001|Overall Study|Adverse Event|6|||
127710621|NCT03505710|459569797|FG002|Overall Study|Adverse Event|28|||
127710622|NCT03505710|459569795|FG000|Overall Study|Withdrawal by Subject|1|||
127710623|NCT03505710|459569796|FG001|Overall Study|Withdrawal by Subject|3|||
127710624|NCT03505710|459569797|FG002|Overall Study|Withdrawal by Subject|7|||
127710625|NCT03505710|459569795|FG000|Overall Study|Physician Decision|1|||
127710626|NCT03505710|459569796|FG001|Overall Study|Physician Decision|1|||
127710627|NCT03505710|459569797|FG002|Overall Study|Physician Decision|2|||
127710628|NCT03505710|459569795|FG000|Overall Study|Death|4|||
127710629|NCT03505710|459569796|FG001|Overall Study|Death|5|||
127710630|NCT03505710|459569797|FG002|Overall Study|Death|6|||
127710631|NCT03505710|459569795|FG000|Overall Study|Other Reasons|1|||
127710632|NCT03505710|459569796|FG001|Overall Study|Other Reasons|1|||
127710633|NCT03505710|459569797|FG002|Overall Study|Other Reasons|1|||
127710634|NCT03505710|459569795|FG000|Overall Study|Study Terminated by Sponsor|0|||
127710635|NCT03505710|459569796|FG001|Overall Study|Study Terminated by Sponsor|0|||
127710636|NCT03505710|459569797|FG002|Overall Study|Study Terminated by Sponsor|1|||
127710637|NCT04389957|459569801|FG000|Overall Study|Providers without data in the post intervention timeframe.|7|||
127710638|NCT04389957|459569802|FG001|Overall Study|Providers without data in the post intervention timeframe.|7|||
127710639|NCT04389957|459569803|FG002|Overall Study|Providers without data in the post intervention timeframe.|12|||
127710640|NCT04389957|459569804|FG003|Overall Study|Providers without data in the post intervention timeframe.|20|||
127710641|NCT04389957|459569805|FG004|Overall Study|Providers without data in the post intervention timeframe.|7|||
127710642|NCT06655818|459569818|FG000|Overall Study|Withdrawal by Subject|1|||
127710643|NCT05007080|459569819|FG000|Overall Study|Lost to Follow-up|0|||
127710644|NCT05007080|459569820|FG001|Overall Study|Lost to Follow-up|1|||
127710645|NCT05007080|459569821|FG002|Overall Study|Lost to Follow-up|0|||
127710646|NCT05007080|459569822|FG003|Overall Study|Lost to Follow-up|1|||
127710647|NCT05007080|459569823|FG004|Overall Study|Lost to Follow-up|1|||
127710648|NCT05007080|459569824|FG005|Overall Study|Lost to Follow-up|1|||
127710649|NCT05007080|459569819|FG000|Overall Study|Death|0|||
127710650|NCT05007080|459569820|FG001|Overall Study|Death|1|||
127710651|NCT05007080|459569821|FG002|Overall Study|Death|0|||
127710652|NCT05007080|459569822|FG003|Overall Study|Death|0|||
127710653|NCT05007080|459569823|FG004|Overall Study|Death|0|||
127710654|NCT05007080|459569824|FG005|Overall Study|Death|0|||
127710655|NCT05007080|459569819|FG000|Overall Study|Withdrawal by Subject|1|||
127710656|NCT05007080|459569820|FG001|Overall Study|Withdrawal by Subject|2|||
127710657|NCT05007080|459569821|FG002|Overall Study|Withdrawal by Subject|0|||
127710658|NCT05007080|459569822|FG003|Overall Study|Withdrawal by Subject|2|||
127710659|NCT05007080|459569823|FG004|Overall Study|Withdrawal by Subject|1|||
127710660|NCT05007080|459569824|FG005|Overall Study|Withdrawal by Subject|1|||
127710661|NCT05007080|459569819|FG000|Overall Study|Other|1|||
127710662|NCT05007080|459569820|FG001|Overall Study|Other|0|||
127710663|NCT05007080|459569821|FG002|Overall Study|Other|1|||
127710664|NCT05007080|459569822|FG003|Overall Study|Other|1|||
127710665|NCT05007080|459569823|FG004|Overall Study|Other|0|||
127710666|NCT05007080|459569824|FG005|Overall Study|Other|2|||
127710667|NCT05007080|459569819|FG000|Overall Study|Randomized not vaccinated|0|||
127710668|NCT05007080|459569820|FG001|Overall Study|Randomized not vaccinated|0|||
127710669|NCT05007080|459569821|FG002|Overall Study|Randomized not vaccinated|0|||
127710670|NCT05007080|459569822|FG003|Overall Study|Randomized not vaccinated|0|||
127710671|NCT05007080|459569823|FG004|Overall Study|Randomized not vaccinated|0|||
127710672|NCT05007080|459569824|FG005|Overall Study|Randomized not vaccinated|1|||
127710673|NCT03652272|459569825|FG000|3 Month|Withdrawal by Subject|1|||
127710674|NCT03652272|459569826|FG001|3 Month|Withdrawal by Subject|1|||
127710675|NCT03652272|459569825|FG000|3 Month|Lost to Follow-up|16|||
127710676|NCT03652272|459569826|FG001|3 Month|Lost to Follow-up|14|||
127710677|NCT03884101|459569831|FG000|Overall Study|Participant Ongoing in Study|202|||
127710678|NCT03884101|459569832|FG001|Overall Study|Participant Ongoing in Study|186|||
127710679|NCT03884101|459569831|FG000|Overall Study|Death|212|||
127710680|NCT03884101|459569832|FG001|Overall Study|Death|224|||
127710681|NCT03884101|459569831|FG000|Overall Study|Lost to Follow-up|0|||
127710682|NCT03884101|459569832|FG001|Overall Study|Lost to Follow-up|1|||
127710683|NCT03884101|459569831|FG000|Overall Study|Withdrawal by Subject|6|||
127710684|NCT03884101|459569832|FG001|Overall Study|Withdrawal by Subject|11|||
127710685|NCT02938520|459569833|FG000|Overall Study|On-going at the time of analysis|258|||
127710686|NCT02938520|459569834|FG001|Overall Study|On-going at the time of analysis|261|||
127710687|NCT02938520|459569833|FG000|Overall Study|Physician Decision|2|||
127710688|NCT02938520|459569834|FG001|Overall Study|Physician Decision|5|||
127710689|NCT02938520|459569833|FG000|Overall Study|Lost to Follow-up|2|||
127710690|NCT02938520|459569834|FG001|Overall Study|Lost to Follow-up|2|||
127710691|NCT02938520|459569833|FG000|Overall Study|Withdrawal by Subject|7|||
127710692|NCT02938520|459569834|FG001|Overall Study|Withdrawal by Subject|7|||
127710693|NCT02938520|459569833|FG000|Overall Study|Protocol Violation|0|||
127710694|NCT02938520|459569834|FG001|Overall Study|Protocol Violation|1|||
127710695|NCT02938520|459569833|FG000|Overall Study|Lack of Efficacy|5|||
127710696|NCT02938520|459569834|FG001|Overall Study|Lack of Efficacy|3|||
127710697|NCT02938520|459569833|FG000|Overall Study|Adverse Event|9|||
127710698|NCT02938520|459569834|FG001|Overall Study|Adverse Event|4|||
127710699|NCT03372057|459569843|FG000|Dose Optimization Phase|Withdrawal by Subject|1|||
127710700|NCT03372057|459569844|FG001|Dose Optimization Phase|Withdrawal by Subject|1|||
127710701|NCT03372057|459569845|FG002|Dose Optimization Phase|Withdrawal by Subject|0|||
127710702|NCT03372057|459569843|FG000|Dose Optimization Phase|Closure Of The Study By The Sponsor|3|||
127710703|NCT03372057|459569844|FG001|Dose Optimization Phase|Closure Of The Study By The Sponsor|1|||
127710704|NCT03372057|459569845|FG002|Dose Optimization Phase|Closure Of The Study By The Sponsor|0|||
127710705|NCT03372057|459569843|FG000|Dose Optimization Phase|Death|16|||
127710706|NCT03372057|459569844|FG001|Dose Optimization Phase|Death|11|||
127710707|NCT03372057|459569845|FG002|Dose Optimization Phase|Death|0|||
127710708|NCT03372057|459569843|FG000|Expansion Phase|Withdrawal by Subject|0|||
127710709|NCT03372057|459569844|FG001|Expansion Phase|Withdrawal by Subject|0|||
127710710|NCT03372057|459569845|FG002|Expansion Phase|Withdrawal by Subject|4|||
127710711|NCT03372057|459569843|FG000|Expansion Phase|Closure Of The Study By The Sponsor|0|||
127710712|NCT03372057|459569844|FG001|Expansion Phase|Closure Of The Study By The Sponsor|0|||
127710713|NCT03372057|459569845|FG002|Expansion Phase|Closure Of The Study By The Sponsor|39|||
127710714|NCT03372057|459569843|FG000|Expansion Phase|Death|0|||
127710715|NCT03372057|459569844|FG001|Expansion Phase|Death|0|||
127710716|NCT03372057|459569845|FG002|Expansion Phase|Death|78|||
127710717|NCT03372057|459569843|FG000|Expansion Phase|Progressive Disease|0|||
127710718|NCT03372057|459569844|FG001|Expansion Phase|Progressive Disease|0|||
127710719|NCT03372057|459569845|FG002|Expansion Phase|Progressive Disease|1|||
127710720|NCT03372057|459569843|FG000|Expansion Phase|Adverse Event|0|||
127710721|NCT03372057|459569844|FG001|Expansion Phase|Adverse Event|0|||
127710722|NCT03372057|459569845|FG002|Expansion Phase|Adverse Event|1|||
127710723|NCT05953740|459569846|FG000|Period 1|Physician Decision|0|||
127710724|NCT05953740|459569847|FG001|Period 1|Physician Decision|1|||
127710725|NCT05953740|459569848|FG002|Period 1|Physician Decision|0|||
127710726|NCT05953740|459569849|FG003|Period 1|Physician Decision|0|||
127710727|NCT05953740|459569850|FG004|Period 1|Physician Decision|0|||
127710728|NCT05953740|459569851|FG005|Period 1|Physician Decision|0|||
127710729|NCT05953740|459569852|FG006|Period 1|Physician Decision|0|||
127710730|NCT05953740|459569853|FG007|Period 1|Physician Decision|0|||
127710731|NCT05953740|459569846|FG000|Period 2|Withdrawal by Subject|0|||
127710732|NCT05953740|459569847|FG001|Period 2|Withdrawal by Subject|1|||
127710733|NCT05953740|459569848|FG002|Period 2|Withdrawal by Subject|1|||
127710734|NCT05953740|459569849|FG003|Period 2|Withdrawal by Subject|0|||
127710735|NCT05953740|459569850|FG004|Period 2|Withdrawal by Subject|0|||
127710736|NCT05953740|459569851|FG005|Period 2|Withdrawal by Subject|0|||
127710737|NCT05953740|459569852|FG006|Period 2|Withdrawal by Subject|0|||
127710738|NCT05953740|459569853|FG007|Period 2|Withdrawal by Subject|0|||
127710739|NCT03880955|459569854|FG000|Overall Study|Adverse Event|1|||
127710740|NCT03880955|459569854|FG000|Overall Study|Death|1|||
127710741|NCT03880955|459569854|FG000|Overall Study|Lost to Follow-up|12|||
127710742|NCT03880955|459569854|FG000|Overall Study|Withdrawal by Subject|4|||
127710743|NCT03880955|459569854|FG000|Overall Study|Missing- Study Site Closed|27|||
127710744|NCT04679389|459569859|FG000|Overall Study|Adverse Event|1|||
127710745|NCT04679389|459569860|FG001|Overall Study|Adverse Event|0|||
127710746|NCT04679389|459569859|FG000|Overall Study|Protocol Violation|2|||
127710747|NCT04679389|459569860|FG001|Overall Study|Protocol Violation|0|||
127710748|NCT04679389|459569859|FG000|Overall Study|Physician Decision|3|||
127710749|NCT04679389|459569860|FG001|Overall Study|Physician Decision|5|||
127710750|NCT04679389|459569859|FG000|Overall Study|Withdrawal by Subject|5|||
127710751|NCT04679389|459569860|FG001|Overall Study|Withdrawal by Subject|7|||
127710752|NCT05112900|459569865|FG000|Overall Study|Withdrawal by Subject|960|||
127710753|NCT05112900|459569866|FG001|Overall Study|Withdrawal by Subject|921|||
127710754|NCT05112900|459569867|FG002|Overall Study|Withdrawal by Subject|968|||
127710755|NCT01438853|459569868|FG000|Overall Study|Death|0|||
127710756|NCT01438853|459569869|FG001|Overall Study|Death|0|||
127710757|NCT01438853|459569870|FG002|Overall Study|Death|0|||
127710758|NCT01438853|459569871|FG003|Overall Study|Death|1|||
127710759|NCT01438853|459569868|FG000|Overall Study|Withdrawal by Subject|0|||
127710760|NCT01438853|459569869|FG001|Overall Study|Withdrawal by Subject|0|||
127710761|NCT01438853|459569870|FG002|Overall Study|Withdrawal by Subject|1|||
127710762|NCT01438853|459569871|FG003|Overall Study|Withdrawal by Subject|0|||
127710763|NCT04743973|459569873|FG000|Overall Study|Withdrawal by Subject|5|||
127710764|NCT03279978|459569874|FG000|Overall Study|Withdrawal by Subject|0|||
127710765|NCT03279978|459569875|FG001|Overall Study|Withdrawal by Subject|1|||
127710766|NCT03279978|459569876|FG002|Overall Study|Withdrawal by Subject|0|||
127710767|NCT03279978|459569877|FG003|Overall Study|Withdrawal by Subject|0|||
127710768|NCT03279978|459569878|FG004|Overall Study|Withdrawal by Subject|0|||
127710769|NCT03279978|459569879|FG005|Overall Study|Withdrawal by Subject|0|||
127710770|NCT03279978|459569880|FG006|Overall Study|Withdrawal by Subject|0|||
127710771|NCT03279978|459569881|FG007|Overall Study|Withdrawal by Subject|0|||
127710772|NCT03279978|459569882|FG008|Overall Study|Withdrawal by Subject|0|||
127710773|NCT03279978|459569883|FG009|Overall Study|Withdrawal by Subject|1|||
127710774|NCT03279978|459569874|FG000|Overall Study|Lost to Follow-up|1|||
127710775|NCT03279978|459569875|FG001|Overall Study|Lost to Follow-up|0|||
127710776|NCT03279978|459569876|FG002|Overall Study|Lost to Follow-up|1|||
127710777|NCT03279978|459569877|FG003|Overall Study|Lost to Follow-up|0|||
127710778|NCT03279978|459569878|FG004|Overall Study|Lost to Follow-up|0|||
127710779|NCT03279978|459569879|FG005|Overall Study|Lost to Follow-up|0|||
127710780|NCT03279978|459569880|FG006|Overall Study|Lost to Follow-up|0|||
127710781|NCT03279978|459569881|FG007|Overall Study|Lost to Follow-up|0|||
127710782|NCT03279978|459569882|FG008|Overall Study|Lost to Follow-up|0|||
127710783|NCT03279978|459569883|FG009|Overall Study|Lost to Follow-up|0|||
127710784|NCT03279978|459569874|FG000|Overall Study|Other than stated above|0|||
127710785|NCT03279978|459569875|FG001|Overall Study|Other than stated above|0|||
127710786|NCT03279978|459569876|FG002|Overall Study|Other than stated above|0|||
127710787|NCT03279978|459569877|FG003|Overall Study|Other than stated above|0|||
127710788|NCT03279978|459569878|FG004|Overall Study|Other than stated above|0|||
127710789|NCT03279978|459569879|FG005|Overall Study|Other than stated above|0|||
127710790|NCT03279978|459569880|FG006|Overall Study|Other than stated above|1|||
127710791|NCT03279978|459569881|FG007|Overall Study|Other than stated above|0|||
127710792|NCT03279978|459569882|FG008|Overall Study|Other than stated above|0|||
127710793|NCT03279978|459569883|FG009|Overall Study|Other than stated above|0|||
127710794|NCT04330040|459569884|FG000|Overall Study|Other: Adverse event|5|||
127710795|NCT04330040|459569885|FG001|Overall Study|Other: Adverse event|0|||
127710796|NCT04330040|459569886|FG002|Overall Study|Other: Adverse event|0|||
127710797|NCT04330040|459569884|FG000|Overall Study|Disease progression|38|||
127710798|NCT04330040|459569885|FG001|Overall Study|Disease progression|10|||
127710799|NCT04330040|459569886|FG002|Overall Study|Disease progression|0|||
127710800|NCT04330040|459569884|FG000|Overall Study|Physician Decision|5|||
127710801|NCT04330040|459569885|FG001|Overall Study|Physician Decision|3|||
127710802|NCT04330040|459569886|FG002|Overall Study|Physician Decision|0|||
127710803|NCT04330040|459569884|FG000|Overall Study|Lost to Follow-up|1|||
127710804|NCT04330040|459569885|FG001|Overall Study|Lost to Follow-up|1|||
127710805|NCT04330040|459569886|FG002|Overall Study|Lost to Follow-up|0|||
127710806|NCT04330040|459569884|FG000|Overall Study|Death|2|||
127710807|NCT04330040|459569885|FG001|Overall Study|Death|1|||
127710808|NCT04330040|459569886|FG002|Overall Study|Death|0|||
127710809|NCT04330040|459569884|FG000|Overall Study|Withdrawal by Subject|3|||
127710810|NCT04330040|459569885|FG001|Overall Study|Withdrawal by Subject|3|||
127710811|NCT04330040|459569886|FG002|Overall Study|Withdrawal by Subject|0|||
127710812|NCT04330040|459569884|FG000|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
127710813|NCT04330040|459569885|FG001|Overall Study|Other: Increased QTc interval and clinical progression found|1|||
127710814|NCT04330040|459569886|FG002|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
127710815|NCT04330040|459569884|FG000|Overall Study|Other: Progressive disease (no confirming documents)|0|||
127710816|NCT04330040|459569885|FG001|Overall Study|Other: Progressive disease (no confirming documents)|1|||
127710817|NCT04330040|459569886|FG002|Overall Study|Other: Progressive disease (no confirming documents)|0|||
127710818|NCT04330040|459569884|FG000|Overall Study|Other: Disease progression|1|||
127710819|NCT04330040|459569885|FG001|Overall Study|Other: Disease progression|0|||
127710820|NCT04330040|459569886|FG002|Overall Study|Other: Disease progression|0|||
127710821|NCT04330040|459569884|FG000|Overall Study|Other: Due to anemia the investigator decided not to continue|1|||
127710822|NCT04330040|459569885|FG001|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
127710823|NCT04330040|459569886|FG002|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
127710824|NCT04330040|459569884|FG000|Overall Study|Other: Due to disease progression and could not tolerate the dose|1|||
127710825|NCT04330040|459569885|FG001|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
127710826|NCT04330040|459569886|FG002|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
127710827|NCT04330040|459569884|FG000|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|2|||
127710828|NCT04330040|459569885|FG001|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
127710829|NCT04330040|459569886|FG002|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
127710830|NCT00626795|459569889|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
127710831|NCT00626795|459569890|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
127710832|NCT00626795|459569891|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
127710833|NCT00626795|459569889|FG000|Blinded Treatment|Lack of Efficacy|2|||
127710834|NCT00626795|459569890|FG001|Blinded Treatment|Lack of Efficacy|0|||
127710835|NCT00626795|459569891|FG002|Blinded Treatment|Lack of Efficacy|0|||
127710836|NCT00626795|459569889|FG000|Blinded Treatment|Unacceptable adverse event|0|||
127710837|NCT00626795|459569890|FG001|Blinded Treatment|Unacceptable adverse event|0|||
127710838|NCT00626795|459569891|FG002|Blinded Treatment|Unacceptable adverse event|1|||
127710839|NCT00626795|459569889|FG000|Blinded Treatment|Protocol Violation|0|||
127710840|NCT00626795|459569890|FG001|Blinded Treatment|Protocol Violation|1|||
127710841|NCT00626795|459569891|FG002|Blinded Treatment|Protocol Violation|1|||
127710842|NCT00626795|459569889|FG000|Blinded Treatment|Withdrawal by Subject|1|||
127710843|NCT00626795|459569890|FG001|Blinded Treatment|Withdrawal by Subject|1|||
127710844|NCT00626795|459569891|FG002|Blinded Treatment|Withdrawal by Subject|0|||
127710845|NCT00626795|459569889|FG000|Blinded Treatment|Other reasons|2|||
127710846|NCT00626795|459569890|FG001|Blinded Treatment|Other reasons|0|||
127710847|NCT00626795|459569891|FG002|Blinded Treatment|Other reasons|2|||
127710848|NCT00626795|459569889|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
127710849|NCT00626795|459569890|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
127710850|NCT00626795|459569891|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
127710851|NCT04159519|459569892|FG000|Overall Study|Adverse Event|1|||
127710852|NCT04159519|459569893|FG001|Overall Study|Adverse Event|1|||
127710853|NCT04159519|459569892|FG000|Overall Study|Lack of Efficacy|1|||
127710854|NCT04159519|459569893|FG001|Overall Study|Lack of Efficacy|0|||
127710855|NCT04159519|459569892|FG000|Overall Study|Discontinued from study|1|||
127710856|NCT04159519|459569893|FG001|Overall Study|Discontinued from study|0|||
127710857|NCT04159519|459569892|FG000|Overall Study|Protocol Violation|1|||
127710858|NCT04159519|459569893|FG001|Overall Study|Protocol Violation|1|||
127710859|NCT04159519|459569892|FG000|Overall Study|Withdrawal by Subject|4|||
127710860|NCT04159519|459569893|FG001|Overall Study|Withdrawal by Subject|4|||
127710861|NCT03636490|459570733|FG000|Overall Study|Dropped out or incomplete data|141|||
127710862|NCT02246127|459570734|FG000|First Course Treatment|Adverse Event|9|||
127710863|NCT02246127|459570735|FG001|First Course Treatment|Adverse Event|7|||
127710864|NCT02246127|459570734|FG000|First Course Treatment|Withdrawal by Subject|6|||
127710865|NCT02246127|459570735|FG001|First Course Treatment|Withdrawal by Subject|7|||
127710866|NCT02246127|459570734|FG000|First Course Treatment|Physician Decision|9|||
127710867|NCT02246127|459570735|FG001|First Course Treatment|Physician Decision|9|||
127710868|NCT02246127|459570734|FG000|First Course Treatment|Death|3|||
127710869|NCT02246127|459570735|FG001|First Course Treatment|Death|3|||
127710870|NCT02246127|459570734|FG000|First Course Treatment|Not reported reasons|6|||
127710871|NCT02246127|459570735|FG001|First Course Treatment|Not reported reasons|7|||
127710872|NCT02246127|459570734|FG000|First Course Treatment|Not treated|3|||
127710873|NCT02246127|459570735|FG001|First Course Treatment|Not treated|3|||
127710874|NCT02095691|459570739|FG000|Overall Study|Physician Decision|1|||
127710875|NCT05147584|459570740|FG000|Overall Study|Subjects consented but did not fully meet inclusion /exclusion criteria|8|||
127710876|NCT05460871|459570741|FG000|Overall Study|Withdrawal by Subject|1|||
127710877|NCT05460871|459570742|FG001|Overall Study|Withdrawal by Subject|2|||
127710878|NCT04623775|459570753|FG000|Randomization|No Longer Meets Study Criteria|2|||
127710879|NCT04623775|459570754|FG001|Randomization|No Longer Meets Study Criteria|1|||
127710880|NCT04623775|459570755|FG002|Randomization|No Longer Meets Study Criteria|0|||
127801318|NCT03891901|459895015|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
127801319|NCT03891901|459895016|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
127801320|NCT03891901|459895008|FG000|Overall Study|Adverse Event|2|||
127801321|NCT03891901|459895009|FG001|Overall Study|Adverse Event|2|||
127710881|NCT04623775|459570756|FG003|Randomization|No Longer Meets Study Criteria|0|||
127710882|NCT04623775|459570753|FG000|Randomization|Withdrew Consent|0|||
127710883|NCT04623775|459570754|FG001|Randomization|Withdrew Consent|0|||
127710884|NCT04623775|459570755|FG002|Randomization|Withdrew Consent|0|||
127801322|NCT03891901|459895010|FG002|Overall Study|Adverse Event|0|||
127710885|NCT04623775|459570756|FG003|Randomization|Withdrew Consent|1|||
127710886|NCT04623775|459570753|FG000|Randomization|Other Reasons|0|||
127710887|NCT04623775|459570754|FG001|Randomization|Other Reasons|0|||
127710888|NCT04623775|459570755|FG002|Randomization|Other Reasons|0|||
127710889|NCT04623775|459570756|FG003|Randomization|Other Reasons|1|||
127710890|NCT04623775|459570753|FG000|Treatment Period|participant withdrew consent|4|||
127710891|NCT04623775|459570754|FG001|Treatment Period|participant withdrew consent|0|||
127801323|NCT03891901|459895011|FG003|Overall Study|Adverse Event|0|||
127801324|NCT03891901|459895012|FG004|Overall Study|Adverse Event|0|||
127710892|NCT04623775|459570755|FG002|Treatment Period|participant withdrew consent|1|||
127710893|NCT04623775|459570756|FG003|Treatment Period|participant withdrew consent|2|||
127710894|NCT04623775|459570753|FG000|Treatment Period|Death|3|||
127710895|NCT04623775|459570754|FG001|Treatment Period|Death|1|||
127710896|NCT04623775|459570755|FG002|Treatment Period|Death|4|||
127710897|NCT04623775|459570756|FG003|Treatment Period|Death|2|||
127710898|NCT04623775|459570753|FG000|Treatment Period|Lost to Follow-up|0|||
127710899|NCT04623775|459570754|FG001|Treatment Period|Lost to Follow-up|2|||
127710900|NCT04623775|459570755|FG002|Treatment Period|Lost to Follow-up|0|||
127710901|NCT04623775|459570756|FG003|Treatment Period|Lost to Follow-up|0|||
127710902|NCT04623775|459570753|FG000|Treatment Period|poor/non compliance|0|||
127710903|NCT04623775|459570754|FG001|Treatment Period|poor/non compliance|0|||
127710904|NCT04623775|459570755|FG002|Treatment Period|poor/non compliance|1|||
127710905|NCT04623775|459570756|FG003|Treatment Period|poor/non compliance|0|||
127710906|NCT04623775|459570753|FG000|Treatment Period|participant no longer meets study criteria|0|||
127710907|NCT04623775|459570754|FG001|Treatment Period|participant no longer meets study criteria|1|||
127710908|NCT04623775|459570755|FG002|Treatment Period|participant no longer meets study criteria|0|||
127710909|NCT04623775|459570756|FG003|Treatment Period|participant no longer meets study criteria|0|||
127710910|NCT04623775|459570753|FG000|Treatment Period|administrative reasons by sponsor|3|||
127710911|NCT04623775|459570754|FG001|Treatment Period|administrative reasons by sponsor|2|||
127710912|NCT04623775|459570755|FG002|Treatment Period|administrative reasons by sponsor|0|||
127710913|NCT04623775|459570756|FG003|Treatment Period|administrative reasons by sponsor|0|||
127710914|NCT04623775|459570753|FG000|Treatment Period|other reasons|2|||
127710915|NCT04623775|459570754|FG001|Treatment Period|other reasons|0|||
127710916|NCT04623775|459570755|FG002|Treatment Period|other reasons|1|||
127710917|NCT04623775|459570756|FG003|Treatment Period|other reasons|1|||
127710918|NCT04623775|459570753|FG000|Treatment Period|disease progression|40|||
127710919|NCT04623775|459570754|FG001|Treatment Period|disease progression|35|||
127710920|NCT04623775|459570755|FG002|Treatment Period|disease progression|63|||
127710921|NCT04623775|459570756|FG003|Treatment Period|disease progression|63|||
127710922|NCT04623775|459570753|FG000|Treatment Period|study drug toxicity|12|||
127710923|NCT04623775|459570754|FG001|Treatment Period|study drug toxicity|15|||
127801325|NCT03891901|459895013|FG005|Overall Study|Adverse Event|0|||
127801326|NCT03891901|459895014|FG006|Overall Study|Adverse Event|0|||
127801327|NCT03891901|459895015|FG007|Overall Study|Adverse Event|0|||
127710924|NCT04623775|459570755|FG002|Treatment Period|study drug toxicity|13|||
127710925|NCT04623775|459570756|FG003|Treatment Period|study drug toxicity|12|||
127710926|NCT04623775|459570753|FG000|Treatment Period|AE unrelated to study drug|4|||
127710927|NCT04623775|459570754|FG001|Treatment Period|AE unrelated to study drug|9|||
127710928|NCT04623775|459570755|FG002|Treatment Period|AE unrelated to study drug|12|||
127710929|NCT04623775|459570756|FG003|Treatment Period|AE unrelated to study drug|9|||
127710930|NCT04623775|459570753|FG000|Treatment Period|participant request to discontinue treatment|0|||
127710931|NCT04623775|459570754|FG001|Treatment Period|participant request to discontinue treatment|2|||
127710932|NCT04623775|459570755|FG002|Treatment Period|participant request to discontinue treatment|2|||
127710933|NCT04623775|459570756|FG003|Treatment Period|participant request to discontinue treatment|0|||
127710934|NCT03498521|459570757|FG000|Overall Study|Death|191|||
127710935|NCT03498521|459570758|FG001|Overall Study|Death|64|||
127710936|NCT03498521|459570759|FG002|Overall Study|Death|72|||
127710937|NCT03498521|459570757|FG000|Overall Study|Exclusion criteria|1|||
127710938|NCT03498521|459570758|FG001|Overall Study|Exclusion criteria|0|||
127710939|NCT03498521|459570759|FG002|Overall Study|Exclusion criteria|0|||
127801328|NCT03891901|459895016|FG008|Overall Study|Adverse Event|0|||
127801329|NCT03891901|459895008|FG000|Overall Study|Poor venous access|1|||
127801330|NCT03891901|459895009|FG001|Overall Study|Poor venous access|0|||
127710940|NCT03498521|459570757|FG000|Overall Study|Lost to Follow-up|3|||
127710941|NCT03498521|459570758|FG001|Overall Study|Lost to Follow-up|3|||
127710942|NCT03498521|459570759|FG002|Overall Study|Lost to Follow-up|3|||
127710943|NCT03498521|459570757|FG000|Overall Study|No profile due to technical failure|1|||
127710944|NCT03498521|459570758|FG001|Overall Study|No profile due to technical failure|0|||
127710945|NCT03498521|459570759|FG002|Overall Study|No profile due to technical failure|0|||
127710946|NCT03498521|459570757|FG000|Overall Study|Physician Decision|0|||
127710947|NCT03498521|459570758|FG001|Overall Study|Physician Decision|1|||
127710948|NCT03498521|459570759|FG002|Overall Study|Physician Decision|0|||
127710949|NCT03498521|459570757|FG000|Overall Study|Withdrawal by Subject|9|||
127710950|NCT03498521|459570758|FG001|Overall Study|Withdrawal by Subject|6|||
127710951|NCT03498521|459570759|FG002|Overall Study|Withdrawal by Subject|2|||
127710952|NCT03498521|459570757|FG000|Overall Study|Study ongoing|121|||
127710953|NCT03498521|459570758|FG001|Overall Study|Study ongoing|36|||
127710954|NCT03498521|459570759|FG002|Overall Study|Study ongoing|15|||
127710955|NCT05830799|459570761|FG000|Overall Study|Withdrawal by Subject|1|||
127710956|NCT04214834|459570762|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|4|||
127710957|NCT04214834|459570763|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
127710958|NCT03370913|459570768|FG000|Overall Study|Death|1|||
127710959|NCT03370913|459570768|FG000|Overall Study|Lost to Follow-up|1|||
127710960|NCT04633538|459570769|FG000|Overall Study|Death|1|||
127710961|NCT04633538|459570769|FG000|Overall Study|Lost to Follow-up|3|||
127710962|NCT04633538|459570769|FG000|Overall Study|Withdrawal by Subject|1|||
127710963|NCT04631016|459570774|FG000|Overall Study|Adverse Event|3|||
127710964|NCT04631016|459570775|FG001|Overall Study|Adverse Event|0|||
127710965|NCT04631016|459570774|FG000|Overall Study|Withdrawal by Subject|5|||
127710966|NCT04631016|459570775|FG001|Overall Study|Withdrawal by Subject|4|||
127710967|NCT04631016|459570774|FG000|Overall Study|Reason unspecified|1|||
127710968|NCT04631016|459570775|FG001|Overall Study|Reason unspecified|0|||
127710969|NCT04631016|459570774|FG000|Overall Study|Failure to meet randomization criteria|2|||
127710970|NCT04631016|459570775|FG001|Overall Study|Failure to meet randomization criteria|1|||
127710971|NCT04496752|459570776|FG000|Second Assessment|Lost to Follow-up|3|||
127801331|NCT03891901|459895010|FG002|Overall Study|Poor venous access|0|||
127801332|NCT03891901|459895011|FG003|Overall Study|Poor venous access|0|||
127801333|NCT03891901|459895012|FG004|Overall Study|Poor venous access|0|||
127888404|NCT00738920|460214023|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
127888405|NCT00738920|460214024|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
127888406|NCT00738920|460214025|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
127888407|NCT00738920|460214023|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
127888408|NCT00738920|460214024|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
127710972|NCT04496752|459570777|FG001|Second Assessment|Lost to Follow-up|3|||
127710973|NCT04496752|459570776|FG000|Second Assessment|Adverse Event|2|||
127710974|NCT04496752|459570777|FG001|Second Assessment|Adverse Event|0|||
127710975|NCT04967599|459570780|FG000|Overall Study|Lost to Follow-up|35|||
127710976|NCT04967599|459570781|FG001|Overall Study|Lost to Follow-up|19|||
127710977|NCT04967599|459570782|FG002|Overall Study|Lost to Follow-up|23|||
127801334|NCT03891901|459895013|FG005|Overall Study|Poor venous access|0|||
127801335|NCT03891901|459895014|FG006|Overall Study|Poor venous access|0|||
127801336|NCT03891901|459895015|FG007|Overall Study|Poor venous access|0|||
127801337|NCT03891901|459895016|FG008|Overall Study|Poor venous access|0|||
127801338|NCT03891901|459895008|FG000|Overall Study|Withdrawal by Subject|0|||
127801339|NCT03891901|459895009|FG001|Overall Study|Withdrawal by Subject|2|||
127888409|NCT00738920|460214025|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
127888410|NCT00738920|460214023|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
127888411|NCT00738920|460214024|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
127888412|NCT00738920|460214025|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
127888413|NCT00738920|460214023|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
127888414|NCT00738920|460214024|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
127888415|NCT00738920|460214025|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
127888416|NCT00738920|460214023|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
127710978|NCT04369911|459570783|FG000|Overall Study|Lost to Follow-up|3|||
127710979|NCT04369911|459570784|FG001|Overall Study|Lost to Follow-up|3|||
127710980|NCT04369911|459570783|FG000|Overall Study|Withdrawal by Subject|1|||
127710981|NCT04369911|459570784|FG001|Overall Study|Withdrawal by Subject|2|||
127710982|NCT05123027|459570790|FG000|Overall Study|Lost to Follow-up|17|||
127888417|NCT00738920|460214024|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
127888418|NCT00738920|460214025|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
127888419|NCT00738920|460214023|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
127888420|NCT00738920|460214024|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
127888421|NCT00738920|460214025|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
127888422|NCT01025193|460214026|FG000|Overall Study|Protocol Violation|1|||
127710983|NCT05123027|459570791|FG001|Overall Study|Lost to Follow-up|22|||
127710984|NCT05123027|459570790|FG000|Overall Study|Incarceration|3|||
127710985|NCT05123027|459570791|FG001|Overall Study|Incarceration|4|||
127710986|NCT05123027|459570790|FG000|Overall Study|Death|2|||
127710987|NCT05123027|459570791|FG001|Overall Study|Death|2|||
127710988|NCT05123027|459570790|FG000|Overall Study|Other|2|||
127710989|NCT05123027|459570791|FG001|Overall Study|Other|0|||
127710990|NCT05541484|459570801|FG000|Overall Study|Withdrawal by Subject|1|||
127710991|NCT05541484|459570802|FG001|Overall Study|Withdrawal by Subject|0|||
127710992|NCT03884439|459570807|FG000|Overall Study|No informed consent for publication of study results|38|||
127710993|NCT03884439|459570807|FG000|Overall Study|Contract violation/deficiency|7|||
127710994|NCT02624050|459570808|FG000|Overall Study|Physician Decision|4|||
127710995|NCT02624050|459570809|FG001|Overall Study|Physician Decision|0|||
127710996|NCT02624050|459570808|FG000|Overall Study|Protocol Violation|2|||
127710997|NCT02624050|459570809|FG001|Overall Study|Protocol Violation|0|||
127710998|NCT03904576|459570810|FG000|Washout Period|Protocol Violation|1|||
127710999|NCT03904576|459570811|FG001|Washout Period|Protocol Violation|1|||
127711000|NCT05215054|459570812|FG000|Overall Study|Lost to Follow-up|1|||
127711001|NCT05215054|459570813|FG001|Overall Study|Lost to Follow-up|1|||
127711002|NCT05215054|459570812|FG000|Overall Study|Protocol Violation|1|||
127711003|NCT05215054|459570813|FG001|Overall Study|Protocol Violation|1|||
127711004|NCT05215054|459570812|FG000|Overall Study|Withdrawal by Subject|4|||
127711005|NCT05215054|459570813|FG001|Overall Study|Withdrawal by Subject|4|||
127711006|NCT01756300|459570814|FG000|Overall Study|Death|1|||
127711007|NCT01756300|459570814|FG000|Overall Study|Withdrawal by Subject|1|||
127711008|NCT06262347|459571361|FG000|Overall Study|Lost to Follow-up|4|||
127711009|NCT06262347|459571362|FG001|Overall Study|Lost to Follow-up|3|||
127711010|NCT06262347|459571361|FG000|Overall Study|Withdrawal by Subject|0|||
127711011|NCT06262347|459571362|FG001|Overall Study|Withdrawal by Subject|1|||
127711012|NCT02163694|459571365|FG000|Overall Study|Adverse event- related to progression|4|||
127711013|NCT02163694|459571366|FG001|Overall Study|Adverse event- related to progression|10|||
127711014|NCT02163694|459571365|FG000|Overall Study|Adverse event- not related to progression|7|||
127711015|NCT02163694|459571366|FG001|Overall Study|Adverse event- not related to progression|22|||
127711016|NCT02163694|459571365|FG000|Overall Study|Withdrew consent|13|||
127711017|NCT02163694|459571366|FG001|Overall Study|Withdrew consent|28|||
127711018|NCT02163694|459571365|FG000|Overall Study|Lost to Follow-up|2|||
127711019|NCT02163694|459571366|FG001|Overall Study|Lost to Follow-up|2|||
127711020|NCT02163694|459571365|FG000|Overall Study|Sponsor discontinued study|3|||
127711021|NCT02163694|459571366|FG001|Overall Study|Sponsor discontinued study|29|||
127711022|NCT02163694|459571365|FG000|Overall Study|Progressive disease per protocol|125|||
127711023|NCT02163694|459571366|FG001|Overall Study|Progressive disease per protocol|224|||
127711024|NCT02163694|459571365|FG000|Overall Study|Other, not specified|17|||
127711025|NCT02163694|459571366|FG001|Overall Study|Other, not specified|22|||
127711026|NCT02163694|459571365|FG000|Overall Study|Randomized but Not Treated|1|||
127711027|NCT02163694|459571366|FG001|Overall Study|Randomized but Not Treated|0|||
127711028|NCT02163694|459571365|FG000|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
127711029|NCT02163694|459571366|FG001|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
127711030|NCT04560179|459571369|FG000|Overall Study|Physician Decision|1|||
127711031|NCT04560179|459571370|FG001|Overall Study|Physician Decision|0|||
127711032|NCT04560179|459571371|FG002|Overall Study|Physician Decision|0|||
127711033|NCT04560179|459571372|FG003|Overall Study|Physician Decision|0|||
127711034|NCT04560179|459571373|FG004|Overall Study|Physician Decision|0|||
127711035|NCT04560179|459571369|FG000|Overall Study|Adverse Event|0|||
127711036|NCT04560179|459571370|FG001|Overall Study|Adverse Event|0|||
127711037|NCT04560179|459571371|FG002|Overall Study|Adverse Event|0|||
127711038|NCT04560179|459571372|FG003|Overall Study|Adverse Event|1|||
127711039|NCT04560179|459571373|FG004|Overall Study|Adverse Event|0|||
127711040|NCT06010836|459571374|FG000|Overall Study|Lost to Follow-up|2|||
127888423|NCT01025193|460214026|FG000|Overall Study|Adverse Event|3|||
127711041|NCT06010836|459571375|FG001|Overall Study|Lost to Follow-up|2|||
127711042|NCT06010836|459571374|FG000|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|8|||
127711043|NCT06010836|459571375|FG001|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|2|||
127711044|NCT06010836|459571374|FG000|Overall Study|Poor or absent audio recording for data collection|1|||
127711045|NCT06010836|459571375|FG001|Overall Study|Poor or absent audio recording for data collection|4|||
127711046|NCT06010836|459571374|FG000|Overall Study|Did not receive intervention discussion|0|||
127711047|NCT06010836|459571375|FG001|Overall Study|Did not receive intervention discussion|4|||
127711048|NCT04524689|459571376|FG000|Overall Study|Withdrawal by Subject|1|||
127711049|NCT04524689|459571377|FG001|Overall Study|Withdrawal by Subject|1|||
127711050|NCT04524689|459571378|FG002|Overall Study|Withdrawal by Subject|0|||
127711051|NCT04524689|459571379|FG003|Overall Study|Withdrawal by Subject|0|||
127711052|NCT04524689|459571380|FG004|Overall Study|Withdrawal by Subject|1|||
127711053|NCT04524689|459571381|FG005|Overall Study|Withdrawal by Subject|0|||
127711054|NCT04524689|459571376|FG000|Overall Study|Not related to Coronavirus disease 2019|2|||
127711055|NCT04524689|459571377|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
127711056|NCT04524689|459571378|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
127711057|NCT04524689|459571379|FG003|Overall Study|Not related to Coronavirus disease 2019|0|||
127711058|NCT04524689|459571380|FG004|Overall Study|Not related to Coronavirus disease 2019|0|||
127711059|NCT04524689|459571381|FG005|Overall Study|Not related to Coronavirus disease 2019|0|||
127711060|NCT04524689|459571376|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|12|||
127711061|NCT04524689|459571377|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|0|||
127711062|NCT04524689|459571378|FG002|Overall Study|Ongoing study treatment at the time of primary analysis|1|||
127711063|NCT04524689|459571379|FG003|Overall Study|Ongoing study treatment at the time of primary analysis|0|||
127711064|NCT04524689|459571380|FG004|Overall Study|Ongoing study treatment at the time of primary analysis|5|||
127711065|NCT04524689|459571381|FG005|Overall Study|Ongoing study treatment at the time of primary analysis|1|||
127711066|NCT05451693|459571382|FG000|Overall Study|Withdrawal by Subject|1|||
127711067|NCT05451693|459571383|FG001|Overall Study|Withdrawal by Subject|1|||
127711068|NCT04490109|459571394|FG000|Overall Study|Lost to Follow-up|3|||
127711069|NCT04490109|459571395|FG001|Overall Study|Lost to Follow-up|10|||
127711070|NCT04490109|459571396|FG002|Overall Study|Lost to Follow-up|4|||
127711071|NCT04490109|459571394|FG000|Overall Study|Withdrawal by Subject|8|||
127711072|NCT04490109|459571395|FG001|Overall Study|Withdrawal by Subject|6|||
127711073|NCT04490109|459571396|FG002|Overall Study|Withdrawal by Subject|9|||
127711074|NCT04490109|459571394|FG000|Overall Study|Physician Decision|0|||
127711075|NCT04490109|459571395|FG001|Overall Study|Physician Decision|2|||
127711076|NCT04490109|459571396|FG002|Overall Study|Physician Decision|3|||
127711077|NCT04490109|459571394|FG000|Overall Study|Adverse Event|2|||
127711078|NCT04490109|459571395|FG001|Overall Study|Adverse Event|1|||
127711079|NCT04490109|459571396|FG002|Overall Study|Adverse Event|0|||
127711080|NCT04490109|459571394|FG000|Overall Study|Significant Non-Compliance|2|||
127711081|NCT04490109|459571395|FG001|Overall Study|Significant Non-Compliance|4|||
127711082|NCT04490109|459571396|FG002|Overall Study|Significant Non-Compliance|4|||
127711083|NCT04490109|459571394|FG000|Overall Study|Significant Clinical Event|0|||
127711084|NCT04490109|459571395|FG001|Overall Study|Significant Clinical Event|1|||
127711085|NCT04490109|459571396|FG002|Overall Study|Significant Clinical Event|0|||
127711086|NCT04490109|459571394|FG000|Overall Study|Other Reason|4|||
127711087|NCT04490109|459571395|FG001|Overall Study|Other Reason|1|||
127711088|NCT04490109|459571396|FG002|Overall Study|Other Reason|1|||
127711089|NCT03817983|459571399|FG000|ProSpA-CD Assess Phase|MRI not performed|0|||
127711090|NCT03817983|459571400|FG001|ProSpA-CD Assess Phase|MRI not performed|0|||
127711091|NCT03817983|459571401|FG002|ProSpA-CD Assess Phase|MRI not performed|7|||
127711092|NCT03744676|459571402|FG000|Pre-Treatment Phase|Disease related complications|2|||
127711093|NCT03744676|459571402|FG000|Pre-Treatment Phase|No longer meets study criteria|4|||
127711094|NCT03744676|459571402|FG000|Pre-Treatment Phase|Death|7|||
127711095|NCT03744676|459571402|FG000|Pre-Treatment Phase|Other Reasons|7|||
127711096|NCT03744676|459571402|FG000|Treatment Phase|Participant withdrew consent|8|||
127711097|NCT03744676|459571402|FG000|Treatment Phase|Death|33|||
127711098|NCT03744676|459571402|FG000|Treatment Phase|other reasons|6|||
127711099|NCT03533257|459571412|FG000|Overall Study|Adverse Event|4|||
127711100|NCT03533257|459571413|FG001|Overall Study|Adverse Event|2|||
127711101|NCT03533257|459571412|FG000|Overall Study|Enrolled in other study, terminated by Sponsor, other|6|||
127711102|NCT03533257|459571413|FG001|Overall Study|Enrolled in other study, terminated by Sponsor, other|0|||
127711103|NCT04780581|459571414|FG000|Full Modified Intention-to-treat Anal.|Protocol Violation|1|||
127711104|NCT04780581|459571415|FG001|Full Modified Intention-to-treat Anal.|Protocol Violation|2|||
127711105|NCT04780581|459571414|FG000|Overall Study (90 Days)|Lost to Follow-up|0|||
127711106|NCT04780581|459571415|FG001|Overall Study (90 Days)|Lost to Follow-up|2|||
127711107|NCT01651000|459571416|FG000|Overall Study|Adverse Event|2|||
127711108|NCT01651000|459571417|FG001|Overall Study|Adverse Event|8|||
127711109|NCT01651000|459571416|FG000|Overall Study|Lost to Follow-up|3|||
127711110|NCT01651000|459571417|FG001|Overall Study|Lost to Follow-up|2|||
127711111|NCT01651000|459571416|FG000|Overall Study|Protocol Violation|0|||
127711112|NCT01651000|459571417|FG001|Overall Study|Protocol Violation|3|||
127711113|NCT01651000|459571416|FG000|Overall Study|Withdrawal by Subject|2|||
127711114|NCT01651000|459571417|FG001|Overall Study|Withdrawal by Subject|10|||
127711115|NCT01651000|459571416|FG000|Overall Study|Subject noncompliance|0|||
127711116|NCT01651000|459571417|FG001|Overall Study|Subject noncompliance|3|||
127711117|NCT01651000|459571416|FG000|Overall Study|Lack of Efficacy|1|||
127711118|NCT01651000|459571417|FG001|Overall Study|Lack of Efficacy|1|||
127711119|NCT01651000|459571416|FG000|Overall Study|Physician Decision|1|||
127711120|NCT01651000|459571417|FG001|Overall Study|Physician Decision|0|||
127711121|NCT01651000|459571416|FG000|Overall Study|Administrative reason|1|||
127711122|NCT01651000|459571417|FG001|Overall Study|Administrative reason|0|||
127888424|NCT04079842|460214027|FG000|Overall Study|Request of subject|2|||
127801340|NCT03891901|459895010|FG002|Overall Study|Withdrawal by Subject|0|||
127801341|NCT03891901|459895011|FG003|Overall Study|Withdrawal by Subject|0|||
127801342|NCT03891901|459895012|FG004|Overall Study|Withdrawal by Subject|0|||
127801343|NCT03891901|459895013|FG005|Overall Study|Withdrawal by Subject|0|||
127801344|NCT03891901|459895014|FG006|Overall Study|Withdrawal by Subject|0|||
127801345|NCT03891901|459895015|FG007|Overall Study|Withdrawal by Subject|0|||
127801346|NCT03891901|459895016|FG008|Overall Study|Withdrawal by Subject|0|||
127801347|NCT02026063|459895022|FG000|Overall Study|Physician Decision|0|||
127801348|NCT02026063|459895023|FG001|Overall Study|Physician Decision|10|||
127801349|NCT02026063|459895022|FG000|Overall Study|Noncompliance with Study Drug|1|||
127801350|NCT02026063|459895023|FG001|Overall Study|Noncompliance with Study Drug|1|||
127801351|NCT02026063|459895022|FG000|Overall Study|Withdrawal of Consent|1|||
127801352|NCT02026063|459895023|FG001|Overall Study|Withdrawal of Consent|6|||
127801353|NCT02026063|459895022|FG000|Overall Study|Adverse Event|5|||
127801354|NCT02026063|459895023|FG001|Overall Study|Adverse Event|20|||
127801355|NCT02026063|459895022|FG000|Overall Study|Lack of Efficacy|0|||
127801356|NCT02026063|459895023|FG001|Overall Study|Lack of Efficacy|4|||
127801357|NCT02026063|459895022|FG000|Overall Study|Lost to Follow-up|0|||
127801358|NCT02026063|459895023|FG001|Overall Study|Lost to Follow-up|1|||
127801359|NCT02026063|459895022|FG000|Overall Study|Reason not Specified|2|||
127801360|NCT02026063|459895023|FG001|Overall Study|Reason not Specified|7|||
127801361|NCT02154087|459895024|FG000|Overall Study|Study Termination|1|||
127801362|NCT01116544|459895026|FG000|Overall Study|Protocol Violation|1|||
127801363|NCT01116544|459895027|FG001|Overall Study|Protocol Violation|0|||
127801364|NCT01116544|459895026|FG000|Overall Study|Withdrawal by Subject|1|||
127801365|NCT01116544|459895027|FG001|Overall Study|Withdrawal by Subject|1|||
127801366|NCT00486278|459895028|FG000|Overall Study|Adverse Event|5|||
127801367|NCT00486278|459895028|FG000|Overall Study|Withdrawal by Subject|2|||
127801368|NCT00486278|459895028|FG000|Overall Study|Physician Decision|2|||
127801369|NCT02183519|459895029|FG000|Overall Study|computer error|3|||
127801370|NCT02183519|459895030|FG001|Overall Study|computer error|0|||
127801371|NCT02183519|459895029|FG000|Overall Study|Did not respond to cough inducter|0|||
127801372|NCT02183519|459895030|FG001|Overall Study|Did not respond to cough inducter|3|||
127801373|NCT00803179|459895033|FG000|Overall Study|Lost to Follow-up|3|||
127888425|NCT04079842|460214027|FG000|Overall Study|Unable to draw Arterial samples|1|||
127888426|NCT02904200|460214028|FG000|Overall Study|Withdrawal by Subject|1|||
127888427|NCT02904200|460214029|FG001|Overall Study|Withdrawal by Subject|0|||
127888428|NCT00185211|460214030|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
127888429|NCT00185211|460214031|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
127888430|NCT00185211|460214030|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
127888431|NCT00185211|460214031|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
127888432|NCT00185211|460214030|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
127888433|NCT00185211|460214031|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
127888434|NCT00185211|460214030|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
127711123|NCT01651000|459571416|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
127711124|NCT01651000|459571417|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
127711125|NCT02765412|459571418|FG000|Overall Study|Death|482|||
127711126|NCT02765412|459571419|FG001|Overall Study|Death|855|||
127711127|NCT04244175|459572578|FG000|Overall Study|Adverse Event|3|||
127711128|NCT04244175|459572579|FG001|Overall Study|Adverse Event|2|||
127711129|NCT04244175|459572580|FG002|Overall Study|Adverse Event|5|||
127711130|NCT04244175|459572578|FG000|Overall Study|Lack of Efficacy|1|||
127711131|NCT04244175|459572579|FG001|Overall Study|Lack of Efficacy|0|||
127711132|NCT04244175|459572580|FG002|Overall Study|Lack of Efficacy|1|||
127711133|NCT04244175|459572578|FG000|Overall Study|Lost to Follow-up|1|||
127711134|NCT04244175|459572579|FG001|Overall Study|Lost to Follow-up|0|||
127711135|NCT04244175|459572580|FG002|Overall Study|Lost to Follow-up|0|||
127711136|NCT04244175|459572578|FG000|Overall Study|Non-compliance with study drug|1|||
127711137|NCT04244175|459572579|FG001|Overall Study|Non-compliance with study drug|0|||
127711138|NCT04244175|459572580|FG002|Overall Study|Non-compliance with study drug|1|||
127711139|NCT04244175|459572578|FG000|Overall Study|Protocol deviation|0|||
127711140|NCT04244175|459572579|FG001|Overall Study|Protocol deviation|1|||
127801374|NCT02419508|459895034|FG000|Overall Study|Adverse Event|9|||
127976280|NCT00325156|460533170|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
127976281|NCT00325156|460533170|FG000|Overall Study|Other|1|||
127801375|NCT02419508|459895035|FG001|Overall Study|Adverse Event|3|||
127801376|NCT02419508|459895034|FG000|Overall Study|Withdrawal by Subject|1|||
127801377|NCT02419508|459895035|FG001|Overall Study|Withdrawal by Subject|0|||
127801378|NCT02419508|459895034|FG000|Overall Study|Other - Reason not specified|0|||
127801379|NCT02419508|459895035|FG001|Overall Study|Other - Reason not specified|1|||
127976282|NCT00325156|460533170|FG000|Overall Study|Withdrawal by Subject|31|||
127711141|NCT04244175|459572580|FG002|Overall Study|Protocol deviation|0|||
127976283|NCT03395184|460533173|FG000|Induction Period (Up to 12 Weeks)|Adverse Event|6|||
127976284|NCT03395184|460533174|FG001|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
127976285|NCT03395184|460533175|FG002|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
127711142|NCT04244175|459572578|FG000|Overall Study|Withdrawal by Subject|1|||
127711143|NCT04244175|459572579|FG001|Overall Study|Withdrawal by Subject|3|||
127711144|NCT04244175|459572580|FG002|Overall Study|Withdrawal by Subject|1|||
127711145|NCT04244175|459572578|FG000|Overall Study|Other, not specified|0|||
127711146|NCT04244175|459572579|FG001|Overall Study|Other, not specified|1|||
127711147|NCT04244175|459572580|FG002|Overall Study|Other, not specified|2|||
127711148|NCT04595331|459572581|FG000|Overall Study|Withdrawal by Subject|0|||
127711149|NCT04595331|459572582|FG001|Overall Study|Withdrawal by Subject|1|||
127711150|NCT04595331|459572581|FG000|Overall Study|Lost to Follow-up|0|||
127711151|NCT04595331|459572582|FG001|Overall Study|Lost to Follow-up|5|||
127711152|NCT04595331|459572581|FG000|Overall Study|Medical reason|0|||
127711153|NCT04595331|459572582|FG001|Overall Study|Medical reason|1|||
127711154|NCT03781089|459572583|FG000|Overall Study|Constipation|1|||
127711155|NCT03781089|459572584|FG001|Overall Study|Constipation|0|||
127711156|NCT03781089|459572583|FG000|Overall Study|Positive pregnancy test|0|||
127711157|NCT03781089|459572584|FG001|Overall Study|Positive pregnancy test|1|||
127711158|NCT05311176|459572585|FG000|Overall Study|Death|6|||
127711159|NCT05311176|459572585|FG000|Overall Study|Sponsor discontinued the study|1|||
127711160|NCT03662022|459572588|FG000|Year 1 2019|prevalent case|83|||
127711161|NCT03662022|459572589|FG001|Year 1 2019|prevalent case|116|||
127711162|NCT03662022|459572590|FG002|Year 1 2019|prevalent case|158|||
127711163|NCT03662022|459572591|FG003|Year 1 2019|prevalent case|99|||
127711164|NCT03662022|459572588|FG000|Year 2 2020|incident case|18|||
127711165|NCT03662022|459572589|FG001|Year 2 2020|incident case|18|||
127711166|NCT03662022|459572590|FG002|Year 2 2020|incident case|16|||
127711167|NCT03662022|459572591|FG003|Year 2 2020|incident case|26|||
127711168|NCT03662022|459572588|FG000|Year 2 2020|other case|18|||
127711169|NCT03662022|459572589|FG001|Year 2 2020|other case|16|||
127711170|NCT03662022|459572590|FG002|Year 2 2020|other case|16|||
127711171|NCT03662022|459572591|FG003|Year 2 2020|other case|24|||
127711172|NCT03662022|459572588|FG000|Year 2 2020|Lost to Follow-up|1633|||
127711173|NCT03662022|459572589|FG001|Year 2 2020|Lost to Follow-up|1183|||
127711174|NCT03662022|459572590|FG002|Year 2 2020|Lost to Follow-up|1381|||
127711175|NCT03662022|459572591|FG003|Year 2 2020|Lost to Follow-up|2858|||
127711176|NCT03662022|459572588|FG000|Year 3 2021|incident case|24|||
127711177|NCT03662022|459572589|FG001|Year 3 2021|incident case|27|||
127711178|NCT03662022|459572590|FG002|Year 3 2021|incident case|24|||
127711179|NCT03662022|459572591|FG003|Year 3 2021|incident case|11|||
127711180|NCT03662022|459572588|FG000|Year 3 2021|other case|4|||
127711181|NCT03662022|459572589|FG001|Year 3 2021|other case|15|||
127711182|NCT03662022|459572590|FG002|Year 3 2021|other case|10|||
127711183|NCT03662022|459572591|FG003|Year 3 2021|other case|14|||
127711184|NCT03662022|459572588|FG000|Year 3 2021|Lost to Follow-up|179|||
127711185|NCT03662022|459572589|FG001|Year 3 2021|Lost to Follow-up|244|||
127711186|NCT03662022|459572590|FG002|Year 3 2021|Lost to Follow-up|480|||
127711187|NCT03662022|459572591|FG003|Year 3 2021|Lost to Follow-up|477|||
127711188|NCT03662022|459572588|FG000|Year 4 2022|incident case|25|||
127711189|NCT03662022|459572589|FG001|Year 4 2022|incident case|41|||
127711190|NCT03662022|459572590|FG002|Year 4 2022|incident case|28|||
127711191|NCT03662022|459572591|FG003|Year 4 2022|incident case|7|||
127711192|NCT03662022|459572588|FG000|Year 4 2022|other case|8|||
127711193|NCT03662022|459572589|FG001|Year 4 2022|other case|19|||
127711194|NCT03662022|459572590|FG002|Year 4 2022|other case|13|||
127711195|NCT03662022|459572591|FG003|Year 4 2022|other case|7|||
127711196|NCT03662022|459572588|FG000|Year 4 2022|Lost to Follow-up|986|||
127711197|NCT03662022|459572589|FG001|Year 4 2022|Lost to Follow-up|1079|||
127711198|NCT03662022|459572590|FG002|Year 4 2022|Lost to Follow-up|1236|||
127711199|NCT03662022|459572591|FG003|Year 4 2022|Lost to Follow-up|1826|||
127711200|NCT05836012|459572592|FG000|Overall Study|Lost to Follow-up|1|||
127711201|NCT05836012|459572593|FG001|Overall Study|Lost to Follow-up|0|||
127711202|NCT05836012|459572592|FG000|Overall Study|Withdrawal by Subject|1|||
127711203|NCT05836012|459572593|FG001|Overall Study|Withdrawal by Subject|3|||
127711204|NCT05836012|459572592|FG000|Overall Study|Reason not included in pre-specified categories|2|||
127711205|NCT05836012|459572593|FG001|Overall Study|Reason not included in pre-specified categories|1|||
127801380|NCT03110900|459895036|FG000|Overall Study|Sponsor withdrew|1|||
127711206|NCT05454514|459572597|FG000|Overall Study|Withdrawal by Subject|4|||
127711207|NCT03547271|459572598|FG000|Overall Study|Adverse Event|1|||
127711208|NCT03547271|459572599|FG001|Overall Study|Adverse Event|1|||
127711209|NCT03547271|459572600|FG002|Overall Study|Adverse Event|0|||
127711210|NCT03547271|459572601|FG003|Overall Study|Adverse Event|0|||
127711211|NCT03547271|459572598|FG000|Overall Study|Protocol deviation|5|||
127711212|NCT03547271|459572599|FG001|Overall Study|Protocol deviation|7|||
127711213|NCT03547271|459572600|FG002|Overall Study|Protocol deviation|3|||
127711214|NCT03547271|459572601|FG003|Overall Study|Protocol deviation|0|||
127801381|NCT03110900|459895037|FG001|Overall Study|Sponsor withdrew|1|||
127711215|NCT03547271|459572598|FG000|Overall Study|Withdrawal by Parent/Guardian|24|||
127711216|NCT03547271|459572599|FG001|Overall Study|Withdrawal by Parent/Guardian|24|||
127711217|NCT03547271|459572600|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
127711218|NCT03547271|459572601|FG003|Overall Study|Withdrawal by Parent/Guardian|4|||
127711219|NCT03547271|459572598|FG000|Overall Study|Lost to Follow-up|3|||
127711220|NCT03547271|459572599|FG001|Overall Study|Lost to Follow-up|3|||
127711221|NCT03547271|459572600|FG002|Overall Study|Lost to Follow-up|1|||
127801382|NCT02320487|459895048|FG000|Overall Study|Reason not Specified|1|||
127801383|NCT02320487|459895048|FG000|Overall Study|Physician Decision|5|||
127801384|NCT02320487|459895048|FG000|Overall Study|Withdrawal by Subject|1|||
127801385|NCT02320487|459895048|FG000|Overall Study|Death|3|||
127801386|NCT02320487|459895048|FG000|Overall Study|Adverse Event|11|||
127801387|NCT00684957|459895055|FG000|Overall Study|Withdrawal by Subject|1|||
127801388|NCT00684957|459895056|FG001|Overall Study|Withdrawal by Subject|1|||
127801389|NCT00684957|459895055|FG000|Overall Study|Lost to Follow-up|1|||
127801390|NCT00684957|459895056|FG001|Overall Study|Lost to Follow-up|0|||
127801391|NCT04484285|459896896|FG000|Overall Study|Unable to operate stimulator|3|||
127801392|NCT04484285|459896897|FG001|Overall Study|Unable to operate stimulator|0|||
127801393|NCT04439175|459896899|FG000|Overall Study|Never started treatment|4|||
127801394|NCT04439175|459896899|FG000|Overall Study|Ineligible|5|||
127801395|NCT04439175|459896899|FG000|Overall Study|Adverse Event|6|||
127801396|NCT04439175|459896899|FG000|Overall Study|Death|4|||
127801397|NCT04439175|459896899|FG000|Overall Study|Disease progression|44|||
127801398|NCT04439175|459896899|FG000|Overall Study|Withdrawal by Subject|4|||
127801399|NCT04439175|459896899|FG000|Overall Study|Alternative Therapy|1|||
127801400|NCT04439175|459896899|FG000|Overall Study|Other|2|||
127801401|NCT02554929|459896900|FG000|Overall Study|Lost to Follow-up|4|||
127801402|NCT02554929|459896901|FG001|Overall Study|Lost to Follow-up|4|||
127801403|NCT02554929|459896900|FG000|Overall Study|Withdrawal by Subject|2|||
127801404|NCT02554929|459896901|FG001|Overall Study|Withdrawal by Subject|8|||
127801405|NCT00546364|459896902|FG000|Overall Study|Disease progression|5|||
127801406|NCT00546364|459896903|FG001|Overall Study|Disease progression|11|||
127801407|NCT00546364|459896904|FG002|Overall Study|Disease progression|8|||
127801408|NCT00546364|459896902|FG000|Overall Study|Completed and off treatment|1|||
127801409|NCT00546364|459896903|FG001|Overall Study|Completed and off treatment|0|||
127801410|NCT00546364|459896904|FG002|Overall Study|Completed and off treatment|2|||
127801411|NCT00546364|459896902|FG000|Overall Study|Administrative reason by sponsor|1|||
127801412|NCT00546364|459896903|FG001|Overall Study|Administrative reason by sponsor|0|||
127801413|NCT00546364|459896904|FG002|Overall Study|Administrative reason by sponsor|0|||
127801414|NCT00546364|459896902|FG000|Overall Study|Poor compliance/noncompliance|0|||
127801415|NCT00546364|459896903|FG001|Overall Study|Poor compliance/noncompliance|0|||
127801416|NCT00546364|459896904|FG002|Overall Study|Poor compliance/noncompliance|1|||
127888435|NCT00185211|460214031|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
127711222|NCT03547271|459572601|FG003|Overall Study|Lost to Follow-up|0|||
127711223|NCT06065735|459572606|FG000|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|2|||
127711224|NCT06065735|459572607|FG001|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
127711225|NCT06065735|459572608|FG002|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
127711226|NCT06065735|459572606|FG000|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|2|||
127711227|NCT06065735|459572607|FG001|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
127711228|NCT06065735|459572608|FG002|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
127711229|NCT06065735|459572606|FG000|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|1|||
127711230|NCT06065735|459572607|FG001|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
127711231|NCT06065735|459572608|FG002|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
127711232|NCT06065735|459572606|FG000|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
127711233|NCT06065735|459572607|FG001|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|1|||
127711234|NCT06065735|459572608|FG002|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
127711235|NCT06065735|459572606|FG000|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
127711236|NCT06065735|459572607|FG001|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
127711237|NCT06065735|459572608|FG002|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|1|||
127711238|NCT02532621|459572609|FG000|Overall Study|Death|3|||
127711239|NCT02532621|459572609|FG000|Overall Study|Lost to Follow-up|3|||
127711240|NCT02532621|459572609|FG000|Overall Study|Withdrawal by Subject|6|||
127888436|NCT00185211|460214030|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
127888437|NCT00185211|460214031|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
127888438|NCT00185211|460214030|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
127888439|NCT00185211|460214031|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
127888440|NCT00185211|460214030|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
127711241|NCT02532621|459572609|FG000|Overall Study|implanted graft abandoned before 6 months|12|||
127801417|NCT00546364|459896902|FG000|Overall Study|No longer meets study criteria|1|||
127801418|NCT00546364|459896903|FG001|Overall Study|No longer meets study criteria|1|||
127801419|NCT00546364|459896904|FG002|Overall Study|No longer meets study criteria|0|||
127801420|NCT00546364|459896902|FG000|Overall Study|Withdrawal by Subject|5|||
127801421|NCT00546364|459896903|FG001|Overall Study|Withdrawal by Subject|6|||
127711242|NCT02532621|459572609|FG000|Overall Study|last follow up performed outside window (<166 days) -censored|2|||
127711243|NCT02919917|459572612|FG000|Overall Study|Withdrawal by Subject|4|||
127711244|NCT02919917|459572613|FG001|Overall Study|Withdrawal by Subject|8|||
127711245|NCT03418740|459572614|FG000|Overall Study|Lost to Follow-up|13|||
127711246|NCT03418740|459572614|FG000|Overall Study|Scheduling Issues|7|||
127711247|NCT03418740|459572614|FG000|Overall Study|Withdrawal by Subject|2|||
127711248|NCT03418740|459572614|FG000|Overall Study|Unable to Continue Consent|1|||
127711249|NCT04157517|459572619|FG000|Overall Study|Death|1|||
127711250|NCT04157517|459572620|FG001|Overall Study|Death|2|||
127711251|NCT04157517|459572621|FG002|Overall Study|Death|2|||
127711252|NCT04157517|459572622|FG003|Overall Study|Death|3|||
127711253|NCT04157517|459572623|FG004|Overall Study|Death|3|||
127711254|NCT04157517|459572624|FG005|Overall Study|Death|4|||
127711255|NCT04157517|459572625|FG006|Overall Study|Death|1|||
127711256|NCT04157517|459572626|FG007|Overall Study|Death|2|||
127711257|NCT04157517|459572627|FG008|Overall Study|Death|4|||
127711258|NCT04157517|459572628|FG009|Overall Study|Death|0|||
127711259|NCT04157517|459572619|FG000|Overall Study|Withdrawal by Subject|1|||
127711260|NCT04157517|459572620|FG001|Overall Study|Withdrawal by Subject|1|||
127711261|NCT04157517|459572621|FG002|Overall Study|Withdrawal by Subject|1|||
127711262|NCT04157517|459572622|FG003|Overall Study|Withdrawal by Subject|0|||
127711263|NCT04157517|459572623|FG004|Overall Study|Withdrawal by Subject|0|||
127711264|NCT04157517|459572624|FG005|Overall Study|Withdrawal by Subject|1|||
127711265|NCT04157517|459572625|FG006|Overall Study|Withdrawal by Subject|0|||
127711266|NCT04157517|459572626|FG007|Overall Study|Withdrawal by Subject|0|||
127711267|NCT04157517|459572627|FG008|Overall Study|Withdrawal by Subject|1|||
127711268|NCT04157517|459572628|FG009|Overall Study|Withdrawal by Subject|0|||
127711269|NCT04157517|459572619|FG000|Overall Study|Other|1|||
127711270|NCT04157517|459572620|FG001|Overall Study|Other|0|||
127711271|NCT04157517|459572621|FG002|Overall Study|Other|0|||
127711272|NCT04157517|459572622|FG003|Overall Study|Other|0|||
127711273|NCT04157517|459572623|FG004|Overall Study|Other|0|||
127711274|NCT04157517|459572624|FG005|Overall Study|Other|1|||
127711275|NCT04157517|459572625|FG006|Overall Study|Other|2|||
127711276|NCT04157517|459572626|FG007|Overall Study|Other|7|||
127711277|NCT04157517|459572627|FG008|Overall Study|Other|7|||
127711278|NCT04157517|459572628|FG009|Overall Study|Other|0|||
127801422|NCT00546364|459896904|FG002|Overall Study|Withdrawal by Subject|3|||
127801423|NCT00546364|459896902|FG000|Overall Study|Prior taxotere|1|||
127801424|NCT00546364|459896903|FG001|Overall Study|Prior taxotere|0|||
127801425|NCT00546364|459896904|FG002|Overall Study|Prior taxotere|0|||
127801426|NCT00546364|459896902|FG000|Overall Study|Mixed response|1|||
127801427|NCT00546364|459896903|FG001|Overall Study|Mixed response|0|||
127801428|NCT00546364|459896904|FG002|Overall Study|Mixed response|0|||
127801429|NCT00546364|459896902|FG000|Overall Study|Palliative treatment|1|||
127801430|NCT00546364|459896903|FG001|Overall Study|Palliative treatment|0|||
127801431|NCT00546364|459896904|FG002|Overall Study|Palliative treatment|1|||
127801432|NCT00546364|459896902|FG000|Overall Study|Target lesions resected|1|||
127801433|NCT00546364|459896903|FG001|Overall Study|Target lesions resected|0|||
127801434|NCT00546364|459896904|FG002|Overall Study|Target lesions resected|0|||
127801435|NCT00546364|459896902|FG000|Overall Study|Physician Decision|0|||
127801436|NCT00546364|459896903|FG001|Overall Study|Physician Decision|0|||
127801437|NCT00546364|459896904|FG002|Overall Study|Physician Decision|1|||
127801438|NCT00546364|459896902|FG000|Overall Study|Sponsor decision|0|||
127801439|NCT00546364|459896903|FG001|Overall Study|Sponsor decision|0|||
127711279|NCT02933489|459572629|FG000|Overall Study|Ineligible|3|||
127711280|NCT02933489|459572630|FG001|Overall Study|Ineligible|3|||
127711281|NCT02933489|459572629|FG000|Overall Study|Withdrawal by Subject|27|||
127711282|NCT02933489|459572630|FG001|Overall Study|Withdrawal by Subject|18|||
127711283|NCT02933489|459572629|FG000|Overall Study|Unable to complete exams (other)|14|||
127711284|NCT02933489|459572630|FG001|Overall Study|Unable to complete exams (other)|7|||
127711285|NCT02461134|459572631|FG000|Overall Study|Adverse Event|1|||
127711286|NCT02994927|459572632|FG000|Overall Study|Withdrawal by parent/guardian|0|||
127711287|NCT02994927|459572633|FG001|Overall Study|Withdrawal by parent/guardian|1|||
127711288|NCT02994927|459572632|FG000|Overall Study|Did not meet eligibility criteria|0|||
127711289|NCT02994927|459572633|FG001|Overall Study|Did not meet eligibility criteria|1|||
127801440|NCT00546364|459896904|FG002|Overall Study|Sponsor decision|1|||
127711290|NCT02994927|459572632|FG000|Overall Study|Physician Decision|4|||
127801441|NCT03593915|459896906|FG000|Overall Study|Adverse Event|0|||
127711291|NCT02994927|459572633|FG001|Overall Study|Physician Decision|3|||
127801442|NCT03593915|459896907|FG001|Overall Study|Adverse Event|0|||
127801443|NCT03593915|459896908|FG002|Overall Study|Adverse Event|0|||
127801444|NCT03593915|459896909|FG003|Overall Study|Adverse Event|1|||
127801445|NCT03593915|459896910|FG004|Overall Study|Adverse Event|0|||
127801446|NCT03593915|459896911|FG005|Overall Study|Adverse Event|0|||
127801447|NCT03593915|459896906|FG000|Overall Study|Physician Decision|0|||
127801448|NCT03593915|459896907|FG001|Overall Study|Physician Decision|0|||
127801449|NCT03593915|459896908|FG002|Overall Study|Physician Decision|0|||
127801450|NCT03593915|459896909|FG003|Overall Study|Physician Decision|0|||
127801451|NCT03593915|459896910|FG004|Overall Study|Physician Decision|0|||
127801452|NCT03593915|459896911|FG005|Overall Study|Physician Decision|1|||
127801453|NCT02894840|459896912|FG000|Overall Study|Lost to Follow-up|1|||
127888441|NCT00185211|460214031|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
127888442|NCT00185211|460214030|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
127711292|NCT02994927|459572632|FG000|Overall Study|Death|4|||
127711293|NCT02994927|459572633|FG001|Overall Study|Death|2|||
127711294|NCT02994927|459572632|FG000|Overall Study|Adverse Event|2|||
127711295|NCT02994927|459572633|FG001|Overall Study|Adverse Event|1|||
127711296|NCT02994927|459572632|FG000|Overall Study|Withdrawal by Subject|3|||
127711297|NCT02994927|459572633|FG001|Overall Study|Withdrawal by Subject|6|||
127711298|NCT02994927|459572632|FG000|Overall Study|Lost to Follow-up|2|||
127711299|NCT02994927|459572633|FG001|Overall Study|Lost to Follow-up|1|||
127711300|NCT03250676|459572634|FG000|Overall Study|Adverse Event|0|||
127711301|NCT03250676|459572635|FG001|Overall Study|Adverse Event|0|||
127711302|NCT03250676|459572636|FG002|Overall Study|Adverse Event|0|||
127711303|NCT03250676|459572637|FG003|Overall Study|Adverse Event|1|||
127711304|NCT03250676|459572638|FG004|Overall Study|Adverse Event|2|||
127711305|NCT03250676|459572639|FG005|Overall Study|Adverse Event|9|||
127711306|NCT03250676|459572634|FG000|Overall Study|Withdrawal by Subject|1|||
127711307|NCT03250676|459572635|FG001|Overall Study|Withdrawal by Subject|0|||
127711308|NCT03250676|459572636|FG002|Overall Study|Withdrawal by Subject|0|||
127711309|NCT03250676|459572637|FG003|Overall Study|Withdrawal by Subject|1|||
127711310|NCT03250676|459572638|FG004|Overall Study|Withdrawal by Subject|1|||
127711311|NCT03250676|459572639|FG005|Overall Study|Withdrawal by Subject|2|||
127711312|NCT03250676|459572634|FG000|Overall Study|Physician Decision|0|||
127711313|NCT03250676|459572635|FG001|Overall Study|Physician Decision|0|||
127711314|NCT03250676|459572636|FG002|Overall Study|Physician Decision|0|||
127711315|NCT03250676|459572637|FG003|Overall Study|Physician Decision|2|||
127711316|NCT03250676|459572638|FG004|Overall Study|Physician Decision|0|||
127711317|NCT03250676|459572639|FG005|Overall Study|Physician Decision|3|||
127711318|NCT03250676|459572634|FG000|Overall Study|Withdrawal of consent|0|||
127711319|NCT03250676|459572635|FG001|Overall Study|Withdrawal of consent|0|||
127711320|NCT03250676|459572636|FG002|Overall Study|Withdrawal of consent|2|||
127711321|NCT03250676|459572637|FG003|Overall Study|Withdrawal of consent|0|||
127711322|NCT03250676|459572638|FG004|Overall Study|Withdrawal of consent|0|||
127711323|NCT03250676|459572639|FG005|Overall Study|Withdrawal of consent|2|||
127711324|NCT03250676|459572634|FG000|Overall Study|Other|1|||
127711325|NCT03250676|459572635|FG001|Overall Study|Other|0|||
127711326|NCT03250676|459572636|FG002|Overall Study|Other|0|||
127711327|NCT03250676|459572637|FG003|Overall Study|Other|0|||
127711328|NCT03250676|459572638|FG004|Overall Study|Other|0|||
127711329|NCT03250676|459572639|FG005|Overall Study|Other|0|||
127711330|NCT03250676|459572634|FG000|Overall Study|Disease progression|4|||
127711331|NCT03250676|459572635|FG001|Overall Study|Disease progression|12|||
127711332|NCT03250676|459572636|FG002|Overall Study|Disease progression|9|||
127711333|NCT03250676|459572637|FG003|Overall Study|Disease progression|7|||
127711334|NCT03250676|459572638|FG004|Overall Study|Disease progression|4|||
127711335|NCT03250676|459572639|FG005|Overall Study|Disease progression|88|||
127711336|NCT03587805|459572640|FG000|Overall Study|Adverse Event|72|||
127711337|NCT03587805|459572640|FG000|Overall Study|Death|1|||
127711338|NCT03587805|459572640|FG000|Overall Study|Lost to Follow-up|78|||
127711339|NCT03587805|459572640|FG000|Overall Study|Withdrawal by Subject|105|||
127711340|NCT03587805|459572640|FG000|Overall Study|Lack of Efficacy|119|||
127801454|NCT02894840|459896913|FG001|Overall Study|Lost to Follow-up|0|||
127801455|NCT02894840|459896914|FG002|Overall Study|Lost to Follow-up|3|||
127888443|NCT00185211|460214031|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
127888444|NCT00185211|460214030|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
127711341|NCT03587805|459572640|FG000|Overall Study|Reason unknown|26|||
127711342|NCT03587805|459572640|FG000|Overall Study|COVID_19 pandemic|4|||
127711343|NCT03587805|459572640|FG000|Overall Study|Various reasons|121|||
127711344|NCT03587805|459572640|FG000|Overall Study|Withdrawal by parent/guardian|3|||
127888445|NCT00185211|460214031|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
127711345|NCT04626427|459572641|FG000|Overall Study|Death|1|||
127711346|NCT04626427|459572641|FG000|Overall Study|Withdrawal by Subject|1|||
127711347|NCT04626427|459572641|FG000|Overall Study|Investigation Early Termination by Sponsor|11|||
127711348|NCT04626427|459572641|FG000|Overall Study|Participant Permanently Moved Abroad|1|||
127711349|NCT03982186|459572642|FG000|Overall Study|Lost to Follow-up|0|||
127801456|NCT02894840|459896915|FG003|Overall Study|Lost to Follow-up|0|||
127801457|NCT00167245|459896917|FG000|Overall Study|Lost to Follow-up|20|||
127711350|NCT03982186|459572643|FG001|Overall Study|Lost to Follow-up|1|||
127711351|NCT03982186|459572644|FG002|Overall Study|Lost to Follow-up|2|||
127711352|NCT03982186|459572645|FG003|Overall Study|Lost to Follow-up|1|||
127711353|NCT03982186|459572646|FG004|Overall Study|Lost to Follow-up|1|||
127711354|NCT03982186|459572647|FG005|Overall Study|Lost to Follow-up|0|||
127711355|NCT03982186|459572642|FG000|Overall Study|Physician Decision|0|||
127711356|NCT03982186|459572643|FG001|Overall Study|Physician Decision|1|||
127711357|NCT03982186|459572644|FG002|Overall Study|Physician Decision|0|||
127711358|NCT03982186|459572645|FG003|Overall Study|Physician Decision|0|||
127711359|NCT03982186|459572646|FG004|Overall Study|Physician Decision|0|||
127711360|NCT03982186|459572647|FG005|Overall Study|Physician Decision|0|||
127711361|NCT03982186|459572642|FG000|Overall Study|Withdrawal by Subject|3|||
127711362|NCT03982186|459572643|FG001|Overall Study|Withdrawal by Subject|4|||
127711363|NCT03982186|459572644|FG002|Overall Study|Withdrawal by Subject|1|||
127711364|NCT03982186|459572645|FG003|Overall Study|Withdrawal by Subject|7|||
127711365|NCT03982186|459572646|FG004|Overall Study|Withdrawal by Subject|2|||
127711366|NCT03982186|459572647|FG005|Overall Study|Withdrawal by Subject|0|||
127711367|NCT03982186|459572642|FG000|Overall Study|Randomized and not treated|0|||
127711368|NCT03982186|459572643|FG001|Overall Study|Randomized and not treated|0|||
127711369|NCT03982186|459572644|FG002|Overall Study|Randomized and not treated|0|||
127711370|NCT03982186|459572645|FG003|Overall Study|Randomized and not treated|1|||
127711371|NCT03982186|459572646|FG004|Overall Study|Randomized and not treated|0|||
127711372|NCT03982186|459572647|FG005|Overall Study|Randomized and not treated|0|||
127711373|NCT05020353|459573272|FG000|Overall Study|Protocol Violation|7|||
127711374|NCT05020353|459573272|FG000|Overall Study|Withdrawal by Subject|33|||
127711375|NCT03417284|459573273|FG000|Overall Study|Inadequate supply on study drug|1|||
127711376|NCT03417284|459573274|FG001|Overall Study|Inadequate supply on study drug|0|||
127711377|NCT03417284|459573275|FG002|Overall Study|Inadequate supply on study drug|0|||
127711378|NCT03417284|459573276|FG003|Overall Study|Inadequate supply on study drug|0|||
127711379|NCT03417284|459573273|FG000|Overall Study|Disease Progression|0|||
127711380|NCT03417284|459573274|FG001|Overall Study|Disease Progression|0|||
127711381|NCT03417284|459573275|FG002|Overall Study|Disease Progression|1|||
127711382|NCT03417284|459573276|FG003|Overall Study|Disease Progression|0|||
127711383|NCT05132400|459573277|FG000|Overall Study|Withdrawal by Subject|14|||
127711384|NCT05132400|459573278|FG001|Overall Study|Withdrawal by Subject|8|||
127711385|NCT05132400|459573277|FG000|Overall Study|Lost to Follow-up|132|||
127711386|NCT05132400|459573278|FG001|Overall Study|Lost to Follow-up|121|||
127711387|NCT01880515|459573280|FG000|Overall Study|Lost to Follow-up|3|||
127711388|NCT01880515|459573281|FG001|Overall Study|Lost to Follow-up|2|||
127711389|NCT01880515|459573280|FG000|Overall Study|Disease Progression|5|||
127711390|NCT01880515|459573281|FG001|Overall Study|Disease Progression|7|||
127711391|NCT03333915|459573307|FG000|Overall Study|Lost to Follow-up|0|||
127711392|NCT03333915|459573308|FG001|Overall Study|Lost to Follow-up|0|||
127711393|NCT03333915|459573309|FG002|Overall Study|Lost to Follow-up|1|||
127711394|NCT03333915|459573310|FG003|Overall Study|Lost to Follow-up|0|||
127711395|NCT03333915|459573311|FG004|Overall Study|Lost to Follow-up|0|||
127711396|NCT03333915|459573307|FG000|Overall Study|Disease Progression|0|||
127711397|NCT03333915|459573308|FG001|Overall Study|Disease Progression|1|||
127711398|NCT03333915|459573309|FG002|Overall Study|Disease Progression|0|||
127711399|NCT03333915|459573310|FG003|Overall Study|Disease Progression|0|||
127711400|NCT03333915|459573311|FG004|Overall Study|Disease Progression|0|||
127711401|NCT03333915|459573307|FG000|Overall Study|Death|0|||
127711402|NCT03333915|459573308|FG001|Overall Study|Death|0|||
127711403|NCT03333915|459573309|FG002|Overall Study|Death|0|||
127711404|NCT03333915|459573310|FG003|Overall Study|Death|37|||
127711405|NCT03333915|459573311|FG004|Overall Study|Death|18|||
127711406|NCT03333915|459573307|FG000|Overall Study|Sponsor's Decision|0|||
127711407|NCT03333915|459573308|FG001|Overall Study|Sponsor's Decision|0|||
127711408|NCT03333915|459573309|FG002|Overall Study|Sponsor's Decision|0|||
127711409|NCT03333915|459573310|FG003|Overall Study|Sponsor's Decision|48|||
127711410|NCT03333915|459573311|FG004|Overall Study|Sponsor's Decision|4|||
127711411|NCT03333915|459573307|FG000|Overall Study|Withdrawal by Subject|0|||
127711412|NCT03333915|459573308|FG001|Overall Study|Withdrawal by Subject|0|||
127711413|NCT03333915|459573309|FG002|Overall Study|Withdrawal by Subject|0|||
127711414|NCT03333915|459573310|FG003|Overall Study|Withdrawal by Subject|5|||
127711415|NCT03333915|459573311|FG004|Overall Study|Withdrawal by Subject|1|||
127711416|NCT02777593|459573323|FG000|Overall Study|Still in study|1|||
127711417|NCT02777593|459573324|FG001|Overall Study|Still in study|32|||
127711418|NCT02777593|459573325|FG002|Overall Study|Still in study|3|||
127711419|NCT02777593|459573326|FG003|Overall Study|Still in study|6|||
127711420|NCT02777593|459573327|FG004|Overall Study|Still in study|5|||
127711421|NCT02777593|459573323|FG000|Overall Study|Death|21|||
127711422|NCT02777593|459573324|FG001|Overall Study|Death|28|||
127711423|NCT02777593|459573325|FG002|Overall Study|Death|0|||
127711424|NCT02777593|459573326|FG003|Overall Study|Death|5|||
127711425|NCT02777593|459573327|FG004|Overall Study|Death|0|||
127711426|NCT02777593|459573323|FG000|Overall Study|Withdrawal by Subject|8|||
127711427|NCT02777593|459573324|FG001|Overall Study|Withdrawal by Subject|4|||
127711428|NCT02777593|459573325|FG002|Overall Study|Withdrawal by Subject|1|||
127711429|NCT02777593|459573326|FG003|Overall Study|Withdrawal by Subject|1|||
127711430|NCT02777593|459573327|FG004|Overall Study|Withdrawal by Subject|0|||
127711431|NCT02777593|459573323|FG000|Overall Study|Lost to Follow-up|8|||
127711432|NCT02777593|459573324|FG001|Overall Study|Lost to Follow-up|16|||
127711433|NCT02777593|459573325|FG002|Overall Study|Lost to Follow-up|5|||
127711434|NCT02777593|459573326|FG003|Overall Study|Lost to Follow-up|0|||
127711435|NCT02777593|459573327|FG004|Overall Study|Lost to Follow-up|1|||
127711436|NCT02777593|459573323|FG000|Overall Study|Physician Decision|2|||
127711437|NCT02777593|459573324|FG001|Overall Study|Physician Decision|2|||
127711438|NCT02777593|459573325|FG002|Overall Study|Physician Decision|0|||
127711439|NCT02777593|459573326|FG003|Overall Study|Physician Decision|0|||
127711440|NCT02777593|459573327|FG004|Overall Study|Physician Decision|0|||
127711441|NCT02777593|459573323|FG000|Overall Study|Discontinued due to Other|1|||
127711442|NCT02777593|459573324|FG001|Overall Study|Discontinued due to Other|0|||
127711443|NCT02777593|459573325|FG002|Overall Study|Discontinued due to Other|0|||
127711444|NCT02777593|459573326|FG003|Overall Study|Discontinued due to Other|0|||
127711445|NCT02777593|459573327|FG004|Overall Study|Discontinued due to Other|0|||
127711446|NCT05785130|459573329|FG000|Overall Study|Withdrawal by Subject|1|||
127711447|NCT05785130|459573330|FG001|Overall Study|Withdrawal by Subject|0|||
127711448|NCT05785130|459573329|FG000|Overall Study|Lack of Efficacy|0|||
127711449|NCT05785130|459573330|FG001|Overall Study|Lack of Efficacy|1|||
127711450|NCT03522298|459573336|FG000|Overall Study|Adverse Event|1|||
127711451|NCT03522298|459573337|FG001|Overall Study|Adverse Event|0|||
127711452|NCT03522298|459573338|FG002|Overall Study|Adverse Event|0|||
127711453|NCT03522298|459573339|FG003|Overall Study|Adverse Event|1|||
127711454|NCT03522298|459573336|FG000|Overall Study|Death|2|||
127711455|NCT03522298|459573337|FG001|Overall Study|Death|4|||
127711456|NCT03522298|459573338|FG002|Overall Study|Death|8|||
127711457|NCT03522298|459573339|FG003|Overall Study|Death|8|||
127711458|NCT03522298|459573336|FG000|Overall Study|Patient decision|0|||
127711459|NCT03522298|459573337|FG001|Overall Study|Patient decision|2|||
127711460|NCT03522298|459573338|FG002|Overall Study|Patient decision|2|||
127711461|NCT03522298|459573339|FG003|Overall Study|Patient decision|2|||
127711462|NCT04795245|459573340|FG000|Overall Study|Unkown reason|7|||
127711463|NCT04795245|459573340|FG000|Overall Study|Death|17|||
127711464|NCT04795245|459573340|FG000|Overall Study|Other than listed|19|||
127711465|NCT04795245|459573340|FG000|Overall Study|Adverse Event|143|||
127711466|NCT04795245|459573340|FG000|Overall Study|Progressive disease|512|||
127711467|NCT04795245|459573340|FG000|Overall Study|Unknown if patients were still on treatment at end of observation period|22|||
127711468|NCT01897441|459573341|FG000|Overall Study|Lost to Follow-up|0|||
127711469|NCT01897441|459573342|FG001|Overall Study|Lost to Follow-up|0|||
127711470|NCT01897441|459573343|FG002|Overall Study|Lost to Follow-up|1|||
127711471|NCT01897441|459573344|FG003|Overall Study|Lost to Follow-up|0|||
127711472|NCT01897441|459573345|FG004|Overall Study|Lost to Follow-up|0|||
127711473|NCT01897441|459573346|FG005|Overall Study|Lost to Follow-up|0|||
127711474|NCT01897441|459573341|FG000|Overall Study|Withdrawal by Subject|0|||
127711475|NCT01897441|459573342|FG001|Overall Study|Withdrawal by Subject|0|||
127711476|NCT01897441|459573343|FG002|Overall Study|Withdrawal by Subject|0|||
127711477|NCT01897441|459573344|FG003|Overall Study|Withdrawal by Subject|0|||
127711478|NCT01897441|459573345|FG004|Overall Study|Withdrawal by Subject|1|||
127711479|NCT01897441|459573346|FG005|Overall Study|Withdrawal by Subject|0|||
127711480|NCT01897441|459573341|FG000|Overall Study|Withdrawn by Provider|0|||
127711481|NCT01897441|459573342|FG001|Overall Study|Withdrawn by Provider|2|||
127711482|NCT01897441|459573343|FG002|Overall Study|Withdrawn by Provider|0|||
127711483|NCT01897441|459573344|FG003|Overall Study|Withdrawn by Provider|0|||
127711484|NCT01897441|459573345|FG004|Overall Study|Withdrawn by Provider|0|||
127711485|NCT01897441|459573346|FG005|Overall Study|Withdrawn by Provider|0|||
127711486|NCT04761198|459573349|FG000|Overall Study|Progressive Disease|1|||
127711487|NCT04761198|459573350|FG001|Overall Study|Progressive Disease|0|||
127711488|NCT04761198|459573351|FG002|Overall Study|Progressive Disease|0|||
127711489|NCT04761198|459573352|FG003|Overall Study|Progressive Disease|1|||
127711490|NCT04761198|459573353|FG004|Overall Study|Progressive Disease|4|||
127711491|NCT04761198|459573354|FG005|Overall Study|Progressive Disease|1|||
127711492|NCT04761198|459573355|FG006|Overall Study|Progressive Disease|2|||
127711493|NCT04761198|459573349|FG000|Overall Study|Protocol Violation|0|||
127711494|NCT04761198|459573350|FG001|Overall Study|Protocol Violation|0|||
127711495|NCT04761198|459573351|FG002|Overall Study|Protocol Violation|0|||
127711496|NCT04761198|459573352|FG003|Overall Study|Protocol Violation|0|||
127711497|NCT04761198|459573353|FG004|Overall Study|Protocol Violation|1|||
127711498|NCT04761198|459573354|FG005|Overall Study|Protocol Violation|0|||
127711499|NCT04761198|459573355|FG006|Overall Study|Protocol Violation|0|||
127711500|NCT04761198|459573349|FG000|Overall Study|Death|2|||
127711501|NCT04761198|459573350|FG001|Overall Study|Death|1|||
127711502|NCT04761198|459573351|FG002|Overall Study|Death|2|||
127711503|NCT04761198|459573352|FG003|Overall Study|Death|5|||
127711504|NCT04761198|459573353|FG004|Overall Study|Death|14|||
127711505|NCT04761198|459573354|FG005|Overall Study|Death|2|||
127711506|NCT04761198|459573355|FG006|Overall Study|Death|5|||
127711507|NCT04761198|459573349|FG000|Overall Study|Lost to Follow-up|0|||
127711508|NCT04761198|459573350|FG001|Overall Study|Lost to Follow-up|0|||
127711509|NCT04761198|459573351|FG002|Overall Study|Lost to Follow-up|0|||
127711510|NCT04761198|459573352|FG003|Overall Study|Lost to Follow-up|0|||
127711511|NCT04761198|459573353|FG004|Overall Study|Lost to Follow-up|1|||
127711512|NCT04761198|459573354|FG005|Overall Study|Lost to Follow-up|0|||
127711513|NCT04761198|459573355|FG006|Overall Study|Lost to Follow-up|0|||
127711514|NCT04761198|459573349|FG000|Overall Study|Withdrawal by Subject|2|||
127711515|NCT04761198|459573350|FG001|Overall Study|Withdrawal by Subject|0|||
127711516|NCT04761198|459573351|FG002|Overall Study|Withdrawal by Subject|1|||
127711517|NCT04761198|459573352|FG003|Overall Study|Withdrawal by Subject|0|||
127711518|NCT04761198|459573353|FG004|Overall Study|Withdrawal by Subject|2|||
127711519|NCT04761198|459573354|FG005|Overall Study|Withdrawal by Subject|0|||
127711520|NCT04761198|459573355|FG006|Overall Study|Withdrawal by Subject|1|||
127711521|NCT04761198|459573349|FG000|Overall Study|Study Terminated by Sponsor|6|||
127711522|NCT04761198|459573350|FG001|Overall Study|Study Terminated by Sponsor|0|||
127711523|NCT04761198|459573351|FG002|Overall Study|Study Terminated by Sponsor|5|||
127711524|NCT04761198|459573352|FG003|Overall Study|Study Terminated by Sponsor|3|||
127711525|NCT04761198|459573353|FG004|Overall Study|Study Terminated by Sponsor|10|||
127711526|NCT04761198|459573354|FG005|Overall Study|Study Terminated by Sponsor|1|||
127711527|NCT04761198|459573355|FG006|Overall Study|Study Terminated by Sponsor|2|||
127711528|NCT04093869|459573363|FG000|Overall Study|Death|0|||
127711529|NCT04093869|459573364|FG001|Overall Study|Death|1|||
127711530|NCT04093869|459573363|FG000|Overall Study|Withdrawal by Subject|1|||
127711531|NCT04093869|459573364|FG001|Overall Study|Withdrawal by Subject|0|||
127711532|NCT05866926|459573365|FG000|Overall Study|Death|16|||
127711533|NCT05866926|459573366|FG001|Overall Study|Death|9|||
127711534|NCT05866926|459573365|FG000|Overall Study|Lost to Follow-up|0|||
127711535|NCT05866926|459573366|FG001|Overall Study|Lost to Follow-up|1|||
127711536|NCT05866926|459573365|FG000|Overall Study|Adverse Event|1|||
127711537|NCT05866926|459573366|FG001|Overall Study|Adverse Event|0|||
127711538|NCT05866926|459573365|FG000|Overall Study|Withdrawal by Subject|5|||
127711539|NCT05866926|459573366|FG001|Overall Study|Withdrawal by Subject|1|||
127711540|NCT05866926|459573365|FG000|Overall Study|Disease progression|1|||
127711541|NCT05866926|459573366|FG001|Overall Study|Disease progression|0|||
127711542|NCT05866926|459573365|FG000|Overall Study|other causes|2|||
127711543|NCT05866926|459573366|FG001|Overall Study|other causes|1|||
127711544|NCT05267639|459573691|FG000|Overall Study|Withdrawal by Subject|1|||
127711545|NCT05267639|459573692|FG001|Overall Study|Withdrawal by Subject|0|||
127711546|NCT02076009|459573698|FG000|Overall Study|Death|172|||
127711547|NCT02076009|459573699|FG001|Overall Study|Death|153|||
127711548|NCT02076009|459573698|FG000|Overall Study|Withdrawal by Subject|16|||
127711549|NCT02076009|459573699|FG001|Overall Study|Withdrawal by Subject|12|||
127711550|NCT02076009|459573698|FG000|Overall Study|Lost to Follow-up|4|||
127711551|NCT02076009|459573699|FG001|Overall Study|Lost to Follow-up|2|||
127711552|NCT02076009|459573698|FG000|Overall Study|Progressive Disease|1|||
127711553|NCT02076009|459573699|FG001|Overall Study|Progressive Disease|0|||
127711554|NCT02076009|459573698|FG000|Overall Study|Physician Decision|0|||
127711555|NCT02076009|459573699|FG001|Overall Study|Physician Decision|1|||
127711556|NCT02076009|459573698|FG000|Overall Study|End of data collection|90|||
127711557|NCT02076009|459573699|FG001|Overall Study|End of data collection|118|||
127711558|NCT03816397|459573705|FG000|Overall Study|Censored at interim analysis date.|13|||
127711559|NCT03816397|459573706|FG001|Overall Study|Censored at interim analysis date.|6|||
127711560|NCT03816397|459573705|FG000|Overall Study|Withdrawal by Subject|1|||
127711561|NCT03816397|459573706|FG001|Overall Study|Withdrawal by Subject|1|||
127711562|NCT05985395|459573707|FG000|Overall Study|Physician Decision|2|||
127711563|NCT05985395|459573708|FG001|Overall Study|Physician Decision|1|||
127711564|NCT05985395|459573707|FG000|Overall Study|Withdrawal by Subject|1|||
127711565|NCT05985395|459573708|FG001|Overall Study|Withdrawal by Subject|0|||
127711566|NCT03493542|459573709|FG000|Base Study|Withdrawal by Subject|0|||
127711567|NCT03493542|459573710|FG001|Base Study|Withdrawal by Subject|4|||
127711568|NCT03493542|459573711|FG002|Base Study|Withdrawal by Subject|0|||
127711569|NCT03493542|459573709|FG000|Extension Study|Consent withdrawal by parent/guardian|0|||
127711570|NCT03493542|459573710|FG001|Extension Study|Consent withdrawal by parent/guardian|0|||
127711571|NCT03493542|459573711|FG002|Extension Study|Consent withdrawal by parent/guardian|2|||
127711572|NCT03493542|459573709|FG000|Extension Study|Withdrawal by Subject|0|||
127711573|NCT03493542|459573710|FG001|Extension Study|Withdrawal by Subject|0|||
127711574|NCT03493542|459573711|FG002|Extension Study|Withdrawal by Subject|25|||
127711575|NCT05485935|459573712|FG000|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
127711576|NCT05485935|459573713|FG001|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
127711577|NCT05485935|459573712|FG000|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|3|||
127711578|NCT05485935|459573713|FG001|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|0|||
127711579|NCT05485935|459573712|FG000|Period 2 (T2 and V3)|Adverse Event|0|||
127711580|NCT05485935|459573713|FG001|Period 2 (T2 and V3)|Adverse Event|1|||
127711581|NCT05485935|459573712|FG000|Period 2 (T2 and V3)|loss of contact|0|||
127711582|NCT05485935|459573713|FG001|Period 2 (T2 and V3)|loss of contact|1|||
127711583|NCT02806726|459573719|FG000|Overall Study|Lost to Follow-up|1|||
127711584|NCT05129501|459573720|FG000|Overall Study|Lost to Follow-up|54|||
127711585|NCT05129501|459573721|FG001|Overall Study|Lost to Follow-up|41|||
127711586|NCT04281498|459573722|FG000|Overall Study|Progression of disease|1|||
127711587|NCT04281498|459573722|FG000|Overall Study|Planned SCT|1|||
127711588|NCT04281498|459573722|FG000|Overall Study|Alternative Treatment|1|||
127711589|NCT01265537|459573725|FG000|Overall Study|Adverse Event|2|||
127711590|NCT01265537|459573726|FG001|Overall Study|Adverse Event|1|||
127711591|NCT01265537|459573725|FG000|Overall Study|Physician Decision|0|||
127711592|NCT01265537|459573726|FG001|Overall Study|Physician Decision|1|||
127711593|NCT03782116|459573727|FG000|Completed Intervetion|Lost to Follow-up|11|||
127711594|NCT03782116|459573728|FG001|Completed Intervetion|Lost to Follow-up|7|||
127711595|NCT03782116|459573727|FG000|Completed Intervetion|Withdrawal by Subject|6|||
127711596|NCT03782116|459573728|FG001|Completed Intervetion|Withdrawal by Subject|5|||
127711597|NCT03782116|459573727|FG000|Included in Analysis|Protocol Violation|5|||
127711598|NCT03782116|459573728|FG001|Included in Analysis|Protocol Violation|5|||
127711599|NCT00447980|459574182|FG000|Overall Study|Withdrawal by Subject|1|||
127711600|NCT00447980|459574183|FG001|Overall Study|Withdrawal by Subject|1|||
127711601|NCT00447980|459574184|FG002|Overall Study|Withdrawal by Subject|4|||
127711602|NCT00447980|459574185|FG003|Overall Study|Withdrawal by Subject|4|||
127711603|NCT00447980|459574182|FG000|Overall Study|Lost to Follow-up|1|||
127711604|NCT00447980|459574183|FG001|Overall Study|Lost to Follow-up|1|||
127711605|NCT00447980|459574184|FG002|Overall Study|Lost to Follow-up|0|||
127711606|NCT00447980|459574185|FG003|Overall Study|Lost to Follow-up|0|||
127711607|NCT00447980|459574182|FG000|Overall Study|Did not proceed with surgery|3|||
127711608|NCT00447980|459574183|FG001|Overall Study|Did not proceed with surgery|3|||
127711609|NCT00447980|459574184|FG002|Overall Study|Did not proceed with surgery|2|||
127711610|NCT00447980|459574185|FG003|Overall Study|Did not proceed with surgery|2|||
127711611|NCT03635567|459574188|FG000|Overall Study|Lost to Follow-up|4|||
127711612|NCT03635567|459574189|FG001|Overall Study|Lost to Follow-up|1|||
127711613|NCT03635567|459574188|FG000|Overall Study|Withdrawal by Subject|11|||
127801458|NCT00167245|459896918|FG001|Overall Study|Lost to Follow-up|31|||
127801459|NCT00167245|459896917|FG000|Overall Study|Withdrawal by Subject|5|||
127801460|NCT00167245|459896918|FG001|Overall Study|Withdrawal by Subject|8|||
127801461|NCT00167245|459896917|FG000|Overall Study|Incarcerated|3|||
127801462|NCT00167245|459896918|FG001|Overall Study|Incarcerated|2|||
127801463|NCT00167245|459896917|FG000|Overall Study|Drowsy|1|||
127801464|NCT00167245|459896918|FG001|Overall Study|Drowsy|0|||
127801465|NCT00804687|459896919|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
127801466|NCT00804687|459896920|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
127801467|NCT00804687|459896921|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
127801468|NCT00804687|459896922|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
127711614|NCT03635567|459574189|FG001|Overall Study|Withdrawal by Subject|16|||
127711615|NCT03635567|459574188|FG000|Overall Study|Sponsor Decision|99|||
127711616|NCT03635567|459574189|FG001|Overall Study|Sponsor Decision|57|||
127711617|NCT03635567|459574188|FG000|Overall Study|Death|194|||
127711618|NCT03635567|459574189|FG001|Overall Study|Death|235|||
127711619|NCT05157841|459574190|FG000|Part A (14 Days)|Withdrawal by Subject|0|||
127711620|NCT05157841|459574191|FG001|Part A (14 Days)|Withdrawal by Subject|1|||
127711621|NCT05157841|459574192|FG002|Part A (14 Days)|Withdrawal by Subject|2|||
127711622|NCT05157841|459574190|FG000|Part A (14 Days)|Adverse Event|1|||
127711623|NCT05157841|459574191|FG001|Part A (14 Days)|Adverse Event|0|||
127801469|NCT00804687|459896923|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
127801470|NCT00804687|459896924|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
127711624|NCT05157841|459574192|FG002|Part A (14 Days)|Adverse Event|0|||
127711625|NCT05157841|459574190|FG000|Part A (14 Days)|Failure to meet continuation criteria|0|||
127711626|NCT05157841|459574191|FG001|Part A (14 Days)|Failure to meet continuation criteria|0|||
127711627|NCT05157841|459574192|FG002|Part A (14 Days)|Failure to meet continuation criteria|1|||
127711628|NCT00942734|459574197|FG000|Overall Study|Adverse Event|2|||
127711629|NCT00942734|459574197|FG000|Overall Study|Protocol Violation|3|||
127711630|NCT00942734|459574197|FG000|Overall Study|Disease Progression|2|||
127711631|NCT00942734|459574197|FG000|Overall Study|Physician Decision|1|||
127711632|NCT05718687|459574203|FG000|Overall Study|Withdrawal by Subject|3|||
127711633|NCT01527188|459574207|FG000|Overall Study|Adverse Event|5|||
127711634|NCT01527188|459574208|FG001|Overall Study|Adverse Event|5|||
127711635|NCT01527188|459574209|FG002|Overall Study|Adverse Event|11|||
127711636|NCT01527188|459574210|FG003|Overall Study|Adverse Event|0|||
127711637|NCT01527188|459574207|FG000|Overall Study|Withdrawal by Subject|3|||
127711638|NCT01527188|459574208|FG001|Overall Study|Withdrawal by Subject|6|||
127711639|NCT01527188|459574209|FG002|Overall Study|Withdrawal by Subject|4|||
127711640|NCT01527188|459574210|FG003|Overall Study|Withdrawal by Subject|4|||
127711641|NCT01527188|459574207|FG000|Overall Study|Any other reason not above-mentioned|6|||
127711642|NCT01527188|459574208|FG001|Overall Study|Any other reason not above-mentioned|7|||
127711643|NCT01527188|459574209|FG002|Overall Study|Any other reason not above-mentioned|8|||
127711644|NCT01527188|459574210|FG003|Overall Study|Any other reason not above-mentioned|8|||
127711645|NCT01220531|459574214|FG000|Overall Study|Death|7|||
127711646|NCT01220531|459574214|FG000|Overall Study|Lost to Follow-up|1|||
127711647|NCT04873232|459574215|FG000|Overall Study|Lost to Follow-up|1|||
127711648|NCT04873232|459574216|FG001|Overall Study|Lost to Follow-up|4|||
127711649|NCT04873232|459574215|FG000|Overall Study|Withdrawal by Subject|1|||
127711650|NCT04873232|459574216|FG001|Overall Study|Withdrawal by Subject|0|||
127711651|NCT02325154|459574217|FG000|Overall Study|Physician Decision|1|||
127711652|NCT03512301|459574686|FG000|Overall Study|Protocol Violation|2|||
127711653|NCT03512301|459574686|FG000|Overall Study|Did Not Qualify|3|||
127711654|NCT03512301|459574686|FG000|Overall Study|Age-ineligible|1|||
127711655|NCT03512301|459574686|FG000|Overall Study|Inadequate fluency with the English language|3|||
127711656|NCT02611687|459574688|FG000|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|2|||
127711657|NCT02611687|459574689|FG001|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|1|||
127711658|NCT04933474|459574690|FG000|Overall Study|Discontinued Intervention Prior to End of Follow-up|2|||
127711659|NCT04933474|459574691|FG001|Overall Study|Discontinued Intervention Prior to End of Follow-up|1|||
127711660|NCT04933474|459574690|FG000|Overall Study|Lost to Follow-up|19|||
127711661|NCT04933474|459574691|FG001|Overall Study|Lost to Follow-up|9|||
127711662|NCT04933474|459574690|FG000|Overall Study|Life Burden - unable to participate|6|||
127711663|NCT04933474|459574691|FG001|Overall Study|Life Burden - unable to participate|2|||
127711664|NCT04933474|459574690|FG000|Overall Study|Disease Burden - unable to participate|4|||
127711665|NCT04933474|459574691|FG001|Overall Study|Disease Burden - unable to participate|1|||
127711666|NCT04933474|459574690|FG000|Overall Study|Surgery/Hospitalization|1|||
127711667|NCT04933474|459574691|FG001|Overall Study|Surgery/Hospitalization|2|||
127711668|NCT04933474|459574690|FG000|Overall Study|Dissatisfied with Intervention|1|||
127711669|NCT04933474|459574691|FG001|Overall Study|Dissatisfied with Intervention|1|||
127711670|NCT04933474|459574690|FG000|Overall Study|Withdrew interest in participation|1|||
127711671|NCT04933474|459574691|FG001|Overall Study|Withdrew interest in participation|0|||
127711672|NCT04933474|459574690|FG000|Overall Study|Had previously enrolled in the study|0|||
127711673|NCT04933474|459574691|FG001|Overall Study|Had previously enrolled in the study|1|||
127711674|NCT03242915|459574704|FG000|Overall Study|Adverse Event|5|||
127711675|NCT03242915|459574705|FG001|Overall Study|Adverse Event|1|||
127711676|NCT03242915|459574704|FG000|Overall Study|Withdrawal by Subject|0|||
127711677|NCT03242915|459574705|FG001|Overall Study|Withdrawal by Subject|2|||
127711678|NCT03242915|459574704|FG000|Overall Study|Physician Decision|4|||
127711679|NCT03242915|459574705|FG001|Overall Study|Physician Decision|1|||
127711680|NCT05988398|459574706|FG000|Overall Study|Lack of time|21|||
127711681|NCT05988398|459574707|FG001|Overall Study|Lack of time|0|||
127711682|NCT05988398|459574706|FG000|Overall Study|Absent from school|0|||
127711683|NCT05988398|459574707|FG001|Overall Study|Absent from school|38|||
127711684|NCT05988398|459574706|FG000|Overall Study|Chose not to participate|0|||
127711685|NCT05988398|459574707|FG001|Overall Study|Chose not to participate|42|||
127711686|NCT05988398|459574706|FG000|Overall Study|Other commitments (e.g., sports)|0|||
127711687|NCT05988398|459574707|FG001|Overall Study|Other commitments (e.g., sports)|25|||
127711688|NCT04908930|459574720|FG000|Overall Study|Lost to Follow-up|1|||
127711689|NCT04908930|459574721|FG001|Overall Study|Lost to Follow-up|1|||
127711690|NCT04908930|459574722|FG002|Overall Study|Lost to Follow-up|0|||
127711691|NCT04908930|459574723|FG003|Overall Study|Lost to Follow-up|0|||
127711692|NCT04908930|459574724|FG004|Overall Study|Lost to Follow-up|0|||
127711693|NCT04908930|459574720|FG000|Overall Study|hardware in mouth|1|||
127711694|NCT04908930|459574721|FG001|Overall Study|hardware in mouth|1|||
127711695|NCT04908930|459574722|FG002|Overall Study|hardware in mouth|0|||
127711696|NCT04908930|459574723|FG003|Overall Study|hardware in mouth|0|||
127711697|NCT04908930|459574724|FG004|Overall Study|hardware in mouth|0|||
127711698|NCT04908930|459574720|FG000|Overall Study|wrong team|1|||
127711699|NCT04908930|459574721|FG001|Overall Study|wrong team|0|||
127711700|NCT04908930|459574722|FG002|Overall Study|wrong team|0|||
127801471|NCT00804687|459896919|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
127801472|NCT00804687|459896920|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
127801473|NCT00804687|459896921|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
127801474|NCT00804687|459896922|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
127801475|NCT00804687|459896923|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
127801476|NCT00804687|459896924|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
127801477|NCT00804687|459896919|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
127801478|NCT00804687|459896920|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
127801479|NCT00804687|459896921|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
127801480|NCT00804687|459896922|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
127801481|NCT00804687|459896923|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
127801482|NCT00804687|459896924|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
127801483|NCT00804687|459896919|FG000|Period 5: Treatment Period|Positive drug test|1|||
127801484|NCT00804687|459896920|FG001|Period 5: Treatment Period|Positive drug test|0|||
127801485|NCT00804687|459896921|FG002|Period 5: Treatment Period|Positive drug test|0|||
127801486|NCT00804687|459896922|FG003|Period 5: Treatment Period|Positive drug test|0|||
127888446|NCT00185211|460214030|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
127888447|NCT00185211|460214031|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
127888448|NCT00185211|460214030|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
127888449|NCT00185211|460214031|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
127711701|NCT04908930|459574723|FG003|Overall Study|wrong team|0|||
127711702|NCT04908930|459574724|FG004|Overall Study|wrong team|0|||
127711703|NCT04908930|459574720|FG000|Overall Study|quit team|2|||
127711704|NCT04908930|459574721|FG001|Overall Study|quit team|4|||
127711705|NCT04908930|459574722|FG002|Overall Study|quit team|0|||
127711706|NCT04908930|459574723|FG003|Overall Study|quit team|0|||
127711707|NCT04908930|459574724|FG004|Overall Study|quit team|0|||
127711708|NCT04908930|459574720|FG000|Overall Study|Withdrawal by Subject|1|||
127711709|NCT04908930|459574721|FG001|Overall Study|Withdrawal by Subject|2|||
127711710|NCT04908930|459574722|FG002|Overall Study|Withdrawal by Subject|0|||
127711711|NCT04908930|459574723|FG003|Overall Study|Withdrawal by Subject|0|||
127711712|NCT04908930|459574724|FG004|Overall Study|Withdrawal by Subject|0|||
127711713|NCT04908930|459574720|FG000|Overall Study|parent not liking program|0|||
127711714|NCT04908930|459574721|FG001|Overall Study|parent not liking program|1|||
127711715|NCT04908930|459574722|FG002|Overall Study|parent not liking program|0|||
127711716|NCT04908930|459574723|FG003|Overall Study|parent not liking program|0|||
127711717|NCT04908930|459574724|FG004|Overall Study|parent not liking program|0|||
127711718|NCT03872466|459574727|FG000|Overall Study|Withdrawal by Subject|1|||
127711719|NCT03872466|459574728|FG001|Overall Study|Withdrawal by Subject|0|||
127711720|NCT03872466|459574727|FG000|Overall Study|Physician Decision|2|||
127711721|NCT03872466|459574728|FG001|Overall Study|Physician Decision|0|||
127711722|NCT05771467|459574729|FG000|Overall Study|Lost to Follow-up|6|||
127711723|NCT05771467|459574730|FG001|Overall Study|Lost to Follow-up|3|||
127711724|NCT00709956|459574733|FG000|Overall Study|Withdrawal by Subject|1|||
127711725|NCT00709956|459574734|FG001|Overall Study|Withdrawal by Subject|1|||
127711726|NCT00709956|459574733|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
127711727|NCT00709956|459574734|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
127711728|NCT03983382|459575366|FG000|Overall Study|Death|1|||
127711729|NCT03983382|459575366|FG000|Overall Study|Lost to Follow-up|3|||
127711730|NCT03983382|459575366|FG000|Overall Study|Physician Decision|2|||
127711731|NCT03983382|459575366|FG000|Overall Study|Withdrawal by Subject|10|||
127711732|NCT03983382|459575366|FG000|Overall Study|Change in cancer treatment|2|||
127711733|NCT04165213|459575367|FG000|Clinician Enrollment|Did not deliver COPE to dyads|1|||
127711734|NCT04165213|459575368|FG001|Clinician Enrollment|Did not deliver COPE to dyads|2|||
127711735|NCT04165213|459575367|FG000|Clinician Enrollment|Withdrawal by Subject|6|||
127711736|NCT04165213|459575368|FG001|Clinician Enrollment|Withdrawal by Subject|0|||
127711737|NCT04165213|459575367|FG000|Clinician Enrollment|Termination from site|0|||
127711738|NCT04165213|459575368|FG001|Clinician Enrollment|Termination from site|1|||
127711739|NCT04165213|459575367|FG000|Caregiver Enrollment|Withdrawal by Subject|0|||
127711740|NCT04165213|459575368|FG001|Caregiver Enrollment|Withdrawal by Subject|5|||
127711741|NCT04165213|459575367|FG000|Caregiver Enrollment|Lost to Follow-up|1|||
127711742|NCT04165213|459575368|FG001|Caregiver Enrollment|Lost to Follow-up|1|||
127711743|NCT04165213|459575367|FG000|Caregiver Enrollment|Physician Decision|1|||
127711744|NCT04165213|459575368|FG001|Caregiver Enrollment|Physician Decision|0|||
127711745|NCT04165213|459575367|FG000|Caregiver Enrollment|PLWD entered long term care, no longer eligible|1|||
127711746|NCT04165213|459575368|FG001|Caregiver Enrollment|PLWD entered long term care, no longer eligible|0|||
127711747|NCT04165213|459575367|FG000|Caregiver Enrollment|PLWD death|2|||
127711748|NCT04165213|459575368|FG001|Caregiver Enrollment|PLWD death|0|||
127711749|NCT04165213|459575367|FG000|Caregiver Enrollment|Did not receive minimal dose of COPE|0|||
127711750|NCT04165213|459575368|FG001|Caregiver Enrollment|Did not receive minimal dose of COPE|4|||
127711751|NCT04165213|459575367|FG000|PLWD Enrollment|Withdrawal by Subject|0|||
127801487|NCT00804687|459896923|FG004|Period 5: Treatment Period|Positive drug test|0|||
127711752|NCT04165213|459575368|FG001|PLWD Enrollment|Withdrawal by Subject|5|||
127801488|NCT00804687|459896924|FG005|Period 5: Treatment Period|Positive drug test|0|||
127801489|NCT03569202|459896925|FG000|Part 3|Physician Decision|1|||
127801490|NCT03569202|459896926|FG001|Part 3|Physician Decision|0|||
127801491|NCT03569202|459896925|FG000|Part 3|Other|1|||
127711753|NCT04165213|459575367|FG000|PLWD Enrollment|Lost to Follow-up|1|||
127711754|NCT04165213|459575368|FG001|PLWD Enrollment|Lost to Follow-up|1|||
127711755|NCT04165213|459575367|FG000|PLWD Enrollment|Physician Decision|1|||
127711756|NCT04165213|459575368|FG001|PLWD Enrollment|Physician Decision|0|||
127711757|NCT04165213|459575367|FG000|PLWD Enrollment|Entered long term care, no longer eligible|1|||
127711758|NCT04165213|459575368|FG001|PLWD Enrollment|Entered long term care, no longer eligible|0|||
127711759|NCT04165213|459575367|FG000|PLWD Enrollment|Death|2|||
127711760|NCT04165213|459575368|FG001|PLWD Enrollment|Death|0|||
127711761|NCT04165213|459575367|FG000|PLWD Enrollment|Did not receive minimal dose of COPE|0|||
127711762|NCT04165213|459575368|FG001|PLWD Enrollment|Did not receive minimal dose of COPE|4|||
127711763|NCT04174170|459575369|FG000|Placebo Run-in Period|Not Randomized|38|||
127711764|NCT04174170|459575370|FG001|Placebo Run-in Period|Not Randomized|0|||
127711765|NCT04174170|459575371|FG002|Placebo Run-in Period|Not Randomized|0|||
127711766|NCT04174170|459575372|FG003|Placebo Run-in Period|Not Randomized|0|||
127711767|NCT04174170|459575369|FG000|Double Blind Treatment Period|Adverse Event|0|||
127711768|NCT04174170|459575370|FG001|Double Blind Treatment Period|Adverse Event|9|||
127711769|NCT04174170|459575371|FG002|Double Blind Treatment Period|Adverse Event|9|||
127711770|NCT04174170|459575372|FG003|Double Blind Treatment Period|Adverse Event|8|||
127711771|NCT04174170|459575369|FG000|Double Blind Treatment Period|Death|0|||
127711772|NCT04174170|459575370|FG001|Double Blind Treatment Period|Death|1|||
127711773|NCT04174170|459575371|FG002|Double Blind Treatment Period|Death|0|||
127711774|NCT04174170|459575372|FG003|Double Blind Treatment Period|Death|0|||
127711775|NCT04174170|459575369|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
127711776|NCT04174170|459575370|FG001|Double Blind Treatment Period|Lost to Follow-up|22|||
127711777|NCT04174170|459575371|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
127711778|NCT04174170|459575372|FG003|Double Blind Treatment Period|Lost to Follow-up|25|||
127711779|NCT04174170|459575369|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
127711780|NCT04174170|459575370|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
127711781|NCT04174170|459575371|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
127711782|NCT04174170|459575372|FG003|Double Blind Treatment Period|Non-Compliance With Study Drug|2|||
127711783|NCT04174170|459575369|FG000|Double Blind Treatment Period|Physician Decision|0|||
127711784|NCT04174170|459575370|FG001|Double Blind Treatment Period|Physician Decision|1|||
127711785|NCT04174170|459575371|FG002|Double Blind Treatment Period|Physician Decision|0|||
127711786|NCT04174170|459575372|FG003|Double Blind Treatment Period|Physician Decision|1|||
127711787|NCT04174170|459575369|FG000|Double Blind Treatment Period|Pregnancy|0|||
127711788|NCT04174170|459575370|FG001|Double Blind Treatment Period|Pregnancy|1|||
127711789|NCT04174170|459575371|FG002|Double Blind Treatment Period|Pregnancy|0|||
127711790|NCT04174170|459575372|FG003|Double Blind Treatment Period|Pregnancy|1|||
127711791|NCT04174170|459575369|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
127711792|NCT04174170|459575370|FG001|Double Blind Treatment Period|Protocol Deviation|7|||
127711793|NCT04174170|459575371|FG002|Double Blind Treatment Period|Protocol Deviation|6|||
127711794|NCT04174170|459575372|FG003|Double Blind Treatment Period|Protocol Deviation|4|||
127711795|NCT04174170|459575369|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
127711796|NCT04174170|459575370|FG001|Double Blind Treatment Period|Withdrawal by Subject|19|||
127711797|NCT04174170|459575371|FG002|Double Blind Treatment Period|Withdrawal by Subject|29|||
127711798|NCT04174170|459575372|FG003|Double Blind Treatment Period|Withdrawal by Subject|14|||
127711799|NCT04174170|459575369|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
127711800|NCT04174170|459575370|FG001|Double Blind Treatment Period|Reason Not Specified|1|||
127711801|NCT04174170|459575371|FG002|Double Blind Treatment Period|Reason Not Specified|3|||
127711802|NCT04174170|459575372|FG003|Double Blind Treatment Period|Reason Not Specified|6|||
127711803|NCT04772534|459575380|FG000|Overall Study|Physician Decision|1|||
127801492|NCT03569202|459896926|FG001|Part 3|Other|1|||
127801493|NCT00420511|459896927|FG000|Overall Study|Adverse Event|1|||
127801494|NCT00420511|459896928|FG001|Overall Study|Adverse Event|1|||
127801495|NCT00420511|459896927|FG000|Overall Study|Lost to Follow-up|1|||
127801496|NCT00420511|459896928|FG001|Overall Study|Lost to Follow-up|0|||
127801497|NCT02415712|459896929|FG000|Overall Study|Protocol Violation|16|||
127801498|NCT01668654|459896930|FG000|Overall Study|Study Closed/Terminated|3|||
127801499|NCT01668654|459896930|FG000|Overall Study|Withdrawal by Subject|1|||
127711804|NCT04772534|459575381|FG001|Overall Study|Physician Decision|0|||
127711805|NCT04772534|459575382|FG002|Overall Study|Physician Decision|0|||
127711806|NCT04772534|459575380|FG000|Overall Study|Withdrawal by Subject|3|||
127711807|NCT04772534|459575381|FG001|Overall Study|Withdrawal by Subject|0|||
127711808|NCT04772534|459575382|FG002|Overall Study|Withdrawal by Subject|1|||
127711809|NCT04194450|459575383|FG000|Overall Study|not eligible|1|||
127711810|NCT04194450|459575384|FG001|Overall Study|not eligible|0|||
127801500|NCT04557384|459896931|FG000|Overall Study|Study Terminated by Sponsor|1|||
127801501|NCT04557384|459896931|FG000|Overall Study|Death|1|||
127801502|NCT02397473|459896933|FG000|Treatment Phase|Adverse Event|1|||
127801503|NCT02397473|459896934|FG001|Treatment Phase|Adverse Event|2|||
127801504|NCT02397473|459896933|FG000|Treatment Phase|Lack of Efficacy|8|||
127801505|NCT02397473|459896934|FG001|Treatment Phase|Lack of Efficacy|1|||
127801506|NCT02397473|459896933|FG000|Treatment Phase|Lost to Follow-up|1|||
127801507|NCT02397473|459896934|FG001|Treatment Phase|Lost to Follow-up|0|||
127801508|NCT02397473|459896933|FG000|Treatment Phase|Withdrawal by Subject|2|||
127801509|NCT02397473|459896934|FG001|Treatment Phase|Withdrawal by Subject|1|||
127801510|NCT02397473|459896933|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
127801511|NCT02397473|459896934|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
127801512|NCT02397473|459896933|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
127801513|NCT02397473|459896934|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
127801514|NCT02397473|459896933|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
127801515|NCT02397473|459896934|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
127801516|NCT02397473|459896933|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
127801517|NCT02397473|459896934|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
127801518|NCT02397473|459896933|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
127801519|NCT02397473|459896934|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
127801520|NCT01337973|459896935|FG000|Overall Study|Lost to Follow-up|2|||
127801521|NCT01337973|459896936|FG001|Overall Study|Lost to Follow-up|4|||
127801522|NCT01337973|459896937|FG002|Overall Study|Lost to Follow-up|3|||
127801523|NCT01337973|459896935|FG000|Overall Study|Death|1|||
127801524|NCT01337973|459896936|FG001|Overall Study|Death|2|||
127801525|NCT01337973|459896937|FG002|Overall Study|Death|1|||
127801526|NCT01337973|459896935|FG000|Overall Study|Withdrawal by Subject|10|||
127801527|NCT01337973|459896936|FG001|Overall Study|Withdrawal by Subject|8|||
127801528|NCT01337973|459896937|FG002|Overall Study|Withdrawal by Subject|4|||
127801529|NCT01337973|459896935|FG000|Overall Study|missing data on primary outcome|3|||
127801530|NCT01337973|459896936|FG001|Overall Study|missing data on primary outcome|1|||
127801531|NCT01337973|459896937|FG002|Overall Study|missing data on primary outcome|3|||
127801532|NCT00254566|459896939|FG000|Overall Study|Death|1|||
127801533|NCT00254566|459896940|FG001|Overall Study|Death|0|||
127801534|NCT00254566|459896939|FG000|Overall Study|Adverse Event|5|||
127801535|NCT00254566|459896940|FG001|Overall Study|Adverse Event|4|||
127801536|NCT00254566|459896939|FG000|Overall Study|Lack of Efficacy|12|||
127801537|NCT00254566|459896940|FG001|Overall Study|Lack of Efficacy|9|||
127801538|NCT00254566|459896939|FG000|Overall Study|Other|1|||
127801539|NCT00254566|459896940|FG001|Overall Study|Other|5|||
127801540|NCT00254566|459896939|FG000|Overall Study|Withdrawal by Subject|5|||
127801541|NCT00254566|459896940|FG001|Overall Study|Withdrawal by Subject|6|||
127801542|NCT00254566|459896939|FG000|Overall Study|Lost to Follow-up|7|||
127801543|NCT00254566|459896940|FG001|Overall Study|Lost to Follow-up|2|||
127801544|NCT00364689|459896944|FG000|Overall Study|Lost to Follow-up|1|||
127711811|NCT04408755|459575396|FG000|Period A (Placebo lead-in)|Other|11|||
127711812|NCT04408755|459575397|FG001|Period A (Placebo lead-in)|Other|0|||
127711813|NCT04408755|459575398|FG002|Period A (Placebo lead-in)|Other|0|||
127711814|NCT04408755|459575399|FG003|Period A (Placebo lead-in)|Other|0|||
127711815|NCT04408755|459575396|FG000|Period B (Randomization Period)|Adverse Event|0|||
127711816|NCT04408755|459575397|FG001|Period B (Randomization Period)|Adverse Event|3|||
127711817|NCT04408755|459575398|FG002|Period B (Randomization Period)|Adverse Event|0|||
127711818|NCT04408755|459575399|FG003|Period B (Randomization Period)|Adverse Event|1|||
127711819|NCT04408755|459575396|FG000|Period B (Randomization Period)|Death|0|||
127711820|NCT04408755|459575397|FG001|Period B (Randomization Period)|Death|0|||
127711821|NCT04408755|459575398|FG002|Period B (Randomization Period)|Death|1|||
127711822|NCT04408755|459575399|FG003|Period B (Randomization Period)|Death|0|||
127711823|NCT04408755|459575396|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
127711824|NCT04408755|459575397|FG001|Period B (Randomization Period)|Lost to Follow-up|1|||
127711825|NCT04408755|459575398|FG002|Period B (Randomization Period)|Lost to Follow-up|1|||
127711826|NCT04408755|459575399|FG003|Period B (Randomization Period)|Lost to Follow-up|0|||
127711827|NCT04408755|459575396|FG000|Period B (Randomization Period)|Physician Decision|0|||
127711828|NCT04408755|459575397|FG001|Period B (Randomization Period)|Physician Decision|0|||
127711829|NCT04408755|459575398|FG002|Period B (Randomization Period)|Physician Decision|1|||
127711830|NCT04408755|459575399|FG003|Period B (Randomization Period)|Physician Decision|0|||
127801545|NCT01114529|459896948|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
127801546|NCT01114529|459896949|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
127801547|NCT01114529|459896950|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
127711831|NCT04408755|459575396|FG000|Period B (Randomization Period)|Protocol Deviation|0|||
127801548|NCT01114529|459896948|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
127801549|NCT01114529|459896949|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
127711832|NCT04408755|459575397|FG001|Period B (Randomization Period)|Protocol Deviation|1|||
127711833|NCT04408755|459575398|FG002|Period B (Randomization Period)|Protocol Deviation|0|||
127711834|NCT04408755|459575399|FG003|Period B (Randomization Period)|Protocol Deviation|0|||
127711835|NCT04408755|459575396|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
127711836|NCT04408755|459575397|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
127711837|NCT04408755|459575398|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
127711838|NCT04408755|459575399|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
127711839|NCT04408755|459575396|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
127711840|NCT04408755|459575397|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|1|||
127711841|NCT04408755|459575398|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|5|||
127711842|NCT04408755|459575399|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|3|||
127711843|NCT04408755|459575396|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
127711844|NCT04408755|459575397|FG001|Period B (Randomization Period)|Withdrawal by Subject|3|||
127711845|NCT04408755|459575398|FG002|Period B (Randomization Period)|Withdrawal by Subject|2|||
127711846|NCT04408755|459575399|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
127711847|NCT04408755|459575396|FG000|Period B (Randomization Period)|Reason not Specified|0|||
127711848|NCT04408755|459575397|FG001|Period B (Randomization Period)|Reason not Specified|1|||
127711849|NCT04408755|459575398|FG002|Period B (Randomization Period)|Reason not Specified|0|||
127711850|NCT04408755|459575399|FG003|Period B (Randomization Period)|Reason not Specified|2|||
127711851|NCT00308997|459575400|FG000|Overall Study|Subject feigned clinical data|0|||
127711852|NCT00308997|459575401|FG001|Overall Study|Subject feigned clinical data|1|||
127711853|NCT00308997|459575400|FG000|Overall Study|Unable to tolerate intervention|1|||
127711854|NCT00308997|459575401|FG001|Overall Study|Unable to tolerate intervention|0|||
127711855|NCT04586244|459575404|FG000|Overall Study|Lost to Follow-up|1|||
127711856|NCT04586244|459575405|FG001|Overall Study|Lost to Follow-up|0|||
127711857|NCT04586244|459575406|FG002|Overall Study|Lost to Follow-up|0|||
127711858|NCT04586244|459575407|FG003|Overall Study|Lost to Follow-up|1|||
127711859|NCT04586244|459575408|FG004|Overall Study|Lost to Follow-up|0|||
127711860|NCT04586244|459575404|FG000|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
127711861|NCT04586244|459575405|FG001|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|1|||
127711862|NCT04586244|459575406|FG002|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
127711863|NCT04586244|459575407|FG003|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
127711864|NCT04586244|459575408|FG004|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
127711865|NCT03142009|459575413|FG000|Overall Study|Lost to Follow-up|45|||
127711866|NCT03142009|459575414|FG001|Overall Study|Lost to Follow-up|30|||
127711867|NCT01778686|459575415|FG000|Overall Study|Adverse Event|0|||
127711868|NCT01778686|459575416|FG001|Overall Study|Adverse Event|0|||
127711869|NCT01778686|459575417|FG002|Overall Study|Adverse Event|1|||
127711870|NCT01499368|459575418|FG000|Overall Study|Did not meet I/E criteria|8|||
127711871|NCT01499368|459575419|FG001|Overall Study|Did not meet I/E criteria|4|||
127711872|NCT01499368|459575420|FG002|Overall Study|Did not meet I/E criteria|4|||
127711873|NCT01499368|459575418|FG000|Overall Study|Prohibited Concomitant medication|1|||
127711874|NCT01499368|459575419|FG001|Overall Study|Prohibited Concomitant medication|1|||
127711875|NCT01499368|459575420|FG002|Overall Study|Prohibited Concomitant medication|0|||
127711876|NCT01499368|459575418|FG000|Overall Study|Withdrawal by Subject|11|||
127711877|NCT01499368|459575419|FG001|Overall Study|Withdrawal by Subject|10|||
127711878|NCT01499368|459575420|FG002|Overall Study|Withdrawal by Subject|8|||
127711879|NCT01499368|459575418|FG000|Overall Study|Lost to Follow-up|3|||
127711880|NCT01499368|459575419|FG001|Overall Study|Lost to Follow-up|2|||
127711881|NCT01499368|459575420|FG002|Overall Study|Lost to Follow-up|5|||
127711882|NCT01499368|459575418|FG000|Overall Study|Adverse Event|4|||
127711883|NCT01499368|459575419|FG001|Overall Study|Adverse Event|0|||
127711884|NCT01499368|459575420|FG002|Overall Study|Adverse Event|2|||
127711885|NCT01499368|459575418|FG000|Overall Study|Physician Decision|0|||
127711886|NCT01499368|459575419|FG001|Overall Study|Physician Decision|1|||
127711887|NCT01499368|459575420|FG002|Overall Study|Physician Decision|0|||
127711888|NCT01499368|459575418|FG000|Overall Study|Deviation from visit window|0|||
127711889|NCT01499368|459575419|FG001|Overall Study|Deviation from visit window|0|||
127711890|NCT01499368|459575420|FG002|Overall Study|Deviation from visit window|1|||
127711891|NCT01499368|459575418|FG000|Overall Study|Error of Prescriptions|0|||
127711892|NCT01499368|459575419|FG001|Overall Study|Error of Prescriptions|0|||
127711893|NCT01499368|459575420|FG002|Overall Study|Error of Prescriptions|1|||
127711894|NCT06059443|459575421|FG000|Overall Study|Withdrawal by Subject|2|||
127711895|NCT06059443|459575422|FG001|Overall Study|Withdrawal by Subject|0|||
127711896|NCT06059443|459575421|FG000|Overall Study|Lost to Follow-up|2|||
127711897|NCT06059443|459575422|FG001|Overall Study|Lost to Follow-up|2|||
127711898|NCT03092674|459575423|FG000|Overall Study|Adverse Event or Side Effects|1|||
127711899|NCT03092674|459575424|FG001|Overall Study|Adverse Event or Side Effects|4|||
127711900|NCT03092674|459575425|FG002|Overall Study|Adverse Event or Side Effects|4|||
127888450|NCT00185211|460214030|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
127888451|NCT00185211|460214031|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
127888452|NCT02544633|460215740|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
127888453|NCT02544633|460215741|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
127711901|NCT03092674|459575423|FG000|Overall Study|Refusal Unrelated to Adverse Event|5|||
127711902|NCT03092674|459575424|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
127711903|NCT03092674|459575425|FG002|Overall Study|Refusal Unrelated to Adverse Event|3|||
127711904|NCT03092674|459575423|FG000|Overall Study|Progression/Relapse|5|||
127711905|NCT03092674|459575424|FG001|Overall Study|Progression/Relapse|4|||
127711906|NCT03092674|459575425|FG002|Overall Study|Progression/Relapse|8|||
127711907|NCT03092674|459575423|FG000|Overall Study|Death|4|||
127711908|NCT03092674|459575424|FG001|Overall Study|Death|8|||
127711909|NCT03092674|459575425|FG002|Overall Study|Death|2|||
127711910|NCT03092674|459575423|FG000|Overall Study|Other - Not Protocol Specified|11|||
127711911|NCT03092674|459575424|FG001|Overall Study|Other - Not Protocol Specified|8|||
127711912|NCT03092674|459575425|FG002|Overall Study|Other - Not Protocol Specified|8|||
127711913|NCT01105091|459575427|FG000|Overall Study|Death|2|||
127711914|NCT01105091|459575428|FG001|Overall Study|Death|0|||
127711915|NCT03008382|459575429|FG000|Overall Study|Withdrawal by Subject|2|||
127711916|NCT03008382|459575430|FG001|Overall Study|Withdrawal by Subject|5|||
127711917|NCT03008382|459575431|FG002|Overall Study|Withdrawal by Subject|2|||
127711918|NCT03008382|459575432|FG003|Overall Study|Withdrawal by Subject|0|||
127711919|NCT03008382|459575429|FG000|Overall Study|Protocol Violation|1|||
127711920|NCT03008382|459575430|FG001|Overall Study|Protocol Violation|0|||
127711921|NCT03008382|459575431|FG002|Overall Study|Protocol Violation|0|||
127711922|NCT03008382|459575432|FG003|Overall Study|Protocol Violation|0|||
127711923|NCT03008382|459575429|FG000|Overall Study|Withdrew from study but did not withdraw consent|0|||
127711924|NCT03008382|459575430|FG001|Overall Study|Withdrew from study but did not withdraw consent|1|||
127711925|NCT03008382|459575431|FG002|Overall Study|Withdrew from study but did not withdraw consent|0|||
127711926|NCT03008382|459575432|FG003|Overall Study|Withdrew from study but did not withdraw consent|0|||
127711927|NCT03008382|459575429|FG000|Overall Study|Lost to Follow-up|0|||
127711928|NCT03008382|459575430|FG001|Overall Study|Lost to Follow-up|0|||
127711929|NCT03008382|459575431|FG002|Overall Study|Lost to Follow-up|1|||
127711930|NCT03008382|459575432|FG003|Overall Study|Lost to Follow-up|0|||
127711931|NCT03008382|459575429|FG000|Overall Study|Screenfail|0|||
127711932|NCT03008382|459575430|FG001|Overall Study|Screenfail|0|||
127711933|NCT03008382|459575431|FG002|Overall Study|Screenfail|2|||
127711934|NCT03008382|459575432|FG003|Overall Study|Screenfail|0|||
127711935|NCT02720068|459576156|FG000|Overall Study|Adverse Event|0|||
127711936|NCT02720068|459576157|FG001|Overall Study|Adverse Event|0|||
127711937|NCT02720068|459576158|FG002|Overall Study|Adverse Event|0|||
127711938|NCT02720068|459576159|FG003|Overall Study|Adverse Event|0|||
127711939|NCT02720068|459576160|FG004|Overall Study|Adverse Event|0|||
127711940|NCT02720068|459576161|FG005|Overall Study|Adverse Event|0|||
127711941|NCT02720068|459576162|FG006|Overall Study|Adverse Event|0|||
127711942|NCT02720068|459576163|FG007|Overall Study|Adverse Event|0|||
127711943|NCT02720068|459576164|FG008|Overall Study|Adverse Event|0|||
127711944|NCT02720068|459576165|FG009|Overall Study|Adverse Event|0|||
127711945|NCT02720068|459576166|FG010|Overall Study|Adverse Event|0|||
127711946|NCT02720068|459576167|FG011|Overall Study|Adverse Event|1|||
127711947|NCT02720068|459576168|FG012|Overall Study|Adverse Event|0|||
127711948|NCT02720068|459576169|FG013|Overall Study|Adverse Event|0|||
127711949|NCT02720068|459576170|FG014|Overall Study|Adverse Event|0|||
127711950|NCT02720068|459576171|FG015|Overall Study|Adverse Event|0|||
127711951|NCT02720068|459576172|FG016|Overall Study|Adverse Event|0|||
127711952|NCT02720068|459576173|FG017|Overall Study|Adverse Event|0|||
127711953|NCT02720068|459576156|FG000|Overall Study|Death|1|||
127711954|NCT02720068|459576157|FG001|Overall Study|Death|3|||
127711955|NCT02720068|459576158|FG002|Overall Study|Death|2|||
127711956|NCT02720068|459576159|FG003|Overall Study|Death|1|||
127711957|NCT02720068|459576160|FG004|Overall Study|Death|2|||
127711958|NCT02720068|459576161|FG005|Overall Study|Death|1|||
127711959|NCT02720068|459576162|FG006|Overall Study|Death|2|||
127711960|NCT02720068|459576163|FG007|Overall Study|Death|2|||
127711961|NCT02720068|459576164|FG008|Overall Study|Death|3|||
127711962|NCT02720068|459576165|FG009|Overall Study|Death|1|||
127711963|NCT02720068|459576166|FG010|Overall Study|Death|20|||
127711964|NCT02720068|459576167|FG011|Overall Study|Death|166|||
127711965|NCT02720068|459576168|FG012|Overall Study|Death|34|||
127711966|NCT02720068|459576169|FG013|Overall Study|Death|30|||
127711967|NCT02720068|459576170|FG014|Overall Study|Death|45|||
127711968|NCT02720068|459576171|FG015|Overall Study|Death|16|||
127711969|NCT02720068|459576172|FG016|Overall Study|Death|20|||
127711970|NCT02720068|459576173|FG017|Overall Study|Death|28|||
127711971|NCT02720068|459576156|FG000|Overall Study|Lost to Follow-up|0|||
127711972|NCT02720068|459576157|FG001|Overall Study|Lost to Follow-up|0|||
127711973|NCT02720068|459576158|FG002|Overall Study|Lost to Follow-up|0|||
127711974|NCT02720068|459576159|FG003|Overall Study|Lost to Follow-up|0|||
127711975|NCT02720068|459576160|FG004|Overall Study|Lost to Follow-up|0|||
127711976|NCT02720068|459576161|FG005|Overall Study|Lost to Follow-up|0|||
127711977|NCT02720068|459576162|FG006|Overall Study|Lost to Follow-up|0|||
127711978|NCT02720068|459576163|FG007|Overall Study|Lost to Follow-up|0|||
127711979|NCT02720068|459576164|FG008|Overall Study|Lost to Follow-up|0|||
127711980|NCT02720068|459576165|FG009|Overall Study|Lost to Follow-up|0|||
127711981|NCT02720068|459576166|FG010|Overall Study|Lost to Follow-up|0|||
127711982|NCT02720068|459576167|FG011|Overall Study|Lost to Follow-up|1|||
127711983|NCT02720068|459576168|FG012|Overall Study|Lost to Follow-up|0|||
127711984|NCT02720068|459576169|FG013|Overall Study|Lost to Follow-up|1|||
127711985|NCT02720068|459576170|FG014|Overall Study|Lost to Follow-up|2|||
127711986|NCT02720068|459576171|FG015|Overall Study|Lost to Follow-up|0|||
127711987|NCT02720068|459576172|FG016|Overall Study|Lost to Follow-up|0|||
127801550|NCT01114529|459896950|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
127711988|NCT02720068|459576173|FG017|Overall Study|Lost to Follow-up|1|||
127711989|NCT02720068|459576156|FG000|Overall Study|Physician Decision|0|||
127711990|NCT02720068|459576157|FG001|Overall Study|Physician Decision|0|||
127711991|NCT02720068|459576158|FG002|Overall Study|Physician Decision|0|||
127711992|NCT02720068|459576159|FG003|Overall Study|Physician Decision|1|||
127711993|NCT02720068|459576160|FG004|Overall Study|Physician Decision|0|||
127711994|NCT02720068|459576161|FG005|Overall Study|Physician Decision|0|||
127711995|NCT02720068|459576162|FG006|Overall Study|Physician Decision|0|||
127711996|NCT02720068|459576163|FG007|Overall Study|Physician Decision|0|||
127711997|NCT02720068|459576164|FG008|Overall Study|Physician Decision|0|||
127711998|NCT02720068|459576165|FG009|Overall Study|Physician Decision|0|||
127711999|NCT02720068|459576166|FG010|Overall Study|Physician Decision|0|||
127712000|NCT02720068|459576167|FG011|Overall Study|Physician Decision|1|||
127712001|NCT02720068|459576168|FG012|Overall Study|Physician Decision|0|||
127712002|NCT02720068|459576169|FG013|Overall Study|Physician Decision|0|||
127712003|NCT02720068|459576170|FG014|Overall Study|Physician Decision|0|||
127712004|NCT02720068|459576171|FG015|Overall Study|Physician Decision|0|||
127712005|NCT02720068|459576172|FG016|Overall Study|Physician Decision|0|||
127712006|NCT02720068|459576173|FG017|Overall Study|Physician Decision|1|||
127712007|NCT02720068|459576156|FG000|Overall Study|Progressive Disease|2|||
127712008|NCT02720068|459576157|FG001|Overall Study|Progressive Disease|3|||
127712009|NCT02720068|459576158|FG002|Overall Study|Progressive Disease|1|||
127712010|NCT02720068|459576159|FG003|Overall Study|Progressive Disease|1|||
127712011|NCT02720068|459576160|FG004|Overall Study|Progressive Disease|1|||
127712012|NCT02720068|459576161|FG005|Overall Study|Progressive Disease|2|||
127712013|NCT02720068|459576162|FG006|Overall Study|Progressive Disease|1|||
127712014|NCT02720068|459576163|FG007|Overall Study|Progressive Disease|1|||
127712015|NCT02720068|459576164|FG008|Overall Study|Progressive Disease|0|||
127712016|NCT02720068|459576165|FG009|Overall Study|Progressive Disease|1|||
127712017|NCT02720068|459576166|FG010|Overall Study|Progressive Disease|0|||
127712018|NCT02720068|459576167|FG011|Overall Study|Progressive Disease|4|||
127712019|NCT02720068|459576168|FG012|Overall Study|Progressive Disease|1|||
127712020|NCT02720068|459576169|FG013|Overall Study|Progressive Disease|0|||
127712021|NCT02720068|459576170|FG014|Overall Study|Progressive Disease|0|||
127712022|NCT02720068|459576171|FG015|Overall Study|Progressive Disease|0|||
127712023|NCT02720068|459576172|FG016|Overall Study|Progressive Disease|0|||
127712024|NCT02720068|459576173|FG017|Overall Study|Progressive Disease|0|||
127712025|NCT02720068|459576156|FG000|Overall Study|Sponsor Decision|0|||
127712026|NCT02720068|459576157|FG001|Overall Study|Sponsor Decision|0|||
127712027|NCT02720068|459576158|FG002|Overall Study|Sponsor Decision|0|||
127712028|NCT02720068|459576159|FG003|Overall Study|Sponsor Decision|0|||
127712029|NCT02720068|459576160|FG004|Overall Study|Sponsor Decision|0|||
127712030|NCT02720068|459576161|FG005|Overall Study|Sponsor Decision|0|||
127712031|NCT02720068|459576162|FG006|Overall Study|Sponsor Decision|0|||
127712032|NCT02720068|459576163|FG007|Overall Study|Sponsor Decision|0|||
127712033|NCT02720068|459576164|FG008|Overall Study|Sponsor Decision|0|||
127712034|NCT02720068|459576165|FG009|Overall Study|Sponsor Decision|0|||
127712035|NCT02720068|459576166|FG010|Overall Study|Sponsor Decision|0|||
127712036|NCT02720068|459576167|FG011|Overall Study|Sponsor Decision|6|||
127712037|NCT02720068|459576168|FG012|Overall Study|Sponsor Decision|3|||
127712038|NCT02720068|459576169|FG013|Overall Study|Sponsor Decision|2|||
127712039|NCT02720068|459576170|FG014|Overall Study|Sponsor Decision|4|||
127712040|NCT02720068|459576171|FG015|Overall Study|Sponsor Decision|4|||
127712041|NCT02720068|459576172|FG016|Overall Study|Sponsor Decision|0|||
127712042|NCT02720068|459576173|FG017|Overall Study|Sponsor Decision|8|||
127712043|NCT02720068|459576156|FG000|Overall Study|Withdrawal by Subject|0|||
127712044|NCT02720068|459576157|FG001|Overall Study|Withdrawal by Subject|0|||
127712045|NCT02720068|459576158|FG002|Overall Study|Withdrawal by Subject|0|||
127712046|NCT02720068|459576159|FG003|Overall Study|Withdrawal by Subject|0|||
127712047|NCT02720068|459576160|FG004|Overall Study|Withdrawal by Subject|0|||
127712048|NCT02720068|459576161|FG005|Overall Study|Withdrawal by Subject|0|||
127712049|NCT02720068|459576162|FG006|Overall Study|Withdrawal by Subject|0|||
127712050|NCT02720068|459576163|FG007|Overall Study|Withdrawal by Subject|0|||
127712051|NCT02720068|459576164|FG008|Overall Study|Withdrawal by Subject|0|||
127712052|NCT02720068|459576165|FG009|Overall Study|Withdrawal by Subject|1|||
127712053|NCT02720068|459576166|FG010|Overall Study|Withdrawal by Subject|0|||
127712054|NCT02720068|459576167|FG011|Overall Study|Withdrawal by Subject|27|||
127712055|NCT02720068|459576168|FG012|Overall Study|Withdrawal by Subject|2|||
127712056|NCT02720068|459576169|FG013|Overall Study|Withdrawal by Subject|8|||
127712057|NCT02720068|459576170|FG014|Overall Study|Withdrawal by Subject|7|||
127712058|NCT02720068|459576171|FG015|Overall Study|Withdrawal by Subject|0|||
127712059|NCT02720068|459576172|FG016|Overall Study|Withdrawal by Subject|0|||
127712060|NCT02720068|459576173|FG017|Overall Study|Withdrawal by Subject|2|||
127712061|NCT02720068|459576156|FG000|Overall Study|Protocol Violation|0|||
127712062|NCT02720068|459576157|FG001|Overall Study|Protocol Violation|0|||
127712063|NCT02720068|459576158|FG002|Overall Study|Protocol Violation|0|||
127712064|NCT02720068|459576159|FG003|Overall Study|Protocol Violation|0|||
127712065|NCT02720068|459576160|FG004|Overall Study|Protocol Violation|0|||
127712066|NCT02720068|459576161|FG005|Overall Study|Protocol Violation|0|||
127712067|NCT02720068|459576162|FG006|Overall Study|Protocol Violation|0|||
127712068|NCT02720068|459576163|FG007|Overall Study|Protocol Violation|0|||
127712069|NCT02720068|459576164|FG008|Overall Study|Protocol Violation|0|||
127712070|NCT02720068|459576165|FG009|Overall Study|Protocol Violation|0|||
127712071|NCT02720068|459576166|FG010|Overall Study|Protocol Violation|1|||
127712072|NCT02720068|459576167|FG011|Overall Study|Protocol Violation|0|||
127712073|NCT02720068|459576168|FG012|Overall Study|Protocol Violation|0|||
127712074|NCT02720068|459576169|FG013|Overall Study|Protocol Violation|0|||
127712075|NCT02720068|459576170|FG014|Overall Study|Protocol Violation|1|||
127712076|NCT02720068|459576171|FG015|Overall Study|Protocol Violation|0|||
127712077|NCT02720068|459576172|FG016|Overall Study|Protocol Violation|1|||
127712078|NCT02720068|459576173|FG017|Overall Study|Protocol Violation|0|||
127712079|NCT02231749|459576176|FG000|Overall Study|Disease progression|229|||
127712080|NCT02231749|459576177|FG001|Overall Study|Disease progression|297|||
127712081|NCT02231749|459576176|FG000|Overall Study|Study Drug Toxicity|134|||
127712082|NCT02231749|459576177|FG001|Overall Study|Study Drug Toxicity|63|||
127712083|NCT02231749|459576176|FG000|Overall Study|Death|1|||
127712084|NCT02231749|459576177|FG001|Overall Study|Death|1|||
127712085|NCT02231749|459576176|FG000|Overall Study|AE unrelated to Study drug|32|||
127712086|NCT02231749|459576177|FG001|Overall Study|AE unrelated to Study drug|31|||
127712087|NCT02231749|459576176|FG000|Overall Study|Participant's request to discontinue|10|||
127712088|NCT02231749|459576177|FG001|Overall Study|Participant's request to discontinue|21|||
127712089|NCT02231749|459576176|FG000|Overall Study|Participant withdrew Consent|8|||
127712090|NCT02231749|459576177|FG001|Overall Study|Participant withdrew Consent|15|||
127712091|NCT02231749|459576176|FG000|Overall Study|Lost to Follow-up|1|||
127712092|NCT02231749|459576177|FG001|Overall Study|Lost to Follow-up|2|||
127712093|NCT02231749|459576176|FG000|Overall Study|Maximum Clinical Benefit|5|||
127712094|NCT02231749|459576177|FG001|Overall Study|Maximum Clinical Benefit|8|||
127712095|NCT02231749|459576176|FG000|Overall Study|Poor/Non-Compliance|0|||
127712096|NCT02231749|459576177|FG001|Overall Study|Poor/Non-Compliance|3|||
127712097|NCT02231749|459576176|FG000|Overall Study|Pregnancy|1|||
127712098|NCT02231749|459576177|FG001|Overall Study|Pregnancy|0|||
127712099|NCT02231749|459576176|FG000|Overall Study|other|0|||
127712100|NCT02231749|459576177|FG001|Overall Study|other|8|||
127712101|NCT02231749|459576176|FG000|Overall Study|No longer meets Study Criteria|1|||
127712102|NCT02231749|459576177|FG001|Overall Study|No longer meets Study Criteria|0|||
127712103|NCT03786926|459576178|FG000|Overall Study|Adverse Event|0|||
127712104|NCT03786926|459576179|FG001|Overall Study|Adverse Event|0|||
127712105|NCT03786926|459576180|FG002|Overall Study|Adverse Event|0|||
127712106|NCT03786926|459576181|FG003|Overall Study|Adverse Event|0|||
127712107|NCT03786926|459576182|FG004|Overall Study|Adverse Event|0|||
127712108|NCT03786926|459576183|FG005|Overall Study|Adverse Event|0|||
127712109|NCT03786926|459576184|FG006|Overall Study|Adverse Event|0|||
127712110|NCT03786926|459576185|FG007|Overall Study|Adverse Event|1|||
127712111|NCT03786926|459576186|FG008|Overall Study|Adverse Event|1|||
127712112|NCT03786926|459576187|FG009|Overall Study|Adverse Event|0|||
127712113|NCT03786926|459576188|FG010|Overall Study|Adverse Event|1|||
127712114|NCT03786926|459576178|FG000|Overall Study|Progressive disease|3|||
127712115|NCT03786926|459576179|FG001|Overall Study|Progressive disease|0|||
127712116|NCT03786926|459576180|FG002|Overall Study|Progressive disease|3|||
127712117|NCT03786926|459576181|FG003|Overall Study|Progressive disease|1|||
127712118|NCT03786926|459576182|FG004|Overall Study|Progressive disease|2|||
127712119|NCT03786926|459576183|FG005|Overall Study|Progressive disease|2|||
127712120|NCT03786926|459576184|FG006|Overall Study|Progressive disease|1|||
127712121|NCT03786926|459576185|FG007|Overall Study|Progressive disease|6|||
127712122|NCT03786926|459576186|FG008|Overall Study|Progressive disease|1|||
127712123|NCT03786926|459576187|FG009|Overall Study|Progressive disease|1|||
127712124|NCT03786926|459576188|FG010|Overall Study|Progressive disease|1|||
127712125|NCT03786926|459576178|FG000|Overall Study|Death|0|||
127712126|NCT03786926|459576179|FG001|Overall Study|Death|1|||
127712127|NCT03786926|459576180|FG002|Overall Study|Death|1|||
127712128|NCT03786926|459576181|FG003|Overall Study|Death|0|||
127712129|NCT03786926|459576182|FG004|Overall Study|Death|0|||
127712130|NCT03786926|459576183|FG005|Overall Study|Death|0|||
127712131|NCT03786926|459576184|FG006|Overall Study|Death|0|||
127712132|NCT03786926|459576185|FG007|Overall Study|Death|0|||
127712133|NCT03786926|459576186|FG008|Overall Study|Death|0|||
127712134|NCT03786926|459576187|FG009|Overall Study|Death|1|||
127712135|NCT03786926|459576188|FG010|Overall Study|Death|2|||
127712136|NCT03786926|459576178|FG000|Overall Study|Physician Decision|0|||
127712137|NCT03786926|459576179|FG001|Overall Study|Physician Decision|1|||
127712138|NCT03786926|459576180|FG002|Overall Study|Physician Decision|0|||
127712139|NCT03786926|459576181|FG003|Overall Study|Physician Decision|1|||
127712140|NCT03786926|459576182|FG004|Overall Study|Physician Decision|2|||
127712141|NCT03786926|459576183|FG005|Overall Study|Physician Decision|0|||
127712142|NCT03786926|459576184|FG006|Overall Study|Physician Decision|0|||
127712143|NCT03786926|459576185|FG007|Overall Study|Physician Decision|2|||
127712144|NCT03786926|459576186|FG008|Overall Study|Physician Decision|1|||
127712145|NCT03786926|459576187|FG009|Overall Study|Physician Decision|1|||
127712146|NCT03786926|459576188|FG010|Overall Study|Physician Decision|0|||
127712147|NCT03786926|459576178|FG000|Overall Study|Withdrawal by Subject|0|||
127712148|NCT03786926|459576179|FG001|Overall Study|Withdrawal by Subject|1|||
127712149|NCT03786926|459576180|FG002|Overall Study|Withdrawal by Subject|1|||
127712150|NCT03786926|459576181|FG003|Overall Study|Withdrawal by Subject|0|||
127712151|NCT03786926|459576182|FG004|Overall Study|Withdrawal by Subject|0|||
127712152|NCT03786926|459576183|FG005|Overall Study|Withdrawal by Subject|0|||
127712153|NCT03786926|459576184|FG006|Overall Study|Withdrawal by Subject|1|||
127712154|NCT03786926|459576185|FG007|Overall Study|Withdrawal by Subject|0|||
127712155|NCT03786926|459576186|FG008|Overall Study|Withdrawal by Subject|1|||
127712156|NCT03786926|459576187|FG009|Overall Study|Withdrawal by Subject|0|||
127712157|NCT03786926|459576188|FG010|Overall Study|Withdrawal by Subject|1|||
127712158|NCT03786926|459576178|FG000|Overall Study|Study terminated by Sponsor|0|||
127712159|NCT03786926|459576179|FG001|Overall Study|Study terminated by Sponsor|0|||
127712160|NCT03786926|459576180|FG002|Overall Study|Study terminated by Sponsor|0|||
127712161|NCT03786926|459576181|FG003|Overall Study|Study terminated by Sponsor|0|||
127712162|NCT03786926|459576182|FG004|Overall Study|Study terminated by Sponsor|1|||
127712163|NCT03786926|459576183|FG005|Overall Study|Study terminated by Sponsor|0|||
127712164|NCT03786926|459576184|FG006|Overall Study|Study terminated by Sponsor|0|||
127712165|NCT03786926|459576185|FG007|Overall Study|Study terminated by Sponsor|4|||
127712166|NCT03786926|459576186|FG008|Overall Study|Study terminated by Sponsor|0|||
127712167|NCT03786926|459576187|FG009|Overall Study|Study terminated by Sponsor|0|||
127712168|NCT03786926|459576188|FG010|Overall Study|Study terminated by Sponsor|0|||
127712169|NCT03786926|459576178|FG000|Overall Study|Anti-neoplasm treatment|0|||
127712170|NCT03786926|459576179|FG001|Overall Study|Anti-neoplasm treatment|0|||
127712171|NCT03786926|459576180|FG002|Overall Study|Anti-neoplasm treatment|0|||
127712172|NCT03786926|459576181|FG003|Overall Study|Anti-neoplasm treatment|0|||
127712173|NCT03786926|459576182|FG004|Overall Study|Anti-neoplasm treatment|1|||
127712174|NCT03786926|459576183|FG005|Overall Study|Anti-neoplasm treatment|0|||
127712175|NCT03786926|459576184|FG006|Overall Study|Anti-neoplasm treatment|1|||
127712176|NCT03786926|459576185|FG007|Overall Study|Anti-neoplasm treatment|0|||
127712177|NCT03786926|459576186|FG008|Overall Study|Anti-neoplasm treatment|0|||
127712178|NCT03786926|459576187|FG009|Overall Study|Anti-neoplasm treatment|0|||
127712179|NCT03786926|459576188|FG010|Overall Study|Anti-neoplasm treatment|0|||
127712180|NCT03786926|459576178|FG000|Overall Study|Other|0|||
127712181|NCT03786926|459576179|FG001|Overall Study|Other|0|||
127712182|NCT03786926|459576180|FG002|Overall Study|Other|0|||
127712183|NCT03786926|459576181|FG003|Overall Study|Other|1|||
127712184|NCT03786926|459576182|FG004|Overall Study|Other|0|||
127712185|NCT03786926|459576183|FG005|Overall Study|Other|1|||
127712186|NCT03786926|459576184|FG006|Overall Study|Other|0|||
127712187|NCT03786926|459576185|FG007|Overall Study|Other|0|||
127712188|NCT03786926|459576186|FG008|Overall Study|Other|2|||
127712189|NCT03786926|459576187|FG009|Overall Study|Other|0|||
127712190|NCT03786926|459576188|FG010|Overall Study|Other|0|||
127712191|NCT05875701|459576192|FG000|Overall Study|Lost to Follow-up|2|||
127712192|NCT05875701|459576193|FG001|Overall Study|Lost to Follow-up|0|||
127712193|NCT05875701|459576192|FG000|Overall Study|Withdrawal by Subject|1|||
127712194|NCT05875701|459576193|FG001|Overall Study|Withdrawal by Subject|1|||
127712195|NCT02989662|459576194|FG000|Overall Study|Lost to Follow-up|0|||
127712196|NCT02989662|459576195|FG001|Overall Study|Lost to Follow-up|0|||
127712197|NCT02989662|459576196|FG002|Overall Study|Lost to Follow-up|0|||
127712198|NCT02989662|459576197|FG003|Overall Study|Lost to Follow-up|2|||
127712199|NCT02989662|459576194|FG000|Overall Study|Physician Decision|3|||
127712200|NCT02989662|459576195|FG001|Overall Study|Physician Decision|0|||
127712201|NCT02989662|459576196|FG002|Overall Study|Physician Decision|0|||
127712202|NCT02989662|459576197|FG003|Overall Study|Physician Decision|0|||
127712203|NCT02989662|459576194|FG000|Overall Study|Withdrawal by Subject|1|||
127712204|NCT02989662|459576195|FG001|Overall Study|Withdrawal by Subject|0|||
127712205|NCT02989662|459576196|FG002|Overall Study|Withdrawal by Subject|0|||
127712206|NCT02989662|459576197|FG003|Overall Study|Withdrawal by Subject|0|||
127712207|NCT00328783|459576198|FG000|Overall Study|Could not tolerate ABC|21|||
127712208|NCT00328783|459576198|FG000|Overall Study|No heart in RT field|4|||
127712209|NCT00328783|459576198|FG000|Overall Study|Withdrawal by Subject|1|||
127712210|NCT04490356|459576200|FG000|Overall Study|Lost to Follow-up|1|||
127712211|NCT03733626|459576201|FG000|Overall Study|Physician Decision|4|||
127712212|NCT03733626|459576202|FG001|Overall Study|Physician Decision|4|||
127712213|NCT04174560|459576207|FG000|Overall Study|Lost to Follow-up|1|||
127712214|NCT04174560|459576208|FG001|Overall Study|Lost to Follow-up|0|||
127712215|NCT04174560|459576209|FG002|Overall Study|Lost to Follow-up|0|||
127712216|NCT04174560|459576210|FG003|Overall Study|Lost to Follow-up|0|||
127712217|NCT04174560|459576207|FG000|Overall Study|Withdrawal by Subject|0|||
127712218|NCT04174560|459576208|FG001|Overall Study|Withdrawal by Subject|0|||
127712219|NCT04174560|459576209|FG002|Overall Study|Withdrawal by Subject|2|||
127712220|NCT04174560|459576210|FG003|Overall Study|Withdrawal by Subject|0|||
127712221|NCT05424718|459576211|FG000|Overall Study|Lost to Follow-up|5|||
127712222|NCT05424718|459576212|FG001|Overall Study|Lost to Follow-up|4|||
127712223|NCT04046549|459576214|FG000|Overall Study|Adverse Event|1|||
127712224|NCT04046549|459576214|FG000|Overall Study|Physician Decision|1|||
127712225|NCT04046549|459576214|FG000|Overall Study|Withdrawal by Subject|3|||
127712226|NCT04046549|459576214|FG000|Overall Study|Other, Not Specified|5|||
127801551|NCT01114529|459896948|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
127801552|NCT01114529|459896949|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
127801553|NCT01114529|459896950|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
127801554|NCT01114529|459896948|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
127801555|NCT01114529|459896949|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
127801556|NCT01114529|459896950|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
127801557|NCT01114529|459896948|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
127801558|NCT01114529|459896949|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
127801559|NCT01114529|459896950|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
127801560|NCT01114529|459896948|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
127801561|NCT01114529|459896949|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
127801562|NCT01114529|459896950|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
127801563|NCT01114529|459896948|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
127801564|NCT01114529|459896949|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
127801565|NCT01114529|459896950|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
127801566|NCT01114529|459896948|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
127801567|NCT01114529|459896949|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
127801568|NCT01114529|459896950|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
127888454|NCT02544633|460215742|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
127888455|NCT02544633|460215743|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
127712227|NCT01553149|459576217|FG000|Overall Study|Adverse Event|0|||
127712228|NCT01553149|459576218|FG001|Overall Study|Adverse Event|9|||
127712229|NCT01553149|459576217|FG000|Overall Study|Physician Decision|5|||
127712230|NCT01553149|459576218|FG001|Overall Study|Physician Decision|10|||
127712231|NCT01553149|459576217|FG000|Overall Study|Ineligible|0|||
127712232|NCT01553149|459576218|FG001|Overall Study|Ineligible|1|||
127712233|NCT03215706|459576229|FG000|Randomization|Adverse Event unrelated to study drug|1|||
127712234|NCT03215706|459576230|FG001|Randomization|Adverse Event unrelated to study drug|0|||
127712235|NCT03215706|459576229|FG000|Randomization|participant withdrew consent|1|||
127712236|NCT03215706|459576230|FG001|Randomization|participant withdrew consent|3|||
127712237|NCT03215706|459576229|FG000|Randomization|no longer meets study criteria|1|||
127712238|NCT03215706|459576230|FG001|Randomization|no longer meets study criteria|4|||
127712239|NCT03215706|459576229|FG000|Randomization|other reasons|0|||
127712240|NCT03215706|459576230|FG001|Randomization|other reasons|2|||
127888456|NCT02544633|460215740|FG000|Treatment Period|Adverse Event|7|||
127888457|NCT02544633|460215741|FG001|Treatment Period|Adverse Event|4|||
127888458|NCT02544633|460215742|FG002|Treatment Period|Adverse Event|0|||
127888459|NCT02544633|460215743|FG003|Treatment Period|Adverse Event|5|||
127712241|NCT03215706|459576229|FG000|Treatment Period|Disease Progression|150|||
127712242|NCT03215706|459576230|FG001|Treatment Period|Disease Progression|142|||
127712243|NCT03215706|459576229|FG000|Treatment Period|Study Drug Toxicity|53|||
127712244|NCT03215706|459576230|FG001|Treatment Period|Study Drug Toxicity|21|||
127712245|NCT03215706|459576229|FG000|Treatment Period|Death|2|||
127712246|NCT03215706|459576230|FG001|Treatment Period|Death|1|||
127712247|NCT03215706|459576229|FG000|Treatment Period|Adverse event unrelated to study drug|24|||
127712248|NCT03215706|459576230|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
127712249|NCT03215706|459576229|FG000|Treatment Period|Request to D/C treatment|1|||
127712250|NCT03215706|459576230|FG001|Treatment Period|Request to D/C treatment|6|||
127801569|NCT01114529|459896948|FG000|Completed Study Medication at Month 24|Death|2|||
127801570|NCT01114529|459896949|FG001|Completed Study Medication at Month 24|Death|1|||
127801571|NCT01114529|459896950|FG002|Completed Study Medication at Month 24|Death|2|||
127801572|NCT01114529|459896948|FG000|Completed Study Medication at Month 24|Graft loss|0|||
127801573|NCT01114529|459896949|FG001|Completed Study Medication at Month 24|Graft loss|2|||
127801574|NCT01114529|459896950|FG002|Completed Study Medication at Month 24|Graft loss|0|||
127801575|NCT01114529|459896948|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
127801576|NCT01114529|459896949|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
127801577|NCT01114529|459896950|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
127801578|NCT01114529|459896948|FG000|Completed Study Medication at Month 24|Missing|2|||
127801579|NCT01114529|459896949|FG001|Completed Study Medication at Month 24|Missing|0|||
127801580|NCT01114529|459896950|FG002|Completed Study Medication at Month 24|Missing|0|||
127801581|NCT01114529|459896948|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
127801582|NCT01114529|459896949|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
127801583|NCT01114529|459896950|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
127801584|NCT01114529|459896948|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
127801585|NCT01114529|459896949|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
127801586|NCT01114529|459896950|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
127801587|NCT01114529|459896948|FG000|Completed Study Phase at Month 24|Death|8|||
127801588|NCT01114529|459896949|FG001|Completed Study Phase at Month 24|Death|5|||
127801589|NCT01114529|459896950|FG002|Completed Study Phase at Month 24|Death|4|||
127801590|NCT01114529|459896948|FG000|Completed Study Phase at Month 24|Other|2|||
127801591|NCT01114529|459896949|FG001|Completed Study Phase at Month 24|Other|0|||
127801592|NCT01114529|459896950|FG002|Completed Study Phase at Month 24|Other|0|||
127801593|NCT01114529|459896948|FG000|Completed Study Phase at Month 24|Missing|2|||
127801594|NCT01114529|459896949|FG001|Completed Study Phase at Month 24|Missing|0|||
127801595|NCT01114529|459896950|FG002|Completed Study Phase at Month 24|Missing|0|||
127801596|NCT03555266|459896953|FG000|Overall Study|Protocol Violation|6|||
127801597|NCT03555266|459896954|FG001|Overall Study|Protocol Violation|4|||
127801598|NCT02167945|459896955|FG000|Overall Study|Adverse Event|16|||
127801599|NCT02167945|459896955|FG000|Overall Study|Withdrew Consent|42|||
127801600|NCT02167945|459896955|FG000|Overall Study|Lost to Follow-up|122|||
127801601|NCT02167945|459896955|FG000|Overall Study|COVID-19 logistical restrictions|6|||
127801602|NCT02167945|459896955|FG000|Overall Study|Other, not specified|63|||
127712251|NCT03215706|459576229|FG000|Treatment Period|Participant withdrew consent|3|||
127712252|NCT03215706|459576230|FG001|Treatment Period|Participant withdrew consent|4|||
127712253|NCT03215706|459576229|FG000|Treatment Period|Lost to Follow-up|0|||
127712254|NCT03215706|459576230|FG001|Treatment Period|Lost to Follow-up|1|||
127712255|NCT03215706|459576229|FG000|Treatment Period|Other Reasons|4|||
127712256|NCT03215706|459576230|FG001|Treatment Period|Other Reasons|5|||
127712257|NCT03215706|459576229|FG000|Treatment Period|Ongoing in the treatment period|105|||
127712258|NCT03215706|459576230|FG001|Treatment Period|Ongoing in the treatment period|43|||
127712259|NCT00945724|459576231|FG000|Overall Study|Withdrawal by Subject|2|||
127712260|NCT00945724|459576231|FG000|Overall Study|Physician Decision|1|||
127712261|NCT00945724|459576231|FG000|Overall Study|Adverse Event|5|||
127712262|NCT00945724|459576231|FG000|Overall Study|Second malignancy|1|||
127712263|NCT00994643|459576938|FG000|Overall Study|Withdrawal by Subject|1|||
127712264|NCT05412004|459576939|FG000|Overall Study|Adverse Event|0|||
127712265|NCT05412004|459576940|FG001|Overall Study|Adverse Event|2|||
127712266|NCT05412004|459576941|FG002|Overall Study|Adverse Event|1|||
127712267|NCT05412004|459576942|FG003|Overall Study|Adverse Event|5|||
127712268|NCT05412004|459576939|FG000|Overall Study|Assigned Treatment by Mistake|5|||
127712269|NCT05412004|459576940|FG001|Overall Study|Assigned Treatment by Mistake|10|||
127712270|NCT05412004|459576941|FG002|Overall Study|Assigned Treatment by Mistake|2|||
127712271|NCT05412004|459576942|FG003|Overall Study|Assigned Treatment by Mistake|5|||
127712272|NCT05412004|459576939|FG000|Overall Study|Lost to Follow-up|3|||
127712273|NCT05412004|459576940|FG001|Overall Study|Lost to Follow-up|0|||
127712274|NCT05412004|459576941|FG002|Overall Study|Lost to Follow-up|0|||
127712275|NCT05412004|459576942|FG003|Overall Study|Lost to Follow-up|0|||
127712276|NCT05412004|459576939|FG000|Overall Study|Patient could not travel to site|0|||
127712277|NCT05412004|459576940|FG001|Overall Study|Patient could not travel to site|1|||
127712278|NCT05412004|459576941|FG002|Overall Study|Patient could not travel to site|0|||
127801603|NCT00132730|459896956|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
127801604|NCT00132730|459896957|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
127801605|NCT00132730|459896958|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
127801606|NCT00132730|459896959|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
127801607|NCT00132730|459896960|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
127801608|NCT00132730|459896961|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
127712279|NCT05412004|459576942|FG003|Overall Study|Patient could not travel to site|0|||
127712280|NCT05412004|459576939|FG000|Overall Study|Physician Decision|0|||
127712281|NCT05412004|459576940|FG001|Overall Study|Physician Decision|1|||
127712282|NCT05412004|459576941|FG002|Overall Study|Physician Decision|0|||
127712283|NCT05412004|459576942|FG003|Overall Study|Physician Decision|0|||
127712284|NCT05412004|459576939|FG000|Overall Study|Pregnancy|0|||
127712285|NCT05412004|459576940|FG001|Overall Study|Pregnancy|1|||
127712286|NCT05412004|459576941|FG002|Overall Study|Pregnancy|0|||
127712287|NCT05412004|459576942|FG003|Overall Study|Pregnancy|0|||
127712288|NCT05412004|459576939|FG000|Overall Study|Protocol Violation|1|||
127712289|NCT05412004|459576940|FG001|Overall Study|Protocol Violation|0|||
127712290|NCT05412004|459576941|FG002|Overall Study|Protocol Violation|0|||
127712291|NCT05412004|459576942|FG003|Overall Study|Protocol Violation|0|||
127712292|NCT05412004|459576939|FG000|Overall Study|Withdrawal by Subject|4|||
127712293|NCT05412004|459576940|FG001|Overall Study|Withdrawal by Subject|19|||
127712294|NCT05412004|459576941|FG002|Overall Study|Withdrawal by Subject|4|||
127712295|NCT05412004|459576942|FG003|Overall Study|Withdrawal by Subject|14|||
127712296|NCT05412004|459576939|FG000|Overall Study|Screen Failure|0|||
127712297|NCT05412004|459576940|FG001|Overall Study|Screen Failure|0|||
127712298|NCT05412004|459576941|FG002|Overall Study|Screen Failure|0|||
127712299|NCT05412004|459576942|FG003|Overall Study|Screen Failure|1|||
127712300|NCT05412004|459576939|FG000|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
127712301|NCT05412004|459576940|FG001|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
127712302|NCT05412004|459576941|FG002|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
127712303|NCT05412004|459576942|FG003|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|1|||
127712304|NCT00968149|459576943|FG000|Overall Study|Adverse Event|5|||
127712305|NCT00968149|459576944|FG001|Overall Study|Adverse Event|1|||
127712306|NCT00968149|459576943|FG000|Overall Study|Lack of Efficacy|0|||
127712307|NCT00968149|459576944|FG001|Overall Study|Lack of Efficacy|4|||
127712308|NCT00968149|459576943|FG000|Overall Study|Lost to Follow-up|0|||
127712309|NCT00968149|459576944|FG001|Overall Study|Lost to Follow-up|1|||
127712310|NCT00968149|459576943|FG000|Overall Study|Protocol Violation|4|||
127712311|NCT00968149|459576944|FG001|Overall Study|Protocol Violation|0|||
127712312|NCT00968149|459576943|FG000|Overall Study|Withdrawal by Subject|2|||
127712313|NCT00968149|459576944|FG001|Overall Study|Withdrawal by Subject|0|||
127712314|NCT03934931|459576945|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
127712315|NCT03934931|459576946|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
127712316|NCT03934931|459576947|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
127712317|NCT02467270|459576950|FG000|Overall Study|Participants Never Treated|0|||
127712318|NCT02467270|459576951|FG001|Overall Study|Participants Never Treated|1|||
127712319|NCT02467270|459576952|FG002|Overall Study|Participants Never Treated|0|||
127712320|NCT02467270|459576950|FG000|Overall Study|Ongoing|50|||
127712321|NCT02467270|459576951|FG001|Overall Study|Ongoing|41|||
127712322|NCT02467270|459576952|FG002|Overall Study|Ongoing|43|||
127712323|NCT02467270|459576950|FG000|Overall Study|Adverse Event|16|||
127712324|NCT02467270|459576951|FG001|Overall Study|Adverse Event|15|||
127712325|NCT02467270|459576952|FG002|Overall Study|Adverse Event|14|||
127712326|NCT02467270|459576950|FG000|Overall Study|Progressive Disease|7|||
127712327|NCT02467270|459576951|FG001|Overall Study|Progressive Disease|7|||
127712328|NCT02467270|459576952|FG002|Overall Study|Progressive Disease|4|||
127712329|NCT02467270|459576950|FG000|Overall Study|Death|2|||
127712330|NCT02467270|459576951|FG001|Overall Study|Death|0|||
127712331|NCT02467270|459576952|FG002|Overall Study|Death|2|||
127712332|NCT02467270|459576950|FG000|Overall Study|Lack of Efficacy|12|||
127712333|NCT02467270|459576951|FG001|Overall Study|Lack of Efficacy|18|||
127712334|NCT02467270|459576952|FG002|Overall Study|Lack of Efficacy|23|||
127712335|NCT02467270|459576950|FG000|Overall Study|Non-compliance With Study Drug|0|||
127712336|NCT02467270|459576951|FG001|Overall Study|Non-compliance With Study Drug|2|||
127712337|NCT02467270|459576952|FG002|Overall Study|Non-compliance With Study Drug|1|||
127712338|NCT02467270|459576950|FG000|Overall Study|Lost to Follow-up|2|||
127712339|NCT02467270|459576951|FG001|Overall Study|Lost to Follow-up|1|||
127712340|NCT02467270|459576952|FG002|Overall Study|Lost to Follow-up|0|||
127712341|NCT02467270|459576950|FG000|Overall Study|Pregnancy|0|||
127712342|NCT02467270|459576951|FG001|Overall Study|Pregnancy|1|||
127712343|NCT02467270|459576952|FG002|Overall Study|Pregnancy|0|||
127712344|NCT02467270|459576950|FG000|Overall Study|Physician Decision|0|||
127712345|NCT02467270|459576951|FG001|Overall Study|Physician Decision|4|||
127712346|NCT02467270|459576952|FG002|Overall Study|Physician Decision|1|||
127712347|NCT02467270|459576950|FG000|Overall Study|Withdrawal by Subject|4|||
127712348|NCT02467270|459576951|FG001|Overall Study|Withdrawal by Subject|3|||
127712349|NCT02467270|459576952|FG002|Overall Study|Withdrawal by Subject|5|||
127712350|NCT02467270|459576950|FG000|Overall Study|Reason not Specified|1|||
127712351|NCT02467270|459576951|FG001|Overall Study|Reason not Specified|2|||
127712352|NCT02467270|459576952|FG002|Overall Study|Reason not Specified|1|||
127712353|NCT04129164|459576959|FG000|Overall Study|Non-compliance with procedures|0|||
127712354|NCT04129164|459576960|FG001|Overall Study|Non-compliance with procedures|0|||
127712355|NCT04129164|459576961|FG002|Overall Study|Non-compliance with procedures|2|||
127712356|NCT04129164|459576962|FG003|Overall Study|Non-compliance with procedures|0|||
127712357|NCT04129164|459576959|FG000|Overall Study|Adverse Event|0|||
127712358|NCT04129164|459576960|FG001|Overall Study|Adverse Event|0|||
127712359|NCT04129164|459576961|FG002|Overall Study|Adverse Event|2|||
127712360|NCT04129164|459576962|FG003|Overall Study|Adverse Event|0|||
127712361|NCT04129164|459576959|FG000|Overall Study|Pregnancy|0|||
127712362|NCT04129164|459576960|FG001|Overall Study|Pregnancy|0|||
127712363|NCT04129164|459576961|FG002|Overall Study|Pregnancy|0|||
127712364|NCT04129164|459576962|FG003|Overall Study|Pregnancy|1|||
127712365|NCT04129164|459576959|FG000|Overall Study|Withdrawal by Subject|3|||
127712366|NCT04129164|459576960|FG001|Overall Study|Withdrawal by Subject|2|||
127712367|NCT04129164|459576961|FG002|Overall Study|Withdrawal by Subject|4|||
127712368|NCT04129164|459576962|FG003|Overall Study|Withdrawal by Subject|6|||
127712369|NCT04129164|459576959|FG000|Overall Study|Death|0|||
127712370|NCT04129164|459576960|FG001|Overall Study|Death|1|||
127712371|NCT04129164|459576961|FG002|Overall Study|Death|0|||
127712372|NCT04129164|459576962|FG003|Overall Study|Death|0|||
127712373|NCT04129164|459576959|FG000|Overall Study|Lost to Follow-up|0|||
127712374|NCT04129164|459576960|FG001|Overall Study|Lost to Follow-up|1|||
127712375|NCT04129164|459576961|FG002|Overall Study|Lost to Follow-up|0|||
127712376|NCT04129164|459576962|FG003|Overall Study|Lost to Follow-up|0|||
127712377|NCT03868930|459576963|FG000|Intervention & Post-Treatment Assessment|Lost to Follow-up|3|||
127712378|NCT03868930|459576964|FG001|Intervention & Post-Treatment Assessment|Lost to Follow-up|1|||
127712379|NCT03868930|459576963|FG000|Intervention & Post-Treatment Assessment|Physician Decision|1|||
127712380|NCT03868930|459576964|FG001|Intervention & Post-Treatment Assessment|Physician Decision|4|||
127712381|NCT03868930|459576963|FG000|Intervention & Post-Treatment Assessment|Did not start treatment|18|||
127712382|NCT03868930|459576964|FG001|Intervention & Post-Treatment Assessment|Did not start treatment|16|||
127712383|NCT03868930|459576963|FG000|Intervention & Post-Treatment Assessment|Withdrawal by Subject|25|||
127712384|NCT03868930|459576964|FG001|Intervention & Post-Treatment Assessment|Withdrawal by Subject|17|||
127712385|NCT03868930|459576963|FG000|Follow-Up Assessment|Lost to Follow-up|9|||
127712386|NCT03868930|459576964|FG001|Follow-Up Assessment|Lost to Follow-up|12|||
127712387|NCT04227899|459576967|FG000|Overall Study|Withdrawal by Subject|6|||
127712388|NCT04227899|459576968|FG001|Overall Study|Withdrawal by Subject|3|||
127712389|NCT04227899|459576967|FG000|Overall Study|Death|12|||
127712390|NCT04227899|459576968|FG001|Overall Study|Death|6|||
127712391|NCT04227899|459576967|FG000|Overall Study|Lost to Follow-up|2|||
127712392|NCT04227899|459576968|FG001|Overall Study|Lost to Follow-up|1|||
127712393|NCT01773993|459576970|FG000|Overall Study|No Visit After Treatment|35|||
127712394|NCT04664881|459576971|FG000|Overall Study|Withdrawal by Subject|1|||
127712395|NCT04664881|459576972|FG001|Overall Study|Withdrawal by Subject|8|||
127712396|NCT04664881|459576971|FG000|Overall Study|Physician Decision|0|||
127712397|NCT04664881|459576972|FG001|Overall Study|Physician Decision|5|||
127801609|NCT00132730|459896956|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
127801610|NCT00132730|459896957|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
127801611|NCT00132730|459896958|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
127801612|NCT00132730|459896959|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
127801613|NCT00132730|459896960|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
127801614|NCT00132730|459896961|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
127801615|NCT00132730|459896956|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
127801616|NCT00132730|459896957|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
127801617|NCT00132730|459896958|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
127801618|NCT00132730|459896959|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
127801619|NCT00132730|459896960|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
127801620|NCT00132730|459896961|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
127801621|NCT00132730|459896956|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
127801622|NCT00132730|459896957|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
127801623|NCT00132730|459896958|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
127801624|NCT00132730|459896959|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
127801625|NCT00132730|459896960|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
127801626|NCT00132730|459896961|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
127801627|NCT00132730|459896956|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
127801628|NCT00132730|459896957|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
127801629|NCT00132730|459896958|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
127801630|NCT00132730|459896959|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
127712398|NCT04664881|459576971|FG000|Overall Study|Lost to Follow-up|1|||
127712399|NCT04664881|459576972|FG001|Overall Study|Lost to Follow-up|0|||
127712400|NCT00357682|459576978|FG000|Overall Study|Did not receive allocated Treatment|10|||
127712401|NCT00357682|459576979|FG001|Overall Study|Did not receive allocated Treatment|9|||
127712402|NCT00357682|459576980|FG002|Overall Study|Did not receive allocated Treatment|9|||
127712403|NCT00357682|459576981|FG003|Overall Study|Did not receive allocated Treatment|10|||
127712404|NCT00357682|459576978|FG000|Overall Study|Withdrew consent|6|||
127712405|NCT00357682|459576979|FG001|Overall Study|Withdrew consent|6|||
127712406|NCT00357682|459576980|FG002|Overall Study|Withdrew consent|5|||
127712407|NCT00357682|459576981|FG003|Overall Study|Withdrew consent|5|||
127712408|NCT00357682|459576978|FG000|Overall Study|Lost to Follow-up|39|||
127712409|NCT00357682|459576979|FG001|Overall Study|Lost to Follow-up|33|||
127712410|NCT00357682|459576980|FG002|Overall Study|Lost to Follow-up|26|||
127712411|NCT00357682|459576981|FG003|Overall Study|Lost to Follow-up|35|||
127712412|NCT00357682|459576978|FG000|Overall Study|Adverse Event|24|||
127712413|NCT00357682|459576979|FG001|Overall Study|Adverse Event|32|||
127712414|NCT00357682|459576980|FG002|Overall Study|Adverse Event|22|||
127712415|NCT00357682|459576981|FG003|Overall Study|Adverse Event|27|||
127712416|NCT00357682|459576978|FG000|Overall Study|Physician Decision|32|||
127712417|NCT00357682|459576979|FG001|Overall Study|Physician Decision|20|||
127712418|NCT00357682|459576980|FG002|Overall Study|Physician Decision|24|||
127712419|NCT00357682|459576981|FG003|Overall Study|Physician Decision|30|||
127712420|NCT00357682|459576978|FG000|Overall Study|Patient decision|73|||
127712421|NCT00357682|459576979|FG001|Overall Study|Patient decision|80|||
127712422|NCT00357682|459576980|FG002|Overall Study|Patient decision|51|||
127712423|NCT00357682|459576981|FG003|Overall Study|Patient decision|59|||
127712424|NCT00357682|459576978|FG000|Overall Study|Other reason|157|||
127712425|NCT00357682|459576979|FG001|Overall Study|Other reason|130|||
127712426|NCT00357682|459576980|FG002|Overall Study|Other reason|114|||
127712427|NCT00357682|459576981|FG003|Overall Study|Other reason|99|||
127712428|NCT02726386|459576986|FG000|Overall Study|Adverse Event|17|||
127712429|NCT02726386|459576987|FG001|Overall Study|Adverse Event|20|||
127712430|NCT02726386|459576986|FG000|Overall Study|Withdrawal by Subject|14|||
127712431|NCT02726386|459576987|FG001|Overall Study|Withdrawal by Subject|28|||
127712432|NCT02726386|459576986|FG000|Overall Study|Other reasons|7|||
127712433|NCT02726386|459576987|FG001|Overall Study|Other reasons|8|||
127712434|NCT04012567|459576995|FG000|Overall Study|Lost to Follow-up|0|||
127712435|NCT04012567|459576996|FG001|Overall Study|Lost to Follow-up|1|||
127712436|NCT04012567|459576995|FG000|Overall Study|Withdrawal by Subject|1|||
127712437|NCT04012567|459576996|FG001|Overall Study|Withdrawal by Subject|0|||
127712438|NCT02951052|459576998|FG000|Overall Study|Adverse Event|13|||
127712439|NCT02951052|459576999|FG001|Overall Study|Adverse Event|5|||
127712440|NCT02951052|459576998|FG000|Overall Study|Withdrawal by Subject|1|||
127712441|NCT02951052|459576999|FG001|Overall Study|Withdrawal by Subject|5|||
127712442|NCT02951052|459576998|FG000|Overall Study|Physician Decision|2|||
127712443|NCT02951052|459576999|FG001|Overall Study|Physician Decision|0|||
127712444|NCT02951052|459576998|FG000|Overall Study|Lost to Follow-up|1|||
127712445|NCT02951052|459576999|FG001|Overall Study|Lost to Follow-up|1|||
127712446|NCT02951052|459576998|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
127712447|NCT02951052|459576999|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
127712448|NCT02951052|459576998|FG000|Overall Study|Protocol Violation|5|||
127712449|NCT02951052|459576999|FG001|Overall Study|Protocol Violation|3|||
127712450|NCT02951052|459576998|FG000|Overall Study|Lack of Efficacy|3|||
127712451|NCT02951052|459576999|FG001|Overall Study|Lack of Efficacy|4|||
127712452|NCT02951052|459576998|FG000|Overall Study|Ongoing|1|||
127712453|NCT02951052|459576999|FG001|Overall Study|Ongoing|0|||
127712454|NCT04644029|459577641|FG000|Overall Study|Death|1|||
127712455|NCT04644029|459577642|FG001|Overall Study|Death|0|||
127712456|NCT04644029|459577641|FG000|Overall Study|Physician Decision|1|||
127712457|NCT04644029|459577642|FG001|Overall Study|Physician Decision|2|||
127712458|NCT04644029|459577641|FG000|Overall Study|Withdrawal by Subject|21|||
127712459|NCT04644029|459577642|FG001|Overall Study|Withdrawal by Subject|19|||
127712460|NCT04644029|459577641|FG000|Overall Study|Lost to Follow-up|31|||
127712461|NCT04644029|459577642|FG001|Overall Study|Lost to Follow-up|34|||
127712462|NCT04644029|459577641|FG000|Overall Study|Study Terminated by Sponsor|308|||
127712463|NCT04644029|459577642|FG001|Overall Study|Study Terminated by Sponsor|309|||
127712464|NCT04644029|459577641|FG000|Overall Study|Randomized in Error|2|||
127712465|NCT04644029|459577642|FG001|Overall Study|Randomized in Error|1|||
127712466|NCT04644029|459577641|FG000|Overall Study|Other|0|||
127712467|NCT04644029|459577642|FG001|Overall Study|Other|1|||
127712468|NCT00113360|459577643|FG000|Overall Study|Adverse Event|3|||
127712469|NCT00113360|459577643|FG000|Overall Study|Subject required surgery|1|||
127712470|NCT00113360|459577643|FG000|Overall Study|Did not meet eligibility criteria|3|||
127712471|NCT00739908|459577644|FG000|Overall Study|Adverse Event|5|||
127712472|NCT00739908|459577645|FG001|Overall Study|Adverse Event|6|||
127712473|NCT00739908|459577644|FG000|Overall Study|Withdrawal by Subject|4|||
127712474|NCT00739908|459577645|FG001|Overall Study|Withdrawal by Subject|2|||
127712475|NCT00739908|459577644|FG000|Overall Study|Lost to Follow-up|14|||
127712476|NCT00739908|459577645|FG001|Overall Study|Lost to Follow-up|9|||
127712477|NCT00739908|459577644|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
127712478|NCT00739908|459577645|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
127712479|NCT00739908|459577644|FG000|Overall Study|Non-Compliance With Study Medication|0|||
127712480|NCT00739908|459577645|FG001|Overall Study|Non-Compliance With Study Medication|3|||
127712481|NCT00739908|459577644|FG000|Overall Study|Lack of Efficacy|0|||
127712482|NCT00739908|459577645|FG001|Overall Study|Lack of Efficacy|1|||
127712483|NCT00739908|459577644|FG000|Overall Study|Relocation|0|||
127712484|NCT00739908|459577645|FG001|Overall Study|Relocation|1|||
127712485|NCT00495677|459577647|FG000|Stage 1 (25 Days)|Adverse Event|0|||
127712486|NCT00495677|459577648|FG001|Stage 1 (25 Days)|Adverse Event|0|||
127712487|NCT00495677|459577649|FG002|Stage 1 (25 Days)|Adverse Event|1|||
127712488|NCT00495677|459577650|FG003|Stage 1 (25 Days)|Adverse Event|0|||
127712489|NCT00495677|459577651|FG004|Stage 1 (25 Days)|Adverse Event|0|||
127712490|NCT00495677|459577652|FG005|Stage 1 (25 Days)|Adverse Event|0|||
127712491|NCT00495677|459577653|FG006|Stage 1 (25 Days)|Adverse Event|0|||
127712492|NCT03286114|459577658|FG000|Overall Study|Adverse Event|6|||
127712493|NCT03286114|459577658|FG000|Overall Study|Death|3|||
127712494|NCT01046825|459577659|FG000|Overall Study|Failed to achieve CR to Induction Therapy|0|||
127712495|NCT01046825|459577660|FG001|Overall Study|Failed to achieve CR to Induction Therapy|1|||
127712496|NCT01046825|459577661|FG002|Overall Study|Failed to achieve CR to Induction Therapy|0|||
127712497|NCT01046825|459577662|FG003|Overall Study|Failed to achieve CR to Induction Therapy|0|||
127712498|NCT01046825|459577663|FG004|Overall Study|Failed to achieve CR to Induction Therapy|0|||
127712499|NCT01046825|459577659|FG000|Overall Study|Physician Decision|0|||
127712500|NCT01046825|459577660|FG001|Overall Study|Physician Decision|1|||
127712501|NCT01046825|459577661|FG002|Overall Study|Physician Decision|2|||
127712502|NCT01046825|459577662|FG003|Overall Study|Physician Decision|0|||
127712503|NCT01046825|459577663|FG004|Overall Study|Physician Decision|0|||
127712504|NCT01046825|459577659|FG000|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
127712505|NCT01046825|459577660|FG001|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
127712506|NCT01046825|459577661|FG002|Overall Study|Participant or family decision to withdraw from protocol treatment|1|||
127712507|NCT01046825|459577662|FG003|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
127712508|NCT01046825|459577663|FG004|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
127712509|NCT01046825|459577659|FG000|Overall Study|Found to be ineligible|0|||
127712510|NCT01046825|459577660|FG001|Overall Study|Found to be ineligible|1|||
127712511|NCT01046825|459577661|FG002|Overall Study|Found to be ineligible|0|||
127712512|NCT01046825|459577662|FG003|Overall Study|Found to be ineligible|0|||
127712513|NCT01046825|459577663|FG004|Overall Study|Found to be ineligible|0|||
127888460|NCT02544633|460215740|FG000|Treatment Period|Lack of Efficacy|17|||
127712514|NCT01046825|459577659|FG000|Overall Study|Death|0|||
127712515|NCT01046825|459577660|FG001|Overall Study|Death|0|||
127712516|NCT01046825|459577661|FG002|Overall Study|Death|0|||
127712517|NCT01046825|459577662|FG003|Overall Study|Death|1|||
127712518|NCT01046825|459577663|FG004|Overall Study|Death|0|||
127712519|NCT01046825|459577659|FG000|Overall Study|Did not submit biology samples|0|||
127712520|NCT01046825|459577660|FG001|Overall Study|Did not submit biology samples|0|||
127712521|NCT01046825|459577661|FG002|Overall Study|Did not submit biology samples|0|||
127712522|NCT01046825|459577662|FG003|Overall Study|Did not submit biology samples|0|||
127712523|NCT01046825|459577663|FG004|Overall Study|Did not submit biology samples|13|||
127712524|NCT04993677|459577671|FG000|Overall Study|Lost to Follow-up|1|||
127712525|NCT04993677|459577672|FG001|Overall Study|Lost to Follow-up|0|||
127712526|NCT04993677|459577673|FG002|Overall Study|Lost to Follow-up|0|||
127712527|NCT04993677|459577674|FG003|Overall Study|Lost to Follow-up|0|||
127712528|NCT04993677|459577671|FG000|Overall Study|Death|11|||
127712529|NCT04993677|459577672|FG001|Overall Study|Death|8|||
127712530|NCT04993677|459577673|FG002|Overall Study|Death|3|||
127712531|NCT04993677|459577674|FG003|Overall Study|Death|1|||
127712532|NCT04993677|459577671|FG000|Overall Study|Subject withdrawal of consent|4|||
127712533|NCT04993677|459577672|FG001|Overall Study|Subject withdrawal of consent|3|||
127712534|NCT04993677|459577673|FG002|Overall Study|Subject withdrawal of consent|0|||
127712535|NCT04993677|459577674|FG003|Overall Study|Subject withdrawal of consent|2|||
127712536|NCT04993677|459577671|FG000|Overall Study|Study termination by sponsor|3|||
127712537|NCT04993677|459577672|FG001|Overall Study|Study termination by sponsor|25|||
127712538|NCT04993677|459577673|FG002|Overall Study|Study termination by sponsor|3|||
127712539|NCT04993677|459577674|FG003|Overall Study|Study termination by sponsor|3|||
127712540|NCT04993677|459577671|FG000|Overall Study|Other|2|||
127712541|NCT04993677|459577672|FG001|Overall Study|Other|3|||
127712542|NCT04993677|459577673|FG002|Overall Study|Other|3|||
127712543|NCT04993677|459577674|FG003|Overall Study|Other|2|||
127712544|NCT00003222|459577677|FG000|Overall Study|Physician Decision|0|||
127712545|NCT00003222|459577678|FG001|Overall Study|Physician Decision|1|||
127712546|NCT04757753|459577679|FG000|Overall Study|Lost to Follow-up|7|||
127712547|NCT04757753|459577680|FG001|Overall Study|Lost to Follow-up|7|||
127712548|NCT04757753|459577679|FG000|Overall Study|Withdrawal by Subject|0|||
127888461|NCT02544633|460215741|FG001|Treatment Period|Lack of Efficacy|11|||
127712549|NCT04757753|459577680|FG001|Overall Study|Withdrawal by Subject|3|||
127712550|NCT04757753|459577679|FG000|Overall Study|Endodontic treatment failure|1|||
127712551|NCT04757753|459577680|FG001|Overall Study|Endodontic treatment failure|2|||
127712552|NCT04757753|459577679|FG000|Overall Study|Tooth fracture/extraction|3|||
127888462|NCT02544633|460215742|FG002|Treatment Period|Lack of Efficacy|5|||
127712553|NCT04757753|459577680|FG001|Overall Study|Tooth fracture/extraction|0|||
127801631|NCT00132730|459896960|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
127801632|NCT00132730|459896961|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
127801633|NCT00132730|459896956|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
127712554|NCT01313559|459577681|FG000|Overall Study|Withdrawal by Subject|1|||
127712555|NCT01313559|459577682|FG001|Overall Study|Withdrawal by Subject|2|||
127712556|NCT01313559|459577681|FG000|Overall Study|Disease progression|1|||
127712557|NCT01313559|459577682|FG001|Overall Study|Disease progression|0|||
127712558|NCT01313559|459577681|FG000|Overall Study|Rising PSA|2|||
127712559|NCT01313559|459577682|FG001|Overall Study|Rising PSA|0|||
127712560|NCT02656706|459577684|FG000|Overall Study|Insurance Denial|1|||
127712561|NCT03725332|459577685|FG000|Overall Study|Adverse Event|5|||
127712562|NCT03725332|459577686|FG001|Overall Study|Adverse Event|10|||
127712563|NCT03725332|459577685|FG000|Overall Study|Death|1|||
127712564|NCT03725332|459577686|FG001|Overall Study|Death|3|||
127712565|NCT03725332|459577685|FG000|Overall Study|Lost to Follow-up|43|||
127712566|NCT03725332|459577686|FG001|Overall Study|Lost to Follow-up|122|||
127712567|NCT03725332|459577685|FG000|Overall Study|Withdrawal by Subject|0|||
127712568|NCT03725332|459577686|FG001|Overall Study|Withdrawal by Subject|1|||
127712569|NCT03725332|459577685|FG000|Overall Study|Duplicate enrollment|0|||
127712570|NCT03725332|459577686|FG001|Overall Study|Duplicate enrollment|1|||
127712571|NCT03725332|459577685|FG000|Overall Study|Did not consent|0|||
127712572|NCT03725332|459577686|FG001|Overall Study|Did not consent|1|||
127712573|NCT03201939|459577689|FG000|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|32|||
127712574|NCT03201939|459577690|FG001|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|34|||
127712575|NCT05707351|459577693|FG000|Overall Study|Withdrawal by Subject|2|||
127712576|NCT05707351|459577693|FG000|Overall Study|Reason Not Specified|1|||
127712577|NCT05795153|459578643|FG000|Overall Study|Adverse Event|2|||
127712578|NCT05795153|459578643|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
127712579|NCT05795153|459578643|FG000|Overall Study|Lost to Follow-up|1|||
127712580|NCT05795153|459578643|FG000|Overall Study|Subject decision|2|||
127712581|NCT05180539|459578644|FG000|Overall Study|Lost to Follow-up|27|||
127712582|NCT05180539|459578645|FG001|Overall Study|Lost to Follow-up|30|||
127712583|NCT02566889|459578648|FG000|Overall Study|Withdrawal by Subject|3|||
127712584|NCT02566889|459578649|FG001|Overall Study|Withdrawal by Subject|1|||
127712585|NCT02566889|459578648|FG000|Overall Study|Adverse Event|4|||
127712586|NCT02566889|459578649|FG001|Overall Study|Adverse Event|2|||
127712587|NCT02566889|459578648|FG000|Overall Study|Other|6|||
127712588|NCT02566889|459578649|FG001|Overall Study|Other|2|||
127712589|NCT04518943|459578650|FG000|Consent Through Baseline|Walked too many steps at baseline|3|||
127712590|NCT04518943|459578651|FG001|Consent Through Baseline|Walked too many steps at baseline|1|||
127712591|NCT04518943|459578652|FG002|Consent Through Baseline|Walked too many steps at baseline|4|||
127712592|NCT04518943|459578653|FG003|Consent Through Baseline|Walked too many steps at baseline|5|||
127712593|NCT04518943|459578654|FG004|Consent Through Baseline|Walked too many steps at baseline|3|||
127712594|NCT04518943|459578655|FG005|Consent Through Baseline|Walked too many steps at baseline|3|||
127712595|NCT04518943|459578656|FG006|Consent Through Baseline|Walked too many steps at baseline|4|||
127712596|NCT04518943|459578657|FG007|Consent Through Baseline|Walked too many steps at baseline|7|||
127712597|NCT04518943|459578658|FG008|Consent Through Baseline|Walked too many steps at baseline|4|||
127712598|NCT04518943|459578659|FG009|Consent Through Baseline|Walked too many steps at baseline|1|||
127712599|NCT04518943|459578660|FG010|Consent Through Baseline|Walked too many steps at baseline|3|||
127712600|NCT04518943|459578661|FG011|Consent Through Baseline|Walked too many steps at baseline|1|||
127712601|NCT04518943|459578662|FG012|Consent Through Baseline|Walked too many steps at baseline|4|||
127712602|NCT04518943|459578663|FG013|Consent Through Baseline|Walked too many steps at baseline|5|||
127712603|NCT04518943|459578664|FG014|Consent Through Baseline|Walked too many steps at baseline|4|||
127712604|NCT04518943|459578665|FG015|Consent Through Baseline|Walked too many steps at baseline|4|||
127712605|NCT03699163|459578667|FG000|Overall Study|Physician Decision|12|||
127712606|NCT03699163|459578668|FG001|Overall Study|Physician Decision|0|||
127712607|NCT03699163|459578667|FG000|Overall Study|failed QC measures|205|||
127712608|NCT03699163|459578668|FG001|Overall Study|failed QC measures|206|||
127801634|NCT00132730|459896957|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
127801635|NCT00132730|459896958|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
127712609|NCT03705793|459578669|FG000|Overall Study|Lost to Follow-up|3|||
127712610|NCT03705793|459578670|FG001|Overall Study|Lost to Follow-up|4|||
127801636|NCT00132730|459896959|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
127712611|NCT03705793|459578669|FG000|Overall Study|Withdrawal by Subject|2|||
127712612|NCT03705793|459578670|FG001|Overall Study|Withdrawal by Subject|1|||
127712613|NCT02719574|459578671|FG000|Phase 1 (Dose Escalation)|Other|0|||
127712614|NCT02719574|459578672|FG001|Phase 1 (Dose Escalation)|Other|2|||
127712615|NCT02719574|459578673|FG002|Phase 1 (Dose Escalation)|Other|1|||
127712616|NCT02719574|459578674|FG003|Phase 1 (Dose Escalation)|Other|2|||
127801637|NCT00132730|459896960|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
127801638|NCT00132730|459896961|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
127801639|NCT00132730|459896956|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
127801640|NCT00132730|459896957|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
127801641|NCT00132730|459896958|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
127801642|NCT00132730|459896959|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
127801643|NCT00132730|459896960|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
127801644|NCT00132730|459896961|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
127801645|NCT00132730|459896956|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
127801646|NCT00132730|459896957|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
127801647|NCT00132730|459896958|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
127801648|NCT00132730|459896959|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
127801649|NCT00132730|459896960|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
127801650|NCT00132730|459896961|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
127801651|NCT00132730|459896956|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
127801652|NCT00132730|459896957|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
127801653|NCT00132730|459896958|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
127801654|NCT00132730|459896959|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
127801655|NCT00132730|459896960|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
127801656|NCT00132730|459896961|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
127801657|NCT00132730|459896956|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
127801658|NCT00132730|459896957|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
127801659|NCT00132730|459896958|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
127801660|NCT00132730|459896959|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
127801661|NCT00132730|459896960|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
127801662|NCT00132730|459896961|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
127801663|NCT00132730|459896956|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
127801664|NCT00132730|459896957|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
127801665|NCT00132730|459896958|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
127801666|NCT00132730|459896959|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
127801667|NCT00132730|459896960|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
127801668|NCT00132730|459896961|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
127801669|NCT00132730|459896956|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
127801670|NCT00132730|459896957|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
127801671|NCT00132730|459896958|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
127801672|NCT00132730|459896959|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
127801673|NCT00132730|459896960|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
127801674|NCT00132730|459896961|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
127801675|NCT01554579|459896962|FG000|Overall Study|Adverse Event|6|||
127888463|NCT02544633|460215743|FG003|Treatment Period|Lack of Efficacy|5|||
127712617|NCT02719574|459578675|FG004|Phase 1 (Dose Escalation)|Other|2|||
127712618|NCT02719574|459578676|FG005|Phase 1 (Dose Escalation)|Other|0|||
127712619|NCT02719574|459578677|FG006|Phase 1 (Dose Escalation)|Other|0|||
127712620|NCT02719574|459578678|FG007|Phase 1 (Dose Escalation)|Other|0|||
127712621|NCT02719574|459578679|FG008|Phase 1 (Dose Escalation)|Other|0|||
127712622|NCT02719574|459578680|FG009|Phase 1 (Dose Escalation)|Other|0|||
127712623|NCT02719574|459578681|FG010|Phase 1 (Dose Escalation)|Other|0|||
127712624|NCT02719574|459578682|FG011|Phase 1 (Dose Escalation)|Other|0|||
127712625|NCT02719574|459578683|FG012|Phase 1 (Dose Escalation)|Other|0|||
127712626|NCT02719574|459578684|FG013|Phase 1 (Dose Escalation)|Other|0|||
127712627|NCT02719574|459578685|FG014|Phase 1 (Dose Escalation)|Other|0|||
127712628|NCT02719574|459578686|FG015|Phase 1 (Dose Escalation)|Other|0|||
127712629|NCT02719574|459578687|FG016|Phase 1 (Dose Escalation)|Other|0|||
127712630|NCT02719574|459578671|FG000|Phase 1 (Dose Escalation)|Progressive Disease|1|||
127712631|NCT02719574|459578672|FG001|Phase 1 (Dose Escalation)|Progressive Disease|3|||
127712632|NCT02719574|459578673|FG002|Phase 1 (Dose Escalation)|Progressive Disease|2|||
127712633|NCT02719574|459578674|FG003|Phase 1 (Dose Escalation)|Progressive Disease|2|||
127712634|NCT02719574|459578675|FG004|Phase 1 (Dose Escalation)|Progressive Disease|1|||
127712635|NCT02719574|459578676|FG005|Phase 1 (Dose Escalation)|Progressive Disease|3|||
127712636|NCT02719574|459578677|FG006|Phase 1 (Dose Escalation)|Progressive Disease|0|||
127712637|NCT02719574|459578678|FG007|Phase 1 (Dose Escalation)|Progressive Disease|0|||
127712638|NCT02719574|459578679|FG008|Phase 1 (Dose Escalation)|Progressive Disease|0|||
127712639|NCT02719574|459578680|FG009|Phase 1 (Dose Escalation)|Progressive Disease|0|||
127712640|NCT02719574|459578681|FG010|Phase 1 (Dose Escalation)|Progressive Disease|0|||
127712641|NCT02719574|459578682|FG011|Phase 1 (Dose Escalation)|Progressive Disease|0|||
127712642|NCT02719574|459578683|FG012|Phase 1 (Dose Escalation)|Progressive Disease|0|||
127712643|NCT02719574|459578684|FG013|Phase 1 (Dose Escalation)|Progressive Disease|0|||
127712644|NCT02719574|459578685|FG014|Phase 1 (Dose Escalation)|Progressive Disease|0|||
127712645|NCT02719574|459578686|FG015|Phase 1 (Dose Escalation)|Progressive Disease|0|||
127712646|NCT02719574|459578687|FG016|Phase 1 (Dose Escalation)|Progressive Disease|0|||
127712647|NCT02719574|459578671|FG000|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
127712648|NCT02719574|459578672|FG001|Phase 1 (Dose Escalation)|HSCT Transplant|1|||
127712649|NCT02719574|459578673|FG002|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
127712650|NCT02719574|459578674|FG003|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
127712651|NCT02719574|459578675|FG004|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
127712652|NCT02719574|459578676|FG005|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
127712653|NCT02719574|459578677|FG006|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
127712654|NCT02719574|459578678|FG007|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
127712655|NCT02719574|459578679|FG008|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
127712656|NCT02719574|459578680|FG009|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
127712657|NCT02719574|459578681|FG010|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
127712658|NCT02719574|459578682|FG011|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
127712659|NCT02719574|459578683|FG012|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
127712660|NCT02719574|459578684|FG013|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
127712661|NCT02719574|459578685|FG014|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
127712662|NCT02719574|459578686|FG015|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
127712663|NCT02719574|459578687|FG016|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
127712664|NCT02719574|459578671|FG000|Phase 1 (Dose Escalation)|Death|2|||
127712665|NCT02719574|459578672|FG001|Phase 1 (Dose Escalation)|Death|1|||
127712666|NCT02719574|459578673|FG002|Phase 1 (Dose Escalation)|Death|1|||
127712667|NCT02719574|459578674|FG003|Phase 1 (Dose Escalation)|Death|0|||
127712668|NCT02719574|459578675|FG004|Phase 1 (Dose Escalation)|Death|0|||
127712669|NCT02719574|459578676|FG005|Phase 1 (Dose Escalation)|Death|0|||
127712670|NCT02719574|459578677|FG006|Phase 1 (Dose Escalation)|Death|0|||
127712671|NCT02719574|459578678|FG007|Phase 1 (Dose Escalation)|Death|0|||
127712672|NCT02719574|459578679|FG008|Phase 1 (Dose Escalation)|Death|0|||
127712673|NCT02719574|459578680|FG009|Phase 1 (Dose Escalation)|Death|0|||
127712674|NCT02719574|459578681|FG010|Phase 1 (Dose Escalation)|Death|0|||
127712675|NCT02719574|459578682|FG011|Phase 1 (Dose Escalation)|Death|0|||
127712676|NCT02719574|459578683|FG012|Phase 1 (Dose Escalation)|Death|0|||
127712677|NCT02719574|459578684|FG013|Phase 1 (Dose Escalation)|Death|0|||
127712678|NCT02719574|459578685|FG014|Phase 1 (Dose Escalation)|Death|0|||
127712679|NCT02719574|459578686|FG015|Phase 1 (Dose Escalation)|Death|0|||
127712680|NCT02719574|459578687|FG016|Phase 1 (Dose Escalation)|Death|0|||
127712681|NCT02719574|459578671|FG000|Phase 1 (Dose Escalation)|Adverse Event|0|||
127712682|NCT02719574|459578672|FG001|Phase 1 (Dose Escalation)|Adverse Event|1|||
127712683|NCT02719574|459578673|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
127712684|NCT02719574|459578674|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
127712685|NCT02719574|459578675|FG004|Phase 1 (Dose Escalation)|Adverse Event|1|||
127712686|NCT02719574|459578676|FG005|Phase 1 (Dose Escalation)|Adverse Event|1|||
127712687|NCT02719574|459578677|FG006|Phase 1 (Dose Escalation)|Adverse Event|0|||
127712688|NCT02719574|459578678|FG007|Phase 1 (Dose Escalation)|Adverse Event|0|||
127712689|NCT02719574|459578679|FG008|Phase 1 (Dose Escalation)|Adverse Event|0|||
127712690|NCT02719574|459578680|FG009|Phase 1 (Dose Escalation)|Adverse Event|0|||
127712691|NCT02719574|459578681|FG010|Phase 1 (Dose Escalation)|Adverse Event|0|||
127712692|NCT02719574|459578682|FG011|Phase 1 (Dose Escalation)|Adverse Event|0|||
127712693|NCT02719574|459578683|FG012|Phase 1 (Dose Escalation)|Adverse Event|0|||
127712694|NCT02719574|459578684|FG013|Phase 1 (Dose Escalation)|Adverse Event|0|||
127712695|NCT02719574|459578685|FG014|Phase 1 (Dose Escalation)|Adverse Event|0|||
127712696|NCT02719574|459578686|FG015|Phase 1 (Dose Escalation)|Adverse Event|0|||
127712697|NCT02719574|459578687|FG016|Phase 1 (Dose Escalation)|Adverse Event|0|||
127712698|NCT02719574|459578671|FG000|Phase 1 (Dose Escalation)|Physician Decision|0|||
127712699|NCT02719574|459578672|FG001|Phase 1 (Dose Escalation)|Physician Decision|0|||
127712700|NCT02719574|459578673|FG002|Phase 1 (Dose Escalation)|Physician Decision|0|||
127712701|NCT02719574|459578674|FG003|Phase 1 (Dose Escalation)|Physician Decision|0|||
127712702|NCT02719574|459578675|FG004|Phase 1 (Dose Escalation)|Physician Decision|1|||
127712703|NCT02719574|459578676|FG005|Phase 1 (Dose Escalation)|Physician Decision|2|||
127712704|NCT02719574|459578677|FG006|Phase 1 (Dose Escalation)|Physician Decision|0|||
127712705|NCT02719574|459578678|FG007|Phase 1 (Dose Escalation)|Physician Decision|0|||
127712706|NCT02719574|459578679|FG008|Phase 1 (Dose Escalation)|Physician Decision|0|||
127712707|NCT02719574|459578680|FG009|Phase 1 (Dose Escalation)|Physician Decision|0|||
127712708|NCT02719574|459578681|FG010|Phase 1 (Dose Escalation)|Physician Decision|0|||
127712709|NCT02719574|459578682|FG011|Phase 1 (Dose Escalation)|Physician Decision|0|||
127712710|NCT02719574|459578683|FG012|Phase 1 (Dose Escalation)|Physician Decision|0|||
127712711|NCT02719574|459578684|FG013|Phase 1 (Dose Escalation)|Physician Decision|0|||
127712712|NCT02719574|459578685|FG014|Phase 1 (Dose Escalation)|Physician Decision|0|||
127712713|NCT02719574|459578686|FG015|Phase 1 (Dose Escalation)|Physician Decision|0|||
127712714|NCT02719574|459578687|FG016|Phase 1 (Dose Escalation)|Physician Decision|0|||
127801676|NCT01554579|459896963|FG001|Overall Study|Adverse Event|25|||
127801677|NCT01554579|459896962|FG000|Overall Study|Lack of Efficacy|2|||
127801678|NCT01554579|459896963|FG001|Overall Study|Lack of Efficacy|1|||
127801679|NCT01554579|459896962|FG000|Overall Study|Withdrawal by Subject|2|||
127801680|NCT01554579|459896963|FG001|Overall Study|Withdrawal by Subject|1|||
127801681|NCT01192347|459896964|FG000|Overall Study|Death|3|||
127801682|NCT01192347|459896964|FG000|Overall Study|Lost to Follow-up|3|||
127801683|NCT01192347|459896964|FG000|Overall Study|Withdrawal by Subject|1|||
127801684|NCT01192347|459896964|FG000|Overall Study|Adverse Event|1|||
127801685|NCT01192347|459896964|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
127801686|NCT01192347|459896964|FG000|Overall Study|Patient seen in different hospital|1|||
127801687|NCT01192347|459896964|FG000|Overall Study|Patient not visiting hospital regularly|1|||
127801688|NCT01192347|459896964|FG000|Overall Study|Patient did not show up for visits|1|||
127801689|NCT02623335|459896965|FG000|Overall Study|Death|8|||
127801690|NCT02623335|459896966|FG001|Overall Study|Death|7|||
127801691|NCT02623335|459896965|FG000|Overall Study|Lost to Follow-up|15|||
127801692|NCT02623335|459896966|FG001|Overall Study|Lost to Follow-up|23|||
127801693|NCT02623335|459896965|FG000|Overall Study|Withdrawal by Subject|2|||
127801694|NCT02623335|459896966|FG001|Overall Study|Withdrawal by Subject|5|||
127801695|NCT02623335|459896965|FG000|Overall Study|Protocol Violation|2|||
127712715|NCT02719574|459578671|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
127712716|NCT02719574|459578672|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
127712717|NCT02719574|459578673|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|1|||
127712718|NCT02719574|459578674|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
127712719|NCT02719574|459578675|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
127712720|NCT02719574|459578676|FG005|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
127712721|NCT02719574|459578677|FG006|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
127712722|NCT02719574|459578678|FG007|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
127712723|NCT02719574|459578679|FG008|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
127712724|NCT02719574|459578680|FG009|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
127712725|NCT02719574|459578681|FG010|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
127712726|NCT02719574|459578682|FG011|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
127712727|NCT02719574|459578683|FG012|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
127712728|NCT02719574|459578684|FG013|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
127712729|NCT02719574|459578685|FG014|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
127712730|NCT02719574|459578686|FG015|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
127712731|NCT02719574|459578687|FG016|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
127712732|NCT02719574|459578671|FG000|Phase 1 (Dose Expansion)|Progressive Disease|0|||
127712733|NCT02719574|459578672|FG001|Phase 1 (Dose Expansion)|Progressive Disease|0|||
127712734|NCT02719574|459578673|FG002|Phase 1 (Dose Expansion)|Progressive Disease|0|||
127712735|NCT02719574|459578674|FG003|Phase 1 (Dose Expansion)|Progressive Disease|0|||
127712736|NCT02719574|459578675|FG004|Phase 1 (Dose Expansion)|Progressive Disease|0|||
127712737|NCT02719574|459578676|FG005|Phase 1 (Dose Expansion)|Progressive Disease|0|||
127712738|NCT02719574|459578677|FG006|Phase 1 (Dose Expansion)|Progressive Disease|3|||
127712739|NCT02719574|459578678|FG007|Phase 1 (Dose Expansion)|Progressive Disease|10|||
127712740|NCT02719574|459578679|FG008|Phase 1 (Dose Expansion)|Progressive Disease|1|||
127712741|NCT02719574|459578680|FG009|Phase 1 (Dose Expansion)|Progressive Disease|0|||
127712742|NCT02719574|459578681|FG010|Phase 1 (Dose Expansion)|Progressive Disease|0|||
127712743|NCT02719574|459578682|FG011|Phase 1 (Dose Expansion)|Progressive Disease|0|||
127712744|NCT02719574|459578683|FG012|Phase 1 (Dose Expansion)|Progressive Disease|0|||
127712745|NCT02719574|459578684|FG013|Phase 1 (Dose Expansion)|Progressive Disease|0|||
127712746|NCT02719574|459578685|FG014|Phase 1 (Dose Expansion)|Progressive Disease|0|||
127801696|NCT02623335|459896966|FG001|Overall Study|Protocol Violation|1|||
127801697|NCT03739528|459896967|FG000|Overall Study|Not treated|8|||
127801698|NCT03739528|459896968|FG001|Overall Study|Not treated|12|||
127801699|NCT03739528|459896967|FG000|Overall Study|Treatment and study discontinued|6|||
127801700|NCT03739528|459896968|FG001|Overall Study|Treatment and study discontinued|2|||
127801701|NCT03739528|459896967|FG000|Overall Study|Treatment discontinued + study completed|1|||
127712747|NCT02719574|459578686|FG015|Phase 1 (Dose Expansion)|Progressive Disease|0|||
127712748|NCT02719574|459578687|FG016|Phase 1 (Dose Expansion)|Progressive Disease|0|||
127712749|NCT02719574|459578671|FG000|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
127712750|NCT02719574|459578672|FG001|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
127712751|NCT02719574|459578673|FG002|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
127801702|NCT03739528|459896968|FG001|Overall Study|Treatment discontinued + study completed|3|||
127801703|NCT01046695|459896969|FG000|Overall Study|Subject had a pacemaker|0|||
127801704|NCT01046695|459896970|FG001|Overall Study|Subject had a pacemaker|1|||
127888464|NCT02544633|460215740|FG000|Treatment Period|Global Deterioration of Health|3|||
127712752|NCT02719574|459578674|FG003|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
127712753|NCT02719574|459578675|FG004|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
127801705|NCT01046695|459896969|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
127801706|NCT01046695|459896970|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
127801707|NCT03072160|459896971|FG000|Overall Study|Adverse Event|3|||
127801708|NCT03072160|459896972|FG001|Overall Study|Adverse Event|1|||
127712754|NCT02719574|459578676|FG005|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
127712755|NCT02719574|459578677|FG006|Phase 1 (Dose Expansion)|HSCT Transplant|1|||
127712756|NCT02719574|459578678|FG007|Phase 1 (Dose Expansion)|HSCT Transplant|5|||
127712757|NCT02719574|459578679|FG008|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
127712758|NCT02719574|459578680|FG009|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
127712759|NCT02719574|459578681|FG010|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
127712760|NCT02719574|459578682|FG011|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
127712761|NCT02719574|459578683|FG012|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
127712762|NCT02719574|459578684|FG013|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
127712763|NCT02719574|459578685|FG014|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
127712764|NCT02719574|459578686|FG015|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
127712765|NCT02719574|459578687|FG016|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
127712766|NCT02719574|459578671|FG000|Phase 1 (Dose Expansion)|Death|0|||
127712767|NCT02719574|459578672|FG001|Phase 1 (Dose Expansion)|Death|0|||
127712768|NCT02719574|459578673|FG002|Phase 1 (Dose Expansion)|Death|0|||
127712769|NCT02719574|459578674|FG003|Phase 1 (Dose Expansion)|Death|0|||
127712770|NCT02719574|459578675|FG004|Phase 1 (Dose Expansion)|Death|0|||
127712771|NCT02719574|459578676|FG005|Phase 1 (Dose Expansion)|Death|0|||
127712772|NCT02719574|459578677|FG006|Phase 1 (Dose Expansion)|Death|1|||
127712773|NCT02719574|459578678|FG007|Phase 1 (Dose Expansion)|Death|6|||
127712774|NCT02719574|459578679|FG008|Phase 1 (Dose Expansion)|Death|0|||
127712775|NCT02719574|459578680|FG009|Phase 1 (Dose Expansion)|Death|0|||
127712776|NCT02719574|459578681|FG010|Phase 1 (Dose Expansion)|Death|0|||
127712777|NCT02719574|459578682|FG011|Phase 1 (Dose Expansion)|Death|0|||
127712778|NCT02719574|459578683|FG012|Phase 1 (Dose Expansion)|Death|0|||
127712779|NCT02719574|459578684|FG013|Phase 1 (Dose Expansion)|Death|0|||
127712780|NCT02719574|459578685|FG014|Phase 1 (Dose Expansion)|Death|0|||
127712781|NCT02719574|459578686|FG015|Phase 1 (Dose Expansion)|Death|0|||
127712782|NCT02719574|459578687|FG016|Phase 1 (Dose Expansion)|Death|0|||
127712783|NCT02719574|459578671|FG000|Phase 1 (Dose Expansion)|Adverse Event|0|||
127712784|NCT02719574|459578672|FG001|Phase 1 (Dose Expansion)|Adverse Event|0|||
127712785|NCT02719574|459578673|FG002|Phase 1 (Dose Expansion)|Adverse Event|0|||
127712786|NCT02719574|459578674|FG003|Phase 1 (Dose Expansion)|Adverse Event|0|||
127712787|NCT02719574|459578675|FG004|Phase 1 (Dose Expansion)|Adverse Event|0|||
127712788|NCT02719574|459578676|FG005|Phase 1 (Dose Expansion)|Adverse Event|0|||
127712789|NCT02719574|459578677|FG006|Phase 1 (Dose Expansion)|Adverse Event|2|||
127712790|NCT02719574|459578678|FG007|Phase 1 (Dose Expansion)|Adverse Event|1|||
127712791|NCT02719574|459578679|FG008|Phase 1 (Dose Expansion)|Adverse Event|0|||
127712792|NCT02719574|459578680|FG009|Phase 1 (Dose Expansion)|Adverse Event|0|||
127712793|NCT02719574|459578681|FG010|Phase 1 (Dose Expansion)|Adverse Event|0|||
127712794|NCT02719574|459578682|FG011|Phase 1 (Dose Expansion)|Adverse Event|0|||
127712795|NCT02719574|459578683|FG012|Phase 1 (Dose Expansion)|Adverse Event|0|||
127712796|NCT02719574|459578684|FG013|Phase 1 (Dose Expansion)|Adverse Event|0|||
127712797|NCT02719574|459578685|FG014|Phase 1 (Dose Expansion)|Adverse Event|0|||
127712798|NCT02719574|459578686|FG015|Phase 1 (Dose Expansion)|Adverse Event|0|||
127712799|NCT02719574|459578687|FG016|Phase 1 (Dose Expansion)|Adverse Event|0|||
127712800|NCT02719574|459578671|FG000|Phase 1 (Dose Expansion)|Physician Decision|0|||
127712801|NCT02719574|459578672|FG001|Phase 1 (Dose Expansion)|Physician Decision|0|||
127712802|NCT02719574|459578673|FG002|Phase 1 (Dose Expansion)|Physician Decision|0|||
127712803|NCT02719574|459578674|FG003|Phase 1 (Dose Expansion)|Physician Decision|0|||
127712804|NCT02719574|459578675|FG004|Phase 1 (Dose Expansion)|Physician Decision|0|||
127712805|NCT02719574|459578676|FG005|Phase 1 (Dose Expansion)|Physician Decision|0|||
127712806|NCT02719574|459578677|FG006|Phase 1 (Dose Expansion)|Physician Decision|1|||
127801709|NCT03072160|459896971|FG000|Overall Study|Refused further treatment|6|||
127801710|NCT03072160|459896972|FG001|Overall Study|Refused further treatment|1|||
127801711|NCT03072160|459896971|FG000|Overall Study|Physician Decision|1|||
127712807|NCT02719574|459578678|FG007|Phase 1 (Dose Expansion)|Physician Decision|2|||
127712808|NCT02719574|459578679|FG008|Phase 1 (Dose Expansion)|Physician Decision|0|||
127712809|NCT02719574|459578680|FG009|Phase 1 (Dose Expansion)|Physician Decision|0|||
127712810|NCT02719574|459578681|FG010|Phase 1 (Dose Expansion)|Physician Decision|0|||
127712811|NCT02719574|459578682|FG011|Phase 1 (Dose Expansion)|Physician Decision|0|||
127712812|NCT02719574|459578683|FG012|Phase 1 (Dose Expansion)|Physician Decision|0|||
127712813|NCT02719574|459578684|FG013|Phase 1 (Dose Expansion)|Physician Decision|0|||
127712814|NCT02719574|459578685|FG014|Phase 1 (Dose Expansion)|Physician Decision|0|||
127712815|NCT02719574|459578686|FG015|Phase 1 (Dose Expansion)|Physician Decision|0|||
127801712|NCT03072160|459896972|FG001|Overall Study|Physician Decision|0|||
127801713|NCT03072160|459896971|FG000|Overall Study|Disease progression on study|1|||
127712816|NCT02719574|459578687|FG016|Phase 1 (Dose Expansion)|Physician Decision|0|||
127712817|NCT02719574|459578671|FG000|Phase 1 (Dose Expansion)|Other|0|||
127712818|NCT02719574|459578672|FG001|Phase 1 (Dose Expansion)|Other|0|||
127712819|NCT02719574|459578673|FG002|Phase 1 (Dose Expansion)|Other|0|||
127712820|NCT02719574|459578674|FG003|Phase 1 (Dose Expansion)|Other|0|||
127712821|NCT02719574|459578675|FG004|Phase 1 (Dose Expansion)|Other|0|||
127712822|NCT02719574|459578676|FG005|Phase 1 (Dose Expansion)|Other|0|||
127712823|NCT02719574|459578677|FG006|Phase 1 (Dose Expansion)|Other|1|||
127712824|NCT02719574|459578678|FG007|Phase 1 (Dose Expansion)|Other|7|||
127712825|NCT02719574|459578679|FG008|Phase 1 (Dose Expansion)|Other|0|||
127712826|NCT02719574|459578680|FG009|Phase 1 (Dose Expansion)|Other|0|||
127712827|NCT02719574|459578681|FG010|Phase 1 (Dose Expansion)|Other|0|||
127712828|NCT02719574|459578682|FG011|Phase 1 (Dose Expansion)|Other|0|||
127712829|NCT02719574|459578683|FG012|Phase 1 (Dose Expansion)|Other|0|||
127712830|NCT02719574|459578684|FG013|Phase 1 (Dose Expansion)|Other|0|||
127712831|NCT02719574|459578685|FG014|Phase 1 (Dose Expansion)|Other|0|||
127712832|NCT02719574|459578686|FG015|Phase 1 (Dose Expansion)|Other|0|||
127712833|NCT02719574|459578687|FG016|Phase 1 (Dose Expansion)|Other|0|||
127712834|NCT02719574|459578671|FG000|Phase 2|Protocol Defined Disease Progression|0|||
127712835|NCT02719574|459578672|FG001|Phase 2|Protocol Defined Disease Progression|0|||
127712836|NCT02719574|459578673|FG002|Phase 2|Protocol Defined Disease Progression|0|||
127712837|NCT02719574|459578674|FG003|Phase 2|Protocol Defined Disease Progression|0|||
127712838|NCT02719574|459578675|FG004|Phase 2|Protocol Defined Disease Progression|0|||
127712839|NCT02719574|459578676|FG005|Phase 2|Protocol Defined Disease Progression|0|||
127712840|NCT02719574|459578677|FG006|Phase 2|Protocol Defined Disease Progression|0|||
127712841|NCT02719574|459578678|FG007|Phase 2|Protocol Defined Disease Progression|0|||
127712842|NCT02719574|459578679|FG008|Phase 2|Protocol Defined Disease Progression|0|||
127712843|NCT02719574|459578680|FG009|Phase 2|Protocol Defined Disease Progression|65|||
127712844|NCT02719574|459578681|FG010|Phase 2|Protocol Defined Disease Progression|8|||
127712845|NCT02719574|459578682|FG011|Phase 2|Protocol Defined Disease Progression|2|||
127712846|NCT02719574|459578683|FG012|Phase 2|Protocol Defined Disease Progression|4|||
127712847|NCT02719574|459578684|FG013|Phase 2|Protocol Defined Disease Progression|9|||
127712848|NCT02719574|459578685|FG014|Phase 2|Protocol Defined Disease Progression|11|||
127712849|NCT02719574|459578686|FG015|Phase 2|Protocol Defined Disease Progression|3|||
127712850|NCT02719574|459578687|FG016|Phase 2|Protocol Defined Disease Progression|4|||
127712851|NCT02719574|459578671|FG000|Phase 2|Adverse Event|0|||
127712852|NCT02719574|459578672|FG001|Phase 2|Adverse Event|0|||
127712853|NCT02719574|459578673|FG002|Phase 2|Adverse Event|0|||
127712854|NCT02719574|459578674|FG003|Phase 2|Adverse Event|0|||
127712855|NCT02719574|459578675|FG004|Phase 2|Adverse Event|0|||
127712856|NCT02719574|459578676|FG005|Phase 2|Adverse Event|0|||
127712857|NCT02719574|459578677|FG006|Phase 2|Adverse Event|0|||
127712858|NCT02719574|459578678|FG007|Phase 2|Adverse Event|0|||
127712859|NCT02719574|459578679|FG008|Phase 2|Adverse Event|0|||
127712860|NCT02719574|459578680|FG009|Phase 2|Adverse Event|27|||
127712861|NCT02719574|459578681|FG010|Phase 2|Adverse Event|0|||
127712862|NCT02719574|459578682|FG011|Phase 2|Adverse Event|1|||
127712863|NCT02719574|459578683|FG012|Phase 2|Adverse Event|1|||
127712864|NCT02719574|459578684|FG013|Phase 2|Adverse Event|1|||
127712865|NCT02719574|459578685|FG014|Phase 2|Adverse Event|2|||
127712866|NCT02719574|459578686|FG015|Phase 2|Adverse Event|2|||
127712867|NCT02719574|459578687|FG016|Phase 2|Adverse Event|3|||
127712868|NCT02719574|459578671|FG000|Phase 2|Other|0|||
127712869|NCT02719574|459578672|FG001|Phase 2|Other|0|||
127712870|NCT02719574|459578673|FG002|Phase 2|Other|0|||
127712871|NCT02719574|459578674|FG003|Phase 2|Other|0|||
127712872|NCT02719574|459578675|FG004|Phase 2|Other|0|||
127712873|NCT02719574|459578676|FG005|Phase 2|Other|0|||
127712874|NCT02719574|459578677|FG006|Phase 2|Other|0|||
127712875|NCT02719574|459578678|FG007|Phase 2|Other|0|||
127712876|NCT02719574|459578679|FG008|Phase 2|Other|0|||
127712877|NCT02719574|459578680|FG009|Phase 2|Other|20|||
127712878|NCT02719574|459578681|FG010|Phase 2|Other|7|||
127712879|NCT02719574|459578682|FG011|Phase 2|Other|0|||
127712880|NCT02719574|459578683|FG012|Phase 2|Other|5|||
127712881|NCT02719574|459578684|FG013|Phase 2|Other|7|||
127712882|NCT02719574|459578685|FG014|Phase 2|Other|0|||
127712883|NCT02719574|459578686|FG015|Phase 2|Other|1|||
127712884|NCT02719574|459578687|FG016|Phase 2|Other|4|||
127712885|NCT02719574|459578671|FG000|Phase 2|Transplant|0|||
127712886|NCT02719574|459578672|FG001|Phase 2|Transplant|0|||
127712887|NCT02719574|459578673|FG002|Phase 2|Transplant|0|||
127712888|NCT02719574|459578674|FG003|Phase 2|Transplant|0|||
127712889|NCT02719574|459578675|FG004|Phase 2|Transplant|0|||
127712890|NCT02719574|459578676|FG005|Phase 2|Transplant|0|||
127712891|NCT02719574|459578677|FG006|Phase 2|Transplant|0|||
127712892|NCT02719574|459578678|FG007|Phase 2|Transplant|0|||
127712893|NCT02719574|459578679|FG008|Phase 2|Transplant|0|||
127712894|NCT02719574|459578680|FG009|Phase 2|Transplant|15|||
127712895|NCT02719574|459578681|FG010|Phase 2|Transplant|2|||
127712896|NCT02719574|459578682|FG011|Phase 2|Transplant|0|||
127712897|NCT02719574|459578683|FG012|Phase 2|Transplant|6|||
127712898|NCT02719574|459578684|FG013|Phase 2|Transplant|1|||
127712899|NCT02719574|459578685|FG014|Phase 2|Transplant|1|||
127712900|NCT02719574|459578686|FG015|Phase 2|Transplant|0|||
127712901|NCT02719574|459578687|FG016|Phase 2|Transplant|0|||
127801714|NCT03072160|459896972|FG001|Overall Study|Disease progression on study|1|||
127801715|NCT03072160|459896971|FG000|Overall Study|No contact|0|||
127801716|NCT03072160|459896972|FG001|Overall Study|No contact|1|||
127801717|NCT01058096|459896973|FG000|Double-blind Treatment Phase|Adverse Event|11|||
127801718|NCT01058096|459896974|FG001|Double-blind Treatment Phase|Adverse Event|15|||
127801719|NCT01058096|459896973|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
127801720|NCT01058096|459896974|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
127801721|NCT01058096|459896973|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
127801722|NCT01058096|459896974|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
127712902|NCT02719574|459578671|FG000|Phase 2|Death|0|||
127712903|NCT02719574|459578672|FG001|Phase 2|Death|0|||
127801723|NCT01058096|459896973|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
127801724|NCT01058096|459896974|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
127801725|NCT01058096|459896973|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
127801726|NCT01058096|459896974|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
127801727|NCT01058096|459896973|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
127801728|NCT01058096|459896974|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
127801729|NCT00939692|459896979|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
127801730|NCT00939692|459896980|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
127801731|NCT00939692|459896979|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
127801732|NCT00939692|459896980|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
127801733|NCT01528787|459896981|FG000|Overall Study|Withdrawal by Subject|0|||
127801734|NCT01528787|459896982|FG001|Overall Study|Withdrawal by Subject|0|||
127801735|NCT01528787|459896983|FG002|Overall Study|Withdrawal by Subject|0|||
127801736|NCT01528787|459896984|FG003|Overall Study|Withdrawal by Subject|1|||
127801737|NCT01528787|459896981|FG000|Overall Study|Family Emergency|0|||
127801738|NCT01528787|459896982|FG001|Overall Study|Family Emergency|0|||
127801739|NCT01528787|459896983|FG002|Overall Study|Family Emergency|1|||
127801740|NCT01528787|459896984|FG003|Overall Study|Family Emergency|0|||
127801741|NCT03433781|459896990|FG000|Overall Study|Progression of Disease|1|||
127801742|NCT03433781|459896991|FG001|Overall Study|Progression of Disease|0|||
127801743|NCT03433781|459896992|FG002|Overall Study|Progression of Disease|0|||
127712904|NCT02719574|459578673|FG002|Phase 2|Death|0|||
127712905|NCT02719574|459578674|FG003|Phase 2|Death|0|||
127712906|NCT02719574|459578675|FG004|Phase 2|Death|0|||
127712907|NCT02719574|459578676|FG005|Phase 2|Death|0|||
127712908|NCT02719574|459578677|FG006|Phase 2|Death|0|||
127712909|NCT02719574|459578678|FG007|Phase 2|Death|0|||
127712910|NCT02719574|459578679|FG008|Phase 2|Death|0|||
127712911|NCT02719574|459578680|FG009|Phase 2|Death|14|||
127712912|NCT02719574|459578681|FG010|Phase 2|Death|0|||
127712913|NCT02719574|459578682|FG011|Phase 2|Death|0|||
127712914|NCT02719574|459578683|FG012|Phase 2|Death|1|||
127712915|NCT02719574|459578684|FG013|Phase 2|Death|1|||
127712916|NCT02719574|459578685|FG014|Phase 2|Death|2|||
127712917|NCT02719574|459578686|FG015|Phase 2|Death|0|||
127712918|NCT02719574|459578687|FG016|Phase 2|Death|0|||
127801744|NCT03433781|459896990|FG000|Overall Study|Physician Decision|0|||
127712919|NCT02719574|459578671|FG000|Phase 2|Investigator Decision|0|||
127801745|NCT03433781|459896991|FG001|Overall Study|Physician Decision|1|||
127712920|NCT02719574|459578672|FG001|Phase 2|Investigator Decision|0|||
127801746|NCT03433781|459896992|FG002|Overall Study|Physician Decision|0|||
127801747|NCT00408694|459896993|FG000|Overall Study|Ineligible|1|||
127801748|NCT00408694|459896993|FG000|Overall Study|No protocol treatment|1|||
127801749|NCT03261531|459896994|FG000|Overall Study|Withdrawal by Subject|4|||
127801750|NCT03543410|459896997|FG000|Overall Study|Adverse Event|10|||
127801751|NCT03543410|459896998|FG001|Overall Study|Adverse Event|8|||
127801752|NCT03543410|459896999|FG002|Overall Study|Adverse Event|2|||
127801753|NCT03543410|459896997|FG000|Overall Study|Lack of Efficacy|0|||
127801754|NCT03543410|459896998|FG001|Overall Study|Lack of Efficacy|1|||
127801755|NCT03543410|459896999|FG002|Overall Study|Lack of Efficacy|0|||
127801756|NCT03543410|459896997|FG000|Overall Study|Lost to Follow-up|0|||
127801757|NCT03543410|459896998|FG001|Overall Study|Lost to Follow-up|1|||
127712921|NCT02719574|459578673|FG002|Phase 2|Investigator Decision|0|||
127712922|NCT02719574|459578674|FG003|Phase 2|Investigator Decision|0|||
127712923|NCT02719574|459578675|FG004|Phase 2|Investigator Decision|0|||
127712924|NCT02719574|459578676|FG005|Phase 2|Investigator Decision|0|||
127801758|NCT03543410|459896999|FG002|Overall Study|Lost to Follow-up|0|||
127801759|NCT03543410|459896997|FG000|Overall Study|Withdrawal by Subject|5|||
127801760|NCT03543410|459896998|FG001|Overall Study|Withdrawal by Subject|2|||
127712925|NCT02719574|459578677|FG006|Phase 2|Investigator Decision|0|||
127712926|NCT02719574|459578678|FG007|Phase 2|Investigator Decision|0|||
127712927|NCT02719574|459578679|FG008|Phase 2|Investigator Decision|0|||
127712928|NCT02719574|459578680|FG009|Phase 2|Investigator Decision|6|||
127712929|NCT02719574|459578681|FG010|Phase 2|Investigator Decision|1|||
127712930|NCT02719574|459578682|FG011|Phase 2|Investigator Decision|2|||
127712931|NCT02719574|459578683|FG012|Phase 2|Investigator Decision|3|||
127712932|NCT02719574|459578684|FG013|Phase 2|Investigator Decision|1|||
127712933|NCT02719574|459578685|FG014|Phase 2|Investigator Decision|3|||
127712934|NCT02719574|459578686|FG015|Phase 2|Investigator Decision|2|||
127712935|NCT02719574|459578687|FG016|Phase 2|Investigator Decision|0|||
127712936|NCT02719574|459578671|FG000|Phase 2|Withdrawal by Subject|0|||
127712937|NCT02719574|459578672|FG001|Phase 2|Withdrawal by Subject|0|||
127712938|NCT02719574|459578673|FG002|Phase 2|Withdrawal by Subject|0|||
127712939|NCT02719574|459578674|FG003|Phase 2|Withdrawal by Subject|0|||
127712940|NCT02719574|459578675|FG004|Phase 2|Withdrawal by Subject|0|||
127712941|NCT02719574|459578676|FG005|Phase 2|Withdrawal by Subject|0|||
127712942|NCT02719574|459578677|FG006|Phase 2|Withdrawal by Subject|0|||
127712943|NCT02719574|459578678|FG007|Phase 2|Withdrawal by Subject|0|||
127712944|NCT02719574|459578679|FG008|Phase 2|Withdrawal by Subject|0|||
127712945|NCT02719574|459578680|FG009|Phase 2|Withdrawal by Subject|5|||
127712946|NCT02719574|459578681|FG010|Phase 2|Withdrawal by Subject|0|||
127712947|NCT02719574|459578682|FG011|Phase 2|Withdrawal by Subject|0|||
127712948|NCT02719574|459578683|FG012|Phase 2|Withdrawal by Subject|0|||
127712949|NCT02719574|459578684|FG013|Phase 2|Withdrawal by Subject|1|||
127712950|NCT02719574|459578685|FG014|Phase 2|Withdrawal by Subject|1|||
127712951|NCT02719574|459578686|FG015|Phase 2|Withdrawal by Subject|2|||
127712952|NCT02719574|459578687|FG016|Phase 2|Withdrawal by Subject|0|||
127712953|NCT02719574|459578671|FG000|Phase 2|Protocol Violation|0|||
127712954|NCT02719574|459578672|FG001|Phase 2|Protocol Violation|0|||
127712955|NCT02719574|459578673|FG002|Phase 2|Protocol Violation|0|||
127712956|NCT02719574|459578674|FG003|Phase 2|Protocol Violation|0|||
127712957|NCT02719574|459578675|FG004|Phase 2|Protocol Violation|0|||
127712958|NCT02719574|459578676|FG005|Phase 2|Protocol Violation|0|||
127712959|NCT02719574|459578677|FG006|Phase 2|Protocol Violation|0|||
127712960|NCT02719574|459578678|FG007|Phase 2|Protocol Violation|0|||
127712961|NCT02719574|459578679|FG008|Phase 2|Protocol Violation|0|||
127712962|NCT02719574|459578680|FG009|Phase 2|Protocol Violation|1|||
127712963|NCT02719574|459578681|FG010|Phase 2|Protocol Violation|0|||
127712964|NCT02719574|459578682|FG011|Phase 2|Protocol Violation|0|||
127712965|NCT02719574|459578683|FG012|Phase 2|Protocol Violation|0|||
127712966|NCT02719574|459578684|FG013|Phase 2|Protocol Violation|0|||
127712967|NCT02719574|459578685|FG014|Phase 2|Protocol Violation|0|||
127712968|NCT02719574|459578686|FG015|Phase 2|Protocol Violation|0|||
127712969|NCT02719574|459578687|FG016|Phase 2|Protocol Violation|0|||
127712970|NCT03875313|459578706|FG000|Overall Study|Withdrawal by Subject|1|||
127712971|NCT03875313|459578707|FG001|Overall Study|Withdrawal by Subject|3|||
127712972|NCT03875313|459578708|FG002|Overall Study|Withdrawal by Subject|0|||
127712973|NCT03875313|459578709|FG003|Overall Study|Withdrawal by Subject|0|||
127712974|NCT03875313|459578710|FG004|Overall Study|Withdrawal by Subject|0|||
127712975|NCT03875313|459578706|FG000|Overall Study|Death|0|||
127712976|NCT03875313|459578707|FG001|Overall Study|Death|0|||
127712977|NCT03875313|459578708|FG002|Overall Study|Death|0|||
127712978|NCT03875313|459578709|FG003|Overall Study|Death|0|||
127712979|NCT03875313|459578710|FG004|Overall Study|Death|1|||
127712980|NCT03875313|459578706|FG000|Overall Study|Lost to Follow-up|0|||
127712981|NCT03875313|459578707|FG001|Overall Study|Lost to Follow-up|0|||
127712982|NCT03875313|459578708|FG002|Overall Study|Lost to Follow-up|0|||
127712983|NCT03875313|459578709|FG003|Overall Study|Lost to Follow-up|0|||
127712984|NCT03875313|459578710|FG004|Overall Study|Lost to Follow-up|1|||
127712985|NCT03875313|459578706|FG000|Overall Study|Study Termination by Sponsor|0|||
127712986|NCT03875313|459578707|FG001|Overall Study|Study Termination by Sponsor|1|||
127712987|NCT03875313|459578708|FG002|Overall Study|Study Termination by Sponsor|1|||
127712988|NCT03875313|459578709|FG003|Overall Study|Study Termination by Sponsor|0|||
127712989|NCT03875313|459578710|FG004|Overall Study|Study Termination by Sponsor|1|||
127712990|NCT03875313|459578706|FG000|Overall Study|New Anticancer Treatment|0|||
127712991|NCT03875313|459578707|FG001|Overall Study|New Anticancer Treatment|1|||
127712992|NCT03875313|459578708|FG002|Overall Study|New Anticancer Treatment|2|||
127712993|NCT03875313|459578709|FG003|Overall Study|New Anticancer Treatment|1|||
127712994|NCT03875313|459578710|FG004|Overall Study|New Anticancer Treatment|0|||
127712995|NCT03875313|459578706|FG000|Overall Study|Other, Not Specified|2|||
127712996|NCT03875313|459578707|FG001|Overall Study|Other, Not Specified|11|||
127712997|NCT03875313|459578708|FG002|Overall Study|Other, Not Specified|3|||
127712998|NCT03875313|459578709|FG003|Overall Study|Other, Not Specified|3|||
127712999|NCT03875313|459578710|FG004|Overall Study|Other, Not Specified|1|||
127713000|NCT04121546|459578711|FG000|Overall Study|Lost to Follow-up|1|||
127713001|NCT04121546|459578712|FG001|Overall Study|Lost to Follow-up|3|||
127713002|NCT02075554|459578713|FG000|Overall Study|Lost to Follow-up|7|||
127713003|NCT02075554|459578713|FG000|Overall Study|Withdrawal by Subject|5|||
127713004|NCT02075554|459578713|FG000|Overall Study|Physician Decision|3|||
127713005|NCT03248492|459578720|FG000|Overall Study|Progressive Disease|24|||
127713006|NCT03248492|459578721|FG001|Overall Study|Progressive Disease|23|||
127713007|NCT03248492|459578722|FG002|Overall Study|Progressive Disease|11|||
127713008|NCT03248492|459578723|FG003|Overall Study|Progressive Disease|66|||
127713009|NCT03248492|459578724|FG004|Overall Study|Progressive Disease|1|||
127713010|NCT03248492|459578720|FG000|Overall Study|Adverse Event|14|||
127713011|NCT03248492|459578721|FG001|Overall Study|Adverse Event|13|||
127713012|NCT03248492|459578722|FG002|Overall Study|Adverse Event|9|||
127713013|NCT03248492|459578723|FG003|Overall Study|Adverse Event|22|||
127713014|NCT03248492|459578724|FG004|Overall Study|Adverse Event|2|||
127713015|NCT03248492|459578720|FG000|Overall Study|Withdrawal by Subject|5|||
127713016|NCT03248492|459578721|FG001|Overall Study|Withdrawal by Subject|4|||
127713017|NCT03248492|459578722|FG002|Overall Study|Withdrawal by Subject|0|||
127713018|NCT03248492|459578723|FG003|Overall Study|Withdrawal by Subject|8|||
127713019|NCT03248492|459578724|FG004|Overall Study|Withdrawal by Subject|1|||
127713020|NCT03248492|459578720|FG000|Overall Study|Physician Decision|1|||
127713021|NCT03248492|459578721|FG001|Overall Study|Physician Decision|1|||
127713022|NCT03248492|459578722|FG002|Overall Study|Physician Decision|1|||
127713023|NCT03248492|459578723|FG003|Overall Study|Physician Decision|7|||
127713024|NCT03248492|459578724|FG004|Overall Study|Physician Decision|0|||
127713025|NCT03248492|459578720|FG000|Overall Study|Death|1|||
127713026|NCT03248492|459578721|FG001|Overall Study|Death|1|||
127713027|NCT03248492|459578722|FG002|Overall Study|Death|0|||
127713028|NCT03248492|459578723|FG003|Overall Study|Death|6|||
127713029|NCT03248492|459578724|FG004|Overall Study|Death|0|||
127713030|NCT03248492|459578720|FG000|Overall Study|Study Terminated by Sponsor|3|||
127713031|NCT03248492|459578721|FG001|Overall Study|Study Terminated by Sponsor|1|||
127713032|NCT03248492|459578722|FG002|Overall Study|Study Terminated by Sponsor|0|||
127713033|NCT03248492|459578723|FG003|Overall Study|Study Terminated by Sponsor|7|||
127713034|NCT03248492|459578724|FG004|Overall Study|Study Terminated by Sponsor|0|||
127713035|NCT03248492|459578720|FG000|Overall Study|Other|2|||
127713036|NCT03248492|459578721|FG001|Overall Study|Other|5|||
127713037|NCT03248492|459578722|FG002|Overall Study|Other|0|||
127713038|NCT03248492|459578723|FG003|Overall Study|Other|14|||
127713039|NCT03248492|459578724|FG004|Overall Study|Other|0|||
127713040|NCT03767335|459578725|FG000|Overall Study|Physician Decision|1|||
127713041|NCT03767335|459578726|FG001|Overall Study|Physician Decision|1|||
127713042|NCT03767335|459578727|FG002|Overall Study|Physician Decision|0|||
127713043|NCT03767335|459578725|FG000|Overall Study|Withdrawal by Subject|0|||
127713044|NCT03767335|459578726|FG001|Overall Study|Withdrawal by Subject|0|||
127713045|NCT03767335|459578727|FG002|Overall Study|Withdrawal by Subject|6|||
127713046|NCT03767335|459578725|FG000|Overall Study|Participant excluded from efficacy population|0|||
127713047|NCT03767335|459578726|FG001|Overall Study|Participant excluded from efficacy population|0|||
127713048|NCT03767335|459578727|FG002|Overall Study|Participant excluded from efficacy population|1|||
127713049|NCT03767335|459578725|FG000|Overall Study|Death|0|||
127713050|NCT03767335|459578726|FG001|Overall Study|Death|0|||
127713051|NCT03767335|459578727|FG002|Overall Study|Death|2|||
127713052|NCT03767335|459578725|FG000|Overall Study|Progressive Disease|2|||
127713053|NCT03767335|459578726|FG001|Overall Study|Progressive Disease|2|||
127713054|NCT03767335|459578727|FG002|Overall Study|Progressive Disease|2|||
127713055|NCT03767335|459578725|FG000|Overall Study|Disease progression needing additional medication|0|||
127713056|NCT03767335|459578726|FG001|Overall Study|Disease progression needing additional medication|0|||
127713057|NCT03767335|459578727|FG002|Overall Study|Disease progression needing additional medication|17|||
127713058|NCT03767335|459578725|FG000|Overall Study|Sponsor decision|0|||
127713059|NCT03767335|459578726|FG001|Overall Study|Sponsor decision|0|||
127713060|NCT03767335|459578727|FG002|Overall Study|Sponsor decision|2|||
127713061|NCT03767335|459578725|FG000|Overall Study|Other Medical Reasons|0|||
127713062|NCT03767335|459578726|FG001|Overall Study|Other Medical Reasons|0|||
127713063|NCT03767335|459578727|FG002|Overall Study|Other Medical Reasons|3|||
127713064|NCT03705390|459578728|FG000|10 Week Initial Treatment Period|Trial suspended prior to completion|2|||
127713065|NCT03705390|459578728|FG000|Treatment Extension|Trial closed early due to COVID-19 pandemic|1|||
127713066|NCT04495621|459578730|FG000|Overall Study|Withdrawal by Subject|0|||
127713067|NCT04495621|459578731|FG001|Overall Study|Withdrawal by Subject|3|||
127713068|NCT04495621|459578730|FG000|Overall Study|Death|7|||
127713069|NCT04495621|459578731|FG001|Overall Study|Death|11|||
127713070|NCT04495621|459578730|FG000|Overall Study|Investigator Decision|0|||
127713071|NCT04495621|459578731|FG001|Overall Study|Investigator Decision|7|||
127713072|NCT04495621|459578730|FG000|Overall Study|Lost to Follow-up|0|||
127713073|NCT04495621|459578731|FG001|Overall Study|Lost to Follow-up|1|||
127713074|NCT02701283|459578745|FG000|Overall Study|Death|25|||
127713075|NCT02701283|459578746|FG001|Overall Study|Death|29|||
127713076|NCT02701283|459578747|FG002|Overall Study|Death|19|||
127713077|NCT02701283|459578745|FG000|Overall Study|Lost to Follow-up|3|||
127713078|NCT02701283|459578746|FG001|Overall Study|Lost to Follow-up|8|||
127713079|NCT02701283|459578747|FG002|Overall Study|Lost to Follow-up|1|||
127713080|NCT02701283|459578745|FG000|Overall Study|Withdrawal by Subject|12|||
127713081|NCT02701283|459578746|FG001|Overall Study|Withdrawal by Subject|41|||
127713082|NCT02701283|459578747|FG002|Overall Study|Withdrawal by Subject|1|||
127713083|NCT02701283|459578745|FG000|Overall Study|Missed 2-year visit|22|||
127713084|NCT02701283|459578746|FG001|Overall Study|Missed 2-year visit|27|||
127713085|NCT02701283|459578747|FG002|Overall Study|Missed 2-year visit|0|||
127713086|NCT02701283|459578745|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
127713087|NCT02701283|459578746|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
127713088|NCT02701283|459578747|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
127713089|NCT01830595|459578748|FG000|First Period|Withdrawal by Subject|1|||
127713090|NCT01830595|459578749|FG001|First Period|Withdrawal by Subject|3|||
127713091|NCT01830595|459578748|FG000|Washout|Withdrawal by Subject|2|||
127713092|NCT01830595|459578749|FG001|Washout|Withdrawal by Subject|2|||
127713093|NCT04908514|459578752|FG000|Overall Study|Lost to Follow-up|2|||
127713094|NCT04908514|459578752|FG000|Overall Study|Withdrawal by Subject|1|||
127713095|NCT02206828|459578755|FG000|Overall Study|Lost to Follow-up|7|||
127713096|NCT03213457|459579274|FG000|Screening Period|Withdrawal by Subject|0|||
127713097|NCT03213457|459579275|FG001|Screening Period|Withdrawal by Subject|1|||
127713098|NCT03213457|459579276|FG002|Screening Period|Withdrawal by Subject|0|||
127713099|NCT03213457|459579274|FG000|Screening Period|Other|1|||
127713100|NCT03213457|459579275|FG001|Screening Period|Other|0|||
127713101|NCT03213457|459579276|FG002|Screening Period|Other|0|||
127713102|NCT03213457|459579274|FG000|Double-Blind Period|Adverse Event|3|||
127713103|NCT03213457|459579275|FG001|Double-Blind Period|Adverse Event|2|||
127713104|NCT03213457|459579276|FG002|Double-Blind Period|Adverse Event|7|||
127713105|NCT03213457|459579274|FG000|Double-Blind Period|Withdrawal by Subject|14|||
127713106|NCT03213457|459579275|FG001|Double-Blind Period|Withdrawal by Subject|2|||
127713107|NCT03213457|459579276|FG002|Double-Blind Period|Withdrawal by Subject|14|||
127713108|NCT03213457|459579274|FG000|Double-Blind Period|Lost to Follow-up|2|||
127713109|NCT03213457|459579275|FG001|Double-Blind Period|Lost to Follow-up|3|||
127713110|NCT03213457|459579276|FG002|Double-Blind Period|Lost to Follow-up|9|||
127713111|NCT03213457|459579274|FG000|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
127713112|NCT03213457|459579275|FG001|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
127713113|NCT03213457|459579276|FG002|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
127713114|NCT03213457|459579274|FG000|Double-Blind Period|Non-compliance with study procedures|0|||
127713115|NCT03213457|459579275|FG001|Double-Blind Period|Non-compliance with study procedures|2|||
127713116|NCT03213457|459579276|FG002|Double-Blind Period|Non-compliance with study procedures|4|||
127713117|NCT03213457|459579274|FG000|Double-Blind Period|Pregnancy|5|||
127713118|NCT03213457|459579275|FG001|Double-Blind Period|Pregnancy|0|||
127713119|NCT03213457|459579276|FG002|Double-Blind Period|Pregnancy|0|||
127713120|NCT03213457|459579274|FG000|Double-Blind Period|Other|10|||
127713121|NCT03213457|459579275|FG001|Double-Blind Period|Other|3|||
127713122|NCT03213457|459579276|FG002|Double-Blind Period|Other|17|||
127713123|NCT03213457|459579274|FG000|Open-Label Period|Adverse Event|1|||
127713124|NCT03213457|459579275|FG001|Open-Label Period|Adverse Event|2|||
127713125|NCT03213457|459579276|FG002|Open-Label Period|Adverse Event|2|||
127713126|NCT03213457|459579274|FG000|Open-Label Period|Withdrawal by Subject|12|||
127713127|NCT03213457|459579275|FG001|Open-Label Period|Withdrawal by Subject|5|||
127713128|NCT03213457|459579276|FG002|Open-Label Period|Withdrawal by Subject|24|||
127713129|NCT03213457|459579274|FG000|Open-Label Period|Lost to Follow-up|1|||
127713130|NCT03213457|459579275|FG001|Open-Label Period|Lost to Follow-up|2|||
127713131|NCT03213457|459579276|FG002|Open-Label Period|Lost to Follow-up|8|||
127713132|NCT03213457|459579274|FG000|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
127713133|NCT03213457|459579275|FG001|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
127713134|NCT03213457|459579276|FG002|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
127801761|NCT03543410|459896999|FG002|Overall Study|Withdrawal by Subject|8|||
127801762|NCT03543410|459896997|FG000|Overall Study|Protocol Violation|0|||
127801763|NCT03543410|459896998|FG001|Overall Study|Protocol Violation|1|||
127801764|NCT03543410|459896999|FG002|Overall Study|Protocol Violation|0|||
127801765|NCT03543410|459896997|FG000|Overall Study|Due to COVID-19|4|||
127801766|NCT03543410|459896998|FG001|Overall Study|Due to COVID-19|0|||
127713135|NCT03213457|459579274|FG000|Open-Label Period|Non-compliance with study procedures|1|||
127713136|NCT03213457|459579275|FG001|Open-Label Period|Non-compliance with study procedures|1|||
127801767|NCT03543410|459896999|FG002|Overall Study|Due to COVID-19|2|||
127713137|NCT03213457|459579276|FG002|Open-Label Period|Non-compliance with study procedures|2|||
127713138|NCT03213457|459579274|FG000|Open-Label Period|Exclusionary medications|0|||
127713139|NCT03213457|459579275|FG001|Open-Label Period|Exclusionary medications|0|||
127801768|NCT03543410|459896997|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
127801769|NCT03543410|459896998|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
127801770|NCT03543410|459896999|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
127801771|NCT03543410|459896997|FG000|Overall Study|Not Due to COVID-19|2|||
127801772|NCT03543410|459896998|FG001|Overall Study|Not Due to COVID-19|0|||
127713140|NCT03213457|459579276|FG002|Open-Label Period|Exclusionary medications|1|||
127713141|NCT03213457|459579274|FG000|Open-Label Period|Other|1|||
127713142|NCT03213457|459579275|FG001|Open-Label Period|Other|1|||
127713143|NCT03213457|459579276|FG002|Open-Label Period|Other|6|||
127713144|NCT03213457|459579274|FG000|Follow-Up Period|Adverse Event|16|||
127713145|NCT03213457|459579275|FG001|Follow-Up Period|Adverse Event|8|||
127713146|NCT03213457|459579276|FG002|Follow-Up Period|Adverse Event|37|||
127713147|NCT03213457|459579274|FG000|Follow-Up Period|Withdrawal by Subject|18|||
127713148|NCT03213457|459579275|FG001|Follow-Up Period|Withdrawal by Subject|11|||
127713149|NCT03213457|459579276|FG002|Follow-Up Period|Withdrawal by Subject|55|||
127713150|NCT03213457|459579274|FG000|Follow-Up Period|Lost to Follow-up|28|||
127713151|NCT03213457|459579275|FG001|Follow-Up Period|Lost to Follow-up|15|||
127713152|NCT03213457|459579276|FG002|Follow-Up Period|Lost to Follow-up|50|||
127713153|NCT03213457|459579274|FG000|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|3|||
127713154|NCT03213457|459579275|FG001|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
127713155|NCT03213457|459579276|FG002|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
127713156|NCT03213457|459579274|FG000|Follow-Up Period|Non-compliance with study procedures|4|||
127713157|NCT03213457|459579275|FG001|Follow-Up Period|Non-compliance with study procedures|1|||
127713158|NCT03213457|459579276|FG002|Follow-Up Period|Non-compliance with study procedures|6|||
127713159|NCT03213457|459579274|FG000|Follow-Up Period|Pregnancy|7|||
127713160|NCT03213457|459579275|FG001|Follow-Up Period|Pregnancy|0|||
127713161|NCT03213457|459579276|FG002|Follow-Up Period|Pregnancy|18|||
127713162|NCT03213457|459579274|FG000|Follow-Up Period|Exclusionary medications|1|||
127713163|NCT03213457|459579275|FG001|Follow-Up Period|Exclusionary medications|1|||
127713164|NCT03213457|459579276|FG002|Follow-Up Period|Exclusionary medications|5|||
127713165|NCT03213457|459579274|FG000|Follow-Up Period|COVID-19 logistical restrictions|1|||
127713166|NCT03213457|459579275|FG001|Follow-Up Period|COVID-19 logistical restrictions|0|||
127713167|NCT03213457|459579276|FG002|Follow-Up Period|COVID-19 logistical restrictions|0|||
127713168|NCT03213457|459579274|FG000|Follow-Up Period|Other|14|||
127713169|NCT03213457|459579275|FG001|Follow-Up Period|Other|10|||
127713170|NCT03213457|459579276|FG002|Follow-Up Period|Other|31|||
127713171|NCT04940624|459579277|FG000|Overall Study|Adverse Event|4|||
127713172|NCT04940624|459579278|FG001|Overall Study|Adverse Event|11|||
127888465|NCT02544633|460215741|FG001|Treatment Period|Global Deterioration of Health|3|||
127888466|NCT02544633|460215742|FG002|Treatment Period|Global Deterioration of Health|0|||
127888467|NCT02544633|460215743|FG003|Treatment Period|Global Deterioration of Health|1|||
127888468|NCT02544633|460215740|FG000|Treatment Period|Withdrawal by Subject|1|||
127888469|NCT02544633|460215741|FG001|Treatment Period|Withdrawal by Subject|0|||
127888470|NCT02544633|460215742|FG002|Treatment Period|Withdrawal by Subject|0|||
127888471|NCT02544633|460215743|FG003|Treatment Period|Withdrawal by Subject|0|||
127888472|NCT02544633|460215740|FG000|Treatment Period|Lost to Follow-up|0|||
127888473|NCT02544633|460215741|FG001|Treatment Period|Lost to Follow-up|1|||
127888474|NCT02544633|460215742|FG002|Treatment Period|Lost to Follow-up|0|||
127888475|NCT02544633|460215743|FG003|Treatment Period|Lost to Follow-up|0|||
127888476|NCT02544633|460215740|FG000|Treatment Period|Death|0|||
127888477|NCT02544633|460215741|FG001|Treatment Period|Death|0|||
127888478|NCT02544633|460215742|FG002|Treatment Period|Death|1|||
127888479|NCT02544633|460215743|FG003|Treatment Period|Death|0|||
127888480|NCT02544633|460215740|FG000|Treatment Period|Non-compliance|0|||
127888481|NCT02544633|460215741|FG001|Treatment Period|Non-compliance|0|||
127888482|NCT02544633|460215742|FG002|Treatment Period|Non-compliance|1|||
127888483|NCT02544633|460215743|FG003|Treatment Period|Non-compliance|0|||
127888484|NCT02544633|460215740|FG000|Treatment Period|Clinical Disease Progression|0|||
127888485|NCT02544633|460215741|FG001|Treatment Period|Clinical Disease Progression|0|||
127888486|NCT02544633|460215742|FG002|Treatment Period|Clinical Disease Progression|0|||
127888487|NCT02544633|460215743|FG003|Treatment Period|Clinical Disease Progression|1|||
127888488|NCT02544633|460215740|FG000|Survival Follow-up Period|Death|12|||
127888489|NCT02544633|460215741|FG001|Survival Follow-up Period|Death|14|||
127888490|NCT02544633|460215742|FG002|Survival Follow-up Period|Death|3|||
127888491|NCT02544633|460215743|FG003|Survival Follow-up Period|Death|9|||
127713173|NCT04940624|459579277|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
127713174|NCT04940624|459579278|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
127713175|NCT04940624|459579277|FG000|Overall Study|Physician Decision|1|||
127713176|NCT04940624|459579278|FG001|Overall Study|Physician Decision|0|||
127713177|NCT04940624|459579277|FG000|Overall Study|Lost to Follow-up|1|||
127888492|NCT02544633|460215740|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
127888493|NCT02544633|460215741|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
127713178|NCT04940624|459579278|FG001|Overall Study|Lost to Follow-up|0|||
127713179|NCT04940624|459579277|FG000|Overall Study|Reason Not Specified|1|||
127713180|NCT04940624|459579278|FG001|Overall Study|Reason Not Specified|0|||
127888494|NCT02544633|460215742|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
127888495|NCT02544633|460215743|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
127888496|NCT02544633|460215740|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
127713181|NCT05714059|459579288|FG000|Overall Study|Withdrawal by Subject|2|||
127713182|NCT05714059|459579289|FG001|Overall Study|Withdrawal by Subject|2|||
127713183|NCT05714059|459579288|FG000|Overall Study|Adverse Event|0|||
127713184|NCT05714059|459579289|FG001|Overall Study|Adverse Event|1|||
127713185|NCT05714059|459579288|FG000|Overall Study|Lost to Follow-up|0|||
127713186|NCT05714059|459579289|FG001|Overall Study|Lost to Follow-up|1|||
127713187|NCT05714059|459579288|FG000|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|3|||
127713188|NCT05714059|459579289|FG001|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|0|||
127713189|NCT05714059|459579288|FG000|Overall Study|TECHNICAL PROBLEMS|0|||
127713190|NCT05714059|459579289|FG001|Overall Study|TECHNICAL PROBLEMS|1|||
127713191|NCT05116774|459579291|FG000|Part 1 (up to 24 Weeks)|Withdrawal by Subject|0|||
127713192|NCT05116774|459579292|FG001|Part 1 (up to 24 Weeks)|Withdrawal by Subject|1|||
127713193|NCT05116774|459579291|FG000|Part 1 (up to 24 Weeks)|Adverse Event|1|||
127713194|NCT05116774|459579292|FG001|Part 1 (up to 24 Weeks)|Adverse Event|0|||
127713195|NCT05116774|459579291|FG000|Part 2 (up to 52 Weeks)|Adverse Event|1|||
127713196|NCT05116774|459579292|FG001|Part 2 (up to 52 Weeks)|Adverse Event|0|||
127713197|NCT05116774|459579291|FG000|Part 2 (up to 52 Weeks)|Miscellaneous|3|||
127713198|NCT05116774|459579292|FG001|Part 2 (up to 52 Weeks)|Miscellaneous|1|||
127713199|NCT03150862|459579294|FG000|Overall Study|Death|2|||
127713200|NCT03150862|459579295|FG001|Overall Study|Death|7|||
127713201|NCT03150862|459579296|FG002|Overall Study|Death|8|||
127713202|NCT03150862|459579297|FG003|Overall Study|Death|27|||
127713203|NCT03150862|459579298|FG004|Overall Study|Death|4|||
127713204|NCT03150862|459579299|FG005|Overall Study|Death|8|||
127713205|NCT03150862|459579300|FG006|Overall Study|Death|6|||
127713206|NCT03150862|459579301|FG007|Overall Study|Death|21|||
127713207|NCT03150862|459579294|FG000|Overall Study|Withdrawal by Subject|1|||
127713208|NCT03150862|459579295|FG001|Overall Study|Withdrawal by Subject|1|||
127713209|NCT03150862|459579296|FG002|Overall Study|Withdrawal by Subject|0|||
127713210|NCT03150862|459579297|FG003|Overall Study|Withdrawal by Subject|3|||
127713211|NCT03150862|459579298|FG004|Overall Study|Withdrawal by Subject|1|||
127713212|NCT03150862|459579299|FG005|Overall Study|Withdrawal by Subject|1|||
127713213|NCT03150862|459579300|FG006|Overall Study|Withdrawal by Subject|1|||
127713214|NCT03150862|459579301|FG007|Overall Study|Withdrawal by Subject|3|||
127713215|NCT03150862|459579294|FG000|Overall Study|Lost to Follow-up|0|||
127713216|NCT03150862|459579295|FG001|Overall Study|Lost to Follow-up|0|||
127713217|NCT03150862|459579296|FG002|Overall Study|Lost to Follow-up|1|||
127713218|NCT03150862|459579297|FG003|Overall Study|Lost to Follow-up|0|||
127713219|NCT03150862|459579298|FG004|Overall Study|Lost to Follow-up|0|||
127713220|NCT03150862|459579299|FG005|Overall Study|Lost to Follow-up|0|||
127713221|NCT03150862|459579300|FG006|Overall Study|Lost to Follow-up|0|||
127713222|NCT03150862|459579301|FG007|Overall Study|Lost to Follow-up|2|||
127713223|NCT03150862|459579294|FG000|Overall Study|Sponsor's decision|0|||
127713224|NCT03150862|459579295|FG001|Overall Study|Sponsor's decision|0|||
127713225|NCT03150862|459579296|FG002|Overall Study|Sponsor's decision|0|||
127713226|NCT03150862|459579297|FG003|Overall Study|Sponsor's decision|10|||
127713227|NCT03150862|459579298|FG004|Overall Study|Sponsor's decision|3|||
127801773|NCT03543410|459896999|FG002|Overall Study|Not Due to COVID-19|1|||
127801774|NCT00666926|459897000|FG000|Overall Study|Adverse Event|0|||
127801775|NCT00666926|459897001|FG001|Overall Study|Adverse Event|0|||
127801776|NCT00666926|459897002|FG002|Overall Study|Adverse Event|0|||
127801777|NCT00666926|459897003|FG003|Overall Study|Adverse Event|0|||
127713228|NCT03150862|459579299|FG005|Overall Study|Sponsor's decision|0|||
127801778|NCT00666926|459897004|FG004|Overall Study|Adverse Event|0|||
127713229|NCT03150862|459579300|FG006|Overall Study|Sponsor's decision|1|||
127713230|NCT03150862|459579301|FG007|Overall Study|Sponsor's decision|1|||
127713231|NCT03150862|459579294|FG000|Overall Study|Change in Methylation status|0|||
127713232|NCT03150862|459579295|FG001|Overall Study|Change in Methylation status|0|||
127713233|NCT03150862|459579296|FG002|Overall Study|Change in Methylation status|0|||
127713234|NCT03150862|459579297|FG003|Overall Study|Change in Methylation status|0|||
127713235|NCT03150862|459579298|FG004|Overall Study|Change in Methylation status|1|||
127713236|NCT03150862|459579299|FG005|Overall Study|Change in Methylation status|0|||
127713237|NCT03150862|459579300|FG006|Overall Study|Change in Methylation status|0|||
127713238|NCT03150862|459579301|FG007|Overall Study|Change in Methylation status|0|||
127801779|NCT00666926|459897005|FG005|Overall Study|Adverse Event|0|||
127801780|NCT00666926|459897006|FG006|Overall Study|Adverse Event|0|||
127713239|NCT03150862|459579294|FG000|Overall Study|Roll over in to Long Term Extension|0|||
127801781|NCT00666926|459897007|FG007|Overall Study|Adverse Event|0|||
127801782|NCT00666926|459897008|FG008|Overall Study|Adverse Event|0|||
127801783|NCT00666926|459897009|FG009|Overall Study|Adverse Event|2|||
127713240|NCT03150862|459579295|FG001|Overall Study|Roll over in to Long Term Extension|0|||
127713241|NCT03150862|459579296|FG002|Overall Study|Roll over in to Long Term Extension|0|||
127713242|NCT03150862|459579297|FG003|Overall Study|Roll over in to Long Term Extension|0|||
127713243|NCT03150862|459579298|FG004|Overall Study|Roll over in to Long Term Extension|0|||
127713244|NCT03150862|459579299|FG005|Overall Study|Roll over in to Long Term Extension|0|||
127713245|NCT03150862|459579300|FG006|Overall Study|Roll over in to Long Term Extension|0|||
127713246|NCT03150862|459579301|FG007|Overall Study|Roll over in to Long Term Extension|1|||
127713247|NCT03150862|459579294|FG000|Overall Study|Progressive Disease|0|||
127713248|NCT03150862|459579295|FG001|Overall Study|Progressive Disease|0|||
127713249|NCT03150862|459579296|FG002|Overall Study|Progressive Disease|0|||
127713250|NCT03150862|459579297|FG003|Overall Study|Progressive Disease|0|||
127713251|NCT03150862|459579298|FG004|Overall Study|Progressive Disease|0|||
127713252|NCT03150862|459579299|FG005|Overall Study|Progressive Disease|0|||
127713253|NCT03150862|459579300|FG006|Overall Study|Progressive Disease|0|||
127713254|NCT03150862|459579301|FG007|Overall Study|Progressive Disease|2|||
127713255|NCT03891758|459579303|FG000|Overall Study|Adverse Event|2|||
127713256|NCT03891758|459579304|FG001|Overall Study|Adverse Event|0|||
127713257|NCT03891758|459579303|FG000|Overall Study|Withdrawal by parent/guardian|0|||
127713258|NCT03891758|459579304|FG001|Overall Study|Withdrawal by parent/guardian|2|||
127713259|NCT05039021|459579754|FG000|Overall Study|Death|1|||
127713260|NCT05039021|459579754|FG000|Overall Study|Lost to Follow-up|3|||
127713261|NCT02422615|459579755|FG000|Treatment Period|Progressive disease|314|||
127713262|NCT02422615|459579756|FG001|Treatment Period|Progressive disease|200|||
127713263|NCT02422615|459579755|FG000|Treatment Period|Adverse Event|51|||
127713264|NCT02422615|459579756|FG001|Treatment Period|Adverse Event|9|||
127713265|NCT02422615|459579755|FG000|Treatment Period|Physician Decision|32|||
127713266|NCT02422615|459579756|FG001|Treatment Period|Physician Decision|8|||
127713267|NCT02422615|459579755|FG000|Treatment Period|Subject/guardian decision|38|||
127713268|NCT02422615|459579756|FG001|Treatment Period|Subject/guardian decision|8|||
127713269|NCT02422615|459579755|FG000|Treatment Period|Death|2|||
127713270|NCT02422615|459579756|FG001|Treatment Period|Death|1|||
127713271|NCT02422615|459579755|FG000|Treatment Period|Technical problems|0|||
127713272|NCT02422615|459579756|FG001|Treatment Period|Technical problems|1|||
127713273|NCT02422615|459579755|FG000|Treatment Period|Protocol deviation|1|||
127713274|NCT02422615|459579756|FG001|Treatment Period|Protocol deviation|1|||
127713275|NCT02422615|459579755|FG000|Treatment Period|Study terminated as per protocol|46|||
127713276|NCT02422615|459579756|FG001|Treatment Period|Study terminated as per protocol|14|||
127713277|NCT02422615|459579755|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
127713278|NCT02422615|459579756|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
127713279|NCT02422615|459579755|FG000|Post-treatment Efficacy Follow-up|Death|2|||
127713280|NCT02422615|459579756|FG001|Post-treatment Efficacy Follow-up|Death|1|||
127713281|NCT02422615|459579755|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
127713282|NCT02422615|459579756|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
127713283|NCT02422615|459579755|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
127713284|NCT02422615|459579756|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
127713285|NCT02422615|459579755|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
127713286|NCT02422615|459579756|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
127713287|NCT02422615|459579755|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
127713288|NCT02422615|459579756|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
127713289|NCT01639131|459579757|FG000|Overall Study|Disease Progression|6|||
127713290|NCT03653364|459579759|FG000|Overall Study|Withdrawal by Subject|1|||
127713291|NCT03653364|459579759|FG000|Overall Study|Enrolled in Error|1|||
127713292|NCT03653364|459579759|FG000|Overall Study|Death|1|||
127713293|NCT00087685|459579760|FG000|Overall Study|Adverse Event|5|||
127713294|NCT00087685|459579760|FG000|Overall Study|Non-Compliance|1|||
127713295|NCT00087685|459579760|FG000|Overall Study|Progressive Disease|5|||
127713296|NCT00087685|459579760|FG000|Overall Study|Withdrawal by Subject|3|||
127713297|NCT05934292|459579761|FG000|Overall Study|Lost to Follow-up|0|||
127713298|NCT05934292|459579762|FG001|Overall Study|Lost to Follow-up|0|||
127713299|NCT05934292|459579763|FG002|Overall Study|Lost to Follow-up|1|||
127713300|NCT05934292|459579764|FG003|Overall Study|Lost to Follow-up|0|||
127713301|NCT04479787|459579765|FG000|Through 6 Months|Withdrawal by Subject|16|||
127713302|NCT04479787|459579766|FG001|Through 6 Months|Withdrawal by Subject|14|||
127801784|NCT00666926|459897010|FG010|Overall Study|Adverse Event|2|||
127713303|NCT04479787|459579765|FG000|Through 6 Months|Unsuccessful Trial|17|||
127713304|NCT04479787|459579766|FG001|Through 6 Months|Unsuccessful Trial|0|||
127713305|NCT04479787|459579765|FG000|Through 6 Months|Subject Participation Terminated By Investigator|12|||
127713306|NCT04479787|459579766|FG001|Through 6 Months|Subject Participation Terminated By Investigator|3|||
127801785|NCT00666926|459897011|FG011|Overall Study|Adverse Event|2|||
127801786|NCT00666926|459897012|FG012|Overall Study|Adverse Event|0|||
127801787|NCT00666926|459897013|FG013|Overall Study|Adverse Event|1|||
127713307|NCT04479787|459579765|FG000|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
127713308|NCT04479787|459579766|FG001|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|0|||
127713309|NCT04479787|459579765|FG000|Through 6 Months|Lost to Follow-up|3|||
127801788|NCT00666926|459897014|FG014|Overall Study|Adverse Event|0|||
127801789|NCT00666926|459897015|FG015|Overall Study|Adverse Event|0|||
127713310|NCT04479787|459579766|FG001|Through 6 Months|Lost to Follow-up|2|||
127713311|NCT04479787|459579765|FG000|Through 6 Months|Death|3|||
127713312|NCT04479787|459579766|FG001|Through 6 Months|Death|0|||
127713313|NCT04479787|459579765|FG000|Through 6 Months|Inclusion/Exclusion|2|||
127713314|NCT04479787|459579766|FG001|Through 6 Months|Inclusion/Exclusion|1|||
127713315|NCT04479787|459579765|FG000|Through 6 Months|Subject Became Pregnant|1|||
127713316|NCT04479787|459579766|FG001|Through 6 Months|Subject Became Pregnant|1|||
127713317|NCT04479787|459579765|FG000|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|0|||
127713318|NCT04479787|459579766|FG001|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|1|||
127713319|NCT04479787|459579765|FG000|Through 6 Months|Withdrawn At Sponsor's Request|1|||
127713320|NCT04479787|459579766|FG001|Through 6 Months|Withdrawn At Sponsor's Request|0|||
127713321|NCT04479787|459579765|FG000|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
127713322|NCT04479787|459579766|FG001|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
127713323|NCT04479787|459579765|FG000|After 6 Months|Withdrawal by Subject|3|||
127713324|NCT04479787|459579766|FG001|After 6 Months|Withdrawal by Subject|13|||
127713325|NCT04479787|459579765|FG000|After 6 Months|Unsuccessful Trial|0|||
127713326|NCT04479787|459579766|FG001|After 6 Months|Unsuccessful Trial|7|||
127713327|NCT04479787|459579765|FG000|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
127713328|NCT04479787|459579766|FG001|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|4|||
127713329|NCT04479787|459579765|FG000|After 6 Months|Subject Participation Terminated By Investigator|2|||
127713330|NCT04479787|459579766|FG001|After 6 Months|Subject Participation Terminated By Investigator|2|||
127713331|NCT04479787|459579765|FG000|After 6 Months|Death|2|||
127713332|NCT04479787|459579766|FG001|After 6 Months|Death|0|||
127713333|NCT04479787|459579765|FG000|After 6 Months|Lost to Follow-up|1|||
127713334|NCT04479787|459579766|FG001|After 6 Months|Lost to Follow-up|1|||
127713335|NCT04479787|459579765|FG000|After 6 Months|Patient Was Withdrawn Due To Study Timelines|0|||
127713336|NCT04479787|459579766|FG001|After 6 Months|Patient Was Withdrawn Due To Study Timelines|1|||
127713337|NCT04479787|459579765|FG000|After 6 Months|Patient's Health Significantly Declined|0|||
127713338|NCT04479787|459579766|FG001|After 6 Months|Patient's Health Significantly Declined|1|||
127713339|NCT04479787|459579765|FG000|After 6 Months|Subject Had Back Surgery On March 1st|0|||
127713340|NCT04479787|459579766|FG001|After 6 Months|Subject Had Back Surgery On March 1st|1|||
127713341|NCT04479787|459579765|FG000|After 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
127713342|NCT04479787|459579766|FG001|After 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
127713343|NCT04899674|459579767|FG000|Test|Adverse Event|1|||
127713344|NCT03774472|459579768|FG000|Overall Study|Physician Decision|1|||
127713345|NCT03774472|459579769|FG001|Overall Study|Physician Decision|0|||
127713346|NCT03774472|459579770|FG002|Overall Study|Physician Decision|0|||
127713347|NCT03774472|459579768|FG000|Overall Study|Progression prior to 4 weeks|0|||
127713348|NCT03774472|459579769|FG001|Overall Study|Progression prior to 4 weeks|1|||
127713349|NCT03774472|459579770|FG002|Overall Study|Progression prior to 4 weeks|0|||
127713350|NCT03774472|459579768|FG000|Overall Study|Withdrawal by Subject|0|||
127713351|NCT03774472|459579769|FG001|Overall Study|Withdrawal by Subject|1|||
127713352|NCT03774472|459579770|FG002|Overall Study|Withdrawal by Subject|0|||
127713353|NCT04059406|459579771|FG000|Overall Study|Early Treatment Termination|5|||
127713354|NCT04059406|459579772|FG001|Overall Study|Early Treatment Termination|5|||
127713355|NCT04059406|459579773|FG002|Overall Study|Early Treatment Termination|15|||
127713356|NCT05155306|459579774|FG000|Wash-out Period 1 to 2|Adverse Event|0|||
127713357|NCT05155306|459579775|FG001|Wash-out Period 1 to 2|Adverse Event|0|||
127713358|NCT05155306|459579776|FG002|Wash-out Period 1 to 2|Adverse Event|0|||
127713359|NCT05155306|459579777|FG003|Wash-out Period 1 to 2|Adverse Event|2|||
127713360|NCT05155306|459579774|FG000|Wash-out Period 3 to 4|Temporal availability|3|||
127713361|NCT05155306|459579775|FG001|Wash-out Period 3 to 4|Temporal availability|1|||
127713362|NCT05155306|459579776|FG002|Wash-out Period 3 to 4|Temporal availability|1|||
127713363|NCT05155306|459579777|FG003|Wash-out Period 3 to 4|Temporal availability|1|||
127713364|NCT05601882|459579780|FG000|Period 1 (Baseline - Week 16)|Lost to Follow-up|2|||
127713365|NCT05601882|459579781|FG001|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
127713366|NCT05601882|459579782|FG002|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
127713367|NCT05601882|459579783|FG003|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
127713368|NCT05601882|459579780|FG000|Period 1 (Baseline - Week 16)|Withdrawal by Subject|21|||
127713369|NCT05601882|459579781|FG001|Period 1 (Baseline - Week 16)|Withdrawal by Subject|24|||
127713370|NCT05601882|459579782|FG002|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
127713371|NCT05601882|459579783|FG003|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
127713372|NCT05601882|459579780|FG000|Period 1 (Baseline - Week 16)|Other, not specified|16|||
127713373|NCT05601882|459579781|FG001|Period 1 (Baseline - Week 16)|Other, not specified|16|||
127713374|NCT05601882|459579782|FG002|Period 1 (Baseline - Week 16)|Other, not specified|0|||
127713375|NCT05601882|459579783|FG003|Period 1 (Baseline - Week 16)|Other, not specified|0|||
127713376|NCT05601882|459579780|FG000|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
127713377|NCT05601882|459579781|FG001|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
127713378|NCT05601882|459579782|FG002|Period 2 (Week 16 - Week 32)|Lost to Follow-up|3|||
127713379|NCT05601882|459579783|FG003|Period 2 (Week 16 - Week 32)|Lost to Follow-up|1|||
127713380|NCT05601882|459579780|FG000|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
127713381|NCT05601882|459579781|FG001|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
127713382|NCT05601882|459579782|FG002|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|3|||
127713383|NCT05601882|459579783|FG003|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|4|||
127713384|NCT05601882|459579780|FG000|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
127713385|NCT05601882|459579781|FG001|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
127713386|NCT05601882|459579782|FG002|Period 2 (Week 16 - Week 32)|Other, not specified|4|||
127713387|NCT05601882|459579783|FG003|Period 2 (Week 16 - Week 32)|Other, not specified|11|||
127713388|NCT04158141|459579784|FG000|Step 1: Registration|Does not meet requirements for Step 2|1|||
127713389|NCT04158141|459579785|FG001|Step 1: Registration|Does not meet requirements for Step 2|0|||
127713390|NCT04158141|459579786|FG002|Step 1: Registration|Does not meet requirements for Step 2|0|||
127713391|NCT04158141|459579784|FG000|Step 1: Registration|Adverse Event|1|||
127713392|NCT04158141|459579785|FG001|Step 1: Registration|Adverse Event|0|||
127713393|NCT04158141|459579786|FG002|Step 1: Registration|Adverse Event|0|||
127713394|NCT04158141|459579784|FG000|Step 1: Registration|Withdrawal by Subject|1|||
127713395|NCT04158141|459579785|FG001|Step 1: Registration|Withdrawal by Subject|0|||
127713396|NCT04158141|459579786|FG002|Step 1: Registration|Withdrawal by Subject|0|||
127713397|NCT04158141|459579784|FG000|Step 1: Registration|Study terminated immediately after patient enrolled|2|||
127713398|NCT04158141|459579785|FG001|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
127713399|NCT04158141|459579786|FG002|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
127713400|NCT04505722|459579790|FG000|DB Phase (Day 1 up to 6 Months)|Adverse Event|1|||
127713401|NCT04505722|459579791|FG001|DB Phase (Day 1 up to 6 Months)|Adverse Event|2|||
127713402|NCT04505722|459579792|FG002|DB Phase (Day 1 up to 6 Months)|Adverse Event|0|||
127713403|NCT04505722|459579790|FG000|DB Phase (Day 1 up to 6 Months)|Death|34|||
127713404|NCT04505722|459579791|FG001|DB Phase (Day 1 up to 6 Months)|Death|63|||
127713405|NCT04505722|459579792|FG002|DB Phase (Day 1 up to 6 Months)|Death|0|||
127713406|NCT04505722|459579790|FG000|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|271|||
127713407|NCT04505722|459579791|FG001|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|333|||
127713408|NCT04505722|459579792|FG002|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|0|||
127713409|NCT04505722|459579790|FG000|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
127713410|NCT04505722|459579791|FG001|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
127713411|NCT04505722|459579792|FG002|DB Phase (Day 1 up to 6 Months)|Physician Decision|0|||
127713412|NCT04505722|459579790|FG000|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
127713413|NCT04505722|459579791|FG001|DB Phase (Day 1 up to 6 Months)|Protocol Violation|1|||
127713414|NCT04505722|459579792|FG002|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
127713415|NCT04505722|459579790|FG000|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|376|||
127713416|NCT04505722|459579791|FG001|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|714|||
127713417|NCT04505722|459579792|FG002|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|0|||
127713418|NCT04505722|459579790|FG000|DB Phase (Day 1 up to 6 Months)|Other|61|||
127713419|NCT04505722|459579791|FG001|DB Phase (Day 1 up to 6 Months)|Other|98|||
127713420|NCT04505722|459579792|FG002|DB Phase (Day 1 up to 6 Months)|Other|0|||
127713421|NCT04505722|459579790|FG000|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|276|||
127713422|NCT04505722|459579791|FG001|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|260|||
127713423|NCT04505722|459579792|FG002|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|0|||
127713424|NCT04505722|459579790|FG000|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
127713425|NCT04505722|459579791|FG001|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
127713426|NCT04505722|459579792|FG002|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|6|||
127713427|NCT04505722|459579790|FG000|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
127713428|NCT04505722|459579791|FG001|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
127713429|NCT04505722|459579792|FG002|DB + OL Phase (2 Years 6.5 Months)|Death|324|||
127713430|NCT04505722|459579790|FG000|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
127713431|NCT04505722|459579791|FG001|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
127713432|NCT04505722|459579792|FG002|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|4978|||
127713433|NCT04505722|459579790|FG000|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
127713434|NCT04505722|459579791|FG001|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
127713435|NCT04505722|459579792|FG002|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|342|||
127713436|NCT04505722|459579790|FG000|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
127713437|NCT04505722|459579791|FG001|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
127713438|NCT04505722|459579792|FG002|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|2|||
127713439|NCT04505722|459579790|FG000|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
127713440|NCT04505722|459579791|FG001|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
127713441|NCT04505722|459579792|FG002|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|4332|||
127713442|NCT04505722|459579790|FG000|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
127713443|NCT04505722|459579791|FG001|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
127713444|NCT04505722|459579792|FG002|DB + OL Phase (2 Years 6.5 Months)|Other|2211|||
127713445|NCT04755595|459579793|FG000|Overall Study|Lost to Follow-up|1|||
127713446|NCT00319696|459579794|FG000|Overall Study|Adverse Event|36|||
127713447|NCT00319696|459579794|FG000|Overall Study|withdrawal of consent|14|||
127713448|NCT00319696|459579794|FG000|Overall Study|administrative|7|||
127713449|NCT00319696|459579794|FG000|Overall Study|Lost to Follow-up|3|||
127713450|NCT04977583|459580499|FG000|Overall Study|Lost to Follow-up|8|||
127713451|NCT04977583|459580500|FG001|Overall Study|Lost to Follow-up|4|||
127713452|NCT04977583|459580501|FG002|Overall Study|Lost to Follow-up|13|||
127713453|NCT04977583|459580499|FG000|Overall Study|Withdrawal by Subject|3|||
127713454|NCT04977583|459580500|FG001|Overall Study|Withdrawal by Subject|2|||
127713455|NCT04977583|459580501|FG002|Overall Study|Withdrawal by Subject|1|||
127713456|NCT00686595|459580507|FG000|Overall Study|Adverse Event|3|||
127713457|NCT00686595|459580507|FG000|Overall Study|Protocol Violation|1|||
127713458|NCT00686595|459580507|FG000|Overall Study|Lost to Follow-up|1|||
127713459|NCT00686595|459580507|FG000|Overall Study|Lack of Efficacy|1|||
127713460|NCT00686595|459580507|FG000|Overall Study|Poor Compliance|1|||
127713461|NCT06688357|459580520|FG000|Overall Study|Adverse Event|0|||
127713462|NCT06688357|459580521|FG001|Overall Study|Adverse Event|1|||
127713463|NCT04121741|459580522|FG000|Overall Study|Protocol Violation|1|||
127713464|NCT04121741|459580523|FG001|Overall Study|Protocol Violation|0|||
127713465|NCT04121741|459580524|FG002|Overall Study|Protocol Violation|0|||
127713466|NCT04121741|459580525|FG003|Overall Study|Protocol Violation|0|||
127713467|NCT04121741|459580526|FG004|Overall Study|Protocol Violation|0|||
127713468|NCT04121741|459580527|FG005|Overall Study|Protocol Violation|0|||
127713469|NCT01084863|459580528|FG000|Main Study Treatment Period|Disease progression|11|||
127713470|NCT01084863|459580529|FG001|Main Study Treatment Period|Disease progression|7|||
127713471|NCT01084863|459580528|FG000|Main Study Treatment Period|Adverse Event|5|||
127713472|NCT01084863|459580529|FG001|Main Study Treatment Period|Adverse Event|3|||
127713473|NCT01084863|459580528|FG000|Main Study Treatment Period|Other Reason|0|||
127713474|NCT01084863|459580529|FG001|Main Study Treatment Period|Other Reason|1|||
127713475|NCT01084863|459580528|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
127713476|NCT01084863|459580529|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
127713477|NCT01084863|459580528|FG000|Treatment Period Beyond Cycle 8|Physician Decision|2|||
127713478|NCT01084863|459580529|FG001|Treatment Period Beyond Cycle 8|Physician Decision|4|||
127713479|NCT01084863|459580528|FG000|Treatment Period Beyond Cycle 8|Disease progression|51|||
127713480|NCT01084863|459580529|FG001|Treatment Period Beyond Cycle 8|Disease progression|45|||
127713481|NCT01084863|459580528|FG000|Treatment Period Beyond Cycle 8|Adverse Event|1|||
127713482|NCT01084863|459580529|FG001|Treatment Period Beyond Cycle 8|Adverse Event|0|||
127713483|NCT01084863|459580528|FG000|Treatment Period Beyond Cycle 8|Other|0|||
127713484|NCT01084863|459580529|FG001|Treatment Period Beyond Cycle 8|Other|1|||
127713485|NCT01084863|459580528|FG000|Treatment Period Beyond Cycle 8|Other reason|2|||
127713486|NCT01084863|459580529|FG001|Treatment Period Beyond Cycle 8|Other reason|2|||
127713487|NCT03473223|459580530|FG000|Overall Study|Lost to Follow-up|1|||
127713488|NCT03473223|459580531|FG001|Overall Study|Lost to Follow-up|1|||
127713489|NCT03473223|459580530|FG000|Overall Study|Withdrawal by Subject|47|||
127713490|NCT03473223|459580531|FG001|Overall Study|Withdrawal by Subject|42|||
127713491|NCT03473223|459580530|FG000|Overall Study|Indirect contact|32|||
127713492|NCT03473223|459580531|FG001|Overall Study|Indirect contact|29|||
127713493|NCT03473223|459580530|FG000|Overall Study|Other (Not specified)|32|||
127713494|NCT03473223|459580531|FG001|Overall Study|Other (Not specified)|20|||
127713495|NCT03524092|459580532|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
127713496|NCT03524092|459580533|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
127713497|NCT03524092|459580534|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
127713498|NCT03524092|459580535|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
127713499|NCT03524092|459580536|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
127713500|NCT03524092|459580537|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
127713501|NCT03524092|459580532|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
127713502|NCT03524092|459580533|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
127713503|NCT03524092|459580534|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
127713504|NCT03524092|459580535|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
127713505|NCT03524092|459580536|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
127713506|NCT03524092|459580537|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
127713507|NCT03524092|459580532|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
127713508|NCT03524092|459580533|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
127801790|NCT00666926|459897000|FG000|Overall Study|Laboratory abnormality|0|||
127801791|NCT00666926|459897001|FG001|Overall Study|Laboratory abnormality|0|||
127801792|NCT00666926|459897002|FG002|Overall Study|Laboratory abnormality|0|||
127801793|NCT00666926|459897003|FG003|Overall Study|Laboratory abnormality|0|||
127801794|NCT00666926|459897004|FG004|Overall Study|Laboratory abnormality|0|||
127801795|NCT00666926|459897005|FG005|Overall Study|Laboratory abnormality|0|||
127801796|NCT00666926|459897006|FG006|Overall Study|Laboratory abnormality|0|||
127801797|NCT00666926|459897007|FG007|Overall Study|Laboratory abnormality|0|||
127713509|NCT03524092|459580534|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
127713510|NCT03524092|459580535|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
127713511|NCT03524092|459580536|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
127713512|NCT03524092|459580537|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
127713513|NCT03524092|459580532|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
127713514|NCT03524092|459580533|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
127713515|NCT03524092|459580534|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
127713516|NCT03524092|459580535|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
127713517|NCT03524092|459580536|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
127713518|NCT03524092|459580537|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
127713519|NCT03524092|459580532|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
127713520|NCT03524092|459580533|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
127713521|NCT03524092|459580534|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
127713522|NCT03524092|459580535|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
127713523|NCT03524092|459580536|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
127713524|NCT03524092|459580537|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
127713525|NCT03524092|459580532|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
127713526|NCT03524092|459580533|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
127713527|NCT03524092|459580534|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
127713528|NCT03524092|459580535|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
127713529|NCT03524092|459580536|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
127713530|NCT03524092|459580537|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
127713531|NCT03524092|459580532|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
127713532|NCT03524092|459580533|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
127713533|NCT03524092|459580534|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
127713534|NCT03524092|459580535|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
127713535|NCT03524092|459580536|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
127713536|NCT03524092|459580537|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
127713537|NCT03524092|459580532|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
127713538|NCT03524092|459580533|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
127713539|NCT03524092|459580534|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
127713540|NCT03524092|459580535|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
127713541|NCT03524092|459580536|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
127801798|NCT00666926|459897008|FG008|Overall Study|Laboratory abnormality|0|||
127801799|NCT00666926|459897009|FG009|Overall Study|Laboratory abnormality|0|||
127801800|NCT00666926|459897010|FG010|Overall Study|Laboratory abnormality|1|||
127801801|NCT00666926|459897011|FG011|Overall Study|Laboratory abnormality|0|||
127801802|NCT00666926|459897012|FG012|Overall Study|Laboratory abnormality|0|||
127801803|NCT00666926|459897013|FG013|Overall Study|Laboratory abnormality|0|||
127801804|NCT00666926|459897014|FG014|Overall Study|Laboratory abnormality|0|||
127713542|NCT03524092|459580537|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
127713543|NCT03524092|459580532|FG000|Loss of Response Rescue Period|Adverse Event|0|||
127713544|NCT03524092|459580533|FG001|Loss of Response Rescue Period|Adverse Event|0|||
127713545|NCT03524092|459580534|FG002|Loss of Response Rescue Period|Adverse Event|0|||
127713546|NCT03524092|459580535|FG003|Loss of Response Rescue Period|Adverse Event|2|||
127713547|NCT03524092|459580536|FG004|Loss of Response Rescue Period|Adverse Event|0|||
127713548|NCT03524092|459580537|FG005|Loss of Response Rescue Period|Adverse Event|0|||
127713549|NCT03524092|459580532|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
127713550|NCT03524092|459580533|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
127713551|NCT03524092|459580534|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
127801805|NCT00666926|459897015|FG015|Overall Study|Laboratory abnormality|1|||
127801806|NCT00666926|459897000|FG000|Overall Study|Lack of Efficacy|0|||
127801807|NCT00666926|459897001|FG001|Overall Study|Lack of Efficacy|0|||
127888497|NCT02544633|460215741|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
127713552|NCT03524092|459580535|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
127713553|NCT03524092|459580536|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
127713554|NCT03524092|459580537|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
127801808|NCT00666926|459897002|FG002|Overall Study|Lack of Efficacy|0|||
127801809|NCT00666926|459897003|FG003|Overall Study|Lack of Efficacy|0|||
127801810|NCT00666926|459897004|FG004|Overall Study|Lack of Efficacy|0|||
127888498|NCT02544633|460215742|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
127713555|NCT03524092|459580532|FG000|Loss of Response Rescue Period|Pregnancy|0|||
127713556|NCT03524092|459580533|FG001|Loss of Response Rescue Period|Pregnancy|0|||
127713557|NCT03524092|459580534|FG002|Loss of Response Rescue Period|Pregnancy|0|||
127713558|NCT03524092|459580535|FG003|Loss of Response Rescue Period|Pregnancy|1|||
127713559|NCT03524092|459580536|FG004|Loss of Response Rescue Period|Pregnancy|0|||
127713560|NCT03524092|459580537|FG005|Loss of Response Rescue Period|Pregnancy|0|||
127713561|NCT03524092|459580532|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
127713562|NCT03524092|459580533|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
127713563|NCT03524092|459580534|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
127713564|NCT03524092|459580535|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
127713565|NCT03524092|459580536|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
127713566|NCT03524092|459580537|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
127713567|NCT03524092|459580532|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
127713568|NCT03524092|459580533|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
127713569|NCT03524092|459580534|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
127713570|NCT03524092|459580535|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
127713571|NCT03524092|459580536|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
127713572|NCT03524092|459580537|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
127713573|NCT03524092|459580532|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
127713574|NCT03524092|459580533|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
127713575|NCT03524092|459580534|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
127713576|NCT03524092|459580535|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
127713577|NCT03524092|459580536|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
127713578|NCT03524092|459580537|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
127713579|NCT03524092|459580532|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
127713580|NCT03524092|459580533|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
127713581|NCT03524092|459580534|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
127713582|NCT03524092|459580535|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
127713583|NCT03524092|459580536|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
127713584|NCT03524092|459580537|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
127713585|NCT03524092|459580532|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
127713586|NCT03524092|459580533|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
127713587|NCT03524092|459580534|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
127713588|NCT03524092|459580535|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
127713589|NCT03524092|459580536|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
127713590|NCT03524092|459580537|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
127713591|NCT03524092|459580532|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
127713592|NCT03524092|459580533|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
127713593|NCT03524092|459580534|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
127713594|NCT03524092|459580535|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
127713595|NCT03524092|459580536|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
127713596|NCT03524092|459580537|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
127713597|NCT03524092|459580532|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
127713598|NCT03524092|459580533|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
127713599|NCT03524092|459580534|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
127713600|NCT03524092|459580535|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
127713601|NCT03524092|459580536|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
127713602|NCT03524092|459580537|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
127713603|NCT03524092|459580532|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
127713604|NCT03524092|459580533|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
127713605|NCT03524092|459580534|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
127713606|NCT03524092|459580535|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
127713607|NCT03524092|459580536|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
127713608|NCT03524092|459580537|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
127713609|NCT03524092|459580532|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
127713610|NCT03524092|459580533|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
127713611|NCT03524092|459580534|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
127713612|NCT03524092|459580535|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
127713613|NCT03524092|459580536|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
127713614|NCT03524092|459580537|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
127713615|NCT03524092|459580532|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
127713616|NCT03524092|459580533|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
127713617|NCT03524092|459580534|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
127713618|NCT03524092|459580535|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
127713619|NCT03524092|459580536|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
127713620|NCT03524092|459580537|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
127713621|NCT03524092|459580532|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
127713622|NCT03524092|459580533|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
127713623|NCT03524092|459580534|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
127713624|NCT03524092|459580535|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
127713625|NCT03524092|459580536|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
127713626|NCT03524092|459580537|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
127713627|NCT03524092|459580532|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
127713628|NCT03524092|459580533|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
127713629|NCT03524092|459580534|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
127713630|NCT03524092|459580535|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
127713631|NCT03524092|459580536|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
127713632|NCT03524092|459580537|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
127713633|NCT03834740|459580538|FG000|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
127713634|NCT03834740|459580539|FG001|Ribo 600mg QD+Eve 70mg Once|Physician Decision|1|||
127713635|NCT03834740|459580540|FG002|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
127713636|NCT03275285|459580543|FG000|Overall Study|Ongoing|45|||
127713637|NCT03275285|459580544|FG001|Overall Study|Ongoing|69|||
127713638|NCT00115934|459580545|FG000|Overall Study|Lost to Follow-up|1|||
127713639|NCT00115934|459580546|FG001|Overall Study|Lost to Follow-up|0|||
127713640|NCT00115934|459580545|FG000|Overall Study|Did not receive intervention|3|||
127713641|NCT00115934|459580546|FG001|Overall Study|Did not receive intervention|2|||
127713642|NCT06191679|459580547|FG000|Baseline|Lost to Follow-up|1|||
127713643|NCT06191679|459580548|FG001|Baseline|Lost to Follow-up|0|||
127713644|NCT06191679|459580549|FG002|Baseline|Lost to Follow-up|1|||
127713645|NCT06191679|459580550|FG003|Baseline|Lost to Follow-up|0|||
127713646|NCT06191679|459580547|FG000|Allocation to Group|Withdrawal by Subject|0|||
127713647|NCT06191679|459580548|FG001|Allocation to Group|Withdrawal by Subject|1|||
127713648|NCT06191679|459580549|FG002|Allocation to Group|Withdrawal by Subject|2|||
127713649|NCT06191679|459580550|FG003|Allocation to Group|Withdrawal by Subject|0|||
127713650|NCT06191679|459580547|FG000|Post-Intervention Assessment|Lost to Follow-up|2|||
127713651|NCT06191679|459580548|FG001|Post-Intervention Assessment|Lost to Follow-up|3|||
127713652|NCT06191679|459580549|FG002|Post-Intervention Assessment|Lost to Follow-up|0|||
127801811|NCT00666926|459897005|FG005|Overall Study|Lack of Efficacy|1|||
127713653|NCT06191679|459580550|FG003|Post-Intervention Assessment|Lost to Follow-up|0|||
127801812|NCT00666926|459897006|FG006|Overall Study|Lack of Efficacy|0|||
127801813|NCT00666926|459897007|FG007|Overall Study|Lack of Efficacy|0|||
127801814|NCT00666926|459897008|FG008|Overall Study|Lack of Efficacy|0|||
127713654|NCT06191679|459580547|FG000|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
127713655|NCT06191679|459580548|FG001|Post-Intervention Qualitative Interview|Lost to Follow-up|7|||
127713656|NCT06191679|459580549|FG002|Post-Intervention Qualitative Interview|Lost to Follow-up|5|||
127713657|NCT06191679|459580550|FG003|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
127713658|NCT06191679|459580547|FG000|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
127713659|NCT06191679|459580548|FG001|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
127713660|NCT06191679|459580549|FG002|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
127713661|NCT06191679|459580550|FG003|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|2|||
127713662|NCT05827068|459580552|FG000|Overall Study|Lost to Follow-up|1|||
127713663|NCT05827068|459580553|FG001|Overall Study|Lost to Follow-up|4|||
127713664|NCT05827068|459580554|FG002|Overall Study|Lost to Follow-up|1|||
127713665|NCT05827068|459580555|FG003|Overall Study|Lost to Follow-up|1|||
127713666|NCT05827068|459580556|FG004|Overall Study|Lost to Follow-up|2|||
127713667|NCT05827068|459580557|FG005|Overall Study|Lost to Follow-up|4|||
127713668|NCT05827068|459580558|FG006|Overall Study|Lost to Follow-up|1|||
127713669|NCT05827068|459580552|FG000|Overall Study|Withdrawal by Subject|4|||
127713670|NCT05827068|459580553|FG001|Overall Study|Withdrawal by Subject|0|||
127713671|NCT05827068|459580554|FG002|Overall Study|Withdrawal by Subject|1|||
127713672|NCT05827068|459580555|FG003|Overall Study|Withdrawal by Subject|2|||
127713673|NCT05827068|459580556|FG004|Overall Study|Withdrawal by Subject|3|||
127713674|NCT05827068|459580557|FG005|Overall Study|Withdrawal by Subject|0|||
127713675|NCT05827068|459580558|FG006|Overall Study|Withdrawal by Subject|1|||
127713676|NCT05827068|459580552|FG000|Overall Study|Physician Decision|0|||
127713677|NCT05827068|459580553|FG001|Overall Study|Physician Decision|0|||
127713678|NCT05827068|459580554|FG002|Overall Study|Physician Decision|0|||
127713679|NCT05827068|459580555|FG003|Overall Study|Physician Decision|0|||
127713680|NCT05827068|459580556|FG004|Overall Study|Physician Decision|1|||
127713681|NCT05827068|459580557|FG005|Overall Study|Physician Decision|0|||
127713682|NCT05827068|459580558|FG006|Overall Study|Physician Decision|1|||
127713683|NCT05827068|459580552|FG000|Overall Study|Other Than Specified|0|||
127713684|NCT05827068|459580553|FG001|Overall Study|Other Than Specified|1|||
127713685|NCT05827068|459580554|FG002|Overall Study|Other Than Specified|0|||
127713686|NCT05827068|459580555|FG003|Overall Study|Other Than Specified|0|||
127713687|NCT05827068|459580556|FG004|Overall Study|Other Than Specified|0|||
127713688|NCT05827068|459580557|FG005|Overall Study|Other Than Specified|0|||
127801815|NCT00666926|459897009|FG009|Overall Study|Lack of Efficacy|0|||
127801816|NCT00666926|459897010|FG010|Overall Study|Lack of Efficacy|0|||
127801817|NCT00666926|459897011|FG011|Overall Study|Lack of Efficacy|1|||
127801818|NCT00666926|459897012|FG012|Overall Study|Lack of Efficacy|0|||
127801819|NCT00666926|459897013|FG013|Overall Study|Lack of Efficacy|0|||
127801820|NCT00666926|459897014|FG014|Overall Study|Lack of Efficacy|0|||
127801821|NCT00666926|459897015|FG015|Overall Study|Lack of Efficacy|0|||
127801822|NCT00666926|459897000|FG000|Overall Study|Lost to Follow-up|0|||
127801823|NCT00666926|459897001|FG001|Overall Study|Lost to Follow-up|0|||
127713689|NCT05827068|459580558|FG006|Overall Study|Other Than Specified|0|||
127713690|NCT00353496|459580559|FG000|Overall Study|Adverse Event|1|||
127713691|NCT00353496|459580560|FG001|Overall Study|Adverse Event|0|||
127713692|NCT00353496|459580559|FG000|Overall Study|Protocol Violation|2|||
127713693|NCT00353496|459580560|FG001|Overall Study|Protocol Violation|2|||
127713694|NCT00353496|459580559|FG000|Overall Study|Withdrawal by Subject|3|||
127713695|NCT00353496|459580560|FG001|Overall Study|Withdrawal by Subject|4|||
127801824|NCT00666926|459897002|FG002|Overall Study|Lost to Follow-up|0|||
127713696|NCT00353496|459580559|FG000|Overall Study|Physician Decision|6|||
127713697|NCT00353496|459580560|FG001|Overall Study|Physician Decision|9|||
127713698|NCT00353496|459580559|FG000|Overall Study|Not otherwise specified|4|||
127713699|NCT00353496|459580560|FG001|Overall Study|Not otherwise specified|2|||
127713700|NCT01470144|459580561|FG000|Overall Study|Adverse Event|2|||
127713701|NCT01470144|459580561|FG000|Overall Study|Death|1|||
127713702|NCT01470144|459580561|FG000|Overall Study|Lung transplant|6|||
127713703|NCT01470144|459580561|FG000|Overall Study|Patient's and investigator's decision|1|||
127713704|NCT02325466|459581267|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
127713705|NCT02325466|459581268|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
127713706|NCT02325466|459581269|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
127713707|NCT02325466|459581267|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
127713708|NCT02325466|459581268|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
127713709|NCT02325466|459581269|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
127713710|NCT02325466|459581267|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
127713711|NCT02325466|459581268|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
127713712|NCT02325466|459581269|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
127713713|NCT02325466|459581267|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
127713714|NCT02325466|459581268|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
127713715|NCT02325466|459581269|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
127713716|NCT02325466|459581267|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
127713717|NCT02325466|459581268|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
127713718|NCT02325466|459581269|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
127713719|NCT02325466|459581267|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
127713720|NCT02325466|459581268|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
127713721|NCT02325466|459581269|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
127713722|NCT02325466|459581267|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
127713723|NCT02325466|459581268|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
127713724|NCT02325466|459581269|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
127713725|NCT02325466|459581267|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
127713726|NCT02325466|459581268|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
127713727|NCT02325466|459581269|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
127713728|NCT02325466|459581267|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
127713729|NCT02325466|459581268|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
127713730|NCT02325466|459581269|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
127713731|NCT01288443|459581270|FG000|Overall Study|Adverse Event|0|||
127713732|NCT01288443|459581271|FG001|Overall Study|Adverse Event|0|||
127713733|NCT01288443|459581272|FG002|Overall Study|Adverse Event|1|||
127713734|NCT01288443|459581273|FG003|Overall Study|Adverse Event|1|||
127713735|NCT01288443|459581274|FG004|Overall Study|Adverse Event|3|||
127713736|NCT01288443|459581275|FG005|Overall Study|Adverse Event|1|||
127713737|NCT01288443|459581270|FG000|Overall Study|Poor compliance to protocol|0|||
127713738|NCT01288443|459581271|FG001|Overall Study|Poor compliance to protocol|0|||
127713739|NCT01288443|459581272|FG002|Overall Study|Poor compliance to protocol|0|||
127713740|NCT01288443|459581273|FG003|Overall Study|Poor compliance to protocol|0|||
127713741|NCT01288443|459581274|FG004|Overall Study|Poor compliance to protocol|0|||
127713742|NCT01288443|459581275|FG005|Overall Study|Poor compliance to protocol|1|||
127713743|NCT01288443|459581270|FG000|Overall Study|Participant Moved|0|||
127713744|NCT01288443|459581271|FG001|Overall Study|Participant Moved|0|||
127713745|NCT01288443|459581272|FG002|Overall Study|Participant Moved|0|||
127713746|NCT01288443|459581273|FG003|Overall Study|Participant Moved|1|||
127713747|NCT01288443|459581274|FG004|Overall Study|Participant Moved|2|||
127713748|NCT01288443|459581275|FG005|Overall Study|Participant Moved|1|||
127713749|NCT01288443|459581270|FG000|Overall Study|Consent withdrawn by Participant|0|||
127713750|NCT01288443|459581271|FG001|Overall Study|Consent withdrawn by Participant|0|||
127713751|NCT01288443|459581272|FG002|Overall Study|Consent withdrawn by Participant|0|||
127713752|NCT01288443|459581273|FG003|Overall Study|Consent withdrawn by Participant|0|||
127713753|NCT01288443|459581274|FG004|Overall Study|Consent withdrawn by Participant|0|||
127713754|NCT01288443|459581275|FG005|Overall Study|Consent withdrawn by Participant|1|||
127713755|NCT01288443|459581270|FG000|Overall Study|Lost to Follow-up|0|||
127713756|NCT01288443|459581271|FG001|Overall Study|Lost to Follow-up|1|||
127713757|NCT01288443|459581272|FG002|Overall Study|Lost to Follow-up|0|||
127713758|NCT01288443|459581273|FG003|Overall Study|Lost to Follow-up|0|||
127713759|NCT01288443|459581274|FG004|Overall Study|Lost to Follow-up|0|||
127713760|NCT01288443|459581275|FG005|Overall Study|Lost to Follow-up|0|||
127713761|NCT01288443|459581270|FG000|Overall Study|Study drug auto-injector administration|0|||
127713762|NCT01288443|459581271|FG001|Overall Study|Study drug auto-injector administration|0|||
127713763|NCT01288443|459581272|FG002|Overall Study|Study drug auto-injector administration|0|||
127713764|NCT01288443|459581273|FG003|Overall Study|Study drug auto-injector administration|0|||
127713765|NCT01288443|459581274|FG004|Overall Study|Study drug auto-injector administration|1|||
127713766|NCT01288443|459581275|FG005|Overall Study|Study drug auto-injector administration|1|||
127713767|NCT01288443|459581270|FG000|Overall Study|Other than above|0|||
127713768|NCT01288443|459581271|FG001|Overall Study|Other than above|0|||
127713769|NCT01288443|459581272|FG002|Overall Study|Other than above|0|||
127713770|NCT01288443|459581273|FG003|Overall Study|Other than above|2|||
127713771|NCT01288443|459581274|FG004|Overall Study|Other than above|1|||
127713772|NCT01288443|459581275|FG005|Overall Study|Other than above|0|||
127713773|NCT01596972|459581276|FG000|Overall Study|Physician Decision|1|||
127713774|NCT01596972|459581277|FG001|Overall Study|Physician Decision|9|||
127713775|NCT01596972|459581276|FG000|Overall Study|Lost to Follow-up|0|||
127713776|NCT01596972|459581277|FG001|Overall Study|Lost to Follow-up|4|||
127713777|NCT01596972|459581276|FG000|Overall Study|Withdrawal by Subject|0|||
127713778|NCT01596972|459581277|FG001|Overall Study|Withdrawal by Subject|1|||
127713779|NCT01105975|459581281|FG000|Overall Study|Adverse Event|2|||
127713780|NCT01105975|459581282|FG001|Overall Study|Adverse Event|1|||
127713781|NCT01105975|459581283|FG002|Overall Study|Adverse Event|5|||
127713782|NCT01105975|459581284|FG003|Overall Study|Adverse Event|1|||
127713783|NCT01105975|459581285|FG004|Overall Study|Adverse Event|0|||
127713784|NCT01105975|459581286|FG005|Overall Study|Adverse Event|1|||
127713785|NCT01105975|459581287|FG006|Overall Study|Adverse Event|2|||
127713786|NCT01105975|459581288|FG007|Overall Study|Adverse Event|4|||
127713787|NCT01105975|459581289|FG008|Overall Study|Adverse Event|1|||
127713788|NCT01105975|459581290|FG009|Overall Study|Adverse Event|4|||
127713789|NCT01105975|459581281|FG000|Overall Study|Withdrawal by Subject|2|||
127713790|NCT01105975|459581282|FG001|Overall Study|Withdrawal by Subject|2|||
127713791|NCT01105975|459581283|FG002|Overall Study|Withdrawal by Subject|2|||
127713792|NCT01105975|459581284|FG003|Overall Study|Withdrawal by Subject|0|||
127713793|NCT01105975|459581285|FG004|Overall Study|Withdrawal by Subject|4|||
127713794|NCT01105975|459581286|FG005|Overall Study|Withdrawal by Subject|1|||
127713795|NCT01105975|459581287|FG006|Overall Study|Withdrawal by Subject|2|||
127713796|NCT01105975|459581288|FG007|Overall Study|Withdrawal by Subject|1|||
127713797|NCT01105975|459581289|FG008|Overall Study|Withdrawal by Subject|0|||
127713798|NCT01105975|459581290|FG009|Overall Study|Withdrawal by Subject|3|||
127713799|NCT01105975|459581281|FG000|Overall Study|Lost to Follow-up|1|||
127713800|NCT01105975|459581282|FG001|Overall Study|Lost to Follow-up|0|||
127713801|NCT01105975|459581283|FG002|Overall Study|Lost to Follow-up|0|||
127801825|NCT00666926|459897003|FG003|Overall Study|Lost to Follow-up|1|||
127801826|NCT00666926|459897004|FG004|Overall Study|Lost to Follow-up|0|||
127801827|NCT00666926|459897005|FG005|Overall Study|Lost to Follow-up|0|||
127801828|NCT00666926|459897006|FG006|Overall Study|Lost to Follow-up|0|||
127801829|NCT00666926|459897007|FG007|Overall Study|Lost to Follow-up|0|||
127801830|NCT00666926|459897008|FG008|Overall Study|Lost to Follow-up|0|||
127801831|NCT00666926|459897009|FG009|Overall Study|Lost to Follow-up|0|||
127801832|NCT00666926|459897010|FG010|Overall Study|Lost to Follow-up|0|||
127801833|NCT00666926|459897011|FG011|Overall Study|Lost to Follow-up|0|||
127801834|NCT00666926|459897012|FG012|Overall Study|Lost to Follow-up|0|||
127801835|NCT00666926|459897013|FG013|Overall Study|Lost to Follow-up|0|||
127713802|NCT01105975|459581284|FG003|Overall Study|Lost to Follow-up|1|||
127801836|NCT00666926|459897014|FG014|Overall Study|Lost to Follow-up|0|||
127801837|NCT00666926|459897015|FG015|Overall Study|Lost to Follow-up|0|||
127801838|NCT00666926|459897000|FG000|Overall Study|Other|2|||
127713803|NCT01105975|459581285|FG004|Overall Study|Lost to Follow-up|1|||
127713804|NCT01105975|459581286|FG005|Overall Study|Lost to Follow-up|0|||
127713805|NCT01105975|459581287|FG006|Overall Study|Lost to Follow-up|0|||
127713806|NCT01105975|459581288|FG007|Overall Study|Lost to Follow-up|0|||
127713807|NCT01105975|459581289|FG008|Overall Study|Lost to Follow-up|1|||
127713808|NCT01105975|459581290|FG009|Overall Study|Lost to Follow-up|0|||
127713809|NCT01105975|459581281|FG000|Overall Study|Physician Decision|0|||
127713810|NCT01105975|459581282|FG001|Overall Study|Physician Decision|0|||
127713811|NCT01105975|459581283|FG002|Overall Study|Physician Decision|0|||
127713812|NCT01105975|459581284|FG003|Overall Study|Physician Decision|0|||
127713813|NCT01105975|459581285|FG004|Overall Study|Physician Decision|0|||
127713814|NCT01105975|459581286|FG005|Overall Study|Physician Decision|0|||
127801839|NCT00666926|459897001|FG001|Overall Study|Other|4|||
127801840|NCT00666926|459897002|FG002|Overall Study|Other|3|||
127801841|NCT00666926|459897003|FG003|Overall Study|Other|3|||
127801842|NCT00666926|459897004|FG004|Overall Study|Other|3|||
127801843|NCT00666926|459897005|FG005|Overall Study|Other|3|||
127801844|NCT00666926|459897006|FG006|Overall Study|Other|4|||
127801845|NCT00666926|459897007|FG007|Overall Study|Other|0|||
127713815|NCT01105975|459581287|FG006|Overall Study|Physician Decision|2|||
127713816|NCT01105975|459581288|FG007|Overall Study|Physician Decision|0|||
127713817|NCT01105975|459581289|FG008|Overall Study|Physician Decision|0|||
127713818|NCT01105975|459581290|FG009|Overall Study|Physician Decision|0|||
127713819|NCT01105975|459581281|FG000|Overall Study|Protocol Violation|0|||
127713820|NCT01105975|459581282|FG001|Overall Study|Protocol Violation|2|||
127713821|NCT01105975|459581283|FG002|Overall Study|Protocol Violation|2|||
127713822|NCT01105975|459581284|FG003|Overall Study|Protocol Violation|0|||
127713823|NCT01105975|459581285|FG004|Overall Study|Protocol Violation|1|||
127713824|NCT01105975|459581286|FG005|Overall Study|Protocol Violation|1|||
127713825|NCT01105975|459581287|FG006|Overall Study|Protocol Violation|1|||
127713826|NCT01105975|459581288|FG007|Overall Study|Protocol Violation|1|||
127713827|NCT01105975|459581289|FG008|Overall Study|Protocol Violation|2|||
127713828|NCT01105975|459581290|FG009|Overall Study|Protocol Violation|2|||
127713829|NCT01105975|459581281|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
127713830|NCT01105975|459581282|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
127713831|NCT01105975|459581283|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
127713832|NCT01105975|459581284|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
127713833|NCT01105975|459581285|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
127713834|NCT01105975|459581286|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
127713835|NCT01105975|459581287|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
127713836|NCT01105975|459581288|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
127713837|NCT01105975|459581289|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
127713838|NCT01105975|459581290|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
127713839|NCT02284113|459581293|FG000|Overall Study|Adverse Event|1|||
127713840|NCT02284113|459581294|FG001|Overall Study|Adverse Event|0|||
127713841|NCT02284113|459581293|FG000|Overall Study|non-compliance|0|||
127713842|NCT02284113|459581294|FG001|Overall Study|non-compliance|1|||
127713843|NCT02284113|459581293|FG000|Overall Study|Withdrawal by Subject|0|||
127713844|NCT02284113|459581294|FG001|Overall Study|Withdrawal by Subject|1|||
127713845|NCT02284113|459581293|FG000|Overall Study|not provided|0|||
127713846|NCT02284113|459581294|FG001|Overall Study|not provided|1|||
127801846|NCT00666926|459897008|FG008|Overall Study|Other|3|||
127801847|NCT00666926|459897009|FG009|Overall Study|Other|5|||
127801848|NCT00666926|459897010|FG010|Overall Study|Other|3|||
127801849|NCT00666926|459897011|FG011|Overall Study|Other|26|||
127801850|NCT00666926|459897012|FG012|Overall Study|Other|3|||
127801851|NCT00666926|459897013|FG013|Overall Study|Other|2|||
127801852|NCT00666926|459897014|FG014|Overall Study|Other|4|||
127713847|NCT02284113|459581293|FG000|Overall Study|surgery cancelled|2|||
127713848|NCT02284113|459581294|FG001|Overall Study|surgery cancelled|0|||
127801853|NCT00666926|459897015|FG015|Overall Study|Other|4|||
127801854|NCT00666926|459897000|FG000|Overall Study|Withdrawal by Subject|0|||
127713849|NCT03885232|459581295|FG000|Overall Study|Lost to Follow-up|74|||
127713850|NCT03885232|459581296|FG001|Overall Study|Lost to Follow-up|32|||
127713851|NCT03885232|459581295|FG000|Overall Study|Staff turnover at enrolled clinics|32|||
127713852|NCT03885232|459581296|FG001|Overall Study|Staff turnover at enrolled clinics|23|||
127713853|NCT01315132|459581297|FG000|Overall Study|not treated due to disease progression|1|||
127713854|NCT03840902|459581300|FG000|Overall Study|Randomized but not treated|1|||
127713855|NCT03840902|459581301|FG001|Overall Study|Randomized but not treated|1|||
127713856|NCT03660930|459581302|FG000|Overall Study|Adverse Event|0|||
127713857|NCT03660930|459581303|FG001|Overall Study|Adverse Event|0|||
127713858|NCT03660930|459581304|FG002|Overall Study|Adverse Event|0|||
127713859|NCT03660930|459581305|FG003|Overall Study|Adverse Event|2|||
127713860|NCT03660930|459581306|FG004|Overall Study|Adverse Event|0|||
127713861|NCT03660930|459581307|FG005|Overall Study|Adverse Event|1|||
127713862|NCT03660930|459581308|FG006|Overall Study|Adverse Event|0|||
127713863|NCT03660930|459581309|FG007|Overall Study|Adverse Event|0|||
127713864|NCT03660930|459581302|FG000|Overall Study|Withdrawal by Subject|0|||
127713865|NCT03660930|459581303|FG001|Overall Study|Withdrawal by Subject|0|||
127713866|NCT03660930|459581304|FG002|Overall Study|Withdrawal by Subject|0|||
127713867|NCT03660930|459581305|FG003|Overall Study|Withdrawal by Subject|0|||
127713868|NCT03660930|459581306|FG004|Overall Study|Withdrawal by Subject|0|||
127713869|NCT03660930|459581307|FG005|Overall Study|Withdrawal by Subject|1|||
127713870|NCT03660930|459581308|FG006|Overall Study|Withdrawal by Subject|0|||
127713871|NCT03660930|459581309|FG007|Overall Study|Withdrawal by Subject|0|||
127713872|NCT05018143|459581313|FG000|Overall Study|Lost to Follow-up|5|||
127713873|NCT05018143|459581314|FG001|Overall Study|Lost to Follow-up|4|||
127713874|NCT05018143|459581313|FG000|Overall Study|Withdrawal by Subject|0|||
127713875|NCT05018143|459581314|FG001|Overall Study|Withdrawal by Subject|1|||
127713876|NCT04018495|459581315|FG000|Overall Study|Physician Decision|1|||
127713877|NCT03280030|459581318|FG000|Part 1 - Safety Evaluation|Physician Decision|2|||
127713878|NCT03280030|459581319|FG001|Part 1 - Safety Evaluation|Physician Decision|0|||
127713879|NCT03280030|459581320|FG002|Part 1 - Safety Evaluation|Physician Decision|0|||
127713880|NCT03280030|459581318|FG000|Part 1 - Safety Evaluation|Disease progression|1|||
127713881|NCT03280030|459581319|FG001|Part 1 - Safety Evaluation|Disease progression|0|||
127713882|NCT03280030|459581320|FG002|Part 1 - Safety Evaluation|Disease progression|0|||
127713883|NCT03280030|459581318|FG000|Part 1 - Safety Evaluation|Adverse Event|2|||
127713884|NCT03280030|459581319|FG001|Part 1 - Safety Evaluation|Adverse Event|0|||
127713885|NCT03280030|459581320|FG002|Part 1 - Safety Evaluation|Adverse Event|0|||
127713886|NCT03280030|459581318|FG000|Part 2 - Efficacy|Adverse Event|0|||
127713887|NCT03280030|459581319|FG001|Part 2 - Efficacy|Adverse Event|4|||
127713888|NCT03280030|459581320|FG002|Part 2 - Efficacy|Adverse Event|6|||
127713889|NCT03280030|459581318|FG000|Part 2 - Efficacy|Death|0|||
127713890|NCT03280030|459581319|FG001|Part 2 - Efficacy|Death|3|||
127713891|NCT03280030|459581320|FG002|Part 2 - Efficacy|Death|0|||
127713892|NCT03280030|459581318|FG000|Part 2 - Efficacy|Physician Decision|0|||
127713893|NCT03280030|459581319|FG001|Part 2 - Efficacy|Physician Decision|10|||
127713894|NCT03280030|459581320|FG002|Part 2 - Efficacy|Physician Decision|16|||
127713895|NCT03280030|459581318|FG000|Part 2 - Efficacy|Withdrawal by Subject|0|||
127713896|NCT03280030|459581319|FG001|Part 2 - Efficacy|Withdrawal by Subject|2|||
127713897|NCT03280030|459581320|FG002|Part 2 - Efficacy|Withdrawal by Subject|1|||
127801855|NCT00666926|459897001|FG001|Overall Study|Withdrawal by Subject|0|||
127801856|NCT00666926|459897002|FG002|Overall Study|Withdrawal by Subject|0|||
127801857|NCT00666926|459897003|FG003|Overall Study|Withdrawal by Subject|0|||
127801858|NCT00666926|459897004|FG004|Overall Study|Withdrawal by Subject|0|||
127801859|NCT00666926|459897005|FG005|Overall Study|Withdrawal by Subject|0|||
127801860|NCT00666926|459897006|FG006|Overall Study|Withdrawal by Subject|0|||
127801861|NCT00666926|459897007|FG007|Overall Study|Withdrawal by Subject|1|||
127801862|NCT00666926|459897008|FG008|Overall Study|Withdrawal by Subject|0|||
127801863|NCT00666926|459897009|FG009|Overall Study|Withdrawal by Subject|3|||
127801864|NCT00666926|459897010|FG010|Overall Study|Withdrawal by Subject|0|||
127713898|NCT03280030|459581318|FG000|Part 2 - Efficacy|Progressive disease|0|||
127713899|NCT03280030|459581319|FG001|Part 2 - Efficacy|Progressive disease|7|||
127713900|NCT03280030|459581320|FG002|Part 2 - Efficacy|Progressive disease|5|||
127801865|NCT00666926|459897011|FG011|Overall Study|Withdrawal by Subject|3|||
127801866|NCT00666926|459897012|FG012|Overall Study|Withdrawal by Subject|0|||
127801867|NCT00666926|459897013|FG013|Overall Study|Withdrawal by Subject|1|||
127713901|NCT02500576|459581323|FG000|Overall Study|Adverse Event|0|||
127713902|NCT02500576|459581324|FG001|Overall Study|Adverse Event|1|||
127713903|NCT02500576|459581323|FG000|Overall Study|Death|2|||
127713904|NCT02500576|459581324|FG001|Overall Study|Death|1|||
127713905|NCT02500576|459581323|FG000|Overall Study|Lack of Efficacy|5|||
127713906|NCT02500576|459581324|FG001|Overall Study|Lack of Efficacy|5|||
127888499|NCT02544633|460215743|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
127888500|NCT02544633|460215740|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
127888501|NCT02544633|460215741|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
127888502|NCT02544633|460215742|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
127801868|NCT00666926|459897014|FG014|Overall Study|Withdrawal by Subject|3|||
127801869|NCT00666926|459897015|FG015|Overall Study|Withdrawal by Subject|3|||
127801870|NCT00666926|459897000|FG000|Overall Study|Death|0|||
127801871|NCT00666926|459897001|FG001|Overall Study|Death|0|||
127801872|NCT00666926|459897002|FG002|Overall Study|Death|0|||
127801873|NCT00666926|459897003|FG003|Overall Study|Death|0|||
127801874|NCT00666926|459897004|FG004|Overall Study|Death|0|||
127801875|NCT00666926|459897005|FG005|Overall Study|Death|0|||
127801876|NCT00666926|459897006|FG006|Overall Study|Death|0|||
127801877|NCT00666926|459897007|FG007|Overall Study|Death|0|||
127801878|NCT00666926|459897008|FG008|Overall Study|Death|0|||
127801879|NCT00666926|459897009|FG009|Overall Study|Death|0|||
127801880|NCT00666926|459897010|FG010|Overall Study|Death|0|||
127801881|NCT00666926|459897011|FG011|Overall Study|Death|1|||
127801882|NCT00666926|459897012|FG012|Overall Study|Death|0|||
127801883|NCT00666926|459897013|FG013|Overall Study|Death|0|||
127801884|NCT00666926|459897014|FG014|Overall Study|Death|0|||
127801885|NCT00666926|459897015|FG015|Overall Study|Death|0|||
127801886|NCT00820755|459897016|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
127801887|NCT00820755|459897017|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
127801888|NCT00820755|459897018|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
127801889|NCT00820755|459897016|FG000|Period 1: Combination Therapy Phase|Death|28|||
127801890|NCT00820755|459897017|FG001|Period 1: Combination Therapy Phase|Death|0|||
127801891|NCT00820755|459897018|FG002|Period 1: Combination Therapy Phase|Death|0|||
127801892|NCT00820755|459897016|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
127801893|NCT00820755|459897017|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
127801894|NCT00820755|459897018|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
127801895|NCT00820755|459897016|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
127801896|NCT00820755|459897017|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
127801897|NCT00820755|459897018|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
127801898|NCT00820755|459897016|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
127801899|NCT00820755|459897017|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
127801900|NCT00820755|459897018|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
127801901|NCT00820755|459897016|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
127801902|NCT00820755|459897017|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
127801903|NCT00820755|459897018|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
127801904|NCT00820755|459897016|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
127801905|NCT00820755|459897017|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
127801906|NCT00820755|459897018|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
127801907|NCT00820755|459897016|FG000|Period 1: Combination Therapy Phase|Other|11|||
127888503|NCT02544633|460215743|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
127713907|NCT02500576|459581323|FG000|Overall Study|Withdrawal by Subject|1|||
127713908|NCT02500576|459581324|FG001|Overall Study|Withdrawal by Subject|1|||
127713909|NCT03691493|459581330|FG000|Overall Study|Withdrawal by Subject|1|||
127713910|NCT03867201|459581331|FG000|Double-Blind Period Until Week 12|Lack of Efficacy|1|||
127713911|NCT03867201|459581332|FG001|Double-Blind Period Until Week 12|Lack of Efficacy|0|||
127713912|NCT03867201|459581331|FG000|Double-Blind Period Until Week 12|Withdrawal by Subject|1|||
127713913|NCT03867201|459581332|FG001|Double-Blind Period Until Week 12|Withdrawal by Subject|2|||
127713914|NCT03867201|459581331|FG000|Double-Blind Period Until Week 12|Protocol Violation|1|||
127713915|NCT03867201|459581332|FG001|Double-Blind Period Until Week 12|Protocol Violation|2|||
127713916|NCT03867201|459581331|FG000|Double-Blind Period Until Week 12|Pregnancy|1|||
127713917|NCT03867201|459581332|FG001|Double-Blind Period Until Week 12|Pregnancy|1|||
127713918|NCT03867201|459581331|FG000|Double-Blind Period Until Week 12|Adverse Event|2|||
127713919|NCT03867201|459581332|FG001|Double-Blind Period Until Week 12|Adverse Event|1|||
127713920|NCT03867201|459581331|FG000|Open-Label Period From Week 12|Adverse Event|5|||
127713921|NCT03867201|459581332|FG001|Open-Label Period From Week 12|Adverse Event|11|||
127713922|NCT03867201|459581331|FG000|Open-Label Period From Week 12|Lost to Follow-up|1|||
127713923|NCT03867201|459581332|FG001|Open-Label Period From Week 12|Lost to Follow-up|0|||
127713924|NCT03867201|459581331|FG000|Open-Label Period From Week 12|Physician Decision|6|||
127801908|NCT00820755|459897017|FG001|Period 1: Combination Therapy Phase|Other|0|||
127713925|NCT03867201|459581332|FG001|Open-Label Period From Week 12|Physician Decision|3|||
127713926|NCT03867201|459581331|FG000|Open-Label Period From Week 12|Pregnancy|2|||
127713927|NCT03867201|459581332|FG001|Open-Label Period From Week 12|Pregnancy|2|||
127713928|NCT03867201|459581331|FG000|Open-Label Period From Week 12|Protocol Violation|2|||
127713929|NCT03867201|459581332|FG001|Open-Label Period From Week 12|Protocol Violation|0|||
127713930|NCT03867201|459581331|FG000|Open-Label Period From Week 12|Withdrawal by Subject|90|||
127713931|NCT03867201|459581332|FG001|Open-Label Period From Week 12|Withdrawal by Subject|85|||
127713932|NCT03867201|459581331|FG000|Open-Label Period From Week 12|No longer clinically benefiting|12|||
127713933|NCT03867201|459581332|FG001|Open-Label Period From Week 12|No longer clinically benefiting|10|||
127713934|NCT03867201|459581331|FG000|Open-Label Period From Week 12|New Therapy for Study Indication|1|||
127713935|NCT03867201|459581332|FG001|Open-Label Period From Week 12|New Therapy for Study Indication|0|||
127713936|NCT01983683|459581333|FG000|Overall Study|Withdrawal by Subject|14|||
127713937|NCT01983683|459581334|FG001|Overall Study|Withdrawal by Subject|18|||
127713938|NCT01983683|459581333|FG000|Overall Study|Death|11|||
127713939|NCT01983683|459581334|FG001|Overall Study|Death|15|||
127713940|NCT01983683|459581333|FG000|Overall Study|Physician Decision|8|||
127713941|NCT01983683|459581334|FG001|Overall Study|Physician Decision|9|||
127713942|NCT01983683|459581333|FG000|Overall Study|Lost to Follow-up|4|||
127713943|NCT01983683|459581334|FG001|Overall Study|Lost to Follow-up|8|||
127713944|NCT01983683|459581333|FG000|Overall Study|Sponsor Decision|1|||
127713945|NCT01983683|459581334|FG001|Overall Study|Sponsor Decision|1|||
127713946|NCT04039113|459581343|FG000|Overall Study|Withdrawal by Subject|8|||
127713947|NCT04039113|459581344|FG001|Overall Study|Withdrawal by Subject|11|||
127713948|NCT04039113|459581343|FG000|Overall Study|Lost to Follow-up|1|||
127713949|NCT04039113|459581344|FG001|Overall Study|Lost to Follow-up|1|||
127713950|NCT04039113|459581343|FG000|Overall Study|Adverse Event|2|||
127713951|NCT04039113|459581344|FG001|Overall Study|Adverse Event|2|||
127713952|NCT04039113|459581343|FG000|Overall Study|Death|2|||
127713953|NCT04039113|459581344|FG001|Overall Study|Death|4|||
127713954|NCT04039113|459581343|FG000|Overall Study|Site Closure|6|||
127713955|NCT04039113|459581344|FG001|Overall Study|Site Closure|0|||
127713956|NCT04039113|459581343|FG000|Overall Study|Failure to meet randomisation criteria|4|||
127801909|NCT00820755|459897018|FG002|Period 1: Combination Therapy Phase|Other|0|||
127801910|NCT00820755|459897016|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
127801911|NCT00820755|459897017|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
127801912|NCT00820755|459897018|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
127801913|NCT00091832|459897028|FG000|Overall Study|Physician Decision|1|||
127801914|NCT00091832|459897029|FG001|Overall Study|Physician Decision|0|||
127801915|NCT00091832|459897030|FG002|Overall Study|Physician Decision|0|||
127801916|NCT00091832|459897031|FG003|Overall Study|Physician Decision|0|||
127801917|NCT00091832|459897032|FG004|Overall Study|Physician Decision|0|||
127801918|NCT00091832|459897033|FG005|Overall Study|Physician Decision|0|||
127801919|NCT00091832|459897028|FG000|Overall Study|Adverse Event|0|||
127801920|NCT00091832|459897029|FG001|Overall Study|Adverse Event|0|||
127801921|NCT00091832|459897030|FG002|Overall Study|Adverse Event|0|||
127801922|NCT00091832|459897031|FG003|Overall Study|Adverse Event|1|||
127801923|NCT00091832|459897032|FG004|Overall Study|Adverse Event|3|||
127801924|NCT00091832|459897033|FG005|Overall Study|Adverse Event|0|||
127801925|NCT00091832|459897028|FG000|Overall Study|Withdrawal by Subject|4|||
127801926|NCT00091832|459897029|FG001|Overall Study|Withdrawal by Subject|5|||
127801927|NCT00091832|459897030|FG002|Overall Study|Withdrawal by Subject|0|||
127801928|NCT00091832|459897031|FG003|Overall Study|Withdrawal by Subject|1|||
127801929|NCT00091832|459897032|FG004|Overall Study|Withdrawal by Subject|3|||
127801930|NCT00091832|459897033|FG005|Overall Study|Withdrawal by Subject|1|||
127801931|NCT00091832|459897028|FG000|Overall Study|Death|6|||
127801932|NCT00091832|459897029|FG001|Overall Study|Death|4|||
127801933|NCT00091832|459897030|FG002|Overall Study|Death|5|||
127801934|NCT00091832|459897031|FG003|Overall Study|Death|8|||
127801935|NCT00091832|459897032|FG004|Overall Study|Death|5|||
127801936|NCT00091832|459897033|FG005|Overall Study|Death|6|||
127801937|NCT00091832|459897028|FG000|Overall Study|Disease Progression|2|||
127801938|NCT00091832|459897029|FG001|Overall Study|Disease Progression|0|||
127801939|NCT00091832|459897030|FG002|Overall Study|Disease Progression|0|||
127801940|NCT00091832|459897031|FG003|Overall Study|Disease Progression|1|||
127801941|NCT00091832|459897032|FG004|Overall Study|Disease Progression|1|||
127801942|NCT00091832|459897033|FG005|Overall Study|Disease Progression|2|||
127801943|NCT00091832|459897028|FG000|Overall Study|Ineligibility Determined|0|||
127801944|NCT00091832|459897029|FG001|Overall Study|Ineligibility Determined|0|||
127713957|NCT04039113|459581344|FG001|Overall Study|Failure to meet randomisation criteria|0|||
127801945|NCT00091832|459897030|FG002|Overall Study|Ineligibility Determined|1|||
127801946|NCT00091832|459897031|FG003|Overall Study|Ineligibility Determined|0|||
127801947|NCT00091832|459897032|FG004|Overall Study|Ineligibility Determined|1|||
127713958|NCT03997474|459581345|FG000|Overall Study|Death|6|||
127801948|NCT00091832|459897033|FG005|Overall Study|Ineligibility Determined|0|||
127801949|NCT00091832|459897028|FG000|Overall Study|Lost to Follow-up|1|||
127713959|NCT03997474|459581346|FG001|Overall Study|Death|2|||
127801950|NCT00091832|459897029|FG001|Overall Study|Lost to Follow-up|0|||
127713960|NCT03997474|459581347|FG002|Overall Study|Death|1|||
127713961|NCT03997474|459581345|FG000|Overall Study|Physician Decision|2|||
127713962|NCT03997474|459581346|FG001|Overall Study|Physician Decision|0|||
127713963|NCT03997474|459581347|FG002|Overall Study|Physician Decision|0|||
127713964|NCT03997474|459581345|FG000|Overall Study|study terminated by sponsor|1|||
127713965|NCT03997474|459581346|FG001|Overall Study|study terminated by sponsor|0|||
127713966|NCT03997474|459581347|FG002|Overall Study|study terminated by sponsor|1|||
127713967|NCT04980300|459581349|FG000|Baseline to 12 Weeks|Withdrawal by Subject|2|||
127713968|NCT04980300|459581350|FG001|Baseline to 12 Weeks|Withdrawal by Subject|1|||
127713969|NCT04980300|459581349|FG000|Baseline to 12 Weeks|Lost to Follow-up|4|||
127713970|NCT04980300|459581350|FG001|Baseline to 12 Weeks|Lost to Follow-up|0|||
127713971|NCT04980300|459581349|FG000|12 Weeks to 24 Weeks|Withdrawal by Subject|2|||
127713972|NCT04980300|459581350|FG001|12 Weeks to 24 Weeks|Withdrawal by Subject|1|||
127713973|NCT04980300|459581349|FG000|12 Weeks to 24 Weeks|Lost to Follow-up|2|||
127713974|NCT04980300|459581350|FG001|12 Weeks to 24 Weeks|Lost to Follow-up|4|||
127713975|NCT03459196|459582381|FG000|Overall Study|Subject didn't receive study catheter|2|||
127713976|NCT03140670|459582388|FG000|Overall Study|Withdrawal by Subject|2|||
127713977|NCT03140670|459582388|FG000|Overall Study|Lost to Follow-up|1|||
127713978|NCT03140670|459582388|FG000|Overall Study|Physician Decision|1|||
127713979|NCT00220805|459582389|FG000|Overall Study|Adverse Event|1|||
127713980|NCT00220805|459582390|FG001|Overall Study|Adverse Event|3|||
127713981|NCT00220805|459582389|FG000|Overall Study|Withdrawal by Subject|3|||
127713982|NCT00220805|459582390|FG001|Overall Study|Withdrawal by Subject|0|||
127713983|NCT00220805|459582389|FG000|Overall Study|Lack of Efficacy|1|||
127713984|NCT00220805|459582390|FG001|Overall Study|Lack of Efficacy|0|||
127713985|NCT00220805|459582389|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
127713986|NCT00220805|459582390|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
127713987|NCT01964300|459582392|FG000|Overall Study|Ineligible after enrollment|0|||
127713988|NCT01964300|459582393|FG001|Overall Study|Ineligible after enrollment|1|||
127713989|NCT01964300|459582392|FG000|Overall Study|Adverse Event|1|||
127713990|NCT01964300|459582393|FG001|Overall Study|Adverse Event|1|||
127713991|NCT01964300|459582392|FG000|Overall Study|Lack of Efficacy|3|||
127713992|NCT01964300|459582393|FG001|Overall Study|Lack of Efficacy|5|||
127713993|NCT01964300|459582392|FG000|Overall Study|Withdrawal by Subject|0|||
127713994|NCT01964300|459582393|FG001|Overall Study|Withdrawal by Subject|1|||
127801951|NCT00091832|459897030|FG002|Overall Study|Lost to Follow-up|3|||
127801952|NCT00091832|459897031|FG003|Overall Study|Lost to Follow-up|3|||
127801953|NCT00091832|459897032|FG004|Overall Study|Lost to Follow-up|2|||
127801954|NCT00091832|459897033|FG005|Overall Study|Lost to Follow-up|1|||
127801955|NCT00091832|459897028|FG000|Overall Study|Noncompliance|0|||
127801956|NCT00091832|459897029|FG001|Overall Study|Noncompliance|1|||
127801957|NCT00091832|459897030|FG002|Overall Study|Noncompliance|0|||
127801958|NCT00091832|459897031|FG003|Overall Study|Noncompliance|0|||
127801959|NCT00091832|459897032|FG004|Overall Study|Noncompliance|0|||
127801960|NCT00091832|459897033|FG005|Overall Study|Noncompliance|0|||
127801961|NCT00091832|459897028|FG000|Overall Study|Other|0|||
127801962|NCT00091832|459897029|FG001|Overall Study|Other|1|||
127801963|NCT00091832|459897030|FG002|Overall Study|Other|2|||
127801964|NCT00091832|459897031|FG003|Overall Study|Other|0|||
127801965|NCT00091832|459897032|FG004|Overall Study|Other|0|||
127801966|NCT00091832|459897033|FG005|Overall Study|Other|0|||
127801967|NCT00091832|459897028|FG000|Overall Study|Protocol Violation|0|||
127801968|NCT00091832|459897029|FG001|Overall Study|Protocol Violation|0|||
127801969|NCT00091832|459897030|FG002|Overall Study|Protocol Violation|1|||
127801970|NCT00091832|459897031|FG003|Overall Study|Protocol Violation|0|||
127801971|NCT00091832|459897032|FG004|Overall Study|Protocol Violation|0|||
127801972|NCT00091832|459897033|FG005|Overall Study|Protocol Violation|1|||
127801973|NCT00464178|459897034|FG000|Overall Study|Protocol Violation|1|||
127801974|NCT00464178|459897034|FG000|Overall Study|Withdrawal by Subject|1|||
127801975|NCT00573794|459897045|FG000|Overall Study|Adverse Event|81|||
127801976|NCT00573794|459897045|FG000|Overall Study|Withdrew Consent|90|||
127801977|NCT00573794|459897045|FG000|Overall Study|Lost to Follow-up|13|||
127713995|NCT01964300|459582392|FG000|Overall Study|To receive alternative therapy|1|||
127713996|NCT01964300|459582393|FG001|Overall Study|To receive alternative therapy|2|||
127713997|NCT01964300|459582392|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
127713998|NCT01964300|459582393|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
127713999|NCT01964300|459582392|FG000|Overall Study|Weight criteria not met|0|||
127714000|NCT01964300|459582393|FG001|Overall Study|Weight criteria not met|1|||
127801978|NCT00573794|459897045|FG000|Overall Study|Protocol Violation|6|||
127801979|NCT00573794|459897045|FG000|Overall Study|Lack of Efficacy|94|||
127801980|NCT00573794|459897045|FG000|Overall Study|Other|46|||
127801981|NCT01725750|459897046|FG000|Overall Study|Adverse Event|1|||
127801982|NCT01725750|459897047|FG001|Overall Study|Adverse Event|0|||
127801983|NCT01725750|459897046|FG000|Overall Study|Lost to Follow-up|1|||
127801984|NCT01725750|459897047|FG001|Overall Study|Lost to Follow-up|1|||
127801985|NCT01725750|459897046|FG000|Overall Study|Withdrawal by Subject|0|||
127801986|NCT01725750|459897047|FG001|Overall Study|Withdrawal by Subject|9|||
127801987|NCT02542072|459897048|FG000|First Intervention (1 Month)|Adverse Event|1|||
127714001|NCT03183050|459582394|FG000|Overall Study|Lost to Follow-up|23|||
127714002|NCT00754065|459582395|FG000|Overall Study|Never received treatment|12|||
127714003|NCT00754065|459582396|FG001|Overall Study|Never received treatment|2|||
127714004|NCT00754065|459582395|FG000|Overall Study|Adverse Event|19|||
127714005|NCT00754065|459582396|FG001|Overall Study|Adverse Event|25|||
127714006|NCT00754065|459582395|FG000|Overall Study|Lost to Follow-up|7|||
127714007|NCT00754065|459582396|FG001|Overall Study|Lost to Follow-up|11|||
127714008|NCT00754065|459582395|FG000|Overall Study|Protocol Violation|12|||
127714009|NCT00754065|459582396|FG001|Overall Study|Protocol Violation|10|||
127714010|NCT00754065|459582395|FG000|Overall Study|Withdrawal by Subject|4|||
127714011|NCT00754065|459582396|FG001|Overall Study|Withdrawal by Subject|5|||
127714012|NCT00754065|459582395|FG000|Overall Study|Pregnancy|6|||
127714013|NCT00754065|459582396|FG001|Overall Study|Pregnancy|0|||
127714014|NCT00754065|459582395|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
127714015|NCT00754065|459582396|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
127714016|NCT01074294|459582397|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
127714017|NCT01074294|459582398|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
127714018|NCT01074294|459582399|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
127714019|NCT01074294|459582400|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
127714020|NCT01074294|459582397|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
127714021|NCT01074294|459582398|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
127714022|NCT01074294|459582399|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
127714023|NCT01074294|459582400|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
127714024|NCT01074294|459582397|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
127714025|NCT01074294|459582398|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
127714026|NCT01074294|459582399|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
127714027|NCT01074294|459582400|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
127714028|NCT01074294|459582397|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
127714029|NCT01074294|459582398|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
127714030|NCT01074294|459582399|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
127714031|NCT01074294|459582400|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
127714032|NCT01074294|459582397|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
127714033|NCT01074294|459582398|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
127714034|NCT01074294|459582399|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
127714035|NCT01074294|459582400|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
127714036|NCT01074294|459582397|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
127714037|NCT01074294|459582398|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
127714038|NCT01074294|459582399|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
127714039|NCT01074294|459582400|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
127714040|NCT01074294|459582397|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
127714041|NCT01074294|459582398|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
127714042|NCT01074294|459582399|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
127714043|NCT01074294|459582400|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
127714044|NCT01074294|459582397|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
127714045|NCT01074294|459582398|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
127714046|NCT01074294|459582399|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
127714047|NCT01074294|459582400|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
127714048|NCT01074294|459582397|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
127714049|NCT01074294|459582398|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
127714050|NCT01074294|459582399|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
127714051|NCT01074294|459582400|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
127714052|NCT01074294|459582397|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
127801988|NCT02542072|459897049|FG001|First Intervention (1 Month)|Adverse Event|1|||
127801989|NCT02542072|459897048|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
127801990|NCT02542072|459897049|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
127801991|NCT02542072|459897048|FG000|First Intervention (1 Month)|Lens discomfort|1|||
127801992|NCT02542072|459897049|FG001|First Intervention (1 Month)|Lens discomfort|2|||
127801993|NCT02542072|459897048|FG000|First Intervention (1 Month)|Protocol Violation|1|||
127801994|NCT02542072|459897049|FG001|First Intervention (1 Month)|Protocol Violation|0|||
127714053|NCT01074294|459582398|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
127801995|NCT02542072|459897048|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
127801996|NCT02542072|459897049|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
127801997|NCT02542072|459897048|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
127801998|NCT02542072|459897049|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
127801999|NCT00654498|459897054|FG000|Overall Study|Not Treated|1|||
127714054|NCT01074294|459582399|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
127802000|NCT00654498|459897055|FG001|Overall Study|Not Treated|0|||
127802001|NCT00654498|459897054|FG000|Overall Study|Adverse Event|6|||
127714055|NCT01074294|459582400|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
127714056|NCT01074294|459582397|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
127714057|NCT01074294|459582398|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
127714058|NCT01074294|459582399|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
127714059|NCT01074294|459582400|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
127714060|NCT01074294|459582397|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
127714061|NCT01074294|459582398|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
127714062|NCT01074294|459582399|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
127714063|NCT01074294|459582400|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
127714064|NCT01074294|459582397|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
127714065|NCT01074294|459582398|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
127714066|NCT01074294|459582399|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
127714067|NCT01074294|459582400|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
127714068|NCT00623194|459582401|FG000|Overall Study|Lack of Efficacy|1|||
127714069|NCT00623194|459582401|FG000|Overall Study|Protocol Violation|3|||
127714070|NCT00623194|459582401|FG000|Overall Study|Unclassified|1|||
127714071|NCT01260896|459582402|FG000|First Intervention|Withdrawn Due to Emesis|2|||
127714072|NCT01260896|459582403|FG001|First Intervention|Withdrawn Due to Emesis|0|||
127714073|NCT00312208|459582405|FG000|Overall Study|Adverse Event|97|||
127714074|NCT00312208|459582406|FG001|Overall Study|Adverse Event|61|||
127714075|NCT00312208|459582405|FG000|Overall Study|Protocol Violation|5|||
127714076|NCT00312208|459582406|FG001|Overall Study|Protocol Violation|3|||
127714077|NCT00312208|459582405|FG000|Overall Study|Death|2|||
127714078|NCT00312208|459582406|FG001|Overall Study|Death|1|||
127714079|NCT00312208|459582405|FG000|Overall Study|Lack of Efficacy|7|||
127714080|NCT00312208|459582406|FG001|Overall Study|Lack of Efficacy|4|||
127714081|NCT00312208|459582405|FG000|Overall Study|Lost to Follow-up|3|||
127714082|NCT00312208|459582406|FG001|Overall Study|Lost to Follow-up|5|||
127714083|NCT00312208|459582405|FG000|Overall Study|Withdrawal by Subject|53|||
127714084|NCT00312208|459582406|FG001|Overall Study|Withdrawal by Subject|42|||
127714085|NCT00312208|459582405|FG000|Overall Study|Other|5|||
127714086|NCT00312208|459582406|FG001|Overall Study|Other|7|||
127714087|NCT00982644|459582409|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
127714088|NCT00982644|459582410|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
127714089|NCT00982644|459582409|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
127714090|NCT00982644|459582410|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
127714091|NCT00982644|459582409|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
127714092|NCT00982644|459582410|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
127714093|NCT00982644|459582409|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
127714094|NCT00982644|459582410|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
127714095|NCT00982644|459582409|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
127714096|NCT00982644|459582410|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
127714097|NCT00982644|459582409|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
127714098|NCT00982644|459582410|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
127714099|NCT00982644|459582409|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
127714100|NCT00982644|459582410|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
127714101|NCT00982644|459582409|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
127714102|NCT00982644|459582410|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
127714103|NCT00982644|459582409|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
127714104|NCT00982644|459582410|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
127714105|NCT00982644|459582409|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
127714106|NCT00982644|459582410|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
127714107|NCT00943917|459582413|FG000|Stage I|Adverse Event|1|||
127714108|NCT00943917|459582414|FG001|Stage I|Adverse Event|2|||
127714109|NCT00943917|459582415|FG002|Stage I|Adverse Event|2|||
127714110|NCT00943917|459582416|FG003|Stage I|Adverse Event|0|||
127714111|NCT00943917|459582417|FG004|Stage I|Adverse Event|0|||
127714112|NCT00943917|459582418|FG005|Stage I|Adverse Event|0|||
127714113|NCT00943917|459582419|FG006|Stage I|Adverse Event|0|||
127714114|NCT00943917|459582420|FG007|Stage I|Adverse Event|0|||
127714115|NCT00943917|459582421|FG008|Stage I|Adverse Event|0|||
127714116|NCT00943917|459582422|FG009|Stage I|Adverse Event|0|||
127802002|NCT00654498|459897055|FG001|Overall Study|Adverse Event|1|||
127802003|NCT00654498|459897054|FG000|Overall Study|Protocol Violation|1|||
127802004|NCT00654498|459897055|FG001|Overall Study|Protocol Violation|1|||
127714117|NCT00943917|459582423|FG010|Stage I|Adverse Event|0|||
127714118|NCT00943917|459582424|FG011|Stage I|Adverse Event|0|||
127714119|NCT00943917|459582425|FG012|Stage I|Adverse Event|0|||
127714120|NCT00943917|459582426|FG013|Stage I|Adverse Event|0|||
127714121|NCT00943917|459582427|FG014|Stage I|Adverse Event|0|||
127802005|NCT00654498|459897054|FG000|Overall Study|Lost to Follow-up|1|||
127802006|NCT00654498|459897055|FG001|Overall Study|Lost to Follow-up|5|||
127888504|NCT01977352|460215744|FG000|Overall Study|Lost to Follow-up|1|||
127888505|NCT01977352|460215745|FG001|Overall Study|Lost to Follow-up|2|||
127888506|NCT02257632|460215746|FG000|Overall Study|Withdrawal by Subject|0|||
127888507|NCT02257632|460215747|FG001|Overall Study|Withdrawal by Subject|1|||
127888508|NCT02257632|460215746|FG000|Overall Study|Adverse Event|1|||
127888509|NCT02257632|460215747|FG001|Overall Study|Adverse Event|2|||
127888510|NCT00331630|460215748|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
127888511|NCT00331630|460215748|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
127888512|NCT00331630|460215748|FG000|Follow up for 5 Years|Death|5|||
127888513|NCT00331630|460215748|FG000|Follow up for 5 Years|Data collection was stopped|24|||
127888514|NCT01059071|460215749|FG000|Overall Study|Lack of Efficacy|1|||
127888515|NCT01059071|460215750|FG001|Overall Study|Lack of Efficacy|4|||
127888516|NCT01059071|460215751|FG002|Overall Study|Lack of Efficacy|2|||
127888517|NCT01059071|460215752|FG003|Overall Study|Lack of Efficacy|3|||
127888518|NCT01059071|460215749|FG000|Overall Study|Withdrawal by Subject|1|||
127888519|NCT01059071|460215750|FG001|Overall Study|Withdrawal by Subject|0|||
127888520|NCT01059071|460215751|FG002|Overall Study|Withdrawal by Subject|0|||
127888521|NCT01059071|460215752|FG003|Overall Study|Withdrawal by Subject|2|||
127888522|NCT01059071|460215749|FG000|Overall Study|Physician Decision|0|||
127888523|NCT01059071|460215750|FG001|Overall Study|Physician Decision|0|||
127888524|NCT01059071|460215751|FG002|Overall Study|Physician Decision|0|||
127888525|NCT01059071|460215752|FG003|Overall Study|Physician Decision|1|||
127888526|NCT03763331|460215753|FG000|Overall Study|Lost to Follow-up|1|||
127888527|NCT03763331|460215754|FG001|Overall Study|Lost to Follow-up|0|||
127888528|NCT03763331|460215753|FG000|Overall Study|Withdrawal by Subject|1|||
127888529|NCT03763331|460215754|FG001|Overall Study|Withdrawal by Subject|0|||
127888530|NCT03763331|460215753|FG000|Overall Study|Non-compliance|0|||
127888531|NCT03763331|460215754|FG001|Overall Study|Non-compliance|3|||
127888532|NCT00936884|460215755|FG000|Double-blind|Withdrawal by Subject|6|||
127888533|NCT00936884|460215756|FG001|Double-blind|Withdrawal by Subject|4|||
127888534|NCT00936884|460215757|FG002|Double-blind|Withdrawal by Subject|0|||
127888535|NCT00936884|460215755|FG000|Double-blind|Death|2|||
127888536|NCT00936884|460215756|FG001|Double-blind|Death|1|||
127888537|NCT00936884|460215757|FG002|Double-blind|Death|0|||
127888538|NCT00936884|460215755|FG000|Double-blind|Lack of Efficacy|1|||
127888539|NCT00936884|460215756|FG001|Double-blind|Lack of Efficacy|1|||
127888540|NCT00936884|460215757|FG002|Double-blind|Lack of Efficacy|0|||
127888541|NCT00936884|460215755|FG000|Double-blind|Adverse Event|1|||
127888542|NCT00936884|460215756|FG001|Double-blind|Adverse Event|0|||
127888543|NCT00936884|460215757|FG002|Double-blind|Adverse Event|0|||
127888544|NCT00936884|460215755|FG000|Double-blind|Physician Decision|1|||
127888545|NCT00936884|460215756|FG001|Double-blind|Physician Decision|0|||
127888546|NCT00936884|460215757|FG002|Double-blind|Physician Decision|0|||
127888547|NCT00936884|460215755|FG000|Double-blind|No post baseline diary entry|1|||
127888548|NCT00936884|460215756|FG001|Double-blind|No post baseline diary entry|0|||
127888549|NCT00936884|460215757|FG002|Double-blind|No post baseline diary entry|0|||
127888550|NCT00936884|460215755|FG000|Double-blind|Did not receive study drug|0|||
127888551|NCT00936884|460215756|FG001|Double-blind|Did not receive study drug|1|||
127888552|NCT00936884|460215757|FG002|Double-blind|Did not receive study drug|0|||
127888553|NCT04741503|460215758|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
127888554|NCT04741503|460215759|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
127888555|NCT04741503|460215760|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
127888556|NCT04741503|460215758|FG000|Initial Enrollment|Overquotas removed|0|||
127888557|NCT04741503|460215759|FG001|Initial Enrollment|Overquotas removed|0|||
127888558|NCT04741503|460215760|FG002|Initial Enrollment|Overquotas removed|186|||
127888559|NCT04741503|460215758|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
127888560|NCT04741503|460215759|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
127888561|NCT04741503|460215760|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
127888562|NCT02280421|460215761|FG000|Washout (2 Weeks)|Adverse Event|0|||
127888563|NCT02280421|460215762|FG001|Washout (2 Weeks)|Adverse Event|1|||
127888564|NCT02280421|460215761|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
127888565|NCT02280421|460215762|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
127888566|NCT01859390|460215769|FG000|Overall Study|Insufficient Sputum Collected|1|||
127888567|NCT01859390|460215770|FG001|Overall Study|Insufficient Sputum Collected|3|||
127888568|NCT01859390|460215769|FG000|Overall Study|Sample Missing Collection Date|0|||
127888569|NCT01859390|460215770|FG001|Overall Study|Sample Missing Collection Date|1|||
127888570|NCT01859390|460215769|FG000|Overall Study|Tube Cracked|0|||
127888571|NCT01859390|460215770|FG001|Overall Study|Tube Cracked|2|||
127888572|NCT01859390|460215769|FG000|Overall Study|Shipment Error|0|||
127888573|NCT01859390|460215770|FG001|Overall Study|Shipment Error|1|||
127888574|NCT02764489|460215775|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
127888575|NCT02764489|460215776|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
127888576|NCT02764489|460215775|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
127888577|NCT02764489|460215776|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
127888578|NCT02764489|460215775|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
127714122|NCT00943917|459582413|FG000|Stage I|Lost to Follow-up|0|||
127714123|NCT00943917|459582414|FG001|Stage I|Lost to Follow-up|0|||
127714124|NCT00943917|459582415|FG002|Stage I|Lost to Follow-up|1|||
127714125|NCT00943917|459582416|FG003|Stage I|Lost to Follow-up|0|||
127714126|NCT00943917|459582417|FG004|Stage I|Lost to Follow-up|0|||
127714127|NCT00943917|459582418|FG005|Stage I|Lost to Follow-up|0|||
127714128|NCT00943917|459582419|FG006|Stage I|Lost to Follow-up|0|||
127714129|NCT00943917|459582420|FG007|Stage I|Lost to Follow-up|0|||
127714130|NCT00943917|459582421|FG008|Stage I|Lost to Follow-up|0|||
127714131|NCT00943917|459582422|FG009|Stage I|Lost to Follow-up|0|||
127714132|NCT00943917|459582423|FG010|Stage I|Lost to Follow-up|0|||
127714133|NCT00943917|459582424|FG011|Stage I|Lost to Follow-up|0|||
127714134|NCT00943917|459582425|FG012|Stage I|Lost to Follow-up|0|||
127714135|NCT00943917|459582426|FG013|Stage I|Lost to Follow-up|0|||
127714136|NCT00943917|459582427|FG014|Stage I|Lost to Follow-up|0|||
127714137|NCT00943917|459582413|FG000|Stage I|hyperglycemia|0|||
127714138|NCT00943917|459582414|FG001|Stage I|hyperglycemia|0|||
127714139|NCT00943917|459582415|FG002|Stage I|hyperglycemia|1|||
127714140|NCT00943917|459582416|FG003|Stage I|hyperglycemia|0|||
127714141|NCT00943917|459582417|FG004|Stage I|hyperglycemia|0|||
127714142|NCT00943917|459582418|FG005|Stage I|hyperglycemia|0|||
127714143|NCT00943917|459582419|FG006|Stage I|hyperglycemia|0|||
127714144|NCT00943917|459582420|FG007|Stage I|hyperglycemia|0|||
127714145|NCT00943917|459582421|FG008|Stage I|hyperglycemia|0|||
127714146|NCT00943917|459582422|FG009|Stage I|hyperglycemia|0|||
127714147|NCT00943917|459582423|FG010|Stage I|hyperglycemia|0|||
127714148|NCT00943917|459582424|FG011|Stage I|hyperglycemia|0|||
127714149|NCT00943917|459582425|FG012|Stage I|hyperglycemia|0|||
127714150|NCT00943917|459582426|FG013|Stage I|hyperglycemia|0|||
127714151|NCT00943917|459582427|FG014|Stage I|hyperglycemia|0|||
127714152|NCT00943917|459582413|FG000|Stage I|A1C elevation|1|||
127714153|NCT00943917|459582414|FG001|Stage I|A1C elevation|0|||
127714154|NCT00943917|459582415|FG002|Stage I|A1C elevation|0|||
127714155|NCT00943917|459582416|FG003|Stage I|A1C elevation|0|||
127714156|NCT00943917|459582417|FG004|Stage I|A1C elevation|0|||
127714157|NCT00943917|459582418|FG005|Stage I|A1C elevation|0|||
127714158|NCT00943917|459582419|FG006|Stage I|A1C elevation|0|||
127714159|NCT00943917|459582420|FG007|Stage I|A1C elevation|0|||
127714160|NCT00943917|459582421|FG008|Stage I|A1C elevation|0|||
127714161|NCT00943917|459582422|FG009|Stage I|A1C elevation|0|||
127714162|NCT00943917|459582423|FG010|Stage I|A1C elevation|0|||
127714163|NCT00943917|459582424|FG011|Stage I|A1C elevation|0|||
127714164|NCT00943917|459582425|FG012|Stage I|A1C elevation|0|||
127714165|NCT00943917|459582426|FG013|Stage I|A1C elevation|0|||
127714166|NCT00943917|459582427|FG014|Stage I|A1C elevation|0|||
127714167|NCT00943917|459582413|FG000|Stage I|Withdrawal by Subject|2|||
127714168|NCT00943917|459582414|FG001|Stage I|Withdrawal by Subject|1|||
127714169|NCT00943917|459582415|FG002|Stage I|Withdrawal by Subject|2|||
127714170|NCT00943917|459582416|FG003|Stage I|Withdrawal by Subject|0|||
127714171|NCT00943917|459582417|FG004|Stage I|Withdrawal by Subject|0|||
127714172|NCT00943917|459582418|FG005|Stage I|Withdrawal by Subject|0|||
127714173|NCT00943917|459582419|FG006|Stage I|Withdrawal by Subject|0|||
127714174|NCT00943917|459582420|FG007|Stage I|Withdrawal by Subject|0|||
127714175|NCT00943917|459582421|FG008|Stage I|Withdrawal by Subject|0|||
127714176|NCT00943917|459582422|FG009|Stage I|Withdrawal by Subject|0|||
127714177|NCT00943917|459582423|FG010|Stage I|Withdrawal by Subject|0|||
127714178|NCT00943917|459582424|FG011|Stage I|Withdrawal by Subject|0|||
127714179|NCT00943917|459582425|FG012|Stage I|Withdrawal by Subject|0|||
127714180|NCT00943917|459582426|FG013|Stage I|Withdrawal by Subject|0|||
127714181|NCT00943917|459582427|FG014|Stage I|Withdrawal by Subject|0|||
127714182|NCT00943917|459582413|FG000|Stage II|Adverse Event|0|||
127714183|NCT00943917|459582414|FG001|Stage II|Adverse Event|0|||
127714184|NCT00943917|459582415|FG002|Stage II|Adverse Event|0|||
127714185|NCT00943917|459582416|FG003|Stage II|Adverse Event|0|||
127714186|NCT00943917|459582417|FG004|Stage II|Adverse Event|0|||
127714187|NCT00943917|459582418|FG005|Stage II|Adverse Event|1|||
127714188|NCT00943917|459582419|FG006|Stage II|Adverse Event|3|||
127714189|NCT00943917|459582420|FG007|Stage II|Adverse Event|0|||
127714190|NCT00943917|459582421|FG008|Stage II|Adverse Event|1|||
127714191|NCT00943917|459582422|FG009|Stage II|Adverse Event|0|||
127714192|NCT00943917|459582423|FG010|Stage II|Adverse Event|0|||
127714193|NCT00943917|459582424|FG011|Stage II|Adverse Event|0|||
127714194|NCT00943917|459582425|FG012|Stage II|Adverse Event|0|||
127714195|NCT00943917|459582426|FG013|Stage II|Adverse Event|0|||
127714196|NCT00943917|459582427|FG014|Stage II|Adverse Event|0|||
127714197|NCT00943917|459582413|FG000|Stage II|Withdrawal by Subject|0|||
127714198|NCT00943917|459582414|FG001|Stage II|Withdrawal by Subject|0|||
127888579|NCT02764489|460215776|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
127888580|NCT02764489|460215775|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
127714199|NCT00943917|459582415|FG002|Stage II|Withdrawal by Subject|0|||
127714200|NCT00943917|459582416|FG003|Stage II|Withdrawal by Subject|0|||
127714201|NCT00943917|459582417|FG004|Stage II|Withdrawal by Subject|0|||
127714202|NCT00943917|459582418|FG005|Stage II|Withdrawal by Subject|1|||
127714203|NCT00943917|459582419|FG006|Stage II|Withdrawal by Subject|0|||
127714204|NCT00943917|459582420|FG007|Stage II|Withdrawal by Subject|0|||
127714205|NCT00943917|459582421|FG008|Stage II|Withdrawal by Subject|0|||
127714206|NCT00943917|459582422|FG009|Stage II|Withdrawal by Subject|0|||
127714207|NCT00943917|459582423|FG010|Stage II|Withdrawal by Subject|0|||
127714208|NCT00943917|459582424|FG011|Stage II|Withdrawal by Subject|0|||
127714209|NCT00943917|459582425|FG012|Stage II|Withdrawal by Subject|0|||
127714210|NCT00943917|459582426|FG013|Stage II|Withdrawal by Subject|0|||
127714211|NCT00943917|459582427|FG014|Stage II|Withdrawal by Subject|0|||
127714212|NCT00943917|459582413|FG000|Stage II|Pregnancy|0|||
127714213|NCT00943917|459582414|FG001|Stage II|Pregnancy|0|||
127714214|NCT00943917|459582415|FG002|Stage II|Pregnancy|0|||
127714215|NCT00943917|459582416|FG003|Stage II|Pregnancy|0|||
127714216|NCT00943917|459582417|FG004|Stage II|Pregnancy|0|||
127714217|NCT00943917|459582418|FG005|Stage II|Pregnancy|1|||
127714218|NCT00943917|459582419|FG006|Stage II|Pregnancy|0|||
127714219|NCT00943917|459582420|FG007|Stage II|Pregnancy|0|||
127714220|NCT00943917|459582421|FG008|Stage II|Pregnancy|0|||
127714221|NCT00943917|459582422|FG009|Stage II|Pregnancy|0|||
127714222|NCT00943917|459582423|FG010|Stage II|Pregnancy|0|||
127714223|NCT00943917|459582424|FG011|Stage II|Pregnancy|0|||
127714224|NCT00943917|459582425|FG012|Stage II|Pregnancy|0|||
127714225|NCT00943917|459582426|FG013|Stage II|Pregnancy|0|||
127714226|NCT00943917|459582427|FG014|Stage II|Pregnancy|0|||
127714227|NCT00943917|459582413|FG000|Stage II Continuation|Adverse Event|0|||
127714228|NCT00943917|459582414|FG001|Stage II Continuation|Adverse Event|0|||
127714229|NCT00943917|459582415|FG002|Stage II Continuation|Adverse Event|0|||
127714230|NCT00943917|459582416|FG003|Stage II Continuation|Adverse Event|0|||
127714231|NCT00943917|459582417|FG004|Stage II Continuation|Adverse Event|0|||
127714232|NCT00943917|459582418|FG005|Stage II Continuation|Adverse Event|0|||
127714233|NCT00943917|459582419|FG006|Stage II Continuation|Adverse Event|0|||
127714234|NCT00943917|459582420|FG007|Stage II Continuation|Adverse Event|0|||
127714235|NCT00943917|459582421|FG008|Stage II Continuation|Adverse Event|0|||
127714236|NCT00943917|459582422|FG009|Stage II Continuation|Adverse Event|0|||
127714237|NCT00943917|459582423|FG010|Stage II Continuation|Adverse Event|0|||
127714238|NCT00943917|459582424|FG011|Stage II Continuation|Adverse Event|1|||
127714239|NCT00943917|459582425|FG012|Stage II Continuation|Adverse Event|2|||
127714240|NCT00943917|459582426|FG013|Stage II Continuation|Adverse Event|1|||
127714241|NCT00943917|459582427|FG014|Stage II Continuation|Adverse Event|1|||
127714242|NCT00943917|459582413|FG000|Stage II Continuation|Withdrawal by Subject|0|||
127714243|NCT00943917|459582414|FG001|Stage II Continuation|Withdrawal by Subject|0|||
127714244|NCT00943917|459582415|FG002|Stage II Continuation|Withdrawal by Subject|0|||
127714245|NCT00943917|459582416|FG003|Stage II Continuation|Withdrawal by Subject|0|||
127714246|NCT00943917|459582417|FG004|Stage II Continuation|Withdrawal by Subject|0|||
127714247|NCT00943917|459582418|FG005|Stage II Continuation|Withdrawal by Subject|0|||
127714248|NCT00943917|459582419|FG006|Stage II Continuation|Withdrawal by Subject|0|||
127714249|NCT00943917|459582420|FG007|Stage II Continuation|Withdrawal by Subject|0|||
127714250|NCT00943917|459582421|FG008|Stage II Continuation|Withdrawal by Subject|0|||
127714251|NCT00943917|459582422|FG009|Stage II Continuation|Withdrawal by Subject|0|||
127714252|NCT00943917|459582423|FG010|Stage II Continuation|Withdrawal by Subject|0|||
127714253|NCT00943917|459582424|FG011|Stage II Continuation|Withdrawal by Subject|0|||
127714254|NCT00943917|459582425|FG012|Stage II Continuation|Withdrawal by Subject|0|||
127714255|NCT00943917|459582426|FG013|Stage II Continuation|Withdrawal by Subject|1|||
127714256|NCT00943917|459582427|FG014|Stage II Continuation|Withdrawal by Subject|3|||
127714257|NCT00943917|459582413|FG000|Stage II Continuation|Protocol Violation|0|||
127714258|NCT00943917|459582414|FG001|Stage II Continuation|Protocol Violation|0|||
127714259|NCT00943917|459582415|FG002|Stage II Continuation|Protocol Violation|0|||
127714260|NCT00943917|459582416|FG003|Stage II Continuation|Protocol Violation|0|||
127714261|NCT00943917|459582417|FG004|Stage II Continuation|Protocol Violation|0|||
127714262|NCT00943917|459582418|FG005|Stage II Continuation|Protocol Violation|0|||
127714263|NCT00943917|459582419|FG006|Stage II Continuation|Protocol Violation|0|||
127714264|NCT00943917|459582420|FG007|Stage II Continuation|Protocol Violation|0|||
127714265|NCT00943917|459582421|FG008|Stage II Continuation|Protocol Violation|0|||
127802007|NCT00654498|459897054|FG000|Overall Study|Withdrawal by Subject|1|||
127802008|NCT00654498|459897055|FG001|Overall Study|Withdrawal by Subject|0|||
127802009|NCT00654498|459897054|FG000|Overall Study|Other reason not defined above|4|||
127802010|NCT00654498|459897055|FG001|Overall Study|Other reason not defined above|5|||
127802011|NCT00695565|459897056|FG000|Overall Study|Lost to Follow-up|4|||
127802012|NCT00695565|459897057|FG001|Overall Study|Lost to Follow-up|4|||
127802013|NCT00695565|459897056|FG000|Overall Study|Adverse Event|3|||
127802014|NCT00695565|459897057|FG001|Overall Study|Adverse Event|1|||
127802015|NCT00695565|459897056|FG000|Overall Study|Protocol Violation|3|||
127802016|NCT00695565|459897057|FG001|Overall Study|Protocol Violation|1|||
127802017|NCT00695565|459897056|FG000|Overall Study|Withdrawal by Subject|1|||
127802018|NCT00695565|459897057|FG001|Overall Study|Withdrawal by Subject|1|||
127802019|NCT00695565|459897056|FG000|Overall Study|Lack of Efficacy|1|||
127802020|NCT00695565|459897057|FG001|Overall Study|Lack of Efficacy|1|||
127802021|NCT00695565|459897056|FG000|Overall Study|Subject did not follow instructions|1|||
127802022|NCT00695565|459897057|FG001|Overall Study|Subject did not follow instructions|1|||
127802023|NCT01738971|459897060|FG000|Overall Study|Lost to Follow-up|19|||
127802024|NCT01738971|459897061|FG001|Overall Study|Lost to Follow-up|30|||
127802025|NCT01738971|459897062|FG002|Overall Study|Lost to Follow-up|17|||
127802026|NCT01031446|459897071|FG000|Overall Study|Disease Progression|38|||
127802027|NCT01031446|459897071|FG000|Overall Study|Adverse Event|9|||
127802028|NCT01031446|459897071|FG000|Overall Study|Physician Decision|4|||
127802029|NCT01031446|459897071|FG000|Overall Study|Withdrawal by Subject|3|||
127802030|NCT01031446|459897071|FG000|Overall Study|Still on treatment|1|||
127802031|NCT02447848|459897072|FG000|Overall Study|Patient discharged|3|||
127714266|NCT00943917|459582422|FG009|Stage II Continuation|Protocol Violation|1|||
127714267|NCT00943917|459582423|FG010|Stage II Continuation|Protocol Violation|0|||
127714268|NCT00943917|459582424|FG011|Stage II Continuation|Protocol Violation|1|||
127714269|NCT00943917|459582425|FG012|Stage II Continuation|Protocol Violation|0|||
127714270|NCT00943917|459582426|FG013|Stage II Continuation|Protocol Violation|0|||
127714271|NCT00943917|459582427|FG014|Stage II Continuation|Protocol Violation|0|||
127714272|NCT00943917|459582413|FG000|Stage II Continuation|hypoglycemia|0|||
127714273|NCT00943917|459582414|FG001|Stage II Continuation|hypoglycemia|0|||
127714274|NCT00943917|459582415|FG002|Stage II Continuation|hypoglycemia|0|||
127714275|NCT00943917|459582416|FG003|Stage II Continuation|hypoglycemia|0|||
127714276|NCT00943917|459582417|FG004|Stage II Continuation|hypoglycemia|0|||
127714277|NCT00943917|459582418|FG005|Stage II Continuation|hypoglycemia|0|||
127714278|NCT00943917|459582419|FG006|Stage II Continuation|hypoglycemia|0|||
127714279|NCT00943917|459582420|FG007|Stage II Continuation|hypoglycemia|0|||
127714280|NCT00943917|459582421|FG008|Stage II Continuation|hypoglycemia|0|||
127714281|NCT00943917|459582422|FG009|Stage II Continuation|hypoglycemia|0|||
127714282|NCT00943917|459582423|FG010|Stage II Continuation|hypoglycemia|0|||
127714283|NCT00943917|459582424|FG011|Stage II Continuation|hypoglycemia|0|||
127714284|NCT00943917|459582425|FG012|Stage II Continuation|hypoglycemia|1|||
127714285|NCT00943917|459582426|FG013|Stage II Continuation|hypoglycemia|0|||
127714286|NCT00943917|459582427|FG014|Stage II Continuation|hypoglycemia|0|||
127714287|NCT00943917|459582413|FG000|Stage II Continuation|A1C elevation|0|||
127714288|NCT00943917|459582414|FG001|Stage II Continuation|A1C elevation|0|||
127714289|NCT00943917|459582415|FG002|Stage II Continuation|A1C elevation|0|||
127714290|NCT00943917|459582416|FG003|Stage II Continuation|A1C elevation|0|||
127714291|NCT00943917|459582417|FG004|Stage II Continuation|A1C elevation|0|||
127714292|NCT00943917|459582418|FG005|Stage II Continuation|A1C elevation|0|||
127714293|NCT00943917|459582419|FG006|Stage II Continuation|A1C elevation|0|||
127714294|NCT00943917|459582420|FG007|Stage II Continuation|A1C elevation|0|||
127714295|NCT00943917|459582421|FG008|Stage II Continuation|A1C elevation|0|||
127714296|NCT00943917|459582422|FG009|Stage II Continuation|A1C elevation|0|||
127714297|NCT00943917|459582423|FG010|Stage II Continuation|A1C elevation|0|||
127802032|NCT02447848|459897072|FG000|Overall Study|Lack of Efficacy|4|||
127802033|NCT02447848|459897072|FG000|Overall Study|Withdrawal by Subject|4|||
127714298|NCT00943917|459582424|FG011|Stage II Continuation|A1C elevation|0|||
127714299|NCT00943917|459582425|FG012|Stage II Continuation|A1C elevation|0|||
127714300|NCT00943917|459582426|FG013|Stage II Continuation|A1C elevation|1|||
127802034|NCT02531646|459897076|FG000|Overall Study|equip. image processing issue|5|||
127802035|NCT02531646|459897077|FG001|Overall Study|equip. image processing issue|1|||
127802036|NCT02531646|459897078|FG002|Overall Study|equip. image processing issue|0|||
127802037|NCT00772668|459897081|FG000|Overall Study|Physician Decision|3|||
127714301|NCT00943917|459582427|FG014|Stage II Continuation|A1C elevation|0|||
127714302|NCT03357952|459582432|FG000|Overall Study|Withdrawal by Subject|0|||
127714303|NCT03357952|459582433|FG001|Overall Study|Withdrawal by Subject|1|||
127714304|NCT03357952|459582432|FG000|Overall Study|Sponsor Decision|9|||
127714305|NCT03357952|459582433|FG001|Overall Study|Sponsor Decision|0|||
127802038|NCT03631706|459897082|FG000|Overall Study|Randomized, not treated|1|||
127802039|NCT03631706|459897083|FG001|Overall Study|Randomized, not treated|0|||
127802040|NCT05888103|459898703|FG000|Overall Study|Participant decision|3|||
127802041|NCT05888103|459898704|FG001|Overall Study|Participant decision|3|||
127802042|NCT02152345|459898705|FG000|Overall Study|Case Cancellations|2|||
127802043|NCT02152345|459898706|FG001|Overall Study|Case Cancellations|4|||
127714306|NCT01371994|459582434|FG000|Overall Study|Adverse Event|3|||
127714307|NCT01371994|459582435|FG001|Overall Study|Adverse Event|6|||
127714308|NCT01371994|459582434|FG000|Overall Study|Lack of Efficacy|3|||
127714309|NCT01371994|459582435|FG001|Overall Study|Lack of Efficacy|0|||
127714310|NCT01371994|459582434|FG000|Overall Study|Withdrawal by Subject|13|||
127714311|NCT01371994|459582435|FG001|Overall Study|Withdrawal by Subject|7|||
127714312|NCT01371994|459582434|FG000|Overall Study|Lost to Follow-up|1|||
127714313|NCT01371994|459582435|FG001|Overall Study|Lost to Follow-up|1|||
127714314|NCT01371994|459582434|FG000|Overall Study|Protocol Violation|24|||
127714315|NCT01371994|459582435|FG001|Overall Study|Protocol Violation|17|||
127714316|NCT01371994|459582434|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
127714317|NCT01371994|459582435|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
127714318|NCT01371994|459582434|FG000|Overall Study|Physician Decision|1|||
127714319|NCT01371994|459582435|FG001|Overall Study|Physician Decision|1|||
127714320|NCT01371994|459582434|FG000|Overall Study|Miscellaneous Reasons|6|||
127714321|NCT01371994|459582435|FG001|Overall Study|Miscellaneous Reasons|4|||
127714322|NCT03222609|459582436|FG000|Overall Study|Withdrew consent|2|||
127714323|NCT03222609|459582437|FG001|Overall Study|Withdrew consent|3|||
127714324|NCT03222609|459582438|FG002|Overall Study|Withdrew consent|4|||
127714325|NCT03222609|459582439|FG003|Overall Study|Withdrew consent|2|||
127714326|NCT03222609|459582436|FG000|Overall Study|Lost to Follow-up|1|||
127714327|NCT03222609|459582437|FG001|Overall Study|Lost to Follow-up|0|||
127714328|NCT03222609|459582438|FG002|Overall Study|Lost to Follow-up|0|||
127714329|NCT03222609|459582439|FG003|Overall Study|Lost to Follow-up|0|||
127714330|NCT03222609|459582436|FG000|Overall Study|Death|16|||
127714331|NCT03222609|459582437|FG001|Overall Study|Death|13|||
127714332|NCT03222609|459582438|FG002|Overall Study|Death|9|||
127714333|NCT03222609|459582439|FG003|Overall Study|Death|6|||
127714334|NCT03222609|459582436|FG000|Overall Study|Remains on treatment or in study follow-up|15|||
127714335|NCT03222609|459582437|FG001|Overall Study|Remains on treatment or in study follow-up|75|||
127714336|NCT03222609|459582438|FG002|Overall Study|Remains on treatment or in study follow-up|21|||
127714337|NCT03222609|459582439|FG003|Overall Study|Remains on treatment or in study follow-up|24|||
127714338|NCT04305327|459582440|FG000|Overall Study|Study early termination|2|||
127714339|NCT04305327|459582441|FG001|Overall Study|Study early termination|5|||
127714340|NCT04305327|459582442|FG002|Overall Study|Study early termination|2|||
127714341|NCT04305327|459582443|FG003|Overall Study|Study early termination|2|||
127714342|NCT04305327|459582440|FG000|Overall Study|Withdrawal by Subject|0|||
127714343|NCT04305327|459582441|FG001|Overall Study|Withdrawal by Subject|1|||
127714344|NCT04305327|459582442|FG002|Overall Study|Withdrawal by Subject|0|||
127714345|NCT04305327|459582443|FG003|Overall Study|Withdrawal by Subject|0|||
127714346|NCT03656718|459582444|FG000|Treatment Period Parts A, B, D, and E|Disease progression|8|||
127714347|NCT03656718|459582445|FG001|Treatment Period Parts A, B, D, and E|Disease progression|11|||
127714348|NCT03656718|459582446|FG002|Treatment Period Parts A, B, D, and E|Disease progression|4|||
127714349|NCT03656718|459582447|FG003|Treatment Period Parts A, B, D, and E|Disease progression|6|||
127714350|NCT03656718|459582448|FG004|Treatment Period Parts A, B, D, and E|Disease progression|0|||
127714351|NCT03656718|459582449|FG005|Treatment Period Parts A, B, D, and E|Disease progression|20|||
127714352|NCT03656718|459582450|FG006|Treatment Period Parts A, B, D, and E|Disease progression|14|||
127714353|NCT03656718|459582444|FG000|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
127714354|NCT03656718|459582445|FG001|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
127714355|NCT03656718|459582446|FG002|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
127714356|NCT03656718|459582447|FG003|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
127714357|NCT03656718|459582448|FG004|Treatment Period Parts A, B, D, and E|Study drug toxicity|0|||
127714358|NCT03656718|459582449|FG005|Treatment Period Parts A, B, D, and E|Study drug toxicity|4|||
127714359|NCT03656718|459582450|FG006|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
127714360|NCT03656718|459582444|FG000|Treatment Period Parts A, B, D, and E|Death|1|||
127714361|NCT03656718|459582445|FG001|Treatment Period Parts A, B, D, and E|Death|0|||
127714362|NCT03656718|459582446|FG002|Treatment Period Parts A, B, D, and E|Death|0|||
127714363|NCT03656718|459582447|FG003|Treatment Period Parts A, B, D, and E|Death|0|||
127714364|NCT03656718|459582448|FG004|Treatment Period Parts A, B, D, and E|Death|0|||
127714365|NCT03656718|459582449|FG005|Treatment Period Parts A, B, D, and E|Death|0|||
127714366|NCT03656718|459582450|FG006|Treatment Period Parts A, B, D, and E|Death|2|||
127714367|NCT03656718|459582444|FG000|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
127714368|NCT03656718|459582445|FG001|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
127714369|NCT03656718|459582446|FG002|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
127714370|NCT03656718|459582447|FG003|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
127802044|NCT02152345|459898705|FG000|Overall Study|Withdrawal by Subject|2|||
127802045|NCT02152345|459898706|FG001|Overall Study|Withdrawal by Subject|1|||
127714371|NCT03656718|459582448|FG004|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
127714372|NCT03656718|459582449|FG005|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|4|||
127714373|NCT03656718|459582450|FG006|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
127714374|NCT03656718|459582444|FG000|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
127714375|NCT03656718|459582445|FG001|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
127714376|NCT03656718|459582446|FG002|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
127714377|NCT03656718|459582447|FG003|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
127714378|NCT03656718|459582448|FG004|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
127714379|NCT03656718|459582449|FG005|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
127714380|NCT03656718|459582450|FG006|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
127714381|NCT03656718|459582444|FG000|Treatment Period Parts A, B, D, and E|Other reasons|0|||
127714382|NCT03656718|459582445|FG001|Treatment Period Parts A, B, D, and E|Other reasons|0|||
127714383|NCT03656718|459582446|FG002|Treatment Period Parts A, B, D, and E|Other reasons|0|||
127714384|NCT03656718|459582447|FG003|Treatment Period Parts A, B, D, and E|Other reasons|0|||
127714385|NCT03656718|459582448|FG004|Treatment Period Parts A, B, D, and E|Other reasons|0|||
127714386|NCT03656718|459582449|FG005|Treatment Period Parts A, B, D, and E|Other reasons|1|||
127714387|NCT03656718|459582450|FG006|Treatment Period Parts A, B, D, and E|Other reasons|3|||
127714388|NCT03656718|459582444|FG000|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
127714389|NCT03656718|459582445|FG001|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
127714390|NCT03656718|459582446|FG002|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
127714391|NCT03656718|459582447|FG003|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
127714392|NCT03656718|459582448|FG004|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
127714393|NCT03656718|459582449|FG005|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
127714394|NCT03656718|459582450|FG006|Treatment Period Parts A, B, D, and E|Continuing study treatment|14|||
127714395|NCT03656718|459582444|FG000|Treatment Period Part C|Disease progression|0|||
127714396|NCT03656718|459582445|FG001|Treatment Period Part C|Disease progression|0|||
127802046|NCT01916980|459898707|FG000|Overall Study|Adverse Event|4|||
127802047|NCT01916980|459898708|FG001|Overall Study|Adverse Event|2|||
127802048|NCT01916980|459898707|FG000|Overall Study|Lack of Efficacy|2|||
127802049|NCT01916980|459898708|FG001|Overall Study|Lack of Efficacy|2|||
127802050|NCT01916980|459898707|FG000|Overall Study|Withdrawal by Subject|1|||
127802051|NCT01916980|459898708|FG001|Overall Study|Withdrawal by Subject|0|||
127888581|NCT02764489|460215776|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
127888582|NCT02038634|460215777|FG000|Overall Study|Lost to Follow-up|0|||
127888583|NCT02038634|460215778|FG001|Overall Study|Lost to Follow-up|1|||
127888584|NCT01664052|460215779|FG000|Phase 1|No device placement|6|||
127888585|NCT01664052|460215780|FG001|Phase 1|No device placement|0|||
127888586|NCT01664052|460215779|FG000|Phase 1|No HSG 1 hr post placement|1|||
127888587|NCT01664052|460215780|FG001|Phase 1|No HSG 1 hr post placement|0|||
127888588|NCT01664052|460215779|FG000|Phase 2|No device placement|0|||
127888589|NCT01664052|460215780|FG001|Phase 2|No device placement|4|||
127888590|NCT01706198|460215783|FG000|Overall Study|Adverse Event|12|||
127888591|NCT01706198|460215784|FG001|Overall Study|Adverse Event|15|||
127888592|NCT01706198|460215783|FG000|Overall Study|Protocol Violation|7|||
127888593|NCT01706198|460215784|FG001|Overall Study|Protocol Violation|5|||
127888594|NCT01706198|460215783|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
127888595|NCT01706198|460215784|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
127888596|NCT01706198|460215783|FG000|Overall Study|Lost to Follow-up|97|||
127888597|NCT01706198|460215784|FG001|Overall Study|Lost to Follow-up|93|||
127888598|NCT01706198|460215783|FG000|Overall Study|Physician Decision|23|||
127888599|NCT01706198|460215784|FG001|Overall Study|Physician Decision|37|||
127888600|NCT01706198|460215783|FG000|Overall Study|Withdrawal by Subject|23|||
127888601|NCT01706198|460215784|FG001|Overall Study|Withdrawal by Subject|31|||
127888602|NCT04313283|460215786|FG000|Overall Study|did not complete intervention|4|||
127714397|NCT03656718|459582446|FG002|Treatment Period Part C|Disease progression|0|||
127714398|NCT03656718|459582447|FG003|Treatment Period Part C|Disease progression|0|||
127802052|NCT02324270|459898709|FG000|Overall Study|Withdrawal by Subject|0|||
127802053|NCT02324270|459898710|FG001|Overall Study|Withdrawal by Subject|1|||
127802054|NCT02324270|459898711|FG002|Overall Study|Withdrawal by Subject|0|||
127888603|NCT00606684|460215800|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
127714399|NCT03656718|459582448|FG004|Treatment Period Part C|Disease progression|12|||
127714400|NCT03656718|459582449|FG005|Treatment Period Part C|Disease progression|0|||
127714401|NCT03656718|459582450|FG006|Treatment Period Part C|Disease progression|0|||
127802055|NCT02324270|459898709|FG000|Overall Study|Lost to Follow-up|4|||
127888604|NCT00606684|460215801|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
127888605|NCT00606684|460215802|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
127888606|NCT00606684|460215803|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
127802056|NCT02324270|459898710|FG001|Overall Study|Lost to Follow-up|3|||
127802057|NCT02324270|459898711|FG002|Overall Study|Lost to Follow-up|4|||
127802058|NCT02324270|459898709|FG000|Overall Study|Protocol Violation|0|||
127802059|NCT02324270|459898710|FG001|Overall Study|Protocol Violation|1|||
127802060|NCT02324270|459898711|FG002|Overall Study|Protocol Violation|1|||
127802061|NCT02324270|459898709|FG000|Overall Study|Non Compliance with Study Drug|1|||
127802062|NCT02324270|459898710|FG001|Overall Study|Non Compliance with Study Drug|2|||
127802063|NCT02324270|459898711|FG002|Overall Study|Non Compliance with Study Drug|0|||
127802064|NCT00680836|459898712|FG000|Overall Study|Withdrawal by Subject|3|||
127802065|NCT00680836|459898713|FG001|Overall Study|Withdrawal by Subject|0|||
127802066|NCT00680836|459898712|FG000|Overall Study|Lost to Follow-up|3|||
127802067|NCT00680836|459898713|FG001|Overall Study|Lost to Follow-up|1|||
127802068|NCT00680836|459898712|FG000|Overall Study|Physician Decision|2|||
127802069|NCT00680836|459898713|FG001|Overall Study|Physician Decision|1|||
127802070|NCT03786432|459898714|FG000|Overall Study|Screen Failure after consent|1|||
127802071|NCT03786432|459898714|FG000|Overall Study|Lost to Follow-up|4|||
127714402|NCT03656718|459582444|FG000|Treatment Period Part C|Death|0|||
127714403|NCT03656718|459582445|FG001|Treatment Period Part C|Death|0|||
127714404|NCT03656718|459582446|FG002|Treatment Period Part C|Death|0|||
127714405|NCT03656718|459582447|FG003|Treatment Period Part C|Death|0|||
127714406|NCT03656718|459582448|FG004|Treatment Period Part C|Death|1|||
127714407|NCT03656718|459582449|FG005|Treatment Period Part C|Death|0|||
127714408|NCT03656718|459582450|FG006|Treatment Period Part C|Death|0|||
127714409|NCT03656718|459582444|FG000|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
127714410|NCT03656718|459582445|FG001|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
127714411|NCT03656718|459582446|FG002|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
127714412|NCT03656718|459582447|FG003|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
127714413|NCT03656718|459582448|FG004|Treatment Period Part C|Participant requested to discontinue study treatment|1|||
127714414|NCT03656718|459582449|FG005|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
127714415|NCT03656718|459582450|FG006|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
127714416|NCT03656718|459582444|FG000|Treatment Period Part C|Other reasons|0|||
127714417|NCT03656718|459582445|FG001|Treatment Period Part C|Other reasons|0|||
127714418|NCT03656718|459582446|FG002|Treatment Period Part C|Other reasons|0|||
127714419|NCT03656718|459582447|FG003|Treatment Period Part C|Other reasons|0|||
127714420|NCT03656718|459582448|FG004|Treatment Period Part C|Other reasons|1|||
127714421|NCT03656718|459582449|FG005|Treatment Period Part C|Other reasons|0|||
127714422|NCT03656718|459582450|FG006|Treatment Period Part C|Other reasons|0|||
127714423|NCT03656718|459582444|FG000|Treatment Period Part C|Maximum clinical benefit|0|||
127714424|NCT03656718|459582445|FG001|Treatment Period Part C|Maximum clinical benefit|0|||
127714425|NCT03656718|459582446|FG002|Treatment Period Part C|Maximum clinical benefit|0|||
127714426|NCT03656718|459582447|FG003|Treatment Period Part C|Maximum clinical benefit|0|||
127714427|NCT03656718|459582448|FG004|Treatment Period Part C|Maximum clinical benefit|1|||
127714428|NCT03656718|459582449|FG005|Treatment Period Part C|Maximum clinical benefit|0|||
127714429|NCT03656718|459582450|FG006|Treatment Period Part C|Maximum clinical benefit|0|||
127714430|NCT03211247|459582451|FG000|Overall Study|Adverse Event|8|||
127714431|NCT03211247|459582452|FG001|Overall Study|Adverse Event|0|||
127714432|NCT03211247|459582453|FG002|Overall Study|Adverse Event|1|||
127714433|NCT03211247|459582454|FG003|Overall Study|Adverse Event|0|||
127714434|NCT03211247|459582455|FG004|Overall Study|Adverse Event|0|||
127714435|NCT03211247|459582451|FG000|Overall Study|Lost to Follow-up|2|||
127714436|NCT03211247|459582452|FG001|Overall Study|Lost to Follow-up|1|||
127714437|NCT03211247|459582453|FG002|Overall Study|Lost to Follow-up|0|||
127714438|NCT03211247|459582454|FG003|Overall Study|Lost to Follow-up|0|||
127714439|NCT03211247|459582455|FG004|Overall Study|Lost to Follow-up|0|||
127714440|NCT03211247|459582451|FG000|Overall Study|Physician Decision|1|||
127714441|NCT03211247|459582452|FG001|Overall Study|Physician Decision|2|||
127714442|NCT03211247|459582453|FG002|Overall Study|Physician Decision|0|||
127714443|NCT03211247|459582454|FG003|Overall Study|Physician Decision|0|||
127714444|NCT03211247|459582455|FG004|Overall Study|Physician Decision|0|||
127714445|NCT03211247|459582451|FG000|Overall Study|Non-compliance with study drug|2|||
127802072|NCT03786432|459898714|FG000|Overall Study|did not complete 12 month CT scan|1|||
127802073|NCT03968419|459898715|FG000|Treatment Period|Adverse Event|0|||
127802074|NCT03968419|459898716|FG001|Treatment Period|Adverse Event|0|||
127802075|NCT03968419|459898717|FG002|Treatment Period|Adverse Event|1|||
127802076|NCT03968419|459898715|FG000|Safety Follow-up Period|Death|3|||
127802077|NCT03968419|459898716|FG001|Safety Follow-up Period|Death|2|||
127714446|NCT03211247|459582452|FG001|Overall Study|Non-compliance with study drug|0|||
127714447|NCT03211247|459582453|FG002|Overall Study|Non-compliance with study drug|0|||
127714448|NCT03211247|459582454|FG003|Overall Study|Non-compliance with study drug|0|||
127714449|NCT03211247|459582455|FG004|Overall Study|Non-compliance with study drug|0|||
127714450|NCT03211247|459582451|FG000|Overall Study|Participant withdrawal by Parent or Caregiver|18|||
127714451|NCT03211247|459582452|FG001|Overall Study|Participant withdrawal by Parent or Caregiver|13|||
127714452|NCT03211247|459582453|FG002|Overall Study|Participant withdrawal by Parent or Caregiver|2|||
127714453|NCT03211247|459582454|FG003|Overall Study|Participant withdrawal by Parent or Caregiver|1|||
127714454|NCT03211247|459582455|FG004|Overall Study|Participant withdrawal by Parent or Caregiver|0|||
127714455|NCT03211247|459582451|FG000|Overall Study|Participant did not want to complete oral food challenge|5|||
127714456|NCT03211247|459582452|FG001|Overall Study|Participant did not want to complete oral food challenge|2|||
127714457|NCT03211247|459582453|FG002|Overall Study|Participant did not want to complete oral food challenge|1|||
127714458|NCT03211247|459582454|FG003|Overall Study|Participant did not want to complete oral food challenge|3|||
127714459|NCT03211247|459582455|FG004|Overall Study|Participant did not want to complete oral food challenge|1|||
127714460|NCT03211247|459582451|FG000|Overall Study|Protocol Violation|0|||
127714461|NCT03211247|459582452|FG001|Overall Study|Protocol Violation|1|||
127714462|NCT03211247|459582453|FG002|Overall Study|Protocol Violation|0|||
127714463|NCT03211247|459582454|FG003|Overall Study|Protocol Violation|0|||
127714464|NCT03211247|459582455|FG004|Overall Study|Protocol Violation|0|||
127714465|NCT04153890|459582456|FG000|Overall Study|Lost to Follow-up|9|||
127714466|NCT04153890|459582457|FG001|Overall Study|Lost to Follow-up|0|||
127714467|NCT04153890|459582458|FG002|Overall Study|Lost to Follow-up|9|||
127714468|NCT04153890|459582459|FG003|Overall Study|Lost to Follow-up|0|||
127714469|NCT04153890|459582456|FG000|Overall Study|Death|0|||
127714470|NCT04153890|459582457|FG001|Overall Study|Death|2|||
127714471|NCT04153890|459582458|FG002|Overall Study|Death|0|||
127714472|NCT04153890|459582459|FG003|Overall Study|Death|0|||
127714473|NCT04153890|459582456|FG000|Overall Study|Withdrawal by Subject|0|||
127714474|NCT04153890|459582457|FG001|Overall Study|Withdrawal by Subject|0|||
127714475|NCT04153890|459582458|FG002|Overall Study|Withdrawal by Subject|0|||
127714476|NCT04153890|459582459|FG003|Overall Study|Withdrawal by Subject|2|||
127714477|NCT05786612|459582460|FG000|Overall Study|Adverse Event|1|||
127714478|NCT05786612|459582461|FG001|Overall Study|Adverse Event|2|||
127714479|NCT05786612|459582460|FG000|Overall Study|one screening failure|0|||
127714480|NCT05786612|459582461|FG001|Overall Study|one screening failure|2|||
127714481|NCT04926740|459582462|FG000|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|2|||
127714482|NCT04926740|459582463|FG001|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|1|||
127714483|NCT04926740|459582462|FG000|Overall Study|Ineligible: subsequently found to not have true DKA|7|||
127714484|NCT04926740|459582463|FG001|Overall Study|Ineligible: subsequently found to not have true DKA|4|||
127714485|NCT00146172|459583585|FG000|Overall Study|Adverse Event|0|||
127714486|NCT00146172|459583586|FG001|Overall Study|Adverse Event|0|||
127714487|NCT00146172|459583587|FG002|Overall Study|Adverse Event|1|||
127714488|NCT00146172|459583588|FG003|Overall Study|Adverse Event|1|||
127714489|NCT00146172|459583589|FG004|Overall Study|Adverse Event|0|||
127714490|NCT00146172|459583590|FG005|Overall Study|Adverse Event|2|||
127714491|NCT00146172|459583591|FG006|Overall Study|Adverse Event|3|||
127714492|NCT00146172|459583592|FG007|Overall Study|Adverse Event|10|||
127714493|NCT00146172|459583585|FG000|Overall Study|Lost to Follow-up|0|||
127714494|NCT00146172|459583586|FG001|Overall Study|Lost to Follow-up|0|||
127802078|NCT03968419|459898717|FG002|Safety Follow-up Period|Death|1|||
127714495|NCT00146172|459583587|FG002|Overall Study|Lost to Follow-up|0|||
127714496|NCT00146172|459583588|FG003|Overall Study|Lost to Follow-up|0|||
127714497|NCT00146172|459583589|FG004|Overall Study|Lost to Follow-up|0|||
127714498|NCT00146172|459583590|FG005|Overall Study|Lost to Follow-up|0|||
127714499|NCT00146172|459583591|FG006|Overall Study|Lost to Follow-up|0|||
127714500|NCT00146172|459583592|FG007|Overall Study|Lost to Follow-up|1|||
127714501|NCT00146172|459583585|FG000|Overall Study|Disease Progression|2|||
127714502|NCT00146172|459583586|FG001|Overall Study|Disease Progression|4|||
127714503|NCT00146172|459583587|FG002|Overall Study|Disease Progression|2|||
127714504|NCT00146172|459583588|FG003|Overall Study|Disease Progression|5|||
127714505|NCT00146172|459583589|FG004|Overall Study|Disease Progression|2|||
127714506|NCT00146172|459583590|FG005|Overall Study|Disease Progression|2|||
127714507|NCT00146172|459583591|FG006|Overall Study|Disease Progression|1|||
127714508|NCT00146172|459583592|FG007|Overall Study|Disease Progression|22|||
127714509|NCT00146172|459583585|FG000|Overall Study|Death|0|||
127714510|NCT00146172|459583586|FG001|Overall Study|Death|0|||
127714511|NCT00146172|459583587|FG002|Overall Study|Death|0|||
127714512|NCT00146172|459583588|FG003|Overall Study|Death|0|||
127714513|NCT00146172|459583589|FG004|Overall Study|Death|0|||
127714514|NCT00146172|459583590|FG005|Overall Study|Death|0|||
127714515|NCT00146172|459583591|FG006|Overall Study|Death|1|||
127714516|NCT00146172|459583592|FG007|Overall Study|Death|0|||
127714517|NCT00146172|459583585|FG000|Overall Study|Physician Decision|0|||
127714518|NCT00146172|459583586|FG001|Overall Study|Physician Decision|0|||
127714519|NCT00146172|459583587|FG002|Overall Study|Physician Decision|0|||
127714520|NCT00146172|459583588|FG003|Overall Study|Physician Decision|0|||
127714521|NCT00146172|459583589|FG004|Overall Study|Physician Decision|0|||
127714522|NCT00146172|459583590|FG005|Overall Study|Physician Decision|0|||
127714523|NCT00146172|459583591|FG006|Overall Study|Physician Decision|0|||
127714524|NCT00146172|459583592|FG007|Overall Study|Physician Decision|1|||
127714525|NCT00146172|459583585|FG000|Overall Study|Withdrawal by Subject|0|||
127714526|NCT00146172|459583586|FG001|Overall Study|Withdrawal by Subject|0|||
127714527|NCT00146172|459583587|FG002|Overall Study|Withdrawal by Subject|0|||
127714528|NCT00146172|459583588|FG003|Overall Study|Withdrawal by Subject|0|||
127714529|NCT00146172|459583589|FG004|Overall Study|Withdrawal by Subject|0|||
127714530|NCT00146172|459583590|FG005|Overall Study|Withdrawal by Subject|1|||
127714531|NCT00146172|459583591|FG006|Overall Study|Withdrawal by Subject|1|||
127714532|NCT00146172|459583592|FG007|Overall Study|Withdrawal by Subject|4|||
127714533|NCT00146172|459583585|FG000|Overall Study|Symptomatic Deterioration|1|||
127714534|NCT00146172|459583586|FG001|Overall Study|Symptomatic Deterioration|0|||
127714535|NCT00146172|459583587|FG002|Overall Study|Symptomatic Deterioration|1|||
127714536|NCT00146172|459583588|FG003|Overall Study|Symptomatic Deterioration|0|||
127714537|NCT00146172|459583589|FG004|Overall Study|Symptomatic Deterioration|1|||
127714538|NCT00146172|459583590|FG005|Overall Study|Symptomatic Deterioration|2|||
127802079|NCT03968419|459898715|FG000|Safety Follow-up Period|Subject Decision|2|||
127802080|NCT03968419|459898716|FG001|Safety Follow-up Period|Subject Decision|1|||
127802081|NCT03968419|459898717|FG002|Safety Follow-up Period|Subject Decision|0|||
127802082|NCT00568555|459898720|FG000|Overall Study|Withdrawal by Subject|1|||
127802083|NCT00568555|459898721|FG001|Overall Study|Withdrawal by Subject|1|||
127802084|NCT00688909|459898726|FG000|Overall Study|Adverse Event|28|||
127802085|NCT00688909|459898726|FG000|Overall Study|Patient withdrew consent|2|||
127802086|NCT00688909|459898726|FG000|Overall Study|Administrative problems|1|||
127802087|NCT00688909|459898726|FG000|Overall Study|Protocol Violation|2|||
127802088|NCT01220414|459898727|FG000|Overall Study|Withdrawal by Subject|1|||
127714539|NCT00146172|459583591|FG006|Overall Study|Symptomatic Deterioration|0|||
127714540|NCT00146172|459583592|FG007|Overall Study|Symptomatic Deterioration|2|||
127714541|NCT03876457|459583595|FG000|Overall Study|Lost to Follow-up|1|||
127714542|NCT03876457|459583596|FG001|Overall Study|Lost to Follow-up|3|||
127802089|NCT01220414|459898728|FG001|Overall Study|Withdrawal by Subject|0|||
127802090|NCT01220414|459898729|FG002|Overall Study|Withdrawal by Subject|0|||
127802091|NCT01220414|459898730|FG003|Overall Study|Withdrawal by Subject|1|||
127714543|NCT01036724|459583597|FG000|Overall Study|Adverse Event|1|||
127714544|NCT01036724|459583598|FG001|Overall Study|Adverse Event|2|||
127714545|NCT01036724|459583597|FG000|Overall Study|Lack of Efficacy|1|||
127714546|NCT01036724|459583598|FG001|Overall Study|Lack of Efficacy|1|||
127714547|NCT01036724|459583597|FG000|Overall Study|Protocol Violation|4|||
127714548|NCT01036724|459583598|FG001|Overall Study|Protocol Violation|5|||
127714549|NCT00557492|459583605|FG000|Overall Study|Change in health insurance|1|||
127714550|NCT04213807|459583606|FG000|Overall Study|Physician Decision|0|||
127714551|NCT04213807|459583607|FG001|Overall Study|Physician Decision|0|||
127714552|NCT04213807|459583608|FG002|Overall Study|Physician Decision|1|||
127714553|NCT01574716|459583609|FG000|Part 1|Death|3|||
127714554|NCT01574716|459583610|FG001|Part 1|Death|1|||
127714555|NCT01574716|459583611|FG002|Part 1|Death|8|||
127714556|NCT01574716|459583612|FG003|Part 1|Death|0|||
127714557|NCT01574716|459583613|FG004|Part 1|Death|0|||
127714558|NCT01574716|459583609|FG000|Part 1|Discontinuation of study by sponsor|0|||
127714559|NCT01574716|459583610|FG001|Part 1|Discontinuation of study by sponsor|0|||
127714560|NCT01574716|459583611|FG002|Part 1|Discontinuation of study by sponsor|1|||
127714561|NCT01574716|459583612|FG003|Part 1|Discontinuation of study by sponsor|0|||
127714562|NCT01574716|459583613|FG004|Part 1|Discontinuation of study by sponsor|0|||
127714563|NCT01574716|459583609|FG000|Part 1|Withdrawal by Subject|0|||
127714564|NCT01574716|459583610|FG001|Part 1|Withdrawal by Subject|2|||
127714565|NCT01574716|459583611|FG002|Part 1|Withdrawal by Subject|0|||
127714566|NCT01574716|459583612|FG003|Part 1|Withdrawal by Subject|0|||
127714567|NCT01574716|459583613|FG004|Part 1|Withdrawal by Subject|0|||
127714568|NCT01574716|459583609|FG000|Part 1|Lost to Follow-up|0|||
127714569|NCT01574716|459583610|FG001|Part 1|Lost to Follow-up|1|||
127714570|NCT01574716|459583611|FG002|Part 1|Lost to Follow-up|0|||
127714571|NCT01574716|459583612|FG003|Part 1|Lost to Follow-up|0|||
127714572|NCT01574716|459583613|FG004|Part 1|Lost to Follow-up|0|||
127714573|NCT01574716|459583609|FG000|Part 2|Progressive disease|0|||
127714574|NCT01574716|459583610|FG001|Part 2|Progressive disease|0|||
127714575|NCT01574716|459583611|FG002|Part 2|Progressive disease|0|||
127714576|NCT01574716|459583612|FG003|Part 2|Progressive disease|1|||
127714577|NCT01574716|459583613|FG004|Part 2|Progressive disease|0|||
127714578|NCT01574716|459583609|FG000|Part 2|Death|0|||
127714579|NCT01574716|459583610|FG001|Part 2|Death|0|||
127714580|NCT01574716|459583611|FG002|Part 2|Death|0|||
127714581|NCT01574716|459583612|FG003|Part 2|Death|76|||
127714582|NCT01574716|459583613|FG004|Part 2|Death|35|||
127714583|NCT01574716|459583609|FG000|Part 2|Discontinuation of study by sponsor|0|||
127714584|NCT01574716|459583610|FG001|Part 2|Discontinuation of study by sponsor|0|||
127714585|NCT01574716|459583611|FG002|Part 2|Discontinuation of study by sponsor|0|||
127714586|NCT01574716|459583612|FG003|Part 2|Discontinuation of study by sponsor|51|||
127714587|NCT01574716|459583613|FG004|Part 2|Discontinuation of study by sponsor|31|||
127714588|NCT01574716|459583609|FG000|Part 2|Withdrawal by Subject|0|||
127714589|NCT01574716|459583610|FG001|Part 2|Withdrawal by Subject|0|||
127714590|NCT01574716|459583611|FG002|Part 2|Withdrawal by Subject|0|||
127714591|NCT01574716|459583612|FG003|Part 2|Withdrawal by Subject|5|||
127714592|NCT01574716|459583613|FG004|Part 2|Withdrawal by Subject|4|||
127714593|NCT01574716|459583609|FG000|Part 2|Brain metastases|0|||
127714594|NCT01574716|459583610|FG001|Part 2|Brain metastases|0|||
127714595|NCT01574716|459583611|FG002|Part 2|Brain metastases|0|||
127714596|NCT01574716|459583612|FG003|Part 2|Brain metastases|1|||
127714597|NCT01574716|459583613|FG004|Part 2|Brain metastases|0|||
127714598|NCT01574716|459583609|FG000|Part 2|Lost to Follow-up|0|||
127714599|NCT01574716|459583610|FG001|Part 2|Lost to Follow-up|0|||
127714600|NCT01574716|459583611|FG002|Part 2|Lost to Follow-up|0|||
127714601|NCT01574716|459583612|FG003|Part 2|Lost to Follow-up|3|||
127714602|NCT01574716|459583613|FG004|Part 2|Lost to Follow-up|0|||
127714603|NCT02438137|459583614|FG000|Overall Study|Lost to Follow-up|3|||
127714604|NCT02438137|459583615|FG001|Overall Study|Lost to Follow-up|2|||
127714605|NCT02438137|459583614|FG000|Overall Study|Adverse Event|1|||
127714606|NCT02438137|459583615|FG001|Overall Study|Adverse Event|0|||
127714607|NCT02438137|459583614|FG000|Overall Study|Withdrawal by Subject|4|||
127714608|NCT02438137|459583615|FG001|Overall Study|Withdrawal by Subject|3|||
127714609|NCT02438137|459583614|FG000|Overall Study|Physician Decision|0|||
127714610|NCT02438137|459583615|FG001|Overall Study|Physician Decision|1|||
127714611|NCT01637402|459583617|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
127714612|NCT01637402|459583618|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
127714613|NCT01637402|459583617|FG000|Standard Dose Regimen|Adverse Event|1|||
127714614|NCT01637402|459583618|FG001|Standard Dose Regimen|Adverse Event|0|||
127714615|NCT01637402|459583617|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
127714616|NCT01637402|459583618|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
127714617|NCT01637402|459583617|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
127714618|NCT01637402|459583618|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
127714619|NCT01637402|459583617|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
127714620|NCT01637402|459583618|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
127714621|NCT01637402|459583617|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
127714622|NCT01637402|459583618|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
127714623|NCT02285270|459583619|FG000|Overall Study|Lost to Follow-up|1|||
127714624|NCT02285270|459583619|FG000|Overall Study|Physician Decision|3|||
127714625|NCT02285270|459583619|FG000|Overall Study|Determined to be ineligible|1|||
127714626|NCT02111096|459583620|FG000|Overall Study|Adverse Event|4|||
127714627|NCT02111096|459583621|FG001|Overall Study|Adverse Event|1|||
127714628|NCT02111096|459583622|FG002|Overall Study|Adverse Event|2|||
127714629|NCT02111096|459583620|FG000|Overall Study|Non-Compliance with Study Drug|1|||
127714630|NCT02111096|459583621|FG001|Overall Study|Non-Compliance with Study Drug|1|||
127714631|NCT02111096|459583622|FG002|Overall Study|Non-Compliance with Study Drug|0|||
127714632|NCT02111096|459583620|FG000|Overall Study|Lost to Follow Up|1|||
127714633|NCT02111096|459583621|FG001|Overall Study|Lost to Follow Up|1|||
127714634|NCT02111096|459583622|FG002|Overall Study|Lost to Follow Up|1|||
127714635|NCT02111096|459583620|FG000|Overall Study|Physician Decision|0|||
127714636|NCT02111096|459583621|FG001|Overall Study|Physician Decision|1|||
127714637|NCT02111096|459583622|FG002|Overall Study|Physician Decision|0|||
127714638|NCT02111096|459583620|FG000|Overall Study|Protocol Violation|1|||
127714639|NCT02111096|459583621|FG001|Overall Study|Protocol Violation|0|||
127714640|NCT02111096|459583622|FG002|Overall Study|Protocol Violation|1|||
127714641|NCT02111096|459583620|FG000|Overall Study|Terminated by Sponsor|53|||
127714642|NCT02111096|459583621|FG001|Overall Study|Terminated by Sponsor|35|||
127714643|NCT02111096|459583622|FG002|Overall Study|Terminated by Sponsor|54|||
127714644|NCT02111096|459583620|FG000|Overall Study|Withdrawal by Subject|4|||
127714645|NCT02111096|459583621|FG001|Overall Study|Withdrawal by Subject|2|||
127714646|NCT02111096|459583622|FG002|Overall Study|Withdrawal by Subject|8|||
127714647|NCT03709706|459583623|FG000|Overall Study|Adverse Event|0|||
127714648|NCT03709706|459583624|FG001|Overall Study|Adverse Event|1|||
127714649|NCT03709706|459583623|FG000|Overall Study|Physician Decision|14|||
127714650|NCT03709706|459583624|FG001|Overall Study|Physician Decision|8|||
127714651|NCT03709706|459583623|FG000|Overall Study|Withdrawal by Subject|2|||
127714652|NCT03709706|459583624|FG001|Overall Study|Withdrawal by Subject|1|||
127714653|NCT03709706|459583623|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
127714654|NCT03709706|459583624|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
127714655|NCT04868617|459583625|FG000|Overall Study|Death|1|||
127714656|NCT04868617|459583626|FG001|Overall Study|Death|0|||
127714657|NCT04868617|459583625|FG000|Overall Study|Adverse Event|1|||
127714658|NCT04868617|459583626|FG001|Overall Study|Adverse Event|0|||
127714659|NCT04868617|459583625|FG000|Overall Study|Withdrawal by Subject|1|||
127714660|NCT04868617|459583626|FG001|Overall Study|Withdrawal by Subject|0|||
127714661|NCT04868617|459583625|FG000|Overall Study|Device deficiency|1|||
127714662|NCT04868617|459583626|FG001|Overall Study|Device deficiency|0|||
127714663|NCT01627561|459583627|FG000|Overall Study|Lost to Follow-up|1|||
127714664|NCT01627561|459583628|FG001|Overall Study|Lost to Follow-up|0|||
127714665|NCT01627561|459583627|FG000|Overall Study|Withdrawal by Subject|0|||
127714666|NCT01627561|459583628|FG001|Overall Study|Withdrawal by Subject|1|||
127714667|NCT01627561|459583627|FG000|Overall Study|Migrated/moved from study area|0|||
127714668|NCT01627561|459583628|FG001|Overall Study|Migrated/moved from study area|2|||
127714669|NCT01579318|459583629|FG000|Overall Study|Disease Progression|1|||
127714670|NCT02797132|459583630|FG000|Part A (15 Days)|Adverse Event|1|||
127714671|NCT02797132|459583630|FG000|Part B (24 Weeks)|Adverse Event|3|||
127714672|NCT01970007|459583631|FG000|Overall Study|Death|5|||
127714673|NCT01970007|459583631|FG000|Overall Study|Withdrawal by Subject|23|||
127714674|NCT01970007|459583631|FG000|Overall Study|Lost to Follow-up|24|||
127714675|NCT01970007|459583631|FG000|Overall Study|"Other endpoint"|3|||
127714676|NCT01171976|459583635|FG000|Overall Study|Protocol Violation|0|||
127714677|NCT01171976|459583636|FG001|Overall Study|Protocol Violation|0|||
127714678|NCT01171976|459583637|FG002|Overall Study|Protocol Violation|1|||
127714679|NCT01171976|459583635|FG000|Overall Study|Death|2|||
127714680|NCT01171976|459583636|FG001|Overall Study|Death|4|||
127714681|NCT01171976|459583637|FG002|Overall Study|Death|1|||
127714682|NCT01171976|459583635|FG000|Overall Study|Lost to Follow-up|4|||
127714683|NCT01171976|459583636|FG001|Overall Study|Lost to Follow-up|0|||
127714684|NCT01171976|459583637|FG002|Overall Study|Lost to Follow-up|2|||
127714685|NCT01171976|459583635|FG000|Overall Study|Withdrawal by Subject|1|||
127714686|NCT01171976|459583636|FG001|Overall Study|Withdrawal by Subject|5|||
127714687|NCT01171976|459583637|FG002|Overall Study|Withdrawal by Subject|6|||
127714688|NCT01171976|459583635|FG000|Overall Study|Abnormal test result|1|||
127714689|NCT01171976|459583636|FG001|Overall Study|Abnormal test result|0|||
127714690|NCT01171976|459583637|FG002|Overall Study|Abnormal test result|0|||
127714691|NCT01171976|459583635|FG000|Overall Study|Adverse Event|6|||
127714692|NCT01171976|459583636|FG001|Overall Study|Adverse Event|2|||
127714693|NCT01171976|459583637|FG002|Overall Study|Adverse Event|5|||
127714694|NCT02844439|459583639|FG000|Overall Study|Withdrawal by Subject|1|||
127714695|NCT02844439|459583639|FG000|Overall Study|Lost to Follow-up|2|||
127714696|NCT02844439|459583639|FG000|Overall Study|Termination by Sponsor|4|||
127714697|NCT02844439|459583639|FG000|Overall Study|Death|28|||
127714698|NCT02844439|459583639|FG000|Overall Study|Other|5|||
127714699|NCT03170648|459583644|FG000|Chemotherapy Education (Cycle 2)|schedule conflict|1|||
127714700|NCT03170648|459583644|FG000|Auricular Acupuncture (Cycle 3)|Adverse Event|1|||
127714701|NCT03509909|459583645|FG000|Overall Study|Withdrawal by Subject|16|||
127714702|NCT03509909|459583646|FG001|Overall Study|Withdrawal by Subject|9|||
127714703|NCT03509909|459583645|FG000|Overall Study|Lost to Follow-up|3|||
127714704|NCT03509909|459583646|FG001|Overall Study|Lost to Follow-up|4|||
127714705|NCT03509909|459583645|FG000|Overall Study|Adverse Event|2|||
127714706|NCT03509909|459583646|FG001|Overall Study|Adverse Event|0|||
127714707|NCT03500549|459583647|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
127714708|NCT03500549|459583648|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
127714709|NCT03500549|459583647|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
127714710|NCT03500549|459583648|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
127714711|NCT02754596|459583649|FG000|Overall Study|Withdrawal by Subject|3|||
127714712|NCT02754596|459583650|FG001|Overall Study|Withdrawal by Subject|4|||
127714713|NCT02754596|459583651|FG002|Overall Study|Withdrawal by Subject|0|||
127714714|NCT02754596|459583649|FG000|Overall Study|Physician Decision|1|||
127714715|NCT02754596|459583650|FG001|Overall Study|Physician Decision|1|||
127714716|NCT02754596|459583651|FG002|Overall Study|Physician Decision|1|||
127714717|NCT02754596|459583649|FG000|Overall Study|Lost to Follow-up|1|||
127714718|NCT02754596|459583650|FG001|Overall Study|Lost to Follow-up|1|||
127714719|NCT02754596|459583651|FG002|Overall Study|Lost to Follow-up|2|||
127714720|NCT02754596|459583649|FG000|Overall Study|Death|0|||
127714721|NCT02754596|459583650|FG001|Overall Study|Death|2|||
127714722|NCT02754596|459583651|FG002|Overall Study|Death|0|||
127714723|NCT02754596|459583649|FG000|Overall Study|Adverse Event|1|||
127714724|NCT02754596|459583650|FG001|Overall Study|Adverse Event|0|||
127714725|NCT02754596|459583651|FG002|Overall Study|Adverse Event|1|||
127714726|NCT02754596|459583649|FG000|Overall Study|Other|1|||
127714727|NCT02754596|459583650|FG001|Overall Study|Other|0|||
127714728|NCT02754596|459583651|FG002|Overall Study|Other|0|||
127714729|NCT02107261|459583652|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
127714730|NCT02107261|459583653|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
127714731|NCT02107261|459583652|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
127714732|NCT02107261|459583653|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
127714733|NCT04337931|459583655|FG000|Overall Study|Death|4|||
127714734|NCT04337931|459583656|FG001|Overall Study|Death|1|||
127714735|NCT04337931|459583657|FG002|Overall Study|Death|7|||
127714736|NCT04337931|459583655|FG000|Overall Study|Withdrawal by Subject|0|||
127714737|NCT04337931|459583656|FG001|Overall Study|Withdrawal by Subject|1|||
127714738|NCT04337931|459583657|FG002|Overall Study|Withdrawal by Subject|0|||
127714739|NCT04337931|459583655|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
127714740|NCT04337931|459583656|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
127714741|NCT04337931|459583657|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
127714742|NCT04337931|459583655|FG000|Overall Study|Study terminated by sponsor|3|||
127714743|NCT04337931|459583656|FG001|Overall Study|Study terminated by sponsor|6|||
127714744|NCT04337931|459583657|FG002|Overall Study|Study terminated by sponsor|2|||
127714745|NCT04337931|459583655|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
127714746|NCT04337931|459583656|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
127714747|NCT04337931|459583657|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
127714748|NCT04337931|459583655|FG000|Overall Study|Colorectal cancer treatment|1|||
127714749|NCT04337931|459583656|FG001|Overall Study|Colorectal cancer treatment|0|||
127714750|NCT04337931|459583657|FG002|Overall Study|Colorectal cancer treatment|0|||
127714751|NCT04337931|459583655|FG000|Overall Study|Participant decision|0|||
127714752|NCT04337931|459583656|FG001|Overall Study|Participant decision|1|||
127714753|NCT04337931|459583657|FG002|Overall Study|Participant decision|0|||
127714754|NCT04436289|459583658|FG000|Overall Study|Death prior to hospital discharge|8|||
127714755|NCT04436289|459583659|FG001|Overall Study|Death prior to hospital discharge|5|||
127714756|NCT04436289|459583660|FG002|Overall Study|Death prior to hospital discharge|0|||
127714757|NCT04436289|459583661|FG003|Overall Study|Death prior to hospital discharge|1|||
127714758|NCT04436289|459583658|FG000|Overall Study|Withdrawal by Subject|0|||
127714759|NCT04436289|459583659|FG001|Overall Study|Withdrawal by Subject|1|||
127714760|NCT04436289|459583660|FG002|Overall Study|Withdrawal by Subject|4|||
127714761|NCT04436289|459583661|FG003|Overall Study|Withdrawal by Subject|0|||
127714762|NCT04436289|459583658|FG000|Overall Study|Extended hospital stay|0|||
127714763|NCT04436289|459583659|FG001|Overall Study|Extended hospital stay|1|||
127714764|NCT04436289|459583660|FG002|Overall Study|Extended hospital stay|0|||
127714765|NCT04436289|459583661|FG003|Overall Study|Extended hospital stay|0|||
127714766|NCT04436289|459583658|FG000|Overall Study|Lost to Follow-up|0|||
127714767|NCT04436289|459583659|FG001|Overall Study|Lost to Follow-up|4|||
127714768|NCT04436289|459583660|FG002|Overall Study|Lost to Follow-up|1|||
127714769|NCT04436289|459583661|FG003|Overall Study|Lost to Follow-up|3|||
127714770|NCT05139992|459583664|FG000|Overall Study|Withdrawal by Subject|12|||
127714771|NCT05139992|459583664|FG000|Overall Study|Lost to Follow-up|6|||
127714772|NCT01208974|459583665|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
127714773|NCT01208974|459583666|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
127714774|NCT01208974|459583667|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
127714775|NCT01208974|459583668|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
127714776|NCT01208974|459583665|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
127714777|NCT01208974|459583666|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
127714778|NCT01208974|459583667|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
127714779|NCT01208974|459583668|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
127714780|NCT01208974|459583665|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
127714781|NCT01208974|459583666|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
127714782|NCT01208974|459583667|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
127714783|NCT01208974|459583668|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
127802092|NCT00860158|459898738|FG000|Overall Study|Study Terminated|1|||
127802093|NCT00669617|459898740|FG000|Period 1|Withdrawal by Subject|0|||
127802094|NCT00669617|459898741|FG001|Period 1|Withdrawal by Subject|0|||
127802095|NCT00669617|459898742|FG002|Period 1|Withdrawal by Subject|1|||
127888607|NCT00606684|460215804|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
127888608|NCT00606684|460215805|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
127888609|NCT00606684|460215806|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
127888610|NCT00606684|460215800|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
127888611|NCT00606684|460215801|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
127888612|NCT00606684|460215802|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
127888613|NCT00606684|460215803|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
127888614|NCT00606684|460215804|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
127888615|NCT00606684|460215805|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
127888616|NCT00606684|460215806|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
127888617|NCT00606684|460215800|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
127888618|NCT00606684|460215801|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
127888619|NCT00606684|460215802|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
127888620|NCT00606684|460215803|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
127888621|NCT00606684|460215804|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
127888622|NCT00606684|460215805|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
127888623|NCT00606684|460215806|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
127888624|NCT00606684|460215800|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
127888625|NCT00606684|460215801|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
127888626|NCT00606684|460215802|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
127888627|NCT00606684|460215803|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
127888628|NCT00606684|460215804|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
127888629|NCT00606684|460215805|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
127888630|NCT00606684|460215806|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
127888631|NCT00606684|460215800|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
127888632|NCT00606684|460215801|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
127888633|NCT00606684|460215802|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
127888634|NCT00606684|460215803|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
127888635|NCT00606684|460215804|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
127888636|NCT00606684|460215805|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
127888637|NCT00606684|460215806|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
127888638|NCT00606684|460215800|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
127714784|NCT05521516|459583669|FG000|Overall Study|Withdrawal by Subject|1|||
127714785|NCT05521516|459583670|FG001|Overall Study|Withdrawal by Subject|1|||
127714786|NCT00747565|459583671|FG000|Overall Study|Withdrawal by Subject|10|||
127714787|NCT00747565|459583672|FG001|Overall Study|Withdrawal by Subject|6|||
127714788|NCT00747565|459583671|FG000|Overall Study|Lost to Follow-up|4|||
127714789|NCT00747565|459583672|FG001|Overall Study|Lost to Follow-up|1|||
127714790|NCT03777657|459583673|FG000|Overall Study|Death|397|||
127714791|NCT03777657|459583674|FG001|Overall Study|Death|431|||
127714792|NCT03777657|459583673|FG000|Overall Study|Study Closed by Sponsor|77|||
127714793|NCT03777657|459583674|FG001|Overall Study|Study Closed by Sponsor|38|||
127714794|NCT03777657|459583673|FG000|Overall Study|Withdrawal by Subject|20|||
127714795|NCT03777657|459583674|FG001|Overall Study|Withdrawal by Subject|17|||
127714796|NCT03777657|459583673|FG000|Overall Study|Lost to Follow-up|6|||
127714797|NCT03777657|459583674|FG001|Overall Study|Lost to Follow-up|10|||
127714798|NCT00545545|459583675|FG000|Overall Study|Progressive Neoplastic Disease|1|||
127714799|NCT00545545|459583676|FG001|Overall Study|Progressive Neoplastic Disease|5|||
127714800|NCT00545545|459583677|FG002|Overall Study|Progressive Neoplastic Disease|0|||
127714801|NCT00545545|459583678|FG003|Overall Study|Progressive Neoplastic Disease|4|||
127714802|NCT00545545|459583679|FG004|Overall Study|Progressive Neoplastic Disease|8|||
127714803|NCT00545545|459583680|FG005|Overall Study|Progressive Neoplastic Disease|7|||
127714804|NCT00545545|459583675|FG000|Overall Study|Withdrawal by Subject|0|||
127714805|NCT00545545|459583676|FG001|Overall Study|Withdrawal by Subject|1|||
127714806|NCT00545545|459583677|FG002|Overall Study|Withdrawal by Subject|0|||
127714807|NCT00545545|459583678|FG003|Overall Study|Withdrawal by Subject|0|||
127714808|NCT00545545|459583679|FG004|Overall Study|Withdrawal by Subject|0|||
127714809|NCT00545545|459583680|FG005|Overall Study|Withdrawal by Subject|0|||
127714810|NCT00545545|459583675|FG000|Overall Study|Physician Decision|1|||
127714811|NCT00545545|459583676|FG001|Overall Study|Physician Decision|0|||
127714812|NCT00545545|459583677|FG002|Overall Study|Physician Decision|0|||
127714813|NCT00545545|459583678|FG003|Overall Study|Physician Decision|0|||
127714814|NCT00545545|459583679|FG004|Overall Study|Physician Decision|0|||
127714815|NCT00545545|459583680|FG005|Overall Study|Physician Decision|1|||
127714816|NCT00545545|459583675|FG000|Overall Study|Irinotecan intolerance|1|||
127714817|NCT00545545|459583676|FG001|Overall Study|Irinotecan intolerance|1|||
127714818|NCT00545545|459583677|FG002|Overall Study|Irinotecan intolerance|0|||
127714819|NCT00545545|459583678|FG003|Overall Study|Irinotecan intolerance|0|||
127714820|NCT00545545|459583679|FG004|Overall Study|Irinotecan intolerance|0|||
127802096|NCT00669617|459898743|FG003|Period 1|Withdrawal by Subject|0|||
127802097|NCT00669617|459898744|FG004|Period 1|Withdrawal by Subject|0|||
127802098|NCT00669617|459898740|FG000|Period 1|Protocol Deviation|0|||
127802099|NCT00669617|459898741|FG001|Period 1|Protocol Deviation|0|||
127802100|NCT00669617|459898742|FG002|Period 1|Protocol Deviation|0|||
127802101|NCT00669617|459898743|FG003|Period 1|Protocol Deviation|0|||
127802102|NCT00669617|459898744|FG004|Period 1|Protocol Deviation|1|||
127888639|NCT00606684|460215801|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
127888640|NCT00606684|460215802|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
127888641|NCT00606684|460215803|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
127888642|NCT00606684|460215804|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
127888643|NCT00606684|460215805|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
127888644|NCT00606684|460215806|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
127888645|NCT00606684|460215800|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
127888646|NCT00606684|460215801|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
127888647|NCT00606684|460215802|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
127888648|NCT00606684|460215803|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
127888649|NCT00606684|460215804|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
127888650|NCT00606684|460215805|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
127888651|NCT00606684|460215806|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
127888652|NCT00606684|460215800|FG000|Double-Blind Treatment Period|Adverse Event|0|||
127888653|NCT00606684|460215801|FG001|Double-Blind Treatment Period|Adverse Event|3|||
127888654|NCT00606684|460215802|FG002|Double-Blind Treatment Period|Adverse Event|2|||
127714821|NCT00545545|459583680|FG005|Overall Study|Irinotecan intolerance|0|||
127714822|NCT00545545|459583675|FG000|Overall Study|No target lesions to track post surgery|0|||
127714823|NCT00545545|459583676|FG001|Overall Study|No target lesions to track post surgery|0|||
127714824|NCT00545545|459583677|FG002|Overall Study|No target lesions to track post surgery|0|||
127714825|NCT00545545|459583678|FG003|Overall Study|No target lesions to track post surgery|0|||
127714826|NCT00545545|459583679|FG004|Overall Study|No target lesions to track post surgery|1|||
127714827|NCT00545545|459583680|FG005|Overall Study|No target lesions to track post surgery|1|||
127714828|NCT05464732|459583686|FG000|Overall Study|Lost to Follow-up|0|||
127714829|NCT05464732|459583687|FG001|Overall Study|Lost to Follow-up|1|||
127714830|NCT05464732|459583686|FG000|Overall Study|Adverse Event|1|||
127714831|NCT05464732|459583687|FG001|Overall Study|Adverse Event|0|||
127714832|NCT00319020|459583688|FG000|Overall Study|Death|2|||
127714833|NCT00319020|459583689|FG001|Overall Study|Death|2|||
127714834|NCT00319020|459583688|FG000|Overall Study|Withdrawal by Subject|4|||
127714835|NCT00319020|459583689|FG001|Overall Study|Withdrawal by Subject|1|||
127714836|NCT00319020|459583688|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
127714837|NCT00319020|459583689|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
127714838|NCT00319020|459583688|FG000|Overall Study|Administrative reason|0|||
127714839|NCT00319020|459583689|FG001|Overall Study|Administrative reason|5|||
127714840|NCT00319020|459583688|FG000|Overall Study|Disease progression|0|||
127714841|NCT00319020|459583689|FG001|Overall Study|Disease progression|2|||
127714842|NCT00319020|459583688|FG000|Overall Study|Transplant|0|||
127714843|NCT00319020|459583689|FG001|Overall Study|Transplant|1|||
127714844|NCT00319020|459583688|FG000|Overall Study|Treatment failure|0|||
127714845|NCT00319020|459583689|FG001|Overall Study|Treatment failure|1|||
127802103|NCT00669617|459898740|FG000|Period 3|Lost to Follow-up|1|||
127802104|NCT00669617|459898741|FG001|Period 3|Lost to Follow-up|0|||
127802105|NCT00669617|459898742|FG002|Period 3|Lost to Follow-up|0|||
127714846|NCT00319020|459583688|FG000|Overall Study|Adverse Event|0|||
127714847|NCT00319020|459583689|FG001|Overall Study|Adverse Event|1|||
127714848|NCT00227266|459583690|FG000|Overall Study|Withdrawal by Subject|0|||
127714849|NCT00227266|459583691|FG001|Overall Study|Withdrawal by Subject|0|||
127714850|NCT00227266|459583692|FG002|Overall Study|Withdrawal by Subject|1|||
127714851|NCT00227266|459583690|FG000|Overall Study|Protocol Violation|1|||
127714852|NCT00227266|459583691|FG001|Overall Study|Protocol Violation|0|||
127714853|NCT00227266|459583692|FG002|Overall Study|Protocol Violation|1|||
127714854|NCT00227266|459583690|FG000|Overall Study|Excessive weight gain|0|||
127714855|NCT00227266|459583691|FG001|Overall Study|Excessive weight gain|0|||
127714856|NCT00227266|459583692|FG002|Overall Study|Excessive weight gain|2|||
127714857|NCT03959423|459583693|FG000|Overall Study|Withdrawal by Subject|2|||
127714858|NCT03959423|459583694|FG001|Overall Study|Withdrawal by Subject|3|||
127714859|NCT03959423|459583693|FG000|Overall Study|Physician Decision|0|||
127714860|NCT03959423|459583694|FG001|Overall Study|Physician Decision|1|||
127714861|NCT03959423|459583693|FG000|Overall Study|Lost to Follow-up|1|||
127714862|NCT03959423|459583694|FG001|Overall Study|Lost to Follow-up|0|||
127714863|NCT03959423|459583693|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
127714864|NCT03959423|459583694|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
127714865|NCT02549352|459583695|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
127714866|NCT02549352|459583696|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
127714867|NCT02549352|459583695|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
127714868|NCT02549352|459583696|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
127714869|NCT02549352|459583695|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
127714870|NCT02549352|459583696|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
127714871|NCT02549352|459583695|FG000|12-month Follow-up|Withdrawal by Subject|4|||
127714872|NCT02549352|459583696|FG001|12-month Follow-up|Withdrawal by Subject|5|||
127714873|NCT02549352|459583695|FG000|12-month Follow-up|Lost to Follow-up|3|||
127714874|NCT02549352|459583696|FG001|12-month Follow-up|Lost to Follow-up|2|||
127714875|NCT02549352|459583695|FG000|12-month Follow-up|Death|0|||
127714876|NCT02549352|459583696|FG001|12-month Follow-up|Death|1|||
127714877|NCT02549352|459583695|FG000|12-month Follow-up|Protocol Violation|0|||
127714878|NCT02549352|459583696|FG001|12-month Follow-up|Protocol Violation|1|||
127714879|NCT02549352|459583695|FG000|12-month Follow-up|Other|1|||
127714880|NCT02549352|459583696|FG001|12-month Follow-up|Other|3|||
127714881|NCT00593840|459583699|FG000|Overall Study|Withdrawal by Subject|1|||
127714882|NCT04530487|459585122|FG000|Overall Study|Death|1|||
127714883|NCT00655499|459585123|FG000|Overall Study|not eligible|4|||
127714884|NCT01184326|459585124|FG000|Overall Study|Adverse Event|1|||
127714885|NCT01184326|459585125|FG001|Overall Study|Adverse Event|2|||
127714886|NCT01184326|459585126|FG002|Overall Study|Adverse Event|0|||
127714887|NCT01184326|459585124|FG000|Overall Study|Death|0|||
127714888|NCT01184326|459585125|FG001|Overall Study|Death|0|||
127714889|NCT01184326|459585126|FG002|Overall Study|Death|1|||
127714890|NCT01184326|459585124|FG000|Overall Study|Withdrawal by Subject|0|||
127714891|NCT01184326|459585125|FG001|Overall Study|Withdrawal by Subject|0|||
127714892|NCT01184326|459585126|FG002|Overall Study|Withdrawal by Subject|1|||
127714893|NCT01184326|459585124|FG000|Overall Study|Physician Decision|1|||
127714894|NCT01184326|459585125|FG001|Overall Study|Physician Decision|1|||
127714895|NCT01184326|459585126|FG002|Overall Study|Physician Decision|0|||
127714896|NCT01184326|459585124|FG000|Overall Study|Disease Progression|1|||
127714897|NCT01184326|459585125|FG001|Overall Study|Disease Progression|3|||
127714898|NCT01184326|459585126|FG002|Overall Study|Disease Progression|12|||
127714899|NCT03621735|459585128|FG000|Overall Study|Withdrawal by Subject|13|||
127714900|NCT03621735|459585129|FG001|Overall Study|Withdrawal by Subject|13|||
127714901|NCT02347332|459585139|FG000|Overall Study|Not treated|5|||
127714902|NCT02347332|459585140|FG001|Overall Study|Not treated|2|||
127714903|NCT02347332|459585139|FG000|Overall Study|Progressive disease|141|||
127714904|NCT02347332|459585140|FG001|Overall Study|Progressive disease|159|||
127714905|NCT02347332|459585139|FG000|Overall Study|Adverse Event|50|||
127714906|NCT02347332|459585140|FG001|Overall Study|Adverse Event|41|||
127714907|NCT02347332|459585139|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
127714908|NCT02347332|459585140|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
127714909|NCT02347332|459585139|FG000|Overall Study|Protocol Violation|1|||
127714910|NCT02347332|459585140|FG001|Overall Study|Protocol Violation|1|||
127714911|NCT02347332|459585139|FG000|Overall Study|Lost to Follow-up|2|||
127714912|NCT02347332|459585140|FG001|Overall Study|Lost to Follow-up|1|||
127714913|NCT02347332|459585139|FG000|Overall Study|Physician Decision|4|||
127714914|NCT02347332|459585140|FG001|Overall Study|Physician Decision|3|||
127714915|NCT02347332|459585139|FG000|Overall Study|Withdrawal by Subject|20|||
127714916|NCT02347332|459585140|FG001|Overall Study|Withdrawal by Subject|14|||
127714917|NCT02347332|459585139|FG000|Overall Study|Protocol requirement|1|||
127714918|NCT02347332|459585140|FG001|Overall Study|Protocol requirement|1|||
127714919|NCT02347332|459585139|FG000|Overall Study|Switch Post-Trial program|0|||
127714920|NCT02347332|459585140|FG001|Overall Study|Switch Post-Trial program|1|||
127714921|NCT00112359|459585141|FG000|Overall Study|Unrelated adverse event|16|||
127714922|NCT00112359|459585142|FG001|Overall Study|Unrelated adverse event|8|||
127802106|NCT00669617|459898743|FG003|Period 3|Lost to Follow-up|0|||
127802107|NCT00669617|459898744|FG004|Period 3|Lost to Follow-up|0|||
127802108|NCT05499520|459898745|FG000|Overall Study|Lost to Follow-up|0|||
127802109|NCT05499520|459898746|FG001|Overall Study|Lost to Follow-up|0|||
127802110|NCT05499520|459898747|FG002|Overall Study|Lost to Follow-up|38|||
127802111|NCT05499520|459898748|FG003|Overall Study|Lost to Follow-up|41|||
127802112|NCT05499520|459898749|FG004|Overall Study|Lost to Follow-up|46|||
127802113|NCT05499520|459898750|FG005|Overall Study|Lost to Follow-up|0|||
127802114|NCT05499520|459898751|FG006|Overall Study|Lost to Follow-up|31|||
127802115|NCT05499520|459898752|FG007|Overall Study|Lost to Follow-up|45|||
127802116|NCT05499520|459898753|FG008|Overall Study|Lost to Follow-up|42|||
127802117|NCT05499520|459898754|FG009|Overall Study|Lost to Follow-up|0|||
127802118|NCT05499520|459898755|FG010|Overall Study|Lost to Follow-up|0|||
127802119|NCT05499520|459898756|FG011|Overall Study|Lost to Follow-up|37|||
127802120|NCT05499520|459898757|FG012|Overall Study|Lost to Follow-up|53|||
127802121|NCT05499520|459898758|FG013|Overall Study|Lost to Follow-up|49|||
127802122|NCT05499520|459898759|FG014|Overall Study|Lost to Follow-up|0|||
127802123|NCT05499520|459898760|FG015|Overall Study|Lost to Follow-up|36|||
127802124|NCT05499520|459898761|FG016|Overall Study|Lost to Follow-up|58|||
127802125|NCT05499520|459898762|FG017|Overall Study|Lost to Follow-up|53|||
127802126|NCT00700180|459898763|FG000|Overall Study|Death|99|||
127802127|NCT00700180|459898764|FG001|Overall Study|Death|114|||
127714923|NCT00112359|459585141|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
127714924|NCT00112359|459585142|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
127714925|NCT00112359|459585141|FG000|Overall Study|Related adverse event|5|||
127714926|NCT00112359|459585142|FG001|Overall Study|Related adverse event|3|||
127714927|NCT00112359|459585141|FG000|Overall Study|Lost to Follow-up|0|||
127714928|NCT00112359|459585142|FG001|Overall Study|Lost to Follow-up|1|||
127714929|NCT00112359|459585141|FG000|Overall Study|Personal/administrative|1|||
127714930|NCT00112359|459585142|FG001|Overall Study|Personal/administrative|1|||
127714931|NCT00112359|459585141|FG000|Overall Study|Other|3|||
127714932|NCT00112359|459585142|FG001|Overall Study|Other|0|||
127714933|NCT01988402|459585143|FG000|Overall Study|Adverse Event|1|||
127714934|NCT01988402|459585144|FG001|Overall Study|Adverse Event|2|||
127714935|NCT01988402|459585143|FG000|Overall Study|Withdrawal by Subject|1|||
127714936|NCT01988402|459585144|FG001|Overall Study|Withdrawal by Subject|0|||
127714937|NCT01961609|459585145|FG000|Initiation|Missing|3|||
127714938|NCT01961609|459585146|FG001|Initiation|Missing|2|||
127714939|NCT01961609|459585147|FG002|Initiation|Missing|0|||
127714940|NCT01961609|459585148|FG003|Initiation|Missing|0|||
127714941|NCT01961609|459585145|FG000|Initiation|Protocol deviation|1|||
127714942|NCT01961609|459585146|FG001|Initiation|Protocol deviation|0|||
127714943|NCT01961609|459585147|FG002|Initiation|Protocol deviation|0|||
127714944|NCT01961609|459585148|FG003|Initiation|Protocol deviation|0|||
127714945|NCT01961609|459585145|FG000|Initiation|Death|0|||
127714946|NCT01961609|459585146|FG001|Initiation|Death|1|||
127714947|NCT01961609|459585147|FG002|Initiation|Death|0|||
127714948|NCT01961609|459585148|FG003|Initiation|Death|0|||
127714949|NCT01961609|459585145|FG000|Initiation|Administrative problems|1|||
127714950|NCT01961609|459585146|FG001|Initiation|Administrative problems|0|||
127714951|NCT01961609|459585147|FG002|Initiation|Administrative problems|0|||
127714952|NCT01961609|459585148|FG003|Initiation|Administrative problems|0|||
127714953|NCT01961609|459585145|FG000|Initiation|Withdrawal by Subject|1|||
127714954|NCT01961609|459585146|FG001|Initiation|Withdrawal by Subject|2|||
127714955|NCT01961609|459585147|FG002|Initiation|Withdrawal by Subject|0|||
127714956|NCT01961609|459585148|FG003|Initiation|Withdrawal by Subject|0|||
127714957|NCT01961609|459585145|FG000|Initiation|Lack of Efficacy|2|||
127714958|NCT01961609|459585146|FG001|Initiation|Lack of Efficacy|1|||
127714959|NCT01961609|459585147|FG002|Initiation|Lack of Efficacy|0|||
127714960|NCT01961609|459585148|FG003|Initiation|Lack of Efficacy|0|||
127714961|NCT01961609|459585145|FG000|Initiation|Abnormal lab values|0|||
127714962|NCT01961609|459585146|FG001|Initiation|Abnormal lab values|1|||
127802128|NCT00700180|459898763|FG000|Overall Study|Alive on treatment|5|||
127802129|NCT00700180|459898764|FG001|Overall Study|Alive on treatment|3|||
127802130|NCT00700180|459898763|FG000|Overall Study|Alive in follow-up|46|||
127714963|NCT01961609|459585147|FG002|Initiation|Abnormal lab values|0|||
127714964|NCT01961609|459585148|FG003|Initiation|Abnormal lab values|0|||
127714965|NCT01961609|459585145|FG000|Initiation|Adverse Event|3|||
127714966|NCT01961609|459585146|FG001|Initiation|Adverse Event|5|||
127714967|NCT01961609|459585147|FG002|Initiation|Adverse Event|0|||
127714968|NCT01961609|459585148|FG003|Initiation|Adverse Event|0|||
127714969|NCT01961609|459585145|FG000|Initiation|Randomized but not treated|1|||
127714970|NCT01961609|459585146|FG001|Initiation|Randomized but not treated|1|||
127714971|NCT01961609|459585147|FG002|Initiation|Randomized but not treated|0|||
127714972|NCT01961609|459585148|FG003|Initiation|Randomized but not treated|0|||
127802131|NCT00700180|459898764|FG001|Overall Study|Alive in follow-up|27|||
127802132|NCT00700180|459898763|FG000|Overall Study|Lost to Follow-up|4|||
127802133|NCT00700180|459898764|FG001|Overall Study|Lost to Follow-up|5|||
127714973|NCT01961609|459585145|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
127802134|NCT01613326|459898765|FG000|Overall Study|Adverse Event|7|||
127802135|NCT01613326|459898766|FG001|Overall Study|Adverse Event|5|||
127802136|NCT01613326|459898765|FG000|Overall Study|Withdrawal by Subject|3|||
127714974|NCT01961609|459585146|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
127714975|NCT01961609|459585147|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
127714976|NCT01961609|459585148|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
127714977|NCT01961609|459585145|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
127714978|NCT01961609|459585146|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
127714979|NCT01961609|459585147|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
127714980|NCT01961609|459585148|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
127714981|NCT01961609|459585145|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
127714982|NCT01961609|459585146|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
127714983|NCT01961609|459585147|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
127714984|NCT01961609|459585148|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
127714985|NCT01961609|459585145|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
127714986|NCT01961609|459585146|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
127714987|NCT01961609|459585147|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
127714988|NCT01961609|459585148|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
127714989|NCT01961609|459585145|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
127714990|NCT01961609|459585146|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
127714991|NCT01961609|459585147|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
127714992|NCT01961609|459585148|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
127714993|NCT01961609|459585145|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
127714994|NCT01961609|459585146|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
127714995|NCT01961609|459585147|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
127714996|NCT01961609|459585148|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
127714997|NCT01961609|459585145|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
127714998|NCT01961609|459585146|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
127714999|NCT01961609|459585147|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
127715000|NCT01961609|459585148|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
127715001|NCT01961609|459585145|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
127715002|NCT01961609|459585146|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
127715003|NCT01961609|459585147|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
127715004|NCT01961609|459585148|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
127715005|NCT01961609|459585145|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
127715006|NCT01961609|459585146|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
127715007|NCT01961609|459585147|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
127715008|NCT01961609|459585148|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
127715009|NCT01961609|459585145|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
127715010|NCT01961609|459585146|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
127715011|NCT01961609|459585147|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
127715012|NCT01961609|459585148|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
127715013|NCT01961609|459585145|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
127715014|NCT01961609|459585146|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
127715015|NCT01961609|459585147|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
127802137|NCT01613326|459898766|FG001|Overall Study|Withdrawal by Subject|4|||
127802138|NCT01613326|459898765|FG000|Overall Study|Abnormal test procedure result(s)|2|||
127802139|NCT01613326|459898766|FG001|Overall Study|Abnormal test procedure result(s)|0|||
127802140|NCT01613326|459898765|FG000|Overall Study|inability to use device|1|||
127802141|NCT01613326|459898766|FG001|Overall Study|inability to use device|0|||
127802142|NCT01613326|459898765|FG000|Overall Study|Lack of Efficacy|0|||
127802143|NCT01613326|459898766|FG001|Overall Study|Lack of Efficacy|1|||
127802144|NCT01613326|459898765|FG000|Overall Study|Lost to Follow-up|0|||
127802145|NCT01613326|459898766|FG001|Overall Study|Lost to Follow-up|1|||
127802146|NCT01613326|459898765|FG000|Overall Study|Administrative|0|||
127802147|NCT01613326|459898766|FG001|Overall Study|Administrative|2|||
127802148|NCT01613326|459898765|FG000|Overall Study|Protocol Violation|0|||
127802149|NCT01613326|459898766|FG001|Overall Study|Protocol Violation|1|||
127802150|NCT03980938|459898767|FG000|Treatment Period 1|Study Terminated|1|||
127802151|NCT03980938|459898768|FG001|Treatment Period 1|Study Terminated|1|||
127802152|NCT03980938|459898767|FG000|Treatment Period 2|Study Terminated|2|||
127802153|NCT03980938|459898768|FG001|Treatment Period 2|Study Terminated|2|||
127802154|NCT00840827|459898769|FG000|Overall Study|Adverse Event|1|||
127802155|NCT00840827|459898769|FG000|Overall Study|Lack of Efficacy|4|||
127802156|NCT00840827|459898769|FG000|Overall Study|Physician Decision|1|||
127802157|NCT01445535|459898770|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
127802158|NCT01445535|459898771|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
127802159|NCT01445535|459898772|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
127802160|NCT01445535|459898773|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
127802161|NCT01445535|459898770|FG000|Overall Study|Disease progression|1|||
127802162|NCT01445535|459898771|FG001|Overall Study|Disease progression|0|||
127802163|NCT01445535|459898772|FG002|Overall Study|Disease progression|1|||
127715016|NCT01961609|459585148|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
127715017|NCT01961609|459585145|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
127715018|NCT01961609|459585146|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
127715019|NCT01961609|459585147|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
127715020|NCT01961609|459585148|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
127715021|NCT00571649|459585150|FG000|Treatment Period|Adverse Event|438|||
127715022|NCT00571649|459585151|FG001|Treatment Period|Adverse Event|385|||
127715023|NCT00571649|459585150|FG000|Treatment Period|Clinical endpoint reached|50|||
127715024|NCT00571649|459585151|FG001|Treatment Period|Clinical endpoint reached|56|||
127715025|NCT00571649|459585150|FG000|Treatment Period|Withdrawal by Subject|285|||
127715026|NCT00571649|459585151|FG001|Treatment Period|Withdrawal by Subject|255|||
127715027|NCT00571649|459585150|FG000|Treatment Period|Death|76|||
127715028|NCT00571649|459585151|FG001|Treatment Period|Death|59|||
127715029|NCT00571649|459585150|FG000|Treatment Period|Physician Decision|8|||
127888655|NCT00606684|460215803|FG003|Double-Blind Treatment Period|Adverse Event|4|||
127715030|NCT00571649|459585151|FG001|Treatment Period|Physician Decision|9|||
127715031|NCT00571649|459585150|FG000|Treatment Period|Lost to Follow-up|43|||
127715032|NCT00571649|459585151|FG001|Treatment Period|Lost to Follow-up|41|||
127715033|NCT00571649|459585150|FG000|Treatment Period|Non-compliant with study medication|88|||
127715034|NCT00571649|459585151|FG001|Treatment Period|Non-compliant with study medication|89|||
127715035|NCT00571649|459585150|FG000|Treatment Period|Patient convenience|11|||
127715036|NCT00571649|459585151|FG001|Treatment Period|Patient convenience|13|||
127715037|NCT00571649|459585150|FG000|Treatment Period|Protocol Violation|90|||
127715038|NCT00571649|459585151|FG001|Treatment Period|Protocol Violation|92|||
127715039|NCT00571649|459585150|FG000|Treatment Period|Technical problems|3|||
127715040|NCT00571649|459585151|FG001|Treatment Period|Technical problems|5|||
127715041|NCT00571649|459585150|FG000|Follow-up Period|Adverse Event|46|||
127715042|NCT00571649|459585151|FG001|Follow-up Period|Adverse Event|40|||
127715043|NCT00571649|459585150|FG000|Follow-up Period|Clinical endpoint reached|5|||
127715044|NCT00571649|459585151|FG001|Follow-up Period|Clinical endpoint reached|2|||
127715045|NCT00571649|459585150|FG000|Follow-up Period|Withdrawal by Subject|119|||
127715046|NCT00571649|459585151|FG001|Follow-up Period|Withdrawal by Subject|115|||
127715047|NCT00571649|459585150|FG000|Follow-up Period|Death|132|||
127715048|NCT00571649|459585151|FG001|Follow-up Period|Death|133|||
127715049|NCT00571649|459585150|FG000|Follow-up Period|Physician Decision|7|||
127715050|NCT00571649|459585151|FG001|Follow-up Period|Physician Decision|13|||
127715051|NCT00571649|459585150|FG000|Follow-up Period|Lost to Follow-up|95|||
127715052|NCT00571649|459585151|FG001|Follow-up Period|Lost to Follow-up|92|||
127715053|NCT00571649|459585150|FG000|Follow-up Period|Patient convenience|136|||
127715054|NCT00571649|459585151|FG001|Follow-up Period|Patient convenience|121|||
127715055|NCT00571649|459585150|FG000|Follow-up Period|Protocol Violation|5|||
127715056|NCT00571649|459585151|FG001|Follow-up Period|Protocol Violation|12|||
127715057|NCT00582972|459585152|FG000|Overall Study|Protocol Violation|2|||
127715058|NCT01566890|459585155|FG000|Overall Study|Adverse Event|1|||
127715059|NCT01566890|459585156|FG001|Overall Study|Adverse Event|0|||
127715060|NCT01566890|459585157|FG002|Overall Study|Adverse Event|0|||
127715061|NCT01566890|459585158|FG003|Overall Study|Adverse Event|0|||
127715062|NCT01566890|459585159|FG004|Overall Study|Adverse Event|0|||
127715063|NCT01566890|459585155|FG000|Overall Study|Withdrawal by Subject|3|||
127715064|NCT01566890|459585156|FG001|Overall Study|Withdrawal by Subject|1|||
127715065|NCT01566890|459585157|FG002|Overall Study|Withdrawal by Subject|1|||
127715066|NCT01566890|459585158|FG003|Overall Study|Withdrawal by Subject|1|||
127715067|NCT01566890|459585159|FG004|Overall Study|Withdrawal by Subject|0|||
127715068|NCT01566890|459585155|FG000|Overall Study|Screen failure|6|||
127715069|NCT01566890|459585156|FG001|Overall Study|Screen failure|0|||
127715070|NCT01566890|459585157|FG002|Overall Study|Screen failure|1|||
127715071|NCT01566890|459585158|FG003|Overall Study|Screen failure|1|||
127715072|NCT01566890|459585159|FG004|Overall Study|Screen failure|0|||
127715073|NCT01566890|459585155|FG000|Overall Study|Incomplete CEU data|1|||
127715074|NCT01566890|459585156|FG001|Overall Study|Incomplete CEU data|3|||
127715075|NCT01566890|459585157|FG002|Overall Study|Incomplete CEU data|5|||
127715076|NCT01566890|459585158|FG003|Overall Study|Incomplete CEU data|8|||
127715077|NCT01566890|459585159|FG004|Overall Study|Incomplete CEU data|0|||
127715078|NCT01566890|459585155|FG000|Overall Study|Lost to Follow-up|0|||
127715079|NCT01566890|459585156|FG001|Overall Study|Lost to Follow-up|0|||
127715080|NCT01566890|459585157|FG002|Overall Study|Lost to Follow-up|4|||
127715081|NCT01566890|459585158|FG003|Overall Study|Lost to Follow-up|4|||
127715082|NCT01566890|459585159|FG004|Overall Study|Lost to Follow-up|0|||
127715083|NCT01566890|459585155|FG000|Overall Study|Other|0|||
127715084|NCT01566890|459585156|FG001|Overall Study|Other|0|||
127715085|NCT01566890|459585157|FG002|Overall Study|Other|0|||
127888656|NCT00606684|460215804|FG004|Double-Blind Treatment Period|Adverse Event|2|||
127715086|NCT01566890|459585158|FG003|Overall Study|Other|0|||
127715087|NCT01566890|459585159|FG004|Overall Study|Other|7|||
127715088|NCT01211184|459585167|FG000|Overall Study|Withdrawal by Subject|0|||
127715089|NCT01211184|459585168|FG001|Overall Study|Withdrawal by Subject|2|||
127715090|NCT01211184|459585169|FG002|Overall Study|Withdrawal by Subject|1|||
127715091|NCT01421667|459585170|FG000|Overall Study|Withdrawal by Subject|0|||
127715092|NCT01421667|459585171|FG001|Overall Study|Withdrawal by Subject|1|||
127715093|NCT01421667|459585172|FG002|Overall Study|Withdrawal by Subject|2|||
127715094|NCT01421667|459585173|FG003|Overall Study|Withdrawal by Subject|1|||
127715095|NCT01421667|459585170|FG000|Overall Study|Lost to Follow-up|0|||
127715096|NCT01421667|459585171|FG001|Overall Study|Lost to Follow-up|1|||
127715097|NCT01421667|459585172|FG002|Overall Study|Lost to Follow-up|0|||
127715098|NCT01421667|459585173|FG003|Overall Study|Lost to Follow-up|0|||
127715099|NCT04060212|459585175|FG000|Overall Study|Withdrawal by Subject|7|||
127715100|NCT02787005|459585193|FG000|Overall Study|Adverse Event|24|||
127715101|NCT02787005|459585194|FG001|Overall Study|Adverse Event|9|||
127715102|NCT02787005|459585195|FG002|Overall Study|Adverse Event|9|||
127715103|NCT02787005|459585196|FG003|Overall Study|Adverse Event|7|||
127715104|NCT02787005|459585197|FG004|Overall Study|Adverse Event|2|||
127715105|NCT02787005|459585193|FG000|Overall Study|Death|100|||
127715106|NCT02787005|459585194|FG001|Overall Study|Death|53|||
127715107|NCT02787005|459585195|FG002|Overall Study|Death|48|||
127715108|NCT02787005|459585196|FG003|Overall Study|Death|69|||
127715109|NCT02787005|459585197|FG004|Overall Study|Death|38|||
127715110|NCT02787005|459585193|FG000|Overall Study|Sponsor Decision|7|||
127715111|NCT02787005|459585194|FG001|Overall Study|Sponsor Decision|4|||
127715112|NCT02787005|459585195|FG002|Overall Study|Sponsor Decision|0|||
127715113|NCT02787005|459585196|FG003|Overall Study|Sponsor Decision|4|||
127715114|NCT02787005|459585197|FG004|Overall Study|Sponsor Decision|5|||
127715115|NCT02787005|459585193|FG000|Overall Study|Withdrawal by Subject|2|||
127715116|NCT02787005|459585194|FG001|Overall Study|Withdrawal by Subject|1|||
127715117|NCT02787005|459585195|FG002|Overall Study|Withdrawal by Subject|1|||
127715118|NCT02787005|459585196|FG003|Overall Study|Withdrawal by Subject|0|||
127715119|NCT02787005|459585197|FG004|Overall Study|Withdrawal by Subject|1|||
127715120|NCT02787005|459585193|FG000|Overall Study|Screen Failure|0|||
127715121|NCT02787005|459585194|FG001|Overall Study|Screen Failure|2|||
127715122|NCT02787005|459585195|FG002|Overall Study|Screen Failure|0|||
127715123|NCT02787005|459585196|FG003|Overall Study|Screen Failure|0|||
127715124|NCT02787005|459585197|FG004|Overall Study|Screen Failure|1|||
127715125|NCT02787005|459585193|FG000|Overall Study|Lost to Follow-up|0|||
127715126|NCT02787005|459585194|FG001|Overall Study|Lost to Follow-up|0|||
127715127|NCT02787005|459585195|FG002|Overall Study|Lost to Follow-up|0|||
127715128|NCT02787005|459585196|FG003|Overall Study|Lost to Follow-up|1|||
127715129|NCT02787005|459585197|FG004|Overall Study|Lost to Follow-up|0|||
127715130|NCT01387516|459585198|FG000|Overall Study|Lost to Follow-up|4|||
127715131|NCT01387516|459585199|FG001|Overall Study|Lost to Follow-up|4|||
127715132|NCT01387516|459585200|FG002|Overall Study|Lost to Follow-up|2|||
127715133|NCT01387516|459585201|FG003|Overall Study|Lost to Follow-up|3|||
127715134|NCT01387516|459585198|FG000|Overall Study|Withdrawal by Subject|1|||
127715135|NCT01387516|459585199|FG001|Overall Study|Withdrawal by Subject|1|||
127715136|NCT01387516|459585200|FG002|Overall Study|Withdrawal by Subject|2|||
127715137|NCT01387516|459585201|FG003|Overall Study|Withdrawal by Subject|0|||
127715138|NCT01387516|459585198|FG000|Overall Study|Death|0|||
127715139|NCT01387516|459585199|FG001|Overall Study|Death|0|||
127715140|NCT01387516|459585200|FG002|Overall Study|Death|0|||
127715141|NCT01387516|459585201|FG003|Overall Study|Death|1|||
127715142|NCT02928172|459585205|FG000|Overall Study|Device did not record data|1|||
127715143|NCT02016872|459585210|FG000|Overall Study|Withdrawal by Subject|10|||
127715144|NCT02016872|459585210|FG000|Overall Study|Death Progression|2|||
127715145|NCT02016872|459585210|FG000|Overall Study|No FMISO scan|1|||
127715146|NCT02016872|459585210|FG000|Overall Study|Ineligible|2|||
127715147|NCT04882917|459585220|FG000|Overall Study|Adverse Event|0|||
127715148|NCT04882917|459585221|FG001|Overall Study|Adverse Event|1|||
127715149|NCT04882917|459585222|FG002|Overall Study|Adverse Event|2|||
127715150|NCT04882917|459585223|FG003|Overall Study|Adverse Event|2|||
127715151|NCT04882917|459585220|FG000|Overall Study|Withdrawal by Subject|1|||
127715152|NCT04882917|459585221|FG001|Overall Study|Withdrawal by Subject|0|||
127715153|NCT04882917|459585222|FG002|Overall Study|Withdrawal by Subject|2|||
127715154|NCT04882917|459585223|FG003|Overall Study|Withdrawal by Subject|1|||
127715155|NCT04882917|459585220|FG000|Overall Study|COVID-19-related and COVID-19-non-related|1|||
127715156|NCT04882917|459585221|FG001|Overall Study|COVID-19-related and COVID-19-non-related|0|||
127715157|NCT04882917|459585222|FG002|Overall Study|COVID-19-related and COVID-19-non-related|0|||
127715158|NCT04882917|459585223|FG003|Overall Study|COVID-19-related and COVID-19-non-related|0|||
127715159|NCT02678689|459585224|FG000|Overall Study|Participant chose to receive commercial drug in their home country|1|||
127715160|NCT02678689|459585225|FG001|Overall Study|Participant chose to receive commercial drug in their home country|0|||
127715161|NCT02761187|459585229|FG000|Overall Study|Too ill to Participate|13|||
127715162|NCT02761187|459585230|FG001|Overall Study|Too ill to Participate|8|||
127715163|NCT02761187|459585229|FG000|Overall Study|Patient declined participation and declined follow-up for survival|34|||
127715164|NCT02761187|459585230|FG001|Overall Study|Patient declined participation and declined follow-up for survival|26|||
127715165|NCT02761187|459585229|FG000|Overall Study|Patient withdrew consent|64|||
127715166|NCT02761187|459585230|FG001|Overall Study|Patient withdrew consent|58|||
127715167|NCT02761187|459585229|FG000|Overall Study|Physician discretion|4|||
127715168|NCT02761187|459585230|FG001|Overall Study|Physician discretion|8|||
127715169|NCT02761187|459585229|FG000|Overall Study|Change in physician or transferred to another treatment center|72|||
127715170|NCT02761187|459585230|FG001|Overall Study|Change in physician or transferred to another treatment center|62|||
127715171|NCT02761187|459585229|FG000|Overall Study|On Hospice|20|||
127715172|NCT02761187|459585230|FG001|Overall Study|On Hospice|26|||
127715173|NCT02761187|459585229|FG000|Overall Study|Deceased|474|||
127715174|NCT02761187|459585230|FG001|Overall Study|Deceased|642|||
127715175|NCT02761187|459585229|FG000|Overall Study|Lost to Follow-up|73|||
127715176|NCT02761187|459585230|FG001|Overall Study|Lost to Follow-up|63|||
127715177|NCT02761187|459585229|FG000|Overall Study|Due to study discontinued at site|100|||
127715178|NCT02761187|459585230|FG001|Overall Study|Due to study discontinued at site|85|||
127715179|NCT02761187|459585229|FG000|Overall Study|Reason not Specified|1484|||
127715180|NCT02761187|459585230|FG001|Overall Study|Reason not Specified|937|||
127715181|NCT03978637|459585231|FG000|Overall Study|Death|0|||
127715182|NCT03978637|459585232|FG001|Overall Study|Death|2|||
127715183|NCT03978637|459585233|FG002|Overall Study|Death|2|||
127715184|NCT03978637|459585234|FG003|Overall Study|Death|0|||
127715185|NCT03978637|459585231|FG000|Overall Study|Withdrawal by Subject|0|||
127888657|NCT00606684|460215805|FG005|Double-Blind Treatment Period|Adverse Event|0|||
127888658|NCT00606684|460215806|FG006|Double-Blind Treatment Period|Adverse Event|1|||
127715186|NCT03978637|459585232|FG001|Overall Study|Withdrawal by Subject|0|||
127715187|NCT03978637|459585233|FG002|Overall Study|Withdrawal by Subject|1|||
127715188|NCT03978637|459585234|FG003|Overall Study|Withdrawal by Subject|0|||
127715189|NCT03978637|459585231|FG000|Overall Study|Transitioned to Itacitinib Rollover Trial|1|||
127715190|NCT03978637|459585232|FG001|Overall Study|Transitioned to Itacitinib Rollover Trial|3|||
127715191|NCT03978637|459585233|FG002|Overall Study|Transitioned to Itacitinib Rollover Trial|2|||
127715192|NCT03978637|459585234|FG003|Overall Study|Transitioned to Itacitinib Rollover Trial|0|||
127715193|NCT02307682|459585235|FG000|Overall Study|Adverse Event|9|||
127715194|NCT02307682|459585236|FG001|Overall Study|Adverse Event|8|||
127715195|NCT02307682|459585237|FG002|Overall Study|Adverse Event|12|||
127715196|NCT02307682|459585235|FG000|Overall Study|Lack of Efficacy|1|||
127715197|NCT02307682|459585236|FG001|Overall Study|Lack of Efficacy|0|||
127715198|NCT02307682|459585237|FG002|Overall Study|Lack of Efficacy|1|||
127715199|NCT02307682|459585235|FG000|Overall Study|Physician Decision|2|||
127715200|NCT02307682|459585236|FG001|Overall Study|Physician Decision|2|||
127715201|NCT02307682|459585237|FG002|Overall Study|Physician Decision|8|||
127715202|NCT02307682|459585235|FG000|Overall Study|Progressive Disease|1|||
127715203|NCT02307682|459585236|FG001|Overall Study|Progressive Disease|0|||
127715204|NCT02307682|459585237|FG002|Overall Study|Progressive Disease|0|||
127715205|NCT02307682|459585235|FG000|Overall Study|Withdrawal by Subject|26|||
127715206|NCT02307682|459585236|FG001|Overall Study|Withdrawal by Subject|34|||
127715207|NCT02307682|459585237|FG002|Overall Study|Withdrawal by Subject|23|||
127715208|NCT02307682|459585235|FG000|Overall Study|Death|9|||
127715209|NCT02307682|459585236|FG001|Overall Study|Death|7|||
127715210|NCT02307682|459585237|FG002|Overall Study|Death|12|||
127715211|NCT02307682|459585235|FG000|Overall Study|Lost to Follow-up|1|||
127715212|NCT02307682|459585236|FG001|Overall Study|Lost to Follow-up|5|||
127715213|NCT02307682|459585237|FG002|Overall Study|Lost to Follow-up|6|||
127715214|NCT02307682|459585235|FG000|Overall Study|Protocol Deviation|0|||
127715215|NCT02307682|459585236|FG001|Overall Study|Protocol Deviation|0|||
127715216|NCT02307682|459585237|FG002|Overall Study|Protocol Deviation|2|||
127802164|NCT01445535|459898773|FG003|Overall Study|Disease progression|0|||
127802165|NCT01445535|459898770|FG000|Overall Study|PI discretion|0|||
127802166|NCT01445535|459898771|FG001|Overall Study|PI discretion|0|||
127802167|NCT01445535|459898772|FG002|Overall Study|PI discretion|0|||
127802168|NCT01445535|459898773|FG003|Overall Study|PI discretion|1|||
127802169|NCT02494596|459898776|FG000|Overall Study|Insufficient Therapeutic Response|3|||
127802170|NCT02494596|459898777|FG001|Overall Study|Insufficient Therapeutic Response|3|||
127715217|NCT02307682|459585235|FG000|Overall Study|Other|1|||
127715218|NCT02307682|459585236|FG001|Overall Study|Other|1|||
127715219|NCT02307682|459585237|FG002|Overall Study|Other|0|||
127715220|NCT05630833|459585238|FG000|Overall Study|Adverse Event|3|||
127802171|NCT02494596|459898778|FG002|Overall Study|Insufficient Therapeutic Response|1|||
127715221|NCT05630833|459585239|FG001|Overall Study|Adverse Event|0|||
127715222|NCT05630833|459585238|FG000|Overall Study|Lack of Efficacy|0|||
127715223|NCT05630833|459585239|FG001|Overall Study|Lack of Efficacy|1|||
127715224|NCT05630833|459585238|FG000|Overall Study|Lost to Follow-up|1|||
127715225|NCT05630833|459585239|FG001|Overall Study|Lost to Follow-up|0|||
127802172|NCT02494596|459898776|FG000|Overall Study|Adverse Event|0|||
127888659|NCT00606684|460215800|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
127715226|NCT05630833|459585238|FG000|Overall Study|Withdrawal by Subject|3|||
127802173|NCT02494596|459898777|FG001|Overall Study|Adverse Event|1|||
127802174|NCT02494596|459898778|FG002|Overall Study|Adverse Event|0|||
127715227|NCT05630833|459585239|FG001|Overall Study|Withdrawal by Subject|1|||
127715228|NCT01084694|459586033|FG000|Overall Study|Withdrawal by Subject|2|||
127715229|NCT01084694|459586034|FG001|Overall Study|Withdrawal by Subject|1|||
127715230|NCT01084694|459586033|FG000|Overall Study|Death|2|||
127715231|NCT01084694|459586034|FG001|Overall Study|Death|12|||
127715232|NCT01084694|459586033|FG000|Overall Study|eligibility not maintained|2|||
127715233|NCT01084694|459586034|FG001|Overall Study|eligibility not maintained|7|||
127715234|NCT00945321|459586035|FG000|Period 1|Adverse Event|0|||
127715235|NCT00945321|459586036|FG001|Period 1|Adverse Event|0|||
127715236|NCT00945321|459586037|FG002|Period 1|Adverse Event|0|||
127715237|NCT00945321|459586038|FG003|Period 1|Adverse Event|0|||
127715238|NCT00945321|459586039|FG004|Period 1|Adverse Event|1|||
127715239|NCT00945321|459586040|FG005|Period 1|Adverse Event|0|||
127715240|NCT00945321|459586035|FG000|Period 4|Lost to Follow-up|0|||
127715241|NCT00945321|459586036|FG001|Period 4|Lost to Follow-up|0|||
127715242|NCT00945321|459586037|FG002|Period 4|Lost to Follow-up|0|||
127715243|NCT00945321|459586038|FG003|Period 4|Lost to Follow-up|0|||
127715244|NCT00945321|459586039|FG004|Period 4|Lost to Follow-up|0|||
127715245|NCT00945321|459586040|FG005|Period 4|Lost to Follow-up|1|||
127715246|NCT02633215|459586041|FG000|Overall Study|Lost to Follow-up|2|||
127715247|NCT02633215|459586042|FG001|Overall Study|Lost to Follow-up|3|||
127715248|NCT04017611|459586043|FG000|Overall Study|Withdrawn prior to completion|1|||
127715249|NCT00692913|459586044|FG000|Overall Study|Adverse Event|8|||
127715250|NCT00692913|459586045|FG001|Overall Study|Adverse Event|4|||
127715251|NCT00692913|459586044|FG000|Overall Study|Lost to Follow-up|3|||
127715252|NCT00692913|459586045|FG001|Overall Study|Lost to Follow-up|5|||
127715253|NCT00692913|459586044|FG000|Overall Study|Physician Decision|2|||
127715254|NCT00692913|459586045|FG001|Overall Study|Physician Decision|0|||
127715255|NCT00692913|459586044|FG000|Overall Study|Protocol Violation|1|||
127715256|NCT00692913|459586045|FG001|Overall Study|Protocol Violation|1|||
127715257|NCT00692913|459586044|FG000|Overall Study|Withdrawal by Subject|15|||
127715258|NCT00692913|459586045|FG001|Overall Study|Withdrawal by Subject|20|||
127715259|NCT02291913|459586054|FG000|Overall Study|Progressive Disease|32|||
127715260|NCT02291913|459586054|FG000|Overall Study|Adverse Event|11|||
127715261|NCT02291913|459586054|FG000|Overall Study|Death|2|||
127715262|NCT02291913|459586054|FG000|Overall Study|Physician Decision|1|||
127715263|NCT02291913|459586054|FG000|Overall Study|Withdrawal by Subject|1|||
127715264|NCT02291913|459586054|FG000|Overall Study|Protocol Violation|1|||
127715265|NCT02866942|459586055|FG000|Overall Study|Invalid consent|1|||
127715266|NCT01268306|459586056|FG000|Overall Study|Lost to Follow-up|1|||
127715267|NCT04334317|459586057|FG000|Overall Study|Adverse Event|1|||
127715268|NCT04334317|459586058|FG001|Overall Study|Adverse Event|2|||
127715269|NCT04334317|459586059|FG002|Overall Study|Adverse Event|0|||
127715270|NCT04334317|459586060|FG003|Overall Study|Adverse Event|0|||
127715271|NCT04334317|459586057|FG000|Overall Study|Protocol Deviation|0|||
127715272|NCT04334317|459586058|FG001|Overall Study|Protocol Deviation|1|||
127715273|NCT04334317|459586059|FG002|Overall Study|Protocol Deviation|0|||
127715274|NCT04334317|459586060|FG003|Overall Study|Protocol Deviation|0|||
127715275|NCT04334317|459586057|FG000|Overall Study|Withdrawal by Subject|2|||
127715276|NCT04334317|459586058|FG001|Overall Study|Withdrawal by Subject|2|||
127715277|NCT04334317|459586059|FG002|Overall Study|Withdrawal by Subject|0|||
127715278|NCT04334317|459586060|FG003|Overall Study|Withdrawal by Subject|0|||
127715279|NCT01128595|459586063|FG000|Treatment Period 3|Withdrawal by Subject|0|||
127715280|NCT01128595|459586064|FG001|Treatment Period 3|Withdrawal by Subject|1|||
127715281|NCT01128595|459586065|FG002|Treatment Period 3|Withdrawal by Subject|0|||
127715282|NCT01128595|459586066|FG003|Treatment Period 3|Withdrawal by Subject|0|||
127802175|NCT02494596|459898776|FG000|Overall Study|Refused Treatment|0|||
127715283|NCT00605306|459586067|FG000|Overall Study|Adverse Event|0|||
127715284|NCT00605306|459586068|FG001|Overall Study|Adverse Event|1|||
127715285|NCT00372775|459586069|FG000|Overall Study|Adverse Event|8|||
127715286|NCT00372775|459586069|FG000|Overall Study|Death|15|||
127715287|NCT00372775|459586069|FG000|Overall Study|Objective progression or relapse|30|||
127715288|NCT00372775|459586069|FG000|Overall Study|Global deterioration of health status|6|||
127802176|NCT02494596|459898777|FG001|Overall Study|Refused Treatment|1|||
127802177|NCT02494596|459898778|FG002|Overall Study|Refused Treatment|0|||
127715289|NCT00372775|459586069|FG000|Overall Study|Withdrawal by Subject|1|||
127715290|NCT00372775|459586069|FG000|Overall Study|Other|1|||
127715291|NCT00372775|459586069|FG000|Overall Study|Not Treated|2|||
127715292|NCT02568215|459586071|FG000|Overall Study|Death|1|||
127715293|NCT02568215|459586072|FG001|Overall Study|Death|2|||
127715294|NCT02568215|459586073|FG002|Overall Study|Death|0|||
127715295|NCT02568215|459586071|FG000|Overall Study|Physician Decision|2|||
127715296|NCT02568215|459586072|FG001|Overall Study|Physician Decision|2|||
127715297|NCT02568215|459586073|FG002|Overall Study|Physician Decision|2|||
127715298|NCT02568215|459586071|FG000|Overall Study|Lost to Follow-up|29|||
127715299|NCT02568215|459586072|FG001|Overall Study|Lost to Follow-up|32|||
127715300|NCT02568215|459586073|FG002|Overall Study|Lost to Follow-up|41|||
127802178|NCT00059202|459898779|FG000|Overall Study|Withdrawal by Subject|5|||
127715301|NCT02568215|459586071|FG000|Overall Study|Withdrawal by Subject|21|||
127715302|NCT02568215|459586072|FG001|Overall Study|Withdrawal by Subject|19|||
127715303|NCT02568215|459586073|FG002|Overall Study|Withdrawal by Subject|22|||
127715304|NCT02568215|459586071|FG000|Overall Study|Protocol Violation|1|||
127715305|NCT02568215|459586072|FG001|Overall Study|Protocol Violation|1|||
127715306|NCT02568215|459586073|FG002|Overall Study|Protocol Violation|0|||
127715307|NCT02568215|459586071|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
127715308|NCT02568215|459586072|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
127715309|NCT02568215|459586073|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
127715310|NCT02568215|459586071|FG000|Overall Study|Other|0|||
127715311|NCT02568215|459586072|FG001|Overall Study|Other|1|||
127715312|NCT02568215|459586073|FG002|Overall Study|Other|4|||
127715313|NCT00336505|459586074|FG000|Overall Study|Adverse Event|10|||
127715314|NCT00336505|459586075|FG001|Overall Study|Adverse Event|9|||
127715315|NCT00336505|459586074|FG000|Overall Study|Lack of Efficacy|8|||
127715316|NCT00336505|459586075|FG001|Overall Study|Lack of Efficacy|4|||
127715317|NCT00336505|459586074|FG000|Overall Study|Lost to Follow-up|7|||
127715318|NCT00336505|459586075|FG001|Overall Study|Lost to Follow-up|4|||
127715319|NCT00336505|459586074|FG000|Overall Study|Withdrawal by Subject|5|||
127715320|NCT00336505|459586075|FG001|Overall Study|Withdrawal by Subject|3|||
127715321|NCT00336505|459586074|FG000|Overall Study|Other|7|||
127715322|NCT00336505|459586075|FG001|Overall Study|Other|7|||
127715323|NCT01561300|459586076|FG000|Run in on Placebo|Adverse Event|1|||
127715324|NCT01561300|459586077|FG001|Run in on Placebo|Adverse Event|0|||
127715325|NCT00246805|459586078|FG000|Phase 1|Lost to Follow-up|1|||
127715326|NCT00246805|459586079|FG001|Phase 1|Lost to Follow-up|0|||
127715327|NCT00609869|459586080|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
127715328|NCT00609869|459586080|FG000|Overall Study|Severe hematologic toxicity|1|||
127715329|NCT00609869|459586080|FG000|Overall Study|Withdrawal by Subject|1|||
127715330|NCT00609869|459586080|FG000|Overall Study|Seizures|1|||
127715331|NCT00609869|459586080|FG000|Overall Study|Severe tumor flare reaction|1|||
127715332|NCT00609869|459586080|FG000|Overall Study|Hepatitis B infection|1|||
127715333|NCT00609869|459586080|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
127715334|NCT00609869|459586080|FG000|Overall Study|Mantle cell: not evaluable|4|||
127715335|NCT00890591|459586082|FG000|Overall Study|Lack of Efficacy|20|||
127715336|NCT00724126|459586083|FG000|Overall Study|Adverse Event|2|||
127715337|NCT00724126|459586084|FG001|Overall Study|Adverse Event|0|||
127715338|NCT00724126|459586083|FG000|Overall Study|Withdrawal by Subject|8|||
127715339|NCT00724126|459586084|FG001|Overall Study|Withdrawal by Subject|6|||
127715340|NCT00724126|459586083|FG000|Overall Study|Lost to Follow-up|6|||
127715341|NCT00724126|459586084|FG001|Overall Study|Lost to Follow-up|6|||
127715342|NCT00724126|459586083|FG000|Overall Study|Noncompliance|2|||
127715343|NCT00724126|459586084|FG001|Overall Study|Noncompliance|1|||
127715344|NCT00724126|459586083|FG000|Overall Study|Subject randomized although ineligible|1|||
127715345|NCT00724126|459586084|FG001|Overall Study|Subject randomized although ineligible|1|||
127715346|NCT00724126|459586083|FG000|Overall Study|Subject had to leave vicinity of site|0|||
127715347|NCT00724126|459586084|FG001|Overall Study|Subject had to leave vicinity of site|1|||
127715348|NCT02502526|459586086|FG000|Overall Study|Lost to Follow-up|2|||
127715349|NCT02502526|459586087|FG001|Overall Study|Lost to Follow-up|2|||
127715350|NCT02502526|459586088|FG002|Overall Study|Lost to Follow-up|3|||
127715351|NCT02502526|459586086|FG000|Overall Study|Withdrawal by Subject|0|||
127715352|NCT02502526|459586087|FG001|Overall Study|Withdrawal by Subject|1|||
127715353|NCT02502526|459586088|FG002|Overall Study|Withdrawal by Subject|1|||
127715354|NCT02502526|459586086|FG000|Overall Study|Disqualified due to cataract grading|0|||
127715355|NCT02502526|459586087|FG001|Overall Study|Disqualified due to cataract grading|0|||
127715356|NCT02502526|459586088|FG002|Overall Study|Disqualified due to cataract grading|1|||
127715357|NCT02502526|459586086|FG000|Overall Study|Enrollment suspension|4|||
127715358|NCT02502526|459586087|FG001|Overall Study|Enrollment suspension|1|||
127715359|NCT02502526|459586088|FG002|Overall Study|Enrollment suspension|1|||
127715360|NCT01952366|459586089|FG000|Overall Study|Death|22|||
127715361|NCT01952366|459586089|FG000|Overall Study|Withdrawal by Subject|9|||
127715362|NCT00293397|459586092|FG000|Overall Study|Death|2|||
127715363|NCT00822120|459586093|FG000|Initial Registration|Adverse Event|1|||
127715364|NCT00822120|459586094|FG001|Initial Registration|Adverse Event|0|||
127715365|NCT00822120|459586095|FG002|Initial Registration|Adverse Event|0|||
127715366|NCT00822120|459586096|FG003|Initial Registration|Adverse Event|0|||
127715367|NCT00822120|459586097|FG004|Initial Registration|Adverse Event|0|||
127715368|NCT00822120|459586098|FG005|Initial Registration|Adverse Event|0|||
127715369|NCT00822120|459586093|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
127715370|NCT00822120|459586094|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
127715371|NCT00822120|459586095|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
127715372|NCT00822120|459586096|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
127715373|NCT00822120|459586097|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
127802179|NCT00059202|459898780|FG001|Overall Study|Withdrawal by Subject|9|||
127802180|NCT00059202|459898779|FG000|Overall Study|Protocol Violation|1|||
127715374|NCT00822120|459586098|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
127715375|NCT00822120|459586093|FG000|Initial Registration|Reasons not Protocol Specified|2|||
127715376|NCT00822120|459586094|FG001|Initial Registration|Reasons not Protocol Specified|0|||
127715377|NCT00822120|459586095|FG002|Initial Registration|Reasons not Protocol Specified|0|||
127715378|NCT00822120|459586096|FG003|Initial Registration|Reasons not Protocol Specified|0|||
127715379|NCT00822120|459586097|FG004|Initial Registration|Reasons not Protocol Specified|0|||
127715380|NCT00822120|459586098|FG005|Initial Registration|Reasons not Protocol Specified|0|||
127715381|NCT00822120|459586093|FG000|Initial Registration|Ineligible|22|||
127715382|NCT00822120|459586094|FG001|Initial Registration|Ineligible|1|||
127715383|NCT00822120|459586095|FG002|Initial Registration|Ineligible|0|||
127715384|NCT00822120|459586096|FG003|Initial Registration|Ineligible|0|||
127715385|NCT00822120|459586097|FG004|Initial Registration|Ineligible|0|||
127715386|NCT00822120|459586098|FG005|Initial Registration|Ineligible|0|||
127715387|NCT00822120|459586093|FG000|PET-directed Therapy|Adverse Event|0|||
127715388|NCT00822120|459586094|FG001|PET-directed Therapy|Adverse Event|0|||
127715389|NCT00822120|459586095|FG002|PET-directed Therapy|Adverse Event|0|||
127715390|NCT00822120|459586096|FG003|PET-directed Therapy|Adverse Event|1|||
127715391|NCT00822120|459586097|FG004|PET-directed Therapy|Adverse Event|0|||
127715392|NCT00822120|459586098|FG005|PET-directed Therapy|Adverse Event|0|||
127715393|NCT00822120|459586093|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
127715394|NCT00822120|459586094|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
127715395|NCT00822120|459586095|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
127715396|NCT00822120|459586096|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
127715397|NCT00822120|459586097|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
127715398|NCT00822120|459586098|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
127715399|NCT00822120|459586093|FG000|PET-directed Therapy|Death|0|||
127715400|NCT00822120|459586094|FG001|PET-directed Therapy|Death|0|||
127715401|NCT00822120|459586095|FG002|PET-directed Therapy|Death|0|||
127715402|NCT00822120|459586096|FG003|PET-directed Therapy|Death|2|||
127715403|NCT00822120|459586097|FG004|PET-directed Therapy|Death|0|||
127715404|NCT00822120|459586098|FG005|PET-directed Therapy|Death|0|||
127715405|NCT00822120|459586093|FG000|PET-directed Therapy|Protocol Violation|0|||
127715406|NCT00822120|459586094|FG001|PET-directed Therapy|Protocol Violation|0|||
127715407|NCT00822120|459586095|FG002|PET-directed Therapy|Protocol Violation|0|||
127715408|NCT00822120|459586096|FG003|PET-directed Therapy|Protocol Violation|6|||
127715409|NCT00822120|459586097|FG004|PET-directed Therapy|Protocol Violation|0|||
127715410|NCT00822120|459586098|FG005|PET-directed Therapy|Protocol Violation|0|||
127715411|NCT00503906|459586099|FG000|Overall Study|Withdrawal by Subject|1|||
127715412|NCT01324310|459586100|FG000|Overall Study|Adverse Event|1|||
127715413|NCT01324310|459586100|FG000|Overall Study|Disease Progression|1|||
127715414|NCT02029235|459586103|FG000|Overall Study|Non-compliance with study meds or diary|4|||
127715415|NCT02029235|459586104|FG001|Overall Study|Non-compliance with study meds or diary|1|||
127715416|NCT01738438|459586106|FG000|Overall Study|Disease Progression|32|||
127715417|NCT01738438|459586106|FG000|Overall Study|Adverse Event|3|||
127715418|NCT04066075|459586107|FG000|Overall Study|Lost to Follow-up|3|||
127715419|NCT04066075|459586108|FG001|Overall Study|Lost to Follow-up|3|||
127715420|NCT04066075|459586107|FG000|Overall Study|no longer eligible or technical issue with intervention or data|4|||
127715421|NCT04066075|459586108|FG001|Overall Study|no longer eligible or technical issue with intervention or data|0|||
127715422|NCT04066075|459586107|FG000|Overall Study|Withdrawal by Subject|2|||
127715423|NCT04066075|459586108|FG001|Overall Study|Withdrawal by Subject|2|||
127715424|NCT00309166|459586109|FG000|Overall Study|Adverse event, non-fatal|1|||
127715425|NCT00309166|459586110|FG001|Overall Study|Adverse event, non-fatal|0|||
127715426|NCT00309166|459586109|FG000|Overall Study|Withdrawal by Subject|4|||
127715427|NCT00309166|459586110|FG001|Overall Study|Withdrawal by Subject|3|||
127715428|NCT03593226|459586129|FG000|Overall Study|Disease progression|6|||
127715429|NCT03593226|459586130|FG001|Overall Study|Disease progression|13|||
127715430|NCT03593226|459586131|FG002|Overall Study|Disease progression|5|||
127715431|NCT03593226|459586132|FG003|Overall Study|Disease progression|6|||
127715432|NCT03593226|459586129|FG000|Overall Study|Adverse Event|0|||
127715433|NCT03593226|459586130|FG001|Overall Study|Adverse Event|1|||
127715434|NCT03593226|459586131|FG002|Overall Study|Adverse Event|0|||
127715435|NCT03593226|459586132|FG003|Overall Study|Adverse Event|0|||
127715436|NCT03593226|459586129|FG000|Overall Study|Withdrawal by Subject|0|||
127715437|NCT03593226|459586130|FG001|Overall Study|Withdrawal by Subject|4|||
127715438|NCT03593226|459586131|FG002|Overall Study|Withdrawal by Subject|1|||
127715439|NCT03593226|459586132|FG003|Overall Study|Withdrawal by Subject|0|||
127715440|NCT03593226|459586129|FG000|Overall Study|Physician Decision|0|||
127802181|NCT00059202|459898780|FG001|Overall Study|Protocol Violation|3|||
127715441|NCT03593226|459586130|FG001|Overall Study|Physician Decision|1|||
127715442|NCT03593226|459586131|FG002|Overall Study|Physician Decision|0|||
127715443|NCT03593226|459586132|FG003|Overall Study|Physician Decision|0|||
127715444|NCT03593226|459586129|FG000|Overall Study|Clinical disease progression|0|||
127715445|NCT03593226|459586130|FG001|Overall Study|Clinical disease progression|0|||
127715446|NCT03593226|459586131|FG002|Overall Study|Clinical disease progression|1|||
127715447|NCT03593226|459586132|FG003|Overall Study|Clinical disease progression|0|||
127715448|NCT04517435|459586133|FG000|Overall Study|Withdrawal by Subject|0|||
127715449|NCT04517435|459586134|FG001|Overall Study|Withdrawal by Subject|0|||
127715450|NCT04517435|459586135|FG002|Overall Study|Withdrawal by Subject|1|||
127715451|NCT04517435|459586133|FG000|Overall Study|Pharmaceutical company discontinued the trial|3|||
127715452|NCT04517435|459586134|FG001|Overall Study|Pharmaceutical company discontinued the trial|6|||
127715453|NCT04517435|459586135|FG002|Overall Study|Pharmaceutical company discontinued the trial|3|||
127715454|NCT03789110|459586136|FG000|Overall Study|Adverse Event|2|||
127715455|NCT03789110|459586136|FG000|Overall Study|Physician Decision|1|||
127715456|NCT03789110|459586136|FG000|Overall Study|Withdrawal by Subject|2|||
127715457|NCT03789110|459586136|FG000|Overall Study|Lack of Efficacy|22|||
127715458|NCT03789110|459586136|FG000|Overall Study|still on treatment|3|||
127715459|NCT03170349|459586138|FG000|From Implant to the 30-Day Visit|Death|1|||
127715460|NCT03170349|459586138|FG000|From 30-Day to 6-Month Visit|Death|3|||
127715461|NCT03170349|459586138|FG000|From 30-Day to 6-Month Visit|Withdrawal by Subject|1|||
127715462|NCT03170349|459586138|FG000|From 30-Day to 6-Month Visit|Exited for Other Reasons|5|||
127715463|NCT03170349|459586138|FG000|From 6-Month to 1-Year Visit|Death|6|||
127715464|NCT03170349|459586138|FG000|From 6-Month to 1-Year Visit|Exited for Other Reasons|2|||
127715465|NCT03170349|459586138|FG000|From 1-Year to 2-Year Visit|Death|13|||
127715466|NCT03170349|459586138|FG000|From 1-Year to 2-Year Visit|Withdrawal by Subject|1|||
127715467|NCT03170349|459586138|FG000|From 1-Year to 2-Year Visit|Missed Visit|4|||
127715468|NCT03170349|459586138|FG000|From 2-Year to 3-Year Visit|Death|10|||
127715469|NCT03170349|459586138|FG000|From 2-Year to 3-Year Visit|Lost to Follow-up|2|||
127715470|NCT03170349|459586138|FG000|From 2-Year to 3-Year Visit|Withdrawal by Subject|2|||
127715471|NCT03170349|459586138|FG000|From 2-Year to 3-Year Visit|Missed Visit|1|||
127715472|NCT03516942|459586139|FG000|Registration Through Baseline Survey Com|Withdrawal by Subject|36|||
127715473|NCT03516942|459586139|FG000|Registration Through Baseline Survey Com|Death|8|||
127715474|NCT03516942|459586139|FG000|Registration Through Baseline Survey Com|Could not contact patient after enrollment|58|||
127715475|NCT03516942|459586139|FG000|T0: Baseline|LOST|13|||
127715476|NCT03516942|459586139|FG000|T1: 3 Months Survey|Withdrawal by Subject|13|||
127715477|NCT03516942|459586139|FG000|T1: 3 Months Survey|Death|10|||
127715478|NCT03516942|459586139|FG000|T1: 3 Months Survey|Lost|163|||
127715479|NCT03516942|459586139|FG000|T2: 6 Month Survey|Withdrawal by Subject|15|||
127715480|NCT03516942|459586139|FG000|T2: 6 Month Survey|Death|14|||
127715481|NCT03516942|459586139|FG000|T2: 6 Month Survey|Lost|180|||
127715482|NCT03516942|459586139|FG000|T3: 12 Month Survey|Withdrawal by Subject|15|||
127715483|NCT03516942|459586139|FG000|T3: 12 Month Survey|Death|19|||
127715484|NCT03516942|459586139|FG000|T3: 12 Month Survey|Lost|209|||
127715485|NCT00065182|459587263|FG000|Overall Study|Adverse Event|24|||
127715486|NCT00065182|459587264|FG001|Overall Study|Adverse Event|17|||
127715487|NCT00065182|459587263|FG000|Overall Study|Lost to Follow-up|0|||
127715488|NCT00065182|459587264|FG001|Overall Study|Lost to Follow-up|4|||
127715489|NCT00065182|459587263|FG000|Overall Study|Protocol Violation|3|||
127715490|NCT00065182|459587264|FG001|Overall Study|Protocol Violation|4|||
127715491|NCT00065182|459587263|FG000|Overall Study|Serious adverse events (SAE)|1|||
127715492|NCT00065182|459587264|FG001|Overall Study|Serious adverse events (SAE)|0|||
127715493|NCT00065182|459587263|FG000|Overall Study|Sponsor Decision|11|||
127715494|NCT00065182|459587264|FG001|Overall Study|Sponsor Decision|7|||
127715495|NCT00065182|459587263|FG000|Overall Study|Withdrawal by Subject|8|||
127715496|NCT00065182|459587264|FG001|Overall Study|Withdrawal by Subject|3|||
127715497|NCT00065182|459587263|FG000|Overall Study|No clinical benefit|1|||
127715498|NCT00065182|459587264|FG001|Overall Study|No clinical benefit|0|||
127715499|NCT00065182|459587263|FG000|Overall Study|Death|0|||
127715500|NCT00065182|459587264|FG001|Overall Study|Death|1|||
127715501|NCT00065182|459587263|FG000|Overall Study|Decline in Status|0|||
127715502|NCT00065182|459587264|FG001|Overall Study|Decline in Status|1|||
127715503|NCT00754325|459587265|FG000|Initial Treatment|Continuing Active Treatment|4|||
127715504|NCT00754325|459587266|FG001|Initial Treatment|Continuing Active Treatment|5|||
127715505|NCT00754325|459587265|FG000|Initial Treatment|Adverse Event|7|||
127802182|NCT00059202|459898779|FG000|Overall Study|drug toxicity|0|||
127802183|NCT00059202|459898780|FG001|Overall Study|drug toxicity|3|||
127802184|NCT02658448|459898784|FG000|Overall Study|Lost to Follow-up|1|||
127802185|NCT00584194|459898785|FG000|Overall Study|Other|135|||
127715506|NCT00754325|459587266|FG001|Initial Treatment|Adverse Event|6|||
127715507|NCT00754325|459587265|FG000|Initial Treatment|Withdrawal by Subject|2|||
127715508|NCT00754325|459587266|FG001|Initial Treatment|Withdrawal by Subject|2|||
127715509|NCT00754325|459587265|FG000|Initial Treatment|Physician Decision|2|||
127715510|NCT00754325|459587266|FG001|Initial Treatment|Physician Decision|0|||
127802186|NCT00927368|459898786|FG000|Overall Study|enrollment in another study|1|||
127802187|NCT00927368|459898787|FG001|Overall Study|enrollment in another study|1|||
127715511|NCT00754325|459587265|FG000|Initial Treatment|Sponsor Request|0|||
127715512|NCT00754325|459587266|FG001|Initial Treatment|Sponsor Request|1|||
127715513|NCT00754325|459587265|FG000|Initial Treatment|Disease Progression|35|||
127715514|NCT00754325|459587266|FG001|Initial Treatment|Disease Progression|35|||
127715515|NCT04876417|459587269|FG000|Overall Study|Lost to Follow-up|5|||
127802188|NCT00927368|459898788|FG002|Overall Study|enrollment in another study|2|||
127715516|NCT04876417|459587270|FG001|Overall Study|Lost to Follow-up|8|||
127715517|NCT04876417|459587271|FG002|Overall Study|Lost to Follow-up|0|||
127715518|NCT04876417|459587272|FG003|Overall Study|Lost to Follow-up|0|||
127715519|NCT03801148|459587273|FG000|Period 1 (2 Days)|Adverse Event|1|||
127715520|NCT03801148|459587274|FG001|Period 1 (2 Days)|Adverse Event|1|||
127715521|NCT03801148|459587275|FG002|Period 1 (2 Days)|Adverse Event|0|||
127715522|NCT03801148|459587276|FG003|Period 1 (2 Days)|Adverse Event|0|||
127715523|NCT03801148|459587273|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
127715524|NCT03801148|459587274|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
127715525|NCT03801148|459587275|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
127715526|NCT03801148|459587276|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
127715527|NCT03801148|459587273|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
127715528|NCT03801148|459587274|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
127715529|NCT03801148|459587275|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
127715530|NCT03801148|459587276|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
127715531|NCT03801148|459587273|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
127715532|NCT03801148|459587274|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
127715533|NCT03801148|459587275|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
127715534|NCT03801148|459587276|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
127715535|NCT00439270|459587279|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
127715536|NCT00439270|459587280|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
127715537|NCT00439270|459587281|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
127715538|NCT00439270|459587282|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
127715539|NCT00439270|459587283|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
127715540|NCT00439270|459587279|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
127715541|NCT00439270|459587280|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
127715542|NCT00439270|459587281|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
127715543|NCT00439270|459587282|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
127715544|NCT00439270|459587283|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
127715545|NCT00439270|459587279|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
127715546|NCT00439270|459587280|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
127715547|NCT00439270|459587281|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
127715548|NCT00439270|459587282|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
127715549|NCT00439270|459587283|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
127715550|NCT00439270|459587279|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
127715551|NCT00439270|459587280|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
127715552|NCT00439270|459587281|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
127715553|NCT00439270|459587282|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
127715554|NCT00439270|459587283|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
127715555|NCT00439270|459587279|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
127715556|NCT00439270|459587280|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
127715557|NCT00439270|459587281|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
127715558|NCT00439270|459587282|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
127715559|NCT00439270|459587283|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
127715560|NCT00439270|459587279|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
127715561|NCT00439270|459587280|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
127715562|NCT00439270|459587281|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
127715563|NCT00439270|459587282|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
127715564|NCT00439270|459587283|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
127715565|NCT00439270|459587279|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
127715566|NCT00439270|459587280|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
127715567|NCT00439270|459587281|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
127715568|NCT00439270|459587282|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
127715569|NCT00439270|459587283|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
127715570|NCT00439270|459587279|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
127715571|NCT00439270|459587280|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
127715572|NCT00439270|459587281|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
127715573|NCT00439270|459587282|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
127715574|NCT00439270|459587283|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
127715575|NCT00439270|459587279|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
127715576|NCT00439270|459587280|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
127715577|NCT00439270|459587281|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
127715578|NCT00439270|459587282|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
127715579|NCT00439270|459587283|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
127715580|NCT00439270|459587279|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
127715581|NCT00439270|459587280|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
127715582|NCT00439270|459587281|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
127715583|NCT00439270|459587282|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
127715584|NCT00439270|459587283|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
127802189|NCT00927368|459898786|FG000|Overall Study|Lost to Follow-up|4|||
127715585|NCT01750684|459587286|FG000|Overall Study|Death|1|||
127715586|NCT01750684|459587287|FG001|Overall Study|Death|0|||
127715587|NCT01750684|459587286|FG000|Overall Study|Non-compliance with Study Drug|0|||
127715588|NCT01750684|459587287|FG001|Overall Study|Non-compliance with Study Drug|1|||
127715589|NCT01750684|459587286|FG000|Overall Study|Withdrawn by Sponsor|0|||
127715590|NCT01750684|459587287|FG001|Overall Study|Withdrawn by Sponsor|1|||
127715591|NCT01750684|459587286|FG000|Overall Study|Protocol Violation|1|||
127715592|NCT01750684|459587287|FG001|Overall Study|Protocol Violation|0|||
127715593|NCT02185794|459587289|FG000|Overall Study|Enrolled but Never Dosed|1|||
127715594|NCT02185794|459587290|FG001|Overall Study|Enrolled but Never Dosed|6|||
127715595|NCT02185794|459587291|FG002|Overall Study|Enrolled but Never Dosed|3|||
127715596|NCT02185794|459587292|FG003|Overall Study|Enrolled but Never Dosed|1|||
127715597|NCT02185794|459587293|FG004|Overall Study|Enrolled but Never Dosed|1|||
127715598|NCT02185794|459587294|FG005|Overall Study|Enrolled but Never Dosed|0|||
127715599|NCT02185794|459587289|FG000|Overall Study|Investigator's Discretion|1|||
127715600|NCT02185794|459587290|FG001|Overall Study|Investigator's Discretion|0|||
127715601|NCT02185794|459587291|FG002|Overall Study|Investigator's Discretion|1|||
127715602|NCT02185794|459587292|FG003|Overall Study|Investigator's Discretion|2|||
127715603|NCT02185794|459587293|FG004|Overall Study|Investigator's Discretion|2|||
127715604|NCT02185794|459587294|FG005|Overall Study|Investigator's Discretion|15|||
127715605|NCT02185794|459587289|FG000|Overall Study|Withdrew Consent|2|||
127715606|NCT02185794|459587290|FG001|Overall Study|Withdrew Consent|5|||
127715607|NCT02185794|459587291|FG002|Overall Study|Withdrew Consent|10|||
127715608|NCT02185794|459587292|FG003|Overall Study|Withdrew Consent|2|||
127715609|NCT02185794|459587293|FG004|Overall Study|Withdrew Consent|0|||
127715610|NCT02185794|459587294|FG005|Overall Study|Withdrew Consent|0|||
127715611|NCT02185794|459587289|FG000|Overall Study|Lost to Follow-up|1|||
127715612|NCT02185794|459587290|FG001|Overall Study|Lost to Follow-up|2|||
127715613|NCT02185794|459587291|FG002|Overall Study|Lost to Follow-up|2|||
127715614|NCT02185794|459587292|FG003|Overall Study|Lost to Follow-up|3|||
127715615|NCT02185794|459587293|FG004|Overall Study|Lost to Follow-up|0|||
127715616|NCT02185794|459587294|FG005|Overall Study|Lost to Follow-up|1|||
127715617|NCT01092416|459587295|FG000|Enrollment|Atherectomy device not inserted|3|||
127715618|NCT01092416|459587295|FG000|30-Day Follow-up|Death|2|||
127715619|NCT01092416|459587295|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
127715620|NCT01092416|459587295|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
127715621|NCT01092416|459587295|FG000|12-Month Follow-up|Death|16|||
127715622|NCT01092416|459587295|FG000|12-Month Follow-up|Lost to Follow-up|4|||
127715623|NCT01092416|459587295|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
127715624|NCT01092416|459587295|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
127715625|NCT01092416|459587295|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
127715626|NCT00366249|459587296|FG000|Overall Study|Adverse Event|53|||
127715627|NCT00366249|459587297|FG001|Overall Study|Adverse Event|28|||
127715628|NCT00366249|459587296|FG000|Overall Study|Death|0|||
127715629|NCT00366249|459587297|FG001|Overall Study|Death|1|||
127715630|NCT00366249|459587296|FG000|Overall Study|Physician Decision|5|||
127715631|NCT00366249|459587297|FG001|Overall Study|Physician Decision|2|||
127715632|NCT00366249|459587296|FG000|Overall Study|Lost to Follow-up|2|||
127715633|NCT00366249|459587297|FG001|Overall Study|Lost to Follow-up|0|||
127715634|NCT00366249|459587296|FG000|Overall Study|Protocol Violation|1|||
127715635|NCT00366249|459587297|FG001|Overall Study|Protocol Violation|2|||
127715636|NCT00366249|459587296|FG000|Overall Study|Withdrawal by Subject|18|||
127715637|NCT00366249|459587297|FG001|Overall Study|Withdrawal by Subject|4|||
127715638|NCT00366249|459587296|FG000|Overall Study|Lack of Efficacy|21|||
127715639|NCT00366249|459587297|FG001|Overall Study|Lack of Efficacy|21|||
127715640|NCT00366249|459587296|FG000|Overall Study|Most due to osteomylitis status|31|||
127715641|NCT00366249|459587297|FG001|Overall Study|Most due to osteomylitis status|20|||
127715642|NCT00777049|459587298|FG000|Overall Study|Withdrawal by Subject|1|||
127715643|NCT00777049|459587299|FG001|Overall Study|Withdrawal by Subject|0|||
127715644|NCT00777049|459587298|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
127715645|NCT00777049|459587299|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
127715646|NCT01185600|459587300|FG000|Overall Study|Adverse Event|1|||
127715647|NCT01185600|459587301|FG001|Overall Study|Adverse Event|1|||
127715648|NCT01185600|459587300|FG000|Overall Study|Death|0|||
127715649|NCT01185600|459587301|FG001|Overall Study|Death|1|||
127715650|NCT01185600|459587300|FG000|Overall Study|Lost to Follow-up|0|||
127715651|NCT01185600|459587301|FG001|Overall Study|Lost to Follow-up|5|||
127715652|NCT01185600|459587300|FG000|Overall Study|Physician Decision|29|||
127715653|NCT01185600|459587301|FG001|Overall Study|Physician Decision|35|||
127715654|NCT01185600|459587300|FG000|Overall Study|Withdrawal by Subject|1|||
127715655|NCT01185600|459587301|FG001|Overall Study|Withdrawal by Subject|1|||
127715656|NCT01185600|459587300|FG000|Overall Study|Hold by DSMB|1|||
127715657|NCT01185600|459587301|FG001|Overall Study|Hold by DSMB|2|||
127715658|NCT00739934|459587302|FG000|Voriconazole IV|Adverse Event|6|||
127715659|NCT00739934|459587302|FG000|Voriconazole Oral|Other|3|||
127715660|NCT03577106|459587303|FG000|Overall Study|Withdrawal by Subject|3|||
127715661|NCT01342367|459587306|FG000|Overall Study|Death|1|||
127715662|NCT01342367|459587307|FG001|Overall Study|Death|0|||
127715663|NCT01342367|459587306|FG000|Overall Study|Withdrawal by Subject|1|||
127802190|NCT00927368|459898787|FG001|Overall Study|Lost to Follow-up|0|||
127802191|NCT00927368|459898788|FG002|Overall Study|Lost to Follow-up|0|||
127802192|NCT00927368|459898786|FG000|Overall Study|equipment failure|1|||
127802193|NCT00927368|459898787|FG001|Overall Study|equipment failure|0|||
127715664|NCT01342367|459587307|FG001|Overall Study|Withdrawal by Subject|2|||
127715665|NCT00640159|459587308|FG000|Overall Study|Lost to Follow-up|2|||
127715666|NCT01500200|459587309|FG000|Stage 1|Adverse Event|1|||
127715667|NCT01500200|459587310|FG001|Stage 1|Adverse Event|4|||
127715668|NCT01500200|459587311|FG002|Stage 1|Adverse Event|5|||
127715669|NCT01500200|459587312|FG003|Stage 1|Adverse Event|0|||
127715670|NCT01500200|459587313|FG004|Stage 1|Adverse Event|0|||
127715671|NCT01500200|459587314|FG005|Stage 1|Adverse Event|0|||
127715672|NCT01500200|459587309|FG000|Stage 1|Lost to Follow-up|2|||
127715673|NCT01500200|459587310|FG001|Stage 1|Lost to Follow-up|2|||
127715674|NCT01500200|459587311|FG002|Stage 1|Lost to Follow-up|1|||
127715675|NCT01500200|459587312|FG003|Stage 1|Lost to Follow-up|0|||
127715676|NCT01500200|459587313|FG004|Stage 1|Lost to Follow-up|0|||
127715677|NCT01500200|459587314|FG005|Stage 1|Lost to Follow-up|0|||
127715678|NCT01500200|459587309|FG000|Stage 1|Withdrawal by Subject|3|||
127715679|NCT01500200|459587310|FG001|Stage 1|Withdrawal by Subject|0|||
127715680|NCT01500200|459587311|FG002|Stage 1|Withdrawal by Subject|0|||
127715681|NCT01500200|459587312|FG003|Stage 1|Withdrawal by Subject|0|||
127715682|NCT01500200|459587313|FG004|Stage 1|Withdrawal by Subject|0|||
127715683|NCT01500200|459587314|FG005|Stage 1|Withdrawal by Subject|0|||
127715684|NCT01500200|459587309|FG000|Stage 1|Noncompliance with Study Drug|1|||
127715685|NCT01500200|459587310|FG001|Stage 1|Noncompliance with Study Drug|0|||
127715686|NCT01500200|459587311|FG002|Stage 1|Noncompliance with Study Drug|0|||
127715687|NCT01500200|459587312|FG003|Stage 1|Noncompliance with Study Drug|0|||
127715688|NCT01500200|459587313|FG004|Stage 1|Noncompliance with Study Drug|0|||
127715689|NCT01500200|459587314|FG005|Stage 1|Noncompliance with Study Drug|0|||
127715690|NCT01500200|459587309|FG000|Stage 1|Physician Decision|1|||
127715691|NCT01500200|459587310|FG001|Stage 1|Physician Decision|0|||
127715692|NCT01500200|459587311|FG002|Stage 1|Physician Decision|0|||
127715693|NCT01500200|459587312|FG003|Stage 1|Physician Decision|0|||
127715694|NCT01500200|459587313|FG004|Stage 1|Physician Decision|0|||
127715695|NCT01500200|459587314|FG005|Stage 1|Physician Decision|0|||
127715696|NCT01500200|459587309|FG000|Stage 2|Adverse Event|0|||
127715697|NCT01500200|459587310|FG001|Stage 2|Adverse Event|0|||
127715698|NCT01500200|459587311|FG002|Stage 2|Adverse Event|0|||
127715699|NCT01500200|459587312|FG003|Stage 2|Adverse Event|0|||
127715700|NCT01500200|459587313|FG004|Stage 2|Adverse Event|5|||
127715701|NCT01500200|459587314|FG005|Stage 2|Adverse Event|4|||
127715702|NCT04860505|459587315|FG000|Overall Study|Lost to Follow-up|2|||
127715703|NCT03066609|459587318|FG000|INDUCTION|Pregnancy|0|||
127715704|NCT03066609|459587319|FG001|INDUCTION|Pregnancy|0|||
127715705|NCT03066609|459587320|FG002|INDUCTION|Pregnancy|1|||
127715706|NCT03066609|459587321|FG003|INDUCTION|Pregnancy|0|||
127715707|NCT03066609|459587318|FG000|INDUCTION|Lack of Efficacy|0|||
127715708|NCT03066609|459587319|FG001|INDUCTION|Lack of Efficacy|0|||
127715709|NCT03066609|459587320|FG002|INDUCTION|Lack of Efficacy|1|||
127715710|NCT03066609|459587321|FG003|INDUCTION|Lack of Efficacy|0|||
127715711|NCT03066609|459587318|FG000|INDUCTION|Adverse Event|2|||
127715712|NCT03066609|459587319|FG001|INDUCTION|Adverse Event|2|||
127715713|NCT03066609|459587320|FG002|INDUCTION|Adverse Event|0|||
127715714|NCT03066609|459587321|FG003|INDUCTION|Adverse Event|0|||
127715715|NCT03066609|459587318|FG000|MAINTENANCE|Adverse Event|0|||
127715716|NCT03066609|459587319|FG001|MAINTENANCE|Adverse Event|0|||
127715717|NCT03066609|459587320|FG002|MAINTENANCE|Adverse Event|0|||
127715718|NCT03066609|459587321|FG003|MAINTENANCE|Adverse Event|1|||
127715719|NCT03066609|459587318|FG000|MAINTENANCE|Withdrawal by Subject|4|||
127715720|NCT03066609|459587319|FG001|MAINTENANCE|Withdrawal by Subject|2|||
127715721|NCT03066609|459587320|FG002|MAINTENANCE|Withdrawal by Subject|1|||
127715722|NCT03066609|459587321|FG003|MAINTENANCE|Withdrawal by Subject|1|||
127715723|NCT03066609|459587318|FG000|MAINTENANCE|Lost to Follow-up|0|||
127802194|NCT00927368|459898788|FG002|Overall Study|equipment failure|0|||
127802195|NCT00927368|459898786|FG000|Overall Study|ineligible post randomization|0|||
127715724|NCT03066609|459587319|FG001|MAINTENANCE|Lost to Follow-up|1|||
127715725|NCT03066609|459587320|FG002|MAINTENANCE|Lost to Follow-up|1|||
127715726|NCT03066609|459587321|FG003|MAINTENANCE|Lost to Follow-up|0|||
127802196|NCT00927368|459898787|FG001|Overall Study|ineligible post randomization|3|||
127802197|NCT00927368|459898788|FG002|Overall Study|ineligible post randomization|1|||
127802198|NCT00927368|459898786|FG000|Overall Study|cancellation of surgery|0|||
127715727|NCT03066609|459587318|FG000|MAINTENANCE|Pregnancy|1|||
127715728|NCT03066609|459587319|FG001|MAINTENANCE|Pregnancy|0|||
127715729|NCT03066609|459587320|FG002|MAINTENANCE|Pregnancy|0|||
127715730|NCT03066609|459587321|FG003|MAINTENANCE|Pregnancy|0|||
127715731|NCT03066609|459587318|FG000|MAINTENANCE|Lack of Efficacy|2|||
127715732|NCT03066609|459587319|FG001|MAINTENANCE|Lack of Efficacy|1|||
127715733|NCT03066609|459587320|FG002|MAINTENANCE|Lack of Efficacy|0|||
127715734|NCT03066609|459587321|FG003|MAINTENANCE|Lack of Efficacy|1|||
127715735|NCT03066609|459587318|FG000|OVERALL STUDY|Adverse Event|2|||
127715736|NCT03066609|459587319|FG001|OVERALL STUDY|Adverse Event|2|||
127715737|NCT03066609|459587320|FG002|OVERALL STUDY|Adverse Event|0|||
127715738|NCT03066609|459587321|FG003|OVERALL STUDY|Adverse Event|1|||
127715739|NCT03066609|459587318|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
127715740|NCT03066609|459587319|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
127715741|NCT03066609|459587320|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
127715742|NCT03066609|459587321|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
127715743|NCT03066609|459587318|FG000|OVERALL STUDY|Lost to Follow-up|1|||
127715744|NCT03066609|459587319|FG001|OVERALL STUDY|Lost to Follow-up|1|||
127715745|NCT03066609|459587320|FG002|OVERALL STUDY|Lost to Follow-up|1|||
127715746|NCT03066609|459587321|FG003|OVERALL STUDY|Lost to Follow-up|1|||
127715747|NCT03066609|459587318|FG000|OVERALL STUDY|Pregnancy|1|||
127715748|NCT03066609|459587319|FG001|OVERALL STUDY|Pregnancy|0|||
127715749|NCT03066609|459587320|FG002|OVERALL STUDY|Pregnancy|1|||
127715750|NCT03066609|459587321|FG003|OVERALL STUDY|Pregnancy|0|||
127715751|NCT03066609|459587318|FG000|OVERALL STUDY|Lack of Efficacy|2|||
127715752|NCT03066609|459587319|FG001|OVERALL STUDY|Lack of Efficacy|1|||
127715753|NCT03066609|459587320|FG002|OVERALL STUDY|Lack of Efficacy|1|||
127715754|NCT03066609|459587321|FG003|OVERALL STUDY|Lack of Efficacy|1|||
127715755|NCT03066609|459587318|FG000|OVERALL STUDY|discontinued follow up|0|||
127715756|NCT03066609|459587319|FG001|OVERALL STUDY|discontinued follow up|2|||
127715757|NCT03066609|459587320|FG002|OVERALL STUDY|discontinued follow up|0|||
127715758|NCT03066609|459587321|FG003|OVERALL STUDY|discontinued follow up|0|||
127715759|NCT00523419|459587324|FG000|Overall Study|Adverse Event|1|||
127715760|NCT00523419|459587324|FG000|Overall Study|Withdrawal by Subject|1|||
127715761|NCT00523419|459587324|FG000|Overall Study|Physician Decision|2|||
127715762|NCT00523419|459587324|FG000|Overall Study|Progressive Disease|22|||
127715763|NCT00523419|459587324|FG000|Overall Study|Death due to Study Disease|4|||
127715764|NCT00523419|459587324|FG000|Overall Study|Death due to Adverse Event|2|||
127715765|NCT01218009|459587325|FG000|Overall Study|Protocol Violation|2|||
127715766|NCT01218009|459587326|FG001|Overall Study|Protocol Violation|1|||
127715767|NCT01218009|459587325|FG000|Overall Study|Withdrawal by Subject|3|||
127715768|NCT01218009|459587326|FG001|Overall Study|Withdrawal by Subject|1|||
127715769|NCT01218009|459587325|FG000|Overall Study|Sponsor terminated study|161|||
127715770|NCT01218009|459587326|FG001|Overall Study|Sponsor terminated study|163|||
127715771|NCT03170882|459587327|FG000|Overall Study|Death|17|||
127715772|NCT03170882|459587328|FG001|Overall Study|Death|29|||
127715773|NCT03170882|459587327|FG000|Overall Study|Lost to Follow-up|0|||
127715774|NCT03170882|459587328|FG001|Overall Study|Lost to Follow-up|1|||
127715775|NCT03170882|459587327|FG000|Overall Study|Withdrawal by Subject|4|||
127715776|NCT03170882|459587328|FG001|Overall Study|Withdrawal by Subject|7|||
127715777|NCT03170882|459587327|FG000|Overall Study|Reason not Specified|28|||
127715778|NCT03170882|459587328|FG001|Overall Study|Reason not Specified|36|||
127715779|NCT00622700|459587329|FG000|Core Treatment Period|Randomized but Not Treated|0|||
127715780|NCT00622700|459587330|FG001|Core Treatment Period|Randomized but Not Treated|2|||
127715781|NCT00622700|459587331|FG002|Core Treatment Period|Randomized but Not Treated|2|||
127715782|NCT00622700|459587332|FG003|Core Treatment Period|Randomized but Not Treated|0|||
127715783|NCT00622700|459587333|FG004|Core Treatment Period|Randomized but Not Treated|0|||
127715784|NCT00622700|459587334|FG005|Core Treatment Period|Randomized but Not Treated|0|||
127715785|NCT00622700|459587335|FG006|Core Treatment Period|Randomized but Not Treated|0|||
127715786|NCT00622700|459587329|FG000|Core Treatment Period|Adverse Event|18|||
127715787|NCT00622700|459587330|FG001|Core Treatment Period|Adverse Event|25|||
127715788|NCT00622700|459587331|FG002|Core Treatment Period|Adverse Event|18|||
127715789|NCT00622700|459587332|FG003|Core Treatment Period|Adverse Event|0|||
127715790|NCT00622700|459587333|FG004|Core Treatment Period|Adverse Event|0|||
127715791|NCT00622700|459587334|FG005|Core Treatment Period|Adverse Event|0|||
127715792|NCT00622700|459587335|FG006|Core Treatment Period|Adverse Event|0|||
127715793|NCT00622700|459587329|FG000|Core Treatment Period|Lack of Efficacy|19|||
127715794|NCT00622700|459587330|FG001|Core Treatment Period|Lack of Efficacy|6|||
127715795|NCT00622700|459587331|FG002|Core Treatment Period|Lack of Efficacy|12|||
127715796|NCT00622700|459587332|FG003|Core Treatment Period|Lack of Efficacy|0|||
127715797|NCT00622700|459587333|FG004|Core Treatment Period|Lack of Efficacy|0|||
127715798|NCT00622700|459587334|FG005|Core Treatment Period|Lack of Efficacy|0|||
127715799|NCT00622700|459587335|FG006|Core Treatment Period|Lack of Efficacy|0|||
127715800|NCT00622700|459587329|FG000|Core Treatment Period|Lost to Follow-up|1|||
127715801|NCT00622700|459587330|FG001|Core Treatment Period|Lost to Follow-up|1|||
127715802|NCT00622700|459587331|FG002|Core Treatment Period|Lost to Follow-up|1|||
127715803|NCT00622700|459587332|FG003|Core Treatment Period|Lost to Follow-up|0|||
127715804|NCT00622700|459587333|FG004|Core Treatment Period|Lost to Follow-up|0|||
127715805|NCT00622700|459587334|FG005|Core Treatment Period|Lost to Follow-up|0|||
127715806|NCT00622700|459587335|FG006|Core Treatment Period|Lost to Follow-up|0|||
127715807|NCT00622700|459587329|FG000|Core Treatment Period|Death|1|||
127715808|NCT00622700|459587330|FG001|Core Treatment Period|Death|0|||
127715809|NCT00622700|459587331|FG002|Core Treatment Period|Death|0|||
127715810|NCT00622700|459587332|FG003|Core Treatment Period|Death|0|||
127715811|NCT00622700|459587333|FG004|Core Treatment Period|Death|0|||
127715812|NCT00622700|459587334|FG005|Core Treatment Period|Death|0|||
127715813|NCT00622700|459587335|FG006|Core Treatment Period|Death|0|||
127715814|NCT00622700|459587329|FG000|Core Treatment Period|Progressive Disease|3|||
127715815|NCT00622700|459587330|FG001|Core Treatment Period|Progressive Disease|1|||
127715816|NCT00622700|459587331|FG002|Core Treatment Period|Progressive Disease|0|||
127715817|NCT00622700|459587332|FG003|Core Treatment Period|Progressive Disease|0|||
127715818|NCT00622700|459587333|FG004|Core Treatment Period|Progressive Disease|0|||
127715819|NCT00622700|459587334|FG005|Core Treatment Period|Progressive Disease|0|||
127802199|NCT00927368|459898787|FG001|Overall Study|cancellation of surgery|1|||
127802200|NCT00927368|459898788|FG002|Overall Study|cancellation of surgery|2|||
127802201|NCT02624492|459898789|FG000|Overall Study|Adverse Event|2|||
127802202|NCT02624492|459898790|FG001|Overall Study|Adverse Event|2|||
127802203|NCT02624492|459898791|FG002|Overall Study|Adverse Event|2|||
127802204|NCT02624492|459898789|FG000|Overall Study|Progressive disease|0|||
127802205|NCT02624492|459898790|FG001|Overall Study|Progressive disease|2|||
127802206|NCT02624492|459898791|FG002|Overall Study|Progressive disease|3|||
127802207|NCT00331409|459898795|FG000|Overall Study|Lack of Efficacy|4|||
127802208|NCT02239263|459898799|FG000|Overall Study|Protocol Violation|6|||
127802209|NCT04276207|459898801|FG000|Period 1|Withdrawal by Subject|0|||
127802210|NCT04276207|459898802|FG001|Period 1|Withdrawal by Subject|1|||
127802211|NCT01463098|459898803|FG000|Part A (11 Days)|Participant Choice|2|||
127802212|NCT01463098|459898804|FG001|Part A (11 Days)|Participant Choice|0|||
127802213|NCT01463098|459898805|FG002|Part A (11 Days)|Participant Choice|0|||
127802214|NCT01463098|459898806|FG003|Part A (11 Days)|Participant Choice|0|||
127715820|NCT00622700|459587335|FG006|Core Treatment Period|Progressive Disease|0|||
127715821|NCT00622700|459587329|FG000|Core Treatment Period|Withdrawal by Subject|12|||
127715822|NCT00622700|459587330|FG001|Core Treatment Period|Withdrawal by Subject|18|||
127715823|NCT00622700|459587331|FG002|Core Treatment Period|Withdrawal by Subject|15|||
127715824|NCT00622700|459587332|FG003|Core Treatment Period|Withdrawal by Subject|0|||
127715825|NCT00622700|459587333|FG004|Core Treatment Period|Withdrawal by Subject|0|||
127715826|NCT00622700|459587334|FG005|Core Treatment Period|Withdrawal by Subject|0|||
127715827|NCT00622700|459587335|FG006|Core Treatment Period|Withdrawal by Subject|0|||
127715828|NCT00622700|459587329|FG000|Core Treatment Period|Other than specified above|2|||
127715829|NCT00622700|459587330|FG001|Core Treatment Period|Other than specified above|2|||
127715830|NCT00622700|459587331|FG002|Core Treatment Period|Other than specified above|5|||
127715831|NCT00622700|459587332|FG003|Core Treatment Period|Other than specified above|0|||
127715832|NCT00622700|459587333|FG004|Core Treatment Period|Other than specified above|0|||
127715833|NCT00622700|459587334|FG005|Core Treatment Period|Other than specified above|0|||
127715834|NCT00622700|459587335|FG006|Core Treatment Period|Other than specified above|0|||
127715835|NCT00622700|459587329|FG000|Extension Treatment Period|Adverse Event|0|||
127715836|NCT00622700|459587330|FG001|Extension Treatment Period|Adverse Event|0|||
127715837|NCT00622700|459587331|FG002|Extension Treatment Period|Adverse Event|0|||
127715838|NCT00622700|459587332|FG003|Extension Treatment Period|Adverse Event|5|||
127715839|NCT00622700|459587333|FG004|Extension Treatment Period|Adverse Event|9|||
127715840|NCT00622700|459587334|FG005|Extension Treatment Period|Adverse Event|6|||
127715841|NCT00622700|459587335|FG006|Extension Treatment Period|Adverse Event|8|||
127715842|NCT00622700|459587329|FG000|Extension Treatment Period|Lack of Efficacy|0|||
127715843|NCT00622700|459587330|FG001|Extension Treatment Period|Lack of Efficacy|0|||
127715844|NCT00622700|459587331|FG002|Extension Treatment Period|Lack of Efficacy|0|||
127715845|NCT00622700|459587332|FG003|Extension Treatment Period|Lack of Efficacy|2|||
127715846|NCT00622700|459587333|FG004|Extension Treatment Period|Lack of Efficacy|8|||
127715847|NCT00622700|459587334|FG005|Extension Treatment Period|Lack of Efficacy|1|||
127715848|NCT00622700|459587335|FG006|Extension Treatment Period|Lack of Efficacy|9|||
127715849|NCT00622700|459587329|FG000|Extension Treatment Period|Protocol Violation|0|||
127715850|NCT00622700|459587330|FG001|Extension Treatment Period|Protocol Violation|0|||
127715851|NCT00622700|459587331|FG002|Extension Treatment Period|Protocol Violation|0|||
127715852|NCT00622700|459587332|FG003|Extension Treatment Period|Protocol Violation|0|||
127715853|NCT00622700|459587333|FG004|Extension Treatment Period|Protocol Violation|0|||
127715854|NCT00622700|459587334|FG005|Extension Treatment Period|Protocol Violation|2|||
127715855|NCT00622700|459587335|FG006|Extension Treatment Period|Protocol Violation|0|||
127715856|NCT00622700|459587329|FG000|Extension Treatment Period|Lost to Follow-up|0|||
127715857|NCT00622700|459587330|FG001|Extension Treatment Period|Lost to Follow-up|0|||
127715858|NCT00622700|459587331|FG002|Extension Treatment Period|Lost to Follow-up|0|||
127715859|NCT00622700|459587332|FG003|Extension Treatment Period|Lost to Follow-up|0|||
127802215|NCT01463098|459898807|FG004|Part A (11 Days)|Participant Choice|0|||
127802216|NCT01463098|459898808|FG005|Part A (11 Days)|Participant Choice|0|||
127802217|NCT01463098|459898809|FG006|Part A (11 Days)|Participant Choice|0|||
127802218|NCT01463098|459898810|FG007|Part A (11 Days)|Participant Choice|0|||
127715860|NCT00622700|459587333|FG004|Extension Treatment Period|Lost to Follow-up|1|||
127715861|NCT00622700|459587334|FG005|Extension Treatment Period|Lost to Follow-up|0|||
127715862|NCT00622700|459587335|FG006|Extension Treatment Period|Lost to Follow-up|0|||
127715863|NCT00622700|459587329|FG000|Extension Treatment Period|Progressive Disease|0|||
127802219|NCT01463098|459898811|FG008|Part A (11 Days)|Participant Choice|1|||
127802220|NCT01463098|459898812|FG009|Part A (11 Days)|Participant Choice|0|||
127802221|NCT01463098|459898813|FG010|Part A (11 Days)|Participant Choice|0|||
127715864|NCT00622700|459587330|FG001|Extension Treatment Period|Progressive Disease|0|||
127715865|NCT00622700|459587331|FG002|Extension Treatment Period|Progressive Disease|0|||
127715866|NCT00622700|459587332|FG003|Extension Treatment Period|Progressive Disease|1|||
127715867|NCT00622700|459587333|FG004|Extension Treatment Period|Progressive Disease|2|||
127715868|NCT00622700|459587334|FG005|Extension Treatment Period|Progressive Disease|0|||
127715869|NCT00622700|459587335|FG006|Extension Treatment Period|Progressive Disease|2|||
127715870|NCT00622700|459587329|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
127715871|NCT00622700|459587330|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
127715872|NCT00622700|459587331|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
127715873|NCT00622700|459587332|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
127715874|NCT00622700|459587333|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
127715875|NCT00622700|459587334|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
127715876|NCT00622700|459587335|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
127715877|NCT00622700|459587329|FG000|Extension Treatment Period|Missing|0|||
127715878|NCT00622700|459587330|FG001|Extension Treatment Period|Missing|0|||
127715879|NCT00622700|459587331|FG002|Extension Treatment Period|Missing|0|||
127715880|NCT00622700|459587332|FG003|Extension Treatment Period|Missing|2|||
127715881|NCT00622700|459587333|FG004|Extension Treatment Period|Missing|3|||
127715882|NCT00622700|459587334|FG005|Extension Treatment Period|Missing|1|||
127715883|NCT00622700|459587335|FG006|Extension Treatment Period|Missing|0|||
127715884|NCT00622700|459587329|FG000|Extension Treatment Period|Other than specified above|0|||
127715885|NCT00622700|459587330|FG001|Extension Treatment Period|Other than specified above|0|||
127715886|NCT00622700|459587331|FG002|Extension Treatment Period|Other than specified above|0|||
127715887|NCT00622700|459587332|FG003|Extension Treatment Period|Other than specified above|0|||
127715888|NCT00622700|459587333|FG004|Extension Treatment Period|Other than specified above|0|||
127715889|NCT00622700|459587334|FG005|Extension Treatment Period|Other than specified above|1|||
127715890|NCT00622700|459587335|FG006|Extension Treatment Period|Other than specified above|1|||
127715891|NCT02646618|459587336|FG000|Overall Study|Lost to Follow-up|10|||
127715892|NCT02646618|459587337|FG001|Overall Study|Lost to Follow-up|14|||
127715893|NCT01753999|459587338|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
127715894|NCT01753999|459587339|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
127715895|NCT01753999|459587338|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
127715896|NCT01753999|459587339|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
127715897|NCT01753999|459587338|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
127715898|NCT01753999|459587339|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
127715899|NCT01753999|459587338|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
127715900|NCT01753999|459587339|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
127715901|NCT01753999|459587338|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
127715902|NCT01753999|459587339|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
127715903|NCT01753999|459587338|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
127715904|NCT01753999|459587339|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
127715905|NCT03477175|459587344|FG000|Overall Study|Unable to travel due to COVID-19|0|||
127715906|NCT03477175|459587345|FG001|Overall Study|Unable to travel due to COVID-19|1|||
127715907|NCT03477175|459587344|FG000|Overall Study|Physician Decision|1|||
127715908|NCT03477175|459587345|FG001|Overall Study|Physician Decision|0|||
127715909|NCT03477175|459587344|FG000|Overall Study|Transitioned to commercial drug|6|||
127715910|NCT03477175|459587345|FG001|Overall Study|Transitioned to commercial drug|6|||
127715911|NCT03477175|459587344|FG000|Overall Study|Lost to Follow-up|1|||
127715912|NCT03477175|459587345|FG001|Overall Study|Lost to Follow-up|1|||
127715913|NCT03477175|459587344|FG000|Overall Study|Withdrawal by Subject|3|||
127715914|NCT03477175|459587345|FG001|Overall Study|Withdrawal by Subject|1|||
127715915|NCT03477175|459587344|FG000|Overall Study|Adverse Event|1|||
127715916|NCT03477175|459587345|FG001|Overall Study|Adverse Event|5|||
127715917|NCT03477175|459587344|FG000|Overall Study|Disease Progression|7|||
127802222|NCT01463098|459898814|FG011|Part A (11 Days)|Participant Choice|0|||
127802223|NCT01463098|459898815|FG012|Part A (11 Days)|Participant Choice|0|||
127802224|NCT01463098|459898816|FG013|Part A (11 Days)|Participant Choice|0|||
127802225|NCT01463098|459898803|FG000|Part A (11 Days)|Lost to Follow-up|0|||
127802226|NCT01463098|459898804|FG001|Part A (11 Days)|Lost to Follow-up|0|||
127802227|NCT01463098|459898805|FG002|Part A (11 Days)|Lost to Follow-up|0|||
127802228|NCT01463098|459898806|FG003|Part A (11 Days)|Lost to Follow-up|0|||
127802229|NCT01463098|459898807|FG004|Part A (11 Days)|Lost to Follow-up|1|||
127802230|NCT01463098|459898808|FG005|Part A (11 Days)|Lost to Follow-up|0|||
127802231|NCT01463098|459898809|FG006|Part A (11 Days)|Lost to Follow-up|0|||
127802232|NCT01463098|459898810|FG007|Part A (11 Days)|Lost to Follow-up|0|||
127802233|NCT01463098|459898811|FG008|Part A (11 Days)|Lost to Follow-up|0|||
127802234|NCT01463098|459898812|FG009|Part A (11 Days)|Lost to Follow-up|0|||
127715918|NCT03477175|459587345|FG001|Overall Study|Disease Progression|7|||
127715919|NCT04088227|459587346|FG000|Overall Study|Withdrawal by Subject|1|||
127802235|NCT01463098|459898813|FG010|Part A (11 Days)|Lost to Follow-up|0|||
127802236|NCT01463098|459898814|FG011|Part A (11 Days)|Lost to Follow-up|0|||
127888660|NCT00606684|460215801|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
127888661|NCT00606684|460215802|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
127888662|NCT00606684|460215803|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
127715920|NCT04088227|459587347|FG001|Overall Study|Withdrawal by Subject|0|||
127715921|NCT04088227|459587346|FG000|Overall Study|Surgery postponed >5weeks|1|||
127715922|NCT04088227|459587347|FG001|Overall Study|Surgery postponed >5weeks|0|||
127715923|NCT02415127|459587348|FG000|Overall Study|Adverse Event|1|||
127715924|NCT02415127|459587349|FG001|Overall Study|Adverse Event|0|||
127715925|NCT04300023|459587350|FG000|Before Crossover to Social Group|Withdrawal by Subject|0|||
127715926|NCT04300023|459587351|FG001|Before Crossover to Social Group|Withdrawal by Subject|1|||
127715927|NCT01855750|459587352|FG000|Overall Study|Death|78|||
127715928|NCT01855750|459587353|FG001|Overall Study|Death|78|||
127715929|NCT01855750|459587352|FG000|Overall Study|Lost to Follow-up|9|||
127715930|NCT01855750|459587353|FG001|Overall Study|Lost to Follow-up|23|||
127715931|NCT01855750|459587352|FG000|Overall Study|Withdrawal by Subject|35|||
127715932|NCT01855750|459587353|FG001|Overall Study|Withdrawal by Subject|28|||
127715933|NCT01855750|459587352|FG000|Overall Study|Sponsor ends the study|297|||
127715934|NCT01855750|459587353|FG001|Overall Study|Sponsor ends the study|290|||
127715935|NCT05525572|459587354|FG000|Overall Study|Lost to Follow-up|2|||
127715936|NCT04057131|459587355|FG000|Overall Study|Protocol Violation|24|||
127715937|NCT03160885|459587356|FG000|Initial Treatment Period|Not dosed|2|||
127715938|NCT03160885|459587357|FG001|Initial Treatment Period|Not dosed|0|||
127715939|NCT03160885|459587358|FG002|Initial Treatment Period|Not dosed|0|||
127715940|NCT03160885|459587359|FG003|Initial Treatment Period|Not dosed|0|||
127715941|NCT03160885|459587360|FG004|Initial Treatment Period|Not dosed|0|||
127715942|NCT03160885|459587361|FG005|Initial Treatment Period|Not dosed|0|||
127715943|NCT03160885|459587362|FG006|Initial Treatment Period|Not dosed|0|||
127715944|NCT03160885|459587356|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
127715945|NCT03160885|459587357|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
127715946|NCT03160885|459587358|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
127715947|NCT03160885|459587359|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
127715948|NCT03160885|459587360|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
127715949|NCT03160885|459587361|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
127715950|NCT03160885|459587362|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
127715951|NCT03160885|459587356|FG000|Open-label Treatment|Not dosed|0|||
127715952|NCT03160885|459587357|FG001|Open-label Treatment|Not dosed|0|||
127715953|NCT03160885|459587358|FG002|Open-label Treatment|Not dosed|0|||
127715954|NCT03160885|459587359|FG003|Open-label Treatment|Not dosed|0|||
127715955|NCT03160885|459587360|FG004|Open-label Treatment|Not dosed|0|||
127715956|NCT03160885|459587361|FG005|Open-label Treatment|Not dosed|0|||
127715957|NCT03160885|459587362|FG006|Open-label Treatment|Not dosed|2|||
127715958|NCT03160885|459587356|FG000|Open-label Treatment|Discontinued IMP|0|||
127715959|NCT03160885|459587357|FG001|Open-label Treatment|Discontinued IMP|0|||
127715960|NCT03160885|459587358|FG002|Open-label Treatment|Discontinued IMP|0|||
127715961|NCT03160885|459587359|FG003|Open-label Treatment|Discontinued IMP|0|||
127715962|NCT03160885|459587360|FG004|Open-label Treatment|Discontinued IMP|0|||
127715963|NCT03160885|459587361|FG005|Open-label Treatment|Discontinued IMP|0|||
127715964|NCT03160885|459587362|FG006|Open-label Treatment|Discontinued IMP|131|||
127715965|NCT03160885|459587356|FG000|Open-label Treatment|Completed Week 50|0|||
127715966|NCT03160885|459587357|FG001|Open-label Treatment|Completed Week 50|0|||
127715967|NCT03160885|459587358|FG002|Open-label Treatment|Completed Week 50|0|||
127715968|NCT03160885|459587359|FG003|Open-label Treatment|Completed Week 50|0|||
127715969|NCT03160885|459587360|FG004|Open-label Treatment|Completed Week 50|0|||
127715970|NCT03160885|459587361|FG005|Open-label Treatment|Completed Week 50|0|||
127715971|NCT03160885|459587362|FG006|Open-label Treatment|Completed Week 50|4|||
127715972|NCT03160885|459587356|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
127715973|NCT03160885|459587357|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
127715974|NCT03160885|459587358|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
127715975|NCT03160885|459587359|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
127715976|NCT03160885|459587360|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
127715977|NCT03160885|459587361|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
127715978|NCT03160885|459587362|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
127715979|NCT03160885|459587356|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
127715980|NCT03160885|459587357|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
127715981|NCT03160885|459587358|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
127715982|NCT03160885|459587359|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
127715983|NCT03160885|459587360|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
127715984|NCT03160885|459587361|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
127715985|NCT03160885|459587362|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
127715986|NCT03160885|459587356|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
127715987|NCT03160885|459587357|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
127715988|NCT03160885|459587358|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
127715989|NCT03160885|459587359|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
127715990|NCT03160885|459587360|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
127715991|NCT03160885|459587361|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
127715992|NCT03160885|459587362|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
127715993|NCT03160885|459587356|FG000|Maintenance Treatment Period|Completed Week 50|0|||
127715994|NCT03160885|459587357|FG001|Maintenance Treatment Period|Completed Week 50|0|||
127715995|NCT03160885|459587358|FG002|Maintenance Treatment Period|Completed Week 50|1|||
127715996|NCT03160885|459587359|FG003|Maintenance Treatment Period|Completed Week 50|0|||
127715997|NCT03160885|459587360|FG004|Maintenance Treatment Period|Completed Week 50|0|||
127715998|NCT03160885|459587361|FG005|Maintenance Treatment Period|Completed Week 50|0|||
127715999|NCT03160885|459587362|FG006|Maintenance Treatment Period|Completed Week 50|0|||
127716000|NCT03425682|459587363|FG000|Overall Study|Lost to Follow-up|2|||
127716001|NCT03425682|459587364|FG001|Overall Study|Lost to Follow-up|4|||
127716002|NCT03425682|459587363|FG000|Overall Study|Withdrawal by Subject|0|||
127716003|NCT03425682|459587364|FG001|Overall Study|Withdrawal by Subject|3|||
127716004|NCT03425682|459587363|FG000|Overall Study|Subject did not meet I/E|4|||
127716005|NCT03425682|459587364|FG001|Overall Study|Subject did not meet I/E|10|||
127716006|NCT03277989|459587367|FG000|Overall Study|Lost to Follow-up|6|||
127716007|NCT03277989|459587367|FG000|Overall Study|Adverse Event|6|||
127716008|NCT03277989|459587367|FG000|Overall Study|Withdrawal by Subject|3|||
127716009|NCT03277989|459587367|FG000|Overall Study|Didn't Receive Study Device|7|||
127716010|NCT03277989|459587367|FG000|Overall Study|Site Closure|26|||
127716011|NCT03277989|459587367|FG000|Overall Study|Sponsor Closure|107|||
127716012|NCT05704725|459587370|FG000|Overall Study|Lost to Follow-up|0|||
127716013|NCT05704725|459587371|FG001|Overall Study|Lost to Follow-up|1|||
127716014|NCT05704725|459587370|FG000|Overall Study|Withdrawal by Subject|1|||
127716015|NCT05704725|459587371|FG001|Overall Study|Withdrawal by Subject|0|||
127716016|NCT03227861|459587372|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
127716017|NCT03227861|459587372|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
127716018|NCT03227861|459587372|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
127716019|NCT03227861|459587372|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
127716020|NCT03227861|459587372|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
127716021|NCT03227861|459587372|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
127716022|NCT03227861|459587372|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
127716023|NCT03227861|459587372|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
127716024|NCT03227861|459587372|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
127716025|NCT03227861|459587372|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
127716026|NCT04551066|459587374|FG000|Overall Study|Death|5|||
127716027|NCT04551066|459587375|FG001|Overall Study|Death|3|||
127716028|NCT04551066|459587374|FG000|Overall Study|Lost to Follow-up|1|||
127716029|NCT04551066|459587375|FG001|Overall Study|Lost to Follow-up|0|||
127716030|NCT04551066|459587374|FG000|Overall Study|Sponsor Decision|103|||
127716031|NCT04551066|459587375|FG001|Overall Study|Sponsor Decision|117|||
127716032|NCT04551066|459587374|FG000|Overall Study|Withdrawal by Subject|8|||
127716033|NCT04551066|459587375|FG001|Overall Study|Withdrawal by Subject|2|||
127716034|NCT04551066|459587374|FG000|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
127716035|NCT04551066|459587375|FG001|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
127716036|NCT04551066|459587374|FG000|Overall Study|Adverse Event|2|||
127716037|NCT04551066|459587375|FG001|Overall Study|Adverse Event|0|||
127716038|NCT04551066|459587374|FG000|Overall Study|Physician Decision|2|||
127716039|NCT04551066|459587375|FG001|Overall Study|Physician Decision|0|||
127716040|NCT04551066|459587374|FG000|Overall Study|Protocol Violation|1|||
127716041|NCT04551066|459587375|FG001|Overall Study|Protocol Violation|0|||
127716042|NCT04551066|459587374|FG000|Overall Study|Lack of Efficacy|0|||
127716043|NCT04551066|459587375|FG001|Overall Study|Lack of Efficacy|1|||
127716044|NCT04551066|459587374|FG000|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|0|||
127716045|NCT04551066|459587375|FG001|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|1|||
127716046|NCT05529992|459587376|FG000|Overall Study|Withdrawal by Subject|1|||
127716047|NCT02798471|459587379|FG000|Overall Study|Adverse Event|7|||
127716048|NCT02798471|459587380|FG001|Overall Study|Adverse Event|2|||
127716049|NCT02798471|459587379|FG000|Overall Study|Physician Decision|3|||
127716050|NCT02798471|459587380|FG001|Overall Study|Physician Decision|7|||
127716051|NCT02798471|459587379|FG000|Overall Study|Death|2|||
127716052|NCT02798471|459587380|FG001|Overall Study|Death|3|||
127716053|NCT02798471|459587379|FG000|Overall Study|Lost to Follow-up|0|||
127716054|NCT02798471|459587380|FG001|Overall Study|Lost to Follow-up|1|||
127716055|NCT02798471|459587379|FG000|Overall Study|Other|5|||
127716056|NCT02798471|459587380|FG001|Overall Study|Other|3|||
127716057|NCT02798471|459587379|FG000|Overall Study|Subject withdrew consent|0|||
127716058|NCT02798471|459587380|FG001|Overall Study|Subject withdrew consent|6|||
127716059|NCT02798471|459587379|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
127716060|NCT02798471|459587380|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
127716061|NCT02798471|459587379|FG000|Overall Study|Randomized, but not treated|0|||
127716062|NCT02798471|459587380|FG001|Overall Study|Randomized, but not treated|2|||
127716063|NCT05293717|459587381|FG000|Overall Study|Physician Decision|1|||
127716064|NCT03762850|459589279|FG000|Overall Study|Death|0|||
127716065|NCT03762850|459589280|FG001|Overall Study|Death|1|||
127716066|NCT03762850|459589279|FG000|Overall Study|Lost to Follow-up|0|||
127716067|NCT03762850|459589280|FG001|Overall Study|Lost to Follow-up|1|||
127716068|NCT03762850|459589279|FG000|Overall Study|Physician Decision|0|||
127716069|NCT03762850|459589280|FG001|Overall Study|Physician Decision|1|||
127716070|NCT03762850|459589279|FG000|Overall Study|Withdrawal by Subject|4|||
127716071|NCT03762850|459589280|FG001|Overall Study|Withdrawal by Subject|9|||
127716072|NCT03083366|459589281|FG000|Screening Period|Did not meet criteria (screen fail)|1|||
127716073|NCT03083366|459589282|FG001|Screening Period|Did not meet criteria (screen fail)|0|||
127716074|NCT03083366|459589281|FG000|Enrollment Period|Lack of Efficacy|1|||
127716075|NCT03083366|459589282|FG001|Enrollment Period|Lack of Efficacy|0|||
127716076|NCT04503681|459589290|FG000|Overall Study|Subjects did not complete outcome questionnaire|5|||
127716077|NCT04503681|459589291|FG001|Overall Study|Subjects did not complete outcome questionnaire|7|||
127716078|NCT02760654|459589293|FG000|Overall Study|Lost to Follow-up|3|||
127716079|NCT02760654|459589294|FG001|Overall Study|Lost to Follow-up|3|||
127716080|NCT02760654|459589293|FG000|Overall Study|Withdrawal by Subject|4|||
127716081|NCT02760654|459589294|FG001|Overall Study|Withdrawal by Subject|3|||
127716082|NCT00210106|459589295|FG000|Overall Study|Death|1|||
127716083|NCT00210106|459589295|FG000|Overall Study|Protocol Violation|13|||
127716084|NCT03478969|459589298|FG000|Overall Study|Withdrawal by Subject|4|||
127716085|NCT03478969|459589299|FG001|Overall Study|Withdrawal by Subject|7|||
127716086|NCT03478969|459589300|FG002|Overall Study|Withdrawal by Subject|6|||
127716087|NCT03478969|459589298|FG000|Overall Study|Adverse Event|2|||
127716088|NCT03478969|459589299|FG001|Overall Study|Adverse Event|0|||
127716089|NCT03478969|459589300|FG002|Overall Study|Adverse Event|1|||
127716090|NCT03478969|459589298|FG000|Overall Study|Pregnancy|1|||
127716091|NCT03478969|459589299|FG001|Overall Study|Pregnancy|0|||
127716092|NCT03478969|459589300|FG002|Overall Study|Pregnancy|0|||
127716093|NCT03478969|459589298|FG000|Overall Study|Personal Reasons|1|||
127716094|NCT03478969|459589299|FG001|Overall Study|Personal Reasons|0|||
127716095|NCT03478969|459589300|FG002|Overall Study|Personal Reasons|1|||
127716096|NCT03478969|459589298|FG000|Overall Study|Covid-19|1|||
127716097|NCT03478969|459589299|FG001|Overall Study|Covid-19|4|||
127716098|NCT03478969|459589300|FG002|Overall Study|Covid-19|3|||
127716099|NCT03478969|459589298|FG000|Overall Study|Multiple Reasons|0|||
127716100|NCT03478969|459589299|FG001|Overall Study|Multiple Reasons|1|||
127716101|NCT03478969|459589300|FG002|Overall Study|Multiple Reasons|1|||
127716102|NCT03478969|459589298|FG000|Overall Study|Eligibility Criteria|0|||
127716103|NCT03478969|459589299|FG001|Overall Study|Eligibility Criteria|0|||
127716104|NCT03478969|459589300|FG002|Overall Study|Eligibility Criteria|5|||
127716105|NCT03478969|459589298|FG000|Overall Study|Lost to Follow-up|0|||
127716106|NCT03478969|459589299|FG001|Overall Study|Lost to Follow-up|0|||
127716107|NCT03478969|459589300|FG002|Overall Study|Lost to Follow-up|1|||
127716108|NCT02941549|459589301|FG000|Overall Study|Adverse Event|1|||
127716109|NCT02941549|459589302|FG001|Overall Study|Adverse Event|0|||
127716110|NCT02941549|459589303|FG002|Overall Study|Adverse Event|0|||
127716111|NCT02941549|459589301|FG000|Overall Study|Withdrawal by Subject|2|||
127716112|NCT02941549|459589302|FG001|Overall Study|Withdrawal by Subject|1|||
127716113|NCT02941549|459589303|FG002|Overall Study|Withdrawal by Subject|2|||
127716114|NCT01436175|459589304|FG000|Overall Study|Adverse Event|111|||
127716115|NCT01436175|459589304|FG000|Overall Study|Protocol Violation|49|||
127716116|NCT01436175|459589304|FG000|Overall Study|Withdrawal by Subject|108|||
127716117|NCT01436175|459589304|FG000|Overall Study|Lost to Follow-up|89|||
127716118|NCT01436175|459589304|FG000|Overall Study|Lack of Efficacy|24|||
127716119|NCT01436175|459589304|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
127716120|NCT01436175|459589304|FG000|Overall Study|Other|826|||
127802237|NCT01463098|459898815|FG012|Part A (11 Days)|Lost to Follow-up|0|||
127802238|NCT01463098|459898816|FG013|Part A (11 Days)|Lost to Follow-up|0|||
127802239|NCT01463098|459898803|FG000|Part B (11 Days)|Participant Choice|0|||
127716121|NCT05405244|459589306|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
127716122|NCT05405244|459589307|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
127716123|NCT05405244|459589306|FG000|Washout (2 Weeks)|Adverse Event|2|||
127716124|NCT05405244|459589307|FG001|Washout (2 Weeks)|Adverse Event|0|||
127716125|NCT05405244|459589306|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
127716126|NCT05405244|459589307|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
127716127|NCT03418922|459589310|FG000|Overall Study|Withdrawal by Subject|0|||
127716128|NCT03418922|459589311|FG001|Overall Study|Withdrawal by Subject|2|||
127716129|NCT03418922|459589310|FG000|Overall Study|Adverse Event|2|||
127716130|NCT03418922|459589311|FG001|Overall Study|Adverse Event|2|||
127716131|NCT03418922|459589310|FG000|Overall Study|Death|0|||
127716132|NCT03418922|459589311|FG001|Overall Study|Death|1|||
127716133|NCT03418922|459589310|FG000|Overall Study|Physician Decision|0|||
127802240|NCT01463098|459898804|FG001|Part B (11 Days)|Participant Choice|0|||
127802241|NCT01463098|459898805|FG002|Part B (11 Days)|Participant Choice|0|||
127802242|NCT01463098|459898806|FG003|Part B (11 Days)|Participant Choice|0|||
127802243|NCT01463098|459898807|FG004|Part B (11 Days)|Participant Choice|0|||
127802244|NCT01463098|459898808|FG005|Part B (11 Days)|Participant Choice|0|||
127802245|NCT01463098|459898809|FG006|Part B (11 Days)|Participant Choice|0|||
127802246|NCT01463098|459898810|FG007|Part B (11 Days)|Participant Choice|0|||
127802247|NCT01463098|459898811|FG008|Part B (11 Days)|Participant Choice|0|||
127802248|NCT01463098|459898812|FG009|Part B (11 Days)|Participant Choice|0|||
127802249|NCT01463098|459898813|FG010|Part B (11 Days)|Participant Choice|0|||
127802250|NCT01463098|459898814|FG011|Part B (11 Days)|Participant Choice|1|||
127802251|NCT01463098|459898815|FG012|Part B (11 Days)|Participant Choice|0|||
127802252|NCT01463098|459898816|FG013|Part B (11 Days)|Participant Choice|0|||
127802253|NCT02769624|459898817|FG000|Overall Study|Lost to Follow-up|0|||
127802254|NCT02769624|459898818|FG001|Overall Study|Lost to Follow-up|1|||
127802255|NCT04451330|459898819|FG000|Overall Study|Adverse Event|1|||
127802256|NCT04451330|459898820|FG001|Overall Study|Adverse Event|2|||
127802257|NCT04451330|459898819|FG000|Overall Study|Lost to Follow-up|5|||
127802258|NCT04451330|459898820|FG001|Overall Study|Lost to Follow-up|0|||
127802259|NCT04451330|459898819|FG000|Overall Study|Withdrawal by Subject|3|||
127802260|NCT04451330|459898820|FG001|Overall Study|Withdrawal by Subject|1|||
127802261|NCT04451330|459898819|FG000|Overall Study|Withdrawal by parent/guardian|1|||
127802262|NCT04451330|459898820|FG001|Overall Study|Withdrawal by parent/guardian|0|||
127802263|NCT04451330|459898819|FG000|Overall Study|Other than specified|0|||
127802264|NCT04451330|459898820|FG001|Overall Study|Other than specified|1|||
127802265|NCT05099640|459898821|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
127802266|NCT05099640|459898822|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
127802267|NCT05099640|459898823|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
127802268|NCT05099640|459898821|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
127802269|NCT05099640|459898822|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
127802270|NCT05099640|459898823|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
127802271|NCT05099640|459898821|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
127802272|NCT05099640|459898822|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
127802273|NCT05099640|459898823|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
127802274|NCT05099640|459898821|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
127802275|NCT05099640|459898822|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
127802276|NCT05099640|459898823|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
127888663|NCT00606684|460215804|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
127888664|NCT00606684|460215805|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
127716134|NCT03418922|459589311|FG001|Overall Study|Physician Decision|1|||
127716135|NCT03451422|459589312|FG000|Overall Study|Lost to Follow-up|0|||
127716136|NCT03451422|459589313|FG001|Overall Study|Lost to Follow-up|0|||
127716137|NCT03451422|459589314|FG002|Overall Study|Lost to Follow-up|0|||
127716138|NCT03451422|459589315|FG003|Overall Study|Lost to Follow-up|0|||
127716139|NCT03451422|459589316|FG004|Overall Study|Lost to Follow-up|0|||
127716140|NCT03451422|459589317|FG005|Overall Study|Lost to Follow-up|1|||
127716141|NCT03451422|459589312|FG000|Overall Study|Decision by sponsor|1|||
127716142|NCT03451422|459589313|FG001|Overall Study|Decision by sponsor|0|||
127716143|NCT03451422|459589314|FG002|Overall Study|Decision by sponsor|1|||
127716144|NCT03451422|459589315|FG003|Overall Study|Decision by sponsor|0|||
127716145|NCT03451422|459589316|FG004|Overall Study|Decision by sponsor|0|||
127716146|NCT03451422|459589317|FG005|Overall Study|Decision by sponsor|0|||
127716147|NCT03451422|459589312|FG000|Overall Study|Withdrawal by Subject|0|||
127716148|NCT03451422|459589313|FG001|Overall Study|Withdrawal by Subject|0|||
127716149|NCT03451422|459589314|FG002|Overall Study|Withdrawal by Subject|2|||
127716150|NCT03451422|459589315|FG003|Overall Study|Withdrawal by Subject|3|||
127716151|NCT03451422|459589316|FG004|Overall Study|Withdrawal by Subject|2|||
127716152|NCT03451422|459589317|FG005|Overall Study|Withdrawal by Subject|1|||
127716153|NCT03601715|459589318|FG000|Second Intervention|Lost to Follow-up|1|||
127716154|NCT03601715|459589319|FG001|Second Intervention|Lost to Follow-up|1|||
127716155|NCT03601715|459589320|FG002|Second Intervention|Lost to Follow-up|0|||
127716156|NCT00918333|459589323|FG000|Overall Study|Drug not taken per protocol|1|||
127716157|NCT00918333|459589324|FG001|Overall Study|Drug not taken per protocol|0|||
127716158|NCT00918333|459589323|FG000|Overall Study|Inadequate amount of drugs provided|1|||
127716159|NCT00918333|459589324|FG001|Overall Study|Inadequate amount of drugs provided|4|||
127802277|NCT05099640|459898821|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
127802278|NCT05099640|459898822|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
127802279|NCT05099640|459898823|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
127888665|NCT00606684|460215806|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
127716160|NCT00918333|459589323|FG000|Overall Study|Ineligible|1|||
127716161|NCT00918333|459589324|FG001|Overall Study|Ineligible|0|||
127716162|NCT00918333|459589323|FG000|Overall Study|Withdrawal by Subject|0|||
127716163|NCT00918333|459589324|FG001|Overall Study|Withdrawal by Subject|1|||
127802280|NCT05099640|459898821|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
127888666|NCT00606684|460215800|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
127888667|NCT00606684|460215801|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
127888668|NCT00606684|460215802|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
127888669|NCT00606684|460215803|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
127888670|NCT00606684|460215804|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
127888671|NCT00606684|460215805|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
127888672|NCT00606684|460215806|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
127888673|NCT00606684|460215800|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
127888674|NCT00606684|460215801|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
127888675|NCT00606684|460215802|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
127888676|NCT00606684|460215803|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
127888677|NCT00606684|460215804|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
127888678|NCT00606684|460215805|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
127888679|NCT00606684|460215806|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
127888680|NCT00606684|460215800|FG000|Double-Blind Treatment Period|Physician Decision|0|||
127888681|NCT00606684|460215801|FG001|Double-Blind Treatment Period|Physician Decision|5|||
127888682|NCT00606684|460215802|FG002|Double-Blind Treatment Period|Physician Decision|1|||
127888683|NCT00606684|460215803|FG003|Double-Blind Treatment Period|Physician Decision|0|||
127888684|NCT00606684|460215804|FG004|Double-Blind Treatment Period|Physician Decision|3|||
127888685|NCT00606684|460215805|FG005|Double-Blind Treatment Period|Physician Decision|1|||
127888686|NCT00606684|460215806|FG006|Double-Blind Treatment Period|Physician Decision|2|||
127888687|NCT00606684|460215800|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
127888688|NCT00606684|460215801|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
127888689|NCT00606684|460215802|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
127888690|NCT00606684|460215803|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
127888691|NCT00606684|460215804|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
127888692|NCT00606684|460215805|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
127888693|NCT00606684|460215806|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
127888694|NCT02763579|460215807|FG000|Global Period|Death|167|||
127888695|NCT02763579|460215808|FG001|Global Period|Death|151|||
127888696|NCT02763579|460215809|FG002|Global Period|Death|0|||
127888697|NCT02763579|460215810|FG003|Global Period|Death|0|||
127888698|NCT02763579|460215807|FG000|Global Period|Lost to Follow-up|2|||
127888699|NCT02763579|460215808|FG001|Global Period|Lost to Follow-up|4|||
127888700|NCT02763579|460215809|FG002|Global Period|Lost to Follow-up|0|||
127888701|NCT02763579|460215810|FG003|Global Period|Lost to Follow-up|0|||
127888702|NCT02763579|460215807|FG000|Global Period|Physician Decision|0|||
127888703|NCT02763579|460215808|FG001|Global Period|Physician Decision|2|||
127888704|NCT02763579|460215809|FG002|Global Period|Physician Decision|0|||
127888705|NCT02763579|460215810|FG003|Global Period|Physician Decision|0|||
127888706|NCT02763579|460215807|FG000|Global Period|Study Terminated By Sponsor|21|||
127888707|NCT02763579|460215808|FG001|Global Period|Study Terminated By Sponsor|26|||
127888708|NCT02763579|460215809|FG002|Global Period|Study Terminated By Sponsor|0|||
127888709|NCT02763579|460215810|FG003|Global Period|Study Terminated By Sponsor|0|||
127888710|NCT02763579|460215807|FG000|Global Period|Withdrawal by Subject|12|||
127888711|NCT02763579|460215808|FG001|Global Period|Withdrawal by Subject|18|||
127716164|NCT01313884|459589326|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
127716165|NCT00263757|459589327|FG000|Overall Study|Withdrawal by Subject|5|||
127716166|NCT00263757|459589328|FG001|Overall Study|Withdrawal by Subject|4|||
127716167|NCT00263757|459589327|FG000|Overall Study|Screen failure|0|||
127716168|NCT00263757|459589328|FG001|Overall Study|Screen failure|1|||
127716169|NCT00263757|459589327|FG000|Overall Study|Adverse Event|3|||
127716170|NCT00263757|459589328|FG001|Overall Study|Adverse Event|3|||
127716171|NCT02964741|459589329|FG000|Overall Study|Protocol Violation|1|||
127716172|NCT02964741|459589330|FG001|Overall Study|Protocol Violation|0|||
127716173|NCT02964741|459589331|FG002|Overall Study|Protocol Violation|0|||
127716174|NCT02964741|459589329|FG000|Overall Study|Withdrawal by Subject|0|||
127716175|NCT02964741|459589330|FG001|Overall Study|Withdrawal by Subject|1|||
127716176|NCT02964741|459589331|FG002|Overall Study|Withdrawal by Subject|0|||
127716177|NCT02964741|459589329|FG000|Overall Study|claustrophobia|1|||
127716178|NCT02964741|459589330|FG001|Overall Study|claustrophobia|0|||
127716179|NCT02964741|459589331|FG002|Overall Study|claustrophobia|0|||
127716180|NCT01212744|459589344|FG000|Overall Study|Withdrawal by Subject|1|||
127716181|NCT02167451|459589345|FG000|Overall Study|Withdrawal by Subject|1|||
127888712|NCT02763579|460215809|FG002|Global Period|Withdrawal by Subject|0|||
127888713|NCT02763579|460215810|FG003|Global Period|Withdrawal by Subject|0|||
127716182|NCT01218659|459589346|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
127888714|NCT02763579|460215807|FG000|China Period|Death|0|||
127888715|NCT02763579|460215808|FG001|China Period|Death|0|||
127716183|NCT01218659|459589347|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
127716184|NCT01218659|459589348|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
127716185|NCT01218659|459589346|FG000|18-Month Randomized Period|Did not receive study drug|0|||
127716186|NCT01218659|459589347|FG001|18-Month Randomized Period|Did not receive study drug|3|||
127716187|NCT01218659|459589348|FG002|18-Month Randomized Period|Did not receive study drug|0|||
127716188|NCT01218659|459589346|FG000|12-Month OLE|Withdrawal by Subject|0|||
127716189|NCT01218659|459589347|FG001|12-Month OLE|Withdrawal by Subject|0|||
127716190|NCT01218659|459589348|FG002|12-Month OLE|Withdrawal by Subject|2|||
127716191|NCT01218659|459589346|FG000|12-Month OLE|Physician Decision|0|||
127716192|NCT01218659|459589347|FG001|12-Month OLE|Physician Decision|0|||
127716193|NCT01218659|459589348|FG002|12-Month OLE|Physician Decision|1|||
127716194|NCT01218659|459589346|FG000|12-Month OLE|Lost to Follow-up|0|||
127716195|NCT01218659|459589347|FG001|12-Month OLE|Lost to Follow-up|0|||
127716196|NCT01218659|459589348|FG002|12-Month OLE|Lost to Follow-up|1|||
127716197|NCT01218659|459589346|FG000|12-Month OLE|Pregnancy|0|||
127716198|NCT01218659|459589347|FG001|12-Month OLE|Pregnancy|0|||
127716199|NCT01218659|459589348|FG002|12-Month OLE|Pregnancy|1|||
127716200|NCT01218659|459589346|FG000|12-Month OLE|Lack of Efficacy|0|||
127716201|NCT01218659|459589347|FG001|12-Month OLE|Lack of Efficacy|0|||
127716202|NCT01218659|459589348|FG002|12-Month OLE|Lack of Efficacy|1|||
127716203|NCT01218659|459589346|FG000|12-Month OLE|Declined to participate in the OLE|0|||
127716204|NCT01218659|459589347|FG001|12-Month OLE|Declined to participate in the OLE|0|||
127716205|NCT01218659|459589348|FG002|12-Month OLE|Declined to participate in the OLE|4|||
127716206|NCT04191824|459589355|FG000|Overall Study|Death|13|||
127716207|NCT04191824|459589356|FG001|Overall Study|Death|12|||
127716208|NCT04191824|459589355|FG000|Overall Study|Lost to Follow-up|456|||
127716209|NCT04191824|459589356|FG001|Overall Study|Lost to Follow-up|435|||
127716210|NCT04191824|459589355|FG000|Overall Study|Physician Decision|2|||
127716211|NCT04191824|459589356|FG001|Overall Study|Physician Decision|1|||
127716212|NCT04191824|459589355|FG000|Overall Study|Protocol Violation|0|||
127716213|NCT04191824|459589356|FG001|Overall Study|Protocol Violation|2|||
127716214|NCT04191824|459589355|FG000|Overall Study|Withdrawal by Subject|16|||
127716215|NCT04191824|459589356|FG001|Overall Study|Withdrawal by Subject|18|||
127716216|NCT04191824|459589355|FG000|Overall Study|Early site closure|24|||
127716217|NCT04191824|459589356|FG001|Overall Study|Early site closure|22|||
127716218|NCT01437319|459589362|FG000|Phase I|Lost to Follow-up|2|||
127716219|NCT01437319|459589363|FG001|Phase I|Lost to Follow-up|0|||
127716220|NCT01437319|459589364|FG002|Phase I|Lost to Follow-up|0|||
127716221|NCT01437319|459589362|FG000|Phase I|Protocol Violation|1|||
127716222|NCT01437319|459589363|FG001|Phase I|Protocol Violation|0|||
127716223|NCT01437319|459589364|FG002|Phase I|Protocol Violation|0|||
127716224|NCT01437319|459589362|FG000|Phase I|Study related symptoms/complaints|27|||
127716225|NCT01437319|459589363|FG001|Phase I|Study related symptoms/complaints|0|||
127716226|NCT01437319|459589364|FG002|Phase I|Study related symptoms/complaints|0|||
127716227|NCT01437319|459589362|FG000|Phase I|Withdrawal by Subject|25|||
127716228|NCT01437319|459589363|FG001|Phase I|Withdrawal by Subject|0|||
127716229|NCT01437319|459589364|FG002|Phase I|Withdrawal by Subject|0|||
127716230|NCT01437319|459589362|FG000|Phase II|Withdrawal by Subject|0|||
127716231|NCT01437319|459589363|FG001|Phase II|Withdrawal by Subject|8|||
127716232|NCT01437319|459589364|FG002|Phase II|Withdrawal by Subject|16|||
127716233|NCT01437319|459589362|FG000|Phase II|Lost to Follow-up|0|||
127716234|NCT01437319|459589363|FG001|Phase II|Lost to Follow-up|7|||
127716235|NCT01437319|459589364|FG002|Phase II|Lost to Follow-up|2|||
127716236|NCT01437319|459589362|FG000|Phase II|Study related symptoms/complaints|0|||
127716237|NCT01437319|459589363|FG001|Phase II|Study related symptoms/complaints|28|||
127716238|NCT01437319|459589364|FG002|Phase II|Study related symptoms/complaints|19|||
127716239|NCT01437319|459589362|FG000|Phase II|Protocol Violation|0|||
127716240|NCT01437319|459589363|FG001|Phase II|Protocol Violation|1|||
127716241|NCT01437319|459589364|FG002|Phase II|Protocol Violation|0|||
127716242|NCT01499849|459589365|FG000|Overall Study|Adverse Event|28|||
127716243|NCT01499849|459589366|FG001|Overall Study|Adverse Event|32|||
127716244|NCT01499849|459589365|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
127716245|NCT01499849|459589366|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
127716246|NCT01499849|459589365|FG000|Overall Study|Withdrawal by Subject|43|||
127716247|NCT01499849|459589366|FG001|Overall Study|Withdrawal by Subject|43|||
127716248|NCT01499849|459589365|FG000|Overall Study|Death|5|||
127716249|NCT01499849|459589366|FG001|Overall Study|Death|7|||
127716250|NCT01499849|459589365|FG000|Overall Study|Disease Progression|11|||
127716251|NCT01499849|459589366|FG001|Overall Study|Disease Progression|10|||
127716252|NCT01499849|459589365|FG000|Overall Study|Protocol Violation|11|||
127716253|NCT01499849|459589366|FG001|Overall Study|Protocol Violation|11|||
127716254|NCT01499849|459589365|FG000|Overall Study|Physician Decision|20|||
127716255|NCT01499849|459589366|FG001|Overall Study|Physician Decision|19|||
127716256|NCT01499849|459589365|FG000|Overall Study|Lack of Efficacy|3|||
127716257|NCT01499849|459589366|FG001|Overall Study|Lack of Efficacy|4|||
127716258|NCT01499849|459589365|FG000|Overall Study|Lost to Follow-up|6|||
127716259|NCT01499849|459589366|FG001|Overall Study|Lost to Follow-up|3|||
127716260|NCT01499849|459589365|FG000|Overall Study|Other Reasons|27|||
127716261|NCT01499849|459589366|FG001|Overall Study|Other Reasons|30|||
127716262|NCT00174252|459589367|FG000|Overall Study|Protocol Violation|2|||
127716263|NCT00811941|459589368|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
127716264|NCT00811941|459589369|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
127716265|NCT00811941|459589368|FG000|All Treated Patients|Adverse Event|2|||
127716266|NCT00811941|459589369|FG001|All Treated Patients|Adverse Event|43|||
127716267|NCT00811941|459589368|FG000|All Treated Patients|Lack of Efficacy|2|||
127716268|NCT00811941|459589369|FG001|All Treated Patients|Lack of Efficacy|3|||
127716269|NCT00811941|459589368|FG000|All Treated Patients|Non-compliance|1|||
127716270|NCT00811941|459589369|FG001|All Treated Patients|Non-compliance|8|||
127716271|NCT00811941|459589368|FG000|All Treated Patients|Protocol Violation|5|||
127716272|NCT00811941|459589369|FG001|All Treated Patients|Protocol Violation|17|||
127716273|NCT00811941|459589368|FG000|All Treated Patients|Withdrawal by Subject|35|||
127716274|NCT00811941|459589369|FG001|All Treated Patients|Withdrawal by Subject|94|||
127802281|NCT05099640|459898822|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
127802282|NCT05099640|459898823|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
127802283|NCT00179959|459898824|FG000|Overall Study|Lost to Follow-up|3|||
127802284|NCT00179959|459898825|FG001|Overall Study|Lost to Follow-up|1|||
127802285|NCT00179959|459898824|FG000|Overall Study|Withdrawal by Subject|3|||
127802286|NCT00179959|459898825|FG001|Overall Study|Withdrawal by Subject|2|||
127802287|NCT00448708|459898826|FG000|Overall Study|Death|21|||
127716275|NCT00811941|459589368|FG000|All Treated Patients|Lost to Follow-up|3|||
127716276|NCT00811941|459589369|FG001|All Treated Patients|Lost to Follow-up|12|||
127716277|NCT00811941|459589368|FG000|All Treated Patients|Other Reason|4|||
127716278|NCT00811941|459589369|FG001|All Treated Patients|Other Reason|14|||
127716279|NCT03802994|459589370|FG000|Overall Study|Lost to Follow-up|0|||
127716280|NCT03802994|459589371|FG001|Overall Study|Lost to Follow-up|2|||
127716281|NCT03802994|459589372|FG002|Overall Study|Lost to Follow-up|3|||
127716282|NCT03802994|459589373|FG003|Overall Study|Lost to Follow-up|2|||
127716283|NCT03802994|459589374|FG004|Overall Study|Lost to Follow-up|2|||
127716284|NCT03611556|459589380|FG000|Overall Study|Death|7|||
127716285|NCT03611556|459589381|FG001|Overall Study|Death|7|||
127716286|NCT03611556|459589382|FG002|Overall Study|Death|3|||
127716287|NCT03611556|459589383|FG003|Overall Study|Death|8|||
127716288|NCT03611556|459589384|FG004|Overall Study|Death|47|||
127716289|NCT03611556|459589385|FG005|Overall Study|Death|32|||
127716290|NCT03611556|459589386|FG006|Overall Study|Death|53|||
127716291|NCT03611556|459589380|FG000|Overall Study|Withdrawal by Subject|0|||
127716292|NCT03611556|459589381|FG001|Overall Study|Withdrawal by Subject|0|||
127716293|NCT03611556|459589382|FG002|Overall Study|Withdrawal by Subject|0|||
127716294|NCT03611556|459589383|FG003|Overall Study|Withdrawal by Subject|0|||
127716295|NCT03611556|459589384|FG004|Overall Study|Withdrawal by Subject|4|||
127716296|NCT03611556|459589385|FG005|Overall Study|Withdrawal by Subject|2|||
127716297|NCT03611556|459589386|FG006|Overall Study|Withdrawal by Subject|4|||
127716298|NCT03611556|459589380|FG000|Overall Study|Sponsor decision|0|||
127716299|NCT03611556|459589381|FG001|Overall Study|Sponsor decision|0|||
127716300|NCT03611556|459589382|FG002|Overall Study|Sponsor decision|0|||
127716301|NCT03611556|459589383|FG003|Overall Study|Sponsor decision|0|||
127716302|NCT03611556|459589384|FG004|Overall Study|Sponsor decision|9|||
127716303|NCT03611556|459589385|FG005|Overall Study|Sponsor decision|4|||
127716304|NCT03611556|459589386|FG006|Overall Study|Sponsor decision|12|||
127716305|NCT03611556|459589380|FG000|Overall Study|Reasons|0|||
127716306|NCT03611556|459589381|FG001|Overall Study|Reasons|0|||
127716307|NCT03611556|459589382|FG002|Overall Study|Reasons|0|||
127716308|NCT03611556|459589383|FG003|Overall Study|Reasons|0|||
127716309|NCT03611556|459589384|FG004|Overall Study|Reasons|2|||
127716310|NCT03611556|459589385|FG005|Overall Study|Reasons|0|||
127716311|NCT03611556|459589386|FG006|Overall Study|Reasons|1|||
127716312|NCT00390884|459589387|FG000|Overall Study|Withdrawal by Subject|2|||
127716313|NCT00390884|459589388|FG001|Overall Study|Withdrawal by Subject|2|||
127716314|NCT04035447|459589389|FG000|Treatment Period|Lost to Follow-up|6|||
127716315|NCT04035447|459589390|FG001|Treatment Period|Lost to Follow-up|5|||
127716316|NCT04035447|459589389|FG000|Treatment Period|Physician Decision|0|||
127716317|NCT04035447|459589390|FG001|Treatment Period|Physician Decision|2|||
127716318|NCT03304587|459589391|FG000|Overall Study|Headache after intervention|0|||
127716319|NCT03304587|459589392|FG001|Overall Study|Headache after intervention|1|||
127716320|NCT03304587|459589391|FG000|Overall Study|Withdrawal by Subject|1|||
127716321|NCT03304587|459589392|FG001|Overall Study|Withdrawal by Subject|0|||
127716322|NCT01458366|459589394|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
127716323|NCT01458366|459589395|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
127716324|NCT01458366|459589396|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
127716325|NCT01458366|459589397|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
127716326|NCT01458366|459589398|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
127716327|NCT01458366|459589394|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
127716328|NCT01458366|459589395|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
127716329|NCT01458366|459589396|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
127716330|NCT01458366|459589397|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
127716331|NCT01458366|459589398|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
127716332|NCT02397096|459589399|FG000|Day 1 to Week 24|Adverse Event|7|||
127716333|NCT02397096|459589400|FG001|Day 1 to Week 24|Adverse Event|1|||
127716334|NCT02397096|459589399|FG000|Day 1 to Week 24|Death|1|||
127716335|NCT02397096|459589400|FG001|Day 1 to Week 24|Death|0|||
127716336|NCT02397096|459589399|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
127716337|NCT02397096|459589400|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
127716338|NCT02397096|459589399|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
127716339|NCT02397096|459589400|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
127716340|NCT02397096|459589399|FG000|Day 1 to Week 24|Physician Decision|2|||
127716341|NCT02397096|459589400|FG001|Day 1 to Week 24|Physician Decision|3|||
127716342|NCT02397096|459589399|FG000|Day 1 to Week 24|Protocol Violation|1|||
127716343|NCT02397096|459589400|FG001|Day 1 to Week 24|Protocol Violation|4|||
127716344|NCT02397096|459589399|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
127716345|NCT02397096|459589400|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
127716346|NCT02397096|459589399|FG000|Day 1 to Week 24|Randomized, not treated|3|||
127716347|NCT02397096|459589400|FG001|Day 1 to Week 24|Randomized, not treated|0|||
127716348|NCT02397096|459589399|FG000|Week 24 to Week 48|Adverse Event|6|||
127716349|NCT02397096|459589400|FG001|Week 24 to Week 48|Adverse Event|2|||
127716350|NCT02397096|459589399|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
127716351|NCT02397096|459589400|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
127716352|NCT02397096|459589399|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
127716353|NCT02397096|459589400|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
127716354|NCT02397096|459589399|FG000|Week 24 to Week 48|Physician Decision|2|||
127716355|NCT02397096|459589400|FG001|Week 24 to Week 48|Physician Decision|1|||
127716356|NCT02397096|459589399|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
127716357|NCT02397096|459589400|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
127716358|NCT02397096|459589399|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
127716359|NCT02397096|459589400|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
127716360|NCT02397096|459589399|FG000|Study Extension 1|Adverse Event|7|||
127716361|NCT02397096|459589400|FG001|Study Extension 1|Adverse Event|5|||
127716362|NCT02397096|459589399|FG000|Study Extension 1|Death|1|||
127716363|NCT02397096|459589400|FG001|Study Extension 1|Death|0|||
127716364|NCT02397096|459589399|FG000|Study Extension 1|Lack of Efficacy|2|||
127716365|NCT02397096|459589400|FG001|Study Extension 1|Lack of Efficacy|5|||
127716366|NCT02397096|459589399|FG000|Study Extension 1|Lost to Follow-up|2|||
127716367|NCT02397096|459589400|FG001|Study Extension 1|Lost to Follow-up|3|||
127716368|NCT02397096|459589399|FG000|Study Extension 1|Non-compliance with study drug|3|||
127716369|NCT02397096|459589400|FG001|Study Extension 1|Non-compliance with study drug|0|||
127716370|NCT02397096|459589399|FG000|Study Extension 1|Physician Decision|4|||
127716371|NCT02397096|459589400|FG001|Study Extension 1|Physician Decision|2|||
127716372|NCT02397096|459589399|FG000|Study Extension 1|Pregnancy|1|||
127716373|NCT02397096|459589400|FG001|Study Extension 1|Pregnancy|0|||
127716374|NCT02397096|459589399|FG000|Study Extension 1|Protocol Violation|0|||
127716375|NCT02397096|459589400|FG001|Study Extension 1|Protocol Violation|1|||
127716376|NCT02397096|459589399|FG000|Study Extension 1|Withdrawal by Subject|21|||
127716377|NCT02397096|459589400|FG001|Study Extension 1|Withdrawal by Subject|7|||
127716378|NCT02397096|459589399|FG000|Study Extension 2|Adverse Event|3|||
127716379|NCT02397096|459589400|FG001|Study Extension 2|Adverse Event|3|||
127716380|NCT02397096|459589399|FG000|Study Extension 2|Availability of study medication locally|152|||
127716381|NCT02397096|459589400|FG001|Study Extension 2|Availability of study medication locally|64|||
127716382|NCT02397096|459589399|FG000|Study Extension 2|Death|2|||
127716383|NCT02397096|459589400|FG001|Study Extension 2|Death|0|||
127802288|NCT00448708|459898827|FG001|Overall Study|Death|17|||
127716384|NCT02397096|459589399|FG000|Study Extension 2|Lack of Efficacy|1|||
127716385|NCT02397096|459589400|FG001|Study Extension 2|Lack of Efficacy|0|||
127716386|NCT02397096|459589399|FG000|Study Extension 2|Lost to Follow-up|2|||
127802289|NCT00448708|459898826|FG000|Overall Study|Withdrawal by Subject|8|||
127802290|NCT00448708|459898827|FG001|Overall Study|Withdrawal by Subject|4|||
127802291|NCT00448708|459898826|FG000|Overall Study|Lost to Follow-up|6|||
127716387|NCT02397096|459589400|FG001|Study Extension 2|Lost to Follow-up|1|||
127716388|NCT02397096|459589399|FG000|Study Extension 2|Non-compliance with study drug|1|||
127716389|NCT02397096|459589400|FG001|Study Extension 2|Non-compliance with study drug|0|||
127716390|NCT02397096|459589399|FG000|Study Extension 2|Physician Decision|2|||
127802292|NCT00448708|459898827|FG001|Overall Study|Lost to Follow-up|8|||
127716391|NCT02397096|459589400|FG001|Study Extension 2|Physician Decision|5|||
127716392|NCT02397096|459589399|FG000|Study Extension 2|Pregnancy|1|||
127716393|NCT02397096|459589400|FG001|Study Extension 2|Pregnancy|0|||
127716394|NCT02397096|459589399|FG000|Study Extension 2|Withdrawal by Subject|10|||
127716395|NCT02397096|459589400|FG001|Study Extension 2|Withdrawal by Subject|3|||
127716396|NCT02397096|459589399|FG000|Study Extension 3|Adverse Event|1|||
127716397|NCT02397096|459589400|FG001|Study Extension 3|Adverse Event|0|||
127716398|NCT02397096|459589399|FG000|Study Extension 3|Availability of study medication locally|11|||
127716399|NCT02397096|459589400|FG001|Study Extension 3|Availability of study medication locally|3|||
127716400|NCT02397096|459589399|FG000|Study Extension 3|Lost to Follow-up|1|||
127716401|NCT02397096|459589400|FG001|Study Extension 3|Lost to Follow-up|0|||
127716402|NCT02397096|459589399|FG000|Study Extension 3|Withdrawal by Subject|2|||
127716403|NCT02397096|459589400|FG001|Study Extension 3|Withdrawal by Subject|1|||
127716404|NCT05580003|459589401|FG000|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
127716405|NCT05580003|459589402|FG001|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
127716406|NCT05580003|459589403|FG002|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
127716407|NCT05580003|459589404|FG003|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
127716408|NCT05580003|459589405|FG004|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
127716409|NCT05580003|459589406|FG005|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
127716410|NCT05580003|459589407|FG006|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
127716411|NCT05580003|459589408|FG007|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
127716412|NCT05580003|459589409|FG008|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
127716413|NCT05580003|459589410|FG009|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
127716414|NCT05580003|459589411|FG010|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
127716415|NCT05580003|459589412|FG011|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
127716416|NCT05580003|459589413|FG012|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
127716417|NCT05580003|459589414|FG013|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
127716418|NCT05580003|459589415|FG014|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
127716419|NCT05580003|459589416|FG015|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
127716420|NCT05580003|459589417|FG016|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
127716421|NCT05580003|459589418|FG017|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
127716422|NCT05580003|459589419|FG018|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
127716423|NCT05580003|459589420|FG019|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
127716424|NCT05580003|459589421|FG020|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
127716425|NCT05580003|459589422|FG021|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
127802293|NCT00448708|459898826|FG000|Overall Study|not listed|0|||
127802294|NCT00448708|459898827|FG001|Overall Study|not listed|2|||
127802295|NCT02400255|459898829|FG000|Overall Study|Relapse|4|||
127802296|NCT02400255|459898830|FG001|Overall Study|Relapse|1|||
127802297|NCT02400255|459898831|FG002|Overall Study|Relapse|1|||
127802298|NCT02400255|459898832|FG003|Overall Study|Relapse|2|||
127716426|NCT05580003|459589423|FG022|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
127716427|NCT05580003|459589424|FG023|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
127716428|NCT05580003|459589425|FG024|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
127716429|NCT05580003|459589426|FG025|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
127716430|NCT05580003|459589427|FG026|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
127716431|NCT05580003|459589428|FG027|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
127716432|NCT05580003|459589401|FG000|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
127716433|NCT05580003|459589402|FG001|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
127716434|NCT05580003|459589403|FG002|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
127716435|NCT05580003|459589404|FG003|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
127716436|NCT05580003|459589405|FG004|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
127716437|NCT05580003|459589406|FG005|Part 1 Treatment Period 2 (Day 1)|Physician Decision|1|||
127716438|NCT05580003|459589407|FG006|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
127716439|NCT05580003|459589408|FG007|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
127716440|NCT05580003|459589409|FG008|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
127716441|NCT05580003|459589410|FG009|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
127716442|NCT05580003|459589411|FG010|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
127716443|NCT05580003|459589412|FG011|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
127716444|NCT05580003|459589413|FG012|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
127716445|NCT05580003|459589414|FG013|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
127716446|NCT05580003|459589415|FG014|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
127716447|NCT05580003|459589416|FG015|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
127716448|NCT05580003|459589417|FG016|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
127716449|NCT05580003|459589418|FG017|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
127716450|NCT05580003|459589419|FG018|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
127716451|NCT05580003|459589420|FG019|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
127716452|NCT05580003|459589421|FG020|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
127716453|NCT05580003|459589422|FG021|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
127716454|NCT05580003|459589423|FG022|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
127802299|NCT02400255|459898829|FG000|Overall Study|Adverse Event|6|||
127802300|NCT02400255|459898830|FG001|Overall Study|Adverse Event|3|||
127802301|NCT02400255|459898831|FG002|Overall Study|Adverse Event|0|||
127802302|NCT02400255|459898832|FG003|Overall Study|Adverse Event|0|||
127802303|NCT02400255|459898829|FG000|Overall Study|Physician Decision|6|||
127802304|NCT02400255|459898830|FG001|Overall Study|Physician Decision|0|||
127802305|NCT02400255|459898831|FG002|Overall Study|Physician Decision|0|||
127802306|NCT02400255|459898832|FG003|Overall Study|Physician Decision|0|||
127716455|NCT05580003|459589424|FG023|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
127716456|NCT05580003|459589425|FG024|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
127716457|NCT05580003|459589426|FG025|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
127716458|NCT05580003|459589427|FG026|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
127716459|NCT05580003|459589428|FG027|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
127716460|NCT05580003|459589401|FG000|Part 1 Treatment Period 2 (Day 1)|Other|0|||
127716461|NCT05580003|459589402|FG001|Part 1 Treatment Period 2 (Day 1)|Other|0|||
127716462|NCT05580003|459589403|FG002|Part 1 Treatment Period 2 (Day 1)|Other|0|||
127716463|NCT05580003|459589404|FG003|Part 1 Treatment Period 2 (Day 1)|Other|1|||
127716464|NCT05580003|459589405|FG004|Part 1 Treatment Period 2 (Day 1)|Other|0|||
127716465|NCT05580003|459589406|FG005|Part 1 Treatment Period 2 (Day 1)|Other|0|||
127716466|NCT05580003|459589407|FG006|Part 1 Treatment Period 2 (Day 1)|Other|0|||
127716467|NCT05580003|459589408|FG007|Part 1 Treatment Period 2 (Day 1)|Other|0|||
127716468|NCT05580003|459589409|FG008|Part 1 Treatment Period 2 (Day 1)|Other|0|||
127716469|NCT05580003|459589410|FG009|Part 1 Treatment Period 2 (Day 1)|Other|0|||
127716470|NCT05580003|459589411|FG010|Part 1 Treatment Period 2 (Day 1)|Other|0|||
127716471|NCT05580003|459589412|FG011|Part 1 Treatment Period 2 (Day 1)|Other|0|||
127716472|NCT05580003|459589413|FG012|Part 1 Treatment Period 2 (Day 1)|Other|0|||
127716473|NCT05580003|459589414|FG013|Part 1 Treatment Period 2 (Day 1)|Other|0|||
127716474|NCT05580003|459589415|FG014|Part 1 Treatment Period 2 (Day 1)|Other|0|||
127716475|NCT05580003|459589416|FG015|Part 1 Treatment Period 2 (Day 1)|Other|0|||
127716476|NCT05580003|459589417|FG016|Part 1 Treatment Period 2 (Day 1)|Other|0|||
127716477|NCT05580003|459589418|FG017|Part 1 Treatment Period 2 (Day 1)|Other|0|||
127716478|NCT05580003|459589419|FG018|Part 1 Treatment Period 2 (Day 1)|Other|0|||
127716479|NCT05580003|459589420|FG019|Part 1 Treatment Period 2 (Day 1)|Other|0|||
127716480|NCT05580003|459589421|FG020|Part 1 Treatment Period 2 (Day 1)|Other|0|||
127716481|NCT05580003|459589422|FG021|Part 1 Treatment Period 2 (Day 1)|Other|0|||
127716482|NCT05580003|459589423|FG022|Part 1 Treatment Period 2 (Day 1)|Other|0|||
127716483|NCT05580003|459589424|FG023|Part 1 Treatment Period 2 (Day 1)|Other|0|||
127716484|NCT05580003|459589425|FG024|Part 1 Treatment Period 2 (Day 1)|Other|0|||
127716485|NCT05580003|459589426|FG025|Part 1 Treatment Period 2 (Day 1)|Other|0|||
127716486|NCT05580003|459589427|FG026|Part 1 Treatment Period 2 (Day 1)|Other|0|||
127716487|NCT05580003|459589428|FG027|Part 1 Treatment Period 2 (Day 1)|Other|0|||
127716488|NCT05580003|459589401|FG000|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
127716489|NCT05580003|459589402|FG001|Part 1: Treatment Period 3 (Day 1)|Physician Decision|1|||
127716490|NCT05580003|459589403|FG002|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
127716491|NCT05580003|459589404|FG003|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
127716492|NCT05580003|459589405|FG004|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
127716493|NCT05580003|459589406|FG005|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
127716494|NCT05580003|459589407|FG006|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
127716495|NCT05580003|459589408|FG007|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
127716496|NCT05580003|459589409|FG008|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
127716497|NCT05580003|459589410|FG009|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
127716498|NCT05580003|459589411|FG010|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
127716499|NCT05580003|459589412|FG011|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
127716500|NCT05580003|459589413|FG012|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
127716501|NCT05580003|459589414|FG013|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
127716502|NCT05580003|459589415|FG014|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
127716503|NCT05580003|459589416|FG015|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
127716504|NCT05580003|459589417|FG016|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
127716505|NCT05580003|459589418|FG017|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
127716506|NCT05580003|459589419|FG018|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
127716507|NCT05580003|459589420|FG019|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
127716508|NCT05580003|459589421|FG020|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
127716509|NCT05580003|459589422|FG021|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
127716510|NCT05580003|459589423|FG022|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
127716511|NCT05580003|459589424|FG023|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
127716512|NCT05580003|459589425|FG024|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
127716513|NCT05580003|459589426|FG025|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
127716514|NCT05580003|459589427|FG026|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
127716515|NCT05580003|459589428|FG027|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
127716516|NCT05580003|459589401|FG000|Part 2 (up to 10 Days)|Other|0|||
127716517|NCT05580003|459589402|FG001|Part 2 (up to 10 Days)|Other|0|||
127716518|NCT05580003|459589403|FG002|Part 2 (up to 10 Days)|Other|0|||
127716519|NCT05580003|459589404|FG003|Part 2 (up to 10 Days)|Other|0|||
127716520|NCT05580003|459589405|FG004|Part 2 (up to 10 Days)|Other|0|||
127716521|NCT05580003|459589406|FG005|Part 2 (up to 10 Days)|Other|0|||
127716522|NCT05580003|459589407|FG006|Part 2 (up to 10 Days)|Other|0|||
127716523|NCT05580003|459589408|FG007|Part 2 (up to 10 Days)|Other|0|||
127716524|NCT05580003|459589409|FG008|Part 2 (up to 10 Days)|Other|0|||
127716525|NCT05580003|459589410|FG009|Part 2 (up to 10 Days)|Other|1|||
127716526|NCT05580003|459589411|FG010|Part 2 (up to 10 Days)|Other|0|||
127716527|NCT05580003|459589412|FG011|Part 2 (up to 10 Days)|Other|0|||
127716528|NCT05580003|459589413|FG012|Part 2 (up to 10 Days)|Other|0|||
127716529|NCT05580003|459589414|FG013|Part 2 (up to 10 Days)|Other|0|||
127716530|NCT05580003|459589415|FG014|Part 2 (up to 10 Days)|Other|0|||
127716531|NCT05580003|459589416|FG015|Part 2 (up to 10 Days)|Other|0|||
127716532|NCT05580003|459589417|FG016|Part 2 (up to 10 Days)|Other|0|||
127716533|NCT05580003|459589418|FG017|Part 2 (up to 10 Days)|Other|0|||
127716534|NCT05580003|459589419|FG018|Part 2 (up to 10 Days)|Other|0|||
127716535|NCT05580003|459589420|FG019|Part 2 (up to 10 Days)|Other|0|||
127716536|NCT05580003|459589421|FG020|Part 2 (up to 10 Days)|Other|0|||
127716537|NCT05580003|459589422|FG021|Part 2 (up to 10 Days)|Other|0|||
127716538|NCT05580003|459589423|FG022|Part 2 (up to 10 Days)|Other|0|||
127716539|NCT05580003|459589424|FG023|Part 2 (up to 10 Days)|Other|0|||
127716540|NCT05580003|459589425|FG024|Part 2 (up to 10 Days)|Other|0|||
127716541|NCT05580003|459589426|FG025|Part 2 (up to 10 Days)|Other|0|||
127716542|NCT05580003|459589427|FG026|Part 2 (up to 10 Days)|Other|0|||
127716543|NCT05580003|459589428|FG027|Part 2 (up to 10 Days)|Other|0|||
127716544|NCT05580003|459589401|FG000|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
127716545|NCT05580003|459589402|FG001|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
127716546|NCT05580003|459589403|FG002|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
127716547|NCT05580003|459589404|FG003|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
127716548|NCT05580003|459589405|FG004|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
127716549|NCT05580003|459589406|FG005|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
127716550|NCT05580003|459589407|FG006|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
127716551|NCT05580003|459589408|FG007|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
127716552|NCT05580003|459589409|FG008|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
127716553|NCT05580003|459589410|FG009|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
127716554|NCT05580003|459589411|FG010|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
127716555|NCT05580003|459589412|FG011|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
127716556|NCT05580003|459589413|FG012|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
127716557|NCT05580003|459589414|FG013|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
127716558|NCT05580003|459589415|FG014|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
127716559|NCT05580003|459589416|FG015|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
127716560|NCT05580003|459589417|FG016|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
127716561|NCT05580003|459589418|FG017|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
127716562|NCT05580003|459589419|FG018|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
127716563|NCT05580003|459589420|FG019|Part 4 (Day 1 to Day 11)|Adverse Event|1|||
127716564|NCT05580003|459589421|FG020|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
127716565|NCT05580003|459589422|FG021|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
127716566|NCT05580003|459589423|FG022|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
127716567|NCT05580003|459589424|FG023|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
127716568|NCT05580003|459589425|FG024|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
127716569|NCT05580003|459589426|FG025|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
127716570|NCT05580003|459589427|FG026|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
127716571|NCT05580003|459589428|FG027|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
127716572|NCT05580003|459589401|FG000|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
127716573|NCT05580003|459589402|FG001|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
127716574|NCT05580003|459589403|FG002|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
127716575|NCT05580003|459589404|FG003|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
127716576|NCT05580003|459589405|FG004|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
127716577|NCT05580003|459589406|FG005|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
127716578|NCT05580003|459589407|FG006|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
127716579|NCT05580003|459589408|FG007|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
127716580|NCT05580003|459589409|FG008|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
127716581|NCT05580003|459589410|FG009|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
127716582|NCT05580003|459589411|FG010|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
127716583|NCT05580003|459589412|FG011|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
127716584|NCT05580003|459589413|FG012|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
127716585|NCT05580003|459589414|FG013|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
127716586|NCT05580003|459589415|FG014|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
127716587|NCT05580003|459589416|FG015|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
127716588|NCT05580003|459589417|FG016|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
127716589|NCT05580003|459589418|FG017|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
127716590|NCT05580003|459589419|FG018|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
127716591|NCT05580003|459589420|FG019|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
127716592|NCT05580003|459589421|FG020|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|1|||
127716593|NCT05580003|459589422|FG021|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
127716594|NCT05580003|459589423|FG022|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
127716595|NCT05580003|459589424|FG023|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
127716596|NCT05580003|459589425|FG024|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
127716597|NCT05580003|459589426|FG025|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
127716598|NCT05580003|459589427|FG026|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
127716599|NCT05580003|459589428|FG027|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
127716600|NCT05580003|459589401|FG000|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
127716601|NCT05580003|459589402|FG001|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
127716602|NCT05580003|459589403|FG002|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
127716603|NCT05580003|459589404|FG003|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
127716604|NCT05580003|459589405|FG004|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
127716605|NCT05580003|459589406|FG005|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
127716606|NCT05580003|459589407|FG006|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
127716607|NCT05580003|459589408|FG007|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
127716608|NCT05580003|459589409|FG008|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
127716609|NCT05580003|459589410|FG009|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
127716610|NCT05580003|459589411|FG010|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
127716611|NCT05580003|459589412|FG011|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
127716612|NCT05580003|459589413|FG012|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
127716613|NCT05580003|459589414|FG013|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
127716614|NCT05580003|459589415|FG014|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
127716615|NCT05580003|459589416|FG015|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
127716616|NCT05580003|459589417|FG016|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
127716617|NCT05580003|459589418|FG017|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
127716618|NCT05580003|459589419|FG018|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
127716619|NCT05580003|459589420|FG019|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
127716620|NCT05580003|459589421|FG020|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
127716621|NCT05580003|459589422|FG021|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|1|||
127716622|NCT05580003|459589423|FG022|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
127716623|NCT05580003|459589424|FG023|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
127716624|NCT05580003|459589425|FG024|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
127716625|NCT05580003|459589426|FG025|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
127716626|NCT05580003|459589427|FG026|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
127716627|NCT05580003|459589428|FG027|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
127716628|NCT05580003|459589401|FG000|Part 6 Period 2 (Day 1)|Adverse Event|0|||
127716629|NCT05580003|459589402|FG001|Part 6 Period 2 (Day 1)|Adverse Event|0|||
127716630|NCT05580003|459589403|FG002|Part 6 Period 2 (Day 1)|Adverse Event|0|||
127716631|NCT05580003|459589404|FG003|Part 6 Period 2 (Day 1)|Adverse Event|0|||
127716632|NCT05580003|459589405|FG004|Part 6 Period 2 (Day 1)|Adverse Event|0|||
127716633|NCT05580003|459589406|FG005|Part 6 Period 2 (Day 1)|Adverse Event|0|||
127716634|NCT05580003|459589407|FG006|Part 6 Period 2 (Day 1)|Adverse Event|0|||
127716635|NCT05580003|459589408|FG007|Part 6 Period 2 (Day 1)|Adverse Event|0|||
127716636|NCT05580003|459589409|FG008|Part 6 Period 2 (Day 1)|Adverse Event|0|||
127716637|NCT05580003|459589410|FG009|Part 6 Period 2 (Day 1)|Adverse Event|0|||
127716638|NCT05580003|459589411|FG010|Part 6 Period 2 (Day 1)|Adverse Event|0|||
127716639|NCT05580003|459589412|FG011|Part 6 Period 2 (Day 1)|Adverse Event|0|||
127716640|NCT05580003|459589413|FG012|Part 6 Period 2 (Day 1)|Adverse Event|0|||
127716641|NCT05580003|459589414|FG013|Part 6 Period 2 (Day 1)|Adverse Event|0|||
127716642|NCT05580003|459589415|FG014|Part 6 Period 2 (Day 1)|Adverse Event|0|||
127716643|NCT05580003|459589416|FG015|Part 6 Period 2 (Day 1)|Adverse Event|0|||
127716644|NCT05580003|459589417|FG016|Part 6 Period 2 (Day 1)|Adverse Event|0|||
127716645|NCT05580003|459589418|FG017|Part 6 Period 2 (Day 1)|Adverse Event|0|||
127716646|NCT05580003|459589419|FG018|Part 6 Period 2 (Day 1)|Adverse Event|0|||
127716647|NCT05580003|459589420|FG019|Part 6 Period 2 (Day 1)|Adverse Event|0|||
127716648|NCT05580003|459589421|FG020|Part 6 Period 2 (Day 1)|Adverse Event|0|||
127716649|NCT05580003|459589422|FG021|Part 6 Period 2 (Day 1)|Adverse Event|0|||
127716650|NCT05580003|459589423|FG022|Part 6 Period 2 (Day 1)|Adverse Event|0|||
127716651|NCT05580003|459589424|FG023|Part 6 Period 2 (Day 1)|Adverse Event|0|||
127716652|NCT05580003|459589425|FG024|Part 6 Period 2 (Day 1)|Adverse Event|0|||
127716653|NCT05580003|459589426|FG025|Part 6 Period 2 (Day 1)|Adverse Event|0|||
127716654|NCT05580003|459589427|FG026|Part 6 Period 2 (Day 1)|Adverse Event|0|||
127716655|NCT05580003|459589428|FG027|Part 6 Period 2 (Day 1)|Adverse Event|1|||
127716656|NCT05580003|459589401|FG000|Part 6 Period 2 (Day 1)|Other|0|||
127716657|NCT05580003|459589402|FG001|Part 6 Period 2 (Day 1)|Other|0|||
127716658|NCT05580003|459589403|FG002|Part 6 Period 2 (Day 1)|Other|0|||
127802307|NCT02400255|459898829|FG000|Overall Study|Loss of insurance|1|||
127802308|NCT02400255|459898830|FG001|Overall Study|Loss of insurance|0|||
127716659|NCT05580003|459589404|FG003|Part 6 Period 2 (Day 1)|Other|0|||
127716660|NCT05580003|459589405|FG004|Part 6 Period 2 (Day 1)|Other|0|||
127716661|NCT05580003|459589406|FG005|Part 6 Period 2 (Day 1)|Other|0|||
127716662|NCT05580003|459589407|FG006|Part 6 Period 2 (Day 1)|Other|0|||
127716663|NCT05580003|459589408|FG007|Part 6 Period 2 (Day 1)|Other|0|||
127802309|NCT02400255|459898831|FG002|Overall Study|Loss of insurance|0|||
127802310|NCT02400255|459898832|FG003|Overall Study|Loss of insurance|0|||
127802311|NCT00713219|459898833|FG000|Overall Study|Death|1|||
127716664|NCT05580003|459589409|FG008|Part 6 Period 2 (Day 1)|Other|0|||
127716665|NCT05580003|459589410|FG009|Part 6 Period 2 (Day 1)|Other|0|||
127716666|NCT05580003|459589411|FG010|Part 6 Period 2 (Day 1)|Other|0|||
127716667|NCT05580003|459589412|FG011|Part 6 Period 2 (Day 1)|Other|0|||
127716668|NCT05580003|459589413|FG012|Part 6 Period 2 (Day 1)|Other|0|||
127716669|NCT05580003|459589414|FG013|Part 6 Period 2 (Day 1)|Other|0|||
127716670|NCT05580003|459589415|FG014|Part 6 Period 2 (Day 1)|Other|0|||
127716671|NCT05580003|459589416|FG015|Part 6 Period 2 (Day 1)|Other|0|||
127716672|NCT05580003|459589417|FG016|Part 6 Period 2 (Day 1)|Other|0|||
127716673|NCT05580003|459589418|FG017|Part 6 Period 2 (Day 1)|Other|0|||
127716674|NCT05580003|459589419|FG018|Part 6 Period 2 (Day 1)|Other|0|||
127716675|NCT05580003|459589420|FG019|Part 6 Period 2 (Day 1)|Other|0|||
127716676|NCT05580003|459589421|FG020|Part 6 Period 2 (Day 1)|Other|0|||
127716677|NCT05580003|459589422|FG021|Part 6 Period 2 (Day 1)|Other|0|||
127716678|NCT05580003|459589423|FG022|Part 6 Period 2 (Day 1)|Other|0|||
127716679|NCT05580003|459589424|FG023|Part 6 Period 2 (Day 1)|Other|0|||
127716680|NCT05580003|459589425|FG024|Part 6 Period 2 (Day 1)|Other|1|||
127716681|NCT05580003|459589426|FG025|Part 6 Period 2 (Day 1)|Other|0|||
127716682|NCT05580003|459589427|FG026|Part 6 Period 2 (Day 1)|Other|0|||
127716683|NCT05580003|459589428|FG027|Part 6 Period 2 (Day 1)|Other|0|||
127716684|NCT02392234|459589429|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
127716685|NCT02392234|459589430|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
127716686|NCT02392234|459589431|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
127716687|NCT02392234|459589432|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
127716688|NCT02392234|459589433|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
127716689|NCT02392234|459589434|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
127716690|NCT02392234|459589429|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
127716691|NCT02392234|459589430|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
127716692|NCT02392234|459589431|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
127716693|NCT02392234|459589432|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
127716694|NCT02392234|459589433|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
127716695|NCT02392234|459589434|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
127716696|NCT02392234|459589429|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
127716697|NCT02392234|459589430|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
127716698|NCT02392234|459589431|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
127716699|NCT02392234|459589432|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
127716700|NCT02392234|459589433|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
127716701|NCT02392234|459589434|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
127716702|NCT02392234|459589429|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
127716703|NCT02392234|459589430|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
127716704|NCT02392234|459589431|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
127716705|NCT02392234|459589432|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
127716706|NCT02392234|459589433|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
127716707|NCT02392234|459589434|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
127716708|NCT02392234|459589429|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
127716709|NCT02392234|459589430|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
127716710|NCT02392234|459589431|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
127716711|NCT02392234|459589432|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
127716712|NCT02392234|459589433|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
127716713|NCT02392234|459589434|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
127716714|NCT02392234|459589429|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
127716715|NCT02392234|459589430|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
127716716|NCT02392234|459589431|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
127716717|NCT02392234|459589432|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
127716718|NCT02392234|459589433|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
127716719|NCT02392234|459589434|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
127716720|NCT02392234|459589429|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
127716721|NCT02392234|459589430|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
127716722|NCT02392234|459589431|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
127716723|NCT02392234|459589432|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
127716724|NCT02392234|459589433|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
127716725|NCT02392234|459589434|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
127716726|NCT02392234|459589429|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
127716727|NCT02392234|459589430|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
127716728|NCT02392234|459589431|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
127716729|NCT02392234|459589432|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
127716730|NCT02392234|459589433|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
127716731|NCT02392234|459589434|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
127716732|NCT02052440|459589435|FG000|Overall Study|Withdrawal by Subject|0|||
127716733|NCT02052440|459589436|FG001|Overall Study|Withdrawal by Subject|1|||
127716734|NCT02130557|459589437|FG000|Overall Study|Withdrawal by Subject|12|||
127716735|NCT02130557|459589438|FG001|Overall Study|Withdrawal by Subject|12|||
127802312|NCT00713219|459898833|FG000|Overall Study|Protocol Violation|1|||
127802313|NCT01557166|459898834|FG000|Overall Study|Adverse Event|20|||
127802314|NCT01557166|459898835|FG001|Overall Study|Adverse Event|6|||
127802315|NCT01557166|459898834|FG000|Overall Study|Lack of Efficacy|2|||
127802316|NCT01557166|459898835|FG001|Overall Study|Lack of Efficacy|1|||
127802317|NCT01557166|459898834|FG000|Overall Study|Protocol Violation|8|||
127802318|NCT01557166|459898835|FG001|Overall Study|Protocol Violation|5|||
127716736|NCT02130557|459589437|FG000|Overall Study|Investigator Request|0|||
127716737|NCT02130557|459589438|FG001|Overall Study|Investigator Request|2|||
127716738|NCT02130557|459589437|FG000|Overall Study|Deceased|14|||
127716739|NCT02130557|459589438|FG001|Overall Study|Deceased|14|||
127716740|NCT02130557|459589437|FG000|Overall Study|Lost to Follow-up|6|||
127716741|NCT02130557|459589438|FG001|Overall Study|Lost to Follow-up|7|||
127716742|NCT02130557|459589437|FG000|Overall Study|Other|2|||
127716743|NCT02130557|459589438|FG001|Overall Study|Other|1|||
127716744|NCT02130557|459589437|FG000|Overall Study|Missing|2|||
127716745|NCT02130557|459589438|FG001|Overall Study|Missing|1|||
127716746|NCT02408887|459589439|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
127716747|NCT02408887|459589440|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
127716748|NCT02408887|459589439|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
127716749|NCT02408887|459589440|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
127716750|NCT03333109|459589441|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
127716751|NCT03333109|459589442|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
127716752|NCT03333109|459589443|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
127716753|NCT03333109|459589441|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
127716754|NCT03333109|459589442|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
127716755|NCT03333109|459589443|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
127716756|NCT03333109|459589441|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
127716757|NCT03333109|459589442|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
127716758|NCT03333109|459589443|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
127716759|NCT03333109|459589441|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
127716760|NCT03333109|459589442|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
127716761|NCT03333109|459589443|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
127716762|NCT03333109|459589441|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
127716763|NCT03333109|459589442|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
127716764|NCT03333109|459589443|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
127716765|NCT03333109|459589441|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
127716766|NCT03333109|459589442|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
127716767|NCT03333109|459589443|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
127716768|NCT03333109|459589441|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
127716769|NCT03333109|459589442|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
127716770|NCT03333109|459589443|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
127716771|NCT03333109|459589441|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
127716772|NCT03333109|459589442|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
127716773|NCT03333109|459589443|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
127716774|NCT00918203|459589447|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
127716775|NCT00918203|459589448|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
127716776|NCT00918203|459589449|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
127716777|NCT00918203|459589447|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
127716778|NCT00918203|459589448|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
127716779|NCT00918203|459589449|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
127716780|NCT00918203|459589447|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
127716781|NCT00918203|459589448|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
127716782|NCT00918203|459589449|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
127716783|NCT00918203|459589447|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
127716784|NCT00918203|459589448|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
127716785|NCT00918203|459589449|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
127716786|NCT00701701|459589452|FG000|Overall Study|Withdrawal by Subject|0|||
127716787|NCT00701701|459589453|FG001|Overall Study|Withdrawal by Subject|1|||
127716788|NCT00701701|459589452|FG000|Overall Study|Adverse Event|0|||
127716789|NCT00701701|459589453|FG001|Overall Study|Adverse Event|1|||
127716790|NCT00589875|459589454|FG000|Enrollment to Treatment Initiation|Patients ineligable for study.|9|||
127716791|NCT00589875|459589454|FG000|Treatment Initiation to Completion|Treatment discontinuation|7|||
127716792|NCT03488719|459589457|FG000|Overall Study|Adverse Event|0|||
127716793|NCT03488719|459589458|FG001|Overall Study|Adverse Event|4|||
127716794|NCT03488719|459589459|FG002|Overall Study|Adverse Event|2|||
127716795|NCT03488719|459589457|FG000|Overall Study|Other|0|||
127716796|NCT03488719|459589458|FG001|Overall Study|Other|0|||
127802319|NCT01557166|459898834|FG000|Overall Study|Withdrawn consent|12|||
127716797|NCT03488719|459589459|FG002|Overall Study|Other|5|||
127716798|NCT02078648|459589460|FG000|Overall Study|Unequivocal Evidence of Disease Progression|36|||
127716799|NCT02078648|459589461|FG001|Overall Study|Unequivocal Evidence of Disease Progression|13|||
127716800|NCT02078648|459589460|FG000|Overall Study|Adverse Event|0|||
127716801|NCT02078648|459589461|FG001|Overall Study|Adverse Event|1|||
127716802|NCT02078648|459589460|FG000|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|1|||
127716803|NCT02078648|459589461|FG001|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|4|||
127716804|NCT02078648|459589460|FG000|Overall Study|Withdrawal by Subject|3|||
127716805|NCT02078648|459589461|FG001|Overall Study|Withdrawal by Subject|1|||
127716806|NCT02078648|459589460|FG000|Overall Study|Investigator Decision|5|||
127716807|NCT02078648|459589461|FG001|Overall Study|Investigator Decision|7|||
127716808|NCT02078648|459589460|FG000|Overall Study|Death|1|||
127716809|NCT02078648|459589461|FG001|Overall Study|Death|1|||
127716810|NCT02078648|459589460|FG000|Overall Study|Undefined|0|||
127716811|NCT02078648|459589461|FG001|Overall Study|Undefined|1|||
127716812|NCT05613907|459589466|FG000|Overall Study|Lost to Follow-up|5|||
127716813|NCT05613907|459589466|FG000|Overall Study|Death|3|||
127716814|NCT05613907|459589466|FG000|Overall Study|Withdrawal by Subject|2|||
127716815|NCT00490139|459589467|FG000|Overall Study|Lost to Follow-up|249|||
127716816|NCT00490139|459589468|FG001|Overall Study|Lost to Follow-up|216|||
127716817|NCT00490139|459589469|FG002|Overall Study|Lost to Follow-up|205|||
127716818|NCT00490139|459589470|FG003|Overall Study|Lost to Follow-up|229|||
127716819|NCT00490139|459589467|FG000|Overall Study|Withdrawal by Subject|333|||
127716820|NCT00490139|459589468|FG001|Overall Study|Withdrawal by Subject|322|||
127716821|NCT00490139|459589469|FG002|Overall Study|Withdrawal by Subject|396|||
127716822|NCT00490139|459589470|FG003|Overall Study|Withdrawal by Subject|295|||
127716823|NCT00490139|459589467|FG000|Overall Study|Patient did not sign ICF 12|169|||
127716824|NCT00490139|459589468|FG001|Overall Study|Patient did not sign ICF 12|176|||
127716825|NCT00490139|459589469|FG002|Overall Study|Patient did not sign ICF 12|139|||
127716826|NCT00490139|459589470|FG003|Overall Study|Patient did not sign ICF 12|167|||
127716827|NCT00490139|459589467|FG000|Overall Study|Data unavailable due to regulatory issues|98|||
127716828|NCT00490139|459589468|FG001|Overall Study|Data unavailable due to regulatory issues|96|||
127716829|NCT00490139|459589469|FG002|Overall Study|Data unavailable due to regulatory issues|85|||
127716830|NCT00490139|459589470|FG003|Overall Study|Data unavailable due to regulatory issues|95|||
127716831|NCT00490139|459589467|FG000|Overall Study|Data unavailable due to lapsed ethical consent|14|||
127716832|NCT00490139|459589468|FG001|Overall Study|Data unavailable due to lapsed ethical consent|13|||
127716833|NCT00490139|459589469|FG002|Overall Study|Data unavailable due to lapsed ethical consent|14|||
127716834|NCT00490139|459589470|FG003|Overall Study|Data unavailable due to lapsed ethical consent|14|||
127716835|NCT00490139|459589467|FG000|Overall Study|Other reasons as defined per protocol|98|||
127716836|NCT00490139|459589468|FG001|Overall Study|Other reasons as defined per protocol|84|||
127716837|NCT00490139|459589469|FG002|Overall Study|Other reasons as defined per protocol|82|||
127716838|NCT00490139|459589470|FG003|Overall Study|Other reasons as defined per protocol|105|||
127716839|NCT04484623|459589471|FG000|Overall Study|Lost to Follow-up|0|||
127716840|NCT04484623|459589472|FG001|Overall Study|Lost to Follow-up|1|||
127716841|NCT04484623|459589471|FG000|Overall Study|Protocol Deviation|1|||
127716842|NCT04484623|459589472|FG001|Overall Study|Protocol Deviation|0|||
127716843|NCT04484623|459589471|FG000|Overall Study|Physician Decision|1|||
127716844|NCT04484623|459589472|FG001|Overall Study|Physician Decision|0|||
127716845|NCT04484623|459589471|FG000|Overall Study|Withdrawal by Subject|11|||
127716846|NCT04484623|459589472|FG001|Overall Study|Withdrawal by Subject|8|||
127716847|NCT04484623|459589471|FG000|Overall Study|Ongoing|94|||
127716848|NCT04484623|459589472|FG001|Overall Study|Ongoing|84|||
127716849|NCT06140290|459589474|FG000|Period 1|Adverse Event|1|||
127716850|NCT06140290|459589475|FG001|Period 1|Adverse Event|0|||
127716851|NCT06140290|459589474|FG000|Period 2|Assigned but not treated|0|||
127716852|NCT06140290|459589475|FG001|Period 2|Assigned but not treated|1|||
127716853|NCT06140290|459589474|FG000|Period 2|Withdrawal by Subject|0|||
127716854|NCT06140290|459589475|FG001|Period 2|Withdrawal by Subject|1|||
127716855|NCT02036970|459590896|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
127716856|NCT02036970|459590897|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
127716857|NCT02036970|459590898|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
127716858|NCT02036970|459590899|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
127716859|NCT02036970|459590900|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
127716860|NCT02036970|459590901|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
127716861|NCT02036970|459590902|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
127716862|NCT02036970|459590903|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
127716863|NCT02036970|459590904|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
127716864|NCT02036970|459590905|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
127716865|NCT02036970|459590896|FG000|Part 1: Day 1 Through Week 16|Death|0|||
127716866|NCT02036970|459590897|FG001|Part 1: Day 1 Through Week 16|Death|0|||
127716867|NCT02036970|459590898|FG002|Part 1: Day 1 Through Week 16|Death|0|||
127716868|NCT02036970|459590899|FG003|Part 1: Day 1 Through Week 16|Death|0|||
127716869|NCT02036970|459590900|FG004|Part 1: Day 1 Through Week 16|Death|0|||
127716870|NCT02036970|459590901|FG005|Part 1: Day 1 Through Week 16|Death|0|||
127716871|NCT02036970|459590902|FG006|Part 1: Day 1 Through Week 16|Death|0|||
127716872|NCT02036970|459590903|FG007|Part 1: Day 1 Through Week 16|Death|0|||
127716873|NCT02036970|459590904|FG008|Part 1: Day 1 Through Week 16|Death|1|||
127716874|NCT02036970|459590905|FG009|Part 1: Day 1 Through Week 16|Death|0|||
127716875|NCT02036970|459590896|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
127716876|NCT02036970|459590897|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
127716877|NCT02036970|459590898|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
127716878|NCT02036970|459590899|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
127716879|NCT02036970|459590900|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
127716880|NCT02036970|459590901|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
127716881|NCT02036970|459590902|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
127716882|NCT02036970|459590903|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
127716883|NCT02036970|459590904|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
127716884|NCT02036970|459590905|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
127716885|NCT02036970|459590896|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
127716886|NCT02036970|459590897|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
127716887|NCT02036970|459590898|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
127716888|NCT02036970|459590899|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
127716889|NCT02036970|459590900|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
127716890|NCT02036970|459590901|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
127716891|NCT02036970|459590902|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
127716892|NCT02036970|459590903|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
127802320|NCT01557166|459898835|FG001|Overall Study|Withdrawn consent|20|||
127802321|NCT01557166|459898834|FG000|Overall Study|Target dose not tolerated|1|||
127802322|NCT01557166|459898835|FG001|Overall Study|Target dose not tolerated|0|||
127802323|NCT01557166|459898834|FG000|Overall Study|Psychiatric disorder|1|||
127802324|NCT01557166|459898835|FG001|Overall Study|Psychiatric disorder|0|||
127802325|NCT01557166|459898834|FG000|Overall Study|Unclassified|2|||
127802326|NCT01557166|459898835|FG001|Overall Study|Unclassified|5|||
127802327|NCT00946309|459898836|FG000|Overall Study|Protocol Violation|1|||
127802328|NCT00946309|459898837|FG001|Overall Study|Protocol Violation|0|||
127802329|NCT00946309|459898836|FG000|Overall Study|Lost to Follow-up|0|||
127802330|NCT00946309|459898837|FG001|Overall Study|Lost to Follow-up|1|||
127802331|NCT00946309|459898836|FG000|Overall Study|Procedure cancelled/discontinued|0|||
127802332|NCT00946309|459898837|FG001|Overall Study|Procedure cancelled/discontinued|3|||
127802333|NCT01469000|459898842|FG000|Overall Study|Withdrawal by Subject|16|||
127802334|NCT01469000|459898843|FG001|Overall Study|Withdrawal by Subject|3|||
127802335|NCT01469000|459898842|FG000|Overall Study|Sponsor Decision|4|||
127802336|NCT01469000|459898843|FG001|Overall Study|Sponsor Decision|1|||
127802337|NCT00686647|459898848|FG000|Overall Study|Lost to Follow-up|1|||
127802338|NCT00686647|459898848|FG000|Overall Study|Death|1|||
127802339|NCT05501119|459898859|FG000|Overall Study|Withdrawal by Subject|2|||
127802340|NCT05501119|459898859|FG000|Overall Study|Lost to Follow-up|5|||
127802341|NCT01356589|459898863|FG000|Overall Study|Enrolled, but not treated|3|||
127802342|NCT01356589|459898863|FG000|Overall Study|Dose data not recorded|2|||
127802343|NCT01462266|459898864|FG000|Overall Study|Adverse Event|7|||
127802344|NCT01462266|459898865|FG001|Overall Study|Adverse Event|6|||
127802345|NCT01462266|459898864|FG000|Overall Study|Death|2|||
127802346|NCT01462266|459898865|FG001|Overall Study|Death|1|||
127802347|NCT01462266|459898864|FG000|Overall Study|Lack of Efficacy|0|||
127802348|NCT01462266|459898865|FG001|Overall Study|Lack of Efficacy|2|||
127802349|NCT01462266|459898864|FG000|Overall Study|Lost to Follow-up|4|||
127802350|NCT01462266|459898865|FG001|Overall Study|Lost to Follow-up|3|||
127802351|NCT01462266|459898864|FG000|Overall Study|Non-compliance with study drug|3|||
127802352|NCT01462266|459898865|FG001|Overall Study|Non-compliance with study drug|0|||
127802353|NCT01462266|459898864|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
127802354|NCT01462266|459898865|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
127802355|NCT01462266|459898864|FG000|Overall Study|Physician Decision|2|||
127802356|NCT01462266|459898865|FG001|Overall Study|Physician Decision|5|||
127802357|NCT01462266|459898864|FG000|Overall Study|Protocol Violation|1|||
127802358|NCT01462266|459898865|FG001|Overall Study|Protocol Violation|3|||
127802359|NCT01462266|459898864|FG000|Overall Study|Withdrawal by Subject|7|||
127802360|NCT01462266|459898865|FG001|Overall Study|Withdrawal by Subject|2|||
127802361|NCT01462266|459898864|FG000|Overall Study|Screen failure|1|||
127802362|NCT01462266|459898865|FG001|Overall Study|Screen failure|1|||
127802363|NCT01106846|459898866|FG000|Overall Study|Change in surgical procedure|0|||
127802364|NCT01106846|459898867|FG001|Overall Study|Change in surgical procedure|1|||
127802365|NCT04698629|459898876|FG000|Overall Study|Adverse Event|1|||
127802366|NCT03344003|459898877|FG000|Overall Study|Switched to alternative treatment|1|||
127716893|NCT02036970|459590904|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
127716894|NCT02036970|459590905|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
127716895|NCT02036970|459590896|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
127716896|NCT02036970|459590897|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
127716897|NCT02036970|459590898|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
127716898|NCT02036970|459590899|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
127716899|NCT02036970|459590900|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
127716900|NCT02036970|459590901|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
127716901|NCT02036970|459590902|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
127716902|NCT02036970|459590903|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
127716903|NCT02036970|459590904|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
127716904|NCT02036970|459590905|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
127716905|NCT02036970|459590896|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
127716906|NCT02036970|459590897|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
127716907|NCT02036970|459590898|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
127716908|NCT02036970|459590899|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
127716909|NCT02036970|459590900|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
127716910|NCT02036970|459590901|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
127716911|NCT02036970|459590902|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
127716912|NCT02036970|459590903|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
127716913|NCT02036970|459590904|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
127716914|NCT02036970|459590905|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
127716915|NCT02036970|459590896|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
127716916|NCT02036970|459590897|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
127716917|NCT02036970|459590898|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
127716918|NCT02036970|459590899|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
127716919|NCT02036970|459590900|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
127716920|NCT02036970|459590901|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
127716921|NCT02036970|459590902|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
127716922|NCT02036970|459590903|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
127716923|NCT02036970|459590904|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
127716924|NCT02036970|459590905|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
127716925|NCT02036970|459590896|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
127716926|NCT02036970|459590897|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
127716927|NCT02036970|459590898|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
127716928|NCT02036970|459590899|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
127716929|NCT02036970|459590900|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
127716930|NCT02036970|459590901|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
127716931|NCT02036970|459590902|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
127716932|NCT02036970|459590903|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
127716933|NCT02036970|459590904|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
127716934|NCT02036970|459590905|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
127716935|NCT02036970|459590896|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
127802367|NCT03344003|459898878|FG001|Overall Study|Switched to alternative treatment|0|||
127802368|NCT03344003|459898877|FG000|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|1|||
127802369|NCT03344003|459898878|FG001|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|0|||
127802370|NCT04426695|459900983|FG000|Overall Study|Death|2|||
127802371|NCT04426695|459900984|FG001|Overall Study|Death|0|||
127802372|NCT04426695|459900985|FG002|Overall Study|Death|1|||
127802373|NCT04426695|459900986|FG003|Overall Study|Death|27|||
127802374|NCT04426695|459900987|FG004|Overall Study|Death|25|||
127802375|NCT04426695|459900988|FG005|Overall Study|Death|21|||
127802376|NCT04426695|459900989|FG006|Overall Study|Death|42|||
127802377|NCT04426695|459900990|FG007|Overall Study|Death|23|||
127802378|NCT04426695|459900991|FG008|Overall Study|Death|37|||
127802379|NCT04426695|459900992|FG009|Overall Study|Death|14|||
127802380|NCT04426695|459900993|FG010|Overall Study|Death|8|||
127802381|NCT04426695|459900994|FG011|Overall Study|Death|7|||
127802382|NCT04426695|459900995|FG012|Overall Study|Death|13|||
127802383|NCT04426695|459900996|FG013|Overall Study|Death|25|||
127802384|NCT04426695|459900997|FG014|Overall Study|Death|19|||
127802385|NCT04426695|459900998|FG015|Overall Study|Death|7|||
127802386|NCT04426695|459900999|FG016|Overall Study|Death|8|||
127802387|NCT04426695|459901000|FG017|Overall Study|Death|4|||
127802388|NCT04426695|459900983|FG000|Overall Study|Lost to Follow-up|2|||
127716936|NCT02036970|459590897|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
127716937|NCT02036970|459590898|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
127716938|NCT02036970|459590899|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
127716939|NCT02036970|459590900|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
127802389|NCT04426695|459900984|FG001|Overall Study|Lost to Follow-up|4|||
127802390|NCT04426695|459900985|FG002|Overall Study|Lost to Follow-up|1|||
127716940|NCT02036970|459590901|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
127802391|NCT04426695|459900986|FG003|Overall Study|Lost to Follow-up|19|||
127802392|NCT04426695|459900987|FG004|Overall Study|Lost to Follow-up|10|||
127716941|NCT02036970|459590902|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
127716942|NCT02036970|459590903|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
127716943|NCT02036970|459590904|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
127716944|NCT02036970|459590905|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
127716945|NCT02386098|459590908|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
127716946|NCT02386098|459590909|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
127716947|NCT02386098|459590910|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
127716948|NCT02386098|459590911|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
127716949|NCT02386098|459590912|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
127716950|NCT02386098|459590908|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
127716951|NCT02386098|459590909|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
127716952|NCT02386098|459590910|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
127716953|NCT02386098|459590911|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
127716954|NCT02386098|459590912|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
127716955|NCT02386098|459590908|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
127716956|NCT02386098|459590909|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
127716957|NCT02386098|459590910|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
127716958|NCT02386098|459590911|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
127716959|NCT02386098|459590912|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
127716960|NCT02386098|459590908|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
127716961|NCT02386098|459590909|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
127716962|NCT02386098|459590910|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
127716963|NCT02386098|459590911|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
127716964|NCT02386098|459590912|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
127716965|NCT02386098|459590908|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
127716966|NCT02386098|459590909|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
127716967|NCT02386098|459590910|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
127716968|NCT02386098|459590911|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
127716969|NCT02386098|459590912|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
127716970|NCT02386098|459590908|FG000|Stage 1 (96 Weeks)|Other|1|||
127716971|NCT02386098|459590909|FG001|Stage 1 (96 Weeks)|Other|0|||
127716972|NCT02386098|459590910|FG002|Stage 1 (96 Weeks)|Other|0|||
127716973|NCT02386098|459590911|FG003|Stage 1 (96 Weeks)|Other|0|||
127716974|NCT02386098|459590912|FG004|Stage 1 (96 Weeks)|Other|0|||
127716975|NCT02386098|459590908|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
127716976|NCT02386098|459590909|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
127716977|NCT02386098|459590910|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
127716978|NCT02386098|459590911|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
127716979|NCT02386098|459590912|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
127716980|NCT03752684|459590914|FG000|Overall Study|Lost to Follow-up|4|||
127716981|NCT03352713|459590917|FG000|Overall Study|Lost to Follow-up|8|||
127716982|NCT03352713|459590917|FG000|Overall Study|Withdrawn by investigator|5|||
127716983|NCT03352713|459590917|FG000|Overall Study|Completed 0 EMAs|8|||
127716984|NCT03352713|459590917|FG000|Overall Study|Device incompatible/stolen|5|||
127716985|NCT01812759|459590918|FG000|Overall Study|Physician Decision|0|||
127716986|NCT01812759|459590919|FG001|Overall Study|Physician Decision|0|||
127716987|NCT01812759|459590920|FG002|Overall Study|Physician Decision|1|||
127716988|NCT00536120|459590921|FG000|Overall Study|Lost to Follow-up|1|||
127716989|NCT00536120|459590922|FG001|Overall Study|Lost to Follow-up|0|||
127716990|NCT00536120|459590921|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
127716991|NCT00536120|459590922|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
127716992|NCT00536120|459590921|FG000|Overall Study|Non-compliance|1|||
127716993|NCT00536120|459590922|FG001|Overall Study|Non-compliance|0|||
127716994|NCT00536120|459590921|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
127716995|NCT00536120|459590922|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
127716996|NCT00536120|459590921|FG000|Overall Study|Steroid Use|0|||
127716997|NCT00536120|459590922|FG001|Overall Study|Steroid Use|2|||
127716998|NCT00536120|459590921|FG000|Overall Study|Missed Study Visit|0|||
127716999|NCT00536120|459590922|FG001|Overall Study|Missed Study Visit|1|||
127717000|NCT02722434|459590923|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
127802393|NCT04426695|459900988|FG005|Overall Study|Lost to Follow-up|14|||
127717001|NCT02722434|459590924|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
127717002|NCT02722434|459590923|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
127717003|NCT02722434|459590924|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
127717004|NCT00360269|459590925|FG000|Overall Study|Lost to Follow-up|7|||
127717005|NCT00360269|459590926|FG001|Overall Study|Lost to Follow-up|9|||
127717006|NCT00360269|459590925|FG000|Overall Study|Physician Decision|1|||
127717007|NCT00360269|459590926|FG001|Overall Study|Physician Decision|2|||
127717008|NCT00360269|459590925|FG000|Overall Study|Adverse Event|1|||
127717009|NCT00360269|459590926|FG001|Overall Study|Adverse Event|0|||
127717010|NCT00360269|459590925|FG000|Overall Study|Withdrawal by Subject|1|||
127802394|NCT04426695|459900989|FG006|Overall Study|Lost to Follow-up|5|||
127717011|NCT00360269|459590926|FG001|Overall Study|Withdrawal by Subject|1|||
127717012|NCT00048932|459590929|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
127717013|NCT00048932|459590930|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
127717014|NCT00048932|459590931|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
127717015|NCT00048932|459590929|FG000|Double Blind Period (DB)|Adverse Event|51|||
127717016|NCT00048932|459590930|FG001|Double Blind Period (DB)|Adverse Event|19|||
127717017|NCT00048932|459590931|FG002|Double Blind Period (DB)|Adverse Event|0|||
127717018|NCT00048932|459590929|FG000|Double Blind Period (DB)|Death|5|||
127717019|NCT00048932|459590930|FG001|Double Blind Period (DB)|Death|3|||
127717020|NCT00048932|459590931|FG002|Double Blind Period (DB)|Death|0|||
127717021|NCT00048932|459590929|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
127717022|NCT00048932|459590930|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
127717023|NCT00048932|459590931|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
127717024|NCT00048932|459590929|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
127717025|NCT00048932|459590930|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
127717026|NCT00048932|459590931|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
127717027|NCT00048932|459590929|FG000|Double Blind Period (DB)|Relocation|1|||
127717028|NCT00048932|459590930|FG001|Double Blind Period (DB)|Relocation|0|||
127717029|NCT00048932|459590931|FG002|Double Blind Period (DB)|Relocation|0|||
127717030|NCT00048932|459590929|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
127717031|NCT00048932|459590930|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
127717032|NCT00048932|459590931|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
127717033|NCT00048932|459590929|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
127717034|NCT00048932|459590930|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
127717035|NCT00048932|459590931|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
127717036|NCT00048932|459590929|FG000|Double Blind Period (DB)|Pregnancy|1|||
127717037|NCT00048932|459590930|FG001|Double Blind Period (DB)|Pregnancy|0|||
127717038|NCT00048932|459590931|FG002|Double Blind Period (DB)|Pregnancy|0|||
127717039|NCT00048932|459590929|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
127717040|NCT00048932|459590930|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
127717041|NCT00048932|459590931|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
127717042|NCT00048932|459590929|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
127717043|NCT00048932|459590930|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
127717044|NCT00048932|459590931|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
127717045|NCT00048932|459590929|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
127717046|NCT00048932|459590930|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
127717047|NCT00048932|459590931|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
127717048|NCT00048932|459590929|FG000|Open Label Period (OL)|Death|0|||
127717049|NCT00048932|459590930|FG001|Open Label Period (OL)|Death|0|||
127717050|NCT00048932|459590931|FG002|Open Label Period (OL)|Death|25|||
127717051|NCT00048932|459590929|FG000|Open Label Period (OL)|Adverse Event|0|||
127717052|NCT00048932|459590930|FG001|Open Label Period (OL)|Adverse Event|0|||
127717053|NCT00048932|459590931|FG002|Open Label Period (OL)|Adverse Event|103|||
127717054|NCT00048932|459590929|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
127717055|NCT00048932|459590930|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
127717056|NCT00048932|459590931|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
127717057|NCT00048932|459590929|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
127717058|NCT00048932|459590930|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
127717059|NCT00048932|459590931|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
127717060|NCT00048932|459590929|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
127717061|NCT00048932|459590930|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
127717062|NCT00048932|459590931|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
127717063|NCT00048932|459590929|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
127717064|NCT00048932|459590930|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
127717065|NCT00048932|459590931|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
127717066|NCT00048932|459590929|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
127717067|NCT00048932|459590930|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
127717068|NCT00048932|459590931|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
127717069|NCT00048932|459590929|FG000|Open Label Period (OL)|Pregnancy|0|||
127717070|NCT00048932|459590930|FG001|Open Label Period (OL)|Pregnancy|0|||
127717071|NCT00048932|459590931|FG002|Open Label Period (OL)|Pregnancy|6|||
127717072|NCT00048932|459590929|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
127717073|NCT00048932|459590930|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
127717074|NCT00048932|459590931|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
127717075|NCT00048932|459590929|FG000|Open Label Period (OL)|Investigator Retiring|0|||
127717076|NCT00048932|459590930|FG001|Open Label Period (OL)|Investigator Retiring|0|||
127717077|NCT00048932|459590931|FG002|Open Label Period (OL)|Investigator Retiring|2|||
127717078|NCT00048932|459590929|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
127717079|NCT00048932|459590930|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
127717080|NCT00048932|459590931|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
127717081|NCT00048932|459590929|FG000|Open Label Period (OL)|Participant Relocated|0|||
127717082|NCT00048932|459590930|FG001|Open Label Period (OL)|Participant Relocated|0|||
127717083|NCT00048932|459590931|FG002|Open Label Period (OL)|Participant Relocated|6|||
127717084|NCT00048932|459590929|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
127717085|NCT00048932|459590930|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
127717086|NCT00048932|459590931|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
127717087|NCT00048932|459590929|FG000|Open Label Period (OL)|Site Closure|0|||
127717088|NCT00048932|459590930|FG001|Open Label Period (OL)|Site Closure|0|||
127717089|NCT00048932|459590931|FG002|Open Label Period (OL)|Site Closure|3|||
127717090|NCT00048932|459590929|FG000|Open Label Period (OL)|Trial Terminated|0|||
127717091|NCT00048932|459590930|FG001|Open Label Period (OL)|Trial Terminated|0|||
127717092|NCT00048932|459590931|FG002|Open Label Period (OL)|Trial Terminated|1|||
127717093|NCT00048932|459590929|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
127717094|NCT00048932|459590930|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
127717095|NCT00048932|459590931|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
127717096|NCT00048932|459590929|FG000|Open Label Period (OL)|Patient Decision|0|||
127717097|NCT00048932|459590930|FG001|Open Label Period (OL)|Patient Decision|0|||
127802395|NCT04426695|459900990|FG007|Overall Study|Lost to Follow-up|14|||
127802396|NCT04426695|459900991|FG008|Overall Study|Lost to Follow-up|10|||
127802397|NCT04426695|459900992|FG009|Overall Study|Lost to Follow-up|11|||
127802398|NCT04426695|459900993|FG010|Overall Study|Lost to Follow-up|12|||
127802399|NCT04426695|459900994|FG011|Overall Study|Lost to Follow-up|6|||
127802400|NCT04426695|459900995|FG012|Overall Study|Lost to Follow-up|2|||
127802401|NCT04426695|459900996|FG013|Overall Study|Lost to Follow-up|2|||
127802402|NCT04426695|459900997|FG014|Overall Study|Lost to Follow-up|2|||
127802403|NCT04426695|459900998|FG015|Overall Study|Lost to Follow-up|0|||
127802404|NCT04426695|459900999|FG016|Overall Study|Lost to Follow-up|0|||
127802405|NCT04426695|459901000|FG017|Overall Study|Lost to Follow-up|0|||
127802406|NCT04426695|459900983|FG000|Overall Study|Participant Decision|1|||
127802407|NCT04426695|459900984|FG001|Overall Study|Participant Decision|2|||
127802408|NCT04426695|459900985|FG002|Overall Study|Participant Decision|2|||
127802409|NCT04426695|459900986|FG003|Overall Study|Participant Decision|12|||
127717098|NCT00048932|459590931|FG002|Open Label Period (OL)|Patient Decision|4|||
127717099|NCT00048932|459590929|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
127717100|NCT00048932|459590930|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
127717101|NCT00048932|459590931|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
127717102|NCT00048932|459590929|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
127717103|NCT00048932|459590930|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
127717104|NCT00048932|459590931|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
127717105|NCT00048932|459590929|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
127802410|NCT04426695|459900987|FG004|Overall Study|Participant Decision|18|||
127802411|NCT04426695|459900988|FG005|Overall Study|Participant Decision|22|||
127802412|NCT04426695|459900989|FG006|Overall Study|Participant Decision|13|||
127802413|NCT04426695|459900990|FG007|Overall Study|Participant Decision|13|||
127802414|NCT04426695|459900991|FG008|Overall Study|Participant Decision|10|||
127802415|NCT04426695|459900992|FG009|Overall Study|Participant Decision|15|||
127717106|NCT00048932|459590930|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
127717107|NCT00048932|459590931|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
127717108|NCT00048932|459590929|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
127717109|NCT00048932|459590930|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
127717110|NCT00048932|459590931|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
127802416|NCT04426695|459900993|FG010|Overall Study|Participant Decision|16|||
127717111|NCT00048932|459590929|FG000|Open Label Period (OL)|Investigator Decision|0|||
127717112|NCT00048932|459590930|FG001|Open Label Period (OL)|Investigator Decision|0|||
127717113|NCT00048932|459590931|FG002|Open Label Period (OL)|Investigator Decision|4|||
127717114|NCT00048932|459590929|FG000|Open Label Period (OL)|Site Staff Issues|0|||
127717115|NCT00048932|459590930|FG001|Open Label Period (OL)|Site Staff Issues|0|||
127717116|NCT00048932|459590931|FG002|Open Label Period (OL)|Site Staff Issues|2|||
127717117|NCT00048932|459590929|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
127717118|NCT00048932|459590930|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
127717119|NCT00048932|459590931|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
127717120|NCT00048932|459590929|FG000|Open Label Period (OL)|Participant Surgery|0|||
127717121|NCT00048932|459590930|FG001|Open Label Period (OL)|Participant Surgery|0|||
127717122|NCT00048932|459590931|FG002|Open Label Period (OL)|Participant Surgery|1|||
127717123|NCT02200705|459590934|FG000|Overall Study|Excluded|12|||
127717124|NCT02200705|459590934|FG000|Overall Study|Death|21|||
127717125|NCT02200705|459590934|FG000|Overall Study|Withdrawal by Subject|22|||
127717126|NCT02200705|459590934|FG000|Overall Study|Lost to Follow-up|13|||
127717127|NCT02200705|459590934|FG000|Overall Study|Physician Decision|5|||
127717128|NCT02200705|459590934|FG000|Overall Study|Adverse Event|2|||
127717129|NCT04989816|459590935|FG000|Overall Study|Death|77|||
127717130|NCT04989816|459590935|FG000|Overall Study|Lost to Follow-up|3|||
127717131|NCT03437733|459590936|FG000|Overall Study|Eligibility criteria not met|0|||
127717132|NCT03437733|459590937|FG001|Overall Study|Eligibility criteria not met|3|||
127717133|NCT01982682|459590938|FG000|Overall Study|Physician Decision|1|||
127717134|NCT00857766|459590939|FG000|Overall Study|Adverse Event|13|||
127717135|NCT00857766|459590940|FG001|Overall Study|Adverse Event|12|||
127717136|NCT00857766|459590939|FG000|Overall Study|Protocol Violation|11|||
127717137|NCT00857766|459590940|FG001|Overall Study|Protocol Violation|11|||
127717138|NCT00857766|459590939|FG000|Overall Study|Lost to Follow-up|1|||
127717139|NCT00857766|459590940|FG001|Overall Study|Lost to Follow-up|0|||
127717140|NCT00857766|459590939|FG000|Overall Study|Investigator Discretion|2|||
127717141|NCT00857766|459590940|FG001|Overall Study|Investigator Discretion|3|||
127717142|NCT00857766|459590939|FG000|Overall Study|Participant Withdrew Consent|4|||
127717143|NCT00857766|459590940|FG001|Overall Study|Participant Withdrew Consent|4|||
127717144|NCT01640951|459590941|FG000|Overall Study|Adverse Event|8|||
127717145|NCT01640951|459590942|FG001|Overall Study|Adverse Event|3|||
127717146|NCT01640951|459590943|FG002|Overall Study|Adverse Event|10|||
127717147|NCT01640951|459590944|FG003|Overall Study|Adverse Event|6|||
127717148|NCT01640951|459590945|FG004|Overall Study|Adverse Event|1|||
127717149|NCT01640951|459590946|FG005|Overall Study|Adverse Event|11|||
127717150|NCT01640951|459590947|FG006|Overall Study|Adverse Event|1|||
127717151|NCT01640951|459590948|FG007|Overall Study|Adverse Event|3|||
127717152|NCT01640951|459590941|FG000|Overall Study|Lack of Efficacy|20|||
127717153|NCT01640951|459590942|FG001|Overall Study|Lack of Efficacy|1|||
127717154|NCT01640951|459590943|FG002|Overall Study|Lack of Efficacy|7|||
127717155|NCT01640951|459590944|FG003|Overall Study|Lack of Efficacy|14|||
127717156|NCT01640951|459590945|FG004|Overall Study|Lack of Efficacy|0|||
127717157|NCT01640951|459590946|FG005|Overall Study|Lack of Efficacy|6|||
127717158|NCT01640951|459590947|FG006|Overall Study|Lack of Efficacy|5|||
127888716|NCT02763579|460215809|FG002|China Period|Death|46|||
127888717|NCT02763579|460215810|FG003|China Period|Death|48|||
127888718|NCT02763579|460215807|FG000|China Period|Lost to Follow-up|0|||
127888719|NCT02763579|460215808|FG001|China Period|Lost to Follow-up|0|||
127717159|NCT01640951|459590948|FG007|Overall Study|Lack of Efficacy|6|||
127717160|NCT01640951|459590941|FG000|Overall Study|Lost to Follow-up|1|||
127717161|NCT01640951|459590942|FG001|Overall Study|Lost to Follow-up|0|||
127717162|NCT01640951|459590943|FG002|Overall Study|Lost to Follow-up|6|||
127717163|NCT01640951|459590944|FG003|Overall Study|Lost to Follow-up|2|||
127717164|NCT01640951|459590945|FG004|Overall Study|Lost to Follow-up|2|||
127717165|NCT01640951|459590946|FG005|Overall Study|Lost to Follow-up|3|||
127717166|NCT01640951|459590947|FG006|Overall Study|Lost to Follow-up|1|||
127717167|NCT01640951|459590948|FG007|Overall Study|Lost to Follow-up|1|||
127717168|NCT01640951|459590941|FG000|Overall Study|Non-compliance with study treatment|0|||
127717169|NCT01640951|459590942|FG001|Overall Study|Non-compliance with study treatment|0|||
127717170|NCT01640951|459590943|FG002|Overall Study|Non-compliance with study treatment|1|||
127717171|NCT01640951|459590944|FG003|Overall Study|Non-compliance with study treatment|1|||
127717172|NCT01640951|459590945|FG004|Overall Study|Non-compliance with study treatment|1|||
127717173|NCT01640951|459590946|FG005|Overall Study|Non-compliance with study treatment|4|||
127717174|NCT01640951|459590947|FG006|Overall Study|Non-compliance with study treatment|1|||
127717175|NCT01640951|459590948|FG007|Overall Study|Non-compliance with study treatment|0|||
127717176|NCT01640951|459590941|FG000|Overall Study|Physician Decision|2|||
127717177|NCT01640951|459590942|FG001|Overall Study|Physician Decision|5|||
127717178|NCT01640951|459590943|FG002|Overall Study|Physician Decision|2|||
127717179|NCT01640951|459590944|FG003|Overall Study|Physician Decision|2|||
127717180|NCT01640951|459590945|FG004|Overall Study|Physician Decision|2|||
127717181|NCT01640951|459590946|FG005|Overall Study|Physician Decision|3|||
127888720|NCT02763579|460215809|FG002|China Period|Lost to Follow-up|1|||
127717182|NCT01640951|459590947|FG006|Overall Study|Physician Decision|3|||
127717183|NCT01640951|459590948|FG007|Overall Study|Physician Decision|0|||
127717184|NCT01640951|459590941|FG000|Overall Study|Pregnancy|3|||
127717185|NCT01640951|459590942|FG001|Overall Study|Pregnancy|0|||
127717186|NCT01640951|459590943|FG002|Overall Study|Pregnancy|0|||
127717187|NCT01640951|459590944|FG003|Overall Study|Pregnancy|4|||
127717188|NCT01640951|459590945|FG004|Overall Study|Pregnancy|0|||
127717189|NCT01640951|459590946|FG005|Overall Study|Pregnancy|0|||
127717190|NCT01640951|459590947|FG006|Overall Study|Pregnancy|2|||
127717191|NCT01640951|459590948|FG007|Overall Study|Pregnancy|0|||
127717192|NCT01640951|459590941|FG000|Overall Study|Protocol Deviation|0|||
127717193|NCT01640951|459590942|FG001|Overall Study|Protocol Deviation|1|||
127717194|NCT01640951|459590943|FG002|Overall Study|Protocol Deviation|2|||
127717195|NCT01640951|459590944|FG003|Overall Study|Protocol Deviation|1|||
127717196|NCT01640951|459590945|FG004|Overall Study|Protocol Deviation|0|||
127717197|NCT01640951|459590946|FG005|Overall Study|Protocol Deviation|1|||
127717198|NCT01640951|459590947|FG006|Overall Study|Protocol Deviation|0|||
127717199|NCT01640951|459590948|FG007|Overall Study|Protocol Deviation|0|||
127717200|NCT01640951|459590941|FG000|Overall Study|Subject/Guardian decision|12|||
127717201|NCT01640951|459590942|FG001|Overall Study|Subject/Guardian decision|4|||
127717202|NCT01640951|459590943|FG002|Overall Study|Subject/Guardian decision|13|||
127717203|NCT01640951|459590944|FG003|Overall Study|Subject/Guardian decision|15|||
127717204|NCT01640951|459590945|FG004|Overall Study|Subject/Guardian decision|7|||
127717205|NCT01640951|459590946|FG005|Overall Study|Subject/Guardian decision|19|||
127717206|NCT01640951|459590947|FG006|Overall Study|Subject/Guardian decision|5|||
127717207|NCT01640951|459590948|FG007|Overall Study|Subject/Guardian decision|4|||
127717208|NCT01640951|459590941|FG000|Overall Study|Death|0|||
127717209|NCT01640951|459590942|FG001|Overall Study|Death|1|||
127717210|NCT01640951|459590943|FG002|Overall Study|Death|1|||
127717211|NCT01640951|459590944|FG003|Overall Study|Death|0|||
127717212|NCT01640951|459590945|FG004|Overall Study|Death|0|||
127717213|NCT01640951|459590946|FG005|Overall Study|Death|0|||
127717214|NCT01640951|459590947|FG006|Overall Study|Death|0|||
127717215|NCT01640951|459590948|FG007|Overall Study|Death|2|||
127717216|NCT03355573|459590949|FG000|Overall Study|Withdrew consent due to refused treatment to AE latent tuberculosis|1|||
127717217|NCT03355573|459590949|FG000|Overall Study|Sponsor's decision|1|||
127717218|NCT03355573|459590949|FG000|Overall Study|Participant withdrew consent due to AEs|1|||
127717219|NCT03355573|459590949|FG000|Overall Study|PI's decision|2|||
127717220|NCT03355573|459590949|FG000|Overall Study|Withdrawal by Subject|23|||
127717221|NCT03355573|459590949|FG000|Overall Study|Lost to Follow-up|4|||
127717222|NCT03355573|459590949|FG000|Overall Study|Lack of Efficacy|2|||
127717223|NCT03355573|459590949|FG000|Overall Study|Adverse Event, non-fatal|17|||
127717224|NCT03355573|459590949|FG000|Overall Study|Adverse Event, serious fatal|2|||
127717225|NCT01536093|459590952|FG000|Overall Study|Death|1|||
127717226|NCT01536093|459590953|FG001|Overall Study|Death|2|||
127717227|NCT01536093|459590952|FG000|Overall Study|absence of maternal colostrum|2|||
127717228|NCT01536093|459590953|FG001|Overall Study|absence of maternal colostrum|0|||
127717229|NCT01536093|459590952|FG000|Overall Study|Withdrawal by Subject|0|||
127717230|NCT01536093|459590953|FG001|Overall Study|Withdrawal by Subject|1|||
127717231|NCT00942266|459590954|FG000|Overall Study|Withdrawal by Subject|1|||
127717232|NCT00942266|459590955|FG001|Overall Study|Withdrawal by Subject|0|||
127717233|NCT00942266|459590954|FG000|Overall Study|Adverse Event|2|||
127717234|NCT00942266|459590955|FG001|Overall Study|Adverse Event|1|||
127717235|NCT00942266|459590954|FG000|Overall Study|Disease Progression|38|||
127802417|NCT04426695|459900994|FG011|Overall Study|Participant Decision|17|||
127802418|NCT04426695|459900995|FG012|Overall Study|Participant Decision|2|||
127802419|NCT04426695|459900996|FG013|Overall Study|Participant Decision|1|||
127802420|NCT04426695|459900997|FG014|Overall Study|Participant Decision|2|||
127717236|NCT00942266|459590955|FG001|Overall Study|Disease Progression|11|||
127717237|NCT00942266|459590954|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
127717238|NCT00942266|459590955|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
127717239|NCT00942266|459590954|FG000|Overall Study|Intercurrent illness|0|||
127717240|NCT00942266|459590955|FG001|Overall Study|Intercurrent illness|1|||
127717241|NCT00942266|459590954|FG000|Overall Study|Physician Decision|2|||
127802421|NCT04426695|459900998|FG015|Overall Study|Participant Decision|0|||
127802422|NCT04426695|459900999|FG016|Overall Study|Participant Decision|0|||
127717242|NCT00942266|459590955|FG001|Overall Study|Physician Decision|0|||
127717243|NCT00942266|459590954|FG000|Overall Study|medical deterioration (pneumonia)|0|||
127717244|NCT00942266|459590955|FG001|Overall Study|medical deterioration (pneumonia)|1|||
127717245|NCT00756574|459590961|FG000|Overall Study|Withdrawal by Subject|9|||
127717246|NCT00756574|459590962|FG001|Overall Study|Withdrawal by Subject|7|||
127717247|NCT00756574|459590961|FG000|Overall Study|Lost to Follow-up|4|||
127717248|NCT00756574|459590962|FG001|Overall Study|Lost to Follow-up|4|||
127802423|NCT04426695|459901000|FG017|Overall Study|Participant Decision|0|||
127802424|NCT04426695|459900983|FG000|Overall Study|Adverse Event|0|||
127717249|NCT04795167|459590963|FG000|Overall Study|Death|1|||
127717250|NCT04795167|459590964|FG001|Overall Study|Death|18|||
127717251|NCT04795167|459590965|FG002|Overall Study|Death|1|||
127717252|NCT04795167|459590963|FG000|Overall Study|Remained in-hospital for >/= 45 Days|4|||
127717253|NCT04795167|459590964|FG001|Overall Study|Remained in-hospital for >/= 45 Days|0|||
127717254|NCT04795167|459590965|FG002|Overall Study|Remained in-hospital for >/= 45 Days|0|||
127717255|NCT01675492|459590969|FG000|Overall Study|study completed early - product approval|42|||
127717256|NCT05025384|459590970|FG000|Overall Study|Physician Decision|5|||
127717257|NCT05025384|459590971|FG001|Overall Study|Physician Decision|6|||
127717258|NCT03610581|459590972|FG000|Overall Study|Study terminated by sponsor|2|||
127717259|NCT03610581|459590973|FG001|Overall Study|Study terminated by sponsor|0|||
127717260|NCT03610581|459590972|FG000|Overall Study|Other|0|||
127717261|NCT03610581|459590973|FG001|Overall Study|Other|1|||
127717262|NCT03610581|459590972|FG000|Overall Study|Withdrawal by Subject|1|||
127717263|NCT03610581|459590973|FG001|Overall Study|Withdrawal by Subject|0|||
127717264|NCT00748709|459590982|FG000|Overall Study|Progressive disease|15|||
127717265|NCT00748709|459590982|FG000|Overall Study|Drug reducing Toxity|2|||
127717266|NCT00748709|459590982|FG000|Overall Study|Other Adverse Event|1|||
127717267|NCT00748709|459590982|FG000|Overall Study|Withdrawal by Subject|1|||
127717268|NCT00748709|459590982|FG000|Overall Study|Other Reasons|1|||
127717269|NCT02751528|459590987|FG000|Overall Study|Withdrawal by Subject|1|||
127717270|NCT02751528|459590987|FG000|Overall Study|Adverse Event|1|||
127717271|NCT05485805|459590988|FG000|Overall Study|Withdrawal by Subject|1|||
127717272|NCT05485805|459590989|FG001|Overall Study|Withdrawal by Subject|2|||
127717273|NCT05485805|459590990|FG002|Overall Study|Withdrawal by Subject|2|||
127717274|NCT05485805|459590991|FG003|Overall Study|Withdrawal by Subject|0|||
127717275|NCT05485805|459590992|FG004|Overall Study|Withdrawal by Subject|2|||
127717276|NCT05485805|459590988|FG000|Overall Study|Adverse Event|0|||
127717277|NCT05485805|459590989|FG001|Overall Study|Adverse Event|1|||
127717278|NCT05485805|459590990|FG002|Overall Study|Adverse Event|0|||
127717279|NCT05485805|459590991|FG003|Overall Study|Adverse Event|0|||
127717280|NCT05485805|459590992|FG004|Overall Study|Adverse Event|0|||
127717281|NCT05485805|459590988|FG000|Overall Study|Lost to Follow-up|1|||
127717282|NCT05485805|459590989|FG001|Overall Study|Lost to Follow-up|1|||
127717283|NCT05485805|459590990|FG002|Overall Study|Lost to Follow-up|3|||
127717284|NCT05485805|459590991|FG003|Overall Study|Lost to Follow-up|1|||
127717285|NCT05485805|459590992|FG004|Overall Study|Lost to Follow-up|0|||
127717286|NCT04218357|459590993|FG000|1st Allocation|Withdrawal by Subject|1|||
127717287|NCT04218357|459590994|FG001|1st Allocation|Withdrawal by Subject|0|||
127717288|NCT05349838|459590995|FG000|Overall Study|Virological Failure|1|||
127717289|NCT05349838|459590996|FG001|Overall Study|Virological Failure|2|||
127717290|NCT05349838|459590995|FG000|Overall Study|Withdrawal by Subject|2|||
127717291|NCT05349838|459590996|FG001|Overall Study|Withdrawal by Subject|3|||
127717292|NCT05349838|459590995|FG000|Overall Study|Adverse Event|3|||
127717293|NCT05349838|459590996|FG001|Overall Study|Adverse Event|1|||
127717294|NCT05349838|459590995|FG000|Overall Study|Lost to Follow-up|1|||
127717295|NCT05349838|459590996|FG001|Overall Study|Lost to Follow-up|2|||
127717296|NCT05349838|459590995|FG000|Overall Study|Other reasons|5|||
127717297|NCT05349838|459590996|FG001|Overall Study|Other reasons|1|||
127717298|NCT01958021|459590998|FG000|Treatment|Progressive disease|206|||
127717299|NCT01958021|459590999|FG001|Treatment|Progressive disease|265|||
127717300|NCT01958021|459590998|FG000|Treatment|Adverse Event|38|||
127717301|NCT01958021|459590999|FG001|Treatment|Adverse Event|10|||
127717302|NCT01958021|459590998|FG000|Treatment|Subject/guardian decision|29|||
127717303|NCT01958021|459590999|FG001|Treatment|Subject/guardian decision|25|||
127802425|NCT04426695|459900984|FG001|Overall Study|Adverse Event|0|||
127802426|NCT04426695|459900985|FG002|Overall Study|Adverse Event|0|||
127802427|NCT04426695|459900986|FG003|Overall Study|Adverse Event|0|||
127802428|NCT04426695|459900987|FG004|Overall Study|Adverse Event|0|||
127802429|NCT04426695|459900988|FG005|Overall Study|Adverse Event|0|||
127802430|NCT04426695|459900989|FG006|Overall Study|Adverse Event|0|||
127717304|NCT01958021|459590998|FG000|Treatment|Physician Decision|28|||
127717305|NCT01958021|459590999|FG001|Treatment|Physician Decision|21|||
127802431|NCT04426695|459900990|FG007|Overall Study|Adverse Event|1|||
127802432|NCT04426695|459900991|FG008|Overall Study|Adverse Event|0|||
127802433|NCT04426695|459900992|FG009|Overall Study|Adverse Event|0|||
127717306|NCT01958021|459590998|FG000|Treatment|Death|6|||
127717307|NCT01958021|459590999|FG001|Treatment|Death|1|||
127717308|NCT01958021|459590998|FG000|Treatment|Protocol deviation|3|||
127717309|NCT01958021|459590999|FG001|Treatment|Protocol deviation|1|||
127717310|NCT01958021|459590998|FG000|Treatment|Sponsor decision|24|||
127717311|NCT01958021|459590999|FG001|Treatment|Sponsor decision|11|||
127717312|NCT01958021|459590998|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
127802434|NCT04426695|459900993|FG010|Overall Study|Adverse Event|1|||
127717313|NCT01958021|459590999|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
127717314|NCT01958021|459590998|FG000|Post-treatment Efficacy Follow-up|Death|1|||
127717315|NCT01958021|459590999|FG001|Post-treatment Efficacy Follow-up|Death|0|||
127717316|NCT01958021|459590998|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
127717317|NCT01958021|459590999|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
127717318|NCT01958021|459590998|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
127717319|NCT01958021|459590999|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
127717320|NCT01958021|459590998|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
127717321|NCT01958021|459590999|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
127717322|NCT01958021|459590998|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|5|||
127717323|NCT01958021|459590999|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|2|||
127717324|NCT01958021|459590998|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian decision|4|||
127717325|NCT01958021|459590999|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian decision|2|||
127717326|NCT02488408|459591001|FG000|Part A|Adverse Event|2|||
127717327|NCT02488408|459591002|FG001|Part A|Adverse Event|0|||
127717328|NCT02488408|459591003|FG002|Part A|Adverse Event|0|||
127717329|NCT02488408|459591004|FG003|Part A|Adverse Event|0|||
127717330|NCT02488408|459591005|FG004|Part A|Adverse Event|0|||
127717331|NCT02488408|459591006|FG005|Part A|Adverse Event|0|||
127717332|NCT02488408|459591007|FG006|Part A|Adverse Event|0|||
127717333|NCT02488408|459591008|FG007|Part A|Adverse Event|0|||
127717334|NCT02488408|459591009|FG008|Part A|Adverse Event|0|||
127717335|NCT02488408|459591010|FG009|Part A|Adverse Event|0|||
127717336|NCT02488408|459591001|FG000|Part A|Death|1|||
127717337|NCT02488408|459591002|FG001|Part A|Death|5|||
127717338|NCT02488408|459591003|FG002|Part A|Death|0|||
127717339|NCT02488408|459591004|FG003|Part A|Death|0|||
127717340|NCT02488408|459591005|FG004|Part A|Death|3|||
127717341|NCT02488408|459591006|FG005|Part A|Death|0|||
127717342|NCT02488408|459591007|FG006|Part A|Death|0|||
127717343|NCT02488408|459591008|FG007|Part A|Death|0|||
127717344|NCT02488408|459591009|FG008|Part A|Death|0|||
127717345|NCT02488408|459591010|FG009|Part A|Death|0|||
127717346|NCT02488408|459591001|FG000|Part A|Disease Progression|2|||
127717347|NCT02488408|459591002|FG001|Part A|Disease Progression|8|||
127717348|NCT02488408|459591003|FG002|Part A|Disease Progression|2|||
127717349|NCT02488408|459591004|FG003|Part A|Disease Progression|3|||
127717350|NCT02488408|459591005|FG004|Part A|Disease Progression|4|||
127717351|NCT02488408|459591006|FG005|Part A|Disease Progression|0|||
127717352|NCT02488408|459591007|FG006|Part A|Disease Progression|0|||
127717353|NCT02488408|459591008|FG007|Part A|Disease Progression|0|||
127717354|NCT02488408|459591009|FG008|Part A|Disease Progression|0|||
127717355|NCT02488408|459591010|FG009|Part A|Disease Progression|0|||
127717356|NCT02488408|459591001|FG000|Part A|Initiation of Alternative Cancer Therapy|0|||
127717357|NCT02488408|459591002|FG001|Part A|Initiation of Alternative Cancer Therapy|0|||
127717358|NCT02488408|459591003|FG002|Part A|Initiation of Alternative Cancer Therapy|0|||
127717359|NCT02488408|459591004|FG003|Part A|Initiation of Alternative Cancer Therapy|1|||
127717360|NCT02488408|459591005|FG004|Part A|Initiation of Alternative Cancer Therapy|0|||
127717361|NCT02488408|459591006|FG005|Part A|Initiation of Alternative Cancer Therapy|0|||
127717362|NCT02488408|459591007|FG006|Part A|Initiation of Alternative Cancer Therapy|0|||
127717363|NCT02488408|459591008|FG007|Part A|Initiation of Alternative Cancer Therapy|0|||
127717364|NCT02488408|459591009|FG008|Part A|Initiation of Alternative Cancer Therapy|0|||
127717365|NCT02488408|459591010|FG009|Part A|Initiation of Alternative Cancer Therapy|0|||
127717366|NCT02488408|459591001|FG000|Part A|Investigator Decision|0|||
127717367|NCT02488408|459591002|FG001|Part A|Investigator Decision|1|||
127717368|NCT02488408|459591003|FG002|Part A|Investigator Decision|1|||
127717369|NCT02488408|459591004|FG003|Part A|Investigator Decision|0|||
127717370|NCT02488408|459591005|FG004|Part A|Investigator Decision|0|||
127717371|NCT02488408|459591006|FG005|Part A|Investigator Decision|0|||
127717372|NCT02488408|459591007|FG006|Part A|Investigator Decision|0|||
127717373|NCT02488408|459591008|FG007|Part A|Investigator Decision|0|||
127717374|NCT02488408|459591009|FG008|Part A|Investigator Decision|0|||
127717375|NCT02488408|459591010|FG009|Part A|Investigator Decision|0|||
127717376|NCT02488408|459591001|FG000|Part A|Withdrawal by Subject|0|||
127717377|NCT02488408|459591002|FG001|Part A|Withdrawal by Subject|0|||
127717378|NCT02488408|459591003|FG002|Part A|Withdrawal by Subject|2|||
127717379|NCT02488408|459591004|FG003|Part A|Withdrawal by Subject|0|||
127717380|NCT02488408|459591005|FG004|Part A|Withdrawal by Subject|0|||
127717381|NCT02488408|459591006|FG005|Part A|Withdrawal by Subject|0|||
127717382|NCT02488408|459591007|FG006|Part A|Withdrawal by Subject|0|||
127717383|NCT02488408|459591008|FG007|Part A|Withdrawal by Subject|0|||
127717384|NCT02488408|459591009|FG008|Part A|Withdrawal by Subject|0|||
127802435|NCT04426695|459900994|FG011|Overall Study|Adverse Event|1|||
127802436|NCT04426695|459900995|FG012|Overall Study|Adverse Event|0|||
127717385|NCT02488408|459591010|FG009|Part A|Withdrawal by Subject|0|||
127717386|NCT02488408|459591001|FG000|Part A|Other|1|||
127717387|NCT02488408|459591002|FG001|Part A|Other|0|||
127717388|NCT02488408|459591003|FG002|Part A|Other|0|||
127717389|NCT02488408|459591004|FG003|Part A|Other|0|||
127717390|NCT02488408|459591005|FG004|Part A|Other|0|||
127717391|NCT02488408|459591006|FG005|Part A|Other|0|||
127717392|NCT02488408|459591007|FG006|Part A|Other|0|||
127717393|NCT02488408|459591008|FG007|Part A|Other|0|||
127802437|NCT04426695|459900996|FG013|Overall Study|Adverse Event|0|||
127802438|NCT04426695|459900997|FG014|Overall Study|Adverse Event|0|||
127717394|NCT02488408|459591009|FG008|Part A|Other|0|||
127717395|NCT02488408|459591010|FG009|Part A|Other|0|||
127717396|NCT02488408|459591001|FG000|Part B|Adverse Event|0|||
127717397|NCT02488408|459591002|FG001|Part B|Adverse Event|0|||
127717398|NCT02488408|459591003|FG002|Part B|Adverse Event|0|||
127717399|NCT02488408|459591004|FG003|Part B|Adverse Event|0|||
127717400|NCT02488408|459591005|FG004|Part B|Adverse Event|0|||
127717401|NCT02488408|459591006|FG005|Part B|Adverse Event|2|||
127717402|NCT02488408|459591007|FG006|Part B|Adverse Event|2|||
127717403|NCT02488408|459591008|FG007|Part B|Adverse Event|7|||
127717404|NCT02488408|459591009|FG008|Part B|Adverse Event|2|||
127717405|NCT02488408|459591010|FG009|Part B|Adverse Event|2|||
127717406|NCT02488408|459591001|FG000|Part B|Death|0|||
127717407|NCT02488408|459591002|FG001|Part B|Death|0|||
127717408|NCT02488408|459591003|FG002|Part B|Death|0|||
127717409|NCT02488408|459591004|FG003|Part B|Death|0|||
127717410|NCT02488408|459591005|FG004|Part B|Death|0|||
127717411|NCT02488408|459591006|FG005|Part B|Death|3|||
127717412|NCT02488408|459591007|FG006|Part B|Death|1|||
127717413|NCT02488408|459591008|FG007|Part B|Death|2|||
127717414|NCT02488408|459591009|FG008|Part B|Death|2|||
127717415|NCT02488408|459591010|FG009|Part B|Death|2|||
127717416|NCT02488408|459591001|FG000|Part B|Death due to Disease Progression|0|||
127717417|NCT02488408|459591002|FG001|Part B|Death due to Disease Progression|0|||
127717418|NCT02488408|459591003|FG002|Part B|Death due to Disease Progression|0|||
127717419|NCT02488408|459591004|FG003|Part B|Death due to Disease Progression|0|||
127717420|NCT02488408|459591005|FG004|Part B|Death due to Disease Progression|0|||
127717421|NCT02488408|459591006|FG005|Part B|Death due to Disease Progression|2|||
127717422|NCT02488408|459591007|FG006|Part B|Death due to Disease Progression|2|||
127717423|NCT02488408|459591008|FG007|Part B|Death due to Disease Progression|1|||
127717424|NCT02488408|459591009|FG008|Part B|Death due to Disease Progression|1|||
127717425|NCT02488408|459591010|FG009|Part B|Death due to Disease Progression|1|||
127717426|NCT02488408|459591001|FG000|Part B|Disease Progression|0|||
127717427|NCT02488408|459591002|FG001|Part B|Disease Progression|0|||
127717428|NCT02488408|459591003|FG002|Part B|Disease Progression|0|||
127717429|NCT02488408|459591004|FG003|Part B|Disease Progression|0|||
127717430|NCT02488408|459591005|FG004|Part B|Disease Progression|0|||
127717431|NCT02488408|459591006|FG005|Part B|Disease Progression|6|||
127717432|NCT02488408|459591007|FG006|Part B|Disease Progression|9|||
127717433|NCT02488408|459591008|FG007|Part B|Disease Progression|7|||
127717434|NCT02488408|459591009|FG008|Part B|Disease Progression|9|||
127717435|NCT02488408|459591010|FG009|Part B|Disease Progression|11|||
127802439|NCT04426695|459900998|FG015|Overall Study|Adverse Event|0|||
127802440|NCT04426695|459900999|FG016|Overall Study|Adverse Event|0|||
127802441|NCT04426695|459901000|FG017|Overall Study|Adverse Event|0|||
127802442|NCT04426695|459900983|FG000|Overall Study|Sponsor Request|0|||
127802443|NCT04426695|459900984|FG001|Overall Study|Sponsor Request|0|||
127802444|NCT04426695|459900985|FG002|Overall Study|Sponsor Request|0|||
127802445|NCT04426695|459900986|FG003|Overall Study|Sponsor Request|0|||
127802446|NCT04426695|459900987|FG004|Overall Study|Sponsor Request|0|||
127802447|NCT04426695|459900988|FG005|Overall Study|Sponsor Request|0|||
127802448|NCT04426695|459900989|FG006|Overall Study|Sponsor Request|1|||
127802449|NCT04426695|459900990|FG007|Overall Study|Sponsor Request|0|||
127802450|NCT04426695|459900991|FG008|Overall Study|Sponsor Request|0|||
127802451|NCT04426695|459900992|FG009|Overall Study|Sponsor Request|0|||
127802452|NCT04426695|459900993|FG010|Overall Study|Sponsor Request|0|||
127802453|NCT04426695|459900994|FG011|Overall Study|Sponsor Request|0|||
127802454|NCT04426695|459900995|FG012|Overall Study|Sponsor Request|0|||
127802455|NCT04426695|459900996|FG013|Overall Study|Sponsor Request|0|||
127802456|NCT04426695|459900997|FG014|Overall Study|Sponsor Request|0|||
127802457|NCT04426695|459900998|FG015|Overall Study|Sponsor Request|0|||
127802458|NCT04426695|459900999|FG016|Overall Study|Sponsor Request|0|||
127802459|NCT04426695|459901000|FG017|Overall Study|Sponsor Request|0|||
127802460|NCT04426695|459900983|FG000|Overall Study|Physician Decision|0|||
127717436|NCT02488408|459591001|FG000|Part B|Initiation of Alternative Cancer Therapy|0|||
127717437|NCT02488408|459591002|FG001|Part B|Initiation of Alternative Cancer Therapy|0|||
127717438|NCT02488408|459591003|FG002|Part B|Initiation of Alternative Cancer Therapy|0|||
127717439|NCT02488408|459591004|FG003|Part B|Initiation of Alternative Cancer Therapy|0|||
127802461|NCT04426695|459900984|FG001|Overall Study|Physician Decision|0|||
127717440|NCT02488408|459591005|FG004|Part B|Initiation of Alternative Cancer Therapy|0|||
127717441|NCT02488408|459591006|FG005|Part B|Initiation of Alternative Cancer Therapy|1|||
127717442|NCT02488408|459591007|FG006|Part B|Initiation of Alternative Cancer Therapy|1|||
127717443|NCT02488408|459591008|FG007|Part B|Initiation of Alternative Cancer Therapy|1|||
127717444|NCT02488408|459591009|FG008|Part B|Initiation of Alternative Cancer Therapy|2|||
127717445|NCT02488408|459591010|FG009|Part B|Initiation of Alternative Cancer Therapy|3|||
127717446|NCT02488408|459591001|FG000|Part B|Investigator Decision|0|||
127717447|NCT02488408|459591002|FG001|Part B|Investigator Decision|0|||
127717448|NCT02488408|459591003|FG002|Part B|Investigator Decision|0|||
127717449|NCT02488408|459591004|FG003|Part B|Investigator Decision|0|||
127802462|NCT04426695|459900985|FG002|Overall Study|Physician Decision|0|||
127717450|NCT02488408|459591005|FG004|Part B|Investigator Decision|0|||
127717451|NCT02488408|459591006|FG005|Part B|Investigator Decision|0|||
127802463|NCT04426695|459900986|FG003|Overall Study|Physician Decision|0|||
127802464|NCT04426695|459900987|FG004|Overall Study|Physician Decision|0|||
127802465|NCT04426695|459900988|FG005|Overall Study|Physician Decision|0|||
127802466|NCT04426695|459900989|FG006|Overall Study|Physician Decision|0|||
127717452|NCT02488408|459591007|FG006|Part B|Investigator Decision|1|||
127717453|NCT02488408|459591008|FG007|Part B|Investigator Decision|0|||
127717454|NCT02488408|459591009|FG008|Part B|Investigator Decision|2|||
127717455|NCT02488408|459591010|FG009|Part B|Investigator Decision|1|||
127717456|NCT05886777|459591013|FG000|Overall Study|Lost to Follow-up|1|||
127717457|NCT05886777|459591014|FG001|Overall Study|Lost to Follow-up|0|||
127717458|NCT05886777|459591015|FG002|Overall Study|Lost to Follow-up|2|||
127717459|NCT05886777|459591016|FG003|Overall Study|Lost to Follow-up|1|||
127717460|NCT05886777|459591017|FG004|Overall Study|Lost to Follow-up|0|||
127717461|NCT05886777|459591018|FG005|Overall Study|Lost to Follow-up|2|||
127717462|NCT05886777|459591019|FG006|Overall Study|Lost to Follow-up|0|||
127717463|NCT05886777|459591013|FG000|Overall Study|Other|0|||
127717464|NCT05886777|459591014|FG001|Overall Study|Other|2|||
127717465|NCT05886777|459591015|FG002|Overall Study|Other|1|||
127717466|NCT05886777|459591016|FG003|Overall Study|Other|0|||
127717467|NCT05886777|459591017|FG004|Overall Study|Other|0|||
127717468|NCT05886777|459591018|FG005|Overall Study|Other|0|||
127717469|NCT05886777|459591019|FG006|Overall Study|Other|0|||
127717470|NCT05886777|459591013|FG000|Overall Study|Withdrawal by Subject|1|||
127717471|NCT05886777|459591014|FG001|Overall Study|Withdrawal by Subject|0|||
127717472|NCT05886777|459591015|FG002|Overall Study|Withdrawal by Subject|1|||
127717473|NCT05886777|459591016|FG003|Overall Study|Withdrawal by Subject|4|||
127717474|NCT05886777|459591017|FG004|Overall Study|Withdrawal by Subject|3|||
127717475|NCT05886777|459591018|FG005|Overall Study|Withdrawal by Subject|1|||
127717476|NCT05886777|459591019|FG006|Overall Study|Withdrawal by Subject|1|||
127717477|NCT05886777|459591013|FG000|Overall Study|Protocol Violation|0|||
127717478|NCT05886777|459591014|FG001|Overall Study|Protocol Violation|0|||
127717479|NCT05886777|459591015|FG002|Overall Study|Protocol Violation|1|||
127717480|NCT05886777|459591016|FG003|Overall Study|Protocol Violation|0|||
127717481|NCT05886777|459591017|FG004|Overall Study|Protocol Violation|0|||
127717482|NCT05886777|459591018|FG005|Overall Study|Protocol Violation|0|||
127717483|NCT05886777|459591019|FG006|Overall Study|Protocol Violation|0|||
127717484|NCT05886777|459591013|FG000|Overall Study|No longer met eligibility criteria|0|||
127717485|NCT05886777|459591014|FG001|Overall Study|No longer met eligibility criteria|1|||
127717486|NCT05886777|459591015|FG002|Overall Study|No longer met eligibility criteria|0|||
127717487|NCT05886777|459591016|FG003|Overall Study|No longer met eligibility criteria|0|||
127717488|NCT05886777|459591017|FG004|Overall Study|No longer met eligibility criteria|0|||
127717489|NCT05886777|459591018|FG005|Overall Study|No longer met eligibility criteria|0|||
127717490|NCT05886777|459591019|FG006|Overall Study|No longer met eligibility criteria|0|||
127717491|NCT03664804|459591021|FG000|Overall Study|Withdrawal by Subject|7|||
127717492|NCT04701203|459591022|FG000|Blinded Period (Weeks 0 to 26)|Death|1|||
127717493|NCT04701203|459591023|FG001|Blinded Period (Weeks 0 to 26)|Death|0|||
127717494|NCT04701203|459591024|FG002|Blinded Period (Weeks 0 to 26)|Death|0|||
127717495|NCT04701203|459591022|FG000|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
127717496|NCT04701203|459591023|FG001|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|1|||
127717497|NCT04701203|459591024|FG002|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
127717498|NCT04701203|459591022|FG000|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
127717499|NCT04701203|459591023|FG001|Blinded Period (Weeks 0 to 26)|Adverse Event|1|||
127717500|NCT04701203|459591024|FG002|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
127717501|NCT04701203|459591022|FG000|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
127717502|NCT04701203|459591023|FG001|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
127717503|NCT04701203|459591024|FG002|Open-Label Period (Weeks 26 to 182)|Study Ongoing|79|||
127717504|NCT02232737|459592421|FG000|Overall Study|Lost to Follow-up|18|||
127717505|NCT02232737|459592422|FG001|Overall Study|Lost to Follow-up|28|||
127717506|NCT02232737|459592423|FG002|Overall Study|Lost to Follow-up|33|||
127717507|NCT02232737|459592421|FG000|Overall Study|Personal reasons|7|||
127717508|NCT02232737|459592422|FG001|Overall Study|Personal reasons|8|||
127717509|NCT02232737|459592423|FG002|Overall Study|Personal reasons|14|||
127717510|NCT02232737|459592421|FG000|Overall Study|Adverse Event|6|||
127717511|NCT02232737|459592422|FG001|Overall Study|Adverse Event|3|||
127717512|NCT02232737|459592423|FG002|Overall Study|Adverse Event|8|||
127717513|NCT02232737|459592421|FG000|Overall Study|Incarcerated|2|||
127717514|NCT02232737|459592422|FG001|Overall Study|Incarcerated|1|||
127717515|NCT02232737|459592423|FG002|Overall Study|Incarcerated|2|||
127717516|NCT02232737|459592421|FG000|Overall Study|Withdrawal by Subject|0|||
127717517|NCT02232737|459592422|FG001|Overall Study|Withdrawal by Subject|1|||
127717518|NCT02232737|459592423|FG002|Overall Study|Withdrawal by Subject|2|||
127717519|NCT02232737|459592421|FG000|Overall Study|Death|0|||
127717520|NCT02232737|459592422|FG001|Overall Study|Death|1|||
127717521|NCT02232737|459592423|FG002|Overall Study|Death|1|||
127717522|NCT02232737|459592421|FG000|Overall Study|Physician Decision|1|||
127717523|NCT02232737|459592422|FG001|Overall Study|Physician Decision|3|||
127717524|NCT02232737|459592423|FG002|Overall Study|Physician Decision|1|||
127717525|NCT02232737|459592421|FG000|Overall Study|Protocol Violation|1|||
127717526|NCT02232737|459592422|FG001|Overall Study|Protocol Violation|0|||
127717527|NCT02232737|459592423|FG002|Overall Study|Protocol Violation|1|||
127717528|NCT02232737|459592421|FG000|Overall Study|Reason unknown|1|||
127717529|NCT02232737|459592422|FG001|Overall Study|Reason unknown|0|||
127717530|NCT02232737|459592423|FG002|Overall Study|Reason unknown|0|||
127717531|NCT04559698|459592424|FG000|Overall Study|Lost to Follow-up|14|||
127717532|NCT04559698|459592425|FG001|Overall Study|Lost to Follow-up|15|||
127717533|NCT04559698|459592424|FG000|Overall Study|Withdrawal by Subject|0|||
127717534|NCT04559698|459592425|FG001|Overall Study|Withdrawal by Subject|1|||
127717535|NCT00786864|459592435|FG000|Overall Study|Lost to Follow-up|0|||
127717536|NCT00786864|459592436|FG001|Overall Study|Lost to Follow-up|1|||
127717537|NCT00786864|459592435|FG000|Overall Study|Sustained serious back injury|1|||
127717538|NCT00786864|459592436|FG001|Overall Study|Sustained serious back injury|0|||
127717539|NCT03442777|459592444|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
127717540|NCT03442777|459592445|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
127717541|NCT03442777|459592446|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
127717542|NCT01641900|459592447|FG000|Overall Study|Withdrawal by Subject|2|||
127717543|NCT01641900|459592448|FG001|Overall Study|Withdrawal by Subject|2|||
127717544|NCT03220724|459592454|FG000|Overall Study|Lost to Follow-up|2|||
127717545|NCT03220724|459592455|FG001|Overall Study|Lost to Follow-up|2|||
127717546|NCT03220724|459592456|FG002|Overall Study|Lost to Follow-up|0|||
127717547|NCT03220724|459592457|FG003|Overall Study|Lost to Follow-up|3|||
127717548|NCT03220724|459592458|FG004|Overall Study|Lost to Follow-up|1|||
127717549|NCT03220724|459592459|FG005|Overall Study|Lost to Follow-up|0|||
127888721|NCT02763579|460215810|FG003|China Period|Lost to Follow-up|1|||
127888722|NCT02763579|460215807|FG000|China Period|Physician Decision|0|||
127888723|NCT02763579|460215808|FG001|China Period|Physician Decision|0|||
127717550|NCT03220724|459592460|FG006|Overall Study|Lost to Follow-up|2|||
127717551|NCT03220724|459592461|FG007|Overall Study|Lost to Follow-up|1|||
127717552|NCT03220724|459592462|FG008|Overall Study|Lost to Follow-up|0|||
127717553|NCT03220724|459592454|FG000|Overall Study|Withdrawal by Subject|1|||
127717554|NCT03220724|459592455|FG001|Overall Study|Withdrawal by Subject|0|||
127717555|NCT03220724|459592456|FG002|Overall Study|Withdrawal by Subject|1|||
127717556|NCT03220724|459592457|FG003|Overall Study|Withdrawal by Subject|0|||
127717557|NCT03220724|459592458|FG004|Overall Study|Withdrawal by Subject|0|||
127717558|NCT03220724|459592459|FG005|Overall Study|Withdrawal by Subject|0|||
127717559|NCT03220724|459592460|FG006|Overall Study|Withdrawal by Subject|0|||
127717560|NCT03220724|459592461|FG007|Overall Study|Withdrawal by Subject|0|||
127717561|NCT03220724|459592462|FG008|Overall Study|Withdrawal by Subject|0|||
127717562|NCT00442104|459592468|FG000|Overall Study|Adverse Event|5|||
127717563|NCT00442104|459592468|FG000|Overall Study|Death|2|||
127717564|NCT00442104|459592468|FG000|Overall Study|Lost to Follow-up|3|||
127717565|NCT00442104|459592468|FG000|Overall Study|Withdrawal by Subject|5|||
127717566|NCT00442104|459592468|FG000|Overall Study|Insufficient Clinical Response|10|||
127717567|NCT00442104|459592468|FG000|Overall Study|Other|21|||
127717568|NCT00442104|459592468|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
127717569|NCT02463448|459592471|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
127717570|NCT02463448|459592471|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
127717571|NCT02463448|459592471|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
127717572|NCT02463448|459592471|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
127717573|NCT00463229|459592475|FG000|Overall Study|Lost to Follow-up|5|||
127717574|NCT00463229|459592476|FG001|Overall Study|Lost to Follow-up|7|||
127717575|NCT00463229|459592475|FG000|Overall Study|Death|4|||
127717576|NCT00463229|459592476|FG001|Overall Study|Death|3|||
127717577|NCT01932970|459592477|FG000|Overall Study|Withdrawal by Subject|5|||
127717578|NCT01932970|459592477|FG000|Overall Study|Death|1|||
127717579|NCT01932970|459592477|FG000|Overall Study|Lost to Follow-up|2|||
127717580|NCT01932970|459592477|FG000|Overall Study|Protocol Specified Criteria|10|||
127717581|NCT01767467|459592478|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
127717582|NCT01767467|459592479|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
127717583|NCT01767467|459592478|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
127717584|NCT01767467|459592479|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
127717585|NCT01767467|459592478|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
127717586|NCT01767467|459592479|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
127717587|NCT01767467|459592478|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
127717588|NCT01767467|459592479|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
127717589|NCT01767467|459592478|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
127717590|NCT01767467|459592479|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
127717591|NCT01767467|459592478|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
127717592|NCT01767467|459592479|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
127717593|NCT01767467|459592478|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
127717594|NCT01767467|459592479|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
127717595|NCT01767467|459592478|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
127717596|NCT01767467|459592479|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
127717597|NCT01767467|459592478|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
127717598|NCT01767467|459592479|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
127717599|NCT01767467|459592478|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
127717600|NCT01767467|459592479|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
127717601|NCT01767467|459592478|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
127717602|NCT01767467|459592479|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
127717603|NCT01767467|459592478|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
127717604|NCT01767467|459592479|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
127717605|NCT01767467|459592478|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
127717606|NCT01767467|459592479|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
127717607|NCT01767467|459592478|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
127717608|NCT01767467|459592479|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
127717609|NCT03113409|459592480|FG000|Overall Study|Withdrawal by Subject|5|||
127717610|NCT03113409|459592481|FG001|Overall Study|Withdrawal by Subject|0|||
127717611|NCT03113409|459592482|FG002|Overall Study|Withdrawal by Subject|0|||
127717612|NCT01787032|459592489|FG000|Overall Study|Protocol Violation|0|||
127717613|NCT01787032|459592490|FG001|Overall Study|Protocol Violation|0|||
127717614|NCT01787032|459592491|FG002|Overall Study|Protocol Violation|0|||
127717615|NCT01787032|459592492|FG003|Overall Study|Protocol Violation|0|||
127717616|NCT01787032|459592493|FG004|Overall Study|Protocol Violation|1|||
127717617|NCT01787032|459592494|FG005|Overall Study|Protocol Violation|1|||
127717618|NCT00776009|459592495|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
127717619|NCT00776009|459592496|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
127717620|NCT00776009|459592497|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
127717621|NCT00776009|459592498|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
127717622|NCT00776009|459592499|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
127717623|NCT00776009|459592500|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
127717624|NCT00776009|459592495|FG000|Period 1: First Intervention|Protocol Violation|0|||
127717625|NCT00776009|459592496|FG001|Period 1: First Intervention|Protocol Violation|1|||
127717626|NCT00776009|459592497|FG002|Period 1: First Intervention|Protocol Violation|0|||
127717627|NCT00776009|459592498|FG003|Period 1: First Intervention|Protocol Violation|0|||
127717628|NCT00776009|459592499|FG004|Period 1: First Intervention|Protocol Violation|1|||
127717629|NCT00776009|459592500|FG005|Period 1: First Intervention|Protocol Violation|0|||
127717630|NCT00776009|459592495|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
127717631|NCT00776009|459592496|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
127717632|NCT00776009|459592497|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
127717633|NCT00776009|459592498|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
127717634|NCT00776009|459592499|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
127717635|NCT00776009|459592500|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
127717636|NCT00776009|459592495|FG000|Period 2: Second Intervention|Protocol Violation|1|||
127717637|NCT00776009|459592496|FG001|Period 2: Second Intervention|Protocol Violation|0|||
127717638|NCT00776009|459592497|FG002|Period 2: Second Intervention|Protocol Violation|1|||
127717639|NCT00776009|459592498|FG003|Period 2: Second Intervention|Protocol Violation|0|||
127717640|NCT00776009|459592499|FG004|Period 2: Second Intervention|Protocol Violation|0|||
127717641|NCT00776009|459592500|FG005|Period 2: Second Intervention|Protocol Violation|0|||
127717642|NCT00776009|459592495|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
127717643|NCT00776009|459592496|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
127717644|NCT00776009|459592497|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
127717645|NCT00776009|459592498|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
127717646|NCT00776009|459592499|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
127717647|NCT00776009|459592500|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
127717648|NCT04971733|459592501|FG000|Overall Study|Adverse Event|1|||
127717649|NCT04971733|459592502|FG001|Overall Study|Adverse Event|1|||
127717650|NCT04971733|459592501|FG000|Overall Study|Subject choice|2|||
127717651|NCT04971733|459592502|FG001|Overall Study|Subject choice|0|||
127717652|NCT04971733|459592501|FG000|Overall Study|Withdrawal by Subject|1|||
127717653|NCT04971733|459592502|FG001|Overall Study|Withdrawal by Subject|0|||
127717654|NCT04971733|459592501|FG000|Overall Study|Other|1|||
127717655|NCT04971733|459592502|FG001|Overall Study|Other|0|||
127717656|NCT02406092|459592506|FG000|Overall Study|Screen failure|10|||
127717657|NCT02406092|459592507|FG001|Overall Study|Screen failure|7|||
127717658|NCT02406092|459592506|FG000|Overall Study|Death|22|||
127717659|NCT02406092|459592507|FG001|Overall Study|Death|5|||
127717660|NCT02406092|459592506|FG000|Overall Study|Lost to Follow-up|4|||
127717661|NCT02406092|459592507|FG001|Overall Study|Lost to Follow-up|1|||
127717662|NCT02406092|459592506|FG000|Overall Study|Adverse Event|1|||
127717663|NCT02406092|459592507|FG001|Overall Study|Adverse Event|0|||
127717664|NCT02406092|459592506|FG000|Overall Study|Withdrawal by Subject|1|||
127717665|NCT02406092|459592507|FG001|Overall Study|Withdrawal by Subject|0|||
127717666|NCT03631407|459592508|FG000|Overall Study|Withdrawal by Subject|3|||
127717667|NCT03631407|459592509|FG001|Overall Study|Withdrawal by Subject|2|||
127717668|NCT03631407|459592508|FG000|Overall Study|Sponsor Decision|0|||
127717669|NCT03631407|459592509|FG001|Overall Study|Sponsor Decision|2|||
127717670|NCT03631407|459592508|FG000|Overall Study|Death|16|||
127717671|NCT03631407|459592509|FG001|Overall Study|Death|16|||
127717672|NCT03631407|459592508|FG000|Overall Study|Randomized by mistake without study treatment|1|||
127717673|NCT03631407|459592509|FG001|Overall Study|Randomized by mistake without study treatment|0|||
127717674|NCT01588951|459592510|FG000|Overall Study|Ineligible in retrospect|0|||
127717675|NCT01588951|459592511|FG001|Overall Study|Ineligible in retrospect|0|||
127717676|NCT01588951|459592512|FG002|Overall Study|Ineligible in retrospect|1|||
127802467|NCT04426695|459900990|FG007|Overall Study|Physician Decision|0|||
127802468|NCT04426695|459900991|FG008|Overall Study|Physician Decision|0|||
127802469|NCT04426695|459900992|FG009|Overall Study|Physician Decision|1|||
127802470|NCT04426695|459900993|FG010|Overall Study|Physician Decision|0|||
127802471|NCT04426695|459900994|FG011|Overall Study|Physician Decision|0|||
127802472|NCT04426695|459900995|FG012|Overall Study|Physician Decision|1|||
127802473|NCT04426695|459900996|FG013|Overall Study|Physician Decision|0|||
127802474|NCT04426695|459900997|FG014|Overall Study|Physician Decision|0|||
127802475|NCT04426695|459900998|FG015|Overall Study|Physician Decision|0|||
127802476|NCT04426695|459900999|FG016|Overall Study|Physician Decision|0|||
127802477|NCT04426695|459901000|FG017|Overall Study|Physician Decision|0|||
127802478|NCT04426695|459900983|FG000|Overall Study|Randomized but Never Treated|3|||
127802479|NCT04426695|459900984|FG001|Overall Study|Randomized but Never Treated|1|||
127802480|NCT04426695|459900985|FG002|Overall Study|Randomized but Never Treated|0|||
127802481|NCT04426695|459900986|FG003|Overall Study|Randomized but Never Treated|4|||
127802482|NCT04426695|459900987|FG004|Overall Study|Randomized but Never Treated|5|||
127802483|NCT04426695|459900988|FG005|Overall Study|Randomized but Never Treated|5|||
127802484|NCT04426695|459900989|FG006|Overall Study|Randomized but Never Treated|4|||
127802485|NCT04426695|459900990|FG007|Overall Study|Randomized but Never Treated|6|||
127802486|NCT04426695|459900991|FG008|Overall Study|Randomized but Never Treated|6|||
127802487|NCT04426695|459900992|FG009|Overall Study|Randomized but Never Treated|3|||
127802488|NCT04426695|459900993|FG010|Overall Study|Randomized but Never Treated|3|||
127802489|NCT04426695|459900994|FG011|Overall Study|Randomized but Never Treated|6|||
127802490|NCT04426695|459900995|FG012|Overall Study|Randomized but Never Treated|1|||
127802491|NCT04426695|459900996|FG013|Overall Study|Randomized but Never Treated|2|||
127802492|NCT04426695|459900997|FG014|Overall Study|Randomized but Never Treated|0|||
127802493|NCT04426695|459900998|FG015|Overall Study|Randomized but Never Treated|0|||
127802494|NCT04426695|459900999|FG016|Overall Study|Randomized but Never Treated|0|||
127802495|NCT04426695|459901000|FG017|Overall Study|Randomized but Never Treated|0|||
127802496|NCT00559273|459901001|FG000|Correction Period (20 Weeks)|Death|3|||
127802497|NCT00559273|459901002|FG001|Correction Period (20 Weeks)|Death|4|||
127802498|NCT00559273|459901001|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
127802499|NCT00559273|459901002|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
127802500|NCT00559273|459901001|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
127802501|NCT00559273|459901002|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
127802502|NCT00559273|459901001|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
127802503|NCT00559273|459901002|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
127802504|NCT00559273|459901001|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
127802505|NCT00559273|459901002|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
127802506|NCT00559273|459901001|FG000|Evaluation Period (8 Weeks)|Death|1|||
127802507|NCT00559273|459901002|FG001|Evaluation Period (8 Weeks)|Death|3|||
127802508|NCT00559273|459901001|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
127802509|NCT00559273|459901002|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
127802510|NCT00559273|459901001|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
127802511|NCT00559273|459901002|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
127802512|NCT00559273|459901001|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
127802513|NCT00559273|459901002|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
127717677|NCT02628626|459592517|FG000|Overall Study|Withdrawal by Subject|2|||
127717678|NCT02628626|459592518|FG001|Overall Study|Withdrawal by Subject|2|||
127802514|NCT00395967|459901003|FG000|Treatment Period|Failed Mobilization|1|||
127802515|NCT00395967|459901003|FG000|Follow-up Period|Death|1|||
127802516|NCT00395967|459901003|FG000|Follow-up Period|Lost to Follow-up|1|||
127802517|NCT03118947|459901008|FG000|Overall Study|Adverse Event|7|||
127802518|NCT03118947|459901008|FG000|Overall Study|Death|3|||
127802519|NCT03118947|459901008|FG000|Overall Study|Lack of Efficacy|4|||
127802520|NCT03118947|459901008|FG000|Overall Study|Non-compliance with study drug|1|||
127802521|NCT03118947|459901008|FG000|Overall Study|Protocol Violation|2|||
127802522|NCT03118947|459901008|FG000|Overall Study|Withdrawal by Subject|3|||
127802523|NCT03118947|459901008|FG000|Overall Study|Withdrawal by caregiver|3|||
127888724|NCT02763579|460215809|FG002|China Period|Physician Decision|0|||
127888725|NCT02763579|460215810|FG003|China Period|Physician Decision|1|||
127717679|NCT01593020|459592519|FG000|Overall Study|Adverse Event|1|||
127802524|NCT03118947|459901008|FG000|Overall Study|Change in patient's living situation|4|||
127802525|NCT03118947|459901008|FG000|Overall Study|Lost to Follow-up|2|||
127802526|NCT01109940|459901009|FG000|Overall Study|Administrative problems|2|||
127802527|NCT01109940|459901010|FG001|Overall Study|Administrative problems|0|||
127802528|NCT01109940|459901011|FG002|Overall Study|Administrative problems|0|||
127802529|NCT01109940|459901012|FG003|Overall Study|Administrative problems|0|||
127802530|NCT01109940|459901009|FG000|Overall Study|Serious Adverse Event|2|||
127802531|NCT01109940|459901010|FG001|Overall Study|Serious Adverse Event|1|||
127802532|NCT01109940|459901011|FG002|Overall Study|Serious Adverse Event|0|||
127802533|NCT01109940|459901012|FG003|Overall Study|Serious Adverse Event|0|||
127802534|NCT01109940|459901009|FG000|Overall Study|Lost to Follow-up|1|||
127802535|NCT01109940|459901010|FG001|Overall Study|Lost to Follow-up|0|||
127717680|NCT01593020|459592520|FG001|Overall Study|Adverse Event|1|||
127717681|NCT01593020|459592519|FG000|Overall Study|Death|0|||
127717682|NCT01593020|459592520|FG001|Overall Study|Death|1|||
127717683|NCT01593020|459592519|FG000|Overall Study|Ineligible|1|||
127717684|NCT01593020|459592520|FG001|Overall Study|Ineligible|0|||
127717685|NCT02063659|459592531|FG000|Double-Blind Treatment Period|Adverse Event|1|||
127717686|NCT02063659|459592532|FG001|Double-Blind Treatment Period|Adverse Event|2|||
127717687|NCT02063659|459592533|FG002|Double-Blind Treatment Period|Adverse Event|0|||
127717688|NCT02063659|459592534|FG003|Double-Blind Treatment Period|Adverse Event|0|||
127717689|NCT02063659|459592531|FG000|Double-Blind Treatment Period|Physician Decision|1|||
127717690|NCT02063659|459592532|FG001|Double-Blind Treatment Period|Physician Decision|0|||
127717691|NCT02063659|459592533|FG002|Double-Blind Treatment Period|Physician Decision|0|||
127717692|NCT02063659|459592534|FG003|Double-Blind Treatment Period|Physician Decision|0|||
127717693|NCT02063659|459592531|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
127717694|NCT02063659|459592532|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
127717695|NCT02063659|459592533|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
127717696|NCT02063659|459592534|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
127717697|NCT02063659|459592531|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
127717698|NCT02063659|459592532|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
127717699|NCT02063659|459592533|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
127717700|NCT02063659|459592534|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
127717701|NCT02063659|459592531|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
127717702|NCT02063659|459592532|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
127717703|NCT02063659|459592533|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
127717704|NCT02063659|459592534|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
127717705|NCT02063659|459592531|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
127717706|NCT02063659|459592532|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
127717707|NCT02063659|459592533|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
127717708|NCT02063659|459592534|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
127717709|NCT02063659|459592531|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
127717710|NCT02063659|459592532|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
127717711|NCT02063659|459592533|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
127717712|NCT02063659|459592534|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
127717713|NCT02063659|459592531|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
127717714|NCT02063659|459592532|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
127717715|NCT02063659|459592533|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
127717716|NCT02063659|459592534|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
127717717|NCT02972359|459592535|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
127717718|NCT02972359|459592535|FG000|Overall Study|Lack of Efficacy|1|||
127717719|NCT02972359|459592535|FG000|Overall Study|Adverse Event|4|||
127717720|NCT02972359|459592535|FG000|Overall Study|Death|1|||
127717721|NCT02972359|459592535|FG000|Overall Study|Withdrawal by Subject|30|||
127717722|NCT02972359|459592535|FG000|Overall Study|Protocol Violation|1|||
127717723|NCT02972359|459592535|FG000|Overall Study|Lost to Follow-up|26|||
127717724|NCT02972359|459592535|FG000|Overall Study|Other reasons|5|||
127717725|NCT02972359|459592535|FG000|Overall Study|Missing|1|||
127717726|NCT03598907|459592540|FG000|Overall Study|Physician Decision|14|||
127717727|NCT03598907|459592541|FG001|Overall Study|Physician Decision|19|||
127717728|NCT04686266|459592545|FG000|Overall Study|Withdrawal by Subject|0|||
127717729|NCT04686266|459592546|FG001|Overall Study|Withdrawal by Subject|1|||
127802536|NCT01109940|459901011|FG002|Overall Study|Lost to Follow-up|0|||
127802537|NCT01109940|459901012|FG003|Overall Study|Lost to Follow-up|0|||
127802538|NCT01109940|459901009|FG000|Overall Study|Patient withdrew consent|1|||
127717730|NCT04306367|459592551|FG000|Overall Study|Progression of Disease|9|||
127717731|NCT04306367|459592551|FG000|Overall Study|Adverse Event|3|||
127717732|NCT04306367|459592551|FG000|Overall Study|Withdrawal by Subject|1|||
127717733|NCT02401815|459592554|FG000|Dose Escalation (up to 670 Days)|Adverse Event|0|||
127802539|NCT01109940|459901010|FG001|Overall Study|Patient withdrew consent|1|||
127717734|NCT02401815|459592555|FG001|Dose Escalation (up to 670 Days)|Adverse Event|0|||
127802540|NCT01109940|459901011|FG002|Overall Study|Patient withdrew consent|0|||
127717735|NCT02401815|459592556|FG002|Dose Escalation (up to 670 Days)|Adverse Event|0|||
127717736|NCT02401815|459592557|FG003|Dose Escalation (up to 670 Days)|Adverse Event|1|||
127717737|NCT02401815|459592558|FG004|Dose Escalation (up to 670 Days)|Adverse Event|0|||
127717738|NCT02401815|459592559|FG005|Dose Escalation (up to 670 Days)|Adverse Event|0|||
127717739|NCT02401815|459592560|FG006|Dose Escalation (up to 670 Days)|Adverse Event|0|||
127717740|NCT02401815|459592561|FG007|Dose Escalation (up to 670 Days)|Adverse Event|0|||
127717741|NCT02401815|459592562|FG008|Dose Escalation (up to 670 Days)|Adverse Event|0|||
127717742|NCT02401815|459592563|FG009|Dose Escalation (up to 670 Days)|Adverse Event|0|||
127717743|NCT02401815|459592554|FG000|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
127717744|NCT02401815|459592555|FG001|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
127717745|NCT02401815|459592556|FG002|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
127717746|NCT02401815|459592557|FG003|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
127717747|NCT02401815|459592558|FG004|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
127717748|NCT02401815|459592559|FG005|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
127717749|NCT02401815|459592560|FG006|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
127717750|NCT02401815|459592561|FG007|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
127717751|NCT02401815|459592562|FG008|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
127717752|NCT02401815|459592563|FG009|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
127717753|NCT02401815|459592554|FG000|Dose Escalation (up to 670 Days)|Death|1|||
127717754|NCT02401815|459592555|FG001|Dose Escalation (up to 670 Days)|Death|2|||
127717755|NCT02401815|459592556|FG002|Dose Escalation (up to 670 Days)|Death|3|||
127717756|NCT02401815|459592557|FG003|Dose Escalation (up to 670 Days)|Death|5|||
127717757|NCT02401815|459592558|FG004|Dose Escalation (up to 670 Days)|Death|4|||
127717758|NCT02401815|459592559|FG005|Dose Escalation (up to 670 Days)|Death|0|||
127717759|NCT02401815|459592560|FG006|Dose Escalation (up to 670 Days)|Death|0|||
127717760|NCT02401815|459592561|FG007|Dose Escalation (up to 670 Days)|Death|0|||
127717761|NCT02401815|459592562|FG008|Dose Escalation (up to 670 Days)|Death|0|||
127717762|NCT02401815|459592563|FG009|Dose Escalation (up to 670 Days)|Death|0|||
127717763|NCT02401815|459592554|FG000|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
127717764|NCT02401815|459592555|FG001|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
127717765|NCT02401815|459592556|FG002|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
127717766|NCT02401815|459592557|FG003|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
127717767|NCT02401815|459592558|FG004|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
127717768|NCT02401815|459592559|FG005|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
127717769|NCT02401815|459592560|FG006|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
127717770|NCT02401815|459592561|FG007|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
127717771|NCT02401815|459592562|FG008|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
127717772|NCT02401815|459592563|FG009|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
127717773|NCT02401815|459592554|FG000|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
127717774|NCT02401815|459592555|FG001|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
127717775|NCT02401815|459592556|FG002|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
127717776|NCT02401815|459592557|FG003|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
127717777|NCT02401815|459592558|FG004|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
127717778|NCT02401815|459592559|FG005|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
127717779|NCT02401815|459592560|FG006|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
127717780|NCT02401815|459592561|FG007|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
127717781|NCT02401815|459592562|FG008|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
127717782|NCT02401815|459592563|FG009|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
127717783|NCT02401815|459592554|FG000|Dose Extension Part 2b (up to 868 Days)|Death|0|||
127717784|NCT02401815|459592555|FG001|Dose Extension Part 2b (up to 868 Days)|Death|0|||
127717785|NCT02401815|459592556|FG002|Dose Extension Part 2b (up to 868 Days)|Death|0|||
127717786|NCT02401815|459592557|FG003|Dose Extension Part 2b (up to 868 Days)|Death|0|||
127717787|NCT02401815|459592558|FG004|Dose Extension Part 2b (up to 868 Days)|Death|0|||
127717788|NCT02401815|459592559|FG005|Dose Extension Part 2b (up to 868 Days)|Death|2|||
127717789|NCT02401815|459592560|FG006|Dose Extension Part 2b (up to 868 Days)|Death|0|||
127717790|NCT02401815|459592561|FG007|Dose Extension Part 2b (up to 868 Days)|Death|0|||
127717791|NCT02401815|459592562|FG008|Dose Extension Part 2b (up to 868 Days)|Death|0|||
127717792|NCT02401815|459592563|FG009|Dose Extension Part 2b (up to 868 Days)|Death|0|||
127717793|NCT02401815|459592554|FG000|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
127717794|NCT02401815|459592555|FG001|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
127717795|NCT02401815|459592556|FG002|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
127717796|NCT02401815|459592557|FG003|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
127717797|NCT02401815|459592558|FG004|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
127717798|NCT02401815|459592559|FG005|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
127717799|NCT02401815|459592560|FG006|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|5|||
127717800|NCT02401815|459592561|FG007|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
127717801|NCT02401815|459592562|FG008|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
127717802|NCT02401815|459592563|FG009|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
127717803|NCT02401815|459592554|FG000|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
127717804|NCT02401815|459592555|FG001|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
127717805|NCT02401815|459592556|FG002|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
127717806|NCT02401815|459592557|FG003|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
127717807|NCT02401815|459592558|FG004|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
127717808|NCT02401815|459592559|FG005|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|1|||
127717809|NCT02401815|459592560|FG006|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|3|||
127717810|NCT02401815|459592561|FG007|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
127717811|NCT02401815|459592562|FG008|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
127717812|NCT02401815|459592563|FG009|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
127717813|NCT02401815|459592554|FG000|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
127717814|NCT02401815|459592555|FG001|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
127717815|NCT02401815|459592556|FG002|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
127717816|NCT02401815|459592557|FG003|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
127717817|NCT02401815|459592558|FG004|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
127717818|NCT02401815|459592559|FG005|Dose Extension Part 2b (up to 868 Days)|Other than specified|1|||
127717819|NCT02401815|459592560|FG006|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
127717820|NCT02401815|459592561|FG007|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
127717821|NCT02401815|459592562|FG008|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
127717822|NCT02401815|459592563|FG009|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
127717823|NCT02401815|459592554|FG000|Dose Extension Part 2e (up to 868 Days)|Death|0|||
127717824|NCT02401815|459592555|FG001|Dose Extension Part 2e (up to 868 Days)|Death|0|||
127717825|NCT02401815|459592556|FG002|Dose Extension Part 2e (up to 868 Days)|Death|0|||
127717826|NCT02401815|459592557|FG003|Dose Extension Part 2e (up to 868 Days)|Death|0|||
127717827|NCT02401815|459592558|FG004|Dose Extension Part 2e (up to 868 Days)|Death|0|||
127717828|NCT02401815|459592559|FG005|Dose Extension Part 2e (up to 868 Days)|Death|0|||
127717829|NCT02401815|459592560|FG006|Dose Extension Part 2e (up to 868 Days)|Death|0|||
127717830|NCT02401815|459592561|FG007|Dose Extension Part 2e (up to 868 Days)|Death|1|||
127717831|NCT02401815|459592562|FG008|Dose Extension Part 2e (up to 868 Days)|Death|2|||
127717832|NCT02401815|459592563|FG009|Dose Extension Part 2e (up to 868 Days)|Death|4|||
127717833|NCT02401815|459592554|FG000|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
127717834|NCT02401815|459592555|FG001|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
127717835|NCT02401815|459592556|FG002|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
127717836|NCT02401815|459592557|FG003|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
127717837|NCT02401815|459592558|FG004|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
127717838|NCT02401815|459592559|FG005|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
127717839|NCT02401815|459592560|FG006|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
127717840|NCT02401815|459592561|FG007|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
127717841|NCT02401815|459592562|FG008|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|2|||
127802541|NCT01109940|459901012|FG003|Overall Study|Patient withdrew consent|0|||
127802542|NCT01109940|459901009|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
127717842|NCT02401815|459592563|FG009|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|1|||
127717843|NCT02401815|459592554|FG000|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
127717844|NCT02401815|459592555|FG001|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
127717845|NCT02401815|459592556|FG002|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
127717846|NCT02401815|459592557|FG003|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
127717847|NCT02401815|459592558|FG004|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
127717848|NCT02401815|459592559|FG005|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
127717849|NCT02401815|459592560|FG006|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
127717850|NCT02401815|459592561|FG007|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
127717851|NCT02401815|459592562|FG008|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
127717852|NCT02401815|459592563|FG009|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|2|||
127717853|NCT02401815|459592554|FG000|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
127717854|NCT02401815|459592555|FG001|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
127717855|NCT02401815|459592556|FG002|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
127717856|NCT02401815|459592557|FG003|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
127717857|NCT02401815|459592558|FG004|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
127717858|NCT02401815|459592559|FG005|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
127717859|NCT02401815|459592560|FG006|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
127717860|NCT02401815|459592561|FG007|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
127717861|NCT02401815|459592562|FG008|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|1|||
127717862|NCT02401815|459592563|FG009|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
127717863|NCT02401815|459592554|FG000|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
127717864|NCT02401815|459592555|FG001|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
127717865|NCT02401815|459592556|FG002|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
127717866|NCT02401815|459592557|FG003|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
127717867|NCT02401815|459592558|FG004|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
127717868|NCT02401815|459592559|FG005|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
127717869|NCT02401815|459592560|FG006|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
127717870|NCT02401815|459592561|FG007|Dose Extension Part 2e (up to 868 Days)|Other than specified|2|||
127717871|NCT02401815|459592562|FG008|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
127717872|NCT02401815|459592563|FG009|Dose Extension Part 2e (up to 868 Days)|Other than specified|3|||
127717873|NCT05071430|459592572|FG000|Overall Study|Adverse Event|1|||
127717874|NCT05071430|459592573|FG001|Overall Study|Adverse Event|2|||
127717875|NCT05071430|459592572|FG000|Overall Study|Lost to Follow-up|4|||
127717876|NCT05071430|459592573|FG001|Overall Study|Lost to Follow-up|4|||
127717877|NCT05071430|459592572|FG000|Overall Study|Protocol Violation|1|||
127717878|NCT05071430|459592573|FG001|Overall Study|Protocol Violation|0|||
127717879|NCT05071430|459592572|FG000|Overall Study|Withdrawal by Subject|3|||
127717880|NCT05071430|459592573|FG001|Overall Study|Withdrawal by Subject|2|||
127717881|NCT05071430|459592572|FG000|Overall Study|Other|1|||
127717882|NCT05071430|459592573|FG001|Overall Study|Other|1|||
127717883|NCT05864209|459594262|FG000|Overall Study|Lost to Follow-up|2|||
127717884|NCT05864209|459594263|FG001|Overall Study|Lost to Follow-up|3|||
127717885|NCT00092534|459594266|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
127717886|NCT00092534|459594267|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
127717887|NCT00092534|459594268|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
127717888|NCT00092534|459594269|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
127717889|NCT00092534|459594270|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
127717890|NCT00092534|459594266|FG000|Base Study Vaccination Period|Adverse Event|3|||
127717891|NCT00092534|459594267|FG001|Base Study Vaccination Period|Adverse Event|1|||
127717892|NCT00092534|459594268|FG002|Base Study Vaccination Period|Adverse Event|0|||
127717893|NCT00092534|459594269|FG003|Base Study Vaccination Period|Adverse Event|0|||
127717894|NCT00092534|459594270|FG004|Base Study Vaccination Period|Adverse Event|0|||
127717895|NCT00092534|459594266|FG000|Base Study Vaccination Period|Death|5|||
127717896|NCT00092534|459594267|FG001|Base Study Vaccination Period|Death|4|||
127717897|NCT00092534|459594268|FG002|Base Study Vaccination Period|Death|0|||
127717898|NCT00092534|459594269|FG003|Base Study Vaccination Period|Death|0|||
127717899|NCT00092534|459594270|FG004|Base Study Vaccination Period|Death|0|||
127717900|NCT00092534|459594266|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
127717901|NCT00092534|459594267|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
127717902|NCT00092534|459594268|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
127717903|NCT00092534|459594269|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
127717904|NCT00092534|459594270|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
127717905|NCT00092534|459594266|FG000|Base Study Vaccination Period|Physician Decision|1|||
127717906|NCT00092534|459594267|FG001|Base Study Vaccination Period|Physician Decision|0|||
127717907|NCT00092534|459594268|FG002|Base Study Vaccination Period|Physician Decision|0|||
127717908|NCT00092534|459594269|FG003|Base Study Vaccination Period|Physician Decision|0|||
127717909|NCT00092534|459594270|FG004|Base Study Vaccination Period|Physician Decision|0|||
127717910|NCT00092534|459594266|FG000|Base Study Vaccination Period|Pregnancy|9|||
127717911|NCT00092534|459594267|FG001|Base Study Vaccination Period|Pregnancy|7|||
127717912|NCT00092534|459594268|FG002|Base Study Vaccination Period|Pregnancy|0|||
127717913|NCT00092534|459594269|FG003|Base Study Vaccination Period|Pregnancy|0|||
127717914|NCT00092534|459594270|FG004|Base Study Vaccination Period|Pregnancy|0|||
127717915|NCT00092534|459594266|FG000|Base Study Vaccination Period|Protocol Violation|2|||
127717916|NCT00092534|459594267|FG001|Base Study Vaccination Period|Protocol Violation|1|||
127717917|NCT00092534|459594268|FG002|Base Study Vaccination Period|Protocol Violation|0|||
127717918|NCT00092534|459594269|FG003|Base Study Vaccination Period|Protocol Violation|0|||
127717919|NCT00092534|459594270|FG004|Base Study Vaccination Period|Protocol Violation|0|||
127717920|NCT00092534|459594266|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
127717921|NCT00092534|459594267|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
127717922|NCT00092534|459594268|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
127717923|NCT00092534|459594269|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
127717924|NCT00092534|459594270|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
127717925|NCT00092534|459594266|FG000|Base Study Vaccination Period|Moved|14|||
127717926|NCT00092534|459594267|FG001|Base Study Vaccination Period|Moved|12|||
127717927|NCT00092534|459594268|FG002|Base Study Vaccination Period|Moved|0|||
127717928|NCT00092534|459594269|FG003|Base Study Vaccination Period|Moved|0|||
127717929|NCT00092534|459594270|FG004|Base Study Vaccination Period|Moved|0|||
127717930|NCT00092534|459594266|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
127717931|NCT00092534|459594267|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
127717932|NCT00092534|459594268|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
127717933|NCT00092534|459594269|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
127717934|NCT00092534|459594270|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
127717935|NCT00092534|459594266|FG000|Base Study Vaccination Period|Travel|1|||
127717936|NCT00092534|459594267|FG001|Base Study Vaccination Period|Travel|0|||
127717937|NCT00092534|459594268|FG002|Base Study Vaccination Period|Travel|0|||
127717938|NCT00092534|459594269|FG003|Base Study Vaccination Period|Travel|0|||
127717939|NCT00092534|459594270|FG004|Base Study Vaccination Period|Travel|0|||
127717940|NCT00092534|459594266|FG000|Base Study Vaccination Period|Site Closed|0|||
127717941|NCT00092534|459594267|FG001|Base Study Vaccination Period|Site Closed|1|||
127717942|NCT00092534|459594268|FG002|Base Study Vaccination Period|Site Closed|0|||
127717943|NCT00092534|459594269|FG003|Base Study Vaccination Period|Site Closed|0|||
127717944|NCT00092534|459594270|FG004|Base Study Vaccination Period|Site Closed|0|||
127717945|NCT00092534|459594266|FG000|Base Study Follow-Up Period|Adverse Event|2|||
127717946|NCT00092534|459594267|FG001|Base Study Follow-Up Period|Adverse Event|4|||
127717947|NCT00092534|459594268|FG002|Base Study Follow-Up Period|Adverse Event|0|||
127717948|NCT00092534|459594269|FG003|Base Study Follow-Up Period|Adverse Event|0|||
127717949|NCT00092534|459594270|FG004|Base Study Follow-Up Period|Adverse Event|0|||
127717950|NCT00092534|459594266|FG000|Base Study Follow-Up Period|Death|2|||
127717951|NCT00092534|459594267|FG001|Base Study Follow-Up Period|Death|1|||
127717952|NCT00092534|459594268|FG002|Base Study Follow-Up Period|Death|0|||
127717953|NCT00092534|459594269|FG003|Base Study Follow-Up Period|Death|0|||
127717954|NCT00092534|459594270|FG004|Base Study Follow-Up Period|Death|0|||
127717955|NCT00092534|459594266|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
127717956|NCT00092534|459594267|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
127717957|NCT00092534|459594268|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
127717958|NCT00092534|459594269|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
127717959|NCT00092534|459594270|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
127717960|NCT00092534|459594266|FG000|Base Study Follow-Up Period|Pregnancy|6|||
127717961|NCT00092534|459594267|FG001|Base Study Follow-Up Period|Pregnancy|10|||
127717962|NCT00092534|459594268|FG002|Base Study Follow-Up Period|Pregnancy|0|||
127717963|NCT00092534|459594269|FG003|Base Study Follow-Up Period|Pregnancy|0|||
127717964|NCT00092534|459594270|FG004|Base Study Follow-Up Period|Pregnancy|0|||
127717965|NCT00092534|459594266|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
127717966|NCT00092534|459594267|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
127717967|NCT00092534|459594268|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
127717968|NCT00092534|459594269|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
127717969|NCT00092534|459594270|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
127717970|NCT00092534|459594266|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
127717971|NCT00092534|459594267|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
127717972|NCT00092534|459594268|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
127717973|NCT00092534|459594269|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
127717974|NCT00092534|459594270|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
127717975|NCT00092534|459594266|FG000|Base Study Follow-Up Period|Moved|62|||
127717976|NCT00092534|459594267|FG001|Base Study Follow-Up Period|Moved|58|||
127717977|NCT00092534|459594268|FG002|Base Study Follow-Up Period|Moved|0|||
127717978|NCT00092534|459594269|FG003|Base Study Follow-Up Period|Moved|0|||
127717979|NCT00092534|459594270|FG004|Base Study Follow-Up Period|Moved|0|||
127717980|NCT00092534|459594266|FG000|Base Study Follow-Up Period|Travel|10|||
127717981|NCT00092534|459594267|FG001|Base Study Follow-Up Period|Travel|7|||
127717982|NCT00092534|459594268|FG002|Base Study Follow-Up Period|Travel|0|||
127717983|NCT00092534|459594269|FG003|Base Study Follow-Up Period|Travel|0|||
127717984|NCT00092534|459594270|FG004|Base Study Follow-Up Period|Travel|0|||
127717985|NCT00092534|459594266|FG000|Base Study Follow-Up Period|Site Closed|0|||
127717986|NCT00092534|459594267|FG001|Base Study Follow-Up Period|Site Closed|2|||
127717987|NCT00092534|459594268|FG002|Base Study Follow-Up Period|Site Closed|0|||
127717988|NCT00092534|459594269|FG003|Base Study Follow-Up Period|Site Closed|0|||
127717989|NCT00092534|459594270|FG004|Base Study Follow-Up Period|Site Closed|0|||
127717990|NCT00092534|459594266|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
127717991|NCT00092534|459594267|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
127717992|NCT00092534|459594268|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
127717993|NCT00092534|459594269|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
127717994|NCT00092534|459594270|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
127717995|NCT00092534|459594266|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
127717996|NCT00092534|459594267|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
127717997|NCT00092534|459594268|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
127717998|NCT00092534|459594269|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
127802543|NCT01109940|459901010|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
127802544|NCT01109940|459901011|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
127802545|NCT01109940|459901012|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
127802546|NCT03653390|459901013|FG000|Overall Study|Lost to Follow-up|12|||
127802547|NCT03653390|459901014|FG001|Overall Study|Lost to Follow-up|8|||
127802548|NCT03653390|459901015|FG002|Overall Study|Lost to Follow-up|7|||
127802549|NCT03653390|459901013|FG000|Overall Study|Withdrawal by Subject|6|||
127802550|NCT03653390|459901014|FG001|Overall Study|Withdrawal by Subject|1|||
127802551|NCT03653390|459901015|FG002|Overall Study|Withdrawal by Subject|1|||
127802552|NCT03653390|459901013|FG000|Overall Study|Death|1|||
127802553|NCT03653390|459901014|FG001|Overall Study|Death|0|||
127802554|NCT03653390|459901015|FG002|Overall Study|Death|0|||
127802555|NCT03653390|459901013|FG000|Overall Study|Paper Survey Lost|1|||
127802556|NCT03653390|459901014|FG001|Overall Study|Paper Survey Lost|0|||
127802557|NCT03653390|459901015|FG002|Overall Study|Paper Survey Lost|0|||
127802558|NCT01262976|459901020|FG000|Up to Month 2|Serious Adverse Event|0|||
127802559|NCT01262976|459901021|FG001|Up to Month 2|Serious Adverse Event|0|||
127802560|NCT01262976|459901022|FG002|Up to Month 2|Serious Adverse Event|1|||
127802561|NCT01262976|459901023|FG003|Up to Month 2|Serious Adverse Event|0|||
127802562|NCT01262976|459901024|FG004|Up to Month 2|Serious Adverse Event|0|||
127802563|NCT01262976|459901025|FG005|Up to Month 2|Serious Adverse Event|0|||
127802564|NCT01262976|459901020|FG000|Up to Month 2|Withdrawal by Subject|1|||
127802565|NCT01262976|459901021|FG001|Up to Month 2|Withdrawal by Subject|0|||
127717999|NCT00092534|459594270|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
127718000|NCT00092534|459594266|FG000|Base Study EXT|Lost to Follow-up|0|||
127718001|NCT00092534|459594267|FG001|Base Study EXT|Lost to Follow-up|0|||
127718002|NCT00092534|459594268|FG002|Base Study EXT|Lost to Follow-up|41|||
127718003|NCT00092534|459594269|FG003|Base Study EXT|Lost to Follow-up|0|||
127802566|NCT01262976|459901022|FG002|Up to Month 2|Withdrawal by Subject|0|||
127718004|NCT00092534|459594270|FG004|Base Study EXT|Lost to Follow-up|0|||
127718005|NCT00092534|459594266|FG000|Base Study EXT|Physician Decision|0|||
127718006|NCT00092534|459594267|FG001|Base Study EXT|Physician Decision|0|||
127718007|NCT00092534|459594268|FG002|Base Study EXT|Physician Decision|1|||
127718008|NCT00092534|459594269|FG003|Base Study EXT|Physician Decision|0|||
127718009|NCT00092534|459594270|FG004|Base Study EXT|Physician Decision|0|||
127718010|NCT00092534|459594266|FG000|Base Study EXT|Pregnancy|0|||
127718011|NCT00092534|459594267|FG001|Base Study EXT|Pregnancy|0|||
127718012|NCT00092534|459594268|FG002|Base Study EXT|Pregnancy|12|||
127718013|NCT00092534|459594269|FG003|Base Study EXT|Pregnancy|0|||
127718014|NCT00092534|459594270|FG004|Base Study EXT|Pregnancy|0|||
127718015|NCT00092534|459594266|FG000|Base Study EXT|Withdrawal by Subject|0|||
127718016|NCT00092534|459594267|FG001|Base Study EXT|Withdrawal by Subject|0|||
127718017|NCT00092534|459594268|FG002|Base Study EXT|Withdrawal by Subject|18|||
127718018|NCT00092534|459594269|FG003|Base Study EXT|Withdrawal by Subject|0|||
127718019|NCT00092534|459594270|FG004|Base Study EXT|Withdrawal by Subject|0|||
127718020|NCT00092534|459594266|FG000|Base Study EXT|Participant moved|0|||
127718021|NCT00092534|459594267|FG001|Base Study EXT|Participant moved|0|||
127718022|NCT00092534|459594268|FG002|Base Study EXT|Participant moved|6|||
127718023|NCT00092534|459594269|FG003|Base Study EXT|Participant moved|0|||
127718024|NCT00092534|459594270|FG004|Base Study EXT|Participant moved|0|||
127718025|NCT00092534|459594266|FG000|Base Study EXT|Travel|0|||
127718026|NCT00092534|459594267|FG001|Base Study EXT|Travel|0|||
127718027|NCT00092534|459594268|FG002|Base Study EXT|Travel|2|||
127718028|NCT00092534|459594269|FG003|Base Study EXT|Travel|0|||
127718029|NCT00092534|459594270|FG004|Base Study EXT|Travel|0|||
127718030|NCT00092534|459594266|FG000|Base Study EXT|Site closed|0|||
127718031|NCT00092534|459594267|FG001|Base Study EXT|Site closed|0|||
127718032|NCT00092534|459594268|FG002|Base Study EXT|Site closed|21|||
127718033|NCT00092534|459594269|FG003|Base Study EXT|Site closed|0|||
127718034|NCT00092534|459594270|FG004|Base Study EXT|Site closed|0|||
127718035|NCT00092534|459594266|FG000|Base Study EXT|Study ended|0|||
127718036|NCT00092534|459594267|FG001|Base Study EXT|Study ended|0|||
127718037|NCT00092534|459594268|FG002|Base Study EXT|Study ended|29|||
127718038|NCT00092534|459594269|FG003|Base Study EXT|Study ended|0|||
127718039|NCT00092534|459594270|FG004|Base Study EXT|Study ended|0|||
127718040|NCT00092534|459594266|FG000|Base Study EXT|Protocol Violation|0|||
127718041|NCT00092534|459594267|FG001|Base Study EXT|Protocol Violation|0|||
127718042|NCT00092534|459594268|FG002|Base Study EXT|Protocol Violation|15|||
127718043|NCT00092534|459594269|FG003|Base Study EXT|Protocol Violation|0|||
127718044|NCT00092534|459594270|FG004|Base Study EXT|Protocol Violation|0|||
127718045|NCT00092534|459594266|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
127718046|NCT00092534|459594267|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
127718047|NCT00092534|459594268|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
127718048|NCT00092534|459594269|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
127718049|NCT00092534|459594270|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
127718050|NCT05029284|459594271|FG000|Overall Study|Lost to Follow-up|1|||
127718051|NCT04001829|459594272|FG000|Overall Study|Never start protocol therapy|5|||
127718052|NCT04001829|459594273|FG001|Overall Study|Never start protocol therapy|5|||
127718053|NCT04001829|459594272|FG000|Overall Study|Adverse Event|11|||
127718054|NCT04001829|459594273|FG001|Overall Study|Adverse Event|7|||
127718055|NCT04001829|459594272|FG000|Overall Study|Alternative therapy|1|||
127718056|NCT04001829|459594273|FG001|Overall Study|Alternative therapy|2|||
127718057|NCT04001829|459594272|FG000|Overall Study|Disease progression/relapse|2|||
127802567|NCT01262976|459901023|FG003|Up to Month 2|Withdrawal by Subject|0|||
127718058|NCT04001829|459594273|FG001|Overall Study|Disease progression/relapse|1|||
127718059|NCT04001829|459594272|FG000|Overall Study|Other complicating disease|1|||
127718060|NCT04001829|459594273|FG001|Overall Study|Other complicating disease|0|||
127718061|NCT04001829|459594272|FG000|Overall Study|Withdrawal by Subject|1|||
127718062|NCT04001829|459594273|FG001|Overall Study|Withdrawal by Subject|4|||
127718063|NCT04001829|459594272|FG000|Overall Study|Ineligible|2|||
127718064|NCT04001829|459594273|FG001|Overall Study|Ineligible|2|||
127718065|NCT04001829|459594272|FG000|Overall Study|Reason missing due to delinquent data|1|||
127718066|NCT04001829|459594273|FG001|Overall Study|Reason missing due to delinquent data|0|||
127718067|NCT03678688|459594274|FG000|Overall Study|Reason not Specified|0|||
127718068|NCT03678688|459594275|FG001|Overall Study|Reason not Specified|0|||
127718069|NCT03678688|459594276|FG002|Overall Study|Reason not Specified|3|||
127718070|NCT03678688|459594277|FG003|Overall Study|Reason not Specified|0|||
127718071|NCT03678688|459594278|FG004|Overall Study|Reason not Specified|1|||
127718072|NCT03678688|459594279|FG005|Overall Study|Reason not Specified|0|||
127718073|NCT03678688|459594280|FG006|Overall Study|Reason not Specified|0|||
127718074|NCT03678688|459594281|FG007|Overall Study|Reason not Specified|0|||
127718075|NCT03678688|459594282|FG008|Overall Study|Reason not Specified|0|||
127718076|NCT03678688|459594274|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
127718077|NCT03678688|459594275|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
127718078|NCT03678688|459594276|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
127718079|NCT03678688|459594277|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
127718080|NCT03678688|459594278|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
127718081|NCT03678688|459594279|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
127718082|NCT03678688|459594280|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
127718083|NCT03678688|459594281|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
127718084|NCT03678688|459594282|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
127718085|NCT03678688|459594274|FG000|Overall Study|Covid Related Adverse Event|0|||
127718086|NCT03678688|459594275|FG001|Overall Study|Covid Related Adverse Event|0|||
127718087|NCT03678688|459594276|FG002|Overall Study|Covid Related Adverse Event|0|||
127718088|NCT03678688|459594277|FG003|Overall Study|Covid Related Adverse Event|0|||
127718089|NCT03678688|459594278|FG004|Overall Study|Covid Related Adverse Event|0|||
127718090|NCT03678688|459594279|FG005|Overall Study|Covid Related Adverse Event|3|||
127718091|NCT03678688|459594280|FG006|Overall Study|Covid Related Adverse Event|1|||
127718092|NCT03678688|459594281|FG007|Overall Study|Covid Related Adverse Event|1|||
127718093|NCT03678688|459594282|FG008|Overall Study|Covid Related Adverse Event|0|||
127718094|NCT03678688|459594274|FG000|Overall Study|Physician Decision|0|||
127718095|NCT03678688|459594275|FG001|Overall Study|Physician Decision|0|||
127718096|NCT03678688|459594276|FG002|Overall Study|Physician Decision|0|||
127718097|NCT03678688|459594277|FG003|Overall Study|Physician Decision|0|||
127718098|NCT03678688|459594278|FG004|Overall Study|Physician Decision|0|||
127718099|NCT03678688|459594279|FG005|Overall Study|Physician Decision|1|||
127718100|NCT03678688|459594280|FG006|Overall Study|Physician Decision|0|||
127718101|NCT03678688|459594281|FG007|Overall Study|Physician Decision|0|||
127718102|NCT03678688|459594282|FG008|Overall Study|Physician Decision|0|||
127718103|NCT03678688|459594274|FG000|Overall Study|Withdrawal by Subject|0|||
127718104|NCT03678688|459594275|FG001|Overall Study|Withdrawal by Subject|0|||
127718105|NCT03678688|459594276|FG002|Overall Study|Withdrawal by Subject|0|||
127718106|NCT03678688|459594277|FG003|Overall Study|Withdrawal by Subject|0|||
127718107|NCT03678688|459594278|FG004|Overall Study|Withdrawal by Subject|0|||
127718108|NCT03678688|459594279|FG005|Overall Study|Withdrawal by Subject|0|||
127718109|NCT03678688|459594280|FG006|Overall Study|Withdrawal by Subject|2|||
127718110|NCT03678688|459594281|FG007|Overall Study|Withdrawal by Subject|1|||
127718111|NCT03678688|459594282|FG008|Overall Study|Withdrawal by Subject|0|||
127718112|NCT03002194|459594288|FG000|Overall Study|Lost to Follow-up|6|||
127718113|NCT03002194|459594288|FG000|Overall Study|Adverse Event|1|||
127718114|NCT03002194|459594288|FG000|Overall Study|Lack of Efficacy|1|||
127718115|NCT03002194|459594288|FG000|Overall Study|Withdrawal by Subject|2|||
127718116|NCT00985088|459594289|FG000|Overall Study|Serious Adverse Event|1|||
127718117|NCT00985088|459594290|FG001|Overall Study|Serious Adverse Event|1|||
127718118|NCT00985088|459594291|FG002|Overall Study|Serious Adverse Event|0|||
127718119|NCT00985088|459594292|FG003|Overall Study|Serious Adverse Event|0|||
127718120|NCT00985088|459594293|FG004|Overall Study|Serious Adverse Event|0|||
127718121|NCT00985088|459594294|FG005|Overall Study|Serious Adverse Event|0|||
127718122|NCT00985088|459594295|FG006|Overall Study|Serious Adverse Event|0|||
127718123|NCT00985088|459594296|FG007|Overall Study|Serious Adverse Event|1|||
127718124|NCT00985088|459594289|FG000|Overall Study|Adverse Event|0|||
127718125|NCT00985088|459594290|FG001|Overall Study|Adverse Event|0|||
127718126|NCT00985088|459594291|FG002|Overall Study|Adverse Event|1|||
127718127|NCT00985088|459594292|FG003|Overall Study|Adverse Event|0|||
127718128|NCT00985088|459594293|FG004|Overall Study|Adverse Event|0|||
127718129|NCT00985088|459594294|FG005|Overall Study|Adverse Event|0|||
127718130|NCT00985088|459594295|FG006|Overall Study|Adverse Event|0|||
127718131|NCT00985088|459594296|FG007|Overall Study|Adverse Event|0|||
127718132|NCT00985088|459594289|FG000|Overall Study|Withdrawal by Subject|4|||
127718133|NCT00985088|459594290|FG001|Overall Study|Withdrawal by Subject|0|||
127718134|NCT00985088|459594291|FG002|Overall Study|Withdrawal by Subject|0|||
127718135|NCT00985088|459594292|FG003|Overall Study|Withdrawal by Subject|1|||
127718136|NCT00985088|459594293|FG004|Overall Study|Withdrawal by Subject|3|||
127718137|NCT00985088|459594294|FG005|Overall Study|Withdrawal by Subject|2|||
127718138|NCT00985088|459594295|FG006|Overall Study|Withdrawal by Subject|1|||
127718139|NCT00985088|459594296|FG007|Overall Study|Withdrawal by Subject|2|||
127718140|NCT00985088|459594289|FG000|Overall Study|Migrated/moved from study area|0|||
127718141|NCT00985088|459594290|FG001|Overall Study|Migrated/moved from study area|0|||
127718142|NCT00985088|459594291|FG002|Overall Study|Migrated/moved from study area|1|||
127718143|NCT00985088|459594292|FG003|Overall Study|Migrated/moved from study area|0|||
127718144|NCT00985088|459594293|FG004|Overall Study|Migrated/moved from study area|0|||
127718145|NCT00985088|459594294|FG005|Overall Study|Migrated/moved from study area|0|||
127718146|NCT00985088|459594295|FG006|Overall Study|Migrated/moved from study area|0|||
127718147|NCT00985088|459594296|FG007|Overall Study|Migrated/moved from study area|1|||
127718148|NCT00985088|459594289|FG000|Overall Study|Lost to Follow-up|6|||
127718149|NCT00985088|459594290|FG001|Overall Study|Lost to Follow-up|1|||
127718150|NCT00985088|459594291|FG002|Overall Study|Lost to Follow-up|2|||
127718151|NCT00985088|459594292|FG003|Overall Study|Lost to Follow-up|6|||
127718152|NCT00985088|459594293|FG004|Overall Study|Lost to Follow-up|6|||
127718153|NCT00985088|459594294|FG005|Overall Study|Lost to Follow-up|5|||
127718154|NCT00985088|459594295|FG006|Overall Study|Lost to Follow-up|3|||
127718155|NCT00985088|459594296|FG007|Overall Study|Lost to Follow-up|2|||
127718156|NCT04162210|459594301|FG000|Overall Study|Lost to Follow-up|4|||
127718157|NCT04162210|459594302|FG001|Overall Study|Lost to Follow-up|1|||
127718158|NCT04162210|459594301|FG000|Overall Study|Withdrawal by Subject|17|||
127718159|NCT04162210|459594302|FG001|Overall Study|Withdrawal by Subject|9|||
127718160|NCT04162210|459594301|FG000|Overall Study|Ongoing|113|||
127718161|NCT04162210|459594302|FG001|Overall Study|Ongoing|59|||
127718162|NCT00371345|459594305|FG000|Overall Study|Disease Progression|21|||
127718163|NCT00371345|459594306|FG001|Overall Study|Disease Progression|35|||
127718164|NCT00371345|459594305|FG000|Overall Study|Study Drug Toxicity|1|||
127718165|NCT00371345|459594306|FG001|Overall Study|Study Drug Toxicity|7|||
127718166|NCT00371345|459594305|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
127718167|NCT00371345|459594306|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
127718168|NCT00371345|459594305|FG000|Overall Study|Participant Request|1|||
127718169|NCT00371345|459594306|FG001|Overall Study|Participant Request|1|||
127718170|NCT00371345|459594305|FG000|Overall Study|Participant Withdrew Consent|0|||
127718171|NCT00371345|459594306|FG001|Overall Study|Participant Withdrew Consent|1|||
127718172|NCT01478594|459594307|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
127718173|NCT01478594|459594308|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
127718174|NCT01478594|459594307|FG000|Overall Study|Death|45|||
127718175|NCT01478594|459594308|FG001|Overall Study|Death|18|||
127718176|NCT01478594|459594307|FG000|Overall Study|Lost to Follow-up|3|||
127718177|NCT01478594|459594308|FG001|Overall Study|Lost to Follow-up|1|||
127718178|NCT01478594|459594307|FG000|Overall Study|Withdrawal by Subject|9|||
127718179|NCT01478594|459594308|FG001|Overall Study|Withdrawal by Subject|3|||
127718180|NCT01478594|459594307|FG000|Overall Study|Study Closed by Sponsor|8|||
127718181|NCT01478594|459594308|FG001|Overall Study|Study Closed by Sponsor|5|||
127718182|NCT00713596|459594309|FG000|Overall Study|Study was terminated|2|||
127718183|NCT00713596|459594310|FG001|Overall Study|Study was terminated|3|||
127718184|NCT00713596|459594311|FG002|Overall Study|Study was terminated|2|||
127718185|NCT04545619|459594312|FG000|Overall Study|due to equipment challenges|1|||
127718186|NCT01359150|459594317|FG000|Overall Study|Lack of Efficacy|1|||
127718187|NCT01359150|459594318|FG001|Overall Study|Lack of Efficacy|1|||
127718188|NCT01359150|459594317|FG000|Overall Study|Withdrawal by Subject|1|||
127718189|NCT01359150|459594318|FG001|Overall Study|Withdrawal by Subject|1|||
127718190|NCT01359150|459594317|FG000|Overall Study|Adverse Event|4|||
127718191|NCT01359150|459594318|FG001|Overall Study|Adverse Event|3|||
127718192|NCT01359150|459594317|FG000|Overall Study|Other|1|||
127718193|NCT01359150|459594318|FG001|Overall Study|Other|0|||
127718194|NCT02040870|459594323|FG000|Overall Study|Completed treatment phase|6|||
127718195|NCT02040870|459594323|FG000|Overall Study|Adverse Event|7|||
127718196|NCT02040870|459594323|FG000|Overall Study|Progressive disease|58|||
127718197|NCT02040870|459594323|FG000|Overall Study|Physician Decision|6|||
127718198|NCT02040870|459594323|FG000|Overall Study|Subject/guardian decision|10|||
127718199|NCT02040870|459594323|FG000|Overall Study|Lost to Follow-up|3|||
127718200|NCT02040870|459594323|FG000|Overall Study|Death|13|||
127718201|NCT02275611|459594326|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
127718202|NCT02275611|459594327|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
127718203|NCT02275611|459594328|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
127718204|NCT02275611|459594329|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
127718205|NCT01759862|459594332|FG000|Overall Study|Physician Decision|3|||
127718206|NCT01759862|459594333|FG001|Overall Study|Physician Decision|1|||
127718207|NCT01759862|459594332|FG000|Overall Study|Adverse Event|0|||
127718208|NCT01759862|459594333|FG001|Overall Study|Adverse Event|1|||
127718209|NCT03041233|459594336|FG000|Overall Study|Death|5|||
127718210|NCT03041233|459594336|FG000|Overall Study|Physician Decision|1|||
127718211|NCT03041233|459594336|FG000|Overall Study|Lost to Follow-up|16|||
127718212|NCT03041233|459594336|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|7|||
127718213|NCT03041233|459594336|FG000|Overall Study|Sponsor Request|1|||
127718214|NCT03041233|459594336|FG000|Overall Study|Duplicate subject|1|||
127718215|NCT03041233|459594336|FG000|Overall Study|Re-ablation|1|||
127718216|NCT03229408|459594337|FG000|Overall Study|Withdrawal by Subject|4|||
127718217|NCT03229408|459594338|FG001|Overall Study|Withdrawal by Subject|1|||
127718218|NCT03229408|459594337|FG000|Overall Study|Adverse Event|2|||
127718219|NCT03229408|459594338|FG001|Overall Study|Adverse Event|0|||
127718220|NCT03229408|459594337|FG000|Overall Study|Pregnancy|0|||
127718221|NCT03229408|459594338|FG001|Overall Study|Pregnancy|1|||
127718222|NCT03229408|459594337|FG000|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
127718223|NCT03229408|459594338|FG001|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
127718224|NCT04541589|459594339|FG000|Treatment Period|Adverse Event|8|||
127718225|NCT04541589|459594340|FG001|Treatment Period|Adverse Event|2|||
127718226|NCT04541589|459594339|FG000|Treatment Period|Physician Decision|3|||
127718227|NCT04541589|459594340|FG001|Treatment Period|Physician Decision|1|||
127718228|NCT04541589|459594339|FG000|Treatment Period|Subject decision|7|||
127718229|NCT04541589|459594340|FG001|Treatment Period|Subject decision|4|||
127718230|NCT04541589|459594339|FG000|Treatment Period|Withdrawal by Subject|1|||
127718231|NCT04541589|459594340|FG001|Treatment Period|Withdrawal by Subject|0|||
127718232|NCT04541589|459594339|FG000|Safety Follow-up Period|Adverse Event|2|||
127718233|NCT04541589|459594340|FG001|Safety Follow-up Period|Adverse Event|1|||
127718234|NCT04541589|459594339|FG000|Safety Follow-up Period|Physician Decision|1|||
127718235|NCT04541589|459594340|FG001|Safety Follow-up Period|Physician Decision|0|||
127718236|NCT04541589|459594339|FG000|Safety Follow-up Period|Subject decision|5|||
127718237|NCT04541589|459594340|FG001|Safety Follow-up Period|Subject decision|3|||
127718238|NCT04541589|459594339|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
127718239|NCT04541589|459594340|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
127718240|NCT00687219|459594344|FG000|Overall Study|Adverse Event|8|||
127718241|NCT00687219|459594344|FG000|Overall Study|Discontinuance criteria met|7|||
127718242|NCT00687219|459594344|FG000|Overall Study|HCV-RNA positive conversion|34|||
127718243|NCT00687219|459594344|FG000|Overall Study|Withdrawal by Subject|1|||
127718244|NCT00687219|459594344|FG000|Overall Study|Lack of Efficacy|1|||
127718245|NCT01400958|459594345|FG000|Overall Study|Physician Decision|0|||
127718246|NCT01400958|459594346|FG001|Overall Study|Physician Decision|1|||
127718247|NCT01400958|459594345|FG000|Overall Study|Withdrawal by Subject|0|||
127718248|NCT01400958|459594346|FG001|Overall Study|Withdrawal by Subject|1|||
127718249|NCT01400958|459594345|FG000|Overall Study|Adverse Event|1|||
127718250|NCT01400958|459594346|FG001|Overall Study|Adverse Event|0|||
127718251|NCT01532999|459594347|FG000|Overall Study|Lost to Follow-up|14|||
127718252|NCT01532999|459594348|FG001|Overall Study|Lost to Follow-up|8|||
127718253|NCT01532999|459594347|FG000|Overall Study|Physician Decision|1|||
127718254|NCT01532999|459594348|FG001|Overall Study|Physician Decision|2|||
127718255|NCT01532999|459594347|FG000|Overall Study|Withdrawal by Subject|5|||
127718256|NCT01532999|459594348|FG001|Overall Study|Withdrawal by Subject|0|||
127718257|NCT01532999|459594347|FG000|Overall Study|Relocated|2|||
127718258|NCT01532999|459594348|FG001|Overall Study|Relocated|0|||
127718259|NCT01532999|459594347|FG000|Overall Study|should not have been randomized|1|||
127718260|NCT01532999|459594348|FG001|Overall Study|should not have been randomized|0|||
127718261|NCT01532999|459594347|FG000|Overall Study|substantial noncompliance|2|||
127718262|NCT01532999|459594348|FG001|Overall Study|substantial noncompliance|0|||
127718263|NCT01532999|459594347|FG000|Overall Study|no show for week 9 assessments|6|||
127718264|NCT01532999|459594348|FG001|Overall Study|no show for week 9 assessments|4|||
127718265|NCT01532999|459594347|FG000|Overall Study|Adverse Event|0|||
127718266|NCT01532999|459594348|FG001|Overall Study|Adverse Event|1|||
127718267|NCT01532999|459594347|FG000|Overall Study|incarcerated|0|||
127718268|NCT01532999|459594348|FG001|Overall Study|incarcerated|1|||
127718269|NCT01532999|459594347|FG000|Overall Study|New job|0|||
127718270|NCT01532999|459594348|FG001|Overall Study|New job|2|||
127718271|NCT00914966|459594349|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
127718272|NCT00914966|459594349|FG000|Step 1: 1500 Units|Physician Decision|1|||
127802568|NCT01262976|459901024|FG004|Up to Month 2|Withdrawal by Subject|0|||
127802569|NCT01262976|459901025|FG005|Up to Month 2|Withdrawal by Subject|0|||
127802570|NCT01262976|459901020|FG000|Up to Month 2|Migrated/moved from study area|0|||
127718273|NCT00914966|459594349|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
127718274|NCT04021862|459594352|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
127802571|NCT01262976|459901021|FG001|Up to Month 2|Migrated/moved from study area|1|||
127718275|NCT04021862|459594353|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
127718276|NCT04021862|459594354|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
127718277|NCT04021862|459594355|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
127718278|NCT04021862|459594356|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
127718279|NCT04021862|459594357|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
127718280|NCT04021862|459594352|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
127718281|NCT04021862|459594353|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
127718282|NCT04021862|459594354|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
127718283|NCT04021862|459594355|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
127718284|NCT04021862|459594356|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
127718285|NCT04021862|459594357|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
127718286|NCT04021862|459594352|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
127718287|NCT04021862|459594353|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
127718288|NCT04021862|459594354|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
127718289|NCT04021862|459594355|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
127718290|NCT04021862|459594356|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
127718291|NCT04021862|459594357|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
127718292|NCT04021862|459594352|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
127718293|NCT04021862|459594353|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
127718294|NCT04021862|459594354|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
127718295|NCT04021862|459594355|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
127718296|NCT04021862|459594356|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
127718297|NCT04021862|459594357|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
127718298|NCT04021862|459594352|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
127718299|NCT04021862|459594353|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
127718300|NCT04021862|459594354|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
127718301|NCT04021862|459594355|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
127718302|NCT04021862|459594356|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
127718303|NCT04021862|459594357|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
127718304|NCT05251363|459594358|FG000|Implant|Subject did not meet LBBA implant criteria|8|||
127718305|NCT05251363|459594358|FG000|Overall Study After Implant Period|Death|9|||
127718306|NCT05251363|459594358|FG000|Overall Study After Implant Period|Solia S lead in LBBA Position Extracted|4|||
127718307|NCT05251363|459594358|FG000|Overall Study After Implant Period|Withdrawal by Subject|4|||
127718308|NCT05251363|459594358|FG000|Overall Study After Implant Period|Lost to Follow-up|2|||
127718309|NCT05251363|459594358|FG000|Overall Study After Implant Period|Physician Decision|1|||
127718310|NCT05251363|459594358|FG000|Overall Study After Implant Period|Subject Moved from Investigational Center|3|||
127718311|NCT03835754|459594361|FG000|Overall Study|Death|4|||
127718312|NCT02830204|459594362|FG000|Overall Study|Death|9|||
127718313|NCT02830204|459594362|FG000|Overall Study|Withdrawal by Subject|1|||
127718314|NCT01690624|459594363|FG000|Overall Study|PD based on IWG criteria or clinical PD|8|||
127718315|NCT01690624|459594364|FG001|Overall Study|PD based on IWG criteria or clinical PD|5|||
127718316|NCT01690624|459594365|FG002|Overall Study|PD based on IWG criteria or clinical PD|2|||
127718317|NCT01690624|459594366|FG003|Overall Study|PD based on IWG criteria or clinical PD|0|||
127718318|NCT01690624|459594363|FG000|Overall Study|Adverse event (other than DLT)|3|||
127718319|NCT01690624|459594364|FG001|Overall Study|Adverse event (other than DLT)|1|||
127718320|NCT01690624|459594365|FG002|Overall Study|Adverse event (other than DLT)|1|||
127718321|NCT01690624|459594366|FG003|Overall Study|Adverse event (other than DLT)|1|||
127718322|NCT01690624|459594363|FG000|Overall Study|Withdrawal by Subject|0|||
127718323|NCT01690624|459594364|FG001|Overall Study|Withdrawal by Subject|0|||
127718324|NCT01690624|459594365|FG002|Overall Study|Withdrawal by Subject|1|||
127718325|NCT01690624|459594366|FG003|Overall Study|Withdrawal by Subject|0|||
127718326|NCT01690624|459594363|FG000|Overall Study|Sponsor is ending trial|0|||
127718327|NCT01690624|459594364|FG001|Overall Study|Sponsor is ending trial|0|||
127718328|NCT01690624|459594365|FG002|Overall Study|Sponsor is ending trial|0|||
127718329|NCT01690624|459594366|FG003|Overall Study|Sponsor is ending trial|1|||
127718330|NCT01690624|459594363|FG000|Overall Study|Physician Decision|0|||
127718331|NCT01690624|459594364|FG001|Overall Study|Physician Decision|0|||
127718332|NCT01690624|459594365|FG002|Overall Study|Physician Decision|0|||
127718333|NCT01690624|459594366|FG003|Overall Study|Physician Decision|1|||
127718334|NCT01690624|459594363|FG000|Overall Study|Withdrawal by Subject|0|||
127718335|NCT01690624|459594364|FG001|Overall Study|Withdrawal by Subject|1|||
127718336|NCT01690624|459594365|FG002|Overall Study|Withdrawal by Subject|0|||
127718337|NCT01690624|459594366|FG003|Overall Study|Withdrawal by Subject|0|||
127718338|NCT01690624|459594363|FG000|Overall Study|Lack of Efficacy|1|||
127718339|NCT01690624|459594364|FG001|Overall Study|Lack of Efficacy|1|||
127718340|NCT01690624|459594365|FG002|Overall Study|Lack of Efficacy|3|||
127802572|NCT01262976|459901022|FG002|Up to Month 2|Migrated/moved from study area|0|||
127802573|NCT01262976|459901023|FG003|Up to Month 2|Migrated/moved from study area|0|||
127718341|NCT01690624|459594366|FG003|Overall Study|Lack of Efficacy|0|||
127718342|NCT02517268|459594368|FG000|Overall Study|Withdrawal by Subject|1|||
127718343|NCT02517268|459594369|FG001|Overall Study|Withdrawal by Subject|0|||
127718344|NCT04445831|459594370|FG000|Overall Study|Withdrawal by Subject|2|||
127718345|NCT04445831|459594371|FG001|Overall Study|Withdrawal by Subject|1|||
127718346|NCT04445831|459594372|FG002|Overall Study|Withdrawal by Subject|1|||
127718347|NCT04445831|459594373|FG003|Overall Study|Withdrawal by Subject|0|||
127718348|NCT04445831|459594374|FG004|Overall Study|Withdrawal by Subject|0|||
127718349|NCT04445831|459594375|FG005|Overall Study|Withdrawal by Subject|0|||
127718350|NCT04445831|459594376|FG006|Overall Study|Withdrawal by Subject|0|||
127718351|NCT04445831|459594370|FG000|Overall Study|Subject withdrawal by caregiver|0|||
127718352|NCT04445831|459594371|FG001|Overall Study|Subject withdrawal by caregiver|1|||
127718353|NCT04445831|459594372|FG002|Overall Study|Subject withdrawal by caregiver|0|||
127718354|NCT04445831|459594373|FG003|Overall Study|Subject withdrawal by caregiver|0|||
127718355|NCT04445831|459594374|FG004|Overall Study|Subject withdrawal by caregiver|0|||
127718356|NCT04445831|459594375|FG005|Overall Study|Subject withdrawal by caregiver|0|||
127718357|NCT04445831|459594376|FG006|Overall Study|Subject withdrawal by caregiver|0|||
127718358|NCT04912856|459594377|FG000|Overall Study|Sponsor Decision; not due to safety reasons|4|||
127718359|NCT04912856|459594378|FG001|Overall Study|Sponsor Decision; not due to safety reasons|2|||
127718360|NCT04912856|459594377|FG000|Overall Study|Not reported in synoptic CSR.|0|||
127718361|NCT04912856|459594378|FG001|Overall Study|Not reported in synoptic CSR.|1|||
127718362|NCT04649047|459594385|FG000|Overall Study|Withdrawal by Subject|3|||
127718363|NCT00719888|459594386|FG000|Overall Study|Death|24|||
127718364|NCT00719888|459594387|FG001|Overall Study|Death|9|||
127718365|NCT00719888|459594386|FG000|Overall Study|Relapse|8|||
127718366|NCT00719888|459594387|FG001|Overall Study|Relapse|3|||
127718367|NCT00719888|459594386|FG000|Overall Study|Physician Decision|1|||
127718368|NCT00719888|459594387|FG001|Overall Study|Physician Decision|0|||
127718369|NCT00719888|459594386|FG000|Overall Study|Withdrawal by Subject|1|||
127718370|NCT00719888|459594387|FG001|Overall Study|Withdrawal by Subject|0|||
127718371|NCT05037513|459594388|FG000|Intervention Period|Lost to Follow-up|1|||
127718372|NCT05037513|459594389|FG001|Intervention Period|Lost to Follow-up|2|||
127718373|NCT05037513|459594388|FG000|Follow Up Period|Lost to Follow-up|16|||
127718374|NCT05037513|459594389|FG001|Follow Up Period|Lost to Follow-up|21|||
127718375|NCT05037513|459594388|FG000|Follow Up Period|Death|0|||
127718376|NCT05037513|459594389|FG001|Follow Up Period|Death|1|||
127718377|NCT05037513|459594388|FG000|Follow Up Period|Incarcerated|4|||
127718378|NCT05037513|459594389|FG001|Follow Up Period|Incarcerated|2|||
127718379|NCT03773107|459594390|FG000|Overall Study|Participant currently on study and in follow up status.|1|||
127718380|NCT03773107|459594391|FG001|Overall Study|Participant currently on study and in follow up status.|0|||
127718381|NCT03773107|459594392|FG002|Overall Study|Participant currently on study and in follow up status.|0|||
127718382|NCT03773107|459594393|FG003|Overall Study|Participant currently on study and in follow up status.|1|||
127718383|NCT02328014|459595558|FG000|Overall Study|Adverse Event|1|||
127718384|NCT02328014|459595559|FG001|Overall Study|Adverse Event|0|||
127718385|NCT02328014|459595560|FG002|Overall Study|Adverse Event|0|||
127718386|NCT02328014|459595561|FG003|Overall Study|Adverse Event|1|||
127718387|NCT02328014|459595558|FG000|Overall Study|Death|0|||
127718388|NCT02328014|459595559|FG001|Overall Study|Death|0|||
127718389|NCT02328014|459595560|FG002|Overall Study|Death|0|||
127718390|NCT02328014|459595561|FG003|Overall Study|Death|4|||
127718391|NCT02328014|459595558|FG000|Overall Study|Physician Decision|0|||
127718392|NCT02328014|459595559|FG001|Overall Study|Physician Decision|0|||
127718393|NCT02328014|459595560|FG002|Overall Study|Physician Decision|0|||
127718394|NCT02328014|459595561|FG003|Overall Study|Physician Decision|1|||
127802574|NCT01262976|459901024|FG004|Up to Month 2|Migrated/moved from study area|1|||
127718395|NCT02328014|459595558|FG000|Overall Study|Disease Progression|1|||
127718396|NCT02328014|459595559|FG001|Overall Study|Disease Progression|0|||
127718397|NCT02328014|459595560|FG002|Overall Study|Disease Progression|1|||
127718398|NCT02328014|459595561|FG003|Overall Study|Disease Progression|3|||
127718399|NCT02328014|459595558|FG000|Overall Study|Study Terminated by Sponsor|4|||
127718400|NCT02328014|459595559|FG001|Overall Study|Study Terminated by Sponsor|1|||
127718401|NCT02328014|459595560|FG002|Overall Study|Study Terminated by Sponsor|1|||
127718402|NCT02328014|459595561|FG003|Overall Study|Study Terminated by Sponsor|0|||
127718403|NCT02328014|459595558|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
127718404|NCT02328014|459595559|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
127718405|NCT02328014|459595560|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
127718406|NCT02328014|459595561|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
127718407|NCT02328014|459595558|FG000|Overall Study|Withdrawal by Subject|0|||
127718408|NCT02328014|459595559|FG001|Overall Study|Withdrawal by Subject|0|||
127718409|NCT02328014|459595560|FG002|Overall Study|Withdrawal by Subject|0|||
127718410|NCT02328014|459595561|FG003|Overall Study|Withdrawal by Subject|1|||
127718411|NCT01274338|459595562|FG000|Overall Study|Lack of Efficacy|72|||
127718412|NCT01274338|459595563|FG001|Overall Study|Lack of Efficacy|108|||
127718413|NCT01274338|459595564|FG002|Overall Study|Lack of Efficacy|116|||
127718414|NCT01274338|459595565|FG003|Overall Study|Lack of Efficacy|0|||
127718415|NCT01274338|459595566|FG004|Overall Study|Lack of Efficacy|0|||
127718416|NCT01274338|459595567|FG005|Overall Study|Lack of Efficacy|0|||
127718417|NCT01274338|459595562|FG000|Overall Study|Adverse Event|272|||
127718418|NCT01274338|459595563|FG001|Overall Study|Adverse Event|105|||
127718419|NCT01274338|459595564|FG002|Overall Study|Adverse Event|180|||
127718420|NCT01274338|459595565|FG003|Overall Study|Adverse Event|1|||
127718421|NCT01274338|459595566|FG004|Overall Study|Adverse Event|0|||
127718422|NCT01274338|459595567|FG005|Overall Study|Adverse Event|0|||
127718423|NCT01274338|459595562|FG000|Overall Study|Death|8|||
127718424|NCT01274338|459595563|FG001|Overall Study|Death|1|||
127718425|NCT01274338|459595564|FG002|Overall Study|Death|0|||
127718426|NCT01274338|459595565|FG003|Overall Study|Death|0|||
127718427|NCT01274338|459595566|FG004|Overall Study|Death|0|||
127718428|NCT01274338|459595567|FG005|Overall Study|Death|0|||
127718429|NCT01274338|459595562|FG000|Overall Study|Withdrawal by Subject|27|||
127718430|NCT01274338|459595563|FG001|Overall Study|Withdrawal by Subject|99|||
127718431|NCT01274338|459595564|FG002|Overall Study|Withdrawal by Subject|17|||
127718432|NCT01274338|459595565|FG003|Overall Study|Withdrawal by Subject|0|||
127718433|NCT01274338|459595566|FG004|Overall Study|Withdrawal by Subject|0|||
127718434|NCT01274338|459595567|FG005|Overall Study|Withdrawal by Subject|0|||
127718435|NCT01274338|459595562|FG000|Overall Study|Did not start treatment|8|||
127718436|NCT01274338|459595563|FG001|Overall Study|Did not start treatment|116|||
127718437|NCT01274338|459595564|FG002|Overall Study|Did not start treatment|7|||
127718438|NCT01274338|459595565|FG003|Overall Study|Did not start treatment|0|||
127718439|NCT01274338|459595566|FG004|Overall Study|Did not start treatment|0|||
127718440|NCT01274338|459595567|FG005|Overall Study|Did not start treatment|0|||
127718441|NCT01274338|459595562|FG000|Overall Study|Alternative therapy|0|||
127718442|NCT01274338|459595563|FG001|Overall Study|Alternative therapy|1|||
127718443|NCT01274338|459595564|FG002|Overall Study|Alternative therapy|0|||
127718444|NCT01274338|459595565|FG003|Overall Study|Alternative therapy|0|||
127718445|NCT01274338|459595566|FG004|Overall Study|Alternative therapy|0|||
127718446|NCT01274338|459595567|FG005|Overall Study|Alternative therapy|0|||
127718447|NCT01274338|459595562|FG000|Overall Study|Other complicating diseases|0|||
127718448|NCT01274338|459595563|FG001|Overall Study|Other complicating diseases|3|||
127718449|NCT01274338|459595564|FG002|Overall Study|Other complicating diseases|1|||
127718450|NCT01274338|459595565|FG003|Overall Study|Other complicating diseases|0|||
127718451|NCT01274338|459595566|FG004|Overall Study|Other complicating diseases|0|||
127718452|NCT01274338|459595567|FG005|Overall Study|Other complicating diseases|0|||
127718453|NCT01274338|459595562|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
127718454|NCT01274338|459595563|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
127718455|NCT01274338|459595564|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
127718456|NCT01274338|459595565|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
127718457|NCT01274338|459595566|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
127718458|NCT01274338|459595567|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
127718459|NCT01274338|459595562|FG000|Overall Study|Pregnancy|0|||
127718460|NCT01274338|459595563|FG001|Overall Study|Pregnancy|0|||
127718461|NCT01274338|459595564|FG002|Overall Study|Pregnancy|1|||
127718462|NCT01274338|459595565|FG003|Overall Study|Pregnancy|0|||
127718463|NCT01274338|459595566|FG004|Overall Study|Pregnancy|0|||
127718464|NCT01274338|459595567|FG005|Overall Study|Pregnancy|0|||
127718465|NCT01274338|459595562|FG000|Overall Study|Reason not reported|12|||
127718466|NCT01274338|459595563|FG001|Overall Study|Reason not reported|21|||
127718467|NCT01274338|459595564|FG002|Overall Study|Reason not reported|3|||
127718468|NCT01274338|459595565|FG003|Overall Study|Reason not reported|0|||
127718469|NCT01274338|459595566|FG004|Overall Study|Reason not reported|1|||
127718470|NCT01274338|459595567|FG005|Overall Study|Reason not reported|0|||
127718471|NCT05422339|459595568|FG000|Overall Study|Withdrawal by Subject|17|||
127718472|NCT05422339|459595569|FG001|Overall Study|Withdrawal by Subject|15|||
127718473|NCT06056310|459595570|FG000|Overall Study|Other Reasons|2|||
127718474|NCT06056310|459595570|FG000|Overall Study|Sponsor Request|16|||
127718475|NCT01278030|459595584|FG000|Overall Study|Withdrawal by Subject|8|||
127718476|NCT01278030|459595585|FG001|Overall Study|Withdrawal by Subject|4|||
127718477|NCT00458783|459595587|FG000|Overall Study|Protocol Violation|1228|||
127718478|NCT00458783|459595588|FG001|Overall Study|Protocol Violation|1220|||
127718479|NCT01737398|459595589|FG000|Overall Study|Adverse event or SAE|16|||
127718480|NCT01737398|459595590|FG001|Overall Study|Adverse event or SAE|1|||
127718481|NCT01737398|459595589|FG000|Overall Study|Stopping rule met|2|||
127718482|NCT01737398|459595590|FG001|Overall Study|Stopping rule met|1|||
127718483|NCT01737398|459595589|FG000|Overall Study|Voluntary withdrawal|2|||
127718484|NCT01737398|459595590|FG001|Overall Study|Voluntary withdrawal|3|||
127718485|NCT01737398|459595589|FG000|Overall Study|Ineligibility|1|||
127718486|NCT01737398|459595590|FG001|Overall Study|Ineligibility|0|||
127718487|NCT01737398|459595589|FG000|Overall Study|Liver transplant|1|||
127718488|NCT01737398|459595590|FG001|Overall Study|Liver transplant|0|||
127718489|NCT01737398|459595589|FG000|Overall Study|Disease progression|2|||
127718490|NCT01737398|459595590|FG001|Overall Study|Disease progression|3|||
127718491|NCT01737398|459595589|FG000|Overall Study|Sponsor's decision|2|||
127718492|NCT01737398|459595590|FG001|Overall Study|Sponsor's decision|0|||
127718493|NCT05250115|459595591|FG000|Overall Study|Premature study end|40|||
127718494|NCT05250115|459595591|FG000|Overall Study|Adverse Event|8|||
127718495|NCT05250115|459595591|FG000|Overall Study|Lost to Follow-up|7|||
127718496|NCT05250115|459595591|FG000|Overall Study|Withdrawal by Subject|6|||
127718497|NCT05250115|459595591|FG000|Overall Study|Withdrawal of informed consent|1|||
127718498|NCT05250115|459595591|FG000|Overall Study|Other|7|||
127718499|NCT05815342|459595592|FG000|Baseline, Standard Therapy (2 Weeks)|Ineligible|4|||
127718500|NCT05815342|459595592|FG000|Baseline, Standard Therapy (2 Weeks)|Withdrawal by Subject|9|||
127718501|NCT05815342|459595592|FG000|Baseline, Standard Therapy (2 Weeks)|Lost to Follow-up|2|||
127718502|NCT05815342|459595592|FG000|Treatment Phase (13 Weeks)|Withdrawal by Subject|14|||
127718503|NCT05815342|459595592|FG000|Treatment Phase (13 Weeks)|Lost to Follow-up|2|||
127718504|NCT00357994|459595595|FG000|Overall Study|Adverse Event|1|||
127718505|NCT00357994|459595596|FG001|Overall Study|Adverse Event|2|||
127718506|NCT00357994|459595595|FG000|Overall Study|Lack of Efficacy|0|||
127718507|NCT00357994|459595596|FG001|Overall Study|Lack of Efficacy|1|||
127718508|NCT00357994|459595595|FG000|Overall Study|Protocol Violation|1|||
127718509|NCT00357994|459595596|FG001|Overall Study|Protocol Violation|0|||
127718510|NCT03244800|459595597|FG000|Overall Study|Adverse Event|0|||
127718511|NCT03244800|459595598|FG001|Overall Study|Adverse Event|1|||
127718512|NCT03244800|459595599|FG002|Overall Study|Adverse Event|0|||
127718513|NCT03244800|459595600|FG003|Overall Study|Adverse Event|1|||
127718514|NCT03244800|459595597|FG000|Overall Study|Withdrew treatment|0|||
127718515|NCT03244800|459595598|FG001|Overall Study|Withdrew treatment|0|||
127718516|NCT03244800|459595599|FG002|Overall Study|Withdrew treatment|0|||
127718517|NCT03244800|459595600|FG003|Overall Study|Withdrew treatment|1|||
127718518|NCT04885998|459595601|FG000|Overall Study|Withdrawal by Subject|0|||
127718519|NCT04885998|459595602|FG001|Overall Study|Withdrawal by Subject|2|||
127718520|NCT04885998|459595603|FG002|Overall Study|Withdrawal by Subject|0|||
127718521|NCT04885998|459595604|FG003|Overall Study|Withdrawal by Subject|3|||
127718522|NCT04885998|459595601|FG000|Overall Study|Lost to Follow-up|1|||
127718523|NCT04885998|459595602|FG001|Overall Study|Lost to Follow-up|1|||
127718524|NCT04885998|459595603|FG002|Overall Study|Lost to Follow-up|0|||
127718525|NCT04885998|459595604|FG003|Overall Study|Lost to Follow-up|0|||
127718526|NCT04885998|459595601|FG000|Overall Study|Death|2|||
127718527|NCT04885998|459595602|FG001|Overall Study|Death|1|||
127718528|NCT04885998|459595603|FG002|Overall Study|Death|2|||
127718529|NCT04885998|459595604|FG003|Overall Study|Death|2|||
127718530|NCT04885998|459595601|FG000|Overall Study|Decision by sponsor|1|||
127718531|NCT04885998|459595602|FG001|Overall Study|Decision by sponsor|1|||
127718532|NCT04885998|459595603|FG002|Overall Study|Decision by sponsor|0|||
127718533|NCT04885998|459595604|FG003|Overall Study|Decision by sponsor|0|||
127718534|NCT03712371|459595608|FG000|Overall Study|Lack of Efficacy|0|||
127718535|NCT03712371|459595609|FG001|Overall Study|Lack of Efficacy|0|||
127718536|NCT03712371|459595610|FG002|Overall Study|Lack of Efficacy|0|||
127718537|NCT03712371|459595611|FG003|Overall Study|Lack of Efficacy|1|||
127718538|NCT02362035|459595616|FG000|Overall Study|Death|67|||
127718539|NCT02362035|459595616|FG000|Overall Study|Lost to Follow-up|3|||
127718540|NCT02362035|459595616|FG000|Overall Study|Adverse Event|1|||
127718541|NCT02362035|459595616|FG000|Overall Study|Physician Decision|1|||
127718542|NCT02362035|459595616|FG000|Overall Study|Subject started another cancer therapy|10|||
127718543|NCT02362035|459595616|FG000|Overall Study|Study terminated by sponsor|45|||
127718544|NCT02362035|459595616|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
127718545|NCT02362035|459595616|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
127718546|NCT02362035|459595616|FG000|Overall Study|Disease progression|11|||
127718547|NCT02362035|459595616|FG000|Overall Study|Withdrawal by Subject|20|||
127718548|NCT02788981|459595617|FG000|Overall Study|Patient chose to pursue alternative treatment|0|||
127718549|NCT02788981|459595618|FG001|Overall Study|Patient chose to pursue alternative treatment|1|||
127718550|NCT04250194|459595621|FG000|Overall Study|Declined to schedule biopsy|6|||
127718551|NCT04250194|459595622|FG001|Overall Study|Declined to schedule biopsy|10|||
127718552|NCT04250194|459595621|FG000|Overall Study|Medically Unfit for Biopsy|2|||
127718553|NCT04250194|459595622|FG001|Overall Study|Medically Unfit for Biopsy|1|||
127718554|NCT04250194|459595621|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|0|||
127718555|NCT04250194|459595622|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|2|||
127718556|NCT04250194|459595621|FG000|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|0|||
127718557|NCT04250194|459595622|FG001|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|2|||
127718558|NCT04250194|459595621|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|0|||
127718559|NCT04250194|459595622|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|1|||
127718560|NCT00229658|459595623|FG000|Overall Study|Administrative|2|||
127718561|NCT00229658|459595624|FG001|Overall Study|Administrative|1|||
127718562|NCT00229658|459595623|FG000|Overall Study|Investigator decision|13|||
127718563|NCT00229658|459595624|FG001|Overall Study|Investigator decision|10|||
127718564|NCT00229658|459595623|FG000|Overall Study|Other|80|||
127718565|NCT00229658|459595624|FG001|Overall Study|Other|60|||
127718566|NCT00229658|459595623|FG000|Overall Study|Lost to Follow-up|82|||
127718567|NCT00229658|459595624|FG001|Overall Study|Lost to Follow-up|55|||
127718568|NCT00229658|459595623|FG000|Overall Study|Serious Adverse Event|2|||
127888726|NCT02763579|460215807|FG000|China Period|Study Terminated By Sponsor|0|||
127888727|NCT02763579|460215808|FG001|China Period|Study Terminated By Sponsor|0|||
127718569|NCT00229658|459595624|FG001|Overall Study|Serious Adverse Event|2|||
127718570|NCT00229658|459595623|FG000|Overall Study|Withdrawal of consent|46|||
127718571|NCT00229658|459595624|FG001|Overall Study|Withdrawal of consent|39|||
127718572|NCT00249769|459595625|FG000|Overall Study|Withdrawal by Subject|1|||
127718573|NCT00249769|459595626|FG001|Overall Study|Withdrawal by Subject|10|||
127888728|NCT02763579|460215809|FG002|China Period|Study Terminated By Sponsor|3|||
127718574|NCT00249769|459595627|FG002|Overall Study|Withdrawal by Subject|6|||
127718575|NCT00249769|459595625|FG000|Overall Study|Migration from Study Area|1|||
127718576|NCT00249769|459595626|FG001|Overall Study|Migration from Study Area|3|||
127718577|NCT00249769|459595627|FG002|Overall Study|Migration from Study Area|14|||
127718578|NCT00249769|459595625|FG000|Overall Study|Miscellaneous|0|||
127718579|NCT00249769|459595626|FG001|Overall Study|Miscellaneous|2|||
127718580|NCT00249769|459595627|FG002|Overall Study|Miscellaneous|2|||
127718581|NCT00249769|459595625|FG000|Overall Study|Adverse Event|0|||
127718582|NCT00249769|459595626|FG001|Overall Study|Adverse Event|0|||
127718583|NCT00249769|459595627|FG002|Overall Study|Adverse Event|1|||
127718584|NCT00249769|459595625|FG000|Overall Study|Physician Decision|0|||
127718585|NCT00249769|459595626|FG001|Overall Study|Physician Decision|0|||
127718586|NCT00249769|459595627|FG002|Overall Study|Physician Decision|2|||
127718587|NCT00249769|459595625|FG000|Overall Study|Lost to Follow-up|0|||
127718588|NCT00249769|459595626|FG001|Overall Study|Lost to Follow-up|0|||
127718589|NCT00249769|459595627|FG002|Overall Study|Lost to Follow-up|3|||
127718590|NCT01953224|459595628|FG000|Overall Study|Lost to Follow-up|1|||
127718591|NCT01953224|459595629|FG001|Overall Study|Lost to Follow-up|1|||
127718592|NCT01953224|459595628|FG000|Overall Study|Withdrawal by Subject|1|||
127718593|NCT01953224|459595629|FG001|Overall Study|Withdrawal by Subject|2|||
127718594|NCT03745313|459595632|FG000|At 30 Days Follow-up|Death|2|||
127718595|NCT03745313|459595632|FG000|At 6 Months Follow-up|Death|1|||
127718596|NCT03745313|459595632|FG000|At 6 Months Follow-up|Missed Visit|1|||
127718597|NCT03745313|459595632|FG000|At 6 Months Follow-up|Exited for Other Reason Within Window|1|||
127718598|NCT03745313|459595632|FG000|At 1 Year Follow-up|Death|2|||
127718599|NCT03745313|459595632|FG000|At 1 Year Follow-up|Missed Visit|2|||
127718600|NCT03745313|459595632|FG000|At 2 Year Follow-up|Missed Visit|1|||
127718601|NCT03516812|459595633|FG000|Overall Study|Adverse Event|4|||
127718602|NCT03516812|459595633|FG000|Overall Study|Lack of Efficacy|2|||
127718603|NCT03890289|459595634|FG000|Overall Study|Adverse Event|1|||
127718604|NCT03890289|459595634|FG000|Overall Study|Physician Decision|1|||
127718605|NCT03890289|459595634|FG000|Overall Study|Lack of Efficacy|2|||
127718606|NCT00274261|459595637|FG000|Overall Study|Adverse Event|19|||
127718607|NCT00274261|459595638|FG001|Overall Study|Adverse Event|11|||
127718608|NCT00274261|459595637|FG000|Overall Study|Pregnancy|114|||
127888729|NCT02763579|460215810|FG003|China Period|Study Terminated By Sponsor|4|||
127888730|NCT02763579|460215807|FG000|China Period|Withdrawal by Subject|0|||
127888731|NCT02763579|460215808|FG001|China Period|Withdrawal by Subject|0|||
127888732|NCT02763579|460215809|FG002|China Period|Withdrawal by Subject|3|||
127888733|NCT02763579|460215810|FG003|China Period|Withdrawal by Subject|3|||
127888734|NCT00910858|460215815|FG000|Pharmacokinetic Phase|Adverse Event|1|||
127718609|NCT00274261|459595638|FG001|Overall Study|Pregnancy|83|||
127718610|NCT00274261|459595637|FG000|Overall Study|Withdrawal by Subject|179|||
127718611|NCT00274261|459595638|FG001|Overall Study|Withdrawal by Subject|126|||
127718612|NCT00274261|459595637|FG000|Overall Study|Protocol Violation|71|||
127718613|NCT00274261|459595638|FG001|Overall Study|Protocol Violation|42|||
127718614|NCT00274261|459595637|FG000|Overall Study|Lost to Follow-up|106|||
127718615|NCT00274261|459595638|FG001|Overall Study|Lost to Follow-up|75|||
127718616|NCT02426138|459595639|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
127718617|NCT02426138|459595640|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
127718618|NCT02816398|459595648|FG000|Overall Study|Death|5|||
127718619|NCT02816398|459595648|FG000|Overall Study|Lack of Efficacy|8|||
127718620|NCT02816398|459595648|FG000|Overall Study|Lost to Follow-up|1|||
127718621|NCT03362190|459595651|FG000|Overall Study|Adverse Event|0|||
127718622|NCT03362190|459595652|FG001|Overall Study|Adverse Event|0|||
127718623|NCT03362190|459595653|FG002|Overall Study|Adverse Event|0|||
127718624|NCT03362190|459595654|FG003|Overall Study|Adverse Event|1|||
127718625|NCT03362190|459595651|FG000|Overall Study|Withdrawal by Subject|0|||
127718626|NCT03362190|459595652|FG001|Overall Study|Withdrawal by Subject|0|||
127718627|NCT03362190|459595653|FG002|Overall Study|Withdrawal by Subject|0|||
127718628|NCT03362190|459595654|FG003|Overall Study|Withdrawal by Subject|1|||
127718629|NCT01367236|459595658|FG000|Overall Study|Withdrawal by Subject|3|||
127718630|NCT01367236|459595659|FG001|Overall Study|Withdrawal by Subject|1|||
127718631|NCT02350634|459595662|FG000|Overall Study|subject survived greater than 6 months following dosing|1|||
127718632|NCT05470114|459595671|FG000|Overall Study|Withdrawal by Subject|1|||
127718633|NCT05470114|459595672|FG001|Overall Study|Withdrawal by Subject|0|||
127718634|NCT05470114|459595671|FG000|Overall Study|Lost to Follow-up|1|||
127718635|NCT05470114|459595672|FG001|Overall Study|Lost to Follow-up|0|||
127718636|NCT01563185|459595675|FG000|Overall Study|Withdrawal by Subject|1|||
127718637|NCT01563185|459595675|FG000|Overall Study|Non-Compliance with study drug|1|||
127718638|NCT04401267|459596345|FG000|Overall Study|Death|0|||
127718639|NCT04401267|459596346|FG001|Overall Study|Death|1|||
127888735|NCT00910858|460215816|FG001|Pharmacokinetic Phase|Adverse Event|0|||
127718640|NCT04401267|459596345|FG000|Overall Study|Discontinuation of TOT17 therapy|4|||
127718641|NCT04401267|459596346|FG001|Overall Study|Discontinuation of TOT17 therapy|2|||
127888736|NCT00910858|460215817|FG002|Pharmacokinetic Phase|Adverse Event|0|||
127718642|NCT04401267|459596345|FG000|Overall Study|Found to be Ineligible|1|||
127718643|NCT04401267|459596346|FG001|Overall Study|Found to be Ineligible|0|||
127718644|NCT02962284|459596347|FG000|Overall Study|Death|2|||
127888737|NCT00910858|460215815|FG000|Monotherapy Phase|Adverse Event|3|||
127718645|NCT02962284|459596348|FG001|Overall Study|Death|0|||
127718646|NCT02962284|459596347|FG000|Overall Study|Progressive disease|2|||
127718647|NCT02962284|459596348|FG001|Overall Study|Progressive disease|3|||
127718648|NCT02962284|459596347|FG000|Overall Study|Withdrawal by Subject|1|||
127718649|NCT02962284|459596348|FG001|Overall Study|Withdrawal by Subject|0|||
127718650|NCT05014412|459596351|FG000|Overall Study|Death|11|||
127718651|NCT05014412|459596352|FG001|Overall Study|Death|7|||
127718652|NCT05014412|459596353|FG002|Overall Study|Death|4|||
127718653|NCT05014412|459596354|FG003|Overall Study|Death|7|||
127718654|NCT05014412|459596351|FG000|Overall Study|Withdrawal by Subject|1|||
127718655|NCT05014412|459596352|FG001|Overall Study|Withdrawal by Subject|1|||
127718656|NCT05014412|459596353|FG002|Overall Study|Withdrawal by Subject|1|||
127718657|NCT05014412|459596354|FG003|Overall Study|Withdrawal by Subject|2|||
127718658|NCT05014412|459596351|FG000|Overall Study|Ongoing|21|||
127718659|NCT05014412|459596352|FG001|Overall Study|Ongoing|4|||
127718660|NCT05014412|459596353|FG002|Overall Study|Ongoing|6|||
127718661|NCT05014412|459596354|FG003|Overall Study|Ongoing|20|||
127718662|NCT01886872|459596355|FG000|Overall Study|Ineligible|7|||
127718663|NCT01886872|459596356|FG001|Overall Study|Ineligible|4|||
127718664|NCT01886872|459596357|FG002|Overall Study|Ineligible|12|||
127718665|NCT04941482|459596358|FG000|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|9|||
127718666|NCT04941482|459596359|FG001|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|3|||
127718667|NCT03389802|459596360|FG000|Overall Study|Lack of Efficacy|3|||
127718668|NCT03389802|459596361|FG001|Overall Study|Lack of Efficacy|3|||
127718669|NCT03389802|459596362|FG002|Overall Study|Lack of Efficacy|13|||
127718670|NCT03389802|459596363|FG003|Overall Study|Lack of Efficacy|6|||
127718671|NCT03389802|459596364|FG004|Overall Study|Lack of Efficacy|1|||
127718672|NCT03389802|459596360|FG000|Overall Study|Adverse Event|0|||
127718673|NCT03389802|459596361|FG001|Overall Study|Adverse Event|0|||
127718674|NCT03389802|459596362|FG002|Overall Study|Adverse Event|1|||
127718675|NCT03389802|459596363|FG003|Overall Study|Adverse Event|0|||
127718676|NCT03389802|459596364|FG004|Overall Study|Adverse Event|4|||
127718677|NCT03389802|459596360|FG000|Overall Study|Subject deemed ineligible after enrollment|0|||
127718678|NCT03389802|459596361|FG001|Overall Study|Subject deemed ineligible after enrollment|0|||
127718679|NCT03389802|459596362|FG002|Overall Study|Subject deemed ineligible after enrollment|1|||
127718680|NCT03389802|459596363|FG003|Overall Study|Subject deemed ineligible after enrollment|0|||
127718681|NCT03389802|459596364|FG004|Overall Study|Subject deemed ineligible after enrollment|0|||
127718682|NCT04745676|459596366|FG000|Overall Study|Death|1|||
127718683|NCT04745676|459596367|FG001|Overall Study|Death|0|||
127718684|NCT04745676|459596368|FG002|Overall Study|Death|0|||
127718685|NCT04827732|459596372|FG000|Overall Study|Did not start treatment|0|||
127718686|NCT04827732|459596373|FG001|Overall Study|Did not start treatment|1|||
127718687|NCT04827732|459596374|FG002|Overall Study|Did not start treatment|0|||
127718688|NCT04827732|459596375|FG003|Overall Study|Did not start treatment|1|||
127718689|NCT03414684|459596379|FG000|First-course Treatment|Complete response|0|||
127718690|NCT03414684|459596380|FG001|First-course Treatment|Complete response|1|||
127718691|NCT03414684|459596379|FG000|First-course Treatment|Intercurrent illness|1|||
127718692|NCT03414684|459596380|FG001|First-course Treatment|Intercurrent illness|0|||
127718693|NCT03414684|459596379|FG000|First-course Treatment|Progressive Disease|31|||
127718694|NCT03414684|459596380|FG001|First-course Treatment|Progressive Disease|32|||
127802575|NCT01262976|459901025|FG005|Up to Month 2|Migrated/moved from study area|1|||
127718695|NCT03414684|459596379|FG000|First-course Treatment|Adverse Event|1|||
127718696|NCT03414684|459596380|FG001|First-course Treatment|Adverse Event|2|||
127802576|NCT01262976|459901020|FG000|Up to Month 2|Lost to Follow-up|1|||
127718697|NCT03414684|459596379|FG000|First-course Treatment|Physician Decision|0|||
127718698|NCT03414684|459596380|FG001|First-course Treatment|Physician Decision|1|||
127718699|NCT03414684|459596379|FG000|First-course Treatment|Withdrawal by Subject|0|||
127718700|NCT03414684|459596380|FG001|First-course Treatment|Withdrawal by Subject|1|||
127718701|NCT03414684|459596379|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
127718702|NCT03414684|459596380|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
127718703|NCT03414684|459596379|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
127718704|NCT03414684|459596380|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
127718705|NCT03414684|459596379|FG000|First-course Treatment|Still on treatment|3|||
127718706|NCT03414684|459596380|FG001|First-course Treatment|Still on treatment|0|||
127718707|NCT03414684|459596379|FG000|First-course Treatment|Never started protocol therapy|2|||
127718708|NCT03414684|459596380|FG001|First-course Treatment|Never started protocol therapy|1|||
127718709|NCT03414684|459596379|FG000|Crossover Treatment|Progressive disease|0|||
127718710|NCT03414684|459596380|FG001|Crossover Treatment|Progressive disease|12|||
127718711|NCT03414684|459596379|FG000|Crossover Treatment|Adverse Event|0|||
127718712|NCT03414684|459596380|FG001|Crossover Treatment|Adverse Event|3|||
127718713|NCT03414684|459596379|FG000|Crossover Treatment|Physician Decision|0|||
127718714|NCT03414684|459596380|FG001|Crossover Treatment|Physician Decision|1|||
127718715|NCT03414684|459596379|FG000|Crossover Treatment|Still on treatment|0|||
127718716|NCT03414684|459596380|FG001|Crossover Treatment|Still on treatment|2|||
127718717|NCT04038580|459596381|FG000|Washout 1|Death|0|||
127718718|NCT04038580|459596382|FG001|Washout 1|Death|0|||
127718719|NCT04038580|459596383|FG002|Washout 1|Death|0|||
127718720|NCT04038580|459596384|FG003|Washout 1|Death|1|||
127718721|NCT04038580|459596385|FG004|Washout 1|Death|0|||
127718722|NCT04038580|459596386|FG005|Washout 1|Death|0|||
127718723|NCT04038580|459596381|FG000|Washout 1|Withdrawal by Subject|0|||
127718724|NCT04038580|459596382|FG001|Washout 1|Withdrawal by Subject|0|||
127718725|NCT04038580|459596383|FG002|Washout 1|Withdrawal by Subject|0|||
127718726|NCT04038580|459596384|FG003|Washout 1|Withdrawal by Subject|0|||
127718727|NCT04038580|459596385|FG004|Washout 1|Withdrawal by Subject|1|||
127718728|NCT04038580|459596386|FG005|Washout 1|Withdrawal by Subject|0|||
127718729|NCT04038580|459596381|FG000|Wash-out 2|Withdrawal by Subject|1|||
127718730|NCT04038580|459596382|FG001|Wash-out 2|Withdrawal by Subject|0|||
127718731|NCT04038580|459596383|FG002|Wash-out 2|Withdrawal by Subject|0|||
127718732|NCT04038580|459596384|FG003|Wash-out 2|Withdrawal by Subject|2|||
127718733|NCT04038580|459596385|FG004|Wash-out 2|Withdrawal by Subject|0|||
127718734|NCT04038580|459596386|FG005|Wash-out 2|Withdrawal by Subject|1|||
127802577|NCT01262976|459901021|FG001|Up to Month 2|Lost to Follow-up|0|||
127802578|NCT01262976|459901022|FG002|Up to Month 2|Lost to Follow-up|0|||
127802579|NCT01262976|459901023|FG003|Up to Month 2|Lost to Follow-up|1|||
127802580|NCT01262976|459901024|FG004|Up to Month 2|Lost to Follow-up|1|||
127802581|NCT01262976|459901025|FG005|Up to Month 2|Lost to Follow-up|1|||
127802582|NCT01262976|459901020|FG000|Up to Month 2|Other|1|||
127802583|NCT01262976|459901021|FG001|Up to Month 2|Other|0|||
127802584|NCT01262976|459901022|FG002|Up to Month 2|Other|0|||
127802585|NCT01262976|459901023|FG003|Up to Month 2|Other|1|||
127802586|NCT01262976|459901024|FG004|Up to Month 2|Other|0|||
127802587|NCT01262976|459901025|FG005|Up to Month 2|Other|2|||
127802588|NCT01262976|459901020|FG000|Up to Month 7|Serious Adverse Event|0|||
127802589|NCT01262976|459901021|FG001|Up to Month 7|Serious Adverse Event|0|||
127802590|NCT01262976|459901022|FG002|Up to Month 7|Serious Adverse Event|2|||
127802591|NCT01262976|459901023|FG003|Up to Month 7|Serious Adverse Event|0|||
127802592|NCT01262976|459901024|FG004|Up to Month 7|Serious Adverse Event|0|||
127802593|NCT01262976|459901025|FG005|Up to Month 7|Serious Adverse Event|0|||
127802594|NCT01262976|459901020|FG000|Up to Month 7|Withdrawal by Subject|1|||
127802595|NCT01262976|459901021|FG001|Up to Month 7|Withdrawal by Subject|0|||
127802596|NCT01262976|459901022|FG002|Up to Month 7|Withdrawal by Subject|0|||
127802597|NCT01262976|459901023|FG003|Up to Month 7|Withdrawal by Subject|0|||
127802598|NCT01262976|459901024|FG004|Up to Month 7|Withdrawal by Subject|0|||
127802599|NCT01262976|459901025|FG005|Up to Month 7|Withdrawal by Subject|0|||
127802600|NCT01262976|459901020|FG000|Up to Month 7|Migrated/moved from study area|0|||
127802601|NCT01262976|459901021|FG001|Up to Month 7|Migrated/moved from study area|0|||
127802602|NCT01262976|459901022|FG002|Up to Month 7|Migrated/moved from study area|1|||
127802603|NCT01262976|459901023|FG003|Up to Month 7|Migrated/moved from study area|3|||
127802604|NCT01262976|459901024|FG004|Up to Month 7|Migrated/moved from study area|1|||
127802605|NCT01262976|459901025|FG005|Up to Month 7|Migrated/moved from study area|1|||
127718735|NCT04038580|459596381|FG000|Experimental Socket #2|Withdrawal by Subject|0|||
127802606|NCT01262976|459901020|FG000|Up to Month 7|Lost to Follow-up|1|||
127802607|NCT01262976|459901021|FG001|Up to Month 7|Lost to Follow-up|0|||
127802608|NCT01262976|459901022|FG002|Up to Month 7|Lost to Follow-up|1|||
127718736|NCT04038580|459596382|FG001|Experimental Socket #2|Withdrawal by Subject|1|||
127718737|NCT04038580|459596383|FG002|Experimental Socket #2|Withdrawal by Subject|0|||
127718738|NCT04038580|459596384|FG003|Experimental Socket #2|Withdrawal by Subject|0|||
127718739|NCT04038580|459596385|FG004|Experimental Socket #2|Withdrawal by Subject|0|||
127718740|NCT04038580|459596386|FG005|Experimental Socket #2|Withdrawal by Subject|0|||
127718741|NCT04038580|459596381|FG000|Wash-out 3|Withdrawal by Subject|1|||
127802609|NCT01262976|459901023|FG003|Up to Month 7|Lost to Follow-up|3|||
127802610|NCT01262976|459901024|FG004|Up to Month 7|Lost to Follow-up|1|||
127802611|NCT01262976|459901025|FG005|Up to Month 7|Lost to Follow-up|3|||
127802612|NCT01262976|459901020|FG000|Up to Month 7|Other|3|||
127802613|NCT01262976|459901021|FG001|Up to Month 7|Other|0|||
127802614|NCT01262976|459901022|FG002|Up to Month 7|Other|2|||
127802615|NCT01262976|459901023|FG003|Up to Month 7|Other|0|||
127802616|NCT01262976|459901024|FG004|Up to Month 7|Other|0|||
127802617|NCT01262976|459901025|FG005|Up to Month 7|Other|0|||
127802618|NCT01262976|459901020|FG000|Up to Year 1|Serious Adverse Event|0|||
127802619|NCT01262976|459901021|FG001|Up to Year 1|Serious Adverse Event|0|||
127802620|NCT01262976|459901022|FG002|Up to Year 1|Serious Adverse Event|2|||
127802621|NCT01262976|459901023|FG003|Up to Year 1|Serious Adverse Event|0|||
127802622|NCT01262976|459901024|FG004|Up to Year 1|Serious Adverse Event|0|||
127802623|NCT01262976|459901025|FG005|Up to Year 1|Serious Adverse Event|0|||
127802624|NCT01262976|459901020|FG000|Up to Year 1|Withdrawal by Subject|1|||
127802625|NCT01262976|459901021|FG001|Up to Year 1|Withdrawal by Subject|0|||
127802626|NCT01262976|459901022|FG002|Up to Year 1|Withdrawal by Subject|0|||
127802627|NCT01262976|459901023|FG003|Up to Year 1|Withdrawal by Subject|0|||
127802628|NCT01262976|459901024|FG004|Up to Year 1|Withdrawal by Subject|0|||
127802629|NCT01262976|459901025|FG005|Up to Year 1|Withdrawal by Subject|0|||
127802630|NCT01262976|459901020|FG000|Up to Year 1|Migrated/moved from study area|1|||
127802631|NCT01262976|459901021|FG001|Up to Year 1|Migrated/moved from study area|0|||
127802632|NCT01262976|459901022|FG002|Up to Year 1|Migrated/moved from study area|0|||
127802633|NCT01262976|459901023|FG003|Up to Year 1|Migrated/moved from study area|3|||
127802634|NCT01262976|459901024|FG004|Up to Year 1|Migrated/moved from study area|3|||
127802635|NCT01262976|459901025|FG005|Up to Year 1|Migrated/moved from study area|2|||
127888738|NCT00910858|460215816|FG001|Monotherapy Phase|Adverse Event|2|||
127888739|NCT00910858|460215817|FG002|Monotherapy Phase|Adverse Event|0|||
127888740|NCT00910858|460215815|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
127888741|NCT00910858|460215816|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
127888742|NCT00910858|460215817|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
127888743|NCT00910858|460215815|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
127888744|NCT00910858|460215816|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
127888745|NCT00910858|460215817|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
127888746|NCT00910858|460215815|FG000|Monotherapy Phase|Protocol Violation|1|||
127718742|NCT04038580|459596382|FG001|Wash-out 3|Withdrawal by Subject|0|||
127718743|NCT04038580|459596383|FG002|Wash-out 3|Withdrawal by Subject|2|||
127718744|NCT04038580|459596384|FG003|Wash-out 3|Withdrawal by Subject|0|||
127718745|NCT04038580|459596385|FG004|Wash-out 3|Withdrawal by Subject|0|||
127718746|NCT04038580|459596386|FG005|Wash-out 3|Withdrawal by Subject|0|||
127718747|NCT04577651|459596393|FG000|Overall Study|Screen Failure|7|||
127718748|NCT04577651|459596393|FG000|Overall Study|Adverse Event|1|||
127718749|NCT04577651|459596393|FG000|Overall Study|Death|1|||
127718750|NCT04577651|459596393|FG000|Overall Study|Physician Decision|1|||
127718751|NCT04577651|459596393|FG000|Overall Study|Withdrawal by Subject|3|||
127718752|NCT03214081|459597093|FG000|Overall Study|Case Report Forms Uncollected|9|||
127718753|NCT03214081|459597093|FG000|Overall Study|Protocol Deviation|54|||
127718754|NCT00345046|459597098|FG000|Overall Study|Protocol Violation|1|||
127718755|NCT00345046|459597099|FG001|Overall Study|Protocol Violation|1|||
127718756|NCT00345046|459597100|FG002|Overall Study|Protocol Violation|2|||
127718757|NCT01372085|459597103|FG000|Washout Period 2|Physician Decision|0|||
127718758|NCT01372085|459597104|FG001|Washout Period 2|Physician Decision|0|||
127718759|NCT01372085|459597105|FG002|Washout Period 2|Physician Decision|0|||
127718760|NCT01372085|459597106|FG003|Washout Period 2|Physician Decision|0|||
127718761|NCT01372085|459597107|FG004|Washout Period 2|Physician Decision|1|||
127718762|NCT01372085|459597108|FG005|Washout Period 2|Physician Decision|0|||
127718763|NCT01372085|459597109|FG006|Washout Period 2|Physician Decision|0|||
127718764|NCT01372085|459597110|FG007|Washout Period 2|Physician Decision|0|||
127718765|NCT01372085|459597111|FG008|Washout Period 2|Physician Decision|0|||
127718766|NCT01372085|459597112|FG009|Washout Period 2|Physician Decision|0|||
127718767|NCT01372085|459597103|FG000|Washout Period 3|Withdrawal by Subject|0|||
127718768|NCT01372085|459597104|FG001|Washout Period 3|Withdrawal by Subject|0|||
127718769|NCT01372085|459597105|FG002|Washout Period 3|Withdrawal by Subject|0|||
127718770|NCT01372085|459597106|FG003|Washout Period 3|Withdrawal by Subject|0|||
127718771|NCT01372085|459597107|FG004|Washout Period 3|Withdrawal by Subject|0|||
127718772|NCT01372085|459597108|FG005|Washout Period 3|Withdrawal by Subject|2|||
127718773|NCT01372085|459597109|FG006|Washout Period 3|Withdrawal by Subject|0|||
127718774|NCT01372085|459597110|FG007|Washout Period 3|Withdrawal by Subject|0|||
127718775|NCT01372085|459597111|FG008|Washout Period 3|Withdrawal by Subject|0|||
127718776|NCT01372085|459597112|FG009|Washout Period 3|Withdrawal by Subject|0|||
127718777|NCT00790569|459597113|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
127802636|NCT01262976|459901020|FG000|Up to Year 1|Lost to Follow-up|4|||
127802637|NCT01262976|459901021|FG001|Up to Year 1|Lost to Follow-up|0|||
127802638|NCT01262976|459901022|FG002|Up to Year 1|Lost to Follow-up|0|||
127802639|NCT01262976|459901023|FG003|Up to Year 1|Lost to Follow-up|1|||
127802640|NCT01262976|459901024|FG004|Up to Year 1|Lost to Follow-up|6|||
127802641|NCT01262976|459901025|FG005|Up to Year 1|Lost to Follow-up|5|||
127802642|NCT01262976|459901020|FG000|Up to Year 1|Other|3|||
127718778|NCT00790569|459597114|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
127718779|NCT00790569|459597115|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
127718780|NCT00790569|459597113|FG000|End of Treatment (6 Month Interview)|Death|0|||
127718781|NCT00790569|459597114|FG001|End of Treatment (6 Month Interview)|Death|2|||
127718782|NCT00790569|459597115|FG002|End of Treatment (6 Month Interview)|Death|1|||
127718783|NCT00790569|459597113|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
127718784|NCT00790569|459597114|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
127718785|NCT00790569|459597115|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
127718786|NCT00790569|459597113|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
127718787|NCT00790569|459597114|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
127718788|NCT00790569|459597115|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
127718789|NCT00790569|459597113|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
127718790|NCT00790569|459597114|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
127718791|NCT00790569|459597115|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
127718792|NCT00790569|459597113|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
127718793|NCT00790569|459597114|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
127718794|NCT00790569|459597115|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
127718795|NCT00705406|459597119|FG000|Overall Study|Lost to Follow-up|3|||
127718796|NCT00705406|459597120|FG001|Overall Study|Lost to Follow-up|3|||
127718797|NCT00705406|459597119|FG000|Overall Study|Did not receive study drug|1|||
127718798|NCT00705406|459597120|FG001|Overall Study|Did not receive study drug|2|||
127718799|NCT02357966|459597121|FG000|Overall Study|Death|0|||
127718800|NCT02357966|459597122|FG001|Overall Study|Death|0|||
127718801|NCT02357966|459597123|FG002|Overall Study|Death|1|||
127718802|NCT02357966|459597124|FG003|Overall Study|Death|0|||
127718803|NCT02357966|459597125|FG004|Overall Study|Death|2|||
127718804|NCT02357966|459597126|FG005|Overall Study|Death|0|||
127718805|NCT02357966|459597121|FG000|Overall Study|Physician Decision|1|||
127718806|NCT02357966|459597122|FG001|Overall Study|Physician Decision|0|||
127718807|NCT02357966|459597123|FG002|Overall Study|Physician Decision|0|||
127718808|NCT02357966|459597124|FG003|Overall Study|Physician Decision|0|||
127718809|NCT02357966|459597125|FG004|Overall Study|Physician Decision|1|||
127718810|NCT02357966|459597126|FG005|Overall Study|Physician Decision|0|||
127718811|NCT01079806|459597127|FG000|Day 1 to Week 96|Adverse Event|0|||
127802643|NCT01262976|459901021|FG001|Up to Year 1|Other|1|||
127802644|NCT01262976|459901022|FG002|Up to Year 1|Other|0|||
127802645|NCT01262976|459901023|FG003|Up to Year 1|Other|0|||
127802646|NCT01262976|459901024|FG004|Up to Year 1|Other|2|||
127802647|NCT01262976|459901025|FG005|Up to Year 1|Other|1|||
127802648|NCT01262976|459901020|FG000|Up to Year 1|Subjects with unknown completion status|0|||
127802649|NCT01262976|459901021|FG001|Up to Year 1|Subjects with unknown completion status|0|||
127802650|NCT01262976|459901022|FG002|Up to Year 1|Subjects with unknown completion status|1|||
127802651|NCT01262976|459901023|FG003|Up to Year 1|Subjects with unknown completion status|0|||
127802652|NCT01262976|459901024|FG004|Up to Year 1|Subjects with unknown completion status|0|||
127802653|NCT01262976|459901025|FG005|Up to Year 1|Subjects with unknown completion status|1|||
127802654|NCT01262976|459901020|FG000|Up to Year 2|Serious Adverse Event|0|||
127802655|NCT01262976|459901021|FG001|Up to Year 2|Serious Adverse Event|0|||
127802656|NCT01262976|459901022|FG002|Up to Year 2|Serious Adverse Event|2|||
127718812|NCT01079806|459597128|FG001|Day 1 to Week 96|Adverse Event|3|||
127718813|NCT01079806|459597127|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
127718814|NCT01079806|459597128|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
127718815|NCT01079806|459597127|FG000|Day 1 to Week 96|Pregnancy|0|||
127718816|NCT01079806|459597128|FG001|Day 1 to Week 96|Pregnancy|1|||
127718817|NCT01079806|459597127|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
127718818|NCT01079806|459597128|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
127718819|NCT01079806|459597127|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
127718820|NCT01079806|459597128|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
127718821|NCT01079806|459597127|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
127718822|NCT01079806|459597128|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
127718823|NCT01079806|459597127|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
127718824|NCT01079806|459597128|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
127718825|NCT01079806|459597127|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
127718826|NCT01079806|459597128|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
127718827|NCT01079806|459597127|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
127718828|NCT01079806|459597128|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
127718829|NCT01079806|459597127|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
127802657|NCT01262976|459901023|FG003|Up to Year 2|Serious Adverse Event|0|||
127802658|NCT01262976|459901024|FG004|Up to Year 2|Serious Adverse Event|0|||
127802659|NCT01262976|459901025|FG005|Up to Year 2|Serious Adverse Event|0|||
127718830|NCT01079806|459597128|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
127718831|NCT03732807|459597129|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
127718832|NCT03732807|459597130|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
127718833|NCT03732807|459597131|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
127718834|NCT03732807|459597132|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
127718835|NCT03732807|459597133|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
127718836|NCT03732807|459597134|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
127718837|NCT03732807|459597135|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
127718838|NCT03732807|459597129|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
127718839|NCT03732807|459597130|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
127718840|NCT03732807|459597131|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
127718841|NCT03732807|459597132|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
127718842|NCT03732807|459597133|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
127718843|NCT03732807|459597134|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
127718844|NCT03732807|459597135|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
127718845|NCT03732807|459597129|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
127718846|NCT03732807|459597130|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
127718847|NCT03732807|459597131|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
127718848|NCT03732807|459597132|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
127718849|NCT03732807|459597133|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
127718850|NCT03732807|459597134|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
127718851|NCT03732807|459597135|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
127718852|NCT03732807|459597129|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
127718853|NCT03732807|459597130|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
127718854|NCT03732807|459597131|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
127718855|NCT03732807|459597132|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
127718856|NCT03732807|459597133|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
127718857|NCT03732807|459597134|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
127718858|NCT03732807|459597135|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
127718859|NCT03732807|459597129|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
127718860|NCT03732807|459597130|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
127718861|NCT03732807|459597131|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
127718862|NCT03732807|459597132|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
127718863|NCT03732807|459597133|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
127718864|NCT03732807|459597134|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
127718865|NCT03732807|459597135|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
127718866|NCT03732807|459597129|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
127718867|NCT03732807|459597130|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
127718868|NCT03732807|459597131|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
127718869|NCT03732807|459597132|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
127718870|NCT03732807|459597133|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
127718871|NCT03732807|459597134|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
127718872|NCT03732807|459597135|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
127718873|NCT03732807|459597129|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
127718874|NCT03732807|459597130|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
127718875|NCT03732807|459597131|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
127718876|NCT03732807|459597132|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
127718877|NCT03732807|459597133|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
127718878|NCT03732807|459597134|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
127718879|NCT03732807|459597135|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
127718880|NCT03732807|459597129|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
127718881|NCT03732807|459597130|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
127718882|NCT03732807|459597131|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
127718883|NCT03732807|459597132|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
127718884|NCT03732807|459597133|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
127718885|NCT03732807|459597134|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
127718886|NCT03732807|459597135|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
127718887|NCT03732807|459597129|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
127718888|NCT03732807|459597130|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
127718889|NCT03732807|459597131|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
127718890|NCT03732807|459597132|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
127718891|NCT03732807|459597133|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
127718892|NCT03732807|459597134|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
127718893|NCT03732807|459597135|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
127802660|NCT01262976|459901020|FG000|Up to Year 2|Withdrawal by Subject|1|||
127802661|NCT01262976|459901021|FG001|Up to Year 2|Withdrawal by Subject|0|||
127802662|NCT01262976|459901022|FG002|Up to Year 2|Withdrawal by Subject|0|||
127802663|NCT01262976|459901023|FG003|Up to Year 2|Withdrawal by Subject|0|||
127802664|NCT01262976|459901024|FG004|Up to Year 2|Withdrawal by Subject|0|||
127802665|NCT01262976|459901025|FG005|Up to Year 2|Withdrawal by Subject|0|||
127802666|NCT01262976|459901020|FG000|Up to Year 2|Migrated/moved from study area|0|||
127802667|NCT01262976|459901021|FG001|Up to Year 2|Migrated/moved from study area|0|||
127802668|NCT01262976|459901022|FG002|Up to Year 2|Migrated/moved from study area|0|||
127802669|NCT01262976|459901023|FG003|Up to Year 2|Migrated/moved from study area|2|||
127802670|NCT01262976|459901024|FG004|Up to Year 2|Migrated/moved from study area|1|||
127802671|NCT01262976|459901025|FG005|Up to Year 2|Migrated/moved from study area|2|||
127802672|NCT01262976|459901020|FG000|Up to Year 2|Lost to Follow-up|1|||
127802673|NCT01262976|459901021|FG001|Up to Year 2|Lost to Follow-up|1|||
127802674|NCT01262976|459901022|FG002|Up to Year 2|Lost to Follow-up|2|||
127802675|NCT01262976|459901023|FG003|Up to Year 2|Lost to Follow-up|2|||
127802676|NCT01262976|459901024|FG004|Up to Year 2|Lost to Follow-up|3|||
127802677|NCT01262976|459901025|FG005|Up to Year 2|Lost to Follow-up|3|||
127802678|NCT01262976|459901020|FG000|Up to Year 2|Subjects with unknown completion status|0|||
127802679|NCT01262976|459901021|FG001|Up to Year 2|Subjects with unknown completion status|0|||
127802680|NCT01262976|459901022|FG002|Up to Year 2|Subjects with unknown completion status|1|||
127802681|NCT01262976|459901023|FG003|Up to Year 2|Subjects with unknown completion status|0|||
127802682|NCT01262976|459901024|FG004|Up to Year 2|Subjects with unknown completion status|0|||
127802683|NCT01262976|459901025|FG005|Up to Year 2|Subjects with unknown completion status|0|||
127802684|NCT01262976|459901020|FG000|Up to Year 2|Other|3|||
127802685|NCT01262976|459901021|FG001|Up to Year 2|Other|0|||
127802686|NCT01262976|459901022|FG002|Up to Year 2|Other|0|||
127802687|NCT01262976|459901023|FG003|Up to Year 2|Other|0|||
127802688|NCT01262976|459901024|FG004|Up to Year 2|Other|0|||
127802689|NCT01262976|459901025|FG005|Up to Year 2|Other|0|||
127802690|NCT01262976|459901020|FG000|Up to Year 3|Serious Adverse Event|0|||
127802691|NCT01262976|459901021|FG001|Up to Year 3|Serious Adverse Event|0|||
127802692|NCT01262976|459901022|FG002|Up to Year 3|Serious Adverse Event|2|||
127802693|NCT01262976|459901023|FG003|Up to Year 3|Serious Adverse Event|0|||
127802694|NCT01262976|459901024|FG004|Up to Year 3|Serious Adverse Event|0|||
127802695|NCT01262976|459901025|FG005|Up to Year 3|Serious Adverse Event|0|||
127802696|NCT01262976|459901020|FG000|Up to Year 3|Withdrawal by Subject|1|||
127802697|NCT01262976|459901021|FG001|Up to Year 3|Withdrawal by Subject|0|||
127802698|NCT01262976|459901022|FG002|Up to Year 3|Withdrawal by Subject|0|||
127802699|NCT01262976|459901023|FG003|Up to Year 3|Withdrawal by Subject|0|||
127802700|NCT01262976|459901024|FG004|Up to Year 3|Withdrawal by Subject|0|||
127802701|NCT01262976|459901025|FG005|Up to Year 3|Withdrawal by Subject|0|||
127802702|NCT01262976|459901020|FG000|Up to Year 3|Migrated/moved from study area|0|||
127802703|NCT01262976|459901021|FG001|Up to Year 3|Migrated/moved from study area|0|||
127802704|NCT01262976|459901022|FG002|Up to Year 3|Migrated/moved from study area|0|||
127802705|NCT01262976|459901023|FG003|Up to Year 3|Migrated/moved from study area|2|||
127802706|NCT01262976|459901024|FG004|Up to Year 3|Migrated/moved from study area|1|||
127802707|NCT01262976|459901025|FG005|Up to Year 3|Migrated/moved from study area|1|||
127802708|NCT01262976|459901020|FG000|Up to Year 3|Lost to Follow-up|2|||
127802709|NCT01262976|459901021|FG001|Up to Year 3|Lost to Follow-up|2|||
127802710|NCT01262976|459901022|FG002|Up to Year 3|Lost to Follow-up|4|||
127802711|NCT01262976|459901023|FG003|Up to Year 3|Lost to Follow-up|3|||
127802712|NCT01262976|459901024|FG004|Up to Year 3|Lost to Follow-up|1|||
127802713|NCT01262976|459901025|FG005|Up to Year 3|Lost to Follow-up|3|||
127802714|NCT01262976|459901020|FG000|Up to Year 3|Subjects with unknown completion status|0|||
127802715|NCT01262976|459901021|FG001|Up to Year 3|Subjects with unknown completion status|0|||
127802716|NCT01262976|459901022|FG002|Up to Year 3|Subjects with unknown completion status|1|||
127802717|NCT01262976|459901023|FG003|Up to Year 3|Subjects with unknown completion status|0|||
127802718|NCT01262976|459901024|FG004|Up to Year 3|Subjects with unknown completion status|0|||
127802719|NCT01262976|459901025|FG005|Up to Year 3|Subjects with unknown completion status|0|||
127802720|NCT01262976|459901020|FG000|Up to Year 3|Other|3|||
127802721|NCT01262976|459901021|FG001|Up to Year 3|Other|0|||
127802722|NCT01262976|459901022|FG002|Up to Year 3|Other|0|||
127802723|NCT01262976|459901023|FG003|Up to Year 3|Other|0|||
127802724|NCT01262976|459901024|FG004|Up to Year 3|Other|0|||
127802725|NCT01262976|459901025|FG005|Up to Year 3|Other|0|||
127802726|NCT02690194|459901026|FG000|Overall Study|Withdrawal by Subject|1|||
127802727|NCT02690194|459901027|FG001|Overall Study|Withdrawal by Subject|4|||
127802728|NCT02690194|459901028|FG002|Overall Study|Withdrawal by Subject|0|||
127802729|NCT01552681|459901029|FG000|Overall Study|Withdrawal by Subject|4|||
127802730|NCT01552681|459901030|FG001|Overall Study|Withdrawal by Subject|0|||
127802731|NCT01552681|459901029|FG000|Overall Study|Physician Decision|1|||
127802732|NCT01552681|459901030|FG001|Overall Study|Physician Decision|0|||
127718894|NCT03732807|459597129|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
127718895|NCT03732807|459597130|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
127718896|NCT03732807|459597131|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
127718897|NCT03732807|459597132|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
127718898|NCT03732807|459597133|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
127718899|NCT03732807|459597134|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
127718900|NCT03732807|459597135|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
127718901|NCT03732807|459597129|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
127718902|NCT03732807|459597130|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
127718903|NCT03732807|459597131|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
127718904|NCT03732807|459597132|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
127718905|NCT03732807|459597133|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
127718906|NCT03732807|459597134|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
127718907|NCT03732807|459597135|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
127718908|NCT03732807|459597129|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
127718909|NCT03732807|459597130|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
127718910|NCT03732807|459597131|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
127718911|NCT03732807|459597132|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
127718912|NCT03732807|459597133|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
127718913|NCT03732807|459597134|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
127718914|NCT03732807|459597135|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
127718915|NCT03732807|459597129|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
127718916|NCT03732807|459597130|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
127718917|NCT03732807|459597131|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
127718918|NCT03732807|459597132|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
127718919|NCT03732807|459597133|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
127718920|NCT03732807|459597134|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
127718921|NCT03732807|459597135|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
127718922|NCT03732807|459597129|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
127718923|NCT03732807|459597130|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
127718924|NCT03732807|459597131|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
127718925|NCT03732807|459597132|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
127718926|NCT03732807|459597133|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
127718927|NCT03732807|459597134|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
127718928|NCT03732807|459597135|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
127718929|NCT01779700|459597136|FG000|Overall Study|Adverse Event|4|||
127718930|NCT01779700|459597137|FG001|Overall Study|Adverse Event|3|||
127718931|NCT01779700|459597136|FG000|Overall Study|Withdrawal by Subject|0|||
127718932|NCT01779700|459597137|FG001|Overall Study|Withdrawal by Subject|2|||
127718933|NCT00019604|459597138|FG000|Overall Study|Death|1|||
127718934|NCT00019604|459597138|FG000|Overall Study|Progressive disease|23|||
127718935|NCT00019604|459597138|FG000|Overall Study|Refused treatment|1|||
127718936|NCT00019604|459597138|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
127718937|NCT00019604|459597138|FG000|Overall Study|Going to have liver transplant|1|||
127718938|NCT00019604|459597138|FG000|Overall Study|Move to a different study|1|||
127718939|NCT00019604|459597138|FG000|Overall Study|Non compliant on systemic CH|1|||
127718940|NCT00019604|459597138|FG000|Overall Study|Non compliant|1|||
127718941|NCT00019604|459597138|FG000|Overall Study|Resectable disease|1|||
127718942|NCT00019604|459597138|FG000|Overall Study|Started new chemo regimen|1|||
127718943|NCT00019604|459597138|FG000|Overall Study|Pt going to immunotherapy study|1|||
127718944|NCT00019604|459597138|FG000|Overall Study|Too much disease|1|||
127718945|NCT00019604|459597138|FG000|Overall Study|Unable to evaluate|1|||
127718946|NCT00019604|459597138|FG000|Overall Study|Details for other not available|4|||
127718947|NCT00586313|459597140|FG000|Overall Study|Lack of Efficacy|2|||
127718948|NCT02101775|459597141|FG000|Overall Study|Adverse Event|4|||
127718949|NCT02101775|459597142|FG001|Overall Study|Adverse Event|0|||
127718950|NCT02101775|459597143|FG002|Overall Study|Adverse Event|0|||
127718951|NCT02101775|459597141|FG000|Overall Study|Admission to Hospital|0|||
127718952|NCT02101775|459597142|FG001|Overall Study|Admission to Hospital|1|||
127718953|NCT02101775|459597143|FG002|Overall Study|Admission to Hospital|0|||
127718954|NCT04200664|459597146|FG000|Overall Study|Withdrawal by Subject|1|||
127718955|NCT04200664|459597147|FG001|Overall Study|Withdrawal by Subject|0|||
127718956|NCT04200664|459597148|FG002|Overall Study|Withdrawal by Subject|0|||
127718957|NCT03582475|459597154|FG000|Treatment Period|Withdrawal by Subject|0|||
127718958|NCT03582475|459597155|FG001|Treatment Period|Withdrawal by Subject|1|||
127718959|NCT03582475|459597154|FG000|Follow-up Period|Withdrawal by Subject|0|||
127888747|NCT00910858|460215816|FG001|Monotherapy Phase|Protocol Violation|0|||
127888748|NCT00910858|460215817|FG002|Monotherapy Phase|Protocol Violation|0|||
127888749|NCT00910858|460215815|FG000|Monotherapy Phase|Other|3|||
127888750|NCT00910858|460215816|FG001|Monotherapy Phase|Other|4|||
127888751|NCT00910858|460215817|FG002|Monotherapy Phase|Other|2|||
127888752|NCT00910858|460215815|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
127888753|NCT00910858|460215816|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
127888754|NCT00910858|460215817|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
127888755|NCT00910858|460215815|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
127888756|NCT00910858|460215816|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
127888757|NCT00910858|460215817|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
127888758|NCT00910858|460215815|FG000|Combined Treatment Phase|Protocol Violation|1|||
127888759|NCT00910858|460215816|FG001|Combined Treatment Phase|Protocol Violation|0|||
127888760|NCT00910858|460215817|FG002|Combined Treatment Phase|Protocol Violation|0|||
127888761|NCT00910858|460215815|FG000|Combined Treatment Phase|Other|0|||
127888762|NCT00910858|460215816|FG001|Combined Treatment Phase|Other|2|||
127888763|NCT00910858|460215817|FG002|Combined Treatment Phase|Other|1|||
127888764|NCT01703741|460215825|FG000|Overall Study|Withdrawal by Subject|6|||
127888765|NCT01703741|460215825|FG000|Overall Study|Adverse Event|2|||
127888766|NCT01703741|460215825|FG000|Overall Study|Physician Decision|2|||
127888767|NCT01703741|460215825|FG000|Overall Study|Protocol Violation|1|||
127888768|NCT01703741|460215825|FG000|Overall Study|Lost to Follow-up|3|||
127888769|NCT01703741|460215825|FG000|Overall Study|Subject did not want to continue|2|||
127888770|NCT01703741|460215825|FG000|Overall Study|Subject cannot comply with study visits|1|||
127888771|NCT01703741|460215825|FG000|Overall Study|Subject started testosterone injections|1|||
127888772|NCT01170364|460215826|FG000|Overall Study|Protocol Violation|4|||
127888773|NCT01170364|460215827|FG001|Overall Study|Protocol Violation|1|||
127888774|NCT01381900|460215828|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
127718960|NCT03582475|459597155|FG001|Follow-up Period|Withdrawal by Subject|1|||
127718961|NCT02744066|459597157|FG000|Overall Study|Withdrawal by parent|0|||
127718962|NCT02744066|459597158|FG001|Overall Study|Withdrawal by parent|1|||
127718963|NCT02744066|459597157|FG000|Overall Study|Discharged from NICU prior to completion|0|||
127718964|NCT02744066|459597158|FG001|Overall Study|Discharged from NICU prior to completion|4|||
127718965|NCT02454959|459597159|FG000|Overall Study|Protocol-Specified Criteria|3|||
127718966|NCT02454959|459597159|FG000|Overall Study|Physician Decision|1|||
127718967|NCT02454959|459597159|FG000|Overall Study|Withdrawal by Subject|3|||
127718968|NCT02454959|459597159|FG000|Overall Study|Adverse Event|2|||
127718969|NCT05810285|459597166|FG000|Overall Study|Death|4|||
127718970|NCT05810285|459597167|FG001|Overall Study|Death|21|||
127718971|NCT05810285|459597166|FG000|Overall Study|Adverse Event|18|||
127718972|NCT05810285|459597167|FG001|Overall Study|Adverse Event|16|||
127718973|NCT05325294|459597168|FG000|Overall Study|Adverse Event|3|||
127718974|NCT05325294|459597169|FG001|Overall Study|Adverse Event|3|||
127718975|NCT05325294|459597168|FG000|Overall Study|Physician Decision|0|||
127718976|NCT05325294|459597169|FG001|Overall Study|Physician Decision|1|||
127718977|NCT05325294|459597168|FG000|Overall Study|Withdrawal by Subject|0|||
127718978|NCT05325294|459597169|FG001|Overall Study|Withdrawal by Subject|3|||
127718979|NCT05325294|459597168|FG000|Overall Study|Lost to Follow-up|1|||
127718980|NCT05325294|459597169|FG001|Overall Study|Lost to Follow-up|0|||
127718981|NCT05325294|459597168|FG000|Overall Study|Sponsor Request|0|||
127718982|NCT05325294|459597169|FG001|Overall Study|Sponsor Request|2|||
127718983|NCT00647387|459597170|FG000|Overall Study|Lost to Follow-up|6|||
127718984|NCT00647387|459597170|FG000|Overall Study|Unsuccessful implant|5|||
127718985|NCT00647387|459597170|FG000|Overall Study|Device explanted|3|||
127718986|NCT00647387|459597170|FG000|Overall Study|Other Reason|3|||
127718987|NCT00647387|459597170|FG000|Overall Study|Death|2|||
127888775|NCT01381900|460215829|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
127718988|NCT02969356|459597171|FG000|Overall Study|Adverse Event|7|||
127888776|NCT01381900|460215830|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
127718989|NCT02969356|459597171|FG000|Overall Study|Consent withdrawn|2|||
127888777|NCT01381900|460215828|FG000|Overall Study|Adverse Event|4|||
127888778|NCT01381900|460215829|FG001|Overall Study|Adverse Event|6|||
127888779|NCT01381900|460215830|FG002|Overall Study|Adverse Event|7|||
127888780|NCT01381900|460215828|FG000|Overall Study|Noncompliance with study drug|0|||
127888781|NCT01381900|460215829|FG001|Overall Study|Noncompliance with study drug|0|||
127888782|NCT01381900|460215830|FG002|Overall Study|Noncompliance with study drug|1|||
127888783|NCT01381900|460215828|FG000|Overall Study|Physician Decision|0|||
127718990|NCT02969356|459597171|FG000|Overall Study|Lost to Follow-up|3|||
127718991|NCT02969356|459597171|FG000|Overall Study|Did not need to be reinjected|6|||
127718992|NCT02969356|459597171|FG000|Overall Study|Personal reasons|5|||
127718993|NCT03147287|459597172|FG000|Overall Study|Randomized Not Treated|2|||
127718994|NCT03147287|459597173|FG001|Overall Study|Randomized Not Treated|1|||
127718995|NCT03147287|459597174|FG002|Overall Study|Randomized Not Treated|1|||
127718996|NCT03147287|459597172|FG000|Overall Study|Progressive Disease RECIST|31|||
127718997|NCT03147287|459597173|FG001|Overall Study|Progressive Disease RECIST|72|||
127718998|NCT03147287|459597174|FG002|Overall Study|Progressive Disease RECIST|32|||
127718999|NCT03147287|459597172|FG000|Overall Study|Progressive Disease not RECIST|13|||
127719000|NCT03147287|459597173|FG001|Overall Study|Progressive Disease not RECIST|21|||
127719001|NCT03147287|459597174|FG002|Overall Study|Progressive Disease not RECIST|13|||
127719002|NCT03147287|459597172|FG000|Overall Study|Physician Decision|1|||
127719003|NCT03147287|459597173|FG001|Overall Study|Physician Decision|2|||
127719004|NCT03147287|459597174|FG002|Overall Study|Physician Decision|1|||
127719005|NCT03147287|459597172|FG000|Overall Study|Intercurrent illness|0|||
127719006|NCT03147287|459597173|FG001|Overall Study|Intercurrent illness|1|||
127719007|NCT03147287|459597174|FG002|Overall Study|Intercurrent illness|0|||
127719008|NCT03147287|459597172|FG000|Overall Study|Withdrawal by Subject|2|||
127719009|NCT03147287|459597173|FG001|Overall Study|Withdrawal by Subject|3|||
127719010|NCT03147287|459597174|FG002|Overall Study|Withdrawal by Subject|2|||
127719011|NCT03147287|459597172|FG000|Overall Study|Patient Non-Compliance|0|||
127719012|NCT03147287|459597173|FG001|Overall Study|Patient Non-Compliance|2|||
127719013|NCT03147287|459597174|FG002|Overall Study|Patient Non-Compliance|0|||
127719014|NCT03147287|459597172|FG000|Overall Study|Patient moved|0|||
127719015|NCT03147287|459597173|FG001|Overall Study|Patient moved|1|||
127719016|NCT03147287|459597174|FG002|Overall Study|Patient moved|0|||
127719017|NCT03147287|459597172|FG000|Overall Study|Arm A crossover without PD|1|||
127719018|NCT03147287|459597173|FG001|Overall Study|Arm A crossover without PD|0|||
127719019|NCT03147287|459597174|FG002|Overall Study|Arm A crossover without PD|0|||
127719020|NCT03147287|459597172|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
127719021|NCT03147287|459597173|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
127719022|NCT03147287|459597174|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
127719023|NCT03945773|459598486|FG000|Overall Study|Consent Withdrawn|1|||
127719024|NCT03945773|459598487|FG001|Overall Study|Consent Withdrawn|1|||
127719025|NCT03945773|459598486|FG000|Overall Study|Lost to Follow-up|1|||
127719026|NCT03945773|459598487|FG001|Overall Study|Lost to Follow-up|0|||
127719027|NCT03945773|459598486|FG000|Overall Study|Death|46|||
127719028|NCT03945773|459598487|FG001|Overall Study|Death|22|||
127719029|NCT03945773|459598486|FG000|Overall Study|Physician Decision|1|||
127719030|NCT03945773|459598487|FG001|Overall Study|Physician Decision|0|||
127719031|NCT03945773|459598486|FG000|Overall Study|Other|1|||
127719032|NCT03945773|459598487|FG001|Overall Study|Other|0|||
127719033|NCT03945773|459598486|FG000|Overall Study|Ongoing at the time of DCO|4|||
127719034|NCT03945773|459598487|FG001|Overall Study|Ongoing at the time of DCO|3|||
127719035|NCT02278796|459598488|FG000|Overall Study|Death|2|||
127719036|NCT02278796|459598489|FG001|Overall Study|Death|3|||
127719037|NCT02824198|459598490|FG000|Overall Study|Non-compliance with the protocol|5|||
127719038|NCT02824198|459598491|FG001|Overall Study|Non-compliance with the protocol|1|||
127719039|NCT02824198|459598490|FG000|Overall Study|Lost to Follow-up|5|||
127719040|NCT02824198|459598491|FG001|Overall Study|Lost to Follow-up|2|||
127719041|NCT02824198|459598490|FG000|Overall Study|Withdrawal by Subject|5|||
127719042|NCT02824198|459598491|FG001|Overall Study|Withdrawal by Subject|0|||
127719043|NCT01613417|459598492|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
127719044|NCT01613417|459598493|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
127719045|NCT00512252|459598494|FG000|Overall Study|Lost to Follow-up|0|||
127719046|NCT00512252|459598495|FG001|Overall Study|Lost to Follow-up|0|||
127719047|NCT00512252|459598496|FG002|Overall Study|Lost to Follow-up|1|||
127719048|NCT00512252|459598494|FG000|Overall Study|Protocol Violation|0|||
127719049|NCT00512252|459598495|FG001|Overall Study|Protocol Violation|0|||
127719050|NCT00512252|459598496|FG002|Overall Study|Protocol Violation|1|||
127719051|NCT00512252|459598494|FG000|Overall Study|Death|0|||
127719052|NCT00512252|459598495|FG001|Overall Study|Death|0|||
127719053|NCT00512252|459598496|FG002|Overall Study|Death|1|||
127719054|NCT04608409|459598499|FG000|Overall Study|Physician Decision|1|||
127719055|NCT04608409|459598500|FG001|Overall Study|Physician Decision|1|||
127719056|NCT04608409|459598501|FG002|Overall Study|Physician Decision|2|||
127719057|NCT00599196|459598502|FG000|Overall Study|Lack of Efficacy|22|||
127719058|NCT00599196|459598502|FG000|Overall Study|Adverse Event|93|||
127719059|NCT00599196|459598502|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
127719060|NCT00599196|459598502|FG000|Overall Study|Subject withdrew consent|43|||
127719061|NCT00599196|459598502|FG000|Overall Study|Study ended per sponsor|197|||
127719062|NCT00599196|459598502|FG000|Overall Study|Lost to Follow-up|17|||
127802733|NCT01552681|459901029|FG000|Overall Study|Subject moved away|0|||
127719063|NCT00599196|459598502|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
127719064|NCT00599196|459598502|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
127719065|NCT00599196|459598502|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
127719066|NCT00599196|459598502|FG000|Overall Study|Other: Pt Moved To Australia|1|||
127719067|NCT00599196|459598502|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
127719068|NCT00599196|459598502|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
127719069|NCT04497415|459598520|FG000|Overall Study|Lost to Follow-up|43|||
127719070|NCT04497415|459598521|FG001|Overall Study|Lost to Follow-up|27|||
127719071|NCT00734578|459598524|FG000|Overall Study|Adverse Event|4|||
127719072|NCT00734578|459598525|FG001|Overall Study|Adverse Event|6|||
127719073|NCT00734578|459598526|FG002|Overall Study|Adverse Event|1|||
127719074|NCT00734578|459598524|FG000|Overall Study|Protocol Violation|8|||
127719075|NCT00734578|459598525|FG001|Overall Study|Protocol Violation|6|||
127719076|NCT00734578|459598526|FG002|Overall Study|Protocol Violation|3|||
127719077|NCT00734578|459598524|FG000|Overall Study|Withdrawal by Subject|7|||
127719078|NCT00734578|459598525|FG001|Overall Study|Withdrawal by Subject|8|||
127719079|NCT00734578|459598526|FG002|Overall Study|Withdrawal by Subject|11|||
127719080|NCT00734578|459598524|FG000|Overall Study|Lost to Follow-up|9|||
127719081|NCT00734578|459598525|FG001|Overall Study|Lost to Follow-up|3|||
127719082|NCT00734578|459598526|FG002|Overall Study|Lost to Follow-up|5|||
127719083|NCT00734578|459598524|FG000|Overall Study|Lack of Efficacy|3|||
127719084|NCT00734578|459598525|FG001|Overall Study|Lack of Efficacy|2|||
127719085|NCT00734578|459598526|FG002|Overall Study|Lack of Efficacy|5|||
127719086|NCT00734578|459598524|FG000|Overall Study|Randomized in error|1|||
127719087|NCT00734578|459598525|FG001|Overall Study|Randomized in error|0|||
127719088|NCT00734578|459598526|FG002|Overall Study|Randomized in error|0|||
127719089|NCT00734578|459598524|FG000|Overall Study|Exclusion criteria|1|||
127719090|NCT00734578|459598525|FG001|Overall Study|Exclusion criteria|0|||
127719091|NCT00734578|459598526|FG002|Overall Study|Exclusion criteria|0|||
127719092|NCT02085941|459598530|FG000|Overall Study|Lack of Efficacy|1|||
127719093|NCT02085941|459598531|FG001|Overall Study|Lack of Efficacy|0|||
127719094|NCT02085941|459598530|FG000|Overall Study|Death|6|||
127719095|NCT02085941|459598531|FG001|Overall Study|Death|1|||
127719096|NCT02085941|459598530|FG000|Overall Study|Lost to Follow-up|1|||
127719097|NCT02085941|459598531|FG001|Overall Study|Lost to Follow-up|0|||
127719098|NCT02085941|459598530|FG000|Overall Study|Physician Decision|0|||
127719099|NCT02085941|459598531|FG001|Overall Study|Physician Decision|2|||
127719100|NCT04652726|459598537|FG000|Part 1 (Double-blind Period)|Physician Decision|1|||
127719101|NCT04652726|459598538|FG001|Part 1 (Double-blind Period)|Physician Decision|0|||
127719102|NCT04652726|459598539|FG002|Part 1 (Double-blind Period)|Physician Decision|0|||
127719103|NCT04652726|459598537|FG000|Part 1 (Double-blind Period)|Participant/guardian decision|1|||
127719104|NCT04652726|459598538|FG001|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
127719105|NCT04652726|459598539|FG002|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
127719106|NCT02157116|459598540|FG000|Overall Study|Withdrawal by Subject|4|||
127719107|NCT02157116|459598540|FG000|Overall Study|Physician Decision|3|||
127719108|NCT02157116|459598540|FG000|Overall Study|Failed Screening|2|||
127719109|NCT00093496|459598541|FG000|Overall Study|Protocol Violation|1|||
127719110|NCT00093496|459598542|FG001|Overall Study|Protocol Violation|3|||
127719111|NCT03274076|459598544|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
127719112|NCT03274076|459598545|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
127719113|NCT03274076|459598546|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
127719114|NCT03274076|459598547|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
127719115|NCT03274076|459598544|FG000|24 Weeks Open Label|Adverse Event|0|||
127719116|NCT03274076|459598545|FG001|24 Weeks Open Label|Adverse Event|0|||
127719117|NCT03274076|459598546|FG002|24 Weeks Open Label|Adverse Event|2|||
127719118|NCT03274076|459598547|FG003|24 Weeks Open Label|Adverse Event|0|||
127719119|NCT03274076|459598544|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
127719120|NCT03274076|459598545|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
127719121|NCT03274076|459598546|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
127719122|NCT03274076|459598547|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
127719123|NCT00975585|459598548|FG000|Overall Study|Adverse Event|0|||
127719124|NCT00975585|459598549|FG001|Overall Study|Adverse Event|4|||
127719125|NCT00975585|459598548|FG000|Overall Study|Lost to Follow-up|3|||
127719126|NCT00975585|459598549|FG001|Overall Study|Lost to Follow-up|5|||
127719127|NCT00975585|459598548|FG000|Overall Study|Withdrawal by Subject|2|||
127719128|NCT00975585|459598549|FG001|Overall Study|Withdrawal by Subject|1|||
127719129|NCT00975585|459598548|FG000|Overall Study|Lens issue|2|||
127719130|NCT00975585|459598549|FG001|Overall Study|Lens issue|2|||
127719131|NCT00795184|459598550|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
127719132|NCT00795184|459598551|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
127719133|NCT00683800|459598552|FG000|Overall Study|Adverse Event|195|||
127719134|NCT00683800|459598553|FG001|Overall Study|Adverse Event|102|||
127719135|NCT00683800|459598552|FG000|Overall Study|Death|0|||
127719136|NCT00683800|459598553|FG001|Overall Study|Death|1|||
127719137|NCT00683800|459598552|FG000|Overall Study|Lost to Follow-up|57|||
127719138|NCT00683800|459598553|FG001|Overall Study|Lost to Follow-up|44|||
127719139|NCT00683800|459598552|FG000|Overall Study|Other|5|||
127719140|NCT00683800|459598553|FG001|Overall Study|Other|2|||
127719141|NCT00683800|459598552|FG000|Overall Study|Protocol Violation|13|||
127719142|NCT00683800|459598553|FG001|Overall Study|Protocol Violation|16|||
127719143|NCT00683800|459598552|FG000|Overall Study|Withdrawal by Subject|66|||
127719144|NCT00683800|459598553|FG001|Overall Study|Withdrawal by Subject|64|||
127719145|NCT00683800|459598552|FG000|Overall Study|Lack of Efficacy|61|||
127719146|NCT00683800|459598553|FG001|Overall Study|Lack of Efficacy|104|||
127719147|NCT00683800|459598552|FG000|Overall Study|Randomized, not treated|35|||
127719148|NCT00683800|459598553|FG001|Overall Study|Randomized, not treated|33|||
127719149|NCT00205179|459598556|FG000|Overall Study|Death|0|||
127719150|NCT00205179|459598557|FG001|Overall Study|Death|2|||
127719151|NCT00205179|459598556|FG000|Overall Study|Physician Decision|1|||
127719152|NCT00205179|459598557|FG001|Overall Study|Physician Decision|1|||
127719153|NCT00205179|459598556|FG000|Overall Study|Adverse Event|1|||
127719154|NCT00205179|459598557|FG001|Overall Study|Adverse Event|1|||
127719155|NCT02079649|459598558|FG000|Overall Study|Lost to Follow-up|0|||
127719156|NCT02079649|459598559|FG001|Overall Study|Lost to Follow-up|0|||
127719157|NCT02079649|459598560|FG002|Overall Study|Lost to Follow-up|0|||
127719158|NCT02079649|459598561|FG003|Overall Study|Lost to Follow-up|1|||
127719159|NCT02079649|459598558|FG000|Overall Study|Withdrawal by Subject|0|||
127719160|NCT02079649|459598559|FG001|Overall Study|Withdrawal by Subject|0|||
127719161|NCT02079649|459598560|FG002|Overall Study|Withdrawal by Subject|0|||
127719162|NCT02079649|459598561|FG003|Overall Study|Withdrawal by Subject|1|||
127719163|NCT02079649|459598558|FG000|Overall Study|Randomization error (prior to treatment)|1|||
127719164|NCT02079649|459598559|FG001|Overall Study|Randomization error (prior to treatment)|0|||
127719165|NCT02079649|459598560|FG002|Overall Study|Randomization error (prior to treatment)|1|||
127719166|NCT02079649|459598561|FG003|Overall Study|Randomization error (prior to treatment)|0|||
127719167|NCT01953692|459598569|FG000|Overall Study|Adverse Event|5|||
127719168|NCT01953692|459598570|FG001|Overall Study|Adverse Event|2|||
127719169|NCT01953692|459598571|FG002|Overall Study|Adverse Event|4|||
127719170|NCT01953692|459598572|FG003|Overall Study|Adverse Event|2|||
127719171|NCT01953692|459598573|FG004|Overall Study|Adverse Event|1|||
127719172|NCT01953692|459598574|FG005|Overall Study|Adverse Event|2|||
127719173|NCT01953692|459598575|FG006|Overall Study|Adverse Event|0|||
127719174|NCT01953692|459598576|FG007|Overall Study|Adverse Event|0|||
127719175|NCT01953692|459598577|FG008|Overall Study|Adverse Event|0|||
127719176|NCT01953692|459598569|FG000|Overall Study|Clinical Progression|0|||
127719177|NCT01953692|459598570|FG001|Overall Study|Clinical Progression|15|||
127719178|NCT01953692|459598571|FG002|Overall Study|Clinical Progression|7|||
127719179|NCT01953692|459598572|FG003|Overall Study|Clinical Progression|5|||
127719180|NCT01953692|459598573|FG004|Overall Study|Clinical Progression|0|||
127719181|NCT01953692|459598574|FG005|Overall Study|Clinical Progression|7|||
127719182|NCT01953692|459598575|FG006|Overall Study|Clinical Progression|20|||
127719183|NCT01953692|459598576|FG007|Overall Study|Clinical Progression|3|||
127719184|NCT01953692|459598577|FG008|Overall Study|Clinical Progression|3|||
127719185|NCT01953692|459598569|FG000|Overall Study|Death|5|||
127719186|NCT01953692|459598570|FG001|Overall Study|Death|0|||
127719187|NCT01953692|459598571|FG002|Overall Study|Death|2|||
127719188|NCT01953692|459598572|FG003|Overall Study|Death|2|||
127719189|NCT01953692|459598573|FG004|Overall Study|Death|1|||
127719190|NCT01953692|459598574|FG005|Overall Study|Death|3|||
127719191|NCT01953692|459598575|FG006|Overall Study|Death|6|||
127719192|NCT01953692|459598576|FG007|Overall Study|Death|2|||
127719193|NCT01953692|459598577|FG008|Overall Study|Death|1|||
127719194|NCT01953692|459598569|FG000|Overall Study|Excluded Medication|1|||
127719195|NCT01953692|459598570|FG001|Overall Study|Excluded Medication|0|||
127719196|NCT01953692|459598571|FG002|Overall Study|Excluded Medication|0|||
127719197|NCT01953692|459598572|FG003|Overall Study|Excluded Medication|0|||
127719198|NCT01953692|459598573|FG004|Overall Study|Excluded Medication|0|||
127719199|NCT01953692|459598574|FG005|Overall Study|Excluded Medication|0|||
127719200|NCT01953692|459598575|FG006|Overall Study|Excluded Medication|0|||
127719201|NCT01953692|459598576|FG007|Overall Study|Excluded Medication|0|||
127719202|NCT01953692|459598577|FG008|Overall Study|Excluded Medication|0|||
127719203|NCT01953692|459598569|FG000|Overall Study|Lost to Follow-up|1|||
127719204|NCT01953692|459598570|FG001|Overall Study|Lost to Follow-up|0|||
127719205|NCT01953692|459598571|FG002|Overall Study|Lost to Follow-up|3|||
127719206|NCT01953692|459598572|FG003|Overall Study|Lost to Follow-up|1|||
127719207|NCT01953692|459598573|FG004|Overall Study|Lost to Follow-up|0|||
127719208|NCT01953692|459598574|FG005|Overall Study|Lost to Follow-up|1|||
127719209|NCT01953692|459598575|FG006|Overall Study|Lost to Follow-up|0|||
127719210|NCT01953692|459598576|FG007|Overall Study|Lost to Follow-up|0|||
127719211|NCT01953692|459598577|FG008|Overall Study|Lost to Follow-up|0|||
127719212|NCT01953692|459598569|FG000|Overall Study|Physician Decision|11|||
127719213|NCT01953692|459598570|FG001|Overall Study|Physician Decision|4|||
127719214|NCT01953692|459598571|FG002|Overall Study|Physician Decision|2|||
127802734|NCT01552681|459901030|FG001|Overall Study|Subject moved away|1|||
127719215|NCT01953692|459598572|FG003|Overall Study|Physician Decision|2|||
127719216|NCT01953692|459598573|FG004|Overall Study|Physician Decision|1|||
127719217|NCT01953692|459598574|FG005|Overall Study|Physician Decision|2|||
127719218|NCT01953692|459598575|FG006|Overall Study|Physician Decision|4|||
127719219|NCT01953692|459598576|FG007|Overall Study|Physician Decision|1|||
127719220|NCT01953692|459598577|FG008|Overall Study|Physician Decision|0|||
127719221|NCT01953692|459598569|FG000|Overall Study|Protocol Violation|0|||
127719222|NCT01953692|459598570|FG001|Overall Study|Protocol Violation|2|||
127719223|NCT01953692|459598571|FG002|Overall Study|Protocol Violation|1|||
127719224|NCT01953692|459598572|FG003|Overall Study|Protocol Violation|0|||
127719225|NCT01953692|459598573|FG004|Overall Study|Protocol Violation|0|||
127719226|NCT01953692|459598574|FG005|Overall Study|Protocol Violation|0|||
127719227|NCT01953692|459598575|FG006|Overall Study|Protocol Violation|0|||
127719228|NCT01953692|459598576|FG007|Overall Study|Protocol Violation|1|||
127719229|NCT01953692|459598577|FG008|Overall Study|Protocol Violation|0|||
127719230|NCT01953692|459598569|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
127719231|NCT01953692|459598570|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
127719232|NCT01953692|459598571|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
127719233|NCT01953692|459598572|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
127719234|NCT01953692|459598573|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
127719235|NCT01953692|459598574|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
127719236|NCT01953692|459598575|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
127719237|NCT01953692|459598576|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
127719238|NCT01953692|459598577|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
127719239|NCT01953692|459598569|FG000|Overall Study|Withdrawal by Subject|4|||
127719240|NCT01953692|459598570|FG001|Overall Study|Withdrawal by Subject|2|||
127719241|NCT01953692|459598571|FG002|Overall Study|Withdrawal by Subject|1|||
127719242|NCT01953692|459598572|FG003|Overall Study|Withdrawal by Subject|2|||
127719243|NCT01953692|459598573|FG004|Overall Study|Withdrawal by Subject|0|||
127719244|NCT01953692|459598574|FG005|Overall Study|Withdrawal by Subject|3|||
127719245|NCT01953692|459598575|FG006|Overall Study|Withdrawal by Subject|2|||
127719246|NCT01953692|459598576|FG007|Overall Study|Withdrawal by Subject|1|||
127719247|NCT01953692|459598577|FG008|Overall Study|Withdrawal by Subject|1|||
127719248|NCT00983294|459598584|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
127719249|NCT00983294|459598584|FG000|Colchicine With Azithromycin|Adverse Event|1|||
127719250|NCT00853593|459598585|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
127719251|NCT00853593|459598585|FG000|Overall Study|Model 4396 lead not attempted|29|||
127719252|NCT00853593|459598585|FG000|Overall Study|Implant not attempted|4|||
127719253|NCT00600353|459598591|FG000|Overall Study|history of malignancy within 5 years|1|||
127719254|NCT00600353|459598592|FG001|Overall Study|history of malignancy within 5 years|0|||
127719255|NCT00600353|459598591|FG000|Overall Study|History of prepartive regimen|0|||
127719256|NCT00600353|459598592|FG001|Overall Study|History of prepartive regimen|1|||
127719257|NCT05966155|459598594|FG000|Overall Study|Death|1|||
127719258|NCT05966155|459598595|FG001|Overall Study|Death|2|||
127719259|NCT05966155|459598594|FG000|Overall Study|Lost to Follow-up|63|||
127719260|NCT05966155|459598595|FG001|Overall Study|Lost to Follow-up|67|||
127719261|NCT05966155|459598594|FG000|Overall Study|Protocol Violation|1|||
127719262|NCT05966155|459598595|FG001|Overall Study|Protocol Violation|0|||
127719263|NCT05966155|459598594|FG000|Overall Study|Withdrawal by Subject|8|||
127719264|NCT05966155|459598595|FG001|Overall Study|Withdrawal by Subject|9|||
127719265|NCT05966155|459598594|FG000|Overall Study|Enrolled Erroneously|0|||
127719266|NCT05966155|459598595|FG001|Overall Study|Enrolled Erroneously|1|||
127719267|NCT05966155|459598594|FG000|Overall Study|Follow-up Incorrectly Scheduled|0|||
127719268|NCT05966155|459598595|FG001|Overall Study|Follow-up Incorrectly Scheduled|1|||
127719269|NCT02743819|459598596|FG000|Overall Study|Lack of Efficacy|5|||
127719270|NCT02743819|459598596|FG000|Overall Study|Death|2|||
127719271|NCT02743819|459598596|FG000|Overall Study|Adverse Event|1|||
127719272|NCT01706159|459598602|FG000|Overall Study|Withdrawal Criteria|2|||
127719273|NCT01706159|459598603|FG001|Overall Study|Withdrawal Criteria|1|||
127719274|NCT01706159|459598602|FG000|Overall Study|Unclassified|6|||
127719275|NCT01706159|459598603|FG001|Overall Study|Unclassified|1|||
127719276|NCT00553332|459598608|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
127719277|NCT03775486|459598609|FG000|Initial Therapy Phase|Other reason provided|0|||
127719278|NCT03775486|459598610|FG001|Initial Therapy Phase|Other reason provided|15|||
127719279|NCT03775486|459598609|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
127719280|NCT03775486|459598610|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
127719281|NCT03775486|459598609|FG000|Initial Therapy Phase|Protocol Violation|0|||
127719282|NCT03775486|459598610|FG001|Initial Therapy Phase|Protocol Violation|2|||
127719283|NCT03775486|459598609|FG000|Initial Therapy Phase|Adverse Event|0|||
127719284|NCT03775486|459598610|FG001|Initial Therapy Phase|Adverse Event|34|||
127719285|NCT03775486|459598609|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
127719286|NCT03775486|459598610|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
127719287|NCT03775486|459598609|FG000|Maintenance Phase|Withdrawal by Subject|13|||
127719288|NCT03775486|459598610|FG001|Maintenance Phase|Withdrawal by Subject|12|||
127719289|NCT03775486|459598609|FG000|Maintenance Phase|Death|44|||
127719290|NCT03775486|459598610|FG001|Maintenance Phase|Death|45|||
127719291|NCT02235298|459598612|FG000|Overall Study|Lost to Follow-up|6|||
127719292|NCT02235298|459598613|FG001|Overall Study|Lost to Follow-up|5|||
127719293|NCT02235298|459598612|FG000|Overall Study|Adverse Event|2|||
127719294|NCT02235298|459598613|FG001|Overall Study|Adverse Event|2|||
127802735|NCT03882424|459901032|FG000|Overall Study|Lost to Follow-up|3|||
127719295|NCT02235298|459598612|FG000|Overall Study|Withdrawal by Subject|0|||
127719296|NCT02235298|459598613|FG001|Overall Study|Withdrawal by Subject|1|||
127719297|NCT03683576|459598617|FG000|Overall Study|Withdrawal by Subject|2|||
127719298|NCT03683576|459598618|FG001|Overall Study|Withdrawal by Subject|0|||
127719299|NCT03683576|459598619|FG002|Overall Study|Withdrawal by Subject|8|||
127719300|NCT03683576|459598620|FG003|Overall Study|Withdrawal by Subject|3|||
127719301|NCT03683576|459598617|FG000|Overall Study|Adverse Event|3|||
127719302|NCT03683576|459598618|FG001|Overall Study|Adverse Event|0|||
127719303|NCT03683576|459598619|FG002|Overall Study|Adverse Event|0|||
127719304|NCT03683576|459598620|FG003|Overall Study|Adverse Event|4|||
127719305|NCT03683576|459598617|FG000|Overall Study|Lack of Efficacy|1|||
127719306|NCT03683576|459598618|FG001|Overall Study|Lack of Efficacy|0|||
127719307|NCT03683576|459598619|FG002|Overall Study|Lack of Efficacy|1|||
127719308|NCT03683576|459598620|FG003|Overall Study|Lack of Efficacy|1|||
127719309|NCT03683576|459598617|FG000|Overall Study|Lost to Follow-up|0|||
127719310|NCT03683576|459598618|FG001|Overall Study|Lost to Follow-up|1|||
127719311|NCT03683576|459598619|FG002|Overall Study|Lost to Follow-up|2|||
127719312|NCT03683576|459598620|FG003|Overall Study|Lost to Follow-up|0|||
127719313|NCT03683576|459598617|FG000|Overall Study|Other, Not Specified|0|||
127719314|NCT03683576|459598618|FG001|Overall Study|Other, Not Specified|2|||
127719315|NCT03683576|459598619|FG002|Overall Study|Other, Not Specified|0|||
127719316|NCT03683576|459598620|FG003|Overall Study|Other, Not Specified|0|||
127719317|NCT03683576|459598617|FG000|Overall Study|Protocol Violation|0|||
127719318|NCT03683576|459598618|FG001|Overall Study|Protocol Violation|1|||
127719319|NCT03683576|459598619|FG002|Overall Study|Protocol Violation|1|||
127719320|NCT03683576|459598620|FG003|Overall Study|Protocol Violation|0|||
127719321|NCT01827839|459598621|FG000|Overall Study|Adverse Event|1|||
127719322|NCT01827839|459598621|FG000|Overall Study|Consent Withdrawal|2|||
127719323|NCT00491894|459598628|FG000|Overall Study|Adverse Event|14|||
127719324|NCT00491894|459598628|FG000|Overall Study|Withdrawal by Subject|5|||
127719325|NCT00491894|459598628|FG000|Overall Study|Death|3|||
127719326|NCT00491894|459598628|FG000|Overall Study|Lost to Follow-up|3|||
127719327|NCT00491894|459598628|FG000|Overall Study|Lack of Efficacy|2|||
127719328|NCT00491894|459598628|FG000|Overall Study|Other-Failed to meet any criteria|2|||
127719329|NCT00491894|459598628|FG000|Overall Study|Physician Decision|2|||
127719330|NCT00491894|459598628|FG000|Overall Study|Protocol Violation|2|||
127719331|NCT00491894|459598628|FG000|Overall Study|Other-Intake of prohibited medication|1|||
127719332|NCT04172675|459600303|FG000|Overall Study|Withdrawal by Subject|7|||
127719333|NCT04172675|459600304|FG001|Overall Study|Withdrawal by Subject|5|||
127719334|NCT04172675|459600305|FG002|Overall Study|Withdrawal by Subject|1|||
127719335|NCT04172675|459600306|FG003|Overall Study|Withdrawal by Subject|4|||
127719336|NCT05349721|459600307|FG000|Part A (24 Weeks)|Adverse Event|9|||
127719337|NCT05349721|459600308|FG001|Part A (24 Weeks)|Adverse Event|2|||
127719338|NCT05349721|459600307|FG000|Part A (24 Weeks)|Death|8|||
127719339|NCT05349721|459600308|FG001|Part A (24 Weeks)|Death|3|||
127719340|NCT05349721|459600307|FG000|Part A (24 Weeks)|Disease Progression|1|||
127719341|NCT05349721|459600308|FG001|Part A (24 Weeks)|Disease Progression|1|||
127719342|NCT05349721|459600307|FG000|Part A (24 Weeks)|Screen Failure|2|||
127719343|NCT05349721|459600308|FG001|Part A (24 Weeks)|Screen Failure|0|||
127719344|NCT05349721|459600307|FG000|Part A (24 Weeks)|Withdrawal by Subject|18|||
127719345|NCT05349721|459600308|FG001|Part A (24 Weeks)|Withdrawal by Subject|7|||
127719346|NCT05349721|459600307|FG000|Part A (24 Weeks)|Other Than Specified|5|||
127719347|NCT05349721|459600308|FG001|Part A (24 Weeks)|Other Than Specified|1|||
127719348|NCT05349721|459600307|FG000|Part B (28 Weeks)|Adverse Event|3|||
127719349|NCT05349721|459600308|FG001|Part B (28 Weeks)|Adverse Event|0|||
127719350|NCT05349721|459600307|FG000|Part B (28 Weeks)|Death|21|||
127719351|NCT05349721|459600308|FG001|Part B (28 Weeks)|Death|11|||
127719352|NCT05349721|459600307|FG000|Part B (28 Weeks)|Disease Progression|2|||
127719353|NCT05349721|459600308|FG001|Part B (28 Weeks)|Disease Progression|1|||
127719354|NCT05349721|459600307|FG000|Part B (28 Weeks)|Lost to Follow-up|2|||
127719355|NCT05349721|459600308|FG001|Part B (28 Weeks)|Lost to Follow-up|1|||
127719356|NCT05349721|459600307|FG000|Part B (28 Weeks)|Physician Decision|1|||
127719357|NCT05349721|459600308|FG001|Part B (28 Weeks)|Physician Decision|0|||
127719358|NCT05349721|459600307|FG000|Part B (28 Weeks)|Study terminated by sponsor|85|||
127719359|NCT05349721|459600308|FG001|Part B (28 Weeks)|Study terminated by sponsor|53|||
127719360|NCT05349721|459600307|FG000|Part B (28 Weeks)|Withdrawal by Subject|17|||
127719361|NCT05349721|459600308|FG001|Part B (28 Weeks)|Withdrawal by Subject|5|||
127719362|NCT05349721|459600307|FG000|Part B (28 Weeks)|Other Than Specified|4|||
127719363|NCT05349721|459600308|FG001|Part B (28 Weeks)|Other Than Specified|2|||
127719364|NCT05349721|459600307|FG000|Part C (108 Weeks)|Death|0|||
127719365|NCT05349721|459600308|FG001|Part C (108 Weeks)|Death|1|||
127719366|NCT05349721|459600307|FG000|Part C (108 Weeks)|Lost to Follow-up|0|||
127719367|NCT05349721|459600308|FG001|Part C (108 Weeks)|Lost to Follow-up|1|||
127719368|NCT05349721|459600307|FG000|Part C (108 Weeks)|Study terminated by sponsor|34|||
127719369|NCT05349721|459600308|FG001|Part C (108 Weeks)|Study terminated by sponsor|23|||
127719370|NCT05349721|459600307|FG000|Part C (108 Weeks)|Withdrawal by Subject|1|||
127719371|NCT05349721|459600308|FG001|Part C (108 Weeks)|Withdrawal by Subject|1|||
127802736|NCT03882424|459901033|FG001|Overall Study|Lost to Follow-up|0|||
127802737|NCT03882424|459901034|FG002|Overall Study|Lost to Follow-up|0|||
127802738|NCT03882424|459901032|FG000|Overall Study|schedule conflict|1|||
127802739|NCT03882424|459901033|FG001|Overall Study|schedule conflict|0|||
127802740|NCT03882424|459901034|FG002|Overall Study|schedule conflict|0|||
127719372|NCT03070392|459600309|FG000|Overall Study|Not Treated|7|||
127719373|NCT03070392|459600310|FG001|Overall Study|Not Treated|0|||
127719374|NCT03070392|459600311|FG002|Overall Study|Not Treated|3|||
127719375|NCT03070392|459600312|FG003|Overall Study|Not Treated|12|||
127719376|NCT03070392|459600309|FG000|Overall Study|Death|3|||
127719377|NCT03070392|459600310|FG001|Overall Study|Death|0|||
127719378|NCT03070392|459600311|FG002|Overall Study|Death|0|||
127719379|NCT03070392|459600312|FG003|Overall Study|Death|1|||
127719380|NCT03070392|459600309|FG000|Overall Study|Withdrawal by Subject|7|||
127719381|NCT03070392|459600310|FG001|Overall Study|Withdrawal by Subject|0|||
127719382|NCT03070392|459600311|FG002|Overall Study|Withdrawal by Subject|0|||
127719383|NCT03070392|459600312|FG003|Overall Study|Withdrawal by Subject|3|||
127719384|NCT03070392|459600309|FG000|Overall Study|Physician Decision|1|||
127719385|NCT03070392|459600310|FG001|Overall Study|Physician Decision|0|||
127719386|NCT03070392|459600311|FG002|Overall Study|Physician Decision|0|||
127719387|NCT03070392|459600312|FG003|Overall Study|Physician Decision|2|||
127719388|NCT03070392|459600309|FG000|Overall Study|Progressive Disease|154|||
127719389|NCT03070392|459600310|FG001|Overall Study|Progressive Disease|6|||
127719390|NCT03070392|459600311|FG002|Overall Study|Progressive Disease|2|||
127719391|NCT03070392|459600312|FG003|Overall Study|Progressive Disease|70|||
127719392|NCT03070392|459600309|FG000|Overall Study|Adverse Event|6|||
127719393|NCT03070392|459600310|FG001|Overall Study|Adverse Event|1|||
127719394|NCT03070392|459600311|FG002|Overall Study|Adverse Event|1|||
127719395|NCT03070392|459600312|FG003|Overall Study|Adverse Event|3|||
127719396|NCT03070392|459600309|FG000|Overall Study|Alternate anticancer treatment|1|||
127719397|NCT03070392|459600310|FG001|Overall Study|Alternate anticancer treatment|0|||
127719398|NCT03070392|459600311|FG002|Overall Study|Alternate anticancer treatment|0|||
127719399|NCT03070392|459600312|FG003|Overall Study|Alternate anticancer treatment|1|||
127719400|NCT03070392|459600309|FG000|Overall Study|Ongoing|73|||
127719401|NCT03070392|459600310|FG001|Overall Study|Ongoing|0|||
127719402|NCT03070392|459600311|FG002|Overall Study|Ongoing|0|||
127719403|NCT03070392|459600312|FG003|Overall Study|Ongoing|11|||
127719404|NCT02972034|459600313|FG000|Overall Study|Death|11|||
127719405|NCT02972034|459600314|FG001|Overall Study|Death|1|||
127719406|NCT02972034|459600315|FG002|Overall Study|Death|3|||
127719407|NCT02972034|459600316|FG003|Overall Study|Death|3|||
127719408|NCT02972034|459600317|FG004|Overall Study|Death|2|||
127719409|NCT02972034|459600318|FG005|Overall Study|Death|2|||
127719410|NCT02972034|459600319|FG006|Overall Study|Death|3|||
127719411|NCT02972034|459600320|FG007|Overall Study|Death|4|||
127719412|NCT02972034|459600321|FG008|Overall Study|Death|8|||
127719413|NCT02972034|459600322|FG009|Overall Study|Death|11|||
127719414|NCT02972034|459600323|FG010|Overall Study|Death|3|||
127719415|NCT02972034|459600324|FG011|Overall Study|Death|2|||
127719416|NCT02972034|459600325|FG012|Overall Study|Death|11|||
127719417|NCT02972034|459600326|FG013|Overall Study|Death|10|||
127719418|NCT02972034|459600327|FG014|Overall Study|Death|9|||
127719419|NCT02972034|459600313|FG000|Overall Study|Lost to Follow-up|0|||
127719420|NCT02972034|459600314|FG001|Overall Study|Lost to Follow-up|0|||
127719421|NCT02972034|459600315|FG002|Overall Study|Lost to Follow-up|0|||
127719422|NCT02972034|459600316|FG003|Overall Study|Lost to Follow-up|0|||
127719423|NCT02972034|459600317|FG004|Overall Study|Lost to Follow-up|1|||
127719424|NCT02972034|459600318|FG005|Overall Study|Lost to Follow-up|0|||
127719425|NCT02972034|459600319|FG006|Overall Study|Lost to Follow-up|0|||
127719426|NCT02972034|459600320|FG007|Overall Study|Lost to Follow-up|1|||
127719427|NCT02972034|459600321|FG008|Overall Study|Lost to Follow-up|0|||
127802741|NCT00236080|459901035|FG000|Overall Study|Adverse Event|0|||
127719428|NCT02972034|459600322|FG009|Overall Study|Lost to Follow-up|0|||
127719429|NCT02972034|459600323|FG010|Overall Study|Lost to Follow-up|0|||
127719430|NCT02972034|459600324|FG011|Overall Study|Lost to Follow-up|0|||
127719431|NCT02972034|459600325|FG012|Overall Study|Lost to Follow-up|0|||
127719432|NCT02972034|459600326|FG013|Overall Study|Lost to Follow-up|0|||
127719433|NCT02972034|459600327|FG014|Overall Study|Lost to Follow-up|1|||
127719434|NCT02972034|459600313|FG000|Overall Study|Physician Decision|0|||
127719435|NCT02972034|459600314|FG001|Overall Study|Physician Decision|0|||
127719436|NCT02972034|459600315|FG002|Overall Study|Physician Decision|0|||
127719437|NCT02972034|459600316|FG003|Overall Study|Physician Decision|0|||
127719438|NCT02972034|459600317|FG004|Overall Study|Physician Decision|0|||
127719439|NCT02972034|459600318|FG005|Overall Study|Physician Decision|0|||
127719440|NCT02972034|459600319|FG006|Overall Study|Physician Decision|0|||
127719441|NCT02972034|459600320|FG007|Overall Study|Physician Decision|1|||
127719442|NCT02972034|459600321|FG008|Overall Study|Physician Decision|0|||
127719443|NCT02972034|459600322|FG009|Overall Study|Physician Decision|0|||
127802742|NCT00236080|459901036|FG001|Overall Study|Adverse Event|0|||
127719444|NCT02972034|459600323|FG010|Overall Study|Physician Decision|1|||
127719445|NCT02972034|459600324|FG011|Overall Study|Physician Decision|0|||
127719446|NCT02972034|459600325|FG012|Overall Study|Physician Decision|0|||
127719447|NCT02972034|459600326|FG013|Overall Study|Physician Decision|0|||
127719448|NCT02972034|459600327|FG014|Overall Study|Physician Decision|0|||
127719449|NCT02972034|459600313|FG000|Overall Study|Sponsor Decision|0|||
127719450|NCT02972034|459600314|FG001|Overall Study|Sponsor Decision|0|||
127719451|NCT02972034|459600315|FG002|Overall Study|Sponsor Decision|0|||
127719452|NCT02972034|459600316|FG003|Overall Study|Sponsor Decision|1|||
127719453|NCT02972034|459600317|FG004|Overall Study|Sponsor Decision|0|||
127719454|NCT02972034|459600318|FG005|Overall Study|Sponsor Decision|0|||
127719455|NCT02972034|459600319|FG006|Overall Study|Sponsor Decision|1|||
127719456|NCT02972034|459600320|FG007|Overall Study|Sponsor Decision|1|||
127719457|NCT02972034|459600321|FG008|Overall Study|Sponsor Decision|1|||
127719458|NCT02972034|459600322|FG009|Overall Study|Sponsor Decision|2|||
127719459|NCT02972034|459600323|FG010|Overall Study|Sponsor Decision|2|||
127719460|NCT02972034|459600324|FG011|Overall Study|Sponsor Decision|0|||
127719461|NCT02972034|459600325|FG012|Overall Study|Sponsor Decision|1|||
127719462|NCT02972034|459600326|FG013|Overall Study|Sponsor Decision|0|||
127719463|NCT02972034|459600327|FG014|Overall Study|Sponsor Decision|1|||
127719464|NCT02972034|459600313|FG000|Overall Study|Withdrawal by Subject|3|||
127719465|NCT02972034|459600314|FG001|Overall Study|Withdrawal by Subject|0|||
127719466|NCT02972034|459600315|FG002|Overall Study|Withdrawal by Subject|0|||
127719467|NCT02972034|459600316|FG003|Overall Study|Withdrawal by Subject|0|||
127719468|NCT02972034|459600317|FG004|Overall Study|Withdrawal by Subject|1|||
127719469|NCT02972034|459600318|FG005|Overall Study|Withdrawal by Subject|1|||
127719470|NCT02972034|459600319|FG006|Overall Study|Withdrawal by Subject|0|||
127719471|NCT02972034|459600320|FG007|Overall Study|Withdrawal by Subject|0|||
127719472|NCT02972034|459600321|FG008|Overall Study|Withdrawal by Subject|1|||
127719473|NCT02972034|459600322|FG009|Overall Study|Withdrawal by Subject|1|||
127719474|NCT02972034|459600323|FG010|Overall Study|Withdrawal by Subject|2|||
127719475|NCT02972034|459600324|FG011|Overall Study|Withdrawal by Subject|1|||
127719476|NCT02972034|459600325|FG012|Overall Study|Withdrawal by Subject|1|||
127719477|NCT02972034|459600326|FG013|Overall Study|Withdrawal by Subject|1|||
127719478|NCT02972034|459600327|FG014|Overall Study|Withdrawal by Subject|0|||
127719479|NCT02972034|459600313|FG000|Overall Study|Screen Failure|0|||
127719480|NCT02972034|459600314|FG001|Overall Study|Screen Failure|0|||
127719481|NCT02972034|459600315|FG002|Overall Study|Screen Failure|0|||
127719482|NCT02972034|459600316|FG003|Overall Study|Screen Failure|0|||
127719483|NCT02972034|459600317|FG004|Overall Study|Screen Failure|0|||
127719484|NCT02972034|459600318|FG005|Overall Study|Screen Failure|0|||
127719485|NCT02972034|459600319|FG006|Overall Study|Screen Failure|0|||
127719486|NCT02972034|459600320|FG007|Overall Study|Screen Failure|0|||
127719487|NCT02972034|459600321|FG008|Overall Study|Screen Failure|0|||
127719488|NCT02972034|459600322|FG009|Overall Study|Screen Failure|0|||
127719489|NCT02972034|459600323|FG010|Overall Study|Screen Failure|0|||
127719490|NCT02972034|459600324|FG011|Overall Study|Screen Failure|0|||
127719491|NCT02972034|459600325|FG012|Overall Study|Screen Failure|1|||
127719492|NCT02972034|459600326|FG013|Overall Study|Screen Failure|0|||
127719493|NCT02972034|459600327|FG014|Overall Study|Screen Failure|0|||
127719494|NCT03861052|459600328|FG000|Overall Study|Adverse Event|1|||
127719495|NCT03861052|459600329|FG001|Overall Study|Adverse Event|1|||
127719496|NCT03861052|459600330|FG002|Overall Study|Adverse Event|2|||
127719497|NCT03861052|459600331|FG003|Overall Study|Adverse Event|4|||
127719498|NCT03861052|459600328|FG000|Overall Study|Lost to Follow-up|0|||
127719499|NCT03861052|459600329|FG001|Overall Study|Lost to Follow-up|0|||
127719500|NCT03861052|459600330|FG002|Overall Study|Lost to Follow-up|0|||
127719501|NCT03861052|459600331|FG003|Overall Study|Lost to Follow-up|1|||
127719502|NCT03861052|459600328|FG000|Overall Study|Physician Decision|0|||
127719503|NCT03861052|459600329|FG001|Overall Study|Physician Decision|1|||
127719504|NCT03861052|459600330|FG002|Overall Study|Physician Decision|0|||
127719505|NCT03861052|459600331|FG003|Overall Study|Physician Decision|0|||
127719506|NCT03861052|459600328|FG000|Overall Study|Withdrawal by Subject|2|||
127719507|NCT03861052|459600329|FG001|Overall Study|Withdrawal by Subject|5|||
127719508|NCT03861052|459600330|FG002|Overall Study|Withdrawal by Subject|3|||
127719509|NCT03861052|459600331|FG003|Overall Study|Withdrawal by Subject|0|||
127719510|NCT03861052|459600328|FG000|Overall Study|Relocation to other city|1|||
127719511|NCT03861052|459600329|FG001|Overall Study|Relocation to other city|0|||
127719512|NCT03861052|459600330|FG002|Overall Study|Relocation to other city|0|||
127719513|NCT03861052|459600331|FG003|Overall Study|Relocation to other city|0|||
127719514|NCT03823703|459600332|FG000|Overall Study|Sponsor request|0|||
127719515|NCT03823703|459600333|FG001|Overall Study|Sponsor request|3|||
127719516|NCT03823703|459600334|FG002|Overall Study|Sponsor request|4|||
127719517|NCT03823703|459600332|FG000|Overall Study|Adverse Event|3|||
127719518|NCT03823703|459600333|FG001|Overall Study|Adverse Event|1|||
127719519|NCT03823703|459600334|FG002|Overall Study|Adverse Event|0|||
127719520|NCT03823703|459600332|FG000|Overall Study|Withdrawal by Subject|0|||
127719521|NCT03823703|459600333|FG001|Overall Study|Withdrawal by Subject|1|||
127719522|NCT03823703|459600334|FG002|Overall Study|Withdrawal by Subject|0|||
127719523|NCT01970878|459600336|FG000|Overall Study|Withdrawal by Subject|11|||
127719524|NCT01970878|459600337|FG001|Overall Study|Withdrawal by Subject|10|||
127719525|NCT01970878|459600338|FG002|Overall Study|Withdrawal by Subject|14|||
127719526|NCT01970878|459600339|FG003|Overall Study|Withdrawal by Subject|7|||
127719527|NCT01970878|459600336|FG000|Overall Study|Lost to Follow-up|1|||
127719528|NCT01970878|459600337|FG001|Overall Study|Lost to Follow-up|3|||
127719529|NCT01970878|459600338|FG002|Overall Study|Lost to Follow-up|2|||
127719530|NCT01970878|459600339|FG003|Overall Study|Lost to Follow-up|4|||
127719531|NCT01970878|459600336|FG000|Overall Study|Administrative Reasons|1|||
127719532|NCT01970878|459600337|FG001|Overall Study|Administrative Reasons|0|||
127719533|NCT01970878|459600338|FG002|Overall Study|Administrative Reasons|0|||
127719534|NCT01970878|459600339|FG003|Overall Study|Administrative Reasons|4|||
127719535|NCT01970878|459600336|FG000|Overall Study|Lack of Efficacy|2|||
127719536|NCT01970878|459600337|FG001|Overall Study|Lack of Efficacy|1|||
127719537|NCT01970878|459600338|FG002|Overall Study|Lack of Efficacy|2|||
127719538|NCT01970878|459600339|FG003|Overall Study|Lack of Efficacy|0|||
127719539|NCT01970878|459600336|FG000|Overall Study|Adverse Event|12|||
127719540|NCT01970878|459600337|FG001|Overall Study|Adverse Event|7|||
127719541|NCT01970878|459600338|FG002|Overall Study|Adverse Event|4|||
127719542|NCT01970878|459600339|FG003|Overall Study|Adverse Event|3|||
127719543|NCT01970878|459600336|FG000|Overall Study|Protocol Specified Criteria|10|||
127719544|NCT01970878|459600337|FG001|Overall Study|Protocol Specified Criteria|4|||
127719545|NCT01970878|459600338|FG002|Overall Study|Protocol Specified Criteria|3|||
127719546|NCT01970878|459600339|FG003|Overall Study|Protocol Specified Criteria|6|||
127719547|NCT01970878|459600336|FG000|Overall Study|Physician Decision|0|||
127719548|NCT01970878|459600337|FG001|Overall Study|Physician Decision|1|||
127719549|NCT01970878|459600338|FG002|Overall Study|Physician Decision|1|||
127719550|NCT01970878|459600339|FG003|Overall Study|Physician Decision|0|||
127719551|NCT01970878|459600336|FG000|Overall Study|No Completion Status|0|||
127719552|NCT01970878|459600337|FG001|Overall Study|No Completion Status|1|||
127719553|NCT01970878|459600338|FG002|Overall Study|No Completion Status|0|||
127719554|NCT01970878|459600339|FG003|Overall Study|No Completion Status|0|||
127719555|NCT02372799|459600342|FG000|Treatment Period|Adverse Event|3|||
127719556|NCT02372799|459600343|FG001|Treatment Period|Adverse Event|10|||
127719557|NCT02372799|459600344|FG002|Treatment Period|Adverse Event|6|||
127719558|NCT02372799|459600342|FG000|Treatment Period|Insufficient therapeutic response|2|||
127719559|NCT02372799|459600343|FG001|Treatment Period|Insufficient therapeutic response|2|||
127719560|NCT02372799|459600344|FG002|Treatment Period|Insufficient therapeutic response|0|||
127719561|NCT02372799|459600342|FG000|Treatment Period|Withdrawal by Subject|10|||
127719562|NCT02372799|459600343|FG001|Treatment Period|Withdrawal by Subject|10|||
127719563|NCT02372799|459600344|FG002|Treatment Period|Withdrawal by Subject|2|||
127719564|NCT02372799|459600342|FG000|Treatment Period|Lost to Follow-up|11|||
127719565|NCT02372799|459600343|FG001|Treatment Period|Lost to Follow-up|5|||
127719566|NCT02372799|459600344|FG002|Treatment Period|Lost to Follow-up|3|||
127719567|NCT02372799|459600342|FG000|Treatment Period|Protocol Violation|3|||
127719568|NCT02372799|459600343|FG001|Treatment Period|Protocol Violation|0|||
127719569|NCT02372799|459600344|FG002|Treatment Period|Protocol Violation|0|||
127719570|NCT02372799|459600342|FG000|Treatment Period|Non-compliance with study drug|4|||
127719571|NCT02372799|459600343|FG001|Treatment Period|Non-compliance with study drug|4|||
127719572|NCT02372799|459600344|FG002|Treatment Period|Non-compliance with study drug|4|||
127719573|NCT02372799|459600342|FG000|Treatment Period|Miscellaneous Reasons|1|||
127719574|NCT02372799|459600343|FG001|Treatment Period|Miscellaneous Reasons|1|||
127719575|NCT02372799|459600344|FG002|Treatment Period|Miscellaneous Reasons|0|||
127719576|NCT02372799|459600342|FG000|Down-taper Period|Lost to Follow-up|1|||
127719577|NCT02372799|459600343|FG001|Down-taper Period|Lost to Follow-up|2|||
127719578|NCT02372799|459600344|FG002|Down-taper Period|Lost to Follow-up|2|||
127719579|NCT00089609|459600345|FG000|Overall Study|Withdrawal by Subject|3|||
127719580|NCT00089609|459600346|FG001|Overall Study|Withdrawal by Subject|1|||
127719581|NCT00747006|459600348|FG000|Overall Study|Adverse Event|1|||
127719582|NCT00747006|459600349|FG001|Overall Study|Adverse Event|0|||
127719583|NCT00747006|459600350|FG002|Overall Study|Adverse Event|0|||
127719584|NCT00747006|459600348|FG000|Overall Study|Lost to Follow-up|0|||
127719585|NCT00747006|459600349|FG001|Overall Study|Lost to Follow-up|1|||
127719586|NCT00747006|459600350|FG002|Overall Study|Lost to Follow-up|0|||
127719587|NCT00747006|459600348|FG000|Overall Study|Physician Decision|2|||
127719588|NCT00747006|459600349|FG001|Overall Study|Physician Decision|0|||
127719589|NCT00747006|459600350|FG002|Overall Study|Physician Decision|1|||
127719590|NCT03689946|459600351|FG000|Overall Study|Withdrawal by Subject|3|||
127719591|NCT03689946|459600351|FG000|Overall Study|Lost to Follow-up|3|||
127888784|NCT01381900|460215829|FG001|Overall Study|Physician Decision|1|||
127719592|NCT03689946|459600351|FG000|Overall Study|Data corruption|2|||
127719593|NCT03499964|459600352|FG000|Overall Study|Lack of Efficacy|6|||
127719594|NCT03499964|459600353|FG001|Overall Study|Lack of Efficacy|26|||
127719595|NCT03499964|459600352|FG000|Overall Study|Adverse Event|1|||
127719596|NCT03499964|459600353|FG001|Overall Study|Adverse Event|0|||
127719597|NCT03499964|459600352|FG000|Overall Study|Death|1|||
127719598|NCT03499964|459600353|FG001|Overall Study|Death|0|||
127719599|NCT03499964|459600352|FG000|Overall Study|Withdrawal by Subject|2|||
127719600|NCT03499964|459600353|FG001|Overall Study|Withdrawal by Subject|1|||
127719601|NCT03499964|459600352|FG000|Overall Study|Lost to Follow-up|1|||
127719602|NCT03499964|459600353|FG001|Overall Study|Lost to Follow-up|0|||
127719603|NCT00853580|459600356|FG000|Overall Study|Lost to Follow-up|3|||
127719604|NCT00853580|459600357|FG001|Overall Study|Lost to Follow-up|5|||
127719605|NCT00853580|459600356|FG000|Overall Study|Protocol Violation|2|||
127719606|NCT00853580|459600357|FG001|Overall Study|Protocol Violation|1|||
127719607|NCT00853580|459600356|FG000|Overall Study|Withdrawal by Subject|2|||
127719608|NCT00853580|459600357|FG001|Overall Study|Withdrawal by Subject|8|||
127719609|NCT00853580|459600356|FG000|Overall Study|Commenced contraindicated therapy|0|||
127719610|NCT00853580|459600357|FG001|Overall Study|Commenced contraindicated therapy|2|||
127719611|NCT01700205|459600358|FG000|Overall Study|Withdrawal by Subject|13|||
127719612|NCT01700205|459600359|FG001|Overall Study|Withdrawal by Subject|13|||
127719613|NCT01700205|459600358|FG000|Overall Study|Protocol Violation|2|||
127719614|NCT01700205|459600359|FG001|Overall Study|Protocol Violation|2|||
127719615|NCT01728324|459600360|FG000|Termination of DBV|Adverse Event|14|||
127719616|NCT01728324|459600361|FG001|Termination of DBV|Adverse Event|13|||
127719617|NCT01728324|459600362|FG002|Termination of DBV|Adverse Event|4|||
127719618|NCT01728324|459600360|FG000|Termination of DBV|Lack of Efficacy|14|||
127719619|NCT01728324|459600361|FG001|Termination of DBV|Lack of Efficacy|12|||
127719620|NCT01728324|459600362|FG002|Termination of DBV|Lack of Efficacy|8|||
127719621|NCT01728324|459600360|FG000|Termination of DBV|Withdrawal by Subject|9|||
127719622|NCT01728324|459600361|FG001|Termination of DBV|Withdrawal by Subject|6|||
127719623|NCT01728324|459600362|FG002|Termination of DBV|Withdrawal by Subject|2|||
127719624|NCT01728324|459600360|FG000|Termination of DBV|Other than stated|1|||
127719625|NCT01728324|459600361|FG001|Termination of DBV|Other than stated|3|||
127719626|NCT01728324|459600362|FG002|Termination of DBV|Other than stated|0|||
127719627|NCT01728324|459600360|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
127719628|NCT01728324|459600361|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
127719629|NCT01728324|459600362|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
127719630|NCT01728324|459600360|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
127802743|NCT00236080|459901037|FG002|Overall Study|Adverse Event|3|||
127802744|NCT00236080|459901038|FG003|Overall Study|Adverse Event|1|||
127802745|NCT00236080|459901039|FG004|Overall Study|Adverse Event|0|||
127802746|NCT00236080|459901035|FG000|Overall Study|Lost to Follow-up|0|||
127802747|NCT00236080|459901036|FG001|Overall Study|Lost to Follow-up|1|||
127802748|NCT00236080|459901037|FG002|Overall Study|Lost to Follow-up|0|||
127802749|NCT00236080|459901038|FG003|Overall Study|Lost to Follow-up|0|||
127802750|NCT00236080|459901039|FG004|Overall Study|Lost to Follow-up|0|||
127802751|NCT00236080|459901035|FG000|Overall Study|Physician Decision|1|||
127802752|NCT00236080|459901036|FG001|Overall Study|Physician Decision|0|||
127802753|NCT00236080|459901037|FG002|Overall Study|Physician Decision|1|||
127802754|NCT00236080|459901038|FG003|Overall Study|Physician Decision|1|||
127802755|NCT00236080|459901039|FG004|Overall Study|Physician Decision|1|||
127802756|NCT00236080|459901035|FG000|Overall Study|Withdrawal by Subject|1|||
127802757|NCT00236080|459901036|FG001|Overall Study|Withdrawal by Subject|0|||
127802758|NCT00236080|459901037|FG002|Overall Study|Withdrawal by Subject|0|||
127802759|NCT00236080|459901038|FG003|Overall Study|Withdrawal by Subject|0|||
127802760|NCT00236080|459901039|FG004|Overall Study|Withdrawal by Subject|0|||
127802761|NCT00236080|459901035|FG000|Overall Study|Miscellaneous|0|||
127802762|NCT00236080|459901036|FG001|Overall Study|Miscellaneous|0|||
127802763|NCT00236080|459901037|FG002|Overall Study|Miscellaneous|1|||
127802764|NCT00236080|459901038|FG003|Overall Study|Miscellaneous|0|||
127802765|NCT00236080|459901039|FG004|Overall Study|Miscellaneous|0|||
127719631|NCT01728324|459600361|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
127719632|NCT01728324|459600362|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
127719633|NCT01728324|459600360|FG000|Termination of FDV|Adverse Event|14|||
127719634|NCT01728324|459600361|FG001|Termination of FDV|Adverse Event|13|||
127802766|NCT01961544|459901043|FG000|Overall Study|Protocol Violation|1|||
127802767|NCT01961544|459901043|FG000|Overall Study|Withdrawal by Subject|7|||
127888785|NCT01381900|460215830|FG002|Overall Study|Physician Decision|1|||
127888786|NCT01381900|460215828|FG000|Overall Study|Protocol Violation|0|||
127719635|NCT01728324|459600362|FG002|Termination of FDV|Adverse Event|4|||
127719636|NCT01728324|459600360|FG000|Termination of FDV|Lack of Efficacy|14|||
127719637|NCT01728324|459600361|FG001|Termination of FDV|Lack of Efficacy|12|||
127719638|NCT01728324|459600362|FG002|Termination of FDV|Lack of Efficacy|8|||
127719639|NCT01728324|459600360|FG000|Termination of FDV|Withdrawal by Subject|9|||
127719640|NCT01728324|459600361|FG001|Termination of FDV|Withdrawal by Subject|6|||
127719641|NCT01728324|459600362|FG002|Termination of FDV|Withdrawal by Subject|2|||
127802768|NCT01961544|459901043|FG000|Overall Study|Adverse Event|1|||
127802769|NCT01961544|459901043|FG000|Overall Study|Physician Decision|2|||
127802770|NCT01961544|459901043|FG000|Overall Study|Poor Tolerance|1|||
127719642|NCT01728324|459600360|FG000|Termination of FDV|Other than stated|1|||
127719643|NCT01728324|459600361|FG001|Termination of FDV|Other than stated|3|||
127719644|NCT01728324|459600362|FG002|Termination of FDV|Other than stated|0|||
127719645|NCT01728324|459600360|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
127719646|NCT01728324|459600361|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
127719647|NCT01728324|459600362|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
127719648|NCT01728324|459600360|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
127719649|NCT01728324|459600361|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
127719650|NCT01728324|459600362|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
127719651|NCT01728324|459600360|FG000|Termination of RBV|Adverse Event|15|||
127719652|NCT01728324|459600361|FG001|Termination of RBV|Adverse Event|16|||
127719653|NCT01728324|459600362|FG002|Termination of RBV|Adverse Event|5|||
127719654|NCT01728324|459600360|FG000|Termination of RBV|Lack of Efficacy|14|||
127719655|NCT01728324|459600361|FG001|Termination of RBV|Lack of Efficacy|11|||
127719656|NCT01728324|459600362|FG002|Termination of RBV|Lack of Efficacy|7|||
127719657|NCT01728324|459600360|FG000|Termination of RBV|Withdrawal by Subject|9|||
127719658|NCT01728324|459600361|FG001|Termination of RBV|Withdrawal by Subject|5|||
127719659|NCT01728324|459600362|FG002|Termination of RBV|Withdrawal by Subject|2|||
127719660|NCT01728324|459600360|FG000|Termination of RBV|Other than stated|1|||
127719661|NCT01728324|459600361|FG001|Termination of RBV|Other than stated|3|||
127719662|NCT01728324|459600362|FG002|Termination of RBV|Other than stated|1|||
127719663|NCT01728324|459600360|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
127719664|NCT01728324|459600361|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
127719665|NCT01728324|459600362|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
127719666|NCT01728324|459600360|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
127719667|NCT01728324|459600361|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
127719668|NCT01728324|459600362|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
127719669|NCT01170208|459600363|FG000|Overall Study|Withdrawal by Subject|5|||
127719670|NCT01170208|459600364|FG001|Overall Study|Withdrawal by Subject|0|||
127719671|NCT01170208|459600365|FG002|Overall Study|Withdrawal by Subject|1|||
127719672|NCT01170208|459600363|FG000|Overall Study|Protocol Violation|1|||
127719673|NCT01170208|459600364|FG001|Overall Study|Protocol Violation|0|||
127719674|NCT01170208|459600365|FG002|Overall Study|Protocol Violation|1|||
127719675|NCT03335488|459600370|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
127719676|NCT03335488|459600371|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
127719677|NCT03335488|459600370|FG000|Safety Extension Period|Adverse Event|1|||
127719678|NCT03335488|459600371|FG001|Safety Extension Period|Adverse Event|0|||
127719679|NCT03335488|459600370|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
127719680|NCT03335488|459600371|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
127719681|NCT00388726|459600372|FG000|Overall Study|Adverse Event|50|||
127719682|NCT00388726|459600373|FG001|Overall Study|Adverse Event|24|||
127719683|NCT00388726|459600372|FG000|Overall Study|Progressive Disease|336|||
127719684|NCT00388726|459600373|FG001|Overall Study|Progressive Disease|153|||
127719685|NCT00388726|459600372|FG000|Overall Study|Clinical Progression|61|||
127719686|NCT00388726|459600373|FG001|Overall Study|Clinical Progression|36|||
127719687|NCT00388726|459600372|FG000|Overall Study|Withdrawal by Subject|10|||
127719688|NCT00388726|459600373|FG001|Overall Study|Withdrawal by Subject|7|||
127719689|NCT00388726|459600372|FG000|Overall Study|Administrative|6|||
127719690|NCT00388726|459600373|FG001|Overall Study|Administrative|9|||
127719691|NCT00388726|459600372|FG000|Overall Study|Physician Decision|18|||
127719692|NCT00388726|459600373|FG001|Overall Study|Physician Decision|13|||
127719693|NCT00388726|459600372|FG000|Overall Study|Death|3|||
127719694|NCT00388726|459600373|FG001|Overall Study|Death|2|||
127719695|NCT04638816|459600374|FG000|Overall Study|Withdrawal by Subject|0|||
127719696|NCT04638816|459600375|FG001|Overall Study|Withdrawal by Subject|1|||
127719697|NCT04638816|459600374|FG000|Overall Study|Lost to Follow-up|0|||
127719698|NCT04638816|459600375|FG001|Overall Study|Lost to Follow-up|1|||
127719699|NCT02251652|459600376|FG000|Overall Study|Withdrawal by Subject|1|||
127719700|NCT01160354|459600379|FG000|Overall Study|Death|0|||
127719701|NCT01160354|459600380|FG001|Overall Study|Death|1|||
127719702|NCT01160354|459600381|FG002|Overall Study|Death|1|||
127719703|NCT01822756|459600382|FG000|Overall Study|Adverse Event|0|||
127719704|NCT01822756|459600383|FG001|Overall Study|Adverse Event|0|||
127719705|NCT01822756|459600384|FG002|Overall Study|Adverse Event|0|||
127719706|NCT01822756|459600385|FG003|Overall Study|Adverse Event|2|||
127719707|NCT01822756|459600386|FG004|Overall Study|Adverse Event|0|||
127719708|NCT01822756|459600382|FG000|Overall Study|Disease progression|11|||
127719709|NCT01822756|459600383|FG001|Overall Study|Disease progression|1|||
127719710|NCT01822756|459600384|FG002|Overall Study|Disease progression|7|||
127719711|NCT01822756|459600385|FG003|Overall Study|Disease progression|2|||
127719712|NCT01822756|459600386|FG004|Overall Study|Disease progression|6|||
127719713|NCT01822756|459600382|FG000|Overall Study|Death|2|||
127719714|NCT01822756|459600383|FG001|Overall Study|Death|2|||
127719715|NCT01822756|459600384|FG002|Overall Study|Death|1|||
127719716|NCT01822756|459600385|FG003|Overall Study|Death|0|||
127719717|NCT01822756|459600386|FG004|Overall Study|Death|0|||
127719718|NCT01822756|459600382|FG000|Overall Study|Lost to Follow-up|1|||
127719719|NCT01822756|459600383|FG001|Overall Study|Lost to Follow-up|0|||
127719720|NCT01822756|459600384|FG002|Overall Study|Lost to Follow-up|1|||
127719721|NCT01822756|459600385|FG003|Overall Study|Lost to Follow-up|0|||
127719722|NCT01822756|459600386|FG004|Overall Study|Lost to Follow-up|1|||
127719723|NCT01822756|459600382|FG000|Overall Study|Physician Decision|0|||
127719724|NCT01822756|459600383|FG001|Overall Study|Physician Decision|1|||
127719725|NCT01822756|459600384|FG002|Overall Study|Physician Decision|0|||
127719726|NCT01822756|459600385|FG003|Overall Study|Physician Decision|0|||
127719727|NCT01822756|459600386|FG004|Overall Study|Physician Decision|0|||
127719728|NCT01822756|459600382|FG000|Overall Study|disease progression & patient preference|2|||
127719729|NCT01822756|459600383|FG001|Overall Study|disease progression & patient preference|0|||
127719730|NCT01822756|459600384|FG002|Overall Study|disease progression & patient preference|1|||
127719731|NCT01822756|459600385|FG003|Overall Study|disease progression & patient preference|0|||
127719732|NCT01822756|459600386|FG004|Overall Study|disease progression & patient preference|0|||
127719733|NCT01328496|459600387|FG000|Overall Study|Significant Change in Health Status|1|||
127719734|NCT01328496|459600388|FG001|Overall Study|Significant Change in Health Status|0|||
127719735|NCT03102034|459600399|FG000|Overall Study|Withdrawal by Subject|1|||
127719736|NCT03102034|459600400|FG001|Overall Study|Withdrawal by Subject|0|||
127719737|NCT03611075|459600403|FG000|Overall Study|Physician Decision|0|||
127719738|NCT03611075|459600404|FG001|Overall Study|Physician Decision|1|||
127719739|NCT03611075|459600405|FG002|Overall Study|Physician Decision|1|||
127719740|NCT03611075|459600406|FG003|Overall Study|Physician Decision|0|||
127719741|NCT03611075|459600407|FG004|Overall Study|Physician Decision|0|||
127719742|NCT03611075|459600408|FG005|Overall Study|Physician Decision|0|||
127719743|NCT03611075|459600409|FG006|Overall Study|Physician Decision|0|||
127719744|NCT03611075|459600410|FG007|Overall Study|Physician Decision|0|||
127719745|NCT03611075|459600411|FG008|Overall Study|Physician Decision|0|||
127719746|NCT03611075|459600403|FG000|Overall Study|Lost to Follow-up|1|||
127719747|NCT03611075|459600404|FG001|Overall Study|Lost to Follow-up|0|||
127719748|NCT03611075|459600405|FG002|Overall Study|Lost to Follow-up|0|||
127719749|NCT03611075|459600406|FG003|Overall Study|Lost to Follow-up|2|||
127719750|NCT03611075|459600407|FG004|Overall Study|Lost to Follow-up|0|||
127719751|NCT03611075|459600408|FG005|Overall Study|Lost to Follow-up|0|||
127719752|NCT03611075|459600409|FG006|Overall Study|Lost to Follow-up|0|||
127719753|NCT03611075|459600410|FG007|Overall Study|Lost to Follow-up|0|||
127719754|NCT03611075|459600411|FG008|Overall Study|Lost to Follow-up|0|||
127719755|NCT03611075|459600403|FG000|Overall Study|Withdrawal by Subject|0|||
127719756|NCT03611075|459600404|FG001|Overall Study|Withdrawal by Subject|1|||
127719757|NCT03611075|459600405|FG002|Overall Study|Withdrawal by Subject|1|||
127719758|NCT03611075|459600406|FG003|Overall Study|Withdrawal by Subject|1|||
127719759|NCT03611075|459600407|FG004|Overall Study|Withdrawal by Subject|0|||
127719760|NCT03611075|459600408|FG005|Overall Study|Withdrawal by Subject|0|||
127719761|NCT03611075|459600409|FG006|Overall Study|Withdrawal by Subject|1|||
127719762|NCT03611075|459600410|FG007|Overall Study|Withdrawal by Subject|0|||
127719763|NCT03611075|459600411|FG008|Overall Study|Withdrawal by Subject|0|||
127719764|NCT03611075|459600403|FG000|Overall Study|Reason unknown|0|||
127719765|NCT03611075|459600404|FG001|Overall Study|Reason unknown|0|||
127719766|NCT03611075|459600405|FG002|Overall Study|Reason unknown|0|||
127719767|NCT03611075|459600406|FG003|Overall Study|Reason unknown|1|||
127719768|NCT03611075|459600407|FG004|Overall Study|Reason unknown|0|||
127719769|NCT03611075|459600408|FG005|Overall Study|Reason unknown|0|||
127719770|NCT03611075|459600409|FG006|Overall Study|Reason unknown|1|||
127802771|NCT01961544|459901043|FG000|Overall Study|Aggravation of Steral Pain|1|||
127802772|NCT03665285|459901044|FG000|Overall Study|Started New Anticancer Treatment|1|||
127802773|NCT03665285|459901045|FG001|Overall Study|Started New Anticancer Treatment|1|||
127802774|NCT03665285|459901046|FG002|Overall Study|Started New Anticancer Treatment|2|||
127719771|NCT03611075|459600410|FG007|Overall Study|Reason unknown|0|||
127719772|NCT03611075|459600411|FG008|Overall Study|Reason unknown|0|||
127719773|NCT00676091|459600412|FG000|Infant Series|Parent or legal guardian request|10|||
127719774|NCT00676091|459600413|FG001|Infant Series|Parent or legal guardian request|8|||
127719775|NCT00676091|459600412|FG000|Infant Series|Protocol Violation|6|||
127719776|NCT00676091|459600413|FG001|Infant Series|Protocol Violation|3|||
127719777|NCT00676091|459600412|FG000|Infant Series|Adverse Event|2|||
127719778|NCT00676091|459600413|FG001|Infant Series|Adverse Event|3|||
127719779|NCT00676091|459600412|FG000|Infant Series|Failed to return|1|||
127719780|NCT00676091|459600413|FG001|Infant Series|Failed to return|3|||
127719781|NCT00676091|459600412|FG000|Infant Series|Lost to Follow-up|1|||
127719782|NCT00676091|459600413|FG001|Infant Series|Lost to Follow-up|0|||
127719783|NCT00676091|459600412|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
127719784|NCT00676091|459600413|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
127719785|NCT00676091|459600412|FG000|After Infant Series|Adverse Event|0|||
127719786|NCT00676091|459600413|FG001|After Infant Series|Adverse Event|1|||
127802775|NCT03665285|459901047|FG003|Overall Study|Started New Anticancer Treatment|4|||
127719787|NCT00676091|459600412|FG000|After Infant Series|Protocol Violation|0|||
127719788|NCT00676091|459600413|FG001|After Infant Series|Protocol Violation|1|||
127719789|NCT00676091|459600412|FG000|After Infant Series|Failed to return|1|||
127719790|NCT00676091|459600413|FG001|After Infant Series|Failed to return|1|||
127719791|NCT00676091|459600412|FG000|Toddler Dose|Failed to return|2|||
127719792|NCT00676091|459600413|FG001|Toddler Dose|Failed to return|0|||
127719793|NCT00676091|459600412|FG000|Toddler Dose|Parent or legal guardian request|1|||
127719794|NCT00676091|459600413|FG001|Toddler Dose|Parent or legal guardian request|0|||
127719795|NCT01701401|459600417|FG000|Overall Study|Randomized But Not Treated|3|||
127719796|NCT01701401|459600418|FG001|Overall Study|Randomized But Not Treated|1|||
127719797|NCT01701401|459600419|FG002|Overall Study|Randomized But Not Treated|0|||
127719798|NCT01701401|459600420|FG003|Overall Study|Randomized But Not Treated|1|||
127719799|NCT01701401|459600417|FG000|Overall Study|Lost to Follow-up|5|||
127719800|NCT01701401|459600418|FG001|Overall Study|Lost to Follow-up|5|||
127719801|NCT01701401|459600419|FG002|Overall Study|Lost to Follow-up|1|||
127719802|NCT01701401|459600420|FG003|Overall Study|Lost to Follow-up|3|||
127719803|NCT01701401|459600417|FG000|Overall Study|Withdrew Consent|0|||
127719804|NCT01701401|459600418|FG001|Overall Study|Withdrew Consent|3|||
127719805|NCT01701401|459600419|FG002|Overall Study|Withdrew Consent|1|||
127719806|NCT01701401|459600420|FG003|Overall Study|Withdrew Consent|2|||
127719807|NCT01701401|459600417|FG000|Overall Study|Lack of Efficacy|1|||
127719808|NCT01701401|459600418|FG001|Overall Study|Lack of Efficacy|0|||
127719809|NCT01701401|459600419|FG002|Overall Study|Lack of Efficacy|2|||
127719810|NCT01701401|459600420|FG003|Overall Study|Lack of Efficacy|0|||
127719811|NCT01701401|459600417|FG000|Overall Study|Adverse Event|1|||
127719812|NCT01701401|459600418|FG001|Overall Study|Adverse Event|0|||
127719813|NCT01701401|459600419|FG002|Overall Study|Adverse Event|0|||
127719814|NCT01701401|459600420|FG003|Overall Study|Adverse Event|0|||
127719815|NCT01701401|459600417|FG000|Overall Study|Protocol Violation|0|||
127719816|NCT01701401|459600418|FG001|Overall Study|Protocol Violation|0|||
127719817|NCT01701401|459600419|FG002|Overall Study|Protocol Violation|1|||
127719818|NCT01701401|459600420|FG003|Overall Study|Protocol Violation|0|||
127719819|NCT00933270|459600421|FG000|Overall Study|Withdrawal by Subject|26|||
127719820|NCT00933270|459600421|FG000|Overall Study|Insufficient Follow-up|10|||
127719821|NCT00933270|459600421|FG000|Overall Study|Lost to Follow-up|14|||
127719822|NCT00933270|459600421|FG000|Overall Study|Adverse Event|1|||
127719823|NCT00933270|459600421|FG000|Overall Study|Missed Visit|2|||
127719824|NCT00933270|459600421|FG000|Overall Study|Death|24|||
127719825|NCT00933270|459600421|FG000|Overall Study|Moved or would not return|10|||
127719826|NCT00989196|459600422|FG000|Treatment Period|Lost to Follow-up|1|||
127719827|NCT00989196|459600423|FG001|Treatment Period|Lost to Follow-up|0|||
127719828|NCT01000805|459600424|FG000|Overall Study|Adverse Event|21|||
127719829|NCT01000805|459600425|FG001|Overall Study|Adverse Event|9|||
127719830|NCT01000805|459600424|FG000|Overall Study|Lack of Efficacy|5|||
127719831|NCT01000805|459600425|FG001|Overall Study|Lack of Efficacy|16|||
127719832|NCT01000805|459600424|FG000|Overall Study|Lost to Follow-up|16|||
127719833|NCT01000805|459600425|FG001|Overall Study|Lost to Follow-up|21|||
127719834|NCT01000805|459600424|FG000|Overall Study|Physician Decision|0|||
127719835|NCT01000805|459600425|FG001|Overall Study|Physician Decision|1|||
127802776|NCT03665285|459901048|FG004|Overall Study|Started New Anticancer Treatment|1|||
127802777|NCT03665285|459901049|FG005|Overall Study|Started New Anticancer Treatment|1|||
127802778|NCT03665285|459901050|FG006|Overall Study|Started New Anticancer Treatment|2|||
127802779|NCT03665285|459901051|FG007|Overall Study|Started New Anticancer Treatment|15|||
127802780|NCT03665285|459901052|FG008|Overall Study|Started New Anticancer Treatment|1|||
127802781|NCT03665285|459901044|FG000|Overall Study|Disease Progression|0|||
127802782|NCT03665285|459901045|FG001|Overall Study|Disease Progression|0|||
127888787|NCT01381900|460215829|FG001|Overall Study|Protocol Violation|1|||
127719836|NCT01000805|459600424|FG000|Overall Study|Protocol Violation|12|||
127719837|NCT01000805|459600425|FG001|Overall Study|Protocol Violation|8|||
127719838|NCT01000805|459600424|FG000|Overall Study|Withdrawal by Subject|16|||
127719839|NCT01000805|459600425|FG001|Overall Study|Withdrawal by Subject|6|||
127719840|NCT01000805|459600424|FG000|Overall Study|Sponsor Decision|0|||
127719841|NCT01000805|459600425|FG001|Overall Study|Sponsor Decision|1|||
127719842|NCT03476798|459600428|FG000|Overall Study|Death|1|||
127719843|NCT03476798|459600428|FG000|Overall Study|Withdrawal by Subject|2|||
127802783|NCT03665285|459901046|FG002|Overall Study|Disease Progression|3|||
127888788|NCT01381900|460215830|FG002|Overall Study|Protocol Violation|1|||
127719844|NCT03476798|459600428|FG000|Overall Study|Protocol Violation|2|||
127719845|NCT02409680|459600433|FG000|Overall Study|Lost to Follow-up|15|||
127719846|NCT02409680|459600434|FG001|Overall Study|Lost to Follow-up|30|||
127719847|NCT03343704|459600438|FG000|Overall Study|Refused to complete follow up|0|||
127719848|NCT03343704|459600439|FG001|Overall Study|Refused to complete follow up|1|||
127802784|NCT03665285|459901047|FG003|Overall Study|Disease Progression|1|||
127719849|NCT03343704|459600438|FG000|Overall Study|Death|0|||
127719850|NCT03343704|459600439|FG001|Overall Study|Death|1|||
127719851|NCT03343704|459600438|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
127719852|NCT03343704|459600439|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
127719853|NCT03789656|459600444|FG000|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
127719854|NCT03789656|459600445|FG001|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
127719855|NCT03789656|459600446|FG002|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
127719856|NCT03789656|459600447|FG003|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
127719857|NCT03789656|459600448|FG004|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
127719858|NCT03789656|459600444|FG000|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
127719859|NCT03789656|459600445|FG001|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
127719860|NCT03789656|459600446|FG002|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|1|||
127719861|NCT03789656|459600447|FG003|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
127719862|NCT03789656|459600448|FG004|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
127719863|NCT03789656|459600444|FG000|Treatment Period: up to 13 Weeks|Unable to Travel|1|||
127719864|NCT03789656|459600445|FG001|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
127719865|NCT03789656|459600446|FG002|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
127719866|NCT03789656|459600447|FG003|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
127719867|NCT03789656|459600448|FG004|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
127719868|NCT03789656|459600444|FG000|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|1|||
127719869|NCT03789656|459600445|FG001|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
127719870|NCT03789656|459600446|FG002|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
127719871|NCT03789656|459600447|FG003|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
127719872|NCT03789656|459600448|FG004|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
127719873|NCT02434328|459600456|FG000|Overall Study|Adverse Event|9|||
127719874|NCT02434328|459600457|FG001|Overall Study|Adverse Event|4|||
127719875|NCT02434328|459600456|FG000|Overall Study|Lack of Efficacy|0|||
127719876|NCT02434328|459600457|FG001|Overall Study|Lack of Efficacy|2|||
127719877|NCT02434328|459600456|FG000|Overall Study|Physician Decision|0|||
127719878|NCT02434328|459600457|FG001|Overall Study|Physician Decision|1|||
127719879|NCT02434328|459600456|FG000|Overall Study|Withdrawal by Subject|12|||
127719880|NCT02434328|459600457|FG001|Overall Study|Withdrawal by Subject|21|||
127719881|NCT02434328|459600456|FG000|Overall Study|Death|4|||
127719882|NCT02434328|459600457|FG001|Overall Study|Death|7|||
127719883|NCT02434328|459600456|FG000|Overall Study|Lost to Follow-up|1|||
127719884|NCT02434328|459600457|FG001|Overall Study|Lost to Follow-up|6|||
127719885|NCT02434328|459600456|FG000|Overall Study|Other|4|||
127719886|NCT02434328|459600457|FG001|Overall Study|Other|1|||
127719887|NCT05432986|459600460|FG000|Overall Study|Withdrawal by Subject|2|||
127719888|NCT05432986|459600460|FG000|Overall Study|incomplete measurement|7|||
127719889|NCT03009344|459601900|FG000|Overall Study|Lack of Efficacy|5|||
127719890|NCT03009344|459601900|FG000|Overall Study|Withdrawal by Subject|1|||
127719891|NCT03009344|459601900|FG000|Overall Study|Adverse Event|1|||
127719892|NCT00378898|459601901|FG000|Overall Study|Withdrawal by Subject|10|||
127719893|NCT00378898|459601902|FG001|Overall Study|Withdrawal by Subject|5|||
127719894|NCT00378898|459601901|FG000|Overall Study|Protocol Violation|1|||
127719895|NCT00378898|459601902|FG001|Overall Study|Protocol Violation|1|||
127719896|NCT02534233|459601905|FG000|Overall Study|2 participants with protocol deviations didn't complete|2|||
127719897|NCT03136159|459601906|FG000|Overall Study|chorioamnionitis|2|||
127719898|NCT03136159|459601907|FG001|Overall Study|chorioamnionitis|0|||
127719899|NCT03136159|459601906|FG000|Overall Study|vertical skin incision|1|||
127719900|NCT03136159|459601907|FG001|Overall Study|vertical skin incision|0|||
127719901|NCT03136159|459601906|FG000|Overall Study|additional dressing|1|||
127719902|NCT03136159|459601907|FG001|Overall Study|additional dressing|0|||
127719903|NCT03136159|459601906|FG000|Overall Study|never got dressing placed|1|||
127719904|NCT03136159|459601907|FG001|Overall Study|never got dressing placed|0|||
127719905|NCT03137459|459601908|FG000|2-month Assessment|Withdrawal by Subject|13|||
127719906|NCT03137459|459601909|FG001|2-month Assessment|Withdrawal by Subject|3|||
127719907|NCT03137459|459601908|FG000|2-month Assessment|Unable to reach|42|||
127802785|NCT03665285|459901048|FG004|Overall Study|Disease Progression|0|||
127719908|NCT03137459|459601909|FG001|2-month Assessment|Unable to reach|32|||
127719909|NCT03137459|459601908|FG000|2-month Assessment|Refused assessment|7|||
127719910|NCT03137459|459601909|FG001|2-month Assessment|Refused assessment|5|||
127719911|NCT03137459|459601908|FG000|2-month Assessment|Acutely ill|6|||
127719912|NCT03137459|459601909|FG001|2-month Assessment|Acutely ill|2|||
127802786|NCT03665285|459901049|FG005|Overall Study|Disease Progression|0|||
127802787|NCT03665285|459901050|FG006|Overall Study|Disease Progression|0|||
127802788|NCT03665285|459901051|FG007|Overall Study|Disease Progression|7|||
127719913|NCT03137459|459601908|FG000|4-month Assessment|Death|4|||
127719914|NCT03137459|459601909|FG001|4-month Assessment|Death|2|||
127719915|NCT03137459|459601908|FG000|4-month Assessment|Withdrawal by Subject|4|||
127802789|NCT03665285|459901052|FG008|Overall Study|Disease Progression|1|||
127802790|NCT03665285|459901044|FG000|Overall Study|Hospice|0|||
127719916|NCT03137459|459601909|FG001|4-month Assessment|Withdrawal by Subject|2|||
127719917|NCT03137459|459601908|FG000|4-month Assessment|Unable to reach|44|||
127719918|NCT03137459|459601909|FG001|4-month Assessment|Unable to reach|29|||
127719919|NCT03137459|459601908|FG000|4-month Assessment|Refused assessment|24|||
127719920|NCT03137459|459601909|FG001|4-month Assessment|Refused assessment|10|||
127719921|NCT03137459|459601908|FG000|4-month Assessment|Acutely ill|2|||
127719922|NCT03137459|459601909|FG001|4-month Assessment|Acutely ill|3|||
127719923|NCT03137459|459601908|FG000|6-months|Lost to Follow-up|14|||
127719924|NCT03137459|459601909|FG001|6-months|Lost to Follow-up|11|||
127719925|NCT03137459|459601908|FG000|6-months|Death|0|||
127719926|NCT03137459|459601909|FG001|6-months|Death|2|||
127719927|NCT03137459|459601908|FG000|6-months|Refused assessment|6|||
127719928|NCT03137459|459601909|FG001|6-months|Refused assessment|3|||
127719929|NCT03137459|459601908|FG000|6-months|Acutely ill|1|||
127719930|NCT03137459|459601909|FG001|6-months|Acutely ill|1|||
127719931|NCT01732757|459601910|FG000|Overall Study|Lost to Follow-up|1|||
127719932|NCT01732757|459601911|FG001|Overall Study|Lost to Follow-up|0|||
127719933|NCT01732757|459601912|FG002|Overall Study|Lost to Follow-up|0|||
127719934|NCT00925548|459601913|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
127719935|NCT00925548|459601914|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
127719936|NCT04921358|459601915|FG000|Overall Study|Withdrawal by Subject|6|||
127719937|NCT04921358|459601916|FG001|Overall Study|Withdrawal by Subject|13|||
127719938|NCT04921358|459601915|FG000|Overall Study|Lost to Follow-up|3|||
127719939|NCT04921358|459601916|FG001|Overall Study|Lost to Follow-up|6|||
127719940|NCT04921358|459601915|FG000|Overall Study|Study Terminated by Sponsor|86|||
127719941|NCT04921358|459601916|FG001|Overall Study|Study Terminated by Sponsor|89|||
127719942|NCT04921358|459601915|FG000|Overall Study|Death|92|||
127719943|NCT04921358|459601916|FG001|Overall Study|Death|82|||
127719944|NCT04926857|459601917|FG000|Overall Study|Withdrawal by Subject|40|||
127719945|NCT04926857|459601917|FG000|Overall Study|Death|9|||
127719946|NCT04926857|459601917|FG000|Overall Study|Study product no longer in use|44|||
127719947|NCT04926857|459601917|FG000|Overall Study|Inadequate data to address primary objective|16|||
127719948|NCT02637063|459601922|FG000|Overall Study|Lost to Follow-up|3|||
127719949|NCT02637063|459601923|FG001|Overall Study|Lost to Follow-up|2|||
127719950|NCT02637063|459601924|FG002|Overall Study|Lost to Follow-up|3|||
127719951|NCT02637063|459601922|FG000|Overall Study|Withdrawal by Subject|2|||
127719952|NCT02637063|459601923|FG001|Overall Study|Withdrawal by Subject|2|||
127719953|NCT02637063|459601924|FG002|Overall Study|Withdrawal by Subject|3|||
127719954|NCT03116464|459601925|FG000|Overall Study|Insufficient enrollment for intervention development|4|||
127719955|NCT00491400|459601926|FG000|Overall Study|Withdrawal by Subject|5|||
127719956|NCT00491400|459601927|FG001|Overall Study|Withdrawal by Subject|4|||
127719957|NCT00597376|459601928|FG000|Overall Study|Withdrawal by Subject|4|||
127719958|NCT00597376|459601929|FG001|Overall Study|Withdrawal by Subject|3|||
127719959|NCT00597376|459601928|FG000|Overall Study|Adverse Event|4|||
127719960|NCT00597376|459601929|FG001|Overall Study|Adverse Event|1|||
127719961|NCT00562094|459601932|FG000|Overall Study|Lost to Follow-up|62|||
127719962|NCT01555138|459601935|FG000|Overall Study|Death|0|||
127719963|NCT01555138|459601936|FG001|Overall Study|Death|1|||
127719964|NCT01555138|459601935|FG000|Overall Study|Lost to Follow-up|1|||
127719965|NCT01555138|459601936|FG001|Overall Study|Lost to Follow-up|0|||
127719966|NCT01555138|459601935|FG000|Overall Study|Abnormal Lab reults|1|||
127719967|NCT01555138|459601936|FG001|Overall Study|Abnormal Lab reults|3|||
127719968|NCT01555138|459601935|FG000|Overall Study|Lack of Efficacy|2|||
127719969|NCT01555138|459601936|FG001|Overall Study|Lack of Efficacy|2|||
127719970|NCT01555138|459601935|FG000|Overall Study|Protocol Violation|5|||
127719971|NCT01555138|459601936|FG001|Overall Study|Protocol Violation|3|||
127719972|NCT01555138|459601935|FG000|Overall Study|Administrative problems|8|||
127719973|NCT01555138|459601936|FG001|Overall Study|Administrative problems|0|||
127719974|NCT01555138|459601935|FG000|Overall Study|Withdrawal by Subject|16|||
127719975|NCT01555138|459601936|FG001|Overall Study|Withdrawal by Subject|15|||
127719976|NCT01555138|459601935|FG000|Overall Study|Adverse Event|14|||
127719977|NCT01555138|459601936|FG001|Overall Study|Adverse Event|14|||
127719978|NCT04693637|459601939|FG000|Overall Study|Death|4|||
127719979|NCT04693637|459601939|FG000|Overall Study|Withdrawal by Subject|3|||
127719980|NCT04693637|459601939|FG000|Overall Study|Physician Decision|2|||
127719981|NCT04693637|459601939|FG000|Overall Study|Lost to Follow-up|1|||
127888789|NCT01381900|460215828|FG000|Overall Study|Withdrawal by Subject|0|||
127719982|NCT04237792|459601940|FG000|Treatment (Day 1)|Adverse Event|1|||
127719983|NCT04237792|459601941|FG001|Treatment (Day 1)|Adverse Event|0|||
127719984|NCT04237792|459601942|FG002|Treatment (Day 1)|Adverse Event|0|||
127719985|NCT04237792|459601943|FG003|Treatment (Day 1)|Adverse Event|0|||
127719986|NCT04237792|459601944|FG004|Treatment (Day 1)|Adverse Event|1|||
127719987|NCT04237792|459601945|FG005|Treatment (Day 1)|Adverse Event|1|||
127719988|NCT04237792|459601940|FG000|Treatment (Day 1)|Other|0|||
127719989|NCT04237792|459601941|FG001|Treatment (Day 1)|Other|0|||
127719990|NCT04237792|459601942|FG002|Treatment (Day 1)|Other|1|||
127719991|NCT04237792|459601943|FG003|Treatment (Day 1)|Other|0|||
127719992|NCT04237792|459601944|FG004|Treatment (Day 1)|Other|0|||
127719993|NCT04237792|459601945|FG005|Treatment (Day 1)|Other|1|||
127719994|NCT04237792|459601940|FG000|Treatment (Day 1)|Not treated|1|||
127888790|NCT01381900|460215829|FG001|Overall Study|Withdrawal by Subject|0|||
127719995|NCT04237792|459601941|FG001|Treatment (Day 1)|Not treated|1|||
127719996|NCT04237792|459601942|FG002|Treatment (Day 1)|Not treated|2|||
127719997|NCT04237792|459601943|FG003|Treatment (Day 1)|Not treated|1|||
127719998|NCT04237792|459601944|FG004|Treatment (Day 1)|Not treated|0|||
127719999|NCT04237792|459601945|FG005|Treatment (Day 1)|Not treated|1|||
127720000|NCT03739866|459601968|FG000|Overall Study|Lost to Follow-up|0|||
127720001|NCT03739866|459601969|FG001|Overall Study|Lost to Follow-up|0|||
127720002|NCT03739866|459601970|FG002|Overall Study|Lost to Follow-up|0|||
127720003|NCT03739866|459601971|FG003|Overall Study|Lost to Follow-up|1|||
127720004|NCT03739866|459601972|FG004|Overall Study|Lost to Follow-up|0|||
127720005|NCT03739866|459601973|FG005|Overall Study|Lost to Follow-up|0|||
127720006|NCT03739866|459601974|FG006|Overall Study|Lost to Follow-up|0|||
127720007|NCT03739866|459601975|FG007|Overall Study|Lost to Follow-up|0|||
127720008|NCT03739866|459601968|FG000|Overall Study|Enrolled but not treated|0|||
127720009|NCT03739866|459601969|FG001|Overall Study|Enrolled but not treated|0|||
127720010|NCT03739866|459601970|FG002|Overall Study|Enrolled but not treated|1|||
127720011|NCT03739866|459601971|FG003|Overall Study|Enrolled but not treated|0|||
127720012|NCT03739866|459601972|FG004|Overall Study|Enrolled but not treated|1|||
127720013|NCT03739866|459601973|FG005|Overall Study|Enrolled but not treated|0|||
127720014|NCT03739866|459601974|FG006|Overall Study|Enrolled but not treated|0|||
127720015|NCT03739866|459601975|FG007|Overall Study|Enrolled but not treated|0|||
127720016|NCT03057600|459601978|FG000|Overall Study|Adverse Event|0|||
127720017|NCT03057600|459601979|FG001|Overall Study|Adverse Event|0|||
127720018|NCT03057600|459601980|FG002|Overall Study|Adverse Event|4|||
127720019|NCT03057600|459601981|FG003|Overall Study|Adverse Event|0|||
127720020|NCT03057600|459601978|FG000|Overall Study|Radiologic Disease Progression|8|||
127720021|NCT03057600|459601979|FG001|Overall Study|Radiologic Disease Progression|7|||
127720022|NCT03057600|459601980|FG002|Overall Study|Radiologic Disease Progression|13|||
127720023|NCT03057600|459601981|FG003|Overall Study|Radiologic Disease Progression|10|||
127720024|NCT03057600|459601978|FG000|Overall Study|Symptomatic Deterioration|0|||
127720025|NCT03057600|459601979|FG001|Overall Study|Symptomatic Deterioration|1|||
127720026|NCT03057600|459601980|FG002|Overall Study|Symptomatic Deterioration|1|||
127720027|NCT03057600|459601981|FG003|Overall Study|Symptomatic Deterioration|0|||
127720028|NCT03057600|459601978|FG000|Overall Study|Investigator Decision|0|||
127720029|NCT03057600|459601979|FG001|Overall Study|Investigator Decision|0|||
127720030|NCT03057600|459601980|FG002|Overall Study|Investigator Decision|1|||
127720031|NCT03057600|459601981|FG003|Overall Study|Investigator Decision|0|||
127720032|NCT03057600|459601978|FG000|Overall Study|Study Termination by Sponsor|0|||
127720033|NCT03057600|459601979|FG001|Overall Study|Study Termination by Sponsor|0|||
127720034|NCT03057600|459601980|FG002|Overall Study|Study Termination by Sponsor|0|||
127720035|NCT03057600|459601981|FG003|Overall Study|Study Termination by Sponsor|2|||
127720036|NCT03057600|459601978|FG000|Overall Study|Withdrawal by Subject|0|||
127720037|NCT03057600|459601979|FG001|Overall Study|Withdrawal by Subject|1|||
127720038|NCT03057600|459601980|FG002|Overall Study|Withdrawal by Subject|0|||
127720039|NCT03057600|459601981|FG003|Overall Study|Withdrawal by Subject|0|||
127720040|NCT03057600|459601978|FG000|Overall Study|Other, Not Specified|1|||
127720041|NCT03057600|459601979|FG001|Overall Study|Other, Not Specified|1|||
127720042|NCT03057600|459601980|FG002|Overall Study|Other, Not Specified|1|||
127720043|NCT03057600|459601981|FG003|Overall Study|Other, Not Specified|1|||
127720044|NCT01968967|459601984|FG000|Treatment Period|Other|22|||
127720045|NCT01968967|459601985|FG001|Treatment Period|Other|22|||
127720046|NCT01968967|459601986|FG002|Treatment Period|Other|0|||
127720047|NCT01968967|459601987|FG003|Treatment Period|Other|0|||
127720048|NCT01968967|459601988|FG004|Treatment Period|Other|0|||
127720049|NCT01968967|459601984|FG000|Treatment Period|Withdrawal by Subject|71|||
127720050|NCT01968967|459601985|FG001|Treatment Period|Withdrawal by Subject|61|||
127720051|NCT01968967|459601986|FG002|Treatment Period|Withdrawal by Subject|0|||
127888791|NCT01381900|460215830|FG002|Overall Study|Withdrawal by Subject|1|||
127720052|NCT01968967|459601987|FG003|Treatment Period|Withdrawal by Subject|0|||
127720053|NCT01968967|459601988|FG004|Treatment Period|Withdrawal by Subject|0|||
127720054|NCT01968967|459601984|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
127720055|NCT01968967|459601985|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
127720056|NCT01968967|459601986|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
127720057|NCT01968967|459601987|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
127720058|NCT01968967|459601988|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
127720059|NCT01968967|459601984|FG000|Treatment Period|Lost to Follow-up|26|||
127720060|NCT01968967|459601985|FG001|Treatment Period|Lost to Follow-up|31|||
127720061|NCT01968967|459601986|FG002|Treatment Period|Lost to Follow-up|0|||
127720062|NCT01968967|459601987|FG003|Treatment Period|Lost to Follow-up|0|||
127720063|NCT01968967|459601988|FG004|Treatment Period|Lost to Follow-up|0|||
127720064|NCT01968967|459601984|FG000|Treatment Period|Protocol Violation|1|||
127720065|NCT01968967|459601985|FG001|Treatment Period|Protocol Violation|2|||
127888792|NCT01381900|460215828|FG000|Overall Study|Early withdraw|3|||
127888793|NCT01381900|460215829|FG001|Overall Study|Early withdraw|1|||
127720066|NCT01968967|459601986|FG002|Treatment Period|Protocol Violation|0|||
127720067|NCT01968967|459601987|FG003|Treatment Period|Protocol Violation|0|||
127720068|NCT01968967|459601988|FG004|Treatment Period|Protocol Violation|0|||
127720069|NCT01968967|459601984|FG000|Treatment Period|Adverse Event|9|||
127720070|NCT01968967|459601985|FG001|Treatment Period|Adverse Event|8|||
127720071|NCT01968967|459601986|FG002|Treatment Period|Adverse Event|0|||
127720072|NCT01968967|459601987|FG003|Treatment Period|Adverse Event|0|||
127720073|NCT01968967|459601988|FG004|Treatment Period|Adverse Event|0|||
127720074|NCT01968967|459601984|FG000|Treatment Period|Death|9|||
127720075|NCT01968967|459601985|FG001|Treatment Period|Death|2|||
127720076|NCT01968967|459601986|FG002|Treatment Period|Death|0|||
127720077|NCT01968967|459601987|FG003|Treatment Period|Death|0|||
127720078|NCT01968967|459601988|FG004|Treatment Period|Death|0|||
127720079|NCT01968967|459601984|FG000|Treatment Period|Randomized Not Treated|6|||
127720080|NCT01968967|459601985|FG001|Treatment Period|Randomized Not Treated|5|||
127720081|NCT01968967|459601986|FG002|Treatment Period|Randomized Not Treated|0|||
127720082|NCT01968967|459601987|FG003|Treatment Period|Randomized Not Treated|0|||
127720083|NCT01968967|459601988|FG004|Treatment Period|Randomized Not Treated|0|||
127720084|NCT01968967|459601984|FG000|Extension Period|Withdrew Consent|0|||
127720085|NCT01968967|459601985|FG001|Extension Period|Withdrew Consent|0|||
127720086|NCT01968967|459601986|FG002|Extension Period|Withdrew Consent|2|||
127720087|NCT01968967|459601987|FG003|Extension Period|Withdrew Consent|0|||
127720088|NCT01968967|459601988|FG004|Extension Period|Withdrew Consent|5|||
127720089|NCT03489369|459601989|FG000|Overall Study|Documented Progressive Disease|3|||
127720090|NCT03489369|459601990|FG001|Overall Study|Documented Progressive Disease|2|||
127720091|NCT03489369|459601991|FG002|Overall Study|Documented Progressive Disease|3|||
127720092|NCT03489369|459601992|FG003|Overall Study|Documented Progressive Disease|6|||
127720093|NCT03489369|459601989|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
127720094|NCT03489369|459601990|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
127720095|NCT03489369|459601991|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
127720096|NCT03489369|459601992|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
127720097|NCT02022670|459601993|FG000|Overall Study|Adverse Event|1|||
127720098|NCT02022670|459601994|FG001|Overall Study|Adverse Event|0|||
127720099|NCT02022670|459601995|FG002|Overall Study|Adverse Event|1|||
127720100|NCT02113449|459601996|FG000|Overall Study|Adverse Event|4|||
127720101|NCT00109031|459601999|FG000|Overall Study|Adverse Event|0|||
127720102|NCT00109031|459602000|FG001|Overall Study|Adverse Event|0|||
127720103|NCT00109031|459602001|FG002|Overall Study|Adverse Event|1|||
127720104|NCT00109031|459602002|FG003|Overall Study|Adverse Event|0|||
127720105|NCT00109031|459601999|FG000|Overall Study|Withdrawal by Subject|0|||
127720106|NCT00109031|459602000|FG001|Overall Study|Withdrawal by Subject|1|||
127720107|NCT00109031|459602001|FG002|Overall Study|Withdrawal by Subject|0|||
127720108|NCT00109031|459602002|FG003|Overall Study|Withdrawal by Subject|0|||
127720109|NCT00109031|459601999|FG000|Overall Study|Physician Decision|0|||
127720110|NCT00109031|459602000|FG001|Overall Study|Physician Decision|1|||
127720111|NCT00109031|459602001|FG002|Overall Study|Physician Decision|0|||
127720112|NCT00109031|459602002|FG003|Overall Study|Physician Decision|0|||
127720113|NCT00109031|459601999|FG000|Overall Study|Protocol Violation|0|||
127720114|NCT00109031|459602000|FG001|Overall Study|Protocol Violation|0|||
127720115|NCT00109031|459602001|FG002|Overall Study|Protocol Violation|1|||
127720116|NCT00109031|459602002|FG003|Overall Study|Protocol Violation|0|||
127720117|NCT02309294|459602003|FG000|Overall Study|Withdrawal by Subject|2|||
127720118|NCT03520036|459602004|FG000|Overall Study|Adverse Event|1|||
127720119|NCT03520036|459602005|FG001|Overall Study|Adverse Event|2|||
127720120|NCT03520036|459602006|FG002|Overall Study|Adverse Event|0|||
127720121|NCT03520036|459602004|FG000|Overall Study|Protocol Violation|1|||
127720122|NCT03520036|459602005|FG001|Overall Study|Protocol Violation|0|||
127720123|NCT03520036|459602006|FG002|Overall Study|Protocol Violation|0|||
127720124|NCT03520036|459602004|FG000|Overall Study|Withdrawal by Subject|0|||
127720125|NCT03520036|459602005|FG001|Overall Study|Withdrawal by Subject|1|||
127720126|NCT03520036|459602006|FG002|Overall Study|Withdrawal by Subject|4|||
127720127|NCT03520036|459602004|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
127720128|NCT03520036|459602005|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
127720129|NCT03520036|459602006|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
127720130|NCT02542943|459602014|FG000|Overall Study|Lost to Follow-up|1|||
127802791|NCT03665285|459901045|FG001|Overall Study|Hospice|0|||
127802792|NCT03665285|459901046|FG002|Overall Study|Hospice|0|||
127802793|NCT03665285|459901047|FG003|Overall Study|Hospice|0|||
127802794|NCT03665285|459901048|FG004|Overall Study|Hospice|0|||
127802795|NCT03665285|459901049|FG005|Overall Study|Hospice|0|||
127802796|NCT03665285|459901050|FG006|Overall Study|Hospice|0|||
127802797|NCT03665285|459901051|FG007|Overall Study|Hospice|2|||
127802798|NCT03665285|459901052|FG008|Overall Study|Hospice|0|||
127720131|NCT02542943|459602015|FG001|Overall Study|Lost to Follow-up|0|||
127720132|NCT02542943|459602016|FG002|Overall Study|Lost to Follow-up|0|||
127720133|NCT02542943|459602014|FG000|Overall Study|Withdrawal by Subject|0|||
127720134|NCT02542943|459602015|FG001|Overall Study|Withdrawal by Subject|1|||
127720135|NCT02542943|459602016|FG002|Overall Study|Withdrawal by Subject|0|||
127802799|NCT03665285|459901044|FG000|Overall Study|Withdrawal by Subject|0|||
127802800|NCT03665285|459901045|FG001|Overall Study|Withdrawal by Subject|0|||
127720136|NCT05824559|459602018|FG000|Overall Study|Adverse Event|2|||
127720137|NCT05824559|459602018|FG000|Overall Study|Physician Decision|2|||
127720138|NCT05824559|459602018|FG000|Overall Study|Progressive Disease|16|||
127720139|NCT05824559|459602018|FG000|Overall Study|Study Terminated by Sponsor|1|||
127720140|NCT05824559|459602018|FG000|Overall Study|Withdrawal by Subject|2|||
127720141|NCT05865392|459602024|FG000|Overall Study|Withdrawal by Subject|4|||
127720142|NCT05865392|459602025|FG001|Overall Study|Withdrawal by Subject|0|||
127720143|NCT05865392|459602024|FG000|Overall Study|Didn't meet inclusion criteria|4|||
127720144|NCT05865392|459602025|FG001|Overall Study|Didn't meet inclusion criteria|0|||
127720145|NCT05366751|459602026|FG000|Overall Study|Adverse Event|25|||
127720146|NCT05366751|459602026|FG000|Overall Study|Physician Decision|3|||
127720147|NCT05366751|459602026|FG000|Overall Study|Lost to Follow-up|2|||
127720148|NCT05366751|459602026|FG000|Overall Study|Withdrawal by Subject|14|||
127720149|NCT05366751|459602026|FG000|Overall Study|Study Terminated by Sponsor|50|||
127720150|NCT05366751|459602026|FG000|Overall Study|Site Terminated by Sponsor|3|||
127720151|NCT00302211|459602036|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
127720152|NCT00302211|459602037|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
127720153|NCT00302211|459602038|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
127720154|NCT00302211|459602039|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
127720155|NCT00302211|459602040|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
127720156|NCT00302211|459602036|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
127720157|NCT00302211|459602037|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
127720158|NCT00302211|459602038|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
127720159|NCT00302211|459602039|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
127720160|NCT00302211|459602040|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
127720161|NCT00302211|459602036|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
127720162|NCT00302211|459602037|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
127720163|NCT00302211|459602038|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
127720164|NCT00302211|459602039|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
127720165|NCT00302211|459602040|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
127720166|NCT00302211|459602036|FG000|Double Blind Period (New Patients)|Disease progression|0|||
127720167|NCT00302211|459602037|FG001|Double Blind Period (New Patients)|Disease progression|1|||
127720168|NCT00302211|459602038|FG002|Double Blind Period (New Patients)|Disease progression|1|||
127720169|NCT00302211|459602039|FG003|Double Blind Period (New Patients)|Disease progression|0|||
127720170|NCT00302211|459602040|FG004|Double Blind Period (New Patients)|Disease progression|0|||
127720171|NCT00302211|459602036|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
127720172|NCT00302211|459602037|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
127720173|NCT00302211|459602038|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
127720174|NCT00302211|459602039|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
127720175|NCT00302211|459602040|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
127720176|NCT00302211|459602036|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
127720177|NCT00302211|459602037|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
127720178|NCT00302211|459602038|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
127720179|NCT00302211|459602039|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
127720180|NCT00302211|459602040|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
127720181|NCT00302211|459602036|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
127720182|NCT00302211|459602037|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
127720183|NCT00302211|459602038|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
127720184|NCT00302211|459602039|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
127720185|NCT00302211|459602040|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
127720186|NCT00302211|459602036|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
127720187|NCT00302211|459602037|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
127720188|NCT00302211|459602038|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
127888794|NCT01381900|460215830|FG002|Overall Study|Early withdraw|1|||
127720189|NCT00302211|459602039|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
127720190|NCT00302211|459602040|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
127720191|NCT00302211|459602036|FG000|Open Label-Patients From Double-Blind|Death|0|||
127720192|NCT00302211|459602037|FG001|Open Label-Patients From Double-Blind|Death|0|||
127720193|NCT00302211|459602038|FG002|Open Label-Patients From Double-Blind|Death|0|||
127720194|NCT00302211|459602039|FG003|Open Label-Patients From Double-Blind|Death|1|||
127720195|NCT00302211|459602040|FG004|Open Label-Patients From Double-Blind|Death|1|||
127720196|NCT00302211|459602036|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
127720197|NCT00302211|459602037|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
127720198|NCT00302211|459602038|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
127720199|NCT00302211|459602039|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
127720200|NCT00302211|459602040|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
127720201|NCT00302211|459602036|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
127720202|NCT00302211|459602037|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
127720203|NCT00302211|459602038|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
127720204|NCT00302211|459602039|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
127720205|NCT00302211|459602040|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
127720206|NCT00302211|459602036|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
127720207|NCT00302211|459602037|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
127720208|NCT00302211|459602038|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
127720209|NCT00302211|459602039|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
127720210|NCT00302211|459602040|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
127720211|NCT02294461|459602041|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
127720212|NCT02294461|459602042|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
127720213|NCT02294461|459602043|FG002|Double-blind Period (up to 29.4 Months)|Death|0|||
127720214|NCT02294461|459602041|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
127720215|NCT02294461|459602042|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
127720216|NCT02294461|459602043|FG002|Double-blind Period (up to 29.4 Months)|Miscellaneous|0|||
127720217|NCT02294461|459602041|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
127720218|NCT02294461|459602042|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
127720219|NCT02294461|459602043|FG002|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|0|||
127720220|NCT02294461|459602041|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
127720221|NCT02294461|459602042|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
127720222|NCT02294461|459602043|FG002|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
127720223|NCT02294461|459602041|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
127720224|NCT02294461|459602042|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
127720225|NCT02294461|459602043|FG002|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
127720226|NCT02294461|459602041|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
127720227|NCT02294461|459602042|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
127720228|NCT02294461|459602043|FG002|Double-blind Period (up to 29.4 Months)|Progressive Disease|0|||
127720229|NCT02294461|459602041|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
127720230|NCT02294461|459602042|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
127720231|NCT02294461|459602043|FG002|Double-blind Period (up to 29.4 Months)|Adverse Event|0|||
127720232|NCT02294461|459602041|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|28|||
127720233|NCT02294461|459602042|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|0|||
127720234|NCT02294461|459602043|FG002|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
127720235|NCT02294461|459602041|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|19|||
127720236|NCT02294461|459602042|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|0|||
127720237|NCT02294461|459602043|FG002|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|10|||
127720238|NCT02294461|459602041|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
127720239|NCT02294461|459602042|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
127720240|NCT02294461|459602043|FG002|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
127720241|NCT02294461|459602041|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|4|||
127720242|NCT02294461|459602042|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|0|||
127720243|NCT02294461|459602043|FG002|Open-label Period (up to 54.3 Months)|Lost to Follow-up|2|||
127720244|NCT02294461|459602041|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|20|||
127720245|NCT02294461|459602042|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|0|||
127720246|NCT02294461|459602043|FG002|Open-label Period (up to 54.3 Months)|Progressive Disease|12|||
127720247|NCT02294461|459602041|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
127720248|NCT02294461|459602042|FG001|Open-label Period (up to 54.3 Months)|Death|0|||
127720249|NCT02294461|459602043|FG002|Open-label Period (up to 54.3 Months)|Death|5|||
127720250|NCT02294461|459602041|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
127720251|NCT02294461|459602042|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|0|||
127720252|NCT02294461|459602043|FG002|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
127720253|NCT00745875|459603433|FG000|Overall Study|Continuing study treatment|4|||
127720254|NCT00745875|459603434|FG001|Overall Study|Continuing study treatment|4|||
127720255|NCT01532648|459603435|FG000|Overall Study|Lost to Follow-up|3|||
127720256|NCT01532648|459603436|FG001|Overall Study|Lost to Follow-up|4|||
127720257|NCT01532648|459603435|FG000|Overall Study|Lack of Efficacy|4|||
127720258|NCT01532648|459603436|FG001|Overall Study|Lack of Efficacy|1|||
127720259|NCT01532648|459603435|FG000|Overall Study|Protocol Violation|1|||
127720260|NCT01532648|459603436|FG001|Overall Study|Protocol Violation|1|||
127720261|NCT01532648|459603435|FG000|Overall Study|Adverse Event|12|||
127720262|NCT01532648|459603436|FG001|Overall Study|Adverse Event|9|||
127720263|NCT01532648|459603435|FG000|Overall Study|Withdrawal by Subject|16|||
127720264|NCT01532648|459603436|FG001|Overall Study|Withdrawal by Subject|2|||
127720265|NCT04652869|459603439|FG000|Overall Study|Withdrawal by Subject|0|||
127720266|NCT04652869|459603440|FG001|Overall Study|Withdrawal by Subject|2|||
127720267|NCT04652869|459603441|FG002|Overall Study|Withdrawal by Subject|0|||
127720268|NCT01833455|459603442|FG000|Overall Study|Withdrawal by Subject|1|||
127720269|NCT01833455|459603443|FG001|Overall Study|Withdrawal by Subject|0|||
127720270|NCT00887224|459603444|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
127720271|NCT00887224|459603445|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
127720272|NCT00887224|459603446|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
127720273|NCT00887224|459603444|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
127720274|NCT00887224|459603445|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
127720275|NCT00887224|459603446|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
127720276|NCT00887224|459603444|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
127720277|NCT00887224|459603445|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
127720278|NCT00887224|459603446|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
127720279|NCT00887224|459603444|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
127720280|NCT00887224|459603445|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
127720281|NCT00887224|459603446|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
127720282|NCT00887224|459603444|FG000|Open-label Response (OLR) Phase|Other|1|||
127720283|NCT00887224|459603445|FG001|Open-label Response (OLR) Phase|Other|0|||
127720284|NCT00887224|459603446|FG002|Open-label Response (OLR) Phase|Other|0|||
127720285|NCT00887224|459603444|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
127720286|NCT00887224|459603445|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
127720287|NCT00887224|459603446|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
127720288|NCT00887224|459603444|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
127720289|NCT00887224|459603445|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
127720290|NCT00887224|459603446|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
127720291|NCT00887224|459603444|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
127720292|NCT00887224|459603445|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
127720293|NCT00887224|459603446|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
127720294|NCT00887224|459603444|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
127720295|NCT00887224|459603445|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
127720296|NCT00887224|459603446|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
127720297|NCT00887224|459603444|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
127720298|NCT00887224|459603445|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
127720299|NCT00887224|459603446|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
127720300|NCT00887224|459603444|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
127720301|NCT00887224|459603445|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
127720302|NCT00887224|459603446|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
127720303|NCT00887224|459603444|FG000|Open-label Stability (OLS) Phase|Other|1|||
127720304|NCT00887224|459603445|FG001|Open-label Stability (OLS) Phase|Other|0|||
127720305|NCT00887224|459603446|FG002|Open-label Stability (OLS) Phase|Other|0|||
127720306|NCT00887224|459603444|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
127720307|NCT00887224|459603445|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
127720308|NCT00887224|459603446|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
127720309|NCT00887224|459603444|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
127720310|NCT00887224|459603445|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
127802801|NCT03665285|459901046|FG002|Overall Study|Withdrawal by Subject|0|||
127802802|NCT03665285|459901047|FG003|Overall Study|Withdrawal by Subject|0|||
127802803|NCT03665285|459901048|FG004|Overall Study|Withdrawal by Subject|1|||
127802804|NCT03665285|459901049|FG005|Overall Study|Withdrawal by Subject|0|||
127720311|NCT00887224|459603446|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
127720312|NCT00887224|459603444|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
127720313|NCT00887224|459603445|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
127720314|NCT00887224|459603446|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
127720315|NCT00887224|459603444|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
127720316|NCT00887224|459603445|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
127802805|NCT03665285|459901050|FG006|Overall Study|Withdrawal by Subject|0|||
127802806|NCT03665285|459901051|FG007|Overall Study|Withdrawal by Subject|2|||
127802807|NCT03665285|459901052|FG008|Overall Study|Withdrawal by Subject|0|||
127802808|NCT03665285|459901044|FG000|Overall Study|Physician Decision|0|||
127888795|NCT02041494|460215831|FG000|Overall Study|Death|1|||
127720317|NCT00887224|459603446|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
127720318|NCT00887224|459603444|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
127720319|NCT00887224|459603445|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
127720320|NCT00887224|459603446|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
127720321|NCT00887224|459603444|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
127720322|NCT00887224|459603445|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
127720323|NCT00887224|459603446|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
127720324|NCT00887224|459603444|FG000|OL Taper Phase / OL Follow Up|Other|30|||
127720325|NCT00887224|459603445|FG001|OL Taper Phase / OL Follow Up|Other|0|||
127720326|NCT00887224|459603446|FG002|OL Taper Phase / OL Follow Up|Other|0|||
127720327|NCT00887224|459603444|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
127720328|NCT00887224|459603445|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
127720329|NCT00887224|459603446|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
127720330|NCT00887224|459603444|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
127720331|NCT00887224|459603445|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
127720332|NCT00887224|459603446|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
127720333|NCT00887224|459603444|FG000|Double-blind (DB) Phase|Adverse Event|0|||
127720334|NCT00887224|459603445|FG001|Double-blind (DB) Phase|Adverse Event|7|||
127720335|NCT00887224|459603446|FG002|Double-blind (DB) Phase|Adverse Event|2|||
127720336|NCT00887224|459603444|FG000|Double-blind (DB) Phase|Failed to return|0|||
127720337|NCT00887224|459603445|FG001|Double-blind (DB) Phase|Failed to return|2|||
127720338|NCT00887224|459603446|FG002|Double-blind (DB) Phase|Failed to return|2|||
127720339|NCT00887224|459603444|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
127720340|NCT00887224|459603445|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
127720341|NCT00887224|459603446|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
127720342|NCT00887224|459603444|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
127720343|NCT00887224|459603445|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
127720344|NCT00887224|459603446|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
127720345|NCT00887224|459603444|FG000|Double-blind (DB) Phase|Other|0|||
127720346|NCT00887224|459603445|FG001|Double-blind (DB) Phase|Other|2|||
127720347|NCT00887224|459603446|FG002|Double-blind (DB) Phase|Other|0|||
127720348|NCT00887224|459603444|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
127720349|NCT00887224|459603445|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
127720350|NCT00887224|459603446|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
127720351|NCT00887224|459603444|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
127720352|NCT00887224|459603445|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
127720353|NCT00887224|459603446|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
127720354|NCT00887224|459603444|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
127720355|NCT00887224|459603445|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
127720356|NCT00887224|459603446|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
127720357|NCT00887224|459603444|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
127720358|NCT00887224|459603445|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
127720359|NCT00887224|459603446|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
127720360|NCT00887224|459603444|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
127720361|NCT00887224|459603445|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
127720362|NCT00887224|459603446|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
127720363|NCT00887224|459603444|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
127720364|NCT00887224|459603445|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
127720365|NCT00887224|459603446|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
127720366|NCT00887224|459603444|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
127720367|NCT00887224|459603445|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
127720368|NCT00887224|459603446|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
127720369|NCT00887224|459603444|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
127720370|NCT00887224|459603445|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
127720371|NCT00887224|459603446|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
127720372|NCT00887224|459603444|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
127720373|NCT00887224|459603445|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
127720374|NCT00887224|459603446|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
127720375|NCT03883828|459603447|FG000|Overall Study|Did not start radiotherapy|1|||
127720376|NCT03883828|459603448|FG001|Overall Study|Did not start radiotherapy|2|||
127720377|NCT01256359|459603451|FG000|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
127720378|NCT01256359|459603452|FG001|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
127720379|NCT01256359|459603451|FG000|Overall Study|Randomised and found to be too unwell to start treatment|2|||
127720380|NCT01256359|459603452|FG001|Overall Study|Randomised and found to be too unwell to start treatment|0|||
127720381|NCT02000752|459603453|FG000|Overall Study|Dystocic delivery|19|||
127720382|NCT02000752|459603454|FG001|Overall Study|Dystocic delivery|8|||
127720383|NCT02000752|459603453|FG000|Overall Study|Shift Changes|12|||
127720384|NCT02000752|459603454|FG001|Overall Study|Shift Changes|5|||
127720385|NCT04938453|459603458|FG000|Washout Period 1|Adverse Event|1|||
127720386|NCT04938453|459603459|FG001|Washout Period 1|Adverse Event|0|||
127720387|NCT04938453|459603458|FG000|Washout Period 1|Physician Decision|0|||
127720388|NCT04938453|459603459|FG001|Washout Period 1|Physician Decision|1|||
127720389|NCT04658784|459603464|FG000|6-month Follow-up|Lost to Follow-up|2|||
127720390|NCT04658784|459603465|FG001|6-month Follow-up|Lost to Follow-up|5|||
127720391|NCT02827201|459603467|FG000|Overall Study|Death|1|||
127720392|NCT02827201|459603468|FG001|Overall Study|Death|2|||
127720393|NCT02827201|459603467|FG000|Overall Study|Patients not treated|1|||
127720394|NCT02827201|459603468|FG001|Overall Study|Patients not treated|1|||
127720395|NCT02095145|459603469|FG000|Overall Study|Withdrawal by Subject|1|||
127720396|NCT02095145|459603470|FG001|Overall Study|Withdrawal by Subject|0|||
127720397|NCT00670488|459603472|FG000|Overall Study|Adverse Event|0|||
127720398|NCT00670488|459603473|FG001|Overall Study|Adverse Event|7|||
127720399|NCT00670488|459603474|FG002|Overall Study|Adverse Event|0|||
127720400|NCT00670488|459603475|FG003|Overall Study|Adverse Event|3|||
127720401|NCT00670488|459603476|FG004|Overall Study|Adverse Event|1|||
127720402|NCT00670488|459603477|FG005|Overall Study|Adverse Event|1|||
127720403|NCT00670488|459603478|FG006|Overall Study|Adverse Event|5|||
127720404|NCT00670488|459603479|FG007|Overall Study|Adverse Event|1|||
127720405|NCT00670488|459603480|FG008|Overall Study|Adverse Event|0|||
127720406|NCT00670488|459603481|FG009|Overall Study|Adverse Event|1|||
127720407|NCT00670488|459603472|FG000|Overall Study|Physician Decision|1|||
127720408|NCT00670488|459603473|FG001|Overall Study|Physician Decision|9|||
127720409|NCT00670488|459603474|FG002|Overall Study|Physician Decision|0|||
127720410|NCT00670488|459603475|FG003|Overall Study|Physician Decision|1|||
127720411|NCT00670488|459603476|FG004|Overall Study|Physician Decision|0|||
127720412|NCT00670488|459603477|FG005|Overall Study|Physician Decision|0|||
127720413|NCT00670488|459603478|FG006|Overall Study|Physician Decision|0|||
127720414|NCT00670488|459603479|FG007|Overall Study|Physician Decision|0|||
127720415|NCT00670488|459603480|FG008|Overall Study|Physician Decision|0|||
127720416|NCT00670488|459603481|FG009|Overall Study|Physician Decision|0|||
127720417|NCT00670488|459603472|FG000|Overall Study|Progressive Disease|2|||
127720418|NCT00670488|459603473|FG001|Overall Study|Progressive Disease|41|||
127720419|NCT00670488|459603474|FG002|Overall Study|Progressive Disease|3|||
127720420|NCT00670488|459603475|FG003|Overall Study|Progressive Disease|2|||
127720421|NCT00670488|459603476|FG004|Overall Study|Progressive Disease|2|||
127720422|NCT00670488|459603477|FG005|Overall Study|Progressive Disease|4|||
127720423|NCT00670488|459603478|FG006|Overall Study|Progressive Disease|11|||
127720424|NCT00670488|459603479|FG007|Overall Study|Progressive Disease|2|||
127720425|NCT00670488|459603480|FG008|Overall Study|Progressive Disease|2|||
127720426|NCT00670488|459603481|FG009|Overall Study|Progressive Disease|1|||
127720427|NCT00670488|459603472|FG000|Overall Study|Withdrawal by Subject|0|||
127720428|NCT00670488|459603473|FG001|Overall Study|Withdrawal by Subject|1|||
127720429|NCT00670488|459603474|FG002|Overall Study|Withdrawal by Subject|0|||
127720430|NCT00670488|459603475|FG003|Overall Study|Withdrawal by Subject|1|||
127720431|NCT00670488|459603476|FG004|Overall Study|Withdrawal by Subject|0|||
127720432|NCT00670488|459603477|FG005|Overall Study|Withdrawal by Subject|0|||
127720433|NCT00670488|459603478|FG006|Overall Study|Withdrawal by Subject|1|||
127720434|NCT00670488|459603479|FG007|Overall Study|Withdrawal by Subject|0|||
127720435|NCT00670488|459603480|FG008|Overall Study|Withdrawal by Subject|1|||
127720436|NCT00670488|459603481|FG009|Overall Study|Withdrawal by Subject|0|||
127720437|NCT03205566|459603488|FG000|Phase 1|Protocol Violation|1|||
127720438|NCT03205566|459603489|FG001|Phase 1|Protocol Violation|1|||
127720439|NCT01034306|459603490|FG000|Overall Study|Adverse Event|1|||
127720440|NCT01034306|459603491|FG001|Overall Study|Adverse Event|0|||
127720441|NCT01034306|459603490|FG000|Overall Study|Lost to Follow-up|0|||
127720442|NCT01034306|459603491|FG001|Overall Study|Lost to Follow-up|1|||
127720443|NCT01034306|459603490|FG000|Overall Study|Withdrawal by Subject|2|||
127720444|NCT01034306|459603491|FG001|Overall Study|Withdrawal by Subject|2|||
127720445|NCT01034306|459603490|FG000|Overall Study|hospitalized and decided to stop|1|||
127720446|NCT01034306|459603491|FG001|Overall Study|hospitalized and decided to stop|0|||
127720447|NCT01034306|459603490|FG000|Overall Study|Noncomplience|1|||
127720448|NCT01034306|459603491|FG001|Overall Study|Noncomplience|0|||
127720449|NCT00836498|459603492|FG000|Overall Study|Adverse Event|1|||
127720450|NCT00836498|459603493|FG001|Overall Study|Adverse Event|0|||
127720451|NCT00836498|459603492|FG000|Overall Study|Lost to Follow-up|1|||
127720452|NCT00836498|459603493|FG001|Overall Study|Lost to Follow-up|0|||
127720453|NCT00836498|459603492|FG000|Overall Study|Withdrawal by Subject|2|||
127720454|NCT00836498|459603493|FG001|Overall Study|Withdrawal by Subject|1|||
127720455|NCT01619059|459603494|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
127720456|NCT01619059|459603495|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
127720457|NCT01619059|459603494|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
127720458|NCT01619059|459603495|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
127720459|NCT01619059|459603494|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
127720460|NCT01619059|459603495|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
127720461|NCT01619059|459603494|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
127720462|NCT01619059|459603495|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
127720463|NCT01619059|459603494|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
127720464|NCT01619059|459603495|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
127720465|NCT01619059|459603494|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
127720466|NCT01619059|459603495|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
127720467|NCT01619059|459603494|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
127720468|NCT01619059|459603495|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
127720469|NCT01619059|459603494|FG000|Long-Term (LT) Treatment Period|Death|1|||
127720470|NCT01619059|459603495|FG001|Long-Term (LT) Treatment Period|Death|0|||
127720471|NCT01619059|459603494|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
127720472|NCT01619059|459603495|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
127720473|NCT01619059|459603494|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
127720474|NCT01619059|459603495|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
127720475|NCT03418545|459603496|FG000|Overall Study|Withdrawal by Participant|2|||
127720476|NCT03418545|459603497|FG001|Overall Study|Withdrawal by Participant|4|||
127720477|NCT03418545|459603496|FG000|Overall Study|Lost to Follow-up|3|||
127720478|NCT03418545|459603497|FG001|Overall Study|Lost to Follow-up|5|||
127720479|NCT03418545|459603496|FG000|Overall Study|Reason Not Specified|0|||
127720480|NCT03418545|459603497|FG001|Overall Study|Reason Not Specified|1|||
127720481|NCT03418545|459603496|FG000|Overall Study|Missing Completion Status|0|||
127720482|NCT03418545|459603497|FG001|Overall Study|Missing Completion Status|1|||
127720483|NCT02384382|459603505|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
127720484|NCT02384382|459603505|FG000|Overall Study|Death|1|||
127720485|NCT02384382|459603505|FG000|Overall Study|Adverse Event|1|||
127720486|NCT02384382|459603505|FG000|Overall Study|Disease progression|16|||
127720487|NCT03567616|459603516|FG000|Overall Study|Disease progression|4|||
127720488|NCT03567616|459603516|FG000|Overall Study|Withdrawal by Subject|1|||
127720489|NCT03567616|459603516|FG000|Overall Study|Physician Decision|1|||
127720490|NCT03567616|459603516|FG000|Overall Study|Death|1|||
127720491|NCT03567616|459603516|FG000|Overall Study|Adverse Event|1|||
127720492|NCT01074242|459603517|FG000|Overall Study|Case report before date of contract|40|||
127720493|NCT01074242|459603517|FG000|Overall Study|Lost to Follow-up|1|||
127720494|NCT01074242|459603517|FG000|Overall Study|Case report unclear|6|||
127720495|NCT01074242|459603517|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
127720496|NCT01074242|459603517|FG000|Overall Study|Duplicate Case Report Form|5|||
127720497|NCT01957163|459603523|FG000|Overall Study|Adverse Event|5|||
127720498|NCT01957163|459603524|FG001|Overall Study|Adverse Event|2|||
127720499|NCT01957163|459603525|FG002|Overall Study|Adverse Event|4|||
127720500|NCT01957163|459603523|FG000|Overall Study|Lack of Efficacy|5|||
127720501|NCT01957163|459603524|FG001|Overall Study|Lack of Efficacy|4|||
127720502|NCT01957163|459603525|FG002|Overall Study|Lack of Efficacy|9|||
127720503|NCT01957163|459603523|FG000|Overall Study|Protocol Violation|1|||
127720504|NCT01957163|459603524|FG001|Overall Study|Protocol Violation|2|||
127720505|NCT01957163|459603525|FG002|Overall Study|Protocol Violation|0|||
127720506|NCT01957163|459603523|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
127720507|NCT01957163|459603524|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
127720508|NCT01957163|459603525|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
127720509|NCT01957163|459603523|FG000|Overall Study|Lost to Follow-up|0|||
127720510|NCT01957163|459603524|FG001|Overall Study|Lost to Follow-up|1|||
127720511|NCT01957163|459603525|FG002|Overall Study|Lost to Follow-up|0|||
127720512|NCT01957163|459603523|FG000|Overall Study|Withdrawal by Subject|4|||
127720513|NCT01957163|459603524|FG001|Overall Study|Withdrawal by Subject|2|||
127720514|NCT01957163|459603525|FG002|Overall Study|Withdrawal by Subject|4|||
127720515|NCT03697603|459603537|FG000|Overall Study|Adverse Event|3|||
127720516|NCT03697603|459603538|FG001|Overall Study|Adverse Event|18|||
127720517|NCT03697603|459603539|FG002|Overall Study|Adverse Event|3|||
127720518|NCT03697603|459603537|FG000|Overall Study|Physician Decision|1|||
127720519|NCT03697603|459603538|FG001|Overall Study|Physician Decision|0|||
127720520|NCT03697603|459603539|FG002|Overall Study|Physician Decision|2|||
127720521|NCT03697603|459603537|FG000|Overall Study|Protocol Violation|3|||
127720522|NCT03697603|459603538|FG001|Overall Study|Protocol Violation|8|||
127720523|NCT03697603|459603539|FG002|Overall Study|Protocol Violation|5|||
127720524|NCT03697603|459603537|FG000|Overall Study|Withdrawal by Subject|5|||
127720525|NCT03697603|459603538|FG001|Overall Study|Withdrawal by Subject|1|||
127720526|NCT03697603|459603539|FG002|Overall Study|Withdrawal by Subject|1|||
127720527|NCT03697603|459603537|FG000|Overall Study|Protocol Violation|0|||
127720528|NCT03697603|459603538|FG001|Overall Study|Protocol Violation|0|||
127720529|NCT03697603|459603539|FG002|Overall Study|Protocol Violation|1|||
127720530|NCT02686658|459603540|FG000|Overall Study|Adverse Event|0|||
127720531|NCT02686658|459603541|FG001|Overall Study|Adverse Event|0|||
127720532|NCT02686658|459603542|FG002|Overall Study|Adverse Event|1|||
127720533|NCT02686658|459603543|FG003|Overall Study|Adverse Event|1|||
127802809|NCT03665285|459901045|FG001|Overall Study|Physician Decision|0|||
127720534|NCT02686658|459603544|FG004|Overall Study|Adverse Event|2|||
127720535|NCT02686658|459603545|FG005|Overall Study|Adverse Event|1|||
127720536|NCT02686658|459603540|FG000|Overall Study|Investigator decision|0|||
127720537|NCT02686658|459603541|FG001|Overall Study|Investigator decision|0|||
127720538|NCT02686658|459603542|FG002|Overall Study|Investigator decision|0|||
127720539|NCT02686658|459603543|FG003|Overall Study|Investigator decision|1|||
127720540|NCT02686658|459603544|FG004|Overall Study|Investigator decision|2|||
127720541|NCT02686658|459603545|FG005|Overall Study|Investigator decision|1|||
127720542|NCT02686658|459603540|FG000|Overall Study|Sponsor decision|1|||
127720543|NCT02686658|459603541|FG001|Overall Study|Sponsor decision|2|||
127720544|NCT02686658|459603542|FG002|Overall Study|Sponsor decision|1|||
127720545|NCT02686658|459603543|FG003|Overall Study|Sponsor decision|5|||
127720546|NCT02686658|459603544|FG004|Overall Study|Sponsor decision|13|||
127720547|NCT02686658|459603545|FG005|Overall Study|Sponsor decision|2|||
127720548|NCT02686658|459603540|FG000|Overall Study|Lost to Follow-up|0|||
127720549|NCT02686658|459603541|FG001|Overall Study|Lost to Follow-up|0|||
127720550|NCT02686658|459603542|FG002|Overall Study|Lost to Follow-up|2|||
127720551|NCT02686658|459603543|FG003|Overall Study|Lost to Follow-up|0|||
127720552|NCT02686658|459603544|FG004|Overall Study|Lost to Follow-up|0|||
127720553|NCT02686658|459603545|FG005|Overall Study|Lost to Follow-up|1|||
127720554|NCT02686658|459603540|FG000|Overall Study|Death|1|||
127720555|NCT02686658|459603541|FG001|Overall Study|Death|0|||
127720556|NCT02686658|459603542|FG002|Overall Study|Death|0|||
127720557|NCT02686658|459603543|FG003|Overall Study|Death|1|||
127720558|NCT02686658|459603544|FG004|Overall Study|Death|1|||
127720559|NCT02686658|459603545|FG005|Overall Study|Death|1|||
127720560|NCT02686658|459603540|FG000|Overall Study|Withdrawal by Subject|2|||
127720561|NCT02686658|459603541|FG001|Overall Study|Withdrawal by Subject|5|||
127720562|NCT02686658|459603542|FG002|Overall Study|Withdrawal by Subject|4|||
127720563|NCT02686658|459603543|FG003|Overall Study|Withdrawal by Subject|4|||
127720564|NCT02686658|459603544|FG004|Overall Study|Withdrawal by Subject|17|||
127720565|NCT02686658|459603545|FG005|Overall Study|Withdrawal by Subject|8|||
127720566|NCT02686658|459603540|FG000|Overall Study|Placed in hospice care|0|||
127720567|NCT02686658|459603541|FG001|Overall Study|Placed in hospice care|0|||
127720568|NCT02686658|459603542|FG002|Overall Study|Placed in hospice care|1|||
127720569|NCT02686658|459603543|FG003|Overall Study|Placed in hospice care|0|||
127720570|NCT02686658|459603544|FG004|Overall Study|Placed in hospice care|0|||
127720571|NCT02686658|459603545|FG005|Overall Study|Placed in hospice care|0|||
127720572|NCT02686658|459603540|FG000|Overall Study|Participant non-compliance|0|||
127720573|NCT02686658|459603541|FG001|Overall Study|Participant non-compliance|0|||
127720574|NCT02686658|459603542|FG002|Overall Study|Participant non-compliance|0|||
127720575|NCT02686658|459603543|FG003|Overall Study|Participant non-compliance|0|||
127720576|NCT02686658|459603544|FG004|Overall Study|Participant non-compliance|0|||
127720577|NCT02686658|459603545|FG005|Overall Study|Participant non-compliance|1|||
127720578|NCT02686658|459603540|FG000|Overall Study|Concern over coronavirus disease care|0|||
127720579|NCT02686658|459603541|FG001|Overall Study|Concern over coronavirus disease care|0|||
127720580|NCT02686658|459603542|FG002|Overall Study|Concern over coronavirus disease care|0|||
127720581|NCT02686658|459603543|FG003|Overall Study|Concern over coronavirus disease care|0|||
127720582|NCT02686658|459603544|FG004|Overall Study|Concern over coronavirus disease care|2|||
127720583|NCT02686658|459603545|FG005|Overall Study|Concern over coronavirus disease care|1|||
127720584|NCT00467272|459603548|FG000|Overall Study|Pneumonia|2|||
127720585|NCT00467272|459603548|FG000|Overall Study|Thrombophlebitis|1|||
127720586|NCT00570505|459603549|FG000|Overall Study|Adverse Event|7|||
127720587|NCT00570505|459603549|FG000|Overall Study|Withdrawal by Subject|7|||
127720588|NCT00570505|459603549|FG000|Overall Study|Lost to Follow-up|23|||
127720589|NCT00570505|459603549|FG000|Overall Study|Other loss to follow-up|4|||
127802810|NCT03665285|459901046|FG002|Overall Study|Physician Decision|0|||
127802811|NCT03665285|459901047|FG003|Overall Study|Physician Decision|0|||
127802812|NCT03665285|459901048|FG004|Overall Study|Physician Decision|0|||
127720590|NCT00614614|459603552|FG000|Primary Vaccination Phase|Adverse Event|6|||
127720591|NCT00614614|459603553|FG001|Primary Vaccination Phase|Adverse Event|0|||
127720592|NCT00614614|459603554|FG002|Primary Vaccination Phase|Adverse Event|0|||
127720593|NCT00614614|459603555|FG003|Primary Vaccination Phase|Adverse Event|0|||
127720594|NCT00614614|459603556|FG004|Primary Vaccination Phase|Adverse Event|0|||
127720595|NCT00614614|459603552|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
127720596|NCT00614614|459603553|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
127720597|NCT00614614|459603554|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
127720598|NCT00614614|459603555|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
127720599|NCT00614614|459603556|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
127720600|NCT00614614|459603552|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
127802813|NCT03665285|459901049|FG005|Overall Study|Physician Decision|0|||
127802814|NCT03665285|459901050|FG006|Overall Study|Physician Decision|0|||
127802815|NCT03665285|459901051|FG007|Overall Study|Physician Decision|2|||
127802816|NCT03665285|459901052|FG008|Overall Study|Physician Decision|0|||
127802817|NCT00354601|459901053|FG000|Overall Study|Protocol Violation|1|||
127802818|NCT00354601|459901053|FG000|Overall Study|progression|1|||
127802819|NCT03603652|459901054|FG000|Overall Study|Death|2|||
127802820|NCT03213366|459901059|FG000|Overall Study|Lost to Follow-up|9|||
127802821|NCT03213366|459901060|FG001|Overall Study|Lost to Follow-up|4|||
127802822|NCT02532855|459901061|FG000|Overall Study|Lost to Follow-up|4|||
127802823|NCT02532855|459901062|FG001|Overall Study|Lost to Follow-up|3|||
127802824|NCT02532855|459901061|FG000|Overall Study|Withdrawal by Subject|4|||
127802825|NCT02532855|459901062|FG001|Overall Study|Withdrawal by Subject|8|||
127802826|NCT01727258|459901063|FG000|Overall Study|Adverse Event|0|||
127802827|NCT01727258|459901064|FG001|Overall Study|Adverse Event|2|||
127802828|NCT01727258|459901065|FG002|Overall Study|Adverse Event|0|||
127802829|NCT01727258|459901063|FG000|Overall Study|Noncompliance with Study Drug|0|||
127802830|NCT01727258|459901064|FG001|Overall Study|Noncompliance with Study Drug|0|||
127802831|NCT01727258|459901065|FG002|Overall Study|Noncompliance with Study Drug|1|||
127802832|NCT01727258|459901063|FG000|Overall Study|Withdrawal by Subject|1|||
127802833|NCT01727258|459901064|FG001|Overall Study|Withdrawal by Subject|1|||
127802834|NCT01727258|459901065|FG002|Overall Study|Withdrawal by Subject|0|||
127802835|NCT01727258|459901063|FG000|Overall Study|Lost to Follow-up|1|||
127802836|NCT01727258|459901064|FG001|Overall Study|Lost to Follow-up|0|||
127802837|NCT01727258|459901065|FG002|Overall Study|Lost to Follow-up|0|||
127802838|NCT01960855|459901066|FG000|Overall Study|Subject noncompliant|1|||
127802839|NCT01960855|459901067|FG001|Overall Study|Subject noncompliant|0|||
127802840|NCT01960855|459901068|FG002|Overall Study|Subject noncompliant|0|||
127802841|NCT01960855|459901069|FG003|Overall Study|Subject noncompliant|0|||
127720601|NCT00614614|459603553|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
127720602|NCT00614614|459603554|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
127720603|NCT00614614|459603555|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
127720604|NCT00614614|459603556|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
127720605|NCT00614614|459603552|FG000|Primary Vaccination Phase|Protocol Violation|9|||
127720606|NCT00614614|459603553|FG001|Primary Vaccination Phase|Protocol Violation|3|||
127720607|NCT00614614|459603554|FG002|Primary Vaccination Phase|Protocol Violation|0|||
127720608|NCT00614614|459603555|FG003|Primary Vaccination Phase|Protocol Violation|0|||
127720609|NCT00614614|459603556|FG004|Primary Vaccination Phase|Protocol Violation|0|||
127720610|NCT00614614|459603552|FG000|Primary Vaccination Phase|Other|4|||
127720611|NCT00614614|459603553|FG001|Primary Vaccination Phase|Other|0|||
127720612|NCT00614614|459603554|FG002|Primary Vaccination Phase|Other|0|||
127720613|NCT00614614|459603555|FG003|Primary Vaccination Phase|Other|0|||
127720614|NCT00614614|459603556|FG004|Primary Vaccination Phase|Other|0|||
127720615|NCT00614614|459603552|FG000|Booster Vaccination Phase|Adverse Event|0|||
127720616|NCT00614614|459603553|FG001|Booster Vaccination Phase|Adverse Event|0|||
127720617|NCT00614614|459603554|FG002|Booster Vaccination Phase|Adverse Event|1|||
127720618|NCT00614614|459603555|FG003|Booster Vaccination Phase|Adverse Event|1|||
127720619|NCT00614614|459603556|FG004|Booster Vaccination Phase|Adverse Event|0|||
127720620|NCT00614614|459603552|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
127720621|NCT00614614|459603553|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
127720622|NCT00614614|459603554|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
127720623|NCT00614614|459603555|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
127720624|NCT00614614|459603556|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
127720625|NCT00614614|459603552|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
127720626|NCT00614614|459603553|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
127720627|NCT00614614|459603554|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
127720628|NCT00614614|459603555|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
127720629|NCT00614614|459603556|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
127720630|NCT00614614|459603552|FG000|Booster Vaccination Phase|Protocol Violation|0|||
127720631|NCT00614614|459603553|FG001|Booster Vaccination Phase|Protocol Violation|0|||
127802842|NCT01960855|459901070|FG004|Overall Study|Subject noncompliant|0|||
127720632|NCT00614614|459603554|FG002|Booster Vaccination Phase|Protocol Violation|2|||
127720633|NCT00614614|459603555|FG003|Booster Vaccination Phase|Protocol Violation|3|||
127720634|NCT00614614|459603556|FG004|Booster Vaccination Phase|Protocol Violation|0|||
127802843|NCT01960855|459901066|FG000|Overall Study|Adverse Event|2|||
127802844|NCT01960855|459901067|FG001|Overall Study|Adverse Event|0|||
127802845|NCT01960855|459901068|FG002|Overall Study|Adverse Event|6|||
127720635|NCT00614614|459603552|FG000|Booster Vaccination Phase|Other|0|||
127720636|NCT00614614|459603553|FG001|Booster Vaccination Phase|Other|1|||
127720637|NCT00614614|459603554|FG002|Booster Vaccination Phase|Other|3|||
127720638|NCT00614614|459603555|FG003|Booster Vaccination Phase|Other|2|||
127720639|NCT00614614|459603556|FG004|Booster Vaccination Phase|Other|1|||
127720640|NCT05426109|459603557|FG000|Overall Study|Withdrawal by Subject|0|||
127720641|NCT05426109|459603558|FG001|Overall Study|Withdrawal by Subject|1|||
127720642|NCT05212285|459603559|FG000|Overall Study|Lack of Efficacy|12|||
127720643|NCT05212285|459603560|FG001|Overall Study|Lack of Efficacy|8|||
127720644|NCT05212285|459603559|FG000|Overall Study|Withdrawal by Subject|8|||
127720645|NCT05212285|459603560|FG001|Overall Study|Withdrawal by Subject|1|||
127720646|NCT05212285|459603559|FG000|Overall Study|Lost to Follow-up|13|||
127720647|NCT05212285|459603560|FG001|Overall Study|Lost to Follow-up|1|||
127720648|NCT05212285|459603559|FG000|Overall Study|miss data|21|||
127720649|NCT05212285|459603560|FG001|Overall Study|miss data|2|||
127720650|NCT02222493|459603561|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
127720651|NCT02222493|459603562|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
127720652|NCT02222493|459603561|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
127720653|NCT02222493|459603562|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
127720654|NCT02222493|459603561|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
127720655|NCT02222493|459603562|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
127720656|NCT02222493|459603561|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
127720657|NCT02222493|459603562|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
127720658|NCT02222493|459603561|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
127720659|NCT02222493|459603562|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
127720660|NCT02222493|459603561|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
127720661|NCT02222493|459603562|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
127720662|NCT02222493|459603561|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
127720663|NCT02222493|459603562|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
127720664|NCT02222493|459603561|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
127720665|NCT02222493|459603562|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
127720666|NCT02222493|459603561|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
127720667|NCT02222493|459603562|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
127720668|NCT02222493|459603561|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
127720669|NCT02222493|459603562|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
127720670|NCT02222493|459603561|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
127720671|NCT02222493|459603562|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
127720672|NCT02222493|459603561|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
127720673|NCT02222493|459603562|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
127720674|NCT02222493|459603561|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
127720675|NCT02222493|459603562|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
127720676|NCT02222493|459603561|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
127720677|NCT02222493|459603562|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
127720678|NCT02222493|459603561|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
127720679|NCT02222493|459603562|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
127720680|NCT02222493|459603561|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
127720681|NCT02222493|459603562|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
127720682|NCT02222493|459603561|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
127720683|NCT02222493|459603562|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
127720684|NCT02222493|459603561|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
127720685|NCT02222493|459603562|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
127720686|NCT02222493|459603561|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
127720687|NCT02222493|459603562|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
127720688|NCT02222493|459603561|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
127720689|NCT02222493|459603562|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
127720690|NCT02222493|459603561|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
127720691|NCT02222493|459603562|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
127720692|NCT02222493|459603561|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
127720693|NCT02222493|459603562|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
127720694|NCT03924869|459603563|FG000|Overall Study|Death|66|||
127720695|NCT03924869|459603564|FG001|Overall Study|Death|53|||
127720696|NCT03924869|459603563|FG000|Overall Study|Lost to Follow-up|2|||
127720697|NCT03924869|459603564|FG001|Overall Study|Lost to Follow-up|0|||
127720698|NCT03924869|459603563|FG000|Overall Study|Physician Decision|0|||
127802846|NCT01960855|459901069|FG003|Overall Study|Adverse Event|2|||
127802847|NCT01960855|459901070|FG004|Overall Study|Adverse Event|2|||
127888796|NCT02041494|460215832|FG001|Overall Study|Death|3|||
127888797|NCT02041494|460215831|FG000|Overall Study|Lost to Follow-up|2|||
127888798|NCT02041494|460215832|FG001|Overall Study|Lost to Follow-up|6|||
127888799|NCT02041494|460215831|FG000|Overall Study|study terminated|16|||
127888800|NCT02041494|460215832|FG001|Overall Study|study terminated|11|||
127720699|NCT03924869|459603564|FG001|Overall Study|Physician Decision|3|||
127720700|NCT03924869|459603563|FG000|Overall Study|Withdrawal by Subject|5|||
127720701|NCT03924869|459603564|FG001|Overall Study|Withdrawal by Subject|1|||
127720702|NCT03924869|459603563|FG000|Overall Study|Participants Ongoing|154|||
127720703|NCT03924869|459603564|FG001|Overall Study|Participants Ongoing|164|||
127720704|NCT04602728|459603567|FG000|Overall Study|Lost to Follow-up|4|||
127720705|NCT04602728|459603568|FG001|Overall Study|Lost to Follow-up|4|||
127720706|NCT04224272|459603569|FG000|Part 1 - Dose Finding|Death|4|||
127720707|NCT04224272|459603569|FG000|Part 1 - Dose Finding|Withdrawal by Subject|2|||
127720708|NCT04224272|459603569|FG000|Part 1 - Dose Finding|Lost to Follow-up|1|||
127720709|NCT04224272|459603569|FG000|Part 2 - Dose Expansion|Death|10|||
127720710|NCT04224272|459603569|FG000|Part 2 - Dose Expansion|Withdrawal by Subject|3|||
127720711|NCT02556918|459605355|FG000|Overall Study|Protocol Violation|5|||
127720712|NCT02556918|459605356|FG001|Overall Study|Protocol Violation|6|||
127720713|NCT02556918|459605355|FG000|Overall Study|Withdrawal by Subject|4|||
127720714|NCT02556918|459605356|FG001|Overall Study|Withdrawal by Subject|4|||
127720715|NCT00551421|459605367|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
127720716|NCT02634307|459605377|FG000|Overall Study|Adverse Event|50|||
127720717|NCT02634307|459605378|FG001|Overall Study|Adverse Event|24|||
127720718|NCT02634307|459605379|FG002|Overall Study|Adverse Event|14|||
127720719|NCT02634307|459605377|FG000|Overall Study|Lost to Follow-up|21|||
127888801|NCT02965820|460215836|FG000|Period 2, Second 30 Days|Adverse Event|1|||
127888802|NCT02965820|460215837|FG001|Period 2, Second 30 Days|Adverse Event|1|||
127888803|NCT01967888|460215838|FG000|Overall Study|Lost to Follow-up|6|||
127720720|NCT02634307|459605378|FG001|Overall Study|Lost to Follow-up|5|||
127720721|NCT02634307|459605379|FG002|Overall Study|Lost to Follow-up|6|||
127720722|NCT02634307|459605377|FG000|Overall Study|Pregnancy|5|||
127720723|NCT02634307|459605378|FG001|Overall Study|Pregnancy|1|||
127720724|NCT02634307|459605379|FG002|Overall Study|Pregnancy|3|||
127720725|NCT02634307|459605377|FG000|Overall Study|Withdrawal by Subject|38|||
127720726|NCT02634307|459605378|FG001|Overall Study|Withdrawal by Subject|24|||
127720727|NCT02634307|459605379|FG002|Overall Study|Withdrawal by Subject|18|||
127720728|NCT02634307|459605377|FG000|Overall Study|Non-Compliance with Study Drug|0|||
127720729|NCT02634307|459605378|FG001|Overall Study|Non-Compliance with Study Drug|2|||
127720730|NCT02634307|459605379|FG002|Overall Study|Non-Compliance with Study Drug|2|||
127720731|NCT02634307|459605377|FG000|Overall Study|Lack of Efficacy|1|||
127720732|NCT02634307|459605378|FG001|Overall Study|Lack of Efficacy|5|||
127720733|NCT02634307|459605379|FG002|Overall Study|Lack of Efficacy|3|||
127720734|NCT02634307|459605377|FG000|Overall Study|Physician Decision|7|||
127720735|NCT02634307|459605378|FG001|Overall Study|Physician Decision|5|||
127720736|NCT02634307|459605379|FG002|Overall Study|Physician Decision|5|||
127720737|NCT02634307|459605377|FG000|Overall Study|Reason not Specified|3|||
127720738|NCT02634307|459605378|FG001|Overall Study|Reason not Specified|5|||
127720739|NCT02634307|459605379|FG002|Overall Study|Reason not Specified|10|||
127720740|NCT02698475|459605380|FG000|Main Study Period|Lack of Efficacy|1|||
127720741|NCT02698475|459605380|FG000|Main Study Period|Protocol Violation|2|||
127720742|NCT02698475|459605380|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
127720743|NCT02698475|459605380|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
127720744|NCT02698475|459605380|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
127720745|NCT02698475|459605380|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
127720746|NCT02698475|459605380|FG000|Long-Term Extension Period|Other|1|||
127720747|NCT02132949|459605381|FG000|Overall Study|Death|7|||
127720748|NCT02132949|459605382|FG001|Overall Study|Death|13|||
127720749|NCT02132949|459605381|FG000|Overall Study|Lost to Follow-up|14|||
127720750|NCT02132949|459605382|FG001|Overall Study|Lost to Follow-up|4|||
127720751|NCT02132949|459605381|FG000|Overall Study|Withdrawal by Subject|6|||
127720752|NCT02132949|459605382|FG001|Overall Study|Withdrawal by Subject|5|||
127720753|NCT02132949|459605381|FG000|Overall Study|Noncompliance|5|||
127720754|NCT02132949|459605382|FG001|Overall Study|Noncompliance|1|||
127720755|NCT02132949|459605381|FG000|Overall Study|Physician Decision|3|||
127720756|NCT02132949|459605382|FG001|Overall Study|Physician Decision|1|||
127720757|NCT02132949|459605381|FG000|Overall Study|Disease Progression|3|||
127720758|NCT02132949|459605382|FG001|Overall Study|Disease Progression|0|||
127720759|NCT02132949|459605381|FG000|Overall Study|Adverse Event|2|||
127720760|NCT02132949|459605382|FG001|Overall Study|Adverse Event|1|||
127720761|NCT02132949|459605381|FG000|Overall Study|Withdrew Prior to Treatment|1|||
127720762|NCT02132949|459605382|FG001|Overall Study|Withdrew Prior to Treatment|2|||
127720763|NCT02132949|459605381|FG000|Overall Study|Reason Unspecified|0|||
127720764|NCT02132949|459605382|FG001|Overall Study|Reason Unspecified|1|||
127720765|NCT02148705|459605390|FG000|Overall Study|Death|2|||
127720766|NCT02148705|459605391|FG001|Overall Study|Death|0|||
127720767|NCT02148705|459605392|FG002|Overall Study|Death|0|||
127720768|NCT02148705|459605390|FG000|Overall Study|Lost to Follow-up|13|||
127720769|NCT02148705|459605391|FG001|Overall Study|Lost to Follow-up|4|||
127720770|NCT02148705|459605392|FG002|Overall Study|Lost to Follow-up|10|||
127720771|NCT02148705|459605390|FG000|Overall Study|Withdrawal by Subject|3|||
127720772|NCT02148705|459605391|FG001|Overall Study|Withdrawal by Subject|0|||
127720773|NCT02148705|459605392|FG002|Overall Study|Withdrawal by Subject|2|||
127720774|NCT02148705|459605390|FG000|Overall Study|Not Treated|0|||
127720775|NCT02148705|459605391|FG001|Overall Study|Not Treated|1|||
127720776|NCT02148705|459605392|FG002|Overall Study|Not Treated|5|||
127720777|NCT01583166|459605393|FG000|Overall Study|Withdrawal by Subject|4|||
127720778|NCT01583166|459605394|FG001|Overall Study|Withdrawal by Subject|6|||
127720779|NCT02310581|459605395|FG000|Overall Study|Adverse Event|1|||
127720780|NCT02310581|459605396|FG001|Overall Study|Adverse Event|1|||
127720781|NCT02310581|459605397|FG002|Overall Study|Adverse Event|1|||
127720782|NCT02310581|459605398|FG003|Overall Study|Adverse Event|0|||
127720783|NCT02310581|459605395|FG000|Overall Study|Withdrawal by Subject|2|||
127720784|NCT02310581|459605396|FG001|Overall Study|Withdrawal by Subject|1|||
127720785|NCT02310581|459605397|FG002|Overall Study|Withdrawal by Subject|0|||
127720786|NCT02310581|459605398|FG003|Overall Study|Withdrawal by Subject|1|||
127720787|NCT01673594|459605399|FG000|Overall Study|Adverse Event|3|||
127720788|NCT01673594|459605400|FG001|Overall Study|Adverse Event|1|||
127720789|NCT01673594|459605399|FG000|Overall Study|Lost to Follow-up|1|||
127720790|NCT01673594|459605400|FG001|Overall Study|Lost to Follow-up|0|||
127720791|NCT01673594|459605399|FG000|Overall Study|Physician Decision|2|||
127720792|NCT01673594|459605400|FG001|Overall Study|Physician Decision|4|||
127720793|NCT01673594|459605399|FG000|Overall Study|Withdrawal by Subject|0|||
127720794|NCT01673594|459605400|FG001|Overall Study|Withdrawal by Subject|1|||
127720795|NCT00454194|459605405|FG000|Overall Study|Adverse Event|7|||
127720796|NCT00454194|459605406|FG001|Overall Study|Adverse Event|2|||
127720797|NCT00454194|459605405|FG000|Overall Study|Withdrawal by Subject|12|||
127720798|NCT00454194|459605406|FG001|Overall Study|Withdrawal by Subject|8|||
127720799|NCT00454194|459605405|FG000|Overall Study|Other Medical Problems|1|||
127720800|NCT00454194|459605406|FG001|Overall Study|Other Medical Problems|2|||
127720801|NCT00454194|459605405|FG000|Overall Study|Other Unspecified Reason|2|||
127720802|NCT00454194|459605406|FG001|Overall Study|Other Unspecified Reason|2|||
127720803|NCT00620854|459605407|FG000|Washout 1|Withdrawal by Subject|0|||
127720804|NCT00620854|459605408|FG001|Washout 1|Withdrawal by Subject|0|||
127720805|NCT00620854|459605409|FG002|Washout 1|Withdrawal by Subject|1|||
127720806|NCT00620854|459605410|FG003|Washout 1|Withdrawal by Subject|1|||
127720807|NCT00620854|459605411|FG004|Washout 1|Withdrawal by Subject|0|||
127720808|NCT00620854|459605412|FG005|Washout 1|Withdrawal by Subject|0|||
127720809|NCT03345979|459605413|FG000|Overall Study|Withdrawal by Subject|20|||
127720810|NCT03345979|459605414|FG001|Overall Study|Withdrawal by Subject|31|||
127720811|NCT03345979|459605413|FG000|Overall Study|Adverse Event|10|||
127720812|NCT03345979|459605414|FG001|Overall Study|Adverse Event|11|||
127720813|NCT03345979|459605413|FG000|Overall Study|Lost to Follow-up|8|||
127720814|NCT03345979|459605414|FG001|Overall Study|Lost to Follow-up|9|||
127720815|NCT03345979|459605413|FG000|Overall Study|Lack of Efficacy|4|||
127720816|NCT03345979|459605414|FG001|Overall Study|Lack of Efficacy|2|||
127720817|NCT03345979|459605413|FG000|Overall Study|Protocol Violation|1|||
127720818|NCT03345979|459605414|FG001|Overall Study|Protocol Violation|3|||
127720819|NCT03345979|459605413|FG000|Overall Study|Physician Decision|0|||
127720820|NCT03345979|459605414|FG001|Overall Study|Physician Decision|2|||
127720821|NCT00487240|459605415|FG000|Overall Study|Withdrawal by Subject|12|||
127720822|NCT00487240|459605416|FG001|Overall Study|Withdrawal by Subject|6|||
127720823|NCT00487240|459605415|FG000|Overall Study|Lost to Follow-up|7|||
127720824|NCT00487240|459605416|FG001|Overall Study|Lost to Follow-up|6|||
127720825|NCT00487240|459605415|FG000|Overall Study|Adverse Event|0|||
127720826|NCT00487240|459605416|FG001|Overall Study|Adverse Event|4|||
127720827|NCT00487240|459605415|FG000|Overall Study|Protocol Violation|5|||
127720828|NCT00487240|459605416|FG001|Overall Study|Protocol Violation|5|||
127720829|NCT00487240|459605415|FG000|Overall Study|Entry Criteria Not Met|3|||
127720830|NCT00487240|459605416|FG001|Overall Study|Entry Criteria Not Met|4|||
127720831|NCT00487240|459605415|FG000|Overall Study|Sponsor Decision|2|||
127720832|NCT00487240|459605416|FG001|Overall Study|Sponsor Decision|1|||
127720833|NCT00487240|459605415|FG000|Overall Study|Physician Decision|2|||
127720834|NCT00487240|459605416|FG001|Overall Study|Physician Decision|0|||
127720835|NCT00999596|459605419|FG000|Overall Study|Statistical population not required|101|||
127720836|NCT02630186|459605420|FG000|Overall Study|Withdrawal by Subject|1|||
127720837|NCT00439218|459605423|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
127720838|NCT03176407|459605424|FG000|Overall Study|Protocol Violation|1|||
127720839|NCT03176407|459605424|FG000|Overall Study|human failure|1|||
127720840|NCT03176407|459605424|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
127720841|NCT01428583|459605426|FG000|Overall Study|Adverse Event|75|||
127720842|NCT01428583|459605426|FG000|Overall Study|Withdrawal by Subject|51|||
127720843|NCT01428583|459605426|FG000|Overall Study|Lack of Efficacy|37|||
127720844|NCT01428583|459605426|FG000|Overall Study|Lost to Follow-up|17|||
127720845|NCT01428583|459605426|FG000|Overall Study|Death|1|||
127720846|NCT01428583|459605426|FG000|Overall Study|Pregnancy|1|||
127720847|NCT01428583|459605426|FG000|Overall Study|Protocol Violation|1|||
127720848|NCT01428583|459605426|FG000|Overall Study|Physician Decision|12|||
127720849|NCT01428583|459605426|FG000|Overall Study|Non-compliant|25|||
127720850|NCT01428583|459605426|FG000|Overall Study|Confirmed positive urine drug test|8|||
127720851|NCT01428583|459605426|FG000|Overall Study|Sponsor's request|3|||
127720852|NCT01428583|459605426|FG000|Overall Study|Other|6|||
127720853|NCT01124045|459605429|FG000|Overall Study|Lost to Follow-up|0|||
127720854|NCT01124045|459605430|FG001|Overall Study|Lost to Follow-up|1|||
127720855|NCT01124045|459605429|FG000|Overall Study|Physician Decision|0|||
127720856|NCT01124045|459605430|FG001|Overall Study|Physician Decision|2|||
127720857|NCT05553366|459605431|FG000|Overall Study|Withdrawal of Consent (not due to AE|4|||
127720858|NCT05553366|459605432|FG001|Overall Study|Withdrawal of Consent (not due to AE|8|||
127720859|NCT05553366|459605433|FG002|Overall Study|Withdrawal of Consent (not due to AE|5|||
127720860|NCT05553366|459605431|FG000|Overall Study|Lost to Follow-up|3|||
127720861|NCT05553366|459605432|FG001|Overall Study|Lost to Follow-up|3|||
127720862|NCT05553366|459605433|FG002|Overall Study|Lost to Follow-up|3|||
127720863|NCT05553366|459605431|FG000|Overall Study|Other non-compliance|1|||
127720864|NCT05553366|459605432|FG001|Overall Study|Other non-compliance|1|||
127720865|NCT05553366|459605433|FG002|Overall Study|Other non-compliance|0|||
127720866|NCT05553366|459605431|FG000|Overall Study|Randomized but not dosed|0|||
127720867|NCT05553366|459605432|FG001|Overall Study|Randomized but not dosed|0|||
127720868|NCT05553366|459605433|FG002|Overall Study|Randomized but not dosed|2|||
127720869|NCT02022657|459605434|FG000|Overall Study|Withdrawal by Subject|2|||
127720870|NCT02022657|459605435|FG001|Overall Study|Withdrawal by Subject|0|||
127720871|NCT02022657|459605436|FG002|Overall Study|Withdrawal by Subject|1|||
127720872|NCT02022657|459605437|FG003|Overall Study|Withdrawal by Subject|0|||
127720873|NCT02022657|459605438|FG004|Overall Study|Withdrawal by Subject|0|||
127720874|NCT02022657|459605439|FG005|Overall Study|Withdrawal by Subject|0|||
127720875|NCT02022657|459605434|FG000|Overall Study|Physician Decision|0|||
127720876|NCT02022657|459605435|FG001|Overall Study|Physician Decision|0|||
127720877|NCT02022657|459605436|FG002|Overall Study|Physician Decision|0|||
127720878|NCT02022657|459605437|FG003|Overall Study|Physician Decision|0|||
127720879|NCT02022657|459605438|FG004|Overall Study|Physician Decision|0|||
127720880|NCT02022657|459605439|FG005|Overall Study|Physician Decision|1|||
127720881|NCT00659373|459605444|FG000|Overall Study|Withdrawal by Subject|3|||
127720882|NCT00659373|459605445|FG001|Overall Study|Withdrawal by Subject|5|||
127720883|NCT00659373|459605444|FG000|Overall Study|Assessment Missed|2|||
127720884|NCT00659373|459605445|FG001|Overall Study|Assessment Missed|2|||
127720885|NCT02382640|459605446|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
127720886|NCT02382640|459605447|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
127720887|NCT02382640|459605448|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
127720888|NCT02382640|459605449|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
127720889|NCT03162614|459605452|FG000|Overall Study|Lost to Follow-up|2|||
127720890|NCT03162614|459605453|FG001|Overall Study|Lost to Follow-up|1|||
127720891|NCT03162614|459605454|FG002|Overall Study|Lost to Follow-up|1|||
127720892|NCT03162614|459605455|FG003|Overall Study|Lost to Follow-up|1|||
127720893|NCT03162614|459605456|FG004|Overall Study|Lost to Follow-up|2|||
127720894|NCT03162614|459605457|FG005|Overall Study|Lost to Follow-up|0|||
127720895|NCT03162614|459605452|FG000|Overall Study|Protocol Violation|0|||
127720896|NCT03162614|459605453|FG001|Overall Study|Protocol Violation|1|||
127720897|NCT03162614|459605454|FG002|Overall Study|Protocol Violation|0|||
127720898|NCT03162614|459605455|FG003|Overall Study|Protocol Violation|1|||
127720899|NCT03162614|459605456|FG004|Overall Study|Protocol Violation|0|||
127720900|NCT03162614|459605457|FG005|Overall Study|Protocol Violation|0|||
127720901|NCT03162614|459605452|FG000|Overall Study|Withdrawal by Subject|2|||
127720902|NCT03162614|459605453|FG001|Overall Study|Withdrawal by Subject|1|||
127720903|NCT03162614|459605454|FG002|Overall Study|Withdrawal by Subject|1|||
127720904|NCT03162614|459605455|FG003|Overall Study|Withdrawal by Subject|1|||
127720905|NCT03162614|459605456|FG004|Overall Study|Withdrawal by Subject|0|||
127720906|NCT03162614|459605457|FG005|Overall Study|Withdrawal by Subject|0|||
127720907|NCT03162614|459605452|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
127720908|NCT03162614|459605453|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
127720909|NCT03162614|459605454|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
127720910|NCT03162614|459605455|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
127720911|NCT03162614|459605456|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
127720912|NCT03162614|459605457|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
127720913|NCT02630966|459605458|FG000|Overall Study|Adverse Event|1|||
127720914|NCT02630966|459605459|FG001|Overall Study|Adverse Event|3|||
127720915|NCT02630966|459605458|FG000|Overall Study|Significant Protocol Deviation|0|||
127720916|NCT02630966|459605459|FG001|Overall Study|Significant Protocol Deviation|2|||
127720917|NCT02630966|459605458|FG000|Overall Study|Voluntary Withdrawal|1|||
127720918|NCT02630966|459605459|FG001|Overall Study|Voluntary Withdrawal|1|||
127720919|NCT02630966|459605458|FG000|Overall Study|Lack of Efficacy|0|||
127720920|NCT02630966|459605459|FG001|Overall Study|Lack of Efficacy|2|||
127720921|NCT00641537|459605460|FG000|96-week Period|Adverse Event|0|||
127720922|NCT00641537|459605461|FG001|96-week Period|Adverse Event|1|||
127720923|NCT00641537|459605462|FG002|96-week Period|Adverse Event|3|||
127720924|NCT00641537|459605463|FG003|96-week Period|Adverse Event|0|||
127720925|NCT00641537|459605464|FG004|96-week Period|Adverse Event|2|||
127720926|NCT00641537|459605465|FG005|96-week Period|Adverse Event|0|||
127720927|NCT00641537|459605466|FG006|96-week Period|Adverse Event|0|||
127720928|NCT00641537|459605467|FG007|96-week Period|Adverse Event|0|||
127720929|NCT00641537|459605460|FG000|96-week Period|Lost to Follow-up|3|||
127720930|NCT00641537|459605461|FG001|96-week Period|Lost to Follow-up|1|||
127720931|NCT00641537|459605462|FG002|96-week Period|Lost to Follow-up|2|||
127720932|NCT00641537|459605463|FG003|96-week Period|Lost to Follow-up|2|||
127720933|NCT00641537|459605464|FG004|96-week Period|Lost to Follow-up|4|||
127720934|NCT00641537|459605465|FG005|96-week Period|Lost to Follow-up|0|||
127720935|NCT00641537|459605466|FG006|96-week Period|Lost to Follow-up|1|||
127720936|NCT00641537|459605467|FG007|96-week Period|Lost to Follow-up|0|||
127720937|NCT00641537|459605460|FG000|96-week Period|Protocol Violation|0|||
127720938|NCT00641537|459605461|FG001|96-week Period|Protocol Violation|1|||
127720939|NCT00641537|459605462|FG002|96-week Period|Protocol Violation|0|||
127720940|NCT00641537|459605463|FG003|96-week Period|Protocol Violation|1|||
127720941|NCT00641537|459605464|FG004|96-week Period|Protocol Violation|0|||
127720942|NCT00641537|459605465|FG005|96-week Period|Protocol Violation|1|||
127720943|NCT00641537|459605466|FG006|96-week Period|Protocol Violation|0|||
127720944|NCT00641537|459605467|FG007|96-week Period|Protocol Violation|0|||
127720945|NCT00641537|459605460|FG000|96-week Period|Death|2|||
127720946|NCT00641537|459605461|FG001|96-week Period|Death|0|||
127720947|NCT00641537|459605462|FG002|96-week Period|Death|1|||
127720948|NCT00641537|459605463|FG003|96-week Period|Death|0|||
127720949|NCT00641537|459605464|FG004|96-week Period|Death|0|||
127720950|NCT00641537|459605465|FG005|96-week Period|Death|0|||
127720951|NCT00641537|459605466|FG006|96-week Period|Death|0|||
127720952|NCT00641537|459605467|FG007|96-week Period|Death|0|||
127720953|NCT00641537|459605460|FG000|96-week Period|Other|4|||
127720954|NCT00641537|459605461|FG001|96-week Period|Other|7|||
127720955|NCT00641537|459605462|FG002|96-week Period|Other|14|||
127720956|NCT00641537|459605463|FG003|96-week Period|Other|9|||
127720957|NCT00641537|459605464|FG004|96-week Period|Other|11|||
127720958|NCT00641537|459605465|FG005|96-week Period|Other|6|||
127720959|NCT00641537|459605466|FG006|96-week Period|Other|4|||
127720960|NCT00641537|459605467|FG007|96-week Period|Other|6|||
127720961|NCT00641537|459605460|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
127720962|NCT00641537|459605461|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
127720963|NCT00641537|459605462|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
127720964|NCT00641537|459605463|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
127720965|NCT00641537|459605464|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
127720966|NCT00641537|459605465|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
127720967|NCT00641537|459605466|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
127720968|NCT00641537|459605467|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
127720969|NCT00641537|459605460|FG000|24-Week Supplemental Follow-up Period|Other|0|||
127720970|NCT00641537|459605461|FG001|24-Week Supplemental Follow-up Period|Other|2|||
127720971|NCT00641537|459605462|FG002|24-Week Supplemental Follow-up Period|Other|2|||
127720972|NCT00641537|459605463|FG003|24-Week Supplemental Follow-up Period|Other|1|||
127720973|NCT00641537|459605464|FG004|24-Week Supplemental Follow-up Period|Other|3|||
127720974|NCT00641537|459605465|FG005|24-Week Supplemental Follow-up Period|Other|0|||
127720975|NCT00641537|459605466|FG006|24-Week Supplemental Follow-up Period|Other|1|||
127720976|NCT00641537|459605467|FG007|24-Week Supplemental Follow-up Period|Other|1|||
127720977|NCT01801007|459605468|FG000|Overall Study|Adverse Event|2|||
127720978|NCT01801007|459605468|FG000|Overall Study|Lost to Follow-up|4|||
127720979|NCT01801007|459605468|FG000|Overall Study|Withdrawal by Subject|5|||
127720980|NCT00243867|459605469|FG000|Overall Study|Adverse Event|24|||
127720981|NCT00243867|459605470|FG001|Overall Study|Adverse Event|34|||
127720982|NCT00243867|459605469|FG000|Overall Study|Lack of Efficacy|115|||
127720983|NCT00243867|459605470|FG001|Overall Study|Lack of Efficacy|78|||
127720984|NCT00243867|459605469|FG000|Overall Study|Withdrawal by Subject|11|||
127720985|NCT00243867|459605470|FG001|Overall Study|Withdrawal by Subject|23|||
127720986|NCT00243867|459605469|FG000|Overall Study|Lost to Follow-up|2|||
127720987|NCT00243867|459605470|FG001|Overall Study|Lost to Follow-up|1|||
127720988|NCT00243867|459605469|FG000|Overall Study|Physician Decision|2|||
127720989|NCT00243867|459605470|FG001|Overall Study|Physician Decision|7|||
127720990|NCT00243867|459605469|FG000|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|22|||
127720991|NCT00243867|459605470|FG001|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|31|||
127720992|NCT01321073|459605471|FG000|Overall Study|Did not attempt implant|4|||
127720993|NCT01321073|459605471|FG000|Overall Study|Death|3|||
127720994|NCT01227421|459605472|FG000|Overall Study|Lost to Follow-up|6|||
127720995|NCT01227421|459605473|FG001|Overall Study|Lost to Follow-up|7|||
127720996|NCT01227421|459605474|FG002|Overall Study|Lost to Follow-up|5|||
127720997|NCT01227421|459605472|FG000|Overall Study|Adverse Event|2|||
127720998|NCT01227421|459605473|FG001|Overall Study|Adverse Event|7|||
127720999|NCT01227421|459605474|FG002|Overall Study|Adverse Event|2|||
127721000|NCT01227421|459605472|FG000|Overall Study|Withdrawal by Subject|1|||
127721001|NCT01227421|459605473|FG001|Overall Study|Withdrawal by Subject|2|||
127721002|NCT01227421|459605474|FG002|Overall Study|Withdrawal by Subject|1|||
127721003|NCT01227421|459605472|FG000|Overall Study|Protocol Violation|1|||
127721004|NCT01227421|459605473|FG001|Overall Study|Protocol Violation|1|||
127721005|NCT01227421|459605474|FG002|Overall Study|Protocol Violation|2|||
127721006|NCT01227421|459605472|FG000|Overall Study|Randomized in error|1|||
127721007|NCT01227421|459605473|FG001|Overall Study|Randomized in error|1|||
127721008|NCT01227421|459605474|FG002|Overall Study|Randomized in error|0|||
127721009|NCT02499328|459605475|FG000|Overall Study|Withdrawal by Subject|1|||
127721010|NCT02499328|459605476|FG001|Overall Study|Withdrawal by Subject|1|||
127721011|NCT02499328|459605477|FG002|Overall Study|Withdrawal by Subject|5|||
127721012|NCT02499328|459605478|FG003|Overall Study|Withdrawal by Subject|3|||
127721013|NCT02499328|459605479|FG004|Overall Study|Withdrawal by Subject|5|||
127721014|NCT02499328|459605480|FG005|Overall Study|Withdrawal by Subject|0|||
127721015|NCT02499328|459605481|FG006|Overall Study|Withdrawal by Subject|0|||
127721016|NCT02499328|459605482|FG007|Overall Study|Withdrawal by Subject|0|||
127721017|NCT02499328|459605483|FG008|Overall Study|Withdrawal by Subject|2|||
127721018|NCT02499328|459605484|FG009|Overall Study|Withdrawal by Subject|2|||
127721019|NCT02499328|459605485|FG010|Overall Study|Withdrawal by Subject|0|||
127721020|NCT02499328|459605486|FG011|Overall Study|Withdrawal by Subject|3|||
127721021|NCT02499328|459605487|FG012|Overall Study|Withdrawal by Subject|7|||
127721022|NCT02499328|459605488|FG013|Overall Study|Withdrawal by Subject|3|||
127721023|NCT02499328|459605489|FG014|Overall Study|Withdrawal by Subject|1|||
127721024|NCT02499328|459605490|FG015|Overall Study|Withdrawal by Subject|0|||
127721025|NCT02499328|459605491|FG016|Overall Study|Withdrawal by Subject|0|||
127721026|NCT02499328|459605492|FG017|Overall Study|Withdrawal by Subject|3|||
127721027|NCT02499328|459605493|FG018|Overall Study|Withdrawal by Subject|0|||
127721028|NCT02499328|459605475|FG000|Overall Study|Lost to Follow-up|0|||
127721029|NCT02499328|459605476|FG001|Overall Study|Lost to Follow-up|1|||
127721030|NCT02499328|459605477|FG002|Overall Study|Lost to Follow-up|1|||
127721031|NCT02499328|459605478|FG003|Overall Study|Lost to Follow-up|2|||
127721032|NCT02499328|459605479|FG004|Overall Study|Lost to Follow-up|0|||
127721033|NCT02499328|459605480|FG005|Overall Study|Lost to Follow-up|0|||
127721034|NCT02499328|459605481|FG006|Overall Study|Lost to Follow-up|0|||
127721035|NCT02499328|459605482|FG007|Overall Study|Lost to Follow-up|2|||
127721036|NCT02499328|459605483|FG008|Overall Study|Lost to Follow-up|3|||
127721037|NCT02499328|459605484|FG009|Overall Study|Lost to Follow-up|0|||
127721038|NCT02499328|459605485|FG010|Overall Study|Lost to Follow-up|0|||
127721039|NCT02499328|459605486|FG011|Overall Study|Lost to Follow-up|0|||
127721040|NCT02499328|459605487|FG012|Overall Study|Lost to Follow-up|0|||
127721041|NCT02499328|459605488|FG013|Overall Study|Lost to Follow-up|0|||
127721042|NCT02499328|459605489|FG014|Overall Study|Lost to Follow-up|0|||
127721043|NCT02499328|459605490|FG015|Overall Study|Lost to Follow-up|0|||
127721044|NCT02499328|459605491|FG016|Overall Study|Lost to Follow-up|0|||
127721045|NCT02499328|459605492|FG017|Overall Study|Lost to Follow-up|0|||
127721046|NCT02499328|459605493|FG018|Overall Study|Lost to Follow-up|1|||
127721047|NCT02499328|459605475|FG000|Overall Study|Death|0|||
127721048|NCT02499328|459605476|FG001|Overall Study|Death|3|||
127721049|NCT02499328|459605477|FG002|Overall Study|Death|3|||
127721050|NCT02499328|459605478|FG003|Overall Study|Death|2|||
127721051|NCT02499328|459605479|FG004|Overall Study|Death|4|||
127721052|NCT02499328|459605480|FG005|Overall Study|Death|7|||
127721053|NCT02499328|459605481|FG006|Overall Study|Death|3|||
127721054|NCT02499328|459605482|FG007|Overall Study|Death|0|||
127721055|NCT02499328|459605483|FG008|Overall Study|Death|2|||
127721056|NCT02499328|459605484|FG009|Overall Study|Death|6|||
127721057|NCT02499328|459605485|FG010|Overall Study|Death|6|||
127721058|NCT02499328|459605486|FG011|Overall Study|Death|20|||
127721059|NCT02499328|459605487|FG012|Overall Study|Death|9|||
127721060|NCT02499328|459605488|FG013|Overall Study|Death|7|||
127721061|NCT02499328|459605489|FG014|Overall Study|Death|3|||
127721062|NCT02499328|459605490|FG015|Overall Study|Death|1|||
127721063|NCT02499328|459605491|FG016|Overall Study|Death|1|||
127721064|NCT02499328|459605492|FG017|Overall Study|Death|16|||
127721065|NCT02499328|459605493|FG018|Overall Study|Death|5|||
127721066|NCT02499328|459605475|FG000|Overall Study|"Other"|2|||
127721067|NCT02499328|459605476|FG001|Overall Study|"Other"|2|||
127721068|NCT02499328|459605477|FG002|Overall Study|"Other"|1|||
127721069|NCT02499328|459605478|FG003|Overall Study|"Other"|3|||
127721070|NCT02499328|459605479|FG004|Overall Study|"Other"|6|||
127721071|NCT02499328|459605480|FG005|Overall Study|"Other"|2|||
127721072|NCT02499328|459605481|FG006|Overall Study|"Other"|3|||
127721073|NCT02499328|459605482|FG007|Overall Study|"Other"|4|||
127721074|NCT02499328|459605483|FG008|Overall Study|"Other"|6|||
127721075|NCT02499328|459605484|FG009|Overall Study|"Other"|16|||
127721076|NCT02499328|459605485|FG010|Overall Study|"Other"|13|||
127721077|NCT02499328|459605486|FG011|Overall Study|"Other"|31|||
127721078|NCT02499328|459605487|FG012|Overall Study|"Other"|8|||
127721079|NCT02499328|459605488|FG013|Overall Study|"Other"|7|||
127721080|NCT02499328|459605489|FG014|Overall Study|"Other"|6|||
127721081|NCT02499328|459605490|FG015|Overall Study|"Other"|0|||
127721082|NCT02499328|459605491|FG016|Overall Study|"Other"|0|||
127721083|NCT02499328|459605492|FG017|Overall Study|"Other"|34|||
127721084|NCT02499328|459605493|FG018|Overall Study|"Other"|43|||
127721085|NCT02499328|459605475|FG000|Overall Study|Disease Progression|0|||
127721086|NCT02499328|459605476|FG001|Overall Study|Disease Progression|0|||
127721087|NCT02499328|459605477|FG002|Overall Study|Disease Progression|0|||
127721088|NCT02499328|459605478|FG003|Overall Study|Disease Progression|0|||
127721089|NCT02499328|459605479|FG004|Overall Study|Disease Progression|0|||
127721090|NCT02499328|459605480|FG005|Overall Study|Disease Progression|0|||
127721091|NCT02499328|459605481|FG006|Overall Study|Disease Progression|1|||
127721092|NCT02499328|459605482|FG007|Overall Study|Disease Progression|0|||
127721093|NCT02499328|459605483|FG008|Overall Study|Disease Progression|1|||
127721094|NCT02499328|459605484|FG009|Overall Study|Disease Progression|0|||
127721095|NCT02499328|459605485|FG010|Overall Study|Disease Progression|1|||
127721096|NCT02499328|459605486|FG011|Overall Study|Disease Progression|0|||
127721097|NCT02499328|459605487|FG012|Overall Study|Disease Progression|0|||
127721098|NCT02499328|459605488|FG013|Overall Study|Disease Progression|0|||
127721099|NCT02499328|459605489|FG014|Overall Study|Disease Progression|0|||
127721100|NCT02499328|459605490|FG015|Overall Study|Disease Progression|0|||
127721101|NCT02499328|459605491|FG016|Overall Study|Disease Progression|0|||
127721102|NCT02499328|459605492|FG017|Overall Study|Disease Progression|2|||
127721103|NCT02499328|459605493|FG018|Overall Study|Disease Progression|0|||
127721104|NCT02499328|459605475|FG000|Overall Study|Adverse Event|1|||
127721105|NCT02499328|459605476|FG001|Overall Study|Adverse Event|0|||
127721106|NCT02499328|459605477|FG002|Overall Study|Adverse Event|0|||
127721107|NCT02499328|459605478|FG003|Overall Study|Adverse Event|1|||
127721108|NCT02499328|459605479|FG004|Overall Study|Adverse Event|0|||
127721109|NCT02499328|459605480|FG005|Overall Study|Adverse Event|0|||
127721110|NCT02499328|459605481|FG006|Overall Study|Adverse Event|0|||
127721111|NCT02499328|459605482|FG007|Overall Study|Adverse Event|0|||
127721112|NCT02499328|459605483|FG008|Overall Study|Adverse Event|0|||
127721113|NCT02499328|459605484|FG009|Overall Study|Adverse Event|0|||
127721114|NCT02499328|459605485|FG010|Overall Study|Adverse Event|0|||
127721115|NCT02499328|459605486|FG011|Overall Study|Adverse Event|0|||
127721116|NCT02499328|459605487|FG012|Overall Study|Adverse Event|1|||
127721117|NCT02499328|459605488|FG013|Overall Study|Adverse Event|0|||
127721118|NCT02499328|459605489|FG014|Overall Study|Adverse Event|0|||
127721119|NCT02499328|459605490|FG015|Overall Study|Adverse Event|0|||
127721120|NCT02499328|459605491|FG016|Overall Study|Adverse Event|0|||
127721121|NCT02499328|459605492|FG017|Overall Study|Adverse Event|0|||
127721122|NCT02499328|459605493|FG018|Overall Study|Adverse Event|0|||
127721123|NCT00145470|459605494|FG000|Overall Study|Adverse Event|19|||
127721124|NCT00145470|459605495|FG001|Overall Study|Adverse Event|25|||
127721125|NCT00145470|459605494|FG000|Overall Study|Lack of Efficacy|27|||
127721126|NCT00145470|459605495|FG001|Overall Study|Lack of Efficacy|13|||
127721127|NCT00145470|459605494|FG000|Overall Study|Withdrawal by Subject|36|||
127721128|NCT00145470|459605495|FG001|Overall Study|Withdrawal by Subject|34|||
127721129|NCT00145470|459605494|FG000|Overall Study|Lost to Follow-up|21|||
127721130|NCT00145470|459605495|FG001|Overall Study|Lost to Follow-up|17|||
127721131|NCT00145470|459605494|FG000|Overall Study|Reason Not Reported|9|||
127721132|NCT00145470|459605495|FG001|Overall Study|Reason Not Reported|9|||
127721133|NCT02831049|459605499|FG000|Overall Study|Lost to Follow-up|0|||
127721134|NCT02831049|459605500|FG001|Overall Study|Lost to Follow-up|0|||
127721135|NCT02831049|459605501|FG002|Overall Study|Lost to Follow-up|1|||
127721136|NCT02831049|459605499|FG000|Overall Study|Withdrawal by Subject|0|||
127721137|NCT02831049|459605500|FG001|Overall Study|Withdrawal by Subject|1|||
127721138|NCT02831049|459605501|FG002|Overall Study|Withdrawal by Subject|1|||
127721139|NCT02831049|459605499|FG000|Overall Study|Pandemic shutdown|1|||
127721140|NCT02831049|459605500|FG001|Overall Study|Pandemic shutdown|0|||
127721141|NCT02831049|459605501|FG002|Overall Study|Pandemic shutdown|0|||
127721142|NCT02609048|459605502|FG000|Overall Study|Adverse Event|3|||
127721143|NCT02609048|459605503|FG001|Overall Study|Adverse Event|0|||
127721144|NCT02609048|459605504|FG002|Overall Study|Adverse Event|0|||
127721145|NCT02609048|459605502|FG000|Overall Study|Randomized but never treated|1|||
127721146|NCT02609048|459605503|FG001|Overall Study|Randomized but never treated|1|||
127721147|NCT02609048|459605504|FG002|Overall Study|Randomized but never treated|1|||
127721148|NCT02609048|459605502|FG000|Overall Study|Withdrawal of informed consent|1|||
127721149|NCT02609048|459605503|FG001|Overall Study|Withdrawal of informed consent|0|||
127721150|NCT02609048|459605504|FG002|Overall Study|Withdrawal of informed consent|0|||
127721151|NCT02609048|459605502|FG000|Overall Study|Reason not specified|6|||
127721152|NCT02609048|459605503|FG001|Overall Study|Reason not specified|9|||
127721153|NCT02609048|459605504|FG002|Overall Study|Reason not specified|9|||
127721154|NCT02485925|459605505|FG000|Overall Study|Withdrawal by Subject|3|||
127721155|NCT02485925|459605505|FG000|Overall Study|Death|1|||
127721156|NCT02485925|459605505|FG000|Overall Study|Lost to Follow-up|11|||
127721157|NCT05995977|459605506|FG000|Overall Study|Withdrawal by Subject|1|||
127721158|NCT05995977|459605507|FG001|Overall Study|Withdrawal by Subject|4|||
127721159|NCT05995977|459605506|FG000|Overall Study|Lost to Follow-up|2|||
127721160|NCT05995977|459605507|FG001|Overall Study|Lost to Follow-up|0|||
127721161|NCT04181788|459605508|FG000|TREATMENT|Adverse Event|0|||
127721162|NCT04181788|459605509|FG001|TREATMENT|Adverse Event|2|||
127721163|NCT04181788|459605510|FG002|TREATMENT|Adverse Event|1|||
127721164|NCT04181788|459605511|FG003|TREATMENT|Adverse Event|0|||
127721165|NCT04181788|459605512|FG004|TREATMENT|Adverse Event|1|||
127721166|NCT04181788|459605513|FG005|TREATMENT|Adverse Event|3|||
127721167|NCT04181788|459605508|FG000|TREATMENT|Death|0|||
127721168|NCT04181788|459605509|FG001|TREATMENT|Death|0|||
127721169|NCT04181788|459605510|FG002|TREATMENT|Death|0|||
127721170|NCT04181788|459605511|FG003|TREATMENT|Death|0|||
127721171|NCT04181788|459605512|FG004|TREATMENT|Death|8|||
127721172|NCT04181788|459605513|FG005|TREATMENT|Death|8|||
127721173|NCT04181788|459605508|FG000|TREATMENT|Physician Decision|0|||
127721174|NCT04181788|459605509|FG001|TREATMENT|Physician Decision|0|||
127721175|NCT04181788|459605510|FG002|TREATMENT|Physician Decision|0|||
127721176|NCT04181788|459605511|FG003|TREATMENT|Physician Decision|0|||
127721177|NCT04181788|459605512|FG004|TREATMENT|Physician Decision|0|||
127721178|NCT04181788|459605513|FG005|TREATMENT|Physician Decision|1|||
127721179|NCT04181788|459605508|FG000|TREATMENT|Progressive disease|3|||
127721180|NCT04181788|459605509|FG001|TREATMENT|Progressive disease|3|||
127721181|NCT04181788|459605510|FG002|TREATMENT|Progressive disease|5|||
127721182|NCT04181788|459605511|FG003|TREATMENT|Progressive disease|7|||
127721183|NCT04181788|459605512|FG004|TREATMENT|Progressive disease|20|||
127721184|NCT04181788|459605513|FG005|TREATMENT|Progressive disease|38|||
127721185|NCT04181788|459605508|FG000|TREATMENT|Global deterioration of health status|0|||
127721186|NCT04181788|459605509|FG001|TREATMENT|Global deterioration of health status|2|||
127721187|NCT04181788|459605510|FG002|TREATMENT|Global deterioration of health status|0|||
127721188|NCT04181788|459605511|FG003|TREATMENT|Global deterioration of health status|0|||
127721189|NCT04181788|459605512|FG004|TREATMENT|Global deterioration of health status|2|||
127721190|NCT04181788|459605513|FG005|TREATMENT|Global deterioration of health status|8|||
127721191|NCT04181788|459605508|FG000|TREATMENT|Withdrawal by Subject|1|||
127721192|NCT04181788|459605509|FG001|TREATMENT|Withdrawal by Subject|2|||
127721193|NCT04181788|459605510|FG002|TREATMENT|Withdrawal by Subject|0|||
127721194|NCT04181788|459605511|FG003|TREATMENT|Withdrawal by Subject|0|||
127721195|NCT04181788|459605512|FG004|TREATMENT|Withdrawal by Subject|3|||
127721196|NCT04181788|459605513|FG005|TREATMENT|Withdrawal by Subject|5|||
127721197|NCT04181788|459605508|FG000|TREATMENT|Other unspecified|0|||
127721198|NCT04181788|459605509|FG001|TREATMENT|Other unspecified|0|||
127721199|NCT04181788|459605510|FG002|TREATMENT|Other unspecified|0|||
127721200|NCT04181788|459605511|FG003|TREATMENT|Other unspecified|0|||
127721201|NCT04181788|459605512|FG004|TREATMENT|Other unspecified|0|||
127721202|NCT04181788|459605513|FG005|TREATMENT|Other unspecified|2|||
127721203|NCT04181788|459605508|FG000|TREATMENT|Ongoing|0|||
127721204|NCT04181788|459605509|FG001|TREATMENT|Ongoing|3|||
127721205|NCT04181788|459605510|FG002|TREATMENT|Ongoing|0|||
127721206|NCT04181788|459605511|FG003|TREATMENT|Ongoing|5|||
127721207|NCT04181788|459605512|FG004|TREATMENT|Ongoing|7|||
127721208|NCT04181788|459605513|FG005|TREATMENT|Ongoing|15|||
127721209|NCT04181788|459605508|FG000|FOLLOW-UP|Death|0|||
127721210|NCT04181788|459605509|FG001|FOLLOW-UP|Death|0|||
127721211|NCT04181788|459605510|FG002|FOLLOW-UP|Death|1|||
127721212|NCT04181788|459605511|FG003|FOLLOW-UP|Death|2|||
127721213|NCT04181788|459605512|FG004|FOLLOW-UP|Death|8|||
127721214|NCT04181788|459605513|FG005|FOLLOW-UP|Death|20|||
127721215|NCT04181788|459605508|FG000|FOLLOW-UP|Lost to Follow-up|0|||
127721216|NCT04181788|459605509|FG001|FOLLOW-UP|Lost to Follow-up|0|||
127721217|NCT04181788|459605510|FG002|FOLLOW-UP|Lost to Follow-up|0|||
127721218|NCT04181788|459605511|FG003|FOLLOW-UP|Lost to Follow-up|0|||
127721219|NCT04181788|459605512|FG004|FOLLOW-UP|Lost to Follow-up|0|||
127721220|NCT04181788|459605513|FG005|FOLLOW-UP|Lost to Follow-up|2|||
127721221|NCT04181788|459605508|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
127721222|NCT04181788|459605509|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
127721223|NCT04181788|459605510|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
127721224|NCT04181788|459605511|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
127721225|NCT04181788|459605512|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
127721226|NCT04181788|459605513|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
127721227|NCT04181788|459605508|FG000|FOLLOW-UP|Other unspecified|0|||
127721228|NCT04181788|459605509|FG001|FOLLOW-UP|Other unspecified|1|||
127721229|NCT04181788|459605510|FG002|FOLLOW-UP|Other unspecified|0|||
127721230|NCT04181788|459605511|FG003|FOLLOW-UP|Other unspecified|0|||
127721231|NCT04181788|459605512|FG004|FOLLOW-UP|Other unspecified|0|||
127721232|NCT04181788|459605513|FG005|FOLLOW-UP|Other unspecified|3|||
127721233|NCT04181788|459605508|FG000|FOLLOW-UP|Ongoing|0|||
127721234|NCT04181788|459605509|FG001|FOLLOW-UP|Ongoing|0|||
127721235|NCT04181788|459605510|FG002|FOLLOW-UP|Ongoing|1|||
127721236|NCT04181788|459605511|FG003|FOLLOW-UP|Ongoing|3|||
127721237|NCT04181788|459605512|FG004|FOLLOW-UP|Ongoing|2|||
127721238|NCT04181788|459605513|FG005|FOLLOW-UP|Ongoing|2|||
127721239|NCT04937504|459605514|FG000|15 Weeks Assessment|Lost to Follow-up|5|||
127721240|NCT04937504|459605515|FG001|15 Weeks Assessment|Lost to Follow-up|9|||
127721241|NCT04937504|459605514|FG000|9 Months Assessment|Lost to Follow-up|3|||
127721242|NCT04937504|459605515|FG001|9 Months Assessment|Lost to Follow-up|2|||
127721243|NCT04186247|459605516|FG000|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|2|||
127721244|NCT04186247|459605517|FG001|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
127721245|NCT04186247|459605518|FG002|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
127721246|NCT04186247|459605519|FG003|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
127721247|NCT04186247|459605520|FG004|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
127721248|NCT03662659|459605521|FG000|Pre-treatment|Participant no longer met study criteria|1|||
127721249|NCT03662659|459605522|FG001|Pre-treatment|Participant no longer met study criteria|1|||
127721250|NCT03662659|459605521|FG000|Pre-treatment|Other reasons|1|||
127721251|NCT03662659|459605522|FG001|Pre-treatment|Other reasons|0|||
127721252|NCT03662659|459605521|FG000|Treatment|Completed Treatment|0|||
127721253|NCT03662659|459605522|FG001|Treatment|Completed Treatment|2|||
127721254|NCT03662659|459605521|FG000|Treatment|Disease Progression|85|||
127721255|NCT03662659|459605522|FG001|Treatment|Disease Progression|97|||
127721256|NCT03662659|459605521|FG000|Treatment|Study Drug Toxicity|19|||
127721257|NCT03662659|459605522|FG001|Treatment|Study Drug Toxicity|9|||
127721258|NCT03662659|459605521|FG000|Treatment|Death|11|||
127721259|NCT03662659|459605522|FG001|Treatment|Death|9|||
127721260|NCT03662659|459605521|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
127721261|NCT03662659|459605522|FG001|Treatment|Adverse Event unrelated to Study Drug|6|||
127721262|NCT03662659|459605521|FG000|Treatment|Withdrawal by Subject|1|||
127721263|NCT03662659|459605522|FG001|Treatment|Withdrawal by Subject|1|||
127721264|NCT03662659|459605521|FG000|Treatment|Poor/Non-compliance|1|||
127721265|NCT03662659|459605522|FG001|Treatment|Poor/Non-compliance|0|||
127721266|NCT03662659|459605521|FG000|Treatment|Participant no longer meets study criteria|1|||
127721267|NCT03662659|459605522|FG001|Treatment|Participant no longer meets study criteria|0|||
127721268|NCT03662659|459605521|FG000|Treatment|Other reasons|10|||
127721269|NCT03662659|459605522|FG001|Treatment|Other reasons|8|||
127721270|NCT03662659|459605521|FG000|Treatment|Administrative reasons by sponsor|1|||
127721271|NCT03662659|459605522|FG001|Treatment|Administrative reasons by sponsor|0|||
127721272|NCT03662659|459605521|FG000|Treatment|maximum clinical benefit|0|||
127721273|NCT03662659|459605522|FG001|Treatment|maximum clinical benefit|2|||
127721274|NCT04118894|459605524|FG000|Overall Study|Lost to Follow-up|21|||
127721275|NCT04118894|459605524|FG000|Overall Study|Withdrawal by Subject|10|||
127721276|NCT04118894|459605524|FG000|Overall Study|Adverse Event|4|||
127721277|NCT04323800|459607098|FG000|Overall Study|Withdrawal by Subject|4|||
127721278|NCT04323800|459607099|FG001|Overall Study|Withdrawal by Subject|4|||
127721279|NCT04323800|459607098|FG000|Overall Study|Incomplete transfusion|1|||
127721280|NCT04323800|459607099|FG001|Overall Study|Incomplete transfusion|0|||
127721281|NCT04323800|459607098|FG000|Overall Study|Other|0|||
127721282|NCT04323800|459607099|FG001|Overall Study|Other|1|||
127721283|NCT04323800|459607098|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
127721284|NCT04323800|459607099|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
127721285|NCT00489554|459607100|FG000|Overall Study|Adverse Event|2|||
127721286|NCT00489554|459607100|FG000|Overall Study|Withdrawal by Subject|1|||
127721287|NCT00489554|459607100|FG000|Overall Study|Lost to Follow-up|1|||
127721288|NCT06571695|459607101|FG000|Overall Study|Lost to Follow-up|1|||
127721289|NCT06571695|459607102|FG001|Overall Study|Lost to Follow-up|6|||
127721290|NCT01380145|459607103|FG000|Overall Study|Progressive disease|4|||
127721291|NCT02038049|459607108|FG000|Overall Study|Lost to Follow-up|1|||
127721292|NCT02038049|459607109|FG001|Overall Study|Lost to Follow-up|0|||
127721293|NCT01808534|459607110|FG000|Overall Study|Disease progression|3|||
127721294|NCT01808534|459607110|FG000|Overall Study|Physician Decision|1|||
127721295|NCT01823224|459607111|FG000|Overall Study|Lost to Follow-up|5|||
127721296|NCT01823224|459607112|FG001|Overall Study|Lost to Follow-up|6|||
127721297|NCT01823224|459607111|FG000|Overall Study|didn't qualify|1|||
127721298|NCT01823224|459607112|FG001|Overall Study|didn't qualify|2|||
127721299|NCT01823224|459607111|FG000|Overall Study|pharmacy error|0|||
127721300|NCT01823224|459607112|FG001|Overall Study|pharmacy error|1|||
127721301|NCT01823224|459607111|FG000|Overall Study|missed med dose|0|||
127721302|NCT01823224|459607112|FG001|Overall Study|missed med dose|1|||
127721303|NCT01823224|459607111|FG000|Overall Study|Withdrawal by Subject|0|||
127721304|NCT01823224|459607112|FG001|Overall Study|Withdrawal by Subject|1|||
127721305|NCT01737021|459607115|FG000|Overall Study|Lost to Follow-up|5|||
127721306|NCT01737021|459607116|FG001|Overall Study|Lost to Follow-up|3|||
127721307|NCT02575365|459607118|FG000|Overall Study|Lost to Follow-up|4|||
127721308|NCT03392194|459607119|FG000|Overall Study|Withdrawal by Subject|1|||
127721309|NCT03392194|459607120|FG001|Overall Study|Withdrawal by Subject|2|||
127721310|NCT03392194|459607119|FG000|Overall Study|Conflicts with personal schedule|1|||
127721311|NCT03392194|459607120|FG001|Overall Study|Conflicts with personal schedule|0|||
127721312|NCT03865732|459607121|FG000|Overall Study|Adverse Event|0|||
127721313|NCT03865732|459607122|FG001|Overall Study|Adverse Event|1|||
127721314|NCT00273052|459607133|FG000|Overall Study|Withdrawal by Subject|16|||
127721315|NCT00273052|459607134|FG001|Overall Study|Withdrawal by Subject|19|||
127721316|NCT00273052|459607133|FG000|Overall Study|Adverse Event|21|||
127721317|NCT00273052|459607134|FG001|Overall Study|Adverse Event|19|||
127888804|NCT01967888|460215839|FG001|Overall Study|Lost to Follow-up|4|||
127888805|NCT01967888|460215838|FG000|Overall Study|Withdrawal by Subject|1|||
127888806|NCT01967888|460215839|FG001|Overall Study|Withdrawal by Subject|1|||
127888807|NCT01967888|460215838|FG000|Overall Study|Did Not Have Transplant|1|||
127888808|NCT01967888|460215839|FG001|Overall Study|Did Not Have Transplant|0|||
127888809|NCT01967888|460215838|FG000|Overall Study|Research visit not done, data recorded|1|||
127888810|NCT01967888|460215839|FG001|Overall Study|Research visit not done, data recorded|0|||
127888811|NCT01967888|460215838|FG000|Overall Study|Subject excluded after randomization|1|||
127721318|NCT00273052|459607133|FG000|Overall Study|Protocol Violation|14|||
127721319|NCT00273052|459607134|FG001|Overall Study|Protocol Violation|18|||
127721320|NCT00273052|459607133|FG000|Overall Study|Lost to Follow-up|7|||
127721321|NCT00273052|459607134|FG001|Overall Study|Lost to Follow-up|25|||
127721322|NCT00273052|459607133|FG000|Overall Study|Lack of Efficacy|6|||
127721323|NCT00273052|459607134|FG001|Overall Study|Lack of Efficacy|4|||
127721324|NCT00273052|459607133|FG000|Overall Study|Non-Compliance|3|||
127721325|NCT00273052|459607134|FG001|Overall Study|Non-Compliance|1|||
127721326|NCT00273052|459607133|FG000|Overall Study|Other|2|||
127721327|NCT00273052|459607134|FG001|Overall Study|Other|0|||
127721328|NCT00273052|459607133|FG000|Overall Study|Worsening serum lipid levels|0|||
127721329|NCT00273052|459607134|FG001|Overall Study|Worsening serum lipid levels|2|||
127721330|NCT01951703|459607135|FG000|First Intervention|Withdrawal by Subject|1|||
127721331|NCT01951703|459607136|FG001|First Intervention|Withdrawal by Subject|0|||
127721332|NCT01951703|459607135|FG000|First Intervention|Subject was not compliant|1|||
127721333|NCT01951703|459607136|FG001|First Intervention|Subject was not compliant|1|||
127721334|NCT01951703|459607135|FG000|First Intervention|Physician Decision|1|||
127721335|NCT01951703|459607136|FG001|First Intervention|Physician Decision|0|||
127721336|NCT01951703|459607135|FG000|Second Intervention|Protocol Violation|0|||
127721337|NCT01951703|459607136|FG001|Second Intervention|Protocol Violation|1|||
127721338|NCT01951703|459607135|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
127721339|NCT01951703|459607136|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
127721340|NCT01009645|459607137|FG000|Overall Study|Lost to Follow-up|2|||
127721341|NCT01009645|459607138|FG001|Overall Study|Lost to Follow-up|8|||
127721342|NCT01009645|459607139|FG002|Overall Study|Lost to Follow-up|4|||
127721343|NCT01009645|459607140|FG003|Overall Study|Lost to Follow-up|5|||
127721344|NCT01019135|459607141|FG000|Overall Study|Did not receive allocated intervention|12|||
127721345|NCT01019135|459607142|FG001|Overall Study|Did not receive allocated intervention|6|||
127721346|NCT01019135|459607143|FG002|Overall Study|Did not receive allocated intervention|25|||
127721347|NCT01019135|459607141|FG000|Overall Study|Did not attend CR|8|||
127721348|NCT01019135|459607142|FG001|Overall Study|Did not attend CR|13|||
127721349|NCT01019135|459607143|FG002|Overall Study|Did not attend CR|6|||
127721350|NCT05124210|459607144|FG000|Overall Study|Lost to Follow-up|1|||
127721351|NCT05124210|459607145|FG001|Overall Study|Lost to Follow-up|0|||
127721352|NCT05124210|459607144|FG000|Overall Study|Withdrawal by Subject|1|||
127721353|NCT05124210|459607145|FG001|Overall Study|Withdrawal by Subject|0|||
127721354|NCT00768755|459607148|FG000|Phase 1|Death|6|||
127888812|NCT01967888|460215839|FG001|Overall Study|Subject excluded after randomization|0|||
127888813|NCT01967888|460215838|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
127721355|NCT00768755|459607149|FG001|Phase 1|Death|0|||
127721356|NCT00768755|459607150|FG002|Phase 1|Death|0|||
127721357|NCT00768755|459607151|FG003|Phase 1|Death|0|||
127721358|NCT00768755|459607148|FG000|Phase 1|Other|4|||
127721359|NCT00768755|459607149|FG001|Phase 1|Other|0|||
127721360|NCT00768755|459607150|FG002|Phase 1|Other|0|||
127721361|NCT00768755|459607151|FG003|Phase 1|Other|0|||
127721362|NCT00768755|459607148|FG000|Phase 2|Death|0|||
127721363|NCT00768755|459607149|FG001|Phase 2|Death|37|||
127721364|NCT00768755|459607150|FG002|Phase 2|Death|48|||
127721365|NCT00768755|459607151|FG003|Phase 2|Death|31|||
127721366|NCT00768755|459607148|FG000|Phase 2|Protocol Violation|0|||
127721367|NCT00768755|459607149|FG001|Phase 2|Protocol Violation|2|||
127721368|NCT00768755|459607150|FG002|Phase 2|Protocol Violation|0|||
127721369|NCT00768755|459607151|FG003|Phase 2|Protocol Violation|1|||
127721370|NCT00768755|459607148|FG000|Phase 2|Lost to Follow-up|0|||
127721371|NCT00768755|459607149|FG001|Phase 2|Lost to Follow-up|1|||
127721372|NCT00768755|459607150|FG002|Phase 2|Lost to Follow-up|1|||
127721373|NCT00768755|459607151|FG003|Phase 2|Lost to Follow-up|4|||
127721374|NCT00768755|459607148|FG000|Phase 2|Withdrawal by Subject|0|||
127721375|NCT00768755|459607149|FG001|Phase 2|Withdrawal by Subject|1|||
127721376|NCT00768755|459607150|FG002|Phase 2|Withdrawal by Subject|0|||
127721377|NCT00768755|459607151|FG003|Phase 2|Withdrawal by Subject|1|||
127721378|NCT00768755|459607148|FG000|Phase 2|Other|0|||
127721379|NCT00768755|459607149|FG001|Phase 2|Other|1|||
127721380|NCT00768755|459607150|FG002|Phase 2|Other|2|||
127721381|NCT00768755|459607151|FG003|Phase 2|Other|4|||
127721382|NCT00768755|459607148|FG000|Phase 2|Study Terminated by Sponsor|0|||
127721383|NCT00768755|459607149|FG001|Phase 2|Study Terminated by Sponsor|13|||
127721384|NCT00768755|459607150|FG002|Phase 2|Study Terminated by Sponsor|7|||
127721385|NCT00768755|459607151|FG003|Phase 2|Study Terminated by Sponsor|14|||
127721386|NCT00768755|459607148|FG000|Phase 2|Randomized but not treated|0|||
127721387|NCT00768755|459607149|FG001|Phase 2|Randomized but not treated|0|||
127721388|NCT00768755|459607150|FG002|Phase 2|Randomized but not treated|0|||
127721389|NCT00768755|459607151|FG003|Phase 2|Randomized but not treated|2|||
127721390|NCT03298087|459607154|FG000|Overall Study|Withdrawal by Subject|4|||
127721391|NCT01530334|459607158|FG000|Overall Study|Adverse Event|3|||
127721392|NCT01530334|459607158|FG000|Overall Study|unknown reason|1|||
127721393|NCT01530334|459607158|FG000|Overall Study|Progressive disease|47|||
127721394|NCT01485887|459607159|FG000|Overall Study|Withdrawal by Subject|2|||
127721395|NCT01485887|459607159|FG000|Overall Study|Adverse Event|8|||
127721396|NCT01485887|459607159|FG000|Overall Study|Deterioration of primary disease|1|||
127721397|NCT01485887|459607159|FG000|Overall Study|Primary disease markedly improved|1|||
127721398|NCT03184987|459607163|FG000|Overall Study|Withdrawal by Subject|0|||
127721399|NCT03184987|459607164|FG001|Overall Study|Withdrawal by Subject|1|||
127721400|NCT03184987|459607165|FG002|Overall Study|Withdrawal by Subject|2|||
127721401|NCT03184987|459607163|FG000|Overall Study|Physician Decision|0|||
127721402|NCT03184987|459607164|FG001|Overall Study|Physician Decision|0|||
127721403|NCT03184987|459607165|FG002|Overall Study|Physician Decision|1|||
127721404|NCT03184987|459607163|FG000|Overall Study|Adverse Event|1|||
127721405|NCT03184987|459607164|FG001|Overall Study|Adverse Event|0|||
127721406|NCT03184987|459607165|FG002|Overall Study|Adverse Event|1|||
127721407|NCT02203799|459607166|FG000|Overall Study|Withdrawal by Subject|3|||
127721408|NCT00681109|459607167|FG000|Overall Study|Lost to Follow-up|2|||
127721409|NCT00681109|459607168|FG001|Overall Study|Lost to Follow-up|6|||
127721410|NCT00681109|459607169|FG002|Overall Study|Lost to Follow-up|0|||
127721411|NCT04660799|459607170|FG000|Overall Study|Progressive Disease|1|||
127721412|NCT04660799|459607171|FG001|Overall Study|Progressive Disease|1|||
127721413|NCT04660799|459607170|FG000|Overall Study|Death|2|||
127721414|NCT04660799|459607171|FG001|Overall Study|Death|1|||
127721415|NCT04660799|459607170|FG000|Overall Study|Adverse Event|2|||
127721416|NCT04660799|459607171|FG001|Overall Study|Adverse Event|1|||
127721417|NCT04660799|459607170|FG000|Overall Study|Withdrawal by Subject|2|||
127721418|NCT04660799|459607171|FG001|Overall Study|Withdrawal by Subject|5|||
127721419|NCT00391170|459607182|FG000|Overall Study|Withdrawal by Subject|1|||
127721420|NCT00391170|459607183|FG001|Overall Study|Withdrawal by Subject|0|||
127721421|NCT00391170|459607182|FG000|Overall Study|Adverse Event|3|||
127721422|NCT00391170|459607183|FG001|Overall Study|Adverse Event|2|||
127721423|NCT00391170|459607182|FG000|Overall Study|Physician Decision|2|||
127721424|NCT00391170|459607183|FG001|Overall Study|Physician Decision|2|||
127721425|NCT03035942|459607188|FG000|Overall Study|Adverse Event|8|||
127721426|NCT03035942|459607189|FG001|Overall Study|Adverse Event|4|||
127721427|NCT03035942|459607190|FG002|Overall Study|Adverse Event|5|||
127721428|NCT05270460|459607191|FG000|Overall Study|Adverse Event|0|||
127721429|NCT05270460|459607192|FG001|Overall Study|Adverse Event|1|||
127721430|NCT05270460|459607193|FG002|Overall Study|Adverse Event|0|||
127721431|NCT05270460|459607191|FG000|Overall Study|Early Termination|0|||
127721432|NCT05270460|459607192|FG001|Overall Study|Early Termination|1|||
127721433|NCT05270460|459607193|FG002|Overall Study|Early Termination|0|||
127721434|NCT00380250|459607194|FG000|Overall Study|Withdrawal by Subject|39|||
127721435|NCT00380250|459607195|FG001|Overall Study|Withdrawal by Subject|28|||
127721436|NCT00380250|459607194|FG000|Overall Study|Adverse Event|20|||
127721437|NCT00380250|459607195|FG001|Overall Study|Adverse Event|9|||
127721438|NCT00380250|459607194|FG000|Overall Study|Lack of Efficacy|10|||
127721439|NCT00380250|459607195|FG001|Overall Study|Lack of Efficacy|8|||
127721440|NCT00380250|459607194|FG000|Overall Study|Protocol Violation|15|||
127721441|NCT00380250|459607195|FG001|Overall Study|Protocol Violation|5|||
127721442|NCT00380250|459607194|FG000|Overall Study|Lost to Follow-up|14|||
127721443|NCT00380250|459607195|FG001|Overall Study|Lost to Follow-up|5|||
127721444|NCT00380250|459607194|FG000|Overall Study|Physician Decision|1|||
127721445|NCT00380250|459607195|FG001|Overall Study|Physician Decision|0|||
127721446|NCT04029090|459607196|FG000|Overall Study|Protocol Violation|1|||
127721447|NCT04029090|459607197|FG001|Overall Study|Protocol Violation|0|||
127721448|NCT04029090|459607198|FG002|Overall Study|Protocol Violation|0|||
127721449|NCT04029090|459607196|FG000|Overall Study|Withdrawal by Subject|0|||
127721450|NCT04029090|459607197|FG001|Overall Study|Withdrawal by Subject|1|||
127721451|NCT04029090|459607198|FG002|Overall Study|Withdrawal by Subject|0|||
127721452|NCT01065779|459607199|FG000|Overall Study|Duplicate Investigation|1|||
127721453|NCT01065779|459607199|FG000|Overall Study|Investigation Before Contract Date|37|||
127721454|NCT01065779|459607199|FG000|Overall Study|Non-enrollment Period Administration|10|||
127721455|NCT01065779|459607199|FG000|Overall Study|Not Administered With Study Drug|17|||
127721456|NCT01065779|459607199|FG000|Overall Study|Failed to Follow-up|10|||
127721457|NCT01065779|459607199|FG000|Overall Study|Inclusion Criteria Violation|7|||
127721458|NCT02157948|459607200|FG000|Overall Study|Withdrawal by Subject|4|||
127721459|NCT02157948|459607201|FG001|Overall Study|Withdrawal by Subject|5|||
127721460|NCT02157948|459607200|FG000|Overall Study|Lost to Follow-up|3|||
127721461|NCT02157948|459607201|FG001|Overall Study|Lost to Follow-up|2|||
127721462|NCT02157948|459607200|FG000|Overall Study|Protocol Specified Criteria|2|||
127721463|NCT02157948|459607201|FG001|Overall Study|Protocol Specified Criteria|1|||
127721464|NCT02157948|459607200|FG000|Overall Study|Decision by Sponsor|0|||
127721465|NCT02157948|459607201|FG001|Overall Study|Decision by Sponsor|1|||
127721466|NCT00665392|459607202|FG000|Overall Study|not treated|1|||
127721467|NCT01638000|459607213|FG000|Overall Study|Randomized but Never Received Drug|7|||
127721468|NCT01638000|459607214|FG001|Overall Study|Randomized but Never Received Drug|10|||
127721469|NCT01638000|459607213|FG000|Overall Study|Adverse Event|14|||
127721470|NCT01638000|459607214|FG001|Overall Study|Adverse Event|16|||
127721471|NCT01638000|459607213|FG000|Overall Study|Lack of Efficacy|5|||
127721472|NCT01638000|459607214|FG001|Overall Study|Lack of Efficacy|6|||
127721473|NCT01638000|459607213|FG000|Overall Study|Protocol Violation|11|||
127721474|NCT01638000|459607214|FG001|Overall Study|Protocol Violation|13|||
127721475|NCT01638000|459607213|FG000|Overall Study|Withdrawal by Subject|21|||
127721476|NCT01638000|459607214|FG001|Overall Study|Withdrawal by Subject|24|||
127721477|NCT01638000|459607213|FG000|Overall Study|Miscellaneous|2|||
127721478|NCT01638000|459607214|FG001|Overall Study|Miscellaneous|2|||
127721479|NCT05352230|459607215|FG000|First Intervention (3 Months)|study terminated|2|||
127721480|NCT05352230|459607216|FG001|First Intervention (3 Months)|study terminated|2|||
127721481|NCT01683409|459607219|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
127721482|NCT01683409|459607220|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
127721483|NCT01683409|459607221|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
127721484|NCT01683409|459607222|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
127721485|NCT01683409|459607223|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
127721486|NCT01683409|459607219|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
127721487|NCT01683409|459607220|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
127721488|NCT01683409|459607221|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
127721489|NCT01683409|459607222|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
127721490|NCT01683409|459607223|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
127721491|NCT01683409|459607219|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
127721492|NCT01683409|459607220|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
127721493|NCT01683409|459607221|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
127721494|NCT01683409|459607222|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
127721495|NCT01683409|459607223|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
127721496|NCT01683409|459607219|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
127721497|NCT01683409|459607220|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
127721498|NCT01683409|459607221|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
127721499|NCT01683409|459607222|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
127802848|NCT01960855|459901066|FG000|Overall Study|Lack of Efficacy|1|||
127802849|NCT01960855|459901067|FG001|Overall Study|Lack of Efficacy|1|||
127802850|NCT01960855|459901068|FG002|Overall Study|Lack of Efficacy|0|||
127802851|NCT01960855|459901069|FG003|Overall Study|Lack of Efficacy|0|||
127802852|NCT01960855|459901070|FG004|Overall Study|Lack of Efficacy|0|||
127802853|NCT01960855|459901066|FG000|Overall Study|Other|2|||
127802854|NCT01960855|459901067|FG001|Overall Study|Other|1|||
127802855|NCT01960855|459901068|FG002|Overall Study|Other|1|||
127721500|NCT01683409|459607223|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
127721501|NCT01683409|459607219|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
127721502|NCT01683409|459607220|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
127721503|NCT01683409|459607221|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
127721504|NCT01683409|459607222|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
127721505|NCT01683409|459607223|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
127721506|NCT01683409|459607219|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
127721507|NCT01683409|459607220|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
127721508|NCT01683409|459607221|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
127721509|NCT01683409|459607222|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
127721510|NCT01683409|459607223|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
127721511|NCT01683409|459607219|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
127721512|NCT01683409|459607220|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
127721513|NCT01683409|459607221|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
127721514|NCT01683409|459607222|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
127721515|NCT01683409|459607223|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
127721516|NCT01683409|459607219|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
127721517|NCT01683409|459607220|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
127721518|NCT01683409|459607221|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
127721519|NCT01683409|459607222|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
127721520|NCT01683409|459607223|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
127721521|NCT01683409|459607219|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
127721522|NCT01683409|459607220|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
127721523|NCT01683409|459607221|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
127721524|NCT01683409|459607222|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
127721525|NCT01683409|459607223|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
127721526|NCT01683409|459607219|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
127721527|NCT01683409|459607220|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
127721528|NCT01683409|459607221|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
127721529|NCT01683409|459607222|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
127721530|NCT01683409|459607223|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
127721531|NCT01683409|459607219|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
127721532|NCT01683409|459607220|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
127721533|NCT01683409|459607221|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
127721534|NCT01683409|459607222|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
127721535|NCT01683409|459607223|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
127721536|NCT04218864|459607224|FG000|Overall Study|Lost to Follow-up|8|||
127721537|NCT04218864|459607225|FG001|Overall Study|Lost to Follow-up|4|||
127721538|NCT04218864|459607224|FG000|Overall Study|Withdrawal by Subject|1|||
127721539|NCT04218864|459607225|FG001|Overall Study|Withdrawal by Subject|3|||
127721540|NCT06269003|459607226|FG000|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
127721541|NCT06269003|459607227|FG001|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
127721542|NCT06269003|459607228|FG002|Overall Study|One participant was excluded for being outside the eligible age range.|1|||
127721543|NCT06269003|459607229|FG003|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
127721544|NCT04447027|459607230|FG000|Dose Escalation|Withdrawal by Subject|1|||
127721545|NCT04447027|459607231|FG001|Dose Escalation|Withdrawal by Subject|4|||
127721546|NCT04447027|459607232|FG002|Dose Escalation|Withdrawal by Subject|3|||
127721547|NCT04447027|459607233|FG003|Dose Escalation|Withdrawal by Subject|3|||
127721548|NCT04447027|459607234|FG004|Dose Escalation|Withdrawal by Subject|1|||
127721549|NCT04447027|459607235|FG005|Dose Escalation|Withdrawal by Subject|0|||
127721550|NCT04447027|459607236|FG006|Dose Escalation|Withdrawal by Subject|0|||
127721551|NCT04447027|459607237|FG007|Dose Escalation|Withdrawal by Subject|0|||
127721552|NCT04447027|459607238|FG008|Dose Escalation|Withdrawal by Subject|0|||
127721553|NCT04447027|459607230|FG000|Dose Escalation|Refused further treatment|0|||
127721554|NCT04447027|459607231|FG001|Dose Escalation|Refused further treatment|1|||
127721555|NCT04447027|459607232|FG002|Dose Escalation|Refused further treatment|1|||
127721556|NCT04447027|459607233|FG003|Dose Escalation|Refused further treatment|0|||
127721557|NCT04447027|459607234|FG004|Dose Escalation|Refused further treatment|0|||
127721558|NCT04447027|459607235|FG005|Dose Escalation|Refused further treatment|0|||
127721559|NCT04447027|459607236|FG006|Dose Escalation|Refused further treatment|0|||
127721560|NCT04447027|459607237|FG007|Dose Escalation|Refused further treatment|0|||
127721561|NCT04447027|459607238|FG008|Dose Escalation|Refused further treatment|0|||
127721562|NCT04447027|459607230|FG000|Dose Expansion|Withdrawal by Subject|0|||
127721563|NCT04447027|459607231|FG001|Dose Expansion|Withdrawal by Subject|0|||
127721564|NCT04447027|459607232|FG002|Dose Expansion|Withdrawal by Subject|0|||
127721565|NCT04447027|459607233|FG003|Dose Expansion|Withdrawal by Subject|0|||
127721566|NCT04447027|459607234|FG004|Dose Expansion|Withdrawal by Subject|0|||
127721567|NCT04447027|459607235|FG005|Dose Expansion|Withdrawal by Subject|2|||
127721568|NCT04447027|459607236|FG006|Dose Expansion|Withdrawal by Subject|0|||
127721569|NCT04447027|459607237|FG007|Dose Expansion|Withdrawal by Subject|2|||
127721570|NCT04447027|459607238|FG008|Dose Expansion|Withdrawal by Subject|0|||
127721571|NCT04535414|459607239|FG000|Overall Study|Taken off study due to principal investigator (PI) discretion.|1|||
127721572|NCT04535414|459607240|FG001|Overall Study|Taken off study due to principal investigator (PI) discretion.|0|||
127721573|NCT04535414|459607239|FG000|Overall Study|Cancelled appointment|1|||
127721574|NCT04535414|459607240|FG001|Overall Study|Cancelled appointment|0|||
127721575|NCT04535414|459607239|FG000|Overall Study|cancelled - food in stomach|2|||
127721576|NCT04535414|459607240|FG001|Overall Study|cancelled - food in stomach|0|||
127721577|NCT04535414|459607239|FG000|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
127721578|NCT04535414|459607240|FG001|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
127721579|NCT04535414|459607239|FG000|Overall Study|Withdrawal by Subject|0|||
127721580|NCT04535414|459607240|FG001|Overall Study|Withdrawal by Subject|1|||
127721581|NCT01567852|459608449|FG000|Overall Study|Withdrawal by Subject|3|||
127721582|NCT01567852|459608450|FG001|Overall Study|Withdrawal by Subject|6|||
127721583|NCT01567852|459608449|FG000|Overall Study|ECT discontinued|1|||
127721584|NCT01567852|459608450|FG001|Overall Study|ECT discontinued|1|||
127721585|NCT04809623|459608451|FG000|Overall Study|Study Terminated by Sponsor|1|||
127721586|NCT04809623|459608452|FG001|Overall Study|Study Terminated by Sponsor|0|||
127721587|NCT02660086|459608453|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
127721588|NCT02660086|459608454|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
127721589|NCT02660086|459608453|FG000|Overall Study- 12-month|Left full-time employment|12|||
127721590|NCT02660086|459608454|FG001|Overall Study- 12-month|Left full-time employment|20|||
127721591|NCT02660086|459608453|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
127721592|NCT02660086|459608454|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
127721593|NCT02660086|459608453|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
127721594|NCT02660086|459608454|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
127721595|NCT02660086|459608453|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
127721596|NCT02660086|459608454|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
127721597|NCT02660086|459608453|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
127721598|NCT02660086|459608454|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
127721599|NCT00667017|459608457|FG000|Overall Study|Withdrawal by Subject|1|||
127721600|NCT02605174|459608464|FG000|Overall Study|Adverse Event|0|||
127721601|NCT02605174|459608465|FG001|Overall Study|Adverse Event|0|||
127721602|NCT02605174|459608466|FG002|Overall Study|Adverse Event|1|||
127721603|NCT02605174|459608467|FG003|Overall Study|Adverse Event|0|||
127721604|NCT02605174|459608468|FG004|Overall Study|Adverse Event|4|||
127721605|NCT02605174|459608469|FG005|Overall Study|Adverse Event|0|||
127721606|NCT02605174|459608470|FG006|Overall Study|Adverse Event|0|||
127721607|NCT02605174|459608464|FG000|Overall Study|Lost to Follow-up|20|||
127721608|NCT02605174|459608465|FG001|Overall Study|Lost to Follow-up|7|||
127721609|NCT02605174|459608466|FG002|Overall Study|Lost to Follow-up|27|||
127721610|NCT02605174|459608467|FG003|Overall Study|Lost to Follow-up|10|||
127721611|NCT02605174|459608468|FG004|Overall Study|Lost to Follow-up|20|||
127721612|NCT02605174|459608469|FG005|Overall Study|Lost to Follow-up|10|||
127721613|NCT02605174|459608470|FG006|Overall Study|Lost to Follow-up|29|||
127721614|NCT02605174|459608464|FG000|Overall Study|Protocol Violation|10|||
127721615|NCT02605174|459608465|FG001|Overall Study|Protocol Violation|4|||
127721616|NCT02605174|459608466|FG002|Overall Study|Protocol Violation|14|||
127721617|NCT02605174|459608467|FG003|Overall Study|Protocol Violation|6|||
127721618|NCT02605174|459608468|FG004|Overall Study|Protocol Violation|7|||
127721619|NCT02605174|459608469|FG005|Overall Study|Protocol Violation|7|||
127721620|NCT02605174|459608470|FG006|Overall Study|Protocol Violation|12|||
127721621|NCT02605174|459608464|FG000|Overall Study|Pregnancy|1|||
127721622|NCT02605174|459608465|FG001|Overall Study|Pregnancy|0|||
127721623|NCT02605174|459608466|FG002|Overall Study|Pregnancy|0|||
127721624|NCT02605174|459608467|FG003|Overall Study|Pregnancy|2|||
127721625|NCT02605174|459608468|FG004|Overall Study|Pregnancy|0|||
127721626|NCT02605174|459608469|FG005|Overall Study|Pregnancy|0|||
127721627|NCT02605174|459608470|FG006|Overall Study|Pregnancy|0|||
127721628|NCT02605174|459608464|FG000|Overall Study|Withdrawal by Subject|9|||
127721629|NCT02605174|459608465|FG001|Overall Study|Withdrawal by Subject|6|||
127802856|NCT01960855|459901069|FG003|Overall Study|Other|1|||
127802857|NCT01960855|459901070|FG004|Overall Study|Other|0|||
127721630|NCT02605174|459608466|FG002|Overall Study|Withdrawal by Subject|14|||
127721631|NCT02605174|459608467|FG003|Overall Study|Withdrawal by Subject|11|||
127721632|NCT02605174|459608468|FG004|Overall Study|Withdrawal by Subject|6|||
127802858|NCT01960855|459901066|FG000|Overall Study|Consent withdrawn by subject|3|||
127721633|NCT02605174|459608469|FG005|Overall Study|Withdrawal by Subject|4|||
127721634|NCT02605174|459608470|FG006|Overall Study|Withdrawal by Subject|15|||
127721635|NCT02605174|459608464|FG000|Overall Study|Physician Decision|2|||
127721636|NCT02605174|459608465|FG001|Overall Study|Physician Decision|0|||
127721637|NCT02605174|459608466|FG002|Overall Study|Physician Decision|0|||
127721638|NCT02605174|459608467|FG003|Overall Study|Physician Decision|0|||
127721639|NCT02605174|459608468|FG004|Overall Study|Physician Decision|0|||
127721640|NCT02605174|459608469|FG005|Overall Study|Physician Decision|0|||
127721641|NCT02605174|459608470|FG006|Overall Study|Physician Decision|3|||
127721642|NCT02605174|459608464|FG000|Overall Study|Randomization Failure|22|||
127721643|NCT02605174|459608465|FG001|Overall Study|Randomization Failure|6|||
127721644|NCT02605174|459608466|FG002|Overall Study|Randomization Failure|20|||
127721645|NCT02605174|459608467|FG003|Overall Study|Randomization Failure|7|||
127721646|NCT02605174|459608468|FG004|Overall Study|Randomization Failure|16|||
127721647|NCT02605174|459608469|FG005|Overall Study|Randomization Failure|11|||
127721648|NCT02605174|459608470|FG006|Overall Study|Randomization Failure|30|||
127721649|NCT03737110|459608471|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
127721650|NCT03737110|459608472|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
127721651|NCT03737110|459608473|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
127721652|NCT03737110|459608474|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
127721653|NCT03737110|459608475|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
127721654|NCT03737110|459608476|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
127721655|NCT03737110|459608471|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
127721656|NCT03737110|459608472|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
127721657|NCT03737110|459608473|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
127721658|NCT03737110|459608474|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
127721659|NCT03737110|459608475|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
127721660|NCT03737110|459608476|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
127721661|NCT03737110|459608471|FG000|Run-in (RI) Period|Adverse Event|4|||
127721662|NCT03737110|459608472|FG001|Run-in (RI) Period|Adverse Event|0|||
127721663|NCT03737110|459608473|FG002|Run-in (RI) Period|Adverse Event|0|||
127721664|NCT03737110|459608474|FG003|Run-in (RI) Period|Adverse Event|0|||
127721665|NCT03737110|459608475|FG004|Run-in (RI) Period|Adverse Event|0|||
127721666|NCT03737110|459608476|FG005|Run-in (RI) Period|Adverse Event|0|||
127721667|NCT03737110|459608471|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
127721668|NCT03737110|459608472|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
127721669|NCT03737110|459608473|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
127721670|NCT03737110|459608474|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
127721671|NCT03737110|459608475|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
127721672|NCT03737110|459608476|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
127721673|NCT03737110|459608471|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
127721674|NCT03737110|459608472|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
127721675|NCT03737110|459608473|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
127721676|NCT03737110|459608474|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
127721677|NCT03737110|459608475|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
127721678|NCT03737110|459608476|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
127721679|NCT03737110|459608471|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
127721680|NCT03737110|459608472|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
127721681|NCT03737110|459608473|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
127721682|NCT03737110|459608474|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
127721683|NCT03737110|459608475|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
127721684|NCT03737110|459608476|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
127721685|NCT03737110|459608471|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
127721686|NCT03737110|459608472|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
127721687|NCT03737110|459608473|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
127721688|NCT03737110|459608474|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
127721689|NCT03737110|459608475|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
127721690|NCT03737110|459608476|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
127721691|NCT03737110|459608471|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
127721692|NCT03737110|459608472|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
127721693|NCT03737110|459608473|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
127721694|NCT03737110|459608474|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
127721695|NCT03737110|459608475|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
127721696|NCT03737110|459608476|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
127721697|NCT01698918|459608490|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
127721698|NCT01698918|459608490|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
127721699|NCT01698918|459608490|FG000|First Line Treatment (Core+Extension)|Death|2|||
127721700|NCT01698918|459608490|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
127721701|NCT01698918|459608490|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
127721702|NCT01698918|459608490|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
127721703|NCT01698918|459608490|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
127721704|NCT01698918|459608490|FG000|Second Line Treatment (Core+Extension)|Death|1|||
127721705|NCT01698918|459608490|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
127721706|NCT01698918|459608490|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
127721707|NCT00310037|459608491|FG000|Overall Study|Adverse Event|7|||
127721708|NCT00310037|459608492|FG001|Overall Study|Adverse Event|14|||
127721709|NCT00310037|459608491|FG000|Overall Study|Withdrawal by Subject|4|||
127721710|NCT00310037|459608492|FG001|Overall Study|Withdrawal by Subject|3|||
127721711|NCT00310037|459608491|FG000|Overall Study|Progression|6|||
127721712|NCT00310037|459608492|FG001|Overall Study|Progression|0|||
127721713|NCT00310037|459608491|FG000|Overall Study|Non-protocol treatment|1|||
127721714|NCT00310037|459608492|FG001|Overall Study|Non-protocol treatment|0|||
127721715|NCT02708498|459608493|FG000|Overall Study|Death|20|||
127721716|NCT02708498|459608494|FG001|Overall Study|Death|19|||
127721717|NCT02708498|459608495|FG002|Overall Study|Death|0|||
127721718|NCT02708498|459608496|FG003|Overall Study|Death|0|||
127721719|NCT02708498|459608497|FG004|Overall Study|Death|1|||
127721720|NCT02708498|459608498|FG005|Overall Study|Death|0|||
127721721|NCT02708498|459608499|FG006|Overall Study|Death|0|||
127721722|NCT02708498|459608500|FG007|Overall Study|Death|0|||
127721723|NCT02708498|459608493|FG000|Overall Study|Unknown reason, missing data|0|||
127721724|NCT02708498|459608494|FG001|Overall Study|Unknown reason, missing data|0|||
127721725|NCT02708498|459608495|FG002|Overall Study|Unknown reason, missing data|62|||
127721726|NCT02708498|459608496|FG003|Overall Study|Unknown reason, missing data|51|||
127721727|NCT02708498|459608497|FG004|Overall Study|Unknown reason, missing data|195|||
127721728|NCT02708498|459608498|FG005|Overall Study|Unknown reason, missing data|132|||
127721729|NCT02708498|459608499|FG006|Overall Study|Unknown reason, missing data|0|||
127721730|NCT02708498|459608500|FG007|Overall Study|Unknown reason, missing data|0|||
127721731|NCT01640288|459608502|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
127721732|NCT01640288|459608503|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
127721733|NCT01640288|459608502|FG000|Overall Study|Screen Failure|20|||
127721734|NCT01640288|459608503|FG001|Overall Study|Screen Failure|18|||
127721735|NCT01640288|459608502|FG000|Overall Study|Withdrawn by PI|5|||
127721736|NCT01640288|459608503|FG001|Overall Study|Withdrawn by PI|0|||
127721737|NCT01640288|459608502|FG000|Overall Study|Withdrawal by Subject|1|||
127721738|NCT01640288|459608503|FG001|Overall Study|Withdrawal by Subject|0|||
127721739|NCT04803734|459608504|FG000|Overall Study|Withdrawal by Subject|0|||
127721740|NCT04803734|459608505|FG001|Overall Study|Withdrawal by Subject|1|||
127721741|NCT04803734|459608504|FG000|Overall Study|Protocol Violation|0|||
127721742|NCT04803734|459608505|FG001|Overall Study|Protocol Violation|1|||
127721743|NCT00195819|459608508|FG000|Double-Blind|Withdrawal by Subject|1|||
127721744|NCT00195819|459608509|FG001|Double-Blind|Withdrawal by Subject|0|||
127721745|NCT00195819|459608508|FG000|Double-Blind|Moved|1|||
127721746|NCT00195819|459608509|FG001|Double-Blind|Moved|0|||
127721747|NCT00195819|459608508|FG000|Open-label|Adverse Event|0|||
127721748|NCT00195819|459608509|FG001|Open-label|Adverse Event|9|||
127721749|NCT00195819|459608508|FG000|Open-label|Lack of Efficacy|0|||
127721750|NCT00195819|459608509|FG001|Open-label|Lack of Efficacy|2|||
127721751|NCT00195819|459608508|FG000|Open-label|Pregnancy|0|||
127721752|NCT00195819|459608509|FG001|Open-label|Pregnancy|1|||
127721753|NCT00195819|459608508|FG000|Open-label|Protocol Violation|0|||
127721754|NCT00195819|459608509|FG001|Open-label|Protocol Violation|2|||
127721755|NCT00195819|459608508|FG000|Open-label|Moved|0|||
127721756|NCT00195819|459608509|FG001|Open-label|Moved|1|||
127721757|NCT00195819|459608508|FG000|Open-label|Withdrawal by Subject|0|||
127721758|NCT00195819|459608509|FG001|Open-label|Withdrawal by Subject|5|||
127721759|NCT03781375|459608512|FG000|Double-blind Phase|Adverse Event|0|||
127721760|NCT03781375|459608513|FG001|Double-blind Phase|Adverse Event|1|||
127721761|NCT03781375|459608512|FG000|Double-blind Phase|Lack of Response|6|||
127721762|NCT03781375|459608513|FG001|Double-blind Phase|Lack of Response|2|||
127721763|NCT03781375|459608512|FG000|Double-blind Phase|Other|1|||
127721764|NCT03781375|459608513|FG001|Double-blind Phase|Other|3|||
127721765|NCT03781375|459608512|FG000|Open-label Phase|Protocol Issues|0|||
127721766|NCT03781375|459608513|FG001|Open-label Phase|Protocol Issues|1|||
127721767|NCT03781375|459608512|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
127721768|NCT03781375|459608513|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
127721769|NCT03781375|459608512|FG000|Open-label Phase|Other|2|||
127888814|NCT01967888|460215839|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
127721770|NCT03781375|459608513|FG001|Open-label Phase|Other|2|||
127721771|NCT01629589|459608514|FG000|Overall Study|Protocol Violation|4|||
127721772|NCT01629589|459608515|FG001|Overall Study|Protocol Violation|2|||
127721773|NCT01629589|459608514|FG000|Overall Study|Lost to Follow-up|2|||
127721774|NCT01629589|459608515|FG001|Overall Study|Lost to Follow-up|1|||
127721775|NCT01629589|459608514|FG000|Overall Study|Withdrawal by Subject|2|||
127721776|NCT01629589|459608515|FG001|Overall Study|Withdrawal by Subject|3|||
127721777|NCT01629589|459608514|FG000|Overall Study|Did not receive study vaccine|0|||
127721778|NCT01629589|459608515|FG001|Overall Study|Did not receive study vaccine|1|||
127721779|NCT01303510|459608516|FG000|Overall Study|Lost to Follow-up|1|||
127721780|NCT01303510|459608517|FG001|Overall Study|Lost to Follow-up|0|||
127888815|NCT01967888|460215838|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
127888816|NCT01967888|460215839|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
127888817|NCT00553540|460215840|FG000|Overall Study|discharged after first visit|2|||
127888818|NCT00553540|460215841|FG001|Overall Study|discharged after first visit|5|||
127888819|NCT02622074|460215842|FG000|Overall Study|Death|4|||
127888820|NCT02622074|460215843|FG001|Overall Study|Death|0|||
127888821|NCT02622074|460215844|FG002|Overall Study|Death|0|||
127888822|NCT02622074|460215845|FG003|Overall Study|Death|1|||
127888823|NCT02622074|460215846|FG004|Overall Study|Death|1|||
127888824|NCT02622074|460215847|FG005|Overall Study|Death|0|||
127888825|NCT02622074|460215842|FG000|Overall Study|Withdrawal by Subject|0|||
127888826|NCT02622074|460215843|FG001|Overall Study|Withdrawal by Subject|1|||
127888827|NCT02622074|460215844|FG002|Overall Study|Withdrawal by Subject|0|||
127888828|NCT02622074|460215845|FG003|Overall Study|Withdrawal by Subject|0|||
127888829|NCT02622074|460215846|FG004|Overall Study|Withdrawal by Subject|0|||
127888830|NCT02622074|460215847|FG005|Overall Study|Withdrawal by Subject|0|||
127888831|NCT02114931|460215848|FG000|Overall Study|Withdrawal by Subject|15|||
127888832|NCT02114931|460215849|FG001|Overall Study|Withdrawal by Subject|18|||
127888833|NCT02114931|460215848|FG000|Overall Study|Adverse Event|4|||
127888834|NCT02114931|460215849|FG001|Overall Study|Adverse Event|6|||
127888835|NCT02114931|460215848|FG000|Overall Study|Lost to Follow-up|3|||
127888836|NCT02114931|460215849|FG001|Overall Study|Lost to Follow-up|3|||
127888837|NCT02114931|460215848|FG000|Overall Study|Physician Decision|1|||
127888838|NCT02114931|460215849|FG001|Overall Study|Physician Decision|2|||
127888839|NCT02114931|460215848|FG000|Overall Study|Other|2|||
127888840|NCT02114931|460215849|FG001|Overall Study|Other|1|||
127888841|NCT03565211|460215851|FG000|Overall Study|Withdrawal by Subject|2|||
127888842|NCT03565211|460215851|FG000|Overall Study|Lost to Follow-up|1|||
127888843|NCT03565211|460215851|FG000|Overall Study|Adverse Event|44|||
127888844|NCT03565211|460215851|FG000|Overall Study|Personal issues|1|||
127888845|NCT01894984|460215855|FG000|Overall Study|Other|314|||
127888846|NCT01894984|460215856|FG001|Overall Study|Other|175|||
127888847|NCT03840135|460215858|FG000|Overall Study|Protocol Violation|6|||
127888848|NCT03840135|460215859|FG001|Overall Study|Protocol Violation|1|||
127888849|NCT03840135|460215858|FG000|Overall Study|Withdrawal by Subject|1|||
127888850|NCT03840135|460215859|FG001|Overall Study|Withdrawal by Subject|0|||
127888851|NCT01827371|460215860|FG000|Overall Study|Adverse Event|0|||
127888852|NCT01827371|460215861|FG001|Overall Study|Adverse Event|0|||
127888853|NCT01827371|460215862|FG002|Overall Study|Adverse Event|4|||
127888854|NCT01827371|460215863|FG003|Overall Study|Adverse Event|2|||
127888855|NCT01827371|460215860|FG000|Overall Study|Lost to Follow-up|0|||
127888856|NCT01827371|460215861|FG001|Overall Study|Lost to Follow-up|2|||
127888857|NCT01827371|460215862|FG002|Overall Study|Lost to Follow-up|0|||
127888858|NCT01827371|460215863|FG003|Overall Study|Lost to Follow-up|4|||
127888859|NCT01827371|460215860|FG000|Overall Study|Protocol Violation|1|||
127888860|NCT01827371|460215861|FG001|Overall Study|Protocol Violation|0|||
127888861|NCT01827371|460215862|FG002|Overall Study|Protocol Violation|0|||
127888862|NCT01827371|460215863|FG003|Overall Study|Protocol Violation|0|||
127888863|NCT01827371|460215860|FG000|Overall Study|Withdrawal by Subject|1|||
127888864|NCT01827371|460215861|FG001|Overall Study|Withdrawal by Subject|2|||
127888865|NCT01827371|460215862|FG002|Overall Study|Withdrawal by Subject|2|||
127888866|NCT01827371|460215863|FG003|Overall Study|Withdrawal by Subject|3|||
127888867|NCT01827371|460215860|FG000|Overall Study|Physician Decision|0|||
127888868|NCT01827371|460215861|FG001|Overall Study|Physician Decision|1|||
127888869|NCT01827371|460215862|FG002|Overall Study|Physician Decision|0|||
127888870|NCT01827371|460215863|FG003|Overall Study|Physician Decision|1|||
127721781|NCT00822900|459608518|FG000|Overall Study|Withdrawal by Subject|14|||
127721782|NCT00822900|459608519|FG001|Overall Study|Withdrawal by Subject|14|||
127721783|NCT00822900|459608518|FG000|Overall Study|Lost to Follow-up|9|||
127721784|NCT00822900|459608519|FG001|Overall Study|Lost to Follow-up|9|||
127721785|NCT00822900|459608518|FG000|Overall Study|Death|83|||
127888871|NCT01827371|460215860|FG000|Overall Study|Temporary study halt to vaccinations|11|||
127888872|NCT01827371|460215861|FG001|Overall Study|Temporary study halt to vaccinations|2|||
127888873|NCT01827371|460215862|FG002|Overall Study|Temporary study halt to vaccinations|5|||
127721786|NCT00822900|459608519|FG001|Overall Study|Death|69|||
127888874|NCT01827371|460215863|FG003|Overall Study|Temporary study halt to vaccinations|13|||
127888875|NCT01361607|460215866|FG000|Overall Study|Adverse Event|38|||
127888876|NCT01361607|460215867|FG001|Overall Study|Adverse Event|29|||
127888877|NCT01361607|460215866|FG000|Overall Study|Withdrawal by Subject|19|||
127888878|NCT01361607|460215867|FG001|Overall Study|Withdrawal by Subject|8|||
127888879|NCT01361607|460215866|FG000|Overall Study|Withdrawal by Investigator|5|||
127888880|NCT01361607|460215867|FG001|Overall Study|Withdrawal by Investigator|3|||
127888881|NCT01361607|460215866|FG000|Overall Study|Lost to Follow-up|1|||
127888882|NCT01361607|460215867|FG001|Overall Study|Lost to Follow-up|0|||
127888883|NCT01361607|460215866|FG000|Overall Study|Met Withdrawal Criteria|1|||
127888884|NCT01361607|460215867|FG001|Overall Study|Met Withdrawal Criteria|1|||
127888885|NCT01809314|460215868|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
127888886|NCT01809314|460215868|FG000|Overall Study|Adverse Event|6|||
127888887|NCT01809314|460215868|FG000|Overall Study|Insufficient Therapeutic Response|14|||
127888888|NCT01809314|460215868|FG000|Overall Study|Lost to Follow-up|724|||
127888889|NCT01814137|460215869|FG000|Overall Study|Adverse Event|0|||
127888890|NCT01814137|460215870|FG001|Overall Study|Adverse Event|1|||
127888891|NCT01814137|460215869|FG000|Overall Study|Withdrawal by Subject|2|||
127888892|NCT01814137|460215870|FG001|Overall Study|Withdrawal by Subject|2|||
127888893|NCT01814137|460215869|FG000|Overall Study|Physician Decision|1|||
127888894|NCT01814137|460215870|FG001|Overall Study|Physician Decision|1|||
127888895|NCT01814137|460215869|FG000|Overall Study|Unclassified|2|||
127888896|NCT01814137|460215870|FG001|Overall Study|Unclassified|1|||
127888897|NCT00219557|460215871|FG000|Phase 1|Lack of Efficacy|3|||
127888898|NCT00219557|460215872|FG001|Phase 1|Lack of Efficacy|0|||
127888899|NCT00219557|460215873|FG002|Phase 1|Lack of Efficacy|0|||
127888900|NCT00219557|460215871|FG000|Phase 1|Adverse Event|2|||
127888901|NCT00219557|460215872|FG001|Phase 1|Adverse Event|0|||
127888902|NCT00219557|460215873|FG002|Phase 1|Adverse Event|0|||
127888903|NCT00219557|460215871|FG000|Phase 1|Withdrawal by Subject|1|||
127888904|NCT00219557|460215872|FG001|Phase 1|Withdrawal by Subject|0|||
127888905|NCT00219557|460215873|FG002|Phase 1|Withdrawal by Subject|0|||
127888906|NCT00219557|460215871|FG000|Phase 1|Started chemotherapy at other institute|1|||
127888907|NCT00219557|460215872|FG001|Phase 1|Started chemotherapy at other institute|0|||
127888908|NCT00219557|460215873|FG002|Phase 1|Started chemotherapy at other institute|0|||
127888909|NCT00219557|460215871|FG000|Phase 2|Lack of Efficacy|0|||
127888910|NCT00219557|460215872|FG001|Phase 2|Lack of Efficacy|21|||
127888911|NCT00219557|460215873|FG002|Phase 2|Lack of Efficacy|15|||
127888912|NCT00219557|460215871|FG000|Phase 2|Adverse Event|0|||
127888913|NCT00219557|460215872|FG001|Phase 2|Adverse Event|22|||
127888914|NCT00219557|460215873|FG002|Phase 2|Adverse Event|2|||
127888915|NCT00219557|460215871|FG000|Phase 2|Death|0|||
127888916|NCT00219557|460215872|FG001|Phase 2|Death|8|||
127888917|NCT00219557|460215873|FG002|Phase 2|Death|2|||
127888918|NCT00219557|460215871|FG000|Phase 2|Other|0|||
127888919|NCT00219557|460215872|FG001|Phase 2|Other|8|||
127888920|NCT00219557|460215873|FG002|Phase 2|Other|6|||
127888921|NCT00219557|460215871|FG000|Phase 2|Withdrawal by Subject|0|||
127888922|NCT00219557|460215872|FG001|Phase 2|Withdrawal by Subject|9|||
127888923|NCT00219557|460215873|FG002|Phase 2|Withdrawal by Subject|5|||
127888924|NCT00219557|460215871|FG000|Phase 2|Treatment not received|0|||
127888925|NCT00219557|460215872|FG001|Phase 2|Treatment not received|1|||
127888926|NCT00219557|460215873|FG002|Phase 2|Treatment not received|3|||
127888927|NCT01427803|460215878|FG000|Overall Study|Lost to Follow-up|32|||
127888928|NCT01427803|460215879|FG001|Overall Study|Lost to Follow-up|26|||
127888929|NCT01427803|460215878|FG000|Overall Study|Withdrawal by Subject|20|||
127888930|NCT01427803|460215879|FG001|Overall Study|Withdrawal by Subject|0|||
127888931|NCT01427803|460215878|FG000|Overall Study|Unable to complete full treatment period|6|||
127888932|NCT01427803|460215879|FG001|Overall Study|Unable to complete full treatment period|0|||
127888933|NCT01427803|460215878|FG000|Overall Study|Protocol Violation|1|||
127888934|NCT01427803|460215879|FG001|Overall Study|Protocol Violation|0|||
127888935|NCT01427803|460215878|FG000|Overall Study|Physician Decision|3|||
127888936|NCT01427803|460215879|FG001|Overall Study|Physician Decision|0|||
127888937|NCT01427803|460215878|FG000|Overall Study|did not take product|1|||
127888938|NCT01427803|460215879|FG001|Overall Study|did not take product|0|||
127888939|NCT00863057|460215882|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
127888940|NCT00863057|460215883|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
127888941|NCT00863057|460215884|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
127888942|NCT00863057|460215885|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
127888943|NCT00863057|460215882|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
127721787|NCT00822900|459608518|FG000|Overall Study|Became a ward of the state|2|||
127721788|NCT00822900|459608519|FG001|Overall Study|Became a ward of the state|1|||
127721789|NCT02095678|459608520|FG000|Overall Study|Withdrawal by Subject|0|||
127888944|NCT00863057|460215883|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
127888945|NCT00863057|460215884|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
127888946|NCT00863057|460215885|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
127888947|NCT00863057|460215882|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
127888948|NCT00863057|460215883|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
127888949|NCT00863057|460215884|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
127888950|NCT00863057|460215885|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
127888951|NCT00863057|460215882|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
127721790|NCT02095678|459608521|FG001|Overall Study|Withdrawal by Subject|1|||
127721791|NCT02095678|459608520|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
127721792|NCT02095678|459608521|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
127721793|NCT02095678|459608520|FG000|Overall Study|lesion impacted by previous treatment|1|||
127721794|NCT02095678|459608521|FG001|Overall Study|lesion impacted by previous treatment|1|||
127721795|NCT02095678|459608520|FG000|Overall Study|No Confirmed Diagnosis|0|||
127721796|NCT02095678|459608521|FG001|Overall Study|No Confirmed Diagnosis|3|||
127721797|NCT02095678|459608520|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
127721798|NCT02095678|459608521|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
127721799|NCT02095678|459608520|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
127721800|NCT02095678|459608521|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
127721801|NCT00701415|459608522|FG000|Overall Study|Adverse Event|0|||
127721802|NCT00701415|459608523|FG001|Overall Study|Adverse Event|1|||
127721803|NCT00701415|459608522|FG000|Overall Study|Social/family issues and needle phobia|1|||
127721804|NCT00701415|459608523|FG001|Overall Study|Social/family issues and needle phobia|0|||
127721805|NCT02106884|459608524|FG000|Overall Study|Change of diagnosis/exclusion|0|||
127721806|NCT02106884|459608525|FG001|Overall Study|Change of diagnosis/exclusion|1|||
127802859|NCT01960855|459901067|FG001|Overall Study|Consent withdrawn by subject|1|||
127802860|NCT01960855|459901068|FG002|Overall Study|Consent withdrawn by subject|2|||
127802861|NCT01960855|459901069|FG003|Overall Study|Consent withdrawn by subject|1|||
127802862|NCT01960855|459901070|FG004|Overall Study|Consent withdrawn by subject|1|||
127802863|NCT01960855|459901066|FG000|Overall Study|Lost to Follow-up|2|||
127802864|NCT01960855|459901067|FG001|Overall Study|Lost to Follow-up|1|||
127802865|NCT01960855|459901068|FG002|Overall Study|Lost to Follow-up|0|||
127802866|NCT01960855|459901069|FG003|Overall Study|Lost to Follow-up|0|||
127802867|NCT01960855|459901070|FG004|Overall Study|Lost to Follow-up|2|||
127802868|NCT02058147|459901071|FG000|Overall Study|Randomized but not treated|0|||
127802869|NCT02058147|459901072|FG001|Overall Study|Randomized but not treated|0|||
127802870|NCT02058147|459901073|FG002|Overall Study|Randomized but not treated|1|||
127802871|NCT02058147|459901071|FG000|Overall Study|Adverse Event|12|||
127802872|NCT02058147|459901072|FG001|Overall Study|Adverse Event|9|||
127802873|NCT02058147|459901073|FG002|Overall Study|Adverse Event|21|||
127802874|NCT02058147|459901071|FG000|Overall Study|Lack of Efficacy|1|||
127802875|NCT02058147|459901072|FG001|Overall Study|Lack of Efficacy|0|||
127802876|NCT02058147|459901073|FG002|Overall Study|Lack of Efficacy|3|||
127802877|NCT02058147|459901071|FG000|Overall Study|Poor compliance to protocol|8|||
127802878|NCT02058147|459901072|FG001|Overall Study|Poor compliance to protocol|9|||
127802879|NCT02058147|459901073|FG002|Overall Study|Poor compliance to protocol|4|||
127802880|NCT02058147|459901071|FG000|Overall Study|Other than specified|8|||
127802881|NCT02058147|459901072|FG001|Overall Study|Other than specified|9|||
127802882|NCT02058147|459901073|FG002|Overall Study|Other than specified|0|||
127802883|NCT03604445|459901080|FG000|Overall Study|Death|0|||
127802884|NCT03604445|459901081|FG001|Overall Study|Death|0|||
127802885|NCT03604445|459901082|FG002|Overall Study|Death|0|||
127802886|NCT03604445|459901083|FG003|Overall Study|Death|0|||
127802887|NCT03604445|459901084|FG004|Overall Study|Death|0|||
127802888|NCT03604445|459901085|FG005|Overall Study|Death|0|||
127802889|NCT03604445|459901086|FG006|Overall Study|Death|0|||
127802890|NCT03604445|459901087|FG007|Overall Study|Death|0|||
127802891|NCT03604445|459901088|FG008|Overall Study|Death|1|||
127802892|NCT03604445|459901080|FG000|Overall Study|Withdrawal by Subject|0|||
127802893|NCT03604445|459901081|FG001|Overall Study|Withdrawal by Subject|0|||
127802894|NCT03604445|459901082|FG002|Overall Study|Withdrawal by Subject|0|||
127802895|NCT03604445|459901083|FG003|Overall Study|Withdrawal by Subject|0|||
127802896|NCT03604445|459901084|FG004|Overall Study|Withdrawal by Subject|0|||
127802897|NCT03604445|459901085|FG005|Overall Study|Withdrawal by Subject|0|||
127802898|NCT03604445|459901086|FG006|Overall Study|Withdrawal by Subject|1|||
127802899|NCT03604445|459901087|FG007|Overall Study|Withdrawal by Subject|0|||
127802900|NCT03604445|459901088|FG008|Overall Study|Withdrawal by Subject|0|||
127802901|NCT03604445|459901080|FG000|Overall Study|Missing visit|0|||
127802902|NCT03604445|459901081|FG001|Overall Study|Missing visit|0|||
127802903|NCT03604445|459901082|FG002|Overall Study|Missing visit|0|||
127802904|NCT03604445|459901083|FG003|Overall Study|Missing visit|0|||
127802905|NCT03604445|459901084|FG004|Overall Study|Missing visit|0|||
127802906|NCT03604445|459901085|FG005|Overall Study|Missing visit|1|||
127802907|NCT03604445|459901086|FG006|Overall Study|Missing visit|0|||
127802908|NCT03604445|459901087|FG007|Overall Study|Missing visit|1|||
127802909|NCT03604445|459901088|FG008|Overall Study|Missing visit|0|||
127802910|NCT03604445|459901080|FG000|Overall Study|Adverse Event|0|||
127802911|NCT03604445|459901081|FG001|Overall Study|Adverse Event|0|||
127802912|NCT03604445|459901082|FG002|Overall Study|Adverse Event|0|||
127802913|NCT03604445|459901083|FG003|Overall Study|Adverse Event|1|||
127721807|NCT02161458|459608526|FG000|Overall Study|Withdrawal by Subject|0|||
127721808|NCT02161458|459608527|FG001|Overall Study|Withdrawal by Subject|4|||
127721809|NCT02161458|459608528|FG002|Overall Study|Withdrawal by Subject|4|||
127721810|NCT02161458|459608529|FG003|Overall Study|Withdrawal by Subject|0|||
127721811|NCT02161458|459608526|FG000|Overall Study|Lost to Follow-up|0|||
127721812|NCT02161458|459608527|FG001|Overall Study|Lost to Follow-up|2|||
127721813|NCT02161458|459608528|FG002|Overall Study|Lost to Follow-up|1|||
127721814|NCT02161458|459608529|FG003|Overall Study|Lost to Follow-up|0|||
127721815|NCT01560429|459608530|FG000|Overall Study|Protocol Violation|3|||
127721816|NCT01560429|459608531|FG001|Overall Study|Protocol Violation|6|||
127721817|NCT00705159|459608532|FG000|Overall Study|Withdrawal by Subject|0|||
127721818|NCT00705159|459608533|FG001|Overall Study|Withdrawal by Subject|1|||
127721819|NCT00705159|459608534|FG002|Overall Study|Withdrawal by Subject|1|||
127721820|NCT00705159|459608535|FG003|Overall Study|Withdrawal by Subject|1|||
127721821|NCT00705159|459608532|FG000|Overall Study|Protocol Violation|0|||
127721822|NCT00705159|459608533|FG001|Overall Study|Protocol Violation|1|||
127721823|NCT00705159|459608534|FG002|Overall Study|Protocol Violation|0|||
127721824|NCT00705159|459608535|FG003|Overall Study|Protocol Violation|0|||
127721825|NCT00705159|459608532|FG000|Overall Study|Adverse Event|0|||
127721826|NCT00705159|459608533|FG001|Overall Study|Adverse Event|0|||
127721827|NCT00705159|459608534|FG002|Overall Study|Adverse Event|1|||
127721828|NCT00705159|459608535|FG003|Overall Study|Adverse Event|0|||
127721829|NCT00705159|459608532|FG000|Overall Study|Lost to Follow-up|0|||
127721830|NCT00705159|459608533|FG001|Overall Study|Lost to Follow-up|0|||
127721831|NCT00705159|459608534|FG002|Overall Study|Lost to Follow-up|3|||
127721832|NCT00705159|459608535|FG003|Overall Study|Lost to Follow-up|2|||
127721833|NCT00705159|459608532|FG000|Overall Study|Screen Failure|0|||
127721834|NCT00705159|459608533|FG001|Overall Study|Screen Failure|0|||
127721835|NCT00705159|459608534|FG002|Overall Study|Screen Failure|0|||
127721836|NCT00705159|459608535|FG003|Overall Study|Screen Failure|1|||
127721837|NCT03026166|459608538|FG000|Overall Study|Death|22|||
127721838|NCT03026166|459608539|FG001|Overall Study|Death|7|||
127721839|NCT03026166|459608538|FG000|Overall Study|Physician Decision|2|||
127721840|NCT03026166|459608539|FG001|Overall Study|Physician Decision|0|||
127721841|NCT03026166|459608538|FG000|Overall Study|Withdrawal by Subject|1|||
127721842|NCT03026166|459608539|FG001|Overall Study|Withdrawal by Subject|2|||
127721843|NCT03026166|459608538|FG000|Overall Study|Lost to Follow-up|1|||
127721844|NCT03026166|459608539|FG001|Overall Study|Lost to Follow-up|0|||
127721845|NCT03026166|459608538|FG000|Overall Study|Study Terminated by Sponsor|3|||
127721846|NCT03026166|459608539|FG001|Overall Study|Study Terminated by Sponsor|3|||
127721847|NCT03026166|459608538|FG000|Overall Study|Other|1|||
127721848|NCT03026166|459608539|FG001|Overall Study|Other|0|||
127721849|NCT02091752|459608540|FG000|Overall Study|Study terminated by Sponsor|2|||
127721850|NCT02091752|459608540|FG000|Overall Study|Adverse Event|1|||
127721851|NCT01989104|459608541|FG000|Overall Study|Withdrawal by Subject|3|||
127721852|NCT01989104|459608542|FG001|Overall Study|Withdrawal by Subject|0|||
127721853|NCT01989104|459608543|FG002|Overall Study|Withdrawal by Subject|0|||
127721854|NCT01989104|459608544|FG003|Overall Study|Withdrawal by Subject|0|||
127721855|NCT01989104|459608545|FG004|Overall Study|Withdrawal by Subject|0|||
127721856|NCT01604824|459608550|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
127721857|NCT01604824|459608551|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
127721858|NCT01604824|459608552|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
127721859|NCT01604824|459608553|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
127721860|NCT01604824|459608554|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
127721861|NCT01604824|459608555|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
127721862|NCT01604824|459608550|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
127721863|NCT01604824|459608551|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
127721864|NCT01604824|459608552|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
127721865|NCT01604824|459608553|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
127721866|NCT01604824|459608554|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
127721867|NCT01604824|459608555|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
127721868|NCT03775213|459608562|FG000|Overall Study|Withdrawal by Subject|51|||
127802914|NCT03604445|459901084|FG004|Overall Study|Adverse Event|0|||
127721869|NCT03775213|459608563|FG001|Overall Study|Withdrawal by Subject|53|||
127721870|NCT03775213|459608562|FG000|Overall Study|Incomplete Survey|7|||
127721871|NCT03775213|459608563|FG001|Overall Study|Incomplete Survey|7|||
127721872|NCT04821271|459608564|FG000|Period 1|Withdrawal by Subject|2|||
127721873|NCT04821271|459608565|FG001|Period 1|Withdrawal by Subject|0|||
127721874|NCT04076059|459608566|FG000|Double Blind Phase|Progressive disease|22|||
127721875|NCT04076059|459608567|FG001|Double Blind Phase|Progressive disease|26|||
127721876|NCT04076059|459608568|FG002|Double Blind Phase|Progressive disease|0|||
127721877|NCT04076059|459608566|FG000|Double Blind Phase|Withdrawal by Subject|4|||
127721878|NCT04076059|459608567|FG001|Double Blind Phase|Withdrawal by Subject|11|||
127802915|NCT03604445|459901085|FG005|Overall Study|Adverse Event|0|||
127721879|NCT04076059|459608568|FG002|Double Blind Phase|Withdrawal by Subject|0|||
127721880|NCT04076059|459608566|FG000|Double Blind Phase|Death|1|||
127721881|NCT04076059|459608567|FG001|Double Blind Phase|Death|1|||
127721882|NCT04076059|459608568|FG002|Double Blind Phase|Death|0|||
127721883|NCT04076059|459608566|FG000|Double Blind Phase|Lost to Follow-up|1|||
127721884|NCT04076059|459608567|FG001|Double Blind Phase|Lost to Follow-up|0|||
127721885|NCT04076059|459608568|FG002|Double Blind Phase|Lost to Follow-up|0|||
127721886|NCT04076059|459608566|FG000|Double Blind Phase|Adverse Event|5|||
127721887|NCT04076059|459608567|FG001|Double Blind Phase|Adverse Event|1|||
127721888|NCT04076059|459608568|FG002|Double Blind Phase|Adverse Event|0|||
127721889|NCT04076059|459608566|FG000|Double Blind Phase|Ongoing Participants|82|||
127721890|NCT04076059|459608567|FG001|Double Blind Phase|Ongoing Participants|18|||
127721891|NCT04076059|459608568|FG002|Double Blind Phase|Ongoing Participants|0|||
127721892|NCT04076059|459608566|FG000|Double Blind Phase|Miscellaneous|3|||
127721893|NCT04076059|459608567|FG001|Double Blind Phase|Miscellaneous|1|||
127888952|NCT00863057|460215883|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
127888953|NCT00863057|460215884|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
127888954|NCT00863057|460215885|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
127888955|NCT05266456|460215887|FG000|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
127721894|NCT04076059|459608568|FG002|Double Blind Phase|Miscellaneous|0|||
127721895|NCT04076059|459608566|FG000|Double Blind Phase|Protocol Deviation|1|||
127721896|NCT04076059|459608567|FG001|Double Blind Phase|Protocol Deviation|1|||
127888956|NCT05266456|460215888|FG001|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
127888957|NCT05266456|460215889|FG002|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
127888958|NCT05266456|460215890|FG003|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
127721897|NCT04076059|459608568|FG002|Double Blind Phase|Protocol Deviation|0|||
127721898|NCT04076059|459608566|FG000|Double Blind Phase|Did not take study drug|1|||
127721899|NCT04076059|459608567|FG001|Double Blind Phase|Did not take study drug|1|||
127721900|NCT04076059|459608568|FG002|Double Blind Phase|Did not take study drug|0|||
127721901|NCT04076059|459608566|FG000|Open Label Phase|Progressive disease|0|||
127721902|NCT04076059|459608567|FG001|Open Label Phase|Progressive disease|0|||
127721903|NCT04076059|459608568|FG002|Open Label Phase|Progressive disease|7|||
127721904|NCT04076059|459608566|FG000|Open Label Phase|Withdrawal by Subject|0|||
127721905|NCT04076059|459608567|FG001|Open Label Phase|Withdrawal by Subject|0|||
127721906|NCT04076059|459608568|FG002|Open Label Phase|Withdrawal by Subject|3|||
127721907|NCT04076059|459608566|FG000|Open Label Phase|Death|0|||
127721908|NCT04076059|459608567|FG001|Open Label Phase|Death|0|||
127721909|NCT04076059|459608568|FG002|Open Label Phase|Death|2|||
127721910|NCT04076059|459608566|FG000|Open Label Phase|Ongoing Participants|0|||
127721911|NCT04076059|459608567|FG001|Open Label Phase|Ongoing Participants|0|||
127721912|NCT04076059|459608568|FG002|Open Label Phase|Ongoing Participants|11|||
127721913|NCT00949117|459609757|FG000|Overall Study|Lack of Efficacy|2|||
127721914|NCT00949117|459609758|FG001|Overall Study|Lack of Efficacy|3|||
127721915|NCT00949117|459609757|FG000|Overall Study|Protocol Violation|1|||
127721916|NCT00949117|459609758|FG001|Overall Study|Protocol Violation|1|||
127721917|NCT00949117|459609757|FG000|Overall Study|Adverse Event|0|||
127721918|NCT00949117|459609758|FG001|Overall Study|Adverse Event|1|||
127721919|NCT00799409|459609759|FG000|Overall Study|Withdrawal by Subject|1|||
127721920|NCT00799409|459609760|FG001|Overall Study|Withdrawal by Subject|0|||
127721921|NCT00799409|459609761|FG002|Overall Study|Withdrawal by Subject|0|||
127721922|NCT00799409|459609759|FG000|Overall Study|Lost to Follow-up|1|||
127721923|NCT00799409|459609760|FG001|Overall Study|Lost to Follow-up|0|||
127721924|NCT00799409|459609761|FG002|Overall Study|Lost to Follow-up|0|||
127721925|NCT00799409|459609759|FG000|Overall Study|Optimal Dose Not Achieved|2|||
127721926|NCT00799409|459609760|FG001|Overall Study|Optimal Dose Not Achieved|0|||
127721927|NCT00799409|459609761|FG002|Overall Study|Optimal Dose Not Achieved|0|||
127721928|NCT00799409|459609759|FG000|Overall Study|Failure to follow study protocol)|1|||
127721929|NCT00799409|459609760|FG001|Overall Study|Failure to follow study protocol)|0|||
127721930|NCT00799409|459609761|FG002|Overall Study|Failure to follow study protocol)|0|||
127721931|NCT00799409|459609759|FG000|Overall Study|Did not attend lab school day 1|1|||
127721932|NCT00799409|459609760|FG001|Overall Study|Did not attend lab school day 1|0|||
127721933|NCT00799409|459609761|FG002|Overall Study|Did not attend lab school day 1|0|||
127721934|NCT00799409|459609759|FG000|Overall Study|medication compliance|1|||
127721935|NCT00799409|459609760|FG001|Overall Study|medication compliance|0|||
127721936|NCT00799409|459609761|FG002|Overall Study|medication compliance|0|||
127721937|NCT03964974|459609762|FG000|Overall Study|Lost to Follow-up|3|||
127721938|NCT03964974|459609763|FG001|Overall Study|Lost to Follow-up|2|||
127721939|NCT03964974|459609762|FG000|Overall Study|Withdrawal by Subject|0|||
127721940|NCT03964974|459609763|FG001|Overall Study|Withdrawal by Subject|3|||
127721941|NCT02713594|459609764|FG000|Overall Study|Withdrawal by Subject|32|||
127721942|NCT02713594|459609765|FG001|Overall Study|Withdrawal by Subject|22|||
127721943|NCT02713594|459609764|FG000|Overall Study|Lost to Follow-up|358|||
127721944|NCT02713594|459609765|FG001|Overall Study|Lost to Follow-up|374|||
127888959|NCT05266456|460215887|FG000|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
127888960|NCT05266456|460215888|FG001|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
127888961|NCT05266456|460215889|FG002|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
127888962|NCT05266456|460215890|FG003|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|1|||
127888963|NCT05266456|460215887|FG000|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
127888964|NCT05266456|460215888|FG001|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
127888965|NCT05266456|460215889|FG002|Phase 2, Adults 50-64 Years|Lost to Follow-up|3|||
127888966|NCT05266456|460215890|FG003|Phase 2, Adults 50-64 Years|Lost to Follow-up|1|||
127888967|NCT05266456|460215887|FG000|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
127888968|NCT05266456|460215888|FG001|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
127888969|NCT05266456|460215889|FG002|Phase 2, Adults 50-64 Years|Withdrawal by Subject|2|||
127888970|NCT05266456|460215890|FG003|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
127888971|NCT05266456|460215887|FG000|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
127888972|NCT05266456|460215888|FG001|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
127888973|NCT05266456|460215889|FG002|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
127888974|NCT05266456|460215890|FG003|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
127888975|NCT01141283|460215891|FG000|Overall Study|Adverse Event|56|||
127888976|NCT01141283|460215891|FG000|Overall Study|Lost to Follow-up|4|||
127888977|NCT01141283|460215891|FG000|Overall Study|Withdrawal by Subject|14|||
127888978|NCT01141283|460215891|FG000|Overall Study|Administrative|4|||
127888979|NCT01141283|460215891|FG000|Overall Study|Lack of Efficacy|10|||
127888980|NCT03124381|460215892|FG000|Overall Study|Lost to Follow-up|1|||
127888981|NCT03124381|460215893|FG001|Overall Study|Lost to Follow-up|1|||
127888982|NCT03124381|460215892|FG000|Overall Study|Withdrawal by Subject|6|||
127888983|NCT03124381|460215893|FG001|Overall Study|Withdrawal by Subject|3|||
127888984|NCT03124381|460215892|FG000|Overall Study|Protocol Violation|0|||
127888985|NCT03124381|460215893|FG001|Overall Study|Protocol Violation|1|||
127888986|NCT03124381|460215892|FG000|Overall Study|Adverse Event|1|||
127888987|NCT03124381|460215893|FG001|Overall Study|Adverse Event|1|||
127888988|NCT03124381|460215892|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
127721945|NCT00670449|459609766|FG000|Overall Study|Adverse Event|6|||
127721946|NCT00670449|459609767|FG001|Overall Study|Adverse Event|2|||
127888989|NCT03124381|460215893|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
127888990|NCT02533999|460215896|FG000|Overall Study|Lost to Follow-up|3|||
127888991|NCT02533999|460215897|FG001|Overall Study|Lost to Follow-up|5|||
127888992|NCT02533999|460215896|FG000|Overall Study|Protocol Violation|3|||
127888993|NCT02533999|460215897|FG001|Overall Study|Protocol Violation|0|||
127888994|NCT02533999|460215896|FG000|Overall Study|Adverse Event|0|||
127888995|NCT02533999|460215897|FG001|Overall Study|Adverse Event|1|||
127888996|NCT02533999|460215896|FG000|Overall Study|Randomized but intervention not received|0|||
127721947|NCT00670449|459609768|FG002|Overall Study|Adverse Event|8|||
127721948|NCT00670449|459609769|FG003|Overall Study|Adverse Event|5|||
127721949|NCT00670449|459609766|FG000|Overall Study|Protocol Deviation|1|||
127721950|NCT00670449|459609767|FG001|Overall Study|Protocol Deviation|2|||
127721951|NCT00670449|459609768|FG002|Overall Study|Protocol Deviation|0|||
127721952|NCT00670449|459609769|FG003|Overall Study|Protocol Deviation|1|||
127721953|NCT00670449|459609766|FG000|Overall Study|Administrative Problems|0|||
127721954|NCT00670449|459609767|FG001|Overall Study|Administrative Problems|2|||
127721955|NCT00670449|459609768|FG002|Overall Study|Administrative Problems|0|||
127721956|NCT00670449|459609769|FG003|Overall Study|Administrative Problems|1|||
127721957|NCT00670449|459609766|FG000|Overall Study|Subject Withdrew Consent|0|||
127721958|NCT00670449|459609767|FG001|Overall Study|Subject Withdrew Consent|2|||
127721959|NCT00670449|459609768|FG002|Overall Study|Subject Withdrew Consent|0|||
127721960|NCT00670449|459609769|FG003|Overall Study|Subject Withdrew Consent|1|||
127721961|NCT00670449|459609766|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
127721962|NCT00670449|459609767|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
127721963|NCT00670449|459609768|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
127721964|NCT00670449|459609769|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
127721965|NCT00670449|459609766|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
127721966|NCT00670449|459609767|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
127721967|NCT00670449|459609768|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
127721968|NCT00670449|459609769|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
127888997|NCT02533999|460215897|FG001|Overall Study|Randomized but intervention not received|1|||
127888998|NCT01875445|460215898|FG000|Overall Study|Lost to Follow-up|5|||
127888999|NCT01875445|460215899|FG001|Overall Study|Lost to Follow-up|0|||
127889000|NCT01875445|460215898|FG000|Overall Study|Withdrawal by Subject|2|||
127889001|NCT01875445|460215899|FG001|Overall Study|Withdrawal by Subject|0|||
127721969|NCT02771366|459609770|FG000|Period 1|Withdrawal by Subject|0|||
127721970|NCT02771366|459609771|FG001|Period 1|Withdrawal by Subject|2|||
127721971|NCT02771366|459609770|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
127721972|NCT02771366|459609771|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
127721973|NCT01214200|459609774|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
127721974|NCT01214200|459609774|FG000|Overall Study|Withdrawal by Subject|2|||
127721975|NCT01719172|459609775|FG000|Overall Study|Lost to Follow-up|1|||
127721976|NCT01719172|459609775|FG000|Overall Study|Death|1|||
127721977|NCT04250636|459609778|FG000|Overall Study|Lost to Follow-up|2|||
127721978|NCT03041090|459609779|FG000|Overall Study|technical error|0|||
127721979|NCT03041090|459609780|FG001|Overall Study|technical error|3|||
127721980|NCT02202317|459609782|FG000|Overall Study|Lost to Follow-up|1|||
127721981|NCT03292406|459609786|FG000|Overall Study|Progressive Disease|6|||
127721982|NCT03292406|459609787|FG001|Overall Study|Progressive Disease|3|||
127721983|NCT03292406|459609788|FG002|Overall Study|Progressive Disease|4|||
127721984|NCT03292406|459609786|FG000|Overall Study|Adverse Event|7|||
127721985|NCT03292406|459609787|FG001|Overall Study|Adverse Event|1|||
127721986|NCT03292406|459609788|FG002|Overall Study|Adverse Event|4|||
127721987|NCT03292406|459609786|FG000|Overall Study|Withdrawal by Subject|0|||
127721988|NCT03292406|459609787|FG001|Overall Study|Withdrawal by Subject|7|||
127721989|NCT03292406|459609788|FG002|Overall Study|Withdrawal by Subject|2|||
127721990|NCT03292406|459609786|FG000|Overall Study|Protocol Violation|0|||
127721991|NCT03292406|459609787|FG001|Overall Study|Protocol Violation|1|||
127721992|NCT03292406|459609788|FG002|Overall Study|Protocol Violation|1|||
127721993|NCT03292406|459609786|FG000|Overall Study|Other|0|||
127721994|NCT03292406|459609787|FG001|Overall Study|Other|1|||
127721995|NCT03292406|459609788|FG002|Overall Study|Other|2|||
127721996|NCT00022672|459609790|FG000|Main Phase: 24 Months|Adverse Event|6|||
127721997|NCT00022672|459609791|FG001|Main Phase: 24 Months|Adverse Event|0|||
127721998|NCT00022672|459609790|FG000|Main Phase: 24 Months|Death|0|||
127721999|NCT00022672|459609791|FG001|Main Phase: 24 Months|Death|3|||
127722000|NCT00022672|459609790|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
127722001|NCT00022672|459609791|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
127722002|NCT00022672|459609790|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
127722003|NCT00022672|459609791|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
127722004|NCT00022672|459609790|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
127722005|NCT00022672|459609791|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
127722006|NCT00022672|459609790|FG000|Main Phase: 24 Months|Refused Treatment|3|||
127722007|NCT00022672|459609791|FG001|Main Phase: 24 Months|Refused Treatment|4|||
127722008|NCT00022672|459609790|FG000|Main Phase: 24 Months|Failure to Return|1|||
127722009|NCT00022672|459609791|FG001|Main Phase: 24 Months|Failure to Return|1|||
127722010|NCT00022672|459609790|FG000|Main Phase: 24 Months|Other|1|||
127722011|NCT00022672|459609791|FG001|Main Phase: 24 Months|Other|0|||
127722012|NCT00022672|459609790|FG000|Extension Phase|Adverse Event|1|||
127722013|NCT00022672|459609791|FG001|Extension Phase|Adverse Event|3|||
127722014|NCT00022672|459609790|FG000|Extension Phase|Death|0|||
127722015|NCT00022672|459609791|FG001|Extension Phase|Death|1|||
127722016|NCT00022672|459609790|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
127722017|NCT00022672|459609791|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
127722018|NCT00022672|459609790|FG000|Extension Phase|Refused Treatment|0|||
127722019|NCT00022672|459609791|FG001|Extension Phase|Refused Treatment|2|||
127722020|NCT00022672|459609790|FG000|Extension Phase|Other|1|||
127722021|NCT00022672|459609791|FG001|Extension Phase|Other|1|||
127722022|NCT00403494|459609792|FG000|Overall Study|Adverse Event|10|||
127722023|NCT00403494|459609793|FG001|Overall Study|Adverse Event|8|||
127722024|NCT00403494|459609792|FG000|Overall Study|Withdrew Consent|3|||
127722025|NCT00403494|459609793|FG001|Overall Study|Withdrew Consent|2|||
127722026|NCT00403494|459609792|FG000|Overall Study|Inappropriately enrolled|0|||
127722027|NCT00403494|459609793|FG001|Overall Study|Inappropriately enrolled|1|||
127722028|NCT00403494|459609792|FG000|Overall Study|Lost to Follow-up|0|||
127722029|NCT00403494|459609793|FG001|Overall Study|Lost to Follow-up|2|||
127722030|NCT00403494|459609792|FG000|Overall Study|Protocol noncompliance|0|||
127722031|NCT00403494|459609793|FG001|Overall Study|Protocol noncompliance|1|||
127722032|NCT00403494|459609792|FG000|Overall Study|Death|1|||
127722033|NCT00403494|459609793|FG001|Overall Study|Death|0|||
127722034|NCT00403494|459609792|FG000|Overall Study|Sponsor Request|1|||
127889002|NCT01328054|460215900|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
127889003|NCT01328054|460215901|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
127722035|NCT00403494|459609793|FG001|Overall Study|Sponsor Request|0|||
127722036|NCT00047385|459609794|FG000|Overall Study|Death before any screening|2|||
127722037|NCT00047385|459609795|FG001|Overall Study|Death before any screening|5|||
127722038|NCT00047385|459609794|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
127722039|NCT00047385|459609795|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
127722040|NCT00047385|459609794|FG000|Overall Study|Eligible for screening but had no screen|260|||
127722041|NCT00047385|459609795|FG001|Overall Study|Eligible for screening but had no screen|492|||
127722042|NCT03490032|459609796|FG000|Overall Study|family issue (child custody)|1|||
127722043|NCT03490032|459609797|FG001|Overall Study|family issue (child custody)|0|||
127722044|NCT03490032|459609798|FG002|Overall Study|family issue (child custody)|0|||
127722045|NCT01852045|459609799|FG000|Overall Study|Adverse Event|1|||
127722046|NCT01852045|459609800|FG001|Overall Study|Adverse Event|0|||
127722047|NCT01852045|459609801|FG002|Overall Study|Adverse Event|0|||
127889004|NCT01328054|460215900|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
127889005|NCT01328054|460215901|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
127889006|NCT01328054|460215900|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
127889007|NCT01328054|460215901|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
127722048|NCT01852045|459609799|FG000|Overall Study|Lack of Efficacy|3|||
127722049|NCT01852045|459609800|FG001|Overall Study|Lack of Efficacy|0|||
127722050|NCT01852045|459609801|FG002|Overall Study|Lack of Efficacy|0|||
127722051|NCT01852045|459609799|FG000|Overall Study|Lost to Follow-up|0|||
127722052|NCT01852045|459609800|FG001|Overall Study|Lost to Follow-up|1|||
127722053|NCT01852045|459609801|FG002|Overall Study|Lost to Follow-up|1|||
127722054|NCT01852045|459609799|FG000|Overall Study|Withdrawal by Subject|1|||
127722055|NCT01852045|459609800|FG001|Overall Study|Withdrawal by Subject|0|||
127722056|NCT01852045|459609801|FG002|Overall Study|Withdrawal by Subject|1|||
127722057|NCT01852045|459609799|FG000|Overall Study|Other Miscellaneous Reasons|1|||
127722058|NCT01852045|459609800|FG001|Overall Study|Other Miscellaneous Reasons|3|||
127722059|NCT01852045|459609801|FG002|Overall Study|Other Miscellaneous Reasons|2|||
127722060|NCT02007070|459609803|FG000|Overall Study|Adverse Event|4|||
127722061|NCT02007070|459609803|FG000|Overall Study|Clinical Progression|4|||
127722062|NCT02007070|459609803|FG000|Overall Study|Death|1|||
127722063|NCT02007070|459609803|FG000|Overall Study|Protocol Violation|2|||
127722064|NCT02007070|459609803|FG000|Overall Study|Physician Decision|1|||
127722065|NCT02007070|459609803|FG000|Overall Study|Progressive Disease|21|||
127722066|NCT03052517|459609806|FG000|Overall Study|Study Terminated By Sponsor|928|||
127722067|NCT03052517|459609807|FG001|Overall Study|Study Terminated By Sponsor|938|||
127722068|NCT03052517|459609808|FG002|Overall Study|Study Terminated By Sponsor|296|||
127722069|NCT03052517|459609806|FG000|Overall Study|Subject/Guardian Decision|50|||
127722070|NCT03052517|459609807|FG001|Overall Study|Subject/Guardian Decision|45|||
127722071|NCT03052517|459609808|FG002|Overall Study|Subject/Guardian Decision|22|||
127722072|NCT03052517|459609806|FG000|Overall Study|Lack of Efficacy|23|||
127722073|NCT03052517|459609807|FG001|Overall Study|Lack of Efficacy|14|||
127722074|NCT03052517|459609808|FG002|Overall Study|Lack of Efficacy|7|||
127722075|NCT03052517|459609806|FG000|Overall Study|Adverse Event|6|||
127722076|NCT03052517|459609807|FG001|Overall Study|Adverse Event|5|||
127722077|NCT03052517|459609808|FG002|Overall Study|Adverse Event|0|||
127722078|NCT03052517|459609806|FG000|Overall Study|Physician Decision|4|||
127722079|NCT03052517|459609807|FG001|Overall Study|Physician Decision|5|||
127722080|NCT03052517|459609808|FG002|Overall Study|Physician Decision|1|||
127722081|NCT03052517|459609806|FG000|Overall Study|Death|3|||
127722082|NCT03052517|459609807|FG001|Overall Study|Death|0|||
127722083|NCT03052517|459609808|FG002|Overall Study|Death|1|||
127722084|NCT03052517|459609806|FG000|Overall Study|Lost to Follow-up|2|||
127722085|NCT03052517|459609807|FG001|Overall Study|Lost to Follow-up|4|||
127722086|NCT03052517|459609808|FG002|Overall Study|Lost to Follow-up|0|||
127722087|NCT03052517|459609806|FG000|Overall Study|Pregnancy|1|||
127722088|NCT03052517|459609807|FG001|Overall Study|Pregnancy|0|||
127722089|NCT03052517|459609808|FG002|Overall Study|Pregnancy|1|||
127722090|NCT03052517|459609806|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
127722091|NCT03052517|459609807|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
127722092|NCT03052517|459609808|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
127722093|NCT03052517|459609806|FG000|Overall Study|Technical Problems|0|||
127722094|NCT03052517|459609807|FG001|Overall Study|Technical Problems|1|||
127722095|NCT03052517|459609808|FG002|Overall Study|Technical Problems|0|||
127722096|NCT02404441|459609812|FG000|Phase 1 Part|Adverse Event|1|||
127722097|NCT02404441|459609813|FG001|Phase 1 Part|Adverse Event|0|||
127722098|NCT02404441|459609814|FG002|Phase 1 Part|Adverse Event|0|||
127722099|NCT02404441|459609815|FG003|Phase 1 Part|Adverse Event|0|||
127722100|NCT02404441|459609816|FG004|Phase 1 Part|Adverse Event|0|||
127722101|NCT02404441|459609817|FG005|Phase 1 Part|Adverse Event|0|||
127722102|NCT02404441|459609818|FG006|Phase 1 Part|Adverse Event|0|||
127722103|NCT02404441|459609819|FG007|Phase 1 Part|Adverse Event|0|||
127722104|NCT02404441|459609820|FG008|Phase 1 Part|Adverse Event|0|||
127722105|NCT02404441|459609821|FG009|Phase 1 Part|Adverse Event|0|||
127722106|NCT02404441|459609812|FG000|Phase 1 Part|Physician Decision|0|||
127722107|NCT02404441|459609813|FG001|Phase 1 Part|Physician Decision|1|||
127722108|NCT02404441|459609814|FG002|Phase 1 Part|Physician Decision|0|||
127722109|NCT02404441|459609815|FG003|Phase 1 Part|Physician Decision|0|||
127722110|NCT02404441|459609816|FG004|Phase 1 Part|Physician Decision|0|||
127722111|NCT02404441|459609817|FG005|Phase 1 Part|Physician Decision|0|||
127722112|NCT02404441|459609818|FG006|Phase 1 Part|Physician Decision|0|||
127722113|NCT02404441|459609819|FG007|Phase 1 Part|Physician Decision|0|||
127722114|NCT02404441|459609820|FG008|Phase 1 Part|Physician Decision|0|||
127722115|NCT02404441|459609821|FG009|Phase 1 Part|Physician Decision|0|||
127722116|NCT02404441|459609812|FG000|Phase 1 Part|Progressive Disease|14|||
127722117|NCT02404441|459609813|FG001|Phase 1 Part|Progressive Disease|11|||
127722118|NCT02404441|459609814|FG002|Phase 1 Part|Progressive Disease|7|||
127722119|NCT02404441|459609815|FG003|Phase 1 Part|Progressive Disease|6|||
127889008|NCT00291330|460215904|FG000|Overall Study|Adverse Event|47|||
127889009|NCT00291330|460215905|FG001|Overall Study|Adverse Event|40|||
127889010|NCT00291330|460215904|FG000|Overall Study|Protocol Violation|13|||
127889011|NCT00291330|460215905|FG001|Overall Study|Protocol Violation|20|||
127889012|NCT00291330|460215904|FG000|Overall Study|Lost to Follow-up|16|||
127889013|NCT00291330|460215905|FG001|Overall Study|Lost to Follow-up|11|||
127889014|NCT00291330|460215904|FG000|Overall Study|Withdrawal by Subject|22|||
127889015|NCT00291330|460215905|FG001|Overall Study|Withdrawal by Subject|25|||
127889016|NCT00291330|460215904|FG000|Overall Study|Other|3|||
127889017|NCT00291330|460215905|FG001|Overall Study|Other|1|||
127889018|NCT02378506|460215910|FG000|Overall Study|Lack of Efficacy|3|||
127889019|NCT02378506|460215910|FG000|Overall Study|Withdrawal by Subject|4|||
127889020|NCT02378506|460215910|FG000|Overall Study|Protocol Violation|2|||
127889021|NCT02378506|460215910|FG000|Overall Study|Death|1|||
127889022|NCT02378506|460215910|FG000|Overall Study|Adverse Event|14|||
127722120|NCT02404441|459609816|FG004|Phase 1 Part|Progressive Disease|9|||
127722121|NCT02404441|459609817|FG005|Phase 1 Part|Progressive Disease|0|||
127722122|NCT02404441|459609818|FG006|Phase 1 Part|Progressive Disease|0|||
127722123|NCT02404441|459609819|FG007|Phase 1 Part|Progressive Disease|0|||
127722124|NCT02404441|459609820|FG008|Phase 1 Part|Progressive Disease|0|||
127722125|NCT02404441|459609821|FG009|Phase 1 Part|Progressive Disease|0|||
127722126|NCT02404441|459609812|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
127722127|NCT02404441|459609813|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
127722128|NCT02404441|459609814|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
127722129|NCT02404441|459609815|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
127722130|NCT02404441|459609816|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
127722131|NCT02404441|459609817|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
127722132|NCT02404441|459609818|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
127722133|NCT02404441|459609819|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
127722134|NCT02404441|459609820|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
127722135|NCT02404441|459609821|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
127722136|NCT02404441|459609812|FG000|Phase 1 Part|Death|1|||
127722137|NCT02404441|459609813|FG001|Phase 1 Part|Death|1|||
127722138|NCT02404441|459609814|FG002|Phase 1 Part|Death|1|||
127722139|NCT02404441|459609815|FG003|Phase 1 Part|Death|0|||
127722140|NCT02404441|459609816|FG004|Phase 1 Part|Death|1|||
127722141|NCT02404441|459609817|FG005|Phase 1 Part|Death|0|||
127722142|NCT02404441|459609818|FG006|Phase 1 Part|Death|0|||
127722143|NCT02404441|459609819|FG007|Phase 1 Part|Death|0|||
127722144|NCT02404441|459609820|FG008|Phase 1 Part|Death|0|||
127722145|NCT02404441|459609821|FG009|Phase 1 Part|Death|0|||
127722146|NCT02404441|459609812|FG000|Phase 2 Part|Adverse Event|0|||
127722147|NCT02404441|459609813|FG001|Phase 2 Part|Adverse Event|0|||
127722148|NCT02404441|459609814|FG002|Phase 2 Part|Adverse Event|0|||
127889023|NCT02378506|460215910|FG000|Overall Study|Randomized But Not Treated|1|||
127722149|NCT02404441|459609815|FG003|Phase 2 Part|Adverse Event|0|||
127722150|NCT02404441|459609816|FG004|Phase 2 Part|Adverse Event|0|||
127722151|NCT02404441|459609817|FG005|Phase 2 Part|Adverse Event|2|||
127722152|NCT02404441|459609818|FG006|Phase 2 Part|Adverse Event|3|||
127722153|NCT02404441|459609819|FG007|Phase 2 Part|Adverse Event|3|||
127722154|NCT02404441|459609820|FG008|Phase 2 Part|Adverse Event|6|||
127722155|NCT02404441|459609821|FG009|Phase 2 Part|Adverse Event|1|||
127722156|NCT02404441|459609812|FG000|Phase 2 Part|Physician Decision|0|||
127722157|NCT02404441|459609813|FG001|Phase 2 Part|Physician Decision|0|||
127722158|NCT02404441|459609814|FG002|Phase 2 Part|Physician Decision|0|||
127722159|NCT02404441|459609815|FG003|Phase 2 Part|Physician Decision|0|||
127722160|NCT02404441|459609816|FG004|Phase 2 Part|Physician Decision|0|||
127722161|NCT02404441|459609817|FG005|Phase 2 Part|Physician Decision|7|||
127722162|NCT02404441|459609818|FG006|Phase 2 Part|Physician Decision|9|||
127722163|NCT02404441|459609819|FG007|Phase 2 Part|Physician Decision|2|||
127722164|NCT02404441|459609820|FG008|Phase 2 Part|Physician Decision|1|||
127722165|NCT02404441|459609821|FG009|Phase 2 Part|Physician Decision|3|||
127722166|NCT02404441|459609812|FG000|Phase 2 Part|Progressive disease|0|||
127722167|NCT02404441|459609813|FG001|Phase 2 Part|Progressive disease|0|||
127722168|NCT02404441|459609814|FG002|Phase 2 Part|Progressive disease|0|||
127889024|NCT01606137|460215911|FG000|Overall Study|Adverse Event|85|||
127889025|NCT01606137|460215911|FG000|Overall Study|Withdrawal by Subject|74|||
127889026|NCT01606137|460215911|FG000|Overall Study|Lack of Efficacy|56|||
127722169|NCT02404441|459609815|FG003|Phase 2 Part|Progressive disease|0|||
127722170|NCT02404441|459609816|FG004|Phase 2 Part|Progressive disease|0|||
127722171|NCT02404441|459609817|FG005|Phase 2 Part|Progressive disease|43|||
127722172|NCT02404441|459609818|FG006|Phase 2 Part|Progressive disease|32|||
127722173|NCT02404441|459609819|FG007|Phase 2 Part|Progressive disease|31|||
127722174|NCT02404441|459609820|FG008|Phase 2 Part|Progressive disease|39|||
127722175|NCT02404441|459609821|FG009|Phase 2 Part|Progressive disease|27|||
127722176|NCT02404441|459609812|FG000|Phase 2 Part|Subject/guardian decision|0|||
127722177|NCT02404441|459609813|FG001|Phase 2 Part|Subject/guardian decision|0|||
127722178|NCT02404441|459609814|FG002|Phase 2 Part|Subject/guardian decision|0|||
127722179|NCT02404441|459609815|FG003|Phase 2 Part|Subject/guardian decision|0|||
127722180|NCT02404441|459609816|FG004|Phase 2 Part|Subject/guardian decision|0|||
127722181|NCT02404441|459609817|FG005|Phase 2 Part|Subject/guardian decision|3|||
127722182|NCT02404441|459609818|FG006|Phase 2 Part|Subject/guardian decision|9|||
127722183|NCT02404441|459609819|FG007|Phase 2 Part|Subject/guardian decision|0|||
127722184|NCT02404441|459609820|FG008|Phase 2 Part|Subject/guardian decision|3|||
127722185|NCT02404441|459609821|FG009|Phase 2 Part|Subject/guardian decision|2|||
127722186|NCT02404441|459609812|FG000|Phase 2 Part|Death|0|||
127722187|NCT02404441|459609813|FG001|Phase 2 Part|Death|0|||
127722188|NCT02404441|459609814|FG002|Phase 2 Part|Death|0|||
127722189|NCT02404441|459609815|FG003|Phase 2 Part|Death|0|||
127722190|NCT02404441|459609816|FG004|Phase 2 Part|Death|0|||
127722191|NCT02404441|459609817|FG005|Phase 2 Part|Death|4|||
127722192|NCT02404441|459609818|FG006|Phase 2 Part|Death|8|||
127722193|NCT02404441|459609819|FG007|Phase 2 Part|Death|4|||
127722194|NCT02404441|459609820|FG008|Phase 2 Part|Death|10|||
127722195|NCT02404441|459609821|FG009|Phase 2 Part|Death|9|||
127722196|NCT01220999|459609828|FG000|Overall Study|Progressive disease|0|||
127722197|NCT01220999|459609829|FG001|Overall Study|Progressive disease|0|||
127722198|NCT01220999|459609830|FG002|Overall Study|Progressive disease|1|||
127722199|NCT01220999|459609831|FG003|Overall Study|Progressive disease|0|||
127722200|NCT01220999|459609832|FG004|Overall Study|Progressive disease|0|||
127722201|NCT03861234|459609833|FG000|Overall Study|Not treated|0|||
127722202|NCT03861234|459609834|FG001|Overall Study|Not treated|0|||
127722203|NCT03861234|459609835|FG002|Overall Study|Not treated|0|||
127722204|NCT03861234|459609836|FG003|Overall Study|Not treated|0|||
127722205|NCT03861234|459609837|FG004|Overall Study|Not treated|0|||
127722206|NCT03861234|459609838|FG005|Overall Study|Not treated|1|||
127722207|NCT03861234|459609839|FG006|Overall Study|Not treated|0|||
127722208|NCT03861234|459609840|FG007|Overall Study|Not treated|0|||
127722209|NCT03861234|459609833|FG000|Overall Study|Adverse Event|0|||
127722210|NCT03861234|459609834|FG001|Overall Study|Adverse Event|0|||
127722211|NCT03861234|459609835|FG002|Overall Study|Adverse Event|0|||
127722212|NCT03861234|459609836|FG003|Overall Study|Adverse Event|0|||
127722213|NCT03861234|459609837|FG004|Overall Study|Adverse Event|0|||
127722214|NCT03861234|459609838|FG005|Overall Study|Adverse Event|1|||
127722215|NCT03861234|459609839|FG006|Overall Study|Adverse Event|0|||
127722216|NCT03861234|459609840|FG007|Overall Study|Adverse Event|0|||
127722217|NCT03861234|459609833|FG000|Overall Study|Study medication discontinued due to safety notification|0|||
127722218|NCT03861234|459609834|FG001|Overall Study|Study medication discontinued due to safety notification|0|||
127722219|NCT03861234|459609835|FG002|Overall Study|Study medication discontinued due to safety notification|0|||
127722220|NCT03861234|459609836|FG003|Overall Study|Study medication discontinued due to safety notification|0|||
127722221|NCT03861234|459609837|FG004|Overall Study|Study medication discontinued due to safety notification|0|||
127722222|NCT03861234|459609838|FG005|Overall Study|Study medication discontinued due to safety notification|1|||
127722223|NCT03861234|459609839|FG006|Overall Study|Study medication discontinued due to safety notification|0|||
127722224|NCT03861234|459609840|FG007|Overall Study|Study medication discontinued due to safety notification|0|||
127722225|NCT03861234|459609833|FG000|Overall Study|As per sponsor decision|0|||
127722226|NCT03861234|459609834|FG001|Overall Study|As per sponsor decision|0|||
127722227|NCT03861234|459609835|FG002|Overall Study|As per sponsor decision|0|||
127722228|NCT03861234|459609836|FG003|Overall Study|As per sponsor decision|0|||
127722229|NCT03861234|459609837|FG004|Overall Study|As per sponsor decision|0|||
127722230|NCT03861234|459609838|FG005|Overall Study|As per sponsor decision|0|||
127722231|NCT03861234|459609839|FG006|Overall Study|As per sponsor decision|1|||
127722232|NCT03861234|459609840|FG007|Overall Study|As per sponsor decision|0|||
127722233|NCT03861234|459609833|FG000|Overall Study|IMP on hold as per sponsor instructions|0|||
127722234|NCT03861234|459609834|FG001|Overall Study|IMP on hold as per sponsor instructions|0|||
127722235|NCT03861234|459609835|FG002|Overall Study|IMP on hold as per sponsor instructions|0|||
127722236|NCT03861234|459609836|FG003|Overall Study|IMP on hold as per sponsor instructions|0|||
127722237|NCT03861234|459609837|FG004|Overall Study|IMP on hold as per sponsor instructions|0|||
127722238|NCT03861234|459609838|FG005|Overall Study|IMP on hold as per sponsor instructions|0|||
127722239|NCT03861234|459609839|FG006|Overall Study|IMP on hold as per sponsor instructions|2|||
127722240|NCT03861234|459609840|FG007|Overall Study|IMP on hold as per sponsor instructions|0|||
127722241|NCT02066636|459609841|FG000|Overall Study|Disease progression|51|||
127722242|NCT02066636|459609842|FG001|Overall Study|Disease progression|60|||
127722243|NCT02066636|459609843|FG002|Overall Study|Disease progression|700|||
127722244|NCT02066636|459609841|FG000|Overall Study|Study drug toxicity|13|||
127722245|NCT02066636|459609842|FG001|Overall Study|Study drug toxicity|2|||
127722246|NCT02066636|459609843|FG002|Overall Study|Study drug toxicity|58|||
127722247|NCT02066636|459609841|FG000|Overall Study|Death|4|||
127722248|NCT02066636|459609842|FG001|Overall Study|Death|2|||
127722249|NCT02066636|459609843|FG002|Overall Study|Death|158|||
127722250|NCT02066636|459609841|FG000|Overall Study|Adverse event unrelated to study drug|6|||
127722251|NCT02066636|459609842|FG001|Overall Study|Adverse event unrelated to study drug|4|||
127722252|NCT02066636|459609843|FG002|Overall Study|Adverse event unrelated to study drug|45|||
127722253|NCT02066636|459609841|FG000|Overall Study|Participant request to discontinue treatment|12|||
127722254|NCT02066636|459609842|FG001|Overall Study|Participant request to discontinue treatment|12|||
127722255|NCT02066636|459609843|FG002|Overall Study|Participant request to discontinue treatment|70|||
127722256|NCT02066636|459609841|FG000|Overall Study|Participant withdrew consent|10|||
127722257|NCT02066636|459609842|FG001|Overall Study|Participant withdrew consent|18|||
127722258|NCT02066636|459609843|FG002|Overall Study|Participant withdrew consent|61|||
127722259|NCT02066636|459609841|FG000|Overall Study|Lost to Follow-up|0|||
127722260|NCT02066636|459609842|FG001|Overall Study|Lost to Follow-up|2|||
127722261|NCT02066636|459609843|FG002|Overall Study|Lost to Follow-up|2|||
127722262|NCT02066636|459609841|FG000|Overall Study|Maximum clinical benefit|2|||
127722263|NCT02066636|459609842|FG001|Overall Study|Maximum clinical benefit|2|||
127722264|NCT02066636|459609843|FG002|Overall Study|Maximum clinical benefit|3|||
127722265|NCT02066636|459609841|FG000|Overall Study|Poor/non-compliance|2|||
127722266|NCT02066636|459609842|FG001|Overall Study|Poor/non-compliance|1|||
127722267|NCT02066636|459609843|FG002|Overall Study|Poor/non-compliance|1|||
127722268|NCT02066636|459609841|FG000|Overall Study|Participant no loner meets study criteria|3|||
127722269|NCT02066636|459609842|FG001|Overall Study|Participant no loner meets study criteria|2|||
127722270|NCT02066636|459609843|FG002|Overall Study|Participant no loner meets study criteria|28|||
127722271|NCT02066636|459609841|FG000|Overall Study|Administrative reasons by sponsor|8|||
127722272|NCT02066636|459609842|FG001|Overall Study|Administrative reasons by sponsor|5|||
127722273|NCT02066636|459609843|FG002|Overall Study|Administrative reasons by sponsor|0|||
127722274|NCT02066636|459609841|FG000|Overall Study|Other reasons|16|||
127722275|NCT02066636|459609842|FG001|Overall Study|Other reasons|15|||
127722276|NCT02066636|459609843|FG002|Overall Study|Other reasons|50|||
127722277|NCT02833948|459609848|FG000|Overall Study|Death|2|||
127722278|NCT02833948|459609849|FG001|Overall Study|Death|3|||
127722279|NCT02833948|459609848|FG000|Overall Study|were not scanned|8|||
127722280|NCT02833948|459609849|FG001|Overall Study|were not scanned|13|||
127722281|NCT02833948|459609848|FG000|Overall Study|scans could not be evaluated|5|||
127722282|NCT02833948|459609849|FG001|Overall Study|scans could not be evaluated|2|||
127722283|NCT02852824|459609850|FG000|Overall Study|Withdrawal by Subject|1|||
127722284|NCT02852824|459609851|FG001|Overall Study|Withdrawal by Subject|0|||
127722285|NCT02852824|459609852|FG002|Overall Study|Withdrawal by Subject|0|||
127722286|NCT02852824|459609853|FG003|Overall Study|Withdrawal by Subject|0|||
127722287|NCT02852824|459609854|FG004|Overall Study|Withdrawal by Subject|0|||
127722288|NCT02852824|459609855|FG005|Overall Study|Withdrawal by Subject|0|||
127722289|NCT02852824|459609856|FG006|Overall Study|Withdrawal by Subject|0|||
127722290|NCT02852824|459609850|FG000|Overall Study|Adverse Event|0|||
127722291|NCT02852824|459609851|FG001|Overall Study|Adverse Event|0|||
127722292|NCT02852824|459609852|FG002|Overall Study|Adverse Event|0|||
127722293|NCT02852824|459609853|FG003|Overall Study|Adverse Event|0|||
127722294|NCT02852824|459609854|FG004|Overall Study|Adverse Event|2|||
127722295|NCT02852824|459609855|FG005|Overall Study|Adverse Event|0|||
127722296|NCT02852824|459609856|FG006|Overall Study|Adverse Event|0|||
127722297|NCT02521493|459609860|FG000|Overall Study|Death|3|||
127722298|NCT02521493|459609861|FG001|Overall Study|Death|4|||
127722299|NCT02521493|459609862|FG002|Overall Study|Death|1|||
127722300|NCT02521493|459609860|FG000|Overall Study|Physician Decision|19|||
127722301|NCT02521493|459609861|FG001|Overall Study|Physician Decision|1|||
127722302|NCT02521493|459609862|FG002|Overall Study|Physician Decision|2|||
127722303|NCT02521493|459609860|FG000|Overall Study|Withdrawal by Subject|3|||
127722304|NCT02521493|459609861|FG001|Overall Study|Withdrawal by Subject|0|||
127722305|NCT02521493|459609862|FG002|Overall Study|Withdrawal by Subject|0|||
127722306|NCT02521493|459609860|FG000|Overall Study|Ineligible|0|||
127722307|NCT02521493|459609861|FG001|Overall Study|Ineligible|1|||
127722308|NCT02521493|459609862|FG002|Overall Study|Ineligible|0|||
127722309|NCT02521493|459609860|FG000|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
127722310|NCT02521493|459609861|FG001|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
127722311|NCT02521493|459609862|FG002|Overall Study|Post Amd4A (MRD < 0.05%)|115|||
127722312|NCT02521493|459609860|FG000|Overall Study|No MRD result|0|||
127722313|NCT02521493|459609861|FG001|Overall Study|No MRD result|0|||
127722314|NCT02521493|459609862|FG002|Overall Study|No MRD result|4|||
127722315|NCT01218594|459609863|FG000|Overall Study|Death|1|||
127722316|NCT01218594|459609863|FG000|Overall Study|Withdrawal by Subject|3|||
127722317|NCT01218594|459609863|FG000|Overall Study|Adverse Event|2|||
127722318|NCT01218594|459609863|FG000|Overall Study|Physician Decision|6|||
127722319|NCT04748341|459609864|FG000|Overall Study|Lost to Follow-up|1|||
127722320|NCT04748341|459609865|FG001|Overall Study|Lost to Follow-up|1|||
127722321|NCT00452114|459609869|FG000|Overall Study|Physician Decision|3|||
127722322|NCT00452114|459609870|FG001|Overall Study|Physician Decision|3|||
127722323|NCT00671853|459611681|FG000|Overall Study|Lack of Efficacy|3|||
127722324|NCT00671853|459611682|FG001|Overall Study|Lack of Efficacy|7|||
127722325|NCT00671853|459611681|FG000|Overall Study|Adverse Event|7|||
127722326|NCT00671853|459611682|FG001|Overall Study|Adverse Event|1|||
127722327|NCT00671853|459611681|FG000|Overall Study|Withdrawal by Subject|1|||
127722328|NCT00671853|459611682|FG001|Overall Study|Withdrawal by Subject|5|||
127722329|NCT00671853|459611681|FG000|Overall Study|Lost to Follow-up|8|||
127722330|NCT00671853|459611682|FG001|Overall Study|Lost to Follow-up|8|||
127722331|NCT00671853|459611681|FG000|Overall Study|Physician Decision|0|||
127722332|NCT00671853|459611682|FG001|Overall Study|Physician Decision|2|||
127722333|NCT00671853|459611681|FG000|Overall Study|Non-adherence with study procedures|1|||
127722334|NCT00671853|459611682|FG001|Overall Study|Non-adherence with study procedures|4|||
127722335|NCT00587171|459611684|FG000|Overall Study|Lost to Follow-up|1|||
127722336|NCT00587171|459611685|FG001|Overall Study|Lost to Follow-up|1|||
127722337|NCT01848483|459611686|FG000|Overall Study|Death|2|||
127722338|NCT01848483|459611687|FG001|Overall Study|Death|1|||
127722339|NCT01848483|459611686|FG000|Overall Study|Lost to Follow-up|6|||
127722340|NCT01848483|459611687|FG001|Overall Study|Lost to Follow-up|8|||
127722341|NCT01848483|459611686|FG000|Overall Study|Withdrawal by Subject|1|||
127722342|NCT01848483|459611687|FG001|Overall Study|Withdrawal by Subject|0|||
127722343|NCT01848483|459611686|FG000|Overall Study|Incarceration|2|||
127722344|NCT01848483|459611687|FG001|Overall Study|Incarceration|2|||
127722345|NCT01148017|459611688|FG000|Overall Study|Withdrawal by Subject|31|||
127722346|NCT01148017|459611689|FG001|Overall Study|Withdrawal by Subject|14|||
127722347|NCT01148017|459611690|FG002|Overall Study|Withdrawal by Subject|0|||
127722348|NCT01148017|459611691|FG003|Overall Study|Withdrawal by Subject|0|||
127722349|NCT01148017|459611688|FG000|Overall Study|Lost to Follow-up|23|||
127722350|NCT01148017|459611689|FG001|Overall Study|Lost to Follow-up|10|||
127722351|NCT01148017|459611690|FG002|Overall Study|Lost to Follow-up|0|||
127722352|NCT01148017|459611691|FG003|Overall Study|Lost to Follow-up|0|||
127722353|NCT01148017|459611688|FG000|Overall Study|Inappropriate enrollment|1|||
127722354|NCT01148017|459611689|FG001|Overall Study|Inappropriate enrollment|0|||
127722355|NCT01148017|459611690|FG002|Overall Study|Inappropriate enrollment|0|||
127722356|NCT01148017|459611691|FG003|Overall Study|Inappropriate enrollment|0|||
127722357|NCT01148017|459611688|FG000|Overall Study|Administrative reason|22|||
127722358|NCT01148017|459611689|FG001|Overall Study|Administrative reason|9|||
127722359|NCT01148017|459611690|FG002|Overall Study|Administrative reason|0|||
127722360|NCT01148017|459611691|FG003|Overall Study|Administrative reason|0|||
127722361|NCT01148017|459611688|FG000|Overall Study|Unable to classify|3|||
127722362|NCT01148017|459611689|FG001|Overall Study|Unable to classify|1|||
127722363|NCT01148017|459611690|FG002|Overall Study|Unable to classify|0|||
127722364|NCT01148017|459611691|FG003|Overall Study|Unable to classify|0|||
127722365|NCT01779050|459611692|FG000|Overall Study|Withdrawal by Subject|1|||
127722366|NCT01779050|459611693|FG001|Overall Study|Withdrawal by Subject|0|||
127722367|NCT01353274|459611694|FG000|Overall Study|No case report form (CRF) collected|28|||
127722368|NCT01409837|459611695|FG000|Overall Study|Withdrawal by Subject|2|||
127722369|NCT01409837|459611696|FG001|Overall Study|Withdrawal by Subject|1|||
127722370|NCT01409837|459611695|FG000|Overall Study|Lost to Follow-up|1|||
127722371|NCT01409837|459611696|FG001|Overall Study|Lost to Follow-up|0|||
127889027|NCT01606137|460215911|FG000|Overall Study|Lost to Follow-up|15|||
127889028|NCT01606137|460215911|FG000|Overall Study|Protocol Violation|1|||
127722372|NCT01409837|459611695|FG000|Overall Study|Physician Decision|0|||
127722373|NCT01409837|459611696|FG001|Overall Study|Physician Decision|1|||
127722374|NCT03960645|459611697|FG000|Overall Study|Protocol Violation|1|||
127722375|NCT03960645|459611698|FG001|Overall Study|Protocol Violation|0|||
127889029|NCT01606137|460215911|FG000|Overall Study|Patient non-compliance|9|||
127889030|NCT01606137|460215911|FG000|Overall Study|Death|1|||
127722376|NCT01450007|459611699|FG000|Overall Study|Late exclusion before treatment|2|||
127722377|NCT01450007|459611700|FG001|Overall Study|Late exclusion before treatment|3|||
127722378|NCT01450007|459611701|FG002|Overall Study|Late exclusion before treatment|2|||
127722379|NCT01450007|459611699|FG000|Overall Study|Protocol Violation|0|||
127722380|NCT01450007|459611700|FG001|Overall Study|Protocol Violation|1|||
127722381|NCT01450007|459611701|FG002|Overall Study|Protocol Violation|1|||
127722382|NCT01450007|459611699|FG000|Overall Study|Adverse Event|0|||
127722383|NCT01450007|459611700|FG001|Overall Study|Adverse Event|1|||
127889031|NCT01606137|460215911|FG000|Overall Study|Decreased/no pain|4|||
127722384|NCT01450007|459611701|FG002|Overall Study|Adverse Event|0|||
127722385|NCT03851094|459611703|FG000|Overall Study|Withdrawal by Subject|0|||
127722386|NCT03851094|459611704|FG001|Overall Study|Withdrawal by Subject|1|||
127722387|NCT03851094|459611703|FG000|Overall Study|Participant lost device|0|||
127722388|NCT03851094|459611704|FG001|Overall Study|Participant lost device|1|||
127722389|NCT03851094|459611703|FG000|Overall Study|Participant returned device|0|||
127722390|NCT03851094|459611704|FG001|Overall Study|Participant returned device|2|||
127722391|NCT01332266|459611705|FG000|Phase 1b|Death|3|||
127722392|NCT01332266|459611706|FG001|Phase 1b|Death|3|||
127722393|NCT01332266|459611707|FG002|Phase 1b|Death|2|||
127722394|NCT01332266|459611708|FG003|Phase 1b|Death|0|||
127722395|NCT01332266|459611709|FG004|Phase 1b|Death|0|||
127722396|NCT01332266|459611705|FG000|Phase 1b|Lost to Follow-up|0|||
127722397|NCT01332266|459611706|FG001|Phase 1b|Lost to Follow-up|1|||
127722398|NCT01332266|459611707|FG002|Phase 1b|Lost to Follow-up|0|||
127722399|NCT01332266|459611708|FG003|Phase 1b|Lost to Follow-up|0|||
127722400|NCT01332266|459611709|FG004|Phase 1b|Lost to Follow-up|0|||
127722401|NCT01332266|459611705|FG000|Phase 1b|Withdrawal by Subject|1|||
127722402|NCT01332266|459611706|FG001|Phase 1b|Withdrawal by Subject|1|||
127722403|NCT01332266|459611707|FG002|Phase 1b|Withdrawal by Subject|1|||
127722404|NCT01332266|459611708|FG003|Phase 1b|Withdrawal by Subject|0|||
127722405|NCT01332266|459611709|FG004|Phase 1b|Withdrawal by Subject|0|||
127722406|NCT01332266|459611705|FG000|Phase 2|Death|0|||
127722407|NCT01332266|459611706|FG001|Phase 2|Death|0|||
127722408|NCT01332266|459611707|FG002|Phase 2|Death|0|||
127722409|NCT01332266|459611708|FG003|Phase 2|Death|33|||
127722410|NCT01332266|459611709|FG004|Phase 2|Death|36|||
127722411|NCT01332266|459611705|FG000|Phase 2|Lost to Follow-up|0|||
127722412|NCT01332266|459611706|FG001|Phase 2|Lost to Follow-up|0|||
127722413|NCT01332266|459611707|FG002|Phase 2|Lost to Follow-up|0|||
127722414|NCT01332266|459611708|FG003|Phase 2|Lost to Follow-up|2|||
127722415|NCT01332266|459611709|FG004|Phase 2|Lost to Follow-up|0|||
127722416|NCT01332266|459611705|FG000|Phase 2|Physician Decision|0|||
127722417|NCT01332266|459611706|FG001|Phase 2|Physician Decision|0|||
127722418|NCT01332266|459611707|FG002|Phase 2|Physician Decision|0|||
127722419|NCT01332266|459611708|FG003|Phase 2|Physician Decision|3|||
127722420|NCT01332266|459611709|FG004|Phase 2|Physician Decision|1|||
127722421|NCT01332266|459611705|FG000|Phase 2|Symptomatic deterioration|0|||
127722422|NCT01332266|459611706|FG001|Phase 2|Symptomatic deterioration|0|||
127722423|NCT01332266|459611707|FG002|Phase 2|Symptomatic deterioration|0|||
127722424|NCT01332266|459611708|FG003|Phase 2|Symptomatic deterioration|0|||
127722425|NCT01332266|459611709|FG004|Phase 2|Symptomatic deterioration|1|||
127722426|NCT01332266|459611705|FG000|Phase 2|Progression Disease|0|||
127722427|NCT01332266|459611706|FG001|Phase 2|Progression Disease|0|||
127722428|NCT01332266|459611707|FG002|Phase 2|Progression Disease|0|||
127722429|NCT01332266|459611708|FG003|Phase 2|Progression Disease|2|||
127722430|NCT01332266|459611709|FG004|Phase 2|Progression Disease|1|||
127722431|NCT01332266|459611705|FG000|Phase 2|Withdrawal by Subject|0|||
127722432|NCT01332266|459611706|FG001|Phase 2|Withdrawal by Subject|0|||
127722433|NCT01332266|459611707|FG002|Phase 2|Withdrawal by Subject|0|||
127722434|NCT01332266|459611708|FG003|Phase 2|Withdrawal by Subject|2|||
127722435|NCT01332266|459611709|FG004|Phase 2|Withdrawal by Subject|2|||
127722436|NCT01536704|459611712|FG000|Washout Period 1|Withdrawal by Subject|1|||
127722437|NCT01536704|459611713|FG001|Washout Period 1|Withdrawal by Subject|2|||
127722438|NCT01536704|459611714|FG002|Washout Period 1|Withdrawal by Subject|0|||
127722439|NCT01536704|459611715|FG003|Washout Period 1|Withdrawal by Subject|0|||
127802916|NCT03604445|459901086|FG006|Overall Study|Adverse Event|0|||
127802917|NCT03604445|459901087|FG007|Overall Study|Adverse Event|0|||
127802918|NCT03604445|459901088|FG008|Overall Study|Adverse Event|1|||
127802919|NCT00130286|459901089|FG000|Overall Study|Withdrawal by Subject|0|||
127802920|NCT00130286|459901090|FG001|Overall Study|Withdrawal by Subject|1|||
127802921|NCT00130286|459901091|FG002|Overall Study|Withdrawal by Subject|2|||
127802922|NCT00130286|459901092|FG003|Overall Study|Withdrawal by Subject|2|||
127722440|NCT01536704|459611712|FG000|Washout Period 2|Adverse Event|1|||
127722441|NCT01536704|459611713|FG001|Washout Period 2|Adverse Event|0|||
127722442|NCT01536704|459611714|FG002|Washout Period 2|Adverse Event|0|||
127722443|NCT01536704|459611715|FG003|Washout Period 2|Adverse Event|0|||
127802923|NCT00130286|459901089|FG000|Overall Study|Adverse Event|0|||
127802924|NCT00130286|459901090|FG001|Overall Study|Adverse Event|0|||
127722444|NCT01536704|459611712|FG000|Washout Period 2|Withdrawal by Subject|0|||
127722445|NCT01536704|459611713|FG001|Washout Period 2|Withdrawal by Subject|0|||
127722446|NCT01536704|459611714|FG002|Washout Period 2|Withdrawal by Subject|0|||
127722447|NCT01536704|459611715|FG003|Washout Period 2|Withdrawal by Subject|1|||
127722448|NCT01536704|459611712|FG000|Period 3|Adverse Event|0|||
127722449|NCT01536704|459611713|FG001|Period 3|Adverse Event|0|||
127722450|NCT01536704|459611714|FG002|Period 3|Adverse Event|0|||
127722451|NCT01536704|459611715|FG003|Period 3|Adverse Event|1|||
127722452|NCT01536704|459611712|FG000|Washout Period 3|Adverse Event|0|||
127722453|NCT01536704|459611713|FG001|Washout Period 3|Adverse Event|0|||
127722454|NCT01536704|459611714|FG002|Washout Period 3|Adverse Event|1|||
127722455|NCT01536704|459611715|FG003|Washout Period 3|Adverse Event|0|||
127722456|NCT02128269|459611720|FG000|Treatment Period|Adverse Event|1|||
127722457|NCT02128269|459611720|FG000|Treatment Period|Physician Decision|1|||
127722458|NCT00878189|459611721|FG000|Overall Study|Death|0|||
127722459|NCT00878189|459611722|FG001|Overall Study|Death|1|||
127722460|NCT00878189|459611723|FG002|Overall Study|Death|0|||
127722461|NCT00878189|459611724|FG003|Overall Study|Death|1|||
127722462|NCT00878189|459611725|FG004|Overall Study|Death|0|||
127722463|NCT00878189|459611726|FG005|Overall Study|Death|0|||
127722464|NCT00878189|459611727|FG006|Overall Study|Death|0|||
127722465|NCT00878189|459611728|FG007|Overall Study|Death|0|||
127722466|NCT00878189|459611729|FG008|Overall Study|Death|1|||
127722467|NCT00878189|459611721|FG000|Overall Study|Participant Refused to Follow-up|0|||
127722468|NCT00878189|459611722|FG001|Overall Study|Participant Refused to Follow-up|0|||
127722469|NCT00878189|459611723|FG002|Overall Study|Participant Refused to Follow-up|0|||
127722470|NCT00878189|459611724|FG003|Overall Study|Participant Refused to Follow-up|0|||
127722471|NCT00878189|459611725|FG004|Overall Study|Participant Refused to Follow-up|0|||
127722472|NCT00878189|459611726|FG005|Overall Study|Participant Refused to Follow-up|4|||
127722473|NCT00878189|459611727|FG006|Overall Study|Participant Refused to Follow-up|0|||
127722474|NCT00878189|459611728|FG007|Overall Study|Participant Refused to Follow-up|0|||
127722475|NCT00878189|459611729|FG008|Overall Study|Participant Refused to Follow-up|0|||
127722476|NCT00878189|459611721|FG000|Overall Study|Other|3|||
127722477|NCT00878189|459611722|FG001|Overall Study|Other|2|||
127722478|NCT00878189|459611723|FG002|Overall Study|Other|4|||
127722479|NCT00878189|459611724|FG003|Overall Study|Other|7|||
127722480|NCT00878189|459611725|FG004|Overall Study|Other|4|||
127722481|NCT00878189|459611726|FG005|Overall Study|Other|18|||
127722482|NCT00878189|459611727|FG006|Overall Study|Other|15|||
127722483|NCT00878189|459611728|FG007|Overall Study|Other|3|||
127722484|NCT00878189|459611729|FG008|Overall Study|Other|4|||
127722485|NCT00878189|459611721|FG000|Overall Study|Lost to Follow-up|0|||
127722486|NCT00878189|459611722|FG001|Overall Study|Lost to Follow-up|0|||
127722487|NCT00878189|459611723|FG002|Overall Study|Lost to Follow-up|0|||
127722488|NCT00878189|459611724|FG003|Overall Study|Lost to Follow-up|0|||
127722489|NCT00878189|459611725|FG004|Overall Study|Lost to Follow-up|0|||
127722490|NCT00878189|459611726|FG005|Overall Study|Lost to Follow-up|1|||
127722491|NCT00878189|459611727|FG006|Overall Study|Lost to Follow-up|1|||
127722492|NCT00878189|459611728|FG007|Overall Study|Lost to Follow-up|0|||
127722493|NCT00878189|459611729|FG008|Overall Study|Lost to Follow-up|0|||
127722494|NCT00878189|459611721|FG000|Overall Study|Objection Progression or Relapse|0|||
127722495|NCT00878189|459611722|FG001|Overall Study|Objection Progression or Relapse|0|||
127722496|NCT00878189|459611723|FG002|Overall Study|Objection Progression or Relapse|0|||
127722497|NCT00878189|459611724|FG003|Overall Study|Objection Progression or Relapse|0|||
127722498|NCT00878189|459611725|FG004|Overall Study|Objection Progression or Relapse|0|||
127722499|NCT00878189|459611726|FG005|Overall Study|Objection Progression or Relapse|0|||
127722500|NCT00878189|459611727|FG006|Overall Study|Objection Progression or Relapse|0|||
127722501|NCT00878189|459611728|FG007|Overall Study|Objection Progression or Relapse|0|||
127722502|NCT00878189|459611729|FG008|Overall Study|Objection Progression or Relapse|3|||
127722503|NCT00703092|459611730|FG000|Overall Study|Withdrawal by Subject|2|||
127722504|NCT01021748|459611731|FG000|Overall Study|Adverse Event|2|||
127722505|NCT01021748|459611732|FG001|Overall Study|Adverse Event|1|||
127722506|NCT01021748|459611733|FG002|Overall Study|Adverse Event|2|||
127722507|NCT01021748|459611734|FG003|Overall Study|Adverse Event|0|||
127722508|NCT01021748|459611735|FG004|Overall Study|Adverse Event|2|||
127722509|NCT01021748|459611736|FG005|Overall Study|Adverse Event|0|||
127722510|NCT01021748|459611737|FG006|Overall Study|Adverse Event|1|||
127722511|NCT01021748|459611738|FG007|Overall Study|Adverse Event|0|||
127722512|NCT01021748|459611739|FG008|Overall Study|Adverse Event|7|||
127722513|NCT01021748|459611731|FG000|Overall Study|Physician Decision|1|||
127722514|NCT01021748|459611732|FG001|Overall Study|Physician Decision|0|||
127722515|NCT01021748|459611733|FG002|Overall Study|Physician Decision|1|||
127722516|NCT01021748|459611734|FG003|Overall Study|Physician Decision|1|||
127722517|NCT01021748|459611735|FG004|Overall Study|Physician Decision|0|||
127722518|NCT01021748|459611736|FG005|Overall Study|Physician Decision|0|||
127722519|NCT01021748|459611737|FG006|Overall Study|Physician Decision|1|||
127722520|NCT01021748|459611738|FG007|Overall Study|Physician Decision|1|||
127722521|NCT01021748|459611739|FG008|Overall Study|Physician Decision|2|||
127722522|NCT01021748|459611731|FG000|Overall Study|Progressive Disease|3|||
127889032|NCT01606137|460215911|FG000|Overall Study|Issues with driving|4|||
127889033|NCT01606137|460215911|FG000|Overall Study|multiple sclerosis less stable|1|||
127889034|NCT01606137|460215911|FG000|Overall Study|Increased bilirubin|1|||
127889035|NCT01606137|460215911|FG000|Overall Study|Spray causes nausea|1|||
127722523|NCT01021748|459611732|FG001|Overall Study|Progressive Disease|3|||
127722524|NCT01021748|459611733|FG002|Overall Study|Progressive Disease|4|||
127722525|NCT01021748|459611734|FG003|Overall Study|Progressive Disease|6|||
127722526|NCT01021748|459611735|FG004|Overall Study|Progressive Disease|7|||
127722527|NCT01021748|459611736|FG005|Overall Study|Progressive Disease|3|||
127722528|NCT01021748|459611737|FG006|Overall Study|Progressive Disease|0|||
127722529|NCT01021748|459611738|FG007|Overall Study|Progressive Disease|5|||
127722530|NCT01021748|459611739|FG008|Overall Study|Progressive Disease|6|||
127722531|NCT01021748|459611731|FG000|Overall Study|Withdrawal by Subject|0|||
127722532|NCT01021748|459611732|FG001|Overall Study|Withdrawal by Subject|0|||
127722533|NCT01021748|459611733|FG002|Overall Study|Withdrawal by Subject|0|||
127722534|NCT01021748|459611734|FG003|Overall Study|Withdrawal by Subject|0|||
127722535|NCT01021748|459611735|FG004|Overall Study|Withdrawal by Subject|0|||
127722536|NCT01021748|459611736|FG005|Overall Study|Withdrawal by Subject|0|||
127722537|NCT01021748|459611737|FG006|Overall Study|Withdrawal by Subject|1|||
127722538|NCT01021748|459611738|FG007|Overall Study|Withdrawal by Subject|0|||
127722539|NCT01021748|459611739|FG008|Overall Study|Withdrawal by Subject|1|||
127722540|NCT01021748|459611731|FG000|Overall Study|Not Treated|0|||
127722541|NCT01021748|459611732|FG001|Overall Study|Not Treated|1|||
127722542|NCT01021748|459611733|FG002|Overall Study|Not Treated|0|||
127722543|NCT01021748|459611734|FG003|Overall Study|Not Treated|0|||
127722544|NCT01021748|459611735|FG004|Overall Study|Not Treated|0|||
127722545|NCT01021748|459611736|FG005|Overall Study|Not Treated|0|||
127722546|NCT01021748|459611737|FG006|Overall Study|Not Treated|0|||
127722547|NCT01021748|459611738|FG007|Overall Study|Not Treated|0|||
127722548|NCT01021748|459611739|FG008|Overall Study|Not Treated|0|||
127722549|NCT01829711|459611744|FG000|Overall Study|Lost to Follow-up|2|||
127722550|NCT01829711|459611744|FG000|Overall Study|Withdrawal by Subject|3|||
127722551|NCT01829711|459611744|FG000|Overall Study|Death|4|||
127722552|NCT01829711|459611744|FG000|Overall Study|Started new therapies|17|||
127722553|NCT01829711|459611744|FG000|Overall Study|Adverse Event|3|||
127722554|NCT01829711|459611744|FG000|Overall Study|Due to progression of disease|13|||
127722555|NCT01829711|459611744|FG000|Overall Study|Due to lack of response|1|||
127722556|NCT01480258|459611747|FG000|Infant Series|Protocol Violation|2|||
127722557|NCT01480258|459611748|FG001|Infant Series|Protocol Violation|0|||
127722558|NCT01480258|459611747|FG000|Infant Series|Physician Decision|0|||
127722559|NCT01480258|459611748|FG001|Infant Series|Physician Decision|1|||
127722560|NCT01480258|459611747|FG000|Infant Series|Not Vaccinated|3|||
127722561|NCT01480258|459611748|FG001|Infant Series|Not Vaccinated|0|||
127722562|NCT01480258|459611747|FG000|Infant Series|Adverse Event|1|||
127722563|NCT01480258|459611748|FG001|Infant Series|Adverse Event|1|||
127722564|NCT01480258|459611747|FG000|Infant Series|Withdrawal by Subject|1|||
127722565|NCT01480258|459611748|FG001|Infant Series|Withdrawal by Subject|6|||
127722566|NCT01480258|459611747|FG000|Interim Period|Lost to Follow-up|0|||
127722567|NCT01480258|459611748|FG001|Interim Period|Lost to Follow-up|2|||
127722568|NCT01480258|459611747|FG000|Interim Period|Physician Decision|1|||
127722569|NCT01480258|459611748|FG001|Interim Period|Physician Decision|0|||
127722570|NCT01480258|459611747|FG000|Interim Period|Protocol Violation|0|||
127722571|NCT01480258|459611748|FG001|Interim Period|Protocol Violation|1|||
127722572|NCT01480258|459611747|FG000|Interim Period|Withdrawal by Subject|9|||
127722573|NCT01480258|459611748|FG001|Interim Period|Withdrawal by Subject|6|||
127722574|NCT03316170|459611749|FG000|Overall Study|Death|1|||
127722575|NCT03316170|459611750|FG001|Overall Study|Death|0|||
127722576|NCT03316170|459611749|FG000|Overall Study|Lost to Follow-up|6|||
127722577|NCT03316170|459611750|FG001|Overall Study|Lost to Follow-up|7|||
127722578|NCT02169414|459611751|FG000|Overall Study|Withdrawal by Subject|1|||
127722579|NCT02169414|459611752|FG001|Overall Study|Withdrawal by Subject|0|||
127722580|NCT02169414|459611753|FG002|Overall Study|Withdrawal by Subject|0|||
127722581|NCT02169414|459611754|FG003|Overall Study|Withdrawal by Subject|0|||
127722582|NCT02169414|459611751|FG000|Overall Study|Adverse Event|0|||
127722583|NCT02169414|459611752|FG001|Overall Study|Adverse Event|1|||
127722584|NCT02169414|459611753|FG002|Overall Study|Adverse Event|0|||
127722585|NCT02169414|459611754|FG003|Overall Study|Adverse Event|0|||
127722586|NCT03374254|459611755|FG000|Overall Study|Death|5|||
127722587|NCT03374254|459611756|FG001|Overall Study|Death|16|||
127722588|NCT03374254|459611757|FG002|Overall Study|Death|13|||
127722589|NCT03374254|459611758|FG003|Overall Study|Death|11|||
127722590|NCT03374254|459611759|FG004|Overall Study|Death|9|||
127722591|NCT03374254|459611760|FG005|Overall Study|Death|12|||
127722592|NCT03374254|459611761|FG006|Overall Study|Death|11|||
127722593|NCT03374254|459611762|FG007|Overall Study|Death|6|||
127722594|NCT03374254|459611763|FG008|Overall Study|Death|7|||
127722595|NCT03374254|459611755|FG000|Overall Study|Lost to Follow-up|0|||
127722596|NCT03374254|459611756|FG001|Overall Study|Lost to Follow-up|0|||
127722597|NCT03374254|459611757|FG002|Overall Study|Lost to Follow-up|0|||
127722598|NCT03374254|459611758|FG003|Overall Study|Lost to Follow-up|0|||
127889036|NCT01606137|460215911|FG000|Overall Study|Not enough improvement|4|||
127722599|NCT03374254|459611759|FG004|Overall Study|Lost to Follow-up|0|||
127722600|NCT03374254|459611760|FG005|Overall Study|Lost to Follow-up|0|||
127722601|NCT03374254|459611761|FG006|Overall Study|Lost to Follow-up|2|||
127722602|NCT03374254|459611762|FG007|Overall Study|Lost to Follow-up|0|||
127722603|NCT03374254|459611763|FG008|Overall Study|Lost to Follow-up|0|||
127722604|NCT03374254|459611755|FG000|Overall Study|Sponsor Decision|1|||
127722605|NCT03374254|459611756|FG001|Overall Study|Sponsor Decision|0|||
127722606|NCT03374254|459611757|FG002|Overall Study|Sponsor Decision|2|||
127722607|NCT03374254|459611758|FG003|Overall Study|Sponsor Decision|3|||
127722608|NCT03374254|459611759|FG004|Overall Study|Sponsor Decision|2|||
127722609|NCT03374254|459611760|FG005|Overall Study|Sponsor Decision|3|||
127722610|NCT03374254|459611761|FG006|Overall Study|Sponsor Decision|3|||
127722611|NCT03374254|459611762|FG007|Overall Study|Sponsor Decision|3|||
127722612|NCT03374254|459611763|FG008|Overall Study|Sponsor Decision|4|||
127722613|NCT03374254|459611755|FG000|Overall Study|Withdrawal by Subject|0|||
127722614|NCT03374254|459611756|FG001|Overall Study|Withdrawal by Subject|0|||
127722615|NCT03374254|459611757|FG002|Overall Study|Withdrawal by Subject|0|||
127722616|NCT03374254|459611758|FG003|Overall Study|Withdrawal by Subject|2|||
127722617|NCT03374254|459611759|FG004|Overall Study|Withdrawal by Subject|0|||
127722618|NCT03374254|459611760|FG005|Overall Study|Withdrawal by Subject|1|||
127722619|NCT03374254|459611761|FG006|Overall Study|Withdrawal by Subject|0|||
127722620|NCT03374254|459611762|FG007|Overall Study|Withdrawal by Subject|0|||
127722621|NCT03374254|459611763|FG008|Overall Study|Withdrawal by Subject|0|||
127722622|NCT02309515|459611764|FG000|Overall Study|Withdrawal by Subject|0|||
127722623|NCT02309515|459611765|FG001|Overall Study|Withdrawal by Subject|1|||
127722624|NCT00624377|459611771|FG000|Overall Study|Lost to Follow-up|355|||
127722625|NCT00624377|459611771|FG000|Overall Study|Withdrawal by Subject|100|||
127722626|NCT00624377|459611771|FG000|Overall Study|Adverse Event|14|||
127722627|NCT00624377|459611771|FG000|Overall Study|Other|91|||
127722628|NCT00624377|459611771|FG000|Overall Study|Non-evaluable population|84|||
127722629|NCT05260437|459611772|FG000|Overall Study|Lost to Follow-up|5|||
127722630|NCT05260437|459611773|FG001|Overall Study|Lost to Follow-up|2|||
127722631|NCT05260437|459611774|FG002|Overall Study|Lost to Follow-up|1|||
127722632|NCT05260437|459611775|FG003|Overall Study|Lost to Follow-up|2|||
127722633|NCT05260437|459611776|FG004|Overall Study|Lost to Follow-up|2|||
127722634|NCT05260437|459611772|FG000|Overall Study|Withdrawal by Subject|3|||
127722635|NCT05260437|459611773|FG001|Overall Study|Withdrawal by Subject|0|||
127722636|NCT05260437|459611774|FG002|Overall Study|Withdrawal by Subject|4|||
127722637|NCT05260437|459611775|FG003|Overall Study|Withdrawal by Subject|5|||
127722638|NCT05260437|459611776|FG004|Overall Study|Withdrawal by Subject|0|||
127722639|NCT05260437|459611772|FG000|Overall Study|Vaccine Not Administered|0|||
127722640|NCT05260437|459611773|FG001|Overall Study|Vaccine Not Administered|1|||
127722641|NCT05260437|459611774|FG002|Overall Study|Vaccine Not Administered|0|||
127722642|NCT05260437|459611775|FG003|Overall Study|Vaccine Not Administered|0|||
127722643|NCT05260437|459611776|FG004|Overall Study|Vaccine Not Administered|0|||
127722644|NCT00910962|459611777|FG000|Overall Study|Adverse Event|5|||
127722645|NCT00910962|459611778|FG001|Overall Study|Adverse Event|20|||
127722646|NCT00910962|459611779|FG002|Overall Study|Adverse Event|17|||
127722647|NCT00910962|459611777|FG000|Overall Study|Protocol Violation|1|||
127722648|NCT00910962|459611778|FG001|Overall Study|Protocol Violation|3|||
127722649|NCT00910962|459611779|FG002|Overall Study|Protocol Violation|3|||
127722650|NCT00910962|459611777|FG000|Overall Study|Lost to Follow-up|0|||
127722651|NCT00910962|459611778|FG001|Overall Study|Lost to Follow-up|3|||
127722652|NCT00910962|459611779|FG002|Overall Study|Lost to Follow-up|1|||
127722653|NCT00910962|459611777|FG000|Overall Study|Physician Decision|0|||
127722654|NCT00910962|459611778|FG001|Overall Study|Physician Decision|6|||
127722655|NCT00910962|459611779|FG002|Overall Study|Physician Decision|6|||
127722656|NCT00910962|459611777|FG000|Overall Study|Withdrawal by Subject|25|||
127722657|NCT00910962|459611778|FG001|Overall Study|Withdrawal by Subject|32|||
127722658|NCT00910962|459611779|FG002|Overall Study|Withdrawal by Subject|32|||
127722659|NCT00910962|459611777|FG000|Overall Study|Reached defined stopping criteria|12|||
127722660|NCT00910962|459611778|FG001|Overall Study|Reached defined stopping criteria|14|||
127722661|NCT00910962|459611779|FG002|Overall Study|Reached defined stopping criteria|17|||
127722662|NCT01858688|459611780|FG000|Overall Study|Withdrawal by Subject|8|||
127722663|NCT01858688|459611780|FG000|Overall Study|Participant began another therapy|3|||
127722664|NCT01858688|459611780|FG000|Overall Study|Physician Decision|2|||
127722665|NCT01858688|459611780|FG000|Overall Study|Progressive Disease|2|||
127722666|NCT01858688|459611780|FG000|Overall Study|Reason not reproted|5|||
127722667|NCT01999335|459611781|FG000|Overall Study|Discontinued before receiving treatment|0|||
127722668|NCT01999335|459611782|FG001|Overall Study|Discontinued before receiving treatment|0|||
127722669|NCT01999335|459611783|FG002|Overall Study|Discontinued before receiving treatment|0|||
127722670|NCT01999335|459611784|FG003|Overall Study|Discontinued before receiving treatment|0|||
127722671|NCT01999335|459611785|FG004|Overall Study|Discontinued before receiving treatment|2|||
127722672|NCT00787176|459611786|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
127722673|NCT00787176|459611787|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
127722674|NCT00787176|459611788|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
127889037|NCT01606137|460215911|FG000|Overall Study|Wanted to try another treatment|1|||
127889038|NCT01606137|460215911|FG000|Overall Study|Patient leaving country|1|||
127889039|NCT01606137|460215911|FG000|Overall Study|Personal reasons|1|||
127889040|NCT01606137|460215911|FG000|Overall Study|Unable to tolerate study med. taste|1|||
127889041|NCT01606137|460215911|FG000|Overall Study|Patient moving|1|||
127889042|NCT01606137|460215911|FG000|Overall Study|Unable to collect consistent data|1|||
127889043|NCT02266706|460217960|FG000|Overall Study|Withdrawal by Subject|0|||
127889044|NCT02266706|460217961|FG001|Overall Study|Withdrawal by Subject|1|||
127889045|NCT02266706|460217962|FG002|Overall Study|Withdrawal by Subject|1|||
127889046|NCT02266706|460217963|FG003|Overall Study|Withdrawal by Subject|0|||
127889047|NCT02266706|460217964|FG004|Overall Study|Withdrawal by Subject|0|||
127889048|NCT02266706|460217965|FG005|Overall Study|Withdrawal by Subject|1|||
127889049|NCT02266706|460217966|FG006|Overall Study|Withdrawal by Subject|0|||
127889050|NCT02266706|460217967|FG007|Overall Study|Withdrawal by Subject|0|||
127889051|NCT02266706|460217968|FG008|Overall Study|Withdrawal by Subject|0|||
127889052|NCT02266706|460217960|FG000|Overall Study|Screen failure|0|||
127889053|NCT02266706|460217961|FG001|Overall Study|Screen failure|0|||
127889054|NCT02266706|460217962|FG002|Overall Study|Screen failure|0|||
127889055|NCT02266706|460217963|FG003|Overall Study|Screen failure|0|||
127722675|NCT00787176|459611789|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
127722676|NCT02234141|459611794|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
127722677|NCT02234141|459611795|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
127722678|NCT02234141|459611796|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
127722679|NCT02234141|459611797|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
127722680|NCT02234141|459611798|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
127722681|NCT02234141|459611799|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
127722682|NCT02234141|459611800|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
127722683|NCT02234141|459611794|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
127722684|NCT02234141|459611795|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
127722685|NCT02234141|459611796|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
127722686|NCT02234141|459611797|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
127722687|NCT02234141|459611798|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
127722688|NCT02234141|459611799|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
127722689|NCT02234141|459611800|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
127889056|NCT02266706|460217964|FG004|Overall Study|Screen failure|0|||
127889057|NCT02266706|460217965|FG005|Overall Study|Screen failure|1|||
127722690|NCT02234141|459611794|FG000|Treatment Period (24 Weeks)|Death|1|||
127722691|NCT02234141|459611795|FG001|Treatment Period (24 Weeks)|Death|2|||
127722692|NCT02234141|459611796|FG002|Treatment Period (24 Weeks)|Death|0|||
127722693|NCT02234141|459611797|FG003|Treatment Period (24 Weeks)|Death|1|||
127722694|NCT02234141|459611798|FG004|Treatment Period (24 Weeks)|Death|0|||
127722695|NCT02234141|459611799|FG005|Treatment Period (24 Weeks)|Death|0|||
127722696|NCT02234141|459611800|FG006|Treatment Period (24 Weeks)|Death|0|||
127722697|NCT02234141|459611794|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
127722698|NCT02234141|459611795|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
127722699|NCT02234141|459611796|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
127722700|NCT02234141|459611797|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
127722701|NCT02234141|459611798|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
127722702|NCT02234141|459611799|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
127722703|NCT02234141|459611800|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
127722704|NCT02234141|459611794|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
127722705|NCT02234141|459611795|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
127722706|NCT02234141|459611796|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
127722707|NCT02234141|459611797|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
127722708|NCT02234141|459611798|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
127722709|NCT02234141|459611799|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
127722710|NCT02234141|459611800|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
127722711|NCT02234141|459611794|FG000|Long-Term Treatment Period|Death|0|||
127722712|NCT02234141|459611795|FG001|Long-Term Treatment Period|Death|0|||
127722713|NCT02234141|459611796|FG002|Long-Term Treatment Period|Death|0|||
127722714|NCT02234141|459611797|FG003|Long-Term Treatment Period|Death|0|||
127722715|NCT02234141|459611798|FG004|Long-Term Treatment Period|Death|0|||
127889058|NCT02266706|460217966|FG006|Overall Study|Screen failure|1|||
127889059|NCT02266706|460217967|FG007|Overall Study|Screen failure|0|||
127722716|NCT02234141|459611799|FG005|Long-Term Treatment Period|Death|1|||
127722717|NCT02234141|459611800|FG006|Long-Term Treatment Period|Death|0|||
127722718|NCT02234141|459611794|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
127722719|NCT02234141|459611795|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
127722720|NCT02234141|459611796|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
127889060|NCT02266706|460217968|FG008|Overall Study|Screen failure|0|||
127889061|NCT02266706|460217960|FG000|Overall Study|Enrollment in another study|0|||
127889062|NCT02266706|460217961|FG001|Overall Study|Enrollment in another study|0|||
127889063|NCT02266706|460217962|FG002|Overall Study|Enrollment in another study|0|||
127889064|NCT02266706|460217963|FG003|Overall Study|Enrollment in another study|1|||
127722721|NCT02234141|459611797|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
127722722|NCT02234141|459611798|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
127722723|NCT02234141|459611799|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
127722724|NCT02234141|459611800|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
127722725|NCT02234141|459611794|FG000|Long-Term Treatment Period|Adverse Event|4|||
127722726|NCT02234141|459611795|FG001|Long-Term Treatment Period|Adverse Event|0|||
127722727|NCT02234141|459611796|FG002|Long-Term Treatment Period|Adverse Event|5|||
127722728|NCT02234141|459611797|FG003|Long-Term Treatment Period|Adverse Event|0|||
127722729|NCT02234141|459611798|FG004|Long-Term Treatment Period|Adverse Event|1|||
127722730|NCT02234141|459611799|FG005|Long-Term Treatment Period|Adverse Event|1|||
127722731|NCT02234141|459611800|FG006|Long-Term Treatment Period|Adverse Event|1|||
127722732|NCT02234141|459611794|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
127722733|NCT02234141|459611795|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
127722734|NCT02234141|459611796|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
127722735|NCT02234141|459611797|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
127722736|NCT02234141|459611798|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
127722737|NCT02234141|459611799|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
127722738|NCT02234141|459611800|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
127722739|NCT02234141|459611794|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
127722740|NCT02234141|459611795|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
127722741|NCT02234141|459611796|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
127722742|NCT02234141|459611797|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
127722743|NCT02234141|459611798|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
127722744|NCT02234141|459611799|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
127722745|NCT02234141|459611800|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
127722746|NCT03042767|459611801|FG000|Overall Study|Lost to Follow-up|1|||
127722747|NCT03042767|459611802|FG001|Overall Study|Lost to Follow-up|2|||
127722748|NCT03326856|459611803|FG000|Overall Study|Lost to Follow-up|1|||
127722749|NCT03326856|459611804|FG001|Overall Study|Lost to Follow-up|1|||
127722750|NCT03326856|459611805|FG002|Overall Study|Lost to Follow-up|0|||
127722751|NCT03326856|459611806|FG003|Overall Study|Lost to Follow-up|0|||
127722752|NCT03326856|459611807|FG004|Overall Study|Lost to Follow-up|0|||
127722753|NCT02037568|459611808|FG000|Overall Study|Withdrawal by Subject|17|||
127722754|NCT02037568|459611809|FG001|Overall Study|Withdrawal by Subject|24|||
127722755|NCT02037568|459611808|FG000|Overall Study|Lost to Follow-up|16|||
127722756|NCT02037568|459611809|FG001|Overall Study|Lost to Follow-up|13|||
127722757|NCT02037568|459611808|FG000|Overall Study|Screen Failure|3|||
127722758|NCT02037568|459611809|FG001|Overall Study|Screen Failure|1|||
127722759|NCT02037568|459611808|FG000|Overall Study|Patient did not receive transplant|0|||
127722760|NCT02037568|459611809|FG001|Overall Study|Patient did not receive transplant|1|||
127722761|NCT00621842|459611810|FG000|Overall Study|Adverse Event|6|||
127722762|NCT00621842|459611810|FG000|Overall Study|Withdrawal by Subject|7|||
127722763|NCT00621842|459611810|FG000|Overall Study|Protocol Violation|4|||
127722764|NCT00621842|459611810|FG000|Overall Study|Lack of Efficacy|2|||
127722765|NCT03692871|459611814|FG000|Overall Study|Death|1|||
127722766|NCT03692871|459611815|FG001|Overall Study|Death|1|||
127722767|NCT03692871|459611814|FG000|Overall Study|Lost to Follow-up|24|||
127722768|NCT03692871|459611815|FG001|Overall Study|Lost to Follow-up|9|||
127722769|NCT03692871|459611814|FG000|Overall Study|Physician Decision|22|||
127722770|NCT03692871|459611815|FG001|Overall Study|Physician Decision|7|||
127722771|NCT03692871|459611814|FG000|Overall Study|Protocol Deviation|1|||
127722772|NCT03692871|459611815|FG001|Overall Study|Protocol Deviation|0|||
127722773|NCT03692871|459611814|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
127722774|NCT03692871|459611815|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
127722775|NCT02644122|459611816|FG000|Overall Study|Withdrawal by Subject|1|||
127722776|NCT03182244|459611817|FG000|Treatment Period (Upto 1917 Days)|Adverse Event|8|||
127722777|NCT03182244|459611818|FG001|Treatment Period (Upto 1917 Days)|Adverse Event|9|||
127722778|NCT03182244|459611817|FG000|Treatment Period (Upto 1917 Days)|Death|19|||
127722779|NCT03182244|459611818|FG001|Treatment Period (Upto 1917 Days)|Death|8|||
127722780|NCT03182244|459611817|FG000|Treatment Period (Upto 1917 Days)|Miscellaneous|12|||
127722781|NCT03182244|459611818|FG001|Treatment Period (Upto 1917 Days)|Miscellaneous|0|||
127722782|NCT03182244|459611817|FG000|Treatment Period (Upto 1917 Days)|Disease Relapse|41|||
127722783|NCT03182244|459611818|FG001|Treatment Period (Upto 1917 Days)|Disease Relapse|5|||
127722784|NCT03182244|459611817|FG000|Treatment Period (Upto 1917 Days)|Physician Decision|5|||
127722785|NCT03182244|459611818|FG001|Treatment Period (Upto 1917 Days)|Physician Decision|10|||
127722786|NCT03182244|459611817|FG000|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|10|||
127722787|NCT03182244|459611818|FG001|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|28|||
127722788|NCT03182244|459611817|FG000|Treatment Period (Upto 1917 Days)|Protocol Violation|4|||
127722789|NCT03182244|459611818|FG001|Treatment Period (Upto 1917 Days)|Protocol Violation|1|||
127722790|NCT03182244|459611817|FG000|Treatment Period (Upto 1917 Days)|Progressive Disease|18|||
127722791|NCT03182244|459611818|FG001|Treatment Period (Upto 1917 Days)|Progressive Disease|9|||
127722792|NCT03182244|459611817|FG000|Treatment Period (Upto 1917 Days)|Lack of Efficacy|20|||
127722793|NCT03182244|459611818|FG001|Treatment Period (Upto 1917 Days)|Lack of Efficacy|43|||
127889065|NCT02266706|460217964|FG004|Overall Study|Enrollment in another study|0|||
127889066|NCT02266706|460217965|FG005|Overall Study|Enrollment in another study|0|||
127889067|NCT02266706|460217966|FG006|Overall Study|Enrollment in another study|0|||
127889068|NCT02266706|460217967|FG007|Overall Study|Enrollment in another study|0|||
127889069|NCT02266706|460217968|FG008|Overall Study|Enrollment in another study|0|||
127889070|NCT00409188|460217969|FG000|Overall Study|Ongoing at data cut-off|383|||
127889071|NCT00409188|460217970|FG001|Overall Study|Ongoing at data cut-off|175|||
127889072|NCT01393990|460217976|FG000|Overall Study|Adverse Event|0|||
127889073|NCT01393990|460217977|FG001|Overall Study|Adverse Event|0|||
127889074|NCT01393990|460217978|FG002|Overall Study|Adverse Event|0|||
127889075|NCT01393990|460217979|FG003|Overall Study|Adverse Event|0|||
127889076|NCT01393990|460217980|FG004|Overall Study|Adverse Event|0|||
127889077|NCT01393990|460217981|FG005|Overall Study|Adverse Event|0|||
127889078|NCT01393990|460217982|FG006|Overall Study|Adverse Event|0|||
127889079|NCT01393990|460217983|FG007|Overall Study|Adverse Event|0|||
127889080|NCT01393990|460217984|FG008|Overall Study|Adverse Event|0|||
127889081|NCT01393990|460217985|FG009|Overall Study|Adverse Event|0|||
127889082|NCT01393990|460217986|FG010|Overall Study|Adverse Event|0|||
127889083|NCT01393990|460217987|FG011|Overall Study|Adverse Event|0|||
127889084|NCT01393990|460217988|FG012|Overall Study|Adverse Event|0|||
127889085|NCT01393990|460217989|FG013|Overall Study|Adverse Event|0|||
127889086|NCT01393990|460217990|FG014|Overall Study|Adverse Event|1|||
127889087|NCT01393990|460217991|FG015|Overall Study|Adverse Event|1|||
127889088|NCT01393990|460217992|FG016|Overall Study|Adverse Event|0|||
127889089|NCT01393990|460217993|FG017|Overall Study|Adverse Event|0|||
127889090|NCT01393990|460217976|FG000|Overall Study|Progressive Disease|1|||
127889091|NCT01393990|460217977|FG001|Overall Study|Progressive Disease|0|||
127889092|NCT01393990|460217978|FG002|Overall Study|Progressive Disease|0|||
127889093|NCT01393990|460217979|FG003|Overall Study|Progressive Disease|1|||
127889094|NCT01393990|460217980|FG004|Overall Study|Progressive Disease|1|||
127889095|NCT01393990|460217981|FG005|Overall Study|Progressive Disease|1|||
127889096|NCT01393990|460217982|FG006|Overall Study|Progressive Disease|1|||
127889097|NCT01393990|460217983|FG007|Overall Study|Progressive Disease|1|||
127889098|NCT01393990|460217984|FG008|Overall Study|Progressive Disease|3|||
127889099|NCT01393990|460217985|FG009|Overall Study|Progressive Disease|1|||
127889100|NCT01393990|460217986|FG010|Overall Study|Progressive Disease|0|||
127889101|NCT01393990|460217987|FG011|Overall Study|Progressive Disease|0|||
127889102|NCT01393990|460217988|FG012|Overall Study|Progressive Disease|0|||
127889103|NCT01393990|460217989|FG013|Overall Study|Progressive Disease|1|||
127889104|NCT01393990|460217990|FG014|Overall Study|Progressive Disease|6|||
127889105|NCT01393990|460217991|FG015|Overall Study|Progressive Disease|1|||
127889106|NCT01393990|460217992|FG016|Overall Study|Progressive Disease|0|||
127889107|NCT01393990|460217993|FG017|Overall Study|Progressive Disease|0|||
127889108|NCT01393990|460217976|FG000|Overall Study|Death|0|||
127889109|NCT01393990|460217977|FG001|Overall Study|Death|0|||
127889110|NCT01393990|460217978|FG002|Overall Study|Death|0|||
127889111|NCT01393990|460217979|FG003|Overall Study|Death|0|||
127889112|NCT01393990|460217980|FG004|Overall Study|Death|1|||
127889113|NCT01393990|460217981|FG005|Overall Study|Death|0|||
127889114|NCT01393990|460217982|FG006|Overall Study|Death|0|||
127889115|NCT01393990|460217983|FG007|Overall Study|Death|0|||
127889116|NCT01393990|460217984|FG008|Overall Study|Death|0|||
127889117|NCT01393990|460217985|FG009|Overall Study|Death|0|||
127889118|NCT01393990|460217986|FG010|Overall Study|Death|0|||
127722794|NCT03182244|459611817|FG000|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|4|||
127722795|NCT03182244|459611818|FG001|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|3|||
127722796|NCT03182244|459611817|FG000|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|5|||
127722797|NCT03182244|459611818|FG001|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|8|||
127722798|NCT03182244|459611817|FG000|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|6|||
127722799|NCT03182244|459611818|FG001|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|7|||
127889119|NCT01393990|460217987|FG011|Overall Study|Death|0|||
127889120|NCT01393990|460217988|FG012|Overall Study|Death|0|||
127889121|NCT01393990|460217989|FG013|Overall Study|Death|1|||
127889122|NCT01393990|460217990|FG014|Overall Study|Death|1|||
127889123|NCT01393990|460217991|FG015|Overall Study|Death|0|||
127889124|NCT01393990|460217992|FG016|Overall Study|Death|0|||
127889125|NCT01393990|460217993|FG017|Overall Study|Death|0|||
127889126|NCT01393990|460217976|FG000|Overall Study|Withdrawal by Subject|0|||
127889127|NCT01393990|460217977|FG001|Overall Study|Withdrawal by Subject|0|||
127889128|NCT01393990|460217978|FG002|Overall Study|Withdrawal by Subject|0|||
127889129|NCT01393990|460217979|FG003|Overall Study|Withdrawal by Subject|0|||
127889130|NCT01393990|460217980|FG004|Overall Study|Withdrawal by Subject|0|||
127889131|NCT01393990|460217981|FG005|Overall Study|Withdrawal by Subject|0|||
127722800|NCT03182244|459611817|FG000|Long Term Follow-up (Up to 1232 Days)|Death|76|||
127722801|NCT03182244|459611818|FG001|Long Term Follow-up (Up to 1232 Days)|Death|75|||
127722802|NCT00680771|459611821|FG000|Overall Study|Withdrawal by Subject|1|||
127722803|NCT00680771|459611822|FG001|Overall Study|Withdrawal by Subject|0|||
127722804|NCT00680771|459611821|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
127722805|NCT00680771|459611822|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
127722806|NCT00680771|459611821|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
127722807|NCT00680771|459611822|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
127722808|NCT01316913|459611823|FG000|Overall Study|Adverse Event|17|||
127722809|NCT01316913|459611824|FG001|Overall Study|Adverse Event|20|||
127722810|NCT01316913|459611825|FG002|Overall Study|Adverse Event|15|||
127722811|NCT01316913|459611826|FG003|Overall Study|Adverse Event|11|||
127722812|NCT01316913|459611823|FG000|Overall Study|Lack of Efficacy|22|||
127722813|NCT01316913|459611824|FG001|Overall Study|Lack of Efficacy|12|||
127722814|NCT01316913|459611825|FG002|Overall Study|Lack of Efficacy|9|||
127722815|NCT01316913|459611826|FG003|Overall Study|Lack of Efficacy|13|||
127722816|NCT01316913|459611823|FG000|Overall Study|Protocol Violation|1|||
127722817|NCT01316913|459611824|FG001|Overall Study|Protocol Violation|4|||
127722818|NCT01316913|459611825|FG002|Overall Study|Protocol Violation|4|||
127722819|NCT01316913|459611826|FG003|Overall Study|Protocol Violation|1|||
127722820|NCT01316913|459611823|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
127722821|NCT01316913|459611824|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
127722822|NCT01316913|459611825|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
127722823|NCT01316913|459611826|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
127722824|NCT01316913|459611823|FG000|Overall Study|Lost to Follow-up|0|||
127722825|NCT01316913|459611824|FG001|Overall Study|Lost to Follow-up|1|||
127722826|NCT01316913|459611825|FG002|Overall Study|Lost to Follow-up|0|||
127722827|NCT01316913|459611826|FG003|Overall Study|Lost to Follow-up|2|||
127722828|NCT01316913|459611823|FG000|Overall Study|Withdrawal by Subject|10|||
127722829|NCT01316913|459611824|FG001|Overall Study|Withdrawal by Subject|9|||
127722830|NCT01316913|459611825|FG002|Overall Study|Withdrawal by Subject|10|||
127722831|NCT01316913|459611826|FG003|Overall Study|Withdrawal by Subject|6|||
127722832|NCT01668719|459611827|FG000|Phase I|On treatment|1|||
127722833|NCT01668719|459611828|FG001|Phase I|On treatment|0|||
127722834|NCT01668719|459611829|FG002|Phase I|On treatment|0|||
127722835|NCT01668719|459611827|FG000|Phase I|Adverse Event|2|||
127722836|NCT01668719|459611828|FG001|Phase I|Adverse Event|0|||
127722837|NCT01668719|459611829|FG002|Phase I|Adverse Event|0|||
127722838|NCT01668719|459611827|FG000|Phase I|Progression/relapse|1|||
127722839|NCT01668719|459611828|FG001|Phase I|Progression/relapse|0|||
127722840|NCT01668719|459611829|FG002|Phase I|Progression/relapse|0|||
127722841|NCT01668719|459611827|FG000|Phase I|not protocol specified|2|||
127722842|NCT01668719|459611828|FG001|Phase I|not protocol specified|0|||
127722843|NCT01668719|459611829|FG002|Phase I|not protocol specified|0|||
127722844|NCT01668719|459611827|FG000|Phase II|On treatment|0|||
127722845|NCT01668719|459611828|FG001|Phase II|On treatment|4|||
127722846|NCT01668719|459611829|FG002|Phase II|On treatment|3|||
127722847|NCT01668719|459611827|FG000|Phase II|Adverse Event|0|||
127722848|NCT01668719|459611828|FG001|Phase II|Adverse Event|18|||
127722849|NCT01668719|459611829|FG002|Phase II|Adverse Event|18|||
127722850|NCT01668719|459611827|FG000|Phase II|Refusal unrelated to adverse event|0|||
127722851|NCT01668719|459611828|FG001|Phase II|Refusal unrelated to adverse event|4|||
127722852|NCT01668719|459611829|FG002|Phase II|Refusal unrelated to adverse event|1|||
127722853|NCT01668719|459611827|FG000|Phase II|Progression/relapse|0|||
127722854|NCT01668719|459611828|FG001|Phase II|Progression/relapse|13|||
127722855|NCT01668719|459611829|FG002|Phase II|Progression/relapse|17|||
127722856|NCT01668719|459611827|FG000|Phase II|Death|0|||
127722857|NCT01668719|459611828|FG001|Phase II|Death|0|||
127722858|NCT01668719|459611829|FG002|Phase II|Death|2|||
127722859|NCT01668719|459611827|FG000|Phase II|not protocol specified|0|||
127889132|NCT01393990|460217982|FG006|Overall Study|Withdrawal by Subject|0|||
127722860|NCT01668719|459611828|FG001|Phase II|not protocol specified|13|||
127889133|NCT01393990|460217983|FG007|Overall Study|Withdrawal by Subject|0|||
127889134|NCT01393990|460217984|FG008|Overall Study|Withdrawal by Subject|0|||
127722861|NCT01668719|459611829|FG002|Phase II|not protocol specified|7|||
127722862|NCT03539055|459611830|FG000|Overall Study|Death|4|||
127722863|NCT03539055|459611830|FG000|Overall Study|Lost to Follow-up|1|||
127722864|NCT03539055|459611830|FG000|Overall Study|Withdrawal by Subject|2|||
127722865|NCT03539055|459611830|FG000|Overall Study|Screen Fail|7|||
127722866|NCT03539055|459611830|FG000|Overall Study|Drug Intolerance|2|||
127722867|NCT00786188|459611831|FG000|Overall Study|Adverse Event|3|||
127722868|NCT00786188|459611832|FG001|Overall Study|Adverse Event|1|||
127722869|NCT00786188|459611831|FG000|Overall Study|Withdrawal by Subject|2|||
127722870|NCT00786188|459611832|FG001|Overall Study|Withdrawal by Subject|0|||
127722871|NCT02950961|459611834|FG000|Overall Study|Study had to stop due to COVID.|7|||
127722872|NCT02241785|459611835|FG000|Overall Study|Sponsor Termination|43|||
127722873|NCT02241785|459611835|FG000|Overall Study|Withdrawal by Subject|1|||
127722874|NCT02241785|459611835|FG000|Overall Study|Lost to Follow-up|2|||
127722875|NCT02241785|459611835|FG000|Overall Study|Adverse Event|1|||
127722876|NCT03055988|459611838|FG000|Period 1|Adverse Event|0|||
127722877|NCT03055988|459611839|FG001|Period 1|Adverse Event|1|||
127722878|NCT03055988|459611838|FG000|Period 1|Lost to Follow-up|1|||
127722879|NCT03055988|459611839|FG001|Period 1|Lost to Follow-up|0|||
127722880|NCT03055988|459611838|FG000|Period 1|Withdrawal by Subject|0|||
127722881|NCT03055988|459611839|FG001|Period 1|Withdrawal by Subject|4|||
127722882|NCT03055988|459611838|FG000|Period 2|Adverse Event|0|||
127722883|NCT03055988|459611839|FG001|Period 2|Adverse Event|1|||
127722884|NCT03055988|459611838|FG000|Period 2|Other than listed|1|||
127722885|NCT03055988|459611839|FG001|Period 2|Other than listed|1|||
127722886|NCT00845520|459611840|FG000|Overall Study|Death|1|||
127722887|NCT00845520|459611841|FG001|Overall Study|Death|2|||
127722888|NCT00845520|459611842|FG002|Overall Study|Death|0|||
127722889|NCT00845520|459611840|FG000|Overall Study|Lost to Follow-up|1|||
127722890|NCT00845520|459611841|FG001|Overall Study|Lost to Follow-up|0|||
127722891|NCT00845520|459611842|FG002|Overall Study|Lost to Follow-up|0|||
127722892|NCT00845520|459611840|FG000|Overall Study|Adverse Event|0|||
127722893|NCT00845520|459611841|FG001|Overall Study|Adverse Event|0|||
127722894|NCT00845520|459611842|FG002|Overall Study|Adverse Event|1|||
127722895|NCT01736475|459611843|FG000|Overall Study|Adverse Event|4|||
127722896|NCT01736475|459611844|FG001|Overall Study|Adverse Event|0|||
127722897|NCT01736475|459611843|FG000|Overall Study|Withdrawal by Subject|2|||
127722898|NCT01736475|459611844|FG001|Overall Study|Withdrawal by Subject|0|||
127722899|NCT01736475|459611843|FG000|Overall Study|Protocol Violation|4|||
127722900|NCT01736475|459611844|FG001|Overall Study|Protocol Violation|0|||
127722901|NCT01736475|459611843|FG000|Overall Study|Other - Screen failure|1|||
127722902|NCT01736475|459611844|FG001|Overall Study|Other - Screen failure|0|||
127722903|NCT01736475|459611843|FG000|Overall Study|Other - Surgical procedure|1|||
127722904|NCT01736475|459611844|FG001|Overall Study|Other - Surgical procedure|0|||
127722905|NCT02807857|459611845|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
127722906|NCT02807857|459611845|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
127722907|NCT02807857|459611845|FG000|Follow-Up Set|Withdrawal by Subject|8|||
127722908|NCT02807857|459611845|FG000|Follow-Up Set|Lost to Follow-up|7|||
127722909|NCT02807857|459611845|FG000|Follow-Up Set|Physician Decision|6|||
127722910|NCT02807857|459611845|FG000|Follow-Up Set|Adverse Event|3|||
127722911|NCT02807857|459611845|FG000|Follow-Up Set|Death|27|||
127722912|NCT02807857|459611845|FG000|Follow-Up Set|Relocation|2|||
127722913|NCT02334215|459611847|FG000|Overall Study|Death|1|||
127722914|NCT02334215|459611848|FG001|Overall Study|Death|1|||
127722915|NCT02334215|459611849|FG002|Overall Study|Death|0|||
127722916|NCT02334215|459611847|FG000|Overall Study|Lost to Follow-up|1|||
127722917|NCT02334215|459611848|FG001|Overall Study|Lost to Follow-up|0|||
127722918|NCT02334215|459611849|FG002|Overall Study|Lost to Follow-up|4|||
127722919|NCT02334215|459611847|FG000|Overall Study|Withdrawal by Subject|2|||
127722920|NCT02334215|459611848|FG001|Overall Study|Withdrawal by Subject|2|||
127722921|NCT02334215|459611849|FG002|Overall Study|Withdrawal by Subject|1|||
127722922|NCT02334215|459611847|FG000|Overall Study|Not released from incarceration on time|3|||
127722923|NCT02334215|459611848|FG001|Overall Study|Not released from incarceration on time|3|||
127722924|NCT02334215|459611849|FG002|Overall Study|Not released from incarceration on time|3|||
127722925|NCT02334215|459611847|FG000|Overall Study|Incarcerated|0|||
127722926|NCT02334215|459611848|FG001|Overall Study|Incarcerated|0|||
127722927|NCT02334215|459611849|FG002|Overall Study|Incarcerated|7|||
127722928|NCT03905642|459611850|FG000|Overall Study|Withdrawal by Subject|3|||
127722929|NCT03905642|459611850|FG000|Overall Study|Pregnancy|1|||
127722930|NCT03905642|459611850|FG000|Overall Study|Adverse Event|1|||
127722931|NCT03905642|459611850|FG000|Overall Study|Lack of Efficacy|1|||
127722932|NCT03905642|459611850|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
127722933|NCT03769090|459613587|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
127722934|NCT03769090|459613588|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
127722935|NCT03769090|459613589|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
127722936|NCT03769090|459613587|FG000|Overall Study|Withdrawal by Subject|52|||
127722937|NCT03769090|459613588|FG001|Overall Study|Withdrawal by Subject|62|||
127722938|NCT03769090|459613589|FG002|Overall Study|Withdrawal by Subject|74|||
127722939|NCT03769090|459613587|FG000|Overall Study|Death|4|||
127722940|NCT03769090|459613588|FG001|Overall Study|Death|2|||
127722941|NCT03769090|459613589|FG002|Overall Study|Death|2|||
127722942|NCT03769090|459613587|FG000|Overall Study|Adverse Event|7|||
127722943|NCT03769090|459613588|FG001|Overall Study|Adverse Event|7|||
127722944|NCT03769090|459613589|FG002|Overall Study|Adverse Event|8|||
127722945|NCT03769090|459613587|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
127722946|NCT03769090|459613588|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
127722947|NCT03769090|459613589|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
127722948|NCT03769090|459613587|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
127802925|NCT00130286|459901091|FG002|Overall Study|Adverse Event|2|||
127722949|NCT03769090|459613588|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
127722950|NCT03769090|459613589|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
127722951|NCT03769090|459613587|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
127722952|NCT03769090|459613588|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
127722953|NCT03769090|459613589|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
127722954|NCT03769090|459613587|FG000|Overall Study|Protocol Violation|5|||
127722955|NCT03769090|459613588|FG001|Overall Study|Protocol Violation|6|||
127722956|NCT03769090|459613589|FG002|Overall Study|Protocol Violation|8|||
127722957|NCT03769090|459613587|FG000|Overall Study|Pregnancy|1|||
127722958|NCT03769090|459613588|FG001|Overall Study|Pregnancy|0|||
127722959|NCT03769090|459613589|FG002|Overall Study|Pregnancy|3|||
127722960|NCT03769090|459613587|FG000|Overall Study|Lost to Follow-up|19|||
127722961|NCT03769090|459613588|FG001|Overall Study|Lost to Follow-up|25|||
127722962|NCT03769090|459613589|FG002|Overall Study|Lost to Follow-up|21|||
127722963|NCT03769090|459613587|FG000|Overall Study|Condition under investigation worsened|2|||
127722964|NCT03769090|459613588|FG001|Overall Study|Condition under investigation worsened|0|||
127722965|NCT03769090|459613589|FG002|Overall Study|Condition under investigation worsened|1|||
127722966|NCT03769090|459613587|FG000|Overall Study|Lack of Efficacy|1|||
127722967|NCT03769090|459613588|FG001|Overall Study|Lack of Efficacy|2|||
127722968|NCT03769090|459613589|FG002|Overall Study|Lack of Efficacy|2|||
127722969|NCT03769090|459613587|FG000|Overall Study|Other reasons|8|||
127722970|NCT03769090|459613588|FG001|Overall Study|Other reasons|12|||
127722971|NCT03769090|459613589|FG002|Overall Study|Other reasons|15|||
127722972|NCT02014402|459613593|FG000|Overall Study|Adverse Event|1|||
127722973|NCT02014402|459613594|FG001|Overall Study|Adverse Event|0|||
127722974|NCT02014402|459613595|FG002|Overall Study|Adverse Event|0|||
127722975|NCT02014402|459613596|FG003|Overall Study|Adverse Event|0|||
127722976|NCT02014402|459613593|FG000|Overall Study|Withdrawal by Subject|1|||
127722977|NCT02014402|459613594|FG001|Overall Study|Withdrawal by Subject|2|||
127722978|NCT02014402|459613595|FG002|Overall Study|Withdrawal by Subject|2|||
127722979|NCT02014402|459613596|FG003|Overall Study|Withdrawal by Subject|1|||
127722980|NCT02014402|459613593|FG000|Overall Study|Subject did not have transportation|0|||
127722981|NCT02014402|459613594|FG001|Overall Study|Subject did not have transportation|1|||
127722982|NCT02014402|459613595|FG002|Overall Study|Subject did not have transportation|0|||
127722983|NCT02014402|459613596|FG003|Overall Study|Subject did not have transportation|0|||
127722984|NCT02014402|459613593|FG000|Overall Study|Lost to Follow-up|0|||
127722985|NCT02014402|459613594|FG001|Overall Study|Lost to Follow-up|0|||
127722986|NCT02014402|459613595|FG002|Overall Study|Lost to Follow-up|1|||
127722987|NCT02014402|459613596|FG003|Overall Study|Lost to Follow-up|2|||
127722988|NCT00443820|459613597|FG000|Overall Study|Adverse Event|1|||
127722989|NCT00443820|459613598|FG001|Overall Study|Adverse Event|1|||
127722990|NCT00443820|459613599|FG002|Overall Study|Adverse Event|0|||
127722991|NCT00443820|459613600|FG003|Overall Study|Adverse Event|0|||
127722992|NCT00443820|459613597|FG000|Overall Study|Lack of Efficacy|3|||
127722993|NCT00443820|459613598|FG001|Overall Study|Lack of Efficacy|2|||
127722994|NCT00443820|459613599|FG002|Overall Study|Lack of Efficacy|1|||
127722995|NCT00443820|459613600|FG003|Overall Study|Lack of Efficacy|1|||
127722996|NCT00443820|459613597|FG000|Overall Study|Protocol Violation|2|||
127722997|NCT00443820|459613598|FG001|Overall Study|Protocol Violation|1|||
127722998|NCT00443820|459613599|FG002|Overall Study|Protocol Violation|2|||
127722999|NCT00443820|459613600|FG003|Overall Study|Protocol Violation|1|||
127723000|NCT00443820|459613597|FG000|Overall Study|Withdrawal by Subject|6|||
127723001|NCT00443820|459613598|FG001|Overall Study|Withdrawal by Subject|7|||
127723002|NCT00443820|459613599|FG002|Overall Study|Withdrawal by Subject|8|||
127723003|NCT00443820|459613600|FG003|Overall Study|Withdrawal by Subject|9|||
127723004|NCT00443820|459613597|FG000|Overall Study|Lost to Follow-up|9|||
127723005|NCT00443820|459613598|FG001|Overall Study|Lost to Follow-up|8|||
127723006|NCT00443820|459613599|FG002|Overall Study|Lost to Follow-up|6|||
127723007|NCT00443820|459613600|FG003|Overall Study|Lost to Follow-up|5|||
127723008|NCT00443820|459613597|FG000|Overall Study|Administrative problems|0|||
127723009|NCT00443820|459613598|FG001|Overall Study|Administrative problems|0|||
127723010|NCT00443820|459613599|FG002|Overall Study|Administrative problems|0|||
127723011|NCT00443820|459613600|FG003|Overall Study|Administrative problems|1|||
127723012|NCT00443820|459613597|FG000|Overall Study|Death|0|||
127723013|NCT00443820|459613598|FG001|Overall Study|Death|0|||
127723014|NCT00443820|459613599|FG002|Overall Study|Death|1|||
127723015|NCT00443820|459613600|FG003|Overall Study|Death|0|||
127723016|NCT04633200|459613601|FG000|Overall Study|Lost to Follow-up|3|||
127723017|NCT04633200|459613602|FG001|Overall Study|Lost to Follow-up|5|||
127723018|NCT01190124|459613603|FG000|Overall Study|Death|3|||
127723019|NCT01190124|459613604|FG001|Overall Study|Death|0|||
127723020|NCT01190124|459613605|FG002|Overall Study|Death|0|||
127723021|NCT01190124|459613603|FG000|Overall Study|Therapeutic Failure|12|||
127723022|NCT01190124|459613604|FG001|Overall Study|Therapeutic Failure|0|||
127723023|NCT01190124|459613605|FG002|Overall Study|Therapeutic Failure|1|||
127723024|NCT01190124|459613603|FG000|Overall Study|Lost to Follow-up|2|||
127723025|NCT01190124|459613604|FG001|Overall Study|Lost to Follow-up|0|||
127723026|NCT01190124|459613605|FG002|Overall Study|Lost to Follow-up|0|||
127723027|NCT03493282|459613606|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
127723028|NCT03493282|459613607|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
127723029|NCT03493282|459613608|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
127723030|NCT03493282|459613606|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
127723031|NCT03493282|459613607|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
127723032|NCT03493282|459613608|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
127723033|NCT00070707|459613609|FG000|Overall Study|Adverse Event|1|||
127723034|NCT00070707|459613610|FG001|Overall Study|Adverse Event|2|||
127723035|NCT00070707|459613609|FG000|Overall Study|Lack of Efficacy|4|||
127723036|NCT00070707|459613610|FG001|Overall Study|Lack of Efficacy|1|||
127723037|NCT00070707|459613609|FG000|Overall Study|Protocol Violation|8|||
127723038|NCT00070707|459613610|FG001|Overall Study|Protocol Violation|4|||
127723039|NCT00070707|459613609|FG000|Overall Study|Unrelated to Study Medication|1|||
127723040|NCT00070707|459613610|FG001|Overall Study|Unrelated to Study Medication|0|||
127723041|NCT03928743|459613611|FG000|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
127723042|NCT03928743|459613612|FG001|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
127723043|NCT03928743|459613613|FG002|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|0|||
127723044|NCT03928743|459613611|FG000|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|1|||
127723045|NCT03928743|459613612|FG001|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|3|||
127723046|NCT03928743|459613613|FG002|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|0|||
127723047|NCT03928743|459613611|FG000|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
127723048|NCT03928743|459613612|FG001|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|1|||
127723049|NCT03928743|459613613|FG002|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
127723050|NCT03928743|459613611|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
127723051|NCT03928743|459613612|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|2|||
127723052|NCT03928743|459613613|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
127723053|NCT03928743|459613611|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
127723054|NCT03928743|459613612|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|1|||
127723055|NCT03928743|459613613|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
127723056|NCT03928743|459613611|FG000|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
127723057|NCT03928743|459613612|FG001|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
127723058|NCT03928743|459613613|FG002|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|1|||
127723059|NCT03928743|459613611|FG000|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
127723060|NCT03928743|459613612|FG001|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
127723061|NCT03928743|459613613|FG002|Maintenance Period: Weeks 16-52|Withdrawal by Subject|4|||
127723062|NCT03928743|459613611|FG000|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
127723063|NCT03928743|459613612|FG001|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
127723064|NCT03928743|459613613|FG002|Maintenance Period: Weeks 16-52|Lost to Follow-up|2|||
127723065|NCT03928743|459613611|FG000|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
127723066|NCT03928743|459613612|FG001|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
127723067|NCT03928743|459613613|FG002|Maintenance Period: Weeks 16-52|Lack of Efficacy|3|||
127723068|NCT03928743|459613611|FG000|Maintenance Period: Weeks 16-52|Adverse Event|0|||
127723069|NCT03928743|459613612|FG001|Maintenance Period: Weeks 16-52|Adverse Event|0|||
127723070|NCT03928743|459613613|FG002|Maintenance Period: Weeks 16-52|Adverse Event|9|||
127723071|NCT03928743|459613611|FG000|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
127723072|NCT03928743|459613612|FG001|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
127723073|NCT03928743|459613613|FG002|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|2|||
127723074|NCT02392507|459613614|FG000|Induction Regimen|Death|3|||
127723075|NCT02392507|459613614|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
127723076|NCT02392507|459613614|FG000|Induction Regimen|Physician Decision|1|||
127723077|NCT02392507|459613614|FG000|Induction Regimen|Withdrawal by Subject|2|||
127723078|NCT02392507|459613614|FG000|Maintenance Regimen|Death|1|||
127723079|NCT02392507|459613614|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
127723080|NCT02224755|459613615|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
127723081|NCT02224755|459613616|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
127723082|NCT02224755|459613615|FG000|Two Year Follow up Post-implant|Death|103|||
127723083|NCT02224755|459613616|FG001|Two Year Follow up Post-implant|Death|98|||
127723084|NCT02224755|459613615|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
127723085|NCT02224755|459613616|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
127723086|NCT02224755|459613615|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
127723087|NCT02224755|459613616|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
127723088|NCT02224755|459613615|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
127723089|NCT02224755|459613616|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
127723090|NCT02736188|459613617|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
127723091|NCT02736188|459613617|FG000|Overall Study|Adverse Event|1|||
127723092|NCT02736188|459613617|FG000|Overall Study|Withdrawal by Subject|1|||
127723093|NCT02736188|459613617|FG000|Overall Study|Other|6|||
127723094|NCT00240994|459613618|FG000|Overall Study|Lost to Follow-up|1|||
127723095|NCT00240994|459613618|FG000|Overall Study|Protocol Violation|1|||
127723096|NCT00240994|459613618|FG000|Overall Study|Graft failure|1|||
127723097|NCT04070105|459613619|FG000|Overall Study|Lost to Follow-up|0|||
127723098|NCT04070105|459613620|FG001|Overall Study|Lost to Follow-up|0|||
127723099|NCT04070105|459613621|FG002|Overall Study|Lost to Follow-up|0|||
127723100|NCT04070105|459613622|FG003|Overall Study|Lost to Follow-up|0|||
127723101|NCT04070105|459613623|FG004|Overall Study|Lost to Follow-up|0|||
127723102|NCT04070105|459613624|FG005|Overall Study|Lost to Follow-up|1|||
127723103|NCT00749944|459613629|FG000|Overall Study|Lost to Follow-up|2|||
127723104|NCT00749944|459613630|FG001|Overall Study|Lost to Follow-up|1|||
127723105|NCT00749944|459613629|FG000|Overall Study|Other|1|||
127723106|NCT00749944|459613630|FG001|Overall Study|Other|0|||
127723107|NCT00749944|459613629|FG000|Overall Study|Withdrawal by Subject|2|||
127723108|NCT00749944|459613630|FG001|Overall Study|Withdrawal by Subject|0|||
127723109|NCT00923078|459613634|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
127723110|NCT00923078|459613635|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
127723111|NCT00923078|459613636|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
127723112|NCT00923078|459613634|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
127723113|NCT00923078|459613635|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
127723114|NCT00923078|459613636|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
127723115|NCT03547154|459613649|FG000|Overall Study|Disease Progression/Recurrence|6|||
127723116|NCT03547154|459613650|FG001|Overall Study|Disease Progression/Recurrence|14|||
127723117|NCT03547154|459613649|FG000|Overall Study|Adverse Event|26|||
127723118|NCT03547154|459613650|FG001|Overall Study|Adverse Event|31|||
127723119|NCT03547154|459613649|FG000|Overall Study|Protocol Violation|6|||
127723120|NCT03547154|459613650|FG001|Overall Study|Protocol Violation|1|||
127723121|NCT03547154|459613649|FG000|Overall Study|Physician Decision|4|||
127723122|NCT03547154|459613650|FG001|Overall Study|Physician Decision|3|||
127723123|NCT03547154|459613649|FG000|Overall Study|Insufficient Therapeutic Response|13|||
127723124|NCT03547154|459613650|FG001|Overall Study|Insufficient Therapeutic Response|10|||
127723125|NCT03547154|459613649|FG000|Overall Study|Withdrawal by Subject|10|||
127723126|NCT03547154|459613650|FG001|Overall Study|Withdrawal by Subject|6|||
127723127|NCT03547154|459613649|FG000|Overall Study|Not Selected|0|||
127723128|NCT03547154|459613650|FG001|Overall Study|Not Selected|1|||
127723129|NCT03547154|459613649|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
127723130|NCT03547154|459613650|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
127723131|NCT04679675|459613651|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
127723132|NCT04679675|459613652|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
127723133|NCT04679675|459613653|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
127723134|NCT04679675|459613654|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
127723135|NCT04679675|459613651|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
127723136|NCT04679675|459613652|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
127723137|NCT04679675|459613653|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
127723138|NCT04679675|459613654|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
127723139|NCT00895245|459613655|FG000|Overall Study|Lack of Efficacy|6|||
127723140|NCT02706483|459613656|FG000|Overall Study|Adverse Event|97|||
127723141|NCT02706483|459613656|FG000|Overall Study|Death|1|||
127723142|NCT02706483|459613656|FG000|Overall Study|Lack of Efficacy|39|||
127723143|NCT02706483|459613656|FG000|Overall Study|Lost to Follow-up|101|||
127723144|NCT02706483|459613656|FG000|Overall Study|Non-compliance with study drug|15|||
127723145|NCT02706483|459613656|FG000|Overall Study|Physician Decision|6|||
127723146|NCT02706483|459613656|FG000|Overall Study|Pregnancy|6|||
127723147|NCT02706483|459613656|FG000|Overall Study|Protocol Violation|18|||
127723148|NCT02706483|459613656|FG000|Overall Study|Withdrawal by Subject|136|||
127723149|NCT02706483|459613656|FG000|Overall Study|Non-compliance with visits|6|||
127723150|NCT02706483|459613656|FG000|Overall Study|Site closure|4|||
127723151|NCT02706483|459613656|FG000|Overall Study|Subject moved|1|||
127723152|NCT01972776|459613657|FG000|Part 1|Withdrawal by Subject|0|||
127723153|NCT01972776|459613658|FG001|Part 1|Withdrawal by Subject|0|||
127723154|NCT01972776|459613659|FG002|Part 1|Withdrawal by Subject|1|||
127723155|NCT01972776|459613660|FG003|Part 1|Withdrawal by Subject|0|||
127723156|NCT01972776|459613661|FG004|Part 1|Withdrawal by Subject|0|||
127723157|NCT01972776|459613662|FG005|Part 1|Withdrawal by Subject|0|||
127723158|NCT01972776|459613657|FG000|Part 1|Adverse Event|0|||
127723159|NCT01972776|459613658|FG001|Part 1|Adverse Event|0|||
127723160|NCT01972776|459613659|FG002|Part 1|Adverse Event|1|||
127723161|NCT01972776|459613660|FG003|Part 1|Adverse Event|1|||
127723162|NCT01972776|459613661|FG004|Part 1|Adverse Event|0|||
127723163|NCT01972776|459613662|FG005|Part 1|Adverse Event|0|||
127723164|NCT01972776|459613657|FG000|Part 2|Adverse Event|0|||
127723165|NCT01972776|459613658|FG001|Part 2|Adverse Event|0|||
127723166|NCT01972776|459613659|FG002|Part 2|Adverse Event|0|||
127723167|NCT01972776|459613660|FG003|Part 2|Adverse Event|0|||
127723168|NCT01972776|459613661|FG004|Part 2|Adverse Event|3|||
127723169|NCT01972776|459613662|FG005|Part 2|Adverse Event|0|||
127723170|NCT01972776|459613657|FG000|Part 2|Administrative problems|0|||
127723171|NCT01972776|459613658|FG001|Part 2|Administrative problems|0|||
127723172|NCT01972776|459613659|FG002|Part 2|Administrative problems|0|||
127723173|NCT01972776|459613660|FG003|Part 2|Administrative problems|0|||
127723174|NCT01972776|459613661|FG004|Part 2|Administrative problems|10|||
127723175|NCT01972776|459613662|FG005|Part 2|Administrative problems|7|||
127723176|NCT01543204|459613663|FG000|Overall Study|Non-compliance|1|||
127723177|NCT01543204|459613663|FG000|Overall Study|Adverse Event|1|||
127723178|NCT01543204|459613663|FG000|Overall Study|Withdrawal by Subject|4|||
127723179|NCT01543204|459613663|FG000|Overall Study|Requirement for Alternative Therapy|1|||
127723180|NCT01543204|459613663|FG000|Overall Study|Lost to Follow-up|1|||
127723181|NCT02449902|459613667|FG000|Overall Study|Adverse Event|0|||
127723182|NCT02449902|459613668|FG001|Overall Study|Adverse Event|1|||
127723183|NCT02449902|459613667|FG000|Overall Study|Withdrawal by Subject|0|||
127723184|NCT02449902|459613668|FG001|Overall Study|Withdrawal by Subject|1|||
127723185|NCT02362789|459613669|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
127723186|NCT02362789|459613670|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
127723187|NCT02362789|459613671|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
127723188|NCT02362789|459613669|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
127723189|NCT02362789|459613670|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
127723190|NCT02362789|459613671|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
127723191|NCT02362789|459613669|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
127723192|NCT02362789|459613670|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
127723193|NCT02362789|459613671|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
127723194|NCT02362789|459613669|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
127723195|NCT02362789|459613670|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
127723196|NCT02362789|459613671|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
127723197|NCT02362789|459613669|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
127723198|NCT02362789|459613670|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
127723199|NCT02362789|459613671|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
127723200|NCT00721734|459613675|FG000|Overall Study|Progressive Disease|3|||
127723201|NCT00721734|459613676|FG001|Overall Study|Progressive Disease|10|||
127723202|NCT00721734|459613677|FG002|Overall Study|Progressive Disease|4|||
127723203|NCT00721734|459613678|FG003|Overall Study|Progressive Disease|5|||
127723204|NCT00721734|459613679|FG004|Overall Study|Progressive Disease|2|||
127723205|NCT00721734|459613675|FG000|Overall Study|Adverse Event|3|||
127723206|NCT00721734|459613676|FG001|Overall Study|Adverse Event|1|||
127723207|NCT00721734|459613677|FG002|Overall Study|Adverse Event|4|||
127723208|NCT00721734|459613678|FG003|Overall Study|Adverse Event|0|||
127723209|NCT00721734|459613679|FG004|Overall Study|Adverse Event|3|||
127723210|NCT00721734|459613675|FG000|Overall Study|Withdrawal by Subject|2|||
127723211|NCT00721734|459613676|FG001|Overall Study|Withdrawal by Subject|1|||
127723212|NCT00721734|459613677|FG002|Overall Study|Withdrawal by Subject|0|||
127723213|NCT00721734|459613678|FG003|Overall Study|Withdrawal by Subject|0|||
127723214|NCT00721734|459613679|FG004|Overall Study|Withdrawal by Subject|1|||
127723215|NCT00721734|459613675|FG000|Overall Study|Other|0|||
127723216|NCT00721734|459613676|FG001|Overall Study|Other|0|||
127723217|NCT00721734|459613677|FG002|Overall Study|Other|0|||
127723218|NCT00721734|459613678|FG003|Overall Study|Other|1|||
127723219|NCT00721734|459613679|FG004|Overall Study|Other|0|||
127723220|NCT01989689|459613681|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
127723221|NCT01989689|459613682|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
127723222|NCT01989689|459613681|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
127723223|NCT01989689|459613682|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
127723224|NCT00526994|459613683|FG000|Overall Study|Lost to Follow-up|98|||
127723225|NCT00526994|459613684|FG001|Overall Study|Lost to Follow-up|108|||
127723226|NCT00526994|459613685|FG002|Overall Study|Lost to Follow-up|96|||
127723227|NCT00526994|459613683|FG000|Overall Study|Death|4|||
127723228|NCT00526994|459613684|FG001|Overall Study|Death|3|||
127723229|NCT00526994|459613685|FG002|Overall Study|Death|3|||
127723230|NCT00526994|459613683|FG000|Overall Study|Withdrawal by Subject|2|||
127723231|NCT00526994|459613684|FG001|Overall Study|Withdrawal by Subject|7|||
127723232|NCT00526994|459613685|FG002|Overall Study|Withdrawal by Subject|5|||
127723233|NCT00526994|459613683|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
127723234|NCT00526994|459613684|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
127723235|NCT00526994|459613685|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
127723236|NCT03938272|459613686|FG000|Overall Study|Withdrawal by Subject|1|||
127723237|NCT03938272|459613687|FG001|Overall Study|Withdrawal by Subject|0|||
127723238|NCT03938272|459613686|FG000|Overall Study|Physician Decision|0|||
127723239|NCT03938272|459613687|FG001|Overall Study|Physician Decision|2|||
127723240|NCT03938272|459613686|FG000|Overall Study|Study termination by sponsor|10|||
127723241|NCT03938272|459613687|FG001|Overall Study|Study termination by sponsor|8|||
127723242|NCT00068107|459613690|FG000|Overall Study|end-stage renal disease|6|||
127723243|NCT00068107|459613690|FG000|Overall Study|Death|2|||
127723244|NCT00068107|459613690|FG000|Overall Study|Withdrawal by Subject|1|||
127723245|NCT03288506|459613691|FG000|Overall Study|Withdrawal by Subject|52|||
127723246|NCT01419184|459613694|FG000|Overall Study|Site data not available|3|||
127723247|NCT01419184|459613695|FG001|Overall Study|Site data not available|2|||
127723248|NCT01419184|459613694|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
127723249|NCT01419184|459613695|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
127723250|NCT01419184|459613694|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
127723251|NCT01419184|459613695|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
127723252|NCT01419184|459613694|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
127723253|NCT01419184|459613695|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
127723254|NCT01419184|459613694|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
127723255|NCT01419184|459613695|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
127723256|NCT01419184|459613694|FG000|Overall Study|Participant randomized, not treated|1|||
127723257|NCT01419184|459613695|FG001|Overall Study|Participant randomized, not treated|0|||
127723258|NCT03989232|459613696|FG000|Overall Study|Lost to Follow-up|3|||
127723259|NCT03989232|459613697|FG001|Overall Study|Lost to Follow-up|10|||
127723260|NCT03989232|459613696|FG000|Overall Study|Withdrawal by Subject|6|||
127723261|NCT03989232|459613697|FG001|Overall Study|Withdrawal by Subject|6|||
127723262|NCT03989232|459613696|FG000|Overall Study|Death|1|||
127723263|NCT03989232|459613697|FG001|Overall Study|Death|2|||
127723264|NCT02691702|459613701|FG000|Overall Study|Adverse Event|1|||
127723265|NCT02691702|459613702|FG001|Overall Study|Adverse Event|0|||
127723266|NCT02691702|459613703|FG002|Overall Study|Adverse Event|0|||
127723267|NCT02691702|459613704|FG003|Overall Study|Adverse Event|0|||
127723268|NCT02691702|459613705|FG004|Overall Study|Adverse Event|0|||
127723269|NCT02691702|459613706|FG005|Overall Study|Adverse Event|0|||
127723270|NCT02691702|459613707|FG006|Overall Study|Adverse Event|0|||
127723271|NCT02691702|459613708|FG007|Overall Study|Adverse Event|0|||
127723272|NCT02691702|459613709|FG008|Overall Study|Adverse Event|1|||
127723273|NCT02691702|459613710|FG009|Overall Study|Adverse Event|0|||
127723274|NCT02691702|459613711|FG010|Overall Study|Adverse Event|1|||
127723275|NCT02691702|459613701|FG000|Overall Study|Lost to Follow-up|0|||
127723276|NCT02691702|459613702|FG001|Overall Study|Lost to Follow-up|0|||
127723277|NCT02691702|459613703|FG002|Overall Study|Lost to Follow-up|1|||
127723278|NCT02691702|459613704|FG003|Overall Study|Lost to Follow-up|0|||
127723279|NCT02691702|459613705|FG004|Overall Study|Lost to Follow-up|0|||
127723280|NCT02691702|459613706|FG005|Overall Study|Lost to Follow-up|2|||
127723281|NCT02691702|459613707|FG006|Overall Study|Lost to Follow-up|0|||
127723282|NCT02691702|459613708|FG007|Overall Study|Lost to Follow-up|0|||
127723283|NCT02691702|459613709|FG008|Overall Study|Lost to Follow-up|0|||
127723284|NCT02691702|459613710|FG009|Overall Study|Lost to Follow-up|0|||
127723285|NCT02691702|459613711|FG010|Overall Study|Lost to Follow-up|1|||
127723286|NCT02691702|459613701|FG000|Overall Study|Withdrawal by Subject|1|||
127723287|NCT02691702|459613702|FG001|Overall Study|Withdrawal by Subject|1|||
127723288|NCT02691702|459613703|FG002|Overall Study|Withdrawal by Subject|0|||
127723289|NCT02691702|459613704|FG003|Overall Study|Withdrawal by Subject|0|||
127723290|NCT02691702|459613705|FG004|Overall Study|Withdrawal by Subject|0|||
127723291|NCT02691702|459613706|FG005|Overall Study|Withdrawal by Subject|1|||
127723292|NCT02691702|459613707|FG006|Overall Study|Withdrawal by Subject|2|||
127723293|NCT02691702|459613708|FG007|Overall Study|Withdrawal by Subject|0|||
127723294|NCT02691702|459613709|FG008|Overall Study|Withdrawal by Subject|0|||
127723295|NCT02691702|459613710|FG009|Overall Study|Withdrawal by Subject|0|||
127723296|NCT02691702|459613711|FG010|Overall Study|Withdrawal by Subject|0|||
127723297|NCT02691702|459613701|FG000|Overall Study|Other|0|||
127723298|NCT02691702|459613702|FG001|Overall Study|Other|0|||
127723299|NCT02691702|459613703|FG002|Overall Study|Other|0|||
127723300|NCT02691702|459613704|FG003|Overall Study|Other|0|||
127723301|NCT02691702|459613705|FG004|Overall Study|Other|0|||
127723302|NCT02691702|459613706|FG005|Overall Study|Other|0|||
127723303|NCT02691702|459613707|FG006|Overall Study|Other|1|||
127723304|NCT02691702|459613708|FG007|Overall Study|Other|0|||
127723305|NCT02691702|459613709|FG008|Overall Study|Other|1|||
127723306|NCT02691702|459613710|FG009|Overall Study|Other|0|||
127723307|NCT02691702|459613711|FG010|Overall Study|Other|0|||
127723308|NCT02691702|459613701|FG000|Overall Study|Protocol Violation|0|||
127723309|NCT02691702|459613702|FG001|Overall Study|Protocol Violation|0|||
127723310|NCT02691702|459613703|FG002|Overall Study|Protocol Violation|0|||
127723311|NCT02691702|459613704|FG003|Overall Study|Protocol Violation|0|||
127723312|NCT02691702|459613705|FG004|Overall Study|Protocol Violation|0|||
127723313|NCT02691702|459613706|FG005|Overall Study|Protocol Violation|0|||
127723314|NCT02691702|459613707|FG006|Overall Study|Protocol Violation|0|||
127723315|NCT02691702|459613708|FG007|Overall Study|Protocol Violation|0|||
127723316|NCT02691702|459613709|FG008|Overall Study|Protocol Violation|0|||
127723317|NCT02691702|459613710|FG009|Overall Study|Protocol Violation|2|||
127723318|NCT02691702|459613711|FG010|Overall Study|Protocol Violation|0|||
127723319|NCT05169684|459613712|FG000|Overall Study|Adverse Event|1|||
127723320|NCT05169684|459613713|FG001|Overall Study|Adverse Event|3|||
127723321|NCT05169684|459613712|FG000|Overall Study|Physician Decision|0|||
127723322|NCT05169684|459613713|FG001|Overall Study|Physician Decision|1|||
127723323|NCT05169684|459613712|FG000|Overall Study|Progressive Disease|1|||
127723324|NCT05169684|459613713|FG001|Overall Study|Progressive Disease|1|||
127723325|NCT05169684|459613712|FG000|Overall Study|Participant request to discontinue treatment|0|||
127723326|NCT05169684|459613713|FG001|Overall Study|Participant request to discontinue treatment|1|||
127723327|NCT05169684|459613712|FG000|Overall Study|Other Reason|0|||
127723328|NCT05169684|459613713|FG001|Overall Study|Other Reason|1|||
127723329|NCT02060487|459613714|FG000|Overall Study|Other|1|||
127723330|NCT02060487|459613715|FG001|Overall Study|Other|2|||
127723331|NCT02060487|459613716|FG002|Overall Study|Other|1|||
127723332|NCT02060487|459613714|FG000|Overall Study|Lack of Efficacy|0|||
127723333|NCT02060487|459613715|FG001|Overall Study|Lack of Efficacy|1|||
127723334|NCT02060487|459613716|FG002|Overall Study|Lack of Efficacy|0|||
127723335|NCT02060487|459613714|FG000|Overall Study|Withdrawal by Subject|3|||
127889135|NCT01393990|460217985|FG009|Overall Study|Withdrawal by Subject|0|||
127889136|NCT01393990|460217986|FG010|Overall Study|Withdrawal by Subject|0|||
127889137|NCT01393990|460217987|FG011|Overall Study|Withdrawal by Subject|0|||
127889138|NCT01393990|460217988|FG012|Overall Study|Withdrawal by Subject|0|||
127889139|NCT01393990|460217989|FG013|Overall Study|Withdrawal by Subject|0|||
127723336|NCT02060487|459613715|FG001|Overall Study|Withdrawal by Subject|10|||
127723337|NCT02060487|459613716|FG002|Overall Study|Withdrawal by Subject|4|||
127723338|NCT02060487|459613714|FG000|Overall Study|Study Terminated By Sponsor|87|||
127723339|NCT02060487|459613715|FG001|Overall Study|Study Terminated By Sponsor|89|||
127723340|NCT02060487|459613716|FG002|Overall Study|Study Terminated By Sponsor|100|||
127889140|NCT01393990|460217990|FG014|Overall Study|Withdrawal by Subject|1|||
127889141|NCT01393990|460217991|FG015|Overall Study|Withdrawal by Subject|1|||
127889142|NCT01393990|460217992|FG016|Overall Study|Withdrawal by Subject|0|||
127723341|NCT02060487|459613714|FG000|Overall Study|Randomized in error|1|||
127889143|NCT01393990|460217993|FG017|Overall Study|Withdrawal by Subject|0|||
127889144|NCT00275028|460217994|FG000|Overall Study|Withdrew consent before treatment began|1|||
127889145|NCT00275028|460217994|FG000|Overall Study|Withdrawal by Subject|5|||
127889146|NCT00275028|460217994|FG000|Overall Study|Adverse Event|9|||
127889147|NCT00275028|460217994|FG000|Overall Study|Progressive Disease|30|||
127889148|NCT00275028|460217994|FG000|Overall Study|Physician Decision|2|||
127889149|NCT00720798|460217996|FG000|Overall Study|Adverse Event|304|||
127889150|NCT00720798|460217996|FG000|Overall Study|Death|39|||
127889151|NCT00720798|460217996|FG000|Overall Study|Insufficient Therapeutic Response|129|||
127723342|NCT02060487|459613715|FG001|Overall Study|Randomized in error|0|||
127723343|NCT02060487|459613716|FG002|Overall Study|Randomized in error|0|||
127723344|NCT02060487|459613714|FG000|Overall Study|Protocol Violation|0|||
127723345|NCT02060487|459613715|FG001|Overall Study|Protocol Violation|1|||
127723346|NCT02060487|459613716|FG002|Overall Study|Protocol Violation|1|||
127723347|NCT02060487|459613714|FG000|Overall Study|Lost to Follow-up|3|||
127723348|NCT02060487|459613715|FG001|Overall Study|Lost to Follow-up|0|||
127723349|NCT02060487|459613716|FG002|Overall Study|Lost to Follow-up|2|||
127723350|NCT02060487|459613714|FG000|Overall Study|Death|34|||
127723351|NCT02060487|459613715|FG001|Overall Study|Death|25|||
127723352|NCT02060487|459613716|FG002|Overall Study|Death|19|||
127723353|NCT02060487|459613714|FG000|Overall Study|Adverse Event|0|||
127723354|NCT02060487|459613715|FG001|Overall Study|Adverse Event|0|||
127723355|NCT02060487|459613716|FG002|Overall Study|Adverse Event|1|||
127723356|NCT05484661|459613717|FG000|Overall Study|Withdrawal by Subject|1|||
127723357|NCT05484661|459613718|FG001|Overall Study|Withdrawal by Subject|0|||
127723358|NCT00875706|459613719|FG000|Overall Study|Withdrawal by Subject|1|||
127723359|NCT00875706|459613720|FG001|Overall Study|Withdrawal by Subject|0|||
127723360|NCT00875706|459613721|FG002|Overall Study|Withdrawal by Subject|0|||
127723361|NCT01856569|459613722|FG000|Overall Study|Other|1|||
127723362|NCT01856569|459613722|FG000|Overall Study|Changed Site/Structure|1|||
127723363|NCT01856569|459613722|FG000|Overall Study|Lost to Follow-up|3|||
127723364|NCT01856569|459613722|FG000|Overall Study|Did not met inclusion criteria|8|||
127723365|NCT02279732|459613724|FG000|Overall Study|Death|23|||
127723366|NCT02279732|459613725|FG001|Overall Study|Death|20|||
127723367|NCT02279732|459613724|FG000|Overall Study|Disease Progression|13|||
127723368|NCT02279732|459613725|FG001|Overall Study|Disease Progression|3|||
127723369|NCT02279732|459613724|FG000|Overall Study|Withdrawal by Subject|2|||
127723370|NCT02279732|459613725|FG001|Overall Study|Withdrawal by Subject|7|||
127723371|NCT02279732|459613724|FG000|Overall Study|Adverse Event|1|||
127723372|NCT02279732|459613725|FG001|Overall Study|Adverse Event|2|||
127723373|NCT02279732|459613724|FG000|Overall Study|Administrative Reason By Sponsor|0|||
127723374|NCT02279732|459613725|FG001|Overall Study|Administrative Reason By Sponsor|2|||
127723375|NCT02279732|459613724|FG000|Overall Study|Study Drug Toxicity|2|||
127723376|NCT02279732|459613725|FG001|Overall Study|Study Drug Toxicity|0|||
127723377|NCT02279732|459613724|FG000|Overall Study|Lost to Follow-up|0|||
127723378|NCT02279732|459613725|FG001|Overall Study|Lost to Follow-up|1|||
127723379|NCT02279732|459613724|FG000|Overall Study|Maximum Clinical Benefit|1|||
127723380|NCT02279732|459613725|FG001|Overall Study|Maximum Clinical Benefit|0|||
127723381|NCT02279732|459613724|FG000|Overall Study|Subject Requested to Discontinue|0|||
127723382|NCT02279732|459613725|FG001|Overall Study|Subject Requested to Discontinue|1|||
127723383|NCT02279732|459613724|FG000|Overall Study|Other|53|||
127723384|NCT02279732|459613725|FG001|Overall Study|Other|67|||
127723385|NCT02279732|459613724|FG000|Overall Study|Other|3|||
127723386|NCT02279732|459613725|FG001|Overall Study|Other|3|||
127723387|NCT00824408|459613726|FG000|Run-in Phase|Progressive disease|4|||
127723388|NCT00824408|459613727|FG001|Run-in Phase|Progressive disease|4|||
127723389|NCT00824408|459613728|FG002|Run-in Phase|Progressive disease|0|||
127723390|NCT00824408|459613729|FG003|Run-in Phase|Progressive disease|0|||
127723391|NCT00824408|459613730|FG004|Run-in Phase|Progressive disease|0|||
127723392|NCT00824408|459613726|FG000|Run-in Phase|Adverse Event|1|||
127723393|NCT00824408|459613727|FG001|Run-in Phase|Adverse Event|1|||
127723394|NCT00824408|459613728|FG002|Run-in Phase|Adverse Event|0|||
127723395|NCT00824408|459613729|FG003|Run-in Phase|Adverse Event|0|||
127723396|NCT00824408|459613730|FG004|Run-in Phase|Adverse Event|0|||
127889152|NCT00720798|460217996|FG000|Overall Study|Protocol Violation|4|||
127723397|NCT00824408|459613726|FG000|Run-in Phase|Refused to continue medication|1|||
127723398|NCT00824408|459613727|FG001|Run-in Phase|Refused to continue medication|0|||
127723399|NCT00824408|459613728|FG002|Run-in Phase|Refused to continue medication|0|||
127723400|NCT00824408|459613729|FG003|Run-in Phase|Refused to continue medication|0|||
127723401|NCT00824408|459613730|FG004|Run-in Phase|Refused to continue medication|0|||
127723402|NCT00824408|459613726|FG000|Run-in Phase|Other reason not defined above|0|||
127723403|NCT00824408|459613727|FG001|Run-in Phase|Other reason not defined above|1|||
127723404|NCT00824408|459613728|FG002|Run-in Phase|Other reason not defined above|0|||
127723405|NCT00824408|459613729|FG003|Run-in Phase|Other reason not defined above|0|||
127723406|NCT00824408|459613730|FG004|Run-in Phase|Other reason not defined above|0|||
127723407|NCT00824408|459613726|FG000|Randomized Phase|Not treated|0|||
127723408|NCT00824408|459613727|FG001|Randomized Phase|Not treated|0|||
127723409|NCT00824408|459613728|FG002|Randomized Phase|Not treated|1|||
127723410|NCT00824408|459613729|FG003|Randomized Phase|Not treated|1|||
127723411|NCT00824408|459613730|FG004|Randomized Phase|Not treated|1|||
127723412|NCT00824408|459613726|FG000|Randomized Phase|Progressive disease|0|||
127723413|NCT00824408|459613727|FG001|Randomized Phase|Progressive disease|0|||
127723414|NCT00824408|459613728|FG002|Randomized Phase|Progressive disease|25|||
127723415|NCT00824408|459613729|FG003|Randomized Phase|Progressive disease|36|||
127723416|NCT00824408|459613730|FG004|Randomized Phase|Progressive disease|34|||
127723417|NCT00824408|459613726|FG000|Randomized Phase|Adverse Event|0|||
127723418|NCT00824408|459613727|FG001|Randomized Phase|Adverse Event|0|||
127723419|NCT00824408|459613728|FG002|Randomized Phase|Adverse Event|4|||
127723420|NCT00824408|459613729|FG003|Randomized Phase|Adverse Event|5|||
127723421|NCT00824408|459613730|FG004|Randomized Phase|Adverse Event|5|||
127723422|NCT00824408|459613726|FG000|Randomized Phase|Refused to continue medication|0|||
127723423|NCT00824408|459613727|FG001|Randomized Phase|Refused to continue medication|0|||
127723424|NCT00824408|459613728|FG002|Randomized Phase|Refused to continue medication|2|||
127723425|NCT00824408|459613729|FG003|Randomized Phase|Refused to continue medication|2|||
127723426|NCT00824408|459613730|FG004|Randomized Phase|Refused to continue medication|2|||
127723427|NCT00824408|459613726|FG000|Randomized Phase|Other reason not defined above|0|||
127723428|NCT00824408|459613727|FG001|Randomized Phase|Other reason not defined above|0|||
127723429|NCT00824408|459613728|FG002|Randomized Phase|Other reason not defined above|4|||
127723430|NCT00824408|459613729|FG003|Randomized Phase|Other reason not defined above|2|||
127723431|NCT00824408|459613730|FG004|Randomized Phase|Other reason not defined above|4|||
127723432|NCT02915783|459613735|FG000|Overall Study|Death|21|||
127723433|NCT02915783|459613735|FG000|Overall Study|Lost to Follow-up|1|||
127723434|NCT02915783|459613735|FG000|Overall Study|Withdrawal by Subject|2|||
127723435|NCT01075152|459613738|FG000|Overall Study|Withdrawal by Subject|1|||
127723436|NCT01075152|459613739|FG001|Overall Study|Withdrawal by Subject|0|||
127723437|NCT01523392|459615421|FG000|Treatment Period 1|Withdrawal by Subject|2|||
127723438|NCT01523392|459615422|FG001|Treatment Period 1|Withdrawal by Subject|0|||
127723439|NCT01523392|459615421|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
127723440|NCT01523392|459615422|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
127723441|NCT01523392|459615421|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
127723442|NCT01523392|459615422|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
127723443|NCT02236611|459615425|FG000|Overall Study|Adverse Event|10|||
127723444|NCT02236611|459615426|FG001|Overall Study|Adverse Event|16|||
127723445|NCT02236611|459615425|FG000|Overall Study|Lack of Efficacy|4|||
127723446|NCT02236611|459615426|FG001|Overall Study|Lack of Efficacy|7|||
127723447|NCT02236611|459615425|FG000|Overall Study|Lost to Follow-up|0|||
127723448|NCT02236611|459615426|FG001|Overall Study|Lost to Follow-up|2|||
127723449|NCT02236611|459615425|FG000|Overall Study|Protocol deviation|3|||
127723450|NCT02236611|459615426|FG001|Overall Study|Protocol deviation|5|||
127723451|NCT02236611|459615425|FG000|Overall Study|Withdrew consent|9|||
127723452|NCT02236611|459615426|FG001|Overall Study|Withdrew consent|4|||
127723453|NCT01128959|459615427|FG000|Lead in Period|Adverse Event|3|||
127723454|NCT01128959|459615427|FG000|Treatment Period|Adverse Event|3|||
127723455|NCT01128959|459615427|FG000|Treatment Period|Withdrawal by Subject|1|||
127723456|NCT02338999|459615428|FG000|First Intervention|Withdrawal by Subject|3|||
127723457|NCT02338999|459615429|FG001|First Intervention|Withdrawal by Subject|1|||
127723458|NCT02338999|459615428|FG000|Washout Period|Withdrawal by Subject|0|||
127723459|NCT02338999|459615429|FG001|Washout Period|Withdrawal by Subject|2|||
127723460|NCT02338999|459615428|FG000|Second Intervention|Withdrawal by Subject|0|||
127723461|NCT02338999|459615429|FG001|Second Intervention|Withdrawal by Subject|2|||
127723462|NCT02701296|459615430|FG000|Overall Study|Incomplete Data|0|||
127723463|NCT02701296|459615431|FG001|Overall Study|Incomplete Data|2|||
127723464|NCT00308308|459615432|FG000|Overall Study|Adverse Event|17|||
127723465|NCT00308308|459615433|FG001|Overall Study|Adverse Event|2|||
127723466|NCT00308308|459615432|FG000|Overall Study|Lost to Follow-up|5|||
127723467|NCT00308308|459615433|FG001|Overall Study|Lost to Follow-up|5|||
127723468|NCT00308308|459615432|FG000|Overall Study|Physician Decision|15|||
127723469|NCT00308308|459615433|FG001|Overall Study|Physician Decision|7|||
127723470|NCT00308308|459615432|FG000|Overall Study|Protocol Violation|3|||
127723471|NCT00308308|459615433|FG001|Overall Study|Protocol Violation|14|||
127723472|NCT00308308|459615432|FG000|Overall Study|Withdrawal by Subject|47|||
127723473|NCT00308308|459615433|FG001|Overall Study|Withdrawal by Subject|19|||
127723474|NCT00308308|459615432|FG000|Overall Study|Various|7|||
127723475|NCT00308308|459615433|FG001|Overall Study|Various|5|||
127723476|NCT00308308|459615432|FG000|Overall Study|Randomized but not dosed|8|||
127723477|NCT00308308|459615433|FG001|Overall Study|Randomized but not dosed|16|||
127723478|NCT00308308|459615432|FG000|Overall Study|Other|1|||
127723479|NCT00308308|459615433|FG001|Overall Study|Other|0|||
127723480|NCT01802333|459615434|FG000|Overall Study|Ineligible|2|||
127723481|NCT01802333|459615435|FG001|Overall Study|Ineligible|6|||
127723482|NCT01802333|459615436|FG002|Overall Study|Ineligible|8|||
127723483|NCT01802333|459615434|FG000|Overall Study|Adverse Event|1|||
127723484|NCT01802333|459615435|FG001|Overall Study|Adverse Event|8|||
127723485|NCT01802333|459615436|FG002|Overall Study|Adverse Event|8|||
127723486|NCT01802333|459615434|FG000|Overall Study|Withdrawal by Subject|6|||
127723487|NCT01802333|459615435|FG001|Overall Study|Withdrawal by Subject|6|||
127723488|NCT01802333|459615436|FG002|Overall Study|Withdrawal by Subject|5|||
127723489|NCT01802333|459615434|FG000|Overall Study|Progression/relapse|1|||
127723490|NCT01802333|459615435|FG001|Overall Study|Progression/relapse|3|||
127723491|NCT01802333|459615436|FG002|Overall Study|Progression/relapse|0|||
127723492|NCT01802333|459615434|FG000|Overall Study|Death|7|||
127723493|NCT01802333|459615435|FG001|Overall Study|Death|14|||
127723494|NCT01802333|459615436|FG002|Overall Study|Death|13|||
127723495|NCT01802333|459615434|FG000|Overall Study|Other - not protocol specified|32|||
127723496|NCT01802333|459615435|FG001|Overall Study|Other - not protocol specified|22|||
127723497|NCT01802333|459615436|FG002|Overall Study|Other - not protocol specified|24|||
127723498|NCT01802333|459615434|FG000|Overall Study|Did not start treatment|0|||
127723499|NCT01802333|459615435|FG001|Overall Study|Did not start treatment|2|||
127723500|NCT01802333|459615436|FG002|Overall Study|Did not start treatment|5|||
127723501|NCT01947491|459615437|FG000|Overall Study|Lost to Follow-up|5|||
127723502|NCT01947491|459615438|FG001|Overall Study|Lost to Follow-up|3|||
127723503|NCT01947491|459615439|FG002|Overall Study|Lost to Follow-up|1|||
127723504|NCT01947491|459615440|FG003|Overall Study|Lost to Follow-up|2|||
127723505|NCT01947491|459615437|FG000|Overall Study|Lack of Efficacy|1|||
127723506|NCT01947491|459615438|FG001|Overall Study|Lack of Efficacy|0|||
127723507|NCT01947491|459615439|FG002|Overall Study|Lack of Efficacy|0|||
127723508|NCT01947491|459615440|FG003|Overall Study|Lack of Efficacy|1|||
127723509|NCT01947491|459615437|FG000|Overall Study|Protocol Violation|1|||
127723510|NCT01947491|459615438|FG001|Overall Study|Protocol Violation|0|||
127723511|NCT01947491|459615439|FG002|Overall Study|Protocol Violation|0|||
127723512|NCT01947491|459615440|FG003|Overall Study|Protocol Violation|0|||
127723513|NCT01947491|459615437|FG000|Overall Study|Withdrawal by Subject|1|||
127723514|NCT01947491|459615438|FG001|Overall Study|Withdrawal by Subject|1|||
127723515|NCT01947491|459615439|FG002|Overall Study|Withdrawal by Subject|1|||
127723516|NCT01947491|459615440|FG003|Overall Study|Withdrawal by Subject|0|||
127723517|NCT01947491|459615437|FG000|Overall Study|Worsening of condition|0|||
127723518|NCT01947491|459615438|FG001|Overall Study|Worsening of condition|1|||
127723519|NCT01947491|459615439|FG002|Overall Study|Worsening of condition|0|||
127723520|NCT01947491|459615440|FG003|Overall Study|Worsening of condition|0|||
127723521|NCT01947491|459615437|FG000|Overall Study|Adverse Event|0|||
127723522|NCT01947491|459615438|FG001|Overall Study|Adverse Event|1|||
127723523|NCT01947491|459615439|FG002|Overall Study|Adverse Event|0|||
127723524|NCT01947491|459615440|FG003|Overall Study|Adverse Event|2|||
127723525|NCT02067663|459615441|FG000|Overall Study|Lost to Follow-up|13|||
127723526|NCT02067663|459615442|FG001|Overall Study|Lost to Follow-up|14|||
127723527|NCT03137784|459615443|FG000|Overall Study|Adverse Event|1|||
127723528|NCT03137784|459615444|FG001|Overall Study|Adverse Event|1|||
127723529|NCT03137784|459615445|FG002|Overall Study|Adverse Event|0|||
127723530|NCT03137784|459615446|FG003|Overall Study|Adverse Event|0|||
127723531|NCT03137784|459615447|FG004|Overall Study|Adverse Event|0|||
127723532|NCT03137784|459615448|FG005|Overall Study|Adverse Event|0|||
127723533|NCT03137784|459615443|FG000|Overall Study|Subject/guardian decision|1|||
127723534|NCT03137784|459615444|FG001|Overall Study|Subject/guardian decision|0|||
127723535|NCT03137784|459615445|FG002|Overall Study|Subject/guardian decision|0|||
127723536|NCT03137784|459615446|FG003|Overall Study|Subject/guardian decision|0|||
127723537|NCT03137784|459615447|FG004|Overall Study|Subject/guardian decision|0|||
127723538|NCT03137784|459615448|FG005|Overall Study|Subject/guardian decision|0|||
127723539|NCT03137784|459615443|FG000|Overall Study|Non-compliance with study treatment|0|||
127723540|NCT03137784|459615444|FG001|Overall Study|Non-compliance with study treatment|0|||
127723541|NCT03137784|459615445|FG002|Overall Study|Non-compliance with study treatment|0|||
127723542|NCT03137784|459615446|FG003|Overall Study|Non-compliance with study treatment|0|||
127723543|NCT03137784|459615447|FG004|Overall Study|Non-compliance with study treatment|1|||
127723544|NCT03137784|459615448|FG005|Overall Study|Non-compliance with study treatment|0|||
127723545|NCT03142932|459615449|FG000|Overall Study|Lost to Follow-up|2|||
127723546|NCT03142932|459615450|FG001|Overall Study|Lost to Follow-up|11|||
127723547|NCT02547974|459615451|FG000|Overall Study|Withdrawal by Subject|1|||
127723548|NCT02547974|459615452|FG001|Overall Study|Withdrawal by Subject|0|||
127723549|NCT02547974|459615453|FG002|Overall Study|Withdrawal by Subject|0|||
127723550|NCT02547974|459615454|FG003|Overall Study|Withdrawal by Subject|0|||
127723551|NCT04766996|459615455|FG000|Overall Study|Withdrawal by Subject|1|||
127723552|NCT04766996|459615456|FG001|Overall Study|Withdrawal by Subject|0|||
127723553|NCT04766996|459615457|FG002|Overall Study|Withdrawal by Subject|13|||
127723554|NCT02988713|459615460|FG000|Overall Study|Withdrawal by Subject|1|||
127723555|NCT02988713|459615460|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
127723556|NCT04248868|459615464|FG000|Overall Study|Death|1|||
127723557|NCT04248868|459615464|FG000|Overall Study|Lost to Follow-up|3|||
127723558|NCT04248868|459615464|FG000|Overall Study|Protocol Violation|2|||
127723559|NCT03131713|459615467|FG000|Overall Study|Lost to Follow-up|5|||
127723560|NCT03131713|459615468|FG001|Overall Study|Lost to Follow-up|0|||
127723561|NCT01976507|459615469|FG000|Overall Study|Adverse Event|6|||
127723562|NCT01976507|459615469|FG000|Overall Study|ablation not done, drug not given|1|||
127723563|NCT02208843|459615470|FG000|Overall Study|Clinical symptoms of progression|2|||
127723564|NCT02208843|459615470|FG000|Overall Study|Progression disease according to RECIST|24|||
127723565|NCT02208843|459615470|FG000|Overall Study|Adverse Event|12|||
127723566|NCT02208843|459615470|FG000|Overall Study|Protocol Violation|1|||
127723567|NCT02208843|459615470|FG000|Overall Study|Withdrawal by Subject|1|||
127723568|NCT02208843|459615470|FG000|Overall Study|Switched to commercial afatinib|20|||
127723569|NCT01794299|459615480|FG000|Overall Study|ATIR manufacturing not possible|1|||
127723570|NCT01794299|459615480|FG000|Overall Study|Death|14|||
127723571|NCT01794299|459615480|FG000|Overall Study|Graft failure|1|||
127723572|NCT01794299|459615480|FG000|Overall Study|ATIR batch rejected|2|||
127723573|NCT01794299|459615480|FG000|Overall Study|Relapse|2|||
127723574|NCT01794299|459615480|FG000|Overall Study|Discontinued from active follow-up|1|||
127723575|NCT01794299|459615480|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
127723576|NCT01029704|459615484|FG000|Overall Study|Adverse Event|0|||
127723577|NCT01029704|459615485|FG001|Overall Study|Adverse Event|0|||
127723578|NCT01029704|459615486|FG002|Overall Study|Adverse Event|0|||
127723579|NCT01029704|459615487|FG003|Overall Study|Adverse Event|0|||
127723580|NCT01029704|459615488|FG004|Overall Study|Adverse Event|0|||
127723581|NCT01029704|459615489|FG005|Overall Study|Adverse Event|0|||
127723582|NCT01029704|459615490|FG006|Overall Study|Adverse Event|1|||
127723583|NCT01029704|459615491|FG007|Overall Study|Adverse Event|1|||
127723584|NCT01029704|459615492|FG008|Overall Study|Adverse Event|0|||
127723585|NCT01029704|459615484|FG000|Overall Study|Withdrawal by Subject|0|||
127723586|NCT01029704|459615485|FG001|Overall Study|Withdrawal by Subject|0|||
127723587|NCT01029704|459615486|FG002|Overall Study|Withdrawal by Subject|0|||
127723588|NCT01029704|459615487|FG003|Overall Study|Withdrawal by Subject|0|||
127723589|NCT01029704|459615488|FG004|Overall Study|Withdrawal by Subject|2|||
127723590|NCT01029704|459615489|FG005|Overall Study|Withdrawal by Subject|1|||
127723591|NCT01029704|459615490|FG006|Overall Study|Withdrawal by Subject|1|||
127723592|NCT01029704|459615491|FG007|Overall Study|Withdrawal by Subject|1|||
127723593|NCT01029704|459615492|FG008|Overall Study|Withdrawal by Subject|0|||
127723594|NCT01029704|459615484|FG000|Overall Study|Lost to Follow-up|0|||
127723595|NCT01029704|459615485|FG001|Overall Study|Lost to Follow-up|0|||
127723596|NCT01029704|459615486|FG002|Overall Study|Lost to Follow-up|0|||
127889153|NCT00720798|460217996|FG000|Overall Study|Refused Treatment|151|||
127889154|NCT00720798|460217996|FG000|Overall Study|Failure to Return|46|||
127723597|NCT01029704|459615487|FG003|Overall Study|Lost to Follow-up|0|||
127723598|NCT01029704|459615488|FG004|Overall Study|Lost to Follow-up|0|||
127723599|NCT01029704|459615489|FG005|Overall Study|Lost to Follow-up|0|||
127723600|NCT01029704|459615490|FG006|Overall Study|Lost to Follow-up|1|||
127723601|NCT01029704|459615491|FG007|Overall Study|Lost to Follow-up|1|||
127723602|NCT01029704|459615492|FG008|Overall Study|Lost to Follow-up|1|||
127723603|NCT01029704|459615484|FG000|Overall Study|Lack of Efficacy|0|||
127723604|NCT01029704|459615485|FG001|Overall Study|Lack of Efficacy|0|||
127723605|NCT01029704|459615486|FG002|Overall Study|Lack of Efficacy|0|||
127723606|NCT01029704|459615487|FG003|Overall Study|Lack of Efficacy|0|||
127723607|NCT01029704|459615488|FG004|Overall Study|Lack of Efficacy|2|||
127723608|NCT01029704|459615489|FG005|Overall Study|Lack of Efficacy|3|||
127723609|NCT01029704|459615490|FG006|Overall Study|Lack of Efficacy|1|||
127723610|NCT01029704|459615491|FG007|Overall Study|Lack of Efficacy|2|||
127723611|NCT01029704|459615492|FG008|Overall Study|Lack of Efficacy|0|||
127723612|NCT01029704|459615484|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
127723613|NCT01029704|459615485|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
127723614|NCT01029704|459615486|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
127723615|NCT01029704|459615487|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
127723616|NCT01029704|459615488|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
127723617|NCT01029704|459615489|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
127723618|NCT01029704|459615490|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
127723619|NCT01029704|459615491|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
127723620|NCT01029704|459615492|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
127723621|NCT00089791|459615493|FG000|Overall Study|Physician Decision|6|||
127723622|NCT00089791|459615494|FG001|Overall Study|Physician Decision|3|||
127723623|NCT00089791|459615493|FG000|Overall Study|Adverse Event|81|||
127723624|NCT00089791|459615494|FG001|Overall Study|Adverse Event|93|||
127723625|NCT00089791|459615493|FG000|Overall Study|Withdrawal by Subject|403|||
127723626|NCT00089791|459615494|FG001|Overall Study|Withdrawal by Subject|344|||
127723627|NCT00089791|459615493|FG000|Overall Study|Death|78|||
127723628|NCT00089791|459615494|FG001|Overall Study|Death|62|||
127723629|NCT00089791|459615493|FG000|Overall Study|Disease progression|7|||
127723630|NCT00089791|459615494|FG001|Overall Study|Disease progression|3|||
127723631|NCT00089791|459615493|FG000|Overall Study|Ineligibility determined|12|||
127723632|NCT00089791|459615494|FG001|Overall Study|Ineligibility determined|9|||
127723633|NCT00089791|459615493|FG000|Overall Study|Lost to Follow-up|57|||
127723634|NCT00089791|459615494|FG001|Overall Study|Lost to Follow-up|57|||
127723635|NCT00089791|459615493|FG000|Overall Study|Noncompliance|17|||
127723636|NCT00089791|459615494|FG001|Overall Study|Noncompliance|13|||
127723637|NCT00089791|459615493|FG000|Overall Study|Other|20|||
127723638|NCT00089791|459615494|FG001|Overall Study|Other|32|||
127723639|NCT00089791|459615493|FG000|Overall Study|Protocol deviation|12|||
127723640|NCT00089791|459615494|FG001|Overall Study|Protocol deviation|10|||
127723641|NCT00089791|459615493|FG000|Overall Study|Requirement for alternative therapy|7|||
127723642|NCT00089791|459615494|FG001|Overall Study|Requirement for alternative therapy|4|||
127723643|NCT00148122|459615495|FG000|Overall Study|Withdrawal by Subject|2|||
127723644|NCT01365546|459615496|FG000|Overall Study|Withdrawal by Subject|1|||
127723645|NCT01365546|459615496|FG000|Overall Study|Screen failure|9|||
127723646|NCT01365546|459615496|FG000|Overall Study|Study termination|1|||
127723647|NCT03200574|459615502|FG000|Overall Study|Death|4|||
127723648|NCT03200574|459615502|FG000|Overall Study|Withdrawal by Subject|8|||
127723649|NCT03200574|459615502|FG000|Overall Study|Long-Term need for anticoagulation|1|||
127723650|NCT03200574|459615502|FG000|Overall Study|Relocation|2|||
127723651|NCT03200574|459615502|FG000|Overall Study|Lost to Follow-up|2|||
127723652|NCT04183491|459615503|FG000|Overall Study|Withdrawal by Subject|0|||
127723653|NCT04183491|459615504|FG001|Overall Study|Withdrawal by Subject|0|||
127723654|NCT04183491|459615505|FG002|Overall Study|Withdrawal by Subject|1|||
127723655|NCT04183491|459615506|FG003|Overall Study|Withdrawal by Subject|0|||
127723656|NCT04183491|459615507|FG004|Overall Study|Withdrawal by Subject|0|||
127723657|NCT04183491|459615508|FG005|Overall Study|Withdrawal by Subject|1|||
127723658|NCT04183491|459615509|FG006|Overall Study|Withdrawal by Subject|0|||
127723659|NCT02538094|459615510|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
127723660|NCT02538094|459615511|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
127723661|NCT02538094|459615510|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
127723662|NCT02538094|459615511|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
127723663|NCT03652610|459615522|FG000|Overall Study|Lost to Follow-up|1|||
127723664|NCT03652610|459615523|FG001|Overall Study|Lost to Follow-up|0|||
127723665|NCT03652610|459615522|FG000|Overall Study|Withdrawal by Subject|3|||
127723666|NCT03652610|459615523|FG001|Overall Study|Withdrawal by Subject|5|||
127723667|NCT01860079|459615524|FG000|Overall Study|Physician Decision|14|||
127723668|NCT01860079|459615525|FG001|Overall Study|Physician Decision|22|||
127723669|NCT00326183|459615526|FG000|Overall Study|Lost to Follow-up|104|||
127723670|NCT00326183|459615527|FG001|Overall Study|Lost to Follow-up|56|||
127723671|NCT00326183|459615526|FG000|Overall Study|Protocol Violation|6|||
127723672|NCT00326183|459615527|FG001|Overall Study|Protocol Violation|3|||
127723673|NCT00326183|459615526|FG000|Overall Study|Withdrawal by Subject|35|||
127723674|NCT00326183|459615527|FG001|Overall Study|Withdrawal by Subject|7|||
127723675|NCT00326183|459615526|FG000|Overall Study|Subject Moved|7|||
127723676|NCT00326183|459615527|FG001|Overall Study|Subject Moved|4|||
127723677|NCT00326183|459615526|FG000|Overall Study|Other|47|||
127723678|NCT00326183|459615527|FG001|Overall Study|Other|13|||
127723679|NCT00326183|459615526|FG000|Overall Study|Adverse Event|1|||
127723680|NCT00326183|459615527|FG001|Overall Study|Adverse Event|0|||
127723681|NCT02970318|459615528|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
127723682|NCT02970318|459615529|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
127723683|NCT02970318|459615530|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
127723684|NCT02970318|459615531|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
127723685|NCT02970318|459615528|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
127723686|NCT02970318|459615529|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
127889155|NCT00720798|460217996|FG000|Overall Study|Reason not Specified|83|||
127889156|NCT00433381|460217997|FG000|Overall Study|Ineligible / no protocol treatment|3|||
127889157|NCT00433381|460217998|FG001|Overall Study|Ineligible / no protocol treatment|3|||
127889158|NCT01084005|460218002|FG000|Overall Study|Adverse Event|1|||
127889159|NCT01084005|460218003|FG001|Overall Study|Adverse Event|8|||
127889160|NCT01084005|460218002|FG000|Overall Study|Protocol Violation|3|||
127889161|NCT01084005|460218003|FG001|Overall Study|Protocol Violation|7|||
127889162|NCT01084005|460218002|FG000|Overall Study|Withdrawal by Subject|1|||
127889163|NCT01084005|460218003|FG001|Overall Study|Withdrawal by Subject|1|||
127889164|NCT00549198|460218004|FG000|Overall Study|Adverse Event|28|||
127889165|NCT00549198|460218005|FG001|Overall Study|Adverse Event|26|||
127889166|NCT00549198|460218004|FG000|Overall Study|Insufficient Viral Load Response|4|||
127889167|NCT00549198|460218005|FG001|Overall Study|Insufficient Viral Load Response|2|||
127889168|NCT00549198|460218004|FG000|Overall Study|Protocol-defined Virological Failure|7|||
127889169|NCT00549198|460218005|FG001|Overall Study|Protocol-defined Virological Failure|0|||
127889170|NCT00549198|460218004|FG000|Overall Study|Non-compliance|2|||
127889171|NCT00549198|460218005|FG001|Overall Study|Non-compliance|4|||
127889172|NCT00549198|460218004|FG000|Overall Study|Lost to Follow-up|7|||
127889173|NCT00549198|460218005|FG001|Overall Study|Lost to Follow-up|8|||
127889174|NCT00549198|460218004|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
127889175|NCT00549198|460218005|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
127889176|NCT00549198|460218004|FG000|Overall Study|Protocol Violation|7|||
127889177|NCT00549198|460218005|FG001|Overall Study|Protocol Violation|2|||
127723687|NCT02970318|459615530|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
127723688|NCT02970318|459615531|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
127723689|NCT02970318|459615528|FG000|Overall for Arm A & Main for Arm B|Death|41|||
127723690|NCT02970318|459615529|FG001|Overall for Arm A & Main for Arm B|Death|33|||
127889178|NCT00549198|460218004|FG000|Overall Study|Investigator Decision|4|||
127889179|NCT00549198|460218005|FG001|Overall Study|Investigator Decision|3|||
127889180|NCT00549198|460218004|FG000|Overall Study|Withdrawal by Subject|7|||
127723691|NCT02970318|459615530|FG002|Overall for Arm A & Main for Arm B|Death|0|||
127723692|NCT02970318|459615531|FG003|Overall for Arm A & Main for Arm B|Death|0|||
127723693|NCT02970318|459615528|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
127723694|NCT02970318|459615529|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
127723695|NCT02970318|459615530|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
127723696|NCT02970318|459615531|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
127723697|NCT02970318|459615528|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
127723698|NCT02970318|459615529|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
127723699|NCT02970318|459615530|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
127723700|NCT02970318|459615531|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
127723701|NCT02970318|459615528|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
127723702|NCT02970318|459615529|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
127723703|NCT02970318|459615530|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
127723704|NCT02970318|459615531|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
127723705|NCT02970318|459615528|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
127723706|NCT02970318|459615529|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
127723707|NCT02970318|459615530|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
127723708|NCT02970318|459615531|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
127723709|NCT01323790|459615536|FG000|Overall Study|Other|3|||
127723710|NCT01323790|459615537|FG001|Overall Study|Other|2|||
127723711|NCT01323790|459615538|FG002|Overall Study|Other|1|||
127723712|NCT01323790|459615536|FG000|Overall Study|Lost to Follow-up|11|||
127723713|NCT01323790|459615537|FG001|Overall Study|Lost to Follow-up|9|||
127723714|NCT01323790|459615538|FG002|Overall Study|Lost to Follow-up|9|||
127723715|NCT01323790|459615536|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
127723716|NCT01323790|459615537|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
127723717|NCT01323790|459615538|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
127723718|NCT01323790|459615536|FG000|Overall Study|Lack of Efficacy|3|||
127723719|NCT01323790|459615537|FG001|Overall Study|Lack of Efficacy|0|||
127723720|NCT01323790|459615538|FG002|Overall Study|Lack of Efficacy|3|||
127723721|NCT01323790|459615536|FG000|Overall Study|Adverse Event|11|||
127723722|NCT01323790|459615537|FG001|Overall Study|Adverse Event|24|||
127723723|NCT01323790|459615538|FG002|Overall Study|Adverse Event|12|||
127889181|NCT00549198|460218005|FG001|Overall Study|Withdrawal by Subject|7|||
127889182|NCT00549198|460218004|FG000|Overall Study|Disease Progression|1|||
127889183|NCT00549198|460218005|FG001|Overall Study|Disease Progression|0|||
127723724|NCT01323790|459615536|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
127723725|NCT01323790|459615537|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
127889184|NCT00549198|460218004|FG000|Overall Study|Participant Moved|2|||
127889185|NCT00549198|460218005|FG001|Overall Study|Participant Moved|0|||
127889186|NCT00549198|460218004|FG000|Overall Study|Participant not able to perform Week 96|1|||
127889187|NCT00549198|460218005|FG001|Overall Study|Participant not able to perform Week 96|0|||
127889188|NCT00549198|460218004|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
127889189|NCT00549198|460218005|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
127889190|NCT00549198|460218004|FG000|Overall Study|Prohibited Medication|1|||
127889191|NCT00549198|460218005|FG001|Overall Study|Prohibited Medication|2|||
127889192|NCT00549198|460218004|FG000|Overall Study|Participant planning pregnancy|1|||
127889193|NCT00549198|460218005|FG001|Overall Study|Participant planning pregnancy|0|||
127889194|NCT00549198|460218004|FG000|Overall Study|Participant overweight, no scan possible|1|||
127889195|NCT00549198|460218005|FG001|Overall Study|Participant overweight, no scan possible|0|||
127889196|NCT00549198|460218004|FG000|Overall Study|No scan facilities|0|||
127889197|NCT00549198|460218005|FG001|Overall Study|No scan facilities|2|||
127889198|NCT00549198|460218004|FG000|Overall Study|Pregnancy|0|||
127889199|NCT00549198|460218005|FG001|Overall Study|Pregnancy|3|||
127889200|NCT00549198|460218004|FG000|Overall Study|Not Exposed to Study Drug|3|||
127889201|NCT00549198|460218005|FG001|Overall Study|Not Exposed to Study Drug|4|||
127889202|NCT02480010|460218006|FG000|Overall Study|Adverse Event|3|||
127889203|NCT02480010|460218007|FG001|Overall Study|Adverse Event|1|||
127889204|NCT02480010|460218006|FG000|Overall Study|Death|1|||
127889205|NCT02480010|460218007|FG001|Overall Study|Death|0|||
127889206|NCT02480010|460218006|FG000|Overall Study|Insufficient therapeutic response|31|||
127889207|NCT02480010|460218007|FG001|Overall Study|Insufficient therapeutic response|29|||
127889208|NCT02480010|460218006|FG000|Overall Study|Refused Treatment|0|||
127889209|NCT02480010|460218007|FG001|Overall Study|Refused Treatment|3|||
127889210|NCT01034137|460218011|FG000|Overall Study|Adverse Event|9|||
127889211|NCT01034137|460218012|FG001|Overall Study|Adverse Event|10|||
127889212|NCT01034137|460218013|FG002|Overall Study|Adverse Event|8|||
127889213|NCT01034137|460218011|FG000|Overall Study|Withdrawal by Subject|4|||
127889214|NCT01034137|460218012|FG001|Overall Study|Withdrawal by Subject|3|||
127889215|NCT01034137|460218013|FG002|Overall Study|Withdrawal by Subject|3|||
127889216|NCT01034137|460218011|FG000|Overall Study|Lack of Efficacy|9|||
127889217|NCT01034137|460218012|FG001|Overall Study|Lack of Efficacy|4|||
127889218|NCT01034137|460218013|FG002|Overall Study|Lack of Efficacy|13|||
127889219|NCT01034137|460218011|FG000|Overall Study|Protocol Violation|2|||
127889220|NCT01034137|460218012|FG001|Overall Study|Protocol Violation|2|||
127889221|NCT01034137|460218013|FG002|Overall Study|Protocol Violation|1|||
127889222|NCT01034137|460218011|FG000|Overall Study|Refused treatment or did not cooperate|2|||
127889223|NCT01034137|460218012|FG001|Overall Study|Refused treatment or did not cooperate|0|||
127889224|NCT01034137|460218013|FG002|Overall Study|Refused treatment or did not cooperate|1|||
127889225|NCT01034137|460218011|FG000|Overall Study|Administrative or other|2|||
127889226|NCT01034137|460218012|FG001|Overall Study|Administrative or other|3|||
127889227|NCT01034137|460218013|FG002|Overall Study|Administrative or other|4|||
127889228|NCT01764854|460218017|FG000|Overall Study|Adverse Event|0|||
127889229|NCT01764854|460218018|FG001|Overall Study|Adverse Event|0|||
127889230|NCT01764854|460218019|FG002|Overall Study|Adverse Event|2|||
127889231|NCT01764854|460218020|FG003|Overall Study|Adverse Event|0|||
127889232|NCT01764854|460218017|FG000|Overall Study|Withdrawal by Subject|0|||
127889233|NCT01764854|460218018|FG001|Overall Study|Withdrawal by Subject|0|||
127889234|NCT01764854|460218019|FG002|Overall Study|Withdrawal by Subject|1|||
127889235|NCT01764854|460218020|FG003|Overall Study|Withdrawal by Subject|0|||
127889236|NCT01764854|460218017|FG000|Overall Study|relocation|0|||
127889237|NCT01764854|460218018|FG001|Overall Study|relocation|0|||
127889238|NCT01764854|460218019|FG002|Overall Study|relocation|2|||
127889239|NCT01764854|460218020|FG003|Overall Study|relocation|0|||
127889240|NCT01764854|460218017|FG000|Overall Study|Protocol Violation|0|||
127889241|NCT01764854|460218018|FG001|Overall Study|Protocol Violation|0|||
127889242|NCT01764854|460218019|FG002|Overall Study|Protocol Violation|1|||
127889243|NCT01764854|460218020|FG003|Overall Study|Protocol Violation|2|||
127889244|NCT03377556|460218029|FG000|Overall Study|Adverse Event|5|||
127889245|NCT03377556|460218029|FG000|Overall Study|Refusal unrelated to adverse events|1|||
127889246|NCT03377556|460218029|FG000|Overall Study|Progression/relapse|38|||
127889247|NCT03377556|460218029|FG000|Overall Study|Death|3|||
127889248|NCT00472446|460218030|FG000|Overall Study|Protocol Violation|0|||
127889249|NCT00472446|460218031|FG001|Overall Study|Protocol Violation|0|||
127889250|NCT00472446|460218032|FG002|Overall Study|Protocol Violation|0|||
127889251|NCT00472446|460218033|FG003|Overall Study|Protocol Violation|1|||
127889252|NCT00472446|460218030|FG000|Overall Study|Reintervention|0|||
127889253|NCT00472446|460218031|FG001|Overall Study|Reintervention|0|||
127889254|NCT00472446|460218032|FG002|Overall Study|Reintervention|1|||
127723726|NCT01323790|459615538|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
127889255|NCT00472446|460218033|FG003|Overall Study|Reintervention|1|||
127889256|NCT00472446|460218030|FG000|Overall Study|Questionnaires not returned|5|||
127889257|NCT00472446|460218031|FG001|Overall Study|Questionnaires not returned|6|||
127889258|NCT00472446|460218032|FG002|Overall Study|Questionnaires not returned|6|||
127723727|NCT01323790|459615536|FG000|Overall Study|Withdrawal by Subject|23|||
127723728|NCT01323790|459615537|FG001|Overall Study|Withdrawal by Subject|20|||
127723729|NCT01323790|459615538|FG002|Overall Study|Withdrawal by Subject|13|||
127723730|NCT01323790|459615536|FG000|Overall Study|Did Not Receive Treatment|2|||
127723731|NCT01323790|459615537|FG001|Overall Study|Did Not Receive Treatment|0|||
127723732|NCT01323790|459615538|FG002|Overall Study|Did Not Receive Treatment|1|||
127723733|NCT01323790|459615536|FG000|Overall Study|Severe non-compliance with protocol|2|||
127723734|NCT01323790|459615537|FG001|Overall Study|Severe non-compliance with protocol|2|||
127723735|NCT01323790|459615538|FG002|Overall Study|Severe non-compliance with protocol|2|||
127723736|NCT01880736|459615539|FG000|Overall Study|Adverse Event|0|||
127723737|NCT01880736|459615540|FG001|Overall Study|Adverse Event|0|||
127723738|NCT01880736|459615541|FG002|Overall Study|Adverse Event|0|||
127723739|NCT01880736|459615542|FG003|Overall Study|Adverse Event|1|||
127723740|NCT01880736|459615539|FG000|Overall Study|Withdrawal Criteria|1|||
127723741|NCT01880736|459615540|FG001|Overall Study|Withdrawal Criteria|2|||
127723742|NCT01880736|459615541|FG002|Overall Study|Withdrawal Criteria|1|||
127723743|NCT01880736|459615542|FG003|Overall Study|Withdrawal Criteria|5|||
127723744|NCT01263496|459615543|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
127723745|NCT01263496|459615544|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
127723746|NCT01263496|459615545|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
127723747|NCT01263496|459615546|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
127723748|NCT01263496|459615547|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
127723749|NCT01263496|459615548|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
127723750|NCT01263496|459615549|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
127723751|NCT01263496|459615550|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
127723752|NCT01263496|459615551|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
127723753|NCT01263496|459615543|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
127723754|NCT01263496|459615544|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
127723755|NCT01263496|459615545|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
127723756|NCT01263496|459615546|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
127723757|NCT01263496|459615547|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
127723758|NCT01263496|459615548|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
127723759|NCT01263496|459615549|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
127723760|NCT01263496|459615550|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
127723761|NCT01263496|459615551|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
127723762|NCT01263496|459615543|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
127723763|NCT01263496|459615544|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
127723764|NCT01263496|459615545|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
127723765|NCT01263496|459615546|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
127723766|NCT01263496|459615547|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
127723767|NCT01263496|459615548|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
127723768|NCT01263496|459615549|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
127723769|NCT01263496|459615550|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
127723770|NCT01263496|459615551|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
127723771|NCT01263496|459615543|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
127723772|NCT01263496|459615544|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
127723773|NCT01263496|459615545|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
127723774|NCT01263496|459615546|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
127723775|NCT01263496|459615547|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
127723776|NCT01263496|459615548|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
127723777|NCT01263496|459615549|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
127723778|NCT01263496|459615550|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
127723779|NCT01263496|459615551|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
127723780|NCT01263496|459615543|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
127723781|NCT01263496|459615544|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
127723782|NCT01263496|459615545|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
127723783|NCT01263496|459615546|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
127723784|NCT01263496|459615547|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
127723785|NCT01263496|459615548|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
127723786|NCT01263496|459615549|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
127723787|NCT01263496|459615550|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
127723788|NCT01263496|459615551|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
127723789|NCT01263496|459615543|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
127723790|NCT01263496|459615544|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
127723791|NCT01263496|459615545|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
127723792|NCT01263496|459615546|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
127723793|NCT01263496|459615547|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
127723794|NCT01263496|459615548|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
127802926|NCT00130286|459901092|FG003|Overall Study|Adverse Event|0|||
127723795|NCT01263496|459615549|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
127723796|NCT01263496|459615550|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
127723797|NCT01263496|459615551|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
127723798|NCT01263496|459615543|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
127723799|NCT01263496|459615544|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
127723800|NCT01263496|459615545|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
127723801|NCT01263496|459615546|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
127723802|NCT01263496|459615547|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
127723803|NCT01263496|459615548|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
127723804|NCT01263496|459615549|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
127723805|NCT01263496|459615550|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
127723806|NCT01263496|459615551|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
127723807|NCT00266656|459615555|FG000|Overall Study|Death|1|||
127723808|NCT00266656|459615556|FG001|Overall Study|Death|0|||
127723809|NCT00266656|459615555|FG000|Overall Study|Lost to Follow-up|4|||
127723810|NCT00266656|459615556|FG001|Overall Study|Lost to Follow-up|1|||
127723811|NCT00266656|459615555|FG000|Overall Study|Withdrawal by Subject|4|||
127723812|NCT00266656|459615556|FG001|Overall Study|Withdrawal by Subject|2|||
127723813|NCT00266656|459615555|FG000|Overall Study|Did Not Reach Final Height|4|||
127723814|NCT00266656|459615556|FG001|Overall Study|Did Not Reach Final Height|8|||
127723815|NCT00266656|459615555|FG000|Overall Study|Parent/Caregiver Decision|1|||
127723816|NCT00266656|459615556|FG001|Overall Study|Parent/Caregiver Decision|2|||
127723817|NCT02203032|459615557|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
127723818|NCT02203032|459615558|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
127723819|NCT02203032|459615559|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
127723820|NCT02203032|459615560|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
127723821|NCT02203032|459615557|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
127723822|NCT02203032|459615558|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
127723823|NCT02203032|459615559|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
127723824|NCT02203032|459615560|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
127723825|NCT02203032|459615557|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
127723826|NCT02203032|459615558|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
127723827|NCT02203032|459615559|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
127723828|NCT02203032|459615560|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
127723829|NCT02203032|459615557|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
127723830|NCT02203032|459615558|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
127723831|NCT02203032|459615559|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
127723832|NCT02203032|459615560|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
127723833|NCT02203032|459615557|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
127723834|NCT02203032|459615558|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
127723835|NCT02203032|459615559|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
127723836|NCT02203032|459615560|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
127723837|NCT02203032|459615557|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
127723838|NCT02203032|459615558|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
127723839|NCT02203032|459615559|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
127723840|NCT02203032|459615560|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
127723841|NCT02203032|459615557|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
127723842|NCT02203032|459615558|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
127723843|NCT02203032|459615559|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
127723844|NCT02203032|459615560|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
127723845|NCT02203032|459615557|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
127723846|NCT02203032|459615558|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
127723847|NCT02203032|459615559|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
127723848|NCT02203032|459615560|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
127723849|NCT02203032|459615557|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
127723850|NCT02203032|459615558|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
127723851|NCT02203032|459615559|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
127723852|NCT02203032|459615560|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
127723853|NCT02203032|459615557|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
127723854|NCT02203032|459615558|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
127723855|NCT02203032|459615559|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
127723856|NCT02203032|459615560|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
127723857|NCT02203032|459615557|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
127723858|NCT02203032|459615558|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
127723859|NCT02203032|459615559|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
127723860|NCT02203032|459615560|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
127723861|NCT02203032|459615557|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
127723862|NCT02203032|459615558|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
127723863|NCT02203032|459615559|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
127723864|NCT02203032|459615560|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
127723865|NCT01915914|459615561|FG000|Acute Phase|Withdrawal by Subject|4|||
127723866|NCT01915914|459615562|FG001|Acute Phase|Withdrawal by Subject|0|||
127723867|NCT01915914|459615563|FG002|Acute Phase|Withdrawal by Subject|0|||
127723868|NCT01915914|459615564|FG003|Acute Phase|Withdrawal by Subject|0|||
127889259|NCT00472446|460218033|FG003|Overall Study|Questionnaires not returned|4|||
127889260|NCT01165684|460218036|FG000|Overall Study|Adverse Event|1|||
127889261|NCT01165684|460218037|FG001|Overall Study|Adverse Event|1|||
127889262|NCT01165684|460218036|FG000|Overall Study|Lack of Efficacy|2|||
127889263|NCT01165684|460218037|FG001|Overall Study|Lack of Efficacy|1|||
127889264|NCT01165684|460218036|FG000|Overall Study|Protocol Violation|7|||
127889265|NCT01165684|460218037|FG001|Overall Study|Protocol Violation|15|||
127889266|NCT01165684|460218036|FG000|Overall Study|Withdrawal Criteria|2|||
127889267|NCT01165684|460218037|FG001|Overall Study|Withdrawal Criteria|13|||
127889268|NCT01165684|460218036|FG000|Overall Study|Unclassified|16|||
127889269|NCT01165684|460218037|FG001|Overall Study|Unclassified|22|||
127723869|NCT01915914|459615561|FG000|Acute Phase|Lost to Follow-up|4|||
127723870|NCT01915914|459615562|FG001|Acute Phase|Lost to Follow-up|0|||
127723871|NCT01915914|459615563|FG002|Acute Phase|Lost to Follow-up|0|||
127723872|NCT01915914|459615564|FG003|Acute Phase|Lost to Follow-up|0|||
127723873|NCT01915914|459615561|FG000|Acute Phase|Physician Decision|1|||
127723874|NCT01915914|459615562|FG001|Acute Phase|Physician Decision|0|||
127723875|NCT01915914|459615563|FG002|Acute Phase|Physician Decision|0|||
127723876|NCT01915914|459615564|FG003|Acute Phase|Physician Decision|0|||
127723877|NCT01915914|459615561|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
127723878|NCT01915914|459615562|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
127723879|NCT01915914|459615563|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
127723880|NCT01915914|459615564|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
127723881|NCT01915914|459615561|FG000|Acute Phase|"Not Achieved treatment success"|1|||
127723882|NCT01915914|459615562|FG001|Acute Phase|"Not Achieved treatment success"|0|||
127723883|NCT01915914|459615563|FG002|Acute Phase|"Not Achieved treatment success"|0|||
127723884|NCT01915914|459615564|FG003|Acute Phase|"Not Achieved treatment success"|0|||
127889270|NCT00671879|460218038|FG000|Overall Study|Withdrawal by Subject|0|||
127889271|NCT00671879|460218039|FG001|Overall Study|Withdrawal by Subject|4|||
127889272|NCT00671879|460218040|FG002|Overall Study|Withdrawal by Subject|6|||
127889273|NCT04633837|460218043|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
127889274|NCT04633837|460218044|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
127889275|NCT00901628|460218045|FG000|Overall Study|disconnection of catheter|4|||
127889276|NCT00901628|460218046|FG001|Overall Study|disconnection of catheter|8|||
127889277|NCT00901628|460218045|FG000|Overall Study|disconnection of drain|0|||
127889278|NCT00901628|460218046|FG001|Overall Study|disconnection of drain|1|||
127723885|NCT01915914|459615561|FG000|Acute Phase|Missing|1|||
127723886|NCT01915914|459615562|FG001|Acute Phase|Missing|0|||
127723887|NCT01915914|459615563|FG002|Acute Phase|Missing|0|||
127723888|NCT01915914|459615564|FG003|Acute Phase|Missing|0|||
127723889|NCT01915914|459615561|FG000|Maintenance Phase|Withdrawal by Subject|0|||
127723890|NCT01915914|459615562|FG001|Maintenance Phase|Withdrawal by Subject|1|||
127723891|NCT01915914|459615563|FG002|Maintenance Phase|Withdrawal by Subject|1|||
127723892|NCT01915914|459615564|FG003|Maintenance Phase|Withdrawal by Subject|0|||
127723893|NCT01915914|459615561|FG000|Maintenance Phase|Lost to Follow-up|0|||
127723894|NCT01915914|459615562|FG001|Maintenance Phase|Lost to Follow-up|4|||
127723895|NCT01915914|459615563|FG002|Maintenance Phase|Lost to Follow-up|1|||
127723896|NCT01915914|459615564|FG003|Maintenance Phase|Lost to Follow-up|0|||
127723897|NCT01915914|459615561|FG000|Maintenance Phase|Missing|0|||
127723898|NCT01915914|459615562|FG001|Maintenance Phase|Missing|1|||
127723899|NCT01915914|459615563|FG002|Maintenance Phase|Missing|0|||
127889279|NCT00901628|460218045|FG000|Overall Study|peroneal nerve palsy|0|||
127889280|NCT00901628|460218046|FG001|Overall Study|peroneal nerve palsy|1|||
127889281|NCT00608205|460218049|FG000|Overall Study|Adverse Event|3|||
127889282|NCT00608205|460218050|FG001|Overall Study|Adverse Event|2|||
127723900|NCT01915914|459615564|FG003|Maintenance Phase|Missing|0|||
127723901|NCT01915914|459615561|FG000|Follow-up Phase|Withdrawal by Subject|0|||
127723902|NCT01915914|459615562|FG001|Follow-up Phase|Withdrawal by Subject|0|||
127723903|NCT01915914|459615563|FG002|Follow-up Phase|Withdrawal by Subject|0|||
127723904|NCT01915914|459615564|FG003|Follow-up Phase|Withdrawal by Subject|1|||
127723905|NCT01915914|459615561|FG000|Follow-up Phase|Physician Decision|0|||
127723906|NCT01915914|459615562|FG001|Follow-up Phase|Physician Decision|0|||
127723907|NCT01915914|459615563|FG002|Follow-up Phase|Physician Decision|0|||
127723908|NCT01915914|459615564|FG003|Follow-up Phase|Physician Decision|1|||
127723909|NCT01528605|459615565|FG000|Overall Study|Lost to Follow-up|1|||
127723910|NCT01528605|459615566|FG001|Overall Study|Lost to Follow-up|0|||
127723911|NCT01528605|459615567|FG002|Overall Study|Lost to Follow-up|1|||
127723912|NCT01528605|459615568|FG003|Overall Study|Lost to Follow-up|1|||
127723913|NCT01528605|459615569|FG004|Overall Study|Lost to Follow-up|0|||
127723914|NCT01528605|459615570|FG005|Overall Study|Lost to Follow-up|0|||
127723915|NCT01528605|459615565|FG000|Overall Study|Death|1|||
127723916|NCT01528605|459615566|FG001|Overall Study|Death|0|||
127723917|NCT01528605|459615567|FG002|Overall Study|Death|0|||
127723918|NCT01528605|459615568|FG003|Overall Study|Death|0|||
127723919|NCT01528605|459615569|FG004|Overall Study|Death|0|||
127723920|NCT01528605|459615570|FG005|Overall Study|Death|0|||
127723921|NCT02432274|459615571|FG000|Overall Study|Death|2|||
127723922|NCT02432274|459615572|FG001|Overall Study|Death|6|||
127723923|NCT02432274|459615573|FG002|Overall Study|Death|7|||
127723924|NCT02432274|459615574|FG003|Overall Study|Death|0|||
127723925|NCT02432274|459615575|FG004|Overall Study|Death|27|||
127723926|NCT02432274|459615576|FG005|Overall Study|Death|7|||
127723927|NCT02432274|459615577|FG006|Overall Study|Death|9|||
127723928|NCT02432274|459615578|FG007|Overall Study|Death|14|||
127723929|NCT02432274|459615571|FG000|Overall Study|Withdrawal of Consent|0|||
127723930|NCT02432274|459615572|FG001|Overall Study|Withdrawal of Consent|0|||
127723931|NCT02432274|459615573|FG002|Overall Study|Withdrawal of Consent|0|||
127889283|NCT00608205|460218049|FG000|Overall Study|Patient non-compliant|0|||
127889284|NCT00608205|460218050|FG001|Overall Study|Patient non-compliant|1|||
127723932|NCT02432274|459615574|FG003|Overall Study|Withdrawal of Consent|0|||
127723933|NCT02432274|459615575|FG004|Overall Study|Withdrawal of Consent|2|||
127723934|NCT02432274|459615576|FG005|Overall Study|Withdrawal of Consent|0|||
127723935|NCT02432274|459615577|FG006|Overall Study|Withdrawal of Consent|1|||
127723936|NCT02432274|459615578|FG007|Overall Study|Withdrawal of Consent|2|||
127723937|NCT00116649|459615579|FG000|Overall Study|Adverse Event|20|||
127723938|NCT00116649|459615579|FG000|Overall Study|Lack of Efficacy|1|||
127723939|NCT00116649|459615579|FG000|Overall Study|Lost to Follow-up|32|||
127723940|NCT00116649|459615579|FG000|Overall Study|Withdrawal by Subject|68|||
127723941|NCT00116649|459615579|FG000|Overall Study|Local Skin Reaction|9|||
127723942|NCT00116649|459615579|FG000|Overall Study|Various Reasons|18|||
127723943|NCT00116649|459615579|FG000|Overall Study|Protocol Specified|7|||
127723944|NCT00513071|459615582|FG000|Overall Study|Adverse Event|1|||
127723945|NCT00513071|459615582|FG000|Overall Study|Withdrawal by Subject|1|||
127723946|NCT00513071|459615582|FG000|Overall Study|Physician Decision|3|||
127723947|NCT02659540|459615584|FG000|Overall Study|Adverse Event|3|||
127723948|NCT02659540|459615585|FG001|Overall Study|Adverse Event|2|||
127723949|NCT02659540|459615584|FG000|Overall Study|Death|1|||
127723950|NCT02659540|459615585|FG001|Overall Study|Death|0|||
127723951|NCT02659540|459615584|FG000|Overall Study|Progressive disease|2|||
127723952|NCT02659540|459615585|FG001|Overall Study|Progressive disease|6|||
127723953|NCT01240590|459615586|FG000|Phase I|Refused further treatment|0|||
127723954|NCT01240590|459615587|FG001|Phase I|Refused further treatment|0|||
127723955|NCT01240590|459615588|FG002|Phase I|Refused further treatment|3|||
127723956|NCT01240590|459615589|FG003|Phase I|Refused further treatment|0|||
127723957|NCT01240590|459615590|FG004|Phase I|Refused further treatment|0|||
127723958|NCT01240590|459615586|FG000|Phase II|Refused further treatment|0|||
127723959|NCT01240590|459615587|FG001|Phase II|Refused further treatment|0|||
127723960|NCT01240590|459615588|FG002|Phase II|Refused further treatment|0|||
127723961|NCT01240590|459615589|FG003|Phase II|Refused further treatment|2|||
127889285|NCT01797120|460218051|FG000|Overall Study|Disesae progression|37|||
127889286|NCT01797120|460218052|FG001|Overall Study|Disesae progression|49|||
127889287|NCT01797120|460218051|FG000|Overall Study|Adverse Event|13|||
127889288|NCT01797120|460218052|FG001|Overall Study|Adverse Event|5|||
127889289|NCT01797120|460218051|FG000|Overall Study|Withdrawal by Subject|6|||
127889290|NCT01797120|460218052|FG001|Overall Study|Withdrawal by Subject|6|||
127889291|NCT01797120|460218051|FG000|Overall Study|Symptomatic progression|2|||
127889292|NCT01797120|460218052|FG001|Overall Study|Symptomatic progression|1|||
127889293|NCT01797120|460218051|FG000|Overall Study|Non-compliance|1|||
127889294|NCT01797120|460218052|FG001|Overall Study|Non-compliance|0|||
127889295|NCT01797120|460218051|FG000|Overall Study|Physician Decision|3|||
127889296|NCT01797120|460218052|FG001|Overall Study|Physician Decision|0|||
127889297|NCT01797120|460218051|FG000|Overall Study|still on treatment|2|||
127889298|NCT01797120|460218052|FG001|Overall Study|still on treatment|4|||
127889299|NCT01797120|460218051|FG000|Overall Study|never start protocol therapy|2|||
127889300|NCT01797120|460218052|FG001|Overall Study|never start protocol therapy|0|||
127889301|NCT01909466|460218058|FG000|Overall Study|Lost to Follow-up|5|||
127889302|NCT01909466|460218059|FG001|Overall Study|Lost to Follow-up|7|||
127889303|NCT01909466|460218058|FG000|Overall Study|Adverse Event|3|||
127889304|NCT01909466|460218059|FG001|Overall Study|Adverse Event|4|||
127889305|NCT01909466|460218058|FG000|Overall Study|Met Withdrawal Criteria|0|||
127889306|NCT01909466|460218059|FG001|Overall Study|Met Withdrawal Criteria|3|||
127889307|NCT01909466|460218058|FG000|Overall Study|Physician Decision|2|||
127723962|NCT01240590|459615590|FG004|Phase II|Refused further treatment|1|||
127723963|NCT02106325|459615591|FG000|Phase 1|Lost to Follow-up|2|||
127723964|NCT02106325|459615592|FG001|Phase 1|Lost to Follow-up|2|||
127723965|NCT02106325|459615591|FG000|Phase 2|Lost to Follow-up|2|||
127723966|NCT02106325|459615592|FG001|Phase 2|Lost to Follow-up|3|||
127723967|NCT02106325|459615591|FG000|Phase 3|Lost to Follow-up|2|||
127723968|NCT02106325|459615592|FG001|Phase 3|Lost to Follow-up|1|||
127723969|NCT04820491|459615593|FG000|Overall Study|Withdrawal by Subject|1|||
127723970|NCT04820491|459615594|FG001|Overall Study|Withdrawal by Subject|0|||
127723971|NCT03976323|459615595|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|251|||
127723972|NCT03976323|459615596|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
127723973|NCT03976323|459615597|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
127723974|NCT03976323|459615595|FG000|Induction Phase|Death|80|||
127723975|NCT03976323|459615596|FG001|Induction Phase|Death|0|||
127723976|NCT03976323|459615597|FG002|Induction Phase|Death|0|||
127723977|NCT03976323|459615595|FG000|Maintenance Phase|Participant Ongoing in Study|0|||
127723978|NCT03976323|459615596|FG001|Maintenance Phase|Participant Ongoing in Study|100|||
127723979|NCT03976323|459615597|FG002|Maintenance Phase|Participant Ongoing in Study|97|||
127723980|NCT03976323|459615595|FG000|Maintenance Phase|Withdrawal by Subject|0|||
127723981|NCT03976323|459615596|FG001|Maintenance Phase|Withdrawal by Subject|9|||
127889308|NCT01909466|460218059|FG001|Overall Study|Physician Decision|0|||
127889309|NCT01909466|460218058|FG000|Overall Study|Withdrawal by Subject|11|||
127889310|NCT01909466|460218059|FG001|Overall Study|Withdrawal by Subject|9|||
127889311|NCT01909466|460218058|FG000|Overall Study|Lack of Efficacy|1|||
127889312|NCT01909466|460218059|FG001|Overall Study|Lack of Efficacy|0|||
127889313|NCT01339910|460218060|FG000|Overall Study|Withdrawal by Subject|1|||
127889314|NCT01339910|460218061|FG001|Overall Study|Withdrawal by Subject|0|||
127889315|NCT01339910|460218060|FG000|Overall Study|Physician Decision|1|||
127889316|NCT01339910|460218061|FG001|Overall Study|Physician Decision|0|||
127889317|NCT01339910|460218060|FG000|Overall Study|Disease relapse|1|||
127889318|NCT01339910|460218061|FG001|Overall Study|Disease relapse|4|||
127889319|NCT01567306|460218063|FG000|Overall Study|Protocol Violation|2|||
127889320|NCT01567306|460218064|FG001|Overall Study|Protocol Violation|2|||
127889321|NCT01567306|460218065|FG002|Overall Study|Protocol Violation|0|||
127889322|NCT01567306|460218066|FG003|Overall Study|Protocol Violation|3|||
127723982|NCT03976323|459615597|FG002|Maintenance Phase|Withdrawal by Subject|3|||
127723983|NCT03976323|459615595|FG000|Maintenance Phase|Physician Decision|0|||
127723984|NCT03976323|459615596|FG001|Maintenance Phase|Physician Decision|0|||
127889323|NCT01567306|460218067|FG004|Overall Study|Protocol Violation|1|||
127889324|NCT01567306|460218068|FG005|Overall Study|Protocol Violation|1|||
127889325|NCT01567306|460218063|FG000|Overall Study|Change site living|1|||
127889326|NCT01567306|460218064|FG001|Overall Study|Change site living|0|||
127889327|NCT01567306|460218065|FG002|Overall Study|Change site living|0|||
127889328|NCT01567306|460218066|FG003|Overall Study|Change site living|0|||
127889329|NCT01567306|460218067|FG004|Overall Study|Change site living|0|||
127889330|NCT01567306|460218068|FG005|Overall Study|Change site living|0|||
127889331|NCT01567306|460218063|FG000|Overall Study|Adverse Event|0|||
127889332|NCT01567306|460218064|FG001|Overall Study|Adverse Event|0|||
127889333|NCT01567306|460218065|FG002|Overall Study|Adverse Event|0|||
127889334|NCT01567306|460218066|FG003|Overall Study|Adverse Event|2|||
127889335|NCT01567306|460218067|FG004|Overall Study|Adverse Event|4|||
127889336|NCT01567306|460218068|FG005|Overall Study|Adverse Event|1|||
127889337|NCT01567306|460218063|FG000|Overall Study|Lost to Follow-up|0|||
127889338|NCT01567306|460218064|FG001|Overall Study|Lost to Follow-up|0|||
127889339|NCT01567306|460218065|FG002|Overall Study|Lost to Follow-up|0|||
127889340|NCT01567306|460218066|FG003|Overall Study|Lost to Follow-up|0|||
127889341|NCT01567306|460218067|FG004|Overall Study|Lost to Follow-up|2|||
127889342|NCT01567306|460218068|FG005|Overall Study|Lost to Follow-up|0|||
127889343|NCT01567306|460218063|FG000|Overall Study|Withdrawal by Subject|0|||
127889344|NCT01567306|460218064|FG001|Overall Study|Withdrawal by Subject|0|||
127889345|NCT01567306|460218065|FG002|Overall Study|Withdrawal by Subject|0|||
127889346|NCT01567306|460218066|FG003|Overall Study|Withdrawal by Subject|0|||
127889347|NCT01567306|460218067|FG004|Overall Study|Withdrawal by Subject|0|||
127889348|NCT01567306|460218068|FG005|Overall Study|Withdrawal by Subject|1|||
127889349|NCT00738673|460218073|FG000|Overall Study|Adverse Event|1|||
127889350|NCT00738673|460218074|FG001|Overall Study|Adverse Event|0|||
127889351|NCT00738673|460218073|FG000|Overall Study|Lack of Efficacy|19|||
127889352|NCT00738673|460218074|FG001|Overall Study|Lack of Efficacy|8|||
127889353|NCT00738673|460218073|FG000|Overall Study|Protocol Violation|1|||
127889354|NCT00738673|460218074|FG001|Overall Study|Protocol Violation|2|||
127889355|NCT00738673|460218073|FG000|Overall Study|Withdrawal by Subject|3|||
127889356|NCT00738673|460218074|FG001|Overall Study|Withdrawal by Subject|1|||
127889357|NCT02736227|460218077|FG000|Overall Study|Withdrawal by Subject|0|||
127889358|NCT02736227|460218078|FG001|Overall Study|Withdrawal by Subject|0|||
127889359|NCT02736227|460218079|FG002|Overall Study|Withdrawal by Subject|1|||
127889360|NCT02736227|460218077|FG000|Overall Study|Physician Decision|0|||
127889361|NCT02736227|460218078|FG001|Overall Study|Physician Decision|0|||
127889362|NCT02736227|460218079|FG002|Overall Study|Physician Decision|5|||
127889363|NCT02736227|460218077|FG000|Overall Study|Non Compliant|0|||
127889364|NCT02736227|460218078|FG001|Overall Study|Non Compliant|0|||
127889365|NCT02736227|460218079|FG002|Overall Study|Non Compliant|2|||
127889366|NCT04120194|460218080|FG000|Overall Study|Lost to Follow-up|11|||
127889367|NCT04120194|460218081|FG001|Overall Study|Lost to Follow-up|8|||
127889368|NCT04120194|460218080|FG000|Overall Study|Adverse Event|4|||
127889369|NCT04120194|460218081|FG001|Overall Study|Adverse Event|5|||
127889370|NCT04120194|460218080|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
127889371|NCT04120194|460218081|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
127889372|NCT04120194|460218080|FG000|Overall Study|Miscellaneous|4|||
127889373|NCT04120194|460218081|FG001|Overall Study|Miscellaneous|5|||
127889374|NCT00827359|460218085|FG000|Overall Study|Progressive Diseas|19|||
127889375|NCT00827359|460218085|FG000|Overall Study|Unacceptable Toxicity|5|||
127889376|NCT00827359|460218085|FG000|Overall Study|Ineligible|1|||
127889377|NCT01159769|460218086|FG000|Overall Study|Adverse Event|1|||
127889378|NCT02555618|460218087|FG000|Overall Study|Sponsor's Circumstances|1|||
127889379|NCT02555618|460218088|FG001|Overall Study|Sponsor's Circumstances|0|||
127889380|NCT02063698|460218089|FG000|Overall Study|did not complete booklet for days 2-8|1|||
127889381|NCT02063698|460218090|FG001|Overall Study|did not complete booklet for days 2-8|2|||
127889382|NCT02741271|460218095|FG000|Overall Study|Lost to Follow-up|2|||
127889383|NCT02741271|460218096|FG001|Overall Study|Lost to Follow-up|0|||
127889384|NCT02741271|460218095|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
127889385|NCT02741271|460218096|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
127889386|NCT01612156|460218097|FG000|Overall Study|Protocol Violation|2|||
127889387|NCT01612156|460218098|FG001|Overall Study|Protocol Violation|0|||
127889388|NCT00410410|460218099|FG000|Induction Period (IP)|Death|1|||
127889389|NCT00410410|460218100|FG001|Induction Period (IP)|Death|0|||
127889390|NCT00410410|460218101|FG002|Induction Period (IP)|Death|0|||
127889391|NCT00410410|460218102|FG003|Induction Period (IP)|Death|0|||
127889392|NCT00410410|460218103|FG004|Induction Period (IP)|Death|0|||
127889393|NCT00410410|460218104|FG005|Induction Period (IP)|Death|0|||
127889394|NCT00410410|460218105|FG006|Induction Period (IP)|Death|0|||
127889395|NCT00410410|460218106|FG007|Induction Period (IP)|Death|0|||
127889396|NCT00410410|460218107|FG008|Induction Period (IP)|Death|0|||
127889397|NCT00410410|460218099|FG000|Induction Period (IP)|Adverse Event|3|||
127889398|NCT00410410|460218100|FG001|Induction Period (IP)|Adverse Event|4|||
127889399|NCT00410410|460218101|FG002|Induction Period (IP)|Adverse Event|2|||
127889400|NCT00410410|460218102|FG003|Induction Period (IP)|Adverse Event|4|||
127889401|NCT00410410|460218103|FG004|Induction Period (IP)|Adverse Event|1|||
127889402|NCT00410410|460218104|FG005|Induction Period (IP)|Adverse Event|0|||
127889403|NCT00410410|460218105|FG006|Induction Period (IP)|Adverse Event|0|||
127889404|NCT00410410|460218106|FG007|Induction Period (IP)|Adverse Event|0|||
127889405|NCT00410410|460218107|FG008|Induction Period (IP)|Adverse Event|0|||
127889406|NCT00410410|460218099|FG000|Induction Period (IP)|Lack of Efficacy|26|||
127889407|NCT00410410|460218100|FG001|Induction Period (IP)|Lack of Efficacy|24|||
127723985|NCT03976323|459615597|FG002|Maintenance Phase|Physician Decision|1|||
127723986|NCT03976323|459615595|FG000|Maintenance Phase|Death|0|||
127723987|NCT03976323|459615596|FG001|Maintenance Phase|Death|228|||
127723988|NCT03976323|459615597|FG002|Maintenance Phase|Death|234|||
127723989|NCT00535626|459617108|FG000|Overall Study|Death|15|||
127723990|NCT00535626|459617108|FG000|Overall Study|Lost to Follow-up|29|||
127723991|NCT00535626|459617108|FG000|Overall Study|Withdrawal by Subject|20|||
127723992|NCT00535626|459617108|FG000|Overall Study|Removal/revision of study component|8|||
127723993|NCT00535626|459617108|FG000|Overall Study|Subject terminated|31|||
127723994|NCT00535626|459617108|FG000|Overall Study|Unable to return|2|||
127723995|NCT02710669|459617111|FG000|Overall Study|Physician Decision|2|||
127723996|NCT02710669|459617112|FG001|Overall Study|Physician Decision|1|||
127723997|NCT02710669|459617113|FG002|Overall Study|Physician Decision|0|||
127723998|NCT02710669|459617111|FG000|Overall Study|Institutional delays (including COVID)|2|||
127723999|NCT02710669|459617112|FG001|Overall Study|Institutional delays (including COVID)|2|||
127724000|NCT02710669|459617113|FG002|Overall Study|Institutional delays (including COVID)|0|||
127724001|NCT02710669|459617111|FG000|Overall Study|arrived in afib/aflutter|10|||
127724002|NCT02710669|459617112|FG001|Overall Study|arrived in afib/aflutter|8|||
127724003|NCT02710669|459617113|FG002|Overall Study|arrived in afib/aflutter|2|||
127724004|NCT00731692|459617114|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
127724005|NCT00731692|459617115|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
127724006|NCT00731692|459617116|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
127724007|NCT00731692|459617114|FG000|Core Study (36 Months)|Physician Decision|1|||
127724008|NCT00731692|459617115|FG001|Core Study (36 Months)|Physician Decision|0|||
127724009|NCT00731692|459617116|FG002|Core Study (36 Months)|Physician Decision|2|||
127724010|NCT00731692|459617114|FG000|Core Study (36 Months)|Death|2|||
127724011|NCT00731692|459617115|FG001|Core Study (36 Months)|Death|1|||
127724012|NCT00731692|459617116|FG002|Core Study (36 Months)|Death|2|||
127724013|NCT00731692|459617114|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
127724014|NCT00731692|459617115|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
127724015|NCT00731692|459617116|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
127724016|NCT00731692|459617114|FG000|Core Study (36 Months)|Administrative|2|||
127724017|NCT00731692|459617115|FG001|Core Study (36 Months)|Administrative|2|||
127724018|NCT00731692|459617116|FG002|Core Study (36 Months)|Administrative|6|||
127724019|NCT00731692|459617114|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
127724020|NCT00731692|459617115|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
127724021|NCT00731692|459617116|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
127724022|NCT00731692|459617114|FG000|Core Study (36 Months)|Protocol Violation|4|||
127724023|NCT00731692|459617115|FG001|Core Study (36 Months)|Protocol Violation|5|||
127724024|NCT00731692|459617116|FG002|Core Study (36 Months)|Protocol Violation|8|||
127724025|NCT00731692|459617114|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
127724026|NCT00731692|459617115|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
127724027|NCT00731692|459617116|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
127724028|NCT00731692|459617114|FG000|Core Study (36 Months)|Adverse Event|25|||
127724029|NCT00731692|459617115|FG001|Core Study (36 Months)|Adverse Event|28|||
127724030|NCT00731692|459617116|FG002|Core Study (36 Months)|Adverse Event|29|||
127724031|NCT00731692|459617114|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
127724032|NCT00731692|459617115|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
127724033|NCT00731692|459617116|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
127724034|NCT00731692|459617114|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
127724035|NCT00731692|459617115|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
127724036|NCT00731692|459617116|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
127724037|NCT00731692|459617114|FG000|Extension Phase|Abnormal test procedure|0|||
127724038|NCT00731692|459617115|FG001|Extension Phase|Abnormal test procedure|0|||
127724039|NCT00731692|459617116|FG002|Extension Phase|Abnormal test procedure|1|||
127724040|NCT00731692|459617114|FG000|Extension Phase|Abnormal lab values|0|||
127724041|NCT00731692|459617115|FG001|Extension Phase|Abnormal lab values|0|||
127724042|NCT00731692|459617116|FG002|Extension Phase|Abnormal lab values|1|||
127724043|NCT00731692|459617114|FG000|Extension Phase|Lost to Follow-up|0|||
127724044|NCT00731692|459617115|FG001|Extension Phase|Lost to Follow-up|1|||
127724045|NCT00731692|459617116|FG002|Extension Phase|Lost to Follow-up|4|||
127724046|NCT00731692|459617114|FG000|Extension Phase|Withdrawal by Subject|4|||
127724047|NCT00731692|459617115|FG001|Extension Phase|Withdrawal by Subject|5|||
127724048|NCT00731692|459617116|FG002|Extension Phase|Withdrawal by Subject|3|||
127724049|NCT00731692|459617114|FG000|Extension Phase|Adverse Event|1|||
127724050|NCT00731692|459617115|FG001|Extension Phase|Adverse Event|1|||
127724051|NCT00731692|459617116|FG002|Extension Phase|Adverse Event|15|||
127724052|NCT03332589|459617117|FG000|Overall Study|Lack of Efficacy|2|||
127724053|NCT03332589|459617118|FG001|Overall Study|Lack of Efficacy|0|||
127724054|NCT03332589|459617119|FG002|Overall Study|Lack of Efficacy|0|||
127724055|NCT03332589|459617117|FG000|Overall Study|Adverse Event|1|||
127724056|NCT03332589|459617118|FG001|Overall Study|Adverse Event|0|||
127724057|NCT03332589|459617119|FG002|Overall Study|Adverse Event|0|||
127724058|NCT03332589|459617117|FG000|Overall Study|Death|1|||
127724059|NCT03332589|459617118|FG001|Overall Study|Death|0|||
127724060|NCT03332589|459617119|FG002|Overall Study|Death|0|||
127724061|NCT00108355|459617124|FG000|Overall Study|Peritonitis at index paracentesis|1|||
127724062|NCT00108355|459617125|FG001|Overall Study|Peritonitis at index paracentesis|1|||
127724063|NCT00108355|459617124|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
127724064|NCT00108355|459617125|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
127724065|NCT02002689|459617130|FG000|Overall Study|Disease Progression|7|||
127724066|NCT02002689|459617130|FG000|Overall Study|Adverse Event|3|||
127724067|NCT01377844|459617131|FG000|Overall Study|Withdrawal by Subject|25|||
127724068|NCT01377844|459617132|FG001|Overall Study|Withdrawal by Subject|28|||
127724069|NCT01377844|459617131|FG000|Overall Study|Protocol Violation|2|||
127724070|NCT01377844|459617132|FG001|Overall Study|Protocol Violation|3|||
127724071|NCT01377844|459617131|FG000|Overall Study|Adverse Event|3|||
127724072|NCT01377844|459617132|FG001|Overall Study|Adverse Event|0|||
127724073|NCT01377844|459617131|FG000|Overall Study|Physician Decision|6|||
127724074|NCT01377844|459617132|FG001|Overall Study|Physician Decision|3|||
127724075|NCT01377844|459617131|FG000|Overall Study|Study terminated by Sponsor|0|||
127724076|NCT01377844|459617132|FG001|Overall Study|Study terminated by Sponsor|1|||
127724077|NCT01185340|459617135|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
127724078|NCT01185340|459617136|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
127724079|NCT01185340|459617137|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
127724080|NCT01185340|459617138|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
127724081|NCT01185340|459617135|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
127724082|NCT01185340|459617136|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
127724083|NCT01185340|459617137|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
127724084|NCT01185340|459617138|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
127724085|NCT01185340|459617135|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
127889408|NCT00410410|460218101|FG002|Induction Period (IP)|Lack of Efficacy|8|||
127889409|NCT00410410|460218102|FG003|Induction Period (IP)|Lack of Efficacy|8|||
127889410|NCT00410410|460218103|FG004|Induction Period (IP)|Lack of Efficacy|7|||
127889411|NCT00410410|460218104|FG005|Induction Period (IP)|Lack of Efficacy|7|||
127889412|NCT00410410|460218105|FG006|Induction Period (IP)|Lack of Efficacy|0|||
127889413|NCT00410410|460218106|FG007|Induction Period (IP)|Lack of Efficacy|0|||
127889414|NCT00410410|460218107|FG008|Induction Period (IP)|Lack of Efficacy|0|||
127889415|NCT00410410|460218099|FG000|Induction Period (IP)|Lost to Follow-up|2|||
127889416|NCT00410410|460218100|FG001|Induction Period (IP)|Lost to Follow-up|2|||
127724086|NCT01185340|459617136|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
127724087|NCT01185340|459617137|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
127724088|NCT01185340|459617138|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
127724089|NCT01185340|459617135|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
127724090|NCT01185340|459617136|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
127724091|NCT01185340|459617137|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
127724092|NCT01185340|459617138|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
127724093|NCT01185340|459617135|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
127724094|NCT01185340|459617136|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
127724095|NCT01185340|459617137|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
127724096|NCT01185340|459617138|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
127724097|NCT01185340|459617135|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
127724098|NCT01185340|459617136|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
127724099|NCT01185340|459617137|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
127724100|NCT01185340|459617138|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
127724101|NCT01185340|459617135|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
127724102|NCT01185340|459617136|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
127724103|NCT01185340|459617137|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
127724104|NCT01185340|459617138|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
127724105|NCT01185340|459617135|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
127724106|NCT01185340|459617136|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
127724107|NCT01185340|459617137|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
127889417|NCT00410410|460218101|FG002|Induction Period (IP)|Lost to Follow-up|2|||
127889418|NCT00410410|460218102|FG003|Induction Period (IP)|Lost to Follow-up|3|||
127889419|NCT00410410|460218103|FG004|Induction Period (IP)|Lost to Follow-up|0|||
127724108|NCT01185340|459617138|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
127724109|NCT01185340|459617135|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
127889420|NCT00410410|460218104|FG005|Induction Period (IP)|Lost to Follow-up|1|||
127724110|NCT01185340|459617136|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
127724111|NCT01185340|459617137|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
127724112|NCT01185340|459617138|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
127724113|NCT01185340|459617135|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
127724114|NCT01185340|459617136|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
127724115|NCT01185340|459617137|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
127724116|NCT01185340|459617138|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
127724117|NCT01185340|459617135|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
127724118|NCT01185340|459617136|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
127724119|NCT01185340|459617137|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
127724120|NCT01185340|459617138|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
127724121|NCT01185340|459617135|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
127724122|NCT01185340|459617136|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
127724123|NCT01185340|459617137|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
127724124|NCT01185340|459617138|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
127724125|NCT01185340|459617135|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
127724126|NCT01185340|459617136|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
127724127|NCT01185340|459617137|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
127724128|NCT01185340|459617138|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
127724129|NCT01185340|459617135|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
127724130|NCT01185340|459617136|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
127724131|NCT01185340|459617137|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
127724132|NCT01185340|459617138|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
127724133|NCT00087516|459617139|FG000|Overall Study|Adverse Event|10|||
127724134|NCT00087516|459617140|FG001|Overall Study|Adverse Event|10|||
127724135|NCT00087516|459617141|FG002|Overall Study|Adverse Event|3|||
127724136|NCT00087516|459617142|FG003|Overall Study|Adverse Event|6|||
127724137|NCT00087516|459617139|FG000|Overall Study|Lack of Efficacy|82|||
127724138|NCT00087516|459617140|FG001|Overall Study|Lack of Efficacy|80|||
127724139|NCT00087516|459617141|FG002|Overall Study|Lack of Efficacy|39|||
127724140|NCT00087516|459617142|FG003|Overall Study|Lack of Efficacy|29|||
127724141|NCT00087516|459617139|FG000|Overall Study|Lost to Follow-up|8|||
127724142|NCT00087516|459617140|FG001|Overall Study|Lost to Follow-up|6|||
127724143|NCT00087516|459617141|FG002|Overall Study|Lost to Follow-up|5|||
127724144|NCT00087516|459617142|FG003|Overall Study|Lost to Follow-up|5|||
127724145|NCT00087516|459617139|FG000|Overall Study|Protocol Violation|4|||
127724146|NCT00087516|459617140|FG001|Overall Study|Protocol Violation|8|||
127724147|NCT00087516|459617141|FG002|Overall Study|Protocol Violation|3|||
127724148|NCT00087516|459617142|FG003|Overall Study|Protocol Violation|6|||
127724149|NCT00087516|459617139|FG000|Overall Study|Withdrawal by Subject|16|||
127724150|NCT00087516|459617140|FG001|Overall Study|Withdrawal by Subject|27|||
127724151|NCT00087516|459617141|FG002|Overall Study|Withdrawal by Subject|11|||
127724152|NCT00087516|459617142|FG003|Overall Study|Withdrawal by Subject|12|||
127724153|NCT00087516|459617139|FG000|Overall Study|Site terminated|0|||
127724154|NCT00087516|459617140|FG001|Overall Study|Site terminated|2|||
127724155|NCT00087516|459617141|FG002|Overall Study|Site terminated|1|||
127724156|NCT00087516|459617142|FG003|Overall Study|Site terminated|0|||
127724157|NCT00087516|459617139|FG000|Overall Study|Protocol specified discontinuation|35|||
127724158|NCT00087516|459617140|FG001|Overall Study|Protocol specified discontinuation|33|||
127724159|NCT00087516|459617141|FG002|Overall Study|Protocol specified discontinuation|33|||
127724160|NCT00087516|459617142|FG003|Overall Study|Protocol specified discontinuation|26|||
127724161|NCT00087516|459617139|FG000|Overall Study|Patient moved|3|||
127724162|NCT00087516|459617140|FG001|Overall Study|Patient moved|2|||
127724163|NCT00087516|459617141|FG002|Overall Study|Patient moved|1|||
127724164|NCT00087516|459617142|FG003|Overall Study|Patient moved|0|||
127724165|NCT00087516|459617139|FG000|Overall Study|Patient was non-compliant|3|||
127724166|NCT00087516|459617140|FG001|Overall Study|Patient was non-compliant|1|||
127724167|NCT00087516|459617141|FG002|Overall Study|Patient was non-compliant|0|||
127724168|NCT00087516|459617142|FG003|Overall Study|Patient was non-compliant|0|||
127724169|NCT00087516|459617139|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
127724170|NCT00087516|459617140|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
127724171|NCT00087516|459617141|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
127724172|NCT00087516|459617142|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
127724173|NCT00087516|459617139|FG000|Overall Study|Other|0|||
127724174|NCT00087516|459617140|FG001|Overall Study|Other|0|||
127724175|NCT00087516|459617141|FG002|Overall Study|Other|1|||
127724176|NCT00087516|459617142|FG003|Overall Study|Other|0|||
127724177|NCT02065895|459617143|FG000|Overall Study|Protocol Violation|1|||
127724178|NCT02065895|459617144|FG001|Overall Study|Protocol Violation|0|||
127724179|NCT02065895|459617145|FG002|Overall Study|Protocol Violation|0|||
127724180|NCT02065895|459617146|FG003|Overall Study|Protocol Violation|1|||
127724181|NCT02065895|459617147|FG004|Overall Study|Protocol Violation|0|||
127724182|NCT02065895|459617148|FG005|Overall Study|Protocol Violation|0|||
127724183|NCT02065895|459617143|FG000|Overall Study|Scheduling conflicts|0|||
127724184|NCT02065895|459617144|FG001|Overall Study|Scheduling conflicts|1|||
127724185|NCT02065895|459617145|FG002|Overall Study|Scheduling conflicts|0|||
127724186|NCT02065895|459617146|FG003|Overall Study|Scheduling conflicts|0|||
127724187|NCT02065895|459617147|FG004|Overall Study|Scheduling conflicts|0|||
127724188|NCT02065895|459617148|FG005|Overall Study|Scheduling conflicts|0|||
127724189|NCT03403036|459617154|FG000|Overall Study|Lack of Efficacy|5|||
127724190|NCT00569166|459617159|FG000|Overall Study|Withdrawal by Subject|7|||
127724191|NCT00569166|459617160|FG001|Overall Study|Withdrawal by Subject|5|||
127724192|NCT00569166|459617161|FG002|Overall Study|Withdrawal by Subject|3|||
127724193|NCT00569166|459617159|FG000|Overall Study|Lost to Follow-up|2|||
127724194|NCT00569166|459617160|FG001|Overall Study|Lost to Follow-up|1|||
127724195|NCT00569166|459617161|FG002|Overall Study|Lost to Follow-up|1|||
127724196|NCT05005247|459617162|FG000|Overall Study|Withdrawal by Subject|0|||
127724197|NCT05005247|459617163|FG001|Overall Study|Withdrawal by Subject|1|||
127724198|NCT05005247|459617164|FG002|Overall Study|Withdrawal by Subject|0|||
127724199|NCT02958553|459617165|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
127724200|NCT02958553|459617165|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
127724201|NCT01686152|459617166|FG000|Overall Study|Withdrawal by Subject|11|||
127724202|NCT01686152|459617167|FG001|Overall Study|Withdrawal by Subject|11|||
127724203|NCT01686152|459617168|FG002|Overall Study|Withdrawal by Subject|3|||
127724204|NCT01686152|459617166|FG000|Overall Study|Drug Code Unblinded|0|||
127724205|NCT01686152|459617167|FG001|Overall Study|Drug Code Unblinded|1|||
127724206|NCT01686152|459617168|FG002|Overall Study|Drug Code Unblinded|0|||
127724207|NCT01686152|459617166|FG000|Overall Study|Protocol Violation|6|||
127724208|NCT01686152|459617167|FG001|Overall Study|Protocol Violation|1|||
127724209|NCT01686152|459617168|FG002|Overall Study|Protocol Violation|0|||
127724210|NCT01686152|459617166|FG000|Overall Study|Adverse Event|12|||
127724211|NCT01686152|459617167|FG001|Overall Study|Adverse Event|11|||
127724212|NCT01686152|459617168|FG002|Overall Study|Adverse Event|0|||
127724213|NCT01686152|459617166|FG000|Overall Study|Lack of Efficacy|0|||
127724214|NCT01686152|459617167|FG001|Overall Study|Lack of Efficacy|0|||
127724215|NCT01686152|459617168|FG002|Overall Study|Lack of Efficacy|1|||
127724216|NCT01686152|459617166|FG000|Overall Study|IP Non-compliance|5|||
127724217|NCT01686152|459617167|FG001|Overall Study|IP Non-compliance|5|||
127724218|NCT01686152|459617168|FG002|Overall Study|IP Non-compliance|0|||
127724219|NCT01686152|459617166|FG000|Overall Study|Lost to Follow-up|7|||
127724220|NCT01686152|459617167|FG001|Overall Study|Lost to Follow-up|6|||
127724221|NCT01686152|459617168|FG002|Overall Study|Lost to Follow-up|5|||
127724222|NCT00704340|459617170|FG000|Overall Study|Lost to Follow-up|2|||
127724223|NCT00704340|459617171|FG001|Overall Study|Lost to Follow-up|1|||
127724224|NCT00704340|459617170|FG000|Overall Study|Death|0|||
127724225|NCT00704340|459617171|FG001|Overall Study|Death|1|||
127724226|NCT01437540|459617172|FG000|Overall Study|Not listed below|7|||
127724227|NCT01437540|459617173|FG001|Overall Study|Not listed below|6|||
127724228|NCT01437540|459617172|FG000|Overall Study|COPD exacerbation|13|||
127724229|NCT01437540|459617173|FG001|Overall Study|COPD exacerbation|3|||
127724230|NCT01437540|459617172|FG000|Overall Study|Lost to Follow-up|3|||
127724231|NCT01437540|459617173|FG001|Overall Study|Lost to Follow-up|5|||
127724232|NCT01437540|459617172|FG000|Overall Study|Lack of Efficacy|23|||
127724233|NCT01437540|459617173|FG001|Overall Study|Lack of Efficacy|11|||
127724234|NCT01437540|459617172|FG000|Overall Study|Protocol Violation|24|||
127724235|NCT01437540|459617173|FG001|Overall Study|Protocol Violation|12|||
127724236|NCT01437540|459617172|FG000|Overall Study|Adverse Event|26|||
127724237|NCT01437540|459617173|FG001|Overall Study|Adverse Event|13|||
127724238|NCT01437540|459617172|FG000|Overall Study|Withdrawal by Subject|31|||
127724239|NCT01437540|459617173|FG001|Overall Study|Withdrawal by Subject|15|||
127724240|NCT00929526|459617175|FG000|Overall Study|Withdrawal by Subject|1|||
127724241|NCT00929526|459617176|FG001|Overall Study|Withdrawal by Subject|11|||
127724242|NCT00929526|459617175|FG000|Overall Study|Lost to Follow-up|8|||
127724243|NCT00929526|459617176|FG001|Overall Study|Lost to Follow-up|12|||
127724244|NCT00929526|459617175|FG000|Overall Study|Other|8|||
127724245|NCT00929526|459617176|FG001|Overall Study|Other|6|||
127724246|NCT01393600|459617182|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
127724247|NCT01393600|459617183|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
127724248|NCT01393600|459617184|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
127724249|NCT01393600|459617185|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
127724250|NCT01393600|459617182|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
127724251|NCT01393600|459617183|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
127724252|NCT01393600|459617184|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
127724253|NCT01393600|459617185|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
127724254|NCT01393600|459617182|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
127724255|NCT01393600|459617183|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
127724256|NCT01393600|459617184|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
127724257|NCT01393600|459617185|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
127724258|NCT01393600|459617182|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
127724259|NCT01393600|459617183|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
127724260|NCT01393600|459617184|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
127724261|NCT01393600|459617185|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
127724262|NCT01393600|459617182|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
127724263|NCT01393600|459617183|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
127724264|NCT01393600|459617184|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
127724265|NCT01393600|459617185|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
127724266|NCT01393600|459617182|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
127724267|NCT01393600|459617183|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
127724268|NCT01393600|459617184|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
127724269|NCT01393600|459617185|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
127724270|NCT01393600|459617182|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
127724271|NCT01393600|459617183|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
127724272|NCT01393600|459617184|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
127724273|NCT01393600|459617185|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
127724274|NCT00603798|459617186|FG000|Overall Study|Adverse Event|4|||
127724275|NCT00603798|459617187|FG001|Overall Study|Adverse Event|2|||
127724276|NCT00603798|459617188|FG002|Overall Study|Adverse Event|1|||
127724277|NCT00603798|459617186|FG000|Overall Study|Withdrawal by Subject|4|||
127724278|NCT00603798|459617187|FG001|Overall Study|Withdrawal by Subject|3|||
127724279|NCT00603798|459617188|FG002|Overall Study|Withdrawal by Subject|4|||
127724280|NCT00603798|459617186|FG000|Overall Study|Lost to Follow-up|1|||
127724281|NCT00603798|459617187|FG001|Overall Study|Lost to Follow-up|0|||
127724282|NCT00603798|459617188|FG002|Overall Study|Lost to Follow-up|1|||
127724283|NCT00603798|459617186|FG000|Overall Study|Non-compliance with study procedures|0|||
127724284|NCT00603798|459617187|FG001|Overall Study|Non-compliance with study procedures|1|||
127724285|NCT00603798|459617188|FG002|Overall Study|Non-compliance with study procedures|0|||
127724286|NCT00603798|459617186|FG000|Overall Study|Not due to AE|1|||
127724287|NCT00603798|459617187|FG001|Overall Study|Not due to AE|1|||
127724288|NCT00603798|459617188|FG002|Overall Study|Not due to AE|4|||
127724289|NCT00889863|459617189|FG000|Part I: Open Label|Death|1|||
127724290|NCT00889863|459617190|FG001|Part I: Open Label|Death|0|||
127724291|NCT00889863|459617189|FG000|Part I: Open Label|Adverse Event|4|||
127724292|NCT00889863|459617190|FG001|Part I: Open Label|Adverse Event|0|||
127724293|NCT00889863|459617189|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
127724294|NCT00889863|459617190|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
127724295|NCT00889863|459617189|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
127724296|NCT00889863|459617190|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
127724297|NCT00889863|459617189|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
127724298|NCT00889863|459617190|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
127724299|NCT00889863|459617189|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
127724300|NCT00889863|459617190|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
127724301|NCT00889863|459617189|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
127724302|NCT00889863|459617190|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
127724303|NCT01918033|459617192|FG000|Overall Study|Adverse Event|1|||
127724304|NCT01918033|459617193|FG001|Overall Study|Adverse Event|0|||
127724305|NCT01918033|459617194|FG002|Overall Study|Adverse Event|2|||
127724306|NCT01918033|459617192|FG000|Overall Study|Lost to Follow-up|0|||
127724307|NCT01918033|459617193|FG001|Overall Study|Lost to Follow-up|1|||
127724308|NCT01918033|459617194|FG002|Overall Study|Lost to Follow-up|0|||
127724309|NCT01918033|459617192|FG000|Overall Study|Protocol Violation|2|||
127724310|NCT01918033|459617193|FG001|Overall Study|Protocol Violation|0|||
127724311|NCT01918033|459617194|FG002|Overall Study|Protocol Violation|1|||
127724312|NCT01918033|459617192|FG000|Overall Study|Withdrawal by Subject|2|||
127724313|NCT01918033|459617193|FG001|Overall Study|Withdrawal by Subject|1|||
127724314|NCT01918033|459617194|FG002|Overall Study|Withdrawal by Subject|0|||
127724315|NCT03259568|459617200|FG000|Overall Study|Participant performance was low|3|||
127724316|NCT03006393|459617201|FG000|Overall Study|Withdrawal by Subject|1|||
127724317|NCT03006393|459617202|FG001|Overall Study|Withdrawal by Subject|1|||
127724318|NCT03006393|459617201|FG000|Overall Study|Pregnancy|0|||
127724319|NCT03006393|459617202|FG001|Overall Study|Pregnancy|1|||
127724320|NCT03006393|459617201|FG000|Overall Study|Lost to Follow-up|0|||
127724321|NCT03006393|459617202|FG001|Overall Study|Lost to Follow-up|1|||
127724322|NCT03136861|459617203|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
127724323|NCT03136861|459617204|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
127724324|NCT03136861|459617205|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
127724325|NCT03136861|459617206|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
127724326|NCT03136861|459617207|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
127724327|NCT03136861|459617208|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
127724328|NCT03136861|459617209|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
127724329|NCT03136861|459617203|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
127724330|NCT03136861|459617204|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
127724331|NCT03136861|459617205|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
127724332|NCT03136861|459617206|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
127724333|NCT03136861|459617207|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
127724334|NCT03136861|459617208|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
127724335|NCT03136861|459617209|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
127724336|NCT03136861|459617203|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
127724337|NCT03136861|459617204|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
127724338|NCT03136861|459617205|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
127724339|NCT03136861|459617206|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
127724340|NCT03136861|459617207|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
127724341|NCT03136861|459617208|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
127724342|NCT03136861|459617209|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
127724343|NCT03136861|459617203|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
127724344|NCT03136861|459617204|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
127724345|NCT03136861|459617205|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
127724346|NCT03136861|459617206|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
127724347|NCT03136861|459617207|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
127724348|NCT03136861|459617208|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
127724349|NCT03136861|459617209|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
127724350|NCT03136861|459617203|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
127724351|NCT03136861|459617204|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
127724352|NCT03136861|459617205|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
127724353|NCT03136861|459617206|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
127724354|NCT03136861|459617207|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
127724355|NCT03136861|459617208|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
127724356|NCT03136861|459617209|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
127724357|NCT03136861|459617203|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
127724358|NCT03136861|459617204|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
127724359|NCT03136861|459617205|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
127724360|NCT03136861|459617206|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
127724361|NCT03136861|459617207|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
127724362|NCT03136861|459617208|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
127724363|NCT03136861|459617209|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
127724364|NCT03136861|459617203|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
127724365|NCT03136861|459617204|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
127724366|NCT03136861|459617205|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
127724367|NCT03136861|459617206|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
127724368|NCT03136861|459617207|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
127724369|NCT03136861|459617208|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
127724370|NCT03136861|459617209|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
127724371|NCT03136861|459617203|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
127724372|NCT03136861|459617204|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
127724373|NCT03136861|459617205|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
127724374|NCT03136861|459617206|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
127724375|NCT03136861|459617207|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
127724376|NCT03136861|459617208|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
127724377|NCT03136861|459617209|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
127724378|NCT01584648|459617210|FG000|Overall Study|Death|136|||
127724379|NCT01584648|459617211|FG001|Overall Study|Death|146|||
127724380|NCT01584648|459617210|FG000|Overall Study|Lost to Follow-up|9|||
127724381|NCT01584648|459617211|FG001|Overall Study|Lost to Follow-up|9|||
127724382|NCT01584648|459617210|FG000|Overall Study|Investigator discretion|3|||
127724383|NCT01584648|459617211|FG001|Overall Study|Investigator discretion|2|||
127724384|NCT01584648|459617210|FG000|Overall Study|Withdrew consent|13|||
127724385|NCT01584648|459617211|FG001|Overall Study|Withdrew consent|4|||
127724386|NCT01584648|459617210|FG000|Overall Study|Study closed/terminated|50|||
127724387|NCT01584648|459617211|FG001|Overall Study|Study closed/terminated|23|||
127724388|NCT01584648|459617210|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
127724389|NCT01584648|459617211|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
127724390|NCT05376397|459617214|FG000|Overall Study|Lost to Follow-up|1|||
127724391|NCT01328756|459617215|FG000|Overall Study|Protocol Violation|4|||
127724392|NCT01328756|459617215|FG000|Overall Study|Adverse Event|39|||
127724393|NCT01328756|459617215|FG000|Overall Study|Lack of Efficacy|5|||
127724394|NCT01328756|459617215|FG000|Overall Study|Withdrawal by Subject|41|||
127724395|NCT01328756|459617215|FG000|Overall Study|Lost to Follow-up|5|||
127724396|NCT01328756|459617215|FG000|Overall Study|Other|29|||
127724397|NCT00472082|459617219|FG000|Overall Study|Study prematurely terminated|5|||
127724398|NCT00761267|459617220|FG000|Overall Study|Death|1|||
127724399|NCT00761267|459617221|FG001|Overall Study|Death|2|||
127724400|NCT00761267|459617222|FG002|Overall Study|Death|5|||
127724401|NCT00761267|459617220|FG000|Overall Study|Lost to Follow-up|0|||
127724402|NCT00761267|459617221|FG001|Overall Study|Lost to Follow-up|0|||
127724403|NCT00761267|459617222|FG002|Overall Study|Lost to Follow-up|1|||
127724404|NCT00761267|459617220|FG000|Overall Study|Randomized but not treated|1|||
127724405|NCT00761267|459617221|FG001|Overall Study|Randomized but not treated|1|||
127724406|NCT00761267|459617222|FG002|Overall Study|Randomized but not treated|0|||
127724407|NCT00761267|459617220|FG000|Overall Study|Withdrawal by Subject|0|||
127724408|NCT00761267|459617221|FG001|Overall Study|Withdrawal by Subject|1|||
127724409|NCT00761267|459617222|FG002|Overall Study|Withdrawal by Subject|0|||
127724410|NCT04492475|459617223|FG000|Overall Study|Enrolled but not treated|8|||
127724411|NCT04492475|459617224|FG001|Overall Study|Enrolled but not treated|8|||
127724412|NCT04492475|459617223|FG000|Overall Study|Withdrawal by Subject|4|||
127724413|NCT04492475|459617224|FG001|Overall Study|Withdrawal by Subject|0|||
127724414|NCT04492475|459617223|FG000|Overall Study|Became ineligible after enrollment|2|||
127724415|NCT04492475|459617224|FG001|Overall Study|Became ineligible after enrollment|0|||
127724416|NCT03205488|459617234|FG000|Overall Study|Adverse Event|1|||
127724417|NCT03205488|459617235|FG001|Overall Study|Adverse Event|2|||
127724418|NCT03205488|459617236|FG002|Overall Study|Adverse Event|4|||
127724419|NCT03205488|459617234|FG000|Overall Study|Protocol Violation|0|||
127724420|NCT03205488|459617235|FG001|Overall Study|Protocol Violation|0|||
127724421|NCT03205488|459617236|FG002|Overall Study|Protocol Violation|1|||
127724422|NCT00428714|459617241|FG000|Overall Study|Progressive Disease|28|||
127724423|NCT00428714|459617242|FG001|Overall Study|Progressive Disease|36|||
127724424|NCT00428714|459617241|FG000|Overall Study|Withdrawal by Subject|0|||
127724425|NCT00428714|459617242|FG001|Overall Study|Withdrawal by Subject|3|||
127724426|NCT00428714|459617241|FG000|Overall Study|Adverse Event|0|||
127724427|NCT00428714|459617242|FG001|Overall Study|Adverse Event|2|||
127724428|NCT00428714|459617241|FG000|Overall Study|Physician Decision|1|||
127724429|NCT00428714|459617242|FG001|Overall Study|Physician Decision|1|||
127724430|NCT00428714|459617241|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
127724431|NCT00428714|459617242|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
127724432|NCT00428714|459617241|FG000|Overall Study|Death due to other then PD|1|||
127724433|NCT00428714|459617242|FG001|Overall Study|Death due to other then PD|0|||
127724434|NCT01681511|459617243|FG000|Overall Study|No Treatment Received|1|||
127724435|NCT01681511|459617244|FG001|Overall Study|No Treatment Received|3|||
127724436|NCT01681511|459617243|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
127724437|NCT01681511|459617244|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
127724438|NCT01681511|459617243|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
127724439|NCT01681511|459617244|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
127724440|NCT01681511|459617243|FG000|Overall Study|No Daily Urine Sample Collected|0|||
127724441|NCT01681511|459617244|FG001|Overall Study|No Daily Urine Sample Collected|1|||
127724442|NCT01681511|459617243|FG000|Overall Study|No post-catheter sample collected|11|||
127724443|NCT01681511|459617244|FG001|Overall Study|No post-catheter sample collected|4|||
127724444|NCT02326220|459617245|FG000|Double-blind Treatment Period|Adverse Event|1|||
127724445|NCT02326220|459617246|FG001|Double-blind Treatment Period|Adverse Event|2|||
127724446|NCT02326220|459617247|FG002|Double-blind Treatment Period|Adverse Event|0|||
127724447|NCT02326220|459617245|FG000|Double-blind Treatment Period|Protocol Violation|0|||
127724448|NCT02326220|459617246|FG001|Double-blind Treatment Period|Protocol Violation|1|||
127724449|NCT02326220|459617247|FG002|Double-blind Treatment Period|Protocol Violation|0|||
127724450|NCT02326220|459617245|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
127724451|NCT02326220|459617246|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
127724452|NCT02326220|459617247|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
127724453|NCT02326220|459617245|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
127724454|NCT02326220|459617246|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
127724455|NCT02326220|459617247|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
127724456|NCT02326220|459617245|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
127724457|NCT02326220|459617246|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
127724458|NCT02326220|459617247|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
127724459|NCT02114515|459617248|FG000|Overall Study|Lost to Follow-up|52|||
127724460|NCT02114515|459617249|FG001|Overall Study|Lost to Follow-up|55|||
127724461|NCT02114515|459617248|FG000|Overall Study|Death|12|||
127724462|NCT02114515|459617249|FG001|Overall Study|Death|12|||
127724463|NCT02114515|459617248|FG000|Overall Study|Withdrawal by Subject|4|||
127724464|NCT02114515|459617249|FG001|Overall Study|Withdrawal by Subject|22|||
127724465|NCT02114515|459617248|FG000|Overall Study|Other|65|||
127724466|NCT02114515|459617249|FG001|Overall Study|Other|61|||
127724467|NCT02699099|459617251|FG000|Overall Study|Adverse Event|1|||
127724468|NCT02699099|459617252|FG001|Overall Study|Adverse Event|0|||
127724469|NCT02699099|459617253|FG002|Overall Study|Adverse Event|2|||
127724470|NCT02699099|459617251|FG000|Overall Study|Lost to Follow-up|0|||
127724471|NCT02699099|459617252|FG001|Overall Study|Lost to Follow-up|1|||
127724472|NCT02699099|459617253|FG002|Overall Study|Lost to Follow-up|0|||
127724473|NCT02699099|459617251|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
127724474|NCT02699099|459617252|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
127724475|NCT02699099|459617253|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
127724476|NCT00667732|459617254|FG000|Run -In (8 Weeks)|Adverse Event|4|||
127724477|NCT00667732|459617255|FG001|Run -In (8 Weeks)|Adverse Event|0|||
127724478|NCT00667732|459617256|FG002|Run -In (8 Weeks)|Adverse Event|0|||
127724479|NCT00667732|459617254|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
127724480|NCT00667732|459617255|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
127724481|NCT00667732|459617256|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
127724482|NCT00667732|459617254|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
127724483|NCT00667732|459617255|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
127724484|NCT00667732|459617256|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
127724485|NCT03890484|459617261|FG000|Overall Study|Lost to Follow-up|1|||
127724486|NCT03890484|459617262|FG001|Overall Study|Lost to Follow-up|1|||
127724487|NCT00824850|459617264|FG000|Overall Study|Withdrawal by Subject|0|||
127724488|NCT00824850|459617265|FG001|Overall Study|Withdrawal by Subject|1|||
127724489|NCT05184062|459617267|FG000|Overall Study|Lost to Follow-up|5|||
127724490|NCT05184062|459617268|FG001|Overall Study|Lost to Follow-up|1|||
127724491|NCT05184062|459617267|FG000|Overall Study|Withdrawal by Subject|1|||
127724492|NCT05184062|459617268|FG001|Overall Study|Withdrawal by Subject|0|||
127724493|NCT03659136|459617273|FG000|Overall Study|Not treated|2|||
127724494|NCT03659136|459617274|FG001|Overall Study|Not treated|0|||
127724495|NCT03659136|459617273|FG000|Overall Study|Covid-19 related|1|||
127724496|NCT03659136|459617274|FG001|Overall Study|Covid-19 related|1|||
127724497|NCT03659136|459617273|FG000|Overall Study|Withdrawal by Subject|1|||
127724498|NCT03659136|459617274|FG001|Overall Study|Withdrawal by Subject|6|||
127724499|NCT03659136|459617273|FG000|Overall Study|Adverse Event|4|||
127724500|NCT03659136|459617274|FG001|Overall Study|Adverse Event|6|||
127724501|NCT03659136|459617273|FG000|Overall Study|Progressive disease|37|||
127724502|NCT03659136|459617274|FG001|Overall Study|Progressive disease|31|||
127724503|NCT03659136|459617273|FG000|Overall Study|Study closure|2|||
127724504|NCT03659136|459617274|FG001|Overall Study|Study closure|2|||
127724505|NCT03659136|459617273|FG000|Overall Study|Sponsor decision/recommendation|3|||
127724506|NCT03659136|459617274|FG001|Overall Study|Sponsor decision/recommendation|2|||
127724507|NCT03659136|459617273|FG000|Overall Study|Switched to other drug/therapy|2|||
127724508|NCT03659136|459617274|FG001|Overall Study|Switched to other drug/therapy|2|||
127724509|NCT03659136|459617273|FG000|Overall Study|Lack of clinical benefit|0|||
127724510|NCT03659136|459617274|FG001|Overall Study|Lack of clinical benefit|1|||
127724511|NCT01668355|459618961|FG000|Overall Study|Death|3|||
127724512|NCT01668355|459618962|FG001|Overall Study|Death|1|||
127724513|NCT01668355|459618961|FG000|Overall Study|Withdrawal by Subject|6|||
127724514|NCT01668355|459618962|FG001|Overall Study|Withdrawal by Subject|1|||
127724515|NCT02830893|459618963|FG000|Overall Study|Relocation to out of the country|1|||
127724516|NCT02830893|459618964|FG001|Overall Study|Relocation to out of the country|0|||
127724517|NCT02830893|459618963|FG000|Overall Study|Lost to Follow-up|0|||
127724518|NCT02830893|459618964|FG001|Overall Study|Lost to Follow-up|2|||
127724519|NCT02830893|459618963|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
127724520|NCT02830893|459618964|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
127724521|NCT01277302|459618965|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
127724522|NCT01277302|459618966|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
127724523|NCT01277302|459618967|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
127724524|NCT01277302|459618965|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
127724525|NCT01277302|459618966|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
127724526|NCT01277302|459618967|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
127724527|NCT01277302|459618965|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
127724528|NCT01277302|459618966|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
127724529|NCT01277302|459618967|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
127724530|NCT01277302|459618965|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
127724531|NCT01277302|459618966|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
127724532|NCT01277302|459618967|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
127724533|NCT01277302|459618965|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
127724534|NCT01277302|459618966|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
127724535|NCT01277302|459618967|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
127724536|NCT01277302|459618965|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
127724537|NCT01277302|459618966|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
127724538|NCT01277302|459618967|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
127724539|NCT01277302|459618965|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
127724540|NCT01277302|459618966|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
127724541|NCT01277302|459618967|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
127724542|NCT01277302|459618965|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
127724543|NCT01277302|459618966|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
127724544|NCT01277302|459618967|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
127724545|NCT01277302|459618965|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
127724546|NCT01277302|459618966|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
127724547|NCT01277302|459618967|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
127724548|NCT00647699|459618968|FG000|Overall Study|Lost to Follow-up|5|||
127724549|NCT00647699|459618969|FG001|Overall Study|Lost to Follow-up|4|||
127724550|NCT00647699|459618968|FG000|Overall Study|Withdrawal by Subject|3|||
127724551|NCT00647699|459618969|FG001|Overall Study|Withdrawal by Subject|8|||
127724552|NCT00413283|459618970|FG000|Overall Study|Withdrawal by Subject|1|||
127724553|NCT00413283|459618971|FG001|Overall Study|Withdrawal by Subject|0|||
127724554|NCT00413283|459618972|FG002|Overall Study|Withdrawal by Subject|0|||
127724555|NCT00413283|459618973|FG003|Overall Study|Withdrawal by Subject|1|||
127724556|NCT00413283|459618970|FG000|Overall Study|Death|0|||
127724557|NCT00413283|459618971|FG001|Overall Study|Death|0|||
127724558|NCT00413283|459618972|FG002|Overall Study|Death|1|||
127724559|NCT00413283|459618973|FG003|Overall Study|Death|1|||
127724560|NCT00413283|459618970|FG000|Overall Study|Adverse Event|0|||
127724561|NCT00413283|459618971|FG001|Overall Study|Adverse Event|0|||
127724562|NCT00413283|459618972|FG002|Overall Study|Adverse Event|0|||
127724563|NCT00413283|459618973|FG003|Overall Study|Adverse Event|1|||
127724564|NCT00413283|459618970|FG000|Overall Study|Ineligibility determined|0|||
127724565|NCT00413283|459618971|FG001|Overall Study|Ineligibility determined|0|||
127724566|NCT00413283|459618972|FG002|Overall Study|Ineligibility determined|0|||
127724567|NCT00413283|459618973|FG003|Overall Study|Ineligibility determined|1|||
127724568|NCT00413283|459618970|FG000|Overall Study|Protocol deviation|0|||
127724569|NCT00413283|459618971|FG001|Overall Study|Protocol deviation|1|||
127724570|NCT00413283|459618972|FG002|Overall Study|Protocol deviation|0|||
127724571|NCT00413283|459618973|FG003|Overall Study|Protocol deviation|0|||
127724572|NCT00413283|459618970|FG000|Overall Study|Requirement for alternative therapy|0|||
127724573|NCT00413283|459618971|FG001|Overall Study|Requirement for alternative therapy|2|||
127724574|NCT00413283|459618972|FG002|Overall Study|Requirement for alternative therapy|0|||
127724575|NCT00413283|459618973|FG003|Overall Study|Requirement for alternative therapy|0|||
127724576|NCT00413283|459618970|FG000|Overall Study|Other|0|||
127724577|NCT00413283|459618971|FG001|Overall Study|Other|0|||
127724578|NCT00413283|459618972|FG002|Overall Study|Other|1|||
127724579|NCT00413283|459618973|FG003|Overall Study|Other|0|||
127724580|NCT02354417|459618974|FG000|Overall Study|Physician Decision|1|||
127724581|NCT00246129|459618975|FG000|Overall Study|Lost to Follow-up|1|||
127724582|NCT00246129|459618976|FG001|Overall Study|Lost to Follow-up|0|||
127724583|NCT00246129|459618975|FG000|Overall Study|Death|2|||
127724584|NCT00246129|459618976|FG001|Overall Study|Death|1|||
127724585|NCT00246129|459618975|FG000|Overall Study|suffered primary non-function|1|||
127724586|NCT00246129|459618976|FG001|Overall Study|suffered primary non-function|0|||
127724587|NCT00246129|459618975|FG000|Overall Study|grafts failed|3|||
127724588|NCT00246129|459618976|FG001|Overall Study|grafts failed|1|||
127724589|NCT03469258|459618977|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
127724590|NCT00484198|459618981|FG000|Overall Study|Participant Withdrew Consent|12|||
127724591|NCT00484198|459618982|FG001|Overall Study|Participant Withdrew Consent|21|||
127724592|NCT00484198|459618983|FG002|Overall Study|Participant Withdrew Consent|47|||
127889421|NCT00410410|460218105|FG006|Induction Period (IP)|Lost to Follow-up|0|||
127889422|NCT00410410|460218106|FG007|Induction Period (IP)|Lost to Follow-up|0|||
127724593|NCT00484198|459618984|FG003|Overall Study|Participant Withdrew Consent|59|||
127724594|NCT00484198|459618981|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
127724595|NCT00484198|459618982|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
127724596|NCT00484198|459618983|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
127724597|NCT00484198|459618984|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
127724598|NCT00484198|459618981|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
127724599|NCT00484198|459618982|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
127724600|NCT00484198|459618983|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
127724601|NCT00484198|459618984|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
127724602|NCT00484198|459618981|FG000|Overall Study|Adverse Event|3|||
127724603|NCT00484198|459618982|FG001|Overall Study|Adverse Event|11|||
127724604|NCT00484198|459618983|FG002|Overall Study|Adverse Event|32|||
127724605|NCT00484198|459618984|FG003|Overall Study|Adverse Event|31|||
127724606|NCT00484198|459618981|FG000|Overall Study|Protocol Violation|0|||
127724607|NCT00484198|459618982|FG001|Overall Study|Protocol Violation|5|||
127724608|NCT00484198|459618983|FG002|Overall Study|Protocol Violation|6|||
127724609|NCT00484198|459618984|FG003|Overall Study|Protocol Violation|8|||
127724610|NCT00484198|459618981|FG000|Overall Study|Other|7|||
127724611|NCT00484198|459618982|FG001|Overall Study|Other|10|||
127724612|NCT00484198|459618983|FG002|Overall Study|Other|31|||
127724613|NCT00484198|459618984|FG003|Overall Study|Other|28|||
127724614|NCT03340961|459618985|FG000|Overall Study|Adverse Event|1|||
127724615|NCT03340961|459618986|FG001|Overall Study|Adverse Event|3|||
127724616|NCT03340961|459618987|FG002|Overall Study|Adverse Event|2|||
127724617|NCT03340961|459618988|FG003|Overall Study|Adverse Event|4|||
127724618|NCT03340961|459618985|FG000|Overall Study|Lost to Follow-up|0|||
127724619|NCT03340961|459618986|FG001|Overall Study|Lost to Follow-up|1|||
127724620|NCT03340961|459618987|FG002|Overall Study|Lost to Follow-up|0|||
127724621|NCT03340961|459618988|FG003|Overall Study|Lost to Follow-up|1|||
127724622|NCT03340961|459618985|FG000|Overall Study|Withdrawal by Subject|3|||
127724623|NCT03340961|459618986|FG001|Overall Study|Withdrawal by Subject|2|||
127724624|NCT03340961|459618987|FG002|Overall Study|Withdrawal by Subject|4|||
127724625|NCT03340961|459618988|FG003|Overall Study|Withdrawal by Subject|7|||
127724626|NCT03340961|459618985|FG000|Overall Study|Use of prohibited treatment|0|||
127724627|NCT03340961|459618986|FG001|Overall Study|Use of prohibited treatment|3|||
127724628|NCT03340961|459618987|FG002|Overall Study|Use of prohibited treatment|2|||
127724629|NCT03340961|459618988|FG003|Overall Study|Use of prohibited treatment|4|||
127724630|NCT03340961|459618985|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
127724631|NCT03340961|459618986|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
127724632|NCT03340961|459618987|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
127724633|NCT03340961|459618988|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
127724634|NCT03340961|459618985|FG000|Overall Study|Subject developed an exclusion criterion|0|||
127724635|NCT03340961|459618986|FG001|Overall Study|Subject developed an exclusion criterion|1|||
127724636|NCT03340961|459618987|FG002|Overall Study|Subject developed an exclusion criterion|0|||
127724637|NCT03340961|459618988|FG003|Overall Study|Subject developed an exclusion criterion|0|||
127724638|NCT03340961|459618985|FG000|Overall Study|Protocol Violation|1|||
127724639|NCT03340961|459618986|FG001|Overall Study|Protocol Violation|0|||
127724640|NCT03340961|459618987|FG002|Overall Study|Protocol Violation|1|||
127724641|NCT03340961|459618988|FG003|Overall Study|Protocol Violation|0|||
127724642|NCT03340961|459618985|FG000|Overall Study|Adverse Event|1|||
127724643|NCT03340961|459618986|FG001|Overall Study|Adverse Event|1|||
127724644|NCT03340961|459618987|FG002|Overall Study|Adverse Event|0|||
127724645|NCT03340961|459618988|FG003|Overall Study|Adverse Event|0|||
127724646|NCT03340961|459618985|FG000|Overall Study|Lack of Efficacy|0|||
127724647|NCT03340961|459618986|FG001|Overall Study|Lack of Efficacy|0|||
127724648|NCT03340961|459618987|FG002|Overall Study|Lack of Efficacy|0|||
127724649|NCT03340961|459618988|FG003|Overall Study|Lack of Efficacy|1|||
127724650|NCT01853384|459618989|FG000|Randomized|Adverse Event|5|||
127724651|NCT01853384|459618990|FG001|Randomized|Adverse Event|3|||
127724652|NCT01853384|459618989|FG000|Randomized|Death|1|||
127724653|NCT01853384|459618990|FG001|Randomized|Death|2|||
127724654|NCT01853384|459618989|FG000|Randomized|Lost to Follow-up|1|||
127724655|NCT01853384|459618990|FG001|Randomized|Lost to Follow-up|1|||
127724656|NCT01853384|459618989|FG000|Randomized|Withdrawal by Subject|5|||
127724657|NCT01853384|459618990|FG001|Randomized|Withdrawal by Subject|3|||
127724658|NCT01853384|459618989|FG000|Randomized|Sponsor Decision|47|||
127889423|NCT00410410|460218107|FG008|Induction Period (IP)|Lost to Follow-up|0|||
127724659|NCT01853384|459618990|FG001|Randomized|Sponsor Decision|34|||
127724660|NCT01853384|459618989|FG000|Randomized|Other|3|||
127724661|NCT01853384|459618990|FG001|Randomized|Other|3|||
127724662|NCT01853384|459618989|FG000|Completed Follow up Visit 1|Early Termination|13|||
127724663|NCT01853384|459618990|FG001|Completed Follow up Visit 1|Early Termination|9|||
127724664|NCT01853384|459618989|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
127724665|NCT01853384|459618990|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
127724666|NCT01853384|459618989|FG000|Completed Follow up Visit 2|Adverse Event|1|||
127724667|NCT01853384|459618990|FG001|Completed Follow up Visit 2|Adverse Event|0|||
127724668|NCT01853384|459618989|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
127724669|NCT01853384|459618990|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
127724670|NCT01853384|459618989|FG000|Completed Follow up Visit 2|Death|1|||
127724671|NCT01853384|459618990|FG001|Completed Follow up Visit 2|Death|0|||
127724672|NCT01853384|459618989|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
127724673|NCT01853384|459618990|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
127724674|NCT01205126|459618991|FG000|Titration Phase|Adverse Event|5|||
127724675|NCT01205126|459618992|FG001|Titration Phase|Adverse Event|3|||
127724676|NCT01205126|459618991|FG000|Titration Phase|Withdrawal by Subject|5|||
127724677|NCT01205126|459618992|FG001|Titration Phase|Withdrawal by Subject|5|||
127724678|NCT01205126|459618991|FG000|Titration Phase|Lost to Follow-up|2|||
127724679|NCT01205126|459618992|FG001|Titration Phase|Lost to Follow-up|2|||
127724680|NCT01205126|459618991|FG000|Titration Phase|No stable titration dose|1|||
127724681|NCT01205126|459618992|FG001|Titration Phase|No stable titration dose|0|||
127724682|NCT01205126|459618991|FG000|Titration Phase|More than maximum dosage required|2|||
127724683|NCT01205126|459618992|FG001|Titration Phase|More than maximum dosage required|3|||
127724684|NCT01205126|459618991|FG000|Titration Phase|Other|8|||
127724685|NCT01205126|459618992|FG001|Titration Phase|Other|6|||
127724686|NCT01205126|459618991|FG000|Between Titration & Maintenance Phase|Other|0|||
127724687|NCT01205126|459618992|FG001|Between Titration & Maintenance Phase|Other|4|||
127724688|NCT01205126|459618991|FG000|Maintenance Phase|Adverse Event|3|||
127724689|NCT01205126|459618992|FG001|Maintenance Phase|Adverse Event|7|||
127724690|NCT01205126|459618991|FG000|Maintenance Phase|Death|4|||
127724691|NCT01205126|459618992|FG001|Maintenance Phase|Death|4|||
127724692|NCT01205126|459618991|FG000|Maintenance Phase|More than the maximum dosage required|5|||
127724693|NCT01205126|459618992|FG001|Maintenance Phase|More than the maximum dosage required|5|||
127724694|NCT01205126|459618991|FG000|Maintenance Phase|Prohibited drugs used|1|||
127724695|NCT01205126|459618992|FG001|Maintenance Phase|Prohibited drugs used|0|||
127724696|NCT01205126|459618991|FG000|Maintenance Phase|Other|11|||
127724697|NCT01205126|459618992|FG001|Maintenance Phase|Other|8|||
127724698|NCT01205126|459618991|FG000|Maintenance Phase|Lost to Follow-up|5|||
127724699|NCT01205126|459618992|FG001|Maintenance Phase|Lost to Follow-up|5|||
127724700|NCT01205126|459618991|FG000|Maintenance Phase|Withdrawal by Subject|8|||
127724701|NCT01205126|459618992|FG001|Maintenance Phase|Withdrawal by Subject|11|||
127724702|NCT00486954|459618993|FG000|Pilot Part|Adverse Event|4|||
127724703|NCT00486954|459618994|FG001|Pilot Part|Adverse Event|0|||
127724704|NCT00486954|459618995|FG002|Pilot Part|Adverse Event|5|||
127724705|NCT00486954|459618996|FG003|Pilot Part|Adverse Event|0|||
127724706|NCT00486954|459618997|FG004|Pilot Part|Adverse Event|0|||
127724707|NCT00486954|459618993|FG000|Pilot Part|Disease Progression|2|||
127724708|NCT00486954|459618994|FG001|Pilot Part|Disease Progression|0|||
127724709|NCT00486954|459618995|FG002|Pilot Part|Disease Progression|1|||
127724710|NCT00486954|459618996|FG003|Pilot Part|Disease Progression|0|||
127724711|NCT00486954|459618997|FG004|Pilot Part|Disease Progression|0|||
127724712|NCT00486954|459618993|FG000|Randomized Part|Lost to Follow-up|0|||
127724713|NCT00486954|459618994|FG001|Randomized Part|Lost to Follow-up|0|||
127724714|NCT00486954|459618995|FG002|Randomized Part|Lost to Follow-up|0|||
127724715|NCT00486954|459618996|FG003|Randomized Part|Lost to Follow-up|0|||
127724716|NCT00486954|459618997|FG004|Randomized Part|Lost to Follow-up|1|||
127724717|NCT00486954|459618993|FG000|Randomized Part|Withdrawal by Subject|0|||
127724718|NCT00486954|459618994|FG001|Randomized Part|Withdrawal by Subject|0|||
127724719|NCT00486954|459618995|FG002|Randomized Part|Withdrawal by Subject|0|||
127724720|NCT00486954|459618996|FG003|Randomized Part|Withdrawal by Subject|1|||
127724721|NCT00486954|459618997|FG004|Randomized Part|Withdrawal by Subject|0|||
127724722|NCT00486954|459618993|FG000|Randomized Part|Sponsor Terminated Study|0|||
127724723|NCT00486954|459618994|FG001|Randomized Part|Sponsor Terminated Study|0|||
127724724|NCT00486954|459618995|FG002|Randomized Part|Sponsor Terminated Study|0|||
127724725|NCT00486954|459618996|FG003|Randomized Part|Sponsor Terminated Study|19|||
127724726|NCT00486954|459618997|FG004|Randomized Part|Sponsor Terminated Study|13|||
127724727|NCT00638456|459619000|FG000|Overall Study|Withdrawal by Subject|6|||
127724728|NCT00638456|459619001|FG001|Overall Study|Withdrawal by Subject|2|||
127724729|NCT03236779|459619002|FG000|Overall Study|Lost to Follow-up|13|||
127724730|NCT03236779|459619003|FG001|Overall Study|Lost to Follow-up|21|||
127724731|NCT00805792|459619004|FG000|Overall Study|Death|3|||
127724732|NCT00805792|459619004|FG000|Overall Study|Lost to Follow-up|2|||
127724733|NCT01836523|459619005|FG000|Overall Study|Adverse Event|15|||
127724734|NCT01836523|459619006|FG001|Overall Study|Adverse Event|41|||
127724735|NCT01836523|459619007|FG002|Overall Study|Adverse Event|49|||
127724736|NCT01836523|459619008|FG003|Overall Study|Adverse Event|14|||
127724737|NCT01836523|459619005|FG000|Overall Study|Protocol Violation|6|||
127724738|NCT01836523|459619006|FG001|Overall Study|Protocol Violation|3|||
127724739|NCT01836523|459619007|FG002|Overall Study|Protocol Violation|2|||
127724740|NCT01836523|459619008|FG003|Overall Study|Protocol Violation|4|||
127724741|NCT01836523|459619005|FG000|Overall Study|Met Withdrawal Criteria|13|||
127724742|NCT01836523|459619006|FG001|Overall Study|Met Withdrawal Criteria|13|||
127724743|NCT01836523|459619007|FG002|Overall Study|Met Withdrawal Criteria|21|||
127724744|NCT01836523|459619008|FG003|Overall Study|Met Withdrawal Criteria|27|||
127724745|NCT01836523|459619005|FG000|Overall Study|Unclassified|17|||
127724746|NCT01836523|459619006|FG001|Overall Study|Unclassified|28|||
127724747|NCT01836523|459619007|FG002|Overall Study|Unclassified|19|||
127724748|NCT01836523|459619008|FG003|Overall Study|Unclassified|29|||
127724749|NCT00813709|459619010|FG000|Double Blind Period|Adverse Event|4|||
127724750|NCT00813709|459619011|FG001|Double Blind Period|Adverse Event|1|||
127724751|NCT00813709|459619012|FG002|Double Blind Period|Adverse Event|4|||
127724752|NCT00813709|459619013|FG003|Double Blind Period|Adverse Event|0|||
127724753|NCT00813709|459619014|FG004|Double Blind Period|Adverse Event|0|||
127724754|NCT00813709|459619015|FG005|Double Blind Period|Adverse Event|0|||
127724755|NCT00813709|459619010|FG000|Double Blind Period|Lost to Follow-up|3|||
127724756|NCT00813709|459619011|FG001|Double Blind Period|Lost to Follow-up|2|||
127889424|NCT00410410|460218099|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
127889425|NCT00410410|460218100|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
127889426|NCT00410410|460218101|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
127889427|NCT00410410|460218102|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
127724757|NCT00813709|459619012|FG002|Double Blind Period|Lost to Follow-up|2|||
127724758|NCT00813709|459619013|FG003|Double Blind Period|Lost to Follow-up|0|||
127724759|NCT00813709|459619014|FG004|Double Blind Period|Lost to Follow-up|0|||
127724760|NCT00813709|459619015|FG005|Double Blind Period|Lost to Follow-up|0|||
127724761|NCT00813709|459619010|FG000|Double Blind Period|Switched to open label phase|9|||
127724762|NCT00813709|459619011|FG001|Double Blind Period|Switched to open label phase|26|||
127724763|NCT00813709|459619012|FG002|Double Blind Period|Switched to open label phase|18|||
127724764|NCT00813709|459619013|FG003|Double Blind Period|Switched to open label phase|0|||
127724765|NCT00813709|459619014|FG004|Double Blind Period|Switched to open label phase|0|||
127724766|NCT00813709|459619015|FG005|Double Blind Period|Switched to open label phase|0|||
127724767|NCT00813709|459619010|FG000|Double Blind Period|Randomized but not treated|1|||
127724768|NCT00813709|459619011|FG001|Double Blind Period|Randomized but not treated|3|||
127724769|NCT00813709|459619012|FG002|Double Blind Period|Randomized but not treated|1|||
127724770|NCT00813709|459619013|FG003|Double Blind Period|Randomized but not treated|0|||
127724771|NCT00813709|459619014|FG004|Double Blind Period|Randomized but not treated|0|||
127724772|NCT00813709|459619015|FG005|Double Blind Period|Randomized but not treated|0|||
127724773|NCT00813709|459619010|FG000|Double Blind Period|Other|14|||
127889428|NCT00410410|460218103|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
127889429|NCT00410410|460218104|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
127724774|NCT00813709|459619011|FG001|Double Blind Period|Other|9|||
127724775|NCT00813709|459619012|FG002|Double Blind Period|Other|6|||
127724776|NCT00813709|459619013|FG003|Double Blind Period|Other|0|||
127724777|NCT00813709|459619014|FG004|Double Blind Period|Other|0|||
127724778|NCT00813709|459619015|FG005|Double Blind Period|Other|0|||
127724779|NCT00813709|459619010|FG000|Open Label Period|Adverse Event|0|||
127724780|NCT00813709|459619011|FG001|Open Label Period|Adverse Event|0|||
127724781|NCT00813709|459619012|FG002|Open Label Period|Adverse Event|0|||
127724782|NCT00813709|459619013|FG003|Open Label Period|Adverse Event|5|||
127724783|NCT00813709|459619014|FG004|Open Label Period|Adverse Event|4|||
127724784|NCT00813709|459619015|FG005|Open Label Period|Adverse Event|3|||
127724785|NCT00813709|459619010|FG000|Open Label Period|Lack of Efficacy|0|||
127724786|NCT00813709|459619011|FG001|Open Label Period|Lack of Efficacy|0|||
127724787|NCT00813709|459619012|FG002|Open Label Period|Lack of Efficacy|0|||
127724788|NCT00813709|459619013|FG003|Open Label Period|Lack of Efficacy|3|||
127724789|NCT00813709|459619014|FG004|Open Label Period|Lack of Efficacy|1|||
127724790|NCT00813709|459619015|FG005|Open Label Period|Lack of Efficacy|1|||
127724791|NCT00813709|459619010|FG000|Open Label Period|Randomized but not treated|0|||
127724792|NCT00813709|459619011|FG001|Open Label Period|Randomized but not treated|0|||
127724793|NCT00813709|459619012|FG002|Open Label Period|Randomized but not treated|0|||
127724794|NCT00813709|459619013|FG003|Open Label Period|Randomized but not treated|1|||
127724795|NCT00813709|459619014|FG004|Open Label Period|Randomized but not treated|0|||
127724796|NCT00813709|459619015|FG005|Open Label Period|Randomized but not treated|1|||
127724797|NCT00813709|459619010|FG000|Open Label Period|Other|0|||
127724798|NCT00813709|459619011|FG001|Open Label Period|Other|0|||
127724799|NCT00813709|459619012|FG002|Open Label Period|Other|0|||
127724800|NCT00813709|459619013|FG003|Open Label Period|Other|11|||
127724801|NCT00813709|459619014|FG004|Open Label Period|Other|5|||
127724802|NCT00813709|459619015|FG005|Open Label Period|Other|6|||
127724803|NCT02753075|459619016|FG000|Overall Study|Adverse Event|2|||
127724804|NCT02753075|459619017|FG001|Overall Study|Adverse Event|1|||
127724805|NCT02753075|459619018|FG002|Overall Study|Adverse Event|0|||
127724806|NCT02753075|459619016|FG000|Overall Study|Lost to Follow-up|2|||
127724807|NCT02753075|459619017|FG001|Overall Study|Lost to Follow-up|0|||
127724808|NCT02753075|459619018|FG002|Overall Study|Lost to Follow-up|0|||
127724809|NCT02753075|459619016|FG000|Overall Study|Withdrawal of Consent|1|||
127724810|NCT02753075|459619017|FG001|Overall Study|Withdrawal of Consent|1|||
127724811|NCT02753075|459619018|FG002|Overall Study|Withdrawal of Consent|3|||
127724812|NCT02753075|459619016|FG000|Overall Study|Physician Decision|3|||
127724813|NCT02753075|459619017|FG001|Overall Study|Physician Decision|1|||
127724814|NCT02753075|459619018|FG002|Overall Study|Physician Decision|0|||
127724815|NCT02245620|459619019|FG000|Overall Study|Physician Decision|1|||
127724816|NCT02245620|459619020|FG001|Overall Study|Physician Decision|1|||
127724817|NCT01102426|459619021|FG000|Overall Study|Randomized but not treated|4|||
127724818|NCT01102426|459619022|FG001|Overall Study|Randomized but not treated|1|||
127724819|NCT01102426|459619021|FG000|Overall Study|Adverse Events (treatment-related)|15|||
127724820|NCT01102426|459619022|FG001|Overall Study|Adverse Events (treatment-related)|8|||
127724821|NCT01102426|459619021|FG000|Overall Study|Physician Decision|9|||
127724822|NCT01102426|459619022|FG001|Overall Study|Physician Decision|6|||
127724823|NCT01102426|459619021|FG000|Overall Study|Progressive Disease|85|||
127724824|NCT01102426|459619022|FG001|Overall Study|Progressive Disease|44|||
127724825|NCT01102426|459619021|FG000|Overall Study|Adverse Events (unrelated to|9|||
127724826|NCT01102426|459619022|FG001|Overall Study|Adverse Events (unrelated to|1|||
127724827|NCT01102426|459619021|FG000|Overall Study|Patient Refusal|24|||
127724828|NCT01102426|459619022|FG001|Overall Study|Patient Refusal|12|||
127724829|NCT01102426|459619021|FG000|Overall Study|Death (due to adverse events|0|||
127724830|NCT01102426|459619022|FG001|Overall Study|Death (due to adverse events|1|||
127724831|NCT01102426|459619021|FG000|Overall Study|Death (non-related to the study|19|||
127724832|NCT01102426|459619022|FG001|Overall Study|Death (non-related to the study|8|||
127724833|NCT04361617|459619023|FG000|Overall Study|Withdrawal by Subject|0|||
127724834|NCT04361617|459619024|FG001|Overall Study|Withdrawal by Subject|1|||
127724835|NCT03265132|459619031|FG000|Overall Study|Adverse Event|0|||
127724836|NCT03265132|459619032|FG001|Overall Study|Adverse Event|1|||
127724837|NCT03265132|459619031|FG000|Overall Study|Lack of Efficacy|0|||
127724838|NCT03265132|459619032|FG001|Overall Study|Lack of Efficacy|2|||
127724839|NCT03265132|459619031|FG000|Overall Study|Progressive disease|0|||
127724840|NCT03265132|459619032|FG001|Overall Study|Progressive disease|2|||
127724841|NCT03265132|459619031|FG000|Overall Study|Withdrawal by Subject|0|||
127724842|NCT03265132|459619032|FG001|Overall Study|Withdrawal by Subject|1|||
127724843|NCT01137682|459619033|FG000|Overall Study|Adverse Event-CORE|2|||
127724844|NCT01137682|459619034|FG001|Overall Study|Adverse Event-CORE|4|||
127724845|NCT01137682|459619035|FG002|Overall Study|Adverse Event-CORE|0|||
127724846|NCT01137682|459619033|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
127889430|NCT00410410|460218105|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
127724847|NCT01137682|459619034|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
127724848|NCT01137682|459619035|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
127724849|NCT01137682|459619033|FG000|Overall Study|Administrative problems-CORE|2|||
127724850|NCT01137682|459619034|FG001|Overall Study|Administrative problems-CORE|1|||
127724851|NCT01137682|459619035|FG002|Overall Study|Administrative problems-CORE|0|||
127724852|NCT01137682|459619033|FG000|Overall Study|Protocol Violation-CORE|0|||
127724853|NCT01137682|459619034|FG001|Overall Study|Protocol Violation-CORE|1|||
127724854|NCT01137682|459619035|FG002|Overall Study|Protocol Violation-CORE|1|||
127724855|NCT01137682|459619033|FG000|Overall Study|Adverse Event-Extension|4|||
127724856|NCT01137682|459619034|FG001|Overall Study|Adverse Event-Extension|8|||
127724857|NCT01137682|459619035|FG002|Overall Study|Adverse Event-Extension|7|||
127724858|NCT01137682|459619033|FG000|Overall Study|Lack of Efficacy-Extension|15|||
127724859|NCT01137682|459619034|FG001|Overall Study|Lack of Efficacy-Extension|9|||
127724860|NCT01137682|459619035|FG002|Overall Study|Lack of Efficacy-Extension|13|||
127724861|NCT01137682|459619033|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
127724862|NCT01137682|459619034|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
127724863|NCT01137682|459619035|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
127724864|NCT01137682|459619033|FG000|Overall Study|Lost to Follow Up-Extension|0|||
127724865|NCT01137682|459619034|FG001|Overall Study|Lost to Follow Up-Extension|1|||
127889431|NCT00410410|460218106|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
127889432|NCT00410410|460218107|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
127889433|NCT00410410|460218099|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
127889434|NCT00410410|460218100|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
127889435|NCT00410410|460218101|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
127889436|NCT00410410|460218102|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
127889437|NCT00410410|460218103|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
127889438|NCT00410410|460218104|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
127889439|NCT00410410|460218105|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
127889440|NCT00410410|460218106|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
127889441|NCT00410410|460218107|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
127889442|NCT00410410|460218099|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
127889443|NCT00410410|460218100|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
127889444|NCT00410410|460218101|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
127889445|NCT00410410|460218102|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
127889446|NCT00410410|460218103|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
127889447|NCT00410410|460218104|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
127889448|NCT00410410|460218105|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
127889449|NCT00410410|460218106|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
127889450|NCT00410410|460218107|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
127889451|NCT00410410|460218099|FG000|Induction Period (IP)|Other|0|||
127889452|NCT00410410|460218100|FG001|Induction Period (IP)|Other|0|||
127889453|NCT00410410|460218101|FG002|Induction Period (IP)|Other|1|||
127889454|NCT00410410|460218102|FG003|Induction Period (IP)|Other|0|||
127889455|NCT00410410|460218103|FG004|Induction Period (IP)|Other|0|||
127724866|NCT01137682|459619035|FG002|Overall Study|Lost to Follow Up-Extension|0|||
127724867|NCT01137682|459619033|FG000|Overall Study|Administrative problems-Extension|0|||
127724868|NCT01137682|459619034|FG001|Overall Study|Administrative problems-Extension|2|||
127724869|NCT01137682|459619035|FG002|Overall Study|Administrative problems-Extension|0|||
127724870|NCT01137682|459619033|FG000|Overall Study|Death-Extension|2|||
127724871|NCT01137682|459619034|FG001|Overall Study|Death-Extension|0|||
127724872|NCT01137682|459619035|FG002|Overall Study|Death-Extension|0|||
127724873|NCT01137682|459619033|FG000|Overall Study|Protocol Violation-Extension|2|||
127724874|NCT01137682|459619034|FG001|Overall Study|Protocol Violation-Extension|1|||
127724875|NCT01137682|459619035|FG002|Overall Study|Protocol Violation-Extension|0|||
127724876|NCT01137682|459619033|FG000|Overall Study|Did not enter extension|2|||
127724877|NCT01137682|459619034|FG001|Overall Study|Did not enter extension|3|||
127724878|NCT01137682|459619035|FG002|Overall Study|Did not enter extension|2|||
127724879|NCT01137682|459619033|FG000|Overall Study|Did not receive treatment in extension|0|||
127724880|NCT01137682|459619034|FG001|Overall Study|Did not receive treatment in extension|0|||
127724881|NCT01137682|459619035|FG002|Overall Study|Did not receive treatment in extension|1|||
127724882|NCT04617847|459619037|FG000|Overall Study|Withdrawal by Subject|1|||
127724883|NCT04617847|459619038|FG001|Overall Study|Withdrawal by Subject|0|||
127724884|NCT04617847|459619037|FG000|Overall Study|Adverse Event|0|||
127724885|NCT04617847|459619038|FG001|Overall Study|Adverse Event|2|||
127724886|NCT04617847|459619037|FG000|Overall Study|Death|0|||
127724887|NCT04617847|459619038|FG001|Overall Study|Death|1|||
127889456|NCT00410410|460218104|FG005|Induction Period (IP)|Other|0|||
127889457|NCT00410410|460218105|FG006|Induction Period (IP)|Other|0|||
127889458|NCT00410410|460218106|FG007|Induction Period (IP)|Other|0|||
127889459|NCT00410410|460218107|FG008|Induction Period (IP)|Other|0|||
127724888|NCT04617847|459619037|FG000|Overall Study|Termination of Study by Sponsor|2|||
127724889|NCT04617847|459619038|FG001|Overall Study|Termination of Study by Sponsor|21|||
127724890|NCT00244751|459619039|FG000|Overall Study|Adverse Event|7|||
127724891|NCT00244751|459619040|FG001|Overall Study|Adverse Event|7|||
127724892|NCT00244751|459619041|FG002|Overall Study|Adverse Event|5|||
127724893|NCT00244751|459619039|FG000|Overall Study|Lost to Follow-up|0|||
127724894|NCT00244751|459619040|FG001|Overall Study|Lost to Follow-up|1|||
127724895|NCT00244751|459619041|FG002|Overall Study|Lost to Follow-up|0|||
127724896|NCT00244751|459619039|FG000|Overall Study|Protocol Violation|1|||
127724897|NCT00244751|459619040|FG001|Overall Study|Protocol Violation|0|||
127724898|NCT00244751|459619041|FG002|Overall Study|Protocol Violation|1|||
127724899|NCT00244751|459619039|FG000|Overall Study|Withdrawal by Subject|7|||
127724900|NCT00244751|459619040|FG001|Overall Study|Withdrawal by Subject|5|||
127724901|NCT00244751|459619041|FG002|Overall Study|Withdrawal by Subject|3|||
127724902|NCT00244751|459619039|FG000|Overall Study|Elevated liver enzymes|1|||
127724903|NCT00244751|459619040|FG001|Overall Study|Elevated liver enzymes|0|||
127724904|NCT00244751|459619041|FG002|Overall Study|Elevated liver enzymes|0|||
127724905|NCT00244751|459619039|FG000|Overall Study|Lack of compliance with protocol|0|||
127724906|NCT00244751|459619040|FG001|Overall Study|Lack of compliance with protocol|1|||
127724907|NCT00244751|459619041|FG002|Overall Study|Lack of compliance with protocol|0|||
127724908|NCT00244751|459619039|FG000|Overall Study|Safety reasons|0|||
127724909|NCT00244751|459619040|FG001|Overall Study|Safety reasons|1|||
127724910|NCT00244751|459619041|FG002|Overall Study|Safety reasons|0|||
127724911|NCT00244751|459619039|FG000|Overall Study|Participant randomized by mistake|0|||
127724912|NCT00244751|459619040|FG001|Overall Study|Participant randomized by mistake|0|||
127724913|NCT00244751|459619041|FG002|Overall Study|Participant randomized by mistake|1|||
127724914|NCT01262456|459619043|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
127724915|NCT01262456|459619044|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
127724916|NCT01262456|459619045|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
127724917|NCT01262456|459619043|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
127724918|NCT01262456|459619044|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
127724919|NCT01262456|459619045|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
127724920|NCT01262456|459619043|FG000|3-Month Double-Blind Period|Adverse Event|6|||
127724921|NCT01262456|459619044|FG001|3-Month Double-Blind Period|Adverse Event|4|||
127724922|NCT01262456|459619045|FG002|3-Month Double-Blind Period|Adverse Event|8|||
127724923|NCT01262456|459619043|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
127724924|NCT01262456|459619044|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
127724925|NCT01262456|459619045|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
127724926|NCT01262456|459619043|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
127724927|NCT01262456|459619044|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
127724928|NCT01262456|459619045|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
127724929|NCT01262456|459619043|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
127724930|NCT01262456|459619044|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
127724931|NCT01262456|459619045|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
127724932|NCT01262456|459619043|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
127724933|NCT01262456|459619044|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
127724934|NCT01262456|459619045|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
127724935|NCT01262456|459619043|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
127724936|NCT01262456|459619044|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
127724937|NCT01262456|459619045|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
127724938|NCT01262456|459619043|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
127724939|NCT01262456|459619044|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
127724940|NCT01262456|459619045|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
127724941|NCT04085614|459619046|FG000|Overall Study|Protocol Violation|9|||
127724942|NCT04085614|459619047|FG001|Overall Study|Protocol Violation|6|||
127724943|NCT02399449|459619048|FG000|Overall Study|Withdrawal by Subject|3|||
127724944|NCT02399449|459619049|FG001|Overall Study|Withdrawal by Subject|9|||
127724945|NCT02399449|459619048|FG000|Overall Study|Physician Decision|0|||
127724946|NCT02399449|459619049|FG001|Overall Study|Physician Decision|1|||
127724947|NCT02516202|459619050|FG000|Overall Study|Withdrawal by Subject|1|||
127724948|NCT02516202|459619051|FG001|Overall Study|Withdrawal by Subject|0|||
127724949|NCT02516202|459619052|FG002|Overall Study|Withdrawal by Subject|1|||
127724950|NCT02516202|459619050|FG000|Overall Study|Lost to Follow-up|1|||
127724951|NCT02516202|459619051|FG001|Overall Study|Lost to Follow-up|1|||
127724952|NCT02516202|459619052|FG002|Overall Study|Lost to Follow-up|1|||
127724953|NCT02516202|459619050|FG000|Overall Study|Stopped Follow-up|0|||
127724954|NCT02516202|459619051|FG001|Overall Study|Stopped Follow-up|0|||
127724955|NCT02516202|459619052|FG002|Overall Study|Stopped Follow-up|1|||
127724956|NCT00337610|459619053|FG000|Overall Study|Adverse Event|2|||
127724957|NCT00337610|459619054|FG001|Overall Study|Adverse Event|2|||
127724958|NCT00337610|459619053|FG000|Overall Study|Death|0|||
127724959|NCT00337610|459619054|FG001|Overall Study|Death|1|||
127724960|NCT00337610|459619053|FG000|Overall Study|Lack of Efficacy|6|||
127724961|NCT00337610|459619054|FG001|Overall Study|Lack of Efficacy|3|||
127724962|NCT00337610|459619053|FG000|Overall Study|Lost to Follow-up|3|||
127724963|NCT00337610|459619054|FG001|Overall Study|Lost to Follow-up|3|||
127724964|NCT00337610|459619053|FG000|Overall Study|Withdrawal by Subject|6|||
127724965|NCT00337610|459619054|FG001|Overall Study|Withdrawal by Subject|5|||
127724966|NCT04867382|459619061|FG000|Overall Study|Did not complete the survey|2|||
127724967|NCT04867382|459619062|FG001|Overall Study|Did not complete the survey|1|||
127724968|NCT05445557|459619066|FG000|Double Blind Part|Lost to Follow-up|1|||
127724969|NCT02008916|459619067|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
127724970|NCT02008916|459619068|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
127724971|NCT02008916|459619069|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
127724972|NCT02008916|459619067|FG000|Week 16 - 156|Adverse Event|4|||
127724973|NCT02008916|459619068|FG001|Week 16 - 156|Adverse Event|2|||
127724974|NCT02008916|459619069|FG002|Week 16 - 156|Adverse Event|3|||
127724975|NCT02008916|459619067|FG000|Week 16 - 156|Withdrawal by Subject|7|||
127724976|NCT02008916|459619068|FG001|Week 16 - 156|Withdrawal by Subject|3|||
127724977|NCT02008916|459619069|FG002|Week 16 - 156|Withdrawal by Subject|5|||
127724978|NCT02008916|459619067|FG000|Week 16 - 156|No longer requires treatment|0|||
127724979|NCT02008916|459619068|FG001|Week 16 - 156|No longer requires treatment|1|||
127724980|NCT02008916|459619069|FG002|Week 16 - 156|No longer requires treatment|0|||
127724981|NCT02008916|459619067|FG000|Week 16 - 156|Lost to Follow-up|5|||
127724982|NCT02008916|459619068|FG001|Week 16 - 156|Lost to Follow-up|0|||
127724983|NCT02008916|459619069|FG002|Week 16 - 156|Lost to Follow-up|0|||
127724984|NCT02008916|459619067|FG000|Week 16 - 156|Lack of Efficacy|3|||
127724985|NCT02008916|459619068|FG001|Week 16 - 156|Lack of Efficacy|5|||
127724986|NCT02008916|459619069|FG002|Week 16 - 156|Lack of Efficacy|2|||
127724987|NCT02008916|459619067|FG000|Week 16 - 156|Pregnancy|0|||
127724988|NCT02008916|459619068|FG001|Week 16 - 156|Pregnancy|1|||
127724989|NCT02008916|459619069|FG002|Week 16 - 156|Pregnancy|0|||
127724990|NCT02008916|459619067|FG000|Week 16 - 156|Physician Decision|0|||
127724991|NCT02008916|459619068|FG001|Week 16 - 156|Physician Decision|1|||
127724992|NCT02008916|459619069|FG002|Week 16 - 156|Physician Decision|0|||
127724993|NCT03803475|459619070|FG000|Overall Study|Physician Decision|1|||
127724994|NCT00392197|459619076|FG000|Overall Study|Adverse Event|4|||
127724995|NCT00392197|459619077|FG001|Overall Study|Adverse Event|12|||
127724996|NCT00392197|459619076|FG000|Overall Study|Lack of Efficacy|3|||
127724997|NCT00392197|459619077|FG001|Overall Study|Lack of Efficacy|4|||
127724998|NCT00392197|459619076|FG000|Overall Study|Lost to Follow-up|0|||
127724999|NCT00392197|459619077|FG001|Overall Study|Lost to Follow-up|1|||
127725000|NCT00392197|459619076|FG000|Overall Study|Physician Decision|3|||
127725001|NCT00392197|459619077|FG001|Overall Study|Physician Decision|2|||
127725002|NCT00392197|459619076|FG000|Overall Study|Protocol Violation|7|||
127725003|NCT00392197|459619077|FG001|Overall Study|Protocol Violation|5|||
127725004|NCT00392197|459619076|FG000|Overall Study|Withdrawal by Subject|4|||
127725005|NCT00392197|459619077|FG001|Overall Study|Withdrawal by Subject|6|||
127725006|NCT01156675|459619078|FG000|Overall Study|Death|5|||
127725007|NCT01156675|459619079|FG001|Overall Study|Death|3|||
127725008|NCT01156675|459619080|FG002|Overall Study|Death|0|||
127725009|NCT01156675|459619078|FG000|Overall Study|No data|29|||
127725010|NCT01156675|459619079|FG001|Overall Study|No data|22|||
127725011|NCT01156675|459619080|FG002|Overall Study|No data|2|||
127725012|NCT01079949|459619096|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
127725013|NCT01079949|459619097|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
127725014|NCT01079949|459619096|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
127725015|NCT01079949|459619097|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
127725016|NCT01079949|459619096|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
127725017|NCT01079949|459619097|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
127725018|NCT01079949|459619096|FG000|Overall Study|Randomized but not treated|1|||
127725019|NCT01079949|459619097|FG001|Overall Study|Randomized but not treated|0|||
127725020|NCT02144285|459619098|FG000|Overall Study|Withdrawal by Subject|0|||
127725021|NCT02144285|459619099|FG001|Overall Study|Withdrawal by Subject|0|||
127725022|NCT02144285|459619100|FG002|Overall Study|Withdrawal by Subject|0|||
127725023|NCT02144285|459619101|FG003|Overall Study|Withdrawal by Subject|0|||
127725024|NCT02144285|459619102|FG004|Overall Study|Withdrawal by Subject|1|||
127725025|NCT02144285|459619103|FG005|Overall Study|Withdrawal by Subject|0|||
127725026|NCT02144285|459619104|FG006|Overall Study|Withdrawal by Subject|0|||
127725027|NCT02144285|459619105|FG007|Overall Study|Withdrawal by Subject|0|||
127725028|NCT02144285|459619106|FG008|Overall Study|Withdrawal by Subject|0|||
127725029|NCT02144285|459619107|FG009|Overall Study|Withdrawal by Subject|0|||
127725030|NCT01529632|459619108|FG000|Overall Study|Administrative problem|2|||
127725031|NCT01529632|459619109|FG001|Overall Study|Administrative problem|1|||
127725032|NCT01529632|459619108|FG000|Overall Study|Protocol Violation|0|||
127725033|NCT01529632|459619109|FG001|Overall Study|Protocol Violation|1|||
127725034|NCT01529632|459619108|FG000|Overall Study|Adverse Event|1|||
127725035|NCT01529632|459619109|FG001|Overall Study|Adverse Event|1|||
127725036|NCT03786471|459619110|FG000|Overall Study|Death|254|||
127725037|NCT03786471|459619111|FG001|Overall Study|Death|223|||
127725038|NCT03786471|459619112|FG002|Overall Study|Death|37|||
127725039|NCT03786471|459619110|FG000|Overall Study|Lost to Follow-up|63|||
127725040|NCT03786471|459619111|FG001|Overall Study|Lost to Follow-up|50|||
127725041|NCT03786471|459619112|FG002|Overall Study|Lost to Follow-up|15|||
127725042|NCT03786471|459619110|FG000|Overall Study|Withdrawal by Subject|99|||
127725043|NCT03786471|459619111|FG001|Overall Study|Withdrawal by Subject|81|||
127725044|NCT03786471|459619112|FG002|Overall Study|Withdrawal by Subject|11|||
127725045|NCT00747149|459620770|FG000|Overall Study|Adverse Event|0|||
127725046|NCT00747149|459620771|FG001|Overall Study|Adverse Event|15|||
127725047|NCT00747149|459620770|FG000|Overall Study|Lost to Follow-up|0|||
127725048|NCT00747149|459620771|FG001|Overall Study|Lost to Follow-up|10|||
127725049|NCT00747149|459620770|FG000|Overall Study|Withdrawal by Subject|0|||
127725050|NCT00747149|459620771|FG001|Overall Study|Withdrawal by Subject|6|||
127725051|NCT00747149|459620770|FG000|Overall Study|Did not receive treatment|0|||
127725052|NCT00747149|459620771|FG001|Overall Study|Did not receive treatment|1|||
127725053|NCT00747149|459620770|FG000|Overall Study|Incorrect enrollment|0|||
127725054|NCT00747149|459620771|FG001|Overall Study|Incorrect enrollment|6|||
127725055|NCT00747149|459620770|FG000|Overall Study|Severe non-compliance to protocol|0|||
127725056|NCT00747149|459620771|FG001|Overall Study|Severe non-compliance to protocol|1|||
127725057|NCT00747149|459620770|FG000|Overall Study|Not reported|1|||
127725058|NCT00747149|459620771|FG001|Overall Study|Not reported|4|||
127725059|NCT01276509|459620774|FG000|Overall Study|Adverse Event|9|||
127725060|NCT01276509|459620775|FG001|Overall Study|Adverse Event|8|||
127725061|NCT01276509|459620776|FG002|Overall Study|Adverse Event|4|||
127725062|NCT01276509|459620777|FG003|Overall Study|Adverse Event|3|||
127725063|NCT01276509|459620774|FG000|Overall Study|Lack of Efficacy|2|||
127725064|NCT01276509|459620775|FG001|Overall Study|Lack of Efficacy|1|||
127725065|NCT01276509|459620776|FG002|Overall Study|Lack of Efficacy|1|||
127725066|NCT01276509|459620777|FG003|Overall Study|Lack of Efficacy|2|||
127725067|NCT01276509|459620774|FG000|Overall Study|Pregnancy|1|||
127725068|NCT01276509|459620775|FG001|Overall Study|Pregnancy|0|||
127725069|NCT01276509|459620776|FG002|Overall Study|Pregnancy|0|||
127725070|NCT01276509|459620777|FG003|Overall Study|Pregnancy|0|||
127725071|NCT01276509|459620774|FG000|Overall Study|Withdrawal by Subject|1|||
127725072|NCT01276509|459620775|FG001|Overall Study|Withdrawal by Subject|2|||
127725073|NCT01276509|459620776|FG002|Overall Study|Withdrawal by Subject|0|||
127725074|NCT01276509|459620777|FG003|Overall Study|Withdrawal by Subject|0|||
127725075|NCT01276509|459620774|FG000|Overall Study|Other|0|||
127725076|NCT01276509|459620775|FG001|Overall Study|Other|1|||
127725077|NCT01276509|459620776|FG002|Overall Study|Other|0|||
127725078|NCT01276509|459620777|FG003|Overall Study|Other|0|||
127725079|NCT02196259|459620781|FG000|Overall Study|Researcher choice|0|||
127725080|NCT02196259|459620782|FG001|Overall Study|Researcher choice|0|||
127725081|NCT02196259|459620783|FG002|Overall Study|Researcher choice|1|||
127725082|NCT02196259|459620781|FG000|Overall Study|Partial data analysis|0|||
127725083|NCT02196259|459620782|FG001|Overall Study|Partial data analysis|3|||
127725084|NCT02196259|459620783|FG002|Overall Study|Partial data analysis|0|||
127725085|NCT00215943|459620784|FG000|Overall Study|Disease Progression|3|||
127725086|NCT00215943|459620785|FG001|Overall Study|Disease Progression|5|||
127725087|NCT00215943|459620784|FG000|Overall Study|Alternate therapy|0|||
127725088|NCT00215943|459620785|FG001|Overall Study|Alternate therapy|1|||
127725089|NCT00215943|459620784|FG000|Overall Study|Adverse Event|3|||
127725090|NCT00215943|459620785|FG001|Overall Study|Adverse Event|6|||
127725091|NCT00215943|459620784|FG000|Overall Study|Other disease|0|||
127725092|NCT00215943|459620785|FG001|Overall Study|Other disease|1|||
127725093|NCT00215943|459620784|FG000|Overall Study|Other complications|3|||
127725094|NCT00215943|459620785|FG001|Overall Study|Other complications|1|||
127725095|NCT04311983|459620786|FG000|Overall Study|Lost to Follow-up|421|||
127725096|NCT04311983|459620787|FG001|Overall Study|Lost to Follow-up|456|||
127725097|NCT04311983|459620786|FG000|Overall Study|Incomplete survey|7|||
127725098|NCT04311983|459620787|FG001|Overall Study|Incomplete survey|9|||
127725099|NCT04311983|459620786|FG000|Overall Study|Death|1|||
127725100|NCT04311983|459620787|FG001|Overall Study|Death|0|||
127725101|NCT01381549|459620791|FG000|Overall Study|Ineligible: No organisms isolated|0|||
127725102|NCT01381549|459620792|FG001|Overall Study|Ineligible: No organisms isolated|0|||
127725103|NCT01381549|459620793|FG002|Overall Study|Ineligible: No organisms isolated|1|||
127725104|NCT00403845|459620800|FG000|Treatment Period 1|Subject withdrew consent|1|||
127725105|NCT00403845|459620801|FG001|Treatment Period 1|Subject withdrew consent|0|||
127725106|NCT00403845|459620802|FG002|Treatment Period 1|Subject withdrew consent|0|||
127725107|NCT00403845|459620803|FG003|Treatment Period 1|Subject withdrew consent|0|||
127725108|NCT00403845|459620800|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
127725109|NCT00403845|459620801|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
127725110|NCT00403845|459620802|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
127725111|NCT00403845|459620803|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
127725112|NCT00403845|459620800|FG000|Treatment Period 2|Subject withdrew consent|1|||
127725113|NCT00403845|459620801|FG001|Treatment Period 2|Subject withdrew consent|0|||
127725114|NCT00403845|459620802|FG002|Treatment Period 2|Subject withdrew consent|0|||
127725115|NCT00403845|459620803|FG003|Treatment Period 2|Subject withdrew consent|0|||
127725116|NCT00403845|459620800|FG000|Treatment Period 3|Subject withdrew consent|0|||
127725117|NCT00403845|459620801|FG001|Treatment Period 3|Subject withdrew consent|0|||
127725118|NCT00403845|459620802|FG002|Treatment Period 3|Subject withdrew consent|0|||
127725119|NCT00403845|459620803|FG003|Treatment Period 3|Subject withdrew consent|1|||
127725120|NCT00403845|459620800|FG000|Treatment Period 3|Adverse Event|0|||
127725121|NCT00403845|459620801|FG001|Treatment Period 3|Adverse Event|0|||
127725122|NCT00403845|459620802|FG002|Treatment Period 3|Adverse Event|0|||
127725123|NCT00403845|459620803|FG003|Treatment Period 3|Adverse Event|1|||
127725124|NCT00578344|459620804|FG000|Overall Study|Insurance problems|1|||
127725125|NCT00578344|459620804|FG000|Overall Study|Graft failure|1|||
127725126|NCT02935673|459620805|FG000|Overall Study|Adverse Event|0|||
127725127|NCT02935673|459620806|FG001|Overall Study|Adverse Event|1|||
127725128|NCT02935673|459620807|FG002|Overall Study|Adverse Event|0|||
127725129|NCT02935673|459620805|FG000|Overall Study|Withdrawal by Subject|1|||
127725130|NCT02935673|459620806|FG001|Overall Study|Withdrawal by Subject|2|||
127725131|NCT02935673|459620807|FG002|Overall Study|Withdrawal by Subject|0|||
127725132|NCT04328467|459620808|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
127725133|NCT04328467|459620809|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
127725134|NCT04328467|459620810|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
127725135|NCT00990184|459620811|FG000|Overall Study|Physician Decision|1|||
127725136|NCT02152384|459620814|FG000|Period 1|Withdrawal by Subject|0|||
127725137|NCT02152384|459620815|FG001|Period 1|Withdrawal by Subject|1|||
127725138|NCT02152384|459620814|FG000|Period 1|Adverse Event|1|||
127725139|NCT02152384|459620815|FG001|Period 1|Adverse Event|1|||
127725140|NCT00930644|459620820|FG000|Overall Study|Withdrawal by Subject|4|||
127725141|NCT00930644|459620820|FG000|Overall Study|Physician Decision|2|||
127725142|NCT00930644|459620820|FG000|Overall Study|Death|1|||
127725143|NCT00930644|459620820|FG000|Overall Study|Adverse Event|16|||
127725144|NCT01393964|459620821|FG000|Overall Study|Disease Progression|4|||
127725145|NCT01393964|459620822|FG001|Overall Study|Disease Progression|3|||
127725146|NCT01393964|459620823|FG002|Overall Study|Disease Progression|5|||
127725147|NCT01393964|459620821|FG000|Overall Study|Study drug toxicity|1|||
127725148|NCT01393964|459620822|FG001|Overall Study|Study drug toxicity|0|||
127725149|NCT01393964|459620823|FG002|Overall Study|Study drug toxicity|0|||
127725150|NCT01393964|459620821|FG000|Overall Study|Withdrawal by Subject|0|||
127725151|NCT01393964|459620822|FG001|Overall Study|Withdrawal by Subject|0|||
127725152|NCT01393964|459620823|FG002|Overall Study|Withdrawal by Subject|1|||
127725153|NCT01393964|459620821|FG000|Overall Study|Adverse event unrelated to study drug|0|||
127725154|NCT01393964|459620822|FG001|Overall Study|Adverse event unrelated to study drug|3|||
127725155|NCT01393964|459620823|FG002|Overall Study|Adverse event unrelated to study drug|0|||
127725156|NCT01393964|459620821|FG000|Overall Study|Subject request stop study treatment|0|||
127725157|NCT01393964|459620822|FG001|Overall Study|Subject request stop study treatment|1|||
127725158|NCT01393964|459620823|FG002|Overall Study|Subject request stop study treatment|0|||
127725159|NCT01393964|459620821|FG000|Overall Study|Subject decided to move to transplant|1|||
127725160|NCT01393964|459620822|FG001|Overall Study|Subject decided to move to transplant|0|||
127725161|NCT01393964|459620823|FG002|Overall Study|Subject decided to move to transplant|0|||
127725162|NCT01393964|459620821|FG000|Overall Study|Subject switched to commercial supply|1|||
127725163|NCT01393964|459620822|FG001|Overall Study|Subject switched to commercial supply|0|||
127725164|NCT01393964|459620823|FG002|Overall Study|Subject switched to commercial supply|2|||
127725165|NCT01393964|459620821|FG000|Overall Study|Subject plateaued in terms of effect|1|||
127725166|NCT01393964|459620822|FG001|Overall Study|Subject plateaued in terms of effect|0|||
127725167|NCT01393964|459620823|FG002|Overall Study|Subject plateaued in terms of effect|0|||
127725168|NCT01393964|459620821|FG000|Overall Study|Investigator removed subject from study|0|||
127725169|NCT01393964|459620822|FG001|Overall Study|Investigator removed subject from study|1|||
127725170|NCT01393964|459620823|FG002|Overall Study|Investigator removed subject from study|0|||
127725171|NCT01393964|459620821|FG000|Overall Study|Subject converted to roll-over study|0|||
127725172|NCT01393964|459620822|FG001|Overall Study|Subject converted to roll-over study|1|||
127725173|NCT01393964|459620823|FG002|Overall Study|Subject converted to roll-over study|0|||
127725174|NCT01393964|459620821|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
127725175|NCT01393964|459620822|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
127725176|NCT01393964|459620823|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
127725177|NCT00088166|459620826|FG000|Overall Study|Adverse Event|11|||
127725178|NCT00088166|459620827|FG001|Overall Study|Adverse Event|9|||
127725179|NCT00088166|459620826|FG000|Overall Study|Death|3|||
127725180|NCT00088166|459620827|FG001|Overall Study|Death|1|||
127725181|NCT00088166|459620826|FG000|Overall Study|Lost to Follow-up|0|||
127725182|NCT00088166|459620827|FG001|Overall Study|Lost to Follow-up|1|||
127725183|NCT00088166|459620826|FG000|Overall Study|Physician Decision|4|||
127725184|NCT00088166|459620827|FG001|Overall Study|Physician Decision|1|||
127725185|NCT00088166|459620826|FG000|Overall Study|Protocol Violation|1|||
127725186|NCT00088166|459620827|FG001|Overall Study|Protocol Violation|5|||
127725187|NCT00088166|459620826|FG000|Overall Study|Patient deterioration|29|||
127725188|NCT00088166|459620827|FG001|Overall Study|Patient deterioration|39|||
127725189|NCT00088166|459620826|FG000|Overall Study|Withdrawal by Subject|5|||
127725190|NCT00088166|459620827|FG001|Overall Study|Withdrawal by Subject|5|||
127725191|NCT02671266|459620828|FG000|Overall Study|Withdrawal by Subject|1|||
127725192|NCT02671266|459620829|FG001|Overall Study|Withdrawal by Subject|1|||
127725193|NCT00666705|459620830|FG000|Overall Study|Withdrawal by Subject|1|||
127725194|NCT00687297|459620831|FG000|Randomization|Withdrawal by Subject|2|||
127725195|NCT00687297|459620832|FG001|Randomization|Withdrawal by Subject|0|||
127725196|NCT00687297|459620831|FG000|Randomization|Withdrew before treatment, ineligible|1|||
127725197|NCT00687297|459620832|FG001|Randomization|Withdrew before treatment, ineligible|1|||
127725198|NCT00687297|459620831|FG000|Induction|Withdrawal by Subject|4|||
127725199|NCT00687297|459620832|FG001|Induction|Withdrawal by Subject|4|||
127725200|NCT00687297|459620831|FG000|Induction|Adverse Event|16|||
127725201|NCT00687297|459620832|FG001|Induction|Adverse Event|15|||
127725202|NCT00687297|459620831|FG000|Induction|Death|7|||
127725203|NCT00687297|459620832|FG001|Induction|Death|11|||
127725204|NCT00687297|459620831|FG000|Induction|Lack of Efficacy|17|||
127725205|NCT00687297|459620832|FG001|Induction|Lack of Efficacy|21|||
127725206|NCT00687297|459620831|FG000|Induction|Ineligible|0|||
127725207|NCT00687297|459620832|FG001|Induction|Ineligible|1|||
127725208|NCT00687297|459620831|FG000|Induction|Patient Noncompliance|1|||
127725209|NCT00687297|459620832|FG001|Induction|Patient Noncompliance|0|||
127725210|NCT00687297|459620831|FG000|Induction|Physician Decision|0|||
127725211|NCT00687297|459620832|FG001|Induction|Physician Decision|2|||
127725212|NCT00687297|459620831|FG000|Induction|Other|0|||
127725213|NCT00687297|459620832|FG001|Induction|Other|1|||
127725214|NCT01228734|459620833|FG000|Overall Study|Randomized, but not treated|0|||
127725215|NCT01228734|459620834|FG001|Overall Study|Randomized, but not treated|4|||
127725216|NCT01109979|459620835|FG000|Overall Study|Physician Decision|2|||
127725217|NCT01109979|459620836|FG001|Overall Study|Physician Decision|0|||
127725218|NCT01109979|459620835|FG000|Overall Study|Withdrawal by Subject|0|||
127725219|NCT01109979|459620836|FG001|Overall Study|Withdrawal by Subject|1|||
127725220|NCT03128099|459620838|FG000|Overall Study|High dose task was too long|0|||
127725221|NCT03128099|459620839|FG001|Overall Study|High dose task was too long|4|||
127725222|NCT03128099|459620840|FG002|Overall Study|High dose task was too long|0|||
127725223|NCT03128099|459620838|FG000|Overall Study|Participant got a full time job.|1|||
127725224|NCT03128099|459620839|FG001|Overall Study|Participant got a full time job.|0|||
127725225|NCT03128099|459620840|FG002|Overall Study|Participant got a full time job.|0|||
127725226|NCT03128099|459620838|FG000|Overall Study|Became homeless and lost contact|1|||
127725227|NCT03128099|459620839|FG001|Overall Study|Became homeless and lost contact|0|||
127725228|NCT03128099|459620840|FG002|Overall Study|Became homeless and lost contact|0|||
127725229|NCT03128099|459620838|FG000|Overall Study|Did not complete all the assessments|0|||
127725230|NCT03128099|459620839|FG001|Overall Study|Did not complete all the assessments|0|||
127725231|NCT03128099|459620840|FG002|Overall Study|Did not complete all the assessments|1|||
127725232|NCT03456856|459620841|FG000|Overall Study|Lost to Follow-up|2|||
127725233|NCT03456856|459620841|FG000|Overall Study|Withdrawal by Subject|1|||
127725234|NCT02542696|459620846|FG000|Overall Study|Adverse Event|167|||
127725235|NCT02542696|459620846|FG000|Overall Study|Lack of Efficacy|26|||
127725236|NCT02542696|459620846|FG000|Overall Study|Lost to Follow-up|6|||
127725237|NCT02542696|459620846|FG000|Overall Study|Withdrawal by Subject|104|||
127725238|NCT02542696|459620846|FG000|Overall Study|Protocol Violation|5|||
127725239|NCT02542696|459620846|FG000|Overall Study|Death|8|||
127725240|NCT02542696|459620846|FG000|Overall Study|DECREASED OFF TIME|1|||
127725241|NCT02542696|459620846|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
127725242|NCT02542696|459620846|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
127725243|NCT02542696|459620846|FG000|Overall Study|MEDICAL HISTORY|1|||
127725244|NCT02542696|459620846|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
127725245|NCT02542696|459620846|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
127725246|NCT02542696|459620846|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
127725247|NCT02542696|459620846|FG000|Overall Study|SPONSOR DECISION|3|||
127725248|NCT02542696|459620846|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
127725249|NCT02542696|459620846|FG000|Overall Study|SUBJECT DECISION|2|||
127725250|NCT02137785|459620850|FG000|Overall Study|Lost to Follow-up|1|||
127725251|NCT02137785|459620851|FG001|Overall Study|Lost to Follow-up|0|||
127725252|NCT02137785|459620850|FG000|Overall Study|Withdrawal by Subject|1|||
127725253|NCT02137785|459620851|FG001|Overall Study|Withdrawal by Subject|4|||
127725254|NCT02137785|459620850|FG000|Overall Study|subject moved out of state|1|||
127725255|NCT02137785|459620851|FG001|Overall Study|subject moved out of state|0|||
127725256|NCT03390166|459620852|FG000|Overall Study|Death|0|||
127725257|NCT03390166|459620853|FG001|Overall Study|Death|1|||
127725258|NCT03390166|459620852|FG000|Overall Study|Lost to Follow-up|6|||
127725259|NCT03390166|459620853|FG001|Overall Study|Lost to Follow-up|4|||
127725260|NCT03390166|459620852|FG000|Overall Study|Physician Decision|2|||
127725261|NCT03390166|459620853|FG001|Overall Study|Physician Decision|1|||
127725262|NCT03390166|459620852|FG000|Overall Study|Move from study area|3|||
127725263|NCT03390166|459620853|FG001|Overall Study|Move from study area|2|||
127725264|NCT03390166|459620852|FG000|Overall Study|To militarycamp for conscript|1|||
127725265|NCT03390166|459620853|FG001|Overall Study|To militarycamp for conscript|0|||
127725266|NCT03390166|459620852|FG000|Overall Study|To drug therapy course|0|||
127725267|NCT03390166|459620853|FG001|Overall Study|To drug therapy course|1|||
127725268|NCT03390166|459620852|FG000|Overall Study|Move to work oversea|0|||
127725269|NCT03390166|459620853|FG001|Overall Study|Move to work oversea|1|||
127725270|NCT02206607|459620856|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
127725271|NCT02206607|459620857|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
127725272|NCT02206607|459620858|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
127725273|NCT02206607|459620859|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
127725274|NCT02206607|459620860|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
127725275|NCT02206607|459620856|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
127725276|NCT02206607|459620857|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
127725277|NCT02206607|459620858|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
127725278|NCT02206607|459620859|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
127725279|NCT02206607|459620860|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
127725280|NCT00879710|459620861|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
127725281|NCT00879710|459620862|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
127725282|NCT00879710|459620863|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
127725283|NCT00879710|459620864|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
127725284|NCT00879710|459620861|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
127725285|NCT00879710|459620862|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
127725286|NCT00879710|459620863|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
127725287|NCT00879710|459620864|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
127725288|NCT03979040|459620865|FG000|Overall Study|Withdrawal by Subject|24|||
127725289|NCT03979040|459620866|FG001|Overall Study|Withdrawal by Subject|32|||
127725290|NCT03979040|459620865|FG000|Overall Study|randomized but never started treatment|32|||
127725291|NCT03979040|459620866|FG001|Overall Study|randomized but never started treatment|39|||
127725292|NCT03979040|459620865|FG000|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|0|||
127725293|NCT03979040|459620866|FG001|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|1|||
127725294|NCT03541369|459620867|FG000|Overall Study|Death|0|||
127725295|NCT03541369|459620868|FG001|Overall Study|Death|0|||
127725296|NCT03541369|459620869|FG002|Overall Study|Death|0|||
127725297|NCT03541369|459620870|FG003|Overall Study|Death|0|||
127725298|NCT03541369|459620871|FG004|Overall Study|Death|1|||
127725299|NCT03541369|459620872|FG005|Overall Study|Death|1|||
127725300|NCT03541369|459620873|FG006|Overall Study|Death|0|||
127725301|NCT03541369|459620874|FG007|Overall Study|Death|2|||
127725302|NCT03541369|459620875|FG008|Overall Study|Death|1|||
127725303|NCT03541369|459620876|FG009|Overall Study|Death|2|||
127725304|NCT03541369|459620877|FG010|Overall Study|Death|1|||
127725305|NCT03541369|459620878|FG011|Overall Study|Death|0|||
127725306|NCT03541369|459620879|FG012|Overall Study|Death|2|||
127725307|NCT03541369|459620880|FG013|Overall Study|Death|1|||
127725308|NCT03541369|459620881|FG014|Overall Study|Death|1|||
127725309|NCT03541369|459620882|FG015|Overall Study|Death|1|||
127725310|NCT03541369|459620883|FG016|Overall Study|Death|0|||
127725311|NCT03541369|459620884|FG017|Overall Study|Death|1|||
127725312|NCT03541369|459620867|FG000|Overall Study|Decision by sponsor|0|||
127725313|NCT03541369|459620868|FG001|Overall Study|Decision by sponsor|0|||
127725314|NCT03541369|459620869|FG002|Overall Study|Decision by sponsor|0|||
127725315|NCT03541369|459620870|FG003|Overall Study|Decision by sponsor|1|||
127725316|NCT03541369|459620871|FG004|Overall Study|Decision by sponsor|0|||
127725317|NCT03541369|459620872|FG005|Overall Study|Decision by sponsor|2|||
127725318|NCT03541369|459620873|FG006|Overall Study|Decision by sponsor|0|||
127725319|NCT03541369|459620874|FG007|Overall Study|Decision by sponsor|1|||
127725320|NCT03541369|459620875|FG008|Overall Study|Decision by sponsor|2|||
127725321|NCT03541369|459620876|FG009|Overall Study|Decision by sponsor|0|||
127725322|NCT03541369|459620877|FG010|Overall Study|Decision by sponsor|0|||
127725323|NCT03541369|459620878|FG011|Overall Study|Decision by sponsor|0|||
127725324|NCT03541369|459620879|FG012|Overall Study|Decision by sponsor|2|||
127725325|NCT03541369|459620880|FG013|Overall Study|Decision by sponsor|2|||
127725326|NCT03541369|459620881|FG014|Overall Study|Decision by sponsor|0|||
127725327|NCT03541369|459620882|FG015|Overall Study|Decision by sponsor|1|||
127725328|NCT03541369|459620883|FG016|Overall Study|Decision by sponsor|1|||
127725329|NCT03541369|459620884|FG017|Overall Study|Decision by sponsor|1|||
127725330|NCT03541369|459620867|FG000|Overall Study|Withdrawal by Subject|0|||
127725331|NCT03541369|459620868|FG001|Overall Study|Withdrawal by Subject|0|||
127725332|NCT03541369|459620869|FG002|Overall Study|Withdrawal by Subject|0|||
127725333|NCT03541369|459620870|FG003|Overall Study|Withdrawal by Subject|0|||
127725334|NCT03541369|459620871|FG004|Overall Study|Withdrawal by Subject|0|||
127725335|NCT03541369|459620872|FG005|Overall Study|Withdrawal by Subject|0|||
127725336|NCT03541369|459620873|FG006|Overall Study|Withdrawal by Subject|1|||
127725337|NCT03541369|459620874|FG007|Overall Study|Withdrawal by Subject|0|||
127725338|NCT03541369|459620875|FG008|Overall Study|Withdrawal by Subject|0|||
127725339|NCT03541369|459620876|FG009|Overall Study|Withdrawal by Subject|0|||
127725340|NCT03541369|459620877|FG010|Overall Study|Withdrawal by Subject|0|||
127725341|NCT03541369|459620878|FG011|Overall Study|Withdrawal by Subject|1|||
127725342|NCT03541369|459620879|FG012|Overall Study|Withdrawal by Subject|0|||
127725343|NCT03541369|459620880|FG013|Overall Study|Withdrawal by Subject|0|||
127725344|NCT03541369|459620881|FG014|Overall Study|Withdrawal by Subject|3|||
127725345|NCT03541369|459620882|FG015|Overall Study|Withdrawal by Subject|0|||
127725346|NCT03541369|459620883|FG016|Overall Study|Withdrawal by Subject|4|||
127725347|NCT03541369|459620884|FG017|Overall Study|Withdrawal by Subject|2|||
127725348|NCT03541369|459620867|FG000|Overall Study|Lost to Follow-up|0|||
127725349|NCT03541369|459620868|FG001|Overall Study|Lost to Follow-up|0|||
127725350|NCT03541369|459620869|FG002|Overall Study|Lost to Follow-up|0|||
127725351|NCT03541369|459620870|FG003|Overall Study|Lost to Follow-up|0|||
127725352|NCT03541369|459620871|FG004|Overall Study|Lost to Follow-up|1|||
127725353|NCT03541369|459620872|FG005|Overall Study|Lost to Follow-up|0|||
127725354|NCT03541369|459620873|FG006|Overall Study|Lost to Follow-up|0|||
127725355|NCT03541369|459620874|FG007|Overall Study|Lost to Follow-up|0|||
127725356|NCT03541369|459620875|FG008|Overall Study|Lost to Follow-up|1|||
127725357|NCT03541369|459620876|FG009|Overall Study|Lost to Follow-up|0|||
127725358|NCT03541369|459620877|FG010|Overall Study|Lost to Follow-up|0|||
127725359|NCT03541369|459620878|FG011|Overall Study|Lost to Follow-up|0|||
127725360|NCT03541369|459620879|FG012|Overall Study|Lost to Follow-up|1|||
127725361|NCT03541369|459620880|FG013|Overall Study|Lost to Follow-up|0|||
127725362|NCT03541369|459620881|FG014|Overall Study|Lost to Follow-up|0|||
127725363|NCT03541369|459620882|FG015|Overall Study|Lost to Follow-up|0|||
127725364|NCT03541369|459620883|FG016|Overall Study|Lost to Follow-up|0|||
127725365|NCT03541369|459620884|FG017|Overall Study|Lost to Follow-up|0|||
127725366|NCT00696241|459620885|FG000|Overall Study|Adverse Event|11|||
127725367|NCT00696241|459620886|FG001|Overall Study|Adverse Event|3|||
127725368|NCT00696241|459620887|FG002|Overall Study|Adverse Event|6|||
127725369|NCT00696241|459620888|FG003|Overall Study|Adverse Event|4|||
127725370|NCT00696241|459620889|FG004|Overall Study|Adverse Event|5|||
127725371|NCT00696241|459620885|FG000|Overall Study|Protocol Violation|1|||
127725372|NCT00696241|459620886|FG001|Overall Study|Protocol Violation|1|||
127725373|NCT00696241|459620887|FG002|Overall Study|Protocol Violation|2|||
127725374|NCT00696241|459620888|FG003|Overall Study|Protocol Violation|0|||
127725375|NCT00696241|459620889|FG004|Overall Study|Protocol Violation|3|||
127725376|NCT00696241|459620885|FG000|Overall Study|Lost to Follow-up|1|||
127725377|NCT00696241|459620886|FG001|Overall Study|Lost to Follow-up|4|||
127725378|NCT00696241|459620887|FG002|Overall Study|Lost to Follow-up|1|||
127725379|NCT00696241|459620888|FG003|Overall Study|Lost to Follow-up|2|||
127725380|NCT00696241|459620889|FG004|Overall Study|Lost to Follow-up|0|||
127725381|NCT00696241|459620885|FG000|Overall Study|Withdrawal by Subject|4|||
127725382|NCT00696241|459620886|FG001|Overall Study|Withdrawal by Subject|8|||
127725383|NCT00696241|459620887|FG002|Overall Study|Withdrawal by Subject|6|||
127725384|NCT00696241|459620888|FG003|Overall Study|Withdrawal by Subject|1|||
127725385|NCT00696241|459620889|FG004|Overall Study|Withdrawal by Subject|0|||
127725386|NCT00696241|459620885|FG000|Overall Study|Lack of Efficacy|1|||
127725387|NCT00696241|459620886|FG001|Overall Study|Lack of Efficacy|5|||
127725388|NCT00696241|459620887|FG002|Overall Study|Lack of Efficacy|4|||
127725389|NCT00696241|459620888|FG003|Overall Study|Lack of Efficacy|5|||
127725390|NCT00696241|459620889|FG004|Overall Study|Lack of Efficacy|3|||
127725391|NCT00696241|459620885|FG000|Overall Study|Other|6|||
127725392|NCT00696241|459620886|FG001|Overall Study|Other|1|||
127725393|NCT00696241|459620887|FG002|Overall Study|Other|5|||
127725394|NCT00696241|459620888|FG003|Overall Study|Other|2|||
127725395|NCT00696241|459620889|FG004|Overall Study|Other|1|||
127725396|NCT03347396|459620896|FG000|Part A (26 Weeks)|Adverse Event|1|||
127725397|NCT03347396|459620897|FG001|Part A (26 Weeks)|Adverse Event|0|||
127725398|NCT03347396|459620896|FG000|Part A (26 Weeks)|Death|0|||
127725399|NCT03347396|459620897|FG001|Part A (26 Weeks)|Death|1|||
127725400|NCT03347396|459620896|FG000|Part B (149 Weeks)|Adverse Event|1|||
127725401|NCT03347396|459620897|FG001|Part B (149 Weeks)|Adverse Event|1|||
127725402|NCT03347396|459620896|FG000|Part B (149 Weeks)|Death|1|||
127725403|NCT03347396|459620897|FG001|Part B (149 Weeks)|Death|0|||
127725404|NCT03060525|459620898|FG000|Overall Study|moved out of state|1|||
127725405|NCT03060525|459620899|FG001|Overall Study|moved out of state|1|||
127725406|NCT03060525|459620900|FG002|Overall Study|moved out of state|1|||
127725407|NCT03060525|459620901|FG003|Overall Study|moved out of state|1|||
127725408|NCT03060525|459620898|FG000|Overall Study|unable to meet time commitment required of study|2|||
127725409|NCT03060525|459620899|FG001|Overall Study|unable to meet time commitment required of study|3|||
127725410|NCT03060525|459620900|FG002|Overall Study|unable to meet time commitment required of study|3|||
127725411|NCT03060525|459620901|FG003|Overall Study|unable to meet time commitment required of study|1|||
127725412|NCT03060525|459620898|FG000|Overall Study|no longer interested in doing intervention|0|||
127725413|NCT03060525|459620899|FG001|Overall Study|no longer interested in doing intervention|0|||
127725414|NCT03060525|459620900|FG002|Overall Study|no longer interested in doing intervention|0|||
127725415|NCT03060525|459620901|FG003|Overall Study|no longer interested in doing intervention|1|||
127725416|NCT00090519|459620902|FG000|Overall Study|Adverse Event|5|||
127725417|NCT00090519|459620903|FG001|Overall Study|Adverse Event|4|||
127725418|NCT00090519|459620902|FG000|Overall Study|Death|9|||
127725419|NCT00090519|459620903|FG001|Overall Study|Death|9|||
127725420|NCT00090519|459620902|FG000|Overall Study|Lost to Follow-up|26|||
127725421|NCT00090519|459620903|FG001|Overall Study|Lost to Follow-up|29|||
127725422|NCT00090519|459620902|FG000|Overall Study|Withdrawal by Subject|28|||
127725423|NCT00090519|459620903|FG001|Overall Study|Withdrawal by Subject|29|||
127725424|NCT00090519|459620902|FG000|Overall Study|Physician Decision|2|||
127725425|NCT00090519|459620903|FG001|Overall Study|Physician Decision|3|||
127725426|NCT00090519|459620902|FG000|Overall Study|Sponsor Decision|3|||
127725427|NCT00090519|459620903|FG001|Overall Study|Sponsor Decision|1|||
127725428|NCT02161146|459620904|FG000|Overall Study|Adverse Event|1|||
127725429|NCT02161146|459620905|FG001|Overall Study|Adverse Event|1|||
127725430|NCT02161146|459620906|FG002|Overall Study|Adverse Event|0|||
127725431|NCT02161146|459620907|FG003|Overall Study|Adverse Event|1|||
127725432|NCT02161146|459620908|FG004|Overall Study|Adverse Event|0|||
127725433|NCT02161146|459620904|FG000|Overall Study|Lost to Follow-up|0|||
127725434|NCT02161146|459620905|FG001|Overall Study|Lost to Follow-up|1|||
127725435|NCT02161146|459620906|FG002|Overall Study|Lost to Follow-up|0|||
127889460|NCT00410410|460218099|FG000|Maintenance Period (MP)|Death|0|||
127725436|NCT02161146|459620907|FG003|Overall Study|Lost to Follow-up|0|||
127725437|NCT02161146|459620908|FG004|Overall Study|Lost to Follow-up|0|||
127725438|NCT02161146|459620904|FG000|Overall Study|Personal Reasons|0|||
127725439|NCT02161146|459620905|FG001|Overall Study|Personal Reasons|1|||
127725440|NCT02161146|459620906|FG002|Overall Study|Personal Reasons|0|||
127725441|NCT02161146|459620907|FG003|Overall Study|Personal Reasons|2|||
127725442|NCT02161146|459620908|FG004|Overall Study|Personal Reasons|1|||
127725443|NCT02161146|459620904|FG000|Overall Study|Other Miscellaneous Reasons|0|||
127725444|NCT02161146|459620905|FG001|Overall Study|Other Miscellaneous Reasons|1|||
127725445|NCT02161146|459620906|FG002|Overall Study|Other Miscellaneous Reasons|0|||
127725446|NCT02161146|459620907|FG003|Overall Study|Other Miscellaneous Reasons|0|||
127725447|NCT02161146|459620908|FG004|Overall Study|Other Miscellaneous Reasons|0|||
127725448|NCT02189759|459620911|FG000|Overall Study|Lost to Follow-up|0|||
127725449|NCT02189759|459620912|FG001|Overall Study|Lost to Follow-up|0|||
127725450|NCT02189759|459620913|FG002|Overall Study|Lost to Follow-up|2|||
127725451|NCT02189759|459620914|FG003|Overall Study|Lost to Follow-up|5|||
127725452|NCT00800176|459620917|FG000|Overall Study|Adverse Event|2|||
127725453|NCT00800176|459620918|FG001|Overall Study|Adverse Event|1|||
127725454|NCT00800176|459620919|FG002|Overall Study|Adverse Event|0|||
127725455|NCT00800176|459620920|FG003|Overall Study|Adverse Event|2|||
127725456|NCT00800176|459620921|FG004|Overall Study|Adverse Event|1|||
127725457|NCT00800176|459620922|FG005|Overall Study|Adverse Event|1|||
127725458|NCT00800176|459620917|FG000|Overall Study|Refused treatment|3|||
127725459|NCT00800176|459620918|FG001|Overall Study|Refused treatment|2|||
127725460|NCT00800176|459620919|FG002|Overall Study|Refused treatment|0|||
127725461|NCT00800176|459620920|FG003|Overall Study|Refused treatment|0|||
127725462|NCT00800176|459620921|FG004|Overall Study|Refused treatment|1|||
127725463|NCT00800176|459620922|FG005|Overall Study|Refused treatment|4|||
127725464|NCT00800176|459620917|FG000|Overall Study|Failure to return|3|||
127725465|NCT00800176|459620918|FG001|Overall Study|Failure to return|3|||
127725466|NCT00800176|459620919|FG002|Overall Study|Failure to return|0|||
127725467|NCT00800176|459620920|FG003|Overall Study|Failure to return|2|||
127725468|NCT00800176|459620921|FG004|Overall Study|Failure to return|0|||
127725469|NCT00800176|459620922|FG005|Overall Study|Failure to return|0|||
127725470|NCT00800176|459620917|FG000|Overall Study|Other|1|||
127725471|NCT00800176|459620918|FG001|Overall Study|Other|0|||
127725472|NCT00800176|459620919|FG002|Overall Study|Other|0|||
127725473|NCT00800176|459620920|FG003|Overall Study|Other|0|||
127725474|NCT00800176|459620921|FG004|Overall Study|Other|2|||
127725475|NCT00800176|459620922|FG005|Overall Study|Other|0|||
127725476|NCT04919499|459620926|FG000|Overall Study|Adverse Event|0|||
127725477|NCT04919499|459620927|FG001|Overall Study|Adverse Event|0|||
127725478|NCT04919499|459620928|FG002|Overall Study|Adverse Event|0|||
127725479|NCT04919499|459620929|FG003|Overall Study|Adverse Event|0|||
127725480|NCT04919499|459620930|FG004|Overall Study|Adverse Event|2|||
127725481|NCT04919499|459620926|FG000|Overall Study|Not treated|0|||
127725482|NCT04919499|459620927|FG001|Overall Study|Not treated|0|||
127725483|NCT04919499|459620928|FG002|Overall Study|Not treated|0|||
127725484|NCT04919499|459620929|FG003|Overall Study|Not treated|1|||
127725485|NCT04919499|459620930|FG004|Overall Study|Not treated|0|||
127725486|NCT04369664|459622691|FG000|Overall Study|Physician Decision|1|||
127725487|NCT04369664|459622692|FG001|Overall Study|Physician Decision|0|||
127725488|NCT03840200|459622693|FG000|Overall Study|Death|6|||
127725489|NCT03840200|459622694|FG001|Overall Study|Death|3|||
127725490|NCT03840200|459622695|FG002|Overall Study|Death|6|||
127725491|NCT03840200|459622696|FG003|Overall Study|Death|10|||
127725492|NCT03840200|459622693|FG000|Overall Study|Reason Not Specified|2|||
127725493|NCT03840200|459622694|FG001|Overall Study|Reason Not Specified|2|||
127725494|NCT03840200|459622695|FG002|Overall Study|Reason Not Specified|1|||
127725495|NCT03840200|459622696|FG003|Overall Study|Reason Not Specified|15|||
127725496|NCT03840200|459622693|FG000|Overall Study|Physician Decision|0|||
127725497|NCT03840200|459622694|FG001|Overall Study|Physician Decision|0|||
127725498|NCT03840200|459622695|FG002|Overall Study|Physician Decision|0|||
127725499|NCT03840200|459622696|FG003|Overall Study|Physician Decision|2|||
127725500|NCT03840200|459622693|FG000|Overall Study|Progressive Disease|0|||
127725501|NCT03840200|459622694|FG001|Overall Study|Progressive Disease|0|||
127725502|NCT03840200|459622695|FG002|Overall Study|Progressive Disease|0|||
127725503|NCT03840200|459622696|FG003|Overall Study|Progressive Disease|1|||
127725504|NCT03840200|459622693|FG000|Overall Study|Withdrawal by Subject|0|||
127725505|NCT03840200|459622694|FG001|Overall Study|Withdrawal by Subject|1|||
127725506|NCT03840200|459622695|FG002|Overall Study|Withdrawal by Subject|0|||
127725507|NCT03840200|459622696|FG003|Overall Study|Withdrawal by Subject|2|||
127725508|NCT05522777|459622699|FG000|Overall Study|Lack of Efficacy|1|||
127725509|NCT05522777|459622699|FG000|Overall Study|Withdrawal by Subject|1|||
127725510|NCT05487300|459622702|FG000|Overall Study|Withdrawal by Subject|1|||
127725511|NCT05487300|459622703|FG001|Overall Study|Withdrawal by Subject|0|||
127725512|NCT05006703|459622704|FG000|Overall Study|Withdrawal by Subject|1|||
127725513|NCT05006703|459622705|FG001|Overall Study|Withdrawal by Subject|0|||
127725514|NCT05006703|459622704|FG000|Overall Study|Lost to Follow-up|13|||
127725515|NCT05006703|459622705|FG001|Overall Study|Lost to Follow-up|5|||
127725516|NCT02164578|459622707|FG000|Treatment Period|Withdrawal by Subject|3|||
127725517|NCT02164578|459622708|FG001|Treatment Period|Withdrawal by Subject|3|||
127725518|NCT02164578|459622707|FG000|Treatment Period|Adverse Event|13|||
127725519|NCT02164578|459622708|FG001|Treatment Period|Adverse Event|6|||
127725520|NCT02164578|459622707|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
127725521|NCT02164578|459622708|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
127725522|NCT02164578|459622707|FG000|Treatment Period|Protocol Violation|0|||
127725523|NCT02164578|459622708|FG001|Treatment Period|Protocol Violation|2|||
127725524|NCT02164578|459622707|FG000|Extension Period|Withdrawal by Subject|2|||
127725525|NCT02164578|459622708|FG001|Extension Period|Withdrawal by Subject|0|||
127725526|NCT02164578|459622707|FG000|Extension Period|Adverse Event|4|||
127725527|NCT02164578|459622708|FG001|Extension Period|Adverse Event|0|||
127725528|NCT02164578|459622707|FG000|Extension Period|Expiry of study medication|1|||
127725529|NCT02164578|459622708|FG001|Extension Period|Expiry of study medication|0|||
127725530|NCT02164578|459622707|FG000|Extension Period|Protocol Violation|0|||
127725531|NCT02164578|459622708|FG001|Extension Period|Protocol Violation|1|||
127725532|NCT02507297|459622709|FG000|Overall Study|Withdrawal by Subject|1|||
127725533|NCT02507297|459622710|FG001|Overall Study|Withdrawal by Subject|0|||
127725534|NCT02507297|459622709|FG000|Overall Study|Lost to Follow-up|0|||
127725535|NCT02507297|459622710|FG001|Overall Study|Lost to Follow-up|1|||
127725536|NCT01018992|459622711|FG000|Overall Study|Adverse Event|8|||
127725537|NCT01018992|459622712|FG001|Overall Study|Adverse Event|3|||
127725538|NCT01018992|459622711|FG000|Overall Study|Withdrawal by Subject|3|||
127725539|NCT01018992|459622712|FG001|Overall Study|Withdrawal by Subject|8|||
127725540|NCT01018992|459622711|FG000|Overall Study|Protocol Violation|0|||
127725541|NCT01018992|459622712|FG001|Overall Study|Protocol Violation|4|||
127725542|NCT01018992|459622711|FG000|Overall Study|Lost to Follow-up|5|||
127725543|NCT01018992|459622712|FG001|Overall Study|Lost to Follow-up|1|||
127725544|NCT03029585|459622713|FG000|Overall Study|Death|1|||
127725545|NCT03029585|459622714|FG001|Overall Study|Death|1|||
127725546|NCT03029585|459622713|FG000|Overall Study|Withdrawal by Subject|1|||
127725547|NCT03029585|459622714|FG001|Overall Study|Withdrawal by Subject|0|||
127725548|NCT00441168|459622715|FG000|Treatment Period|Death|3|||
127725549|NCT00441168|459622716|FG001|Treatment Period|Death|0|||
127725550|NCT00441168|459622715|FG000|Treatment Period|Adverse Event|1|||
127725551|NCT00441168|459622716|FG001|Treatment Period|Adverse Event|2|||
127725552|NCT00441168|459622715|FG000|Treatment Period|Progressive Disease|0|||
127725553|NCT00441168|459622716|FG001|Treatment Period|Progressive Disease|2|||
127725554|NCT00441168|459622715|FG000|Treatment Period|Protocol Violation|0|||
127725555|NCT00441168|459622716|FG001|Treatment Period|Protocol Violation|1|||
127725556|NCT00441168|459622715|FG000|Treatment Period|Lost to Follow-up|0|||
127725557|NCT00441168|459622716|FG001|Treatment Period|Lost to Follow-up|1|||
127725558|NCT00441168|459622715|FG000|Treatment Period|Withdrawal by Subject|3|||
127725559|NCT00441168|459622716|FG001|Treatment Period|Withdrawal by Subject|0|||
127725560|NCT00441168|459622715|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
127725561|NCT00441168|459622716|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
127725562|NCT00441168|459622715|FG000|Treatment Period|refractory disease|1|||
127725563|NCT00441168|459622716|FG001|Treatment Period|refractory disease|0|||
127725564|NCT00441168|459622715|FG000|Follow-up Period|Death|3|||
127725565|NCT00441168|459622716|FG001|Follow-up Period|Death|0|||
127725566|NCT00441168|459622715|FG000|Follow-up Period|Lost to Follow-up|5|||
127725567|NCT00441168|459622716|FG001|Follow-up Period|Lost to Follow-up|6|||
127725568|NCT00441168|459622715|FG000|Follow-up Period|Withdrawal by Subject|3|||
127725569|NCT00441168|459622716|FG001|Follow-up Period|Withdrawal by Subject|0|||
127725570|NCT00441168|459622715|FG000|Follow-up Period|Other|1|||
127725571|NCT00441168|459622716|FG001|Follow-up Period|Other|3|||
127725572|NCT03909100|459622717|FG000|Overall Study|Protocol Deviation|2|||
127725573|NCT03909100|459622717|FG000|Overall Study|Technical Problems|4|||
127725574|NCT03909100|459622717|FG000|Overall Study|Withdrawal by Subject|4|||
127725575|NCT03909100|459622717|FG000|Overall Study|Lost to Follow-up|1|||
127725576|NCT03909100|459622717|FG000|Overall Study|Reason not Specified|4|||
127725577|NCT00807599|459622718|FG000|Overall Study|Not treated on protocol study|0|||
127725578|NCT00807599|459622719|FG001|Overall Study|Not treated on protocol study|0|||
127725579|NCT00807599|459622720|FG002|Overall Study|Not treated on protocol study|2|||
127725580|NCT00807599|459622718|FG000|Overall Study|Adverse Event|0|||
127725581|NCT00807599|459622719|FG001|Overall Study|Adverse Event|0|||
127725582|NCT00807599|459622720|FG002|Overall Study|Adverse Event|5|||
127725583|NCT00807599|459622718|FG000|Overall Study|Inadequate response to induction|0|||
127725584|NCT00807599|459622719|FG001|Overall Study|Inadequate response to induction|0|||
127725585|NCT00807599|459622720|FG002|Overall Study|Inadequate response to induction|9|||
127725586|NCT00807599|459622718|FG000|Overall Study|Withdrawal by Subject|0|||
127725587|NCT00807599|459622719|FG001|Overall Study|Withdrawal by Subject|0|||
127725588|NCT00807599|459622720|FG002|Overall Study|Withdrawal by Subject|1|||
127725589|NCT01670877|459622721|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
127725590|NCT01670877|459622722|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
127725591|NCT01670877|459622723|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
127889461|NCT00410410|460218100|FG001|Maintenance Period (MP)|Death|0|||
127889462|NCT00410410|460218101|FG002|Maintenance Period (MP)|Death|0|||
127889463|NCT00410410|460218102|FG003|Maintenance Period (MP)|Death|0|||
127889464|NCT00410410|460218103|FG004|Maintenance Period (MP)|Death|0|||
127889465|NCT00410410|460218104|FG005|Maintenance Period (MP)|Death|0|||
127889466|NCT00410410|460218105|FG006|Maintenance Period (MP)|Death|1|||
127889467|NCT00410410|460218106|FG007|Maintenance Period (MP)|Death|0|||
127889468|NCT00410410|460218107|FG008|Maintenance Period (MP)|Death|0|||
127889469|NCT00410410|460218099|FG000|Maintenance Period (MP)|Adverse Event|0|||
127889470|NCT00410410|460218100|FG001|Maintenance Period (MP)|Adverse Event|0|||
127889471|NCT00410410|460218101|FG002|Maintenance Period (MP)|Adverse Event|0|||
127889472|NCT00410410|460218102|FG003|Maintenance Period (MP)|Adverse Event|0|||
127889473|NCT00410410|460218103|FG004|Maintenance Period (MP)|Adverse Event|0|||
127889474|NCT00410410|460218104|FG005|Maintenance Period (MP)|Adverse Event|0|||
127889475|NCT00410410|460218105|FG006|Maintenance Period (MP)|Adverse Event|1|||
127889476|NCT00410410|460218106|FG007|Maintenance Period (MP)|Adverse Event|3|||
127889477|NCT00410410|460218107|FG008|Maintenance Period (MP)|Adverse Event|0|||
127889478|NCT00410410|460218099|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
127889479|NCT00410410|460218100|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
127889480|NCT00410410|460218101|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
127889481|NCT00410410|460218102|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
127889482|NCT00410410|460218103|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
127889483|NCT00410410|460218104|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
127889484|NCT00410410|460218105|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
127889485|NCT00410410|460218106|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
127889486|NCT00410410|460218107|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
127889487|NCT00410410|460218099|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
127889488|NCT00410410|460218100|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
127889489|NCT00410410|460218101|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
127889490|NCT00410410|460218102|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
127889491|NCT00410410|460218103|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
127889492|NCT00410410|460218104|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
127889493|NCT00410410|460218105|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
127889494|NCT00410410|460218106|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
127889495|NCT00410410|460218107|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
127889496|NCT00410410|460218099|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
127889497|NCT00410410|460218100|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
127889498|NCT00410410|460218101|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
127889499|NCT00410410|460218102|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
127889500|NCT00410410|460218103|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
127889501|NCT00410410|460218104|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
127889502|NCT00410410|460218105|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
127889503|NCT00410410|460218106|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
127889504|NCT00410410|460218107|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
127725592|NCT01670877|459622724|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
127725593|NCT01670877|459622725|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
127725594|NCT01670877|459622726|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
127725595|NCT01670877|459622721|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
127725596|NCT01670877|459622722|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
127725597|NCT01670877|459622723|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
127725598|NCT01670877|459622724|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
127725599|NCT01670877|459622725|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
127725600|NCT01670877|459622726|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
127725601|NCT01670877|459622721|FG000|Part I and Part 2|Grade 2 vomiting|0|||
127889505|NCT00410410|460218099|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
127889506|NCT00410410|460218100|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
127889507|NCT00410410|460218101|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
127889508|NCT00410410|460218102|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
127889509|NCT00410410|460218103|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
127889510|NCT00410410|460218104|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
127889511|NCT00410410|460218105|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
127889512|NCT00410410|460218106|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
127889513|NCT00410410|460218107|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
127889514|NCT00410410|460218099|FG000|Open-Label Period (OL)|Death|0|||
127889515|NCT00410410|460218100|FG001|Open-Label Period (OL)|Death|0|||
127889516|NCT00410410|460218101|FG002|Open-Label Period (OL)|Death|0|||
127725602|NCT01670877|459622722|FG001|Part I and Part 2|Grade 2 vomiting|0|||
127725603|NCT01670877|459622723|FG002|Part I and Part 2|Grade 2 vomiting|0|||
127725604|NCT01670877|459622724|FG003|Part I and Part 2|Grade 2 vomiting|1|||
127725605|NCT01670877|459622725|FG004|Part I and Part 2|Grade 2 vomiting|0|||
127725606|NCT01670877|459622726|FG005|Part I and Part 2|Grade 2 vomiting|0|||
127725607|NCT01670877|459622721|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
127725608|NCT01670877|459622722|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
127725609|NCT01670877|459622723|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
127725610|NCT01670877|459622724|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
127725611|NCT01670877|459622725|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
127725612|NCT01670877|459622726|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
127725613|NCT01670877|459622721|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
127725614|NCT01670877|459622722|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
127725615|NCT01670877|459622723|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
127725616|NCT01670877|459622724|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
127725617|NCT01670877|459622725|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
127725618|NCT01670877|459622726|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
127725619|NCT00113529|459622727|FG000|Overall Study|Adverse Event|4|||
127725620|NCT00113529|459622727|FG000|Overall Study|Lack of Efficacy|20|||
127725621|NCT00113529|459622727|FG000|Overall Study|Decision of sponsor|6|||
127725622|NCT00113529|459622727|FG000|Overall Study|Withdrawal by Subject|4|||
127725623|NCT02825550|459622729|FG000|Overall Study|Physician Decision|1|||
127725624|NCT00042939|459622733|FG000|Overall Study|Adverse Event|6|||
127725625|NCT00042939|459622734|FG001|Overall Study|Adverse Event|7|||
127725626|NCT00042939|459622733|FG000|Overall Study|Death|3|||
127725627|NCT00042939|459622734|FG001|Overall Study|Death|2|||
127725628|NCT00042939|459622733|FG000|Overall Study|Withdrawal by Subject|3|||
127725629|NCT00042939|459622734|FG001|Overall Study|Withdrawal by Subject|4|||
127725630|NCT00042939|459622733|FG000|Overall Study|Other disease|1|||
127725631|NCT00042939|459622734|FG001|Overall Study|Other disease|0|||
127725632|NCT00042939|459622733|FG000|Overall Study|Ineligible|2|||
127725633|NCT00042939|459622734|FG001|Overall Study|Ineligible|2|||
127725634|NCT00042939|459622733|FG000|Overall Study|Deterioration of health|3|||
127725635|NCT00042939|459622734|FG001|Overall Study|Deterioration of health|4|||
127725636|NCT00042939|459622733|FG000|Overall Study|QOL diminished|1|||
127725637|NCT00042939|459622734|FG001|Overall Study|QOL diminished|0|||
127725638|NCT00042939|459622733|FG000|Overall Study|Rising ca 19-9|1|||
127725639|NCT00042939|459622734|FG001|Overall Study|Rising ca 19-9|0|||
127725640|NCT00042939|459622733|FG000|Overall Study|Patient non-compliance|1|||
127725641|NCT00042939|459622734|FG001|Overall Study|Patient non-compliance|0|||
127725642|NCT00042939|459622733|FG000|Overall Study|Still on treatment|1|||
127725643|NCT00042939|459622734|FG001|Overall Study|Still on treatment|0|||
127725644|NCT00042939|459622733|FG000|Overall Study|Treatment break > 4 weeks|0|||
127725645|NCT00042939|459622734|FG001|Overall Study|Treatment break > 4 weeks|1|||
127725646|NCT00042939|459622733|FG000|Overall Study|Did not start treatment|2|||
127725647|NCT00042939|459622734|FG001|Overall Study|Did not start treatment|1|||
127725648|NCT03349476|459622735|FG000|Overall Study|Physician Decision|3|||
127725649|NCT00795639|459622736|FG000|Overall Study|Death|1|||
127725650|NCT00795639|459622737|FG001|Overall Study|Death|6|||
127725651|NCT00795639|459622736|FG000|Overall Study|Withdrawal by Subject|1|||
127725652|NCT00795639|459622737|FG001|Overall Study|Withdrawal by Subject|3|||
127725653|NCT00795639|459622736|FG000|Overall Study|Pregnancy|1|||
127725654|NCT00795639|459622737|FG001|Overall Study|Pregnancy|0|||
127725655|NCT00795639|459622736|FG000|Overall Study|Adverse Event|5|||
127725656|NCT00795639|459622737|FG001|Overall Study|Adverse Event|2|||
127725657|NCT00795639|459622736|FG000|Overall Study|Other|0|||
127725658|NCT00795639|459622737|FG001|Overall Study|Other|2|||
127725659|NCT00795639|459622736|FG000|Overall Study|Terminated by sponsor|13|||
127725660|NCT00795639|459622737|FG001|Overall Study|Terminated by sponsor|12|||
127725661|NCT00795639|459622736|FG000|Overall Study|Randomized and not treated|0|||
127725662|NCT00795639|459622737|FG001|Overall Study|Randomized and not treated|1|||
127725663|NCT02525744|459622738|FG000|Period 1|Physician Decision|0|||
127725664|NCT02525744|459622739|FG001|Period 1|Physician Decision|0|||
127725665|NCT02525744|459622740|FG002|Period 1|Physician Decision|1|||
127725666|NCT02525744|459622741|FG003|Period 1|Physician Decision|0|||
127725667|NCT02525744|459622738|FG000|Period 3|Adverse Event|0|||
127725668|NCT02525744|459622739|FG001|Period 3|Adverse Event|1|||
127725669|NCT02525744|459622740|FG002|Period 3|Adverse Event|0|||
127725670|NCT02525744|459622741|FG003|Period 3|Adverse Event|0|||
127725671|NCT02525744|459622738|FG000|Period 4|Withdrawal by Subject|1|||
127725672|NCT02525744|459622739|FG001|Period 4|Withdrawal by Subject|0|||
127725673|NCT02525744|459622740|FG002|Period 4|Withdrawal by Subject|0|||
127725674|NCT02525744|459622741|FG003|Period 4|Withdrawal by Subject|0|||
127725675|NCT02525744|459622738|FG000|Period 5|Physician Decision|1|||
127725676|NCT02525744|459622739|FG001|Period 5|Physician Decision|0|||
127725677|NCT02525744|459622740|FG002|Period 5|Physician Decision|0|||
127725678|NCT02525744|459622741|FG003|Period 5|Physician Decision|0|||
127725679|NCT04421456|459622748|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
127725680|NCT04421456|459622749|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
127725681|NCT04421456|459622750|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
127725682|NCT04421456|459622748|FG000|Randomized Treatment Period|Adverse Event|0|||
127725683|NCT04421456|459622749|FG001|Randomized Treatment Period|Adverse Event|1|||
127725684|NCT04421456|459622750|FG002|Randomized Treatment Period|Adverse Event|0|||
127725685|NCT04421456|459622748|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
127889517|NCT00410410|460218102|FG003|Open-Label Period (OL)|Death|0|||
127889518|NCT00410410|460218103|FG004|Open-Label Period (OL)|Death|0|||
127889519|NCT00410410|460218104|FG005|Open-Label Period (OL)|Death|0|||
127889520|NCT00410410|460218105|FG006|Open-Label Period (OL)|Death|0|||
127889521|NCT00410410|460218106|FG007|Open-Label Period (OL)|Death|0|||
127889522|NCT00410410|460218107|FG008|Open-Label Period (OL)|Death|1|||
127889523|NCT00410410|460218099|FG000|Open-Label Period (OL)|Adverse Event|0|||
127725686|NCT04421456|459622749|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
127725687|NCT04421456|459622750|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
127725688|NCT04421456|459622748|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
127725689|NCT04421456|459622749|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
127725690|NCT04421456|459622750|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
127725691|NCT04421456|459622748|FG000|Randomized Treatment Period|Participant non-compliance|1|||
127725692|NCT04421456|459622749|FG001|Randomized Treatment Period|Participant non-compliance|1|||
127725693|NCT04421456|459622750|FG002|Randomized Treatment Period|Participant non-compliance|2|||
127725694|NCT04421456|459622748|FG000|Randomized Treatment Period|Other|0|||
127725695|NCT04421456|459622749|FG001|Randomized Treatment Period|Other|1|||
127725696|NCT04421456|459622750|FG002|Randomized Treatment Period|Other|3|||
127889524|NCT00410410|460218100|FG001|Open-Label Period (OL)|Adverse Event|0|||
127889525|NCT00410410|460218101|FG002|Open-Label Period (OL)|Adverse Event|0|||
127725697|NCT00274287|459622751|FG000|Overall Study|Withdrawal by Subject|1|||
127725698|NCT00274287|459622751|FG000|Overall Study|subject non-compliance|1|||
127889526|NCT00410410|460218102|FG003|Open-Label Period (OL)|Adverse Event|0|||
127889527|NCT00410410|460218103|FG004|Open-Label Period (OL)|Adverse Event|0|||
127889528|NCT00410410|460218104|FG005|Open-Label Period (OL)|Adverse Event|0|||
127889529|NCT00410410|460218105|FG006|Open-Label Period (OL)|Adverse Event|0|||
127889530|NCT00410410|460218106|FG007|Open-Label Period (OL)|Adverse Event|0|||
127889531|NCT00410410|460218107|FG008|Open-Label Period (OL)|Adverse Event|10|||
127889532|NCT00410410|460218099|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
127889533|NCT00410410|460218100|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
127889534|NCT00410410|460218101|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
127889535|NCT00410410|460218102|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
127889536|NCT00410410|460218103|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
127889537|NCT00410410|460218104|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
127889538|NCT00410410|460218105|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
127889539|NCT00410410|460218106|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
127889540|NCT00410410|460218107|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
127889541|NCT00410410|460218099|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
127889542|NCT00410410|460218100|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
127889543|NCT00410410|460218101|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
127889544|NCT00410410|460218102|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
127889545|NCT00410410|460218103|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
127889546|NCT00410410|460218104|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
127889547|NCT00410410|460218105|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
127889548|NCT00410410|460218106|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
127889549|NCT00410410|460218107|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
127889550|NCT00410410|460218099|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
127889551|NCT00410410|460218100|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
127889552|NCT00410410|460218101|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
127725699|NCT01777932|459622754|FG000|Overall Study|Disease progression|136|||
127889553|NCT00410410|460218102|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
127725700|NCT01777932|459622754|FG000|Overall Study|Death|3|||
127725701|NCT01777932|459622754|FG000|Overall Study|Adverse Event|34|||
127725702|NCT01777932|459622754|FG000|Overall Study|Lost to Follow-up|3|||
127725703|NCT01777932|459622754|FG000|Overall Study|Investigator decision|10|||
127889554|NCT00410410|460218103|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
127889555|NCT00410410|460218104|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
127889556|NCT00410410|460218105|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
127889557|NCT00410410|460218106|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
127889558|NCT00410410|460218107|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
127889559|NCT00410410|460218099|FG000|Open-Label Period (OL)|Pregnancy|0|||
127725704|NCT01777932|459622754|FG000|Overall Study|Reimbursement limit|9|||
127725705|NCT01777932|459622754|FG000|Overall Study|Patient refused further treatment|10|||
127725706|NCT01930188|459622760|FG000|Overall Study|unclassified|4|||
127725707|NCT01930188|459622761|FG001|Overall Study|unclassified|5|||
127725708|NCT01930188|459622762|FG002|Overall Study|unclassified|3|||
127725709|NCT01930188|459622760|FG000|Overall Study|Missing follow-up information|2|||
127725710|NCT01930188|459622761|FG001|Overall Study|Missing follow-up information|2|||
127725711|NCT01930188|459622762|FG002|Overall Study|Missing follow-up information|3|||
127725712|NCT01930188|459622760|FG000|Overall Study|Lost to Follow-up|5|||
127725713|NCT01930188|459622761|FG001|Overall Study|Lost to Follow-up|2|||
127725714|NCT01930188|459622762|FG002|Overall Study|Lost to Follow-up|2|||
127725715|NCT01930188|459622760|FG000|Overall Study|Death|2|||
127725716|NCT01930188|459622761|FG001|Overall Study|Death|1|||
127725717|NCT01930188|459622762|FG002|Overall Study|Death|3|||
127725718|NCT01930188|459622760|FG000|Overall Study|Withdrawal by Subject|9|||
127725719|NCT01930188|459622761|FG001|Overall Study|Withdrawal by Subject|11|||
127725720|NCT01930188|459622762|FG002|Overall Study|Withdrawal by Subject|8|||
127725721|NCT02514824|459622763|FG000|Overall Study|Withdrawal by Subject|1|||
127725722|NCT02514824|459622764|FG001|Overall Study|Withdrawal by Subject|0|||
127725723|NCT02514824|459622765|FG002|Overall Study|Withdrawal by Subject|0|||
127725724|NCT02514824|459622766|FG003|Overall Study|Withdrawal by Subject|0|||
127725725|NCT02514824|459622763|FG000|Overall Study|Dose-Limiting Toxicity|0|||
127725726|NCT02514824|459622764|FG001|Overall Study|Dose-Limiting Toxicity|1|||
127725727|NCT02514824|459622765|FG002|Overall Study|Dose-Limiting Toxicity|0|||
127725728|NCT02514824|459622766|FG003|Overall Study|Dose-Limiting Toxicity|0|||
127725729|NCT03150589|459622767|FG000|Overall Study|Withdrawal by Subject|16|||
127725730|NCT03150589|459622768|FG001|Overall Study|Withdrawal by Subject|9|||
127725731|NCT03150589|459622767|FG000|Overall Study|Adverse Event|7|||
127725732|NCT03150589|459622768|FG001|Overall Study|Adverse Event|6|||
127725733|NCT03150589|459622767|FG000|Overall Study|Protocol Violation|4|||
127725734|NCT03150589|459622768|FG001|Overall Study|Protocol Violation|3|||
127725735|NCT03150589|459622767|FG000|Overall Study|Lost to Follow-up|3|||
127725736|NCT03150589|459622768|FG001|Overall Study|Lost to Follow-up|3|||
127725737|NCT03150589|459622767|FG000|Overall Study|Death|2|||
127725738|NCT03150589|459622768|FG001|Overall Study|Death|3|||
127725739|NCT03150589|459622767|FG000|Overall Study|IP non-compliance and other reasons|12|||
127725740|NCT03150589|459622768|FG001|Overall Study|IP non-compliance and other reasons|3|||
127725741|NCT01020435|459622771|FG000|Overall Study|Lost to Follow-up|0|||
127725742|NCT01020435|459622772|FG001|Overall Study|Lost to Follow-up|1|||
127725743|NCT01000649|459622773|FG000|Overall Study|Adverse Event|5|||
127725744|NCT01000649|459622774|FG001|Overall Study|Adverse Event|1|||
127725745|NCT01000649|459622775|FG002|Overall Study|Adverse Event|2|||
127725746|NCT01000649|459622776|FG003|Overall Study|Adverse Event|4|||
127725747|NCT01000649|459622773|FG000|Overall Study|Lost to Follow-up|0|||
127725748|NCT01000649|459622774|FG001|Overall Study|Lost to Follow-up|2|||
127725749|NCT01000649|459622775|FG002|Overall Study|Lost to Follow-up|0|||
127725750|NCT01000649|459622776|FG003|Overall Study|Lost to Follow-up|2|||
127725751|NCT00346398|459622777|FG000|Overall Study|Lost to Follow-up|3|||
127725752|NCT00346398|459622778|FG001|Overall Study|Lost to Follow-up|0|||
127725753|NCT00346398|459622777|FG000|Overall Study|Withdrawal by Subject|0|||
127725754|NCT00346398|459622778|FG001|Overall Study|Withdrawal by Subject|2|||
127725755|NCT02607956|459622779|FG000|Double-Blinded Phase|Withdrew Consent|17|||
127725756|NCT02607956|459622780|FG001|Double-Blinded Phase|Withdrew Consent|19|||
127725757|NCT02607956|459622781|FG002|Double-Blinded Phase|Withdrew Consent|0|||
127725758|NCT02607956|459622782|FG003|Double-Blinded Phase|Withdrew Consent|0|||
127725759|NCT02607956|459622779|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
127725760|NCT02607956|459622780|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
127725761|NCT02607956|459622781|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
127725762|NCT02607956|459622782|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
127725763|NCT02607956|459622779|FG000|Double-Blinded Phase|Randomized but never treated|7|||
127725764|NCT02607956|459622780|FG001|Double-Blinded Phase|Randomized but never treated|5|||
127725765|NCT02607956|459622781|FG002|Double-Blinded Phase|Randomized but never treated|0|||
127725766|NCT02607956|459622782|FG003|Double-Blinded Phase|Randomized but never treated|0|||
127725767|NCT02607956|459622779|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
127725768|NCT02607956|459622780|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
127725769|NCT02607956|459622781|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
127725770|NCT02607956|459622782|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
127725771|NCT02607956|459622779|FG000|Double-Blinded Phase|Death|4|||
127725772|NCT02607956|459622780|FG001|Double-Blinded Phase|Death|4|||
127725773|NCT02607956|459622781|FG002|Double-Blinded Phase|Death|0|||
127725774|NCT02607956|459622782|FG003|Double-Blinded Phase|Death|0|||
127725775|NCT02607956|459622779|FG000|Double-Blinded Phase|Adverse Event|4|||
127725776|NCT02607956|459622780|FG001|Double-Blinded Phase|Adverse Event|3|||
127725777|NCT02607956|459622781|FG002|Double-Blinded Phase|Adverse Event|0|||
127725778|NCT02607956|459622782|FG003|Double-Blinded Phase|Adverse Event|0|||
127725779|NCT02607956|459622779|FG000|Double-Blinded Phase|Protocol Violation|3|||
127725780|NCT02607956|459622780|FG001|Double-Blinded Phase|Protocol Violation|1|||
127889560|NCT00410410|460218100|FG001|Open-Label Period (OL)|Pregnancy|0|||
127889561|NCT00410410|460218101|FG002|Open-Label Period (OL)|Pregnancy|0|||
127889562|NCT00410410|460218102|FG003|Open-Label Period (OL)|Pregnancy|0|||
127889563|NCT00410410|460218103|FG004|Open-Label Period (OL)|Pregnancy|0|||
127889564|NCT00410410|460218104|FG005|Open-Label Period (OL)|Pregnancy|0|||
127889565|NCT00410410|460218105|FG006|Open-Label Period (OL)|Pregnancy|0|||
127889566|NCT00410410|460218106|FG007|Open-Label Period (OL)|Pregnancy|0|||
127889567|NCT00410410|460218107|FG008|Open-Label Period (OL)|Pregnancy|1|||
127889568|NCT00410410|460218099|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
127889569|NCT00410410|460218100|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
127889570|NCT00410410|460218101|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
127889571|NCT00410410|460218102|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
127889572|NCT00410410|460218103|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
127889573|NCT00410410|460218104|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
127889574|NCT00410410|460218105|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
127889575|NCT00410410|460218106|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
127889576|NCT00410410|460218107|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
127889577|NCT00410410|460218099|FG000|Open-Label Period (OL)|Other|0|||
127889578|NCT00410410|460218100|FG001|Open-Label Period (OL)|Other|0|||
127889579|NCT00410410|460218101|FG002|Open-Label Period (OL)|Other|0|||
127889580|NCT00410410|460218102|FG003|Open-Label Period (OL)|Other|0|||
127889581|NCT00410410|460218103|FG004|Open-Label Period (OL)|Other|0|||
127889582|NCT00410410|460218104|FG005|Open-Label Period (OL)|Other|0|||
127889583|NCT00410410|460218105|FG006|Open-Label Period (OL)|Other|0|||
127889584|NCT00410410|460218106|FG007|Open-Label Period (OL)|Other|0|||
127889585|NCT00410410|460218107|FG008|Open-Label Period (OL)|Other|7|||
127889586|NCT01023269|460218108|FG000|Overall Study|early termination of the study|2|||
127889587|NCT01023269|460218109|FG001|Overall Study|early termination of the study|0|||
127889588|NCT00814658|460218111|FG000|Overall Study|Lost to Follow-up|0|||
127889589|NCT00814658|460218112|FG001|Overall Study|Lost to Follow-up|1|||
127889590|NCT00814658|460218111|FG000|Overall Study|Physician Decision|1|||
127889591|NCT00814658|460218112|FG001|Overall Study|Physician Decision|0|||
127889592|NCT00814658|460218111|FG000|Overall Study|Adverse Event|3|||
127889593|NCT00814658|460218112|FG001|Overall Study|Adverse Event|3|||
127889594|NCT02868281|460218113|FG000|Overall Study|Adverse Event|2|||
127725781|NCT02607956|459622781|FG002|Double-Blinded Phase|Protocol Violation|0|||
127725782|NCT02607956|459622782|FG003|Double-Blinded Phase|Protocol Violation|0|||
127725783|NCT02607956|459622779|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
127725784|NCT02607956|459622780|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
127725785|NCT02607956|459622781|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
127725786|NCT02607956|459622782|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
127725787|NCT02607956|459622779|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
127725788|NCT02607956|459622780|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
127725789|NCT02607956|459622781|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
127725790|NCT02607956|459622782|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
127725791|NCT02607956|459622779|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
127725792|NCT02607956|459622780|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
127725793|NCT02607956|459622781|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
127725794|NCT02607956|459622782|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
127725795|NCT02607956|459622779|FG000|Open-Label Extension Phase|Death|0|||
127725796|NCT02607956|459622780|FG001|Open-Label Extension Phase|Death|0|||
127725797|NCT02607956|459622781|FG002|Open-Label Extension Phase|Death|1|||
127725798|NCT02607956|459622782|FG003|Open-Label Extension Phase|Death|3|||
127725799|NCT02607956|459622779|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
127889595|NCT02868281|460218114|FG001|Overall Study|Adverse Event|2|||
127889596|NCT02868281|460218113|FG000|Overall Study|Protocol Violation|13|||
127889597|NCT02868281|460218114|FG001|Overall Study|Protocol Violation|10|||
127889598|NCT02868281|460218113|FG000|Overall Study|Lost to Follow-up|3|||
127889599|NCT02868281|460218114|FG001|Overall Study|Lost to Follow-up|6|||
127889600|NCT02868281|460218113|FG000|Overall Study|Withdrawal by Subject|11|||
127889601|NCT02868281|460218114|FG001|Overall Study|Withdrawal by Subject|15|||
127889602|NCT02868281|460218113|FG000|Overall Study|Physician Decision|2|||
127485446|NCT01240863|458741181|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
127725800|NCT02607956|459622780|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
127725801|NCT02607956|459622781|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
127725802|NCT02607956|459622782|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
127725803|NCT02607956|459622779|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
127725804|NCT02607956|459622780|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
127725805|NCT02607956|459622781|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
127725806|NCT02607956|459622782|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
127725807|NCT02607956|459622779|FG000|Open-Label Extension Phase|Protocol Violation|0|||
127725808|NCT02607956|459622780|FG001|Open-Label Extension Phase|Protocol Violation|0|||
127725809|NCT02607956|459622781|FG002|Open-Label Extension Phase|Protocol Violation|0|||
127725810|NCT02607956|459622782|FG003|Open-Label Extension Phase|Protocol Violation|2|||
127725811|NCT02607956|459622779|FG000|Open-Label Extension Phase|Pregnancy|0|||
127725812|NCT02607956|459622780|FG001|Open-Label Extension Phase|Pregnancy|0|||
127725813|NCT02607956|459622781|FG002|Open-Label Extension Phase|Pregnancy|0|||
127725814|NCT02607956|459622782|FG003|Open-Label Extension Phase|Pregnancy|1|||
127725815|NCT00103857|459622783|FG000|54-Week Base Study|Adverse Event|12|||
127725816|NCT00103857|459622784|FG001|54-Week Base Study|Adverse Event|9|||
127725817|NCT00103857|459622785|FG002|54-Week Base Study|Adverse Event|11|||
127725818|NCT00103857|459622786|FG003|54-Week Base Study|Adverse Event|6|||
127725819|NCT00103857|459622787|FG004|54-Week Base Study|Adverse Event|5|||
127725820|NCT00103857|459622788|FG005|54-Week Base Study|Adverse Event|11|||
127725821|NCT00103857|459622789|FG006|54-Week Base Study|Adverse Event|3|||
127725822|NCT00103857|459622783|FG000|54-Week Base Study|Death|0|||
127725823|NCT00103857|459622784|FG001|54-Week Base Study|Death|0|||
127725824|NCT00103857|459622785|FG002|54-Week Base Study|Death|0|||
127725825|NCT00103857|459622786|FG003|54-Week Base Study|Death|0|||
127725826|NCT00103857|459622787|FG004|54-Week Base Study|Death|1|||
127725827|NCT00103857|459622788|FG005|54-Week Base Study|Death|1|||
127725828|NCT00103857|459622789|FG006|54-Week Base Study|Death|0|||
127725829|NCT00103857|459622783|FG000|54-Week Base Study|Lack of Efficacy|11|||
127725830|NCT00103857|459622784|FG001|54-Week Base Study|Lack of Efficacy|14|||
127725831|NCT00103857|459622785|FG002|54-Week Base Study|Lack of Efficacy|8|||
127725832|NCT00103857|459622786|FG003|54-Week Base Study|Lack of Efficacy|4|||
127725833|NCT00103857|459622787|FG004|54-Week Base Study|Lack of Efficacy|3|||
127725834|NCT00103857|459622788|FG005|54-Week Base Study|Lack of Efficacy|14|||
127725835|NCT00103857|459622789|FG006|54-Week Base Study|Lack of Efficacy|19|||
127725836|NCT00103857|459622783|FG000|54-Week Base Study|Lost to Follow-up|5|||
127725837|NCT00103857|459622784|FG001|54-Week Base Study|Lost to Follow-up|4|||
127725838|NCT00103857|459622785|FG002|54-Week Base Study|Lost to Follow-up|7|||
127725839|NCT00103857|459622786|FG003|54-Week Base Study|Lost to Follow-up|5|||
127725840|NCT00103857|459622787|FG004|54-Week Base Study|Lost to Follow-up|10|||
127725841|NCT00103857|459622788|FG005|54-Week Base Study|Lost to Follow-up|9|||
127725842|NCT00103857|459622789|FG006|54-Week Base Study|Lost to Follow-up|3|||
127725843|NCT00103857|459622783|FG000|54-Week Base Study|Physician Decision|1|||
127725844|NCT00103857|459622784|FG001|54-Week Base Study|Physician Decision|1|||
127725845|NCT00103857|459622785|FG002|54-Week Base Study|Physician Decision|0|||
127725846|NCT00103857|459622786|FG003|54-Week Base Study|Physician Decision|0|||
127725847|NCT00103857|459622787|FG004|54-Week Base Study|Physician Decision|1|||
127725848|NCT00103857|459622788|FG005|54-Week Base Study|Physician Decision|0|||
127725849|NCT00103857|459622789|FG006|54-Week Base Study|Physician Decision|0|||
127725850|NCT00103857|459622783|FG000|54-Week Base Study|Pregnancy|1|||
127725851|NCT00103857|459622784|FG001|54-Week Base Study|Pregnancy|0|||
127725852|NCT00103857|459622785|FG002|54-Week Base Study|Pregnancy|0|||
127725853|NCT00103857|459622786|FG003|54-Week Base Study|Pregnancy|0|||
127725854|NCT00103857|459622787|FG004|54-Week Base Study|Pregnancy|1|||
127725855|NCT00103857|459622788|FG005|54-Week Base Study|Pregnancy|0|||
127725856|NCT00103857|459622789|FG006|54-Week Base Study|Pregnancy|1|||
127725857|NCT00103857|459622783|FG000|54-Week Base Study|Protocol Violation|6|||
127725858|NCT00103857|459622784|FG001|54-Week Base Study|Protocol Violation|4|||
127725859|NCT00103857|459622785|FG002|54-Week Base Study|Protocol Violation|2|||
127725860|NCT00103857|459622786|FG003|54-Week Base Study|Protocol Violation|4|||
127725861|NCT00103857|459622787|FG004|54-Week Base Study|Protocol Violation|0|||
127725862|NCT00103857|459622788|FG005|54-Week Base Study|Protocol Violation|3|||
127725863|NCT00103857|459622789|FG006|54-Week Base Study|Protocol Violation|3|||
127725864|NCT00103857|459622783|FG000|54-Week Base Study|Withdrawal by Subject|17|||
127725865|NCT00103857|459622784|FG001|54-Week Base Study|Withdrawal by Subject|16|||
127725866|NCT00103857|459622785|FG002|54-Week Base Study|Withdrawal by Subject|16|||
127725867|NCT00103857|459622786|FG003|54-Week Base Study|Withdrawal by Subject|15|||
127725868|NCT00103857|459622787|FG004|54-Week Base Study|Withdrawal by Subject|10|||
127725869|NCT00103857|459622788|FG005|54-Week Base Study|Withdrawal by Subject|15|||
127725870|NCT00103857|459622789|FG006|54-Week Base Study|Withdrawal by Subject|4|||
127725871|NCT00103857|459622783|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
127725872|NCT00103857|459622784|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
127725873|NCT00103857|459622785|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
127725874|NCT00103857|459622786|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
127725875|NCT00103857|459622787|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
127725876|NCT00103857|459622788|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
127725877|NCT00103857|459622789|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
127725878|NCT00103857|459622783|FG000|54-Week Base Study|patient moved|0|||
127725879|NCT00103857|459622784|FG001|54-Week Base Study|patient moved|1|||
127725880|NCT00103857|459622785|FG002|54-Week Base Study|patient moved|1|||
127725881|NCT00103857|459622786|FG003|54-Week Base Study|patient moved|2|||
127725882|NCT00103857|459622787|FG004|54-Week Base Study|patient moved|3|||
127725883|NCT00103857|459622788|FG005|54-Week Base Study|patient moved|1|||
127725884|NCT00103857|459622789|FG006|54-Week Base Study|patient moved|0|||
127725885|NCT00103857|459622783|FG000|54-Week Base Study|non-compliance with study procedures|1|||
127725886|NCT00103857|459622784|FG001|54-Week Base Study|non-compliance with study procedures|2|||
127725887|NCT00103857|459622785|FG002|54-Week Base Study|non-compliance with study procedures|0|||
127725888|NCT00103857|459622786|FG003|54-Week Base Study|non-compliance with study procedures|0|||
127725889|NCT00103857|459622787|FG004|54-Week Base Study|non-compliance with study procedures|0|||
127725890|NCT00103857|459622788|FG005|54-Week Base Study|non-compliance with study procedures|2|||
127725891|NCT00103857|459622789|FG006|54-Week Base Study|non-compliance with study procedures|0|||
127725892|NCT00103857|459622783|FG000|54-Week Base Study|patient incarcerated|0|||
127725893|NCT00103857|459622784|FG001|54-Week Base Study|patient incarcerated|0|||
127725894|NCT00103857|459622785|FG002|54-Week Base Study|patient incarcerated|0|||
127725895|NCT00103857|459622786|FG003|54-Week Base Study|patient incarcerated|0|||
127725896|NCT00103857|459622787|FG004|54-Week Base Study|patient incarcerated|1|||
127725897|NCT00103857|459622788|FG005|54-Week Base Study|patient incarcerated|1|||
127725898|NCT00103857|459622789|FG006|54-Week Base Study|patient incarcerated|0|||
127725899|NCT00103857|459622783|FG000|54-Week Base Study|laboratory reporting error|0|||
127725900|NCT00103857|459622784|FG001|54-Week Base Study|laboratory reporting error|0|||
127725901|NCT00103857|459622785|FG002|54-Week Base Study|laboratory reporting error|0|||
127725902|NCT00103857|459622786|FG003|54-Week Base Study|laboratory reporting error|0|||
127725903|NCT00103857|459622787|FG004|54-Week Base Study|laboratory reporting error|1|||
127725904|NCT00103857|459622788|FG005|54-Week Base Study|laboratory reporting error|0|||
127725905|NCT00103857|459622789|FG006|54-Week Base Study|laboratory reporting error|0|||
127725906|NCT00103857|459622783|FG000|54-Week Base Study|site error|0|||
127725907|NCT00103857|459622784|FG001|54-Week Base Study|site error|0|||
127725908|NCT00103857|459622785|FG002|54-Week Base Study|site error|0|||
127725909|NCT00103857|459622786|FG003|54-Week Base Study|site error|0|||
127725910|NCT00103857|459622787|FG004|54-Week Base Study|site error|0|||
127725911|NCT00103857|459622788|FG005|54-Week Base Study|site error|1|||
127725912|NCT00103857|459622789|FG006|54-Week Base Study|site error|0|||
127725913|NCT00103857|459622783|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
127725914|NCT00103857|459622784|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
127725915|NCT00103857|459622785|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
127725916|NCT00103857|459622786|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
127725917|NCT00103857|459622787|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
127725918|NCT00103857|459622788|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
127725919|NCT00103857|459622789|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
127725920|NCT00103857|459622783|FG000|50-Week Extension Study|Adverse Event|2|||
127725921|NCT00103857|459622784|FG001|50-Week Extension Study|Adverse Event|3|||
127725922|NCT00103857|459622785|FG002|50-Week Extension Study|Adverse Event|2|||
127725923|NCT00103857|459622786|FG003|50-Week Extension Study|Adverse Event|0|||
127725924|NCT00103857|459622787|FG004|50-Week Extension Study|Adverse Event|1|||
127725925|NCT00103857|459622788|FG005|50-Week Extension Study|Adverse Event|1|||
127725926|NCT00103857|459622789|FG006|50-Week Extension Study|Adverse Event|0|||
127725927|NCT00103857|459622783|FG000|50-Week Extension Study|Death|0|||
127725928|NCT00103857|459622784|FG001|50-Week Extension Study|Death|0|||
127725929|NCT00103857|459622785|FG002|50-Week Extension Study|Death|0|||
127725930|NCT00103857|459622786|FG003|50-Week Extension Study|Death|1|||
127725931|NCT00103857|459622787|FG004|50-Week Extension Study|Death|0|||
127725932|NCT00103857|459622788|FG005|50-Week Extension Study|Death|1|||
127725933|NCT00103857|459622789|FG006|50-Week Extension Study|Death|0|||
127725934|NCT00103857|459622783|FG000|50-Week Extension Study|Lack of Efficacy|26|||
127725935|NCT00103857|459622784|FG001|50-Week Extension Study|Lack of Efficacy|15|||
127725936|NCT00103857|459622785|FG002|50-Week Extension Study|Lack of Efficacy|13|||
127725937|NCT00103857|459622786|FG003|50-Week Extension Study|Lack of Efficacy|16|||
127725938|NCT00103857|459622787|FG004|50-Week Extension Study|Lack of Efficacy|8|||
127725939|NCT00103857|459622788|FG005|50-Week Extension Study|Lack of Efficacy|8|||
127725940|NCT00103857|459622789|FG006|50-Week Extension Study|Lack of Efficacy|0|||
127725941|NCT00103857|459622783|FG000|50-Week Extension Study|Lost to Follow-up|4|||
127725942|NCT00103857|459622784|FG001|50-Week Extension Study|Lost to Follow-up|0|||
127725943|NCT00103857|459622785|FG002|50-Week Extension Study|Lost to Follow-up|1|||
127725944|NCT00103857|459622786|FG003|50-Week Extension Study|Lost to Follow-up|4|||
127725945|NCT00103857|459622787|FG004|50-Week Extension Study|Lost to Follow-up|3|||
127725946|NCT00103857|459622788|FG005|50-Week Extension Study|Lost to Follow-up|3|||
127725947|NCT00103857|459622789|FG006|50-Week Extension Study|Lost to Follow-up|0|||
127889603|NCT02868281|460218114|FG001|Overall Study|Physician Decision|0|||
127889604|NCT02868281|460218113|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
127889605|NCT02868281|460218114|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
127889606|NCT02868281|460218113|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
127889607|NCT02868281|460218114|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
127889608|NCT02868281|460218113|FG000|Overall Study|Long journey/moving away|1|||
127889609|NCT02868281|460218114|FG001|Overall Study|Long journey/moving away|1|||
127889610|NCT01783730|460218118|FG000|Overall Study|Failed to meet inclusion criteria|6|||
127889611|NCT01841359|460218119|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
127889612|NCT01841359|460218119|FG000|Overall Study|Concommitant medical issues|2|||
127889613|NCT01841359|460218119|FG000|Overall Study|Adverse Event|3|||
127889614|NCT01841359|460218119|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
127889615|NCT02151461|460218120|FG000|Overall Study|Adverse Event|5|||
127889616|NCT02151461|460218121|FG001|Overall Study|Adverse Event|1|||
127889617|NCT02151461|460218122|FG002|Overall Study|Adverse Event|0|||
127889618|NCT02151461|460218123|FG003|Overall Study|Adverse Event|2|||
127725948|NCT00103857|459622783|FG000|50-Week Extension Study|Physician Decision|0|||
127725949|NCT00103857|459622784|FG001|50-Week Extension Study|Physician Decision|1|||
127725950|NCT00103857|459622785|FG002|50-Week Extension Study|Physician Decision|1|||
127725951|NCT00103857|459622786|FG003|50-Week Extension Study|Physician Decision|0|||
127725952|NCT00103857|459622787|FG004|50-Week Extension Study|Physician Decision|0|||
127725953|NCT00103857|459622788|FG005|50-Week Extension Study|Physician Decision|0|||
127725954|NCT00103857|459622789|FG006|50-Week Extension Study|Physician Decision|0|||
127725955|NCT00103857|459622783|FG000|50-Week Extension Study|Pregnancy|0|||
127725956|NCT00103857|459622784|FG001|50-Week Extension Study|Pregnancy|0|||
127725957|NCT00103857|459622785|FG002|50-Week Extension Study|Pregnancy|1|||
127725958|NCT00103857|459622786|FG003|50-Week Extension Study|Pregnancy|0|||
127725959|NCT00103857|459622787|FG004|50-Week Extension Study|Pregnancy|1|||
127725960|NCT00103857|459622788|FG005|50-Week Extension Study|Pregnancy|0|||
127725961|NCT00103857|459622789|FG006|50-Week Extension Study|Pregnancy|0|||
127725962|NCT00103857|459622783|FG000|50-Week Extension Study|Protocol Violation|1|||
127725963|NCT00103857|459622784|FG001|50-Week Extension Study|Protocol Violation|1|||
127725964|NCT00103857|459622785|FG002|50-Week Extension Study|Protocol Violation|1|||
127725965|NCT00103857|459622786|FG003|50-Week Extension Study|Protocol Violation|2|||
127725966|NCT00103857|459622787|FG004|50-Week Extension Study|Protocol Violation|0|||
127725967|NCT00103857|459622788|FG005|50-Week Extension Study|Protocol Violation|1|||
127725968|NCT00103857|459622789|FG006|50-Week Extension Study|Protocol Violation|0|||
127725969|NCT00103857|459622783|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
127725970|NCT00103857|459622784|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
127725971|NCT00103857|459622785|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
127725972|NCT00103857|459622786|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
127725973|NCT00103857|459622787|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
127725974|NCT00103857|459622788|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
127725975|NCT00103857|459622789|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
127725976|NCT00103857|459622783|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
127725977|NCT00103857|459622784|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
127725978|NCT00103857|459622785|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
127725979|NCT00103857|459622786|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
127725980|NCT00103857|459622787|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
127725981|NCT00103857|459622788|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
127725982|NCT00103857|459622789|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
127725983|NCT00103857|459622783|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
127725984|NCT00103857|459622784|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
127725985|NCT00103857|459622785|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
127725986|NCT00103857|459622786|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
127725987|NCT00103857|459622787|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
127889619|NCT02151461|460218120|FG000|Overall Study|Lost to Follow-up|0|||
127725988|NCT00103857|459622788|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
127725989|NCT00103857|459622789|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
127725990|NCT00103857|459622783|FG000|50-Week Extension Study|patient moved|0|||
127725991|NCT00103857|459622784|FG001|50-Week Extension Study|patient moved|0|||
127725992|NCT00103857|459622785|FG002|50-Week Extension Study|patient moved|1|||
127889620|NCT02151461|460218121|FG001|Overall Study|Lost to Follow-up|0|||
127889621|NCT02151461|460218122|FG002|Overall Study|Lost to Follow-up|1|||
127889622|NCT02151461|460218123|FG003|Overall Study|Lost to Follow-up|1|||
127725993|NCT00103857|459622786|FG003|50-Week Extension Study|patient moved|2|||
127725994|NCT00103857|459622787|FG004|50-Week Extension Study|patient moved|0|||
127725995|NCT00103857|459622788|FG005|50-Week Extension Study|patient moved|0|||
127725996|NCT00103857|459622789|FG006|50-Week Extension Study|patient moved|0|||
127725997|NCT00103857|459622783|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
127725998|NCT00103857|459622784|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
127725999|NCT00103857|459622785|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
127726000|NCT00103857|459622786|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
127726001|NCT00103857|459622787|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
127726002|NCT00103857|459622788|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
127726003|NCT00103857|459622789|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
127726004|NCT00103857|459622783|FG000|50-Week Extension Study|reason unspecified|0|||
127726005|NCT00103857|459622784|FG001|50-Week Extension Study|reason unspecified|0|||
127726006|NCT00103857|459622785|FG002|50-Week Extension Study|reason unspecified|0|||
127726007|NCT00103857|459622786|FG003|50-Week Extension Study|reason unspecified|0|||
127726008|NCT00103857|459622787|FG004|50-Week Extension Study|reason unspecified|1|||
127726009|NCT00103857|459622788|FG005|50-Week Extension Study|reason unspecified|0|||
127726010|NCT00103857|459622789|FG006|50-Week Extension Study|reason unspecified|0|||
127726011|NCT01005914|459622790|FG000|Overall Study|Adverse Event|4|||
127726012|NCT01005914|459622790|FG000|Overall Study|Death|4|||
127726013|NCT01005914|459622790|FG000|Overall Study|Lack of Efficacy|1|||
127726014|NCT01005914|459622790|FG000|Overall Study|Withdrawal by Subject|1|||
127889623|NCT02151461|460218120|FG000|Overall Study|Withdrawal by Subject|1|||
127889624|NCT02151461|460218121|FG001|Overall Study|Withdrawal by Subject|0|||
127726015|NCT01240785|459622792|FG000|Overall Study|Lost to Follow-up|1|||
127726016|NCT01240785|459622793|FG001|Overall Study|Lost to Follow-up|0|||
127726017|NCT01240785|459622792|FG000|Overall Study|Protocol Violation|0|||
127726018|NCT01240785|459622793|FG001|Overall Study|Protocol Violation|3|||
127726019|NCT02132195|459622796|FG000|Initial Assignment|Relapsed|14|||
127726020|NCT02132195|459622797|FG001|Initial Assignment|Relapsed|0|||
127726021|NCT02132195|459622798|FG002|Initial Assignment|Relapsed|0|||
127726022|NCT02132195|459622796|FG000|Rescue Therapy|Relapsed|0|||
127726023|NCT02132195|459622797|FG001|Rescue Therapy|Relapsed|0|||
127726024|NCT02132195|459622798|FG002|Rescue Therapy|Relapsed|7|||
127726025|NCT02132195|459622796|FG000|Rescue Therapy|Physician Decision|0|||
127726026|NCT02132195|459622797|FG001|Rescue Therapy|Physician Decision|0|||
127726027|NCT02132195|459622798|FG002|Rescue Therapy|Physician Decision|1|||
127726028|NCT02132195|459622796|FG000|Rescue Therapy|Withdrawal by Subject|0|||
127726029|NCT02132195|459622797|FG001|Rescue Therapy|Withdrawal by Subject|0|||
127726030|NCT02132195|459622798|FG002|Rescue Therapy|Withdrawal by Subject|1|||
127726031|NCT02132195|459622796|FG000|Rescue Therapy|Adverse Event|0|||
127726032|NCT02132195|459622797|FG001|Rescue Therapy|Adverse Event|0|||
127726033|NCT02132195|459622798|FG002|Rescue Therapy|Adverse Event|2|||
127726034|NCT03065400|459622801|FG000|Overall Study|Adverse Event|1|||
127726035|NCT03065400|459622801|FG000|Overall Study|Physician Decision|3|||
127726036|NCT03065400|459622801|FG000|Overall Study|Withdrawal by Subject|1|||
127726037|NCT03065400|459622801|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
127726038|NCT02102724|459622802|FG000|Overall Study|Lost to Follow-up|1|||
127726039|NCT02102724|459622803|FG001|Overall Study|Lost to Follow-up|0|||
127726040|NCT02102724|459622802|FG000|Overall Study|surgery for brain aneurysm|1|||
127726041|NCT02102724|459622803|FG001|Overall Study|surgery for brain aneurysm|1|||
127726042|NCT03072862|459622804|FG000|Overall Study|Withdrawal by Subject|4|||
127726043|NCT03072862|459622804|FG000|Overall Study|Lost to Follow-up|6|||
127726044|NCT03072862|459622804|FG000|Overall Study|Protocol Violation|4|||
127726045|NCT03072862|459622804|FG000|Overall Study|Physician Decision|2|||
127726046|NCT03072862|459622804|FG000|Overall Study|Death|1|||
127726047|NCT03072862|459622804|FG000|Overall Study|Adverse Event|1|||
127726048|NCT02203513|459622805|FG000|Overall Study|Refused further treatment|2|||
127726049|NCT02203513|459622806|FG001|Overall Study|Refused further treatment|0|||
127726050|NCT02203513|459622807|FG002|Overall Study|Refused further treatment|1|||
127726051|NCT02203513|459622808|FG003|Overall Study|Refused further treatment|0|||
127726052|NCT02203513|459622809|FG004|Overall Study|Refused further treatment|0|||
127726053|NCT02203513|459622805|FG000|Overall Study|Switched to alternative treatment|3|||
127726054|NCT02203513|459622806|FG001|Overall Study|Switched to alternative treatment|4|||
127726055|NCT02203513|459622807|FG002|Overall Study|Switched to alternative treatment|0|||
127726056|NCT02203513|459622808|FG003|Overall Study|Switched to alternative treatment|0|||
127726057|NCT02203513|459622809|FG004|Overall Study|Switched to alternative treatment|4|||
127726058|NCT02203513|459622805|FG000|Overall Study|Did not receive investigational product (IP)|0|||
127889625|NCT02151461|460218122|FG002|Overall Study|Withdrawal by Subject|1|||
127726059|NCT02203513|459622806|FG001|Overall Study|Did not receive investigational product (IP)|1|||
127726060|NCT02203513|459622807|FG002|Overall Study|Did not receive investigational product (IP)|0|||
127726061|NCT02203513|459622808|FG003|Overall Study|Did not receive investigational product (IP)|0|||
127726062|NCT02203513|459622809|FG004|Overall Study|Did not receive investigational product (IP)|0|||
127726063|NCT02203513|459622805|FG000|Overall Study|Death (unrelated to study therapy)|1|||
127726064|NCT02203513|459622806|FG001|Overall Study|Death (unrelated to study therapy)|3|||
127726065|NCT02203513|459622807|FG002|Overall Study|Death (unrelated to study therapy)|1|||
127726066|NCT02203513|459622808|FG003|Overall Study|Death (unrelated to study therapy)|0|||
127726067|NCT02203513|459622809|FG004|Overall Study|Death (unrelated to study therapy)|2|||
127726068|NCT02203513|459622805|FG000|Overall Study|Lost to Follow-up|0|||
127726069|NCT02203513|459622806|FG001|Overall Study|Lost to Follow-up|0|||
127726070|NCT02203513|459622807|FG002|Overall Study|Lost to Follow-up|1|||
127726071|NCT02203513|459622808|FG003|Overall Study|Lost to Follow-up|1|||
127726072|NCT02203513|459622809|FG004|Overall Study|Lost to Follow-up|0|||
127726073|NCT02513667|459622810|FG000|Overall Study|Withdrawal by Subject|0|||
127726074|NCT02513667|459622811|FG001|Overall Study|Withdrawal by Subject|1|||
127726075|NCT00912964|459622820|FG000|Overall Study|Eligibility criterion not met|1|||
127726076|NCT00912964|459622821|FG001|Overall Study|Eligibility criterion not met|1|||
127726077|NCT00912964|459622822|FG002|Overall Study|Eligibility criterion not met|0|||
127726078|NCT00912964|459622820|FG000|Overall Study|Adverse Event|15|||
127726079|NCT00912964|459622821|FG001|Overall Study|Adverse Event|18|||
127726080|NCT00912964|459622822|FG002|Overall Study|Adverse Event|12|||
127726081|NCT00912964|459622820|FG000|Overall Study|Lack of Efficacy|11|||
127726082|NCT00912964|459622821|FG001|Overall Study|Lack of Efficacy|4|||
127726083|NCT00912964|459622822|FG002|Overall Study|Lack of Efficacy|3|||
127726084|NCT00912964|459622820|FG000|Overall Study|Withdrawal by Subject|20|||
127726085|NCT00912964|459622821|FG001|Overall Study|Withdrawal by Subject|12|||
127726086|NCT00912964|459622822|FG002|Overall Study|Withdrawal by Subject|18|||
127726087|NCT00912964|459622820|FG000|Overall Study|Lost to Follow-up|4|||
127726088|NCT00912964|459622821|FG001|Overall Study|Lost to Follow-up|3|||
127726089|NCT00912964|459622822|FG002|Overall Study|Lost to Follow-up|3|||
127726090|NCT00912964|459622820|FG000|Overall Study|Protocol Violation|5|||
127726091|NCT00912964|459622821|FG001|Overall Study|Protocol Violation|3|||
127726092|NCT00912964|459622822|FG002|Overall Study|Protocol Violation|8|||
127726093|NCT00912964|459622820|FG000|Overall Study|Taking exclusionary medications|7|||
127726094|NCT00912964|459622821|FG001|Overall Study|Taking exclusionary medications|4|||
127726095|NCT00912964|459622822|FG002|Overall Study|Taking exclusionary medications|8|||
127726096|NCT00912964|459622820|FG000|Overall Study|Medical History|1|||
127726097|NCT00912964|459622821|FG001|Overall Study|Medical History|0|||
127726098|NCT00912964|459622822|FG002|Overall Study|Medical History|0|||
127726099|NCT00912964|459622820|FG000|Overall Study|Non-compliance with study procedures|2|||
127726100|NCT00912964|459622821|FG001|Overall Study|Non-compliance with study procedures|0|||
127726101|NCT00912964|459622822|FG002|Overall Study|Non-compliance with study procedures|0|||
127726102|NCT00912964|459622820|FG000|Overall Study|Violation of exclusion criterion|0|||
127726103|NCT00912964|459622821|FG001|Overall Study|Violation of exclusion criterion|0|||
127726104|NCT00912964|459622822|FG002|Overall Study|Violation of exclusion criterion|2|||
127726105|NCT00912964|459622820|FG000|Overall Study|Randomized but never received study drug|0|||
127726106|NCT00912964|459622821|FG001|Overall Study|Randomized but never received study drug|1|||
127726107|NCT00912964|459622822|FG002|Overall Study|Randomized but never received study drug|0|||
127726108|NCT02978716|459622823|FG000|Overall Study|Death|25|||
127726109|NCT02978716|459622824|FG001|Overall Study|Death|13|||
127726110|NCT02978716|459622825|FG002|Overall Study|Death|20|||
127726111|NCT02978716|459622823|FG000|Overall Study|Lost to Follow-up|0|||
127726112|NCT02978716|459622824|FG001|Overall Study|Lost to Follow-up|0|||
127726113|NCT02978716|459622825|FG002|Overall Study|Lost to Follow-up|1|||
127726114|NCT02978716|459622823|FG000|Overall Study|Withdrawal by Subject|6|||
127726115|NCT02978716|459622824|FG001|Overall Study|Withdrawal by Subject|4|||
127726116|NCT02978716|459622825|FG002|Overall Study|Withdrawal by Subject|5|||
127726117|NCT02978716|459622823|FG000|Overall Study|Sponsor terminated|2|||
127726118|NCT02978716|459622824|FG001|Overall Study|Sponsor terminated|13|||
127726119|NCT02978716|459622825|FG002|Overall Study|Sponsor terminated|9|||
127726120|NCT02978716|459622823|FG000|Overall Study|Other|1|||
127726121|NCT02978716|459622824|FG001|Overall Study|Other|3|||
127726122|NCT02978716|459622825|FG002|Overall Study|Other|0|||
127726123|NCT02613403|459622828|FG000|Overall Study|Lost to Follow-up|0|||
127726124|NCT02613403|459622829|FG001|Overall Study|Lost to Follow-up|1|||
127726125|NCT02613403|459622830|FG002|Overall Study|Lost to Follow-up|0|||
127726126|NCT02613403|459622831|FG003|Overall Study|Lost to Follow-up|0|||
127726127|NCT02613403|459622832|FG004|Overall Study|Lost to Follow-up|0|||
127726128|NCT02613403|459622828|FG000|Overall Study|Withdrawal by Subject|2|||
127726129|NCT02613403|459622829|FG001|Overall Study|Withdrawal by Subject|0|||
127726130|NCT02613403|459622830|FG002|Overall Study|Withdrawal by Subject|0|||
127726131|NCT02613403|459622831|FG003|Overall Study|Withdrawal by Subject|0|||
127726132|NCT02613403|459622832|FG004|Overall Study|Withdrawal by Subject|0|||
127726133|NCT02470806|459622833|FG000|Overall Study|Lost to Follow-up|1|||
127726134|NCT02470806|459622834|FG001|Overall Study|Lost to Follow-up|1|||
127726135|NCT02470806|459622833|FG000|Overall Study|Adverse Event|5|||
127726136|NCT02470806|459622834|FG001|Overall Study|Adverse Event|2|||
127726137|NCT02470806|459622833|FG000|Overall Study|Protocol Violation|4|||
127726138|NCT02470806|459622834|FG001|Overall Study|Protocol Violation|11|||
127726139|NCT02470806|459622833|FG000|Overall Study|Physician Decision|0|||
127726140|NCT02470806|459622834|FG001|Overall Study|Physician Decision|3|||
127726141|NCT02470806|459622833|FG000|Overall Study|Withdrawal by Subject|3|||
127726142|NCT02470806|459622834|FG001|Overall Study|Withdrawal by Subject|10|||
127726143|NCT02470806|459622833|FG000|Overall Study|Lack of Efficacy|5|||
127726144|NCT02470806|459622834|FG001|Overall Study|Lack of Efficacy|15|||
127726145|NCT01147471|459622835|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
127726146|NCT01147471|459622836|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
127726147|NCT01147471|459622835|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
127726148|NCT01147471|459622836|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
127726149|NCT01147471|459622835|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
127726150|NCT01147471|459622836|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
127726151|NCT01147471|459622835|FG000|3 Month Follow Up|Lost to Follow-up|1|||
127726152|NCT01147471|459622836|FG001|3 Month Follow Up|Lost to Follow-up|1|||
127726153|NCT01147471|459622835|FG000|3 Month Follow Up|Physician Decision|0|||
127726154|NCT01147471|459622836|FG001|3 Month Follow Up|Physician Decision|1|||
127726155|NCT01147471|459622835|FG000|6 Month Follow Up|Lost to Follow-up|4|||
127726156|NCT01147471|459622836|FG001|6 Month Follow Up|Lost to Follow-up|2|||
127726157|NCT01294644|459622844|FG000|Overall Study|Adverse Event|2|||
127726158|NCT01294644|459622845|FG001|Overall Study|Adverse Event|0|||
127726159|NCT01294644|459622846|FG002|Overall Study|Adverse Event|1|||
127726160|NCT01294644|459622844|FG000|Overall Study|Withdrawal by Subject|3|||
127726161|NCT01294644|459622845|FG001|Overall Study|Withdrawal by Subject|7|||
127726162|NCT01294644|459622846|FG002|Overall Study|Withdrawal by Subject|4|||
127726163|NCT01294644|459622844|FG000|Overall Study|Lost to Follow-up|3|||
127726164|NCT01294644|459622845|FG001|Overall Study|Lost to Follow-up|2|||
127726165|NCT01294644|459622846|FG002|Overall Study|Lost to Follow-up|5|||
127726166|NCT01294644|459622844|FG000|Overall Study|Miscellaneous Reason|2|||
127726167|NCT01294644|459622845|FG001|Overall Study|Miscellaneous Reason|1|||
127726168|NCT01294644|459622846|FG002|Overall Study|Miscellaneous Reason|4|||
127726169|NCT02188459|459622847|FG000|Overall Study|Lost to Follow-up|3|||
127726170|NCT02188459|459622848|FG001|Overall Study|Lost to Follow-up|4|||
127726171|NCT02188459|459622847|FG000|Overall Study|Early Termination|0|||
127726172|NCT02188459|459622848|FG001|Overall Study|Early Termination|3|||
127726173|NCT01986348|459622849|FG000|Overall Study|Death|8|||
127726174|NCT01986348|459622850|FG001|Overall Study|Death|22|||
127726175|NCT01986348|459622851|FG002|Overall Study|Death|10|||
127726176|NCT01986348|459622852|FG003|Overall Study|Death|21|||
127726177|NCT01986348|459622849|FG000|Overall Study|Lost to Follow-up|0|||
127726178|NCT01986348|459622850|FG001|Overall Study|Lost to Follow-up|0|||
127726179|NCT01986348|459622851|FG002|Overall Study|Lost to Follow-up|0|||
127726180|NCT01986348|459622852|FG003|Overall Study|Lost to Follow-up|2|||
127726181|NCT01986348|459622849|FG000|Overall Study|Physician Decision|0|||
127726182|NCT01986348|459622850|FG001|Overall Study|Physician Decision|0|||
127726183|NCT01986348|459622851|FG002|Overall Study|Physician Decision|0|||
127726184|NCT01986348|459622852|FG003|Overall Study|Physician Decision|1|||
127726185|NCT01986348|459622849|FG000|Overall Study|Progressive Disease|0|||
127726186|NCT01986348|459622850|FG001|Overall Study|Progressive Disease|0|||
127726187|NCT01986348|459622851|FG002|Overall Study|Progressive Disease|2|||
127726188|NCT01986348|459622852|FG003|Overall Study|Progressive Disease|0|||
127726189|NCT01986348|459622849|FG000|Overall Study|Withdrawal by Participant|0|||
127726190|NCT01986348|459622850|FG001|Overall Study|Withdrawal by Participant|1|||
127726191|NCT01986348|459622851|FG002|Overall Study|Withdrawal by Participant|2|||
127726192|NCT01986348|459622852|FG003|Overall Study|Withdrawal by Participant|1|||
127726193|NCT01986348|459622849|FG000|Overall Study|Study Terminated by Sponsor|0|||
127726194|NCT01986348|459622850|FG001|Overall Study|Study Terminated by Sponsor|0|||
127726195|NCT01986348|459622851|FG002|Overall Study|Study Terminated by Sponsor|0|||
127726196|NCT01986348|459622852|FG003|Overall Study|Study Terminated by Sponsor|3|||
127726197|NCT01986348|459622849|FG000|Overall Study|Other-unspecified|0|||
127726198|NCT01986348|459622850|FG001|Overall Study|Other-unspecified|1|||
127726199|NCT01986348|459622851|FG002|Overall Study|Other-unspecified|0|||
127726200|NCT01986348|459622852|FG003|Overall Study|Other-unspecified|2|||
127726201|NCT02548585|459622853|FG000|Overall Study|Withdrawal by Subject|0|||
127726202|NCT02548585|459622854|FG001|Overall Study|Withdrawal by Subject|0|||
127726203|NCT02548585|459622855|FG002|Overall Study|Withdrawal by Subject|0|||
127726204|NCT02548585|459622856|FG003|Overall Study|Withdrawal by Subject|0|||
127726205|NCT02548585|459622857|FG004|Overall Study|Withdrawal by Subject|0|||
127726206|NCT02548585|459622858|FG005|Overall Study|Withdrawal by Subject|1|||
127726207|NCT02548585|459622859|FG006|Overall Study|Withdrawal by Subject|0|||
127726208|NCT02548585|459622853|FG000|Overall Study|Lost to Follow-up|1|||
127726209|NCT02548585|459622854|FG001|Overall Study|Lost to Follow-up|0|||
127726210|NCT02548585|459622855|FG002|Overall Study|Lost to Follow-up|0|||
127726211|NCT02548585|459622856|FG003|Overall Study|Lost to Follow-up|0|||
127726212|NCT02548585|459622857|FG004|Overall Study|Lost to Follow-up|0|||
127726213|NCT02548585|459622858|FG005|Overall Study|Lost to Follow-up|0|||
127726214|NCT02548585|459622859|FG006|Overall Study|Lost to Follow-up|0|||
127726215|NCT02548585|459622853|FG000|Overall Study|Other|1|||
127726216|NCT02548585|459622854|FG001|Overall Study|Other|0|||
127726217|NCT02548585|459622855|FG002|Overall Study|Other|0|||
127726218|NCT02548585|459622856|FG003|Overall Study|Other|2|||
127726219|NCT02548585|459622857|FG004|Overall Study|Other|3|||
127726220|NCT02548585|459622858|FG005|Overall Study|Other|0|||
127726221|NCT02548585|459622859|FG006|Overall Study|Other|1|||
127726222|NCT02548585|459622853|FG000|Overall Study|Randomized but not treated|0|||
127726223|NCT02548585|459622854|FG001|Overall Study|Randomized but not treated|0|||
127726224|NCT02548585|459622855|FG002|Overall Study|Randomized but not treated|0|||
127726225|NCT02548585|459622856|FG003|Overall Study|Randomized but not treated|0|||
127726226|NCT02548585|459622857|FG004|Overall Study|Randomized but not treated|0|||
127726227|NCT02548585|459622858|FG005|Overall Study|Randomized but not treated|1|||
127726228|NCT02548585|459622859|FG006|Overall Study|Randomized but not treated|0|||
127726229|NCT02935894|459622861|FG000|Overall Study|Subject dismissed|1|||
127726230|NCT03242863|459622864|FG000|Study Week 1|Withdrawal by Subject|0|||
127726231|NCT03242863|459622865|FG001|Study Week 1|Withdrawal by Subject|1|||
127726232|NCT03242863|459622866|FG002|Study Week 1|Withdrawal by Subject|0|||
127726233|NCT03242863|459622867|FG003|Study Week 1|Withdrawal by Subject|0|||
127726234|NCT03242863|459622868|FG004|Study Week 1|Withdrawal by Subject|3|||
127726235|NCT03242863|459622869|FG005|Study Week 1|Withdrawal by Subject|0|||
127726236|NCT04620733|459624448|FG000|Overall Study|Adverse Event|4|||
127726237|NCT04620733|459624449|FG001|Overall Study|Adverse Event|3|||
127726238|NCT04620733|459624448|FG000|Overall Study|Withdrawal by Subject|2|||
127726239|NCT04620733|459624449|FG001|Overall Study|Withdrawal by Subject|5|||
127726240|NCT04620733|459624448|FG000|Overall Study|Lost to Follow-up|1|||
127726241|NCT04620733|459624449|FG001|Overall Study|Lost to Follow-up|1|||
127726242|NCT04620733|459624448|FG000|Overall Study|Protocol Deviation|1|||
127726243|NCT04620733|459624449|FG001|Overall Study|Protocol Deviation|1|||
127726244|NCT04620733|459624448|FG000|Overall Study|Reason Not Specified|0|||
127726245|NCT04620733|459624449|FG001|Overall Study|Reason Not Specified|1|||
127726246|NCT03924193|459624450|FG000|Overall Study|Adverse Event|10|||
127726247|NCT03924193|459624451|FG001|Overall Study|Adverse Event|0|||
127726248|NCT03924193|459624452|FG002|Overall Study|Adverse Event|10|||
127726249|NCT03924193|459624450|FG000|Overall Study|Withdrawal by Subject|5|||
127726250|NCT03924193|459624451|FG001|Overall Study|Withdrawal by Subject|10|||
127726251|NCT03924193|459624452|FG002|Overall Study|Withdrawal by Subject|2|||
127726252|NCT02489799|459624453|FG000|Overall Study|Lost to Follow-up|4|||
127726253|NCT02489799|459624454|FG001|Overall Study|Lost to Follow-up|1|||
127726254|NCT02489799|459624453|FG000|Overall Study|Failure to Maintain Eligibility|4|||
127726255|NCT02489799|459624454|FG001|Overall Study|Failure to Maintain Eligibility|6|||
127726256|NCT02489799|459624453|FG000|Overall Study|Withdrawal by Subject|1|||
127726257|NCT02489799|459624454|FG001|Overall Study|Withdrawal by Subject|1|||
127726258|NCT02489799|459624453|FG000|Overall Study|Death|0|||
127726259|NCT02489799|459624454|FG001|Overall Study|Death|1|||
127726260|NCT04909593|459624455|FG000|Overall Study|Withdrawal by Subject|1|||
127726261|NCT01241448|459624456|FG000|Overall Study|Adverse Event|1|||
127726262|NCT01241448|459624457|FG001|Overall Study|Adverse Event|0|||
127726263|NCT01241448|459624458|FG002|Overall Study|Adverse Event|2|||
127726264|NCT01241448|459624459|FG003|Overall Study|Adverse Event|2|||
127726265|NCT01241448|459624456|FG000|Overall Study|Lost to Follow-up|2|||
127726266|NCT01241448|459624457|FG001|Overall Study|Lost to Follow-up|1|||
127726267|NCT01241448|459624458|FG002|Overall Study|Lost to Follow-up|1|||
127726268|NCT01241448|459624459|FG003|Overall Study|Lost to Follow-up|1|||
127726269|NCT01241448|459624456|FG000|Overall Study|Physician Decision|0|||
127726270|NCT01241448|459624457|FG001|Overall Study|Physician Decision|2|||
127726271|NCT01241448|459624458|FG002|Overall Study|Physician Decision|0|||
127726272|NCT01241448|459624459|FG003|Overall Study|Physician Decision|0|||
127726273|NCT01241448|459624456|FG000|Overall Study|Protocol Violation|10|||
127726274|NCT01241448|459624457|FG001|Overall Study|Protocol Violation|5|||
127726275|NCT01241448|459624458|FG002|Overall Study|Protocol Violation|3|||
127726276|NCT01241448|459624459|FG003|Overall Study|Protocol Violation|6|||
127726277|NCT01241448|459624456|FG000|Overall Study|Sponsor Decision|17|||
127726278|NCT01241448|459624457|FG001|Overall Study|Sponsor Decision|14|||
127726279|NCT01241448|459624458|FG002|Overall Study|Sponsor Decision|12|||
127726280|NCT01241448|459624459|FG003|Overall Study|Sponsor Decision|6|||
127726281|NCT01241448|459624456|FG000|Overall Study|Withdrawal by Subject|4|||
127726282|NCT01241448|459624457|FG001|Overall Study|Withdrawal by Subject|5|||
127726283|NCT01241448|459624458|FG002|Overall Study|Withdrawal by Subject|3|||
127726284|NCT01241448|459624459|FG003|Overall Study|Withdrawal by Subject|6|||
127726285|NCT01241448|459624456|FG000|Overall Study|Excluded due to data integrity issues|3|||
127726286|NCT01241448|459624457|FG001|Overall Study|Excluded due to data integrity issues|2|||
127726287|NCT01241448|459624458|FG002|Overall Study|Excluded due to data integrity issues|2|||
127726288|NCT01241448|459624459|FG003|Overall Study|Excluded due to data integrity issues|2|||
127726289|NCT02092285|459624460|FG000|Induction Phase|Adverse Event|7|||
127726290|NCT02092285|459624460|FG000|Induction Phase|Physician Decision|4|||
127726291|NCT02092285|459624460|FG000|Induction Phase|Pregnancy|1|||
127726292|NCT02092285|459624460|FG000|Induction Phase|Relapse/Recurrence|7|||
127726293|NCT02092285|459624460|FG000|Induction Phase|Withdrawal by Subject|2|||
127726294|NCT02092285|459624460|FG000|Induction Phase|Lack of Efficacy|14|||
127726295|NCT02092285|459624460|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
127726296|NCT02092285|459624460|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
127726297|NCT02092285|459624460|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
127726298|NCT02092285|459624460|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
127726299|NCT02092285|459624460|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
127726300|NCT02092285|459624460|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
127726301|NCT02092285|459624460|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
127726302|NCT02092285|459624460|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
127726303|NCT02092285|459624460|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
127726304|NCT01825785|459624461|FG000|Overall Study|Adverse Event|0|||
127726305|NCT01825785|459624462|FG001|Overall Study|Adverse Event|0|||
127726306|NCT01825785|459624463|FG002|Overall Study|Adverse Event|0|||
127726307|NCT01825785|459624464|FG003|Overall Study|Adverse Event|0|||
127726308|NCT01825785|459624465|FG004|Overall Study|Adverse Event|1|||
127726309|NCT01825785|459624466|FG005|Overall Study|Adverse Event|0|||
127726310|NCT01825785|459624467|FG006|Overall Study|Adverse Event|0|||
127726311|NCT01825785|459624461|FG000|Overall Study|Withdrawal by Subject|0|||
127726312|NCT01825785|459624462|FG001|Overall Study|Withdrawal by Subject|0|||
127726313|NCT01825785|459624463|FG002|Overall Study|Withdrawal by Subject|0|||
127726314|NCT01825785|459624464|FG003|Overall Study|Withdrawal by Subject|0|||
127726315|NCT01825785|459624465|FG004|Overall Study|Withdrawal by Subject|1|||
127726316|NCT01825785|459624466|FG005|Overall Study|Withdrawal by Subject|1|||
127726317|NCT01825785|459624467|FG006|Overall Study|Withdrawal by Subject|0|||
127726318|NCT01304940|459624469|FG000|Overall Study|not meet symptom severity requirement|3|||
127726319|NCT01304940|459624470|FG001|Overall Study|not meet symptom severity requirement|0|||
127726320|NCT00278395|459624473|FG000|Overall Study|Adverse Event|2|||
127726321|NCT00278395|459624473|FG000|Overall Study|Nonevaluable|1|||
127726322|NCT03740737|459624474|FG000|Overall Study|Protocol deviation|13|||
127726323|NCT03740737|459624475|FG001|Overall Study|Protocol deviation|0|||
127726324|NCT03740737|459624474|FG000|Overall Study|Adverse Event|2|||
127726325|NCT03740737|459624475|FG001|Overall Study|Adverse Event|0|||
127726326|NCT03740737|459624474|FG000|Overall Study|Lost to Follow-up|1|||
127726327|NCT03740737|459624475|FG001|Overall Study|Lost to Follow-up|0|||
127726328|NCT03740737|459624474|FG000|Overall Study|Randomization failure|1|||
127726329|NCT03740737|459624475|FG001|Overall Study|Randomization failure|0|||
127726330|NCT03740737|459624474|FG000|Overall Study|Participant withdrew consent|1|||
127726331|NCT03740737|459624475|FG001|Overall Study|Participant withdrew consent|0|||
127726332|NCT03740737|459624474|FG000|Overall Study|Participant withdrew from trial|2|||
127726333|NCT03740737|459624475|FG001|Overall Study|Participant withdrew from trial|1|||
127726334|NCT01286311|459624477|FG000|Overall Study|Physician did not want outreach sent|14|||
127726335|NCT01286311|459624478|FG001|Overall Study|Physician did not want outreach sent|0|||
127726336|NCT02981953|459624484|FG000|Overall Study|Death|9|||
127726337|NCT02981953|459624484|FG000|Overall Study|Withdrawal by Subject|1|||
127726338|NCT02981953|459624484|FG000|Overall Study|Withdrawal to non-compliance|1|||
127726339|NCT02889900|459624485|FG000|Overall Study|Adverse Event|11|||
127726340|NCT02889900|459624485|FG000|Overall Study|Condition under investigation worsened|32|||
127726341|NCT02889900|459624485|FG000|Overall Study|Other|5|||
127726342|NCT02889900|459624485|FG000|Overall Study|Withdrawal by Subject|7|||
127726343|NCT02889900|459624485|FG000|Overall Study|Not treated|2|||
127726344|NCT01416285|459624487|FG000|Overall Study|owing to the care model or moving to other cities of the country|0|||
127726345|NCT01416285|459624488|FG001|Overall Study|owing to the care model or moving to other cities of the country|9|||
127726346|NCT01090739|459624496|FG000|Enrollment|Withdrawal by Subject|24|||
127726347|NCT01090739|459624496|FG000|Enrollment|Protocol Violation|14|||
127726348|NCT01090739|459624496|FG000|Enrollment|Lost to Follow-up|5|||
127726349|NCT01090739|459624496|FG000|Enrollment|Physician Decision|5|||
127726350|NCT01090739|459624496|FG000|Enrollment|Sponsor termination of site|4|||
127726351|NCT01090739|459624496|FG000|Enrollment|Study implant limit reached|2|||
127726352|NCT01090739|459624496|FG000|Enrollment|Adverse Event|1|||
127726353|NCT01090739|459624496|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
127726354|NCT01090739|459624496|FG000|12 Month Follow-up|Lost to Follow-up|1|||
127726355|NCT01090739|459624496|FG000|12 Month Follow-up|Physician Decision|1|||
127726356|NCT01090739|459624496|FG000|12 Month Follow-up|Death|1|||
127726357|NCT01090739|459624496|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
127726358|NCT01090739|459624496|FG000|24 Month Follow-up|Lost to Follow-up|1|||
127726359|NCT01090739|459624496|FG000|24 Month Follow-up|Death|1|||
127726360|NCT01090739|459624496|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
127726361|NCT01090739|459624496|FG000|36 Month Follow-up|Visit still pending|17|||
127726362|NCT02410278|459624499|FG000|Run-in Period|Adverse Event|5|||
127726363|NCT02410278|459624500|FG001|Run-in Period|Adverse Event|0|||
127726364|NCT02410278|459624501|FG002|Run-in Period|Adverse Event|0|||
127726365|NCT02410278|459624499|FG000|Run-in Period|GSRS Threshold Not Met|30|||
127726366|NCT02410278|459624500|FG001|Run-in Period|GSRS Threshold Not Met|0|||
127726367|NCT02410278|459624501|FG002|Run-in Period|GSRS Threshold Not Met|0|||
127726368|NCT02410278|459624499|FG000|Run-in Period|Lost to Follow-up|1|||
127726369|NCT02410278|459624500|FG001|Run-in Period|Lost to Follow-up|0|||
127889626|NCT02151461|460218123|FG003|Overall Study|Withdrawal by Subject|1|||
127726370|NCT02410278|459624501|FG002|Run-in Period|Lost to Follow-up|0|||
127726371|NCT02410278|459624499|FG000|Run-in Period|Withdrawal by Subject|1|||
127726372|NCT02410278|459624500|FG001|Run-in Period|Withdrawal by Subject|0|||
127726373|NCT02410278|459624501|FG002|Run-in Period|Withdrawal by Subject|0|||
127726374|NCT02410278|459624499|FG000|Run-in Period|Pregnancy|1|||
127726375|NCT02410278|459624500|FG001|Run-in Period|Pregnancy|0|||
127726376|NCT02410278|459624501|FG002|Run-in Period|Pregnancy|0|||
127726377|NCT02410278|459624499|FG000|Study Treatment Period|Adverse Event|0|||
127726378|NCT02410278|459624500|FG001|Study Treatment Period|Adverse Event|6|||
127726379|NCT02410278|459624501|FG002|Study Treatment Period|Adverse Event|3|||
127726380|NCT02410278|459624499|FG000|Study Treatment Period|Physician Decision|0|||
127726381|NCT02410278|459624500|FG001|Study Treatment Period|Physician Decision|0|||
127726382|NCT02410278|459624501|FG002|Study Treatment Period|Physician Decision|1|||
127726383|NCT02410278|459624499|FG000|Study Treatment Period|Withdrawal by Subject|0|||
127726384|NCT02410278|459624500|FG001|Study Treatment Period|Withdrawal by Subject|1|||
127726385|NCT02410278|459624501|FG002|Study Treatment Period|Withdrawal by Subject|0|||
127726386|NCT02410278|459624499|FG000|Study Treatment Period|Other|0|||
127726387|NCT02410278|459624500|FG001|Study Treatment Period|Other|3|||
127726388|NCT02410278|459624501|FG002|Study Treatment Period|Other|0|||
127726389|NCT02410278|459624499|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
127726390|NCT02410278|459624500|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
127726391|NCT02410278|459624501|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
127726392|NCT03695185|459624502|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
127726393|NCT03695185|459624502|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
127726394|NCT03695185|459624502|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
127726395|NCT03695185|459624502|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
127726396|NCT03695185|459624502|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
127726397|NCT03695185|459624502|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
127726398|NCT02584257|459624503|FG000|Period 1|Withdrawal by Subject|0|||
127726399|NCT02584257|459624504|FG001|Period 1|Withdrawal by Subject|0|||
127726400|NCT02584257|459624505|FG002|Period 1|Withdrawal by Subject|0|||
127726401|NCT02584257|459624506|FG003|Period 1|Withdrawal by Subject|0|||
127726402|NCT02584257|459624507|FG004|Period 1|Withdrawal by Subject|0|||
127726403|NCT02584257|459624508|FG005|Period 1|Withdrawal by Subject|0|||
127726404|NCT02584257|459624509|FG006|Period 1|Withdrawal by Subject|1|||
127726405|NCT02584257|459624510|FG007|Period 1|Withdrawal by Subject|0|||
127726406|NCT02584257|459624511|FG008|Period 1|Withdrawal by Subject|0|||
127726407|NCT02584257|459624503|FG000|Period 2|Physician Decision|1|||
127726408|NCT02584257|459624504|FG001|Period 2|Physician Decision|0|||
127726409|NCT02584257|459624505|FG002|Period 2|Physician Decision|0|||
127726410|NCT02584257|459624506|FG003|Period 2|Physician Decision|0|||
127726411|NCT02584257|459624507|FG004|Period 2|Physician Decision|0|||
127726412|NCT02584257|459624508|FG005|Period 2|Physician Decision|0|||
127726413|NCT02584257|459624509|FG006|Period 2|Physician Decision|0|||
127726414|NCT02584257|459624510|FG007|Period 2|Physician Decision|0|||
127726415|NCT02584257|459624511|FG008|Period 2|Physician Decision|0|||
127726416|NCT02584257|459624503|FG000|Period 2|Adverse Event|0|||
127726417|NCT02584257|459624504|FG001|Period 2|Adverse Event|1|||
127726418|NCT02584257|459624505|FG002|Period 2|Adverse Event|0|||
127726419|NCT02584257|459624506|FG003|Period 2|Adverse Event|0|||
127726420|NCT02584257|459624507|FG004|Period 2|Adverse Event|0|||
127726421|NCT02584257|459624508|FG005|Period 2|Adverse Event|0|||
127726422|NCT02584257|459624509|FG006|Period 2|Adverse Event|0|||
127726423|NCT02584257|459624510|FG007|Period 2|Adverse Event|0|||
127726424|NCT02584257|459624511|FG008|Period 2|Adverse Event|0|||
127726425|NCT03693989|459624513|FG000|Overall Study|Protocol Violation|3|||
127726426|NCT03693989|459624514|FG001|Overall Study|Protocol Violation|4|||
127726427|NCT03146845|459624515|FG000|Overall Study|Reference ulcer healed|1|||
127726428|NCT03146845|459624516|FG001|Overall Study|Reference ulcer healed|0|||
127726429|NCT03146845|459624515|FG000|Overall Study|Physician Decision|1|||
127726430|NCT03146845|459624516|FG001|Overall Study|Physician Decision|0|||
127726431|NCT03146845|459624515|FG000|Overall Study|Adverse Event|1|||
127726432|NCT03146845|459624516|FG001|Overall Study|Adverse Event|0|||
127726433|NCT03146845|459624515|FG000|Overall Study|Withdrawal by Subject|2|||
127726434|NCT03146845|459624516|FG001|Overall Study|Withdrawal by Subject|0|||
127726435|NCT03146845|459624515|FG000|Overall Study|Noncompliance|0|||
127726436|NCT03146845|459624516|FG001|Overall Study|Noncompliance|1|||
127726437|NCT03146845|459624515|FG000|Overall Study|Protocol Violation|0|||
127726438|NCT03146845|459624516|FG001|Overall Study|Protocol Violation|2|||
127726439|NCT03146845|459624515|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
127802927|NCT00130286|459901089|FG000|Overall Study|Missing lab specimens|0|||
127889627|NCT02151461|460218120|FG000|Overall Study|Treatment discontinuation|0|||
127889628|NCT02151461|460218121|FG001|Overall Study|Treatment discontinuation|0|||
127889629|NCT02151461|460218122|FG002|Overall Study|Treatment discontinuation|1|||
127889630|NCT02151461|460218123|FG003|Overall Study|Treatment discontinuation|0|||
127802928|NCT00130286|459901090|FG001|Overall Study|Missing lab specimens|2|||
127802929|NCT00130286|459901091|FG002|Overall Study|Missing lab specimens|0|||
127802930|NCT00130286|459901092|FG003|Overall Study|Missing lab specimens|0|||
127802931|NCT01360645|459901093|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
127802932|NCT01360645|459901094|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
127802933|NCT01360645|459901095|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
127802934|NCT01360645|459901096|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
127802935|NCT01360645|459901093|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
127802936|NCT01360645|459901094|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
127802937|NCT01360645|459901095|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
127802938|NCT01360645|459901096|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
127802939|NCT01360645|459901093|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
127802940|NCT01360645|459901094|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
127889631|NCT02168270|460218124|FG000|Overall Study|Lack of Efficacy|4|||
127889632|NCT01102777|460218125|FG000|Overall Study|Death|2|||
127889633|NCT01102777|460218126|FG001|Overall Study|Death|6|||
127889634|NCT01102777|460218125|FG000|Overall Study|Lost to Follow-up|7|||
127889635|NCT01102777|460218126|FG001|Overall Study|Lost to Follow-up|10|||
127889636|NCT00771901|460218127|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
127889637|NCT00771901|460218128|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
127889638|NCT00771901|460218129|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
127889639|NCT01965652|460218130|FG000|Overall Study|Adverse Event|40|||
127889640|NCT01965652|460218131|FG001|Overall Study|Adverse Event|37|||
127889641|NCT01965652|460218130|FG000|Overall Study|Withdrawal by Subject|62|||
127889642|NCT01965652|460218131|FG001|Overall Study|Withdrawal by Subject|69|||
127889643|NCT01965652|460218130|FG000|Overall Study|Lost to Follow-up|53|||
127889644|NCT01965652|460218131|FG001|Overall Study|Lost to Follow-up|40|||
127889645|NCT01965652|460218130|FG000|Overall Study|Protocol Violation|34|||
127889646|NCT01965652|460218131|FG001|Overall Study|Protocol Violation|38|||
127889647|NCT01965652|460218130|FG000|Overall Study|Death|3|||
127889648|NCT01965652|460218131|FG001|Overall Study|Death|4|||
127889649|NCT01965652|460218130|FG000|Overall Study|Other - Miscellaneous|18|||
127889650|NCT01965652|460218131|FG001|Overall Study|Other - Miscellaneous|21|||
127889651|NCT01965652|460218130|FG000|Overall Study|Pregnancy|0|||
127889652|NCT01965652|460218131|FG001|Overall Study|Pregnancy|1|||
127889653|NCT01121900|460218132|FG000|First Intervention Period|Adverse Event|1|||
127889654|NCT01121900|460218133|FG001|First Intervention Period|Adverse Event|1|||
127889655|NCT01121900|460218132|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
127889656|NCT01121900|460218133|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
127889657|NCT03493698|460218134|FG000|Treatment Period C|Adverse Event|1|||
127889658|NCT03493698|460218134|FG000|Treatment Period C|Withdrawal by Subject|1|||
127889659|NCT03760510|460218135|FG000|Overall Study|Not ventilated for 24 hours|105|||
127889660|NCT03760510|460218136|FG001|Overall Study|Not ventilated for 24 hours|97|||
127889661|NCT00566709|460218137|FG000|Overall Study|Protocol Violation|5|||
127889662|NCT00566709|460218138|FG001|Overall Study|Protocol Violation|0|||
127889663|NCT01829295|460218139|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
127889664|NCT01829295|460218140|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
127889665|NCT01829295|460218141|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
127889666|NCT01829295|460218142|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
127889667|NCT01829295|460218139|FG000|6-12 Months|Adverse Event|0|||
127726440|NCT03146845|459624516|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
127726441|NCT01535261|459624523|FG000|Overall Study|Physician Decision|8|||
127726442|NCT01535261|459624523|FG000|Overall Study|Protocol Violation|3|||
127726443|NCT01535261|459624523|FG000|Overall Study|Death|5|||
127726444|NCT01535261|459624523|FG000|Overall Study|Lost to Follow-up|8|||
127726445|NCT01535261|459624523|FG000|Overall Study|Withdrawal by Subject|14|||
127726446|NCT01535261|459624523|FG000|Overall Study|Adverse Event|12|||
127726447|NCT01757288|459624527|FG000|Overall Study|Consent withdrawal|0|||
127726448|NCT01757288|459624528|FG001|Overall Study|Consent withdrawal|4|||
127726449|NCT01757288|459624529|FG002|Overall Study|Consent withdrawal|4|||
127889668|NCT01829295|460218140|FG001|6-12 Months|Adverse Event|0|||
127726450|NCT01757288|459624527|FG000|Overall Study|Patient off study, IRB hold.|0|||
127726451|NCT01757288|459624528|FG001|Overall Study|Patient off study, IRB hold.|0|||
127726452|NCT01757288|459624529|FG002|Overall Study|Patient off study, IRB hold.|1|||
127889669|NCT01829295|460218141|FG002|6-12 Months|Adverse Event|3|||
127889670|NCT01829295|460218142|FG003|6-12 Months|Adverse Event|2|||
127889671|NCT01829295|460218139|FG000|6-12 Months|Lost to Follow-up|2|||
127889672|NCT01829295|460218140|FG001|6-12 Months|Lost to Follow-up|0|||
127889673|NCT01829295|460218141|FG002|6-12 Months|Lost to Follow-up|0|||
127889674|NCT01829295|460218142|FG003|6-12 Months|Lost to Follow-up|0|||
127889675|NCT01829295|460218139|FG000|6-12 Months|Withdrawal by Subject|2|||
127889676|NCT01829295|460218140|FG001|6-12 Months|Withdrawal by Subject|2|||
127726453|NCT01757288|459624527|FG000|Overall Study|Patient death prior to starting treatment|0|||
127726454|NCT01757288|459624528|FG001|Overall Study|Patient death prior to starting treatment|0|||
127726455|NCT01757288|459624529|FG002|Overall Study|Patient death prior to starting treatment|1|||
127726456|NCT01757288|459624527|FG000|Overall Study|Wrong medication administered|0|||
127726457|NCT01757288|459624528|FG001|Overall Study|Wrong medication administered|1|||
127726458|NCT01757288|459624529|FG002|Overall Study|Wrong medication administered|0|||
127726459|NCT01757288|459624527|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
127726460|NCT01757288|459624528|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
127726461|NCT01757288|459624529|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
127726462|NCT01757288|459624527|FG000|Overall Study|Not meeting protocol constraints|0|||
127726463|NCT01757288|459624528|FG001|Overall Study|Not meeting protocol constraints|1|||
127726464|NCT01757288|459624529|FG002|Overall Study|Not meeting protocol constraints|1|||
127726465|NCT01757288|459624527|FG000|Overall Study|Multiple missed appointments|0|||
127726466|NCT01757288|459624528|FG001|Overall Study|Multiple missed appointments|1|||
127726467|NCT01757288|459624529|FG002|Overall Study|Multiple missed appointments|0|||
127726468|NCT01757288|459624527|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
127726469|NCT01757288|459624528|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
127726470|NCT01757288|459624529|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
127726471|NCT01757288|459624527|FG000|Overall Study|>2 weeks treatment break|0|||
127726472|NCT01757288|459624528|FG001|Overall Study|>2 weeks treatment break|0|||
127726473|NCT01757288|459624529|FG002|Overall Study|>2 weeks treatment break|1|||
127726474|NCT03031782|459624536|FG000|Treatment Period 1|Lack of Efficacy|3|||
127726475|NCT03031782|459624537|FG001|Treatment Period 1|Lack of Efficacy|0|||
127726476|NCT03031782|459624538|FG002|Treatment Period 1|Lack of Efficacy|0|||
127726477|NCT03031782|459624539|FG003|Treatment Period 1|Lack of Efficacy|0|||
127726478|NCT03031782|459624540|FG004|Treatment Period 1|Lack of Efficacy|0|||
127726479|NCT03031782|459624536|FG000|Treatment Period 2|Physician Decision|0|||
127726480|NCT03031782|459624537|FG001|Treatment Period 2|Physician Decision|1|||
127726481|NCT03031782|459624538|FG002|Treatment Period 2|Physician Decision|0|||
127726482|NCT03031782|459624539|FG003|Treatment Period 2|Physician Decision|0|||
127726483|NCT03031782|459624540|FG004|Treatment Period 2|Physician Decision|3|||
127726484|NCT03031782|459624536|FG000|Treatment Period 2|Lack of Efficacy|0|||
127726485|NCT03031782|459624537|FG001|Treatment Period 2|Lack of Efficacy|1|||
127726486|NCT03031782|459624538|FG002|Treatment Period 2|Lack of Efficacy|0|||
127726487|NCT03031782|459624539|FG003|Treatment Period 2|Lack of Efficacy|0|||
127726488|NCT03031782|459624540|FG004|Treatment Period 2|Lack of Efficacy|1|||
127726489|NCT03031782|459624536|FG000|Treatment Period 2|Withdrawal by Subject|0|||
127726490|NCT03031782|459624537|FG001|Treatment Period 2|Withdrawal by Subject|3|||
127726491|NCT03031782|459624538|FG002|Treatment Period 2|Withdrawal by Subject|0|||
127726492|NCT03031782|459624539|FG003|Treatment Period 2|Withdrawal by Subject|0|||
127726493|NCT03031782|459624540|FG004|Treatment Period 2|Withdrawal by Subject|1|||
127726494|NCT03031782|459624536|FG000|Treatment Period 2|Adverse Event|0|||
127726495|NCT03031782|459624537|FG001|Treatment Period 2|Adverse Event|1|||
127726496|NCT03031782|459624538|FG002|Treatment Period 2|Adverse Event|2|||
127726497|NCT03031782|459624539|FG003|Treatment Period 2|Adverse Event|0|||
127726498|NCT03031782|459624540|FG004|Treatment Period 2|Adverse Event|0|||
127726499|NCT03031782|459624536|FG000|Treatment Period 3|Withdrawal by Subject|0|||
127726500|NCT03031782|459624537|FG001|Treatment Period 3|Withdrawal by Subject|0|||
127726501|NCT03031782|459624538|FG002|Treatment Period 3|Withdrawal by Subject|0|||
127726502|NCT03031782|459624539|FG003|Treatment Period 3|Withdrawal by Subject|1|||
127726503|NCT03031782|459624540|FG004|Treatment Period 3|Withdrawal by Subject|0|||
127726504|NCT02170207|459624543|FG000|Overall Study|Case report forms unavailable|5|||
127726505|NCT00886834|459624544|FG000|Overall Study|Protocol Violation|0|||
127726506|NCT00886834|459624545|FG001|Overall Study|Protocol Violation|3|||
127726507|NCT03122860|459624546|FG000|Overall Study|Discontinued Before Treatment|1|||
127726508|NCT03122860|459624547|FG001|Overall Study|Discontinued Before Treatment|1|||
127726509|NCT03122860|459624548|FG002|Overall Study|Discontinued Before Treatment|2|||
127726510|NCT03122860|459624549|FG003|Overall Study|Discontinued Before Treatment|0|||
127726511|NCT03122860|459624550|FG004|Overall Study|Discontinued Before Treatment|1|||
127726512|NCT03122860|459624551|FG005|Overall Study|Discontinued Before Treatment|0|||
127726513|NCT03122860|459624546|FG000|Overall Study|Adverse Event|1|||
127726514|NCT03122860|459624547|FG001|Overall Study|Adverse Event|0|||
127726515|NCT03122860|459624548|FG002|Overall Study|Adverse Event|1|||
127726516|NCT03122860|459624549|FG003|Overall Study|Adverse Event|1|||
127726517|NCT03122860|459624550|FG004|Overall Study|Adverse Event|0|||
127726518|NCT03122860|459624551|FG005|Overall Study|Adverse Event|0|||
127726519|NCT03122860|459624546|FG000|Overall Study|Lost to Follow-up|5|||
127726520|NCT03122860|459624547|FG001|Overall Study|Lost to Follow-up|2|||
127889677|NCT01829295|460218141|FG002|6-12 Months|Withdrawal by Subject|0|||
127889678|NCT01829295|460218142|FG003|6-12 Months|Withdrawal by Subject|0|||
127889679|NCT03443869|460218143|FG000|Overall Study|Death|3|||
127889680|NCT03443869|460218144|FG001|Overall Study|Death|3|||
127889681|NCT03443869|460218143|FG000|Overall Study|Withdrawal by Subject|34|||
127889682|NCT03443869|460218144|FG001|Overall Study|Withdrawal by Subject|22|||
127889683|NCT03443869|460218143|FG000|Overall Study|Lost to Follow-up|1|||
127889684|NCT03443869|460218144|FG001|Overall Study|Lost to Follow-up|2|||
127726521|NCT03122860|459624548|FG002|Overall Study|Lost to Follow-up|3|||
127726522|NCT03122860|459624549|FG003|Overall Study|Lost to Follow-up|3|||
127726523|NCT03122860|459624550|FG004|Overall Study|Lost to Follow-up|5|||
127726524|NCT03122860|459624551|FG005|Overall Study|Lost to Follow-up|4|||
127726525|NCT03122860|459624546|FG000|Overall Study|Subject Non-Compliance|0|||
127726526|NCT03122860|459624547|FG001|Overall Study|Subject Non-Compliance|0|||
127726527|NCT03122860|459624548|FG002|Overall Study|Subject Non-Compliance|1|||
127726528|NCT03122860|459624549|FG003|Overall Study|Subject Non-Compliance|0|||
127726529|NCT03122860|459624550|FG004|Overall Study|Subject Non-Compliance|0|||
127726530|NCT03122860|459624551|FG005|Overall Study|Subject Non-Compliance|0|||
127726531|NCT03122860|459624546|FG000|Overall Study|Withdrawal by Subject|3|||
127726532|NCT03122860|459624547|FG001|Overall Study|Withdrawal by Subject|2|||
127726533|NCT03122860|459624548|FG002|Overall Study|Withdrawal by Subject|5|||
127726534|NCT03122860|459624549|FG003|Overall Study|Withdrawal by Subject|7|||
127726535|NCT03122860|459624550|FG004|Overall Study|Withdrawal by Subject|9|||
127726536|NCT03122860|459624551|FG005|Overall Study|Withdrawal by Subject|8|||
127726537|NCT01138657|459624552|FG000|Overall Study|Adverse Event|3|||
127726538|NCT01138657|459624553|FG001|Overall Study|Adverse Event|10|||
127726539|NCT01138657|459624552|FG000|Overall Study|Lack of Efficacy|2|||
127726540|NCT01138657|459624553|FG001|Overall Study|Lack of Efficacy|1|||
127726541|NCT01138657|459624552|FG000|Overall Study|Lost to Follow-up|0|||
127726542|NCT01138657|459624553|FG001|Overall Study|Lost to Follow-up|3|||
127726543|NCT01138657|459624552|FG000|Overall Study|Miscellaneous Reasons|3|||
127726544|NCT01138657|459624553|FG001|Overall Study|Miscellaneous Reasons|4|||
127726545|NCT00529529|459624558|FG000|Overall Study|Adverse Event|12|||
127726546|NCT00529529|459624559|FG001|Overall Study|Adverse Event|17|||
127726547|NCT00529529|459624560|FG002|Overall Study|Adverse Event|8|||
127726548|NCT00529529|459624558|FG000|Overall Study|Subject withdrew consent|12|||
127726549|NCT00529529|459624559|FG001|Overall Study|Subject withdrew consent|9|||
127726550|NCT00529529|459624560|FG002|Overall Study|Subject withdrew consent|12|||
127726551|NCT00529529|459624558|FG000|Overall Study|Protocol deviation|8|||
127726552|NCT00529529|459624559|FG001|Overall Study|Protocol deviation|12|||
127889685|NCT03443869|460218143|FG000|Overall Study|Physician Decision|3|||
127889686|NCT03443869|460218144|FG001|Overall Study|Physician Decision|3|||
127889687|NCT03443869|460218143|FG000|Overall Study|Other|4|||
127726553|NCT00529529|459624560|FG002|Overall Study|Protocol deviation|5|||
127726554|NCT00529529|459624558|FG000|Overall Study|Lost to Follow-up|5|||
127726555|NCT00529529|459624559|FG001|Overall Study|Lost to Follow-up|3|||
127726556|NCT00529529|459624560|FG002|Overall Study|Lost to Follow-up|1|||
127726557|NCT00529529|459624558|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
127726558|NCT00529529|459624559|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
127726559|NCT00529529|459624560|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
127726560|NCT00529529|459624558|FG000|Overall Study|Death|2|||
127726561|NCT00529529|459624559|FG001|Overall Study|Death|0|||
127726562|NCT00529529|459624560|FG002|Overall Study|Death|0|||
127726563|NCT00529529|459624558|FG000|Overall Study|Abnormal test procedure result(s)|1|||
127726564|NCT00529529|459624559|FG001|Overall Study|Abnormal test procedure result(s)|0|||
127726565|NCT00529529|459624560|FG002|Overall Study|Abnormal test procedure result(s)|0|||
127726566|NCT00529529|459624558|FG000|Overall Study|Administrative problems|1|||
127726567|NCT00529529|459624559|FG001|Overall Study|Administrative problems|0|||
127726568|NCT00529529|459624560|FG002|Overall Study|Administrative problems|3|||
127726569|NCT00960206|459624561|FG000|Overall Study|Death|7|||
127726570|NCT00960206|459624562|FG001|Overall Study|Death|4|||
127726571|NCT00960206|459624563|FG002|Overall Study|Death|1|||
127726572|NCT00960206|459624561|FG000|Overall Study|Unwilling/Unable to return|1|||
127726573|NCT00960206|459624562|FG001|Overall Study|Unwilling/Unable to return|2|||
127726574|NCT00960206|459624563|FG002|Overall Study|Unwilling/Unable to return|0|||
127726575|NCT00960206|459624561|FG000|Overall Study|Lost to Follow-up|8|||
127726576|NCT00960206|459624562|FG001|Overall Study|Lost to Follow-up|14|||
127726577|NCT00960206|459624563|FG002|Overall Study|Lost to Follow-up|8|||
127726578|NCT00960206|459624561|FG000|Overall Study|Withdrawal by Subject|2|||
127726579|NCT00960206|459624562|FG001|Overall Study|Withdrawal by Subject|4|||
127726580|NCT00960206|459624563|FG002|Overall Study|Withdrawal by Subject|0|||
127726581|NCT00960206|459624561|FG000|Overall Study|Revision of study component|2|||
127726582|NCT00960206|459624562|FG001|Overall Study|Revision of study component|2|||
127726583|NCT00960206|459624563|FG002|Overall Study|Revision of study component|2|||
127726584|NCT00960206|459624561|FG000|Overall Study|Missing 10 year data|20|||
127726585|NCT00960206|459624562|FG001|Overall Study|Missing 10 year data|1|||
127889688|NCT03443869|460218144|FG001|Overall Study|Other|4|||
127889689|NCT00299728|460218145|FG000|Overall Study|Lost to Follow-up|0|||
127726586|NCT00960206|459624563|FG002|Overall Study|Missing 10 year data|1|||
127726587|NCT03075878|459624567|FG000|Overall Study|Physician Decision|1|||
127726588|NCT02612285|459624568|FG000|Overall Study|Withdrawal by Subject|1|||
127726589|NCT00805441|459624569|FG000|Overall Study|Adverse Event|5|||
127726590|NCT00805441|459624570|FG001|Overall Study|Adverse Event|2|||
127726591|NCT00805441|459624569|FG000|Overall Study|Lack of Efficacy|0|||
127726592|NCT00805441|459624570|FG001|Overall Study|Lack of Efficacy|2|||
127726593|NCT00805441|459624569|FG000|Overall Study|Protocol Violation|4|||
127726594|NCT00805441|459624570|FG001|Overall Study|Protocol Violation|8|||
127726595|NCT00805441|459624569|FG000|Overall Study|Lost to Follow-up|10|||
127726596|NCT00805441|459624570|FG001|Overall Study|Lost to Follow-up|13|||
127726597|NCT00805441|459624569|FG000|Overall Study|Withdrawal by Subject|15|||
127726598|NCT00805441|459624570|FG001|Overall Study|Withdrawal by Subject|9|||
127726599|NCT00805441|459624569|FG000|Overall Study|Physician Decision|0|||
127726600|NCT00805441|459624570|FG001|Overall Study|Physician Decision|1|||
127726601|NCT00805441|459624569|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
127726602|NCT00805441|459624570|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
127726603|NCT00853957|459624575|FG000|Overall Study|Adverse Event|9|||
127726604|NCT00853957|459624576|FG001|Overall Study|Adverse Event|3|||
127726605|NCT00853957|459624575|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
127726606|NCT00853957|459624576|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
127726607|NCT00853957|459624575|FG000|Overall Study|Subject withdrew consent|4|||
127726608|NCT00853957|459624576|FG001|Overall Study|Subject withdrew consent|5|||
127726609|NCT00853957|459624575|FG000|Overall Study|Lost to Follow-up|1|||
127726610|NCT00853957|459624576|FG001|Overall Study|Lost to Follow-up|6|||
127726611|NCT00853957|459624575|FG000|Overall Study|Protocol deviation|0|||
127726612|NCT00853957|459624576|FG001|Overall Study|Protocol deviation|3|||
127726613|NCT02158806|459624577|FG000|Overall Study|Death|2|||
127726614|NCT02158806|459624578|FG001|Overall Study|Death|0|||
127726615|NCT02158806|459624577|FG000|Overall Study|Withdrawal by Subject|2|||
127726616|NCT02158806|459624578|FG001|Overall Study|Withdrawal by Subject|0|||
127726617|NCT02158806|459624577|FG000|Overall Study|Lost to Follow-up|0|||
127726618|NCT02158806|459624578|FG001|Overall Study|Lost to Follow-up|3|||
127726619|NCT02158806|459624577|FG000|Overall Study|Moved out of area|0|||
127726620|NCT02158806|459624578|FG001|Overall Study|Moved out of area|1|||
127726621|NCT02158806|459624577|FG000|Overall Study|Transferred to palliative care|0|||
127726622|NCT02158806|459624578|FG001|Overall Study|Transferred to palliative care|1|||
127726623|NCT01898299|459624579|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
127726624|NCT01898299|459624580|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
127726625|NCT02340806|459624581|FG000|Overall Study|Protocol Violation|2|||
127726626|NCT02340806|459624582|FG001|Overall Study|Protocol Violation|0|||
127726627|NCT02340806|459624581|FG000|Overall Study|epidural catheter replaced|2|||
127726628|NCT02340806|459624582|FG001|Overall Study|epidural catheter replaced|1|||
127726629|NCT02340806|459624581|FG000|Overall Study|history of chronic pain medication|1|||
127726630|NCT02340806|459624582|FG001|Overall Study|history of chronic pain medication|0|||
127726631|NCT02340806|459624581|FG000|Overall Study|re-dose < 90 min of CSE|1|||
127726632|NCT02340806|459624582|FG001|Overall Study|re-dose < 90 min of CSE|3|||
127726633|NCT00452452|459624583|FG000|Overall Study|Protocol Violation|0|||
127726634|NCT00452452|459624584|FG001|Overall Study|Protocol Violation|0|||
127726635|NCT00452452|459624585|FG002|Overall Study|Protocol Violation|1|||
127726636|NCT00452452|459624583|FG000|Overall Study|Withdrawal by Subject|1|||
127726637|NCT00452452|459624584|FG001|Overall Study|Withdrawal by Subject|0|||
127726638|NCT00452452|459624585|FG002|Overall Study|Withdrawal by Subject|0|||
127726639|NCT00452452|459624583|FG000|Overall Study|Lost to Follow-up|1|||
127726640|NCT00452452|459624584|FG001|Overall Study|Lost to Follow-up|0|||
127726641|NCT00452452|459624585|FG002|Overall Study|Lost to Follow-up|0|||
127726642|NCT03070301|459624590|FG000|Overall Study|Progression of disease|16|||
127726643|NCT03070301|459624590|FG000|Overall Study|Physician Decision|3|||
127726644|NCT03070301|459624590|FG000|Overall Study|Withdrawal by Subject|1|||
127726645|NCT04520256|459624594|FG000|Overall Study|Lost to Follow-up|6|||
127726646|NCT04520256|459624595|FG001|Overall Study|Lost to Follow-up|4|||
127726647|NCT04520256|459624596|FG002|Overall Study|Lost to Follow-up|2|||
127726648|NCT04520256|459624597|FG003|Overall Study|Lost to Follow-up|3|||
127726649|NCT04520256|459624598|FG004|Overall Study|Lost to Follow-up|6|||
127726650|NCT04520256|459624599|FG005|Overall Study|Lost to Follow-up|6|||
127726651|NCT04520256|459624600|FG006|Overall Study|Lost to Follow-up|4|||
127726652|NCT04520256|459624601|FG007|Overall Study|Lost to Follow-up|6|||
127726653|NCT04520256|459624602|FG008|Overall Study|Lost to Follow-up|1|||
127726654|NCT04520256|459624603|FG009|Overall Study|Lost to Follow-up|3|||
127726655|NCT04520256|459624604|FG010|Overall Study|Lost to Follow-up|3|||
127726656|NCT04520256|459624605|FG011|Overall Study|Lost to Follow-up|2|||
127726657|NCT04520256|459624606|FG012|Overall Study|Lost to Follow-up|5|||
127726658|NCT04520256|459624607|FG013|Overall Study|Lost to Follow-up|3|||
127726659|NCT04520256|459624608|FG014|Overall Study|Lost to Follow-up|3|||
127726660|NCT04520256|459624609|FG015|Overall Study|Lost to Follow-up|6|||
127726661|NCT04520256|459624610|FG016|Overall Study|Lost to Follow-up|6|||
127726662|NCT04520256|459624611|FG017|Overall Study|Lost to Follow-up|4|||
127726663|NCT04520256|459624612|FG018|Overall Study|Lost to Follow-up|3|||
127726664|NCT04520256|459624613|FG019|Overall Study|Lost to Follow-up|3|||
127726665|NCT04520256|459624614|FG020|Overall Study|Lost to Follow-up|7|||
127726666|NCT04520256|459624615|FG021|Overall Study|Lost to Follow-up|3|||
127726667|NCT04520256|459624616|FG022|Overall Study|Lost to Follow-up|3|||
127726668|NCT04520256|459624617|FG023|Overall Study|Lost to Follow-up|8|||
127726669|NCT04520256|459624618|FG024|Overall Study|Lost to Follow-up|5|||
127726670|NCT04520256|459624619|FG025|Overall Study|Lost to Follow-up|4|||
127726671|NCT04520256|459624620|FG026|Overall Study|Lost to Follow-up|3|||
127726672|NCT04520256|459624621|FG027|Overall Study|Lost to Follow-up|4|||
127726673|NCT04520256|459624622|FG028|Overall Study|Lost to Follow-up|3|||
127726674|NCT04520256|459624623|FG029|Overall Study|Lost to Follow-up|4|||
127726675|NCT04520256|459624624|FG030|Overall Study|Lost to Follow-up|4|||
127726676|NCT04520256|459624625|FG031|Overall Study|Lost to Follow-up|4|||
127726677|NCT02880293|459626474|FG000|Overall Study|Inevaluable|5|||
127726678|NCT00264576|459626481|FG000|Overall Study|Lost to Follow-up|1|||
127726679|NCT00264576|459626482|FG001|Overall Study|Lost to Follow-up|1|||
127726680|NCT02659059|459626485|FG000|Overall Study|Other reasons|6|||
127726681|NCT02659059|459626486|FG001|Overall Study|Other reasons|1|||
127726682|NCT02659059|459626485|FG000|Overall Study|Disease Progression|143|||
127726683|NCT02659059|459626486|FG001|Overall Study|Disease Progression|16|||
127726684|NCT02659059|459626485|FG000|Overall Study|Study Drug toxicity|56|||
127726685|NCT02659059|459626486|FG001|Overall Study|Study Drug toxicity|9|||
127726686|NCT02659059|459626485|FG000|Overall Study|Death|3|||
127726687|NCT02659059|459626486|FG001|Overall Study|Death|1|||
127726688|NCT02659059|459626485|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
127726689|NCT02659059|459626486|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
127726690|NCT02659059|459626485|FG000|Overall Study|Participant request to discontinue study treatment|5|||
127726691|NCT02659059|459626486|FG001|Overall Study|Participant request to discontinue study treatment|0|||
127726692|NCT02659059|459626485|FG000|Overall Study|Participant withdrew consent|6|||
127889690|NCT00299728|460218146|FG001|Overall Study|Lost to Follow-up|1|||
127726693|NCT02659059|459626486|FG001|Overall Study|Participant withdrew consent|1|||
127726694|NCT03976102|459626489|FG000|Overall Study|Withdrawal by Subject|4|||
127726695|NCT03976102|459626490|FG001|Overall Study|Withdrawal by Subject|4|||
127726696|NCT03976102|459626489|FG000|Overall Study|Adverse Event|2|||
127726697|NCT03976102|459626490|FG001|Overall Study|Adverse Event|4|||
127726698|NCT03976102|459626489|FG000|Overall Study|Not related to Covid-19|9|||
127726699|NCT03976102|459626490|FG001|Overall Study|Not related to Covid-19|13|||
127726700|NCT03976102|459626489|FG000|Overall Study|Lost to Follow-up|0|||
127726701|NCT03976102|459626490|FG001|Overall Study|Lost to Follow-up|2|||
127726702|NCT03976102|459626489|FG000|Overall Study|Death|3|||
127726703|NCT03976102|459626490|FG001|Overall Study|Death|2|||
127726704|NCT03976102|459626489|FG000|Overall Study|Physician Decision|1|||
127726705|NCT03976102|459626490|FG001|Overall Study|Physician Decision|1|||
127726706|NCT00092456|459626498|FG000|Overall Study|Adverse Event|0|||
127726707|NCT00092456|459626499|FG001|Overall Study|Adverse Event|0|||
127726708|NCT00092456|459626500|FG002|Overall Study|Adverse Event|1|||
127726709|NCT00092456|459626501|FG003|Overall Study|Adverse Event|1|||
127726710|NCT00092456|459626498|FG000|Overall Study|Lost to Follow-up|2|||
127726711|NCT00092456|459626499|FG001|Overall Study|Lost to Follow-up|2|||
127726712|NCT00092456|459626500|FG002|Overall Study|Lost to Follow-up|1|||
127726713|NCT00092456|459626501|FG003|Overall Study|Lost to Follow-up|2|||
127726714|NCT00092456|459626498|FG000|Overall Study|Protocol Violation|5|||
127726715|NCT00092456|459626499|FG001|Overall Study|Protocol Violation|7|||
127726716|NCT00092456|459626500|FG002|Overall Study|Protocol Violation|8|||
127726717|NCT00092456|459626501|FG003|Overall Study|Protocol Violation|6|||
127726718|NCT00092456|459626498|FG000|Overall Study|Withdrawal by Subject|13|||
127726719|NCT00092456|459626499|FG001|Overall Study|Withdrawal by Subject|5|||
127726720|NCT00092456|459626500|FG002|Overall Study|Withdrawal by Subject|16|||
127726721|NCT00092456|459626501|FG003|Overall Study|Withdrawal by Subject|6|||
127726722|NCT00092456|459626498|FG000|Overall Study|Moved|1|||
127726723|NCT00092456|459626499|FG001|Overall Study|Moved|1|||
127726724|NCT00092456|459626500|FG002|Overall Study|Moved|0|||
127726725|NCT00092456|459626501|FG003|Overall Study|Moved|1|||
127726726|NCT00092456|459626498|FG000|Overall Study|Other|4|||
127726727|NCT00092456|459626499|FG001|Overall Study|Other|2|||
127726728|NCT00092456|459626500|FG002|Overall Study|Other|3|||
127726729|NCT00092456|459626501|FG003|Overall Study|Other|0|||
127726730|NCT04783389|459626502|FG000|Overall Study|Withdrawal by Subject|2|||
127726731|NCT04783389|459626503|FG001|Overall Study|Withdrawal by Subject|0|||
127726732|NCT04783389|459626504|FG002|Overall Study|Withdrawal by Subject|0|||
127726733|NCT04783389|459626502|FG000|Overall Study|Termination of Study by Sponsor|10|||
127726734|NCT04783389|459626503|FG001|Overall Study|Termination of Study by Sponsor|12|||
127726735|NCT04783389|459626504|FG002|Overall Study|Termination of Study by Sponsor|14|||
127726736|NCT00451906|459626505|FG000|Overall Study|Adverse Event|515|||
127726737|NCT00451906|459626505|FG000|Overall Study|Lost to Follow-up|31|||
127726738|NCT00451906|459626505|FG000|Overall Study|Withdrawal by Subject|111|||
127726739|NCT00451906|459626505|FG000|Overall Study|Protocol Violation|21|||
127726740|NCT00451906|459626505|FG000|Overall Study|Progressive disease|1328|||
127726741|NCT00451906|459626505|FG000|Overall Study|Termination of the study|108|||
127726742|NCT00451906|459626505|FG000|Overall Study|Other Reasons|121|||
127726743|NCT00451906|459626505|FG000|Overall Study|Did not complete final visit|4|||
127726744|NCT02121808|459626510|FG000|Overall Study|Technical problem|3|||
127726745|NCT04820023|459626511|FG000|Overall Study|Death|0|||
127726746|NCT04820023|459626512|FG001|Overall Study|Death|0|||
127726747|NCT04820023|459626513|FG002|Overall Study|Death|0|||
127726748|NCT04820023|459626514|FG003|Overall Study|Death|0|||
127726749|NCT04820023|459626515|FG004|Overall Study|Death|0|||
127726750|NCT04820023|459626516|FG005|Overall Study|Death|0|||
127726751|NCT04820023|459626517|FG006|Overall Study|Death|1|||
127726752|NCT04820023|459626518|FG007|Overall Study|Death|0|||
127726753|NCT04820023|459626519|FG008|Overall Study|Death|1|||
127726754|NCT04820023|459626511|FG000|Overall Study|Withdrawal by Subject|1|||
127726755|NCT04820023|459626512|FG001|Overall Study|Withdrawal by Subject|2|||
127726756|NCT04820023|459626513|FG002|Overall Study|Withdrawal by Subject|2|||
127726757|NCT04820023|459626514|FG003|Overall Study|Withdrawal by Subject|1|||
127726758|NCT04820023|459626515|FG004|Overall Study|Withdrawal by Subject|4|||
127726759|NCT04820023|459626516|FG005|Overall Study|Withdrawal by Subject|3|||
127726760|NCT04820023|459626517|FG006|Overall Study|Withdrawal by Subject|3|||
127726761|NCT04820023|459626518|FG007|Overall Study|Withdrawal by Subject|6|||
127726762|NCT04820023|459626519|FG008|Overall Study|Withdrawal by Subject|5|||
127726763|NCT04820023|459626511|FG000|Overall Study|Progressive Disease|3|||
127726764|NCT04820023|459626512|FG001|Overall Study|Progressive Disease|0|||
127726765|NCT04820023|459626513|FG002|Overall Study|Progressive Disease|2|||
127726766|NCT04820023|459626514|FG003|Overall Study|Progressive Disease|2|||
127726767|NCT04820023|459626515|FG004|Overall Study|Progressive Disease|2|||
127726768|NCT04820023|459626516|FG005|Overall Study|Progressive Disease|0|||
127726769|NCT04820023|459626517|FG006|Overall Study|Progressive Disease|1|||
127726770|NCT04820023|459626518|FG007|Overall Study|Progressive Disease|1|||
127726771|NCT04820023|459626519|FG008|Overall Study|Progressive Disease|0|||
127726772|NCT04820023|459626511|FG000|Overall Study|New anti-cancer therapy|0|||
127726773|NCT04820023|459626512|FG001|Overall Study|New anti-cancer therapy|0|||
127726774|NCT04820023|459626513|FG002|Overall Study|New anti-cancer therapy|0|||
127726775|NCT04820023|459626514|FG003|Overall Study|New anti-cancer therapy|0|||
127726776|NCT04820023|459626515|FG004|Overall Study|New anti-cancer therapy|2|||
127726777|NCT04820023|459626516|FG005|Overall Study|New anti-cancer therapy|0|||
127726778|NCT04820023|459626517|FG006|Overall Study|New anti-cancer therapy|0|||
127726779|NCT04820023|459626518|FG007|Overall Study|New anti-cancer therapy|0|||
127726780|NCT04820023|459626519|FG008|Overall Study|New anti-cancer therapy|0|||
127726781|NCT04820023|459626511|FG000|Overall Study|Other|0|||
127726782|NCT04820023|459626512|FG001|Overall Study|Other|1|||
127726783|NCT04820023|459626513|FG002|Overall Study|Other|0|||
127726784|NCT04820023|459626514|FG003|Overall Study|Other|0|||
127726785|NCT04820023|459626515|FG004|Overall Study|Other|0|||
127726786|NCT04820023|459626516|FG005|Overall Study|Other|0|||
127726787|NCT04820023|459626517|FG006|Overall Study|Other|0|||
127726788|NCT04820023|459626518|FG007|Overall Study|Other|2|||
127726789|NCT04820023|459626519|FG008|Overall Study|Other|0|||
127726790|NCT05066230|459626520|FG000|Primary Study (Through Week 48)|Adverse Event|1|||
127726791|NCT05066230|459626521|FG001|Primary Study (Through Week 48)|Adverse Event|4|||
127726792|NCT05066230|459626520|FG000|Primary Study (Through Week 48)|Non-compliance with study schedule|0|||
127726793|NCT05066230|459626521|FG001|Primary Study (Through Week 48)|Non-compliance with study schedule|1|||
127726794|NCT05066230|459626520|FG000|Primary Study (Through Week 48)|Withdrawal by Subject|4|||
127726795|NCT05066230|459626521|FG001|Primary Study (Through Week 48)|Withdrawal by Subject|2|||
127726796|NCT05066230|459626520|FG000|Primary Study (Through Week 48)|Lost to Follow-up|2|||
127726797|NCT05066230|459626521|FG001|Primary Study (Through Week 48)|Lost to Follow-up|3|||
127726798|NCT05066230|459626520|FG000|Primary Study (Through Week 48)|Participant relocated|1|||
127726799|NCT05066230|459626521|FG001|Primary Study (Through Week 48)|Participant relocated|0|||
127726800|NCT05066230|459626520|FG000|After Week 48|Adverse Event|1|||
127726801|NCT05066230|459626521|FG001|After Week 48|Adverse Event|0|||
127726802|NCT05066230|459626520|FG000|After Week 48|Non-compliance with study schedule|1|||
127726803|NCT05066230|459626521|FG001|After Week 48|Non-compliance with study schedule|0|||
127726804|NCT05066230|459626520|FG000|After Week 48|Withdrawal by Subject|0|||
127726805|NCT05066230|459626521|FG001|After Week 48|Withdrawal by Subject|1|||
127726806|NCT05066230|459626520|FG000|After Week 48|Lost to Follow-up|3|||
127726807|NCT05066230|459626521|FG001|After Week 48|Lost to Follow-up|3|||
127726808|NCT05066230|459626520|FG000|After Week 48|Sponsor Request|115|||
127726809|NCT05066230|459626521|FG001|After Week 48|Sponsor Request|111|||
127726810|NCT03072238|459626522|FG000|Overall Study|Withdrawal by Subject|44|||
127726811|NCT03072238|459626523|FG001|Overall Study|Withdrawal by Subject|64|||
127726812|NCT03072238|459626522|FG000|Overall Study|Lost to Follow-up|14|||
127726813|NCT03072238|459626523|FG001|Overall Study|Lost to Follow-up|5|||
127726814|NCT03072238|459626522|FG000|Overall Study|Physician Decision|4|||
127726815|NCT03072238|459626523|FG001|Overall Study|Physician Decision|6|||
127726816|NCT03072238|459626522|FG000|Overall Study|Death|351|||
127726817|NCT03072238|459626523|FG001|Overall Study|Death|318|||
127726818|NCT03072238|459626522|FG000|Overall Study|Progressive Disease|3|||
127726819|NCT03072238|459626523|FG001|Overall Study|Progressive Disease|4|||
127726820|NCT03072238|459626522|FG000|Overall Study|Reason Not Specified|138|||
127726821|NCT03072238|459626523|FG001|Overall Study|Reason Not Specified|150|||
127726822|NCT01863368|459626529|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
127726823|NCT01863368|459626530|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
127726824|NCT01863368|459626529|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
127726825|NCT01863368|459626530|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
127726826|NCT01863368|459626529|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
127726827|NCT01863368|459626530|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
127726828|NCT01863368|459626529|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
127726829|NCT01863368|459626530|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
127726830|NCT01863368|459626529|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
127726831|NCT01863368|459626530|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
127726832|NCT01863368|459626529|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
127726833|NCT01863368|459626530|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
127726834|NCT02165202|459626531|FG000|Oral Phase|Refused further participation|5|||
127726835|NCT02165202|459626532|FG001|Oral Phase|Refused further participation|1|||
127726836|NCT02165202|459626531|FG000|Oral Phase|Study product Related Toxicity|1|||
127726837|NCT02165202|459626532|FG001|Oral Phase|Study product Related Toxicity|0|||
127726838|NCT02165202|459626531|FG000|Oral Phase|Unable to contact Participant|1|||
127726839|NCT02165202|459626532|FG001|Oral Phase|Unable to contact Participant|1|||
127726840|NCT02165202|459626531|FG000|Oral Phase|Clinical reasons|1|||
127726841|NCT02165202|459626532|FG001|Oral Phase|Clinical reasons|0|||
127726842|NCT02165202|459626531|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
127726843|NCT02165202|459626532|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
127726844|NCT02165202|459626531|FG000|Oral Phase|CMC advised termination|1|||
127726845|NCT02165202|459626532|FG001|Oral Phase|CMC advised termination|0|||
127726846|NCT02165202|459626531|FG000|Oral Phase|Relocated, no follow-up planned|1|||
127726847|NCT02165202|459626532|FG001|Oral Phase|Relocated, no follow-up planned|0|||
127726848|NCT02165202|459626531|FG000|Oral Phase|Abnormal EKG|0|||
127726849|NCT02165202|459626532|FG001|Oral Phase|Abnormal EKG|1|||
127726850|NCT02165202|459626531|FG000|Injection Phase|Abnormal Lab Value|5|||
127726851|NCT02165202|459626532|FG001|Injection Phase|Abnormal Lab Value|1|||
127726852|NCT02165202|459626531|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
127726853|NCT02165202|459626532|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
127726854|NCT02165202|459626531|FG000|Injection Phase|Unable to attend within Visit Window|1|||
127726855|NCT02165202|459626532|FG001|Injection Phase|Unable to attend within Visit Window|0|||
127726856|NCT02165202|459626531|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
127726857|NCT02165202|459626532|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
127726858|NCT02165202|459626531|FG000|Injection Phase|End of Study|2|||
127726859|NCT02165202|459626532|FG001|Injection Phase|End of Study|1|||
127726860|NCT02165202|459626531|FG000|Injection Phase|Study Product related Toxicity|1|||
127726861|NCT02165202|459626532|FG001|Injection Phase|Study Product related Toxicity|0|||
127726862|NCT02165202|459626531|FG000|Injection Phase|No longer interested|0|||
127726863|NCT02165202|459626532|FG001|Injection Phase|No longer interested|1|||
127726864|NCT02165202|459626531|FG000|Injection Phase|Participant unwilling to comply|1|||
127726865|NCT02165202|459626532|FG001|Injection Phase|Participant unwilling to comply|0|||
127726866|NCT01655498|459626537|FG000|Overall Study|Unrelated health issue|2|||
127726867|NCT01655498|459626537|FG000|Overall Study|Protocol Violation|2|||
127726868|NCT01655498|459626537|FG000|Overall Study|Withdrawal by Subject|1|||
127726869|NCT01072149|459626540|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
127726870|NCT01072149|459626541|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
127726871|NCT01072149|459626542|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
127726872|NCT01072149|459626543|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
127726873|NCT01072149|459626544|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
127726874|NCT01072149|459626545|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
127726875|NCT01072149|459626546|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
127726876|NCT01072149|459626547|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
127726877|NCT01072149|459626548|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
127726878|NCT01072149|459626549|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
127726879|NCT01072149|459626550|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
127726880|NCT01072149|459626551|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
127726881|NCT01072149|459626552|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
127726882|NCT01072149|459626553|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
127726883|NCT01072149|459626554|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
127726884|NCT01072149|459626555|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
127726885|NCT01072149|459626556|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
127726886|NCT01072149|459626557|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
127726887|NCT01072149|459626540|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
127726888|NCT01072149|459626541|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
127726889|NCT01072149|459626542|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
127726890|NCT01072149|459626543|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
127726891|NCT01072149|459626544|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
127726892|NCT01072149|459626545|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
127726893|NCT01072149|459626546|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
127726894|NCT01072149|459626547|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
127726895|NCT01072149|459626548|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
127726896|NCT01072149|459626549|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
127726897|NCT01072149|459626550|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
127726898|NCT01072149|459626551|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
127726899|NCT01072149|459626552|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
127726900|NCT01072149|459626553|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
127726901|NCT01072149|459626554|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
127726902|NCT01072149|459626555|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
127726903|NCT01072149|459626556|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
127726904|NCT01072149|459626557|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
127726905|NCT01072149|459626540|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
127726906|NCT01072149|459626541|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
127726907|NCT01072149|459626542|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
127726908|NCT01072149|459626543|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
127726909|NCT01072149|459626544|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
127726910|NCT01072149|459626545|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
127726911|NCT01072149|459626546|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
127726912|NCT01072149|459626547|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
127726913|NCT01072149|459626548|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
127889691|NCT00299728|460218145|FG000|Overall Study|Withdrawal by Subject|0|||
127889692|NCT00299728|460218146|FG001|Overall Study|Withdrawal by Subject|1|||
127726914|NCT01072149|459626549|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
127726915|NCT01072149|459626550|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
127726916|NCT01072149|459626551|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
127726917|NCT01072149|459626552|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
127726918|NCT01072149|459626553|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
127726919|NCT01072149|459626554|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
127726920|NCT01072149|459626555|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
127726921|NCT01072149|459626556|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
127726922|NCT01072149|459626557|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
127726923|NCT01072149|459626540|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
127726924|NCT01072149|459626541|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
127726925|NCT01072149|459626542|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
127726926|NCT01072149|459626543|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
127726927|NCT01072149|459626544|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
127726928|NCT01072149|459626545|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
127726929|NCT01072149|459626546|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
127726930|NCT01072149|459626547|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
127726931|NCT01072149|459626548|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
127726932|NCT01072149|459626549|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
127726933|NCT01072149|459626550|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
127726934|NCT01072149|459626551|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
127726935|NCT01072149|459626552|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
127726936|NCT01072149|459626553|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
127726937|NCT01072149|459626554|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
127726938|NCT01072149|459626555|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
127726939|NCT01072149|459626556|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
127889693|NCT00299728|460218145|FG000|Overall Study|Progressive disease|0|||
127889694|NCT00299728|460218146|FG001|Overall Study|Progressive disease|1|||
127889695|NCT03372083|460219864|FG000|Overall Study|Adverse Event|3|||
127889696|NCT03372083|460219864|FG000|Overall Study|Physician Decision|1|||
127889697|NCT03372083|460219864|FG000|Overall Study|Withdrawal by Subject|1|||
127889698|NCT00827827|460219866|FG000|Overall Study|Lost to Follow-up|3|||
127889699|NCT00827827|460219867|FG001|Overall Study|Lost to Follow-up|0|||
127889700|NCT00827827|460219866|FG000|Overall Study|Fall at home- hospitalization|1|||
127889701|NCT00827827|460219867|FG001|Overall Study|Fall at home- hospitalization|0|||
127889702|NCT00827827|460219866|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
127889703|NCT00827827|460219867|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
127889704|NCT00827827|460219866|FG000|Overall Study|Gout|1|||
127889705|NCT00827827|460219867|FG001|Overall Study|Gout|0|||
127889706|NCT00827827|460219866|FG000|Overall Study|Transportation issues|1|||
127889707|NCT00827827|460219867|FG001|Overall Study|Transportation issues|0|||
127889708|NCT00827827|460219866|FG000|Overall Study|Burned with water at home|1|||
127889709|NCT00827827|460219867|FG001|Overall Study|Burned with water at home|0|||
127889710|NCT02884206|460219868|FG000|Valsartan Run-in Period|Death|1|||
127889711|NCT02884206|460219869|FG001|Valsartan Run-in Period|Death|0|||
127889712|NCT02884206|460219870|FG002|Valsartan Run-in Period|Death|0|||
127889713|NCT02884206|460219868|FG000|Valsartan Run-in Period|Adverse Event|31|||
127889714|NCT02884206|460219869|FG001|Valsartan Run-in Period|Adverse Event|0|||
127889715|NCT02884206|460219870|FG002|Valsartan Run-in Period|Adverse Event|0|||
127889716|NCT02884206|460219868|FG000|Valsartan Run-in Period|Patient/guardian decision|9|||
127889717|NCT02884206|460219869|FG001|Valsartan Run-in Period|Patient/guardian decision|0|||
127889718|NCT02884206|460219870|FG002|Valsartan Run-in Period|Patient/guardian decision|0|||
127726940|NCT01072149|459626557|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
127726941|NCT01072149|459626540|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
127726942|NCT01072149|459626541|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
127726943|NCT01072149|459626542|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
127726944|NCT01072149|459626543|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
127726945|NCT01072149|459626544|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
127726946|NCT01072149|459626545|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
127726947|NCT01072149|459626546|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
127726948|NCT01072149|459626547|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
127726949|NCT01072149|459626548|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
127889719|NCT02884206|460219868|FG000|Valsartan Run-in Period|Protocol deviation|4|||
127889720|NCT02884206|460219869|FG001|Valsartan Run-in Period|Protocol deviation|0|||
127889721|NCT02884206|460219870|FG002|Valsartan Run-in Period|Protocol deviation|0|||
127889722|NCT02884206|460219868|FG000|Valsartan Run-in Period|Non-compliance with study treatment|1|||
127889723|NCT02884206|460219869|FG001|Valsartan Run-in Period|Non-compliance with study treatment|0|||
127889724|NCT02884206|460219870|FG002|Valsartan Run-in Period|Non-compliance with study treatment|0|||
127726950|NCT01072149|459626549|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
127726951|NCT01072149|459626550|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
127726952|NCT01072149|459626551|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
127726953|NCT01072149|459626552|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
127726954|NCT01072149|459626553|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
127726955|NCT01072149|459626554|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
127726956|NCT01072149|459626555|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
127726957|NCT01072149|459626556|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
127726958|NCT01072149|459626557|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
127726959|NCT01072149|459626540|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
127726960|NCT01072149|459626541|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
127726961|NCT01072149|459626542|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
127726962|NCT01072149|459626543|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
127726963|NCT01072149|459626544|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
127726964|NCT01072149|459626545|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
127726965|NCT01072149|459626546|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
127726966|NCT01072149|459626547|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
127726967|NCT01072149|459626548|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
127726968|NCT01072149|459626549|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
127726969|NCT01072149|459626550|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
127726970|NCT01072149|459626551|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
127726971|NCT01072149|459626552|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
127726972|NCT01072149|459626553|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
127726973|NCT01072149|459626554|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
127726974|NCT01072149|459626555|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
127726975|NCT01072149|459626556|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
127726976|NCT01072149|459626557|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
127726977|NCT01072149|459626540|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
127726978|NCT01072149|459626541|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
127726979|NCT01072149|459626542|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
127726980|NCT01072149|459626543|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
127726981|NCT01072149|459626544|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
127726982|NCT01072149|459626545|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
127726983|NCT01072149|459626546|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
127726984|NCT01072149|459626547|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
127726985|NCT01072149|459626548|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
127726986|NCT01072149|459626549|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
127726987|NCT01072149|459626550|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
127726988|NCT01072149|459626551|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
127726989|NCT01072149|459626552|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
127726990|NCT01072149|459626553|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
127726991|NCT01072149|459626554|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
127726992|NCT01072149|459626555|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
127726993|NCT01072149|459626556|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
127726994|NCT01072149|459626557|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
127726995|NCT01072149|459626540|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
127726996|NCT01072149|459626541|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
127726997|NCT01072149|459626542|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
127726998|NCT01072149|459626543|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
127726999|NCT01072149|459626544|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
127727000|NCT01072149|459626545|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
127727001|NCT01072149|459626546|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
127727002|NCT01072149|459626547|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
127727003|NCT01072149|459626548|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
127727004|NCT01072149|459626549|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
127727005|NCT01072149|459626550|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
127727006|NCT01072149|459626551|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
127727007|NCT01072149|459626552|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
127727008|NCT01072149|459626553|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
127727009|NCT01072149|459626554|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
127727010|NCT01072149|459626555|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
127727011|NCT01072149|459626556|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
127727012|NCT01072149|459626557|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
127727013|NCT01072149|459626540|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
127727014|NCT01072149|459626541|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
127727015|NCT01072149|459626542|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
127727016|NCT01072149|459626543|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
127727017|NCT01072149|459626544|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
127727018|NCT01072149|459626545|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
127727019|NCT01072149|459626546|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
127727020|NCT01072149|459626547|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
127727021|NCT01072149|459626548|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
127727022|NCT01072149|459626549|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
127727023|NCT01072149|459626550|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
127727024|NCT01072149|459626551|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
127727025|NCT01072149|459626552|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
127727026|NCT01072149|459626553|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
127727027|NCT01072149|459626554|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
127727028|NCT01072149|459626555|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
127727029|NCT01072149|459626556|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
127727030|NCT01072149|459626557|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
127727031|NCT01072149|459626540|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
127727032|NCT01072149|459626541|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
127727033|NCT01072149|459626542|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
127727034|NCT01072149|459626543|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
127727035|NCT01072149|459626544|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
127727036|NCT01072149|459626545|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
127727037|NCT01072149|459626546|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
127727038|NCT01072149|459626547|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
127727039|NCT01072149|459626548|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
127727040|NCT01072149|459626549|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
127727041|NCT01072149|459626550|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
127727042|NCT01072149|459626551|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
127727043|NCT01072149|459626552|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
127727044|NCT01072149|459626553|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
127727045|NCT01072149|459626554|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
127727046|NCT01072149|459626555|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
127727047|NCT01072149|459626556|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
127727048|NCT01072149|459626557|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
127727049|NCT01072149|459626540|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
127727050|NCT01072149|459626541|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
127727051|NCT01072149|459626542|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
127889725|NCT02884206|460219868|FG000|Valsartan Run-in Period|Physician Decision|1|||
127889726|NCT02884206|460219869|FG001|Valsartan Run-in Period|Physician Decision|0|||
127889727|NCT02884206|460219870|FG002|Valsartan Run-in Period|Physician Decision|0|||
127727052|NCT01072149|459626543|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
127727053|NCT01072149|459626544|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
127727054|NCT01072149|459626545|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
127727055|NCT01072149|459626546|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
127727056|NCT01072149|459626547|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
127727057|NCT01072149|459626548|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
127727058|NCT01072149|459626549|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
127727059|NCT01072149|459626550|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
127727060|NCT01072149|459626551|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
127727061|NCT01072149|459626552|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
127727062|NCT01072149|459626553|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
127727063|NCT01072149|459626554|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
127727064|NCT01072149|459626555|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
127889728|NCT02884206|460219868|FG000|LCZ696 Run-in Period|Adverse Event|38|||
127727065|NCT01072149|459626556|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
127727066|NCT01072149|459626557|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
127727067|NCT02784834|459626558|FG000|Overall Study|Lack of Efficacy|1|||
127727068|NCT00080119|459626559|FG000|Overall Study|Discontinued because of study closure|0|||
127727069|NCT00080119|459626560|FG001|Overall Study|Discontinued because of study closure|0|||
127727070|NCT00080119|459626561|FG002|Overall Study|Discontinued because of study closure|130|||
127727071|NCT00080119|459626562|FG003|Overall Study|Discontinued because of study closure|141|||
127727072|NCT00080119|459626559|FG000|Overall Study|Unable to get to clinic|24|||
127727073|NCT00080119|459626560|FG001|Overall Study|Unable to get to clinic|24|||
127727074|NCT00080119|459626561|FG002|Overall Study|Unable to get to clinic|7|||
127727075|NCT00080119|459626562|FG003|Overall Study|Unable to get to clinic|1|||
127727076|NCT00080119|459626559|FG000|Overall Study|Consent withdrawn|13|||
127727077|NCT00080119|459626560|FG001|Overall Study|Consent withdrawn|17|||
127727078|NCT00080119|459626561|FG002|Overall Study|Consent withdrawn|4|||
127727079|NCT00080119|459626562|FG003|Overall Study|Consent withdrawn|6|||
127727080|NCT00080119|459626559|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
127727081|NCT00080119|459626560|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
127727082|NCT00080119|459626561|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
127727083|NCT00080119|459626562|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
127727084|NCT00080119|459626559|FG000|Overall Study|Lost to Follow-up|16|||
127727085|NCT00080119|459626560|FG001|Overall Study|Lost to Follow-up|19|||
127727086|NCT00080119|459626561|FG002|Overall Study|Lost to Follow-up|19|||
127727087|NCT00080119|459626562|FG003|Overall Study|Lost to Follow-up|14|||
127727088|NCT01919489|459626564|FG000|Overall Study|Rejected the need of injections|4|||
127727089|NCT01919489|459626565|FG001|Overall Study|Rejected the need of injections|7|||
127727090|NCT01919489|459626564|FG000|Overall Study|Adverse Event|10|||
127727091|NCT01919489|459626565|FG001|Overall Study|Adverse Event|0|||
127727092|NCT01919489|459626564|FG000|Overall Study|Hospital readmission|2|||
127727093|NCT01919489|459626565|FG001|Overall Study|Hospital readmission|9|||
127727094|NCT01919489|459626564|FG000|Overall Study|Death|2|||
127727095|NCT01919489|459626565|FG001|Overall Study|Death|1|||
127727096|NCT01919489|459626564|FG000|Overall Study|Lost to Follow-up|38|||
127727097|NCT01919489|459626565|FG001|Overall Study|Lost to Follow-up|27|||
127727098|NCT01322386|459626566|FG000|Overall Study|Protocol Violation|0|||
127727099|NCT01322386|459626567|FG001|Overall Study|Protocol Violation|1|||
127727100|NCT01322386|459626566|FG000|Overall Study|Physician Decision|0|||
127727101|NCT01322386|459626567|FG001|Overall Study|Physician Decision|1|||
127727102|NCT00871494|459626571|FG000|Overall Study|Protocol Violation|5|||
127727103|NCT00871494|459626571|FG000|Overall Study|Lack of Efficacy|4|||
127727104|NCT00871494|459626571|FG000|Overall Study|Adverse Event|4|||
127727105|NCT00871494|459626571|FG000|Overall Study|Lost to Follow-up|1|||
127727106|NCT00963924|459626572|FG000|Overall Study|Adverse Event|1|||
127727107|NCT00963924|459626573|FG001|Overall Study|Adverse Event|0|||
127727108|NCT00963924|459626572|FG000|Overall Study|Withdrawal by Subject|0|||
127727109|NCT00963924|459626573|FG001|Overall Study|Withdrawal by Subject|1|||
127727110|NCT00963924|459626572|FG000|Overall Study|Changed antipsychotic|0|||
127727111|NCT00963924|459626573|FG001|Overall Study|Changed antipsychotic|1|||
127727112|NCT00963924|459626572|FG000|Overall Study|Lost to Follow-up|0|||
127727113|NCT00963924|459626573|FG001|Overall Study|Lost to Follow-up|1|||
127727114|NCT03875729|459626574|FG000|Overall Study|Adverse Event|0|||
127727115|NCT03875729|459626575|FG001|Overall Study|Adverse Event|5|||
127727116|NCT03875729|459626574|FG000|Overall Study|Withdrawal by Subject|8|||
127727117|NCT03875729|459626575|FG001|Overall Study|Withdrawal by Subject|11|||
127727118|NCT03875729|459626574|FG000|Overall Study|Pregnancy|0|||
127727119|NCT03875729|459626575|FG001|Overall Study|Pregnancy|1|||
127727120|NCT03875729|459626574|FG000|Overall Study|Lost to Follow-up|0|||
127727121|NCT03875729|459626575|FG001|Overall Study|Lost to Follow-up|5|||
127727122|NCT03875729|459626574|FG000|Overall Study|Personal reasons|2|||
127727123|NCT03875729|459626575|FG001|Overall Study|Personal reasons|0|||
127727124|NCT02764320|459626576|FG000|Overall Study|Withdrawal by Subject|35|||
127727125|NCT02764320|459626577|FG001|Overall Study|Withdrawal by Subject|38|||
127727126|NCT02764320|459626576|FG000|Overall Study|Protocol Violation|11|||
127727127|NCT02764320|459626577|FG001|Overall Study|Protocol Violation|6|||
127727128|NCT02764320|459626576|FG000|Overall Study|Adverse Event|2|||
127727129|NCT02764320|459626577|FG001|Overall Study|Adverse Event|0|||
127727130|NCT02764320|459626576|FG000|Overall Study|Health Issues unable to continue|2|||
127727131|NCT02764320|459626577|FG001|Overall Study|Health Issues unable to continue|0|||
127727132|NCT02764320|459626576|FG000|Overall Study|Did not meet inclusion criteria|1|||
127727133|NCT02764320|459626577|FG001|Overall Study|Did not meet inclusion criteria|0|||
127727134|NCT02764320|459626576|FG000|Overall Study|Subject moved|0|||
127727135|NCT02764320|459626577|FG001|Overall Study|Subject moved|2|||
127727136|NCT02764320|459626576|FG000|Overall Study|Overused medication unavailable|0|||
127727137|NCT02764320|459626577|FG001|Overall Study|Overused medication unavailable|1|||
127727138|NCT02764320|459626576|FG000|Overall Study|Seeking care outside site|0|||
127727139|NCT02764320|459626577|FG001|Overall Study|Seeking care outside site|1|||
127727140|NCT02764320|459626576|FG000|Overall Study|Technology barriers|0|||
127727141|NCT02764320|459626577|FG001|Overall Study|Technology barriers|1|||
127727142|NCT01405508|459626580|FG000|Overall Study|AE, non-serious non-fatal|1|||
127727143|NCT01405508|459626581|FG001|Overall Study|AE, non-serious non-fatal|1|||
127727144|NCT01405508|459626582|FG002|Overall Study|AE, non-serious non-fatal|0|||
127727145|NCT01405508|459626583|FG003|Overall Study|AE, non-serious non-fatal|0|||
127727146|NCT00476957|459626584|FG000|Overall Study|Lost to Follow-up|176|||
127727147|NCT00476957|459626585|FG001|Overall Study|Lost to Follow-up|193|||
127727148|NCT02159352|459626586|FG000|Overall Study|Adverse Event|3|||
127727149|NCT02159352|459626587|FG001|Overall Study|Adverse Event|1|||
127727150|NCT02159352|459626586|FG000|Overall Study|Withdrawal by Subject|0|||
127727151|NCT02159352|459626587|FG001|Overall Study|Withdrawal by Subject|1|||
127727152|NCT00237809|459626592|FG000|Overall Study|Lost to Follow-up|11|||
127727153|NCT00237809|459626593|FG001|Overall Study|Lost to Follow-up|10|||
127727154|NCT00237809|459626594|FG002|Overall Study|Lost to Follow-up|9|||
127727155|NCT00237809|459626595|FG003|Overall Study|Lost to Follow-up|9|||
127727156|NCT00871715|459626600|FG000|Overall Study|Withdrawal by Subject|6|||
127727157|NCT00871715|459626601|FG001|Overall Study|Withdrawal by Subject|10|||
127727158|NCT00871715|459626602|FG002|Overall Study|Withdrawal by Subject|15|||
127727159|NCT00871715|459626600|FG000|Overall Study|Physician Decision|6|||
127727160|NCT00871715|459626601|FG001|Overall Study|Physician Decision|0|||
127727161|NCT00871715|459626602|FG002|Overall Study|Physician Decision|2|||
127802941|NCT01360645|459901095|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
127802942|NCT01360645|459901096|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
127802943|NCT01360645|459901093|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
127802944|NCT01360645|459901094|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
127802945|NCT01360645|459901095|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
127802946|NCT01360645|459901096|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
127802947|NCT01360645|459901093|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
127802948|NCT01360645|459901094|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
127802949|NCT01360645|459901095|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
127802950|NCT01360645|459901096|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
127802951|NCT01360645|459901093|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
127802952|NCT01360645|459901094|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
127802953|NCT01360645|459901095|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
127802954|NCT01360645|459901096|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
127802955|NCT01360645|459901093|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
127802956|NCT01360645|459901094|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
127802957|NCT01360645|459901095|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
127802958|NCT01360645|459901096|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
127802959|NCT01360645|459901093|FG000|Phase B (6 Weeks)|Adverse Event|0|||
127802960|NCT01360645|459901094|FG001|Phase B (6 Weeks)|Adverse Event|6|||
127802961|NCT01360645|459901095|FG002|Phase B (6 Weeks)|Adverse Event|0|||
127802962|NCT01360645|459901096|FG003|Phase B (6 Weeks)|Adverse Event|0|||
127802963|NCT01360645|459901093|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
127802964|NCT01360645|459901094|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
127802965|NCT01360645|459901095|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
127802966|NCT01360645|459901096|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
127802967|NCT01360645|459901093|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
127802968|NCT01360645|459901094|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
127802969|NCT01360645|459901095|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
127802970|NCT01360645|459901096|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
127802971|NCT01360645|459901093|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
127802972|NCT01360645|459901094|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
127802973|NCT01360645|459901095|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
127802974|NCT01360645|459901096|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
127802975|NCT01360645|459901093|FG000|Phase A+|Lost to Follow-up|0|||
127802976|NCT01360645|459901094|FG001|Phase A+|Lost to Follow-up|0|||
127802977|NCT01360645|459901095|FG002|Phase A+|Lost to Follow-up|0|||
127802978|NCT01360645|459901096|FG003|Phase A+|Lost to Follow-up|7|||
127802979|NCT01360645|459901093|FG000|Phase A+|Adverse Event|0|||
127802980|NCT01360645|459901094|FG001|Phase A+|Adverse Event|0|||
127727162|NCT00871715|459626600|FG000|Overall Study|Lost to Follow-up|3|||
127727163|NCT00871715|459626601|FG001|Overall Study|Lost to Follow-up|6|||
127727164|NCT00871715|459626602|FG002|Overall Study|Lost to Follow-up|9|||
127727165|NCT03015220|459626603|FG000|Overall Study|Withdrawal by Subject|3|||
127727166|NCT03015220|459626604|FG001|Overall Study|Withdrawal by Subject|2|||
127727167|NCT03015220|459626605|FG002|Overall Study|Withdrawal by Subject|2|||
127727168|NCT03015220|459626606|FG003|Overall Study|Withdrawal by Subject|2|||
127727169|NCT03015220|459626603|FG000|Overall Study|Lost to Follow-up|0|||
127727170|NCT03015220|459626604|FG001|Overall Study|Lost to Follow-up|0|||
127727171|NCT03015220|459626605|FG002|Overall Study|Lost to Follow-up|1|||
127727172|NCT03015220|459626606|FG003|Overall Study|Lost to Follow-up|0|||
127727173|NCT01670526|459626607|FG000|Overall Study|Withdrawal by Subject|3|||
127727174|NCT01670526|459626608|FG001|Overall Study|Withdrawal by Subject|1|||
127727175|NCT01670526|459626607|FG000|Overall Study|Lost to Follow-up|9|||
127727176|NCT01670526|459626608|FG001|Overall Study|Lost to Follow-up|5|||
127727177|NCT02291549|459626609|FG000|Overall Study|Lost to Follow-up|1|||
127727178|NCT02291549|459626610|FG001|Overall Study|Lost to Follow-up|0|||
127727179|NCT02291549|459626609|FG000|Overall Study|Withdrawal by Subject|0|||
127727180|NCT02291549|459626610|FG001|Overall Study|Withdrawal by Subject|1|||
127727181|NCT01970527|459626612|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
127727182|NCT01970527|459626613|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
127727183|NCT01970527|459626612|FG000|Treatment|Disease progression|0|||
127727184|NCT01970527|459626613|FG001|Treatment|Disease progression|1|||
127727185|NCT01970527|459626612|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
127727186|NCT01970527|459626613|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
127727187|NCT01970527|459626612|FG000|Treatment|Death|0|||
127727188|NCT01970527|459626613|FG001|Treatment|Death|1|||
127727189|NCT01970527|459626612|FG000|Follow-up Clinic Visit|Disease progression|1|||
127727190|NCT01970527|459626613|FG001|Follow-up Clinic Visit|Disease progression|1|||
127727191|NCT01970527|459626612|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
127727192|NCT01970527|459626613|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
127727193|NCT01970527|459626612|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
127727194|NCT01970527|459626613|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
127727195|NCT01964547|459626614|FG000|Overall Study|Adverse Event|8|||
127727196|NCT01964547|459626615|FG001|Overall Study|Adverse Event|2|||
127727197|NCT01964547|459626614|FG000|Overall Study|Withdrawal by Subject|4|||
127727198|NCT01964547|459626615|FG001|Overall Study|Withdrawal by Subject|7|||
127727199|NCT01964547|459626614|FG000|Overall Study|Lost to Follow-up|0|||
127727200|NCT01964547|459626615|FG001|Overall Study|Lost to Follow-up|1|||
127727201|NCT01964547|459626614|FG000|Overall Study|Withdrawal by Investigator|0|||
127727202|NCT01964547|459626615|FG001|Overall Study|Withdrawal by Investigator|1|||
127727203|NCT04447287|459626616|FG000|Period 1: Run-in Period|Adverse Event|3|||
127727204|NCT04447287|459626617|FG001|Period 1: Run-in Period|Adverse Event|0|||
127727205|NCT04447287|459626618|FG002|Period 1: Run-in Period|Adverse Event|0|||
127727206|NCT04447287|459626616|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
127727207|NCT04447287|459626617|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
127727208|NCT04447287|459626618|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
127727209|NCT04447287|459626616|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
127727210|NCT04447287|459626617|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
127727211|NCT04447287|459626618|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
127727212|NCT02147093|459626621|FG000|Period 1|Lost to Follow-up|0|||
127727213|NCT02147093|459626622|FG001|Period 1|Lost to Follow-up|1|||
127727214|NCT02147093|459626621|FG000|Period 2|Protocol Violation|2|||
127727215|NCT02147093|459626622|FG001|Period 2|Protocol Violation|0|||
127727216|NCT03246724|459626623|FG000|Overall Study|Withdrawal by Subject|5|||
127727217|NCT03246724|459626624|FG001|Overall Study|Withdrawal by Subject|2|||
127727218|NCT03246724|459626625|FG002|Overall Study|Withdrawal by Subject|4|||
127727219|NCT03246724|459626626|FG003|Overall Study|Withdrawal by Subject|2|||
127727220|NCT03246724|459626623|FG000|Overall Study|Ineligible on day of surgery|7|||
127727221|NCT03246724|459626624|FG001|Overall Study|Ineligible on day of surgery|2|||
127727222|NCT03246724|459626625|FG002|Overall Study|Ineligible on day of surgery|0|||
127727223|NCT03246724|459626626|FG003|Overall Study|Ineligible on day of surgery|3|||
127727224|NCT03246724|459626623|FG000|Overall Study|Study completed before surgical date|2|||
127727225|NCT03246724|459626624|FG001|Overall Study|Study completed before surgical date|1|||
127727226|NCT03246724|459626625|FG002|Overall Study|Study completed before surgical date|8|||
127727227|NCT03246724|459626626|FG003|Overall Study|Study completed before surgical date|1|||
127727228|NCT03246724|459626623|FG000|Overall Study|Transferred to other arm|0|||
127727229|NCT03246724|459626624|FG001|Overall Study|Transferred to other arm|0|||
127727230|NCT03246724|459626625|FG002|Overall Study|Transferred to other arm|1|||
127727231|NCT03246724|459626626|FG003|Overall Study|Transferred to other arm|0|||
127727232|NCT03246724|459626623|FG000|Overall Study|Unable to obtain medication timely|0|||
127727233|NCT03246724|459626624|FG001|Overall Study|Unable to obtain medication timely|2|||
127727234|NCT03246724|459626625|FG002|Overall Study|Unable to obtain medication timely|2|||
127727235|NCT03246724|459626626|FG003|Overall Study|Unable to obtain medication timely|1|||
127727236|NCT03246724|459626623|FG000|Overall Study|Re-consented to participate|0|||
127727237|NCT03246724|459626624|FG001|Overall Study|Re-consented to participate|0|||
127727238|NCT03246724|459626625|FG002|Overall Study|Re-consented to participate|0|||
127727239|NCT03246724|459626626|FG003|Overall Study|Re-consented to participate|1|||
127727240|NCT01662505|459626628|FG000|Overall Study|Progressive disease|6|||
127727241|NCT01662505|459626629|FG001|Overall Study|Progressive disease|1|||
127727242|NCT01662505|459626630|FG002|Overall Study|Progressive disease|5|||
127727243|NCT01662505|459626628|FG000|Overall Study|Refused cont. medication|0|||
127727244|NCT01662505|459626629|FG001|Overall Study|Refused cont. medication|0|||
127727245|NCT01662505|459626630|FG002|Overall Study|Refused cont. medication|1|||
127727246|NCT01662505|459626628|FG000|Overall Study|Not specified above|1|||
127727247|NCT01662505|459626629|FG001|Overall Study|Not specified above|3|||
127727248|NCT01662505|459626630|FG002|Overall Study|Not specified above|2|||
127727249|NCT02255474|459626631|FG000|Overall Study|Lost to Follow-up|1|||
127727250|NCT02255474|459626632|FG001|Overall Study|Lost to Follow-up|1|||
127727251|NCT02255474|459626633|FG002|Overall Study|Lost to Follow-up|3|||
127727252|NCT02255474|459626631|FG000|Overall Study|Withdrawal by Subject|1|||
127727253|NCT02255474|459626632|FG001|Overall Study|Withdrawal by Subject|1|||
127727254|NCT02255474|459626633|FG002|Overall Study|Withdrawal by Subject|0|||
127727255|NCT01229176|459626634|FG000|Overall Study|Withdrawal by Subject|0|||
127727256|NCT01229176|459626635|FG001|Overall Study|Withdrawal by Subject|0|||
127727257|NCT01229176|459626636|FG002|Overall Study|Withdrawal by Subject|0|||
127727258|NCT01229176|459626637|FG003|Overall Study|Withdrawal by Subject|1|||
127727259|NCT01229176|459626638|FG004|Overall Study|Withdrawal by Subject|1|||
127727260|NCT01229176|459626639|FG005|Overall Study|Withdrawal by Subject|1|||
127727261|NCT01229176|459626640|FG006|Overall Study|Withdrawal by Subject|0|||
127727262|NCT01229176|459626641|FG007|Overall Study|Withdrawal by Subject|1|||
127727263|NCT01229176|459626634|FG000|Overall Study|Lost to Follow-up|0|||
127727264|NCT01229176|459626635|FG001|Overall Study|Lost to Follow-up|3|||
127727265|NCT01229176|459626636|FG002|Overall Study|Lost to Follow-up|0|||
127727266|NCT01229176|459626637|FG003|Overall Study|Lost to Follow-up|0|||
127727267|NCT01229176|459626638|FG004|Overall Study|Lost to Follow-up|1|||
127727268|NCT01229176|459626639|FG005|Overall Study|Lost to Follow-up|1|||
127727269|NCT01229176|459626640|FG006|Overall Study|Lost to Follow-up|0|||
127727270|NCT01229176|459626641|FG007|Overall Study|Lost to Follow-up|2|||
127727271|NCT02367794|459626647|FG000|Overall Study|Death|252|||
127727272|NCT02367794|459626648|FG001|Overall Study|Death|245|||
127727273|NCT02367794|459626649|FG002|Overall Study|Death|243|||
127727274|NCT02367794|459626647|FG000|Overall Study|Lost to Follow-up|1|||
127727275|NCT02367794|459626648|FG001|Overall Study|Lost to Follow-up|2|||
127727276|NCT02367794|459626649|FG002|Overall Study|Lost to Follow-up|2|||
127727277|NCT02367794|459626647|FG000|Overall Study|Physician Decision|0|||
127727278|NCT02367794|459626648|FG001|Overall Study|Physician Decision|5|||
127727279|NCT02367794|459626649|FG002|Overall Study|Physician Decision|3|||
127727280|NCT02367794|459626647|FG000|Overall Study|Protocol Violation|1|||
127727281|NCT02367794|459626648|FG001|Overall Study|Protocol Violation|0|||
127727282|NCT02367794|459626649|FG002|Overall Study|Protocol Violation|1|||
127727283|NCT02367794|459626647|FG000|Overall Study|Withdrawal by Subject|25|||
127727284|NCT02367794|459626648|FG001|Overall Study|Withdrawal by Subject|12|||
127727285|NCT02367794|459626649|FG002|Overall Study|Withdrawal by Subject|20|||
127727286|NCT02367794|459626647|FG000|Overall Study|Brain metastasis|1|||
127727287|NCT02367794|459626648|FG001|Overall Study|Brain metastasis|0|||
127727288|NCT02367794|459626649|FG002|Overall Study|Brain metastasis|0|||
127727289|NCT02367794|459626647|FG000|Overall Study|Randomized in error|0|||
127727290|NCT02367794|459626648|FG001|Overall Study|Randomized in error|0|||
127727291|NCT02367794|459626649|FG002|Overall Study|Randomized in error|1|||
127727292|NCT02367794|459626647|FG000|Overall Study|Patient unable to receive carboplatin|0|||
127727293|NCT02367794|459626648|FG001|Overall Study|Patient unable to receive carboplatin|0|||
127727294|NCT02367794|459626649|FG002|Overall Study|Patient unable to receive carboplatin|1|||
127727295|NCT02367794|459626647|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
127727296|NCT02367794|459626648|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
127727297|NCT02367794|459626649|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
127727298|NCT02367794|459626647|FG000|Overall Study|Adverse Event|0|||
127727299|NCT02367794|459626648|FG001|Overall Study|Adverse Event|0|||
127727300|NCT02367794|459626649|FG002|Overall Study|Adverse Event|2|||
127727301|NCT02367794|459626647|FG000|Overall Study|Study Terminated By Sponsor|0|||
127727302|NCT02367794|459626648|FG001|Overall Study|Study Terminated By Sponsor|1|||
127727303|NCT02367794|459626649|FG002|Overall Study|Study Terminated By Sponsor|1|||
127727304|NCT02367794|459626647|FG000|Overall Study|Moved to Roll-Over Study|0|||
127727305|NCT02367794|459626648|FG001|Overall Study|Moved to Roll-Over Study|15|||
127727306|NCT02367794|459626649|FG002|Overall Study|Moved to Roll-Over Study|13|||
127889729|NCT02884206|460219869|FG001|LCZ696 Run-in Period|Adverse Event|0|||
127727307|NCT02367794|459626647|FG000|Overall Study|Sponsor Request|60|||
127727308|NCT02367794|459626648|FG001|Overall Study|Sponsor Request|57|||
127727309|NCT02367794|459626649|FG002|Overall Study|Sponsor Request|45|||
127727310|NCT02367794|459626647|FG000|Overall Study|Moved into PTAP Study|0|||
127727311|NCT02367794|459626648|FG001|Overall Study|Moved into PTAP Study|2|||
127727312|NCT02367794|459626649|FG002|Overall Study|Moved into PTAP Study|3|||
127727313|NCT02367794|459626647|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
127727314|NCT02367794|459626648|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
127727315|NCT02367794|459626649|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
127727316|NCT02367794|459626647|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
127727317|NCT02367794|459626648|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
127727318|NCT02367794|459626649|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
127727319|NCT02367794|459626647|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
127727320|NCT02367794|459626648|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
127802981|NCT01360645|459901095|FG002|Phase A+|Adverse Event|0|||
127727321|NCT02367794|459626649|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
127727322|NCT02367794|459626647|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
127727323|NCT02367794|459626648|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
127727324|NCT02367794|459626649|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
127727325|NCT00882050|459626650|FG000|Overall Study|Physician Decision|1|||
127727326|NCT00882050|459626651|FG001|Overall Study|Physician Decision|0|||
127727327|NCT00882050|459626652|FG002|Overall Study|Physician Decision|0|||
127727328|NCT02010684|459626653|FG000|Overall Study|Lost to Follow-up|8|||
127727329|NCT02010684|459626654|FG001|Overall Study|Lost to Follow-up|18|||
127727330|NCT02010684|459626653|FG000|Overall Study|Withdrawal by Subject|4|||
127727331|NCT02010684|459626654|FG001|Overall Study|Withdrawal by Subject|5|||
127727332|NCT00091572|459626659|FG000|Overall Study|Lost to Follow-up|1|||
127727333|NCT00091572|459626660|FG001|Overall Study|Lost to Follow-up|1|||
127727334|NCT00091572|459626659|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
127727335|NCT00091572|459626660|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
127727336|NCT00091572|459626659|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
127727337|NCT00091572|459626660|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
127727338|NCT00091572|459626659|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
127727339|NCT00091572|459626660|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
127727340|NCT00091572|459626659|FG000|Overall Study|Other Reason|6|||
127727341|NCT00091572|459626660|FG001|Overall Study|Other Reason|13|||
127727342|NCT00091572|459626659|FG000|Overall Study|Ongoing (still on treatment)|8|||
127727343|NCT00091572|459626660|FG001|Overall Study|Ongoing (still on treatment)|12|||
127727344|NCT00091572|459626659|FG000|Overall Study|Major Protocol Violation|2|||
127727345|NCT00091572|459626660|FG001|Overall Study|Major Protocol Violation|0|||
127727346|NCT00091572|459626659|FG000|Overall Study|Toxicity (Related AE)|53|||
127727347|NCT00091572|459626660|FG001|Overall Study|Toxicity (Related AE)|9|||
127727348|NCT02942771|459626662|FG000|Overall Study|Adverse Event|1|||
127727349|NCT02942771|459626663|FG001|Overall Study|Adverse Event|0|||
127727350|NCT02942771|459626664|FG002|Overall Study|Adverse Event|0|||
127727351|NCT02942771|459626665|FG003|Overall Study|Adverse Event|0|||
127727352|NCT02942771|459626666|FG004|Overall Study|Adverse Event|2|||
127727353|NCT02942771|459626662|FG000|Overall Study|Lost to Follow-up|1|||
127727354|NCT02942771|459626663|FG001|Overall Study|Lost to Follow-up|0|||
127727355|NCT02942771|459626664|FG002|Overall Study|Lost to Follow-up|0|||
127727356|NCT02942771|459626665|FG003|Overall Study|Lost to Follow-up|0|||
127727357|NCT02942771|459626666|FG004|Overall Study|Lost to Follow-up|0|||
127727358|NCT02942771|459626662|FG000|Overall Study|Withdrawal by Subject|1|||
127727359|NCT02942771|459626663|FG001|Overall Study|Withdrawal by Subject|0|||
127889730|NCT02884206|460219870|FG002|LCZ696 Run-in Period|Adverse Event|0|||
127889731|NCT02884206|460219868|FG000|LCZ696 Run-in Period|Death|2|||
127889732|NCT02884206|460219869|FG001|LCZ696 Run-in Period|Death|0|||
127889733|NCT02884206|460219870|FG002|LCZ696 Run-in Period|Death|0|||
127889734|NCT02884206|460219868|FG000|LCZ696 Run-in Period|Patient/guardian decision|16|||
127889735|NCT02884206|460219869|FG001|LCZ696 Run-in Period|Patient/guardian decision|0|||
127889736|NCT02884206|460219870|FG002|LCZ696 Run-in Period|Patient/guardian decision|0|||
127889737|NCT02884206|460219868|FG000|LCZ696 Run-in Period|Protocol deviation|6|||
127889738|NCT02884206|460219869|FG001|LCZ696 Run-in Period|Protocol deviation|0|||
127889739|NCT02884206|460219870|FG002|LCZ696 Run-in Period|Protocol deviation|0|||
127727360|NCT02942771|459626664|FG002|Overall Study|Withdrawal by Subject|0|||
127727361|NCT02942771|459626665|FG003|Overall Study|Withdrawal by Subject|0|||
127727362|NCT02942771|459626666|FG004|Overall Study|Withdrawal by Subject|2|||
127889740|NCT02884206|460219868|FG000|LCZ696 Run-in Period|Non-compliance with study treatment|3|||
127889741|NCT02884206|460219869|FG001|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
127889742|NCT02884206|460219870|FG002|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
127889743|NCT02884206|460219868|FG000|LCZ696 Run-in Period|Physician Decision|1|||
127889744|NCT02884206|460219869|FG001|LCZ696 Run-in Period|Physician Decision|0|||
127889745|NCT02884206|460219870|FG002|LCZ696 Run-in Period|Physician Decision|0|||
127889746|NCT02884206|460219868|FG000|LCZ696 Run-in Period|Lost to Follow-up|1|||
127727363|NCT01186809|459626670|FG000|Overall Study|Death|30|||
127727364|NCT04895085|459626671|FG000|Overall Study|Death|1|||
127727365|NCT04895085|459626671|FG000|Overall Study|Withdrawal by Subject|1|||
127889747|NCT02884206|460219869|FG001|LCZ696 Run-in Period|Lost to Follow-up|0|||
127889748|NCT02884206|460219870|FG002|LCZ696 Run-in Period|Lost to Follow-up|0|||
127727366|NCT04895085|459626671|FG000|Overall Study|No longer eligible: Moved from area|1|||
127889749|NCT02884206|460219868|FG000|Double-Blind Period|Death|0|||
127727367|NCT01159600|459626673|FG000|Overall Study|Not treated|0|||
127727368|NCT01159600|459626674|FG001|Overall Study|Not treated|0|||
127889750|NCT02884206|460219869|FG001|Double-Blind Period|Death|28|||
127889751|NCT02884206|460219870|FG002|Double-Blind Period|Death|39|||
127889752|NCT02884206|460219868|FG000|Double-Blind Period|Patient/guardian decision|0|||
127727369|NCT01159600|459626675|FG002|Overall Study|Not treated|1|||
127727370|NCT01159600|459626676|FG003|Overall Study|Not treated|0|||
127727371|NCT01159600|459626677|FG004|Overall Study|Not treated|0|||
127727372|NCT01159600|459626678|FG005|Overall Study|Not treated|1|||
127727373|NCT01159600|459626679|FG006|Overall Study|Not treated|2|||
127727374|NCT01159600|459626680|FG007|Overall Study|Not treated|2|||
127727375|NCT01159600|459626673|FG000|Overall Study|Adverse Event|7|||
127727376|NCT01159600|459626674|FG001|Overall Study|Adverse Event|2|||
127727377|NCT01159600|459626675|FG002|Overall Study|Adverse Event|5|||
127727378|NCT01159600|459626676|FG003|Overall Study|Adverse Event|1|||
127727379|NCT01159600|459626677|FG004|Overall Study|Adverse Event|8|||
127727380|NCT01159600|459626678|FG005|Overall Study|Adverse Event|6|||
127727381|NCT01159600|459626679|FG006|Overall Study|Adverse Event|7|||
127727382|NCT01159600|459626680|FG007|Overall Study|Adverse Event|5|||
127727383|NCT01159600|459626673|FG000|Overall Study|Lack of Efficacy|0|||
127727384|NCT01159600|459626674|FG001|Overall Study|Lack of Efficacy|0|||
127727385|NCT01159600|459626675|FG002|Overall Study|Lack of Efficacy|0|||
127727386|NCT01159600|459626676|FG003|Overall Study|Lack of Efficacy|0|||
127727387|NCT01159600|459626677|FG004|Overall Study|Lack of Efficacy|2|||
127727388|NCT01159600|459626678|FG005|Overall Study|Lack of Efficacy|0|||
127727389|NCT01159600|459626679|FG006|Overall Study|Lack of Efficacy|0|||
127727390|NCT01159600|459626680|FG007|Overall Study|Lack of Efficacy|1|||
127727391|NCT01159600|459626673|FG000|Overall Study|Non compliant with protocol|2|||
127727392|NCT01159600|459626674|FG001|Overall Study|Non compliant with protocol|1|||
127727393|NCT01159600|459626675|FG002|Overall Study|Non compliant with protocol|0|||
127727394|NCT01159600|459626676|FG003|Overall Study|Non compliant with protocol|0|||
127727395|NCT01159600|459626677|FG004|Overall Study|Non compliant with protocol|2|||
127727396|NCT01159600|459626678|FG005|Overall Study|Non compliant with protocol|0|||
127727397|NCT01159600|459626679|FG006|Overall Study|Non compliant with protocol|2|||
127727398|NCT01159600|459626680|FG007|Overall Study|Non compliant with protocol|0|||
127727399|NCT01159600|459626673|FG000|Overall Study|Lost to Follow-up|2|||
127727400|NCT01159600|459626674|FG001|Overall Study|Lost to Follow-up|3|||
127727401|NCT01159600|459626675|FG002|Overall Study|Lost to Follow-up|4|||
127727402|NCT01159600|459626676|FG003|Overall Study|Lost to Follow-up|3|||
127727403|NCT01159600|459626677|FG004|Overall Study|Lost to Follow-up|3|||
127727404|NCT01159600|459626678|FG005|Overall Study|Lost to Follow-up|0|||
127727405|NCT01159600|459626679|FG006|Overall Study|Lost to Follow-up|3|||
127727406|NCT01159600|459626680|FG007|Overall Study|Lost to Follow-up|2|||
127727407|NCT01159600|459626673|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
127727408|NCT01159600|459626674|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
127727409|NCT01159600|459626675|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
127727410|NCT01159600|459626676|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
127727411|NCT01159600|459626677|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
127727412|NCT01159600|459626678|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
127727413|NCT01159600|459626679|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
127727414|NCT01159600|459626680|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
127727415|NCT01159600|459626673|FG000|Overall Study|Other reason not defined above|3|||
127727416|NCT01159600|459626674|FG001|Overall Study|Other reason not defined above|0|||
127727417|NCT01159600|459626675|FG002|Overall Study|Other reason not defined above|4|||
127727418|NCT01159600|459626676|FG003|Overall Study|Other reason not defined above|2|||
127727419|NCT01159600|459626677|FG004|Overall Study|Other reason not defined above|5|||
127727420|NCT01159600|459626678|FG005|Overall Study|Other reason not defined above|7|||
127727421|NCT01159600|459626679|FG006|Overall Study|Other reason not defined above|3|||
127727422|NCT01159600|459626680|FG007|Overall Study|Other reason not defined above|3|||
127727423|NCT04433091|459626681|FG000|Overall Study|Lost to Follow-up|1|||
127727424|NCT04433091|459626682|FG001|Overall Study|Lost to Follow-up|0|||
127727425|NCT04433091|459626681|FG000|Overall Study|Withdrawn .|2|||
127727426|NCT04433091|459626682|FG001|Overall Study|Withdrawn .|4|||
127727427|NCT04097535|459626683|FG000|Overall Study|[18F]FPIA/radiotracer production failure - Participant subsequently withdrew consent.|1|||
127727428|NCT00307489|459628292|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
127727429|NCT00307489|459628293|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
127727430|NCT00307489|459628292|FG000|Baseline Through Week 48|Physician Decision|1|||
127727431|NCT00307489|459628293|FG001|Baseline Through Week 48|Physician Decision|0|||
127727432|NCT00307489|459628292|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
127727433|NCT00307489|459628293|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
127727434|NCT00307489|459628292|FG000|Week 48 Through Week 168|Adverse Event|1|||
127727435|NCT00307489|459628293|FG001|Week 48 Through Week 168|Adverse Event|0|||
127727436|NCT00307489|459628292|FG000|Week 48 Through Week 168|Physician Decision|1|||
127727437|NCT00307489|459628293|FG001|Week 48 Through Week 168|Physician Decision|0|||
127727438|NCT00307489|459628292|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
127727439|NCT00307489|459628293|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
127727440|NCT00307489|459628292|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
127727441|NCT00307489|459628293|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
127727442|NCT00307489|459628292|FG000|Week 48 Through Week 168|Death|0|||
127727443|NCT00307489|459628293|FG001|Week 48 Through Week 168|Death|1|||
127802982|NCT01360645|459901096|FG003|Phase A+|Adverse Event|2|||
127727444|NCT00307489|459628292|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
127727445|NCT00307489|459628293|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
127727446|NCT00307489|459628292|FG000|Week 48 Through Week 168|Seroconversion|1|||
127727447|NCT00307489|459628293|FG001|Week 48 Through Week 168|Seroconversion|0|||
127727448|NCT01975701|459628300|FG000|Overall Study|Lost to Follow-up|1|||
127727449|NCT01975701|459628300|FG000|Overall Study|Death|23|||
127727450|NCT01975701|459628300|FG000|Overall Study|Physician Decision|1|||
127727451|NCT02143713|459628305|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
127727452|NCT02143713|459628306|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
127727453|NCT02143713|459628307|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
127727454|NCT02143713|459628308|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
127727455|NCT02143713|459628305|FG000|Treatment Period (6 Months)|Adverse Event|7|||
127727456|NCT02143713|459628306|FG001|Treatment Period (6 Months)|Adverse Event|8|||
127727457|NCT02143713|459628307|FG002|Treatment Period (6 Months)|Adverse Event|8|||
127727458|NCT02143713|459628308|FG003|Treatment Period (6 Months)|Adverse Event|9|||
127727459|NCT02143713|459628305|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
127727460|NCT02143713|459628306|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
127727461|NCT02143713|459628307|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
127727462|NCT02143713|459628308|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
127727463|NCT02143713|459628305|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
127727464|NCT02143713|459628306|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
127727465|NCT02143713|459628307|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
127727466|NCT02143713|459628308|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
127727467|NCT02143713|459628305|FG000|Treatment Period (6 Months)|Pregnancy|0|||
127727468|NCT02143713|459628306|FG001|Treatment Period (6 Months)|Pregnancy|2|||
127727469|NCT02143713|459628307|FG002|Treatment Period (6 Months)|Pregnancy|2|||
127727470|NCT02143713|459628308|FG003|Treatment Period (6 Months)|Pregnancy|0|||
127727471|NCT02143713|459628305|FG000|Treatment Period (6 Months)|Non-compliance|1|||
127727472|NCT02143713|459628306|FG001|Treatment Period (6 Months)|Non-compliance|0|||
127727473|NCT02143713|459628307|FG002|Treatment Period (6 Months)|Non-compliance|0|||
127727474|NCT02143713|459628308|FG003|Treatment Period (6 Months)|Non-compliance|3|||
127727475|NCT02143713|459628305|FG000|Treatment Period (6 Months)|Other|3|||
127727476|NCT02143713|459628306|FG001|Treatment Period (6 Months)|Other|0|||
127889753|NCT02884206|460219869|FG001|Double-Blind Period|Patient/guardian decision|10|||
127889754|NCT02884206|460219870|FG002|Double-Blind Period|Patient/guardian decision|13|||
127727477|NCT02143713|459628307|FG002|Treatment Period (6 Months)|Other|3|||
127727478|NCT02143713|459628308|FG003|Treatment Period (6 Months)|Other|2|||
127727479|NCT02143713|459628305|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
127727480|NCT02143713|459628306|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
127727481|NCT02143713|459628307|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
127727482|NCT02143713|459628308|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
127727483|NCT02143713|459628305|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
127727484|NCT02143713|459628306|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
127727485|NCT02143713|459628307|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
127727486|NCT02143713|459628308|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
127727487|NCT02143713|459628305|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
127727488|NCT02143713|459628306|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
127727489|NCT02143713|459628307|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
127727490|NCT02143713|459628308|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
127727491|NCT02143713|459628305|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
127727492|NCT02143713|459628306|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
127727493|NCT02143713|459628307|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
127727494|NCT02143713|459628308|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
127727495|NCT02143713|459628305|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
127727496|NCT02143713|459628306|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
127727497|NCT02143713|459628307|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
127727498|NCT02143713|459628308|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
127727499|NCT02143713|459628305|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
127727500|NCT02143713|459628306|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
127727501|NCT02143713|459628307|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
127727502|NCT02143713|459628308|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
127727503|NCT02143713|459628305|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
127727504|NCT02143713|459628306|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
127727505|NCT02143713|459628307|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
127727506|NCT02143713|459628308|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
127727507|NCT02143713|459628305|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
127727508|NCT02143713|459628306|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
127727509|NCT02143713|459628307|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
127727510|NCT02143713|459628308|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
127727511|NCT02143713|459628305|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
127727512|NCT02143713|459628306|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
127727513|NCT02143713|459628307|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
127727514|NCT02143713|459628308|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
127727515|NCT01768572|459628311|FG000|Overall Study|Adverse Event|7|||
127727516|NCT01768572|459628312|FG001|Overall Study|Adverse Event|8|||
127727517|NCT01768572|459628313|FG002|Overall Study|Adverse Event|4|||
127727518|NCT01768572|459628311|FG000|Overall Study|Lack of Efficacy|1|||
127727519|NCT01768572|459628312|FG001|Overall Study|Lack of Efficacy|3|||
127727520|NCT01768572|459628313|FG002|Overall Study|Lack of Efficacy|1|||
127727521|NCT01768572|459628311|FG000|Overall Study|Other, Not due to an adverse event|1|||
127727522|NCT01768572|459628312|FG001|Overall Study|Other, Not due to an adverse event|1|||
127889755|NCT02884206|460219868|FG000|Double-Blind Period|Lost to Follow-up|0|||
127889756|NCT02884206|460219869|FG001|Double-Blind Period|Lost to Follow-up|4|||
127889757|NCT02884206|460219870|FG002|Double-Blind Period|Lost to Follow-up|4|||
127889758|NCT02884206|460219868|FG000|Double-Blind Period|Physician Decision|0|||
127889759|NCT02884206|460219869|FG001|Double-Blind Period|Physician Decision|2|||
127889760|NCT02884206|460219870|FG002|Double-Blind Period|Physician Decision|0|||
127889761|NCT02884206|460219868|FG000|Double-Blind Period|Adverse Event|0|||
127889762|NCT02884206|460219869|FG001|Double-Blind Period|Adverse Event|0|||
127889763|NCT02884206|460219870|FG002|Double-Blind Period|Adverse Event|3|||
127889764|NCT02884206|460219868|FG000|Double-Blind Period|Non-compliance with study treatment|0|||
127889765|NCT02884206|460219869|FG001|Double-Blind Period|Non-compliance with study treatment|0|||
127889766|NCT02884206|460219870|FG002|Double-Blind Period|Non-compliance with study treatment|1|||
127889767|NCT03038113|460219871|FG000|Overall Study|Withdrawal by Subject|0|||
127889768|NCT03038113|460219872|FG001|Overall Study|Withdrawal by Subject|0|||
127889769|NCT03038113|460219873|FG002|Overall Study|Withdrawal by Subject|1|||
127889770|NCT03038113|460219874|FG003|Overall Study|Withdrawal by Subject|0|||
127889771|NCT03038113|460219875|FG004|Overall Study|Withdrawal by Subject|0|||
127889772|NCT03038113|460219876|FG005|Overall Study|Withdrawal by Subject|0|||
127889773|NCT03038113|460219877|FG006|Overall Study|Withdrawal by Subject|0|||
127889774|NCT03038113|460219878|FG007|Overall Study|Withdrawal by Subject|0|||
127889775|NCT03038113|460219879|FG008|Overall Study|Withdrawal by Subject|0|||
127889776|NCT03038113|460219880|FG009|Overall Study|Withdrawal by Subject|0|||
127889777|NCT03038113|460219881|FG010|Overall Study|Withdrawal by Subject|0|||
127889778|NCT03038113|460219882|FG011|Overall Study|Withdrawal by Subject|0|||
127889779|NCT03038113|460219883|FG012|Overall Study|Withdrawal by Subject|0|||
127889780|NCT03038113|460219884|FG013|Overall Study|Withdrawal by Subject|1|||
127889781|NCT03038113|460219871|FG000|Overall Study|Lost to Follow-up|0|||
127889782|NCT03038113|460219872|FG001|Overall Study|Lost to Follow-up|0|||
127889783|NCT03038113|460219873|FG002|Overall Study|Lost to Follow-up|0|||
127889784|NCT03038113|460219874|FG003|Overall Study|Lost to Follow-up|0|||
127889785|NCT03038113|460219875|FG004|Overall Study|Lost to Follow-up|0|||
127889786|NCT03038113|460219876|FG005|Overall Study|Lost to Follow-up|0|||
127889787|NCT03038113|460219877|FG006|Overall Study|Lost to Follow-up|1|||
127889788|NCT03038113|460219878|FG007|Overall Study|Lost to Follow-up|0|||
127889789|NCT03038113|460219879|FG008|Overall Study|Lost to Follow-up|0|||
127889790|NCT03038113|460219880|FG009|Overall Study|Lost to Follow-up|0|||
127889791|NCT03038113|460219881|FG010|Overall Study|Lost to Follow-up|0|||
127889792|NCT03038113|460219882|FG011|Overall Study|Lost to Follow-up|0|||
127889793|NCT03038113|460219883|FG012|Overall Study|Lost to Follow-up|0|||
127889794|NCT03038113|460219884|FG013|Overall Study|Lost to Follow-up|0|||
127889795|NCT01418352|460219887|FG000|Overall Study|Lost to Follow-up|2|||
127889796|NCT01418352|460219888|FG001|Overall Study|Lost to Follow-up|0|||
127889797|NCT01418352|460219889|FG002|Overall Study|Lost to Follow-up|0|||
127889798|NCT01418352|460219890|FG003|Overall Study|Lost to Follow-up|0|||
127889799|NCT01418352|460219887|FG000|Overall Study|Adverse Event|0|||
127889800|NCT01418352|460219888|FG001|Overall Study|Adverse Event|1|||
127889801|NCT01418352|460219889|FG002|Overall Study|Adverse Event|0|||
127889802|NCT01418352|460219890|FG003|Overall Study|Adverse Event|0|||
127889803|NCT01418352|460219887|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
127889804|NCT01418352|460219888|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
127889805|NCT01418352|460219889|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
127889806|NCT01418352|460219890|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
127727523|NCT01768572|459628313|FG002|Overall Study|Other, Not due to an adverse event|1|||
127727524|NCT02291861|459628318|FG000|Overall Study|Adverse Event|2|||
127727525|NCT02291861|459628319|FG001|Overall Study|Adverse Event|4|||
127727526|NCT02291861|459628320|FG002|Overall Study|Adverse Event|1|||
127889807|NCT01418352|460219887|FG000|Overall Study|Subject Withdrew Consent|0|||
127889808|NCT01418352|460219888|FG001|Overall Study|Subject Withdrew Consent|1|||
127889809|NCT01418352|460219889|FG002|Overall Study|Subject Withdrew Consent|2|||
127889810|NCT01418352|460219890|FG003|Overall Study|Subject Withdrew Consent|1|||
127889811|NCT01418352|460219887|FG000|Overall Study|Protocol Deviation|0|||
127727527|NCT02291861|459628321|FG003|Overall Study|Adverse Event|2|||
127727528|NCT02291861|459628318|FG000|Overall Study|Death|0|||
127727529|NCT02291861|459628319|FG001|Overall Study|Death|0|||
127727530|NCT02291861|459628320|FG002|Overall Study|Death|1|||
127727531|NCT02291861|459628321|FG003|Overall Study|Death|1|||
127727532|NCT02291861|459628318|FG000|Overall Study|Protocol Violation|1|||
127727533|NCT02291861|459628319|FG001|Overall Study|Protocol Violation|0|||
127727534|NCT02291861|459628320|FG002|Overall Study|Protocol Violation|0|||
127727535|NCT02291861|459628321|FG003|Overall Study|Protocol Violation|1|||
127727536|NCT02291861|459628318|FG000|Overall Study|Withdrawal by Subject|1|||
127727537|NCT02291861|459628319|FG001|Overall Study|Withdrawal by Subject|2|||
127727538|NCT02291861|459628320|FG002|Overall Study|Withdrawal by Subject|1|||
127727539|NCT02291861|459628321|FG003|Overall Study|Withdrawal by Subject|4|||
127727540|NCT02291861|459628318|FG000|Overall Study|Noncompliance|1|||
127727541|NCT02291861|459628319|FG001|Overall Study|Noncompliance|1|||
127727542|NCT02291861|459628320|FG002|Overall Study|Noncompliance|2|||
127727543|NCT02291861|459628321|FG003|Overall Study|Noncompliance|1|||
127727544|NCT02291861|459628318|FG000|Overall Study|Lost to Follow-up|2|||
127727545|NCT02291861|459628319|FG001|Overall Study|Lost to Follow-up|1|||
127727546|NCT02291861|459628320|FG002|Overall Study|Lost to Follow-up|4|||
127727547|NCT02291861|459628321|FG003|Overall Study|Lost to Follow-up|0|||
127727548|NCT02291861|459628318|FG000|Overall Study|Other|0|||
127727549|NCT02291861|459628319|FG001|Overall Study|Other|0|||
127727550|NCT02291861|459628320|FG002|Overall Study|Other|0|||
127727551|NCT02291861|459628321|FG003|Overall Study|Other|1|||
127727552|NCT02823574|459628325|FG000|Randomization|Disease Progression|0|||
127727553|NCT02823574|459628326|FG001|Randomization|Disease Progression|0|||
127727554|NCT02823574|459628327|FG002|Randomization|Disease Progression|1|||
127727555|NCT02823574|459628328|FG003|Randomization|Disease Progression|0|||
127727556|NCT02823574|459628325|FG000|Randomization|AE unrelated to Study Drug|1|||
127727557|NCT02823574|459628326|FG001|Randomization|AE unrelated to Study Drug|0|||
127727558|NCT02823574|459628327|FG002|Randomization|AE unrelated to Study Drug|0|||
127727559|NCT02823574|459628328|FG003|Randomization|AE unrelated to Study Drug|0|||
127727560|NCT02823574|459628325|FG000|Treatment Period|Poor/Non Compliance|1|||
127727561|NCT02823574|459628326|FG001|Treatment Period|Poor/Non Compliance|0|||
127727562|NCT02823574|459628327|FG002|Treatment Period|Poor/Non Compliance|0|||
127727563|NCT02823574|459628328|FG003|Treatment Period|Poor/Non Compliance|1|||
127727564|NCT02823574|459628325|FG000|Treatment Period|Maximum Clinical Benefit|8|||
127727565|NCT02823574|459628326|FG001|Treatment Period|Maximum Clinical Benefit|4|||
127727566|NCT02823574|459628327|FG002|Treatment Period|Maximum Clinical Benefit|7|||
127727567|NCT02823574|459628328|FG003|Treatment Period|Maximum Clinical Benefit|1|||
127727568|NCT02823574|459628325|FG000|Treatment Period|Lost to Follow-up|1|||
127727569|NCT02823574|459628326|FG001|Treatment Period|Lost to Follow-up|1|||
127727570|NCT02823574|459628327|FG002|Treatment Period|Lost to Follow-up|0|||
127727571|NCT02823574|459628328|FG003|Treatment Period|Lost to Follow-up|0|||
127727572|NCT02823574|459628325|FG000|Treatment Period|Participant withdrew consent|4|||
127727573|NCT02823574|459628326|FG001|Treatment Period|Participant withdrew consent|0|||
127727574|NCT02823574|459628327|FG002|Treatment Period|Participant withdrew consent|0|||
127727575|NCT02823574|459628328|FG003|Treatment Period|Participant withdrew consent|1|||
127727576|NCT02823574|459628325|FG000|Treatment Period|Participant request to discontinue|5|||
127727577|NCT02823574|459628326|FG001|Treatment Period|Participant request to discontinue|0|||
127727578|NCT02823574|459628327|FG002|Treatment Period|Participant request to discontinue|3|||
127727579|NCT02823574|459628328|FG003|Treatment Period|Participant request to discontinue|2|||
127727580|NCT02823574|459628325|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
127727581|NCT02823574|459628326|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
127727582|NCT02823574|459628327|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
127727583|NCT02823574|459628328|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
127727584|NCT02823574|459628325|FG000|Treatment Period|Study Drug Toxicity|11|||
127727585|NCT02823574|459628326|FG001|Treatment Period|Study Drug Toxicity|2|||
127727586|NCT02823574|459628327|FG002|Treatment Period|Study Drug Toxicity|14|||
127727587|NCT02823574|459628328|FG003|Treatment Period|Study Drug Toxicity|4|||
127727588|NCT02823574|459628325|FG000|Treatment Period|Disease Progression|113|||
127727589|NCT02823574|459628326|FG001|Treatment Period|Disease Progression|64|||
127727590|NCT02823574|459628327|FG002|Treatment Period|Disease Progression|82|||
127727591|NCT02823574|459628328|FG003|Treatment Period|Disease Progression|43|||
127727592|NCT02823574|459628325|FG000|Treatment Period|Other reasons|5|||
127727593|NCT02823574|459628326|FG001|Treatment Period|Other reasons|9|||
127727594|NCT02823574|459628327|FG002|Treatment Period|Other reasons|3|||
127727595|NCT02823574|459628328|FG003|Treatment Period|Other reasons|6|||
127727596|NCT02823574|459628325|FG000|Treatment Period|Participant no longer meets study criteria|0|||
127727597|NCT02823574|459628326|FG001|Treatment Period|Participant no longer meets study criteria|0|||
127727598|NCT02823574|459628327|FG002|Treatment Period|Participant no longer meets study criteria|1|||
127727599|NCT02823574|459628328|FG003|Treatment Period|Participant no longer meets study criteria|0|||
127727600|NCT02823574|459628325|FG000|Treatment Period|Death|0|||
127727601|NCT02823574|459628326|FG001|Treatment Period|Death|0|||
127727602|NCT02823574|459628327|FG002|Treatment Period|Death|3|||
127889812|NCT01418352|460219888|FG001|Overall Study|Protocol Deviation|0|||
127889813|NCT01418352|460219889|FG002|Overall Study|Protocol Deviation|1|||
127889814|NCT01418352|460219890|FG003|Overall Study|Protocol Deviation|0|||
127889815|NCT01418352|460219887|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
127889816|NCT01418352|460219888|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
127889817|NCT01418352|460219889|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
127889818|NCT01418352|460219890|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
127889819|NCT00619619|460219891|FG000|Overall Study|Physician Decision|0|||
127889820|NCT00619619|460219892|FG001|Overall Study|Physician Decision|0|||
127889821|NCT00619619|460219893|FG002|Overall Study|Physician Decision|1|||
127889822|NCT00619619|460219894|FG003|Overall Study|Physician Decision|0|||
127889823|NCT00619619|460219895|FG004|Overall Study|Physician Decision|0|||
127889824|NCT00619619|460219896|FG005|Overall Study|Physician Decision|0|||
127889825|NCT00619619|460219897|FG006|Overall Study|Physician Decision|0|||
127889826|NCT00619619|460219898|FG007|Overall Study|Physician Decision|0|||
127889827|NCT00619619|460219891|FG000|Overall Study|Protocol Violation|0|||
127889828|NCT00619619|460219892|FG001|Overall Study|Protocol Violation|0|||
127889829|NCT00619619|460219893|FG002|Overall Study|Protocol Violation|0|||
127889830|NCT00619619|460219894|FG003|Overall Study|Protocol Violation|1|||
127889831|NCT00619619|460219895|FG004|Overall Study|Protocol Violation|0|||
127889832|NCT00619619|460219896|FG005|Overall Study|Protocol Violation|0|||
127889833|NCT00619619|460219897|FG006|Overall Study|Protocol Violation|1|||
127889834|NCT00619619|460219898|FG007|Overall Study|Protocol Violation|1|||
127889835|NCT00619619|460219891|FG000|Overall Study|Adverse Event|0|||
127889836|NCT00619619|460219892|FG001|Overall Study|Adverse Event|0|||
127889837|NCT00619619|460219893|FG002|Overall Study|Adverse Event|0|||
127889838|NCT00619619|460219894|FG003|Overall Study|Adverse Event|0|||
127889839|NCT00619619|460219895|FG004|Overall Study|Adverse Event|2|||
127889840|NCT00619619|460219896|FG005|Overall Study|Adverse Event|0|||
127889841|NCT00619619|460219897|FG006|Overall Study|Adverse Event|0|||
127889842|NCT00619619|460219898|FG007|Overall Study|Adverse Event|2|||
127889843|NCT01092702|460219899|FG000|Overall Study|Withdrawal by Subject|7|||
127889844|NCT01092702|460219899|FG000|Overall Study|Lost to Follow-up|2|||
127889845|NCT03652961|460219900|FG000|Overall Study|Lost to Follow-up|3|||
127889846|NCT03652961|460219900|FG000|Overall Study|Screen Failure|1|||
127889847|NCT01783496|460219901|FG000|Overall Study|Lost to Follow-up|0|||
127889848|NCT01783496|460219902|FG001|Overall Study|Lost to Follow-up|0|||
127889849|NCT01783496|460219903|FG002|Overall Study|Lost to Follow-up|0|||
127802983|NCT01360645|459901093|FG000|Phase A+|Met Withdrawal Criteria|0|||
127802984|NCT01360645|459901094|FG001|Phase A+|Met Withdrawal Criteria|0|||
127802985|NCT01360645|459901095|FG002|Phase A+|Met Withdrawal Criteria|0|||
127802986|NCT01360645|459901096|FG003|Phase A+|Met Withdrawal Criteria|4|||
127802987|NCT01360645|459901093|FG000|Phase A+|Physician Decision|0|||
127802988|NCT01360645|459901094|FG001|Phase A+|Physician Decision|0|||
127802989|NCT01360645|459901095|FG002|Phase A+|Physician Decision|0|||
127802990|NCT01360645|459901096|FG003|Phase A+|Physician Decision|2|||
127802991|NCT01360645|459901093|FG000|Phase A+|Withdrawal by Subject|0|||
127802992|NCT01360645|459901094|FG001|Phase A+|Withdrawal by Subject|0|||
127802993|NCT01360645|459901095|FG002|Phase A+|Withdrawal by Subject|0|||
127802994|NCT01360645|459901096|FG003|Phase A+|Withdrawal by Subject|5|||
127802995|NCT01360645|459901093|FG000|Phase A+|Protocol Deviation|0|||
127802996|NCT01360645|459901094|FG001|Phase A+|Protocol Deviation|0|||
127802997|NCT01360645|459901095|FG002|Phase A+|Protocol Deviation|0|||
127802998|NCT01360645|459901096|FG003|Phase A+|Protocol Deviation|4|||
127802999|NCT01014585|459901101|FG000|Overall Study|Adverse Event|0|||
127803000|NCT01014585|459901102|FG001|Overall Study|Adverse Event|2|||
127803001|NCT01014585|459901103|FG002|Overall Study|Adverse Event|0|||
127803002|NCT01014585|459901104|FG003|Overall Study|Adverse Event|3|||
127803003|NCT01014585|459901101|FG000|Overall Study|Withdrawal by Subject|2|||
127889850|NCT01783496|460219904|FG003|Overall Study|Lost to Follow-up|2|||
127889851|NCT01783496|460219905|FG004|Overall Study|Lost to Follow-up|0|||
127889852|NCT01783496|460219906|FG005|Overall Study|Lost to Follow-up|1|||
127889853|NCT01783496|460219901|FG000|Overall Study|Withdrawal by Subject|1|||
127803004|NCT01014585|459901102|FG001|Overall Study|Withdrawal by Subject|0|||
127803005|NCT01014585|459901103|FG002|Overall Study|Withdrawal by Subject|1|||
127889854|NCT01783496|460219902|FG001|Overall Study|Withdrawal by Subject|0|||
127889855|NCT01783496|460219903|FG002|Overall Study|Withdrawal by Subject|0|||
127889856|NCT01783496|460219904|FG003|Overall Study|Withdrawal by Subject|0|||
127889857|NCT01783496|460219905|FG004|Overall Study|Withdrawal by Subject|0|||
127803006|NCT01014585|459901104|FG003|Overall Study|Withdrawal by Subject|3|||
127803007|NCT01014585|459901101|FG000|Overall Study|Lost to Follow-up|0|||
127889858|NCT01783496|460219906|FG005|Overall Study|Withdrawal by Subject|0|||
127889859|NCT01953783|460219907|FG000|Overall Study|Progressive disease|2|||
127803008|NCT01014585|459901102|FG001|Overall Study|Lost to Follow-up|0|||
127889860|NCT00686920|460219910|FG000|Overall Study|Death|45|||
127889861|NCT00686920|460219911|FG001|Overall Study|Death|14|||
127803009|NCT01014585|459901103|FG002|Overall Study|Lost to Follow-up|0|||
127803010|NCT01014585|459901104|FG003|Overall Study|Lost to Follow-up|2|||
127803011|NCT01014585|459901101|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
127727603|NCT02823574|459628328|FG003|Treatment Period|Death|1|||
127727604|NCT00590759|459628329|FG000|Overall Study|Death|52|||
127727605|NCT00590759|459628329|FG000|Overall Study|Lost to Follow-up|28|||
127727606|NCT03845517|459628336|FG000|Treatment Period (52 Weeks)|Adverse Event|12|||
127727607|NCT03845517|459628337|FG001|Treatment Period (52 Weeks)|Adverse Event|7|||
127727608|NCT03845517|459628338|FG002|Treatment Period (52 Weeks)|Adverse Event|10|||
127727609|NCT03845517|459628339|FG003|Treatment Period (52 Weeks)|Adverse Event|17|||
127727610|NCT03845517|459628336|FG000|Treatment Period (52 Weeks)|Death|0|||
127727611|NCT03845517|459628337|FG001|Treatment Period (52 Weeks)|Death|0|||
127727612|NCT03845517|459628338|FG002|Treatment Period (52 Weeks)|Death|1|||
127727613|NCT03845517|459628339|FG003|Treatment Period (52 Weeks)|Death|0|||
127727614|NCT03845517|459628336|FG000|Treatment Period (52 Weeks)|Lack of Efficacy|8|||
127727615|NCT03845517|459628337|FG001|Treatment Period (52 Weeks)|Lack of Efficacy|1|||
127727616|NCT03845517|459628338|FG002|Treatment Period (52 Weeks)|Lack of Efficacy|3|||
127727617|NCT03845517|459628339|FG003|Treatment Period (52 Weeks)|Lack of Efficacy|4|||
127727618|NCT03845517|459628336|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
127727619|NCT03845517|459628337|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
127727620|NCT03845517|459628338|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|1|||
127727621|NCT03845517|459628339|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
127727622|NCT03845517|459628336|FG000|Treatment Period (52 Weeks)|Non-compliance with study drug|1|||
127727623|NCT03845517|459628337|FG001|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
127727624|NCT03845517|459628338|FG002|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
127727625|NCT03845517|459628339|FG003|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
127727626|NCT03845517|459628336|FG000|Treatment Period (52 Weeks)|Physician's decision|0|||
127727627|NCT03845517|459628337|FG001|Treatment Period (52 Weeks)|Physician's decision|0|||
127727628|NCT03845517|459628338|FG002|Treatment Period (52 Weeks)|Physician's decision|1|||
127727629|NCT03845517|459628339|FG003|Treatment Period (52 Weeks)|Physician's decision|0|||
127727630|NCT03845517|459628336|FG000|Treatment Period (52 Weeks)|Site Terminated by Sponsor|2|||
127727631|NCT03845517|459628337|FG001|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
127727632|NCT03845517|459628338|FG002|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
127727633|NCT03845517|459628339|FG003|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
127727634|NCT03845517|459628336|FG000|Treatment Period (52 Weeks)|Other|2|||
127727635|NCT03845517|459628337|FG001|Treatment Period (52 Weeks)|Other|0|||
127727636|NCT03845517|459628338|FG002|Treatment Period (52 Weeks)|Other|0|||
127727637|NCT03845517|459628339|FG003|Treatment Period (52 Weeks)|Other|0|||
127727638|NCT03845517|459628336|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
127727639|NCT03845517|459628337|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
127727640|NCT03845517|459628338|FG002|Treatment Period (52 Weeks)|Pregnancy|0|||
127727641|NCT03845517|459628339|FG003|Treatment Period (52 Weeks)|Pregnancy|1|||
127727642|NCT03845517|459628336|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
127727643|NCT03845517|459628337|FG001|Treatment Period (52 Weeks)|Protocol Violation|0|||
127727644|NCT03845517|459628338|FG002|Treatment Period (52 Weeks)|Protocol Violation|1|||
127727645|NCT03845517|459628339|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
127727646|NCT03845517|459628336|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|4|||
127727647|NCT03845517|459628337|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
127727648|NCT03845517|459628338|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
127727649|NCT03845517|459628339|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
127727650|NCT03845517|459628336|FG000|Follow-up Period (4 Weeks)|Adverse Event|4|||
127727651|NCT03845517|459628337|FG001|Follow-up Period (4 Weeks)|Adverse Event|2|||
127727652|NCT03845517|459628338|FG002|Follow-up Period (4 Weeks)|Adverse Event|0|||
127727653|NCT03845517|459628339|FG003|Follow-up Period (4 Weeks)|Adverse Event|2|||
127727654|NCT03845517|459628336|FG000|Follow-up Period (4 Weeks)|Death|0|||
127727655|NCT03845517|459628337|FG001|Follow-up Period (4 Weeks)|Death|0|||
127803012|NCT01014585|459901102|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
127803013|NCT01014585|459901103|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
127803014|NCT01014585|459901104|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
127803015|NCT04178772|459901108|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
127803016|NCT04178772|459901108|FG000|Overall Study|study terminated early due to COVID-19|7|||
127727656|NCT03845517|459628338|FG002|Follow-up Period (4 Weeks)|Death|1|||
127727657|NCT03845517|459628339|FG003|Follow-up Period (4 Weeks)|Death|1|||
127727658|NCT03845517|459628336|FG000|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
127727659|NCT03845517|459628337|FG001|Follow-up Period (4 Weeks)|Lost to Follow-up|1|||
127727660|NCT03845517|459628338|FG002|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
127727661|NCT03845517|459628339|FG003|Follow-up Period (4 Weeks)|Lost to Follow-up|0|||
127803017|NCT02817087|459901111|FG000|Overall Study|Withdrawal by Subject|2|||
127727662|NCT03845517|459628336|FG000|Follow-up Period (4 Weeks)|Physician's decision|0|||
127727663|NCT03845517|459628337|FG001|Follow-up Period (4 Weeks)|Physician's decision|0|||
127727664|NCT03845517|459628338|FG002|Follow-up Period (4 Weeks)|Physician's decision|1|||
127727665|NCT03845517|459628339|FG003|Follow-up Period (4 Weeks)|Physician's decision|1|||
127727666|NCT03845517|459628336|FG000|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
127727667|NCT03845517|459628337|FG001|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
127803018|NCT02817087|459901112|FG001|Overall Study|Withdrawal by Subject|0|||
127727668|NCT03845517|459628338|FG002|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
127727669|NCT03845517|459628339|FG003|Follow-up Period (4 Weeks)|Study terminated by sponsor|1|||
127727670|NCT03845517|459628336|FG000|Follow-up Period (4 Weeks)|Other|1|||
127727671|NCT03845517|459628337|FG001|Follow-up Period (4 Weeks)|Other|0|||
127727672|NCT03845517|459628338|FG002|Follow-up Period (4 Weeks)|Other|1|||
127727673|NCT03845517|459628339|FG003|Follow-up Period (4 Weeks)|Other|0|||
127727674|NCT03845517|459628336|FG000|Follow-up Period (4 Weeks)|Pregnancy|1|||
127727675|NCT03845517|459628337|FG001|Follow-up Period (4 Weeks)|Pregnancy|0|||
127727676|NCT03845517|459628338|FG002|Follow-up Period (4 Weeks)|Pregnancy|0|||
127727677|NCT03845517|459628339|FG003|Follow-up Period (4 Weeks)|Pregnancy|0|||
127727678|NCT03845517|459628336|FG000|Follow-up Period (4 Weeks)|Protocol Violation|0|||
127727679|NCT03845517|459628337|FG001|Follow-up Period (4 Weeks)|Protocol Violation|0|||
127727680|NCT03845517|459628338|FG002|Follow-up Period (4 Weeks)|Protocol Violation|0|||
127727681|NCT03845517|459628339|FG003|Follow-up Period (4 Weeks)|Protocol Violation|1|||
127727682|NCT03845517|459628336|FG000|Follow-up Period (4 Weeks)|Withdrawal by Subject|3|||
127727683|NCT03845517|459628337|FG001|Follow-up Period (4 Weeks)|Withdrawal by Subject|5|||
127727684|NCT03845517|459628338|FG002|Follow-up Period (4 Weeks)|Withdrawal by Subject|7|||
127727685|NCT03845517|459628339|FG003|Follow-up Period (4 Weeks)|Withdrawal by Subject|1|||
127727686|NCT00417885|459628340|FG000|Overall Study|Adverse Event|1|||
127727687|NCT00417885|459628340|FG000|Overall Study|Objective Progression or Relapse|3|||
127727688|NCT00417885|459628340|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
127727689|NCT01190436|459628341|FG000|Overall Study|Lost to Follow-up|35|||
127727690|NCT01190436|459628341|FG000|Overall Study|Other|4|||
127727691|NCT02721147|459628342|FG000|Overall Study|Lost to Follow-up|2|||
127803019|NCT00508391|459901113|FG000|First Treatment|Withdrawal by Subject|6|||
127803020|NCT00508391|459901114|FG001|First Treatment|Withdrawal by Subject|3|||
127727692|NCT02721147|459628343|FG001|Overall Study|Lost to Follow-up|0|||
127803021|NCT00508391|459901113|FG000|Second Treatment|Withdrawal by Subject|2|||
127803022|NCT00508391|459901114|FG001|Second Treatment|Withdrawal by Subject|0|||
127803023|NCT00802360|459901115|FG000|Overall Study|Stimulation failure|4|||
127803024|NCT00802360|459901116|FG001|Overall Study|Stimulation failure|0|||
127803025|NCT00802360|459901117|FG002|Overall Study|Stimulation failure|3|||
127803026|NCT00802360|459901118|FG003|Overall Study|Stimulation failure|3|||
127803027|NCT00802360|459901115|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
127803028|NCT00802360|459901116|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
127803029|NCT00802360|459901117|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
127803030|NCT00802360|459901118|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
127803031|NCT00802360|459901115|FG000|Overall Study|Cycle cancelled|0|||
127889862|NCT00686920|460219910|FG000|Overall Study|Liver Transplant|23|||
127889863|NCT00686920|460219911|FG001|Overall Study|Liver Transplant|8|||
127889864|NCT00686920|460219910|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
127889865|NCT00686920|460219911|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
127889866|NCT00686920|460219910|FG000|Overall Study|Withdrawal by Subject|23|||
127803032|NCT00802360|459901116|FG001|Overall Study|Cycle cancelled|1|||
127803033|NCT00802360|459901117|FG002|Overall Study|Cycle cancelled|1|||
127727693|NCT02721147|459628344|FG002|Overall Study|Lost to Follow-up|0|||
127727694|NCT01722097|459628346|FG000|Overall Study|Patient sheets not returned|6|||
127727695|NCT01722097|459628347|FG001|Overall Study|Patient sheets not returned|5|||
127727696|NCT02009332|459628350|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
127727697|NCT02009332|459628351|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
127727698|NCT02009332|459628352|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
127727699|NCT02009332|459628353|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
127727700|NCT02009332|459628354|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
127727701|NCT02009332|459628355|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
127803034|NCT00802360|459901118|FG003|Overall Study|Cycle cancelled|1|||
127803035|NCT00802360|459901115|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
127803036|NCT00802360|459901116|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
127803037|NCT00802360|459901117|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
127803038|NCT00802360|459901118|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
127803039|NCT00802360|459901115|FG000|Overall Study|No positive serum pregnancy|17|||
127803040|NCT00802360|459901116|FG001|Overall Study|No positive serum pregnancy|20|||
127803041|NCT00802360|459901117|FG002|Overall Study|No positive serum pregnancy|14|||
127803042|NCT00802360|459901118|FG003|Overall Study|No positive serum pregnancy|10|||
127803043|NCT00802360|459901115|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
127803044|NCT00802360|459901116|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
127803045|NCT00802360|459901117|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
127803046|NCT00802360|459901118|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
127803047|NCT00802360|459901115|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
127803048|NCT00802360|459901116|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
127803049|NCT00802360|459901117|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
127803050|NCT00802360|459901118|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
127803051|NCT00802360|459901115|FG000|Overall Study|Other|2|||
127803052|NCT00802360|459901116|FG001|Overall Study|Other|3|||
127803053|NCT00802360|459901117|FG002|Overall Study|Other|6|||
127727702|NCT02009332|459628350|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
127727703|NCT02009332|459628351|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
127727704|NCT02009332|459628352|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
127727705|NCT02009332|459628353|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
127727706|NCT02009332|459628354|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
127727707|NCT02009332|459628355|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
127727708|NCT02009332|459628350|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
127727709|NCT02009332|459628351|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
127727710|NCT02009332|459628352|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
127727711|NCT02009332|459628353|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
127727712|NCT02009332|459628354|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
127727713|NCT02009332|459628355|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
127727714|NCT01912599|459628356|FG000|Overall Study|Withdrawal by Subject|0|||
127727715|NCT01912599|459628357|FG001|Overall Study|Withdrawal by Subject|1|||
127727716|NCT03386344|459628358|FG000|Overall Study|Adverse Event|6|||
127727717|NCT03386344|459628359|FG001|Overall Study|Adverse Event|3|||
127727718|NCT03386344|459628360|FG002|Overall Study|Adverse Event|1|||
127727719|NCT03386344|459628358|FG000|Overall Study|Poor Compliance to Protocol|0|||
127727720|NCT03386344|459628359|FG001|Overall Study|Poor Compliance to Protocol|1|||
127727721|NCT03386344|459628360|FG002|Overall Study|Poor Compliance to Protocol|0|||
127727722|NCT03386344|459628358|FG000|Overall Study|Study Terminated by Sponsor|101|||
127727723|NCT03386344|459628359|FG001|Overall Study|Study Terminated by Sponsor|102|||
127727724|NCT03386344|459628360|FG002|Overall Study|Study Terminated by Sponsor|106|||
127727725|NCT03386344|459628358|FG000|Overall Study|Lost to Follow-up|3|||
127727726|NCT03386344|459628359|FG001|Overall Study|Lost to Follow-up|2|||
127727727|NCT03386344|459628360|FG002|Overall Study|Lost to Follow-up|1|||
127727728|NCT03386344|459628358|FG000|Overall Study|At the Participant's own Request|7|||
127727729|NCT03386344|459628359|FG001|Overall Study|At the Participant's own Request|7|||
127727730|NCT03386344|459628360|FG002|Overall Study|At the Participant's own Request|8|||
127727731|NCT03386344|459628358|FG000|Overall Study|Reason not Specified|0|||
127727732|NCT03386344|459628359|FG001|Overall Study|Reason not Specified|1|||
127727733|NCT03386344|459628360|FG002|Overall Study|Reason not Specified|0|||
127727734|NCT01280721|459628361|FG000|Overall Study|Adverse Event|4|||
127727735|NCT01280721|459628361|FG000|Overall Study|Physician Decision|3|||
127727736|NCT01280721|459628361|FG000|Overall Study|Withdrawal by Subject|6|||
127727737|NCT01280721|459628361|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
127727738|NCT01280721|459628361|FG000|Overall Study|No tolerability for the lowest dose|2|||
127727739|NCT01180400|459628362|FG000|Overall Study|Withdrawal by Subject|5|||
127727740|NCT01180400|459628363|FG001|Overall Study|Withdrawal by Subject|6|||
127727741|NCT01180400|459628362|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
127727742|NCT01180400|459628363|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
127727743|NCT01180400|459628362|FG000|Overall Study|Adverse Event|12|||
127889867|NCT00686920|460219911|FG001|Overall Study|Withdrawal by Subject|5|||
127889868|NCT00686920|460219910|FG000|Overall Study|Protocol Violation|2|||
127889869|NCT00686920|460219911|FG001|Overall Study|Protocol Violation|1|||
127889870|NCT00686920|460219910|FG000|Overall Study|Adverse Event|10|||
127889871|NCT00686920|460219911|FG001|Overall Study|Adverse Event|2|||
127889872|NCT00686920|460219910|FG000|Overall Study|Personal Reason|0|||
127889873|NCT00686920|460219911|FG001|Overall Study|Personal Reason|1|||
127889874|NCT00686920|460219910|FG000|Overall Study|Lost to Follow-up|15|||
127889875|NCT00686920|460219911|FG001|Overall Study|Lost to Follow-up|3|||
127889876|NCT00686920|460219910|FG000|Overall Study|Moved to Another State|1|||
127889877|NCT00686920|460219911|FG001|Overall Study|Moved to Another State|0|||
127889878|NCT00686920|460219910|FG000|Overall Study|Transferred to Nursing Home|1|||
127889879|NCT00686920|460219911|FG001|Overall Study|Transferred to Nursing Home|0|||
127889880|NCT00686920|460219910|FG000|Overall Study|Noncompliance|9|||
127889881|NCT00686920|460219911|FG001|Overall Study|Noncompliance|0|||
127889882|NCT00686920|460219910|FG000|Overall Study|Principal Investigator Decision|2|||
127889883|NCT00686920|460219911|FG001|Overall Study|Principal Investigator Decision|0|||
127889884|NCT01271933|460219917|FG000|Single-Blind Phase|Lack of Efficacy|37|||
127889885|NCT01271933|460219918|FG001|Single-Blind Phase|Lack of Efficacy|0|||
127889886|NCT01271933|460219919|FG002|Single-Blind Phase|Lack of Efficacy|0|||
127889887|NCT01271933|460219917|FG000|Single-Blind Phase|Lost to Follow-up|10|||
127889888|NCT01271933|460219918|FG001|Single-Blind Phase|Lost to Follow-up|0|||
127889889|NCT01271933|460219919|FG002|Single-Blind Phase|Lost to Follow-up|0|||
127889890|NCT01271933|460219917|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
127889891|NCT01271933|460219918|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
127889892|NCT01271933|460219919|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
127889893|NCT01271933|460219917|FG000|Single-Blind Phase|Protocol Violation|3|||
127889894|NCT01271933|460219918|FG001|Single-Blind Phase|Protocol Violation|0|||
127889895|NCT01271933|460219919|FG002|Single-Blind Phase|Protocol Violation|0|||
127803054|NCT00802360|459901118|FG003|Overall Study|Other|3|||
127803055|NCT02041962|459901119|FG000|Overall Study|Lost Aetna Coverage|43|||
127803056|NCT02041962|459901120|FG001|Overall Study|Lost Aetna Coverage|40|||
127803057|NCT02041962|459901119|FG000|Overall Study|Death|1|||
127803058|NCT02041962|459901120|FG001|Overall Study|Death|1|||
127803059|NCT02041962|459901119|FG000|Overall Study|Lost to Follow-up|37|||
127803060|NCT02041962|459901120|FG001|Overall Study|Lost to Follow-up|32|||
127803061|NCT02041962|459901119|FG000|Overall Study|Withdrawal by Subject|0|||
127803062|NCT02041962|459901120|FG001|Overall Study|Withdrawal by Subject|11|||
127803063|NCT01225562|459901121|FG000|Overall Study|Withdrawal by Subject|52|||
127727744|NCT01180400|459628363|FG001|Overall Study|Adverse Event|10|||
127727745|NCT01180400|459628362|FG000|Overall Study|Severe non-compliance to protocol|1|||
127727746|NCT01180400|459628363|FG001|Overall Study|Severe non-compliance to protocol|2|||
127803064|NCT01225562|459901122|FG001|Overall Study|Withdrawal by Subject|50|||
127803065|NCT01225562|459901123|FG002|Overall Study|Withdrawal by Subject|52|||
127803066|NCT01225562|459901121|FG000|Overall Study|Lost to Follow-up|3|||
127803067|NCT01225562|459901122|FG001|Overall Study|Lost to Follow-up|6|||
127803068|NCT01225562|459901123|FG002|Overall Study|Lost to Follow-up|1|||
127889896|NCT01271933|460219917|FG000|Single-Blind Phase|Adverse Event|52|||
127889897|NCT01271933|460219918|FG001|Single-Blind Phase|Adverse Event|0|||
127727747|NCT01180400|459628362|FG000|Overall Study|Condition under investigation worsened|2|||
127727748|NCT01180400|459628363|FG001|Overall Study|Condition under investigation worsened|1|||
127727749|NCT01180400|459628362|FG000|Overall Study|Lack of Efficacy|2|||
127727750|NCT01180400|459628363|FG001|Overall Study|Lack of Efficacy|0|||
127727751|NCT01180400|459628362|FG000|Overall Study|Study-specific withdrawal criteria|1|||
127727752|NCT01180400|459628363|FG001|Overall Study|Study-specific withdrawal criteria|2|||
127727753|NCT01180400|459628362|FG000|Overall Study|Lost to Follow-up|2|||
127727754|NCT01180400|459628363|FG001|Overall Study|Lost to Follow-up|3|||
127727755|NCT01180400|459628362|FG000|Overall Study|Other|0|||
127727756|NCT01180400|459628363|FG001|Overall Study|Other|1|||
127727757|NCT00248794|459628365|FG000|Overall Study|Lost to Follow-up|6|||
127727758|NCT00248794|459628366|FG001|Overall Study|Lost to Follow-up|8|||
127727759|NCT00248794|459628367|FG002|Overall Study|Lost to Follow-up|3|||
127727760|NCT02632747|459628368|FG000|Wash-out Period|Adverse Event|1|||
127727761|NCT02632747|459628369|FG001|Wash-out Period|Adverse Event|0|||
127727762|NCT03449979|459628370|FG000|Overall Study|Technical difficulty|0|||
127727763|NCT03449979|459628371|FG001|Overall Study|Technical difficulty|0|||
127727764|NCT03449979|459628372|FG002|Overall Study|Technical difficulty|0|||
127727765|NCT03449979|459628373|FG003|Overall Study|Technical difficulty|1|||
127727766|NCT02069379|459628374|FG000|Baseline Measurements|Lost to Follow-up|1|||
127727767|NCT02069379|459628375|FG001|Baseline Measurements|Lost to Follow-up|0|||
127727768|NCT02069379|459628376|FG002|Baseline Measurements|Lost to Follow-up|0|||
127727769|NCT02069379|459628377|FG003|Baseline Measurements|Lost to Follow-up|0|||
127727770|NCT02069379|459628374|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
127803069|NCT01481896|459901126|FG000|Overall Study|Lost to Follow-up|12|||
127889898|NCT01271933|460219919|FG002|Single-Blind Phase|Adverse Event|0|||
127727771|NCT02069379|459628375|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
127727772|NCT02069379|459628376|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
127727773|NCT02069379|459628377|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
127727774|NCT02069379|459628374|FG000|First Treatment Arm|Lost to Follow-up|0|||
127803070|NCT01818726|459901127|FG000|Overall Study|Administrative reasons|5|||
127803071|NCT01818726|459901128|FG001|Overall Study|Administrative reasons|1|||
127803072|NCT01818726|459901127|FG000|Overall Study|Withdrawal by Subject|0|||
127803073|NCT01818726|459901128|FG001|Overall Study|Withdrawal by Subject|1|||
127803074|NCT01818726|459901127|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
127803075|NCT01818726|459901128|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
127803076|NCT01162421|459901129|FG000|Overall Study|Did not receive study drug|2|||
127803077|NCT01162421|459901130|FG001|Overall Study|Did not receive study drug|1|||
127803078|NCT01162421|459901129|FG000|Overall Study|Adverse Event|2|||
127727775|NCT02069379|459628375|FG001|First Treatment Arm|Lost to Follow-up|1|||
127727776|NCT02069379|459628376|FG002|First Treatment Arm|Lost to Follow-up|1|||
127727777|NCT02069379|459628377|FG003|First Treatment Arm|Lost to Follow-up|0|||
127727778|NCT02069379|459628374|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
127727779|NCT02069379|459628375|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
127727780|NCT02069379|459628376|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
127727781|NCT02069379|459628377|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
127727782|NCT02069379|459628374|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
127727783|NCT02069379|459628375|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
127727784|NCT02069379|459628376|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
127727785|NCT02069379|459628377|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
127727786|NCT02069379|459628374|FG000|Second Treatment Arm|Lost to Follow-up|0|||
127727787|NCT02069379|459628375|FG001|Second Treatment Arm|Lost to Follow-up|0|||
127727788|NCT02069379|459628376|FG002|Second Treatment Arm|Lost to Follow-up|1|||
127889899|NCT01271933|460219917|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
127727789|NCT02069379|459628377|FG003|Second Treatment Arm|Lost to Follow-up|0|||
127727790|NCT00700999|459628380|FG000|Overall Study|Lost to Follow-up|7|||
127727791|NCT00700999|459628381|FG001|Overall Study|Lost to Follow-up|7|||
127727792|NCT00700999|459628380|FG000|Overall Study|Excluded - did not meet study criteria|0|||
127727793|NCT00700999|459628381|FG001|Overall Study|Excluded - did not meet study criteria|1|||
127889900|NCT01271933|460219918|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
127889901|NCT01271933|460219919|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
127889902|NCT01271933|460219917|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
127889903|NCT01271933|460219918|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
127889904|NCT01271933|460219919|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
127889905|NCT01271933|460219917|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
127889906|NCT01271933|460219918|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
127889907|NCT01271933|460219919|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
127889908|NCT01271933|460219917|FG000|Double-Blind Phase|Randomized but not treated|0|||
127889909|NCT01271933|460219918|FG001|Double-Blind Phase|Randomized but not treated|0|||
127889910|NCT01271933|460219919|FG002|Double-Blind Phase|Randomized but not treated|1|||
127889911|NCT01271933|460219917|FG000|Double-Blind Phase|Lack of Efficacy|0|||
127889912|NCT01271933|460219918|FG001|Double-Blind Phase|Lack of Efficacy|6|||
127889913|NCT01271933|460219919|FG002|Double-Blind Phase|Lack of Efficacy|9|||
127889914|NCT01271933|460219917|FG000|Double-Blind Phase|Lost to Follow-up|0|||
127889915|NCT01271933|460219918|FG001|Double-Blind Phase|Lost to Follow-up|1|||
127727794|NCT00700999|459628380|FG000|Overall Study|Withdrawal by Subject|8|||
127727795|NCT00700999|459628381|FG001|Overall Study|Withdrawal by Subject|1|||
127727796|NCT03481725|459628382|FG000|Overall Study|Withdrawal by Subject|1|||
127727797|NCT03481725|459628383|FG001|Overall Study|Withdrawal by Subject|0|||
127727798|NCT03651271|459628384|FG000|Overall Study|Death|4|||
127727799|NCT03651271|459628385|FG001|Overall Study|Death|37|||
127727800|NCT03651271|459628386|FG002|Overall Study|Death|0|||
127727801|NCT03651271|459628387|FG003|Overall Study|Death|2|||
127727802|NCT03651271|459628388|FG004|Overall Study|Death|6|||
127727803|NCT03651271|459628384|FG000|Overall Study|Lost to Follow-up|1|||
127727804|NCT03651271|459628385|FG001|Overall Study|Lost to Follow-up|5|||
127727805|NCT03651271|459628386|FG002|Overall Study|Lost to Follow-up|0|||
127727806|NCT03651271|459628387|FG003|Overall Study|Lost to Follow-up|1|||
127727807|NCT03651271|459628388|FG004|Overall Study|Lost to Follow-up|0|||
127727808|NCT03651271|459628384|FG000|Overall Study|Physician Decision|0|||
127727809|NCT03651271|459628385|FG001|Overall Study|Physician Decision|2|||
127727810|NCT03651271|459628386|FG002|Overall Study|Physician Decision|0|||
127727811|NCT03651271|459628387|FG003|Overall Study|Physician Decision|0|||
127727812|NCT03651271|459628388|FG004|Overall Study|Physician Decision|0|||
127727813|NCT03651271|459628384|FG000|Overall Study|Withdrawal by Subject|1|||
127727814|NCT03651271|459628385|FG001|Overall Study|Withdrawal by Subject|15|||
127727815|NCT03651271|459628386|FG002|Overall Study|Withdrawal by Subject|0|||
127727816|NCT03651271|459628387|FG003|Overall Study|Withdrawal by Subject|0|||
127727817|NCT03651271|459628388|FG004|Overall Study|Withdrawal by Subject|1|||
127727818|NCT03651271|459628384|FG000|Overall Study|Patient medically unable to continue|0|||
127727819|NCT03651271|459628385|FG001|Overall Study|Patient medically unable to continue|0|||
127727820|NCT03651271|459628386|FG002|Overall Study|Patient medically unable to continue|0|||
127727821|NCT03651271|459628387|FG003|Overall Study|Patient medically unable to continue|1|||
127727822|NCT03651271|459628388|FG004|Overall Study|Patient medically unable to continue|0|||
127727823|NCT02991118|459628395|FG000|Overall Study|Death|3|||
127727824|NCT02991118|459628396|FG001|Overall Study|Death|8|||
127727825|NCT02991118|459628395|FG000|Overall Study|Protocol Violation|0|||
127727826|NCT02991118|459628396|FG001|Overall Study|Protocol Violation|3|||
127727827|NCT02991118|459628395|FG000|Overall Study|Physician Decision|0|||
127727828|NCT02991118|459628396|FG001|Overall Study|Physician Decision|1|||
127727829|NCT02991118|459628395|FG000|Overall Study|Moved out of the country|0|||
127727830|NCT02991118|459628396|FG001|Overall Study|Moved out of the country|1|||
127727831|NCT02991118|459628395|FG000|Overall Study|Adverse Event|2|||
127889916|NCT01271933|460219919|FG002|Double-Blind Phase|Lost to Follow-up|1|||
127889917|NCT01271933|460219917|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
127889918|NCT01271933|460219918|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
127889919|NCT01271933|460219919|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
127889920|NCT01271933|460219917|FG000|Double-Blind Phase|Adverse Event|0|||
127889921|NCT01271933|460219918|FG001|Double-Blind Phase|Adverse Event|3|||
127889922|NCT01271933|460219919|FG002|Double-Blind Phase|Adverse Event|0|||
127889923|NCT01271933|460219917|FG000|Double-Blind Phase|Participant request-personal reason|0|||
127727832|NCT02991118|459628396|FG001|Overall Study|Adverse Event|2|||
127727833|NCT02991118|459628395|FG000|Overall Study|Withdrawal by Subject|1|||
127727834|NCT02991118|459628396|FG001|Overall Study|Withdrawal by Subject|7|||
127727835|NCT02991118|459628395|FG000|Overall Study|Could not attend study visits|0|||
127727836|NCT02991118|459628396|FG001|Overall Study|Could not attend study visits|1|||
127727837|NCT02991118|459628395|FG000|Overall Study|Lost to Follow-up|1|||
127727838|NCT02991118|459628396|FG001|Overall Study|Lost to Follow-up|9|||
127727839|NCT00595959|459628397|FG000|Overall Study|Withdrawal by Subject|1|||
127727840|NCT00595959|459628397|FG000|Overall Study|Lost to Follow-up|1|||
127727841|NCT00446095|459628401|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
127727842|NCT00446095|459628402|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
127727843|NCT00446095|459628403|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
127727844|NCT00446095|459628404|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
127803079|NCT01162421|459901130|FG001|Overall Study|Adverse Event|5|||
127803080|NCT01162421|459901129|FG000|Overall Study|Lost to Follow-up|0|||
127803081|NCT01162421|459901130|FG001|Overall Study|Lost to Follow-up|2|||
127803082|NCT01162421|459901129|FG000|Overall Study|Lack of Efficacy|2|||
127803083|NCT01162421|459901130|FG001|Overall Study|Lack of Efficacy|2|||
127803084|NCT01162421|459901129|FG000|Overall Study|Other|2|||
127803085|NCT01162421|459901130|FG001|Overall Study|Other|3|||
127803086|NCT03336502|459901131|FG000|Overall Study|Physician Decision|0|||
127803087|NCT03336502|459901132|FG001|Overall Study|Physician Decision|1|||
127803088|NCT03336502|459901131|FG000|Overall Study|Prohibited Drugs|1|||
127803089|NCT03336502|459901132|FG001|Overall Study|Prohibited Drugs|1|||
127803090|NCT03336502|459901131|FG000|Overall Study|Death|1|||
127889924|NCT01271933|460219918|FG001|Double-Blind Phase|Participant request-personal reason|1|||
127889925|NCT01271933|460219919|FG002|Double-Blind Phase|Participant request-personal reason|0|||
127803091|NCT03336502|459901132|FG001|Overall Study|Death|2|||
127803092|NCT03336502|459901131|FG000|Overall Study|Adverse Event|2|||
127803093|NCT03336502|459901132|FG001|Overall Study|Adverse Event|5|||
127803094|NCT00480857|459901134|FG000|Overall Study|Lack of Efficacy|2|||
127803095|NCT00611247|459901135|FG000|Overall Study|Death|1|||
127727845|NCT00446095|459628405|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
127727846|NCT00446095|459628401|FG000|Phase II (8 Weeks)|Adverse Event|0|||
127727847|NCT00446095|459628402|FG001|Phase II (8 Weeks)|Adverse Event|1|||
127727848|NCT00446095|459628403|FG002|Phase II (8 Weeks)|Adverse Event|1|||
127727849|NCT00446095|459628404|FG003|Phase II (8 Weeks)|Adverse Event|0|||
127727850|NCT00446095|459628405|FG004|Phase II (8 Weeks)|Adverse Event|0|||
127727851|NCT00446095|459628401|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
127727852|NCT00446095|459628402|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
127727853|NCT00446095|459628403|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
127727854|NCT00446095|459628404|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
127727855|NCT00446095|459628405|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
127727856|NCT00446095|459628401|FG000|Phase II (8 Weeks)|Physician Decision|1|||
127727857|NCT00446095|459628402|FG001|Phase II (8 Weeks)|Physician Decision|0|||
127727858|NCT00446095|459628403|FG002|Phase II (8 Weeks)|Physician Decision|0|||
127727859|NCT00446095|459628404|FG003|Phase II (8 Weeks)|Physician Decision|0|||
127727860|NCT00446095|459628405|FG004|Phase II (8 Weeks)|Physician Decision|0|||
127727861|NCT00446095|459628401|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
127727862|NCT00446095|459628402|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
127727863|NCT00446095|459628403|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
127727864|NCT00446095|459628404|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
127727865|NCT00446095|459628405|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
127727866|NCT00446095|459628401|FG000|Phase II (8 Weeks)|Ongoing|0|||
127727867|NCT00446095|459628402|FG001|Phase II (8 Weeks)|Ongoing|0|||
127727868|NCT00446095|459628403|FG002|Phase II (8 Weeks)|Ongoing|1|||
127727869|NCT00446095|459628404|FG003|Phase II (8 Weeks)|Ongoing|0|||
127727870|NCT00446095|459628405|FG004|Phase II (8 Weeks)|Ongoing|0|||
127727871|NCT00446095|459628401|FG000|Phase I (28 Days)|Adverse Event|0|||
127727872|NCT00446095|459628402|FG001|Phase I (28 Days)|Adverse Event|0|||
127727873|NCT00446095|459628403|FG002|Phase I (28 Days)|Adverse Event|0|||
127727874|NCT00446095|459628404|FG003|Phase I (28 Days)|Adverse Event|1|||
127803096|NCT00611247|459901136|FG001|Overall Study|Death|5|||
127803097|NCT00611247|459901135|FG000|Overall Study|Lack of Efficacy|1|||
127803098|NCT00611247|459901136|FG001|Overall Study|Lack of Efficacy|16|||
127727875|NCT00446095|459628405|FG004|Phase I (28 Days)|Adverse Event|0|||
127727876|NCT00446095|459628401|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
127727877|NCT00446095|459628402|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
127803099|NCT00565617|459901137|FG000|Overall Study|Withdrawal by Subject|1|||
127803100|NCT01890421|459901138|FG000|Overall Study|Adverse Event|1|||
127803101|NCT01890421|459901138|FG000|Overall Study|Other reason|10|||
127803102|NCT01446419|459901147|FG000|Overall Study|Death|1|||
127803103|NCT01446419|459901148|FG001|Overall Study|Death|0|||
127803104|NCT01446419|459901147|FG000|Overall Study|Withdrawal by Subject|1|||
127803105|NCT01446419|459901148|FG001|Overall Study|Withdrawal by Subject|1|||
127803106|NCT01446419|459901147|FG000|Overall Study|Terminated per protocol|3|||
127803107|NCT01446419|459901148|FG001|Overall Study|Terminated per protocol|0|||
127803108|NCT02867761|459901151|FG000|Overall Study|Participant withdrawn by investigator|0|||
127803109|NCT02867761|459901152|FG001|Overall Study|Participant withdrawn by investigator|1|||
127803110|NCT02867761|459901151|FG000|Overall Study|Lost to Follow-up|25|||
127803111|NCT02867761|459901152|FG001|Overall Study|Lost to Follow-up|18|||
127889926|NCT01138150|460219920|FG000|Overall Study|blood unable to be processed|0|||
127727878|NCT00446095|459628403|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
127727879|NCT00446095|459628404|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
127727880|NCT00446095|459628405|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
127727881|NCT01916109|459628406|FG000|Overall Study|Withdrawal by Subject|1|||
127727882|NCT00636168|459628409|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
127727883|NCT00636168|459628410|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
127727884|NCT00636168|459628409|FG000|Randomized to Study Drug|Adverse Event|1|||
127727885|NCT00636168|459628410|FG001|Randomized to Study Drug|Adverse Event|0|||
127727886|NCT00636168|459628409|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
127727887|NCT00636168|459628410|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
127727888|NCT00636168|459628409|FG000|Treated With Study Drug|Recurrence of disease|135|||
127727889|NCT00636168|459628410|FG001|Treated With Study Drug|Recurrence of disease|282|||
127727890|NCT00636168|459628409|FG000|Treated With Study Drug|Adverse Event|250|||
127727891|NCT00636168|459628410|FG001|Treated With Study Drug|Adverse Event|22|||
127727892|NCT00636168|459628409|FG000|Treated With Study Drug|Participant withdrew consent|16|||
127727893|NCT00636168|459628410|FG001|Treated With Study Drug|Participant withdrew consent|21|||
127727894|NCT00636168|459628409|FG000|Treated With Study Drug|Poor/non-compliance|1|||
127727895|NCT00636168|459628410|FG001|Treated With Study Drug|Poor/non-compliance|3|||
127727896|NCT00636168|459628409|FG000|Treated With Study Drug|Death|3|||
127727897|NCT00636168|459628410|FG001|Treated With Study Drug|Death|0|||
127727898|NCT00636168|459628409|FG000|Treated With Study Drug|Pregnancy|1|||
127727899|NCT00636168|459628410|FG001|Treated With Study Drug|Pregnancy|0|||
127727900|NCT00636168|459628409|FG000|Treated With Study Drug|No longer meets study criteria|1|||
127727901|NCT00636168|459628410|FG001|Treated With Study Drug|No longer meets study criteria|0|||
127727902|NCT00636168|459628409|FG000|Treated With Study Drug|Other reason|1|||
127727903|NCT00636168|459628410|FG001|Treated With Study Drug|Other reason|3|||
127727904|NCT00636168|459628409|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
127727905|NCT00636168|459628410|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
127727906|NCT00636168|459628409|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
127727907|NCT00636168|459628410|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
127727908|NCT00636168|459628409|FG000|Long Term Follow-Up|Death|8|||
127727909|NCT00636168|459628410|FG001|Long Term Follow-Up|Death|9|||
127727910|NCT02707952|459628413|FG000|Overall Study|Adverse Event|1|||
127727911|NCT02707952|459628414|FG001|Overall Study|Adverse Event|0|||
127727912|NCT02707952|459628415|FG002|Overall Study|Adverse Event|0|||
127727913|NCT02707952|459628416|FG003|Overall Study|Adverse Event|0|||
127727914|NCT02707952|459628413|FG000|Overall Study|Lost to Follow-up|1|||
127727915|NCT02707952|459628414|FG001|Overall Study|Lost to Follow-up|0|||
127727916|NCT02707952|459628415|FG002|Overall Study|Lost to Follow-up|0|||
127727917|NCT02707952|459628416|FG003|Overall Study|Lost to Follow-up|0|||
127727918|NCT02707952|459628413|FG000|Overall Study|Withdrawal by Subject|0|||
127727919|NCT02707952|459628414|FG001|Overall Study|Withdrawal by Subject|1|||
127727920|NCT02707952|459628415|FG002|Overall Study|Withdrawal by Subject|2|||
127727921|NCT02707952|459628416|FG003|Overall Study|Withdrawal by Subject|0|||
127727922|NCT02006641|459628417|FG000|Overall Study|Withdrawal before treatment|2|||
127727923|NCT02006641|459628418|FG001|Overall Study|Withdrawal before treatment|5|||
127727924|NCT02006641|459628419|FG002|Overall Study|Withdrawal before treatment|3|||
127727925|NCT02006641|459628417|FG000|Overall Study|Adverse Event|15|||
127727926|NCT02006641|459628418|FG001|Overall Study|Adverse Event|11|||
127727927|NCT02006641|459628419|FG002|Overall Study|Adverse Event|15|||
127727928|NCT02006641|459628417|FG000|Overall Study|Protocol Violation|0|||
127727929|NCT02006641|459628418|FG001|Overall Study|Protocol Violation|2|||
127727930|NCT02006641|459628419|FG002|Overall Study|Protocol Violation|2|||
127727931|NCT02006641|459628417|FG000|Overall Study|Lost to Follow-up|0|||
127727932|NCT02006641|459628418|FG001|Overall Study|Lost to Follow-up|1|||
127727933|NCT02006641|459628419|FG002|Overall Study|Lost to Follow-up|0|||
127727934|NCT02006641|459628417|FG000|Overall Study|Withdrawal by Subject|7|||
127727935|NCT02006641|459628418|FG001|Overall Study|Withdrawal by Subject|12|||
127727936|NCT02006641|459628419|FG002|Overall Study|Withdrawal by Subject|11|||
127727937|NCT02006641|459628417|FG000|Overall Study|Other reason: patient didn't show up|1|||
127727938|NCT02006641|459628418|FG001|Overall Study|Other reason: patient didn't show up|0|||
127727939|NCT02006641|459628419|FG002|Overall Study|Other reason: patient didn't show up|0|||
127727940|NCT02006641|459628417|FG000|Overall Study|Other reason:patient didn't want to come|0|||
127727941|NCT02006641|459628418|FG001|Overall Study|Other reason:patient didn't want to come|0|||
127727942|NCT02006641|459628419|FG002|Overall Study|Other reason:patient didn't want to come|1|||
127727943|NCT02006641|459628417|FG000|Overall Study|Other reason: patient has moved|1|||
127727944|NCT02006641|459628418|FG001|Overall Study|Other reason: patient has moved|0|||
127727945|NCT02006641|459628419|FG002|Overall Study|Other reason: patient has moved|1|||
127727946|NCT02006641|459628417|FG000|Overall Study|Other reason: caregiver in hospital|0|||
127727947|NCT02006641|459628418|FG001|Overall Study|Other reason: caregiver in hospital|1|||
127727948|NCT02006641|459628419|FG002|Overall Study|Other reason: caregiver in hospital|0|||
127727949|NCT02006641|459628417|FG000|Overall Study|Other reason: patient's wife has died|0|||
127727950|NCT02006641|459628418|FG001|Overall Study|Other reason: patient's wife has died|0|||
127727951|NCT02006641|459628419|FG002|Overall Study|Other reason: patient's wife has died|1|||
127727952|NCT02006641|459628417|FG000|Overall Study|Other reason: hospitalisation|0|||
127727953|NCT02006641|459628418|FG001|Overall Study|Other reason: hospitalisation|1|||
127727954|NCT02006641|459628419|FG002|Overall Study|Other reason: hospitalisation|0|||
127727955|NCT02006641|459628417|FG000|Overall Study|Other reason: caregiver impossibility|0|||
127727956|NCT02006641|459628418|FG001|Overall Study|Other reason: caregiver impossibility|0|||
127727957|NCT02006641|459628419|FG002|Overall Study|Other reason: caregiver impossibility|1|||
127727958|NCT02006641|459628417|FG000|Overall Study|Other reason: protocol non-compliance|0|||
127727959|NCT02006641|459628418|FG001|Overall Study|Other reason: protocol non-compliance|0|||
127727960|NCT02006641|459628419|FG002|Overall Study|Other reason: protocol non-compliance|1|||
127727961|NCT01287832|459628420|FG000|Overall Study|Adverse Event|1|||
127727962|NCT01287832|459628421|FG001|Overall Study|Adverse Event|0|||
127727963|NCT01287832|459628420|FG000|Overall Study|Death|0|||
127727964|NCT01287832|459628421|FG001|Overall Study|Death|1|||
127727965|NCT04749797|459628423|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
127727966|NCT04749797|459628424|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
127727967|NCT04749797|459628425|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
127727968|NCT00632736|459628426|FG000|Overall Study|Adverse Event|104|||
127727969|NCT00632736|459628426|FG000|Overall Study|Lost to Follow-up|15|||
127727970|NCT00632736|459628426|FG000|Overall Study|Protocol Violation|14|||
127727971|NCT00632736|459628426|FG000|Overall Study|Withdrawal by Subject|99|||
127727972|NCT00632736|459628426|FG000|Overall Study|Lack of Efficacy|5|||
127727973|NCT00632736|459628426|FG000|Overall Study|Sponsor terminated study|5|||
127727974|NCT00632736|459628426|FG000|Overall Study|Non-compliance|10|||
127727975|NCT00632736|459628426|FG000|Overall Study|Other|16|||
127803112|NCT02867761|459901151|FG000|Overall Study|Unable to complete protocol|3|||
127803113|NCT02867761|459901152|FG001|Overall Study|Unable to complete protocol|7|||
127803114|NCT04506294|459901153|FG000|Overall Study|Lost to Follow-up|70|||
127803115|NCT04506294|459901154|FG001|Overall Study|Lost to Follow-up|20|||
127803116|NCT04506294|459901153|FG000|Overall Study|Withdrawal by Subject|16|||
127803117|NCT04506294|459901154|FG001|Overall Study|Withdrawal by Subject|2|||
127803118|NCT01465659|459901155|FG000|Completed 1 Cycle of Treatment|Death|0|||
127803119|NCT01465659|459901156|FG001|Completed 1 Cycle of Treatment|Death|1|||
127727976|NCT01441596|459628427|FG000|Overall Study|Other reason not defined below|0|||
127727977|NCT01441596|459628428|FG001|Overall Study|Other reason not defined below|2|||
127727978|NCT01441596|459628429|FG002|Overall Study|Other reason not defined below|1|||
127727979|NCT01441596|459628427|FG000|Overall Study|Withdrawal by Subject|4|||
127727980|NCT01441596|459628428|FG001|Overall Study|Withdrawal by Subject|0|||
127727981|NCT01441596|459628429|FG002|Overall Study|Withdrawal by Subject|2|||
127727982|NCT01441596|459628427|FG000|Overall Study|Not treated|0|||
127727983|NCT01441596|459628428|FG001|Overall Study|Not treated|1|||
127727984|NCT01441596|459628429|FG002|Overall Study|Not treated|1|||
127727985|NCT01794689|459628433|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
127727986|NCT01794689|459628434|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
127727987|NCT01794689|459628435|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
127727988|NCT01794689|459628436|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
127727989|NCT01794689|459628433|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
127727990|NCT01794689|459628434|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
127727991|NCT01794689|459628435|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
127727992|NCT01794689|459628436|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
127727993|NCT01794689|459628433|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
127727994|NCT01794689|459628434|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
127727995|NCT01794689|459628435|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
127727996|NCT01794689|459628436|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
127727997|NCT01794689|459628433|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
127727998|NCT01794689|459628434|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
127727999|NCT01794689|459628435|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
127728000|NCT01794689|459628436|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
127728001|NCT01697956|459628437|FG000|Overall Study|Protocol Violation|1|||
127728002|NCT01697956|459628438|FG001|Overall Study|Protocol Violation|1|||
127728003|NCT01115309|459628439|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
127728004|NCT01115309|459628439|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
127728005|NCT01115309|459628439|FG000|Long-term Follow-up|Lost to Follow-up|6|||
127728006|NCT05700851|459628440|FG000|Overall Study|Received a kidney transplant|1|||
127728007|NCT05700851|459628440|FG000|Overall Study|Hospitalisation before starting baseline assessments|1|||
127728008|NCT05700851|459628440|FG000|Overall Study|Withdrawal by Subject|1|||
127728009|NCT00655824|459628441|FG000|Overall Study|Adverse Event|3|||
127728010|NCT00655824|459628441|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
127803120|NCT01465659|459901157|FG002|Completed 1 Cycle of Treatment|Death|0|||
127803121|NCT01465659|459901158|FG003|Completed 1 Cycle of Treatment|Death|0|||
127803122|NCT01465659|459901155|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
127728011|NCT00655824|459628441|FG000|Overall Study|Protocol Violation|1|||
127728012|NCT00655824|459628441|FG000|Overall Study|Withdrawal by Subject|4|||
127728013|NCT00655824|459628441|FG000|Overall Study|Deterioration of Trial Disease|2|||
127728014|NCT00589628|459628442|FG000|Overall Study|Lost to Follow-up|0|||
127728015|NCT00589628|459628443|FG001|Overall Study|Lost to Follow-up|1|||
127728016|NCT03032198|459628456|FG000|Overall Study|Screen Fail|1|||
127728017|NCT01307800|459628457|FG000|Overall Study|Adverse Event|9|||
127728018|NCT01307800|459628458|FG001|Overall Study|Adverse Event|8|||
127728019|NCT01307800|459628459|FG002|Overall Study|Adverse Event|10|||
127728020|NCT01307800|459628460|FG003|Overall Study|Adverse Event|14|||
127803123|NCT01465659|459901156|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
127803124|NCT01465659|459901157|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
127803125|NCT01465659|459901158|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
127803126|NCT01465659|459901155|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
127728021|NCT01307800|459628457|FG000|Overall Study|Entry Criteria Not Met|0|||
127728022|NCT01307800|459628458|FG001|Overall Study|Entry Criteria Not Met|0|||
127728023|NCT01307800|459628459|FG002|Overall Study|Entry Criteria Not Met|0|||
127728024|NCT01307800|459628460|FG003|Overall Study|Entry Criteria Not Met|2|||
127728025|NCT01307800|459628457|FG000|Overall Study|Lost to Follow-up|5|||
127728026|NCT01307800|459628458|FG001|Overall Study|Lost to Follow-up|6|||
127728027|NCT01307800|459628459|FG002|Overall Study|Lost to Follow-up|2|||
127728028|NCT01307800|459628460|FG003|Overall Study|Lost to Follow-up|8|||
127728029|NCT01307800|459628457|FG000|Overall Study|Perceived Lack of Efficacy|24|||
127803127|NCT01465659|459901156|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
127803128|NCT01465659|459901157|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
127803129|NCT01465659|459901158|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
127803130|NCT01465659|459901155|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
127728030|NCT01307800|459628458|FG001|Overall Study|Perceived Lack of Efficacy|23|||
127728031|NCT01307800|459628459|FG002|Overall Study|Perceived Lack of Efficacy|20|||
127728032|NCT01307800|459628460|FG003|Overall Study|Perceived Lack of Efficacy|33|||
127728033|NCT01307800|459628457|FG000|Overall Study|Protocol Violation|0|||
127728034|NCT01307800|459628458|FG001|Overall Study|Protocol Violation|3|||
127728035|NCT01307800|459628459|FG002|Overall Study|Protocol Violation|4|||
127728036|NCT01307800|459628460|FG003|Overall Study|Protocol Violation|5|||
127728037|NCT01307800|459628457|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
127728038|NCT01307800|459628458|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
127728039|NCT01307800|459628459|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
127728040|NCT01307800|459628460|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
127728041|NCT01307800|459628457|FG000|Overall Study|Sponsor Decision|6|||
127728042|NCT01307800|459628458|FG001|Overall Study|Sponsor Decision|9|||
127728043|NCT01307800|459628459|FG002|Overall Study|Sponsor Decision|12|||
127728044|NCT01307800|459628460|FG003|Overall Study|Sponsor Decision|28|||
127728045|NCT01307800|459628457|FG000|Overall Study|Withdrawal by Subject|10|||
127728046|NCT01307800|459628458|FG001|Overall Study|Withdrawal by Subject|11|||
127728047|NCT01307800|459628459|FG002|Overall Study|Withdrawal by Subject|8|||
127728048|NCT01307800|459628460|FG003|Overall Study|Withdrawal by Subject|15|||
127728049|NCT01307800|459628457|FG000|Overall Study|Participant Moved|0|||
127728050|NCT01307800|459628458|FG001|Overall Study|Participant Moved|2|||
127728051|NCT01307800|459628459|FG002|Overall Study|Participant Moved|1|||
127728052|NCT01307800|459628460|FG003|Overall Study|Participant Moved|3|||
127728053|NCT02892019|459628461|FG000|Overall Study|randomized but not treated|0|||
127728054|NCT02892019|459628462|FG001|Overall Study|randomized but not treated|1|||
127728055|NCT02892019|459628461|FG000|Overall Study|Withdrawal by Subject|0|||
127728056|NCT02892019|459628462|FG001|Overall Study|Withdrawal by Subject|1|||
127728057|NCT02892019|459628461|FG000|Overall Study|Adverse Event|1|||
127728058|NCT02892019|459628462|FG001|Overall Study|Adverse Event|1|||
127728059|NCT00689351|459628463|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
127728060|NCT00689351|459628464|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
127728061|NCT00689351|459628463|FG000|Infant Series of Dosing|Adverse Event|1|||
127728062|NCT00689351|459628464|FG001|Infant Series of Dosing|Adverse Event|0|||
127728063|NCT00689351|459628463|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
127728064|NCT00689351|459628464|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
127728065|NCT00689351|459628463|FG000|After Infant Series|Parent/legal guardian request|1|||
127728066|NCT00689351|459628464|FG001|After Infant Series|Parent/legal guardian request|0|||
127728067|NCT01766206|459628465|FG000|Overall Study|Withdrawal by Subject|22|||
127728068|NCT01766206|459628465|FG000|Overall Study|Lost to Follow-up|10|||
127728069|NCT01766206|459628465|FG000|Overall Study|Inappropriate enrollment|18|||
127728070|NCT01766206|459628465|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
127728071|NCT01884571|459628468|FG000|Overall Study|Adverse Event|1|||
127728072|NCT01884571|459628468|FG000|Overall Study|Death|2|||
127728073|NCT01884571|459628468|FG000|Overall Study|Withdrawal by Subject|2|||
127728074|NCT01884571|459628468|FG000|Overall Study|Disease progression|3|||
127728075|NCT01562275|459630495|FG000|Stage 1|Adverse Event|0|||
127728076|NCT01562275|459630496|FG001|Stage 1|Adverse Event|0|||
127728077|NCT01562275|459630497|FG002|Stage 1|Adverse Event|0|||
127728078|NCT01562275|459630498|FG003|Stage 1|Adverse Event|1|||
127728079|NCT01562275|459630499|FG004|Stage 1|Adverse Event|1|||
127728080|NCT01562275|459630500|FG005|Stage 1|Adverse Event|0|||
127728081|NCT01562275|459630501|FG006|Stage 1|Adverse Event|0|||
127728082|NCT01562275|459630502|FG007|Stage 1|Adverse Event|0|||
127728083|NCT01562275|459630503|FG008|Stage 1|Adverse Event|0|||
127728084|NCT01562275|459630504|FG009|Stage 1|Adverse Event|1|||
127728085|NCT01562275|459630505|FG010|Stage 1|Adverse Event|0|||
127728086|NCT01562275|459630506|FG011|Stage 1|Adverse Event|0|||
127728087|NCT01562275|459630507|FG012|Stage 1|Adverse Event|0|||
127728088|NCT01562275|459630495|FG000|Stage 1|Death|1|||
127728089|NCT01562275|459630496|FG001|Stage 1|Death|0|||
127728090|NCT01562275|459630497|FG002|Stage 1|Death|0|||
127728091|NCT01562275|459630498|FG003|Stage 1|Death|0|||
127728092|NCT01562275|459630499|FG004|Stage 1|Death|0|||
127728093|NCT01562275|459630500|FG005|Stage 1|Death|0|||
127728094|NCT01562275|459630501|FG006|Stage 1|Death|0|||
127728095|NCT01562275|459630502|FG007|Stage 1|Death|0|||
127728096|NCT01562275|459630503|FG008|Stage 1|Death|0|||
127728097|NCT01562275|459630504|FG009|Stage 1|Death|0|||
127728098|NCT01562275|459630505|FG010|Stage 1|Death|0|||
127728099|NCT01562275|459630506|FG011|Stage 1|Death|0|||
127728100|NCT01562275|459630507|FG012|Stage 1|Death|0|||
127728101|NCT01562275|459630495|FG000|Stage 1|Non Compliance|0|||
127728102|NCT01562275|459630496|FG001|Stage 1|Non Compliance|0|||
127728103|NCT01562275|459630497|FG002|Stage 1|Non Compliance|1|||
127728104|NCT01562275|459630498|FG003|Stage 1|Non Compliance|0|||
127803131|NCT01465659|459901156|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
127803132|NCT01465659|459901157|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
127728105|NCT01562275|459630499|FG004|Stage 1|Non Compliance|0|||
127728106|NCT01562275|459630500|FG005|Stage 1|Non Compliance|0|||
127728107|NCT01562275|459630501|FG006|Stage 1|Non Compliance|0|||
127728108|NCT01562275|459630502|FG007|Stage 1|Non Compliance|0|||
127728109|NCT01562275|459630503|FG008|Stage 1|Non Compliance|0|||
127728110|NCT01562275|459630504|FG009|Stage 1|Non Compliance|0|||
127728111|NCT01562275|459630505|FG010|Stage 1|Non Compliance|0|||
127728112|NCT01562275|459630506|FG011|Stage 1|Non Compliance|0|||
127728113|NCT01562275|459630507|FG012|Stage 1|Non Compliance|0|||
127728114|NCT01562275|459630495|FG000|Stage 1|Physician Decision|0|||
127728115|NCT01562275|459630496|FG001|Stage 1|Physician Decision|0|||
127728116|NCT01562275|459630497|FG002|Stage 1|Physician Decision|0|||
127728117|NCT01562275|459630498|FG003|Stage 1|Physician Decision|0|||
127728118|NCT01562275|459630499|FG004|Stage 1|Physician Decision|1|||
127728119|NCT01562275|459630500|FG005|Stage 1|Physician Decision|0|||
127728120|NCT01562275|459630501|FG006|Stage 1|Physician Decision|1|||
127728121|NCT01562275|459630502|FG007|Stage 1|Physician Decision|0|||
127728122|NCT01562275|459630503|FG008|Stage 1|Physician Decision|1|||
127728123|NCT01562275|459630504|FG009|Stage 1|Physician Decision|0|||
127728124|NCT01562275|459630505|FG010|Stage 1|Physician Decision|0|||
127728125|NCT01562275|459630506|FG011|Stage 1|Physician Decision|0|||
127728126|NCT01562275|459630507|FG012|Stage 1|Physician Decision|0|||
127728127|NCT01562275|459630495|FG000|Stage 1|Progression of Disease|2|||
127728128|NCT01562275|459630496|FG001|Stage 1|Progression of Disease|6|||
127728129|NCT01562275|459630497|FG002|Stage 1|Progression of Disease|2|||
127728130|NCT01562275|459630498|FG003|Stage 1|Progression of Disease|1|||
127728131|NCT01562275|459630499|FG004|Stage 1|Progression of Disease|2|||
127728132|NCT01562275|459630500|FG005|Stage 1|Progression of Disease|4|||
127728133|NCT01562275|459630501|FG006|Stage 1|Progression of Disease|1|||
127728134|NCT01562275|459630502|FG007|Stage 1|Progression of Disease|7|||
127728135|NCT01562275|459630503|FG008|Stage 1|Progression of Disease|2|||
127728136|NCT01562275|459630504|FG009|Stage 1|Progression of Disease|5|||
127728137|NCT01562275|459630505|FG010|Stage 1|Progression of Disease|3|||
127728138|NCT01562275|459630506|FG011|Stage 1|Progression of Disease|0|||
127728139|NCT01562275|459630507|FG012|Stage 1|Progression of Disease|0|||
127728140|NCT01562275|459630495|FG000|Stage 1|Withdrawal by Subject|0|||
127728141|NCT01562275|459630496|FG001|Stage 1|Withdrawal by Subject|1|||
127728142|NCT01562275|459630497|FG002|Stage 1|Withdrawal by Subject|0|||
127728143|NCT01562275|459630498|FG003|Stage 1|Withdrawal by Subject|2|||
127728144|NCT01562275|459630499|FG004|Stage 1|Withdrawal by Subject|0|||
127728145|NCT01562275|459630500|FG005|Stage 1|Withdrawal by Subject|0|||
127728146|NCT01562275|459630501|FG006|Stage 1|Withdrawal by Subject|1|||
127728147|NCT01562275|459630502|FG007|Stage 1|Withdrawal by Subject|0|||
127728148|NCT01562275|459630503|FG008|Stage 1|Withdrawal by Subject|0|||
127728149|NCT01562275|459630504|FG009|Stage 1|Withdrawal by Subject|1|||
127728150|NCT01562275|459630505|FG010|Stage 1|Withdrawal by Subject|0|||
127728151|NCT01562275|459630506|FG011|Stage 1|Withdrawal by Subject|0|||
127728152|NCT01562275|459630507|FG012|Stage 1|Withdrawal by Subject|0|||
127728153|NCT01562275|459630495|FG000|Stage 2|Death|0|||
127728154|NCT01562275|459630496|FG001|Stage 2|Death|0|||
127728155|NCT01562275|459630497|FG002|Stage 2|Death|0|||
127728156|NCT01562275|459630498|FG003|Stage 2|Death|0|||
127728157|NCT01562275|459630499|FG004|Stage 2|Death|0|||
127728158|NCT01562275|459630500|FG005|Stage 2|Death|0|||
127803133|NCT01465659|459901158|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
127803134|NCT01465659|459901155|FG000|Completed Follow for 1 Year|Death|6|||
127803135|NCT01465659|459901156|FG001|Completed Follow for 1 Year|Death|3|||
127803136|NCT01465659|459901157|FG002|Completed Follow for 1 Year|Death|2|||
127803137|NCT01465659|459901158|FG003|Completed Follow for 1 Year|Death|4|||
127803138|NCT02445586|459901160|FG000|Overall Study|Death|14|||
127803139|NCT02445586|459901160|FG000|Overall Study|Withdrawal by Subject|13|||
127803140|NCT02445586|459901160|FG000|Overall Study|Disease Progression|10|||
127803141|NCT02445586|459901160|FG000|Overall Study|Protocol Violation|1|||
127803142|NCT02445586|459901160|FG000|Overall Study|Medical Condition|1|||
127803143|NCT01931059|459901161|FG000|Day 1|Pregnancy|0|||
127889927|NCT01138150|460219921|FG001|Overall Study|blood unable to be processed|1|||
127889928|NCT01138150|460219920|FG000|Overall Study|Physician Decision|1|||
127728159|NCT01562275|459630501|FG006|Stage 2|Death|0|||
127728160|NCT01562275|459630502|FG007|Stage 2|Death|0|||
127728161|NCT01562275|459630503|FG008|Stage 2|Death|0|||
127728162|NCT01562275|459630504|FG009|Stage 2|Death|0|||
127728163|NCT01562275|459630505|FG010|Stage 2|Death|0|||
127728164|NCT01562275|459630506|FG011|Stage 2|Death|2|||
127728165|NCT01562275|459630507|FG012|Stage 2|Death|1|||
127728166|NCT01562275|459630495|FG000|Stage 2|Progression of Disease|0|||
127728167|NCT01562275|459630496|FG001|Stage 2|Progression of Disease|0|||
127728168|NCT01562275|459630497|FG002|Stage 2|Progression of Disease|0|||
127728169|NCT01562275|459630498|FG003|Stage 2|Progression of Disease|0|||
127803144|NCT01931059|459901162|FG001|Day 1|Pregnancy|1|||
127803145|NCT01931059|459901161|FG000|Day3|Lost to Follow-up|1|||
127889929|NCT01138150|460219921|FG001|Overall Study|Physician Decision|0|||
127728170|NCT01562275|459630499|FG004|Stage 2|Progression of Disease|0|||
127728171|NCT01562275|459630500|FG005|Stage 2|Progression of Disease|0|||
127728172|NCT01562275|459630501|FG006|Stage 2|Progression of Disease|0|||
127728173|NCT01562275|459630502|FG007|Stage 2|Progression of Disease|0|||
127728174|NCT01562275|459630503|FG008|Stage 2|Progression of Disease|0|||
127728175|NCT01562275|459630504|FG009|Stage 2|Progression of Disease|0|||
127728176|NCT01562275|459630505|FG010|Stage 2|Progression of Disease|0|||
127728177|NCT01562275|459630506|FG011|Stage 2|Progression of Disease|12|||
127728178|NCT01562275|459630507|FG012|Stage 2|Progression of Disease|4|||
127728179|NCT01020487|459630508|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
127728180|NCT01020487|459630509|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
127728181|NCT01020487|459630510|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
127728182|NCT01020487|459630508|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
127728183|NCT01020487|459630509|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
127728184|NCT01020487|459630510|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
127728185|NCT01020487|459630508|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
127728186|NCT01020487|459630509|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
127728187|NCT01020487|459630510|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
127803146|NCT01931059|459901162|FG001|Day3|Lost to Follow-up|0|||
127889930|NCT01620983|460219922|FG000|Overall Study|Lost to Follow-up|8|||
127889931|NCT01620983|460219923|FG001|Overall Study|Lost to Follow-up|4|||
127889932|NCT01620983|460219924|FG002|Overall Study|Lost to Follow-up|9|||
127728188|NCT01020487|459630508|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
127728189|NCT01020487|459630509|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
127728190|NCT01020487|459630510|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
127728191|NCT01020487|459630508|FG000|Part 2 Open-label Period|Adverse Event|0|||
127728192|NCT01020487|459630509|FG001|Part 2 Open-label Period|Adverse Event|4|||
127728193|NCT01020487|459630510|FG002|Part 2 Open-label Period|Adverse Event|1|||
127803147|NCT00428597|459901163|FG000|Overall Study|Randomized but not treated|3|||
127803148|NCT00428597|459901164|FG001|Overall Study|Randomized but not treated|3|||
127803149|NCT00428597|459901163|FG000|Overall Study|Objective Progression or Relapse|19|||
127889933|NCT01620983|460219922|FG000|Overall Study|Withdrawal by Subject|6|||
127728194|NCT02400749|459630511|FG000|Week 0 -16|Withdrawal by Subject|5|||
127728195|NCT02400749|459630512|FG001|Week 0 -16|Withdrawal by Subject|5|||
127728196|NCT02400749|459630511|FG000|Week 0 -16|Adverse Event|3|||
127728197|NCT02400749|459630512|FG001|Week 0 -16|Adverse Event|1|||
127728198|NCT02400749|459630511|FG000|Week 0 -16|Lost to Follow-up|2|||
127728199|NCT02400749|459630512|FG001|Week 0 -16|Lost to Follow-up|0|||
127728200|NCT02400749|459630511|FG000|Week 0 -16|Protocol Violation|1|||
127728201|NCT02400749|459630512|FG001|Week 0 -16|Protocol Violation|0|||
127728202|NCT02400749|459630511|FG000|Week 17 - 32|Withdrawal by Subject|3|||
127728203|NCT02400749|459630512|FG001|Week 17 - 32|Withdrawal by Subject|2|||
127728204|NCT02400749|459630511|FG000|Week 17 - 32|Adverse Event|2|||
127728205|NCT02400749|459630512|FG001|Week 17 - 32|Adverse Event|1|||
127728206|NCT04425252|459630515|FG000|Overall Study|Withdrawal by Subject|2|||
127728207|NCT04425252|459630516|FG001|Overall Study|Withdrawal by Subject|1|||
127728208|NCT04425252|459630515|FG000|Overall Study|Lost to Follow-up|1|||
127728209|NCT04425252|459630516|FG001|Overall Study|Lost to Follow-up|0|||
127803150|NCT00428597|459901164|FG001|Overall Study|Objective Progression or Relapse|47|||
127803151|NCT00428597|459901163|FG000|Overall Study|Study Terminated by Sponsor|41|||
127803152|NCT00428597|459901164|FG001|Overall Study|Study Terminated by Sponsor|16|||
127803153|NCT00428597|459901163|FG000|Overall Study|Adverse Event|15|||
127803154|NCT00428597|459901164|FG001|Overall Study|Adverse Event|7|||
127803155|NCT00428597|459901163|FG000|Overall Study|Global Deterioration of Health Status|1|||
127803156|NCT00428597|459901164|FG001|Overall Study|Global Deterioration of Health Status|5|||
127803157|NCT00428597|459901163|FG000|Overall Study|Protocol Violation|2|||
127803158|NCT00428597|459901164|FG001|Overall Study|Protocol Violation|1|||
127728210|NCT04425252|459630515|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
127728211|NCT04425252|459630516|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
127728212|NCT02446015|459630520|FG000|Overall Study|Adverse Event|0|||
127728213|NCT02446015|459630521|FG001|Overall Study|Adverse Event|1|||
127728214|NCT02446015|459630520|FG000|Overall Study|Withdrawal by Subject|1|||
127728215|NCT02446015|459630521|FG001|Overall Study|Withdrawal by Subject|0|||
127728216|NCT03761849|459630523|FG000|Overall Study|transferred to OpenLabelExtension|35|||
127728217|NCT03761849|459630524|FG001|Overall Study|transferred to OpenLabelExtension|34|||
127728218|NCT03761849|459630525|FG002|Overall Study|transferred to OpenLabelExtension|36|||
127728219|NCT03761849|459630526|FG003|Overall Study|transferred to OpenLabelExtension|0|||
127728220|NCT03761849|459630527|FG004|Overall Study|transferred to OpenLabelExtension|0|||
127728221|NCT03761849|459630528|FG005|Overall Study|transferred to OpenLabelExtension|0|||
127728222|NCT03761849|459630523|FG000|Overall Study|Adverse Event|1|||
127728223|NCT03761849|459630524|FG001|Overall Study|Adverse Event|0|||
127728224|NCT03761849|459630525|FG002|Overall Study|Adverse Event|0|||
127728225|NCT03761849|459630526|FG003|Overall Study|Adverse Event|0|||
127728226|NCT03761849|459630527|FG004|Overall Study|Adverse Event|2|||
127728227|NCT03761849|459630528|FG005|Overall Study|Adverse Event|3|||
127728228|NCT03761849|459630523|FG000|Overall Study|Withdrawal by Subject|0|||
127728229|NCT03761849|459630524|FG001|Overall Study|Withdrawal by Subject|0|||
127728230|NCT03761849|459630525|FG002|Overall Study|Withdrawal by Subject|0|||
127728231|NCT03761849|459630526|FG003|Overall Study|Withdrawal by Subject|41|||
127803159|NCT00428597|459901163|FG000|Overall Study|Withdrawal by Subject|2|||
127803160|NCT00428597|459901164|FG001|Overall Study|Withdrawal by Subject|1|||
127803161|NCT00428597|459901163|FG000|Overall Study|Other|1|||
127803162|NCT00428597|459901164|FG001|Overall Study|Other|1|||
127803163|NCT00428597|459901163|FG000|Overall Study|Lost to Follow-up|0|||
127803164|NCT00428597|459901164|FG001|Overall Study|Lost to Follow-up|1|||
127803165|NCT00428597|459901163|FG000|Overall Study|Pregnancy|1|||
127803166|NCT00428597|459901164|FG001|Overall Study|Pregnancy|0|||
127803167|NCT00428597|459901163|FG000|Overall Study|Death|1|||
127803168|NCT00428597|459901164|FG001|Overall Study|Death|3|||
127803169|NCT00578643|459901165|FG000|Overall Study|Death|1|||
127728232|NCT03761849|459630527|FG004|Overall Study|Withdrawal by Subject|43|||
127728233|NCT03761849|459630528|FG005|Overall Study|Withdrawal by Subject|35|||
127728234|NCT03761849|459630523|FG000|Overall Study|Lost to Follow-up|0|||
127728235|NCT03761849|459630524|FG001|Overall Study|Lost to Follow-up|1|||
127728236|NCT03761849|459630525|FG002|Overall Study|Lost to Follow-up|0|||
127728237|NCT03761849|459630526|FG003|Overall Study|Lost to Follow-up|2|||
127728238|NCT03761849|459630527|FG004|Overall Study|Lost to Follow-up|4|||
127728239|NCT03761849|459630528|FG005|Overall Study|Lost to Follow-up|5|||
127728240|NCT03761849|459630523|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
127728241|NCT03761849|459630524|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
127728242|NCT03761849|459630525|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
127728243|NCT03761849|459630526|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
127728244|NCT03761849|459630527|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
127728245|NCT03761849|459630528|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
127728246|NCT03761849|459630523|FG000|Overall Study|Physician Decision|0|||
127728247|NCT03761849|459630524|FG001|Overall Study|Physician Decision|0|||
127728248|NCT03761849|459630525|FG002|Overall Study|Physician Decision|0|||
127728249|NCT03761849|459630526|FG003|Overall Study|Physician Decision|1|||
127728250|NCT03761849|459630527|FG004|Overall Study|Physician Decision|4|||
127728251|NCT03761849|459630528|FG005|Overall Study|Physician Decision|4|||
127728252|NCT03761849|459630523|FG000|Overall Study|Death|0|||
127728253|NCT03761849|459630524|FG001|Overall Study|Death|0|||
127728254|NCT03761849|459630525|FG002|Overall Study|Death|0|||
127728255|NCT03761849|459630526|FG003|Overall Study|Death|1|||
127728256|NCT03761849|459630527|FG004|Overall Study|Death|1|||
127728257|NCT03761849|459630528|FG005|Overall Study|Death|3|||
127728258|NCT03761849|459630523|FG000|Overall Study|Protocol Violation|0|||
127728259|NCT03761849|459630524|FG001|Overall Study|Protocol Violation|0|||
127728260|NCT03761849|459630525|FG002|Overall Study|Protocol Violation|0|||
127728261|NCT03761849|459630526|FG003|Overall Study|Protocol Violation|2|||
127728262|NCT03761849|459630527|FG004|Overall Study|Protocol Violation|2|||
127728263|NCT03761849|459630528|FG005|Overall Study|Protocol Violation|1|||
127728264|NCT03761849|459630523|FG000|Overall Study|Participant could not come to site|0|||
127728265|NCT03761849|459630524|FG001|Overall Study|Participant could not come to site|0|||
127728266|NCT03761849|459630525|FG002|Overall Study|Participant could not come to site|0|||
127728267|NCT03761849|459630526|FG003|Overall Study|Participant could not come to site|0|||
127728268|NCT03761849|459630527|FG004|Overall Study|Participant could not come to site|1|||
127728269|NCT03761849|459630528|FG005|Overall Study|Participant could not come to site|0|||
127728270|NCT03761849|459630523|FG000|Overall Study|SF- safety Finding|0|||
127728271|NCT03761849|459630524|FG001|Overall Study|SF- safety Finding|0|||
127728272|NCT03761849|459630525|FG002|Overall Study|SF- safety Finding|0|||
127728273|NCT03761849|459630526|FG003|Overall Study|SF- safety Finding|0|||
127728274|NCT03761849|459630527|FG004|Overall Study|SF- safety Finding|0|||
127728275|NCT03761849|459630528|FG005|Overall Study|SF- safety Finding|1|||
127728276|NCT03761849|459630523|FG000|Overall Study|Patient did not attend visit|0|||
127728277|NCT03761849|459630524|FG001|Overall Study|Patient did not attend visit|0|||
127803170|NCT00578643|459901165|FG000|Overall Study|Lost to Follow-up|1|||
127728278|NCT03761849|459630525|FG002|Overall Study|Patient did not attend visit|0|||
127728279|NCT03761849|459630526|FG003|Overall Study|Patient did not attend visit|0|||
127803171|NCT01990261|459901167|FG000|Overall Study|Death Before Treatment Start|2|||
127728280|NCT03761849|459630527|FG004|Overall Study|Patient did not attend visit|0|||
127728281|NCT03761849|459630528|FG005|Overall Study|Patient did not attend visit|1|||
127728282|NCT03344458|459630529|FG000|Overall Study|Physician Decision|1|||
127728283|NCT03344458|459630529|FG000|Overall Study|Withdrawal by Subject|16|||
127728284|NCT03344458|459630529|FG000|Overall Study|Other reasons|10|||
127728285|NCT03344458|459630529|FG000|Overall Study|Lost to Follow-up|9|||
127728286|NCT03344458|459630529|FG000|Overall Study|Protocol Violation|3|||
127728287|NCT03840993|459630530|FG000|Overall Study|Adverse Event|1|||
127728288|NCT03840993|459630531|FG001|Overall Study|Adverse Event|0|||
127728289|NCT03840993|459630530|FG000|Overall Study|Lost to Follow-up|4|||
127728290|NCT03840993|459630531|FG001|Overall Study|Lost to Follow-up|0|||
127728291|NCT03840993|459630530|FG000|Overall Study|Physician Decision|0|||
127728292|NCT03840993|459630531|FG001|Overall Study|Physician Decision|1|||
127728293|NCT03840993|459630530|FG000|Overall Study|Pregnancy|0|||
127728294|NCT03840993|459630531|FG001|Overall Study|Pregnancy|1|||
127728295|NCT03840993|459630530|FG000|Overall Study|Withdrawal by Subject|1|||
127728296|NCT03840993|459630531|FG001|Overall Study|Withdrawal by Subject|3|||
127728297|NCT03840993|459630530|FG000|Overall Study|Neutrophil count decrease, COVID-19|3|||
127728298|NCT03840993|459630531|FG001|Overall Study|Neutrophil count decrease, COVID-19|2|||
127728299|NCT00988429|459630532|FG000|Overall Study|Adverse Event|9|||
127728300|NCT00988429|459630533|FG001|Overall Study|Adverse Event|21|||
127728301|NCT00988429|459630534|FG002|Overall Study|Adverse Event|45|||
127728302|NCT00988429|459630532|FG000|Overall Study|Lack of Efficacy|0|||
127728303|NCT00988429|459630533|FG001|Overall Study|Lack of Efficacy|0|||
127728304|NCT00988429|459630534|FG002|Overall Study|Lack of Efficacy|1|||
127728305|NCT00988429|459630532|FG000|Overall Study|Non-Compliance with Study Drug|5|||
127728306|NCT00988429|459630533|FG001|Overall Study|Non-Compliance with Study Drug|1|||
127728307|NCT00988429|459630534|FG002|Overall Study|Non-Compliance with Study Drug|3|||
127728308|NCT00988429|459630532|FG000|Overall Study|Physician Decision|1|||
127728309|NCT00988429|459630533|FG001|Overall Study|Physician Decision|0|||
127728310|NCT00988429|459630534|FG002|Overall Study|Physician Decision|3|||
127728311|NCT00988429|459630532|FG000|Overall Study|Pregnancy|2|||
127728312|NCT00988429|459630533|FG001|Overall Study|Pregnancy|1|||
127728313|NCT00988429|459630534|FG002|Overall Study|Pregnancy|0|||
127728314|NCT00988429|459630532|FG000|Overall Study|Protocol Violation|4|||
127728315|NCT00988429|459630533|FG001|Overall Study|Protocol Violation|3|||
127728316|NCT00988429|459630534|FG002|Overall Study|Protocol Violation|3|||
127728317|NCT00988429|459630532|FG000|Overall Study|Withdrawal by Subject|7|||
127728318|NCT00988429|459630533|FG001|Overall Study|Withdrawal by Subject|7|||
127728319|NCT00988429|459630534|FG002|Overall Study|Withdrawal by Subject|12|||
127728320|NCT00988429|459630532|FG000|Overall Study|Administrative Reasons|1|||
127728321|NCT00988429|459630533|FG001|Overall Study|Administrative Reasons|2|||
127728322|NCT00988429|459630534|FG002|Overall Study|Administrative Reasons|1|||
127728323|NCT00988429|459630532|FG000|Overall Study|other reasons|8|||
127728324|NCT00988429|459630533|FG001|Overall Study|other reasons|8|||
127728325|NCT00988429|459630534|FG002|Overall Study|other reasons|1|||
127728326|NCT02964234|459630535|FG000|Overall Study|Lost to Follow-up|22|||
127728327|NCT02964234|459630536|FG001|Overall Study|Lost to Follow-up|13|||
127728328|NCT01074229|459630537|FG000|Overall Study|Lost to Follow-up|1|||
127728329|NCT01074229|459630538|FG001|Overall Study|Lost to Follow-up|0|||
127728330|NCT01074229|459630539|FG002|Overall Study|Lost to Follow-up|0|||
127889934|NCT01620983|460219923|FG001|Overall Study|Withdrawal by Subject|8|||
127889935|NCT01620983|460219924|FG002|Overall Study|Withdrawal by Subject|1|||
127889936|NCT01620983|460219922|FG000|Overall Study|Death|2|||
127889937|NCT01620983|460219923|FG001|Overall Study|Death|0|||
127728331|NCT01074229|459630537|FG000|Overall Study|Change to open surgical procedure|1|||
127728332|NCT01074229|459630538|FG001|Overall Study|Change to open surgical procedure|3|||
127728333|NCT01074229|459630539|FG002|Overall Study|Change to open surgical procedure|4|||
127728334|NCT02163499|459630542|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
127728335|NCT02163499|459630542|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
127728336|NCT02163499|459630542|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
127728337|NCT02163499|459630542|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
127728338|NCT02163499|459630542|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
127728339|NCT02163499|459630542|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
127728340|NCT02163499|459630542|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
127728341|NCT02163499|459630542|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
127728342|NCT02163499|459630542|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
127728343|NCT02163499|459630542|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
127728344|NCT02163499|459630542|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
127728345|NCT02163499|459630542|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
127728346|NCT02163499|459630542|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
127728347|NCT02163499|459630542|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
127728348|NCT02163499|459630542|FG000|Extended Dosing Phase: ZS|Death|8|||
127728349|NCT02163499|459630542|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
127728350|NCT02163499|459630542|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
127728351|NCT02163499|459630542|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
127728352|NCT01540474|459630543|FG000|Vaccination Period|Lost to Follow-up|0|||
127728353|NCT01540474|459630544|FG001|Vaccination Period|Lost to Follow-up|1|||
127728354|NCT01540474|459630545|FG002|Vaccination Period|Lost to Follow-up|0|||
127728355|NCT01540474|459630546|FG003|Vaccination Period|Lost to Follow-up|0|||
127728356|NCT00857311|459630547|FG000|Overall Study|Lost to Follow-up|1|||
127728357|NCT00857311|459630548|FG001|Overall Study|Lost to Follow-up|0|||
127728358|NCT00857311|459630549|FG002|Overall Study|Lost to Follow-up|0|||
127728359|NCT00857311|459630550|FG003|Overall Study|Lost to Follow-up|0|||
127728360|NCT01587703|459630551|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
127728361|NCT01587703|459630552|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
127728362|NCT01587703|459630553|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
127728363|NCT01587703|459630554|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
127728364|NCT01587703|459630555|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
127728365|NCT01587703|459630556|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
127728366|NCT01587703|459630557|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
127728367|NCT01587703|459630558|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
127728368|NCT01587703|459630559|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
127728369|NCT01587703|459630560|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
127728370|NCT01587703|459630561|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
127728371|NCT01587703|459630562|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
127728372|NCT01587703|459630563|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
127728373|NCT01587703|459630564|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
127728374|NCT01587703|459630565|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
127728375|NCT01587703|459630566|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
127728376|NCT01587703|459630567|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
127728377|NCT01587703|459630568|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
127728378|NCT01587703|459630569|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
127728379|NCT01587703|459630551|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
127728380|NCT01587703|459630552|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
127728381|NCT01587703|459630553|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
127728382|NCT01587703|459630554|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
127728383|NCT01587703|459630555|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
127728384|NCT01587703|459630556|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
127728385|NCT01587703|459630557|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
127728386|NCT01587703|459630558|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
127728387|NCT01587703|459630559|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
127889938|NCT01620983|460219924|FG002|Overall Study|Death|0|||
127889939|NCT01620983|460219922|FG000|Overall Study|Physician Decision|3|||
127889940|NCT01620983|460219923|FG001|Overall Study|Physician Decision|10|||
127728388|NCT01587703|459630560|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
127728389|NCT01587703|459630561|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
127728390|NCT01587703|459630562|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
127728391|NCT01587703|459630563|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
127728392|NCT01587703|459630564|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
127728393|NCT01587703|459630565|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
127728394|NCT01587703|459630566|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
127728395|NCT01587703|459630567|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
127728396|NCT01587703|459630568|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
127728397|NCT01587703|459630569|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
127728398|NCT01587703|459630551|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
127728399|NCT01587703|459630552|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
127728400|NCT01587703|459630553|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
127728401|NCT01587703|459630554|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
127728402|NCT01587703|459630555|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
127728403|NCT01587703|459630556|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
127728404|NCT01587703|459630557|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
127728405|NCT01587703|459630558|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
127728406|NCT01587703|459630559|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
127728407|NCT01587703|459630560|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
127728408|NCT01587703|459630561|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
127728409|NCT01587703|459630562|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
127728410|NCT01587703|459630563|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
127728411|NCT01587703|459630564|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
127728412|NCT01587703|459630565|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
127728413|NCT01587703|459630566|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
127728414|NCT01587703|459630567|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
127728415|NCT01587703|459630568|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
127728416|NCT01587703|459630569|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
127728417|NCT01587703|459630551|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
127728418|NCT01587703|459630552|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
127728419|NCT01587703|459630553|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
127728420|NCT01587703|459630554|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
127728421|NCT01587703|459630555|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
127728422|NCT01587703|459630556|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
127728423|NCT01587703|459630557|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
127728424|NCT01587703|459630558|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
127728425|NCT01587703|459630559|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
127889941|NCT01620983|460219924|FG002|Overall Study|Physician Decision|5|||
127889942|NCT05085964|460219926|FG000|Overall Study|Premature termination of study|21|||
127889943|NCT05085964|460219927|FG001|Overall Study|Premature termination of study|0|||
127889944|NCT00545233|460219928|FG000|Overall Study|Adverse Event|10|||
127889945|NCT00545233|460219929|FG001|Overall Study|Adverse Event|5|||
127889946|NCT00545233|460219928|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
127889947|NCT00545233|460219929|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
127889948|NCT00545233|460219928|FG000|Overall Study|Protocol Violation|2|||
127889949|NCT00545233|460219929|FG001|Overall Study|Protocol Violation|0|||
127889950|NCT00545233|460219928|FG000|Overall Study|Refused Treatment|9|||
127889951|NCT00545233|460219929|FG001|Overall Study|Refused Treatment|7|||
127889952|NCT00545233|460219928|FG000|Overall Study|Failure to Return|4|||
127889953|NCT00545233|460219929|FG001|Overall Study|Failure to Return|6|||
127889954|NCT00545233|460219928|FG000|Overall Study|Insufficient response|14|||
127889955|NCT00545233|460219929|FG001|Overall Study|Insufficient response|15|||
127889956|NCT00545233|460219928|FG000|Overall Study|Physician Decision|2|||
127889957|NCT00545233|460219929|FG001|Overall Study|Physician Decision|1|||
127889958|NCT01208402|460219930|FG000|Overall Study|Withdrawal by Subject|1|||
127889959|NCT01208402|460219931|FG001|Overall Study|Withdrawal by Subject|0|||
127889960|NCT03156270|460219934|FG000|Overall Study|Failed pre-treatment screening|1|||
127889961|NCT03156270|460219934|FG000|Overall Study|Lost to Follow-up|1|||
127889962|NCT00591253|460219935|FG000|Overall Study|Adverse Event|3|||
127889963|NCT00591253|460219936|FG001|Overall Study|Adverse Event|3|||
127889964|NCT00591253|460219937|FG002|Overall Study|Adverse Event|1|||
127889965|NCT00591253|460219935|FG000|Overall Study|Protocol Violation|2|||
127889966|NCT00591253|460219936|FG001|Overall Study|Protocol Violation|2|||
127889967|NCT00591253|460219937|FG002|Overall Study|Protocol Violation|2|||
127889968|NCT00591253|460219935|FG000|Overall Study|Lost to Follow-up|2|||
127889969|NCT00591253|460219936|FG001|Overall Study|Lost to Follow-up|4|||
127889970|NCT00591253|460219937|FG002|Overall Study|Lost to Follow-up|0|||
127889971|NCT00591253|460219935|FG000|Overall Study|Withdrawal by Subject|1|||
127889972|NCT00591253|460219936|FG001|Overall Study|Withdrawal by Subject|7|||
127889973|NCT00591253|460219937|FG002|Overall Study|Withdrawal by Subject|6|||
127889974|NCT00591253|460219935|FG000|Overall Study|Lack of Efficacy|1|||
127889975|NCT00591253|460219936|FG001|Overall Study|Lack of Efficacy|0|||
127889976|NCT00591253|460219937|FG002|Overall Study|Lack of Efficacy|3|||
127889977|NCT00591253|460219935|FG000|Overall Study|Other|5|||
127889978|NCT00591253|460219936|FG001|Overall Study|Other|5|||
127889979|NCT00591253|460219937|FG002|Overall Study|Other|3|||
127889980|NCT03811249|460219940|FG000|Overall Study|Withdrawal by Subject|44|||
127889981|NCT03811249|460219940|FG000|Overall Study|Missed Visit|24|||
127889982|NCT01504867|460219944|FG000|Overall Study|Inclusion criteria not met|2|||
127889983|NCT01504867|460219945|FG001|Overall Study|Inclusion criteria not met|2|||
127889984|NCT01504867|460219944|FG000|Overall Study|Consent revoked|5|||
127889985|NCT01504867|460219945|FG001|Overall Study|Consent revoked|1|||
127889986|NCT00871169|460219946|FG000|Overall Study|Protocol Violation|1|||
127889987|NCT00871169|460219946|FG000|Overall Study|Patient did not receive study treatment|2|||
127889988|NCT03210259|460219950|FG000|12-Week Run-in Period|Adverse Event|1|||
127889989|NCT03210259|460219951|FG001|12-Week Run-in Period|Adverse Event|0|||
127889990|NCT03210259|460219952|FG002|12-Week Run-in Period|Adverse Event|0|||
127889991|NCT03210259|460219950|FG000|12-Week Run-in Period|Death|1|||
127889992|NCT03210259|460219951|FG001|12-Week Run-in Period|Death|0|||
127889993|NCT03210259|460219952|FG002|12-Week Run-in Period|Death|0|||
127889994|NCT03210259|460219950|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
127889995|NCT03210259|460219951|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
127889996|NCT03210259|460219952|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
127889997|NCT03210259|460219950|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
127889998|NCT03210259|460219951|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
127889999|NCT03210259|460219952|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
127890000|NCT03210259|460219950|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
127728426|NCT01587703|459630560|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
127728427|NCT01587703|459630561|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
127728428|NCT01587703|459630562|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
127728429|NCT01587703|459630563|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
127890001|NCT03210259|460219951|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
127890002|NCT03210259|460219952|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
127890003|NCT03210259|460219950|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
127890004|NCT03210259|460219951|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
127890005|NCT03210259|460219952|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
127890006|NCT03210259|460219950|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
127890007|NCT03210259|460219951|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
127890008|NCT03210259|460219952|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
127890009|NCT03210259|460219950|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
127890010|NCT03210259|460219951|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
127890011|NCT03210259|460219952|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
127803172|NCT01990261|459901167|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
127803173|NCT01990261|459901167|FG000|Overall Study|Death From other Causes|1|||
127728430|NCT01587703|459630564|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
127728431|NCT01587703|459630565|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
127728432|NCT01587703|459630566|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
127803174|NCT01990261|459901167|FG000|Overall Study|Disease Progression (PD)|8|||
127803175|NCT01990261|459901167|FG000|Overall Study|PD Before Treatment Start|1|||
127803176|NCT01990261|459901167|FG000|Overall Study|Dossier not Approved|1|||
127803177|NCT01990261|459901167|FG000|Overall Study|Lost to Follow-up|2|||
127803178|NCT01445678|459901176|FG000|Overall Study|Adverse Event|12|||
127803179|NCT01445678|459901177|FG001|Overall Study|Adverse Event|8|||
127803180|NCT01445678|459901176|FG000|Overall Study|Lack of Efficacy|0|||
127803181|NCT01445678|459901177|FG001|Overall Study|Lack of Efficacy|2|||
127803182|NCT01445678|459901176|FG000|Overall Study|Lost to Follow-up|8|||
127803183|NCT01445678|459901177|FG001|Overall Study|Lost to Follow-up|5|||
127803184|NCT01445678|459901176|FG000|Overall Study|Protocol Violation|1|||
127803185|NCT01445678|459901177|FG001|Overall Study|Protocol Violation|1|||
127803186|NCT01445678|459901176|FG000|Overall Study|Withdrawal by Subject|9|||
127803187|NCT01445678|459901177|FG001|Overall Study|Withdrawal by Subject|5|||
127803188|NCT02307370|459901178|FG000|Overall Study|Death|5|||
127803189|NCT02307370|459901178|FG000|Overall Study|Lost to Follow-up|1|||
127803190|NCT02307370|459901178|FG000|Overall Study|Withdrawal by Subject|1|||
127803191|NCT02307370|459901178|FG000|Overall Study|Declined Addendum ICF|6|||
127803192|NCT02307370|459901178|FG000|Overall Study|No response during telephone contact|5|||
127803193|NCT02307370|459901178|FG000|Overall Study|Protocol Violation|1|||
127803194|NCT05847686|459903572|FG000|Overall Study|Withdrawal by Subject|3|||
127803195|NCT06272370|459903573|FG000|Overall Study|Lost to Follow-up|0|||
127803196|NCT06272370|459903574|FG001|Overall Study|Lost to Follow-up|3|||
127803197|NCT06272370|459903575|FG002|Overall Study|Lost to Follow-up|1|||
127803198|NCT06272370|459903576|FG003|Overall Study|Lost to Follow-up|1|||
127803199|NCT00352534|459903578|FG000|Initial Staging|Ineligible|8|||
127728433|NCT01587703|459630567|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
127728434|NCT01587703|459630568|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
127728435|NCT01587703|459630569|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
127728436|NCT01587703|459630551|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
127728437|NCT01587703|459630552|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
127728438|NCT01587703|459630553|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
127728439|NCT01587703|459630554|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
127728440|NCT01587703|459630555|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
127728441|NCT01587703|459630556|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
127728442|NCT01587703|459630557|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
127728443|NCT01587703|459630558|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
127728444|NCT01587703|459630559|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
127728445|NCT01587703|459630560|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
127728446|NCT01587703|459630561|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
127728447|NCT01587703|459630562|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
127728448|NCT01587703|459630563|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
127728449|NCT01587703|459630564|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
127728450|NCT01587703|459630565|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
127728451|NCT01587703|459630566|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
127728452|NCT01587703|459630567|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
127728453|NCT01587703|459630568|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
127728454|NCT01587703|459630569|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
127728455|NCT01587703|459630551|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
127728456|NCT01587703|459630552|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
127728457|NCT01587703|459630553|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
127728458|NCT01587703|459630554|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
127803200|NCT00352534|459903579|FG001|Initial Staging|Ineligible|9|||
127803201|NCT00352534|459903580|FG002|Initial Staging|Ineligible|0|||
127803202|NCT00352534|459903581|FG003|Initial Staging|Ineligible|0|||
127803203|NCT00352534|459903582|FG004|Initial Staging|Ineligible|0|||
127803204|NCT00352534|459903583|FG005|Initial Staging|Ineligible|0|||
127803205|NCT00352534|459903584|FG006|Initial Staging|Ineligible|0|||
127890012|NCT03210259|460219950|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
127728459|NCT01587703|459630555|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
127728460|NCT01587703|459630556|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
127728461|NCT01587703|459630557|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
127728462|NCT01587703|459630558|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
127728463|NCT01587703|459630559|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
127728464|NCT01587703|459630560|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
127728465|NCT01587703|459630561|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
127728466|NCT01587703|459630562|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
127728467|NCT01587703|459630563|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
127728468|NCT01587703|459630564|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
127728469|NCT01587703|459630565|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
127728470|NCT01587703|459630566|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
127728471|NCT01587703|459630567|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
127728472|NCT01587703|459630568|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
127803206|NCT00352534|459903578|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
127803207|NCT00352534|459903579|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
127803208|NCT00352534|459903580|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
127803209|NCT00352534|459903581|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
127803210|NCT00352534|459903582|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
127803211|NCT00352534|459903583|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
127803212|NCT00352534|459903584|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
127803213|NCT00352534|459903578|FG000|Final Risk Group Assignment|Physician Decision|0|||
127803214|NCT00352534|459903579|FG001|Final Risk Group Assignment|Physician Decision|0|||
127803215|NCT00352534|459903580|FG002|Final Risk Group Assignment|Physician Decision|0|||
127728473|NCT01587703|459630569|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
127728474|NCT01587703|459630551|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
127728475|NCT01587703|459630552|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
127728476|NCT01587703|459630553|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
127728477|NCT01587703|459630554|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
127728478|NCT01587703|459630555|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
127728479|NCT01587703|459630556|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
127728480|NCT01587703|459630557|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
127728481|NCT01587703|459630558|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
127728482|NCT01587703|459630559|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
127728483|NCT01587703|459630560|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
127728484|NCT01587703|459630561|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
127728485|NCT01587703|459630562|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
127728486|NCT01587703|459630563|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
127728487|NCT01587703|459630564|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
127728488|NCT01587703|459630565|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
127728489|NCT01587703|459630566|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
127728490|NCT01587703|459630567|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
127728491|NCT01587703|459630568|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
127728492|NCT01587703|459630569|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
127728493|NCT01587703|459630551|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
127728494|NCT01587703|459630552|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
127728495|NCT01587703|459630553|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
127728496|NCT01587703|459630554|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
127728497|NCT01587703|459630555|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
127728498|NCT01587703|459630556|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
127728499|NCT01587703|459630557|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
127728500|NCT01587703|459630558|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
127728501|NCT01587703|459630559|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
127728502|NCT01587703|459630560|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
127728503|NCT01587703|459630561|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
127728504|NCT01587703|459630562|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
127728505|NCT01587703|459630563|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
127728506|NCT01587703|459630564|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
127728507|NCT01587703|459630565|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
127728508|NCT01587703|459630566|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
127728509|NCT01587703|459630567|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
127803216|NCT00352534|459903581|FG003|Final Risk Group Assignment|Physician Decision|0|||
127803217|NCT00352534|459903582|FG004|Final Risk Group Assignment|Physician Decision|0|||
127803218|NCT00352534|459903583|FG005|Final Risk Group Assignment|Physician Decision|8|||
127728510|NCT01587703|459630568|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
127728511|NCT01587703|459630569|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
127728512|NCT01587703|459630551|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
127728513|NCT01587703|459630552|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
127728514|NCT01587703|459630553|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
127728515|NCT01587703|459630554|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
127728516|NCT01587703|459630555|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
127728517|NCT01587703|459630556|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
127728518|NCT01587703|459630557|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
127728519|NCT01587703|459630558|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
127728520|NCT01587703|459630559|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
127728521|NCT01587703|459630560|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
127728522|NCT01587703|459630561|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
127728523|NCT01587703|459630562|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
127728524|NCT01587703|459630563|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
127728525|NCT01587703|459630564|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
127728526|NCT01587703|459630565|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
127728527|NCT01587703|459630566|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
127728528|NCT01587703|459630567|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
127728529|NCT01587703|459630568|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
127728530|NCT01587703|459630569|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
127728531|NCT01587703|459630551|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
127728532|NCT01587703|459630552|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
127728533|NCT01587703|459630553|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
127728534|NCT01587703|459630554|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
127728535|NCT01587703|459630555|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
127728536|NCT01587703|459630556|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
127728537|NCT01587703|459630557|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
127728538|NCT01587703|459630558|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
127728539|NCT01587703|459630559|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
127728540|NCT01587703|459630560|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
127728541|NCT01587703|459630561|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
127728542|NCT01587703|459630562|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
127728543|NCT01587703|459630563|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
127728544|NCT01587703|459630564|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
127728545|NCT01587703|459630565|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
127728546|NCT01587703|459630566|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
127728547|NCT01587703|459630567|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
127728548|NCT01587703|459630568|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
127728549|NCT01587703|459630569|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
127728550|NCT01587703|459630551|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
127728551|NCT01587703|459630552|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
127728552|NCT01587703|459630553|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
127728553|NCT01587703|459630554|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
127728554|NCT01587703|459630555|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
127728555|NCT01587703|459630556|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
127728556|NCT01587703|459630557|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
127728557|NCT01587703|459630558|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
127728558|NCT01587703|459630559|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
127728559|NCT01587703|459630560|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
127728560|NCT01587703|459630561|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
127728561|NCT01587703|459630562|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
127728562|NCT01587703|459630563|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
127728563|NCT01587703|459630564|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
127728564|NCT01587703|459630565|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
127728565|NCT01587703|459630566|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
127728566|NCT01587703|459630567|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
127728567|NCT01587703|459630568|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
127728568|NCT01587703|459630569|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
127728569|NCT01587703|459630551|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
127728570|NCT01587703|459630552|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
127728571|NCT01587703|459630553|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
127728572|NCT01587703|459630554|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
127728573|NCT01587703|459630555|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
127728574|NCT01587703|459630556|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
127728575|NCT01587703|459630557|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
127728576|NCT01587703|459630558|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
127728577|NCT01587703|459630559|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
127728578|NCT01587703|459630560|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
127728579|NCT01587703|459630561|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
127728580|NCT01587703|459630562|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
127728581|NCT01587703|459630563|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
127728582|NCT01587703|459630564|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
127728583|NCT01587703|459630565|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
127728584|NCT01587703|459630566|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
127728585|NCT01587703|459630567|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
127728586|NCT01587703|459630568|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
127728587|NCT01587703|459630569|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
127728588|NCT01587703|459630551|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
127728589|NCT01587703|459630552|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
127728590|NCT01587703|459630553|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
127728591|NCT01587703|459630554|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
127728592|NCT01587703|459630555|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
127728593|NCT01587703|459630556|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
127728594|NCT01587703|459630557|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
127728595|NCT01587703|459630558|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
127728596|NCT01587703|459630559|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
127728597|NCT01587703|459630560|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
127728598|NCT01587703|459630561|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
127728599|NCT01587703|459630562|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
127728600|NCT01587703|459630563|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
127728601|NCT01587703|459630564|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
127728602|NCT01587703|459630565|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
127728603|NCT01587703|459630566|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
127728604|NCT01587703|459630567|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
127728605|NCT01587703|459630568|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
127728606|NCT01587703|459630569|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
127728607|NCT01587703|459630551|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
127728608|NCT01587703|459630552|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
127728609|NCT01587703|459630553|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
127728610|NCT01587703|459630554|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
127728611|NCT01587703|459630555|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
127728612|NCT01587703|459630556|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
127728613|NCT01587703|459630557|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
127728614|NCT01587703|459630558|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
127728615|NCT01587703|459630559|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
127728616|NCT01587703|459630560|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
127728617|NCT01587703|459630561|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
127728618|NCT01587703|459630562|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
127728619|NCT01587703|459630563|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
127728620|NCT01587703|459630564|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
127728621|NCT01587703|459630565|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
127728622|NCT01587703|459630566|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
127728623|NCT01587703|459630567|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
127728624|NCT01587703|459630568|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
127728625|NCT01587703|459630569|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
127728626|NCT01587703|459630551|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
127728627|NCT01587703|459630552|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
127803219|NCT00352534|459903584|FG006|Final Risk Group Assignment|Physician Decision|0|||
127803220|NCT00352534|459903578|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
127803221|NCT00352534|459903579|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
127728628|NCT01587703|459630553|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
127728629|NCT01587703|459630554|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
127728630|NCT01587703|459630555|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
127803222|NCT00352534|459903580|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
127803223|NCT00352534|459903581|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
127803224|NCT00352534|459903582|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
127728631|NCT01587703|459630556|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
127728632|NCT01587703|459630557|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
127728633|NCT01587703|459630558|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
127728634|NCT01587703|459630559|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
127728635|NCT01587703|459630560|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
127728636|NCT01587703|459630561|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
127728637|NCT01587703|459630562|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
127728638|NCT01587703|459630563|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
127728639|NCT01587703|459630564|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
127728640|NCT01587703|459630565|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
127728641|NCT01587703|459630566|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
127728642|NCT01587703|459630567|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
127728643|NCT01587703|459630568|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
127728644|NCT01587703|459630569|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
127728645|NCT01799993|459630573|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
127728646|NCT01799993|459630574|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
127728647|NCT01799993|459630573|FG000|Overall Study|Death|61|||
127728648|NCT01799993|459630574|FG001|Overall Study|Death|45|||
127728649|NCT01799993|459630573|FG000|Overall Study|Withdrawal by Subject|23|||
127728650|NCT01799993|459630574|FG001|Overall Study|Withdrawal by Subject|24|||
127728651|NCT01799993|459630573|FG000|Overall Study|Lost to Follow-up|5|||
127728652|NCT01799993|459630574|FG001|Overall Study|Lost to Follow-up|8|||
127728653|NCT01799993|459630573|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
127728654|NCT01799993|459630574|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
127728655|NCT01799993|459630573|FG000|Overall Study|Protocol driven decision point|0|||
127728656|NCT01799993|459630574|FG001|Overall Study|Protocol driven decision point|3|||
127728657|NCT01799993|459630573|FG000|Overall Study|Protocol Violation|1|||
127728658|NCT01799993|459630574|FG001|Overall Study|Protocol Violation|1|||
127728659|NCT01799993|459630573|FG000|Overall Study|Deterioration of general conditions|2|||
127728660|NCT01799993|459630574|FG001|Overall Study|Deterioration of general conditions|0|||
127728661|NCT01799993|459630573|FG000|Overall Study|Screen failure|0|||
127728662|NCT01799993|459630574|FG001|Overall Study|Screen failure|1|||
127728663|NCT01799993|459630573|FG000|Overall Study|Adverse Event|1|||
127728664|NCT01799993|459630574|FG001|Overall Study|Adverse Event|0|||
127728665|NCT01799993|459630573|FG000|Overall Study|Lack of Efficacy|1|||
127728666|NCT01799993|459630574|FG001|Overall Study|Lack of Efficacy|0|||
127728667|NCT01799993|459630573|FG000|Overall Study|Recovery|0|||
127728668|NCT01799993|459630574|FG001|Overall Study|Recovery|1|||
127728669|NCT01799993|459630573|FG000|Overall Study|Logistical difficulties|1|||
127728670|NCT01799993|459630574|FG001|Overall Study|Logistical difficulties|0|||
127728671|NCT01799993|459630573|FG000|Overall Study|Protocol deviation|1|||
127728672|NCT01799993|459630574|FG001|Overall Study|Protocol deviation|0|||
127728673|NCT01799993|459630573|FG000|Overall Study|Non-compliance with medical device|1|||
127728674|NCT01799993|459630574|FG001|Overall Study|Non-compliance with medical device|0|||
127803225|NCT00352534|459903583|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
127803226|NCT00352534|459903584|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
127803227|NCT00352534|459903578|FG000|Final Risk Group Assignment|Ineligible|0|||
127803228|NCT00352534|459903579|FG001|Final Risk Group Assignment|Ineligible|0|||
127803229|NCT00352534|459903580|FG002|Final Risk Group Assignment|Ineligible|3|||
127803230|NCT00352534|459903581|FG003|Final Risk Group Assignment|Ineligible|1|||
127803231|NCT00352534|459903582|FG004|Final Risk Group Assignment|Ineligible|0|||
127803232|NCT00352534|459903583|FG005|Final Risk Group Assignment|Ineligible|13|||
127803233|NCT00352534|459903584|FG006|Final Risk Group Assignment|Ineligible|0|||
127803234|NCT00352534|459903578|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
127803235|NCT00352534|459903579|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
127803236|NCT00352534|459903580|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
127803237|NCT00352534|459903581|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
127803238|NCT00352534|459903582|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
127803239|NCT00352534|459903583|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
127803240|NCT00352534|459903584|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
127803241|NCT00352534|459903578|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
127803242|NCT00352534|459903579|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
127803243|NCT00352534|459903580|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
127803244|NCT00352534|459903581|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
127803245|NCT00352534|459903582|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
127890013|NCT03210259|460219951|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
127890014|NCT03210259|460219952|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
127728675|NCT01799993|459630573|FG000|Overall Study|Withdrawal by parent/guardian|0|||
127728676|NCT01799993|459630574|FG001|Overall Study|Withdrawal by parent/guardian|1|||
127728677|NCT01799993|459630573|FG000|Overall Study|Other|1|||
127803246|NCT00352534|459903583|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
127803247|NCT00352534|459903584|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
127728678|NCT01799993|459630574|FG001|Overall Study|Other|0|||
127728679|NCT01799993|459630573|FG000|Overall Study|Subject didn't return for follow-up|0|||
127728680|NCT01799993|459630574|FG001|Overall Study|Subject didn't return for follow-up|1|||
127728681|NCT04271254|459630575|FG000|Overall Study|Withdrawal by Subject|3|||
127728682|NCT04410445|459630576|FG000|Overall Study|Lost to Follow-up|3|||
127728683|NCT04410445|459630577|FG001|Overall Study|Lost to Follow-up|9|||
127728684|NCT04410445|459630576|FG000|Overall Study|Withdrawal by Subject|27|||
127728685|NCT04410445|459630577|FG001|Overall Study|Withdrawal by Subject|15|||
127728686|NCT01123356|459630578|FG000|Overall Study|Adverse Event|2|||
127728687|NCT01123356|459630578|FG000|Overall Study|Lack of Efficacy|4|||
127890015|NCT03210259|460219950|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
127890016|NCT03210259|460219951|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
127890017|NCT03210259|460219952|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
127890018|NCT03210259|460219950|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
127728688|NCT01123356|459630578|FG000|Overall Study|Withdrawal by Subject|1|||
127728689|NCT02005484|459630583|FG000|Overall Study|Death|1|||
127728690|NCT02005484|459630583|FG000|Overall Study|Disease progression|1|||
127728691|NCT02005484|459630583|FG000|Overall Study|Changed to a Different Study|1|||
127728692|NCT02005484|459630583|FG000|Overall Study|Sponsor decision|1|||
127728693|NCT01129011|459630584|FG000|Overall Study|Adverse Event|20|||
127728694|NCT01129011|459630585|FG001|Overall Study|Adverse Event|30|||
127728695|NCT01129011|459630584|FG000|Overall Study|Withdrawal by Subject|24|||
127728696|NCT01129011|459630585|FG001|Overall Study|Withdrawal by Subject|8|||
127728697|NCT01129011|459630584|FG000|Overall Study|Lost to Follow-up|6|||
127728698|NCT01129011|459630585|FG001|Overall Study|Lost to Follow-up|7|||
127728699|NCT01129011|459630584|FG000|Overall Study|Duodenal Ulcer|2|||
127728700|NCT01129011|459630585|FG001|Overall Study|Duodenal Ulcer|8|||
127728701|NCT01129011|459630584|FG000|Overall Study|misc|7|||
127728702|NCT01129011|459630585|FG001|Overall Study|misc|4|||
127728703|NCT01113541|459630591|FG000|Overall Study|Withdrawal by Subject|1|||
127728704|NCT01113541|459630591|FG000|Overall Study|Protocol Violation|1|||
127728705|NCT01113541|459630591|FG000|Overall Study|Study Terminated by Sponsor|7|||
127728706|NCT01113541|459630591|FG000|Overall Study|Adverse Event|4|||
127728707|NCT03745651|459630592|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
127728708|NCT03745651|459630593|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
127728709|NCT03745651|459630594|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
127728710|NCT03745651|459630595|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
127728711|NCT03745651|459630596|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
127728712|NCT03745651|459630597|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
127728713|NCT03745651|459630598|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
127728714|NCT03745651|459630592|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
127728715|NCT03745651|459630593|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
127728716|NCT03745651|459630594|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
127728717|NCT03745651|459630595|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
127728718|NCT03745651|459630596|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
127728719|NCT03745651|459630597|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
127728720|NCT03745651|459630598|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
127728721|NCT03745651|459630592|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
127728722|NCT03745651|459630593|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
127728723|NCT03745651|459630594|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
127728724|NCT03745651|459630595|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
127728725|NCT03745651|459630596|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
127728726|NCT03745651|459630597|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
127728727|NCT03745651|459630598|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
127728728|NCT03745651|459630592|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
127728729|NCT03745651|459630593|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
127728730|NCT03745651|459630594|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
127728731|NCT03745651|459630595|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
127728732|NCT03745651|459630596|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
127728733|NCT03745651|459630597|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
127728734|NCT03745651|459630598|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
127728735|NCT03745651|459630592|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
127728736|NCT03745651|459630593|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
127728737|NCT03745651|459630594|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
127728738|NCT03745651|459630595|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
127728739|NCT03745651|459630596|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
127728740|NCT03745651|459630597|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
127728741|NCT03745651|459630598|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
127728742|NCT03745651|459630592|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
127803248|NCT00352534|459903578|FG000|Final Risk Group Assignment|Death|0|||
127803249|NCT00352534|459903579|FG001|Final Risk Group Assignment|Death|0|||
127803250|NCT00352534|459903580|FG002|Final Risk Group Assignment|Death|0|||
127803251|NCT00352534|459903581|FG003|Final Risk Group Assignment|Death|0|||
127803252|NCT00352534|459903582|FG004|Final Risk Group Assignment|Death|0|||
127803253|NCT00352534|459903583|FG005|Final Risk Group Assignment|Death|2|||
127803254|NCT00352534|459903584|FG006|Final Risk Group Assignment|Death|0|||
127803255|NCT01602341|459903585|FG000|Overall Study|Adverse Event|0|||
127803256|NCT01602341|459903586|FG001|Overall Study|Adverse Event|1|||
127803257|NCT04439279|459903587|FG000|Overall Study|Adverse Event|7|||
127803258|NCT04439279|459903587|FG000|Overall Study|Death|4|||
127803259|NCT04439279|459903587|FG000|Overall Study|Disease progression|17|||
127803260|NCT04439279|459903587|FG000|Overall Study|Complicating disease|3|||
127803261|NCT04439279|459903587|FG000|Overall Study|Withdrawal by Subject|2|||
127803262|NCT04439279|459903587|FG000|Overall Study|Ineligible|1|||
127803263|NCT04439279|459903587|FG000|Overall Study|Treatment still ongoing|1|||
127803264|NCT03521791|459903588|FG000|Overall Study|Protocol Violation|7|||
127803265|NCT03521791|459903589|FG001|Overall Study|Protocol Violation|17|||
127803266|NCT02090855|459903590|FG000|Overall Study|no evaluable Standard of Truth results|2|||
127803267|NCT00388947|459903592|FG000|Overall Study|Protocol Violation|47|||
127803268|NCT03038308|459903593|FG000|Overall Study|Surgical resection|1|||
127803269|NCT03038308|459903593|FG000|Overall Study|Withdrawal by Subject|2|||
127803270|NCT03038308|459903593|FG000|Overall Study|Lost to Follow-up|1|||
127803271|NCT04187092|459903594|FG000|Overall Study|Lost to Follow-up|1|||
127803272|NCT04187092|459903595|FG001|Overall Study|Lost to Follow-up|1|||
127803273|NCT04187092|459903594|FG000|Overall Study|Withdrawal by Subject|1|||
127803274|NCT04187092|459903595|FG001|Overall Study|Withdrawal by Subject|1|||
127803275|NCT04187092|459903594|FG000|Overall Study|Adverse Event|0|||
127803276|NCT04187092|459903595|FG001|Overall Study|Adverse Event|1|||
127803277|NCT00544869|459903598|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
127803278|NCT00544869|459903599|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
127803279|NCT00544869|459903600|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
127803280|NCT00544869|459903598|FG000|Overall Study|Adverse Event|6|||
127803281|NCT00544869|459903599|FG001|Overall Study|Adverse Event|1|||
127803282|NCT00544869|459903600|FG002|Overall Study|Adverse Event|0|||
127803283|NCT00544869|459903598|FG000|Overall Study|Lack of Efficacy|1|||
127803284|NCT00544869|459903599|FG001|Overall Study|Lack of Efficacy|1|||
127803285|NCT00544869|459903600|FG002|Overall Study|Lack of Efficacy|0|||
127803286|NCT00544869|459903598|FG000|Overall Study|Physician Decision|2|||
127728743|NCT03745651|459630593|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
127728744|NCT03745651|459630594|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
127728745|NCT03745651|459630595|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
127728746|NCT03745651|459630596|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
127728747|NCT03745651|459630597|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
127728748|NCT03745651|459630598|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
127728749|NCT03745651|459630592|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
127728750|NCT03745651|459630593|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
127728751|NCT03745651|459630594|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
127728752|NCT03745651|459630595|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
127728753|NCT03745651|459630596|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
127728754|NCT03745651|459630597|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
127728755|NCT03745651|459630598|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
127728756|NCT03745651|459630592|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
127728757|NCT03745651|459630593|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
127728758|NCT03745651|459630594|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
127728759|NCT03745651|459630595|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
127728760|NCT03745651|459630596|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
127728761|NCT03745651|459630597|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
127728762|NCT03745651|459630598|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
127728763|NCT03745651|459630592|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
127728764|NCT03745651|459630593|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
127728765|NCT03745651|459630594|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
127728766|NCT03745651|459630595|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
127728767|NCT03745651|459630596|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
127728768|NCT03745651|459630597|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
127728769|NCT03745651|459630598|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
127728770|NCT03745651|459630592|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
127728771|NCT03745651|459630593|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
127728772|NCT03745651|459630594|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
127728773|NCT03745651|459630595|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
127728774|NCT03745651|459630596|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
127728775|NCT03745651|459630597|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
127728776|NCT03745651|459630598|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
127728777|NCT03745651|459630592|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
127728778|NCT03745651|459630593|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
127728779|NCT03745651|459630594|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
127728780|NCT03745651|459630595|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
127728781|NCT03745651|459630596|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
127728782|NCT03745651|459630597|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
127728783|NCT03745651|459630598|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
127728784|NCT03745651|459630592|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
127728785|NCT03745651|459630593|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
127728786|NCT03745651|459630594|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
127728787|NCT03745651|459630595|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
127728788|NCT03745651|459630596|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
127728789|NCT03745651|459630597|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
127728790|NCT03745651|459630598|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
127728791|NCT03745651|459630592|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
127728792|NCT03745651|459630593|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
127728793|NCT03745651|459630594|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
127728794|NCT03745651|459630595|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
127728795|NCT03745651|459630596|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
127728796|NCT03745651|459630597|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
127803287|NCT00544869|459903599|FG001|Overall Study|Physician Decision|0|||
127803288|NCT00544869|459903600|FG002|Overall Study|Physician Decision|0|||
127803289|NCT01777763|459903613|FG000|Overall Study|Adverse Event|2|||
127803290|NCT01777763|459903614|FG001|Overall Study|Adverse Event|32|||
127803291|NCT01777763|459903613|FG000|Overall Study|Protocol Violation|1|||
127803292|NCT01777763|459903614|FG001|Overall Study|Protocol Violation|7|||
127803293|NCT01777763|459903613|FG000|Overall Study|Withdrawal by Subject|0|||
127803294|NCT01777763|459903614|FG001|Overall Study|Withdrawal by Subject|2|||
127803295|NCT01777763|459903613|FG000|Overall Study|Treatment Failure|1|||
127803296|NCT01777763|459903614|FG001|Overall Study|Treatment Failure|6|||
127803297|NCT00925600|459903623|FG000|Overall Study|Withdrawal by Subject|16|||
127803298|NCT00925600|459903624|FG001|Overall Study|Withdrawal by Subject|14|||
127728797|NCT03745651|459630598|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
127728798|NCT03745651|459630592|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
127728799|NCT03745651|459630593|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
127728800|NCT03745651|459630594|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
127728801|NCT03745651|459630595|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
127728802|NCT03745651|459630596|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
127728803|NCT03745651|459630597|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
127728804|NCT03745651|459630598|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
127728805|NCT01494467|459630599|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
127728806|NCT01494467|459630600|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
127728807|NCT01494467|459630599|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
127728808|NCT01494467|459630600|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
127728809|NCT01494467|459630599|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
127728810|NCT01494467|459630600|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
127728811|NCT01494467|459630599|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
127728812|NCT01494467|459630600|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
127728813|NCT01494467|459630599|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
127728814|NCT01494467|459630600|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
127728815|NCT01494467|459630599|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
127728816|NCT01494467|459630600|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
127728817|NCT01494467|459630599|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
127728818|NCT01494467|459630600|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
127728819|NCT01494467|459630599|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
127728820|NCT01494467|459630600|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
127728821|NCT01494467|459630599|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
127728822|NCT01494467|459630600|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
127728823|NCT01494467|459630599|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
127728824|NCT01494467|459630600|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
127728825|NCT01494467|459630599|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
127728826|NCT01494467|459630600|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
127728827|NCT01494467|459630599|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
127728828|NCT01494467|459630600|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
127728829|NCT01494467|459630599|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
127728830|NCT01494467|459630600|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
127728831|NCT01494467|459630599|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
127728832|NCT01494467|459630600|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
127728833|NCT02309892|459630601|FG000|Overall Study|Physician Decision|1|||
127728834|NCT02309892|459630602|FG001|Overall Study|Physician Decision|0|||
127728835|NCT02309892|459630603|FG002|Overall Study|Physician Decision|0|||
127728836|NCT02309892|459630604|FG003|Overall Study|Physician Decision|0|||
127728837|NCT02309892|459630605|FG004|Overall Study|Physician Decision|0|||
127728838|NCT02309892|459630606|FG005|Overall Study|Physician Decision|0|||
127728839|NCT02309892|459630607|FG006|Overall Study|Physician Decision|0|||
127728840|NCT02309892|459630601|FG000|Overall Study|Adverse Event|1|||
127728841|NCT02309892|459630602|FG001|Overall Study|Adverse Event|0|||
127728842|NCT02309892|459630603|FG002|Overall Study|Adverse Event|1|||
127728843|NCT02309892|459630604|FG003|Overall Study|Adverse Event|0|||
127803299|NCT00925600|459903623|FG000|Overall Study|Death|4|||
127803300|NCT00925600|459903624|FG001|Overall Study|Death|3|||
127803301|NCT00925600|459903623|FG000|Overall Study|Lost to Follow-up|2|||
127803302|NCT00925600|459903624|FG001|Overall Study|Lost to Follow-up|2|||
127803303|NCT00925600|459903623|FG000|Overall Study|Disease Progression|1|||
127803304|NCT00925600|459903624|FG001|Overall Study|Disease Progression|3|||
127803305|NCT00925600|459903623|FG000|Overall Study|Administrative Decision|1|||
127803306|NCT00925600|459903624|FG001|Overall Study|Administrative Decision|1|||
127803307|NCT00925600|459903623|FG000|Overall Study|Noncompliance|2|||
127728844|NCT02309892|459630605|FG004|Overall Study|Adverse Event|0|||
127728845|NCT02309892|459630606|FG005|Overall Study|Adverse Event|0|||
127728846|NCT02309892|459630607|FG006|Overall Study|Adverse Event|0|||
127728847|NCT02309892|459630601|FG000|Overall Study|Progressive Disease|0|||
127728848|NCT02309892|459630602|FG001|Overall Study|Progressive Disease|1|||
127728849|NCT02309892|459630603|FG002|Overall Study|Progressive Disease|0|||
127728850|NCT02309892|459630604|FG003|Overall Study|Progressive Disease|0|||
127728851|NCT02309892|459630605|FG004|Overall Study|Progressive Disease|1|||
127728852|NCT02309892|459630606|FG005|Overall Study|Progressive Disease|0|||
127728853|NCT02309892|459630607|FG006|Overall Study|Progressive Disease|0|||
127728854|NCT02309892|459630601|FG000|Overall Study|Death|0|||
127728855|NCT02309892|459630602|FG001|Overall Study|Death|0|||
127803308|NCT00925600|459903624|FG001|Overall Study|Noncompliance|0|||
127803309|NCT00925600|459903623|FG000|Overall Study|Ineligibility Determined|2|||
127803310|NCT00925600|459903624|FG001|Overall Study|Ineligibility Determined|0|||
127728856|NCT02309892|459630603|FG002|Overall Study|Death|0|||
127728857|NCT02309892|459630604|FG003|Overall Study|Death|0|||
127728858|NCT02309892|459630605|FG004|Overall Study|Death|0|||
127728859|NCT02309892|459630606|FG005|Overall Study|Death|1|||
127728860|NCT02309892|459630607|FG006|Overall Study|Death|0|||
127728861|NCT03262389|459630608|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
127728862|NCT03262389|459630608|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
127728863|NCT03262389|459630608|FG000|Overall Study|opted out of PET/MR|1|||
127728864|NCT01052272|459630609|FG000|Overall Study|Death|0|||
127728865|NCT01052272|459630610|FG001|Overall Study|Death|0|||
127728866|NCT01052272|459630611|FG002|Overall Study|Death|1|||
127728867|NCT01052272|459630612|FG003|Overall Study|Death|1|||
127728868|NCT01052272|459630609|FG000|Overall Study|Physician Decision|0|||
127728869|NCT01052272|459630610|FG001|Overall Study|Physician Decision|1|||
127728870|NCT01052272|459630611|FG002|Overall Study|Physician Decision|0|||
127728871|NCT01052272|459630612|FG003|Overall Study|Physician Decision|0|||
127728872|NCT01052272|459630609|FG000|Overall Study|patient refuses follow-up|5|||
127728873|NCT01052272|459630610|FG001|Overall Study|patient refuses follow-up|4|||
127728874|NCT01052272|459630611|FG002|Overall Study|patient refuses follow-up|2|||
127728875|NCT01052272|459630612|FG003|Overall Study|patient refuses follow-up|4|||
127728876|NCT01052272|459630609|FG000|Overall Study|Withdrawal by Subject|0|||
127728877|NCT01052272|459630610|FG001|Overall Study|Withdrawal by Subject|2|||
127728878|NCT01052272|459630611|FG002|Overall Study|Withdrawal by Subject|3|||
127728879|NCT01052272|459630612|FG003|Overall Study|Withdrawal by Subject|2|||
127728880|NCT01052272|459630609|FG000|Overall Study|placed in long-term care|0|||
127728881|NCT01052272|459630610|FG001|Overall Study|placed in long-term care|0|||
127728882|NCT01052272|459630611|FG002|Overall Study|placed in long-term care|1|||
127728883|NCT01052272|459630612|FG003|Overall Study|placed in long-term care|0|||
127728884|NCT01052272|459630609|FG000|Overall Study|decline in health|0|||
127728885|NCT01052272|459630610|FG001|Overall Study|decline in health|0|||
127728886|NCT01052272|459630611|FG002|Overall Study|decline in health|1|||
127728887|NCT01052272|459630612|FG003|Overall Study|decline in health|0|||
127728888|NCT04739306|459630613|FG000|Main Study Period|Adverse Event|6|||
127728889|NCT04739306|459630614|FG001|Main Study Period|Adverse Event|7|||
127728890|NCT04739306|459630613|FG000|Main Study Period|Lost to Follow-up|4|||
127728891|NCT04739306|459630614|FG001|Main Study Period|Lost to Follow-up|6|||
127728892|NCT04739306|459630613|FG000|Main Study Period|Physician Decision|1|||
127728893|NCT04739306|459630614|FG001|Main Study Period|Physician Decision|1|||
127728894|NCT04739306|459630613|FG000|Main Study Period|Withdrawal by Subject|8|||
127728895|NCT04739306|459630614|FG001|Main Study Period|Withdrawal by Subject|6|||
127728896|NCT04739306|459630613|FG000|Main Study Period|Protocol Violation|0|||
127728897|NCT04739306|459630614|FG001|Main Study Period|Protocol Violation|1|||
127728898|NCT04739306|459630613|FG000|Main Study Period|War in Ukraine|1|||
127728899|NCT04739306|459630614|FG001|Main Study Period|War in Ukraine|1|||
127728900|NCT01077284|459630615|FG000|Overall Study|Adverse Event|2|||
127728901|NCT01077284|459630616|FG001|Overall Study|Adverse Event|0|||
127728902|NCT01077284|459630617|FG002|Overall Study|Adverse Event|1|||
127728903|NCT01077284|459630615|FG000|Overall Study|Lost to Follow-up|1|||
127728904|NCT01077284|459630616|FG001|Overall Study|Lost to Follow-up|2|||
127728905|NCT01077284|459630617|FG002|Overall Study|Lost to Follow-up|0|||
127728906|NCT01077284|459630615|FG000|Overall Study|Withdrawal by Subject|2|||
127728907|NCT01077284|459630616|FG001|Overall Study|Withdrawal by Subject|3|||
127728908|NCT01077284|459630617|FG002|Overall Study|Withdrawal by Subject|1|||
127728909|NCT01077284|459630615|FG000|Overall Study|Other|0|||
127728910|NCT01077284|459630616|FG001|Overall Study|Other|0|||
127728911|NCT01077284|459630617|FG002|Overall Study|Other|1|||
127728912|NCT03444155|459630622|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
127728913|NCT03444155|459630623|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
127728914|NCT02877680|459630628|FG000|Overall Study|Lost to Follow-up|1|||
127728915|NCT02877680|459630629|FG001|Overall Study|Lost to Follow-up|1|||
127728916|NCT01133678|459630630|FG000|Overall Study|Death|1|||
127728917|NCT01133678|459630631|FG001|Overall Study|Death|1|||
127728918|NCT05104242|459630632|FG000|Overall Study|Withdrawal by Subject|1|||
127728919|NCT05104242|459630633|FG001|Overall Study|Withdrawal by Subject|5|||
127728920|NCT05104242|459630632|FG000|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
127728921|NCT05104242|459630633|FG001|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
127728922|NCT01864200|459630634|FG000|Overall Study|Lost to Follow-up|1|||
127728923|NCT01864200|459630635|FG001|Overall Study|Lost to Follow-up|3|||
127728924|NCT01864200|459630634|FG000|Overall Study|Protocol Violation|1|||
127728925|NCT01864200|459630635|FG001|Overall Study|Protocol Violation|0|||
127728926|NCT02077374|459630636|FG000|Overall Study|Withdrawal by Subject|0|||
127728927|NCT02077374|459630637|FG001|Overall Study|Withdrawal by Subject|1|||
127728928|NCT02077374|459630636|FG000|Overall Study|Protocol Violation|0|||
127728929|NCT02077374|459630637|FG001|Overall Study|Protocol Violation|1|||
127728930|NCT00424476|459630639|FG000|Overall Study|Withdrawal by Subject|7|||
127728931|NCT00424476|459630640|FG001|Overall Study|Withdrawal by Subject|6|||
127803311|NCT00925600|459903623|FG000|Overall Study|Protocol Deviation|0|||
127803312|NCT00925600|459903624|FG001|Overall Study|Protocol Deviation|1|||
127803313|NCT00925600|459903623|FG000|Overall Study|Requirement for Alternative Therapy|0|||
127728932|NCT00424476|459630641|FG002|Overall Study|Withdrawal by Subject|3|||
127728933|NCT00424476|459630639|FG000|Overall Study|Adverse Event|19|||
127728934|NCT00424476|459630640|FG001|Overall Study|Adverse Event|16|||
127728935|NCT00424476|459630641|FG002|Overall Study|Adverse Event|15|||
127728936|NCT00424476|459630639|FG000|Overall Study|Lack of Efficacy|16|||
127728937|NCT00424476|459630640|FG001|Overall Study|Lack of Efficacy|12|||
127728938|NCT00424476|459630641|FG002|Overall Study|Lack of Efficacy|12|||
127728939|NCT00424476|459630639|FG000|Overall Study|Lack of Compliance|1|||
127728940|NCT00424476|459630640|FG001|Overall Study|Lack of Compliance|1|||
127728941|NCT00424476|459630641|FG002|Overall Study|Lack of Compliance|1|||
127728942|NCT00424476|459630639|FG000|Overall Study|Lost to Follow-up|4|||
127728943|NCT00424476|459630640|FG001|Overall Study|Lost to Follow-up|6|||
127728944|NCT00424476|459630641|FG002|Overall Study|Lost to Follow-up|3|||
127728945|NCT00424476|459630639|FG000|Overall Study|Protocol Violation|7|||
127728946|NCT00424476|459630640|FG001|Overall Study|Protocol Violation|2|||
127728947|NCT00424476|459630641|FG002|Overall Study|Protocol Violation|3|||
127728948|NCT00424476|459630639|FG000|Overall Study|Physician Decision|3|||
127728949|NCT00424476|459630640|FG001|Overall Study|Physician Decision|2|||
127728950|NCT00424476|459630641|FG002|Overall Study|Physician Decision|3|||
127728951|NCT00424476|459630639|FG000|Overall Study|Other|4|||
127728952|NCT00424476|459630640|FG001|Overall Study|Other|3|||
127728953|NCT00424476|459630641|FG002|Overall Study|Other|9|||
127728954|NCT00657709|459630642|FG000|Overall Study|AE or Death|7|||
127728955|NCT00657709|459630643|FG001|Overall Study|AE or Death|7|||
127728956|NCT00657709|459630644|FG002|Overall Study|AE or Death|6|||
127728957|NCT00657709|459630645|FG003|Overall Study|AE or Death|7|||
127728958|NCT00657709|459630646|FG004|Overall Study|AE or Death|1|||
127728959|NCT00657709|459630642|FG000|Overall Study|Withdrawal by Subject|7|||
127728960|NCT00657709|459630643|FG001|Overall Study|Withdrawal by Subject|15|||
127728961|NCT00657709|459630644|FG002|Overall Study|Withdrawal by Subject|15|||
127728962|NCT00657709|459630645|FG003|Overall Study|Withdrawal by Subject|5|||
127728963|NCT00657709|459630646|FG004|Overall Study|Withdrawal by Subject|9|||
127728964|NCT00657709|459630642|FG000|Overall Study|Lost to Follow-up|9|||
127728965|NCT00657709|459630643|FG001|Overall Study|Lost to Follow-up|9|||
127728966|NCT00657709|459630644|FG002|Overall Study|Lost to Follow-up|7|||
127728967|NCT00657709|459630645|FG003|Overall Study|Lost to Follow-up|1|||
127728968|NCT00657709|459630646|FG004|Overall Study|Lost to Follow-up|21|||
127728969|NCT00657709|459630642|FG000|Overall Study|Protocol Violation|0|||
127728970|NCT00657709|459630643|FG001|Overall Study|Protocol Violation|2|||
127728971|NCT00657709|459630644|FG002|Overall Study|Protocol Violation|0|||
127728972|NCT00657709|459630645|FG003|Overall Study|Protocol Violation|1|||
127728973|NCT00657709|459630646|FG004|Overall Study|Protocol Violation|2|||
127728974|NCT02574286|459630647|FG000|Overall Study|Adverse Event|3|||
127728975|NCT02574286|459630647|FG000|Overall Study|Withdrawal by Subject|2|||
127728976|NCT01280656|459630648|FG000|Overall Study|Adverse Event|1|||
127728977|NCT01280656|459630649|FG001|Overall Study|Adverse Event|14|||
127728978|NCT01280656|459630650|FG002|Overall Study|Adverse Event|13|||
127728979|NCT01280656|459630648|FG000|Overall Study|Lack of Efficacy|1|||
127728980|NCT01280656|459630649|FG001|Overall Study|Lack of Efficacy|22|||
127728981|NCT01280656|459630650|FG002|Overall Study|Lack of Efficacy|38|||
127728982|NCT01280656|459630648|FG000|Overall Study|Treatment shortening (RGT)|0|||
127728983|NCT01280656|459630649|FG001|Overall Study|Treatment shortening (RGT)|4|||
127728984|NCT01280656|459630650|FG002|Overall Study|Treatment shortening (RGT)|5|||
127728985|NCT01280656|459630648|FG000|Overall Study|Other|1|||
127728986|NCT01280656|459630649|FG001|Overall Study|Other|7|||
127728987|NCT01280656|459630650|FG002|Overall Study|Other|7|||
127728988|NCT00409747|459630651|FG000|Overall Study|Withdrawal by Subject|1|||
127728989|NCT00736502|459630659|FG000|Overall Study|Adverse Event|22|||
127728990|NCT00736502|459630659|FG000|Overall Study|Lack of Efficacy|16|||
127728991|NCT00736502|459630659|FG000|Overall Study|Lost to Follow-up|27|||
127728992|NCT03100370|459630660|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
127728993|NCT03100370|459630661|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
127728994|NCT03100370|459630662|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
127728995|NCT03100370|459630663|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
127728996|NCT03100370|459630664|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
127803314|NCT00925600|459903624|FG001|Overall Study|Requirement for Alternative Therapy|1|||
127803315|NCT00925600|459903623|FG000|Overall Study|Other|3|||
127728997|NCT03100370|459630665|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
127728998|NCT01313663|459630666|FG000|Overall Study|Study Closed/Terminated|2|||
127728999|NCT01313663|459630667|FG001|Overall Study|Study Closed/Terminated|4|||
127729000|NCT01313663|459630666|FG000|Overall Study|Lost to Follow-up|0|||
127729001|NCT01313663|459630667|FG001|Overall Study|Lost to Follow-up|1|||
127729002|NCT01313663|459630666|FG000|Overall Study|Physician Decision|0|||
127729003|NCT01313663|459630667|FG001|Overall Study|Physician Decision|2|||
127729004|NCT01313663|459630666|FG000|Overall Study|Withdrawal by Subject|2|||
127729005|NCT01313663|459630667|FG001|Overall Study|Withdrawal by Subject|1|||
127729006|NCT00515112|459632049|FG000|Overall Study|Death|0|||
127729007|NCT00515112|459632050|FG001|Overall Study|Death|1|||
127729008|NCT00515112|459632049|FG000|Overall Study|The study was terminated|3|||
127729009|NCT00515112|459632050|FG001|Overall Study|The study was terminated|2|||
127729010|NCT04049578|459632051|FG000|Overall Study|Physician Decision|1|||
127729011|NCT01945593|459632054|FG000|Overall Study|Adverse Event|0|||
127729012|NCT01945593|459632055|FG001|Overall Study|Adverse Event|0|||
127729013|NCT01945593|459632056|FG002|Overall Study|Adverse Event|0|||
127729014|NCT01945593|459632057|FG003|Overall Study|Adverse Event|5|||
127729015|NCT01945593|459632054|FG000|Overall Study|Physician Decision|0|||
127729016|NCT01945593|459632055|FG001|Overall Study|Physician Decision|0|||
127729017|NCT01945593|459632056|FG002|Overall Study|Physician Decision|1|||
127729018|NCT01945593|459632057|FG003|Overall Study|Physician Decision|1|||
127803316|NCT00925600|459903624|FG001|Overall Study|Other|1|||
127803317|NCT00925600|459903623|FG000|Overall Study|Adverse Event|1|||
127803318|NCT00925600|459903624|FG001|Overall Study|Adverse Event|2|||
127803319|NCT01974817|459903627|FG000|Overall Study|Death|4|||
127803320|NCT01974817|459903627|FG000|Overall Study|Lost to Follow-up|2|||
127803321|NCT01974817|459903627|FG000|Overall Study|Protocol Violation|2|||
127803322|NCT05512949|459903628|FG000|Overall Study|Lost to Follow-up|4|||
127803323|NCT05512949|459903629|FG001|Overall Study|Lost to Follow-up|6|||
127803324|NCT05512949|459903630|FG002|Overall Study|Lost to Follow-up|2|||
127803325|NCT05512949|459903628|FG000|Overall Study|Protocol Violation|0|||
127803326|NCT05512949|459903629|FG001|Overall Study|Protocol Violation|0|||
127803327|NCT05512949|459903630|FG002|Overall Study|Protocol Violation|1|||
127803328|NCT05512949|459903628|FG000|Overall Study|Withdrawal by Subject|1|||
127803329|NCT05512949|459903629|FG001|Overall Study|Withdrawal by Subject|1|||
127803330|NCT05512949|459903630|FG002|Overall Study|Withdrawal by Subject|2|||
127803331|NCT05512949|459903628|FG000|Overall Study|Completion status unknown|1|||
127803332|NCT05512949|459903629|FG001|Overall Study|Completion status unknown|3|||
127803333|NCT05512949|459903630|FG002|Overall Study|Completion status unknown|0|||
127803334|NCT01583179|459903631|FG000|Overall Study|Screen failure|1|||
127803335|NCT01583179|459903632|FG001|Overall Study|Screen failure|2|||
127803336|NCT01246206|459903633|FG000|Overall Study|Patient did not receive study regiments.|1|||
127803337|NCT04660643|459903634|FG000|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|50|||
127803338|NCT04660643|459903635|FG001|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
127803339|NCT04660643|459903636|FG002|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
127729019|NCT01945593|459632054|FG000|Overall Study|Withdrawal by Subject|0|||
127729020|NCT01945593|459632055|FG001|Overall Study|Withdrawal by Subject|2|||
127803340|NCT04660643|459903634|FG000|Open-label Lead-in Period (Week 0 - 36)|Death|1|||
127803341|NCT04660643|459903635|FG001|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
127803342|NCT04660643|459903636|FG002|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
127729021|NCT01945593|459632056|FG002|Overall Study|Withdrawal by Subject|0|||
127729022|NCT01945593|459632057|FG003|Overall Study|Withdrawal by Subject|4|||
127729023|NCT01945593|459632054|FG000|Overall Study|Protocol Violation|0|||
127729024|NCT01945593|459632055|FG001|Overall Study|Protocol Violation|2|||
127729025|NCT01945593|459632056|FG002|Overall Study|Protocol Violation|1|||
127729026|NCT01945593|459632057|FG003|Overall Study|Protocol Violation|3|||
127729027|NCT01945593|459632054|FG000|Overall Study|Death|0|||
127803343|NCT04660643|459903634|FG000|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|14|||
127729028|NCT01945593|459632055|FG001|Overall Study|Death|0|||
127729029|NCT01945593|459632056|FG002|Overall Study|Death|1|||
127803344|NCT04660643|459903635|FG001|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
127729030|NCT01945593|459632057|FG003|Overall Study|Death|0|||
127729031|NCT01945593|459632054|FG000|Overall Study|Other: Terminated|0|||
127729032|NCT01945593|459632055|FG001|Overall Study|Other: Terminated|0|||
127729033|NCT01945593|459632056|FG002|Overall Study|Other: Terminated|0|||
127729034|NCT01945593|459632057|FG003|Overall Study|Other: Terminated|1|||
127729035|NCT01945593|459632054|FG000|Overall Study|Other: Surgical Procedure|0|||
127729036|NCT01945593|459632055|FG001|Overall Study|Other: Surgical Procedure|2|||
127729037|NCT01945593|459632056|FG002|Overall Study|Other: Surgical Procedure|0|||
127729038|NCT01945593|459632057|FG003|Overall Study|Other: Surgical Procedure|6|||
127729039|NCT01945593|459632054|FG000|Overall Study|Other: Screen Failure|0|||
127729040|NCT01945593|459632055|FG001|Overall Study|Other: Screen Failure|2|||
127729041|NCT01945593|459632056|FG002|Overall Study|Other: Screen Failure|0|||
127729042|NCT01945593|459632057|FG003|Overall Study|Other: Screen Failure|0|||
127729043|NCT00608959|459632060|FG000|Part 1|Did not meet eligibility criteria|1|||
127729044|NCT01005602|459632063|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
127729045|NCT01005602|459632064|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
127729046|NCT01248715|459632065|FG000|Overall Study|Not influenza positive|501|||
127729047|NCT01248715|459632066|FG001|Overall Study|Not influenza positive|510|||
127729048|NCT03409276|459632072|FG000|Overall Study|Withdrawal by Subject|0|||
127729049|NCT03409276|459632073|FG001|Overall Study|Withdrawal by Subject|0|||
127729050|NCT03409276|459632074|FG002|Overall Study|Withdrawal by Subject|0|||
127729051|NCT03409276|459632075|FG003|Overall Study|Withdrawal by Subject|0|||
127729052|NCT03409276|459632076|FG004|Overall Study|Withdrawal by Subject|1|||
127729053|NCT03409276|459632072|FG000|Overall Study|Lost to Follow-up|0|||
127729054|NCT03409276|459632073|FG001|Overall Study|Lost to Follow-up|0|||
127729055|NCT03409276|459632074|FG002|Overall Study|Lost to Follow-up|0|||
127729056|NCT03409276|459632075|FG003|Overall Study|Lost to Follow-up|2|||
127729057|NCT03409276|459632076|FG004|Overall Study|Lost to Follow-up|2|||
127729058|NCT03605745|459632077|FG000|Overall Study|Study was terminated for business reasons|47|||
127729059|NCT01279447|459632078|FG000|Overall Study|Lost to Follow-up|3|||
127729060|NCT01279447|459632079|FG001|Overall Study|Lost to Follow-up|1|||
127729061|NCT01215253|459632080|FG000|Overall Study|Withdrawal by Subject|57|||
127729062|NCT01215253|459632081|FG001|Overall Study|Withdrawal by Subject|35|||
127729063|NCT01215253|459632080|FG000|Overall Study|Physician Decision|9|||
127729064|NCT01215253|459632081|FG001|Overall Study|Physician Decision|12|||
127729065|NCT01215253|459632080|FG000|Overall Study|Lost to Follow-up|6|||
127729066|NCT01215253|459632081|FG001|Overall Study|Lost to Follow-up|4|||
127729067|NCT01215253|459632080|FG000|Overall Study|Other|14|||
127729068|NCT01215253|459632081|FG001|Overall Study|Other|12|||
127729069|NCT01131325|459632085|FG000|Overall Study|Adverse Event|1|||
127729070|NCT01131325|459632085|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
127729071|NCT03884478|459632086|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
127729072|NCT03884478|459632087|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
127729073|NCT03884478|459632088|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
127729074|NCT03884478|459632086|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
127729075|NCT03884478|459632087|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
127729076|NCT03884478|459632088|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
127729077|NCT03884478|459632086|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
127729078|NCT03884478|459632087|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
127729079|NCT03884478|459632088|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
127729080|NCT03884478|459632086|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
127729081|NCT03884478|459632087|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
127729082|NCT03884478|459632088|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
127729083|NCT02213094|459632089|FG000|Overall Study|Adverse Event|1|||
127729084|NCT02213094|459632090|FG001|Overall Study|Adverse Event|0|||
127729085|NCT04454125|459632091|FG000|Overall Study|Lost to Follow-up|0|||
127729086|NCT04454125|459632092|FG001|Overall Study|Lost to Follow-up|1|||
127729087|NCT00828139|459632098|FG000|Overall Study|Adverse Event|8|||
127729088|NCT00828139|459632099|FG001|Overall Study|Adverse Event|1|||
127729089|NCT00828139|459632100|FG002|Overall Study|Adverse Event|10|||
127729090|NCT00828139|459632101|FG003|Overall Study|Adverse Event|5|||
127729091|NCT00828139|459632098|FG000|Overall Study|Death|2|||
127729092|NCT00828139|459632099|FG001|Overall Study|Death|1|||
127729093|NCT00828139|459632100|FG002|Overall Study|Death|0|||
127729094|NCT00828139|459632101|FG003|Overall Study|Death|2|||
127729095|NCT00828139|459632098|FG000|Overall Study|Refusal unrelated to toxicity|3|||
127729096|NCT00828139|459632099|FG001|Overall Study|Refusal unrelated to toxicity|4|||
127729097|NCT00828139|459632100|FG002|Overall Study|Refusal unrelated to toxicity|5|||
127729098|NCT00828139|459632101|FG003|Overall Study|Refusal unrelated to toxicity|3|||
127729099|NCT00828139|459632098|FG000|Overall Study|Disease Progression|24|||
127729100|NCT00828139|459632099|FG001|Overall Study|Disease Progression|33|||
127729101|NCT00828139|459632100|FG002|Overall Study|Disease Progression|35|||
127729102|NCT00828139|459632101|FG003|Overall Study|Disease Progression|39|||
127729103|NCT00828139|459632098|FG000|Overall Study|Other|4|||
127890019|NCT03210259|460219951|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
127729104|NCT00828139|459632099|FG001|Overall Study|Other|2|||
127729105|NCT00828139|459632100|FG002|Overall Study|Other|5|||
127729106|NCT00828139|459632101|FG003|Overall Study|Other|2|||
127729107|NCT01714947|459632102|FG000|Part B|Progressive Disease|3|||
127729108|NCT01922102|459632103|FG000|Overall Study|Withdrawal by Subject|7|||
127729109|NCT01922102|459632104|FG001|Overall Study|Withdrawal by Subject|3|||
127729110|NCT01922102|459632105|FG002|Overall Study|Withdrawal by Subject|7|||
127729111|NCT01922102|459632103|FG000|Overall Study|Physician Decision|0|||
127729112|NCT01922102|459632104|FG001|Overall Study|Physician Decision|2|||
127729113|NCT01922102|459632105|FG002|Overall Study|Physician Decision|1|||
127729114|NCT01922102|459632103|FG000|Overall Study|Adverse Event|1|||
127729115|NCT01922102|459632104|FG001|Overall Study|Adverse Event|2|||
127729116|NCT01922102|459632105|FG002|Overall Study|Adverse Event|0|||
127729117|NCT01922102|459632103|FG000|Overall Study|Lost to Follow-up|1|||
127729118|NCT01922102|459632104|FG001|Overall Study|Lost to Follow-up|0|||
127729119|NCT01922102|459632105|FG002|Overall Study|Lost to Follow-up|0|||
127729120|NCT01922102|459632103|FG000|Overall Study|Administrative problems|0|||
127729121|NCT01922102|459632104|FG001|Overall Study|Administrative problems|2|||
127729122|NCT01922102|459632105|FG002|Overall Study|Administrative problems|0|||
127729123|NCT01320683|459632107|FG000|Overall Study|Positive antibody response|1|||
127729124|NCT00759681|459632108|FG000|Overall Study|Death|2|||
127729125|NCT00759681|459632109|FG001|Overall Study|Death|5|||
127729126|NCT00759681|459632108|FG000|Overall Study|Lost to Follow-up|8|||
127729127|NCT00759681|459632109|FG001|Overall Study|Lost to Follow-up|5|||
127729128|NCT00476151|459632110|FG000|Overall Study|Adverse Event|0|||
127729129|NCT00476151|459632111|FG001|Overall Study|Adverse Event|2|||
127729130|NCT00476151|459632110|FG000|Overall Study|Protocol Violation|1|||
127729131|NCT00476151|459632111|FG001|Overall Study|Protocol Violation|3|||
127729132|NCT00476151|459632110|FG000|Overall Study|Withdrawal by Subject|2|||
127729133|NCT00476151|459632111|FG001|Overall Study|Withdrawal by Subject|0|||
127729134|NCT00476151|459632110|FG000|Overall Study|Physician Decision|0|||
127729135|NCT00476151|459632111|FG001|Overall Study|Physician Decision|2|||
127729136|NCT00096278|459632116|FG000|Overall Study|No follow-up data|15|||
127729137|NCT00096278|459632117|FG001|Overall Study|No follow-up data|18|||
127729138|NCT00096278|459632116|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
127729139|NCT00096278|459632117|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
127729140|NCT00821093|459632118|FG000|Overall Study|Adverse Event|20|||
127729141|NCT00821093|459632119|FG001|Overall Study|Adverse Event|12|||
127729142|NCT00821093|459632118|FG000|Overall Study|Withdrawal by Subject|9|||
127729143|NCT00821093|459632119|FG001|Overall Study|Withdrawal by Subject|13|||
127729144|NCT00821093|459632118|FG000|Overall Study|Lost to Follow-up|9|||
127729145|NCT00821093|459632119|FG001|Overall Study|Lost to Follow-up|3|||
127729146|NCT00821093|459632118|FG000|Overall Study|Protocol deviation|3|||
127729147|NCT00821093|459632119|FG001|Overall Study|Protocol deviation|6|||
127729148|NCT00821093|459632118|FG000|Overall Study|Abnormal laboratory value(s)|2|||
127729149|NCT00821093|459632119|FG001|Overall Study|Abnormal laboratory value(s)|0|||
127729150|NCT00821093|459632118|FG000|Overall Study|Lack of Efficacy|2|||
127729151|NCT00821093|459632119|FG001|Overall Study|Lack of Efficacy|2|||
127729152|NCT00821093|459632118|FG000|Overall Study|Death|2|||
127729153|NCT00821093|459632119|FG001|Overall Study|Death|1|||
127729154|NCT00821093|459632118|FG000|Overall Study|Abnormal test procedure result(s)|1|||
127729155|NCT00821093|459632119|FG001|Overall Study|Abnormal test procedure result(s)|1|||
127729156|NCT00821093|459632118|FG000|Overall Study|Administrative problems|1|||
127729157|NCT00821093|459632119|FG001|Overall Study|Administrative problems|2|||
127729158|NCT01894620|459632120|FG000|Overall Study|Withdrawal by Subject|0|||
127729159|NCT01894620|459632121|FG001|Overall Study|Withdrawal by Subject|1|||
127729160|NCT05265247|459632126|FG000|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|1|||
127729161|NCT05265247|459632127|FG001|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|3|||
127729162|NCT05265247|459632126|FG000|Washout Period (7 Days)|Withdrawal by Subject|0|||
127729163|NCT05265247|459632127|FG001|Washout Period (7 Days)|Withdrawal by Subject|1|||
127729164|NCT05265247|459632126|FG000|Washout Period (7 Days)|Non-compliance with study requirements|3|||
127729165|NCT05265247|459632127|FG001|Washout Period (7 Days)|Non-compliance with study requirements|3|||
127729166|NCT00134056|459632130|FG000|Randomization|Not eligible for assigned treatment|22|||
127729167|NCT00134056|459632131|FG001|Randomization|Not eligible for assigned treatment|20|||
127729168|NCT00134056|459632130|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
127729169|NCT00134056|459632131|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
127729170|NCT00134056|459632130|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
127729171|NCT00134056|459632131|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
127890020|NCT03210259|460219952|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
127729172|NCT00134056|459632130|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
127729173|NCT00134056|459632131|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
127729174|NCT00134056|459632130|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
127729175|NCT00134056|459632131|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
127729176|NCT02555397|459632135|FG000|Overall Study|Withdrawal by Subject|1|||
127729177|NCT02555397|459632136|FG001|Overall Study|Withdrawal by Subject|0|||
127729178|NCT02555397|459632137|FG002|Overall Study|Withdrawal by Subject|0|||
127729179|NCT02555397|459632138|FG003|Overall Study|Withdrawal by Subject|0|||
127729180|NCT02555397|459632139|FG004|Overall Study|Withdrawal by Subject|0|||
127729181|NCT00537914|459632143|FG000|Overall Study|Death|1|||
127729182|NCT00537914|459632143|FG000|Overall Study|Adverse Event|7|||
127729183|NCT00537914|459632143|FG000|Overall Study|Treatment failure|10|||
127729184|NCT00537914|459632143|FG000|Overall Study|patients documented other as reason for study discontinuation|16|||
127729185|NCT00537914|459632143|FG000|Overall Study|Lost to Follow-up|19|||
127729186|NCT00537914|459632143|FG000|Overall Study|Withdrawal of informed consent|59|||
127729187|NCT02312258|459632144|FG000|Overall Study|Lost to Follow-up|8|||
127729188|NCT02312258|459632145|FG001|Overall Study|Lost to Follow-up|8|||
127729189|NCT02312258|459632144|FG000|Overall Study|Withdrawal by Patient|49|||
127729190|NCT02312258|459632145|FG001|Overall Study|Withdrawal by Patient|76|||
127729191|NCT02312258|459632144|FG000|Overall Study|Reason not Specified|107|||
127729192|NCT02312258|459632145|FG001|Overall Study|Reason not Specified|159|||
127729193|NCT02312258|459632144|FG000|Overall Study|Missing|2|||
127729194|NCT02312258|459632145|FG001|Overall Study|Missing|1|||
127729195|NCT02312258|459632144|FG000|Overall Study|Death|115|||
127729196|NCT02312258|459632145|FG001|Overall Study|Death|181|||
127729197|NCT01468597|459632147|FG000|Overall Study|Found ineligible|17|||
127729198|NCT01468597|459632147|FG000|Overall Study|concomitant valves|12|||
127729199|NCT01468597|459632147|FG000|Overall Study|off-pump CABG|1|||
127729200|NCT01468597|459632147|FG000|Overall Study|no platelet function data|5|||
127729201|NCT02260154|459632148|FG000|Overall Study|Screening failure|2|||
127729202|NCT02561195|459632150|FG000|Vaccination 1 to 3|Adverse Event|4|||
127729203|NCT02561195|459632151|FG001|Vaccination 1 to 3|Adverse Event|5|||
127729204|NCT02561195|459632152|FG002|Vaccination 1 to 3|Adverse Event|0|||
127729205|NCT02561195|459632153|FG003|Vaccination 1 to 3|Adverse Event|3|||
127729206|NCT02561195|459632154|FG004|Vaccination 1 to 3|Adverse Event|4|||
127729207|NCT02561195|459632155|FG005|Vaccination 1 to 3|Adverse Event|0|||
127729208|NCT02561195|459632156|FG006|Vaccination 1 to 3|Adverse Event|0|||
127729209|NCT02561195|459632157|FG007|Vaccination 1 to 3|Adverse Event|0|||
127729210|NCT02561195|459632158|FG008|Vaccination 1 to 3|Adverse Event|0|||
127729211|NCT02561195|459632159|FG009|Vaccination 1 to 3|Adverse Event|0|||
127729212|NCT02561195|459632160|FG010|Vaccination 1 to 3|Adverse Event|0|||
127803345|NCT04660643|459903636|FG002|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
127803346|NCT04660643|459903634|FG000|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|1|||
127803347|NCT04660643|459903635|FG001|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
127803348|NCT04660643|459903636|FG002|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
127803349|NCT04660643|459903634|FG000|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|1|||
127729213|NCT02561195|459632161|FG011|Vaccination 1 to 3|Adverse Event|0|||
127803350|NCT04660643|459903635|FG001|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
127803351|NCT04660643|459903636|FG002|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
127803352|NCT04660643|459903634|FG000|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|10|||
127803353|NCT04660643|459903635|FG001|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
127803354|NCT04660643|459903636|FG002|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
127803355|NCT04660643|459903634|FG000|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|32|||
127803356|NCT04660643|459903635|FG001|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
127803357|NCT04660643|459903636|FG002|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
127803358|NCT04660643|459903634|FG000|Open-label Lead-in Period (Week 0 - 36)|Covid-19|1|||
127803359|NCT04660643|459903635|FG001|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
127803360|NCT04660643|459903636|FG002|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
127729214|NCT02561195|459632162|FG012|Vaccination 1 to 3|Adverse Event|0|||
127729215|NCT02561195|459632163|FG013|Vaccination 1 to 3|Adverse Event|0|||
127729216|NCT02561195|459632150|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
127729217|NCT02561195|459632151|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
127729218|NCT02561195|459632152|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
127729219|NCT02561195|459632153|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
127729220|NCT02561195|459632154|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
127890021|NCT02110706|460219953|FG000|Overall Study|Adverse Event|2|||
127729221|NCT02561195|459632155|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
127729222|NCT02561195|459632156|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
127890022|NCT02110706|460219954|FG001|Overall Study|Adverse Event|3|||
127729223|NCT02561195|459632157|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
127729224|NCT02561195|459632158|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
127729225|NCT02561195|459632159|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
127729226|NCT02561195|459632160|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
127729227|NCT02561195|459632161|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
127729228|NCT02561195|459632162|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
127729229|NCT02561195|459632163|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
127729230|NCT02561195|459632150|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
127729231|NCT02561195|459632151|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
127729232|NCT02561195|459632152|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
127729233|NCT02561195|459632153|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
127729234|NCT02561195|459632154|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
127729235|NCT02561195|459632155|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
127729236|NCT02561195|459632156|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
127729237|NCT02561195|459632157|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
127729238|NCT02561195|459632158|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
127729239|NCT02561195|459632159|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
127729240|NCT02561195|459632160|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
127729241|NCT02561195|459632161|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
127729242|NCT02561195|459632162|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
127729243|NCT02561195|459632163|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
127729244|NCT02561195|459632150|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
127729245|NCT02561195|459632151|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
127729246|NCT02561195|459632152|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
127729247|NCT02561195|459632153|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
127729248|NCT02561195|459632154|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
127729249|NCT02561195|459632155|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
127729250|NCT02561195|459632156|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
127729251|NCT02561195|459632157|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
127729252|NCT02561195|459632158|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
127729253|NCT02561195|459632159|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
127729254|NCT02561195|459632160|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
127729255|NCT02561195|459632161|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
127729256|NCT02561195|459632162|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
127729257|NCT02561195|459632163|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
127729258|NCT02561195|459632150|FG000|Vaccination 1 to 3|Other|7|||
127729259|NCT02561195|459632151|FG001|Vaccination 1 to 3|Other|3|||
127729260|NCT02561195|459632152|FG002|Vaccination 1 to 3|Other|1|||
127729261|NCT02561195|459632153|FG003|Vaccination 1 to 3|Other|7|||
127729262|NCT02561195|459632154|FG004|Vaccination 1 to 3|Other|5|||
127729263|NCT02561195|459632155|FG005|Vaccination 1 to 3|Other|1|||
127729264|NCT02561195|459632156|FG006|Vaccination 1 to 3|Other|0|||
127729265|NCT02561195|459632157|FG007|Vaccination 1 to 3|Other|0|||
127729266|NCT02561195|459632158|FG008|Vaccination 1 to 3|Other|0|||
127729267|NCT02561195|459632159|FG009|Vaccination 1 to 3|Other|0|||
127729268|NCT02561195|459632160|FG010|Vaccination 1 to 3|Other|0|||
127729269|NCT02561195|459632161|FG011|Vaccination 1 to 3|Other|0|||
127729270|NCT02561195|459632162|FG012|Vaccination 1 to 3|Other|0|||
127729271|NCT02561195|459632163|FG013|Vaccination 1 to 3|Other|0|||
127729272|NCT02561195|459632150|FG000|Vaccination 1 to 3|Protocol Violation|1|||
127729273|NCT02561195|459632151|FG001|Vaccination 1 to 3|Protocol Violation|0|||
127729274|NCT02561195|459632152|FG002|Vaccination 1 to 3|Protocol Violation|1|||
127729275|NCT02561195|459632153|FG003|Vaccination 1 to 3|Protocol Violation|2|||
127729276|NCT02561195|459632154|FG004|Vaccination 1 to 3|Protocol Violation|5|||
127729277|NCT02561195|459632155|FG005|Vaccination 1 to 3|Protocol Violation|2|||
127729278|NCT02561195|459632156|FG006|Vaccination 1 to 3|Protocol Violation|0|||
127729279|NCT02561195|459632157|FG007|Vaccination 1 to 3|Protocol Violation|0|||
127729280|NCT02561195|459632158|FG008|Vaccination 1 to 3|Protocol Violation|0|||
127729281|NCT02561195|459632159|FG009|Vaccination 1 to 3|Protocol Violation|0|||
127729282|NCT02561195|459632160|FG010|Vaccination 1 to 3|Protocol Violation|0|||
127729283|NCT02561195|459632161|FG011|Vaccination 1 to 3|Protocol Violation|0|||
127729284|NCT02561195|459632162|FG012|Vaccination 1 to 3|Protocol Violation|0|||
127729285|NCT02561195|459632163|FG013|Vaccination 1 to 3|Protocol Violation|0|||
127729286|NCT02561195|459632150|FG000|Vaccination 1 to 3|Death|2|||
127729287|NCT02561195|459632151|FG001|Vaccination 1 to 3|Death|1|||
127729288|NCT02561195|459632152|FG002|Vaccination 1 to 3|Death|0|||
127729289|NCT02561195|459632153|FG003|Vaccination 1 to 3|Death|2|||
127729290|NCT02561195|459632154|FG004|Vaccination 1 to 3|Death|0|||
127729291|NCT02561195|459632155|FG005|Vaccination 1 to 3|Death|0|||
127803361|NCT04660643|459903634|FG000|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|2|||
127803362|NCT04660643|459903635|FG001|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
127803363|NCT04660643|459903636|FG002|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
127803364|NCT04660643|459903634|FG000|Double-blind Study Period (Week 36 - 92)|Death|0|||
127803365|NCT04660643|459903635|FG001|Double-blind Study Period (Week 36 - 92)|Death|1|||
127803366|NCT04660643|459903636|FG002|Double-blind Study Period (Week 36 - 92)|Death|1|||
127803367|NCT04660643|459903634|FG000|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|0|||
127803368|NCT04660643|459903635|FG001|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|10|||
127803369|NCT04660643|459903636|FG002|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|8|||
127803370|NCT04660643|459903634|FG000|Double-blind Study Period (Week 36 - 92)|Pregnancy|0|||
127803371|NCT04660643|459903635|FG001|Double-blind Study Period (Week 36 - 92)|Pregnancy|2|||
127803372|NCT04660643|459903636|FG002|Double-blind Study Period (Week 36 - 92)|Pregnancy|1|||
127803373|NCT04660643|459903634|FG000|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|0|||
127803374|NCT04660643|459903635|FG001|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|22|||
127803375|NCT04660643|459903636|FG002|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|13|||
127803376|NCT04660643|459903634|FG000|Double-blind Study Period (Week 36 - 92)|Protocol deviation|0|||
127803377|NCT04660643|459903635|FG001|Double-blind Study Period (Week 36 - 92)|Protocol deviation|1|||
127803378|NCT04660643|459903636|FG002|Double-blind Study Period (Week 36 - 92)|Protocol deviation|2|||
127803379|NCT04660643|459903634|FG000|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
127803380|NCT04660643|459903635|FG001|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|8|||
127803381|NCT04660643|459903636|FG002|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
127803382|NCT04660643|459903634|FG000|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
127803383|NCT04660643|459903635|FG001|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|1|||
127803384|NCT04660643|459903636|FG002|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
127803385|NCT03988907|459903637|FG000|Overall Study|Unable to complete visit|0|||
127803386|NCT03988907|459903638|FG001|Overall Study|Unable to complete visit|1|||
127803387|NCT02810964|459903639|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
127803388|NCT02810964|459903640|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
127729292|NCT02561195|459632156|FG006|Vaccination 1 to 3|Death|0|||
127729293|NCT02561195|459632157|FG007|Vaccination 1 to 3|Death|0|||
127729294|NCT02561195|459632158|FG008|Vaccination 1 to 3|Death|0|||
127729295|NCT02561195|459632159|FG009|Vaccination 1 to 3|Death|0|||
127729296|NCT02561195|459632160|FG010|Vaccination 1 to 3|Death|0|||
127729297|NCT02561195|459632161|FG011|Vaccination 1 to 3|Death|0|||
127729298|NCT02561195|459632162|FG012|Vaccination 1 to 3|Death|0|||
127729299|NCT02561195|459632163|FG013|Vaccination 1 to 3|Death|0|||
127729300|NCT02561195|459632150|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
127729301|NCT02561195|459632151|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
127729302|NCT02561195|459632152|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
127729303|NCT02561195|459632153|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
127729304|NCT02561195|459632154|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
127729305|NCT02561195|459632155|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
127729306|NCT02561195|459632156|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
127729307|NCT02561195|459632157|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
127729308|NCT02561195|459632158|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
127729309|NCT02561195|459632159|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
127729310|NCT02561195|459632160|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
127729311|NCT02561195|459632161|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
127729312|NCT02561195|459632162|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
127729313|NCT02561195|459632163|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
127729314|NCT02561195|459632150|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
127729315|NCT02561195|459632151|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
127729316|NCT02561195|459632152|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
127729317|NCT02561195|459632153|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
127729318|NCT02561195|459632154|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
127729319|NCT02561195|459632155|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
127729320|NCT02561195|459632156|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
127729321|NCT02561195|459632157|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
127729322|NCT02561195|459632158|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
127729323|NCT02561195|459632159|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
127729324|NCT02561195|459632160|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
127729325|NCT02561195|459632161|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
127729326|NCT02561195|459632162|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
127803389|NCT02810964|459903639|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
127729327|NCT02561195|459632163|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
127729328|NCT02561195|459632150|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
127729329|NCT02561195|459632151|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
127729330|NCT02561195|459632152|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
127729331|NCT02561195|459632153|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
127729332|NCT02561195|459632154|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
127729333|NCT02561195|459632155|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
127729334|NCT02561195|459632156|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
127729335|NCT02561195|459632157|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
127729336|NCT02561195|459632158|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
127729337|NCT02561195|459632159|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
127729338|NCT02561195|459632160|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
127729339|NCT02561195|459632161|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
127729340|NCT02561195|459632162|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
127729341|NCT02561195|459632163|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
127729342|NCT02561195|459632150|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
127729343|NCT02561195|459632151|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
127729344|NCT02561195|459632152|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
127729345|NCT02561195|459632153|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
127729346|NCT02561195|459632154|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
127729347|NCT02561195|459632155|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
127729348|NCT02561195|459632156|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
127729349|NCT02561195|459632157|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
127729350|NCT02561195|459632158|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
127729351|NCT02561195|459632159|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
127729352|NCT02561195|459632160|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
127729353|NCT02561195|459632161|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
127729354|NCT02561195|459632162|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
127729355|NCT02561195|459632163|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
127729356|NCT02561195|459632150|FG000|Extension Stage (Vaccination 4)|Death|0|||
127729357|NCT02561195|459632151|FG001|Extension Stage (Vaccination 4)|Death|0|||
127729358|NCT02561195|459632152|FG002|Extension Stage (Vaccination 4)|Death|0|||
127729359|NCT02561195|459632153|FG003|Extension Stage (Vaccination 4)|Death|0|||
127729360|NCT02561195|459632154|FG004|Extension Stage (Vaccination 4)|Death|0|||
127729361|NCT02561195|459632155|FG005|Extension Stage (Vaccination 4)|Death|0|||
127729362|NCT02561195|459632156|FG006|Extension Stage (Vaccination 4)|Death|0|||
127729363|NCT02561195|459632157|FG007|Extension Stage (Vaccination 4)|Death|0|||
127729364|NCT02561195|459632158|FG008|Extension Stage (Vaccination 4)|Death|0|||
127729365|NCT02561195|459632159|FG009|Extension Stage (Vaccination 4)|Death|1|||
127729366|NCT02561195|459632160|FG010|Extension Stage (Vaccination 4)|Death|0|||
127729367|NCT02561195|459632161|FG011|Extension Stage (Vaccination 4)|Death|0|||
127729368|NCT02561195|459632162|FG012|Extension Stage (Vaccination 4)|Death|0|||
127729369|NCT02561195|459632163|FG013|Extension Stage (Vaccination 4)|Death|0|||
127729370|NCT02561195|459632150|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
127729371|NCT02561195|459632151|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
127729372|NCT02561195|459632152|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
127729373|NCT02561195|459632153|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
127729374|NCT02561195|459632154|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
127729375|NCT02561195|459632155|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
127729376|NCT02561195|459632156|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
127729377|NCT02561195|459632157|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
127729378|NCT02561195|459632158|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
127729379|NCT02561195|459632159|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
127729380|NCT02561195|459632160|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
127729381|NCT02561195|459632161|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
127729382|NCT02561195|459632162|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
127729383|NCT02561195|459632163|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
127729384|NCT02561195|459632150|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
127729385|NCT02561195|459632151|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
127729386|NCT02561195|459632152|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
127729387|NCT02561195|459632153|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
127729388|NCT02561195|459632154|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
127729389|NCT02561195|459632155|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
127729390|NCT02561195|459632156|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
127729391|NCT02561195|459632157|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
127729392|NCT02561195|459632158|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
127729393|NCT02561195|459632159|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
127803390|NCT02810964|459903640|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
127803391|NCT02810964|459903639|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
127729394|NCT02561195|459632160|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
127729395|NCT02561195|459632161|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
127729396|NCT02561195|459632162|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
127729397|NCT02561195|459632163|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
127729398|NCT02561195|459632150|FG000|Extension Stage (Vaccination 4)|Other|0|||
127729399|NCT02561195|459632151|FG001|Extension Stage (Vaccination 4)|Other|0|||
127729400|NCT02561195|459632152|FG002|Extension Stage (Vaccination 4)|Other|0|||
127729401|NCT02561195|459632153|FG003|Extension Stage (Vaccination 4)|Other|0|||
127729402|NCT02561195|459632154|FG004|Extension Stage (Vaccination 4)|Other|0|||
127729403|NCT02561195|459632155|FG005|Extension Stage (Vaccination 4)|Other|0|||
127729404|NCT02561195|459632156|FG006|Extension Stage (Vaccination 4)|Other|0|||
127729405|NCT02561195|459632157|FG007|Extension Stage (Vaccination 4)|Other|0|||
127729406|NCT02561195|459632158|FG008|Extension Stage (Vaccination 4)|Other|0|||
127729407|NCT02561195|459632159|FG009|Extension Stage (Vaccination 4)|Other|0|||
127729408|NCT02561195|459632160|FG010|Extension Stage (Vaccination 4)|Other|2|||
127729409|NCT02561195|459632161|FG011|Extension Stage (Vaccination 4)|Other|2|||
127729410|NCT02561195|459632162|FG012|Extension Stage (Vaccination 4)|Other|1|||
127729411|NCT02561195|459632163|FG013|Extension Stage (Vaccination 4)|Other|0|||
127729412|NCT02561195|459632150|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
127729413|NCT02561195|459632151|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
127729414|NCT02561195|459632152|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
127729415|NCT02561195|459632153|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
127729416|NCT02561195|459632154|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
127729417|NCT02561195|459632155|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
127729418|NCT02561195|459632156|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
127729419|NCT02561195|459632157|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
127729420|NCT02561195|459632158|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
127729421|NCT02561195|459632159|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
127729422|NCT02561195|459632160|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
127729423|NCT02561195|459632161|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
127729424|NCT02561195|459632162|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
127729425|NCT02561195|459632163|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
127729426|NCT01199302|459632169|FG000|Overall Study|Adverse Event|1|||
127729427|NCT01199302|459632170|FG001|Overall Study|Adverse Event|1|||
127729428|NCT01199302|459632171|FG002|Overall Study|Adverse Event|2|||
127729429|NCT01199302|459632172|FG003|Overall Study|Adverse Event|0|||
127729430|NCT01199302|459632169|FG000|Overall Study|Withdrawal by Subject|2|||
127729431|NCT01199302|459632170|FG001|Overall Study|Withdrawal by Subject|2|||
127729432|NCT01199302|459632171|FG002|Overall Study|Withdrawal by Subject|3|||
127729433|NCT01199302|459632172|FG003|Overall Study|Withdrawal by Subject|0|||
127729434|NCT01199302|459632169|FG000|Overall Study|Disease Progression|3|||
127729435|NCT01199302|459632170|FG001|Overall Study|Disease Progression|4|||
127729436|NCT01199302|459632171|FG002|Overall Study|Disease Progression|4|||
127729437|NCT01199302|459632172|FG003|Overall Study|Disease Progression|2|||
127729438|NCT01199302|459632169|FG000|Overall Study|Study Termination|13|||
127729439|NCT01199302|459632170|FG001|Overall Study|Study Termination|8|||
127729440|NCT01199302|459632171|FG002|Overall Study|Study Termination|11|||
127729441|NCT01199302|459632172|FG003|Overall Study|Study Termination|9|||
127729442|NCT01199302|459632169|FG000|Overall Study|Lost to Follow-up|0|||
127729443|NCT01199302|459632170|FG001|Overall Study|Lost to Follow-up|1|||
127729444|NCT01199302|459632171|FG002|Overall Study|Lost to Follow-up|0|||
127729445|NCT01199302|459632172|FG003|Overall Study|Lost to Follow-up|0|||
127729446|NCT01199302|459632169|FG000|Overall Study|Other|1|||
127729447|NCT01199302|459632170|FG001|Overall Study|Other|0|||
127729448|NCT01199302|459632171|FG002|Overall Study|Other|0|||
127729449|NCT01199302|459632172|FG003|Overall Study|Other|0|||
127729450|NCT01634165|459632175|FG000|Period 2|Adverse Event|0|||
127729451|NCT01634165|459632176|FG001|Period 2|Adverse Event|1|||
127729452|NCT01634165|459632177|FG002|Period 2|Adverse Event|0|||
127729453|NCT01634165|459632178|FG003|Period 2|Adverse Event|0|||
127729454|NCT03820024|459632179|FG000|Overall Study|Physician Decision|1|||
127729455|NCT03820024|459632180|FG001|Overall Study|Physician Decision|2|||
127729456|NCT00946998|459633751|FG000|Overall Study|Exited prior to first outcome assessment|5|||
127729457|NCT00946998|459633752|FG001|Overall Study|Exited prior to first outcome assessment|3|||
127729458|NCT03978130|459633755|FG000|Overall Study|Lost to Follow-up|13|||
127729459|NCT03978130|459633756|FG001|Overall Study|Lost to Follow-up|14|||
127729460|NCT03978130|459633755|FG000|Overall Study|Withdrawal by Subject|12|||
127729461|NCT03978130|459633756|FG001|Overall Study|Withdrawal by Subject|2|||
127729462|NCT03978130|459633755|FG000|Overall Study|Adverse Event|2|||
127729463|NCT03978130|459633756|FG001|Overall Study|Adverse Event|1|||
127729464|NCT00304278|459633758|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
127729465|NCT00304278|459633758|FG000|Overall Study|PT had medical condition preventing TX|1|||
127729466|NCT00507429|459633759|FG000|Treatment Phase|Disease Progression|12|||
127729467|NCT00507429|459633760|FG001|Treatment Phase|Disease Progression|5|||
127729468|NCT00507429|459633759|FG000|Treatment Phase|Adverse Event|12|||
127729469|NCT00507429|459633760|FG001|Treatment Phase|Adverse Event|5|||
127729470|NCT00507429|459633759|FG000|Treatment Phase|Withdrawal by Subject|3|||
127729471|NCT00507429|459633760|FG001|Treatment Phase|Withdrawal by Subject|3|||
127729472|NCT00507429|459633759|FG000|Treatment Phase|Physician Decision|4|||
127729473|NCT00507429|459633760|FG001|Treatment Phase|Physician Decision|2|||
127729474|NCT00507429|459633759|FG000|Treatment Phase|Other|6|||
127729475|NCT00507429|459633760|FG001|Treatment Phase|Other|3|||
127729476|NCT00507429|459633759|FG000|Maintenance Phase|Progressive Disease|14|||
127729477|NCT00507429|459633760|FG001|Maintenance Phase|Progressive Disease|0|||
127729478|NCT04025762|459633762|FG000|Crossover Study Period 1 (16 Weeks)|Death|0|||
127729479|NCT04025762|459633763|FG001|Crossover Study Period 1 (16 Weeks)|Death|1|||
127729480|NCT01807234|459633769|FG000|Overall Study|Lost to Follow-up|2|||
127729481|NCT01807234|459633770|FG001|Overall Study|Lost to Follow-up|5|||
127729482|NCT01807234|459633771|FG002|Overall Study|Lost to Follow-up|1|||
127729483|NCT01807234|459633772|FG003|Overall Study|Lost to Follow-up|1|||
127729484|NCT01807234|459633773|FG004|Overall Study|Lost to Follow-up|1|||
127729485|NCT01807234|459633774|FG005|Overall Study|Lost to Follow-up|2|||
127729486|NCT01807234|459633769|FG000|Overall Study|Withdrawal by Subject|3|||
127729487|NCT01807234|459633770|FG001|Overall Study|Withdrawal by Subject|1|||
127729488|NCT01807234|459633771|FG002|Overall Study|Withdrawal by Subject|1|||
127729489|NCT01807234|459633772|FG003|Overall Study|Withdrawal by Subject|1|||
127729490|NCT01807234|459633773|FG004|Overall Study|Withdrawal by Subject|2|||
127729491|NCT01807234|459633774|FG005|Overall Study|Withdrawal by Subject|1|||
127729492|NCT01807234|459633769|FG000|Overall Study|Lack of Efficacy|0|||
127729493|NCT01807234|459633770|FG001|Overall Study|Lack of Efficacy|0|||
127729494|NCT01807234|459633771|FG002|Overall Study|Lack of Efficacy|0|||
127729495|NCT01807234|459633772|FG003|Overall Study|Lack of Efficacy|0|||
127729496|NCT01807234|459633773|FG004|Overall Study|Lack of Efficacy|1|||
127729497|NCT01807234|459633774|FG005|Overall Study|Lack of Efficacy|1|||
127729498|NCT00538629|459633775|FG000|Overall Study|At subject's request|1|||
127729499|NCT00538629|459633775|FG000|Overall Study|Adverse Event|2|||
127729500|NCT00538629|459633775|FG000|Overall Study|Lack of Efficacy|12|||
127729501|NCT00538629|459633775|FG000|Overall Study|Lost to Follow-up|6|||
127729502|NCT00538629|459633775|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
127729503|NCT00555620|459633776|FG000|Overall Study|Death|0|||
127729504|NCT00555620|459633777|FG001|Overall Study|Death|1|||
127729505|NCT00555620|459633778|FG002|Overall Study|Death|0|||
127729506|NCT00555620|459633779|FG003|Overall Study|Death|0|||
127729507|NCT00555620|459633780|FG004|Overall Study|Death|0|||
127729508|NCT00555620|459633781|FG005|Overall Study|Death|1|||
127729509|NCT00555620|459633776|FG000|Overall Study|Study terminated by sponsor|0|||
127729510|NCT00555620|459633777|FG001|Overall Study|Study terminated by sponsor|0|||
127729511|NCT00555620|459633778|FG002|Overall Study|Study terminated by sponsor|1|||
127729512|NCT00555620|459633779|FG003|Overall Study|Study terminated by sponsor|0|||
127729513|NCT00555620|459633780|FG004|Overall Study|Study terminated by sponsor|0|||
127729514|NCT00555620|459633781|FG005|Overall Study|Study terminated by sponsor|0|||
127729515|NCT00555620|459633776|FG000|Overall Study|Adverse Event|0|||
127729516|NCT00555620|459633777|FG001|Overall Study|Adverse Event|0|||
127729517|NCT00555620|459633778|FG002|Overall Study|Adverse Event|1|||
127729518|NCT00555620|459633779|FG003|Overall Study|Adverse Event|5|||
127729519|NCT00555620|459633780|FG004|Overall Study|Adverse Event|0|||
127729520|NCT00555620|459633781|FG005|Overall Study|Adverse Event|1|||
127803392|NCT02810964|459903640|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
127803393|NCT02810964|459903639|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
127729521|NCT00555620|459633776|FG000|Overall Study|Objective progression or relapse|6|||
127729522|NCT00555620|459633777|FG001|Overall Study|Objective progression or relapse|5|||
127729523|NCT00555620|459633778|FG002|Overall Study|Objective progression or relapse|12|||
127729524|NCT00555620|459633779|FG003|Overall Study|Objective progression or relapse|17|||
127729525|NCT00555620|459633780|FG004|Overall Study|Objective progression or relapse|3|||
127729526|NCT00555620|459633781|FG005|Overall Study|Objective progression or relapse|16|||
127729527|NCT00555620|459633776|FG000|Overall Study|Participant refused treatment|0|||
127729528|NCT00555620|459633777|FG001|Overall Study|Participant refused treatment|1|||
127729529|NCT00555620|459633778|FG002|Overall Study|Participant refused treatment|1|||
127729530|NCT00555620|459633779|FG003|Overall Study|Participant refused treatment|0|||
127729531|NCT00555620|459633780|FG004|Overall Study|Participant refused treatment|0|||
127729532|NCT00555620|459633781|FG005|Overall Study|Participant refused treatment|1|||
127729533|NCT00555620|459633776|FG000|Overall Study|Other|0|||
127729534|NCT00555620|459633777|FG001|Overall Study|Other|0|||
127729535|NCT00555620|459633778|FG002|Overall Study|Other|0|||
127729536|NCT00555620|459633779|FG003|Overall Study|Other|1|||
127729537|NCT00555620|459633780|FG004|Overall Study|Other|0|||
127729538|NCT00555620|459633781|FG005|Overall Study|Other|3|||
127729539|NCT05203822|459633782|FG000|Overall Study|Adverse Event|1|||
127729540|NCT05203822|459633782|FG000|Overall Study|Withdrawal by Subject|1|||
127729541|NCT01345253|459633783|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
127729542|NCT01345253|459633784|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
127729543|NCT01345253|459633783|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
127729544|NCT01345253|459633784|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
127729545|NCT01345253|459633783|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
127729546|NCT01345253|459633784|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
127729547|NCT01345253|459633783|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
127729548|NCT01345253|459633784|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
127729549|NCT01345253|459633783|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
127729550|NCT01345253|459633784|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
127729551|NCT01345253|459633783|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
127729552|NCT01345253|459633784|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
127729553|NCT01345253|459633783|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
127729554|NCT01345253|459633784|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
127729555|NCT01345253|459633783|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
127729556|NCT01345253|459633784|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
127729557|NCT01345253|459633783|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
127729558|NCT01345253|459633784|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
127729559|NCT01345253|459633783|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
127729560|NCT01345253|459633784|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
127729561|NCT01345253|459633783|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
127729562|NCT01345253|459633784|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
127729563|NCT01345253|459633783|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
127729564|NCT01345253|459633784|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
127729565|NCT01345253|459633783|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
127729566|NCT01345253|459633784|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
127729567|NCT01345253|459633783|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
127729568|NCT01345253|459633784|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
127729569|NCT01345253|459633783|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
127729570|NCT01345253|459633784|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
127729571|NCT01767376|459633791|FG000|Overall Study|Lost to Follow-up|3|||
127729572|NCT01767376|459633792|FG001|Overall Study|Lost to Follow-up|2|||
127729573|NCT01767376|459633793|FG002|Overall Study|Lost to Follow-up|0|||
127729574|NCT01767376|459633791|FG000|Overall Study|Withdrawal by Subject|1|||
127729575|NCT01767376|459633792|FG001|Overall Study|Withdrawal by Subject|1|||
127729576|NCT01767376|459633793|FG002|Overall Study|Withdrawal by Subject|0|||
127729577|NCT04175834|459633795|FG000|Overall Study|Withdrawal by Subject|1|||
127729578|NCT04175834|459633796|FG001|Overall Study|Withdrawal by Subject|0|||
127729579|NCT00946088|459633797|FG000|Overall Study|Withdrawal by Subject|0|||
127729580|NCT00946088|459633798|FG001|Overall Study|Withdrawal by Subject|1|||
127729581|NCT04883541|459633799|FG000|Overall Study|Not attending regular yoga class|16|||
127729582|NCT04883541|459633800|FG001|Overall Study|Not attending regular yoga class|0|||
127729583|NCT04883541|459633799|FG000|Overall Study|Not attending the pregnancy school|0|||
127729584|NCT04883541|459633800|FG001|Overall Study|Not attending the pregnancy school|9|||
127729585|NCT00648895|459633808|FG000|Overall Study|Lack of Efficacy|0|||
127729586|NCT00648895|459633809|FG001|Overall Study|Lack of Efficacy|1|||
127729587|NCT02865083|459633810|FG000|Overall Study|Early Termination|3|||
127729588|NCT02865083|459633811|FG001|Overall Study|Early Termination|1|||
127729589|NCT00841321|459633812|FG000|Overall Study|Lost to Follow-up|1|||
127729590|NCT00841321|459633813|FG001|Overall Study|Lost to Follow-up|1|||
127729591|NCT00841321|459633812|FG000|Overall Study|Adverse Event|0|||
127729592|NCT00841321|459633813|FG001|Overall Study|Adverse Event|2|||
127729593|NCT01358175|459633814|FG000|Overall Study|Death|1|||
127729594|NCT01358175|459633815|FG001|Overall Study|Death|0|||
127729595|NCT01358175|459633816|FG002|Overall Study|Death|1|||
127729596|NCT01358175|459633814|FG000|Overall Study|Withdrawal by Subject|9|||
127729597|NCT01358175|459633815|FG001|Overall Study|Withdrawal by Subject|5|||
127729598|NCT01358175|459633816|FG002|Overall Study|Withdrawal by Subject|10|||
127729599|NCT01358175|459633814|FG000|Overall Study|Technical issues|0|||
127803394|NCT02810964|459903640|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
127803395|NCT01097629|459903655|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
127729600|NCT01358175|459633815|FG001|Overall Study|Technical issues|1|||
127729601|NCT01358175|459633816|FG002|Overall Study|Technical issues|0|||
127729602|NCT01358175|459633814|FG000|Overall Study|Pregnancy|0|||
127729603|NCT01358175|459633815|FG001|Overall Study|Pregnancy|1|||
127729604|NCT01358175|459633816|FG002|Overall Study|Pregnancy|0|||
127729605|NCT01358175|459633814|FG000|Overall Study|Physician Decision|1|||
127729606|NCT01358175|459633815|FG001|Overall Study|Physician Decision|0|||
127729607|NCT01358175|459633816|FG002|Overall Study|Physician Decision|0|||
127729608|NCT01358175|459633814|FG000|Overall Study|Non Compliance with Study Treatment|0|||
127729609|NCT01358175|459633815|FG001|Overall Study|Non Compliance with Study Treatment|1|||
127729610|NCT01358175|459633816|FG002|Overall Study|Non Compliance with Study Treatment|1|||
127729611|NCT01358175|459633814|FG000|Overall Study|Lost to Follow-up|1|||
127729612|NCT01358175|459633815|FG001|Overall Study|Lost to Follow-up|1|||
127729613|NCT01358175|459633816|FG002|Overall Study|Lost to Follow-up|3|||
127729614|NCT01358175|459633814|FG000|Overall Study|Lack of Efficacy|3|||
127729615|NCT01358175|459633815|FG001|Overall Study|Lack of Efficacy|8|||
127729616|NCT01358175|459633816|FG002|Overall Study|Lack of Efficacy|6|||
127729617|NCT01358175|459633814|FG000|Overall Study|Adverse Event|6|||
127729618|NCT01358175|459633815|FG001|Overall Study|Adverse Event|11|||
127729619|NCT01358175|459633816|FG002|Overall Study|Adverse Event|11|||
127729620|NCT01525875|459633817|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
127729621|NCT01525875|459633818|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
127729622|NCT01525875|459633817|FG000|Open-label Period|Lost to Follow-up|0|||
127729623|NCT01525875|459633818|FG001|Open-label Period|Lost to Follow-up|2|||
127729624|NCT02379078|459633819|FG000|Overall Study|Lost to Follow-up|33|||
127729625|NCT02379078|459633820|FG001|Overall Study|Lost to Follow-up|30|||
127729626|NCT02379078|459633819|FG000|Overall Study|Withdrawal by Subject|6|||
127729627|NCT02379078|459633820|FG001|Overall Study|Withdrawal by Subject|5|||
127729628|NCT04908488|459633821|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
127729629|NCT04908488|459633822|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
127729630|NCT04908488|459633821|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
127729631|NCT04908488|459633822|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
127729632|NCT01107912|459633825|FG000|Period 1|Adverse Event|0|||
127729633|NCT01107912|459633826|FG001|Period 1|Adverse Event|0|||
127729634|NCT01107912|459633827|FG002|Period 1|Adverse Event|0|||
127729635|NCT01107912|459633828|FG003|Period 1|Adverse Event|0|||
127729636|NCT01107912|459633829|FG004|Period 1|Adverse Event|2|||
127729637|NCT01107912|459633830|FG005|Period 1|Adverse Event|0|||
127729638|NCT01107912|459633825|FG000|Period 1|Physician Decision|0|||
127729639|NCT01107912|459633826|FG001|Period 1|Physician Decision|0|||
127729640|NCT01107912|459633827|FG002|Period 1|Physician Decision|0|||
127729641|NCT01107912|459633828|FG003|Period 1|Physician Decision|0|||
127729642|NCT01107912|459633829|FG004|Period 1|Physician Decision|1|||
127729643|NCT01107912|459633830|FG005|Period 1|Physician Decision|0|||
127729644|NCT01107912|459633825|FG000|Period 1|Withdrawal by Subject|1|||
127729645|NCT01107912|459633826|FG001|Period 1|Withdrawal by Subject|0|||
127729646|NCT01107912|459633827|FG002|Period 1|Withdrawal by Subject|0|||
127729647|NCT01107912|459633828|FG003|Period 1|Withdrawal by Subject|0|||
127729648|NCT01107912|459633829|FG004|Period 1|Withdrawal by Subject|0|||
127729649|NCT01107912|459633830|FG005|Period 1|Withdrawal by Subject|0|||
127729650|NCT01107912|459633825|FG000|Period 2|Physician Decision|0|||
127729651|NCT01107912|459633826|FG001|Period 2|Physician Decision|0|||
127729652|NCT01107912|459633827|FG002|Period 2|Physician Decision|1|||
127729653|NCT01107912|459633828|FG003|Period 2|Physician Decision|0|||
127729654|NCT01107912|459633829|FG004|Period 2|Physician Decision|0|||
127729655|NCT01107912|459633830|FG005|Period 2|Physician Decision|0|||
127729656|NCT01107912|459633825|FG000|Period 3|Adverse Event|0|||
127729657|NCT01107912|459633826|FG001|Period 3|Adverse Event|1|||
127729658|NCT01107912|459633827|FG002|Period 3|Adverse Event|1|||
127729659|NCT01107912|459633828|FG003|Period 3|Adverse Event|0|||
127729660|NCT01107912|459633829|FG004|Period 3|Adverse Event|0|||
127729661|NCT01107912|459633830|FG005|Period 3|Adverse Event|0|||
127729662|NCT01107912|459633825|FG000|Period 3|Withdrawal by Subject|0|||
127729663|NCT01107912|459633826|FG001|Period 3|Withdrawal by Subject|0|||
127729664|NCT01107912|459633827|FG002|Period 3|Withdrawal by Subject|0|||
127729665|NCT01107912|459633828|FG003|Period 3|Withdrawal by Subject|1|||
127729666|NCT01107912|459633829|FG004|Period 3|Withdrawal by Subject|0|||
127729667|NCT01107912|459633830|FG005|Period 3|Withdrawal by Subject|0|||
127729668|NCT01901302|459633834|FG000|Overall Study|Adverse Event|2|||
127729669|NCT01901302|459633835|FG001|Overall Study|Adverse Event|1|||
127729670|NCT01901302|459633834|FG000|Overall Study|Lack of Efficacy|0|||
127729671|NCT01901302|459633835|FG001|Overall Study|Lack of Efficacy|2|||
127729672|NCT01901302|459633834|FG000|Overall Study|Study Terminated by Sponsor|23|||
127729673|NCT01901302|459633835|FG001|Overall Study|Study Terminated by Sponsor|20|||
127729674|NCT01901302|459633834|FG000|Overall Study|Withdrawal by Subject|2|||
127729675|NCT01901302|459633835|FG001|Overall Study|Withdrawal by Subject|0|||
127729676|NCT01124916|459633836|FG000|Overall Study|Lost to Follow-up|3|||
127729677|NCT01124916|459633837|FG001|Overall Study|Lost to Follow-up|2|||
127729678|NCT00901459|459633841|FG000|Overall Study|Withdrawal by Subject|6|||
127729679|NCT04765046|459633842|FG000|Overall Study|Screen Failure|2|||
127890023|NCT02110706|460219953|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
127890024|NCT02110706|460219954|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
127890025|NCT02087059|460219955|FG000|Overall Study|Disease Progression|1|||
127890026|NCT02087059|460219955|FG000|Overall Study|Adverse Event|5|||
127890027|NCT02087059|460219955|FG000|Overall Study|Lost to Follow-up|1|||
127890028|NCT00252187|460219956|FG000|Overall Study|Adverse Event|3|||
127890029|NCT00252187|460219957|FG001|Overall Study|Adverse Event|1|||
127890030|NCT00252187|460219956|FG000|Overall Study|Withdrawal by Subject|1|||
127890031|NCT00252187|460219957|FG001|Overall Study|Withdrawal by Subject|0|||
127890032|NCT00706706|460219960|FG000|Overall Study|Death|53|||
127890033|NCT00706706|460219960|FG000|Overall Study|Lost to Follow-up|7|||
127890034|NCT00706706|460219960|FG000|Overall Study|Study endpoint had reached|45|||
127890035|NCT05017493|460219961|FG000|Overall Study|Withdrawal by Subject|26|||
127890036|NCT05017493|460219962|FG001|Overall Study|Withdrawal by Subject|0|||
127890037|NCT05017493|460219961|FG000|Overall Study|Physician Decision|15|||
127890038|NCT05017493|460219962|FG001|Overall Study|Physician Decision|0|||
127890039|NCT05017493|460219961|FG000|Overall Study|Protocol Violation|81|||
127890040|NCT05017493|460219962|FG001|Overall Study|Protocol Violation|0|||
127890041|NCT02175966|460219967|FG000|Follow-up Period|Lack of Efficacy|10|||
127890042|NCT02175966|460219968|FG001|Follow-up Period|Lack of Efficacy|6|||
127890043|NCT01154153|460219969|FG000|Overall Study|Poor compliance to protocol|2|||
127890044|NCT01154153|460219970|FG001|Overall Study|Poor compliance to protocol|0|||
127890045|NCT01154153|460219969|FG000|Overall Study|Unable to use labs|2|||
127890046|NCT01154153|460219970|FG001|Overall Study|Unable to use labs|3|||
127890047|NCT01154153|460219969|FG000|Overall Study|Withdrew consent|1|||
127890048|NCT01154153|460219970|FG001|Overall Study|Withdrew consent|0|||
127890049|NCT00210626|460219977|FG000|Overall Study|Adverse Event|1|||
127890050|NCT00210626|460219978|FG001|Overall Study|Adverse Event|2|||
127729680|NCT04765046|459633842|FG000|Overall Study|Withdrawal by Subject|4|||
127729681|NCT04765046|459633842|FG000|Overall Study|Physician Decision|4|||
127729682|NCT04765046|459633842|FG000|Overall Study|Surgery Cancelled|8|||
127729683|NCT02959866|459633844|FG000|Overall Study|Withdrawal by Subject|1|||
127729684|NCT00952523|459633845|FG000|Overall Study|Withdrawal by Subject|7|||
127729685|NCT00848198|459633846|FG000|Overall Study|Incomplete Case Report Forms|15|||
127729686|NCT03529942|459633847|FG000|Overall Study|Withdrawal by Subject|13|||
127729687|NCT03529942|459633847|FG000|Overall Study|Physician Decision|1|||
127729688|NCT03529942|459633847|FG000|Overall Study|Lost to Follow-up|7|||
127729689|NCT03529942|459633847|FG000|Overall Study|Needle inserted but no drug administered|1|||
127729690|NCT03529942|459633847|FG000|Overall Study|Personal reasons|1|||
127729691|NCT03905512|459633848|FG000|Overall Study|Withdrawal by Subject|9|||
127729692|NCT03905512|459633849|FG001|Overall Study|Withdrawal by Subject|8|||
127729693|NCT03905512|459633848|FG000|Overall Study|Adverse Event|1|||
127729694|NCT03905512|459633849|FG001|Overall Study|Adverse Event|2|||
127729695|NCT03905512|459633848|FG000|Overall Study|Lost to Follow-up|4|||
127729696|NCT03905512|459633849|FG001|Overall Study|Lost to Follow-up|3|||
127729697|NCT03905512|459633848|FG000|Overall Study|Other than Specified|7|||
127729698|NCT03905512|459633849|FG001|Overall Study|Other than Specified|4|||
127729699|NCT00866619|459633852|FG000|Overall Study|Adverse Event|112|||
127729700|NCT00866619|459633853|FG001|Overall Study|Adverse Event|106|||
127729701|NCT00866619|459633854|FG002|Overall Study|Adverse Event|47|||
127729702|NCT00866619|459633855|FG003|Overall Study|Adverse Event|44|||
127729703|NCT00866619|459633852|FG000|Overall Study|Protocol Violation|2|||
127729704|NCT00866619|459633853|FG001|Overall Study|Protocol Violation|39|||
127729705|NCT00866619|459633854|FG002|Overall Study|Protocol Violation|2|||
127729706|NCT00866619|459633855|FG003|Overall Study|Protocol Violation|17|||
127729707|NCT00866619|459633852|FG000|Overall Study|Withdrawal by Subject|587|||
127729708|NCT00866619|459633853|FG001|Overall Study|Withdrawal by Subject|295|||
127729709|NCT00866619|459633854|FG002|Overall Study|Withdrawal by Subject|272|||
127729710|NCT00866619|459633855|FG003|Overall Study|Withdrawal by Subject|144|||
127729711|NCT00866619|459633852|FG000|Overall Study|Lost to Follow-up|1145|||
127729712|NCT00866619|459633853|FG001|Overall Study|Lost to Follow-up|830|||
127890051|NCT00210626|460219977|FG000|Overall Study|Protocol Violation|1|||
127890052|NCT00210626|460219978|FG001|Overall Study|Protocol Violation|5|||
127729713|NCT00866619|459633854|FG002|Overall Study|Lost to Follow-up|568|||
127729714|NCT00866619|459633855|FG003|Overall Study|Lost to Follow-up|425|||
127890053|NCT00210626|460219977|FG000|Overall Study|Lost to Follow-up|11|||
127890054|NCT00210626|460219978|FG001|Overall Study|Lost to Follow-up|11|||
127890055|NCT00210626|460219977|FG000|Overall Study|Death|1|||
127890056|NCT00210626|460219978|FG001|Overall Study|Death|0|||
127729715|NCT00645411|459633856|FG000|Overall Study|Adverse Event|0|||
127729716|NCT00645411|459633857|FG001|Overall Study|Adverse Event|0|||
127729717|NCT00645411|459633858|FG002|Overall Study|Adverse Event|0|||
127729718|NCT00645411|459633859|FG003|Overall Study|Adverse Event|2|||
127729719|NCT00645411|459633856|FG000|Overall Study|Withdrawal by Subject|2|||
127729720|NCT00645411|459633857|FG001|Overall Study|Withdrawal by Subject|1|||
127803396|NCT01097629|459903656|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
127803397|NCT01097629|459903657|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
127803398|NCT01097629|459903658|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
127803399|NCT01097629|459903659|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
127803400|NCT01097629|459903660|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
127803401|NCT01097629|459903661|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
127803402|NCT01097629|459903662|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
127803403|NCT01097629|459903655|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
127803404|NCT01097629|459903656|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
127803405|NCT01097629|459903657|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
127803406|NCT01097629|459903658|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
127803407|NCT01097629|459903659|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
127803408|NCT01097629|459903660|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
127729721|NCT00645411|459633858|FG002|Overall Study|Withdrawal by Subject|19|||
127729722|NCT00645411|459633859|FG003|Overall Study|Withdrawal by Subject|21|||
127729723|NCT00645411|459633856|FG000|Overall Study|Lost to Follow-up|10|||
127729724|NCT00645411|459633857|FG001|Overall Study|Lost to Follow-up|5|||
127729725|NCT00645411|459633858|FG002|Overall Study|Lost to Follow-up|124|||
127729726|NCT00645411|459633859|FG003|Overall Study|Lost to Follow-up|75|||
127729727|NCT00645411|459633856|FG000|Overall Study|Protocol Violation|1|||
127729728|NCT00645411|459633857|FG001|Overall Study|Protocol Violation|0|||
127729729|NCT00645411|459633858|FG002|Overall Study|Protocol Violation|1|||
127729730|NCT00645411|459633859|FG003|Overall Study|Protocol Violation|0|||
127729731|NCT00645411|459633856|FG000|Overall Study|Inappropriate enrollment|0|||
127729732|NCT00645411|459633857|FG001|Overall Study|Inappropriate enrollment|0|||
127729733|NCT00645411|459633858|FG002|Overall Study|Inappropriate enrollment|4|||
127729734|NCT00645411|459633859|FG003|Overall Study|Inappropriate enrollment|1|||
127729735|NCT00645411|459633856|FG000|Overall Study|Unable to classify|0|||
127729736|NCT00645411|459633857|FG001|Overall Study|Unable to classify|0|||
127729737|NCT00645411|459633858|FG002|Overall Study|Unable to classify|3|||
127729738|NCT00645411|459633859|FG003|Overall Study|Unable to classify|4|||
127729739|NCT03560206|459633860|FG000|Overall Study|Lost to Follow-up|19|||
127729740|NCT03560206|459633861|FG001|Overall Study|Lost to Follow-up|11|||
127729741|NCT03560206|459633860|FG000|Overall Study|Withdrawal by Subject|2|||
127729742|NCT03560206|459633861|FG001|Overall Study|Withdrawal by Subject|4|||
127729743|NCT03560206|459633860|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
127729744|NCT03560206|459633861|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
127729745|NCT03560206|459633860|FG000|Overall Study|Busy schedule|14|||
127729746|NCT03560206|459633861|FG001|Overall Study|Busy schedule|2|||
127729747|NCT03560206|459633860|FG000|Overall Study|patients' new health condition such as cancer|10|||
127729748|NCT03560206|459633861|FG001|Overall Study|patients' new health condition such as cancer|1|||
127729749|NCT03987074|459633862|FG000|Overall Study|Withdrew Consent|1|||
127729750|NCT03987074|459633863|FG001|Overall Study|Withdrew Consent|1|||
127729751|NCT03987074|459633864|FG002|Overall Study|Withdrew Consent|0|||
127729752|NCT03987074|459633865|FG003|Overall Study|Withdrew Consent|2|||
127729753|NCT03987074|459633866|FG004|Overall Study|Withdrew Consent|1|||
127729754|NCT03987074|459633862|FG000|Overall Study|Adverse Event|2|||
127729755|NCT03987074|459633863|FG001|Overall Study|Adverse Event|1|||
127729756|NCT03987074|459633864|FG002|Overall Study|Adverse Event|0|||
127729757|NCT03987074|459633865|FG003|Overall Study|Adverse Event|0|||
127729758|NCT03987074|459633866|FG004|Overall Study|Adverse Event|1|||
127729759|NCT03987074|459633862|FG000|Overall Study|Lost to Follow-up|0|||
127729760|NCT03987074|459633863|FG001|Overall Study|Lost to Follow-up|0|||
127803409|NCT01097629|459903661|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
127803410|NCT01097629|459903662|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
127803411|NCT01097629|459903655|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
127803412|NCT01097629|459903656|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
127803413|NCT01097629|459903657|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
127803414|NCT01097629|459903658|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
127729761|NCT03987074|459633864|FG002|Overall Study|Lost to Follow-up|1|||
127729762|NCT03987074|459633865|FG003|Overall Study|Lost to Follow-up|1|||
127729763|NCT03987074|459633866|FG004|Overall Study|Lost to Follow-up|0|||
127729764|NCT03987074|459633862|FG000|Overall Study|Investigator's Discretion|0|||
127729765|NCT03987074|459633863|FG001|Overall Study|Investigator's Discretion|0|||
127729766|NCT03987074|459633864|FG002|Overall Study|Investigator's Discretion|0|||
127729767|NCT03987074|459633865|FG003|Overall Study|Investigator's Discretion|1|||
127729768|NCT03987074|459633866|FG004|Overall Study|Investigator's Discretion|0|||
127729769|NCT01334606|459633871|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
127729770|NCT02674399|459633872|FG000|Overall Study|Lost to Follow-up|2|||
127729771|NCT02674399|459633873|FG001|Overall Study|Lost to Follow-up|0|||
127729772|NCT02138838|459633874|FG000|Overall Study|Study Closure|7|||
127729773|NCT02138838|459633875|FG001|Overall Study|Study Closure|6|||
127729774|NCT02138838|459633874|FG000|Overall Study|Withdrawal by Subject|1|||
127729775|NCT02138838|459633875|FG001|Overall Study|Withdrawal by Subject|5|||
127729776|NCT02993926|459633878|FG000|Enantone Treatment Phase|Adverse Event|1|||
127729777|NCT02993926|459633879|FG001|Enantone Treatment Phase|Adverse Event|0|||
127729778|NCT02993926|459633880|FG002|Enantone Treatment Phase|Adverse Event|0|||
127729779|NCT02993926|459633878|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
127729780|NCT02993926|459633879|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
127729781|NCT02993926|459633880|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
127729782|NCT02993926|459633878|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
127729783|NCT02993926|459633879|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
127729784|NCT02993926|459633880|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
127729785|NCT02993926|459633878|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
127729786|NCT02993926|459633879|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
127729787|NCT02993926|459633880|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
127729788|NCT01084772|459633882|FG000|Baseline|Withdrawal by Subject|7|||
127729789|NCT01084772|459633883|FG001|Baseline|Withdrawal by Subject|6|||
127729790|NCT01084772|459633882|FG000|3 Months|Death|1|||
127729791|NCT01084772|459633883|FG001|3 Months|Death|0|||
127729792|NCT01084772|459633882|FG000|3 Months|Study Termination|2|||
127729793|NCT01084772|459633883|FG001|3 Months|Study Termination|2|||
127729794|NCT01084772|459633882|FG000|1 Year|Withdrawal by Subject|0|||
127729795|NCT01084772|459633883|FG001|1 Year|Withdrawal by Subject|1|||
127729796|NCT01084772|459633882|FG000|1 Year|Lost to Follow-up|3|||
127729797|NCT01084772|459633883|FG001|1 Year|Lost to Follow-up|0|||
127729798|NCT01084772|459633882|FG000|1 Year|Study Termination|0|||
127729799|NCT01084772|459633883|FG001|1 Year|Study Termination|7|||
127729800|NCT01084772|459633882|FG000|2 Years|Withdrawal by Subject|1|||
127729801|NCT01084772|459633883|FG001|2 Years|Withdrawal by Subject|0|||
127729802|NCT01084772|459633882|FG000|2 Years|Lost to Follow-up|5|||
127729803|NCT01084772|459633883|FG001|2 Years|Lost to Follow-up|2|||
127729804|NCT01084772|459633882|FG000|2 Years|Study Termination|3|||
127729805|NCT01084772|459633883|FG001|2 Years|Study Termination|2|||
127729806|NCT01867307|459633884|FG000|Overall Study|Protocol Violation|2|||
127729807|NCT01867307|459633885|FG001|Overall Study|Protocol Violation|0|||
127729808|NCT01867307|459633884|FG000|Overall Study|Other Adverse Event|1|||
127803415|NCT01097629|459903659|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
127803416|NCT01097629|459903660|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
127803417|NCT01097629|459903661|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
127803418|NCT01097629|459903662|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
127803419|NCT01097629|459903655|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
127803420|NCT01097629|459903656|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
127803421|NCT01097629|459903657|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
127803422|NCT01097629|459903658|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
127803423|NCT01097629|459903659|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
127803424|NCT01097629|459903660|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
127803425|NCT01097629|459903661|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
127803426|NCT01097629|459903662|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
127803427|NCT01097629|459903655|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
127803428|NCT01097629|459903656|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
127803429|NCT01097629|459903657|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
127803430|NCT01097629|459903658|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
127803431|NCT01097629|459903659|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
127803432|NCT01097629|459903660|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
127803433|NCT01097629|459903661|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
127803434|NCT01097629|459903662|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
127803435|NCT01097629|459903655|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
127803436|NCT01097629|459903656|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
127803437|NCT01097629|459903657|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
127803438|NCT01097629|459903658|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
127803439|NCT01097629|459903659|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
127803440|NCT01097629|459903660|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
127803441|NCT01097629|459903661|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
127803442|NCT01097629|459903662|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
127803443|NCT01097629|459903655|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
127729809|NCT01867307|459633885|FG001|Overall Study|Other Adverse Event|3|||
127729810|NCT00518206|459633886|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
127729811|NCT00518206|459633887|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
127729812|NCT00518206|459633886|FG000|Overall Study|Withdrawal by Subject|2|||
127729813|NCT00518206|459633887|FG001|Overall Study|Withdrawal by Subject|0|||
127729814|NCT00518206|459633886|FG000|Overall Study|Drug Supply Issue|1|||
127729815|NCT00518206|459633887|FG001|Overall Study|Drug Supply Issue|0|||
127729816|NCT00518206|459633886|FG000|Overall Study|Reason Unknown|1|||
127729817|NCT00518206|459633887|FG001|Overall Study|Reason Unknown|0|||
127729818|NCT00518206|459633886|FG000|Overall Study|Completion Status Unknown|1|||
127729819|NCT00518206|459633887|FG001|Overall Study|Completion Status Unknown|0|||
127729820|NCT00760877|459635404|FG000|Overall Study|Protocol Violation|1|||
127729821|NCT00760877|459635405|FG001|Overall Study|Protocol Violation|0|||
127729822|NCT00760877|459635404|FG000|Overall Study|Non-compliance with protocol treatment|2|||
127729823|NCT00760877|459635405|FG001|Overall Study|Non-compliance with protocol treatment|1|||
127729824|NCT00760877|459635404|FG000|Overall Study|Pregnancy|1|||
127729825|NCT00760877|459635405|FG001|Overall Study|Pregnancy|4|||
127729826|NCT00760877|459635404|FG000|Overall Study|Death|2|||
127729827|NCT00760877|459635405|FG001|Overall Study|Death|1|||
127729828|NCT00760877|459635404|FG000|Overall Study|Withdrawal by Subject|7|||
127729829|NCT00760877|459635405|FG001|Overall Study|Withdrawal by Subject|3|||
127729830|NCT00760877|459635404|FG000|Overall Study|Adverse Event|19|||
127803444|NCT01097629|459903656|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
127803445|NCT01097629|459903657|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
127803446|NCT01097629|459903658|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
127803447|NCT01097629|459903659|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
127803448|NCT01097629|459903660|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
127803449|NCT01097629|459903661|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
127803450|NCT01097629|459903662|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
127803451|NCT01097629|459903655|FG000|DB RO Phase|Withdrawal by Subject|0|||
127803452|NCT01097629|459903656|FG001|DB RO Phase|Withdrawal by Subject|0|||
127803453|NCT01097629|459903657|FG002|DB RO Phase|Withdrawal by Subject|0|||
127803454|NCT01097629|459903658|FG003|DB RO Phase|Withdrawal by Subject|0|||
127803455|NCT01097629|459903659|FG004|DB RO Phase|Withdrawal by Subject|0|||
127803456|NCT01097629|459903660|FG005|DB RO Phase|Withdrawal by Subject|0|||
127803457|NCT01097629|459903661|FG006|DB RO Phase|Withdrawal by Subject|0|||
127803458|NCT01097629|459903662|FG007|DB RO Phase|Withdrawal by Subject|1|||
127803459|NCT01097629|459903655|FG000|DB RO Phase|Protocol Violation|0|||
127803460|NCT01097629|459903656|FG001|DB RO Phase|Protocol Violation|0|||
127803461|NCT01097629|459903657|FG002|DB RO Phase|Protocol Violation|0|||
127803462|NCT01097629|459903658|FG003|DB RO Phase|Protocol Violation|1|||
127803463|NCT01097629|459903659|FG004|DB RO Phase|Protocol Violation|0|||
127803464|NCT01097629|459903660|FG005|DB RO Phase|Protocol Violation|1|||
127803465|NCT01097629|459903661|FG006|DB RO Phase|Protocol Violation|1|||
127803466|NCT01097629|459903662|FG007|DB RO Phase|Protocol Violation|0|||
127803467|NCT01097629|459903655|FG000|DB RO Phase|Lost to Follow-up|0|||
127803468|NCT01097629|459903656|FG001|DB RO Phase|Lost to Follow-up|0|||
127803469|NCT01097629|459903657|FG002|DB RO Phase|Lost to Follow-up|0|||
127803470|NCT01097629|459903658|FG003|DB RO Phase|Lost to Follow-up|0|||
127803471|NCT01097629|459903659|FG004|DB RO Phase|Lost to Follow-up|0|||
127803472|NCT01097629|459903660|FG005|DB RO Phase|Lost to Follow-up|0|||
127803473|NCT01097629|459903661|FG006|DB RO Phase|Lost to Follow-up|2|||
127803474|NCT01097629|459903662|FG007|DB RO Phase|Lost to Follow-up|0|||
127803475|NCT00132041|459903664|FG000|Baseline|Ineligible|6|||
127803476|NCT00132041|459903664|FG000|3 Months Post Ablation|Transplant|1|||
127803477|NCT00132041|459903664|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
127803478|NCT00132041|459903664|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
127803479|NCT00132041|459903664|FG000|6 Months Post Ablation|Death|2|||
127803480|NCT00132041|459903664|FG000|6 Months Post Ablation|Transplant|6|||
127803481|NCT00132041|459903664|FG000|9 Months Post Ablation|Death|1|||
127803482|NCT00132041|459903664|FG000|9 Months Post Ablation|Transplant|1|||
127729831|NCT00760877|459635405|FG001|Overall Study|Adverse Event|12|||
127729832|NCT00760877|459635404|FG000|Overall Study|Participant diagnosed with AML|0|||
127729833|NCT00760877|459635405|FG001|Overall Study|Participant diagnosed with AML|1|||
127729834|NCT00760877|459635404|FG000|Overall Study|Participant not eligible to cross-over|0|||
127803483|NCT00132041|459903664|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
127803484|NCT00132041|459903664|FG000|12 Months Post Ablation|Death|1|||
127803485|NCT00132041|459903664|FG000|12 Months Post Ablation|Transplant|1|||
127803486|NCT00132041|459903664|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
127803487|NCT00132041|459903664|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
127803488|NCT00132041|459903664|FG000|15 Months Post Ablation|Death|1|||
127803489|NCT00132041|459903664|FG000|15 Months Post Ablation|Transplant|5|||
127803490|NCT00132041|459903664|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
127803491|NCT00132041|459903664|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
127803492|NCT00132041|459903664|FG000|18 Months Post Ablation|Transplant|1|||
127803493|NCT00132041|459903664|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
127890057|NCT00210626|460219977|FG000|Overall Study|Withdrawal by Subject|29|||
127729835|NCT00760877|459635405|FG001|Overall Study|Participant not eligible to cross-over|1|||
127729836|NCT00760877|459635404|FG000|Overall Study|Physician Decision|1|||
127729837|NCT00760877|459635405|FG001|Overall Study|Physician Decision|2|||
127729838|NCT00760877|459635404|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
127729839|NCT00760877|459635405|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
127729840|NCT00760877|459635404|FG000|Overall Study|Treatment failure|1|||
127729841|NCT00760877|459635405|FG001|Overall Study|Treatment failure|0|||
127729842|NCT05379400|459635408|FG000|Overall Study|Lost to Follow-up|1|||
127729843|NCT05379400|459635409|FG001|Overall Study|Lost to Follow-up|1|||
127729844|NCT01263223|459635419|FG000|Period 2|Withdrawal by Subject|0|||
127729845|NCT01263223|459635420|FG001|Period 2|Withdrawal by Subject|1|||
127729846|NCT01263223|459635419|FG000|7-day Follow-up|Withdrawal by Subject|0|||
127729847|NCT01263223|459635420|FG001|7-day Follow-up|Withdrawal by Subject|1|||
127729848|NCT01263223|459635419|FG000|7-day Follow-up|Lost to Follow-up|1|||
127729849|NCT01263223|459635420|FG001|7-day Follow-up|Lost to Follow-up|0|||
127729850|NCT01322347|459635421|FG000|Overall Study|Adverse Event|7|||
127729851|NCT01322347|459635422|FG001|Overall Study|Adverse Event|2|||
127729852|NCT01322347|459635421|FG000|Overall Study|Death|5|||
127729853|NCT01322347|459635422|FG001|Overall Study|Death|3|||
127729854|NCT01322347|459635421|FG000|Overall Study|Physician Decision|2|||
127729855|NCT01322347|459635422|FG001|Overall Study|Physician Decision|1|||
127729856|NCT01322347|459635421|FG000|Overall Study|Protocol Violation|5|||
127729857|NCT01322347|459635422|FG001|Overall Study|Protocol Violation|2|||
127729858|NCT01322347|459635421|FG000|Overall Study|Withdrawal by Subject|1|||
127729859|NCT01322347|459635422|FG001|Overall Study|Withdrawal by Subject|4|||
127729860|NCT01322347|459635421|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
127729861|NCT01322347|459635422|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
127729862|NCT01322347|459635421|FG000|Overall Study|blood transfusion|5|||
127729863|NCT01322347|459635422|FG001|Overall Study|blood transfusion|5|||
127729864|NCT01322347|459635421|FG000|Overall Study|sponsor decision|1|||
127729865|NCT01322347|459635422|FG001|Overall Study|sponsor decision|3|||
127729866|NCT01322347|459635421|FG000|Overall Study|ineligible|6|||
127729867|NCT01322347|459635422|FG001|Overall Study|ineligible|3|||
127729868|NCT01322347|459635421|FG000|Overall Study|kidney transplant|3|||
127729869|NCT01322347|459635422|FG001|Overall Study|kidney transplant|1|||
127729870|NCT01322347|459635421|FG000|Overall Study|study drug withheld > 12 wks|0|||
127729871|NCT01322347|459635422|FG001|Overall Study|study drug withheld > 12 wks|1|||
127729872|NCT01322347|459635421|FG000|Overall Study|moved/changed dialysis|2|||
127729873|NCT01322347|459635422|FG001|Overall Study|moved/changed dialysis|4|||
127729874|NCT01369147|459635424|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
127729875|NCT01369147|459635425|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
127729876|NCT01369147|459635426|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
127729877|NCT03184519|459635427|FG000|Overall Study|Lost to Follow-up|6|||
127729878|NCT03184519|459635427|FG000|Overall Study|Physician Decision|21|||
127729879|NCT04239911|459635428|FG000|Overall Study|Lost to Follow-up|2|||
127729880|NCT04239911|459635429|FG001|Overall Study|Lost to Follow-up|1|||
127729881|NCT00584909|459635435|FG000|Overall Study|Adverse Event|4|||
127729882|NCT03345407|459635436|FG000|Overall Study|Withdrawal by Subject|11|||
127729883|NCT03345407|459635437|FG001|Overall Study|Withdrawal by Subject|1|||
127729884|NCT03345407|459635438|FG002|Overall Study|Withdrawal by Subject|5|||
127803494|NCT00132041|459903664|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
127803495|NCT01171820|459903665|FG000|Overall Study|Death|3|||
127803496|NCT01171820|459903666|FG001|Overall Study|Death|3|||
127803497|NCT01171820|459903665|FG000|Overall Study|Lost to Follow-up|0|||
127803498|NCT01171820|459903666|FG001|Overall Study|Lost to Follow-up|1|||
127803499|NCT01171820|459903665|FG000|Overall Study|Withdrawal by Subject|2|||
127803500|NCT01171820|459903666|FG001|Overall Study|Withdrawal by Subject|0|||
127803501|NCT01171820|459903665|FG000|Overall Study|Physician Decision|0|||
127803502|NCT01171820|459903666|FG001|Overall Study|Physician Decision|1|||
127803503|NCT01171820|459903665|FG000|Overall Study|1-Year Missed Visit|1|||
127803504|NCT01171820|459903666|FG001|Overall Study|1-Year Missed Visit|1|||
127729885|NCT03345407|459635439|FG003|Overall Study|Withdrawal by Subject|6|||
127729886|NCT03345407|459635440|FG004|Overall Study|Withdrawal by Subject|3|||
127729887|NCT03345407|459635441|FG005|Overall Study|Withdrawal by Subject|6|||
127803505|NCT03969875|459903667|FG000|Overall Study|did not receive allocated intervention|3|||
127803506|NCT03969875|459903668|FG001|Overall Study|did not receive allocated intervention|3|||
127803507|NCT03969875|459903669|FG002|Overall Study|did not receive allocated intervention|4|||
127803508|NCT03969875|459903667|FG000|Overall Study|Protocol Violation|4|||
127803509|NCT03969875|459903668|FG001|Overall Study|Protocol Violation|2|||
127803510|NCT03969875|459903669|FG002|Overall Study|Protocol Violation|2|||
127803511|NCT01307033|459903670|FG000|8-week Double-blind Period|Adverse Event|2|||
127803512|NCT01307033|459903671|FG001|8-week Double-blind Period|Adverse Event|0|||
127803513|NCT01307033|459903672|FG002|8-week Double-blind Period|Adverse Event|0|||
127803514|NCT01307033|459903673|FG003|8-week Double-blind Period|Adverse Event|0|||
127803515|NCT01307033|459903670|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
127803516|NCT01307033|459903671|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
127803517|NCT01307033|459903672|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
127803518|NCT01307033|459903673|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
127729888|NCT03345407|459635442|FG006|Overall Study|Withdrawal by Subject|16|||
127729889|NCT03345407|459635436|FG000|Overall Study|Physician Decision|3|||
127729890|NCT03345407|459635437|FG001|Overall Study|Physician Decision|1|||
127729891|NCT03345407|459635438|FG002|Overall Study|Physician Decision|0|||
127729892|NCT03345407|459635439|FG003|Overall Study|Physician Decision|0|||
127729893|NCT03345407|459635440|FG004|Overall Study|Physician Decision|1|||
127729894|NCT03345407|459635441|FG005|Overall Study|Physician Decision|2|||
127729895|NCT03345407|459635442|FG006|Overall Study|Physician Decision|3|||
127729896|NCT03345407|459635436|FG000|Overall Study|Lost to Follow-up|2|||
127729897|NCT03345407|459635437|FG001|Overall Study|Lost to Follow-up|0|||
127729898|NCT03345407|459635438|FG002|Overall Study|Lost to Follow-up|1|||
127729899|NCT03345407|459635439|FG003|Overall Study|Lost to Follow-up|0|||
127729900|NCT03345407|459635440|FG004|Overall Study|Lost to Follow-up|1|||
127729901|NCT03345407|459635441|FG005|Overall Study|Lost to Follow-up|2|||
127729902|NCT03345407|459635442|FG006|Overall Study|Lost to Follow-up|3|||
127729903|NCT03345407|459635436|FG000|Overall Study|Protocol-defined stopping criteria|9|||
127729904|NCT03345407|459635437|FG001|Overall Study|Protocol-defined stopping criteria|0|||
127729905|NCT03345407|459635438|FG002|Overall Study|Protocol-defined stopping criteria|0|||
127729906|NCT03345407|459635439|FG003|Overall Study|Protocol-defined stopping criteria|0|||
127729907|NCT03345407|459635440|FG004|Overall Study|Protocol-defined stopping criteria|2|||
127729908|NCT03345407|459635441|FG005|Overall Study|Protocol-defined stopping criteria|1|||
127729909|NCT03345407|459635442|FG006|Overall Study|Protocol-defined stopping criteria|1|||
127729910|NCT03345407|459635436|FG000|Overall Study|Protocol Violation|2|||
127729911|NCT03345407|459635437|FG001|Overall Study|Protocol Violation|0|||
127729912|NCT03345407|459635438|FG002|Overall Study|Protocol Violation|0|||
127729913|NCT03345407|459635439|FG003|Overall Study|Protocol Violation|0|||
127729914|NCT03345407|459635440|FG004|Overall Study|Protocol Violation|1|||
127729915|NCT03345407|459635441|FG005|Overall Study|Protocol Violation|0|||
127729916|NCT03345407|459635442|FG006|Overall Study|Protocol Violation|3|||
127729917|NCT03345407|459635436|FG000|Overall Study|Lack of Efficacy|1|||
127729918|NCT03345407|459635437|FG001|Overall Study|Lack of Efficacy|1|||
127729919|NCT03345407|459635438|FG002|Overall Study|Lack of Efficacy|1|||
127729920|NCT03345407|459635439|FG003|Overall Study|Lack of Efficacy|1|||
127729921|NCT03345407|459635440|FG004|Overall Study|Lack of Efficacy|1|||
127729922|NCT03345407|459635441|FG005|Overall Study|Lack of Efficacy|0|||
127729923|NCT03345407|459635442|FG006|Overall Study|Lack of Efficacy|3|||
127729924|NCT03345407|459635436|FG000|Overall Study|Adverse Event|4|||
127729925|NCT03345407|459635437|FG001|Overall Study|Adverse Event|0|||
127729926|NCT03345407|459635438|FG002|Overall Study|Adverse Event|5|||
127729927|NCT03345407|459635439|FG003|Overall Study|Adverse Event|4|||
127729928|NCT03345407|459635440|FG004|Overall Study|Adverse Event|6|||
127729929|NCT03345407|459635441|FG005|Overall Study|Adverse Event|5|||
127729930|NCT03345407|459635442|FG006|Overall Study|Adverse Event|16|||
127729931|NCT02092909|459635445|FG000|Overall Study|Adverse Event|0|||
127729932|NCT02092909|459635446|FG001|Overall Study|Adverse Event|0|||
127729933|NCT02092909|459635447|FG002|Overall Study|Adverse Event|4|||
127729934|NCT02092909|459635448|FG003|Overall Study|Adverse Event|2|||
127729935|NCT02092909|459635445|FG000|Overall Study|Lack of Efficacy|0|||
127729936|NCT02092909|459635446|FG001|Overall Study|Lack of Efficacy|2|||
127729937|NCT02092909|459635447|FG002|Overall Study|Lack of Efficacy|1|||
127729938|NCT02092909|459635448|FG003|Overall Study|Lack of Efficacy|0|||
127729939|NCT02092909|459635445|FG000|Overall Study|Withdrawal by Subject|0|||
127729940|NCT02092909|459635446|FG001|Overall Study|Withdrawal by Subject|0|||
127729941|NCT02092909|459635447|FG002|Overall Study|Withdrawal by Subject|2|||
127729942|NCT02092909|459635448|FG003|Overall Study|Withdrawal by Subject|1|||
127729943|NCT02092909|459635445|FG000|Overall Study|Study terminated by Sponsor|0|||
127729944|NCT02092909|459635446|FG001|Overall Study|Study terminated by Sponsor|0|||
127729945|NCT02092909|459635447|FG002|Overall Study|Study terminated by Sponsor|0|||
127729946|NCT02092909|459635448|FG003|Overall Study|Study terminated by Sponsor|2|||
127729947|NCT02092909|459635445|FG000|Overall Study|Miscellaneous|1|||
127729948|NCT02092909|459635446|FG001|Overall Study|Miscellaneous|1|||
127729949|NCT02092909|459635447|FG002|Overall Study|Miscellaneous|2|||
127729950|NCT02092909|459635448|FG003|Overall Study|Miscellaneous|1|||
127729951|NCT04626128|459635449|FG000|Overall Study|Withdrawal by Subject|0|||
127729952|NCT04626128|459635450|FG001|Overall Study|Withdrawal by Subject|1|||
127729953|NCT04626128|459635451|FG002|Overall Study|Withdrawal by Subject|0|||
127729954|NCT04626128|459635452|FG003|Overall Study|Withdrawal by Subject|0|||
127729955|NCT01182285|459635453|FG000|First Intervention Week 1-10|Disease progression|1|||
127729956|NCT01182285|459635454|FG001|First Intervention Week 1-10|Disease progression|0|||
127729957|NCT01182285|459635455|FG002|First Intervention Week 1-10|Disease progression|0|||
127729958|NCT01182285|459635453|FG000|First Intervention Week 1-10|Adverse Event|1|||
127803519|NCT01307033|459903670|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
127729959|NCT01182285|459635454|FG001|First Intervention Week 1-10|Adverse Event|0|||
127729960|NCT01182285|459635455|FG002|First Intervention Week 1-10|Adverse Event|0|||
127729961|NCT01182285|459635453|FG000|First Intervention Week 1-10|Non-compliance|1|||
127729962|NCT01182285|459635454|FG001|First Intervention Week 1-10|Non-compliance|0|||
127729963|NCT01182285|459635455|FG002|First Intervention Week 1-10|Non-compliance|0|||
127729964|NCT01182285|459635453|FG000|Third Intervention Week 11-52|Disease Progression|0|||
127729965|NCT01182285|459635454|FG001|Third Intervention Week 11-52|Disease Progression|0|||
127729966|NCT01182285|459635455|FG002|Third Intervention Week 11-52|Disease Progression|6|||
127729967|NCT01182285|459635453|FG000|Third Intervention Week 11-52|Other|0|||
127729968|NCT01182285|459635454|FG001|Third Intervention Week 11-52|Other|0|||
127729969|NCT01182285|459635455|FG002|Third Intervention Week 11-52|Other|2|||
127729970|NCT00379210|459635458|FG000|Overall Study|Withdrawal by Subject|10|||
127729971|NCT00379210|459635459|FG001|Overall Study|Withdrawal by Subject|7|||
127729972|NCT03209492|459635460|FG000|Overall Study|Case Report Forms Uncollected|5|||
127729973|NCT01762345|459635461|FG000|Overall Study|Adverse Event|5|||
127729974|NCT01762345|459635461|FG000|Overall Study|Protocol Violation|2|||
127729975|NCT05072795|459635462|FG000|Overall Study|Lost to Follow-up|5|||
127729976|NCT00753896|459635469|FG000|Overall Study|Adverse Event|4|||
127729977|NCT00753896|459635469|FG000|Overall Study|Death|1|||
127729978|NCT00753896|459635469|FG000|Overall Study|Lost to Follow-up|2|||
127729979|NCT00753896|459635469|FG000|Overall Study|Protocol Violation|1|||
127729980|NCT00753896|459635469|FG000|Overall Study|Withdrawal by Subject|4|||
127729981|NCT00753896|459635469|FG000|Overall Study|Entry Criteria Not Met|4|||
127729982|NCT01029925|459635473|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
127729983|NCT01029925|459635473|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
127729984|NCT01029925|459635473|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
127729985|NCT03708744|459635474|FG000|Overall Study|Withdrawal by Subject|0|||
127729986|NCT03708744|459635475|FG001|Overall Study|Withdrawal by Subject|0|||
127729987|NCT03708744|459635476|FG002|Overall Study|Withdrawal by Subject|1|||
127729988|NCT03708744|459635477|FG003|Overall Study|Withdrawal by Subject|0|||
127729989|NCT04930263|459635478|FG000|Overall Study|Withdrawal by Subject|3|||
127729990|NCT04930263|459635479|FG001|Overall Study|Withdrawal by Subject|5|||
127729991|NCT01989156|459635485|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
127729992|NCT01989156|459635486|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
127729993|NCT01989156|459635487|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
127729994|NCT01989156|459635485|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
127803520|NCT01307033|459903671|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
127803521|NCT01307033|459903672|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
127803522|NCT01307033|459903673|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
127803523|NCT01307033|459903670|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
127803524|NCT01307033|459903671|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
127803525|NCT01307033|459903672|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
127803526|NCT01307033|459903673|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
127803527|NCT01307033|459903670|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
127803528|NCT01307033|459903671|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
127803529|NCT01307033|459903672|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
127803530|NCT01307033|459903673|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
127803531|NCT01307033|459903670|FG000|44-week Open-label Extension|Adverse Event|0|||
127803532|NCT01307033|459903671|FG001|44-week Open-label Extension|Adverse Event|0|||
127803533|NCT01307033|459903672|FG002|44-week Open-label Extension|Adverse Event|2|||
127803534|NCT01307033|459903673|FG003|44-week Open-label Extension|Adverse Event|1|||
127803535|NCT01307033|459903670|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
127803536|NCT01307033|459903671|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
127803537|NCT01307033|459903672|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
127803538|NCT01307033|459903673|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
127803539|NCT01307033|459903670|FG000|44-week Open-label Extension|Physician Decision|0|||
127803540|NCT01307033|459903671|FG001|44-week Open-label Extension|Physician Decision|0|||
127803541|NCT01307033|459903672|FG002|44-week Open-label Extension|Physician Decision|1|||
127729995|NCT01989156|459635486|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
127729996|NCT01989156|459635487|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
127729997|NCT01989156|459635485|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
127729998|NCT01989156|459635486|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
127729999|NCT01989156|459635487|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
127803542|NCT01307033|459903673|FG003|44-week Open-label Extension|Physician Decision|0|||
127803543|NCT01307033|459903670|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
127803544|NCT01307033|459903671|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
127803545|NCT01307033|459903672|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
127803546|NCT01307033|459903673|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
127803547|NCT01307033|459903670|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
127803548|NCT01307033|459903671|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
127803549|NCT01307033|459903672|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
127730000|NCT01989156|459635485|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
127730001|NCT01989156|459635486|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
127730002|NCT01989156|459635487|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
127730003|NCT01989156|459635485|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
127730004|NCT01989156|459635486|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
127730005|NCT01989156|459635487|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
127730006|NCT01989156|459635485|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
127730007|NCT01989156|459635486|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
127730008|NCT01989156|459635487|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
127730009|NCT01989156|459635485|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
127730010|NCT01989156|459635486|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
127730011|NCT01989156|459635487|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
127730012|NCT01989156|459635485|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
127730013|NCT01989156|459635486|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
127730014|NCT01989156|459635487|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
127730015|NCT00850993|459635490|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
127730016|NCT00850993|459635491|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
127730017|NCT00850993|459635492|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
127730018|NCT00850993|459635493|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
127730019|NCT03839355|459635494|FG000|Overall Study|Withdrawal by Subject|1|||
127730020|NCT03839355|459635495|FG001|Overall Study|Withdrawal by Subject|0|||
127730021|NCT01721109|459635504|FG000|Overall Study|Lack of Efficacy|1|||
127730022|NCT01721109|459635504|FG000|Overall Study|Non- Compliance with Study Drug|3|||
127730023|NCT01721109|459635504|FG000|Overall Study|Withdrew Consent|1|||
127730024|NCT01721109|459635504|FG000|Overall Study|Lost to Follow-up|2|||
127730025|NCT01536795|459635505|FG000|Overall Study|Lost to Follow-up|0|||
127730026|NCT01536795|459635506|FG001|Overall Study|Lost to Follow-up|2|||
127730027|NCT01536795|459635505|FG000|Overall Study|Lack of Efficacy|1|||
127730028|NCT01536795|459635506|FG001|Overall Study|Lack of Efficacy|0|||
127730029|NCT01699178|459635508|FG000|Overall Study|Adverse Event|1|||
127730030|NCT01699178|459635509|FG001|Overall Study|Adverse Event|5|||
127730031|NCT01699178|459635508|FG000|Overall Study|Lost to Follow-up|1|||
127730032|NCT01699178|459635509|FG001|Overall Study|Lost to Follow-up|6|||
127730033|NCT01699178|459635508|FG000|Overall Study|Non-compliance with Study Drug|3|||
127730034|NCT01699178|459635509|FG001|Overall Study|Non-compliance with Study Drug|1|||
127803550|NCT01307033|459903673|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
127803551|NCT01307033|459903670|FG000|44-week Open-label Extension|Death|0|||
127803552|NCT01307033|459903671|FG001|44-week Open-label Extension|Death|0|||
127803553|NCT01307033|459903672|FG002|44-week Open-label Extension|Death|0|||
127803554|NCT01307033|459903673|FG003|44-week Open-label Extension|Death|1|||
127803555|NCT01231555|459903674|FG000|Overall Study|Study terminated|8|||
127803556|NCT01231555|459903675|FG001|Overall Study|Study terminated|5|||
127803557|NCT01231555|459903676|FG002|Overall Study|Study terminated|8|||
127803558|NCT01231555|459903674|FG000|Overall Study|Withdrawal by Subject|0|||
127803559|NCT01231555|459903675|FG001|Overall Study|Withdrawal by Subject|2|||
127803560|NCT01231555|459903676|FG002|Overall Study|Withdrawal by Subject|0|||
127803561|NCT00947531|459903677|FG000|Overall Study|Withdrawal by Subject|10|||
127803562|NCT00947531|459903678|FG001|Overall Study|Withdrawal by Subject|7|||
127803563|NCT00947531|459903677|FG000|Overall Study|Administrative Reason|0|||
127803564|NCT00947531|459903678|FG001|Overall Study|Administrative Reason|1|||
127803565|NCT00947531|459903677|FG000|Overall Study|Adverse Event|2|||
127803566|NCT00947531|459903678|FG001|Overall Study|Adverse Event|2|||
127803567|NCT00947531|459903677|FG000|Overall Study|Lack of Efficacy|1|||
127803568|NCT00947531|459903678|FG001|Overall Study|Lack of Efficacy|0|||
127803569|NCT00947531|459903677|FG000|Overall Study|Other|1|||
127803570|NCT00947531|459903678|FG001|Overall Study|Other|1|||
127803571|NCT01773421|459903680|FG000|Treatment Phase|Other|0|||
127803572|NCT01773421|459903681|FG001|Treatment Phase|Other|0|||
127803573|NCT01773421|459903682|FG002|Treatment Phase|Other|2|||
127803574|NCT01773421|459903683|FG003|Treatment Phase|Other|0|||
127803575|NCT01773421|459903684|FG004|Treatment Phase|Other|0|||
127803576|NCT01773421|459903685|FG005|Treatment Phase|Other|0|||
127803577|NCT01773421|459903686|FG006|Treatment Phase|Other|0|||
127803578|NCT01773421|459903680|FG000|Treatment Phase|Adverse Event|0|||
127803579|NCT01773421|459903681|FG001|Treatment Phase|Adverse Event|0|||
127803580|NCT01773421|459903682|FG002|Treatment Phase|Adverse Event|3|||
127803581|NCT01773421|459903683|FG003|Treatment Phase|Adverse Event|1|||
127730035|NCT01699178|459635508|FG000|Overall Study|Physician Decision|1|||
127730036|NCT01699178|459635509|FG001|Overall Study|Physician Decision|0|||
127730037|NCT01699178|459635508|FG000|Overall Study|Withdrawal by Subject|4|||
127803582|NCT01773421|459903684|FG004|Treatment Phase|Adverse Event|0|||
127803583|NCT01773421|459903685|FG005|Treatment Phase|Adverse Event|0|||
127803584|NCT01773421|459903686|FG006|Treatment Phase|Adverse Event|0|||
127803585|NCT01773421|459903680|FG000|Treatment Phase|Withdrawal by Subject|0|||
127730038|NCT01699178|459635509|FG001|Overall Study|Withdrawal by Subject|12|||
127730039|NCT01699178|459635508|FG000|Overall Study|Hematocrit >54%|1|||
127730040|NCT01699178|459635509|FG001|Overall Study|Hematocrit >54%|1|||
127730041|NCT01699178|459635508|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
127730042|NCT01699178|459635509|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
127730043|NCT01699178|459635508|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
127730044|NCT01699178|459635509|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
127730045|NCT00321555|459635511|FG000|Overall Study|Developed antibodies|1|||
127730046|NCT00321555|459635511|FG000|Overall Study|Switched to alternative treatment|3|||
127730047|NCT00321555|459635511|FG000|Overall Study|Physician Decision|1|||
127730048|NCT00321555|459635511|FG000|Overall Study|Disease progression on study|1|||
127730049|NCT02066389|459635513|FG000|Overall Study|Adverse Event|1|||
127730050|NCT02066389|459635514|FG001|Overall Study|Adverse Event|1|||
127730051|NCT02066389|459635515|FG002|Overall Study|Adverse Event|1|||
127730052|NCT02066389|459635516|FG003|Overall Study|Adverse Event|1|||
127730053|NCT02066389|459635517|FG004|Overall Study|Adverse Event|5|||
127730054|NCT02066389|459635518|FG005|Overall Study|Adverse Event|1|||
127730055|NCT02066389|459635513|FG000|Overall Study|Withdrawal by Subject|4|||
127730056|NCT02066389|459635514|FG001|Overall Study|Withdrawal by Subject|0|||
127730057|NCT02066389|459635515|FG002|Overall Study|Withdrawal by Subject|5|||
127730058|NCT02066389|459635516|FG003|Overall Study|Withdrawal by Subject|1|||
127730059|NCT02066389|459635517|FG004|Overall Study|Withdrawal by Subject|1|||
127730060|NCT02066389|459635518|FG005|Overall Study|Withdrawal by Subject|2|||
127730061|NCT02066389|459635513|FG000|Overall Study|Lost to Follow-up|0|||
127730062|NCT02066389|459635514|FG001|Overall Study|Lost to Follow-up|0|||
127730063|NCT02066389|459635515|FG002|Overall Study|Lost to Follow-up|0|||
127730064|NCT02066389|459635516|FG003|Overall Study|Lost to Follow-up|1|||
127730065|NCT02066389|459635517|FG004|Overall Study|Lost to Follow-up|1|||
127730066|NCT02066389|459635518|FG005|Overall Study|Lost to Follow-up|1|||
127730067|NCT02066389|459635513|FG000|Overall Study|Randomized in Error|0|||
127730068|NCT02066389|459635514|FG001|Overall Study|Randomized in Error|0|||
127730069|NCT02066389|459635515|FG002|Overall Study|Randomized in Error|0|||
127730070|NCT02066389|459635516|FG003|Overall Study|Randomized in Error|0|||
127730071|NCT02066389|459635517|FG004|Overall Study|Randomized in Error|0|||
127730072|NCT02066389|459635518|FG005|Overall Study|Randomized in Error|1|||
127730073|NCT01755598|459635523|FG000|Overall Study|Other|109|||
127730074|NCT01755598|459635524|FG001|Overall Study|Other|109|||
127730075|NCT01755598|459635523|FG000|Overall Study|Lost to Follow-up|32|||
127730076|NCT01755598|459635524|FG001|Overall Study|Lost to Follow-up|43|||
127803586|NCT01773421|459903681|FG001|Treatment Phase|Withdrawal by Subject|0|||
127803587|NCT01773421|459903682|FG002|Treatment Phase|Withdrawal by Subject|1|||
127803588|NCT01773421|459903683|FG003|Treatment Phase|Withdrawal by Subject|1|||
127803589|NCT01773421|459903684|FG004|Treatment Phase|Withdrawal by Subject|0|||
127803590|NCT01773421|459903685|FG005|Treatment Phase|Withdrawal by Subject|0|||
127803591|NCT01773421|459903686|FG006|Treatment Phase|Withdrawal by Subject|0|||
127803592|NCT01773421|459903680|FG000|Extension Phase|Other|0|||
127803593|NCT01773421|459903681|FG001|Extension Phase|Other|0|||
127803594|NCT01773421|459903682|FG002|Extension Phase|Other|0|||
127803595|NCT01773421|459903683|FG003|Extension Phase|Other|0|||
127803596|NCT01773421|459903684|FG004|Extension Phase|Other|1|||
127803597|NCT01773421|459903685|FG005|Extension Phase|Other|2|||
127803598|NCT01773421|459903686|FG006|Extension Phase|Other|0|||
127803599|NCT01773421|459903680|FG000|Extension Phase|Adverse Event|0|||
127803600|NCT01773421|459903681|FG001|Extension Phase|Adverse Event|0|||
127803601|NCT01773421|459903682|FG002|Extension Phase|Adverse Event|0|||
127803602|NCT01773421|459903683|FG003|Extension Phase|Adverse Event|0|||
127803603|NCT01773421|459903684|FG004|Extension Phase|Adverse Event|2|||
127803604|NCT01773421|459903685|FG005|Extension Phase|Adverse Event|0|||
127803605|NCT01773421|459903686|FG006|Extension Phase|Adverse Event|0|||
127803606|NCT03502330|459903687|FG000|Overall Study|Adverse Event|2|||
127803607|NCT03502330|459903688|FG001|Overall Study|Adverse Event|1|||
127803608|NCT03502330|459903689|FG002|Overall Study|Adverse Event|0|||
127803609|NCT03502330|459903690|FG003|Overall Study|Adverse Event|0|||
127730077|NCT01755598|459635523|FG000|Overall Study|Migrated/moved from study area|76|||
127730078|NCT01755598|459635524|FG001|Overall Study|Migrated/moved from study area|65|||
127730079|NCT01755598|459635523|FG000|Overall Study|Withdrawal by Subject|22|||
127730080|NCT01755598|459635524|FG001|Overall Study|Withdrawal by Subject|31|||
127730081|NCT01755598|459635523|FG000|Overall Study|Protocol Violation|7|||
127730082|NCT01755598|459635524|FG001|Overall Study|Protocol Violation|7|||
127803610|NCT03502330|459903691|FG004|Overall Study|Adverse Event|1|||
127803611|NCT03502330|459903692|FG005|Overall Study|Adverse Event|0|||
127803612|NCT03502330|459903693|FG006|Overall Study|Adverse Event|1|||
127803613|NCT03502330|459903694|FG007|Overall Study|Adverse Event|1|||
127803614|NCT03502330|459903695|FG008|Overall Study|Adverse Event|0|||
127803615|NCT03502330|459903687|FG000|Overall Study|Lack of Efficacy|1|||
127730083|NCT01755598|459635523|FG000|Overall Study|Adverse Event|19|||
127730084|NCT01755598|459635524|FG001|Overall Study|Adverse Event|28|||
127730085|NCT02924051|459635527|FG000|Overall Study|Withdrawal by Subject|1|||
127730086|NCT02924051|459635528|FG001|Overall Study|Withdrawal by Subject|9|||
127730087|NCT03547167|459635533|FG000|Overall Study|Withdrawal by Subject|34|||
127730088|NCT03547167|459635534|FG001|Overall Study|Withdrawal by Subject|12|||
127730089|NCT03547167|459635533|FG000|Overall Study|Screen Failure|0|||
127730090|NCT03547167|459635534|FG001|Overall Study|Screen Failure|1|||
127730091|NCT03547167|459635533|FG000|Overall Study|Lost to Follow-up|59|||
127730092|NCT03547167|459635534|FG001|Overall Study|Lost to Follow-up|15|||
127730093|NCT03547167|459635533|FG000|Overall Study|Death|4|||
127730094|NCT03547167|459635534|FG001|Overall Study|Death|2|||
127730095|NCT03138499|459635536|FG000|Overall Study|Lost to Follow-up|1|||
127730096|NCT03138499|459635537|FG001|Overall Study|Lost to Follow-up|0|||
127730097|NCT03138499|459635536|FG000|Overall Study|Participants withdrew consent|1|||
127730098|NCT03138499|459635537|FG001|Overall Study|Participants withdrew consent|0|||
127730099|NCT03138499|459635536|FG000|Overall Study|Participant discontinued study before treatment|0|||
127730100|NCT03138499|459635537|FG001|Overall Study|Participant discontinued study before treatment|1|||
127730101|NCT03138499|459635536|FG000|Overall Study|Disease Progression|2|||
127730102|NCT03138499|459635537|FG001|Overall Study|Disease Progression|6|||
127730103|NCT03138499|459635536|FG000|Overall Study|Study drug toxicity|2|||
127730104|NCT03138499|459635537|FG001|Overall Study|Study drug toxicity|2|||
127730105|NCT03138499|459635536|FG000|Overall Study|Participant request to discontinue study treatment|1|||
127730106|NCT03138499|459635537|FG001|Overall Study|Participant request to discontinue study treatment|1|||
127730107|NCT03138499|459635536|FG000|Overall Study|Other reasons|2|||
127730108|NCT03138499|459635537|FG001|Overall Study|Other reasons|0|||
127730109|NCT01661972|459635538|FG000|Overall Study|Adverse Event|1|||
127730110|NCT01661972|459635539|FG001|Overall Study|Adverse Event|2|||
127730111|NCT01661972|459635538|FG000|Overall Study|Death during Treatment period|1|||
127730112|NCT01661972|459635539|FG001|Overall Study|Death during Treatment period|1|||
127730113|NCT01661972|459635538|FG000|Overall Study|Withdrawal by Subject|0|||
127730114|NCT01661972|459635539|FG001|Overall Study|Withdrawal by Subject|1|||
127730115|NCT02009865|459635542|FG000|Overall Study|Adverse Event|0|||
127730116|NCT02009865|459635543|FG001|Overall Study|Adverse Event|2|||
127730117|NCT02009865|459635542|FG000|Overall Study|Protocol Violation|0|||
127730118|NCT02009865|459635543|FG001|Overall Study|Protocol Violation|2|||
127730119|NCT02009865|459635542|FG000|Overall Study|Withdrawal by Subject|1|||
127730120|NCT02009865|459635543|FG001|Overall Study|Withdrawal by Subject|1|||
127730121|NCT01760876|459635544|FG000|Overall Study|Non-cardiac death (head injury)|1|||
127730122|NCT01760876|459635544|FG000|Overall Study|Carcinoma of prostate|1|||
127730123|NCT01760876|459635544|FG000|Overall Study|Impaired renal function|1|||
127730124|NCT01760876|459635544|FG000|Overall Study|Major depression|1|||
127730125|NCT01760876|459635544|FG000|Overall Study|Very poor baseline OCT quality|2|||
127730126|NCT01517282|459635545|FG000|Overall Study|Consent withdrawn|0|||
127730127|NCT01517282|459635546|FG001|Overall Study|Consent withdrawn|1|||
127730128|NCT01517282|459635547|FG002|Overall Study|Consent withdrawn|1|||
127730129|NCT01517282|459635548|FG003|Overall Study|Consent withdrawn|1|||
127730130|NCT01517282|459635545|FG000|Overall Study|Physician Decision|1|||
127730131|NCT01517282|459635546|FG001|Overall Study|Physician Decision|0|||
127730132|NCT01517282|459635547|FG002|Overall Study|Physician Decision|0|||
127730133|NCT01517282|459635548|FG003|Overall Study|Physician Decision|0|||
127730134|NCT00525915|459635549|FG000|Overall Study|Non-Compliance|0|||
127730135|NCT00525915|459635550|FG001|Overall Study|Non-Compliance|1|||
127730136|NCT00525915|459635549|FG000|Overall Study|Disease Progression|5|||
127730137|NCT00525915|459635550|FG001|Overall Study|Disease Progression|6|||
127730138|NCT00525915|459635549|FG000|Overall Study|Withdrawal by Subject|1|||
127730139|NCT00525915|459635550|FG001|Overall Study|Withdrawal by Subject|0|||
127730140|NCT00525915|459635549|FG000|Overall Study|Refused Surgery|1|||
127730141|NCT00525915|459635550|FG001|Overall Study|Refused Surgery|2|||
127730142|NCT00525915|459635549|FG000|Overall Study|Unrelated illness|1|||
127730143|NCT00525915|459635550|FG001|Overall Study|Unrelated illness|0|||
127730144|NCT02332889|459635554|FG000|Overall Study|Physician Decision|1|||
127730145|NCT00711555|459636816|FG000|Overall Study|Adverse Event|3|||
127730146|NCT04914897|459636817|FG000|Overall Study|Withdrawal by Subject|3|||
127730147|NCT04914897|459636818|FG001|Overall Study|Withdrawal by Subject|1|||
127730148|NCT04914897|459636819|FG002|Overall Study|Withdrawal by Subject|1|||
127730149|NCT04914897|459636820|FG003|Overall Study|Withdrawal by Subject|1|||
127730150|NCT04914897|459636817|FG000|Overall Study|Poor compliance to protocol|0|||
127730151|NCT04914897|459636818|FG001|Overall Study|Poor compliance to protocol|0|||
127730152|NCT04914897|459636819|FG002|Overall Study|Poor compliance to protocol|1|||
127730153|NCT04914897|459636820|FG003|Overall Study|Poor compliance to protocol|0|||
127730154|NCT04914897|459636817|FG000|Overall Study|Progressive disease|5|||
127730155|NCT04914897|459636818|FG001|Overall Study|Progressive disease|14|||
127730156|NCT04914897|459636819|FG002|Overall Study|Progressive disease|30|||
127730157|NCT04914897|459636820|FG003|Overall Study|Progressive disease|21|||
127730158|NCT04914897|459636817|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
127730159|NCT04914897|459636818|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
127730160|NCT04914897|459636819|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|7|||
127730161|NCT04914897|459636820|FG003|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|6|||
127730162|NCT04914897|459636817|FG000|Overall Study|Other|1|||
127730163|NCT04914897|459636818|FG001|Overall Study|Other|0|||
127730164|NCT04914897|459636819|FG002|Overall Study|Other|0|||
127730165|NCT04914897|459636820|FG003|Overall Study|Other|1|||
127730166|NCT05356130|459636821|FG000|Overall Study|Withdrawal by Subject|0|||
127730167|NCT05356130|459636822|FG001|Overall Study|Withdrawal by Subject|0|||
127730168|NCT05356130|459636823|FG002|Overall Study|Withdrawal by Subject|3|||
127730169|NCT03141177|459636824|FG000|Overall Study|Death|62|||
127730170|NCT03141177|459636825|FG001|Overall Study|Death|13|||
127730171|NCT03141177|459636826|FG002|Overall Study|Death|84|||
127730172|NCT03141177|459636824|FG000|Overall Study|Participant withdrew consent|9|||
127730173|NCT03141177|459636825|FG001|Overall Study|Participant withdrew consent|2|||
127730174|NCT03141177|459636826|FG002|Overall Study|Participant withdrew consent|13|||
127730175|NCT03141177|459636824|FG000|Overall Study|Not reported|1|||
127730176|NCT03141177|459636825|FG001|Overall Study|Not reported|0|||
127730177|NCT03141177|459636826|FG002|Overall Study|Not reported|1|||
127730178|NCT03141177|459636824|FG000|Overall Study|Lost to Follow-up|2|||
127730179|NCT03141177|459636825|FG001|Overall Study|Lost to Follow-up|1|||
127730180|NCT03141177|459636826|FG002|Overall Study|Lost to Follow-up|1|||
127730181|NCT03141177|459636824|FG000|Overall Study|Other reasons|4|||
127730182|NCT03141177|459636825|FG001|Overall Study|Other reasons|0|||
127730183|NCT03141177|459636826|FG002|Overall Study|Other reasons|11|||
127730184|NCT03141177|459636824|FG000|Overall Study|Participants did not start treatment period|3|||
127730185|NCT03141177|459636825|FG001|Overall Study|Participants did not start treatment period|0|||
127730186|NCT03141177|459636826|FG002|Overall Study|Participants did not start treatment period|8|||
127730187|NCT03020914|459636829|FG000|Overall Study|Surgery Cancelled|1|||
127730188|NCT03020914|459636830|FG001|Overall Study|Surgery Cancelled|0|||
127730189|NCT00409006|459636835|FG000|Overall Study|Death|15|||
127730190|NCT00409006|459636836|FG001|Overall Study|Death|6|||
127730191|NCT00409006|459636835|FG000|Overall Study|Lost to Follow-up|1|||
127730192|NCT00409006|459636836|FG001|Overall Study|Lost to Follow-up|2|||
127730193|NCT00409006|459636835|FG000|Overall Study|Withdrawal by Subject|3|||
127730194|NCT00409006|459636836|FG001|Overall Study|Withdrawal by Subject|2|||
127730195|NCT00409006|459636835|FG000|Overall Study|Physician Decision|1|||
127730196|NCT00409006|459636836|FG001|Overall Study|Physician Decision|2|||
127730197|NCT00228813|459636837|FG000|Overall Study|Death|4|||
127730198|NCT00668746|459636838|FG000|Overall Study|Lost to Follow-up|2|||
127730199|NCT00668746|459636839|FG001|Overall Study|Lost to Follow-up|1|||
127730200|NCT02109172|459636840|FG000|Overall Study|Withdrawal by Subject|1|||
127730201|NCT02109172|459636841|FG001|Overall Study|Withdrawal by Subject|0|||
127730202|NCT02109172|459636842|FG002|Overall Study|Withdrawal by Subject|0|||
127730203|NCT02109172|459636843|FG003|Overall Study|Withdrawal by Subject|1|||
127730204|NCT02109172|459636844|FG004|Overall Study|Withdrawal by Subject|0|||
127730205|NCT02109172|459636845|FG005|Overall Study|Withdrawal by Subject|0|||
127730206|NCT02109172|459636840|FG000|Overall Study|Adverse Event|0|||
127730207|NCT02109172|459636841|FG001|Overall Study|Adverse Event|0|||
127730208|NCT02109172|459636842|FG002|Overall Study|Adverse Event|1|||
127730209|NCT02109172|459636843|FG003|Overall Study|Adverse Event|0|||
127730210|NCT02109172|459636844|FG004|Overall Study|Adverse Event|0|||
127730211|NCT02109172|459636845|FG005|Overall Study|Adverse Event|1|||
127730212|NCT02109172|459636840|FG000|Overall Study|Death|0|||
127730213|NCT02109172|459636841|FG001|Overall Study|Death|0|||
127730214|NCT02109172|459636842|FG002|Overall Study|Death|0|||
127730215|NCT02109172|459636843|FG003|Overall Study|Death|0|||
127730216|NCT02109172|459636844|FG004|Overall Study|Death|1|||
127730217|NCT02109172|459636845|FG005|Overall Study|Death|0|||
127730218|NCT02011568|459636846|FG000|Overall Study|Withdrawal by Subject|8|||
127730219|NCT02011568|459636847|FG001|Overall Study|Withdrawal by Subject|10|||
127730220|NCT02011568|459636846|FG000|Overall Study|Physician Decision|1|||
127730221|NCT02011568|459636847|FG001|Overall Study|Physician Decision|3|||
127730222|NCT03696342|459636851|FG000|Overall Study|Lost to Follow-up|1|||
127730223|NCT03696342|459636852|FG001|Overall Study|Lost to Follow-up|0|||
127730224|NCT05361304|459636855|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
127730225|NCT05361304|459636856|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
127730226|NCT05361304|459636855|FG000|Overall Study|COVID-19 Related|1|||
127730227|NCT05361304|459636856|FG001|Overall Study|COVID-19 Related|2|||
127730228|NCT05361304|459636855|FG000|Overall Study|Withdrawal by Subject|1|||
127730229|NCT05361304|459636856|FG001|Overall Study|Withdrawal by Subject|0|||
127730230|NCT01816165|459636857|FG000|Overall Study|Adverse Event|1|||
127730231|NCT01816165|459636858|FG001|Overall Study|Adverse Event|0|||
127730232|NCT01816165|459636859|FG002|Overall Study|Adverse Event|0|||
127730233|NCT01816165|459636860|FG003|Overall Study|Adverse Event|0|||
127730234|NCT02409732|459636861|FG000|Overall Study|Withdrawal by Subject|4|||
127730235|NCT02409732|459636861|FG000|Overall Study|Lost to Follow-up|2|||
127730236|NCT00376259|459636862|FG000|Overall Study|Sponsor request - study termination|21|||
127730237|NCT00376259|459636863|FG001|Overall Study|Sponsor request - study termination|21|||
127730238|NCT00376259|459636862|FG000|Overall Study|Patient request|1|||
127730239|NCT00376259|459636863|FG001|Overall Study|Patient request|0|||
127730240|NCT01877720|459636864|FG000|Overall Study|Adverse Event|1|||
127730241|NCT01877720|459636865|FG001|Overall Study|Adverse Event|0|||
127730242|NCT00447499|459636866|FG000|Overall Study|Adverse Event|1|||
127730243|NCT00447499|459636866|FG000|Overall Study|Patient Decision|4|||
127730244|NCT00447499|459636866|FG000|Overall Study|Sponsor Decision|1|||
127730245|NCT00447499|459636866|FG000|Overall Study|Physician Decision|1|||
127730246|NCT02068352|459636868|FG000|Overall Study|Lost to Follow-up|0|||
127730247|NCT02068352|459636869|FG001|Overall Study|Lost to Follow-up|2|||
127730248|NCT02068352|459636870|FG002|Overall Study|Lost to Follow-up|0|||
127730249|NCT02068352|459636868|FG000|Overall Study|Adverse Event|4|||
127730250|NCT02068352|459636869|FG001|Overall Study|Adverse Event|2|||
127730251|NCT02068352|459636870|FG002|Overall Study|Adverse Event|7|||
127730252|NCT02068352|459636868|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
127730253|NCT02068352|459636869|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
127730254|NCT02068352|459636870|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
127730255|NCT02068352|459636868|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
127730256|NCT02068352|459636869|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
127730257|NCT02068352|459636870|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
127730258|NCT02068352|459636868|FG000|Overall Study|Protocol Deviation|0|||
127730259|NCT02068352|459636869|FG001|Overall Study|Protocol Deviation|0|||
127730260|NCT02068352|459636870|FG002|Overall Study|Protocol Deviation|1|||
127730261|NCT03960437|459636871|FG000|Overall Study|Removed by PI|4|||
127730262|NCT03960437|459636871|FG000|Overall Study|Lost to Follow-up|2|||
127730263|NCT03960437|459636871|FG000|Overall Study|Withdrawal by Subject|1|||
127730264|NCT03960437|459636871|FG000|Overall Study|Death|2|||
127730265|NCT00473512|459636874|FG000|Period 1 (Phase 1)|Adverse Event|0|||
127730266|NCT00473512|459636875|FG001|Period 1 (Phase 1)|Adverse Event|0|||
127730267|NCT00473512|459636876|FG002|Period 1 (Phase 1)|Adverse Event|0|||
127730268|NCT00473512|459636877|FG003|Period 1 (Phase 1)|Adverse Event|5|||
127730269|NCT00473512|459636878|FG004|Period 1 (Phase 1)|Adverse Event|0|||
127730270|NCT00473512|459636874|FG000|Period 1 (Phase 1)|Death|0|||
127730271|NCT00473512|459636875|FG001|Period 1 (Phase 1)|Death|0|||
127730272|NCT00473512|459636876|FG002|Period 1 (Phase 1)|Death|0|||
127730273|NCT00473512|459636877|FG003|Period 1 (Phase 1)|Death|1|||
127730274|NCT00473512|459636878|FG004|Period 1 (Phase 1)|Death|0|||
127730275|NCT00473512|459636874|FG000|Period 1 (Phase 1)|Disease Progression|1|||
127730276|NCT00473512|459636875|FG001|Period 1 (Phase 1)|Disease Progression|1|||
127803616|NCT03502330|459903688|FG001|Overall Study|Lack of Efficacy|5|||
127803617|NCT03502330|459903689|FG002|Overall Study|Lack of Efficacy|3|||
127803618|NCT03502330|459903690|FG003|Overall Study|Lack of Efficacy|5|||
127730277|NCT00473512|459636876|FG002|Period 1 (Phase 1)|Disease Progression|0|||
127730278|NCT00473512|459636877|FG003|Period 1 (Phase 1)|Disease Progression|10|||
127730279|NCT00473512|459636878|FG004|Period 1 (Phase 1)|Disease Progression|1|||
127730280|NCT00473512|459636874|FG000|Period 1 (Phase 1)|Other|0|||
127730281|NCT00473512|459636875|FG001|Period 1 (Phase 1)|Other|0|||
127730282|NCT00473512|459636876|FG002|Period 1 (Phase 1)|Other|0|||
127730283|NCT00473512|459636877|FG003|Period 1 (Phase 1)|Other|1|||
127730284|NCT00473512|459636878|FG004|Period 1 (Phase 1)|Other|0|||
127730285|NCT00473512|459636874|FG000|Period 2 (Phase 2)|Adverse Event|0|||
127730286|NCT00473512|459636875|FG001|Period 2 (Phase 2)|Adverse Event|0|||
127730287|NCT00473512|459636876|FG002|Period 2 (Phase 2)|Adverse Event|0|||
127730288|NCT00473512|459636877|FG003|Period 2 (Phase 2)|Adverse Event|1|||
127730289|NCT00473512|459636878|FG004|Period 2 (Phase 2)|Adverse Event|0|||
127730290|NCT00473512|459636874|FG000|Period 2 (Phase 2)|Death|0|||
127730291|NCT00473512|459636875|FG001|Period 2 (Phase 2)|Death|0|||
127730292|NCT00473512|459636876|FG002|Period 2 (Phase 2)|Death|0|||
127730293|NCT00473512|459636877|FG003|Period 2 (Phase 2)|Death|1|||
127730294|NCT00473512|459636878|FG004|Period 2 (Phase 2)|Death|1|||
127730295|NCT00473512|459636874|FG000|Period 2 (Phase 2)|Disease Progression|0|||
127730296|NCT00473512|459636875|FG001|Period 2 (Phase 2)|Disease Progression|2|||
127730297|NCT00473512|459636876|FG002|Period 2 (Phase 2)|Disease Progression|2|||
127730298|NCT00473512|459636877|FG003|Period 2 (Phase 2)|Disease Progression|17|||
127730299|NCT00473512|459636878|FG004|Period 2 (Phase 2)|Disease Progression|1|||
127730300|NCT00473512|459636874|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
127730301|NCT00473512|459636875|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
127730302|NCT00473512|459636876|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
127730303|NCT00473512|459636877|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
127730304|NCT00473512|459636878|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
127730305|NCT00473512|459636874|FG000|Period 2 (Phase 2)|Other|1|||
127730306|NCT00473512|459636875|FG001|Period 2 (Phase 2)|Other|0|||
127730307|NCT00473512|459636876|FG002|Period 2 (Phase 2)|Other|0|||
127730308|NCT00473512|459636877|FG003|Period 2 (Phase 2)|Other|3|||
127730309|NCT00473512|459636878|FG004|Period 2 (Phase 2)|Other|0|||
127730310|NCT00267956|459636879|FG000|Controlled Period|Adverse Event|4|||
127730311|NCT00267956|459636880|FG001|Controlled Period|Adverse Event|1|||
127730312|NCT00267956|459636881|FG002|Controlled Period|Adverse Event|0|||
127730313|NCT00267956|459636882|FG003|Controlled Period|Adverse Event|0|||
127730314|NCT00267956|459636879|FG000|Controlled Period|Lack of Efficacy|4|||
127730315|NCT00267956|459636880|FG001|Controlled Period|Lack of Efficacy|2|||
127730316|NCT00267956|459636881|FG002|Controlled Period|Lack of Efficacy|0|||
127730317|NCT00267956|459636882|FG003|Controlled Period|Lack of Efficacy|0|||
127730318|NCT00267956|459636879|FG000|Controlled Period|Lost to Follow-up|2|||
127730319|NCT00267956|459636880|FG001|Controlled Period|Lost to Follow-up|0|||
127730320|NCT00267956|459636881|FG002|Controlled Period|Lost to Follow-up|0|||
127730321|NCT00267956|459636882|FG003|Controlled Period|Lost to Follow-up|0|||
127730322|NCT00267956|459636879|FG000|Controlled Period|Withdrew consent|3|||
127730323|NCT00267956|459636880|FG001|Controlled Period|Withdrew consent|1|||
127730324|NCT00267956|459636881|FG002|Controlled Period|Withdrew consent|0|||
127730325|NCT00267956|459636882|FG003|Controlled Period|Withdrew consent|0|||
127730326|NCT00267956|459636879|FG000|After Controlled Period|Adverse Event|0|||
127730327|NCT00267956|459636880|FG001|After Controlled Period|Adverse Event|0|||
127730328|NCT00267956|459636881|FG002|After Controlled Period|Adverse Event|2|||
127730329|NCT00267956|459636882|FG003|After Controlled Period|Adverse Event|1|||
127730330|NCT00267956|459636879|FG000|After Controlled Period|Lack of Efficacy|0|||
127730331|NCT00267956|459636880|FG001|After Controlled Period|Lack of Efficacy|0|||
127730332|NCT00267956|459636881|FG002|After Controlled Period|Lack of Efficacy|1|||
127730333|NCT00267956|459636882|FG003|After Controlled Period|Lack of Efficacy|1|||
127730334|NCT00267956|459636879|FG000|After Controlled Period|Lost to Follow-up|0|||
127730335|NCT00267956|459636880|FG001|After Controlled Period|Lost to Follow-up|0|||
127730336|NCT00267956|459636881|FG002|After Controlled Period|Lost to Follow-up|1|||
127803619|NCT03502330|459903691|FG004|Overall Study|Lack of Efficacy|1|||
127803620|NCT03502330|459903692|FG005|Overall Study|Lack of Efficacy|5|||
127803621|NCT03502330|459903693|FG006|Overall Study|Lack of Efficacy|5|||
127803622|NCT03502330|459903694|FG007|Overall Study|Lack of Efficacy|6|||
127803623|NCT03502330|459903695|FG008|Overall Study|Lack of Efficacy|0|||
127803624|NCT03502330|459903687|FG000|Overall Study|Physician Decision|0|||
127803625|NCT03502330|459903688|FG001|Overall Study|Physician Decision|0|||
127803626|NCT03502330|459903689|FG002|Overall Study|Physician Decision|0|||
127803627|NCT03502330|459903690|FG003|Overall Study|Physician Decision|0|||
127803628|NCT03502330|459903691|FG004|Overall Study|Physician Decision|1|||
127803629|NCT03502330|459903692|FG005|Overall Study|Physician Decision|0|||
127730337|NCT00267956|459636882|FG003|After Controlled Period|Lost to Follow-up|0|||
127730338|NCT00267956|459636879|FG000|After Controlled Period|Withdrew consent|0|||
127730339|NCT00267956|459636880|FG001|After Controlled Period|Withdrew consent|0|||
127730340|NCT00267956|459636881|FG002|After Controlled Period|Withdrew consent|1|||
127730341|NCT00267956|459636882|FG003|After Controlled Period|Withdrew consent|0|||
127730342|NCT02246647|459636883|FG000|Overall Study|Withdrawal by Subject|1|||
127730343|NCT02246647|459636884|FG001|Overall Study|Withdrawal by Subject|1|||
127730344|NCT01012999|459636885|FG000|Overall Study|Protocol Violation|1|||
127803630|NCT03502330|459903693|FG006|Overall Study|Physician Decision|0|||
127803631|NCT03502330|459903694|FG007|Overall Study|Physician Decision|0|||
127803632|NCT03502330|459903695|FG008|Overall Study|Physician Decision|0|||
127730345|NCT03557307|459636886|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
127730346|NCT03557307|459636886|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
127730347|NCT03557307|459636886|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
127803633|NCT03502330|459903687|FG000|Overall Study|Withdrawal by Subject|0|||
127730348|NCT03557307|459636886|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
127730349|NCT03557307|459636886|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
127730350|NCT03557307|459636886|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
127730351|NCT03557307|459636886|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
127730352|NCT03557307|459636886|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
127730353|NCT03557307|459636886|FG000|Period 2: Maintenance Phase|Death|3|||
127730354|NCT03557307|459636886|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
127730355|NCT03557307|459636886|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
127730356|NCT03557307|459636886|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
127730357|NCT03557307|459636886|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
127730358|NCT03557307|459636886|FG000|Period 2: Maintenance Phase|other|3|||
127730359|NCT02069366|459636887|FG000|Overall Study|Lost to Follow-up|0|||
127730360|NCT02069366|459636888|FG001|Overall Study|Lost to Follow-up|0|||
127730361|NCT02069366|459636889|FG002|Overall Study|Lost to Follow-up|1|||
127730362|NCT02069366|459636890|FG003|Overall Study|Lost to Follow-up|0|||
127730363|NCT02069366|459636891|FG004|Overall Study|Lost to Follow-up|0|||
127730364|NCT02069366|459636892|FG005|Overall Study|Lost to Follow-up|2|||
127730365|NCT02069366|459636887|FG000|Overall Study|Protocol Violation|0|||
127730366|NCT02069366|459636888|FG001|Overall Study|Protocol Violation|0|||
127730367|NCT02069366|459636889|FG002|Overall Study|Protocol Violation|1|||
127730368|NCT02069366|459636890|FG003|Overall Study|Protocol Violation|0|||
127730369|NCT02069366|459636891|FG004|Overall Study|Protocol Violation|0|||
127730370|NCT02069366|459636892|FG005|Overall Study|Protocol Violation|0|||
127730371|NCT02069366|459636887|FG000|Overall Study|Withdrawal by Subject|1|||
127730372|NCT02069366|459636888|FG001|Overall Study|Withdrawal by Subject|0|||
127730373|NCT02069366|459636889|FG002|Overall Study|Withdrawal by Subject|1|||
127730374|NCT02069366|459636890|FG003|Overall Study|Withdrawal by Subject|2|||
127730375|NCT02069366|459636891|FG004|Overall Study|Withdrawal by Subject|0|||
127730376|NCT02069366|459636892|FG005|Overall Study|Withdrawal by Subject|0|||
127730377|NCT02256553|459636893|FG000|Period I|Adverse Event|5|||
127730378|NCT02256553|459636893|FG000|Period I|Protocol Violation|1|||
127730379|NCT02256553|459636893|FG000|Period II|Adverse Event|1|||
127730380|NCT02256553|459636893|FG000|Period II|Subject Moved|1|||
127730381|NCT02256553|459636893|FG000|Period III|Adverse Event|3|||
127730382|NCT03436797|459636894|FG000|Main Study|Withdrawal by Subject|2|||
127730383|NCT03436797|459636894|FG000|Main Study|Adverse Event|4|||
127730384|NCT03436797|459636894|FG000|Main Study|Lost to Follow-up|1|||
127730385|NCT03436797|459636894|FG000|Main Study|Death|1|||
127730386|NCT03436797|459636894|FG000|Main Study|Non-Specific|2|||
127730387|NCT03436797|459636894|FG000|Extended Dosing|Patient decision|1|||
127730388|NCT01951105|459636897|FG000|Overall Study|Adverse Event|0|||
127730389|NCT01951105|459636898|FG001|Overall Study|Adverse Event|5|||
127730390|NCT01951105|459636899|FG002|Overall Study|Adverse Event|0|||
127730391|NCT01951105|459636897|FG000|Overall Study|Lost to Follow-up|0|||
127730392|NCT01951105|459636898|FG001|Overall Study|Lost to Follow-up|1|||
127730393|NCT01951105|459636899|FG002|Overall Study|Lost to Follow-up|0|||
127730394|NCT01951105|459636897|FG000|Overall Study|Protocol Violation|1|||
127730395|NCT01951105|459636898|FG001|Overall Study|Protocol Violation|1|||
127730396|NCT01951105|459636899|FG002|Overall Study|Protocol Violation|1|||
127730397|NCT01951105|459636897|FG000|Overall Study|Withdrawal by Subject|0|||
127730398|NCT01951105|459636898|FG001|Overall Study|Withdrawal by Subject|3|||
127730399|NCT01951105|459636899|FG002|Overall Study|Withdrawal by Subject|1|||
127730400|NCT01601821|459636900|FG000|Overall Study|Death|2|||
127730401|NCT01601821|459636901|FG001|Overall Study|Death|5|||
127730402|NCT01601821|459636900|FG000|Overall Study|Protocol Violation|2|||
127730403|NCT01601821|459636901|FG001|Overall Study|Protocol Violation|2|||
127730404|NCT01601821|459636900|FG000|Overall Study|Lost to Follow-up|6|||
127730405|NCT01601821|459636901|FG001|Overall Study|Lost to Follow-up|14|||
127730406|NCT01601821|459636900|FG000|Overall Study|Withdrawal by Subject|1|||
127730407|NCT01601821|459636901|FG001|Overall Study|Withdrawal by Subject|0|||
127730408|NCT01601821|459636900|FG000|Overall Study|Graft Loss|6|||
127730409|NCT01601821|459636901|FG001|Overall Study|Graft Loss|6|||
127730410|NCT01601821|459636900|FG000|Overall Study|Study Events|7|||
127730411|NCT01601821|459636901|FG001|Overall Study|Study Events|1|||
127730412|NCT01601821|459636900|FG000|Overall Study|Other|5|||
127730413|NCT01601821|459636901|FG001|Overall Study|Other|1|||
127730414|NCT02469155|459636904|FG000|Overall Study|Adverse Event|6|||
127730415|NCT02469155|459636905|FG001|Overall Study|Adverse Event|0|||
127730416|NCT02469155|459636906|FG002|Overall Study|Adverse Event|1|||
127730417|NCT02469155|459636907|FG003|Overall Study|Adverse Event|10|||
127730418|NCT02469155|459636904|FG000|Overall Study|Lack of Efficacy|13|||
127730419|NCT02469155|459636905|FG001|Overall Study|Lack of Efficacy|10|||
127730420|NCT02469155|459636906|FG002|Overall Study|Lack of Efficacy|10|||
127730421|NCT02469155|459636907|FG003|Overall Study|Lack of Efficacy|8|||
127730422|NCT02469155|459636904|FG000|Overall Study|Death|0|||
127730423|NCT02469155|459636905|FG001|Overall Study|Death|0|||
127730424|NCT02469155|459636906|FG002|Overall Study|Death|0|||
127730425|NCT02469155|459636907|FG003|Overall Study|Death|1|||
127730426|NCT02469155|459636904|FG000|Overall Study|Lost to Follow-up|5|||
127730427|NCT02469155|459636905|FG001|Overall Study|Lost to Follow-up|2|||
127730428|NCT02469155|459636906|FG002|Overall Study|Lost to Follow-up|7|||
127730429|NCT02469155|459636907|FG003|Overall Study|Lost to Follow-up|2|||
127730430|NCT02469155|459636904|FG000|Overall Study|Physician Decision|0|||
127730431|NCT02469155|459636905|FG001|Overall Study|Physician Decision|0|||
127730432|NCT02469155|459636906|FG002|Overall Study|Physician Decision|1|||
127730433|NCT02469155|459636907|FG003|Overall Study|Physician Decision|0|||
127730434|NCT02469155|459636904|FG000|Overall Study|Withdrawal by Subject|34|||
127730435|NCT02469155|459636905|FG001|Overall Study|Withdrawal by Subject|30|||
127730436|NCT02469155|459636906|FG002|Overall Study|Withdrawal by Subject|20|||
127730437|NCT02469155|459636907|FG003|Overall Study|Withdrawal by Subject|37|||
127730438|NCT02469155|459636904|FG000|Overall Study|Other|3|||
127730439|NCT02469155|459636905|FG001|Overall Study|Other|3|||
127730440|NCT02469155|459636906|FG002|Overall Study|Other|2|||
127730441|NCT02469155|459636907|FG003|Overall Study|Other|10|||
127730442|NCT02469155|459636904|FG000|Overall Study|Protocol Violation|0|||
127730443|NCT02469155|459636905|FG001|Overall Study|Protocol Violation|1|||
127730444|NCT02469155|459636906|FG002|Overall Study|Protocol Violation|0|||
127730445|NCT02469155|459636907|FG003|Overall Study|Protocol Violation|1|||
127730446|NCT00442559|459636908|FG000|Overall Study|Lost to Follow-up|32|||
127730447|NCT00442559|459636909|FG001|Overall Study|Lost to Follow-up|34|||
127730448|NCT00442559|459636908|FG000|Overall Study|Protocol Violation|1|||
127730449|NCT00442559|459636909|FG001|Overall Study|Protocol Violation|1|||
127730450|NCT00442559|459636908|FG000|Overall Study|Withdrawal by Subject|1|||
127730451|NCT00442559|459636909|FG001|Overall Study|Withdrawal by Subject|0|||
127730452|NCT02604199|459636919|FG000|Overall Study|Pregnancy|0|||
127730453|NCT02604199|459636920|FG001|Overall Study|Pregnancy|0|||
127730454|NCT02604199|459636921|FG002|Overall Study|Pregnancy|0|||
127730455|NCT02604199|459636922|FG003|Overall Study|Pregnancy|1|||
127730456|NCT02604199|459636919|FG000|Overall Study|Study terminated by sponsor|0|||
127730457|NCT02604199|459636920|FG001|Overall Study|Study terminated by sponsor|2|||
127730458|NCT02604199|459636921|FG002|Overall Study|Study terminated by sponsor|0|||
127730459|NCT02604199|459636922|FG003|Overall Study|Study terminated by sponsor|2|||
127730460|NCT02604199|459636919|FG000|Overall Study|Withdrawal by Subject|0|||
127730461|NCT02604199|459636920|FG001|Overall Study|Withdrawal by Subject|1|||
127730462|NCT02604199|459636921|FG002|Overall Study|Withdrawal by Subject|0|||
127730463|NCT02604199|459636922|FG003|Overall Study|Withdrawal by Subject|0|||
127730464|NCT02812706|459636923|FG000|Phase 1|Adverse Event|0|||
127730465|NCT02812706|459636924|FG001|Phase 1|Adverse Event|2|||
127730466|NCT02812706|459636925|FG002|Phase 1|Adverse Event|0|||
127730467|NCT02812706|459636923|FG000|Phase 1|Progressive disease|3|||
127730468|NCT02812706|459636924|FG001|Phase 1|Progressive disease|3|||
127730469|NCT02812706|459636925|FG002|Phase 1|Progressive disease|0|||
127730470|NCT02812706|459636923|FG000|Phase 2|Adverse Event|0|||
127730471|NCT02812706|459636924|FG001|Phase 2|Adverse Event|0|||
127730472|NCT02812706|459636925|FG002|Phase 2|Adverse Event|2|||
127730473|NCT02812706|459636923|FG000|Phase 2|Progressive disease|0|||
127730474|NCT02812706|459636924|FG001|Phase 2|Progressive disease|0|||
127730475|NCT02812706|459636925|FG002|Phase 2|Progressive disease|22|||
127730476|NCT02812706|459636923|FG000|Phase 2|Other-Unspecified|0|||
127730477|NCT02812706|459636924|FG001|Phase 2|Other-Unspecified|0|||
127730478|NCT02812706|459636925|FG002|Phase 2|Other-Unspecified|4|||
127730479|NCT04362176|459636931|FG000|Overall Study|Lost to Follow-up|5|||
127730480|NCT04362176|459636932|FG001|Overall Study|Lost to Follow-up|8|||
127730481|NCT04362176|459636931|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
127730482|NCT04362176|459636932|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
127730483|NCT00742560|459636933|FG000|Overall Study|Adverse Event|0|||
127730484|NCT00742560|459636934|FG001|Overall Study|Adverse Event|0|||
127730485|NCT00742560|459636935|FG002|Overall Study|Adverse Event|1|||
127730486|NCT00742560|459636936|FG003|Overall Study|Adverse Event|1|||
127730487|NCT00742560|459636937|FG004|Overall Study|Adverse Event|1|||
127730488|NCT00742560|459636933|FG000|Overall Study|Death|0|||
127730489|NCT00742560|459636934|FG001|Overall Study|Death|2|||
127730490|NCT00742560|459636935|FG002|Overall Study|Death|0|||
127730491|NCT00742560|459636936|FG003|Overall Study|Death|2|||
127730492|NCT00742560|459636937|FG004|Overall Study|Death|3|||
127730493|NCT00742560|459636933|FG000|Overall Study|Subject's Decision|1|||
127730494|NCT00742560|459636934|FG001|Overall Study|Subject's Decision|0|||
127730495|NCT00742560|459636935|FG002|Overall Study|Subject's Decision|2|||
127730496|NCT00742560|459636936|FG003|Overall Study|Subject's Decision|3|||
127730497|NCT00742560|459636937|FG004|Overall Study|Subject's Decision|3|||
127730498|NCT00742560|459636933|FG000|Overall Study|Investigator's Decision|0|||
127730499|NCT00742560|459636934|FG001|Overall Study|Investigator's Decision|0|||
127730500|NCT00742560|459636935|FG002|Overall Study|Investigator's Decision|4|||
127730501|NCT00742560|459636936|FG003|Overall Study|Investigator's Decision|1|||
127730502|NCT00742560|459636937|FG004|Overall Study|Investigator's Decision|0|||
127730503|NCT00742560|459636933|FG000|Overall Study|Disease Progression|1|||
127730504|NCT00742560|459636934|FG001|Overall Study|Disease Progression|0|||
127730505|NCT00742560|459636935|FG002|Overall Study|Disease Progression|5|||
127730506|NCT00742560|459636936|FG003|Overall Study|Disease Progression|17|||
127730507|NCT00742560|459636937|FG004|Overall Study|Disease Progression|16|||
127730508|NCT00742560|459636933|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
127730509|NCT00742560|459636934|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
127730510|NCT00742560|459636935|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
127730511|NCT00742560|459636936|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
127730512|NCT00742560|459636937|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
127730513|NCT00742560|459636933|FG000|Overall Study|Other|0|||
127730514|NCT00742560|459636934|FG001|Overall Study|Other|1|||
127730515|NCT00742560|459636935|FG002|Overall Study|Other|8|||
127730516|NCT00742560|459636936|FG003|Overall Study|Other|9|||
127730517|NCT00742560|459636937|FG004|Overall Study|Other|9|||
127730518|NCT00742560|459636933|FG000|Overall Study|MIssing|0|||
127730519|NCT00742560|459636934|FG001|Overall Study|MIssing|0|||
127730520|NCT00742560|459636935|FG002|Overall Study|MIssing|0|||
127730521|NCT00742560|459636936|FG003|Overall Study|MIssing|0|||
127730522|NCT00742560|459636937|FG004|Overall Study|MIssing|1|||
127730523|NCT01426217|459636939|FG000|Overall Study|lost sample|8|||
127730524|NCT01426217|459636940|FG001|Overall Study|lost sample|14|||
127730525|NCT01812837|459636941|FG000|Overall Study|Lost to Follow-up|1|||
127730526|NCT01812837|459636942|FG001|Overall Study|Lost to Follow-up|1|||
127730527|NCT01812837|459636943|FG002|Overall Study|Lost to Follow-up|0|||
127730528|NCT01812837|459636941|FG000|Overall Study|Protocol Violation|1|||
127730529|NCT01812837|459636942|FG001|Overall Study|Protocol Violation|0|||
127730530|NCT01812837|459636943|FG002|Overall Study|Protocol Violation|0|||
127730531|NCT05008224|459636944|FG000|Overall Study|Death|3|||
127730532|NCT05008224|459636944|FG000|Overall Study|Lost to Follow-up|2|||
127730533|NCT05008224|459636944|FG000|Overall Study|Did Not Continue on Extension Study|39|||
127730534|NCT05008224|459636944|FG000|Overall Study|Transferred to Extension Study|100|||
127730535|NCT05008224|459636944|FG000|Overall Study|Withdrawal by Subject|2|||
127730536|NCT05234632|459636945|FG000|Overall Study|Participant Withdrawn: Non-Compliance|1|||
127730537|NCT05234632|459636946|FG001|Overall Study|Participant Withdrawn: Non-Compliance|0|||
127730538|NCT05234632|459636945|FG000|Overall Study|Withdrawal by Subject|2|||
127730539|NCT05234632|459636946|FG001|Overall Study|Withdrawal by Subject|0|||
127730540|NCT05234632|459636945|FG000|Overall Study|Adverse Event|0|||
127730541|NCT05234632|459636946|FG001|Overall Study|Adverse Event|4|||
127730542|NCT05234632|459636945|FG000|Overall Study|Physician Decision|1|||
127730543|NCT05234632|459636946|FG001|Overall Study|Physician Decision|1|||
127730544|NCT05234632|459636945|FG000|Overall Study|Participant tested positive for COVID-19 and is in isolation|0|||
127730545|NCT05234632|459636946|FG001|Overall Study|Participant tested positive for COVID-19 and is in isolation|1|||
127730546|NCT05234632|459636945|FG000|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|1|||
127730547|NCT05234632|459636946|FG001|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|0|||
127730548|NCT00658632|459636947|FG000|Overall Study|Adverse Event|13|||
127730549|NCT00658632|459636948|FG001|Overall Study|Adverse Event|11|||
127730550|NCT00658632|459636947|FG000|Overall Study|Lost to Follow-up|25|||
127730551|NCT00658632|459636948|FG001|Overall Study|Lost to Follow-up|23|||
127730552|NCT00658632|459636947|FG000|Overall Study|Withdrawal by Subject|10|||
127730553|NCT00658632|459636948|FG001|Overall Study|Withdrawal by Subject|7|||
127730554|NCT00658632|459636947|FG000|Overall Study|Lack of Efficacy|0|||
127730555|NCT00658632|459636948|FG001|Overall Study|Lack of Efficacy|1|||
127730556|NCT00658632|459636947|FG000|Overall Study|Withdrawal of consent|8|||
127730557|NCT00658632|459636948|FG001|Overall Study|Withdrawal of consent|14|||
127730558|NCT00658632|459636947|FG000|Overall Study|Pregnancy|1|||
127730559|NCT00658632|459636948|FG001|Overall Study|Pregnancy|1|||
127730560|NCT00658632|459636947|FG000|Overall Study|Other|7|||
127803634|NCT03502330|459903688|FG001|Overall Study|Withdrawal by Subject|0|||
127803635|NCT03502330|459903689|FG002|Overall Study|Withdrawal by Subject|0|||
127803636|NCT03502330|459903690|FG003|Overall Study|Withdrawal by Subject|0|||
127803637|NCT03502330|459903691|FG004|Overall Study|Withdrawal by Subject|0|||
127730561|NCT00658632|459636948|FG001|Overall Study|Other|8|||
127730562|NCT04501614|459636949|FG000|Overall Study|Study Terminated by Sponsor|6|||
127730563|NCT04501614|459636950|FG001|Overall Study|Study Terminated by Sponsor|3|||
127730564|NCT04501614|459636949|FG000|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
127730565|NCT04501614|459636950|FG001|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
127730566|NCT02991456|459636952|FG000|Overall Study|Adverse Event|2|||
127730567|NCT02991456|459636953|FG001|Overall Study|Adverse Event|0|||
127730568|NCT02991456|459636952|FG000|Overall Study|Lost to Follow-up|0|||
127730569|NCT02991456|459636953|FG001|Overall Study|Lost to Follow-up|2|||
127730570|NCT02991456|459636952|FG000|Overall Study|Withdrawal by Subject|1|||
127730571|NCT02991456|459636953|FG001|Overall Study|Withdrawal by Subject|0|||
127730572|NCT00738400|459636956|FG000|Overall Study|Adverse Event|3|||
127730573|NCT00738400|459636957|FG001|Overall Study|Adverse Event|1|||
127730574|NCT00738400|459636956|FG000|Overall Study|Withdrawal by Subject|0|||
127730575|NCT00738400|459636957|FG001|Overall Study|Withdrawal by Subject|1|||
127730576|NCT00738400|459636956|FG000|Overall Study|Lack of Efficacy|0|||
127730577|NCT00738400|459636957|FG001|Overall Study|Lack of Efficacy|1|||
127730578|NCT00738400|459636956|FG000|Overall Study|Lost to Follow-up|0|||
127730579|NCT00738400|459636957|FG001|Overall Study|Lost to Follow-up|3|||
127730580|NCT00738400|459636956|FG000|Overall Study|Protocol Violation|1|||
127730581|NCT00738400|459636957|FG001|Overall Study|Protocol Violation|0|||
127730582|NCT00738400|459636956|FG000|Overall Study|Non-compliant with study medication|0|||
127730583|NCT00738400|459636957|FG001|Overall Study|Non-compliant with study medication|1|||
127730584|NCT00508144|459636958|FG000|Overall Study|Not eligible|6|||
127730585|NCT00508144|459636958|FG000|Overall Study|Death|5|||
127730586|NCT05927753|459637619|FG000|Overall Study|Withdrawal by Subject|0|||
127730587|NCT05927753|459637620|FG001|Overall Study|Withdrawal by Subject|2|||
127730588|NCT05927753|459637619|FG000|Overall Study|Physician Decision|0|||
127730589|NCT05927753|459637620|FG001|Overall Study|Physician Decision|1|||
127730590|NCT05381948|459637621|FG000|Overall Study|Adverse Event: Ocular - Study Eye|0|||
127730591|NCT05381948|459637622|FG001|Overall Study|Adverse Event: Ocular - Study Eye|1|||
127730592|NCT05381948|459637623|FG002|Overall Study|Adverse Event: Ocular - Study Eye|0|||
127730593|NCT05381948|459637621|FG000|Overall Study|Adverse Event: Non-ocular|0|||
127730594|NCT05381948|459637622|FG001|Overall Study|Adverse Event: Non-ocular|1|||
127730595|NCT05381948|459637623|FG002|Overall Study|Adverse Event: Non-ocular|0|||
127730596|NCT05381948|459637621|FG000|Overall Study|Lost to Follow-up|1|||
127730597|NCT05381948|459637622|FG001|Overall Study|Lost to Follow-up|0|||
127730598|NCT05381948|459637623|FG002|Overall Study|Lost to Follow-up|0|||
127730599|NCT05381948|459637621|FG000|Overall Study|Protocol Deviation|0|||
127730600|NCT05381948|459637622|FG001|Overall Study|Protocol Deviation|2|||
127730601|NCT05381948|459637623|FG002|Overall Study|Protocol Deviation|0|||
127730602|NCT05381948|459637621|FG000|Overall Study|Withdrawal by Subject|1|||
127730603|NCT05381948|459637622|FG001|Overall Study|Withdrawal by Subject|0|||
127730604|NCT05381948|459637623|FG002|Overall Study|Withdrawal by Subject|1|||
127730605|NCT05381948|459637621|FG000|Overall Study|Death|0|||
127730606|NCT05381948|459637622|FG001|Overall Study|Death|2|||
127730607|NCT05381948|459637623|FG002|Overall Study|Death|0|||
127730608|NCT05381948|459637621|FG000|Overall Study|Discontinued study without receiving study drug|0|||
127730609|NCT05381948|459637622|FG001|Overall Study|Discontinued study without receiving study drug|0|||
127730610|NCT05381948|459637623|FG002|Overall Study|Discontinued study without receiving study drug|1|||
127730611|NCT04198428|459637624|FG000|Overall Study|Withdrawal by Subject|150|||
127730612|NCT04198428|459637625|FG001|Overall Study|Withdrawal by Subject|156|||
127730613|NCT04649359|459637629|FG000|Overall Study|Withdrawal by Subject|7|||
127730614|NCT04649359|459637630|FG001|Overall Study|Withdrawal by Subject|7|||
127730615|NCT04649359|459637629|FG000|Overall Study|Death|41|||
127730616|NCT04649359|459637630|FG001|Overall Study|Death|26|||
127730617|NCT04649359|459637629|FG000|Overall Study|Ongoing in the study|75|||
127730618|NCT04649359|459637630|FG001|Overall Study|Ongoing in the study|31|||
127730619|NCT04751929|459637634|FG000|Overall Study|Withdrawal by Subject|2|||
127730620|NCT04751929|459637635|FG001|Overall Study|Withdrawal by Subject|0|||
127730621|NCT04751929|459637636|FG002|Overall Study|Withdrawal by Subject|0|||
127730622|NCT04751929|459637637|FG003|Overall Study|Withdrawal by Subject|0|||
127730623|NCT04751929|459637634|FG000|Overall Study|Rising PSA|0|||
127730624|NCT04751929|459637635|FG001|Overall Study|Rising PSA|1|||
127730625|NCT04751929|459637636|FG002|Overall Study|Rising PSA|0|||
127730626|NCT04751929|459637637|FG003|Overall Study|Rising PSA|0|||
127730627|NCT04751929|459637634|FG000|Overall Study|Adverse Event|1|||
127730628|NCT04751929|459637635|FG001|Overall Study|Adverse Event|2|||
127730629|NCT04751929|459637636|FG002|Overall Study|Adverse Event|0|||
127730630|NCT04751929|459637637|FG003|Overall Study|Adverse Event|0|||
127730631|NCT04751929|459637634|FG000|Overall Study|Progressive Disease|3|||
127730632|NCT04751929|459637635|FG001|Overall Study|Progressive Disease|4|||
127730633|NCT04751929|459637636|FG002|Overall Study|Progressive Disease|4|||
127730634|NCT04751929|459637637|FG003|Overall Study|Progressive Disease|0|||
127730635|NCT04751929|459637634|FG000|Overall Study|Death|1|||
127730636|NCT04751929|459637635|FG001|Overall Study|Death|1|||
127730637|NCT04751929|459637636|FG002|Overall Study|Death|0|||
127730638|NCT04751929|459637637|FG003|Overall Study|Death|0|||
127730639|NCT02062827|459637639|FG000|Overall Study|Death|1|||
127730640|NCT02062827|459637640|FG001|Overall Study|Death|0|||
127730641|NCT02062827|459637641|FG002|Overall Study|Death|0|||
127730642|NCT02062827|459637642|FG003|Overall Study|Death|0|||
127730643|NCT02062827|459637643|FG004|Overall Study|Death|0|||
127730644|NCT02062827|459637644|FG005|Overall Study|Death|0|||
127730645|NCT02062827|459637645|FG006|Overall Study|Death|0|||
127730646|NCT02062827|459637646|FG007|Overall Study|Death|0|||
127730647|NCT02062827|459637639|FG000|Overall Study|Withdrawal by Subject|3|||
127730648|NCT02062827|459637640|FG001|Overall Study|Withdrawal by Subject|1|||
127730649|NCT02062827|459637641|FG002|Overall Study|Withdrawal by Subject|1|||
127730650|NCT02062827|459637642|FG003|Overall Study|Withdrawal by Subject|2|||
127730651|NCT02062827|459637643|FG004|Overall Study|Withdrawal by Subject|6|||
127730652|NCT02062827|459637644|FG005|Overall Study|Withdrawal by Subject|0|||
127730653|NCT02062827|459637645|FG006|Overall Study|Withdrawal by Subject|5|||
127730654|NCT02062827|459637646|FG007|Overall Study|Withdrawal by Subject|0|||
127730655|NCT02062827|459637639|FG000|Overall Study|Screen Fail|0|||
127730656|NCT02062827|459637640|FG001|Overall Study|Screen Fail|0|||
127730657|NCT02062827|459637641|FG002|Overall Study|Screen Fail|0|||
127730658|NCT02062827|459637642|FG003|Overall Study|Screen Fail|0|||
127730659|NCT02062827|459637643|FG004|Overall Study|Screen Fail|0|||
127730660|NCT02062827|459637644|FG005|Overall Study|Screen Fail|0|||
127730661|NCT02062827|459637645|FG006|Overall Study|Screen Fail|0|||
127730662|NCT02062827|459637646|FG007|Overall Study|Screen Fail|8|||
127730663|NCT00288353|459637647|FG000|Overall Study|Lack of Efficacy|2|||
127730664|NCT00288353|459637648|FG001|Overall Study|Lack of Efficacy|2|||
127730665|NCT00288353|459637647|FG000|Overall Study|Withdrawal by Subject|5|||
127730666|NCT00288353|459637648|FG001|Overall Study|Withdrawal by Subject|5|||
127730667|NCT04985604|459637649|FG000|Overall Study|Death|4|||
127730668|NCT04985604|459637650|FG001|Overall Study|Death|6|||
127730669|NCT04985604|459637649|FG000|Overall Study|Withdrawal by Subject|0|||
127730670|NCT04985604|459637650|FG001|Overall Study|Withdrawal by Subject|1|||
127730671|NCT02282761|459637651|FG000|Overall Study|Death|0|||
127730672|NCT02282761|459637652|FG001|Overall Study|Death|0|||
127730673|NCT02282761|459637653|FG002|Overall Study|Death|1|||
127730674|NCT02282761|459637651|FG000|Overall Study|Adverse Event|6|||
127730675|NCT02282761|459637652|FG001|Overall Study|Adverse Event|2|||
127730676|NCT02282761|459637653|FG002|Overall Study|Adverse Event|0|||
127730677|NCT02282761|459637651|FG000|Overall Study|Lack of Efficacy|11|||
127730678|NCT02282761|459637652|FG001|Overall Study|Lack of Efficacy|6|||
127730679|NCT02282761|459637653|FG002|Overall Study|Lack of Efficacy|17|||
127730680|NCT02282761|459637651|FG000|Overall Study|Lost to Follow-up|2|||
127730681|NCT02282761|459637652|FG001|Overall Study|Lost to Follow-up|2|||
127730682|NCT02282761|459637653|FG002|Overall Study|Lost to Follow-up|1|||
127730683|NCT02282761|459637651|FG000|Overall Study|Physician Decision|0|||
127730684|NCT02282761|459637652|FG001|Overall Study|Physician Decision|0|||
127730685|NCT02282761|459637653|FG002|Overall Study|Physician Decision|2|||
127730686|NCT02282761|459637651|FG000|Overall Study|Withdrawal by Subject|8|||
127730687|NCT02282761|459637652|FG001|Overall Study|Withdrawal by Subject|10|||
127730688|NCT02282761|459637653|FG002|Overall Study|Withdrawal by Subject|16|||
127803638|NCT03502330|459903692|FG005|Overall Study|Withdrawal by Subject|1|||
127803639|NCT03502330|459903693|FG006|Overall Study|Withdrawal by Subject|0|||
127803640|NCT03502330|459903694|FG007|Overall Study|Withdrawal by Subject|1|||
127730689|NCT02282761|459637651|FG000|Overall Study|Other|3|||
127730690|NCT02282761|459637652|FG001|Overall Study|Other|2|||
127730691|NCT02282761|459637653|FG002|Overall Study|Other|1|||
127730692|NCT05263492|459637654|FG000|Overall Study|Adverse Event|1|||
127730693|NCT05263492|459637654|FG000|Overall Study|Disease progression during active treatment|3|||
127730694|NCT03345420|459637657|FG000|Overall Study|Withdrawal by Subject|1|||
127730695|NCT05216835|459637658|FG000|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
127730696|NCT05216835|459637659|FG001|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
127730697|NCT05216835|459637660|FG002|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
127730698|NCT05216835|459637661|FG003|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
127730699|NCT05216835|459637662|FG004|Overall Study|Ongoing as of DCO (30 Aug 2024)|3|||
127730700|NCT05216835|459637663|FG005|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
127730701|NCT05216835|459637664|FG006|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
127730702|NCT05216835|459637665|FG007|Overall Study|Ongoing as of DCO (30 Aug 2024)|9|||
127730703|NCT05216835|459637658|FG000|Overall Study|Death|0|||
127730704|NCT05216835|459637659|FG001|Overall Study|Death|0|||
127730705|NCT05216835|459637660|FG002|Overall Study|Death|0|||
127730706|NCT05216835|459637661|FG003|Overall Study|Death|1|||
127730707|NCT05216835|459637662|FG004|Overall Study|Death|1|||
127730708|NCT05216835|459637663|FG005|Overall Study|Death|1|||
127730709|NCT05216835|459637664|FG006|Overall Study|Death|1|||
127730710|NCT05216835|459637665|FG007|Overall Study|Death|1|||
127730711|NCT05216835|459637658|FG000|Overall Study|Physician Decision|0|||
127803641|NCT03502330|459903695|FG008|Overall Study|Withdrawal by Subject|0|||
127803642|NCT03502330|459903687|FG000|Overall Study|Death|0|||
127730712|NCT05216835|459637659|FG001|Overall Study|Physician Decision|0|||
127730713|NCT05216835|459637660|FG002|Overall Study|Physician Decision|0|||
127730714|NCT05216835|459637661|FG003|Overall Study|Physician Decision|0|||
127730715|NCT05216835|459637662|FG004|Overall Study|Physician Decision|0|||
127730716|NCT05216835|459637663|FG005|Overall Study|Physician Decision|1|||
127730717|NCT05216835|459637664|FG006|Overall Study|Physician Decision|1|||
127730718|NCT05216835|459637665|FG007|Overall Study|Physician Decision|0|||
127730719|NCT05216835|459637658|FG000|Overall Study|Study terminated by Sponsor|0|||
127803643|NCT03502330|459903688|FG001|Overall Study|Death|0|||
127730720|NCT05216835|459637659|FG001|Overall Study|Study terminated by Sponsor|0|||
127730721|NCT05216835|459637660|FG002|Overall Study|Study terminated by Sponsor|0|||
127730722|NCT05216835|459637661|FG003|Overall Study|Study terminated by Sponsor|0|||
127730723|NCT05216835|459637662|FG004|Overall Study|Study terminated by Sponsor|0|||
127730724|NCT05216835|459637663|FG005|Overall Study|Study terminated by Sponsor|0|||
127730725|NCT05216835|459637664|FG006|Overall Study|Study terminated by Sponsor|0|||
127730726|NCT05216835|459637665|FG007|Overall Study|Study terminated by Sponsor|1|||
127730727|NCT05216835|459637658|FG000|Overall Study|Withdrawal by Subject|1|||
127730728|NCT05216835|459637659|FG001|Overall Study|Withdrawal by Subject|0|||
127730729|NCT05216835|459637660|FG002|Overall Study|Withdrawal by Subject|1|||
127730730|NCT05216835|459637661|FG003|Overall Study|Withdrawal by Subject|0|||
127730731|NCT05216835|459637662|FG004|Overall Study|Withdrawal by Subject|1|||
127730732|NCT05216835|459637663|FG005|Overall Study|Withdrawal by Subject|0|||
127730733|NCT05216835|459637664|FG006|Overall Study|Withdrawal by Subject|0|||
127730734|NCT05216835|459637665|FG007|Overall Study|Withdrawal by Subject|1|||
127730735|NCT05216835|459637658|FG000|Overall Study|Other|0|||
127730736|NCT05216835|459637659|FG001|Overall Study|Other|1|||
127730737|NCT05216835|459637660|FG002|Overall Study|Other|0|||
127730738|NCT05216835|459637661|FG003|Overall Study|Other|0|||
127730739|NCT05216835|459637662|FG004|Overall Study|Other|0|||
127730740|NCT05216835|459637663|FG005|Overall Study|Other|0|||
127730741|NCT05216835|459637664|FG006|Overall Study|Other|0|||
127730742|NCT05216835|459637665|FG007|Overall Study|Other|0|||
127730743|NCT05179603|459637666|FG000|Overall Study|Unspecified: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
127730744|NCT05179603|459637666|FG000|Overall Study|Withdrawal by Subject|1|||
127730745|NCT05179603|459637666|FG000|Overall Study|Progressive disease|4|||
127730746|NCT05179603|459637666|FG000|Overall Study|Adverse event: Not related to COVID-19|4|||
127730747|NCT04551053|459637669|FG000|Overall Study|Death|10|||
127803644|NCT03502330|459903689|FG002|Overall Study|Death|0|||
127803645|NCT03502330|459903690|FG003|Overall Study|Death|0|||
127803646|NCT03502330|459903691|FG004|Overall Study|Death|0|||
127803647|NCT03502330|459903692|FG005|Overall Study|Death|0|||
127803648|NCT03502330|459903693|FG006|Overall Study|Death|2|||
127803649|NCT03502330|459903694|FG007|Overall Study|Death|0|||
127803650|NCT03502330|459903695|FG008|Overall Study|Death|0|||
127803651|NCT02804763|459903696|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
127803652|NCT02804763|459903697|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
127730748|NCT04551053|459637670|FG001|Overall Study|Death|9|||
127730749|NCT04551053|459637669|FG000|Overall Study|Lost to Follow-up|0|||
127730750|NCT04551053|459637670|FG001|Overall Study|Lost to Follow-up|2|||
127730751|NCT04551053|459637669|FG000|Overall Study|Study Terminated by Sponsor|57|||
127730752|NCT04551053|459637670|FG001|Overall Study|Study Terminated by Sponsor|65|||
127730753|NCT04551053|459637669|FG000|Overall Study|Withdrawal by Subject|12|||
127730754|NCT04551053|459637670|FG001|Overall Study|Withdrawal by Subject|5|||
127730755|NCT04551053|459637669|FG000|Overall Study|Adverse Event|2|||
127730756|NCT04551053|459637670|FG001|Overall Study|Adverse Event|0|||
127730757|NCT04551053|459637669|FG000|Overall Study|Lack of Efficacy|2|||
127730758|NCT04551053|459637670|FG001|Overall Study|Lack of Efficacy|1|||
127730759|NCT04551053|459637669|FG000|Overall Study|Transitioned to Rollover per Protocol|5|||
127730760|NCT04551053|459637670|FG001|Overall Study|Transitioned to Rollover per Protocol|4|||
127730761|NCT04551053|459637669|FG000|Overall Study|Splenapendectomi|1|||
127730762|NCT04551053|459637670|FG001|Overall Study|Splenapendectomi|0|||
127730763|NCT04551053|459637669|FG000|Overall Study|Medical Decision|1|||
127730764|NCT04551053|459637670|FG001|Overall Study|Medical Decision|1|||
127730765|NCT04529941|459637671|FG000|Week 12/Month 3 Follow Up|Withdrawal by Subject|1|||
127730766|NCT04529941|459637672|FG001|Week 12/Month 3 Follow Up|Withdrawal by Subject|0|||
127730767|NCT04016415|459637673|FG000|Overall Study|Adverse Event|2|||
127730768|NCT04016415|459637674|FG001|Overall Study|Adverse Event|1|||
127730769|NCT04016415|459637673|FG000|Overall Study|Lost to Follow-up|6|||
127730770|NCT04016415|459637674|FG001|Overall Study|Lost to Follow-up|2|||
127730771|NCT04016415|459637673|FG000|Overall Study|Physician Decision|5|||
127730772|NCT04016415|459637674|FG001|Overall Study|Physician Decision|1|||
127730773|NCT04016415|459637673|FG000|Overall Study|Pregnancy|0|||
127730774|NCT04016415|459637674|FG001|Overall Study|Pregnancy|1|||
127730775|NCT04016415|459637673|FG000|Overall Study|Withdrawal by Subject|24|||
127730776|NCT04016415|459637674|FG001|Overall Study|Withdrawal by Subject|27|||
127730777|NCT04016415|459637673|FG000|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|2|||
127730778|NCT04016415|459637674|FG001|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|0|||
127803653|NCT02804763|459903698|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
127803654|NCT02804763|459903699|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
127803655|NCT02804763|459903696|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
127803656|NCT02804763|459903697|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
127803657|NCT02804763|459903698|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
127730779|NCT02101554|459638027|FG000|Overall Study|Protocol Violation|0|||
127730780|NCT02101554|459638028|FG001|Overall Study|Protocol Violation|1|||
127730781|NCT02101554|459638029|FG002|Overall Study|Protocol Violation|0|||
127730782|NCT02101554|459638027|FG000|Overall Study|Insufficient Clinical Response|0|||
127730783|NCT02101554|459638028|FG001|Overall Study|Insufficient Clinical Response|2|||
127730784|NCT02101554|459638029|FG002|Overall Study|Insufficient Clinical Response|0|||
127730785|NCT02101554|459638027|FG000|Overall Study|Adverse Event|2|||
127730786|NCT02101554|459638028|FG001|Overall Study|Adverse Event|1|||
127730787|NCT02101554|459638029|FG002|Overall Study|Adverse Event|1|||
127730788|NCT02101554|459638027|FG000|Overall Study|Lost to Follow-up|0|||
127730789|NCT02101554|459638028|FG001|Overall Study|Lost to Follow-up|1|||
127730790|NCT02101554|459638029|FG002|Overall Study|Lost to Follow-up|0|||
127730791|NCT02101554|459638027|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
127730792|NCT02101554|459638028|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
127730793|NCT02101554|459638029|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
127730794|NCT05615870|459638032|FG000|Overall Study|Lost to Follow-up|10|||
127730795|NCT05615870|459638033|FG001|Overall Study|Lost to Follow-up|13|||
127730796|NCT05615870|459638032|FG000|Overall Study|Physician Decision|2|||
127730797|NCT05615870|459638033|FG001|Overall Study|Physician Decision|0|||
127730798|NCT05615870|459638032|FG000|Overall Study|Withdrawal by Subject|0|||
127730799|NCT05615870|459638033|FG001|Overall Study|Withdrawal by Subject|2|||
127730800|NCT05615870|459638032|FG000|Overall Study|Protocol Violation|0|||
127730801|NCT05615870|459638033|FG001|Overall Study|Protocol Violation|3|||
127730802|NCT05615870|459638032|FG000|Overall Study|Unable to complete study activities after moving residences|0|||
127730803|NCT05615870|459638033|FG001|Overall Study|Unable to complete study activities after moving residences|2|||
127730804|NCT05615870|459638032|FG000|Overall Study|Terminated from the experimental or control intervention only and continued with the study|1|||
127730805|NCT05615870|459638033|FG001|Overall Study|Terminated from the experimental or control intervention only and continued with the study|0|||
127730806|NCT05615870|459638032|FG000|Overall Study|The participant thought the study was done and shipped the devices back.|0|||
127730807|NCT05615870|459638033|FG001|Overall Study|The participant thought the study was done and shipped the devices back.|1|||
127730808|NCT00070317|459638034|FG000|Overall Study|Inevaluable (Never Treated)|1|||
127730809|NCT00070317|459638034|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
127730810|NCT00070317|459638034|FG000|Overall Study|Ineligible required test not done|1|||
127730811|NCT00070317|459638034|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
127730812|NCT00070317|459638034|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
127730813|NCT01885559|459638035|FG000|Overall Study|Lost to Follow-up|15|||
127730814|NCT01885559|459638036|FG001|Overall Study|Lost to Follow-up|16|||
127730815|NCT01885559|459638035|FG000|Overall Study|Less than full participation|9|||
127730816|NCT01885559|459638036|FG001|Overall Study|Less than full participation|19|||
127730817|NCT01885559|459638035|FG000|Overall Study|Protocol Violation|0|||
127730818|NCT01885559|459638036|FG001|Overall Study|Protocol Violation|1|||
127730819|NCT01549951|459638040|FG000|Overall Study|Adverse Event|15|||
127730820|NCT01549951|459638040|FG000|Overall Study|Withdrawal by Subject|2|||
127730821|NCT01549951|459638040|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
127730822|NCT01549951|459638040|FG000|Overall Study|Progressive disease|29|||
127730823|NCT01549951|459638040|FG000|Overall Study|Symptomatic deterioration|1|||
127730824|NCT01549951|459638040|FG000|Overall Study|Other|2|||
127730825|NCT02312245|459638041|FG000|Overall Study|Death|0|||
127730826|NCT02312245|459638042|FG001|Overall Study|Death|0|||
127803658|NCT02804763|459903699|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
127803659|NCT02804763|459903696|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
127730827|NCT02312245|459638043|FG002|Overall Study|Death|0|||
127730828|NCT02312245|459638044|FG003|Overall Study|Death|1|||
127730829|NCT02312245|459638041|FG000|Overall Study|Withdrawal by Subject|1|||
127730830|NCT02312245|459638042|FG001|Overall Study|Withdrawal by Subject|1|||
127730831|NCT02312245|459638043|FG002|Overall Study|Withdrawal by Subject|0|||
127730832|NCT02312245|459638044|FG003|Overall Study|Withdrawal by Subject|2|||
127730833|NCT02312245|459638041|FG000|Overall Study|Alternative Therapy|1|||
127730834|NCT02312245|459638042|FG001|Overall Study|Alternative Therapy|0|||
127890058|NCT00210626|460219978|FG001|Overall Study|Withdrawal by Subject|20|||
127890059|NCT00210626|460219977|FG000|Overall Study|Physician Decision|0|||
127890060|NCT00210626|460219978|FG001|Overall Study|Physician Decision|2|||
127890061|NCT00210626|460219977|FG000|Overall Study|Sponser Request|1|||
127890062|NCT00210626|460219978|FG001|Overall Study|Sponser Request|0|||
127890063|NCT00210626|460219977|FG000|Overall Study|Other|4|||
127890064|NCT00210626|460219978|FG001|Overall Study|Other|5|||
127890065|NCT02473510|460219979|FG000|Overall Study|Lost to Follow-up|1|||
127890066|NCT02473510|460219980|FG001|Overall Study|Lost to Follow-up|2|||
127890067|NCT01306253|460219981|FG000|Overall Study|Lost to Follow-up|1|||
127890068|NCT01306253|460219982|FG001|Overall Study|Lost to Follow-up|1|||
127890069|NCT01261325|460219983|FG000|Overall Study|Lack of Efficacy|1|||
127890070|NCT01261325|460219984|FG001|Overall Study|Lack of Efficacy|1|||
127890071|NCT01261325|460219985|FG002|Overall Study|Lack of Efficacy|0|||
127890072|NCT01261325|460219983|FG000|Overall Study|Withdrawal by Subject|2|||
127890073|NCT01261325|460219984|FG001|Overall Study|Withdrawal by Subject|2|||
127890074|NCT01261325|460219985|FG002|Overall Study|Withdrawal by Subject|4|||
127890075|NCT01261325|460219983|FG000|Overall Study|SAE, non-fatal|1|||
127890076|NCT01261325|460219984|FG001|Overall Study|SAE, non-fatal|5|||
127890077|NCT01261325|460219985|FG002|Overall Study|SAE, non-fatal|1|||
127890078|NCT01261325|460219983|FG000|Overall Study|AE, non-serious non-fatal|9|||
127890079|NCT01261325|460219984|FG001|Overall Study|AE, non-serious non-fatal|15|||
127890080|NCT01261325|460219985|FG002|Overall Study|AE, non-serious non-fatal|13|||
127890081|NCT01261325|460219983|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
127730835|NCT02312245|459638043|FG002|Overall Study|Alternative Therapy|0|||
127730836|NCT02312245|459638044|FG003|Overall Study|Alternative Therapy|0|||
127730837|NCT02312245|459638041|FG000|Overall Study|Progression|0|||
127730838|NCT02312245|459638042|FG001|Overall Study|Progression|0|||
127730839|NCT02312245|459638043|FG002|Overall Study|Progression|0|||
127730840|NCT02312245|459638044|FG003|Overall Study|Progression|5|||
127730841|NCT02312245|459638041|FG000|Overall Study|Patient went to hospice|0|||
127730842|NCT02312245|459638042|FG001|Overall Study|Patient went to hospice|0|||
127730843|NCT02312245|459638043|FG002|Overall Study|Patient went to hospice|0|||
127730844|NCT02312245|459638044|FG003|Overall Study|Patient went to hospice|1|||
127730845|NCT02312245|459638041|FG000|Overall Study|Ineligible|1|||
127730846|NCT02312245|459638042|FG001|Overall Study|Ineligible|0|||
127730847|NCT02312245|459638043|FG002|Overall Study|Ineligible|0|||
127730848|NCT02312245|459638044|FG003|Overall Study|Ineligible|0|||
127730849|NCT01123200|459638046|FG000|Overall Study|Withdrawal by Subject|1|||
127890082|NCT01261325|460219984|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
127890083|NCT01261325|460219985|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
127890084|NCT01261325|460219983|FG000|Overall Study|Non Compliance|2|||
127890085|NCT01261325|460219984|FG001|Overall Study|Non Compliance|0|||
127890086|NCT01261325|460219985|FG002|Overall Study|Non Compliance|0|||
127890087|NCT01261325|460219983|FG000|Overall Study|Patient Randomized by Mistake|0|||
127890088|NCT01261325|460219984|FG001|Overall Study|Patient Randomized by Mistake|1|||
127890089|NCT01261325|460219985|FG002|Overall Study|Patient Randomized by Mistake|0|||
127890090|NCT01261325|460219983|FG000|Overall Study|Erroneously Randomized|1|||
127890091|NCT01261325|460219984|FG001|Overall Study|Erroneously Randomized|0|||
127890092|NCT01261325|460219985|FG002|Overall Study|Erroneously Randomized|0|||
127730850|NCT02819141|459638049|FG000|Overall Study|Extubated or discontinued prior to day 7|6|||
127730851|NCT02819141|459638050|FG001|Overall Study|Extubated or discontinued prior to day 7|20|||
127730852|NCT03556891|459638055|FG000|Initial Pivotal Study|Adverse Event|4|||
127730853|NCT03556891|459638055|FG000|Initial Pivotal Study|MRI Need|3|||
127730854|NCT03556891|459638055|FG000|Initial Pivotal Study|Device Failure|1|||
127730855|NCT03556891|459638055|FG000|Initial Pivotal Study|Death|1|||
127730856|NCT03556891|459638055|FG000|Initial Pivotal Study|Lost to Follow-up|1|||
127730857|NCT03556891|459638055|FG000|Initial Pivotal Study|Missing at random|1|||
127730858|NCT03556891|459638055|FG000|Initial Pivotal Study|Missing due to COVID|1|||
127730859|NCT03556891|459638055|FG000|Initial Pivotal Study|Protocol Violation|1|||
127730860|NCT01730118|459639174|FG000|Dose Escalation|Death on study|5|||
127730861|NCT01730118|459639175|FG001|Dose Escalation|Death on study|7|||
127730862|NCT01730118|459639176|FG002|Dose Escalation|Death on study|2|||
127730863|NCT01730118|459639177|FG003|Dose Escalation|Death on study|6|||
127730864|NCT01730118|459639178|FG004|Dose Escalation|Death on study|0|||
127730865|NCT01730118|459639179|FG005|Dose Escalation|Death on study|0|||
127730866|NCT01730118|459639180|FG006|Dose Escalation|Death on study|0|||
127730867|NCT01730118|459639174|FG000|Dose Escalation|Died before treatment|0|||
127730868|NCT01730118|459639175|FG001|Dose Escalation|Died before treatment|0|||
127730869|NCT01730118|459639176|FG002|Dose Escalation|Died before treatment|0|||
127730870|NCT01730118|459639177|FG003|Dose Escalation|Died before treatment|0|||
127730871|NCT01730118|459639178|FG004|Dose Escalation|Died before treatment|0|||
127730872|NCT01730118|459639179|FG005|Dose Escalation|Died before treatment|0|||
127890093|NCT01261325|460219983|FG000|Overall Study|Screen Failure|1|||
127890094|NCT01261325|460219984|FG001|Overall Study|Screen Failure|0|||
127890095|NCT01261325|460219985|FG002|Overall Study|Screen Failure|0|||
127730873|NCT01730118|459639180|FG006|Dose Escalation|Died before treatment|1|||
127890096|NCT01261325|460219983|FG000|Overall Study|Randomized in Error|0|||
127730874|NCT01730118|459639174|FG000|Dose Escalation|Chose to start a different treatment|1|||
127730875|NCT01730118|459639175|FG001|Dose Escalation|Chose to start a different treatment|0|||
127730876|NCT01730118|459639176|FG002|Dose Escalation|Chose to start a different treatment|0|||
127730877|NCT01730118|459639177|FG003|Dose Escalation|Chose to start a different treatment|0|||
127730878|NCT01730118|459639178|FG004|Dose Escalation|Chose to start a different treatment|0|||
127730879|NCT01730118|459639179|FG005|Dose Escalation|Chose to start a different treatment|0|||
127730880|NCT01730118|459639180|FG006|Dose Escalation|Chose to start a different treatment|0|||
127803660|NCT02804763|459903697|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
127803661|NCT02804763|459903698|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
127803662|NCT02804763|459903699|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
127803663|NCT02804763|459903696|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
127803664|NCT02804763|459903697|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
127803665|NCT02804763|459903698|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
127803666|NCT02804763|459903699|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
127803667|NCT02804763|459903696|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
127803668|NCT02804763|459903697|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
127803669|NCT02804763|459903698|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
127803670|NCT02804763|459903699|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
127803671|NCT02804763|459903696|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
127803672|NCT02804763|459903697|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
127803673|NCT02804763|459903698|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
127803674|NCT02804763|459903699|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
127803675|NCT04656990|459903700|FG000|Baseline|pandemic|20|||
127803676|NCT04656990|459903701|FG001|Baseline|pandemic|24|||
127803677|NCT04656990|459903700|FG000|Follow Up Period|Lost to Follow-up|61|||
127803678|NCT04656990|459903701|FG001|Follow Up Period|Lost to Follow-up|73|||
127803679|NCT00282243|459903704|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
127803680|NCT00282243|459903704|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
127803681|NCT00282243|459903704|FG000|Extension Treatment Period|Adverse Event|15|||
127803682|NCT00282243|459903704|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
127803683|NCT00282243|459903704|FG000|Extension Treatment Period|Non-compliance|2|||
127803684|NCT00282243|459903704|FG000|Extension Treatment Period|Physician Decision|1|||
127803685|NCT01070329|459903705|FG000|Overall Study|Adverse Event|13|||
127803686|NCT01070329|459903706|FG001|Overall Study|Adverse Event|10|||
127803687|NCT01070329|459903705|FG000|Overall Study|Lost to Follow-up|22|||
127803688|NCT01070329|459903706|FG001|Overall Study|Lost to Follow-up|12|||
127890097|NCT01261325|460219984|FG001|Overall Study|Randomized in Error|0|||
127890098|NCT01261325|460219985|FG002|Overall Study|Randomized in Error|1|||
127890099|NCT01261325|460219983|FG000|Overall Study|Protocol Violation|0|||
127890100|NCT01261325|460219984|FG001|Overall Study|Protocol Violation|3|||
127730881|NCT01730118|459639174|FG000|Dose Escalation|Withdrawal by Subject|0|||
127730882|NCT01730118|459639175|FG001|Dose Escalation|Withdrawal by Subject|0|||
127730883|NCT01730118|459639176|FG002|Dose Escalation|Withdrawal by Subject|1|||
127730884|NCT01730118|459639177|FG003|Dose Escalation|Withdrawal by Subject|0|||
127803689|NCT01070329|459903705|FG000|Overall Study|Withdrawal by Subject|9|||
127803690|NCT01070329|459903706|FG001|Overall Study|Withdrawal by Subject|11|||
127803691|NCT01070329|459903705|FG000|Overall Study|Protocol Violation|3|||
127803692|NCT01070329|459903706|FG001|Overall Study|Protocol Violation|8|||
127890101|NCT01261325|460219985|FG002|Overall Study|Protocol Violation|1|||
127890102|NCT01261325|460219983|FG000|Overall Study|Lost to Follow-up|0|||
127890103|NCT01261325|460219984|FG001|Overall Study|Lost to Follow-up|1|||
127890104|NCT01261325|460219985|FG002|Overall Study|Lost to Follow-up|3|||
127890105|NCT01261325|460219983|FG000|Overall Study|AE, serious fatal|0|||
127890106|NCT01261325|460219984|FG001|Overall Study|AE, serious fatal|0|||
127890107|NCT01261325|460219985|FG002|Overall Study|AE, serious fatal|2|||
127890108|NCT03469271|460219990|FG000|Overall Study|Withdrawal by Subject|2|||
127890109|NCT03469271|460219991|FG001|Overall Study|Withdrawal by Subject|0|||
127890110|NCT03469271|460219992|FG002|Overall Study|Withdrawal by Subject|0|||
127890111|NCT03469271|460219993|FG003|Overall Study|Withdrawal by Subject|1|||
127890112|NCT02826603|460219998|FG000|Overall Study|Adverse Event|17|||
127890113|NCT02826603|460219999|FG001|Overall Study|Adverse Event|9|||
127890114|NCT02826603|460219998|FG000|Overall Study|Lack of Efficacy|4|||
127730885|NCT01730118|459639178|FG004|Dose Escalation|Withdrawal by Subject|0|||
127730886|NCT01730118|459639179|FG005|Dose Escalation|Withdrawal by Subject|0|||
127803693|NCT01070329|459903705|FG000|Overall Study|Lack of Efficacy|2|||
127803694|NCT01070329|459903706|FG001|Overall Study|Lack of Efficacy|6|||
127803695|NCT01070329|459903705|FG000|Overall Study|Physician Decision|2|||
127890115|NCT02826603|460219999|FG001|Overall Study|Lack of Efficacy|9|||
127890116|NCT02826603|460219998|FG000|Overall Study|Lost to Follow-up|13|||
127890117|NCT02826603|460219999|FG001|Overall Study|Lost to Follow-up|12|||
127730887|NCT01730118|459639180|FG006|Dose Escalation|Withdrawal by Subject|0|||
127890118|NCT02826603|460219998|FG000|Overall Study|Noncompliance with treatment|0|||
127890119|NCT02826603|460219999|FG001|Overall Study|Noncompliance with treatment|2|||
127730888|NCT01730118|459639174|FG000|Dose Escalation|Disease progression prior to treatment|0|||
127730889|NCT01730118|459639175|FG001|Dose Escalation|Disease progression prior to treatment|0|||
127730890|NCT01730118|459639176|FG002|Dose Escalation|Disease progression prior to treatment|0|||
127730891|NCT01730118|459639177|FG003|Dose Escalation|Disease progression prior to treatment|0|||
127730892|NCT01730118|459639178|FG004|Dose Escalation|Disease progression prior to treatment|0|||
127730893|NCT01730118|459639179|FG005|Dose Escalation|Disease progression prior to treatment|0|||
127730894|NCT01730118|459639180|FG006|Dose Escalation|Disease progression prior to treatment|1|||
127730895|NCT01730118|459639174|FG000|Dose Expansion|Death|0|||
127730896|NCT01730118|459639175|FG001|Dose Expansion|Death|0|||
127730897|NCT01730118|459639176|FG002|Dose Expansion|Death|0|||
127730898|NCT01730118|459639177|FG003|Dose Expansion|Death|0|||
127730899|NCT01730118|459639178|FG004|Dose Expansion|Death|1|||
127730900|NCT01730118|459639179|FG005|Dose Expansion|Death|0|||
127730901|NCT01730118|459639180|FG006|Dose Expansion|Death|0|||
127730902|NCT01730118|459639174|FG000|Dose Expansion|Other medical condition|0|||
127730903|NCT01730118|459639175|FG001|Dose Expansion|Other medical condition|0|||
127730904|NCT01730118|459639176|FG002|Dose Expansion|Other medical condition|0|||
127730905|NCT01730118|459639177|FG003|Dose Expansion|Other medical condition|0|||
127730906|NCT01730118|459639178|FG004|Dose Expansion|Other medical condition|1|||
127730907|NCT01730118|459639179|FG005|Dose Expansion|Other medical condition|0|||
127730908|NCT01730118|459639180|FG006|Dose Expansion|Other medical condition|0|||
127730909|NCT01730118|459639174|FG000|Dose Expansion|Withdrawal by Subject|0|||
127730910|NCT01730118|459639175|FG001|Dose Expansion|Withdrawal by Subject|0|||
127730911|NCT01730118|459639176|FG002|Dose Expansion|Withdrawal by Subject|0|||
127730912|NCT01730118|459639177|FG003|Dose Expansion|Withdrawal by Subject|0|||
127730913|NCT01730118|459639178|FG004|Dose Expansion|Withdrawal by Subject|1|||
127730914|NCT01730118|459639179|FG005|Dose Expansion|Withdrawal by Subject|0|||
127730915|NCT01730118|459639180|FG006|Dose Expansion|Withdrawal by Subject|0|||
127730916|NCT01730118|459639174|FG000|Dose Expansion|Disease progression|0|||
127730917|NCT01730118|459639175|FG001|Dose Expansion|Disease progression|0|||
127730918|NCT01730118|459639176|FG002|Dose Expansion|Disease progression|0|||
127730919|NCT01730118|459639177|FG003|Dose Expansion|Disease progression|0|||
127730920|NCT01730118|459639178|FG004|Dose Expansion|Disease progression|0|||
127730921|NCT01730118|459639179|FG005|Dose Expansion|Disease progression|1|||
127730922|NCT01730118|459639180|FG006|Dose Expansion|Disease progression|0|||
127730923|NCT01730118|459639174|FG000|Dose Expansion|Inability to return|0|||
127730924|NCT01730118|459639175|FG001|Dose Expansion|Inability to return|0|||
127730925|NCT01730118|459639176|FG002|Dose Expansion|Inability to return|0|||
127730926|NCT01730118|459639177|FG003|Dose Expansion|Inability to return|0|||
127730927|NCT01730118|459639178|FG004|Dose Expansion|Inability to return|0|||
127730928|NCT01730118|459639179|FG005|Dose Expansion|Inability to return|1|||
127730929|NCT01730118|459639180|FG006|Dose Expansion|Inability to return|0|||
127730930|NCT01730118|459639174|FG000|Dose Expansion|Physician Decision|0|||
127730931|NCT01730118|459639175|FG001|Dose Expansion|Physician Decision|0|||
127730932|NCT01730118|459639176|FG002|Dose Expansion|Physician Decision|0|||
127730933|NCT01730118|459639177|FG003|Dose Expansion|Physician Decision|0|||
127730934|NCT01730118|459639178|FG004|Dose Expansion|Physician Decision|0|||
127730935|NCT01730118|459639179|FG005|Dose Expansion|Physician Decision|1|||
127730936|NCT01730118|459639180|FG006|Dose Expansion|Physician Decision|0|||
127730937|NCT00489489|459639182|FG000|Overall Study|Not treated due to protocol violation|0|||
127730938|NCT00489489|459639183|FG001|Overall Study|Not treated due to protocol violation|1|||
127730939|NCT00489489|459639184|FG002|Overall Study|Not treated due to protocol violation|1|||
127730940|NCT00489489|459639182|FG000|Overall Study|Adverse Event|1|||
127730941|NCT00489489|459639183|FG001|Overall Study|Adverse Event|1|||
127730942|NCT00489489|459639184|FG002|Overall Study|Adverse Event|1|||
127730943|NCT00489489|459639182|FG000|Overall Study|Protocol Violation|1|||
127730944|NCT00489489|459639183|FG001|Overall Study|Protocol Violation|0|||
127730945|NCT00489489|459639184|FG002|Overall Study|Protocol Violation|1|||
127730946|NCT00489489|459639182|FG000|Overall Study|Progressive disease|0|||
127730947|NCT00489489|459639183|FG001|Overall Study|Progressive disease|1|||
127730948|NCT00489489|459639184|FG002|Overall Study|Progressive disease|0|||
127730949|NCT00489489|459639182|FG000|Overall Study|Participant did not wish to continue|1|||
127730950|NCT00489489|459639183|FG001|Overall Study|Participant did not wish to continue|1|||
127730951|NCT00489489|459639184|FG002|Overall Study|Participant did not wish to continue|0|||
127730952|NCT00489489|459639182|FG000|Overall Study|Other than above|0|||
127730953|NCT00489489|459639183|FG001|Overall Study|Other than above|1|||
127730954|NCT00489489|459639184|FG002|Overall Study|Other than above|0|||
127730955|NCT04851587|459639187|FG000|Overall Study|Lost to Follow-up|18|||
127730956|NCT01350102|459639191|FG000|Overall Study|Adverse Event|0|||
127730957|NCT01350102|459639192|FG001|Overall Study|Adverse Event|0|||
127730958|NCT01350102|459639193|FG002|Overall Study|Adverse Event|1|||
127730959|NCT01350102|459639194|FG003|Overall Study|Adverse Event|0|||
127730960|NCT04523571|459639195|FG000|Received 2 Doses|Withdrawal by Subject|0|||
127730961|NCT04523571|459639196|FG001|Received 2 Doses|Withdrawal by Subject|0|||
127730962|NCT04523571|459639197|FG002|Received 2 Doses|Withdrawal by Subject|0|||
127730963|NCT04523571|459639198|FG003|Received 2 Doses|Withdrawal by Subject|1|||
127730964|NCT04523571|459639199|FG004|Received 2 Doses|Withdrawal by Subject|1|||
127730965|NCT04523571|459639200|FG005|Received 2 Doses|Withdrawal by Subject|0|||
127730966|NCT04523571|459639195|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
127730967|NCT04523571|459639196|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
127730968|NCT04523571|459639197|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
127730969|NCT04523571|459639198|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
127730970|NCT04523571|459639199|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
127730971|NCT04523571|459639200|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
127730972|NCT04523571|459639195|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
127730973|NCT04523571|459639196|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
127730974|NCT04523571|459639197|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
127730975|NCT04523571|459639198|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
127730976|NCT04523571|459639199|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
127730977|NCT04523571|459639200|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
127730978|NCT04523571|459639195|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
127730979|NCT04523571|459639196|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
127730980|NCT04523571|459639197|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
127730981|NCT04523571|459639198|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
127730982|NCT04523571|459639199|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
127730983|NCT04523571|459639200|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
127730984|NCT03694210|459639202|FG000|Overall Study|Death|1|||
127803696|NCT01070329|459903706|FG001|Overall Study|Physician Decision|1|||
127803697|NCT01070329|459903705|FG000|Overall Study|Entry Criteria Not Met|1|||
127803698|NCT01070329|459903706|FG001|Overall Study|Entry Criteria Not Met|0|||
127803699|NCT01070329|459903705|FG000|Overall Study|Sponsor Decision|0|||
127803700|NCT01070329|459903706|FG001|Overall Study|Sponsor Decision|1|||
127803701|NCT02863848|459903707|FG000|Overall Study|Lost to Follow-up|1|||
127803702|NCT02863848|459903708|FG001|Overall Study|Lost to Follow-up|1|||
127803703|NCT02863848|459903707|FG000|Overall Study|Protocol Violation|1|||
127730985|NCT03694210|459639202|FG000|Overall Study|Screen Failure|7|||
127730986|NCT04385849|459639203|FG000|Overall Study|Lost to Follow-up|1|||
127730987|NCT04385849|459639204|FG001|Overall Study|Lost to Follow-up|0|||
127890120|NCT02826603|460219998|FG000|Overall Study|Physician Decision|1|||
127890121|NCT02826603|460219999|FG001|Overall Study|Physician Decision|7|||
127890122|NCT02826603|460219998|FG000|Overall Study|Pregnancy|1|||
127890123|NCT02826603|460219999|FG001|Overall Study|Pregnancy|2|||
127890124|NCT02826603|460219998|FG000|Overall Study|Protocol Violation|3|||
127890125|NCT02826603|460219999|FG001|Overall Study|Protocol Violation|3|||
127890126|NCT02826603|460219998|FG000|Overall Study|Withdrawal by Subject|20|||
127730988|NCT01375777|459639205|FG000|Overall Study|Withdrawal by Subject|0|||
127890127|NCT02826603|460219999|FG001|Overall Study|Withdrawal by Subject|19|||
127890128|NCT02826603|460219998|FG000|Overall Study|Death|2|||
127890129|NCT02826603|460219999|FG001|Overall Study|Death|0|||
127890130|NCT02826603|460219998|FG000|Overall Study|New therapy for study indication|0|||
127890131|NCT02826603|460219999|FG001|Overall Study|New therapy for study indication|1|||
127730989|NCT01375777|459639206|FG001|Overall Study|Withdrawal by Subject|2|||
127730990|NCT01375777|459639207|FG002|Overall Study|Withdrawal by Subject|1|||
127730991|NCT01375777|459639208|FG003|Overall Study|Withdrawal by Subject|0|||
127730992|NCT01375777|459639209|FG004|Overall Study|Withdrawal by Subject|1|||
127730993|NCT01375777|459639210|FG005|Overall Study|Withdrawal by Subject|1|||
127730994|NCT01375777|459639211|FG006|Overall Study|Withdrawal by Subject|1|||
127730995|NCT01375777|459639212|FG007|Overall Study|Withdrawal by Subject|2|||
127730996|NCT01375777|459639213|FG008|Overall Study|Withdrawal by Subject|1|||
127730997|NCT01375777|459639205|FG000|Overall Study|Lost to Follow-up|1|||
127730998|NCT01375777|459639206|FG001|Overall Study|Lost to Follow-up|0|||
127730999|NCT01375777|459639207|FG002|Overall Study|Lost to Follow-up|0|||
127731000|NCT01375777|459639208|FG003|Overall Study|Lost to Follow-up|0|||
127731001|NCT01375777|459639209|FG004|Overall Study|Lost to Follow-up|0|||
127731002|NCT01375777|459639210|FG005|Overall Study|Lost to Follow-up|0|||
127731003|NCT01375777|459639211|FG006|Overall Study|Lost to Follow-up|1|||
127890132|NCT01337050|460220003|FG000|Overall Study|Death|0|||
127890133|NCT01337050|460220004|FG001|Overall Study|Death|0|||
127890134|NCT01337050|460220005|FG002|Overall Study|Death|4|||
127890135|NCT01337050|460220003|FG000|Overall Study|Other|4|||
127890136|NCT01337050|460220004|FG001|Overall Study|Other|6|||
127890137|NCT01337050|460220005|FG002|Overall Study|Other|8|||
127890138|NCT01337050|460220003|FG000|Overall Study|Participants refused further follow-up|0|||
127890139|NCT01337050|460220004|FG001|Overall Study|Participants refused further follow-up|7|||
127890140|NCT01337050|460220005|FG002|Overall Study|Participants refused further follow-up|7|||
127890141|NCT00003102|460220006|FG000|Overall Study|Physician Decision|1|||
127890142|NCT00003102|460220007|FG001|Overall Study|Physician Decision|1|||
127890143|NCT00003102|460220008|FG002|Overall Study|Physician Decision|0|||
127890144|NCT00003102|460220006|FG000|Overall Study|Progressive Disease|0|||
127890145|NCT00003102|460220007|FG001|Overall Study|Progressive Disease|1|||
127890146|NCT00003102|460220008|FG002|Overall Study|Progressive Disease|0|||
127890147|NCT00003102|460220006|FG000|Overall Study|Adverse Event|0|||
127890148|NCT00003102|460220007|FG001|Overall Study|Adverse Event|1|||
127890149|NCT00003102|460220008|FG002|Overall Study|Adverse Event|1|||
127890150|NCT00003102|460220006|FG000|Overall Study|Death|0|||
127890151|NCT00003102|460220007|FG001|Overall Study|Death|0|||
127890152|NCT00003102|460220008|FG002|Overall Study|Death|1|||
127731004|NCT01375777|459639212|FG007|Overall Study|Lost to Follow-up|0|||
127731005|NCT01375777|459639213|FG008|Overall Study|Lost to Follow-up|0|||
127731006|NCT01375777|459639205|FG000|Overall Study|Other|1|||
127731007|NCT01375777|459639206|FG001|Overall Study|Other|1|||
127731008|NCT01375777|459639207|FG002|Overall Study|Other|0|||
127731009|NCT01375777|459639208|FG003|Overall Study|Other|0|||
127731010|NCT01375777|459639209|FG004|Overall Study|Other|0|||
127731011|NCT01375777|459639210|FG005|Overall Study|Other|0|||
127731012|NCT01375777|459639211|FG006|Overall Study|Other|0|||
127731013|NCT01375777|459639212|FG007|Overall Study|Other|0|||
127731014|NCT01375777|459639213|FG008|Overall Study|Other|1|||
127731015|NCT05878990|459639214|FG000|Overall Study|Lost to Follow-up|7|||
127731016|NCT05878990|459639214|FG000|Overall Study|Withdrawal by Subject|1|||
127731017|NCT01838499|459639217|FG000|Overall Study|Protocol Violation|0|||
127731018|NCT01838499|459639218|FG001|Overall Study|Protocol Violation|1|||
127890153|NCT00583596|460220009|FG000|Overall Study|Lost to Follow-up|110|||
127890154|NCT00583596|460220009|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
127890155|NCT00583596|460220009|FG000|Overall Study|Death|2|||
127890156|NCT00583596|460220009|FG000|Overall Study|Withdrawal by Subject|6|||
127731019|NCT01838499|459639217|FG000|Overall Study|Lost to Follow-up|2|||
127731020|NCT01838499|459639218|FG001|Overall Study|Lost to Follow-up|4|||
127731021|NCT01838499|459639217|FG000|Overall Study|Lack of Efficacy|1|||
127731022|NCT01838499|459639218|FG001|Overall Study|Lack of Efficacy|2|||
127731023|NCT01838499|459639217|FG000|Overall Study|Adverse Event|2|||
127731024|NCT01838499|459639218|FG001|Overall Study|Adverse Event|1|||
127890157|NCT00583596|460220009|FG000|Overall Study|Lost to Follow-up|94|||
127731025|NCT01838499|459639217|FG000|Overall Study|Withdrawal by Subject|19|||
127890158|NCT00583596|460220009|FG000|Overall Study|Data not complete|1|||
127890159|NCT00583596|460220009|FG000|Overall Study|Not consented|15|||
127731026|NCT01838499|459639218|FG001|Overall Study|Withdrawal by Subject|9|||
127731027|NCT01136733|459639219|FG000|Phase 1b|Adverse Event|0|||
127731028|NCT01136733|459639220|FG001|Phase 1b|Adverse Event|3|||
127731029|NCT01136733|459639221|FG002|Phase 1b|Adverse Event|1|||
127731030|NCT01136733|459639222|FG003|Phase 1b|Adverse Event|0|||
127731031|NCT01136733|459639223|FG004|Phase 1b|Adverse Event|0|||
127731032|NCT01136733|459639224|FG005|Phase 1b|Adverse Event|0|||
127731033|NCT01136733|459639225|FG006|Phase 1b|Adverse Event|0|||
127731034|NCT01136733|459639219|FG000|Phase 1b|Participant Choice|0|||
127731035|NCT01136733|459639220|FG001|Phase 1b|Participant Choice|0|||
127731036|NCT01136733|459639221|FG002|Phase 1b|Participant Choice|1|||
127731037|NCT01136733|459639222|FG003|Phase 1b|Participant Choice|0|||
127731038|NCT01136733|459639223|FG004|Phase 1b|Participant Choice|0|||
127731039|NCT01136733|459639224|FG005|Phase 1b|Participant Choice|0|||
127731040|NCT01136733|459639225|FG006|Phase 1b|Participant Choice|0|||
127731041|NCT01136733|459639219|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
127731042|NCT01136733|459639220|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
127731043|NCT01136733|459639221|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
127731044|NCT01136733|459639222|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
127731045|NCT01136733|459639223|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
127731046|NCT01136733|459639224|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
127731047|NCT01136733|459639225|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
127731048|NCT01136733|459639219|FG000|Phase 1b|Clinical Progression|1|||
127731049|NCT01136733|459639220|FG001|Phase 1b|Clinical Progression|1|||
127731050|NCT01136733|459639221|FG002|Phase 1b|Clinical Progression|0|||
127731051|NCT01136733|459639222|FG003|Phase 1b|Clinical Progression|0|||
127731052|NCT01136733|459639223|FG004|Phase 1b|Clinical Progression|0|||
127731053|NCT01136733|459639224|FG005|Phase 1b|Clinical Progression|0|||
127731054|NCT01136733|459639225|FG006|Phase 1b|Clinical Progression|0|||
127731055|NCT01136733|459639219|FG000|Phase 2|Disease Progression|0|||
127731056|NCT01136733|459639220|FG001|Phase 2|Disease Progression|0|||
127731057|NCT01136733|459639221|FG002|Phase 2|Disease Progression|0|||
127731058|NCT01136733|459639222|FG003|Phase 2|Disease Progression|0|||
127731059|NCT01136733|459639223|FG004|Phase 2|Disease Progression|30|||
127731060|NCT01136733|459639224|FG005|Phase 2|Disease Progression|32|||
127731061|NCT01136733|459639225|FG006|Phase 2|Disease Progression|38|||
127731062|NCT01136733|459639219|FG000|Phase 2|Adverse Event|0|||
127731063|NCT01136733|459639220|FG001|Phase 2|Adverse Event|0|||
127731064|NCT01136733|459639221|FG002|Phase 2|Adverse Event|0|||
127731065|NCT01136733|459639222|FG003|Phase 2|Adverse Event|0|||
127731066|NCT01136733|459639223|FG004|Phase 2|Adverse Event|11|||
127731067|NCT01136733|459639224|FG005|Phase 2|Adverse Event|13|||
127731068|NCT01136733|459639225|FG006|Phase 2|Adverse Event|5|||
127731069|NCT01136733|459639219|FG000|Phase 2|Participant Choice|0|||
127731070|NCT01136733|459639220|FG001|Phase 2|Participant Choice|0|||
127731071|NCT01136733|459639221|FG002|Phase 2|Participant Choice|0|||
127731072|NCT01136733|459639222|FG003|Phase 2|Participant Choice|0|||
127731073|NCT01136733|459639223|FG004|Phase 2|Participant Choice|3|||
127731074|NCT01136733|459639224|FG005|Phase 2|Participant Choice|0|||
127731075|NCT01136733|459639225|FG006|Phase 2|Participant Choice|1|||
127731076|NCT01136733|459639219|FG000|Phase 2|Administrative-Withdrew Consent|0|||
127731077|NCT01136733|459639220|FG001|Phase 2|Administrative-Withdrew Consent|0|||
127731078|NCT01136733|459639221|FG002|Phase 2|Administrative-Withdrew Consent|0|||
127731079|NCT01136733|459639222|FG003|Phase 2|Administrative-Withdrew Consent|0|||
127731080|NCT01136733|459639223|FG004|Phase 2|Administrative-Withdrew Consent|1|||
127803704|NCT02863848|459903708|FG001|Overall Study|Protocol Violation|2|||
127803705|NCT03588741|459903713|FG000|Overall Study|Withdrawal by Subject|1|||
127803706|NCT00548548|459903714|FG000|Overall Study|Death|345|||
127803707|NCT00548548|459903715|FG001|Overall Study|Death|348|||
127731081|NCT01136733|459639224|FG005|Phase 2|Administrative-Withdrew Consent|0|||
127731082|NCT01136733|459639225|FG006|Phase 2|Administrative-Withdrew Consent|0|||
127731083|NCT01136733|459639219|FG000|Phase 2|Other|0|||
127731084|NCT01136733|459639220|FG001|Phase 2|Other|0|||
127731085|NCT01136733|459639221|FG002|Phase 2|Other|0|||
127731086|NCT01136733|459639222|FG003|Phase 2|Other|0|||
127731087|NCT01136733|459639223|FG004|Phase 2|Other|6|||
127803708|NCT00548548|459903714|FG000|Overall Study|Lost to Follow-up|17|||
127803709|NCT00548548|459903715|FG001|Overall Study|Lost to Follow-up|18|||
127803710|NCT01705691|459903716|FG000|Overall Study|Death|1|||
127803711|NCT01705691|459903717|FG001|Overall Study|Death|2|||
127731088|NCT01136733|459639224|FG005|Phase 2|Other|7|||
127731089|NCT01136733|459639225|FG006|Phase 2|Other|6|||
127731090|NCT03360071|459639227|FG000|Overall Study|Lost to Follow-up|1|||
127731091|NCT03360071|459639228|FG001|Overall Study|Lost to Follow-up|0|||
127731092|NCT04175392|459639234|FG000|Overall Study|Withdrawal by Subject|3|||
127731093|NCT04175392|459639235|FG001|Overall Study|Withdrawal by Subject|2|||
127731094|NCT02727998|459639236|FG000|Overall Study|Lost to Follow-up|3|||
127731095|NCT02727998|459639237|FG001|Overall Study|Lost to Follow-up|3|||
127803712|NCT01705691|459903716|FG000|Overall Study|Withdrawal by Subject|1|||
127731096|NCT02727998|459639236|FG000|Overall Study|Withdrawal by Subject|0|||
127731097|NCT02727998|459639237|FG001|Overall Study|Withdrawal by Subject|1|||
127731098|NCT02105688|459639238|FG000|Part A: Double-Blind|Adverse Event|1|||
127803713|NCT01705691|459903717|FG001|Overall Study|Withdrawal by Subject|2|||
127803714|NCT01705691|459903716|FG000|Overall Study|Lost to Follow-up|1|||
127803715|NCT01705691|459903717|FG001|Overall Study|Lost to Follow-up|1|||
127803716|NCT01705691|459903716|FG000|Overall Study|Other|0|||
127803717|NCT01705691|459903717|FG001|Overall Study|Other|1|||
127803718|NCT02913313|459903718|FG000|Overall Study|DISEASE PROGRESSION|1|||
127803719|NCT02913313|459903719|FG001|Overall Study|DISEASE PROGRESSION|2|||
127803720|NCT02913313|459903720|FG002|Overall Study|DISEASE PROGRESSION|2|||
127803721|NCT02913313|459903721|FG003|Overall Study|DISEASE PROGRESSION|4|||
127803722|NCT02913313|459903722|FG004|Overall Study|DISEASE PROGRESSION|6|||
127803723|NCT02913313|459903723|FG005|Overall Study|DISEASE PROGRESSION|4|||
127803724|NCT02913313|459903724|FG006|Overall Study|DISEASE PROGRESSION|19|||
127803725|NCT02913313|459903725|FG007|Overall Study|DISEASE PROGRESSION|3|||
127803726|NCT02913313|459903726|FG008|Overall Study|DISEASE PROGRESSION|4|||
127803727|NCT02913313|459903727|FG009|Overall Study|DISEASE PROGRESSION|4|||
127803728|NCT02913313|459903728|FG010|Overall Study|DISEASE PROGRESSION|11|||
127803729|NCT02913313|459903729|FG011|Overall Study|DISEASE PROGRESSION|5|||
127803730|NCT02913313|459903730|FG012|Overall Study|DISEASE PROGRESSION|14|||
127803731|NCT02913313|459903731|FG013|Overall Study|DISEASE PROGRESSION|3|||
127803732|NCT02913313|459903718|FG000|Overall Study|Not Reported|0|||
127803733|NCT02913313|459903719|FG001|Overall Study|Not Reported|0|||
127803734|NCT02913313|459903720|FG002|Overall Study|Not Reported|0|||
127803735|NCT02913313|459903721|FG003|Overall Study|Not Reported|0|||
127803736|NCT02913313|459903722|FG004|Overall Study|Not Reported|1|||
127803737|NCT02913313|459903723|FG005|Overall Study|Not Reported|0|||
127803738|NCT02913313|459903724|FG006|Overall Study|Not Reported|0|||
127803739|NCT02913313|459903725|FG007|Overall Study|Not Reported|0|||
127803740|NCT02913313|459903726|FG008|Overall Study|Not Reported|0|||
127803741|NCT02913313|459903727|FG009|Overall Study|Not Reported|0|||
127803742|NCT02913313|459903728|FG010|Overall Study|Not Reported|4|||
127803743|NCT02913313|459903729|FG011|Overall Study|Not Reported|0|||
127803744|NCT02913313|459903730|FG012|Overall Study|Not Reported|0|||
127803745|NCT02913313|459903731|FG013|Overall Study|Not Reported|0|||
127803746|NCT02913313|459903718|FG000|Overall Study|Other reasons|0|||
127803747|NCT02913313|459903719|FG001|Overall Study|Other reasons|0|||
127803748|NCT02913313|459903720|FG002|Overall Study|Other reasons|0|||
127803749|NCT02913313|459903721|FG003|Overall Study|Other reasons|0|||
127803750|NCT02913313|459903722|FG004|Overall Study|Other reasons|1|||
127803751|NCT02913313|459903723|FG005|Overall Study|Other reasons|0|||
127803752|NCT02913313|459903724|FG006|Overall Study|Other reasons|0|||
127803753|NCT02913313|459903725|FG007|Overall Study|Other reasons|0|||
127803754|NCT02913313|459903726|FG008|Overall Study|Other reasons|0|||
127803755|NCT02913313|459903727|FG009|Overall Study|Other reasons|0|||
127803756|NCT02913313|459903728|FG010|Overall Study|Other reasons|1|||
127803757|NCT02913313|459903729|FG011|Overall Study|Other reasons|0|||
127803758|NCT02913313|459903730|FG012|Overall Study|Other reasons|0|||
127803759|NCT02913313|459903731|FG013|Overall Study|Other reasons|0|||
127803760|NCT02913313|459903718|FG000|Overall Study|Withdrawal by Subject|0|||
127803761|NCT02913313|459903719|FG001|Overall Study|Withdrawal by Subject|0|||
127803762|NCT02913313|459903720|FG002|Overall Study|Withdrawal by Subject|1|||
127803763|NCT02913313|459903721|FG003|Overall Study|Withdrawal by Subject|0|||
127803764|NCT02913313|459903722|FG004|Overall Study|Withdrawal by Subject|0|||
127803765|NCT02913313|459903723|FG005|Overall Study|Withdrawal by Subject|0|||
127803766|NCT02913313|459903724|FG006|Overall Study|Withdrawal by Subject|1|||
127803767|NCT02913313|459903725|FG007|Overall Study|Withdrawal by Subject|1|||
127803768|NCT02913313|459903726|FG008|Overall Study|Withdrawal by Subject|0|||
127803769|NCT02913313|459903727|FG009|Overall Study|Withdrawal by Subject|0|||
127803770|NCT02913313|459903728|FG010|Overall Study|Withdrawal by Subject|1|||
127803771|NCT02913313|459903729|FG011|Overall Study|Withdrawal by Subject|0|||
127803772|NCT02913313|459903730|FG012|Overall Study|Withdrawal by Subject|0|||
127803773|NCT02913313|459903731|FG013|Overall Study|Withdrawal by Subject|0|||
127803774|NCT02913313|459903718|FG000|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
127890160|NCT00583596|460220009|FG000|Overall Study|Outside f-up window|26|||
127890161|NCT00656019|460220010|FG000|Overall Study|Not Eligible|10|||
127890162|NCT00656019|460220011|FG001|Overall Study|Not Eligible|0|||
127803775|NCT02913313|459903719|FG001|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
127803776|NCT02913313|459903720|FG002|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
127803777|NCT02913313|459903721|FG003|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
127803778|NCT02913313|459903722|FG004|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
127803779|NCT02913313|459903723|FG005|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
127803780|NCT02913313|459903724|FG006|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
127890163|NCT00656019|460220012|FG002|Overall Study|Not Eligible|0|||
127803781|NCT02913313|459903725|FG007|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
127803782|NCT02913313|459903726|FG008|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
127803783|NCT02913313|459903727|FG009|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
127803784|NCT02913313|459903728|FG010|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
127731099|NCT02105688|459639239|FG001|Part A: Double-Blind|Adverse Event|0|||
127731100|NCT02105688|459639238|FG000|Part A: Double-Blind|Death|0|||
127731101|NCT02105688|459639239|FG001|Part A: Double-Blind|Death|1|||
127731102|NCT02105688|459639238|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
127731103|NCT02105688|459639239|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
127731104|NCT02105688|459639238|FG000|Part A: Double-Blind|Physician Decision|0|||
127731105|NCT02105688|459639239|FG001|Part A: Double-Blind|Physician Decision|1|||
127731106|NCT02105688|459639238|FG000|Part A: Double-Blind|Status Unknown|0|||
127731107|NCT02105688|459639239|FG001|Part A: Double-Blind|Status Unknown|2|||
127731108|NCT02105688|459639238|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
127731109|NCT02105688|459639239|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
127731110|NCT02105688|459639238|FG000|Part B: Observational Follow-up|Death|2|||
127731111|NCT02105688|459639239|FG001|Part B: Observational Follow-up|Death|1|||
127731112|NCT02105688|459639238|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
127731113|NCT02105688|459639239|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
127731114|NCT02105688|459639238|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
127731115|NCT02105688|459639239|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
127731116|NCT02105688|459639238|FG000|Part B: Observational Follow-up|Physician Decision|3|||
127731117|NCT02105688|459639239|FG001|Part B: Observational Follow-up|Physician Decision|1|||
127731118|NCT03166215|459639243|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
127731119|NCT03166215|459639244|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
127731120|NCT03166215|459639245|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
127731121|NCT03166215|459639243|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
127731122|NCT03166215|459639244|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
127731123|NCT03166215|459639245|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
127731124|NCT02632045|459639246|FG000|Overall Study|Withdrawal by Subject|1|||
127731125|NCT02632045|459639247|FG001|Overall Study|Withdrawal by Subject|2|||
127731126|NCT05878522|459639248|FG000|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
127731127|NCT05878522|459639249|FG001|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
127731128|NCT05878522|459639250|FG002|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
127731129|NCT05878522|459639251|FG003|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
127731130|NCT05878522|459639252|FG004|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
127731131|NCT05878522|459639253|FG005|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
127731132|NCT05878522|459639254|FG006|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
127731133|NCT05878522|459639255|FG007|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
127731134|NCT05878522|459639256|FG008|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|1|||
127731135|NCT05878522|459639257|FG009|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
127731136|NCT05878522|459639258|FG010|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
127731137|NCT05878522|459639259|FG011|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
127731138|NCT05878522|459639248|FG000|Treatment Period- 2 (3 Days)|Physician Decision|1|||
127731139|NCT05878522|459639249|FG001|Treatment Period- 2 (3 Days)|Physician Decision|0|||
127731140|NCT05878522|459639250|FG002|Treatment Period- 2 (3 Days)|Physician Decision|0|||
127731141|NCT05878522|459639251|FG003|Treatment Period- 2 (3 Days)|Physician Decision|0|||
127731142|NCT05878522|459639252|FG004|Treatment Period- 2 (3 Days)|Physician Decision|0|||
127731143|NCT05878522|459639253|FG005|Treatment Period- 2 (3 Days)|Physician Decision|0|||
127731144|NCT05878522|459639254|FG006|Treatment Period- 2 (3 Days)|Physician Decision|0|||
127731145|NCT05878522|459639255|FG007|Treatment Period- 2 (3 Days)|Physician Decision|0|||
127731146|NCT05878522|459639256|FG008|Treatment Period- 2 (3 Days)|Physician Decision|0|||
127731147|NCT05878522|459639257|FG009|Treatment Period- 2 (3 Days)|Physician Decision|1|||
127731148|NCT05878522|459639258|FG010|Treatment Period- 2 (3 Days)|Physician Decision|0|||
127731149|NCT05878522|459639259|FG011|Treatment Period- 2 (3 Days)|Physician Decision|0|||
127731150|NCT05878522|459639248|FG000|Treatment Period- 2 (3 Days)|Adverse Event|0|||
127731151|NCT05878522|459639249|FG001|Treatment Period- 2 (3 Days)|Adverse Event|1|||
127731152|NCT05878522|459639250|FG002|Treatment Period- 2 (3 Days)|Adverse Event|0|||
127731153|NCT05878522|459639251|FG003|Treatment Period- 2 (3 Days)|Adverse Event|1|||
127731154|NCT05878522|459639252|FG004|Treatment Period- 2 (3 Days)|Adverse Event|0|||
127731155|NCT05878522|459639253|FG005|Treatment Period- 2 (3 Days)|Adverse Event|0|||
127731156|NCT05878522|459639254|FG006|Treatment Period- 2 (3 Days)|Adverse Event|0|||
127731157|NCT05878522|459639255|FG007|Treatment Period- 2 (3 Days)|Adverse Event|0|||
127731158|NCT05878522|459639256|FG008|Treatment Period- 2 (3 Days)|Adverse Event|0|||
127731159|NCT05878522|459639257|FG009|Treatment Period- 2 (3 Days)|Adverse Event|0|||
127731160|NCT05878522|459639258|FG010|Treatment Period- 2 (3 Days)|Adverse Event|0|||
127731161|NCT05878522|459639259|FG011|Treatment Period- 2 (3 Days)|Adverse Event|0|||
127803785|NCT02913313|459903729|FG011|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
127803786|NCT02913313|459903730|FG012|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
127803787|NCT02913313|459903731|FG013|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
127803788|NCT02913313|459903718|FG000|Overall Study|STUDY DRUG TOXICITY|0|||
127731162|NCT05878522|459639248|FG000|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
127731163|NCT05878522|459639249|FG001|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
127731164|NCT05878522|459639250|FG002|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
127731165|NCT05878522|459639251|FG003|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
127731166|NCT05878522|459639252|FG004|Treatment Period- 2 (3 Days)|Withdrawal by Subject|1|||
127731167|NCT05878522|459639253|FG005|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
127731168|NCT05878522|459639254|FG006|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
127803789|NCT02913313|459903719|FG001|Overall Study|STUDY DRUG TOXICITY|0|||
127731169|NCT05878522|459639255|FG007|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
127731170|NCT05878522|459639256|FG008|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
127731171|NCT05878522|459639257|FG009|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
127731172|NCT05878522|459639258|FG010|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
127731173|NCT05878522|459639259|FG011|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
127731174|NCT02252172|459639260|FG000|Overall Study|Lost to Follow-up|3|||
127731175|NCT02252172|459639261|FG001|Overall Study|Lost to Follow-up|1|||
127731176|NCT02252172|459639260|FG000|Overall Study|Ongoing|276|||
127731177|NCT02252172|459639261|FG001|Overall Study|Ongoing|298|||
127731178|NCT05740371|459639262|FG000|Overall Study|Death|1|||
127731179|NCT01613599|459639264|FG000|Overall Study|Death|9|||
127731180|NCT01613599|459639264|FG000|Overall Study|Lost to Follow-up|5|||
127803790|NCT02913313|459903720|FG002|Overall Study|STUDY DRUG TOXICITY|0|||
127803791|NCT02913313|459903721|FG003|Overall Study|STUDY DRUG TOXICITY|0|||
127803792|NCT02913313|459903722|FG004|Overall Study|STUDY DRUG TOXICITY|0|||
127803793|NCT02913313|459903723|FG005|Overall Study|STUDY DRUG TOXICITY|0|||
127803794|NCT02913313|459903724|FG006|Overall Study|STUDY DRUG TOXICITY|0|||
127803795|NCT02913313|459903725|FG007|Overall Study|STUDY DRUG TOXICITY|0|||
127803796|NCT02913313|459903726|FG008|Overall Study|STUDY DRUG TOXICITY|0|||
127803797|NCT02913313|459903727|FG009|Overall Study|STUDY DRUG TOXICITY|0|||
127803798|NCT02913313|459903728|FG010|Overall Study|STUDY DRUG TOXICITY|0|||
127803799|NCT02913313|459903729|FG011|Overall Study|STUDY DRUG TOXICITY|1|||
127803800|NCT02913313|459903730|FG012|Overall Study|STUDY DRUG TOXICITY|2|||
127803801|NCT02913313|459903731|FG013|Overall Study|STUDY DRUG TOXICITY|1|||
127803802|NCT04088409|459903732|FG000|Part A|Withdrawal by Subject|2|||
127803803|NCT04088409|459903733|FG001|Part A|Withdrawal by Subject|1|||
127803804|NCT04088409|459903732|FG000|Part A|Did Not Meet Randomization Criteria|2|||
127803805|NCT04088409|459903733|FG001|Part A|Did Not Meet Randomization Criteria|0|||
127803806|NCT04088409|459903732|FG000|Part A|Lack of Efficacy|9|||
127803807|NCT04088409|459903733|FG001|Part A|Lack of Efficacy|0|||
127803808|NCT04088409|459903732|FG000|Part A|Lost to Follow-up|1|||
127803809|NCT04088409|459903733|FG001|Part A|Lost to Follow-up|0|||
127803810|NCT04088409|459903732|FG000|Part A|Adverse Event|1|||
127803811|NCT04088409|459903733|FG001|Part A|Adverse Event|0|||
127803812|NCT04088409|459903732|FG000|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|0|||
127803813|NCT04088409|459903733|FG001|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|4|||
127803814|NCT04088409|459903732|FG000|Part B|Ongoing Treatment|10|||
127803815|NCT04088409|459903733|FG001|Part B|Ongoing Treatment|0|||
127803816|NCT04233229|459903734|FG000|Overall Study|Withdrawal by Subject|0|||
127803817|NCT04233229|459903735|FG001|Overall Study|Withdrawal by Subject|1|||
127803818|NCT04233229|459903734|FG000|Overall Study|Exclusion criterion found the day after initiation visit|1|||
127803819|NCT04233229|459903735|FG001|Overall Study|Exclusion criterion found the day after initiation visit|0|||
127803820|NCT04233229|459903734|FG000|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|0|||
127803821|NCT04233229|459903735|FG001|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|2|||
127803822|NCT00841763|459903736|FG000|Overall Study|Withdrawal by Subject|60|||
127803823|NCT00841763|459903737|FG001|Overall Study|Withdrawal by Subject|17|||
127803824|NCT00841763|459903738|FG002|Overall Study|Withdrawal by Subject|4|||
127803825|NCT00841763|459903739|FG003|Overall Study|Withdrawal by Subject|1|||
127803826|NCT00841763|459903736|FG000|Overall Study|Adverse Event|9|||
127803827|NCT00841763|459903737|FG001|Overall Study|Adverse Event|10|||
127803828|NCT00841763|459903738|FG002|Overall Study|Adverse Event|3|||
127803829|NCT00841763|459903739|FG003|Overall Study|Adverse Event|2|||
127803830|NCT00841763|459903736|FG000|Overall Study|Lost to Follow-up|63|||
127803831|NCT00841763|459903737|FG001|Overall Study|Lost to Follow-up|25|||
127803832|NCT00841763|459903738|FG002|Overall Study|Lost to Follow-up|0|||
127803833|NCT00841763|459903739|FG003|Overall Study|Lost to Follow-up|0|||
127803834|NCT00841763|459903736|FG000|Overall Study|Protocol Violation|20|||
127803835|NCT00841763|459903737|FG001|Overall Study|Protocol Violation|3|||
127803836|NCT00841763|459903738|FG002|Overall Study|Protocol Violation|1|||
127803837|NCT00841763|459903739|FG003|Overall Study|Protocol Violation|0|||
127803838|NCT00841763|459903736|FG000|Overall Study|Administrative Reasons|3|||
127803839|NCT00841763|459903737|FG001|Overall Study|Administrative Reasons|1|||
127803840|NCT00841763|459903738|FG002|Overall Study|Administrative Reasons|0|||
127803841|NCT00841763|459903739|FG003|Overall Study|Administrative Reasons|0|||
127803842|NCT00841763|459903736|FG000|Overall Study|Unable to Classify|7|||
127803843|NCT00841763|459903737|FG001|Overall Study|Unable to Classify|1|||
127803844|NCT00841763|459903738|FG002|Overall Study|Unable to Classify|0|||
127803845|NCT00841763|459903739|FG003|Overall Study|Unable to Classify|0|||
127803846|NCT02631538|459903740|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
127803847|NCT02631538|459903741|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
127803848|NCT02631538|459903742|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
127803849|NCT02631538|459903743|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
127803850|NCT02631538|459903740|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
127803851|NCT02631538|459903741|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
127803852|NCT02631538|459903742|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
127803853|NCT02631538|459903743|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
127803854|NCT02631538|459903740|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
127803855|NCT02631538|459903741|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
127803856|NCT02631538|459903742|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
127803857|NCT02631538|459903743|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
127803858|NCT02631538|459903740|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
127803859|NCT02631538|459903741|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
127803860|NCT02631538|459903742|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
127803861|NCT02631538|459903743|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
127803862|NCT02631538|459903740|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
127803863|NCT02631538|459903741|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
127803864|NCT02631538|459903742|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
127803865|NCT02631538|459903743|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
127803866|NCT02631538|459903740|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
127803867|NCT02631538|459903741|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
127803868|NCT02631538|459903742|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
127803869|NCT02631538|459903743|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
127803870|NCT00648167|459903744|FG000|Overall Study|Adverse Event|6|||
127803871|NCT00648167|459903744|FG000|Overall Study|unable to swallow tablets|1|||
127803872|NCT01482910|459903749|FG000|Overall Study|Adverse Event|6|||
127803873|NCT01482910|459903750|FG001|Overall Study|Adverse Event|5|||
127803874|NCT01482910|459903749|FG000|Overall Study|Lost to Follow-up|0|||
127803875|NCT01482910|459903750|FG001|Overall Study|Lost to Follow-up|1|||
127803876|NCT01482910|459903749|FG000|Overall Study|Protocol Violation|1|||
127803877|NCT01482910|459903750|FG001|Overall Study|Protocol Violation|1|||
127803878|NCT01482910|459903749|FG000|Overall Study|Withdrawal by Subject|7|||
127803879|NCT01482910|459903750|FG001|Overall Study|Withdrawal by Subject|2|||
127485447|NCT01240863|458741182|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
127731181|NCT01613599|459639264|FG000|Overall Study|Withdrawal by Subject|8|||
127731182|NCT01613599|459639264|FG000|Overall Study|Reason not specified|3|||
127731183|NCT00617708|459639268|FG000|Overall Study|Adverse Event|0|||
127731184|NCT00617708|459639269|FG001|Overall Study|Adverse Event|6|||
127731185|NCT00617708|459639270|FG002|Overall Study|Adverse Event|9|||
127731186|NCT00617708|459639268|FG000|Overall Study|Withdrawal by Subject|1|||
127731187|NCT00617708|459639269|FG001|Overall Study|Withdrawal by Subject|1|||
127731188|NCT00617708|459639270|FG002|Overall Study|Withdrawal by Subject|7|||
127731189|NCT00617708|459639268|FG000|Overall Study|Death|0|||
127731190|NCT00617708|459639269|FG001|Overall Study|Death|6|||
127731191|NCT00617708|459639270|FG002|Overall Study|Death|5|||
127731192|NCT00617708|459639268|FG000|Overall Study|Progression/Relapse|7|||
127731193|NCT00617708|459639269|FG001|Overall Study|Progression/Relapse|40|||
127731194|NCT00617708|459639270|FG002|Overall Study|Progression/Relapse|36|||
127731195|NCT00617708|459639268|FG000|Overall Study|Not protocol specified|1|||
127731196|NCT00617708|459639269|FG001|Overall Study|Not protocol specified|4|||
127731197|NCT00617708|459639270|FG002|Overall Study|Not protocol specified|2|||
127731198|NCT00617708|459639268|FG000|Overall Study|Not eligible|1|||
127731199|NCT00617708|459639269|FG001|Overall Study|Not eligible|3|||
127731200|NCT00617708|459639270|FG002|Overall Study|Not eligible|5|||
127731201|NCT01075815|459639271|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
127731202|NCT01075815|459639272|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
127731203|NCT01075815|459639271|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
127731204|NCT01075815|459639272|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
127731205|NCT01075815|459639271|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
127731206|NCT01075815|459639272|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
127731207|NCT02058992|459639273|FG000|Overall Study|Lost to Follow-up|4|||
127731208|NCT02058992|459639273|FG000|Overall Study|Protocol Violation|92|||
127731209|NCT02058992|459639273|FG000|Overall Study|CRF Uncollected|20|||
127731210|NCT03503188|459639274|FG000|Overall Study|Non eligible in the sub study|0|||
127731211|NCT03503188|459639275|FG001|Overall Study|Non eligible in the sub study|1|||
127731212|NCT03747575|459639282|FG000|Overall Study|Withdrawal by Subject|6|||
127731213|NCT03747575|459639283|FG001|Overall Study|Withdrawal by Subject|3|||
127731214|NCT03747575|459639282|FG000|Overall Study|Lost to Follow-up|3|||
127803880|NCT01482910|459903749|FG000|Overall Study|Death|1|||
127890164|NCT00656019|460220013|FG003|Overall Study|Not Eligible|0|||
127731215|NCT03747575|459639283|FG001|Overall Study|Lost to Follow-up|3|||
127731216|NCT03747575|459639282|FG000|Overall Study|Adverse Event|0|||
127731217|NCT03747575|459639283|FG001|Overall Study|Adverse Event|1|||
127731218|NCT03005106|459639284|FG000|Overall Study|Lost to Follow-up|16|||
127731219|NCT03005106|459639284|FG000|Overall Study|Adverse Event|1|||
127731220|NCT03005106|459639284|FG000|Overall Study|Physician Decision|1|||
127731221|NCT03005106|459639284|FG000|Overall Study|Death|2|||
127731222|NCT00321672|459639285|FG000|Overall Study|Withdrawal by Subject|5|||
127731223|NCT00321672|459639286|FG001|Overall Study|Withdrawal by Subject|1|||
127731224|NCT00321672|459639287|FG002|Overall Study|Withdrawal by Subject|2|||
127731225|NCT00321672|459639288|FG003|Overall Study|Withdrawal by Subject|0|||
127731226|NCT00321672|459639285|FG000|Overall Study|Noncompliance|1|||
127731227|NCT00321672|459639286|FG001|Overall Study|Noncompliance|2|||
127731228|NCT00321672|459639287|FG002|Overall Study|Noncompliance|1|||
127731229|NCT00321672|459639288|FG003|Overall Study|Noncompliance|0|||
127731230|NCT00321672|459639285|FG000|Overall Study|Adverse Event|1|||
127731231|NCT00321672|459639286|FG001|Overall Study|Adverse Event|1|||
127731232|NCT00321672|459639287|FG002|Overall Study|Adverse Event|0|||
127731233|NCT00321672|459639288|FG003|Overall Study|Adverse Event|0|||
127731234|NCT00321672|459639285|FG000|Overall Study|Lack of Efficacy|1|||
127731235|NCT00321672|459639286|FG001|Overall Study|Lack of Efficacy|1|||
127731236|NCT00321672|459639287|FG002|Overall Study|Lack of Efficacy|0|||
127731237|NCT00321672|459639288|FG003|Overall Study|Lack of Efficacy|0|||
127731238|NCT00321672|459639285|FG000|Overall Study|Lost to Follow-up|2|||
127731239|NCT00321672|459639286|FG001|Overall Study|Lost to Follow-up|0|||
127731240|NCT00321672|459639287|FG002|Overall Study|Lost to Follow-up|4|||
127731241|NCT00321672|459639288|FG003|Overall Study|Lost to Follow-up|2|||
127731242|NCT00321672|459639285|FG000|Overall Study|Death|1|||
127731243|NCT00321672|459639286|FG001|Overall Study|Death|0|||
127731244|NCT00321672|459639287|FG002|Overall Study|Death|0|||
127731245|NCT00321672|459639288|FG003|Overall Study|Death|0|||
127731246|NCT00321672|459639285|FG000|Overall Study|Too far to travel for visits|1|||
127731247|NCT00321672|459639286|FG001|Overall Study|Too far to travel for visits|0|||
127731248|NCT00321672|459639287|FG002|Overall Study|Too far to travel for visits|0|||
127731249|NCT00321672|459639288|FG003|Overall Study|Too far to travel for visits|0|||
127731250|NCT00321672|459639285|FG000|Overall Study|Incarcerated|0|||
127731251|NCT00321672|459639286|FG001|Overall Study|Incarcerated|0|||
127731252|NCT00321672|459639287|FG002|Overall Study|Incarcerated|2|||
127731253|NCT00321672|459639288|FG003|Overall Study|Incarcerated|0|||
127731254|NCT00321672|459639285|FG000|Overall Study|Moved out of state|0|||
127731255|NCT00321672|459639286|FG001|Overall Study|Moved out of state|1|||
127731256|NCT00321672|459639287|FG002|Overall Study|Moved out of state|1|||
127731257|NCT00321672|459639288|FG003|Overall Study|Moved out of state|0|||
127731258|NCT00321672|459639285|FG000|Overall Study|Protocol Violation|0|||
127731259|NCT00321672|459639286|FG001|Overall Study|Protocol Violation|0|||
127731260|NCT00321672|459639287|FG002|Overall Study|Protocol Violation|1|||
127731261|NCT00321672|459639288|FG003|Overall Study|Protocol Violation|0|||
127731262|NCT00321672|459639285|FG000|Overall Study|Diagnosis of testicular cancer|0|||
127731263|NCT00321672|459639286|FG001|Overall Study|Diagnosis of testicular cancer|1|||
127731264|NCT00321672|459639287|FG002|Overall Study|Diagnosis of testicular cancer|0|||
127731265|NCT00321672|459639288|FG003|Overall Study|Diagnosis of testicular cancer|0|||
127731266|NCT00321672|459639285|FG000|Overall Study|Extensive travel required for new job|0|||
127731267|NCT00321672|459639286|FG001|Overall Study|Extensive travel required for new job|1|||
127731268|NCT00321672|459639287|FG002|Overall Study|Extensive travel required for new job|0|||
127731269|NCT00321672|459639288|FG003|Overall Study|Extensive travel required for new job|0|||
127731270|NCT00512902|459639291|FG000|Overall Study|Adverse Event|7|||
127731271|NCT00512902|459639291|FG000|Overall Study|Lost to Follow-up|1|||
127731272|NCT03019289|459639292|FG000|Overall Study|Adverse Event|1|||
127731273|NCT03019289|459639293|FG001|Overall Study|Adverse Event|0|||
127731274|NCT03019289|459639294|FG002|Overall Study|Adverse Event|0|||
127731275|NCT03019289|459639295|FG003|Overall Study|Adverse Event|0|||
127731276|NCT03019289|459639296|FG004|Overall Study|Adverse Event|0|||
127731277|NCT03019289|459639297|FG005|Overall Study|Adverse Event|0|||
127731278|NCT03019289|459639298|FG006|Overall Study|Adverse Event|0|||
127731279|NCT03019289|459639299|FG007|Overall Study|Adverse Event|0|||
127731280|NCT03019289|459639300|FG008|Overall Study|Adverse Event|1|||
127731281|NCT03019289|459639292|FG000|Overall Study|Other|1|||
127731282|NCT03019289|459639293|FG001|Overall Study|Other|0|||
127731283|NCT03019289|459639294|FG002|Overall Study|Other|0|||
127731284|NCT03019289|459639295|FG003|Overall Study|Other|0|||
127731285|NCT03019289|459639296|FG004|Overall Study|Other|0|||
127731286|NCT03019289|459639297|FG005|Overall Study|Other|0|||
127731287|NCT03019289|459639298|FG006|Overall Study|Other|0|||
127731288|NCT03019289|459639299|FG007|Overall Study|Other|0|||
127731289|NCT03019289|459639300|FG008|Overall Study|Other|0|||
127731290|NCT01429285|459639301|FG000|Overall Study|Protocol Violation|9|||
127731291|NCT01429285|459639302|FG001|Overall Study|Protocol Violation|4|||
127731292|NCT01429285|459639301|FG000|Overall Study|Missing Data|5|||
127803881|NCT01482910|459903750|FG001|Overall Study|Death|0|||
127803882|NCT00440726|459903751|FG000|Phase 1|Dose-Limiting Toxicity|0|||
127803883|NCT00440726|459903752|FG001|Phase 1|Dose-Limiting Toxicity|1|||
127803884|NCT00440726|459903753|FG002|Phase 1|Dose-Limiting Toxicity|0|||
127803885|NCT00440726|459903751|FG000|Phase 1|Physician Decision|1|||
127803886|NCT00440726|459903752|FG001|Phase 1|Physician Decision|0|||
127803887|NCT00440726|459903753|FG002|Phase 1|Physician Decision|0|||
127803888|NCT00440726|459903751|FG000|Phase 2|Death|0|||
127803889|NCT00440726|459903752|FG001|Phase 2|Death|0|||
127803890|NCT00440726|459903753|FG002|Phase 2|Death|1|||
127803891|NCT00440726|459903751|FG000|Phase 2|Adverse Event|0|||
127803892|NCT00440726|459903752|FG001|Phase 2|Adverse Event|0|||
127803893|NCT00440726|459903753|FG002|Phase 2|Adverse Event|1|||
127890165|NCT00656019|460220010|FG000|Overall Study|Withdrawal by Subject|2|||
127890166|NCT00656019|460220011|FG001|Overall Study|Withdrawal by Subject|0|||
127890167|NCT00656019|460220012|FG002|Overall Study|Withdrawal by Subject|0|||
127890168|NCT00656019|460220013|FG003|Overall Study|Withdrawal by Subject|0|||
127890169|NCT00656019|460220010|FG000|Overall Study|Lost to Follow-up|2|||
127890170|NCT00656019|460220011|FG001|Overall Study|Lost to Follow-up|1|||
127890171|NCT00656019|460220012|FG002|Overall Study|Lost to Follow-up|0|||
127890172|NCT00656019|460220013|FG003|Overall Study|Lost to Follow-up|0|||
127890173|NCT00096486|460220014|FG000|Overall Study|Withdrawal by Subject|0|||
127890174|NCT00096486|460220015|FG001|Overall Study|Withdrawal by Subject|0|||
127731293|NCT01429285|459639302|FG001|Overall Study|Missing Data|3|||
127731294|NCT01429285|459639301|FG000|Overall Study|Erroneously Enrolled Twice|8|||
127731295|NCT01429285|459639302|FG001|Overall Study|Erroneously Enrolled Twice|2|||
127731296|NCT03689452|459639309|FG000|Overall Study|Lost to Follow-up|1|||
127731297|NCT03689452|459639310|FG001|Overall Study|Lost to Follow-up|1|||
127731298|NCT02676778|459639311|FG000|Overall Study|Disease Progression|7|||
127731299|NCT02676778|459639312|FG001|Overall Study|Disease Progression|3|||
127731300|NCT02676778|459639313|FG002|Overall Study|Disease Progression|1|||
127731301|NCT02676778|459639311|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
127890175|NCT00096486|460220016|FG002|Overall Study|Withdrawal by Subject|1|||
127890176|NCT00096486|460220017|FG003|Overall Study|Withdrawal by Subject|1|||
127890177|NCT00096486|460220014|FG000|Overall Study|Not Treated|0|||
127890178|NCT00096486|460220015|FG001|Overall Study|Not Treated|0|||
127890179|NCT00096486|460220016|FG002|Overall Study|Not Treated|1|||
127890180|NCT00096486|460220017|FG003|Overall Study|Not Treated|1|||
127890181|NCT03558997|460220018|FG000|Overall Study|Adverse Event|0|||
127890182|NCT03558997|460220019|FG001|Overall Study|Adverse Event|2|||
127890183|NCT03558997|460220020|FG002|Overall Study|Adverse Event|5|||
127890184|NCT03558997|460220021|FG003|Overall Study|Adverse Event|1|||
127890185|NCT03558997|460220018|FG000|Overall Study|Physician Decision|0|||
127890186|NCT03558997|460220019|FG001|Overall Study|Physician Decision|0|||
127890187|NCT03558997|460220020|FG002|Overall Study|Physician Decision|1|||
127890188|NCT03558997|460220021|FG003|Overall Study|Physician Decision|0|||
127890189|NCT03558997|460220018|FG000|Overall Study|Withdrawal by Subject|1|||
127890190|NCT03558997|460220019|FG001|Overall Study|Withdrawal by Subject|0|||
127890191|NCT03558997|460220020|FG002|Overall Study|Withdrawal by Subject|1|||
127731302|NCT02676778|459639312|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
127731303|NCT02676778|459639313|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
127731304|NCT02676778|459639311|FG000|Overall Study|Withdrawal by Subject|3|||
127803894|NCT02614079|459903757|FG000|Overall Study|Withdrawal by Subject|1|||
127803895|NCT03370770|459903758|FG000|Overall Study|Patient was followed in another hospital center|1|||
127803896|NCT03370770|459903758|FG000|Overall Study|Progressive Disease|98|||
127890192|NCT03558997|460220021|FG003|Overall Study|Withdrawal by Subject|1|||
127890193|NCT03558997|460220018|FG000|Overall Study|Lost to Follow-up|0|||
127803897|NCT03370770|459903758|FG000|Overall Study|Adverse Event|2|||
127731305|NCT02676778|459639312|FG001|Overall Study|Withdrawal by Subject|2|||
127731306|NCT02676778|459639313|FG002|Overall Study|Withdrawal by Subject|0|||
127803898|NCT03370770|459903758|FG000|Overall Study|Death|5|||
127890194|NCT03558997|460220019|FG001|Overall Study|Lost to Follow-up|0|||
127890195|NCT03558997|460220020|FG002|Overall Study|Lost to Follow-up|1|||
127890196|NCT03558997|460220021|FG003|Overall Study|Lost to Follow-up|0|||
127890197|NCT02230085|460220024|FG000|Overall Study|Physician Decision|1|||
127803899|NCT00234039|459903759|FG000|Overall Study|Adverse Event|2|||
127803900|NCT00234039|459903759|FG000|Overall Study|Progression/relapse|34|||
127803901|NCT00234039|459903759|FG000|Overall Study|Other - Not Protocol Specified|3|||
127803902|NCT00234039|459903759|FG000|Overall Study|Ineligible|9|||
127731307|NCT02676778|459639311|FG000|Overall Study|Other|4|||
127731308|NCT02676778|459639312|FG001|Overall Study|Other|3|||
127731309|NCT02676778|459639313|FG002|Overall Study|Other|0|||
127731310|NCT02676778|459639311|FG000|Overall Study|Adverse Event|2|||
127731311|NCT02676778|459639312|FG001|Overall Study|Adverse Event|3|||
127731312|NCT02676778|459639313|FG002|Overall Study|Adverse Event|0|||
127731313|NCT00732498|459639317|FG000|Overall Study|Ineligible|1|||
127731314|NCT00732498|459639317|FG000|Overall Study|Adverse Event|2|||
127731315|NCT00732498|459639317|FG000|Overall Study|Physician Decision|3|||
127731316|NCT03394508|459639322|FG000|Overall Study|Protocol Violation|0|||
127731317|NCT03394508|459639323|FG001|Overall Study|Protocol Violation|3|||
127731318|NCT03394508|459639322|FG000|Overall Study|Lost to Follow-up|1|||
127731319|NCT03394508|459639323|FG001|Overall Study|Lost to Follow-up|0|||
127731320|NCT01288729|459639324|FG000|Overall Study|Withdrawal by Subject|1|||
127731321|NCT01288729|459639325|FG001|Overall Study|Withdrawal by Subject|0|||
127731322|NCT03214198|459639326|FG000|Overall Study|Case Report Forms Uncollected|18|||
127731323|NCT03214198|459639326|FG000|Overall Study|Protocol Deviation|18|||
127731324|NCT04295499|459639327|FG000|Overall Study|moving out of state|1|||
127731325|NCT04295499|459639328|FG001|Overall Study|moving out of state|0|||
127731326|NCT04295499|459639327|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
127731327|NCT04295499|459639328|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
127731328|NCT03122548|459639329|FG000|Overall Study|Death|2|||
127731329|NCT03122548|459639329|FG000|Overall Study|Progression - subject went into hospice|1|||
127731330|NCT03122548|459639329|FG000|Overall Study|Study Terminated by Sponsor|2|||
127731331|NCT02135445|459639330|FG000|Overall Study|Lost to Follow-up|1|||
127731332|NCT02135445|459639331|FG001|Overall Study|Lost to Follow-up|0|||
127731333|NCT02135445|459639330|FG000|Overall Study|Withdrawal by Subject|1|||
127731334|NCT02135445|459639331|FG001|Overall Study|Withdrawal by Subject|0|||
127731335|NCT04448561|459639337|FG000|Overall Study|Noncompliance|1|||
127731336|NCT04448561|459639338|FG001|Overall Study|Noncompliance|0|||
127731337|NCT02136797|459640742|FG000|Overall Study|Not Treated|8|||
127731338|NCT03050372|459640743|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
127731339|NCT03050372|459640744|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
127731340|NCT03050372|459640743|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
127731341|NCT03050372|459640744|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
127731342|NCT03672188|459640747|FG000|Overall Study|Withdrawal by Subject|0|||
127731343|NCT03672188|459640748|FG001|Overall Study|Withdrawal by Subject|0|||
127731344|NCT03672188|459640749|FG002|Overall Study|Withdrawal by Subject|0|||
127731345|NCT03672188|459640750|FG003|Overall Study|Withdrawal by Subject|3|||
127731346|NCT03672188|459640751|FG004|Overall Study|Withdrawal by Subject|0|||
127731347|NCT03672188|459640752|FG005|Overall Study|Withdrawal by Subject|0|||
127731348|NCT03672188|459640753|FG006|Overall Study|Withdrawal by Subject|0|||
127731349|NCT03672188|459640754|FG007|Overall Study|Withdrawal by Subject|0|||
127731350|NCT03672188|459640755|FG008|Overall Study|Withdrawal by Subject|0|||
127731351|NCT03672188|459640756|FG009|Overall Study|Withdrawal by Subject|0|||
127731352|NCT03672188|459640757|FG010|Overall Study|Withdrawal by Subject|0|||
127731353|NCT03672188|459640758|FG011|Overall Study|Withdrawal by Subject|0|||
127731354|NCT03672188|459640759|FG012|Overall Study|Withdrawal by Subject|0|||
127731355|NCT03672188|459640760|FG013|Overall Study|Withdrawal by Subject|0|||
127731356|NCT03672188|459640761|FG014|Overall Study|Withdrawal by Subject|0|||
127731357|NCT03672188|459640747|FG000|Overall Study|Death|0|||
127731358|NCT03672188|459640748|FG001|Overall Study|Death|0|||
127731359|NCT03672188|459640749|FG002|Overall Study|Death|0|||
127731360|NCT03672188|459640750|FG003|Overall Study|Death|0|||
127731361|NCT03672188|459640751|FG004|Overall Study|Death|0|||
127731362|NCT03672188|459640752|FG005|Overall Study|Death|0|||
127731363|NCT03672188|459640753|FG006|Overall Study|Death|0|||
127731364|NCT03672188|459640754|FG007|Overall Study|Death|0|||
127731365|NCT03672188|459640755|FG008|Overall Study|Death|0|||
127731366|NCT03672188|459640756|FG009|Overall Study|Death|0|||
127731367|NCT03672188|459640757|FG010|Overall Study|Death|0|||
127731368|NCT03672188|459640758|FG011|Overall Study|Death|0|||
127731369|NCT03672188|459640759|FG012|Overall Study|Death|1|||
127731370|NCT03672188|459640760|FG013|Overall Study|Death|0|||
127890198|NCT02230085|460220024|FG000|Overall Study|Withdrawal by Subject|3|||
127731371|NCT03672188|459640761|FG014|Overall Study|Death|0|||
127731372|NCT03672188|459640747|FG000|Overall Study|Lost to Follow-up|0|||
127731373|NCT03672188|459640748|FG001|Overall Study|Lost to Follow-up|0|||
127731374|NCT03672188|459640749|FG002|Overall Study|Lost to Follow-up|1|||
127731375|NCT03672188|459640750|FG003|Overall Study|Lost to Follow-up|0|||
127731376|NCT03672188|459640751|FG004|Overall Study|Lost to Follow-up|0|||
127731377|NCT03672188|459640752|FG005|Overall Study|Lost to Follow-up|0|||
127731378|NCT03672188|459640753|FG006|Overall Study|Lost to Follow-up|0|||
127803903|NCT00234039|459903759|FG000|Overall Study|No Protocol Treatment Received|2|||
127803904|NCT03683394|459903762|FG000|Overall Study|Withdrawal by Subject|4|||
127803905|NCT03683394|459903763|FG001|Overall Study|Withdrawal by Subject|8|||
127803906|NCT03683394|459903762|FG000|Overall Study|Lost to Follow-up|7|||
127803907|NCT03683394|459903763|FG001|Overall Study|Lost to Follow-up|0|||
127803908|NCT03683394|459903762|FG000|Overall Study|Death|3|||
127803909|NCT03683394|459903763|FG001|Overall Study|Death|1|||
127803910|NCT00110019|459903764|FG000|Overall Study|Lack of Efficacy|253|||
127803911|NCT00110019|459903765|FG001|Overall Study|Lack of Efficacy|285|||
127803912|NCT00110019|459903764|FG000|Overall Study|Adverse Event|61|||
127803913|NCT00110019|459903765|FG001|Overall Study|Adverse Event|40|||
127803914|NCT00110019|459903764|FG000|Overall Study|Death|13|||
127803915|NCT00110019|459903765|FG001|Overall Study|Death|15|||
127803916|NCT00110019|459903764|FG000|Overall Study|Withdrawal by Subject|21|||
127803917|NCT00110019|459903765|FG001|Overall Study|Withdrawal by Subject|9|||
127803918|NCT00110019|459903764|FG000|Overall Study|alternative therapy|5|||
127890199|NCT01360632|460220028|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
127731379|NCT03672188|459640754|FG007|Overall Study|Lost to Follow-up|0|||
127731380|NCT03672188|459640755|FG008|Overall Study|Lost to Follow-up|0|||
127731381|NCT03672188|459640756|FG009|Overall Study|Lost to Follow-up|0|||
127731382|NCT03672188|459640757|FG010|Overall Study|Lost to Follow-up|0|||
127731383|NCT03672188|459640758|FG011|Overall Study|Lost to Follow-up|0|||
127731384|NCT03672188|459640759|FG012|Overall Study|Lost to Follow-up|0|||
127731385|NCT03672188|459640760|FG013|Overall Study|Lost to Follow-up|0|||
127731386|NCT03672188|459640761|FG014|Overall Study|Lost to Follow-up|0|||
127731387|NCT03320941|459640769|FG000|Overall Study|subject/guardian decision|0|||
127731388|NCT03320941|459640770|FG001|Overall Study|subject/guardian decision|0|||
127731389|NCT03320941|459640771|FG002|Overall Study|subject/guardian decision|0|||
127731390|NCT03320941|459640772|FG003|Overall Study|subject/guardian decision|1|||
127731391|NCT03320941|459640773|FG004|Overall Study|subject/guardian decision|0|||
127731392|NCT03614923|459640774|FG000|Overall Study|Withdrawal by Subject|2|||
127731393|NCT03614923|459640775|FG001|Overall Study|Withdrawal by Subject|1|||
127731394|NCT03614923|459640776|FG002|Overall Study|Withdrawal by Subject|1|||
127731395|NCT03614923|459640774|FG000|Overall Study|Adverse Event|0|||
127731396|NCT03614923|459640775|FG001|Overall Study|Adverse Event|2|||
127731397|NCT03614923|459640776|FG002|Overall Study|Adverse Event|1|||
127731398|NCT03614923|459640774|FG000|Overall Study|Lost to Follow-up|1|||
127731399|NCT03614923|459640775|FG001|Overall Study|Lost to Follow-up|0|||
127731400|NCT03614923|459640776|FG002|Overall Study|Lost to Follow-up|1|||
127731401|NCT03614923|459640774|FG000|Overall Study|Lack of Efficacy|2|||
127731402|NCT03614923|459640775|FG001|Overall Study|Lack of Efficacy|0|||
127731403|NCT03614923|459640776|FG002|Overall Study|Lack of Efficacy|1|||
127731404|NCT03614923|459640774|FG000|Overall Study|Non-compliance|0|||
127731405|NCT03614923|459640775|FG001|Overall Study|Non-compliance|1|||
127731406|NCT03614923|459640776|FG002|Overall Study|Non-compliance|0|||
127731407|NCT03614923|459640774|FG000|Overall Study|Other|0|||
127731408|NCT03614923|459640775|FG001|Overall Study|Other|1|||
127803919|NCT00110019|459903765|FG001|Overall Study|alternative therapy|1|||
127890200|NCT01360632|460220029|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
127890201|NCT01360632|460220030|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
127890202|NCT01360632|460220031|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
127890203|NCT01360632|460220032|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
127890204|NCT01360632|460220028|FG000|Phase A (8 Weeks)|Adverse Event|60|||
127890205|NCT01360632|460220029|FG001|Phase A (8 Weeks)|Adverse Event|0|||
127890206|NCT01360632|460220030|FG002|Phase A (8 Weeks)|Adverse Event|0|||
127890207|NCT01360632|460220031|FG003|Phase A (8 Weeks)|Adverse Event|0|||
127890208|NCT01360632|460220032|FG004|Phase A (8 Weeks)|Adverse Event|0|||
127890209|NCT01360632|460220028|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
127731409|NCT03614923|459640776|FG002|Overall Study|Other|1|||
127731410|NCT01107353|459640777|FG000|Overall Study|Positive Drug Screen|1|||
127731411|NCT01107353|459640778|FG001|Overall Study|Positive Drug Screen|0|||
127731412|NCT01193283|459640779|FG000|Overall Study|Death|1|||
127731413|NCT02368691|459640782|FG000|Overall Study|Death|13|||
127731414|NCT02368691|459640782|FG000|Overall Study|Lack of Efficacy|15|||
127731415|NCT02368691|459640782|FG000|Overall Study|Physician Decision|4|||
127803920|NCT00110019|459903764|FG000|Overall Study|complicating disease|1|||
127731416|NCT03314233|459640786|FG000|Overall Study|No longer eligible at time of delivery|1|||
127731417|NCT00168805|459640788|FG000|Overall Study|Adverse Event|7|||
127731418|NCT00168805|459640789|FG001|Overall Study|Adverse Event|11|||
127731419|NCT00168805|459640790|FG002|Overall Study|Adverse Event|16|||
127731420|NCT00168805|459640788|FG000|Overall Study|Protocol Violation|12|||
127803921|NCT00110019|459903765|FG001|Overall Study|complicating disease|1|||
127803922|NCT00110019|459903764|FG000|Overall Study|symptom deterioration|13|||
127803923|NCT00110019|459903765|FG001|Overall Study|symptom deterioration|16|||
127731421|NCT00168805|459640789|FG001|Overall Study|Protocol Violation|11|||
127731422|NCT00168805|459640790|FG002|Overall Study|Protocol Violation|8|||
127890210|NCT01360632|460220029|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
127731423|NCT00168805|459640788|FG000|Overall Study|Lost to Follow-up|12|||
127803924|NCT00110019|459903764|FG000|Overall Study|Not start protocol therapy|17|||
127890211|NCT01360632|460220030|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
127890212|NCT01360632|460220031|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
127890213|NCT01360632|460220032|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
127890214|NCT01360632|460220028|FG000|Phase A (8 Weeks)|Physician Decision|10|||
127890215|NCT01360632|460220029|FG001|Phase A (8 Weeks)|Physician Decision|0|||
127890216|NCT01360632|460220030|FG002|Phase A (8 Weeks)|Physician Decision|0|||
127890217|NCT01360632|460220031|FG003|Phase A (8 Weeks)|Physician Decision|0|||
127890218|NCT01360632|460220032|FG004|Phase A (8 Weeks)|Physician Decision|0|||
127890219|NCT01360632|460220028|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
127890220|NCT01360632|460220029|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
127890221|NCT01360632|460220030|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
127890222|NCT01360632|460220031|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
127890223|NCT01360632|460220032|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
127890224|NCT01360632|460220028|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
127890225|NCT01360632|460220029|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
127890226|NCT01360632|460220030|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
127890227|NCT01360632|460220031|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
127890228|NCT01360632|460220032|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
127890229|NCT01360632|460220028|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
127890230|NCT01360632|460220029|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
127890231|NCT01360632|460220030|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
127890232|NCT01360632|460220031|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
127890233|NCT01360632|460220032|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
127890234|NCT01360632|460220028|FG000|Phase B (6 Weeks)|Adverse Event|0|||
127890235|NCT01360632|460220029|FG001|Phase B (6 Weeks)|Adverse Event|3|||
127890236|NCT01360632|460220030|FG002|Phase B (6 Weeks)|Adverse Event|9|||
127890237|NCT01360632|460220031|FG003|Phase B (6 Weeks)|Adverse Event|3|||
127890238|NCT01360632|460220032|FG004|Phase B (6 Weeks)|Adverse Event|0|||
127890239|NCT01360632|460220028|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
127890240|NCT01360632|460220029|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
127890241|NCT01360632|460220030|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
127890242|NCT01360632|460220031|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
127890243|NCT01360632|460220032|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
127890244|NCT01360632|460220028|FG000|Phase B (6 Weeks)|Physician Decision|0|||
127890245|NCT01360632|460220029|FG001|Phase B (6 Weeks)|Physician Decision|0|||
127890246|NCT01360632|460220030|FG002|Phase B (6 Weeks)|Physician Decision|0|||
127890247|NCT01360632|460220031|FG003|Phase B (6 Weeks)|Physician Decision|1|||
127890248|NCT01360632|460220032|FG004|Phase B (6 Weeks)|Physician Decision|0|||
127890249|NCT01360632|460220028|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
127890250|NCT01360632|460220029|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
127890251|NCT01360632|460220030|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
127890252|NCT01360632|460220031|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
127890253|NCT01360632|460220032|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
127890254|NCT01360632|460220028|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
127890255|NCT01360632|460220029|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
127890256|NCT01360632|460220030|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
127890257|NCT01360632|460220031|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
127890258|NCT01360632|460220032|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
127890259|NCT01360632|460220028|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
127890260|NCT01360632|460220029|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
127890261|NCT01360632|460220030|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
127890262|NCT01360632|460220031|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
127890263|NCT01360632|460220032|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
127890264|NCT01360632|460220028|FG000|Phase A+|Lost to Follow-up|0|||
127890265|NCT01360632|460220029|FG001|Phase A+|Lost to Follow-up|0|||
127890266|NCT01360632|460220030|FG002|Phase A+|Lost to Follow-up|0|||
127890267|NCT01360632|460220031|FG003|Phase A+|Lost to Follow-up|0|||
127890268|NCT01360632|460220032|FG004|Phase A+|Lost to Follow-up|2|||
127890269|NCT01360632|460220028|FG000|Phase A+|Adverse Event|0|||
127890270|NCT01360632|460220029|FG001|Phase A+|Adverse Event|0|||
127890271|NCT01360632|460220030|FG002|Phase A+|Adverse Event|0|||
127890272|NCT01360632|460220031|FG003|Phase A+|Adverse Event|0|||
127890273|NCT01360632|460220032|FG004|Phase A+|Adverse Event|2|||
127890274|NCT01360632|460220028|FG000|Phase A+|Met Withdrawal Criteria|0|||
127890275|NCT01360632|460220029|FG001|Phase A+|Met Withdrawal Criteria|0|||
127731424|NCT00168805|459640789|FG001|Overall Study|Lost to Follow-up|17|||
127890276|NCT01360632|460220030|FG002|Phase A+|Met Withdrawal Criteria|0|||
127890277|NCT01360632|460220031|FG003|Phase A+|Met Withdrawal Criteria|0|||
127890278|NCT01360632|460220032|FG004|Phase A+|Met Withdrawal Criteria|7|||
127890279|NCT01360632|460220028|FG000|Phase A+|Physician Decision|0|||
127890280|NCT01360632|460220029|FG001|Phase A+|Physician Decision|0|||
127890281|NCT01360632|460220030|FG002|Phase A+|Physician Decision|0|||
127803925|NCT00110019|459903765|FG001|Overall Study|Not start protocol therapy|16|||
127803926|NCT00110019|459903764|FG000|Overall Study|other reasons|22|||
127803927|NCT00110019|459903765|FG001|Overall Study|other reasons|30|||
127803928|NCT02154425|459903770|FG000|Screening Period|Adverse Event|1|||
127803929|NCT00773279|459903771|FG000|Period 1|Adverse Event|2|||
127803930|NCT00773279|459903772|FG001|Period 1|Adverse Event|1|||
127803931|NCT00773279|459903771|FG000|Period 1|Lack of Efficacy|0|||
127803932|NCT00773279|459903772|FG001|Period 1|Lack of Efficacy|2|||
127731425|NCT00168805|459640790|FG002|Overall Study|Lost to Follow-up|11|||
127731426|NCT00168805|459640788|FG000|Overall Study|Withdrawal by Subject|16|||
127731427|NCT00168805|459640789|FG001|Overall Study|Withdrawal by Subject|18|||
127731428|NCT00168805|459640790|FG002|Overall Study|Withdrawal by Subject|21|||
127731429|NCT00168805|459640788|FG000|Overall Study|Other|24|||
127731430|NCT00168805|459640789|FG001|Overall Study|Other|21|||
127731431|NCT00168805|459640790|FG002|Overall Study|Other|22|||
127731432|NCT00168805|459640788|FG000|Treatment|Adverse Event|25|||
127731433|NCT00168805|459640789|FG001|Treatment|Adverse Event|26|||
127731434|NCT00168805|459640790|FG002|Treatment|Adverse Event|32|||
127731435|NCT00168805|459640788|FG000|Treatment|Protocol Violation|3|||
127731436|NCT00168805|459640789|FG001|Treatment|Protocol Violation|5|||
127731437|NCT00168805|459640790|FG002|Treatment|Protocol Violation|5|||
127731438|NCT00168805|459640788|FG000|Treatment|Withdrawal by Subject|3|||
127731439|NCT00168805|459640789|FG001|Treatment|Withdrawal by Subject|7|||
127731440|NCT00168805|459640790|FG002|Treatment|Withdrawal by Subject|8|||
127731441|NCT00168805|459640788|FG000|Treatment|Other|18|||
127731442|NCT00168805|459640789|FG001|Treatment|Other|18|||
127731443|NCT00168805|459640790|FG002|Treatment|Other|17|||
127731444|NCT01114217|459640791|FG000|Overall Study|Adverse Event|5|||
127731445|NCT01114217|459640792|FG001|Overall Study|Adverse Event|3|||
127731446|NCT01114217|459640791|FG000|Overall Study|Lost to Follow-up|17|||
127731447|NCT01114217|459640792|FG001|Overall Study|Lost to Follow-up|33|||
127731448|NCT01114217|459640791|FG000|Overall Study|Withdrawal by Subject|21|||
127731449|NCT01114217|459640792|FG001|Overall Study|Withdrawal by Subject|28|||
127731450|NCT01114217|459640791|FG000|Overall Study|Other-Clerical Error|3|||
127731451|NCT01114217|459640792|FG001|Overall Study|Other-Clerical Error|0|||
127731452|NCT01114217|459640791|FG000|Overall Study|Other-Early termination|6|||
127731453|NCT01114217|459640792|FG001|Overall Study|Other-Early termination|10|||
127731454|NCT01114217|459640791|FG000|Overall Study|Other-Procedure|1|||
127731455|NCT01114217|459640792|FG001|Overall Study|Other-Procedure|1|||
127731456|NCT01114217|459640791|FG000|Overall Study|Other-Pregnancy|2|||
127731457|NCT01114217|459640792|FG001|Overall Study|Other-Pregnancy|4|||
127731458|NCT01114217|459640791|FG000|Overall Study|Other-Protocol Violation|1|||
127731459|NCT01114217|459640792|FG001|Overall Study|Other-Protocol Violation|3|||
127731460|NCT01114217|459640791|FG000|Overall Study|Other-Lack of Efficacy|1|||
127731461|NCT01114217|459640792|FG001|Overall Study|Other-Lack of Efficacy|0|||
127731462|NCT01114217|459640791|FG000|Overall Study|Other-Non Compliance|2|||
127731463|NCT01114217|459640792|FG001|Overall Study|Other-Non Compliance|0|||
127731464|NCT01114217|459640791|FG000|Overall Study|Other-Physician Decision|1|||
127731465|NCT01114217|459640792|FG001|Overall Study|Other-Physician Decision|1|||
127731466|NCT01114217|459640791|FG000|Overall Study|Other-Sponsor Decision|10|||
127731467|NCT01114217|459640792|FG001|Overall Study|Other-Sponsor Decision|12|||
127803933|NCT00773279|459903771|FG000|Period 1|Unclassified|5|||
127803934|NCT00773279|459903772|FG001|Period 1|Unclassified|1|||
127731468|NCT01114217|459640791|FG000|Overall Study|Other-Study Termination|0|||
127731469|NCT01114217|459640792|FG001|Overall Study|Other-Study Termination|1|||
127731470|NCT01114217|459640791|FG000|Overall Study|Other-Study Withdrawn|1|||
127731471|NCT01114217|459640792|FG001|Overall Study|Other-Study Withdrawn|1|||
127731472|NCT01114217|459640791|FG000|Overall Study|Other-Site Stopped Communicating|2|||
127803935|NCT00773279|459903771|FG000|Period 2|Adverse Event|0|||
127803936|NCT00773279|459903772|FG001|Period 2|Adverse Event|1|||
127731473|NCT01114217|459640792|FG001|Overall Study|Other-Site Stopped Communicating|0|||
127731474|NCT01114217|459640791|FG000|Overall Study|Other-Lost to Follow-up|1|||
127731475|NCT01114217|459640792|FG001|Overall Study|Other-Lost to Follow-up|0|||
127731476|NCT01114217|459640791|FG000|Overall Study|Other-Withdrawal by Subject|1|||
127731477|NCT01114217|459640792|FG001|Overall Study|Other-Withdrawal by Subject|1|||
127731478|NCT01183013|459640793|FG000|Overall Study|Adverse Event|6|||
127731479|NCT01183013|459640794|FG001|Overall Study|Adverse Event|8|||
127731480|NCT01183013|459640795|FG002|Overall Study|Adverse Event|5|||
127731481|NCT01183013|459640796|FG003|Overall Study|Adverse Event|5|||
127803937|NCT00773279|459903771|FG000|Period 2|Lack of Efficacy|1|||
127803938|NCT00773279|459903772|FG001|Period 2|Lack of Efficacy|0|||
127731482|NCT01183013|459640797|FG004|Overall Study|Adverse Event|10|||
127731483|NCT01183013|459640798|FG005|Overall Study|Adverse Event|10|||
127731484|NCT01183013|459640799|FG006|Overall Study|Adverse Event|6|||
127731485|NCT01183013|459640793|FG000|Overall Study|Lack of Efficacy|3|||
127731486|NCT01183013|459640794|FG001|Overall Study|Lack of Efficacy|2|||
127731487|NCT01183013|459640795|FG002|Overall Study|Lack of Efficacy|1|||
127731488|NCT01183013|459640796|FG003|Overall Study|Lack of Efficacy|2|||
127731489|NCT01183013|459640797|FG004|Overall Study|Lack of Efficacy|1|||
127731490|NCT01183013|459640798|FG005|Overall Study|Lack of Efficacy|2|||
127731491|NCT01183013|459640799|FG006|Overall Study|Lack of Efficacy|0|||
127731492|NCT01183013|459640793|FG000|Overall Study|Protocol Violation|5|||
127731493|NCT01183013|459640794|FG001|Overall Study|Protocol Violation|2|||
127731494|NCT01183013|459640795|FG002|Overall Study|Protocol Violation|4|||
127731495|NCT01183013|459640796|FG003|Overall Study|Protocol Violation|0|||
127731496|NCT01183013|459640797|FG004|Overall Study|Protocol Violation|4|||
127731497|NCT01183013|459640798|FG005|Overall Study|Protocol Violation|3|||
127731498|NCT01183013|459640799|FG006|Overall Study|Protocol Violation|3|||
127731499|NCT01183013|459640793|FG000|Overall Study|Lost to Follow-up|7|||
127731500|NCT01183013|459640794|FG001|Overall Study|Lost to Follow-up|3|||
127731501|NCT01183013|459640795|FG002|Overall Study|Lost to Follow-up|4|||
127731502|NCT01183013|459640796|FG003|Overall Study|Lost to Follow-up|3|||
127731503|NCT01183013|459640797|FG004|Overall Study|Lost to Follow-up|2|||
127731504|NCT01183013|459640798|FG005|Overall Study|Lost to Follow-up|6|||
127731505|NCT01183013|459640799|FG006|Overall Study|Lost to Follow-up|5|||
127731506|NCT01183013|459640793|FG000|Overall Study|Withdrawal by Subject|9|||
127731507|NCT01183013|459640794|FG001|Overall Study|Withdrawal by Subject|13|||
127731508|NCT01183013|459640795|FG002|Overall Study|Withdrawal by Subject|10|||
127731509|NCT01183013|459640796|FG003|Overall Study|Withdrawal by Subject|8|||
127731510|NCT01183013|459640797|FG004|Overall Study|Withdrawal by Subject|7|||
127731511|NCT01183013|459640798|FG005|Overall Study|Withdrawal by Subject|9|||
127731512|NCT01183013|459640799|FG006|Overall Study|Withdrawal by Subject|10|||
127731513|NCT01183013|459640793|FG000|Overall Study|Reasons other than stated above|15|||
127731514|NCT01183013|459640794|FG001|Overall Study|Reasons other than stated above|11|||
127731515|NCT01183013|459640795|FG002|Overall Study|Reasons other than stated above|17|||
127731516|NCT01183013|459640796|FG003|Overall Study|Reasons other than stated above|12|||
127731517|NCT01183013|459640797|FG004|Overall Study|Reasons other than stated above|12|||
127731518|NCT01183013|459640798|FG005|Overall Study|Reasons other than stated above|15|||
127731519|NCT01183013|459640799|FG006|Overall Study|Reasons other than stated above|13|||
127731520|NCT02722278|459640802|FG000|Overall Study|Withdrawal by Subject|5|||
127731521|NCT02722278|459640803|FG001|Overall Study|Withdrawal by Subject|3|||
127731522|NCT02722278|459640802|FG000|Overall Study|Adverse Event|4|||
127731523|NCT02722278|459640803|FG001|Overall Study|Adverse Event|1|||
127731524|NCT02722278|459640802|FG000|Overall Study|Lost to Follow-up|2|||
127731525|NCT02722278|459640803|FG001|Overall Study|Lost to Follow-up|0|||
127731526|NCT02722278|459640802|FG000|Overall Study|Protocol Violation|1|||
127731527|NCT02722278|459640803|FG001|Overall Study|Protocol Violation|0|||
127731528|NCT02722278|459640802|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
127731529|NCT02722278|459640803|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
127731530|NCT02722278|459640802|FG000|Overall Study|Subject declined after tx assignment|0|||
127731531|NCT02722278|459640803|FG001|Overall Study|Subject declined after tx assignment|1|||
127731532|NCT02722278|459640802|FG000|Overall Study|Site closure not study related|0|||
127731533|NCT02722278|459640803|FG001|Overall Study|Site closure not study related|1|||
127731534|NCT00472199|459640804|FG000|Overall Study|Adverse Event|19|||
127731535|NCT00472199|459640805|FG001|Overall Study|Adverse Event|23|||
127731536|NCT00472199|459640804|FG000|Overall Study|Lack of Efficacy|4|||
127731537|NCT00472199|459640805|FG001|Overall Study|Lack of Efficacy|25|||
127731538|NCT00472199|459640804|FG000|Overall Study|Lost to Follow-up|2|||
127731539|NCT00472199|459640805|FG001|Overall Study|Lost to Follow-up|4|||
127731540|NCT00472199|459640804|FG000|Overall Study|Protocol Violation|3|||
127731541|NCT00472199|459640805|FG001|Overall Study|Protocol Violation|2|||
127731542|NCT00472199|459640804|FG000|Overall Study|Withdrawal by Subject|6|||
127731543|NCT00472199|459640805|FG001|Overall Study|Withdrawal by Subject|5|||
127731544|NCT00472199|459640804|FG000|Overall Study|personal reason|0|||
127731545|NCT00472199|459640805|FG001|Overall Study|personal reason|1|||
127731546|NCT00472199|459640804|FG000|Overall Study|patient was asymptomatic|1|||
127731547|NCT00472199|459640805|FG001|Overall Study|patient was asymptomatic|0|||
127731548|NCT02446912|459640807|FG000|Overall Study|Adverse Event|3|||
127731549|NCT02446912|459640808|FG001|Overall Study|Adverse Event|13|||
127731550|NCT02446912|459640809|FG002|Overall Study|Adverse Event|5|||
127731551|NCT02446912|459640807|FG000|Overall Study|Condition under investigation worsened|0|||
127731552|NCT02446912|459640808|FG001|Overall Study|Condition under investigation worsened|1|||
127731553|NCT02446912|459640809|FG002|Overall Study|Condition under investigation worsened|1|||
127731554|NCT02446912|459640807|FG000|Overall Study|Study-specific withdrawal criteria|1|||
127731555|NCT02446912|459640808|FG001|Overall Study|Study-specific withdrawal criteria|0|||
127731556|NCT02446912|459640809|FG002|Overall Study|Study-specific withdrawal criteria|0|||
127731557|NCT02446912|459640807|FG000|Overall Study|Lack of Efficacy|1|||
127731558|NCT02446912|459640808|FG001|Overall Study|Lack of Efficacy|4|||
127890282|NCT01360632|460220031|FG003|Phase A+|Physician Decision|0|||
127890283|NCT01360632|460220032|FG004|Phase A+|Physician Decision|3|||
127890284|NCT01360632|460220028|FG000|Phase A+|Withdrawal by Subject|0|||
127890285|NCT01360632|460220029|FG001|Phase A+|Withdrawal by Subject|0|||
127890286|NCT01360632|460220030|FG002|Phase A+|Withdrawal by Subject|0|||
127890287|NCT01360632|460220031|FG003|Phase A+|Withdrawal by Subject|0|||
127890288|NCT01360632|460220032|FG004|Phase A+|Withdrawal by Subject|8|||
127890289|NCT01360632|460220028|FG000|Phase A+|Protocol Deviation|0|||
127890290|NCT01360632|460220029|FG001|Phase A+|Protocol Deviation|0|||
127731559|NCT02446912|459640809|FG002|Overall Study|Lack of Efficacy|7|||
127731560|NCT02446912|459640807|FG000|Overall Study|Lost to Follow-up|0|||
127731561|NCT02446912|459640808|FG001|Overall Study|Lost to Follow-up|0|||
127731562|NCT02446912|459640809|FG002|Overall Study|Lost to Follow-up|2|||
127731563|NCT02446912|459640807|FG000|Overall Study|Severe non-compliance to protocol|1|||
127731564|NCT02446912|459640808|FG001|Overall Study|Severe non-compliance to protocol|0|||
127731565|NCT02446912|459640809|FG002|Overall Study|Severe non-compliance to protocol|1|||
127731566|NCT02446912|459640807|FG000|Overall Study|Withdrawal by Subject|10|||
127731567|NCT02446912|459640808|FG001|Overall Study|Withdrawal by Subject|15|||
127731568|NCT02446912|459640809|FG002|Overall Study|Withdrawal by Subject|15|||
127731569|NCT02446912|459640807|FG000|Overall Study|Miscellaneous|2|||
127731570|NCT02446912|459640808|FG001|Overall Study|Miscellaneous|2|||
127731571|NCT02446912|459640809|FG002|Overall Study|Miscellaneous|4|||
127731572|NCT01268488|459640810|FG000|Overall Study|Adverse Event|3|||
127731573|NCT01268488|459640810|FG000|Overall Study|Physician Decision|2|||
127731574|NCT01757171|459640811|FG000|Overall Study|Adverse Event|5|||
127731575|NCT01757171|459640812|FG001|Overall Study|Adverse Event|1|||
127731576|NCT01757171|459640811|FG000|Overall Study|Disease Progression|1|||
127731577|NCT01757171|459640812|FG001|Overall Study|Disease Progression|0|||
127731578|NCT01757171|459640811|FG000|Overall Study|Hospitalization|1|||
127731579|NCT01757171|459640812|FG001|Overall Study|Hospitalization|0|||
127731580|NCT01757171|459640811|FG000|Overall Study|ECOG decline|1|||
127731581|NCT01757171|459640812|FG001|Overall Study|ECOG decline|0|||
127731582|NCT01014013|459640814|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
127731583|NCT01014013|459640815|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
127731584|NCT01014013|459640814|FG000|Overall Study|Clinical adverse experience|4|||
127731585|NCT01014013|459640815|FG001|Overall Study|Clinical adverse experience|2|||
127731586|NCT01014013|459640814|FG000|Overall Study|Laboratory adverse experience|1|||
127731587|NCT01014013|459640815|FG001|Overall Study|Laboratory adverse experience|1|||
127731588|NCT01014013|459640814|FG000|Overall Study|Protocol Violation|1|||
127731589|NCT01014013|459640815|FG001|Overall Study|Protocol Violation|3|||
127731590|NCT01014013|459640814|FG000|Overall Study|Withdrawal by Subject|7|||
127731591|NCT01014013|459640815|FG001|Overall Study|Withdrawal by Subject|4|||
127731592|NCT01014013|459640814|FG000|Overall Study|Clinical/microbiologic failure|1|||
127731593|NCT01014013|459640815|FG001|Overall Study|Clinical/microbiologic failure|2|||
127731594|NCT01014013|459640814|FG000|Overall Study|Pathogen culture = no growth|26|||
127731595|NCT01014013|459640815|FG001|Overall Study|Pathogen culture = no growth|34|||
127731596|NCT01014013|459640814|FG000|Overall Study|Negative urine culture|2|||
127731597|NCT01014013|459640815|FG001|Overall Study|Negative urine culture|0|||
127731598|NCT01014013|459640814|FG000|Overall Study|Pathogen resistant|7|||
127731599|NCT01014013|459640815|FG001|Overall Study|Pathogen resistant|4|||
127731600|NCT01014013|459640814|FG000|Overall Study|Physician Decision|0|||
127731601|NCT01014013|459640815|FG001|Overall Study|Physician Decision|1|||
127731602|NCT01014013|459640814|FG000|Overall Study|Another antibiotic therapy required|0|||
127731603|NCT01014013|459640815|FG001|Overall Study|Another antibiotic therapy required|1|||
127890291|NCT01360632|460220030|FG002|Phase A+|Protocol Deviation|0|||
127890292|NCT01360632|460220031|FG003|Phase A+|Protocol Deviation|0|||
127890293|NCT01360632|460220032|FG004|Phase A+|Protocol Deviation|3|||
127731604|NCT01014013|459640814|FG000|Overall Study|Appendectomy|1|||
127731605|NCT01014013|459640815|FG001|Overall Study|Appendectomy|0|||
127731606|NCT01014013|459640814|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
127731607|NCT01014013|459640815|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
127731608|NCT00316121|459640816|FG000|Overall Study|Death|1|||
127731609|NCT00316121|459640817|FG001|Overall Study|Death|0|||
127731610|NCT00316121|459640816|FG000|Overall Study|Lost to Follow-up|14|||
127890294|NCT02173301|460220035|FG000|Overall Study|Adverse Event|7|||
127890295|NCT02173301|460220036|FG001|Overall Study|Adverse Event|8|||
127890296|NCT02173301|460220037|FG002|Overall Study|Adverse Event|13|||
127890297|NCT02173301|460220038|FG003|Overall Study|Adverse Event|5|||
127890298|NCT02173301|460220035|FG000|Overall Study|Withdrawal by Subject|8|||
127890299|NCT02173301|460220036|FG001|Overall Study|Withdrawal by Subject|10|||
127890300|NCT02173301|460220037|FG002|Overall Study|Withdrawal by Subject|4|||
127890301|NCT02173301|460220038|FG003|Overall Study|Withdrawal by Subject|8|||
127731611|NCT00316121|459640817|FG001|Overall Study|Lost to Follow-up|8|||
127731612|NCT00316121|459640816|FG000|Overall Study|Withdrawal by Subject|2|||
127731613|NCT00316121|459640817|FG001|Overall Study|Withdrawal by Subject|0|||
127731614|NCT00316121|459640816|FG000|Overall Study|Reason is missing|1|||
127731615|NCT00316121|459640817|FG001|Overall Study|Reason is missing|0|||
127731616|NCT00316121|459640816|FG000|Overall Study|Subject relocated|1|||
127731617|NCT00316121|459640817|FG001|Overall Study|Subject relocated|1|||
127731618|NCT00316121|459640816|FG000|Overall Study|Subject refused to return|1|||
127731619|NCT00316121|459640817|FG001|Overall Study|Subject refused to return|0|||
127731620|NCT00316121|459640816|FG000|Overall Study|Subject no show for visit x 3|1|||
127731621|NCT00316121|459640817|FG001|Overall Study|Subject no show for visit x 3|0|||
127731622|NCT00316121|459640816|FG000|Overall Study|Subject did not have 24 month visit|1|||
127731623|NCT00316121|459640817|FG001|Overall Study|Subject did not have 24 month visit|0|||
127731624|NCT02305797|459640818|FG000|Overall Study|Adverse Event|11|||
127731625|NCT02305797|459640819|FG001|Overall Study|Adverse Event|2|||
127731626|NCT02305797|459640818|FG000|Overall Study|Withdrawal by Subject|9|||
127731627|NCT02305797|459640819|FG001|Overall Study|Withdrawal by Subject|10|||
127731628|NCT02305797|459640818|FG000|Overall Study|Lack of Efficacy|6|||
127731629|NCT02305797|459640819|FG001|Overall Study|Lack of Efficacy|0|||
127731630|NCT02305797|459640818|FG000|Overall Study|Lost to Follow-up|5|||
127731631|NCT02305797|459640819|FG001|Overall Study|Lost to Follow-up|11|||
127731632|NCT02305797|459640818|FG000|Overall Study|Pregnancy|0|||
127731633|NCT02305797|459640819|FG001|Overall Study|Pregnancy|2|||
127731634|NCT02305797|459640818|FG000|Overall Study|Noncompliance|14|||
127731635|NCT02305797|459640819|FG001|Overall Study|Noncompliance|12|||
127731636|NCT02305797|459640818|FG000|Overall Study|Reason not collected|0|||
127731637|NCT02305797|459640819|FG001|Overall Study|Reason not collected|1|||
127731638|NCT05274906|459640820|FG000|Overall Study|Withdrawal by Subject|2|||
127731639|NCT05274906|459640821|FG001|Overall Study|Withdrawal by Subject|1|||
127731640|NCT00460577|459640824|FG000|Overall Study|Protocol Violation|2|||
127731641|NCT00460577|459640825|FG001|Overall Study|Protocol Violation|6|||
127731642|NCT02213458|459640826|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
127731643|NCT02213458|459640827|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
127731644|NCT02213458|459640826|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
127731645|NCT02213458|459640827|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
127731646|NCT02213458|459640826|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
127731647|NCT02213458|459640827|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
127731648|NCT02213458|459640826|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
127731649|NCT02213458|459640827|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
127731650|NCT02213458|459640826|FG000|Overall Study|Refused re-consent|6|||
127731651|NCT02213458|459640827|FG001|Overall Study|Refused re-consent|0|||
127731652|NCT02213458|459640826|FG000|Overall Study|Lost to Follow-up|2|||
127731653|NCT02213458|459640827|FG001|Overall Study|Lost to Follow-up|2|||
127731654|NCT02213458|459640826|FG000|Overall Study|Withdrawal by Subject|26|||
127731655|NCT02213458|459640827|FG001|Overall Study|Withdrawal by Subject|8|||
127731656|NCT00910871|459640828|FG000|Overall Study|Adverse Event|5|||
127731657|NCT00910871|459640828|FG000|Overall Study|Death|12|||
127731658|NCT00910871|459640828|FG000|Overall Study|Lost to Follow-up|8|||
127731659|NCT00910871|459640828|FG000|Overall Study|Protocol Violation|11|||
127731660|NCT00910871|459640828|FG000|Overall Study|Withdrawal by Subject|12|||
127731661|NCT00910871|459640828|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
127731662|NCT00910871|459640828|FG000|Overall Study|Undefined|1|||
127731663|NCT01878253|459640829|FG000|Overall Study|Death|1|||
127731664|NCT01878253|459640829|FG000|Overall Study|SIdus System Removal|3|||
127731665|NCT01878253|459640829|FG000|Overall Study|Withdrawal by Subject|1|||
127731666|NCT01878253|459640829|FG000|Overall Study|Lost to Follow-up|2|||
127731667|NCT01878253|459640829|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
127731668|NCT04043806|459640830|FG000|Overall Study|Commercial drug is available for participants|13|||
127731669|NCT04043806|459640830|FG000|Overall Study|Physician Decision|2|||
127731670|NCT04043806|459640830|FG000|Overall Study|Other|12|||
127731671|NCT04043806|459640830|FG000|Overall Study|Adverse Event|2|||
127890302|NCT02173301|460220035|FG000|Overall Study|Lost to Follow-up|4|||
127890303|NCT02173301|460220036|FG001|Overall Study|Lost to Follow-up|4|||
127731672|NCT04043806|459640830|FG000|Overall Study|Lost to Follow-up|6|||
127731673|NCT04043806|459640830|FG000|Overall Study|Other non-compliance|2|||
127731674|NCT04043806|459640830|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
127731675|NCT04043806|459640830|FG000|Overall Study|Never Dosed|1|||
127731676|NCT04799587|459640832|FG000|Overall Study|Withdrawal by Subject|0|||
127731677|NCT04799587|459640833|FG001|Overall Study|Withdrawal by Subject|1|||
127731678|NCT02130401|459640840|FG000|Overall Study|Poor enrollment|6|||
127731679|NCT00936065|459640841|FG000|Overall Study|Adverse Event|1|||
127731680|NCT00936065|459640842|FG001|Overall Study|Adverse Event|0|||
127731681|NCT00936065|459640843|FG002|Overall Study|Adverse Event|1|||
127731682|NCT00936065|459640841|FG000|Overall Study|Lack of Efficacy|1|||
127731683|NCT00936065|459640842|FG001|Overall Study|Lack of Efficacy|0|||
127731684|NCT00936065|459640843|FG002|Overall Study|Lack of Efficacy|1|||
127731685|NCT00936065|459640841|FG000|Overall Study|Lost to Follow-up|1|||
127731686|NCT00936065|459640842|FG001|Overall Study|Lost to Follow-up|0|||
127731687|NCT00936065|459640843|FG002|Overall Study|Lost to Follow-up|0|||
127731688|NCT00936065|459640841|FG000|Overall Study|Protocol Violation|1|||
127731689|NCT00936065|459640842|FG001|Overall Study|Protocol Violation|2|||
127731690|NCT00936065|459640843|FG002|Overall Study|Protocol Violation|1|||
127731691|NCT00936065|459640841|FG000|Overall Study|Withdrawal by Subject|0|||
127731692|NCT00936065|459640842|FG001|Overall Study|Withdrawal by Subject|2|||
127731693|NCT00936065|459640843|FG002|Overall Study|Withdrawal by Subject|4|||
127731694|NCT02389894|459640844|FG000|Overall Study|Death|4|||
127731695|NCT02389894|459640845|FG001|Overall Study|Death|5|||
127731696|NCT02389894|459640846|FG002|Overall Study|Death|3|||
127731697|NCT02389894|459640844|FG000|Overall Study|Withdrawal by Subject|2|||
127731698|NCT02389894|459640845|FG001|Overall Study|Withdrawal by Subject|4|||
127731699|NCT02389894|459640846|FG002|Overall Study|Withdrawal by Subject|5|||
127731700|NCT02389894|459640844|FG000|Overall Study|Lost to Follow-up|2|||
127731701|NCT02389894|459640845|FG001|Overall Study|Lost to Follow-up|1|||
127731702|NCT02389894|459640846|FG002|Overall Study|Lost to Follow-up|1|||
127731703|NCT00145496|459640849|FG000|Overall Study|Adverse Event|42|||
127731704|NCT00145496|459640850|FG001|Overall Study|Adverse Event|30|||
127731705|NCT00145496|459640849|FG000|Overall Study|Lack of Efficacy|12|||
127731706|NCT00145496|459640850|FG001|Overall Study|Lack of Efficacy|7|||
127731707|NCT00145496|459640849|FG000|Overall Study|Withdrawal by Subject|32|||
127731708|NCT00145496|459640850|FG001|Overall Study|Withdrawal by Subject|26|||
127731709|NCT00145496|459640849|FG000|Overall Study|Lost to Follow-up|12|||
127731710|NCT00145496|459640850|FG001|Overall Study|Lost to Follow-up|5|||
127731711|NCT00145496|459640849|FG000|Overall Study|Other|25|||
127731712|NCT00145496|459640850|FG001|Overall Study|Other|13|||
127731713|NCT01052714|459640853|FG000|Overall Study|Adverse Event|6|||
127731714|NCT01052714|459640854|FG001|Overall Study|Adverse Event|3|||
127731715|NCT01052714|459640855|FG002|Overall Study|Adverse Event|0|||
127731716|NCT01052714|459640853|FG000|Overall Study|Death|1|||
127731717|NCT01052714|459640854|FG001|Overall Study|Death|2|||
127731718|NCT01052714|459640855|FG002|Overall Study|Death|0|||
127731719|NCT01052714|459640853|FG000|Overall Study|Lost to Follow-up|2|||
127731720|NCT01052714|459640854|FG001|Overall Study|Lost to Follow-up|3|||
127731721|NCT01052714|459640855|FG002|Overall Study|Lost to Follow-up|0|||
127731722|NCT01052714|459640853|FG000|Overall Study|Physician Decision|9|||
127731723|NCT01052714|459640854|FG001|Overall Study|Physician Decision|9|||
127731724|NCT01052714|459640855|FG002|Overall Study|Physician Decision|1|||
127731725|NCT01052714|459640853|FG000|Overall Study|Withdrawal by Subject|7|||
127731726|NCT01052714|459640854|FG001|Overall Study|Withdrawal by Subject|12|||
127731727|NCT01052714|459640855|FG002|Overall Study|Withdrawal by Subject|1|||
127803939|NCT00773279|459903771|FG000|Period 2|Protocol Violation|0|||
127803940|NCT00773279|459903772|FG001|Period 2|Protocol Violation|3|||
127803941|NCT00773279|459903771|FG000|Period 2|Unclassified|2|||
127731728|NCT00267865|459640858|FG000|Induction Treatment|Died before completing.|2|||
127731729|NCT00267865|459640858|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
127731730|NCT03686176|459640859|FG000|Overall Study|Procedure cancelled|1|||
127731731|NCT03686176|459640860|FG001|Overall Study|Procedure cancelled|0|||
127731732|NCT03686176|459640861|FG002|Overall Study|Procedure cancelled|0|||
127803942|NCT00773279|459903772|FG001|Period 2|Unclassified|2|||
127803943|NCT02908516|459903779|FG000|Overall Study|Study Terminated|3|||
127803944|NCT02908516|459903780|FG001|Overall Study|Study Terminated|3|||
127803945|NCT02251912|459903781|FG000|Overall Study|Withdrawal by Subject|2|||
127803946|NCT02251912|459903782|FG001|Overall Study|Withdrawal by Subject|3|||
127803947|NCT02251912|459903781|FG000|Overall Study|Adverse Event|0|||
127803948|NCT02251912|459903782|FG001|Overall Study|Adverse Event|2|||
127803949|NCT01107444|459903783|FG000|Overall Study|Withdrawal by Subject|8|||
127803950|NCT01107444|459903784|FG001|Overall Study|Withdrawal by Subject|12|||
127803951|NCT01107444|459903783|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
127803952|NCT01107444|459903784|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
127803953|NCT01948830|459903785|FG000|Overall Study|Physician Decision|1|||
127803954|NCT01948830|459903786|FG001|Overall Study|Physician Decision|3|||
127803955|NCT01948830|459903785|FG000|Overall Study|Protocol deviation|1|||
127803956|NCT01948830|459903786|FG001|Overall Study|Protocol deviation|2|||
127803957|NCT01948830|459903785|FG000|Overall Study|Lost to Follow-up|5|||
127803958|NCT01948830|459903786|FG001|Overall Study|Lost to Follow-up|4|||
127803959|NCT01948830|459903785|FG000|Overall Study|Withdrawal by Subject|14|||
127803960|NCT01948830|459903786|FG001|Overall Study|Withdrawal by Subject|17|||
127803961|NCT01948830|459903785|FG000|Overall Study|Adverse Event|9|||
127803962|NCT01948830|459903786|FG001|Overall Study|Adverse Event|2|||
127803963|NCT01948830|459903785|FG000|Overall Study|Death|3|||
127803964|NCT01948830|459903786|FG001|Overall Study|Death|4|||
127803965|NCT01133171|459903787|FG000|Overall Study|Withdrawal by Subject|1|||
127803966|NCT01133171|459903788|FG001|Overall Study|Withdrawal by Subject|2|||
127803967|NCT01133171|459903789|FG002|Overall Study|Withdrawal by Subject|0|||
127803968|NCT02526550|459903790|FG000|Overall Study|Lost to Follow-up|1|||
127803969|NCT03969888|459903791|FG000|Overall Study|Never Received Study Drug|0|||
127803970|NCT03969888|459903792|FG001|Overall Study|Never Received Study Drug|0|||
127803971|NCT03969888|459903793|FG002|Overall Study|Never Received Study Drug|1|||
127803972|NCT03969888|459903794|FG003|Overall Study|Never Received Study Drug|0|||
127803973|NCT03969888|459903795|FG004|Overall Study|Never Received Study Drug|0|||
127803974|NCT03969888|459903796|FG005|Overall Study|Never Received Study Drug|0|||
127803975|NCT03969888|459903797|FG006|Overall Study|Never Received Study Drug|1|||
127803976|NCT03969888|459903798|FG007|Overall Study|Never Received Study Drug|0|||
127803977|NCT03969888|459903791|FG000|Overall Study|Reason Not Specified|0|||
127803978|NCT03969888|459903792|FG001|Overall Study|Reason Not Specified|0|||
127803979|NCT03969888|459903793|FG002|Overall Study|Reason Not Specified|0|||
127803980|NCT03969888|459903794|FG003|Overall Study|Reason Not Specified|0|||
127803981|NCT03969888|459903795|FG004|Overall Study|Reason Not Specified|0|||
127803982|NCT03969888|459903796|FG005|Overall Study|Reason Not Specified|0|||
127803983|NCT03969888|459903797|FG006|Overall Study|Reason Not Specified|0|||
127803984|NCT03969888|459903798|FG007|Overall Study|Reason Not Specified|1|||
127803985|NCT00769119|459903802|FG000|Overall Study|Voluntary discontinuation|0|||
127803986|NCT00769119|459903803|FG001|Overall Study|Voluntary discontinuation|2|||
127803987|NCT00769119|459903802|FG000|Overall Study|Adverse Event|1|||
127803988|NCT00769119|459903803|FG001|Overall Study|Adverse Event|1|||
127803989|NCT00769119|459903802|FG000|Overall Study|Disallowed medication|1|||
127803990|NCT00769119|459903803|FG001|Overall Study|Disallowed medication|0|||
127803991|NCT01961115|459903807|FG000|Overall Study|Disease Progression|1|||
127803992|NCT01961115|459903808|FG001|Overall Study|Disease Progression|0|||
127803993|NCT01961115|459903809|FG002|Overall Study|Disease Progression|3|||
127803994|NCT01961115|459903807|FG000|Overall Study|Adverse Event|1|||
127803995|NCT01961115|459903808|FG001|Overall Study|Adverse Event|0|||
127803996|NCT01961115|459903809|FG002|Overall Study|Adverse Event|1|||
127803997|NCT03828487|459903810|FG000|Overall Study|Physician Decision|1|||
127803998|NCT00778830|459905713|FG000|Overall Study|Ongoing at data cut-off|0|||
127803999|NCT00778830|459905714|FG001|Overall Study|Ongoing at data cut-off|1|||
127804000|NCT04047797|459905715|FG000|Overall Study|Progressive Disease|1|||
127804001|NCT03523351|459905716|FG000|Overall Study|Death|13|||
127804002|NCT03523351|459905717|FG001|Overall Study|Death|11|||
127804003|NCT03523351|459905716|FG000|Overall Study|Lost to Follow-up|2|||
127804004|NCT03523351|459905717|FG001|Overall Study|Lost to Follow-up|3|||
127804005|NCT03523351|459905716|FG000|Overall Study|Withdrawal by Subject|4|||
127804006|NCT03523351|459905717|FG001|Overall Study|Withdrawal by Subject|0|||
127804007|NCT03523351|459905716|FG000|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|0|||
127804008|NCT03523351|459905717|FG001|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|2|||
127804009|NCT03609619|459905720|FG000|Overall Study|Adverse Event|1|||
127804010|NCT03609619|459905721|FG001|Overall Study|Adverse Event|0|||
127890304|NCT02173301|460220037|FG002|Overall Study|Lost to Follow-up|2|||
127890305|NCT02173301|460220038|FG003|Overall Study|Lost to Follow-up|2|||
127890306|NCT02173301|460220035|FG000|Overall Study|Protocol Violation|0|||
127890307|NCT02173301|460220036|FG001|Overall Study|Protocol Violation|1|||
127890308|NCT02173301|460220037|FG002|Overall Study|Protocol Violation|0|||
127890309|NCT02173301|460220038|FG003|Overall Study|Protocol Violation|0|||
127890310|NCT02173301|460220035|FG000|Overall Study|Physician Decision|0|||
127890311|NCT02173301|460220036|FG001|Overall Study|Physician Decision|0|||
127890312|NCT02173301|460220037|FG002|Overall Study|Physician Decision|1|||
127890313|NCT02173301|460220038|FG003|Overall Study|Physician Decision|0|||
127890314|NCT02173301|460220035|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
127890315|NCT02173301|460220036|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
127890316|NCT02173301|460220037|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
127731733|NCT03686176|459640859|FG000|Overall Study|VR Malfunction|1|||
127731734|NCT03686176|459640860|FG001|Overall Study|VR Malfunction|0|||
127731735|NCT03686176|459640861|FG002|Overall Study|VR Malfunction|0|||
127731736|NCT03530345|459640867|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
127731737|NCT03530345|459640868|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
127731738|NCT03530345|459640867|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
127731739|NCT03530345|459640868|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
127731740|NCT03530345|459640867|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
127731741|NCT03530345|459640868|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
127731742|NCT03530345|459640867|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
127731743|NCT03530345|459640868|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
127731744|NCT02661490|459642438|FG000|Overall Study|Lost to Follow-up|0|||
127731745|NCT02661490|459642439|FG001|Overall Study|Lost to Follow-up|1|||
127731746|NCT02661490|459642440|FG002|Overall Study|Lost to Follow-up|0|||
127731747|NCT02661490|459642441|FG003|Overall Study|Lost to Follow-up|0|||
127890317|NCT02173301|460220038|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
127890318|NCT03016078|460220040|FG000|Overall Study|Protocol Violation|1|||
127890319|NCT03016078|460220040|FG000|Overall Study|Protocol Violation|1|||
127890320|NCT00112489|460222292|FG000|Overall Study|Refused further treatment|8|||
127890321|NCT00112489|460222292|FG000|Overall Study|Adverse Event|12|||
127890322|NCT00112489|460222292|FG000|Overall Study|Death|2|||
127890323|NCT00112489|460222292|FG000|Overall Study|Other, Not Specified|9|||
127890324|NCT00112489|460222292|FG000|Overall Study|Patient never treated|2|||
127890325|NCT00112489|460222292|FG000|Overall Study|Ineligible|7|||
127890326|NCT05751629|460222293|FG000|Overall Study|Withdrawal by Subject|6|||
127890327|NCT05751629|460222293|FG000|Overall Study|Death|25|||
127890328|NCT05751629|460222293|FG000|Overall Study|Study Site Closed|9|||
127890329|NCT05751629|460222293|FG000|Overall Study|Physician Decision|1|||
127890330|NCT00295854|460222296|FG000|Overall Study|Adverse Event|7|||
127890331|NCT00295854|460222297|FG001|Overall Study|Adverse Event|7|||
127890332|NCT00295854|460222298|FG002|Overall Study|Adverse Event|6|||
127890333|NCT00295854|460222296|FG000|Overall Study|Protocol Violation|1|||
127890334|NCT00295854|460222297|FG001|Overall Study|Protocol Violation|1|||
127890335|NCT00295854|460222298|FG002|Overall Study|Protocol Violation|1|||
127890336|NCT00295854|460222296|FG000|Overall Study|Lost to Follow-up|2|||
127890337|NCT00295854|460222297|FG001|Overall Study|Lost to Follow-up|0|||
127890338|NCT00295854|460222298|FG002|Overall Study|Lost to Follow-up|1|||
127890339|NCT00295854|460222296|FG000|Overall Study|Withdrawal by Subject|3|||
127890340|NCT00295854|460222297|FG001|Overall Study|Withdrawal by Subject|7|||
127890341|NCT00295854|460222298|FG002|Overall Study|Withdrawal by Subject|4|||
127890342|NCT00295854|460222296|FG000|Overall Study|did not continue to meet criteria|1|||
127890343|NCT00295854|460222297|FG001|Overall Study|did not continue to meet criteria|1|||
127890344|NCT00295854|460222298|FG002|Overall Study|did not continue to meet criteria|2|||
127890345|NCT00295854|460222296|FG000|Overall Study|required a prohibited medication|1|||
127890346|NCT00295854|460222297|FG001|Overall Study|required a prohibited medication|0|||
127890347|NCT00295854|460222298|FG002|Overall Study|required a prohibited medication|0|||
127890348|NCT00295854|460222296|FG000|Overall Study|Other|3|||
127890349|NCT00295854|460222297|FG001|Overall Study|Other|5|||
127890350|NCT00295854|460222298|FG002|Overall Study|Other|1|||
127890351|NCT00672620|460222299|FG000|Overall Study|Adverse Event|7|||
127890352|NCT00672620|460222300|FG001|Overall Study|Adverse Event|7|||
127890353|NCT00672620|460222301|FG002|Overall Study|Adverse Event|12|||
127890354|NCT00672620|460222302|FG003|Overall Study|Adverse Event|17|||
127890355|NCT00672620|460222299|FG000|Overall Study|Lack of Efficacy|1|||
127890356|NCT00672620|460222300|FG001|Overall Study|Lack of Efficacy|2|||
127890357|NCT00672620|460222301|FG002|Overall Study|Lack of Efficacy|2|||
127890358|NCT00672620|460222302|FG003|Overall Study|Lack of Efficacy|0|||
127890359|NCT00672620|460222299|FG000|Overall Study|Noncompliance with Study Drug|3|||
127890360|NCT00672620|460222300|FG001|Overall Study|Noncompliance with Study Drug|4|||
127890361|NCT00672620|460222301|FG002|Overall Study|Noncompliance with Study Drug|0|||
127890362|NCT00672620|460222302|FG003|Overall Study|Noncompliance with Study Drug|2|||
127890363|NCT00672620|460222299|FG000|Overall Study|Protocol Deviations|5|||
127890364|NCT00672620|460222300|FG001|Overall Study|Protocol Deviations|7|||
127890365|NCT00672620|460222301|FG002|Overall Study|Protocol Deviations|2|||
127890366|NCT00672620|460222302|FG003|Overall Study|Protocol Deviations|5|||
127890367|NCT00672620|460222299|FG000|Overall Study|Withdrawal of Consent|6|||
127890368|NCT00672620|460222300|FG001|Overall Study|Withdrawal of Consent|12|||
127890369|NCT00672620|460222301|FG002|Overall Study|Withdrawal of Consent|5|||
127890370|NCT00672620|460222302|FG003|Overall Study|Withdrawal of Consent|6|||
127890371|NCT00672620|460222299|FG000|Overall Study|Lost to Follow-up|8|||
127890372|NCT00672620|460222300|FG001|Overall Study|Lost to Follow-up|19|||
127890373|NCT00672620|460222301|FG002|Overall Study|Lost to Follow-up|8|||
127890374|NCT00672620|460222302|FG003|Overall Study|Lost to Follow-up|11|||
127890375|NCT00672620|460222299|FG000|Overall Study|Reason not Specified|3|||
127890376|NCT00672620|460222300|FG001|Overall Study|Reason not Specified|3|||
127890377|NCT00672620|460222301|FG002|Overall Study|Reason not Specified|2|||
127890378|NCT00672620|460222302|FG003|Overall Study|Reason not Specified|1|||
127731748|NCT02661490|459642442|FG004|Overall Study|Lost to Follow-up|2|||
127731749|NCT02661490|459642438|FG000|Overall Study|Withdrawal by Subject|2|||
127731750|NCT02661490|459642439|FG001|Overall Study|Withdrawal by Subject|0|||
127731751|NCT02661490|459642440|FG002|Overall Study|Withdrawal by Subject|2|||
127731752|NCT02661490|459642441|FG003|Overall Study|Withdrawal by Subject|0|||
127731753|NCT02661490|459642442|FG004|Overall Study|Withdrawal by Subject|0|||
127731754|NCT02661490|459642438|FG000|Overall Study|Death|1|||
127731755|NCT02661490|459642439|FG001|Overall Study|Death|1|||
127731756|NCT02661490|459642440|FG002|Overall Study|Death|0|||
127731757|NCT02661490|459642441|FG003|Overall Study|Death|1|||
127731758|NCT02661490|459642442|FG004|Overall Study|Death|0|||
127731759|NCT02661490|459642438|FG000|Overall Study|Reason not Specified|0|||
127731760|NCT02661490|459642439|FG001|Overall Study|Reason not Specified|0|||
127731761|NCT02661490|459642440|FG002|Overall Study|Reason not Specified|0|||
127890379|NCT00772577|460222303|FG000|Overall Study|Adverse Event|6|||
127890380|NCT00772577|460222304|FG001|Overall Study|Adverse Event|3|||
127890381|NCT00772577|460222303|FG000|Overall Study|Abnormal laboratory values|0|||
127890382|NCT00772577|460222304|FG001|Overall Study|Abnormal laboratory values|1|||
127890383|NCT00772577|460222303|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
127890384|NCT00772577|460222304|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
127890385|NCT00772577|460222303|FG000|Overall Study|Patient withdrew consent|8|||
127890386|NCT00772577|460222304|FG001|Overall Study|Patient withdrew consent|5|||
127890387|NCT00772577|460222303|FG000|Overall Study|Lost to Follow-up|4|||
127890388|NCT00772577|460222304|FG001|Overall Study|Lost to Follow-up|3|||
127731762|NCT02661490|459642441|FG003|Overall Study|Reason not Specified|0|||
127731763|NCT02661490|459642442|FG004|Overall Study|Reason not Specified|1|||
127731764|NCT00644332|459642443|FG000|Overall Study|Adverse Event|11|||
127731765|NCT00644332|459642443|FG000|Overall Study|Withdrawal by Subject|6|||
127731766|NCT00644332|459642443|FG000|Overall Study|Completion Status Unknown|2|||
127731767|NCT00644332|459642443|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
127731768|NCT00644332|459642443|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
127731769|NCT02706834|459642446|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
127731770|NCT02706834|459642447|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
127731771|NCT02706834|459642448|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
127731772|NCT02706834|459642449|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
127731773|NCT02706834|459642450|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
127731774|NCT02706834|459642451|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
127731775|NCT02706834|459642452|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
127731776|NCT02706834|459642453|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
127731777|NCT02706834|459642454|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
127731778|NCT02706834|459642455|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
127731779|NCT02706834|459642456|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
127731780|NCT02706834|459642446|FG000|Overall Study|Lost to Follow-up|0|||
127804011|NCT03609619|459905720|FG000|Overall Study|Lack of Efficacy|1|||
127804012|NCT03609619|459905721|FG001|Overall Study|Lack of Efficacy|2|||
127804013|NCT03609619|459905720|FG000|Overall Study|Protocol Violation|5|||
127804014|NCT03609619|459905721|FG001|Overall Study|Protocol Violation|0|||
127804015|NCT03609619|459905720|FG000|Overall Study|Withdrawal by Subject|2|||
127804016|NCT03609619|459905721|FG001|Overall Study|Withdrawal by Subject|3|||
127804017|NCT03609619|459905720|FG000|Overall Study|Lost to Follow-up|1|||
127804018|NCT03609619|459905721|FG001|Overall Study|Lost to Follow-up|1|||
127804019|NCT02327260|459905722|FG000|Overall Study|Lost to Follow-up|2|||
127804020|NCT02327260|459905723|FG001|Overall Study|Lost to Follow-up|3|||
127804021|NCT02327260|459905724|FG002|Overall Study|Lost to Follow-up|2|||
127804022|NCT02327260|459905722|FG000|Overall Study|invalid phone number|1|||
127804023|NCT02327260|459905723|FG001|Overall Study|invalid phone number|1|||
127804024|NCT02327260|459905724|FG002|Overall Study|invalid phone number|0|||
127804025|NCT02327260|459905722|FG000|Overall Study|non-adherence to protocol|2|||
127804026|NCT02327260|459905723|FG001|Overall Study|non-adherence to protocol|0|||
127804027|NCT02327260|459905724|FG002|Overall Study|non-adherence to protocol|0|||
127804028|NCT02327260|459905722|FG000|Overall Study|cognitive concerns|1|||
127804029|NCT02327260|459905723|FG001|Overall Study|cognitive concerns|0|||
127804030|NCT02327260|459905724|FG002|Overall Study|cognitive concerns|0|||
127804031|NCT02472847|459905726|FG000|Overall Study|Withdrawal by Subject|1|||
127804032|NCT02472847|459905727|FG001|Overall Study|Withdrawal by Subject|5|||
127804033|NCT00623831|459905728|FG000|Overall Study|Withdrawal by Subject|1|||
127804034|NCT00623831|459905729|FG001|Overall Study|Withdrawal by Subject|0|||
127804035|NCT00623831|459905728|FG000|Overall Study|Progressive Disease|0|||
127804036|NCT00623831|459905729|FG001|Overall Study|Progressive Disease|1|||
127804037|NCT00270894|459905730|FG000|Overall Study|Adverse Event|1|||
127804038|NCT00270894|459905730|FG000|Overall Study|Withdrawal by Subject|1|||
127804039|NCT01748071|459905733|FG000|Overall Study|Adverse Event|2|||
127804040|NCT01748071|459905734|FG001|Overall Study|Adverse Event|2|||
127804041|NCT01748071|459905735|FG002|Overall Study|Adverse Event|0|||
127804042|NCT00793793|459905736|FG000|Overall Study|Adverse Event|0|||
127804043|NCT00793793|459905737|FG001|Overall Study|Adverse Event|0|||
127804044|NCT00793793|459905738|FG002|Overall Study|Adverse Event|1|||
127804045|NCT00793793|459905739|FG003|Overall Study|Adverse Event|1|||
127804046|NCT00793793|459905740|FG004|Overall Study|Adverse Event|0|||
127804047|NCT00793793|459905741|FG005|Overall Study|Adverse Event|1|||
127804048|NCT00793793|459905742|FG006|Overall Study|Adverse Event|2|||
127804049|NCT00793793|459905743|FG007|Overall Study|Adverse Event|0|||
127804050|NCT00793793|459905744|FG008|Overall Study|Adverse Event|0|||
127804051|NCT00793793|459905745|FG009|Overall Study|Adverse Event|0|||
127804052|NCT00793793|459905746|FG010|Overall Study|Adverse Event|0|||
127890389|NCT00772577|460222303|FG000|Overall Study|Administrative problems|2|||
127731781|NCT02706834|459642447|FG001|Overall Study|Lost to Follow-up|0|||
127804053|NCT00793793|459905747|FG011|Overall Study|Adverse Event|2|||
127804054|NCT00793793|459905736|FG000|Overall Study|Protocol Violation|0|||
127804055|NCT00793793|459905737|FG001|Overall Study|Protocol Violation|0|||
127804056|NCT00793793|459905738|FG002|Overall Study|Protocol Violation|0|||
127804057|NCT00793793|459905739|FG003|Overall Study|Protocol Violation|1|||
127804058|NCT00793793|459905740|FG004|Overall Study|Protocol Violation|0|||
127804059|NCT00793793|459905741|FG005|Overall Study|Protocol Violation|0|||
127731782|NCT02706834|459642448|FG002|Overall Study|Lost to Follow-up|1|||
127731783|NCT02706834|459642449|FG003|Overall Study|Lost to Follow-up|0|||
127731784|NCT02706834|459642450|FG004|Overall Study|Lost to Follow-up|0|||
127731785|NCT02706834|459642451|FG005|Overall Study|Lost to Follow-up|0|||
127731786|NCT02706834|459642452|FG006|Overall Study|Lost to Follow-up|0|||
127731787|NCT02706834|459642453|FG007|Overall Study|Lost to Follow-up|0|||
127731788|NCT02706834|459642454|FG008|Overall Study|Lost to Follow-up|0|||
127731789|NCT02706834|459642455|FG009|Overall Study|Lost to Follow-up|0|||
127731790|NCT02706834|459642456|FG010|Overall Study|Lost to Follow-up|0|||
127731791|NCT02706834|459642446|FG000|Overall Study|Voluntary Withdrawal|1|||
127731792|NCT02706834|459642447|FG001|Overall Study|Voluntary Withdrawal|0|||
127731793|NCT02706834|459642448|FG002|Overall Study|Voluntary Withdrawal|0|||
127731794|NCT02706834|459642449|FG003|Overall Study|Voluntary Withdrawal|0|||
127731795|NCT02706834|459642450|FG004|Overall Study|Voluntary Withdrawal|0|||
127731796|NCT02706834|459642451|FG005|Overall Study|Voluntary Withdrawal|0|||
127731797|NCT02706834|459642452|FG006|Overall Study|Voluntary Withdrawal|0|||
127731798|NCT02706834|459642453|FG007|Overall Study|Voluntary Withdrawal|0|||
127731799|NCT02706834|459642454|FG008|Overall Study|Voluntary Withdrawal|0|||
127731800|NCT02706834|459642455|FG009|Overall Study|Voluntary Withdrawal|1|||
127731801|NCT02706834|459642456|FG010|Overall Study|Voluntary Withdrawal|0|||
127731802|NCT02706834|459642446|FG000|Overall Study|Other Reason Not Specified|1|||
127731803|NCT02706834|459642447|FG001|Overall Study|Other Reason Not Specified|0|||
127731804|NCT02706834|459642448|FG002|Overall Study|Other Reason Not Specified|0|||
127731805|NCT02706834|459642449|FG003|Overall Study|Other Reason Not Specified|0|||
127731806|NCT02706834|459642450|FG004|Overall Study|Other Reason Not Specified|1|||
127731807|NCT02706834|459642451|FG005|Overall Study|Other Reason Not Specified|0|||
127731808|NCT02706834|459642452|FG006|Overall Study|Other Reason Not Specified|0|||
127731809|NCT02706834|459642453|FG007|Overall Study|Other Reason Not Specified|0|||
127731810|NCT02706834|459642454|FG008|Overall Study|Other Reason Not Specified|0|||
127731811|NCT02706834|459642455|FG009|Overall Study|Other Reason Not Specified|0|||
127731812|NCT02706834|459642456|FG010|Overall Study|Other Reason Not Specified|0|||
127731813|NCT00627523|459642459|FG000|Overall Study|Lack of Efficacy|1|||
127731814|NCT00627523|459642460|FG001|Overall Study|Lack of Efficacy|0|||
127731815|NCT00627523|459642459|FG000|Overall Study|Withdrawal by Subject|0|||
127731816|NCT00627523|459642460|FG001|Overall Study|Withdrawal by Subject|2|||
127731817|NCT00627523|459642459|FG000|Overall Study|Other|1|||
127731818|NCT00627523|459642460|FG001|Overall Study|Other|0|||
127731819|NCT00355784|459642461|FG000|Overall Study|Withdrawal by Subject|0|||
127731820|NCT00355784|459642462|FG001|Overall Study|Withdrawal by Subject|0|||
127731821|NCT00355784|459642463|FG002|Overall Study|Withdrawal by Subject|2|||
127731822|NCT02543294|459642464|FG000|Overall Study|Lost to Follow-up|3|||
127731823|NCT02543294|459642464|FG000|Overall Study|Physician Decision|2|||
127731824|NCT02543294|459642464|FG000|Overall Study|Withdrawal by Subject|7|||
127731825|NCT03602053|459642468|FG000|Overall Study|Withdrawal by Subject|7|||
127731826|NCT03602053|459642469|FG001|Overall Study|Withdrawal by Subject|9|||
127731827|NCT03602053|459642470|FG002|Overall Study|Withdrawal by Subject|7|||
127731828|NCT03602053|459642468|FG000|Overall Study|Lost to Follow-up|5|||
127804060|NCT00793793|459905742|FG006|Overall Study|Protocol Violation|0|||
127804061|NCT00793793|459905743|FG007|Overall Study|Protocol Violation|0|||
127804062|NCT00793793|459905744|FG008|Overall Study|Protocol Violation|0|||
127804063|NCT00793793|459905745|FG009|Overall Study|Protocol Violation|0|||
127804064|NCT00793793|459905746|FG010|Overall Study|Protocol Violation|0|||
127804065|NCT00793793|459905747|FG011|Overall Study|Protocol Violation|0|||
127804066|NCT00793793|459905736|FG000|Overall Study|Lost to Follow-up|0|||
127804067|NCT00793793|459905737|FG001|Overall Study|Lost to Follow-up|0|||
127804068|NCT00793793|459905738|FG002|Overall Study|Lost to Follow-up|1|||
127804069|NCT00793793|459905739|FG003|Overall Study|Lost to Follow-up|0|||
127804070|NCT00793793|459905740|FG004|Overall Study|Lost to Follow-up|0|||
127804071|NCT00793793|459905741|FG005|Overall Study|Lost to Follow-up|0|||
127804072|NCT00793793|459905742|FG006|Overall Study|Lost to Follow-up|0|||
127731829|NCT03602053|459642469|FG001|Overall Study|Lost to Follow-up|6|||
127731830|NCT03602053|459642470|FG002|Overall Study|Lost to Follow-up|0|||
127731831|NCT03602053|459642468|FG000|Overall Study|Protocol Violation|3|||
127731832|NCT03602053|459642469|FG001|Overall Study|Protocol Violation|0|||
127731833|NCT03602053|459642470|FG002|Overall Study|Protocol Violation|4|||
127731834|NCT03602053|459642468|FG000|Overall Study|Physician Decision|1|||
127731835|NCT03602053|459642469|FG001|Overall Study|Physician Decision|0|||
127804073|NCT00793793|459905743|FG007|Overall Study|Lost to Follow-up|0|||
127804074|NCT00793793|459905744|FG008|Overall Study|Lost to Follow-up|1|||
127804075|NCT00793793|459905745|FG009|Overall Study|Lost to Follow-up|3|||
127804076|NCT00793793|459905746|FG010|Overall Study|Lost to Follow-up|1|||
127890390|NCT00772577|460222304|FG001|Overall Study|Administrative problems|1|||
127890391|NCT00772577|460222303|FG000|Overall Study|Protocol Deviation|3|||
127890392|NCT00772577|460222304|FG001|Overall Study|Protocol Deviation|2|||
127890393|NCT03211156|460222305|FG000|Overall Study|Withdrawal by Subject|0|||
127890394|NCT03211156|460222306|FG001|Overall Study|Withdrawal by Subject|2|||
127890395|NCT03211156|460222305|FG000|Overall Study|Lost to Follow-up|1|||
127890396|NCT03211156|460222306|FG001|Overall Study|Lost to Follow-up|1|||
127731836|NCT03602053|459642470|FG002|Overall Study|Physician Decision|0|||
127731837|NCT03602053|459642468|FG000|Overall Study|migration|2|||
127731838|NCT03602053|459642469|FG001|Overall Study|migration|3|||
127731839|NCT03602053|459642470|FG002|Overall Study|migration|0|||
127731840|NCT03602053|459642468|FG000|Overall Study|Other|1|||
127731841|NCT03602053|459642469|FG001|Overall Study|Other|0|||
127731842|NCT03602053|459642470|FG002|Overall Study|Other|0|||
127731843|NCT01038128|459642471|FG000|Overall Study|Lack of Efficacy|1|||
127731844|NCT01038128|459642471|FG000|Overall Study|Lost to Follow-up|1|||
127731845|NCT01038128|459642471|FG000|Overall Study|Withdrawal by Subject|2|||
127731846|NCT00396409|459642478|FG000|Period 1 - 2007|Adverse Event|0|||
127731847|NCT00396409|459642479|FG001|Period 1 - 2007|Adverse Event|1|||
127731848|NCT00396409|459642478|FG000|Period 1 - 2007|Lack of Efficacy|0|||
127731849|NCT00396409|459642479|FG001|Period 1 - 2007|Lack of Efficacy|1|||
127731850|NCT00396409|459642478|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
127731851|NCT00396409|459642479|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
127731852|NCT00396409|459642478|FG000|Period 1 - 2007|Lost to Follow-up|2|||
127731853|NCT00396409|459642479|FG001|Period 1 - 2007|Lost to Follow-up|3|||
127731854|NCT00396409|459642478|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
127731855|NCT00396409|459642479|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
127731856|NCT00396409|459642478|FG000|Period 2 - 2008|Protocol Violation|1|||
127731857|NCT00396409|459642479|FG001|Period 2 - 2008|Protocol Violation|0|||
127731858|NCT00396409|459642478|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
127731859|NCT00396409|459642479|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
127731860|NCT00396409|459642478|FG000|Period 2 - 2008|Lost to Follow-up|3|||
127731861|NCT00396409|459642479|FG001|Period 2 - 2008|Lost to Follow-up|1|||
127731862|NCT04203199|459642482|FG000|First Intervention Period|Lost to Follow-up|0|||
127731863|NCT04203199|459642483|FG001|First Intervention Period|Lost to Follow-up|1|||
127731864|NCT04203199|459642482|FG000|Second Intervention Period|Medication change|1|||
127731865|NCT04203199|459642483|FG001|Second Intervention Period|Medication change|0|||
127731866|NCT01745380|459642484|FG000|Overall Study|Lost to Follow-up|1|||
127731867|NCT01745380|459642485|FG001|Overall Study|Lost to Follow-up|0|||
127731868|NCT01745380|459642484|FG000|Overall Study|Lack of Efficacy|0|||
127731869|NCT01745380|459642485|FG001|Overall Study|Lack of Efficacy|1|||
127731870|NCT01882088|459642486|FG000|Overall Study|Intolerance of esophageal manometry|1|||
127731871|NCT01882088|459642486|FG000|Overall Study|no possibility to place the catheter|1|||
127731872|NCT01882088|459642486|FG000|Overall Study|Protocol Violation|1|||
127731873|NCT01882088|459642486|FG000|Overall Study|inadequate pH-impedance tracings|2|||
127731874|NCT04468633|459642487|FG000|Overall Study|Withdrawal by Subject|4|||
127731875|NCT04468633|459642488|FG001|Overall Study|Withdrawal by Subject|0|||
127731876|NCT00460434|459642491|FG000|Overall Study|Lost to Follow-up|3|||
127731877|NCT00460434|459642492|FG001|Overall Study|Lost to Follow-up|7|||
127731878|NCT02023099|459642493|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
127731879|NCT02023099|459642494|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
127731880|NCT02023099|459642495|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
127731881|NCT02023099|459642493|FG000|Overall Study|Withdrawn Consent|3|||
127731882|NCT02023099|459642494|FG001|Overall Study|Withdrawn Consent|0|||
127731883|NCT02023099|459642495|FG002|Overall Study|Withdrawn Consent|1|||
127731884|NCT02023099|459642493|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
127731885|NCT02023099|459642494|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
127731886|NCT02023099|459642495|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
127731887|NCT00147745|459642520|FG000|Overall Study|Withdrawal by Subject|1|||
127731888|NCT00147745|459642521|FG001|Overall Study|Withdrawal by Subject|0|||
127731889|NCT00147745|459642522|FG002|Overall Study|Withdrawal by Subject|0|||
127731890|NCT02504502|459642523|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
127731891|NCT02504502|459642524|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
127731892|NCT02504502|459642523|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
127731893|NCT02504502|459642524|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
127731894|NCT01047306|459642535|FG000|Overall Study|Withdrawal by Subject|2|||
127731895|NCT01047306|459642536|FG001|Overall Study|Withdrawal by Subject|0|||
127731896|NCT01047306|459642535|FG000|Overall Study|Lost to Follow-up|1|||
127731897|NCT01047306|459642536|FG001|Overall Study|Lost to Follow-up|0|||
127731898|NCT01622088|459642537|FG000|Overall Study|Adverse Event|20|||
127731899|NCT01622088|459642537|FG000|Overall Study|Lost to Follow-up|1|||
127731900|NCT01622088|459642537|FG000|Overall Study|Withdrawal by Subject|20|||
127890397|NCT03211156|460222305|FG000|Overall Study|Adverse Event|1|||
127731901|NCT01622088|459642537|FG000|Overall Study|Investigator Decision|1|||
127731902|NCT01622088|459642537|FG000|Overall Study|Death|53|||
127731903|NCT01622088|459642537|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
127890398|NCT03211156|460222306|FG001|Overall Study|Adverse Event|0|||
127731904|NCT00274846|459642538|FG000|Overall Study|Did not receive adequate NK cells|1|||
127731905|NCT01648699|459642541|FG000|Overall Study|Death|1|||
127731906|NCT01648699|459642541|FG000|Overall Study|Lost to Follow-up|2|||
127731907|NCT01648699|459642541|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
127731908|NCT02267746|459642542|FG000|Overall Study|Adverse Event|0|||
127731909|NCT02267746|459642543|FG001|Overall Study|Adverse Event|2|||
127731910|NCT02267746|459642544|FG002|Overall Study|Adverse Event|1|||
127731911|NCT02267746|459642542|FG000|Overall Study|Protocol Violation|8|||
127731912|NCT02267746|459642543|FG001|Overall Study|Protocol Violation|7|||
127731913|NCT02267746|459642544|FG002|Overall Study|Protocol Violation|3|||
127731914|NCT02267746|459642542|FG000|Overall Study|Lack of Efficacy|11|||
127731915|NCT02267746|459642543|FG001|Overall Study|Lack of Efficacy|11|||
127731916|NCT02267746|459642544|FG002|Overall Study|Lack of Efficacy|15|||
127731917|NCT02267746|459642542|FG000|Overall Study|Protocol Violation|1|||
127731918|NCT02267746|459642543|FG001|Overall Study|Protocol Violation|2|||
127731919|NCT02267746|459642544|FG002|Overall Study|Protocol Violation|1|||
127731920|NCT02267746|459642542|FG000|Overall Study|Miscellaneous|1|||
127731921|NCT02267746|459642543|FG001|Overall Study|Miscellaneous|0|||
127731922|NCT02267746|459642544|FG002|Overall Study|Miscellaneous|1|||
127731923|NCT04598776|459642549|FG000|Overall Study|Protocol Violation|5|||
127731924|NCT04598776|459642549|FG000|Overall Study|Physician Decision|4|||
127731925|NCT00728884|459642550|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
127731926|NCT00728884|459642550|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
127731927|NCT00348283|459642551|FG000|Induction|Adverse Event|0|||
127731928|NCT00348283|459642552|FG001|Induction|Adverse Event|2|||
127731929|NCT00348283|459642551|FG000|Induction|Protocol Violation|0|||
127731930|NCT00348283|459642552|FG001|Induction|Protocol Violation|4|||
127731931|NCT00348283|459642551|FG000|Double Blind|Adverse Event|2|||
127731932|NCT00348283|459642552|FG001|Double Blind|Adverse Event|5|||
127731933|NCT00348283|459642551|FG000|Double Blind|Withdrawal by Subject|1|||
127731934|NCT00348283|459642552|FG001|Double Blind|Withdrawal by Subject|1|||
127731935|NCT00348283|459642551|FG000|Double Blind|Protocol Violation|0|||
127804077|NCT00793793|459905747|FG011|Overall Study|Lost to Follow-up|0|||
127804078|NCT00793793|459905736|FG000|Overall Study|Withdrawal by Subject|0|||
127804079|NCT00793793|459905737|FG001|Overall Study|Withdrawal by Subject|0|||
127804080|NCT00793793|459905738|FG002|Overall Study|Withdrawal by Subject|0|||
127804081|NCT00793793|459905739|FG003|Overall Study|Withdrawal by Subject|0|||
127804082|NCT00793793|459905740|FG004|Overall Study|Withdrawal by Subject|1|||
127804083|NCT00793793|459905741|FG005|Overall Study|Withdrawal by Subject|0|||
127804084|NCT00793793|459905742|FG006|Overall Study|Withdrawal by Subject|0|||
127804085|NCT00793793|459905743|FG007|Overall Study|Withdrawal by Subject|0|||
127804086|NCT00793793|459905744|FG008|Overall Study|Withdrawal by Subject|1|||
127804087|NCT00793793|459905745|FG009|Overall Study|Withdrawal by Subject|0|||
127890399|NCT00829413|460222307|FG000|Overall Study|No study drug admimnistered|13|||
127804088|NCT00793793|459905746|FG010|Overall Study|Withdrawal by Subject|0|||
127731936|NCT00348283|459642552|FG001|Double Blind|Protocol Violation|1|||
127731937|NCT00348283|459642551|FG000|Double Blind|Lack of Efficacy|2|||
127804089|NCT00793793|459905747|FG011|Overall Study|Withdrawal by Subject|0|||
127731938|NCT00348283|459642552|FG001|Double Blind|Lack of Efficacy|2|||
127731939|NCT00348283|459642551|FG000|Double Blind|Pregnancy|0|||
127890400|NCT00829413|460222307|FG000|Overall Study|Training Patients|67|||
127890401|NCT00829413|460222307|FG000|Overall Study|No truth standard procedure available|9|||
127890402|NCT00829413|460222307|FG000|Overall Study|Technically inadequate truth standard|2|||
127890403|NCT00829413|460222307|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
127890404|NCT03487796|460222309|FG000|Overall Study|Lost to Follow-up|18|||
127890405|NCT03487796|460222310|FG001|Overall Study|Lost to Follow-up|6|||
127890406|NCT04272775|460222311|FG000|Overall Study|Study Terminated by Sponsor|1|||
127890407|NCT04272775|460222312|FG001|Overall Study|Study Terminated by Sponsor|0|||
127890408|NCT04272775|460222311|FG000|Overall Study|Protocol Violation|0|||
127890409|NCT04272775|460222312|FG001|Overall Study|Protocol Violation|1|||
127890410|NCT04272775|460222311|FG000|Overall Study|Symptomatic Deterioration|1|||
127890411|NCT04272775|460222312|FG001|Overall Study|Symptomatic Deterioration|1|||
127890412|NCT04272775|460222311|FG000|Overall Study|Withdrawal by Subject|1|||
127890413|NCT04272775|460222312|FG001|Overall Study|Withdrawal by Subject|2|||
127890414|NCT04272775|460222311|FG000|Overall Study|Adverse Event|1|||
127890415|NCT04272775|460222312|FG001|Overall Study|Adverse Event|2|||
127890416|NCT04272775|460222311|FG000|Overall Study|Progressive Disease|3|||
127890417|NCT04272775|460222312|FG001|Overall Study|Progressive Disease|1|||
127890418|NCT00124020|460222313|FG000|Overall Study|Death|67|||
127890419|NCT00124020|460222314|FG001|Overall Study|Death|71|||
127731940|NCT00348283|459642552|FG001|Double Blind|Pregnancy|1|||
127731941|NCT00348283|459642551|FG000|Open Label|Adverse Event|0|||
127731942|NCT00348283|459642552|FG001|Open Label|Adverse Event|8|||
127731943|NCT00348283|459642551|FG000|Open Label|Withdrawal by Subject|0|||
127731944|NCT00348283|459642552|FG001|Open Label|Withdrawal by Subject|4|||
127731945|NCT00348283|459642551|FG000|Open Label|Lost to Follow-up|0|||
127731946|NCT00348283|459642552|FG001|Open Label|Lost to Follow-up|1|||
127731947|NCT00348283|459642551|FG000|Open Label|Lack of Efficacy|0|||
127731948|NCT00348283|459642552|FG001|Open Label|Lack of Efficacy|13|||
127731949|NCT00348283|459642551|FG000|Open Label|Administrative reasons|0|||
127731950|NCT00348283|459642552|FG001|Open Label|Administrative reasons|5|||
127731951|NCT00348283|459642551|FG000|Open Label|Subject moved to the United States|0|||
127731952|NCT00348283|459642552|FG001|Open Label|Subject moved to the United States|1|||
127731953|NCT00348283|459642551|FG000|Open Label|Pregnancy|0|||
127731954|NCT00348283|459642552|FG001|Open Label|Pregnancy|1|||
127731955|NCT00348283|459642551|FG000|Open Label|Sponsor decision|0|||
127731956|NCT00348283|459642552|FG001|Open Label|Sponsor decision|1|||
127731957|NCT06312566|459642560|FG000|Overall Study|Protocol Violation|0|||
127731958|NCT06312566|459642561|FG001|Overall Study|Protocol Violation|1|||
127731959|NCT04736472|459642562|FG000|Overall Study|Lost to Follow-up|1|||
127890420|NCT00124020|460222313|FG000|Overall Study|Withdrawal by Subject|13|||
127890421|NCT00124020|460222314|FG001|Overall Study|Withdrawal by Subject|11|||
127890422|NCT00124020|460222313|FG000|Overall Study|Lost to Follow-up|5|||
127890423|NCT00124020|460222314|FG001|Overall Study|Lost to Follow-up|8|||
127890424|NCT00124020|460222313|FG000|Overall Study|Other|1|||
127890425|NCT00124020|460222314|FG001|Overall Study|Other|1|||
127731960|NCT04736472|459642563|FG001|Overall Study|Lost to Follow-up|0|||
127731961|NCT04736472|459642564|FG002|Overall Study|Lost to Follow-up|0|||
127890426|NCT00124020|460222313|FG000|Overall Study|Transfer to another hospital|2|||
127731962|NCT04736472|459642562|FG000|Overall Study|Withdrawal by Subject|2|||
127731963|NCT04736472|459642563|FG001|Overall Study|Withdrawal by Subject|0|||
127731964|NCT04736472|459642564|FG002|Overall Study|Withdrawal by Subject|0|||
127731965|NCT04736472|459642562|FG000|Overall Study|Protocol Violation|48|||
127731966|NCT04736472|459642563|FG001|Overall Study|Protocol Violation|0|||
127731967|NCT04736472|459642564|FG002|Overall Study|Protocol Violation|6|||
127731968|NCT02116582|459642565|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
127731969|NCT02116582|459642565|FG000|Overall Study|Adverse Event|22|||
127731970|NCT02116582|459642565|FG000|Overall Study|Death|9|||
127731971|NCT02116582|459642565|FG000|Overall Study|Progressive Disease|148|||
127731972|NCT02116582|459642565|FG000|Overall Study|Protocol Violation|3|||
127731973|NCT02116582|459642565|FG000|Overall Study|Withdrawal by Subject|8|||
127731974|NCT02116582|459642565|FG000|Overall Study|Other: Miscellaneous|11|||
127731975|NCT02116582|459642565|FG000|Overall Study|Lost to Follow-up|1|||
127731976|NCT02116582|459642565|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
127731977|NCT03861078|459642566|FG000|Overall Study|COVID-19 shut down|4|||
127804090|NCT00793793|459905736|FG000|Overall Study|reason not specified|0|||
127804091|NCT00793793|459905737|FG001|Overall Study|reason not specified|1|||
127804092|NCT00793793|459905738|FG002|Overall Study|reason not specified|0|||
127804093|NCT00793793|459905739|FG003|Overall Study|reason not specified|1|||
127804094|NCT00793793|459905740|FG004|Overall Study|reason not specified|1|||
127804095|NCT00793793|459905741|FG005|Overall Study|reason not specified|1|||
127804096|NCT00793793|459905742|FG006|Overall Study|reason not specified|2|||
127804097|NCT00793793|459905743|FG007|Overall Study|reason not specified|0|||
127804098|NCT00793793|459905744|FG008|Overall Study|reason not specified|7|||
127804099|NCT00793793|459905745|FG009|Overall Study|reason not specified|6|||
127804100|NCT00793793|459905746|FG010|Overall Study|reason not specified|2|||
127804101|NCT00793793|459905747|FG011|Overall Study|reason not specified|4|||
127804102|NCT00950170|459905748|FG000|Overall Study|Parent/Legal Guardian Request|1|||
127804103|NCT00950170|459905748|FG000|Overall Study|Adverse Event|2|||
127804104|NCT00950170|459905748|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
127804105|NCT02522767|459905749|FG000|Double-blind|Withdrawal by Subject|8|||
127804106|NCT02522767|459905750|FG001|Double-blind|Withdrawal by Subject|11|||
127804107|NCT02522767|459905749|FG000|Double-blind|Lost to Follow-up|1|||
127804108|NCT02522767|459905750|FG001|Double-blind|Lost to Follow-up|0|||
127804109|NCT02522767|459905749|FG000|Double-blind|Adverse Event|1|||
127804110|NCT02522767|459905750|FG001|Double-blind|Adverse Event|10|||
127804111|NCT02522767|459905749|FG000|Double-blind|Protocol Violation|0|||
127804112|NCT02522767|459905750|FG001|Double-blind|Protocol Violation|1|||
127804113|NCT02522767|459905749|FG000|Double-blind|Lack of Efficacy|0|||
127804114|NCT02522767|459905750|FG001|Double-blind|Lack of Efficacy|2|||
127804115|NCT02522767|459905749|FG000|Double-blind|Protocol Deviation|1|||
127804116|NCT02522767|459905750|FG001|Double-blind|Protocol Deviation|0|||
127804117|NCT02522767|459905749|FG000|Open-label|Withdrawal by Subject|2|||
127804118|NCT02522767|459905750|FG001|Open-label|Withdrawal by Subject|3|||
127804119|NCT02522767|459905749|FG000|Open-label|Lost to Follow-up|0|||
127731978|NCT03861078|459642566|FG000|Overall Study|Lost to Follow-up|1|||
127731979|NCT03861078|459642566|FG000|Overall Study|Protocol Violation|2|||
127731980|NCT03861078|459642566|FG000|Overall Study|lack of venous access|1|||
127731981|NCT02971683|459642567|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
127731982|NCT02971683|459642568|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
127731983|NCT02971683|459642567|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
127731984|NCT02971683|459642568|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
127731985|NCT02971683|459642567|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
127731986|NCT02971683|459642568|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
127731987|NCT02971683|459642567|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
127731988|NCT02971683|459642568|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
127804120|NCT02522767|459905750|FG001|Open-label|Lost to Follow-up|1|||
127804121|NCT02522767|459905749|FG000|Open-label|Adverse Event|2|||
127804122|NCT02522767|459905750|FG001|Open-label|Adverse Event|1|||
127804123|NCT02522767|459905749|FG000|Open-label|Lack of Efficacy|1|||
127804124|NCT02522767|459905750|FG001|Open-label|Lack of Efficacy|1|||
127804125|NCT02522767|459905749|FG000|Open-label|Protocol Violation|0|||
127804126|NCT02522767|459905750|FG001|Open-label|Protocol Violation|1|||
127804127|NCT00214461|459905751|FG000|Overall Study|Adverse Event|0|||
127804128|NCT00214461|459905752|FG001|Overall Study|Adverse Event|0|||
127804129|NCT00214461|459905753|FG002|Overall Study|Adverse Event|1|||
127804130|NCT00214461|459905754|FG003|Overall Study|Adverse Event|1|||
127804131|NCT00214461|459905751|FG000|Overall Study|Withdrawal by Subject|0|||
127731989|NCT02971683|459642567|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
127731990|NCT02971683|459642568|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
127731991|NCT02971683|459642567|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
127731992|NCT02971683|459642568|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
127731993|NCT02971683|459642567|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
127731994|NCT02971683|459642568|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
127804132|NCT00214461|459905752|FG001|Overall Study|Withdrawal by Subject|0|||
127804133|NCT00214461|459905753|FG002|Overall Study|Withdrawal by Subject|1|||
127804134|NCT00214461|459905754|FG003|Overall Study|Withdrawal by Subject|0|||
127804135|NCT03502187|459905755|FG000|Overall Study|Withdrawal by Subject|4|||
127804136|NCT03502187|459905756|FG001|Overall Study|Withdrawal by Subject|3|||
127804137|NCT03502187|459905757|FG002|Overall Study|Withdrawal by Subject|3|||
127804138|NCT03502187|459905755|FG000|Overall Study|Lost to Follow-up|5|||
127804139|NCT03502187|459905756|FG001|Overall Study|Lost to Follow-up|4|||
127804140|NCT03502187|459905757|FG002|Overall Study|Lost to Follow-up|5|||
127804141|NCT00400400|459905759|FG000|Overall Study|Adverse Event|9|||
127804142|NCT00400400|459905760|FG001|Overall Study|Adverse Event|8|||
127804143|NCT00400400|459905759|FG000|Overall Study|Protocol Violation|2|||
127804144|NCT00400400|459905760|FG001|Overall Study|Protocol Violation|0|||
127804145|NCT00400400|459905759|FG000|Overall Study|Withdrawal by Subject|1|||
127804146|NCT00400400|459905760|FG001|Overall Study|Withdrawal by Subject|3|||
127804147|NCT00400400|459905759|FG000|Overall Study|Administrative Problem|1|||
127804148|NCT00400400|459905760|FG001|Overall Study|Administrative Problem|0|||
127804149|NCT00400400|459905759|FG000|Overall Study|Lost to Follow-up|0|||
127804150|NCT00400400|459905760|FG001|Overall Study|Lost to Follow-up|1|||
127804151|NCT00400400|459905759|FG000|Overall Study|Did not receive study drug|1|||
127804152|NCT00400400|459905760|FG001|Overall Study|Did not receive study drug|3|||
127804153|NCT01688050|459905761|FG000|Overall Study|Death|7|||
127804154|NCT01688050|459905761|FG000|Overall Study|Conversion to open repair|1|||
127804155|NCT01688050|459905761|FG000|Overall Study|Lost to Follow-up|13|||
127804156|NCT01688050|459905761|FG000|Overall Study|Withdrawal by Subject|10|||
127804157|NCT04303000|459905762|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
127804158|NCT04303000|459905763|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
127804159|NCT04303000|459905764|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
127804160|NCT01987908|459905775|FG000|Placebo Lead-in Period|Adverse Event|2|||
127804161|NCT01987908|459905776|FG001|Placebo Lead-in Period|Adverse Event|0|||
127804162|NCT01987908|459905777|FG002|Placebo Lead-in Period|Adverse Event|0|||
127804163|NCT01987908|459905775|FG000|Placebo Lead-in Period|Physician Decision|2|||
127804164|NCT01987908|459905776|FG001|Placebo Lead-in Period|Physician Decision|0|||
127731995|NCT02971683|459642567|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
127804165|NCT01987908|459905777|FG002|Placebo Lead-in Period|Physician Decision|0|||
127804166|NCT01987908|459905775|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
127804167|NCT01987908|459905776|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
127804168|NCT01987908|459905777|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
127890427|NCT00124020|460222314|FG001|Overall Study|Transfer to another hospital|0|||
127731996|NCT02971683|459642568|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
127731997|NCT02971683|459642567|FG000|Open-Label|Lost to Follow-up|1|||
127731998|NCT02971683|459642568|FG001|Open-Label|Lost to Follow-up|0|||
127731999|NCT02971683|459642567|FG000|Open-Label|Participants withdrew consent|0|||
127732000|NCT02971683|459642568|FG001|Open-Label|Participants withdrew consent|2|||
127732001|NCT02971683|459642567|FG000|Open-Label|Participant request to discontinue study treatment|1|||
127732002|NCT02971683|459642568|FG001|Open-Label|Participant request to discontinue study treatment|0|||
127732003|NCT02971683|459642567|FG000|Open-Label|Lack of Efficacy|2|||
127732004|NCT02971683|459642568|FG001|Open-Label|Lack of Efficacy|0|||
127732005|NCT02971683|459642567|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
127732006|NCT02971683|459642568|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
127732007|NCT02971683|459642567|FG000|Long-Term Open Label|Participant withdrew consent|1|||
127732008|NCT02971683|459642568|FG001|Long-Term Open Label|Participant withdrew consent|0|||
127732009|NCT02971683|459642567|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
127804169|NCT01987908|459905775|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
127804170|NCT01987908|459905776|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
127804171|NCT01987908|459905777|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
127804172|NCT01987908|459905775|FG000|Treatment Period|Adverse Event|0|||
127804173|NCT01987908|459905776|FG001|Treatment Period|Adverse Event|1|||
127804174|NCT01987908|459905777|FG002|Treatment Period|Adverse Event|1|||
127890428|NCT02043366|460222315|FG000|Overall Study|Lost to Follow-up|2|||
127890429|NCT02043366|460222316|FG001|Overall Study|Lost to Follow-up|2|||
127890430|NCT02043366|460222317|FG002|Overall Study|Lost to Follow-up|2|||
127890431|NCT02043366|460222318|FG003|Overall Study|Lost to Follow-up|2|||
127890432|NCT02043366|460222319|FG004|Overall Study|Lost to Follow-up|2|||
127890433|NCT02043366|460222320|FG005|Overall Study|Lost to Follow-up|2|||
127890434|NCT00891774|460222323|FG000|Overall Study|Lost to Follow-up|5|||
127890435|NCT00891774|460222323|FG000|Overall Study|Illness (Self/Mother)|3|||
127890436|NCT00891774|460222323|FG000|Overall Study|Withdrawal by Subject|2|||
127890437|NCT00891774|460222323|FG000|Overall Study|Protocol Violation|4|||
127890438|NCT01977092|460222325|FG000|Overall Study|Death|3|||
127890439|NCT01977092|460222326|FG001|Overall Study|Death|4|||
127890440|NCT01977092|460222325|FG000|Overall Study|Lost to Follow-up|23|||
127890441|NCT01977092|460222326|FG001|Overall Study|Lost to Follow-up|14|||
127890442|NCT01977092|460222325|FG000|Overall Study|Withdrawal by Subject|2|||
127890443|NCT01977092|460222326|FG001|Overall Study|Withdrawal by Subject|1|||
127732010|NCT02971683|459642568|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
127732011|NCT02971683|459642567|FG000|Long-Term Open Label|Adverse Event|1|||
127732012|NCT02971683|459642568|FG001|Long-Term Open Label|Adverse Event|2|||
127732013|NCT02971683|459642567|FG000|Long-Term Open Label|Lack of Efficacy|1|||
127732014|NCT02971683|459642568|FG001|Long-Term Open Label|Lack of Efficacy|1|||
127732015|NCT02268526|459642571|FG000|Overall Study|Adverse Event|0|||
127732016|NCT02268526|459642572|FG001|Overall Study|Adverse Event|2|||
127732017|NCT02268526|459642573|FG002|Overall Study|Adverse Event|1|||
127732018|NCT02268526|459642571|FG000|Overall Study|Death|1|||
127732019|NCT02268526|459642572|FG001|Overall Study|Death|11|||
127732020|NCT02268526|459642573|FG002|Overall Study|Death|0|||
127732021|NCT02268526|459642571|FG000|Overall Study|protocol deviation|0|||
127732022|NCT02268526|459642572|FG001|Overall Study|protocol deviation|1|||
127732023|NCT02268526|459642573|FG002|Overall Study|protocol deviation|0|||
127804175|NCT01987908|459905775|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
127804176|NCT01987908|459905776|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
127868807|NCT01072175|460137394|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
127732024|NCT02268526|459642571|FG000|Overall Study|Physician Decision|0|||
127732025|NCT02268526|459642572|FG001|Overall Study|Physician Decision|0|||
127732026|NCT02268526|459642573|FG002|Overall Study|Physician Decision|1|||
127732027|NCT02268526|459642571|FG000|Overall Study|Subject/guardian decision|0|||
127732028|NCT02268526|459642572|FG001|Overall Study|Subject/guardian decision|7|||
127732029|NCT02268526|459642573|FG002|Overall Study|Subject/guardian decision|3|||
127732030|NCT00596960|459642574|FG000|Overall Study|Death|1|||
127732031|NCT00596960|459642575|FG001|Overall Study|Death|2|||
127732032|NCT00596960|459642574|FG000|Overall Study|Lost to Follow-up|6|||
127732033|NCT00596960|459642575|FG001|Overall Study|Lost to Follow-up|5|||
127732034|NCT00596960|459642574|FG000|Overall Study|Withdrawal by Subject|1|||
127732035|NCT00596960|459642575|FG001|Overall Study|Withdrawal by Subject|0|||
127732036|NCT00596960|459642574|FG000|Overall Study|Incarcerated|2|||
127732037|NCT00596960|459642575|FG001|Overall Study|Incarcerated|0|||
127732038|NCT00596960|459642574|FG000|Overall Study|Physician Decision|1|||
127732039|NCT00596960|459642575|FG001|Overall Study|Physician Decision|0|||
127732040|NCT00596960|459642574|FG000|Overall Study|Protocol Violation|0|||
127732041|NCT00596960|459642575|FG001|Overall Study|Protocol Violation|1|||
127732042|NCT00596960|459642574|FG000|Overall Study|No alcohol use data|0|||
127732043|NCT00596960|459642575|FG001|Overall Study|No alcohol use data|1|||
127732044|NCT02374476|459642578|FG000|VT Induced Ablation|Screening Failures|36|||
127732045|NCT02374476|459642579|FG001|VT Induced Ablation|Screening Failures|0|||
127732046|NCT02374476|459642580|FG002|VT Induced Ablation|Screening Failures|0|||
127732047|NCT02374476|459642578|FG000|Arm Assignment|Withdrawal by Subject|0|||
127732048|NCT02374476|459642579|FG001|Arm Assignment|Withdrawal by Subject|0|||
127732049|NCT02374476|459642580|FG002|Arm Assignment|Withdrawal by Subject|1|||
127732050|NCT03305458|459642581|FG000|Overall Study|Withdrawal by Subject|50|||
127732051|NCT03305458|459642582|FG001|Overall Study|Withdrawal by Subject|46|||
127732052|NCT03305458|459642583|FG002|Overall Study|Withdrawal by Subject|93|||
127732053|NCT03305458|459642581|FG000|Overall Study|Lost to Follow-up|85|||
127732054|NCT03305458|459642582|FG001|Overall Study|Lost to Follow-up|85|||
127732055|NCT03305458|459642583|FG002|Overall Study|Lost to Follow-up|35|||
127732056|NCT05431543|459642584|FG000|Overall Study|Medical History|1|||
127732057|NCT05431543|459642585|FG001|Overall Study|Medical History|0|||
127732058|NCT05431543|459642586|FG002|Overall Study|Medical History|0|||
127732059|NCT00440037|459642587|FG000|Overall Study|Withdrawal by Subject|6|||
127732060|NCT00440037|459642587|FG000|Overall Study|Administrative decision|3|||
127732061|NCT00498797|459642588|FG000|Overall Study|Withdrawal by Subject|4|||
127732062|NCT00498797|459642589|FG001|Overall Study|Withdrawal by Subject|2|||
127732063|NCT00498797|459642588|FG000|Overall Study|Adverse Event|12|||
127732064|NCT00498797|459642589|FG001|Overall Study|Adverse Event|5|||
127732065|NCT00498797|459642588|FG000|Overall Study|Condition under investigation worsened|19|||
127732066|NCT00498797|459642589|FG001|Overall Study|Condition under investigation worsened|21|||
127732067|NCT00498797|459642588|FG000|Overall Study|Other|3|||
127732068|NCT00498797|459642589|FG001|Overall Study|Other|1|||
127732069|NCT00448344|459642590|FG000|Overall Study|Lost to Follow-up|20|||
127804177|NCT01987908|459905777|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
127804178|NCT01987908|459905775|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
127804179|NCT01987908|459905776|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
127804180|NCT01987908|459905777|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
127732070|NCT00448344|459642591|FG001|Overall Study|Lost to Follow-up|22|||
127732071|NCT00448344|459642590|FG000|Overall Study|Withdrawal by Subject|6|||
127804181|NCT00849667|459905781|FG000|Overall Study|Withdrawal by Subject|16|||
127732072|NCT00448344|459642591|FG001|Overall Study|Withdrawal by Subject|8|||
127732073|NCT00448344|459642590|FG000|Overall Study|Death|3|||
127732074|NCT00448344|459642591|FG001|Overall Study|Death|4|||
127732075|NCT00448344|459642590|FG000|Overall Study|Physician Decision|1|||
127732076|NCT00448344|459642591|FG001|Overall Study|Physician Decision|2|||
127732077|NCT01636778|459642597|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
127732078|NCT01636778|459642598|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
127732079|NCT01636778|459642599|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
127804182|NCT00849667|459905782|FG001|Overall Study|Withdrawal by Subject|33|||
127804183|NCT00849667|459905783|FG002|Overall Study|Withdrawal by Subject|35|||
127804184|NCT00849667|459905781|FG000|Overall Study|Lost to Follow-up|8|||
127804185|NCT00849667|459905782|FG001|Overall Study|Lost to Follow-up|8|||
127804186|NCT00849667|459905783|FG002|Overall Study|Lost to Follow-up|8|||
127804187|NCT00849667|459905781|FG000|Overall Study|Adverse Event|1|||
127804188|NCT00849667|459905782|FG001|Overall Study|Adverse Event|2|||
127804189|NCT00849667|459905783|FG002|Overall Study|Adverse Event|0|||
127804190|NCT00849667|459905781|FG000|Overall Study|Other|18|||
127804191|NCT00849667|459905782|FG001|Overall Study|Other|19|||
127804192|NCT00849667|459905783|FG002|Overall Study|Other|18|||
127804193|NCT00849667|459905781|FG000|Overall Study|Progressive disease|119|||
127804194|NCT00849667|459905782|FG001|Overall Study|Progressive disease|100|||
127804195|NCT00849667|459905783|FG002|Overall Study|Progressive disease|112|||
127804196|NCT00849667|459905781|FG000|Overall Study|Sponsor decision|208|||
127804197|NCT00849667|459905782|FG001|Overall Study|Sponsor decision|204|||
127804198|NCT00849667|459905783|FG002|Overall Study|Sponsor decision|190|||
127804199|NCT00849667|459905781|FG000|Overall Study|Investigator discretion|0|||
127804200|NCT00849667|459905782|FG001|Overall Study|Investigator discretion|0|||
127804201|NCT00849667|459905783|FG002|Overall Study|Investigator discretion|1|||
127804202|NCT00189462|459905784|FG000|Overall Study|Lack of Efficacy|5|||
127804203|NCT00189462|459905785|FG001|Overall Study|Lack of Efficacy|1|||
127804204|NCT00189462|459905784|FG000|Overall Study|Lost to Follow-up|18|||
127804205|NCT00189462|459905785|FG001|Overall Study|Lost to Follow-up|20|||
127804206|NCT01262625|459905788|FG000|Overall Study|Administrative Error|1|||
127804207|NCT01262625|459905789|FG001|Overall Study|Administrative Error|1|||
127804208|NCT01262625|459905788|FG000|Overall Study|Site Closed|1|||
127804209|NCT01262625|459905789|FG001|Overall Study|Site Closed|0|||
127804210|NCT02789657|459905790|FG000|Overall Study|Withdrawal by Subject|2|||
127804211|NCT02789657|459905791|FG001|Overall Study|Withdrawal by Subject|0|||
127804212|NCT02789657|459905792|FG002|Overall Study|Withdrawal by Subject|0|||
127804213|NCT02789657|459905793|FG003|Overall Study|Withdrawal by Subject|0|||
127804214|NCT01214044|459905794|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
127804215|NCT01214044|459905794|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
127732080|NCT01636778|459642597|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
127732081|NCT01636778|459642598|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
127732082|NCT01636778|459642599|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
127732083|NCT01636778|459642597|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
127732084|NCT01636778|459642598|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
127732085|NCT01636778|459642599|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
127732086|NCT01636778|459642597|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
127732087|NCT01636778|459642598|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
127732088|NCT01636778|459642599|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
127732089|NCT01636778|459642597|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
127732090|NCT01636778|459642598|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
127804216|NCT01214044|459905794|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
127804217|NCT01214044|459905794|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
127804218|NCT01214044|459905794|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
127804219|NCT01214044|459905794|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
127804220|NCT04698525|459905795|FG000|Overall Study|Lost to Follow-up|1|||
127804221|NCT04698525|459905796|FG001|Overall Study|Lost to Follow-up|2|||
127804222|NCT04698525|459905795|FG000|Overall Study|Three suffered of Covid-19|2|||
127804223|NCT04698525|459905796|FG001|Overall Study|Three suffered of Covid-19|1|||
127804224|NCT00510276|459905800|FG000|Acute Double-Blind Phase|Adverse Event|21|||
127804225|NCT00510276|459905801|FG001|Acute Double-Blind Phase|Adverse Event|6|||
127804226|NCT00510276|459905800|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
127804227|NCT00510276|459905801|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
127804228|NCT00510276|459905800|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
127804229|NCT00510276|459905801|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
127804230|NCT00510276|459905800|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
127804231|NCT00510276|459905801|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
127804232|NCT00510276|459905800|FG000|Acute Double-Blind Phase|Physician Decision|0|||
127804233|NCT00510276|459905801|FG001|Acute Double-Blind Phase|Physician Decision|3|||
127804234|NCT00510276|459905800|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
127890444|NCT01977092|460222325|FG000|Overall Study|In prison|3|||
127804235|NCT00510276|459905801|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
127804236|NCT00510276|459905800|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
127804237|NCT00510276|459905801|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
127804238|NCT00510276|459905800|FG000|Acute Double-Blind Phase|Subject Decision|26|||
127804239|NCT00510276|459905801|FG001|Acute Double-Blind Phase|Subject Decision|28|||
127804240|NCT00510276|459905800|FG000|Extension Open-Label Phase|Adverse Event|9|||
127804241|NCT00510276|459905801|FG001|Extension Open-Label Phase|Adverse Event|18|||
127804242|NCT00510276|459905800|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
127804243|NCT00510276|459905801|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
127804244|NCT00510276|459905800|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
127804245|NCT00510276|459905801|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
127804246|NCT00510276|459905800|FG000|Extension Open-Label Phase|Physician Decision|2|||
127804247|NCT00510276|459905801|FG001|Extension Open-Label Phase|Physician Decision|3|||
127804248|NCT00510276|459905800|FG000|Extension Open-Label Phase|Protocol Violation|0|||
127804249|NCT00510276|459905801|FG001|Extension Open-Label Phase|Protocol Violation|1|||
127804250|NCT00510276|459905800|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
127804251|NCT00510276|459905801|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
127804252|NCT00510276|459905800|FG000|Extension Open-Label Phase|Subject Decision|7|||
127804253|NCT00510276|459905801|FG001|Extension Open-Label Phase|Subject Decision|9|||
127804254|NCT03486392|459905804|FG000|Overall Study|Lost to Follow-up|0|||
127804255|NCT03486392|459905805|FG001|Overall Study|Lost to Follow-up|0|||
127804256|NCT03486392|459905806|FG002|Overall Study|Lost to Follow-up|8|||
127804257|NCT03486392|459905807|FG003|Overall Study|Lost to Follow-up|5|||
127804258|NCT03486392|459905808|FG004|Overall Study|Lost to Follow-up|2|||
127804259|NCT03486392|459905804|FG000|Overall Study|Withdrawal by Subject|3|||
127804260|NCT03486392|459905805|FG001|Overall Study|Withdrawal by Subject|0|||
127804261|NCT03486392|459905806|FG002|Overall Study|Withdrawal by Subject|6|||
127804262|NCT03486392|459905807|FG003|Overall Study|Withdrawal by Subject|4|||
127804263|NCT03486392|459905808|FG004|Overall Study|Withdrawal by Subject|1|||
127804264|NCT03486392|459905804|FG000|Overall Study|Death|0|||
127804265|NCT03486392|459905805|FG001|Overall Study|Death|0|||
127804266|NCT03486392|459905806|FG002|Overall Study|Death|0|||
127804267|NCT03486392|459905807|FG003|Overall Study|Death|0|||
127804268|NCT03486392|459905808|FG004|Overall Study|Death|1|||
127804269|NCT00441792|459905813|FG000|Overall Study|Lost to Follow-up|0|||
127804270|NCT00441792|459905814|FG001|Overall Study|Lost to Follow-up|2|||
127804271|NCT01731678|459905815|FG000|Overall Study|Withdrawal by Subject|3|||
127804272|NCT01731678|459905815|FG000|Overall Study|Did not meet inclusion criteria|1|||
127804273|NCT01731678|459905815|FG000|Overall Study|RMT too high, making TMS difficult|3|||
127804274|NCT00888355|459905822|FG000|Overall Study|Adverse Event|10|||
127804275|NCT00888355|459905823|FG001|Overall Study|Adverse Event|0|||
127804276|NCT00888355|459905824|FG002|Overall Study|Adverse Event|3|||
127804277|NCT00888355|459905825|FG003|Overall Study|Adverse Event|3|||
127804278|NCT00888355|459905822|FG000|Overall Study|Lack of Efficacy|9|||
127804279|NCT00888355|459905823|FG001|Overall Study|Lack of Efficacy|2|||
127804280|NCT00888355|459905824|FG002|Overall Study|Lack of Efficacy|5|||
127804281|NCT00888355|459905825|FG003|Overall Study|Lack of Efficacy|2|||
127804282|NCT00888355|459905822|FG000|Overall Study|Lost to Follow-up|0|||
127804283|NCT00888355|459905823|FG001|Overall Study|Lost to Follow-up|2|||
127804284|NCT00888355|459905824|FG002|Overall Study|Lost to Follow-up|2|||
127804285|NCT00888355|459905825|FG003|Overall Study|Lost to Follow-up|0|||
127804286|NCT00888355|459905822|FG000|Overall Study|Protocol Violation|3|||
127804287|NCT00888355|459905823|FG001|Overall Study|Protocol Violation|2|||
127804288|NCT00888355|459905824|FG002|Overall Study|Protocol Violation|1|||
127804289|NCT00888355|459905825|FG003|Overall Study|Protocol Violation|2|||
127804290|NCT00888355|459905822|FG000|Overall Study|Withdrawal by Subject|0|||
127804291|NCT00888355|459905823|FG001|Overall Study|Withdrawal by Subject|3|||
127804292|NCT00888355|459905824|FG002|Overall Study|Withdrawal by Subject|1|||
127804293|NCT00888355|459905825|FG003|Overall Study|Withdrawal by Subject|3|||
127804294|NCT01551693|459905827|FG000|Overall Study|Disease Progression|1|||
127804295|NCT01551693|459905828|FG001|Overall Study|Disease Progression|0|||
127804296|NCT01551693|459905827|FG000|Overall Study|Adverse Event|0|||
127804297|NCT01551693|459905828|FG001|Overall Study|Adverse Event|1|||
127890445|NCT01977092|460222326|FG001|Overall Study|In prison|11|||
127890446|NCT02927847|460222327|FG000|Overall Study|Lost to Follow-up|1|||
127890447|NCT02927847|460222328|FG001|Overall Study|Lost to Follow-up|0|||
127890448|NCT02927847|460222327|FG000|Overall Study|Withdrawal by Subject|4|||
127890449|NCT02927847|460222328|FG001|Overall Study|Withdrawal by Subject|2|||
127890450|NCT02927847|460222327|FG000|Overall Study|PI withdrawn due to missed visits|1|||
127890451|NCT02927847|460222328|FG001|Overall Study|PI withdrawn due to missed visits|1|||
127890452|NCT00723554|460222329|FG000|Overall Study|Adverse Event|12|||
127890453|NCT00723554|460222329|FG000|Overall Study|Investigator's judgement|5|||
127890454|NCT00723554|460222329|FG000|Overall Study|Inhaled medication other than iloprost|4|||
127890455|NCT00723554|460222329|FG000|Overall Study|Withdrawal of consent|3|||
127890456|NCT00723554|460222329|FG000|Overall Study|Other|3|||
127732091|NCT01636778|459642599|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
127732092|NCT01636778|459642597|FG000|Follow-up Period After Part 2|Other|0|||
127732093|NCT01636778|459642598|FG001|Follow-up Period After Part 2|Other|0|||
127732094|NCT01636778|459642599|FG002|Follow-up Period After Part 2|Other|1|||
127732095|NCT01636778|459642597|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
127732096|NCT01636778|459642598|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
127732097|NCT01636778|459642599|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
127732098|NCT01636778|459642597|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
127732099|NCT01636778|459642598|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
127732100|NCT01636778|459642599|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
127732101|NCT00705614|459644536|FG000|Initial Intervention|Adverse Event|40|||
127732102|NCT00705614|459644537|FG001|Initial Intervention|Adverse Event|21|||
127732103|NCT00705614|459644536|FG000|Initial Intervention|Lost to Follow-up|310|||
127732104|NCT00705614|459644537|FG001|Initial Intervention|Lost to Follow-up|191|||
127732105|NCT00705614|459644536|FG000|Initial Intervention|Withdrawal by Subject|114|||
127732106|NCT00705614|459644537|FG001|Initial Intervention|Withdrawal by Subject|71|||
127732107|NCT00705614|459644536|FG000|Initial Intervention|Administrative Reason|51|||
127732108|NCT00705614|459644537|FG001|Initial Intervention|Administrative Reason|38|||
127732109|NCT00705614|459644536|FG000|Initial Intervention|Status completion unknown|3|||
127732110|NCT00705614|459644537|FG001|Initial Intervention|Status completion unknown|0|||
127732111|NCT00705614|459644536|FG000|Switch to Remicade|Adverse Event|0|||
127732112|NCT00705614|459644537|FG001|Switch to Remicade|Adverse Event|5|||
127732113|NCT00705614|459644536|FG000|Switch to Remicade|Lost to Follow-up|0|||
127732114|NCT00705614|459644537|FG001|Switch to Remicade|Lost to Follow-up|23|||
127732115|NCT00705614|459644536|FG000|Switch to Remicade|Withdrawal by Subject|0|||
127732116|NCT00705614|459644537|FG001|Switch to Remicade|Withdrawal by Subject|12|||
127804298|NCT01551693|459905827|FG000|Overall Study|Withdrawal by Subject|0|||
127804299|NCT01551693|459905828|FG001|Overall Study|Withdrawal by Subject|1|||
127804300|NCT02649634|459905829|FG000|Overall Study|Withdrawal by Subject|3|||
127804301|NCT02649634|459905830|FG001|Overall Study|Withdrawal by Subject|5|||
127804302|NCT02649634|459905829|FG000|Overall Study|Lost to Follow-up|0|||
127804303|NCT02649634|459905830|FG001|Overall Study|Lost to Follow-up|1|||
127804304|NCT01486199|459905831|FG000|Two Year Period Between Study Days|Physician Decision|1|||
127804305|NCT01486199|459905832|FG001|Two Year Period Between Study Days|Physician Decision|0|||
127804306|NCT02471716|459905833|FG000|Overall Study|Withdrawal by Subject|0|||
127804307|NCT02471716|459905834|FG001|Overall Study|Withdrawal by Subject|1|||
127804308|NCT02471716|459905835|FG002|Overall Study|Withdrawal by Subject|0|||
127804309|NCT02471716|459905836|FG003|Overall Study|Withdrawal by Subject|2|||
127804310|NCT02471716|459905837|FG004|Overall Study|Withdrawal by Subject|5|||
127804311|NCT02471716|459905833|FG000|Overall Study|Study Terminiated by sponsor|0|||
127804312|NCT02471716|459905834|FG001|Overall Study|Study Terminiated by sponsor|0|||
127804313|NCT02471716|459905835|FG002|Overall Study|Study Terminiated by sponsor|0|||
127804314|NCT02471716|459905836|FG003|Overall Study|Study Terminiated by sponsor|1|||
127804315|NCT02471716|459905837|FG004|Overall Study|Study Terminiated by sponsor|0|||
127804316|NCT02471716|459905833|FG000|Overall Study|Lost to Follow-up|0|||
127804317|NCT02471716|459905834|FG001|Overall Study|Lost to Follow-up|0|||
127804318|NCT02471716|459905835|FG002|Overall Study|Lost to Follow-up|0|||
127890457|NCT00723554|460222329|FG000|Overall Study|Lost to Follow-up|1|||
127732117|NCT00705614|459644536|FG000|Switch to Remicade|Administrative Reason|0|||
127732118|NCT00705614|459644537|FG001|Switch to Remicade|Administrative Reason|9|||
127890458|NCT00723554|460222329|FG000|Overall Study|Non-compliance|1|||
127732119|NCT00676195|459644540|FG000|Overall Study|Lost to Follow-up|1|||
127732120|NCT00676195|459644540|FG000|Overall Study|Adverse Event|1|||
127732121|NCT00676195|459644540|FG000|Overall Study|Physician Decision|1|||
127732122|NCT04050722|459644541|FG000|Overall Study|Withdrawal by Subject|1|||
127732123|NCT04050722|459644542|FG001|Overall Study|Withdrawal by Subject|0|||
127732124|NCT03451292|459644545|FG000|Overall Study|Death|44|||
127732125|NCT03451292|459644546|FG001|Overall Study|Death|59|||
127732126|NCT03451292|459644545|FG000|Overall Study|Withdrawal by Subject|18|||
127732127|NCT03451292|459644546|FG001|Overall Study|Withdrawal by Subject|13|||
127732128|NCT03451292|459644545|FG000|Overall Study|Transplantation|18|||
127732129|NCT03451292|459644546|FG001|Overall Study|Transplantation|12|||
127732130|NCT03451292|459644545|FG000|Overall Study|Lost to Follow-up|4|||
127732131|NCT03451292|459644546|FG001|Overall Study|Lost to Follow-up|12|||
127732132|NCT03451292|459644545|FG000|Overall Study|Physician Decision|4|||
127732133|NCT03451292|459644546|FG001|Overall Study|Physician Decision|3|||
127732134|NCT03451292|459644545|FG000|Overall Study|Adverse Event|3|||
127732135|NCT03451292|459644546|FG001|Overall Study|Adverse Event|3|||
127732136|NCT03451292|459644545|FG000|Overall Study|Non-compliance with Study Drug|2|||
127732137|NCT03451292|459644546|FG001|Overall Study|Non-compliance with Study Drug|0|||
127732138|NCT01572493|459644554|FG000|Overall Study|Physician Decision|1|||
127732139|NCT01572493|459644555|FG001|Overall Study|Physician Decision|0|||
127732140|NCT01572493|459644556|FG002|Overall Study|Physician Decision|0|||
127732141|NCT01572493|459644557|FG003|Overall Study|Physician Decision|0|||
127732142|NCT01572493|459644558|FG004|Overall Study|Physician Decision|0|||
127732143|NCT01572493|459644559|FG005|Overall Study|Physician Decision|0|||
127732144|NCT01572493|459644560|FG006|Overall Study|Physician Decision|0|||
127732145|NCT01572493|459644561|FG007|Overall Study|Physician Decision|0|||
127732146|NCT01572493|459644562|FG008|Overall Study|Physician Decision|0|||
127732147|NCT01572493|459644554|FG000|Overall Study|Switched to alternative treatment|0|||
127732148|NCT01572493|459644555|FG001|Overall Study|Switched to alternative treatment|1|||
127732149|NCT01572493|459644556|FG002|Overall Study|Switched to alternative treatment|2|||
127732150|NCT01572493|459644557|FG003|Overall Study|Switched to alternative treatment|1|||
127732151|NCT01572493|459644558|FG004|Overall Study|Switched to alternative treatment|2|||
127732152|NCT01572493|459644559|FG005|Overall Study|Switched to alternative treatment|0|||
127732153|NCT01572493|459644560|FG006|Overall Study|Switched to alternative treatment|2|||
127732154|NCT01572493|459644561|FG007|Overall Study|Switched to alternative treatment|0|||
127732155|NCT01572493|459644562|FG008|Overall Study|Switched to alternative treatment|2|||
127732156|NCT01572493|459644554|FG000|Overall Study|Death|0|||
127732157|NCT01572493|459644555|FG001|Overall Study|Death|0|||
127732158|NCT01572493|459644556|FG002|Overall Study|Death|0|||
127732159|NCT01572493|459644557|FG003|Overall Study|Death|1|||
127732160|NCT01572493|459644558|FG004|Overall Study|Death|0|||
127732161|NCT01572493|459644559|FG005|Overall Study|Death|1|||
127732162|NCT01572493|459644560|FG006|Overall Study|Death|0|||
127732163|NCT01572493|459644561|FG007|Overall Study|Death|0|||
127732164|NCT01572493|459644562|FG008|Overall Study|Death|0|||
127732165|NCT01572493|459644554|FG000|Overall Study|Adverse Event|0|||
127732166|NCT01572493|459644555|FG001|Overall Study|Adverse Event|0|||
127732167|NCT01572493|459644556|FG002|Overall Study|Adverse Event|0|||
127732168|NCT01572493|459644557|FG003|Overall Study|Adverse Event|0|||
127732169|NCT01572493|459644558|FG004|Overall Study|Adverse Event|0|||
127732170|NCT01572493|459644559|FG005|Overall Study|Adverse Event|0|||
127732171|NCT01572493|459644560|FG006|Overall Study|Adverse Event|1|||
127732172|NCT01572493|459644561|FG007|Overall Study|Adverse Event|0|||
127732173|NCT01572493|459644562|FG008|Overall Study|Adverse Event|0|||
127732174|NCT01234675|459644563|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
127732175|NCT01234675|459644564|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
127732176|NCT01234675|459644563|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
127732177|NCT01234675|459644564|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
127732178|NCT00609245|459644565|FG000|Overall Study|Adverse Event|1|||
127732179|NCT02889809|459644566|FG000|Overall Study|Withdrawal by Subject|30|||
127804319|NCT02471716|459905836|FG003|Overall Study|Lost to Follow-up|3|||
127804320|NCT02471716|459905837|FG004|Overall Study|Lost to Follow-up|2|||
127804321|NCT02471716|459905833|FG000|Overall Study|Death|0|||
127804322|NCT02471716|459905834|FG001|Overall Study|Death|0|||
127804323|NCT02471716|459905835|FG002|Overall Study|Death|0|||
127804324|NCT02471716|459905836|FG003|Overall Study|Death|1|||
127804325|NCT02471716|459905837|FG004|Overall Study|Death|0|||
127804326|NCT02471716|459905833|FG000|Overall Study|Other|0|||
127804327|NCT02471716|459905834|FG001|Overall Study|Other|0|||
127804328|NCT02471716|459905835|FG002|Overall Study|Other|0|||
127804329|NCT02471716|459905836|FG003|Overall Study|Other|8|||
127804330|NCT02471716|459905837|FG004|Overall Study|Other|9|||
127804331|NCT02211261|459905842|FG000|Overall Study|Withdrawal by Subject|0|||
127804332|NCT02211261|459905843|FG001|Overall Study|Withdrawal by Subject|0|||
127732180|NCT02889809|459644567|FG001|Overall Study|Withdrawal by Subject|21|||
127732181|NCT02889809|459644566|FG000|Overall Study|Lost to Follow-up|1|||
127804333|NCT02211261|459905844|FG002|Overall Study|Withdrawal by Subject|1|||
127804334|NCT02211261|459905845|FG003|Overall Study|Withdrawal by Subject|0|||
127804335|NCT02211261|459905846|FG004|Overall Study|Withdrawal by Subject|2|||
127804336|NCT02211261|459905847|FG005|Overall Study|Withdrawal by Subject|0|||
127804337|NCT02211261|459905848|FG006|Overall Study|Withdrawal by Subject|0|||
127732182|NCT02889809|459644567|FG001|Overall Study|Lost to Follow-up|1|||
127732183|NCT02889809|459644566|FG000|Overall Study|Site Closed|12|||
127732184|NCT02889809|459644567|FG001|Overall Study|Site Closed|11|||
127732185|NCT03034772|459644571|FG000|Overall Study|Adverse Event|0|||
127732186|NCT03034772|459644572|FG001|Overall Study|Adverse Event|1|||
127804338|NCT02211261|459905849|FG007|Overall Study|Withdrawal by Subject|0|||
127732187|NCT03034772|459644571|FG000|Overall Study|Withdrawal by Subject|0|||
127732188|NCT03034772|459644572|FG001|Overall Study|Withdrawal by Subject|1|||
127732189|NCT02660034|459644573|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
127732190|NCT02660034|459644574|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
127732191|NCT02660034|459644575|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
127732192|NCT02660034|459644576|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
127732193|NCT02660034|459644577|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
127732194|NCT02660034|459644578|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
127732195|NCT02660034|459644579|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
127732196|NCT02660034|459644580|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
127732197|NCT02660034|459644581|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
127732198|NCT02660034|459644582|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
127732199|NCT02660034|459644583|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
127732200|NCT02660034|459644584|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
127732201|NCT02660034|459644585|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
127732202|NCT02660034|459644586|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
127890459|NCT01405820|460222330|FG000|Randomized Treatment Period|Adverse Event|3|||
127890460|NCT01405820|460222331|FG001|Randomized Treatment Period|Adverse Event|3|||
127804339|NCT02211261|459905850|FG008|Overall Study|Withdrawal by Subject|0|||
127804340|NCT02211261|459905851|FG009|Overall Study|Withdrawal by Subject|0|||
127804341|NCT02211261|459905852|FG010|Overall Study|Withdrawal by Subject|0|||
127804342|NCT02211261|459905842|FG000|Overall Study|Other|0|||
127804343|NCT02211261|459905843|FG001|Overall Study|Other|0|||
127804344|NCT02211261|459905844|FG002|Overall Study|Other|0|||
127804345|NCT02211261|459905845|FG003|Overall Study|Other|0|||
127804346|NCT02211261|459905846|FG004|Overall Study|Other|0|||
127804347|NCT02211261|459905847|FG005|Overall Study|Other|1|||
127732203|NCT02660034|459644573|FG000|Overall Study|Progressive Disease (Clinical)|7|||
127732204|NCT02660034|459644574|FG001|Overall Study|Progressive Disease (Clinical)|8|||
127732205|NCT02660034|459644575|FG002|Overall Study|Progressive Disease (Clinical)|3|||
127732206|NCT02660034|459644576|FG003|Overall Study|Progressive Disease (Clinical)|9|||
127732207|NCT02660034|459644577|FG004|Overall Study|Progressive Disease (Clinical)|3|||
127732208|NCT02660034|459644578|FG005|Overall Study|Progressive Disease (Clinical)|0|||
127732209|NCT02660034|459644579|FG006|Overall Study|Progressive Disease (Clinical)|0|||
127732210|NCT02660034|459644580|FG007|Overall Study|Progressive Disease (Clinical)|0|||
127732211|NCT02660034|459644581|FG008|Overall Study|Progressive Disease (Clinical)|0|||
127732212|NCT02660034|459644582|FG009|Overall Study|Progressive Disease (Clinical)|0|||
127732213|NCT02660034|459644583|FG010|Overall Study|Progressive Disease (Clinical)|0|||
127732214|NCT02660034|459644584|FG011|Overall Study|Progressive Disease (Clinical)|0|||
127732215|NCT02660034|459644585|FG012|Overall Study|Progressive Disease (Clinical)|0|||
127804348|NCT02211261|459905848|FG006|Overall Study|Other|0|||
127804349|NCT02211261|459905849|FG007|Overall Study|Other|0|||
127804350|NCT02211261|459905850|FG008|Overall Study|Other|0|||
127804351|NCT02211261|459905851|FG009|Overall Study|Other|2|||
127804352|NCT02211261|459905852|FG010|Overall Study|Other|0|||
127804353|NCT02211261|459905842|FG000|Overall Study|Lost to Follow-up|0|||
127804354|NCT02211261|459905843|FG001|Overall Study|Lost to Follow-up|0|||
127804355|NCT02211261|459905844|FG002|Overall Study|Lost to Follow-up|0|||
127804356|NCT02211261|459905845|FG003|Overall Study|Lost to Follow-up|0|||
127804357|NCT02211261|459905846|FG004|Overall Study|Lost to Follow-up|0|||
127804358|NCT02211261|459905847|FG005|Overall Study|Lost to Follow-up|0|||
127804359|NCT02211261|459905848|FG006|Overall Study|Lost to Follow-up|0|||
127804360|NCT02211261|459905849|FG007|Overall Study|Lost to Follow-up|1|||
127804361|NCT02211261|459905850|FG008|Overall Study|Lost to Follow-up|0|||
127804362|NCT02211261|459905851|FG009|Overall Study|Lost to Follow-up|0|||
127804363|NCT02211261|459905852|FG010|Overall Study|Lost to Follow-up|0|||
127804364|NCT04897867|459905853|FG000|Overall Study|Withdrawal of Consent|1|||
127804365|NCT04897867|459905853|FG000|Overall Study|Pregnancy|1|||
127804366|NCT04897867|459905853|FG000|Overall Study|Lost to Follow-up|7|||
127804367|NCT04897867|459905853|FG000|Overall Study|Reason not Specified|2|||
127804368|NCT01078805|459905858|FG000|Overall Study|Clinically significant abnormal lab|5|||
127804369|NCT01078805|459905858|FG000|Overall Study|Death|134|||
127804370|NCT01078805|459905858|FG000|Overall Study|Lost to Follow-up|676|||
127804371|NCT01078805|459905858|FG000|Overall Study|Physician Decision|169|||
127804372|NCT01078805|459905858|FG000|Overall Study|Serious adverse event|26|||
127804373|NCT01078805|459905858|FG000|Overall Study|Sponsor decision|46|||
127804374|NCT01078805|459905858|FG000|Overall Study|Withdrawal by Subject|739|||
127804375|NCT01078805|459905858|FG000|Overall Study|Other|173|||
127804376|NCT01078805|459905858|FG000|Overall Study|Didn't take study drug|82|||
127804377|NCT02474329|459905859|FG000|Overall Study|Withdraw or did not contribute data.|13|||
127804378|NCT00865020|459905866|FG000|Overall Study|Withdrawal by Subject|22|||
127804379|NCT00865020|459905867|FG001|Overall Study|Withdrawal by Subject|16|||
127804380|NCT00865020|459905866|FG000|Overall Study|Adverse Event|9|||
127804381|NCT00865020|459905867|FG001|Overall Study|Adverse Event|14|||
127804382|NCT00865020|459905866|FG000|Overall Study|Abnormal test procedure result(s)|6|||
127804383|NCT00865020|459905867|FG001|Overall Study|Abnormal test procedure result(s)|8|||
127804384|NCT00865020|459905866|FG000|Overall Study|Lost to Follow-up|6|||
127804385|NCT00865020|459905867|FG001|Overall Study|Lost to Follow-up|4|||
127804386|NCT00865020|459905866|FG000|Overall Study|Protocol deviation|4|||
127804387|NCT00865020|459905867|FG001|Overall Study|Protocol deviation|1|||
127804388|NCT00865020|459905866|FG000|Overall Study|Administrative problems|0|||
127804389|NCT00865020|459905867|FG001|Overall Study|Administrative problems|2|||
127804390|NCT00865020|459905866|FG000|Overall Study|Abnormal laboratory value(s)|0|||
127804391|NCT00865020|459905867|FG001|Overall Study|Abnormal laboratory value(s)|1|||
127732216|NCT02660034|459644586|FG013|Overall Study|Progressive Disease (Clinical)|0|||
127732217|NCT02660034|459644573|FG000|Overall Study|Lost to Follow-up|0|||
127732218|NCT02660034|459644574|FG001|Overall Study|Lost to Follow-up|0|||
127804392|NCT00865020|459905866|FG000|Overall Study|Death|0|||
127804393|NCT00865020|459905867|FG001|Overall Study|Death|1|||
127804394|NCT00865020|459905866|FG000|Overall Study|Randomized but discontinued|2|||
127804395|NCT00865020|459905867|FG001|Overall Study|Randomized but discontinued|4|||
127804396|NCT03641560|459905868|FG000|Overall Study|Withdrawal by Subject|6|||
127804397|NCT03641560|459905868|FG000|Overall Study|Progressive disease|40|||
127804398|NCT03641560|459905868|FG000|Overall Study|Death|6|||
127804399|NCT05900115|459907500|FG000|Overall Study|Lost to Follow-up|129|||
127804400|NCT05900115|459907501|FG001|Overall Study|Lost to Follow-up|98|||
127804401|NCT00619502|459907502|FG000|Overall Study|Lost to Follow-up|8|||
127804402|NCT00619502|459907503|FG001|Overall Study|Lost to Follow-up|10|||
127732219|NCT02660034|459644575|FG002|Overall Study|Lost to Follow-up|1|||
127732220|NCT02660034|459644576|FG003|Overall Study|Lost to Follow-up|1|||
127732221|NCT02660034|459644577|FG004|Overall Study|Lost to Follow-up|0|||
127732222|NCT02660034|459644578|FG005|Overall Study|Lost to Follow-up|0|||
127732223|NCT02660034|459644579|FG006|Overall Study|Lost to Follow-up|0|||
127732224|NCT02660034|459644580|FG007|Overall Study|Lost to Follow-up|0|||
127732225|NCT02660034|459644581|FG008|Overall Study|Lost to Follow-up|0|||
127732226|NCT02660034|459644582|FG009|Overall Study|Lost to Follow-up|1|||
127732227|NCT02660034|459644583|FG010|Overall Study|Lost to Follow-up|1|||
127732228|NCT02660034|459644584|FG011|Overall Study|Lost to Follow-up|1|||
127732229|NCT02660034|459644585|FG012|Overall Study|Lost to Follow-up|0|||
127732230|NCT02660034|459644586|FG013|Overall Study|Lost to Follow-up|0|||
127732231|NCT02660034|459644573|FG000|Overall Study|Participant moved into special access scheme|1|||
127732232|NCT02660034|459644574|FG001|Overall Study|Participant moved into special access scheme|2|||
127732233|NCT02660034|459644575|FG002|Overall Study|Participant moved into special access scheme|0|||
127732234|NCT02660034|459644576|FG003|Overall Study|Participant moved into special access scheme|0|||
127732235|NCT02660034|459644577|FG004|Overall Study|Participant moved into special access scheme|0|||
127732236|NCT02660034|459644578|FG005|Overall Study|Participant moved into special access scheme|0|||
127732237|NCT02660034|459644579|FG006|Overall Study|Participant moved into special access scheme|0|||
127732238|NCT02660034|459644580|FG007|Overall Study|Participant moved into special access scheme|0|||
127732239|NCT02660034|459644581|FG008|Overall Study|Participant moved into special access scheme|0|||
127732240|NCT02660034|459644582|FG009|Overall Study|Participant moved into special access scheme|0|||
127732241|NCT02660034|459644583|FG010|Overall Study|Participant moved into special access scheme|0|||
127890461|NCT01405820|460222332|FG002|Randomized Treatment Period|Adverse Event|3|||
127890462|NCT01405820|460222333|FG003|Randomized Treatment Period|Adverse Event|0|||
127890463|NCT01405820|460222334|FG004|Randomized Treatment Period|Adverse Event|2|||
127890464|NCT01405820|460222335|FG005|Randomized Treatment Period|Adverse Event|1|||
127890465|NCT01405820|460222330|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
127890466|NCT01405820|460222331|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
127890467|NCT01405820|460222332|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
127890468|NCT01405820|460222333|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
127890469|NCT01405820|460222334|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
127890470|NCT01405820|460222335|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
127890471|NCT01405820|460222330|FG000|Randomized Treatment Period|Other|2|||
127890472|NCT01405820|460222331|FG001|Randomized Treatment Period|Other|2|||
127732242|NCT02660034|459644584|FG011|Overall Study|Participant moved into special access scheme|0|||
127804403|NCT00771472|459907504|FG000|Overall Study|Physician Decision|2|||
127732243|NCT02660034|459644585|FG012|Overall Study|Participant moved into special access scheme|0|||
127732244|NCT02660034|459644586|FG013|Overall Study|Participant moved into special access scheme|0|||
127732245|NCT02660034|459644573|FG000|Overall Study|Adverse Event|1|||
127732246|NCT02660034|459644574|FG001|Overall Study|Adverse Event|0|||
127732247|NCT02660034|459644575|FG002|Overall Study|Adverse Event|0|||
127732248|NCT02660034|459644576|FG003|Overall Study|Adverse Event|0|||
127732249|NCT02660034|459644577|FG004|Overall Study|Adverse Event|0|||
127732250|NCT02660034|459644578|FG005|Overall Study|Adverse Event|0|||
127732251|NCT02660034|459644579|FG006|Overall Study|Adverse Event|0|||
127732252|NCT02660034|459644580|FG007|Overall Study|Adverse Event|0|||
127732253|NCT02660034|459644581|FG008|Overall Study|Adverse Event|0|||
127732254|NCT02660034|459644582|FG009|Overall Study|Adverse Event|0|||
127732255|NCT02660034|459644583|FG010|Overall Study|Adverse Event|0|||
127732256|NCT02660034|459644584|FG011|Overall Study|Adverse Event|0|||
127732257|NCT02660034|459644585|FG012|Overall Study|Adverse Event|0|||
127732258|NCT02660034|459644586|FG013|Overall Study|Adverse Event|0|||
127732259|NCT02660034|459644573|FG000|Overall Study|Sponsor Decision|0|||
127732260|NCT02660034|459644574|FG001|Overall Study|Sponsor Decision|1|||
127732261|NCT02660034|459644575|FG002|Overall Study|Sponsor Decision|2|||
127732262|NCT02660034|459644576|FG003|Overall Study|Sponsor Decision|2|||
127732263|NCT02660034|459644577|FG004|Overall Study|Sponsor Decision|3|||
127732264|NCT02660034|459644578|FG005|Overall Study|Sponsor Decision|0|||
127732265|NCT02660034|459644579|FG006|Overall Study|Sponsor Decision|0|||
127732266|NCT02660034|459644580|FG007|Overall Study|Sponsor Decision|0|||
127732267|NCT02660034|459644581|FG008|Overall Study|Sponsor Decision|0|||
127732268|NCT02660034|459644582|FG009|Overall Study|Sponsor Decision|0|||
127732269|NCT02660034|459644583|FG010|Overall Study|Sponsor Decision|0|||
127732270|NCT02660034|459644584|FG011|Overall Study|Sponsor Decision|0|||
127732271|NCT02660034|459644585|FG012|Overall Study|Sponsor Decision|0|||
127732272|NCT02660034|459644586|FG013|Overall Study|Sponsor Decision|1|||
127732273|NCT02660034|459644573|FG000|Overall Study|Withdrawal by Subject|0|||
127732274|NCT02660034|459644574|FG001|Overall Study|Withdrawal by Subject|0|||
127732275|NCT02660034|459644575|FG002|Overall Study|Withdrawal by Subject|0|||
127732276|NCT02660034|459644576|FG003|Overall Study|Withdrawal by Subject|0|||
127732277|NCT02660034|459644577|FG004|Overall Study|Withdrawal by Subject|0|||
127732278|NCT02660034|459644578|FG005|Overall Study|Withdrawal by Subject|0|||
127732279|NCT02660034|459644579|FG006|Overall Study|Withdrawal by Subject|1|||
127732280|NCT02660034|459644580|FG007|Overall Study|Withdrawal by Subject|1|||
127732281|NCT02660034|459644581|FG008|Overall Study|Withdrawal by Subject|1|||
127732282|NCT02660034|459644582|FG009|Overall Study|Withdrawal by Subject|0|||
127732283|NCT02660034|459644583|FG010|Overall Study|Withdrawal by Subject|0|||
127732284|NCT02660034|459644584|FG011|Overall Study|Withdrawal by Subject|1|||
127732285|NCT02660034|459644585|FG012|Overall Study|Withdrawal by Subject|2|||
127732286|NCT02660034|459644586|FG013|Overall Study|Withdrawal by Subject|0|||
127732287|NCT02660034|459644573|FG000|Overall Study|Death|0|||
127804404|NCT00771472|459907505|FG001|Overall Study|Physician Decision|3|||
127804405|NCT00771472|459907504|FG000|Overall Study|Progressive Disease|3|||
127804406|NCT00771472|459907505|FG001|Overall Study|Progressive Disease|1|||
127804407|NCT00771472|459907504|FG000|Overall Study|Protocol Violation|1|||
127804408|NCT00771472|459907505|FG001|Overall Study|Protocol Violation|0|||
127804409|NCT00880750|459907508|FG000|First Intervention|Adverse Event|1|||
127804410|NCT00880750|459907509|FG001|First Intervention|Adverse Event|0|||
127804411|NCT00880750|459907508|FG000|First Intervention|Unable to collect urine|4|||
127804412|NCT00880750|459907509|FG001|First Intervention|Unable to collect urine|0|||
127804413|NCT00880750|459907508|FG000|First Intervention|Non-compliance with meals|0|||
127804414|NCT00880750|459907509|FG001|First Intervention|Non-compliance with meals|1|||
127732288|NCT02660034|459644574|FG001|Overall Study|Death|0|||
127732289|NCT02660034|459644575|FG002|Overall Study|Death|0|||
127732290|NCT02660034|459644576|FG003|Overall Study|Death|0|||
127732291|NCT02660034|459644577|FG004|Overall Study|Death|0|||
127804415|NCT00880750|459907508|FG000|First Intervention|Withdrawal by Subject|2|||
127804416|NCT00880750|459907509|FG001|First Intervention|Withdrawal by Subject|0|||
127732292|NCT02660034|459644578|FG005|Overall Study|Death|13|||
127732293|NCT02660034|459644579|FG006|Overall Study|Death|14|||
127732294|NCT02660034|459644580|FG007|Overall Study|Death|10|||
127732295|NCT02660034|459644581|FG008|Overall Study|Death|9|||
127732296|NCT02660034|459644582|FG009|Overall Study|Death|21|||
127732297|NCT02660034|459644583|FG010|Overall Study|Death|17|||
127732298|NCT02660034|459644584|FG011|Overall Study|Death|15|||
127732299|NCT02660034|459644585|FG012|Overall Study|Death|18|||
127732300|NCT02660034|459644586|FG013|Overall Study|Death|7|||
127732301|NCT02660034|459644573|FG000|Overall Study|Physician Decision|0|||
127732302|NCT02660034|459644574|FG001|Overall Study|Physician Decision|0|||
127732303|NCT02660034|459644575|FG002|Overall Study|Physician Decision|0|||
127804417|NCT00880750|459907508|FG000|First Intervention|Lost to Follow-up|2|||
127732304|NCT02660034|459644576|FG003|Overall Study|Physician Decision|0|||
127732305|NCT02660034|459644577|FG004|Overall Study|Physician Decision|0|||
127732306|NCT02660034|459644578|FG005|Overall Study|Physician Decision|0|||
127732307|NCT02660034|459644579|FG006|Overall Study|Physician Decision|0|||
127732308|NCT02660034|459644580|FG007|Overall Study|Physician Decision|0|||
127732309|NCT02660034|459644581|FG008|Overall Study|Physician Decision|0|||
127732310|NCT02660034|459644582|FG009|Overall Study|Physician Decision|0|||
127732311|NCT02660034|459644583|FG010|Overall Study|Physician Decision|0|||
127732312|NCT02660034|459644584|FG011|Overall Study|Physician Decision|0|||
127732313|NCT02660034|459644585|FG012|Overall Study|Physician Decision|0|||
127732314|NCT02660034|459644586|FG013|Overall Study|Physician Decision|1|||
127732315|NCT02660034|459644573|FG000|Overall Study|Participants transferred to LTE|0|||
127732316|NCT02660034|459644574|FG001|Overall Study|Participants transferred to LTE|0|||
127732317|NCT02660034|459644575|FG002|Overall Study|Participants transferred to LTE|0|||
127732318|NCT02660034|459644576|FG003|Overall Study|Participants transferred to LTE|0|||
127732319|NCT02660034|459644577|FG004|Overall Study|Participants transferred to LTE|0|||
127732320|NCT02660034|459644578|FG005|Overall Study|Participants transferred to LTE|10|||
127732321|NCT02660034|459644579|FG006|Overall Study|Participants transferred to LTE|8|||
127732322|NCT02660034|459644580|FG007|Overall Study|Participants transferred to LTE|8|||
127732323|NCT02660034|459644581|FG008|Overall Study|Participants transferred to LTE|10|||
127732324|NCT02660034|459644582|FG009|Overall Study|Participants transferred to LTE|1|||
127732325|NCT02660034|459644583|FG010|Overall Study|Participants transferred to LTE|2|||
127732326|NCT02660034|459644584|FG011|Overall Study|Participants transferred to LTE|4|||
127732327|NCT02660034|459644585|FG012|Overall Study|Participants transferred to LTE|1|||
127732328|NCT02660034|459644586|FG013|Overall Study|Participants transferred to LTE|1|||
127732329|NCT01838447|459644587|FG000|Overall Study|Change in surgical plan|1|||
127732330|NCT01838447|459644588|FG001|Overall Study|Change in surgical plan|2|||
127732331|NCT01838447|459644587|FG000|Overall Study|Withdrawal by Subject|1|||
127732332|NCT01838447|459644588|FG001|Overall Study|Withdrawal by Subject|1|||
127732333|NCT01533181|459644591|FG000|Overall Study|Disease progression pre-active treatment|0|||
127732334|NCT01533181|459644592|FG001|Overall Study|Disease progression pre-active treatment|1|||
127732335|NCT01533181|459644591|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
127732336|NCT01533181|459644592|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
127732337|NCT01837719|459644595|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
127732338|NCT01837719|459644595|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
127732339|NCT01703988|459644596|FG000|Overall Study|Investigator Judgment|0|||
127732340|NCT01703988|459644597|FG001|Overall Study|Investigator Judgment|0|||
127732341|NCT01703988|459644598|FG002|Overall Study|Investigator Judgment|0|||
127732342|NCT01703988|459644599|FG003|Overall Study|Investigator Judgment|1|||
127732343|NCT06247488|459644600|FG000|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|1|||
127732344|NCT06247488|459644601|FG001|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
127732345|NCT06247488|459644602|FG002|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
127732346|NCT06247488|459644603|FG003|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
127732347|NCT06247488|459644604|FG004|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
127732348|NCT06247488|459644605|FG005|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
127732349|NCT06247488|459644600|FG000|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
127732350|NCT06247488|459644601|FG001|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
127732351|NCT06247488|459644602|FG002|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
127732352|NCT06247488|459644603|FG003|Washout From 2nd Dose (3 Days)|Physician Decision|1|||
127732353|NCT06247488|459644604|FG004|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
127732354|NCT06247488|459644605|FG005|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
127732355|NCT06247488|459644600|FG000|Washout of Third Dose (3 Days)|Withdrawal by Subject|1|||
127732356|NCT06247488|459644601|FG001|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
127732357|NCT06247488|459644602|FG002|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
127732358|NCT06247488|459644603|FG003|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
127732359|NCT06247488|459644604|FG004|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
127732360|NCT06247488|459644605|FG005|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
127732361|NCT06247488|459644600|FG000|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
127732362|NCT06247488|459644601|FG001|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
127732363|NCT06247488|459644602|FG002|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
127732364|NCT06247488|459644603|FG003|Washout of Fourth Dose (3 Days)|Physician Decision|1|||
127732365|NCT06247488|459644604|FG004|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
127732366|NCT06247488|459644605|FG005|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
127732367|NCT06247488|459644600|FG000|Washout of 5th Dose (3 Days)|Pregnancy|0|||
127732368|NCT06247488|459644601|FG001|Washout of 5th Dose (3 Days)|Pregnancy|0|||
127732369|NCT06247488|459644602|FG002|Washout of 5th Dose (3 Days)|Pregnancy|0|||
127732370|NCT06247488|459644603|FG003|Washout of 5th Dose (3 Days)|Pregnancy|0|||
127732371|NCT06247488|459644604|FG004|Washout of 5th Dose (3 Days)|Pregnancy|0|||
127732372|NCT06247488|459644605|FG005|Washout of 5th Dose (3 Days)|Pregnancy|1|||
127732373|NCT06247488|459644600|FG000|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
127732374|NCT06247488|459644601|FG001|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
127732375|NCT06247488|459644602|FG002|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
127732376|NCT06247488|459644603|FG003|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
127732377|NCT06247488|459644604|FG004|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
127732378|NCT06247488|459644605|FG005|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
127732379|NCT06247488|459644600|FG000|Washout of 5th Dose (3 Days)|Adverse Event|0|||
127732380|NCT06247488|459644601|FG001|Washout of 5th Dose (3 Days)|Adverse Event|0|||
127732381|NCT06247488|459644602|FG002|Washout of 5th Dose (3 Days)|Adverse Event|0|||
127732382|NCT06247488|459644603|FG003|Washout of 5th Dose (3 Days)|Adverse Event|0|||
127732383|NCT06247488|459644604|FG004|Washout of 5th Dose (3 Days)|Adverse Event|0|||
127732384|NCT06247488|459644605|FG005|Washout of 5th Dose (3 Days)|Adverse Event|1|||
127732385|NCT02995733|459644606|FG000|Overall Study|Study site closed|9|||
127732386|NCT02995733|459644607|FG001|Overall Study|Study site closed|10|||
127732387|NCT02995733|459644606|FG000|Overall Study|Death|3|||
127732388|NCT02995733|459644607|FG001|Overall Study|Death|4|||
127732389|NCT02995733|459644606|FG000|Overall Study|Withdrawal by Subject|6|||
127732390|NCT02995733|459644607|FG001|Overall Study|Withdrawal by Subject|2|||
127732391|NCT02995733|459644606|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
127732392|NCT02995733|459644607|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
127732393|NCT02995733|459644606|FG000|Overall Study|Lost to Follow-up|48|||
127732394|NCT02995733|459644607|FG001|Overall Study|Lost to Follow-up|37|||
127732395|NCT02995733|459644606|FG000|Overall Study|Other|0|||
127732396|NCT02995733|459644607|FG001|Overall Study|Other|1|||
127732397|NCT03785210|459644610|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
127732398|NCT03785210|459644611|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
127732399|NCT02720198|459644615|FG000|Overall Study|Withdrawal by Subject|0|||
127732400|NCT02720198|459644616|FG001|Overall Study|Withdrawal by Subject|1|||
127732401|NCT04879823|459644617|FG000|Overall Study|Physician Decision|3|||
127732402|NCT04879823|459644618|FG001|Overall Study|Physician Decision|1|||
127732403|NCT04879823|459644617|FG000|Overall Study|Protocol Violation|2|||
127732404|NCT04879823|459644618|FG001|Overall Study|Protocol Violation|3|||
127732405|NCT04879823|459644617|FG000|Overall Study|Lost to Follow-up|43|||
127732406|NCT04879823|459644618|FG001|Overall Study|Lost to Follow-up|35|||
127732407|NCT02465866|459644621|FG000|Period 3|Withdrawal by Subject|0|||
127732408|NCT02465866|459644622|FG001|Period 3|Withdrawal by Subject|1|||
127804418|NCT00880750|459907509|FG001|First Intervention|Lost to Follow-up|0|||
127804419|NCT00880750|459907508|FG000|Second Intervention|Withdrawal by Subject|2|||
127804420|NCT00880750|459907509|FG001|Second Intervention|Withdrawal by Subject|2|||
127804421|NCT00880750|459907508|FG000|Second Intervention|Protocol Violation|1|||
127804422|NCT00880750|459907509|FG001|Second Intervention|Protocol Violation|0|||
127804423|NCT00880750|459907508|FG000|Second Intervention|Unable to collect urine|1|||
127804424|NCT00880750|459907509|FG001|Second Intervention|Unable to collect urine|0|||
127804425|NCT00483327|459907510|FG000|Overall Study|Adverse Event|1|||
127804426|NCT00483327|459907510|FG000|Overall Study|Withdrawal by Subject|3|||
127804427|NCT00483327|459907510|FG000|Overall Study|Lost to Follow-up|4|||
127804428|NCT00483327|459907510|FG000|Overall Study|Patient Non Compliance|2|||
127804429|NCT00670007|459907511|FG000|Overall Study|Drug abuse|1|||
127732409|NCT02465866|459644623|FG002|Period 3|Withdrawal by Subject|0|||
127804430|NCT00670007|459907511|FG000|Overall Study|Lung transplant|1|||
127732410|NCT02465866|459644624|FG003|Period 3|Withdrawal by Subject|0|||
127732411|NCT00203502|459644625|FG000|Overall Study|Death|1|||
127732412|NCT01469819|459644626|FG000|Overall Study|Withdrawal by Subject|1|||
127732413|NCT01469819|459644626|FG000|Overall Study|Did not meet inclusionary criteria|2|||
127732414|NCT01469819|459644626|FG000|Overall Study|Could not swallow SmartPill|2|||
127732415|NCT01469819|459644626|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
127732416|NCT01403805|459644627|FG000|Overall Study|Withdrawal by Subject|0|||
127732417|NCT01403805|459644628|FG001|Overall Study|Withdrawal by Subject|4|||
127732418|NCT01403805|459644627|FG000|Overall Study|Lost to Follow-up|0|||
127732419|NCT01403805|459644628|FG001|Overall Study|Lost to Follow-up|2|||
127732420|NCT01403805|459644627|FG000|Overall Study|Death|0|||
127732421|NCT01403805|459644628|FG001|Overall Study|Death|1|||
127890473|NCT01405820|460222332|FG002|Randomized Treatment Period|Other|1|||
127890474|NCT01405820|460222333|FG003|Randomized Treatment Period|Other|1|||
127890475|NCT01405820|460222334|FG004|Randomized Treatment Period|Other|0|||
127890476|NCT01405820|460222335|FG005|Randomized Treatment Period|Other|0|||
127890477|NCT01405820|460222330|FG000|Randomized Treatment Period|Physician Decision|0|||
127890478|NCT01405820|460222331|FG001|Randomized Treatment Period|Physician Decision|2|||
127890479|NCT01405820|460222332|FG002|Randomized Treatment Period|Physician Decision|1|||
127890480|NCT01405820|460222333|FG003|Randomized Treatment Period|Physician Decision|0|||
127890481|NCT01405820|460222334|FG004|Randomized Treatment Period|Physician Decision|0|||
127890482|NCT01405820|460222335|FG005|Randomized Treatment Period|Physician Decision|0|||
127890483|NCT01405820|460222330|FG000|Randomized Treatment Period|Rescue|0|||
127890484|NCT01405820|460222331|FG001|Randomized Treatment Period|Rescue|1|||
127890485|NCT01405820|460222332|FG002|Randomized Treatment Period|Rescue|13|||
127890486|NCT01405820|460222333|FG003|Randomized Treatment Period|Rescue|10|||
127890487|NCT01405820|460222334|FG004|Randomized Treatment Period|Rescue|8|||
127890488|NCT01405820|460222335|FG005|Randomized Treatment Period|Rescue|8|||
127890489|NCT01405820|460222330|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
127890490|NCT01405820|460222331|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
127890491|NCT01405820|460222332|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
127890492|NCT01405820|460222333|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
127890493|NCT01405820|460222334|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
127890494|NCT01405820|460222335|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
127890495|NCT01405820|460222330|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
127890496|NCT01405820|460222331|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
127890497|NCT01405820|460222332|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
127890498|NCT01405820|460222333|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
127890499|NCT01405820|460222334|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
127890500|NCT01405820|460222335|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
127890501|NCT01405820|460222330|FG000|Randomized Treatment Period|Death|0|||
127890502|NCT01405820|460222331|FG001|Randomized Treatment Period|Death|0|||
127890503|NCT01405820|460222332|FG002|Randomized Treatment Period|Death|0|||
127890504|NCT01405820|460222333|FG003|Randomized Treatment Period|Death|1|||
127890505|NCT01405820|460222334|FG004|Randomized Treatment Period|Death|0|||
127890506|NCT01405820|460222335|FG005|Randomized Treatment Period|Death|0|||
127890507|NCT01405820|460222330|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
127890508|NCT01405820|460222331|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
127890509|NCT01405820|460222332|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
127890510|NCT01405820|460222333|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
127890511|NCT01405820|460222334|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
127890512|NCT01405820|460222335|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
127890513|NCT01405820|460222330|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
127890514|NCT01405820|460222331|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
127890515|NCT01405820|460222332|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
127732422|NCT04057937|459644629|FG000|Placebo-controlled Phase|Adverse Event|3|||
127732423|NCT04057937|459644630|FG001|Placebo-controlled Phase|Adverse Event|0|||
127890516|NCT01405820|460222333|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
127890517|NCT01405820|460222334|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
127890518|NCT01405820|460222335|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
127890519|NCT01405820|460222330|FG000|Open-Label Treatment Period|Other|1|||
127890520|NCT01405820|460222331|FG001|Open-Label Treatment Period|Other|1|||
127890521|NCT01405820|460222332|FG002|Open-Label Treatment Period|Other|1|||
127890522|NCT01405820|460222333|FG003|Open-Label Treatment Period|Other|1|||
127890523|NCT01405820|460222334|FG004|Open-Label Treatment Period|Other|1|||
127890524|NCT01405820|460222335|FG005|Open-Label Treatment Period|Other|1|||
127890525|NCT01405820|460222330|FG000|Open-Label Treatment Period|Physician Decision|0|||
127890526|NCT01405820|460222331|FG001|Open-Label Treatment Period|Physician Decision|0|||
127890527|NCT01405820|460222332|FG002|Open-Label Treatment Period|Physician Decision|1|||
127890528|NCT01405820|460222333|FG003|Open-Label Treatment Period|Physician Decision|2|||
127890529|NCT01405820|460222334|FG004|Open-Label Treatment Period|Physician Decision|1|||
127890530|NCT01405820|460222335|FG005|Open-Label Treatment Period|Physician Decision|0|||
127890531|NCT01405820|460222330|FG000|Open-Label Treatment Period|Adverse Event|0|||
127890532|NCT01405820|460222331|FG001|Open-Label Treatment Period|Adverse Event|0|||
127890533|NCT01405820|460222332|FG002|Open-Label Treatment Period|Adverse Event|0|||
127890534|NCT01405820|460222333|FG003|Open-Label Treatment Period|Adverse Event|1|||
127890535|NCT01405820|460222334|FG004|Open-Label Treatment Period|Adverse Event|0|||
127890536|NCT01405820|460222335|FG005|Open-Label Treatment Period|Adverse Event|0|||
127890537|NCT03263819|460222342|FG000|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|1|||
127890538|NCT03263819|460222343|FG001|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|0|||
127890539|NCT02280356|460222348|FG000|Overall Study|Not Treated|2|||
127890540|NCT02280356|460222348|FG000|Overall Study|Withdrawal by Subject|1|||
127890541|NCT02280356|460222348|FG000|Overall Study|Not evaluable|2|||
127890542|NCT01086215|460222352|FG000|Overall Study|Death|14|||
127804431|NCT00670007|459907511|FG000|Overall Study|Travel/Vacation|1|||
127804432|NCT00670007|459907511|FG000|Overall Study|Adverse event, serious fatal|1|||
127804433|NCT00670007|459907511|FG000|Overall Study|Adverse Event|1|||
127804434|NCT00670007|459907511|FG000|Overall Study|Withdrawal by Subject|4|||
127804435|NCT00618722|459907512|FG000|Overall Study|Refusal of Treatment|0|||
127804436|NCT00618722|459907513|FG001|Overall Study|Refusal of Treatment|0|||
127804437|NCT00618722|459907514|FG002|Overall Study|Refusal of Treatment|1|||
127804438|NCT00618722|459907515|FG003|Overall Study|Refusal of Treatment|0|||
127804439|NCT00618722|459907512|FG000|Overall Study|Patient Request|1|||
127804440|NCT00618722|459907513|FG001|Overall Study|Patient Request|1|||
127804441|NCT00618722|459907514|FG002|Overall Study|Patient Request|1|||
127804442|NCT00618722|459907515|FG003|Overall Study|Patient Request|1|||
127804443|NCT00618722|459907512|FG000|Overall Study|Inability to Complete Study Procedure|0|||
127804444|NCT00618722|459907513|FG001|Overall Study|Inability to Complete Study Procedure|1|||
127804445|NCT00618722|459907514|FG002|Overall Study|Inability to Complete Study Procedure|0|||
127804446|NCT00618722|459907515|FG003|Overall Study|Inability to Complete Study Procedure|0|||
127804447|NCT00618722|459907512|FG000|Overall Study|Lost to Follow-up|2|||
127804448|NCT00618722|459907513|FG001|Overall Study|Lost to Follow-up|0|||
127804449|NCT00618722|459907514|FG002|Overall Study|Lost to Follow-up|0|||
127804450|NCT00618722|459907515|FG003|Overall Study|Lost to Follow-up|2|||
127804451|NCT00618722|459907512|FG000|Overall Study|Miscellaneous Reasons|0|||
127804452|NCT00618722|459907513|FG001|Overall Study|Miscellaneous Reasons|0|||
127804453|NCT00618722|459907514|FG002|Overall Study|Miscellaneous Reasons|1|||
127804454|NCT00618722|459907515|FG003|Overall Study|Miscellaneous Reasons|1|||
127804455|NCT00200057|459907518|FG000|Overall Study|Lack of Efficacy|3|||
127804456|NCT00200057|459907518|FG000|Overall Study|Exited due to terminal illness of PI|2|||
127804457|NCT00200057|459907518|FG000|Overall Study|Withdrawal by Subject|1|||
127804458|NCT00200057|459907518|FG000|Overall Study|Change in medical condition|1|||
127804459|NCT00200057|459907518|FG000|Overall Study|Infection|1|||
127804460|NCT00200057|459907518|FG000|Overall Study|Death|1|||
127804461|NCT01891643|459907519|FG000|Overall Study|Adverse event unrelated to study drug|2|||
127804462|NCT01891643|459907520|FG001|Overall Study|Adverse event unrelated to study drug|5|||
127804463|NCT01891643|459907519|FG000|Overall Study|Disease Progression|4|||
127804464|NCT01891643|459907520|FG001|Overall Study|Disease Progression|3|||
127804465|NCT01891643|459907519|FG000|Overall Study|Study Drug Toxicity|3|||
127804466|NCT01891643|459907520|FG001|Overall Study|Study Drug Toxicity|0|||
127804467|NCT01891643|459907519|FG000|Overall Study|Maximum Clinical Benefit|0|||
127804468|NCT01891643|459907520|FG001|Overall Study|Maximum Clinical Benefit|1|||
127804469|NCT01891643|459907519|FG000|Overall Study|Poor/Non-compliance|0|||
127804470|NCT01891643|459907520|FG001|Overall Study|Poor/Non-compliance|1|||
127804471|NCT01891643|459907519|FG000|Overall Study|Participant request to discontinue|1|||
127804472|NCT01891643|459907520|FG001|Overall Study|Participant request to discontinue|0|||
127804473|NCT02965716|459907521|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
127804474|NCT02965716|459907522|FG001|Overall Study|Refusal Unrelated to Adverse Event|5|||
127804475|NCT02965716|459907521|FG000|Overall Study|Progression/Relapse|8|||
127804476|NCT02965716|459907522|FG001|Overall Study|Progression/Relapse|16|||
127804477|NCT02965716|459907521|FG000|Overall Study|Death|1|||
127804478|NCT02965716|459907522|FG001|Overall Study|Death|0|||
127804479|NCT02965716|459907521|FG000|Overall Study|Not Protocol Specified|1|||
127804480|NCT02965716|459907522|FG001|Overall Study|Not Protocol Specified|3|||
127804481|NCT02613208|459907524|FG000|Overall Study|Withdrawal by Subject|1|||
127804482|NCT02613208|459907524|FG000|Overall Study|Change of address|2|||
127804483|NCT02613208|459907524|FG000|Overall Study|Physician Decision|2|||
127804484|NCT02613208|459907524|FG000|Overall Study|Lost to Follow-up|5|||
127732424|NCT04057937|459644629|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
127732425|NCT04057937|459644630|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
127732426|NCT04057937|459644629|FG000|Active-treatment Phase|Pregnancy|0|||
127732427|NCT04057937|459644630|FG001|Active-treatment Phase|Pregnancy|1|||
127732428|NCT04057937|459644629|FG000|Active-treatment Phase|Physician Decision|0|||
127732429|NCT04057937|459644630|FG001|Active-treatment Phase|Physician Decision|1|||
127732430|NCT00428441|459644631|FG000|Overall Study|Lost to Follow-up|1|||
127732431|NCT00510783|459644633|FG000|Overall Study|Lost to Follow-up|29|||
127732432|NCT00510783|459644634|FG001|Overall Study|Lost to Follow-up|25|||
127804485|NCT02613208|459907524|FG000|Overall Study|Death|37|||
127804486|NCT02663895|459907525|FG000|Overall Study|Adverse Event|3|||
127804487|NCT02663895|459907525|FG000|Overall Study|Physician Decision|2|||
127485448|NCT01240863|458741183|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
127732433|NCT00510783|459644633|FG000|Overall Study|Withdrawal by Subject|2|||
127804488|NCT02663895|459907525|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
127804489|NCT02663895|459907525|FG000|Overall Study|Withdrawal by Subject|1|||
127732434|NCT00510783|459644634|FG001|Overall Study|Withdrawal by Subject|3|||
127732435|NCT00510783|459644633|FG000|Overall Study|Protocol Violation|0|||
127732436|NCT00510783|459644634|FG001|Overall Study|Protocol Violation|1|||
127732437|NCT00422162|459644641|FG000|Overall Study|Adverse Event|11|||
127732438|NCT00422162|459644642|FG001|Overall Study|Adverse Event|9|||
127732439|NCT00422162|459644641|FG000|Overall Study|Lack of Efficacy|4|||
127732440|NCT00422162|459644642|FG001|Overall Study|Lack of Efficacy|10|||
127732441|NCT00422162|459644641|FG000|Overall Study|Withdrawal by Subject|7|||
127732442|NCT00422162|459644642|FG001|Overall Study|Withdrawal by Subject|6|||
127732443|NCT00422162|459644641|FG000|Overall Study|Lost to Follow-up|1|||
127732444|NCT00422162|459644642|FG001|Overall Study|Lost to Follow-up|2|||
127732445|NCT00422162|459644641|FG000|Overall Study|Non-Compliant with Protocol|1|||
127732446|NCT00422162|459644642|FG001|Overall Study|Non-Compliant with Protocol|1|||
127732447|NCT00422162|459644641|FG000|Overall Study|Other|0|||
127732448|NCT00422162|459644642|FG001|Overall Study|Other|1|||
127732449|NCT00422162|459644641|FG000|Overall Study|Didn't Receive Treatment|0|||
127732450|NCT00422162|459644642|FG001|Overall Study|Didn't Receive Treatment|1|||
127732451|NCT03508830|459644643|FG000|Overall Study|Withdrawal by Subject|3|||
127485449|NCT01240863|458741181|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
127732452|NCT03508830|459644644|FG001|Overall Study|Withdrawal by Subject|4|||
127732453|NCT03508830|459644643|FG000|Overall Study|Physician Decision|2|||
127732454|NCT03508830|459644644|FG001|Overall Study|Physician Decision|2|||
127732455|NCT02522299|459644645|FG000|Overall Study|Adverse Event|2|||
127732456|NCT02522299|459644646|FG001|Overall Study|Adverse Event|0|||
127732457|NCT02522299|459644645|FG000|Overall Study|Physician Decision|0|||
127732458|NCT02522299|459644646|FG001|Overall Study|Physician Decision|1|||
127732459|NCT02522299|459644645|FG000|Overall Study|Withdrawal by Subject|2|||
127732460|NCT02522299|459644646|FG001|Overall Study|Withdrawal by Subject|0|||
127732461|NCT04908800|459644649|FG000|Overall Study|Adverse Event|0|||
127732462|NCT04908800|459644650|FG001|Overall Study|Adverse Event|0|||
127732463|NCT04908800|459644651|FG002|Overall Study|Adverse Event|0|||
127732464|NCT04908800|459644652|FG003|Overall Study|Adverse Event|0|||
127732465|NCT04908800|459644653|FG004|Overall Study|Adverse Event|0|||
127732466|NCT04908800|459644654|FG005|Overall Study|Adverse Event|0|||
127732467|NCT04908800|459644655|FG006|Overall Study|Adverse Event|0|||
127732468|NCT04908800|459644656|FG007|Overall Study|Adverse Event|0|||
127732469|NCT04908800|459644657|FG008|Overall Study|Adverse Event|0|||
127732470|NCT04908800|459644658|FG009|Overall Study|Adverse Event|0|||
127732471|NCT04908800|459644659|FG010|Overall Study|Adverse Event|1|||
127732472|NCT04908800|459644660|FG011|Overall Study|Adverse Event|0|||
127732473|NCT04908800|459644661|FG012|Overall Study|Adverse Event|0|||
127732474|NCT01348763|459644663|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
127732475|NCT01348763|459644663|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
127732476|NCT03045302|459644674|FG000|Overall Study|Pre-treatment adverse event|1|||
127732477|NCT05287178|459644675|FG000|Overall Study|Lost to Follow-up|2|||
127732478|NCT02038803|459644676|FG000|Overall Study|poor adherence of subjects to protocol and withdrawal from study.|4|||
127732479|NCT02038803|459644676|FG000|Overall Study|Lost to Follow-up|1|||
127732480|NCT01855399|459644677|FG000|6 Month|Lost to Follow-up|12|||
127732481|NCT01855399|459644678|FG001|6 Month|Lost to Follow-up|9|||
127732482|NCT01855399|459644677|FG000|6 Month|Withdrawal by Subject|8|||
127732483|NCT01855399|459644678|FG001|6 Month|Withdrawal by Subject|6|||
127732484|NCT01855399|459644677|FG000|12 Month|Lost to Follow-up|7|||
127732485|NCT01855399|459644678|FG001|12 Month|Lost to Follow-up|11|||
127732486|NCT03953079|459644679|FG000|Core Study|Withdrawal by Subject|1|||
127732487|NCT03953079|459644680|FG001|Core Study|Withdrawal by Subject|2|||
127732488|NCT03953079|459644681|FG002|Core Study|Withdrawal by Subject|1|||
127732489|NCT03953079|459644679|FG000|Core Study|COVID-19|0|||
127732490|NCT03953079|459644680|FG001|Core Study|COVID-19|1|||
127732491|NCT03953079|459644681|FG002|Core Study|COVID-19|0|||
127732492|NCT03953079|459644679|FG000|Core Study|Difficulties leaving the house|0|||
127732493|NCT03953079|459644680|FG001|Core Study|Difficulties leaving the house|1|||
127732494|NCT03953079|459644681|FG002|Core Study|Difficulties leaving the house|0|||
127732495|NCT03953079|459644679|FG000|Extension Study|Withdrawal by Subject|1|||
127732496|NCT03953079|459644680|FG001|Extension Study|Withdrawal by Subject|0|||
127732497|NCT03953079|459644681|FG002|Extension Study|Withdrawal by Subject|0|||
127732498|NCT03953079|459644679|FG000|Extension Study|Received Rescue Treatment|5|||
127732499|NCT03953079|459644680|FG001|Extension Study|Received Rescue Treatment|6|||
127804490|NCT01276821|459907526|FG000|Overall Study|Protocol Violation|0|||
127804491|NCT01276821|459907527|FG001|Overall Study|Protocol Violation|1|||
127804492|NCT00605267|459907528|FG000|Overall Study|Adverse Event|0|||
127804493|NCT00605267|459907529|FG001|Overall Study|Adverse Event|1|||
127804494|NCT00605267|459907528|FG000|Overall Study|Lack of Efficacy|1|||
127804495|NCT00605267|459907529|FG001|Overall Study|Lack of Efficacy|5|||
127804496|NCT00605267|459907528|FG000|Overall Study|Withdrawal by Subject|2|||
127804497|NCT00605267|459907529|FG001|Overall Study|Withdrawal by Subject|3|||
127804498|NCT02720757|459907530|FG000|Overall Study|Other reason|5|||
127804499|NCT02720757|459907530|FG000|Overall Study|Loss of contact|4|||
127804500|NCT02720757|459907530|FG000|Overall Study|Informed consent withdrawal|1|||
127804501|NCT02720757|459907530|FG000|Overall Study|Patients wish to withdraw|2|||
127804502|NCT02720757|459907530|FG000|Overall Study|Missing|3|||
127804503|NCT02720757|459907530|FG000|Overall Study|General exclusion|3|||
127804504|NCT00883493|459907531|FG000|Overall Study|Adverse Event|11|||
127804505|NCT00883493|459907532|FG001|Overall Study|Adverse Event|12|||
127804506|NCT00883493|459907531|FG000|Overall Study|Lack of Efficacy|4|||
127804507|NCT00883493|459907532|FG001|Overall Study|Lack of Efficacy|3|||
127804508|NCT00883493|459907531|FG000|Overall Study|Lost to Follow-up|7|||
127804509|NCT00883493|459907532|FG001|Overall Study|Lost to Follow-up|6|||
127804510|NCT00883493|459907531|FG000|Overall Study|Withdrawal by Subject|11|||
127804511|NCT00883493|459907532|FG001|Overall Study|Withdrawal by Subject|20|||
127804512|NCT00883493|459907531|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
127732500|NCT03953079|459644681|FG002|Extension Study|Received Rescue Treatment|5|||
127732501|NCT04394624|459644682|FG000|Overall Study|Adverse Event|6|||
127732502|NCT04394624|459644683|FG001|Overall Study|Adverse Event|0|||
127732503|NCT04394624|459644682|FG000|Overall Study|Progressive disease|24|||
127732504|NCT04394624|459644683|FG001|Overall Study|Progressive disease|0|||
127732505|NCT04394624|459644682|FG000|Overall Study|Not related to COVID-19|1|||
127732506|NCT04394624|459644683|FG001|Overall Study|Not related to COVID-19|0|||
127732507|NCT00141271|459644689|FG000|Overall Study|Adverse Event|31|||
127732508|NCT00141271|459644690|FG001|Overall Study|Adverse Event|19|||
127732509|NCT00141271|459644691|FG002|Overall Study|Adverse Event|17|||
127732510|NCT00141271|459644689|FG000|Overall Study|Laboratory Abnormality|2|||
127732511|NCT00141271|459644690|FG001|Overall Study|Laboratory Abnormality|1|||
127732512|NCT00141271|459644691|FG002|Overall Study|Laboratory Abnormality|1|||
127732513|NCT00141271|459644689|FG000|Overall Study|Lack of Efficacy|7|||
127732514|NCT00141271|459644690|FG001|Overall Study|Lack of Efficacy|7|||
127732515|NCT00141271|459644691|FG002|Overall Study|Lack of Efficacy|3|||
127732516|NCT00141271|459644689|FG000|Overall Study|Lost to Follow-up|15|||
127732517|NCT00141271|459644690|FG001|Overall Study|Lost to Follow-up|15|||
127732518|NCT00141271|459644691|FG002|Overall Study|Lost to Follow-up|21|||
127732519|NCT00141271|459644689|FG000|Overall Study|Withdrawal by Subject|14|||
127732520|NCT00141271|459644690|FG001|Overall Study|Withdrawal by Subject|9|||
127732521|NCT00141271|459644691|FG002|Overall Study|Withdrawal by Subject|10|||
127732522|NCT00141271|459644689|FG000|Overall Study|Other|11|||
127732523|NCT00141271|459644690|FG001|Overall Study|Other|12|||
127732524|NCT00141271|459644691|FG002|Overall Study|Other|5|||
127732525|NCT00990314|459644692|FG000|Overall Study|Death|2|||
127732526|NCT00990314|459644692|FG000|Overall Study|Adverse Event|2|||
127732527|NCT00990314|459644692|FG000|Overall Study|Withdrawal by Subject|3|||
127732528|NCT00990314|459644692|FG000|Overall Study|Non-Compliance|1|||
127732529|NCT00990314|459644692|FG000|Overall Study|Physician Decision|3|||
127732530|NCT00990314|459644692|FG000|Overall Study|Lack of Efficacy|1|||
127732531|NCT04853394|459644699|FG000|Follow-up Interviews|Lost to Follow-up|22|||
127732532|NCT04853394|459644700|FG001|Follow-up Interviews|Lost to Follow-up|15|||
127732533|NCT04212299|459644701|FG000|42-week Follow up in Sub-ischial Socket|Participant experienced a heart attack|1|||
127732534|NCT04413149|459646019|FG000|Overall Study|Death|10|||
127732535|NCT04413149|459646020|FG001|Overall Study|Death|5|||
127732536|NCT04413149|459646019|FG000|Overall Study|Lung transplantation|1|||
127732537|NCT04413149|459646020|FG001|Overall Study|Lung transplantation|0|||
127732538|NCT02878590|459646021|FG000|Overall Study|Withdrawal by Subject|2|||
127732539|NCT05335005|459646025|FG000|Overall Study|Lost to Follow-up|1|||
127732540|NCT02339506|459646028|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
127732541|NCT02339506|459646029|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
127732542|NCT02339506|459646028|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
127732543|NCT02339506|459646029|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
127732544|NCT00331799|459646030|FG000|Overall Study|Withdrawal by Subject|2|||
127732545|NCT00331799|459646030|FG000|Overall Study|Sedation|1|||
127732546|NCT01090076|459646033|FG000|Overall Study|Death|1|||
127732547|NCT01090076|459646034|FG001|Overall Study|Death|1|||
127732548|NCT01090076|459646033|FG000|Overall Study|Withdrawal by Subject|0|||
127732549|NCT01090076|459646034|FG001|Overall Study|Withdrawal by Subject|1|||
127732550|NCT01116440|459646036|FG000|Treatment|Withdrawal by Subject|2|||
127732551|NCT01116440|459646037|FG001|Treatment|Withdrawal by Subject|2|||
127732552|NCT01116440|459646036|FG000|Treatment|Lost to Follow-up|1|||
127732553|NCT01116440|459646037|FG001|Treatment|Lost to Follow-up|1|||
127732554|NCT01116440|459646036|FG000|Treatment|Protocol Violation|0|||
127732555|NCT01116440|459646037|FG001|Treatment|Protocol Violation|2|||
127732556|NCT01116440|459646036|FG000|Treatment|Lack of Efficacy|0|||
127732557|NCT01116440|459646037|FG001|Treatment|Lack of Efficacy|1|||
127732558|NCT01116440|459646036|FG000|Treatment|Adverse Event|0|||
127732559|NCT01116440|459646037|FG001|Treatment|Adverse Event|1|||
127732560|NCT01116440|459646036|FG000|Withdrawal|Withdrawal by Subject|0|||
127732561|NCT01116440|459646037|FG001|Withdrawal|Withdrawal by Subject|1|||
127732562|NCT01116440|459646036|FG000|Withdrawal|Lost to Follow-up|0|||
127732563|NCT01116440|459646037|FG001|Withdrawal|Lost to Follow-up|1|||
127732564|NCT01116440|459646036|FG000|Follow-up|Lost to Follow-up|0|||
127732565|NCT01116440|459646037|FG001|Follow-up|Lost to Follow-up|1|||
127732566|NCT01116440|459646036|FG000|Follow-up|Withdrawal by Subject|0|||
127732567|NCT01116440|459646037|FG001|Follow-up|Withdrawal by Subject|1|||
127732568|NCT01870999|459646043|FG000|Overall Study|Adverse Event|0|||
127732569|NCT01870999|459646044|FG001|Overall Study|Adverse Event|4|||
127732570|NCT01870999|459646045|FG002|Overall Study|Adverse Event|1|||
127732571|NCT01870999|459646043|FG000|Overall Study|Subject met withdrawal criteria|3|||
127732572|NCT01870999|459646044|FG001|Overall Study|Subject met withdrawal criteria|2|||
127804513|NCT00883493|459907532|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
127804514|NCT00883493|459907531|FG000|Overall Study|Study specific disc. criteria|2|||
127804515|NCT00883493|459907532|FG001|Overall Study|Study specific disc. criteria|0|||
127804516|NCT00883493|459907531|FG000|Overall Study|Other|5|||
127804517|NCT00883493|459907532|FG001|Overall Study|Other|3|||
127804518|NCT01084551|459907535|FG000|Overall Study|Adverse Event|2|||
127804519|NCT01084551|459907536|FG001|Overall Study|Adverse Event|9|||
127732573|NCT01870999|459646045|FG002|Overall Study|Subject met withdrawal criteria|0|||
127732574|NCT01870999|459646043|FG000|Overall Study|Subject withdrawn by Investigator|1|||
127732575|NCT01870999|459646044|FG001|Overall Study|Subject withdrawn by Investigator|0|||
127732576|NCT01870999|459646045|FG002|Overall Study|Subject withdrawn by Investigator|0|||
127732577|NCT01870999|459646043|FG000|Overall Study|Withdrawal by Subject|0|||
127732578|NCT01870999|459646044|FG001|Overall Study|Withdrawal by Subject|2|||
127732579|NCT01870999|459646045|FG002|Overall Study|Withdrawal by Subject|5|||
127732580|NCT01870999|459646043|FG000|Overall Study|Protocol Violation|0|||
127804520|NCT01084551|459907537|FG002|Overall Study|Adverse Event|4|||
127804521|NCT01084551|459907535|FG000|Overall Study|Lack of Efficacy|2|||
127804522|NCT01084551|459907536|FG001|Overall Study|Lack of Efficacy|0|||
127804523|NCT01084551|459907537|FG002|Overall Study|Lack of Efficacy|1|||
127804524|NCT01084551|459907535|FG000|Overall Study|Withdrawal by Subject|2|||
127804525|NCT01084551|459907536|FG001|Overall Study|Withdrawal by Subject|1|||
127804526|NCT01084551|459907537|FG002|Overall Study|Withdrawal by Subject|0|||
127804527|NCT01084551|459907535|FG000|Overall Study|Protocol Violation|2|||
127804528|NCT01084551|459907536|FG001|Overall Study|Protocol Violation|4|||
127804529|NCT01084551|459907537|FG002|Overall Study|Protocol Violation|0|||
127804530|NCT01084551|459907535|FG000|Overall Study|Lost to Follow-up|0|||
127804531|NCT01084551|459907536|FG001|Overall Study|Lost to Follow-up|0|||
127804532|NCT01084551|459907537|FG002|Overall Study|Lost to Follow-up|3|||
127804533|NCT01084551|459907535|FG000|Overall Study|Physician Decision|1|||
127804534|NCT01084551|459907536|FG001|Overall Study|Physician Decision|0|||
127804535|NCT01084551|459907537|FG002|Overall Study|Physician Decision|0|||
127804536|NCT00988247|459907538|FG000|Overall Study|Adverse Event|17|||
127804537|NCT00988247|459907539|FG001|Overall Study|Adverse Event|3|||
127804538|NCT00988247|459907538|FG000|Overall Study|Withdrawal by Subject|44|||
127804539|NCT00988247|459907539|FG001|Overall Study|Withdrawal by Subject|13|||
127804540|NCT00988247|459907538|FG000|Overall Study|Pregnancy|1|||
127804541|NCT00988247|459907539|FG001|Overall Study|Pregnancy|2|||
127804542|NCT00988247|459907538|FG000|Overall Study|Lost to Follow-up|11|||
127804543|NCT00988247|459907539|FG001|Overall Study|Lost to Follow-up|2|||
127804544|NCT00988247|459907538|FG000|Overall Study|Protocol Violation|4|||
127804545|NCT00988247|459907539|FG001|Overall Study|Protocol Violation|5|||
127804546|NCT00988247|459907538|FG000|Overall Study|Sponsor requested withdrawal|3|||
127804547|NCT00988247|459907539|FG001|Overall Study|Sponsor requested withdrawal|1|||
127804548|NCT00988247|459907538|FG000|Overall Study|Other|3|||
127804549|NCT00988247|459907539|FG001|Overall Study|Other|0|||
127804550|NCT02661594|459907540|FG000|Overall Study|Protocol Violation|1|||
127804551|NCT02661594|459907541|FG001|Overall Study|Protocol Violation|0|||
127804552|NCT02661594|459907542|FG002|Overall Study|Protocol Violation|1|||
127804553|NCT02661594|459907543|FG003|Overall Study|Protocol Violation|0|||
127804554|NCT00289913|459907544|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
127804555|NCT00289913|459907545|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
127804556|NCT00289913|459907546|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
127804557|NCT00289913|459907547|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
127804558|NCT00289913|459907548|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
127804559|NCT00289913|459907544|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
127804560|NCT00289913|459907545|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
127804561|NCT00289913|459907546|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
127804562|NCT00289913|459907547|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
127804563|NCT00289913|459907548|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
127804564|NCT00289913|459907544|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
127804565|NCT00289913|459907545|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
127804566|NCT00289913|459907546|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
127804567|NCT00289913|459907547|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
127804568|NCT00289913|459907548|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
127804569|NCT00289913|459907544|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
127804570|NCT00289913|459907545|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
127804571|NCT00289913|459907546|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
127804572|NCT00289913|459907547|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
127804573|NCT00289913|459907548|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
127804574|NCT00289913|459907544|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
127804575|NCT00289913|459907545|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
127804576|NCT00289913|459907546|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
127804577|NCT00289913|459907547|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
127804578|NCT00289913|459907548|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
127804579|NCT00289913|459907544|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
127804580|NCT00289913|459907545|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
127804581|NCT00289913|459907546|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
127804582|NCT00289913|459907547|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
127804583|NCT00289913|459907548|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
127804584|NCT00289913|459907544|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
127804585|NCT00289913|459907545|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
127804586|NCT00289913|459907546|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
127804587|NCT00289913|459907547|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
127804588|NCT00289913|459907548|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
127804589|NCT00289913|459907544|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
127890543|NCT01086215|460222353|FG001|Overall Study|Death|8|||
127732581|NCT01870999|459646044|FG001|Overall Study|Protocol Violation|0|||
127732582|NCT01870999|459646045|FG002|Overall Study|Protocol Violation|1|||
127732583|NCT01636258|459646046|FG000|Overall Study|Lost to Follow-up|1|||
127732584|NCT01636258|459646047|FG001|Overall Study|Lost to Follow-up|0|||
127732585|NCT00116584|459646060|FG000|Overall Study|Withdrawal by Subject|1|||
127732586|NCT00116584|459646061|FG001|Overall Study|Withdrawal by Subject|0|||
127732587|NCT00116584|459646060|FG000|Overall Study|Protocol Violation|1|||
127732588|NCT00116584|459646061|FG001|Overall Study|Protocol Violation|1|||
127732589|NCT02798861|459646064|FG000|Overall Study|Lost to Follow-up|22|||
127732590|NCT02798861|459646064|FG000|Overall Study|Withdrawal by Subject|1|||
127732591|NCT02186015|459646065|FG000|Overall Study|Physician Decision|1|||
127732592|NCT02186015|459646066|FG001|Overall Study|Physician Decision|0|||
127732593|NCT00907517|459646067|FG000|Overall Study|Progressive Disease|3|||
127732594|NCT00907517|459646068|FG001|Overall Study|Progressive Disease|3|||
127732595|NCT00907517|459646069|FG002|Overall Study|Progressive Disease|4|||
127732596|NCT00907517|459646070|FG003|Overall Study|Progressive Disease|4|||
127732597|NCT00907517|459646071|FG004|Overall Study|Progressive Disease|4|||
127732598|NCT00907517|459646067|FG000|Overall Study|Symptomatic Deterioration|0|||
127732599|NCT00907517|459646068|FG001|Overall Study|Symptomatic Deterioration|0|||
127732600|NCT00907517|459646069|FG002|Overall Study|Symptomatic Deterioration|0|||
127804590|NCT00289913|459907545|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
127804591|NCT00289913|459907546|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
127804592|NCT00289913|459907547|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
127804593|NCT00289913|459907548|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
127804594|NCT00289913|459907544|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
127804595|NCT00289913|459907545|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
127804596|NCT00289913|459907546|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
127804597|NCT00289913|459907547|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
127804598|NCT00289913|459907548|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
127804599|NCT00289913|459907544|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
127804600|NCT00289913|459907545|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
127804601|NCT00289913|459907546|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
127804602|NCT00289913|459907547|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
127804603|NCT00289913|459907548|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
127804604|NCT00289913|459907544|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
127804605|NCT00289913|459907545|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
127804606|NCT00289913|459907546|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
127804607|NCT00289913|459907547|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
127890544|NCT01086215|460222354|FG002|Overall Study|Death|8|||
127804608|NCT00289913|459907548|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
127804609|NCT00289913|459907544|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
127804610|NCT00289913|459907545|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
127804611|NCT00289913|459907546|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
127804612|NCT00289913|459907547|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
127804613|NCT00289913|459907548|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
127804614|NCT00289913|459907544|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
127804615|NCT00289913|459907545|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
127804616|NCT00289913|459907546|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
127804617|NCT00289913|459907547|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
127804618|NCT00289913|459907548|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
127804619|NCT00289913|459907544|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
127804620|NCT00289913|459907545|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
127804621|NCT00289913|459907546|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
127804622|NCT00289913|459907547|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
127804623|NCT00289913|459907548|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
127804624|NCT00289913|459907544|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
127804625|NCT00289913|459907545|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
127804626|NCT00289913|459907546|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
127804627|NCT00289913|459907547|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
127804628|NCT00289913|459907548|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
127804629|NCT00289913|459907544|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
127804630|NCT00289913|459907545|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
127804631|NCT00289913|459907546|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
127804632|NCT00289913|459907547|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
127804633|NCT00289913|459907548|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
127804634|NCT00289913|459907544|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
127804635|NCT00289913|459907545|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
127804636|NCT00289913|459907546|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
127804637|NCT00289913|459907547|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
127804638|NCT00289913|459907548|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
127804639|NCT00289913|459907544|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
127804640|NCT00289913|459907545|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
127804641|NCT00289913|459907546|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
127804642|NCT00289913|459907547|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
127804643|NCT00289913|459907548|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
127804644|NCT00289913|459907544|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
127804645|NCT00289913|459907545|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
127804646|NCT00289913|459907546|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
127804647|NCT00289913|459907547|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
127804648|NCT00289913|459907548|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
127804649|NCT00289913|459907544|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
127804650|NCT00289913|459907545|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
127804651|NCT00289913|459907546|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
127804652|NCT00289913|459907547|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
127804653|NCT00289913|459907548|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
127804654|NCT00289913|459907544|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
127804655|NCT00289913|459907545|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
127804656|NCT00289913|459907546|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
127804657|NCT00289913|459907547|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
127804658|NCT00289913|459907548|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
127804659|NCT00289913|459907544|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
127804660|NCT00289913|459907545|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
127804661|NCT00289913|459907546|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
127804662|NCT00289913|459907547|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
127804663|NCT00289913|459907548|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
127804664|NCT00289913|459907544|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
127804665|NCT00289913|459907545|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
127804666|NCT00289913|459907546|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
127804667|NCT00289913|459907547|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
127804668|NCT00289913|459907548|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
127804669|NCT00289913|459907544|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
127804670|NCT00289913|459907545|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
127804671|NCT00289913|459907546|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
127890545|NCT01086215|460222355|FG003|Overall Study|Death|1|||
127890546|NCT01086215|460222352|FG000|Overall Study|Lost to Follow-up|22|||
127890547|NCT01086215|460222353|FG001|Overall Study|Lost to Follow-up|39|||
127890548|NCT01086215|460222354|FG002|Overall Study|Lost to Follow-up|18|||
127732601|NCT00907517|459646070|FG003|Overall Study|Symptomatic Deterioration|0|||
127732602|NCT00907517|459646071|FG004|Overall Study|Symptomatic Deterioration|1|||
127732603|NCT01797705|459646075|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
127732604|NCT01797705|459646075|FG000|Overall Study|Withdrawal by Subject|1|||
127732605|NCT02030847|459646076|FG000|Overall Study|Death|10|||
127732606|NCT02030847|459646076|FG000|Overall Study|Disease Progression|15|||
127732607|NCT02030847|459646076|FG000|Overall Study|New Cancer Therapy|8|||
127732608|NCT02030847|459646076|FG000|Overall Study|Physician Decision|3|||
127732609|NCT02030847|459646076|FG000|Overall Study|Withdrawal by Subject|1|||
127732610|NCT02592434|459646077|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
127732611|NCT02592434|459646078|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
127732612|NCT02592434|459646079|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
127732613|NCT02592434|459646077|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
127732614|NCT02592434|459646078|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
127732615|NCT02592434|459646079|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
127732616|NCT02592434|459646077|FG000|Open-Label Phase (18 Weeks)|Other|3|||
127732617|NCT02592434|459646078|FG001|Open-Label Phase (18 Weeks)|Other|0|||
127732618|NCT02592434|459646079|FG002|Open-Label Phase (18 Weeks)|Other|0|||
127732619|NCT02592434|459646077|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
127732620|NCT02592434|459646078|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
127732621|NCT02592434|459646079|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
127732622|NCT02592434|459646077|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
127732623|NCT02592434|459646078|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
127732624|NCT02592434|459646079|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
127732625|NCT02592434|459646077|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
127732626|NCT02592434|459646078|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
127732627|NCT02592434|459646079|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
127732628|NCT02592434|459646077|FG000|Double Blind Phase (26 Weeks)|Other|0|||
127732629|NCT02592434|459646078|FG001|Double Blind Phase (26 Weeks)|Other|1|||
127732630|NCT02592434|459646079|FG002|Double Blind Phase (26 Weeks)|Other|0|||
127732631|NCT02592434|459646077|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
127732632|NCT02592434|459646078|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
127732633|NCT02592434|459646079|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
127732634|NCT02592434|459646077|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
127732635|NCT02592434|459646078|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
127732636|NCT02592434|459646079|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
127732637|NCT02592434|459646077|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
127732638|NCT02592434|459646078|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
127890549|NCT01086215|460222355|FG003|Overall Study|Lost to Follow-up|2|||
127732639|NCT02592434|459646079|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
127732640|NCT00561678|459646080|FG000|Overall Study|Withdrawal by Subject|4|||
127732641|NCT00561678|459646081|FG001|Overall Study|Withdrawal by Subject|3|||
127732642|NCT00561678|459646080|FG000|Overall Study|surgery cancelled|1|||
127732643|NCT00561678|459646081|FG001|Overall Study|surgery cancelled|1|||
127732644|NCT00561678|459646080|FG000|Overall Study|surgery rescheduled to different site|2|||
127732645|NCT00561678|459646081|FG001|Overall Study|surgery rescheduled to different site|2|||
127732646|NCT00561678|459646080|FG000|Overall Study|anesthesia provider refusal|1|||
127732647|NCT00561678|459646081|FG001|Overall Study|anesthesia provider refusal|0|||
127732648|NCT01103141|459646084|FG000|Overall Study|Death|0|||
127732649|NCT01103141|459646085|FG001|Overall Study|Death|1|||
127890550|NCT03361956|460222356|FG000|Overall Study|Adverse Event|1|||
127890551|NCT03361956|460222357|FG001|Overall Study|Adverse Event|0|||
127890552|NCT03361956|460222358|FG002|Overall Study|Adverse Event|1|||
127890553|NCT03361956|460222359|FG003|Overall Study|Adverse Event|1|||
127890554|NCT03361956|460222360|FG004|Overall Study|Adverse Event|0|||
127890555|NCT03361956|460222356|FG000|Overall Study|Other|0|||
127890556|NCT03361956|460222357|FG001|Overall Study|Other|0|||
127890557|NCT03361956|460222358|FG002|Overall Study|Other|0|||
127890558|NCT03361956|460222359|FG003|Overall Study|Other|1|||
127732650|NCT01103141|459646084|FG000|Overall Study|Lost to Follow-up|2|||
127732651|NCT01103141|459646085|FG001|Overall Study|Lost to Follow-up|1|||
127732652|NCT01695993|459646086|FG000|Overall Study|Lost to Follow-up|2|||
127732653|NCT01695993|459646087|FG001|Overall Study|Lost to Follow-up|1|||
127732654|NCT01695993|459646088|FG002|Overall Study|Lost to Follow-up|3|||
127732655|NCT01695993|459646086|FG000|Overall Study|Withdrawal by Subject|2|||
127732656|NCT01695993|459646087|FG001|Overall Study|Withdrawal by Subject|2|||
127732657|NCT01695993|459646088|FG002|Overall Study|Withdrawal by Subject|2|||
127732658|NCT01695993|459646086|FG000|Overall Study|To ill to continue|1|||
127732659|NCT01695993|459646087|FG001|Overall Study|To ill to continue|2|||
127732660|NCT01695993|459646088|FG002|Overall Study|To ill to continue|0|||
127732661|NCT01695993|459646086|FG000|Overall Study|Changed Medical Facility|0|||
127732662|NCT01695993|459646087|FG001|Overall Study|Changed Medical Facility|0|||
127804672|NCT00289913|459907547|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
127804673|NCT00289913|459907548|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
127804674|NCT00289913|459907544|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
127890559|NCT03361956|460222360|FG004|Overall Study|Other|0|||
127890560|NCT03361956|460222356|FG000|Overall Study|Withdrawal by Subject|2|||
127890561|NCT03361956|460222357|FG001|Overall Study|Withdrawal by Subject|2|||
127890562|NCT03361956|460222358|FG002|Overall Study|Withdrawal by Subject|2|||
127890563|NCT03361956|460222359|FG003|Overall Study|Withdrawal by Subject|0|||
127890564|NCT03361956|460222360|FG004|Overall Study|Withdrawal by Subject|3|||
127890565|NCT03361956|460222356|FG000|Overall Study|Disease Relapse|0|||
127890566|NCT03361956|460222357|FG001|Overall Study|Disease Relapse|0|||
127890567|NCT03361956|460222358|FG002|Overall Study|Disease Relapse|1|||
127890568|NCT03361956|460222359|FG003|Overall Study|Disease Relapse|0|||
127890569|NCT03361956|460222360|FG004|Overall Study|Disease Relapse|0|||
127890570|NCT03361956|460222356|FG000|Overall Study|Physician Decision|0|||
127804675|NCT00289913|459907545|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
127804676|NCT00289913|459907546|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
127804677|NCT00289913|459907547|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
127804678|NCT00289913|459907548|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
127804679|NCT00289913|459907544|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
127804680|NCT00289913|459907545|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
127804681|NCT00289913|459907546|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
127804682|NCT00289913|459907547|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
127804683|NCT00289913|459907548|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
127804684|NCT00289913|459907544|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
127804685|NCT00289913|459907545|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
127804686|NCT00289913|459907546|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
127804687|NCT00289913|459907547|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
127804688|NCT00289913|459907548|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
127804689|NCT00289913|459907544|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
127804690|NCT00289913|459907545|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
127804691|NCT00289913|459907546|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
127804692|NCT00289913|459907547|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
127804693|NCT00289913|459907548|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
127804694|NCT00289913|459907544|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
127804695|NCT00289913|459907545|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
127804696|NCT00289913|459907546|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
127804697|NCT00289913|459907547|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
127804698|NCT00289913|459907548|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
127804699|NCT00289913|459907544|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
127890571|NCT03361956|460222357|FG001|Overall Study|Physician Decision|2|||
127890572|NCT03361956|460222358|FG002|Overall Study|Physician Decision|0|||
127890573|NCT03361956|460222359|FG003|Overall Study|Physician Decision|1|||
127890574|NCT03361956|460222360|FG004|Overall Study|Physician Decision|0|||
127890575|NCT03361956|460222356|FG000|Overall Study|Lost to Follow-up|0|||
127890576|NCT03361956|460222357|FG001|Overall Study|Lost to Follow-up|0|||
127732663|NCT01695993|459646088|FG002|Overall Study|Changed Medical Facility|1|||
127732664|NCT02029521|459646089|FG000|Overall Study|Protocol Violation|1|||
127732665|NCT02029521|459646090|FG001|Overall Study|Protocol Violation|0|||
127732666|NCT02029521|459646089|FG000|Overall Study|Withdrawal by Subject|1|||
127890577|NCT03361956|460222358|FG002|Overall Study|Lost to Follow-up|1|||
127890578|NCT03361956|460222359|FG003|Overall Study|Lost to Follow-up|1|||
127732667|NCT02029521|459646090|FG001|Overall Study|Withdrawal by Subject|1|||
127732668|NCT01072396|459646092|FG000|Period One|Adverse Event|1|||
127732669|NCT01072396|459646093|FG001|Period One|Adverse Event|1|||
127732670|NCT01072396|459646092|FG000|Period One|Protocol Violation|2|||
127732671|NCT01072396|459646093|FG001|Period One|Protocol Violation|1|||
127732672|NCT01072396|459646092|FG000|Period One|Withdrawal by Subject|2|||
127732673|NCT01072396|459646093|FG001|Period One|Withdrawal by Subject|0|||
127732674|NCT01072396|459646092|FG000|Washout Period|Missing termination information|0|||
127732675|NCT01072396|459646093|FG001|Washout Period|Missing termination information|1|||
127732676|NCT01072396|459646092|FG000|Period Two|Adverse Event|0|||
127732677|NCT01072396|459646093|FG001|Period Two|Adverse Event|3|||
127732678|NCT01072396|459646092|FG000|Period Two|Lost to Follow-up|1|||
127732679|NCT01072396|459646093|FG001|Period Two|Lost to Follow-up|0|||
127732680|NCT01106586|459646094|FG000|Overall Study|Adverse Event|9|||
127732681|NCT01106586|459646095|FG001|Overall Study|Adverse Event|15|||
127732682|NCT01106586|459646094|FG000|Overall Study|Death|1|||
127732683|NCT01106586|459646095|FG001|Overall Study|Death|3|||
127732684|NCT01106586|459646094|FG000|Overall Study|Pregnancy|2|||
127732685|NCT01106586|459646095|FG001|Overall Study|Pregnancy|2|||
127732686|NCT01106586|459646094|FG000|Overall Study|Lack of Efficacy|1|||
127732687|NCT01106586|459646095|FG001|Overall Study|Lack of Efficacy|0|||
127732688|NCT01106586|459646094|FG000|Overall Study|Investigator's Discretion|5|||
127732689|NCT01106586|459646095|FG001|Overall Study|Investigator's Discretion|8|||
127732690|NCT01106586|459646094|FG000|Overall Study|Withdrew Consent|18|||
127732691|NCT01106586|459646095|FG001|Overall Study|Withdrew Consent|30|||
127732692|NCT01106586|459646094|FG000|Overall Study|Lost to Follow-up|24|||
127732693|NCT01106586|459646095|FG001|Overall Study|Lost to Follow-up|20|||
127890579|NCT03361956|460222360|FG004|Overall Study|Lost to Follow-up|2|||
127890580|NCT00408876|460222361|FG000|Overall Study|Adverse Event|9|||
127890581|NCT00408876|460222362|FG001|Overall Study|Adverse Event|17|||
127732694|NCT01106586|459646094|FG000|Overall Study|Participant Noncompliance|12|||
127732695|NCT01106586|459646095|FG001|Overall Study|Participant Noncompliance|10|||
127732696|NCT01106586|459646094|FG000|Overall Study|Protocol Violation|1|||
127732697|NCT01106586|459646095|FG001|Overall Study|Protocol Violation|0|||
127732698|NCT01106586|459646094|FG000|Overall Study|Participant Transferred to Another Study|212|||
127732699|NCT01106586|459646095|FG001|Overall Study|Participant Transferred to Another Study|197|||
127732700|NCT01379521|459646096|FG000|Overall Study -Treatment Period|Adverse Event|3|||
127732701|NCT01379521|459646097|FG001|Overall Study -Treatment Period|Adverse Event|0|||
127732702|NCT01379521|459646096|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
127732703|NCT01379521|459646097|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
127804700|NCT00289913|459907545|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
127804701|NCT00289913|459907546|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
127804702|NCT00289913|459907547|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
127804703|NCT00289913|459907548|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
127804704|NCT00289913|459907544|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
127804705|NCT00289913|459907545|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
127804706|NCT00289913|459907546|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
127804707|NCT00289913|459907547|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
127804708|NCT00289913|459907548|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
127804709|NCT04173741|459907549|FG000|Overall Study|IVC measurement cannot be done|1|||
127804710|NCT04173741|459907550|FG001|Overall Study|IVC measurement cannot be done|1|||
127804711|NCT01169779|459907553|FG000|Overall Study|Adverse Event|3|||
127804712|NCT01169779|459907554|FG001|Overall Study|Adverse Event|11|||
127804713|NCT01169779|459907553|FG000|Overall Study|Lack of Efficacy|1|||
127804714|NCT01169779|459907554|FG001|Overall Study|Lack of Efficacy|0|||
127804715|NCT01169779|459907553|FG000|Overall Study|Protocol Violation|1|||
127804716|NCT01169779|459907554|FG001|Overall Study|Protocol Violation|1|||
127804717|NCT01169779|459907553|FG000|Overall Study|Withdrawal by Subject|3|||
127804718|NCT01169779|459907554|FG001|Overall Study|Withdrawal by Subject|2|||
127804719|NCT01169779|459907553|FG000|Overall Study|Familial and personal reasons|3|||
127804720|NCT01169779|459907554|FG001|Overall Study|Familial and personal reasons|3|||
127804721|NCT03617705|459907559|FG000|Overall Study|Withdrawal by Subject|2|||
127804722|NCT03617705|459907559|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
127804723|NCT03617705|459907559|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
127804724|NCT01061008|459907560|FG000|Overall Study|Badiocephalic fistula failed|3|||
127804725|NCT01061008|459907561|FG001|Overall Study|Badiocephalic fistula failed|2|||
127804726|NCT01061008|459907560|FG000|Overall Study|Death|1|||
127804727|NCT01061008|459907561|FG001|Overall Study|Death|0|||
127804728|NCT01061008|459907560|FG000|Overall Study|Withdrawal by Subject|1|||
127804729|NCT01061008|459907561|FG001|Overall Study|Withdrawal by Subject|3|||
127804730|NCT01061008|459907560|FG000|Overall Study|Unable to exercise following surgery|1|||
127804731|NCT01061008|459907561|FG001|Overall Study|Unable to exercise following surgery|0|||
127804732|NCT01061008|459907560|FG000|Overall Study|Adverse Event|0|||
127804733|NCT01061008|459907561|FG001|Overall Study|Adverse Event|1|||
127804734|NCT02024971|459907562|FG000|Overall Study|Data Not Available|30|||
127804735|NCT02024971|459907562|FG000|Overall Study|Lost to Follow-up|6|||
127804736|NCT02908100|459907563|FG000|Overall Study|Adverse Event|7|||
127804737|NCT02908100|459907564|FG001|Overall Study|Adverse Event|6|||
127804738|NCT02908100|459907565|FG002|Overall Study|Adverse Event|9|||
127804739|NCT02908100|459907563|FG000|Overall Study|Death|2|||
127804740|NCT02908100|459907564|FG001|Overall Study|Death|0|||
127804741|NCT02908100|459907565|FG002|Overall Study|Death|0|||
127804742|NCT02908100|459907563|FG000|Overall Study|Lack of Efficacy|2|||
127804743|NCT02908100|459907564|FG001|Overall Study|Lack of Efficacy|3|||
127804744|NCT02908100|459907565|FG002|Overall Study|Lack of Efficacy|3|||
127804745|NCT02908100|459907563|FG000|Overall Study|Lost to Follow-up|0|||
127804746|NCT02908100|459907564|FG001|Overall Study|Lost to Follow-up|1|||
127804747|NCT02908100|459907565|FG002|Overall Study|Lost to Follow-up|2|||
127804748|NCT02908100|459907563|FG000|Overall Study|Non-Compliance With Study Drug|1|||
127804749|NCT02908100|459907564|FG001|Overall Study|Non-Compliance With Study Drug|1|||
127804750|NCT02908100|459907565|FG002|Overall Study|Non-Compliance With Study Drug|2|||
127804751|NCT02908100|459907563|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
127804752|NCT02908100|459907564|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
127804753|NCT02908100|459907565|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
127804754|NCT02908100|459907563|FG000|Overall Study|Physician Decision|0|||
127804755|NCT02908100|459907564|FG001|Overall Study|Physician Decision|1|||
127804756|NCT02908100|459907565|FG002|Overall Study|Physician Decision|0|||
127804757|NCT02908100|459907563|FG000|Overall Study|Pregnancy|1|||
127804758|NCT02908100|459907564|FG001|Overall Study|Pregnancy|2|||
127804759|NCT02908100|459907565|FG002|Overall Study|Pregnancy|0|||
127804760|NCT02908100|459907563|FG000|Overall Study|Withdrawal by Subject|8|||
127804761|NCT02908100|459907564|FG001|Overall Study|Withdrawal by Subject|7|||
127804762|NCT02908100|459907565|FG002|Overall Study|Withdrawal by Subject|5|||
127804763|NCT02908100|459907563|FG000|Overall Study|Randomised in Error|1|||
127804764|NCT02908100|459907564|FG001|Overall Study|Randomised in Error|0|||
127804765|NCT02908100|459907565|FG002|Overall Study|Randomised in Error|0|||
127804766|NCT01299727|459907568|FG000|Overall Study|Withdrawal by Subject|1|||
127804767|NCT01299727|459907569|FG001|Overall Study|Withdrawal by Subject|0|||
127804768|NCT01299727|459907570|FG002|Overall Study|Withdrawal by Subject|0|||
127804769|NCT01299727|459907568|FG000|Overall Study|Adverse Event|0|||
127804770|NCT01299727|459907569|FG001|Overall Study|Adverse Event|0|||
127804771|NCT01299727|459907570|FG002|Overall Study|Adverse Event|1|||
127804772|NCT01299727|459907568|FG000|Overall Study|Completed the Treatment Period|3|||
127804773|NCT01299727|459907569|FG001|Overall Study|Completed the Treatment Period|4|||
127804774|NCT01299727|459907570|FG002|Overall Study|Completed the Treatment Period|3|||
127732704|NCT01379521|459646096|FG000|Overall Study -Treatment Period|Disease Progression|23|||
127732705|NCT01379521|459646097|FG001|Overall Study -Treatment Period|Disease Progression|22|||
127732706|NCT01379521|459646096|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
127732707|NCT01379521|459646097|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
127732708|NCT01379521|459646096|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
127732709|NCT01379521|459646097|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
127732710|NCT01379521|459646096|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
127732711|NCT01379521|459646097|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
127732712|NCT01379521|459646096|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
127732713|NCT01379521|459646097|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
127732714|NCT01379521|459646096|FG000|Overall Study -Treatment Period|Death|2|||
127732715|NCT01379521|459646097|FG001|Overall Study -Treatment Period|Death|1|||
127732716|NCT01379521|459646096|FG000|Post-Treatment Evaluations|Disease Progression|22|||
127732717|NCT01379521|459646097|FG001|Post-Treatment Evaluations|Disease Progression|20|||
127732718|NCT01379521|459646096|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
127890582|NCT00408876|460222363|FG002|Overall Study|Adverse Event|27|||
127732719|NCT01379521|459646097|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
127732720|NCT01379521|459646096|FG000|Post-Treatment Evaluations|Death|1|||
127804775|NCT00944034|459907573|FG000|Overall Study|Inappropriate enrollment|0|||
127804776|NCT00944034|459907574|FG001|Overall Study|Inappropriate enrollment|1|||
127804777|NCT00944034|459907575|FG002|Overall Study|Inappropriate enrollment|0|||
127804778|NCT00944034|459907576|FG003|Overall Study|Inappropriate enrollment|1|||
127804779|NCT00944034|459907577|FG004|Overall Study|Inappropriate enrollment|2|||
127804780|NCT00944034|459907578|FG005|Overall Study|Inappropriate enrollment|1|||
127804781|NCT00944034|459907579|FG006|Overall Study|Inappropriate enrollment|0|||
127804782|NCT00944034|459907580|FG007|Overall Study|Inappropriate enrollment|0|||
127804783|NCT00944034|459907581|FG008|Overall Study|Inappropriate enrollment|1|||
127804784|NCT00944034|459907582|FG009|Overall Study|Inappropriate enrollment|1|||
127804785|NCT00944034|459907583|FG010|Overall Study|Inappropriate enrollment|0|||
127804786|NCT00944034|459907584|FG011|Overall Study|Inappropriate enrollment|0|||
127804787|NCT00944034|459907573|FG000|Overall Study|Withdrawal by Subject|3|||
127804788|NCT00944034|459907574|FG001|Overall Study|Withdrawal by Subject|2|||
127804789|NCT00944034|459907575|FG002|Overall Study|Withdrawal by Subject|6|||
127804790|NCT00944034|459907576|FG003|Overall Study|Withdrawal by Subject|2|||
127804791|NCT00944034|459907577|FG004|Overall Study|Withdrawal by Subject|5|||
127804792|NCT00944034|459907578|FG005|Overall Study|Withdrawal by Subject|8|||
127804793|NCT00944034|459907579|FG006|Overall Study|Withdrawal by Subject|2|||
127804794|NCT00944034|459907580|FG007|Overall Study|Withdrawal by Subject|2|||
127804795|NCT00944034|459907581|FG008|Overall Study|Withdrawal by Subject|3|||
127804796|NCT00944034|459907582|FG009|Overall Study|Withdrawal by Subject|4|||
127804797|NCT00944034|459907583|FG010|Overall Study|Withdrawal by Subject|0|||
127804798|NCT00944034|459907584|FG011|Overall Study|Withdrawal by Subject|4|||
127804799|NCT00944034|459907573|FG000|Overall Study|Lost to Follow-up|0|||
127804800|NCT00944034|459907574|FG001|Overall Study|Lost to Follow-up|4|||
127804801|NCT00944034|459907575|FG002|Overall Study|Lost to Follow-up|2|||
127804802|NCT00944034|459907576|FG003|Overall Study|Lost to Follow-up|0|||
127804803|NCT00944034|459907577|FG004|Overall Study|Lost to Follow-up|5|||
127804804|NCT00944034|459907578|FG005|Overall Study|Lost to Follow-up|7|||
127804805|NCT00944034|459907579|FG006|Overall Study|Lost to Follow-up|0|||
127804806|NCT00944034|459907580|FG007|Overall Study|Lost to Follow-up|1|||
127804807|NCT00944034|459907581|FG008|Overall Study|Lost to Follow-up|5|||
127804808|NCT00944034|459907582|FG009|Overall Study|Lost to Follow-up|1|||
127804809|NCT00944034|459907583|FG010|Overall Study|Lost to Follow-up|1|||
127804810|NCT00944034|459907584|FG011|Overall Study|Lost to Follow-up|0|||
127804811|NCT00944034|459907573|FG000|Overall Study|Death|0|||
127804812|NCT00944034|459907574|FG001|Overall Study|Death|0|||
127804813|NCT00944034|459907575|FG002|Overall Study|Death|1|||
127804814|NCT00944034|459907576|FG003|Overall Study|Death|0|||
127804815|NCT00944034|459907577|FG004|Overall Study|Death|0|||
127804816|NCT00944034|459907578|FG005|Overall Study|Death|0|||
127804817|NCT00944034|459907579|FG006|Overall Study|Death|0|||
127804818|NCT00944034|459907580|FG007|Overall Study|Death|0|||
127732721|NCT01379521|459646097|FG001|Post-Treatment Evaluations|Death|0|||
127732722|NCT00938041|459646098|FG000|Overall Study|Lost to Follow-up|6|||
127732723|NCT00938041|459646098|FG000|Overall Study|Received Alternative Therapy|1|||
127732724|NCT00938041|459646098|FG000|Overall Study|Progressive Disease|5|||
127732725|NCT00938041|459646098|FG000|Overall Study|Death|12|||
127732726|NCT00938041|459646098|FG000|Overall Study|Adrenal Insufficiency|3|||
127732727|NCT01026103|459646099|FG000|Overall Study|Physician Decision|1|||
127732728|NCT01026103|459646099|FG000|Overall Study|did not receive study device bc of error|1|||
127732729|NCT00105521|459646100|FG000|Overall Study|Other|1|||
127732730|NCT00105521|459646101|FG001|Overall Study|Other|1|||
127732731|NCT00105521|459646102|FG002|Overall Study|Other|2|||
127732732|NCT00105521|459646103|FG003|Overall Study|Other|0|||
127732733|NCT00105521|459646100|FG000|Overall Study|Adverse Event|10|||
127804819|NCT00944034|459907581|FG008|Overall Study|Death|0|||
127804820|NCT00944034|459907582|FG009|Overall Study|Death|0|||
127804821|NCT00944034|459907583|FG010|Overall Study|Death|0|||
127804822|NCT00944034|459907584|FG011|Overall Study|Death|0|||
127804823|NCT00944034|459907573|FG000|Overall Study|Protocol Violation|2|||
127804824|NCT00944034|459907574|FG001|Overall Study|Protocol Violation|0|||
127804825|NCT00944034|459907575|FG002|Overall Study|Protocol Violation|0|||
127804826|NCT00944034|459907576|FG003|Overall Study|Protocol Violation|1|||
127804827|NCT00944034|459907577|FG004|Overall Study|Protocol Violation|2|||
127804828|NCT00944034|459907578|FG005|Overall Study|Protocol Violation|3|||
127804829|NCT00944034|459907579|FG006|Overall Study|Protocol Violation|0|||
127804830|NCT00944034|459907580|FG007|Overall Study|Protocol Violation|1|||
127804831|NCT00944034|459907581|FG008|Overall Study|Protocol Violation|1|||
127732734|NCT00105521|459646101|FG001|Overall Study|Adverse Event|4|||
127732735|NCT00105521|459646102|FG002|Overall Study|Adverse Event|10|||
127732736|NCT00105521|459646103|FG003|Overall Study|Adverse Event|8|||
127732737|NCT00105521|459646100|FG000|Overall Study|Withdrawal by Subject|1|||
127804832|NCT00944034|459907582|FG009|Overall Study|Protocol Violation|4|||
127890583|NCT00408876|460222364|FG003|Overall Study|Adverse Event|10|||
127890584|NCT00408876|460222361|FG000|Overall Study|Withdrawal by Subject|3|||
127890585|NCT00408876|460222362|FG001|Overall Study|Withdrawal by Subject|6|||
127732738|NCT00105521|459646101|FG001|Overall Study|Withdrawal by Subject|0|||
127732739|NCT00105521|459646102|FG002|Overall Study|Withdrawal by Subject|1|||
127732740|NCT00105521|459646103|FG003|Overall Study|Withdrawal by Subject|4|||
127732741|NCT00105521|459646100|FG000|Overall Study|Lack of Efficacy|0|||
127732742|NCT00105521|459646101|FG001|Overall Study|Lack of Efficacy|0|||
127732743|NCT00105521|459646102|FG002|Overall Study|Lack of Efficacy|0|||
127732744|NCT00105521|459646103|FG003|Overall Study|Lack of Efficacy|1|||
127732745|NCT00105521|459646100|FG000|Overall Study|Protocol Violation|3|||
127732746|NCT00105521|459646101|FG001|Overall Study|Protocol Violation|5|||
127732747|NCT00105521|459646102|FG002|Overall Study|Protocol Violation|4|||
127732748|NCT00105521|459646103|FG003|Overall Study|Protocol Violation|4|||
127732749|NCT00105521|459646100|FG000|Overall Study|Lost to Follow-up|0|||
127732750|NCT00105521|459646101|FG001|Overall Study|Lost to Follow-up|1|||
127732751|NCT00105521|459646102|FG002|Overall Study|Lost to Follow-up|0|||
127732752|NCT00105521|459646103|FG003|Overall Study|Lost to Follow-up|0|||
127732753|NCT02475733|459646104|FG000|Overall Study|Withdrawal by Subject|1|||
127732754|NCT02475733|459646105|FG001|Overall Study|Withdrawal by Subject|0|||
127732755|NCT02475733|459646104|FG000|Overall Study|Physician Decision|1|||
127732756|NCT02475733|459646105|FG001|Overall Study|Physician Decision|0|||
127732757|NCT00404547|459646106|FG000|Overall Study|Adverse Event|39|||
127732758|NCT00404547|459646107|FG001|Overall Study|Adverse Event|6|||
127732759|NCT00404547|459646106|FG000|Overall Study|Withdrawal by Subject|19|||
127732760|NCT00404547|459646107|FG001|Overall Study|Withdrawal by Subject|2|||
127732761|NCT00404547|459646106|FG000|Overall Study|Protocol Violation|0|||
127732762|NCT00404547|459646107|FG001|Overall Study|Protocol Violation|1|||
127732763|NCT00404547|459646106|FG000|Overall Study|Lost to Follow-up|20|||
127732764|NCT00404547|459646107|FG001|Overall Study|Lost to Follow-up|9|||
127732765|NCT00404547|459646106|FG000|Overall Study|Lack of compliance|5|||
127732766|NCT00404547|459646107|FG001|Overall Study|Lack of compliance|1|||
127732767|NCT00404547|459646106|FG000|Overall Study|Other|4|||
127732768|NCT00404547|459646107|FG001|Overall Study|Other|0|||
127732769|NCT00404547|459646106|FG000|Overall Study|Reason not stated|3|||
127732770|NCT00404547|459646107|FG001|Overall Study|Reason not stated|6|||
127732771|NCT02744898|459646110|FG000|Overall Study|Progressive Disease|2|||
127732772|NCT02744898|459646110|FG000|Overall Study|Physician Decision|1|||
127732773|NCT02744898|459646110|FG000|Overall Study|Toxicity|1|||
127732774|NCT01078571|459646111|FG000|Overall Study|Adverse Event|36|||
127732775|NCT01078571|459646111|FG000|Overall Study|Lack of effectiveness|36|||
127732776|NCT01078571|459646111|FG000|Overall Study|Reason not reported|21|||
127732777|NCT01078571|459646111|FG000|Overall Study|Withdrawal by Subject|12|||
127732778|NCT01078571|459646111|FG000|Overall Study|Lost to Follow-up|8|||
127732779|NCT01078571|459646111|FG000|Overall Study|Protocol Violation|2|||
127732780|NCT02588027|459646112|FG000|Overall Study|Withdrawal by Subject|1|||
127732781|NCT02588027|459646113|FG001|Overall Study|Withdrawal by Subject|3|||
127732782|NCT02588027|459646112|FG000|Overall Study|Protocol Violation|4|||
127732783|NCT02588027|459646113|FG001|Overall Study|Protocol Violation|1|||
127732784|NCT04372186|459646114|FG000|Overall Study|Death|24|||
127732785|NCT04372186|459646115|FG001|Overall Study|Death|11|||
127732786|NCT04372186|459646114|FG000|Overall Study|Transferred to a different facility for care|0|||
127732787|NCT04372186|459646115|FG001|Overall Study|Transferred to a different facility for care|2|||
127732788|NCT03219216|459646116|FG000|Overall Study|Lost to Follow-up|0|||
127732789|NCT03219216|459646117|FG001|Overall Study|Lost to Follow-up|1|||
127732790|NCT02332824|459646118|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
127732791|NCT02332824|459646119|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
127732792|NCT02332824|459646120|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
127732793|NCT02332824|459646121|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
127732794|NCT02332824|459646122|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
127890586|NCT00408876|460222363|FG002|Overall Study|Withdrawal by Subject|6|||
127890587|NCT00408876|460222364|FG003|Overall Study|Withdrawal by Subject|14|||
127732795|NCT02332824|459646123|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
127732796|NCT02332824|459646118|FG000|Overall Study|Voluntary Withdrawal|1|||
127732797|NCT02332824|459646119|FG001|Overall Study|Voluntary Withdrawal|0|||
127732798|NCT02332824|459646120|FG002|Overall Study|Voluntary Withdrawal|0|||
127732799|NCT02332824|459646121|FG003|Overall Study|Voluntary Withdrawal|0|||
127732800|NCT02332824|459646122|FG004|Overall Study|Voluntary Withdrawal|0|||
127732801|NCT02332824|459646123|FG005|Overall Study|Voluntary Withdrawal|0|||
127732802|NCT02332824|459646118|FG000|Overall Study|Inconvenient schedule|1|||
127732803|NCT02332824|459646119|FG001|Overall Study|Inconvenient schedule|1|||
127732804|NCT02332824|459646120|FG002|Overall Study|Inconvenient schedule|0|||
127732805|NCT02332824|459646121|FG003|Overall Study|Inconvenient schedule|0|||
127732806|NCT02332824|459646122|FG004|Overall Study|Inconvenient schedule|0|||
127732807|NCT02332824|459646123|FG005|Overall Study|Inconvenient schedule|0|||
127732808|NCT02332824|459646118|FG000|Overall Study|Transfer|0|||
127732809|NCT02332824|459646119|FG001|Overall Study|Transfer|0|||
127732810|NCT02332824|459646120|FG002|Overall Study|Transfer|1|||
127732811|NCT02332824|459646121|FG003|Overall Study|Transfer|1|||
127732812|NCT02332824|459646122|FG004|Overall Study|Transfer|0|||
127732813|NCT02332824|459646123|FG005|Overall Study|Transfer|0|||
127732814|NCT00914732|459646124|FG000|Overall Study|Lost to Follow-up|6|||
127732815|NCT00914732|459646125|FG001|Overall Study|Lost to Follow-up|7|||
127732816|NCT00914732|459646126|FG002|Overall Study|Lost to Follow-up|9|||
127732817|NCT00914732|459646124|FG000|Overall Study|Withdrawal by Subject|3|||
127732818|NCT00914732|459646125|FG001|Overall Study|Withdrawal by Subject|0|||
127732819|NCT00914732|459646126|FG002|Overall Study|Withdrawal by Subject|2|||
127732820|NCT00914732|459646124|FG000|Overall Study|Adverse Event|1|||
127732821|NCT00914732|459646125|FG001|Overall Study|Adverse Event|0|||
127732822|NCT00914732|459646126|FG002|Overall Study|Adverse Event|0|||
127732823|NCT03840148|459646129|FG000|Study Drug Disposition|Adverse Event|13|||
127732824|NCT03840148|459646130|FG001|Study Drug Disposition|Adverse Event|2|||
127732825|NCT03840148|459646129|FG000|Study Drug Disposition|Withdrawal by Subject|8|||
127732826|NCT03840148|459646130|FG001|Study Drug Disposition|Withdrawal by Subject|2|||
127732827|NCT03840148|459646129|FG000|Study Drug Disposition|Lack of Efficacy|3|||
127732828|NCT03840148|459646130|FG001|Study Drug Disposition|Lack of Efficacy|0|||
127732829|NCT03840148|459646129|FG000|Study Drug Disposition|Physician Decision|2|||
127732830|NCT03840148|459646130|FG001|Study Drug Disposition|Physician Decision|0|||
127732831|NCT03840148|459646129|FG000|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|1|||
127732832|NCT03840148|459646130|FG001|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|4|||
127732833|NCT03840148|459646129|FG000|Study Completion Disposition|Withdrawal by Subject|6|||
127732834|NCT03840148|459646130|FG001|Study Completion Disposition|Withdrawal by Subject|2|||
127732835|NCT03840148|459646129|FG000|Study Completion Disposition|Physician Decision|2|||
127732836|NCT03840148|459646130|FG001|Study Completion Disposition|Physician Decision|0|||
127732837|NCT03840148|459646129|FG000|Study Completion Disposition|Covid-19 related|2|||
127732838|NCT03840148|459646130|FG001|Study Completion Disposition|Covid-19 related|0|||
127732839|NCT03840148|459646129|FG000|Study Completion Disposition|Lost to Follow-up|1|||
127732840|NCT03840148|459646130|FG001|Study Completion Disposition|Lost to Follow-up|1|||
127732841|NCT03840148|459646129|FG000|Study Completion Disposition|Death|1|||
127732842|NCT03840148|459646130|FG001|Study Completion Disposition|Death|0|||
127732843|NCT03840148|459646129|FG000|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
127732844|NCT03840148|459646130|FG001|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
127732845|NCT00990821|459646134|FG000|Overall Study|Withdrawal by Subject|0|||
127732846|NCT00990821|459646135|FG001|Overall Study|Withdrawal by Subject|2|||
127732847|NCT00990821|459646136|FG002|Overall Study|Withdrawal by Subject|0|||
127732848|NCT00990821|459646137|FG003|Overall Study|Withdrawal by Subject|0|||
127732849|NCT00990821|459646138|FG004|Overall Study|Withdrawal by Subject|3|||
127732850|NCT00990821|459646139|FG005|Overall Study|Withdrawal by Subject|3|||
127732851|NCT00990821|459646140|FG006|Overall Study|Withdrawal by Subject|1|||
127732852|NCT00990821|459646141|FG007|Overall Study|Withdrawal by Subject|0|||
127804833|NCT00944034|459907583|FG010|Overall Study|Protocol Violation|0|||
127804834|NCT00944034|459907584|FG011|Overall Study|Protocol Violation|0|||
127804835|NCT00944034|459907573|FG000|Overall Study|Unable to classify|0|||
127804836|NCT00944034|459907574|FG001|Overall Study|Unable to classify|0|||
127804837|NCT00944034|459907575|FG002|Overall Study|Unable to classify|0|||
127804838|NCT00944034|459907576|FG003|Overall Study|Unable to classify|0|||
127804839|NCT00944034|459907577|FG004|Overall Study|Unable to classify|0|||
127804840|NCT00944034|459907578|FG005|Overall Study|Unable to classify|1|||
127804841|NCT00944034|459907579|FG006|Overall Study|Unable to classify|1|||
127804842|NCT00944034|459907580|FG007|Overall Study|Unable to classify|1|||
127804843|NCT00944034|459907581|FG008|Overall Study|Unable to classify|0|||
127804844|NCT00944034|459907582|FG009|Overall Study|Unable to classify|0|||
127804845|NCT00944034|459907583|FG010|Overall Study|Unable to classify|0|||
127804846|NCT00944034|459907584|FG011|Overall Study|Unable to classify|0|||
127804847|NCT00944034|459907573|FG000|Overall Study|Administrative reason|0|||
127732853|NCT00990821|459646142|FG008|Overall Study|Withdrawal by Subject|0|||
127732854|NCT00990821|459646143|FG009|Overall Study|Withdrawal by Subject|1|||
127732855|NCT00990821|459646144|FG010|Overall Study|Withdrawal by Subject|3|||
127732856|NCT00990821|459646145|FG011|Overall Study|Withdrawal by Subject|5|||
127732857|NCT00990821|459646146|FG012|Overall Study|Withdrawal by Subject|2|||
127732858|NCT00990821|459646147|FG013|Overall Study|Withdrawal by Subject|1|||
127732859|NCT04150250|459646148|FG000|Overall Study|Lost to Follow-up|0|||
127732860|NCT04150250|459646149|FG001|Overall Study|Lost to Follow-up|2|||
127732861|NCT01786551|459646150|FG000|Overall Study|Participant withdrew consent|2|||
127732862|NCT02442622|459646153|FG000|Overall Study|Withdrawal by Subject|3|||
127732863|NCT02442622|459646154|FG001|Overall Study|Withdrawal by Subject|1|||
127732864|NCT01123642|459647971|FG000|Overall Study|Lost to Follow-up|23|||
127732865|NCT01123642|459647971|FG000|Overall Study|Withdrawal by Subject|9|||
127732866|NCT01123642|459647971|FG000|Overall Study|ineligible at baseline assessment|36|||
127732867|NCT03322514|459647972|FG000|Overall Study|Withdrawal by Subject|1|||
127732868|NCT03322514|459647973|FG001|Overall Study|Withdrawal by Subject|1|||
127732869|NCT01184859|459647974|FG000|Period 1: Single Dose|Insufficient urine production|0|||
127732870|NCT01184859|459647975|FG001|Period 1: Single Dose|Insufficient urine production|1|||
127732871|NCT01184859|459647976|FG002|Period 1: Single Dose|Insufficient urine production|0|||
127732872|NCT01184859|459647977|FG003|Period 1: Single Dose|Insufficient urine production|0|||
127732873|NCT01184859|459647978|FG004|Period 1: Single Dose|Insufficient urine production|0|||
127732874|NCT01184859|459647974|FG000|Period 1: Single Dose|Protocol Violation|0|||
127732875|NCT01184859|459647975|FG001|Period 1: Single Dose|Protocol Violation|1|||
127732876|NCT01184859|459647976|FG002|Period 1: Single Dose|Protocol Violation|0|||
127732877|NCT01184859|459647977|FG003|Period 1: Single Dose|Protocol Violation|0|||
127732878|NCT01184859|459647978|FG004|Period 1: Single Dose|Protocol Violation|0|||
127732879|NCT01184859|459647974|FG000|Period 1: Single Dose|Adverse Event|0|||
127732880|NCT01184859|459647975|FG001|Period 1: Single Dose|Adverse Event|0|||
127732881|NCT01184859|459647976|FG002|Period 1: Single Dose|Adverse Event|0|||
127732882|NCT01184859|459647977|FG003|Period 1: Single Dose|Adverse Event|0|||
127732883|NCT01184859|459647978|FG004|Period 1: Single Dose|Adverse Event|1|||
127732884|NCT01184859|459647974|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
127732885|NCT01184859|459647975|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
127732886|NCT01184859|459647976|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
127732887|NCT01184859|459647977|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
127890588|NCT00408876|460222361|FG000|Overall Study|Lack of Efficacy|2|||
127732888|NCT01184859|459647978|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
127732889|NCT01184859|459647974|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
127732890|NCT01184859|459647975|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
127732891|NCT01184859|459647976|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
127732892|NCT01184859|459647977|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
127732893|NCT01184859|459647978|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
127732894|NCT01904019|459647979|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
127732895|NCT01904019|459647979|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
127732896|NCT01904019|459647979|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
127732897|NCT01904019|459647979|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
127732898|NCT01904019|459647979|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
127732899|NCT01904019|459647979|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
127732900|NCT01537120|459647980|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
127732901|NCT01537120|459647980|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
127732902|NCT01503515|459647984|FG000|Overall Study|Adverse Event|4|||
127732903|NCT01503515|459647985|FG001|Overall Study|Adverse Event|5|||
127732904|NCT01503515|459647984|FG000|Overall Study|Death|0|||
127732905|NCT01503515|459647985|FG001|Overall Study|Death|1|||
127732906|NCT01503515|459647984|FG000|Overall Study|Physician Decision|14|||
127732907|NCT01503515|459647985|FG001|Overall Study|Physician Decision|23|||
127732908|NCT01503515|459647984|FG000|Overall Study|Withdrawal by Subject|0|||
127732909|NCT01503515|459647985|FG001|Overall Study|Withdrawal by Subject|1|||
127732910|NCT01503515|459647984|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
127732911|NCT01503515|459647985|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
127732912|NCT01503515|459647984|FG000|Overall Study|Ineligible|1|||
127732913|NCT01503515|459647985|FG001|Overall Study|Ineligible|1|||
127732914|NCT03087851|459647990|FG000|Overall Study|Withdraw on medical grounds|0|||
127732915|NCT03087851|459647991|FG001|Overall Study|Withdraw on medical grounds|1|||
127732916|NCT03087851|459647992|FG002|Overall Study|Withdraw on medical grounds|2|||
127732917|NCT02123797|459647995|FG000|Baseline Intervention|Death|9|||
127732918|NCT02123797|459647996|FG001|Baseline Intervention|Death|16|||
127890589|NCT00408876|460222362|FG001|Overall Study|Lack of Efficacy|4|||
127890590|NCT00408876|460222363|FG002|Overall Study|Lack of Efficacy|5|||
127890591|NCT00408876|460222364|FG003|Overall Study|Lack of Efficacy|6|||
127890592|NCT00408876|460222361|FG000|Overall Study|Lost to Follow-up|1|||
127890593|NCT00408876|460222362|FG001|Overall Study|Lost to Follow-up|6|||
127890594|NCT00408876|460222363|FG002|Overall Study|Lost to Follow-up|5|||
127890595|NCT00408876|460222364|FG003|Overall Study|Lost to Follow-up|2|||
127890596|NCT00408876|460222361|FG000|Overall Study|Protocol Violation|0|||
127890597|NCT00408876|460222362|FG001|Overall Study|Protocol Violation|3|||
127890598|NCT00408876|460222363|FG002|Overall Study|Protocol Violation|4|||
127890599|NCT00408876|460222364|FG003|Overall Study|Protocol Violation|3|||
127890600|NCT00408876|460222361|FG000|Overall Study|Physician Decision|1|||
127732919|NCT02123797|459647997|FG002|Baseline Intervention|Death|0|||
127732920|NCT02123797|459647998|FG003|Baseline Intervention|Death|0|||
127890601|NCT00408876|460222362|FG001|Overall Study|Physician Decision|0|||
127890602|NCT00408876|460222363|FG002|Overall Study|Physician Decision|3|||
127890603|NCT00408876|460222364|FG003|Overall Study|Physician Decision|0|||
127890604|NCT02006147|460222365|FG000|Overall Study|Protocol Violation|1|||
127732921|NCT02123797|459647999|FG004|Baseline Intervention|Death|0|||
127732922|NCT02123797|459647995|FG000|Baseline Intervention|Withdrawal by Subject|2|||
127732923|NCT02123797|459647996|FG001|Baseline Intervention|Withdrawal by Subject|8|||
127732924|NCT02123797|459647997|FG002|Baseline Intervention|Withdrawal by Subject|0|||
127732925|NCT02123797|459647998|FG003|Baseline Intervention|Withdrawal by Subject|0|||
127732926|NCT02123797|459647999|FG004|Baseline Intervention|Withdrawal by Subject|0|||
127890605|NCT02006147|460222366|FG001|Overall Study|Protocol Violation|1|||
127732927|NCT02123797|459647995|FG000|Baseline Intervention|Relocation|2|||
127732928|NCT02123797|459647996|FG001|Baseline Intervention|Relocation|0|||
127732929|NCT02123797|459647997|FG002|Baseline Intervention|Relocation|0|||
127732930|NCT02123797|459647998|FG003|Baseline Intervention|Relocation|0|||
127732931|NCT02123797|459647999|FG004|Baseline Intervention|Relocation|0|||
127732932|NCT02123797|459647995|FG000|Baseline Intervention|Out of window for initial survey|6|||
127732933|NCT02123797|459647996|FG001|Baseline Intervention|Out of window for initial survey|13|||
127732934|NCT02123797|459647997|FG002|Baseline Intervention|Out of window for initial survey|0|||
127732935|NCT02123797|459647998|FG003|Baseline Intervention|Out of window for initial survey|0|||
127732936|NCT02123797|459647999|FG004|Baseline Intervention|Out of window for initial survey|0|||
127732937|NCT02123797|459647995|FG000|Baseline Intervention|Lost to Follow-up|0|||
127732938|NCT02123797|459647996|FG001|Baseline Intervention|Lost to Follow-up|5|||
127732939|NCT02123797|459647997|FG002|Baseline Intervention|Lost to Follow-up|0|||
127732940|NCT02123797|459647998|FG003|Baseline Intervention|Lost to Follow-up|0|||
127732941|NCT02123797|459647999|FG004|Baseline Intervention|Lost to Follow-up|0|||
127732942|NCT02123797|459647995|FG000|Baseline Intervention|Other Disease|3|||
127732943|NCT02123797|459647996|FG001|Baseline Intervention|Other Disease|0|||
127732944|NCT02123797|459647997|FG002|Baseline Intervention|Other Disease|0|||
127732945|NCT02123797|459647998|FG003|Baseline Intervention|Other Disease|0|||
127732946|NCT02123797|459647999|FG004|Baseline Intervention|Other Disease|0|||
127732947|NCT02123797|459647995|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
127732948|NCT02123797|459647996|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
127732949|NCT02123797|459647997|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
127732950|NCT02123797|459647998|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
127732951|NCT02123797|459647999|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
127732952|NCT02123797|459647995|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
127732953|NCT02123797|459647996|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
127732954|NCT02123797|459647997|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
127732955|NCT02123797|459647998|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
127804848|NCT00944034|459907574|FG001|Overall Study|Administrative reason|0|||
127804849|NCT00944034|459907575|FG002|Overall Study|Administrative reason|0|||
127804850|NCT00944034|459907576|FG003|Overall Study|Administrative reason|0|||
127804851|NCT00944034|459907577|FG004|Overall Study|Administrative reason|0|||
127804852|NCT00944034|459907578|FG005|Overall Study|Administrative reason|0|||
127804853|NCT00944034|459907579|FG006|Overall Study|Administrative reason|1|||
127804854|NCT00944034|459907580|FG007|Overall Study|Administrative reason|0|||
127804855|NCT00944034|459907581|FG008|Overall Study|Administrative reason|0|||
127804856|NCT00944034|459907582|FG009|Overall Study|Administrative reason|0|||
127804857|NCT00944034|459907583|FG010|Overall Study|Administrative reason|0|||
127804858|NCT00944034|459907584|FG011|Overall Study|Administrative reason|0|||
127804859|NCT02772757|459907585|FG000|Overall Study|Withdrawal by Subject|1|||
127804860|NCT02772757|459907586|FG001|Overall Study|Withdrawal by Subject|0|||
127804861|NCT02772757|459907587|FG002|Overall Study|Withdrawal by Subject|1|||
127804862|NCT02772757|459907585|FG000|Overall Study|Protocol Violation|0|||
127804863|NCT02772757|459907586|FG001|Overall Study|Protocol Violation|0|||
127804864|NCT02772757|459907587|FG002|Overall Study|Protocol Violation|1|||
127804865|NCT02772757|459907585|FG000|Overall Study|Physician Decision|0|||
127804866|NCT02772757|459907586|FG001|Overall Study|Physician Decision|3|||
127804867|NCT02772757|459907587|FG002|Overall Study|Physician Decision|3|||
127804868|NCT01318122|459907595|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
127804869|NCT01318122|459907596|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
127804870|NCT01318122|459907597|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
127804871|NCT01318122|459907598|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
127804872|NCT01318122|459907595|FG000|Enrolled - Long-Term Extension Study|Other|1|||
127804873|NCT01318122|459907596|FG001|Enrolled - Long-Term Extension Study|Other|0|||
127804874|NCT01318122|459907597|FG002|Enrolled - Long-Term Extension Study|Other|0|||
127804875|NCT01318122|459907598|FG003|Enrolled - Long-Term Extension Study|Other|0|||
127804876|NCT01318122|459907595|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
127804877|NCT01318122|459907596|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
127804878|NCT01318122|459907597|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
127804879|NCT01318122|459907598|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
127804880|NCT01318122|459907595|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
127804881|NCT01318122|459907596|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
127804882|NCT01318122|459907597|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
127804883|NCT01318122|459907598|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
127804884|NCT01318122|459907595|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
127804885|NCT01318122|459907596|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
127804886|NCT01318122|459907597|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
127804887|NCT01318122|459907598|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
127804888|NCT01318122|459907595|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
127804889|NCT01318122|459907596|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
127804890|NCT01318122|459907597|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
127804891|NCT01318122|459907598|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
127804892|NCT01737931|459907603|FG000|Overall Study|Withdrawal by Subject|0|||
127890606|NCT02006147|460222367|FG002|Overall Study|Protocol Violation|0|||
127890607|NCT02006147|460222368|FG003|Overall Study|Protocol Violation|0|||
127732956|NCT02123797|459647999|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
127732957|NCT02123797|459647995|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
127732958|NCT02123797|459647996|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
127732959|NCT02123797|459647997|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
127732960|NCT02123797|459647998|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
127732961|NCT02123797|459647999|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
127732962|NCT02123797|459647995|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
127732963|NCT02123797|459647996|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
127732964|NCT02123797|459647997|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
127732965|NCT02123797|459647998|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
127732966|NCT02123797|459647999|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
127732967|NCT02123797|459647995|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
127732968|NCT02123797|459647996|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
127732969|NCT02123797|459647997|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
127732970|NCT02123797|459647998|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
127732971|NCT02123797|459647999|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
127804893|NCT01737931|459907604|FG001|Overall Study|Withdrawal by Subject|1|||
127732972|NCT02123797|459647995|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
127890608|NCT02006147|460222365|FG000|Overall Study|Withdrawal by Subject|0|||
127890609|NCT02006147|460222366|FG001|Overall Study|Withdrawal by Subject|1|||
127732973|NCT02123797|459647996|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
127732974|NCT02123797|459647997|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
127732975|NCT02123797|459647998|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
127732976|NCT02123797|459647999|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
127732977|NCT02123797|459647995|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
127732978|NCT02123797|459647996|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
127732979|NCT02123797|459647997|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
127804894|NCT01737931|459907605|FG002|Overall Study|Withdrawal by Subject|1|||
127804895|NCT01737931|459907603|FG000|Overall Study|Physician Decision|0|||
127804896|NCT01737931|459907604|FG001|Overall Study|Physician Decision|1|||
127804897|NCT01737931|459907605|FG002|Overall Study|Physician Decision|0|||
127804898|NCT03183128|459907606|FG000|Overall Study|Adverse Event|1|||
127804899|NCT03183128|459907607|FG001|Overall Study|Adverse Event|2|||
127804900|NCT03183128|459907606|FG000|Overall Study|Withdrawal by Subject|1|||
127804901|NCT03183128|459907607|FG001|Overall Study|Withdrawal by Subject|8|||
127804902|NCT03183128|459907606|FG000|Overall Study|Protocol Violation|2|||
127804903|NCT03183128|459907607|FG001|Overall Study|Protocol Violation|0|||
127804904|NCT03183128|459907606|FG000|Overall Study|Lack of Efficacy|4|||
127804905|NCT03183128|459907607|FG001|Overall Study|Lack of Efficacy|27|||
127804906|NCT03183128|459907606|FG000|Overall Study|Lost to Follow-up|1|||
127804907|NCT03183128|459907607|FG001|Overall Study|Lost to Follow-up|0|||
127732980|NCT02123797|459647998|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
127890610|NCT02006147|460222367|FG002|Overall Study|Withdrawal by Subject|0|||
127732981|NCT02123797|459647999|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
127732982|NCT02123797|459647995|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
127732983|NCT02123797|459647996|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
127732984|NCT02123797|459647997|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
127732985|NCT02123797|459647998|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
127732986|NCT02123797|459647999|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
127732987|NCT02123797|459647995|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
127732988|NCT02123797|459647996|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
127732989|NCT02123797|459647997|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
127804908|NCT03183128|459907606|FG000|Overall Study|Death|2|||
127804909|NCT03183128|459907607|FG001|Overall Study|Death|0|||
127804910|NCT03183128|459907606|FG000|Overall Study|Physician Decision|1|||
127804911|NCT03183128|459907607|FG001|Overall Study|Physician Decision|0|||
127804912|NCT01384292|459907613|FG000|Part B|Severe non-compliance to protocol|1|||
127804913|NCT01384292|459907614|FG001|Part B|Severe non-compliance to protocol|0|||
127804914|NCT01384292|459907615|FG002|Part B|Severe non-compliance to protocol|0|||
127732990|NCT02123797|459647998|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
127804915|NCT01171612|459907616|FG000|Overall Study|Lost to Follow-up|51|||
127732991|NCT02123797|459647999|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
127732992|NCT00443755|459648000|FG000|Overall Study|Withdrawal by Subject|2|||
127732993|NCT00443755|459648001|FG001|Overall Study|Withdrawal by Subject|1|||
127732994|NCT00678899|459648004|FG000|Overall Study|Adverse Event|1|||
127732995|NCT03997409|459648010|FG000|Overall Study|Protocol Violation|1|||
127732996|NCT03997409|459648011|FG001|Overall Study|Protocol Violation|1|||
127732997|NCT03997409|459648012|FG002|Overall Study|Protocol Violation|0|||
127732998|NCT03997409|459648010|FG000|Overall Study|Withdrawal by Subject|3|||
127732999|NCT03997409|459648011|FG001|Overall Study|Withdrawal by Subject|0|||
127733000|NCT03997409|459648012|FG002|Overall Study|Withdrawal by Subject|0|||
127733001|NCT03997409|459648010|FG000|Overall Study|Lost to Follow-up|0|||
127733002|NCT03997409|459648011|FG001|Overall Study|Lost to Follow-up|0|||
127733003|NCT03997409|459648012|FG002|Overall Study|Lost to Follow-up|1|||
127733004|NCT01498445|459648014|FG000|Overall Study|Lack of Efficacy|0|||
127733005|NCT01498445|459648015|FG001|Overall Study|Lack of Efficacy|0|||
127733006|NCT01498445|459648016|FG002|Overall Study|Lack of Efficacy|1|||
127733007|NCT01498445|459648017|FG003|Overall Study|Lack of Efficacy|2|||
127733008|NCT01498445|459648018|FG004|Overall Study|Lack of Efficacy|0|||
127733009|NCT01498445|459648019|FG005|Overall Study|Lack of Efficacy|0|||
127733010|NCT01498445|459648014|FG000|Overall Study|Screen Failure|0|||
127733011|NCT01498445|459648015|FG001|Overall Study|Screen Failure|0|||
127733012|NCT01498445|459648016|FG002|Overall Study|Screen Failure|0|||
127733013|NCT01498445|459648017|FG003|Overall Study|Screen Failure|0|||
127733014|NCT01498445|459648018|FG004|Overall Study|Screen Failure|1|||
127733015|NCT01498445|459648019|FG005|Overall Study|Screen Failure|1|||
127733016|NCT02350127|459648022|FG000|4-Month Assessment|Withdrawal by Subject|10|||
127733017|NCT02350127|459648023|FG001|4-Month Assessment|Withdrawal by Subject|9|||
127733018|NCT02350127|459648022|FG000|4-Month Assessment|Death|1|||
127733019|NCT02350127|459648023|FG001|4-Month Assessment|Death|0|||
127733020|NCT02350127|459648022|FG000|8-Month Assessment|Death|1|||
127733021|NCT02350127|459648023|FG001|8-Month Assessment|Death|1|||
127733022|NCT02350127|459648022|FG000|8-Month Assessment|Withdrawal by Subject|5|||
127733023|NCT02350127|459648023|FG001|8-Month Assessment|Withdrawal by Subject|8|||
127733024|NCT03906240|459648024|FG000|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|4|||
127733025|NCT03906240|459648025|FG001|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|0|||
127733026|NCT03906240|459648024|FG000|Overall Study|Lost to Follow-up|1|||
127733027|NCT03906240|459648025|FG001|Overall Study|Lost to Follow-up|0|||
127733028|NCT03906240|459648024|FG000|Overall Study|Withdrawal by Subject|0|||
127733029|NCT03906240|459648025|FG001|Overall Study|Withdrawal by Subject|1|||
127804916|NCT00243659|459907619|FG000|Overall Study|Withdrawal by Subject|1|||
127733030|NCT03751280|459648035|FG000|Overall Study|Adverse Event|0|||
127733031|NCT03751280|459648036|FG001|Overall Study|Adverse Event|1|||
127733032|NCT03751280|459648035|FG000|Overall Study|Lost to Follow-up|3|||
127733033|NCT03751280|459648036|FG001|Overall Study|Lost to Follow-up|5|||
127733034|NCT03751280|459648035|FG000|Overall Study|Physician Decision|0|||
127733035|NCT03751280|459648036|FG001|Overall Study|Physician Decision|2|||
127733036|NCT03751280|459648035|FG000|Overall Study|Protocol Violation|0|||
127733037|NCT03751280|459648036|FG001|Overall Study|Protocol Violation|2|||
127733038|NCT03751280|459648035|FG000|Overall Study|Withdrawal by Subject|5|||
127733039|NCT03751280|459648036|FG001|Overall Study|Withdrawal by Subject|2|||
127804917|NCT00243659|459907620|FG001|Overall Study|Withdrawal by Subject|1|||
127804918|NCT00243659|459907619|FG000|Overall Study|Protocol Violation|1|||
127804919|NCT00243659|459907620|FG001|Overall Study|Protocol Violation|2|||
127804920|NCT03310970|459907621|FG000|Overall Study|Withdrawal by Subject|0|||
127733040|NCT00296504|459648037|FG000|Interim Analysis|Withdrawal by Subject|8|||
127733041|NCT00296504|459648038|FG001|Interim Analysis|Withdrawal by Subject|0|||
127733042|NCT00296504|459648039|FG002|Interim Analysis|Withdrawal by Subject|12|||
127733043|NCT00296504|459648040|FG003|Interim Analysis|Withdrawal by Subject|0|||
127733044|NCT00296504|459648041|FG004|Interim Analysis|Withdrawal by Subject|5|||
127733045|NCT00296504|459648042|FG005|Interim Analysis|Withdrawal by Subject|5|||
127733046|NCT00296504|459648043|FG006|Interim Analysis|Withdrawal by Subject|9|||
127733047|NCT00296504|459648044|FG007|Interim Analysis|Withdrawal by Subject|3|||
127733048|NCT00296504|459648045|FG008|Interim Analysis|Withdrawal by Subject|0|||
127733049|NCT00296504|459648037|FG000|Interim Analysis|Lost to Follow-up|13|||
127733050|NCT00296504|459648038|FG001|Interim Analysis|Lost to Follow-up|3|||
127733051|NCT00296504|459648039|FG002|Interim Analysis|Lost to Follow-up|26|||
127733052|NCT00296504|459648040|FG003|Interim Analysis|Lost to Follow-up|8|||
127733053|NCT00296504|459648041|FG004|Interim Analysis|Lost to Follow-up|14|||
127733054|NCT00296504|459648042|FG005|Interim Analysis|Lost to Follow-up|4|||
127733055|NCT00296504|459648043|FG006|Interim Analysis|Lost to Follow-up|11|||
127733056|NCT00296504|459648044|FG007|Interim Analysis|Lost to Follow-up|4|||
127733057|NCT00296504|459648045|FG008|Interim Analysis|Lost to Follow-up|0|||
127733058|NCT00296504|459648037|FG000|Interim Analysis|Clinical Progression|1|||
127733059|NCT00296504|459648038|FG001|Interim Analysis|Clinical Progression|0|||
127733060|NCT00296504|459648039|FG002|Interim Analysis|Clinical Progression|1|||
127733061|NCT00296504|459648040|FG003|Interim Analysis|Clinical Progression|1|||
127733062|NCT00296504|459648041|FG004|Interim Analysis|Clinical Progression|0|||
127733063|NCT00296504|459648042|FG005|Interim Analysis|Clinical Progression|2|||
127804921|NCT03310970|459907622|FG001|Overall Study|Withdrawal by Subject|1|||
127804922|NCT04062214|459907623|FG000|Week 12|Death|1|||
127804923|NCT04062214|459907624|FG001|Week 12|Death|1|||
127804924|NCT04062214|459907623|FG000|Week 12|Withdrawal by Subject|14|||
127804925|NCT04062214|459907624|FG001|Week 12|Withdrawal by Subject|13|||
127804926|NCT04062214|459907623|FG000|Week 12|Lost to Follow-up|55|||
127804927|NCT04062214|459907624|FG001|Week 12|Lost to Follow-up|68|||
127804928|NCT04062214|459907623|FG000|Week 12|Intermittent missing|31|||
127804929|NCT04062214|459907624|FG001|Week 12|Intermittent missing|29|||
127804930|NCT04062214|459907623|FG000|Week 36|Withdrawal by Subject|4|||
127804931|NCT04062214|459907624|FG001|Week 36|Withdrawal by Subject|5|||
127804932|NCT04062214|459907623|FG000|Week 36|Lost to Follow-up|50|||
127804933|NCT04062214|459907624|FG001|Week 36|Lost to Follow-up|46|||
127804934|NCT04062214|459907623|FG000|Week 36|Death|0|||
127804935|NCT04062214|459907624|FG001|Week 36|Death|1|||
127804936|NCT04666038|459907625|FG000|Overall Study|Progressive Disease|2|||
127804937|NCT04666038|459907626|FG001|Overall Study|Progressive Disease|0|||
127804938|NCT04666038|459907625|FG000|Overall Study|Death|38|||
127804939|NCT04666038|459907626|FG001|Overall Study|Death|32|||
127804940|NCT04666038|459907625|FG000|Overall Study|Withdrawal by Subject|10|||
127733064|NCT00296504|459648043|FG006|Interim Analysis|Clinical Progression|1|||
127733065|NCT00296504|459648044|FG007|Interim Analysis|Clinical Progression|2|||
127733066|NCT00296504|459648045|FG008|Interim Analysis|Clinical Progression|0|||
127733067|NCT00296504|459648037|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
127733068|NCT00296504|459648038|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
127804941|NCT04666038|459907626|FG001|Overall Study|Withdrawal by Subject|19|||
127804942|NCT04666038|459907625|FG000|Overall Study|Lost to Follow-up|0|||
127733069|NCT00296504|459648039|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
127733070|NCT00296504|459648040|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
127733071|NCT00296504|459648041|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
127733072|NCT00296504|459648042|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
127733073|NCT00296504|459648043|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
127733074|NCT00296504|459648044|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
127733075|NCT00296504|459648045|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
127733076|NCT00296504|459648037|FG000|Interim Analysis|Adverse Event|0|||
127733077|NCT00296504|459648038|FG001|Interim Analysis|Adverse Event|0|||
127733078|NCT00296504|459648039|FG002|Interim Analysis|Adverse Event|13|||
127733079|NCT00296504|459648040|FG003|Interim Analysis|Adverse Event|4|||
127733080|NCT00296504|459648041|FG004|Interim Analysis|Adverse Event|6|||
127733081|NCT00296504|459648042|FG005|Interim Analysis|Adverse Event|3|||
127733082|NCT00296504|459648043|FG006|Interim Analysis|Adverse Event|4|||
127733083|NCT00296504|459648044|FG007|Interim Analysis|Adverse Event|5|||
127733084|NCT00296504|459648045|FG008|Interim Analysis|Adverse Event|0|||
127733085|NCT00296504|459648037|FG000|Interim Analysis|Protocol Violation|0|||
127733086|NCT00296504|459648038|FG001|Interim Analysis|Protocol Violation|0|||
127733087|NCT00296504|459648039|FG002|Interim Analysis|Protocol Violation|2|||
127733088|NCT00296504|459648040|FG003|Interim Analysis|Protocol Violation|0|||
127733089|NCT00296504|459648041|FG004|Interim Analysis|Protocol Violation|1|||
127733090|NCT00296504|459648042|FG005|Interim Analysis|Protocol Violation|0|||
127733091|NCT00296504|459648043|FG006|Interim Analysis|Protocol Violation|0|||
127733092|NCT00296504|459648044|FG007|Interim Analysis|Protocol Violation|1|||
127733093|NCT00296504|459648045|FG008|Interim Analysis|Protocol Violation|0|||
127733094|NCT00296504|459648037|FG000|Interim Analysis|Insufficient CD4 Response|0|||
127733095|NCT00296504|459648038|FG001|Interim Analysis|Insufficient CD4 Response|0|||
127733096|NCT00296504|459648039|FG002|Interim Analysis|Insufficient CD4 Response|0|||
127733097|NCT00296504|459648040|FG003|Interim Analysis|Insufficient CD4 Response|0|||
127733098|NCT00296504|459648041|FG004|Interim Analysis|Insufficient CD4 Response|1|||
127733099|NCT00296504|459648042|FG005|Interim Analysis|Insufficient CD4 Response|1|||
127733100|NCT00296504|459648043|FG006|Interim Analysis|Insufficient CD4 Response|0|||
127733101|NCT00296504|459648044|FG007|Interim Analysis|Insufficient CD4 Response|0|||
127733102|NCT00296504|459648045|FG008|Interim Analysis|Insufficient CD4 Response|0|||
127733103|NCT00296504|459648037|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
127733104|NCT00296504|459648038|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
127733105|NCT00296504|459648039|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
127733106|NCT00296504|459648040|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
127733107|NCT00296504|459648041|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
127733108|NCT00296504|459648042|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
127733109|NCT00296504|459648043|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
127733110|NCT00296504|459648044|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
127733111|NCT00296504|459648045|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
127733112|NCT00296504|459648037|FG000|Interim Analysis|Pregnancy|4|||
127733113|NCT00296504|459648038|FG001|Interim Analysis|Pregnancy|1|||
127733114|NCT00296504|459648039|FG002|Interim Analysis|Pregnancy|4|||
127733115|NCT00296504|459648040|FG003|Interim Analysis|Pregnancy|2|||
127733116|NCT00296504|459648041|FG004|Interim Analysis|Pregnancy|0|||
127733117|NCT00296504|459648042|FG005|Interim Analysis|Pregnancy|1|||
127733118|NCT00296504|459648043|FG006|Interim Analysis|Pregnancy|1|||
127733119|NCT00296504|459648044|FG007|Interim Analysis|Pregnancy|1|||
127733120|NCT00296504|459648045|FG008|Interim Analysis|Pregnancy|0|||
127733121|NCT00296504|459648037|FG000|Interim Analysis|Death|1|||
127733122|NCT00296504|459648038|FG001|Interim Analysis|Death|0|||
127733123|NCT00296504|459648039|FG002|Interim Analysis|Death|3|||
127733124|NCT00296504|459648040|FG003|Interim Analysis|Death|0|||
127733125|NCT00296504|459648041|FG004|Interim Analysis|Death|0|||
127733126|NCT00296504|459648042|FG005|Interim Analysis|Death|0|||
127733127|NCT00296504|459648043|FG006|Interim Analysis|Death|0|||
127733128|NCT00296504|459648044|FG007|Interim Analysis|Death|0|||
127733129|NCT00296504|459648045|FG008|Interim Analysis|Death|0|||
127733130|NCT00296504|459648037|FG000|Interim Analysis|Participant Non-compliant|0|||
127733131|NCT00296504|459648038|FG001|Interim Analysis|Participant Non-compliant|1|||
127733132|NCT00296504|459648039|FG002|Interim Analysis|Participant Non-compliant|2|||
127733133|NCT00296504|459648040|FG003|Interim Analysis|Participant Non-compliant|1|||
127733134|NCT00296504|459648041|FG004|Interim Analysis|Participant Non-compliant|1|||
127733135|NCT00296504|459648042|FG005|Interim Analysis|Participant Non-compliant|3|||
127733136|NCT00296504|459648043|FG006|Interim Analysis|Participant Non-compliant|6|||
127733137|NCT00296504|459648044|FG007|Interim Analysis|Participant Non-compliant|2|||
127733138|NCT00296504|459648045|FG008|Interim Analysis|Participant Non-compliant|0|||
127733139|NCT00296504|459648037|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
127733140|NCT00296504|459648038|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
127733141|NCT00296504|459648039|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
127733142|NCT00296504|459648040|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
127733143|NCT00296504|459648041|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
127733144|NCT00296504|459648042|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
127733145|NCT00296504|459648043|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
127733146|NCT00296504|459648044|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
127733147|NCT00296504|459648045|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
127733148|NCT00296504|459648037|FG000|Interim Analysis|To Simplify Treatment|0|||
127804943|NCT04666038|459907626|FG001|Overall Study|Lost to Follow-up|2|||
127804944|NCT04666038|459907625|FG000|Overall Study|On Study Treatment|46|||
127804945|NCT04666038|459907626|FG001|Overall Study|On Study Treatment|5|||
127804946|NCT04666038|459907625|FG000|Overall Study|Off treatment on post-treatment-discontinuation follow-up|23|||
127804947|NCT04666038|459907626|FG001|Overall Study|Off treatment on post-treatment-discontinuation follow-up|61|||
127733149|NCT00296504|459648038|FG001|Interim Analysis|To Simplify Treatment|0|||
127733150|NCT00296504|459648039|FG002|Interim Analysis|To Simplify Treatment|1|||
127804948|NCT01282229|459907637|FG000|Overall Study|Protocol Violation|2|||
127733151|NCT00296504|459648040|FG003|Interim Analysis|To Simplify Treatment|0|||
127733152|NCT00296504|459648041|FG004|Interim Analysis|To Simplify Treatment|0|||
127733153|NCT00296504|459648042|FG005|Interim Analysis|To Simplify Treatment|0|||
127733154|NCT00296504|459648043|FG006|Interim Analysis|To Simplify Treatment|2|||
127733155|NCT00296504|459648044|FG007|Interim Analysis|To Simplify Treatment|0|||
127733156|NCT00296504|459648045|FG008|Interim Analysis|To Simplify Treatment|0|||
127733157|NCT00296504|459648037|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
127733158|NCT00296504|459648038|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
127733159|NCT00296504|459648039|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
127733160|NCT00296504|459648040|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
127733161|NCT00296504|459648041|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
127733162|NCT00296504|459648042|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
127733163|NCT00296504|459648043|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
127733164|NCT00296504|459648044|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
127733165|NCT00296504|459648045|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
127733166|NCT00296504|459648037|FG000|Interim Analysis|Participant Moved|1|||
127733167|NCT00296504|459648038|FG001|Interim Analysis|Participant Moved|0|||
127733168|NCT00296504|459648039|FG002|Interim Analysis|Participant Moved|1|||
127733169|NCT00296504|459648040|FG003|Interim Analysis|Participant Moved|0|||
127733170|NCT00296504|459648041|FG004|Interim Analysis|Participant Moved|0|||
127733171|NCT00296504|459648042|FG005|Interim Analysis|Participant Moved|1|||
127733172|NCT00296504|459648043|FG006|Interim Analysis|Participant Moved|1|||
127733173|NCT00296504|459648044|FG007|Interim Analysis|Participant Moved|0|||
127733174|NCT00296504|459648045|FG008|Interim Analysis|Participant Moved|0|||
127733175|NCT00296504|459648037|FG000|Interim Analysis|Participant Was Incarcerated|2|||
127733176|NCT00296504|459648038|FG001|Interim Analysis|Participant Was Incarcerated|0|||
127733177|NCT00296504|459648039|FG002|Interim Analysis|Participant Was Incarcerated|1|||
127733178|NCT00296504|459648040|FG003|Interim Analysis|Participant Was Incarcerated|0|||
127733179|NCT00296504|459648041|FG004|Interim Analysis|Participant Was Incarcerated|0|||
127733180|NCT00296504|459648042|FG005|Interim Analysis|Participant Was Incarcerated|0|||
127733181|NCT00296504|459648043|FG006|Interim Analysis|Participant Was Incarcerated|0|||
127733182|NCT00296504|459648044|FG007|Interim Analysis|Participant Was Incarcerated|0|||
127733183|NCT00296504|459648045|FG008|Interim Analysis|Participant Was Incarcerated|0|||
127733184|NCT00296504|459648037|FG000|Interim Analysis|Resistance to FPV|0|||
127733185|NCT00296504|459648038|FG001|Interim Analysis|Resistance to FPV|0|||
127733186|NCT00296504|459648039|FG002|Interim Analysis|Resistance to FPV|1|||
127733187|NCT00296504|459648040|FG003|Interim Analysis|Resistance to FPV|0|||
127733188|NCT00296504|459648041|FG004|Interim Analysis|Resistance to FPV|0|||
127733189|NCT00296504|459648042|FG005|Interim Analysis|Resistance to FPV|0|||
127733190|NCT00296504|459648043|FG006|Interim Analysis|Resistance to FPV|0|||
127733191|NCT00296504|459648044|FG007|Interim Analysis|Resistance to FPV|0|||
127733192|NCT00296504|459648045|FG008|Interim Analysis|Resistance to FPV|0|||
127733193|NCT00296504|459648037|FG000|Interim Analysis|Physician Decision|0|||
127733194|NCT00296504|459648038|FG001|Interim Analysis|Physician Decision|0|||
127733195|NCT00296504|459648039|FG002|Interim Analysis|Physician Decision|1|||
127733196|NCT00296504|459648040|FG003|Interim Analysis|Physician Decision|0|||
127733197|NCT00296504|459648041|FG004|Interim Analysis|Physician Decision|0|||
127733198|NCT00296504|459648042|FG005|Interim Analysis|Physician Decision|0|||
127733199|NCT00296504|459648043|FG006|Interim Analysis|Physician Decision|0|||
127733200|NCT00296504|459648044|FG007|Interim Analysis|Physician Decision|0|||
127733201|NCT00296504|459648045|FG008|Interim Analysis|Physician Decision|0|||
127733202|NCT00296504|459648037|FG000|Interim Analysis|Principle Investigator Discretion|2|||
127733203|NCT00296504|459648038|FG001|Interim Analysis|Principle Investigator Discretion|0|||
127733204|NCT00296504|459648039|FG002|Interim Analysis|Principle Investigator Discretion|1|||
127733205|NCT00296504|459648040|FG003|Interim Analysis|Principle Investigator Discretion|1|||
127733206|NCT00296504|459648041|FG004|Interim Analysis|Principle Investigator Discretion|0|||
127733207|NCT00296504|459648042|FG005|Interim Analysis|Principle Investigator Discretion|0|||
127733208|NCT00296504|459648043|FG006|Interim Analysis|Principle Investigator Discretion|0|||
127733209|NCT00296504|459648044|FG007|Interim Analysis|Principle Investigator Discretion|0|||
127733210|NCT00296504|459648045|FG008|Interim Analysis|Principle Investigator Discretion|0|||
127733211|NCT00296504|459648037|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
127733212|NCT00296504|459648038|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
127733213|NCT00296504|459648039|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
127733214|NCT00296504|459648040|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
127733215|NCT00296504|459648041|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
127733216|NCT00296504|459648042|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
127733217|NCT00296504|459648043|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
127733218|NCT00296504|459648044|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
127733219|NCT00296504|459648045|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
127733220|NCT00296504|459648037|FG000|Interim Analysis|Non-adherence|2|||
127733221|NCT00296504|459648038|FG001|Interim Analysis|Non-adherence|0|||
127733222|NCT00296504|459648039|FG002|Interim Analysis|Non-adherence|0|||
127733223|NCT00296504|459648040|FG003|Interim Analysis|Non-adherence|0|||
127733224|NCT00296504|459648041|FG004|Interim Analysis|Non-adherence|1|||
127733225|NCT00296504|459648042|FG005|Interim Analysis|Non-adherence|0|||
127733226|NCT00296504|459648043|FG006|Interim Analysis|Non-adherence|0|||
127733227|NCT00296504|459648044|FG007|Interim Analysis|Non-adherence|1|||
127733228|NCT00296504|459648045|FG008|Interim Analysis|Non-adherence|0|||
127733229|NCT00296504|459648037|FG000|Interim Analysis|Site Closing|1|||
127733230|NCT00296504|459648038|FG001|Interim Analysis|Site Closing|0|||
127733231|NCT00296504|459648039|FG002|Interim Analysis|Site Closing|0|||
127733232|NCT00296504|459648040|FG003|Interim Analysis|Site Closing|0|||
127733233|NCT00296504|459648041|FG004|Interim Analysis|Site Closing|0|||
127733234|NCT00296504|459648042|FG005|Interim Analysis|Site Closing|1|||
127733235|NCT00296504|459648043|FG006|Interim Analysis|Site Closing|2|||
127733236|NCT00296504|459648044|FG007|Interim Analysis|Site Closing|0|||
127733237|NCT00296504|459648045|FG008|Interim Analysis|Site Closing|0|||
127733238|NCT00296504|459648037|FG000|Interim Analysis|Lack of Personnel at Site|1|||
127733239|NCT00296504|459648038|FG001|Interim Analysis|Lack of Personnel at Site|0|||
127733240|NCT00296504|459648039|FG002|Interim Analysis|Lack of Personnel at Site|0|||
127733241|NCT00296504|459648040|FG003|Interim Analysis|Lack of Personnel at Site|0|||
127733242|NCT00296504|459648041|FG004|Interim Analysis|Lack of Personnel at Site|0|||
127733243|NCT00296504|459648042|FG005|Interim Analysis|Lack of Personnel at Site|0|||
127733244|NCT00296504|459648043|FG006|Interim Analysis|Lack of Personnel at Site|0|||
127733245|NCT00296504|459648044|FG007|Interim Analysis|Lack of Personnel at Site|0|||
127733246|NCT00296504|459648045|FG008|Interim Analysis|Lack of Personnel at Site|0|||
127733247|NCT00296504|459648037|FG000|Interim Analysis|Missed Schedule Date|1|||
127733248|NCT00296504|459648038|FG001|Interim Analysis|Missed Schedule Date|0|||
127733249|NCT00296504|459648039|FG002|Interim Analysis|Missed Schedule Date|0|||
127733250|NCT00296504|459648040|FG003|Interim Analysis|Missed Schedule Date|0|||
127733251|NCT00296504|459648041|FG004|Interim Analysis|Missed Schedule Date|0|||
127733252|NCT00296504|459648042|FG005|Interim Analysis|Missed Schedule Date|0|||
127733253|NCT00296504|459648043|FG006|Interim Analysis|Missed Schedule Date|0|||
127733254|NCT00296504|459648044|FG007|Interim Analysis|Missed Schedule Date|0|||
127733255|NCT00296504|459648045|FG008|Interim Analysis|Missed Schedule Date|0|||
127733256|NCT00296504|459648037|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
127733257|NCT00296504|459648038|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
127733258|NCT00296504|459648039|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
127733259|NCT00296504|459648040|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
127733260|NCT00296504|459648041|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
127733261|NCT00296504|459648042|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
127733262|NCT00296504|459648043|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
127733263|NCT00296504|459648044|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
127733264|NCT00296504|459648045|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
127733265|NCT00296504|459648037|FG000|Interim Analysis|Participant Stopped|0|||
127804949|NCT03094195|459907643|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
127804950|NCT03094195|459907644|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
127804951|NCT03094195|459907645|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
127804952|NCT03094195|459907646|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
127804953|NCT03094195|459907647|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
127804954|NCT03094195|459907648|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
127804955|NCT03094195|459907649|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
127804956|NCT03094195|459907650|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
127804957|NCT03094195|459907643|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
127733266|NCT00296504|459648038|FG001|Interim Analysis|Participant Stopped|0|||
127733267|NCT00296504|459648039|FG002|Interim Analysis|Participant Stopped|0|||
127733268|NCT00296504|459648040|FG003|Interim Analysis|Participant Stopped|0|||
127733269|NCT00296504|459648041|FG004|Interim Analysis|Participant Stopped|1|||
127733270|NCT00296504|459648042|FG005|Interim Analysis|Participant Stopped|0|||
127733271|NCT00296504|459648043|FG006|Interim Analysis|Participant Stopped|0|||
127733272|NCT00296504|459648044|FG007|Interim Analysis|Participant Stopped|0|||
127733273|NCT00296504|459648045|FG008|Interim Analysis|Participant Stopped|0|||
127733274|NCT00296504|459648037|FG000|Interim Analysis|Physician and Participant Decision|0|||
127733275|NCT00296504|459648038|FG001|Interim Analysis|Physician and Participant Decision|0|||
127733276|NCT00296504|459648039|FG002|Interim Analysis|Physician and Participant Decision|0|||
127733277|NCT00296504|459648040|FG003|Interim Analysis|Physician and Participant Decision|0|||
127733278|NCT00296504|459648041|FG004|Interim Analysis|Physician and Participant Decision|0|||
127733279|NCT00296504|459648042|FG005|Interim Analysis|Physician and Participant Decision|1|||
127733280|NCT00296504|459648043|FG006|Interim Analysis|Physician and Participant Decision|0|||
127733281|NCT00296504|459648044|FG007|Interim Analysis|Physician and Participant Decision|0|||
127733282|NCT00296504|459648045|FG008|Interim Analysis|Physician and Participant Decision|0|||
127733283|NCT00296504|459648037|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
127733284|NCT00296504|459648038|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
127733285|NCT00296504|459648039|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
127733286|NCT00296504|459648040|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
127733287|NCT00296504|459648041|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
127733288|NCT00296504|459648042|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
127733289|NCT00296504|459648043|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
127733290|NCT00296504|459648044|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
127733291|NCT00296504|459648045|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
127733292|NCT00296504|459648037|FG000|Interim Analysis|Study Ended|0|||
127733293|NCT00296504|459648038|FG001|Interim Analysis|Study Ended|0|||
127733294|NCT00296504|459648039|FG002|Interim Analysis|Study Ended|0|||
127733295|NCT00296504|459648040|FG003|Interim Analysis|Study Ended|0|||
127733296|NCT00296504|459648041|FG004|Interim Analysis|Study Ended|0|||
127733297|NCT00296504|459648042|FG005|Interim Analysis|Study Ended|0|||
127733298|NCT00296504|459648043|FG006|Interim Analysis|Study Ended|1|||
127733299|NCT00296504|459648044|FG007|Interim Analysis|Study Ended|0|||
127733300|NCT00296504|459648045|FG008|Interim Analysis|Study Ended|0|||
127733301|NCT00296504|459648037|FG000|Interim Analysis|Participant Needed Interferon|0|||
127733302|NCT00296504|459648038|FG001|Interim Analysis|Participant Needed Interferon|0|||
127733303|NCT00296504|459648039|FG002|Interim Analysis|Participant Needed Interferon|0|||
127733304|NCT00296504|459648040|FG003|Interim Analysis|Participant Needed Interferon|0|||
127733305|NCT00296504|459648041|FG004|Interim Analysis|Participant Needed Interferon|0|||
127733306|NCT00296504|459648042|FG005|Interim Analysis|Participant Needed Interferon|0|||
127733307|NCT00296504|459648043|FG006|Interim Analysis|Participant Needed Interferon|0|||
127733308|NCT00296504|459648044|FG007|Interim Analysis|Participant Needed Interferon|1|||
127733309|NCT00296504|459648045|FG008|Interim Analysis|Participant Needed Interferon|0|||
127733310|NCT00296504|459648037|FG000|Interim Analysis|Ongoing|32|||
127733311|NCT00296504|459648038|FG001|Interim Analysis|Ongoing|12|||
127733312|NCT00296504|459648039|FG002|Interim Analysis|Ongoing|16|||
127733313|NCT00296504|459648040|FG003|Interim Analysis|Ongoing|22|||
127733314|NCT00296504|459648041|FG004|Interim Analysis|Ongoing|0|||
127733315|NCT00296504|459648042|FG005|Interim Analysis|Ongoing|0|||
127733316|NCT00296504|459648043|FG006|Interim Analysis|Ongoing|30|||
127733317|NCT00296504|459648044|FG007|Interim Analysis|Ongoing|1|||
127733318|NCT00296504|459648045|FG008|Interim Analysis|Ongoing|0|||
127733319|NCT00296504|459648037|FG000|Final Analysis|Withdrawal by Subject|0|||
127733320|NCT00296504|459648038|FG001|Final Analysis|Withdrawal by Subject|0|||
127733321|NCT00296504|459648039|FG002|Final Analysis|Withdrawal by Subject|0|||
127733322|NCT00296504|459648040|FG003|Final Analysis|Withdrawal by Subject|0|||
127733323|NCT00296504|459648041|FG004|Final Analysis|Withdrawal by Subject|0|||
127733324|NCT00296504|459648042|FG005|Final Analysis|Withdrawal by Subject|0|||
127733325|NCT00296504|459648043|FG006|Final Analysis|Withdrawal by Subject|0|||
127733326|NCT00296504|459648044|FG007|Final Analysis|Withdrawal by Subject|0|||
127733327|NCT00296504|459648045|FG008|Final Analysis|Withdrawal by Subject|1|||
127733328|NCT00296504|459648037|FG000|Final Analysis|Lost to Follow-up|0|||
127733329|NCT00296504|459648038|FG001|Final Analysis|Lost to Follow-up|0|||
127733330|NCT00296504|459648039|FG002|Final Analysis|Lost to Follow-up|0|||
127733331|NCT00296504|459648040|FG003|Final Analysis|Lost to Follow-up|0|||
127733332|NCT00296504|459648041|FG004|Final Analysis|Lost to Follow-up|0|||
127733333|NCT00296504|459648042|FG005|Final Analysis|Lost to Follow-up|0|||
127733334|NCT00296504|459648043|FG006|Final Analysis|Lost to Follow-up|0|||
127733335|NCT00296504|459648044|FG007|Final Analysis|Lost to Follow-up|0|||
127733336|NCT00296504|459648045|FG008|Final Analysis|Lost to Follow-up|5|||
127733337|NCT00296504|459648037|FG000|Final Analysis|Insufficient Viral Load Response|0|||
127733338|NCT00296504|459648038|FG001|Final Analysis|Insufficient Viral Load Response|0|||
127733339|NCT00296504|459648039|FG002|Final Analysis|Insufficient Viral Load Response|0|||
127733340|NCT00296504|459648040|FG003|Final Analysis|Insufficient Viral Load Response|0|||
127733341|NCT00296504|459648041|FG004|Final Analysis|Insufficient Viral Load Response|0|||
127733342|NCT00296504|459648042|FG005|Final Analysis|Insufficient Viral Load Response|0|||
127733343|NCT00296504|459648043|FG006|Final Analysis|Insufficient Viral Load Response|0|||
127733344|NCT00296504|459648044|FG007|Final Analysis|Insufficient Viral Load Response|0|||
127733345|NCT00296504|459648045|FG008|Final Analysis|Insufficient Viral Load Response|6|||
127733346|NCT00296504|459648037|FG000|Final Analysis|Adverse Event|0|||
127733347|NCT00296504|459648038|FG001|Final Analysis|Adverse Event|0|||
127733348|NCT00296504|459648039|FG002|Final Analysis|Adverse Event|0|||
127733349|NCT00296504|459648040|FG003|Final Analysis|Adverse Event|0|||
127733350|NCT00296504|459648041|FG004|Final Analysis|Adverse Event|0|||
127733351|NCT00296504|459648042|FG005|Final Analysis|Adverse Event|0|||
127733352|NCT00296504|459648043|FG006|Final Analysis|Adverse Event|0|||
127733353|NCT00296504|459648044|FG007|Final Analysis|Adverse Event|0|||
127733354|NCT00296504|459648045|FG008|Final Analysis|Adverse Event|2|||
127733355|NCT00296504|459648037|FG000|Final Analysis|Pregnancy|0|||
127733356|NCT00296504|459648038|FG001|Final Analysis|Pregnancy|0|||
127733357|NCT00296504|459648039|FG002|Final Analysis|Pregnancy|0|||
127733358|NCT00296504|459648040|FG003|Final Analysis|Pregnancy|0|||
127733359|NCT00296504|459648041|FG004|Final Analysis|Pregnancy|0|||
127733360|NCT00296504|459648042|FG005|Final Analysis|Pregnancy|0|||
127733361|NCT00296504|459648043|FG006|Final Analysis|Pregnancy|0|||
127733362|NCT00296504|459648044|FG007|Final Analysis|Pregnancy|0|||
127733363|NCT00296504|459648045|FG008|Final Analysis|Pregnancy|4|||
127733364|NCT00296504|459648037|FG000|Final Analysis|Tuberculosis|0|||
127733365|NCT00296504|459648038|FG001|Final Analysis|Tuberculosis|0|||
127733366|NCT00296504|459648039|FG002|Final Analysis|Tuberculosis|0|||
127733367|NCT00296504|459648040|FG003|Final Analysis|Tuberculosis|0|||
127733368|NCT00296504|459648041|FG004|Final Analysis|Tuberculosis|0|||
127733369|NCT00296504|459648042|FG005|Final Analysis|Tuberculosis|0|||
127733370|NCT00296504|459648043|FG006|Final Analysis|Tuberculosis|0|||
127733371|NCT00296504|459648044|FG007|Final Analysis|Tuberculosis|0|||
127733372|NCT00296504|459648045|FG008|Final Analysis|Tuberculosis|1|||
127733373|NCT00296504|459648037|FG000|Final Analysis|Participant Moved to Another Country|0|||
127733374|NCT00296504|459648038|FG001|Final Analysis|Participant Moved to Another Country|0|||
127733375|NCT00296504|459648039|FG002|Final Analysis|Participant Moved to Another Country|0|||
127733376|NCT00296504|459648040|FG003|Final Analysis|Participant Moved to Another Country|0|||
127804958|NCT03094195|459907644|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
127733377|NCT00296504|459648041|FG004|Final Analysis|Participant Moved to Another Country|0|||
127733378|NCT00296504|459648042|FG005|Final Analysis|Participant Moved to Another Country|0|||
127733379|NCT00296504|459648043|FG006|Final Analysis|Participant Moved to Another Country|0|||
127733380|NCT00296504|459648044|FG007|Final Analysis|Participant Moved to Another Country|0|||
127733381|NCT00296504|459648045|FG008|Final Analysis|Participant Moved to Another Country|1|||
127804959|NCT03094195|459907645|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
127804960|NCT03094195|459907646|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
127804961|NCT03094195|459907647|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
127804962|NCT03094195|459907648|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
127804963|NCT03094195|459907649|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
127804964|NCT03094195|459907650|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
127733382|NCT00296504|459648037|FG000|Final Analysis|Poor Adherence|0|||
127733383|NCT00296504|459648038|FG001|Final Analysis|Poor Adherence|0|||
127733384|NCT00296504|459648039|FG002|Final Analysis|Poor Adherence|0|||
127733385|NCT00296504|459648040|FG003|Final Analysis|Poor Adherence|0|||
127733386|NCT00296504|459648041|FG004|Final Analysis|Poor Adherence|0|||
127733387|NCT00296504|459648042|FG005|Final Analysis|Poor Adherence|0|||
127733388|NCT00296504|459648043|FG006|Final Analysis|Poor Adherence|0|||
127733389|NCT00296504|459648044|FG007|Final Analysis|Poor Adherence|0|||
127733390|NCT00296504|459648045|FG008|Final Analysis|Poor Adherence|1|||
127733391|NCT02162771|459648051|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
127733392|NCT02162771|459648052|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
127733393|NCT02162771|459648051|FG000|Core Study Period (Part 2)|Adverse Event|4|||
127733394|NCT02162771|459648052|FG001|Core Study Period (Part 2)|Adverse Event|1|||
127733395|NCT02162771|459648051|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
127733396|NCT02162771|459648052|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
127733397|NCT02162771|459648051|FG000|Core Study Period (Part 2)|Physician Decision|0|||
127733398|NCT02162771|459648052|FG001|Core Study Period (Part 2)|Physician Decision|2|||
127733399|NCT02162771|459648051|FG000|Core Study Period (Part 2)|Death|1|||
127733400|NCT02162771|459648052|FG001|Core Study Period (Part 2)|Death|0|||
127733401|NCT02162771|459648051|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
127733402|NCT02162771|459648052|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
127733403|NCT02162771|459648051|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
127733404|NCT02162771|459648052|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
127733405|NCT02162771|459648051|FG000|Maintenance Study Period (Part 2)|Death|2|||
127733406|NCT02162771|459648052|FG001|Maintenance Study Period (Part 2)|Death|1|||
127733407|NCT02162771|459648051|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
127733408|NCT02162771|459648052|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
127733409|NCT02162771|459648051|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
127733410|NCT02162771|459648052|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
127733411|NCT02162771|459648051|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
127733412|NCT02162771|459648052|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
127733413|NCT03647709|459648060|FG000|Overall Study|Lost to Follow-up|5|||
127733414|NCT03647709|459648060|FG000|Overall Study|Physician Decision|6|||
127733415|NCT03647709|459648060|FG000|Overall Study|Withdrawal by Subject|3|||
127733416|NCT00449033|459648061|FG000|Treatment Period|Adverse Event|117|||
127733417|NCT00449033|459648062|FG001|Treatment Period|Adverse Event|83|||
127733418|NCT00449033|459648061|FG000|Treatment Period|Death|21|||
127733419|NCT00449033|459648062|FG001|Treatment Period|Death|12|||
127733420|NCT00449033|459648061|FG000|Treatment Period|Lost to Follow-up|0|||
127733421|NCT00449033|459648062|FG001|Treatment Period|Lost to Follow-up|2|||
127733422|NCT00449033|459648061|FG000|Treatment Period|Physician Decision|4|||
127733423|NCT00449033|459648062|FG001|Treatment Period|Physician Decision|5|||
127733424|NCT00449033|459648061|FG000|Treatment Period|Protocol Violation|8|||
127733425|NCT00449033|459648062|FG001|Treatment Period|Protocol Violation|7|||
127733426|NCT00449033|459648061|FG000|Treatment Period|Disease Progression|231|||
127733427|NCT00449033|459648062|FG001|Treatment Period|Disease Progression|288|||
127733428|NCT00449033|459648061|FG000|Treatment Period|Consent Withdrawn|36|||
127733429|NCT00449033|459648062|FG001|Treatment Period|Consent Withdrawn|20|||
127733430|NCT00449033|459648061|FG000|Treatment Period|Amended Protocol Criteria|22|||
127733431|NCT00449033|459648062|FG001|Treatment Period|Amended Protocol Criteria|18|||
127733432|NCT00449033|459648061|FG000|Treatment Period|Non-compliance|7|||
127733433|NCT00449033|459648062|FG001|Treatment Period|Non-compliance|8|||
127733434|NCT00449033|459648061|FG000|Treatment Period|Second Malignancy|0|||
127733435|NCT00449033|459648062|FG001|Treatment Period|Second Malignancy|1|||
127733436|NCT00449033|459648061|FG000|Treatment Period|Reason Missing|0|||
127733437|NCT00449033|459648062|FG001|Treatment Period|Reason Missing|4|||
127733438|NCT00449033|459648061|FG000|Treatment Period|Treatment Ongoing|6|||
127733439|NCT00449033|459648062|FG001|Treatment Period|Treatment Ongoing|4|||
127733440|NCT00449033|459648061|FG000|Follow-up Period|Death|299|||
127733441|NCT00449033|459648062|FG001|Follow-up Period|Death|311|||
127733442|NCT00449033|459648061|FG000|Follow-up Period|Lost to Follow-up|6|||
127804965|NCT03094195|459907643|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
127804966|NCT03094195|459907644|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
127733443|NCT00449033|459648062|FG001|Follow-up Period|Lost to Follow-up|10|||
127804967|NCT03094195|459907645|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
127804968|NCT03094195|459907646|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
127733444|NCT00449033|459648061|FG000|Follow-up Period|Reason Missing|120|||
127733445|NCT00449033|459648062|FG001|Follow-up Period|Reason Missing|113|||
127733446|NCT01257698|459648065|FG000|Overall Study|Protocol Violation|4|||
127733447|NCT01257698|459648066|FG001|Overall Study|Protocol Violation|0|||
127733448|NCT04393779|459648067|FG000|Overall Study|Death|1|||
127733449|NCT04393779|459648067|FG000|Overall Study|Device reintervention or explant|4|||
127733450|NCT03802513|459648068|FG000|Overall Study|Lost to Follow-up|1|||
127733451|NCT01190228|459648079|FG000|Overall Study|Protocol Violation|4|||
127804969|NCT03094195|459907647|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
127804970|NCT03094195|459907648|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
127804971|NCT03094195|459907649|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
127804972|NCT03094195|459907650|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
127804973|NCT03094195|459907643|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
127804974|NCT03094195|459907644|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
127804975|NCT03094195|459907645|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
127804976|NCT03094195|459907646|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
127804977|NCT03094195|459907647|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
127804978|NCT03094195|459907648|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
127804979|NCT03094195|459907649|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
127804980|NCT03094195|459907650|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
127804981|NCT03887130|459907656|FG000|Overall Study|Progressive disease|23|||
127804982|NCT03887130|459907657|FG001|Overall Study|Progressive disease|14|||
127804983|NCT03887130|459907658|FG002|Overall Study|Progressive disease|7|||
127804984|NCT03887130|459907656|FG000|Overall Study|Protocol Violation|3|||
127804985|NCT03887130|459907657|FG001|Overall Study|Protocol Violation|1|||
127804986|NCT03887130|459907658|FG002|Overall Study|Protocol Violation|2|||
127804987|NCT03887130|459907656|FG000|Overall Study|Drug related toxicity|7|||
127804988|NCT03887130|459907657|FG001|Overall Study|Drug related toxicity|7|||
127804989|NCT03887130|459907658|FG002|Overall Study|Drug related toxicity|13|||
127804990|NCT03887130|459907656|FG000|Overall Study|Non drug related toxicity|3|||
127804991|NCT03887130|459907657|FG001|Overall Study|Non drug related toxicity|0|||
127804992|NCT03887130|459907658|FG002|Overall Study|Non drug related toxicity|0|||
127804993|NCT03887130|459907656|FG000|Overall Study|Death|2|||
127804994|NCT03887130|459907657|FG001|Overall Study|Death|2|||
127804995|NCT03887130|459907658|FG002|Overall Study|Death|1|||
127804996|NCT03887130|459907656|FG000|Overall Study|Withdrawal by Subject|7|||
127804997|NCT03887130|459907657|FG001|Overall Study|Withdrawal by Subject|6|||
127804998|NCT03887130|459907658|FG002|Overall Study|Withdrawal by Subject|11|||
127804999|NCT03887130|459907656|FG000|Overall Study|other reason|6|||
127805000|NCT03887130|459907657|FG001|Overall Study|other reason|20|||
127805001|NCT03887130|459907658|FG002|Overall Study|other reason|17|||
127805002|NCT04082663|459907659|FG000|Overall Study|Adverse Event|6|||
127805003|NCT04082663|459907659|FG000|Overall Study|Lost to Follow-up|1|||
127805004|NCT02440581|459907660|FG000|Overall Study|Death|0|||
127805005|NCT02440581|459907661|FG001|Overall Study|Death|0|||
127805006|NCT02440581|459907662|FG002|Overall Study|Death|7|||
127805007|NCT02440581|459907663|FG003|Overall Study|Death|5|||
127805008|NCT02440581|459907660|FG000|Overall Study|Transplanted|1|||
127805009|NCT02440581|459907661|FG001|Overall Study|Transplanted|0|||
127805010|NCT02440581|459907662|FG002|Overall Study|Transplanted|3|||
127805011|NCT02440581|459907663|FG003|Overall Study|Transplanted|2|||
127805012|NCT02440581|459907660|FG000|Overall Study|Withdrawal by Subject|4|||
127805013|NCT02440581|459907661|FG001|Overall Study|Withdrawal by Subject|11|||
127805014|NCT02440581|459907662|FG002|Overall Study|Withdrawal by Subject|3|||
127805015|NCT02440581|459907663|FG003|Overall Study|Withdrawal by Subject|7|||
127805016|NCT03430986|459907664|FG000|24-week Control Period|Adverse Event|1|||
127805017|NCT03430986|459907665|FG001|24-week Control Period|Adverse Event|0|||
127805018|NCT03430986|459907664|FG000|24-week Control Period|Lost to Follow-up|2|||
127805019|NCT03430986|459907665|FG001|24-week Control Period|Lost to Follow-up|2|||
127805020|NCT03430986|459907664|FG000|24-week Control Period|Withdrawal by Participant|5|||
127805021|NCT03430986|459907665|FG001|24-week Control Period|Withdrawal by Participant|0|||
127733452|NCT01190228|459648080|FG001|Overall Study|Protocol Violation|0|||
127733453|NCT01190228|459648081|FG002|Overall Study|Protocol Violation|0|||
127805022|NCT03430986|459907664|FG000|24-week Control Period|Protocol Deviation|0|||
127805023|NCT03430986|459907665|FG001|24-week Control Period|Protocol Deviation|2|||
127805024|NCT03430986|459907664|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
127805025|NCT03430986|459907665|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
127805026|NCT03430986|459907664|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
127805027|NCT03430986|459907665|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
127805028|NCT01609842|459907667|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
127805029|NCT01609842|459907668|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
127805030|NCT03186989|459907669|FG000|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
127805031|NCT03186989|459907670|FG001|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
127805032|NCT03186989|459907671|FG002|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
127805033|NCT03186989|459907672|FG003|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
127805034|NCT03186989|459907673|FG004|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
127805035|NCT03186989|459907674|FG005|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
127805036|NCT03186989|459907675|FG006|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
127805037|NCT03186989|459907676|FG007|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
127805038|NCT03186989|459907677|FG008|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
127805039|NCT03186989|459907678|FG009|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
127805040|NCT03186989|459907679|FG010|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
127805041|NCT03186989|459907669|FG000|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
127805042|NCT03186989|459907670|FG001|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
127805043|NCT03186989|459907671|FG002|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
127805044|NCT03186989|459907672|FG003|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
127805045|NCT03186989|459907673|FG004|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
127805046|NCT03186989|459907674|FG005|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|1|||
127805047|NCT03186989|459907675|FG006|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
127805048|NCT03186989|459907676|FG007|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
127805049|NCT03186989|459907677|FG008|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
127805050|NCT03186989|459907678|FG009|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
127805051|NCT03186989|459907679|FG010|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
127805052|NCT03186989|459907669|FG000|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
127805053|NCT03186989|459907670|FG001|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
127805054|NCT03186989|459907671|FG002|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
127805055|NCT03186989|459907672|FG003|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
127805056|NCT03186989|459907673|FG004|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
127805057|NCT03186989|459907674|FG005|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
127805058|NCT03186989|459907675|FG006|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|1|||
127805059|NCT03186989|459907676|FG007|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
127805060|NCT03186989|459907677|FG008|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
127805061|NCT03186989|459907678|FG009|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
127805062|NCT03186989|459907679|FG010|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
127805063|NCT03186989|459907669|FG000|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
127805064|NCT03186989|459907670|FG001|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
127805065|NCT03186989|459907671|FG002|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
127805066|NCT03186989|459907672|FG003|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
127805067|NCT03186989|459907673|FG004|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
127805068|NCT03186989|459907674|FG005|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
127805069|NCT03186989|459907675|FG006|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
127805070|NCT03186989|459907676|FG007|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
127805071|NCT03186989|459907677|FG008|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
127805072|NCT03186989|459907678|FG009|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
127805073|NCT03186989|459907679|FG010|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
127805074|NCT01583374|459907680|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
127805075|NCT01583374|459907681|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
127805076|NCT01583374|459907682|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
127890611|NCT02006147|460222368|FG003|Overall Study|Withdrawal by Subject|0|||
127890612|NCT02006147|460222365|FG000|Overall Study|Withdrawal by Sponsor|1|||
127733454|NCT01190228|459648079|FG000|Overall Study|Withdrawal by Subject|1|||
127733455|NCT01190228|459648080|FG001|Overall Study|Withdrawal by Subject|0|||
127733456|NCT01190228|459648081|FG002|Overall Study|Withdrawal by Subject|0|||
127733457|NCT01876823|459648085|FG000|Overall Study|Withdrawal by Subject|5|||
127733458|NCT01876823|459648085|FG000|Overall Study|Physician Decision|2|||
127733459|NCT01876823|459648085|FG000|Overall Study|Patients moved|2|||
127733460|NCT01770509|459648086|FG000|Overall Study|Injury|0|||
127733461|NCT01770509|459648087|FG001|Overall Study|Injury|1|||
127733462|NCT01770509|459648086|FG000|Overall Study|Lost to Follow-up|1|||
127733463|NCT01770509|459648087|FG001|Overall Study|Lost to Follow-up|2|||
127733464|NCT03615404|459648088|FG000|Overall Study|Death|1|||
127733465|NCT03615404|459648088|FG000|Overall Study|vaccine did not pass quality assurance|1|||
127733466|NCT01774929|459648089|FG000|Overall Study|Adverse Event|3|||
127733467|NCT00603278|459648091|FG000|Overall Study|Lack of Efficacy|35|||
127733468|NCT00603278|459648092|FG001|Overall Study|Lack of Efficacy|10|||
127733469|NCT00603278|459648093|FG002|Overall Study|Lack of Efficacy|11|||
127733470|NCT00603278|459648094|FG003|Overall Study|Lack of Efficacy|8|||
127733471|NCT00603278|459648095|FG004|Overall Study|Lack of Efficacy|7|||
127733472|NCT00603278|459648096|FG005|Overall Study|Lack of Efficacy|14|||
127733473|NCT00603278|459648091|FG000|Overall Study|Adverse Event|0|||
127733474|NCT00603278|459648092|FG001|Overall Study|Adverse Event|3|||
127733475|NCT00603278|459648093|FG002|Overall Study|Adverse Event|1|||
127733476|NCT00603278|459648094|FG003|Overall Study|Adverse Event|0|||
127733477|NCT00603278|459648095|FG004|Overall Study|Adverse Event|2|||
127733478|NCT00603278|459648096|FG005|Overall Study|Adverse Event|1|||
127733479|NCT00603278|459648091|FG000|Overall Study|Withdrawal by Subject|2|||
127733480|NCT00603278|459648092|FG001|Overall Study|Withdrawal by Subject|3|||
127733481|NCT00603278|459648093|FG002|Overall Study|Withdrawal by Subject|1|||
127733482|NCT00603278|459648094|FG003|Overall Study|Withdrawal by Subject|2|||
127733483|NCT00603278|459648095|FG004|Overall Study|Withdrawal by Subject|1|||
127733484|NCT00603278|459648096|FG005|Overall Study|Withdrawal by Subject|2|||
127733485|NCT00603278|459648091|FG000|Overall Study|Protocol Violation|3|||
127733486|NCT00603278|459648092|FG001|Overall Study|Protocol Violation|0|||
127733487|NCT00603278|459648093|FG002|Overall Study|Protocol Violation|1|||
127733488|NCT00603278|459648094|FG003|Overall Study|Protocol Violation|1|||
127733489|NCT00603278|459648095|FG004|Overall Study|Protocol Violation|0|||
127733490|NCT00603278|459648096|FG005|Overall Study|Protocol Violation|1|||
127733491|NCT00603278|459648091|FG000|Overall Study|Physician Decision|0|||
127733492|NCT00603278|459648092|FG001|Overall Study|Physician Decision|1|||
127733493|NCT00603278|459648093|FG002|Overall Study|Physician Decision|0|||
127733494|NCT00603278|459648094|FG003|Overall Study|Physician Decision|0|||
127733495|NCT00603278|459648095|FG004|Overall Study|Physician Decision|2|||
127733496|NCT00603278|459648096|FG005|Overall Study|Physician Decision|1|||
127733497|NCT00603278|459648091|FG000|Overall Study|Lost to Follow-up|1|||
127733498|NCT00603278|459648092|FG001|Overall Study|Lost to Follow-up|0|||
127733499|NCT00603278|459648093|FG002|Overall Study|Lost to Follow-up|0|||
127733500|NCT00603278|459648094|FG003|Overall Study|Lost to Follow-up|0|||
127733501|NCT00603278|459648095|FG004|Overall Study|Lost to Follow-up|1|||
127733502|NCT00603278|459648096|FG005|Overall Study|Lost to Follow-up|0|||
127733503|NCT04374253|459648100|FG000|Overall Study|Adverse Event|0|||
127733504|NCT04374253|459648101|FG001|Overall Study|Adverse Event|26|||
127733505|NCT04374253|459648102|FG002|Overall Study|Adverse Event|2|||
127733506|NCT04374253|459648103|FG003|Overall Study|Adverse Event|12|||
127733507|NCT04374253|459648100|FG000|Overall Study|Study terminated by sponsor|13|||
127733508|NCT04374253|459648101|FG001|Overall Study|Study terminated by sponsor|593|||
127733509|NCT04374253|459648102|FG002|Overall Study|Study terminated by sponsor|21|||
127733510|NCT04374253|459648103|FG003|Overall Study|Study terminated by sponsor|567|||
127733511|NCT04374253|459648100|FG000|Overall Study|Withdrawal by Subject|0|||
127733512|NCT04374253|459648101|FG001|Overall Study|Withdrawal by Subject|55|||
127733513|NCT04374253|459648102|FG002|Overall Study|Withdrawal by Subject|3|||
127733514|NCT04374253|459648103|FG003|Overall Study|Withdrawal by Subject|40|||
127733515|NCT04374253|459648100|FG000|Overall Study|Physician Decision|1|||
127733516|NCT04374253|459648101|FG001|Overall Study|Physician Decision|10|||
127733517|NCT04374253|459648102|FG002|Overall Study|Physician Decision|1|||
127733518|NCT04374253|459648103|FG003|Overall Study|Physician Decision|10|||
127733519|NCT04374253|459648100|FG000|Overall Study|Protocol Violation|0|||
127733520|NCT04374253|459648101|FG001|Overall Study|Protocol Violation|0|||
127733521|NCT04374253|459648102|FG002|Overall Study|Protocol Violation|0|||
127733522|NCT04374253|459648103|FG003|Overall Study|Protocol Violation|2|||
127733523|NCT04374253|459648100|FG000|Overall Study|Death|0|||
127733524|NCT04374253|459648101|FG001|Overall Study|Death|3|||
127733525|NCT04374253|459648102|FG002|Overall Study|Death|1|||
127733526|NCT04374253|459648103|FG003|Overall Study|Death|1|||
127733527|NCT04374253|459648100|FG000|Overall Study|Lack of Efficacy|0|||
127733528|NCT04374253|459648101|FG001|Overall Study|Lack of Efficacy|0|||
127733529|NCT04374253|459648102|FG002|Overall Study|Lack of Efficacy|0|||
127733530|NCT04374253|459648103|FG003|Overall Study|Lack of Efficacy|1|||
127733531|NCT04374253|459648100|FG000|Overall Study|Lost to Follow-up|1|||
127733532|NCT04374253|459648101|FG001|Overall Study|Lost to Follow-up|1|||
127733533|NCT04374253|459648102|FG002|Overall Study|Lost to Follow-up|0|||
127733534|NCT04374253|459648103|FG003|Overall Study|Lost to Follow-up|2|||
127733535|NCT04374253|459648100|FG000|Overall Study|Reason Not Specified|0|||
127733536|NCT04374253|459648101|FG001|Overall Study|Reason Not Specified|8|||
127733537|NCT04374253|459648102|FG002|Overall Study|Reason Not Specified|0|||
127733538|NCT04374253|459648103|FG003|Overall Study|Reason Not Specified|8|||
127733539|NCT01207453|459648104|FG000|First Intervention|Adverse Event|2|||
127733540|NCT01207453|459648105|FG001|First Intervention|Adverse Event|1|||
127733541|NCT01207453|459648104|FG000|Washout|Adverse Event|1|||
127733542|NCT01207453|459648105|FG001|Washout|Adverse Event|0|||
127733543|NCT01207453|459648104|FG000|Washout|Lost to Follow-up|1|||
127733544|NCT01207453|459648105|FG001|Washout|Lost to Follow-up|0|||
127733545|NCT01207453|459648104|FG000|2nd Intervention|Adverse Event|1|||
127733546|NCT01207453|459648105|FG001|2nd Intervention|Adverse Event|2|||
127733547|NCT01207453|459648104|FG000|2nd Intervention|Lost to Follow-up|1|||
127733548|NCT01207453|459648105|FG001|2nd Intervention|Lost to Follow-up|0|||
127733549|NCT02577315|459648111|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
127733550|NCT02577315|459648112|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
127733551|NCT00417989|459648113|FG000|Overall Study|Withdrawal by Subject|13|||
127733552|NCT00417989|459648114|FG001|Overall Study|Withdrawal by Subject|13|||
127733553|NCT00417989|459648113|FG000|Overall Study|Lost to Follow-up|1|||
127805077|NCT01583374|459907683|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
127805078|NCT01583374|459907684|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
127733554|NCT00417989|459648114|FG001|Overall Study|Lost to Follow-up|6|||
127733555|NCT00417989|459648113|FG000|Overall Study|Protocol Violation|1|||
127733556|NCT00417989|459648114|FG001|Overall Study|Protocol Violation|0|||
127733557|NCT00417989|459648113|FG000|Overall Study|Death|0|||
127733558|NCT00417989|459648114|FG001|Overall Study|Death|1|||
127733559|NCT00417989|459648113|FG000|Overall Study|Physician Decision|5|||
127733560|NCT00417989|459648114|FG001|Overall Study|Physician Decision|2|||
127733561|NCT01945086|459648115|FG000|Overall Study|Withdrawal by Subject|1|||
127733562|NCT01945086|459648116|FG001|Overall Study|Withdrawal by Subject|0|||
127733563|NCT01945086|459648117|FG002|Overall Study|Withdrawal by Subject|1|||
127733564|NCT01945086|459648115|FG000|Overall Study|Adverse Event|0|||
127733565|NCT01945086|459648116|FG001|Overall Study|Adverse Event|0|||
127733566|NCT01945086|459648117|FG002|Overall Study|Adverse Event|1|||
127733567|NCT00308113|459648118|FG000|Overall Study|Protocol closure|0|||
127733568|NCT00308113|459648119|FG001|Overall Study|Protocol closure|0|||
127733569|NCT00308113|459648120|FG002|Overall Study|Protocol closure|0|||
127733570|NCT00308113|459648121|FG003|Overall Study|Protocol closure|1|||
127733571|NCT00170950|459648123|FG000|Overall Study|Death|236|||
127733572|NCT00170950|459648124|FG001|Overall Study|Death|274|||
127733573|NCT00170950|459648123|FG000|Overall Study|Withdrawal by Subject|496|||
127733574|NCT00170950|459648124|FG001|Overall Study|Withdrawal by Subject|498|||
127733575|NCT00170950|459648123|FG000|Overall Study|Lost to Follow-up|134|||
127733576|NCT00170950|459648124|FG001|Overall Study|Lost to Follow-up|115|||
127733577|NCT00170950|459648123|FG000|Overall Study|Missing|2|||
127805079|NCT01583374|459907685|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
127733578|NCT00170950|459648124|FG001|Overall Study|Missing|1|||
127733579|NCT00170950|459648123|FG000|Overall Study|Termination Data Not Recorded|17|||
127733580|NCT00170950|459648124|FG001|Overall Study|Termination Data Not Recorded|22|||
127733581|NCT00748098|459648125|FG000|First Treatment Intervention Period|Adverse Event|1|||
127805080|NCT01583374|459907686|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
127805081|NCT01583374|459907687|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
127733582|NCT00748098|459648126|FG001|First Treatment Intervention Period|Adverse Event|1|||
127733583|NCT00748098|459648125|FG000|First Treatment Intervention Period|Protocol Violation|1|||
127733584|NCT00748098|459648126|FG001|First Treatment Intervention Period|Protocol Violation|0|||
127733585|NCT00748098|459648125|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
127733586|NCT00748098|459648126|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
127733587|NCT00748098|459648125|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
127733588|NCT00748098|459648126|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
127733589|NCT00748098|459648125|FG000|First Taper Period|Protocol Violation|1|||
127733590|NCT00748098|459648126|FG001|First Taper Period|Protocol Violation|0|||
127733591|NCT00748098|459648125|FG000|First Taper Period|Withdrawal by Subject|2|||
127733592|NCT00748098|459648126|FG001|First Taper Period|Withdrawal by Subject|0|||
127733593|NCT00748098|459648125|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
127733594|NCT00748098|459648126|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
127733595|NCT00748098|459648125|FG000|1-Week Washout Period|Adverse Event|0|||
127733596|NCT00748098|459648126|FG001|1-Week Washout Period|Adverse Event|1|||
127733597|NCT00748098|459648125|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
127733598|NCT00748098|459648126|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
127733599|NCT00748098|459648125|FG000|Second Treatment Intervention Period|Adverse Event|4|||
127733600|NCT00748098|459648126|FG001|Second Treatment Intervention Period|Adverse Event|1|||
127733601|NCT00748098|459648125|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
127733602|NCT00748098|459648126|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
127733603|NCT00748098|459648125|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
127733604|NCT00748098|459648126|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
127733605|NCT00961298|459649612|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
127733606|NCT00961298|459649612|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
127733607|NCT00961298|459649612|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
127733608|NCT01232569|459649613|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
127733609|NCT01232569|459649614|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
127733610|NCT01232569|459649615|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
127733611|NCT01232569|459649616|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
127733612|NCT01232569|459649613|FG000|Double-blind Treatment Period|Escape|2|||
127733613|NCT01232569|459649614|FG001|Double-blind Treatment Period|Escape|2|||
127733614|NCT01232569|459649615|FG002|Double-blind Treatment Period|Escape|0|||
127733615|NCT01232569|459649616|FG003|Double-blind Treatment Period|Escape|0|||
127733616|NCT01232569|459649613|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
127733617|NCT01232569|459649614|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
127733618|NCT01232569|459649615|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
127733619|NCT01232569|459649616|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
127733620|NCT01232569|459649613|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
127733621|NCT01232569|459649614|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
127733622|NCT01232569|459649615|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
127733623|NCT01232569|459649616|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
127733624|NCT01232569|459649613|FG000|Double-blind Treatment Period|Physician Decision|1|||
127733625|NCT01232569|459649614|FG001|Double-blind Treatment Period|Physician Decision|0|||
127733626|NCT01232569|459649615|FG002|Double-blind Treatment Period|Physician Decision|0|||
127733627|NCT01232569|459649616|FG003|Double-blind Treatment Period|Physician Decision|0|||
127733628|NCT01232569|459649613|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
127733629|NCT01232569|459649614|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
127733630|NCT01232569|459649615|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
127733631|NCT01232569|459649616|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
127733632|NCT01232569|459649613|FG000|Double-blind Treatment Period|Death|2|||
127733633|NCT01232569|459649614|FG001|Double-blind Treatment Period|Death|0|||
127733634|NCT01232569|459649615|FG002|Double-blind Treatment Period|Death|0|||
127733635|NCT01232569|459649616|FG003|Double-blind Treatment Period|Death|0|||
127733636|NCT04044352|459649617|FG000|Overall Study|Lost to Follow-up|9|||
127733637|NCT04044352|459649617|FG000|Overall Study|Withdrawal by Subject|2|||
127733638|NCT00651937|459649618|FG000|Overall Study|Withdrawal by Subject|4|||
127733639|NCT00651937|459649619|FG001|Overall Study|Withdrawal by Subject|1|||
127805082|NCT01583374|459907688|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
127805083|NCT01583374|459907680|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
127733640|NCT00814632|459649621|FG000|Overall Study|Lack of Efficacy|2|||
127733641|NCT02514577|459649626|FG000|Overall Study|Lost to Follow-up|6|||
127733642|NCT02514577|459649627|FG001|Overall Study|Lost to Follow-up|6|||
127733643|NCT02514577|459649626|FG000|Overall Study|Protocol Violation|1|||
127733644|NCT02514577|459649627|FG001|Overall Study|Protocol Violation|0|||
127733645|NCT02514577|459649626|FG000|Overall Study|Withdrawal by Subject|6|||
127733646|NCT02514577|459649627|FG001|Overall Study|Withdrawal by Subject|6|||
127805084|NCT01583374|459907681|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
127733647|NCT02514577|459649626|FG000|Overall Study|Adverse Event|1|||
127733648|NCT02514577|459649627|FG001|Overall Study|Adverse Event|1|||
127733649|NCT02388932|459649628|FG000|Overall Study|Death|1|||
127733650|NCT01753323|459649629|FG000|Overall Study|Lack of Efficacy|0|||
127733651|NCT01753323|459649630|FG001|Overall Study|Lack of Efficacy|0|||
127733652|NCT01753323|459649631|FG002|Overall Study|Lack of Efficacy|8|||
127733653|NCT01753323|459649629|FG000|Overall Study|Protocol deviation|1|||
127733654|NCT01753323|459649630|FG001|Overall Study|Protocol deviation|0|||
127733655|NCT01753323|459649631|FG002|Overall Study|Protocol deviation|0|||
127733656|NCT01753323|459649629|FG000|Overall Study|Adverse Event|0|||
127733657|NCT01753323|459649630|FG001|Overall Study|Adverse Event|0|||
127733658|NCT01753323|459649631|FG002|Overall Study|Adverse Event|1|||
127733659|NCT03568708|459649634|FG000|Overall Study|Withdrawal by Subject|1|||
127733660|NCT03568708|459649635|FG001|Overall Study|Withdrawal by Subject|1|||
127733661|NCT03568708|459649634|FG000|Overall Study|Lost to Follow-up|0|||
127733662|NCT03568708|459649635|FG001|Overall Study|Lost to Follow-up|1|||
127733663|NCT00511147|459649636|FG000|Overall Study|Withdrawal by Subject|1|||
127733664|NCT00511147|459649636|FG000|Overall Study|Disease progression|5|||
127733665|NCT00511147|459649636|FG000|Overall Study|Required platelet transfusion|1|||
127733666|NCT00809783|459649637|FG000|Overall Study|Death|1|||
127733667|NCT00809783|459649638|FG001|Overall Study|Death|0|||
127733668|NCT00809783|459649639|FG002|Overall Study|Death|0|||
127733669|NCT00809783|459649637|FG000|Overall Study|Adverse Event|34|||
127733670|NCT00809783|459649638|FG001|Overall Study|Adverse Event|52|||
127733671|NCT00809783|459649639|FG002|Overall Study|Adverse Event|71|||
127733672|NCT00809783|459649637|FG000|Overall Study|Lack of Efficacy|39|||
127733673|NCT00809783|459649638|FG001|Overall Study|Lack of Efficacy|52|||
127733674|NCT00809783|459649639|FG002|Overall Study|Lack of Efficacy|63|||
127733675|NCT00809783|459649637|FG000|Overall Study|Lost to Follow-up|0|||
127733676|NCT00809783|459649638|FG001|Overall Study|Lost to Follow-up|3|||
127733677|NCT00809783|459649639|FG002|Overall Study|Lost to Follow-up|4|||
127733678|NCT00809783|459649637|FG000|Overall Study|Withdrawal by Subject|47|||
127733679|NCT00809783|459649638|FG001|Overall Study|Withdrawal by Subject|72|||
127733680|NCT00809783|459649639|FG002|Overall Study|Withdrawal by Subject|64|||
127733681|NCT00809783|459649637|FG000|Overall Study|Protocol Violation|2|||
127733682|NCT00809783|459649638|FG001|Overall Study|Protocol Violation|6|||
127733683|NCT00809783|459649639|FG002|Overall Study|Protocol Violation|5|||
127733684|NCT00809783|459649637|FG000|Overall Study|Randomized, but not treated|3|||
127733685|NCT00809783|459649638|FG001|Overall Study|Randomized, but not treated|0|||
127733686|NCT00809783|459649639|FG002|Overall Study|Randomized, but not treated|2|||
127733687|NCT00809783|459649637|FG000|Overall Study|Study Terminated by Sponsor|378|||
127733688|NCT00809783|459649638|FG001|Overall Study|Study Terminated by Sponsor|626|||
127733689|NCT00809783|459649639|FG002|Overall Study|Study Terminated by Sponsor|565|||
127733690|NCT00809783|459649637|FG000|Overall Study|Other|21|||
127733691|NCT00809783|459649638|FG001|Overall Study|Other|21|||
127733692|NCT00809783|459649639|FG002|Overall Study|Other|16|||
127733693|NCT00126555|459649640|FG000|Overall Study|Withdrawal by Subject|1|||
127733694|NCT00126555|459649640|FG000|Overall Study|Adverse Event|2|||
127733695|NCT00126555|459649640|FG000|Overall Study|Progressive Disease|3|||
127733696|NCT00396097|459649643|FG000|Overall Study|Withdrawal by Subject|17|||
127733697|NCT00396097|459649644|FG001|Overall Study|Withdrawal by Subject|17|||
127733698|NCT00396097|459649643|FG000|Overall Study|Lost to Follow-up|4|||
127733699|NCT00396097|459649644|FG001|Overall Study|Lost to Follow-up|9|||
127733700|NCT00396097|459649643|FG000|Overall Study|Other|3|||
127733701|NCT00396097|459649644|FG001|Overall Study|Other|5|||
127733702|NCT00396097|459649643|FG000|Overall Study|Protocol Violation|0|||
127733703|NCT00396097|459649644|FG001|Overall Study|Protocol Violation|6|||
127733704|NCT00396097|459649643|FG000|Overall Study|Adverse Event|1|||
127733705|NCT00396097|459649644|FG001|Overall Study|Adverse Event|5|||
127733706|NCT00396097|459649643|FG000|Overall Study|Insufficient Clinical Response|1|||
127733707|NCT00396097|459649644|FG001|Overall Study|Insufficient Clinical Response|4|||
127733708|NCT01732588|459649645|FG000|First Intervention (7 Days)|Adverse Event|0|||
127890613|NCT02006147|460222366|FG001|Overall Study|Withdrawal by Sponsor|0|||
127890614|NCT02006147|460222367|FG002|Overall Study|Withdrawal by Sponsor|0|||
127733709|NCT01732588|459649646|FG001|First Intervention (7 Days)|Adverse Event|1|||
127733710|NCT01732588|459649647|FG002|First Intervention (7 Days)|Adverse Event|0|||
127733711|NCT00730925|459649651|FG000|Overall Study|Progressive Disease|21|||
127733712|NCT00730925|459649651|FG000|Overall Study|Dose reducing Event|2|||
127733713|NCT00730925|459649651|FG000|Overall Study|Other Averse Event|7|||
127733714|NCT00730925|459649651|FG000|Overall Study|Protocol Violation|1|||
127733715|NCT00730925|459649651|FG000|Overall Study|Withdrawal by Subject|1|||
127733716|NCT00730925|459649651|FG000|Overall Study|Switch to combination therapy|8|||
127733717|NCT00730925|459649651|FG000|Overall Study|Other|1|||
127733718|NCT01732627|459649652|FG000|Overall Study|Withdrawal by Subject|1|||
127733719|NCT01732627|459649653|FG001|Overall Study|Withdrawal by Subject|0|||
127733720|NCT00005908|459649656|FG000|Overall Study|Withdrawal by Subject|1|||
127733721|NCT00005908|459649657|FG001|Overall Study|Withdrawal by Subject|0|||
127733722|NCT04736602|459649660|FG000|Main Study Phase|Withdrawal by Parent/Guardian|2|||
127733723|NCT04736602|459649660|FG000|Extension Phase|Withdrawal by Parent/Guardian|1|||
127733724|NCT02131155|459649666|FG000|Overall Study|Adverse Event|1|||
127733725|NCT02131155|459649667|FG001|Overall Study|Adverse Event|0|||
127733726|NCT02131155|459649666|FG000|Overall Study|Treatment completed|1|||
127733727|NCT02131155|459649667|FG001|Overall Study|Treatment completed|0|||
127733728|NCT02131155|459649666|FG000|Overall Study|Primary tumour recurrence|2|||
127733729|NCT02131155|459649667|FG001|Overall Study|Primary tumour recurrence|1|||
127733730|NCT02131155|459649666|FG000|Overall Study|Refused to continue study medication|1|||
127733731|NCT02131155|459649667|FG001|Overall Study|Refused to continue study medication|0|||
127733732|NCT02131155|459649666|FG000|Overall Study|Study early termination|20|||
127733733|NCT02131155|459649667|FG001|Overall Study|Study early termination|10|||
127733734|NCT01887418|459649668|FG000|Overall Study|Travelling difficulties|0|||
127733735|NCT01887418|459649669|FG001|Overall Study|Travelling difficulties|0|||
127733736|NCT01887418|459649670|FG002|Overall Study|Travelling difficulties|1|||
127733737|NCT00475735|459649671|FG000|Treatment Period 1|Adverse Event|2|||
127733738|NCT00475735|459649672|FG001|Treatment Period 1|Adverse Event|0|||
127733739|NCT00475735|459649673|FG002|Treatment Period 1|Adverse Event|0|||
127733740|NCT00475735|459649674|FG003|Treatment Period 1|Adverse Event|0|||
127733741|NCT00475735|459649675|FG004|Treatment Period 1|Adverse Event|0|||
127733742|NCT00475735|459649676|FG005|Treatment Period 1|Adverse Event|0|||
127733743|NCT00475735|459649671|FG000|Treatment Period 1|Lack of Efficacy|1|||
127733744|NCT00475735|459649672|FG001|Treatment Period 1|Lack of Efficacy|0|||
127733745|NCT00475735|459649673|FG002|Treatment Period 1|Lack of Efficacy|0|||
127733746|NCT00475735|459649674|FG003|Treatment Period 1|Lack of Efficacy|0|||
127733747|NCT00475735|459649675|FG004|Treatment Period 1|Lack of Efficacy|0|||
127733748|NCT00475735|459649676|FG005|Treatment Period 1|Lack of Efficacy|0|||
127733749|NCT00475735|459649671|FG000|Treatment Period 1|Lost to Follow-up|0|||
127733750|NCT00475735|459649672|FG001|Treatment Period 1|Lost to Follow-up|0|||
127733751|NCT00475735|459649673|FG002|Treatment Period 1|Lost to Follow-up|0|||
127733752|NCT00475735|459649674|FG003|Treatment Period 1|Lost to Follow-up|0|||
127733753|NCT00475735|459649675|FG004|Treatment Period 1|Lost to Follow-up|0|||
127733754|NCT00475735|459649676|FG005|Treatment Period 1|Lost to Follow-up|1|||
127733755|NCT00475735|459649671|FG000|Treatment Period 1|Protocol Violation|0|||
127733756|NCT00475735|459649672|FG001|Treatment Period 1|Protocol Violation|0|||
127733757|NCT00475735|459649673|FG002|Treatment Period 1|Protocol Violation|0|||
127733758|NCT00475735|459649674|FG003|Treatment Period 1|Protocol Violation|1|||
127733759|NCT00475735|459649675|FG004|Treatment Period 1|Protocol Violation|0|||
127733760|NCT00475735|459649676|FG005|Treatment Period 1|Protocol Violation|0|||
127733761|NCT00475735|459649671|FG000|Treatment Period 1|Withdrawal by Subject|1|||
127733762|NCT00475735|459649672|FG001|Treatment Period 1|Withdrawal by Subject|1|||
127733763|NCT00475735|459649673|FG002|Treatment Period 1|Withdrawal by Subject|0|||
127733764|NCT00475735|459649674|FG003|Treatment Period 1|Withdrawal by Subject|0|||
127733765|NCT00475735|459649675|FG004|Treatment Period 1|Withdrawal by Subject|0|||
127733766|NCT00475735|459649676|FG005|Treatment Period 1|Withdrawal by Subject|0|||
127733767|NCT00475735|459649671|FG000|Treatment Period 1|DC due to AE but continuing|0|||
127733768|NCT00475735|459649672|FG001|Treatment Period 1|DC due to AE but continuing|0|||
127733769|NCT00475735|459649673|FG002|Treatment Period 1|DC due to AE but continuing|0|||
127733770|NCT00475735|459649674|FG003|Treatment Period 1|DC due to AE but continuing|1|||
127733771|NCT00475735|459649675|FG004|Treatment Period 1|DC due to AE but continuing|2|||
127733772|NCT00475735|459649676|FG005|Treatment Period 1|DC due to AE but continuing|2|||
127733773|NCT00475735|459649671|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
127733774|NCT00475735|459649672|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
127733775|NCT00475735|459649673|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
127733776|NCT00475735|459649674|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
127733777|NCT00475735|459649675|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
127733778|NCT00475735|459649676|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
127733779|NCT00475735|459649671|FG000|Treatment Washout|Lost to Follow-up|0|||
127733780|NCT00475735|459649672|FG001|Treatment Washout|Lost to Follow-up|1|||
127733781|NCT00475735|459649673|FG002|Treatment Washout|Lost to Follow-up|0|||
127733782|NCT00475735|459649674|FG003|Treatment Washout|Lost to Follow-up|0|||
127733783|NCT00475735|459649675|FG004|Treatment Washout|Lost to Follow-up|0|||
127733784|NCT00475735|459649676|FG005|Treatment Washout|Lost to Follow-up|0|||
127733785|NCT00475735|459649671|FG000|Treatment Washout|Protocol Violation|0|||
127733786|NCT00475735|459649672|FG001|Treatment Washout|Protocol Violation|1|||
127733787|NCT00475735|459649673|FG002|Treatment Washout|Protocol Violation|0|||
127733788|NCT00475735|459649674|FG003|Treatment Washout|Protocol Violation|0|||
127733789|NCT00475735|459649675|FG004|Treatment Washout|Protocol Violation|0|||
127733790|NCT00475735|459649676|FG005|Treatment Washout|Protocol Violation|0|||
127733791|NCT00475735|459649671|FG000|Treatment Period 2|Adverse Event|0|||
127733792|NCT00475735|459649672|FG001|Treatment Period 2|Adverse Event|1|||
127733793|NCT00475735|459649673|FG002|Treatment Period 2|Adverse Event|0|||
127733794|NCT00475735|459649674|FG003|Treatment Period 2|Adverse Event|2|||
127733795|NCT00475735|459649675|FG004|Treatment Period 2|Adverse Event|0|||
127733796|NCT00475735|459649676|FG005|Treatment Period 2|Adverse Event|0|||
127733797|NCT00475735|459649671|FG000|Treatment Period 2|Lack of Efficacy|0|||
127733798|NCT00475735|459649672|FG001|Treatment Period 2|Lack of Efficacy|0|||
127733799|NCT00475735|459649673|FG002|Treatment Period 2|Lack of Efficacy|0|||
127733800|NCT00475735|459649674|FG003|Treatment Period 2|Lack of Efficacy|0|||
127733801|NCT00475735|459649675|FG004|Treatment Period 2|Lack of Efficacy|0|||
127733802|NCT00475735|459649676|FG005|Treatment Period 2|Lack of Efficacy|1|||
127733803|NCT00475735|459649671|FG000|Treatment Period 2|Withdrawal by Subject|0|||
127733804|NCT00475735|459649672|FG001|Treatment Period 2|Withdrawal by Subject|0|||
127733805|NCT00475735|459649673|FG002|Treatment Period 2|Withdrawal by Subject|0|||
127733806|NCT00475735|459649674|FG003|Treatment Period 2|Withdrawal by Subject|0|||
127733807|NCT00475735|459649675|FG004|Treatment Period 2|Withdrawal by Subject|1|||
127733808|NCT00475735|459649676|FG005|Treatment Period 2|Withdrawal by Subject|0|||
127733809|NCT03132753|459649677|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
127733810|NCT03132753|459649678|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
127733811|NCT03132753|459649677|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
127733812|NCT03132753|459649678|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
127733813|NCT00125853|459649679|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
127733814|NCT00125853|459649680|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
127733815|NCT02097056|459649684|FG000|Overall Study|Protocol Violation|2|||
127733816|NCT02097056|459649684|FG000|Overall Study|Withdrawal by Subject|15|||
127733817|NCT02097056|459649684|FG000|Overall Study|Lost to Follow-up|2|||
127733818|NCT02097056|459649684|FG000|Overall Study|Adverse Event|37|||
127733819|NCT02097056|459649684|FG000|Overall Study|Other|2|||
127733820|NCT01446042|459649685|FG000|Overall Study|Withdrawal by Subject|12|||
127733821|NCT01446042|459649686|FG001|Overall Study|Withdrawal by Subject|2|||
127733822|NCT01446042|459649687|FG002|Overall Study|Withdrawal by Subject|4|||
127733823|NCT01446042|459649685|FG000|Overall Study|Adverse Event|1|||
127733824|NCT01446042|459649686|FG001|Overall Study|Adverse Event|0|||
127733825|NCT01446042|459649687|FG002|Overall Study|Adverse Event|4|||
127733826|NCT01446042|459649685|FG000|Overall Study|Lost to Follow-up|5|||
127733827|NCT01446042|459649686|FG001|Overall Study|Lost to Follow-up|0|||
127733828|NCT01446042|459649687|FG002|Overall Study|Lost to Follow-up|0|||
127733829|NCT01446042|459649685|FG000|Overall Study|Other reasons|2|||
127733830|NCT01446042|459649686|FG001|Overall Study|Other reasons|1|||
127733831|NCT01446042|459649687|FG002|Overall Study|Other reasons|1|||
127733832|NCT03575572|459649688|FG000|Overall Study|Withdrawal by Subject|2|||
127733833|NCT03575572|459649688|FG000|Overall Study|Physician Decision|2|||
127733834|NCT00157209|459649691|FG000|Overall Study|Ongoing at data cut-off|10|||
127733835|NCT00157209|459649692|FG001|Overall Study|Ongoing at data cut-off|0|||
127733836|NCT03023878|459649708|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
127733837|NCT03023878|459649708|FG000|Pre-Study Run-In Period|Death|1|||
127733838|NCT03023878|459649708|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
127733839|NCT03023878|459649708|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
127733840|NCT03023878|459649708|FG000|Treatment Period|Disease Progression|1|||
127733841|NCT03023878|459649708|FG000|Treatment Period|Withdrawal by Subject|1|||
127733842|NCT03023878|459649708|FG000|Treatment Period|Adverse Event|1|||
127733843|NCT03023878|459649708|FG000|Long Term Follow-Up Period|Death|2|||
127733844|NCT01247922|459649709|FG000|Overall Study|Disease progression|4|||
127733845|NCT00577096|459649712|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
127733846|NCT00577096|459649713|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
127733847|NCT00577096|459649712|FG000|Short Term Participation|Withdrawal by Subject|3|||
127733848|NCT00577096|459649713|FG001|Short Term Participation|Withdrawal by Subject|5|||
127733849|NCT00577096|459649712|FG000|Short Term Participation|Death|1|||
127733850|NCT00577096|459649713|FG001|Short Term Participation|Death|1|||
127733851|NCT00985621|459649718|FG000|Overall Study|Adverse Event|2|||
127733852|NCT00985621|459649719|FG001|Overall Study|Adverse Event|3|||
127733853|NCT00985621|459649720|FG002|Overall Study|Adverse Event|4|||
127733854|NCT00985621|459649721|FG003|Overall Study|Adverse Event|16|||
127733855|NCT00985621|459649718|FG000|Overall Study|Lack of Efficacy|10|||
127733856|NCT00985621|459649719|FG001|Overall Study|Lack of Efficacy|6|||
127733857|NCT00985621|459649720|FG002|Overall Study|Lack of Efficacy|5|||
127733858|NCT00985621|459649721|FG003|Overall Study|Lack of Efficacy|12|||
127733859|NCT00985621|459649718|FG000|Overall Study|Lost to Follow-up|2|||
127733860|NCT00985621|459649719|FG001|Overall Study|Lost to Follow-up|3|||
127733861|NCT00985621|459649720|FG002|Overall Study|Lost to Follow-up|4|||
127733862|NCT00985621|459649721|FG003|Overall Study|Lost to Follow-up|4|||
127733863|NCT00985621|459649718|FG000|Overall Study|Study Terminated by Sponsor|89|||
127733864|NCT00985621|459649719|FG001|Overall Study|Study Terminated by Sponsor|108|||
127733865|NCT00985621|459649720|FG002|Overall Study|Study Terminated by Sponsor|99|||
127733866|NCT00985621|459649721|FG003|Overall Study|Study Terminated by Sponsor|92|||
127733867|NCT00985621|459649718|FG000|Overall Study|Protocol Violation|1|||
127733868|NCT00985621|459649719|FG001|Overall Study|Protocol Violation|1|||
127733869|NCT00985621|459649720|FG002|Overall Study|Protocol Violation|1|||
127733870|NCT00985621|459649721|FG003|Overall Study|Protocol Violation|0|||
127733871|NCT00985621|459649718|FG000|Overall Study|Withdrawal by Subject|8|||
127733872|NCT00985621|459649719|FG001|Overall Study|Withdrawal by Subject|10|||
127733873|NCT00985621|459649720|FG002|Overall Study|Withdrawal by Subject|8|||
127733874|NCT00985621|459649721|FG003|Overall Study|Withdrawal by Subject|12|||
127733875|NCT00985621|459649718|FG000|Overall Study|Other|1|||
127733876|NCT00985621|459649719|FG001|Overall Study|Other|0|||
127733877|NCT00985621|459649720|FG002|Overall Study|Other|0|||
127733878|NCT00985621|459649721|FG003|Overall Study|Other|0|||
127733879|NCT00985621|459649718|FG000|Overall Study|Randomized but not Treated|1|||
127733880|NCT00985621|459649719|FG001|Overall Study|Randomized but not Treated|0|||
127733881|NCT00985621|459649720|FG002|Overall Study|Randomized but not Treated|2|||
127733882|NCT00985621|459649721|FG003|Overall Study|Randomized but not Treated|1|||
127733883|NCT01911819|459649722|FG000|Overall Study|Adverse Event|0|||
127733884|NCT01911819|459649723|FG001|Overall Study|Adverse Event|1|||
127733885|NCT01911819|459649724|FG002|Overall Study|Adverse Event|0|||
127733886|NCT01911819|459649722|FG000|Overall Study|Withdrawal by Subject|1|||
127733887|NCT01911819|459649723|FG001|Overall Study|Withdrawal by Subject|1|||
127733888|NCT01911819|459649724|FG002|Overall Study|Withdrawal by Subject|0|||
127733889|NCT03849300|459649725|FG000|Overall Study|move out to different area|1|||
127733890|NCT03849300|459649726|FG001|Overall Study|move out to different area|3|||
127733891|NCT03849300|459649727|FG002|Overall Study|move out to different area|1|||
127733892|NCT03849300|459649728|FG003|Overall Study|move out to different area|4|||
127733893|NCT03849300|459649725|FG000|Overall Study|scheduling/transportation conflict|4|||
127733894|NCT03849300|459649726|FG001|Overall Study|scheduling/transportation conflict|4|||
127733895|NCT03849300|459649727|FG002|Overall Study|scheduling/transportation conflict|3|||
127733896|NCT03849300|459649728|FG003|Overall Study|scheduling/transportation conflict|2|||
127733897|NCT00464737|459649729|FG000|Overall Study|Adverse Event|12|||
127733898|NCT00464737|459649730|FG001|Overall Study|Adverse Event|17|||
127733899|NCT00464737|459649731|FG002|Overall Study|Adverse Event|33|||
127733900|NCT00464737|459649729|FG000|Overall Study|Lack of Efficacy|7|||
127733901|NCT00464737|459649730|FG001|Overall Study|Lack of Efficacy|7|||
127733902|NCT00464737|459649731|FG002|Overall Study|Lack of Efficacy|4|||
127733903|NCT00464737|459649729|FG000|Overall Study|Withdrawal by Subject|5|||
127733904|NCT00464737|459649730|FG001|Overall Study|Withdrawal by Subject|3|||
127733905|NCT00464737|459649731|FG002|Overall Study|Withdrawal by Subject|5|||
127733906|NCT00464737|459649729|FG000|Overall Study|Protocol Violation|1|||
127733907|NCT00464737|459649730|FG001|Overall Study|Protocol Violation|1|||
127733908|NCT00464737|459649731|FG002|Overall Study|Protocol Violation|5|||
127733909|NCT00464737|459649729|FG000|Overall Study|Non-compliance|0|||
127733910|NCT00464737|459649730|FG001|Overall Study|Non-compliance|1|||
127733911|NCT00464737|459649731|FG002|Overall Study|Non-compliance|1|||
127733912|NCT00464737|459649729|FG000|Overall Study|Lost to Follow-up|5|||
127733913|NCT00464737|459649730|FG001|Overall Study|Lost to Follow-up|2|||
127733914|NCT00464737|459649731|FG002|Overall Study|Lost to Follow-up|5|||
127733915|NCT00464737|459649729|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
127805085|NCT01583374|459907682|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
127805086|NCT01583374|459907683|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
127805087|NCT01583374|459907684|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
127733916|NCT00464737|459649730|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
127733917|NCT00464737|459649731|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
127733918|NCT00464737|459649729|FG000|Overall Study|Other: Subject left town; family illness|1|||
127733919|NCT00464737|459649730|FG001|Overall Study|Other: Subject left town; family illness|0|||
127733920|NCT00464737|459649731|FG002|Overall Study|Other: Subject left town; family illness|0|||
127733921|NCT00464737|459649729|FG000|Overall Study|Other: Study demands too great|0|||
127805088|NCT01583374|459907685|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
127733922|NCT00464737|459649730|FG001|Overall Study|Other: Study demands too great|1|||
127733923|NCT00464737|459649731|FG002|Overall Study|Other: Study demands too great|0|||
127733924|NCT00464737|459649729|FG000|Overall Study|Other: Personal family reasons|0|||
127733925|NCT00464737|459649730|FG001|Overall Study|Other: Personal family reasons|0|||
127733926|NCT00464737|459649731|FG002|Overall Study|Other: Personal family reasons|1|||
127733927|NCT00464737|459649729|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
127805089|NCT01583374|459907686|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
127805090|NCT01583374|459907687|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
127733928|NCT00464737|459649730|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
127733929|NCT00464737|459649731|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
127805091|NCT01583374|459907688|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
127805092|NCT01583374|459907680|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
127805093|NCT01583374|459907681|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
127805094|NCT01583374|459907682|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
127805095|NCT01583374|459907683|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
127805096|NCT01583374|459907684|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
127805097|NCT01583374|459907685|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
127805098|NCT01583374|459907686|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
127805099|NCT01583374|459907687|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
127805100|NCT01583374|459907688|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
127805101|NCT01583374|459907680|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
127805102|NCT01583374|459907681|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
127890615|NCT02006147|460222368|FG003|Overall Study|Withdrawal by Sponsor|0|||
127890616|NCT00871728|460222374|FG000|Overall Study|Adverse Event|1|||
127890617|NCT00871728|460222374|FG000|Overall Study|Protocol Violation|7|||
127733930|NCT00676663|459649734|FG000|Overall Study|Death|43|||
127733931|NCT00676663|459649735|FG001|Overall Study|Death|27|||
127733932|NCT00676663|459649734|FG000|Overall Study|Withdrew Consent|1|||
127733933|NCT00676663|459649735|FG001|Overall Study|Withdrew Consent|8|||
127733934|NCT00676663|459649734|FG000|Overall Study|Lost to Follow-up|1|||
127733935|NCT00676663|459649735|FG001|Overall Study|Lost to Follow-up|3|||
127733936|NCT01399905|459649736|FG000|Overall Study|Withdrawal by Subject|1|||
127733937|NCT01399905|459649737|FG001|Overall Study|Withdrawal by Subject|1|||
127733938|NCT00925288|459651627|FG000|Overall Study|Lost to Follow-up|9|||
127733939|NCT00925288|459651628|FG001|Overall Study|Lost to Follow-up|7|||
127733940|NCT00635570|459651631|FG000|Overall Study|Lost to Follow-up|8|||
127733941|NCT00635570|459651632|FG001|Overall Study|Lost to Follow-up|8|||
127733942|NCT00635570|459651631|FG000|Overall Study|Withdrawal by Subject|1|||
127733943|NCT00635570|459651632|FG001|Overall Study|Withdrawal by Subject|1|||
127733944|NCT00635570|459651631|FG000|Overall Study|Adverse Event|2|||
127733945|NCT00635570|459651632|FG001|Overall Study|Adverse Event|0|||
127733946|NCT00635570|459651631|FG000|Overall Study|Physician Decision|1|||
127733947|NCT00635570|459651632|FG001|Overall Study|Physician Decision|0|||
127733948|NCT00635570|459651631|FG000|Overall Study|Did not complete survey|2|||
127733949|NCT00635570|459651632|FG001|Overall Study|Did not complete survey|1|||
127733950|NCT00635570|459651631|FG000|Overall Study|Early termination(No sexual activity)|1|||
127733951|NCT00635570|459651632|FG001|Overall Study|Early termination(No sexual activity)|1|||
127733952|NCT04816708|459651642|FG000|Overall Study|Lost to Follow-up|10|||
127733953|NCT04816708|459651643|FG001|Overall Study|Lost to Follow-up|4|||
127733954|NCT05135156|459651648|FG000|Overall Study|Lost to Follow-up|0|||
127733955|NCT05135156|459651649|FG001|Overall Study|Lost to Follow-up|0|||
127733956|NCT05135156|459651650|FG002|Overall Study|Lost to Follow-up|2|||
127733957|NCT02986659|459651654|FG000|First Intervention Period|Adverse Event|3|||
127733958|NCT02986659|459651655|FG001|First Intervention Period|Adverse Event|1|||
127733959|NCT02986659|459651654|FG000|First Intervention Period|Lost to Follow-up|1|||
127733960|NCT02986659|459651655|FG001|First Intervention Period|Lost to Follow-up|0|||
127733961|NCT02986659|459651654|FG000|First Intervention Period|Withdrawal by Subject|0|||
127733962|NCT02986659|459651655|FG001|First Intervention Period|Withdrawal by Subject|1|||
127733963|NCT02986659|459651654|FG000|Second Intervention Period|Adverse Event|0|||
127733964|NCT02986659|459651655|FG001|Second Intervention Period|Adverse Event|6|||
127733965|NCT03461211|459651664|FG000|Overall Study|Adverse Event|1|||
127733966|NCT03461211|459651665|FG001|Overall Study|Adverse Event|1|||
127733967|NCT03461211|459651664|FG000|Overall Study|Lack of Efficacy|0|||
127733968|NCT03461211|459651665|FG001|Overall Study|Lack of Efficacy|1|||
127733969|NCT01284634|459651666|FG000|Overall Study|Adverse Event|1|||
127733970|NCT01284634|459651667|FG001|Overall Study|Adverse Event|0|||
127733971|NCT01284634|459651668|FG002|Overall Study|Adverse Event|2|||
127733972|NCT01284634|459651669|FG003|Overall Study|Adverse Event|1|||
127733973|NCT01059526|459651670|FG000|Overall Study|Patient enrolled but not treated|20|||
127733974|NCT01059526|459651671|FG001|Overall Study|Patient enrolled but not treated|17|||
127733975|NCT01059526|459651670|FG000|Overall Study|Adverse Event|2|||
127805103|NCT01583374|459907682|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
127805104|NCT01583374|459907683|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
127805105|NCT01583374|459907684|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
127805106|NCT01583374|459907685|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
127805107|NCT01583374|459907686|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
127890618|NCT00871728|460222374|FG000|Overall Study|Lost to Follow-up|2|||
127890619|NCT00871728|460222374|FG000|Overall Study|Failed to Visit Hospital|4|||
127733976|NCT01059526|459651671|FG001|Overall Study|Adverse Event|2|||
127733977|NCT01059526|459651670|FG000|Overall Study|Protocol Violation|0|||
127733978|NCT01059526|459651671|FG001|Overall Study|Protocol Violation|1|||
127733979|NCT01059526|459651670|FG000|Overall Study|Withdrawal by Subject|3|||
127733980|NCT01059526|459651671|FG001|Overall Study|Withdrawal by Subject|1|||
127733981|NCT01059526|459651670|FG000|Overall Study|Lost to Follow-up|4|||
127733982|NCT01059526|459651671|FG001|Overall Study|Lost to Follow-up|1|||
127733983|NCT01059526|459651670|FG000|Overall Study|Patient found to be dermatographic|1|||
127733984|NCT01059526|459651671|FG001|Overall Study|Patient found to be dermatographic|0|||
127733985|NCT02720081|459651672|FG000|Overall Study|Adverse Event|0|||
127733986|NCT02720081|459651673|FG001|Overall Study|Adverse Event|3|||
127733987|NCT02720081|459651672|FG000|Overall Study|Protocol Violation|4|||
127733988|NCT02720081|459651673|FG001|Overall Study|Protocol Violation|1|||
127733989|NCT03772041|459651674|FG000|Overall Study|Adverse Event|8|||
127733990|NCT03772041|459651675|FG001|Overall Study|Adverse Event|3|||
127733991|NCT03772041|459651674|FG000|Overall Study|Withdrawal by Subject|0|||
127733992|NCT03772041|459651675|FG001|Overall Study|Withdrawal by Subject|2|||
127733993|NCT03772041|459651674|FG000|Overall Study|Protocol Violation|4|||
127733994|NCT03772041|459651675|FG001|Overall Study|Protocol Violation|2|||
127733995|NCT03772041|459651674|FG000|Overall Study|Physician Decision|2|||
127733996|NCT03772041|459651675|FG001|Overall Study|Physician Decision|3|||
127733997|NCT05012397|459651685|FG000|Overall Study|Death|10|||
127733998|NCT05012397|459651685|FG000|Overall Study|Physician Decision|9|||
127733999|NCT05012397|459651685|FG000|Overall Study|Withdrawal by Subject|5|||
127734000|NCT05012397|459651685|FG000|Overall Study|Lost to Follow-up|2|||
127734001|NCT03334747|459651686|FG000|Treatment Phase|Technical problems|0|||
127734002|NCT03334747|459651687|FG001|Treatment Phase|Technical problems|0|||
127734003|NCT03334747|459651688|FG002|Treatment Phase|Technical problems|0|||
127734004|NCT03334747|459651689|FG003|Treatment Phase|Technical problems|0|||
127734005|NCT03334747|459651690|FG004|Treatment Phase|Technical problems|1|||
127734006|NCT03334747|459651691|FG005|Treatment Phase|Technical problems|0|||
127734007|NCT03334747|459651692|FG006|Treatment Phase|Technical problems|0|||
127734008|NCT03334747|459651693|FG007|Treatment Phase|Technical problems|0|||
127734009|NCT03334747|459651694|FG008|Treatment Phase|Technical problems|0|||
127734010|NCT03334747|459651686|FG000|Treatment Phase|Subject/guardian decision|1|||
127734011|NCT03334747|459651687|FG001|Treatment Phase|Subject/guardian decision|0|||
127734012|NCT03334747|459651688|FG002|Treatment Phase|Subject/guardian decision|0|||
127734013|NCT03334747|459651689|FG003|Treatment Phase|Subject/guardian decision|0|||
127734014|NCT03334747|459651690|FG004|Treatment Phase|Subject/guardian decision|0|||
127805108|NCT01583374|459907687|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
127805109|NCT01583374|459907688|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
127805110|NCT01583374|459907680|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
127805111|NCT01583374|459907681|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
127805112|NCT01583374|459907682|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
127805113|NCT01583374|459907683|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
127805114|NCT01583374|459907684|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
127805115|NCT01583374|459907685|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
127805116|NCT01583374|459907686|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
127805117|NCT01583374|459907687|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
127805118|NCT01583374|459907688|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
127805119|NCT01583374|459907680|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
127805120|NCT01583374|459907681|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
127805121|NCT01583374|459907682|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
127805122|NCT01583374|459907683|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
127805123|NCT01583374|459907684|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
127805124|NCT01583374|459907685|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
127805125|NCT01583374|459907686|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
127805126|NCT01583374|459907687|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
127805127|NCT01583374|459907688|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
127805128|NCT01583374|459907680|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
127805129|NCT01583374|459907681|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
127805130|NCT01583374|459907682|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
127805131|NCT01583374|459907683|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
127805132|NCT01583374|459907684|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
127805133|NCT01583374|459907685|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
127734015|NCT03334747|459651691|FG005|Treatment Phase|Subject/guardian decision|1|||
127734016|NCT03334747|459651692|FG006|Treatment Phase|Subject/guardian decision|0|||
127734017|NCT03334747|459651693|FG007|Treatment Phase|Subject/guardian decision|0|||
127734018|NCT03334747|459651694|FG008|Treatment Phase|Subject/guardian decision|0|||
127734019|NCT03334747|459651686|FG000|Follow-Up Phase|Subject/guardian decision|0|||
127734020|NCT03334747|459651687|FG001|Follow-Up Phase|Subject/guardian decision|0|||
127805134|NCT01583374|459907686|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
127805135|NCT01583374|459907687|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
127805136|NCT01583374|459907688|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
127805137|NCT01583374|459907680|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
127805138|NCT01583374|459907681|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
127805139|NCT01583374|459907682|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
127805140|NCT01583374|459907683|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
127805141|NCT01583374|459907684|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
127805142|NCT01583374|459907685|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
127805143|NCT01583374|459907686|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
127805144|NCT01583374|459907687|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
127805145|NCT01583374|459907688|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
127805146|NCT01583374|459907680|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
127805147|NCT01583374|459907681|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
127805148|NCT01583374|459907682|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
127805149|NCT01583374|459907683|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
127805150|NCT01583374|459907684|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
127805151|NCT01583374|459907685|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
127805152|NCT01583374|459907686|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
127805153|NCT01583374|459907687|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
127805154|NCT01583374|459907688|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
127805155|NCT01583374|459907680|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
127805156|NCT01583374|459907681|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
127805157|NCT01583374|459907682|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
127805158|NCT01583374|459907683|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
127805159|NCT01583374|459907684|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
127805160|NCT01583374|459907685|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
127805161|NCT01583374|459907686|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
127805162|NCT01583374|459907687|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
127805163|NCT01583374|459907688|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
127805164|NCT01583374|459907680|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
127805165|NCT01583374|459907681|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
127805166|NCT01583374|459907682|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
127805167|NCT01583374|459907683|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
127805168|NCT01583374|459907684|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
127805169|NCT01583374|459907685|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
127805170|NCT01583374|459907686|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
127805171|NCT01583374|459907687|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
127805172|NCT01583374|459907688|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
127805173|NCT01583374|459907680|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
127805174|NCT01583374|459907681|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
127805175|NCT01583374|459907682|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
127805176|NCT01583374|459907683|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
127805177|NCT01583374|459907684|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
127805178|NCT01583374|459907685|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
127805179|NCT01583374|459907686|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
127805180|NCT01583374|459907687|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
127805181|NCT01583374|459907688|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
127805182|NCT01583374|459907680|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
127805183|NCT01583374|459907681|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
127805184|NCT01583374|459907682|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
127805185|NCT01583374|459907683|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
127805186|NCT01583374|459907684|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
127805187|NCT01583374|459907685|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
127805188|NCT01583374|459907686|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
127805189|NCT01583374|459907687|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
127805190|NCT01583374|459907688|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
127805191|NCT01583374|459907680|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
127805192|NCT01583374|459907681|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
127805193|NCT01583374|459907682|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
127805194|NCT01583374|459907683|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
127805195|NCT01583374|459907684|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
127805196|NCT01583374|459907685|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
127805197|NCT01583374|459907686|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
127890620|NCT00871728|460222374|FG000|Overall Study|Participant Non-compliance|1|||
127734021|NCT03334747|459651688|FG002|Follow-Up Phase|Subject/guardian decision|0|||
127734022|NCT03334747|459651689|FG003|Follow-Up Phase|Subject/guardian decision|0|||
127734023|NCT03334747|459651690|FG004|Follow-Up Phase|Subject/guardian decision|0|||
127734024|NCT03334747|459651691|FG005|Follow-Up Phase|Subject/guardian decision|0|||
127734025|NCT03334747|459651692|FG006|Follow-Up Phase|Subject/guardian decision|1|||
127734026|NCT03334747|459651693|FG007|Follow-Up Phase|Subject/guardian decision|0|||
127734027|NCT03334747|459651694|FG008|Follow-Up Phase|Subject/guardian decision|1|||
127734028|NCT02567227|459651695|FG000|9 Weeks|Adverse Event|5|||
127734029|NCT02567227|459651696|FG001|9 Weeks|Adverse Event|5|||
127734030|NCT02567227|459651695|FG000|9 Weeks|Withdrawal by Subject|18|||
127734031|NCT02567227|459651696|FG001|9 Weeks|Withdrawal by Subject|8|||
127734032|NCT02567227|459651695|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
127734033|NCT02567227|459651696|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
127734034|NCT02567227|459651695|FG000|6 Month|Death|2|||
127734035|NCT02567227|459651696|FG001|6 Month|Death|0|||
127734036|NCT02567227|459651695|FG000|6 Month|Lost to Follow-up|43|||
127890621|NCT00871728|460222374|FG000|Overall Study|Withdrawal of Informed Consent|5|||
127890622|NCT04147715|460222375|FG000|Overall Study|Adverse Event|0|||
127890623|NCT04147715|460222376|FG001|Overall Study|Adverse Event|0|||
127890624|NCT04147715|460222377|FG002|Overall Study|Adverse Event|0|||
127734037|NCT02567227|459651696|FG001|6 Month|Lost to Follow-up|40|||
127734038|NCT02567227|459651695|FG000|12 Months|Lost to Follow-up|31|||
127734039|NCT02567227|459651696|FG001|12 Months|Lost to Follow-up|32|||
127734040|NCT02567227|459651695|FG000|12 Months|Death|0|||
127890625|NCT04147715|460222378|FG003|Overall Study|Adverse Event|0|||
127890626|NCT04147715|460222379|FG004|Overall Study|Adverse Event|0|||
127890627|NCT04147715|460222380|FG005|Overall Study|Adverse Event|0|||
127890628|NCT04147715|460222381|FG006|Overall Study|Adverse Event|0|||
127890629|NCT04147715|460222382|FG007|Overall Study|Adverse Event|2|||
127890630|NCT04147715|460222383|FG008|Overall Study|Adverse Event|1|||
127890631|NCT04147715|460222384|FG009|Overall Study|Adverse Event|0|||
127890632|NCT04147715|460222385|FG010|Overall Study|Adverse Event|0|||
127890633|NCT04147715|460222386|FG011|Overall Study|Adverse Event|0|||
127890634|NCT03404206|460222387|FG000|Overall Study|Withdrawal by Subject|1|||
127890635|NCT03404206|460222388|FG001|Overall Study|Withdrawal by Subject|1|||
127890636|NCT03404206|460222389|FG002|Overall Study|Withdrawal by Subject|0|||
127890637|NCT03404206|460222387|FG000|Overall Study|Lost to Follow-up|3|||
127734041|NCT02567227|459651696|FG001|12 Months|Death|2|||
127734042|NCT04748445|459651697|FG000|Overall Study|No longer met eligibility criteria|12|||
127734043|NCT04748445|459651697|FG000|Overall Study|Other|36|||
127734044|NCT04748445|459651697|FG000|Overall Study|Withdrawal by Subject|553|||
127734045|NCT04748445|459651697|FG000|Overall Study|Lost to Follow-up|30|||
127734046|NCT02498418|459651699|FG000|Overall Study|Lack of Efficacy|0|||
127734047|NCT02498418|459651700|FG001|Overall Study|Lack of Efficacy|0|||
127734048|NCT02498418|459651701|FG002|Overall Study|Lack of Efficacy|1|||
127734049|NCT02498418|459651699|FG000|Overall Study|Withdrawal by Subject|2|||
127734050|NCT02498418|459651700|FG001|Overall Study|Withdrawal by Subject|0|||
127734051|NCT02498418|459651701|FG002|Overall Study|Withdrawal by Subject|3|||
127734052|NCT02498418|459651699|FG000|Overall Study|Lost to Follow-up|0|||
127734053|NCT02498418|459651700|FG001|Overall Study|Lost to Follow-up|1|||
127734054|NCT02498418|459651701|FG002|Overall Study|Lost to Follow-up|1|||
127734055|NCT02498418|459651699|FG000|Overall Study|Participant taken prohibited medication|0|||
127734056|NCT02498418|459651700|FG001|Overall Study|Participant taken prohibited medication|1|||
127734057|NCT02498418|459651701|FG002|Overall Study|Participant taken prohibited medication|1|||
127734058|NCT00762502|459651702|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
127734059|NCT00762502|459651703|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
127734060|NCT00762502|459651704|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
127734061|NCT00762502|459651702|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
127890638|NCT03404206|460222388|FG001|Overall Study|Lost to Follow-up|1|||
127890639|NCT03404206|460222389|FG002|Overall Study|Lost to Follow-up|0|||
127890640|NCT01626859|460222400|FG000|Overall Study|Adverse Event|1|||
127890641|NCT01626859|460222401|FG001|Overall Study|Adverse Event|3|||
127890642|NCT01626859|460222402|FG002|Overall Study|Adverse Event|2|||
127890643|NCT01626859|460222400|FG000|Overall Study|Physician Decision|0|||
127890644|NCT01626859|460222401|FG001|Overall Study|Physician Decision|1|||
127890645|NCT01626859|460222402|FG002|Overall Study|Physician Decision|0|||
127890646|NCT01626859|460222400|FG000|Overall Study|Withdrawal by Subject|1|||
127890647|NCT01626859|460222401|FG001|Overall Study|Withdrawal by Subject|4|||
127890648|NCT01626859|460222402|FG002|Overall Study|Withdrawal by Subject|2|||
127890649|NCT02629965|460222403|FG000|Period 1|Adverse Event|1|||
127890650|NCT02629965|460222404|FG001|Period 1|Adverse Event|0|||
127890651|NCT02629965|460222403|FG000|Period 1|Unexpected worsening of disease|2|||
127890652|NCT02629965|460222404|FG001|Period 1|Unexpected worsening of disease|0|||
127890653|NCT02629965|460222403|FG000|Period 1|Other than listed above|1|||
127890654|NCT02629965|460222404|FG001|Period 1|Other than listed above|2|||
127890655|NCT02629965|460222403|FG000|Period 2|Adverse Event|1|||
127890656|NCT02629965|460222404|FG001|Period 2|Adverse Event|0|||
127890657|NCT02330081|460222405|FG000|Overall Study|Adverse Event|1|||
127890658|NCT02330081|460222405|FG000|Overall Study|Donation did not meet criteria|1|||
127890659|NCT02330081|460222405|FG000|Overall Study|Protocol Violation|6|||
127890660|NCT00905489|460222410|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
127890661|NCT00905489|460222410|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
127890662|NCT00905489|460222410|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
127890663|NCT02668302|460222412|FG000|Overall Study|Withdrawal by Subject|1|||
127890664|NCT02668302|460222413|FG001|Overall Study|Withdrawal by Subject|0|||
127890665|NCT00895583|460222418|FG000|Overall Study|Adverse Event|28|||
127890666|NCT00895583|460222419|FG001|Overall Study|Adverse Event|4|||
127890667|NCT00895583|460222418|FG000|Overall Study|Death|2|||
127890668|NCT00895583|460222419|FG001|Overall Study|Death|1|||
127890669|NCT00895583|460222418|FG000|Overall Study|Physician Decision|3|||
127805198|NCT01583374|459907687|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
127805199|NCT01583374|459907688|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
127805200|NCT01583374|459907680|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
127805201|NCT01583374|459907681|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
127805202|NCT01583374|459907682|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
127805203|NCT01583374|459907683|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
127805204|NCT01583374|459907684|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
127805205|NCT01583374|459907685|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
127805206|NCT01583374|459907686|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
127805207|NCT01583374|459907687|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
127805208|NCT01583374|459907688|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
127805209|NCT01583374|459907680|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
127805210|NCT01583374|459907681|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
127805211|NCT01583374|459907682|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
127805212|NCT01583374|459907683|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
127805213|NCT01583374|459907684|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
127890670|NCT00895583|460222419|FG001|Overall Study|Physician Decision|1|||
127890671|NCT00895583|460222418|FG000|Overall Study|Lost to Follow-up|1|||
127890672|NCT00895583|460222419|FG001|Overall Study|Lost to Follow-up|3|||
127890673|NCT00895583|460222418|FG000|Overall Study|Protocol Violation|1|||
127890674|NCT00895583|460222419|FG001|Overall Study|Protocol Violation|0|||
127890675|NCT00895583|460222418|FG000|Overall Study|Withdrawal by Subject|4|||
127890676|NCT00895583|460222419|FG001|Overall Study|Withdrawal by Subject|2|||
127890677|NCT00895583|460222418|FG000|Overall Study|Lack of Efficacy|5|||
127890678|NCT00895583|460222419|FG001|Overall Study|Lack of Efficacy|0|||
127890679|NCT00895583|460222418|FG000|Overall Study|Other|0|||
127890680|NCT00895583|460222419|FG001|Overall Study|Other|1|||
127890681|NCT00616928|460222420|FG000|Overall Study|Adverse Event|6|||
127890682|NCT00616928|460222421|FG001|Overall Study|Adverse Event|3|||
127890683|NCT00616928|460222422|FG002|Overall Study|Adverse Event|2|||
127890684|NCT00616928|460222423|FG003|Overall Study|Adverse Event|2|||
127890685|NCT00616928|460222420|FG000|Overall Study|Other|51|||
127890686|NCT00616928|460222421|FG001|Overall Study|Other|8|||
127890687|NCT00616928|460222422|FG002|Overall Study|Other|15|||
127890688|NCT00616928|460222423|FG003|Overall Study|Other|5|||
127890689|NCT00616928|460222420|FG000|Overall Study|Lost to Follow-up|5|||
127890690|NCT00616928|460222421|FG001|Overall Study|Lost to Follow-up|7|||
127890691|NCT00616928|460222422|FG002|Overall Study|Lost to Follow-up|0|||
127805214|NCT01583374|459907685|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
127805215|NCT01583374|459907686|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
127890692|NCT00616928|460222423|FG003|Overall Study|Lost to Follow-up|0|||
127890693|NCT04535583|460222424|FG000|Overall Study|Lost to Follow-up|1|||
127890694|NCT04535583|460222424|FG000|Overall Study|Physician Decision|1|||
127890695|NCT04535583|460222424|FG000|Overall Study|Withdrawal by Subject|1|||
127890696|NCT01078090|460222425|FG000|Overall Study|Lost to Follow-up|2363|||
127890697|NCT01078090|460222425|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
127890698|NCT01078090|460222425|FG000|Overall Study|Lack of Efficacy|1193|||
127734062|NCT00762502|459651703|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
127734063|NCT00762502|459651704|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
127734064|NCT00762502|459651702|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
127734065|NCT00762502|459651703|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
127734066|NCT00762502|459651704|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
127734067|NCT03042559|459651705|FG000|Overall Study|drop out|1|||
127734068|NCT03042559|459651706|FG001|Overall Study|drop out|1|||
127734069|NCT01536535|459651709|FG000|Overall Study|Withdrawal by Subject|10|||
127734070|NCT01536535|459651710|FG001|Overall Study|Withdrawal by Subject|5|||
127734071|NCT01536535|459651709|FG000|Overall Study|Lost to Follow-up|4|||
127734072|NCT01536535|459651710|FG001|Overall Study|Lost to Follow-up|6|||
127734073|NCT01536535|459651709|FG000|Overall Study|Physician Decision|1|||
127734074|NCT01536535|459651710|FG001|Overall Study|Physician Decision|1|||
127734075|NCT01536535|459651709|FG000|Overall Study|Participant moved|0|||
127734076|NCT01536535|459651710|FG001|Overall Study|Participant moved|1|||
127734077|NCT00385697|459651713|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
127734078|NCT00385697|459651714|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
127734079|NCT00385697|459651715|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
127734080|NCT00385697|459651716|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
127734081|NCT00385697|459651717|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
127734082|NCT00385697|459651713|FG000|Open-label Segment 1|Lost to Follow-up|1|||
127734083|NCT00385697|459651714|FG001|Open-label Segment 1|Lost to Follow-up|0|||
127734084|NCT00385697|459651715|FG002|Open-label Segment 1|Lost to Follow-up|0|||
127734085|NCT00385697|459651716|FG003|Open-label Segment 1|Lost to Follow-up|0|||
127734086|NCT00385697|459651717|FG004|Open-label Segment 1|Lost to Follow-up|0|||
127734087|NCT00385697|459651713|FG000|Double-blind Segment 2|Adverse Event|0|||
127734088|NCT00385697|459651714|FG001|Double-blind Segment 2|Adverse Event|3|||
127734089|NCT00385697|459651715|FG002|Double-blind Segment 2|Adverse Event|1|||
127734090|NCT00385697|459651716|FG003|Double-blind Segment 2|Adverse Event|0|||
127734091|NCT00385697|459651717|FG004|Double-blind Segment 2|Adverse Event|0|||
127734092|NCT00385697|459651713|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
127734093|NCT00385697|459651714|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
127734094|NCT00385697|459651715|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
127734095|NCT00385697|459651716|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
127734096|NCT00385697|459651717|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
127734097|NCT00385697|459651713|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
127734098|NCT00385697|459651714|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
127734099|NCT00385697|459651715|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
127734100|NCT00385697|459651716|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
127734101|NCT00385697|459651717|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
127734102|NCT00385697|459651713|FG000|Double-blind Segment 2|Other|0|||
127734103|NCT00385697|459651714|FG001|Double-blind Segment 2|Other|2|||
127734104|NCT00385697|459651715|FG002|Double-blind Segment 2|Other|0|||
127734105|NCT00385697|459651716|FG003|Double-blind Segment 2|Other|0|||
127734106|NCT00385697|459651717|FG004|Double-blind Segment 2|Other|0|||
127734107|NCT01485991|459651718|FG000|Overall Study|Adverse Event|0|||
127734108|NCT01485991|459651719|FG001|Overall Study|Adverse Event|4|||
127734109|NCT01485991|459651718|FG000|Overall Study|Lost to Follow-up|13|||
127734110|NCT01485991|459651719|FG001|Overall Study|Lost to Follow-up|10|||
127734111|NCT01485991|459651718|FG000|Overall Study|Withdrawal by Subject|13|||
127734112|NCT01485991|459651719|FG001|Overall Study|Withdrawal by Subject|20|||
127734113|NCT01485991|459651718|FG000|Overall Study|randomized but not treated|6|||
127734114|NCT01485991|459651719|FG001|Overall Study|randomized but not treated|2|||
127734115|NCT02382406|459651725|FG000|Study Treatment|Disease Progression|8|||
127734116|NCT02382406|459651726|FG001|Study Treatment|Disease Progression|0|||
127734117|NCT02382406|459651727|FG002|Study Treatment|Disease Progression|20|||
127734118|NCT02382406|459651725|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
127734119|NCT02382406|459651726|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
127734120|NCT02382406|459651727|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
127734121|NCT02382406|459651725|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
127734122|NCT02382406|459651726|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
127734123|NCT02382406|459651727|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
127734124|NCT02382406|459651725|FG000|Study Treatment|symptomatic deterioration|1|||
127734125|NCT02382406|459651726|FG001|Study Treatment|symptomatic deterioration|0|||
127734126|NCT02382406|459651727|FG002|Study Treatment|symptomatic deterioration|1|||
127734127|NCT02382406|459651725|FG000|Study Treatment|Death|0|||
127734128|NCT02382406|459651726|FG001|Study Treatment|Death|0|||
127734129|NCT02382406|459651727|FG002|Study Treatment|Death|2|||
127734130|NCT02382406|459651725|FG000|Follow up|Death|11|||
127734131|NCT02382406|459651726|FG001|Follow up|Death|0|||
127734132|NCT02382406|459651727|FG002|Follow up|Death|19|||
127734133|NCT02382406|459651725|FG000|Follow up|Symptomatic deterioration|1|||
127734134|NCT02382406|459651726|FG001|Follow up|Symptomatic deterioration|0|||
127734135|NCT02382406|459651727|FG002|Follow up|Symptomatic deterioration|1|||
127734136|NCT02382406|459651725|FG000|Follow up|Patient Refused Follow-up|1|||
127734137|NCT02382406|459651726|FG001|Follow up|Patient Refused Follow-up|0|||
127734138|NCT02382406|459651727|FG002|Follow up|Patient Refused Follow-up|0|||
127734139|NCT02382406|459651725|FG000|Follow up|Study Terminated|1|||
127734140|NCT02382406|459651726|FG001|Follow up|Study Terminated|0|||
127734141|NCT02382406|459651727|FG002|Follow up|Study Terminated|8|||
127734142|NCT02382406|459651725|FG000|Follow up|Withdrawal by Subject|0|||
127734143|NCT02382406|459651726|FG001|Follow up|Withdrawal by Subject|0|||
127734144|NCT02382406|459651727|FG002|Follow up|Withdrawal by Subject|2|||
127734145|NCT03794609|459651730|FG000|Overall Study|Other|10|||
127734146|NCT03794609|459651730|FG000|Overall Study|Withdrawal by Subject|66|||
127734147|NCT03794609|459651730|FG000|Overall Study|The child is enrolled in an interventional study|70|||
127734148|NCT03794609|459651730|FG000|Overall Study|Inclusion/exclusion criteria|8|||
127734149|NCT03794609|459651730|FG000|Overall Study|At sponsor's request|151|||
127734150|NCT03794609|459651730|FG000|Overall Study|Physician Decision|1|||
127734151|NCT03794609|459651730|FG000|Overall Study|Lost to Follow-up|5|||
127734152|NCT04543942|459651731|FG000|First Intervention (2-3 Days)|Scheduling conflict|2|||
127734153|NCT04543942|459651732|FG001|First Intervention (2-3 Days)|Scheduling conflict|2|||
127734154|NCT04543942|459651731|FG000|Interval Period (2 Weeks)|scheduling conflict|1|||
127805216|NCT01583374|459907687|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
127805217|NCT01583374|459907688|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
127805218|NCT01583374|459907680|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
127805219|NCT01583374|459907681|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
127805220|NCT01583374|459907682|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
127805221|NCT01583374|459907683|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
127805222|NCT01583374|459907684|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
127805223|NCT01583374|459907685|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
127805224|NCT01583374|459907686|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
127805225|NCT01583374|459907687|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
127805226|NCT01583374|459907688|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
127805227|NCT01583374|459907680|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
127805228|NCT01583374|459907681|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
127805229|NCT01583374|459907682|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
127805230|NCT01583374|459907683|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
127805231|NCT01583374|459907684|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
127805232|NCT01583374|459907685|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
127805233|NCT01583374|459907686|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
127805234|NCT01583374|459907687|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
127805235|NCT01583374|459907688|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
127805236|NCT01583374|459907680|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
127805237|NCT01583374|459907681|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
127805238|NCT01583374|459907682|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
127805239|NCT01583374|459907683|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
127805240|NCT01583374|459907684|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
127805241|NCT01583374|459907685|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
127805242|NCT01583374|459907686|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
127805243|NCT01583374|459907687|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
127890699|NCT01078090|460222425|FG000|Overall Study|ADR and lack of efficacy|61|||
127805244|NCT01583374|459907688|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
127805245|NCT00956943|459909251|FG000|Overall Study|Lost to Follow-up|9|||
127805246|NCT00956943|459909252|FG001|Overall Study|Lost to Follow-up|10|||
127805247|NCT01400932|459909256|FG000|Overall Study|Adverse Event|10|||
127805248|NCT01400932|459909257|FG001|Overall Study|Adverse Event|5|||
127805249|NCT01400932|459909256|FG000|Overall Study|Lack of Efficacy|0|||
127805250|NCT01400932|459909257|FG001|Overall Study|Lack of Efficacy|3|||
127805251|NCT01400932|459909256|FG000|Overall Study|Withdrawal by Subject|2|||
127805252|NCT01400932|459909257|FG001|Overall Study|Withdrawal by Subject|6|||
127805253|NCT01400932|459909256|FG000|Overall Study|Lost to Follow-up|1|||
127805254|NCT01400932|459909257|FG001|Overall Study|Lost to Follow-up|0|||
127734155|NCT04543942|459651732|FG001|Interval Period (2 Weeks)|scheduling conflict|1|||
127734156|NCT00832650|459651752|FG000|Overall Study|Randomized but not treated|0|||
127734157|NCT00832650|459651753|FG001|Overall Study|Randomized but not treated|0|||
127734158|NCT00832650|459651754|FG002|Overall Study|Randomized but not treated|1|||
127734159|NCT00794573|459651759|FG000|Overall Study|Death|3|||
127734160|NCT00794573|459651760|FG001|Overall Study|Death|0|||
127734161|NCT00794573|459651759|FG000|Overall Study|Withdrawal by Subject|9|||
127734162|NCT00794573|459651760|FG001|Overall Study|Withdrawal by Subject|12|||
127734163|NCT00794573|459651759|FG000|Overall Study|Lost to Follow-up|26|||
127734164|NCT00794573|459651760|FG001|Overall Study|Lost to Follow-up|33|||
127734165|NCT03928821|459651761|FG000|Overall Study|Death|0|||
127734166|NCT03928821|459651762|FG001|Overall Study|Death|1|||
127734167|NCT03928821|459651763|FG002|Overall Study|Death|0|||
127734168|NCT03928821|459651764|FG003|Overall Study|Death|0|||
127734169|NCT03928821|459651761|FG000|Overall Study|Lost to Follow-up|0|||
127734170|NCT03928821|459651762|FG001|Overall Study|Lost to Follow-up|2|||
127805255|NCT01400932|459909256|FG000|Overall Study|Protocol Deviation|0|||
127805256|NCT01400932|459909257|FG001|Overall Study|Protocol Deviation|1|||
127805257|NCT01400932|459909256|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
127805258|NCT01400932|459909257|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
127805259|NCT03244059|459909259|FG000|Specific Aim 1|Physician Decision|1|||
127805260|NCT03244059|459909260|FG001|Specific Aim 1|Physician Decision|0|||
127805261|NCT03244059|459909259|FG000|Specific Aim 2|Physician Decision|1|||
127805262|NCT03244059|459909260|FG001|Specific Aim 2|Physician Decision|0|||
127805263|NCT02939131|459909261|FG000|Overall Study|Unable to get to clinic|6|||
127805264|NCT02939131|459909262|FG001|Overall Study|Unable to get to clinic|4|||
127805265|NCT02939131|459909261|FG000|Overall Study|Lost to Follow-up|2|||
127805266|NCT02939131|459909262|FG001|Overall Study|Lost to Follow-up|4|||
127805267|NCT02939131|459909261|FG000|Overall Study|severe debilitation|1|||
127805268|NCT02939131|459909262|FG001|Overall Study|severe debilitation|0|||
127805269|NCT02939131|459909261|FG000|Overall Study|Other|0|||
127805270|NCT02939131|459909262|FG001|Overall Study|Other|1|||
127805271|NCT02939131|459909261|FG000|Overall Study|not willing to adhere to protocol|2|||
127805272|NCT02939131|459909262|FG001|Overall Study|not willing to adhere to protocol|0|||
127805273|NCT01254669|459909263|FG000|Overall Study|Withdrawal by Subject|0|||
127805274|NCT01254669|459909264|FG001|Overall Study|Withdrawal by Subject|1|||
127805275|NCT01254669|459909263|FG000|Overall Study|time constraint|2|||
127805276|NCT01254669|459909264|FG001|Overall Study|time constraint|2|||
127805277|NCT01254669|459909263|FG000|Overall Study|called to clinic during intervention|1|||
127805278|NCT01254669|459909264|FG001|Overall Study|called to clinic during intervention|1|||
127805279|NCT00463476|459909265|FG000|Overall Study|Withdrawal by Subject|1|||
127805280|NCT00463476|459909266|FG001|Overall Study|Withdrawal by Subject|2|||
127805281|NCT00463476|459909265|FG000|Overall Study|Lost to Follow-up|1|||
127805282|NCT00463476|459909266|FG001|Overall Study|Lost to Follow-up|1|||
127805283|NCT01279057|459909270|FG000|Overall Study|Adverse Event|1|||
127805284|NCT01279057|459909271|FG001|Overall Study|Adverse Event|0|||
127805285|NCT01279057|459909272|FG002|Overall Study|Adverse Event|1|||
127805286|NCT01279057|459909270|FG000|Overall Study|Insufficient therapeutic response|0|||
127805287|NCT01279057|459909271|FG001|Overall Study|Insufficient therapeutic response|0|||
127805288|NCT01279057|459909272|FG002|Overall Study|Insufficient therapeutic response|1|||
127805289|NCT01279057|459909270|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
127734171|NCT03928821|459651763|FG002|Overall Study|Lost to Follow-up|3|||
127734172|NCT03928821|459651764|FG003|Overall Study|Lost to Follow-up|0|||
127734173|NCT03928821|459651761|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
127734174|NCT03928821|459651762|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
127734175|NCT03928821|459651763|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
127734176|NCT03928821|459651764|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
127734177|NCT02784535|459651765|FG000|Overall Study|Adverse Event|1|||
127734178|NCT02784535|459651766|FG001|Overall Study|Adverse Event|0|||
127805290|NCT01279057|459909271|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
127805291|NCT01279057|459909272|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
127805292|NCT01279057|459909270|FG000|Overall Study|Withdrew consent|2|||
127805293|NCT01279057|459909271|FG001|Overall Study|Withdrew consent|0|||
127805294|NCT01279057|459909272|FG002|Overall Study|Withdrew consent|1|||
127805295|NCT01279057|459909270|FG000|Overall Study|Pregnancy|0|||
127805296|NCT01279057|459909271|FG001|Overall Study|Pregnancy|1|||
127805297|NCT01279057|459909272|FG002|Overall Study|Pregnancy|0|||
127805298|NCT01279057|459909270|FG000|Overall Study|Other|3|||
127805299|NCT01279057|459909271|FG001|Overall Study|Other|3|||
127805300|NCT01279057|459909272|FG002|Overall Study|Other|0|||
127805301|NCT01427309|459909274|FG000|Overall Study|Lost to Follow-up|130|||
127805302|NCT01427309|459909275|FG001|Overall Study|Lost to Follow-up|145|||
127805303|NCT01427309|459909276|FG002|Overall Study|Lost to Follow-up|122|||
127805304|NCT01427309|459909277|FG003|Overall Study|Lost to Follow-up|135|||
127805305|NCT01427309|459909274|FG000|Overall Study|Protocol Violation|42|||
127805306|NCT01427309|459909275|FG001|Overall Study|Protocol Violation|69|||
127805307|NCT01427309|459909276|FG002|Overall Study|Protocol Violation|125|||
127805308|NCT01427309|459909277|FG003|Overall Study|Protocol Violation|124|||
127805309|NCT01427309|459909274|FG000|Overall Study|Adverse Event|0|||
127805310|NCT01427309|459909275|FG001|Overall Study|Adverse Event|0|||
127805311|NCT01427309|459909276|FG002|Overall Study|Adverse Event|3|||
127805312|NCT01427309|459909277|FG003|Overall Study|Adverse Event|1|||
127805313|NCT01427309|459909274|FG000|Overall Study|Serious adverse event|52|||
127805314|NCT01427309|459909275|FG001|Overall Study|Serious adverse event|45|||
127805315|NCT01427309|459909276|FG002|Overall Study|Serious adverse event|50|||
127805316|NCT01427309|459909277|FG003|Overall Study|Serious adverse event|61|||
127805317|NCT01427309|459909274|FG000|Overall Study|Withdrawal by Subject|148|||
127805318|NCT01427309|459909275|FG001|Overall Study|Withdrawal by Subject|148|||
127805319|NCT01427309|459909276|FG002|Overall Study|Withdrawal by Subject|61|||
127805320|NCT01427309|459909277|FG003|Overall Study|Withdrawal by Subject|55|||
127805321|NCT00531960|459909281|FG000|Overall Study|Adverse Event|5|||
127805322|NCT00531960|459909282|FG001|Overall Study|Adverse Event|4|||
127805323|NCT00531960|459909281|FG000|Overall Study|Death|3|||
127805324|NCT00531960|459909282|FG001|Overall Study|Death|2|||
127805325|NCT00531960|459909281|FG000|Overall Study|Lack of Efficacy|42|||
127805326|NCT00531960|459909282|FG001|Overall Study|Lack of Efficacy|41|||
127805327|NCT00531960|459909281|FG000|Overall Study|Violation of Selection Criteria|2|||
127805328|NCT00531960|459909282|FG001|Overall Study|Violation of Selection Criteria|0|||
127805329|NCT00531960|459909281|FG000|Overall Study|Refused Treatment|5|||
127805330|NCT00531960|459909282|FG001|Overall Study|Refused Treatment|6|||
127805331|NCT00531960|459909281|FG000|Overall Study|Other|4|||
127805332|NCT00531960|459909282|FG001|Overall Study|Other|10|||
127805333|NCT01500057|459909283|FG000|Overall Study|Lost to Follow-up|6|||
127805334|NCT01500057|459909284|FG001|Overall Study|Lost to Follow-up|4|||
127805335|NCT00330187|459909294|FG000|Overall Study|Lost to Follow-up|12|||
127805336|NCT00330187|459909295|FG001|Overall Study|Lost to Follow-up|13|||
127805337|NCT00330187|459909296|FG002|Overall Study|Lost to Follow-up|14|||
127805338|NCT00330187|459909297|FG003|Overall Study|Lost to Follow-up|10|||
127805339|NCT00330187|459909294|FG000|Overall Study|Withdrawal by Subject|8|||
127805340|NCT00330187|459909295|FG001|Overall Study|Withdrawal by Subject|5|||
127805341|NCT00330187|459909296|FG002|Overall Study|Withdrawal by Subject|4|||
127805342|NCT00330187|459909297|FG003|Overall Study|Withdrawal by Subject|4|||
127805343|NCT03258814|459909300|FG000|Overall Study|Early Termination|4|||
127805344|NCT03258814|459909301|FG001|Overall Study|Early Termination|3|||
127805345|NCT03258814|459909302|FG002|Overall Study|Early Termination|10|||
127805346|NCT01413958|459909303|FG000|Overall Study|Lost to Follow-up|0|||
127805347|NCT01413958|459909304|FG001|Overall Study|Lost to Follow-up|1|||
127805348|NCT01900002|459909305|FG000|Overall Study|Withdrawal by Subject|2|||
127805349|NCT01900002|459909305|FG000|Overall Study|ineligible for Y-90|4|||
127805350|NCT01573910|459909312|FG000|Overall Study|Adverse Event|4|||
127805351|NCT01573910|459909313|FG001|Overall Study|Adverse Event|4|||
127805352|NCT01573910|459909312|FG000|Overall Study|Lost to Follow-up|2|||
127805353|NCT01573910|459909313|FG001|Overall Study|Lost to Follow-up|1|||
127805354|NCT01573910|459909312|FG000|Overall Study|Withdrawal by Subject|0|||
127805355|NCT01573910|459909313|FG001|Overall Study|Withdrawal by Subject|1|||
127805356|NCT01573910|459909312|FG000|Overall Study|Protocol Violation|3|||
127805357|NCT01573910|459909313|FG001|Overall Study|Protocol Violation|0|||
127805358|NCT01573910|459909312|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
127805359|NCT01573910|459909313|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
127805360|NCT00364182|459909316|FG000|First Intervention|Secondary prophylaxis|1|||
127805361|NCT00364182|459909317|FG001|First Intervention|Secondary prophylaxis|0|||
127805362|NCT00364182|459909318|FG002|First Intervention|Secondary prophylaxis|0|||
127805363|NCT00364182|459909316|FG000|First Intervention|Withdrawal by Subject|2|||
127805364|NCT00364182|459909317|FG001|First Intervention|Withdrawal by Subject|0|||
127805365|NCT00364182|459909318|FG002|First Intervention|Withdrawal by Subject|0|||
127805366|NCT00364182|459909316|FG000|Second Intervention|non-compliance|0|||
127805367|NCT00364182|459909317|FG001|Second Intervention|non-compliance|1|||
127805368|NCT00364182|459909318|FG002|Second Intervention|non-compliance|1|||
127890700|NCT01078090|460222425|FG000|Overall Study|Other|523|||
127890701|NCT04049552|460222426|FG000|Overall Study|Lost to Follow-up|1|||
127890702|NCT02123459|460222429|FG000|Washout Period (1 Day)|Adverse Event|1|||
127890703|NCT02123459|460222430|FG001|Washout Period (1 Day)|Adverse Event|0|||
127890704|NCT02196506|460222435|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
127890705|NCT02196506|460222436|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
127890706|NCT02196506|460222437|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
127890707|NCT02196506|460222438|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
127890708|NCT02196506|460222435|FG000|Phase A|Withdrawal by Subject|34|||
127890709|NCT02196506|460222436|FG001|Phase A|Withdrawal by Subject|0|||
127890710|NCT02196506|460222437|FG002|Phase A|Withdrawal by Subject|0|||
127890711|NCT02196506|460222438|FG003|Phase A|Withdrawal by Subject|0|||
127890712|NCT02196506|460222435|FG000|Phase A|Adverse Event|22|||
127890713|NCT02196506|460222436|FG001|Phase A|Adverse Event|0|||
127890714|NCT02196506|460222437|FG002|Phase A|Adverse Event|0|||
127890715|NCT02196506|460222438|FG003|Phase A|Adverse Event|0|||
127890716|NCT02196506|460222435|FG000|Phase A|Lost to Follow-up|9|||
127890717|NCT02196506|460222436|FG001|Phase A|Lost to Follow-up|0|||
127890718|NCT02196506|460222437|FG002|Phase A|Lost to Follow-up|0|||
127890719|NCT02196506|460222438|FG003|Phase A|Lost to Follow-up|0|||
127890720|NCT02196506|460222435|FG000|Phase A|Protocol deviation|12|||
127890721|NCT02196506|460222436|FG001|Phase A|Protocol deviation|0|||
127890722|NCT02196506|460222437|FG002|Phase A|Protocol deviation|0|||
127890723|NCT02196506|460222438|FG003|Phase A|Protocol deviation|0|||
127890724|NCT02196506|460222435|FG000|Phase A|Participant withdrawn by investigator|10|||
127890725|NCT02196506|460222436|FG001|Phase A|Participant withdrawn by investigator|0|||
127890726|NCT02196506|460222437|FG002|Phase A|Participant withdrawn by investigator|0|||
127890727|NCT02196506|460222438|FG003|Phase A|Participant withdrawn by investigator|0|||
127890728|NCT02196506|460222435|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
127890729|NCT02196506|460222436|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
127890730|NCT02196506|460222437|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
127890731|NCT02196506|460222438|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
127890732|NCT02196506|460222435|FG000|Phase B|Lack of Efficacy|0|||
127890733|NCT02196506|460222436|FG001|Phase B|Lack of Efficacy|1|||
127890734|NCT02196506|460222437|FG002|Phase B|Lack of Efficacy|2|||
127890735|NCT02196506|460222438|FG003|Phase B|Lack of Efficacy|0|||
127890736|NCT02196506|460222435|FG000|Phase B|Withdrawal by Participant|0|||
127890737|NCT02196506|460222436|FG001|Phase B|Withdrawal by Participant|8|||
127890738|NCT02196506|460222437|FG002|Phase B|Withdrawal by Participant|1|||
127890739|NCT02196506|460222438|FG003|Phase B|Withdrawal by Participant|0|||
127890740|NCT02196506|460222435|FG000|Phase B|Adverse Event|0|||
127890741|NCT02196506|460222436|FG001|Phase B|Adverse Event|4|||
127890742|NCT02196506|460222437|FG002|Phase B|Adverse Event|1|||
127890743|NCT02196506|460222438|FG003|Phase B|Adverse Event|0|||
127890744|NCT02196506|460222435|FG000|Phase B|Lost to Follow-up|0|||
127890745|NCT02196506|460222436|FG001|Phase B|Lost to Follow-up|2|||
127890746|NCT02196506|460222437|FG002|Phase B|Lost to Follow-up|1|||
127890747|NCT02196506|460222438|FG003|Phase B|Lost to Follow-up|0|||
127890748|NCT02196506|460222435|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
127890749|NCT02196506|460222436|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
127890750|NCT02196506|460222437|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
127890751|NCT02196506|460222438|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
127890752|NCT02196506|460222435|FG000|Phase A+|Withdrawal by Participant|0|||
127890753|NCT02196506|460222436|FG001|Phase A+|Withdrawal by Participant|0|||
127890754|NCT02196506|460222437|FG002|Phase A+|Withdrawal by Participant|0|||
127890755|NCT02196506|460222438|FG003|Phase A+|Withdrawal by Participant|5|||
127890756|NCT02196506|460222435|FG000|Phase A+|Adverse Event|0|||
127890757|NCT02196506|460222436|FG001|Phase A+|Adverse Event|0|||
127890758|NCT02196506|460222437|FG002|Phase A+|Adverse Event|0|||
127890759|NCT02196506|460222438|FG003|Phase A+|Adverse Event|1|||
127890760|NCT02196506|460222435|FG000|Phase A+|Lost to Follow-up|0|||
127890761|NCT02196506|460222436|FG001|Phase A+|Lost to Follow-up|0|||
127890762|NCT02196506|460222437|FG002|Phase A+|Lost to Follow-up|0|||
127890763|NCT02196506|460222438|FG003|Phase A+|Lost to Follow-up|6|||
127890764|NCT02196506|460222435|FG000|Phase A+|Participant withdrawn by investigator|0|||
127890765|NCT02196506|460222436|FG001|Phase A+|Participant withdrawn by investigator|0|||
127890766|NCT02196506|460222437|FG002|Phase A+|Participant withdrawn by investigator|0|||
127890767|NCT02196506|460222438|FG003|Phase A+|Participant withdrawn by investigator|1|||
127890768|NCT00254397|460222439|FG000|Overall Study|Disease Progression|4|||
127890769|NCT00254397|460222440|FG001|Overall Study|Disease Progression|1|||
127890770|NCT00254397|460222441|FG002|Overall Study|Disease Progression|16|||
127890771|NCT00254397|460222442|FG003|Overall Study|Disease Progression|23|||
127890772|NCT00254397|460222439|FG000|Overall Study|Non-Compliant|0|||
127890773|NCT00254397|460222440|FG001|Overall Study|Non-Compliant|0|||
127890774|NCT00254397|460222441|FG002|Overall Study|Non-Compliant|0|||
127890775|NCT00254397|460222442|FG003|Overall Study|Non-Compliant|1|||
127890776|NCT00254397|460222439|FG000|Overall Study|Adverse Event|2|||
127890777|NCT00254397|460222440|FG001|Overall Study|Adverse Event|0|||
127890778|NCT00254397|460222441|FG002|Overall Study|Adverse Event|3|||
127890779|NCT00254397|460222442|FG003|Overall Study|Adverse Event|1|||
127890780|NCT01715415|460222454|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
127890781|NCT01715415|460222455|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
127890782|NCT01715415|460222454|FG000|Double-blind Treatment|Adverse Event|3|||
127890783|NCT01715415|460222455|FG001|Double-blind Treatment|Adverse Event|0|||
127890784|NCT01715415|460222454|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
127890785|NCT01715415|460222455|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
127890786|NCT01715415|460222454|FG000|Double-blind Treatment|Other|1|||
127890787|NCT01715415|460222455|FG001|Double-blind Treatment|Other|0|||
127890788|NCT01715415|460222454|FG000|Open-label Treatment|Adverse Event|0|||
127890789|NCT01715415|460222455|FG001|Open-label Treatment|Adverse Event|1|||
127890790|NCT01715415|460222454|FG000|Open-label Treatment|Subject Noncompliant|0|||
127890791|NCT01715415|460222455|FG001|Open-label Treatment|Subject Noncompliant|1|||
127890792|NCT05028751|460222456|FG000|Overall Study|Study Terminated by Sponsor|3|||
127890793|NCT05028751|460222457|FG001|Overall Study|Study Terminated by Sponsor|0|||
127890794|NCT05028751|460222458|FG002|Overall Study|Study Terminated by Sponsor|0|||
127890795|NCT05028751|460222459|FG003|Overall Study|Study Terminated by Sponsor|0|||
127890796|NCT05028751|460222456|FG000|Overall Study|Death|9|||
127890797|NCT05028751|460222457|FG001|Overall Study|Death|3|||
127890798|NCT05028751|460222458|FG002|Overall Study|Death|2|||
127890799|NCT05028751|460222459|FG003|Overall Study|Death|4|||
127890800|NCT05028751|460222456|FG000|Overall Study|Withdrawal by Subject|0|||
127890801|NCT05028751|460222457|FG001|Overall Study|Withdrawal by Subject|0|||
127890802|NCT05028751|460222458|FG002|Overall Study|Withdrawal by Subject|1|||
127890803|NCT05028751|460222459|FG003|Overall Study|Withdrawal by Subject|0|||
127890804|NCT05028751|460222456|FG000|Overall Study|Miscellaneous|2|||
127890805|NCT05028751|460222457|FG001|Overall Study|Miscellaneous|0|||
127890806|NCT05028751|460222458|FG002|Overall Study|Miscellaneous|0|||
127890807|NCT05028751|460222459|FG003|Overall Study|Miscellaneous|0|||
127890808|NCT03586830|460222461|FG000|Overall Study|Site terminated by Sponsor|1|||
127890809|NCT03586830|460222462|FG001|Overall Study|Site terminated by Sponsor|4|||
127890810|NCT03586830|460222463|FG002|Overall Study|Site terminated by Sponsor|3|||
127890811|NCT03586830|460222464|FG003|Overall Study|Site terminated by Sponsor|3|||
127890812|NCT03586830|460222461|FG000|Overall Study|Lost to Follow-up|0|||
127890813|NCT03586830|460222462|FG001|Overall Study|Lost to Follow-up|2|||
127890814|NCT03586830|460222463|FG002|Overall Study|Lost to Follow-up|2|||
127890815|NCT03586830|460222464|FG003|Overall Study|Lost to Follow-up|1|||
127890816|NCT03586830|460222461|FG000|Overall Study|Withdrawal by Subject|1|||
127890817|NCT03586830|460222462|FG001|Overall Study|Withdrawal by Subject|0|||
127890818|NCT03586830|460222463|FG002|Overall Study|Withdrawal by Subject|3|||
127890819|NCT03586830|460222464|FG003|Overall Study|Withdrawal by Subject|1|||
127890820|NCT04578548|460222465|FG000|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
127890821|NCT04578548|460222466|FG001|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
127890822|NCT04578548|460222465|FG000|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
127890823|NCT04578548|460222466|FG001|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
127890824|NCT04578548|460222465|FG000|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
127890825|NCT04578548|460222466|FG001|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
127890826|NCT04578548|460222465|FG000|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
127890827|NCT04578548|460222466|FG001|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
127890828|NCT04578548|460222465|FG000|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
127890829|NCT04578548|460222466|FG001|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
127890830|NCT04578548|460222465|FG000|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|34|||
127890831|NCT04578548|460222466|FG001|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|15|||
127890832|NCT00395083|460222469|FG000|Overall Study|Withdrawal by Subject|6|||
127890833|NCT00395083|460222470|FG001|Overall Study|Withdrawal by Subject|5|||
127890834|NCT00395083|460222469|FG000|Overall Study|Developed another disease|4|||
127890835|NCT00395083|460222470|FG001|Overall Study|Developed another disease|3|||
127890836|NCT00972153|460222471|FG000|Overall Study|Equipment malfunction during case|0|||
127890837|NCT00972153|460222472|FG001|Overall Study|Equipment malfunction during case|1|||
127890838|NCT00972153|460222473|FG002|Overall Study|Equipment malfunction during case|0|||
127890839|NCT04136626|460222474|FG000|Treatment Phase|Withdrawal by Subject|1|||
127890840|NCT04136626|460222475|FG001|Treatment Phase|Withdrawal by Subject|9|||
127890841|NCT04136626|460222474|FG000|Treatment Phase|Adverse Event|1|||
127890842|NCT04136626|460222475|FG001|Treatment Phase|Adverse Event|0|||
127890843|NCT04136626|460222474|FG000|Treatment Phase|Lost to Follow-up|1|||
127890844|NCT04136626|460222475|FG001|Treatment Phase|Lost to Follow-up|5|||
127890845|NCT04136626|460222474|FG000|12-month Follow-up|Lost to Follow-up|8|||
127890846|NCT04136626|460222475|FG001|12-month Follow-up|Lost to Follow-up|7|||
127890847|NCT00628745|460222476|FG000|Overall Study|Withdrawal by Subject|63|||
127890848|NCT00628745|460222477|FG001|Overall Study|Withdrawal by Subject|3|||
127890849|NCT00628745|460222478|FG002|Overall Study|Withdrawal by Subject|9|||
127805369|NCT00364182|459909316|FG000|Second Intervention|Protocol Violation|0|||
127805370|NCT00364182|459909317|FG001|Second Intervention|Protocol Violation|1|||
127805371|NCT00364182|459909318|FG002|Second Intervention|Protocol Violation|0|||
127805372|NCT00364182|459909316|FG000|Second Intervention|Adverse Event|0|||
127805373|NCT00364182|459909317|FG001|Second Intervention|Adverse Event|0|||
127805374|NCT00364182|459909318|FG002|Second Intervention|Adverse Event|1|||
127805375|NCT00364182|459909316|FG000|Third Intervention|non-compliance|0|||
127805376|NCT00364182|459909317|FG001|Third Intervention|non-compliance|1|||
127805377|NCT00364182|459909318|FG002|Third Intervention|non-compliance|0|||
127805378|NCT00364182|459909316|FG000|Third Intervention|Lost to Follow-up|0|||
127805379|NCT00364182|459909317|FG001|Third Intervention|Lost to Follow-up|0|||
127805380|NCT00364182|459909318|FG002|Third Intervention|Lost to Follow-up|1|||
127805381|NCT02601573|459909326|FG000|Overall Study|Lost to Follow-up|0|||
127805382|NCT02601573|459909327|FG001|Overall Study|Lost to Follow-up|3|||
127805383|NCT02601573|459909328|FG002|Overall Study|Lost to Follow-up|1|||
127805384|NCT02601573|459909329|FG003|Overall Study|Lost to Follow-up|0|||
127805385|NCT02601573|459909330|FG004|Overall Study|Lost to Follow-up|2|||
127805386|NCT02601573|459909326|FG000|Overall Study|Withdrawal by Subject|0|||
127805387|NCT02601573|459909327|FG001|Overall Study|Withdrawal by Subject|1|||
127805388|NCT02601573|459909328|FG002|Overall Study|Withdrawal by Subject|0|||
127805389|NCT02601573|459909329|FG003|Overall Study|Withdrawal by Subject|1|||
127805390|NCT02601573|459909330|FG004|Overall Study|Withdrawal by Subject|0|||
127805391|NCT00974220|459909331|FG000|Treatment Period 1|Adverse Event|2|||
127805392|NCT00974220|459909332|FG001|Treatment Period 1|Adverse Event|1|||
127805393|NCT00974220|459909331|FG000|Treatment Period 1|noncompliant subjects|0|||
127805394|NCT00974220|459909332|FG001|Treatment Period 1|noncompliant subjects|1|||
127805395|NCT02921425|459909333|FG000|Overall Study|Protocol Violation|9|||
127805396|NCT01227967|459909334|FG000|Overall Study|Protocol Violation|3|||
127805397|NCT01227967|459909335|FG001|Overall Study|Protocol Violation|1|||
127805398|NCT01227967|459909334|FG000|Overall Study|Death|0|||
127805399|NCT01227967|459909335|FG001|Overall Study|Death|1|||
127805400|NCT01227967|459909334|FG000|Overall Study|Lost to Follow-up|8|||
127805401|NCT01227967|459909335|FG001|Overall Study|Lost to Follow-up|3|||
127805402|NCT01227967|459909334|FG000|Overall Study|Withdrawal by Subject|4|||
127805403|NCT01227967|459909335|FG001|Overall Study|Withdrawal by Subject|3|||
127805404|NCT01227967|459909334|FG000|Overall Study|Physician Decision|0|||
127805405|NCT01227967|459909335|FG001|Overall Study|Physician Decision|1|||
127805406|NCT01227967|459909334|FG000|Overall Study|Never Started Treatment|0|||
127805407|NCT01227967|459909335|FG001|Overall Study|Never Started Treatment|4|||
127805408|NCT01227967|459909334|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
127805409|NCT01227967|459909335|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
127805410|NCT03403400|459909336|FG000|Overall Study|Lost to Follow-up|1|||
127805411|NCT03403400|459909337|FG001|Overall Study|Lost to Follow-up|0|||
127805412|NCT03403400|459909338|FG002|Overall Study|Lost to Follow-up|1|||
127805413|NCT03403400|459909336|FG000|Overall Study|Hospitalization|1|||
127805414|NCT03403400|459909337|FG001|Overall Study|Hospitalization|0|||
127805415|NCT03403400|459909338|FG002|Overall Study|Hospitalization|0|||
127805416|NCT03403400|459909336|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
127805417|NCT03403400|459909337|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
127805418|NCT03403400|459909338|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
127890850|NCT00628745|460222479|FG003|Overall Study|Withdrawal by Subject|2|||
127890851|NCT00628745|460222480|FG004|Overall Study|Withdrawal by Subject|69|||
127890852|NCT00628745|460222476|FG000|Overall Study|Does not meet inclusion criteria|0|||
127890853|NCT00628745|460222477|FG001|Overall Study|Does not meet inclusion criteria|12|||
127890854|NCT00628745|460222478|FG002|Overall Study|Does not meet inclusion criteria|0|||
127890855|NCT00628745|460222479|FG003|Overall Study|Does not meet inclusion criteria|0|||
127805419|NCT01763164|459909339|FG000|Treatment Phase|Participant/Guardian decision|26|||
127805420|NCT01763164|459909340|FG001|Treatment Phase|Participant/Guardian decision|14|||
127805421|NCT01763164|459909339|FG000|Treatment Phase|Protocol Violation|1|||
127805422|NCT01763164|459909340|FG001|Treatment Phase|Protocol Violation|1|||
127805423|NCT01763164|459909339|FG000|Treatment Phase|Progressive Disease|142|||
127805424|NCT01763164|459909340|FG001|Treatment Phase|Progressive Disease|76|||
127805425|NCT01763164|459909339|FG000|Treatment Phase|Physician Decision|24|||
127805426|NCT01763164|459909340|FG001|Treatment Phase|Physician Decision|13|||
127805427|NCT01763164|459909339|FG000|Treatment Phase|Death|10|||
127805428|NCT01763164|459909340|FG001|Treatment Phase|Death|1|||
127805429|NCT01763164|459909339|FG000|Treatment Phase|Adverse Event|66|||
127805430|NCT01763164|459909340|FG001|Treatment Phase|Adverse Event|8|||
127805431|NCT01763164|459909339|FG000|Treatment Phase|Randomized but not Treated|0|||
127805432|NCT01763164|459909340|FG001|Treatment Phase|Randomized but not Treated|19|||
127805433|NCT01763164|459909339|FG000|Treatment Phase|Other|0|||
127805434|NCT01763164|459909340|FG001|Treatment Phase|Other|1|||
127805435|NCT01763164|459909339|FG000|Follow up Phase|New therapy for study indication|12|||
127805436|NCT01763164|459909340|FG001|Follow up Phase|New therapy for study indication|3|||
127890856|NCT00628745|460222480|FG004|Overall Study|Does not meet inclusion criteria|18|||
127890857|NCT00628745|460222476|FG000|Overall Study|Participation in an interventional clinical trial|81|||
127890858|NCT00628745|460222477|FG001|Overall Study|Participation in an interventional clinical trial|4|||
127890859|NCT00628745|460222478|FG002|Overall Study|Participation in an interventional clinical trial|7|||
127890860|NCT00628745|460222479|FG003|Overall Study|Participation in an interventional clinical trial|0|||
127890861|NCT00628745|460222480|FG004|Overall Study|Participation in an interventional clinical trial|63|||
127890862|NCT00628745|460222476|FG000|Overall Study|Physician Decision|8|||
127890863|NCT00628745|460222477|FG001|Overall Study|Physician Decision|4|||
127890864|NCT00628745|460222478|FG002|Overall Study|Physician Decision|3|||
127890865|NCT00628745|460222479|FG003|Overall Study|Physician Decision|0|||
127890866|NCT00628745|460222480|FG004|Overall Study|Physician Decision|30|||
127890867|NCT00628745|460222476|FG000|Overall Study|Lost to Follow-up|109|||
127890868|NCT00628745|460222477|FG001|Overall Study|Lost to Follow-up|7|||
127890869|NCT00628745|460222478|FG002|Overall Study|Lost to Follow-up|7|||
127890870|NCT00628745|460222479|FG003|Overall Study|Lost to Follow-up|0|||
127890871|NCT00628745|460222480|FG004|Overall Study|Lost to Follow-up|498|||
127890872|NCT00628745|460222476|FG000|Overall Study|Death|197|||
127890873|NCT00628745|460222477|FG001|Overall Study|Death|81|||
127890874|NCT00628745|460222478|FG002|Overall Study|Death|12|||
127890875|NCT00628745|460222479|FG003|Overall Study|Death|4|||
127890876|NCT00628745|460222480|FG004|Overall Study|Death|939|||
127734179|NCT02784535|459651765|FG000|Overall Study|Withdrawal by Subject|0|||
127734180|NCT02784535|459651766|FG001|Overall Study|Withdrawal by Subject|1|||
127734181|NCT02784535|459651765|FG000|Overall Study|Physician Decision|0|||
127734182|NCT02784535|459651766|FG001|Overall Study|Physician Decision|1|||
127734183|NCT02335242|459651771|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
127890877|NCT00628745|460222476|FG000|Overall Study|Participant transferred to another THAOS site|6|||
127890878|NCT00628745|460222477|FG001|Overall Study|Participant transferred to another THAOS site|0|||
127890879|NCT00628745|460222478|FG002|Overall Study|Participant transferred to another THAOS site|0|||
127890880|NCT00628745|460222479|FG003|Overall Study|Participant transferred to another THAOS site|0|||
127890881|NCT00628745|460222480|FG004|Overall Study|Participant transferred to another THAOS site|7|||
127890882|NCT00628745|460222476|FG000|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|37|||
127890883|NCT00628745|460222477|FG001|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|29|||
127890884|NCT00628745|460222478|FG002|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|46|||
127890885|NCT00628745|460222479|FG003|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|0|||
127890886|NCT00628745|460222480|FG004|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|91|||
127890887|NCT00628745|460222476|FG000|Overall Study|Site closure|152|||
127890888|NCT00628745|460222477|FG001|Overall Study|Site closure|146|||
127890889|NCT00628745|460222478|FG002|Overall Study|Site closure|6|||
127890890|NCT00628745|460222479|FG003|Overall Study|Site closure|8|||
127890891|NCT00628745|460222480|FG004|Overall Study|Site closure|691|||
127890892|NCT00628745|460222476|FG000|Overall Study|Duplicate participant|0|||
127890893|NCT00628745|460222477|FG001|Overall Study|Duplicate participant|0|||
127890894|NCT00628745|460222478|FG002|Overall Study|Duplicate participant|0|||
127890895|NCT00628745|460222479|FG003|Overall Study|Duplicate participant|0|||
127890896|NCT00628745|460222480|FG004|Overall Study|Duplicate participant|1|||
127890897|NCT00628745|460222476|FG000|Overall Study|Missing|4|||
127890898|NCT00628745|460222477|FG001|Overall Study|Missing|3|||
127890899|NCT00628745|460222478|FG002|Overall Study|Missing|0|||
127890900|NCT00628745|460222479|FG003|Overall Study|Missing|0|||
127890901|NCT00628745|460222480|FG004|Overall Study|Missing|10|||
127890902|NCT00628745|460222476|FG000|Overall Study|Othe reasons|987|||
127890903|NCT00628745|460222477|FG001|Overall Study|Othe reasons|373|||
127890904|NCT00628745|460222478|FG002|Overall Study|Othe reasons|105|||
127890905|NCT00628745|460222479|FG003|Overall Study|Othe reasons|1|||
127890906|NCT00628745|460222480|FG004|Overall Study|Othe reasons|1772|||
127890907|NCT03322462|460224162|FG000|Overall Study|Technical difficulties|2|||
127890908|NCT03322462|460224162|FG000|Overall Study|Other|1|||
127890909|NCT00598559|460224163|FG000|Overall Study|Adverse Event|11|||
127890910|NCT00598559|460224164|FG001|Overall Study|Adverse Event|7|||
127890911|NCT00598559|460224165|FG002|Overall Study|Adverse Event|0|||
127890912|NCT00598559|460224163|FG000|Overall Study|Withdrawal by Subject|2|||
127890913|NCT00598559|460224164|FG001|Overall Study|Withdrawal by Subject|2|||
127890914|NCT00598559|460224165|FG002|Overall Study|Withdrawal by Subject|0|||
127890915|NCT00598559|460224163|FG000|Overall Study|Protocol Non-compliance|1|||
127890916|NCT00598559|460224164|FG001|Overall Study|Protocol Non-compliance|0|||
127890917|NCT00598559|460224165|FG002|Overall Study|Protocol Non-compliance|0|||
127890918|NCT00598559|460224163|FG000|Overall Study|Early discharge from hospital|9|||
127890919|NCT00598559|460224164|FG001|Overall Study|Early discharge from hospital|12|||
127890920|NCT00598559|460224165|FG002|Overall Study|Early discharge from hospital|3|||
127734184|NCT02335242|459651772|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
127890921|NCT00598559|460224163|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
127890922|NCT00598559|460224164|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
127890923|NCT00598559|460224165|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
127890924|NCT03381248|460224166|FG000|0-6 Months|Withdrawal by Subject|4|||
127890925|NCT03381248|460224167|FG001|0-6 Months|Withdrawal by Subject|1|||
127890926|NCT03381248|460224166|FG000|0-6 Months|Lost to Follow-up|3|||
127890927|NCT03381248|460224167|FG001|0-6 Months|Lost to Follow-up|2|||
127890928|NCT03381248|460224166|FG000|0-6 Months|Lack of Efficacy|1|||
127890929|NCT03381248|460224167|FG001|0-6 Months|Lack of Efficacy|0|||
127890930|NCT03381248|460224166|FG000|0-6 Months|Adverse Event|1|||
127890931|NCT03381248|460224167|FG001|0-6 Months|Adverse Event|0|||
127890932|NCT03381248|460224166|FG000|0-6 Months|Protocol Violation|2|||
127890933|NCT03381248|460224167|FG001|0-6 Months|Protocol Violation|1|||
127890934|NCT03381248|460224166|FG000|0-6 Months|Physician Decision|1|||
127890935|NCT03381248|460224167|FG001|0-6 Months|Physician Decision|0|||
127890936|NCT03381248|460224166|FG000|0-6 Months|Planning another procedure|1|||
127890937|NCT03381248|460224167|FG001|0-6 Months|Planning another procedure|2|||
127890938|NCT03381248|460224166|FG000|6-12 Months|Withdrawal by Subject|1|||
127890939|NCT03381248|460224167|FG001|6-12 Months|Withdrawal by Subject|3|||
127890940|NCT03381248|460224166|FG000|6-12 Months|Lost to Follow-up|0|||
127890941|NCT03381248|460224167|FG001|6-12 Months|Lost to Follow-up|2|||
127890942|NCT03381248|460224166|FG000|6-12 Months|Protocol Violation|3|||
127890943|NCT03381248|460224167|FG001|6-12 Months|Protocol Violation|2|||
127890944|NCT03381248|460224166|FG000|6-12 Months|Planning another procedure|6|||
127890945|NCT03381248|460224167|FG001|6-12 Months|Planning another procedure|2|||
127890946|NCT03381248|460224166|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
127890947|NCT03381248|460224167|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
127890948|NCT03381248|460224166|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
127890949|NCT03381248|460224167|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
127890950|NCT03381248|460224166|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
127890951|NCT03381248|460224167|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
127890952|NCT01405950|460224174|FG000|Overall Study|Withdrawal by Subject|1|||
127890953|NCT01405950|460224175|FG001|Overall Study|Withdrawal by Subject|0|||
127890954|NCT01405950|460224176|FG002|Overall Study|Withdrawal by Subject|0|||
127890955|NCT01405950|460224177|FG003|Overall Study|Withdrawal by Subject|0|||
127890956|NCT02410252|460224178|FG000|Overall Study|Withdrawal by Subject|4|||
127890957|NCT02410252|460224178|FG000|Overall Study|Physician Decision|2|||
127890958|NCT00387712|460224181|FG000|Overall Study|Physician Decision|6|||
127890959|NCT00387712|460224182|FG001|Overall Study|Physician Decision|4|||
127890960|NCT00387712|460224181|FG000|Overall Study|Lost to Follow-up|17|||
127890961|NCT00387712|460224182|FG001|Overall Study|Lost to Follow-up|20|||
127890962|NCT00387712|460224181|FG000|Overall Study|Withdrawal by Subject|6|||
127890963|NCT00387712|460224182|FG001|Overall Study|Withdrawal by Subject|12|||
127890964|NCT01907737|460224191|FG000|Overall Study|Withdrawal by Subject|1|||
127890965|NCT01772368|460224193|FG000|Overall Study|Adverse Event|1|||
127890966|NCT01772368|460224193|FG000|Overall Study|Withdrawal by Subject|3|||
127890967|NCT01772368|460224193|FG000|Overall Study|Protocol Violation|2|||
127890968|NCT01772368|460224193|FG000|Overall Study|Other|1|||
127890969|NCT01452529|460224194|FG000|Run-in Period|Adverse Event|96|||
127890970|NCT01452529|460224195|FG001|Run-in Period|Adverse Event|0|||
127890971|NCT01452529|460224196|FG002|Run-in Period|Adverse Event|0|||
127890972|NCT01452529|460224194|FG000|Run-in Period|Withdrawal by Subject|49|||
127890973|NCT01452529|460224195|FG001|Run-in Period|Withdrawal by Subject|0|||
127890974|NCT01452529|460224196|FG002|Run-in Period|Withdrawal by Subject|0|||
127890975|NCT01452529|460224194|FG000|Run-in Period|Lost to Follow-up|19|||
127890976|NCT01452529|460224195|FG001|Run-in Period|Lost to Follow-up|0|||
127890977|NCT01452529|460224196|FG002|Run-in Period|Lost to Follow-up|0|||
127890978|NCT01452529|460224194|FG000|Run-in Period|Lack of Efficacy|46|||
127890979|NCT01452529|460224195|FG001|Run-in Period|Lack of Efficacy|0|||
127890980|NCT01452529|460224196|FG002|Run-in Period|Lack of Efficacy|0|||
127890981|NCT01452529|460224194|FG000|Run-in Period|Confirmed or suspected diversion|23|||
127734185|NCT02335242|459651771|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
127734186|NCT02335242|459651772|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
127734187|NCT02335242|459651771|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
127734188|NCT02335242|459651772|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
127734189|NCT00257556|459651775|FG000|Overall Study|Adverse Event|1|||
127734190|NCT00257556|459651776|FG001|Overall Study|Adverse Event|4|||
127734191|NCT00257556|459651775|FG000|Overall Study|Physician Decision|6|||
127734192|NCT00257556|459651776|FG001|Overall Study|Physician Decision|0|||
127734193|NCT00257556|459651775|FG000|Overall Study|Did not meet hCG criterion|3|||
127890982|NCT01452529|460224195|FG001|Run-in Period|Confirmed or suspected diversion|0|||
127890983|NCT01452529|460224196|FG002|Run-in Period|Confirmed or suspected diversion|0|||
127890984|NCT01452529|460224194|FG000|Run-in Period|Administrative|21|||
127890985|NCT01452529|460224195|FG001|Run-in Period|Administrative|0|||
127890986|NCT01452529|460224196|FG002|Run-in Period|Administrative|0|||
127890987|NCT01452529|460224194|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
127890988|NCT01452529|460224195|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
127890989|NCT01452529|460224196|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
127805437|NCT01763164|459909339|FG000|Follow up Phase|Death|21|||
127805438|NCT01763164|459909340|FG001|Follow up Phase|Death|4|||
127805439|NCT01763164|459909339|FG000|Follow up Phase|Subject/guardian decision|9|||
127805440|NCT01763164|459909340|FG001|Follow up Phase|Subject/guardian decision|2|||
127805441|NCT01763164|459909339|FG000|Follow up Phase|Progressive disease|127|||
127805442|NCT01763164|459909340|FG001|Follow up Phase|Progressive disease|62|||
127805443|NCT01763164|459909339|FG000|Follow up Phase|Physician Decision|10|||
127805444|NCT01763164|459909340|FG001|Follow up Phase|Physician Decision|3|||
127805445|NCT01763164|459909339|FG000|Follow up Phase|Lost to Follow-up|1|||
127805446|NCT01763164|459909340|FG001|Follow up Phase|Lost to Follow-up|0|||
127805447|NCT01763164|459909339|FG000|Follow up Phase|Adverse Event|17|||
127805448|NCT01763164|459909340|FG001|Follow up Phase|Adverse Event|1|||
127805449|NCT01273064|459909341|FG000|Overall Study|Adverse Event|5|||
127805450|NCT01273064|459909342|FG001|Overall Study|Adverse Event|1|||
127805451|NCT01273064|459909343|FG002|Overall Study|Adverse Event|3|||
127805452|NCT01273064|459909344|FG003|Overall Study|Adverse Event|2|||
127805453|NCT01273064|459909345|FG004|Overall Study|Adverse Event|1|||
127805454|NCT01273064|459909341|FG000|Overall Study|Withdrawal by Subject|4|||
127805455|NCT01273064|459909342|FG001|Overall Study|Withdrawal by Subject|2|||
127805456|NCT01273064|459909343|FG002|Overall Study|Withdrawal by Subject|2|||
127805457|NCT01273064|459909344|FG003|Overall Study|Withdrawal by Subject|2|||
127805458|NCT01273064|459909345|FG004|Overall Study|Withdrawal by Subject|0|||
127805459|NCT01273064|459909341|FG000|Overall Study|Study Termination|13|||
127805460|NCT01273064|459909342|FG001|Overall Study|Study Termination|27|||
127805461|NCT01273064|459909343|FG002|Overall Study|Study Termination|26|||
127805462|NCT01273064|459909344|FG003|Overall Study|Study Termination|16|||
127805463|NCT01273064|459909345|FG004|Overall Study|Study Termination|8|||
127805464|NCT01273064|459909341|FG000|Overall Study|Lost to Follow-up|1|||
127805465|NCT01273064|459909342|FG001|Overall Study|Lost to Follow-up|0|||
127805466|NCT01273064|459909343|FG002|Overall Study|Lost to Follow-up|0|||
127805467|NCT01273064|459909344|FG003|Overall Study|Lost to Follow-up|0|||
127805468|NCT01273064|459909345|FG004|Overall Study|Lost to Follow-up|0|||
127805469|NCT01273064|459909341|FG000|Overall Study|Physician Decision|0|||
127805470|NCT01273064|459909342|FG001|Overall Study|Physician Decision|0|||
127805471|NCT01273064|459909343|FG002|Overall Study|Physician Decision|0|||
127805472|NCT01273064|459909344|FG003|Overall Study|Physician Decision|0|||
127805473|NCT01273064|459909345|FG004|Overall Study|Physician Decision|1|||
127805474|NCT00291551|459909346|FG000|Overall Study|Death|7|||
127805475|NCT00291551|459909346|FG000|Overall Study|Withdrawal by Subject|6|||
127805476|NCT02658812|459909347|FG000|Overall Study|Disease Progression|7|||
127805477|NCT02658812|459909347|FG000|Overall Study|Unrelated to study treatment|1|||
127805478|NCT02658812|459909347|FG000|Overall Study|Adverse Event|1|||
127805479|NCT01512264|459909348|FG000|Overall Study|Lost to Follow-up|0|||
127805480|NCT01512264|459909349|FG001|Overall Study|Lost to Follow-up|0|||
127805481|NCT01512264|459909350|FG002|Overall Study|Lost to Follow-up|0|||
127805482|NCT01512264|459909351|FG003|Overall Study|Lost to Follow-up|1|||
127805483|NCT02411747|459909352|FG000|Overall Study|Withdrawal by Subject|1|||
127805484|NCT02411747|459909353|FG001|Overall Study|Withdrawal by Subject|0|||
127805485|NCT02411747|459909352|FG000|Overall Study|Protocol Violation|2|||
127805486|NCT02411747|459909353|FG001|Overall Study|Protocol Violation|4|||
127805487|NCT00996203|459909354|FG000|Overall Study|Adverse Event|3|||
127805488|NCT00996203|459909354|FG000|Overall Study|Lost to Follow-up|1|||
127805489|NCT00996203|459909354|FG000|Overall Study|Lack of Efficacy|1|||
127805490|NCT00996203|459909354|FG000|Overall Study|Protocol Violation|2|||
127805491|NCT03686969|459909356|FG000|Overall Study|Study terminated|1|||
127805492|NCT03686969|459909357|FG001|Overall Study|Study terminated|0|||
127734194|NCT00257556|459651776|FG001|Overall Study|Did not meet hCG criterion|0|||
127734195|NCT00257556|459651775|FG000|Overall Study|other reason|4|||
127734196|NCT00257556|459651776|FG001|Overall Study|other reason|6|||
127734197|NCT00905255|459651780|FG000|Overall Study|Adverse Event|7|||
127734198|NCT00905255|459651781|FG001|Overall Study|Adverse Event|5|||
127734199|NCT00905255|459651780|FG000|Overall Study|Withdrawal by Subject|5|||
127734200|NCT00905255|459651781|FG001|Overall Study|Withdrawal by Subject|4|||
127734201|NCT00905255|459651780|FG000|Overall Study|Familial and Personal Reasons|1|||
127734202|NCT00905255|459651781|FG001|Overall Study|Familial and Personal Reasons|0|||
127734203|NCT04839289|459651782|FG000|Overall Study|Withdrawal by Subject|1|||
127734204|NCT04839289|459651783|FG001|Overall Study|Withdrawal by Subject|0|||
127734205|NCT02418819|459651787|FG000|Overall Study|Adverse Event|0|||
127734206|NCT02418819|459651788|FG001|Overall Study|Adverse Event|0|||
127734207|NCT02418819|459651789|FG002|Overall Study|Adverse Event|1|||
127734208|NCT02418819|459651790|FG003|Overall Study|Adverse Event|0|||
127734209|NCT02418819|459651787|FG000|Overall Study|Lost to Follow-up|1|||
127734210|NCT02418819|459651788|FG001|Overall Study|Lost to Follow-up|0|||
127805493|NCT00560755|459909358|FG000|Overall Study|Protocol Violation|15|||
127805494|NCT00560755|459909358|FG000|Overall Study|Withdrawal by Subject|26|||
127805495|NCT00560755|459909358|FG000|Overall Study|Lost to Follow-up|9|||
127805496|NCT00560755|459909358|FG000|Overall Study|Adverse Event|8|||
127805497|NCT00560755|459909358|FG000|Overall Study|Physician Decision|2|||
127805498|NCT00848120|459909359|FG000|Overall Study|Adverse Event|1|||
127734211|NCT02418819|459651789|FG002|Overall Study|Lost to Follow-up|0|||
127734212|NCT02418819|459651790|FG003|Overall Study|Lost to Follow-up|0|||
127734213|NCT02418819|459651787|FG000|Overall Study|No longer meets eligibility criteria|0|||
127734214|NCT02418819|459651788|FG001|Overall Study|No longer meets eligibility criteria|0|||
127734215|NCT02418819|459651789|FG002|Overall Study|No longer meets eligibility criteria|1|||
127734216|NCT02418819|459651790|FG003|Overall Study|No longer meets eligibility criteria|0|||
127734217|NCT02418819|459651787|FG000|Overall Study|No longer willing to participate|0|||
127734218|NCT02418819|459651788|FG001|Overall Study|No longer willing to participate|0|||
127805499|NCT01988090|459909365|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
127805500|NCT01988090|459909366|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
127805501|NCT01988090|459909365|FG000|Start Treament After Randomization|Protocol Violation|0|||
127805502|NCT01988090|459909366|FG001|Start Treament After Randomization|Protocol Violation|1|||
127805503|NCT01988090|459909365|FG000|Complete Study After Start|Withdrawal by Subject|2|||
127805504|NCT01988090|459909366|FG001|Complete Study After Start|Withdrawal by Subject|0|||
127805505|NCT01988090|459909365|FG000|Complete Study After Start|Protocol Violation|1|||
127805506|NCT01988090|459909366|FG001|Complete Study After Start|Protocol Violation|1|||
127805507|NCT01439945|459909371|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
127805508|NCT01439945|459909372|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
127805509|NCT01439945|459909373|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
127805510|NCT01439945|459909374|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
127805511|NCT01439945|459909371|FG000|Double-Blind Treatment Phase|Ineligible|1|||
127805512|NCT01439945|459909372|FG001|Double-Blind Treatment Phase|Ineligible|2|||
127805513|NCT01439945|459909373|FG002|Double-Blind Treatment Phase|Ineligible|0|||
127805514|NCT01439945|459909374|FG003|Double-Blind Treatment Phase|Ineligible|1|||
127805515|NCT00705263|459909375|FG000|Overall Study|Withdrawal by Subject|2|||
127805516|NCT01752023|459909376|FG000|Overall Study|Physician Decision|2|||
127805517|NCT01752023|459909377|FG001|Overall Study|Physician Decision|1|||
127805518|NCT02899156|459909378|FG000|Overall Study|Death|1|||
127805519|NCT02899156|459909379|FG001|Overall Study|Death|0|||
127805520|NCT02899156|459909378|FG000|Overall Study|Physician Decision|0|||
127805521|NCT02899156|459909379|FG001|Overall Study|Physician Decision|1|||
127805522|NCT00787787|459909383|FG000|Overall Study|Lack of Efficacy|4|||
127805523|NCT00787787|459909383|FG000|Overall Study|Adverse Event|3|||
127805524|NCT01412957|459909385|FG000|Overall Study|Withdrawal by Subject|6|||
127805525|NCT01412957|459909386|FG001|Overall Study|Withdrawal by Subject|22|||
127805526|NCT01412957|459909385|FG000|Overall Study|Lost to Follow-up|7|||
127805527|NCT01412957|459909386|FG001|Overall Study|Lost to Follow-up|2|||
127805528|NCT01412957|459909385|FG000|Overall Study|Death|136|||
127805529|NCT01412957|459909386|FG001|Overall Study|Death|133|||
127805530|NCT04722991|459909392|FG000|Overall Study|Adverse Event|12|||
127805531|NCT04722991|459909393|FG001|Overall Study|Adverse Event|4|||
127805532|NCT04722991|459909392|FG000|Overall Study|Death|2|||
127805533|NCT04722991|459909393|FG001|Overall Study|Death|0|||
127805534|NCT04722991|459909392|FG000|Overall Study|Lost to Follow-up|1|||
127805535|NCT04722991|459909393|FG001|Overall Study|Lost to Follow-up|1|||
127805536|NCT04722991|459909392|FG000|Overall Study|Withdrawal cirterion met|2|||
127805537|NCT04722991|459909393|FG001|Overall Study|Withdrawal cirterion met|2|||
127805538|NCT04722991|459909392|FG000|Overall Study|Other|1|||
127805539|NCT04722991|459909393|FG001|Overall Study|Other|0|||
127805540|NCT04722991|459909392|FG000|Overall Study|Non-compliance|0|||
127805541|NCT04722991|459909393|FG001|Overall Study|Non-compliance|1|||
127805542|NCT04722991|459909392|FG000|Overall Study|Withdrawal by Subject|0|||
127805543|NCT04722991|459909393|FG001|Overall Study|Withdrawal by Subject|1|||
127805544|NCT00413959|459909394|FG000|Overall Study|Pt had only one cycle.|1|||
127805545|NCT04343651|459909398|FG000|Overall Study|Physician Decision|2|||
127805546|NCT04343651|459909399|FG001|Overall Study|Physician Decision|1|||
127805547|NCT04343651|459909398|FG000|Overall Study|Lost to Follow-up|2|||
127805548|NCT04343651|459909399|FG001|Overall Study|Lost to Follow-up|1|||
127805549|NCT04343651|459909398|FG000|Overall Study|Protocol Violation|4|||
127805550|NCT04343651|459909399|FG001|Overall Study|Protocol Violation|6|||
127805551|NCT04343651|459909398|FG000|Overall Study|Missing|3|||
127805552|NCT04343651|459909399|FG001|Overall Study|Missing|9|||
127805553|NCT04343651|459909398|FG000|Overall Study|Withdrawal by Subject|0|||
127805554|NCT04343651|459909399|FG001|Overall Study|Withdrawal by Subject|4|||
127805555|NCT04343651|459909398|FG000|Overall Study|Death|0|||
127805556|NCT04343651|459909399|FG001|Overall Study|Death|1|||
127890990|NCT01452529|460224194|FG000|Double-blind (DB) Period|Adverse Event|0|||
127805557|NCT04343651|459909398|FG000|Overall Study|Did not start treatment|1|||
127805558|NCT04343651|459909399|FG001|Overall Study|Did not start treatment|1|||
127805559|NCT04343651|459909398|FG000|Overall Study|Patient did not complete visits 3-6|0|||
127805560|NCT04343651|459909399|FG001|Overall Study|Patient did not complete visits 3-6|1|||
127805561|NCT02246621|459909400|FG000|Overall Study|Withdrawal by Subject|28|||
127805562|NCT02246621|459909401|FG001|Overall Study|Withdrawal by Subject|16|||
127805563|NCT02246621|459909400|FG000|Overall Study|Lost to Follow-up|1|||
127805564|NCT02246621|459909401|FG001|Overall Study|Lost to Follow-up|0|||
127805565|NCT02246621|459909400|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
127890991|NCT01452529|460224195|FG001|Double-blind (DB) Period|Adverse Event|18|||
127890992|NCT01452529|460224196|FG002|Double-blind (DB) Period|Adverse Event|11|||
127890993|NCT01452529|460224194|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
127890994|NCT01452529|460224195|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
127890995|NCT01452529|460224196|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
127890996|NCT01452529|460224194|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
127890997|NCT01452529|460224195|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
127890998|NCT01452529|460224196|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
127890999|NCT01452529|460224194|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
127891000|NCT01452529|460224195|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
127891001|NCT01452529|460224196|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
127891002|NCT01452529|460224194|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
127891003|NCT01452529|460224195|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
127891004|NCT01452529|460224196|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
127891005|NCT01452529|460224194|FG000|Double-blind (DB) Period|Administrative|0|||
127891006|NCT01452529|460224195|FG001|Double-blind (DB) Period|Administrative|11|||
127891007|NCT01452529|460224196|FG002|Double-blind (DB) Period|Administrative|7|||
127891008|NCT03551730|460224200|FG000|Overall Study|Adverse Event|1|||
127891009|NCT03551730|460224201|FG001|Overall Study|Adverse Event|0|||
127891010|NCT03551730|460224202|FG002|Overall Study|Adverse Event|0|||
127891011|NCT03551730|460224203|FG003|Overall Study|Adverse Event|0|||
127891012|NCT03347695|460224207|FG000|Overall Study|Death|0|||
127891013|NCT03347695|460224208|FG001|Overall Study|Death|4|||
127891014|NCT03347695|460224207|FG000|Overall Study|Lost to Follow-up|0|||
127891015|NCT03347695|460224208|FG001|Overall Study|Lost to Follow-up|1|||
127891016|NCT02668783|460224227|FG000|Overall Study|Pregnancy|0|||
127891017|NCT02668783|460224228|FG001|Overall Study|Pregnancy|1|||
127891018|NCT02668783|460224227|FG000|Overall Study|Protocol Violation|2|||
127891019|NCT02668783|460224228|FG001|Overall Study|Protocol Violation|1|||
127891020|NCT02668783|460224227|FG000|Overall Study|Study terminated by sponsor|9|||
127891021|NCT02668783|460224228|FG001|Overall Study|Study terminated by sponsor|10|||
127891022|NCT02668783|460224227|FG000|Overall Study|Subject moved|1|||
127891023|NCT02668783|460224228|FG001|Overall Study|Subject moved|0|||
127891024|NCT02668783|460224227|FG000|Overall Study|Withdrawal by Subject|1|||
127891025|NCT02668783|460224228|FG001|Overall Study|Withdrawal by Subject|0|||
127891026|NCT01003886|460224231|FG000|Overall Study|Lack of Efficacy|5|||
127891027|NCT01003886|460224231|FG000|Overall Study|Lost to Follow-up|169|||
127891028|NCT01003886|460224231|FG000|Overall Study|Withdrawal by Subject|39|||
127891029|NCT01003886|460224231|FG000|Overall Study|Other|14|||
127891030|NCT01003886|460224231|FG000|Overall Study|Adverse Event|3|||
127891031|NCT04467697|460224232|FG000|Overall Study|Adverse Event|2|||
127891032|NCT04467697|460224232|FG000|Overall Study|Lost to Follow-up|6|||
127891033|NCT04467697|460224232|FG000|Overall Study|Withdrawal by Subject|9|||
127891034|NCT04467697|460224232|FG000|Overall Study|Protocol Violation|3|||
127891035|NCT03907280|460224235|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
127891036|NCT03907280|460224236|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
127891037|NCT03907280|460224237|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
127891038|NCT00909727|460224238|FG000|Overall Study|Adverse Event|1|||
127891039|NCT00909727|460224239|FG001|Overall Study|Adverse Event|0|||
127891040|NCT00909727|460224238|FG000|Overall Study|Wrong Genotype|1|||
127891041|NCT00909727|460224239|FG001|Overall Study|Wrong Genotype|0|||
127891042|NCT00909727|460224238|FG000|Overall Study|Withdrawal of Consent|1|||
127891043|NCT00909727|460224239|FG001|Overall Study|Withdrawal of Consent|0|||
127891044|NCT00909727|460224238|FG000|Overall Study|Prohibited Medication|1|||
127891045|NCT00909727|460224239|FG001|Overall Study|Prohibited Medication|0|||
127891046|NCT02231710|460224240|FG000|Overall Study|Physician Decision|1|||
127891047|NCT04081337|460224241|FG000|Overall Study|Adverse Event|0|||
127891048|NCT04081337|460224242|FG001|Overall Study|Adverse Event|1|||
127891049|NCT04081337|460224241|FG000|Overall Study|Withdrawal by Subject|2|||
127891050|NCT04081337|460224242|FG001|Overall Study|Withdrawal by Subject|0|||
127891051|NCT04081337|460224241|FG000|Overall Study|Physician Decision|1|||
127891052|NCT04081337|460224242|FG001|Overall Study|Physician Decision|2|||
127891053|NCT04081337|460224241|FG000|Overall Study|Lost to Follow-up|1|||
127891054|NCT04081337|460224242|FG001|Overall Study|Lost to Follow-up|0|||
127891055|NCT00673361|460224247|FG000|Overall Study|Screen Failure|2|||
127891056|NCT01799590|460224250|FG000|Overall Study|Adverse Event|13|||
127891057|NCT01799590|460224251|FG001|Overall Study|Adverse Event|7|||
127891058|NCT01799590|460224252|FG002|Overall Study|Adverse Event|5|||
127891059|NCT01799590|460224250|FG000|Overall Study|Pregnancy|2|||
127891060|NCT01799590|460224251|FG001|Overall Study|Pregnancy|0|||
127891061|NCT01799590|460224252|FG002|Overall Study|Pregnancy|0|||
127891062|NCT01799590|460224250|FG000|Overall Study|Lack of Efficacy|3|||
127891063|NCT01799590|460224251|FG001|Overall Study|Lack of Efficacy|1|||
127891064|NCT01799590|460224252|FG002|Overall Study|Lack of Efficacy|3|||
127891065|NCT01799590|460224250|FG000|Overall Study|Participants convenience|4|||
127891066|NCT01799590|460224251|FG001|Overall Study|Participants convenience|4|||
127891067|NCT01799590|460224252|FG002|Overall Study|Participants convenience|2|||
127891068|NCT01799590|460224250|FG000|Overall Study|Aggravation of complications|0|||
127891069|NCT01799590|460224251|FG001|Overall Study|Aggravation of complications|1|||
127891070|NCT01799590|460224252|FG002|Overall Study|Aggravation of complications|1|||
127891071|NCT01799590|460224250|FG000|Overall Study|Using drugs with restricted days of use|0|||
127891072|NCT01799590|460224251|FG001|Overall Study|Using drugs with restricted days of use|3|||
127891073|NCT01799590|460224252|FG002|Overall Study|Using drugs with restricted days of use|2|||
127891074|NCT01799590|460224250|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
127891075|NCT01799590|460224251|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
127891076|NCT01799590|460224252|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
127891077|NCT01799590|460224250|FG000|Overall Study|Other|3|||
127891078|NCT01799590|460224251|FG001|Overall Study|Other|0|||
127891079|NCT01799590|460224252|FG002|Overall Study|Other|1|||
127891080|NCT01489956|460224253|FG000|Overall Study|Lost to Follow-up|1|||
127734219|NCT02418819|459651789|FG002|Overall Study|No longer willing to participate|2|||
127734220|NCT02418819|459651790|FG003|Overall Study|No longer willing to participate|1|||
127734221|NCT04743999|459651791|FG000|3-month Questionnaire|Death|1|||
127734222|NCT04743999|459651791|FG000|6-month Questionnaire|Study terminated due to low accrual|1|||
127734223|NCT04743999|459651791|FG000|12-month Questionnaire|Study terminated due to low accrual|1|||
127734224|NCT04743999|459651791|FG000|24-month Questionnaire|Study terminated due to low accrual|5|||
127734225|NCT01721759|459651792|FG000|Treatment Period|Disease Progression|85|||
127734226|NCT01721759|459651792|FG000|Treatment Period|Study drug toxicity|14|||
127734227|NCT01721759|459651792|FG000|Treatment Period|Death|1|||
127734228|NCT01721759|459651792|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
127734229|NCT01721759|459651792|FG000|Treatment Period|Participant request to withdraw|3|||
127734230|NCT01721759|459651792|FG000|Treatment Period|Other Reasons|3|||
127734231|NCT01721759|459651792|FG000|End of Study Period|Participant Withdrew Consent|5|||
127734232|NCT01721759|459651792|FG000|End of Study Period|Death|101|||
127734233|NCT01721759|459651792|FG000|End of Study Period|Lost to Follow-up|1|||
127734234|NCT01721759|459651792|FG000|End of Study Period|Other Reasons|10|||
127891081|NCT01489956|460224254|FG001|Overall Study|Lost to Follow-up|0|||
127891082|NCT01489956|460224255|FG002|Overall Study|Lost to Follow-up|0|||
127891083|NCT01489956|460224253|FG000|Overall Study|Withdrawal by Subject|0|||
127891084|NCT01489956|460224254|FG001|Overall Study|Withdrawal by Subject|0|||
127891085|NCT01489956|460224255|FG002|Overall Study|Withdrawal by Subject|1|||
127891086|NCT03175120|460224258|FG000|Overall Study|Adverse Event|2|||
127891087|NCT03175120|460224259|FG001|Overall Study|Adverse Event|2|||
127891088|NCT03175120|460224258|FG000|Overall Study|Protocol Violation|5|||
127891089|NCT03175120|460224259|FG001|Overall Study|Protocol Violation|2|||
127891090|NCT03175120|460224258|FG000|Overall Study|Lost to Follow-up|1|||
127891091|NCT03175120|460224259|FG001|Overall Study|Lost to Follow-up|0|||
127891092|NCT03175120|460224258|FG000|Overall Study|Withdrawal by Subject|2|||
127891093|NCT03175120|460224259|FG001|Overall Study|Withdrawal by Subject|5|||
127891094|NCT03175120|460224258|FG000|Overall Study|Other|2|||
127891095|NCT03175120|460224259|FG001|Overall Study|Other|3|||
127891096|NCT00678392|460224260|FG000|Overall Study|Adverse Event|0|||
127891097|NCT00678392|460224261|FG001|Overall Study|Adverse Event|6|||
127891098|NCT00678392|460224260|FG000|Overall Study|Death|280|||
127891099|NCT00678392|460224261|FG001|Overall Study|Death|269|||
127891100|NCT00678392|460224260|FG000|Overall Study|Lost to Follow-up|15|||
127891101|NCT00678392|460224261|FG001|Overall Study|Lost to Follow-up|13|||
127891102|NCT00678392|460224260|FG000|Overall Study|Objective Progression or Relapse|3|||
127891103|NCT00678392|460224261|FG001|Overall Study|Objective Progression or Relapse|8|||
127891104|NCT00678392|460224260|FG000|Overall Study|Sponsor's Decision|1|||
127891105|NCT00678392|460224261|FG001|Overall Study|Sponsor's Decision|2|||
127891106|NCT00678392|460224260|FG000|Overall Study|Withdrawal by Subject|4|||
127891107|NCT00678392|460224261|FG001|Overall Study|Withdrawal by Subject|4|||
127891108|NCT00678392|460224260|FG000|Overall Study|Randomized But Not Treated|2|||
127891109|NCT00678392|460224261|FG001|Overall Study|Randomized But Not Treated|7|||
127891110|NCT00678392|460224260|FG000|Overall Study|Other|56|||
127891111|NCT00678392|460224261|FG001|Overall Study|Other|53|||
127891112|NCT03341507|460224263|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
127891113|NCT03255031|460224264|FG000|Overall Study|Adverse Event|5|||
127891114|NCT03255031|460224265|FG001|Overall Study|Adverse Event|3|||
127891115|NCT03255031|460224264|FG000|Overall Study|Physician Decision|2|||
127891116|NCT03255031|460224265|FG001|Overall Study|Physician Decision|1|||
127734235|NCT00580047|459651793|FG000|Overall Study|Lost to Follow-up|1|||
127734236|NCT00580047|459651794|FG001|Overall Study|Lost to Follow-up|1|||
127734237|NCT00580047|459651795|FG002|Overall Study|Lost to Follow-up|0|||
127891117|NCT03255031|460224264|FG000|Overall Study|Withdrawal by Subject|9|||
127891118|NCT03255031|460224265|FG001|Overall Study|Withdrawal by Subject|3|||
127891119|NCT01689974|460224267|FG000|Overall Study|Termination of Study|5|||
127891120|NCT01689974|460224268|FG001|Overall Study|Termination of Study|5|||
127891121|NCT00415532|460224272|FG000|Treatment Period|Adverse Event|2|||
127891122|NCT00415532|460224273|FG001|Treatment Period|Adverse Event|3|||
127805566|NCT02246621|459909401|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
127891123|NCT00415532|460224272|FG000|Treatment Period|Death|2|||
127805567|NCT01292057|459909407|FG000|Overall Study|Protocol Violation|1|||
127805568|NCT01292057|459909408|FG001|Overall Study|Protocol Violation|1|||
127805569|NCT01292057|459909407|FG000|Overall Study|Lost to Follow-up|1|||
127891124|NCT00415532|460224273|FG001|Treatment Period|Death|1|||
127891125|NCT00415532|460224272|FG000|Treatment Period|Lost to Follow-up|1|||
127891126|NCT00415532|460224273|FG001|Treatment Period|Lost to Follow-up|1|||
127891127|NCT00415532|460224272|FG000|Treatment Period|Protocol Violation|1|||
127891128|NCT00415532|460224273|FG001|Treatment Period|Protocol Violation|0|||
127891129|NCT00415532|460224272|FG000|Treatment Period|Withdrawal by Subject|6|||
127891130|NCT00415532|460224273|FG001|Treatment Period|Withdrawal by Subject|6|||
127891131|NCT00415532|460224272|FG000|Treatment Period|Other|2|||
127891132|NCT00415532|460224273|FG001|Treatment Period|Other|2|||
127891133|NCT00415532|460224272|FG000|Treatment Period|Ineligibility determined|1|||
127891134|NCT00415532|460224273|FG001|Treatment Period|Ineligibility determined|1|||
127891135|NCT00415532|460224272|FG000|Treatment Period|Noncompliance|1|||
127891136|NCT00415532|460224273|FG001|Treatment Period|Noncompliance|1|||
127891137|NCT00415532|460224272|FG000|Treatment Period|Requirement for alternative therapy|1|||
127891138|NCT00415532|460224273|FG001|Treatment Period|Requirement for alternative therapy|0|||
127891139|NCT00415532|460224272|FG000|Safety Follow Up Period|Adverse Event|1|||
127891140|NCT00415532|460224273|FG001|Safety Follow Up Period|Adverse Event|3|||
127891141|NCT00415532|460224272|FG000|Safety Follow Up Period|Death|3|||
127891142|NCT00415532|460224273|FG001|Safety Follow Up Period|Death|0|||
127891143|NCT00415532|460224272|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
127891144|NCT00415532|460224273|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
127891145|NCT00415532|460224272|FG000|Safety Follow Up Period|Other|1|||
127891146|NCT00415532|460224273|FG001|Safety Follow Up Period|Other|4|||
127891147|NCT00415532|460224272|FG000|Safety Follow Up Period|Ineligibility determined|1|||
127891148|NCT00415532|460224273|FG001|Safety Follow Up Period|Ineligibility determined|1|||
127734238|NCT00580047|459651793|FG000|Overall Study|Withdrawal by Subject|1|||
127734239|NCT00580047|459651794|FG001|Overall Study|Withdrawal by Subject|1|||
127734240|NCT00580047|459651795|FG002|Overall Study|Withdrawal by Subject|2|||
127734241|NCT00580047|459651793|FG000|Overall Study|Withdrawal by Subject|1|||
127734242|NCT00580047|459651794|FG001|Overall Study|Withdrawal by Subject|0|||
127734243|NCT00580047|459651795|FG002|Overall Study|Withdrawal by Subject|0|||
127734244|NCT04382053|459651796|FG000|Overall Study|Death|6|||
127734245|NCT04382053|459651797|FG001|Overall Study|Death|8|||
127734246|NCT04382053|459651796|FG000|Overall Study|Lost to Follow-up|0|||
127734247|NCT04382053|459651797|FG001|Overall Study|Lost to Follow-up|2|||
127734248|NCT04382053|459651796|FG000|Overall Study|Protocol Deviation|1|||
127734249|NCT04382053|459651797|FG001|Overall Study|Protocol Deviation|2|||
127734250|NCT04382053|459651796|FG000|Overall Study|Withdrawal by Subject|2|||
127734251|NCT04382053|459651797|FG001|Overall Study|Withdrawal by Subject|1|||
127734252|NCT00390806|459651801|FG000|Overall Study|Lost to Follow-up|7|||
127734253|NCT00390806|459651802|FG001|Overall Study|Lost to Follow-up|6|||
127734254|NCT00390806|459651801|FG000|Overall Study|Protocol Violation|2|||
127734255|NCT00390806|459651802|FG001|Overall Study|Protocol Violation|2|||
127734256|NCT00390806|459651801|FG000|Overall Study|Withdrawal by Subject|12|||
127734257|NCT00390806|459651802|FG001|Overall Study|Withdrawal by Subject|15|||
127734258|NCT00390806|459651801|FG000|Overall Study|Investigator Decision|4|||
127805570|NCT01292057|459909408|FG001|Overall Study|Lost to Follow-up|1|||
127805571|NCT01475734|459911065|FG000|Overall Study|Withdrawal by Subject|1|||
127805572|NCT01475734|459911066|FG001|Overall Study|Withdrawal by Subject|0|||
127805573|NCT01475734|459911065|FG000|Overall Study|Protocol Violation|1|||
127805574|NCT01475734|459911066|FG001|Overall Study|Protocol Violation|0|||
127805575|NCT01475734|459911065|FG000|Overall Study|Physician Decision|0|||
127805576|NCT01475734|459911066|FG001|Overall Study|Physician Decision|1|||
127805577|NCT00376961|459911070|FG000|Initial Registration|Adverse Event|1|||
127805578|NCT00376961|459911071|FG001|Initial Registration|Adverse Event|0|||
127805579|NCT00376961|459911070|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
127805580|NCT00376961|459911071|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
127734259|NCT00390806|459651802|FG001|Overall Study|Investigator Decision|6|||
127734260|NCT00390806|459651801|FG000|Overall Study|Death|1|||
127891149|NCT00415532|460224272|FG000|Safety Follow Up Period|Noncompliance|1|||
127734261|NCT00390806|459651802|FG001|Overall Study|Death|0|||
127891150|NCT00415532|460224273|FG001|Safety Follow Up Period|Noncompliance|0|||
127891151|NCT00415532|460224272|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
127891152|NCT00415532|460224273|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
127891153|NCT01698320|460224274|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
127734262|NCT00390806|459651801|FG000|Overall Study|Physician Decision|0|||
127734263|NCT00390806|459651802|FG001|Overall Study|Physician Decision|1|||
127734264|NCT00390806|459651801|FG000|Overall Study|Ongoing|4|||
127734265|NCT00390806|459651802|FG001|Overall Study|Ongoing|2|||
127805581|NCT00376961|459911070|FG000|Initial Registration|Progression/relapse|1|||
127891154|NCT01698320|460224275|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
127891155|NCT01698320|460224276|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
127891156|NCT01698320|460224274|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
127891157|NCT01698320|460224275|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
127734266|NCT02785900|459651808|FG000|Overall Study|Study Termination by Sponsor|64|||
127734267|NCT02785900|459651809|FG001|Overall Study|Study Termination by Sponsor|81|||
127734268|NCT02785900|459651808|FG000|Overall Study|Death|46|||
127734269|NCT02785900|459651809|FG001|Overall Study|Death|32|||
127734270|NCT02785900|459651808|FG000|Overall Study|Withdrawal by Subject|4|||
127891158|NCT01698320|460224276|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
127891159|NCT01698320|460224274|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
127891160|NCT01698320|460224275|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
127891161|NCT01698320|460224276|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
127891162|NCT01698320|460224274|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
127891163|NCT01698320|460224275|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
127891164|NCT01698320|460224276|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
127891165|NCT01698320|460224274|FG000|12-Week Double-Blind Period|Adverse Event|0|||
127891166|NCT01698320|460224275|FG001|12-Week Double-Blind Period|Adverse Event|1|||
127891167|NCT01698320|460224276|FG002|12-Week Double-Blind Period|Adverse Event|1|||
127891168|NCT01698320|460224274|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
127891169|NCT01698320|460224275|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
127891170|NCT01698320|460224276|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
127891171|NCT01698320|460224274|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
127891172|NCT01698320|460224275|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
127891173|NCT01698320|460224276|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
127891174|NCT01698320|460224274|FG000|12-Week Double-Blind Period|Pregnancy|0|||
127891175|NCT01698320|460224275|FG001|12-Week Double-Blind Period|Pregnancy|1|||
127891176|NCT01698320|460224276|FG002|12-Week Double-Blind Period|Pregnancy|1|||
127891177|NCT01698320|460224274|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
127891178|NCT01698320|460224275|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
127891179|NCT01698320|460224276|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
127891180|NCT01698320|460224274|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
127891181|NCT01698320|460224275|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
127891182|NCT01698320|460224276|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
127891183|NCT01698320|460224274|FG000|40-Week Open-Label Period|Adverse Event|0|||
127891184|NCT01698320|460224275|FG001|40-Week Open-Label Period|Adverse Event|3|||
127891185|NCT01698320|460224276|FG002|40-Week Open-Label Period|Adverse Event|2|||
127891186|NCT01698320|460224274|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
127891187|NCT01698320|460224275|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
127891188|NCT01698320|460224276|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
127891189|NCT01698320|460224274|FG000|40-Week Open-Label Period|Pregnancy|0|||
127891190|NCT01698320|460224275|FG001|40-Week Open-Label Period|Pregnancy|2|||
127891191|NCT01698320|460224276|FG002|40-Week Open-Label Period|Pregnancy|1|||
127891192|NCT01698320|460224274|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
127891193|NCT01698320|460224275|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
127891194|NCT01698320|460224276|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
127891195|NCT01698320|460224274|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
127891196|NCT01698320|460224275|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
127891197|NCT01698320|460224276|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
127891198|NCT01952574|460224277|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
127891199|NCT01952574|460224278|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
127891200|NCT01952574|460224279|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
127891201|NCT01952574|460224280|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
127891202|NCT01952574|460224281|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
127891203|NCT01952574|460224282|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
127891204|NCT01952574|460224283|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
127891205|NCT01952574|460224277|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
127891206|NCT01952574|460224278|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
127891207|NCT01952574|460224279|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
127891208|NCT01952574|460224280|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
127891209|NCT01952574|460224281|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
127891210|NCT01952574|460224282|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
127891211|NCT01952574|460224283|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
127891212|NCT01952574|460224277|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
127891213|NCT01952574|460224278|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
127891214|NCT01952574|460224279|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
127891215|NCT01952574|460224280|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
127891216|NCT01952574|460224281|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
127734271|NCT02785900|459651809|FG001|Overall Study|Withdrawal by Subject|8|||
127734272|NCT02785900|459651808|FG000|Overall Study|Physician Decision|3|||
127734273|NCT02785900|459651809|FG001|Overall Study|Physician Decision|2|||
127734274|NCT01808144|459651810|FG000|Overall Study|Death|1|||
127734275|NCT01808144|459651811|FG001|Overall Study|Death|0|||
127891217|NCT01952574|460224282|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
127891218|NCT01952574|460224283|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
127891219|NCT01952574|460224277|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
127734276|NCT01808144|459651810|FG000|Overall Study|Withdrawal by Subject|16|||
127734277|NCT01808144|459651811|FG001|Overall Study|Withdrawal by Subject|23|||
127734278|NCT01808144|459651810|FG000|Overall Study|Lost to Follow-up|6|||
127734279|NCT01808144|459651811|FG001|Overall Study|Lost to Follow-up|3|||
127734280|NCT01808144|459651810|FG000|Overall Study|Protocol Violation|6|||
127734281|NCT01808144|459651811|FG001|Overall Study|Protocol Violation|6|||
127734282|NCT01808144|459651810|FG000|Overall Study|Gout flare|0|||
127734283|NCT01808144|459651811|FG001|Overall Study|Gout flare|1|||
127734284|NCT01808144|459651810|FG000|Overall Study|Adverse Event|11|||
127734285|NCT01808144|459651811|FG001|Overall Study|Adverse Event|15|||
127734286|NCT00383500|459651812|FG000|Overall Study|Withdrawal by Subject|8|||
127734287|NCT00383500|459651813|FG001|Overall Study|Withdrawal by Subject|3|||
127734288|NCT00383500|459651814|FG002|Overall Study|Withdrawal by Subject|0|||
127734289|NCT00383500|459651812|FG000|Overall Study|Lost to Follow-up|0|||
127891220|NCT01952574|460224278|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
127891221|NCT01952574|460224279|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
127891222|NCT01952574|460224280|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
127891223|NCT01952574|460224281|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
127891224|NCT01952574|460224282|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
127891225|NCT01952574|460224283|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
127891226|NCT01952574|460224277|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
127891227|NCT01952574|460224278|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
127891228|NCT01952574|460224279|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
127891229|NCT01952574|460224280|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
127891230|NCT01952574|460224281|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
127891231|NCT01952574|460224282|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
127891232|NCT01952574|460224283|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
127891233|NCT01952574|460224277|FG000|Open-label Treatment Phase|Missing|0|||
127891234|NCT01952574|460224278|FG001|Open-label Treatment Phase|Missing|0|||
127891235|NCT01952574|460224279|FG002|Open-label Treatment Phase|Missing|0|||
127891236|NCT01952574|460224280|FG003|Open-label Treatment Phase|Missing|0|||
127891237|NCT01952574|460224281|FG004|Open-label Treatment Phase|Missing|4|||
127891238|NCT01952574|460224282|FG005|Open-label Treatment Phase|Missing|0|||
127891239|NCT01952574|460224283|FG006|Open-label Treatment Phase|Missing|0|||
127891240|NCT01952574|460224277|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
127891241|NCT01952574|460224278|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
127891242|NCT01952574|460224279|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
127891243|NCT01952574|460224280|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
127891244|NCT01952574|460224281|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
127734290|NCT00383500|459651813|FG001|Overall Study|Lost to Follow-up|0|||
127891245|NCT01952574|460224282|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
127891246|NCT01952574|460224283|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
127891247|NCT01952574|460224277|FG000|Open-label Treatment Phase|Death|0|||
127891248|NCT01952574|460224278|FG001|Open-label Treatment Phase|Death|0|||
127891249|NCT01952574|460224279|FG002|Open-label Treatment Phase|Death|0|||
127734291|NCT00383500|459651814|FG002|Overall Study|Lost to Follow-up|2|||
127734292|NCT02176356|459653076|FG000|Overall Study|Screen Failure|14|||
127734293|NCT02176356|459653076|FG000|Overall Study|Lost to Follow-up|4|||
127734294|NCT02176356|459653076|FG000|Overall Study|Personal Reasons|3|||
127734295|NCT02176356|459653076|FG000|Overall Study|Other Miscellaneous Reasons|2|||
127734296|NCT00332488|459653077|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
127734297|NCT00332488|459653078|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
127734298|NCT00332488|459653079|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
127734299|NCT00332488|459653077|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
127734300|NCT00332488|459653078|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
127734301|NCT00332488|459653079|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
127734302|NCT00332488|459653077|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
127734303|NCT00332488|459653078|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
127734304|NCT00332488|459653079|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
127734305|NCT00332488|459653077|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
127734306|NCT00332488|459653078|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
127734307|NCT00332488|459653079|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
127734308|NCT00332488|459653077|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
127734309|NCT00332488|459653078|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
127734310|NCT00332488|459653079|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
127734311|NCT00332488|459653077|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
127734312|NCT00332488|459653078|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
127734313|NCT00332488|459653079|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
127734314|NCT00332488|459653077|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
127734315|NCT00332488|459653078|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
127734316|NCT00332488|459653079|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
127734317|NCT00332488|459653077|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
127734318|NCT00332488|459653078|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
127734319|NCT00332488|459653079|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
127734320|NCT00332488|459653077|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
127734321|NCT00332488|459653078|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
127734322|NCT00332488|459653079|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
127734323|NCT00332488|459653077|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
127734324|NCT00332488|459653078|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
127734325|NCT00332488|459653079|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
127734326|NCT00332488|459653077|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
127734327|NCT00332488|459653078|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
127734328|NCT00332488|459653079|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
127734329|NCT00332488|459653077|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
127734330|NCT00332488|459653078|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
127734331|NCT00332488|459653079|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
127734332|NCT00792259|459653080|FG000|Overall Study|Poor Quality Scans|1|||
127734333|NCT00792259|459653081|FG001|Overall Study|Poor Quality Scans|0|||
127734334|NCT00792259|459653082|FG002|Overall Study|Poor Quality Scans|0|||
127734335|NCT00371462|459653083|FG000|Overall Study|Withdrawal by Subject|1|||
127734336|NCT00371462|459653084|FG001|Overall Study|Withdrawal by Subject|0|||
127734337|NCT00371462|459653083|FG000|Overall Study|Other|7|||
127734338|NCT00371462|459653084|FG001|Overall Study|Other|8|||
127734339|NCT03721978|459653086|FG000|Overall Study|Withdrawal by Subject|6|||
127734340|NCT03721978|459653087|FG001|Overall Study|Withdrawal by Subject|1|||
127734341|NCT03721978|459653086|FG000|Overall Study|Adverse Event|1|||
127734342|NCT03721978|459653087|FG001|Overall Study|Adverse Event|1|||
127734343|NCT03721978|459653086|FG000|Overall Study|Progressive Disease|1|||
127734344|NCT03721978|459653087|FG001|Overall Study|Progressive Disease|0|||
127734345|NCT03721978|459653086|FG000|Overall Study|Lost to Follow-up|5|||
127734346|NCT03721978|459653087|FG001|Overall Study|Lost to Follow-up|1|||
127734347|NCT03721978|459653086|FG000|Overall Study|Reason not Specified|0|||
127734348|NCT03721978|459653087|FG001|Overall Study|Reason not Specified|2|||
127734349|NCT05244226|459653088|FG000|Overall Study|Adverse Event|1|||
127734350|NCT05244226|459653089|FG001|Overall Study|Adverse Event|0|||
127734351|NCT05244226|459653090|FG002|Overall Study|Adverse Event|0|||
127734352|NCT05244226|459653088|FG000|Overall Study|Lost to Follow-up|0|||
127734353|NCT05244226|459653089|FG001|Overall Study|Lost to Follow-up|0|||
127734354|NCT05244226|459653090|FG002|Overall Study|Lost to Follow-up|1|||
127734355|NCT05244226|459653088|FG000|Overall Study|Protocol Violation|0|||
127734356|NCT05244226|459653089|FG001|Overall Study|Protocol Violation|2|||
127734357|NCT05244226|459653090|FG002|Overall Study|Protocol Violation|2|||
127734358|NCT02507687|459653091|FG000|Overall Study|Adverse Event|3|||
127734359|NCT02507687|459653092|FG001|Overall Study|Adverse Event|2|||
127734360|NCT02507687|459653093|FG002|Overall Study|Adverse Event|2|||
127734361|NCT02507687|459653094|FG003|Overall Study|Adverse Event|2|||
127734362|NCT02507687|459653091|FG000|Overall Study|Withdrawal by Subject|1|||
127734363|NCT02507687|459653092|FG001|Overall Study|Withdrawal by Subject|4|||
127891250|NCT01952574|460224280|FG003|Open-label Treatment Phase|Death|0|||
127891251|NCT01952574|460224281|FG004|Open-label Treatment Phase|Death|1|||
127891252|NCT01952574|460224282|FG005|Open-label Treatment Phase|Death|0|||
127891253|NCT01952574|460224283|FG006|Open-label Treatment Phase|Death|0|||
127891254|NCT01952574|460224277|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
127891255|NCT01952574|460224278|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
127891256|NCT01952574|460224279|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
127891257|NCT01952574|460224280|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
127891258|NCT01952574|460224281|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
127891259|NCT01952574|460224282|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
127891260|NCT01952574|460224283|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
127891261|NCT01952574|460224277|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
127891262|NCT01952574|460224278|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
127805582|NCT00376961|459911071|FG001|Initial Registration|Progression/relapse|0|||
127805583|NCT00376961|459911070|FG000|Initial Registration|Ineligible|3|||
127805584|NCT00376961|459911071|FG001|Initial Registration|Ineligible|0|||
127805585|NCT00376961|459911070|FG000|Maintenance|Adverse Event|0|||
127805586|NCT00376961|459911071|FG001|Maintenance|Adverse Event|1|||
127805587|NCT00376961|459911070|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
127805588|NCT00376961|459911071|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
127805589|NCT00376961|459911070|FG000|Maintenance|Progression/relapse|0|||
127805590|NCT00376961|459911071|FG001|Maintenance|Progression/relapse|18|||
127805591|NCT00376961|459911070|FG000|Maintenance|Ineligible|0|||
127805592|NCT00376961|459911071|FG001|Maintenance|Ineligible|3|||
127805593|NCT01059448|459911073|FG000|Overall Study|Adverse Event|1|||
127805594|NCT01059448|459911074|FG001|Overall Study|Adverse Event|3|||
127805595|NCT01059448|459911075|FG002|Overall Study|Adverse Event|0|||
127805596|NCT01059448|459911076|FG003|Overall Study|Adverse Event|1|||
127805597|NCT01059448|459911073|FG000|Overall Study|Withdrawal by Subject|2|||
127805598|NCT01059448|459911074|FG001|Overall Study|Withdrawal by Subject|0|||
127891263|NCT01952574|460224279|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
127891264|NCT01952574|460224280|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
127891265|NCT01952574|460224281|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
127891266|NCT01952574|460224282|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
127891267|NCT01952574|460224283|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
127891268|NCT00770991|460224290|FG000|Overall Study|Physician Decision|2|||
127891269|NCT00770991|460224291|FG001|Overall Study|Physician Decision|0|||
127891270|NCT00770991|460224290|FG000|Overall Study|Withdrawal by Subject|1|||
127891271|NCT00770991|460224291|FG001|Overall Study|Withdrawal by Subject|0|||
127891272|NCT00770991|460224290|FG000|Overall Study|Adverse Event|1|||
127891273|NCT00770991|460224291|FG001|Overall Study|Adverse Event|5|||
127891274|NCT00770991|460224290|FG000|Overall Study|Pregnancy|1|||
127891275|NCT00770991|460224291|FG001|Overall Study|Pregnancy|0|||
127891276|NCT02040766|460224293|FG000|Overall Study|Adverse Event|1|||
127891277|NCT02040766|460224294|FG001|Overall Study|Adverse Event|1|||
127891278|NCT02040766|460224295|FG002|Overall Study|Adverse Event|1|||
127891279|NCT02040766|460224296|FG003|Overall Study|Adverse Event|0|||
127891280|NCT02040766|460224297|FG004|Overall Study|Adverse Event|2|||
127891281|NCT02040766|460224293|FG000|Overall Study|Withdrawal by Subject|4|||
127891282|NCT02040766|460224294|FG001|Overall Study|Withdrawal by Subject|3|||
127891283|NCT02040766|460224295|FG002|Overall Study|Withdrawal by Subject|2|||
127891284|NCT02040766|460224296|FG003|Overall Study|Withdrawal by Subject|3|||
127891285|NCT02040766|460224297|FG004|Overall Study|Withdrawal by Subject|2|||
127891286|NCT02040766|460224293|FG000|Overall Study|Non-compliance|0|||
127891287|NCT02040766|460224294|FG001|Overall Study|Non-compliance|1|||
127891288|NCT02040766|460224295|FG002|Overall Study|Non-compliance|0|||
127891289|NCT02040766|460224296|FG003|Overall Study|Non-compliance|0|||
127891290|NCT02040766|460224297|FG004|Overall Study|Non-compliance|0|||
127891291|NCT02040766|460224293|FG000|Overall Study|Protocol Violation|2|||
127891292|NCT02040766|460224294|FG001|Overall Study|Protocol Violation|1|||
127891293|NCT02040766|460224295|FG002|Overall Study|Protocol Violation|2|||
127891294|NCT02040766|460224296|FG003|Overall Study|Protocol Violation|3|||
127734364|NCT02507687|459653093|FG002|Overall Study|Withdrawal by Subject|6|||
127734365|NCT02507687|459653094|FG003|Overall Study|Withdrawal by Subject|6|||
127734366|NCT02507687|459653091|FG000|Overall Study|Protocol Violation|1|||
127734367|NCT02507687|459653092|FG001|Overall Study|Protocol Violation|0|||
127734368|NCT02507687|459653093|FG002|Overall Study|Protocol Violation|2|||
127734369|NCT02507687|459653094|FG003|Overall Study|Protocol Violation|0|||
127734370|NCT02507687|459653091|FG000|Overall Study|Lost to Follow-up|0|||
127734371|NCT02507687|459653092|FG001|Overall Study|Lost to Follow-up|0|||
127734372|NCT02507687|459653093|FG002|Overall Study|Lost to Follow-up|2|||
127734373|NCT02507687|459653094|FG003|Overall Study|Lost to Follow-up|1|||
127734374|NCT02507687|459653091|FG000|Overall Study|Screen Failure|0|||
127734375|NCT02507687|459653092|FG001|Overall Study|Screen Failure|0|||
127891295|NCT02040766|460224297|FG004|Overall Study|Protocol Violation|0|||
127891296|NCT02040766|460224293|FG000|Overall Study|Lost to Follow-up|4|||
127891297|NCT02040766|460224294|FG001|Overall Study|Lost to Follow-up|1|||
127891298|NCT02040766|460224295|FG002|Overall Study|Lost to Follow-up|3|||
127734376|NCT02507687|459653093|FG002|Overall Study|Screen Failure|1|||
127805599|NCT01059448|459911075|FG002|Overall Study|Withdrawal by Subject|2|||
127805600|NCT01059448|459911076|FG003|Overall Study|Withdrawal by Subject|4|||
127805601|NCT01059448|459911073|FG000|Overall Study|Disease Progression|2|||
127805602|NCT01059448|459911074|FG001|Overall Study|Disease Progression|1|||
127805603|NCT01059448|459911075|FG002|Overall Study|Disease Progression|4|||
127805604|NCT01059448|459911076|FG003|Overall Study|Disease Progression|2|||
127805605|NCT01059448|459911073|FG000|Overall Study|Administrative Decision|43|||
127805606|NCT01059448|459911074|FG001|Overall Study|Administrative Decision|49|||
127805607|NCT01059448|459911075|FG002|Overall Study|Administrative Decision|45|||
127891299|NCT02040766|460224296|FG003|Overall Study|Lost to Follow-up|1|||
127891300|NCT02040766|460224297|FG004|Overall Study|Lost to Follow-up|4|||
127891301|NCT02040766|460224293|FG000|Overall Study|Not reported|1|||
127891302|NCT02040766|460224294|FG001|Overall Study|Not reported|0|||
127891303|NCT02040766|460224295|FG002|Overall Study|Not reported|0|||
127891304|NCT02040766|460224296|FG003|Overall Study|Not reported|0|||
127891305|NCT02040766|460224297|FG004|Overall Study|Not reported|0|||
127891306|NCT02040766|460224293|FG000|Overall Study|Lack of Efficacy|6|||
127891307|NCT02040766|460224294|FG001|Overall Study|Lack of Efficacy|3|||
127891308|NCT02040766|460224295|FG002|Overall Study|Lack of Efficacy|4|||
127891309|NCT02040766|460224296|FG003|Overall Study|Lack of Efficacy|6|||
127891310|NCT02040766|460224297|FG004|Overall Study|Lack of Efficacy|5|||
127891311|NCT02974114|460224298|FG000|Overall Study|Other (Not specified)|0|||
127891312|NCT02974114|460224299|FG001|Overall Study|Other (Not specified)|1|||
127891313|NCT02974114|460224300|FG002|Overall Study|Other (Not specified)|2|||
127891314|NCT01580020|460224301|FG000|Overall Study|Lack of Efficacy|0|||
127891315|NCT01580020|460224302|FG001|Overall Study|Lack of Efficacy|5|||
127891316|NCT01580020|460224303|FG002|Overall Study|Lack of Efficacy|0|||
127891317|NCT01580020|460224304|FG003|Overall Study|Lack of Efficacy|1|||
127891318|NCT01580020|460224301|FG000|Overall Study|Withdrawal by Subject|0|||
127891319|NCT01580020|460224302|FG001|Overall Study|Withdrawal by Subject|1|||
127891320|NCT01580020|460224303|FG002|Overall Study|Withdrawal by Subject|1|||
127891321|NCT01580020|460224304|FG003|Overall Study|Withdrawal by Subject|0|||
127891322|NCT01580020|460224301|FG000|Overall Study|Adverse Event|1|||
127891323|NCT01580020|460224302|FG001|Overall Study|Adverse Event|1|||
127891324|NCT01580020|460224303|FG002|Overall Study|Adverse Event|1|||
127891325|NCT01580020|460224304|FG003|Overall Study|Adverse Event|1|||
127891326|NCT01580020|460224301|FG000|Overall Study|Administrative Problems|0|||
127891327|NCT01580020|460224302|FG001|Overall Study|Administrative Problems|0|||
127891328|NCT01580020|460224303|FG002|Overall Study|Administrative Problems|1|||
127891329|NCT01580020|460224304|FG003|Overall Study|Administrative Problems|0|||
127891330|NCT01580020|460224301|FG000|Overall Study|Lost to Follow-up|0|||
127891331|NCT01580020|460224302|FG001|Overall Study|Lost to Follow-up|0|||
127891332|NCT01580020|460224303|FG002|Overall Study|Lost to Follow-up|1|||
127891333|NCT01580020|460224304|FG003|Overall Study|Lost to Follow-up|0|||
127891334|NCT01724359|460224305|FG000|Overall Study|Adverse Event|10|||
127891335|NCT01724359|460224305|FG000|Overall Study|Death|1|||
127891336|NCT01724359|460224305|FG000|Overall Study|Other|20|||
127891337|NCT01335464|460224312|FG000|Overall Study|Adverse Event|15|||
127891338|NCT01335464|460224313|FG001|Overall Study|Adverse Event|25|||
127891339|NCT01335464|460224312|FG000|Overall Study|Non compliant with protocol|2|||
127891340|NCT01335464|460224313|FG001|Overall Study|Non compliant with protocol|0|||
127891341|NCT01335464|460224312|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
127891342|NCT01335464|460224313|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
127891343|NCT01335464|460224312|FG000|Overall Study|Not treated|2|||
127891344|NCT01335464|460224313|FG001|Overall Study|Not treated|0|||
127891345|NCT01335464|460224312|FG000|Overall Study|Reason other than those stated above|1|||
127891346|NCT01335464|460224313|FG001|Overall Study|Reason other than those stated above|1|||
127891347|NCT00446654|460224314|FG000|Overall Study|Withdrawal by Subject|1|||
127891348|NCT00446654|460224315|FG001|Overall Study|Withdrawal by Subject|0|||
127891349|NCT00446654|460224314|FG000|Overall Study|Adverse Event|1|||
127891350|NCT00446654|460224315|FG001|Overall Study|Adverse Event|0|||
127891351|NCT00593333|460224320|FG000|Overall Study|Lost to Follow-up|10|||
127891352|NCT00593333|460224321|FG001|Overall Study|Lost to Follow-up|11|||
127891353|NCT01752920|460224322|FG000|Overall Study|Adverse Event|1|||
127891354|NCT01752920|460224323|FG001|Overall Study|Adverse Event|0|||
127891355|NCT01752920|460224324|FG002|Overall Study|Adverse Event|5|||
127891356|NCT01752920|460224325|FG003|Overall Study|Adverse Event|10|||
127891357|NCT01752920|460224322|FG000|Overall Study|Clinical Disease Progression|6|||
127891358|NCT01752920|460224323|FG001|Overall Study|Clinical Disease Progression|4|||
127891359|NCT01752920|460224324|FG002|Overall Study|Clinical Disease Progression|1|||
127891360|NCT01752920|460224325|FG003|Overall Study|Clinical Disease Progression|13|||
127891361|NCT01752920|460224322|FG000|Overall Study|Physician Decision|1|||
127891362|NCT01752920|460224323|FG001|Overall Study|Physician Decision|0|||
127891363|NCT01752920|460224324|FG002|Overall Study|Physician Decision|0|||
127891364|NCT01752920|460224325|FG003|Overall Study|Physician Decision|3|||
127891365|NCT01752920|460224322|FG000|Overall Study|Radiographic Disease Progression|20|||
127891366|NCT01752920|460224323|FG001|Overall Study|Radiographic Disease Progression|7|||
127891367|NCT01752920|460224324|FG002|Overall Study|Radiographic Disease Progression|12|||
127891368|NCT01752920|460224325|FG003|Overall Study|Radiographic Disease Progression|29|||
127891369|NCT01752920|460224322|FG000|Overall Study|Study Terminated by Sponsor|0|||
127891370|NCT01752920|460224323|FG001|Overall Study|Study Terminated by Sponsor|0|||
127891371|NCT01752920|460224324|FG002|Overall Study|Study Terminated by Sponsor|0|||
127891372|NCT01752920|460224325|FG003|Overall Study|Study Terminated by Sponsor|1|||
127891373|NCT01752920|460224322|FG000|Overall Study|Withdrawal by Subject|0|||
127891374|NCT01752920|460224323|FG001|Overall Study|Withdrawal by Subject|1|||
127891375|NCT01752920|460224324|FG002|Overall Study|Withdrawal by Subject|0|||
127891376|NCT01752920|460224325|FG003|Overall Study|Withdrawal by Subject|1|||
127891377|NCT01752920|460224322|FG000|Overall Study|Lack of clinical benefit|1|||
127891378|NCT01752920|460224323|FG001|Overall Study|Lack of clinical benefit|1|||
127891379|NCT01752920|460224324|FG002|Overall Study|Lack of clinical benefit|1|||
127891380|NCT01752920|460224325|FG003|Overall Study|Lack of clinical benefit|1|||
127891381|NCT01738581|460224326|FG000|Overall Study|Lost to Follow-up|1|||
127891382|NCT01738581|460224327|FG001|Overall Study|Lost to Follow-up|0|||
127891383|NCT00696709|460224328|FG000|Overall Study|Withdrawal by Subject|1|||
127891384|NCT00696709|460224329|FG001|Overall Study|Withdrawal by Subject|2|||
127891385|NCT00696709|460224330|FG002|Overall Study|Withdrawal by Subject|1|||
127891386|NCT00696709|460224331|FG003|Overall Study|Withdrawal by Subject|4|||
127891387|NCT00696709|460224332|FG004|Overall Study|Withdrawal by Subject|3|||
127891388|NCT00696709|460224328|FG000|Overall Study|Protocol Violation|1|||
127891389|NCT00696709|460224329|FG001|Overall Study|Protocol Violation|0|||
127891390|NCT00696709|460224330|FG002|Overall Study|Protocol Violation|0|||
127891391|NCT00696709|460224331|FG003|Overall Study|Protocol Violation|0|||
127891392|NCT00696709|460224332|FG004|Overall Study|Protocol Violation|0|||
127891393|NCT00696709|460224328|FG000|Overall Study|Lost to Follow-up|1|||
127891394|NCT00696709|460224329|FG001|Overall Study|Lost to Follow-up|1|||
127891395|NCT00696709|460224330|FG002|Overall Study|Lost to Follow-up|0|||
127891396|NCT00696709|460224331|FG003|Overall Study|Lost to Follow-up|0|||
127891397|NCT00696709|460224332|FG004|Overall Study|Lost to Follow-up|0|||
127891398|NCT00696709|460224328|FG000|Overall Study|Adverse Event|0|||
127891399|NCT00696709|460224329|FG001|Overall Study|Adverse Event|0|||
127891400|NCT00696709|460224330|FG002|Overall Study|Adverse Event|0|||
127891401|NCT00696709|460224331|FG003|Overall Study|Adverse Event|1|||
127891402|NCT00696709|460224332|FG004|Overall Study|Adverse Event|0|||
127891403|NCT01186978|460224333|FG000|Overall Study|Withdrawal by Subject|1|||
127891404|NCT01227668|460224334|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
127891405|NCT01227668|460224335|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
127891406|NCT01227668|460224334|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
127891407|NCT01227668|460224335|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
127891408|NCT01227668|460224334|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
127891409|NCT01227668|460224335|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
127891410|NCT01227668|460224334|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
127891411|NCT01227668|460224335|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
127891412|NCT01227668|460224334|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
127891413|NCT01227668|460224335|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
127891414|NCT01227668|460224334|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
127891415|NCT01227668|460224335|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
127891416|NCT01227668|460224334|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
127891417|NCT01227668|460224335|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
127891418|NCT01227668|460224334|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
127891419|NCT01227668|460224335|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
127891420|NCT01227668|460224334|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
127891421|NCT01227668|460224335|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
127891422|NCT01227668|460224334|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
127891423|NCT01227668|460224335|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
127891424|NCT01227668|460224334|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
127891425|NCT01227668|460224335|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
127891426|NCT01227668|460224334|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
127891427|NCT01227668|460224335|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
127891428|NCT01709383|460224341|FG000|Overall Study|Lost to Follow-up|1|||
127891429|NCT01709383|460224342|FG001|Overall Study|Lost to Follow-up|0|||
127891430|NCT03264066|460224343|FG000|Overall Study|Adverse Event|1|||
127891431|NCT03264066|460224344|FG001|Overall Study|Adverse Event|1|||
127891432|NCT03264066|460224345|FG002|Overall Study|Adverse Event|0|||
127891433|NCT03264066|460224346|FG003|Overall Study|Adverse Event|0|||
127891434|NCT03264066|460224347|FG004|Overall Study|Adverse Event|0|||
127891435|NCT03264066|460224348|FG005|Overall Study|Adverse Event|0|||
127891436|NCT03264066|460224343|FG000|Overall Study|Death|12|||
127891437|NCT03264066|460224344|FG001|Overall Study|Death|12|||
127891438|NCT03264066|460224345|FG002|Overall Study|Death|8|||
127891439|NCT03264066|460224346|FG003|Overall Study|Death|10|||
127891440|NCT03264066|460224347|FG004|Overall Study|Death|6|||
127891441|NCT03264066|460224348|FG005|Overall Study|Death|1|||
127891442|NCT03264066|460224343|FG000|Overall Study|Lost to Follow-up|1|||
127891443|NCT03264066|460224344|FG001|Overall Study|Lost to Follow-up|0|||
127891444|NCT03264066|460224345|FG002|Overall Study|Lost to Follow-up|0|||
127891445|NCT03264066|460224346|FG003|Overall Study|Lost to Follow-up|0|||
127891446|NCT03264066|460224347|FG004|Overall Study|Lost to Follow-up|0|||
127891447|NCT03264066|460224348|FG005|Overall Study|Lost to Follow-up|0|||
127891448|NCT03264066|460224343|FG000|Overall Study|Progressive Disease|0|||
127891449|NCT03264066|460224344|FG001|Overall Study|Progressive Disease|2|||
127891450|NCT03264066|460224345|FG002|Overall Study|Progressive Disease|1|||
127891451|NCT03264066|460224346|FG003|Overall Study|Progressive Disease|0|||
127891452|NCT03264066|460224347|FG004|Overall Study|Progressive Disease|0|||
127891453|NCT03264066|460224348|FG005|Overall Study|Progressive Disease|0|||
127891454|NCT03264066|460224343|FG000|Overall Study|Study Terminated by Sponsor|5|||
127891455|NCT03264066|460224344|FG001|Overall Study|Study Terminated by Sponsor|5|||
127891456|NCT03264066|460224345|FG002|Overall Study|Study Terminated by Sponsor|8|||
127891457|NCT03264066|460224346|FG003|Overall Study|Study Terminated by Sponsor|5|||
127891458|NCT03264066|460224347|FG004|Overall Study|Study Terminated by Sponsor|1|||
127891459|NCT03264066|460224348|FG005|Overall Study|Study Terminated by Sponsor|2|||
127891460|NCT03264066|460224343|FG000|Overall Study|Withdrawal by Subject|1|||
127891461|NCT03264066|460224344|FG001|Overall Study|Withdrawal by Subject|0|||
127891462|NCT03264066|460224345|FG002|Overall Study|Withdrawal by Subject|0|||
127891463|NCT03264066|460224346|FG003|Overall Study|Withdrawal by Subject|5|||
127891464|NCT03264066|460224347|FG004|Overall Study|Withdrawal by Subject|0|||
127891465|NCT03264066|460224348|FG005|Overall Study|Withdrawal by Subject|0|||
127891466|NCT01015612|460224355|FG000|Overall Study|Death|113|||
127891467|NCT01015612|460224355|FG000|Overall Study|Withdrawal by Subject|40|||
127891468|NCT00066807|460224356|FG000|Overall Study|Study was terminated early|14|||
127891469|NCT00066807|460224357|FG001|Overall Study|Study was terminated early|15|||
127891470|NCT02468557|460225512|FG000|Overall Study|Adverse Event|1|||
127891471|NCT02468557|460225512|FG000|Overall Study|Death|1|||
127891472|NCT02468557|460225512|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
127891473|NCT02468557|460225512|FG000|Overall Study|All Enrolled but Never Dosed|4|||
127891474|NCT00982410|460225513|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
127891475|NCT00982410|460225514|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
127891476|NCT00982410|460225513|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
127891477|NCT00982410|460225514|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
127891478|NCT00982410|460225513|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
127891479|NCT00982410|460225514|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
127891480|NCT00982410|460225513|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
127891481|NCT00982410|460225514|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
127891482|NCT00982410|460225513|FG000|6-month Follow-up Assessment|participant no transportation|1|||
127891483|NCT00982410|460225514|FG001|6-month Follow-up Assessment|participant no transportation|0|||
127891484|NCT00982410|460225513|FG000|6-month Follow-up Assessment|incarceration|0|||
127891485|NCT00982410|460225514|FG001|6-month Follow-up Assessment|incarceration|2|||
127891486|NCT00982410|460225513|FG000|6-month Follow-up Assessment|patent surgery|0|||
127891487|NCT00982410|460225514|FG001|6-month Follow-up Assessment|patent surgery|1|||
127891488|NCT00982410|460225513|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
127891489|NCT00982410|460225514|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
127891490|NCT00982410|460225513|FG000|12-month Follow-up Assessment|Death|0|||
127891491|NCT00982410|460225514|FG001|12-month Follow-up Assessment|Death|2|||
127891492|NCT00982410|460225513|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
127891493|NCT00982410|460225514|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
127891494|NCT00982410|460225513|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
127891495|NCT00982410|460225514|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
127891496|NCT00982410|460225513|FG000|12-month Follow-up Assessment|incarceration|2|||
127891497|NCT00982410|460225514|FG001|12-month Follow-up Assessment|incarceration|1|||
127891498|NCT00982410|460225513|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
127891499|NCT00982410|460225514|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
127891500|NCT04014959|460225520|FG000|Baseline MRI and Assessments|Physician Decision|2|||
127891501|NCT04014959|460225520|FG000|Targeting TMS Scan|Lost to Follow-up|1|||
127891502|NCT04014959|460225520|FG000|Mini TMS Sessions (3 Visits)|Withdrawal by Subject|1|||
127891503|NCT02034799|460225522|FG000|Overall Study|Withdrawal by Subject|0|||
127891504|NCT02034799|460225523|FG001|Overall Study|Withdrawal by Subject|2|||
127891505|NCT02034799|460225522|FG000|Overall Study|Lost to Follow-up|0|||
127891506|NCT02034799|460225523|FG001|Overall Study|Lost to Follow-up|1|||
127891507|NCT02034799|460225522|FG000|Overall Study|Death|2|||
127891508|NCT02034799|460225523|FG001|Overall Study|Death|1|||
127734377|NCT02507687|459653094|FG003|Overall Study|Screen Failure|0|||
127891509|NCT01133821|460225528|FG000|Overall Study|Lost to Follow-up|8|||
127891510|NCT01133821|460225529|FG001|Overall Study|Lost to Follow-up|11|||
127891511|NCT01133821|460225528|FG000|Overall Study|Withdrawal by Subject|8|||
127891512|NCT01133821|460225529|FG001|Overall Study|Withdrawal by Subject|3|||
127891513|NCT01133821|460225528|FG000|Overall Study|preferred other treatment|1|||
127891514|NCT01133821|460225529|FG001|Overall Study|preferred other treatment|1|||
127891515|NCT01133821|460225528|FG000|Overall Study|Protocol Violation|0|||
127891516|NCT01133821|460225529|FG001|Overall Study|Protocol Violation|1|||
127891517|NCT01133821|460225528|FG000|Overall Study|Refused participation|1|||
127891518|NCT01133821|460225529|FG001|Overall Study|Refused participation|3|||
127891519|NCT03572933|460225531|FG000|Overall Study|Adverse Event|4|||
127891520|NCT03572933|460225532|FG001|Overall Study|Adverse Event|1|||
127891521|NCT03572933|460225531|FG000|Overall Study|Withdrawal by Subject|0|||
127891522|NCT03572933|460225532|FG001|Overall Study|Withdrawal by Subject|1|||
127891523|NCT01466686|460225537|FG000|Overall Study|Withdrawal by Subject|1|||
127891524|NCT00633152|460225540|FG000|Overall Study|Adverse Event|1|||
127891525|NCT00633152|460225541|FG001|Overall Study|Adverse Event|0|||
127891526|NCT00633152|460225540|FG000|Overall Study|Randomized, did not receive study drug|5|||
127891527|NCT00633152|460225541|FG001|Overall Study|Randomized, did not receive study drug|2|||
127891528|NCT00633152|460225540|FG000|Overall Study|Withdrawal by Subject|1|||
127891529|NCT00633152|460225541|FG001|Overall Study|Withdrawal by Subject|1|||
127891530|NCT00633152|460225540|FG000|Overall Study|Lost to Follow-up|4|||
127891531|NCT00633152|460225541|FG001|Overall Study|Lost to Follow-up|1|||
127891532|NCT00633152|460225540|FG000|Overall Study|Miscellaneous Other|3|||
127891533|NCT00633152|460225541|FG001|Overall Study|Miscellaneous Other|2|||
127891534|NCT02049359|460225542|FG000|Overall Study|Lost to Follow-up|26|||
127891535|NCT02049359|460225543|FG001|Overall Study|Lost to Follow-up|19|||
127891536|NCT03273387|460225544|FG000|Overall Study|Death|2|||
127891537|NCT03273387|460225545|FG001|Overall Study|Death|2|||
127891538|NCT03273387|460225544|FG000|Overall Study|Withdrawal by Subject|1|||
127891539|NCT03273387|460225545|FG001|Overall Study|Withdrawal by Subject|1|||
127891540|NCT01907087|460225546|FG000|Overall Study|Withdrawal by Subject|1|||
127891541|NCT05216978|460225547|FG000|Overall Study|Withdrawal by Subject|3|||
127891542|NCT05216978|460225547|FG000|Overall Study|Lost to Follow-up|5|||
127891543|NCT02180061|460225548|FG000|Overall Study|Adverse Event|4|||
127891544|NCT02180061|460225549|FG001|Overall Study|Adverse Event|2|||
127891545|NCT02180061|460225548|FG000|Overall Study|Clinical Progression|5|||
127891546|NCT02180061|460225549|FG001|Overall Study|Clinical Progression|1|||
127891547|NCT02180061|460225548|FG000|Overall Study|Progressive Disease|15|||
127891548|NCT02180061|460225549|FG001|Overall Study|Progressive Disease|5|||
127891549|NCT02180061|460225548|FG000|Overall Study|Physician Decision|1|||
127891550|NCT02180061|460225549|FG001|Overall Study|Physician Decision|0|||
127891551|NCT00658320|460225553|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
127891552|NCT00658320|460225554|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
127891553|NCT00658320|460225553|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
127891554|NCT00658320|460225554|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
127891555|NCT00658320|460225553|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
127891556|NCT00658320|460225554|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
127891557|NCT00658320|460225553|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
127891558|NCT00658320|460225554|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
127891559|NCT01464827|460225562|FG000|Overall Study|Adverse Event|0|||
127891560|NCT01464827|460225563|FG001|Overall Study|Adverse Event|0|||
127891561|NCT01464827|460225564|FG002|Overall Study|Adverse Event|0|||
127891562|NCT01464827|460225565|FG003|Overall Study|Adverse Event|0|||
127891563|NCT01464827|460225566|FG004|Overall Study|Adverse Event|0|||
127891564|NCT01464827|460225567|FG005|Overall Study|Adverse Event|0|||
127891565|NCT01464827|460225568|FG006|Overall Study|Adverse Event|0|||
127891566|NCT01464827|460225569|FG007|Overall Study|Adverse Event|0|||
127891567|NCT01464827|460225570|FG008|Overall Study|Adverse Event|0|||
127734378|NCT02507687|459653091|FG000|Overall Study|Other, Not Specified|0|||
127734379|NCT02507687|459653092|FG001|Overall Study|Other, Not Specified|0|||
127734380|NCT02507687|459653093|FG002|Overall Study|Other, Not Specified|2|||
127734381|NCT02507687|459653094|FG003|Overall Study|Other, Not Specified|4|||
127734382|NCT00733226|459653095|FG000|Overall Study|Withdrawal by Subject|1|||
127734383|NCT00733226|459653096|FG001|Overall Study|Withdrawal by Subject|0|||
127734384|NCT00733226|459653095|FG000|Overall Study|Lost to Follow-up|2|||
127734385|NCT00733226|459653096|FG001|Overall Study|Lost to Follow-up|0|||
127734386|NCT00733226|459653095|FG000|Overall Study|moved to another place|2|||
127734387|NCT00733226|459653096|FG001|Overall Study|moved to another place|0|||
127734388|NCT03722485|459653097|FG000|Overall Study|Withdrawal by Subject|1|||
127734389|NCT03722485|459653098|FG001|Overall Study|Withdrawal by Subject|0|||
127734390|NCT03722485|459653097|FG000|Overall Study|Adverse Event|0|||
127734391|NCT03722485|459653098|FG001|Overall Study|Adverse Event|2|||
127734392|NCT03722485|459653097|FG000|Overall Study|subject discharged prior to study completion|1|||
127891568|NCT01464827|460225571|FG009|Overall Study|Adverse Event|0|||
127734393|NCT03722485|459653098|FG001|Overall Study|subject discharged prior to study completion|5|||
127891569|NCT01464827|460225572|FG010|Overall Study|Adverse Event|0|||
127891570|NCT01464827|460225573|FG011|Overall Study|Adverse Event|0|||
127891571|NCT01464827|460225574|FG012|Overall Study|Adverse Event|1|||
127891572|NCT01464827|460225575|FG013|Overall Study|Adverse Event|0|||
127891573|NCT01464827|460225562|FG000|Overall Study|Withdrawal by Subject|1|||
127891574|NCT01464827|460225563|FG001|Overall Study|Withdrawal by Subject|0|||
127891575|NCT01464827|460225564|FG002|Overall Study|Withdrawal by Subject|0|||
127891576|NCT01464827|460225565|FG003|Overall Study|Withdrawal by Subject|0|||
127891577|NCT01464827|460225566|FG004|Overall Study|Withdrawal by Subject|1|||
127891578|NCT01464827|460225567|FG005|Overall Study|Withdrawal by Subject|0|||
127891579|NCT01464827|460225568|FG006|Overall Study|Withdrawal by Subject|0|||
127891580|NCT01464827|460225569|FG007|Overall Study|Withdrawal by Subject|1|||
127891581|NCT01464827|460225570|FG008|Overall Study|Withdrawal by Subject|0|||
127891582|NCT01464827|460225571|FG009|Overall Study|Withdrawal by Subject|0|||
127891583|NCT01464827|460225572|FG010|Overall Study|Withdrawal by Subject|0|||
127891584|NCT01464827|460225573|FG011|Overall Study|Withdrawal by Subject|0|||
127891585|NCT01464827|460225574|FG012|Overall Study|Withdrawal by Subject|0|||
127891586|NCT01464827|460225575|FG013|Overall Study|Withdrawal by Subject|0|||
127891587|NCT01464827|460225562|FG000|Overall Study|Lost to Follow-up|0|||
127891588|NCT01464827|460225563|FG001|Overall Study|Lost to Follow-up|2|||
127891589|NCT01464827|460225564|FG002|Overall Study|Lost to Follow-up|0|||
127891590|NCT01464827|460225565|FG003|Overall Study|Lost to Follow-up|2|||
127891591|NCT01464827|460225566|FG004|Overall Study|Lost to Follow-up|3|||
127891592|NCT01464827|460225567|FG005|Overall Study|Lost to Follow-up|1|||
127891593|NCT01464827|460225568|FG006|Overall Study|Lost to Follow-up|2|||
127891594|NCT01464827|460225569|FG007|Overall Study|Lost to Follow-up|2|||
127891595|NCT01464827|460225570|FG008|Overall Study|Lost to Follow-up|0|||
127891596|NCT01464827|460225571|FG009|Overall Study|Lost to Follow-up|0|||
127891597|NCT01464827|460225572|FG010|Overall Study|Lost to Follow-up|0|||
127891598|NCT01464827|460225573|FG011|Overall Study|Lost to Follow-up|1|||
127891599|NCT01464827|460225574|FG012|Overall Study|Lost to Follow-up|0|||
127891600|NCT01464827|460225575|FG013|Overall Study|Lost to Follow-up|1|||
127891601|NCT01464827|460225562|FG000|Overall Study|Other|2|||
127891602|NCT01464827|460225563|FG001|Overall Study|Other|3|||
127891603|NCT01464827|460225564|FG002|Overall Study|Other|0|||
127891604|NCT01464827|460225565|FG003|Overall Study|Other|2|||
127891605|NCT01464827|460225566|FG004|Overall Study|Other|3|||
127891606|NCT01464827|460225567|FG005|Overall Study|Other|0|||
127891607|NCT01464827|460225568|FG006|Overall Study|Other|1|||
127891608|NCT01464827|460225569|FG007|Overall Study|Other|0|||
127734394|NCT03722485|459653097|FG000|Overall Study|eligibility criteria not met|2|||
127734395|NCT03722485|459653098|FG001|Overall Study|eligibility criteria not met|0|||
127734396|NCT00349622|459653099|FG000|Overall Study|Death|168|||
127734397|NCT00349622|459653100|FG001|Overall Study|Death|86|||
127734398|NCT00349622|459653099|FG000|Overall Study|Lost to Follow-up|5|||
127734399|NCT00349622|459653100|FG001|Overall Study|Lost to Follow-up|1|||
127734400|NCT00349622|459653099|FG000|Overall Study|Withdrawal by Subject|5|||
127734401|NCT00349622|459653100|FG001|Overall Study|Withdrawal by Subject|9|||
127734402|NCT01902381|459653101|FG000|Overall Study|Withdrawal by Subject|1|||
127734403|NCT00755716|459653102|FG000|Overall Study|Adverse Event|1|||
127734404|NCT00755716|459653103|FG001|Overall Study|Adverse Event|4|||
127734405|NCT00755716|459653104|FG002|Overall Study|Adverse Event|1|||
127734406|NCT00755716|459653102|FG000|Overall Study|Lack of Efficacy|2|||
127734407|NCT00755716|459653103|FG001|Overall Study|Lack of Efficacy|0|||
127734408|NCT00755716|459653104|FG002|Overall Study|Lack of Efficacy|0|||
127734409|NCT00755716|459653102|FG000|Overall Study|Lost to Follow-up|5|||
127734410|NCT00755716|459653103|FG001|Overall Study|Lost to Follow-up|3|||
127734411|NCT00755716|459653104|FG002|Overall Study|Lost to Follow-up|1|||
127734412|NCT00755716|459653102|FG000|Overall Study|work schedule issues|0|||
127734413|NCT00755716|459653103|FG001|Overall Study|work schedule issues|1|||
127734414|NCT00755716|459653104|FG002|Overall Study|work schedule issues|1|||
127734415|NCT02762500|459653105|FG000|Overall Study|Lack of Efficacy|1|||
127734416|NCT02762500|459653106|FG001|Overall Study|Lack of Efficacy|0|||
127734417|NCT02762500|459653105|FG000|Overall Study|Withdrawal by Subject|1|||
127734418|NCT02762500|459653106|FG001|Overall Study|Withdrawal by Subject|1|||
127734419|NCT02762500|459653105|FG000|Overall Study|Adverse Event|0|||
127734420|NCT02762500|459653106|FG001|Overall Study|Adverse Event|2|||
127734421|NCT00377312|459653109|FG000|Overall Study|Adverse Event|1|||
127734422|NCT00377312|459653110|FG001|Overall Study|Adverse Event|1|||
127734423|NCT02775214|459653111|FG000|Overall Study|Withdrawal by Subject|2|||
127734424|NCT02775214|459653112|FG001|Overall Study|Withdrawal by Subject|0|||
127734425|NCT00762723|459653113|FG000|Overall Study|Study Terminated slow enrollement|5|||
127734426|NCT00762723|459653114|FG001|Overall Study|Study Terminated slow enrollement|5|||
127734427|NCT00762723|459653115|FG002|Overall Study|Study Terminated slow enrollement|3|||
127734428|NCT01191697|459653116|FG000|Overall Study|Death|1|||
127734429|NCT01191697|459653116|FG000|Overall Study|Physician Decision|2|||
127734430|NCT01191697|459653116|FG000|Overall Study|Pursue chemoradiation|2|||
127734431|NCT01191697|459653116|FG000|Overall Study|Break from chemotherapy|2|||
127734432|NCT01191697|459653116|FG000|Overall Study|Withdrawal by Subject|1|||
127734433|NCT01191697|459653116|FG000|Overall Study|Surveillance|1|||
127734434|NCT01191697|459653116|FG000|Overall Study|Adverse Event|2|||
127734435|NCT01191697|459653116|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
127734436|NCT01191697|459653116|FG000|Overall Study|Not completed but analyzed|25|||
127891609|NCT01464827|460225570|FG008|Overall Study|Other|3|||
127891610|NCT01464827|460225571|FG009|Overall Study|Other|1|||
127734437|NCT05372913|459653125|FG000|Overall Study|Withdrawal by Subject|0|||
127734438|NCT05372913|459653126|FG001|Overall Study|Withdrawal by Subject|2|||
127734439|NCT05372913|459653125|FG000|Overall Study|Protocol Violation|2|||
127891611|NCT01464827|460225572|FG010|Overall Study|Other|2|||
127891612|NCT01464827|460225573|FG011|Overall Study|Other|0|||
127891613|NCT01464827|460225574|FG012|Overall Study|Other|1|||
127891614|NCT01464827|460225575|FG013|Overall Study|Other|0|||
127891615|NCT01464827|460225562|FG000|Overall Study|Not Treated|0|||
127891616|NCT01464827|460225563|FG001|Overall Study|Not Treated|2|||
127891617|NCT01464827|460225564|FG002|Overall Study|Not Treated|0|||
127891618|NCT01464827|460225565|FG003|Overall Study|Not Treated|0|||
127891619|NCT01464827|460225566|FG004|Overall Study|Not Treated|1|||
127891620|NCT01464827|460225567|FG005|Overall Study|Not Treated|0|||
127891621|NCT01464827|460225568|FG006|Overall Study|Not Treated|1|||
127891622|NCT01464827|460225569|FG007|Overall Study|Not Treated|0|||
127891623|NCT01464827|460225570|FG008|Overall Study|Not Treated|0|||
127891624|NCT01464827|460225571|FG009|Overall Study|Not Treated|2|||
127734440|NCT05372913|459653126|FG001|Overall Study|Protocol Violation|2|||
127734441|NCT05372913|459653125|FG000|Overall Study|Adverse Event|0|||
127734442|NCT05372913|459653126|FG001|Overall Study|Adverse Event|1|||
127734443|NCT03275402|459653127|FG000|Overall Study|Death|17|||
127734444|NCT03275402|459653127|FG000|Overall Study|Study terminated by sponsor|21|||
127734445|NCT03275402|459653127|FG000|Overall Study|Withdrawal by Subject|1|||
127734446|NCT02402465|459653129|FG000|Overall Study|Withdrawal by Subject|0|||
127734447|NCT02402465|459653130|FG001|Overall Study|Withdrawal by Subject|0|||
127734448|NCT02402465|459653131|FG002|Overall Study|Withdrawal by Subject|0|||
127734449|NCT02402465|459653132|FG003|Overall Study|Withdrawal by Subject|0|||
127734450|NCT02402465|459653133|FG004|Overall Study|Withdrawal by Subject|0|||
127734451|NCT02402465|459653134|FG005|Overall Study|Withdrawal by Subject|1|||
127734452|NCT02402465|459653129|FG000|Overall Study|Lost to Follow-up|0|||
127734453|NCT02402465|459653130|FG001|Overall Study|Lost to Follow-up|1|||
127734454|NCT02402465|459653131|FG002|Overall Study|Lost to Follow-up|0|||
127734455|NCT02402465|459653132|FG003|Overall Study|Lost to Follow-up|0|||
127734456|NCT02402465|459653133|FG004|Overall Study|Lost to Follow-up|1|||
127734457|NCT02402465|459653134|FG005|Overall Study|Lost to Follow-up|0|||
127734458|NCT03807700|459653135|FG000|Overall Study|Withdrawal by Subject|2|||
127734459|NCT03807700|459653136|FG001|Overall Study|Withdrawal by Subject|1|||
127734460|NCT02005029|459653137|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
127734461|NCT02005029|459653138|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
127734462|NCT01370018|459653139|FG000|Overall Study|Did not meet criteria for analysis|1|||
127734463|NCT01525641|459653140|FG000|Overall Study|Case report form not collected|25|||
127734464|NCT01525641|459653140|FG000|Overall Study|No visit since the first visit|16|||
127734465|NCT01525641|459653140|FG000|Overall Study|Adverse Event|73|||
127734466|NCT01525641|459653140|FG000|Overall Study|Lack of Efficacy|24|||
127734467|NCT01525641|459653140|FG000|Overall Study|Improvement|5|||
127734468|NCT01525641|459653140|FG000|Overall Study|Lost to follow-up (relocation)|1|||
127734469|NCT01525641|459653140|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
127734470|NCT01525641|459653140|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
127734471|NCT01525641|459653140|FG000|Overall Study|Other than stated above|7|||
127734472|NCT00191984|459653149|FG000|Overall Study|Disease Progression|21|||
127734473|NCT00191984|459653149|FG000|Overall Study|Adverse Event|4|||
127734474|NCT00191984|459653149|FG000|Overall Study|Death|2|||
127734475|NCT00191984|459653149|FG000|Overall Study|Entry Criteria Exclusion|1|||
127734476|NCT00191984|459653149|FG000|Overall Study|Withdrawal by Subject|7|||
127734477|NCT00191984|459653149|FG000|Overall Study|Physician Decision|4|||
127805608|NCT01059448|459911076|FG003|Overall Study|Administrative Decision|46|||
127805609|NCT01059448|459911073|FG000|Overall Study|Lost to Follow-up|0|||
127805610|NCT01059448|459911074|FG001|Overall Study|Lost to Follow-up|0|||
127805611|NCT01059448|459911075|FG002|Overall Study|Lost to Follow-up|2|||
127805612|NCT01059448|459911076|FG003|Overall Study|Lost to Follow-up|0|||
127805613|NCT01059448|459911073|FG000|Overall Study|Death|0|||
127805614|NCT01059448|459911074|FG001|Overall Study|Death|1|||
127805615|NCT01059448|459911075|FG002|Overall Study|Death|0|||
127805616|NCT01059448|459911076|FG003|Overall Study|Death|0|||
127805617|NCT01059448|459911073|FG000|Overall Study|Other|1|||
127805618|NCT01059448|459911074|FG001|Overall Study|Other|1|||
127805619|NCT01059448|459911075|FG002|Overall Study|Other|0|||
127805620|NCT01059448|459911076|FG003|Overall Study|Other|1|||
127805621|NCT04188197|459911077|FG000|Overall Study|Lost to Follow-up|4|||
127805622|NCT04188197|459911078|FG001|Overall Study|Lost to Follow-up|1|||
127805623|NCT04188197|459911077|FG000|Overall Study|Withdrawal by Subject|1|||
127805624|NCT04188197|459911078|FG001|Overall Study|Withdrawal by Subject|1|||
127734478|NCT02137239|459653150|FG000|Overall Study|Discontinued Study Treatment|0|||
127734479|NCT02137239|459653151|FG001|Overall Study|Discontinued Study Treatment|3|||
127734480|NCT02137239|459653150|FG000|Overall Study|Withdrew Consent|1|||
127734481|NCT02137239|459653151|FG001|Overall Study|Withdrew Consent|1|||
127734482|NCT02137239|459653150|FG000|Overall Study|Adverse Event|2|||
127805625|NCT04188197|459911077|FG000|Overall Study|Pregnancy|0|||
127805626|NCT04188197|459911078|FG001|Overall Study|Pregnancy|1|||
127805627|NCT02107703|459911079|FG000|Overall Study|Withdrawal by Subject|46|||
127891625|NCT01464827|460225572|FG010|Overall Study|Not Treated|0|||
127734483|NCT02137239|459653151|FG001|Overall Study|Adverse Event|2|||
127734484|NCT02538471|459653155|FG000|Overall Study|Progression of disease|2|||
127734485|NCT01475370|459653156|FG000|Overall Study|Exacerbation of primary disease|2|||
127734486|NCT01475370|459653157|FG001|Overall Study|Exacerbation of primary disease|2|||
127734487|NCT01475370|459653158|FG002|Overall Study|Exacerbation of primary disease|2|||
127734488|NCT01475370|459653156|FG000|Overall Study|Study drug administration difficult|0|||
127734489|NCT01475370|459653157|FG001|Overall Study|Study drug administration difficult|1|||
127734490|NCT01475370|459653158|FG002|Overall Study|Study drug administration difficult|1|||
127734491|NCT01475370|459653156|FG000|Overall Study|Other than specified|1|||
127734492|NCT01475370|459653157|FG001|Overall Study|Other than specified|0|||
127734493|NCT01475370|459653158|FG002|Overall Study|Other than specified|0|||
127734494|NCT01675050|459653161|FG000|Period One Treatment|Withdrawal by Subject|1|||
127734495|NCT01675050|459653162|FG001|Period One Treatment|Withdrawal by Subject|0|||
127734496|NCT00084747|459653163|FG000|Overall Study|Relapsed|8|||
127734497|NCT00084747|459653163|FG000|Overall Study|Death|3|||
127734498|NCT00084747|459653163|FG000|Overall Study|Withdrawal by Subject|2|||
127734499|NCT04474691|459653164|FG000|Overall Study|Withdrawal by Subject|9|||
127734500|NCT01323309|459653165|FG000|Overall Study|Death|9|||
127734501|NCT01323309|459653166|FG001|Overall Study|Death|15|||
127734502|NCT01323309|459653167|FG002|Overall Study|Death|5|||
127734503|NCT01323309|459653165|FG000|Overall Study|Lost to Follow-up|11|||
127734504|NCT01323309|459653166|FG001|Overall Study|Lost to Follow-up|14|||
127734505|NCT01323309|459653167|FG002|Overall Study|Lost to Follow-up|24|||
127734506|NCT01323309|459653165|FG000|Overall Study|Withdrawal by Subject|14|||
127734507|NCT01323309|459653166|FG001|Overall Study|Withdrawal by Subject|14|||
127734508|NCT01323309|459653167|FG002|Overall Study|Withdrawal by Subject|18|||
127734509|NCT01323309|459653165|FG000|Overall Study|Disease progression|5|||
127734510|NCT01323309|459653166|FG001|Overall Study|Disease progression|11|||
127734511|NCT01323309|459653167|FG002|Overall Study|Disease progression|4|||
127734512|NCT03048058|459653168|FG000|Overall Study|Lost to Follow-up|4|||
127734513|NCT03048058|459653169|FG001|Overall Study|Lost to Follow-up|0|||
127734514|NCT03048058|459653168|FG000|Overall Study|Withdrawal by Subject|0|||
127734515|NCT03048058|459653169|FG001|Overall Study|Withdrawal by Subject|4|||
127734516|NCT02625922|459653171|FG000|Overall Study|Non-availability of IMP|1|||
127805628|NCT02107703|459911080|FG001|Overall Study|Withdrawal by Subject|21|||
127805629|NCT02107703|459911079|FG000|Overall Study|Lost to Follow-up|20|||
127805630|NCT02107703|459911080|FG001|Overall Study|Lost to Follow-up|9|||
127805631|NCT02107703|459911079|FG000|Overall Study|On study treatment/follow up|48|||
127805632|NCT02107703|459911080|FG001|Overall Study|On study treatment/follow up|5|||
127805633|NCT02911688|459911081|FG000|Washout|Lost to Follow-up|1|||
127805634|NCT02911688|459911082|FG001|Washout|Lost to Follow-up|1|||
127805635|NCT02911688|459911081|FG000|Washout|Withdrawal by Subject|0|||
127805636|NCT02911688|459911082|FG001|Washout|Withdrawal by Subject|1|||
127805637|NCT00809328|459911083|FG000|Overall Study|Lack of Efficacy|18|||
127805638|NCT00809328|459911083|FG000|Overall Study|Adverse Event|6|||
127805639|NCT00809328|459911083|FG000|Overall Study|Protocol Violation|3|||
127805640|NCT00809328|459911083|FG000|Overall Study|Withdrawal by Subject|2|||
127805641|NCT06441877|459911088|FG000|Overall Study|Withdrawal by Subject|0|||
127805642|NCT06441877|459911089|FG001|Overall Study|Withdrawal by Subject|2|||
127805643|NCT06441877|459911090|FG002|Overall Study|Withdrawal by Subject|0|||
127805644|NCT06441877|459911091|FG003|Overall Study|Withdrawal by Subject|0|||
127805645|NCT00066690|459911092|FG000|Overall Study|Adverse Event|145|||
127805646|NCT00066690|459911093|FG001|Overall Study|Adverse Event|58|||
127805647|NCT00066690|459911094|FG002|Overall Study|Adverse Event|126|||
127734517|NCT02625922|459653172|FG001|Overall Study|Non-availability of IMP|1|||
127734518|NCT02625922|459653171|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
127734519|NCT02625922|459653172|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
127805648|NCT00066690|459911092|FG000|Overall Study|Death|3|||
127805649|NCT00066690|459911093|FG001|Overall Study|Death|0|||
127805650|NCT00066690|459911094|FG002|Overall Study|Death|2|||
127805651|NCT00066690|459911092|FG000|Overall Study|Lack of Efficacy|114|||
127805652|NCT00066690|459911093|FG001|Overall Study|Lack of Efficacy|110|||
127805653|NCT00066690|459911094|FG002|Overall Study|Lack of Efficacy|76|||
127805654|NCT00066690|459911092|FG000|Overall Study|Lost to Follow-up|40|||
127805655|NCT00066690|459911093|FG001|Overall Study|Lost to Follow-up|21|||
127891626|NCT01464827|460225573|FG011|Overall Study|Not Treated|1|||
127891627|NCT01464827|460225574|FG012|Overall Study|Not Treated|0|||
127891628|NCT01464827|460225575|FG013|Overall Study|Not Treated|2|||
127891629|NCT05487456|460225576|FG000|Overall Study|Withdrawal by Subject|0|||
127891630|NCT05487456|460225577|FG001|Overall Study|Withdrawal by Subject|0|||
127891631|NCT05487456|460225578|FG002|Overall Study|Withdrawal by Subject|1|||
127891632|NCT05487456|460225579|FG003|Overall Study|Withdrawal by Subject|0|||
127891633|NCT03882047|460225582|FG000|Overall Study|Adverse Event|0|||
127891634|NCT03882047|460225583|FG001|Overall Study|Adverse Event|2|||
127891635|NCT03882047|460225584|FG002|Overall Study|Adverse Event|2|||
127891636|NCT03882047|460225582|FG000|Overall Study|Treatment Failure|3|||
127891637|NCT03882047|460225583|FG001|Overall Study|Treatment Failure|3|||
127891638|NCT03882047|460225584|FG002|Overall Study|Treatment Failure|12|||
127891639|NCT03882047|460225582|FG000|Overall Study|Lost to Follow-up|0|||
127734520|NCT02359552|459653173|FG000|Overall Study|Lost to Follow-up|3|||
127734521|NCT02359552|459653174|FG001|Overall Study|Lost to Follow-up|4|||
127734522|NCT01395914|459653175|FG000|Overall Study|Unrelated to study drug AE|6|||
127734523|NCT01395914|459653176|FG001|Overall Study|Unrelated to study drug AE|1|||
127734524|NCT01395914|459653175|FG000|Overall Study|Death|23|||
127734525|NCT01395914|459653176|FG001|Overall Study|Death|17|||
127734526|NCT01395914|459653175|FG000|Overall Study|Other|9|||
127734527|NCT01395914|459653176|FG001|Overall Study|Other|3|||
127734528|NCT01395914|459653175|FG000|Overall Study|Withdrawal by patient|27|||
127734529|NCT01395914|459653176|FG001|Overall Study|Withdrawal by patient|14|||
127734530|NCT01395914|459653175|FG000|Overall Study|Study drug-related AE|1|||
127734531|NCT01395914|459653176|FG001|Overall Study|Study drug-related AE|0|||
127734532|NCT01395914|459653175|FG000|Overall Study|Lost to Follow-up|6|||
127734533|NCT01395914|459653176|FG001|Overall Study|Lost to Follow-up|2|||
127734534|NCT02849509|459653180|FG000|Overall Study|Worsening of disease under study|1|||
127734535|NCT02849509|459653181|FG001|Overall Study|Worsening of disease under study|1|||
127734536|NCT02849509|459653182|FG002|Overall Study|Worsening of disease under study|1|||
127734537|NCT02849509|459653180|FG000|Overall Study|Worsening of other pre-existing disease|0|||
127734538|NCT02849509|459653181|FG001|Overall Study|Worsening of other pre-existing disease|1|||
127734539|NCT02849509|459653182|FG002|Overall Study|Worsening of other pre-existing disease|2|||
127734540|NCT02849509|459653180|FG000|Overall Study|Other adverse event|36|||
127734541|NCT02849509|459653181|FG001|Overall Study|Other adverse event|41|||
127734542|NCT02849509|459653182|FG002|Overall Study|Other adverse event|8|||
127734543|NCT02849509|459653180|FG000|Overall Study|Withdrawal by Subject|6|||
127734544|NCT02849509|459653181|FG001|Overall Study|Withdrawal by Subject|17|||
127734545|NCT02849509|459653182|FG002|Overall Study|Withdrawal by Subject|12|||
127734546|NCT02849509|459653180|FG000|Overall Study|Lost to Follow-up|27|||
127734547|NCT02849509|459653181|FG001|Overall Study|Lost to Follow-up|67|||
127734548|NCT02849509|459653182|FG002|Overall Study|Lost to Follow-up|36|||
127734549|NCT02849509|459653180|FG000|Overall Study|Other, reason not specified|14|||
127734550|NCT02849509|459653181|FG001|Overall Study|Other, reason not specified|29|||
127734551|NCT02849509|459653182|FG002|Overall Study|Other, reason not specified|25|||
127734552|NCT02849509|459653180|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
127734553|NCT02849509|459653181|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
127734554|NCT02849509|459653182|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
127734555|NCT01261793|459653183|FG000|Overall Study|Lack of Efficacy|44|||
127734556|NCT01261793|459653184|FG001|Overall Study|Lack of Efficacy|37|||
127734557|NCT01261793|459653185|FG002|Overall Study|Lack of Efficacy|32|||
127734558|NCT01261793|459653183|FG000|Overall Study|Protocol Violation|3|||
127734559|NCT01261793|459653184|FG001|Overall Study|Protocol Violation|5|||
127734560|NCT01261793|459653185|FG002|Overall Study|Protocol Violation|6|||
127734561|NCT01261793|459653183|FG000|Overall Study|Lost to Follow-up|10|||
127734562|NCT01261793|459653184|FG001|Overall Study|Lost to Follow-up|3|||
127734563|NCT01261793|459653185|FG002|Overall Study|Lost to Follow-up|7|||
127734564|NCT01261793|459653183|FG000|Overall Study|Withdrawal by Subject|12|||
127734565|NCT01261793|459653184|FG001|Overall Study|Withdrawal by Subject|14|||
127891640|NCT03882047|460225583|FG001|Overall Study|Lost to Follow-up|1|||
127734566|NCT01261793|459653185|FG002|Overall Study|Withdrawal by Subject|14|||
127734567|NCT01261793|459653183|FG000|Overall Study|Death|3|||
127734568|NCT01261793|459653184|FG001|Overall Study|Death|1|||
127734569|NCT01261793|459653185|FG002|Overall Study|Death|0|||
127734570|NCT01261793|459653183|FG000|Overall Study|Adverse Event|9|||
127734571|NCT01261793|459653184|FG001|Overall Study|Adverse Event|24|||
127891641|NCT03882047|460225584|FG002|Overall Study|Lost to Follow-up|0|||
127734572|NCT01261793|459653185|FG002|Overall Study|Adverse Event|19|||
127734573|NCT01261793|459653183|FG000|Overall Study|Patient non-availability|1|||
127734574|NCT01261793|459653184|FG001|Overall Study|Patient non-availability|1|||
127734575|NCT01261793|459653185|FG002|Overall Study|Patient non-availability|1|||
127734576|NCT01261793|459653183|FG000|Overall Study|Suspected pregnancy|1|||
127734577|NCT01261793|459653184|FG001|Overall Study|Suspected pregnancy|1|||
127891642|NCT03882047|460225582|FG000|Overall Study|Did Not Wish to Continue|1|||
127805656|NCT00066690|459911094|FG002|Overall Study|Lost to Follow-up|29|||
127805657|NCT00066690|459911092|FG000|Overall Study|Withdrawal by Subject|50|||
127805658|NCT00066690|459911093|FG001|Overall Study|Withdrawal by Subject|55|||
127805659|NCT00066690|459911094|FG002|Overall Study|Withdrawal by Subject|49|||
127805660|NCT00066690|459911092|FG000|Overall Study|Treatment Ongoing|246|||
127805661|NCT00066690|459911093|FG001|Overall Study|Treatment Ongoing|278|||
127805662|NCT00066690|459911094|FG002|Overall Study|Treatment Ongoing|282|||
127805663|NCT03706365|459911098|FG000|Overall Study|Lost to Follow-up|7|||
127805664|NCT03706365|459911099|FG001|Overall Study|Lost to Follow-up|0|||
127805665|NCT03706365|459911098|FG000|Overall Study|Withdrawal by Subject|17|||
127805666|NCT03706365|459911099|FG001|Overall Study|Withdrawal by Subject|15|||
127805667|NCT03706365|459911098|FG000|Overall Study|On Study Treatment|51|||
127805668|NCT03706365|459911099|FG001|Overall Study|On Study Treatment|51|||
127805669|NCT03116113|459911100|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
127805670|NCT03116113|459911101|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
127805671|NCT03116113|459911102|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
127805672|NCT03116113|459911103|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
127805673|NCT03116113|459911104|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
127805674|NCT03116113|459911105|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
127805675|NCT03116113|459911106|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
127805676|NCT03116113|459911107|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
127805677|NCT03116113|459911108|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
127805678|NCT02159807|459911109|FG000|Overall Study|Adverse Event|0|||
127805679|NCT02159807|459911110|FG001|Overall Study|Adverse Event|0|||
127805680|NCT02159807|459911111|FG002|Overall Study|Adverse Event|1|||
127805681|NCT02159807|459911109|FG000|Overall Study|No CSF|1|||
127805682|NCT02159807|459911110|FG001|Overall Study|No CSF|1|||
127805683|NCT02159807|459911111|FG002|Overall Study|No CSF|1|||
127805684|NCT02159807|459911109|FG000|Overall Study|elevated blood pressure|0|||
127805685|NCT02159807|459911110|FG001|Overall Study|elevated blood pressure|0|||
127805686|NCT02159807|459911111|FG002|Overall Study|elevated blood pressure|1|||
127805687|NCT05195528|459911113|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
127805688|NCT05195528|459911114|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
127805689|NCT05195528|459911115|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
127805690|NCT05195528|459911116|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
127805691|NCT05195528|459911117|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
127805692|NCT05195528|459911113|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
127805693|NCT05195528|459911114|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
127805694|NCT05195528|459911115|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
127805695|NCT05195528|459911116|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
127805696|NCT05195528|459911117|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
127805697|NCT05195528|459911113|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
127805698|NCT05195528|459911114|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
127805699|NCT05195528|459911115|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
127805700|NCT05195528|459911116|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
127805701|NCT05195528|459911117|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
127805702|NCT05195528|459911113|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
127805703|NCT05195528|459911114|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
127805704|NCT05195528|459911115|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
127805705|NCT05195528|459911116|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
127805706|NCT05195528|459911117|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
127805707|NCT05195528|459911113|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
127805708|NCT05195528|459911114|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
127805709|NCT05195528|459911115|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
127805710|NCT05195528|459911116|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
127805711|NCT05195528|459911117|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
127805712|NCT05195528|459911113|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
127805713|NCT05195528|459911114|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
127805714|NCT05195528|459911115|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
127891643|NCT03882047|460225583|FG001|Overall Study|Did Not Wish to Continue|4|||
127891644|NCT03882047|460225584|FG002|Overall Study|Did Not Wish to Continue|1|||
127805715|NCT05195528|459911116|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
127805716|NCT05195528|459911117|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
127805717|NCT05195528|459911113|FG000|Placebo-controlled Treatment Period|Other|0|||
127805718|NCT05195528|459911114|FG001|Placebo-controlled Treatment Period|Other|0|||
127805719|NCT05195528|459911115|FG002|Placebo-controlled Treatment Period|Other|1|||
127805720|NCT05195528|459911116|FG003|Placebo-controlled Treatment Period|Other|0|||
127805721|NCT05195528|459911117|FG004|Placebo-controlled Treatment Period|Other|0|||
127805722|NCT05195528|459911113|FG000|Extension Period|PTE or AE or SAE|0|||
127805723|NCT05195528|459911114|FG001|Extension Period|PTE or AE or SAE|4|||
127805724|NCT05195528|459911115|FG002|Extension Period|PTE or AE or SAE|5|||
127805725|NCT05195528|459911116|FG003|Extension Period|PTE or AE or SAE|4|||
127805726|NCT05195528|459911117|FG004|Extension Period|PTE or AE or SAE|4|||
127805727|NCT05195528|459911113|FG000|Extension Period|Protocol Violation|0|||
127805728|NCT05195528|459911114|FG001|Extension Period|Protocol Violation|2|||
127805729|NCT05195528|459911115|FG002|Extension Period|Protocol Violation|1|||
127805730|NCT05195528|459911116|FG003|Extension Period|Protocol Violation|0|||
127805731|NCT05195528|459911117|FG004|Extension Period|Protocol Violation|1|||
127805732|NCT05195528|459911113|FG000|Extension Period|Lost to Follow-up|0|||
127805733|NCT05195528|459911114|FG001|Extension Period|Lost to Follow-up|6|||
127805734|NCT05195528|459911115|FG002|Extension Period|Lost to Follow-up|13|||
127805735|NCT05195528|459911116|FG003|Extension Period|Lost to Follow-up|3|||
127805736|NCT05195528|459911117|FG004|Extension Period|Lost to Follow-up|7|||
127805737|NCT05195528|459911113|FG000|Extension Period|Withdrawal by Subject|0|||
127805738|NCT05195528|459911114|FG001|Extension Period|Withdrawal by Subject|12|||
127805739|NCT05195528|459911115|FG002|Extension Period|Withdrawal by Subject|9|||
127805740|NCT05195528|459911116|FG003|Extension Period|Withdrawal by Subject|6|||
127805741|NCT05195528|459911117|FG004|Extension Period|Withdrawal by Subject|5|||
127805742|NCT05195528|459911113|FG000|Extension Period|Lack of Efficacy|0|||
127805743|NCT05195528|459911114|FG001|Extension Period|Lack of Efficacy|3|||
127805744|NCT05195528|459911115|FG002|Extension Period|Lack of Efficacy|0|||
127805745|NCT05195528|459911116|FG003|Extension Period|Lack of Efficacy|0|||
127805746|NCT05195528|459911117|FG004|Extension Period|Lack of Efficacy|2|||
127805747|NCT05195528|459911113|FG000|Extension Period|Not Treated|0|||
127805748|NCT05195528|459911114|FG001|Extension Period|Not Treated|0|||
127805749|NCT05195528|459911115|FG002|Extension Period|Not Treated|2|||
127805750|NCT05195528|459911116|FG003|Extension Period|Not Treated|3|||
127805751|NCT05195528|459911117|FG004|Extension Period|Not Treated|0|||
127805752|NCT05195528|459911113|FG000|Extension Period|Other|0|||
127805753|NCT05195528|459911114|FG001|Extension Period|Other|1|||
127805754|NCT05195528|459911115|FG002|Extension Period|Other|1|||
127805755|NCT05195528|459911116|FG003|Extension Period|Other|0|||
127805756|NCT05195528|459911117|FG004|Extension Period|Other|0|||
127805757|NCT01552902|459911118|FG000|Overall Study|Adverse Event|1|||
127805758|NCT01552902|459911119|FG001|Overall Study|Adverse Event|15|||
127805759|NCT01552902|459911120|FG002|Overall Study|Adverse Event|14|||
127805760|NCT01552902|459911118|FG000|Overall Study|Protocol Violation|3|||
127805761|NCT01552902|459911119|FG001|Overall Study|Protocol Violation|3|||
127805762|NCT01552902|459911120|FG002|Overall Study|Protocol Violation|3|||
127805763|NCT01552902|459911118|FG000|Overall Study|Lack of Efficacy|4|||
127805764|NCT01552902|459911119|FG001|Overall Study|Lack of Efficacy|3|||
127805765|NCT01552902|459911120|FG002|Overall Study|Lack of Efficacy|1|||
127805766|NCT01552902|459911118|FG000|Overall Study|Withdrawal by Subject|1|||
127805767|NCT01552902|459911119|FG001|Overall Study|Withdrawal by Subject|9|||
127805768|NCT01552902|459911120|FG002|Overall Study|Withdrawal by Subject|6|||
127805769|NCT01552902|459911118|FG000|Overall Study|Lost to Follow-up|1|||
127805770|NCT01552902|459911119|FG001|Overall Study|Lost to Follow-up|3|||
127805771|NCT01552902|459911120|FG002|Overall Study|Lost to Follow-up|6|||
127805772|NCT01552902|459911118|FG000|Overall Study|Other|3|||
127805773|NCT01552902|459911119|FG001|Overall Study|Other|4|||
127805774|NCT01552902|459911120|FG002|Overall Study|Other|3|||
127805775|NCT02487108|459911126|FG000|Overall Study|Adverse Event|1|||
127805776|NCT02487108|459911127|FG001|Overall Study|Adverse Event|6|||
127891645|NCT03882047|460225582|FG000|Overall Study|Noncompliance With Protocol|2|||
127891646|NCT03882047|460225583|FG001|Overall Study|Noncompliance With Protocol|0|||
127891647|NCT03882047|460225584|FG002|Overall Study|Noncompliance With Protocol|0|||
127805777|NCT02487108|459911128|FG002|Overall Study|Adverse Event|12|||
127805778|NCT02487108|459911129|FG003|Overall Study|Adverse Event|6|||
127805779|NCT02487108|459911126|FG000|Overall Study|Withdrawal by Subject|8|||
127805780|NCT02487108|459911127|FG001|Overall Study|Withdrawal by Subject|5|||
127805781|NCT02487108|459911128|FG002|Overall Study|Withdrawal by Subject|5|||
127805782|NCT02487108|459911129|FG003|Overall Study|Withdrawal by Subject|0|||
127891648|NCT03882047|460225582|FG000|Overall Study|Did Not Meet Eligibility|0|||
127805783|NCT02487108|459911126|FG000|Overall Study|Non-compliance to study medication|3|||
127805784|NCT02487108|459911127|FG001|Overall Study|Non-compliance to study medication|2|||
127805785|NCT02487108|459911128|FG002|Overall Study|Non-compliance to study medication|5|||
127805786|NCT02487108|459911129|FG003|Overall Study|Non-compliance to study medication|4|||
127805787|NCT02487108|459911126|FG000|Overall Study|Protocol Violation|1|||
127805788|NCT02487108|459911127|FG001|Overall Study|Protocol Violation|1|||
127805789|NCT02487108|459911128|FG002|Overall Study|Protocol Violation|2|||
127805790|NCT02487108|459911129|FG003|Overall Study|Protocol Violation|0|||
127805791|NCT02487108|459911126|FG000|Overall Study|Non-compliance to study procedures|0|||
127805792|NCT02487108|459911127|FG001|Overall Study|Non-compliance to study procedures|0|||
127805793|NCT02487108|459911128|FG002|Overall Study|Non-compliance to study procedures|0|||
127805794|NCT02487108|459911129|FG003|Overall Study|Non-compliance to study procedures|1|||
127734578|NCT01261793|459653185|FG002|Overall Study|Suspected pregnancy|0|||
127734579|NCT01261793|459653183|FG000|Overall Study|Patient non-compliance|1|||
127734580|NCT01261793|459653184|FG001|Overall Study|Patient non-compliance|0|||
127734581|NCT01261793|459653185|FG002|Overall Study|Patient non-compliance|1|||
127734582|NCT01261793|459653183|FG000|Overall Study|Patient pregnant|1|||
127734583|NCT01261793|459653184|FG001|Overall Study|Patient pregnant|0|||
127734584|NCT01261793|459653185|FG002|Overall Study|Patient pregnant|0|||
127734585|NCT01261793|459653183|FG000|Overall Study|Outside the study area|0|||
127734586|NCT01261793|459653184|FG001|Overall Study|Outside the study area|2|||
127734587|NCT01261793|459653185|FG002|Overall Study|Outside the study area|1|||
127734588|NCT01261793|459653183|FG000|Overall Study|Lack of efficacy & patient not available|0|||
127734589|NCT01261793|459653184|FG001|Overall Study|Lack of efficacy & patient not available|1|||
127734590|NCT01261793|459653185|FG002|Overall Study|Lack of efficacy & patient not available|0|||
127734591|NCT01261793|459653183|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
127734592|NCT01261793|459653184|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
127734593|NCT01261793|459653185|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
127734594|NCT01261793|459653183|FG000|Overall Study|Randomization error|0|||
127734595|NCT01261793|459653184|FG001|Overall Study|Randomization error|1|||
127734596|NCT01261793|459653185|FG002|Overall Study|Randomization error|0|||
127734597|NCT01261793|459653183|FG000|Overall Study|Patient unable to start IV line|0|||
127734598|NCT01261793|459653184|FG001|Overall Study|Patient unable to start IV line|0|||
127734599|NCT01261793|459653185|FG002|Overall Study|Patient unable to start IV line|1|||
127734600|NCT02133131|459653186|FG000|Overall Study|Adverse Event|0|||
127734601|NCT02133131|459653187|FG001|Overall Study|Adverse Event|0|||
127734602|NCT02133131|459653188|FG002|Overall Study|Adverse Event|0|||
127734603|NCT02133131|459653189|FG003|Overall Study|Adverse Event|1|||
127734604|NCT02133131|459653190|FG004|Overall Study|Adverse Event|0|||
127734605|NCT02133131|459653191|FG005|Overall Study|Adverse Event|0|||
127734606|NCT02133131|459653192|FG006|Overall Study|Adverse Event|0|||
127734607|NCT02133131|459653186|FG000|Overall Study|Lost to Follow-up|1|||
127734608|NCT02133131|459653187|FG001|Overall Study|Lost to Follow-up|0|||
127734609|NCT02133131|459653188|FG002|Overall Study|Lost to Follow-up|0|||
127734610|NCT02133131|459653189|FG003|Overall Study|Lost to Follow-up|1|||
127734611|NCT02133131|459653190|FG004|Overall Study|Lost to Follow-up|0|||
127734612|NCT02133131|459653191|FG005|Overall Study|Lost to Follow-up|0|||
127734613|NCT02133131|459653192|FG006|Overall Study|Lost to Follow-up|0|||
127734614|NCT02133131|459653186|FG000|Overall Study|Status not recorded|4|||
127734615|NCT02133131|459653187|FG001|Overall Study|Status not recorded|5|||
127734616|NCT02133131|459653188|FG002|Overall Study|Status not recorded|1|||
127734617|NCT02133131|459653189|FG003|Overall Study|Status not recorded|4|||
127734618|NCT02133131|459653190|FG004|Overall Study|Status not recorded|0|||
127734619|NCT02133131|459653191|FG005|Overall Study|Status not recorded|0|||
127734620|NCT02133131|459653192|FG006|Overall Study|Status not recorded|0|||
127734621|NCT02133131|459653186|FG000|Overall Study|Ongoing in study|0|||
127734622|NCT02133131|459653187|FG001|Overall Study|Ongoing in study|0|||
127734623|NCT02133131|459653188|FG002|Overall Study|Ongoing in study|0|||
127805795|NCT02487108|459911126|FG000|Overall Study|Other than specified|3|||
127805796|NCT02487108|459911127|FG001|Overall Study|Other than specified|2|||
127805797|NCT02487108|459911128|FG002|Overall Study|Other than specified|2|||
127805798|NCT02487108|459911129|FG003|Overall Study|Other than specified|0|||
127805799|NCT02367521|459911130|FG000|Overall Study|severe headache after intervention|2|||
127805800|NCT02367521|459911131|FG001|Overall Study|severe headache after intervention|0|||
127805801|NCT02367521|459911130|FG000|Overall Study|unable to find transportation|2|||
127805802|NCT02367521|459911131|FG001|Overall Study|unable to find transportation|0|||
127805803|NCT00600171|459911132|FG000|Overall Study|Adverse Event|0|||
127805804|NCT00600171|459911133|FG001|Overall Study|Adverse Event|1|||
127805805|NCT00600171|459911134|FG002|Overall Study|Adverse Event|0|||
127805806|NCT00600171|459911135|FG003|Overall Study|Adverse Event|0|||
127805807|NCT00600171|459911136|FG004|Overall Study|Adverse Event|1|||
127805808|NCT00600171|459911137|FG005|Overall Study|Adverse Event|0|||
127805809|NCT00600171|459911132|FG000|Overall Study|Lack of Efficacy|9|||
127805810|NCT00600171|459911133|FG001|Overall Study|Lack of Efficacy|12|||
127805811|NCT00600171|459911134|FG002|Overall Study|Lack of Efficacy|3|||
127805812|NCT00600171|459911135|FG003|Overall Study|Lack of Efficacy|5|||
127805813|NCT00600171|459911136|FG004|Overall Study|Lack of Efficacy|4|||
127805814|NCT00600171|459911137|FG005|Overall Study|Lack of Efficacy|0|||
127805815|NCT00600171|459911132|FG000|Overall Study|Protocol Violation|1|||
127805816|NCT00600171|459911133|FG001|Overall Study|Protocol Violation|2|||
127805817|NCT00600171|459911134|FG002|Overall Study|Protocol Violation|0|||
127805818|NCT00600171|459911135|FG003|Overall Study|Protocol Violation|1|||
127805819|NCT00600171|459911136|FG004|Overall Study|Protocol Violation|0|||
127734624|NCT02133131|459653189|FG003|Overall Study|Ongoing in study|0|||
127734625|NCT02133131|459653190|FG004|Overall Study|Ongoing in study|15|||
127734626|NCT02133131|459653191|FG005|Overall Study|Ongoing in study|14|||
127734627|NCT02133131|459653192|FG006|Overall Study|Ongoing in study|11|||
127734628|NCT02133131|459653186|FG000|Overall Study|Protocol Violation|0|||
127734629|NCT02133131|459653187|FG001|Overall Study|Protocol Violation|0|||
127805820|NCT00600171|459911137|FG005|Overall Study|Protocol Violation|0|||
127891649|NCT03882047|460225583|FG001|Overall Study|Did Not Meet Eligibility|0|||
127891650|NCT03882047|460225584|FG002|Overall Study|Did Not Meet Eligibility|1|||
127891651|NCT00441584|460225585|FG000|Overall Study|Lack of Efficacy|79|||
127891652|NCT00441584|460225585|FG000|Overall Study|Withdrawal by Subject|8|||
127891653|NCT00441584|460225585|FG000|Overall Study|Adverse Event|6|||
127891654|NCT00441584|460225585|FG000|Overall Study|Protocol Violation|5|||
127891655|NCT00441584|460225585|FG000|Overall Study|Lost to Follow-up|4|||
127891656|NCT00441584|460225585|FG000|Overall Study|Failure to meet eligibility criteria|3|||
127891657|NCT03465891|460225588|FG000|Overall Study|Withdrawal by Subject|0|||
127891658|NCT03465891|460225589|FG001|Overall Study|Withdrawal by Subject|1|||
127891659|NCT03465891|460225588|FG000|Overall Study|Disease progression|1|||
127891660|NCT03465891|460225589|FG001|Overall Study|Disease progression|0|||
127891661|NCT01001169|460225590|FG000|Overall Study|Withdrawal by Subject|2|||
127891662|NCT01001169|460225591|FG001|Overall Study|Withdrawal by Subject|1|||
127891663|NCT00798889|460225596|FG000|Overall Study|Adverse Event|53|||
127805821|NCT00600171|459911132|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
127805822|NCT00600171|459911133|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
127805823|NCT00600171|459911134|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
127805824|NCT00600171|459911135|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
127805825|NCT00600171|459911136|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
127805826|NCT00600171|459911137|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
127734630|NCT02133131|459653188|FG002|Overall Study|Protocol Violation|0|||
127805827|NCT00600171|459911132|FG000|Overall Study|Withdrawal by Subject|3|||
127805828|NCT00600171|459911133|FG001|Overall Study|Withdrawal by Subject|0|||
127805829|NCT00600171|459911134|FG002|Overall Study|Withdrawal by Subject|0|||
127805830|NCT00600171|459911135|FG003|Overall Study|Withdrawal by Subject|1|||
127805831|NCT00600171|459911136|FG004|Overall Study|Withdrawal by Subject|1|||
127805832|NCT00600171|459911137|FG005|Overall Study|Withdrawal by Subject|1|||
127805833|NCT00600171|459911132|FG000|Overall Study|Physician Decision|0|||
127805834|NCT00600171|459911133|FG001|Overall Study|Physician Decision|1|||
127805835|NCT00600171|459911134|FG002|Overall Study|Physician Decision|0|||
127805836|NCT00600171|459911135|FG003|Overall Study|Physician Decision|1|||
127805837|NCT00600171|459911136|FG004|Overall Study|Physician Decision|0|||
127805838|NCT00600171|459911137|FG005|Overall Study|Physician Decision|2|||
127805839|NCT00600171|459911132|FG000|Overall Study|Lost to Follow-up|0|||
127805840|NCT00600171|459911133|FG001|Overall Study|Lost to Follow-up|0|||
127805841|NCT00600171|459911134|FG002|Overall Study|Lost to Follow-up|0|||
127805842|NCT00600171|459911135|FG003|Overall Study|Lost to Follow-up|1|||
127805843|NCT00600171|459911136|FG004|Overall Study|Lost to Follow-up|0|||
127805844|NCT00600171|459911137|FG005|Overall Study|Lost to Follow-up|0|||
127805845|NCT00542191|459911141|FG000|Overall Study|Death|3|||
127805846|NCT00469612|459911142|FG000|Overall Study|Study terminated before data collected|2|||
127805847|NCT00469612|459911143|FG001|Overall Study|Study terminated before data collected|0|||
127805848|NCT00849017|459911144|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
127805849|NCT00849017|459911145|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
127805850|NCT00849017|459911146|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
127891664|NCT00798889|460225596|FG000|Overall Study|Protocol Violation|2|||
127891665|NCT00798889|460225596|FG000|Overall Study|Withdrawal by Subject|31|||
127891666|NCT00798889|460225596|FG000|Overall Study|Lost to Follow-up|1|||
127891667|NCT00798889|460225596|FG000|Overall Study|Lack of Efficacy|213|||
127734631|NCT02133131|459653189|FG003|Overall Study|Protocol Violation|0|||
127734632|NCT02133131|459653190|FG004|Overall Study|Protocol Violation|0|||
127734633|NCT02133131|459653191|FG005|Overall Study|Protocol Violation|0|||
127734634|NCT02133131|459653192|FG006|Overall Study|Protocol Violation|1|||
127734635|NCT01544153|459653193|FG000|Overall Study|Under 18|0|||
127734636|NCT01544153|459653194|FG001|Overall Study|Under 18|1|||
127734637|NCT01544153|459653195|FG002|Overall Study|Under 18|0|||
127734638|NCT01544153|459653196|FG003|Overall Study|Under 18|0|||
127734639|NCT01544153|459653193|FG000|Overall Study|Non-smoker|0|||
127734640|NCT01544153|459653194|FG001|Overall Study|Non-smoker|0|||
127734641|NCT01544153|459653195|FG002|Overall Study|Non-smoker|1|||
127805851|NCT00849017|459911144|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
127805852|NCT00849017|459911145|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
127805853|NCT00849017|459911146|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
127805854|NCT00849017|459911144|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
127805855|NCT00849017|459911145|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
127805856|NCT00849017|459911146|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
127891668|NCT00798889|460225596|FG000|Overall Study|Decision of Sponsor|11|||
127891669|NCT00798889|460225596|FG000|Overall Study|Enrolled, Not treated|3|||
127891670|NCT00358826|460225597|FG000|Core Study|Adverse Event|1|||
127891671|NCT00358826|460225598|FG001|Core Study|Adverse Event|3|||
127805857|NCT00849017|459911144|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
127891672|NCT00358826|460225599|FG002|Core Study|Adverse Event|1|||
127734642|NCT01544153|459653196|FG003|Overall Study|Non-smoker|0|||
127734643|NCT00884793|459653201|FG000|Overall Study|Withdrawal by Subject|1|||
127734644|NCT01032200|459653202|FG000|Overall Study|Death|1|||
127734645|NCT01032200|459653203|FG001|Overall Study|Death|1|||
127891673|NCT00358826|460225600|FG003|Core Study|Adverse Event|1|||
127891674|NCT00358826|460225601|FG004|Core Study|Adverse Event|0|||
127891675|NCT00358826|460225602|FG005|Core Study|Adverse Event|0|||
127891676|NCT00358826|460225603|FG006|Core Study|Adverse Event|0|||
127891677|NCT00358826|460225604|FG007|Core Study|Adverse Event|0|||
127891678|NCT00358826|460225597|FG000|Core Study|Withdrawal by Subject|2|||
127891679|NCT00358826|460225598|FG001|Core Study|Withdrawal by Subject|2|||
127891680|NCT00358826|460225599|FG002|Core Study|Withdrawal by Subject|0|||
127891681|NCT00358826|460225600|FG003|Core Study|Withdrawal by Subject|0|||
127891682|NCT00358826|460225601|FG004|Core Study|Withdrawal by Subject|0|||
127891683|NCT00358826|460225602|FG005|Core Study|Withdrawal by Subject|0|||
127891684|NCT00358826|460225603|FG006|Core Study|Withdrawal by Subject|0|||
127891685|NCT00358826|460225604|FG007|Core Study|Withdrawal by Subject|0|||
127891686|NCT00358826|460225597|FG000|Core Study|Lost to Follow-up|0|||
127891687|NCT00358826|460225598|FG001|Core Study|Lost to Follow-up|0|||
127891688|NCT00358826|460225599|FG002|Core Study|Lost to Follow-up|0|||
127891689|NCT00358826|460225600|FG003|Core Study|Lost to Follow-up|1|||
127891690|NCT00358826|460225601|FG004|Core Study|Lost to Follow-up|0|||
127891691|NCT00358826|460225602|FG005|Core Study|Lost to Follow-up|0|||
127891692|NCT00358826|460225603|FG006|Core Study|Lost to Follow-up|0|||
127891693|NCT00358826|460225604|FG007|Core Study|Lost to Follow-up|0|||
127891694|NCT00358826|460225597|FG000|Core Study|Physician Decision|0|||
127891695|NCT00358826|460225598|FG001|Core Study|Physician Decision|0|||
127891696|NCT00358826|460225599|FG002|Core Study|Physician Decision|1|||
127891697|NCT00358826|460225600|FG003|Core Study|Physician Decision|0|||
127891698|NCT00358826|460225601|FG004|Core Study|Physician Decision|0|||
127891699|NCT00358826|460225602|FG005|Core Study|Physician Decision|0|||
127891700|NCT00358826|460225603|FG006|Core Study|Physician Decision|0|||
127734646|NCT01032200|459653202|FG000|Overall Study|Withdrawal by Subject|1|||
127734647|NCT01032200|459653203|FG001|Overall Study|Withdrawal by Subject|3|||
127734648|NCT01032200|459653202|FG000|Overall Study|Toxicity|0|||
127734649|NCT01032200|459653203|FG001|Overall Study|Toxicity|2|||
127734650|NCT01032200|459653202|FG000|Overall Study|Progression|1|||
127734651|NCT01032200|459653203|FG001|Overall Study|Progression|0|||
127734652|NCT01032200|459653202|FG000|Overall Study|Multiple|1|||
127734653|NCT01032200|459653203|FG001|Overall Study|Multiple|1|||
127734654|NCT00714688|459653207|FG000|Overall Study|Lack of Efficacy|14|||
127734655|NCT00714688|459653208|FG001|Overall Study|Lack of Efficacy|1|||
127734656|NCT00714688|459653209|FG002|Overall Study|Lack of Efficacy|4|||
127734657|NCT00714688|459653207|FG000|Overall Study|Withdrawal by Subject|4|||
127734658|NCT00714688|459653208|FG001|Overall Study|Withdrawal by Subject|3|||
127734659|NCT00714688|459653209|FG002|Overall Study|Withdrawal by Subject|3|||
127734660|NCT00714688|459653207|FG000|Overall Study|Lost to Follow-up|5|||
127734661|NCT00714688|459653208|FG001|Overall Study|Lost to Follow-up|2|||
127734662|NCT00714688|459653209|FG002|Overall Study|Lost to Follow-up|0|||
127891701|NCT00358826|460225604|FG007|Core Study|Physician Decision|0|||
127891702|NCT00358826|460225597|FG000|MDCT Substudy|Adverse Event|0|||
127891703|NCT00358826|460225598|FG001|MDCT Substudy|Adverse Event|0|||
127891704|NCT00358826|460225599|FG002|MDCT Substudy|Adverse Event|0|||
127891705|NCT00358826|460225600|FG003|MDCT Substudy|Adverse Event|0|||
127891706|NCT00358826|460225601|FG004|MDCT Substudy|Adverse Event|1|||
127891707|NCT00358826|460225602|FG005|MDCT Substudy|Adverse Event|0|||
127891708|NCT00358826|460225603|FG006|MDCT Substudy|Adverse Event|0|||
127891709|NCT00358826|460225604|FG007|MDCT Substudy|Adverse Event|0|||
127891710|NCT00358826|460225597|FG000|MDCT Substudy|Lost to Follow-up|0|||
127891711|NCT00358826|460225598|FG001|MDCT Substudy|Lost to Follow-up|0|||
127891712|NCT00358826|460225599|FG002|MDCT Substudy|Lost to Follow-up|0|||
127891713|NCT00358826|460225600|FG003|MDCT Substudy|Lost to Follow-up|0|||
127891714|NCT00358826|460225601|FG004|MDCT Substudy|Lost to Follow-up|0|||
127891715|NCT00358826|460225602|FG005|MDCT Substudy|Lost to Follow-up|1|||
127891716|NCT00358826|460225603|FG006|MDCT Substudy|Lost to Follow-up|0|||
127891717|NCT00358826|460225604|FG007|MDCT Substudy|Lost to Follow-up|0|||
127891718|NCT00358826|460225597|FG000|MDCT Substudy|Withdrawal by Subject|0|||
127891719|NCT00358826|460225598|FG001|MDCT Substudy|Withdrawal by Subject|0|||
127891720|NCT00358826|460225599|FG002|MDCT Substudy|Withdrawal by Subject|0|||
127891721|NCT00358826|460225600|FG003|MDCT Substudy|Withdrawal by Subject|0|||
127891722|NCT00358826|460225601|FG004|MDCT Substudy|Withdrawal by Subject|0|||
127891723|NCT00358826|460225602|FG005|MDCT Substudy|Withdrawal by Subject|1|||
127891724|NCT00358826|460225603|FG006|MDCT Substudy|Withdrawal by Subject|0|||
127891725|NCT00358826|460225604|FG007|MDCT Substudy|Withdrawal by Subject|0|||
127891726|NCT01716754|460225609|FG000|Overall Study|Death|0|||
127734663|NCT00714688|459653207|FG000|Overall Study|Adverse Event|2|||
127734664|NCT00714688|459653208|FG001|Overall Study|Adverse Event|15|||
127734665|NCT00714688|459653209|FG002|Overall Study|Adverse Event|19|||
127734666|NCT00714688|459653207|FG000|Overall Study|Subject Non-compliant|3|||
127734667|NCT00714688|459653208|FG001|Overall Study|Subject Non-compliant|5|||
127891727|NCT01716754|460225610|FG001|Overall Study|Death|0|||
127891728|NCT01716754|460225611|FG002|Overall Study|Death|0|||
127891729|NCT01716754|460225612|FG003|Overall Study|Death|1|||
127891730|NCT01716754|460225609|FG000|Overall Study|Protocol deviation|0|||
127891731|NCT01716754|460225610|FG001|Overall Study|Protocol deviation|2|||
127734668|NCT00714688|459653209|FG002|Overall Study|Subject Non-compliant|5|||
127734669|NCT00714688|459653207|FG000|Overall Study|Ineligible to Continue the Study|0|||
127734670|NCT00714688|459653208|FG001|Overall Study|Ineligible to Continue the Study|1|||
127734671|NCT00714688|459653209|FG002|Overall Study|Ineligible to Continue the Study|1|||
127734672|NCT00714688|459653207|FG000|Overall Study|Sponsor's Decision|0|||
127734673|NCT00714688|459653208|FG001|Overall Study|Sponsor's Decision|2|||
127734674|NCT00714688|459653209|FG002|Overall Study|Sponsor's Decision|0|||
127734675|NCT00714688|459653207|FG000|Overall Study|Other|1|||
127734676|NCT00714688|459653208|FG001|Overall Study|Other|6|||
127734677|NCT00714688|459653209|FG002|Overall Study|Other|5|||
127734678|NCT02316171|459653213|FG000|Overall Study|difficulties with urinary catheter|1|||
127734679|NCT02316171|459653214|FG001|Overall Study|difficulties with urinary catheter|0|||
127734680|NCT02316171|459653215|FG002|Overall Study|difficulties with urinary catheter|0|||
127734681|NCT02316171|459653216|FG003|Overall Study|difficulties with urinary catheter|0|||
127734682|NCT01524887|459653217|FG000|Overall Study|Withdrawal by Subject|6|||
127734683|NCT01524887|459653218|FG001|Overall Study|Withdrawal by Subject|2|||
127734684|NCT01524887|459653219|FG002|Overall Study|Withdrawal by Subject|3|||
127734685|NCT01524887|459653217|FG000|Overall Study|Adverse Event|5|||
127734686|NCT01524887|459653218|FG001|Overall Study|Adverse Event|1|||
127734687|NCT01524887|459653219|FG002|Overall Study|Adverse Event|1|||
127734688|NCT01524887|459653217|FG000|Overall Study|Protocol Violation|0|||
127734689|NCT01524887|459653218|FG001|Overall Study|Protocol Violation|0|||
127734690|NCT01524887|459653219|FG002|Overall Study|Protocol Violation|1|||
127734691|NCT01524887|459653217|FG000|Overall Study|Study termination|73|||
127734692|NCT01524887|459653218|FG001|Overall Study|Study termination|87|||
127734693|NCT01524887|459653219|FG002|Overall Study|Study termination|79|||
127734694|NCT01524887|459653217|FG000|Overall Study|Withdrawal by Caregiver|0|||
127734695|NCT01524887|459653218|FG001|Overall Study|Withdrawal by Caregiver|0|||
127734696|NCT01524887|459653219|FG002|Overall Study|Withdrawal by Caregiver|2|||
127734697|NCT01524887|459653217|FG000|Overall Study|Use of prohibited medication|1|||
127734698|NCT01524887|459653218|FG001|Overall Study|Use of prohibited medication|0|||
127734699|NCT01524887|459653219|FG002|Overall Study|Use of prohibited medication|0|||
127734700|NCT01804140|459653220|FG000|Overall Study|No sampling or biopsy procedures done|114|||
127734701|NCT03993054|459653221|FG000|Overall Study|PI Decision|1|||
127734702|NCT04341584|459653225|FG000|Overall Study|Withdrew consent|0|||
127734703|NCT04341584|459653226|FG001|Overall Study|Withdrew consent|2|||
127734704|NCT04341584|459653227|FG002|Overall Study|Withdrew consent|2|||
127734705|NCT04341584|459653228|FG003|Overall Study|Withdrew consent|1|||
127734706|NCT01002547|459655183|FG000|Overall Study|Withdrawal by Subject|4|||
127734707|NCT01002547|459655184|FG001|Overall Study|Withdrawal by Subject|0|||
127734708|NCT01002547|459655185|FG002|Overall Study|Withdrawal by Subject|5|||
127734709|NCT01002547|459655183|FG000|Overall Study|Lost to Follow-up|2|||
127734710|NCT01002547|459655184|FG001|Overall Study|Lost to Follow-up|1|||
127734711|NCT01002547|459655185|FG002|Overall Study|Lost to Follow-up|1|||
127734712|NCT01002547|459655183|FG000|Overall Study|Physician Decision|1|||
127734713|NCT01002547|459655184|FG001|Overall Study|Physician Decision|0|||
127734714|NCT01002547|459655185|FG002|Overall Study|Physician Decision|0|||
127734715|NCT01002547|459655183|FG000|Overall Study|Death|0|||
127734716|NCT01002547|459655184|FG001|Overall Study|Death|2|||
127734717|NCT01002547|459655185|FG002|Overall Study|Death|2|||
127734718|NCT01002547|459655183|FG000|Overall Study|Adverse Event|1|||
127734719|NCT01002547|459655184|FG001|Overall Study|Adverse Event|0|||
127734720|NCT01002547|459655185|FG002|Overall Study|Adverse Event|0|||
127734721|NCT02093897|459655192|FG000|Overall Study|Physician Decision|1|||
127734722|NCT02093897|459655192|FG000|Overall Study|Planned age group closure - no's reached|17|||
127734723|NCT02093897|459655192|FG000|Overall Study|Adverse event, non-fatal|1|||
127734724|NCT02081196|459655194|FG000|Overall Study|Lost to Follow-up|1|||
127734725|NCT03098797|459655197|FG000|Part 2 Open Label Extension|Adverse Event|2|||
127734726|NCT03098797|459655198|FG001|Part 2 Open Label Extension|Adverse Event|0|||
127734727|NCT00434577|459655199|FG000|Months 0-3|Serious Adverse Event|0|||
127734728|NCT00434577|459655200|FG001|Months 0-3|Serious Adverse Event|0|||
127734729|NCT00434577|459655201|FG002|Months 0-3|Serious Adverse Event|1|||
127734730|NCT00434577|459655202|FG003|Months 0-3|Serious Adverse Event|0|||
127734731|NCT00434577|459655203|FG004|Months 0-3|Serious Adverse Event|0|||
127734732|NCT00434577|459655199|FG000|Months 0-3|Adverse Event|0|||
127734733|NCT00434577|459655200|FG001|Months 0-3|Adverse Event|1|||
127734734|NCT00434577|459655201|FG002|Months 0-3|Adverse Event|1|||
127734735|NCT00434577|459655202|FG003|Months 0-3|Adverse Event|0|||
127734736|NCT00434577|459655203|FG004|Months 0-3|Adverse Event|0|||
127734737|NCT00434577|459655199|FG000|Months 0-3|Lost to Follow-up|0|||
127734738|NCT00434577|459655200|FG001|Months 0-3|Lost to Follow-up|0|||
127734739|NCT00434577|459655201|FG002|Months 0-3|Lost to Follow-up|0|||
127734740|NCT00434577|459655202|FG003|Months 0-3|Lost to Follow-up|0|||
127734741|NCT00434577|459655203|FG004|Months 0-3|Lost to Follow-up|2|||
127734742|NCT00434577|459655199|FG000|Months 0-3|Protocol Violation|1|||
127734743|NCT00434577|459655200|FG001|Months 0-3|Protocol Violation|0|||
127734744|NCT00434577|459655201|FG002|Months 0-3|Protocol Violation|1|||
127734745|NCT00434577|459655202|FG003|Months 0-3|Protocol Violation|0|||
127734746|NCT00434577|459655203|FG004|Months 0-3|Protocol Violation|0|||
127805858|NCT00849017|459911145|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
127805859|NCT00849017|459911146|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
127805860|NCT00849017|459911144|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
127805861|NCT00849017|459911145|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
127805862|NCT00849017|459911146|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
127734747|NCT00434577|459655199|FG000|Months 0-3|Withdrawal by Subject|2|||
127734748|NCT00434577|459655200|FG001|Months 0-3|Withdrawal by Subject|1|||
127805863|NCT00849017|459911144|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
127805864|NCT00849017|459911145|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
127805865|NCT00849017|459911146|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
127805866|NCT00849017|459911144|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
127805867|NCT00849017|459911145|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
127805868|NCT00849017|459911146|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
127734749|NCT00434577|459655201|FG002|Months 0-3|Withdrawal by Subject|1|||
127734750|NCT00434577|459655202|FG003|Months 0-3|Withdrawal by Subject|1|||
127734751|NCT00434577|459655203|FG004|Months 0-3|Withdrawal by Subject|1|||
127734752|NCT01589523|459655212|FG000|Overall Study|Withdrawal by Subject|1|||
127734753|NCT00961896|459655213|FG000|Overall Study|Abnormal laboratory value|0|||
127734754|NCT00961896|459655214|FG001|Overall Study|Abnormal laboratory value|0|||
127734755|NCT00961896|459655215|FG002|Overall Study|Abnormal laboratory value|1|||
127734756|NCT00506922|459655216|FG000|Overall Study|Physician Decision|0|||
127734757|NCT00506922|459655217|FG001|Overall Study|Physician Decision|0|||
127734758|NCT00506922|459655218|FG002|Overall Study|Physician Decision|0|||
127734759|NCT00506922|459655219|FG003|Overall Study|Physician Decision|2|||
127734760|NCT00506922|459655220|FG004|Overall Study|Physician Decision|0|||
127734761|NCT00506922|459655216|FG000|Overall Study|Withdrawal by Subject|0|||
127734762|NCT00506922|459655217|FG001|Overall Study|Withdrawal by Subject|0|||
127734763|NCT00506922|459655218|FG002|Overall Study|Withdrawal by Subject|0|||
127734764|NCT00506922|459655219|FG003|Overall Study|Withdrawal by Subject|0|||
127734765|NCT00506922|459655220|FG004|Overall Study|Withdrawal by Subject|1|||
127734766|NCT02675998|459655227|FG000|8-Week Treatment Period|Adverse Event|6|||
127734767|NCT02675998|459655228|FG001|8-Week Treatment Period|Adverse Event|5|||
127734768|NCT02675998|459655229|FG002|8-Week Treatment Period|Adverse Event|6|||
127734769|NCT02675998|459655230|FG003|8-Week Treatment Period|Adverse Event|0|||
127734770|NCT02675998|459655227|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
127734771|NCT02675998|459655228|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
127734772|NCT02675998|459655229|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
127734773|NCT02675998|459655230|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
127734774|NCT02675998|459655227|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
127734775|NCT02675998|459655228|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
127734776|NCT02675998|459655229|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
127734777|NCT02675998|459655230|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
127734778|NCT02675998|459655227|FG000|8-Week Treatment Period|Physician Decision|1|||
127734779|NCT02675998|459655228|FG001|8-Week Treatment Period|Physician Decision|0|||
127734780|NCT02675998|459655229|FG002|8-Week Treatment Period|Physician Decision|2|||
127734781|NCT02675998|459655230|FG003|8-Week Treatment Period|Physician Decision|0|||
127734782|NCT02675998|459655227|FG000|8-Week Treatment Period|GI side Effects|1|||
127734783|NCT02675998|459655228|FG001|8-Week Treatment Period|GI side Effects|4|||
127734784|NCT02675998|459655229|FG002|8-Week Treatment Period|GI side Effects|2|||
127734785|NCT02675998|459655230|FG003|8-Week Treatment Period|GI side Effects|0|||
127734786|NCT02675998|459655227|FG000|8-Week Treatment Period|Protocol Violation|1|||
127734787|NCT02675998|459655228|FG001|8-Week Treatment Period|Protocol Violation|1|||
127734788|NCT02675998|459655229|FG002|8-Week Treatment Period|Protocol Violation|1|||
127734789|NCT02675998|459655230|FG003|8-Week Treatment Period|Protocol Violation|0|||
127734790|NCT02675998|459655227|FG000|8-Week Treatment Period|Other|3|||
127734791|NCT02675998|459655228|FG001|8-Week Treatment Period|Other|1|||
127734792|NCT02675998|459655229|FG002|8-Week Treatment Period|Other|2|||
127734793|NCT02675998|459655230|FG003|8-Week Treatment Period|Other|0|||
127734794|NCT02675998|459655227|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
127805869|NCT00849017|459911144|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
127805870|NCT00849017|459911145|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
127734795|NCT02675998|459655228|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
127734796|NCT02675998|459655229|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
127868808|NCT01072175|460137395|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
127868809|NCT01072175|460137383|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
127734797|NCT02675998|459655230|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
127734798|NCT02675998|459655227|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
127734799|NCT02675998|459655228|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
127734800|NCT02675998|459655229|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
127868810|NCT01072175|460137384|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
127868811|NCT01072175|460137385|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
127868812|NCT01072175|460137386|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
127734801|NCT02675998|459655230|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
127734802|NCT02675998|459655227|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
127734803|NCT02675998|459655228|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
127734804|NCT02675998|459655229|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
127734805|NCT02675998|459655230|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
127734806|NCT02675998|459655227|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
127734807|NCT02675998|459655228|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
127734808|NCT02675998|459655229|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
127734809|NCT02675998|459655230|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
127734810|NCT02675998|459655227|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
127734811|NCT02675998|459655228|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
127734812|NCT02675998|459655229|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
127734813|NCT02675998|459655230|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
127734814|NCT04357964|459655231|FG000|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|5|||
127734815|NCT04357964|459655232|FG001|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|0|||
127734816|NCT04357964|459655231|FG000|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|13|||
127734817|NCT04357964|459655232|FG001|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|0|||
127734818|NCT04357964|459655231|FG000|Overall Study|Adipose sample was insufficient quality|0|||
127734819|NCT04357964|459655232|FG001|Overall Study|Adipose sample was insufficient quality|1|||
127734820|NCT00848393|459655233|FG000|Overall Study|Protocol Violation|0|||
127734821|NCT00848393|459655234|FG001|Overall Study|Protocol Violation|0|||
127734822|NCT00848393|459655235|FG002|Overall Study|Protocol Violation|1|||
127734823|NCT00848393|459655233|FG000|Overall Study|surgical complications unrelated to stud|0|||
127734824|NCT00848393|459655234|FG001|Overall Study|surgical complications unrelated to stud|0|||
127734825|NCT00848393|459655235|FG002|Overall Study|surgical complications unrelated to stud|2|||
127734826|NCT00043186|459655240|FG000|Overall Study|Physician Decision|0|||
127734827|NCT00043186|459655241|FG001|Overall Study|Physician Decision|0|||
127734828|NCT00043186|459655242|FG002|Overall Study|Physician Decision|3|||
127734829|NCT00043186|459655243|FG003|Overall Study|Physician Decision|0|||
127734830|NCT00043186|459655244|FG004|Overall Study|Physician Decision|1|||
127734831|NCT00043186|459655245|FG005|Overall Study|Physician Decision|0|||
127734832|NCT00043186|459655246|FG006|Overall Study|Physician Decision|0|||
127734833|NCT00043186|459655247|FG007|Overall Study|Physician Decision|1|||
127734834|NCT00043186|459655248|FG008|Overall Study|Physician Decision|1|||
127734835|NCT00043186|459655240|FG000|Overall Study|Adverse Event|2|||
127734836|NCT00043186|459655241|FG001|Overall Study|Adverse Event|2|||
127734837|NCT00043186|459655242|FG002|Overall Study|Adverse Event|2|||
127734838|NCT00043186|459655243|FG003|Overall Study|Adverse Event|3|||
127734839|NCT00043186|459655244|FG004|Overall Study|Adverse Event|2|||
127734840|NCT00043186|459655245|FG005|Overall Study|Adverse Event|1|||
127734841|NCT00043186|459655246|FG006|Overall Study|Adverse Event|2|||
127734842|NCT00043186|459655247|FG007|Overall Study|Adverse Event|1|||
127734843|NCT00043186|459655248|FG008|Overall Study|Adverse Event|3|||
127734844|NCT00043186|459655240|FG000|Overall Study|Withdrawal by Subject|11|||
127734845|NCT00043186|459655241|FG001|Overall Study|Withdrawal by Subject|8|||
127734846|NCT00043186|459655242|FG002|Overall Study|Withdrawal by Subject|11|||
127734847|NCT00043186|459655243|FG003|Overall Study|Withdrawal by Subject|13|||
127734848|NCT00043186|459655244|FG004|Overall Study|Withdrawal by Subject|14|||
127734849|NCT00043186|459655245|FG005|Overall Study|Withdrawal by Subject|6|||
127734850|NCT00043186|459655246|FG006|Overall Study|Withdrawal by Subject|12|||
127734851|NCT00043186|459655247|FG007|Overall Study|Withdrawal by Subject|9|||
127734852|NCT00043186|459655248|FG008|Overall Study|Withdrawal by Subject|10|||
127734853|NCT00043186|459655240|FG000|Overall Study|Death|0|||
127734854|NCT00043186|459655241|FG001|Overall Study|Death|0|||
127734855|NCT00043186|459655242|FG002|Overall Study|Death|1|||
127734856|NCT00043186|459655243|FG003|Overall Study|Death|0|||
127734857|NCT00043186|459655244|FG004|Overall Study|Death|0|||
127734858|NCT00043186|459655245|FG005|Overall Study|Death|0|||
127734859|NCT00043186|459655246|FG006|Overall Study|Death|2|||
127734860|NCT00043186|459655247|FG007|Overall Study|Death|0|||
127734861|NCT00043186|459655248|FG008|Overall Study|Death|0|||
127805871|NCT00849017|459911146|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
127805872|NCT00849017|459911144|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
127805873|NCT00849017|459911145|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
127805874|NCT00849017|459911146|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
127805875|NCT00849017|459911144|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
127805876|NCT00849017|459911145|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
127805877|NCT00849017|459911146|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
127805878|NCT00849017|459911144|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
127805879|NCT00849017|459911145|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
127805880|NCT00849017|459911146|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
127891732|NCT01716754|460225611|FG002|Overall Study|Protocol deviation|7|||
127891733|NCT01716754|460225612|FG003|Overall Study|Protocol deviation|2|||
127891734|NCT01716754|460225609|FG000|Overall Study|Non-compliance with study treatment|0|||
127891735|NCT01716754|460225610|FG001|Overall Study|Non-compliance with study treatment|0|||
127891736|NCT01716754|460225611|FG002|Overall Study|Non-compliance with study treatment|1|||
127891737|NCT01716754|460225612|FG003|Overall Study|Non-compliance with study treatment|0|||
127891738|NCT01716754|460225609|FG000|Overall Study|Physician Decision|1|||
127891739|NCT01716754|460225610|FG001|Overall Study|Physician Decision|0|||
127891740|NCT01716754|460225611|FG002|Overall Study|Physician Decision|0|||
127891741|NCT01716754|460225612|FG003|Overall Study|Physician Decision|0|||
127891742|NCT01716754|460225609|FG000|Overall Study|Lost to Follow-up|1|||
127891743|NCT01716754|460225610|FG001|Overall Study|Lost to Follow-up|0|||
127891744|NCT01716754|460225611|FG002|Overall Study|Lost to Follow-up|0|||
127891745|NCT01716754|460225612|FG003|Overall Study|Lost to Follow-up|1|||
127891746|NCT01716754|460225609|FG000|Overall Study|Adverse Event|4|||
127891747|NCT01716754|460225610|FG001|Overall Study|Adverse Event|2|||
127891748|NCT01716754|460225611|FG002|Overall Study|Adverse Event|2|||
127891749|NCT01716754|460225612|FG003|Overall Study|Adverse Event|1|||
127891750|NCT01716754|460225609|FG000|Overall Study|Withdrawal by Subject|5|||
127891751|NCT01716754|460225610|FG001|Overall Study|Withdrawal by Subject|0|||
127891752|NCT01716754|460225611|FG002|Overall Study|Withdrawal by Subject|4|||
127891753|NCT01716754|460225612|FG003|Overall Study|Withdrawal by Subject|3|||
127734862|NCT00043186|459655240|FG000|Overall Study|Disease progression|1|||
127734863|NCT00043186|459655241|FG001|Overall Study|Disease progression|0|||
127734864|NCT00043186|459655242|FG002|Overall Study|Disease progression|0|||
127734865|NCT00043186|459655243|FG003|Overall Study|Disease progression|3|||
127734866|NCT00043186|459655244|FG004|Overall Study|Disease progression|0|||
127734867|NCT00043186|459655245|FG005|Overall Study|Disease progression|0|||
127734868|NCT00043186|459655246|FG006|Overall Study|Disease progression|0|||
127734869|NCT00043186|459655247|FG007|Overall Study|Disease progression|4|||
127734870|NCT00043186|459655248|FG008|Overall Study|Disease progression|0|||
127734871|NCT00043186|459655240|FG000|Overall Study|Ineligibility determined|0|||
127734872|NCT00043186|459655241|FG001|Overall Study|Ineligibility determined|0|||
127734873|NCT00043186|459655242|FG002|Overall Study|Ineligibility determined|0|||
127734874|NCT00043186|459655243|FG003|Overall Study|Ineligibility determined|0|||
127734875|NCT00043186|459655244|FG004|Overall Study|Ineligibility determined|0|||
127734876|NCT00043186|459655245|FG005|Overall Study|Ineligibility determined|0|||
127734877|NCT00043186|459655246|FG006|Overall Study|Ineligibility determined|0|||
127734878|NCT00043186|459655247|FG007|Overall Study|Ineligibility determined|0|||
127734879|NCT00043186|459655248|FG008|Overall Study|Ineligibility determined|1|||
127734880|NCT00043186|459655240|FG000|Overall Study|Lost to Follow-up|3|||
127734881|NCT00043186|459655241|FG001|Overall Study|Lost to Follow-up|5|||
127734882|NCT00043186|459655242|FG002|Overall Study|Lost to Follow-up|1|||
127734883|NCT00043186|459655243|FG003|Overall Study|Lost to Follow-up|1|||
127734884|NCT00043186|459655244|FG004|Overall Study|Lost to Follow-up|1|||
127734885|NCT00043186|459655245|FG005|Overall Study|Lost to Follow-up|1|||
127734886|NCT00043186|459655246|FG006|Overall Study|Lost to Follow-up|1|||
127734887|NCT00043186|459655247|FG007|Overall Study|Lost to Follow-up|1|||
127734888|NCT00043186|459655248|FG008|Overall Study|Lost to Follow-up|2|||
127734889|NCT00043186|459655240|FG000|Overall Study|Noncompliance|0|||
127734890|NCT00043186|459655241|FG001|Overall Study|Noncompliance|0|||
127734891|NCT00043186|459655242|FG002|Overall Study|Noncompliance|1|||
127734892|NCT00043186|459655243|FG003|Overall Study|Noncompliance|1|||
127734893|NCT00043186|459655244|FG004|Overall Study|Noncompliance|0|||
127734894|NCT00043186|459655245|FG005|Overall Study|Noncompliance|0|||
127734895|NCT00043186|459655246|FG006|Overall Study|Noncompliance|0|||
127734896|NCT00043186|459655247|FG007|Overall Study|Noncompliance|0|||
127734897|NCT00043186|459655248|FG008|Overall Study|Noncompliance|0|||
127734898|NCT00043186|459655240|FG000|Overall Study|Other|0|||
127734899|NCT00043186|459655241|FG001|Overall Study|Other|0|||
127734900|NCT00043186|459655242|FG002|Overall Study|Other|1|||
127734901|NCT00043186|459655243|FG003|Overall Study|Other|1|||
127734902|NCT00043186|459655244|FG004|Overall Study|Other|0|||
127734903|NCT00043186|459655245|FG005|Overall Study|Other|0|||
127734904|NCT00043186|459655246|FG006|Overall Study|Other|0|||
127734905|NCT00043186|459655247|FG007|Overall Study|Other|0|||
127891754|NCT00481247|460225613|FG000|Overall Study|Death|0|||
127891755|NCT00481247|460225614|FG001|Overall Study|Death|1|||
127734906|NCT00043186|459655248|FG008|Overall Study|Other|0|||
127734907|NCT02229396|459655253|FG000|Overall Study|Adverse Event|6|||
127734908|NCT02229396|459655254|FG001|Overall Study|Adverse Event|12|||
127734909|NCT02229396|459655255|FG002|Overall Study|Adverse Event|12|||
127734910|NCT02229396|459655253|FG000|Overall Study|Death|2|||
127734911|NCT02229396|459655254|FG001|Overall Study|Death|3|||
127891756|NCT00481247|460225613|FG000|Overall Study|Disease progression|18|||
127891757|NCT00481247|460225614|FG001|Overall Study|Disease progression|22|||
127734912|NCT02229396|459655255|FG002|Overall Study|Death|1|||
127734913|NCT02229396|459655253|FG000|Overall Study|Lost to Follow-up|14|||
127734914|NCT02229396|459655254|FG001|Overall Study|Lost to Follow-up|14|||
127734915|NCT02229396|459655255|FG002|Overall Study|Lost to Follow-up|21|||
127891758|NCT00481247|460225613|FG000|Overall Study|Intolerance|42|||
127891759|NCT00481247|460225614|FG001|Overall Study|Intolerance|17|||
127891760|NCT00481247|460225613|FG000|Overall Study|Treatment failure|10|||
127891761|NCT00481247|460225614|FG001|Overall Study|Treatment failure|14|||
127891762|NCT00481247|460225613|FG000|Overall Study|AE unrelated to study drug|13|||
127891763|NCT00481247|460225614|FG001|Overall Study|AE unrelated to study drug|4|||
127891764|NCT00481247|460225613|FG000|Overall Study|Withdrawal by Subject|8|||
127891765|NCT00481247|460225614|FG001|Overall Study|Withdrawal by Subject|13|||
127891766|NCT00481247|460225613|FG000|Overall Study|Pregnancy|2|||
127891767|NCT00481247|460225614|FG001|Overall Study|Pregnancy|1|||
127891768|NCT00481247|460225613|FG000|Overall Study|Lost to Follow-up|1|||
127891769|NCT00481247|460225614|FG001|Overall Study|Lost to Follow-up|2|||
127891770|NCT00481247|460225613|FG000|Overall Study|Poor compliance/noncompliance|1|||
127891771|NCT00481247|460225614|FG001|Overall Study|Poor compliance/noncompliance|7|||
127891772|NCT00481247|460225613|FG000|Overall Study|Administrative reason by sponsor|157|||
127891773|NCT00481247|460225614|FG001|Overall Study|Administrative reason by sponsor|162|||
127891774|NCT00481247|460225613|FG000|Overall Study|Varied|6|||
127891775|NCT00481247|460225614|FG001|Overall Study|Varied|15|||
127891776|NCT00481247|460225613|FG000|Overall Study|Did not receive treatment|1|||
127891777|NCT00481247|460225614|FG001|Overall Study|Did not receive treatment|2|||
127891778|NCT02535000|460225616|FG000|Overall Study|Cancellation of surgery.|1|||
127891779|NCT02535000|460225617|FG001|Overall Study|Cancellation of surgery.|2|||
127891780|NCT04317781|460225618|FG000|Overall Study|Adverse Event|1|||
127891781|NCT04317781|460225618|FG000|Overall Study|Disease relapse|1|||
127891782|NCT04317781|460225618|FG000|Overall Study|Withdrawal by Subject|1|||
127891783|NCT01620489|460225619|FG000|Overall Study|Adverse Event|17|||
127891784|NCT01620489|460225620|FG001|Overall Study|Adverse Event|4|||
127891785|NCT01620489|460225619|FG000|Overall Study|Protocol Violation|0|||
127891786|NCT01620489|460225620|FG001|Overall Study|Protocol Violation|3|||
127891787|NCT01620489|460225619|FG000|Overall Study|Withdrawal Criteria|17|||
127891788|NCT01620489|460225620|FG001|Overall Study|Withdrawal Criteria|25|||
127891789|NCT01620489|460225619|FG000|Overall Study|Unclassified|1|||
127891790|NCT01620489|460225620|FG001|Overall Study|Unclassified|2|||
127891791|NCT00321711|460225621|FG000|Part A|Adverse Event|3|||
127891792|NCT00321711|460225622|FG001|Part A|Adverse Event|3|||
127891793|NCT00321711|460225623|FG002|Part A|Adverse Event|2|||
127891794|NCT00321711|460225624|FG003|Part A|Adverse Event|0|||
127891795|NCT00321711|460225625|FG004|Part A|Adverse Event|0|||
127891796|NCT00321711|460225621|FG000|Part A|Withdrawal by Subject|1|||
127891797|NCT00321711|460225622|FG001|Part A|Withdrawal by Subject|1|||
127891798|NCT00321711|460225623|FG002|Part A|Withdrawal by Subject|1|||
127891799|NCT00321711|460225624|FG003|Part A|Withdrawal by Subject|0|||
127891800|NCT00321711|460225625|FG004|Part A|Withdrawal by Subject|0|||
127891801|NCT00321711|460225621|FG000|Part A|Disease progression|0|||
127891802|NCT00321711|460225622|FG001|Part A|Disease progression|1|||
127891803|NCT00321711|460225623|FG002|Part A|Disease progression|0|||
127891804|NCT00321711|460225624|FG003|Part A|Disease progression|0|||
127891805|NCT00321711|460225625|FG004|Part A|Disease progression|0|||
127891806|NCT00321711|460225621|FG000|Part A|Requirement for alternative therapy|0|||
127891807|NCT00321711|460225622|FG001|Part A|Requirement for alternative therapy|2|||
127891808|NCT00321711|460225623|FG002|Part A|Requirement for alternative therapy|1|||
127891809|NCT00321711|460225624|FG003|Part A|Requirement for alternative therapy|0|||
127891810|NCT00321711|460225625|FG004|Part A|Requirement for alternative therapy|0|||
127891811|NCT00321711|460225621|FG000|Part A|Physician Decision|0|||
127891812|NCT00321711|460225622|FG001|Part A|Physician Decision|1|||
127891813|NCT00321711|460225623|FG002|Part A|Physician Decision|3|||
127891814|NCT00321711|460225624|FG003|Part A|Physician Decision|0|||
127891815|NCT00321711|460225625|FG004|Part A|Physician Decision|0|||
127891816|NCT00321711|460225621|FG000|Part A|Other|1|||
127891817|NCT00321711|460225622|FG001|Part A|Other|2|||
127891818|NCT00321711|460225623|FG002|Part A|Other|3|||
127891819|NCT00321711|460225624|FG003|Part A|Other|0|||
127891820|NCT00321711|460225625|FG004|Part A|Other|0|||
127891821|NCT00321711|460225621|FG000|Part A|Protocol deviation|0|||
127734916|NCT02229396|459655253|FG000|Overall Study|Protocol Violation|2|||
127734917|NCT02229396|459655254|FG001|Overall Study|Protocol Violation|1|||
127734918|NCT02229396|459655255|FG002|Overall Study|Protocol Violation|0|||
127734919|NCT02229396|459655253|FG000|Overall Study|Patient Incorrectly Randomized|0|||
127891822|NCT00321711|460225622|FG001|Part A|Protocol deviation|0|||
127891823|NCT00321711|460225623|FG002|Part A|Protocol deviation|1|||
127891824|NCT00321711|460225624|FG003|Part A|Protocol deviation|0|||
127891825|NCT00321711|460225625|FG004|Part A|Protocol deviation|0|||
127891826|NCT00321711|460225621|FG000|Part B|Noncompliance|0|||
127891827|NCT00321711|460225622|FG001|Part B|Noncompliance|0|||
127891828|NCT00321711|460225623|FG002|Part B|Noncompliance|0|||
127891829|NCT00321711|460225624|FG003|Part B|Noncompliance|0|||
127891830|NCT00321711|460225625|FG004|Part B|Noncompliance|1|||
127891831|NCT00321711|460225621|FG000|Part B|Adverse Event|0|||
127891832|NCT00321711|460225622|FG001|Part B|Adverse Event|0|||
127891833|NCT00321711|460225623|FG002|Part B|Adverse Event|0|||
127891834|NCT00321711|460225624|FG003|Part B|Adverse Event|2|||
127891835|NCT00321711|460225625|FG004|Part B|Adverse Event|1|||
127891836|NCT00321711|460225621|FG000|Part B|Disease progression|0|||
127891837|NCT00321711|460225622|FG001|Part B|Disease progression|0|||
127891838|NCT00321711|460225623|FG002|Part B|Disease progression|0|||
127891839|NCT00321711|460225624|FG003|Part B|Disease progression|1|||
127891840|NCT00321711|460225625|FG004|Part B|Disease progression|0|||
127891841|NCT00321711|460225621|FG000|Part B|Physician Decision|0|||
127891842|NCT00321711|460225622|FG001|Part B|Physician Decision|0|||
127891843|NCT00321711|460225623|FG002|Part B|Physician Decision|0|||
127891844|NCT00321711|460225624|FG003|Part B|Physician Decision|1|||
127891845|NCT00321711|460225625|FG004|Part B|Physician Decision|2|||
127891846|NCT00321711|460225621|FG000|Part B|Death|0|||
127891847|NCT00321711|460225622|FG001|Part B|Death|0|||
127891848|NCT00321711|460225623|FG002|Part B|Death|0|||
127891849|NCT00321711|460225624|FG003|Part B|Death|2|||
127891850|NCT00321711|460225625|FG004|Part B|Death|1|||
127891851|NCT01484028|460225630|FG000|Period 1|Lost to Follow-up|0|||
127891852|NCT01484028|460225631|FG001|Period 1|Lost to Follow-up|1|||
127891853|NCT01484028|460225632|FG002|Period 1|Lost to Follow-up|0|||
127891854|NCT01484028|460225633|FG003|Period 1|Lost to Follow-up|0|||
127891855|NCT01484028|460225630|FG000|Period 1|Non-Compliance to Protocol|0|||
127891856|NCT01484028|460225631|FG001|Period 1|Non-Compliance to Protocol|1|||
127891857|NCT01484028|460225632|FG002|Period 1|Non-Compliance to Protocol|0|||
127891858|NCT01484028|460225633|FG003|Period 1|Non-Compliance to Protocol|1|||
127891859|NCT01484028|460225630|FG000|Period 1|Lens Discomfort|0|||
127891860|NCT01484028|460225631|FG001|Period 1|Lens Discomfort|1|||
127891861|NCT01484028|460225632|FG002|Period 1|Lens Discomfort|0|||
127891862|NCT01484028|460225633|FG003|Period 1|Lens Discomfort|0|||
127891863|NCT01193517|460225636|FG000|Overall Study|Early Progression|1|||
127891864|NCT01193517|460225637|FG001|Overall Study|Early Progression|0|||
127891865|NCT01193517|460225638|FG002|Overall Study|Early Progression|0|||
127891866|NCT02115256|460225641|FG000|Overall Study|Withdrawal by Subject|0|||
127891867|NCT02115256|460225642|FG001|Overall Study|Withdrawal by Subject|1|||
127891868|NCT03775681|460225643|FG000|Overall Study|Physician Decision|3|||
127891869|NCT01855126|460225644|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
127891870|NCT01855126|460225645|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
127891871|NCT01855126|460225644|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
127891872|NCT01855126|460225645|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
127891873|NCT01512979|460225654|FG000|Overall Study|Adverse Event|2|||
127891874|NCT01512979|460225655|FG001|Overall Study|Adverse Event|2|||
127891875|NCT01512979|460225654|FG000|Overall Study|Protocol Violation|1|||
127891876|NCT01512979|460225655|FG001|Overall Study|Protocol Violation|4|||
127891877|NCT01512979|460225654|FG000|Overall Study|Lost to Follow-up|2|||
127891878|NCT01512979|460225655|FG001|Overall Study|Lost to Follow-up|5|||
127891879|NCT01512979|460225654|FG000|Overall Study|Withdrawal by Subject|1|||
127891880|NCT01512979|460225655|FG001|Overall Study|Withdrawal by Subject|2|||
127891881|NCT01512979|460225654|FG000|Overall Study|Reason other than stated above|13|||
127891882|NCT01512979|460225655|FG001|Overall Study|Reason other than stated above|9|||
127891883|NCT01748890|460225665|FG000|Overall Study|Insufficient recruitment for analysis|4|||
127891884|NCT00526890|460225666|FG000|Overall Study|Adverse Event|2|||
127891885|NCT03529955|460225667|FG000|Overall Study|Adverse Event|1|||
127891886|NCT03529955|460225667|FG000|Overall Study|Lack of Efficacy|1|||
127891887|NCT00580983|460225668|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
127891888|NCT03740100|460225669|FG000|Overall Study|Adverse Event|1|||
127891889|NCT03740100|460225669|FG000|Overall Study|Death|1|||
127891890|NCT03387059|460225671|FG000|Overall Study|Study termination|5|||
127891891|NCT03387059|460225672|FG001|Overall Study|Study termination|4|||
127891892|NCT01859702|460225673|FG000|Overall Study|Protocol deviation|3|||
127891893|NCT01859702|460225673|FG000|Overall Study|Adverse Event|2|||
127891894|NCT02004847|460227355|FG000|Overall Study|Protocol Violation|1|||
127891895|NCT02004847|460227356|FG001|Overall Study|Protocol Violation|1|||
127891896|NCT02806232|460227363|FG000|Overall Study|Lost to Follow-up|1|||
127891897|NCT02806232|460227364|FG001|Overall Study|Lost to Follow-up|2|||
127891898|NCT02806232|460227365|FG002|Overall Study|Lost to Follow-up|1|||
127891899|NCT02806232|460227366|FG003|Overall Study|Lost to Follow-up|0|||
127891900|NCT02806232|460227367|FG004|Overall Study|Lost to Follow-up|0|||
127891901|NCT02806232|460227368|FG005|Overall Study|Lost to Follow-up|1|||
127891902|NCT02806232|460227369|FG006|Overall Study|Lost to Follow-up|0|||
127891903|NCT02806232|460227370|FG007|Overall Study|Lost to Follow-up|0|||
127891904|NCT02806232|460227371|FG008|Overall Study|Lost to Follow-up|0|||
127891905|NCT02806232|460227363|FG000|Overall Study|Withdrawal by Subject|0|||
127891906|NCT02806232|460227364|FG001|Overall Study|Withdrawal by Subject|2|||
127891907|NCT02806232|460227365|FG002|Overall Study|Withdrawal by Subject|0|||
127891908|NCT02806232|460227366|FG003|Overall Study|Withdrawal by Subject|0|||
127891909|NCT02806232|460227367|FG004|Overall Study|Withdrawal by Subject|2|||
127891910|NCT02806232|460227368|FG005|Overall Study|Withdrawal by Subject|1|||
127891911|NCT02806232|460227369|FG006|Overall Study|Withdrawal by Subject|0|||
127891912|NCT02806232|460227370|FG007|Overall Study|Withdrawal by Subject|0|||
127891913|NCT02806232|460227371|FG008|Overall Study|Withdrawal by Subject|0|||
127891914|NCT00759148|460227372|FG000|Overall Study|Adverse Event|1|||
127891915|NCT00759148|460227373|FG001|Overall Study|Adverse Event|6|||
127891916|NCT00759148|460227372|FG000|Overall Study|Withdrawal by Subject|3|||
127891917|NCT00759148|460227373|FG001|Overall Study|Withdrawal by Subject|7|||
127891918|NCT00759148|460227372|FG000|Overall Study|Lost to Follow-up|3|||
127891919|NCT00759148|460227373|FG001|Overall Study|Lost to Follow-up|9|||
127891920|NCT00759148|460227372|FG000|Overall Study|Treatment Failure|6|||
127891921|NCT00759148|460227373|FG001|Overall Study|Treatment Failure|10|||
127891922|NCT00759148|460227372|FG000|Overall Study|Reason not given|1|||
127891923|NCT00759148|460227373|FG001|Overall Study|Reason not given|0|||
127891924|NCT00434161|460227376|FG000|Overall Study|Adverse Event|5|||
127891925|NCT00434161|460227377|FG001|Overall Study|Adverse Event|1|||
127891926|NCT00434161|460227378|FG002|Overall Study|Adverse Event|4|||
127891927|NCT00434161|460227376|FG000|Overall Study|Lost to Follow-up|0|||
127891928|NCT00434161|460227377|FG001|Overall Study|Lost to Follow-up|1|||
127891929|NCT00434161|460227378|FG002|Overall Study|Lost to Follow-up|0|||
127891930|NCT00434161|460227376|FG000|Overall Study|Death|1|||
127891931|NCT00434161|460227377|FG001|Overall Study|Death|0|||
127891932|NCT00434161|460227378|FG002|Overall Study|Death|1|||
127891933|NCT00434161|460227376|FG000|Overall Study|Non-Compliance|1|||
127891934|NCT00434161|460227377|FG001|Overall Study|Non-Compliance|1|||
127891935|NCT00434161|460227378|FG002|Overall Study|Non-Compliance|0|||
127891936|NCT00434161|460227376|FG000|Overall Study|Withdrawal by Subject|2|||
127891937|NCT00434161|460227377|FG001|Overall Study|Withdrawal by Subject|0|||
127891938|NCT00434161|460227378|FG002|Overall Study|Withdrawal by Subject|3|||
127734920|NCT02229396|459655254|FG001|Overall Study|Patient Incorrectly Randomized|0|||
127734921|NCT02229396|459655255|FG002|Overall Study|Patient Incorrectly Randomized|1|||
127734922|NCT02229396|459655253|FG000|Overall Study|Other|10|||
127734923|NCT02229396|459655254|FG001|Overall Study|Other|18|||
127734924|NCT02229396|459655255|FG002|Overall Study|Other|15|||
127734925|NCT02229396|459655253|FG000|Overall Study|Withdrawal by Subject|42|||
127734926|NCT02229396|459655254|FG001|Overall Study|Withdrawal by Subject|28|||
127734927|NCT02229396|459655255|FG002|Overall Study|Withdrawal by Subject|41|||
127734928|NCT02229396|459655253|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
127734929|NCT02229396|459655254|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
127734930|NCT02229396|459655255|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
127734931|NCT02229396|459655253|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
127734932|NCT02229396|459655254|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
127734933|NCT02229396|459655255|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
127734934|NCT03681353|459655261|FG000|Overall Study|Lost to Follow-up|2|||
127734935|NCT03681353|459655261|FG000|Overall Study|Withdrawal by Subject|3|||
127734936|NCT03681353|459655261|FG000|Overall Study|withdrawn by PI|2|||
127734937|NCT00111839|459655267|FG000|Overall Study|Disease Progression|30|||
127734938|NCT00111839|459655268|FG001|Overall Study|Disease Progression|33|||
127734939|NCT00111839|459655269|FG002|Overall Study|Disease Progression|33|||
127734940|NCT00111839|459655267|FG000|Overall Study|Adverse Event|5|||
127734941|NCT00111839|459655268|FG001|Overall Study|Adverse Event|3|||
127734942|NCT00111839|459655269|FG002|Overall Study|Adverse Event|1|||
127734943|NCT00111839|459655267|FG000|Overall Study|Protocol Violation|2|||
127734944|NCT00111839|459655268|FG001|Overall Study|Protocol Violation|4|||
127734945|NCT00111839|459655269|FG002|Overall Study|Protocol Violation|2|||
127734946|NCT00111839|459655267|FG000|Overall Study|Death|1|||
127734947|NCT00111839|459655268|FG001|Overall Study|Death|1|||
127734948|NCT00111839|459655269|FG002|Overall Study|Death|6|||
127805881|NCT00849017|459911144|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
127805882|NCT00849017|459911145|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
127805883|NCT00849017|459911146|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
127805884|NCT00849017|459911144|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
127805885|NCT00849017|459911145|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
127805886|NCT00849017|459911146|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
127805887|NCT00849017|459911144|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
127891939|NCT00434161|460227376|FG000|Overall Study|Logistical error study assessments|1|||
127891940|NCT00434161|460227377|FG001|Overall Study|Logistical error study assessments|0|||
127734949|NCT00111839|459655267|FG000|Overall Study|Withdrawal by Subject|2|||
127805888|NCT00849017|459911145|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
127805889|NCT00849017|459911146|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
127805890|NCT00849017|459911144|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
127891941|NCT00434161|460227378|FG002|Overall Study|Logistical error study assessments|3|||
127891942|NCT03342898|460227379|FG000|Overall Study|Adverse Event|3|||
127891943|NCT03342898|460227380|FG001|Overall Study|Adverse Event|1|||
127891944|NCT03342898|460227381|FG002|Overall Study|Adverse Event|0|||
127891945|NCT03342898|460227379|FG000|Overall Study|Lost to Follow-up|44|||
127891946|NCT03342898|460227380|FG001|Overall Study|Lost to Follow-up|40|||
127891947|NCT03342898|460227381|FG002|Overall Study|Lost to Follow-up|42|||
127891948|NCT03342898|460227379|FG000|Overall Study|Withdrawal of Consent|5|||
127891949|NCT03342898|460227380|FG001|Overall Study|Withdrawal of Consent|9|||
127734950|NCT00111839|459655268|FG001|Overall Study|Withdrawal by Subject|2|||
127891950|NCT03342898|460227381|FG002|Overall Study|Withdrawal of Consent|11|||
127891951|NCT03342898|460227379|FG000|Overall Study|Death|0|||
127891952|NCT03342898|460227380|FG001|Overall Study|Death|1|||
127891953|NCT03342898|460227381|FG002|Overall Study|Death|1|||
127891954|NCT03342898|460227379|FG000|Overall Study|Reason not Specified|2|||
127891955|NCT03342898|460227380|FG001|Overall Study|Reason not Specified|2|||
127891956|NCT03342898|460227381|FG002|Overall Study|Reason not Specified|0|||
127891957|NCT01387282|460227382|FG000|Overall Study|Death|47|||
127891958|NCT01387282|460227383|FG001|Overall Study|Death|16|||
127891959|NCT01387282|460227382|FG000|Overall Study|Other|5|||
127891960|NCT01387282|460227383|FG001|Overall Study|Other|1|||
127891961|NCT01387282|460227382|FG000|Overall Study|Unrelated AE|6|||
127891962|NCT01387282|460227383|FG001|Overall Study|Unrelated AE|4|||
127891963|NCT01387282|460227382|FG000|Overall Study|Withdrawal by patient|33|||
127891964|NCT01387282|460227383|FG001|Overall Study|Withdrawal by patient|23|||
127891965|NCT01387282|460227382|FG000|Overall Study|Study drug-related AE|2|||
127891966|NCT01387282|460227383|FG001|Overall Study|Study drug-related AE|2|||
127891967|NCT01387282|460227382|FG000|Overall Study|Lost to Follow-up|4|||
127891968|NCT01387282|460227383|FG001|Overall Study|Lost to Follow-up|1|||
127891969|NCT03997448|460227386|FG000|Study Treatment|Disease Progression|1|||
127891970|NCT03997448|460227386|FG000|Study Treatment|Symptomatic Deterioration|1|||
127891971|NCT03997448|460227386|FG000|Follow up|Death|2|||
127891972|NCT03997448|460227386|FG000|Follow up|study terminated|1|||
127891973|NCT02482805|460227389|FG000|Overall Study|Lost to Follow-up|4|||
127891974|NCT02482805|460227390|FG001|Overall Study|Lost to Follow-up|4|||
127891975|NCT02482805|460227391|FG002|Overall Study|Lost to Follow-up|0|||
127891976|NCT01267266|460227392|FG000|Enrollment Phase|Withdrawal by Subject|2|||
127891977|NCT01267266|460227393|FG001|Enrollment Phase|Withdrawal by Subject|0|||
127891978|NCT01267266|460227392|FG000|Lead-in Phase|Lack of Efficacy|20|||
127891979|NCT01267266|460227393|FG001|Lead-in Phase|Lack of Efficacy|0|||
127891980|NCT01267266|460227392|FG000|Lead-in Phase|Adverse Event|2|||
127891981|NCT01267266|460227393|FG001|Lead-in Phase|Adverse Event|0|||
127891982|NCT01267266|460227392|FG000|Lead-in Phase|Withdrawal by Subject|1|||
127891983|NCT01267266|460227393|FG001|Lead-in Phase|Withdrawal by Subject|0|||
127891984|NCT01007916|460227418|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
127891985|NCT01007916|460227419|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
127891986|NCT01007916|460227418|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
127891987|NCT01007916|460227419|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
127891988|NCT01927757|460227436|FG000|Overall Study|Withdrawal by Subject|14|||
127891989|NCT01927757|460227436|FG000|Overall Study|Lost to Follow-up|2|||
127891990|NCT01927757|460227436|FG000|Overall Study|Decision by Sponsor|2|||
127891991|NCT01927757|460227436|FG000|Overall Study|Other|1|||
127891992|NCT01927757|460227436|FG000|Overall Study|Ethical Reasons|4|||
127891993|NCT00268346|460227437|FG000|Overall Study|Adverse Event|0|||
127891994|NCT00268346|460227438|FG001|Overall Study|Adverse Event|1|||
127891995|NCT00268346|460227437|FG000|Overall Study|Death|0|||
127891996|NCT00268346|460227438|FG001|Overall Study|Death|1|||
127891997|NCT00268346|460227437|FG000|Overall Study|Withdrawal by Subject|0|||
127891998|NCT00268346|460227438|FG001|Overall Study|Withdrawal by Subject|1|||
127891999|NCT01958281|460227439|FG000|Overall Study|Lack of Efficacy|5|||
127892000|NCT01958281|460227440|FG001|Overall Study|Lack of Efficacy|2|||
127892001|NCT01958281|460227441|FG002|Overall Study|Lack of Efficacy|0|||
127892002|NCT01958281|460227439|FG000|Overall Study|Adverse Event|0|||
127892003|NCT01958281|460227440|FG001|Overall Study|Adverse Event|2|||
127892004|NCT01958281|460227441|FG002|Overall Study|Adverse Event|0|||
127892005|NCT01958281|460227439|FG000|Overall Study|Withdrew Consent|1|||
127892006|NCT01958281|460227440|FG001|Overall Study|Withdrew Consent|0|||
127892007|NCT01958281|460227441|FG002|Overall Study|Withdrew Consent|0|||
127892008|NCT02784106|460227442|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
127892009|NCT02784106|460227443|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
127892010|NCT02784106|460227444|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
127892011|NCT02784106|460227445|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
127892012|NCT02784106|460227442|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
127892013|NCT02784106|460227443|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
127892014|NCT02784106|460227444|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
127892015|NCT02784106|460227445|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
127892016|NCT02784106|460227442|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
127892017|NCT02784106|460227443|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
127892018|NCT02784106|460227444|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
127892019|NCT02784106|460227445|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
127892020|NCT02784106|460227442|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
127892021|NCT02784106|460227443|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
127892022|NCT02784106|460227444|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
127892023|NCT02784106|460227445|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
127892024|NCT02784106|460227442|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
127892025|NCT02784106|460227443|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
127892026|NCT02784106|460227444|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
127892027|NCT02784106|460227445|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
127892028|NCT02784106|460227442|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
127892029|NCT02784106|460227443|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
127892030|NCT02784106|460227444|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
127892031|NCT02784106|460227445|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
127892032|NCT03222141|460227448|FG000|Overall Study|Death|15|||
127892033|NCT03222141|460227448|FG000|Overall Study|Lost to Follow-up|3|||
127892034|NCT02022007|460227449|FG000|Overall Study|Withdrawal by Subject|1|||
127892035|NCT02022007|460227450|FG001|Overall Study|Withdrawal by Subject|1|||
127892036|NCT02022007|460227451|FG002|Overall Study|Withdrawal by Subject|1|||
127892037|NCT02022007|460227449|FG000|Overall Study|Noncompliant|0|||
127892038|NCT02022007|460227450|FG001|Overall Study|Noncompliant|0|||
127892039|NCT02022007|460227451|FG002|Overall Study|Noncompliant|1|||
127892040|NCT01107535|460227452|FG000|Overall Study|Death|5|||
127892041|NCT00192296|460227457|FG000|Overall Study|Withdrawal by Subject|0|||
127892042|NCT00192296|460227458|FG001|Overall Study|Withdrawal by Subject|1|||
127892043|NCT00192296|460227459|FG002|Overall Study|Withdrawal by Subject|0|||
127892044|NCT00192296|460227460|FG003|Overall Study|Withdrawal by Subject|0|||
127892045|NCT02536378|460227461|FG000|Overall Study|Physician Decision|0|||
127892046|NCT02536378|460227462|FG001|Overall Study|Physician Decision|2|||
127892047|NCT02536378|460227461|FG000|Overall Study|Withdrawal by Subject|0|||
127892048|NCT02536378|460227462|FG001|Overall Study|Withdrawal by Subject|1|||
127892049|NCT02536378|460227461|FG000|Overall Study|Death|1|||
127892050|NCT02536378|460227462|FG001|Overall Study|Death|2|||
127892051|NCT02536378|460227461|FG000|Overall Study|Patient refused further follow up|6|||
127892052|NCT02536378|460227462|FG001|Overall Study|Patient refused further follow up|2|||
127892053|NCT00617461|460227463|FG000|First Treatment Intervention Period|Adverse Event|2|||
127892054|NCT00617461|460227464|FG001|First Treatment Intervention Period|Adverse Event|0|||
127892055|NCT00617461|460227463|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
127892056|NCT00617461|460227464|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
127892057|NCT00617461|460227463|FG000|First Treatment Intervention Period|Protocol Violation|2|||
127892058|NCT00617461|460227464|FG001|First Treatment Intervention Period|Protocol Violation|1|||
127892059|NCT00617461|460227463|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
127892060|NCT00617461|460227464|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
127892061|NCT00617461|460227463|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
127892062|NCT00617461|460227464|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
127892063|NCT00617461|460227463|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
127892064|NCT00617461|460227464|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
127892065|NCT00617461|460227463|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
127892066|NCT00617461|460227464|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
127892067|NCT00617461|460227463|FG000|Second Treatment Intervention Period|Adverse Event|0|||
127892068|NCT00617461|460227464|FG001|Second Treatment Intervention Period|Adverse Event|1|||
127892069|NCT00617461|460227463|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
127892070|NCT00617461|460227464|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
127892071|NCT00617461|460227463|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
127892072|NCT00617461|460227464|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
127892073|NCT00617461|460227463|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
127892074|NCT00617461|460227464|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
127892075|NCT00903383|460227468|FG000|Overall Study|Adverse Event|1|||
127892076|NCT00903383|460227469|FG001|Overall Study|Adverse Event|2|||
127892077|NCT00903383|460227470|FG002|Overall Study|Adverse Event|3|||
127892078|NCT00903383|460227471|FG003|Overall Study|Adverse Event|1|||
127892079|NCT00903383|460227468|FG000|Overall Study|Physician Decision|1|||
127892080|NCT00903383|460227469|FG001|Overall Study|Physician Decision|2|||
127892081|NCT00903383|460227470|FG002|Overall Study|Physician Decision|0|||
127892082|NCT00903383|460227471|FG003|Overall Study|Physician Decision|0|||
127892083|NCT00903383|460227468|FG000|Overall Study|Lost to Follow-up|0|||
127892084|NCT00903383|460227469|FG001|Overall Study|Lost to Follow-up|0|||
127892085|NCT00903383|460227470|FG002|Overall Study|Lost to Follow-up|0|||
127892086|NCT00903383|460227471|FG003|Overall Study|Lost to Follow-up|1|||
127892087|NCT00903383|460227468|FG000|Overall Study|Decision of Sponsor|1|||
127892088|NCT00903383|460227469|FG001|Overall Study|Decision of Sponsor|0|||
127892089|NCT00903383|460227470|FG002|Overall Study|Decision of Sponsor|0|||
127892090|NCT00903383|460227471|FG003|Overall Study|Decision of Sponsor|0|||
127892091|NCT00903383|460227468|FG000|Overall Study|Withdrawal by Subject|4|||
127892092|NCT00903383|460227469|FG001|Overall Study|Withdrawal by Subject|1|||
127892093|NCT00903383|460227470|FG002|Overall Study|Withdrawal by Subject|0|||
127892094|NCT00903383|460227471|FG003|Overall Study|Withdrawal by Subject|2|||
127892095|NCT00903383|460227468|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
127892096|NCT00903383|460227469|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
127892097|NCT00903383|460227470|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
127892098|NCT00903383|460227471|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
127892099|NCT00903383|460227468|FG000|Overall Study|Patient Decision|0|||
127892100|NCT00903383|460227469|FG001|Overall Study|Patient Decision|0|||
127892101|NCT00903383|460227470|FG002|Overall Study|Patient Decision|0|||
127892102|NCT00903383|460227471|FG003|Overall Study|Patient Decision|1|||
127892103|NCT01821625|460227474|FG000|Overall Study|Withdrawal by Subject|2|||
127892104|NCT01821625|460227474|FG000|Overall Study|Lack of Efficacy|2|||
127892105|NCT01821625|460227474|FG000|Overall Study|Adverse Event|1|||
127892106|NCT01821625|460227474|FG000|Overall Study|Medical contraindication|1|||
127892107|NCT00320593|460227477|FG000|Overall Study|Lost to Follow-up|3|||
127892108|NCT00320593|460227478|FG001|Overall Study|Lost to Follow-up|0|||
127892109|NCT00320593|460227477|FG000|Overall Study|Moved to another state|1|||
127892110|NCT00320593|460227478|FG001|Overall Study|Moved to another state|0|||
127892111|NCT00320593|460227477|FG000|Overall Study|Withdrawal by Subject|2|||
127892112|NCT00320593|460227478|FG001|Overall Study|Withdrawal by Subject|1|||
127892113|NCT00320593|460227477|FG000|Overall Study|Withdrawal by clinical center|1|||
127892114|NCT00320593|460227478|FG001|Overall Study|Withdrawal by clinical center|0|||
127892115|NCT00457665|460227479|FG000|12 Months|Drug allergy|1|||
127892116|NCT00457665|460227480|FG001|12 Months|Drug allergy|1|||
127892117|NCT00457665|460227479|FG000|12 Months|High HIV viral load|5|||
127892118|NCT00457665|460227480|FG001|12 Months|High HIV viral load|1|||
127892119|NCT00457665|460227479|FG000|12 Months|Lipodystrophy|2|||
127892120|NCT00457665|460227480|FG001|12 Months|Lipodystrophy|0|||
127892121|NCT00457665|460227479|FG000|12 Months|Withdrawal by Subject|0|||
127892122|NCT00457665|460227480|FG001|12 Months|Withdrawal by Subject|2|||
127892123|NCT00457665|460227479|FG000|12 Months|Abnormal Liver function tests|0|||
127892124|NCT00457665|460227480|FG001|12 Months|Abnormal Liver function tests|5|||
127892125|NCT00457665|460227479|FG000|24 Months|Withdrawal by Subject|3|||
127892126|NCT00457665|460227480|FG001|24 Months|Withdrawal by Subject|2|||
127892127|NCT00457665|460227479|FG000|24 Months|Lipodystrophy|1|||
127892128|NCT00457665|460227480|FG001|24 Months|Lipodystrophy|1|||
127892129|NCT00457665|460227479|FG000|24 Months|Abnormal liver function tests|1|||
127892130|NCT00457665|460227480|FG001|24 Months|Abnormal liver function tests|5|||
127892131|NCT01851590|460227486|FG000|Overall Study|Withdrawal by Subject|0|||
127892132|NCT01851590|460227487|FG001|Overall Study|Withdrawal by Subject|0|||
127892133|NCT01851590|460227488|FG002|Overall Study|Withdrawal by Subject|1|||
127892134|NCT01851590|460227486|FG000|Overall Study|Adverse Event|0|||
127892135|NCT01851590|460227487|FG001|Overall Study|Adverse Event|0|||
127892136|NCT01851590|460227488|FG002|Overall Study|Adverse Event|2|||
127892137|NCT01851590|460227486|FG000|Overall Study|Lack of Efficacy|0|||
127892138|NCT01851590|460227487|FG001|Overall Study|Lack of Efficacy|1|||
127892139|NCT01851590|460227488|FG002|Overall Study|Lack of Efficacy|0|||
127892140|NCT02611752|460227491|FG000|Overall Study|Adverse Event|0|||
127892141|NCT02611752|460227492|FG001|Overall Study|Adverse Event|1|||
127892142|NCT00310856|460227493|FG000|Overall Study|Withdrawal by Subject|2|||
127892143|NCT00310856|460227494|FG001|Overall Study|Withdrawal by Subject|2|||
127892144|NCT00310856|460227495|FG002|Overall Study|Withdrawal by Subject|2|||
127892145|NCT00310856|460227493|FG000|Overall Study|Lost to Follow-up|1|||
127892146|NCT00310856|460227494|FG001|Overall Study|Lost to Follow-up|2|||
127892147|NCT00310856|460227495|FG002|Overall Study|Lost to Follow-up|6|||
127892148|NCT00310856|460227493|FG000|Overall Study|Inappropriate enrollment|1|||
127892149|NCT00310856|460227494|FG001|Overall Study|Inappropriate enrollment|1|||
127892150|NCT00310856|460227495|FG002|Overall Study|Inappropriate enrollment|0|||
127892151|NCT00310856|460227493|FG000|Overall Study|Unable to classify|1|||
127892152|NCT00310856|460227494|FG001|Overall Study|Unable to classify|0|||
127892153|NCT00310856|460227495|FG002|Overall Study|Unable to classify|0|||
127892154|NCT02843074|460227499|FG000|Overall Study|Withdrawal by Subject|5|||
127892155|NCT02843074|460227499|FG000|Overall Study|Progressive disease|1|||
127892156|NCT02843074|460227499|FG000|Overall Study|Physician Decision|1|||
127892157|NCT02843074|460227499|FG000|Overall Study|Lost to Follow-up|1|||
127892158|NCT02843074|460227499|FG000|Overall Study|Death|9|||
127892159|NCT00947856|460227502|FG000|Treatment Period|Progressive Disease|33|||
127892160|NCT00947856|460227503|FG001|Treatment Period|Progressive Disease|12|||
127892161|NCT00947856|460227502|FG000|Treatment Period|Adverse Event|15|||
127892162|NCT00947856|460227503|FG001|Treatment Period|Adverse Event|9|||
127892163|NCT00947856|460227502|FG000|Treatment Period|Physician Decision|14|||
127892164|NCT00947856|460227503|FG001|Treatment Period|Physician Decision|6|||
127892165|NCT00947856|460227502|FG000|Treatment Period|Study Stopped by Sponsor|4|||
127892166|NCT00947856|460227503|FG001|Treatment Period|Study Stopped by Sponsor|4|||
127892167|NCT00947856|460227502|FG000|Treatment Period|Withdrawal by Subject|12|||
127892168|NCT00947856|460227503|FG001|Treatment Period|Withdrawal by Subject|1|||
127892169|NCT00947856|460227502|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
127892170|NCT00947856|460227503|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
127892171|NCT00947856|460227502|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
127892172|NCT00947856|460227503|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
127892173|NCT00947856|460227502|FG000|Follow-up Period|Lost to Follow-up|7|||
127892174|NCT00947856|460227503|FG001|Follow-up Period|Lost to Follow-up|0|||
127892175|NCT00947856|460227502|FG000|Follow-up Period|Patient unavailable for site visits|1|||
127892176|NCT00947856|460227503|FG001|Follow-up Period|Patient unavailable for site visits|0|||
127892177|NCT00947856|460227502|FG000|Follow-up Period|Withdrawal by Subject|1|||
127892178|NCT00947856|460227503|FG001|Follow-up Period|Withdrawal by Subject|0|||
127892179|NCT01211769|460227504|FG000|Overall Study|Lost to Follow-up|7|||
127892180|NCT01211769|460227505|FG001|Overall Study|Lost to Follow-up|9|||
127892181|NCT01211769|460227506|FG002|Overall Study|Lost to Follow-up|5|||
127892182|NCT01211769|460227507|FG003|Overall Study|Lost to Follow-up|9|||
127892183|NCT01211769|460227504|FG000|Overall Study|Physician Decision|2|||
127892184|NCT01211769|460227505|FG001|Overall Study|Physician Decision|0|||
127892185|NCT01211769|460227506|FG002|Overall Study|Physician Decision|2|||
127892186|NCT01211769|460227507|FG003|Overall Study|Physician Decision|1|||
127892187|NCT01211769|460227504|FG000|Overall Study|Adverse Event|0|||
127892188|NCT01211769|460227505|FG001|Overall Study|Adverse Event|1|||
127892189|NCT01211769|460227506|FG002|Overall Study|Adverse Event|1|||
127892190|NCT01211769|460227507|FG003|Overall Study|Adverse Event|1|||
127892191|NCT01348542|460227508|FG000|Overall Study|Withdrawal by Subject|3|||
127892192|NCT01348542|460227509|FG001|Overall Study|Withdrawal by Subject|0|||
127892193|NCT03402893|460227510|FG000|Overall Study|Withdrawal by Subject|1|||
127892194|NCT00926289|460227511|FG000|Overall Study|Adverse Event|9|||
127892195|NCT00926289|460227512|FG001|Overall Study|Adverse Event|11|||
127892196|NCT00926289|460227511|FG000|Overall Study|Protocol Violation|8|||
127892197|NCT00926289|460227512|FG001|Overall Study|Protocol Violation|12|||
127892198|NCT00926289|460227511|FG000|Overall Study|Lost to Follow-up|3|||
127892199|NCT00926289|460227512|FG001|Overall Study|Lost to Follow-up|6|||
127892200|NCT00926289|460227511|FG000|Overall Study|Withdrawal by Subject|4|||
127892201|NCT00926289|460227512|FG001|Overall Study|Withdrawal by Subject|4|||
127892202|NCT00926289|460227511|FG000|Overall Study|Other|1|||
127892203|NCT00926289|460227512|FG001|Overall Study|Other|3|||
127892204|NCT00146770|460227514|FG000|Overall Study|Adverse Event|2|||
127892205|NCT00146770|460227515|FG001|Overall Study|Adverse Event|0|||
127892206|NCT00146770|460227514|FG000|Overall Study|Pregnancy|1|||
127892207|NCT00146770|460227515|FG001|Overall Study|Pregnancy|0|||
127892208|NCT00146770|460227514|FG000|Overall Study|Withdrawal by Subject|2|||
127892209|NCT00146770|460227515|FG001|Overall Study|Withdrawal by Subject|0|||
127892210|NCT02995837|460227521|FG000|Overall Study|Lost to Follow-up|9|||
127892211|NCT02995837|460227522|FG001|Overall Study|Lost to Follow-up|8|||
127892212|NCT01077713|460227523|FG000|Overall Study|Withdrawal by Subject|1|||
127892213|NCT01077713|460227524|FG001|Overall Study|Withdrawal by Subject|2|||
127892214|NCT01077713|460227523|FG000|Overall Study|Progressive Disease (PD)|0|||
127892215|NCT01077713|460227524|FG001|Overall Study|Progressive Disease (PD)|1|||
127892216|NCT01077713|460227523|FG000|Overall Study|Death|28|||
127892217|NCT01077713|460227524|FG001|Overall Study|Death|29|||
127892218|NCT01077713|460227523|FG000|Overall Study|Lost to Follow-up|1|||
127892219|NCT01077713|460227524|FG001|Overall Study|Lost to Follow-up|1|||
127892220|NCT01077713|460227523|FG000|Overall Study|Adverse Event|2|||
127892221|NCT01077713|460227524|FG001|Overall Study|Adverse Event|1|||
127892222|NCT01077713|460227523|FG000|Overall Study|Other|4|||
127892223|NCT01077713|460227524|FG001|Overall Study|Other|2|||
127892224|NCT00289458|460227525|FG000|Overall Study|Death|1|||
127892225|NCT00289458|460227526|FG001|Overall Study|Death|0|||
127892226|NCT00289458|460227527|FG002|Overall Study|Death|0|||
127892227|NCT00289458|460227525|FG000|Overall Study|Physician Decision|3|||
127892228|NCT00289458|460227526|FG001|Overall Study|Physician Decision|4|||
127892229|NCT00289458|460227527|FG002|Overall Study|Physician Decision|2|||
127892230|NCT00289458|460227525|FG000|Overall Study|Withdrawal by Subject|2|||
127892231|NCT00289458|460227526|FG001|Overall Study|Withdrawal by Subject|2|||
127892232|NCT00289458|460227527|FG002|Overall Study|Withdrawal by Subject|4|||
127892233|NCT00874757|460227528|FG000|Overall Study|Baseline laboratories outside of normal limits (screen fails).|4|||
127892234|NCT01144663|460229493|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
127892235|NCT01144663|460229494|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
127892236|NCT01144663|460229495|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
127892237|NCT01144663|460229496|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
127892238|NCT01144663|460229493|FG000|Primary Vaccination Phase|Adverse Event|1|||
127892239|NCT01144663|460229494|FG001|Primary Vaccination Phase|Adverse Event|0|||
127892240|NCT01144663|460229495|FG002|Primary Vaccination Phase|Adverse Event|0|||
127892241|NCT01144663|460229496|FG003|Primary Vaccination Phase|Adverse Event|1|||
127892242|NCT01144663|460229493|FG000|Primary Vaccination Phase|Protocol Violation|2|||
127892243|NCT01144663|460229494|FG001|Primary Vaccination Phase|Protocol Violation|0|||
127892244|NCT01144663|460229495|FG002|Primary Vaccination Phase|Protocol Violation|1|||
127892245|NCT01144663|460229496|FG003|Primary Vaccination Phase|Protocol Violation|0|||
127892246|NCT01144663|460229493|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
127892247|NCT01144663|460229494|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
127892248|NCT01144663|460229495|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
127892249|NCT01144663|460229496|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
127892250|NCT01144663|460229493|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
127892251|NCT01144663|460229494|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
127892252|NCT01144663|460229495|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
127892253|NCT01144663|460229496|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
127892254|NCT01144663|460229493|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
127892255|NCT01144663|460229494|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
127892256|NCT01144663|460229495|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
127892257|NCT01144663|460229496|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
127892258|NCT01144663|460229493|FG000|Primary Vaccination Phase|Other|0|||
127892259|NCT01144663|460229494|FG001|Primary Vaccination Phase|Other|1|||
127892260|NCT01144663|460229495|FG002|Primary Vaccination Phase|Other|0|||
127892261|NCT01144663|460229496|FG003|Primary Vaccination Phase|Other|2|||
127892262|NCT01144663|460229493|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
127892263|NCT01144663|460229494|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
127892264|NCT01144663|460229495|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
127892265|NCT01144663|460229496|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
127892266|NCT01144663|460229493|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
127734951|NCT00111839|459655269|FG002|Overall Study|Withdrawal by Subject|2|||
127734952|NCT00111839|459655267|FG000|Overall Study|Lost to Follow-up|1|||
127892267|NCT01144663|460229494|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
127892268|NCT01144663|460229495|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
127892269|NCT01144663|460229496|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
127892270|NCT01144663|460229493|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
127892271|NCT01144663|460229494|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
127892272|NCT01144663|460229495|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
127892273|NCT01144663|460229496|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
127892274|NCT01144663|460229493|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
127892275|NCT01144663|460229494|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
127892276|NCT01144663|460229495|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
127892277|NCT01144663|460229496|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
127892278|NCT01144663|460229493|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
127892279|NCT01144663|460229494|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
127892280|NCT01144663|460229495|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
127892281|NCT01144663|460229496|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
127892282|NCT01144663|460229493|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
127892283|NCT01144663|460229494|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
127892284|NCT01144663|460229495|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
127734953|NCT00111839|459655268|FG001|Overall Study|Lost to Follow-up|0|||
127734954|NCT00111839|459655269|FG002|Overall Study|Lost to Follow-up|0|||
127734955|NCT00111839|459655267|FG000|Overall Study|Logistical Constraint|1|||
127734956|NCT00111839|459655268|FG001|Overall Study|Logistical Constraint|0|||
127734957|NCT00111839|459655269|FG002|Overall Study|Logistical Constraint|0|||
127734958|NCT00111839|459655267|FG000|Overall Study|Other|6|||
127734959|NCT00111839|459655268|FG001|Overall Study|Other|3|||
127734960|NCT00111839|459655269|FG002|Overall Study|Other|3|||
127734961|NCT00111839|459655267|FG000|Overall Study|Randomized but Not Treated|0|||
127734962|NCT00111839|459655268|FG001|Overall Study|Randomized but Not Treated|0|||
127734963|NCT00111839|459655269|FG002|Overall Study|Randomized but Not Treated|2|||
127892285|NCT01144663|460229496|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
127892286|NCT01335477|460229498|FG000|Overall Study|Adverse Event|30|||
127892287|NCT01335477|460229499|FG001|Overall Study|Adverse Event|42|||
127892288|NCT01335477|460229498|FG000|Overall Study|Non compliant with protocol|0|||
127892289|NCT01335477|460229499|FG001|Overall Study|Non compliant with protocol|2|||
127892290|NCT01335477|460229498|FG000|Overall Study|Lost to Follow-up|1|||
127892291|NCT01335477|460229499|FG001|Overall Study|Lost to Follow-up|2|||
127892292|NCT01335477|460229498|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
127892293|NCT01335477|460229499|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
127892294|NCT01335477|460229498|FG000|Overall Study|Not treated|1|||
127892295|NCT01335477|460229499|FG001|Overall Study|Not treated|2|||
127892296|NCT01335477|460229498|FG000|Overall Study|Reason other than those stated above|2|||
127892297|NCT01335477|460229499|FG001|Overall Study|Reason other than those stated above|2|||
127892298|NCT02497391|460229502|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
127892299|NCT02497391|460229503|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
127892300|NCT02497391|460229504|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
127892301|NCT02497391|460229505|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
127892302|NCT02497391|460229506|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
127892303|NCT02497391|460229507|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
127892304|NCT02497391|460229502|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
127892305|NCT02497391|460229503|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
127892306|NCT02497391|460229504|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
127892307|NCT02497391|460229505|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
127892308|NCT02497391|460229506|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
127892309|NCT02497391|460229507|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
127892310|NCT02497391|460229502|FG000|Period 3 (14 Days)|Adverse Event|0|||
127892311|NCT02497391|460229503|FG001|Period 3 (14 Days)|Adverse Event|1|||
127892312|NCT02497391|460229504|FG002|Period 3 (14 Days)|Adverse Event|0|||
127734964|NCT01011049|459655270|FG000|Overall Study|Protocol Violation|0|||
127892313|NCT02497391|460229505|FG003|Period 3 (14 Days)|Adverse Event|0|||
127892314|NCT02497391|460229506|FG004|Period 3 (14 Days)|Adverse Event|0|||
127734965|NCT01011049|459655271|FG001|Overall Study|Protocol Violation|0|||
127734966|NCT01011049|459655272|FG002|Overall Study|Protocol Violation|2|||
127734967|NCT01011049|459655273|FG003|Overall Study|Protocol Violation|0|||
127734968|NCT01011049|459655270|FG000|Overall Study|Lost to Follow-up|1|||
127734969|NCT01011049|459655271|FG001|Overall Study|Lost to Follow-up|2|||
127734970|NCT01011049|459655272|FG002|Overall Study|Lost to Follow-up|1|||
127734971|NCT01011049|459655273|FG003|Overall Study|Lost to Follow-up|0|||
127734972|NCT01011049|459655270|FG000|Overall Study|Withdrawal by Subject|0|||
127734973|NCT01011049|459655271|FG001|Overall Study|Withdrawal by Subject|0|||
127734974|NCT01011049|459655272|FG002|Overall Study|Withdrawal by Subject|1|||
127734975|NCT01011049|459655273|FG003|Overall Study|Withdrawal by Subject|0|||
127734976|NCT00352053|459655279|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
127734977|NCT00352053|459655280|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
127734978|NCT00352053|459655279|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
127734979|NCT00352053|459655280|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
127734980|NCT00352053|459655279|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
127734981|NCT00352053|459655280|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
127734982|NCT00352053|459655279|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
127892315|NCT02497391|460229507|FG005|Period 3 (14 Days)|Adverse Event|0|||
127734983|NCT00352053|459655280|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
127734984|NCT00352053|459655279|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
127734985|NCT00352053|459655280|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
127734986|NCT00352053|459655279|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
127734987|NCT00352053|459655280|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
127734988|NCT00352053|459655279|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
127734989|NCT00352053|459655280|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
127892316|NCT02497391|460229502|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
127892317|NCT02497391|460229503|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
127892318|NCT02497391|460229504|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
127734990|NCT00352053|459655279|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
127734991|NCT00352053|459655280|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
127734992|NCT00352053|459655279|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
127734993|NCT00352053|459655280|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
127805891|NCT00849017|459911145|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
127805892|NCT00849017|459911146|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
127805893|NCT00849017|459911144|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
127805894|NCT00849017|459911145|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
127805895|NCT00849017|459911146|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
127805896|NCT00849017|459911144|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
127805897|NCT00849017|459911145|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
127805898|NCT00849017|459911146|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
127805899|NCT00849017|459911144|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
127805900|NCT00849017|459911145|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
127805901|NCT00849017|459911146|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
127805902|NCT00849017|459911144|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
127805903|NCT00849017|459911145|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
127734994|NCT00352053|459655279|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
127734995|NCT00352053|459655280|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
127734996|NCT00352053|459655279|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
127734997|NCT00352053|459655280|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
127734998|NCT00352053|459655279|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
127734999|NCT00352053|459655280|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
127735000|NCT00352053|459655279|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
127735001|NCT00352053|459655280|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
127735002|NCT00520403|459655281|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
127735003|NCT00520403|459655281|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
127735004|NCT00520403|459655281|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
127735005|NCT00520403|459655281|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
127735006|NCT00520403|459655281|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
127735007|NCT00520403|459655281|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
127805904|NCT00849017|459911146|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
127805905|NCT05254418|459911150|FG000|Overall Study|Adverse Event|2|||
127805906|NCT03624946|459911155|FG000|Overall Study|Lost to Follow-up|0|||
127805907|NCT03624946|459911156|FG001|Overall Study|Lost to Follow-up|1|||
127805908|NCT01869348|459911158|FG000|Overall Study|Withdrawal by Subject|1|||
127805909|NCT01869348|459911159|FG001|Overall Study|Withdrawal by Subject|1|||
127805910|NCT00624520|459911160|FG000|Overall Study|Withdrawal by Subject|12|||
127805911|NCT00624520|459911161|FG001|Overall Study|Withdrawal by Subject|7|||
127805912|NCT00624520|459911160|FG000|Overall Study|Death|0|||
127805913|NCT00624520|459911161|FG001|Overall Study|Death|1|||
127805914|NCT01925209|459911162|FG000|Treatment Epoch|Physician Decision|1|||
127805915|NCT01925209|459911163|FG001|Treatment Epoch|Physician Decision|0|||
127805916|NCT01925209|459911164|FG002|Treatment Epoch|Physician Decision|0|||
127805917|NCT01925209|459911165|FG003|Treatment Epoch|Physician Decision|0|||
127805918|NCT01925209|459911162|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
127805919|NCT01925209|459911163|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
127805920|NCT01925209|459911164|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
127805921|NCT01925209|459911165|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
127805922|NCT01925209|459911162|FG000|Treatment Epoch|Death|1|||
127805923|NCT01925209|459911163|FG001|Treatment Epoch|Death|0|||
127805924|NCT01925209|459911164|FG002|Treatment Epoch|Death|0|||
127805925|NCT01925209|459911165|FG003|Treatment Epoch|Death|0|||
127805926|NCT01925209|459911162|FG000|Treatment Epoch|Protocol deviation|0|||
127805927|NCT01925209|459911163|FG001|Treatment Epoch|Protocol deviation|0|||
127805928|NCT01925209|459911164|FG002|Treatment Epoch|Protocol deviation|1|||
127805929|NCT01925209|459911165|FG003|Treatment Epoch|Protocol deviation|1|||
127805930|NCT01925209|459911162|FG000|Treatment Epoch|Withdrawal by Subject|4|||
127805931|NCT01925209|459911163|FG001|Treatment Epoch|Withdrawal by Subject|3|||
127805932|NCT01925209|459911164|FG002|Treatment Epoch|Withdrawal by Subject|3|||
127805933|NCT01925209|459911165|FG003|Treatment Epoch|Withdrawal by Subject|2|||
127805934|NCT01925209|459911162|FG000|Treatment Epoch|Adverse Event|3|||
127805935|NCT01925209|459911163|FG001|Treatment Epoch|Adverse Event|5|||
127805936|NCT01925209|459911164|FG002|Treatment Epoch|Adverse Event|3|||
127805937|NCT01925209|459911165|FG003|Treatment Epoch|Adverse Event|1|||
127805938|NCT01925209|459911162|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
127805939|NCT01925209|459911163|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
127805940|NCT01925209|459911164|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
127805941|NCT01925209|459911165|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
127892319|NCT02497391|460229505|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
127735008|NCT00520403|459655281|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
127735009|NCT00520403|459655281|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
127735010|NCT01145417|459655282|FG000|Overall Study|Death|1|||
127735011|NCT01145417|459655283|FG001|Overall Study|Death|0|||
127735012|NCT01145417|459655282|FG000|Overall Study|Lost to Follow-up|2|||
127805942|NCT01925209|459911162|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
127805943|NCT01925209|459911163|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
127805944|NCT01925209|459911164|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
127805945|NCT01925209|459911165|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
127805946|NCT01925209|459911162|FG000|Follow-up|Adverse Event|1|||
127805947|NCT01925209|459911163|FG001|Follow-up|Adverse Event|4|||
127805948|NCT01925209|459911164|FG002|Follow-up|Adverse Event|0|||
127805949|NCT01925209|459911165|FG003|Follow-up|Adverse Event|1|||
127805950|NCT01925209|459911162|FG000|Follow-up|Physician Decision|0|||
127805951|NCT01925209|459911163|FG001|Follow-up|Physician Decision|0|||
127805952|NCT01925209|459911164|FG002|Follow-up|Physician Decision|1|||
127805953|NCT01925209|459911165|FG003|Follow-up|Physician Decision|0|||
127805954|NCT01925209|459911162|FG000|Follow-up|Non-compliance with study treatment|0|||
127805955|NCT01925209|459911163|FG001|Follow-up|Non-compliance with study treatment|0|||
127805956|NCT01925209|459911164|FG002|Follow-up|Non-compliance with study treatment|0|||
127805957|NCT01925209|459911165|FG003|Follow-up|Non-compliance with study treatment|1|||
127805958|NCT01925209|459911162|FG000|Follow-up|Withdrawal by Subject|0|||
127805959|NCT01925209|459911163|FG001|Follow-up|Withdrawal by Subject|2|||
127805960|NCT01925209|459911164|FG002|Follow-up|Withdrawal by Subject|0|||
127805961|NCT01925209|459911165|FG003|Follow-up|Withdrawal by Subject|2|||
127805962|NCT03075163|459911166|FG000|Overall Study|not eligible for treatment limb|138|||
127805963|NCT03075163|459911167|FG001|Overall Study|not eligible for treatment limb|138|||
127805964|NCT02796755|459911168|FG000|Overall Study|Adverse Event|2|||
127805965|NCT02796755|459911169|FG001|Overall Study|Adverse Event|0|||
127805966|NCT00110994|459911170|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
127805967|NCT00110994|459911171|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
127805968|NCT00110994|459911170|FG000|Double-blind (DB) Treatment|Death|1|||
127805969|NCT00110994|459911171|FG001|Double-blind (DB) Treatment|Death|0|||
127805970|NCT00110994|459911170|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
127805971|NCT00110994|459911171|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
127805972|NCT00110994|459911170|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
127805973|NCT00110994|459911171|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
127805974|NCT00110994|459911170|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
127805975|NCT00110994|459911171|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
127805976|NCT00110994|459911170|FG000|Double-blind (DB) Treatment|other reasons|2|||
127805977|NCT00110994|459911171|FG001|Double-blind (DB) Treatment|other reasons|3|||
127805978|NCT00110994|459911170|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
127805979|NCT00110994|459911171|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
127805980|NCT00110994|459911170|FG000|Active Follow-up|Other reasons|0|||
127805981|NCT00110994|459911171|FG001|Active Follow-up|Other reasons|2|||
127805982|NCT00110994|459911170|FG000|Long Term Follow-up|Death|19|||
127805983|NCT00110994|459911171|FG001|Long Term Follow-up|Death|17|||
127805984|NCT00556426|459911175|FG000|Overall Study|Withdrawal by Subject|3|||
127805985|NCT00556426|459911175|FG000|Overall Study|Death|6|||
127805986|NCT01570244|459911176|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
127805987|NCT00792298|459911182|FG000|Treatment Period 1|Adverse Event|0|||
127805988|NCT00792298|459911183|FG001|Treatment Period 1|Adverse Event|1|||
127805989|NCT00792298|459911184|FG002|Treatment Period 1|Adverse Event|0|||
127805990|NCT00792298|459911185|FG003|Treatment Period 1|Adverse Event|1|||
127805991|NCT00792298|459911186|FG004|Treatment Period 1|Adverse Event|0|||
127805992|NCT00792298|459911187|FG005|Treatment Period 1|Adverse Event|1|||
127805993|NCT00792298|459911188|FG006|Treatment Period 1|Adverse Event|1|||
127805994|NCT00792298|459911189|FG007|Treatment Period 1|Adverse Event|0|||
127805995|NCT00792298|459911182|FG000|Treatment Period 1|Lack of Efficacy|0|||
127805996|NCT00792298|459911183|FG001|Treatment Period 1|Lack of Efficacy|0|||
127805997|NCT00792298|459911184|FG002|Treatment Period 1|Lack of Efficacy|1|||
127805998|NCT00792298|459911185|FG003|Treatment Period 1|Lack of Efficacy|0|||
127805999|NCT00792298|459911186|FG004|Treatment Period 1|Lack of Efficacy|0|||
127806000|NCT00792298|459911187|FG005|Treatment Period 1|Lack of Efficacy|0|||
127806001|NCT00792298|459911188|FG006|Treatment Period 1|Lack of Efficacy|0|||
127806002|NCT00792298|459911189|FG007|Treatment Period 1|Lack of Efficacy|0|||
127806003|NCT00792298|459911182|FG000|Treatment Period 1|Withdrawal by Subject|1|||
127806004|NCT00792298|459911183|FG001|Treatment Period 1|Withdrawal by Subject|0|||
127806005|NCT00792298|459911184|FG002|Treatment Period 1|Withdrawal by Subject|1|||
127806006|NCT00792298|459911185|FG003|Treatment Period 1|Withdrawal by Subject|2|||
127806007|NCT00792298|459911186|FG004|Treatment Period 1|Withdrawal by Subject|0|||
127806008|NCT00792298|459911187|FG005|Treatment Period 1|Withdrawal by Subject|2|||
127806009|NCT00792298|459911188|FG006|Treatment Period 1|Withdrawal by Subject|1|||
127806010|NCT00792298|459911189|FG007|Treatment Period 1|Withdrawal by Subject|0|||
127806011|NCT00792298|459911182|FG000|Treatment Period 1|Lost to Follow-up|0|||
127806012|NCT00792298|459911183|FG001|Treatment Period 1|Lost to Follow-up|0|||
127806013|NCT00792298|459911184|FG002|Treatment Period 1|Lost to Follow-up|0|||
127806014|NCT00792298|459911185|FG003|Treatment Period 1|Lost to Follow-up|0|||
127806015|NCT00792298|459911186|FG004|Treatment Period 1|Lost to Follow-up|0|||
127806016|NCT00792298|459911187|FG005|Treatment Period 1|Lost to Follow-up|0|||
127806017|NCT00792298|459911188|FG006|Treatment Period 1|Lost to Follow-up|1|||
127892320|NCT02497391|460229506|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
127892321|NCT02497391|460229507|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
127892322|NCT02497391|460229502|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
127892323|NCT02497391|460229503|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
127892324|NCT02497391|460229504|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
127892325|NCT02497391|460229505|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
127892326|NCT02497391|460229506|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
127892327|NCT02497391|460229507|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
127892328|NCT03031899|460229508|FG000|Overall Study|Protocol Violation|1|||
127892329|NCT03031899|460229508|FG000|Overall Study|lesion disappeared after stopping habit|1|||
127892330|NCT03740698|460229509|FG000|Overall Study|Physician Decision|0|||
127892331|NCT03740698|460229510|FG001|Overall Study|Physician Decision|1|||
127892332|NCT03740698|460229511|FG002|Overall Study|Physician Decision|1|||
127892333|NCT01469364|460229512|FG000|Overall Study|Adverse Event|1|||
127892334|NCT01469364|460229512|FG000|Overall Study|Withdrawal by Subject|1|||
127892335|NCT03433001|460229515|FG000|Overall Study|Lack of Efficacy|109|||
127892336|NCT03433001|460229515|FG000|Overall Study|Adverse Event|69|||
127892337|NCT03433001|460229515|FG000|Overall Study|Withdrawal by Subject|10|||
127892338|NCT03433001|460229515|FG000|Overall Study|Death|12|||
127892339|NCT03433001|460229515|FG000|Overall Study|Lost to Follow-up|4|||
127892340|NCT03433001|460229515|FG000|Overall Study|Other|25|||
127892341|NCT01162499|460229516|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
127892342|NCT01162499|460229517|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
127892343|NCT02040428|460229518|FG000|Overall Study|Death|4|||
127892344|NCT02040428|460229519|FG001|Overall Study|Death|3|||
127892345|NCT02040428|460229518|FG000|Overall Study|Withdrawal by Subject|1|||
127892346|NCT02040428|460229519|FG001|Overall Study|Withdrawal by Subject|1|||
127892347|NCT01165996|460229520|FG000|Overall Study|Death|1|||
127892348|NCT01165996|460229520|FG000|Overall Study|Physician Decision|1|||
127892349|NCT01399723|460229521|FG000|Overall Study|Lost to Follow-up|0|||
127892350|NCT01399723|460229522|FG001|Overall Study|Lost to Follow-up|1|||
127892351|NCT00294723|460229526|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
127892352|NCT00294723|460229527|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
127892353|NCT00294723|460229528|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
127735013|NCT01145417|459655283|FG001|Overall Study|Lost to Follow-up|1|||
127735014|NCT01145417|459655282|FG000|Overall Study|Withdrawal by Subject|1|||
127735015|NCT01145417|459655283|FG001|Overall Study|Withdrawal by Subject|2|||
127892354|NCT00294723|460229526|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
127892355|NCT00294723|460229527|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
127892356|NCT00294723|460229528|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
127892357|NCT00294723|460229526|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
127892358|NCT00294723|460229527|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
127892359|NCT00294723|460229528|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
127892360|NCT00294723|460229526|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
127892361|NCT00294723|460229527|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
127892362|NCT00294723|460229528|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
127892363|NCT00294723|460229526|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
127892364|NCT00294723|460229527|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
127892365|NCT00294723|460229528|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
127892366|NCT00294723|460229526|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
127892367|NCT00294723|460229527|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
127892368|NCT00294723|460229528|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
127892369|NCT00294723|460229526|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
127892370|NCT00294723|460229527|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
127892371|NCT00294723|460229528|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
127892372|NCT00294723|460229526|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
127892373|NCT00294723|460229527|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
127892374|NCT00294723|460229528|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
127892375|NCT00294723|460229526|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
127892376|NCT00294723|460229527|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
127892377|NCT00294723|460229528|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
127892378|NCT00294723|460229526|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
127892379|NCT00294723|460229527|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
127892380|NCT00294723|460229528|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
127892381|NCT00294723|460229526|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
127892382|NCT00294723|460229527|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
127892383|NCT00294723|460229528|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
127735016|NCT01145417|459655282|FG000|Overall Study|Pregnancy|1|||
127735017|NCT01145417|459655283|FG001|Overall Study|Pregnancy|0|||
127735018|NCT01145417|459655282|FG000|Overall Study|Adverse Event|0|||
127735019|NCT01145417|459655283|FG001|Overall Study|Adverse Event|1|||
127735020|NCT01145417|459655282|FG000|Overall Study|Study terminated by sponsor|35|||
127735021|NCT01145417|459655283|FG001|Overall Study|Study terminated by sponsor|43|||
127735022|NCT01145417|459655282|FG000|Overall Study|Other|1|||
127735023|NCT01145417|459655283|FG001|Overall Study|Other|0|||
127735024|NCT02435381|459655284|FG000|Overall Study|Lost to Follow-up|2|||
127735025|NCT02435381|459655285|FG001|Overall Study|Lost to Follow-up|1|||
127735026|NCT01066897|459655286|FG000|Overall Study|Withdrawal by Subject|1|||
127735027|NCT01066897|459655287|FG001|Overall Study|Withdrawal by Subject|0|||
127735028|NCT01066897|459655286|FG000|Overall Study|stopped study after developing the flu.|1|||
127735029|NCT01066897|459655287|FG001|Overall Study|stopped study after developing the flu.|0|||
127735030|NCT00139659|459655292|FG000|Overall Study|Adverse Event|12|||
127735031|NCT00139659|459655293|FG001|Overall Study|Adverse Event|1|||
127735032|NCT00139659|459655292|FG000|Overall Study|Lack of Efficacy|1|||
127735033|NCT00139659|459655293|FG001|Overall Study|Lack of Efficacy|1|||
127735034|NCT00139659|459655292|FG000|Overall Study|Lost to Follow-up|7|||
127735035|NCT00139659|459655293|FG001|Overall Study|Lost to Follow-up|3|||
127735036|NCT00139659|459655292|FG000|Overall Study|Reason not Specified|6|||
127735037|NCT00139659|459655293|FG001|Overall Study|Reason not Specified|3|||
127735038|NCT00139659|459655292|FG000|Overall Study|Withdrawal by Subject|14|||
127735039|NCT00139659|459655293|FG001|Overall Study|Withdrawal by Subject|10|||
127735040|NCT02391116|459655296|FG000|Treatment|Withdrawal by Subject|1|||
127735041|NCT02391116|459655296|FG000|Treatment|Protocol Violation|1|||
127735042|NCT02391116|459655296|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
127735043|NCT02391116|459655296|FG000|Treatment|AE with Clinical PD|3|||
127735044|NCT02391116|459655296|FG000|Safety Follow-up|Adverse Event|1|||
127735045|NCT02391116|459655296|FG000|Safety Follow-up|Withdrawal by Subject|4|||
127735046|NCT02391116|459655296|FG000|Safety Follow-up|Switching to Other Therapy|4|||
127735047|NCT02391116|459655296|FG000|Safety Follow-up|No Follow Up|1|||
127735048|NCT02391116|459655296|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
127735049|NCT02391116|459655296|FG000|Active Follow-up|Withdrawal by Subject|1|||
127735050|NCT02391116|459655296|FG000|Active Follow-up|Switching to Other Therapy|2|||
127735051|NCT02391116|459655296|FG000|Survival Follow-up|Withdrawal by Subject|3|||
127735052|NCT02391116|459655296|FG000|Survival Follow-up|Switching to Other Therapy|1|||
127735053|NCT02282917|459655298|FG000|Overall Study|Withdrawal by Subject|1|||
127806018|NCT00792298|459911189|FG007|Treatment Period 1|Lost to Follow-up|0|||
127806019|NCT00792298|459911182|FG000|Treatment Period 1|Physician Decision|0|||
127806020|NCT00792298|459911183|FG001|Treatment Period 1|Physician Decision|0|||
127806021|NCT00792298|459911184|FG002|Treatment Period 1|Physician Decision|0|||
127806022|NCT00792298|459911185|FG003|Treatment Period 1|Physician Decision|1|||
127806023|NCT00792298|459911186|FG004|Treatment Period 1|Physician Decision|0|||
127806024|NCT00792298|459911187|FG005|Treatment Period 1|Physician Decision|0|||
127806025|NCT00792298|459911188|FG006|Treatment Period 1|Physician Decision|1|||
127806026|NCT00792298|459911189|FG007|Treatment Period 1|Physician Decision|0|||
127806027|NCT00792298|459911182|FG000|Treatment Period 1|Protocol Violation|0|||
127806028|NCT00792298|459911183|FG001|Treatment Period 1|Protocol Violation|0|||
127806029|NCT00792298|459911184|FG002|Treatment Period 1|Protocol Violation|0|||
127735054|NCT02282917|459655298|FG000|Overall Study|Screen Failure/Not Eligible|1|||
127735055|NCT01747629|459655299|FG000|Overall Study|Adverse Event|1|||
127735056|NCT01747629|459655300|FG001|Overall Study|Adverse Event|2|||
127735057|NCT01747629|459655299|FG000|Overall Study|Withdrawal by Subject|2|||
127735058|NCT01747629|459655300|FG001|Overall Study|Withdrawal by Subject|2|||
127735059|NCT01747629|459655299|FG000|Overall Study|Noncompliance|1|||
127735060|NCT01747629|459655300|FG001|Overall Study|Noncompliance|1|||
127735061|NCT01747629|459655299|FG000|Overall Study|Inclusion criteria not met|1|||
127806030|NCT00792298|459911185|FG003|Treatment Period 1|Protocol Violation|0|||
127806031|NCT00792298|459911186|FG004|Treatment Period 1|Protocol Violation|0|||
127806032|NCT00792298|459911187|FG005|Treatment Period 1|Protocol Violation|0|||
127735062|NCT01747629|459655300|FG001|Overall Study|Inclusion criteria not met|0|||
127735063|NCT01747629|459655299|FG000|Overall Study|Not treated|1|||
127735064|NCT01747629|459655300|FG001|Overall Study|Not treated|0|||
127735065|NCT01747629|459655299|FG000|Overall Study|Other|2|||
127735066|NCT01747629|459655300|FG001|Overall Study|Other|1|||
127735067|NCT04414397|459655301|FG000|Control Period|Withdrawal by Subject|2|||
127735068|NCT04414397|459655302|FG001|Control Period|Withdrawal by Subject|2|||
127735069|NCT04414397|459655301|FG000|Control Period|Lost to Follow-up|0|||
127735070|NCT04414397|459655302|FG001|Control Period|Lost to Follow-up|4|||
127806033|NCT00792298|459911188|FG006|Treatment Period 1|Protocol Violation|0|||
127892384|NCT00294723|460229526|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
127892385|NCT00294723|460229527|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
127892386|NCT00294723|460229528|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
127892387|NCT00752791|460229529|FG000|Overall Study|Adverse Event|7|||
127892388|NCT00752791|460229529|FG000|Overall Study|Withdrawal by Subject|1|||
127892389|NCT00752791|460229529|FG000|Overall Study|Physician Decision|1|||
127892390|NCT00752791|460229529|FG000|Overall Study|Death|1|||
127892391|NCT00752791|460229529|FG000|Overall Study|Renal transplant|3|||
127892392|NCT00752791|460229529|FG000|Overall Study|Switched to hemodialysis|2|||
127892393|NCT00752791|460229529|FG000|Overall Study|Protocol deviation|1|||
127892394|NCT01992107|460229530|FG000|Overall Study|Administrative reasons|2|||
127892395|NCT01992107|460229531|FG001|Overall Study|Administrative reasons|0|||
127892396|NCT01992107|460229532|FG002|Overall Study|Administrative reasons|0|||
127892397|NCT01992107|460229530|FG000|Overall Study|Adverse Event|0|||
127892398|NCT01992107|460229531|FG001|Overall Study|Adverse Event|1|||
127892399|NCT01992107|460229532|FG002|Overall Study|Adverse Event|0|||
127892400|NCT01992107|460229530|FG000|Overall Study|Lost to Follow-up|46|||
127892401|NCT01992107|460229531|FG001|Overall Study|Lost to Follow-up|22|||
127892402|NCT01992107|460229532|FG002|Overall Study|Lost to Follow-up|26|||
127892403|NCT01992107|460229530|FG000|Overall Study|noncompliance and were unavailable|7|||
127892404|NCT01992107|460229531|FG001|Overall Study|noncompliance and were unavailable|3|||
127892405|NCT01992107|460229532|FG002|Overall Study|noncompliance and were unavailable|2|||
127892406|NCT01992107|460229530|FG000|Overall Study|Withdrawal by Subject|13|||
127892407|NCT01992107|460229531|FG001|Overall Study|Withdrawal by Subject|7|||
127892408|NCT01992107|460229532|FG002|Overall Study|Withdrawal by Subject|8|||
127892409|NCT02087046|460229535|FG000|Overall Study|Adverse Event|4|||
127892410|NCT02087046|460229535|FG000|Overall Study|Death|1|||
127892411|NCT02087046|460229535|FG000|Overall Study|Lost to Follow-up|3|||
127892412|NCT02087046|460229535|FG000|Overall Study|Withdrawal by Subject|2|||
127892413|NCT02087046|460229535|FG000|Overall Study|Physician Decision|1|||
127892414|NCT01214603|460229536|FG000|Overall Study|Adverse Event|0|||
127892415|NCT01214603|460229537|FG001|Overall Study|Adverse Event|0|||
127892416|NCT01214603|460229538|FG002|Overall Study|Adverse Event|1|||
127892417|NCT01214603|460229536|FG000|Overall Study|Death|1|||
127892418|NCT01214603|460229537|FG001|Overall Study|Death|0|||
127892419|NCT01214603|460229538|FG002|Overall Study|Death|0|||
127892420|NCT01214603|460229536|FG000|Overall Study|Progressive Disease|4|||
127892421|NCT01214603|460229537|FG001|Overall Study|Progressive Disease|1|||
127892422|NCT01214603|460229538|FG002|Overall Study|Progressive Disease|3|||
127892423|NCT01388647|460229539|FG000|Overall Study|Adverse Event|1|||
127892424|NCT01388647|460229540|FG001|Overall Study|Adverse Event|2|||
127892425|NCT02444533|460229541|FG000|Overall Study|Not able to complete forms|0|||
127892426|NCT02444533|460229542|FG001|Overall Study|Not able to complete forms|2|||
127892427|NCT02444533|460229541|FG000|Overall Study|Only gave post-procedure complications|2|||
127892428|NCT02444533|460229542|FG001|Overall Study|Only gave post-procedure complications|2|||
127892429|NCT03567057|460229544|FG000|Overall Study|Adverse Event|56|||
127892430|NCT03567057|460229545|FG001|Overall Study|Adverse Event|53|||
127892431|NCT03567057|460229546|FG002|Overall Study|Adverse Event|28|||
127892432|NCT03567057|460229544|FG000|Overall Study|Withdrawal by Subject|22|||
127892433|NCT03567057|460229545|FG001|Overall Study|Withdrawal by Subject|24|||
127892434|NCT03567057|460229546|FG002|Overall Study|Withdrawal by Subject|13|||
127892435|NCT03567057|460229544|FG000|Overall Study|Lost to Follow-up|3|||
127892436|NCT03567057|460229545|FG001|Overall Study|Lost to Follow-up|5|||
127892437|NCT03567057|460229546|FG002|Overall Study|Lost to Follow-up|2|||
127892438|NCT03567057|460229544|FG000|Overall Study|COVID-19 pandemic|4|||
127892439|NCT03567057|460229545|FG001|Overall Study|COVID-19 pandemic|3|||
127892440|NCT03567057|460229546|FG002|Overall Study|COVID-19 pandemic|0|||
127892441|NCT03567057|460229544|FG000|Overall Study|Non-compliance with study drug|4|||
127892442|NCT03567057|460229545|FG001|Overall Study|Non-compliance with study drug|2|||
127806034|NCT00792298|459911189|FG007|Treatment Period 1|Protocol Violation|1|||
127806035|NCT00792298|459911182|FG000|Washout|Adverse Event|0|||
127806036|NCT00792298|459911183|FG001|Washout|Adverse Event|0|||
127806037|NCT00792298|459911184|FG002|Washout|Adverse Event|0|||
127806038|NCT00792298|459911185|FG003|Washout|Adverse Event|0|||
127806039|NCT00792298|459911186|FG004|Washout|Adverse Event|0|||
127806040|NCT00792298|459911187|FG005|Washout|Adverse Event|1|||
127806041|NCT00792298|459911188|FG006|Washout|Adverse Event|0|||
127806042|NCT00792298|459911189|FG007|Washout|Adverse Event|0|||
127806043|NCT00792298|459911182|FG000|Washout|Withdrawal by Subject|0|||
127892443|NCT03567057|460229546|FG002|Overall Study|Non-compliance with study drug|0|||
127892444|NCT03567057|460229544|FG000|Overall Study|Lack of Efficacy|3|||
127892445|NCT03567057|460229545|FG001|Overall Study|Lack of Efficacy|0|||
127806044|NCT00792298|459911183|FG001|Washout|Withdrawal by Subject|0|||
127735071|NCT04414397|459655301|FG000|Control Period|Protocol deviation|0|||
127735072|NCT04414397|459655302|FG001|Control Period|Protocol deviation|1|||
127735073|NCT04414397|459655301|FG000|Post-Control Period|Withdrawal by Subject|3|||
127735074|NCT04414397|459655302|FG001|Post-Control Period|Withdrawal by Subject|6|||
127735075|NCT04414397|459655301|FG000|Post-Control Period|Lost to Follow-up|4|||
127735076|NCT04414397|459655302|FG001|Post-Control Period|Lost to Follow-up|9|||
127806045|NCT00792298|459911184|FG002|Washout|Withdrawal by Subject|1|||
127806046|NCT00792298|459911185|FG003|Washout|Withdrawal by Subject|0|||
127806047|NCT00792298|459911186|FG004|Washout|Withdrawal by Subject|0|||
127806048|NCT00792298|459911187|FG005|Washout|Withdrawal by Subject|1|||
127806049|NCT00792298|459911188|FG006|Washout|Withdrawal by Subject|0|||
127806050|NCT00792298|459911189|FG007|Washout|Withdrawal by Subject|0|||
127806051|NCT00792298|459911182|FG000|Treatment Period 2|Lack of Efficacy|0|||
127806052|NCT00792298|459911183|FG001|Treatment Period 2|Lack of Efficacy|0|||
127806053|NCT00792298|459911184|FG002|Treatment Period 2|Lack of Efficacy|0|||
127806054|NCT00792298|459911185|FG003|Treatment Period 2|Lack of Efficacy|0|||
127806055|NCT00792298|459911186|FG004|Treatment Period 2|Lack of Efficacy|1|||
127806056|NCT00792298|459911187|FG005|Treatment Period 2|Lack of Efficacy|0|||
127806057|NCT00792298|459911188|FG006|Treatment Period 2|Lack of Efficacy|0|||
127806058|NCT00792298|459911189|FG007|Treatment Period 2|Lack of Efficacy|0|||
127806059|NCT00792298|459911182|FG000|Treatment Period 2|Physician Decision|0|||
127806060|NCT00792298|459911183|FG001|Treatment Period 2|Physician Decision|0|||
127806061|NCT00792298|459911184|FG002|Treatment Period 2|Physician Decision|0|||
127806062|NCT00792298|459911185|FG003|Treatment Period 2|Physician Decision|0|||
127806063|NCT00792298|459911186|FG004|Treatment Period 2|Physician Decision|0|||
127806064|NCT00792298|459911187|FG005|Treatment Period 2|Physician Decision|0|||
127806065|NCT00792298|459911188|FG006|Treatment Period 2|Physician Decision|1|||
127806066|NCT00792298|459911189|FG007|Treatment Period 2|Physician Decision|0|||
127806067|NCT00792298|459911182|FG000|Treatment Period 2|Pregnancy|0|||
127806068|NCT00792298|459911183|FG001|Treatment Period 2|Pregnancy|0|||
127806069|NCT00792298|459911184|FG002|Treatment Period 2|Pregnancy|1|||
127806070|NCT00792298|459911185|FG003|Treatment Period 2|Pregnancy|0|||
127806071|NCT00792298|459911186|FG004|Treatment Period 2|Pregnancy|0|||
127806072|NCT00792298|459911187|FG005|Treatment Period 2|Pregnancy|0|||
127806073|NCT00792298|459911188|FG006|Treatment Period 2|Pregnancy|0|||
127806074|NCT00792298|459911189|FG007|Treatment Period 2|Pregnancy|0|||
127806075|NCT00792298|459911182|FG000|Treatment Period 2|Withdrawal by Subject|1|||
127806076|NCT00792298|459911183|FG001|Treatment Period 2|Withdrawal by Subject|1|||
127806077|NCT00792298|459911184|FG002|Treatment Period 2|Withdrawal by Subject|0|||
127806078|NCT00792298|459911185|FG003|Treatment Period 2|Withdrawal by Subject|2|||
127806079|NCT00792298|459911186|FG004|Treatment Period 2|Withdrawal by Subject|1|||
127806080|NCT00792298|459911187|FG005|Treatment Period 2|Withdrawal by Subject|0|||
127806081|NCT00792298|459911188|FG006|Treatment Period 2|Withdrawal by Subject|0|||
127806082|NCT00792298|459911189|FG007|Treatment Period 2|Withdrawal by Subject|2|||
127806083|NCT04258579|459911196|FG000|Overall Study|Withdrawal by Subject|7|||
127806084|NCT04258579|459911196|FG000|Overall Study|Lost to Follow-up|3|||
127806085|NCT04258579|459911196|FG000|Overall Study|Protocol Violation|2|||
127806086|NCT04258579|459911196|FG000|Overall Study|Adverse Event|1|||
127806087|NCT01950819|459911201|FG000|Overall Study|Graft Loss|35|||
127806088|NCT01950819|459911202|FG001|Overall Study|Graft Loss|30|||
127806089|NCT01950819|459911201|FG000|Overall Study|Death|29|||
127806090|NCT01950819|459911202|FG001|Overall Study|Death|34|||
127806091|NCT01950819|459911201|FG000|Overall Study|Subject / Gardian decision|54|||
127806092|NCT01950819|459911202|FG001|Overall Study|Subject / Gardian decision|51|||
127806093|NCT01950819|459911201|FG000|Overall Study|technical problems|2|||
127806094|NCT01950819|459911202|FG001|Overall Study|technical problems|0|||
127806095|NCT01950819|459911201|FG000|Overall Study|Pregnancy|0|||
127806096|NCT01950819|459911202|FG001|Overall Study|Pregnancy|2|||
127806097|NCT01950819|459911201|FG000|Overall Study|Lost to Follow-up|9|||
127806098|NCT01950819|459911202|FG001|Overall Study|Lost to Follow-up|17|||
127806099|NCT04134494|459911204|FG000|Overall Study|Lost to Follow-up|2|||
127806100|NCT00781365|459911205|FG000|Overall Study|Withdrawal by Subject|13|||
127806101|NCT00781365|459911206|FG001|Overall Study|Withdrawal by Subject|8|||
127806102|NCT00781365|459911205|FG000|Overall Study|Did Not Attend Visit|20|||
127806103|NCT00781365|459911206|FG001|Overall Study|Did Not Attend Visit|28|||
127806104|NCT00781365|459911205|FG000|Overall Study|Language barrier|1|||
127806105|NCT00781365|459911206|FG001|Overall Study|Language barrier|0|||
127806106|NCT01879410|459911207|FG000|Overall Study|Adverse Event|9|||
127806107|NCT01879410|459911208|FG001|Overall Study|Adverse Event|14|||
127806108|NCT01879410|459911207|FG000|Overall Study|Lack of Efficacy|4|||
127806109|NCT01879410|459911208|FG001|Overall Study|Lack of Efficacy|6|||
127806110|NCT01879410|459911207|FG000|Overall Study|Protocol Violation|1|||
127806111|NCT01879410|459911208|FG001|Overall Study|Protocol Violation|7|||
127806112|NCT01879410|459911207|FG000|Overall Study|Lost to Follow-up|2|||
127806113|NCT01879410|459911208|FG001|Overall Study|Lost to Follow-up|1|||
127806114|NCT01879410|459911207|FG000|Overall Study|Withdrawal by Subject|7|||
127735077|NCT04414397|459655301|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
127735078|NCT04414397|459655302|FG001|Maintenance Treatment Period|Withdrawal by Subject|2|||
127735079|NCT04414397|459655301|FG000|Maintenance Treatment Period|Lost to Follow-up|0|||
127735080|NCT04414397|459655302|FG001|Maintenance Treatment Period|Lost to Follow-up|3|||
127735081|NCT01920178|459655307|FG000|Overall Study|Lost to Follow-up|2|||
127735082|NCT01920178|459655308|FG001|Overall Study|Lost to Follow-up|1|||
127735083|NCT02391545|459655309|FG000|Overall Study|Death|0|||
127735084|NCT02391545|459655310|FG001|Overall Study|Death|2|||
127892446|NCT03567057|460229546|FG002|Overall Study|Lack of Efficacy|1|||
127892447|NCT03567057|460229544|FG000|Overall Study|Death|1|||
127892448|NCT03567057|460229545|FG001|Overall Study|Death|0|||
127892449|NCT03567057|460229546|FG002|Overall Study|Death|0|||
127892450|NCT03567057|460229544|FG000|Overall Study|Physician Decision|1|||
127892451|NCT03567057|460229545|FG001|Overall Study|Physician Decision|0|||
127892452|NCT03567057|460229546|FG002|Overall Study|Physician Decision|0|||
127892453|NCT03567057|460229544|FG000|Overall Study|Unstable medical condition|1|||
127892454|NCT03567057|460229545|FG001|Overall Study|Unstable medical condition|0|||
127892455|NCT03567057|460229546|FG002|Overall Study|Unstable medical condition|0|||
127892456|NCT03567057|460229544|FG000|Overall Study|Medical history event|0|||
127892457|NCT03567057|460229545|FG001|Overall Study|Medical history event|0|||
127892458|NCT03567057|460229546|FG002|Overall Study|Medical history event|1|||
127892459|NCT03567057|460229544|FG000|Overall Study|Other|0|||
127892460|NCT03567057|460229545|FG001|Overall Study|Other|0|||
127892461|NCT03567057|460229546|FG002|Overall Study|Other|1|||
127892462|NCT01507896|460229547|FG000|Overall Study|Withdrawal by Subject|1|||
127892463|NCT01507896|460229547|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
127892464|NCT00490061|460229548|FG000|Overall Study|Physician Decision|1|||
127892465|NCT01155583|460229549|FG000|Phase I|Screen failure - did not start treatment|0|||
127892466|NCT01155583|460229550|FG001|Phase I|Screen failure - did not start treatment|0|||
127892467|NCT01155583|460229551|FG002|Phase I|Screen failure - did not start treatment|0|||
127892468|NCT01155583|460229552|FG003|Phase I|Screen failure - did not start treatment|0|||
127892469|NCT01155583|460229553|FG004|Phase I|Screen failure - did not start treatment|1|||
127892470|NCT01155583|460229554|FG005|Phase I|Screen failure - did not start treatment|0|||
127892471|NCT01155583|460229555|FG006|Phase I|Screen failure - did not start treatment|0|||
127892472|NCT01155583|460229556|FG007|Phase I|Screen failure - did not start treatment|2|||
127892473|NCT01155583|460229557|FG008|Phase I|Screen failure - did not start treatment|0|||
127892474|NCT01155583|460229549|FG000|Phase I|Withdrawal by Subject|0|||
127892475|NCT01155583|460229550|FG001|Phase I|Withdrawal by Subject|0|||
127892476|NCT01155583|460229551|FG002|Phase I|Withdrawal by Subject|0|||
127892477|NCT01155583|460229552|FG003|Phase I|Withdrawal by Subject|0|||
127892478|NCT01155583|460229553|FG004|Phase I|Withdrawal by Subject|0|||
127892479|NCT01155583|460229554|FG005|Phase I|Withdrawal by Subject|0|||
127892480|NCT01155583|460229555|FG006|Phase I|Withdrawal by Subject|0|||
127892481|NCT01155583|460229556|FG007|Phase I|Withdrawal by Subject|1|||
127892482|NCT01155583|460229557|FG008|Phase I|Withdrawal by Subject|0|||
127892483|NCT00952484|460229558|FG000|Overall Study|Withdrawal by Subject|0|||
127892484|NCT00952484|460229559|FG001|Overall Study|Withdrawal by Subject|1|||
127892485|NCT00952484|460229560|FG002|Overall Study|Withdrawal by Subject|0|||
127892486|NCT00886483|460229568|FG000|Overall Study|Lost to Follow-up|0|||
127892487|NCT00886483|460229569|FG001|Overall Study|Lost to Follow-up|1|||
127892488|NCT00886483|460229568|FG000|Overall Study|Pursue medications|1|||
127892489|NCT00886483|460229569|FG001|Overall Study|Pursue medications|2|||
127892490|NCT00886483|460229568|FG000|Overall Study|Distance to center, poor grades|1|||
127892491|NCT00886483|460229569|FG001|Overall Study|Distance to center, poor grades|0|||
127892492|NCT00585351|460229572|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
127892493|NCT00585351|460229573|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
127892494|NCT00585351|460229574|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
127892495|NCT00585351|460229575|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
127892496|NCT00585351|460229576|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
127892497|NCT00585351|460229577|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
127892498|NCT00585351|460229578|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
127892499|NCT00585351|460229579|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
127892500|NCT00585351|460229572|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
127892501|NCT00585351|460229573|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
127892502|NCT00585351|460229574|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
127892503|NCT00585351|460229575|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
127892504|NCT00585351|460229576|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
127735085|NCT02391545|459655309|FG000|Overall Study|Lost to Follow-up|0|||
127735086|NCT02391545|459655310|FG001|Overall Study|Lost to Follow-up|1|||
127892505|NCT00585351|460229577|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
127892506|NCT00585351|460229578|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
127892507|NCT00585351|460229579|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
127892508|NCT00585351|460229572|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
127892509|NCT00585351|460229573|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
127806115|NCT01879410|459911208|FG001|Overall Study|Withdrawal by Subject|8|||
127806116|NCT01879410|459911207|FG000|Overall Study|Randomised in Error|1|||
127806117|NCT01879410|459911208|FG001|Overall Study|Randomised in Error|2|||
127806118|NCT01756456|459911211|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
127806119|NCT01756456|459911212|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
127806120|NCT01756456|459911213|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
127806121|NCT01756456|459911214|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
127806122|NCT01756456|459911215|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
127806123|NCT01756456|459911216|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
127806124|NCT01756456|459911211|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
127806125|NCT01756456|459911212|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
127806126|NCT01756456|459911213|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
127806127|NCT01756456|459911214|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
127806128|NCT01756456|459911215|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
127806129|NCT01756456|459911216|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
127806130|NCT01756456|459911211|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
127806131|NCT01756456|459911212|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
127806132|NCT01756456|459911213|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
127806133|NCT01756456|459911214|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
127806134|NCT01756456|459911215|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
127806135|NCT01756456|459911216|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
127806136|NCT01756456|459911211|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
127806137|NCT01756456|459911212|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
127806138|NCT01756456|459911213|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
127806139|NCT01756456|459911214|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
127806140|NCT01756456|459911215|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
127806141|NCT01756456|459911216|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
127892510|NCT00585351|460229574|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
127892511|NCT00585351|460229575|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
127892512|NCT00585351|460229576|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
127806142|NCT01756456|459911211|FG000|Treatment Period: Phase I/II|Other causes|0|||
127806143|NCT01756456|459911212|FG001|Treatment Period: Phase I/II|Other causes|0|||
127806144|NCT01756456|459911213|FG002|Treatment Period: Phase I/II|Other causes|0|||
127806145|NCT01756456|459911214|FG003|Treatment Period: Phase I/II|Other causes|1|||
127806146|NCT01756456|459911215|FG004|Treatment Period: Phase I/II|Other causes|2|||
127806147|NCT01756456|459911216|FG005|Treatment Period: Phase I/II|Other causes|2|||
127806148|NCT01756456|459911211|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
127806149|NCT01756456|459911212|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
127806150|NCT01756456|459911213|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
127806151|NCT01756456|459911214|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
127806152|NCT01756456|459911215|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
127806153|NCT01756456|459911216|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
127806154|NCT01756456|459911211|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
127806155|NCT01756456|459911212|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
127806156|NCT01756456|459911213|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
127806157|NCT01756456|459911214|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
127806158|NCT01756456|459911215|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
127892513|NCT00585351|460229577|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
127892514|NCT00585351|460229578|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
127892515|NCT00585351|460229579|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
127892516|NCT00585351|460229572|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
127892517|NCT00585351|460229573|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
127892518|NCT00585351|460229574|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
127892519|NCT00585351|460229575|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
127892520|NCT00585351|460229576|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
127892521|NCT00585351|460229577|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
127892522|NCT00585351|460229578|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
127892523|NCT00585351|460229579|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
127892524|NCT00585351|460229572|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
127892525|NCT00585351|460229573|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
127806159|NCT01756456|459911216|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
127806160|NCT01756456|459911211|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
127806161|NCT01756456|459911212|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
127806162|NCT01756456|459911213|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
127806163|NCT01756456|459911214|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
127735087|NCT02391545|459655309|FG000|Overall Study|Termination of study by sponsor|20|||
127735088|NCT02391545|459655310|FG001|Overall Study|Termination of study by sponsor|20|||
127735089|NCT02391545|459655309|FG000|Overall Study|Withdrawal by Subject|0|||
127735090|NCT02391545|459655310|FG001|Overall Study|Withdrawal by Subject|1|||
127735091|NCT02391545|459655309|FG000|Overall Study|Other Reasons|6|||
127735092|NCT02391545|459655310|FG001|Overall Study|Other Reasons|4|||
127735093|NCT04754594|459655311|FG000|Blinded Period|Withdrawal by Subject|4|||
127735094|NCT04754594|459655312|FG001|Blinded Period|Withdrawal by Subject|9|||
127735095|NCT04754594|459655313|FG002|Blinded Period|Withdrawal by Subject|0|||
127735096|NCT04754594|459655314|FG003|Blinded Period|Withdrawal by Subject|0|||
127735097|NCT04754594|459655311|FG000|Blinded Period|Protocol Violation|2|||
127735098|NCT04754594|459655312|FG001|Blinded Period|Protocol Violation|2|||
127735099|NCT04754594|459655313|FG002|Blinded Period|Protocol Violation|0|||
127735100|NCT04754594|459655314|FG003|Blinded Period|Protocol Violation|0|||
127735101|NCT04754594|459655311|FG000|Blinded Period|Lost to Follow-up|1|||
127735102|NCT04754594|459655312|FG001|Blinded Period|Lost to Follow-up|1|||
127735103|NCT04754594|459655313|FG002|Blinded Period|Lost to Follow-up|0|||
127735104|NCT04754594|459655314|FG003|Blinded Period|Lost to Follow-up|0|||
127806164|NCT01756456|459911215|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
127806165|NCT01756456|459911216|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
127806166|NCT01756456|459911211|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
127806167|NCT01756456|459911212|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
127806168|NCT01756456|459911213|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
127806169|NCT01756456|459911214|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
127806170|NCT01756456|459911215|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
127806171|NCT01756456|459911216|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
127735105|NCT04754594|459655311|FG000|Blinded Period|Unblinded before 1-month postdelivery visit|6|||
127735106|NCT04754594|459655312|FG001|Blinded Period|Unblinded before 1-month postdelivery visit|3|||
127735107|NCT04754594|459655313|FG002|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
127735108|NCT04754594|459655314|FG003|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
127735109|NCT04754594|459655311|FG000|Unblinded Period|Withdrawal by Subject|6|||
127735110|NCT04754594|459655312|FG001|Unblinded Period|Withdrawal by Subject|8|||
127735111|NCT04754594|459655313|FG002|Unblinded Period|Withdrawal by Subject|0|||
127806172|NCT01756456|459911211|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
127806173|NCT01756456|459911212|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
127806174|NCT01756456|459911213|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
127806175|NCT01756456|459911214|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
127806176|NCT01756456|459911215|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
127806177|NCT01756456|459911216|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
127806178|NCT01756456|459911211|FG000|Follow Up Period Phase I/II|Other causes|0|||
127806179|NCT01756456|459911212|FG001|Follow Up Period Phase I/II|Other causes|0|||
127806180|NCT01756456|459911213|FG002|Follow Up Period Phase I/II|Other causes|0|||
127806181|NCT01756456|459911214|FG003|Follow Up Period Phase I/II|Other causes|1|||
127806182|NCT01756456|459911215|FG004|Follow Up Period Phase I/II|Other causes|3|||
127806183|NCT01756456|459911216|FG005|Follow Up Period Phase I/II|Other causes|5|||
127806184|NCT00854828|459911217|FG000|Overall Study|Death|1|||
127806185|NCT00854828|459911218|FG001|Overall Study|Death|0|||
127806186|NCT00854828|459911219|FG002|Overall Study|Death|0|||
127806187|NCT00854828|459911220|FG003|Overall Study|Death|0|||
127806188|NCT00854828|459911217|FG000|Overall Study|Withdrawal by Subject|1|||
127806189|NCT00854828|459911218|FG001|Overall Study|Withdrawal by Subject|1|||
127806190|NCT00854828|459911219|FG002|Overall Study|Withdrawal by Subject|0|||
127806191|NCT00854828|459911220|FG003|Overall Study|Withdrawal by Subject|9|||
127806192|NCT00854828|459911217|FG000|Overall Study|Missed 24mo visit|1|||
127806193|NCT00854828|459911218|FG001|Overall Study|Missed 24mo visit|1|||
127806194|NCT00854828|459911219|FG002|Overall Study|Missed 24mo visit|8|||
127806195|NCT00854828|459911220|FG003|Overall Study|Missed 24mo visit|8|||
127806196|NCT04957290|459911221|FG000|Overall Study|Progressive disease|3|||
127806197|NCT04957290|459911222|FG001|Overall Study|Progressive disease|3|||
127806198|NCT04957290|459911223|FG002|Overall Study|Progressive disease|2|||
127806199|NCT04957290|459911224|FG003|Overall Study|Progressive disease|0|||
127806200|NCT04957290|459911225|FG004|Overall Study|Progressive disease|0|||
127806201|NCT04957290|459911226|FG005|Overall Study|Progressive disease|0|||
127806202|NCT04957290|459911221|FG000|Overall Study|Withdrawal by Subject|1|||
127806203|NCT04957290|459911222|FG001|Overall Study|Withdrawal by Subject|0|||
127806204|NCT04957290|459911223|FG002|Overall Study|Withdrawal by Subject|1|||
127806205|NCT04957290|459911224|FG003|Overall Study|Withdrawal by Subject|0|||
127806206|NCT04957290|459911225|FG004|Overall Study|Withdrawal by Subject|0|||
127806207|NCT04957290|459911226|FG005|Overall Study|Withdrawal by Subject|0|||
127892526|NCT00585351|460229574|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
127892527|NCT00585351|460229575|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
127892528|NCT00585351|460229576|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
127892529|NCT00585351|460229577|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
127892530|NCT00585351|460229578|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
127892531|NCT00585351|460229579|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
127892532|NCT00585351|460229572|FG000|Enrollment Period (Intervention)|Death|0|||
127892533|NCT00585351|460229573|FG001|Enrollment Period (Intervention)|Death|0|||
127892534|NCT00585351|460229574|FG002|Enrollment Period (Intervention)|Death|0|||
127892535|NCT00585351|460229575|FG003|Enrollment Period (Intervention)|Death|0|||
127892536|NCT00585351|460229576|FG004|Enrollment Period (Intervention)|Death|1|||
127892537|NCT00585351|460229577|FG005|Enrollment Period (Intervention)|Death|0|||
127892538|NCT00585351|460229578|FG006|Enrollment Period (Intervention)|Death|1|||
127892539|NCT00585351|460229579|FG007|Enrollment Period (Intervention)|Death|0|||
127892540|NCT00585351|460229572|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
127892541|NCT00585351|460229573|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
127892542|NCT00585351|460229574|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
127892543|NCT00585351|460229575|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
127735112|NCT04754594|459655314|FG003|Unblinded Period|Withdrawal by Subject|0|||
127735113|NCT04754594|459655311|FG000|Unblinded Period|Lost to Follow-up|5|||
127735114|NCT04754594|459655312|FG001|Unblinded Period|Lost to Follow-up|3|||
127735115|NCT04754594|459655313|FG002|Unblinded Period|Lost to Follow-up|0|||
127735116|NCT04754594|459655314|FG003|Unblinded Period|Lost to Follow-up|0|||
127735117|NCT04754594|459655311|FG000|Unblinded Period|Protocol Violation|2|||
127735118|NCT04754594|459655312|FG001|Unblinded Period|Protocol Violation|4|||
127735119|NCT04754594|459655313|FG002|Unblinded Period|Protocol Violation|0|||
127735120|NCT04754594|459655314|FG003|Unblinded Period|Protocol Violation|0|||
127735121|NCT04754594|459655311|FG000|Unblinded Period|Other|3|||
127735122|NCT04754594|459655312|FG001|Unblinded Period|Other|0|||
127735123|NCT04754594|459655313|FG002|Unblinded Period|Other|0|||
127735124|NCT04754594|459655314|FG003|Unblinded Period|Other|0|||
127735125|NCT04754594|459655311|FG000|Infant Participants|Withdrawal by Subject|0|||
127735126|NCT04754594|459655312|FG001|Infant Participants|Withdrawal by Subject|0|||
127735127|NCT04754594|459655313|FG002|Infant Participants|Withdrawal by Subject|9|||
127735128|NCT04754594|459655314|FG003|Infant Participants|Withdrawal by Subject|17|||
127735129|NCT04754594|459655311|FG000|Infant Participants|Lost to Follow-up|0|||
127735130|NCT04754594|459655312|FG001|Infant Participants|Lost to Follow-up|0|||
127735131|NCT04754594|459655313|FG002|Infant Participants|Lost to Follow-up|4|||
127735132|NCT04754594|459655314|FG003|Infant Participants|Lost to Follow-up|10|||
127735133|NCT04754594|459655311|FG000|Infant Participants|Death|0|||
127735134|NCT04754594|459655312|FG001|Infant Participants|Death|0|||
127735135|NCT04754594|459655313|FG002|Infant Participants|Death|1|||
127735136|NCT04754594|459655314|FG003|Infant Participants|Death|1|||
127735137|NCT04754594|459655311|FG000|Infant Participants|Other|0|||
127735138|NCT04754594|459655312|FG001|Infant Participants|Other|0|||
127735139|NCT04754594|459655313|FG002|Infant Participants|Other|1|||
127735140|NCT04754594|459655314|FG003|Infant Participants|Other|1|||
127735141|NCT00497198|459655324|FG000|Overall Study|Adverse Event|4|||
127735142|NCT00497198|459655325|FG001|Overall Study|Adverse Event|2|||
127735143|NCT00497198|459655324|FG000|Overall Study|Physician Decision|1|||
127735144|NCT00497198|459655325|FG001|Overall Study|Physician Decision|2|||
127735145|NCT00497198|459655324|FG000|Overall Study|Withdrawal by Subject|0|||
127735146|NCT00497198|459655325|FG001|Overall Study|Withdrawal by Subject|1|||
127735147|NCT04267393|459655328|FG000|Randomization|Adverse Event|1|||
127735148|NCT04267393|459655329|FG001|Randomization|Adverse Event|0|||
127735149|NCT04267393|459655330|FG002|Randomization|Adverse Event|0|||
127735150|NCT04267393|459655328|FG000|Randomization|Administrative Reasons by Sponsor|0|||
127735151|NCT04267393|459655329|FG001|Randomization|Administrative Reasons by Sponsor|1|||
127735152|NCT04267393|459655330|FG002|Randomization|Administrative Reasons by Sponsor|0|||
127735153|NCT04267393|459655328|FG000|Treatment Period|Adverse Event|0|||
127735154|NCT04267393|459655329|FG001|Treatment Period|Adverse Event|2|||
127735155|NCT04267393|459655330|FG002|Treatment Period|Adverse Event|3|||
127735156|NCT04267393|459655328|FG000|Treatment Period|Participant Withdrew Consent|0|||
127735157|NCT04267393|459655329|FG001|Treatment Period|Participant Withdrew Consent|0|||
127735158|NCT04267393|459655330|FG002|Treatment Period|Participant Withdrew Consent|1|||
127735159|NCT04267393|459655328|FG000|Treatment Period|Administrative Reasons by Sponsor|3|||
127735160|NCT04267393|459655329|FG001|Treatment Period|Administrative Reasons by Sponsor|4|||
127735161|NCT04267393|459655330|FG002|Treatment Period|Administrative Reasons by Sponsor|3|||
127735162|NCT02799745|459655331|FG000|Overall Study|Participant moved out of state|1|||
127735163|NCT02799745|459655332|FG001|Overall Study|Participant moved out of state|0|||
127735164|NCT02799745|459655331|FG000|Overall Study|Discontinued due to planned surgery|1|||
127735165|NCT02799745|459655332|FG001|Overall Study|Discontinued due to planned surgery|0|||
127735166|NCT02799745|459655331|FG000|Overall Study|Withdrawal by Subject|16|||
127735167|NCT02799745|459655332|FG001|Overall Study|Withdrawal by Subject|25|||
127892544|NCT00585351|460229576|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
127892545|NCT00585351|460229577|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
127892546|NCT00585351|460229578|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
127892547|NCT00585351|460229579|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
127892548|NCT01842958|460229581|FG000|Overall Study|Lost to Follow-up|1|||
127892549|NCT01842958|460229582|FG001|Overall Study|Lost to Follow-up|1|||
127892550|NCT01829477|460229583|FG000|Overall Study|Study Terminated by Sponsor|15|||
127892551|NCT01829477|460229584|FG001|Overall Study|Study Terminated by Sponsor|15|||
127892552|NCT01829477|460229583|FG000|Overall Study|Withdrawal by Subject|1|||
127892553|NCT01829477|460229584|FG001|Overall Study|Withdrawal by Subject|0|||
127892554|NCT00818623|460229589|FG000|Overall Study|Adverse Event|1|||
127892555|NCT00818623|460229590|FG001|Overall Study|Adverse Event|0|||
127892556|NCT00818623|460229591|FG002|Overall Study|Adverse Event|1|||
127892557|NCT00818623|460229592|FG003|Overall Study|Adverse Event|0|||
127892558|NCT00818623|460229593|FG004|Overall Study|Adverse Event|0|||
127892559|NCT00818623|460229594|FG005|Overall Study|Adverse Event|1|||
127892560|NCT00818623|460229595|FG006|Overall Study|Adverse Event|0|||
127892561|NCT00818623|460229596|FG007|Overall Study|Adverse Event|0|||
127892562|NCT00818623|460229589|FG000|Overall Study|Bad prostate specific antigen response|0|||
127892563|NCT00818623|460229590|FG001|Overall Study|Bad prostate specific antigen response|3|||
127892564|NCT00818623|460229591|FG002|Overall Study|Bad prostate specific antigen response|2|||
127892565|NCT00818623|460229592|FG003|Overall Study|Bad prostate specific antigen response|5|||
127892566|NCT00818623|460229593|FG004|Overall Study|Bad prostate specific antigen response|0|||
127892567|NCT00818623|460229594|FG005|Overall Study|Bad prostate specific antigen response|1|||
127892568|NCT00818623|460229595|FG006|Overall Study|Bad prostate specific antigen response|0|||
127892569|NCT00818623|460229596|FG007|Overall Study|Bad prostate specific antigen response|0|||
127892570|NCT00818623|460229589|FG000|Overall Study|Withdrawal by Subject|0|||
127892571|NCT00818623|460229590|FG001|Overall Study|Withdrawal by Subject|1|||
127892572|NCT00818623|460229591|FG002|Overall Study|Withdrawal by Subject|1|||
127892573|NCT00818623|460229592|FG003|Overall Study|Withdrawal by Subject|0|||
127892574|NCT00818623|460229593|FG004|Overall Study|Withdrawal by Subject|0|||
127892575|NCT00818623|460229594|FG005|Overall Study|Withdrawal by Subject|1|||
127892576|NCT00818623|460229595|FG006|Overall Study|Withdrawal by Subject|1|||
127892577|NCT00818623|460229596|FG007|Overall Study|Withdrawal by Subject|1|||
127892578|NCT00818623|460229589|FG000|Overall Study|Protocol Violation|1|||
127892579|NCT00818623|460229590|FG001|Overall Study|Protocol Violation|0|||
127892580|NCT00818623|460229591|FG002|Overall Study|Protocol Violation|0|||
127892581|NCT00818623|460229592|FG003|Overall Study|Protocol Violation|0|||
127892582|NCT00818623|460229593|FG004|Overall Study|Protocol Violation|1|||
127892583|NCT00818623|460229594|FG005|Overall Study|Protocol Violation|0|||
127892584|NCT00818623|460229595|FG006|Overall Study|Protocol Violation|1|||
127892585|NCT00818623|460229596|FG007|Overall Study|Protocol Violation|0|||
127892586|NCT00818623|460229589|FG000|Overall Study|Need of additional treatment|0|||
127892587|NCT00818623|460229590|FG001|Overall Study|Need of additional treatment|0|||
127892588|NCT00818623|460229591|FG002|Overall Study|Need of additional treatment|0|||
127892589|NCT00818623|460229592|FG003|Overall Study|Need of additional treatment|0|||
127892590|NCT00818623|460229593|FG004|Overall Study|Need of additional treatment|1|||
127892591|NCT00818623|460229594|FG005|Overall Study|Need of additional treatment|0|||
127892592|NCT00818623|460229595|FG006|Overall Study|Need of additional treatment|0|||
127892593|NCT00818623|460229596|FG007|Overall Study|Need of additional treatment|0|||
127892594|NCT00818623|460229589|FG000|Overall Study|Lack of trial drug at site|0|||
127892595|NCT00818623|460229590|FG001|Overall Study|Lack of trial drug at site|0|||
127892596|NCT00818623|460229591|FG002|Overall Study|Lack of trial drug at site|0|||
127735168|NCT02799745|459655331|FG000|Overall Study|Protocol Deviation|4|||
127735169|NCT02799745|459655332|FG001|Overall Study|Protocol Deviation|5|||
127735170|NCT02799745|459655331|FG000|Overall Study|Progressive Disease|28|||
127735171|NCT02799745|459655332|FG001|Overall Study|Progressive Disease|38|||
127735172|NCT02799745|459655331|FG000|Overall Study|Lost to Follow-up|3|||
127735173|NCT02799745|459655332|FG001|Overall Study|Lost to Follow-up|2|||
127735174|NCT02799745|459655331|FG000|Overall Study|Death|3|||
127735175|NCT02799745|459655332|FG001|Overall Study|Death|0|||
127735176|NCT02799745|459655331|FG000|Overall Study|Adverse Event|0|||
127735177|NCT02799745|459655332|FG001|Overall Study|Adverse Event|1|||
127892597|NCT00818623|460229592|FG003|Overall Study|Lack of trial drug at site|0|||
127892598|NCT00818623|460229593|FG004|Overall Study|Lack of trial drug at site|2|||
127735178|NCT04853238|459655333|FG000|Overall Study|Death|4|||
127735179|NCT04853238|459655334|FG001|Overall Study|Death|0|||
127735180|NCT04853238|459655335|FG002|Overall Study|Death|2|||
127735181|NCT04853238|459655333|FG000|Overall Study|Lost to Follow-up|16|||
127892599|NCT00818623|460229594|FG005|Overall Study|Lack of trial drug at site|0|||
127892600|NCT00818623|460229595|FG006|Overall Study|Lack of trial drug at site|1|||
127892601|NCT00818623|460229596|FG007|Overall Study|Lack of trial drug at site|0|||
127892602|NCT00818623|460229589|FG000|Overall Study|Disease progression|0|||
127892603|NCT00818623|460229590|FG001|Overall Study|Disease progression|0|||
127892604|NCT00818623|460229591|FG002|Overall Study|Disease progression|0|||
127892605|NCT00818623|460229592|FG003|Overall Study|Disease progression|0|||
127735182|NCT04853238|459655334|FG001|Overall Study|Lost to Follow-up|2|||
127735183|NCT04853238|459655335|FG002|Overall Study|Lost to Follow-up|37|||
127735184|NCT04853238|459655333|FG000|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
127735185|NCT04853238|459655334|FG001|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
127735186|NCT04853238|459655335|FG002|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|10|||
127735187|NCT04853238|459655333|FG000|Overall Study|Withdrawal by Subject|6|||
127735188|NCT04853238|459655334|FG001|Overall Study|Withdrawal by Subject|0|||
127735189|NCT04853238|459655335|FG002|Overall Study|Withdrawal by Subject|21|||
127735190|NCT04853238|459655333|FG000|Overall Study|Physician Decision|0|||
127735191|NCT04853238|459655334|FG001|Overall Study|Physician Decision|0|||
127735192|NCT04853238|459655335|FG002|Overall Study|Physician Decision|2|||
127735193|NCT04853238|459655333|FG000|Overall Study|Violation of inclusion/exclusion criteria|3|||
127735194|NCT04853238|459655334|FG001|Overall Study|Violation of inclusion/exclusion criteria|0|||
127735195|NCT04853238|459655335|FG002|Overall Study|Violation of inclusion/exclusion criteria|1|||
127735196|NCT00088452|459657498|FG000|Overall Study|Did not receive intervention|1|||
127735197|NCT00088452|459657499|FG001|Overall Study|Did not receive intervention|0|||
127735198|NCT00088452|459657500|FG002|Overall Study|Did not receive intervention|1|||
127735199|NCT02329223|459657501|FG000|Overall Study|Withdrawal by Subject|1|||
127735200|NCT02329223|459657502|FG001|Overall Study|Withdrawal by Subject|2|||
127735201|NCT02329223|459657503|FG002|Overall Study|Withdrawal by Subject|5|||
127735202|NCT02329223|459657501|FG000|Overall Study|Physician Decision|0|||
127735203|NCT02329223|459657502|FG001|Overall Study|Physician Decision|0|||
127806208|NCT04957290|459911221|FG000|Overall Study|Death|0|||
127806209|NCT04957290|459911222|FG001|Overall Study|Death|2|||
127806210|NCT04957290|459911223|FG002|Overall Study|Death|1|||
127806211|NCT04957290|459911224|FG003|Overall Study|Death|0|||
127806212|NCT04957290|459911225|FG004|Overall Study|Death|0|||
127806213|NCT04957290|459911226|FG005|Overall Study|Death|0|||
127806214|NCT04957290|459911221|FG000|Overall Study|non compliance with study drug|0|||
127806215|NCT04957290|459911222|FG001|Overall Study|non compliance with study drug|1|||
127806216|NCT04957290|459911223|FG002|Overall Study|non compliance with study drug|0|||
127806217|NCT04957290|459911224|FG003|Overall Study|non compliance with study drug|0|||
127806218|NCT04957290|459911225|FG004|Overall Study|non compliance with study drug|0|||
127806219|NCT04957290|459911226|FG005|Overall Study|non compliance with study drug|0|||
127806220|NCT04957290|459911221|FG000|Overall Study|none specified.|0|||
127806221|NCT04957290|459911222|FG001|Overall Study|none specified.|1|||
127806222|NCT04957290|459911223|FG002|Overall Study|none specified.|2|||
127806223|NCT04957290|459911224|FG003|Overall Study|none specified.|0|||
127806224|NCT04957290|459911225|FG004|Overall Study|none specified.|0|||
127806225|NCT04957290|459911226|FG005|Overall Study|none specified.|0|||
127806226|NCT04957290|459911221|FG000|Overall Study|unacceptable toxicity|0|||
127806227|NCT04957290|459911222|FG001|Overall Study|unacceptable toxicity|0|||
127806228|NCT04957290|459911223|FG002|Overall Study|unacceptable toxicity|1|||
127806229|NCT04957290|459911224|FG003|Overall Study|unacceptable toxicity|0|||
127806230|NCT04957290|459911225|FG004|Overall Study|unacceptable toxicity|0|||
127806231|NCT04957290|459911226|FG005|Overall Study|unacceptable toxicity|0|||
127806232|NCT04957290|459911221|FG000|Overall Study|Adverse Event|0|||
127806233|NCT04957290|459911222|FG001|Overall Study|Adverse Event|0|||
127806234|NCT04957290|459911223|FG002|Overall Study|Adverse Event|1|||
127806235|NCT04957290|459911224|FG003|Overall Study|Adverse Event|0|||
127806236|NCT04957290|459911225|FG004|Overall Study|Adverse Event|0|||
127806237|NCT04957290|459911226|FG005|Overall Study|Adverse Event|0|||
127806238|NCT04957290|459911221|FG000|Overall Study|study terminated by sponsor|0|||
127806239|NCT04957290|459911222|FG001|Overall Study|study terminated by sponsor|0|||
127735204|NCT02329223|459657503|FG002|Overall Study|Physician Decision|1|||
127735205|NCT02329223|459657501|FG000|Overall Study|Adverse Event|0|||
127735206|NCT02329223|459657502|FG001|Overall Study|Adverse Event|1|||
127735207|NCT02329223|459657503|FG002|Overall Study|Adverse Event|0|||
127735208|NCT01231464|459657508|FG000|Overall Study|Adverse Event|0|||
127735209|NCT01231464|459657509|FG001|Overall Study|Adverse Event|1|||
127735210|NCT01231464|459657508|FG000|Overall Study|Protocol Violation|1|||
127735211|NCT01231464|459657509|FG001|Overall Study|Protocol Violation|2|||
127735212|NCT01231464|459657508|FG000|Overall Study|Lost to Follow-up|1|||
127735213|NCT01231464|459657509|FG001|Overall Study|Lost to Follow-up|2|||
127806240|NCT04957290|459911223|FG002|Overall Study|study terminated by sponsor|2|||
127806241|NCT04957290|459911224|FG003|Overall Study|study terminated by sponsor|0|||
127806242|NCT04957290|459911225|FG004|Overall Study|study terminated by sponsor|0|||
127806243|NCT04957290|459911226|FG005|Overall Study|study terminated by sponsor|0|||
127806244|NCT01459614|459911227|FG000|Overall Study|Adverse Event|1|||
127806245|NCT01459614|459911228|FG001|Overall Study|Adverse Event|0|||
127806246|NCT01506882|459911232|FG000|Overall Study|Lack of Efficacy|4|||
127806247|NCT01506882|459911233|FG001|Overall Study|Lack of Efficacy|3|||
127806248|NCT01506882|459911232|FG000|Overall Study|Lost to Follow-up|1|||
127806249|NCT01506882|459911233|FG001|Overall Study|Lost to Follow-up|0|||
127806250|NCT01506882|459911232|FG000|Overall Study|Withdrawal by Subject|9|||
127806251|NCT01506882|459911233|FG001|Overall Study|Withdrawal by Subject|3|||
127735214|NCT01231464|459657508|FG000|Overall Study|Withdrawal by Subject|3|||
127735215|NCT01231464|459657509|FG001|Overall Study|Withdrawal by Subject|2|||
127735216|NCT00550771|459657511|FG000|Overall Study|Adverse Event|11|||
127735217|NCT00550771|459657512|FG001|Overall Study|Adverse Event|3|||
127735218|NCT00550771|459657511|FG000|Overall Study|Discontinued for study-related reasons|0|||
127735219|NCT00550771|459657512|FG001|Overall Study|Discontinued for study-related reasons|1|||
127735220|NCT00550771|459657511|FG000|Overall Study|Physician Decision|2|||
127735221|NCT00550771|459657512|FG001|Overall Study|Physician Decision|0|||
127735222|NCT00550771|459657511|FG000|Overall Study|Withdrawal by Subject|0|||
127735223|NCT00550771|459657512|FG001|Overall Study|Withdrawal by Subject|1|||
127735224|NCT00550771|459657511|FG000|Overall Study|Protocol Violation|4|||
127735225|NCT00550771|459657512|FG001|Overall Study|Protocol Violation|5|||
127735226|NCT00730847|459657514|FG000|Overall Study|Adverse Event|1|||
127735227|NCT00730847|459657514|FG000|Overall Study|Protocol Violation|2|||
127735228|NCT00730847|459657514|FG000|Overall Study|Withdrawal by Subject|16|||
127735229|NCT00730847|459657514|FG000|Overall Study|Lost to Follow-up|67|||
127735230|NCT00730847|459657514|FG000|Overall Study|Unknown completion status|21|||
127735231|NCT00730847|459657514|FG000|Overall Study|Other|24|||
127735232|NCT03022578|459657515|FG000|Overall Study|Adverse Event|1|||
127735233|NCT03022578|459657515|FG000|Overall Study|Lack of Efficacy|2|||
127735234|NCT03022578|459657515|FG000|Overall Study|Withdrawal by Subject|1|||
127735235|NCT00726388|459657518|FG000|Overall Study|Withdrawal by Subject|5|||
127735236|NCT00726388|459657518|FG000|Overall Study|Adverse Event|3|||
127735237|NCT00726388|459657518|FG000|Overall Study|Lost to Follow-up|10|||
127735238|NCT00726388|459657518|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
127735239|NCT00726388|459657518|FG000|Overall Study|Other|5|||
127735240|NCT00726388|459657518|FG000|Overall Study|Enrolled, Not Treated|79|||
127735241|NCT00382408|459657519|FG000|Overall Study|Did not meet protocol requirement|3|||
127735242|NCT00382408|459657520|FG001|Overall Study|Did not meet protocol requirement|3|||
127735243|NCT00382408|459657519|FG000|Overall Study|Protocol Violation|2|||
127735244|NCT00382408|459657520|FG001|Overall Study|Protocol Violation|2|||
127735245|NCT00382408|459657519|FG000|Overall Study|Physician Decision|1|||
127735246|NCT00382408|459657520|FG001|Overall Study|Physician Decision|0|||
127735247|NCT00382408|459657519|FG000|Overall Study|Withdrawal by Subject|17|||
127735248|NCT00382408|459657520|FG001|Overall Study|Withdrawal by Subject|6|||
127735249|NCT00382408|459657519|FG000|Overall Study|Pregnancy|2|||
127735250|NCT00382408|459657520|FG001|Overall Study|Pregnancy|0|||
127735251|NCT00382408|459657519|FG000|Overall Study|Lost to Follow-up|19|||
127735252|NCT00382408|459657520|FG001|Overall Study|Lost to Follow-up|8|||
127735253|NCT00382408|459657519|FG000|Overall Study|Other|100|||
127735254|NCT00382408|459657520|FG001|Overall Study|Other|35|||
127735255|NCT00405912|459657521|FG000|Overall Study|Withdrawal by Subject|12|||
127735256|NCT00405912|459657522|FG001|Overall Study|Withdrawal by Subject|11|||
127735257|NCT00405912|459657523|FG002|Overall Study|Withdrawal by Subject|12|||
127735258|NCT00405912|459657521|FG000|Overall Study|Lost to Follow-up|4|||
127735259|NCT00405912|459657522|FG001|Overall Study|Lost to Follow-up|8|||
127735260|NCT00405912|459657523|FG002|Overall Study|Lost to Follow-up|4|||
127735261|NCT03730662|459657524|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
127735262|NCT03730662|459657525|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
127735263|NCT03730662|459657526|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
127806252|NCT01506882|459911232|FG000|Overall Study|SAE, non-fatal|2|||
127806253|NCT01506882|459911233|FG001|Overall Study|SAE, non-fatal|0|||
127806254|NCT01506882|459911232|FG000|Overall Study|AE, non-serious non-fatal|3|||
127806255|NCT01506882|459911233|FG001|Overall Study|AE, non-serious non-fatal|1|||
127806256|NCT01506882|459911232|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
127735264|NCT03730662|459657527|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
127735265|NCT03730662|459657524|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
127735266|NCT03730662|459657525|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
127735267|NCT03730662|459657526|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
127735268|NCT03730662|459657527|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
127735269|NCT03730662|459657524|FG000|Treatment Period (52 Weeks)|Death|6|||
127735270|NCT03730662|459657525|FG001|Treatment Period (52 Weeks)|Death|2|||
127735271|NCT03730662|459657526|FG002|Treatment Period (52 Weeks)|Death|2|||
127735272|NCT03730662|459657527|FG003|Treatment Period (52 Weeks)|Death|9|||
127735273|NCT03730662|459657524|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
127735274|NCT03730662|459657525|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
127735275|NCT03730662|459657526|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
127735276|NCT03730662|459657527|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
127735277|NCT03730662|459657524|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
127735278|NCT03730662|459657525|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
127735279|NCT03730662|459657526|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
127735280|NCT03730662|459657527|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
127735281|NCT03730662|459657524|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
127735282|NCT03730662|459657525|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
127735283|NCT03730662|459657526|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
127806257|NCT01506882|459911233|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
127735284|NCT03730662|459657527|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
127735285|NCT03730662|459657524|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
127735286|NCT03730662|459657525|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
127735287|NCT03730662|459657526|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
127735288|NCT03730662|459657527|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
127735289|NCT03730662|459657524|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
127735290|NCT03730662|459657525|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
127735291|NCT03730662|459657526|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
127735292|NCT03730662|459657527|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
127735293|NCT03730662|459657524|FG000|Variable Treatment Period|Adverse Event|1|||
127735294|NCT03730662|459657525|FG001|Variable Treatment Period|Adverse Event|2|||
127735295|NCT03730662|459657526|FG002|Variable Treatment Period|Adverse Event|0|||
127735296|NCT03730662|459657527|FG003|Variable Treatment Period|Adverse Event|7|||
127735297|NCT03730662|459657524|FG000|Variable Treatment Period|Death|9|||
127735298|NCT03730662|459657525|FG001|Variable Treatment Period|Death|0|||
127735299|NCT03730662|459657526|FG002|Variable Treatment Period|Death|6|||
127735300|NCT03730662|459657527|FG003|Variable Treatment Period|Death|26|||
127735301|NCT03730662|459657524|FG000|Variable Treatment Period|Lost to Follow-up|2|||
127735302|NCT03730662|459657525|FG001|Variable Treatment Period|Lost to Follow-up|1|||
127735303|NCT03730662|459657526|FG002|Variable Treatment Period|Lost to Follow-up|4|||
127735304|NCT03730662|459657527|FG003|Variable Treatment Period|Lost to Follow-up|11|||
127735305|NCT03730662|459657524|FG000|Variable Treatment Period|Personal Reason|0|||
127735306|NCT03730662|459657525|FG001|Variable Treatment Period|Personal Reason|2|||
127735307|NCT03730662|459657526|FG002|Variable Treatment Period|Personal Reason|1|||
127735308|NCT03730662|459657527|FG003|Variable Treatment Period|Personal Reason|6|||
127735309|NCT03730662|459657524|FG000|Variable Treatment Period|Physician Decision|0|||
127735310|NCT03730662|459657525|FG001|Variable Treatment Period|Physician Decision|0|||
127735311|NCT03730662|459657526|FG002|Variable Treatment Period|Physician Decision|0|||
127735312|NCT03730662|459657527|FG003|Variable Treatment Period|Physician Decision|3|||
127735313|NCT03730662|459657524|FG000|Variable Treatment Period|Protocol Violation|0|||
127735314|NCT03730662|459657525|FG001|Variable Treatment Period|Protocol Violation|1|||
127735315|NCT03730662|459657526|FG002|Variable Treatment Period|Protocol Violation|1|||
127735316|NCT03730662|459657527|FG003|Variable Treatment Period|Protocol Violation|1|||
127735317|NCT03730662|459657524|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
127735318|NCT03730662|459657525|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
127735319|NCT03730662|459657526|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
127735320|NCT03730662|459657527|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
127735321|NCT01309243|459657528|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
127735322|NCT01309243|459657529|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
127735323|NCT01309243|459657528|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
127735324|NCT01309243|459657529|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
127735325|NCT01309243|459657528|FG000|Randomized Phase Through Week 96|Death|0|||
127735326|NCT01309243|459657529|FG001|Randomized Phase Through Week 96|Death|1|||
127735327|NCT01309243|459657528|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
127735328|NCT01309243|459657529|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
127735329|NCT01309243|459657528|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
127735330|NCT01309243|459657529|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
127735331|NCT01309243|459657528|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
127735332|NCT01309243|459657529|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
127735333|NCT01309243|459657528|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
127735334|NCT01309243|459657529|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
127735335|NCT01309243|459657528|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
127735336|NCT01309243|459657529|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
127735337|NCT01309243|459657528|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
127735338|NCT01309243|459657529|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
127735339|NCT01309243|459657528|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
127735340|NCT01309243|459657529|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
127735341|NCT01309243|459657528|FG000|Extension Phase|Lost to Follow-up|6|||
127735342|NCT01309243|459657529|FG001|Extension Phase|Lost to Follow-up|0|||
127735343|NCT00632931|459657532|FG000|Part 1, Period 1|Protocol Violation|1|||
127735344|NCT00632931|459657533|FG001|Part 1, Period 1|Protocol Violation|0|||
127735345|NCT00632931|459657534|FG002|Part 1, Period 1|Protocol Violation|0|||
127735346|NCT00632931|459657532|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
127735347|NCT00632931|459657533|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
127735348|NCT00632931|459657534|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
127735349|NCT00632931|459657532|FG000|Part 2|Adverse Event|0|||
127735350|NCT00632931|459657533|FG001|Part 2|Adverse Event|0|||
127735351|NCT00632931|459657534|FG002|Part 2|Adverse Event|3|||
127735352|NCT00632931|459657532|FG000|Part 2|Death|0|||
127735353|NCT00632931|459657533|FG001|Part 2|Death|0|||
127735354|NCT00632931|459657534|FG002|Part 2|Death|1|||
127735355|NCT00632931|459657532|FG000|Part 2|Lack of Efficacy|0|||
127735356|NCT00632931|459657533|FG001|Part 2|Lack of Efficacy|0|||
127735357|NCT00632931|459657534|FG002|Part 2|Lack of Efficacy|17|||
127735358|NCT00632931|459657532|FG000|Part 2|Withdrawal by Subject|0|||
127735359|NCT00632931|459657533|FG001|Part 2|Withdrawal by Subject|0|||
127735360|NCT00632931|459657534|FG002|Part 2|Withdrawal by Subject|3|||
127735361|NCT01441583|459657537|FG000|Overall Study|Withdrawal by Subject|1|||
127735362|NCT01441583|459657538|FG001|Overall Study|Withdrawal by Subject|1|||
127735363|NCT01441583|459657539|FG002|Overall Study|Withdrawal by Subject|1|||
127735364|NCT01441583|459657537|FG000|Overall Study|Death|1|||
127735365|NCT01441583|459657538|FG001|Overall Study|Death|0|||
127735366|NCT01441583|459657539|FG002|Overall Study|Death|4|||
127735367|NCT01441583|459657537|FG000|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
127735368|NCT01441583|459657538|FG001|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
127735369|NCT01441583|459657539|FG002|Overall Study|Underwent anaesthesia, but not finally implanted|4|||
127735370|NCT03341312|459657540|FG000|Period 1|Withdrawal by Subject|0|||
127735371|NCT03341312|459657541|FG001|Period 1|Withdrawal by Subject|1|||
127735372|NCT03341312|459657542|FG002|Period 1|Withdrawal by Subject|0|||
127735373|NCT03341312|459657543|FG003|Period 1|Withdrawal by Subject|0|||
127735374|NCT00839306|459657544|FG000|Overall Study|Adverse Event|3|||
127735375|NCT00839306|459657545|FG001|Overall Study|Adverse Event|5|||
127735376|NCT00839306|459657544|FG000|Overall Study|Lost to Follow-up|6|||
127735377|NCT00839306|459657545|FG001|Overall Study|Lost to Follow-up|9|||
127735378|NCT00839306|459657544|FG000|Overall Study|Withdrawal by Subject|5|||
127735379|NCT00839306|459657545|FG001|Overall Study|Withdrawal by Subject|7|||
127735380|NCT00839306|459657544|FG000|Overall Study|Lack of Efficacy|5|||
127735381|NCT00839306|459657545|FG001|Overall Study|Lack of Efficacy|4|||
127735382|NCT00839306|459657544|FG000|Overall Study|Other|6|||
127735383|NCT00839306|459657545|FG001|Overall Study|Other|18|||
127735384|NCT01812707|459657546|FG000|Overall Study|Adverse Event|0|||
127735385|NCT01812707|459657547|FG001|Overall Study|Adverse Event|0|||
127735386|NCT01812707|459657548|FG002|Overall Study|Adverse Event|0|||
127735387|NCT01812707|459657549|FG003|Overall Study|Adverse Event|2|||
127735388|NCT01812707|459657546|FG000|Overall Study|Poor compliance to protocol|1|||
127735389|NCT01812707|459657547|FG001|Overall Study|Poor compliance to protocol|0|||
127735390|NCT01812707|459657548|FG002|Overall Study|Poor compliance to protocol|0|||
127735391|NCT01812707|459657549|FG003|Overall Study|Poor compliance to protocol|0|||
127735392|NCT01812707|459657546|FG000|Overall Study|Consent withdrawn by participant|1|||
127735393|NCT01812707|459657547|FG001|Overall Study|Consent withdrawn by participant|0|||
127735394|NCT01812707|459657548|FG002|Overall Study|Consent withdrawn by participant|0|||
127735395|NCT01812707|459657549|FG003|Overall Study|Consent withdrawn by participant|0|||
127735396|NCT05060237|459657550|FG000|Overall Study|Withdrawal by Subject|4|||
127735397|NCT05060237|459657550|FG000|Overall Study|Screening failure|8|||
127735398|NCT01697592|459657551|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
127735399|NCT01697592|459657552|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
127735400|NCT01697592|459657553|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
127735401|NCT01697592|459657554|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
127735402|NCT01697592|459657555|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
127735403|NCT01697592|459657556|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
127735404|NCT01697592|459657557|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
127735405|NCT01697592|459657558|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
127735406|NCT01697592|459657559|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
127735407|NCT01697592|459657560|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
127735408|NCT01697592|459657551|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
127735409|NCT01697592|459657552|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
127735410|NCT01697592|459657553|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
127735411|NCT01697592|459657554|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
127735412|NCT01697592|459657555|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
127735413|NCT01697592|459657556|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
127735414|NCT01697592|459657557|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
127735415|NCT01697592|459657558|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
127735416|NCT01697592|459657559|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
127735417|NCT01697592|459657560|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
127735418|NCT01697592|459657551|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
127735419|NCT01697592|459657552|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
127735420|NCT01697592|459657553|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
127735421|NCT01697592|459657554|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
127735422|NCT01697592|459657555|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
127735423|NCT01697592|459657556|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
127735424|NCT01697592|459657557|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
127735425|NCT01697592|459657558|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
127735426|NCT01697592|459657559|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
127735427|NCT01697592|459657560|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
127735428|NCT01697592|459657551|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
127735429|NCT01697592|459657552|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
127806258|NCT01506882|459911232|FG000|Overall Study|Other Reason|2|||
127806259|NCT01506882|459911233|FG001|Overall Study|Other Reason|0|||
127806260|NCT00821678|459911238|FG000|Overall Study|Withdrawal by Subject|8|||
127806261|NCT00821678|459911239|FG001|Overall Study|Withdrawal by Subject|0|||
127806262|NCT00821678|459911238|FG000|Overall Study|Lost to Follow-up|13|||
127806263|NCT00821678|459911239|FG001|Overall Study|Lost to Follow-up|12|||
127806264|NCT00821678|459911238|FG000|Overall Study|Death|0|||
127806265|NCT00821678|459911239|FG001|Overall Study|Death|2|||
127806266|NCT02591615|459913370|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
127806267|NCT02591615|459913371|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
127806268|NCT02591615|459913372|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
127892606|NCT00818623|460229593|FG004|Overall Study|Disease progression|0|||
127735430|NCT01697592|459657553|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
127735431|NCT01697592|459657554|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
127735432|NCT01697592|459657555|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
127735433|NCT01697592|459657556|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
127735434|NCT01697592|459657557|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
127735435|NCT01697592|459657558|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
127735436|NCT01697592|459657559|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
127735437|NCT01697592|459657560|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
127735438|NCT01697592|459657551|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
127735439|NCT01697592|459657552|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
127735440|NCT01697592|459657553|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
127735441|NCT01697592|459657554|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
127735442|NCT01697592|459657555|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
127735443|NCT01697592|459657556|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
127735444|NCT01697592|459657557|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
127735445|NCT01697592|459657558|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
127735446|NCT01697592|459657559|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
127735447|NCT01697592|459657560|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
127735448|NCT01697592|459657551|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
127735449|NCT01697592|459657552|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
127735450|NCT01697592|459657553|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
127735451|NCT01697592|459657554|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
127735452|NCT01697592|459657555|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
127735453|NCT01697592|459657556|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
127735454|NCT01697592|459657557|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
127735455|NCT01697592|459657558|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
127735456|NCT01697592|459657559|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
127735457|NCT01697592|459657560|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
127735458|NCT01697592|459657551|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
127735459|NCT01697592|459657552|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
127735460|NCT01697592|459657553|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
127735461|NCT01697592|459657554|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
127735462|NCT01697592|459657555|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
127735463|NCT01697592|459657556|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
127735464|NCT01697592|459657557|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
127806269|NCT02591615|459913373|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
127806270|NCT02591615|459913370|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
127892607|NCT00818623|460229594|FG005|Overall Study|Disease progression|0|||
127892608|NCT00818623|460229595|FG006|Overall Study|Disease progression|1|||
127892609|NCT00818623|460229596|FG007|Overall Study|Disease progression|0|||
127892610|NCT00602030|460229597|FG000|Lead-in Phase|Disease Progression|2|||
127892611|NCT00602030|460229598|FG001|Lead-in Phase|Disease Progression|3|||
127892612|NCT00602030|460229599|FG002|Lead-in Phase|Disease Progression|0|||
127892613|NCT00602030|460229600|FG003|Lead-in Phase|Disease Progression|0|||
127892614|NCT00602030|460229601|FG004|Lead-in Phase|Disease Progression|0|||
127892615|NCT00602030|460229597|FG000|Lead-in Phase|Adverse Event|0|||
127892616|NCT00602030|460229598|FG001|Lead-in Phase|Adverse Event|2|||
127892617|NCT00602030|460229599|FG002|Lead-in Phase|Adverse Event|0|||
127892618|NCT00602030|460229600|FG003|Lead-in Phase|Adverse Event|0|||
127892619|NCT00602030|460229601|FG004|Lead-in Phase|Adverse Event|0|||
127892620|NCT00602030|460229597|FG000|Double-blind Phase|Disease progression|0|||
127892621|NCT00602030|460229598|FG001|Double-blind Phase|Disease progression|0|||
127806271|NCT02591615|459913371|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
127806272|NCT02591615|459913372|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
127892622|NCT00602030|460229599|FG002|Double-blind Phase|Disease progression|33|||
127892623|NCT00602030|460229600|FG003|Double-blind Phase|Disease progression|30|||
127892624|NCT00602030|460229601|FG004|Double-blind Phase|Disease progression|0|||
127892625|NCT00602030|460229597|FG000|Double-blind Phase|Adverse Event|0|||
127735465|NCT01697592|459657558|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
127735466|NCT01697592|459657559|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
127735467|NCT01697592|459657560|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
127735468|NCT01697592|459657551|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
127735469|NCT01697592|459657552|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
127735470|NCT01697592|459657553|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
127735471|NCT01697592|459657554|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
127735472|NCT01697592|459657555|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
127735473|NCT01697592|459657556|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
127735474|NCT01697592|459657557|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
127735475|NCT01697592|459657558|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
127735476|NCT01697592|459657559|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
127735477|NCT01697592|459657560|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
127735478|NCT02396758|459657561|FG000|Overall Study|Withdrawal by Subject|2|||
127735479|NCT02396758|459657562|FG001|Overall Study|Withdrawal by Subject|0|||
127735480|NCT02396758|459657563|FG002|Overall Study|Withdrawal by Subject|0|||
127735481|NCT02396758|459657564|FG003|Overall Study|Withdrawal by Subject|1|||
127735482|NCT02396758|459657561|FG000|Overall Study|Lost to Follow-up|8|||
127735483|NCT02396758|459657562|FG001|Overall Study|Lost to Follow-up|5|||
127735484|NCT02396758|459657563|FG002|Overall Study|Lost to Follow-up|3|||
127735485|NCT02396758|459657564|FG003|Overall Study|Lost to Follow-up|3|||
127735486|NCT02396758|459657561|FG000|Overall Study|Death|1|||
127735487|NCT02396758|459657562|FG001|Overall Study|Death|1|||
127735488|NCT02396758|459657563|FG002|Overall Study|Death|0|||
127735489|NCT02396758|459657564|FG003|Overall Study|Death|1|||
127735490|NCT02396758|459657561|FG000|Overall Study|Randomized but not treated|1|||
127735491|NCT02396758|459657562|FG001|Overall Study|Randomized but not treated|0|||
127735492|NCT02396758|459657563|FG002|Overall Study|Randomized but not treated|1|||
127735493|NCT02396758|459657564|FG003|Overall Study|Randomized but not treated|0|||
127735494|NCT00265096|459657565|FG000|Overall Study|Adverse Event|14|||
127735495|NCT00265096|459657566|FG001|Overall Study|Adverse Event|18|||
127735496|NCT00265096|459657567|FG002|Overall Study|Adverse Event|18|||
127735497|NCT00265096|459657565|FG000|Overall Study|Lost to Follow-up|2|||
127735498|NCT00265096|459657566|FG001|Overall Study|Lost to Follow-up|5|||
127735499|NCT00265096|459657567|FG002|Overall Study|Lost to Follow-up|3|||
127806273|NCT02591615|459913373|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
127806274|NCT02591615|459913370|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
127806275|NCT02591615|459913371|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
127806276|NCT02591615|459913372|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
127806277|NCT02591615|459913373|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
127806278|NCT02591615|459913370|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
127806279|NCT02591615|459913371|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
127806280|NCT02591615|459913372|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
127806281|NCT02591615|459913373|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
127806282|NCT02591615|459913370|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
127806283|NCT02591615|459913371|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
127806284|NCT02591615|459913372|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
127806285|NCT02591615|459913373|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
127806286|NCT02591615|459913370|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
127806287|NCT02591615|459913371|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
127806288|NCT02591615|459913372|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
127892626|NCT00602030|460229598|FG001|Double-blind Phase|Adverse Event|0|||
127892627|NCT00602030|460229599|FG002|Double-blind Phase|Adverse Event|9|||
127892628|NCT00602030|460229600|FG003|Double-blind Phase|Adverse Event|18|||
127892629|NCT00602030|460229601|FG004|Double-blind Phase|Adverse Event|0|||
127806289|NCT02591615|459913373|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
127806290|NCT02591615|459913370|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
127806291|NCT02591615|459913371|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
127806292|NCT02591615|459913372|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
127806293|NCT02591615|459913373|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
127892630|NCT00602030|460229597|FG000|Double-blind Phase|Consent withdrawal|0|||
127806294|NCT02591615|459913370|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
127892631|NCT00602030|460229598|FG001|Double-blind Phase|Consent withdrawal|0|||
127892632|NCT00602030|460229599|FG002|Double-blind Phase|Consent withdrawal|4|||
127892633|NCT00602030|460229600|FG003|Double-blind Phase|Consent withdrawal|3|||
127892634|NCT00602030|460229601|FG004|Double-blind Phase|Consent withdrawal|0|||
127892635|NCT00602030|460229597|FG000|Double-blind Phase|Death|0|||
127735500|NCT00265096|459657565|FG000|Overall Study|Death|0|||
127735501|NCT00265096|459657566|FG001|Overall Study|Death|1|||
127735502|NCT00265096|459657567|FG002|Overall Study|Death|2|||
127735503|NCT00265096|459657565|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
127735504|NCT00265096|459657566|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
127735505|NCT00265096|459657567|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
127892636|NCT00602030|460229598|FG001|Double-blind Phase|Death|0|||
127892637|NCT00602030|460229599|FG002|Double-blind Phase|Death|3|||
127892638|NCT00602030|460229600|FG003|Double-blind Phase|Death|3|||
127892639|NCT00602030|460229601|FG004|Double-blind Phase|Death|0|||
127892640|NCT00602030|460229597|FG000|Double-blind Phase|Administrative decision|0|||
127892641|NCT00602030|460229598|FG001|Double-blind Phase|Administrative decision|0|||
127892642|NCT00602030|460229599|FG002|Double-blind Phase|Administrative decision|0|||
127892643|NCT00602030|460229600|FG003|Double-blind Phase|Administrative decision|2|||
127892644|NCT00602030|460229601|FG004|Double-blind Phase|Administrative decision|0|||
127892645|NCT00602030|460229597|FG000|Double-blind Phase|Ineligibility|0|||
127892646|NCT00602030|460229598|FG001|Double-blind Phase|Ineligibility|0|||
127892647|NCT00602030|460229599|FG002|Double-blind Phase|Ineligibility|0|||
127892648|NCT00602030|460229600|FG003|Double-blind Phase|Ineligibility|1|||
127892649|NCT00602030|460229601|FG004|Double-blind Phase|Ineligibility|0|||
127892650|NCT00602030|460229597|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
127892651|NCT00602030|460229598|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
127892652|NCT00602030|460229599|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
127892653|NCT00602030|460229600|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
127892654|NCT00602030|460229601|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
127892655|NCT00602030|460229597|FG000|Double-blind Phase|Reason not specified|0|||
127892656|NCT00602030|460229598|FG001|Double-blind Phase|Reason not specified|0|||
127892657|NCT00602030|460229599|FG002|Double-blind Phase|Reason not specified|4|||
127892658|NCT00602030|460229600|FG003|Double-blind Phase|Reason not specified|2|||
127892659|NCT00602030|460229601|FG004|Double-blind Phase|Reason not specified|0|||
127892660|NCT00602030|460229597|FG000|Crossover Phase|Disease Progression|0|||
127892661|NCT00602030|460229598|FG001|Crossover Phase|Disease Progression|0|||
127892662|NCT00602030|460229599|FG002|Crossover Phase|Disease Progression|0|||
127735506|NCT00265096|459657565|FG000|Overall Study|Other|11|||
127735507|NCT00265096|459657566|FG001|Overall Study|Other|19|||
127735508|NCT00265096|459657567|FG002|Overall Study|Other|10|||
127735509|NCT00774306|459657568|FG000|Overall Study|Adverse Event|3|||
127735510|NCT00774306|459657569|FG001|Overall Study|Adverse Event|0|||
127735511|NCT00774306|459657570|FG002|Overall Study|Adverse Event|0|||
127735512|NCT00774306|459657571|FG003|Overall Study|Adverse Event|0|||
127735513|NCT00774306|459657568|FG000|Overall Study|Protocol Violation|2|||
127735514|NCT00774306|459657569|FG001|Overall Study|Protocol Violation|0|||
127735515|NCT00774306|459657570|FG002|Overall Study|Protocol Violation|3|||
127735516|NCT00774306|459657571|FG003|Overall Study|Protocol Violation|0|||
127735517|NCT00774306|459657568|FG000|Overall Study|Withdrawal by Subject|6|||
127735518|NCT00774306|459657569|FG001|Overall Study|Withdrawal by Subject|1|||
127735519|NCT00774306|459657570|FG002|Overall Study|Withdrawal by Subject|1|||
127735520|NCT00774306|459657571|FG003|Overall Study|Withdrawal by Subject|0|||
127735521|NCT00774306|459657568|FG000|Overall Study|Lost to Follow-up|6|||
127735522|NCT00774306|459657569|FG001|Overall Study|Lost to Follow-up|0|||
127735523|NCT00774306|459657570|FG002|Overall Study|Lost to Follow-up|4|||
127735524|NCT00774306|459657571|FG003|Overall Study|Lost to Follow-up|5|||
127735525|NCT00774306|459657568|FG000|Overall Study|Death|1|||
127735526|NCT00774306|459657569|FG001|Overall Study|Death|1|||
127735527|NCT00774306|459657570|FG002|Overall Study|Death|0|||
127735528|NCT00774306|459657571|FG003|Overall Study|Death|0|||
127735529|NCT00666835|459657574|FG000|Overall Study|Withdrawal by Subject|5|||
127735530|NCT00666835|459657575|FG001|Overall Study|Withdrawal by Subject|2|||
127735531|NCT00666835|459657574|FG000|Overall Study|Lack of Efficacy|0|||
127735532|NCT00666835|459657575|FG001|Overall Study|Lack of Efficacy|1|||
127735533|NCT00666835|459657574|FG000|Overall Study|Incl./excl. not fulfilled|7|||
127735534|NCT00666835|459657575|FG001|Overall Study|Incl./excl. not fulfilled|2|||
127735535|NCT00666835|459657574|FG000|Overall Study|Adverse Event|7|||
127735536|NCT00666835|459657575|FG001|Overall Study|Adverse Event|6|||
127735537|NCT00666835|459657574|FG000|Overall Study|Protocol Violation|2|||
127735538|NCT00666835|459657575|FG001|Overall Study|Protocol Violation|0|||
127735539|NCT00666835|459657574|FG000|Overall Study|Death|15|||
127892663|NCT00602030|460229600|FG003|Crossover Phase|Disease Progression|0|||
127892664|NCT00602030|460229601|FG004|Crossover Phase|Disease Progression|11|||
127735540|NCT00666835|459657575|FG001|Overall Study|Death|4|||
127735541|NCT00666835|459657574|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
127735542|NCT00666835|459657575|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
127735543|NCT00666835|459657574|FG000|Overall Study|Hemoglobulin concentration|4|||
127735544|NCT00666835|459657575|FG001|Overall Study|Hemoglobulin concentration|3|||
127735545|NCT00666835|459657574|FG000|Overall Study|Planned operation|2|||
127892665|NCT00602030|460229597|FG000|Crossover Phase|Adverse Event|0|||
127892666|NCT00602030|460229598|FG001|Crossover Phase|Adverse Event|0|||
127892667|NCT00602030|460229599|FG002|Crossover Phase|Adverse Event|0|||
127892668|NCT00602030|460229600|FG003|Crossover Phase|Adverse Event|0|||
127892669|NCT00602030|460229601|FG004|Crossover Phase|Adverse Event|3|||
127735546|NCT00666835|459657575|FG001|Overall Study|Planned operation|0|||
127735547|NCT00666835|459657574|FG000|Overall Study|Physician Decision|1|||
127735548|NCT00666835|459657575|FG001|Overall Study|Physician Decision|2|||
127735549|NCT01126879|459657576|FG000|Overall Study|Progressive Disease|3|||
127735550|NCT01126879|459657577|FG001|Overall Study|Progressive Disease|1|||
127735551|NCT01126879|459657576|FG000|Overall Study|Withdrawal by Subject|1|||
127735552|NCT01126879|459657577|FG001|Overall Study|Withdrawal by Subject|0|||
127735553|NCT01126879|459657576|FG000|Overall Study|Adverse Event|0|||
127735554|NCT01126879|459657577|FG001|Overall Study|Adverse Event|1|||
127735555|NCT01126879|459657576|FG000|Overall Study|Physician Decision|1|||
127735556|NCT01126879|459657577|FG001|Overall Study|Physician Decision|0|||
127735557|NCT03319719|459657578|FG000|Overall Study|Lost to Follow-up|1|||
127735558|NCT00498433|459657579|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
127735559|NCT00498433|459657580|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
127735560|NCT00498433|459657581|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
127735561|NCT00498433|459657579|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
127735562|NCT00498433|459657580|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
127735563|NCT00498433|459657581|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
127735564|NCT00498433|459657579|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
127735565|NCT00498433|459657580|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
127735566|NCT00498433|459657581|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
127735567|NCT00498433|459657579|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
127735568|NCT00498433|459657580|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
127735569|NCT00498433|459657581|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
127735570|NCT00744796|459657582|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
127735571|NCT03193216|459657586|FG000|Overall Study|Lost to Follow-up|1|||
127892670|NCT00602030|460229597|FG000|Crossover Phase|Consent withdrawal|0|||
127892671|NCT00602030|460229598|FG001|Crossover Phase|Consent withdrawal|0|||
127735572|NCT03193216|459657587|FG001|Overall Study|Lost to Follow-up|0|||
127735573|NCT03193216|459657586|FG000|Overall Study|Withdrawal by Subject|5|||
127735574|NCT03193216|459657587|FG001|Overall Study|Withdrawal by Subject|0|||
127735575|NCT03193216|459657586|FG000|Overall Study|Physician Decision|4|||
127735576|NCT03193216|459657587|FG001|Overall Study|Physician Decision|0|||
127735577|NCT02316847|459657588|FG000|Overall Study|Adverse Event|0|||
127735578|NCT02316847|459657589|FG001|Overall Study|Adverse Event|3|||
127735579|NCT02316847|459657588|FG000|Overall Study|Lost to Follow-up|0|||
127735580|NCT02316847|459657589|FG001|Overall Study|Lost to Follow-up|2|||
127735581|NCT02316847|459657588|FG000|Overall Study|Physician Decision|0|||
127735582|NCT02316847|459657589|FG001|Overall Study|Physician Decision|1|||
127735583|NCT02316847|459657588|FG000|Overall Study|Pregnancy|0|||
127735584|NCT02316847|459657589|FG001|Overall Study|Pregnancy|1|||
127735585|NCT02316847|459657588|FG000|Overall Study|Withdrawal by Subject|2|||
127735586|NCT02316847|459657589|FG001|Overall Study|Withdrawal by Subject|9|||
127735587|NCT02316847|459657588|FG000|Overall Study|Noncompliance with study drug|0|||
127735588|NCT02316847|459657589|FG001|Overall Study|Noncompliance with study drug|3|||
127735589|NCT02316847|459657588|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
127735590|NCT02316847|459657589|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
127735591|NCT02236598|459657593|FG000|Overall Study|Adverse Event|0|||
127735592|NCT02236598|459657594|FG001|Overall Study|Adverse Event|1|||
127735593|NCT02236598|459657593|FG000|Overall Study|Withdrawal by Subject|0|||
127735594|NCT02236598|459657594|FG001|Overall Study|Withdrawal by Subject|1|||
127735595|NCT01264887|459657596|FG000|Overall Study|Adverse Event|5|||
127735596|NCT01264887|459657596|FG000|Overall Study|Death|7|||
127735597|NCT01264887|459657596|FG000|Overall Study|Lack of Efficacy|5|||
127735598|NCT01264887|459657596|FG000|Overall Study|Physician Decision|4|||
127735599|NCT01264887|459657596|FG000|Overall Study|Withdrawal by Subject|6|||
127735600|NCT01264887|459657596|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
127735601|NCT01264887|459657596|FG000|Overall Study|Other|2|||
127892672|NCT00602030|460229599|FG002|Crossover Phase|Consent withdrawal|0|||
127892673|NCT00602030|460229600|FG003|Crossover Phase|Consent withdrawal|0|||
127892674|NCT00602030|460229601|FG004|Crossover Phase|Consent withdrawal|2|||
127892675|NCT00638157|460229624|FG000|Overall Study|Adverse Event|0|||
127892676|NCT00638157|460229625|FG001|Overall Study|Adverse Event|1|||
127892677|NCT00638157|460229624|FG000|Overall Study|Clinical (symptomatic) failure|1|||
127892678|NCT00638157|460229625|FG001|Overall Study|Clinical (symptomatic) failure|1|||
127892679|NCT00638157|460229624|FG000|Overall Study|Microbiological failure|1|||
127892680|NCT00638157|460229625|FG001|Overall Study|Microbiological failure|0|||
127892681|NCT00638157|460229624|FG000|Overall Study|Lost to Follow-up|1|||
127892682|NCT00638157|460229625|FG001|Overall Study|Lost to Follow-up|0|||
127892683|NCT00638157|460229624|FG000|Overall Study|Physician Decision|1|||
127892684|NCT00638157|460229625|FG001|Overall Study|Physician Decision|0|||
127892685|NCT00638157|460229624|FG000|Overall Study|Other|1|||
127892686|NCT00638157|460229625|FG001|Overall Study|Other|2|||
127892687|NCT00638157|460229624|FG000|Overall Study|Randomized, not treated|2|||
127892688|NCT00638157|460229625|FG001|Overall Study|Randomized, not treated|0|||
127892689|NCT02649231|460229626|FG000|Overall Study|Adverse Event|0|||
127892690|NCT02649231|460229627|FG001|Overall Study|Adverse Event|0|||
127892691|NCT02649231|460229628|FG002|Overall Study|Adverse Event|0|||
127735602|NCT01061775|459657597|FG000|Overall Study|Physician Decision|2|||
127735603|NCT01061775|459657597|FG000|Overall Study|Lost to Follow-up|1|||
127735604|NCT01313299|459657600|FG000|Overall Study|Adverse Event|3|||
127735605|NCT01313299|459657601|FG001|Overall Study|Adverse Event|1|||
127735606|NCT01313299|459657602|FG002|Overall Study|Adverse Event|1|||
127735607|NCT01313299|459657600|FG000|Overall Study|Lost to Follow-up|1|||
127735608|NCT01313299|459657601|FG001|Overall Study|Lost to Follow-up|0|||
127735609|NCT01313299|459657602|FG002|Overall Study|Lost to Follow-up|0|||
127735610|NCT01313299|459657600|FG000|Overall Study|Protocol Violation|2|||
127735611|NCT01313299|459657601|FG001|Overall Study|Protocol Violation|0|||
127735612|NCT01313299|459657602|FG002|Overall Study|Protocol Violation|0|||
127735613|NCT01313299|459657600|FG000|Overall Study|Withdrawal by Subject|1|||
127735614|NCT01313299|459657601|FG001|Overall Study|Withdrawal by Subject|0|||
127735615|NCT01313299|459657602|FG002|Overall Study|Withdrawal by Subject|2|||
127735616|NCT01313299|459657600|FG000|Overall Study|Family reason and moved out of state|0|||
127735617|NCT01313299|459657601|FG001|Overall Study|Family reason and moved out of state|2|||
127735618|NCT01313299|459657602|FG002|Overall Study|Family reason and moved out of state|0|||
127735619|NCT01313299|459657600|FG000|Overall Study|Lack of subject compliance|0|||
127735620|NCT01313299|459657601|FG001|Overall Study|Lack of subject compliance|0|||
127735621|NCT01313299|459657602|FG002|Overall Study|Lack of subject compliance|1|||
127735622|NCT04089332|459657606|FG000|Overall Study|COVID-19 Pandemic safety issues|6|||
127735623|NCT04089332|459657606|FG000|Overall Study|Moved in the MRI, no analysis possible|1|||
127735624|NCT04089332|459657606|FG000|Overall Study|Completed only OGTT, no analysis possible|1|||
127735625|NCT03340766|459657607|FG000|Overall Study|Withdrawal by Subject|2|||
127735626|NCT03340766|459657608|FG001|Overall Study|Withdrawal by Subject|1|||
127735627|NCT03340766|459657609|FG002|Overall Study|Withdrawal by Subject|3|||
127735628|NCT03340766|459657607|FG000|Overall Study|Lost to Follow-up|0|||
127735629|NCT03340766|459657608|FG001|Overall Study|Lost to Follow-up|0|||
127735630|NCT03340766|459657609|FG002|Overall Study|Lost to Follow-up|1|||
127735631|NCT03340766|459657607|FG000|Overall Study|Death|6|||
127735632|NCT03340766|459657608|FG001|Overall Study|Death|7|||
127735633|NCT03340766|459657609|FG002|Overall Study|Death|4|||
127735634|NCT02256488|459657612|FG000|Overall Study|Lost to Follow-up|6|||
127735635|NCT02256488|459657613|FG001|Overall Study|Lost to Follow-up|6|||
127735636|NCT02256488|459657614|FG002|Overall Study|Lost to Follow-up|9|||
127735637|NCT02256488|459657615|FG003|Overall Study|Lost to Follow-up|3|||
127735638|NCT02256488|459657612|FG000|Overall Study|OTHER|1|||
127735639|NCT02256488|459657613|FG001|Overall Study|OTHER|0|||
127735640|NCT02256488|459657614|FG002|Overall Study|OTHER|1|||
127735641|NCT02256488|459657615|FG003|Overall Study|OTHER|1|||
127735642|NCT02256488|459657612|FG000|Overall Study|Withdrawal by Subject|1|||
127735643|NCT02256488|459657613|FG001|Overall Study|Withdrawal by Subject|0|||
127735644|NCT02256488|459657614|FG002|Overall Study|Withdrawal by Subject|0|||
127735645|NCT02256488|459657615|FG003|Overall Study|Withdrawal by Subject|2|||
127735646|NCT00975130|459657619|FG000|Study Part 1|Adverse Event|150|||
127735647|NCT00975130|459657620|FG001|Study Part 1|Adverse Event|0|||
127735648|NCT00975130|459657621|FG002|Study Part 1|Adverse Event|0|||
127735649|NCT00975130|459657619|FG000|Study Part 1|Lost to Follow-up|19|||
127735650|NCT00975130|459657620|FG001|Study Part 1|Lost to Follow-up|0|||
127735651|NCT00975130|459657621|FG002|Study Part 1|Lost to Follow-up|0|||
127735652|NCT00975130|459657619|FG000|Study Part 1|Withdrawal by Subject|61|||
127735653|NCT00975130|459657620|FG001|Study Part 1|Withdrawal by Subject|0|||
127735654|NCT00975130|459657621|FG002|Study Part 1|Withdrawal by Subject|0|||
127735655|NCT00975130|459657619|FG000|Study Part 1|Protocol Violation|13|||
127735656|NCT00975130|459657620|FG001|Study Part 1|Protocol Violation|0|||
127735657|NCT00975130|459657621|FG002|Study Part 1|Protocol Violation|0|||
127735658|NCT00975130|459657619|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
127735659|NCT00975130|459657620|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
127735660|NCT00975130|459657621|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
127735661|NCT00975130|459657619|FG000|Study Part 1|Administrative|4|||
127735662|NCT00975130|459657620|FG001|Study Part 1|Administrative|0|||
127735663|NCT00975130|459657621|FG002|Study Part 1|Administrative|0|||
127735664|NCT00975130|459657619|FG000|Study Part 1|Withdrew Consent|24|||
127735665|NCT00975130|459657620|FG001|Study Part 1|Withdrew Consent|0|||
127735666|NCT00975130|459657621|FG002|Study Part 1|Withdrew Consent|0|||
127735667|NCT00975130|459657619|FG000|Study Part 2|Adverse Event|0|||
127735668|NCT00975130|459657620|FG001|Study Part 2|Adverse Event|14|||
127735669|NCT00975130|459657621|FG002|Study Part 2|Adverse Event|7|||
127735670|NCT00975130|459657619|FG000|Study Part 2|Lost to Follow-up|0|||
127735671|NCT00975130|459657620|FG001|Study Part 2|Lost to Follow-up|0|||
127892692|NCT02649231|460229629|FG003|Overall Study|Adverse Event|1|||
127735672|NCT00975130|459657621|FG002|Study Part 2|Lost to Follow-up|1|||
127735673|NCT00975130|459657619|FG000|Study Part 2|Withdrawal by Subject|0|||
127735674|NCT00975130|459657620|FG001|Study Part 2|Withdrawal by Subject|13|||
127735675|NCT00975130|459657621|FG002|Study Part 2|Withdrawal by Subject|5|||
127735676|NCT00975130|459657619|FG000|Study Part 2|Withdrew Consent|0|||
127735677|NCT00975130|459657620|FG001|Study Part 2|Withdrew Consent|6|||
127735678|NCT00975130|459657621|FG002|Study Part 2|Withdrew Consent|2|||
127735679|NCT00975130|459657619|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
127735680|NCT00975130|459657620|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
127735681|NCT00975130|459657621|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
127735682|NCT00975130|459657619|FG000|Study Part 2|Administrative|0|||
127735683|NCT00975130|459657620|FG001|Study Part 2|Administrative|1|||
127735684|NCT00975130|459657621|FG002|Study Part 2|Administrative|0|||
127735685|NCT00975130|459657619|FG000|Study Part 2|Protocol Violation|0|||
127735686|NCT00975130|459657620|FG001|Study Part 2|Protocol Violation|0|||
127735687|NCT00975130|459657621|FG002|Study Part 2|Protocol Violation|1|||
127735688|NCT00734851|459657622|FG000|Overall Study|Withdrawal by Subject|2|||
127735689|NCT00734851|459657622|FG000|Overall Study|Lost to Follow-up|1|||
127735690|NCT00734851|459657622|FG000|Overall Study|Physician Decision|18|||
127735691|NCT00818519|459657623|FG000|Overall Study|Adverse Event|2|||
127735692|NCT00818519|459657624|FG001|Overall Study|Adverse Event|2|||
127735693|NCT00818519|459657623|FG000|Overall Study|Lost to Follow-up|4|||
127735694|NCT00818519|459657624|FG001|Overall Study|Lost to Follow-up|6|||
127735695|NCT00818519|459657623|FG000|Overall Study|Protocol Violation|2|||
127735696|NCT00818519|459657624|FG001|Overall Study|Protocol Violation|1|||
127735697|NCT00818519|459657623|FG000|Overall Study|Pregnancy|0|||
127735698|NCT00818519|459657624|FG001|Overall Study|Pregnancy|1|||
127735699|NCT00818519|459657623|FG000|Overall Study|Withdrawal by Subject|4|||
127735700|NCT00818519|459657624|FG001|Overall Study|Withdrawal by Subject|9|||
127735701|NCT00818519|459657623|FG000|Overall Study|participant recovered completely|1|||
127735702|NCT00818519|459657624|FG001|Overall Study|participant recovered completely|0|||
127735703|NCT00818519|459657623|FG000|Overall Study|participant will leave for long tme|1|||
127735704|NCT00818519|459657624|FG001|Overall Study|participant will leave for long tme|0|||
127735705|NCT03562117|459657625|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
127735706|NCT03562117|459657626|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
127735707|NCT03562117|459657627|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
127735708|NCT01294358|459657628|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
127735709|NCT01294358|459657629|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
127735710|NCT01294358|459657630|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
127735711|NCT01294358|459657631|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
127735712|NCT01294358|459657632|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
127735713|NCT01294358|459657628|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
127735714|NCT01294358|459657629|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
127735715|NCT01294358|459657630|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
127735716|NCT01294358|459657631|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
127735717|NCT01294358|459657632|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
127735718|NCT01294358|459657628|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
127735719|NCT01294358|459657629|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
127735720|NCT01294358|459657630|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
127735721|NCT01294358|459657631|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
127735722|NCT01294358|459657632|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
127735723|NCT01294358|459657628|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
127735724|NCT01294358|459657629|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
127735725|NCT01294358|459657630|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
127735726|NCT01294358|459657631|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
127735727|NCT01294358|459657632|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
127735728|NCT03356145|459657633|FG000|Overall Study|Withdrawal by Subject|2|||
127735729|NCT03356145|459657634|FG001|Overall Study|Withdrawal by Subject|1|||
127735730|NCT03356145|459657633|FG000|Overall Study|Did not meet inclusion criteria|1|||
127735731|NCT03356145|459657634|FG001|Overall Study|Did not meet inclusion criteria|0|||
127735732|NCT02963922|459657635|FG000|Overall Study|Adverse Event|15|||
127735733|NCT02963922|459657636|FG001|Overall Study|Adverse Event|6|||
127735734|NCT02963922|459657635|FG000|Overall Study|Protocol deviation|6|||
127735735|NCT02963922|459657636|FG001|Overall Study|Protocol deviation|6|||
127735736|NCT02963922|459657635|FG000|Overall Study|Lack of Efficacy|1|||
127735737|NCT02963922|459657636|FG001|Overall Study|Lack of Efficacy|1|||
127735738|NCT02963922|459657635|FG000|Overall Study|Lost to Follow-up|2|||
127735739|NCT02963922|459657636|FG001|Overall Study|Lost to Follow-up|3|||
127735740|NCT02963922|459657635|FG000|Overall Study|Other|8|||
127735741|NCT02963922|459657636|FG001|Overall Study|Other|14|||
127735742|NCT00655668|459657646|FG000|Overall Study|Adverse Event|6|||
127735743|NCT00655668|459657646|FG000|Overall Study|Death|5|||
127735744|NCT00655668|459657646|FG000|Overall Study|Disease Progression|27|||
127735745|NCT00655668|459657646|FG000|Overall Study|Study Terminated|9|||
127735746|NCT00655668|459657646|FG000|Overall Study|Other|1|||
127735747|NCT00655668|459657646|FG000|Overall Study|New Lymphoma Treatment Started|4|||
127735748|NCT00655668|459657646|FG000|Overall Study|Withdrawal by Subject|2|||
127735749|NCT03740919|459657647|FG000|Lead-in Period|Lost to Follow-up|1|||
127735750|NCT03740919|459657648|FG001|Lead-in Period|Lost to Follow-up|0|||
127735751|NCT03740919|459657649|FG002|Lead-in Period|Lost to Follow-up|0|||
127735752|NCT03740919|459657650|FG003|Lead-in Period|Lost to Follow-up|0|||
127735753|NCT03740919|459657647|FG000|Lead-in Period|Physician Decision|2|||
127735754|NCT03740919|459657648|FG001|Lead-in Period|Physician Decision|0|||
127735755|NCT03740919|459657649|FG002|Lead-in Period|Physician Decision|0|||
127735756|NCT03740919|459657650|FG003|Lead-in Period|Physician Decision|0|||
127735757|NCT03740919|459657647|FG000|Lead-in Period|Protocol Violation|1|||
127735758|NCT03740919|459657648|FG001|Lead-in Period|Protocol Violation|0|||
127735759|NCT03740919|459657649|FG002|Lead-in Period|Protocol Violation|0|||
127735760|NCT03740919|459657650|FG003|Lead-in Period|Protocol Violation|0|||
127735761|NCT03740919|459657647|FG000|Lead-in Period|Withdrawal by Subject|10|||
127735762|NCT03740919|459657648|FG001|Lead-in Period|Withdrawal by Subject|0|||
127735763|NCT03740919|459657649|FG002|Lead-in Period|Withdrawal by Subject|0|||
127735764|NCT03740919|459657650|FG003|Lead-in Period|Withdrawal by Subject|0|||
127735765|NCT03740919|459657647|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
127735766|NCT03740919|459657648|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
127735767|NCT03740919|459657649|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
127735768|NCT03740919|459657650|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
127735769|NCT03740919|459657647|FG000|Lead-in Period|Study Task Too Burdensome|1|||
127735770|NCT03740919|459657648|FG001|Lead-in Period|Study Task Too Burdensome|0|||
127735771|NCT03740919|459657649|FG002|Lead-in Period|Study Task Too Burdensome|0|||
127735772|NCT03740919|459657650|FG003|Lead-in Period|Study Task Too Burdensome|0|||
127735773|NCT03740919|459657647|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
127735774|NCT03740919|459657648|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
127735775|NCT03740919|459657649|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
127735776|NCT03740919|459657650|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
127735777|NCT03740919|459657647|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
127735778|NCT03740919|459657648|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
127735779|NCT03740919|459657649|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
127735780|NCT03740919|459657650|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
127735781|NCT03740919|459657647|FG000|Treatment Period|Adverse Event|0|||
127735782|NCT03740919|459657648|FG001|Treatment Period|Adverse Event|0|||
127735783|NCT03740919|459657649|FG002|Treatment Period|Adverse Event|2|||
127735784|NCT03740919|459657650|FG003|Treatment Period|Adverse Event|0|||
127735785|NCT03740919|459657647|FG000|Treatment Period|Protocol Violation|0|||
127735786|NCT03740919|459657648|FG001|Treatment Period|Protocol Violation|1|||
127735787|NCT03740919|459657649|FG002|Treatment Period|Protocol Violation|0|||
127735788|NCT03740919|459657650|FG003|Treatment Period|Protocol Violation|0|||
127735789|NCT03740919|459657647|FG000|Treatment Period|Withdrawal by Subject|0|||
127735790|NCT03740919|459657648|FG001|Treatment Period|Withdrawal by Subject|7|||
127735791|NCT03740919|459657649|FG002|Treatment Period|Withdrawal by Subject|6|||
127735792|NCT03740919|459657650|FG003|Treatment Period|Withdrawal by Subject|2|||
127735793|NCT03740919|459657647|FG000|Treatment Period|Terminated by Sponsor|0|||
127735794|NCT03740919|459657648|FG001|Treatment Period|Terminated by Sponsor|1|||
127735795|NCT03740919|459657649|FG002|Treatment Period|Terminated by Sponsor|0|||
127735796|NCT03740919|459657650|FG003|Treatment Period|Terminated by Sponsor|0|||
127735797|NCT03740919|459657647|FG000|Treatment Period|Issue with Insulin Pump|0|||
127735798|NCT03740919|459657648|FG001|Treatment Period|Issue with Insulin Pump|1|||
127735799|NCT03740919|459657649|FG002|Treatment Period|Issue with Insulin Pump|0|||
127735800|NCT03740919|459657650|FG003|Treatment Period|Issue with Insulin Pump|0|||
127735801|NCT03740919|459657647|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
127735802|NCT03740919|459657648|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
127735803|NCT03740919|459657649|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
127735804|NCT03740919|459657650|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
127735805|NCT03740919|459657647|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
127735806|NCT03740919|459657648|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
127735807|NCT03740919|459657649|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
127806295|NCT02591615|459913371|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
127806296|NCT02591615|459913372|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
127806297|NCT02591615|459913373|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
127806298|NCT02591615|459913370|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
127806299|NCT02591615|459913371|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
127806300|NCT02591615|459913372|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
127806301|NCT02591615|459913373|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
127892693|NCT02649231|460229626|FG000|Overall Study|Lost to Follow-up|2|||
127892694|NCT02649231|460229627|FG001|Overall Study|Lost to Follow-up|1|||
127735808|NCT03740919|459657650|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
127735809|NCT03740919|459657647|FG000|Treatment Period|Not Completing Diary|0|||
127735810|NCT03740919|459657648|FG001|Treatment Period|Not Completing Diary|0|||
127735811|NCT03740919|459657649|FG002|Treatment Period|Not Completing Diary|1|||
127806302|NCT02591615|459913370|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
127806303|NCT02591615|459913371|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
127806304|NCT02591615|459913372|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
127892695|NCT02649231|460229628|FG002|Overall Study|Lost to Follow-up|1|||
127735812|NCT03740919|459657650|FG003|Treatment Period|Not Completing Diary|0|||
127735813|NCT03740919|459657647|FG000|Treatment Period|Insulin Painful to Participant|0|||
127735814|NCT03740919|459657648|FG001|Treatment Period|Insulin Painful to Participant|0|||
127735815|NCT03740919|459657649|FG002|Treatment Period|Insulin Painful to Participant|1|||
127735816|NCT03740919|459657650|FG003|Treatment Period|Insulin Painful to Participant|0|||
127735817|NCT03873038|459657653|FG000|Part 2|Withdrawal by Subject|0|||
127735818|NCT03873038|459657654|FG001|Part 2|Withdrawal by Subject|0|||
127735819|NCT03873038|459657655|FG002|Part 2|Withdrawal by Subject|0|||
127735820|NCT03873038|459657656|FG003|Part 2|Withdrawal by Subject|0|||
127735821|NCT03873038|459657657|FG004|Part 2|Withdrawal by Subject|0|||
127735822|NCT03873038|459657658|FG005|Part 2|Withdrawal by Subject|1|||
127735823|NCT03873038|459657653|FG000|Part 2|Unknon|0|||
127735824|NCT03873038|459657654|FG001|Part 2|Unknon|0|||
127735825|NCT03873038|459657655|FG002|Part 2|Unknon|0|||
127735826|NCT03873038|459657656|FG003|Part 2|Unknon|0|||
127735827|NCT03873038|459657657|FG004|Part 2|Unknon|1|||
127735828|NCT03873038|459657658|FG005|Part 2|Unknon|0|||
127735829|NCT04222088|459657659|FG000|Overall Study|Lost to Follow-up|5|||
127735830|NCT04222088|459657660|FG001|Overall Study|Lost to Follow-up|1|||
127735831|NCT04222088|459657659|FG000|Overall Study|Withdrawal by Subject|4|||
127735832|NCT04222088|459657660|FG001|Overall Study|Withdrawal by Subject|0|||
127735833|NCT00595764|459657661|FG000|Overall Study|Protocol Violation|24|||
127735834|NCT00595764|459657662|FG001|Overall Study|Protocol Violation|19|||
127735835|NCT00595764|459657661|FG000|Overall Study|Missed Medication >1 week|10|||
127735836|NCT00595764|459657662|FG001|Overall Study|Missed Medication >1 week|17|||
127735837|NCT00595764|459657661|FG000|Overall Study|Missed 3 PM visits|1|||
127735838|NCT00595764|459657662|FG001|Overall Study|Missed 3 PM visits|7|||
127735839|NCT00595764|459657661|FG000|Overall Study|Withdrawal by Subject|4|||
127735840|NCT00595764|459657662|FG001|Overall Study|Withdrawal by Subject|0|||
127735841|NCT01332318|459657663|FG000|Overall Study|Adverse Event|0|||
127735842|NCT01332318|459657664|FG001|Overall Study|Adverse Event|3|||
127735843|NCT01332318|459657665|FG002|Overall Study|Adverse Event|0|||
127735844|NCT01332318|459657666|FG003|Overall Study|Adverse Event|0|||
127735845|NCT01332318|459657663|FG000|Overall Study|Withdrawal by Subject|1|||
127735846|NCT01332318|459657664|FG001|Overall Study|Withdrawal by Subject|1|||
127735847|NCT01332318|459657665|FG002|Overall Study|Withdrawal by Subject|0|||
127735848|NCT01332318|459657666|FG003|Overall Study|Withdrawal by Subject|1|||
127735849|NCT01332318|459657663|FG000|Overall Study|Protocol Violation|1|||
127735850|NCT01332318|459657664|FG001|Overall Study|Protocol Violation|0|||
127735851|NCT01332318|459657665|FG002|Overall Study|Protocol Violation|1|||
127735852|NCT01332318|459657666|FG003|Overall Study|Protocol Violation|1|||
127735853|NCT02820298|459657669|FG000|Overall Study|Withdrawal by Subject|0|||
127735854|NCT02820298|459657670|FG001|Overall Study|Withdrawal by Subject|1|||
127735855|NCT02820298|459657669|FG000|Overall Study|Physician Decision|1|||
127735856|NCT02820298|459657670|FG001|Overall Study|Physician Decision|0|||
127735857|NCT02820298|459657669|FG000|Overall Study|Protocol Violation|0|||
127735858|NCT02820298|459657670|FG001|Overall Study|Protocol Violation|1|||
127735859|NCT01894256|459657671|FG000|Part A|Adverse Event|0|||
127735860|NCT01894256|459657672|FG001|Part A|Adverse Event|1|||
127735861|NCT01894256|459657673|FG002|Part A|Adverse Event|0|||
127735862|NCT01894256|459657671|FG000|Part B|Death|0|||
127735863|NCT01894256|459657672|FG001|Part B|Death|1|||
127735864|NCT01894256|459657673|FG002|Part B|Death|1|||
127735865|NCT01894256|459657671|FG000|Part B|Withdrawal by Subject|0|||
127735866|NCT01894256|459657672|FG001|Part B|Withdrawal by Subject|1|||
127735867|NCT01894256|459657673|FG002|Part B|Withdrawal by Subject|0|||
127735868|NCT01894256|459657671|FG000|Part B|Lack of Efficacy|15|||
127735869|NCT01894256|459657672|FG001|Part B|Lack of Efficacy|12|||
127806305|NCT02591615|459913373|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
127806306|NCT02591615|459913370|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
127806307|NCT02591615|459913371|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
127806308|NCT02591615|459913372|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
127806309|NCT02591615|459913373|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
127735870|NCT01894256|459657673|FG002|Part B|Lack of Efficacy|13|||
127735871|NCT01780584|459657674|FG000|Overall Study|Death|1|||
127735872|NCT01780584|459657675|FG001|Overall Study|Death|0|||
127735873|NCT01780584|459657676|FG002|Overall Study|Death|1|||
127735874|NCT01780584|459657674|FG000|Overall Study|Adverse Event|0|||
127735875|NCT01780584|459657675|FG001|Overall Study|Adverse Event|1|||
127735876|NCT01780584|459657676|FG002|Overall Study|Adverse Event|0|||
127806310|NCT02591615|459913370|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
127806311|NCT02591615|459913371|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
127806312|NCT02591615|459913372|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
127806313|NCT02591615|459913373|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
127735877|NCT01780584|459657674|FG000|Overall Study|Protocol Violation|0|||
127735878|NCT01780584|459657675|FG001|Overall Study|Protocol Violation|0|||
127735879|NCT01780584|459657676|FG002|Overall Study|Protocol Violation|1|||
127735880|NCT04783519|459657677|FG000|Overall Study|Withdrawal by Subject|2|||
127735881|NCT04783519|459657678|FG001|Overall Study|Withdrawal by Subject|7|||
127735882|NCT04783519|459657679|FG002|Overall Study|Withdrawal by Subject|3|||
127735883|NCT04783519|459657677|FG000|Overall Study|Lost to Follow-up|9|||
127735884|NCT04783519|459657678|FG001|Overall Study|Lost to Follow-up|7|||
127735885|NCT04783519|459657679|FG002|Overall Study|Lost to Follow-up|6|||
127735886|NCT00727259|459657680|FG000|Overall Study|Not all questionnaires completed|1055|||
127735887|NCT01021683|459657681|FG000|Overall Study|Lack of Efficacy|12|||
127735888|NCT01021683|459657681|FG000|Overall Study|Recovery of neutrophil count|51|||
127892696|NCT02649231|460229629|FG003|Overall Study|Lost to Follow-up|0|||
127735889|NCT01021683|459657681|FG000|Overall Study|Other|8|||
127735890|NCT00500539|459657682|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
127735891|NCT00500539|459657682|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
127735892|NCT00500539|459657682|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
127735893|NCT00500539|459657682|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
127735894|NCT00500539|459657682|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
127735895|NCT00500539|459657682|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
127735896|NCT00500539|459657682|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
127735897|NCT00500539|459657682|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
127735898|NCT00500539|459657682|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
127735899|NCT00500539|459657682|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
127735900|NCT00500539|459657682|FG000|Follow-up Period (16 Weeks)|Death|1|||
127735901|NCT00500539|459657682|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
127735902|NCT00500539|459657682|FG000|Follow-up Period (16 Weeks)|Missing|3|||
127735903|NCT00645099|459657683|FG000|Overall Study|Lack of Efficacy|15|||
127735904|NCT00645099|459657684|FG001|Overall Study|Lack of Efficacy|6|||
127735905|NCT00645099|459657683|FG000|Overall Study|Withdrawal by Subject|30|||
127735906|NCT00645099|459657684|FG001|Overall Study|Withdrawal by Subject|22|||
127735907|NCT00645099|459657683|FG000|Overall Study|Lost to Follow-up|6|||
127735908|NCT00645099|459657684|FG001|Overall Study|Lost to Follow-up|4|||
127735909|NCT00645099|459657683|FG000|Overall Study|Adverse Event|11|||
127735910|NCT00645099|459657684|FG001|Overall Study|Adverse Event|5|||
127735911|NCT00645099|459657683|FG000|Overall Study|Other|9|||
127735912|NCT00645099|459657684|FG001|Overall Study|Other|5|||
127735913|NCT01201915|459657685|FG000|Overall Study|Adverse Event|2|||
127735914|NCT01201915|459657686|FG001|Overall Study|Adverse Event|1|||
127735915|NCT01201915|459657687|FG002|Overall Study|Adverse Event|1|||
127735916|NCT01201915|459657685|FG000|Overall Study|Lost to Follow-up|0|||
127735917|NCT01201915|459657686|FG001|Overall Study|Lost to Follow-up|4|||
127735918|NCT01201915|459657687|FG002|Overall Study|Lost to Follow-up|0|||
127806314|NCT02591615|459913370|FG000|Maintenance MK-3475|Adverse Event|0|||
127806315|NCT02591615|459913371|FG001|Maintenance MK-3475|Adverse Event|3|||
127806316|NCT02591615|459913372|FG002|Maintenance MK-3475|Adverse Event|1|||
127806317|NCT02591615|459913373|FG003|Maintenance MK-3475|Adverse Event|2|||
127806318|NCT02591615|459913370|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
127806319|NCT02591615|459913371|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
127806320|NCT02591615|459913372|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
127806321|NCT02591615|459913373|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
127806322|NCT02591615|459913370|FG000|Maintenance MK-3475|Death|0|||
127806323|NCT02591615|459913371|FG001|Maintenance MK-3475|Death|1|||
127806324|NCT02591615|459913372|FG002|Maintenance MK-3475|Death|1|||
127806325|NCT02591615|459913373|FG003|Maintenance MK-3475|Death|0|||
127806326|NCT02591615|459913370|FG000|Maintenance MK-3475|Physician discretion|0|||
127806327|NCT02591615|459913371|FG001|Maintenance MK-3475|Physician discretion|0|||
127806328|NCT02591615|459913372|FG002|Maintenance MK-3475|Physician discretion|1|||
127806329|NCT02591615|459913373|FG003|Maintenance MK-3475|Physician discretion|0|||
127806330|NCT02591615|459913370|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
127806331|NCT02591615|459913371|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
127806332|NCT02591615|459913372|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
127806333|NCT02591615|459913373|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
127806334|NCT02591615|459913370|FG000|Maintenance MK-3475|In active treatment|2|||
127806335|NCT02591615|459913371|FG001|Maintenance MK-3475|In active treatment|0|||
127892697|NCT02649231|460229626|FG000|Overall Study|Withdrawal by Subject|0|||
127892698|NCT02649231|460229627|FG001|Overall Study|Withdrawal by Subject|1|||
127892699|NCT02649231|460229628|FG002|Overall Study|Withdrawal by Subject|0|||
127892700|NCT02649231|460229629|FG003|Overall Study|Withdrawal by Subject|1|||
127892701|NCT02649231|460229626|FG000|Overall Study|Protocol Violation|2|||
127892702|NCT02649231|460229627|FG001|Overall Study|Protocol Violation|1|||
127892703|NCT02649231|460229628|FG002|Overall Study|Protocol Violation|1|||
127892704|NCT02649231|460229629|FG003|Overall Study|Protocol Violation|0|||
127735919|NCT01201915|459657685|FG000|Overall Study|Physician Decision|3|||
127806336|NCT02591615|459913372|FG002|Maintenance MK-3475|In active treatment|0|||
127806337|NCT02591615|459913373|FG003|Maintenance MK-3475|In active treatment|1|||
127806338|NCT04574999|459913376|FG000|Overall Study|Adverse Event|1|||
127806339|NCT04574999|459913377|FG001|Overall Study|Adverse Event|0|||
127892705|NCT01214330|460229630|FG000|Overall Study|Withdrawal by Subject|2|||
127735920|NCT01201915|459657686|FG001|Overall Study|Physician Decision|0|||
127735921|NCT01201915|459657687|FG002|Overall Study|Physician Decision|0|||
127735922|NCT01201915|459657685|FG000|Overall Study|Subject Decision|3|||
127806340|NCT04574999|459913376|FG000|Overall Study|Lack of Efficacy|2|||
127892706|NCT01214330|460229630|FG000|Overall Study|Withdrawal by Subject|2|||
127806341|NCT04574999|459913377|FG001|Overall Study|Lack of Efficacy|3|||
127806342|NCT04574999|459913376|FG000|Overall Study|Protocol Violation|1|||
127806343|NCT04574999|459913377|FG001|Overall Study|Protocol Violation|0|||
127806344|NCT04574999|459913376|FG000|Overall Study|Withdrawal by Subject|2|||
127806345|NCT04574999|459913377|FG001|Overall Study|Withdrawal by Subject|2|||
127806346|NCT04574999|459913376|FG000|Overall Study|Lost to Follow-up|1|||
127806347|NCT04574999|459913377|FG001|Overall Study|Lost to Follow-up|0|||
127806348|NCT04574999|459913376|FG000|Overall Study|Personal problems|1|||
127806349|NCT04574999|459913377|FG001|Overall Study|Personal problems|0|||
127806350|NCT04574999|459913376|FG000|Overall Study|Previous planned surgery|1|||
127806351|NCT04574999|459913377|FG001|Overall Study|Previous planned surgery|0|||
127892707|NCT00686036|460229632|FG000|Overall Study|Adverse Event|3|||
127735923|NCT01201915|459657686|FG001|Overall Study|Subject Decision|3|||
127735924|NCT01201915|459657687|FG002|Overall Study|Subject Decision|5|||
127735925|NCT01201915|459657685|FG000|Overall Study|Target Lesion Progression|0|||
127735926|NCT01201915|459657686|FG001|Overall Study|Target Lesion Progression|3|||
127735927|NCT01201915|459657687|FG002|Overall Study|Target Lesion Progression|0|||
127735928|NCT03406507|459657688|FG000|Extension Period|Lack of Efficacy|0|||
127735929|NCT03406507|459657689|FG001|Extension Period|Lack of Efficacy|1|||
127735930|NCT00663923|459657690|FG000|Overall Study|Lost to Follow-up|2|||
127735931|NCT00547300|459657691|FG000|Overall Study|Study was Administratively Terminated|25|||
127735932|NCT00547300|459657692|FG001|Overall Study|Study was Administratively Terminated|24|||
127735933|NCT00547300|459657691|FG000|Overall Study|Did not Meet Entry Criteria|0|||
127735934|NCT00547300|459657692|FG001|Overall Study|Did not Meet Entry Criteria|2|||
127735935|NCT04380688|459657695|FG000|Overall Study|Death|2|||
127735936|NCT04380688|459657696|FG001|Overall Study|Death|2|||
127735937|NCT04380688|459657695|FG000|Overall Study|Lost to Follow-up|2|||
127735938|NCT04380688|459657696|FG001|Overall Study|Lost to Follow-up|4|||
127735939|NCT04380688|459657695|FG000|Overall Study|Withdrawal by Subject|3|||
127735940|NCT04380688|459657696|FG001|Overall Study|Withdrawal by Subject|3|||
127735941|NCT01967719|459659029|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
127735942|NCT01967719|459659030|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
127735943|NCT01967719|459659031|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
127735944|NCT01967719|459659032|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
127735945|NCT01967719|459659029|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
127735946|NCT01967719|459659030|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
127735947|NCT01967719|459659031|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
127735948|NCT01967719|459659032|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
127735949|NCT00796614|459659033|FG000|Overall Study|Adverse Event|1|||
127735950|NCT00796614|459659034|FG001|Overall Study|Adverse Event|2|||
127735951|NCT00796614|459659035|FG002|Overall Study|Adverse Event|0|||
127735952|NCT00796614|459659036|FG003|Overall Study|Adverse Event|0|||
127735953|NCT00796614|459659033|FG000|Overall Study|Protocol Violation|0|||
127735954|NCT00796614|459659034|FG001|Overall Study|Protocol Violation|0|||
127735955|NCT00796614|459659035|FG002|Overall Study|Protocol Violation|2|||
127735956|NCT00796614|459659036|FG003|Overall Study|Protocol Violation|0|||
127735957|NCT00796614|459659033|FG000|Overall Study|Lost to Follow-up|2|||
127735958|NCT00796614|459659034|FG001|Overall Study|Lost to Follow-up|2|||
127735959|NCT00796614|459659035|FG002|Overall Study|Lost to Follow-up|1|||
127735960|NCT00796614|459659036|FG003|Overall Study|Lost to Follow-up|0|||
127735961|NCT00796614|459659033|FG000|Overall Study|Withdrawal by Subject|1|||
127735962|NCT00796614|459659034|FG001|Overall Study|Withdrawal by Subject|0|||
127735963|NCT00796614|459659035|FG002|Overall Study|Withdrawal by Subject|0|||
127735964|NCT00796614|459659036|FG003|Overall Study|Withdrawal by Subject|1|||
127735965|NCT00796614|459659033|FG000|Overall Study|Other than stated|1|||
127735966|NCT00796614|459659034|FG001|Overall Study|Other than stated|0|||
127735967|NCT00796614|459659035|FG002|Overall Study|Other than stated|0|||
127735968|NCT00796614|459659036|FG003|Overall Study|Other than stated|0|||
127735969|NCT00381888|459659037|FG000|Overall Study|Death|1|||
127735970|NCT00381888|459659037|FG000|Overall Study|Withdrawal by Subject|1|||
127735971|NCT00381888|459659037|FG000|Overall Study|Physician Decision|1|||
127735972|NCT00381888|459659037|FG000|Overall Study|Protocol Violation|9|||
127735973|NCT00381888|459659037|FG000|Overall Study|Had laparoscopic surgery|2|||
127735974|NCT00381888|459659037|FG000|Overall Study|Surgery was cancelled|2|||
127735975|NCT00381888|459659037|FG000|Overall Study|Adverse Event|1|||
127735976|NCT03449134|459659038|FG000|52-Week Treatment Period|Death|2|||
127735977|NCT03449134|459659039|FG001|52-Week Treatment Period|Death|1|||
127735978|NCT03449134|459659040|FG002|52-Week Treatment Period|Death|0|||
127735979|NCT03449134|459659038|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
127735980|NCT03449134|459659039|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
127735981|NCT03449134|459659040|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
127735982|NCT03449134|459659038|FG000|52-Week Treatment Period|Physician Decision|2|||
127735983|NCT03449134|459659039|FG001|52-Week Treatment Period|Physician Decision|3|||
127735984|NCT03449134|459659040|FG002|52-Week Treatment Period|Physician Decision|3|||
127735985|NCT03449134|459659038|FG000|52-Week Treatment Period|Screen Failure|1|||
127806352|NCT00008385|459913397|FG000|Overall Study|Off treatment reasons not reported|79|||
127806353|NCT00008385|459913398|FG001|Overall Study|Off treatment reasons not reported|70|||
127806354|NCT00008385|459913397|FG000|Overall Study|Progressive disease|52|||
127806355|NCT00008385|459913398|FG001|Overall Study|Progressive disease|117|||
127806356|NCT00008385|459913397|FG000|Overall Study|Adverse Event|8|||
127806357|NCT00008385|459913398|FG001|Overall Study|Adverse Event|20|||
127806358|NCT00008385|459913397|FG000|Overall Study|Death|12|||
127806359|NCT00008385|459913398|FG001|Overall Study|Death|18|||
127806360|NCT00008385|459913397|FG000|Overall Study|Withdrawal by Subject|67|||
127806361|NCT00008385|459913398|FG001|Overall Study|Withdrawal by Subject|157|||
127806362|NCT00008385|459913397|FG000|Overall Study|Start non-protocol therapy|3|||
127735986|NCT03449134|459659039|FG001|52-Week Treatment Period|Screen Failure|0|||
127735987|NCT03449134|459659040|FG002|52-Week Treatment Period|Screen Failure|1|||
127735988|NCT03449134|459659038|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
127735989|NCT03449134|459659039|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
127735990|NCT03449134|459659040|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
127735991|NCT03449134|459659038|FG000|52-Week Treatment Period|Site Closure|1|||
127735992|NCT03449134|459659039|FG001|52-Week Treatment Period|Site Closure|0|||
127735993|NCT03449134|459659040|FG002|52-Week Treatment Period|Site Closure|0|||
127735994|NCT00957996|459659046|FG000|Overall Study|Death|4|||
127735995|NCT00957996|459659047|FG001|Overall Study|Death|10|||
127735996|NCT00957996|459659046|FG000|Overall Study|Lost to Follow-up|4|||
127735997|NCT00957996|459659047|FG001|Overall Study|Lost to Follow-up|7|||
127735998|NCT00957996|459659046|FG000|Overall Study|Withdrawal by Subject|9|||
127735999|NCT00957996|459659047|FG001|Overall Study|Withdrawal by Subject|2|||
127736000|NCT00957996|459659046|FG000|Overall Study|Adverse Event|2|||
127736001|NCT00957996|459659047|FG001|Overall Study|Adverse Event|1|||
127736002|NCT00957996|459659046|FG000|Overall Study|Physician Decision|1|||
127736003|NCT00957996|459659047|FG001|Overall Study|Physician Decision|1|||
127736004|NCT00957996|459659046|FG000|Overall Study|Influenza-related complication|0|||
127736005|NCT00957996|459659047|FG001|Overall Study|Influenza-related complication|1|||
127736006|NCT00957996|459659046|FG000|Overall Study|Missing|1|||
127736007|NCT00957996|459659047|FG001|Overall Study|Missing|0|||
127736008|NCT00957996|459659046|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
127736009|NCT00957996|459659047|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
127736010|NCT01960348|459659055|FG000|Overall Study|Adverse event, not serious|2|||
127736011|NCT01960348|459659056|FG001|Overall Study|Adverse event, not serious|2|||
127736012|NCT01960348|459659055|FG000|Overall Study|Adverse event, serious fatal|6|||
127736013|NCT01960348|459659056|FG001|Overall Study|Adverse event, serious fatal|5|||
127736014|NCT01960348|459659055|FG000|Overall Study|Adverse event, serious non-fatal|0|||
127736015|NCT01960348|459659056|FG001|Overall Study|Adverse event, serious non-fatal|3|||
127736016|NCT01960348|459659055|FG000|Overall Study|Withdrawal by Subject|1|||
127736017|NCT01960348|459659056|FG001|Overall Study|Withdrawal by Subject|11|||
127736018|NCT01960348|459659055|FG000|Overall Study|Physician Decision|0|||
127736019|NCT01960348|459659056|FG001|Overall Study|Physician Decision|1|||
127736020|NCT01960348|459659055|FG000|Overall Study|Protocol Violation|1|||
127736021|NCT01960348|459659056|FG001|Overall Study|Protocol Violation|0|||
127736022|NCT01580995|459659057|FG000|Overall Study|Lost to Follow-up|2|||
127736023|NCT01580995|459659058|FG001|Overall Study|Lost to Follow-up|2|||
127736024|NCT02916706|459659059|FG000|Overall Study|Adverse Event|0|||
127736025|NCT02916706|459659060|FG001|Overall Study|Adverse Event|1|||
127736026|NCT02916706|459659059|FG000|Overall Study|Lost to Follow-up|0|||
127736027|NCT02916706|459659060|FG001|Overall Study|Lost to Follow-up|1|||
127736028|NCT02916706|459659059|FG000|Overall Study|Physician Decision|1|||
127736029|NCT02916706|459659060|FG001|Overall Study|Physician Decision|0|||
127736030|NCT02916706|459659059|FG000|Overall Study|Protocol Violation|3|||
127736031|NCT02916706|459659060|FG001|Overall Study|Protocol Violation|1|||
127736032|NCT02916706|459659059|FG000|Overall Study|Withdrawal by Subject|6|||
127736033|NCT02916706|459659060|FG001|Overall Study|Withdrawal by Subject|9|||
127806363|NCT00008385|459913398|FG001|Overall Study|Start non-protocol therapy|1|||
127806364|NCT00008385|459913397|FG000|Overall Study|Other complicating disease|17|||
127806365|NCT00008385|459913398|FG001|Overall Study|Other complicating disease|30|||
127806366|NCT00008385|459913397|FG000|Overall Study|Maximum dose reached|0|||
127806367|NCT00008385|459913398|FG001|Overall Study|Maximum dose reached|2|||
127806368|NCT00008385|459913397|FG000|Overall Study|Other|105|||
127806369|NCT00008385|459913398|FG001|Overall Study|Other|212|||
127806370|NCT00008385|459913397|FG000|Overall Study|Not start protocol therapy|44|||
127736034|NCT02916706|459659059|FG000|Overall Study|Other|5|||
127806371|NCT00008385|459913398|FG001|Overall Study|Not start protocol therapy|175|||
127892708|NCT00686036|460229633|FG001|Overall Study|Adverse Event|0|||
127736035|NCT02916706|459659060|FG001|Overall Study|Other|19|||
127736036|NCT00275301|459659061|FG000|Overall Study|Adverse Event|5|||
127736037|NCT02561078|459659070|FG000|Overall Study|Adverse Event|5|||
127736038|NCT02561078|459659071|FG001|Overall Study|Adverse Event|2|||
127736039|NCT02561078|459659070|FG000|Overall Study|Death|2|||
127736040|NCT02561078|459659071|FG001|Overall Study|Death|1|||
127736041|NCT02561078|459659070|FG000|Overall Study|Lost to Follow-up|2|||
127736042|NCT02561078|459659071|FG001|Overall Study|Lost to Follow-up|6|||
127736043|NCT02561078|459659070|FG000|Overall Study|Non-Compliance with Study Drug|6|||
127736044|NCT02561078|459659071|FG001|Overall Study|Non-Compliance with Study Drug|3|||
127736045|NCT02561078|459659070|FG000|Overall Study|Physician Decision|2|||
127736046|NCT02561078|459659071|FG001|Overall Study|Physician Decision|3|||
127736047|NCT02561078|459659070|FG000|Overall Study|Withdrawal by Subject|13|||
127736048|NCT02561078|459659071|FG001|Overall Study|Withdrawal by Subject|10|||
127736049|NCT00598871|459659074|FG000|Overall Study|Adverse Event|0|||
127736050|NCT00598871|459659075|FG001|Overall Study|Adverse Event|1|||
127736051|NCT01194271|459659076|FG000|Overall Study|Withdrawal by Subject|1|||
127736052|NCT01194271|459659076|FG000|Overall Study|Ineligible, Screen Failure|1|||
127736053|NCT01194271|459659076|FG000|Overall Study|Death|1|||
127736054|NCT01983462|459659077|FG000|Overall Study|Adverse Event|1|||
127736055|NCT01983462|459659078|FG001|Overall Study|Adverse Event|0|||
127736056|NCT01983462|459659079|FG002|Overall Study|Adverse Event|0|||
127736057|NCT00381797|459659080|FG000|Overall Study|Withdrawal by Subject|1|||
127736058|NCT00381797|459659081|FG001|Overall Study|Withdrawal by Subject|1|||
127736059|NCT00381797|459659082|FG002|Overall Study|Withdrawal by Subject|0|||
127736060|NCT00381797|459659083|FG003|Overall Study|Withdrawal by Subject|0|||
127736061|NCT00381797|459659084|FG004|Overall Study|Withdrawal by Subject|2|||
127736062|NCT00381797|459659080|FG000|Overall Study|Ineligible|0|||
127736063|NCT00381797|459659081|FG001|Overall Study|Ineligible|0|||
127736064|NCT00381797|459659082|FG002|Overall Study|Ineligible|0|||
127736065|NCT00381797|459659083|FG003|Overall Study|Ineligible|1|||
127736066|NCT00381797|459659084|FG004|Overall Study|Ineligible|0|||
127736067|NCT00443898|459659085|FG000|Overall Study|Adverse Event|0|||
127736068|NCT00443898|459659086|FG001|Overall Study|Adverse Event|0|||
127736069|NCT00443898|459659087|FG002|Overall Study|Adverse Event|1|||
127736070|NCT00443898|459659088|FG003|Overall Study|Adverse Event|1|||
127736071|NCT00443898|459659085|FG000|Overall Study|Lack of Efficacy|2|||
127736072|NCT00443898|459659086|FG001|Overall Study|Lack of Efficacy|3|||
127736073|NCT00443898|459659087|FG002|Overall Study|Lack of Efficacy|3|||
127736074|NCT00443898|459659088|FG003|Overall Study|Lack of Efficacy|1|||
127736075|NCT00443898|459659085|FG000|Overall Study|Protocol Violation|1|||
127736076|NCT00443898|459659086|FG001|Overall Study|Protocol Violation|1|||
127736077|NCT00443898|459659087|FG002|Overall Study|Protocol Violation|1|||
127736078|NCT00443898|459659088|FG003|Overall Study|Protocol Violation|0|||
127736079|NCT00443898|459659085|FG000|Overall Study|Withdrawal by Subject|11|||
127736080|NCT00443898|459659086|FG001|Overall Study|Withdrawal by Subject|10|||
127736081|NCT00443898|459659087|FG002|Overall Study|Withdrawal by Subject|10|||
127736082|NCT00443898|459659088|FG003|Overall Study|Withdrawal by Subject|6|||
127736083|NCT00443898|459659085|FG000|Overall Study|Lost to Follow-up|10|||
127736084|NCT00443898|459659086|FG001|Overall Study|Lost to Follow-up|10|||
127736085|NCT00443898|459659087|FG002|Overall Study|Lost to Follow-up|14|||
127736086|NCT00443898|459659088|FG003|Overall Study|Lost to Follow-up|10|||
127736087|NCT00443898|459659085|FG000|Overall Study|Death|0|||
127736088|NCT00443898|459659086|FG001|Overall Study|Death|1|||
127736089|NCT00443898|459659087|FG002|Overall Study|Death|0|||
127736090|NCT00443898|459659088|FG003|Overall Study|Death|0|||
127736091|NCT00958711|459659089|FG000|Overall Study|Withdrawal by Subject|0|||
127736092|NCT00958711|459659090|FG001|Overall Study|Withdrawal by Subject|4|||
127736093|NCT00958711|459659089|FG000|Overall Study|Physician Decision|5|||
127736094|NCT00958711|459659090|FG001|Overall Study|Physician Decision|7|||
127736095|NCT00958711|459659089|FG000|Overall Study|Lost to Follow-up|4|||
127736096|NCT00958711|459659090|FG001|Overall Study|Lost to Follow-up|1|||
127736097|NCT00958711|459659089|FG000|Overall Study|Other|2|||
127736098|NCT00958711|459659090|FG001|Overall Study|Other|5|||
127736099|NCT00958711|459659089|FG000|Overall Study|Death|1|||
127736100|NCT00958711|459659090|FG001|Overall Study|Death|2|||
127736101|NCT00958711|459659089|FG000|Overall Study|Adverse Event|1|||
127736102|NCT00958711|459659090|FG001|Overall Study|Adverse Event|2|||
127736103|NCT01797562|459659095|FG000|Overall Study|Protocol Violation|5|||
127736104|NCT01631825|459659096|FG000|Overall Study|Adverse Event|42|||
127736105|NCT01631825|459659096|FG000|Overall Study|Lack of Efficacy|7|||
127736106|NCT01631825|459659096|FG000|Overall Study|Withdrawal by Subject|9|||
127736107|NCT01631825|459659096|FG000|Overall Study|Protocol Violation|4|||
127736108|NCT01631825|459659096|FG000|Overall Study|Discontinuation criteria|1|||
127736109|NCT01631825|459659096|FG000|Overall Study|Physician Decision|2|||
127736110|NCT05109117|459659097|FG000|Overall Study|Lost to Follow-up|1|||
127736111|NCT05109117|459659097|FG000|Overall Study|Discontinued for non-compliance|1|||
127736112|NCT03226353|459659098|FG000|Overall Study|Withdrawal by Subject|1|||
127736113|NCT03226353|459659098|FG000|Overall Study|Screen Failure|5|||
127736114|NCT01514864|459659100|FG000|Overall Study|Disease progression|7|||
127736115|NCT01514864|459659101|FG001|Overall Study|Disease progression|5|||
127736116|NCT01514864|459659100|FG000|Overall Study|Study drug toxicity|2|||
127736117|NCT01514864|459659101|FG001|Overall Study|Study drug toxicity|0|||
127736118|NCT02253147|459659103|FG000|Overall Study|Protocol Violation|30|||
127736119|NCT02253147|459659103|FG000|Overall Study|Did not consent to study extension|9|||
127736120|NCT02253147|459659103|FG000|Overall Study|Conditional re-treatment at W52|5|||
127736121|NCT02253147|459659103|FG000|Overall Study|Lost to Follow-up|2|||
127736122|NCT02253147|459659103|FG000|Overall Study|Withdrawal by Subject|1|||
127736123|NCT02254681|459659104|FG000|Overall Study|Lack of Efficacy|6|||
127736124|NCT00797511|459659105|FG000|Overall Study|Withdrawal by Subject|1|||
127736125|NCT02959177|459659106|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
127736126|NCT02959177|459659107|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
127736127|NCT02959177|459659108|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
127736128|NCT02959177|459659106|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
127736129|NCT02959177|459659107|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
127736130|NCT02959177|459659108|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
127736131|NCT02959177|459659106|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
127736132|NCT02959177|459659107|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
127736133|NCT02959177|459659108|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
127736134|NCT02959177|459659106|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
127736135|NCT02959177|459659107|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
127736136|NCT02959177|459659108|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
127736137|NCT02959177|459659106|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
127736138|NCT02959177|459659107|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
127736139|NCT02959177|459659108|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
127736140|NCT02959177|459659106|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
127736141|NCT02959177|459659107|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
127736142|NCT02959177|459659108|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
127736143|NCT02959177|459659106|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
127736144|NCT02959177|459659107|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
127736145|NCT02959177|459659108|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
127736146|NCT04772313|459659115|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
127736147|NCT04772313|459659115|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
127736148|NCT03303521|459659116|FG000|Overall Study|Withdrawal by Subject|2|||
127736149|NCT03303521|459659117|FG001|Overall Study|Withdrawal by Subject|0|||
127736150|NCT03303521|459659116|FG000|Overall Study|Death|1|||
127736151|NCT03303521|459659117|FG001|Overall Study|Death|0|||
127736152|NCT03303521|459659116|FG000|Overall Study|Kidney transplantation|0|||
127736153|NCT03303521|459659117|FG001|Overall Study|Kidney transplantation|1|||
127736154|NCT03303521|459659116|FG000|Overall Study|Investigational product discontinuation|0|||
127736155|NCT03303521|459659117|FG001|Overall Study|Investigational product discontinuation|1|||
127736156|NCT03303521|459659116|FG000|Overall Study|Transferred to non-study dialysis center|1|||
127736157|NCT03303521|459659117|FG001|Overall Study|Transferred to non-study dialysis center|0|||
127736158|NCT03303521|459659116|FG000|Overall Study|Non-comliance to study protocol|0|||
127736159|NCT03303521|459659117|FG001|Overall Study|Non-comliance to study protocol|1|||
127736160|NCT03303521|459659116|FG000|Overall Study|Adverse Event|1|||
127736161|NCT03303521|459659117|FG001|Overall Study|Adverse Event|0|||
127736162|NCT04194541|459659118|FG000|Day 1 Through 13|Lost to Follow-up|3|||
127736163|NCT04194541|459659118|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
127736164|NCT04194541|459659118|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
127736165|NCT02642159|459659119|FG000|Overall Study|Randomized but not treated|1|||
127736166|NCT02642159|459659120|FG001|Overall Study|Randomized but not treated|0|||
127736167|NCT02642159|459659119|FG000|Overall Study|Adverse Event|10|||
127736168|NCT02642159|459659120|FG001|Overall Study|Adverse Event|4|||
127736169|NCT02642159|459659119|FG000|Overall Study|Withdrawal by Subject|9|||
127736170|NCT02642159|459659120|FG001|Overall Study|Withdrawal by Subject|1|||
127736171|NCT02642159|459659119|FG000|Overall Study|Poor compliance to study protocol|1|||
127736172|NCT02642159|459659120|FG001|Overall Study|Poor compliance to study protocol|0|||
127736173|NCT02642159|459659119|FG000|Overall Study|Other than specified above|10|||
127736174|NCT02642159|459659120|FG001|Overall Study|Other than specified above|3|||
127736175|NCT03635775|459659121|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
127736176|NCT03635775|459659122|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
127736177|NCT03635775|459659123|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
127736178|NCT03635775|459659124|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
127736179|NCT00240097|459659125|FG000|Part I|Adverse Event|1|||
127736180|NCT00240097|459659125|FG000|Part I|Death|1|||
127736181|NCT00240097|459659125|FG000|Part I|histology|1|||
127736182|NCT00240097|459659125|FG000|Part I|unevaluable|1|||
127736183|NCT00240097|459659125|FG000|Part II|did not continue from Part I|23|||
127736184|NCT03613454|459659128|FG000|Overall Study|Protocol Violation|1|||
127736185|NCT03613454|459659129|FG001|Overall Study|Protocol Violation|0|||
127736186|NCT03613454|459659128|FG000|Overall Study|Protocol Violation|0|||
127736187|NCT03613454|459659129|FG001|Overall Study|Protocol Violation|1|||
127736188|NCT01071317|459659131|FG000|Overall Study|Lost to Follow-up|2|||
127736189|NCT01071317|459659132|FG001|Overall Study|Lost to Follow-up|2|||
127736190|NCT02040532|459659134|FG000|Overall Study|Lost to Follow-up|1|||
127736191|NCT02040532|459659134|FG000|Overall Study|Physician Decision|4|||
127736192|NCT02040532|459659134|FG000|Overall Study|Adverse Event|4|||
127806372|NCT00398112|459913399|FG000|Overall Study|Adverse Event|4|||
127806373|NCT00398112|459913399|FG000|Overall Study|Disease progression|9|||
127736193|NCT02040532|459659134|FG000|Overall Study|Withdrawal by Subject|3|||
127736194|NCT03640754|459659137|FG000|Overall Study|Withdrawal by Subject|1|||
127736195|NCT03640754|459659138|FG001|Overall Study|Withdrawal by Subject|0|||
127736196|NCT03640754|459659137|FG000|Overall Study|Lost to Follow-up|0|||
127736197|NCT03640754|459659138|FG001|Overall Study|Lost to Follow-up|1|||
127736198|NCT01679613|459659144|FG000|Overall Study|other than stated above|0|||
127736199|NCT01679613|459659145|FG001|Overall Study|other than stated above|1|||
127736200|NCT01679613|459659146|FG002|Overall Study|other than stated above|2|||
127736201|NCT01679613|459659147|FG003|Overall Study|other than stated above|2|||
127736202|NCT03169530|459659148|FG000|Overall Study|Study ended by NIH|15|||
127736203|NCT03169530|459659149|FG001|Overall Study|Study ended by NIH|17|||
127736204|NCT02154516|459659150|FG000|Overall Study|Withdrawal by Subject|0|||
127736205|NCT02154516|459659151|FG001|Overall Study|Withdrawal by Subject|1|||
127736206|NCT02154516|459659150|FG000|Overall Study|Lost to Follow-up|1|||
127736207|NCT02154516|459659151|FG001|Overall Study|Lost to Follow-up|0|||
127736208|NCT02154516|459659150|FG000|Overall Study|Removal/revision of device|1|||
127736209|NCT02154516|459659151|FG001|Overall Study|Removal/revision of device|0|||
127736210|NCT02154516|459659150|FG000|Overall Study|Death|2|||
127736211|NCT02154516|459659151|FG001|Overall Study|Death|1|||
127736212|NCT02965599|459659152|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
127736213|NCT02965599|459659153|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
127736214|NCT00230971|459659154|FG000|Randomization|No study drug administered|3|||
127736215|NCT00230971|459659155|FG001|Randomization|No study drug administered|3|||
127736216|NCT00230971|459659154|FG000|Baseline Participants|Lost to Follow-up|5|||
127736217|NCT00230971|459659155|FG001|Baseline Participants|Lost to Follow-up|12|||
127736218|NCT00230971|459659154|FG000|Baseline Participants|Death|6|||
127736219|NCT00230971|459659155|FG001|Baseline Participants|Death|5|||
127736220|NCT00230971|459659154|FG000|Baseline Participants|Withdrawal by Subject|7|||
127736221|NCT00230971|459659155|FG001|Baseline Participants|Withdrawal by Subject|1|||
127736222|NCT00230971|459659154|FG000|Baseline Participants|Adverse Event|1|||
127736223|NCT00230971|459659155|FG001|Baseline Participants|Adverse Event|0|||
127736224|NCT00230971|459659154|FG000|Baseline Participants|No bacteria observed|1|||
127736225|NCT00230971|459659155|FG001|Baseline Participants|No bacteria observed|0|||
127736226|NCT00230971|459659154|FG000|Baseline Participants|Failure to return|1|||
127736227|NCT00230971|459659155|FG001|Baseline Participants|Failure to return|1|||
127736228|NCT00230971|459659154|FG000|Baseline Participants|Reintervention|1|||
127736229|NCT00230971|459659155|FG001|Baseline Participants|Reintervention|0|||
127736230|NCT00684203|459660619|FG000|Overall Study|Adverse Event|6|||
127736231|NCT00684203|459660620|FG001|Overall Study|Adverse Event|4|||
127736232|NCT00684203|459660621|FG002|Overall Study|Adverse Event|8|||
127736233|NCT00684203|459660622|FG003|Overall Study|Adverse Event|0|||
127736234|NCT00684203|459660623|FG004|Overall Study|Adverse Event|0|||
127736235|NCT00684203|459660624|FG005|Overall Study|Adverse Event|0|||
127736236|NCT00684203|459660619|FG000|Overall Study|Protocol-defined clinical event|3|||
127736237|NCT00684203|459660620|FG001|Overall Study|Protocol-defined clinical event|1|||
127736238|NCT00684203|459660621|FG002|Overall Study|Protocol-defined clinical event|0|||
127736239|NCT00684203|459660622|FG003|Overall Study|Protocol-defined clinical event|0|||
127736240|NCT00684203|459660623|FG004|Overall Study|Protocol-defined clinical event|0|||
127736241|NCT00684203|459660624|FG005|Overall Study|Protocol-defined clinical event|0|||
127736242|NCT00684203|459660619|FG000|Overall Study|Withdrawal by Subject|0|||
127736243|NCT00684203|459660620|FG001|Overall Study|Withdrawal by Subject|2|||
127736244|NCT00684203|459660621|FG002|Overall Study|Withdrawal by Subject|1|||
127736245|NCT00684203|459660622|FG003|Overall Study|Withdrawal by Subject|0|||
127736246|NCT00684203|459660623|FG004|Overall Study|Withdrawal by Subject|0|||
127736247|NCT00684203|459660624|FG005|Overall Study|Withdrawal by Subject|0|||
127736248|NCT00684203|459660619|FG000|Overall Study|Did not meet protocol eligibility|0|||
127736249|NCT00684203|459660620|FG001|Overall Study|Did not meet protocol eligibility|1|||
127736250|NCT00684203|459660621|FG002|Overall Study|Did not meet protocol eligibility|0|||
127736251|NCT00684203|459660622|FG003|Overall Study|Did not meet protocol eligibility|0|||
127736252|NCT00684203|459660623|FG004|Overall Study|Did not meet protocol eligibility|0|||
127736253|NCT00684203|459660624|FG005|Overall Study|Did not meet protocol eligibility|0|||
127736254|NCT00719212|459660627|FG000|Overall Study|Death|41|||
127736255|NCT00719212|459660627|FG000|Overall Study|Lost to Follow-up|2|||
127736256|NCT00719212|459660627|FG000|Overall Study|Withdrawal by Subject|1|||
127736257|NCT02151643|459660630|FG000|Overall Study|Adverse Event|2|||
127806374|NCT00398112|459913399|FG000|Overall Study|Alternative treatment|1|||
127806375|NCT00398112|459913399|FG000|Overall Study|Withdrawal by Subject|3|||
127736258|NCT02151643|459660631|FG001|Overall Study|Adverse Event|0|||
127736259|NCT02151643|459660632|FG002|Overall Study|Adverse Event|1|||
127736260|NCT02151643|459660633|FG003|Overall Study|Adverse Event|4|||
127736261|NCT02151643|459660634|FG004|Overall Study|Adverse Event|0|||
127736262|NCT02151643|459660630|FG000|Overall Study|Withdrawal by Subject|0|||
127736263|NCT02151643|459660631|FG001|Overall Study|Withdrawal by Subject|1|||
127736264|NCT02151643|459660632|FG002|Overall Study|Withdrawal by Subject|1|||
127736265|NCT02151643|459660633|FG003|Overall Study|Withdrawal by Subject|1|||
127806376|NCT00398112|459913399|FG000|Overall Study|Death|1|||
127736266|NCT02151643|459660634|FG004|Overall Study|Withdrawal by Subject|1|||
127736267|NCT02151643|459660630|FG000|Overall Study|Hyperphosphataemia|1|||
127736268|NCT02151643|459660631|FG001|Overall Study|Hyperphosphataemia|0|||
127736269|NCT02151643|459660632|FG002|Overall Study|Hyperphosphataemia|0|||
127736270|NCT02151643|459660633|FG003|Overall Study|Hyperphosphataemia|0|||
127736271|NCT02151643|459660634|FG004|Overall Study|Hyperphosphataemia|1|||
127736272|NCT02151643|459660630|FG000|Overall Study|High Ferritin levels|3|||
127736273|NCT02151643|459660631|FG001|Overall Study|High Ferritin levels|3|||
127736274|NCT02151643|459660632|FG002|Overall Study|High Ferritin levels|2|||
127736275|NCT02151643|459660633|FG003|Overall Study|High Ferritin levels|2|||
127736276|NCT02151643|459660634|FG004|Overall Study|High Ferritin levels|1|||
127736277|NCT00508274|459660637|FG000|Overall Study|Adverse Event|5|||
127736278|NCT00508274|459660637|FG000|Overall Study|Death|7|||
127736279|NCT00508274|459660637|FG000|Overall Study|Disease progression|32|||
127736280|NCT00508274|459660637|FG000|Overall Study|Withdrawal by Subject|1|||
127736281|NCT00508274|459660637|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
127736282|NCT00508274|459660637|FG000|Overall Study|Missing|3|||
127736283|NCT03296566|459660638|FG000|Overall Study|Lost to Follow-up|19|||
127736284|NCT03296566|459660639|FG001|Overall Study|Lost to Follow-up|46|||
127736285|NCT03296566|459660638|FG000|Overall Study|Withdrawal by Subject|0|||
127736286|NCT03296566|459660639|FG001|Overall Study|Withdrawal by Subject|3|||
127736287|NCT01084239|459660642|FG000|28-Day Follow-up|Lost to Follow-up|4|||
127736288|NCT01084239|459660643|FG001|28-Day Follow-up|Lost to Follow-up|9|||
127736289|NCT02679079|459660644|FG000|Overall Study|Adverse Event|2|||
127736290|NCT02679079|459660645|FG001|Overall Study|Adverse Event|0|||
127736291|NCT02679079|459660646|FG002|Overall Study|Adverse Event|2|||
127736292|NCT02679079|459660644|FG000|Overall Study|Protocol Violation|0|||
127736293|NCT02679079|459660645|FG001|Overall Study|Protocol Violation|1|||
127736294|NCT02679079|459660646|FG002|Overall Study|Protocol Violation|0|||
127736295|NCT02679079|459660644|FG000|Overall Study|Withdrawal by Subject|2|||
127736296|NCT02679079|459660645|FG001|Overall Study|Withdrawal by Subject|1|||
127736297|NCT02679079|459660646|FG002|Overall Study|Withdrawal by Subject|0|||
127736298|NCT03924947|459660647|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
127736299|NCT03924947|459660648|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
127736300|NCT03924947|459660649|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
127736301|NCT03924947|459660650|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
127736302|NCT03924947|459660651|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
127736303|NCT03924947|459660652|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
127736304|NCT04150341|459660653|FG000|Overall Study|Physician Decision|0|||
127736305|NCT04150341|459660654|FG001|Overall Study|Physician Decision|0|||
127736306|NCT04150341|459660655|FG002|Overall Study|Physician Decision|1|||
127736307|NCT04150341|459660656|FG003|Overall Study|Physician Decision|0|||
127736308|NCT04150341|459660657|FG004|Overall Study|Physician Decision|0|||
127736309|NCT04150341|459660658|FG005|Overall Study|Physician Decision|0|||
127736310|NCT04150341|459660653|FG000|Overall Study|Adverse Event|0|||
127736311|NCT04150341|459660654|FG001|Overall Study|Adverse Event|0|||
127736312|NCT04150341|459660655|FG002|Overall Study|Adverse Event|0|||
127736313|NCT04150341|459660656|FG003|Overall Study|Adverse Event|0|||
127736314|NCT04150341|459660657|FG004|Overall Study|Adverse Event|1|||
127736315|NCT04150341|459660658|FG005|Overall Study|Adverse Event|0|||
127806377|NCT05148884|459913400|FG000|Overall Study|Withdrawal by Subject|3|||
127806378|NCT05148884|459913401|FG001|Overall Study|Withdrawal by Subject|0|||
127806379|NCT05148884|459913400|FG000|Overall Study|Deep brain stimulation operation|0|||
127806380|NCT05148884|459913401|FG001|Overall Study|Deep brain stimulation operation|1|||
127806381|NCT01993888|459913404|FG000|Overall Study|Death|1|||
127806382|NCT01993888|459913405|FG001|Overall Study|Death|1|||
127806383|NCT01993888|459913404|FG000|Overall Study|Lost to Follow-up|1|||
127806384|NCT01993888|459913405|FG001|Overall Study|Lost to Follow-up|1|||
127806385|NCT01993888|459913404|FG000|Overall Study|Withdrawal by Subject|0|||
127806386|NCT01993888|459913405|FG001|Overall Study|Withdrawal by Subject|1|||
127806387|NCT00365989|459913406|FG000|Overall Study|Withdrawal by Subject|1|||
127806388|NCT00365989|459913406|FG000|Overall Study|Non-compliance|1|||
127806389|NCT00832819|459913408|FG000|Overall Study|Adverse Event|0|||
127806390|NCT00832819|459913409|FG001|Overall Study|Adverse Event|1|||
127806391|NCT00832819|459913410|FG002|Overall Study|Adverse Event|0|||
127806392|NCT00832819|459913408|FG000|Overall Study|Protocol Violation|0|||
127806393|NCT00832819|459913409|FG001|Overall Study|Protocol Violation|0|||
127806394|NCT00832819|459913410|FG002|Overall Study|Protocol Violation|1|||
127806395|NCT00317044|459913411|FG000|Overall Study|Protocol Violation|28|||
127806396|NCT00317044|459913412|FG001|Overall Study|Protocol Violation|22|||
127806397|NCT00317044|459913413|FG002|Overall Study|Protocol Violation|20|||
127806398|NCT00317044|459913411|FG000|Overall Study|Adverse Event|4|||
127806399|NCT00317044|459913412|FG001|Overall Study|Adverse Event|7|||
127806400|NCT00317044|459913413|FG002|Overall Study|Adverse Event|4|||
127806401|NCT00317044|459913411|FG000|Overall Study|Withdrawal by Subject|10|||
127736316|NCT00899379|459660659|FG000|Overall Study|Adverse Event|2|||
127806402|NCT00317044|459913412|FG001|Overall Study|Withdrawal by Subject|7|||
127736317|NCT00899379|459660660|FG001|Overall Study|Adverse Event|2|||
127806403|NCT00317044|459913413|FG002|Overall Study|Withdrawal by Subject|12|||
127806404|NCT00317044|459913411|FG000|Overall Study|Lost to Follow-up|0|||
127806405|NCT00317044|459913412|FG001|Overall Study|Lost to Follow-up|2|||
127806406|NCT00317044|459913413|FG002|Overall Study|Lost to Follow-up|3|||
127806407|NCT00317044|459913411|FG000|Overall Study|Multiple Reasons|6|||
127806408|NCT00317044|459913412|FG001|Overall Study|Multiple Reasons|2|||
127806409|NCT00317044|459913413|FG002|Overall Study|Multiple Reasons|6|||
127806410|NCT02318095|459913414|FG000|Overall Study|Adverse Event|1|||
127806411|NCT00686127|459913415|FG000|Overall Study|Withdrawal by Subject|14|||
127806412|NCT00686127|459913416|FG001|Overall Study|Withdrawal by Subject|6|||
127806413|NCT05742984|459913417|FG000|Overall Study|Adverse Event|0|||
127806414|NCT05742984|459913418|FG001|Overall Study|Adverse Event|0|||
127806415|NCT05742984|459913419|FG002|Overall Study|Adverse Event|1|||
127806416|NCT05742984|459913420|FG003|Overall Study|Adverse Event|0|||
127806417|NCT05742984|459913421|FG004|Overall Study|Adverse Event|1|||
127806418|NCT05742984|459913422|FG005|Overall Study|Adverse Event|1|||
127806419|NCT05742984|459913417|FG000|Overall Study|Withdrawal by Subject|0|||
127806420|NCT05742984|459913418|FG001|Overall Study|Withdrawal by Subject|1|||
127806421|NCT05742984|459913419|FG002|Overall Study|Withdrawal by Subject|0|||
127806422|NCT05742984|459913420|FG003|Overall Study|Withdrawal by Subject|0|||
127806423|NCT05742984|459913421|FG004|Overall Study|Withdrawal by Subject|0|||
127806424|NCT05742984|459913422|FG005|Overall Study|Withdrawal by Subject|2|||
127806425|NCT00379340|459913423|FG000|Overall Study|Death|0|||
127806426|NCT00379340|459913424|FG001|Overall Study|Death|0|||
127806427|NCT00379340|459913425|FG002|Overall Study|Death|0|||
127806428|NCT00379340|459913426|FG003|Overall Study|Death|2|||
127806429|NCT00379340|459913427|FG004|Overall Study|Death|0|||
127806430|NCT00379340|459913423|FG000|Overall Study|Lack of Efficacy|6|||
127806431|NCT00379340|459913424|FG001|Overall Study|Lack of Efficacy|1|||
127806432|NCT00379340|459913425|FG002|Overall Study|Lack of Efficacy|0|||
127806433|NCT00379340|459913426|FG003|Overall Study|Lack of Efficacy|4|||
127806434|NCT00379340|459913427|FG004|Overall Study|Lack of Efficacy|3|||
127806435|NCT00379340|459913423|FG000|Overall Study|Physician Decision|6|||
127806436|NCT00379340|459913424|FG001|Overall Study|Physician Decision|2|||
127806437|NCT00379340|459913425|FG002|Overall Study|Physician Decision|1|||
127736318|NCT00899379|459660661|FG002|Overall Study|Adverse Event|1|||
127736319|NCT00899379|459660662|FG003|Overall Study|Adverse Event|1|||
127736320|NCT00899379|459660663|FG004|Overall Study|Adverse Event|2|||
127736321|NCT00899379|459660659|FG000|Overall Study|Lack of Efficacy|0|||
127736322|NCT00899379|459660660|FG001|Overall Study|Lack of Efficacy|4|||
127736323|NCT00899379|459660661|FG002|Overall Study|Lack of Efficacy|3|||
127736324|NCT00899379|459660662|FG003|Overall Study|Lack of Efficacy|0|||
127736325|NCT00899379|459660663|FG004|Overall Study|Lack of Efficacy|1|||
127736326|NCT00899379|459660659|FG000|Overall Study|Lost to Follow-up|9|||
127736327|NCT00899379|459660660|FG001|Overall Study|Lost to Follow-up|3|||
127736328|NCT00899379|459660661|FG002|Overall Study|Lost to Follow-up|0|||
127736329|NCT00899379|459660662|FG003|Overall Study|Lost to Follow-up|6|||
127736330|NCT00899379|459660663|FG004|Overall Study|Lost to Follow-up|2|||
127736331|NCT00899379|459660659|FG000|Overall Study|Protocol Violation|0|||
127736332|NCT00899379|459660660|FG001|Overall Study|Protocol Violation|0|||
127736333|NCT00899379|459660661|FG002|Overall Study|Protocol Violation|1|||
127736334|NCT00899379|459660662|FG003|Overall Study|Protocol Violation|1|||
127736335|NCT00899379|459660663|FG004|Overall Study|Protocol Violation|0|||
127736336|NCT00899379|459660659|FG000|Overall Study|Withdrawal by Subject|2|||
127736337|NCT00899379|459660660|FG001|Overall Study|Withdrawal by Subject|4|||
127736338|NCT00899379|459660661|FG002|Overall Study|Withdrawal by Subject|2|||
127736339|NCT00899379|459660662|FG003|Overall Study|Withdrawal by Subject|3|||
127806438|NCT00379340|459913426|FG003|Overall Study|Physician Decision|2|||
127806439|NCT00379340|459913427|FG004|Overall Study|Physician Decision|3|||
127806440|NCT00379340|459913423|FG000|Overall Study|Withdrawal by Subject|0|||
127806441|NCT00379340|459913424|FG001|Overall Study|Withdrawal by Subject|0|||
127806442|NCT00379340|459913425|FG002|Overall Study|Withdrawal by Subject|0|||
127806443|NCT00379340|459913426|FG003|Overall Study|Withdrawal by Subject|1|||
127806444|NCT00379340|459913427|FG004|Overall Study|Withdrawal by Subject|0|||
127806445|NCT00379340|459913423|FG000|Overall Study|Refusal of further protocol therapy|1|||
127806446|NCT00379340|459913424|FG001|Overall Study|Refusal of further protocol therapy|0|||
127806447|NCT00379340|459913425|FG002|Overall Study|Refusal of further protocol therapy|1|||
127806448|NCT00379340|459913426|FG003|Overall Study|Refusal of further protocol therapy|1|||
127806449|NCT00379340|459913427|FG004|Overall Study|Refusal of further protocol therapy|7|||
127806450|NCT00379340|459913423|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
127806451|NCT00379340|459913424|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
127806452|NCT00379340|459913425|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
127806453|NCT00379340|459913426|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
127736340|NCT00899379|459660663|FG004|Overall Study|Withdrawal by Subject|6|||
127806454|NCT00379340|459913427|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
127736341|NCT00899379|459660659|FG000|Overall Study|Pregnancy|0|||
127736342|NCT00899379|459660660|FG001|Overall Study|Pregnancy|0|||
127736343|NCT00899379|459660661|FG002|Overall Study|Pregnancy|1|||
127736344|NCT00899379|459660662|FG003|Overall Study|Pregnancy|0|||
127736345|NCT00899379|459660663|FG004|Overall Study|Pregnancy|1|||
127736346|NCT00899379|459660659|FG000|Overall Study|Patient Uncooperative|0|||
127736347|NCT00899379|459660660|FG001|Overall Study|Patient Uncooperative|1|||
127736348|NCT00899379|459660661|FG002|Overall Study|Patient Uncooperative|0|||
127736349|NCT00899379|459660662|FG003|Overall Study|Patient Uncooperative|1|||
127736350|NCT00899379|459660663|FG004|Overall Study|Patient Uncooperative|2|||
127736351|NCT00899379|459660659|FG000|Overall Study|Abnormal Baseline ECG|0|||
127736352|NCT00899379|459660660|FG001|Overall Study|Abnormal Baseline ECG|0|||
127736353|NCT00899379|459660661|FG002|Overall Study|Abnormal Baseline ECG|0|||
127736354|NCT00899379|459660662|FG003|Overall Study|Abnormal Baseline ECG|1|||
127736355|NCT00899379|459660663|FG004|Overall Study|Abnormal Baseline ECG|0|||
127736356|NCT00899379|459660659|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
127736357|NCT00899379|459660660|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
127736358|NCT00899379|459660661|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
127736359|NCT00899379|459660662|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
127736360|NCT00899379|459660663|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
127736361|NCT00899379|459660659|FG000|Overall Study|Not Completed/Entered Extn|5|||
127736362|NCT00899379|459660660|FG001|Overall Study|Not Completed/Entered Extn|1|||
127736363|NCT00899379|459660661|FG002|Overall Study|Not Completed/Entered Extn|6|||
127736364|NCT00899379|459660662|FG003|Overall Study|Not Completed/Entered Extn|4|||
127736365|NCT00899379|459660663|FG004|Overall Study|Not Completed/Entered Extn|3|||
127736366|NCT00899379|459660659|FG000|Overall Study|Study Terminated|3|||
127736367|NCT00899379|459660660|FG001|Overall Study|Study Terminated|0|||
127736368|NCT00899379|459660661|FG002|Overall Study|Study Terminated|3|||
127736369|NCT00899379|459660662|FG003|Overall Study|Study Terminated|3|||
127736370|NCT00899379|459660663|FG004|Overall Study|Study Terminated|1|||
127736371|NCT00899379|459660659|FG000|Overall Study|Lost to Follow-up|3|||
127736372|NCT00899379|459660660|FG001|Overall Study|Lost to Follow-up|1|||
127736373|NCT00899379|459660661|FG002|Overall Study|Lost to Follow-up|0|||
127736374|NCT00899379|459660662|FG003|Overall Study|Lost to Follow-up|2|||
127736375|NCT00899379|459660663|FG004|Overall Study|Lost to Follow-up|5|||
127736376|NCT00899379|459660659|FG000|Overall Study|Withdrawal by Subject|4|||
127736377|NCT00899379|459660660|FG001|Overall Study|Withdrawal by Subject|7|||
127736378|NCT00899379|459660661|FG002|Overall Study|Withdrawal by Subject|4|||
127736379|NCT00899379|459660662|FG003|Overall Study|Withdrawal by Subject|7|||
127736380|NCT00899379|459660663|FG004|Overall Study|Withdrawal by Subject|2|||
127736381|NCT00899379|459660659|FG000|Overall Study|Pregnancy|1|||
127736382|NCT00899379|459660660|FG001|Overall Study|Pregnancy|0|||
127736383|NCT00899379|459660661|FG002|Overall Study|Pregnancy|0|||
127736384|NCT00899379|459660662|FG003|Overall Study|Pregnancy|0|||
127736385|NCT00899379|459660663|FG004|Overall Study|Pregnancy|0|||
127736386|NCT00899379|459660659|FG000|Overall Study|Patient Uncooperative|0|||
127736387|NCT00899379|459660660|FG001|Overall Study|Patient Uncooperative|0|||
127736388|NCT00899379|459660661|FG002|Overall Study|Patient Uncooperative|0|||
127736389|NCT00899379|459660662|FG003|Overall Study|Patient Uncooperative|1|||
127736390|NCT00899379|459660663|FG004|Overall Study|Patient Uncooperative|0|||
127736391|NCT00899379|459660659|FG000|Overall Study|Abnormal Prestudy Labs|0|||
127736392|NCT00899379|459660660|FG001|Overall Study|Abnormal Prestudy Labs|0|||
127736393|NCT00899379|459660661|FG002|Overall Study|Abnormal Prestudy Labs|0|||
127736394|NCT00899379|459660662|FG003|Overall Study|Abnormal Prestudy Labs|0|||
127736395|NCT00899379|459660663|FG004|Overall Study|Abnormal Prestudy Labs|2|||
127736396|NCT00899379|459660659|FG000|Overall Study|Abnormal Baseline ECG|0|||
127736397|NCT00899379|459660660|FG001|Overall Study|Abnormal Baseline ECG|0|||
127736398|NCT00899379|459660661|FG002|Overall Study|Abnormal Baseline ECG|1|||
127736399|NCT00899379|459660662|FG003|Overall Study|Abnormal Baseline ECG|1|||
127736400|NCT00899379|459660663|FG004|Overall Study|Abnormal Baseline ECG|0|||
127736401|NCT00899379|459660659|FG000|Overall Study|No Attack Pretreatment|3|||
127736402|NCT00899379|459660660|FG001|Overall Study|No Attack Pretreatment|5|||
127736403|NCT00899379|459660661|FG002|Overall Study|No Attack Pretreatment|5|||
127736404|NCT00899379|459660662|FG003|Overall Study|No Attack Pretreatment|6|||
127736405|NCT00899379|459660663|FG004|Overall Study|No Attack Pretreatment|4|||
127736406|NCT00899379|459660659|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
127736407|NCT00899379|459660660|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
127736408|NCT00899379|459660661|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
127736409|NCT00899379|459660662|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
127736410|NCT00899379|459660663|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
127736411|NCT00899379|459660659|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
127736412|NCT00899379|459660660|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
127736413|NCT00899379|459660661|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
127736414|NCT00899379|459660662|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
127736415|NCT00899379|459660663|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
127736416|NCT02581189|459660668|FG000|Overall Study|Failure to return|36|||
127736417|NCT02581189|459660668|FG000|Overall Study|Withdrew consent|5|||
127736418|NCT02581189|459660668|FG000|Overall Study|Death|3|||
127736419|NCT02581189|459660668|FG000|Overall Study|Insufficient virological response|2|||
127736420|NCT02581189|459660668|FG000|Overall Study|Other, not specified|7|||
127892709|NCT00686036|460229632|FG000|Overall Study|Withdrawal by Subject|3|||
127736421|NCT00843115|459660669|FG000|Overall Study|Death|4|||
127736422|NCT00843115|459660669|FG000|Overall Study|Adverse Event|30|||
127736423|NCT00843115|459660669|FG000|Overall Study|Lost to Follow-up|4|||
127736424|NCT00843115|459660669|FG000|Overall Study|Withdrawal by Subject|17|||
127736425|NCT00843115|459660669|FG000|Overall Study|Family wanted meds stopped|1|||
127736426|NCT00843115|459660669|FG000|Overall Study|Family does not want continuation|1|||
127736427|NCT00843115|459660669|FG000|Overall Study|Patient forgot to take meds|1|||
127736428|NCT00843115|459660669|FG000|Overall Study|Does not meet entrance criteria|1|||
127736429|NCT00843115|459660669|FG000|Overall Study|Physician Decision|1|||
127736430|NCT00843115|459660669|FG000|Overall Study|Family discontinued meds|1|||
127736431|NCT00843115|459660669|FG000|Overall Study|patient took for 2 days then stopped|1|||
127736432|NCT00843115|459660669|FG000|Overall Study|patient never took the medication|1|||
127736433|NCT00843115|459660669|FG000|Overall Study|hospitalized due to deterioration|1|||
127736434|NCT00843115|459660669|FG000|Overall Study|week 12 not done|1|||
127736435|NCT00843115|459660669|FG000|Overall Study|Syndrome De Glissement|1|||
127736436|NCT02621047|459660670|FG000|Overall Study|Adverse Event|0|||
127736437|NCT02621047|459660671|FG001|Overall Study|Adverse Event|0|||
127736438|NCT02621047|459660672|FG002|Overall Study|Adverse Event|1|||
127736439|NCT02204319|459660682|FG000|Overall Study|Pregnancy|1|||
127736440|NCT02204319|459660682|FG000|Overall Study|Withdrawal by Subject|2|||
127736441|NCT03371485|459660683|FG000|Main Trial (6 AST-VAC2 Vaccinations)|Participant died before receiving AST-VAC2.|1|||
127736442|NCT03371485|459660683|FG000|2-year Follow-up|Death|5|||
127736443|NCT02171130|459660686|FG000|Overall Study|Death|1|||
127736444|NCT02171130|459660686|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
127736445|NCT02171130|459660686|FG000|Overall Study|Discontinued; Site Termination|5|||
127736446|NCT02171130|459660686|FG000|Overall Study|Withdrawal by Subject|3|||
127736447|NCT02171130|459660686|FG000|Overall Study|Physician Decision|1|||
127736448|NCT02171130|459660686|FG000|Overall Study|Lost to Follow-up|1|||
127736449|NCT02171130|459660686|FG000|Overall Study|Met Exclusion Criteria|1|||
127736450|NCT04531813|459660687|FG000|Overall Study|Protocol Violation|1|||
127736451|NCT04531813|459660687|FG000|Overall Study|Withdrawal by Subject|1|||
127736452|NCT02853305|459660688|FG000|Overall Study|Death|287|||
127736453|NCT02853305|459660689|FG001|Overall Study|Death|249|||
127736454|NCT02853305|459660690|FG002|Overall Study|Death|300|||
127736455|NCT02853305|459660688|FG000|Overall Study|Withdrawal by Subject|2|||
127736456|NCT02853305|459660689|FG001|Overall Study|Withdrawal by Subject|8|||
127736457|NCT02853305|459660690|FG002|Overall Study|Withdrawal by Subject|3|||
127736458|NCT02853305|459660688|FG000|Overall Study|Transferred to Extension Study|46|||
127736459|NCT02853305|459660689|FG001|Overall Study|Transferred to Extension Study|30|||
127892710|NCT00686036|460229633|FG001|Overall Study|Withdrawal by Subject|1|||
127892711|NCT00686036|460229632|FG000|Overall Study|Study terminated by AstraZeneca|2|||
127892712|NCT00686036|460229633|FG001|Overall Study|Study terminated by AstraZeneca|1|||
127892713|NCT00686036|460229632|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
127892714|NCT00686036|460229633|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
127892715|NCT00686036|460229632|FG000|Overall Study|Other reasons not identified|0|||
127736460|NCT02853305|459660690|FG002|Overall Study|Transferred to Extension Study|25|||
127736461|NCT02853305|459660688|FG000|Overall Study|Did Not Continue on Extension Study|16|||
127736462|NCT02853305|459660689|FG001|Overall Study|Did Not Continue on Extension Study|20|||
127736463|NCT02853305|459660690|FG002|Overall Study|Did Not Continue on Extension Study|24|||
127736464|NCT02381652|459660693|FG000|Overall Study|Withdrawal by Subject|0|||
127736465|NCT02381652|459660694|FG001|Overall Study|Withdrawal by Subject|0|||
127736466|NCT02381652|459660695|FG002|Overall Study|Withdrawal by Subject|1|||
127736467|NCT01340300|459660696|FG000|Overall Study|Lost to Follow-up|3|||
127736468|NCT01340300|459660697|FG001|Overall Study|Lost to Follow-up|0|||
127736469|NCT01340300|459660698|FG002|Overall Study|Lost to Follow-up|5|||
127892716|NCT00686036|460229633|FG001|Overall Study|Other reasons not identified|4|||
127892717|NCT01199601|460229637|FG000|Overall Study|Lost to Follow-up|47|||
127892718|NCT01199601|460229638|FG001|Overall Study|Lost to Follow-up|66|||
127892719|NCT01199601|460229637|FG000|Overall Study|Withdrawal by Subject|15|||
127736470|NCT01340300|459660699|FG003|Overall Study|Lost to Follow-up|10|||
127736471|NCT01340300|459660696|FG000|Overall Study|Withdrawal by Subject|5|||
127736472|NCT01340300|459660697|FG001|Overall Study|Withdrawal by Subject|6|||
127736473|NCT01340300|459660698|FG002|Overall Study|Withdrawal by Subject|6|||
127892720|NCT01199601|460229638|FG001|Overall Study|Withdrawal by Subject|3|||
127736474|NCT01340300|459660699|FG003|Overall Study|Withdrawal by Subject|3|||
127736475|NCT01340300|459660696|FG000|Overall Study|Adverse Event|1|||
127736476|NCT01340300|459660697|FG001|Overall Study|Adverse Event|0|||
127736477|NCT01340300|459660698|FG002|Overall Study|Adverse Event|4|||
127736478|NCT01340300|459660699|FG003|Overall Study|Adverse Event|0|||
127736479|NCT01340300|459660696|FG000|Overall Study|Physician Decision|0|||
127736480|NCT01340300|459660697|FG001|Overall Study|Physician Decision|1|||
127736481|NCT01340300|459660698|FG002|Overall Study|Physician Decision|0|||
127736482|NCT01340300|459660699|FG003|Overall Study|Physician Decision|0|||
127736483|NCT01340300|459660696|FG000|Overall Study|Unrelated sickness|0|||
127736484|NCT01340300|459660697|FG001|Overall Study|Unrelated sickness|2|||
127736485|NCT01340300|459660698|FG002|Overall Study|Unrelated sickness|0|||
127736486|NCT01340300|459660699|FG003|Overall Study|Unrelated sickness|1|||
127736487|NCT03544229|459660700|FG000|Overall Study|Adverse Event|1|||
127736488|NCT03544229|459660701|FG001|Overall Study|Adverse Event|0|||
127736489|NCT03544229|459660702|FG002|Overall Study|Adverse Event|1|||
127736490|NCT03544229|459660703|FG003|Overall Study|Adverse Event|0|||
127736491|NCT03544229|459660700|FG000|Overall Study|Protocol Deviation|0|||
127736492|NCT03544229|459660701|FG001|Overall Study|Protocol Deviation|0|||
127736493|NCT03544229|459660702|FG002|Overall Study|Protocol Deviation|1|||
127736494|NCT03544229|459660703|FG003|Overall Study|Protocol Deviation|0|||
127736495|NCT03544229|459660700|FG000|Overall Study|Lost to Follow-up|3|||
127736496|NCT03544229|459660701|FG001|Overall Study|Lost to Follow-up|0|||
127736497|NCT03544229|459660702|FG002|Overall Study|Lost to Follow-up|0|||
127736498|NCT03544229|459660703|FG003|Overall Study|Lost to Follow-up|2|||
127736499|NCT03544229|459660700|FG000|Overall Study|Voluntary Withdrawal|2|||
127736500|NCT03544229|459660701|FG001|Overall Study|Voluntary Withdrawal|1|||
127736501|NCT03544229|459660702|FG002|Overall Study|Voluntary Withdrawal|3|||
127736502|NCT03544229|459660703|FG003|Overall Study|Voluntary Withdrawal|0|||
127736503|NCT03544229|459660700|FG000|Overall Study|Lack of Efficacy|0|||
127736504|NCT03544229|459660701|FG001|Overall Study|Lack of Efficacy|1|||
127736505|NCT03544229|459660702|FG002|Overall Study|Lack of Efficacy|0|||
127736506|NCT03544229|459660703|FG003|Overall Study|Lack of Efficacy|0|||
127736507|NCT01951261|459660704|FG000|Overall Study|Death|1|||
127736508|NCT01951261|459660705|FG001|Overall Study|Death|0|||
127736509|NCT01951261|459660704|FG000|Overall Study|Lost to Follow-up|4|||
127736510|NCT01951261|459660705|FG001|Overall Study|Lost to Follow-up|3|||
127736511|NCT01951261|459660704|FG000|Overall Study|Protocol Violation|4|||
127736512|NCT01951261|459660705|FG001|Overall Study|Protocol Violation|3|||
127736513|NCT01924806|459660706|FG000|Overall Study|Physician Decision|2|||
127736514|NCT01924806|459660707|FG001|Overall Study|Physician Decision|1|||
127736515|NCT01954771|459660708|FG000|Overall Study|Missing HbA1c of end-point|1|||
127736516|NCT01954771|459660709|FG001|Overall Study|Missing HbA1c of end-point|1|||
127736517|NCT01954771|459660710|FG002|Overall Study|Missing HbA1c of end-point|0|||
127736518|NCT01954771|459660708|FG000|Overall Study|Missing CGMS of end-point|1|||
127736519|NCT01954771|459660709|FG001|Overall Study|Missing CGMS of end-point|1|||
127736520|NCT01954771|459660710|FG002|Overall Study|Missing CGMS of end-point|0|||
127736521|NCT01954771|459660708|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
127736522|NCT01954771|459660709|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
127736523|NCT01954771|459660710|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
127736524|NCT00297778|459660715|FG000|Overall Study|Adverse Event|16|||
127736525|NCT00297778|459660716|FG001|Overall Study|Adverse Event|10|||
127736526|NCT00297778|459660715|FG000|Overall Study|Withdrawal by Subject|1|||
127736527|NCT00297778|459660716|FG001|Overall Study|Withdrawal by Subject|5|||
127736528|NCT00297778|459660715|FG000|Overall Study|Lack of Efficacy|2|||
127736529|NCT00297778|459660716|FG001|Overall Study|Lack of Efficacy|1|||
127736530|NCT00297778|459660715|FG000|Overall Study|Non-compliant with trial protocol|0|||
127736531|NCT00297778|459660716|FG001|Overall Study|Non-compliant with trial protocol|3|||
127736532|NCT00297778|459660715|FG000|Overall Study|Other|0|||
127736533|NCT00297778|459660716|FG001|Overall Study|Other|1|||
127736534|NCT00679549|459660717|FG000|Overall Study|dropout|2|||
127736535|NCT00679549|459660718|FG001|Overall Study|dropout|4|||
127736536|NCT00679549|459660717|FG000|Overall Study|missing outcome echocardiograms|4|||
127736537|NCT00679549|459660718|FG001|Overall Study|missing outcome echocardiograms|5|||
127736538|NCT03280108|459660719|FG000|Overall Study|Lost to Follow-up|2|||
127736539|NCT03280108|459660720|FG001|Overall Study|Lost to Follow-up|0|||
127736540|NCT02996097|459660721|FG000|Overall Study|Lost to Follow-up|11|||
127736541|NCT02996097|459660722|FG001|Overall Study|Lost to Follow-up|11|||
127736542|NCT02201771|459660723|FG000|Overall Study|Death|3|||
127736543|NCT02201771|459660724|FG001|Overall Study|Death|2|||
127736544|NCT02201771|459660725|FG002|Overall Study|Death|0|||
127736545|NCT02201771|459660723|FG000|Overall Study|Protocol Violation|10|||
127736546|NCT02201771|459660724|FG001|Overall Study|Protocol Violation|8|||
127736547|NCT02201771|459660725|FG002|Overall Study|Protocol Violation|10|||
127736548|NCT01820637|459660726|FG000|Overall Study|Death|2|||
127736549|NCT01820637|459660726|FG000|Overall Study|Withdrawal by Subject|1|||
127736550|NCT00583115|459660727|FG000|Overall Study|Death|1|||
127736551|NCT00264498|459660728|FG000|Randomized Treatment|Death|0|||
127736552|NCT00264498|459660729|FG001|Randomized Treatment|Death|3|||
127736553|NCT00264498|459660728|FG000|Randomized Treatment|Withdrawal by Subject|0|||
127736554|NCT00264498|459660729|FG001|Randomized Treatment|Withdrawal by Subject|1|||
127736555|NCT00264498|459660728|FG000|Randomized Treatment|Objective disease Progression|13|||
127736556|NCT00264498|459660729|FG001|Randomized Treatment|Objective disease Progression|14|||
127736557|NCT00264498|459660728|FG000|Randomized Treatment|Physician Decision|1|||
127736558|NCT00264498|459660729|FG001|Randomized Treatment|Physician Decision|0|||
127736559|NCT00264498|459660728|FG000|Randomized Treatment|Incorrectly randomized|1|||
127736560|NCT00264498|459660729|FG001|Randomized Treatment|Incorrectly randomized|0|||
127736561|NCT00264498|459660728|FG000|Randomized Treatment|Study Closure|1|||
127736562|NCT00264498|459660729|FG001|Randomized Treatment|Study Closure|0|||
127736563|NCT00264498|459660728|FG000|Randomized Treatment|Protocol Violation|1|||
127736564|NCT00264498|459660729|FG001|Randomized Treatment|Protocol Violation|0|||
127736565|NCT00264498|459660728|FG000|Crossover Treatment|Death|1|||
127736566|NCT00264498|459660729|FG001|Crossover Treatment|Death|3|||
127736567|NCT00264498|459660728|FG000|Crossover Treatment|Objective disease progression|4|||
127736568|NCT00264498|459660729|FG001|Crossover Treatment|Objective disease progression|5|||
127736569|NCT00264498|459660728|FG000|Crossover Treatment|Study closure|0|||
127736570|NCT00264498|459660729|FG001|Crossover Treatment|Study closure|1|||
127736571|NCT00264498|459660728|FG000|Crossover Treatment|Withdrawal by Subject|1|||
127736572|NCT00264498|459660729|FG001|Crossover Treatment|Withdrawal by Subject|0|||
127736573|NCT02205476|459660730|FG000|Overall Study|Study termination by Sponsor|7|||
127736574|NCT02205476|459660731|FG001|Overall Study|Study termination by Sponsor|3|||
127736575|NCT02109107|459660734|FG000|Overall Study|Lost to Follow-up|2|||
127736576|NCT00607789|459660740|FG000|Overall Study|Adverse Event|3|||
127736577|NCT00607789|459660741|FG001|Overall Study|Adverse Event|0|||
127736578|NCT00607789|459660740|FG000|Overall Study|Lack of Efficacy|0|||
127736579|NCT00607789|459660741|FG001|Overall Study|Lack of Efficacy|1|||
127736580|NCT00607789|459660740|FG000|Overall Study|Inadequate adherence|3|||
127736581|NCT00607789|459660741|FG001|Overall Study|Inadequate adherence|0|||
127736582|NCT00607789|459660740|FG000|Overall Study|Lost to Follow-up|0|||
127736583|NCT00607789|459660741|FG001|Overall Study|Lost to Follow-up|5|||
127736584|NCT00607789|459660740|FG000|Overall Study|Withdrawal by Subject|1|||
127736585|NCT00607789|459660741|FG001|Overall Study|Withdrawal by Subject|0|||
127736586|NCT02506881|459660742|FG000|First Intervention (Day 1)|Protocol Violation|0|||
127736587|NCT02506881|459660743|FG001|First Intervention (Day 1)|Protocol Violation|0|||
127736588|NCT02506881|459660744|FG002|First Intervention (Day 1)|Protocol Violation|1|||
127736589|NCT02506881|459660745|FG003|First Intervention (Day 1)|Protocol Violation|0|||
127736590|NCT02506881|459660742|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
127736591|NCT02506881|459660743|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
127736592|NCT02506881|459660744|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
127736593|NCT02506881|459660745|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
127736594|NCT02506881|459660742|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
127736595|NCT02506881|459660743|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
127736596|NCT02506881|459660744|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
127736597|NCT02506881|459660745|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
127736598|NCT01919398|459660746|FG000|Overall Study|Progressive Disease|0|||
127736599|NCT01919398|459660747|FG001|Overall Study|Progressive Disease|0|||
127736600|NCT01919398|459660748|FG002|Overall Study|Progressive Disease|4|||
127736601|NCT02016690|459660751|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
127736602|NCT02016690|459660751|FG000|Overall Study|Excluded from SAS: Duplication|2|||
127736603|NCT02016690|459660751|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
127736604|NCT02016690|459660751|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
127736605|NCT02016690|459660751|FG000|Overall Study|Did not meet inclusion criteria|13|||
127736606|NCT02016690|459660751|FG000|Overall Study|Hospitalized for RSV at study start|3|||
127736607|NCT00050167|459660752|FG000|Overall Study|not eligible not invasive|1|||
127736608|NCT00050167|459660753|FG001|Overall Study|not eligible not invasive|1|||
127736609|NCT00495612|459660756|FG000|Overall Study|Lost to Follow-up|1|||
127736610|NCT00495612|459660757|FG001|Overall Study|Lost to Follow-up|0|||
127736611|NCT00495612|459660756|FG000|Overall Study|Subject's Decision to Withdraw|3|||
127736612|NCT00495612|459660757|FG001|Overall Study|Subject's Decision to Withdraw|0|||
127736613|NCT06016127|459660760|FG000|Overall Study|Withdrawal by Subject|4|||
127736614|NCT06016127|459660761|FG001|Overall Study|Withdrawal by Subject|3|||
127736615|NCT02864147|459660767|FG000|Overall Study|Withdrawal by Subject|3|||
127736616|NCT02864147|459660768|FG001|Overall Study|Withdrawal by Subject|2|||
127736617|NCT02864147|459660769|FG002|Overall Study|Withdrawal by Subject|1|||
127736618|NCT02864147|459660767|FG000|Overall Study|Lost to Follow-up|0|||
127736619|NCT02864147|459660768|FG001|Overall Study|Lost to Follow-up|4|||
127736620|NCT02864147|459660769|FG002|Overall Study|Lost to Follow-up|0|||
127736621|NCT02864147|459660767|FG000|Overall Study|Adverse Event|0|||
127736622|NCT02864147|459660768|FG001|Overall Study|Adverse Event|1|||
127736623|NCT02864147|459660769|FG002|Overall Study|Adverse Event|0|||
127736624|NCT02864147|459660767|FG000|Overall Study|Pregnancy|4|||
127736625|NCT02864147|459660768|FG001|Overall Study|Pregnancy|0|||
127736626|NCT02864147|459660769|FG002|Overall Study|Pregnancy|0|||
127736627|NCT02864147|459660767|FG000|Overall Study|Physician Decision|0|||
127736628|NCT02864147|459660768|FG001|Overall Study|Physician Decision|0|||
127736629|NCT02864147|459660769|FG002|Overall Study|Physician Decision|1|||
127736630|NCT02864147|459660767|FG000|Overall Study|Opted for excisional procedures|0|||
127736631|NCT02864147|459660768|FG001|Overall Study|Opted for excisional procedures|0|||
127736632|NCT02864147|459660769|FG002|Overall Study|Opted for excisional procedures|3|||
127736633|NCT02269917|459660770|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
127736634|NCT02269917|459660771|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
127736635|NCT02269917|459660772|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
127736636|NCT02269917|459660770|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
127736637|NCT02269917|459660771|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
127736638|NCT02269917|459660772|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
127736639|NCT02269917|459660770|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
127736640|NCT02269917|459660771|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
127736641|NCT02269917|459660772|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
127736642|NCT02269917|459660770|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
127736643|NCT02269917|459660771|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
127736644|NCT02269917|459660772|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
127736645|NCT02269917|459660770|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
127736646|NCT02269917|459660771|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
127736647|NCT02269917|459660772|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
127736648|NCT02269917|459660770|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
127736649|NCT02269917|459660771|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
127736650|NCT02269917|459660772|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
127736651|NCT02269917|459660770|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
127736652|NCT02269917|459660771|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
127736653|NCT02269917|459660772|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
127736654|NCT02269917|459660770|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
127736655|NCT02269917|459660771|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
127736656|NCT02269917|459660772|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
127736657|NCT02269917|459660770|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
127736658|NCT02269917|459660771|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
127736659|NCT02269917|459660772|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
127736660|NCT02269917|459660770|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
127736661|NCT02269917|459660771|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
127736662|NCT02269917|459660772|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
127736663|NCT02269917|459660770|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
127736664|NCT02269917|459660771|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
127736665|NCT02269917|459660772|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
127736666|NCT02269917|459660770|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
127736667|NCT02269917|459660771|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
127736668|NCT02269917|459660772|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
127736669|NCT02269917|459660770|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
127736670|NCT02269917|459660771|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
127736671|NCT02269917|459660772|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
127736672|NCT02269917|459660770|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
127736673|NCT02269917|459660771|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
127736674|NCT02269917|459660772|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
127736675|NCT02269917|459660770|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
127736676|NCT02269917|459660771|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
127736677|NCT02269917|459660772|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
127736678|NCT02269917|459660770|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
127736679|NCT02269917|459660771|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
127736680|NCT02269917|459660772|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
127736681|NCT02383927|459660773|FG000|Overall Study|Disease Progression|8|||
127806455|NCT00379340|459913423|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
127806456|NCT00379340|459913424|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
127806457|NCT00379340|459913425|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
127806458|NCT00379340|459913426|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
127806459|NCT00379340|459913427|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
127806460|NCT02162862|459913431|FG000|Overall Study|Lost to Follow-up|0|||
127806461|NCT02162862|459913432|FG001|Overall Study|Lost to Follow-up|11|||
127806462|NCT02162862|459913433|FG002|Overall Study|Lost to Follow-up|0|||
127806463|NCT02162862|459913431|FG000|Overall Study|Subject did not feel the med was needed|0|||
127806464|NCT02162862|459913432|FG001|Overall Study|Subject did not feel the med was needed|0|||
127806465|NCT02162862|459913433|FG002|Overall Study|Subject did not feel the med was needed|4|||
127806466|NCT00103012|459913436|FG000|Overall Study|Withdrawal by Subject|2|||
127806467|NCT00103012|459913437|FG001|Overall Study|Withdrawal by Subject|1|||
127806468|NCT00103012|459913438|FG002|Overall Study|Withdrawal by Subject|2|||
127806469|NCT00103012|459913436|FG000|Overall Study|Pregnancy|1|||
127806470|NCT00103012|459913437|FG001|Overall Study|Pregnancy|0|||
127806471|NCT00103012|459913438|FG002|Overall Study|Pregnancy|0|||
127806472|NCT00103012|459913436|FG000|Overall Study|Adverse Event|0|||
127736682|NCT02383927|459660774|FG001|Overall Study|Disease Progression|8|||
127736683|NCT02383927|459660775|FG002|Overall Study|Disease Progression|15|||
127736684|NCT02383927|459660776|FG003|Overall Study|Disease Progression|4|||
127736685|NCT02383927|459660773|FG000|Overall Study|Physician Decision|0|||
127736686|NCT02383927|459660774|FG001|Overall Study|Physician Decision|0|||
127736687|NCT02383927|459660775|FG002|Overall Study|Physician Decision|2|||
127736688|NCT02383927|459660776|FG003|Overall Study|Physician Decision|0|||
127736689|NCT02383927|459660773|FG000|Overall Study|Termination by Symptomatic Deterioration|0|||
127736690|NCT02383927|459660774|FG001|Overall Study|Termination by Symptomatic Deterioration|0|||
127736691|NCT02383927|459660775|FG002|Overall Study|Termination by Symptomatic Deterioration|6|||
127736692|NCT02383927|459660776|FG003|Overall Study|Termination by Symptomatic Deterioration|0|||
127736693|NCT02383927|459660773|FG000|Overall Study|Adverse Event|4|||
127736694|NCT02383927|459660774|FG001|Overall Study|Adverse Event|1|||
127736695|NCT02383927|459660775|FG002|Overall Study|Adverse Event|3|||
127736696|NCT02383927|459660776|FG003|Overall Study|Adverse Event|5|||
127736697|NCT02383927|459660773|FG000|Overall Study|Miscellaneous|1|||
127736698|NCT02383927|459660774|FG001|Overall Study|Miscellaneous|0|||
127736699|NCT02383927|459660775|FG002|Overall Study|Miscellaneous|0|||
127736700|NCT02383927|459660776|FG003|Overall Study|Miscellaneous|1|||
127736701|NCT02383927|459660773|FG000|Overall Study|Withdrawal by Subject|0|||
127736702|NCT02383927|459660774|FG001|Overall Study|Withdrawal by Subject|1|||
127736703|NCT02383927|459660775|FG002|Overall Study|Withdrawal by Subject|4|||
127736704|NCT02383927|459660776|FG003|Overall Study|Withdrawal by Subject|0|||
127736705|NCT02865135|459660777|FG000|Overall Study|Death|0|||
127736706|NCT02865135|459660778|FG001|Overall Study|Death|1|||
127736707|NCT02865135|459660779|FG002|Overall Study|Death|0|||
127736708|NCT02865135|459660777|FG000|Overall Study|Progression|6|||
127736709|NCT02865135|459660778|FG001|Overall Study|Progression|2|||
127736710|NCT02865135|459660779|FG002|Overall Study|Progression|2|||
127736711|NCT01772147|459662947|FG000|Overall Study|Adverse Event|13|||
127736712|NCT01772147|459662948|FG001|Overall Study|Adverse Event|10|||
127736713|NCT01772147|459662949|FG002|Overall Study|Adverse Event|6|||
127736714|NCT01772147|459662947|FG000|Overall Study|Withdrew Consent|7|||
127736715|NCT01772147|459662948|FG001|Overall Study|Withdrew Consent|8|||
127736716|NCT01772147|459662949|FG002|Overall Study|Withdrew Consent|4|||
127736717|NCT01772147|459662947|FG000|Overall Study|Lost to Follow-up|1|||
127736718|NCT01772147|459662948|FG001|Overall Study|Lost to Follow-up|0|||
127736719|NCT01772147|459662949|FG002|Overall Study|Lost to Follow-up|1|||
127736720|NCT01772147|459662947|FG000|Overall Study|Protocol Deviation|2|||
127736721|NCT01772147|459662948|FG001|Overall Study|Protocol Deviation|1|||
127736722|NCT01772147|459662949|FG002|Overall Study|Protocol Deviation|1|||
127736723|NCT01772147|459662947|FG000|Overall Study|Lack of Efficacy|8|||
127736724|NCT01772147|459662948|FG001|Overall Study|Lack of Efficacy|6|||
127736725|NCT01772147|459662949|FG002|Overall Study|Lack of Efficacy|6|||
127736726|NCT02972242|459662950|FG000|Overall Study|Withdrawal by Subject|1|||
127736727|NCT02972242|459662951|FG001|Overall Study|Withdrawal by Subject|0|||
127736728|NCT04572997|459662952|FG000|Overall Study|Adverse Event|1|||
127736729|NCT02956278|459662953|FG000|Overall Study|Withdrawal by Subject|6|||
127736730|NCT02956278|459662954|FG001|Overall Study|Withdrawal by Subject|2|||
127736731|NCT02956278|459662955|FG002|Overall Study|Withdrawal by Subject|0|||
127736732|NCT00509821|459662965|FG000|Study Period 1 (Induction)|Death|0|||
127736733|NCT00509821|459662966|FG001|Study Period 1 (Induction)|Death|1|||
127736734|NCT00509821|459662965|FG000|Study Period 1 (Induction)|Adverse Event|0|||
127736735|NCT00509821|459662966|FG001|Study Period 1 (Induction)|Adverse Event|2|||
127736736|NCT00509821|459662965|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
127736737|NCT00509821|459662966|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
127736738|NCT01816685|459662970|FG000|Overall Study|Lost to Follow-up|7|||
127736739|NCT01816685|459662971|FG001|Overall Study|Lost to Follow-up|9|||
127736740|NCT01816685|459662970|FG000|Overall Study|Surgery Cancelled|3|||
127736741|NCT01816685|459662971|FG001|Overall Study|Surgery Cancelled|2|||
127736742|NCT02720185|459662972|FG000|Overall Study|Lost to Follow-up|1|||
127736743|NCT01157351|459662973|FG000|Overall Study|Adverse Event|5|||
127736744|NCT01157351|459662974|FG001|Overall Study|Adverse Event|4|||
127736745|NCT01157351|459662973|FG000|Overall Study|Death|1|||
127736746|NCT01157351|459662974|FG001|Overall Study|Death|0|||
127736747|NCT01157351|459662973|FG000|Overall Study|Lost to Follow-up|53|||
127736748|NCT01157351|459662974|FG001|Overall Study|Lost to Follow-up|55|||
127736749|NCT01157351|459662973|FG000|Overall Study|Withdrawal by Subject|37|||
127736750|NCT01157351|459662974|FG001|Overall Study|Withdrawal by Subject|27|||
127736751|NCT01157351|459662973|FG000|Overall Study|Physician Decision|5|||
127736752|NCT01157351|459662974|FG001|Overall Study|Physician Decision|4|||
127736753|NCT01157351|459662973|FG000|Overall Study|Protocol Violation|0|||
127736754|NCT01157351|459662974|FG001|Overall Study|Protocol Violation|1|||
127736755|NCT01157351|459662973|FG000|Overall Study|Other|32|||
127736756|NCT01157351|459662974|FG001|Overall Study|Other|36|||
127736757|NCT01157351|459662973|FG000|Overall Study|Noncompliance with Study Drug|0|||
127736758|NCT01157351|459662974|FG001|Overall Study|Noncompliance with Study Drug|3|||
127736759|NCT01157351|459662973|FG000|Overall Study|Randomized but not Treated|4|||
127736760|NCT01157351|459662974|FG001|Overall Study|Randomized but not Treated|2|||
127736761|NCT03418493|459662975|FG000|Overall Study|Adverse Event|1|||
127736762|NCT03418493|459662976|FG001|Overall Study|Adverse Event|0|||
127736763|NCT03418493|459662977|FG002|Overall Study|Adverse Event|0|||
127736764|NCT03418493|459662978|FG003|Overall Study|Adverse Event|0|||
127736765|NCT03418493|459662979|FG004|Overall Study|Adverse Event|0|||
127736766|NCT03418493|459662980|FG005|Overall Study|Adverse Event|0|||
127736767|NCT03418493|459662981|FG006|Overall Study|Adverse Event|0|||
127736768|NCT03418493|459662982|FG007|Overall Study|Adverse Event|0|||
127736769|NCT03418493|459662983|FG008|Overall Study|Adverse Event|0|||
127736770|NCT03418493|459662984|FG009|Overall Study|Adverse Event|0|||
127736771|NCT03418493|459662985|FG010|Overall Study|Adverse Event|0|||
127736772|NCT03418493|459662975|FG000|Overall Study|Protocol Violation|0|||
127736773|NCT03418493|459662976|FG001|Overall Study|Protocol Violation|0|||
127736774|NCT03418493|459662977|FG002|Overall Study|Protocol Violation|0|||
127736775|NCT03418493|459662978|FG003|Overall Study|Protocol Violation|0|||
127736776|NCT03418493|459662979|FG004|Overall Study|Protocol Violation|0|||
127736777|NCT03418493|459662980|FG005|Overall Study|Protocol Violation|0|||
127736778|NCT03418493|459662981|FG006|Overall Study|Protocol Violation|0|||
127736779|NCT03418493|459662982|FG007|Overall Study|Protocol Violation|0|||
127736780|NCT03418493|459662983|FG008|Overall Study|Protocol Violation|0|||
127736781|NCT03418493|459662984|FG009|Overall Study|Protocol Violation|1|||
127736782|NCT03418493|459662985|FG010|Overall Study|Protocol Violation|0|||
127736783|NCT05446714|459662986|FG000|Overall Study|Lost to Follow-up|1|||
127736784|NCT05446714|459662987|FG001|Overall Study|Lost to Follow-up|3|||
127736785|NCT05446714|459662988|FG002|Overall Study|Lost to Follow-up|2|||
127736786|NCT05446714|459662986|FG000|Overall Study|Protocol Violation|2|||
127736787|NCT05446714|459662987|FG001|Overall Study|Protocol Violation|0|||
127736788|NCT05446714|459662988|FG002|Overall Study|Protocol Violation|0|||
127736789|NCT00197106|459662991|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
127736790|NCT00197106|459662992|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
127736791|NCT00197106|459662993|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
127736792|NCT00197106|459662991|FG000|Overall Treatment Period|Lack of Efficacy|0|||
127736793|NCT00197106|459662992|FG001|Overall Treatment Period|Lack of Efficacy|1|||
127736794|NCT00197106|459662993|FG002|Overall Treatment Period|Lack of Efficacy|0|||
127736795|NCT00197106|459662991|FG000|Overall Treatment Period|Lost to Follow-up|0|||
127736796|NCT00197106|459662992|FG001|Overall Treatment Period|Lost to Follow-up|0|||
127736797|NCT00197106|459662993|FG002|Overall Treatment Period|Lost to Follow-up|2|||
127736798|NCT00197106|459662991|FG000|Overall Treatment Period|Protocol Violation|0|||
127736799|NCT00197106|459662992|FG001|Overall Treatment Period|Protocol Violation|0|||
127736800|NCT00197106|459662993|FG002|Overall Treatment Period|Protocol Violation|2|||
127736801|NCT00197106|459662991|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
127736802|NCT00197106|459662992|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
127736803|NCT00197106|459662993|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
127736804|NCT01990313|459662996|FG000|Overall Study|Lost to Follow-up|1|||
127736805|NCT00837096|459662997|FG000|Overall Study|Physician Decision|1|||
127736806|NCT00837096|459662998|FG001|Overall Study|Physician Decision|1|||
127736807|NCT00837096|459662997|FG000|Overall Study|Not reported|9|||
127736808|NCT00837096|459662998|FG001|Overall Study|Not reported|8|||
127736809|NCT02396953|459663001|FG000|Overall Study|Withdrawal by Subject|0|||
127736810|NCT02396953|459663002|FG001|Overall Study|Withdrawal by Subject|0|||
127736811|NCT02396953|459663003|FG002|Overall Study|Withdrawal by Subject|1|||
127736812|NCT02396953|459663001|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
127736813|NCT02396953|459663002|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
127736814|NCT02396953|459663003|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
127736815|NCT02396953|459663001|FG000|Overall Study|Personal Reasons|1|||
127736816|NCT02396953|459663002|FG001|Overall Study|Personal Reasons|1|||
127736817|NCT02396953|459663003|FG002|Overall Study|Personal Reasons|0|||
127736818|NCT00329550|459663005|FG000|Overall Study|Adverse Event|3|||
127736819|NCT00329550|459663006|FG001|Overall Study|Adverse Event|4|||
127736820|NCT00329550|459663007|FG002|Overall Study|Adverse Event|2|||
127736821|NCT00329550|459663005|FG000|Overall Study|Withdrawal of Consent|1|||
127736822|NCT00329550|459663006|FG001|Overall Study|Withdrawal of Consent|0|||
127806473|NCT00103012|459913437|FG001|Overall Study|Adverse Event|0|||
127806474|NCT00103012|459913438|FG002|Overall Study|Adverse Event|1|||
127806475|NCT00103012|459913436|FG000|Overall Study|Subject non-compliant with medications|0|||
127806476|NCT00103012|459913437|FG001|Overall Study|Subject non-compliant with medications|0|||
127806477|NCT00103012|459913438|FG002|Overall Study|Subject non-compliant with medications|1|||
127806478|NCT00430755|459913439|FG000|Overall Study|Withdrawal by Subject|53|||
127806479|NCT05019131|459913443|FG000|Overall Study|Lost to Follow-up|0|||
127806480|NCT05019131|459913444|FG001|Overall Study|Lost to Follow-up|3|||
127806481|NCT04684420|459913445|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
127806482|NCT04684420|459913446|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
127736823|NCT00329550|459663007|FG002|Overall Study|Withdrawal of Consent|1|||
127736824|NCT00329550|459663005|FG000|Overall Study|Due to Relocation|0|||
127736825|NCT00329550|459663006|FG001|Overall Study|Due to Relocation|0|||
127736826|NCT00329550|459663007|FG002|Overall Study|Due to Relocation|1|||
127736827|NCT00833898|459663017|FG000|Overall Study|Withdrawal by Subject|33|||
127736828|NCT00833898|459663018|FG001|Overall Study|Withdrawal by Subject|27|||
127736829|NCT00833898|459663017|FG000|Overall Study|Lost to Follow-up|7|||
127736830|NCT00833898|459663018|FG001|Overall Study|Lost to Follow-up|7|||
127736831|NCT00833898|459663017|FG000|Overall Study|Patient did not receive transplant|0|||
127736832|NCT00833898|459663018|FG001|Overall Study|Patient did not receive transplant|2|||
127736833|NCT00805285|459663019|FG000|Overall Study|Lack of Efficacy|1|||
127736834|NCT00917462|459663020|FG000|Overall Study|Clinical Deterioration|1|||
127736835|NCT01402063|459663021|FG000|Overall Study|Withdrawal by Subject|3|||
127736836|NCT01402063|459663022|FG001|Overall Study|Withdrawal by Subject|3|||
127736837|NCT02110225|459663026|FG000|Overall Study|Lost to Follow-up|0|||
127736838|NCT02110225|459663027|FG001|Overall Study|Lost to Follow-up|1|||
127736839|NCT02110225|459663028|FG002|Overall Study|Lost to Follow-up|0|||
127736840|NCT02176018|459663029|FG000|Overall Study|Adverse Event|0|||
127736841|NCT02176018|459663030|FG001|Overall Study|Adverse Event|2|||
127736842|NCT02176018|459663029|FG000|Overall Study|Lost to Follow-up|3|||
127736843|NCT02176018|459663030|FG001|Overall Study|Lost to Follow-up|1|||
127736844|NCT02176018|459663029|FG000|Overall Study|Protocol Violation|1|||
127736845|NCT02176018|459663030|FG001|Overall Study|Protocol Violation|1|||
127736846|NCT02176018|459663029|FG000|Overall Study|Withdrawal by Subject|1|||
127736847|NCT02176018|459663030|FG001|Overall Study|Withdrawal by Subject|2|||
127736848|NCT03022045|459663031|FG000|Overall Study|Adverse Event|0|||
127736849|NCT03022045|459663032|FG001|Overall Study|Adverse Event|1|||
127736850|NCT03022045|459663031|FG000|Overall Study|Withdrawal by Subject|1|||
127736851|NCT03022045|459663032|FG001|Overall Study|Withdrawal by Subject|1|||
127736852|NCT02499835|459663036|FG000|Overall Study|Withdrawal by Subject|1|||
127736853|NCT02499835|459663037|FG001|Overall Study|Withdrawal by Subject|0|||
127736854|NCT02499835|459663038|FG002|Overall Study|Withdrawal by Subject|0|||
127736855|NCT02499835|459663039|FG003|Overall Study|Withdrawal by Subject|1|||
127736856|NCT02499835|459663036|FG000|Overall Study|Physician Decision|0|||
127736857|NCT02499835|459663037|FG001|Overall Study|Physician Decision|3|||
127736858|NCT02499835|459663038|FG002|Overall Study|Physician Decision|18|||
127736859|NCT02499835|459663039|FG003|Overall Study|Physician Decision|7|||
127736860|NCT02499835|459663036|FG000|Overall Study|Adverse Event|0|||
127736861|NCT02499835|459663037|FG001|Overall Study|Adverse Event|0|||
127736862|NCT02499835|459663038|FG002|Overall Study|Adverse Event|0|||
127736863|NCT02499835|459663039|FG003|Overall Study|Adverse Event|1|||
127736864|NCT02499835|459663036|FG000|Overall Study|Disease progression|2|||
127736865|NCT02499835|459663037|FG001|Overall Study|Disease progression|1|||
127736866|NCT02499835|459663038|FG002|Overall Study|Disease progression|0|||
127736867|NCT02499835|459663039|FG003|Overall Study|Disease progression|7|||
127736868|NCT03972137|459663040|FG000|Overall Study|Lost to Follow-up|2|||
127736869|NCT03972137|459663040|FG000|Overall Study|Withdrawal by Subject|4|||
127736870|NCT03220776|459663048|FG000|Overall Study|Claustrophobia|0|||
127736871|NCT03220776|459663049|FG001|Overall Study|Claustrophobia|1|||
127736872|NCT03220776|459663050|FG002|Overall Study|Claustrophobia|1|||
127736873|NCT03220776|459663051|FG003|Overall Study|Claustrophobia|0|||
127736874|NCT03220776|459663052|FG004|Overall Study|Claustrophobia|1|||
127736875|NCT03220776|459663053|FG005|Overall Study|Claustrophobia|0|||
127736876|NCT03220776|459663048|FG000|Overall Study|MRI Equipment Failure|1|||
127736877|NCT03220776|459663049|FG001|Overall Study|MRI Equipment Failure|0|||
127736878|NCT03220776|459663050|FG002|Overall Study|MRI Equipment Failure|0|||
127736879|NCT03220776|459663051|FG003|Overall Study|MRI Equipment Failure|0|||
127736880|NCT03220776|459663052|FG004|Overall Study|MRI Equipment Failure|0|||
127736881|NCT03220776|459663053|FG005|Overall Study|MRI Equipment Failure|0|||
127806483|NCT04684420|459913447|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
127806484|NCT04684420|459913448|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
127806485|NCT04684420|459913445|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
127736882|NCT03220776|459663048|FG000|Overall Study|Inclimate Weather|0|||
127736883|NCT03220776|459663049|FG001|Overall Study|Inclimate Weather|0|||
127806486|NCT04684420|459913446|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
127736884|NCT03220776|459663050|FG002|Overall Study|Inclimate Weather|0|||
127736885|NCT03220776|459663051|FG003|Overall Study|Inclimate Weather|0|||
127736886|NCT03220776|459663052|FG004|Overall Study|Inclimate Weather|0|||
127736887|NCT03220776|459663053|FG005|Overall Study|Inclimate Weather|1|||
127736888|NCT03220776|459663048|FG000|Overall Study|Physician Decision|0|||
127736889|NCT03220776|459663049|FG001|Overall Study|Physician Decision|0|||
127736890|NCT03220776|459663050|FG002|Overall Study|Physician Decision|0|||
127736891|NCT03220776|459663051|FG003|Overall Study|Physician Decision|1|||
127736892|NCT03220776|459663052|FG004|Overall Study|Physician Decision|0|||
127736893|NCT03220776|459663053|FG005|Overall Study|Physician Decision|0|||
127736894|NCT03220776|459663048|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
127736895|NCT03220776|459663049|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
127736896|NCT03220776|459663050|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
127736897|NCT03220776|459663051|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
127736898|NCT03220776|459663052|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
127736899|NCT03220776|459663053|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
127736900|NCT03220776|459663048|FG000|Overall Study|Protocol Violation|0|||
127736901|NCT03220776|459663049|FG001|Overall Study|Protocol Violation|0|||
127736902|NCT03220776|459663050|FG002|Overall Study|Protocol Violation|0|||
127736903|NCT03220776|459663051|FG003|Overall Study|Protocol Violation|2|||
127736904|NCT03220776|459663052|FG004|Overall Study|Protocol Violation|0|||
127736905|NCT03220776|459663053|FG005|Overall Study|Protocol Violation|1|||
127736906|NCT03220776|459663048|FG000|Overall Study|Withdrawal by Subject|1|||
127736907|NCT03220776|459663049|FG001|Overall Study|Withdrawal by Subject|0|||
127736908|NCT03220776|459663050|FG002|Overall Study|Withdrawal by Subject|0|||
127736909|NCT03220776|459663051|FG003|Overall Study|Withdrawal by Subject|0|||
127736910|NCT03220776|459663052|FG004|Overall Study|Withdrawal by Subject|0|||
127736911|NCT03220776|459663053|FG005|Overall Study|Withdrawal by Subject|0|||
127736912|NCT03441789|459663055|FG000|Overall Study|Withdrawal by Subject|1|||
127736913|NCT03441789|459663056|FG001|Overall Study|Withdrawal by Subject|1|||
127736914|NCT03441789|459663055|FG000|Overall Study|Adverse Event|0|||
127736915|NCT03441789|459663056|FG001|Overall Study|Adverse Event|1|||
127736916|NCT03441789|459663055|FG000|Overall Study|Protocol Violation|0|||
127736917|NCT03441789|459663056|FG001|Overall Study|Protocol Violation|1|||
127736918|NCT03441789|459663055|FG000|Overall Study|Lost to Follow-up|0|||
127736919|NCT03441789|459663056|FG001|Overall Study|Lost to Follow-up|1|||
127736920|NCT01780545|459663057|FG000|Overall Study|Withdrawal by Subject|3|||
127736921|NCT01780545|459663058|FG001|Overall Study|Withdrawal by Subject|1|||
127736922|NCT01780545|459663057|FG000|Overall Study|Lost to Follow-up|1|||
127736923|NCT01780545|459663058|FG001|Overall Study|Lost to Follow-up|1|||
127736924|NCT04491006|459663059|FG000|Overall Study|Adverse Event|0|||
127736925|NCT04491006|459663060|FG001|Overall Study|Adverse Event|3|||
127736926|NCT04491006|459663061|FG002|Overall Study|Adverse Event|5|||
127736927|NCT04491006|459663059|FG000|Overall Study|Withdrawal by Subject|1|||
127736928|NCT04491006|459663060|FG001|Overall Study|Withdrawal by Subject|0|||
127736929|NCT04491006|459663061|FG002|Overall Study|Withdrawal by Subject|2|||
127736930|NCT01960114|459663065|FG000|Overall Study|Adverse Event|1|||
127736931|NCT01960114|459663066|FG001|Overall Study|Adverse Event|0|||
127736932|NCT01960114|459663065|FG000|Overall Study|Could not swallow study medication|0|||
127736933|NCT01960114|459663066|FG001|Overall Study|Could not swallow study medication|1|||
127736934|NCT02469077|459663067|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
127736935|NCT02469077|459663068|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
127736936|NCT02469077|459663067|FG000|Post Randomization/Intervention Period|Relocated|1|||
127736937|NCT02469077|459663068|FG001|Post Randomization/Intervention Period|Relocated|1|||
127736938|NCT02469077|459663067|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
127736939|NCT02469077|459663068|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
127736940|NCT02469077|459663067|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
127736941|NCT02469077|459663068|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
127736942|NCT01040403|459663069|FG000|Overall Study|Adverse Event|10|||
127736943|NCT01040403|459663069|FG000|Overall Study|Protocol Violation|2|||
127736944|NCT01040403|459663069|FG000|Overall Study|Lost to Follow-up|1|||
127736945|NCT01040403|459663069|FG000|Overall Study|Not treated|1|||
127736946|NCT01040403|459663069|FG000|Overall Study|Other reason not defined above|6|||
127736947|NCT01885936|459663070|FG000|Overall Study|Withdrawal by Subject|1|||
127736948|NCT01885936|459663071|FG001|Overall Study|Withdrawal by Subject|0|||
127736949|NCT03036150|459663072|FG000|Overall Study|Withdrawal by Subject|8|||
127736950|NCT03036150|459663073|FG001|Overall Study|Withdrawal by Subject|3|||
127736951|NCT03036150|459663072|FG000|Overall Study|Lost to Follow-up|2|||
127736952|NCT03036150|459663073|FG001|Overall Study|Lost to Follow-up|2|||
127736953|NCT02845375|459663074|FG000|Overall Study|upper airway obstruction|1|||
127736954|NCT02845375|459663075|FG001|Overall Study|upper airway obstruction|2|||
127736955|NCT02845375|459663076|FG002|Overall Study|upper airway obstruction|1|||
127736956|NCT01037413|459663077|FG000|Part A: Skin Testing|Adverse Event|1|||
127736957|NCT01037413|459663078|FG001|Part A: Skin Testing|Adverse Event|0|||
127736958|NCT01037413|459663077|FG000|Part A: Skin Testing|Protocol Violation|1|||
127736959|NCT01037413|459663078|FG001|Part A: Skin Testing|Protocol Violation|0|||
127736960|NCT01037413|459663077|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
127736961|NCT01037413|459663078|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
127892721|NCT01199601|460229637|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
127736962|NCT01037413|459663077|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
127736963|NCT01037413|459663078|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
127736964|NCT00619983|459663082|FG000|Test Drug Alone|Withdrawal by Subject|1|||
127736965|NCT00619983|459663083|FG001|Test Drug Alone|Withdrawal by Subject|0|||
127736966|NCT00619983|459663084|FG002|Test Drug Alone|Withdrawal by Subject|0|||
127736967|NCT00619983|459663085|FG003|Test Drug Alone|Withdrawal by Subject|1|||
127736968|NCT00619983|459663082|FG000|Test Drug Alone|Failure of daily diary device|1|||
127736969|NCT00619983|459663083|FG001|Test Drug Alone|Failure of daily diary device|1|||
127736970|NCT00619983|459663084|FG002|Test Drug Alone|Failure of daily diary device|2|||
127736971|NCT00619983|459663085|FG003|Test Drug Alone|Failure of daily diary device|2|||
127736972|NCT01177137|459663086|FG000|Overall Study|Withdrawal by Subject|10|||
127892722|NCT01199601|460229638|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
127736973|NCT01177137|459663087|FG001|Overall Study|Withdrawal by Subject|10|||
127736974|NCT01177137|459663088|FG002|Overall Study|Withdrawal by Subject|2|||
127736975|NCT01836198|459663090|FG000|Part A, Period 2|Protocol Violation|0|||
127736976|NCT01836198|459663091|FG001|Part A, Period 2|Protocol Violation|1|||
127736977|NCT01836198|459663092|FG002|Part A, Period 2|Protocol Violation|0|||
127736978|NCT03187353|459663093|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
127736979|NCT03187353|459663094|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
127736980|NCT03187353|459663093|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
127736981|NCT03187353|459663094|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
127736982|NCT03187353|459663093|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
127736983|NCT03187353|459663094|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
127736984|NCT03187353|459663093|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
127736985|NCT03187353|459663094|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
127736986|NCT03187353|459663093|FG000|Washout (2 Weeks)|Adverse Event|2|||
127736987|NCT03187353|459663094|FG001|Washout (2 Weeks)|Adverse Event|0|||
127736988|NCT03187353|459663093|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
127736989|NCT03187353|459663094|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
127736990|NCT02215954|459663095|FG000|Overall Study|Adverse Event|0|||
127736991|NCT02215954|459663096|FG001|Overall Study|Adverse Event|0|||
127736992|NCT02215954|459663097|FG002|Overall Study|Adverse Event|1|||
127736993|NCT02215954|459663095|FG000|Overall Study|Withdrawal by Subject|0|||
127736994|NCT02215954|459663096|FG001|Overall Study|Withdrawal by Subject|0|||
127736995|NCT02215954|459663097|FG002|Overall Study|Withdrawal by Subject|2|||
127736996|NCT02215954|459663095|FG000|Overall Study|Not exposed|1|||
127736997|NCT02215954|459663096|FG001|Overall Study|Not exposed|1|||
127736998|NCT02215954|459663097|FG002|Overall Study|Not exposed|3|||
127736999|NCT02460562|459663099|FG000|Overall Study|Lost to Follow-up|15|||
127737000|NCT02460562|459663100|FG001|Overall Study|Lost to Follow-up|16|||
127737001|NCT01654289|459663101|FG000|Overall Study|Withdrawal by Subject|10|||
127737002|NCT01654289|459663102|FG001|Overall Study|Withdrawal by Subject|8|||
127737003|NCT01654289|459663103|FG002|Overall Study|Withdrawal by Subject|5|||
127737004|NCT01654289|459663101|FG000|Overall Study|Withdrew from intervention only|17|||
127737005|NCT01654289|459663102|FG001|Overall Study|Withdrew from intervention only|20|||
127737006|NCT01654289|459663103|FG002|Overall Study|Withdrew from intervention only|0|||
127737007|NCT03746483|459663104|FG000|Overall Study|Adverse Event|0|||
127737008|NCT03746483|459663105|FG001|Overall Study|Adverse Event|1|||
127737009|NCT03746483|459663104|FG000|Overall Study|Lack of Efficacy|3|||
127737010|NCT03746483|459663105|FG001|Overall Study|Lack of Efficacy|2|||
127737011|NCT03746483|459663104|FG000|Overall Study|Lost to Follow-up|1|||
127737012|NCT03746483|459663105|FG001|Overall Study|Lost to Follow-up|0|||
127737013|NCT03746483|459663104|FG000|Overall Study|Protocol Violation|2|||
127737014|NCT03746483|459663105|FG001|Overall Study|Protocol Violation|0|||
127737015|NCT00187135|459663106|FG000|Visit One|Withdrawal by Subject|1|||
127737016|NCT00187135|459663107|FG001|Visit One|Withdrawal by Subject|0|||
127737017|NCT00187135|459663108|FG002|Visit One|Withdrawal by Subject|0|||
127737018|NCT00187135|459663109|FG003|Visit One|Withdrawal by Subject|0|||
127737019|NCT00187135|459663110|FG004|Visit One|Withdrawal by Subject|0|||
127737020|NCT00187135|459663111|FG005|Visit One|Withdrawal by Subject|1|||
127737021|NCT00187135|459663106|FG000|Visit One|Physician Decision|3|||
127737022|NCT00187135|459663107|FG001|Visit One|Physician Decision|1|||
127737023|NCT00187135|459663108|FG002|Visit One|Physician Decision|0|||
127737024|NCT00187135|459663109|FG003|Visit One|Physician Decision|0|||
127737025|NCT00187135|459663110|FG004|Visit One|Physician Decision|0|||
127737026|NCT00187135|459663111|FG005|Visit One|Physician Decision|1|||
127737027|NCT00187135|459663106|FG000|Visit Two|Death|0|||
127737028|NCT00187135|459663107|FG001|Visit Two|Death|0|||
127737029|NCT00187135|459663108|FG002|Visit Two|Death|0|||
127737030|NCT00187135|459663109|FG003|Visit Two|Death|1|||
127737031|NCT00187135|459663110|FG004|Visit Two|Death|0|||
127737032|NCT00187135|459663111|FG005|Visit Two|Death|1|||
127737033|NCT00187135|459663106|FG000|Visit Two|Physician Decision|1|||
127737034|NCT00187135|459663107|FG001|Visit Two|Physician Decision|0|||
127737035|NCT00187135|459663108|FG002|Visit Two|Physician Decision|0|||
127737036|NCT00187135|459663109|FG003|Visit Two|Physician Decision|0|||
127737037|NCT00187135|459663110|FG004|Visit Two|Physician Decision|0|||
127737038|NCT00187135|459663111|FG005|Visit Two|Physician Decision|0|||
127737039|NCT00187135|459663106|FG000|Visit Two|Withdrawal by Subject|1|||
127737040|NCT00187135|459663107|FG001|Visit Two|Withdrawal by Subject|1|||
127737041|NCT00187135|459663108|FG002|Visit Two|Withdrawal by Subject|1|||
127737042|NCT00187135|459663109|FG003|Visit Two|Withdrawal by Subject|0|||
127737043|NCT00187135|459663110|FG004|Visit Two|Withdrawal by Subject|1|||
127737044|NCT00187135|459663111|FG005|Visit Two|Withdrawal by Subject|1|||
127737045|NCT00187135|459663106|FG000|Visit Two|Study Discontinued|3|||
127737046|NCT00187135|459663107|FG001|Visit Two|Study Discontinued|2|||
127737047|NCT00187135|459663108|FG002|Visit Two|Study Discontinued|1|||
127737048|NCT00187135|459663109|FG003|Visit Two|Study Discontinued|7|||
127737049|NCT00187135|459663110|FG004|Visit Two|Study Discontinued|5|||
127737050|NCT00187135|459663111|FG005|Visit Two|Study Discontinued|6|||
127737051|NCT00187135|459663106|FG000|Visit Three|Death|0|||
127737052|NCT00187135|459663107|FG001|Visit Three|Death|0|||
127737053|NCT00187135|459663108|FG002|Visit Three|Death|1|||
127737054|NCT00187135|459663109|FG003|Visit Three|Death|0|||
127737055|NCT00187135|459663110|FG004|Visit Three|Death|1|||
127737056|NCT00187135|459663111|FG005|Visit Three|Death|0|||
127737057|NCT00187135|459663106|FG000|Visit Three|Withdrawal by Subject|0|||
127737058|NCT00187135|459663107|FG001|Visit Three|Withdrawal by Subject|1|||
127737059|NCT00187135|459663108|FG002|Visit Three|Withdrawal by Subject|1|||
127737060|NCT00187135|459663109|FG003|Visit Three|Withdrawal by Subject|2|||
127737061|NCT00187135|459663110|FG004|Visit Three|Withdrawal by Subject|0|||
127737062|NCT00187135|459663111|FG005|Visit Three|Withdrawal by Subject|0|||
127737063|NCT00187135|459663106|FG000|Visit Three|Study Discontinued|7|||
127737064|NCT00187135|459663107|FG001|Visit Three|Study Discontinued|6|||
127737065|NCT00187135|459663108|FG002|Visit Three|Study Discontinued|7|||
127737066|NCT00187135|459663109|FG003|Visit Three|Study Discontinued|7|||
127737067|NCT00187135|459663110|FG004|Visit Three|Study Discontinued|7|||
127737068|NCT00187135|459663111|FG005|Visit Three|Study Discontinued|6|||
127737069|NCT01287416|459663112|FG000|Pre-post Training|Withdrawal by Subject|17|||
127737070|NCT01287416|459663113|FG001|Pre-post Training|Withdrawal by Subject|24|||
127737071|NCT01287416|459663112|FG000|Pre-post Training|Lost to Follow-up|5|||
127737072|NCT01287416|459663113|FG001|Pre-post Training|Lost to Follow-up|1|||
127737073|NCT01287416|459663112|FG000|6 Month Follow-up|Lost to Follow-up|3|||
127737074|NCT01287416|459663113|FG001|6 Month Follow-up|Lost to Follow-up|2|||
127737075|NCT03915951|459663114|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
127737076|NCT03915951|459663115|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
127737077|NCT03915951|459663114|FG000|Overall Study|Adverse Event|12|||
127737078|NCT03915951|459663115|FG001|Overall Study|Adverse Event|6|||
127737079|NCT03915951|459663114|FG000|Overall Study|Disease progression (radiological)|17|||
127737080|NCT03915951|459663115|FG001|Overall Study|Disease progression (radiological)|15|||
127737081|NCT03915951|459663114|FG000|Overall Study|Disease progression (clinical)|4|||
127737082|NCT03915951|459663115|FG001|Overall Study|Disease progression (clinical)|1|||
127737083|NCT03915951|459663114|FG000|Overall Study|Patient decision|0|||
127737084|NCT03915951|459663115|FG001|Overall Study|Patient decision|4|||
127737085|NCT03915951|459663114|FG000|Overall Study|Investigator decision|0|||
127737086|NCT03915951|459663115|FG001|Overall Study|Investigator decision|1|||
127737087|NCT03915951|459663114|FG000|Overall Study|Consent withdrawn|1|||
127737088|NCT03915951|459663115|FG001|Overall Study|Consent withdrawn|1|||
127737089|NCT03915951|459663114|FG000|Overall Study|Death|0|||
127737090|NCT03915951|459663115|FG001|Overall Study|Death|3|||
127737091|NCT01121185|459663119|FG000|Overall Study|Not infused|0|||
127737092|NCT01121185|459663120|FG001|Overall Study|Not infused|1|||
127737093|NCT01121185|459663119|FG000|Overall Study|Not transplanted|1|||
127737094|NCT01121185|459663120|FG001|Overall Study|Not transplanted|0|||
127737095|NCT01196741|459663121|FG000|Overall Study|Disease progression|34|||
127737096|NCT01196741|459663122|FG001|Overall Study|Disease progression|14|||
127737097|NCT01196741|459663121|FG000|Overall Study|Adverse Event|10|||
127737098|NCT01196741|459663122|FG001|Overall Study|Adverse Event|6|||
127737099|NCT01196741|459663121|FG000|Overall Study|Serious Adverse Event|3|||
127737100|NCT01196741|459663122|FG001|Overall Study|Serious Adverse Event|1|||
127737101|NCT01196741|459663121|FG000|Overall Study|Dose limiting Adverse Event|2|||
127737102|NCT01196741|459663122|FG001|Overall Study|Dose limiting Adverse Event|1|||
127737103|NCT01196741|459663121|FG000|Overall Study|Withdrawal by Subject|3|||
127737104|NCT01196741|459663122|FG001|Overall Study|Withdrawal by Subject|0|||
127737105|NCT01196741|459663121|FG000|Overall Study|Other reason|3|||
127737106|NCT01196741|459663122|FG001|Overall Study|Other reason|3|||
127737107|NCT01196741|459663121|FG000|Overall Study|Other|3|||
127737108|NCT01196741|459663122|FG001|Overall Study|Other|2|||
127737109|NCT01196741|459663121|FG000|Overall Study|Protocol Violation|2|||
127737110|NCT01196741|459663122|FG001|Overall Study|Protocol Violation|1|||
127737111|NCT01204775|459663128|FG000|Overall Study|Poor/non-compliance|0|||
127737112|NCT01204775|459663129|FG001|Overall Study|Poor/non-compliance|1|||
127737113|NCT01204775|459663128|FG000|Overall Study|Withdrawal by Subject|1|||
127737114|NCT01204775|459663129|FG001|Overall Study|Withdrawal by Subject|0|||
127737115|NCT02273180|459663130|FG000|Overall Study|Adverse Event|2|||
127737116|NCT02273180|459663131|FG001|Overall Study|Adverse Event|2|||
127737117|NCT02273180|459663130|FG000|Overall Study|Lack of Efficacy|1|||
127737118|NCT02273180|459663131|FG001|Overall Study|Lack of Efficacy|0|||
127737119|NCT02273180|459663130|FG000|Overall Study|Protocol Violation|1|||
127737120|NCT02273180|459663131|FG001|Overall Study|Protocol Violation|7|||
127737121|NCT02273180|459663130|FG000|Overall Study|Randomized but not treated|1|||
127737122|NCT02273180|459663131|FG001|Overall Study|Randomized but not treated|0|||
127737123|NCT02273180|459663130|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
127737124|NCT02273180|459663131|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
127737125|NCT02273180|459663130|FG000|Overall Study|Other than specified above|21|||
127737126|NCT02273180|459663131|FG001|Overall Study|Other than specified above|10|||
127892723|NCT02669264|460229639|FG000|Overall Study|Death|5|||
127737127|NCT00509925|459663132|FG000|Overall Study|Personal reasons|0|||
127737128|NCT00509925|459663133|FG001|Overall Study|Personal reasons|1|||
127737129|NCT03749616|459663136|FG000|Overall Study|Lost to Follow-up|4|||
127737130|NCT03749616|459663137|FG001|Overall Study|Lost to Follow-up|7|||
127737131|NCT03749616|459663136|FG000|Overall Study|Screen Failure|1|||
127737132|NCT03749616|459663137|FG001|Overall Study|Screen Failure|1|||
127737133|NCT03749616|459663136|FG000|Overall Study|Withdrawal by Subject|2|||
127737134|NCT03749616|459663137|FG001|Overall Study|Withdrawal by Subject|0|||
127737135|NCT04435522|459663138|FG000|Overall Study|Withdrawal by Subject|2|||
127737136|NCT00919061|459663139|FG000|Overall Study|Adverse Event|1|||
127737137|NCT00919061|459663139|FG000|Overall Study|Withdrawal by Subject|1|||
127737138|NCT05294328|459663148|FG000|Overall Study|Adverse Event|1|||
127737139|NCT05294328|459663149|FG001|Overall Study|Adverse Event|0|||
127737140|NCT05294328|459663150|FG002|Overall Study|Adverse Event|0|||
127737141|NCT05294328|459663148|FG000|Overall Study|Physician Decision|1|||
127737142|NCT05294328|459663149|FG001|Overall Study|Physician Decision|1|||
127737143|NCT05294328|459663150|FG002|Overall Study|Physician Decision|0|||
127737144|NCT05294328|459663148|FG000|Overall Study|Withdrawal by Subject|0|||
127737145|NCT05294328|459663149|FG001|Overall Study|Withdrawal by Subject|2|||
127737146|NCT05294328|459663150|FG002|Overall Study|Withdrawal by Subject|1|||
127737147|NCT05294328|459663148|FG000|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
127737148|NCT05294328|459663149|FG001|Overall Study|Other (Corneal Surface Disease and Distance VA)|1|||
127737149|NCT05294328|459663150|FG002|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
127737150|NCT02056873|459663151|FG000|Responsive DBS|CDBS parameters of 3 subjects|3|||
127737151|NCT00740597|459664757|FG000|Overall Study|insurance would not cover treatment|1|||
127737152|NCT00552513|459664758|FG000|Overall Study|Lost to Follow-up|5|||
127737153|NCT00552513|459664759|FG001|Overall Study|Lost to Follow-up|1|||
127737154|NCT00280683|459664760|FG000|Overall Study|Withdrawal by Subject|1|||
127737155|NCT00280683|459664761|FG001|Overall Study|Withdrawal by Subject|2|||
127737156|NCT00280683|459664760|FG000|Overall Study|Adverse Event|1|||
127737157|NCT00280683|459664761|FG001|Overall Study|Adverse Event|1|||
127737158|NCT03712449|459664765|FG000|Overall Study|Withdraw Consent|0|||
127737159|NCT03712449|459664766|FG001|Overall Study|Withdraw Consent|1|||
127737160|NCT00666198|459664770|FG000|Overall Study|Protocol Violation|10|||
127737161|NCT00666198|459664770|FG000|Overall Study|No Visit After First Day of Treatment|13|||
127737162|NCT00666198|459664770|FG000|Overall Study|Safety Not Assessable|6|||
127737163|NCT00666198|459664770|FG000|Overall Study|No Drug Administration|4|||
127737164|NCT05153499|459664771|FG000|Overall Study|Withdrawal by Subject|1|||
127737165|NCT05153499|459664772|FG001|Overall Study|Withdrawal by Subject|0|||
127737166|NCT05153499|459664771|FG000|Overall Study|Clinical Hold|1|||
127737167|NCT05153499|459664772|FG001|Overall Study|Clinical Hold|0|||
127737168|NCT05153499|459664771|FG000|Overall Study|Study Termination|6|||
127737169|NCT05153499|459664772|FG001|Overall Study|Study Termination|5|||
127737170|NCT03168425|459664776|FG000|Overall Study|Lost to Follow-up|5|||
127737171|NCT03168425|459664777|FG001|Overall Study|Lost to Follow-up|8|||
127737172|NCT03168425|459664776|FG000|Overall Study|unable to confirm post op opioids|2|||
127737173|NCT03168425|459664777|FG001|Overall Study|unable to confirm post op opioids|3|||
127737174|NCT03029234|459664778|FG000|Overall Study|Sponsor Decision|1|||
127737175|NCT03029234|459664778|FG000|Overall Study|Withdrawal by Subject|5|||
127737176|NCT03029234|459664778|FG000|Overall Study|Death|91|||
127737177|NCT03029234|459664778|FG000|Overall Study|Lost to Follow-up|2|||
127737178|NCT02166047|459664779|FG000|Overall Study|Withdrawal by Participant|0|||
127737179|NCT02166047|459664780|FG001|Overall Study|Withdrawal by Participant|1|||
127737180|NCT02166047|459664781|FG002|Overall Study|Withdrawal by Participant|2|||
127737181|NCT02166047|459664782|FG003|Overall Study|Withdrawal by Participant|0|||
127737182|NCT02166047|459664783|FG004|Overall Study|Withdrawal by Participant|0|||
127737183|NCT02166047|459664784|FG005|Overall Study|Withdrawal by Participant|0|||
127737184|NCT02166047|459664785|FG006|Overall Study|Withdrawal by Participant|1|||
127737185|NCT02166047|459664786|FG007|Overall Study|Withdrawal by Participant|0|||
127892724|NCT02669264|460229640|FG001|Overall Study|Death|5|||
127892725|NCT02669264|460229641|FG002|Overall Study|Death|3|||
127892726|NCT02669264|460229642|FG003|Overall Study|Death|3|||
127892727|NCT02669264|460229643|FG004|Overall Study|Death|3|||
127892728|NCT02669264|460229644|FG005|Overall Study|Death|6|||
127737186|NCT02166047|459664787|FG008|Overall Study|Withdrawal by Participant|0|||
127737187|NCT02166047|459664788|FG009|Overall Study|Withdrawal by Participant|0|||
127737188|NCT02166047|459664789|FG010|Overall Study|Withdrawal by Participant|0|||
127737189|NCT02166047|459664790|FG011|Overall Study|Withdrawal by Participant|0|||
127737190|NCT02166047|459664779|FG000|Overall Study|Adverse Event|0|||
127737191|NCT02166047|459664780|FG001|Overall Study|Adverse Event|0|||
127892729|NCT02669264|460229645|FG006|Overall Study|Death|3|||
127737192|NCT02166047|459664781|FG002|Overall Study|Adverse Event|0|||
127737193|NCT02166047|459664782|FG003|Overall Study|Adverse Event|0|||
127737194|NCT02166047|459664783|FG004|Overall Study|Adverse Event|1|||
127892730|NCT02669264|460229639|FG000|Overall Study|Withdrawal by Subject|0|||
127892731|NCT02669264|460229640|FG001|Overall Study|Withdrawal by Subject|1|||
127737195|NCT02166047|459664784|FG005|Overall Study|Adverse Event|0|||
127737196|NCT02166047|459664785|FG006|Overall Study|Adverse Event|1|||
127737197|NCT02166047|459664786|FG007|Overall Study|Adverse Event|0|||
127737198|NCT02166047|459664787|FG008|Overall Study|Adverse Event|0|||
127737199|NCT02166047|459664788|FG009|Overall Study|Adverse Event|0|||
127892732|NCT02669264|460229641|FG002|Overall Study|Withdrawal by Subject|0|||
127806487|NCT04684420|459913447|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
127737200|NCT02166047|459664789|FG010|Overall Study|Adverse Event|2|||
127737201|NCT02166047|459664790|FG011|Overall Study|Adverse Event|0|||
127737202|NCT01649297|459664791|FG000|Overall Study|Adverse Event|5|||
127737203|NCT01649297|459664792|FG001|Overall Study|Adverse Event|5|||
127737204|NCT01649297|459664793|FG002|Overall Study|Adverse Event|4|||
127737205|NCT01649297|459664794|FG003|Overall Study|Adverse Event|13|||
127737206|NCT01649297|459664795|FG004|Overall Study|Adverse Event|1|||
127737207|NCT01649297|459664791|FG000|Overall Study|Lack of Efficacy|0|||
127737208|NCT01649297|459664792|FG001|Overall Study|Lack of Efficacy|0|||
127737209|NCT01649297|459664793|FG002|Overall Study|Lack of Efficacy|0|||
127737210|NCT01649297|459664794|FG003|Overall Study|Lack of Efficacy|0|||
127737211|NCT01649297|459664795|FG004|Overall Study|Lack of Efficacy|1|||
127737212|NCT01649297|459664791|FG000|Overall Study|Non compliant with Protocol|1|||
127737213|NCT01649297|459664792|FG001|Overall Study|Non compliant with Protocol|0|||
127737214|NCT01649297|459664793|FG002|Overall Study|Non compliant with Protocol|3|||
127737215|NCT01649297|459664794|FG003|Overall Study|Non compliant with Protocol|2|||
127737216|NCT01649297|459664795|FG004|Overall Study|Non compliant with Protocol|1|||
127737217|NCT01649297|459664791|FG000|Overall Study|Lost to Follow-up|1|||
127737218|NCT01649297|459664792|FG001|Overall Study|Lost to Follow-up|1|||
127737219|NCT01649297|459664793|FG002|Overall Study|Lost to Follow-up|4|||
127737220|NCT01649297|459664794|FG003|Overall Study|Lost to Follow-up|3|||
127737221|NCT01649297|459664795|FG004|Overall Study|Lost to Follow-up|0|||
127737222|NCT01649297|459664791|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
127737223|NCT01649297|459664792|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
127737224|NCT01649297|459664793|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
127806488|NCT04684420|459913448|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
127806489|NCT03480802|459913449|FG000|Overall Study|Lost to Follow-up|5|||
127806490|NCT03480802|459913450|FG001|Overall Study|Lost to Follow-up|1|||
127806491|NCT03480802|459913449|FG000|Overall Study|Withdrawal by Subject|2|||
127806492|NCT03480802|459913450|FG001|Overall Study|Withdrawal by Subject|1|||
127806493|NCT03480802|459913449|FG000|Overall Study|Relocated|0|||
127806494|NCT03480802|459913450|FG001|Overall Study|Relocated|1|||
127806495|NCT01703000|459913451|FG000|Overall Study|Death|1|||
127806496|NCT03822884|459913452|FG000|Overall Study|Withdrawal by Subject|0|||
127806497|NCT03822884|459913453|FG001|Overall Study|Withdrawal by Subject|0|||
127806498|NCT03822884|459913454|FG002|Overall Study|Withdrawal by Subject|0|||
127892733|NCT02669264|460229642|FG003|Overall Study|Withdrawal by Subject|0|||
127892734|NCT02669264|460229643|FG004|Overall Study|Withdrawal by Subject|1|||
127737225|NCT01649297|459664794|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
127737226|NCT01649297|459664795|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
127737227|NCT01649297|459664791|FG000|Overall Study|For other reason|4|||
127737228|NCT01649297|459664792|FG001|Overall Study|For other reason|1|||
127737229|NCT01649297|459664793|FG002|Overall Study|For other reason|2|||
127737230|NCT01649297|459664794|FG003|Overall Study|For other reason|0|||
127737231|NCT01649297|459664795|FG004|Overall Study|For other reason|0|||
127737232|NCT01685047|459664796|FG000|Overall Study|Withdrawal by Subject|20|||
127737233|NCT01685047|459664796|FG000|Overall Study|Death|26|||
127737234|NCT01685047|459664796|FG000|Overall Study|Lost to Follow-up|8|||
127737235|NCT01685047|459664796|FG000|Overall Study|Physician Decision|25|||
127737236|NCT01685047|459664796|FG000|Overall Study|Adverse Event|5|||
127737237|NCT01685047|459664796|FG000|Overall Study|patient withdrawn by sponsor|1|||
127737238|NCT02490878|459664802|FG000|Overall Study|deemed ineligible|0|||
127737239|NCT02490878|459664803|FG001|Overall Study|deemed ineligible|1|||
127737240|NCT02490878|459664802|FG000|Overall Study|progression prior to treatment|0|||
127737241|NCT02490878|459664803|FG001|Overall Study|progression prior to treatment|1|||
127737242|NCT02490878|459664802|FG000|Overall Study|only submitted baseline QOL|0|||
127737243|NCT02490878|459664803|FG001|Overall Study|only submitted baseline QOL|1|||
127737244|NCT00451555|459664805|FG000|Overall Study|Protocol Violation|2|||
127737245|NCT00451555|459664806|FG001|Overall Study|Protocol Violation|2|||
127806499|NCT03822884|459913455|FG003|Overall Study|Withdrawal by Subject|0|||
127892735|NCT02669264|460229644|FG005|Overall Study|Withdrawal by Subject|0|||
127892736|NCT02669264|460229645|FG006|Overall Study|Withdrawal by Subject|0|||
127737246|NCT00451555|459664805|FG000|Overall Study|Adverse Event|3|||
127737247|NCT00451555|459664806|FG001|Overall Study|Adverse Event|1|||
127737248|NCT00451555|459664805|FG000|Overall Study|Withdrawal by Subject|6|||
127737249|NCT00451555|459664806|FG001|Overall Study|Withdrawal by Subject|0|||
127737250|NCT00451555|459664805|FG000|Overall Study|Physician Decision|2|||
127737251|NCT00451555|459664806|FG001|Overall Study|Physician Decision|1|||
127737252|NCT00922441|459664809|FG000|Overall Study|Protocol Violation|0|||
127737253|NCT00922441|459664810|FG001|Overall Study|Protocol Violation|0|||
127737254|NCT00922441|459664811|FG002|Overall Study|Protocol Violation|2|||
127737255|NCT00922441|459664809|FG000|Overall Study|Withdrawal by Subject|0|||
127806500|NCT03822884|459913456|FG004|Overall Study|Withdrawal by Subject|1|||
127737256|NCT00922441|459664810|FG001|Overall Study|Withdrawal by Subject|0|||
127737257|NCT00922441|459664811|FG002|Overall Study|Withdrawal by Subject|1|||
127737258|NCT02973477|459664814|FG000|First Intervention|Lost to Follow-up|0|||
127806501|NCT03822884|459913457|FG005|Overall Study|Withdrawal by Subject|0|||
127737259|NCT02973477|459664815|FG001|First Intervention|Lost to Follow-up|2|||
127737260|NCT02973477|459664814|FG000|Washout|Withdrawal by Subject|1|||
127737261|NCT02973477|459664815|FG001|Washout|Withdrawal by Subject|0|||
127737262|NCT02973477|459664814|FG000|Second Intervention|Lost to Follow-up|1|||
127737263|NCT02973477|459664815|FG001|Second Intervention|Lost to Follow-up|0|||
127737264|NCT00317603|459664821|FG000|Overall Study|Progressive Disease|3|||
127737265|NCT00523549|459664822|FG000|Overall Study|Adverse Event|6|||
127737266|NCT00523549|459664823|FG001|Overall Study|Adverse Event|3|||
127737267|NCT00523549|459664822|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
127737268|NCT00523549|459664823|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
127737269|NCT00523549|459664822|FG000|Overall Study|Protocol Deviation|3|||
127737270|NCT00523549|459664823|FG001|Overall Study|Protocol Deviation|1|||
127737271|NCT00523549|459664822|FG000|Overall Study|Patient withdrew consent|7|||
127737272|NCT00523549|459664823|FG001|Overall Study|Patient withdrew consent|6|||
127737273|NCT00523549|459664822|FG000|Overall Study|Lost to Follow-up|3|||
127737274|NCT00523549|459664823|FG001|Overall Study|Lost to Follow-up|5|||
127737275|NCT00427778|459664828|FG000|First Intervention (4 Weeks)|no longer interested|1|||
127737276|NCT00427778|459664829|FG001|First Intervention (4 Weeks)|no longer interested|0|||
127737277|NCT00427778|459664828|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
127737278|NCT00427778|459664829|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
127737279|NCT00427778|459664828|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
127737280|NCT00427778|459664829|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
127737281|NCT00427778|459664828|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
127737282|NCT00427778|459664829|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
127737283|NCT00439647|459664830|FG000|Overall Study|Withdrawal by Subject|25|||
127737284|NCT00439647|459664831|FG001|Overall Study|Withdrawal by Subject|22|||
127737285|NCT00439647|459664830|FG000|Overall Study|Death|15|||
127737286|NCT00439647|459664831|FG001|Overall Study|Death|18|||
127737287|NCT00439647|459664830|FG000|Overall Study|Adverse Event|11|||
127737288|NCT00439647|459664831|FG001|Overall Study|Adverse Event|11|||
127737289|NCT00439647|459664830|FG000|Overall Study|Lost to Follow-up|4|||
127737290|NCT00439647|459664831|FG001|Overall Study|Lost to Follow-up|12|||
127737291|NCT00439647|459664830|FG000|Overall Study|Protocol Violation|3|||
127737292|NCT00439647|459664831|FG001|Overall Study|Protocol Violation|4|||
127737293|NCT00439647|459664830|FG000|Overall Study|Lack of Efficacy|0|||
127737294|NCT00439647|459664831|FG001|Overall Study|Lack of Efficacy|4|||
127737295|NCT00053352|459664832|FG000|Overall Study|Lost to Follow-up|0|||
127737296|NCT00053352|459664833|FG001|Overall Study|Lost to Follow-up|1|||
127737297|NCT00053352|459664832|FG000|Overall Study|Physician Decision|11|||
127737298|NCT00053352|459664833|FG001|Overall Study|Physician Decision|1|||
127737299|NCT00053352|459664832|FG000|Overall Study|Withdrawal by Subject|1|||
127737300|NCT00053352|459664833|FG001|Overall Study|Withdrawal by Subject|0|||
127737301|NCT00053352|459664832|FG000|Overall Study|Ineligible|8|||
127737302|NCT00053352|459664833|FG001|Overall Study|Ineligible|8|||
127737303|NCT00053352|459664832|FG000|Overall Study|Disease at new site|1|||
127737304|NCT00053352|459664833|FG001|Overall Study|Disease at new site|0|||
127737305|NCT00570921|459664834|FG000|Overall Study|Protocol Violation|1|||
127806502|NCT00191854|459913463|FG000|Overall Study|Death|26|||
127806503|NCT00191854|459913464|FG001|Overall Study|Death|23|||
127806504|NCT00191854|459913465|FG002|Overall Study|Death|29|||
127806505|NCT00191854|459913463|FG000|Overall Study|Lost to Follow-up|7|||
127806506|NCT00191854|459913464|FG001|Overall Study|Lost to Follow-up|5|||
127737306|NCT00570921|459664834|FG000|Overall Study|Physician Decision|1|||
127806507|NCT00191854|459913465|FG002|Overall Study|Lost to Follow-up|5|||
127806508|NCT00191854|459913463|FG000|Overall Study|Withdrawal by Subject|4|||
127806509|NCT00191854|459913464|FG001|Overall Study|Withdrawal by Subject|2|||
127806510|NCT00191854|459913465|FG002|Overall Study|Withdrawal by Subject|3|||
127806511|NCT00191854|459913463|FG000|Overall Study|Sponsor Decision|0|||
127806512|NCT00191854|459913464|FG001|Overall Study|Sponsor Decision|0|||
127737307|NCT00784277|459664836|FG000|IR Treatment|Adverse Event|4|||
127737308|NCT00784277|459664837|FG001|IR Treatment|Adverse Event|8|||
127737309|NCT00784277|459664838|FG002|IR Treatment|Adverse Event|19|||
127737310|NCT00784277|459664839|FG003|IR Treatment|Adverse Event|35|||
127737311|NCT00784277|459664840|FG004|IR Treatment|Adverse Event|0|||
127737312|NCT00784277|459664841|FG005|IR Treatment|Adverse Event|0|||
127737313|NCT00784277|459664842|FG006|IR Treatment|Adverse Event|0|||
127737314|NCT00784277|459664836|FG000|IR Treatment|Lack of Efficacy|4|||
127737315|NCT00784277|459664837|FG001|IR Treatment|Lack of Efficacy|4|||
127806513|NCT00191854|459913465|FG002|Overall Study|Sponsor Decision|1|||
127806514|NCT00191854|459913463|FG000|Overall Study|Screen Failure|0|||
127806515|NCT00191854|459913464|FG001|Overall Study|Screen Failure|0|||
127892737|NCT02669264|460229639|FG000|Overall Study|Lost to Follow-up|0|||
127737316|NCT00784277|459664838|FG002|IR Treatment|Lack of Efficacy|1|||
127737317|NCT00784277|459664839|FG003|IR Treatment|Lack of Efficacy|0|||
127737318|NCT00784277|459664840|FG004|IR Treatment|Lack of Efficacy|0|||
127737319|NCT00784277|459664841|FG005|IR Treatment|Lack of Efficacy|0|||
127806516|NCT00191854|459913465|FG002|Overall Study|Screen Failure|1|||
127737320|NCT00784277|459664842|FG006|IR Treatment|Lack of Efficacy|0|||
127737321|NCT00784277|459664836|FG000|IR Treatment|Lost to Follow-up|1|||
127737322|NCT00784277|459664837|FG001|IR Treatment|Lost to Follow-up|0|||
127737323|NCT00784277|459664838|FG002|IR Treatment|Lost to Follow-up|1|||
127737324|NCT00784277|459664839|FG003|IR Treatment|Lost to Follow-up|0|||
127737325|NCT00784277|459664840|FG004|IR Treatment|Lost to Follow-up|0|||
127737326|NCT00784277|459664841|FG005|IR Treatment|Lost to Follow-up|0|||
127737327|NCT00784277|459664842|FG006|IR Treatment|Lost to Follow-up|0|||
127737328|NCT00784277|459664836|FG000|IR Treatment|Withdrawal by Subject|5|||
127737329|NCT00784277|459664837|FG001|IR Treatment|Withdrawal by Subject|1|||
127737330|NCT00784277|459664838|FG002|IR Treatment|Withdrawal by Subject|4|||
127737331|NCT00784277|459664839|FG003|IR Treatment|Withdrawal by Subject|6|||
127737332|NCT00784277|459664840|FG004|IR Treatment|Withdrawal by Subject|0|||
127737333|NCT00784277|459664841|FG005|IR Treatment|Withdrawal by Subject|0|||
127737334|NCT00784277|459664842|FG006|IR Treatment|Withdrawal by Subject|0|||
127737335|NCT00784277|459664836|FG000|IR Treatment|Resolution Of Pain|0|||
127737336|NCT00784277|459664837|FG001|IR Treatment|Resolution Of Pain|1|||
127737337|NCT00784277|459664838|FG002|IR Treatment|Resolution Of Pain|0|||
127737338|NCT00784277|459664839|FG003|IR Treatment|Resolution Of Pain|0|||
127737339|NCT00784277|459664840|FG004|IR Treatment|Resolution Of Pain|0|||
127737340|NCT00784277|459664841|FG005|IR Treatment|Resolution Of Pain|0|||
127737341|NCT00784277|459664842|FG006|IR Treatment|Resolution Of Pain|0|||
127737342|NCT00784277|459664836|FG000|IR Treatment|Other|2|||
127737343|NCT00784277|459664837|FG001|IR Treatment|Other|3|||
127737344|NCT00784277|459664838|FG002|IR Treatment|Other|3|||
127737345|NCT00784277|459664839|FG003|IR Treatment|Other|2|||
127737346|NCT00784277|459664840|FG004|IR Treatment|Other|0|||
127737347|NCT00784277|459664841|FG005|IR Treatment|Other|0|||
127737348|NCT00784277|459664842|FG006|IR Treatment|Other|0|||
127737349|NCT00784277|459664836|FG000|ER Treatment|Adverse Event|0|||
127737350|NCT00784277|459664837|FG001|ER Treatment|Adverse Event|0|||
127737351|NCT00784277|459664838|FG002|ER Treatment|Adverse Event|0|||
127737352|NCT00784277|459664839|FG003|ER Treatment|Adverse Event|0|||
127737353|NCT00784277|459664840|FG004|ER Treatment|Adverse Event|1|||
127737354|NCT00784277|459664841|FG005|ER Treatment|Adverse Event|7|||
127737355|NCT00784277|459664842|FG006|ER Treatment|Adverse Event|7|||
127737356|NCT00784277|459664836|FG000|ER Treatment|Lack of Efficacy|0|||
127737357|NCT00784277|459664837|FG001|ER Treatment|Lack of Efficacy|0|||
127737358|NCT00784277|459664838|FG002|ER Treatment|Lack of Efficacy|0|||
127737359|NCT00784277|459664839|FG003|ER Treatment|Lack of Efficacy|0|||
127737360|NCT00784277|459664840|FG004|ER Treatment|Lack of Efficacy|3|||
127737361|NCT00784277|459664841|FG005|ER Treatment|Lack of Efficacy|4|||
127737362|NCT00784277|459664842|FG006|ER Treatment|Lack of Efficacy|0|||
127737363|NCT00784277|459664836|FG000|ER Treatment|Lost to Follow-up|0|||
127737364|NCT00784277|459664837|FG001|ER Treatment|Lost to Follow-up|0|||
127737365|NCT00784277|459664838|FG002|ER Treatment|Lost to Follow-up|0|||
127737366|NCT00784277|459664839|FG003|ER Treatment|Lost to Follow-up|0|||
127737367|NCT00784277|459664840|FG004|ER Treatment|Lost to Follow-up|0|||
127737368|NCT00784277|459664841|FG005|ER Treatment|Lost to Follow-up|2|||
127737369|NCT00784277|459664842|FG006|ER Treatment|Lost to Follow-up|0|||
127737370|NCT00784277|459664836|FG000|ER Treatment|Withdrawal by Subject|0|||
127737371|NCT00784277|459664837|FG001|ER Treatment|Withdrawal by Subject|0|||
127737372|NCT00784277|459664838|FG002|ER Treatment|Withdrawal by Subject|0|||
127737373|NCT00784277|459664839|FG003|ER Treatment|Withdrawal by Subject|0|||
127737374|NCT00784277|459664840|FG004|ER Treatment|Withdrawal by Subject|2|||
127737375|NCT00784277|459664841|FG005|ER Treatment|Withdrawal by Subject|5|||
127737376|NCT00784277|459664842|FG006|ER Treatment|Withdrawal by Subject|3|||
127737377|NCT00784277|459664836|FG000|ER Treatment|Study Medication Non-Compliant|0|||
127737378|NCT00784277|459664837|FG001|ER Treatment|Study Medication Non-Compliant|0|||
127737379|NCT00784277|459664838|FG002|ER Treatment|Study Medication Non-Compliant|0|||
127737380|NCT00784277|459664839|FG003|ER Treatment|Study Medication Non-Compliant|0|||
127737381|NCT00784277|459664840|FG004|ER Treatment|Study Medication Non-Compliant|2|||
127737382|NCT00784277|459664841|FG005|ER Treatment|Study Medication Non-Compliant|3|||
127737383|NCT00784277|459664842|FG006|ER Treatment|Study Medication Non-Compliant|3|||
127737384|NCT00784277|459664836|FG000|ER Treatment|Other|0|||
127737385|NCT00784277|459664837|FG001|ER Treatment|Other|0|||
127737386|NCT00784277|459664838|FG002|ER Treatment|Other|0|||
127737387|NCT00784277|459664839|FG003|ER Treatment|Other|0|||
127737388|NCT00784277|459664840|FG004|ER Treatment|Other|1|||
127737389|NCT00784277|459664841|FG005|ER Treatment|Other|3|||
127737390|NCT00784277|459664842|FG006|ER Treatment|Other|2|||
127737391|NCT03041701|459664849|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
127737392|NCT03041701|459664850|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
127737393|NCT03041701|459664851|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
127737394|NCT03041701|459664849|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
127737395|NCT03041701|459664850|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
127737396|NCT03041701|459664851|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
127806517|NCT06118385|459913467|FG000|Overall Study|Protocol Violation|0|||
127737397|NCT03569475|459664852|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
127737398|NCT03569475|459664853|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
127737399|NCT03569475|459664854|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
127737400|NCT03569475|459664852|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
127737401|NCT03569475|459664853|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
127737402|NCT03569475|459664854|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
127737403|NCT03569475|459664852|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
127737404|NCT03569475|459664853|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
127737405|NCT03569475|459664854|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
127737406|NCT03569475|459664852|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
127806518|NCT06118385|459913468|FG001|Overall Study|Protocol Violation|0|||
127806519|NCT06118385|459913469|FG002|Overall Study|Protocol Violation|0|||
127806520|NCT06118385|459913470|FG003|Overall Study|Protocol Violation|0|||
127806521|NCT06118385|459913471|FG004|Overall Study|Protocol Violation|0|||
127806522|NCT06118385|459913472|FG005|Overall Study|Protocol Violation|0|||
127806523|NCT06118385|459913473|FG006|Overall Study|Protocol Violation|0|||
127806524|NCT06118385|459913474|FG007|Overall Study|Protocol Violation|0|||
127806525|NCT06118385|459913475|FG008|Overall Study|Protocol Violation|1|||
127806526|NCT06118385|459913476|FG009|Overall Study|Protocol Violation|0|||
127806527|NCT06118385|459913477|FG010|Overall Study|Protocol Violation|0|||
127737407|NCT03569475|459664853|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
127737408|NCT03569475|459664854|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
127737409|NCT03569475|459664852|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
127737410|NCT03569475|459664853|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
127737411|NCT03569475|459664854|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
127737412|NCT03569475|459664852|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
127737413|NCT03569475|459664853|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
127737414|NCT03569475|459664854|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
127737415|NCT03569475|459664852|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
127737416|NCT03569475|459664853|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
127737417|NCT03569475|459664854|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
127737418|NCT03569475|459664852|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
127737419|NCT03569475|459664853|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
127737420|NCT03569475|459664854|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
127737421|NCT03569475|459664852|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
127737422|NCT03569475|459664853|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
127737423|NCT03569475|459664854|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
127737424|NCT03638258|459664856|FG000|Overall Study|Adverse Event|1|||
127737425|NCT03638258|459664857|FG001|Overall Study|Adverse Event|0|||
127737426|NCT03638258|459664858|FG002|Overall Study|Adverse Event|2|||
127737427|NCT03638258|459664856|FG000|Overall Study|Lost to Follow-up|2|||
127737428|NCT03638258|459664857|FG001|Overall Study|Lost to Follow-up|4|||
127737429|NCT03638258|459664858|FG002|Overall Study|Lost to Follow-up|5|||
127737430|NCT03638258|459664856|FG000|Overall Study|Pregnancy|0|||
127737431|NCT03638258|459664857|FG001|Overall Study|Pregnancy|0|||
127737432|NCT03638258|459664858|FG002|Overall Study|Pregnancy|1|||
127737433|NCT03638258|459664856|FG000|Overall Study|Protocol Violation|0|||
127737434|NCT03638258|459664857|FG001|Overall Study|Protocol Violation|0|||
127737435|NCT03638258|459664858|FG002|Overall Study|Protocol Violation|1|||
127737436|NCT03638258|459664856|FG000|Overall Study|Withdrawal by Subject|4|||
127737437|NCT03638258|459664857|FG001|Overall Study|Withdrawal by Subject|5|||
127737438|NCT03638258|459664858|FG002|Overall Study|Withdrawal by Subject|12|||
127737439|NCT03638258|459664856|FG000|Overall Study|Lack of Efficacy|0|||
127737440|NCT03638258|459664857|FG001|Overall Study|Lack of Efficacy|0|||
127737441|NCT03638258|459664858|FG002|Overall Study|Lack of Efficacy|2|||
127737442|NCT02630706|459664859|FG000|Overall Study|Adverse Event|2|||
127737443|NCT02630706|459664860|FG001|Overall Study|Adverse Event|1|||
127737444|NCT02630706|459664861|FG002|Overall Study|Adverse Event|1|||
127737445|NCT02630706|459664859|FG000|Overall Study|Lost to Follow-up|0|||
127737446|NCT02630706|459664860|FG001|Overall Study|Lost to Follow-up|1|||
127737447|NCT02630706|459664861|FG002|Overall Study|Lost to Follow-up|2|||
127806528|NCT06118385|459913478|FG011|Overall Study|Protocol Violation|0|||
127806529|NCT06118385|459913467|FG000|Overall Study|Out-of-range blood tests|0|||
127806530|NCT06118385|459913468|FG001|Overall Study|Out-of-range blood tests|0|||
127806531|NCT06118385|459913469|FG002|Overall Study|Out-of-range blood tests|0|||
127806532|NCT06118385|459913470|FG003|Overall Study|Out-of-range blood tests|0|||
127737448|NCT02630706|459664859|FG000|Overall Study|Physician Decision|1|||
127806533|NCT06118385|459913471|FG004|Overall Study|Out-of-range blood tests|0|||
127737449|NCT02630706|459664860|FG001|Overall Study|Physician Decision|1|||
127737450|NCT02630706|459664861|FG002|Overall Study|Physician Decision|0|||
127806534|NCT06118385|459913472|FG005|Overall Study|Out-of-range blood tests|0|||
127806535|NCT06118385|459913473|FG006|Overall Study|Out-of-range blood tests|0|||
127737451|NCT02630706|459664859|FG000|Overall Study|Pregnancy|0|||
127737452|NCT02630706|459664860|FG001|Overall Study|Pregnancy|1|||
127737453|NCT02630706|459664861|FG002|Overall Study|Pregnancy|0|||
127737454|NCT02630706|459664859|FG000|Overall Study|Withdrawal by Subject|4|||
127737455|NCT02630706|459664860|FG001|Overall Study|Withdrawal by Subject|5|||
127737456|NCT02630706|459664861|FG002|Overall Study|Withdrawal by Subject|7|||
127737457|NCT01678898|459664862|FG000|PB-102-F01|Adverse Event|0|||
127737458|NCT01678898|459664863|FG001|PB-102-F01|Adverse Event|1|||
127737459|NCT01678898|459664864|FG002|PB-102-F01|Adverse Event|0|||
127737460|NCT01678898|459664862|FG000|PB-102-F01|Physician Decision|0|||
127737461|NCT01678898|459664863|FG001|PB-102-F01|Physician Decision|1|||
127737462|NCT01678898|459664864|FG002|PB-102-F01|Physician Decision|0|||
127737463|NCT01527500|459664867|FG000|Part A|Administrative|11|||
127737464|NCT01527500|459664868|FG001|Part A|Administrative|7|||
127737465|NCT01527500|459664867|FG000|Part A|Adverse Event|4|||
127737466|NCT01527500|459664868|FG001|Part A|Adverse Event|2|||
127737467|NCT01527500|459664867|FG000|Part A|Death|4|||
127737468|NCT01527500|459664868|FG001|Part A|Death|1|||
127737469|NCT01527500|459664867|FG000|Part A|Lost to Follow-up|0|||
127737470|NCT01527500|459664868|FG001|Part A|Lost to Follow-up|1|||
127737471|NCT01527500|459664867|FG000|Part A|Protocol Deviation|9|||
127737472|NCT01527500|459664868|FG001|Part A|Protocol Deviation|2|||
127737473|NCT01527500|459664867|FG000|Part A|Withdrawal by Subject|2|||
127737474|NCT01527500|459664868|FG001|Part A|Withdrawal by Subject|0|||
127737475|NCT01527500|459664867|FG000|Part B|Adverse Event|1|||
127737476|NCT01527500|459664868|FG001|Part B|Adverse Event|0|||
127737477|NCT03078751|459664876|FG000|Overall Study|Adverse Event|4|||
127737478|NCT03078751|459664877|FG001|Overall Study|Adverse Event|0|||
127737479|NCT03078751|459664876|FG000|Overall Study|Physician Decision|1|||
127737480|NCT03078751|459664877|FG001|Overall Study|Physician Decision|0|||
127737481|NCT03078751|459664876|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
127892738|NCT02669264|460229640|FG001|Overall Study|Lost to Follow-up|0|||
127892739|NCT02669264|460229641|FG002|Overall Study|Lost to Follow-up|0|||
127892740|NCT02669264|460229642|FG003|Overall Study|Lost to Follow-up|0|||
127737482|NCT03078751|459664877|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
127737483|NCT03078751|459664876|FG000|Overall Study|Subject/guardian decision|8|||
127737484|NCT03078751|459664877|FG001|Overall Study|Subject/guardian decision|1|||
127737485|NCT03078751|459664876|FG000|Overall Study|Untreated|0|||
127737486|NCT03078751|459664877|FG001|Overall Study|Untreated|4|||
127737487|NCT01209286|459664878|FG000|Overall Study|Adverse Event|4|||
127737488|NCT01209286|459664879|FG001|Overall Study|Adverse Event|3|||
127737489|NCT01209286|459664880|FG002|Overall Study|Adverse Event|1|||
127737490|NCT01209286|459664878|FG000|Overall Study|Hematological Relapse After Remission|0|||
127737491|NCT01209286|459664879|FG001|Overall Study|Hematological Relapse After Remission|1|||
127737492|NCT01209286|459664880|FG002|Overall Study|Hematological Relapse After Remission|1|||
127737493|NCT01209286|459664878|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
127737494|NCT01209286|459664879|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
127737495|NCT01209286|459664880|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
127737496|NCT01209286|459664878|FG000|Overall Study|Physician Decision|0|||
127737497|NCT01209286|459664879|FG001|Overall Study|Physician Decision|2|||
127737498|NCT01209286|459664880|FG002|Overall Study|Physician Decision|0|||
127737499|NCT01209286|459664878|FG000|Overall Study|Other|0|||
127737500|NCT01209286|459664879|FG001|Overall Study|Other|1|||
127737501|NCT01209286|459664880|FG002|Overall Study|Other|0|||
127737502|NCT01363297|459664884|FG000|Overall Study|Other|0|||
127737503|NCT01363297|459664885|FG001|Overall Study|Other|0|||
127737504|NCT01363297|459664886|FG002|Overall Study|Other|0|||
127737505|NCT01363297|459664887|FG003|Overall Study|Other|0|||
127737506|NCT01363297|459664888|FG004|Overall Study|Other|1|||
127737507|NCT01363297|459664884|FG000|Overall Study|Death|3|||
127737508|NCT01363297|459664885|FG001|Overall Study|Death|6|||
127737509|NCT01363297|459664886|FG002|Overall Study|Death|6|||
127737510|NCT01363297|459664887|FG003|Overall Study|Death|10|||
127892741|NCT02669264|460229643|FG004|Overall Study|Lost to Follow-up|1|||
127892742|NCT02669264|460229644|FG005|Overall Study|Lost to Follow-up|0|||
127737511|NCT01363297|459664888|FG004|Overall Study|Death|30|||
127737512|NCT02515097|459664889|FG000|Overall Study|Lost to Follow-up|4|||
127737513|NCT02515097|459664890|FG001|Overall Study|Lost to Follow-up|2|||
127737514|NCT02515097|459664889|FG000|Overall Study|Withdrawal by Subject|1|||
127737515|NCT02515097|459664890|FG001|Overall Study|Withdrawal by Subject|3|||
127737516|NCT02515097|459664889|FG000|Overall Study|Adverse Event|2|||
127737517|NCT02515097|459664890|FG001|Overall Study|Adverse Event|1|||
127737518|NCT01180790|459664896|FG000|Overall Study|Adverse Event|1|||
127737519|NCT01180790|459664897|FG001|Overall Study|Adverse Event|1|||
127737520|NCT01180790|459664898|FG002|Overall Study|Adverse Event|2|||
127892743|NCT02669264|460229645|FG006|Overall Study|Lost to Follow-up|0|||
127737521|NCT01180790|459664899|FG003|Overall Study|Adverse Event|0|||
127737522|NCT01180790|459664900|FG004|Overall Study|Adverse Event|1|||
127737523|NCT01180790|459664901|FG005|Overall Study|Adverse Event|3|||
127737524|NCT01180790|459664902|FG006|Overall Study|Adverse Event|0|||
127892744|NCT02669264|460229639|FG000|Overall Study|Miscellaneous|0|||
127737525|NCT01180790|459664896|FG000|Overall Study|Withdrawal by Subject|3|||
127737526|NCT01180790|459664897|FG001|Overall Study|Withdrawal by Subject|0|||
127737527|NCT01180790|459664898|FG002|Overall Study|Withdrawal by Subject|5|||
127737528|NCT01180790|459664899|FG003|Overall Study|Withdrawal by Subject|0|||
127737529|NCT01180790|459664900|FG004|Overall Study|Withdrawal by Subject|2|||
127737530|NCT01180790|459664901|FG005|Overall Study|Withdrawal by Subject|1|||
127737531|NCT01180790|459664902|FG006|Overall Study|Withdrawal by Subject|0|||
127737532|NCT01180790|459664896|FG000|Overall Study|Lost to Follow-up|3|||
127737533|NCT01180790|459664897|FG001|Overall Study|Lost to Follow-up|1|||
127737534|NCT01180790|459664898|FG002|Overall Study|Lost to Follow-up|0|||
127737535|NCT01180790|459664899|FG003|Overall Study|Lost to Follow-up|2|||
127737536|NCT01180790|459664900|FG004|Overall Study|Lost to Follow-up|1|||
127737537|NCT01180790|459664901|FG005|Overall Study|Lost to Follow-up|0|||
127737538|NCT01180790|459664902|FG006|Overall Study|Lost to Follow-up|1|||
127737539|NCT01180790|459664896|FG000|Overall Study|Physician Decision|1|||
127737540|NCT01180790|459664897|FG001|Overall Study|Physician Decision|0|||
127737541|NCT01180790|459664898|FG002|Overall Study|Physician Decision|0|||
127737542|NCT01180790|459664899|FG003|Overall Study|Physician Decision|1|||
127737543|NCT01180790|459664900|FG004|Overall Study|Physician Decision|0|||
127737544|NCT01180790|459664901|FG005|Overall Study|Physician Decision|0|||
127737545|NCT01180790|459664902|FG006|Overall Study|Physician Decision|0|||
127737546|NCT01180790|459664896|FG000|Overall Study|Lack of Efficacy|1|||
127737547|NCT01180790|459664897|FG001|Overall Study|Lack of Efficacy|2|||
127737548|NCT01180790|459664898|FG002|Overall Study|Lack of Efficacy|5|||
127737549|NCT01180790|459664899|FG003|Overall Study|Lack of Efficacy|6|||
127737550|NCT01180790|459664900|FG004|Overall Study|Lack of Efficacy|1|||
127737551|NCT01180790|459664901|FG005|Overall Study|Lack of Efficacy|3|||
127737552|NCT01180790|459664902|FG006|Overall Study|Lack of Efficacy|0|||
127737553|NCT01180790|459664896|FG000|Overall Study|compliance|0|||
127737554|NCT01180790|459664897|FG001|Overall Study|compliance|1|||
127737555|NCT01180790|459664898|FG002|Overall Study|compliance|0|||
127737556|NCT01180790|459664899|FG003|Overall Study|compliance|0|||
127737557|NCT01180790|459664900|FG004|Overall Study|compliance|0|||
127737558|NCT01180790|459664901|FG005|Overall Study|compliance|0|||
127737559|NCT01180790|459664902|FG006|Overall Study|compliance|0|||
127737560|NCT01180790|459664896|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
127737561|NCT01180790|459664897|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
127737562|NCT01180790|459664898|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
127737563|NCT01180790|459664899|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
127737564|NCT01180790|459664900|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
127737565|NCT01180790|459664901|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
127737566|NCT01180790|459664902|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
127737567|NCT01064856|459664905|FG000|Double-blind (DB) Period|Adverse Event|1|||
127737568|NCT01064856|459664906|FG001|Double-blind (DB) Period|Adverse Event|0|||
127737569|NCT01064856|459664907|FG002|Double-blind (DB) Period|Adverse Event|0|||
127737570|NCT01064856|459664908|FG003|Double-blind (DB) Period|Adverse Event|0|||
127737571|NCT01064856|459664905|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
127737572|NCT01064856|459664906|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
127737573|NCT01064856|459664907|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
127737574|NCT01064856|459664908|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
127737575|NCT01064856|459664905|FG000|Open-label (OL) Period|Adverse Event|0|||
127737576|NCT01064856|459664906|FG001|Open-label (OL) Period|Adverse Event|0|||
127737577|NCT01064856|459664907|FG002|Open-label (OL) Period|Adverse Event|12|||
127737578|NCT01064856|459664908|FG003|Open-label (OL) Period|Adverse Event|6|||
127737579|NCT01064856|459664905|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
127737580|NCT01064856|459664906|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
127737581|NCT01064856|459664907|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
127737582|NCT01064856|459664908|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
127737583|NCT01064856|459664905|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
127737584|NCT01064856|459664906|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
127806536|NCT06118385|459913474|FG007|Overall Study|Out-of-range blood tests|0|||
127806537|NCT06118385|459913475|FG008|Overall Study|Out-of-range blood tests|1|||
127737585|NCT01064856|459664907|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
127737586|NCT01064856|459664908|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
127737587|NCT01064856|459664905|FG000|Open-label (OL) Period|Other|0|||
127806538|NCT06118385|459913476|FG009|Overall Study|Out-of-range blood tests|0|||
127737588|NCT01064856|459664906|FG001|Open-label (OL) Period|Other|0|||
127737589|NCT01064856|459664907|FG002|Open-label (OL) Period|Other|7|||
127806539|NCT06118385|459913477|FG010|Overall Study|Out-of-range blood tests|0|||
127806540|NCT06118385|459913478|FG011|Overall Study|Out-of-range blood tests|0|||
127806541|NCT01323478|459913479|FG000|Overall Study|Adverse Event|7|||
127806542|NCT01323478|459913479|FG000|Overall Study|Lack of Efficacy|4|||
127806543|NCT01323478|459913479|FG000|Overall Study|Non-compliance With Study Product|3|||
127806544|NCT01323478|459913479|FG000|Overall Study|Protocol Violation|1|||
127806545|NCT01323478|459913479|FG000|Overall Study|Withdrawal of Consent|1|||
127806546|NCT01323478|459913479|FG000|Overall Study|Administrative or Other Reasons|8|||
127737590|NCT01064856|459664908|FG003|Open-label (OL) Period|Other|7|||
127737591|NCT03302559|459664911|FG000|Overall Study|Adverse Event|2|||
127737592|NCT03302559|459664911|FG000|Overall Study|Lost to Follow-up|1|||
127737593|NCT03302559|459664911|FG000|Overall Study|Withdrew Consent|3|||
127737594|NCT00951171|459664912|FG000|Overall Study|Adverse Event|2|||
127737595|NCT00951171|459664913|FG001|Overall Study|Adverse Event|0|||
127737596|NCT00746785|459666713|FG000|Overall Study|Lost to Follow-up|29|||
127737597|NCT00746785|459666714|FG001|Overall Study|Lost to Follow-up|25|||
127737598|NCT00746785|459666715|FG002|Overall Study|Lost to Follow-up|27|||
127737599|NCT00113269|459666716|FG000|Overall Study|Not transplanted, donor issues|4|||
127737600|NCT00113269|459666717|FG001|Overall Study|Not transplanted, donor issues|0|||
127737601|NCT00113269|459666718|FG002|Overall Study|Not transplanted, donor issues|2|||
127737602|NCT00113269|459666719|FG003|Overall Study|Not transplanted, donor issues|2|||
127737603|NCT00113269|459666716|FG000|Overall Study|Not transplanted, recipient issues|2|||
127737604|NCT00113269|459666717|FG001|Overall Study|Not transplanted, recipient issues|1|||
127737605|NCT00113269|459666718|FG002|Overall Study|Not transplanted, recipient issues|7|||
127737606|NCT00113269|459666719|FG003|Overall Study|Not transplanted, recipient issues|4|||
127737607|NCT00113269|459666716|FG000|Overall Study|Early graft loss, technical|0|||
127737608|NCT00113269|459666717|FG001|Overall Study|Early graft loss, technical|0|||
127737609|NCT00113269|459666718|FG002|Overall Study|Early graft loss, technical|2|||
127737610|NCT00113269|459666719|FG003|Overall Study|Early graft loss, technical|0|||
127737611|NCT00113269|459666716|FG000|Overall Study|Death in operating room|0|||
127737612|NCT00113269|459666717|FG001|Overall Study|Death in operating room|0|||
127737613|NCT00113269|459666718|FG002|Overall Study|Death in operating room|0|||
127737614|NCT00113269|459666719|FG003|Overall Study|Death in operating room|1|||
127737615|NCT00113269|459666716|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
127737616|NCT00113269|459666717|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
127737617|NCT00113269|459666718|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
127737618|NCT00113269|459666719|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
127737619|NCT00113269|459666716|FG000|Overall Study|Adverse Event|2|||
127737620|NCT00113269|459666717|FG001|Overall Study|Adverse Event|7|||
127737621|NCT00113269|459666718|FG002|Overall Study|Adverse Event|11|||
127737622|NCT00113269|459666719|FG003|Overall Study|Adverse Event|7|||
127737623|NCT00113269|459666716|FG000|Overall Study|Withdrawal by Subject|4|||
127737624|NCT00113269|459666717|FG001|Overall Study|Withdrawal by Subject|3|||
127737625|NCT00113269|459666718|FG002|Overall Study|Withdrawal by Subject|4|||
127737626|NCT00113269|459666719|FG003|Overall Study|Withdrawal by Subject|2|||
127737627|NCT00113269|459666716|FG000|Overall Study|Graft loss|6|||
127737628|NCT00113269|459666717|FG001|Overall Study|Graft loss|6|||
127737629|NCT00113269|459666718|FG002|Overall Study|Graft loss|4|||
127737630|NCT00113269|459666719|FG003|Overall Study|Graft loss|9|||
127737631|NCT00113269|459666716|FG000|Overall Study|Protocol Violation|1|||
127737632|NCT00113269|459666717|FG001|Overall Study|Protocol Violation|0|||
127737633|NCT00113269|459666718|FG002|Overall Study|Protocol Violation|4|||
127737634|NCT00113269|459666719|FG003|Overall Study|Protocol Violation|2|||
127737635|NCT00113269|459666716|FG000|Overall Study|Lost to Follow-up|2|||
127737636|NCT00113269|459666717|FG001|Overall Study|Lost to Follow-up|3|||
127737637|NCT00113269|459666718|FG002|Overall Study|Lost to Follow-up|6|||
127737638|NCT00113269|459666719|FG003|Overall Study|Lost to Follow-up|3|||
127737639|NCT00113269|459666716|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
127737640|NCT00113269|459666717|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
127737641|NCT00113269|459666718|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
127737642|NCT00113269|459666719|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
127737643|NCT00113269|459666716|FG000|Overall Study|Discontinued due to rejection|0|||
127806547|NCT02411448|459913480|FG000|Overall Study|Withdrawal by Subject|1|||
127806548|NCT02411448|459913481|FG001|Overall Study|Withdrawal by Subject|14|||
127806549|NCT02411448|459913482|FG002|Overall Study|Withdrawal by Subject|9|||
127806550|NCT02411448|459913480|FG000|Overall Study|Other|0|||
127806551|NCT02411448|459913481|FG001|Overall Study|Other|2|||
127806552|NCT02411448|459913482|FG002|Overall Study|Other|0|||
127806553|NCT02411448|459913480|FG000|Overall Study|Did not receive study treatment|0|||
127806554|NCT02411448|459913481|FG001|Overall Study|Did not receive study treatment|3|||
127892745|NCT02669264|460229640|FG001|Overall Study|Miscellaneous|0|||
127737644|NCT00113269|459666717|FG001|Overall Study|Discontinued due to rejection|0|||
127737645|NCT00113269|459666718|FG002|Overall Study|Discontinued due to rejection|1|||
127737646|NCT00113269|459666719|FG003|Overall Study|Discontinued due to rejection|0|||
127737647|NCT00113269|459666716|FG000|Overall Study|Moved|0|||
127737648|NCT00113269|459666717|FG001|Overall Study|Moved|1|||
127737649|NCT00113269|459666718|FG002|Overall Study|Moved|0|||
127737650|NCT00113269|459666719|FG003|Overall Study|Moved|3|||
127737651|NCT00113269|459666716|FG000|Overall Study|Received pancreas transplant|0|||
127737652|NCT00113269|459666717|FG001|Overall Study|Received pancreas transplant|0|||
127737653|NCT00113269|459666718|FG002|Overall Study|Received pancreas transplant|0|||
127737654|NCT00113269|459666719|FG003|Overall Study|Received pancreas transplant|2|||
127737655|NCT00113269|459666716|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
127737656|NCT00113269|459666717|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
127737657|NCT00113269|459666718|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
127737658|NCT00113269|459666719|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
127737659|NCT00113269|459666716|FG000|Overall Study|Did not meet eligibility criteria|1|||
127737660|NCT00113269|459666717|FG001|Overall Study|Did not meet eligibility criteria|0|||
127737661|NCT00113269|459666718|FG002|Overall Study|Did not meet eligibility criteria|0|||
127737662|NCT00113269|459666719|FG003|Overall Study|Did not meet eligibility criteria|1|||
127737663|NCT00113269|459666716|FG000|Overall Study|Unable to return for follow up|2|||
127737664|NCT00113269|459666717|FG001|Overall Study|Unable to return for follow up|1|||
127737665|NCT00113269|459666718|FG002|Overall Study|Unable to return for follow up|0|||
127737666|NCT00113269|459666719|FG003|Overall Study|Unable to return for follow up|0|||
127737667|NCT00966979|459666724|FG000|Overall Study|Death|1|||
127737668|NCT00966979|459666724|FG000|Overall Study|Lost to Follow-up|6|||
127737669|NCT00966979|459666724|FG000|Overall Study|Withdrawal by Subject|14|||
127737670|NCT00966979|459666724|FG000|Overall Study|Adverse Event|5|||
127737671|NCT00966979|459666724|FG000|Overall Study|Sponsor terminated early|49|||
127737672|NCT00966979|459666724|FG000|Overall Study|Censored because surgery not done|2|||
127737673|NCT00966979|459666724|FG000|Overall Study|Censored because study device was not implanted|14|||
127737674|NCT00966979|459666724|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
127737675|NCT04140266|459666725|FG000|Overall Study|Physician Decision|2|||
127737676|NCT04140266|459666726|FG001|Overall Study|Physician Decision|0|||
127737677|NCT04140266|459666725|FG000|Overall Study|Withdrawal by Subject|4|||
127737678|NCT04140266|459666726|FG001|Overall Study|Withdrawal by Subject|2|||
127737679|NCT03511378|459666730|FG000|Overall Study|Withdrawal by Subject|2|||
127737680|NCT03511378|459666731|FG001|Overall Study|Withdrawal by Subject|2|||
127737681|NCT03511378|459666730|FG000|Overall Study|Patient not coming or schedule visit|1|||
127737682|NCT03511378|459666731|FG001|Overall Study|Patient not coming or schedule visit|0|||
127737683|NCT01243411|459666732|FG000|Overall Study|Withdrawal by Subject|18|||
127737684|NCT01243411|459666732|FG000|Overall Study|Lost to Follow-up|10|||
127737685|NCT01243411|459666732|FG000|Overall Study|Adverse Event|5|||
127737686|NCT01243411|459666732|FG000|Overall Study|Other|8|||
127737687|NCT00510198|459666733|FG000|Overall Study|Withdrawal by Subject|5|||
127737688|NCT00510198|459666734|FG001|Overall Study|Withdrawal by Subject|4|||
127737689|NCT00488319|459666740|FG000|Overall Study|Adverse Event|1|||
127737690|NCT00488319|459666741|FG001|Overall Study|Adverse Event|2|||
127737691|NCT00488319|459666742|FG002|Overall Study|Adverse Event|23|||
127737692|NCT00488319|459666740|FG000|Overall Study|Lack of Efficacy|6|||
127737693|NCT00488319|459666741|FG001|Overall Study|Lack of Efficacy|12|||
127737694|NCT00488319|459666742|FG002|Overall Study|Lack of Efficacy|27|||
127737695|NCT00488319|459666740|FG000|Overall Study|Lost to Follow-up|3|||
127737696|NCT00488319|459666741|FG001|Overall Study|Lost to Follow-up|5|||
127737697|NCT00488319|459666742|FG002|Overall Study|Lost to Follow-up|16|||
127737698|NCT00488319|459666740|FG000|Overall Study|Withdrawal by Subject|5|||
127737699|NCT00488319|459666741|FG001|Overall Study|Withdrawal by Subject|20|||
127737700|NCT00488319|459666742|FG002|Overall Study|Withdrawal by Subject|44|||
127737701|NCT00488319|459666740|FG000|Overall Study|Other reasons for withdrawal|0|||
127737702|NCT00488319|459666741|FG001|Overall Study|Other reasons for withdrawal|4|||
127737703|NCT00488319|459666742|FG002|Overall Study|Other reasons for withdrawal|12|||
127737704|NCT01649557|459666743|FG000|Overall Study|Lost to Follow-up|5|||
127737705|NCT01649557|459666744|FG001|Overall Study|Lost to Follow-up|0|||
127737706|NCT01649557|459666745|FG002|Overall Study|Lost to Follow-up|3|||
127737707|NCT01649557|459666743|FG000|Overall Study|Adverse Event|7|||
127737708|NCT01649557|459666744|FG001|Overall Study|Adverse Event|5|||
127737709|NCT01649557|459666745|FG002|Overall Study|Adverse Event|1|||
127806555|NCT02411448|459913482|FG002|Overall Study|Did not receive study treatment|0|||
127806556|NCT02411448|459913480|FG000|Overall Study|Alive on study treatment|3|||
127806557|NCT02411448|459913481|FG001|Overall Study|Alive on study treatment|64|||
127806558|NCT02411448|459913482|FG002|Overall Study|Alive on study treatment|43|||
127806559|NCT02771522|459913485|FG000|Overall Study|Lost to Follow-up|3|||
127806560|NCT02771522|459913485|FG000|Overall Study|Withdrawal by Subject|2|||
127806561|NCT02771522|459913485|FG000|Overall Study|No white spot lesions|3|||
127806562|NCT05655377|459913488|FG000|Overall Study|Withdrawal by Subject|2|||
127806563|NCT01256177|459913489|FG000|Overall Study|Withdrawal by Subject|23|||
127806564|NCT01256177|459913490|FG001|Overall Study|Withdrawal by Subject|22|||
127806565|NCT01256177|459913489|FG000|Overall Study|Lost to Follow-up|2|||
127806566|NCT01256177|459913490|FG001|Overall Study|Lost to Follow-up|2|||
127806567|NCT01256177|459913489|FG000|Overall Study|Adverse Event|8|||
127806568|NCT01256177|459913490|FG001|Overall Study|Adverse Event|9|||
127806569|NCT01256177|459913489|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
127806570|NCT01256177|459913490|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
127806571|NCT01256177|459913489|FG000|Overall Study|Condition under Investigation Worsened|1|||
127806572|NCT01256177|459913490|FG001|Overall Study|Condition under Investigation Worsened|0|||
127737710|NCT01649557|459666743|FG000|Overall Study|Met withdrawal criteria|4|||
127737711|NCT01649557|459666744|FG001|Overall Study|Met withdrawal criteria|0|||
127737712|NCT01649557|459666745|FG002|Overall Study|Met withdrawal criteria|0|||
127737713|NCT01649557|459666743|FG000|Overall Study|Physician Decision|8|||
127737714|NCT01649557|459666744|FG001|Overall Study|Physician Decision|2|||
127737715|NCT01649557|459666745|FG002|Overall Study|Physician Decision|1|||
127737716|NCT01649557|459666743|FG000|Overall Study|Withdrawal by Subject|15|||
127737717|NCT01649557|459666744|FG001|Overall Study|Withdrawal by Subject|5|||
127737718|NCT01649557|459666745|FG002|Overall Study|Withdrawal by Subject|4|||
127737719|NCT01649557|459666743|FG000|Overall Study|Protocol deviation|0|||
127737720|NCT01649557|459666744|FG001|Overall Study|Protocol deviation|2|||
127737721|NCT01649557|459666745|FG002|Overall Study|Protocol deviation|0|||
127737722|NCT01649557|459666743|FG000|Overall Study|Lack of Efficacy|5|||
127737723|NCT01649557|459666744|FG001|Overall Study|Lack of Efficacy|0|||
127737724|NCT01649557|459666745|FG002|Overall Study|Lack of Efficacy|0|||
127737725|NCT02544113|459666748|FG000|Overall Study|Death|3|||
127892746|NCT02669264|460229641|FG002|Overall Study|Miscellaneous|0|||
127892747|NCT02669264|460229642|FG003|Overall Study|Miscellaneous|0|||
127892748|NCT02669264|460229643|FG004|Overall Study|Miscellaneous|0|||
127892749|NCT02669264|460229644|FG005|Overall Study|Miscellaneous|0|||
127892750|NCT02669264|460229645|FG006|Overall Study|Miscellaneous|2|||
127892751|NCT01688037|460229646|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
127737726|NCT02544113|459666749|FG001|Overall Study|Death|4|||
127737727|NCT02847637|459666750|FG000|Overall Study|Withdrawal by Subject|0|||
127737728|NCT02847637|459666751|FG001|Overall Study|Withdrawal by Subject|1|||
127737729|NCT02847637|459666752|FG002|Overall Study|Withdrawal by Subject|1|||
127737730|NCT02847637|459666753|FG003|Overall Study|Withdrawal by Subject|0|||
127737731|NCT02847637|459666750|FG000|Overall Study|Lost to Follow-up|1|||
127737732|NCT02847637|459666751|FG001|Overall Study|Lost to Follow-up|1|||
127737733|NCT02847637|459666752|FG002|Overall Study|Lost to Follow-up|0|||
127737734|NCT02847637|459666753|FG003|Overall Study|Lost to Follow-up|0|||
127737735|NCT01388478|459666754|FG000|Overall Study|Adverse Event|4|||
127737736|NCT01388478|459666754|FG000|Overall Study|Withdrawal by Subject|1|||
127737737|NCT01990664|459666755|FG000|Overall Study|Lost to Follow-up|2|||
127737738|NCT01990664|459666756|FG001|Overall Study|Lost to Follow-up|6|||
127737739|NCT01990664|459666755|FG000|Overall Study|Withdrawal by Subject|2|||
127737740|NCT01990664|459666756|FG001|Overall Study|Withdrawal by Subject|3|||
127737741|NCT01990664|459666755|FG000|Overall Study|Protocol Violation|1|||
127737742|NCT01990664|459666756|FG001|Overall Study|Protocol Violation|0|||
127737743|NCT01990664|459666755|FG000|Overall Study|Lens Discomfort|1|||
127737744|NCT01990664|459666756|FG001|Overall Study|Lens Discomfort|1|||
127737745|NCT01990664|459666755|FG000|Overall Study|Lens Handling Difficulties|1|||
127737746|NCT01990664|459666756|FG001|Overall Study|Lens Handling Difficulties|0|||
127737747|NCT01990664|459666755|FG000|Overall Study|Unsatisfactory Visual Response|0|||
127737748|NCT01990664|459666756|FG001|Overall Study|Unsatisfactory Visual Response|1|||
127737749|NCT00931918|459666757|FG000|Overall Study|Adverse Event|4|||
127737750|NCT00931918|459666758|FG001|Overall Study|Adverse Event|6|||
127737751|NCT00931918|459666757|FG000|Overall Study|Progressive Disease|2|||
127737752|NCT00931918|459666758|FG001|Overall Study|Progressive Disease|1|||
127737753|NCT00931918|459666757|FG000|Overall Study|Symptomatic Deterioration|1|||
127737754|NCT00931918|459666758|FG001|Overall Study|Symptomatic Deterioration|0|||
127737755|NCT00931918|459666757|FG000|Overall Study|Withdrawal by Patient|3|||
127737756|NCT00931918|459666758|FG001|Overall Study|Withdrawal by Patient|4|||
127737757|NCT00931918|459666757|FG000|Overall Study|Other Reason not Specified|4|||
127737758|NCT00931918|459666758|FG001|Overall Study|Other Reason not Specified|4|||
127737759|NCT00931918|459666757|FG000|Overall Study|Did not receive study drug|3|||
127737760|NCT00931918|459666758|FG001|Overall Study|Did not receive study drug|2|||
127737761|NCT00588341|459666759|FG000|Overall Study|Withdrawal by Subject|3|||
127737762|NCT00588341|459666759|FG000|Overall Study|Not treated due to metastatic disease|1|||
127737763|NCT00588341|459666759|FG000|Overall Study|Patient ineligible|1|||
127737764|NCT02025985|459666765|FG000|Overall Study|Consent withdrawn|0|||
127737765|NCT02025985|459666766|FG001|Overall Study|Consent withdrawn|0|||
127737766|NCT02025985|459666767|FG002|Overall Study|Consent withdrawn|1|||
127737767|NCT02025985|459666768|FG003|Overall Study|Consent withdrawn|0|||
127737768|NCT02025985|459666769|FG004|Overall Study|Consent withdrawn|0|||
127737769|NCT02025985|459666765|FG000|Overall Study|Termination of study by Sponsor|4|||
127737770|NCT02025985|459666766|FG001|Overall Study|Termination of study by Sponsor|3|||
127737771|NCT02025985|459666767|FG002|Overall Study|Termination of study by Sponsor|1|||
127737772|NCT02025985|459666768|FG003|Overall Study|Termination of study by Sponsor|1|||
127737773|NCT02025985|459666769|FG004|Overall Study|Termination of study by Sponsor|3|||
127737774|NCT02025985|459666765|FG000|Overall Study|Death|21|||
127737775|NCT02025985|459666766|FG001|Overall Study|Death|20|||
127737776|NCT02025985|459666767|FG002|Overall Study|Death|23|||
127737777|NCT02025985|459666768|FG003|Overall Study|Death|20|||
127737778|NCT02025985|459666769|FG004|Overall Study|Death|17|||
127737779|NCT00745121|459666770|FG000|Overall Study|Death|3|||
127737780|NCT00745121|459666771|FG001|Overall Study|Death|0|||
127737781|NCT00745121|459666770|FG000|Overall Study|Adverse Event|1|||
127737782|NCT00745121|459666771|FG001|Overall Study|Adverse Event|0|||
127737783|NCT00745121|459666770|FG000|Overall Study|Lost to Follow-up|1|||
127892752|NCT01688037|460229647|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
127892753|NCT01688037|460229648|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
127892754|NCT01688037|460229646|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
127892755|NCT01688037|460229647|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
127892756|NCT01688037|460229648|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
127892757|NCT01688037|460229646|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
127892758|NCT01688037|460229647|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
127892759|NCT01688037|460229648|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
127892760|NCT01688037|460229646|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
127892761|NCT01688037|460229647|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
127892762|NCT01688037|460229648|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
127892763|NCT01688037|460229646|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
127892764|NCT01688037|460229647|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
127892765|NCT01688037|460229648|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
127892766|NCT01688037|460229646|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
127892767|NCT01688037|460229647|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
127892768|NCT01688037|460229648|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
127892769|NCT01688037|460229646|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
127892770|NCT01688037|460229647|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
127892771|NCT01688037|460229648|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
127892772|NCT01688037|460229646|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
127892773|NCT01688037|460229647|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
127737784|NCT00745121|459666771|FG001|Overall Study|Lost to Follow-up|0|||
127737785|NCT00745121|459666770|FG000|Overall Study|Withdrawal by Subject|4|||
127737786|NCT00745121|459666771|FG001|Overall Study|Withdrawal by Subject|2|||
127737787|NCT03723915|459666773|FG000|Screening|Failed to meet screening requirements.|2|||
127737788|NCT03723915|459666773|FG000|On Treatment|Failed to meet treatment requirements|2|||
127737789|NCT01187407|459666775|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
127737790|NCT01187407|459666776|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
127737791|NCT01187407|459666777|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
127737792|NCT01187407|459666778|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
127737793|NCT01187407|459666779|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
127737794|NCT01187407|459666775|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
127737795|NCT01187407|459666776|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
127737796|NCT01187407|459666777|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
127737797|NCT01187407|459666778|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
127737798|NCT01187407|459666779|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
127737799|NCT01187407|459666775|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
127737800|NCT01187407|459666776|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
127737801|NCT01187407|459666777|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
127737802|NCT01187407|459666778|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
127737803|NCT01187407|459666779|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
127737804|NCT01187407|459666775|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
127737805|NCT01187407|459666776|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
127737806|NCT01187407|459666777|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
127737807|NCT01187407|459666778|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
127737808|NCT01187407|459666779|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
127737809|NCT01187407|459666775|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
127737810|NCT01187407|459666776|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
127737811|NCT01187407|459666777|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
127737812|NCT01187407|459666778|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
127737813|NCT01187407|459666779|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
127737814|NCT01187407|459666775|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
127737815|NCT01187407|459666776|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
127737816|NCT01187407|459666777|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
127737817|NCT01187407|459666778|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
127737818|NCT01187407|459666779|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
127737819|NCT01187407|459666775|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
127737820|NCT01187407|459666776|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
127737821|NCT01187407|459666777|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
127737822|NCT01187407|459666778|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
127737823|NCT01187407|459666779|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
127737824|NCT01187407|459666775|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
127737825|NCT01187407|459666776|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
127737826|NCT01187407|459666777|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
127737827|NCT01187407|459666778|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
127892774|NCT01688037|460229648|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
127737828|NCT01187407|459666779|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
127892775|NCT01688037|460229646|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
127892776|NCT01688037|460229647|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
127892777|NCT01688037|460229648|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
127892778|NCT01688037|460229646|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
127892779|NCT01688037|460229647|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
127892780|NCT01688037|460229648|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
127892781|NCT03035227|460229649|FG000|Overall Study|study stopped due to PI leaving institut|1|||
127892782|NCT03035227|460229650|FG001|Overall Study|study stopped due to PI leaving institut|1|||
127892783|NCT02100956|460229651|FG000|At Least One Week Between Injections|Adverse Event|0|||
127737829|NCT01187407|459666775|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
127737830|NCT01187407|459666776|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
127737831|NCT01187407|459666777|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
127737832|NCT01187407|459666778|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
127737833|NCT01187407|459666779|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
127737834|NCT01187407|459666775|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
127737835|NCT01187407|459666776|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
127737836|NCT01187407|459666777|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
127737837|NCT01187407|459666778|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
127737838|NCT01187407|459666779|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
127737839|NCT01187407|459666775|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
127737840|NCT01187407|459666776|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
127737841|NCT01187407|459666777|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
127737842|NCT01187407|459666778|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
127737843|NCT01187407|459666779|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
127737844|NCT01187407|459666775|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
127737845|NCT01187407|459666776|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
127737846|NCT01187407|459666777|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
127737847|NCT01187407|459666778|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
127737848|NCT01187407|459666779|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
127737849|NCT01187407|459666775|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
127737850|NCT01187407|459666776|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
127737851|NCT01187407|459666777|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
127737852|NCT01187407|459666778|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
127737853|NCT01187407|459666779|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
127737854|NCT01187407|459666775|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
127737855|NCT01187407|459666776|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
127737856|NCT01187407|459666777|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
127737857|NCT01187407|459666778|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
127737858|NCT01187407|459666779|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
127737859|NCT01713998|459666782|FG000|Overall Study|Lost to Follow-up|2|||
127737860|NCT01713998|459666783|FG001|Overall Study|Lost to Follow-up|0|||
127737861|NCT01713998|459666784|FG002|Overall Study|Lost to Follow-up|2|||
127737862|NCT01713998|459666782|FG000|Overall Study|Withdrawal by Subject|1|||
127737863|NCT01713998|459666783|FG001|Overall Study|Withdrawal by Subject|0|||
127737864|NCT01713998|459666784|FG002|Overall Study|Withdrawal by Subject|0|||
127737865|NCT02101268|459666785|FG000|Randomized Treatment Phase|Subject Decision|8|||
127737866|NCT02101268|459666786|FG001|Randomized Treatment Phase|Subject Decision|4|||
127737867|NCT02101268|459666787|FG002|Randomized Treatment Phase|Subject Decision|0|||
127737868|NCT02101268|459666788|FG003|Randomized Treatment Phase|Subject Decision|0|||
127737869|NCT02101268|459666785|FG000|Randomized Treatment Phase|Physician Decision|4|||
127737870|NCT02101268|459666786|FG001|Randomized Treatment Phase|Physician Decision|1|||
127737871|NCT02101268|459666787|FG002|Randomized Treatment Phase|Physician Decision|0|||
127737872|NCT02101268|459666788|FG003|Randomized Treatment Phase|Physician Decision|0|||
127737873|NCT02101268|459666785|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
127737874|NCT02101268|459666786|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
127737875|NCT02101268|459666787|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
127737876|NCT02101268|459666788|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
127737877|NCT02101268|459666785|FG000|Randomized Treatment Phase|Adverse Event|6|||
127737878|NCT02101268|459666786|FG001|Randomized Treatment Phase|Adverse Event|0|||
127737879|NCT02101268|459666787|FG002|Randomized Treatment Phase|Adverse Event|0|||
127737880|NCT02101268|459666788|FG003|Randomized Treatment Phase|Adverse Event|0|||
127737881|NCT02101268|459666785|FG000|Randomized Treatment Phase|Death|5|||
127737882|NCT02101268|459666786|FG001|Randomized Treatment Phase|Death|4|||
127737883|NCT02101268|459666787|FG002|Randomized Treatment Phase|Death|0|||
127737884|NCT02101268|459666788|FG003|Randomized Treatment Phase|Death|0|||
127892784|NCT02100956|460229652|FG001|At Least One Week Between Injections|Adverse Event|1|||
127737885|NCT02101268|459666785|FG000|Randomized Treatment Phase|Disease Progression|4|||
127737886|NCT02101268|459666786|FG001|Randomized Treatment Phase|Disease Progression|1|||
127806573|NCT01256177|459913489|FG000|Overall Study|Lack of Efficacy|11|||
127806574|NCT01256177|459913490|FG001|Overall Study|Lack of Efficacy|2|||
127806575|NCT01256177|459913489|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
127806576|NCT01256177|459913490|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
127806577|NCT00553462|459913492|FG000|Overall Study|Adverse Event|4|||
127806578|NCT00553462|459913492|FG000|Overall Study|Progression|4|||
127806579|NCT00553462|459913492|FG000|Overall Study|Withdrawal by Subject|5|||
127806580|NCT00553462|459913492|FG000|Overall Study|Physician Decision|1|||
127892785|NCT00859469|460229654|FG000|Overall Study|Adverse Event|2|||
127892786|NCT00859469|460229654|FG000|Overall Study|Lack of Efficacy|9|||
127892787|NCT00859469|460229654|FG000|Overall Study|Withdrawal by Subject|1|||
127892788|NCT00859469|460229654|FG000|Overall Study|Death|16|||
127892789|NCT02220907|460229655|FG000|Overall Study|Adverse Event|7|||
127892790|NCT02220907|460229655|FG000|Overall Study|Physician Decision|1|||
127892791|NCT02220907|460229655|FG000|Overall Study|Withdrawal by Subject|2|||
127892792|NCT02220907|460229655|FG000|Overall Study|Conflict with the stopping criteria|1|||
127892793|NCT03111147|460229656|FG000|Overall Study|Lost to Follow-up|2|||
127892794|NCT03111147|460229657|FG001|Overall Study|Lost to Follow-up|5|||
127892795|NCT03111147|460229656|FG000|Overall Study|Withdrawal by Subject|4|||
127892796|NCT03111147|460229657|FG001|Overall Study|Withdrawal by Subject|3|||
127892797|NCT03111147|460229656|FG000|Overall Study|Protocol Violation|2|||
127737887|NCT02101268|459666787|FG002|Randomized Treatment Phase|Disease Progression|0|||
127892798|NCT03111147|460229657|FG001|Overall Study|Protocol Violation|1|||
127892799|NCT03111147|460229656|FG000|Overall Study|Death|1|||
127892800|NCT03111147|460229657|FG001|Overall Study|Death|1|||
127892801|NCT00095199|460229660|FG000|Overall Study|Adverse Event|40|||
127892802|NCT00095199|460229661|FG001|Overall Study|Adverse Event|22|||
127892803|NCT00095199|460229662|FG002|Overall Study|Adverse Event|26|||
127892804|NCT00095199|460229663|FG003|Overall Study|Adverse Event|11|||
127892805|NCT00095199|460229660|FG000|Overall Study|Progressive disease|213|||
127892806|NCT00095199|460229661|FG001|Overall Study|Progressive disease|179|||
127892807|NCT00095199|460229662|FG002|Overall Study|Progressive disease|105|||
127892808|NCT00095199|460229663|FG003|Overall Study|Progressive disease|98|||
127892809|NCT00095199|460229660|FG000|Overall Study|Death|10|||
127892810|NCT00095199|460229661|FG001|Overall Study|Death|6|||
127892811|NCT00095199|460229662|FG002|Overall Study|Death|11|||
127892812|NCT00095199|460229663|FG003|Overall Study|Death|9|||
127892813|NCT00095199|460229660|FG000|Overall Study|Withdrawal by Subject|21|||
127892814|NCT00095199|460229661|FG001|Overall Study|Withdrawal by Subject|16|||
127892815|NCT00095199|460229662|FG002|Overall Study|Withdrawal by Subject|13|||
127892816|NCT00095199|460229663|FG003|Overall Study|Withdrawal by Subject|22|||
127892817|NCT00095199|460229660|FG000|Overall Study|Protocol Violation|4|||
127892818|NCT00095199|460229661|FG001|Overall Study|Protocol Violation|4|||
127892819|NCT00095199|460229662|FG002|Overall Study|Protocol Violation|2|||
127892820|NCT00095199|460229663|FG003|Overall Study|Protocol Violation|0|||
127892821|NCT00095199|460229660|FG000|Overall Study|Liver function test results elevated|0|||
127892822|NCT00095199|460229661|FG001|Overall Study|Liver function test results elevated|0|||
127737888|NCT02101268|459666788|FG003|Randomized Treatment Phase|Disease Progression|0|||
127737889|NCT02101268|459666785|FG000|Extended Treatment Phase|Subject Decision|0|||
127737890|NCT02101268|459666786|FG001|Extended Treatment Phase|Subject Decision|0|||
127737891|NCT02101268|459666787|FG002|Extended Treatment Phase|Subject Decision|3|||
127737892|NCT02101268|459666788|FG003|Extended Treatment Phase|Subject Decision|2|||
127737893|NCT02101268|459666785|FG000|Extended Treatment Phase|Physician Decision|0|||
127737894|NCT02101268|459666786|FG001|Extended Treatment Phase|Physician Decision|0|||
127737895|NCT02101268|459666787|FG002|Extended Treatment Phase|Physician Decision|5|||
127737896|NCT02101268|459666788|FG003|Extended Treatment Phase|Physician Decision|2|||
127737897|NCT02101268|459666785|FG000|Extended Treatment Phase|Adverse Event|0|||
127737898|NCT02101268|459666786|FG001|Extended Treatment Phase|Adverse Event|0|||
127737899|NCT02101268|459666787|FG002|Extended Treatment Phase|Adverse Event|14|||
127737900|NCT02101268|459666788|FG003|Extended Treatment Phase|Adverse Event|18|||
127737901|NCT02101268|459666785|FG000|Extended Treatment Phase|Death|0|||
127737902|NCT02101268|459666786|FG001|Extended Treatment Phase|Death|0|||
127737903|NCT02101268|459666787|FG002|Extended Treatment Phase|Death|5|||
127892823|NCT00095199|460229662|FG002|Overall Study|Liver function test results elevated|1|||
127892824|NCT00095199|460229663|FG003|Overall Study|Liver function test results elevated|1|||
127892825|NCT00095199|460229660|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
127892826|NCT00095199|460229661|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
127737904|NCT02101268|459666788|FG003|Extended Treatment Phase|Death|1|||
127737905|NCT02101268|459666785|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
127806581|NCT01728779|459913493|FG000|Overall Study|Withdrawal by Subject|1|||
127806582|NCT00675025|459913494|FG000|Overall Study|Study Terminated by Sponsor|38|||
127806583|NCT00675025|459913495|FG001|Overall Study|Study Terminated by Sponsor|42|||
127892827|NCT00095199|460229662|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
127892828|NCT00095199|460229663|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
127892829|NCT00095199|460229660|FG000|Overall Study|Physician Decision|5|||
127892830|NCT00095199|460229661|FG001|Overall Study|Physician Decision|6|||
127892831|NCT00095199|460229662|FG002|Overall Study|Physician Decision|1|||
127892832|NCT00095199|460229663|FG003|Overall Study|Physician Decision|1|||
127892833|NCT00095199|460229660|FG000|Overall Study|Not eligible|1|||
127737906|NCT02101268|459666786|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
127737907|NCT02101268|459666787|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
127737908|NCT02101268|459666788|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
127737909|NCT02101268|459666785|FG000|Extended Treatment Phase|Disease Progression|0|||
127737910|NCT02101268|459666786|FG001|Extended Treatment Phase|Disease Progression|0|||
127737911|NCT02101268|459666787|FG002|Extended Treatment Phase|Disease Progression|13|||
127737912|NCT02101268|459666788|FG003|Extended Treatment Phase|Disease Progression|6|||
127737913|NCT02101268|459666785|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
127737914|NCT02101268|459666786|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
127737915|NCT02101268|459666787|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
127737916|NCT02101268|459666788|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
127737917|NCT00740870|459666789|FG000|Overall Study|Not Catheterized|4|||
127737918|NCT00740870|459666789|FG000|Overall Study|Further testing contraindicated implant|17|||
127737919|NCT00839332|459666794|FG000|Phase 1|Disease Progression|38|||
127737920|NCT00839332|459666795|FG001|Phase 1|Disease Progression|0|||
127737921|NCT00839332|459666796|FG002|Phase 1|Disease Progression|0|||
127737922|NCT00839332|459666794|FG000|Phase 1|Adverse Event|6|||
127737923|NCT00839332|459666795|FG001|Phase 1|Adverse Event|0|||
127892834|NCT00095199|460229661|FG001|Overall Study|Not eligible|7|||
127892835|NCT00095199|460229662|FG002|Overall Study|Not eligible|0|||
127892836|NCT00095199|460229663|FG003|Overall Study|Not eligible|1|||
127737924|NCT00839332|459666796|FG002|Phase 1|Adverse Event|0|||
127737925|NCT00839332|459666794|FG000|Phase 1|Withdrawal by Subject|4|||
127737926|NCT00839332|459666795|FG001|Phase 1|Withdrawal by Subject|0|||
127737927|NCT00839332|459666796|FG002|Phase 1|Withdrawal by Subject|0|||
127737928|NCT00839332|459666794|FG000|Phase 1|Physician Decision|2|||
127737929|NCT00839332|459666795|FG001|Phase 1|Physician Decision|0|||
127737930|NCT00839332|459666796|FG002|Phase 1|Physician Decision|0|||
127737931|NCT00839332|459666794|FG000|Phase 2|Protocol Violation|0|||
127737932|NCT00839332|459666795|FG001|Phase 2|Protocol Violation|1|||
127737933|NCT00839332|459666796|FG002|Phase 2|Protocol Violation|0|||
127737934|NCT00839332|459666794|FG000|Phase 2|Disease Progression|0|||
127892837|NCT00095199|460229660|FG000|Overall Study|Started Palliative Radiotherapy|1|||
127737935|NCT00839332|459666795|FG001|Phase 2|Disease Progression|46|||
127737936|NCT00839332|459666796|FG002|Phase 2|Disease Progression|21|||
127737937|NCT00839332|459666794|FG000|Phase 2|Adverse Event|0|||
127737938|NCT00839332|459666795|FG001|Phase 2|Adverse Event|8|||
127737939|NCT00839332|459666796|FG002|Phase 2|Adverse Event|6|||
127737940|NCT00839332|459666794|FG000|Phase 2|Death|0|||
127737941|NCT00839332|459666795|FG001|Phase 2|Death|4|||
127737942|NCT00839332|459666796|FG002|Phase 2|Death|2|||
127737943|NCT00839332|459666794|FG000|Phase 2|Withdrawal by Subject|0|||
127737944|NCT00839332|459666795|FG001|Phase 2|Withdrawal by Subject|5|||
127737945|NCT00839332|459666796|FG002|Phase 2|Withdrawal by Subject|8|||
127737946|NCT00839332|459666794|FG000|Phase 2|Physician Decision|0|||
127737947|NCT00839332|459666795|FG001|Phase 2|Physician Decision|4|||
127737948|NCT00839332|459666796|FG002|Phase 2|Physician Decision|1|||
127737949|NCT00839332|459666794|FG000|Phase 2|Lost to Follow-up|0|||
127737950|NCT00839332|459666795|FG001|Phase 2|Lost to Follow-up|0|||
127737951|NCT00839332|459666796|FG002|Phase 2|Lost to Follow-up|1|||
127737952|NCT01200485|459666797|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
127737953|NCT01200485|459666798|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
127737954|NCT01200485|459666799|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
127737955|NCT01200485|459666797|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
127737956|NCT01200485|459666798|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
127737957|NCT01200485|459666799|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
127737958|NCT06080438|459666800|FG000|Overall Study|Lost to Follow-up|2|||
127737959|NCT00640042|459666801|FG000|Enrollment|Did not receive study drug|83|||
127737960|NCT00776984|459666802|FG000|Overall Study|Adverse Event|8|||
127737961|NCT00776984|459666803|FG001|Overall Study|Adverse Event|2|||
127737962|NCT00776984|459666802|FG000|Overall Study|Protocol Violation|4|||
127737963|NCT00776984|459666803|FG001|Overall Study|Protocol Violation|2|||
127737964|NCT00776984|459666802|FG000|Overall Study|Lost to Follow-up|2|||
127737965|NCT00776984|459666803|FG001|Overall Study|Lost to Follow-up|0|||
127806584|NCT00675025|459913494|FG000|Overall Study|Adverse Event|6|||
127806585|NCT00675025|459913495|FG001|Overall Study|Adverse Event|11|||
127806586|NCT00675025|459913494|FG000|Overall Study|Lost to Follow-up|6|||
127806587|NCT00675025|459913495|FG001|Overall Study|Lost to Follow-up|4|||
127806588|NCT00675025|459913494|FG000|Overall Study|Withdrawal by Subject|4|||
127806589|NCT00675025|459913495|FG001|Overall Study|Withdrawal by Subject|6|||
127806590|NCT04398732|459913496|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
127806591|NCT01596257|459913498|FG000|Overall Study|Inadequate Collection|23|||
127806592|NCT01596257|459913499|FG001|Overall Study|Inadequate Collection|19|||
127806593|NCT02928952|459913500|FG000|Overall Study|Lost to Follow-up|5|||
127806594|NCT02928952|459913501|FG001|Overall Study|Lost to Follow-up|5|||
127806595|NCT02928952|459913500|FG000|Overall Study|Withdrawal by Subject|5|||
127806596|NCT02928952|459913501|FG001|Overall Study|Withdrawal by Subject|1|||
127806597|NCT02928952|459913500|FG000|Overall Study|Physician Decision|0|||
127806598|NCT02928952|459913501|FG001|Overall Study|Physician Decision|1|||
127806599|NCT01850615|459913502|FG000|Overall Study|Protocol Violation|4|||
127806600|NCT01850615|459913503|FG001|Overall Study|Protocol Violation|1|||
127806601|NCT01850615|459913502|FG000|Overall Study|Adverse Event|2|||
127806602|NCT01850615|459913503|FG001|Overall Study|Adverse Event|1|||
127806603|NCT01850615|459913502|FG000|Overall Study|Withdrawal by Subject|3|||
127806604|NCT01850615|459913503|FG001|Overall Study|Withdrawal by Subject|1|||
127806605|NCT01850615|459913502|FG000|Overall Study|Lost to Follow-up|0|||
127806606|NCT01850615|459913503|FG001|Overall Study|Lost to Follow-up|1|||
127806607|NCT01850615|459913502|FG000|Overall Study|Unclassified|0|||
127806608|NCT01850615|459913503|FG001|Overall Study|Unclassified|1|||
127806609|NCT02266433|459913504|FG000|Overall Study|Lost to Follow-up|54|||
127806610|NCT02266433|459913505|FG001|Overall Study|Lost to Follow-up|46|||
127806611|NCT02266433|459913504|FG000|Overall Study|Withdrawal by Subject|5|||
127806612|NCT02266433|459913505|FG001|Overall Study|Withdrawal by Subject|7|||
127806613|NCT04525703|459913509|FG000|Overall Study|Lost to Follow-up|6|||
127806614|NCT04525703|459913510|FG001|Overall Study|Lost to Follow-up|15|||
127806615|NCT04525703|459913511|FG002|Overall Study|Lost to Follow-up|8|||
127806616|NCT00712348|459913512|FG000|Overall Study|Withdrawal by Subject|1|||
127806617|NCT01375764|459913514|FG000|Overall Study|Lost to Follow-up|0|||
127737966|NCT00776984|459666802|FG000|Overall Study|Withdrawal by Subject|12|||
127737967|NCT00776984|459666803|FG001|Overall Study|Withdrawal by Subject|7|||
127737968|NCT00776984|459666802|FG000|Overall Study|Lack of Efficacy|0|||
127737969|NCT00776984|459666803|FG001|Overall Study|Lack of Efficacy|1|||
127737970|NCT00776984|459666802|FG000|Overall Study|Other|5|||
127737971|NCT00776984|459666803|FG001|Overall Study|Other|9|||
127737972|NCT02573883|459666808|FG000|Six Month Follow Up|Lost to Follow-up|1|||
127737973|NCT02573883|459666809|FG001|Six Month Follow Up|Lost to Follow-up|0|||
127806618|NCT01375764|459913515|FG001|Overall Study|Lost to Follow-up|1|||
127806619|NCT01375764|459913516|FG002|Overall Study|Lost to Follow-up|0|||
127806620|NCT01375764|459913517|FG003|Overall Study|Lost to Follow-up|0|||
127806621|NCT01375764|459913518|FG004|Overall Study|Lost to Follow-up|0|||
127806622|NCT01375764|459913514|FG000|Overall Study|Withdrawal by Subject|2|||
127806623|NCT01375764|459913515|FG001|Overall Study|Withdrawal by Subject|0|||
127737974|NCT02573883|459666810|FG002|Six Month Follow Up|Lost to Follow-up|0|||
127737975|NCT02573883|459666811|FG003|Six Month Follow Up|Lost to Follow-up|0|||
127737976|NCT02573883|459666808|FG000|One Year Follow Up|Lost to Follow-up|2|||
127737977|NCT02573883|459666809|FG001|One Year Follow Up|Lost to Follow-up|1|||
127737978|NCT02573883|459666810|FG002|One Year Follow Up|Lost to Follow-up|0|||
127737979|NCT02573883|459666811|FG003|One Year Follow Up|Lost to Follow-up|0|||
127737980|NCT01544309|459666815|FG000|Overall Study|Withdrawal by Subject|12|||
127737981|NCT01544309|459666816|FG001|Overall Study|Withdrawal by Subject|7|||
127737982|NCT01544309|459666815|FG000|Overall Study|Protocol Violation|2|||
127737983|NCT01544309|459666816|FG001|Overall Study|Protocol Violation|1|||
127737984|NCT01544309|459666815|FG000|Overall Study|Physician Decision|4|||
127737985|NCT01544309|459666816|FG001|Overall Study|Physician Decision|1|||
127737986|NCT01544309|459666815|FG000|Overall Study|Not performed pre-dose examination|1|||
127737987|NCT01544309|459666816|FG001|Overall Study|Not performed pre-dose examination|2|||
127737988|NCT01544309|459666815|FG000|Overall Study|Administered prohibit prior medication|1|||
127737989|NCT01544309|459666816|FG001|Overall Study|Administered prohibit prior medication|0|||
127737990|NCT00118703|459666817|FG000|Overall Study|Protocol Violation|1|||
127737991|NCT00118703|459666818|FG001|Overall Study|Protocol Violation|0|||
127737992|NCT00118703|459666817|FG000|Overall Study|Adverse Event|1|||
127737993|NCT00118703|459666818|FG001|Overall Study|Adverse Event|1|||
127737994|NCT00118703|459666817|FG000|Overall Study|Participant took two different treatment|0|||
127737995|NCT00118703|459666818|FG001|Overall Study|Participant took two different treatment|1|||
127737996|NCT00118703|459666817|FG000|Overall Study|Withdrawal by Subject|2|||
127737997|NCT00118703|459666818|FG001|Overall Study|Withdrawal by Subject|5|||
127737998|NCT00118703|459666817|FG000|Overall Study|Lost to Follow-up|1|||
127737999|NCT00118703|459666818|FG001|Overall Study|Lost to Follow-up|2|||
127738000|NCT03796208|459666823|FG000|Overall Study|Withdrawal by Subject|3|||
127738001|NCT03796208|459666824|FG001|Overall Study|Withdrawal by Subject|0|||
127738002|NCT03796208|459666823|FG000|Overall Study|Loss of pregnancy|1|||
127738003|NCT03796208|459666824|FG001|Overall Study|Loss of pregnancy|1|||
127738004|NCT03796208|459666823|FG000|Overall Study|Changed prenatal clinics|0|||
127738005|NCT03796208|459666824|FG001|Overall Study|Changed prenatal clinics|5|||
127738006|NCT03796208|459666823|FG000|Overall Study|Lost to Follow-up|20|||
127738007|NCT03796208|459666824|FG001|Overall Study|Lost to Follow-up|16|||
127738008|NCT02725008|459666825|FG000|Overall Study|Lost to Follow-up|7|||
127738009|NCT02725008|459666826|FG001|Overall Study|Lost to Follow-up|9|||
127738010|NCT02725008|459666825|FG000|Overall Study|Withdrawal by Subject|2|||
127738011|NCT02725008|459666826|FG001|Overall Study|Withdrawal by Subject|2|||
127738012|NCT02725008|459666825|FG000|Overall Study|Admitted to hospital|0|||
127738013|NCT02725008|459666826|FG001|Overall Study|Admitted to hospital|1|||
127738014|NCT00519285|459666827|FG000|Overall Study|Adverse Event|127|||
127738015|NCT00519285|459666828|FG001|Overall Study|Adverse Event|266|||
127738016|NCT00519285|459666827|FG000|Overall Study|Disease progression|334|||
127738017|NCT00519285|459666828|FG001|Overall Study|Disease progression|186|||
127738018|NCT00519285|459666827|FG000|Overall Study|Physician Decision|75|||
127738019|NCT00519285|459666828|FG001|Overall Study|Physician Decision|47|||
127738020|NCT00519285|459666827|FG000|Overall Study|Participant's request|53|||
127738021|NCT00519285|459666828|FG001|Overall Study|Participant's request|84|||
127738022|NCT00519285|459666827|FG000|Overall Study|Consent withdrawn|4|||
127738023|NCT00519285|459666828|FG001|Overall Study|Consent withdrawn|5|||
127738024|NCT00519285|459666827|FG000|Overall Study|Poor compliance to protocol|5|||
127738025|NCT00519285|459666828|FG001|Overall Study|Poor compliance to protocol|7|||
127738026|NCT00519285|459666827|FG000|Overall Study|Reason unspecified|5|||
127738027|NCT00519285|459666828|FG001|Overall Study|Reason unspecified|8|||
127738028|NCT00519285|459666827|FG000|Overall Study|Not treated|8|||
127738029|NCT00519285|459666828|FG001|Overall Study|Not treated|7|||
127738030|NCT00519285|459666827|FG000|Overall Study|Treatment ongoing|1|||
127738031|NCT00519285|459666828|FG001|Overall Study|Treatment ongoing|2|||
127738032|NCT02175745|459666829|FG000|Overall Study|Not Eligible|1|||
127738033|NCT00981578|459666832|FG000|Overall Study|Death|1|||
127738034|NCT00981578|459666832|FG000|Overall Study|Withdrawal by Subject|2|||
127738035|NCT03015181|459666833|FG000|Overall Study|Enrolled, but product never administered|1|||
127738036|NCT03015181|459666834|FG001|Overall Study|Enrolled, but product never administered|0|||
127738037|NCT03015181|459666835|FG002|Overall Study|Enrolled, but product never administered|0|||
127738038|NCT03015181|459666836|FG003|Overall Study|Enrolled, but product never administered|0|||
127738039|NCT03015181|459666837|FG004|Overall Study|Enrolled, but product never administered|0|||
127738040|NCT03015181|459666838|FG005|Overall Study|Enrolled, but product never administered|0|||
127738041|NCT03015181|459666839|FG006|Overall Study|Enrolled, but product never administered|0|||
127738042|NCT03015181|459666833|FG000|Overall Study|Withdrawal by Subject|0|||
127738043|NCT03015181|459666834|FG001|Overall Study|Withdrawal by Subject|0|||
127738044|NCT03015181|459666835|FG002|Overall Study|Withdrawal by Subject|0|||
127738045|NCT03015181|459666836|FG003|Overall Study|Withdrawal by Subject|0|||
127738046|NCT03015181|459666837|FG004|Overall Study|Withdrawal by Subject|0|||
127738047|NCT03015181|459666838|FG005|Overall Study|Withdrawal by Subject|1|||
127738048|NCT03015181|459666839|FG006|Overall Study|Withdrawal by Subject|0|||
127738049|NCT03015181|459666833|FG000|Overall Study|Physician Decision|0|||
127892838|NCT00095199|460229661|FG001|Overall Study|Started Palliative Radiotherapy|0|||
127892839|NCT00095199|460229662|FG002|Overall Study|Started Palliative Radiotherapy|0|||
127892840|NCT00095199|460229663|FG003|Overall Study|Started Palliative Radiotherapy|0|||
127892841|NCT00095199|460229660|FG000|Overall Study|Started radiotherapy regimen|0|||
127892842|NCT00095199|460229661|FG001|Overall Study|Started radiotherapy regimen|1|||
127892843|NCT00095199|460229662|FG002|Overall Study|Started radiotherapy regimen|0|||
127892844|NCT00095199|460229663|FG003|Overall Study|Started radiotherapy regimen|0|||
127892845|NCT00095199|460229660|FG000|Overall Study|Primary tumor removed in other surgery|0|||
127892846|NCT00095199|460229661|FG001|Overall Study|Primary tumor removed in other surgery|1|||
127892847|NCT00095199|460229662|FG002|Overall Study|Primary tumor removed in other surgery|0|||
127892848|NCT00095199|460229663|FG003|Overall Study|Primary tumor removed in other surgery|0|||
127892849|NCT00095199|460229660|FG000|Overall Study|Data inadvertently lost by site|1|||
127738050|NCT03015181|459666834|FG001|Overall Study|Physician Decision|0|||
127738051|NCT03015181|459666835|FG002|Overall Study|Physician Decision|0|||
127738052|NCT03015181|459666836|FG003|Overall Study|Physician Decision|0|||
127738053|NCT03015181|459666837|FG004|Overall Study|Physician Decision|0|||
127738054|NCT03015181|459666838|FG005|Overall Study|Physician Decision|0|||
127738055|NCT03015181|459666839|FG006|Overall Study|Physician Decision|1|||
127738056|NCT04582864|459666840|FG000|Overall Study|Did not complete cycle 1 due to disease progression|2|||
127738057|NCT04582864|459666840|FG000|Overall Study|Death|1|||
127738058|NCT01482819|459666841|FG000|Overall Study|Lost to Follow-up|2|||
127738059|NCT00562484|459666844|FG000|Overall Study|Adverse Event|6|||
127738060|NCT00562484|459666845|FG001|Overall Study|Adverse Event|1|||
127738061|NCT00562484|459666844|FG000|Overall Study|Protocol Violation|11|||
127738062|NCT00562484|459666845|FG001|Overall Study|Protocol Violation|2|||
127738063|NCT00562484|459666844|FG000|Overall Study|Withdrawal by Subject|12|||
127738064|NCT00562484|459666845|FG001|Overall Study|Withdrawal by Subject|9|||
127738065|NCT00562484|459666844|FG000|Overall Study|Moved away from the study area|20|||
127738066|NCT00562484|459666845|FG001|Overall Study|Moved away from the study area|9|||
127738067|NCT00562484|459666844|FG000|Overall Study|Lost to Follow-up|132|||
127738068|NCT00562484|459666845|FG001|Overall Study|Lost to Follow-up|71|||
127738069|NCT00562484|459666844|FG000|Overall Study|Reason not provided or not specified|25|||
127738070|NCT00562484|459666845|FG001|Overall Study|Reason not provided or not specified|12|||
127738071|NCT00702520|459666847|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
127738072|NCT00702520|459666848|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
127738073|NCT00702520|459666849|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
127738074|NCT00702520|459666850|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
127738075|NCT00702520|459666847|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
127738076|NCT00702520|459666848|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
127738077|NCT00702520|459666849|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
127738078|NCT00702520|459666850|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
127738079|NCT00702520|459666847|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
127738080|NCT00702520|459666848|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
127738081|NCT00702520|459666849|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
127738082|NCT00702520|459666850|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
127738083|NCT02481934|459666851|FG000|Overall Study|Death|2|||
127738084|NCT00942188|459666852|FG000|Overall Study|Adverse Event|0|||
127738085|NCT00942188|459666853|FG001|Overall Study|Adverse Event|3|||
127738086|NCT00942188|459666854|FG002|Overall Study|Adverse Event|2|||
127738087|NCT00942188|459666855|FG003|Overall Study|Adverse Event|0|||
127738088|NCT00942188|459666852|FG000|Overall Study|Lack of Efficacy|0|||
127738089|NCT00942188|459666853|FG001|Overall Study|Lack of Efficacy|0|||
127738090|NCT00942188|459666854|FG002|Overall Study|Lack of Efficacy|0|||
127738091|NCT00942188|459666855|FG003|Overall Study|Lack of Efficacy|1|||
127738092|NCT00942188|459666852|FG000|Overall Study|Protocol Violation|1|||
127738093|NCT00942188|459666853|FG001|Overall Study|Protocol Violation|1|||
127738094|NCT00942188|459666854|FG002|Overall Study|Protocol Violation|0|||
127738095|NCT00942188|459666855|FG003|Overall Study|Protocol Violation|0|||
127738096|NCT00942188|459666852|FG000|Overall Study|Lost to Follow-up|2|||
127738097|NCT00942188|459666853|FG001|Overall Study|Lost to Follow-up|1|||
127738098|NCT00942188|459666854|FG002|Overall Study|Lost to Follow-up|2|||
127738099|NCT00942188|459666855|FG003|Overall Study|Lost to Follow-up|0|||
127738100|NCT00942188|459666852|FG000|Overall Study|Withdrawal by Subject|1|||
127738101|NCT00942188|459666853|FG001|Overall Study|Withdrawal by Subject|3|||
127738102|NCT00942188|459666854|FG002|Overall Study|Withdrawal by Subject|4|||
127738103|NCT00942188|459666855|FG003|Overall Study|Withdrawal by Subject|2|||
127738104|NCT00942188|459666852|FG000|Overall Study|Physician Decision|0|||
127738105|NCT00942188|459666853|FG001|Overall Study|Physician Decision|0|||
127738106|NCT00942188|459666854|FG002|Overall Study|Physician Decision|1|||
127738107|NCT00942188|459666855|FG003|Overall Study|Physician Decision|0|||
127738108|NCT00942188|459666852|FG000|Overall Study|Sponsor Decision|0|||
127738109|NCT00942188|459666853|FG001|Overall Study|Sponsor Decision|2|||
127738110|NCT00942188|459666854|FG002|Overall Study|Sponsor Decision|0|||
127892850|NCT00095199|460229661|FG001|Overall Study|Data inadvertently lost by site|0|||
127738111|NCT00942188|459666855|FG003|Overall Study|Sponsor Decision|1|||
127738112|NCT04130061|459666860|FG000|Overall Study|OR team forgot to request membrane|1|||
127738113|NCT04130061|459666861|FG001|Overall Study|OR team forgot to request membrane|0|||
127738114|NCT01568112|459666862|FG000|Overall Study|Randomized But Not Treated|0|||
127738115|NCT01568112|459666863|FG001|Overall Study|Randomized But Not Treated|1|||
127738116|NCT01568112|459666864|FG002|Overall Study|Randomized But Not Treated|0|||
127738117|NCT01568112|459666865|FG003|Overall Study|Randomized But Not Treated|0|||
127738118|NCT01568112|459666862|FG000|Overall Study|Withdrew due to Adverse Event|2|||
127738119|NCT01568112|459666863|FG001|Overall Study|Withdrew due to Adverse Event|4|||
127738120|NCT01568112|459666864|FG002|Overall Study|Withdrew due to Adverse Event|6|||
127738121|NCT01568112|459666865|FG003|Overall Study|Withdrew due to Adverse Event|3|||
127738122|NCT01568112|459666862|FG000|Overall Study|Lost to Follow-up|0|||
127738123|NCT01568112|459666863|FG001|Overall Study|Lost to Follow-up|0|||
127738124|NCT01568112|459666864|FG002|Overall Study|Lost to Follow-up|0|||
127738125|NCT01568112|459666865|FG003|Overall Study|Lost to Follow-up|1|||
127738126|NCT01568112|459666862|FG000|Overall Study|Withdrawal by Subject|2|||
127738127|NCT01568112|459666863|FG001|Overall Study|Withdrawal by Subject|3|||
127738128|NCT01568112|459666864|FG002|Overall Study|Withdrawal by Subject|0|||
127738129|NCT01568112|459666865|FG003|Overall Study|Withdrawal by Subject|7|||
127738130|NCT01568112|459666862|FG000|Overall Study|Withdrawal by Physician|1|||
127738131|NCT01568112|459666863|FG001|Overall Study|Withdrawal by Physician|0|||
127738132|NCT01568112|459666864|FG002|Overall Study|Withdrawal by Physician|1|||
127738133|NCT01568112|459666865|FG003|Overall Study|Withdrawal by Physician|1|||
127738134|NCT00560313|459668581|FG000|Overall Study|Adverse Events or Death|2|||
127738135|NCT00560313|459668581|FG000|Overall Study|Withdrawal by Subject|2|||
127738136|NCT00560313|459668581|FG000|Overall Study|Lost to Follow-up|1|||
127738137|NCT00560313|459668581|FG000|Overall Study|Protocol Violation|1|||
127738138|NCT01821729|459668582|FG000|Overall Study|Withdrawal by Subject|1|||
127738139|NCT02517528|459668583|FG000|Overall Study|Withdrawal by Subject|1|||
127738140|NCT01093599|459668586|FG000|Overall Study|Lost to Follow-up|32|||
127738141|NCT01093599|459668587|FG001|Overall Study|Lost to Follow-up|46|||
127738142|NCT01703845|459668588|FG000|Overall Study|Adverse Event|1|||
127738143|NCT01703845|459668589|FG001|Overall Study|Adverse Event|0|||
127738144|NCT01703845|459668588|FG000|Overall Study|Protocol Violation|1|||
127738145|NCT01703845|459668589|FG001|Overall Study|Protocol Violation|0|||
127738146|NCT01703845|459668588|FG000|Overall Study|other than stated above|1|||
127738147|NCT01703845|459668589|FG001|Overall Study|other than stated above|0|||
127738148|NCT01644188|459668590|FG000|Overall Study|Adverse Event|44|||
127738149|NCT01644188|459668591|FG001|Overall Study|Adverse Event|20|||
127738150|NCT01644188|459668590|FG000|Overall Study|Poor compliance to protocol|26|||
127738151|NCT01644188|459668591|FG001|Overall Study|Poor compliance to protocol|14|||
127738152|NCT01644188|459668590|FG000|Overall Study|Physician Decision|1|||
127738153|NCT01644188|459668591|FG001|Overall Study|Physician Decision|3|||
127738154|NCT01644188|459668590|FG000|Overall Study|Participant moved|7|||
127738155|NCT01644188|459668591|FG001|Overall Study|Participant moved|2|||
127738156|NCT01644188|459668590|FG000|Overall Study|Related to auto-injector administration|2|||
127738157|NCT01644188|459668591|FG001|Overall Study|Related to auto-injector administration|2|||
127738158|NCT01644188|459668590|FG000|Overall Study|Consent withdrawn by participant|14|||
127738159|NCT01644188|459668591|FG001|Overall Study|Consent withdrawn by participant|7|||
127738160|NCT01644188|459668590|FG000|Overall Study|Selection criteria finally not met|2|||
127738161|NCT01644188|459668591|FG001|Overall Study|Selection criteria finally not met|0|||
127738162|NCT01644188|459668590|FG000|Overall Study|Lost to Follow-up|1|||
127738163|NCT01644188|459668591|FG001|Overall Study|Lost to Follow-up|0|||
127738164|NCT01644188|459668590|FG000|Overall Study|Death|4|||
127738165|NCT01644188|459668591|FG001|Overall Study|Death|3|||
127738166|NCT01644188|459668590|FG000|Overall Study|Last visit outside protocol visit window|14|||
127738167|NCT01644188|459668591|FG001|Overall Study|Last visit outside protocol visit window|16|||
127738168|NCT01644188|459668590|FG000|Overall Study|Site closure|1|||
127738169|NCT01644188|459668591|FG001|Overall Study|Site closure|1|||
127738170|NCT01644188|459668590|FG000|Overall Study|Other than specified above|6|||
127738171|NCT01644188|459668591|FG001|Overall Study|Other than specified above|7|||
127738172|NCT03119688|459668592|FG000|Overall Study|Adverse Event|4|||
127738173|NCT03226106|459668593|FG000|Overall Study|Withdrawal by Subject|2|||
127738174|NCT03226106|459668594|FG001|Overall Study|Withdrawal by Subject|0|||
127738175|NCT03226106|459668593|FG000|Overall Study|Adverse Event|1|||
127738176|NCT03226106|459668594|FG001|Overall Study|Adverse Event|0|||
127738177|NCT03226106|459668593|FG000|Overall Study|Lost to Follow-up|2|||
127738178|NCT03226106|459668594|FG001|Overall Study|Lost to Follow-up|0|||
127738179|NCT00721214|459668595|FG000|Overall Study|Chose another center for transplant|1|||
127738180|NCT00721214|459668595|FG000|Overall Study|Death|3|||
127738181|NCT05006417|459668596|FG000|Overall Study|PI terminated study for problems with strength testing equipment|1|||
127738182|NCT02158247|459668597|FG000|Overall Study|Invisible vocal cords|5|||
127738183|NCT00875615|459668604|FG000|Overall Study|Withdrawal by Subject|1|||
127738184|NCT01772823|459668605|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
127738185|NCT01772823|459668606|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
127738186|NCT01772823|459668605|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
127738187|NCT01772823|459668606|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
127738188|NCT01772823|459668605|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
127738189|NCT01772823|459668606|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
127738190|NCT01772823|459668605|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
127738191|NCT01772823|459668606|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
127738192|NCT01772823|459668605|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
127738193|NCT01772823|459668606|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
127738194|NCT01772823|459668605|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
127738195|NCT01772823|459668606|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
127738196|NCT01772823|459668605|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
127738197|NCT01772823|459668606|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
127738198|NCT01772823|459668605|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
127738199|NCT01772823|459668606|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
127738200|NCT01772823|459668605|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
127738201|NCT01772823|459668606|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
127738202|NCT01772823|459668605|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
127738203|NCT01772823|459668606|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
127738204|NCT01772823|459668605|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
127738205|NCT01772823|459668606|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
127738206|NCT01772823|459668605|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
127738207|NCT01772823|459668606|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
127738208|NCT01772823|459668605|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
127738209|NCT01772823|459668606|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
127738210|NCT01772823|459668605|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
127738211|NCT01772823|459668606|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
127738212|NCT01772823|459668605|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
127738213|NCT01772823|459668606|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
127738214|NCT01772823|459668605|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
127738215|NCT01772823|459668606|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
127738216|NCT01746108|459668614|FG000|Overall Study|Migrated /moved from study area|0|||
127738217|NCT01746108|459668615|FG001|Overall Study|Migrated /moved from study area|1|||
127738218|NCT01746108|459668616|FG002|Overall Study|Migrated /moved from study area|0|||
127738219|NCT01746108|459668614|FG000|Overall Study|Adverse event, non-fatal|0|||
127738220|NCT01746108|459668615|FG001|Overall Study|Adverse event, non-fatal|1|||
127738221|NCT01746108|459668616|FG002|Overall Study|Adverse event, non-fatal|0|||
127738222|NCT01746108|459668614|FG000|Overall Study|Withdrawal by Subject|0|||
127738223|NCT01746108|459668615|FG001|Overall Study|Withdrawal by Subject|1|||
127738224|NCT01746108|459668616|FG002|Overall Study|Withdrawal by Subject|0|||
127738225|NCT01746108|459668614|FG000|Overall Study|Lost to Follow-up|0|||
127738226|NCT01746108|459668615|FG001|Overall Study|Lost to Follow-up|1|||
127738227|NCT01746108|459668616|FG002|Overall Study|Lost to Follow-up|0|||
127738228|NCT02741713|459668622|FG000|Overall Study|Surgery type changed intra-operatively|2|||
127738229|NCT02741713|459668623|FG001|Overall Study|Surgery type changed intra-operatively|1|||
127738230|NCT00809341|459668626|FG000|Overall Study|Physician Decision|0|||
127738231|NCT00809341|459668627|FG001|Overall Study|Physician Decision|1|||
127738232|NCT03503162|459668628|FG000|Overall Study|did not meet eligibility|1|||
127738233|NCT02246218|459668629|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
127738234|NCT02246218|459668630|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
127738235|NCT02246218|459668629|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
127738236|NCT02246218|459668630|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
127738237|NCT02246218|459668629|FG000|Overall Study|Adverse Event|1|||
127738238|NCT02246218|459668630|FG001|Overall Study|Adverse Event|1|||
127738239|NCT02246218|459668629|FG000|Overall Study|Lost to Follow-up|1|||
127738240|NCT02246218|459668630|FG001|Overall Study|Lost to Follow-up|0|||
127738241|NCT03891641|459668631|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
127738242|NCT03891641|459668632|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
127738243|NCT01093222|459668633|FG000|Overall Study|Ineligible|6|||
127738244|NCT01093222|459668633|FG000|Overall Study|Adverse Event|7|||
127738245|NCT01093222|459668633|FG000|Overall Study|Progression/relapse|24|||
127738246|NCT01093222|459668633|FG000|Overall Study|Death|2|||
127738247|NCT01093222|459668633|FG000|Overall Study|Not protocol specified|1|||
127738248|NCT01281917|459668641|FG000|Overall Study|Withdrawal by Subject|1|||
127738249|NCT01978236|459668643|FG000|Overall Study|Discontinued due to study close|2|||
127738250|NCT00634920|459668645|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
127738251|NCT00634920|459668646|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
127738252|NCT00634920|459668647|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
127892851|NCT00095199|460229662|FG002|Overall Study|Data inadvertently lost by site|0|||
127738253|NCT00634920|459668645|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
127738254|NCT00634920|459668646|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
127738255|NCT00634920|459668647|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
127738256|NCT00634920|459668645|FG000|Period 1 - Pre-Randomization|Rejections|0|||
127738257|NCT00634920|459668646|FG001|Period 1 - Pre-Randomization|Rejections|0|||
127738258|NCT00634920|459668647|FG002|Period 1 - Pre-Randomization|Rejections|55|||
127738259|NCT00634920|459668645|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
127738260|NCT00634920|459668646|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
127738261|NCT00634920|459668647|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
127738262|NCT00634920|459668645|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
127738263|NCT00634920|459668646|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
127738264|NCT00634920|459668647|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
127738265|NCT00634920|459668645|FG000|Period 1 - Pre-Randomization|Other issues|0|||
127738266|NCT00634920|459668646|FG001|Period 1 - Pre-Randomization|Other issues|0|||
127738267|NCT00634920|459668647|FG002|Period 1 - Pre-Randomization|Other issues|6|||
127738268|NCT00634920|459668645|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
127738269|NCT00634920|459668646|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
127738270|NCT00634920|459668647|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
127738271|NCT00634920|459668645|FG000|Period 2 - Post-Randomization|Rejection|11|||
127738272|NCT00634920|459668646|FG001|Period 2 - Post-Randomization|Rejection|5|||
127738273|NCT00634920|459668647|FG002|Period 2 - Post-Randomization|Rejection|0|||
127738274|NCT00634920|459668645|FG000|Period 2 - Post-Randomization|Death|2|||
127738275|NCT00634920|459668646|FG001|Period 2 - Post-Randomization|Death|5|||
127738276|NCT00634920|459668647|FG002|Period 2 - Post-Randomization|Death|0|||
127738277|NCT00634920|459668645|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
127738278|NCT00634920|459668646|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
127738279|NCT00634920|459668647|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
127738280|NCT00634920|459668645|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
127738281|NCT00634920|459668646|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
127738282|NCT00634920|459668647|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
127738283|NCT00607997|459668650|FG000|Overall Study|Lack of Efficacy|6|||
127738284|NCT00607997|459668651|FG001|Overall Study|Lack of Efficacy|20|||
127738285|NCT00607997|459668652|FG002|Overall Study|Lack of Efficacy|14|||
127738286|NCT00607997|459668653|FG003|Overall Study|Lack of Efficacy|10|||
127738287|NCT00607997|459668650|FG000|Overall Study|Death|8|||
127738288|NCT00607997|459668651|FG001|Overall Study|Death|5|||
127738289|NCT00607997|459668652|FG002|Overall Study|Death|2|||
127738290|NCT00607997|459668653|FG003|Overall Study|Death|5|||
127738291|NCT00607997|459668650|FG000|Overall Study|Adverse Event|3|||
127738292|NCT00607997|459668651|FG001|Overall Study|Adverse Event|1|||
127738293|NCT00607997|459668652|FG002|Overall Study|Adverse Event|2|||
127738294|NCT00607997|459668653|FG003|Overall Study|Adverse Event|0|||
127738295|NCT00607997|459668650|FG000|Overall Study|Physician Decision|4|||
127738296|NCT00607997|459668651|FG001|Overall Study|Physician Decision|1|||
127738297|NCT00607997|459668652|FG002|Overall Study|Physician Decision|0|||
127738298|NCT00607997|459668653|FG003|Overall Study|Physician Decision|0|||
127738299|NCT00607997|459668650|FG000|Overall Study|Relapse, recurrent illness|4|||
127738300|NCT00607997|459668651|FG001|Overall Study|Relapse, recurrent illness|0|||
127738301|NCT00607997|459668652|FG002|Overall Study|Relapse, recurrent illness|2|||
127738302|NCT00607997|459668653|FG003|Overall Study|Relapse, recurrent illness|0|||
127738303|NCT00607997|459668650|FG000|Overall Study|Other without explanation|2|||
127806624|NCT01375764|459913516|FG002|Overall Study|Withdrawal by Subject|0|||
127806625|NCT01375764|459913517|FG003|Overall Study|Withdrawal by Subject|0|||
127806626|NCT01375764|459913518|FG004|Overall Study|Withdrawal by Subject|1|||
127806627|NCT01375764|459913514|FG000|Overall Study|Other|0|||
127806628|NCT01375764|459913515|FG001|Overall Study|Other|0|||
127738304|NCT00607997|459668651|FG001|Overall Study|Other without explanation|0|||
127806629|NCT01375764|459913516|FG002|Overall Study|Other|0|||
127806630|NCT01375764|459913517|FG003|Overall Study|Other|1|||
127806631|NCT01375764|459913518|FG004|Overall Study|Other|0|||
127738305|NCT00607997|459668652|FG002|Overall Study|Other without explanation|4|||
127738306|NCT00607997|459668653|FG003|Overall Study|Other without explanation|1|||
127738307|NCT00576823|459668654|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
127738308|NCT00576823|459668655|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
127738309|NCT00576823|459668656|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
127738310|NCT00576823|459668654|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
127738311|NCT00576823|459668655|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
127738312|NCT00576823|459668656|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
127738313|NCT00510146|459668659|FG000|Double-Blind Treatment|Adverse Event|30|||
127806632|NCT03595280|459913519|FG000|Overall Study|Lost to Follow-up|6|||
127806633|NCT03595280|459913520|FG001|Overall Study|Lost to Follow-up|9|||
127806634|NCT03595280|459913521|FG002|Overall Study|Lost to Follow-up|15|||
127806635|NCT01194440|459913522|FG000|Baseline (First Dose)|Reason not specified|4|||
127806636|NCT01194440|459913522|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
127738314|NCT00510146|459668660|FG001|Double-Blind Treatment|Adverse Event|13|||
127738315|NCT00510146|459668659|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
127738316|NCT00510146|459668660|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
127738317|NCT00510146|459668659|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
127738318|NCT00510146|459668660|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
127738319|NCT00510146|459668659|FG000|Double-Blind Treatment|Physician Decision|6|||
127738320|NCT00510146|459668660|FG001|Double-Blind Treatment|Physician Decision|0|||
127738321|NCT00510146|459668659|FG000|Double-Blind Treatment|Protocol Violation|1|||
127738322|NCT00510146|459668660|FG001|Double-Blind Treatment|Protocol Violation|2|||
127738323|NCT00510146|459668659|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
127738324|NCT00510146|459668660|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
127738325|NCT00510146|459668659|FG000|Double-Blind Treatment|Clinical Relapse|0|||
127738326|NCT00510146|459668660|FG001|Double-Blind Treatment|Clinical Relapse|1|||
127738327|NCT00510146|459668659|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
127738328|NCT00510146|459668660|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
127738329|NCT00510146|459668659|FG000|Open-Label Treatment|Adverse Event|22|||
127738330|NCT00510146|459668660|FG001|Open-Label Treatment|Adverse Event|8|||
127738331|NCT00510146|459668659|FG000|Open-Label Treatment|Death|1|||
127738332|NCT00510146|459668660|FG001|Open-Label Treatment|Death|1|||
127738333|NCT00510146|459668659|FG000|Open-Label Treatment|Lack of Efficacy|4|||
127738334|NCT00510146|459668660|FG001|Open-Label Treatment|Lack of Efficacy|0|||
127738335|NCT00510146|459668659|FG000|Open-Label Treatment|Lost to Follow-up|10|||
127738336|NCT00510146|459668660|FG001|Open-Label Treatment|Lost to Follow-up|1|||
127738337|NCT00510146|459668659|FG000|Open-Label Treatment|Physician Decision|3|||
127738338|NCT00510146|459668660|FG001|Open-Label Treatment|Physician Decision|1|||
127738339|NCT00510146|459668659|FG000|Open-Label Treatment|Protocol Violation|4|||
127738340|NCT00510146|459668660|FG001|Open-Label Treatment|Protocol Violation|2|||
127738341|NCT00510146|459668659|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
127738342|NCT00510146|459668660|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
127738343|NCT00510146|459668659|FG000|Open-Label Treatment|Clinical Relapse|1|||
127738344|NCT00510146|459668660|FG001|Open-Label Treatment|Clinical Relapse|1|||
127738345|NCT00510146|459668659|FG000|Open-Label Treatment|Sponsor Decision|2|||
127738346|NCT00510146|459668660|FG001|Open-Label Treatment|Sponsor Decision|0|||
127738347|NCT02864342|459668662|FG000|Overall Study|Eligibility Criteria Deviation|2|||
127738348|NCT02864342|459668663|FG001|Overall Study|Eligibility Criteria Deviation|3|||
127738349|NCT02864342|459668662|FG000|Overall Study|Withdrawal by Subject|4|||
127738350|NCT02864342|459668663|FG001|Overall Study|Withdrawal by Subject|2|||
127738351|NCT02864342|459668662|FG000|Overall Study|Device Technology Issue|6|||
127738352|NCT02864342|459668663|FG001|Overall Study|Device Technology Issue|7|||
127738353|NCT02864342|459668662|FG000|Overall Study|Death|0|||
127738354|NCT02864342|459668663|FG001|Overall Study|Death|1|||
127738355|NCT02864342|459668662|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
127738356|NCT02864342|459668663|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
127738357|NCT02864342|459668662|FG000|Overall Study|Lost to Follow-up|1|||
127738358|NCT02864342|459668663|FG001|Overall Study|Lost to Follow-up|5|||
127738359|NCT02864342|459668662|FG000|Overall Study|Lost Device|1|||
127738360|NCT02864342|459668663|FG001|Overall Study|Lost Device|0|||
127738361|NCT02864342|459668662|FG000|Overall Study|Adverse Event|1|||
127738362|NCT02864342|459668663|FG001|Overall Study|Adverse Event|0|||
127738363|NCT01560585|459668668|FG000|Overall Study|Physician Decision|3|||
127738364|NCT04688086|459668677|FG000|Overall Study|Lost to Follow-up|164|||
127738365|NCT04688086|459668677|FG000|Overall Study|Imaging error;|64|||
127738366|NCT00853021|459668680|FG000|Overall Study|Adverse Event|2|||
127738367|NCT00853021|459668680|FG000|Overall Study|Withdrawal by Subject|2|||
127738368|NCT00853021|459668680|FG000|Overall Study|Death|1|||
127738369|NCT01329419|459668681|FG000|Overall Study|Protocol Violation|235|||
127738370|NCT04522778|459668684|FG000|Overall Study|Patient did not want to wear the device|1|||
127738371|NCT04522778|459668685|FG001|Overall Study|Patient did not want to wear the device|0|||
127738372|NCT04522778|459668684|FG000|Overall Study|Lost to Follow-up|0|||
127738373|NCT04522778|459668685|FG001|Overall Study|Lost to Follow-up|1|||
127738374|NCT04206384|459668689|FG000|Overall Study|Withdrawal by Subject|8|||
127738375|NCT04206384|459668689|FG000|Overall Study|Adverse Event|2|||
127738376|NCT02212197|459668690|FG000|Overall Study|Need for radiotherapy|1|||
127738377|NCT02212197|459668691|FG001|Overall Study|Need for radiotherapy|0|||
127738378|NCT02212197|459668692|FG002|Overall Study|Need for radiotherapy|0|||
127738379|NCT02551692|459668694|FG000|Overall Study|Lost to Follow-up|0|||
127738380|NCT02551692|459668695|FG001|Overall Study|Lost to Follow-up|1|||
127738381|NCT02551692|459668696|FG002|Overall Study|Lost to Follow-up|4|||
127738382|NCT02551692|459668694|FG000|Overall Study|Withdrawal by Subject|1|||
127738383|NCT02551692|459668695|FG001|Overall Study|Withdrawal by Subject|0|||
127738384|NCT02551692|459668696|FG002|Overall Study|Withdrawal by Subject|1|||
127738385|NCT01091519|459668697|FG000|Overall Study|Adverse Event|12|||
127738386|NCT01091519|459668698|FG001|Overall Study|Adverse Event|16|||
127738387|NCT01091519|459668697|FG000|Overall Study|Death|1|||
127738388|NCT01091519|459668698|FG001|Overall Study|Death|0|||
127738389|NCT01091519|459668697|FG000|Overall Study|Lack of Efficacy|16|||
127738390|NCT01091519|459668698|FG001|Overall Study|Lack of Efficacy|19|||
127738391|NCT01091519|459668697|FG000|Overall Study|Lost to Follow-up|14|||
127738392|NCT01091519|459668698|FG001|Overall Study|Lost to Follow-up|24|||
127738393|NCT01091519|459668697|FG000|Overall Study|Withdrawal by Subject|2|||
127738394|NCT01091519|459668698|FG001|Overall Study|Withdrawal by Subject|2|||
127738395|NCT01091519|459668697|FG000|Overall Study|Other|6|||
127738396|NCT01091519|459668698|FG001|Overall Study|Other|8|||
127738397|NCT01091519|459668697|FG000|Overall Study|Randomized not treated|4|||
127738398|NCT01091519|459668698|FG001|Overall Study|Randomized not treated|4|||
127738399|NCT03030599|459668701|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
127738400|NCT03030599|459668702|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
127738401|NCT03030599|459668703|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
127738402|NCT03030599|459668701|FG000|Open Label Treatment and Titration|Other|1|||
127738403|NCT03030599|459668702|FG001|Open Label Treatment and Titration|Other|0|||
127738404|NCT03030599|459668703|FG002|Open Label Treatment and Titration|Other|0|||
127738405|NCT03030599|459668701|FG000|Open Label Treatment and Titration|Physician Decision|3|||
127738406|NCT03030599|459668702|FG001|Open Label Treatment and Titration|Physician Decision|0|||
127738407|NCT03030599|459668703|FG002|Open Label Treatment and Titration|Physician Decision|0|||
127738408|NCT03030599|459668701|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
127738409|NCT03030599|459668702|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
127738410|NCT03030599|459668703|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
127738411|NCT03030599|459668701|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
127738412|NCT03030599|459668702|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
127738413|NCT03030599|459668703|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
127738414|NCT03030599|459668701|FG000|Open Label Treatment and Titration|Adverse Event|18|||
127738415|NCT03030599|459668702|FG001|Open Label Treatment and Titration|Adverse Event|0|||
127738416|NCT03030599|459668703|FG002|Open Label Treatment and Titration|Adverse Event|0|||
127738417|NCT03030599|459668701|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
127738418|NCT03030599|459668702|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
127738419|NCT03030599|459668703|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
127738420|NCT03030599|459668701|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
127738421|NCT03030599|459668702|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
127738422|NCT03030599|459668703|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
127738423|NCT03030599|459668701|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
127738424|NCT03030599|459668702|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
127738425|NCT03030599|459668703|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
127738426|NCT03030599|459668701|FG000|Stable Dose|Protocol deviation|3|||
127738427|NCT03030599|459668702|FG001|Stable Dose|Protocol deviation|0|||
127738428|NCT03030599|459668703|FG002|Stable Dose|Protocol deviation|0|||
127738429|NCT03030599|459668701|FG000|Stable Dose|Adverse Event|1|||
127738430|NCT03030599|459668702|FG001|Stable Dose|Adverse Event|0|||
127738431|NCT03030599|459668703|FG002|Stable Dose|Adverse Event|0|||
127738432|NCT03030599|459668701|FG000|Stable Dose|Lost to Follow-up|1|||
127738433|NCT03030599|459668702|FG001|Stable Dose|Lost to Follow-up|0|||
127738434|NCT03030599|459668703|FG002|Stable Dose|Lost to Follow-up|0|||
127738435|NCT03030599|459668701|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
127738436|NCT03030599|459668702|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
127738437|NCT03030599|459668703|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
127738438|NCT03030599|459668701|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
127738439|NCT03030599|459668702|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
127738440|NCT03030599|459668703|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
127738441|NCT03030599|459668701|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
127738442|NCT03030599|459668702|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
127738443|NCT03030599|459668703|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
127738444|NCT03030599|459668701|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
127738445|NCT03030599|459668702|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
127738446|NCT03030599|459668703|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
127738447|NCT03030599|459668701|FG000|Open-label Extension|Adverse Event|3|||
127738448|NCT03030599|459668702|FG001|Open-label Extension|Adverse Event|0|||
127738449|NCT03030599|459668703|FG002|Open-label Extension|Adverse Event|0|||
127738450|NCT03030599|459668701|FG000|Open-label Extension|Lost to Follow-up|2|||
127738451|NCT03030599|459668702|FG001|Open-label Extension|Lost to Follow-up|0|||
127738452|NCT03030599|459668703|FG002|Open-label Extension|Lost to Follow-up|0|||
127892852|NCT00095199|460229663|FG003|Overall Study|Data inadvertently lost by site|0|||
127738453|NCT03030599|459668701|FG000|Open-label Extension|Lack of Efficacy|1|||
127738454|NCT03030599|459668702|FG001|Open-label Extension|Lack of Efficacy|0|||
127738455|NCT03030599|459668703|FG002|Open-label Extension|Lack of Efficacy|0|||
127738456|NCT03030599|459668701|FG000|Open-label Extension|Other Reason|1|||
127738457|NCT03030599|459668702|FG001|Open-label Extension|Other Reason|0|||
127738458|NCT03030599|459668703|FG002|Open-label Extension|Other Reason|0|||
127738459|NCT01177228|459668704|FG000|Overall Study|Positive tuberculosis test|0|||
127738460|NCT01177228|459668705|FG001|Overall Study|Positive tuberculosis test|1|||
127806637|NCT01194440|459913522|FG000|Baseline (First Dose)|Change in therapy|1|||
127806638|NCT01194440|459913522|FG000|Baseline (First Dose)|Adverse Event|1|||
127806639|NCT01194440|459913522|FG000|6-months (2nd Dose)|Change in therapy|4|||
127806640|NCT00896532|459913524|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
127738461|NCT01177228|459668706|FG002|Overall Study|Positive tuberculosis test|0|||
127738462|NCT01177228|459668707|FG003|Overall Study|Positive tuberculosis test|0|||
127738463|NCT01177228|459668704|FG000|Overall Study|Worsening disease activity|1|||
127738464|NCT01177228|459668705|FG001|Overall Study|Worsening disease activity|0|||
127738465|NCT01177228|459668706|FG002|Overall Study|Worsening disease activity|0|||
127738466|NCT01177228|459668707|FG003|Overall Study|Worsening disease activity|0|||
127738467|NCT01177228|459668704|FG000|Overall Study|Withdrawal by Subject|0|||
127738468|NCT01177228|459668705|FG001|Overall Study|Withdrawal by Subject|1|||
127738469|NCT01177228|459668706|FG002|Overall Study|Withdrawal by Subject|0|||
127738470|NCT01177228|459668707|FG003|Overall Study|Withdrawal by Subject|0|||
127738471|NCT04167085|459668708|FG000|Baseline|Withdrawal by Subject|2|||
127738472|NCT04167085|459668709|FG001|Baseline|Withdrawal by Subject|1|||
127738473|NCT04167085|459668708|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
127738474|NCT04167085|459668709|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
127738475|NCT00006436|459668711|FG000|Overall Study|Refused further treatment|2|||
127738476|NCT00006436|459668711|FG000|Overall Study|Declined to participate (before treatment started)|1|||
127738477|NCT00316589|459668712|FG000|Overall Study|Withdrawal by Subject|0|||
127738478|NCT00316589|459668713|FG001|Overall Study|Withdrawal by Subject|5|||
127738479|NCT00316589|459668714|FG002|Overall Study|Withdrawal by Subject|0|||
127738480|NCT00316589|459668715|FG003|Overall Study|Withdrawal by Subject|1|||
127738481|NCT00316589|459668712|FG000|Overall Study|Subject unwilling/unable to comply|0|||
127738482|NCT00316589|459668713|FG001|Overall Study|Subject unwilling/unable to comply|6|||
127738483|NCT00316589|459668714|FG002|Overall Study|Subject unwilling/unable to comply|0|||
127738484|NCT00316589|459668715|FG003|Overall Study|Subject unwilling/unable to comply|2|||
127738485|NCT00316589|459668712|FG000|Overall Study|Adverse Event|1|||
127738486|NCT00316589|459668713|FG001|Overall Study|Adverse Event|0|||
127738487|NCT00316589|459668714|FG002|Overall Study|Adverse Event|0|||
127738488|NCT00316589|459668715|FG003|Overall Study|Adverse Event|1|||
127738489|NCT00316589|459668712|FG000|Overall Study|Physician Decision|0|||
127738490|NCT00316589|459668713|FG001|Overall Study|Physician Decision|1|||
127738491|NCT00316589|459668714|FG002|Overall Study|Physician Decision|0|||
127738492|NCT00316589|459668715|FG003|Overall Study|Physician Decision|0|||
127738493|NCT00316589|459668712|FG000|Overall Study|Other reason|0|||
127738494|NCT00316589|459668713|FG001|Overall Study|Other reason|12|||
127738495|NCT00316589|459668714|FG002|Overall Study|Other reason|1|||
127738496|NCT00316589|459668715|FG003|Overall Study|Other reason|1|||
127738497|NCT00276016|459668716|FG000|Intervention 1|Withdrawal by Subject|0|||
127738498|NCT00276016|459668717|FG001|Intervention 1|Withdrawal by Subject|1|||
127738499|NCT00276016|459668718|FG002|Intervention 1|Withdrawal by Subject|0|||
127738500|NCT00276016|459668719|FG003|Intervention 1|Withdrawal by Subject|0|||
127738501|NCT00276016|459668720|FG004|Intervention 1|Withdrawal by Subject|0|||
127738502|NCT00276016|459668721|FG005|Intervention 1|Withdrawal by Subject|0|||
127738503|NCT05041439|459668722|FG000|Overall Study|Withdrawal by Subject|1|||
127738504|NCT05041439|459668723|FG001|Overall Study|Withdrawal by Subject|1|||
127738505|NCT05041439|459668722|FG000|Overall Study|Death|1|||
127806641|NCT00896532|459913525|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
127806642|NCT00896532|459913526|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
127738506|NCT05041439|459668723|FG001|Overall Study|Death|0|||
127738507|NCT01374971|459668724|FG000|Overall Study|Withdrawal by Subject|1|||
127738508|NCT00943618|459670331|FG000|Overall Study|Lost to Follow-up|38|||
127738509|NCT00943618|459670332|FG001|Overall Study|Lost to Follow-up|48|||
127738510|NCT00943618|459670333|FG002|Overall Study|Lost to Follow-up|20|||
127738511|NCT00943618|459670331|FG000|Overall Study|Discontinued Medication|17|||
127738512|NCT00943618|459670332|FG001|Overall Study|Discontinued Medication|29|||
127738513|NCT00943618|459670333|FG002|Overall Study|Discontinued Medication|11|||
127806643|NCT00896532|459913527|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
127806644|NCT00896532|459913528|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
127738514|NCT03713281|459670334|FG000|Overall Study|Lens handling difficuluties|2|||
127738515|NCT03713281|459670334|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
127738516|NCT00320398|459670335|FG000|Overall Study|Adverse Event|1|||
127738517|NCT00320398|459670336|FG001|Overall Study|Adverse Event|4|||
127738518|NCT00320398|459670335|FG000|Overall Study|Other|1|||
127738519|NCT00320398|459670336|FG001|Overall Study|Other|0|||
127738520|NCT00630552|459670338|FG000|Overall Study|Adverse Event|0|||
127892853|NCT01896297|460229666|FG000|Overall Study|Died in post treatment phase|1|||
127738521|NCT00630552|459670339|FG001|Overall Study|Adverse Event|1|||
127738522|NCT00630552|459670340|FG002|Overall Study|Adverse Event|5|||
127738523|NCT00630552|459670341|FG003|Overall Study|Adverse Event|4|||
127738524|NCT00630552|459670342|FG004|Overall Study|Adverse Event|2|||
127738525|NCT00630552|459670338|FG000|Overall Study|Disease progression|5|||
127738526|NCT00630552|459670339|FG001|Overall Study|Disease progression|6|||
127738527|NCT00630552|459670340|FG002|Overall Study|Disease progression|27|||
127738528|NCT00630552|459670341|FG003|Overall Study|Disease progression|22|||
127738529|NCT00630552|459670342|FG004|Overall Study|Disease progression|31|||
127738530|NCT00630552|459670338|FG000|Overall Study|Never received IP|0|||
127738531|NCT00630552|459670339|FG001|Overall Study|Never received IP|0|||
127738532|NCT00630552|459670340|FG002|Overall Study|Never received IP|0|||
127738533|NCT00630552|459670341|FG003|Overall Study|Never received IP|2|||
127738534|NCT00630552|459670342|FG004|Overall Study|Never received IP|2|||
127738535|NCT00630552|459670338|FG000|Overall Study|Ineligibility determined|0|||
127738536|NCT00630552|459670339|FG001|Overall Study|Ineligibility determined|0|||
127738537|NCT00630552|459670340|FG002|Overall Study|Ineligibility determined|0|||
127738538|NCT00630552|459670341|FG003|Overall Study|Ineligibility determined|0|||
127738539|NCT00630552|459670342|FG004|Overall Study|Ineligibility determined|1|||
127738540|NCT00630552|459670338|FG000|Overall Study|Protocol Violation|0|||
127738541|NCT00630552|459670339|FG001|Overall Study|Protocol Violation|0|||
127738542|NCT00630552|459670340|FG002|Overall Study|Protocol Violation|0|||
127738543|NCT00630552|459670341|FG003|Overall Study|Protocol Violation|1|||
127738544|NCT00630552|459670342|FG004|Overall Study|Protocol Violation|0|||
127738545|NCT00630552|459670338|FG000|Overall Study|Physician Decision|0|||
127738546|NCT00630552|459670339|FG001|Overall Study|Physician Decision|0|||
127738547|NCT00630552|459670340|FG002|Overall Study|Physician Decision|0|||
127738548|NCT00630552|459670341|FG003|Overall Study|Physician Decision|0|||
127738549|NCT00630552|459670342|FG004|Overall Study|Physician Decision|1|||
127738550|NCT00630552|459670338|FG000|Overall Study|Death|0|||
127738551|NCT00630552|459670339|FG001|Overall Study|Death|0|||
127738552|NCT00630552|459670340|FG002|Overall Study|Death|1|||
127738553|NCT00630552|459670341|FG003|Overall Study|Death|2|||
127738554|NCT00630552|459670342|FG004|Overall Study|Death|2|||
127738555|NCT00630552|459670338|FG000|Overall Study|Withdrawal by Subject|0|||
127738556|NCT00630552|459670339|FG001|Overall Study|Withdrawal by Subject|0|||
127738557|NCT00630552|459670340|FG002|Overall Study|Withdrawal by Subject|0|||
127738558|NCT00630552|459670341|FG003|Overall Study|Withdrawal by Subject|1|||
127738559|NCT00630552|459670342|FG004|Overall Study|Withdrawal by Subject|0|||
127738560|NCT00630552|459670338|FG000|Overall Study|Other|0|||
127738561|NCT00630552|459670339|FG001|Overall Study|Other|0|||
127738562|NCT00630552|459670340|FG002|Overall Study|Other|4|||
127738563|NCT00630552|459670341|FG003|Overall Study|Other|2|||
127738564|NCT00630552|459670342|FG004|Overall Study|Other|0|||
127738565|NCT01169636|459670344|FG000|Overall Study|Adverse Event|0|||
127738566|NCT01169636|459670345|FG001|Overall Study|Adverse Event|0|||
127738567|NCT01169636|459670346|FG002|Overall Study|Adverse Event|1|||
127738568|NCT01169636|459670347|FG003|Overall Study|Adverse Event|1|||
127738569|NCT01169636|459670348|FG004|Overall Study|Adverse Event|0|||
127738570|NCT01169636|459670344|FG000|Overall Study|Screen failure|0|||
127738571|NCT01169636|459670345|FG001|Overall Study|Screen failure|0|||
127738572|NCT01169636|459670346|FG002|Overall Study|Screen failure|2|||
127738573|NCT01169636|459670347|FG003|Overall Study|Screen failure|0|||
127738574|NCT01169636|459670348|FG004|Overall Study|Screen failure|0|||
127738575|NCT01169636|459670344|FG000|Overall Study|Withdrawal by Subject|0|||
127738576|NCT01169636|459670345|FG001|Overall Study|Withdrawal by Subject|0|||
127738577|NCT01169636|459670346|FG002|Overall Study|Withdrawal by Subject|0|||
127738578|NCT01169636|459670347|FG003|Overall Study|Withdrawal by Subject|0|||
127738579|NCT01169636|459670348|FG004|Overall Study|Withdrawal by Subject|3|||
127738580|NCT02705625|459670349|FG000|Overall Study|Protocol Violation|1|||
127738581|NCT02705625|459670350|FG001|Overall Study|Protocol Violation|0|||
127738582|NCT02705625|459670351|FG002|Overall Study|Protocol Violation|0|||
127738583|NCT02705625|459670349|FG000|Overall Study|Adverse Event|6|||
127738584|NCT02705625|459670350|FG001|Overall Study|Adverse Event|5|||
127738585|NCT02705625|459670351|FG002|Overall Study|Adverse Event|2|||
127738586|NCT02705625|459670349|FG000|Overall Study|Death|0|||
127738587|NCT02705625|459670350|FG001|Overall Study|Death|0|||
127738588|NCT02705625|459670351|FG002|Overall Study|Death|1|||
127738589|NCT02705625|459670349|FG000|Overall Study|Withdrawal by Subject|1|||
127738590|NCT02705625|459670350|FG001|Overall Study|Withdrawal by Subject|4|||
127738591|NCT02705625|459670351|FG002|Overall Study|Withdrawal by Subject|5|||
127738592|NCT02705625|459670349|FG000|Overall Study|Lost to Follow-up|0|||
127738593|NCT02705625|459670350|FG001|Overall Study|Lost to Follow-up|0|||
127738594|NCT02705625|459670351|FG002|Overall Study|Lost to Follow-up|1|||
127738595|NCT02705625|459670349|FG000|Overall Study|Non-compliance|0|||
127738596|NCT02705625|459670350|FG001|Overall Study|Non-compliance|1|||
127738597|NCT02705625|459670351|FG002|Overall Study|Non-compliance|1|||
127738598|NCT02705625|459670349|FG000|Overall Study|Overdosing|0|||
127738599|NCT02705625|459670350|FG001|Overall Study|Overdosing|0|||
127738600|NCT02705625|459670351|FG002|Overall Study|Overdosing|1|||
127738601|NCT00494026|459670352|FG000|Overall Study|Sponsor Decision|4|||
127738602|NCT02815735|459670353|FG000|First Intervention (4 Weeks)|Discomfort|1|||
127738603|NCT02815735|459670354|FG001|First Intervention (4 Weeks)|Discomfort|0|||
127738604|NCT02815735|459670353|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
127738605|NCT02815735|459670354|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
127738606|NCT02815735|459670353|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
127738607|NCT02815735|459670354|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
127738608|NCT02815735|459670353|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
127738609|NCT02815735|459670354|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
127738610|NCT00468858|459670358|FG000|Overall Study|Adverse Event|0|||
127738611|NCT00468858|459670359|FG001|Overall Study|Adverse Event|1|||
127738612|NCT00468858|459670360|FG002|Overall Study|Adverse Event|0|||
127738613|NCT00468858|459670358|FG000|Overall Study|Withdrawal by Subject|7|||
127738614|NCT00468858|459670359|FG001|Overall Study|Withdrawal by Subject|4|||
127738615|NCT00468858|459670360|FG002|Overall Study|Withdrawal by Subject|5|||
127738616|NCT00468858|459670358|FG000|Overall Study|Relocation|1|||
127738617|NCT00468858|459670359|FG001|Overall Study|Relocation|3|||
127738618|NCT00468858|459670360|FG002|Overall Study|Relocation|3|||
127738619|NCT00468858|459670358|FG000|Overall Study|Lost to Follow-up|1|||
127738620|NCT00468858|459670359|FG001|Overall Study|Lost to Follow-up|2|||
127738621|NCT00468858|459670360|FG002|Overall Study|Lost to Follow-up|5|||
127738622|NCT00468858|459670358|FG000|Overall Study|Other|0|||
127738623|NCT00468858|459670359|FG001|Overall Study|Other|0|||
127738624|NCT00468858|459670360|FG002|Overall Study|Other|1|||
127738625|NCT00225277|459670367|FG000|Overall Study|Adverse Event|30|||
127738626|NCT00225277|459670368|FG001|Overall Study|Adverse Event|34|||
127738627|NCT00225277|459670367|FG000|Overall Study|Lack of Efficacy|4|||
127738628|NCT00225277|459670368|FG001|Overall Study|Lack of Efficacy|1|||
127738629|NCT00225277|459670367|FG000|Overall Study|Lost to Follow-up|4|||
127738630|NCT00225277|459670368|FG001|Overall Study|Lost to Follow-up|6|||
127738631|NCT00225277|459670367|FG000|Overall Study|Physician Decision|6|||
127738632|NCT00225277|459670368|FG001|Overall Study|Physician Decision|8|||
127738633|NCT00225277|459670367|FG000|Overall Study|Protocol Violation|6|||
127738634|NCT00225277|459670368|FG001|Overall Study|Protocol Violation|3|||
127738635|NCT00225277|459670367|FG000|Overall Study|Withdrawal by Subject|40|||
127738636|NCT00225277|459670368|FG001|Overall Study|Withdrawal by Subject|34|||
127738637|NCT00225277|459670367|FG000|Overall Study|Other|7|||
127738638|NCT00225277|459670368|FG001|Overall Study|Other|9|||
127738639|NCT04582669|459670375|FG000|Overall Study|Subject missed appointment(s).|1|||
127738640|NCT04582669|459670376|FG001|Overall Study|Subject missed appointment(s).|0|||
127738641|NCT04582669|459670377|FG002|Overall Study|Subject missed appointment(s).|1|||
127738642|NCT04582669|459670378|FG003|Overall Study|Subject missed appointment(s).|2|||
127738643|NCT04582669|459670375|FG000|Overall Study|Protocol Violation|0|||
127738644|NCT04582669|459670376|FG001|Overall Study|Protocol Violation|1|||
127738645|NCT04582669|459670377|FG002|Overall Study|Protocol Violation|1|||
127738646|NCT04582669|459670378|FG003|Overall Study|Protocol Violation|0|||
127738647|NCT00591409|459670379|FG000|Overall Study|Not Treated|0|||
127738648|NCT00591409|459670380|FG001|Overall Study|Not Treated|0|||
127738649|NCT00591409|459670381|FG002|Overall Study|Not Treated|0|||
127738650|NCT00591409|459670382|FG003|Overall Study|Not Treated|0|||
127738651|NCT00591409|459670383|FG004|Overall Study|Not Treated|1|||
127738652|NCT00591409|459670384|FG005|Overall Study|Not Treated|0|||
127738653|NCT00591409|459670385|FG006|Overall Study|Not Treated|0|||
127806645|NCT00896532|459913529|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
127806646|NCT00896532|459913530|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
127738654|NCT00591409|459670386|FG007|Overall Study|Not Treated|0|||
127738655|NCT00591409|459670387|FG008|Overall Study|Not Treated|0|||
127738656|NCT00591409|459670388|FG009|Overall Study|Not Treated|1|||
127738657|NCT00677092|459670389|FG000|Overall Study|Adverse Event|1|||
127738658|NCT00677092|459670389|FG000|Overall Study|Lost to Follow-up|1|||
127738659|NCT00677092|459670389|FG000|Overall Study|Withdrawal by Subject|3|||
127738660|NCT00677092|459670389|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
127738661|NCT02716298|459670390|FG000|First Intervention (1 Month)|Lens discomfort|1|||
127738662|NCT02716298|459670391|FG001|First Intervention (1 Month)|Lens discomfort|1|||
127806647|NCT00896532|459913531|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
127806648|NCT00896532|459913532|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
127806649|NCT00896532|459913533|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
127806650|NCT00896532|459913534|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
127738663|NCT00550446|459670392|FG000|Up To Week 12|Adverse Event|2|||
127738664|NCT00550446|459670393|FG001|Up To Week 12|Adverse Event|2|||
127738665|NCT00550446|459670394|FG002|Up To Week 12|Adverse Event|0|||
127738666|NCT00550446|459670395|FG003|Up To Week 12|Adverse Event|0|||
127738667|NCT00550446|459670396|FG004|Up To Week 12|Adverse Event|2|||
127738668|NCT00550446|459670397|FG005|Up To Week 12|Adverse Event|2|||
127738669|NCT00550446|459670398|FG006|Up To Week 12|Adverse Event|1|||
127738670|NCT00550446|459670399|FG007|Up To Week 12|Adverse Event|0|||
127738671|NCT00550446|459670400|FG008|Up To Week 12|Adverse Event|0|||
127806651|NCT00896532|459913535|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
127738672|NCT00550446|459670401|FG009|Up To Week 12|Adverse Event|0|||
127738673|NCT00550446|459670402|FG010|Up To Week 12|Adverse Event|0|||
127738674|NCT00550446|459670392|FG000|Up To Week 12|Lack of Efficacy|3|||
127738675|NCT00550446|459670393|FG001|Up To Week 12|Lack of Efficacy|1|||
127738676|NCT00550446|459670394|FG002|Up To Week 12|Lack of Efficacy|0|||
127738677|NCT00550446|459670395|FG003|Up To Week 12|Lack of Efficacy|1|||
127738678|NCT00550446|459670396|FG004|Up To Week 12|Lack of Efficacy|0|||
127738679|NCT00550446|459670397|FG005|Up To Week 12|Lack of Efficacy|3|||
127738680|NCT00550446|459670398|FG006|Up To Week 12|Lack of Efficacy|3|||
127738681|NCT00550446|459670399|FG007|Up To Week 12|Lack of Efficacy|0|||
127738682|NCT00550446|459670400|FG008|Up To Week 12|Lack of Efficacy|0|||
127738683|NCT00550446|459670401|FG009|Up To Week 12|Lack of Efficacy|0|||
127738684|NCT00550446|459670402|FG010|Up To Week 12|Lack of Efficacy|0|||
127738685|NCT00550446|459670392|FG000|Up To Week 12|Lost to Follow-up|0|||
127738686|NCT00550446|459670393|FG001|Up To Week 12|Lost to Follow-up|1|||
127738687|NCT00550446|459670394|FG002|Up To Week 12|Lost to Follow-up|0|||
127738688|NCT00550446|459670395|FG003|Up To Week 12|Lost to Follow-up|0|||
127738689|NCT00550446|459670396|FG004|Up To Week 12|Lost to Follow-up|1|||
127738690|NCT00550446|459670397|FG005|Up To Week 12|Lost to Follow-up|1|||
127738691|NCT00550446|459670398|FG006|Up To Week 12|Lost to Follow-up|2|||
127738692|NCT00550446|459670399|FG007|Up To Week 12|Lost to Follow-up|0|||
127738693|NCT00550446|459670400|FG008|Up To Week 12|Lost to Follow-up|0|||
127738694|NCT00550446|459670401|FG009|Up To Week 12|Lost to Follow-up|0|||
127738695|NCT00550446|459670402|FG010|Up To Week 12|Lost to Follow-up|0|||
127738696|NCT00550446|459670392|FG000|Up To Week 12|Withdrawal by Subject|2|||
127738697|NCT00550446|459670393|FG001|Up To Week 12|Withdrawal by Subject|0|||
127738698|NCT00550446|459670394|FG002|Up To Week 12|Withdrawal by Subject|3|||
127738699|NCT00550446|459670395|FG003|Up To Week 12|Withdrawal by Subject|2|||
127738700|NCT00550446|459670396|FG004|Up To Week 12|Withdrawal by Subject|0|||
127738701|NCT00550446|459670397|FG005|Up To Week 12|Withdrawal by Subject|1|||
127738702|NCT00550446|459670398|FG006|Up To Week 12|Withdrawal by Subject|3|||
127738703|NCT00550446|459670399|FG007|Up To Week 12|Withdrawal by Subject|0|||
127738704|NCT00550446|459670400|FG008|Up To Week 12|Withdrawal by Subject|0|||
127738705|NCT00550446|459670401|FG009|Up To Week 12|Withdrawal by Subject|0|||
127738706|NCT00550446|459670402|FG010|Up To Week 12|Withdrawal by Subject|0|||
127738707|NCT00550446|459670392|FG000|Up To Week 12|Other|3|||
127738708|NCT00550446|459670393|FG001|Up To Week 12|Other|0|||
127738709|NCT00550446|459670394|FG002|Up To Week 12|Other|0|||
127738710|NCT00550446|459670395|FG003|Up To Week 12|Other|0|||
127738711|NCT00550446|459670396|FG004|Up To Week 12|Other|0|||
127738712|NCT00550446|459670397|FG005|Up To Week 12|Other|1|||
127738713|NCT00550446|459670398|FG006|Up To Week 12|Other|4|||
127738714|NCT00550446|459670399|FG007|Up To Week 12|Other|0|||
127738715|NCT00550446|459670400|FG008|Up To Week 12|Other|0|||
127738716|NCT00550446|459670401|FG009|Up To Week 12|Other|0|||
127738717|NCT00550446|459670402|FG010|Up To Week 12|Other|0|||
127738718|NCT00550446|459670392|FG000|Up To Week 12|Randomized not treated|0|||
127738719|NCT00550446|459670393|FG001|Up To Week 12|Randomized not treated|1|||
127738720|NCT00550446|459670394|FG002|Up To Week 12|Randomized not treated|1|||
127738721|NCT00550446|459670395|FG003|Up To Week 12|Randomized not treated|0|||
127738722|NCT00550446|459670396|FG004|Up To Week 12|Randomized not treated|0|||
127738723|NCT00550446|459670397|FG005|Up To Week 12|Randomized not treated|0|||
127738724|NCT00550446|459670398|FG006|Up To Week 12|Randomized not treated|0|||
127738725|NCT00550446|459670399|FG007|Up To Week 12|Randomized not treated|0|||
127738726|NCT00550446|459670400|FG008|Up To Week 12|Randomized not treated|0|||
127738727|NCT00550446|459670401|FG009|Up To Week 12|Randomized not treated|0|||
127738728|NCT00550446|459670402|FG010|Up To Week 12|Randomized not treated|0|||
127738729|NCT00550446|459670392|FG000|Post Week 12|Adverse Event|2|||
127738730|NCT00550446|459670393|FG001|Post Week 12|Adverse Event|1|||
127738731|NCT00550446|459670394|FG002|Post Week 12|Adverse Event|1|||
127806652|NCT00896532|459913536|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
127806653|NCT00896532|459913537|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
127806654|NCT00896532|459913538|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
127806655|NCT00896532|459913539|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
127806656|NCT00896532|459913540|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
127806657|NCT00896532|459913541|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
127806658|NCT00896532|459913542|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
127892854|NCT01098240|460229667|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
127738732|NCT00550446|459670395|FG003|Post Week 12|Adverse Event|1|||
127806659|NCT00896532|459913543|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
127892855|NCT01098240|460229668|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
127738733|NCT00550446|459670396|FG004|Post Week 12|Adverse Event|1|||
127738734|NCT00550446|459670397|FG005|Post Week 12|Adverse Event|1|||
127738735|NCT00550446|459670398|FG006|Post Week 12|Adverse Event|0|||
127738736|NCT00550446|459670399|FG007|Post Week 12|Adverse Event|0|||
127738737|NCT00550446|459670400|FG008|Post Week 12|Adverse Event|0|||
127892856|NCT01098240|460229669|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
127892857|NCT01098240|460229667|FG000|Open-Label Phase|Protocol Violation|4|||
127892858|NCT01098240|460229668|FG001|Open-Label Phase|Protocol Violation|0|||
127738738|NCT00550446|459670401|FG009|Post Week 12|Adverse Event|4|||
127738739|NCT00550446|459670402|FG010|Post Week 12|Adverse Event|0|||
127738740|NCT00550446|459670392|FG000|Post Week 12|Lack of Efficacy|0|||
127738741|NCT00550446|459670393|FG001|Post Week 12|Lack of Efficacy|0|||
127738742|NCT00550446|459670394|FG002|Post Week 12|Lack of Efficacy|1|||
127738743|NCT00550446|459670395|FG003|Post Week 12|Lack of Efficacy|0|||
127738744|NCT00550446|459670396|FG004|Post Week 12|Lack of Efficacy|0|||
127738745|NCT00550446|459670397|FG005|Post Week 12|Lack of Efficacy|0|||
127738746|NCT00550446|459670398|FG006|Post Week 12|Lack of Efficacy|0|||
127738747|NCT00550446|459670399|FG007|Post Week 12|Lack of Efficacy|1|||
127738748|NCT00550446|459670400|FG008|Post Week 12|Lack of Efficacy|1|||
127738749|NCT00550446|459670401|FG009|Post Week 12|Lack of Efficacy|2|||
127738750|NCT00550446|459670402|FG010|Post Week 12|Lack of Efficacy|1|||
127738751|NCT00550446|459670392|FG000|Post Week 12|Lost to Follow-up|0|||
127738752|NCT00550446|459670393|FG001|Post Week 12|Lost to Follow-up|0|||
127738753|NCT00550446|459670394|FG002|Post Week 12|Lost to Follow-up|1|||
127738754|NCT00550446|459670395|FG003|Post Week 12|Lost to Follow-up|1|||
127738755|NCT00550446|459670396|FG004|Post Week 12|Lost to Follow-up|0|||
127738756|NCT00550446|459670397|FG005|Post Week 12|Lost to Follow-up|0|||
127738757|NCT00550446|459670398|FG006|Post Week 12|Lost to Follow-up|1|||
127738758|NCT00550446|459670399|FG007|Post Week 12|Lost to Follow-up|0|||
127738759|NCT00550446|459670400|FG008|Post Week 12|Lost to Follow-up|0|||
127738760|NCT00550446|459670401|FG009|Post Week 12|Lost to Follow-up|0|||
127738761|NCT00550446|459670402|FG010|Post Week 12|Lost to Follow-up|0|||
127738762|NCT00550446|459670392|FG000|Post Week 12|Withdrawal by Subject|0|||
127738763|NCT00550446|459670393|FG001|Post Week 12|Withdrawal by Subject|0|||
127738764|NCT00550446|459670394|FG002|Post Week 12|Withdrawal by Subject|0|||
127738765|NCT00550446|459670395|FG003|Post Week 12|Withdrawal by Subject|0|||
127738766|NCT00550446|459670396|FG004|Post Week 12|Withdrawal by Subject|1|||
127738767|NCT00550446|459670397|FG005|Post Week 12|Withdrawal by Subject|0|||
127738768|NCT00550446|459670398|FG006|Post Week 12|Withdrawal by Subject|0|||
127738769|NCT00550446|459670399|FG007|Post Week 12|Withdrawal by Subject|0|||
127738770|NCT00550446|459670400|FG008|Post Week 12|Withdrawal by Subject|0|||
127738771|NCT00550446|459670401|FG009|Post Week 12|Withdrawal by Subject|0|||
127738772|NCT00550446|459670402|FG010|Post Week 12|Withdrawal by Subject|0|||
127738773|NCT00550446|459670392|FG000|Post Week 12|Other|1|||
127738774|NCT00550446|459670393|FG001|Post Week 12|Other|1|||
127738775|NCT00550446|459670394|FG002|Post Week 12|Other|0|||
127738776|NCT00550446|459670395|FG003|Post Week 12|Other|1|||
127738777|NCT00550446|459670396|FG004|Post Week 12|Other|0|||
127738778|NCT00550446|459670397|FG005|Post Week 12|Other|0|||
127738779|NCT00550446|459670398|FG006|Post Week 12|Other|1|||
127738780|NCT00550446|459670399|FG007|Post Week 12|Other|0|||
127738781|NCT00550446|459670400|FG008|Post Week 12|Other|1|||
127738782|NCT00550446|459670401|FG009|Post Week 12|Other|1|||
127738783|NCT00550446|459670402|FG010|Post Week 12|Other|0|||
127738784|NCT04952701|459670403|FG000|Control Lens|Physician Decision|4|||
127738785|NCT04952701|459670403|FG000|Test Lens|Physician Decision|1|||
127738786|NCT01670188|459670406|FG000|Overall Study|Death|0|||
127738787|NCT01670188|459670407|FG001|Overall Study|Death|1|||
127738788|NCT02212301|459670408|FG000|Period 1|Lost to Follow-up|0|||
127738789|NCT02212301|459670409|FG001|Period 1|Lost to Follow-up|1|||
127738790|NCT03927222|459670410|FG000|Overall Study|Progression|3|||
127738791|NCT03927222|459670410|FG000|Overall Study|CMV testing results inconclusive|1|||
127738792|NCT03927222|459670410|FG000|Overall Study|Unable to generate enough vaccines|1|||
127738793|NCT03927222|459670410|FG000|Overall Study|Early study termination|1|||
127738794|NCT00578318|459670413|FG000|Overall Study|Lost to Follow-up|2|||
127738795|NCT00578318|459670414|FG001|Overall Study|Lost to Follow-up|0|||
127738796|NCT00578318|459670413|FG000|Overall Study|Physician Decision|1|||
127738797|NCT00578318|459670414|FG001|Overall Study|Physician Decision|0|||
127738798|NCT00866918|459670415|FG000|Overall Study|Death|1|||
127738799|NCT00866918|459670416|FG001|Overall Study|Death|5|||
127738800|NCT00866918|459670415|FG000|Overall Study|Lack of Efficacy|1|||
127738801|NCT00866918|459670416|FG001|Overall Study|Lack of Efficacy|1|||
127738802|NCT00866918|459670415|FG000|Overall Study|Physician Decision|10|||
127738803|NCT00866918|459670416|FG001|Overall Study|Physician Decision|2|||
127806660|NCT00896532|459913544|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
127738804|NCT00866918|459670415|FG000|Overall Study|Ineligible|2|||
127738805|NCT00866918|459670416|FG001|Overall Study|Ineligible|4|||
127738806|NCT00866918|459670415|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
127738807|NCT00866918|459670416|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
127738808|NCT00866918|459670415|FG000|Overall Study|Secondary malignancy|1|||
127806661|NCT00896532|459913545|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
127806662|NCT00896532|459913546|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
127806663|NCT00896532|459913524|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
127806664|NCT00896532|459913525|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
127738809|NCT00866918|459670416|FG001|Overall Study|Secondary malignancy|0|||
127738810|NCT00527514|459670418|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
127738811|NCT00527514|459670418|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
127738812|NCT00527514|459670418|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
127738813|NCT00527514|459670418|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
127738814|NCT00527514|459670418|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
127892859|NCT01098240|460229669|FG002|Open-Label Phase|Protocol Violation|0|||
127892860|NCT01098240|460229667|FG000|Open-Label Phase|Lost to Follow-up|13|||
127738815|NCT00527514|459670418|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
127738816|NCT00527514|459670418|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
127738817|NCT00920699|459670425|FG000|Overall Study|Withdrawal by Subject|2|||
127738818|NCT00920699|459670426|FG001|Overall Study|Withdrawal by Subject|0|||
127738819|NCT00920699|459670427|FG002|Overall Study|Withdrawal by Subject|2|||
127738820|NCT00920699|459670425|FG000|Overall Study|no longer met eligibility|0|||
127738821|NCT00920699|459670426|FG001|Overall Study|no longer met eligibility|1|||
127738822|NCT00920699|459670427|FG002|Overall Study|no longer met eligibility|0|||
127738823|NCT00920699|459670425|FG000|Overall Study|Lost to Follow-up|0|||
127738824|NCT00920699|459670426|FG001|Overall Study|Lost to Follow-up|0|||
127738825|NCT00920699|459670427|FG002|Overall Study|Lost to Follow-up|2|||
127738826|NCT00001941|459670428|FG000|Overall Study|not treated- rapidly progressing disease|0|||
127738827|NCT00001941|459670429|FG001|Overall Study|not treated- rapidly progressing disease|0|||
127738828|NCT00001941|459670430|FG002|Overall Study|not treated- rapidly progressing disease|0|||
127738829|NCT00001941|459670431|FG003|Overall Study|not treated- rapidly progressing disease|0|||
127738830|NCT00001941|459670432|FG004|Overall Study|not treated- rapidly progressing disease|1|||
127738831|NCT00819013|459670449|FG000|Overall Study|Not meeting continuing study eligibility|2|||
127738832|NCT00819013|459670450|FG001|Overall Study|Not meeting continuing study eligibility|1|||
127738833|NCT00819013|459670451|FG002|Overall Study|Not meeting continuing study eligibility|2|||
127738834|NCT00819013|459670452|FG003|Overall Study|Not meeting continuing study eligibility|1|||
127738835|NCT00819013|459670449|FG000|Overall Study|Adverse Event|0|||
127738836|NCT00819013|459670450|FG001|Overall Study|Adverse Event|0|||
127738837|NCT00819013|459670451|FG002|Overall Study|Adverse Event|1|||
127738838|NCT00819013|459670452|FG003|Overall Study|Adverse Event|0|||
127738839|NCT00819013|459670449|FG000|Overall Study|Withdrawal by Subject|1|||
127738840|NCT00819013|459670450|FG001|Overall Study|Withdrawal by Subject|0|||
127738841|NCT00819013|459670451|FG002|Overall Study|Withdrawal by Subject|1|||
127738842|NCT00819013|459670452|FG003|Overall Study|Withdrawal by Subject|0|||
127738843|NCT00819013|459670449|FG000|Overall Study|Lost to Follow-up|0|||
127738844|NCT00819013|459670450|FG001|Overall Study|Lost to Follow-up|0|||
127738845|NCT00819013|459670451|FG002|Overall Study|Lost to Follow-up|1|||
127738846|NCT00819013|459670452|FG003|Overall Study|Lost to Follow-up|2|||
127738847|NCT00819013|459670449|FG000|Overall Study|Death|0|||
127738848|NCT00819013|459670450|FG001|Overall Study|Death|0|||
127738849|NCT00819013|459670451|FG002|Overall Study|Death|0|||
127738850|NCT00819013|459670452|FG003|Overall Study|Death|1|||
127738851|NCT01930214|459670454|FG000|Overall Study|Death|4|||
127738852|NCT01930214|459670455|FG001|Overall Study|Death|4|||
127738853|NCT01930214|459670456|FG002|Overall Study|Death|11|||
127738854|NCT01930214|459670454|FG000|Overall Study|Lost to Follow-up|12|||
127892861|NCT01098240|460229668|FG001|Open-Label Phase|Lost to Follow-up|0|||
127892862|NCT01098240|460229669|FG002|Open-Label Phase|Lost to Follow-up|0|||
127892863|NCT01098240|460229667|FG000|Open-Label Phase|Other|19|||
127892864|NCT01098240|460229668|FG001|Open-Label Phase|Other|0|||
127892865|NCT01098240|460229669|FG002|Open-Label Phase|Other|0|||
127892866|NCT01098240|460229667|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
127892867|NCT01098240|460229668|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
127892868|NCT01098240|460229669|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
127892869|NCT01098240|460229667|FG000|Open-Label Phase|Pregnancy|1|||
127892870|NCT01098240|460229668|FG001|Open-Label Phase|Pregnancy|0|||
127892871|NCT01098240|460229669|FG002|Open-Label Phase|Pregnancy|0|||
127892872|NCT01098240|460229667|FG000|Open-Label Phase|Withdrawal by Subject|9|||
127892873|NCT01098240|460229668|FG001|Open-Label Phase|Withdrawal by Subject|0|||
127892874|NCT01098240|460229669|FG002|Open-Label Phase|Withdrawal by Subject|0|||
127892875|NCT01098240|460229667|FG000|Open-Label Phase|Adverse Event|12|||
127892876|NCT01098240|460229668|FG001|Open-Label Phase|Adverse Event|0|||
127892877|NCT01098240|460229669|FG002|Open-Label Phase|Adverse Event|0|||
127892878|NCT01098240|460229667|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
127892879|NCT01098240|460229668|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
127892880|NCT01098240|460229669|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
127892881|NCT01098240|460229667|FG000|Double-Blind Phase|Protocol Violation|0|||
127892882|NCT01098240|460229668|FG001|Double-Blind Phase|Protocol Violation|2|||
127892883|NCT01098240|460229669|FG002|Double-Blind Phase|Protocol Violation|4|||
127892884|NCT01098240|460229667|FG000|Double-Blind Phase|Lost to Follow-up|0|||
127892885|NCT01098240|460229668|FG001|Double-Blind Phase|Lost to Follow-up|2|||
127892886|NCT01098240|460229669|FG002|Double-Blind Phase|Lost to Follow-up|0|||
127892887|NCT01098240|460229667|FG000|Double-Blind Phase|Other|0|||
127892888|NCT01098240|460229668|FG001|Double-Blind Phase|Other|2|||
127892889|NCT01098240|460229669|FG002|Double-Blind Phase|Other|2|||
127892890|NCT01098240|460229667|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
127892891|NCT01098240|460229668|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
127738855|NCT01930214|459670455|FG001|Overall Study|Lost to Follow-up|13|||
127738856|NCT01930214|459670456|FG002|Overall Study|Lost to Follow-up|12|||
127738857|NCT01930214|459670454|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
127892892|NCT01098240|460229669|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
127738858|NCT01930214|459670455|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
127738859|NCT01930214|459670456|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
127738860|NCT01930214|459670454|FG000|Overall Study|Physician Decision|2|||
127738861|NCT01930214|459670455|FG001|Overall Study|Physician Decision|0|||
127738862|NCT01930214|459670456|FG002|Overall Study|Physician Decision|0|||
127738863|NCT02132117|459670457|FG000|Overall Study|Adverse Event|6|||
127738864|NCT02132117|459670458|FG001|Overall Study|Adverse Event|1|||
127738865|NCT02132117|459670457|FG000|Overall Study|Lost to Follow-up|2|||
127738866|NCT02132117|459670458|FG001|Overall Study|Lost to Follow-up|2|||
127738867|NCT02132117|459670457|FG000|Overall Study|Personal Reasons|1|||
127738868|NCT02132117|459670458|FG001|Overall Study|Personal Reasons|2|||
127738869|NCT02132117|459670457|FG000|Overall Study|Other Miscellaneous Reasons|2|||
127738870|NCT02132117|459670458|FG001|Overall Study|Other Miscellaneous Reasons|0|||
127738871|NCT03589300|459670459|FG000|Overall Study|Adverse Event|2|||
127738872|NCT03589300|459670459|FG000|Overall Study|Death|4|||
127738873|NCT03589300|459670459|FG000|Overall Study|Lost to Follow-up|12|||
127738874|NCT03589300|459670459|FG000|Overall Study|Withdrawal by Subject|5|||
127738875|NCT01020747|459670464|FG000|Overall Study|Withdrawal by Subject|1|||
127738876|NCT01222078|459670465|FG000|Overall Study|Early termination of the study|1|||
127738877|NCT02970305|459670466|FG000|Overall Study|Adverse Event|10|||
127738878|NCT02970305|459670467|FG001|Overall Study|Adverse Event|6|||
127738879|NCT02970305|459670466|FG000|Overall Study|Lack of Efficacy|1|||
127738880|NCT02970305|459670467|FG001|Overall Study|Lack of Efficacy|1|||
127738881|NCT02970305|459670466|FG000|Overall Study|Noncompliance with study drug|2|||
127738882|NCT02970305|459670467|FG001|Overall Study|Noncompliance with study drug|4|||
127738883|NCT02970305|459670466|FG000|Overall Study|Protocol Violation|2|||
127738884|NCT02970305|459670467|FG001|Overall Study|Protocol Violation|2|||
127738885|NCT02970305|459670466|FG000|Overall Study|Withdrawal by Subject|12|||
127738886|NCT02970305|459670467|FG001|Overall Study|Withdrawal by Subject|11|||
127738887|NCT02970305|459670466|FG000|Overall Study|Not further specified|1|||
127738888|NCT02970305|459670467|FG001|Overall Study|Not further specified|2|||
127738889|NCT02970305|459670466|FG000|Overall Study|Lost to Follow-up|1|||
127738890|NCT02970305|459670467|FG001|Overall Study|Lost to Follow-up|2|||
127738891|NCT00983892|459670468|FG000|Overall Study|Withdrawal by Subject|10|||
127738892|NCT00983892|459670469|FG001|Overall Study|Withdrawal by Subject|12|||
127738893|NCT00808899|459670470|FG000|Overall Study|Death|1|||
127738894|NCT00808899|459670470|FG000|Overall Study|Physician Decision|3|||
127738895|NCT01225159|459670471|FG000|Overall Study|Change operation|1|||
127738896|NCT01225159|459670472|FG001|Overall Study|Change operation|0|||
127738897|NCT01592383|459670473|FG000|Overall Study|Adverse Event|1|||
127738898|NCT01904136|459672288|FG000|Overall Study|Physician Decision|0|||
127738899|NCT01904136|459672289|FG001|Overall Study|Physician Decision|0|||
127738900|NCT01904136|459672290|FG002|Overall Study|Physician Decision|0|||
127738901|NCT01904136|459672291|FG003|Overall Study|Physician Decision|0|||
127738902|NCT01904136|459672292|FG004|Overall Study|Physician Decision|0|||
127738903|NCT01904136|459672293|FG005|Overall Study|Physician Decision|1|||
127738904|NCT01904136|459672294|FG006|Overall Study|Physician Decision|0|||
127738905|NCT01904136|459672295|FG007|Overall Study|Physician Decision|0|||
127738906|NCT01904136|459672296|FG008|Overall Study|Physician Decision|0|||
127738907|NCT00853372|459672297|FG000|Overall Study|Death|30|||
127738908|NCT00853372|459672298|FG001|Overall Study|Death|26|||
127738909|NCT00853372|459672297|FG000|Overall Study|Lost to Follow-up|1|||
127738910|NCT00853372|459672298|FG001|Overall Study|Lost to Follow-up|2|||
127738911|NCT00853372|459672297|FG000|Overall Study|Full Consent Withdrawn|1|||
127738912|NCT00853372|459672298|FG001|Overall Study|Full Consent Withdrawn|1|||
127738913|NCT01268098|459672301|FG000|Overall Study|Adverse Event|1|||
127738914|NCT01268098|459672302|FG001|Overall Study|Adverse Event|0|||
127738915|NCT01929876|459672304|FG000|Period 2|Non-Compliance|1|||
127738916|NCT01845649|459672305|FG000|Overall Study|Adverse Event|7|||
127738917|NCT01845649|459672306|FG001|Overall Study|Adverse Event|10|||
127738918|NCT01845649|459672305|FG000|Overall Study|Lack of Efficacy|1|||
127892893|NCT01098240|460229667|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
127738919|NCT01845649|459672306|FG001|Overall Study|Lack of Efficacy|1|||
127738920|NCT01845649|459672305|FG000|Overall Study|Lost to Follow-up|2|||
127738921|NCT01845649|459672306|FG001|Overall Study|Lost to Follow-up|2|||
127738922|NCT01845649|459672305|FG000|Overall Study|Withdrew Consent|12|||
127738923|NCT01845649|459672306|FG001|Overall Study|Withdrew Consent|4|||
127738924|NCT01845649|459672305|FG000|Overall Study|Protocol Deviation|7|||
127738925|NCT01845649|459672306|FG001|Overall Study|Protocol Deviation|4|||
127738926|NCT01845649|459672305|FG000|Overall Study|Reason not Specified|2|||
127738927|NCT01845649|459672306|FG001|Overall Study|Reason not Specified|1|||
127738928|NCT03991988|459672307|FG000|Overall Study|Withdrawal by Subject|2|||
127738929|NCT03991988|459672308|FG001|Overall Study|Withdrawal by Subject|2|||
127738930|NCT01222533|459672310|FG000|Overall Study|Adverse Event|5|||
127892894|NCT01098240|460229668|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
127738931|NCT01222533|459672310|FG000|Overall Study|Withdrawal by Subject|5|||
127738932|NCT01222533|459672310|FG000|Overall Study|Other|4|||
127738933|NCT01947517|459672311|FG000|Overall Study|Withdrawal by Subject|1|||
127738934|NCT01947517|459672312|FG001|Overall Study|Withdrawal by Subject|1|||
127738935|NCT00526097|459672316|FG000|Overall Study|Adverse Event|6|||
127738936|NCT00526097|459672317|FG001|Overall Study|Adverse Event|44|||
127738937|NCT00526097|459672316|FG000|Overall Study|Protocol Violation|4|||
127738938|NCT00526097|459672317|FG001|Overall Study|Protocol Violation|10|||
127738939|NCT00526097|459672316|FG000|Overall Study|Withdrawal by Subject|3|||
127738940|NCT00526097|459672317|FG001|Overall Study|Withdrawal by Subject|1|||
127738941|NCT00526097|459672316|FG000|Overall Study|Other|2|||
127738942|NCT00526097|459672317|FG001|Overall Study|Other|1|||
127738943|NCT00460564|459672318|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
127738944|NCT00460564|459672319|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
127738945|NCT00460564|459672320|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
127738946|NCT00460564|459672321|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
127738947|NCT00460564|459672322|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
127738948|NCT00460564|459672323|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
127738949|NCT00460564|459672324|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
127738950|NCT00460564|459672325|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
127738951|NCT00460564|459672318|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
127738952|NCT00460564|459672319|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
127738953|NCT00460564|459672320|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
127738954|NCT00460564|459672321|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
127738955|NCT00460564|459672322|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
127738956|NCT00460564|459672323|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
127738957|NCT00460564|459672324|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
127738958|NCT00460564|459672325|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
127738959|NCT00460564|459672318|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
127738960|NCT00460564|459672319|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
127738961|NCT00460564|459672320|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
127738962|NCT00460564|459672321|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
127738963|NCT00460564|459672322|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
127738964|NCT00460564|459672323|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
127738965|NCT00460564|459672324|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
127738966|NCT00460564|459672325|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
127738967|NCT00460564|459672318|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
127738968|NCT00460564|459672319|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
127738969|NCT00460564|459672320|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
127738970|NCT00460564|459672321|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
127738971|NCT00460564|459672322|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
127738972|NCT00460564|459672323|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
127738973|NCT00460564|459672324|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
127738974|NCT00460564|459672325|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
127738975|NCT00460564|459672318|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
127738976|NCT00460564|459672319|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
127738977|NCT00460564|459672320|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
127738978|NCT00460564|459672321|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
127738979|NCT00460564|459672322|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
127738980|NCT00460564|459672323|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
127738981|NCT00460564|459672324|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
127738982|NCT00460564|459672325|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
127738983|NCT02412111|459672340|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
127738984|NCT02412111|459672341|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
127738985|NCT02412111|459672342|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
127738986|NCT02412111|459672340|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
127738987|NCT02412111|459672341|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
127738988|NCT02412111|459672342|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
127738989|NCT02412111|459672340|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
127738990|NCT02412111|459672341|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
127738991|NCT02412111|459672342|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
127738992|NCT02412111|459672340|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
127738993|NCT02412111|459672341|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
127738994|NCT02412111|459672342|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
127738995|NCT02412111|459672340|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
127738996|NCT02412111|459672341|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
127738997|NCT02412111|459672342|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
127738998|NCT02412111|459672340|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
127738999|NCT02412111|459672341|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
127806665|NCT00896532|459913526|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
127806666|NCT00896532|459913527|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
127739000|NCT02412111|459672342|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
127739001|NCT02412111|459672340|FG000|Active Comparator Period (8 Weeks)|Other|0|||
127739002|NCT02412111|459672341|FG001|Active Comparator Period (8 Weeks)|Other|0|||
127739003|NCT02412111|459672342|FG002|Active Comparator Period (8 Weeks)|Other|2|||
127739004|NCT00487552|459672343|FG000|Overall Study|Unsuccessful magnet placements|3|||
127739005|NCT00487552|459672343|FG000|Overall Study|Death due to progressive malignancy|2|||
127739006|NCT00487552|459672343|FG000|Overall Study|Stent not placed|1|||
127739007|NCT04349644|459672344|FG000|Allocation/Pretest|Lost to pretest|0|||
127739008|NCT04349644|459672345|FG001|Allocation/Pretest|Lost to pretest|3|||
127739009|NCT04349644|459672344|FG000|Posttest|Lost to posttest|0|||
127739010|NCT04349644|459672345|FG001|Posttest|Lost to posttest|8|||
127739011|NCT04349644|459672344|FG000|Posttest|Discontinued intervention|6|||
127739012|NCT04349644|459672345|FG001|Posttest|Discontinued intervention|0|||
127739013|NCT04349644|459672344|FG000|Follow-up|Lost to Follow-up|0|||
127739014|NCT04349644|459672345|FG001|Follow-up|Lost to Follow-up|2|||
127739015|NCT00983905|459672346|FG000|Theophylline Alone|Adverse Event|1|||
127892895|NCT01098240|460229669|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
127892896|NCT01098240|460229667|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
127739016|NCT00983905|459672346|FG000|Colchicine Alone|Adverse Event|2|||
127739017|NCT01114139|459672347|FG000|Overall Study|Adverse Event|3|||
127739018|NCT01114139|459672348|FG001|Overall Study|Adverse Event|2|||
127739019|NCT01114139|459672347|FG000|Overall Study|Lost to Follow-up|15|||
127739020|NCT01114139|459672348|FG001|Overall Study|Lost to Follow-up|3|||
127739021|NCT01114139|459672347|FG000|Overall Study|Withdrawal by Subject|17|||
127739022|NCT01114139|459672348|FG001|Overall Study|Withdrawal by Subject|6|||
127739023|NCT01114139|459672347|FG000|Overall Study|Other-Missed 1 visit|1|||
127739024|NCT01114139|459672348|FG001|Overall Study|Other-Missed 1 visit|0|||
127739025|NCT01114139|459672347|FG000|Overall Study|Other-Protocol Violation|1|||
127739026|NCT01114139|459672348|FG001|Overall Study|Other-Protocol Violation|0|||
127739027|NCT01114139|459672347|FG000|Overall Study|Other-Out of window for study drug dose|1|||
127739028|NCT01114139|459672348|FG001|Overall Study|Other-Out of window for study drug dose|0|||
127739029|NCT01114139|459672347|FG000|Overall Study|Other-Participant falsified records|0|||
127739030|NCT01114139|459672348|FG001|Overall Study|Other-Participant falsified records|1|||
127739031|NCT01114139|459672347|FG000|Overall Study|Other-Participant went on hospice|0|||
127739032|NCT01114139|459672348|FG001|Overall Study|Other-Participant went on hospice|1|||
127739033|NCT01114139|459672347|FG000|Overall Study|Other-Physician changed treatment|1|||
127739034|NCT01114139|459672348|FG001|Overall Study|Other-Physician changed treatment|0|||
127739035|NCT01114139|459672347|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
127739036|NCT01114139|459672348|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
127739037|NCT00784147|459672350|FG000|Overall Study|Lost to Follow-up|2|||
127739038|NCT00784147|459672351|FG001|Overall Study|Lost to Follow-up|4|||
127739039|NCT00784147|459672350|FG000|Overall Study|Withdrawal by Subject|1|||
127739040|NCT00784147|459672351|FG001|Overall Study|Withdrawal by Subject|3|||
127739041|NCT00784147|459672350|FG000|Overall Study|Physician Decision|2|||
127739042|NCT00784147|459672351|FG001|Overall Study|Physician Decision|1|||
127739043|NCT00784147|459672350|FG000|Overall Study|Protocol Violation|1|||
127739044|NCT00784147|459672351|FG001|Overall Study|Protocol Violation|1|||
127739045|NCT00784147|459672350|FG000|Overall Study|Death|2|||
127739046|NCT00784147|459672351|FG001|Overall Study|Death|0|||
127739047|NCT02637856|459672352|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
127739048|NCT02637856|459672353|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
127739049|NCT02637856|459672352|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
127739050|NCT02637856|459672353|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
127739051|NCT02637856|459672352|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
127739052|NCT02637856|459672353|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
127739053|NCT02637856|459672352|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
127739054|NCT02637856|459672353|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
127739055|NCT02637856|459672352|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
127739056|NCT02637856|459672353|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
127739057|NCT02637856|459672352|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
127739058|NCT02637856|459672353|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
127739059|NCT02637856|459672352|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
127739060|NCT02637856|459672353|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
127739061|NCT02637856|459672352|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
127739062|NCT02637856|459672353|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
127739063|NCT02637856|459672352|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
127739064|NCT02637856|459672353|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
127739065|NCT02637856|459672352|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
127739066|NCT02637856|459672353|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
127892897|NCT01098240|460229668|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
127739067|NCT02637856|459672352|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
127892898|NCT01098240|460229669|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
127892899|NCT01098240|460229667|FG000|Double-Blind Phase|Adverse Event|0|||
127739068|NCT02637856|459672353|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
127739069|NCT02637856|459672352|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
127739070|NCT02637856|459672353|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
127739071|NCT02637856|459672352|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
127739072|NCT02637856|459672353|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
127739073|NCT01057251|459672354|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
127739074|NCT01057251|459672355|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
127739075|NCT01057251|459672354|FG000|Overall Study|Adverse Event|4|||
127739076|NCT01057251|459672355|FG001|Overall Study|Adverse Event|2|||
127739077|NCT01057251|459672354|FG000|Overall Study|Lack of Efficacy|2|||
127739078|NCT01057251|459672355|FG001|Overall Study|Lack of Efficacy|11|||
127739079|NCT01057251|459672354|FG000|Overall Study|Protocol Violation|6|||
127739080|NCT01057251|459672355|FG001|Overall Study|Protocol Violation|2|||
127739081|NCT01057251|459672354|FG000|Overall Study|Withdrawal by Subject|4|||
127739082|NCT01057251|459672355|FG001|Overall Study|Withdrawal by Subject|5|||
127739083|NCT01057251|459672354|FG000|Overall Study|Lost to Follow-up|7|||
127739084|NCT01057251|459672355|FG001|Overall Study|Lost to Follow-up|6|||
127739085|NCT01057251|459672354|FG000|Overall Study|Other Reason|1|||
127739086|NCT01057251|459672355|FG001|Overall Study|Other Reason|1|||
127739087|NCT04544865|459672359|FG000|Overall Study|Death|0|||
127739088|NCT04544865|459672360|FG001|Overall Study|Death|2|||
127739089|NCT04544865|459672359|FG000|Overall Study|Lost to Follow-up|11|||
127739090|NCT04544865|459672360|FG001|Overall Study|Lost to Follow-up|7|||
127739091|NCT04544865|459672359|FG000|Overall Study|Withdrawal by Subject|0|||
127739092|NCT04544865|459672360|FG001|Overall Study|Withdrawal by Subject|1|||
127739093|NCT04544865|459672359|FG000|Overall Study|Other|0|||
127739094|NCT04544865|459672360|FG001|Overall Study|Other|1|||
127739095|NCT01732926|459672362|FG000|Overall Study|Study Terminated by Sponsor|168|||
127739096|NCT01732926|459672363|FG001|Overall Study|Study Terminated by Sponsor|80|||
127739097|NCT01732926|459672362|FG000|Overall Study|Withdrawal by Subject|46|||
127739098|NCT01732926|459672363|FG001|Overall Study|Withdrawal by Subject|8|||
127739099|NCT01732926|459672362|FG000|Overall Study|Physician Decision|24|||
127739100|NCT01732926|459672363|FG001|Overall Study|Physician Decision|11|||
127739101|NCT01732926|459672362|FG000|Overall Study|Other Reason|21|||
127739102|NCT01732926|459672363|FG001|Overall Study|Other Reason|4|||
127739103|NCT01732926|459672362|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
127739104|NCT01732926|459672363|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
127739105|NCT01732926|459672362|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
127739106|NCT01732926|459672363|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
127739107|NCT02262364|459672365|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
127739108|NCT01049984|459672366|FG000|Overall Study|Withdrawal by Subject|1|||
127739109|NCT01049984|459672367|FG001|Overall Study|Withdrawal by Subject|5|||
127739110|NCT01049984|459672366|FG000|Overall Study|Protocol Violation|3|||
127739111|NCT01049984|459672367|FG001|Overall Study|Protocol Violation|4|||
127739112|NCT01049984|459672366|FG000|Overall Study|Lost to Follow-up|2|||
127739113|NCT01049984|459672367|FG001|Overall Study|Lost to Follow-up|1|||
127739114|NCT01049984|459672366|FG000|Overall Study|Adverse Event|13|||
127739115|NCT01049984|459672367|FG001|Overall Study|Adverse Event|7|||
127739116|NCT01049984|459672366|FG000|Overall Study|Treatment failure|0|||
127739117|NCT01049984|459672367|FG001|Overall Study|Treatment failure|2|||
127739118|NCT02287883|459672372|FG000|Overall Study|Death|8|||
127739119|NCT02287883|459672373|FG001|Overall Study|Death|7|||
127806667|NCT00896532|459913528|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
127806668|NCT00896532|459913529|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
127806669|NCT00896532|459913530|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
127806670|NCT00896532|459913531|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
127806671|NCT00896532|459913532|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
127806672|NCT00896532|459913533|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
127806673|NCT00896532|459913534|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
127806674|NCT00896532|459913535|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
127806675|NCT00896532|459913536|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
127806676|NCT00896532|459913537|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
127806677|NCT00896532|459913538|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
127806678|NCT00896532|459913539|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
127806679|NCT00896532|459913540|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
127806680|NCT00896532|459913541|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
127806681|NCT00896532|459913542|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
127806682|NCT00896532|459913543|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
127892900|NCT01098240|460229668|FG001|Double-Blind Phase|Adverse Event|3|||
127739120|NCT02287883|459672372|FG000|Overall Study|No longer eligible|222|||
127739121|NCT02287883|459672373|FG001|Overall Study|No longer eligible|182|||
127739122|NCT02287883|459672372|FG000|Overall Study|Non-response to survey|229|||
127739123|NCT02287883|459672373|FG001|Overall Study|Non-response to survey|237|||
127739124|NCT00802438|459672374|FG000|Overall Study|Screen Failure|20|||
127739125|NCT00802438|459672374|FG000|Overall Study|Withdrawal by Subject|7|||
127739126|NCT00802438|459672374|FG000|Overall Study|Physician Decision|1|||
127739127|NCT03175198|459672375|FG000|Overall Study|Adverse Event|480|||
127739128|NCT03175198|459672375|FG000|Overall Study|No actual visit|120|||
127739129|NCT03175198|459672375|FG000|Overall Study|Registration rule not followed|4|||
127739130|NCT03175198|459672375|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
127739131|NCT03175198|459672375|FG000|Overall Study|Other personal reason|509|||
127739132|NCT03175198|459672375|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
127739133|NCT03175198|459672375|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
127739134|NCT03175198|459672375|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
127739135|NCT03175198|459672375|FG000|Overall Study|To conduct invasive treatment of operation|53|||
127739136|NCT03175198|459672375|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
127739137|NCT00363649|459672377|FG000|Overall Study|Withdrawal by Subject|1|||
127739138|NCT00363649|459672378|FG001|Overall Study|Withdrawal by Subject|1|||
127806683|NCT00896532|459913544|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
127806684|NCT00896532|459913545|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
127806685|NCT00896532|459913546|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
127806686|NCT00896532|459913524|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
127892901|NCT01098240|460229669|FG002|Double-Blind Phase|Adverse Event|3|||
127892902|NCT01070394|460229670|FG000|Overall Study|Adverse Event|6|||
127892903|NCT01070394|460229670|FG000|Overall Study|Withdrawal by Subject|1|||
127892904|NCT03280537|460229671|FG000|Overall Study|Withdrawal by Subject|2|||
127892905|NCT03280537|460229672|FG001|Overall Study|Withdrawal by Subject|4|||
127892906|NCT01588106|460229673|FG000|Overall Study|Withdrawal by Subject|5|||
127892907|NCT01588106|460229674|FG001|Overall Study|Withdrawal by Subject|4|||
127892908|NCT03083132|460229675|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
127892909|NCT03083132|460229676|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
127892910|NCT03083132|460229675|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
127892911|NCT03083132|460229676|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
127892912|NCT03083132|460229675|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
127892913|NCT03083132|460229676|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
127892914|NCT03118739|460229677|FG000|Overall Study|Physician Decision|0|||
127892915|NCT03118739|460229678|FG001|Overall Study|Physician Decision|1|||
127892916|NCT03118739|460229677|FG000|Overall Study|Withdrawal by Subject|5|||
127892917|NCT03118739|460229678|FG001|Overall Study|Withdrawal by Subject|3|||
127892918|NCT03118739|460229677|FG000|Overall Study|Lost to Follow-up|2|||
127892919|NCT03118739|460229678|FG001|Overall Study|Lost to Follow-up|0|||
127892920|NCT00669955|460229679|FG000|Overall Study|Adverse Event|3|||
127892921|NCT00669955|460229680|FG001|Overall Study|Adverse Event|5|||
127892922|NCT00669955|460229679|FG000|Overall Study|Death|0|||
127892923|NCT00669955|460229680|FG001|Overall Study|Death|1|||
127892924|NCT00669955|460229679|FG000|Overall Study|Withdrawal by Subject|2|||
127892925|NCT00669955|460229680|FG001|Overall Study|Withdrawal by Subject|3|||
127892926|NCT00669955|460229679|FG000|Overall Study|Lost to Follow-up|5|||
127892927|NCT00669955|460229680|FG001|Overall Study|Lost to Follow-up|7|||
127892928|NCT00669955|460229679|FG000|Overall Study|Protocol Violation|2|||
127892929|NCT00669955|460229680|FG001|Overall Study|Protocol Violation|7|||
127892930|NCT00669955|460229679|FG000|Overall Study|Investigator Sponsor Judgement|0|||
127892931|NCT00669955|460229680|FG001|Overall Study|Investigator Sponsor Judgement|1|||
127892932|NCT00669955|460229679|FG000|Overall Study|not compliant with study drug/visit|2|||
127892933|NCT00669955|460229680|FG001|Overall Study|not compliant with study drug/visit|3|||
127892934|NCT03507439|460229685|FG000|Overall Study|Other|2|||
127892935|NCT03507439|460229686|FG001|Overall Study|Other|1|||
127892936|NCT03507439|460229685|FG000|Overall Study|Withdrawal by Subject|1|||
127892937|NCT03507439|460229686|FG001|Overall Study|Withdrawal by Subject|0|||
127892938|NCT03507439|460229685|FG000|Overall Study|Death|1|||
127806687|NCT00896532|459913525|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
127806688|NCT00896532|459913526|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
127806689|NCT00896532|459913527|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
127806690|NCT00896532|459913528|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
127806691|NCT00896532|459913529|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
127806692|NCT00896532|459913530|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
127806693|NCT00896532|459913531|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
127892939|NCT03507439|460229686|FG001|Overall Study|Death|1|||
127892940|NCT04274192|460229687|FG000|Overall Study|Protocol Violation|1|||
127739139|NCT00363649|459672377|FG000|Overall Study|Adverse Event|6|||
127892941|NCT04274192|460229688|FG001|Overall Study|Protocol Violation|0|||
127892942|NCT01621490|460231281|FG000|Overall Study|Subject no longer meets study criteria|0|||
127892943|NCT01621490|460231282|FG001|Overall Study|Subject no longer meets study criteria|0|||
127892944|NCT01621490|460231283|FG002|Overall Study|Subject no longer meets study criteria|0|||
127892945|NCT01621490|460231284|FG003|Overall Study|Subject no longer meets study criteria|0|||
127739140|NCT00363649|459672378|FG001|Overall Study|Adverse Event|0|||
127739141|NCT03188536|459672379|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
127739142|NCT03188536|459672379|FG000|Overall Study|Not participated/met inclusion criteria|1|||
127739143|NCT02161185|459672383|FG000|Treatment Phase|Administrative/Other|7|||
127739144|NCT00372255|459672384|FG000|Overall Study|Withdrawn for other reasons|2|||
127739145|NCT00372255|459672385|FG001|Overall Study|Withdrawn for other reasons|1|||
127739146|NCT03120949|459672392|FG000|Overall Study|randomized in error|1|||
127739147|NCT03120949|459672393|FG001|Overall Study|randomized in error|0|||
127739148|NCT03120949|459672392|FG000|Overall Study|Death|13|||
127739149|NCT03120949|459672393|FG001|Overall Study|Death|13|||
127739150|NCT03120949|459672392|FG000|Overall Study|Lost to Follow-up|23|||
127739151|NCT03120949|459672393|FG001|Overall Study|Lost to Follow-up|13|||
127739152|NCT03120949|459672392|FG000|Overall Study|Withdrawal by Subject|139|||
127739153|NCT03120949|459672393|FG001|Overall Study|Withdrawal by Subject|124|||
127739154|NCT03120949|459672392|FG000|Overall Study|Covid-19|43|||
127739155|NCT03120949|459672393|FG001|Overall Study|Covid-19|34|||
127739156|NCT03120949|459672392|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
127739157|NCT03120949|459672393|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
127739158|NCT03120949|459672392|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
127739159|NCT03120949|459672393|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
127739160|NCT03120949|459672392|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
127739161|NCT03120949|459672393|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
127739162|NCT03120949|459672392|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
127739163|NCT03120949|459672393|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
127739164|NCT03120949|459672392|FG000|Overall Study|Site was closed|2|||
127739165|NCT03120949|459672393|FG001|Overall Study|Site was closed|3|||
127739166|NCT03120949|459672392|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
127739167|NCT03120949|459672393|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
127739168|NCT03120949|459672392|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
127739169|NCT03120949|459672393|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
127739170|NCT03120949|459672392|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
127739171|NCT03120949|459672393|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
127739172|NCT03120949|459672392|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
127739173|NCT03120949|459672393|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
127739174|NCT03120949|459672392|FG000|Overall Study|Other: Adverse Event|0|||
127892946|NCT01621490|460231285|FG004|Overall Study|Subject no longer meets study criteria|1|||
127892947|NCT01621490|460231286|FG005|Overall Study|Subject no longer meets study criteria|0|||
127892948|NCT01621490|460231287|FG006|Overall Study|Subject no longer meets study criteria|0|||
127892949|NCT01621490|460231288|FG007|Overall Study|Subject no longer meets study criteria|0|||
127892950|NCT01621490|460231289|FG008|Overall Study|Subject no longer meets study criteria|0|||
127892951|NCT01621490|460231290|FG009|Overall Study|Subject no longer meets study criteria|0|||
127892952|NCT01621490|460231291|FG010|Overall Study|Subject no longer meets study criteria|0|||
127892953|NCT01621490|460231281|FG000|Overall Study|Maximum clinical benefit|3|||
127892954|NCT01621490|460231282|FG001|Overall Study|Maximum clinical benefit|2|||
127892955|NCT01621490|460231283|FG002|Overall Study|Maximum clinical benefit|0|||
127892956|NCT01621490|460231284|FG003|Overall Study|Maximum clinical benefit|0|||
127806694|NCT00896532|459913532|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
127806695|NCT00896532|459913533|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
127806696|NCT00896532|459913534|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
127806697|NCT00896532|459913535|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
127806698|NCT00896532|459913536|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
127806699|NCT00896532|459913537|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
127806700|NCT00896532|459913538|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
127806701|NCT00896532|459913539|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
127806702|NCT00896532|459913540|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
127806703|NCT00896532|459913541|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
127806704|NCT00896532|459913542|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
127806705|NCT00896532|459913543|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
127806706|NCT00896532|459913544|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
127806707|NCT00896532|459913545|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
127806708|NCT00896532|459913546|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
127806709|NCT00896532|459913524|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
127892957|NCT01621490|460231285|FG004|Overall Study|Maximum clinical benefit|0|||
127892958|NCT01621490|460231286|FG005|Overall Study|Maximum clinical benefit|0|||
127892959|NCT01621490|460231287|FG006|Overall Study|Maximum clinical benefit|1|||
127892960|NCT01621490|460231288|FG007|Overall Study|Maximum clinical benefit|2|||
127892961|NCT01621490|460231289|FG008|Overall Study|Maximum clinical benefit|2|||
127892962|NCT01621490|460231290|FG009|Overall Study|Maximum clinical benefit|0|||
127892963|NCT01621490|460231291|FG010|Overall Study|Maximum clinical benefit|0|||
127739175|NCT03120949|459672393|FG001|Overall Study|Other: Adverse Event|1|||
127739176|NCT03120949|459672392|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
127739177|NCT03120949|459672393|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
127739178|NCT03120949|459672392|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
127739179|NCT03120949|459672393|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
127739180|NCT03120949|459672392|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
127739181|NCT03120949|459672393|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
127739182|NCT03120949|459672392|FG000|Overall Study|Personal Reasons|0|||
127739183|NCT03120949|459672393|FG001|Overall Study|Personal Reasons|1|||
127739184|NCT03120949|459672392|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
127739185|NCT03120949|459672393|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
127739186|NCT03120949|459672392|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
127739187|NCT03120949|459672393|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
127739188|NCT03120949|459672392|FG000|Overall Study|Compliance With Medication|0|||
127739189|NCT03120949|459672393|FG001|Overall Study|Compliance With Medication|1|||
127739190|NCT03120949|459672392|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
127739191|NCT03120949|459672393|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
127739192|NCT03120949|459672392|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
127739193|NCT03120949|459672393|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
127739194|NCT03120949|459672392|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
127739195|NCT03120949|459672393|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
127739196|NCT00988117|459672394|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
127739197|NCT00988117|459672394|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
127739198|NCT00312845|459672395|FG000|Overall Study|Adverse Event|19|||
127739199|NCT00312845|459672396|FG001|Overall Study|Adverse Event|5|||
127739200|NCT00312845|459672395|FG000|Overall Study|Death|2|||
127739201|NCT00312845|459672396|FG001|Overall Study|Death|2|||
127739202|NCT00312845|459672395|FG000|Overall Study|Withdrawal by Subject|14|||
127739203|NCT00312845|459672396|FG001|Overall Study|Withdrawal by Subject|6|||
127739204|NCT00312845|459672395|FG000|Overall Study|Disease Progression|56|||
127739205|NCT00312845|459672396|FG001|Overall Study|Disease Progression|77|||
127739206|NCT00312845|459672395|FG000|Overall Study|Lost to Follow-up|2|||
127739207|NCT00312845|459672396|FG001|Overall Study|Lost to Follow-up|0|||
127739208|NCT00312845|459672395|FG000|Overall Study|Other|6|||
127739209|NCT00312845|459672396|FG001|Overall Study|Other|5|||
127739210|NCT01220856|459672397|FG000|Overall Study|graft loss|3|||
127739211|NCT01220856|459672398|FG001|Overall Study|graft loss|3|||
127739212|NCT01220856|459672397|FG000|Overall Study|Lost to Follow-up|1|||
127739213|NCT01220856|459672398|FG001|Overall Study|Lost to Follow-up|0|||
127739214|NCT04088500|459672399|FG000|Overall Study|Reason unknown|1|||
127739215|NCT04088500|459672399|FG000|Overall Study|Participant withdrew consent|1|||
127739216|NCT04088500|459672399|FG000|Overall Study|Disease progression|3|||
127739217|NCT01078584|459672402|FG000|Overall Study|Final Status Unknown|1073|||
127739218|NCT01078584|459672402|FG000|Overall Study|Lost to Follow-up|670|||
127739219|NCT01078584|459672402|FG000|Overall Study|Non-serious Adverse Event|577|||
127739220|NCT01078584|459672402|FG000|Overall Study|Withdrawal of Consent|244|||
127739221|NCT01078584|459672402|FG000|Overall Study|Physician Withdrew from Study|90|||
127739222|NCT01078584|459672402|FG000|Overall Study|Non-compliance|67|||
127739223|NCT01078584|459672402|FG000|Overall Study|Blood Pressure Controlled|49|||
127739224|NCT01078584|459672402|FG000|Overall Study|Physician Switched Medication|26|||
127739225|NCT01078584|459672402|FG000|Overall Study|Physician Discontinued Patient|12|||
127806710|NCT00896532|459913525|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
127806711|NCT00896532|459913526|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
127806712|NCT00896532|459913527|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
127806713|NCT00896532|459913528|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
127806714|NCT00896532|459913529|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
127806715|NCT00896532|459913530|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
127806716|NCT00896532|459913531|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
127806717|NCT00896532|459913532|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
127806718|NCT00896532|459913533|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
127892964|NCT01621490|460231281|FG000|Overall Study|Withdrawal by Subject|1|||
127892965|NCT01621490|460231282|FG001|Overall Study|Withdrawal by Subject|0|||
127739226|NCT01078584|459672402|FG000|Overall Study|Lack of Efficacy|98|||
127739227|NCT01078584|459672402|FG000|Overall Study|Protocol Violation|75|||
127739228|NCT01078584|459672402|FG000|Overall Study|Serious Adverse Event|27|||
127739229|NCT01078584|459672402|FG000|Overall Study|Multiple Reasons|2|||
127739230|NCT01208870|459672403|FG000|Overall Study|Lost to Follow-up|2|||
127739231|NCT01208870|459672404|FG001|Overall Study|Lost to Follow-up|8|||
127739232|NCT00496834|459672405|FG000|Overall Study|Withdrawal by Subject|4|||
127739233|NCT00496834|459672406|FG001|Overall Study|Withdrawal by Subject|6|||
127739234|NCT00496834|459672405|FG000|Overall Study|Contraindicated medication administered|0|||
127739235|NCT00496834|459672406|FG001|Overall Study|Contraindicated medication administered|1|||
127739236|NCT00496834|459672405|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
127739237|NCT00496834|459672406|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
127739238|NCT00496834|459672405|FG000|Overall Study|Adverse Event|5|||
127739239|NCT00496834|459672406|FG001|Overall Study|Adverse Event|3|||
127739240|NCT00496834|459672405|FG000|Overall Study|IP administration violation|2|||
127739241|NCT00496834|459672406|FG001|Overall Study|IP administration violation|0|||
127806719|NCT00896532|459913534|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
127806720|NCT00896532|459913535|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
127806721|NCT00896532|459913536|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
127806722|NCT00896532|459913537|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
127892966|NCT01621490|460231283|FG002|Overall Study|Withdrawal by Subject|0|||
127892967|NCT01621490|460231284|FG003|Overall Study|Withdrawal by Subject|0|||
127892968|NCT01621490|460231285|FG004|Overall Study|Withdrawal by Subject|0|||
127892969|NCT01621490|460231286|FG005|Overall Study|Withdrawal by Subject|1|||
127892970|NCT01621490|460231287|FG006|Overall Study|Withdrawal by Subject|0|||
127892971|NCT01621490|460231288|FG007|Overall Study|Withdrawal by Subject|0|||
127739242|NCT00496834|459672405|FG000|Overall Study|Lost to Follow-up|2|||
127892972|NCT01621490|460231289|FG008|Overall Study|Withdrawal by Subject|0|||
127892973|NCT01621490|460231290|FG009|Overall Study|Withdrawal by Subject|0|||
127892974|NCT01621490|460231291|FG010|Overall Study|Withdrawal by Subject|0|||
127892975|NCT01621490|460231281|FG000|Overall Study|Subject request to discontinue study|1|||
127892976|NCT01621490|460231282|FG001|Overall Study|Subject request to discontinue study|3|||
127739243|NCT00496834|459672406|FG001|Overall Study|Lost to Follow-up|0|||
127739244|NCT00496834|459672405|FG000|Overall Study|Blood Pressure control failure|2|||
127806723|NCT00896532|459913538|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
127806724|NCT00896532|459913539|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
127806725|NCT00896532|459913540|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
127806726|NCT00896532|459913541|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
127806727|NCT00896532|459913542|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
127806728|NCT00896532|459913543|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
127806729|NCT00896532|459913544|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
127806730|NCT00896532|459913545|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
127806731|NCT00896532|459913546|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
127806732|NCT00896532|459913524|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
127806733|NCT00896532|459913525|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
127806734|NCT00896532|459913526|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
127806735|NCT00896532|459913527|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
127806736|NCT00896532|459913528|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
127806737|NCT00896532|459913529|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
127806738|NCT00896532|459913530|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
127806739|NCT00896532|459913531|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
127806740|NCT00896532|459913532|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
127806741|NCT00896532|459913533|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
127806742|NCT00896532|459913534|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
127739245|NCT00496834|459672406|FG001|Overall Study|Blood Pressure control failure|1|||
127739246|NCT01227928|459672407|FG000|Overall Study|Lost to Follow-up|4|||
127739247|NCT01227928|459672408|FG001|Overall Study|Lost to Follow-up|2|||
127892977|NCT01621490|460231283|FG002|Overall Study|Subject request to discontinue study|1|||
127892978|NCT01621490|460231284|FG003|Overall Study|Subject request to discontinue study|1|||
127739248|NCT01227928|459672407|FG000|Overall Study|Withdrawal by Subject|4|||
127739249|NCT01227928|459672408|FG001|Overall Study|Withdrawal by Subject|3|||
127739250|NCT01227928|459672407|FG000|Overall Study|Death|14|||
127739251|NCT01227928|459672408|FG001|Overall Study|Death|12|||
127739252|NCT01494298|459672411|FG000|Overall Study|Protocol Violation|2|||
127739253|NCT01494298|459672412|FG001|Overall Study|Protocol Violation|8|||
127739254|NCT04159805|459672413|FG000|Overall Study|Withdrawal by Subject|0|||
127739255|NCT04159805|459672414|FG001|Overall Study|Withdrawal by Subject|2|||
127739256|NCT04159805|459672415|FG002|Overall Study|Withdrawal by Subject|2|||
127739257|NCT01393613|459672416|FG000|Overall Study|Adverse Event|11|||
127739258|NCT01393613|459672417|FG001|Overall Study|Adverse Event|11|||
127739259|NCT01393613|459672418|FG002|Overall Study|Adverse Event|13|||
127739260|NCT01393613|459672419|FG003|Overall Study|Adverse Event|22|||
127739261|NCT01393613|459672416|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
127739262|NCT01393613|459672417|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
127739263|NCT01393613|459672418|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
127739264|NCT01393613|459672419|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
127739265|NCT01393613|459672416|FG000|Overall Study|Physician Decision|2|||
127739266|NCT01393613|459672417|FG001|Overall Study|Physician Decision|0|||
127739267|NCT01393613|459672418|FG002|Overall Study|Physician Decision|0|||
127739268|NCT01393613|459672419|FG003|Overall Study|Physician Decision|1|||
127739269|NCT01393613|459672416|FG000|Overall Study|Withdrawal by Subject|15|||
127739270|NCT01393613|459672417|FG001|Overall Study|Withdrawal by Subject|25|||
127739271|NCT01393613|459672418|FG002|Overall Study|Withdrawal by Subject|23|||
127739272|NCT01393613|459672419|FG003|Overall Study|Withdrawal by Subject|21|||
127739273|NCT01393613|459672416|FG000|Overall Study|Protocol Deviation|2|||
127739274|NCT01393613|459672417|FG001|Overall Study|Protocol Deviation|1|||
127739275|NCT01393613|459672418|FG002|Overall Study|Protocol Deviation|0|||
127739276|NCT01393613|459672419|FG003|Overall Study|Protocol Deviation|0|||
127739277|NCT01393613|459672416|FG000|Overall Study|Lack of Efficacy|9|||
127739278|NCT01393613|459672417|FG001|Overall Study|Lack of Efficacy|20|||
127739279|NCT01393613|459672418|FG002|Overall Study|Lack of Efficacy|16|||
127739280|NCT01393613|459672419|FG003|Overall Study|Lack of Efficacy|21|||
127739281|NCT03821064|459672420|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
127739282|NCT01283971|459672425|FG000|Overall Study|Adverse Event|3|||
127739283|NCT01283971|459672426|FG001|Overall Study|Adverse Event|5|||
127739284|NCT01283971|459672425|FG000|Overall Study|Insufficient therapeutic responses|3|||
127739285|NCT01283971|459672426|FG001|Overall Study|Insufficient therapeutic responses|3|||
127739286|NCT01283971|459672425|FG000|Overall Study|Protocol Violation|5|||
127739287|NCT01283971|459672426|FG001|Overall Study|Protocol Violation|1|||
127739288|NCT01283971|459672425|FG000|Overall Study|Refused treatment|3|||
127739289|NCT01283971|459672426|FG001|Overall Study|Refused treatment|1|||
127739290|NCT01283971|459672425|FG000|Overall Study|Failure to return|0|||
127739291|NCT01283971|459672426|FG001|Overall Study|Failure to return|1|||
127739292|NCT01283971|459672425|FG000|Overall Study|Administrative reasons|1|||
127739293|NCT01283971|459672426|FG001|Overall Study|Administrative reasons|1|||
127739294|NCT02598934|459672435|FG000|Overall Study|Adverse Event|11|||
127739295|NCT02598934|459672436|FG001|Overall Study|Adverse Event|13|||
127739296|NCT02598934|459672435|FG000|Overall Study|Failure to Return|3|||
127739297|NCT02598934|459672436|FG001|Overall Study|Failure to Return|3|||
127739298|NCT02598934|459672435|FG000|Overall Study|Withdrawal by Subject|2|||
127739299|NCT02598934|459672436|FG001|Overall Study|Withdrawal by Subject|3|||
127739300|NCT02598934|459672435|FG000|Overall Study|Administrative|2|||
127739301|NCT02598934|459672436|FG001|Overall Study|Administrative|1|||
127739302|NCT02598934|459672435|FG000|Overall Study|Protocol Violation|1|||
127739303|NCT02598934|459672436|FG001|Overall Study|Protocol Violation|2|||
127739304|NCT03325608|459672439|FG000|Overall Study|Lost to Follow-up|23|||
127739305|NCT03325608|459672440|FG001|Overall Study|Lost to Follow-up|23|||
127739306|NCT03325608|459672441|FG002|Overall Study|Lost to Follow-up|30|||
127739307|NCT03325608|459672442|FG003|Overall Study|Lost to Follow-up|30|||
127739308|NCT03325608|459672439|FG000|Overall Study|Death of Caregiver|0|||
127739309|NCT03325608|459672440|FG001|Overall Study|Death of Caregiver|0|||
127739310|NCT03325608|459672441|FG002|Overall Study|Death of Caregiver|2|||
127739311|NCT03325608|459672442|FG003|Overall Study|Death of Caregiver|2|||
127739312|NCT03325608|459672439|FG000|Overall Study|Death of Care Recipient|34|||
127739313|NCT03325608|459672440|FG001|Overall Study|Death of Care Recipient|34|||
127806743|NCT00896532|459913535|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
127806744|NCT00896532|459913536|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
127739314|NCT03325608|459672441|FG002|Overall Study|Death of Care Recipient|28|||
127739315|NCT03325608|459672442|FG003|Overall Study|Death of Care Recipient|28|||
127739316|NCT03325608|459672439|FG000|Overall Study|Withdrawal by Subject|49|||
127739317|NCT03325608|459672440|FG001|Overall Study|Withdrawal by Subject|49|||
127739318|NCT03325608|459672441|FG002|Overall Study|Withdrawal by Subject|35|||
127739319|NCT03325608|459672442|FG003|Overall Study|Withdrawal by Subject|35|||
127739320|NCT03325608|459672439|FG000|Overall Study|Ineligible|7|||
127739321|NCT03325608|459672440|FG001|Overall Study|Ineligible|7|||
127739322|NCT03325608|459672441|FG002|Overall Study|Ineligible|5|||
127739323|NCT03325608|459672442|FG003|Overall Study|Ineligible|5|||
127739324|NCT02154347|459672443|FG000|Double-blind Period|Adverse Event|1|||
127739325|NCT02154347|459672444|FG001|Double-blind Period|Adverse Event|2|||
127739326|NCT02154347|459672443|FG000|Double-blind Period|Lack of Efficacy|1|||
127739327|NCT02154347|459672444|FG001|Double-blind Period|Lack of Efficacy|0|||
127739328|NCT02154347|459672443|FG000|Double-blind Period|Physician Decision|0|||
127739329|NCT02154347|459672444|FG001|Double-blind Period|Physician Decision|1|||
127739330|NCT02154347|459672443|FG000|Double-blind Period|Withdrawal by Subject|1|||
127739331|NCT02154347|459672444|FG001|Double-blind Period|Withdrawal by Subject|1|||
127739332|NCT02154347|459672443|FG000|Open-label Period|Adverse Event|3|||
127739333|NCT02154347|459672444|FG001|Open-label Period|Adverse Event|4|||
127739334|NCT02154347|459672443|FG000|Open-label Period|Lack of Efficacy|4|||
127739335|NCT02154347|459672444|FG001|Open-label Period|Lack of Efficacy|19|||
127739336|NCT02154347|459672443|FG000|Open-label Period|Protocol Violation|0|||
127739337|NCT02154347|459672444|FG001|Open-label Period|Protocol Violation|1|||
127739338|NCT02154347|459672443|FG000|Open-label Period|Withdrawal by Subject|0|||
127739339|NCT02154347|459672444|FG001|Open-label Period|Withdrawal by Subject|1|||
127739340|NCT02188784|459672445|FG000|Overall Study|Death|3|||
127739341|NCT02188784|459672446|FG001|Overall Study|Death|1|||
127739342|NCT02188784|459672445|FG000|Overall Study|Lost to Follow-up|1|||
127739343|NCT02188784|459672446|FG001|Overall Study|Lost to Follow-up|0|||
127739344|NCT02188784|459672445|FG000|Overall Study|Withdrawal by Subject|3|||
127739345|NCT02188784|459672446|FG001|Overall Study|Withdrawal by Subject|9|||
127739346|NCT02188784|459672445|FG000|Overall Study|Physician Decision|2|||
127739347|NCT02188784|459672446|FG001|Overall Study|Physician Decision|3|||
127739348|NCT02473913|459672447|FG000|Overall Study|Lost to Follow-up|3|||
127739349|NCT02473913|459672448|FG001|Overall Study|Lost to Follow-up|3|||
127739350|NCT01190449|459672452|FG000|Overall Study|Ineligible|0|||
127739351|NCT01190449|459672453|FG001|Overall Study|Ineligible|4|||
127739352|NCT04944784|459672454|FG000|Double-blind Period|Study Terminated by Sponsor|96|||
127739353|NCT04944784|459672455|FG001|Double-blind Period|Study Terminated by Sponsor|46|||
127739354|NCT04944784|459672456|FG002|Double-blind Period|Study Terminated by Sponsor|0|||
127739355|NCT04944784|459672457|FG003|Double-blind Period|Study Terminated by Sponsor|0|||
127739356|NCT04944784|459672454|FG000|Double-blind Period|Adverse Event|20|||
127739357|NCT04944784|459672455|FG001|Double-blind Period|Adverse Event|4|||
127739358|NCT04944784|459672456|FG002|Double-blind Period|Adverse Event|0|||
127739359|NCT04944784|459672457|FG003|Double-blind Period|Adverse Event|0|||
127739360|NCT04944784|459672454|FG000|Double-blind Period|Withdrawal by Subject|15|||
127739361|NCT04944784|459672455|FG001|Double-blind Period|Withdrawal by Subject|4|||
127739362|NCT04944784|459672456|FG002|Double-blind Period|Withdrawal by Subject|0|||
127739363|NCT04944784|459672457|FG003|Double-blind Period|Withdrawal by Subject|0|||
127739364|NCT04944784|459672454|FG000|Double-blind Period|Death|7|||
127739365|NCT04944784|459672455|FG001|Double-blind Period|Death|2|||
127739366|NCT04944784|459672456|FG002|Double-blind Period|Death|0|||
127739367|NCT04944784|459672457|FG003|Double-blind Period|Death|0|||
127739368|NCT04944784|459672454|FG000|Double-blind Period|Physician Decision|2|||
127739369|NCT04944784|459672455|FG001|Double-blind Period|Physician Decision|1|||
127739370|NCT04944784|459672456|FG002|Double-blind Period|Physician Decision|0|||
127739371|NCT04944784|459672457|FG003|Double-blind Period|Physician Decision|0|||
127739372|NCT04944784|459672454|FG000|Double-blind Period|Lack of Efficacy|0|||
127806745|NCT00896532|459913537|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
127806746|NCT00896532|459913538|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
127806747|NCT00896532|459913539|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
127806748|NCT00896532|459913540|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
127806749|NCT00896532|459913541|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
127806750|NCT00896532|459913542|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
127806751|NCT00896532|459913543|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
127806752|NCT00896532|459913544|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
127806753|NCT00896532|459913545|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
127806754|NCT00896532|459913546|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
127806755|NCT00896532|459913524|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
127806756|NCT00896532|459913525|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
127806757|NCT00896532|459913526|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
127806758|NCT00896532|459913527|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
127739373|NCT04944784|459672455|FG001|Double-blind Period|Lack of Efficacy|1|||
127806759|NCT00896532|459913528|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
127892979|NCT01621490|460231285|FG004|Overall Study|Subject request to discontinue study|0|||
127892980|NCT01621490|460231286|FG005|Overall Study|Subject request to discontinue study|2|||
127892981|NCT01621490|460231287|FG006|Overall Study|Subject request to discontinue study|1|||
127739374|NCT04944784|459672456|FG002|Double-blind Period|Lack of Efficacy|0|||
127739375|NCT04944784|459672457|FG003|Double-blind Period|Lack of Efficacy|0|||
127739376|NCT04944784|459672454|FG000|Double-blind Period|Sponsor Request|2|||
127739377|NCT04944784|459672455|FG001|Double-blind Period|Sponsor Request|1|||
127739378|NCT04944784|459672456|FG002|Double-blind Period|Sponsor Request|0|||
127739379|NCT04944784|459672457|FG003|Double-blind Period|Sponsor Request|0|||
127739380|NCT04944784|459672454|FG000|Double-blind Period|Planned Medical Assistance in Dying|0|||
127739381|NCT04944784|459672455|FG001|Double-blind Period|Planned Medical Assistance in Dying|3|||
127739382|NCT04944784|459672456|FG002|Double-blind Period|Planned Medical Assistance in Dying|0|||
127739383|NCT04944784|459672457|FG003|Double-blind Period|Planned Medical Assistance in Dying|0|||
127739384|NCT04944784|459672454|FG000|Double-blind Period|Participant Choice|1|||
127739385|NCT04944784|459672455|FG001|Double-blind Period|Participant Choice|1|||
127739386|NCT04944784|459672456|FG002|Double-blind Period|Participant Choice|0|||
127739387|NCT04944784|459672457|FG003|Double-blind Period|Participant Choice|0|||
127739388|NCT04944784|459672454|FG000|Double-blind Period|Progressive Disease|2|||
127739389|NCT04944784|459672455|FG001|Double-blind Period|Progressive Disease|2|||
127739390|NCT04944784|459672456|FG002|Double-blind Period|Progressive Disease|0|||
127739391|NCT04944784|459672457|FG003|Double-blind Period|Progressive Disease|0|||
127739392|NCT04944784|459672454|FG000|Active Drug Period|Study Terminated by Sponsor|0|||
127739393|NCT04944784|459672455|FG001|Active Drug Period|Study Terminated by Sponsor|0|||
127739394|NCT04944784|459672456|FG002|Active Drug Period|Study Terminated by Sponsor|49|||
127739395|NCT04944784|459672457|FG003|Active Drug Period|Study Terminated by Sponsor|92|||
127739396|NCT04944784|459672454|FG000|Active Drug Period|Adverse Event|0|||
127739397|NCT04944784|459672455|FG001|Active Drug Period|Adverse Event|0|||
127739398|NCT04944784|459672456|FG002|Active Drug Period|Adverse Event|3|||
127739399|NCT04944784|459672457|FG003|Active Drug Period|Adverse Event|6|||
127739400|NCT04944784|459672454|FG000|Active Drug Period|Withdrawal by Subject|0|||
127739401|NCT04944784|459672455|FG001|Active Drug Period|Withdrawal by Subject|0|||
127739402|NCT04944784|459672456|FG002|Active Drug Period|Withdrawal by Subject|4|||
127739403|NCT04944784|459672457|FG003|Active Drug Period|Withdrawal by Subject|7|||
127739404|NCT04944784|459672454|FG000|Active Drug Period|Death|0|||
127739405|NCT04944784|459672455|FG001|Active Drug Period|Death|0|||
127739406|NCT04944784|459672456|FG002|Active Drug Period|Death|3|||
127739407|NCT04944784|459672457|FG003|Active Drug Period|Death|4|||
127739408|NCT04944784|459672454|FG000|Active Drug Period|Lack of Efficacy|0|||
127806760|NCT00896532|459913529|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
127806761|NCT00896532|459913530|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
127806762|NCT00896532|459913531|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
127739409|NCT04944784|459672455|FG001|Active Drug Period|Lack of Efficacy|0|||
127739410|NCT04944784|459672456|FG002|Active Drug Period|Lack of Efficacy|2|||
127739411|NCT04944784|459672457|FG003|Active Drug Period|Lack of Efficacy|2|||
127739412|NCT04944784|459672454|FG000|Active Drug Period|Planned Medical Assistance in Dying|0|||
127739413|NCT04944784|459672455|FG001|Active Drug Period|Planned Medical Assistance in Dying|0|||
127739414|NCT04944784|459672456|FG002|Active Drug Period|Planned Medical Assistance in Dying|0|||
127739415|NCT04944784|459672457|FG003|Active Drug Period|Planned Medical Assistance in Dying|1|||
127739416|NCT04944784|459672454|FG000|Active Drug Period|Participant Choice|0|||
127739417|NCT04944784|459672455|FG001|Active Drug Period|Participant Choice|0|||
127739418|NCT04944784|459672456|FG002|Active Drug Period|Participant Choice|0|||
127739419|NCT04944784|459672457|FG003|Active Drug Period|Participant Choice|1|||
127739420|NCT04944784|459672454|FG000|Active Drug Period|Progressive Disease|0|||
127739421|NCT04944784|459672455|FG001|Active Drug Period|Progressive Disease|0|||
127739422|NCT04944784|459672456|FG002|Active Drug Period|Progressive Disease|4|||
127739423|NCT04944784|459672457|FG003|Active Drug Period|Progressive Disease|4|||
127739424|NCT04944784|459672454|FG000|Active Drug Period|Lost to Follow-up|0|||
127739425|NCT04944784|459672455|FG001|Active Drug Period|Lost to Follow-up|0|||
127739426|NCT04944784|459672456|FG002|Active Drug Period|Lost to Follow-up|0|||
127739427|NCT04944784|459672457|FG003|Active Drug Period|Lost to Follow-up|1|||
127739428|NCT02210208|459674345|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
127739429|NCT02210208|459674345|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
127739430|NCT02210208|459674345|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
127739431|NCT01171183|459674346|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
127739432|NCT01171183|459674347|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
127739433|NCT01171183|459674346|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
127739434|NCT01171183|459674347|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
127892982|NCT01621490|460231288|FG007|Overall Study|Subject request to discontinue study|0|||
127892983|NCT01621490|460231289|FG008|Overall Study|Subject request to discontinue study|1|||
127739435|NCT01171183|459674346|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
127806763|NCT00896532|459913532|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
127806764|NCT00896532|459913533|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
127806765|NCT00896532|459913534|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
127806766|NCT00896532|459913535|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
127806767|NCT00896532|459913536|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
127892984|NCT01621490|460231290|FG009|Overall Study|Subject request to discontinue study|0|||
127739436|NCT01171183|459674347|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
127739437|NCT01171183|459674346|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
127739438|NCT01171183|459674347|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
127739439|NCT01171183|459674346|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
127739440|NCT01171183|459674347|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
127739441|NCT01171183|459674346|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
127892985|NCT01621490|460231291|FG010|Overall Study|Subject request to discontinue study|0|||
127892986|NCT01621490|460231281|FG000|Overall Study|Adverse event unrelated to study drug|1|||
127892987|NCT01621490|460231282|FG001|Overall Study|Adverse event unrelated to study drug|1|||
127892988|NCT01621490|460231283|FG002|Overall Study|Adverse event unrelated to study drug|0|||
127892989|NCT01621490|460231284|FG003|Overall Study|Adverse event unrelated to study drug|0|||
127892990|NCT01621490|460231285|FG004|Overall Study|Adverse event unrelated to study drug|0|||
127892991|NCT01621490|460231286|FG005|Overall Study|Adverse event unrelated to study drug|0|||
127892992|NCT01621490|460231287|FG006|Overall Study|Adverse event unrelated to study drug|0|||
127892993|NCT01621490|460231288|FG007|Overall Study|Adverse event unrelated to study drug|2|||
127739442|NCT01171183|459674347|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
127739443|NCT01066936|459674348|FG000|Overall Study|Death|2|||
127739444|NCT01066936|459674348|FG000|Overall Study|Device revised/removed|1|||
127739445|NCT01066936|459674348|FG000|Overall Study|Lost to Follow-up|3|||
127739446|NCT01066936|459674348|FG000|Overall Study|Withdrawal by Subject|4|||
127739447|NCT02418845|459674351|FG000|Overall Study|Lost to Follow-up|7|||
127739448|NCT02418845|459674352|FG001|Overall Study|Lost to Follow-up|2|||
127739449|NCT02418845|459674351|FG000|Overall Study|Lack of Efficacy|0|||
127739450|NCT02418845|459674352|FG001|Overall Study|Lack of Efficacy|3|||
127739451|NCT02418845|459674351|FG000|Overall Study|Physician Decision|5|||
127739452|NCT02418845|459674352|FG001|Overall Study|Physician Decision|5|||
127739453|NCT02418845|459674351|FG000|Overall Study|Protocol Violation|1|||
127739454|NCT02418845|459674352|FG001|Overall Study|Protocol Violation|0|||
127739455|NCT02418845|459674351|FG000|Overall Study|Withdrawal by Subject|3|||
127739456|NCT02418845|459674352|FG001|Overall Study|Withdrawal by Subject|2|||
127739457|NCT04984239|459674353|FG000|Overall Study|Lost to Follow-up|1|||
127739458|NCT04190225|459674354|FG000|Overall Study|Lost to Follow-up|2|||
127739459|NCT04190225|459674355|FG001|Overall Study|Lost to Follow-up|3|||
127739460|NCT04190225|459674354|FG000|Overall Study|Withdrawal by Subject|3|||
127739461|NCT04190225|459674355|FG001|Overall Study|Withdrawal by Subject|2|||
127739462|NCT04190225|459674354|FG000|Overall Study|Unrelated health condition|2|||
127739463|NCT04190225|459674355|FG001|Overall Study|Unrelated health condition|0|||
127739464|NCT02994784|459674357|FG000|6 Months Follow-up|Lost to Follow-up|3|||
127739465|NCT02466243|459674359|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
127739466|NCT02466243|459674360|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
127739467|NCT02466243|459674359|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
127739468|NCT02466243|459674360|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
127739469|NCT02466243|459674359|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
127739470|NCT02466243|459674360|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
127739471|NCT02466243|459674359|FG000|Part B Open-label Treatment Period|Missing|2|||
127739472|NCT02466243|459674360|FG001|Part B Open-label Treatment Period|Missing|2|||
127739473|NCT00477464|459674361|FG000|Overall Study|Lost to Follow-up|1|||
127739474|NCT00477464|459674361|FG000|Overall Study|Death|36|||
127739475|NCT00477464|459674361|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
127739476|NCT00639769|459674362|FG000|Overall Study|Death|2|||
127739477|NCT00639769|459674362|FG000|Overall Study|Adverse Event|7|||
127739478|NCT00639769|459674362|FG000|Overall Study|Lack of Efficacy|1|||
127739479|NCT00639769|459674362|FG000|Overall Study|Disease progression|26|||
127739480|NCT00639769|459674362|FG000|Overall Study|Withdrawal by Subject|4|||
127739481|NCT00863798|459674363|FG000|Overall Study|Adverse Event|5|||
127739482|NCT00863798|459674364|FG001|Overall Study|Adverse Event|2|||
127739483|NCT00863798|459674365|FG002|Overall Study|Adverse Event|4|||
127739484|NCT00863798|459674363|FG000|Overall Study|Participant failed to return|2|||
127806768|NCT00896532|459913537|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
127806769|NCT00896532|459913538|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
127806770|NCT00896532|459913539|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
127806771|NCT00896532|459913540|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
127806772|NCT00896532|459913541|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
127806773|NCT00896532|459913542|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
127806774|NCT00896532|459913543|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
127806775|NCT00896532|459913544|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
127806776|NCT00896532|459913545|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
127806777|NCT00896532|459913546|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
127806778|NCT00896532|459913524|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
127806779|NCT00896532|459913525|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
127739485|NCT00863798|459674364|FG001|Overall Study|Participant failed to return|1|||
127739486|NCT00863798|459674365|FG002|Overall Study|Participant failed to return|0|||
127739487|NCT00863798|459674363|FG000|Overall Study|Investigator request|1|||
127739488|NCT00863798|459674364|FG001|Overall Study|Investigator request|2|||
127739489|NCT00863798|459674365|FG002|Overall Study|Investigator request|1|||
127739490|NCT00863798|459674363|FG000|Overall Study|Lack of Efficacy|4|||
127739491|NCT00863798|459674364|FG001|Overall Study|Lack of Efficacy|3|||
127739492|NCT00863798|459674365|FG002|Overall Study|Lack of Efficacy|6|||
127739493|NCT00863798|459674363|FG000|Overall Study|Lost to Follow-up|6|||
127739494|NCT00863798|459674364|FG001|Overall Study|Lost to Follow-up|9|||
127739495|NCT00863798|459674365|FG002|Overall Study|Lost to Follow-up|5|||
127739496|NCT00863798|459674363|FG000|Overall Study|Other|2|||
127739497|NCT00863798|459674364|FG001|Overall Study|Other|3|||
127739498|NCT00863798|459674365|FG002|Overall Study|Other|1|||
127892994|NCT01621490|460231289|FG008|Overall Study|Adverse event unrelated to study drug|0|||
127892995|NCT01621490|460231290|FG009|Overall Study|Adverse event unrelated to study drug|0|||
127892996|NCT01621490|460231291|FG010|Overall Study|Adverse event unrelated to study drug|0|||
127892997|NCT01621490|460231281|FG000|Overall Study|Disease progression|27|||
127892998|NCT01621490|460231282|FG001|Overall Study|Disease progression|28|||
127892999|NCT01621490|460231283|FG002|Overall Study|Disease progression|1|||
127893000|NCT01621490|460231284|FG003|Overall Study|Disease progression|5|||
127893001|NCT01621490|460231285|FG004|Overall Study|Disease progression|3|||
127893002|NCT01621490|460231286|FG005|Overall Study|Disease progression|8|||
127893003|NCT01621490|460231287|FG006|Overall Study|Disease progression|7|||
127893004|NCT01621490|460231288|FG007|Overall Study|Disease progression|1|||
127893005|NCT01621490|460231289|FG008|Overall Study|Disease progression|4|||
127893006|NCT01621490|460231290|FG009|Overall Study|Disease progression|1|||
127893007|NCT01621490|460231291|FG010|Overall Study|Disease progression|1|||
127893008|NCT01621490|460231281|FG000|Overall Study|Study drug toxicity|1|||
127893009|NCT01621490|460231282|FG001|Overall Study|Study drug toxicity|4|||
127893010|NCT01621490|460231283|FG002|Overall Study|Study drug toxicity|5|||
127893011|NCT01621490|460231284|FG003|Overall Study|Study drug toxicity|3|||
127893012|NCT01621490|460231285|FG004|Overall Study|Study drug toxicity|1|||
127739499|NCT00863798|459674363|FG000|Overall Study|Protocol Violation|0|||
127739500|NCT00863798|459674364|FG001|Overall Study|Protocol Violation|1|||
127739501|NCT00863798|459674365|FG002|Overall Study|Protocol Violation|1|||
127739502|NCT00863798|459674363|FG000|Overall Study|Withdrawal by Subject|8|||
127739503|NCT00863798|459674364|FG001|Overall Study|Withdrawal by Subject|7|||
127739504|NCT00863798|459674365|FG002|Overall Study|Withdrawal by Subject|4|||
127739505|NCT00863798|459674363|FG000|Overall Study|Randomized not treated|4|||
127739506|NCT00863798|459674364|FG001|Overall Study|Randomized not treated|2|||
127739507|NCT00863798|459674365|FG002|Overall Study|Randomized not treated|3|||
127739508|NCT04238520|459674366|FG000|Overall Study|Withdrawal by Subject|1|||
127739509|NCT04238520|459674367|FG001|Overall Study|Withdrawal by Subject|1|||
127739510|NCT04238520|459674366|FG000|Overall Study|Lost to Follow-up|1|||
127739511|NCT04238520|459674367|FG001|Overall Study|Lost to Follow-up|2|||
127739512|NCT04238520|459674366|FG000|Overall Study|Death|0|||
127739513|NCT04238520|459674367|FG001|Overall Study|Death|2|||
127739514|NCT04238520|459674366|FG000|Overall Study|Unsafe home environment for research staff|0|||
127739515|NCT04238520|459674367|FG001|Overall Study|Unsafe home environment for research staff|1|||
127739516|NCT01470599|459674368|FG000|Overall Study|Did not meet entrance criteria|1|||
127739517|NCT01470599|459674369|FG001|Overall Study|Did not meet entrance criteria|0|||
127739518|NCT01470599|459674368|FG000|Overall Study|Lost to Follow-up|2|||
127739519|NCT01470599|459674369|FG001|Overall Study|Lost to Follow-up|1|||
127739520|NCT01470599|459674368|FG000|Overall Study|Withdrawal by Subject|3|||
127739521|NCT01470599|459674369|FG001|Overall Study|Withdrawal by Subject|4|||
127739522|NCT01470599|459674368|FG000|Overall Study|Other|1|||
127739523|NCT01470599|459674369|FG001|Overall Study|Other|0|||
127739524|NCT01470599|459674368|FG000|Overall Study|Protocol Violation|3|||
127739525|NCT01470599|459674369|FG001|Overall Study|Protocol Violation|1|||
127739526|NCT01470599|459674368|FG000|Overall Study|Adverse event related to study drug|2|||
127739527|NCT01470599|459674369|FG001|Overall Study|Adverse event related to study drug|5|||
127739528|NCT01470599|459674368|FG000|Overall Study|Insufficient clinical response|6|||
127739529|NCT01470599|459674369|FG001|Overall Study|Insufficient clinical response|27|||
127739530|NCT01470599|459674368|FG000|Overall Study|Adverse event not related to study drug|1|||
127739531|NCT01470599|459674369|FG001|Overall Study|Adverse event not related to study drug|5|||
127739532|NCT00195442|459674370|FG000|Overall Study|Less than expected therapeutic effect|38|||
127739533|NCT00195442|459674370|FG000|Overall Study|Lost to Follow-up|27|||
127739534|NCT00195442|459674370|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
127739535|NCT00195442|459674370|FG000|Overall Study|Intermittent product shortage|21|||
127893013|NCT01621490|460231286|FG005|Overall Study|Study drug toxicity|10|||
127893014|NCT01621490|460231287|FG006|Overall Study|Study drug toxicity|1|||
127893015|NCT01621490|460231288|FG007|Overall Study|Study drug toxicity|4|||
127893016|NCT01621490|460231289|FG008|Overall Study|Study drug toxicity|1|||
127739536|NCT00195442|459674370|FG000|Overall Study|Death|7|||
127739537|NCT00195442|459674370|FG000|Overall Study|No reason specified|4|||
127739538|NCT00195442|459674370|FG000|Overall Study|Poor cooperation|2|||
127739539|NCT00195442|459674370|FG000|Overall Study|Other|14|||
127739540|NCT01917006|459674371|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
127739541|NCT01917006|459674372|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
127739542|NCT01917006|459674373|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
127893017|NCT01621490|460231290|FG009|Overall Study|Study drug toxicity|0|||
127739543|NCT01917006|459674374|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
127739544|NCT01917006|459674375|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
127739545|NCT01917006|459674376|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
127739546|NCT01917006|459674377|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
127739547|NCT01917006|459674378|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
127739548|NCT01917006|459674371|FG000|Randomized-treatment Period|Personal Reasons|0|||
127739549|NCT01917006|459674372|FG001|Randomized-treatment Period|Personal Reasons|0|||
127739550|NCT01917006|459674373|FG002|Randomized-treatment Period|Personal Reasons|0|||
127739551|NCT01917006|459674374|FG003|Randomized-treatment Period|Personal Reasons|0|||
127739552|NCT01917006|459674375|FG004|Randomized-treatment Period|Personal Reasons|0|||
127739553|NCT01917006|459674376|FG005|Randomized-treatment Period|Personal Reasons|1|||
127739554|NCT01917006|459674377|FG006|Randomized-treatment Period|Personal Reasons|0|||
127739555|NCT01917006|459674378|FG007|Randomized-treatment Period|Personal Reasons|0|||
127739556|NCT01917006|459674371|FG000|Randomized-treatment Period|Protocol Violation|1|||
127739557|NCT01917006|459674372|FG001|Randomized-treatment Period|Protocol Violation|0|||
127739558|NCT01917006|459674373|FG002|Randomized-treatment Period|Protocol Violation|0|||
127739559|NCT01917006|459674374|FG003|Randomized-treatment Period|Protocol Violation|0|||
127739560|NCT01917006|459674375|FG004|Randomized-treatment Period|Protocol Violation|0|||
127739561|NCT01917006|459674376|FG005|Randomized-treatment Period|Protocol Violation|0|||
127739562|NCT01917006|459674377|FG006|Randomized-treatment Period|Protocol Violation|0|||
127739563|NCT01917006|459674378|FG007|Randomized-treatment Period|Protocol Violation|0|||
127739564|NCT01917006|459674371|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
127739565|NCT01917006|459674372|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
127739566|NCT01917006|459674373|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
127739567|NCT01917006|459674374|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
127739568|NCT01917006|459674375|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
127739569|NCT01917006|459674376|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
127739570|NCT01917006|459674377|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
127739571|NCT01917006|459674378|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
127739572|NCT01917006|459674371|FG000|Open-label Period|Adverse Event|0|||
127739573|NCT01917006|459674372|FG001|Open-label Period|Adverse Event|0|||
127739574|NCT01917006|459674373|FG002|Open-label Period|Adverse Event|0|||
127739575|NCT01917006|459674374|FG003|Open-label Period|Adverse Event|0|||
127739576|NCT01917006|459674375|FG004|Open-label Period|Adverse Event|0|||
127739577|NCT01917006|459674376|FG005|Open-label Period|Adverse Event|0|||
127739578|NCT01917006|459674377|FG006|Open-label Period|Adverse Event|0|||
127739579|NCT01917006|459674378|FG007|Open-label Period|Adverse Event|1|||
127739580|NCT01917006|459674371|FG000|Open-label Period|Lost to Follow-up|0|||
127739581|NCT01917006|459674372|FG001|Open-label Period|Lost to Follow-up|0|||
127739582|NCT01917006|459674373|FG002|Open-label Period|Lost to Follow-up|0|||
127739583|NCT01917006|459674374|FG003|Open-label Period|Lost to Follow-up|0|||
127739584|NCT01917006|459674375|FG004|Open-label Period|Lost to Follow-up|0|||
127739585|NCT01917006|459674376|FG005|Open-label Period|Lost to Follow-up|0|||
127739586|NCT01917006|459674377|FG006|Open-label Period|Lost to Follow-up|0|||
127739587|NCT01917006|459674378|FG007|Open-label Period|Lost to Follow-up|1|||
127739588|NCT00847132|459674381|FG000|Overall Study|Death|1|||
127739589|NCT00847132|459674382|FG001|Overall Study|Death|1|||
127739590|NCT03596242|459674383|FG000|Overall Study|Lost to Follow-up|2|||
127739591|NCT03596242|459674384|FG001|Overall Study|Lost to Follow-up|2|||
127739592|NCT02509312|459674385|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
127739593|NCT02509312|459674386|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
127739594|NCT02509312|459674385|FG000|Overall Study|Obstetrician refusal|0|||
127739595|NCT02509312|459674386|FG001|Overall Study|Obstetrician refusal|1|||
127739596|NCT02509312|459674385|FG000|Overall Study|Patient elected for TOLAC|1|||
127739597|NCT02509312|459674386|FG001|Overall Study|Patient elected for TOLAC|0|||
127739598|NCT02509312|459674385|FG000|Overall Study|Cesarean deemed stat|1|||
127739599|NCT02509312|459674386|FG001|Overall Study|Cesarean deemed stat|0|||
127739600|NCT02509312|459674385|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
127739601|NCT02509312|459674386|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
127739602|NCT03357471|459674392|FG000|Overall Study|Adverse Event|1|||
127739603|NCT03357471|459674393|FG001|Overall Study|Adverse Event|0|||
127739604|NCT03357471|459674392|FG000|Overall Study|Lost to Follow-up|1|||
127739605|NCT03357471|459674393|FG001|Overall Study|Lost to Follow-up|0|||
127739606|NCT02973802|459674394|FG000|Overall Study|Lost to Follow-up|1|||
127739607|NCT02973802|459674394|FG000|Overall Study|Withdrawal by Subject|1|||
127739608|NCT00706914|459674395|FG000|Overall Study|Lack of Efficacy|0|||
127739609|NCT00706914|459674396|FG001|Overall Study|Lack of Efficacy|1|||
127739610|NCT00706914|459674397|FG002|Overall Study|Lack of Efficacy|0|||
127739611|NCT00706914|459674395|FG000|Overall Study|Lost to Follow-up|1|||
127739612|NCT00706914|459674396|FG001|Overall Study|Lost to Follow-up|0|||
127739613|NCT00706914|459674397|FG002|Overall Study|Lost to Follow-up|0|||
127739614|NCT00706914|459674395|FG000|Overall Study|Adverse Event|2|||
127739615|NCT00706914|459674396|FG001|Overall Study|Adverse Event|2|||
127739616|NCT00706914|459674397|FG002|Overall Study|Adverse Event|0|||
127739617|NCT00706914|459674395|FG000|Overall Study|Protocol Violation|3|||
127739618|NCT00706914|459674396|FG001|Overall Study|Protocol Violation|1|||
127739619|NCT00706914|459674397|FG002|Overall Study|Protocol Violation|1|||
127739620|NCT01751165|459674399|FG000|Overall Study|Adverse event, serious fatal|1|||
127739621|NCT01751165|459674400|FG001|Overall Study|Adverse event, serious fatal|0|||
127739622|NCT01751165|459674401|FG002|Overall Study|Adverse event, serious fatal|1|||
127739623|NCT01751165|459674399|FG000|Overall Study|Withdrawal by Subject|0|||
127739624|NCT01751165|459674400|FG001|Overall Study|Withdrawal by Subject|0|||
127739625|NCT01751165|459674401|FG002|Overall Study|Withdrawal by Subject|1|||
127739626|NCT01751165|459674399|FG000|Overall Study|Serious adverse event|0|||
127739627|NCT01751165|459674400|FG001|Overall Study|Serious adverse event|2|||
127739628|NCT01751165|459674401|FG002|Overall Study|Serious adverse event|0|||
127739629|NCT01751165|459674399|FG000|Overall Study|Lost to Follow-up|1|||
127739630|NCT01751165|459674400|FG001|Overall Study|Lost to Follow-up|1|||
127739631|NCT01751165|459674401|FG002|Overall Study|Lost to Follow-up|1|||
127739632|NCT00988533|459674406|FG000|Overall Study|Lost to Follow-up|3|||
127739633|NCT00943722|459674409|FG000|Base Study|Adverse Event|0|||
127739634|NCT00943722|459674410|FG001|Base Study|Adverse Event|0|||
127739635|NCT00943722|459674411|FG002|Base Study|Adverse Event|0|||
127739636|NCT00943722|459674412|FG003|Base Study|Adverse Event|1|||
127739637|NCT00943722|459674413|FG004|Base Study|Adverse Event|0|||
127739638|NCT00943722|459674414|FG005|Base Study|Adverse Event|0|||
127739639|NCT00943722|459674415|FG006|Base Study|Adverse Event|0|||
127739640|NCT00943722|459674409|FG000|Base Study|Lost to Follow-up|12|||
127739641|NCT00943722|459674410|FG001|Base Study|Lost to Follow-up|8|||
127739642|NCT00943722|459674411|FG002|Base Study|Lost to Follow-up|10|||
127739643|NCT00943722|459674412|FG003|Base Study|Lost to Follow-up|8|||
127739644|NCT00943722|459674413|FG004|Base Study|Lost to Follow-up|11|||
127739645|NCT00943722|459674414|FG005|Base Study|Lost to Follow-up|0|||
127739646|NCT00943722|459674415|FG006|Base Study|Lost to Follow-up|0|||
127739647|NCT00943722|459674409|FG000|Base Study|Physician Decision|1|||
127739648|NCT00943722|459674410|FG001|Base Study|Physician Decision|0|||
127739649|NCT00943722|459674411|FG002|Base Study|Physician Decision|0|||
127739650|NCT00943722|459674412|FG003|Base Study|Physician Decision|0|||
127739651|NCT00943722|459674413|FG004|Base Study|Physician Decision|1|||
127739652|NCT00943722|459674414|FG005|Base Study|Physician Decision|0|||
127739653|NCT00943722|459674415|FG006|Base Study|Physician Decision|0|||
127739654|NCT00943722|459674409|FG000|Base Study|Pregnancy|0|||
127739655|NCT00943722|459674410|FG001|Base Study|Pregnancy|0|||
127739656|NCT00943722|459674411|FG002|Base Study|Pregnancy|1|||
127739657|NCT00943722|459674412|FG003|Base Study|Pregnancy|0|||
127739658|NCT00943722|459674413|FG004|Base Study|Pregnancy|2|||
127739659|NCT00943722|459674414|FG005|Base Study|Pregnancy|0|||
127739660|NCT00943722|459674415|FG006|Base Study|Pregnancy|0|||
127739661|NCT00943722|459674409|FG000|Base Study|Protocol Violation|0|||
127739662|NCT00943722|459674410|FG001|Base Study|Protocol Violation|1|||
127739663|NCT00943722|459674411|FG002|Base Study|Protocol Violation|0|||
127739664|NCT00943722|459674412|FG003|Base Study|Protocol Violation|0|||
127739665|NCT00943722|459674413|FG004|Base Study|Protocol Violation|2|||
127739666|NCT00943722|459674414|FG005|Base Study|Protocol Violation|0|||
127739667|NCT00943722|459674415|FG006|Base Study|Protocol Violation|0|||
127739668|NCT00943722|459674409|FG000|Base Study|Withdrawal by Subject|12|||
127739669|NCT00943722|459674410|FG001|Base Study|Withdrawal by Subject|13|||
127739670|NCT00943722|459674411|FG002|Base Study|Withdrawal by Subject|2|||
127739671|NCT00943722|459674412|FG003|Base Study|Withdrawal by Subject|13|||
127739672|NCT00943722|459674413|FG004|Base Study|Withdrawal by Subject|8|||
127739673|NCT00943722|459674414|FG005|Base Study|Withdrawal by Subject|0|||
127739674|NCT00943722|459674415|FG006|Base Study|Withdrawal by Subject|0|||
127739675|NCT00943722|459674409|FG000|Base Study|Month 12 visit not completed|0|||
127739676|NCT00943722|459674410|FG001|Base Study|Month 12 visit not completed|0|||
127739677|NCT00943722|459674411|FG002|Base Study|Month 12 visit not completed|0|||
127739678|NCT00943722|459674412|FG003|Base Study|Month 12 visit not completed|0|||
127739679|NCT00943722|459674413|FG004|Base Study|Month 12 visit not completed|2|||
127739680|NCT00943722|459674414|FG005|Base Study|Month 12 visit not completed|0|||
127739681|NCT00943722|459674415|FG006|Base Study|Month 12 visit not completed|0|||
127739682|NCT00943722|459674409|FG000|First Extension Study: EXT 1|Adverse Event|0|||
127739683|NCT00943722|459674410|FG001|First Extension Study: EXT 1|Adverse Event|0|||
127739684|NCT00943722|459674411|FG002|First Extension Study: EXT 1|Adverse Event|0|||
127739685|NCT00943722|459674412|FG003|First Extension Study: EXT 1|Adverse Event|0|||
127739686|NCT00943722|459674413|FG004|First Extension Study: EXT 1|Adverse Event|0|||
127739687|NCT00943722|459674414|FG005|First Extension Study: EXT 1|Adverse Event|1|||
127739688|NCT00943722|459674415|FG006|First Extension Study: EXT 1|Adverse Event|0|||
127739689|NCT00943722|459674409|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
127739690|NCT00943722|459674410|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
127739691|NCT00943722|459674411|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
127739692|NCT00943722|459674412|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
127739693|NCT00943722|459674413|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
127739694|NCT00943722|459674414|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
127739695|NCT00943722|459674415|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
127739696|NCT00943722|459674409|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
127739697|NCT00943722|459674410|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
127739698|NCT00943722|459674411|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
127739699|NCT00943722|459674412|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
127739700|NCT00943722|459674413|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
127739701|NCT00943722|459674414|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
127739702|NCT00943722|459674415|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
127739703|NCT00943722|459674409|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
127739704|NCT00943722|459674410|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
127739705|NCT00943722|459674411|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
127739706|NCT00943722|459674412|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
127739707|NCT00943722|459674413|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
127739708|NCT00943722|459674414|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
127739709|NCT00943722|459674415|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
127739710|NCT00943722|459674409|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
127739711|NCT00943722|459674410|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
127739712|NCT00943722|459674411|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
127739713|NCT00943722|459674412|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
127739714|NCT00943722|459674413|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
127739715|NCT00943722|459674414|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
127739716|NCT00943722|459674415|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
127739717|NCT00943722|459674409|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
127739718|NCT00943722|459674410|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
127739719|NCT00943722|459674411|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
127739720|NCT00943722|459674412|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
127739721|NCT00943722|459674413|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
127739722|NCT00943722|459674414|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
127739723|NCT00943722|459674415|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
127739724|NCT00943722|459674409|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
127739725|NCT00943722|459674410|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
127739726|NCT00943722|459674411|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
127739727|NCT00943722|459674412|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
127739728|NCT00943722|459674413|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
127739729|NCT00943722|459674414|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
127739730|NCT00943722|459674415|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
127739731|NCT00943722|459674409|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
127739732|NCT00943722|459674410|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
127739733|NCT00943722|459674411|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
127739734|NCT00943722|459674412|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
127739735|NCT00943722|459674413|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
127739736|NCT00943722|459674414|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
127739737|NCT00943722|459674415|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
127739738|NCT00943722|459674409|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
127739739|NCT00943722|459674410|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
127739740|NCT00943722|459674411|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
127739741|NCT00943722|459674412|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
127739742|NCT00943722|459674413|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
127739743|NCT00943722|459674414|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
127739744|NCT00943722|459674415|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
127739745|NCT01036165|459674420|FG000|Overall Study|Adverse Event|6|||
127739746|NCT01036165|459674420|FG000|Overall Study|Lost to Follow-up|2|||
127739747|NCT01036165|459674420|FG000|Overall Study|Withdrawal by Subject|3|||
127739748|NCT01036165|459674420|FG000|Overall Study|Device Related Issues|3|||
127739749|NCT01036165|459674420|FG000|Overall Study|Problems finding proper area to inject|1|||
127739750|NCT00916305|459674427|FG000|Overall Study|Lost to Follow-up|21|||
127739751|NCT00916305|459674428|FG001|Overall Study|Lost to Follow-up|27|||
127739752|NCT00916305|459674427|FG000|Overall Study|Withdrawal by Subject|0|||
127739753|NCT00916305|459674428|FG001|Overall Study|Withdrawal by Subject|1|||
127739754|NCT00307164|459674429|FG000|Overall Study|Death|1|||
127739755|NCT00307164|459674430|FG001|Overall Study|Death|0|||
127739756|NCT00307164|459674429|FG000|Overall Study|Severe debilitation, unable to continue|1|||
127739757|NCT00307164|459674430|FG001|Overall Study|Severe debilitation, unable to continue|0|||
127739758|NCT00307164|459674429|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
127739759|NCT00307164|459674430|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
127739760|NCT00307164|459674429|FG000|Overall Study|Withdrawal by Subject|1|||
127893018|NCT01621490|460231291|FG010|Overall Study|Study drug toxicity|0|||
127739761|NCT00307164|459674430|FG001|Overall Study|Withdrawal by Subject|8|||
127739762|NCT00307164|459674429|FG000|Overall Study|Not compliant with requirements|4|||
127739763|NCT00307164|459674430|FG001|Overall Study|Not compliant with requirements|4|||
127739764|NCT00307164|459674429|FG000|Overall Study|Lost to Follow-up|6|||
127806780|NCT00896532|459913526|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
127806781|NCT00896532|459913527|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
127806782|NCT00896532|459913528|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
127806783|NCT00896532|459913529|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
127806784|NCT00896532|459913530|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
127806785|NCT00896532|459913531|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
127806786|NCT00896532|459913532|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
127806787|NCT00896532|459913533|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
127806788|NCT00896532|459913534|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
127806789|NCT00896532|459913535|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
127806790|NCT00896532|459913536|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
127806791|NCT00896532|459913537|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
127806792|NCT00896532|459913538|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
127806793|NCT00896532|459913539|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
127806794|NCT00896532|459913540|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
127806795|NCT00896532|459913541|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
127806796|NCT00896532|459913542|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
127806797|NCT00896532|459913543|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
127806798|NCT00896532|459913544|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
127806799|NCT00896532|459913545|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
127806800|NCT00896532|459913546|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
127806801|NCT00896532|459913524|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
127806802|NCT00896532|459913525|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
127806803|NCT00896532|459913526|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
127806804|NCT00896532|459913527|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
127806805|NCT00896532|459913528|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
127806806|NCT00896532|459913529|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
127806807|NCT00896532|459913530|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
127806808|NCT00896532|459913531|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
127739765|NCT00307164|459674430|FG001|Overall Study|Lost to Follow-up|1|||
127739766|NCT04191148|459674436|FG000|Overall Study|Withdrawal by Subject|1|||
127893019|NCT01621490|460231281|FG000|Overall Study|Death|0|||
127893020|NCT01621490|460231282|FG001|Overall Study|Death|0|||
127893021|NCT01621490|460231283|FG002|Overall Study|Death|0|||
127893022|NCT01621490|460231284|FG003|Overall Study|Death|0|||
127739767|NCT04191148|459674437|FG001|Overall Study|Withdrawal by Subject|0|||
127739768|NCT04191148|459674436|FG000|Overall Study|Adverse Event|1|||
127739769|NCT04191148|459674437|FG001|Overall Study|Adverse Event|0|||
127739770|NCT01274559|459674440|FG000|Overall Study|Adverse Event|57|||
127739771|NCT01274559|459674441|FG001|Overall Study|Adverse Event|13|||
127739772|NCT01274559|459674440|FG000|Overall Study|Death|1|||
127739773|NCT01274559|459674441|FG001|Overall Study|Death|1|||
127739774|NCT01274559|459674440|FG000|Overall Study|Lost to Follow-up|3|||
127739775|NCT01274559|459674441|FG001|Overall Study|Lost to Follow-up|3|||
127739776|NCT01274559|459674440|FG000|Overall Study|Non-compliance with Study Drug|2|||
127739777|NCT01274559|459674441|FG001|Overall Study|Non-compliance with Study Drug|4|||
127739778|NCT01274559|459674440|FG000|Overall Study|Physician Decision|2|||
127739779|NCT01274559|459674441|FG001|Overall Study|Physician Decision|1|||
127739780|NCT01274559|459674440|FG000|Overall Study|Protocol Violation|28|||
127739781|NCT01274559|459674441|FG001|Overall Study|Protocol Violation|23|||
127739782|NCT01274559|459674440|FG000|Overall Study|Study Terminated by Sponsor|79|||
127739783|NCT01274559|459674441|FG001|Overall Study|Study Terminated by Sponsor|87|||
127739784|NCT01274559|459674440|FG000|Overall Study|Withdrawal by Subject|25|||
127739785|NCT01274559|459674441|FG001|Overall Study|Withdrawal by Subject|13|||
127739786|NCT02560389|459674442|FG000|Overall Study|Lost to Follow-up|1|||
127739787|NCT02560389|459674443|FG001|Overall Study|Lost to Follow-up|2|||
127739788|NCT02560389|459674444|FG002|Overall Study|Lost to Follow-up|2|||
127739789|NCT02560389|459674442|FG000|Overall Study|Tested positive for illicit substance|0|||
127806809|NCT00896532|459913532|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
127806810|NCT00896532|459913533|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
127806811|NCT00896532|459913534|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
127806812|NCT00896532|459913535|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
127806813|NCT00896532|459913536|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
127806814|NCT00896532|459913537|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
127893023|NCT01621490|460231285|FG004|Overall Study|Death|0|||
127893024|NCT01621490|460231286|FG005|Overall Study|Death|0|||
127739790|NCT02560389|459674443|FG001|Overall Study|Tested positive for illicit substance|1|||
127739791|NCT02560389|459674444|FG002|Overall Study|Tested positive for illicit substance|0|||
127739792|NCT03409731|459674446|FG000|Overall Study|Withdrawal by Subject|17|||
127739793|NCT03409731|459674446|FG000|Overall Study|Death|4|||
127739794|NCT04016805|459674452|FG000|Overall Study|Sponsor's Discretion|30|||
127739795|NCT04016805|459674453|FG001|Overall Study|Sponsor's Discretion|6|||
127739796|NCT04016805|459674454|FG002|Overall Study|Sponsor's Discretion|5|||
127739797|NCT01193218|459674455|FG000|0-12 Weeks|Adverse Event|6|||
127739798|NCT01193218|459674456|FG001|0-12 Weeks|Adverse Event|0|||
127739799|NCT01193218|459674457|FG002|0-12 Weeks|Adverse Event|1|||
127739800|NCT01193218|459674458|FG003|0-12 Weeks|Adverse Event|0|||
127739801|NCT01193218|459674459|FG004|0-12 Weeks|Adverse Event|0|||
127739802|NCT01193218|459674460|FG005|0-12 Weeks|Adverse Event|2|||
127739803|NCT01193218|459674461|FG006|0-12 Weeks|Adverse Event|2|||
127739804|NCT01193218|459674462|FG007|0-12 Weeks|Adverse Event|0|||
127739805|NCT01193218|459674455|FG000|0-12 Weeks|Protocol Violation|0|||
127739806|NCT01193218|459674456|FG001|0-12 Weeks|Protocol Violation|0|||
127739807|NCT01193218|459674457|FG002|0-12 Weeks|Protocol Violation|0|||
127739808|NCT01193218|459674458|FG003|0-12 Weeks|Protocol Violation|0|||
127739809|NCT01193218|459674459|FG004|0-12 Weeks|Protocol Violation|1|||
127739810|NCT01193218|459674460|FG005|0-12 Weeks|Protocol Violation|1|||
127739811|NCT01193218|459674461|FG006|0-12 Weeks|Protocol Violation|0|||
127739812|NCT01193218|459674462|FG007|0-12 Weeks|Protocol Violation|0|||
127739813|NCT01193218|459674455|FG000|0-12 Weeks|Withdrawal by Subject|3|||
127739814|NCT01193218|459674456|FG001|0-12 Weeks|Withdrawal by Subject|0|||
127739815|NCT01193218|459674457|FG002|0-12 Weeks|Withdrawal by Subject|2|||
127739816|NCT01193218|459674458|FG003|0-12 Weeks|Withdrawal by Subject|0|||
127806815|NCT00896532|459913538|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
127806816|NCT00896532|459913539|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
127806817|NCT00896532|459913540|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
127806818|NCT00896532|459913541|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
127806819|NCT00896532|459913542|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
127806820|NCT00896532|459913543|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
127806821|NCT00896532|459913544|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
127806822|NCT00896532|459913545|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
127806823|NCT00896532|459913546|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
127806824|NCT00896532|459913524|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
127806825|NCT00896532|459913525|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
127806826|NCT00896532|459913526|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
127806827|NCT00896532|459913527|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
127806828|NCT00896532|459913528|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
127806829|NCT00896532|459913529|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
127806830|NCT00896532|459913530|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
127806831|NCT00896532|459913531|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
127806832|NCT00896532|459913532|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
127806833|NCT00896532|459913533|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
127806834|NCT00896532|459913534|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
127806835|NCT00896532|459913535|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
127806836|NCT00896532|459913536|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
127806837|NCT00896532|459913537|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
127806838|NCT00896532|459913538|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
127806839|NCT00896532|459913539|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
127806840|NCT00896532|459913540|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
127806841|NCT00896532|459913541|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
127806842|NCT00896532|459913542|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
127806843|NCT00896532|459913543|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
127806844|NCT00896532|459913544|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
127806845|NCT00896532|459913545|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
127806846|NCT00896532|459913546|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
127806847|NCT00896532|459913524|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
127806848|NCT00896532|459913525|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
127806849|NCT00896532|459913526|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
127806850|NCT00896532|459913527|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
127806851|NCT00896532|459913528|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
127806852|NCT00896532|459913529|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
127806853|NCT00896532|459913530|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
127806854|NCT00896532|459913531|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
127739817|NCT01193218|459674459|FG004|0-12 Weeks|Withdrawal by Subject|0|||
127739818|NCT01193218|459674460|FG005|0-12 Weeks|Withdrawal by Subject|0|||
127739819|NCT01193218|459674461|FG006|0-12 Weeks|Withdrawal by Subject|1|||
127739820|NCT01193218|459674462|FG007|0-12 Weeks|Withdrawal by Subject|0|||
127739821|NCT01193218|459674455|FG000|12-52 Weeks|Adverse Event|1|||
127739822|NCT01193218|459674456|FG001|12-52 Weeks|Adverse Event|0|||
127739823|NCT01193218|459674457|FG002|12-52 Weeks|Adverse Event|1|||
127739824|NCT01193218|459674458|FG003|12-52 Weeks|Adverse Event|2|||
127806855|NCT00896532|459913532|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
127739825|NCT01193218|459674459|FG004|12-52 Weeks|Adverse Event|3|||
127739826|NCT01193218|459674460|FG005|12-52 Weeks|Adverse Event|3|||
127739827|NCT01193218|459674461|FG006|12-52 Weeks|Adverse Event|1|||
127739828|NCT01193218|459674462|FG007|12-52 Weeks|Adverse Event|2|||
127739829|NCT01193218|459674455|FG000|12-52 Weeks|Lack of Efficacy|0|||
127739830|NCT01193218|459674456|FG001|12-52 Weeks|Lack of Efficacy|0|||
127739831|NCT01193218|459674457|FG002|12-52 Weeks|Lack of Efficacy|0|||
127739832|NCT01193218|459674458|FG003|12-52 Weeks|Lack of Efficacy|0|||
127739833|NCT01193218|459674459|FG004|12-52 Weeks|Lack of Efficacy|0|||
127739834|NCT01193218|459674460|FG005|12-52 Weeks|Lack of Efficacy|0|||
127739835|NCT01193218|459674461|FG006|12-52 Weeks|Lack of Efficacy|1|||
127739836|NCT01193218|459674462|FG007|12-52 Weeks|Lack of Efficacy|0|||
127739837|NCT01193218|459674455|FG000|12-52 Weeks|Withdrawal by Subject|3|||
127739838|NCT01193218|459674456|FG001|12-52 Weeks|Withdrawal by Subject|0|||
127739839|NCT01193218|459674457|FG002|12-52 Weeks|Withdrawal by Subject|3|||
127739840|NCT01193218|459674458|FG003|12-52 Weeks|Withdrawal by Subject|0|||
127739841|NCT01193218|459674459|FG004|12-52 Weeks|Withdrawal by Subject|0|||
127739842|NCT01193218|459674460|FG005|12-52 Weeks|Withdrawal by Subject|2|||
127739843|NCT01193218|459674461|FG006|12-52 Weeks|Withdrawal by Subject|1|||
127739844|NCT01193218|459674462|FG007|12-52 Weeks|Withdrawal by Subject|2|||
127739845|NCT01193218|459674455|FG000|12-52 Weeks|Other reason than above|1|||
127739846|NCT01193218|459674456|FG001|12-52 Weeks|Other reason than above|0|||
127739847|NCT01193218|459674457|FG002|12-52 Weeks|Other reason than above|0|||
127739848|NCT01193218|459674458|FG003|12-52 Weeks|Other reason than above|1|||
127739849|NCT01193218|459674459|FG004|12-52 Weeks|Other reason than above|1|||
127739850|NCT01193218|459674460|FG005|12-52 Weeks|Other reason than above|0|||
127739851|NCT01193218|459674461|FG006|12-52 Weeks|Other reason than above|0|||
127739852|NCT01193218|459674462|FG007|12-52 Weeks|Other reason than above|0|||
127739853|NCT03811834|459674463|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
127739854|NCT04947436|459674466|FG000|Overall Study|Lost to Follow-up|3|||
127739855|NCT04947436|459674467|FG001|Overall Study|Lost to Follow-up|7|||
127739856|NCT04947436|459674468|FG002|Overall Study|Lost to Follow-up|5|||
127739857|NCT04947436|459674466|FG000|Overall Study|Death|1|||
127739858|NCT04947436|459674467|FG001|Overall Study|Death|1|||
127739859|NCT04947436|459674468|FG002|Overall Study|Death|1|||
127806856|NCT00896532|459913533|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
127806857|NCT00896532|459913534|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
127806858|NCT00896532|459913535|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
127806859|NCT00896532|459913536|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
127806860|NCT00896532|459913537|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
127806861|NCT00896532|459913538|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
127806862|NCT00896532|459913539|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
127806863|NCT00896532|459913540|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
127806864|NCT00896532|459913541|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
127806865|NCT00896532|459913542|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
127806866|NCT00896532|459913543|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
127806867|NCT00896532|459913544|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
127806868|NCT00896532|459913545|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
127806869|NCT00896532|459913546|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
127806870|NCT00896532|459913524|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
127806871|NCT00896532|459913525|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
127806872|NCT00896532|459913526|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
127806873|NCT00896532|459913527|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
127806874|NCT00896532|459913528|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
127806875|NCT00896532|459913529|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
127806876|NCT00896532|459913530|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
127739860|NCT01215032|459674469|FG000|Overall Study|Adverse Event|3|||
127739861|NCT01215032|459674469|FG000|Overall Study|Lack of Efficacy|17|||
127806877|NCT00896532|459913531|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
127806878|NCT00896532|459913532|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
127806879|NCT00896532|459913533|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
127893025|NCT01621490|460231287|FG006|Overall Study|Death|0|||
127893026|NCT01621490|460231288|FG007|Overall Study|Death|0|||
127739862|NCT01424189|459674470|FG000|Overall Study|Adverse Event|1|||
127739863|NCT01424189|459674471|FG001|Overall Study|Adverse Event|0|||
127739864|NCT01424189|459674470|FG000|Overall Study|Lost to Follow-up|4|||
127893027|NCT01621490|460231289|FG008|Overall Study|Death|1|||
127893028|NCT01621490|460231290|FG009|Overall Study|Death|0|||
127739865|NCT01424189|459674471|FG001|Overall Study|Lost to Follow-up|1|||
127739866|NCT01424189|459674470|FG000|Overall Study|Withdrawal by Subject|4|||
127739867|NCT01424189|459674471|FG001|Overall Study|Withdrawal by Subject|4|||
127739868|NCT01424189|459674470|FG000|Overall Study|Subject moved|1|||
127739869|NCT01424189|459674471|FG001|Overall Study|Subject moved|0|||
127739870|NCT01424189|459674470|FG000|Overall Study|Death|3|||
127739871|NCT01424189|459674471|FG001|Overall Study|Death|1|||
127739872|NCT01203956|459674474|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
127739873|NCT01203956|459674475|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
127739874|NCT00069277|459674476|FG000|Overall Study|Adverse Event|3|||
127739875|NCT00069277|459674476|FG000|Overall Study|Withdrawal by Subject|1|||
127739876|NCT00069277|459674476|FG000|Overall Study|Progressive Disease|15|||
127739877|NCT00069277|459674476|FG000|Overall Study|Physician Decision|2|||
127739878|NCT02230306|459674477|FG000|Overall Study|Did not receive study treatment|1|||
127739879|NCT00361842|459674482|FG000|Overall Study|Withdrawal by Subject|2|||
127739880|NCT00361842|459674483|FG001|Overall Study|Withdrawal by Subject|3|||
127739881|NCT00361842|459674482|FG000|Overall Study|Death|2|||
127739882|NCT00361842|459674483|FG001|Overall Study|Death|1|||
127739883|NCT00361842|459674482|FG000|Overall Study|Disease progression|19|||
127739884|NCT00361842|459674483|FG001|Overall Study|Disease progression|20|||
127739885|NCT00361842|459674482|FG000|Overall Study|Adverse Event|2|||
127739886|NCT00361842|459674483|FG001|Overall Study|Adverse Event|3|||
127739887|NCT00361842|459674482|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
127739888|NCT00361842|459674483|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
127739889|NCT00361842|459674482|FG000|Overall Study|Other|1|||
127739890|NCT00361842|459674483|FG001|Overall Study|Other|0|||
127739891|NCT00361842|459674482|FG000|Overall Study|Other|0|||
127739892|NCT00361842|459674483|FG001|Overall Study|Other|2|||
127739893|NCT03512288|459674484|FG000|Overall Study|Adverse Event|1|||
127739894|NCT03512288|459674485|FG001|Overall Study|Adverse Event|0|||
127739895|NCT03512288|459674484|FG000|Overall Study|Lost to Follow-up|12|||
127739896|NCT03512288|459674485|FG001|Overall Study|Lost to Follow-up|15|||
127739897|NCT03512288|459674484|FG000|Overall Study|Physician Decision|0|||
127739898|NCT03512288|459674485|FG001|Overall Study|Physician Decision|2|||
127739899|NCT03512288|459674484|FG000|Overall Study|Protocol Violation|6|||
127739900|NCT03512288|459674485|FG001|Overall Study|Protocol Violation|4|||
127739901|NCT03512288|459674484|FG000|Overall Study|Medication error without associated adverse event|1|||
127739902|NCT03512288|459674485|FG001|Overall Study|Medication error without associated adverse event|0|||
127739903|NCT03512288|459674484|FG000|Overall Study|No longer met eligibility criteria|5|||
127739904|NCT03512288|459674485|FG001|Overall Study|No longer met eligibility criteria|2|||
127739905|NCT03512288|459674484|FG000|Overall Study|Withdrawal by parent/guardian|14|||
127739906|NCT03512288|459674485|FG001|Overall Study|Withdrawal by parent/guardian|18|||
127739907|NCT03512288|459674484|FG000|Overall Study|Other|1|||
127739908|NCT03512288|459674485|FG001|Overall Study|Other|1|||
127739909|NCT03512288|459674484|FG000|Overall Study|Randomized but not treated|1|||
127739910|NCT03512288|459674485|FG001|Overall Study|Randomized but not treated|1|||
127739911|NCT04814992|459674486|FG000|Overall Study|Withdrawal by Subject|6|||
127739912|NCT04814992|459674487|FG001|Overall Study|Withdrawal by Subject|3|||
127739913|NCT04814992|459674486|FG000|Overall Study|Lost to Follow-up|1|||
127739914|NCT04814992|459674487|FG001|Overall Study|Lost to Follow-up|4|||
127739915|NCT01077622|459674488|FG000|Overall Study|Physician Decision|2|||
127739916|NCT01077622|459674488|FG000|Overall Study|Withdrawal by Subject|1|||
127739917|NCT01260142|459674489|FG000|Treatment Period 1|Study on hold|1|||
127739918|NCT01260142|459674490|FG001|Treatment Period 1|Study on hold|1|||
127739919|NCT01260142|459674491|FG002|Treatment Period 1|Study on hold|0|||
127739920|NCT01260142|459674492|FG003|Treatment Period 1|Study on hold|0|||
127739921|NCT01260142|459674493|FG004|Treatment Period 1|Study on hold|1|||
127739922|NCT01260142|459674494|FG005|Treatment Period 1|Study on hold|2|||
127739923|NCT01260142|459674489|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
127739924|NCT01260142|459674490|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
127739925|NCT01260142|459674491|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
127739926|NCT01260142|459674492|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
127739927|NCT01260142|459674493|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
127739928|NCT01260142|459674494|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
127739929|NCT01260142|459674489|FG000|Treatment Period 1|Withdrawal by Subject|0|||
127739930|NCT01260142|459674490|FG001|Treatment Period 1|Withdrawal by Subject|0|||
127739931|NCT01260142|459674491|FG002|Treatment Period 1|Withdrawal by Subject|0|||
127739932|NCT01260142|459674492|FG003|Treatment Period 1|Withdrawal by Subject|0|||
127739933|NCT01260142|459674493|FG004|Treatment Period 1|Withdrawal by Subject|0|||
127739934|NCT01260142|459674494|FG005|Treatment Period 1|Withdrawal by Subject|1|||
127739935|NCT00424177|459674495|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
127739936|NCT00424177|459674495|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
127739937|NCT00424177|459674495|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
127739938|NCT00424177|459674495|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
127739939|NCT00424177|459674495|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
127806880|NCT00896532|459913534|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
127739940|NCT00424177|459674495|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
127739941|NCT00424177|459674495|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
127739942|NCT00424177|459674495|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
127739943|NCT00424177|459674495|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
127739944|NCT00424177|459674495|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
127739945|NCT00691678|459674501|FG000|Overall Study|Adverse Event|5|||
127739946|NCT00691678|459674501|FG000|Overall Study|life events, pain|11|||
127739947|NCT02930837|459674502|FG000|Overall Study|Adverse Event|6|||
127739948|NCT02930837|459674502|FG000|Overall Study|Lost to Follow-up|5|||
127739949|NCT02930837|459674502|FG000|Overall Study|Withdrawal by Subject|1|||
127739950|NCT01831726|459674503|FG000|Overall Study|Adverse Event|16|||
127739951|NCT01831726|459674503|FG000|Overall Study|Death|7|||
127739952|NCT01831726|459674503|FG000|Overall Study|Disease Progression|49|||
127739953|NCT01831726|459674503|FG000|Overall Study|Physician Decision|1|||
127739954|NCT01831726|459674503|FG000|Overall Study|Subject/guardian decision|7|||
127739955|NCT01502371|459674506|FG000|Overall Study|Withdrawal by Subject|1|||
127739956|NCT01502371|459674507|FG001|Overall Study|Withdrawal by Subject|2|||
127739957|NCT01502371|459674508|FG002|Overall Study|Withdrawal by Subject|1|||
127739958|NCT01502371|459674509|FG003|Overall Study|Withdrawal by Subject|1|||
127739959|NCT01502371|459674510|FG004|Overall Study|Withdrawal by Subject|1|||
127739960|NCT01502371|459674506|FG000|Overall Study|Adverse Event|2|||
127739961|NCT01502371|459674507|FG001|Overall Study|Adverse Event|1|||
127739962|NCT01502371|459674508|FG002|Overall Study|Adverse Event|0|||
127739963|NCT01502371|459674509|FG003|Overall Study|Adverse Event|4|||
127739964|NCT01502371|459674510|FG004|Overall Study|Adverse Event|3|||
127739965|NCT01502371|459674506|FG000|Overall Study|Treatment Failure|22|||
127739966|NCT01502371|459674507|FG001|Overall Study|Treatment Failure|20|||
127739967|NCT01502371|459674508|FG002|Overall Study|Treatment Failure|12|||
127739968|NCT01502371|459674509|FG003|Overall Study|Treatment Failure|19|||
127739969|NCT01502371|459674510|FG004|Overall Study|Treatment Failure|30|||
127739970|NCT01502371|459674506|FG000|Overall Study|Lack of Efficacy|3|||
127739971|NCT01502371|459674507|FG001|Overall Study|Lack of Efficacy|3|||
127739972|NCT01502371|459674508|FG002|Overall Study|Lack of Efficacy|2|||
127739973|NCT01502371|459674509|FG003|Overall Study|Lack of Efficacy|2|||
127739974|NCT01502371|459674510|FG004|Overall Study|Lack of Efficacy|4|||
127739975|NCT01502371|459674506|FG000|Overall Study|Physician Decision|3|||
127739976|NCT01502371|459674507|FG001|Overall Study|Physician Decision|0|||
127739977|NCT01502371|459674508|FG002|Overall Study|Physician Decision|0|||
127739978|NCT01502371|459674509|FG003|Overall Study|Physician Decision|0|||
127739979|NCT01502371|459674510|FG004|Overall Study|Physician Decision|1|||
127739980|NCT01502371|459674506|FG000|Overall Study|Noncompliance with Study Drug|0|||
127739981|NCT01502371|459674507|FG001|Overall Study|Noncompliance with Study Drug|0|||
127739982|NCT01502371|459674508|FG002|Overall Study|Noncompliance with Study Drug|1|||
127739983|NCT01502371|459674509|FG003|Overall Study|Noncompliance with Study Drug|2|||
127739984|NCT01502371|459674510|FG004|Overall Study|Noncompliance with Study Drug|1|||
127739985|NCT01502371|459674506|FG000|Overall Study|Technical Problems|1|||
127739986|NCT01502371|459674507|FG001|Overall Study|Technical Problems|0|||
127739987|NCT01502371|459674508|FG002|Overall Study|Technical Problems|2|||
127739988|NCT01502371|459674509|FG003|Overall Study|Technical Problems|4|||
127739989|NCT01502371|459674510|FG004|Overall Study|Technical Problems|1|||
127739990|NCT01502371|459674506|FG000|Overall Study|Protocol Violation|9|||
127739991|NCT01502371|459674507|FG001|Overall Study|Protocol Violation|5|||
127739992|NCT01502371|459674508|FG002|Overall Study|Protocol Violation|6|||
127739993|NCT01502371|459674509|FG003|Overall Study|Protocol Violation|5|||
127739994|NCT01502371|459674510|FG004|Overall Study|Protocol Violation|10|||
127739995|NCT01502371|459674506|FG000|Overall Study|Excluded Medication|0|||
127739996|NCT01502371|459674507|FG001|Overall Study|Excluded Medication|1|||
127739997|NCT01502371|459674508|FG002|Overall Study|Excluded Medication|1|||
127739998|NCT01502371|459674509|FG003|Overall Study|Excluded Medication|0|||
127739999|NCT01502371|459674510|FG004|Overall Study|Excluded Medication|1|||
127740000|NCT00605566|459675859|FG000|Overall Study|Adverse Event|1|||
127740001|NCT00605566|459675859|FG000|Overall Study|Clinical deterioration|1|||
127740002|NCT00605566|459675859|FG000|Overall Study|Poor compliance in run-in period|1|||
127740003|NCT04156399|459675860|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
127740004|NCT04156399|459675860|FG000|Overall Study|study suspension due to COVID pandemic|3|||
127740005|NCT03440047|459675861|FG000|Overall Study|Withdrawal by Subject|2|||
127740006|NCT01181609|459675862|FG000|Overall Study|Adverse Event|1|||
127740007|NCT01181609|459675862|FG000|Overall Study|Withdrawal by Subject|1|||
127740008|NCT01181609|459675862|FG000|Overall Study|Lost to Follow-up|1|||
127740009|NCT01181609|459675862|FG000|Overall Study|Death|50|||
127740010|NCT00478647|459675863|FG000|Overall Study|Adverse Event|1|||
127740011|NCT00478647|459675863|FG000|Overall Study|Withdrawal by Subject|1|||
127740012|NCT00511836|459675864|FG000|Double-blind Period|Lost to Follow-up|1|||
127740013|NCT00511836|459675865|FG001|Double-blind Period|Lost to Follow-up|0|||
127740014|NCT00702650|459675869|FG000|Overall Study|Withdrawal by Subject|9|||
127740015|NCT00702650|459675869|FG000|Overall Study|Non-Compliance of Study Drug|3|||
127740016|NCT00702650|459675869|FG000|Overall Study|Lost to Follow-up|2|||
127740017|NCT00702650|459675869|FG000|Overall Study|Non-Compliance with Site Directives|1|||
127740018|NCT00702650|459675869|FG000|Overall Study|Sponsor Request|1|||
127740019|NCT00702650|459675869|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
127740020|NCT00702650|459675869|FG000|Overall Study|Adverse Event|3|||
127740021|NCT01850823|459675873|FG000|Overall Study|Early Visit Window|0|||
127740022|NCT01850823|459675874|FG001|Overall Study|Early Visit Window|1|||
127740023|NCT01850823|459675875|FG002|Overall Study|Early Visit Window|4|||
127740024|NCT01850823|459675873|FG000|Overall Study|Enrolled in Error|0|||
127740025|NCT01850823|459675874|FG001|Overall Study|Enrolled in Error|1|||
127740026|NCT01850823|459675875|FG002|Overall Study|Enrolled in Error|2|||
127740027|NCT01850823|459675873|FG000|Overall Study|Lack of Efficacy|1|||
127740028|NCT01850823|459675874|FG001|Overall Study|Lack of Efficacy|0|||
127740029|NCT01850823|459675875|FG002|Overall Study|Lack of Efficacy|0|||
127740030|NCT01850823|459675873|FG000|Overall Study|Lost to Follow-up|0|||
127740031|NCT01850823|459675874|FG001|Overall Study|Lost to Follow-up|0|||
127740032|NCT01850823|459675875|FG002|Overall Study|Lost to Follow-up|1|||
127740033|NCT01850823|459675873|FG000|Overall Study|Restricted Medication|0|||
127740034|NCT01850823|459675874|FG001|Overall Study|Restricted Medication|0|||
127740035|NCT01850823|459675875|FG002|Overall Study|Restricted Medication|2|||
127740036|NCT01850823|459675873|FG000|Overall Study|Significant worstening of SAR|0|||
127740037|NCT01850823|459675874|FG001|Overall Study|Significant worstening of SAR|1|||
127740038|NCT01850823|459675875|FG002|Overall Study|Significant worstening of SAR|0|||
127740039|NCT01850823|459675873|FG000|Overall Study|Withdrawal by Subject|2|||
127740040|NCT01850823|459675874|FG001|Overall Study|Withdrawal by Subject|0|||
127740041|NCT01850823|459675875|FG002|Overall Study|Withdrawal by Subject|1|||
127740042|NCT00913523|459675876|FG000|Overall Study|Withdrawal by Subject|3|||
127740043|NCT00913523|459675877|FG001|Overall Study|Withdrawal by Subject|2|||
127740044|NCT00913523|459675878|FG002|Overall Study|Withdrawal by Subject|2|||
127740045|NCT00913523|459675876|FG000|Overall Study|Lost to Follow-up|1|||
127740046|NCT00913523|459675877|FG001|Overall Study|Lost to Follow-up|1|||
127740047|NCT00913523|459675878|FG002|Overall Study|Lost to Follow-up|1|||
127740048|NCT00913523|459675876|FG000|Overall Study|Adverse Event|1|||
127740049|NCT00913523|459675877|FG001|Overall Study|Adverse Event|0|||
127740050|NCT00913523|459675878|FG002|Overall Study|Adverse Event|0|||
127740051|NCT00913523|459675876|FG000|Overall Study|Protocol Violation|5|||
127740052|NCT00913523|459675877|FG001|Overall Study|Protocol Violation|8|||
127740053|NCT00913523|459675878|FG002|Overall Study|Protocol Violation|8|||
127740054|NCT00913523|459675876|FG000|Overall Study|Pregnancy|1|||
127740055|NCT00913523|459675877|FG001|Overall Study|Pregnancy|3|||
127740056|NCT00913523|459675878|FG002|Overall Study|Pregnancy|0|||
127740057|NCT00913523|459675876|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
127740058|NCT00913523|459675877|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
127740059|NCT00913523|459675878|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
127740060|NCT02895360|459675879|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
127740061|NCT02895360|459675880|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
127740062|NCT02895360|459675881|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
127740063|NCT02895360|459675882|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
127740064|NCT02895360|459675883|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
127740065|NCT02895360|459675884|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
127740066|NCT02895360|459675879|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
127740067|NCT02895360|459675880|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
127740068|NCT02895360|459675881|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
127740069|NCT02895360|459675882|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
127740070|NCT02895360|459675883|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
127740071|NCT02895360|459675884|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
127740072|NCT02895360|459675879|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
127740073|NCT02895360|459675880|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
127740074|NCT02895360|459675881|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
127740075|NCT02895360|459675882|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
127740076|NCT02895360|459675883|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
127740077|NCT02895360|459675884|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
127740078|NCT02895360|459675879|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
127740079|NCT02895360|459675880|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
127740080|NCT02895360|459675881|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
127740081|NCT02895360|459675882|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
127740082|NCT02895360|459675883|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
127740083|NCT02895360|459675884|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
127740084|NCT02895360|459675879|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
127740085|NCT02895360|459675880|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
127740086|NCT02895360|459675881|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
127740087|NCT02895360|459675882|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
127740088|NCT02895360|459675883|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
127740089|NCT02895360|459675884|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
127740090|NCT02895360|459675879|FG000|Phase 2a|Adverse Event|0|||
127740091|NCT02895360|459675880|FG001|Phase 2a|Adverse Event|0|||
127740092|NCT02895360|459675881|FG002|Phase 2a|Adverse Event|0|||
127740093|NCT02895360|459675882|FG003|Phase 2a|Adverse Event|0|||
127740094|NCT02895360|459675883|FG004|Phase 2a|Adverse Event|0|||
127740095|NCT02895360|459675884|FG005|Phase 2a|Adverse Event|1|||
127740096|NCT02895360|459675879|FG000|Phase 2a|Progressive disease|0|||
127740097|NCT02895360|459675880|FG001|Phase 2a|Progressive disease|0|||
127740098|NCT02895360|459675881|FG002|Phase 2a|Progressive disease|0|||
127740099|NCT02895360|459675882|FG003|Phase 2a|Progressive disease|0|||
127740100|NCT02895360|459675883|FG004|Phase 2a|Progressive disease|11|||
127740101|NCT02895360|459675884|FG005|Phase 2a|Progressive disease|11|||
127740102|NCT01844726|459675885|FG000|Overall Study|Withdrawal by Subject|0|||
127740103|NCT01844726|459675886|FG001|Overall Study|Withdrawal by Subject|1|||
127740104|NCT01844726|459675885|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
127740105|NCT01844726|459675886|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
127740106|NCT01475461|459675889|FG000|Run-in Period|Not meet eligibility criteria|16|||
127740107|NCT01475461|459675890|FG001|Run-in Period|Not meet eligibility criteria|0|||
127740108|NCT01475461|459675891|FG002|Run-in Period|Not meet eligibility criteria|0|||
127740109|NCT01475461|459675892|FG003|Run-in Period|Not meet eligibility criteria|0|||
127740110|NCT01475461|459675893|FG004|Run-in Period|Not meet eligibility criteria|0|||
127740111|NCT01475461|459675894|FG005|Run-in Period|Not meet eligibility criteria|0|||
127740112|NCT01475461|459675895|FG006|Run-in Period|Not meet eligibility criteria|0|||
127740113|NCT01475461|459675889|FG000|Run-in Period|Lost to Follow-up|7|||
127740114|NCT01475461|459675890|FG001|Run-in Period|Lost to Follow-up|0|||
127740115|NCT01475461|459675891|FG002|Run-in Period|Lost to Follow-up|0|||
127740116|NCT01475461|459675892|FG003|Run-in Period|Lost to Follow-up|0|||
127740117|NCT01475461|459675893|FG004|Run-in Period|Lost to Follow-up|0|||
127740118|NCT01475461|459675894|FG005|Run-in Period|Lost to Follow-up|0|||
127740119|NCT01475461|459675895|FG006|Run-in Period|Lost to Follow-up|0|||
127740120|NCT01475461|459675889|FG000|Run-in Period|Withdrawal by Subject|11|||
127740121|NCT01475461|459675890|FG001|Run-in Period|Withdrawal by Subject|0|||
127740122|NCT01475461|459675891|FG002|Run-in Period|Withdrawal by Subject|0|||
127740123|NCT01475461|459675892|FG003|Run-in Period|Withdrawal by Subject|0|||
127740124|NCT01475461|459675893|FG004|Run-in Period|Withdrawal by Subject|0|||
127740125|NCT01475461|459675894|FG005|Run-in Period|Withdrawal by Subject|0|||
127740126|NCT01475461|459675895|FG006|Run-in Period|Withdrawal by Subject|0|||
127740127|NCT01475461|459675889|FG000|Run-in Period|Other|3|||
127740128|NCT01475461|459675890|FG001|Run-in Period|Other|0|||
127740129|NCT01475461|459675891|FG002|Run-in Period|Other|0|||
127740130|NCT01475461|459675892|FG003|Run-in Period|Other|0|||
127740131|NCT01475461|459675893|FG004|Run-in Period|Other|0|||
127740132|NCT01475461|459675894|FG005|Run-in Period|Other|0|||
127740133|NCT01475461|459675895|FG006|Run-in Period|Other|0|||
127740134|NCT01475461|459675889|FG000|Run-in Period|Protocol Violation|4|||
127740135|NCT01475461|459675890|FG001|Run-in Period|Protocol Violation|0|||
127740136|NCT01475461|459675891|FG002|Run-in Period|Protocol Violation|0|||
127740137|NCT01475461|459675892|FG003|Run-in Period|Protocol Violation|0|||
127740138|NCT01475461|459675893|FG004|Run-in Period|Protocol Violation|0|||
127740139|NCT01475461|459675894|FG005|Run-in Period|Protocol Violation|0|||
127740140|NCT01475461|459675895|FG006|Run-in Period|Protocol Violation|0|||
127740141|NCT01475461|459675889|FG000|Treatment Period|Death|0|||
127740142|NCT01475461|459675890|FG001|Treatment Period|Death|0|||
127740143|NCT01475461|459675891|FG002|Treatment Period|Death|0|||
127740144|NCT01475461|459675892|FG003|Treatment Period|Death|1|||
127740145|NCT01475461|459675893|FG004|Treatment Period|Death|0|||
127740146|NCT01475461|459675894|FG005|Treatment Period|Death|0|||
127740147|NCT01475461|459675895|FG006|Treatment Period|Death|0|||
127740148|NCT01475461|459675889|FG000|Treatment Period|Lost to Follow-up|0|||
127740149|NCT01475461|459675890|FG001|Treatment Period|Lost to Follow-up|3|||
127740150|NCT01475461|459675891|FG002|Treatment Period|Lost to Follow-up|2|||
127740151|NCT01475461|459675892|FG003|Treatment Period|Lost to Follow-up|3|||
127740152|NCT01475461|459675893|FG004|Treatment Period|Lost to Follow-up|1|||
127740153|NCT01475461|459675894|FG005|Treatment Period|Lost to Follow-up|2|||
127740154|NCT01475461|459675895|FG006|Treatment Period|Lost to Follow-up|1|||
127740155|NCT01475461|459675889|FG000|Treatment Period|Withdrawal by Subject|0|||
127740156|NCT01475461|459675890|FG001|Treatment Period|Withdrawal by Subject|2|||
127740157|NCT01475461|459675891|FG002|Treatment Period|Withdrawal by Subject|2|||
127740158|NCT01475461|459675892|FG003|Treatment Period|Withdrawal by Subject|0|||
127740159|NCT01475461|459675893|FG004|Treatment Period|Withdrawal by Subject|2|||
127740160|NCT01475461|459675894|FG005|Treatment Period|Withdrawal by Subject|2|||
127740161|NCT01475461|459675895|FG006|Treatment Period|Withdrawal by Subject|0|||
127740162|NCT01475461|459675889|FG000|Treatment Period|Other|0|||
127740163|NCT01475461|459675890|FG001|Treatment Period|Other|1|||
127740164|NCT01475461|459675891|FG002|Treatment Period|Other|0|||
127740165|NCT01475461|459675892|FG003|Treatment Period|Other|0|||
127740166|NCT01475461|459675893|FG004|Treatment Period|Other|0|||
127740167|NCT01475461|459675894|FG005|Treatment Period|Other|0|||
127740168|NCT01475461|459675895|FG006|Treatment Period|Other|0|||
127740169|NCT01475461|459675889|FG000|Treatment Period|Protocol Violation|0|||
127740170|NCT01475461|459675890|FG001|Treatment Period|Protocol Violation|1|||
127740171|NCT01475461|459675891|FG002|Treatment Period|Protocol Violation|0|||
127740172|NCT01475461|459675892|FG003|Treatment Period|Protocol Violation|0|||
127740173|NCT01475461|459675893|FG004|Treatment Period|Protocol Violation|0|||
127740174|NCT01475461|459675894|FG005|Treatment Period|Protocol Violation|0|||
127740175|NCT01475461|459675895|FG006|Treatment Period|Protocol Violation|1|||
127740176|NCT01475461|459675889|FG000|Treatment Period|Lack of Efficacy|0|||
127740177|NCT01475461|459675890|FG001|Treatment Period|Lack of Efficacy|2|||
127740178|NCT01475461|459675891|FG002|Treatment Period|Lack of Efficacy|0|||
127740179|NCT01475461|459675892|FG003|Treatment Period|Lack of Efficacy|2|||
127740180|NCT01475461|459675893|FG004|Treatment Period|Lack of Efficacy|1|||
127740181|NCT01475461|459675894|FG005|Treatment Period|Lack of Efficacy|1|||
127740182|NCT01475461|459675895|FG006|Treatment Period|Lack of Efficacy|0|||
127740183|NCT01475461|459675889|FG000|Treatment Period|Medication Error|0|||
127740184|NCT01475461|459675890|FG001|Treatment Period|Medication Error|0|||
127740185|NCT01475461|459675891|FG002|Treatment Period|Medication Error|0|||
127740186|NCT01475461|459675892|FG003|Treatment Period|Medication Error|1|||
127740187|NCT01475461|459675893|FG004|Treatment Period|Medication Error|0|||
127740188|NCT01475461|459675894|FG005|Treatment Period|Medication Error|0|||
127740189|NCT01475461|459675895|FG006|Treatment Period|Medication Error|0|||
127740190|NCT01475461|459675889|FG000|Treatment Period|Adverse Event|0|||
127740191|NCT01475461|459675890|FG001|Treatment Period|Adverse Event|0|||
127740192|NCT01475461|459675891|FG002|Treatment Period|Adverse Event|0|||
127740193|NCT01475461|459675892|FG003|Treatment Period|Adverse Event|1|||
127740194|NCT01475461|459675893|FG004|Treatment Period|Adverse Event|0|||
127740195|NCT01475461|459675894|FG005|Treatment Period|Adverse Event|0|||
127740196|NCT01475461|459675895|FG006|Treatment Period|Adverse Event|0|||
127740197|NCT02512861|459675898|FG000|Overall Study|Protocol Violation|3|||
127740198|NCT02512861|459675899|FG001|Overall Study|Protocol Violation|7|||
127740199|NCT02512861|459675898|FG000|Overall Study|Physician Decision|3|||
127740200|NCT02512861|459675899|FG001|Overall Study|Physician Decision|1|||
127740201|NCT02512861|459675898|FG000|Overall Study|Withdrawal by Subject|0|||
127740202|NCT02512861|459675899|FG001|Overall Study|Withdrawal by Subject|1|||
127740203|NCT03214250|459675902|FG000|Overall Study|Death|5|||
127740204|NCT03214250|459675903|FG001|Overall Study|Death|5|||
127740205|NCT03214250|459675904|FG002|Overall Study|Death|7|||
127740206|NCT03214250|459675905|FG003|Overall Study|Death|4|||
127740207|NCT03214250|459675906|FG004|Overall Study|Death|23|||
127740208|NCT03214250|459675907|FG005|Overall Study|Death|23|||
127740209|NCT03214250|459675908|FG006|Overall Study|Death|24|||
127740210|NCT03214250|459675902|FG000|Overall Study|Lost to Follow-up|0|||
127740211|NCT03214250|459675903|FG001|Overall Study|Lost to Follow-up|0|||
127740212|NCT03214250|459675904|FG002|Overall Study|Lost to Follow-up|0|||
127740213|NCT03214250|459675905|FG003|Overall Study|Lost to Follow-up|1|||
127740214|NCT03214250|459675906|FG004|Overall Study|Lost to Follow-up|1|||
127740215|NCT03214250|459675907|FG005|Overall Study|Lost to Follow-up|2|||
127740216|NCT03214250|459675908|FG006|Overall Study|Lost to Follow-up|0|||
127740217|NCT03214250|459675902|FG000|Overall Study|Other|0|||
127740218|NCT03214250|459675903|FG001|Overall Study|Other|0|||
127740219|NCT03214250|459675904|FG002|Overall Study|Other|0|||
127740220|NCT03214250|459675905|FG003|Overall Study|Other|0|||
127740221|NCT03214250|459675906|FG004|Overall Study|Other|1|||
127740222|NCT03214250|459675907|FG005|Overall Study|Other|1|||
127740223|NCT03214250|459675908|FG006|Overall Study|Other|2|||
127740224|NCT03214250|459675902|FG000|Overall Study|Remains on Study|2|||
127806881|NCT00896532|459913535|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
127806882|NCT00896532|459913536|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
127806883|NCT00896532|459913537|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
127740225|NCT03214250|459675903|FG001|Overall Study|Remains on Study|2|||
127740226|NCT03214250|459675904|FG002|Overall Study|Remains on Study|0|||
127740227|NCT03214250|459675905|FG003|Overall Study|Remains on Study|1|||
127740228|NCT03214250|459675906|FG004|Overall Study|Remains on Study|7|||
127740229|NCT03214250|459675907|FG005|Overall Study|Remains on Study|5|||
127806884|NCT00896532|459913538|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
127740230|NCT03214250|459675908|FG006|Overall Study|Remains on Study|3|||
127740231|NCT03214250|459675902|FG000|Overall Study|Withdrawal by Subject|0|||
127740232|NCT03214250|459675903|FG001|Overall Study|Withdrawal by Subject|0|||
127740233|NCT03214250|459675904|FG002|Overall Study|Withdrawal by Subject|1|||
127740234|NCT03214250|459675905|FG003|Overall Study|Withdrawal by Subject|2|||
127893029|NCT01621490|460231291|FG010|Overall Study|Death|0|||
127740235|NCT03214250|459675906|FG004|Overall Study|Withdrawal by Subject|5|||
127740236|NCT03214250|459675907|FG005|Overall Study|Withdrawal by Subject|0|||
127740237|NCT03214250|459675908|FG006|Overall Study|Withdrawal by Subject|2|||
127740238|NCT00292981|459675912|FG000|Overall Study|Adverse Event|1|||
127740239|NCT00292981|459675912|FG000|Overall Study|Lost to Follow-up|13|||
127740240|NCT00292981|459675912|FG000|Overall Study|Withdrawal by Subject|22|||
127740241|NCT00292981|459675912|FG000|Overall Study|Other|3|||
127740242|NCT00594178|459675913|FG000|Overall Study|Physician Decision|5|||
127740243|NCT00496626|459675914|FG000|Overall Study|Lost to Follow-up|0|||
127740244|NCT00496626|459675915|FG001|Overall Study|Lost to Follow-up|1|||
127740245|NCT00496626|459675914|FG000|Overall Study|Protocol Violation|1|||
127740246|NCT00496626|459675915|FG001|Overall Study|Protocol Violation|0|||
127740247|NCT00496626|459675914|FG000|Overall Study|Withdrawal by Subject|5|||
127740248|NCT00496626|459675915|FG001|Overall Study|Withdrawal by Subject|4|||
127740249|NCT00496626|459675914|FG000|Overall Study|Relocated|0|||
127740250|NCT00496626|459675915|FG001|Overall Study|Relocated|1|||
127740251|NCT00727415|459675916|FG000|Phase I|Dose Limiting Toxicity|2|||
127740252|NCT02971228|459675920|FG000|Overall Study|Withdrawal by Subject|1|||
127740253|NCT02971228|459675921|FG001|Overall Study|Withdrawal by Subject|1|||
127740254|NCT02971228|459675922|FG002|Overall Study|Withdrawal by Subject|0|||
127740255|NCT02971228|459675923|FG003|Overall Study|Withdrawal by Subject|0|||
127740256|NCT02971228|459675924|FG004|Overall Study|Withdrawal by Subject|0|||
127740257|NCT02971228|459675920|FG000|Overall Study|Logistical challenges|0|||
127740258|NCT02971228|459675921|FG001|Overall Study|Logistical challenges|1|||
127740259|NCT02971228|459675922|FG002|Overall Study|Logistical challenges|0|||
127740260|NCT02971228|459675923|FG003|Overall Study|Logistical challenges|0|||
127740261|NCT02971228|459675924|FG004|Overall Study|Logistical challenges|0|||
127740262|NCT01167192|459675925|FG000|Overall Study|Adverse Event|1|||
127740263|NCT01167192|459675925|FG000|Overall Study|Death|1|||
127740264|NCT01167192|459675925|FG000|Overall Study|Withdrawal by Subject|1|||
127740265|NCT01167192|459675925|FG000|Overall Study|Insurance denial|1|||
127740266|NCT00827775|459675935|FG000|Overall Study|Withdrawal by Subject|0|||
127740267|NCT00827775|459675936|FG001|Overall Study|Withdrawal by Subject|5|||
127740268|NCT00545571|459675939|FG000|Overall Study|Administrative Reasons|1|||
127740269|NCT00545571|459675939|FG000|Overall Study|Adverse Event|2|||
127740270|NCT00545571|459675939|FG000|Overall Study|Death|5|||
127740271|NCT00545571|459675939|FG000|Overall Study|Lack of Efficacy|1|||
127740272|NCT00545571|459675939|FG000|Overall Study|Protocol Violation|2|||
127740273|NCT00545571|459675939|FG000|Overall Study|Refused Treatment|1|||
127740274|NCT00545571|459675939|FG000|Overall Study|Screen Failure|16|||
127740275|NCT00545571|459675939|FG000|Overall Study|Transfusion|12|||
127740276|NCT00545571|459675939|FG000|Overall Study|Early Termination of Study|24|||
127740277|NCT00545571|459675939|FG000|Overall Study|Kidney Transplantation|3|||
127740278|NCT01013740|459675940|FG000|Overall Study|Lost to Follow-up|3|||
127740279|NCT01013740|459675941|FG001|Overall Study|Lost to Follow-up|5|||
127740280|NCT01013740|459675940|FG000|Overall Study|Physician Decision|2|||
127740281|NCT01013740|459675941|FG001|Overall Study|Physician Decision|0|||
127740282|NCT01013740|459675940|FG000|Overall Study|Withdrawal by Subject|2|||
127740283|NCT01013740|459675941|FG001|Overall Study|Withdrawal by Subject|10|||
127740284|NCT01013740|459675940|FG000|Overall Study|study close / terminated : done in error|2|||
127740285|NCT01013740|459675941|FG001|Overall Study|study close / terminated : done in error|1|||
127740286|NCT01013740|459675940|FG000|Overall Study|Missing|2|||
127740287|NCT01013740|459675941|FG001|Overall Study|Missing|1|||
127740288|NCT01013740|459675940|FG000|Overall Study|Ongoing: Study records not completed|0|||
127740289|NCT01013740|459675941|FG001|Overall Study|Ongoing: Study records not completed|2|||
127740290|NCT00338949|459675942|FG000|Subject Screening|Screen failures|11|||
127740291|NCT00338949|459675943|FG001|Subject Screening|Screen failures|11|||
127740292|NCT00338949|459675942|FG000|Randomization|Withdrawal by Subject|1|||
127740293|NCT00338949|459675943|FG001|Randomization|Withdrawal by Subject|0|||
127740294|NCT00338949|459675942|FG000|Randomization|Adverse Event|0|||
127740295|NCT00338949|459675943|FG001|Randomization|Adverse Event|5|||
127740296|NCT01242371|459675944|FG000|Overall Study|Withdrawal by Subject|2|||
127740297|NCT01242371|459675945|FG001|Overall Study|Withdrawal by Subject|2|||
127740298|NCT01242371|459675944|FG000|Overall Study|Protocol Violation|0|||
127740299|NCT01242371|459675945|FG001|Overall Study|Protocol Violation|3|||
127740300|NCT00025662|459675946|FG000|Overall Study|Withdrawal by Subject|2|||
127740301|NCT00025662|459675946|FG000|Overall Study|Technical failure of manipulation|1|||
127740302|NCT00582114|459675947|FG000|Overall Study|Death|4|||
127740303|NCT00582114|459675948|FG001|Overall Study|Death|4|||
127740304|NCT00582114|459675947|FG000|Overall Study|Kidney Transplant|3|||
127740305|NCT00582114|459675948|FG001|Overall Study|Kidney Transplant|1|||
127740306|NCT00582114|459675947|FG000|Overall Study|Lost to Follow-up|7|||
127806885|NCT00896532|459913539|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
127806886|NCT00896532|459913540|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
127806887|NCT00896532|459913541|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
127806888|NCT00896532|459913542|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
127806889|NCT00896532|459913543|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
127806890|NCT00896532|459913544|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
127806891|NCT00896532|459913545|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
127806892|NCT00896532|459913546|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
127806893|NCT00896532|459913524|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
127740307|NCT00582114|459675948|FG001|Overall Study|Lost to Follow-up|6|||
127740308|NCT00582114|459675947|FG000|Overall Study|Withdrawal by Subject|8|||
127740309|NCT00582114|459675948|FG001|Overall Study|Withdrawal by Subject|16|||
127740310|NCT00582114|459675947|FG000|Overall Study|Adverse Event|1|||
127740311|NCT00582114|459675948|FG001|Overall Study|Adverse Event|1|||
127740312|NCT00582114|459675947|FG000|Overall Study|Physician Decision|0|||
127740313|NCT00582114|459675948|FG001|Overall Study|Physician Decision|6|||
127740314|NCT00582114|459675947|FG000|Overall Study|Stopped by data safety monitoring board|19|||
127740315|NCT00582114|459675948|FG001|Overall Study|Stopped by data safety monitoring board|20|||
127740316|NCT02604342|459675949|FG000|Overall Study|Death|32|||
127740317|NCT02604342|459675950|FG001|Overall Study|Death|16|||
127740318|NCT02604342|459675949|FG000|Overall Study|Progression of disease|1|||
127740319|NCT02604342|459675950|FG001|Overall Study|Progression of disease|0|||
127740320|NCT02604342|459675949|FG000|Overall Study|Withdrawal by Subject|5|||
127740321|NCT02604342|459675950|FG001|Overall Study|Withdrawal by Subject|6|||
127740322|NCT02604342|459675949|FG000|Overall Study|Other|1|||
127740323|NCT02604342|459675950|FG001|Overall Study|Other|0|||
127740324|NCT02604342|459675949|FG000|Overall Study|Study Termination by Sponsor|1|||
127740325|NCT02604342|459675950|FG001|Overall Study|Study Termination by Sponsor|0|||
127740326|NCT02604342|459675949|FG000|Overall Study|Lost to Follow-up|1|||
127740327|NCT02604342|459675950|FG001|Overall Study|Lost to Follow-up|1|||
127740328|NCT02604342|459675949|FG000|Overall Study|Physician Decision|2|||
127740329|NCT02604342|459675950|FG001|Overall Study|Physician Decision|0|||
127740330|NCT00130728|459675951|FG000|Overall Study|Death|258|||
127740331|NCT00130728|459675952|FG001|Overall Study|Death|258|||
127740332|NCT00130728|459675951|FG000|Overall Study|Lost to Follow-up|4|||
127740333|NCT00130728|459675952|FG001|Overall Study|Lost to Follow-up|0|||
127740334|NCT00130728|459675951|FG000|Overall Study|Withdrawal by Subject|0|||
127740335|NCT00130728|459675952|FG001|Overall Study|Withdrawal by Subject|2|||
127740336|NCT01349036|459675953|FG000|Overall Study|Disease progression|13|||
127740337|NCT01349036|459675954|FG001|Overall Study|Disease progression|22|||
127740338|NCT01349036|459675953|FG000|Overall Study|Other|1|||
127740339|NCT01349036|459675954|FG001|Overall Study|Other|0|||
127740340|NCT01349036|459675953|FG000|Overall Study|Withdrawal by Subject|0|||
127740341|NCT01349036|459675954|FG001|Overall Study|Withdrawal by Subject|2|||
127740342|NCT00746356|459675955|FG000|Overall Study|Withdrawal by Subject|2|||
127740343|NCT00746356|459675956|FG001|Overall Study|Withdrawal by Subject|3|||
127740344|NCT00746356|459675955|FG000|Overall Study|Death|7|||
127740345|NCT00746356|459675956|FG001|Overall Study|Death|3|||
127740346|NCT00746356|459675955|FG000|Overall Study|Lost to Follow-up|1|||
127740347|NCT00746356|459675956|FG001|Overall Study|Lost to Follow-up|0|||
127740348|NCT00746356|459675955|FG000|Overall Study|Removal of Device|0|||
127740349|NCT00746356|459675956|FG001|Overall Study|Removal of Device|1|||
127806894|NCT00896532|459913525|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
127806895|NCT00896532|459913526|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
127806896|NCT00896532|459913527|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
127806897|NCT00896532|459913528|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
127806898|NCT00896532|459913529|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
127806899|NCT00896532|459913530|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
127806900|NCT00896532|459913531|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
127806901|NCT00896532|459913532|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
127806902|NCT00896532|459913533|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
127806903|NCT00896532|459913534|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
127806904|NCT00896532|459913535|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
127806905|NCT00896532|459913536|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
127806906|NCT00896532|459913537|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
127806907|NCT00896532|459913538|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
127806908|NCT00896532|459913539|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
127806909|NCT00896532|459913540|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
127806910|NCT00896532|459913541|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
127806911|NCT00896532|459913542|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
127806912|NCT00896532|459913543|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
127806913|NCT00896532|459913544|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
127806914|NCT00896532|459913545|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
127806915|NCT00896532|459913546|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
127806916|NCT00896532|459913524|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
127806917|NCT00896532|459913525|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
127806918|NCT00896532|459913526|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
127806919|NCT00896532|459913527|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
127806920|NCT00896532|459913528|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
127806921|NCT00896532|459913529|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
127806922|NCT00896532|459913530|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
127806923|NCT00896532|459913531|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
127893030|NCT01621490|460231281|FG000|Overall Study|Other reasons|7|||
127893031|NCT01621490|460231282|FG001|Overall Study|Other reasons|6|||
127740350|NCT00746356|459675955|FG000|Overall Study|Patient relocated|1|||
127740351|NCT00746356|459675956|FG001|Overall Study|Patient relocated|0|||
127740352|NCT01125566|459675961|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
127740353|NCT01125566|459675962|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
127740354|NCT01125566|459675963|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
127740355|NCT01125566|459675961|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
127740356|NCT01125566|459675962|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
127740357|NCT01125566|459675963|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
127740358|NCT01125566|459675961|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
127740359|NCT01125566|459675962|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
127740360|NCT01125566|459675963|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
127740361|NCT01125566|459675961|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
127740362|NCT01125566|459675962|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
127740363|NCT01125566|459675963|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
127740364|NCT01125566|459675961|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
127740365|NCT01125566|459675962|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
127740366|NCT01125566|459675963|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
127740367|NCT01125566|459675961|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
127740368|NCT01125566|459675962|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
127740369|NCT01125566|459675963|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
127740370|NCT01125566|459675961|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
127806924|NCT00896532|459913532|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
127740371|NCT01125566|459675962|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
127740372|NCT01125566|459675963|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
127740373|NCT01125566|459675961|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
127740374|NCT01125566|459675962|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
127740375|NCT01125566|459675963|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
127740376|NCT01125566|459675961|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
127740377|NCT01125566|459675962|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
127740378|NCT01125566|459675963|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
127740379|NCT01125566|459675961|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
127740380|NCT01125566|459675962|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
127740381|NCT01125566|459675963|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
127740382|NCT01125566|459675961|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
127740383|NCT01125566|459675962|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
127740384|NCT01125566|459675963|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
127740385|NCT01125566|459675961|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
127740386|NCT01125566|459675962|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
127740387|NCT01125566|459675963|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
127740388|NCT02881047|459675964|FG000|Overall Study|Adverse Event|1|||
127740389|NCT02881047|459675964|FG000|Overall Study|Withdrawal by Subject|1|||
127740390|NCT03028012|459675965|FG000|Overall Study|Lost to Follow-up|2|||
127740391|NCT03028012|459675966|FG001|Overall Study|Lost to Follow-up|3|||
127740392|NCT03028012|459675967|FG002|Overall Study|Lost to Follow-up|3|||
127740393|NCT02484547|459675976|FG000|Placebo-Controlled Period|Adverse Event|10|||
127740394|NCT02484547|459675977|FG001|Placebo-Controlled Period|Adverse Event|13|||
127740395|NCT02484547|459675978|FG002|Placebo-Controlled Period|Adverse Event|20|||
127740396|NCT02484547|459675979|FG003|Placebo-Controlled Period|Adverse Event|0|||
127740397|NCT02484547|459675980|FG004|Placebo-Controlled Period|Adverse Event|0|||
127740398|NCT02484547|459675981|FG005|Placebo-Controlled Period|Adverse Event|0|||
127740399|NCT02484547|459675982|FG006|Placebo-Controlled Period|Adverse Event|0|||
127740400|NCT02484547|459675976|FG000|Placebo-Controlled Period|Change of Treatment|0|||
127740401|NCT02484547|459675977|FG001|Placebo-Controlled Period|Change of Treatment|0|||
127740402|NCT02484547|459675978|FG002|Placebo-Controlled Period|Change of Treatment|1|||
127740403|NCT02484547|459675979|FG003|Placebo-Controlled Period|Change of Treatment|0|||
127740404|NCT02484547|459675980|FG004|Placebo-Controlled Period|Change of Treatment|0|||
127740405|NCT02484547|459675981|FG005|Placebo-Controlled Period|Change of Treatment|0|||
127740406|NCT02484547|459675982|FG006|Placebo-Controlled Period|Change of Treatment|0|||
127740407|NCT02484547|459675976|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
127740408|NCT02484547|459675977|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
127740409|NCT02484547|459675978|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
127740410|NCT02484547|459675979|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
127740411|NCT02484547|459675980|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
127806925|NCT00896532|459913533|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
127806926|NCT00896532|459913534|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
127806927|NCT00896532|459913535|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
127806928|NCT00896532|459913536|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
127806929|NCT00896532|459913537|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
127806930|NCT00896532|459913538|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
127806931|NCT00896532|459913539|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
127740412|NCT02484547|459675981|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
127740413|NCT02484547|459675982|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
127806932|NCT00896532|459913540|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
127806933|NCT00896532|459913541|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
127806934|NCT00896532|459913542|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
127806935|NCT00896532|459913543|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
127806936|NCT00896532|459913544|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
127806937|NCT00896532|459913545|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
127806938|NCT00896532|459913546|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
127740414|NCT02484547|459675976|FG000|Placebo-Controlled Period|Death|5|||
127740415|NCT02484547|459675977|FG001|Placebo-Controlled Period|Death|0|||
127740416|NCT02484547|459675978|FG002|Placebo-Controlled Period|Death|6|||
127740417|NCT02484547|459675979|FG003|Placebo-Controlled Period|Death|0|||
127740418|NCT02484547|459675980|FG004|Placebo-Controlled Period|Death|0|||
127740419|NCT02484547|459675981|FG005|Placebo-Controlled Period|Death|0|||
127740420|NCT02484547|459675982|FG006|Placebo-Controlled Period|Death|0|||
127740421|NCT02484547|459675976|FG000|Placebo-Controlled Period|Disease Progression|2|||
127740422|NCT02484547|459675977|FG001|Placebo-Controlled Period|Disease Progression|0|||
127740423|NCT02484547|459675978|FG002|Placebo-Controlled Period|Disease Progression|1|||
127740424|NCT02484547|459675979|FG003|Placebo-Controlled Period|Disease Progression|0|||
127806939|NCT00896532|459913524|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
127806940|NCT00896532|459913525|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
127806941|NCT00896532|459913526|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
127806942|NCT00896532|459913527|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
127806943|NCT00896532|459913528|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
127806944|NCT00896532|459913529|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
127740425|NCT02484547|459675980|FG004|Placebo-Controlled Period|Disease Progression|0|||
127740426|NCT02484547|459675981|FG005|Placebo-Controlled Period|Disease Progression|0|||
127806945|NCT00896532|459913530|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
127806946|NCT00896532|459913531|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
127806947|NCT00896532|459913532|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
127806948|NCT00896532|459913533|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
127806949|NCT00896532|459913534|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
127806950|NCT00896532|459913535|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
127806951|NCT00896532|459913536|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
127806952|NCT00896532|459913537|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
127806953|NCT00896532|459913538|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
127806954|NCT00896532|459913539|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
127806955|NCT00896532|459913540|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
127806956|NCT00896532|459913541|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
127806957|NCT00896532|459913542|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
127806958|NCT00896532|459913543|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
127806959|NCT00896532|459913544|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
127806960|NCT00896532|459913545|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
127806961|NCT00896532|459913546|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
127806962|NCT00896532|459913524|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
127806963|NCT00896532|459913525|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
127806964|NCT00896532|459913526|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
127806965|NCT00896532|459913527|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
127806966|NCT00896532|459913528|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
127806967|NCT00896532|459913529|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
127806968|NCT00896532|459913530|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
127806969|NCT00896532|459913531|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
127806970|NCT00896532|459913532|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
127806971|NCT00896532|459913533|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
127806972|NCT00896532|459913534|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
127806973|NCT00896532|459913535|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
127806974|NCT00896532|459913536|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
127806975|NCT00896532|459913537|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
127806976|NCT00896532|459913538|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
127806977|NCT00896532|459913539|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
127806978|NCT00896532|459913540|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
127806979|NCT00896532|459913541|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
127806980|NCT00896532|459913542|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
127806981|NCT00896532|459913543|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
127806982|NCT00896532|459913544|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
127806983|NCT00896532|459913545|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
127893032|NCT01621490|460231283|FG002|Overall Study|Other reasons|4|||
127740427|NCT02484547|459675982|FG006|Placebo-Controlled Period|Disease Progression|0|||
127740428|NCT02484547|459675976|FG000|Placebo-Controlled Period|Investigator Decision|2|||
127740429|NCT02484547|459675977|FG001|Placebo-Controlled Period|Investigator Decision|2|||
127740430|NCT02484547|459675978|FG002|Placebo-Controlled Period|Investigator Decision|5|||
127740431|NCT02484547|459675979|FG003|Placebo-Controlled Period|Investigator Decision|0|||
127740432|NCT02484547|459675980|FG004|Placebo-Controlled Period|Investigator Decision|0|||
127740433|NCT02484547|459675981|FG005|Placebo-Controlled Period|Investigator Decision|0|||
127740434|NCT02484547|459675982|FG006|Placebo-Controlled Period|Investigator Decision|0|||
127740435|NCT02484547|459675976|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
127740436|NCT02484547|459675977|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
127740437|NCT02484547|459675978|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
127740438|NCT02484547|459675979|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
127740439|NCT02484547|459675980|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
127740440|NCT02484547|459675981|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
127740441|NCT02484547|459675982|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
127740442|NCT02484547|459675976|FG000|Placebo-Controlled Period|Relocation|1|||
127740443|NCT02484547|459675977|FG001|Placebo-Controlled Period|Relocation|1|||
127740444|NCT02484547|459675978|FG002|Placebo-Controlled Period|Relocation|1|||
127740445|NCT02484547|459675979|FG003|Placebo-Controlled Period|Relocation|0|||
127740446|NCT02484547|459675980|FG004|Placebo-Controlled Period|Relocation|0|||
127740447|NCT02484547|459675981|FG005|Placebo-Controlled Period|Relocation|0|||
127740448|NCT02484547|459675982|FG006|Placebo-Controlled Period|Relocation|0|||
127740449|NCT02484547|459675976|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
127740450|NCT02484547|459675977|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
127740451|NCT02484547|459675978|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
127740452|NCT02484547|459675979|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
127740453|NCT02484547|459675980|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
127740454|NCT02484547|459675981|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
127740455|NCT02484547|459675982|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
127740456|NCT02484547|459675976|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
127740457|NCT02484547|459675977|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
127740458|NCT02484547|459675978|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
127740459|NCT02484547|459675979|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
127740460|NCT02484547|459675980|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
127740461|NCT02484547|459675981|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
127740462|NCT02484547|459675982|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
127740463|NCT02484547|459675976|FG000|Placebo-Controlled Period|Reason not Specified|216|||
127740464|NCT02484547|459675977|FG001|Placebo-Controlled Period|Reason not Specified|194|||
127740465|NCT02484547|459675978|FG002|Placebo-Controlled Period|Reason not Specified|183|||
127740466|NCT02484547|459675979|FG003|Placebo-Controlled Period|Reason not Specified|0|||
127806984|NCT00896532|459913546|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
127806985|NCT00896532|459913524|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
127806986|NCT00896532|459913525|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
127806987|NCT00896532|459913526|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
127806988|NCT00896532|459913527|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
127806989|NCT00896532|459913528|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
127806990|NCT00896532|459913529|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
127806991|NCT00896532|459913530|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
127806992|NCT00896532|459913531|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
127806993|NCT00896532|459913532|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
127806994|NCT00896532|459913533|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
127893033|NCT01621490|460231284|FG003|Overall Study|Other reasons|1|||
127893034|NCT01621490|460231285|FG004|Overall Study|Other reasons|1|||
127893035|NCT01621490|460231286|FG005|Overall Study|Other reasons|3|||
127893036|NCT01621490|460231287|FG006|Overall Study|Other reasons|1|||
127893037|NCT01621490|460231288|FG007|Overall Study|Other reasons|1|||
127893038|NCT01621490|460231289|FG008|Overall Study|Other reasons|1|||
127893039|NCT01621490|460231290|FG009|Overall Study|Other reasons|0|||
127893040|NCT01621490|460231291|FG010|Overall Study|Other reasons|0|||
127893041|NCT00461500|460231292|FG000|Overall Study|Adverse Event|1|||
127893042|NCT00461500|460231293|FG001|Overall Study|Adverse Event|0|||
127893043|NCT00461500|460231292|FG000|Overall Study|Lack of Efficacy|0|||
127893044|NCT00461500|460231293|FG001|Overall Study|Lack of Efficacy|1|||
127893045|NCT00461500|460231292|FG000|Overall Study|Expired Drug Treatment|1|||
127893046|NCT00461500|460231293|FG001|Overall Study|Expired Drug Treatment|1|||
127893047|NCT00461500|460231292|FG000|Overall Study|Study Stopped|1|||
127893048|NCT00461500|460231293|FG001|Overall Study|Study Stopped|2|||
127893049|NCT00461500|460231292|FG000|Overall Study|Drug Treatment Misuse|1|||
127893050|NCT00461500|460231293|FG001|Overall Study|Drug Treatment Misuse|0|||
127740467|NCT02484547|459675980|FG004|Placebo-Controlled Period|Reason not Specified|0|||
127740468|NCT02484547|459675981|FG005|Placebo-Controlled Period|Reason not Specified|0|||
127740469|NCT02484547|459675982|FG006|Placebo-Controlled Period|Reason not Specified|0|||
127740470|NCT02484547|459675976|FG000|Long-Term Extension Period|Adverse Event|0|||
127893051|NCT00461500|460231292|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
127893052|NCT00461500|460231293|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
127893053|NCT00461500|460231292|FG000|Overall Study|Lost to Follow-up|2|||
127893054|NCT00461500|460231293|FG001|Overall Study|Lost to Follow-up|2|||
127893055|NCT01806597|460231294|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
127893056|NCT01806597|460231295|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
127893057|NCT01806597|460231296|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
127893058|NCT01806597|460231297|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
127740471|NCT02484547|459675977|FG001|Long-Term Extension Period|Adverse Event|0|||
127740472|NCT02484547|459675978|FG002|Long-Term Extension Period|Adverse Event|0|||
127740473|NCT02484547|459675979|FG003|Long-Term Extension Period|Adverse Event|0|||
127740474|NCT02484547|459675980|FG004|Long-Term Extension Period|Adverse Event|1|||
127740475|NCT02484547|459675981|FG005|Long-Term Extension Period|Adverse Event|3|||
127740476|NCT02484547|459675982|FG006|Long-Term Extension Period|Adverse Event|2|||
127740477|NCT02484547|459675976|FG000|Long-Term Extension Period|Death|0|||
127740478|NCT02484547|459675977|FG001|Long-Term Extension Period|Death|0|||
127740479|NCT02484547|459675978|FG002|Long-Term Extension Period|Death|0|||
127740480|NCT02484547|459675979|FG003|Long-Term Extension Period|Death|0|||
127740481|NCT02484547|459675980|FG004|Long-Term Extension Period|Death|0|||
127740482|NCT02484547|459675981|FG005|Long-Term Extension Period|Death|3|||
127740483|NCT02484547|459675982|FG006|Long-Term Extension Period|Death|0|||
127740484|NCT02484547|459675976|FG000|Long-Term Extension Period|Disease Progression|0|||
127740485|NCT02484547|459675977|FG001|Long-Term Extension Period|Disease Progression|0|||
127740486|NCT02484547|459675978|FG002|Long-Term Extension Period|Disease Progression|0|||
127740487|NCT02484547|459675979|FG003|Long-Term Extension Period|Disease Progression|0|||
127740488|NCT02484547|459675980|FG004|Long-Term Extension Period|Disease Progression|2|||
127740489|NCT02484547|459675981|FG005|Long-Term Extension Period|Disease Progression|4|||
127740490|NCT02484547|459675982|FG006|Long-Term Extension Period|Disease Progression|0|||
127740491|NCT02484547|459675976|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
127740492|NCT02484547|459675977|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
127740493|NCT02484547|459675978|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
127740494|NCT02484547|459675979|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
127740495|NCT02484547|459675980|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
127740496|NCT02484547|459675981|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
127740497|NCT02484547|459675982|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
127740498|NCT02484547|459675976|FG000|Long-Term Extension Period|Loss of Capacity|0|||
127740499|NCT02484547|459675977|FG001|Long-Term Extension Period|Loss of Capacity|0|||
127740500|NCT02484547|459675978|FG002|Long-Term Extension Period|Loss of Capacity|0|||
127740501|NCT02484547|459675979|FG003|Long-Term Extension Period|Loss of Capacity|0|||
127740502|NCT02484547|459675980|FG004|Long-Term Extension Period|Loss of Capacity|1|||
127740503|NCT02484547|459675981|FG005|Long-Term Extension Period|Loss of Capacity|0|||
127740504|NCT02484547|459675982|FG006|Long-Term Extension Period|Loss of Capacity|0|||
127740505|NCT02484547|459675976|FG000|Long-Term Extension Period|Change of Treatment|0|||
127740506|NCT02484547|459675977|FG001|Long-Term Extension Period|Change of Treatment|0|||
127740507|NCT02484547|459675978|FG002|Long-Term Extension Period|Change of Treatment|0|||
127740508|NCT02484547|459675979|FG003|Long-Term Extension Period|Change of Treatment|0|||
127740509|NCT02484547|459675980|FG004|Long-Term Extension Period|Change of Treatment|0|||
127740510|NCT02484547|459675981|FG005|Long-Term Extension Period|Change of Treatment|0|||
127740511|NCT02484547|459675982|FG006|Long-Term Extension Period|Change of Treatment|1|||
127740512|NCT02484547|459675976|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
127740513|NCT02484547|459675977|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
127740514|NCT02484547|459675978|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
127740515|NCT02484547|459675979|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
127740516|NCT02484547|459675980|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
127893059|NCT01806597|460231298|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
127893060|NCT01806597|460231299|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
127893061|NCT01806597|460231294|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
127893062|NCT01806597|460231295|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
127893063|NCT01806597|460231296|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
127893064|NCT01806597|460231297|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
127740517|NCT02484547|459675981|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
127893065|NCT01806597|460231298|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
127740518|NCT02484547|459675982|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
127740519|NCT02484547|459675976|FG000|Long-Term Extension Period|Investigator Decision|0|||
127740520|NCT02484547|459675977|FG001|Long-Term Extension Period|Investigator Decision|0|||
127893066|NCT01806597|460231299|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
127740521|NCT02484547|459675978|FG002|Long-Term Extension Period|Investigator Decision|0|||
127740522|NCT02484547|459675979|FG003|Long-Term Extension Period|Investigator Decision|2|||
127740523|NCT02484547|459675980|FG004|Long-Term Extension Period|Investigator Decision|1|||
127740524|NCT02484547|459675981|FG005|Long-Term Extension Period|Investigator Decision|0|||
127740525|NCT02484547|459675982|FG006|Long-Term Extension Period|Investigator Decision|1|||
127740526|NCT02484547|459675976|FG000|Long-Term Extension Period|Relocation|0|||
127806995|NCT00896532|459913534|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
127806996|NCT00896532|459913535|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
127806997|NCT00896532|459913536|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
127806998|NCT00896532|459913537|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
127806999|NCT00896532|459913538|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
127807000|NCT00896532|459913539|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
127893067|NCT01806597|460231294|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
127893068|NCT01806597|460231295|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
127893069|NCT01806597|460231296|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
127893070|NCT01806597|460231297|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
127893071|NCT01806597|460231298|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
127893072|NCT01806597|460231299|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
127893073|NCT01806597|460231294|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
127893074|NCT01806597|460231295|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
127893075|NCT01806597|460231296|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
127893076|NCT01806597|460231297|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
127893077|NCT01806597|460231298|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
127893078|NCT01806597|460231299|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
127893079|NCT01806597|460231294|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
127740527|NCT02484547|459675977|FG001|Long-Term Extension Period|Relocation|0|||
127740528|NCT02484547|459675978|FG002|Long-Term Extension Period|Relocation|0|||
127740529|NCT02484547|459675979|FG003|Long-Term Extension Period|Relocation|1|||
127740530|NCT02484547|459675980|FG004|Long-Term Extension Period|Relocation|1|||
127740531|NCT02484547|459675981|FG005|Long-Term Extension Period|Relocation|0|||
127740532|NCT02484547|459675982|FG006|Long-Term Extension Period|Relocation|0|||
127740533|NCT02484547|459675976|FG000|Long-Term Extension Period|Study Visit Burden|0|||
127740534|NCT02484547|459675977|FG001|Long-Term Extension Period|Study Visit Burden|0|||
127740535|NCT02484547|459675978|FG002|Long-Term Extension Period|Study Visit Burden|0|||
127893080|NCT01806597|460231295|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
127893081|NCT01806597|460231296|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
127893082|NCT01806597|460231297|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
127893083|NCT01806597|460231298|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
127893084|NCT01806597|460231299|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
127893085|NCT01806597|460231294|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
127893086|NCT01806597|460231295|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
127893087|NCT01806597|460231296|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
127893088|NCT01806597|460231297|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
127893089|NCT01806597|460231298|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
127893090|NCT01806597|460231299|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
127893091|NCT01806597|460231294|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
127893092|NCT01806597|460231295|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
127893093|NCT01806597|460231296|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
127893094|NCT01806597|460231297|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
127893095|NCT01806597|460231298|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
127740536|NCT02484547|459675979|FG003|Long-Term Extension Period|Study Visit Burden|2|||
127740537|NCT02484547|459675980|FG004|Long-Term Extension Period|Study Visit Burden|0|||
127740538|NCT02484547|459675981|FG005|Long-Term Extension Period|Study Visit Burden|0|||
127740539|NCT02484547|459675982|FG006|Long-Term Extension Period|Study Visit Burden|3|||
127740540|NCT02484547|459675976|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
127740541|NCT02484547|459675977|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
127740542|NCT02484547|459675978|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
127740543|NCT02484547|459675979|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
127740544|NCT02484547|459675980|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
127740545|NCT02484547|459675981|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
127740546|NCT02484547|459675982|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
127740547|NCT02484547|459675976|FG000|Long-Term Extension Period|Reason not Specified|0|||
127740548|NCT02484547|459675977|FG001|Long-Term Extension Period|Reason not Specified|0|||
127807001|NCT00896532|459913540|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
127807002|NCT00896532|459913541|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
127807003|NCT00896532|459913542|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
127807004|NCT00896532|459913543|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
127807005|NCT00896532|459913544|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
127893096|NCT01806597|460231299|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
127893097|NCT01806597|460231294|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
127893098|NCT01806597|460231295|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
127893099|NCT01806597|460231296|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
127740549|NCT02484547|459675978|FG002|Long-Term Extension Period|Reason not Specified|0|||
127740550|NCT02484547|459675979|FG003|Long-Term Extension Period|Reason not Specified|119|||
127740551|NCT02484547|459675980|FG004|Long-Term Extension Period|Reason not Specified|117|||
127740552|NCT02484547|459675981|FG005|Long-Term Extension Period|Reason not Specified|223|||
127740553|NCT02484547|459675982|FG006|Long-Term Extension Period|Reason not Specified|231|||
127740554|NCT01813305|459675983|FG000|Overall Study|Withdrawal by Subject|12|||
127740555|NCT01813305|459675984|FG001|Overall Study|Withdrawal by Subject|5|||
127740556|NCT01813305|459675983|FG000|Overall Study|Safety Concern|4|||
127740557|NCT01813305|459675984|FG001|Overall Study|Safety Concern|0|||
127740558|NCT01813305|459675983|FG000|Overall Study|Ulcer became worse|4|||
127740559|NCT01813305|459675984|FG001|Overall Study|Ulcer became worse|0|||
127740560|NCT01813305|459675983|FG000|Overall Study|Physician Decision|4|||
127740561|NCT01813305|459675984|FG001|Overall Study|Physician Decision|0|||
127740562|NCT01813305|459675983|FG000|Overall Study|Lost to Follow-up|3|||
127740563|NCT01813305|459675984|FG001|Overall Study|Lost to Follow-up|1|||
127740564|NCT01813305|459675983|FG000|Overall Study|Protocol Violation|1|||
127740565|NCT01813305|459675984|FG001|Overall Study|Protocol Violation|0|||
127740566|NCT01813305|459675983|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
127740567|NCT01813305|459675984|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
127740568|NCT01665599|459675988|FG000|Overall Study|Adverse Event|1|||
127740569|NCT01665599|459675988|FG000|Overall Study|Consent Withdrawn|1|||
127740570|NCT01665599|459675988|FG000|Overall Study|Investigator/Sponsor decision|1|||
127740571|NCT01665599|459675988|FG000|Overall Study|Death|1|||
127740572|NCT01665599|459675988|FG000|Overall Study|Lost to Follow-up|2|||
127807006|NCT00896532|459913545|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
127807007|NCT00896532|459913546|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
127807008|NCT00896532|459913524|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
127807009|NCT00896532|459913525|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
127807010|NCT00896532|459913526|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
127807011|NCT00896532|459913527|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
127807012|NCT00896532|459913528|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
127807013|NCT00896532|459913529|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
127807014|NCT00896532|459913530|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
127807015|NCT00896532|459913531|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
127807016|NCT00896532|459913532|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
127807017|NCT00896532|459913533|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
127807018|NCT00896532|459913534|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
127807019|NCT00896532|459913535|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
127807020|NCT00896532|459913536|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
127807021|NCT00896532|459913537|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
127807022|NCT00896532|459913538|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
127807023|NCT00896532|459913539|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
127893100|NCT01806597|460231297|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
127893101|NCT01806597|460231298|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
127893102|NCT01806597|460231299|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
127893103|NCT01806597|460231294|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
127893104|NCT01806597|460231295|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
127893105|NCT01806597|460231296|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
127893106|NCT01806597|460231297|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
127893107|NCT01806597|460231298|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
127893108|NCT01806597|460231299|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
127893109|NCT01806597|460231294|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
127893110|NCT01806597|460231295|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
127893111|NCT01806597|460231296|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
127893112|NCT01806597|460231297|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
127893113|NCT01806597|460231298|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
127893114|NCT01806597|460231299|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
127893115|NCT01806597|460231294|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
127893116|NCT01806597|460231295|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
127893117|NCT01806597|460231296|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
127893118|NCT01806597|460231297|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
127740573|NCT01665599|459675988|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
127740574|NCT01665599|459675988|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
127740575|NCT01705145|459675989|FG000|Part B|Adverse Event|1|||
127740576|NCT01503164|459675996|FG000|Overall Study|Withdrawal by Subject|2|||
127740577|NCT01503164|459675997|FG001|Overall Study|Withdrawal by Subject|1|||
127740578|NCT03049306|459675998|FG000|First Intervention (1 Night)|Lost to Follow-up|1|||
127807024|NCT00896532|459913540|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
127807025|NCT00896532|459913541|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
127807026|NCT00896532|459913542|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
127807027|NCT00896532|459913543|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
127807028|NCT00896532|459913544|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
127807029|NCT00896532|459913545|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
127807030|NCT00896532|459913546|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
127807031|NCT00896532|459913524|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
127807032|NCT00896532|459913525|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
127807033|NCT00896532|459913526|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
127807034|NCT00896532|459913527|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
127807035|NCT00896532|459913528|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
127807036|NCT00896532|459913529|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
127807037|NCT00896532|459913530|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
127807038|NCT00896532|459913531|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
127807039|NCT00896532|459913532|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
127807040|NCT00896532|459913533|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
127807041|NCT00896532|459913534|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
127807042|NCT00896532|459913535|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
127807043|NCT00896532|459913536|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
127807044|NCT00896532|459913537|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
127807045|NCT00896532|459913538|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
127807046|NCT00896532|459913539|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
127807047|NCT00896532|459913540|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
127807048|NCT00896532|459913541|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
127807049|NCT00896532|459913542|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
127807050|NCT00896532|459913543|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
127807051|NCT00896532|459913544|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
127807052|NCT00896532|459913545|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
127807053|NCT00896532|459913546|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
127893119|NCT01806597|460231298|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
127893120|NCT01806597|460231299|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
127893121|NCT01806597|460231294|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
127807054|NCT00896532|459913524|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
127807055|NCT00896532|459913525|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
127807056|NCT00896532|459913526|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
127807057|NCT00896532|459913527|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
127807058|NCT00896532|459913528|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
127807059|NCT00896532|459913529|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
127807060|NCT00896532|459913530|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
127807061|NCT00896532|459913531|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
127807062|NCT00896532|459913532|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
127807063|NCT00896532|459913533|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
127807064|NCT00896532|459913534|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
127893122|NCT01806597|460231295|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
127893123|NCT01806597|460231296|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
127740579|NCT03049306|459675999|FG001|First Intervention (1 Night)|Lost to Follow-up|1|||
127740580|NCT03151551|459676000|FG000|Open-Label Treatment Period|Adverse Event|0|||
127740581|NCT03151551|459676001|FG001|Open-Label Treatment Period|Adverse Event|2|||
127740582|NCT03151551|459676000|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
127740583|NCT03151551|459676001|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
127740584|NCT03151551|459676000|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
127740585|NCT03151551|459676001|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
127740586|NCT03151551|459676000|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
127740587|NCT03151551|459676001|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
127740588|NCT03151551|459676000|FG000|Open-Label Treatment Period|Physician Decision|3|||
127740589|NCT03151551|459676001|FG001|Open-Label Treatment Period|Physician Decision|0|||
127740590|NCT03151551|459676000|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
127740591|NCT03151551|459676001|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
127740592|NCT03151551|459676000|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
127740593|NCT03151551|459676001|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
127740594|NCT03151551|459676000|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
127740595|NCT03151551|459676001|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
127740596|NCT03151551|459676000|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
127740597|NCT03151551|459676001|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
127807065|NCT00896532|459913535|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
127740598|NCT03151551|459676000|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
127740599|NCT03151551|459676001|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
127740600|NCT00514813|459676006|FG000|Overall Study|Study terminated|14|||
127740601|NCT00514813|459676007|FG001|Overall Study|Study terminated|74|||
127740602|NCT00514813|459676008|FG002|Overall Study|Study terminated|40|||
127740603|NCT00514813|459676009|FG003|Overall Study|Study terminated|2|||
127740604|NCT00514813|459676006|FG000|Overall Study|Adverse Event|0|||
127740605|NCT00514813|459676007|FG001|Overall Study|Adverse Event|2|||
127740606|NCT00514813|459676008|FG002|Overall Study|Adverse Event|2|||
127740607|NCT00514813|459676009|FG003|Overall Study|Adverse Event|0|||
127740608|NCT00514813|459676006|FG000|Overall Study|Protocol Violation|1|||
127740609|NCT00514813|459676007|FG001|Overall Study|Protocol Violation|0|||
127740610|NCT00514813|459676008|FG002|Overall Study|Protocol Violation|0|||
127740611|NCT00514813|459676009|FG003|Overall Study|Protocol Violation|0|||
127740612|NCT00514813|459676006|FG000|Overall Study|Withdrawal by Subject|0|||
127740613|NCT00514813|459676007|FG001|Overall Study|Withdrawal by Subject|1|||
127740614|NCT00514813|459676008|FG002|Overall Study|Withdrawal by Subject|0|||
127740615|NCT00514813|459676009|FG003|Overall Study|Withdrawal by Subject|0|||
127740616|NCT00514813|459676006|FG000|Overall Study|Lack of Efficacy|0|||
127740617|NCT00514813|459676007|FG001|Overall Study|Lack of Efficacy|1|||
127740618|NCT00514813|459676008|FG002|Overall Study|Lack of Efficacy|0|||
127740619|NCT00514813|459676009|FG003|Overall Study|Lack of Efficacy|0|||
127740620|NCT00514813|459676006|FG000|Overall Study|Kidney transplant|0|||
127740621|NCT00514813|459676007|FG001|Overall Study|Kidney transplant|6|||
127740622|NCT00514813|459676008|FG002|Overall Study|Kidney transplant|2|||
127740623|NCT00514813|459676009|FG003|Overall Study|Kidney transplant|0|||
127740624|NCT00514813|459676006|FG000|Overall Study|Death|0|||
127740625|NCT00514813|459676007|FG001|Overall Study|Death|2|||
127740626|NCT00514813|459676008|FG002|Overall Study|Death|3|||
127740627|NCT00514813|459676009|FG003|Overall Study|Death|2|||
127740628|NCT02979613|459676010|FG000|Double-Blind Phase|Withdrew Consent|2|||
127740629|NCT02979613|459676011|FG001|Double-Blind Phase|Withdrew Consent|4|||
127740630|NCT02979613|459676010|FG000|Double-Blind Phase|Pregnancy|2|||
127740631|NCT02979613|459676011|FG001|Double-Blind Phase|Pregnancy|2|||
127740632|NCT02979613|459676010|FG000|Double-Blind Phase|Adverse Event|2|||
127740633|NCT02979613|459676011|FG001|Double-Blind Phase|Adverse Event|0|||
127740634|NCT02979613|459676010|FG000|Double-Blind Phase|Lost to Follow-up|1|||
127740635|NCT02979613|459676011|FG001|Double-Blind Phase|Lost to Follow-up|1|||
127740636|NCT02979613|459676010|FG000|Double-Blind Phase|Protocol Violation|1|||
127740637|NCT02979613|459676011|FG001|Double-Blind Phase|Protocol Violation|1|||
127740638|NCT02979613|459676010|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
127740639|NCT02979613|459676011|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
127740640|NCT02979613|459676010|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
127740641|NCT02979613|459676011|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
127740642|NCT02979613|459676010|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
127740643|NCT02979613|459676011|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
127740644|NCT02979613|459676010|FG000|Open-Label Extension (OLE) Phase|Death|0|||
127740645|NCT02979613|459676011|FG001|Open-Label Extension (OLE) Phase|Death|1|||
127740646|NCT02979613|459676010|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
127740647|NCT02979613|459676011|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
127740648|NCT03282799|459676014|FG000|Overall Study|Pregnancy|1|||
127740649|NCT03282799|459676015|FG001|Overall Study|Pregnancy|0|||
127740650|NCT03282799|459676014|FG000|Overall Study|Physician Decision|1|||
127740651|NCT03282799|459676015|FG001|Overall Study|Physician Decision|0|||
127740652|NCT00143598|459676020|FG000|Overall Study|Lost to Follow-up|23|||
127740653|NCT00143598|459676021|FG001|Overall Study|Lost to Follow-up|21|||
127740654|NCT00143598|459676020|FG000|Overall Study|Withdrawal by Subject|33|||
127740655|NCT00143598|459676021|FG001|Overall Study|Withdrawal by Subject|37|||
127740656|NCT00143598|459676020|FG000|Overall Study|Death|36|||
127740657|NCT00143598|459676021|FG001|Overall Study|Death|36|||
127740658|NCT00695136|459677660|FG000|Overall Study|Withdrawal by Subject|1|||
127740659|NCT00695136|459677660|FG000|Overall Study|unrelated adverse event|1|||
127740660|NCT01726049|459677662|FG000|Overall Study|Death|1|||
127740661|NCT01726049|459677663|FG001|Overall Study|Death|1|||
127807066|NCT00896532|459913536|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
127740662|NCT01726049|459677662|FG000|Overall Study|Adverse Event|4|||
127740663|NCT01726049|459677663|FG001|Overall Study|Adverse Event|1|||
127740664|NCT01726049|459677662|FG000|Overall Study|refused second HC|0|||
127807067|NCT00896532|459913537|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
127807068|NCT00896532|459913538|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
127740665|NCT01726049|459677663|FG001|Overall Study|refused second HC|2|||
127740666|NCT02806505|459677665|FG000|Overall Study|Adverse event/intercurrent illness|1|||
127740667|NCT02806505|459677666|FG001|Overall Study|Adverse event/intercurrent illness|3|||
127740668|NCT02806505|459677665|FG000|Overall Study|Death|4|||
127740669|NCT02806505|459677666|FG001|Overall Study|Death|0|||
127740670|NCT02806505|459677665|FG000|Overall Study|Did not cooperate/refused treatment|3|||
127807069|NCT00896532|459913539|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
127807070|NCT00896532|459913540|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
127807071|NCT00896532|459913541|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
127807072|NCT00896532|459913542|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
127807073|NCT00896532|459913543|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
127807074|NCT00896532|459913544|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
127807075|NCT00896532|459913545|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
127807076|NCT00896532|459913546|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
127807077|NCT00896532|459913524|FG000|Months 48-72: Follow-on Phase|Death|0|||
127740671|NCT02806505|459677666|FG001|Overall Study|Did not cooperate/refused treatment|3|||
127740672|NCT02806505|459677665|FG000|Overall Study|Failure to return|0|||
127740673|NCT02806505|459677666|FG001|Overall Study|Failure to return|1|||
127740674|NCT02806505|459677665|FG000|Overall Study|Insufficient therapeutic response|2|||
127740675|NCT02806505|459677666|FG001|Overall Study|Insufficient therapeutic response|4|||
127740676|NCT01722045|459677673|FG000|Overall Study|Adverse Event|8|||
127740677|NCT01722045|459677673|FG000|Overall Study|Death|3|||
127740678|NCT01722045|459677673|FG000|Overall Study|Withdrawal by Subject|8|||
127740679|NCT01722045|459677673|FG000|Overall Study|Lost to Follow-up|4|||
127740680|NCT01722045|459677673|FG000|Overall Study|Protocol Deviation|1|||
127740681|NCT01722045|459677673|FG000|Overall Study|Physician Decision|3|||
127740682|NCT01722045|459677673|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
127740683|NCT01333111|459677674|FG000|Overall Study|patient undergoing major surgery|0|||
127740684|NCT01333111|459677675|FG001|Overall Study|patient undergoing major surgery|2|||
127740685|NCT01333111|459677676|FG002|Overall Study|patient undergoing major surgery|0|||
127740686|NCT01333111|459677674|FG000|Overall Study|personal reasons|0|||
127740687|NCT01333111|459677675|FG001|Overall Study|personal reasons|0|||
127740688|NCT01333111|459677676|FG002|Overall Study|personal reasons|1|||
127740689|NCT01333111|459677674|FG000|Overall Study|unclassified|1|||
127740690|NCT01333111|459677675|FG001|Overall Study|unclassified|0|||
127740691|NCT01333111|459677676|FG002|Overall Study|unclassified|0|||
127740692|NCT01333111|459677674|FG000|Overall Study|withdrawal criteria|0|||
127740693|NCT01333111|459677675|FG001|Overall Study|withdrawal criteria|1|||
127740694|NCT01333111|459677676|FG002|Overall Study|withdrawal criteria|0|||
127740695|NCT01333111|459677674|FG000|Overall Study|Non-compliance|1|||
127740696|NCT01333111|459677675|FG001|Overall Study|Non-compliance|0|||
127740697|NCT01333111|459677676|FG002|Overall Study|Non-compliance|0|||
127740698|NCT01333111|459677674|FG000|Overall Study|Ineffective therapy|0|||
127740699|NCT01333111|459677675|FG001|Overall Study|Ineffective therapy|0|||
127740700|NCT01333111|459677676|FG002|Overall Study|Ineffective therapy|1|||
127740701|NCT04732871|459677679|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
127740702|NCT04732871|459677680|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
127740703|NCT04732871|459677681|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
127740704|NCT04732871|459677679|FG000|Overall Study|Lost to Follow-up|7|||
127740705|NCT04732871|459677680|FG001|Overall Study|Lost to Follow-up|4|||
127740706|NCT04732871|459677681|FG002|Overall Study|Lost to Follow-up|3|||
127740707|NCT04732871|459677679|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
127740708|NCT04732871|459677680|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
127740709|NCT04732871|459677681|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
127740710|NCT04732871|459677679|FG000|Overall Study|Migrated / moved from the study area|5|||
127740711|NCT04732871|459677680|FG001|Overall Study|Migrated / moved from the study area|0|||
127740712|NCT04732871|459677681|FG002|Overall Study|Migrated / moved from the study area|0|||
127740713|NCT04732871|459677679|FG000|Overall Study|Other|1|||
127740714|NCT04732871|459677680|FG001|Overall Study|Other|0|||
127740715|NCT04732871|459677681|FG002|Overall Study|Other|1|||
127740716|NCT04732871|459677679|FG000|Overall Study|Ongoing|6|||
127807078|NCT00896532|459913525|FG001|Months 48-72: Follow-on Phase|Death|0|||
127807079|NCT00896532|459913526|FG002|Months 48-72: Follow-on Phase|Death|0|||
127807080|NCT00896532|459913527|FG003|Months 48-72: Follow-on Phase|Death|0|||
127807081|NCT00896532|459913528|FG004|Months 48-72: Follow-on Phase|Death|0|||
127807082|NCT00896532|459913529|FG005|Months 48-72: Follow-on Phase|Death|0|||
127807083|NCT00896532|459913530|FG006|Months 48-72: Follow-on Phase|Death|0|||
127807084|NCT00896532|459913531|FG007|Months 48-72: Follow-on Phase|Death|0|||
127807085|NCT00896532|459913532|FG008|Months 48-72: Follow-on Phase|Death|0|||
127740717|NCT04732871|459677680|FG001|Overall Study|Ongoing|0|||
127740718|NCT04732871|459677681|FG002|Overall Study|Ongoing|1|||
127740719|NCT04732871|459677679|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
127740720|NCT04732871|459677680|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
127740721|NCT04732871|459677681|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
127740722|NCT03834623|459677691|FG000|Overall Study|Progression|0|||
127740723|NCT03834623|459677692|FG001|Overall Study|Progression|1|||
127807086|NCT00896532|459913533|FG009|Months 48-72: Follow-on Phase|Death|0|||
127740724|NCT01755546|459677695|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
127740725|NCT01755546|459677695|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
127740726|NCT01755546|459677695|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
127740727|NCT01755546|459677695|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
127740728|NCT01755546|459677695|FG000|Titration Phase|Adverse Event|11|||
127740729|NCT01755546|459677695|FG000|Titration Phase|Lack of Efficacy|18|||
127740730|NCT01755546|459677695|FG000|Titration Phase|Protocol Violation|9|||
127740731|NCT01755546|459677695|FG000|Titration Phase|Lost to Follow-up|2|||
127740732|NCT01755546|459677695|FG000|Titration Phase|Other and Continuing|22|||
127740733|NCT01755546|459677695|FG000|Titration Phase|Withdrawal by Subject|8|||
127740734|NCT01755546|459677695|FG000|Long Term Treatment|Adverse Event|12|||
127740735|NCT01755546|459677695|FG000|Long Term Treatment|Lack of Efficacy|6|||
127740736|NCT01755546|459677695|FG000|Long Term Treatment|Protocol Violation|10|||
127740737|NCT01755546|459677695|FG000|Long Term Treatment|Withdrawal by Subject|35|||
127740738|NCT01755546|459677695|FG000|Long Term Treatment|Lost to Follow-up|17|||
127740739|NCT01755546|459677695|FG000|Long Term Treatment|other and ongoing|41|||
127740740|NCT03294941|459677698|FG000|Overall Study|Withdrawal by Subject|0|||
127740741|NCT03294941|459677699|FG001|Overall Study|Withdrawal by Subject|2|||
127740742|NCT03927690|459677700|FG000|Overall Study|Withdrawal by Subject|3|||
127740743|NCT03927690|459677701|FG001|Overall Study|Withdrawal by Subject|1|||
127740744|NCT03927690|459677702|FG002|Overall Study|Withdrawal by Subject|1|||
127740745|NCT03927690|459677700|FG000|Overall Study|Adverse Event|1|||
127740746|NCT03927690|459677701|FG001|Overall Study|Adverse Event|0|||
127740747|NCT03927690|459677702|FG002|Overall Study|Adverse Event|0|||
127740748|NCT03927690|459677700|FG000|Overall Study|Death|1|||
127740749|NCT03927690|459677701|FG001|Overall Study|Death|0|||
127740750|NCT03927690|459677702|FG002|Overall Study|Death|0|||
127740751|NCT03927690|459677700|FG000|Overall Study|Lost to Follow-up|2|||
127740752|NCT03927690|459677701|FG001|Overall Study|Lost to Follow-up|2|||
127740753|NCT03927690|459677702|FG002|Overall Study|Lost to Follow-up|1|||
127740754|NCT04051242|459677708|FG000|Overall Study|Withdrawal by Subject|1|||
127740755|NCT04051242|459677708|FG000|Overall Study|Physician Decision|1|||
127740756|NCT00337285|459677710|FG000|Overall Study|Withdrawal by Subject|42|||
127740757|NCT00337285|459677710|FG000|Overall Study|Lost to Follow-up|41|||
127740758|NCT00337285|459677710|FG000|Overall Study|Adverse Event|28|||
127740759|NCT00337285|459677710|FG000|Overall Study|Protocol Violation|27|||
127740760|NCT00337285|459677710|FG000|Overall Study|Lack of Efficacy|11|||
127740761|NCT00337285|459677710|FG000|Overall Study|Death|1|||
127740762|NCT00337285|459677710|FG000|Overall Study|Physician Decision|1|||
127740763|NCT00337285|459677710|FG000|Overall Study|Lack of protocol compliance|7|||
127740764|NCT01774019|459677711|FG000|Overall Study|No longer meets protocol criteria|2|||
127740765|NCT01774019|459677712|FG001|Overall Study|No longer meets protocol criteria|0|||
127740766|NCT01774019|459677711|FG000|Overall Study|Withdrawal by Subject|1|||
127740767|NCT01774019|459677712|FG001|Overall Study|Withdrawal by Subject|0|||
127740768|NCT01774019|459677711|FG000|Overall Study|Surgery delayed > 120 days|1|||
127740769|NCT01774019|459677712|FG001|Overall Study|Surgery delayed > 120 days|0|||
127807087|NCT00896532|459913534|FG010|Months 48-72: Follow-on Phase|Death|0|||
127807088|NCT00896532|459913535|FG011|Months 48-72: Follow-on Phase|Death|0|||
127807089|NCT00896532|459913536|FG012|Months 48-72: Follow-on Phase|Death|0|||
127807090|NCT00896532|459913537|FG013|Months 48-72: Follow-on Phase|Death|0|||
127807091|NCT00896532|459913538|FG014|Months 48-72: Follow-on Phase|Death|0|||
127807092|NCT00896532|459913539|FG015|Months 48-72: Follow-on Phase|Death|0|||
127807093|NCT00896532|459913540|FG016|Months 48-72: Follow-on Phase|Death|0|||
127807094|NCT00896532|459913541|FG017|Months 48-72: Follow-on Phase|Death|0|||
127807095|NCT00896532|459913542|FG018|Months 48-72: Follow-on Phase|Death|1|||
127807096|NCT00896532|459913543|FG019|Months 48-72: Follow-on Phase|Death|0|||
127807097|NCT00896532|459913544|FG020|Months 48-72: Follow-on Phase|Death|0|||
127807098|NCT00896532|459913545|FG021|Months 48-72: Follow-on Phase|Death|0|||
127807099|NCT00896532|459913546|FG022|Months 48-72: Follow-on Phase|Death|0|||
127807100|NCT00896532|459913524|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
127807101|NCT00896532|459913525|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
127893124|NCT01806597|460231297|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
127740770|NCT01774019|459677711|FG000|Overall Study|Patient refused surgery|1|||
127893125|NCT01806597|460231298|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
127740771|NCT01774019|459677712|FG001|Overall Study|Patient refused surgery|1|||
127740772|NCT01774019|459677711|FG000|Overall Study|Unable to implant study device|1|||
127740773|NCT01774019|459677712|FG001|Overall Study|Unable to implant study device|0|||
127740774|NCT01774019|459677711|FG000|Overall Study|Lost to Follow-up|0|||
127740775|NCT01774019|459677712|FG001|Overall Study|Lost to Follow-up|3|||
127740776|NCT01004185|459677713|FG000|Overall Study|Adverse Event|1|||
127740777|NCT01004185|459677714|FG001|Overall Study|Adverse Event|1|||
127740778|NCT01004185|459677713|FG000|Overall Study|Lost to Follow-up|0|||
127740779|NCT01004185|459677714|FG001|Overall Study|Lost to Follow-up|1|||
127807102|NCT00896532|459913526|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
127807103|NCT00896532|459913527|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
127807104|NCT00896532|459913528|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
127740780|NCT01004185|459677713|FG000|Overall Study|Lack of Efficacy|2|||
127740781|NCT01004185|459677714|FG001|Overall Study|Lack of Efficacy|1|||
127740782|NCT01004185|459677713|FG000|Overall Study|Sponsor Terminated Study|4|||
127740783|NCT01004185|459677714|FG001|Overall Study|Sponsor Terminated Study|5|||
127740784|NCT01004185|459677713|FG000|Overall Study|Withdrawal by Subject|2|||
127740785|NCT01004185|459677714|FG001|Overall Study|Withdrawal by Subject|1|||
127740786|NCT03481556|459677717|FG000|Overall Study|Adverse Event|1|||
127740787|NCT03481556|459677718|FG001|Overall Study|Adverse Event|0|||
127740788|NCT03481556|459677719|FG002|Overall Study|Adverse Event|0|||
127740789|NCT03481556|459677720|FG003|Overall Study|Adverse Event|0|||
127740790|NCT03481556|459677717|FG000|Overall Study|Death|4|||
127740791|NCT03481556|459677718|FG001|Overall Study|Death|2|||
127740792|NCT03481556|459677719|FG002|Overall Study|Death|3|||
127740793|NCT03481556|459677720|FG003|Overall Study|Death|16|||
127740794|NCT03481556|459677717|FG000|Overall Study|Study Terminated by Sponsor|10|||
127740795|NCT03481556|459677718|FG001|Overall Study|Study Terminated by Sponsor|5|||
127740796|NCT03481556|459677719|FG002|Overall Study|Study Terminated by Sponsor|2|||
127740797|NCT03481556|459677720|FG003|Overall Study|Study Terminated by Sponsor|9|||
127740798|NCT03463577|459677721|FG000|Overall Study|Lost to Follow-up|238|||
127740799|NCT03463577|459677722|FG001|Overall Study|Lost to Follow-up|435|||
127740800|NCT03463577|459677723|FG002|Overall Study|Lost to Follow-up|0|||
127740801|NCT03463577|459677724|FG003|Overall Study|Lost to Follow-up|0|||
127740802|NCT03463577|459677725|FG004|Overall Study|Lost to Follow-up|0|||
127740803|NCT03463577|459677726|FG005|Overall Study|Lost to Follow-up|0|||
127740804|NCT03463577|459677721|FG000|Overall Study|With unknown pregnancy outcome|0|||
127740805|NCT03463577|459677722|FG001|Overall Study|With unknown pregnancy outcome|5|||
127740806|NCT03463577|459677723|FG002|Overall Study|With unknown pregnancy outcome|0|||
127740807|NCT03463577|459677724|FG003|Overall Study|With unknown pregnancy outcome|0|||
127740808|NCT03463577|459677725|FG004|Overall Study|With unknown pregnancy outcome|0|||
127740809|NCT03463577|459677726|FG005|Overall Study|With unknown pregnancy outcome|0|||
127740810|NCT03463577|459677721|FG000|Overall Study|Maternal death|2|||
127740811|NCT03463577|459677722|FG001|Overall Study|Maternal death|0|||
127740812|NCT03463577|459677723|FG002|Overall Study|Maternal death|0|||
127740813|NCT03463577|459677724|FG003|Overall Study|Maternal death|0|||
127740814|NCT03463577|459677725|FG004|Overall Study|Maternal death|0|||
127740815|NCT03463577|459677726|FG005|Overall Study|Maternal death|0|||
127740816|NCT03463577|459677721|FG000|Overall Study|Neonatal death|0|||
127740817|NCT03463577|459677722|FG001|Overall Study|Neonatal death|0|||
127740818|NCT03463577|459677723|FG002|Overall Study|Neonatal death|0|||
127740819|NCT03463577|459677724|FG003|Overall Study|Neonatal death|15|||
127740820|NCT03463577|459677725|FG004|Overall Study|Neonatal death|17|||
127740821|NCT03463577|459677726|FG005|Overall Study|Neonatal death|0|||
127740822|NCT01101997|459677728|FG000|Overall Study|Withdrawal by Subject|2|||
127740823|NCT02172950|459677729|FG000|Overall Study|Physician Decision|3|||
127740824|NCT02172950|459677730|FG001|Overall Study|Physician Decision|3|||
127740825|NCT02172950|459677729|FG000|Overall Study|Lack of Efficacy|1|||
127740826|NCT02172950|459677730|FG001|Overall Study|Lack of Efficacy|0|||
127740827|NCT02172950|459677729|FG000|Overall Study|Adverse Event|4|||
127740828|NCT02172950|459677730|FG001|Overall Study|Adverse Event|1|||
127740829|NCT02172950|459677729|FG000|Overall Study|Withdrawal by Subject|10|||
127740830|NCT02172950|459677730|FG001|Overall Study|Withdrawal by Subject|0|||
127740831|NCT02172950|459677729|FG000|Overall Study|Protocol Violation|1|||
127740832|NCT02172950|459677730|FG001|Overall Study|Protocol Violation|0|||
127740833|NCT02172950|459677729|FG000|Overall Study|Lost to Follow-up|1|||
127740834|NCT02172950|459677730|FG001|Overall Study|Lost to Follow-up|0|||
127740835|NCT02172950|459677729|FG000|Overall Study|Death|1|||
127740836|NCT02172950|459677730|FG001|Overall Study|Death|0|||
127740837|NCT02172950|459677729|FG000|Overall Study|Patient traveling|1|||
127740838|NCT02172950|459677730|FG001|Overall Study|Patient traveling|0|||
127740839|NCT02172950|459677729|FG000|Overall Study|Patient went to other country|1|||
127740840|NCT02172950|459677730|FG001|Overall Study|Patient went to other country|0|||
127740841|NCT02172950|459677729|FG000|Overall Study|Patient relocated overseas|1|||
127740842|NCT02172950|459677730|FG001|Overall Study|Patient relocated overseas|1|||
127893126|NCT01806597|460231299|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
127893127|NCT01806597|460231294|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
127893128|NCT01806597|460231295|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
127740843|NCT02172950|459677729|FG000|Overall Study|Patient moving|1|||
127740844|NCT02172950|459677730|FG001|Overall Study|Patient moving|0|||
127740845|NCT00611715|459677731|FG000|Overall Study|Disease Progression|24|||
127740846|NCT00611715|459677732|FG001|Overall Study|Disease Progression|4|||
127740847|NCT00611715|459677731|FG000|Overall Study|Withdrawal by Subject|5|||
127740848|NCT00611715|459677732|FG001|Overall Study|Withdrawal by Subject|1|||
127740849|NCT00611715|459677731|FG000|Overall Study|Adverse Event|9|||
127740850|NCT00611715|459677732|FG001|Overall Study|Adverse Event|1|||
127740851|NCT00611715|459677731|FG000|Overall Study|Death|1|||
127740852|NCT00611715|459677732|FG001|Overall Study|Death|0|||
127740853|NCT00611715|459677731|FG000|Overall Study|two patients are still on treatment|2|||
127807105|NCT00896532|459913529|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
127740854|NCT00611715|459677732|FG001|Overall Study|two patients are still on treatment|0|||
127740855|NCT00107978|459677733|FG000|Overall Study|Adverse Event|1|||
127740856|NCT00107978|459677734|FG001|Overall Study|Adverse Event|5|||
127740857|NCT00107978|459677733|FG000|Overall Study|Death|3|||
127740858|NCT00107978|459677734|FG001|Overall Study|Death|3|||
127740859|NCT00107978|459677733|FG000|Overall Study|Lost to Follow-up|20|||
127740860|NCT00107978|459677734|FG001|Overall Study|Lost to Follow-up|28|||
127740861|NCT00107978|459677733|FG000|Overall Study|Withdrawal by Subject|4|||
127740862|NCT00107978|459677734|FG001|Overall Study|Withdrawal by Subject|9|||
127740863|NCT00107978|459677733|FG000|Overall Study|Protocol Violation|0|||
127740864|NCT00107978|459677734|FG001|Overall Study|Protocol Violation|1|||
127740865|NCT00107978|459677733|FG000|Overall Study|Other|5|||
127740866|NCT00107978|459677734|FG001|Overall Study|Other|4|||
127740867|NCT00704171|459677737|FG000|Overall Study|Withdrawal by Subject|1|||
127740868|NCT00704171|459677738|FG001|Overall Study|Withdrawal by Subject|0|||
127740869|NCT01874665|459677739|FG000|Overall Study|Adverse Event|6|||
127740870|NCT01874665|459677740|FG001|Overall Study|Adverse Event|2|||
127740871|NCT01874665|459677739|FG000|Overall Study|Withdrawal by Subject|4|||
127740872|NCT01874665|459677740|FG001|Overall Study|Withdrawal by Subject|1|||
127740873|NCT01874665|459677739|FG000|Overall Study|Physician Decision|3|||
127740874|NCT01874665|459677740|FG001|Overall Study|Physician Decision|0|||
127740875|NCT01874665|459677739|FG000|Overall Study|Clinical Progressive Disease|4|||
127740876|NCT01874665|459677740|FG001|Overall Study|Clinical Progressive Disease|3|||
127740877|NCT01874665|459677739|FG000|Overall Study|Study Terminated by Sponsor|0|||
127740878|NCT01874665|459677740|FG001|Overall Study|Study Terminated by Sponsor|2|||
127740879|NCT01874665|459677739|FG000|Overall Study|Documented Progressive Disease|11|||
127740880|NCT01874665|459677740|FG001|Overall Study|Documented Progressive Disease|7|||
127740881|NCT01874665|459677739|FG000|Overall Study|Other|2|||
127740882|NCT01874665|459677740|FG001|Overall Study|Other|0|||
127740883|NCT00350298|459677743|FG000|Overall Study|Death|7|||
127740884|NCT00350298|459677744|FG001|Overall Study|Death|8|||
127740885|NCT00350298|459677743|FG000|Overall Study|Lost to Follow-up|1|||
127740886|NCT00350298|459677744|FG001|Overall Study|Lost to Follow-up|2|||
127740887|NCT00350298|459677743|FG000|Overall Study|Withdrawal by Subject|1|||
127740888|NCT00350298|459677744|FG001|Overall Study|Withdrawal by Subject|3|||
127807106|NCT00896532|459913530|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
127807107|NCT00896532|459913531|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
127807108|NCT00896532|459913532|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
127807109|NCT00896532|459913533|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
127807110|NCT00896532|459913534|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
127807111|NCT00896532|459913535|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
127807112|NCT00896532|459913536|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
127807113|NCT00896532|459913537|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
127807114|NCT00896532|459913538|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
127807115|NCT00896532|459913539|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
127807116|NCT00896532|459913540|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
127807117|NCT00896532|459913541|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
127807118|NCT00896532|459913542|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
127807119|NCT00896532|459913543|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
127807120|NCT00896532|459913544|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
127807121|NCT00896532|459913545|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
127807122|NCT00896532|459913546|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
127807123|NCT00896532|459913524|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
127807124|NCT00896532|459913525|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
127807125|NCT00896532|459913526|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
127807126|NCT00896532|459913527|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
127807127|NCT00896532|459913528|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
127807128|NCT00896532|459913529|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
127807129|NCT00896532|459913530|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
127740889|NCT00233389|459677745|FG000|Overall Study|Adverse Event|5|||
127893129|NCT01806597|460231296|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
127740890|NCT00233389|459677746|FG001|Overall Study|Adverse Event|5|||
127740891|NCT00233389|459677745|FG000|Overall Study|Lack of Efficacy|11|||
127740892|NCT00233389|459677746|FG001|Overall Study|Lack of Efficacy|8|||
127740893|NCT00233389|459677745|FG000|Overall Study|Lost to Follow-up|1|||
127740894|NCT00233389|459677746|FG001|Overall Study|Lost to Follow-up|1|||
127740895|NCT00233389|459677745|FG000|Overall Study|Physician Decision|1|||
127740896|NCT00233389|459677746|FG001|Overall Study|Physician Decision|0|||
127740897|NCT00233389|459677745|FG000|Overall Study|Protocol Violation|0|||
127740898|NCT00233389|459677746|FG001|Overall Study|Protocol Violation|1|||
127807130|NCT00896532|459913531|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
127807131|NCT00896532|459913532|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
127807132|NCT00896532|459913533|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
127740899|NCT00233389|459677745|FG000|Overall Study|Withdrawal by Subject|0|||
127740900|NCT00233389|459677746|FG001|Overall Study|Withdrawal by Subject|1|||
127807133|NCT00896532|459913534|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
127807134|NCT00896532|459913535|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
127807135|NCT00896532|459913536|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
127807136|NCT00896532|459913537|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
127807137|NCT00896532|459913538|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
127807138|NCT00896532|459913539|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
127807139|NCT00896532|459913540|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
127807140|NCT00896532|459913541|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
127807141|NCT00896532|459913542|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
127807142|NCT00896532|459913543|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
127807143|NCT00896532|459913544|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
127807144|NCT00896532|459913545|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
127807145|NCT00896532|459913546|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
127807146|NCT02149810|459913547|FG000|Overall Study|Physician Decision|1|||
127807147|NCT02149810|459913548|FG001|Overall Study|Physician Decision|2|||
127807148|NCT02149810|459913547|FG000|Overall Study|Lost to Follow-up|2|||
127807149|NCT02149810|459913548|FG001|Overall Study|Lost to Follow-up|1|||
127807150|NCT02149810|459913547|FG000|Overall Study|Withdrawal by Subject|5|||
127807151|NCT02149810|459913548|FG001|Overall Study|Withdrawal by Subject|1|||
127807152|NCT01176916|459913549|FG000|Overall Study|Adverse Event|61|||
127807153|NCT01176916|459913549|FG000|Overall Study|Death|1|||
127740901|NCT04962698|459677749|FG000|Motor Imagery|Technical difficulty|1|||
127740902|NCT04962698|459677750|FG001|Motor Imagery|Technical difficulty|0|||
127740903|NCT04962698|459677749|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
127740904|NCT04962698|459677750|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
127740905|NCT04962698|459677749|FG000|Kinesthetic MI|Technical difficulty|1|||
127740906|NCT04962698|459677750|FG001|Kinesthetic MI|Technical difficulty|0|||
127740907|NCT04962698|459677749|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
127740908|NCT04962698|459677750|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
127740909|NCT04962698|459677749|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
127740910|NCT04962698|459677750|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
127740911|NCT04962698|459677749|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
127740912|NCT04962698|459677750|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
127740913|NCT04962698|459677749|FG000|Virtual-hand Interaction|Technical difficulty|1|||
127740914|NCT04962698|459677750|FG001|Virtual-hand Interaction|Technical difficulty|0|||
127740915|NCT04962698|459677749|FG000|Robotic Action Observation|Technical difficulty|1|||
127740916|NCT04962698|459677750|FG001|Robotic Action Observation|Technical difficulty|0|||
127740917|NCT04962698|459677749|FG000|Rest|Technical difficulty|1|||
127740918|NCT04962698|459677750|FG001|Rest|Technical difficulty|0|||
127740919|NCT04962698|459677749|FG000|Rest|Exclusion criteria met after enrollment|0|||
127740920|NCT04962698|459677750|FG001|Rest|Exclusion criteria met after enrollment|2|||
127740921|NCT00853229|459677751|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
127740922|NCT00853229|459677752|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
127740923|NCT03201900|459677756|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
127740924|NCT03201900|459677756|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
127740925|NCT03201900|459677756|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
127740926|NCT03201900|459677756|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
127740927|NCT03201900|459677756|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
127740928|NCT03201900|459677756|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
127740929|NCT03201900|459677756|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
127740930|NCT03201900|459677756|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
127740931|NCT03201900|459677756|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
127807154|NCT01176916|459913549|FG000|Overall Study|Lost to Follow-up|15|||
127807155|NCT01176916|459913549|FG000|Overall Study|Objective progression or relapse|17|||
127807156|NCT01176916|459913549|FG000|Overall Study|Protocol Violation|24|||
127807157|NCT01176916|459913549|FG000|Overall Study|Withdrawal by Subject|37|||
127807158|NCT01176916|459913549|FG000|Overall Study|Other|6|||
127807159|NCT01176916|459913549|FG000|Overall Study|Withdrawal prior to Treatment|6|||
127740932|NCT03201900|459677756|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
127740933|NCT03201900|459677756|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
127740934|NCT03201900|459677756|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
127740935|NCT03201900|459677756|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
127740936|NCT00776659|459677775|FG000|Overall Study|Lost to Follow-up|15|||
127807160|NCT03158220|459913552|FG000|Overall Study|Screen Failure|0|||
127807161|NCT03158220|459913553|FG001|Overall Study|Screen Failure|1|||
127807162|NCT03158220|459913552|FG000|Overall Study|Withdrawal by Subject|8|||
127807163|NCT03158220|459913553|FG001|Overall Study|Withdrawal by Subject|9|||
127740937|NCT00776659|459677775|FG000|Overall Study|Withdrawal by Subject|10|||
127740938|NCT00776659|459677775|FG000|Overall Study|Study Terminated by Sponsor|1|||
127740939|NCT01664923|459677776|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
127740940|NCT01664923|459677777|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
127740941|NCT01664923|459677776|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
127740942|NCT01664923|459677777|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
127740943|NCT01664923|459677776|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
127740944|NCT01664923|459677777|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
127740945|NCT01664923|459677776|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
127740946|NCT01664923|459677777|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
127740947|NCT01664923|459677776|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
127740948|NCT01664923|459677777|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
127740949|NCT01664923|459677776|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
127740950|NCT01664923|459677777|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
127740951|NCT01664923|459677776|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
127740952|NCT01664923|459677777|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
127740953|NCT01664923|459677776|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
127740954|NCT01664923|459677777|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
127740955|NCT01664923|459677776|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
127740956|NCT01664923|459677777|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
127740957|NCT01664923|459677776|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
127740958|NCT01664923|459677777|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
127740959|NCT01664923|459677776|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
127740960|NCT01664923|459677777|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
127740961|NCT01664923|459677776|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
127740962|NCT01664923|459677777|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
127740963|NCT01664923|459677776|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
127740964|NCT01664923|459677777|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
127740965|NCT01664923|459677776|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
127740966|NCT01664923|459677777|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
127740967|NCT01233999|459677778|FG000|Overall Study|Withdrawal by Subject|1|||
127740968|NCT01233999|459677778|FG000|Overall Study|Lost to Follow-up|1|||
127740969|NCT00129649|459677788|FG000|Overall Study|Withdrawal by Subject|76|||
127740970|NCT00129649|459677789|FG001|Overall Study|Withdrawal by Subject|65|||
127740971|NCT01321723|459677790|FG000|Overall Study|Adverse Event|3|||
127740972|NCT01321723|459677791|FG001|Overall Study|Adverse Event|5|||
127740973|NCT01321723|459677792|FG002|Overall Study|Adverse Event|2|||
127740974|NCT01321723|459677790|FG000|Overall Study|Withdrawal by Subject|2|||
127740975|NCT01321723|459677791|FG001|Overall Study|Withdrawal by Subject|0|||
127740976|NCT01321723|459677792|FG002|Overall Study|Withdrawal by Subject|2|||
127740977|NCT00025506|459677793|FG000|Overall Study|Ineligible: clerical error|1|||
127740978|NCT00025506|459677793|FG000|Overall Study|Ineligible: wrong cell type|5|||
127740979|NCT00025506|459677793|FG000|Overall Study|Ineligible: inadequate pathology|2|||
127740980|NCT00025506|459677793|FG000|Overall Study|Never Treated|2|||
127740981|NCT00713206|459677794|FG000|Overall Study|Lost to Follow-up|4|||
127740982|NCT00713206|459677795|FG001|Overall Study|Lost to Follow-up|4|||
127740983|NCT00713206|459677794|FG000|Overall Study|Death|1|||
127740984|NCT00713206|459677795|FG001|Overall Study|Death|0|||
127740985|NCT02561806|459677796|FG000|Induction Period|Adverse Event|0|||
127740986|NCT02561806|459677797|FG001|Induction Period|Adverse Event|2|||
127740987|NCT02561806|459677796|FG000|Induction Period|Lack of Efficacy|1|||
127740988|NCT02561806|459677797|FG001|Induction Period|Lack of Efficacy|0|||
127807164|NCT03158220|459913552|FG000|Overall Study|Status unknown|0|||
127807165|NCT03158220|459913553|FG001|Overall Study|Status unknown|1|||
127807166|NCT03158220|459913552|FG000|Overall Study|Lost to Follow-up|8|||
127807167|NCT03158220|459913553|FG001|Overall Study|Lost to Follow-up|5|||
127807168|NCT03158220|459913552|FG000|Overall Study|Physician Decision|1|||
127807169|NCT03158220|459913553|FG001|Overall Study|Physician Decision|0|||
127807170|NCT01015833|459913554|FG000|Overall Study|Death|1|||
127807171|NCT01015833|459913555|FG001|Overall Study|Death|0|||
127807172|NCT01015833|459913554|FG000|Overall Study|Withdrawal by Subject|3|||
127740989|NCT02561806|459677796|FG000|Induction Period|Withdrawal by Subject|0|||
127740990|NCT02561806|459677797|FG001|Induction Period|Withdrawal by Subject|2|||
127740991|NCT02561806|459677796|FG000|Induction Period|Site staff became unblinded|1|||
127807173|NCT01015833|459913555|FG001|Overall Study|Withdrawal by Subject|2|||
127807174|NCT01015833|459913554|FG000|Overall Study|Adverse Event|0|||
127893130|NCT01806597|460231297|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
127807175|NCT01015833|459913555|FG001|Overall Study|Adverse Event|1|||
127740992|NCT02561806|459677797|FG001|Induction Period|Site staff became unblinded|0|||
127740993|NCT02561806|459677796|FG000|Induction Period|Randomized but not treated|0|||
127740994|NCT02561806|459677797|FG001|Induction Period|Randomized but not treated|1|||
127740995|NCT02561806|459677796|FG000|Maintenance Period|Adverse Event|2|||
127807176|NCT01015833|459913554|FG000|Overall Study|Physician Decision|2|||
127740996|NCT02561806|459677797|FG001|Maintenance Period|Adverse Event|1|||
127740997|NCT02561806|459677796|FG000|Maintenance Period|Lack of Efficacy|3|||
127740998|NCT02561806|459677797|FG001|Maintenance Period|Lack of Efficacy|1|||
127740999|NCT02561806|459677796|FG000|Maintenance Period|Lost to Follow-up|2|||
127741000|NCT02561806|459677797|FG001|Maintenance Period|Lost to Follow-up|2|||
127741001|NCT02561806|459677796|FG000|Maintenance Period|Protocol Violation|1|||
127741002|NCT02561806|459677797|FG001|Maintenance Period|Protocol Violation|0|||
127741003|NCT02561806|459677796|FG000|Maintenance Period|Withdrawal by Subject|5|||
127741004|NCT02561806|459677797|FG001|Maintenance Period|Withdrawal by Subject|3|||
127741005|NCT02561806|459677796|FG000|Maintenance Period|Site staff became unblinded|0|||
127741006|NCT02561806|459677797|FG001|Maintenance Period|Site staff became unblinded|1|||
127741007|NCT02561806|459677796|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
127741008|NCT02561806|459677797|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
127741009|NCT02561806|459677796|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
127741010|NCT02561806|459677797|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
127741011|NCT02547441|459677798|FG000|Double-Blind Study Period|Adverse Event|4|||
127741012|NCT02547441|459677799|FG001|Double-Blind Study Period|Adverse Event|9|||
127741013|NCT02547441|459677798|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
127741014|NCT02547441|459677799|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
127741015|NCT02547441|459677798|FG000|Double-Blind Study Period|Physician Decision|1|||
127741016|NCT02547441|459677799|FG001|Double-Blind Study Period|Physician Decision|0|||
127741017|NCT02547441|459677798|FG000|Double-Blind Study Period|Protocol Violation|1|||
127741018|NCT02547441|459677799|FG001|Double-Blind Study Period|Protocol Violation|2|||
127741019|NCT02547441|459677798|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
127741020|NCT02547441|459677799|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
127741021|NCT02547441|459677798|FG000|Double-Blind Study Period|Sponsor Decision|1|||
127741022|NCT02547441|459677799|FG001|Double-Blind Study Period|Sponsor Decision|0|||
127741023|NCT02547441|459677798|FG000|Open-Label Study Period|Adverse Event|10|||
127741024|NCT02547441|459677799|FG001|Open-Label Study Period|Adverse Event|11|||
127741025|NCT02547441|459677798|FG000|Open-Label Study Period|Lack of Efficacy|3|||
127741026|NCT02547441|459677799|FG001|Open-Label Study Period|Lack of Efficacy|2|||
127741027|NCT02547441|459677798|FG000|Open-Label Study Period|Lost to Follow-up|7|||
127741028|NCT02547441|459677799|FG001|Open-Label Study Period|Lost to Follow-up|8|||
127741029|NCT02547441|459677798|FG000|Open-Label Study Period|Physician Decision|1|||
127741030|NCT02547441|459677799|FG001|Open-Label Study Period|Physician Decision|0|||
127741031|NCT02547441|459677798|FG000|Open-Label Study Period|Protocol Violation|2|||
127741032|NCT02547441|459677799|FG001|Open-Label Study Period|Protocol Violation|0|||
127741033|NCT02547441|459677798|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
127741034|NCT02547441|459677799|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
127741035|NCT02547441|459677798|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
127741036|NCT02547441|459677799|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
127741037|NCT01322009|459677801|FG000|Overall Study|Death|0|||
127741038|NCT01322009|459677802|FG001|Overall Study|Death|1|||
127741039|NCT01322009|459677801|FG000|Overall Study|Adverse Event|0|||
127741040|NCT01322009|459677802|FG001|Overall Study|Adverse Event|1|||
127741041|NCT01322009|459677801|FG000|Overall Study|ng tube discontinued|0|||
127741042|NCT01322009|459677802|FG001|Overall Study|ng tube discontinued|1|||
127741043|NCT00905034|459677803|FG000|Overall Study|Withdrawal by Subject|1|||
127741044|NCT00394589|459677804|FG000|Overall Study|Adverse Event|2|||
127741045|NCT00394589|459677805|FG001|Overall Study|Adverse Event|1|||
127741046|NCT00394589|459677806|FG002|Overall Study|Adverse Event|2|||
127741047|NCT00394589|459677804|FG000|Overall Study|Lack of Efficacy|2|||
127741048|NCT00394589|459677805|FG001|Overall Study|Lack of Efficacy|2|||
127741049|NCT00394589|459677806|FG002|Overall Study|Lack of Efficacy|3|||
127741050|NCT00394589|459677804|FG000|Overall Study|Protocol Violation|4|||
127741051|NCT00394589|459677805|FG001|Overall Study|Protocol Violation|0|||
127741052|NCT00394589|459677806|FG002|Overall Study|Protocol Violation|2|||
127741053|NCT04081389|459677807|FG000|Overall Study|Withdrawal by Subject|0|||
127741054|NCT04081389|459677808|FG001|Overall Study|Withdrawal by Subject|0|||
127741055|NCT04081389|459677809|FG002|Overall Study|Withdrawal by Subject|1|||
127807177|NCT01015833|459913555|FG001|Overall Study|Physician Decision|0|||
127807178|NCT01015833|459913554|FG000|Overall Study|Symptomatic deterioration|0|||
127807179|NCT01015833|459913555|FG001|Overall Study|Symptomatic deterioration|1|||
127807180|NCT01015833|459913554|FG000|Overall Study|Other|5|||
127741056|NCT04081389|459677810|FG003|Overall Study|Withdrawal by Subject|0|||
127741057|NCT01710800|459677811|FG000|Overall Study|Withdrawal by Subject|21|||
127741058|NCT01710800|459677811|FG000|Overall Study|Protocol Violation|1|||
127741059|NCT02427958|459677815|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
127741060|NCT02427958|459677815|FG000|Overall Study|Lost to Follow-up|6|||
127741061|NCT02427958|459677815|FG000|Overall Study|Withdrawal by Subject|14|||
127741062|NCT02427958|459677815|FG000|Overall Study|Lack of Efficacy|1|||
127741063|NCT00511797|459677816|FG000|Overall Study|Adverse Event|1|||
127741064|NCT00511797|459677817|FG001|Overall Study|Adverse Event|2|||
127807181|NCT01015833|459913555|FG001|Overall Study|Other|1|||
127807182|NCT01015833|459913554|FG000|Overall Study|Motor Vehicle Accidents|1|||
127741065|NCT00511797|459677818|FG002|Overall Study|Adverse Event|2|||
127741066|NCT00511797|459677819|FG003|Overall Study|Adverse Event|2|||
127741067|NCT00511797|459677816|FG000|Overall Study|Lost to Follow-up|1|||
127741068|NCT00511797|459677817|FG001|Overall Study|Lost to Follow-up|0|||
127741069|NCT00511797|459677818|FG002|Overall Study|Lost to Follow-up|0|||
127741070|NCT00511797|459677819|FG003|Overall Study|Lost to Follow-up|1|||
127741071|NCT00511797|459677816|FG000|Overall Study|Pregnancy|0|||
127741072|NCT00511797|459677817|FG001|Overall Study|Pregnancy|0|||
127741073|NCT00511797|459677818|FG002|Overall Study|Pregnancy|0|||
127741074|NCT00511797|459677819|FG003|Overall Study|Pregnancy|1|||
127741075|NCT00511797|459677816|FG000|Overall Study|Protocol Violation|0|||
127741076|NCT00511797|459677817|FG001|Overall Study|Protocol Violation|2|||
127741077|NCT00511797|459677818|FG002|Overall Study|Protocol Violation|2|||
127741078|NCT00511797|459677819|FG003|Overall Study|Protocol Violation|3|||
127741079|NCT00511797|459677816|FG000|Overall Study|Withdrawal by Subject|3|||
127741080|NCT00511797|459677817|FG001|Overall Study|Withdrawal by Subject|3|||
127741081|NCT00511797|459677818|FG002|Overall Study|Withdrawal by Subject|4|||
127741082|NCT00511797|459677819|FG003|Overall Study|Withdrawal by Subject|2|||
127741083|NCT00511797|459677816|FG000|Overall Study|Never dispensed|1|||
127741084|NCT00511797|459677817|FG001|Overall Study|Never dispensed|0|||
127741085|NCT00511797|459677818|FG002|Overall Study|Never dispensed|1|||
127741086|NCT00511797|459677819|FG003|Overall Study|Never dispensed|3|||
127741087|NCT00511797|459677816|FG000|Overall Study|Study drug not taken|0|||
127741088|NCT00511797|459677817|FG001|Overall Study|Study drug not taken|1|||
127741089|NCT00511797|459677818|FG002|Overall Study|Study drug not taken|0|||
127741090|NCT00511797|459677819|FG003|Overall Study|Study drug not taken|1|||
127741091|NCT00511797|459677816|FG000|Overall Study|Partially missing diary|0|||
127741092|NCT00511797|459677817|FG001|Overall Study|Partially missing diary|0|||
127741093|NCT00511797|459677818|FG002|Overall Study|Partially missing diary|1|||
127741094|NCT00511797|459677819|FG003|Overall Study|Partially missing diary|0|||
127741095|NCT00511797|459677816|FG000|Overall Study|Other (moving etc)|1|||
127741096|NCT00511797|459677817|FG001|Overall Study|Other (moving etc)|0|||
127741097|NCT00511797|459677818|FG002|Overall Study|Other (moving etc)|1|||
127741098|NCT00511797|459677819|FG003|Overall Study|Other (moving etc)|2|||
127741099|NCT03974100|459677820|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
127741100|NCT03974100|459677821|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
127741101|NCT03974100|459677822|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
127741102|NCT03974100|459677823|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
127741103|NCT03974100|459677824|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
127741104|NCT03974100|459677820|FG000|TP1 - Day 1 to Week 52|Death|1|||
127741105|NCT03974100|459677821|FG001|TP1 - Day 1 to Week 52|Death|0|||
127741106|NCT03974100|459677822|FG002|TP1 - Day 1 to Week 52|Death|0|||
127741107|NCT03974100|459677823|FG003|TP1 - Day 1 to Week 52|Death|0|||
127741108|NCT03974100|459677824|FG004|TP1 - Day 1 to Week 52|Death|0|||
127741109|NCT03974100|459677820|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
127741110|NCT03974100|459677821|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
127741111|NCT03974100|459677822|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
127741112|NCT03974100|459677823|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
127741113|NCT03974100|459677824|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
127741114|NCT03974100|459677820|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
127741115|NCT03974100|459677821|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
127741116|NCT03974100|459677822|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
127741117|NCT03974100|459677823|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
127741118|NCT03974100|459677824|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
127741119|NCT03974100|459677820|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
127807183|NCT01015833|459913555|FG001|Overall Study|Motor Vehicle Accidents|0|||
127807184|NCT01015833|459913554|FG000|Overall Study|Did not start treatment|1|||
127807185|NCT01015833|459913555|FG001|Overall Study|Did not start treatment|0|||
127807186|NCT01671280|459913556|FG000|Overall Study|Withdrawal by Subject|2|||
127807187|NCT01959165|459913557|FG000|Overall Study|Adverse Event|0|||
127807188|NCT01959165|459913558|FG001|Overall Study|Adverse Event|0|||
127807189|NCT01959165|459913559|FG002|Overall Study|Adverse Event|0|||
127807190|NCT01959165|459913560|FG003|Overall Study|Adverse Event|1|||
127807191|NCT01959165|459913557|FG000|Overall Study|Lack of Efficacy|1|||
127807192|NCT01959165|459913558|FG001|Overall Study|Lack of Efficacy|0|||
127741120|NCT03974100|459677821|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
127741121|NCT03974100|459677822|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
127741122|NCT03974100|459677823|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
127741123|NCT03974100|459677824|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
127741124|NCT03974100|459677820|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
127741125|NCT03974100|459677821|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
127741126|NCT03974100|459677822|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
127741127|NCT03974100|459677823|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
127741128|NCT03974100|459677824|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
127741129|NCT03974100|459677820|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
127741130|NCT03974100|459677821|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
127807193|NCT01959165|459913559|FG002|Overall Study|Lack of Efficacy|0|||
127807194|NCT01959165|459913560|FG003|Overall Study|Lack of Efficacy|0|||
127741131|NCT03974100|459677822|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
127741132|NCT03974100|459677823|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
127741133|NCT03974100|459677824|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
127741134|NCT01560871|459677827|FG000|Overall Study|transportation issues|2|||
127741135|NCT01560871|459677828|FG001|Overall Study|transportation issues|1|||
127741136|NCT01560871|459677827|FG000|Overall Study|relocation|1|||
127741137|NCT01560871|459677828|FG001|Overall Study|relocation|0|||
127741138|NCT01560871|459677827|FG000|Overall Study|readmission to a hospital|2|||
127741139|NCT01560871|459677828|FG001|Overall Study|readmission to a hospital|1|||
127741140|NCT01560871|459677827|FG000|Overall Study|Lost to Follow-up|1|||
127741141|NCT01560871|459677828|FG001|Overall Study|Lost to Follow-up|0|||
127741142|NCT02024750|459677829|FG000|Overall Study|Withdrawal by Subject|2|||
127741143|NCT02024750|459677830|FG001|Overall Study|Withdrawal by Subject|1|||
127741144|NCT00934700|459677837|FG000|Overall Study|missing scan|5|||
127741145|NCT00934700|459677838|FG001|Overall Study|missing scan|9|||
127741146|NCT00934700|459677837|FG000|Overall Study|Death|8|||
127741147|NCT00934700|459677838|FG001|Overall Study|Death|3|||
127741148|NCT03900715|459677841|FG000|Overall Study|Protocol Deviation|1|||
127741149|NCT03900715|459677841|FG000|Overall Study|Lack of Efficacy|1|||
127741150|NCT03900715|459677841|FG000|Overall Study|Progressive Disease|6|||
127741151|NCT03900715|459677841|FG000|Overall Study|Adverse Event|2|||
127741152|NCT03900715|459677841|FG000|Overall Study|Other reasons|11|||
127741153|NCT00092521|459679409|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
127741154|NCT00092521|459679410|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
127741155|NCT00092521|459679411|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
127741156|NCT00092521|459679412|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
127741157|NCT00092521|459679409|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
127741158|NCT00092521|459679410|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
127741159|NCT00092521|459679411|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
127741160|NCT00092521|459679412|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
127741161|NCT00092521|459679409|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
127741162|NCT00092521|459679410|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
127741163|NCT00092521|459679411|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
127741164|NCT00092521|459679412|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
127741165|NCT00092521|459679409|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
127741166|NCT00092521|459679410|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
127741167|NCT00092521|459679411|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
127741168|NCT00092521|459679412|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
127741169|NCT00092521|459679409|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
127741170|NCT00092521|459679410|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
127741171|NCT00092521|459679411|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
127741172|NCT00092521|459679412|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
127741173|NCT00092521|459679409|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
127741174|NCT00092521|459679410|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
127741175|NCT00092521|459679411|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
127741176|NCT00092521|459679412|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
127741177|NCT00092521|459679409|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
127741178|NCT00092521|459679410|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
127741179|NCT00092521|459679411|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
127741180|NCT00092521|459679412|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
127741181|NCT00092521|459679409|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
127741182|NCT00092521|459679410|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
127741183|NCT00092521|459679411|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
127741184|NCT00092521|459679412|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
127741185|NCT00092521|459679409|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
127741186|NCT00092521|459679410|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
127741187|NCT00092521|459679411|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
127741188|NCT00092521|459679412|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
127807195|NCT01959165|459913557|FG000|Overall Study|overdose|0|||
127807196|NCT01959165|459913558|FG001|Overall Study|overdose|0|||
127807197|NCT01959165|459913559|FG002|Overall Study|overdose|0|||
127807198|NCT01959165|459913560|FG003|Overall Study|overdose|1|||
127807199|NCT01959165|459913557|FG000|Overall Study|Welfare recipient|0|||
127741189|NCT00092521|459679409|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
127741190|NCT00092521|459679410|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
127741191|NCT00092521|459679411|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
127807200|NCT01959165|459913558|FG001|Overall Study|Welfare recipient|1|||
127741192|NCT00092521|459679412|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
127741193|NCT00092521|459679409|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
127741194|NCT00092521|459679410|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
127807201|NCT01959165|459913559|FG002|Overall Study|Welfare recipient|0|||
127741195|NCT00092521|459679411|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
127807202|NCT01959165|459913560|FG003|Overall Study|Welfare recipient|0|||
127741196|NCT00092521|459679412|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
127741197|NCT00092521|459679409|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
127741198|NCT00092521|459679410|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
127741199|NCT00092521|459679411|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
127741200|NCT00092521|459679412|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
127741201|NCT00092521|459679409|FG000|Follow-Up (After Month 7)|Death|2|||
127741202|NCT00092521|459679410|FG001|Follow-Up (After Month 7)|Death|0|||
127741203|NCT00092521|459679411|FG002|Follow-Up (After Month 7)|Death|1|||
127741204|NCT00092521|459679412|FG003|Follow-Up (After Month 7)|Death|0|||
127741205|NCT00092521|459679409|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
127741206|NCT00092521|459679410|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
127741207|NCT00092521|459679411|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
127741208|NCT00092521|459679412|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
127741209|NCT00092521|459679409|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
127741210|NCT00092521|459679410|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
127741211|NCT00092521|459679411|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
127741212|NCT00092521|459679412|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
127741213|NCT00092521|459679409|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
127741214|NCT00092521|459679410|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
127741215|NCT00092521|459679411|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
127741216|NCT00092521|459679412|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
127741217|NCT00092521|459679409|FG000|Follow-Up (After Month 7)|Moved|32|||
127741218|NCT00092521|459679410|FG001|Follow-Up (After Month 7)|Moved|2|||
127741219|NCT00092521|459679411|FG002|Follow-Up (After Month 7)|Moved|28|||
127741220|NCT00092521|459679412|FG003|Follow-Up (After Month 7)|Moved|0|||
127741221|NCT00092521|459679409|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
127741222|NCT00092521|459679410|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
127741223|NCT00092521|459679411|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
127741224|NCT00092521|459679412|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
127741225|NCT00092521|459679409|FG000|Follow-Up (After Month 7)|Travel|2|||
127741226|NCT00092521|459679410|FG001|Follow-Up (After Month 7)|Travel|0|||
127741227|NCT00092521|459679411|FG002|Follow-Up (After Month 7)|Travel|0|||
127741228|NCT00092521|459679412|FG003|Follow-Up (After Month 7)|Travel|0|||
127741229|NCT00092521|459679409|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
127741230|NCT00092521|459679410|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
127741231|NCT00092521|459679411|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
127741232|NCT00092521|459679412|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
127741233|NCT00092521|459679409|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
127741234|NCT00092521|459679410|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
127741235|NCT00092521|459679411|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
127741236|NCT00092521|459679412|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
127741237|NCT00092521|459679409|FG000|Extension Study (Group 4)|Adverse Event|0|||
127741238|NCT00092521|459679410|FG001|Extension Study (Group 4)|Adverse Event|0|||
127741239|NCT00092521|459679411|FG002|Extension Study (Group 4)|Adverse Event|0|||
127741240|NCT00092521|459679412|FG003|Extension Study (Group 4)|Adverse Event|2|||
127741241|NCT00092521|459679409|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
127741242|NCT00092521|459679410|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
127741243|NCT00092521|459679411|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
127741244|NCT00092521|459679412|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
127741245|NCT00092521|459679409|FG000|Extension Study (Group 4)|Pregnancy|0|||
127741246|NCT00092521|459679410|FG001|Extension Study (Group 4)|Pregnancy|0|||
127741247|NCT00092521|459679411|FG002|Extension Study (Group 4)|Pregnancy|0|||
127741248|NCT00092521|459679412|FG003|Extension Study (Group 4)|Pregnancy|4|||
127741249|NCT00092521|459679409|FG000|Extension Study (Group 4)|Protocol Violation|0|||
127741250|NCT00092521|459679410|FG001|Extension Study (Group 4)|Protocol Violation|0|||
127741251|NCT00092521|459679411|FG002|Extension Study (Group 4)|Protocol Violation|0|||
127741252|NCT00092521|459679412|FG003|Extension Study (Group 4)|Protocol Violation|2|||
127807203|NCT00927563|459913573|FG000|Overall Study|Lost to Follow-up|1|||
127807204|NCT00927563|459913573|FG000|Overall Study|Withdrawal by Subject|1|||
127807205|NCT01468987|459913576|FG000|Overall Study|Adverse Event|12|||
127807206|NCT01468987|459913577|FG001|Overall Study|Adverse Event|9|||
127807207|NCT01468987|459913576|FG000|Overall Study|Death|4|||
127807208|NCT01468987|459913577|FG001|Overall Study|Death|1|||
127807209|NCT01468987|459913576|FG000|Overall Study|Lost to Follow-up|10|||
127807210|NCT01468987|459913577|FG001|Overall Study|Lost to Follow-up|5|||
127807211|NCT01468987|459913576|FG000|Overall Study|Protocol Violation|8|||
127807212|NCT01468987|459913577|FG001|Overall Study|Protocol Violation|2|||
127807213|NCT01468987|459913576|FG000|Overall Study|Withdrawal by Subject|28|||
127807214|NCT01468987|459913577|FG001|Overall Study|Withdrawal by Subject|28|||
127807215|NCT01468987|459913576|FG000|Overall Study|Physician Decision|8|||
127807216|NCT01468987|459913577|FG001|Overall Study|Physician Decision|15|||
127807217|NCT01468987|459913576|FG000|Overall Study|Sponsor Decision|1|||
127807218|NCT01468987|459913577|FG001|Overall Study|Sponsor Decision|0|||
127807219|NCT05032950|459913579|FG000|Overall Study|Adverse Event|0|||
127807220|NCT05032950|459913580|FG001|Overall Study|Adverse Event|0|||
127893131|NCT01806597|460231298|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
127741253|NCT00092521|459679409|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
127741254|NCT00092521|459679410|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
127741255|NCT00092521|459679411|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
127741256|NCT00092521|459679412|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
127741257|NCT00092521|459679409|FG000|Extension Study (Group 4)|Moved|0|||
127741258|NCT00092521|459679410|FG001|Extension Study (Group 4)|Moved|0|||
127741259|NCT00092521|459679411|FG002|Extension Study (Group 4)|Moved|0|||
127741260|NCT00092521|459679412|FG003|Extension Study (Group 4)|Moved|16|||
127741261|NCT00092521|459679409|FG000|Extension Study (Group 4)|Site Terminated|0|||
127741262|NCT00092521|459679410|FG001|Extension Study (Group 4)|Site Terminated|0|||
127741263|NCT00092521|459679411|FG002|Extension Study (Group 4)|Site Terminated|0|||
127741264|NCT00092521|459679412|FG003|Extension Study (Group 4)|Site Terminated|4|||
127741265|NCT00092521|459679409|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
127741266|NCT00092521|459679410|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
127741267|NCT00092521|459679411|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
127741268|NCT00092521|459679412|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
127741269|NCT03464383|459679413|FG000|Overall Study|Lost to Follow-up|1|||
127741270|NCT03464383|459679414|FG001|Overall Study|Lost to Follow-up|0|||
127741271|NCT03464383|459679415|FG002|Overall Study|Lost to Follow-up|0|||
127741272|NCT03464383|459679413|FG000|Overall Study|Withdrawal by Subject|0|||
127741273|NCT03464383|459679414|FG001|Overall Study|Withdrawal by Subject|1|||
127741274|NCT03464383|459679415|FG002|Overall Study|Withdrawal by Subject|0|||
127741275|NCT02161406|459679419|FG000|Overall Study|Death|2|||
127741276|NCT02161406|459679420|FG001|Overall Study|Death|1|||
127741277|NCT02161406|459679419|FG000|Overall Study|Lost to Follow-up|2|||
127741278|NCT02161406|459679420|FG001|Overall Study|Lost to Follow-up|1|||
127741279|NCT02161406|459679419|FG000|Overall Study|Withdrawal by Subject|2|||
127741280|NCT02161406|459679420|FG001|Overall Study|Withdrawal by Subject|4|||
127741281|NCT02161406|459679419|FG000|Overall Study|investigator withdrew subject|3|||
127741282|NCT02161406|459679420|FG001|Overall Study|investigator withdrew subject|1|||
127741283|NCT02161406|459679419|FG000|Overall Study|Lack of Efficacy|1|||
127741284|NCT02161406|459679420|FG001|Overall Study|Lack of Efficacy|1|||
127741285|NCT02161406|459679419|FG000|Overall Study|relocation|0|||
127741286|NCT02161406|459679420|FG001|Overall Study|relocation|1|||
127741287|NCT03458728|459679421|FG000|Overall Study|Adverse Event|1|||
127741288|NCT03458728|459679422|FG001|Overall Study|Adverse Event|0|||
127741289|NCT03458728|459679421|FG000|Overall Study|Physician Decision|1|||
127741290|NCT03458728|459679422|FG001|Overall Study|Physician Decision|0|||
127741291|NCT03458728|459679421|FG000|Overall Study|Progressive disease - clinical assessment|1|||
127741292|NCT03458728|459679422|FG001|Overall Study|Progressive disease - clinical assessment|0|||
127741293|NCT03458728|459679421|FG000|Overall Study|Progressive disease - radiological progression|21|||
127741294|NCT03458728|459679422|FG001|Overall Study|Progressive disease - radiological progression|6|||
127741295|NCT03458728|459679421|FG000|Overall Study|Withdrawal by Subject|0|||
127741296|NCT03458728|459679422|FG001|Overall Study|Withdrawal by Subject|1|||
127741297|NCT00908349|459679423|FG000|Overall Study|Adverse Event|10|||
127741298|NCT00908349|459679423|FG000|Overall Study|Withdrawal by Subject|9|||
127741299|NCT00908349|459679423|FG000|Overall Study|Physician Decision|5|||
127741300|NCT00908349|459679423|FG000|Overall Study|Lost to Follow-up|5|||
127741301|NCT00908349|459679423|FG000|Overall Study|Various|6|||
127741302|NCT00362375|459679426|FG000|Overall Study|Lost to Follow-up|40|||
127741303|NCT00362375|459679427|FG001|Overall Study|Lost to Follow-up|35|||
127741304|NCT04606199|459679428|FG000|Overall Study|Withdrawal by Subject|2|||
127741305|NCT02624869|459679432|FG000|Overall Study|Lost to Follow-up|0|||
127741306|NCT02624869|459679433|FG001|Overall Study|Lost to Follow-up|0|||
127741307|NCT02624869|459679434|FG002|Overall Study|Lost to Follow-up|1|||
127741308|NCT02624869|459679432|FG000|Overall Study|Withdrawal by Subject|1|||
127741309|NCT02624869|459679433|FG001|Overall Study|Withdrawal by Subject|3|||
127741310|NCT02624869|459679434|FG002|Overall Study|Withdrawal by Subject|1|||
127741311|NCT01085812|459679437|FG000|Open-Label Period|Adverse Event|0|||
127741312|NCT01085812|459679438|FG001|Open-Label Period|Adverse Event|80|||
127741313|NCT01085812|459679437|FG000|Open-Label Period|Lack of Efficacy|0|||
127741314|NCT01085812|459679438|FG001|Open-Label Period|Lack of Efficacy|26|||
127741315|NCT01085812|459679437|FG000|Open-Label Period|Protocol Violation|0|||
127741316|NCT01085812|459679438|FG001|Open-Label Period|Protocol Violation|39|||
127741317|NCT01085812|459679437|FG000|Open-Label Period|Withdrawal by Subject|0|||
127741318|NCT01085812|459679438|FG001|Open-Label Period|Withdrawal by Subject|53|||
127741319|NCT01085812|459679437|FG000|Open-Label Period|Lost to Follow-up|0|||
127741320|NCT01085812|459679438|FG001|Open-Label Period|Lost to Follow-up|42|||
127741321|NCT01085812|459679437|FG000|Double-Blind Period|Adverse Event|3|||
127741322|NCT01085812|459679438|FG001|Double-Blind Period|Adverse Event|8|||
127741323|NCT01085812|459679437|FG000|Double-Blind Period|Protocol Violation|2|||
127741324|NCT01085812|459679438|FG001|Double-Blind Period|Protocol Violation|7|||
127741325|NCT01085812|459679437|FG000|Double-Blind Period|Withdrawal by Subject|11|||
127741326|NCT01085812|459679438|FG001|Double-Blind Period|Withdrawal by Subject|24|||
127741327|NCT01085812|459679437|FG000|Double-Blind Period|Lost to Follow-up|5|||
127741328|NCT01085812|459679438|FG001|Double-Blind Period|Lost to Follow-up|17|||
127741329|NCT01085812|459679437|FG000|Double-Blind Period|Other Reasons|0|||
127741330|NCT01085812|459679438|FG001|Double-Blind Period|Other Reasons|2|||
127741331|NCT01085812|459679437|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
127741332|NCT01085812|459679438|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
127741333|NCT01085812|459679437|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
127741334|NCT01085812|459679438|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
127741335|NCT01085812|459679437|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
127741336|NCT01085812|459679438|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
127741337|NCT01085812|459679437|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
127741338|NCT01085812|459679438|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
127741339|NCT01085812|459679437|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
127741340|NCT01085812|459679438|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
127741341|NCT01172639|459679441|FG000|Overall Study|Death|1|||
127741342|NCT01172639|459679442|FG001|Overall Study|Death|1|||
127741343|NCT01172639|459679443|FG002|Overall Study|Death|0|||
127741344|NCT01172639|459679444|FG003|Overall Study|Death|0|||
127741345|NCT01172639|459679445|FG004|Overall Study|Death|0|||
127741346|NCT01172639|459679441|FG000|Overall Study|Lost to Follow-up|9|||
127741347|NCT01172639|459679442|FG001|Overall Study|Lost to Follow-up|7|||
127741348|NCT01172639|459679443|FG002|Overall Study|Lost to Follow-up|11|||
127741349|NCT01172639|459679444|FG003|Overall Study|Lost to Follow-up|6|||
127741350|NCT01172639|459679445|FG004|Overall Study|Lost to Follow-up|6|||
127741351|NCT01172639|459679441|FG000|Overall Study|Withdrawal by Subject|3|||
127741352|NCT01172639|459679442|FG001|Overall Study|Withdrawal by Subject|3|||
127741353|NCT01172639|459679443|FG002|Overall Study|Withdrawal by Subject|5|||
127807221|NCT05032950|459913581|FG002|Overall Study|Adverse Event|1|||
127807222|NCT05032950|459913582|FG003|Overall Study|Adverse Event|1|||
127807223|NCT05032950|459913583|FG004|Overall Study|Adverse Event|0|||
127807224|NCT05032950|459913584|FG005|Overall Study|Adverse Event|0|||
127807225|NCT02959814|459913588|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
127807226|NCT02959814|459913588|FG000|Overall Study|Excluded based on anatomical criteria|2|||
127807227|NCT02959814|459913588|FG000|Overall Study|Protocol Violation|7|||
127807228|NCT02959814|459913588|FG000|Overall Study|FFR not measured|2|||
127807229|NCT02959814|459913588|FG000|Overall Study|In-procedure QFR not computed|6|||
127893132|NCT01806597|460231299|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
127893133|NCT01806597|460231294|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
127893134|NCT01806597|460231295|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
127893135|NCT01806597|460231296|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
127893136|NCT01806597|460231297|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
127893137|NCT01806597|460231298|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
127893138|NCT01806597|460231299|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
127893139|NCT01806597|460231294|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
127893140|NCT01806597|460231295|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
127893141|NCT01806597|460231296|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
127893142|NCT01806597|460231297|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
127893143|NCT01806597|460231298|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
127893144|NCT01806597|460231299|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
127893145|NCT01806597|460231294|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
127893146|NCT01806597|460231295|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
127893147|NCT01806597|460231296|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
127893148|NCT01806597|460231297|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
127893149|NCT01806597|460231298|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
127893150|NCT01806597|460231299|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
127893151|NCT01806597|460231294|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
127893152|NCT01806597|460231295|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
127893153|NCT01806597|460231296|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
127893154|NCT01806597|460231297|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
127893155|NCT01806597|460231298|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
127893156|NCT01806597|460231299|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
127893157|NCT01806597|460231294|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
127741354|NCT01172639|459679444|FG003|Overall Study|Withdrawal by Subject|5|||
127807230|NCT02959814|459913588|FG000|Overall Study|Excluded by FFR core-lab|24|||
127893158|NCT01806597|460231295|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
127893159|NCT01806597|460231296|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
127893160|NCT01806597|460231297|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
127893161|NCT01806597|460231298|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
127807231|NCT02116621|459913589|FG000|Baseline|Withdrawal by Subject|0|||
127741355|NCT01172639|459679445|FG004|Overall Study|Withdrawal by Subject|0|||
127741356|NCT00469456|459679446|FG000|Overall Study|Adverse Event|4|||
127741357|NCT00469456|459679447|FG001|Overall Study|Adverse Event|3|||
127741358|NCT00469456|459679446|FG000|Overall Study|Protocol Violation|1|||
127741359|NCT00469456|459679447|FG001|Overall Study|Protocol Violation|0|||
127741360|NCT00469456|459679446|FG000|Overall Study|Withdrawal by Subject|4|||
127741361|NCT00469456|459679447|FG001|Overall Study|Withdrawal by Subject|1|||
127741362|NCT03634839|459679448|FG000|First Intervention (2 Hours)|Adverse Event|0|||
127741363|NCT03634839|459679449|FG001|First Intervention (2 Hours)|Adverse Event|2|||
127741364|NCT02447432|459679452|FG000|Epoch 001|Adverse Event|1|||
127741365|NCT02447432|459679453|FG001|Epoch 001|Adverse Event|1|||
127741366|NCT02447432|459679452|FG000|Epoch 001|Withdrawal by Subject|0|||
127741367|NCT02447432|459679453|FG001|Epoch 001|Withdrawal by Subject|4|||
127741368|NCT02447432|459679452|FG000|Epoch 001|Migrated/moved from study area|3|||
127741369|NCT02447432|459679453|FG001|Epoch 001|Migrated/moved from study area|5|||
127741370|NCT02447432|459679452|FG000|Epoch 001|Lost to Follow-up|1|||
127741371|NCT02447432|459679453|FG001|Epoch 001|Lost to Follow-up|3|||
127741372|NCT00302159|459679456|FG000|Overall Study|pt declined before treatment started|1|||
127741373|NCT00302159|459679456|FG000|Overall Study|pt started Avastin|1|||
127741374|NCT02835092|459679461|FG000|Overall Study|Withdrawal by Subject|3|||
127741375|NCT02835092|459679462|FG001|Overall Study|Withdrawal by Subject|6|||
127741376|NCT02835092|459679463|FG002|Overall Study|Withdrawal by Subject|3|||
127741377|NCT02835092|459679461|FG000|Overall Study|Lost to Follow-up|0|||
127741378|NCT02835092|459679462|FG001|Overall Study|Lost to Follow-up|2|||
127741379|NCT02835092|459679463|FG002|Overall Study|Lost to Follow-up|0|||
127741380|NCT01657877|459679465|FG000|Overall Study|Withdrawal by Subject|4|||
127741381|NCT01657877|459679465|FG000|Overall Study|Protocol Violation|6|||
127741382|NCT01657877|459679465|FG000|Overall Study|Adverse Event|2|||
127741383|NCT01657877|459679465|FG000|Overall Study|Other Reason|2|||
127741384|NCT01114672|459679467|FG000|Overall Study|Death|0|||
127741385|NCT01114672|459679468|FG001|Overall Study|Death|1|||
127741386|NCT01114672|459679467|FG000|Overall Study|Withdrawal by Subject|2|||
127741387|NCT01114672|459679468|FG001|Overall Study|Withdrawal by Subject|1|||
127741388|NCT01114672|459679467|FG000|Overall Study|Lost to Follow-up|1|||
127741389|NCT01114672|459679468|FG001|Overall Study|Lost to Follow-up|0|||
127741390|NCT01114672|459679467|FG000|Overall Study|transplanted|1|||
127741391|NCT01114672|459679468|FG001|Overall Study|transplanted|0|||
127741392|NCT04545476|459679469|FG000|Overall Study|Lost to Follow-up|1|||
127741393|NCT04545476|459679470|FG001|Overall Study|Lost to Follow-up|1|||
127741394|NCT04545476|459679471|FG002|Overall Study|Lost to Follow-up|0|||
127741395|NCT04545476|459679472|FG003|Overall Study|Lost to Follow-up|0|||
127741396|NCT00690378|459679475|FG000|Overall Study|Adverse Event|1|||
127741397|NCT00690378|459679476|FG001|Overall Study|Adverse Event|0|||
127741398|NCT00690378|459679475|FG000|Overall Study|Withdrawal by Subject|2|||
127741399|NCT00690378|459679476|FG001|Overall Study|Withdrawal by Subject|0|||
127741400|NCT00690378|459679475|FG000|Overall Study|Protocol Violation|1|||
127741401|NCT00690378|459679476|FG001|Overall Study|Protocol Violation|0|||
127741402|NCT00690378|459679475|FG000|Overall Study|Lost to Follow-up|2|||
127741403|NCT00690378|459679476|FG001|Overall Study|Lost to Follow-up|3|||
127741404|NCT00690378|459679475|FG000|Overall Study|Did not meet inc/exc criteria|13|||
127741405|NCT00690378|459679476|FG001|Overall Study|Did not meet inc/exc criteria|11|||
127741406|NCT00690378|459679475|FG000|Overall Study|Social problem|1|||
127741407|NCT00690378|459679476|FG001|Overall Study|Social problem|0|||
127741408|NCT02019641|459679477|FG000|10-Week Follow up|Withdrawal by investigator|2|||
127741409|NCT02019641|459679478|FG001|10-Week Follow up|Withdrawal by investigator|0|||
127741410|NCT02019641|459679479|FG002|10-Week Follow up|Withdrawal by investigator|0|||
127741411|NCT02019641|459679477|FG000|10-Week Follow up|Withdrawal by Subject|1|||
127741412|NCT02019641|459679478|FG001|10-Week Follow up|Withdrawal by Subject|1|||
127807232|NCT02116621|459913590|FG001|Baseline|Withdrawal by Subject|4|||
127807233|NCT02116621|459913589|FG000|Three Month Follow-up|Death|1|||
127807234|NCT02116621|459913590|FG001|Three Month Follow-up|Death|1|||
127807235|NCT02116621|459913589|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
127807236|NCT02116621|459913590|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
127807237|NCT02116621|459913589|FG000|Three Month Follow-up|Lost to Follow-up|0|||
127807238|NCT02116621|459913590|FG001|Three Month Follow-up|Lost to Follow-up|1|||
127807239|NCT02116621|459913589|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
127807240|NCT02116621|459913590|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
127807241|NCT02116621|459913589|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
127807242|NCT02116621|459913590|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
127807243|NCT02116621|459913589|FG000|Six Month Follow-up|Lost to Follow-up|2|||
127807244|NCT02116621|459913590|FG001|Six Month Follow-up|Lost to Follow-up|1|||
127807245|NCT02116621|459913589|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
127807246|NCT02116621|459913590|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
127807247|NCT02116621|459913589|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
127807248|NCT02116621|459913590|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
127807249|NCT02116621|459913589|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
127893162|NCT01806597|460231299|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
127893163|NCT01806597|460231294|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
127893164|NCT01806597|460231295|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
127893165|NCT01806597|460231296|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
127893166|NCT01806597|460231297|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
127893167|NCT01806597|460231298|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
127893168|NCT01806597|460231299|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
127893169|NCT02247479|460231301|FG000|Overall Study|Adverse Event|8|||
127893170|NCT02247479|460231302|FG001|Overall Study|Adverse Event|9|||
127893171|NCT02247479|460231303|FG002|Overall Study|Adverse Event|8|||
127893172|NCT02247479|460231301|FG000|Overall Study|Death|5|||
127893173|NCT02247479|460231302|FG001|Overall Study|Death|4|||
127741413|NCT02019641|459679479|FG002|10-Week Follow up|Withdrawal by Subject|0|||
127741414|NCT02019641|459679477|FG000|20-Week Follow up|Withdrawal by investigator|0|||
127741415|NCT02019641|459679478|FG001|20-Week Follow up|Withdrawal by investigator|0|||
127741416|NCT02019641|459679479|FG002|20-Week Follow up|Withdrawal by investigator|1|||
127741417|NCT03318783|459679480|FG000|Overall Study|Withdrawal by Subject|0|||
127741418|NCT03318783|459679481|FG001|Overall Study|Withdrawal by Subject|1|||
127741419|NCT03318783|459679480|FG000|Overall Study|Death|0|||
127741420|NCT03318783|459679481|FG001|Overall Study|Death|1|||
127741421|NCT03410108|459679484|FG000|Overall Study|Ongoing|41|||
127741422|NCT03410108|459679484|FG000|Overall Study|Adverse Event|4|||
127741423|NCT03410108|459679484|FG000|Overall Study|Progressive Disease|58|||
127741424|NCT03410108|459679484|FG000|Overall Study|Withdrawal by Subject|1|||
127741425|NCT04035577|459679488|FG000|Overall Study|Lost to Follow-up|1|||
127741426|NCT04035577|459679488|FG000|Overall Study|Withdrawal by Subject|1|||
127741427|NCT03269695|459679489|FG000|Overall Study|Adverse Event|2|||
127741428|NCT03269695|459679490|FG001|Overall Study|Adverse Event|1|||
127741429|NCT03269695|459679489|FG000|Overall Study|Lack of Efficacy|0|||
127741430|NCT03269695|459679490|FG001|Overall Study|Lack of Efficacy|1|||
127741431|NCT03269695|459679489|FG000|Overall Study|Withdrawal by Subject|0|||
127741432|NCT03269695|459679490|FG001|Overall Study|Withdrawal by Subject|1|||
127741433|NCT00104637|459679492|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
127741434|NCT00104637|459679493|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
127741435|NCT01313624|459679494|FG000|Double-Blind Phase|Adverse Event|27|||
127741436|NCT01313624|459679495|FG001|Double-Blind Phase|Adverse Event|4|||
127741437|NCT01313624|459679494|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
127741438|NCT01313624|459679495|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
127741439|NCT01313624|459679494|FG000|Double-Blind Phase|Lost to Follow-up|0|||
127741440|NCT01313624|459679495|FG001|Double-Blind Phase|Lost to Follow-up|2|||
127741441|NCT01313624|459679494|FG000|Double-Blind Phase|Physician Decision|1|||
127741442|NCT01313624|459679495|FG001|Double-Blind Phase|Physician Decision|0|||
127741443|NCT01313624|459679494|FG000|Double-Blind Phase|Lack of Efficacy|1|||
127741444|NCT01313624|459679495|FG001|Double-Blind Phase|Lack of Efficacy|0|||
127741445|NCT01313624|459679494|FG000|Open-Label Phase|Adverse Event|1|||
127741446|NCT01313624|459679495|FG001|Open-Label Phase|Adverse Event|10|||
127741447|NCT01313624|459679494|FG000|Open-Label Phase|Withdrawal by Subject|2|||
127741448|NCT01313624|459679495|FG001|Open-Label Phase|Withdrawal by Subject|2|||
127741449|NCT01313624|459679494|FG000|Open-Label Phase|Lost to Follow-up|1|||
127741450|NCT01313624|459679495|FG001|Open-Label Phase|Lost to Follow-up|1|||
127741451|NCT00505414|459679496|FG000|Titration Phase|Adverse Event|0|||
127741452|NCT00505414|459679497|FG001|Titration Phase|Adverse Event|0|||
127741453|NCT00505414|459679498|FG002|Titration Phase|Adverse Event|0|||
127741454|NCT00505414|459679499|FG003|Titration Phase|Adverse Event|8|||
127741455|NCT00505414|459679500|FG004|Titration Phase|Adverse Event|3|||
127741456|NCT00505414|459679496|FG000|Titration Phase|Death|0|||
127741457|NCT00505414|459679497|FG001|Titration Phase|Death|0|||
127741458|NCT00505414|459679498|FG002|Titration Phase|Death|0|||
127741459|NCT00505414|459679499|FG003|Titration Phase|Death|2|||
127741460|NCT00505414|459679500|FG004|Titration Phase|Death|0|||
127741461|NCT00505414|459679496|FG000|Titration Phase|Lack of Efficacy|0|||
127741462|NCT00505414|459679497|FG001|Titration Phase|Lack of Efficacy|0|||
127741463|NCT00505414|459679498|FG002|Titration Phase|Lack of Efficacy|0|||
127741464|NCT00505414|459679499|FG003|Titration Phase|Lack of Efficacy|10|||
127741465|NCT00505414|459679500|FG004|Titration Phase|Lack of Efficacy|1|||
127741466|NCT00505414|459679496|FG000|Titration Phase|Protocol Violation|0|||
127741467|NCT00505414|459679497|FG001|Titration Phase|Protocol Violation|0|||
127741468|NCT00505414|459679498|FG002|Titration Phase|Protocol Violation|0|||
127741469|NCT00505414|459679499|FG003|Titration Phase|Protocol Violation|0|||
127741470|NCT00505414|459679500|FG004|Titration Phase|Protocol Violation|1|||
127807250|NCT02116621|459913590|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
127807251|NCT02116621|459913589|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
127807252|NCT02116621|459913590|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
127807253|NCT02116621|459913589|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
127807254|NCT02116621|459913590|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
127807255|NCT00961961|459913591|FG000|Phase I|Withdrawal by Subject|7|||
127807256|NCT00961961|459913592|FG001|Phase I|Withdrawal by Subject|0|||
127807257|NCT00961961|459913593|FG002|Phase I|Withdrawal by Subject|0|||
127807258|NCT00961961|459913594|FG003|Phase I|Withdrawal by Subject|0|||
127807259|NCT00961961|459913591|FG000|Phase I|Lost to Follow-up|10|||
127807260|NCT00961961|459913592|FG001|Phase I|Lost to Follow-up|0|||
127807261|NCT00961961|459913593|FG002|Phase I|Lost to Follow-up|0|||
127807262|NCT00961961|459913594|FG003|Phase I|Lost to Follow-up|0|||
127807263|NCT00961961|459913591|FG000|Phase I|Lack of Efficacy|94|||
127807264|NCT00961961|459913592|FG001|Phase I|Lack of Efficacy|0|||
127807265|NCT00961961|459913593|FG002|Phase I|Lack of Efficacy|0|||
127807266|NCT00961961|459913594|FG003|Phase I|Lack of Efficacy|0|||
127807267|NCT00961961|459913591|FG000|Phase I|Adverse Event|7|||
127807268|NCT00961961|459913592|FG001|Phase I|Adverse Event|0|||
127807269|NCT00961961|459913593|FG002|Phase I|Adverse Event|0|||
127807270|NCT00961961|459913594|FG003|Phase I|Adverse Event|0|||
127807271|NCT00961961|459913591|FG000|Phase I|Physician Decision|8|||
127807272|NCT00961961|459913592|FG001|Phase I|Physician Decision|0|||
127807273|NCT00961961|459913593|FG002|Phase I|Physician Decision|0|||
127807274|NCT00961961|459913594|FG003|Phase I|Physician Decision|0|||
127807275|NCT00961961|459913591|FG000|Phase II|Lost to Follow-up|0|||
127807276|NCT00961961|459913592|FG001|Phase II|Lost to Follow-up|0|||
127807277|NCT00961961|459913593|FG002|Phase II|Lost to Follow-up|10|||
127807278|NCT00961961|459913594|FG003|Phase II|Lost to Follow-up|7|||
127807279|NCT00961961|459913591|FG000|Phase II|Adverse Event|0|||
127807280|NCT00961961|459913592|FG001|Phase II|Adverse Event|0|||
127741471|NCT00505414|459679496|FG000|Titration Phase|Withdrawal by Subject|0|||
127741472|NCT00505414|459679497|FG001|Titration Phase|Withdrawal by Subject|0|||
127741473|NCT00505414|459679498|FG002|Titration Phase|Withdrawal by Subject|0|||
127741474|NCT00505414|459679499|FG003|Titration Phase|Withdrawal by Subject|3|||
127741475|NCT00505414|459679500|FG004|Titration Phase|Withdrawal by Subject|4|||
127741476|NCT00505414|459679496|FG000|Titration Phase|Underlying disease and therapy required|0|||
127741477|NCT00505414|459679497|FG001|Titration Phase|Underlying disease and therapy required|0|||
127741478|NCT00505414|459679498|FG002|Titration Phase|Underlying disease and therapy required|0|||
127741479|NCT00505414|459679499|FG003|Titration Phase|Underlying disease and therapy required|7|||
127741480|NCT00505414|459679500|FG004|Titration Phase|Underlying disease and therapy required|3|||
127741481|NCT00505414|459679496|FG000|Maintenance Phase|Adverse Event|2|||
127741482|NCT00505414|459679497|FG001|Maintenance Phase|Adverse Event|2|||
127741483|NCT00505414|459679498|FG002|Maintenance Phase|Adverse Event|3|||
127741484|NCT00505414|459679499|FG003|Maintenance Phase|Adverse Event|0|||
127741485|NCT00505414|459679500|FG004|Maintenance Phase|Adverse Event|0|||
127741486|NCT00505414|459679496|FG000|Maintenance Phase|Death|2|||
127741487|NCT00505414|459679497|FG001|Maintenance Phase|Death|0|||
127741488|NCT00505414|459679498|FG002|Maintenance Phase|Death|1|||
127741489|NCT00505414|459679499|FG003|Maintenance Phase|Death|0|||
127741490|NCT00505414|459679500|FG004|Maintenance Phase|Death|0|||
127741491|NCT00505414|459679496|FG000|Maintenance Phase|Lack of Efficacy|2|||
127741492|NCT00505414|459679497|FG001|Maintenance Phase|Lack of Efficacy|1|||
127741493|NCT00505414|459679498|FG002|Maintenance Phase|Lack of Efficacy|1|||
127741494|NCT00505414|459679499|FG003|Maintenance Phase|Lack of Efficacy|0|||
127741495|NCT00505414|459679500|FG004|Maintenance Phase|Lack of Efficacy|0|||
127741496|NCT00505414|459679496|FG000|Maintenance Phase|Withdrawal by Subject|0|||
127807281|NCT00961961|459913593|FG002|Phase II|Adverse Event|0|||
127807282|NCT00961961|459913594|FG003|Phase II|Adverse Event|1|||
127807283|NCT00961961|459913591|FG000|Phase II|Physician Decision|0|||
127893174|NCT02247479|460231303|FG002|Overall Study|Death|6|||
127741497|NCT00505414|459679497|FG001|Maintenance Phase|Withdrawal by Subject|0|||
127893175|NCT02247479|460231301|FG000|Overall Study|Lost to Follow-up|3|||
127741498|NCT00505414|459679498|FG002|Maintenance Phase|Withdrawal by Subject|1|||
127807284|NCT00961961|459913592|FG001|Phase II|Physician Decision|0|||
127807285|NCT00961961|459913593|FG002|Phase II|Physician Decision|1|||
127807286|NCT00961961|459913594|FG003|Phase II|Physician Decision|0|||
127807287|NCT00961961|459913591|FG000|Phase II|Withdrawal by Subject|0|||
127807288|NCT00961961|459913592|FG001|Phase II|Withdrawal by Subject|0|||
127807289|NCT00961961|459913593|FG002|Phase II|Withdrawal by Subject|1|||
127807290|NCT00961961|459913594|FG003|Phase II|Withdrawal by Subject|0|||
127741499|NCT00505414|459679499|FG003|Maintenance Phase|Withdrawal by Subject|0|||
127741500|NCT00505414|459679500|FG004|Maintenance Phase|Withdrawal by Subject|0|||
127741501|NCT00505414|459679496|FG000|Maintenance Phase|underlying disease and therapy required|0|||
127741502|NCT00505414|459679497|FG001|Maintenance Phase|underlying disease and therapy required|2|||
127741503|NCT00505414|459679498|FG002|Maintenance Phase|underlying disease and therapy required|2|||
127741504|NCT00505414|459679499|FG003|Maintenance Phase|underlying disease and therapy required|0|||
127741505|NCT00505414|459679500|FG004|Maintenance Phase|underlying disease and therapy required|0|||
127741506|NCT00846768|459679501|FG000|Overall Study|Adverse Event|0|||
127741507|NCT00846768|459679502|FG001|Overall Study|Adverse Event|1|||
127741508|NCT00846768|459679503|FG002|Overall Study|Adverse Event|0|||
127741509|NCT00846768|459679504|FG003|Overall Study|Adverse Event|0|||
127741510|NCT00644878|459679505|FG000|Overall Study|Adverse Event|2|||
127741511|NCT00644878|459679505|FG000|Overall Study|Abnormal laboratory value|3|||
127807291|NCT02425098|459913597|FG000|Overall Study|Lost to Follow-up|7|||
127807292|NCT02425098|459913598|FG001|Overall Study|Lost to Follow-up|7|||
127807293|NCT02425098|459913597|FG000|Overall Study|Withdrawal by Subject|4|||
127807294|NCT02425098|459913598|FG001|Overall Study|Withdrawal by Subject|8|||
127807295|NCT02425098|459913597|FG000|Overall Study|Pregnancy|2|||
127807296|NCT02425098|459913598|FG001|Overall Study|Pregnancy|0|||
127807297|NCT02425098|459913597|FG000|Overall Study|Reason not Specified|0|||
127807298|NCT02425098|459913598|FG001|Overall Study|Reason not Specified|1|||
127807299|NCT01929135|459913599|FG000|Overall Study|Lost to Follow-up|1|||
127807300|NCT01929135|459913600|FG001|Overall Study|Lost to Follow-up|1|||
127807301|NCT02078219|459913601|FG000|Overall Study|Other|2|||
127807302|NCT02078219|459913602|FG001|Overall Study|Other|2|||
127807303|NCT02078219|459913603|FG002|Overall Study|Other|3|||
127807304|NCT02078219|459913604|FG003|Overall Study|Other|0|||
127807305|NCT02078219|459913605|FG004|Overall Study|Other|1|||
127807306|NCT02078219|459913601|FG000|Overall Study|Withdrawal by Subject|0|||
127807307|NCT02078219|459913602|FG001|Overall Study|Withdrawal by Subject|1|||
127807308|NCT02078219|459913603|FG002|Overall Study|Withdrawal by Subject|0|||
127807309|NCT02078219|459913604|FG003|Overall Study|Withdrawal by Subject|1|||
127807310|NCT02078219|459913605|FG004|Overall Study|Withdrawal by Subject|1|||
127807311|NCT02078219|459913601|FG000|Overall Study|Protocol Violation|0|||
127807312|NCT02078219|459913602|FG001|Overall Study|Protocol Violation|0|||
127807313|NCT02078219|459913603|FG002|Overall Study|Protocol Violation|0|||
127807314|NCT02078219|459913604|FG003|Overall Study|Protocol Violation|1|||
127807315|NCT02078219|459913605|FG004|Overall Study|Protocol Violation|0|||
127807316|NCT02078219|459913601|FG000|Overall Study|Death|0|||
127807317|NCT02078219|459913602|FG001|Overall Study|Death|0|||
127807318|NCT02078219|459913603|FG002|Overall Study|Death|0|||
127807319|NCT02078219|459913604|FG003|Overall Study|Death|1|||
127807320|NCT02078219|459913605|FG004|Overall Study|Death|0|||
127807321|NCT02078219|459913601|FG000|Overall Study|Adverse Event|1|||
127807322|NCT02078219|459913602|FG001|Overall Study|Adverse Event|1|||
127807323|NCT02078219|459913603|FG002|Overall Study|Adverse Event|3|||
127807324|NCT02078219|459913604|FG003|Overall Study|Adverse Event|1|||
127807325|NCT02078219|459913605|FG004|Overall Study|Adverse Event|0|||
127807326|NCT03283085|459913612|FG000|Overall Study|Adverse Event|18|||
127807327|NCT03283085|459913613|FG001|Overall Study|Adverse Event|3|||
127807328|NCT03283085|459913614|FG002|Overall Study|Adverse Event|13|||
127807329|NCT03283085|459913615|FG003|Overall Study|Adverse Event|0|||
127807330|NCT03283085|459913616|FG004|Overall Study|Adverse Event|0|||
127807331|NCT03283085|459913617|FG005|Overall Study|Adverse Event|5|||
127807332|NCT03283085|459913612|FG000|Overall Study|Death|0|||
127807333|NCT03283085|459913613|FG001|Overall Study|Death|0|||
127807334|NCT03283085|459913614|FG002|Overall Study|Death|3|||
127807335|NCT03283085|459913615|FG003|Overall Study|Death|1|||
127807336|NCT03283085|459913616|FG004|Overall Study|Death|0|||
127807337|NCT03283085|459913617|FG005|Overall Study|Death|0|||
127807338|NCT03283085|459913612|FG000|Overall Study|Withdrawal by Subject|42|||
127893176|NCT02247479|460231302|FG001|Overall Study|Lost to Follow-up|3|||
127893177|NCT02247479|460231303|FG002|Overall Study|Lost to Follow-up|1|||
127893178|NCT02247479|460231301|FG000|Overall Study|Non-compliance|0|||
127893179|NCT02247479|460231302|FG001|Overall Study|Non-compliance|0|||
127893180|NCT02247479|460231303|FG002|Overall Study|Non-compliance|1|||
127741512|NCT00644878|459679505|FG000|Overall Study|Protocol deviation|2|||
127807339|NCT03283085|459913613|FG001|Overall Study|Withdrawal by Subject|21|||
127807340|NCT03283085|459913614|FG002|Overall Study|Withdrawal by Subject|66|||
127807341|NCT03283085|459913615|FG003|Overall Study|Withdrawal by Subject|3|||
127807342|NCT03283085|459913616|FG004|Overall Study|Withdrawal by Subject|3|||
127807343|NCT03283085|459913617|FG005|Overall Study|Withdrawal by Subject|5|||
127807344|NCT03283085|459913612|FG000|Overall Study|Physician Decision|14|||
127807345|NCT03283085|459913613|FG001|Overall Study|Physician Decision|8|||
127807346|NCT03283085|459913614|FG002|Overall Study|Physician Decision|19|||
127807347|NCT03283085|459913615|FG003|Overall Study|Physician Decision|0|||
127807348|NCT03283085|459913616|FG004|Overall Study|Physician Decision|0|||
127807349|NCT03283085|459913617|FG005|Overall Study|Physician Decision|2|||
127807350|NCT03283085|459913612|FG000|Overall Study|Site Terminated by Sponsor|1|||
127893181|NCT02247479|460231301|FG000|Overall Study|Withdrawal by Subject|25|||
127741513|NCT00644878|459679505|FG000|Overall Study|Treatment duration completed as per protocol|11|||
127741514|NCT00591591|459679510|FG000|Overall Study|Withdrawal by Subject|1|||
127741515|NCT00591591|459679511|FG001|Overall Study|Withdrawal by Subject|37|||
127741516|NCT00591591|459679510|FG000|Overall Study|Lack of Efficacy|10|||
127741517|NCT00591591|459679511|FG001|Overall Study|Lack of Efficacy|2|||
127741518|NCT01841112|459679515|FG000|Single Dose Segment (Day 1)|Not Treated|1|||
127741519|NCT01841112|459679516|FG001|Single Dose Segment (Day 1)|Not Treated|1|||
127741520|NCT01841112|459679517|FG002|Single Dose Segment (Day 1)|Not Treated|1|||
127741521|NCT01841112|459679518|FG003|Single Dose Segment (Day 1)|Not Treated|0|||
127741522|NCT01841112|459679519|FG004|Single Dose Segment (Day 1)|Not Treated|0|||
127741523|NCT00878553|459679520|FG000|Sleep Study|Withdrawal by Subject|2|||
127741524|NCT00878553|459679521|FG001|Sleep Study|Withdrawal by Subject|0|||
127741525|NCT00878553|459679522|FG002|Sleep Study|Withdrawal by Subject|0|||
127741526|NCT00878553|459679523|FG003|Sleep Study|Withdrawal by Subject|0|||
127741527|NCT00878553|459679524|FG004|Sleep Study|Withdrawal by Subject|0|||
127741528|NCT00878553|459679520|FG000|Sleep Study|Lost to Follow-up|1|||
127741529|NCT00878553|459679521|FG001|Sleep Study|Lost to Follow-up|0|||
127741530|NCT00878553|459679522|FG002|Sleep Study|Lost to Follow-up|0|||
127741531|NCT00878553|459679523|FG003|Sleep Study|Lost to Follow-up|0|||
127741532|NCT00878553|459679524|FG004|Sleep Study|Lost to Follow-up|0|||
127741533|NCT00878553|459679520|FG000|Sleep Study|car accident|1|||
127741534|NCT00878553|459679521|FG001|Sleep Study|car accident|0|||
127741535|NCT00878553|459679522|FG002|Sleep Study|car accident|0|||
127741536|NCT00878553|459679523|FG003|Sleep Study|car accident|0|||
127741537|NCT00878553|459679524|FG004|Sleep Study|car accident|0|||
127741538|NCT00878553|459679520|FG000|Sleep Study|family emergency|1|||
127741539|NCT00878553|459679521|FG001|Sleep Study|family emergency|0|||
127741540|NCT00878553|459679522|FG002|Sleep Study|family emergency|0|||
127741541|NCT00878553|459679523|FG003|Sleep Study|family emergency|0|||
127741542|NCT00878553|459679524|FG004|Sleep Study|family emergency|0|||
127741543|NCT00878553|459679520|FG000|PK Study|Withdrawal by Subject|0|||
127741544|NCT00878553|459679521|FG001|PK Study|Withdrawal by Subject|0|||
127741545|NCT00878553|459679522|FG002|PK Study|Withdrawal by Subject|0|||
127741546|NCT00878553|459679523|FG003|PK Study|Withdrawal by Subject|1|||
127741547|NCT00878553|459679524|FG004|PK Study|Withdrawal by Subject|0|||
127741548|NCT00912223|459679525|FG000|Overall Study|Withdrawal by Subject|1|||
127741549|NCT00912223|459679525|FG000|Overall Study|Not transplanted|1|||
127741550|NCT00912223|459679525|FG000|Overall Study|Transformed disease|1|||
127741551|NCT00461123|459679526|FG000|Overall Study|Adverse Event|1|||
127741552|NCT00461123|459679527|FG001|Overall Study|Adverse Event|0|||
127741553|NCT00461123|459679526|FG000|Overall Study|Lost to Follow-up|1|||
127741554|NCT00461123|459679527|FG001|Overall Study|Lost to Follow-up|1|||
127741555|NCT00461123|459679526|FG000|Overall Study|Protocol Violation|3|||
127741556|NCT00461123|459679527|FG001|Overall Study|Protocol Violation|2|||
127741557|NCT00461123|459679526|FG000|Overall Study|Withdrawal by Subject|1|||
127741558|NCT00461123|459679527|FG001|Overall Study|Withdrawal by Subject|3|||
127741559|NCT00927901|459679528|FG000|Treatment Period 1|Subject withdrew consent|0|||
127741560|NCT00927901|459679529|FG001|Treatment Period 1|Subject withdrew consent|0|||
127741561|NCT00927901|459679530|FG002|Treatment Period 1|Subject withdrew consent|1|||
127741562|NCT00927901|459679531|FG003|Treatment Period 1|Subject withdrew consent|0|||
127741563|NCT00927901|459679528|FG000|Treatment Period 4|Adverse Event|0|||
127741564|NCT00927901|459679529|FG001|Treatment Period 4|Adverse Event|0|||
127741565|NCT00927901|459679530|FG002|Treatment Period 4|Adverse Event|0|||
127741566|NCT00927901|459679531|FG003|Treatment Period 4|Adverse Event|1|||
127741567|NCT00927901|459679528|FG000|Treatment Period 4|Subject withdrew consent|0|||
127741568|NCT00927901|459679529|FG001|Treatment Period 4|Subject withdrew consent|0|||
127741569|NCT00927901|459679530|FG002|Treatment Period 4|Subject withdrew consent|1|||
127741570|NCT00927901|459679531|FG003|Treatment Period 4|Subject withdrew consent|0|||
127741571|NCT03029819|459679532|FG000|Overall Study|Lost to Follow-up|3|||
127741572|NCT03029819|459679533|FG001|Overall Study|Lost to Follow-up|5|||
127741573|NCT03029819|459679532|FG000|Overall Study|Removed due to disruptive behavior|0|||
127741574|NCT03029819|459679533|FG001|Overall Study|Removed due to disruptive behavior|1|||
127741575|NCT03605368|459679536|FG000|Overall Study|Lost to Follow-up|2|||
127741576|NCT03605368|459679537|FG001|Overall Study|Lost to Follow-up|1|||
127741577|NCT03605368|459679538|FG002|Overall Study|Lost to Follow-up|3|||
127741578|NCT03605368|459679539|FG003|Overall Study|Lost to Follow-up|2|||
127741579|NCT03605368|459679536|FG000|Overall Study|Withdrawal by Subject|0|||
127741580|NCT03605368|459679537|FG001|Overall Study|Withdrawal by Subject|0|||
127741581|NCT03605368|459679538|FG002|Overall Study|Withdrawal by Subject|4|||
127741582|NCT03605368|459679539|FG003|Overall Study|Withdrawal by Subject|3|||
127741583|NCT02650466|459679541|FG000|Overall Study|Physician Decision|1|||
127741584|NCT02650466|459679541|FG000|Overall Study|Withdrawal by Subject|5|||
127741585|NCT02650466|459679541|FG000|Overall Study|Lost to Follow-up|1|||
127741586|NCT01837797|459679542|FG000|Period 1|Adverse Event|9|||
127741587|NCT01837797|459679543|FG001|Period 1|Adverse Event|0|||
127741588|NCT01837797|459679544|FG002|Period 1|Adverse Event|0|||
127741589|NCT01837797|459679545|FG003|Period 1|Adverse Event|0|||
127741590|NCT01837797|459679546|FG004|Period 1|Adverse Event|0|||
127741591|NCT01837797|459679542|FG000|Period 1|Withdrawal by Subject|6|||
127741592|NCT01837797|459679543|FG001|Period 1|Withdrawal by Subject|0|||
127741593|NCT01837797|459679544|FG002|Period 1|Withdrawal by Subject|0|||
127741594|NCT01837797|459679545|FG003|Period 1|Withdrawal by Subject|0|||
127741595|NCT01837797|459679546|FG004|Period 1|Withdrawal by Subject|0|||
127741596|NCT01837797|459679542|FG000|Period 1|Administrative reasons|76|||
127741597|NCT01837797|459679543|FG001|Period 1|Administrative reasons|0|||
127741598|NCT01837797|459679544|FG002|Period 1|Administrative reasons|0|||
127741599|NCT01837797|459679545|FG003|Period 1|Administrative reasons|0|||
127741600|NCT01837797|459679546|FG004|Period 1|Administrative reasons|0|||
127741601|NCT01837797|459679542|FG000|Period 1|Withdrawal of consent before treatment|1|||
127741602|NCT01837797|459679543|FG001|Period 1|Withdrawal of consent before treatment|0|||
127741603|NCT01837797|459679544|FG002|Period 1|Withdrawal of consent before treatment|0|||
127741604|NCT01837797|459679545|FG003|Period 1|Withdrawal of consent before treatment|0|||
127741605|NCT01837797|459679546|FG004|Period 1|Withdrawal of consent before treatment|0|||
127741606|NCT01837797|459679542|FG000|Period 1|Other|10|||
127741607|NCT01837797|459679543|FG001|Period 1|Other|0|||
127741608|NCT01837797|459679544|FG002|Period 1|Other|0|||
127741609|NCT01837797|459679545|FG003|Period 1|Other|0|||
127741610|NCT01837797|459679546|FG004|Period 1|Other|0|||
127741611|NCT01837797|459679542|FG000|Period 2|Administrative or other reasons|0|||
127741612|NCT01837797|459679543|FG001|Period 2|Administrative or other reasons|5|||
127741613|NCT01837797|459679544|FG002|Period 2|Administrative or other reasons|2|||
127741614|NCT01837797|459679545|FG003|Period 2|Administrative or other reasons|4|||
127741615|NCT01837797|459679546|FG004|Period 2|Administrative or other reasons|0|||
127741616|NCT01837797|459679542|FG000|Period 2|Adverse Event|0|||
127741617|NCT01837797|459679543|FG001|Period 2|Adverse Event|0|||
127741618|NCT01837797|459679544|FG002|Period 2|Adverse Event|0|||
127741619|NCT01837797|459679545|FG003|Period 2|Adverse Event|1|||
127741620|NCT01837797|459679546|FG004|Period 2|Adverse Event|0|||
127741621|NCT01837797|459679542|FG000|Period 3|Adverse Event|0|||
127741622|NCT01837797|459679543|FG001|Period 3|Adverse Event|0|||
127741623|NCT01837797|459679544|FG002|Period 3|Adverse Event|0|||
127741624|NCT01837797|459679545|FG003|Period 3|Adverse Event|0|||
127741625|NCT01837797|459679546|FG004|Period 3|Adverse Event|1|||
127741626|NCT01837797|459679542|FG000|Period 3|Administrative reasons|0|||
127741627|NCT01837797|459679543|FG001|Period 3|Administrative reasons|0|||
127741628|NCT01837797|459679544|FG002|Period 3|Administrative reasons|0|||
127741629|NCT01837797|459679545|FG003|Period 3|Administrative reasons|0|||
127741630|NCT01837797|459679546|FG004|Period 3|Administrative reasons|20|||
127741631|NCT01837797|459679542|FG000|Period 3|Other|0|||
127741632|NCT01837797|459679543|FG001|Period 3|Other|0|||
127741633|NCT01837797|459679544|FG002|Period 3|Other|0|||
127741634|NCT01837797|459679545|FG003|Period 3|Other|0|||
127741635|NCT01837797|459679546|FG004|Period 3|Other|2|||
127741636|NCT04088136|459679548|FG000|Overall Study|Withdrawal by Subject|5|||
127741637|NCT04088136|459679549|FG001|Overall Study|Withdrawal by Subject|0|||
127741638|NCT04088136|459679548|FG000|Overall Study|Lack of Efficacy|0|||
127741639|NCT04088136|459679549|FG001|Overall Study|Lack of Efficacy|1|||
127741640|NCT01075100|459679550|FG000|Overall Study|Adverse Event|15|||
127741641|NCT01075100|459679551|FG001|Overall Study|Adverse Event|18|||
127741642|NCT01075100|459679550|FG000|Overall Study|Patient Request|4|||
127741643|NCT01075100|459679551|FG001|Overall Study|Patient Request|4|||
127741644|NCT01075100|459679550|FG000|Overall Study|Investigator Request|2|||
127741645|NCT01075100|459679551|FG001|Overall Study|Investigator Request|1|||
127741646|NCT01075100|459679550|FG000|Overall Study|Disease Progression|25|||
127741647|NCT01075100|459679551|FG001|Overall Study|Disease Progression|29|||
127741648|NCT01075100|459679550|FG000|Overall Study|Other|3|||
127741649|NCT01075100|459679551|FG001|Overall Study|Other|1|||
127893182|NCT02247479|460231302|FG001|Overall Study|Withdrawal by Subject|29|||
127893183|NCT02247479|460231303|FG002|Overall Study|Withdrawal by Subject|24|||
127741650|NCT02250183|459679552|FG000|Overall Study|Withdrawal by Subject|2|||
127741651|NCT02250183|459679552|FG000|Overall Study|Adverse Event|5|||
127741652|NCT02250183|459679552|FG000|Overall Study|Lost to Follow-up|1|||
127741653|NCT05896696|459679553|FG000|Overall Study|Screening Failure|7|||
127741654|NCT05896696|459679553|FG000|Overall Study|Withdrawal by Subject|2|||
127741655|NCT01878383|459681926|FG000|Overall Study|Lost to Follow-up|0|||
127741656|NCT01878383|459681927|FG001|Overall Study|Lost to Follow-up|1499|||
127741657|NCT03475056|459681928|FG000|Overall Study|Lost to Follow-up|0|||
127741658|NCT03475056|459681929|FG001|Overall Study|Lost to Follow-up|1|||
127741659|NCT03475056|459681928|FG000|Overall Study|Moved from Area|0|||
127741660|NCT03475056|459681929|FG001|Overall Study|Moved from Area|2|||
127741661|NCT01932762|459681932|FG000|Overall Study|Withdrawal by Subject|1|||
127741662|NCT01932762|459681933|FG001|Overall Study|Withdrawal by Subject|2|||
127741663|NCT01932762|459681934|FG002|Overall Study|Withdrawal by Subject|0|||
127741664|NCT01932762|459681935|FG003|Overall Study|Withdrawal by Subject|0|||
127741665|NCT01932762|459681932|FG000|Overall Study|Lost to Follow-up|4|||
127741666|NCT01932762|459681933|FG001|Overall Study|Lost to Follow-up|0|||
127741667|NCT01932762|459681934|FG002|Overall Study|Lost to Follow-up|0|||
127741668|NCT01932762|459681935|FG003|Overall Study|Lost to Follow-up|1|||
127741669|NCT01932762|459681932|FG000|Overall Study|Physician Decision|1|||
127741670|NCT01932762|459681933|FG001|Overall Study|Physician Decision|0|||
127893184|NCT02247479|460231301|FG000|Overall Study|Study Terminated by Sponsor|98|||
127807351|NCT03283085|459913613|FG001|Overall Study|Site Terminated by Sponsor|0|||
127807352|NCT03283085|459913614|FG002|Overall Study|Site Terminated by Sponsor|3|||
127807353|NCT03283085|459913615|FG003|Overall Study|Site Terminated by Sponsor|0|||
127807354|NCT03283085|459913616|FG004|Overall Study|Site Terminated by Sponsor|0|||
127807355|NCT03283085|459913617|FG005|Overall Study|Site Terminated by Sponsor|0|||
127807356|NCT03283085|459913612|FG000|Overall Study|Lost to Follow-up|2|||
127807357|NCT03283085|459913613|FG001|Overall Study|Lost to Follow-up|0|||
127807358|NCT03283085|459913614|FG002|Overall Study|Lost to Follow-up|2|||
127807359|NCT03283085|459913615|FG003|Overall Study|Lost to Follow-up|0|||
127807360|NCT03283085|459913616|FG004|Overall Study|Lost to Follow-up|0|||
127807361|NCT03283085|459913617|FG005|Overall Study|Lost to Follow-up|1|||
127807362|NCT03283085|459913612|FG000|Overall Study|Pregnancy|0|||
127807363|NCT03283085|459913613|FG001|Overall Study|Pregnancy|0|||
127807364|NCT03283085|459913614|FG002|Overall Study|Pregnancy|1|||
127807365|NCT03283085|459913615|FG003|Overall Study|Pregnancy|0|||
127807366|NCT03283085|459913616|FG004|Overall Study|Pregnancy|0|||
127807367|NCT03283085|459913617|FG005|Overall Study|Pregnancy|0|||
127807368|NCT03283085|459913612|FG000|Overall Study|Lack of Efficacy|12|||
127807369|NCT03283085|459913613|FG001|Overall Study|Lack of Efficacy|6|||
127807370|NCT03283085|459913614|FG002|Overall Study|Lack of Efficacy|24|||
127807371|NCT03283085|459913615|FG003|Overall Study|Lack of Efficacy|1|||
127807372|NCT03283085|459913616|FG004|Overall Study|Lack of Efficacy|1|||
127807373|NCT03283085|459913617|FG005|Overall Study|Lack of Efficacy|0|||
127807374|NCT03283085|459913612|FG000|Overall Study|Reason not Specified|0|||
127807375|NCT03283085|459913613|FG001|Overall Study|Reason not Specified|4|||
127807376|NCT03283085|459913614|FG002|Overall Study|Reason not Specified|8|||
127807377|NCT03283085|459913615|FG003|Overall Study|Reason not Specified|0|||
127807378|NCT03283085|459913616|FG004|Overall Study|Reason not Specified|0|||
127807379|NCT03283085|459913617|FG005|Overall Study|Reason not Specified|1|||
127807380|NCT03136107|459913618|FG000|Overall Study|Other (Not specified)|1|||
127807381|NCT02292771|459913622|FG000|Overall Study|Withdrawal by Subject|2|||
127807382|NCT02292771|459913623|FG001|Overall Study|Withdrawal by Subject|1|||
127807383|NCT02292771|459913622|FG000|Overall Study|Lost to Follow-up|2|||
127807384|NCT02292771|459913623|FG001|Overall Study|Lost to Follow-up|1|||
127807385|NCT04025632|459915672|FG000|Overall Study|Adverse Event|1|||
127807386|NCT04025632|459915673|FG001|Overall Study|Adverse Event|1|||
127893185|NCT02247479|460231302|FG001|Overall Study|Study Terminated by Sponsor|88|||
127893186|NCT02247479|460231303|FG002|Overall Study|Study Terminated by Sponsor|94|||
127893187|NCT02247479|460231301|FG000|Overall Study|Physician Decision|1|||
127893188|NCT02247479|460231302|FG001|Overall Study|Physician Decision|0|||
127893189|NCT02247479|460231303|FG002|Overall Study|Physician Decision|2|||
127893190|NCT02247479|460231301|FG000|Overall Study|Unspecified Reason|2|||
127893191|NCT02247479|460231302|FG001|Overall Study|Unspecified Reason|5|||
127893192|NCT02247479|460231303|FG002|Overall Study|Unspecified Reason|2|||
127893193|NCT01073020|460231304|FG000|Overall Study|Withdrawal by Subject|6|||
127893194|NCT01073020|460231305|FG001|Overall Study|Withdrawal by Subject|4|||
127741671|NCT01932762|459681934|FG002|Overall Study|Physician Decision|0|||
127741672|NCT01932762|459681935|FG003|Overall Study|Physician Decision|0|||
127741673|NCT01101334|459681936|FG000|Overall Study|Adverse Event|9|||
127741674|NCT01101334|459681937|FG001|Overall Study|Adverse Event|4|||
127741675|NCT01101334|459681936|FG000|Overall Study|Death|7|||
127741676|NCT01101334|459681937|FG001|Overall Study|Death|1|||
127741677|NCT01101334|459681936|FG000|Overall Study|Withdrawal by Subject|4|||
127741678|NCT01101334|459681937|FG001|Overall Study|Withdrawal by Subject|3|||
127741679|NCT01101334|459681936|FG000|Overall Study|Withdrawal by Sponsor|1|||
127741680|NCT01101334|459681937|FG001|Overall Study|Withdrawal by Sponsor|1|||
127893195|NCT01073020|460231306|FG002|Overall Study|Withdrawal by Subject|1|||
127741681|NCT01101334|459681936|FG000|Overall Study|Progressive Disease|22|||
127741682|NCT01101334|459681937|FG001|Overall Study|Progressive Disease|35|||
127741683|NCT01101334|459681936|FG000|Overall Study|Other|2|||
127741684|NCT01101334|459681937|FG001|Overall Study|Other|1|||
127807387|NCT04025632|459915672|FG000|Overall Study|Withdrawal by Subject|1|||
127807388|NCT04025632|459915673|FG001|Overall Study|Withdrawal by Subject|1|||
127893196|NCT01073020|460231307|FG003|Overall Study|Withdrawal by Subject|2|||
127807389|NCT04025632|459915672|FG000|Overall Study|Study Terminated by Sponsor|10|||
127893197|NCT01073020|460231304|FG000|Overall Study|Physician Decision|1|||
127893198|NCT01073020|460231305|FG001|Overall Study|Physician Decision|0|||
127893199|NCT01073020|460231306|FG002|Overall Study|Physician Decision|2|||
127741685|NCT03864341|459681940|FG000|Overall Study|Withdrawal by Subject|1|||
127741686|NCT02826798|459681942|FG000|Overall Study|Withdrawal by Subject|0|||
127807390|NCT04025632|459915673|FG001|Overall Study|Study Terminated by Sponsor|9|||
127807391|NCT04025632|459915672|FG000|Overall Study|Physician Decision|3|||
127807392|NCT04025632|459915673|FG001|Overall Study|Physician Decision|1|||
127807393|NCT00127127|459915674|FG000|Overall Study|Adverse Event|0|||
127807394|NCT00127127|459915675|FG001|Overall Study|Adverse Event|2|||
127807395|NCT00127127|459915676|FG002|Overall Study|Adverse Event|0|||
127807396|NCT00127127|459915677|FG003|Overall Study|Adverse Event|1|||
127807397|NCT00127127|459915674|FG000|Overall Study|Lack of Efficacy|1|||
127807398|NCT00127127|459915675|FG001|Overall Study|Lack of Efficacy|3|||
127807399|NCT00127127|459915676|FG002|Overall Study|Lack of Efficacy|0|||
127741687|NCT02826798|459681943|FG001|Overall Study|Withdrawal by Subject|1|||
127741688|NCT02826798|459681944|FG002|Overall Study|Withdrawal by Subject|0|||
127741689|NCT02826798|459681945|FG003|Overall Study|Withdrawal by Subject|1|||
127741690|NCT02826798|459681946|FG004|Overall Study|Withdrawal by Subject|0|||
127741691|NCT00263211|459681949|FG000|Overall Study|Death|1|||
127741692|NCT00263211|459681950|FG001|Overall Study|Death|0|||
127741693|NCT00263211|459681949|FG000|Overall Study|Withdrawal by Subject|3|||
127741694|NCT00263211|459681950|FG001|Overall Study|Withdrawal by Subject|0|||
127741695|NCT00263211|459681949|FG000|Overall Study|Protocol Violation|1|||
127741696|NCT00263211|459681950|FG001|Overall Study|Protocol Violation|0|||
127741697|NCT00263211|459681949|FG000|Overall Study|Disease Progression|0|||
127741698|NCT00263211|459681950|FG001|Overall Study|Disease Progression|1|||
127741699|NCT00760513|459681951|FG000|Overall Study|Withdrawal by Subject|5|||
127741700|NCT00760513|459681952|FG001|Overall Study|Withdrawal by Subject|7|||
127741701|NCT01468077|459681954|FG000|Overall Study|Adverse Event|2|||
127741702|NCT01468077|459681955|FG001|Overall Study|Adverse Event|2|||
127741703|NCT01468077|459681954|FG000|Overall Study|Lack of Efficacy|1|||
127741704|NCT01468077|459681955|FG001|Overall Study|Lack of Efficacy|1|||
127741705|NCT01468077|459681954|FG000|Overall Study|Physician Decision|1|||
127741706|NCT01468077|459681955|FG001|Overall Study|Physician Decision|0|||
127741707|NCT01951378|459681956|FG000|Overall Study|Study Terminated-Not completed|23|||
127741708|NCT01951378|459681957|FG001|Overall Study|Study Terminated-Not completed|17|||
127741709|NCT03491215|459681959|FG000|Overall Study|Death|6|||
127741710|NCT03491215|459681960|FG001|Overall Study|Death|2|||
127741711|NCT03491215|459681961|FG002|Overall Study|Death|1|||
127741712|NCT03491215|459681962|FG003|Overall Study|Death|0|||
127741713|NCT03491215|459681959|FG000|Overall Study|Physician Decision|1|||
127741714|NCT03491215|459681960|FG001|Overall Study|Physician Decision|0|||
127741715|NCT03491215|459681961|FG002|Overall Study|Physician Decision|0|||
127741716|NCT03491215|459681962|FG003|Overall Study|Physician Decision|0|||
127741717|NCT01202409|459681965|FG000|Overall Study|Adverse Event|1|||
127741718|NCT01202409|459681965|FG000|Overall Study|Ineligible - KRAS mutants|7|||
127741719|NCT00553605|459681966|FG000|Overall Study|Did not meet entrance criteria|1|||
127741720|NCT00553605|459681967|FG001|Overall Study|Did not meet entrance criteria|3|||
127741721|NCT00553605|459681966|FG000|Overall Study|Did not receive full dose|1|||
127741722|NCT00553605|459681967|FG001|Overall Study|Did not receive full dose|0|||
127741723|NCT00553605|459681966|FG000|Overall Study|Randomized but not treated|2|||
127741724|NCT00553605|459681967|FG001|Overall Study|Randomized but not treated|0|||
127741725|NCT02669407|459681970|FG000|Overall Study|Physician Decision|3|||
127741726|NCT02647788|459681976|FG000|Overall Study|Lost to Follow-up|13|||
127741727|NCT02647788|459681977|FG001|Overall Study|Lost to Follow-up|11|||
127741728|NCT02647788|459681976|FG000|Overall Study|Did not want opiate|0|||
127741729|NCT02647788|459681977|FG001|Overall Study|Did not want opiate|1|||
127741730|NCT02647788|459681976|FG000|Overall Study|Withdrawal by Subject|1|||
127741731|NCT02647788|459681977|FG001|Overall Study|Withdrawal by Subject|0|||
127741732|NCT02647788|459681976|FG000|Overall Study|Felt itchy with assigned medication|1|||
127741733|NCT02647788|459681977|FG001|Overall Study|Felt itchy with assigned medication|0|||
127741734|NCT02647788|459681976|FG000|Overall Study|Felt nauseous with assigned medication|1|||
127741735|NCT02647788|459681977|FG001|Overall Study|Felt nauseous with assigned medication|1|||
127741736|NCT00719043|459681983|FG000|Overall Study|Adverse Event|5|||
127741737|NCT00719043|459681984|FG001|Overall Study|Adverse Event|1|||
127741738|NCT00719043|459681985|FG002|Overall Study|Adverse Event|2|||
127741739|NCT00719043|459681986|FG003|Overall Study|Adverse Event|2|||
127741740|NCT00719043|459681987|FG004|Overall Study|Adverse Event|1|||
127741741|NCT00719043|459681988|FG005|Overall Study|Adverse Event|4|||
127741742|NCT00719043|459681989|FG006|Overall Study|Adverse Event|4|||
127741743|NCT00719043|459681983|FG000|Overall Study|Lost to Follow-up|14|||
127741744|NCT00719043|459681984|FG001|Overall Study|Lost to Follow-up|10|||
127741745|NCT00719043|459681985|FG002|Overall Study|Lost to Follow-up|8|||
127741746|NCT00719043|459681986|FG003|Overall Study|Lost to Follow-up|9|||
127741747|NCT00719043|459681987|FG004|Overall Study|Lost to Follow-up|10|||
127741748|NCT00719043|459681988|FG005|Overall Study|Lost to Follow-up|9|||
127741749|NCT00719043|459681989|FG006|Overall Study|Lost to Follow-up|9|||
127741750|NCT00719043|459681983|FG000|Overall Study|Protocol Violation|0|||
127741751|NCT00719043|459681984|FG001|Overall Study|Protocol Violation|0|||
127741752|NCT00719043|459681985|FG002|Overall Study|Protocol Violation|0|||
127741753|NCT00719043|459681986|FG003|Overall Study|Protocol Violation|0|||
127741754|NCT00719043|459681987|FG004|Overall Study|Protocol Violation|0|||
127893200|NCT01073020|460231307|FG003|Overall Study|Physician Decision|0|||
127893201|NCT01073020|460231304|FG000|Overall Study|Death|0|||
127741755|NCT00719043|459681988|FG005|Overall Study|Protocol Violation|1|||
127741756|NCT00719043|459681989|FG006|Overall Study|Protocol Violation|0|||
127741757|NCT00719043|459681983|FG000|Overall Study|Other|1|||
127741758|NCT00719043|459681984|FG001|Overall Study|Other|0|||
127741759|NCT00719043|459681985|FG002|Overall Study|Other|1|||
127741760|NCT00719043|459681986|FG003|Overall Study|Other|2|||
127741761|NCT00719043|459681987|FG004|Overall Study|Other|0|||
127741762|NCT00719043|459681988|FG005|Overall Study|Other|2|||
127741763|NCT00719043|459681989|FG006|Overall Study|Other|1|||
127741764|NCT00719043|459681983|FG000|Overall Study|Withdrawal by Subject|12|||
127741765|NCT00719043|459681984|FG001|Overall Study|Withdrawal by Subject|14|||
127741766|NCT00719043|459681985|FG002|Overall Study|Withdrawal by Subject|9|||
127741767|NCT00719043|459681986|FG003|Overall Study|Withdrawal by Subject|10|||
127741768|NCT00719043|459681987|FG004|Overall Study|Withdrawal by Subject|16|||
127741769|NCT00719043|459681988|FG005|Overall Study|Withdrawal by Subject|18|||
127741770|NCT00719043|459681989|FG006|Overall Study|Withdrawal by Subject|14|||
127741771|NCT01588366|459681990|FG000|Overall Study|Adverse Event|0|||
127741772|NCT01588366|459681991|FG001|Overall Study|Adverse Event|1|||
127741773|NCT01588366|459681992|FG002|Overall Study|Adverse Event|0|||
127741774|NCT01588366|459681993|FG003|Overall Study|Adverse Event|1|||
127741775|NCT01588366|459681994|FG004|Overall Study|Adverse Event|0|||
127741776|NCT01588366|459681995|FG005|Overall Study|Adverse Event|2|||
127741777|NCT03245619|459681996|FG000|Part A (Up to Day 22)|Physician Decision|4|||
127741778|NCT03245619|459681997|FG001|Part A (Up to Day 22)|Physician Decision|6|||
127741779|NCT03245619|459681998|FG002|Part A (Up to Day 22)|Physician Decision|6|||
127741780|NCT03245619|459681999|FG003|Part A (Up to Day 22)|Physician Decision|0|||
127741781|NCT03245619|459682000|FG004|Part A (Up to Day 22)|Physician Decision|0|||
127741782|NCT03245619|459682001|FG005|Part A (Up to Day 22)|Physician Decision|0|||
127741783|NCT03245619|459682002|FG006|Part A (Up to Day 22)|Physician Decision|0|||
127741784|NCT03245619|459682003|FG007|Part A (Up to Day 22)|Physician Decision|0|||
127741785|NCT03245619|459682004|FG008|Part A (Up to Day 22)|Physician Decision|0|||
127741786|NCT03245619|459682005|FG009|Part A (Up to Day 22)|Physician Decision|0|||
127741787|NCT03245619|459682006|FG010|Part A (Up to Day 22)|Physician Decision|0|||
127741788|NCT03245619|459682007|FG011|Part A (Up to Day 22)|Physician Decision|0|||
127741789|NCT03245619|459682008|FG012|Part A (Up to Day 22)|Physician Decision|0|||
127741790|NCT03245619|459682009|FG013|Part A (Up to Day 22)|Physician Decision|0|||
127741791|NCT03245619|459682010|FG014|Part A (Up to Day 22)|Physician Decision|0|||
127741792|NCT03245619|459682011|FG015|Part A (Up to Day 22)|Physician Decision|0|||
127741793|NCT03245619|459682012|FG016|Part A (Up to Day 22)|Physician Decision|0|||
127741794|NCT01336205|459682013|FG000|Overall Study|Other|22|||
127741795|NCT01336205|459682014|FG001|Overall Study|Other|9|||
127741796|NCT01336205|459682013|FG000|Overall Study|Lost to Follow-up|40|||
127741797|NCT01336205|459682014|FG001|Overall Study|Lost to Follow-up|20|||
127741798|NCT01336205|459682013|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
127741799|NCT01336205|459682014|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
127741800|NCT01336205|459682013|FG000|Overall Study|Lack of Efficacy|4|||
127741801|NCT01336205|459682014|FG001|Overall Study|Lack of Efficacy|0|||
127741802|NCT01336205|459682013|FG000|Overall Study|Severe noncompliance with protocol|9|||
127741803|NCT01336205|459682014|FG001|Overall Study|Severe noncompliance with protocol|2|||
127741804|NCT01336205|459682013|FG000|Overall Study|Adverse Event|56|||
127741805|NCT01336205|459682014|FG001|Overall Study|Adverse Event|6|||
127741806|NCT01336205|459682013|FG000|Overall Study|Death|1|||
127741807|NCT01336205|459682014|FG001|Overall Study|Death|1|||
127741808|NCT01336205|459682013|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
127741809|NCT01336205|459682014|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
127741810|NCT01336205|459682013|FG000|Overall Study|Withdrawal by Subject|72|||
127741811|NCT01336205|459682014|FG001|Overall Study|Withdrawal by Subject|38|||
127741812|NCT01336205|459682013|FG000|Overall Study|Did not receive treatment|4|||
127741813|NCT01336205|459682014|FG001|Overall Study|Did not receive treatment|0|||
127741814|NCT01006616|459682015|FG000|Period 1 (6 Months)|Adverse Event|10|||
127741815|NCT01006616|459682016|FG001|Period 1 (6 Months)|Adverse Event|31|||
127741816|NCT01006616|459682017|FG002|Period 1 (6 Months)|Adverse Event|37|||
127741817|NCT01006616|459682018|FG003|Period 1 (6 Months)|Adverse Event|9|||
127741818|NCT01006616|459682015|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
127741819|NCT01006616|459682016|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
127741820|NCT01006616|459682017|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
127741821|NCT01006616|459682018|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
127741822|NCT01006616|459682015|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
127741823|NCT01006616|459682016|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
127741824|NCT01006616|459682017|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
127741825|NCT01006616|459682018|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
127741826|NCT01006616|459682015|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
127741827|NCT01006616|459682016|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
127741828|NCT01006616|459682017|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
127741829|NCT01006616|459682018|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
127741830|NCT01006616|459682015|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
127741831|NCT01006616|459682016|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
127741832|NCT01006616|459682017|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
127741833|NCT01006616|459682018|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
127741834|NCT01006616|459682015|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
127741835|NCT01006616|459682016|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
127741836|NCT01006616|459682017|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
127741837|NCT01006616|459682018|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
127741838|NCT01006616|459682015|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
127741839|NCT01006616|459682016|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
127807400|NCT00127127|459915677|FG003|Overall Study|Lack of Efficacy|2|||
127807401|NCT01524991|459915680|FG000|Overall Study|Adverse Event|12|||
127807402|NCT01524991|459915680|FG000|Overall Study|Death|1|||
127807403|NCT01524991|459915680|FG000|Overall Study|Disease ProgressionDu|17|||
127807404|NCT01524991|459915680|FG000|Overall Study|Other complicating disease|1|||
127807405|NCT01524991|459915680|FG000|Overall Study|Withdrawal by Subject|2|||
127807406|NCT01524991|459915680|FG000|Overall Study|Symptomatic Deterioration|1|||
127807407|NCT01805180|459915681|FG000|Lead-in Donor Phase|screen failure|1|||
127807408|NCT01805180|459915682|FG001|Lead-in Donor Phase|screen failure|0|||
127807409|NCT01805180|459915683|FG002|Lead-in Donor Phase|screen failure|0|||
127807410|NCT00582556|459915687|FG000|Overall Study|Withdrawal by Subject|0|||
127807411|NCT00582556|459915688|FG001|Overall Study|Withdrawal by Subject|1|||
127807412|NCT00582556|459915689|FG002|Overall Study|Withdrawal by Subject|1|||
127807413|NCT00582556|459915687|FG000|Overall Study|Physician Decision|0|||
127807414|NCT00582556|459915688|FG001|Overall Study|Physician Decision|0|||
127807415|NCT00582556|459915689|FG002|Overall Study|Physician Decision|1|||
127807416|NCT00851903|459915690|FG000|Overall Study|Withdrawal by Subject|2|||
127807417|NCT02300129|459915691|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
127807418|NCT02300129|459915692|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
127807419|NCT02300129|459915693|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
127807420|NCT02300129|459915694|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
127807421|NCT02300129|459915691|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
127807422|NCT02300129|459915692|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
127807423|NCT02300129|459915693|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
127741840|NCT01006616|459682017|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
127741841|NCT01006616|459682018|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
127741842|NCT01006616|459682015|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
127741843|NCT01006616|459682016|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
127741844|NCT01006616|459682017|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
127741845|NCT01006616|459682018|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
127741846|NCT01006616|459682015|FG000|Period 1 (6 Months)|Not Treated|0|||
127741847|NCT01006616|459682016|FG001|Period 1 (6 Months)|Not Treated|0|||
127741848|NCT01006616|459682017|FG002|Period 1 (6 Months)|Not Treated|1|||
127741849|NCT01006616|459682018|FG003|Period 1 (6 Months)|Not Treated|1|||
127741850|NCT01006616|459682015|FG000|Period 2 (18 Months)|Adverse Event|6|||
127741851|NCT01006616|459682016|FG001|Period 2 (18 Months)|Adverse Event|6|||
127741852|NCT01006616|459682017|FG002|Period 2 (18 Months)|Adverse Event|6|||
127741853|NCT01006616|459682018|FG003|Period 2 (18 Months)|Adverse Event|4|||
127741854|NCT01006616|459682015|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
127741855|NCT01006616|459682016|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
127741856|NCT01006616|459682017|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
127741857|NCT01006616|459682018|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
127741858|NCT01006616|459682015|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
127741859|NCT01006616|459682016|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
127741860|NCT01006616|459682017|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
127741861|NCT01006616|459682018|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
127741862|NCT01006616|459682015|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
127741863|NCT01006616|459682016|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
127741864|NCT01006616|459682017|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
127741865|NCT01006616|459682018|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
127741866|NCT01006616|459682015|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
127741867|NCT01006616|459682016|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
127741868|NCT01006616|459682017|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
127741869|NCT01006616|459682018|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
127741870|NCT01006616|459682015|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
127741871|NCT01006616|459682016|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
127741872|NCT01006616|459682017|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
127741873|NCT01006616|459682018|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
127741874|NCT01006616|459682015|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
127741875|NCT01006616|459682016|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
127807424|NCT02300129|459915694|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
127807425|NCT02300129|459915691|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
127807426|NCT02300129|459915692|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
127807427|NCT02300129|459915693|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
127807428|NCT02300129|459915694|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
127807429|NCT00522392|459915697|FG000|Overall Study|Disease progression|0|||
127807430|NCT00522392|459915698|FG001|Overall Study|Disease progression|3|||
127807431|NCT00522392|459915697|FG000|Overall Study|Adverse Event|7|||
127807432|NCT00522392|459915698|FG001|Overall Study|Adverse Event|7|||
127807433|NCT00522392|459915697|FG000|Overall Study|Withdrawal by Subject|1|||
127807434|NCT00522392|459915698|FG001|Overall Study|Withdrawal by Subject|1|||
127807435|NCT00522392|459915697|FG000|Overall Study|Physician Decision|0|||
127807436|NCT00522392|459915698|FG001|Overall Study|Physician Decision|1|||
127807437|NCT00522392|459915697|FG000|Overall Study|Non-compliance|0|||
127807438|NCT00522392|459915698|FG001|Overall Study|Non-compliance|1|||
127807439|NCT00332709|459915707|FG000|Overall Study|Adverse Event|11|||
127807440|NCT00332709|459915708|FG001|Overall Study|Adverse Event|14|||
127807441|NCT00332709|459915707|FG000|Overall Study|Withdrawal by Subject|2|||
127807442|NCT00332709|459915708|FG001|Overall Study|Withdrawal by Subject|3|||
127807443|NCT00332709|459915707|FG000|Overall Study|Lost to Follow-up|2|||
127807444|NCT00332709|459915708|FG001|Overall Study|Lost to Follow-up|0|||
127807445|NCT00332709|459915707|FG000|Overall Study|Administrative Problems|0|||
127807446|NCT00332709|459915708|FG001|Overall Study|Administrative Problems|3|||
127807447|NCT00332709|459915707|FG000|Overall Study|Abnormal test procedure result|1|||
127807448|NCT00332709|459915708|FG001|Overall Study|Abnormal test procedure result|0|||
127807449|NCT01409928|459915711|FG000|Overall Study|Physician Decision|12|||
127807450|NCT00432237|459915714|FG000|Overall Study|Adverse Event|0|||
127807451|NCT00432237|459915715|FG001|Overall Study|Adverse Event|0|||
127807452|NCT00432237|459915716|FG002|Overall Study|Adverse Event|0|||
127807453|NCT00432237|459915717|FG003|Overall Study|Adverse Event|1|||
127807454|NCT00432237|459915714|FG000|Overall Study|Lack of Efficacy|0|||
127807455|NCT00432237|459915715|FG001|Overall Study|Lack of Efficacy|0|||
127807456|NCT00432237|459915716|FG002|Overall Study|Lack of Efficacy|0|||
127807457|NCT00432237|459915717|FG003|Overall Study|Lack of Efficacy|1|||
127807458|NCT00432237|459915714|FG000|Overall Study|Lost to Follow-up|10|||
127807459|NCT00432237|459915715|FG001|Overall Study|Lost to Follow-up|10|||
127807460|NCT00432237|459915716|FG002|Overall Study|Lost to Follow-up|18|||
127807461|NCT00432237|459915717|FG003|Overall Study|Lost to Follow-up|18|||
127807462|NCT00432237|459915714|FG000|Overall Study|Physician Decision|1|||
127807463|NCT00432237|459915715|FG001|Overall Study|Physician Decision|3|||
127807464|NCT00432237|459915716|FG002|Overall Study|Physician Decision|2|||
127807465|NCT00432237|459915717|FG003|Overall Study|Physician Decision|1|||
127807466|NCT00432237|459915714|FG000|Overall Study|Pregnancy|0|||
127807467|NCT00432237|459915715|FG001|Overall Study|Pregnancy|1|||
127807468|NCT00432237|459915716|FG002|Overall Study|Pregnancy|0|||
127807469|NCT00432237|459915717|FG003|Overall Study|Pregnancy|0|||
127807470|NCT00432237|459915714|FG000|Overall Study|Protocol Violation|13|||
127807471|NCT00432237|459915715|FG001|Overall Study|Protocol Violation|10|||
127807472|NCT00432237|459915716|FG002|Overall Study|Protocol Violation|11|||
127807473|NCT00432237|459915717|FG003|Overall Study|Protocol Violation|8|||
127807474|NCT00432237|459915714|FG000|Overall Study|Withdrawal by Subject|5|||
127807475|NCT00432237|459915715|FG001|Overall Study|Withdrawal by Subject|6|||
127807476|NCT00432237|459915716|FG002|Overall Study|Withdrawal by Subject|9|||
127807477|NCT00432237|459915717|FG003|Overall Study|Withdrawal by Subject|11|||
127807478|NCT00432237|459915714|FG000|Overall Study|Lack of Qualifying Event|38|||
127807479|NCT00432237|459915715|FG001|Overall Study|Lack of Qualifying Event|71|||
127807480|NCT00432237|459915716|FG002|Overall Study|Lack of Qualifying Event|69|||
127807481|NCT00432237|459915717|FG003|Overall Study|Lack of Qualifying Event|84|||
127807482|NCT00603239|459915718|FG000|Overall Study|Adverse Event|4|||
127807483|NCT00603239|459915719|FG001|Overall Study|Adverse Event|1|||
127807484|NCT00603239|459915718|FG000|Overall Study|Entry criteria not met|0|||
127807485|NCT00603239|459915719|FG001|Overall Study|Entry criteria not met|1|||
127807486|NCT00603239|459915718|FG000|Overall Study|Loss of glucose control|3|||
127807487|NCT00603239|459915719|FG001|Overall Study|Loss of glucose control|0|||
127807488|NCT00603239|459915718|FG000|Overall Study|Lost to Follow-up|2|||
127807489|NCT00603239|459915719|FG001|Overall Study|Lost to Follow-up|1|||
127807490|NCT00603239|459915718|FG000|Overall Study|Physician Decision|2|||
127807491|NCT00603239|459915719|FG001|Overall Study|Physician Decision|0|||
127807492|NCT00603239|459915718|FG000|Overall Study|Protocol Violation|2|||
127807493|NCT00603239|459915719|FG001|Overall Study|Protocol Violation|0|||
127807494|NCT00603239|459915718|FG000|Overall Study|Subject decision|2|||
127807495|NCT00603239|459915719|FG001|Overall Study|Subject decision|1|||
127807496|NCT01354132|459915720|FG000|Randomization|Physician Decision|1|||
127807497|NCT01354132|459915721|FG001|Randomization|Physician Decision|0|||
127807498|NCT01354132|459915720|FG000|Randomization|Withdrawal by Subject|0|||
127807499|NCT01354132|459915721|FG001|Randomization|Withdrawal by Subject|1|||
127893202|NCT01073020|460231305|FG001|Overall Study|Death|1|||
127807500|NCT01354132|459915720|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
127807501|NCT01354132|459915721|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
127807502|NCT01354132|459915720|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
127807503|NCT01354132|459915721|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
127807504|NCT01354132|459915720|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
127807505|NCT01354132|459915721|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
127807506|NCT02357420|459915722|FG000|Overall Study|Adverse Event|3|||
127807507|NCT02357420|459915723|FG001|Overall Study|Adverse Event|3|||
127807508|NCT02357420|459915724|FG002|Overall Study|Adverse Event|8|||
127807509|NCT02357420|459915725|FG003|Overall Study|Adverse Event|9|||
127807510|NCT02357420|459915722|FG000|Overall Study|Investigator Decision|1|||
127807511|NCT02357420|459915723|FG001|Overall Study|Investigator Decision|0|||
127807512|NCT02357420|459915724|FG002|Overall Study|Investigator Decision|0|||
127893203|NCT01073020|460231306|FG002|Overall Study|Death|0|||
127893204|NCT01073020|460231307|FG003|Overall Study|Death|0|||
127741876|NCT01006616|459682017|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
127741877|NCT01006616|459682018|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
127741878|NCT01006616|459682015|FG000|Period 2 (18 Months)|Study Terminated|63|||
127741879|NCT01006616|459682016|FG001|Period 2 (18 Months)|Study Terminated|46|||
127741880|NCT01006616|459682017|FG002|Period 2 (18 Months)|Study Terminated|44|||
127741881|NCT01006616|459682018|FG003|Period 2 (18 Months)|Study Terminated|70|||
127741882|NCT03672175|459682019|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
127741883|NCT03672175|459682020|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
127741884|NCT03672175|459682021|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
127741885|NCT03672175|459682019|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
127741886|NCT03672175|459682020|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
127741887|NCT03672175|459682021|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
127741888|NCT03672175|459682019|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
127741889|NCT03672175|459682020|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
127741890|NCT03672175|459682021|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
127741891|NCT03672175|459682019|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
127741892|NCT03672175|459682020|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
127741893|NCT03672175|459682021|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
127741894|NCT03672175|459682019|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
127741895|NCT03672175|459682020|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
127741896|NCT03672175|459682021|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
127741897|NCT03672175|459682019|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
127741898|NCT03672175|459682020|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
127741899|NCT03672175|459682021|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
127741900|NCT03672175|459682019|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
127741901|NCT03672175|459682020|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
127741902|NCT03672175|459682021|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
127741903|NCT03672175|459682019|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
127741904|NCT03672175|459682020|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
127741905|NCT03672175|459682021|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
127741906|NCT03672175|459682019|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
127741907|NCT03672175|459682020|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
127741908|NCT03672175|459682021|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
127741909|NCT03672175|459682019|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
127741910|NCT03672175|459682020|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
127741911|NCT03672175|459682021|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
127741912|NCT03672175|459682019|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
127741913|NCT03672175|459682020|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
127741914|NCT03672175|459682021|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
127741915|NCT03672175|459682019|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
127741916|NCT03672175|459682020|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
127741917|NCT03672175|459682021|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
127741918|NCT02482935|459682022|FG000|Period 1|Withdrawal by Subject|1|||
127741919|NCT02482935|459682023|FG001|Period 1|Withdrawal by Subject|0|||
127741920|NCT03414047|459682024|FG000|Overall Study|Adverse Event|0|||
127741921|NCT03414047|459682025|FG001|Overall Study|Adverse Event|0|||
127741922|NCT03414047|459682026|FG002|Overall Study|Adverse Event|1|||
127741923|NCT03414047|459682027|FG003|Overall Study|Adverse Event|1|||
127741924|NCT03414047|459682024|FG000|Overall Study|Physician Decision|1|||
127741925|NCT03414047|459682025|FG001|Overall Study|Physician Decision|0|||
127741926|NCT03414047|459682026|FG002|Overall Study|Physician Decision|0|||
127807513|NCT02357420|459915725|FG003|Overall Study|Investigator Decision|0|||
127807514|NCT02357420|459915722|FG000|Overall Study|Prohibited Medication|1|||
127807515|NCT02357420|459915723|FG001|Overall Study|Prohibited Medication|1|||
127807516|NCT02357420|459915724|FG002|Overall Study|Prohibited Medication|0|||
127807517|NCT02357420|459915725|FG003|Overall Study|Prohibited Medication|0|||
127807518|NCT02357420|459915722|FG000|Overall Study|Protocol Non-compliance|0|||
127807519|NCT02357420|459915723|FG001|Overall Study|Protocol Non-compliance|0|||
127807520|NCT02357420|459915724|FG002|Overall Study|Protocol Non-compliance|0|||
127807521|NCT02357420|459915725|FG003|Overall Study|Protocol Non-compliance|1|||
127807522|NCT02357420|459915722|FG000|Overall Study|Withdrawn Consent|4|||
127893205|NCT01590433|460231314|FG000|Overall Study|Lost to Follow-up|20|||
127893206|NCT01590433|460231315|FG001|Overall Study|Lost to Follow-up|8|||
127741927|NCT03414047|459682027|FG003|Overall Study|Physician Decision|1|||
127741928|NCT03414047|459682024|FG000|Overall Study|Withdrawal by Subject|1|||
127807523|NCT02357420|459915723|FG001|Overall Study|Withdrawn Consent|8|||
127893207|NCT01590433|460231314|FG000|Overall Study|Withdrawal by Subject|21|||
127893208|NCT01590433|460231315|FG001|Overall Study|Withdrawal by Subject|11|||
127893209|NCT01590433|460231314|FG000|Overall Study|Adverse Event|11|||
127893210|NCT01590433|460231315|FG001|Overall Study|Adverse Event|3|||
127741929|NCT03414047|459682025|FG001|Overall Study|Withdrawal by Subject|0|||
127741930|NCT03414047|459682026|FG002|Overall Study|Withdrawal by Subject|2|||
127741931|NCT03414047|459682027|FG003|Overall Study|Withdrawal by Subject|0|||
127741932|NCT02586415|459682034|FG000|Overall Study|Death|13|||
127741933|NCT02586415|459682035|FG001|Overall Study|Death|23|||
127741934|NCT02586415|459682034|FG000|Overall Study|Lost to Follow-up|1|||
127741935|NCT02586415|459682035|FG001|Overall Study|Lost to Follow-up|2|||
127741936|NCT02872311|459682036|FG000|Overall Study|Death|2|||
127741937|NCT02872311|459682037|FG001|Overall Study|Death|0|||
127741938|NCT02872311|459682038|FG002|Overall Study|Death|0|||
127741939|NCT02872311|459682039|FG003|Overall Study|Death|0|||
127741940|NCT02872311|459682040|FG004|Overall Study|Death|0|||
127741941|NCT02872311|459682036|FG000|Overall Study|Lost to Follow-up|2|||
127741942|NCT02872311|459682037|FG001|Overall Study|Lost to Follow-up|0|||
127741943|NCT02872311|459682038|FG002|Overall Study|Lost to Follow-up|0|||
127741944|NCT02872311|459682039|FG003|Overall Study|Lost to Follow-up|0|||
127741945|NCT02872311|459682040|FG004|Overall Study|Lost to Follow-up|0|||
127741946|NCT02872311|459682036|FG000|Overall Study|Protocol Violation|0|||
127741947|NCT02872311|459682037|FG001|Overall Study|Protocol Violation|2|||
127741948|NCT02872311|459682038|FG002|Overall Study|Protocol Violation|1|||
127741949|NCT02872311|459682039|FG003|Overall Study|Protocol Violation|0|||
127741950|NCT02872311|459682040|FG004|Overall Study|Protocol Violation|0|||
127741951|NCT01585298|459682043|FG000|Overall Study|Study completion was not documented.|1|||
127741952|NCT01585298|459682043|FG000|Overall Study|Protocol deviation|1|||
127741953|NCT01585298|459682043|FG000|Overall Study|Administrative problems|4|||
127741954|NCT01585298|459682043|FG000|Overall Study|Lost to Follow-up|2|||
127741955|NCT01585298|459682043|FG000|Overall Study|Withdrawal by Subject|4|||
127741956|NCT01585298|459682043|FG000|Overall Study|Abnormal test procedure results|1|||
127741957|NCT01585298|459682043|FG000|Overall Study|Adverse Event|24|||
127741958|NCT02777242|459682045|FG000|Overall Study|Other|2|||
127741959|NCT02777242|459682045|FG000|Overall Study|Lost to Follow-up|1|||
127741960|NCT02777242|459682045|FG000|Overall Study|Multiple|1|||
127741961|NCT02777242|459682045|FG000|Overall Study|Sponsor's request|1|||
127741962|NCT02777242|459682045|FG000|Overall Study|Withdrawal by Subject|1|||
127741963|NCT01898442|459682046|FG000|Overall Study|Hemolysis/technical problems|1|||
127741964|NCT01898442|459682047|FG001|Overall Study|Hemolysis/technical problems|2|||
127741965|NCT01898442|459682048|FG002|Overall Study|Hemolysis/technical problems|2|||
127741966|NCT01898442|459682046|FG000|Overall Study|Patient vomited pills|0|||
127741967|NCT01898442|459682047|FG001|Overall Study|Patient vomited pills|0|||
127741968|NCT01898442|459682048|FG002|Overall Study|Patient vomited pills|1|||
127741969|NCT05178979|459682049|FG000|Overall Study|Death|0|||
127741970|NCT05178979|459682050|FG001|Overall Study|Death|5|||
127741971|NCT05178979|459682051|FG002|Overall Study|Death|0|||
127741972|NCT05178979|459682052|FG003|Overall Study|Death|3|||
127741973|NCT05178979|459682049|FG000|Overall Study|Adverse Event|0|||
127741974|NCT05178979|459682050|FG001|Overall Study|Adverse Event|1|||
127741975|NCT05178979|459682051|FG002|Overall Study|Adverse Event|0|||
127741976|NCT05178979|459682052|FG003|Overall Study|Adverse Event|0|||
127741977|NCT05178979|459682049|FG000|Overall Study|Lost to Follow-up|1|||
127741978|NCT05178979|459682050|FG001|Overall Study|Lost to Follow-up|8|||
127741979|NCT05178979|459682051|FG002|Overall Study|Lost to Follow-up|3|||
127741980|NCT05178979|459682052|FG003|Overall Study|Lost to Follow-up|8|||
127741981|NCT01099579|459682064|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
127741982|NCT01099579|459682065|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
127741983|NCT01099579|459682066|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
127741984|NCT01099579|459682064|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
127741985|NCT01099579|459682065|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
127741986|NCT01099579|459682066|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
127741987|NCT01099579|459682064|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
127741988|NCT01099579|459682065|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
127741989|NCT01099579|459682066|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
127741990|NCT01099579|459682064|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
127741991|NCT01099579|459682065|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
127741992|NCT01099579|459682066|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
127741993|NCT01099579|459682064|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
127741994|NCT01099579|459682065|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
127741995|NCT01099579|459682066|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
127741996|NCT01099579|459682064|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
127741997|NCT01099579|459682065|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
127741998|NCT01099579|459682066|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
127741999|NCT01099579|459682064|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
127742000|NCT01099579|459682065|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
127742001|NCT01099579|459682066|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
127893211|NCT00555009|460231316|FG000|Overall Study|Withdrawal by Subject|0|||
127742002|NCT01099579|459682064|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
127742003|NCT01099579|459682065|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
127742004|NCT01099579|459682066|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
127742005|NCT01099579|459682064|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
127742006|NCT01099579|459682065|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
127742007|NCT01099579|459682066|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
127742008|NCT01099579|459682064|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
127742009|NCT01099579|459682065|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
127742010|NCT01099579|459682066|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
127742011|NCT00909532|459682067|FG000|Overall Study|Adverse Event|4|||
127742012|NCT00909532|459682068|FG001|Overall Study|Adverse Event|1|||
127742013|NCT00909532|459682067|FG000|Overall Study|Pregnancy|0|||
127742014|NCT00909532|459682068|FG001|Overall Study|Pregnancy|1|||
127742015|NCT00909532|459682067|FG000|Overall Study|Prohibited Medication|2|||
127742016|NCT00909532|459682068|FG001|Overall Study|Prohibited Medication|1|||
127742017|NCT00909532|459682067|FG000|Overall Study|Withdrawal of Consent|1|||
127742018|NCT00909532|459682068|FG001|Overall Study|Withdrawal of Consent|1|||
127742019|NCT00909532|459682067|FG000|Overall Study|Noncompliance with Study Requirements|0|||
127742020|NCT00909532|459682068|FG001|Overall Study|Noncompliance with Study Requirements|2|||
127742021|NCT00909532|459682067|FG000|Overall Study|Physician Decision|1|||
127742022|NCT00909532|459682068|FG001|Overall Study|Physician Decision|0|||
127742023|NCT00909532|459682067|FG000|Overall Study|Wrong Genotype|1|||
127742024|NCT00909532|459682068|FG001|Overall Study|Wrong Genotype|0|||
127742025|NCT00909532|459682067|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
127742026|NCT00909532|459682068|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
127742027|NCT01726517|459682074|FG000|Overall Study|Withdrawal by Subject|0|||
127742028|NCT01726517|459682075|FG001|Overall Study|Withdrawal by Subject|0|||
127742029|NCT01726517|459682076|FG002|Overall Study|Withdrawal by Subject|1|||
127893212|NCT00555009|460231317|FG001|Overall Study|Withdrawal by Subject|1|||
127893213|NCT00555009|460231316|FG000|Overall Study|Terminated by Sponsor|2|||
127893214|NCT00555009|460231317|FG001|Overall Study|Terminated by Sponsor|5|||
127893215|NCT00449072|460231336|FG000|Overall Study|Adverse Event|3|||
127893216|NCT00449072|460231337|FG001|Overall Study|Adverse Event|1|||
127893217|NCT00449072|460231336|FG000|Overall Study|Protocol Violation|14|||
127893218|NCT00449072|460231337|FG001|Overall Study|Protocol Violation|12|||
127893219|NCT00449072|460231336|FG000|Overall Study|Lost to Follow-up|5|||
127742030|NCT01726517|459682077|FG003|Overall Study|Withdrawal by Subject|0|||
127742031|NCT01726517|459682078|FG004|Overall Study|Withdrawal by Subject|0|||
127742032|NCT00573651|459682079|FG000|Overall Study|Lost to Follow-up|3|||
127742033|NCT00573651|459682079|FG000|Overall Study|Withdrawal by Subject|1|||
127742034|NCT03797989|459682100|FG000|VAC069A|Withdrawal by Subject|0|||
127742035|NCT03797989|459682101|FG001|VAC069A|Withdrawal by Subject|0|||
127742036|NCT03797989|459682102|FG002|VAC069A|Withdrawal by Subject|1|||
127742037|NCT03797989|459682103|FG003|VAC069A|Withdrawal by Subject|0|||
127742038|NCT03797989|459682104|FG004|VAC069A|Withdrawal by Subject|0|||
127742039|NCT03797989|459682105|FG005|VAC069A|Withdrawal by Subject|0|||
127742040|NCT03797989|459682106|FG006|VAC069A|Withdrawal by Subject|0|||
127742041|NCT03797989|459682107|FG007|VAC069A|Withdrawal by Subject|0|||
127742042|NCT03797989|459682108|FG008|VAC069A|Withdrawal by Subject|0|||
127742043|NCT03797989|459682109|FG009|VAC069A|Withdrawal by Subject|0|||
127742044|NCT03797989|459682110|FG010|VAC069A|Withdrawal by Subject|0|||
127742045|NCT03797989|459682111|FG011|VAC069A|Withdrawal by Subject|0|||
127742046|NCT04052997|459682112|FG000|Overall Study|Withdrawal by Subject|17|||
127742047|NCT04052997|459682112|FG000|Overall Study|Physician Decision|50|||
127742048|NCT04052997|459682112|FG000|Overall Study|Death|43|||
127742049|NCT04052997|459682112|FG000|Overall Study|Lost to Follow-up|5|||
127742050|NCT04052997|459682112|FG000|Overall Study|Progression of Disease|1|||
127742051|NCT01024036|459682113|FG000|Blinded Treatment|Adverse Event|1|||
127742052|NCT01024036|459682114|FG001|Blinded Treatment|Adverse Event|1|||
127742053|NCT01024036|459682113|FG000|Blinded Treatment|Lack of Efficacy|16|||
127742054|NCT01024036|459682114|FG001|Blinded Treatment|Lack of Efficacy|14|||
127742055|NCT01024036|459682113|FG000|Blinded Treatment|Physician Decision|1|||
127742056|NCT01024036|459682114|FG001|Blinded Treatment|Physician Decision|0|||
127742057|NCT01024036|459682113|FG000|Blinded Treatment|Death|0|||
127742058|NCT01024036|459682114|FG001|Blinded Treatment|Death|2|||
127893220|NCT00449072|460231337|FG001|Overall Study|Lost to Follow-up|7|||
127742059|NCT01024036|459682113|FG000|Blinded Treatment|Withdrawal by Subject|4|||
127742060|NCT01024036|459682114|FG001|Blinded Treatment|Withdrawal by Subject|3|||
127742061|NCT01024036|459682113|FG000|Unblinded Treatment|Adverse Event|0|||
127742062|NCT01024036|459682114|FG001|Unblinded Treatment|Adverse Event|1|||
127742063|NCT01024036|459682113|FG000|Unblinded Treatment|Lack of Efficacy|0|||
127893221|NCT00449072|460231336|FG000|Overall Study|Withdrawal by Subject|11|||
127742064|NCT01024036|459682114|FG001|Unblinded Treatment|Lack of Efficacy|2|||
127742065|NCT01024036|459682113|FG000|Follow-Up Period|Lost to Follow-up|1|||
127742066|NCT01024036|459682114|FG001|Follow-Up Period|Lost to Follow-up|1|||
127742067|NCT01024036|459682113|FG000|Follow-Up Period|Withdrawal by Subject|0|||
127742068|NCT01024036|459682114|FG001|Follow-Up Period|Withdrawal by Subject|1|||
127742069|NCT01024036|459682113|FG000|Follow-Up Period|Adverse Event|4|||
127742070|NCT01024036|459682114|FG001|Follow-Up Period|Adverse Event|1|||
127742071|NCT00604188|459682119|FG000|Overall Study|Adverse Event|1|||
127742072|NCT00604188|459682120|FG001|Overall Study|Adverse Event|4|||
127742073|NCT00604188|459682119|FG000|Overall Study|Lost to Follow-up|17|||
127742074|NCT00604188|459682120|FG001|Overall Study|Lost to Follow-up|15|||
127742075|NCT00604188|459682119|FG000|Overall Study|Withdrawal by Subject|5|||
127742076|NCT00604188|459682120|FG001|Overall Study|Withdrawal by Subject|1|||
127742077|NCT00604188|459682119|FG000|Overall Study|Non-compliance with protocol|4|||
127742078|NCT00604188|459682120|FG001|Overall Study|Non-compliance with protocol|4|||
127742079|NCT00604188|459682119|FG000|Overall Study|Did not receive study drug|0|||
127742080|NCT00604188|459682120|FG001|Overall Study|Did not receive study drug|1|||
127742081|NCT00356759|459682123|FG000|Overall Study|Death|5|||
127742082|NCT00356759|459682124|FG001|Overall Study|Death|2|||
127742083|NCT00356759|459682123|FG000|Overall Study|Withdrawal by Subject|2|||
127742084|NCT00356759|459682124|FG001|Overall Study|Withdrawal by Subject|2|||
127742085|NCT00356759|459682123|FG000|Overall Study|Adverse Event|1|||
127742086|NCT00356759|459682124|FG001|Overall Study|Adverse Event|3|||
127742087|NCT00356759|459682123|FG000|Overall Study|Lost to Follow-up|1|||
127742088|NCT00356759|459682124|FG001|Overall Study|Lost to Follow-up|1|||
127742089|NCT00356759|459682123|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
127742090|NCT00356759|459682124|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
127742091|NCT00474383|459682126|FG000|Main Study|Adverse Event|11|||
127742092|NCT00474383|459682127|FG001|Main Study|Adverse Event|0|||
127742093|NCT00474383|459682126|FG000|Main Study|Symptomatic Deterioration|1|||
127742094|NCT00474383|459682127|FG001|Main Study|Symptomatic Deterioration|0|||
127742095|NCT00474383|459682126|FG000|Main Study|Progressive Disease|23|||
127742096|NCT00474383|459682127|FG001|Main Study|Progressive Disease|0|||
127742097|NCT00474383|459682126|FG000|Main Study|Other|1|||
127742098|NCT00474383|459682127|FG001|Main Study|Other|0|||
127742099|NCT00474383|459682126|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
127742100|NCT00474383|459682127|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
127742101|NCT00474383|459682126|FG000|Extension|Progressive Disease|0|||
127742102|NCT00474383|459682127|FG001|Extension|Progressive Disease|5|||
127742103|NCT02998918|459682128|FG000|Overall Study|Withdrawal by Subject|1|||
127742104|NCT02998918|459682129|FG001|Overall Study|Withdrawal by Subject|0|||
127742105|NCT00443599|459682130|FG000|Overall Study|Physician Decision|2|||
127742106|NCT00443599|459682131|FG001|Overall Study|Physician Decision|1|||
127742107|NCT00443599|459682130|FG000|Overall Study|Death|1|||
127742108|NCT00443599|459682131|FG001|Overall Study|Death|1|||
127742109|NCT00443599|459682130|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
127742110|NCT00443599|459682131|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
127742111|NCT02080403|459683987|FG000|Overall Study|Adverse Event|5|||
127742112|NCT02080403|459683988|FG001|Overall Study|Adverse Event|1|||
127742113|NCT02080403|459683987|FG000|Overall Study|Death|0|||
127742114|NCT02080403|459683988|FG001|Overall Study|Death|2|||
127742115|NCT02080403|459683987|FG000|Overall Study|Lost to Follow-up|2|||
127742116|NCT02080403|459683988|FG001|Overall Study|Lost to Follow-up|0|||
127742117|NCT02080403|459683987|FG000|Overall Study|Pregnancy|0|||
127742118|NCT02080403|459683988|FG001|Overall Study|Pregnancy|1|||
127742119|NCT02080403|459683987|FG000|Overall Study|Protocol Violation|3|||
127742120|NCT02080403|459683988|FG001|Overall Study|Protocol Violation|7|||
127742121|NCT02080403|459683987|FG000|Overall Study|Withdrawal by Subject|5|||
127742122|NCT02080403|459683988|FG001|Overall Study|Withdrawal by Subject|1|||
127742123|NCT01999972|459683989|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
127742124|NCT01999972|459683990|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
127742125|NCT01999972|459683991|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
127742126|NCT01999972|459683992|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
127742127|NCT01999972|459683993|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
127742128|NCT01999972|459683994|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
127742129|NCT01999972|459683989|FG000|Dose Escalation Part|Death|0|||
127742130|NCT01999972|459683990|FG001|Dose Escalation Part|Death|1|||
127742131|NCT01999972|459683991|FG002|Dose Escalation Part|Death|0|||
127742132|NCT01999972|459683992|FG003|Dose Escalation Part|Death|0|||
127742133|NCT01999972|459683993|FG004|Dose Escalation Part|Death|0|||
127742134|NCT01999972|459683994|FG005|Dose Escalation Part|Death|0|||
127742135|NCT01999972|459683989|FG000|Dose Escalation Part|Enrolled but not treated|0|||
127742136|NCT01999972|459683990|FG001|Dose Escalation Part|Enrolled but not treated|0|||
127742137|NCT01999972|459683991|FG002|Dose Escalation Part|Enrolled but not treated|1|||
127742138|NCT01999972|459683992|FG003|Dose Escalation Part|Enrolled but not treated|1|||
127742139|NCT01999972|459683993|FG004|Dose Escalation Part|Enrolled but not treated|0|||
127742140|NCT01999972|459683994|FG005|Dose Escalation Part|Enrolled but not treated|0|||
127807524|NCT02357420|459915724|FG002|Overall Study|Withdrawn Consent|6|||
127807525|NCT02357420|459915725|FG003|Overall Study|Withdrawn Consent|6|||
127807526|NCT02357420|459915722|FG000|Overall Study|Lost to Follow-up|3|||
127807527|NCT02357420|459915723|FG001|Overall Study|Lost to Follow-up|0|||
127807528|NCT02357420|459915724|FG002|Overall Study|Lost to Follow-up|2|||
127807529|NCT02357420|459915725|FG003|Overall Study|Lost to Follow-up|3|||
127807530|NCT00928070|459915728|FG000|Overall Study|Lost to Follow-up|1|||
127807531|NCT00928070|459915729|FG001|Overall Study|Lost to Follow-up|2|||
127893222|NCT00449072|460231337|FG001|Overall Study|Withdrawal by Subject|8|||
127893223|NCT00449072|460231336|FG000|Overall Study|Lack of Efficacy|1|||
127893224|NCT00449072|460231337|FG001|Overall Study|Lack of Efficacy|1|||
127893225|NCT00449072|460231336|FG000|Overall Study|Physician Decision|1|||
127893226|NCT00449072|460231337|FG001|Overall Study|Physician Decision|0|||
127893227|NCT00449072|460231336|FG000|Overall Study|Not treated|0|||
127893228|NCT00449072|460231337|FG001|Overall Study|Not treated|1|||
127893229|NCT00449072|460231336|FG000|Overall Study|Excluded medication|0|||
127893230|NCT00449072|460231337|FG001|Overall Study|Excluded medication|2|||
127893231|NCT00449072|460231336|FG000|Overall Study|Non-compliance|2|||
127893232|NCT00449072|460231337|FG001|Overall Study|Non-compliance|5|||
127893233|NCT00449072|460231336|FG000|Overall Study|Sponsor decision|1|||
127893234|NCT00449072|460231337|FG001|Overall Study|Sponsor decision|3|||
127893235|NCT00449072|460231336|FG000|Overall Study|Relocation|3|||
127893236|NCT00449072|460231337|FG001|Overall Study|Relocation|2|||
127893237|NCT01787825|460231338|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
127893238|NCT01787825|460231339|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
127893239|NCT01787825|460231338|FG000|Overall Study|Data Not Analyzable|5|||
127893240|NCT01787825|460231339|FG001|Overall Study|Data Not Analyzable|1|||
127893241|NCT00989261|460231344|FG000|Overall Study|Still in follow up|12|||
127893242|NCT00989261|460231345|FG001|Overall Study|Still in follow up|21|||
127893243|NCT00989261|460231344|FG000|Overall Study|Withdrawal by Subject|0|||
127893244|NCT00989261|460231345|FG001|Overall Study|Withdrawal by Subject|1|||
127893245|NCT00989261|460231344|FG000|Overall Study|Lost to Follow-up|3|||
127893246|NCT00989261|460231345|FG001|Overall Study|Lost to Follow-up|0|||
127893247|NCT00718159|460231346|FG000|Overall Study|Progressive Disease|3|||
127893248|NCT00718159|460231347|FG001|Overall Study|Progressive Disease|3|||
127893249|NCT00718159|460231348|FG002|Overall Study|Progressive Disease|2|||
127893250|NCT00718159|460231349|FG003|Overall Study|Progressive Disease|0|||
127893251|NCT00718159|460231350|FG004|Overall Study|Progressive Disease|6|||
127893252|NCT00718159|460231351|FG005|Overall Study|Progressive Disease|0|||
127893253|NCT00718159|460231352|FG006|Overall Study|Progressive Disease|0|||
127893254|NCT00718159|460231346|FG000|Overall Study|Death due to Adverse Event|0|||
127893255|NCT00718159|460231347|FG001|Overall Study|Death due to Adverse Event|0|||
127893256|NCT00718159|460231348|FG002|Overall Study|Death due to Adverse Event|0|||
127893257|NCT00718159|460231349|FG003|Overall Study|Death due to Adverse Event|2|||
127893258|NCT00718159|460231350|FG004|Overall Study|Death due to Adverse Event|2|||
127893259|NCT00718159|460231351|FG005|Overall Study|Death due to Adverse Event|0|||
127893260|NCT00718159|460231352|FG006|Overall Study|Death due to Adverse Event|0|||
127893261|NCT00718159|460231346|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
127893262|NCT00718159|460231347|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
127893263|NCT00718159|460231348|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
127893264|NCT00718159|460231349|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
127893265|NCT00718159|460231350|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
127893266|NCT00718159|460231351|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
127742141|NCT01999972|459683989|FG000|Dose Escalation Part|Disease progression|3|||
127742142|NCT01999972|459683990|FG001|Dose Escalation Part|Disease progression|2|||
127742143|NCT01999972|459683991|FG002|Dose Escalation Part|Disease progression|3|||
127742144|NCT01999972|459683992|FG003|Dose Escalation Part|Disease progression|6|||
127742145|NCT01999972|459683993|FG004|Dose Escalation Part|Disease progression|0|||
127742146|NCT01999972|459683994|FG005|Dose Escalation Part|Disease progression|0|||
127742147|NCT01999972|459683989|FG000|Dose Escalation Part|Adverse Event|0|||
127742148|NCT01999972|459683990|FG001|Dose Escalation Part|Adverse Event|0|||
127742149|NCT01999972|459683991|FG002|Dose Escalation Part|Adverse Event|0|||
127742150|NCT01999972|459683992|FG003|Dose Escalation Part|Adverse Event|2|||
127742151|NCT01999972|459683993|FG004|Dose Escalation Part|Adverse Event|0|||
127742152|NCT01999972|459683994|FG005|Dose Escalation Part|Adverse Event|0|||
127893267|NCT00718159|460231352|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
127893268|NCT00718159|460231346|FG000|Overall Study|Investigator Decision|0|||
127893269|NCT00718159|460231347|FG001|Overall Study|Investigator Decision|0|||
127893270|NCT00718159|460231348|FG002|Overall Study|Investigator Decision|0|||
127893271|NCT00718159|460231349|FG003|Overall Study|Investigator Decision|0|||
127893272|NCT00718159|460231350|FG004|Overall Study|Investigator Decision|0|||
127742153|NCT01999972|459683989|FG000|Dose Escalation Part|Global deterioration of health status|1|||
127742154|NCT01999972|459683990|FG001|Dose Escalation Part|Global deterioration of health status|0|||
127893273|NCT00718159|460231351|FG005|Overall Study|Investigator Decision|1|||
127893274|NCT00718159|460231352|FG006|Overall Study|Investigator Decision|1|||
127893275|NCT01798485|460231367|FG000|Overall Study|Adverse Event|32|||
127893276|NCT01798485|460231368|FG001|Overall Study|Adverse Event|40|||
127742155|NCT01999972|459683991|FG002|Dose Escalation Part|Global deterioration of health status|0|||
127742156|NCT01999972|459683992|FG003|Dose Escalation Part|Global deterioration of health status|1|||
127893277|NCT01798485|460231367|FG000|Overall Study|Withdrawal by Subject|27|||
127893278|NCT01798485|460231368|FG001|Overall Study|Withdrawal by Subject|31|||
127893279|NCT01798485|460231367|FG000|Overall Study|Lost to Follow-up|0|||
127893280|NCT01798485|460231368|FG001|Overall Study|Lost to Follow-up|3|||
127893281|NCT01798485|460231367|FG000|Overall Study|Physician Decision|14|||
127742157|NCT01999972|459683993|FG004|Dose Escalation Part|Global deterioration of health status|0|||
127807532|NCT00928070|459915728|FG000|Overall Study|Withdrawal by Subject|10|||
127807533|NCT00928070|459915729|FG001|Overall Study|Withdrawal by Subject|3|||
127807534|NCT00928070|459915728|FG000|Overall Study|Adverse Event|14|||
127807535|NCT00928070|459915729|FG001|Overall Study|Adverse Event|26|||
127807536|NCT00928070|459915728|FG000|Overall Study|Lack of Efficacy|9|||
127807537|NCT00928070|459915729|FG001|Overall Study|Lack of Efficacy|5|||
127807538|NCT00928070|459915728|FG000|Overall Study|Did not meet entrance criteria|16|||
127807539|NCT00928070|459915729|FG001|Overall Study|Did not meet entrance criteria|9|||
127807540|NCT00928070|459915728|FG000|Overall Study|Protocol Violation|6|||
127807541|NCT00928070|459915729|FG001|Overall Study|Protocol Violation|5|||
127807542|NCT00928070|459915728|FG000|Overall Study|Randomized but not treated|2|||
127807543|NCT00928070|459915729|FG001|Overall Study|Randomized but not treated|2|||
127807544|NCT00928070|459915728|FG000|Overall Study|Other|5|||
127807545|NCT00928070|459915729|FG001|Overall Study|Other|5|||
127742158|NCT01999972|459683994|FG005|Dose Escalation Part|Global deterioration of health status|0|||
127807546|NCT04067518|459915730|FG000|Overall Study|Adverse Event|1|||
127807547|NCT04067518|459915731|FG001|Overall Study|Adverse Event|3|||
127807548|NCT04067518|459915730|FG000|Overall Study|Screen failures|0|||
127807549|NCT04067518|459915731|FG001|Overall Study|Screen failures|1|||
127807550|NCT04067518|459915730|FG000|Overall Study|Enrolled but not treated|0|||
127807551|NCT04067518|459915731|FG001|Overall Study|Enrolled but not treated|1|||
127807552|NCT00862251|459915732|FG000|Overall Study|Adverse Event|8|||
127807553|NCT00862251|459915733|FG001|Overall Study|Adverse Event|3|||
127807554|NCT00862251|459915734|FG002|Overall Study|Adverse Event|1|||
127807555|NCT00862251|459915732|FG000|Overall Study|Lost to Follow-up|0|||
127807556|NCT00862251|459915733|FG001|Overall Study|Lost to Follow-up|0|||
127807557|NCT00862251|459915734|FG002|Overall Study|Lost to Follow-up|1|||
127807558|NCT00862251|459915732|FG000|Overall Study|Protocol Violation|2|||
127807559|NCT00862251|459915733|FG001|Overall Study|Protocol Violation|0|||
127807560|NCT00862251|459915734|FG002|Overall Study|Protocol Violation|1|||
127807561|NCT00862251|459915732|FG000|Overall Study|Withdrawal by Subject|9|||
127807562|NCT00862251|459915733|FG001|Overall Study|Withdrawal by Subject|2|||
127807563|NCT00862251|459915734|FG002|Overall Study|Withdrawal by Subject|6|||
127807564|NCT02054702|459915740|FG000|Overall Study|Lost to Follow-up|3|||
127807565|NCT02054702|459915741|FG001|Overall Study|Lost to Follow-up|5|||
127807566|NCT02054702|459915740|FG000|Overall Study|Adverse Event|3|||
127807567|NCT02054702|459915741|FG001|Overall Study|Adverse Event|1|||
127807568|NCT02054702|459915740|FG000|Overall Study|Met Withdrawal Criteria|4|||
127807569|NCT02054702|459915741|FG001|Overall Study|Met Withdrawal Criteria|1|||
127807570|NCT02054702|459915740|FG000|Overall Study|Physician Decision|0|||
127807571|NCT02054702|459915741|FG001|Overall Study|Physician Decision|1|||
127807572|NCT02054702|459915740|FG000|Overall Study|Withdrawal by Subject|14|||
127807573|NCT02054702|459915741|FG001|Overall Study|Withdrawal by Subject|4|||
127742159|NCT01999972|459683989|FG000|Dose Expansion Part|Death|0|||
127742160|NCT01999972|459683990|FG001|Dose Expansion Part|Death|0|||
127742161|NCT01999972|459683991|FG002|Dose Expansion Part|Death|0|||
127742162|NCT01999972|459683992|FG003|Dose Expansion Part|Death|0|||
127742163|NCT01999972|459683993|FG004|Dose Expansion Part|Death|2|||
127742164|NCT01999972|459683994|FG005|Dose Expansion Part|Death|1|||
127742165|NCT01999972|459683989|FG000|Dose Expansion Part|Disease progression|0|||
127742166|NCT01999972|459683990|FG001|Dose Expansion Part|Disease progression|0|||
127742167|NCT01999972|459683991|FG002|Dose Expansion Part|Disease progression|0|||
127742168|NCT01999972|459683992|FG003|Dose Expansion Part|Disease progression|0|||
127742169|NCT01999972|459683993|FG004|Dose Expansion Part|Disease progression|9|||
127742170|NCT01999972|459683994|FG005|Dose Expansion Part|Disease progression|3|||
127742171|NCT01999972|459683989|FG000|Dose Expansion Part|Sponsor decision|0|||
127742172|NCT01999972|459683990|FG001|Dose Expansion Part|Sponsor decision|0|||
127742173|NCT01999972|459683991|FG002|Dose Expansion Part|Sponsor decision|0|||
127742174|NCT01999972|459683992|FG003|Dose Expansion Part|Sponsor decision|0|||
127742175|NCT01999972|459683993|FG004|Dose Expansion Part|Sponsor decision|1|||
127742176|NCT01999972|459683994|FG005|Dose Expansion Part|Sponsor decision|0|||
127807574|NCT00934102|459915745|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
127807575|NCT00934102|459915746|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
127807576|NCT00934102|459915747|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
127807577|NCT02318784|459915748|FG000|Overall Study|Adverse Event|13|||
127807578|NCT02318784|459915748|FG000|Overall Study|Death|2|||
127742177|NCT01999972|459683989|FG000|Dose Expansion Part|Adverse Event|0|||
127742178|NCT01999972|459683990|FG001|Dose Expansion Part|Adverse Event|0|||
127742179|NCT01999972|459683991|FG002|Dose Expansion Part|Adverse Event|0|||
127742180|NCT01999972|459683992|FG003|Dose Expansion Part|Adverse Event|0|||
127742181|NCT01999972|459683993|FG004|Dose Expansion Part|Adverse Event|4|||
127807579|NCT02318784|459915748|FG000|Overall Study|Progressive Disease|37|||
127807580|NCT02318784|459915748|FG000|Overall Study|Withdrawal by Subject|10|||
127807581|NCT02304926|459915749|FG000|Overall Study|Lost to Follow-up|2|||
127807582|NCT02304926|459915750|FG001|Overall Study|Lost to Follow-up|1|||
127807583|NCT02388295|459915752|FG000|Dose Escalation Week 1|Adverse Event|1|||
127807584|NCT02388295|459915753|FG001|Dose Escalation Week 1|Adverse Event|2|||
127742182|NCT01999972|459683994|FG005|Dose Expansion Part|Adverse Event|2|||
127742183|NCT01999972|459683989|FG000|Dose Expansion Part|Participant's non-compliance|0|||
127742184|NCT01999972|459683990|FG001|Dose Expansion Part|Participant's non-compliance|0|||
127742185|NCT01999972|459683991|FG002|Dose Expansion Part|Participant's non-compliance|0|||
127742186|NCT01999972|459683992|FG003|Dose Expansion Part|Participant's non-compliance|0|||
127742187|NCT01999972|459683993|FG004|Dose Expansion Part|Participant's non-compliance|0|||
127742188|NCT01999972|459683994|FG005|Dose Expansion Part|Participant's non-compliance|1|||
127742189|NCT01999972|459683989|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
127742190|NCT01999972|459683990|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
127742191|NCT01999972|459683991|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
127742192|NCT01999972|459683992|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
127742193|NCT01999972|459683993|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
127742194|NCT01999972|459683994|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
127742195|NCT01999972|459683989|FG000|Dose Expansion Part|Changed to standard of care|0|||
127742196|NCT01999972|459683990|FG001|Dose Expansion Part|Changed to standard of care|0|||
127742197|NCT01999972|459683991|FG002|Dose Expansion Part|Changed to standard of care|0|||
127742198|NCT01999972|459683992|FG003|Dose Expansion Part|Changed to standard of care|0|||
127742199|NCT01999972|459683993|FG004|Dose Expansion Part|Changed to standard of care|1|||
127742200|NCT01999972|459683994|FG005|Dose Expansion Part|Changed to standard of care|0|||
127742201|NCT02202109|459683995|FG000|Overall Study|Lost to Follow-up|88|||
127742202|NCT02202109|459683996|FG001|Overall Study|Lost to Follow-up|87|||
127742203|NCT02202109|459683995|FG000|Overall Study|Withdrawal by Subject|2|||
127742204|NCT02202109|459683996|FG001|Overall Study|Withdrawal by Subject|0|||
127742205|NCT00612352|459683998|FG000|Overall Study|Adverse Event|1|||
127742206|NCT00612352|459683999|FG001|Overall Study|Adverse Event|0|||
127742207|NCT00612352|459683998|FG000|Overall Study|Withdrawal by Subject|3|||
127742208|NCT00612352|459683999|FG001|Overall Study|Withdrawal by Subject|5|||
127742209|NCT00612352|459683998|FG000|Overall Study|moved out of state|1|||
127742210|NCT00612352|459683999|FG001|Overall Study|moved out of state|0|||
127742211|NCT00612352|459683998|FG000|Overall Study|didn't return calls/show up on test date|4|||
127742212|NCT00612352|459683999|FG001|Overall Study|didn't return calls/show up on test date|1|||
127742213|NCT01986114|459684000|FG000|Overall Study|Adverse Event|59|||
127742214|NCT01986114|459684000|FG000|Overall Study|Lack of Efficacy|23|||
127742215|NCT01986114|459684000|FG000|Overall Study|Withdrawal by Subject|58|||
127742216|NCT01986114|459684000|FG000|Overall Study|Noncompliance|3|||
127742217|NCT01986114|459684000|FG000|Overall Study|Protocol Violation|1|||
127742218|NCT01986114|459684000|FG000|Overall Study|Lost to Follow-up|5|||
127742219|NCT01986114|459684000|FG000|Overall Study|Other reason|7|||
127742220|NCT00664105|459684001|FG000|Overall Study|Death|3|||
127742221|NCT00664105|459684001|FG000|Overall Study|Withdrawal by Subject|5|||
127742222|NCT00664105|459684001|FG000|Overall Study|Adverse Event|9|||
127742223|NCT00664105|459684001|FG000|Overall Study|Disease progression|7|||
127742224|NCT02034162|459684002|FG000|Double-blind|Lost to Follow-up|3|||
127742225|NCT02034162|459684003|FG001|Double-blind|Lost to Follow-up|0|||
127742226|NCT02034162|459684004|FG002|Double-blind|Lost to Follow-up|0|||
127742227|NCT02034162|459684002|FG000|Double-blind|Physician Decision|1|||
127742228|NCT02034162|459684003|FG001|Double-blind|Physician Decision|0|||
127742229|NCT02034162|459684004|FG002|Double-blind|Physician Decision|0|||
127742230|NCT02034162|459684002|FG000|Double-blind|Protocol Violation|0|||
127742231|NCT02034162|459684003|FG001|Double-blind|Protocol Violation|1|||
127742232|NCT02034162|459684004|FG002|Double-blind|Protocol Violation|0|||
127893282|NCT01798485|460231368|FG001|Overall Study|Physician Decision|10|||
127893283|NCT01798485|460231367|FG000|Overall Study|Objective Disease Progression|152|||
127893284|NCT01798485|460231368|FG001|Overall Study|Objective Disease Progression|106|||
127893285|NCT01798485|460231367|FG000|Overall Study|Death|25|||
127893286|NCT01798485|460231368|FG001|Overall Study|Death|22|||
127742233|NCT02034162|459684002|FG000|Double-blind|Withdrawal by Subject|5|||
127893287|NCT01798485|460231367|FG000|Overall Study|Sponsor Decision|61|||
127893288|NCT01798485|460231368|FG001|Overall Study|Sponsor Decision|54|||
127742234|NCT02034162|459684003|FG001|Double-blind|Withdrawal by Subject|7|||
127742235|NCT02034162|459684004|FG002|Double-blind|Withdrawal by Subject|0|||
127742236|NCT00761956|459684008|FG000|Overall Study|Lost to Follow-up|6|||
127742237|NCT00761956|459684009|FG001|Overall Study|Lost to Follow-up|11|||
127893289|NCT01798485|460231367|FG000|Overall Study|Clinical Progression|35|||
127742238|NCT00761956|459684008|FG000|Overall Study|Withdrawal by Subject|3|||
127742239|NCT00761956|459684009|FG001|Overall Study|Withdrawal by Subject|8|||
127742240|NCT00761956|459684008|FG000|Overall Study|Death|0|||
127742241|NCT00761956|459684009|FG001|Overall Study|Death|1|||
127742242|NCT00761956|459684008|FG000|Overall Study|Adverse Event|26|||
127742243|NCT00761956|459684009|FG001|Overall Study|Adverse Event|34|||
127742244|NCT03024996|459684010|FG000|Overall Study|Death|57|||
127893290|NCT01798485|460231368|FG001|Overall Study|Clinical Progression|24|||
127742245|NCT03024996|459684011|FG001|Overall Study|Death|55|||
127742246|NCT03024996|459684010|FG000|Overall Study|Disease relapse|1|||
127742247|NCT03024996|459684011|FG001|Overall Study|Disease relapse|0|||
127742248|NCT03024996|459684010|FG000|Overall Study|Lost to Follow-up|5|||
127893291|NCT00681863|460231369|FG000|Overall Study|Adverse Event|1|||
127893292|NCT00681863|460231369|FG000|Overall Study|Lost to Follow-up|2|||
127893293|NCT00681863|460231369|FG000|Overall Study|Lack of Efficacy|2|||
127893294|NCT00681863|460231369|FG000|Overall Study|Other|18|||
127893295|NCT01333033|460231370|FG000|Overall Study|Ineligible|0|||
127893296|NCT01333033|460231371|FG001|Overall Study|Ineligible|0|||
127893297|NCT01333033|460231372|FG002|Overall Study|Ineligible|0|||
127893298|NCT01333033|460231373|FG003|Overall Study|Ineligible|0|||
127893299|NCT01333033|460231374|FG004|Overall Study|Ineligible|6|||
127893300|NCT01333033|460231375|FG005|Overall Study|Ineligible|8|||
127893301|NCT01333033|460231370|FG000|Overall Study|Withdrawal by Subject|0|||
127893302|NCT01333033|460231371|FG001|Overall Study|Withdrawal by Subject|0|||
127893303|NCT01333033|460231372|FG002|Overall Study|Withdrawal by Subject|0|||
127893304|NCT01333033|460231373|FG003|Overall Study|Withdrawal by Subject|0|||
127893305|NCT01333033|460231374|FG004|Overall Study|Withdrawal by Subject|4|||
127893306|NCT01333033|460231375|FG005|Overall Study|Withdrawal by Subject|2|||
127893307|NCT01333033|460231370|FG000|Overall Study|PET inevaluable|0|||
127893308|NCT01333033|460231371|FG001|Overall Study|PET inevaluable|0|||
127893309|NCT01333033|460231372|FG002|Overall Study|PET inevaluable|0|||
127893310|NCT01333033|460231373|FG003|Overall Study|PET inevaluable|0|||
127893311|NCT01333033|460231374|FG004|Overall Study|PET inevaluable|2|||
127893312|NCT01333033|460231375|FG005|Overall Study|PET inevaluable|4|||
127893313|NCT01333033|460231370|FG000|Overall Study|Adverse Event|0|||
127893314|NCT01333033|460231371|FG001|Overall Study|Adverse Event|0|||
127893315|NCT01333033|460231372|FG002|Overall Study|Adverse Event|0|||
127893316|NCT01333033|460231373|FG003|Overall Study|Adverse Event|0|||
127893317|NCT01333033|460231374|FG004|Overall Study|Adverse Event|2|||
127893318|NCT01333033|460231375|FG005|Overall Study|Adverse Event|1|||
127893319|NCT01333033|460231370|FG000|Overall Study|Progression|0|||
127893320|NCT01333033|460231371|FG001|Overall Study|Progression|0|||
127893321|NCT01333033|460231372|FG002|Overall Study|Progression|0|||
127893322|NCT01333033|460231373|FG003|Overall Study|Progression|0|||
127893323|NCT01333033|460231374|FG004|Overall Study|Progression|0|||
127893324|NCT01333033|460231375|FG005|Overall Study|Progression|1|||
127893325|NCT01333033|460231370|FG000|Overall Study|MD Decision|0|||
127893326|NCT01333033|460231371|FG001|Overall Study|MD Decision|0|||
127893327|NCT01333033|460231372|FG002|Overall Study|MD Decision|0|||
127893328|NCT01333033|460231373|FG003|Overall Study|MD Decision|0|||
127893329|NCT01333033|460231374|FG004|Overall Study|MD Decision|0|||
127893330|NCT01333033|460231375|FG005|Overall Study|MD Decision|2|||
127893331|NCT03687125|460231376|FG000|Overall Study|Progressive Disease|2|||
127893332|NCT03687125|460231377|FG001|Overall Study|Progressive Disease|1|||
127893333|NCT03687125|460231376|FG000|Overall Study|Protocol Violation|1|||
127893334|NCT03687125|460231377|FG001|Overall Study|Protocol Violation|0|||
127893335|NCT01076166|460231378|FG000|Overall Study|Adverse Event|3|||
127893336|NCT01076166|460231378|FG000|Overall Study|Symptoms improved/resolved|6|||
127893337|NCT00876733|460231383|FG000|Overall Study|Adverse Event|34|||
127893338|NCT00876733|460231384|FG001|Overall Study|Adverse Event|20|||
127893339|NCT00876733|460231385|FG002|Overall Study|Adverse Event|10|||
127893340|NCT00876733|460231386|FG003|Overall Study|Adverse Event|3|||
127893341|NCT00876733|460231383|FG000|Overall Study|Lack of Efficacy|17|||
127893342|NCT00876733|460231384|FG001|Overall Study|Lack of Efficacy|9|||
127893343|NCT00876733|460231385|FG002|Overall Study|Lack of Efficacy|10|||
127893344|NCT00876733|460231386|FG003|Overall Study|Lack of Efficacy|1|||
127893345|NCT00876733|460231383|FG000|Overall Study|Lost to Follow-up|26|||
127893346|NCT00876733|460231384|FG001|Overall Study|Lost to Follow-up|10|||
127893347|NCT00876733|460231385|FG002|Overall Study|Lost to Follow-up|3|||
127893348|NCT00876733|460231386|FG003|Overall Study|Lost to Follow-up|2|||
127893349|NCT00876733|460231383|FG000|Overall Study|Data not available|14|||
127893350|NCT00876733|460231384|FG001|Overall Study|Data not available|3|||
127893351|NCT00876733|460231385|FG002|Overall Study|Data not available|7|||
127742249|NCT03024996|459684011|FG001|Overall Study|Lost to Follow-up|10|||
127742250|NCT03024996|459684010|FG000|Overall Study|Other|3|||
127742251|NCT03024996|459684011|FG001|Overall Study|Other|3|||
127893352|NCT00876733|460231386|FG003|Overall Study|Data not available|1|||
127893353|NCT00543439|460231387|FG000|Period 1|Adverse Event|0|||
127893354|NCT00543439|460231388|FG001|Period 1|Adverse Event|2|||
127893355|NCT00543439|460231389|FG002|Period 1|Adverse Event|1|||
127893356|NCT00543439|460231387|FG000|Period 1|Withdrawal by Subject|1|||
127893357|NCT00543439|460231388|FG001|Period 1|Withdrawal by Subject|1|||
127742252|NCT03024996|459684010|FG000|Overall Study|Physician Decision|0|||
127742253|NCT03024996|459684011|FG001|Overall Study|Physician Decision|1|||
127742254|NCT03024996|459684010|FG000|Overall Study|Study terminated by sponsor|303|||
127893358|NCT00543439|460231389|FG002|Period 1|Withdrawal by Subject|0|||
127893359|NCT00543439|460231387|FG000|Period 1|Physician Decision|0|||
127893360|NCT00543439|460231388|FG001|Period 1|Physician Decision|0|||
127893361|NCT00543439|460231389|FG002|Period 1|Physician Decision|1|||
127893362|NCT00543439|460231387|FG000|Period 2|Protocol Violation|1|||
127893363|NCT00543439|460231388|FG001|Period 2|Protocol Violation|0|||
127893364|NCT00543439|460231389|FG002|Period 2|Protocol Violation|1|||
127893365|NCT00543439|460231387|FG000|Period 2|Adverse Event|0|||
127893366|NCT00543439|460231388|FG001|Period 2|Adverse Event|1|||
127893367|NCT00543439|460231389|FG002|Period 2|Adverse Event|1|||
127893368|NCT05476679|460231390|FG000|Overall Study|Withdrawal by Subject|0|||
127742255|NCT03024996|459684011|FG001|Overall Study|Study terminated by sponsor|283|||
127742256|NCT03024996|459684010|FG000|Overall Study|Withdrawal by Subject|21|||
127742257|NCT03024996|459684011|FG001|Overall Study|Withdrawal by Subject|36|||
127742258|NCT02106195|459684014|FG000|Overall Study|Adverse Event|2|||
127742259|NCT02106195|459684014|FG000|Overall Study|Protocol Violation|1|||
127742260|NCT04469465|459684015|FG000|Treatment Period 1 (TP1)|Adverse Event|2|||
127742261|NCT04469465|459684016|FG001|Treatment Period 1 (TP1)|Adverse Event|1|||
127742262|NCT04469465|459684015|FG000|Treatment Period 1 (TP1)|Withdrawal by Subject|0|||
127742263|NCT04469465|459684016|FG001|Treatment Period 1 (TP1)|Withdrawal by Subject|1|||
127742264|NCT04469465|459684015|FG000|Treatment Period 2 (TP2)|Adverse Event|1|||
127742265|NCT04469465|459684016|FG001|Treatment Period 2 (TP2)|Adverse Event|1|||
127742266|NCT04469465|459684015|FG000|Long-Term Extension (LTE)|Withdrawal by Subject|3|||
127742267|NCT04469465|459684016|FG001|Long-Term Extension (LTE)|Withdrawal by Subject|0|||
127742268|NCT04469465|459684015|FG000|Long-Term Extension (LTE)|Physician Decision|3|||
127742269|NCT04469465|459684016|FG001|Long-Term Extension (LTE)|Physician Decision|0|||
127742270|NCT04469465|459684015|FG000|Long-Term Extension (LTE)|Noncompliance with study intervention|1|||
127742271|NCT04469465|459684016|FG001|Long-Term Extension (LTE)|Noncompliance with study intervention|0|||
127742272|NCT04469465|459684015|FG000|Long-Term Extension (LTE)|Death|0|||
127742273|NCT04469465|459684016|FG001|Long-Term Extension (LTE)|Death|1|||
127742274|NCT04469465|459684015|FG000|Long-Term Extension (LTE)|Adverse Event|1|||
127742275|NCT04469465|459684016|FG001|Long-Term Extension (LTE)|Adverse Event|1|||
127742276|NCT03568812|459684017|FG000|Overall Study|Physician Decision|0|||
127742277|NCT03568812|459684018|FG001|Overall Study|Physician Decision|1|||
127742278|NCT03194867|459684019|FG000|Overall Study|Incorrect completion of end of study form|0|||
127742279|NCT03194867|459684020|FG001|Overall Study|Incorrect completion of end of study form|0|||
127742280|NCT03194867|459684021|FG002|Overall Study|Incorrect completion of end of study form|1|||
127742281|NCT03194867|459684022|FG003|Overall Study|Incorrect completion of end of study form|0|||
127742282|NCT00464945|459684023|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
127742283|NCT00464945|459684024|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
127742284|NCT00464945|459684023|FG000|Infant Series|Protocol Violation|1|||
127742285|NCT00464945|459684024|FG001|Infant Series|Protocol Violation|0|||
127742286|NCT00464945|459684023|FG000|Infant Series|Lost to Follow-up|1|||
127742287|NCT00464945|459684024|FG001|Infant Series|Lost to Follow-up|0|||
127742288|NCT00464945|459684023|FG000|After Infant Series|Withdrawal by Subject|0|||
127742289|NCT00464945|459684024|FG001|After Infant Series|Withdrawal by Subject|2|||
127742290|NCT00464945|459684023|FG000|Toddler Dose|Lost to Follow-up|0|||
127742291|NCT00464945|459684024|FG001|Toddler Dose|Lost to Follow-up|1|||
127742292|NCT03305809|459684027|FG000|Overall Study|Adverse Event|2|||
127742293|NCT03305809|459684028|FG001|Overall Study|Adverse Event|2|||
127742294|NCT03305809|459684029|FG002|Overall Study|Adverse Event|6|||
127742295|NCT03305809|459684030|FG003|Overall Study|Adverse Event|6|||
127742296|NCT03305809|459684027|FG000|Overall Study|Death|0|||
127742297|NCT03305809|459684028|FG001|Overall Study|Death|0|||
127742298|NCT03305809|459684029|FG002|Overall Study|Death|1|||
127742299|NCT03305809|459684030|FG003|Overall Study|Death|1|||
127742300|NCT03305809|459684027|FG000|Overall Study|Lost to Follow-up|1|||
127742301|NCT03305809|459684028|FG001|Overall Study|Lost to Follow-up|2|||
127742302|NCT03305809|459684029|FG002|Overall Study|Lost to Follow-up|0|||
127742303|NCT03305809|459684030|FG003|Overall Study|Lost to Follow-up|0|||
127742304|NCT03305809|459684027|FG000|Overall Study|Sponsor Decision|1|||
127742305|NCT03305809|459684028|FG001|Overall Study|Sponsor Decision|0|||
127742306|NCT03305809|459684029|FG002|Overall Study|Sponsor Decision|1|||
127742307|NCT03305809|459684030|FG003|Overall Study|Sponsor Decision|8|||
127742308|NCT03305809|459684027|FG000|Overall Study|Physician Decision|0|||
127742309|NCT03305809|459684028|FG001|Overall Study|Physician Decision|0|||
127742310|NCT03305809|459684029|FG002|Overall Study|Physician Decision|2|||
127742311|NCT03305809|459684030|FG003|Overall Study|Physician Decision|4|||
127742312|NCT03305809|459684027|FG000|Overall Study|Progressive Disease|0|||
127742313|NCT03305809|459684028|FG001|Overall Study|Progressive Disease|0|||
127742314|NCT03305809|459684029|FG002|Overall Study|Progressive Disease|1|||
127742315|NCT03305809|459684030|FG003|Overall Study|Progressive Disease|0|||
127742316|NCT03305809|459684027|FG000|Overall Study|Protocol Violation|1|||
127742317|NCT03305809|459684028|FG001|Overall Study|Protocol Violation|0|||
127742318|NCT03305809|459684029|FG002|Overall Study|Protocol Violation|2|||
127742319|NCT03305809|459684030|FG003|Overall Study|Protocol Violation|3|||
127742320|NCT03305809|459684027|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
127742321|NCT03305809|459684028|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
127742322|NCT03305809|459684029|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
127742323|NCT03305809|459684030|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
127742324|NCT03305809|459684027|FG000|Overall Study|Withdrawal by Subject|2|||
127742325|NCT03305809|459684028|FG001|Overall Study|Withdrawal by Subject|4|||
127742326|NCT03305809|459684029|FG002|Overall Study|Withdrawal by Subject|5|||
127742327|NCT03305809|459684030|FG003|Overall Study|Withdrawal by Subject|2|||
127742328|NCT03305809|459684027|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
127742329|NCT03305809|459684028|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
127893369|NCT05476679|460231391|FG001|Overall Study|Withdrawal by Subject|0|||
127893370|NCT05476679|460231392|FG002|Overall Study|Withdrawal by Subject|0|||
127893371|NCT05476679|460231393|FG003|Overall Study|Withdrawal by Subject|1|||
127893372|NCT05476679|460231394|FG004|Overall Study|Withdrawal by Subject|0|||
127893373|NCT05476679|460231390|FG000|Overall Study|Lost to Follow-up|0|||
127742330|NCT03305809|459684029|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
127742331|NCT03305809|459684030|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
127742332|NCT03065933|459684031|FG000|Overall Study|study terminated|5|||
127742333|NCT02536742|459684032|FG000|Overall Study|Did not start protocol therapy|1|||
127742334|NCT02536742|459684032|FG000|Overall Study|Patient determined to have triple-negative breast cancer, thus not having the target disease|1|||
127742335|NCT04629443|459684033|FG000|Overall Study|Adverse Event|2|||
127742336|NCT04629443|459684034|FG001|Overall Study|Adverse Event|1|||
127742337|NCT04629443|459684035|FG002|Overall Study|Adverse Event|2|||
127742338|NCT04629443|459684033|FG000|Overall Study|Progressive Disease|2|||
127742339|NCT04629443|459684034|FG001|Overall Study|Progressive Disease|3|||
127742340|NCT04629443|459684035|FG002|Overall Study|Progressive Disease|3|||
127742341|NCT04629443|459684033|FG000|Overall Study|Physician Decision|1|||
127742342|NCT04629443|459684034|FG001|Overall Study|Physician Decision|3|||
127742343|NCT04629443|459684035|FG002|Overall Study|Physician Decision|0|||
127742344|NCT01547117|459684036|FG000|Overall Study|Physician Decision|0|||
127742345|NCT01547117|459684037|FG001|Overall Study|Physician Decision|1|||
127742346|NCT01547117|459684038|FG002|Overall Study|Physician Decision|1|||
127742347|NCT01547117|459684039|FG003|Overall Study|Physician Decision|3|||
127742348|NCT01547117|459684036|FG000|Overall Study|Withdrawal by Subject|1|||
127742349|NCT01547117|459684037|FG001|Overall Study|Withdrawal by Subject|2|||
127742350|NCT01547117|459684038|FG002|Overall Study|Withdrawal by Subject|1|||
127742351|NCT01547117|459684039|FG003|Overall Study|Withdrawal by Subject|2|||
127742352|NCT01660256|459684042|FG000|Overall Study|Adverse Event|4|||
127742353|NCT01660256|459684043|FG001|Overall Study|Adverse Event|0|||
127742354|NCT01660256|459684044|FG002|Overall Study|Adverse Event|2|||
127742355|NCT01660256|459684042|FG000|Overall Study|Withdrawal by Subject|1|||
127742356|NCT01660256|459684043|FG001|Overall Study|Withdrawal by Subject|0|||
127742357|NCT01660256|459684044|FG002|Overall Study|Withdrawal by Subject|2|||
127742358|NCT00551135|459684047|FG000|Overall Study|Adverse Event|1|||
127742359|NCT00551135|459684048|FG001|Overall Study|Adverse Event|0|||
127742360|NCT00551135|459684049|FG002|Overall Study|Adverse Event|1|||
127742361|NCT00551135|459684050|FG003|Overall Study|Adverse Event|1|||
127742362|NCT00551135|459684047|FG000|Overall Study|Lost to Follow-up|0|||
127742363|NCT00551135|459684048|FG001|Overall Study|Lost to Follow-up|0|||
127742364|NCT00551135|459684049|FG002|Overall Study|Lost to Follow-up|0|||
127742365|NCT00551135|459684050|FG003|Overall Study|Lost to Follow-up|1|||
127742366|NCT00551135|459684047|FG000|Overall Study|Other|3|||
127742367|NCT00551135|459684048|FG001|Overall Study|Other|2|||
127742368|NCT00551135|459684049|FG002|Overall Study|Other|1|||
127742369|NCT00551135|459684050|FG003|Overall Study|Other|2|||
127742370|NCT00551135|459684047|FG000|Overall Study|Withdrawal by Subject|1|||
127742371|NCT00551135|459684048|FG001|Overall Study|Withdrawal by Subject|0|||
127742372|NCT00551135|459684049|FG002|Overall Study|Withdrawal by Subject|3|||
127742373|NCT00551135|459684050|FG003|Overall Study|Withdrawal by Subject|1|||
127742374|NCT00858247|459684051|FG000|Baseline Assessment|Withdrawal by Subject|1|||
127742375|NCT00858247|459684052|FG001|Baseline Assessment|Withdrawal by Subject|1|||
127742376|NCT00858247|459684051|FG000|Baseline Assessment|Poor IV access|1|||
127742377|NCT00858247|459684052|FG001|Baseline Assessment|Poor IV access|0|||
127742378|NCT00858247|459684051|FG000|Baseline Assessment|Protocol Violation|0|||
127742379|NCT00858247|459684052|FG001|Baseline Assessment|Protocol Violation|1|||
127742380|NCT00858247|459684051|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
127742381|NCT00858247|459684052|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
127742382|NCT00585975|459684053|FG000|Overall Study|Withdrawal by Subject|3|||
127742383|NCT00585975|459684054|FG001|Overall Study|Withdrawal by Subject|3|||
127742384|NCT00585975|459684053|FG000|Overall Study|Lost to Follow-up|2|||
127742385|NCT00585975|459684054|FG001|Overall Study|Lost to Follow-up|1|||
127742386|NCT00585975|459684053|FG000|Overall Study|Enrollment met/over-enrolled|10|||
127742387|NCT00585975|459684054|FG001|Overall Study|Enrollment met/over-enrolled|9|||
127742388|NCT01747837|459684055|FG000|Overall Study|Lost to Follow-up|5|||
127742389|NCT01747837|459684056|FG001|Overall Study|Lost to Follow-up|2|||
127742390|NCT01747837|459684055|FG000|Overall Study|Death|4|||
127742391|NCT01747837|459684056|FG001|Overall Study|Death|4|||
127742392|NCT01253447|459684057|FG000|Overall Study|Adverse Event|2|||
127893374|NCT05476679|460231391|FG001|Overall Study|Lost to Follow-up|0|||
127893375|NCT05476679|460231392|FG002|Overall Study|Lost to Follow-up|0|||
127893376|NCT05476679|460231393|FG003|Overall Study|Lost to Follow-up|1|||
127742393|NCT01435798|459684058|FG000|Overall Study|Withdrawal by Subject|1|||
127742394|NCT02299427|459684059|FG000|Overall Study|Withdrawal by Subject|1|||
127742395|NCT02299427|459684060|FG001|Overall Study|Withdrawal by Subject|0|||
127742396|NCT02299427|459684059|FG000|Overall Study|Lost to Follow-up|1|||
127742397|NCT02299427|459684060|FG001|Overall Study|Lost to Follow-up|3|||
127742398|NCT02299427|459684059|FG000|Overall Study|not adherent to dog website use|21|||
127893377|NCT05476679|460231394|FG004|Overall Study|Lost to Follow-up|0|||
127742399|NCT02299427|459684060|FG001|Overall Study|not adherent to dog website use|0|||
127742400|NCT01704547|459684068|FG000|Overall Study|Physician Decision|4|||
127742401|NCT01704547|459684068|FG000|Overall Study|Withdrawal by Subject|1|||
127742402|NCT00937521|459684070|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
127742403|NCT00937521|459684071|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
127742404|NCT00937521|459684072|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
127742405|NCT00937521|459684073|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
127742406|NCT00937521|459684074|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
127742407|NCT00937521|459684075|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
127742408|NCT00937521|459684076|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
127742409|NCT00937521|459684077|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
127742410|NCT00937521|459684070|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
127742411|NCT00937521|459684071|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
127742412|NCT00937521|459684072|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
127742413|NCT00937521|459684073|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
127742414|NCT00937521|459684074|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
127742415|NCT00937521|459684075|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
127742416|NCT00937521|459684076|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
127742417|NCT00937521|459684077|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
127742418|NCT00937521|459684070|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
127742419|NCT00937521|459684071|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
127742420|NCT00937521|459684072|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
127742421|NCT00937521|459684073|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
127742422|NCT00937521|459684074|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
127742423|NCT00937521|459684075|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
127742424|NCT00937521|459684076|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
127742425|NCT00937521|459684077|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
127742426|NCT00937521|459684070|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
127742427|NCT00937521|459684071|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
127742428|NCT00937521|459684072|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
127742429|NCT00937521|459684073|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
127742430|NCT00937521|459684074|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
127742431|NCT00937521|459684075|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
127742432|NCT00937521|459684076|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
127742433|NCT00937521|459684077|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
127742434|NCT00937521|459684070|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
127742435|NCT00937521|459684071|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
127742436|NCT00937521|459684072|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
127742437|NCT00937521|459684073|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
127742438|NCT00937521|459684074|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
127742439|NCT00937521|459684075|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
127742440|NCT00937521|459684076|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
127742441|NCT00937521|459684077|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
127742442|NCT00937521|459684070|FG000|Booster Phase|Adverse Event|0|||
127742443|NCT00937521|459684071|FG001|Booster Phase|Adverse Event|0|||
127742444|NCT00937521|459684072|FG002|Booster Phase|Adverse Event|0|||
127742445|NCT00937521|459684073|FG003|Booster Phase|Adverse Event|0|||
127742446|NCT00937521|459684074|FG004|Booster Phase|Adverse Event|0|||
127742447|NCT00937521|459684075|FG005|Booster Phase|Adverse Event|0|||
127742448|NCT00937521|459684076|FG006|Booster Phase|Adverse Event|1|||
127742449|NCT00937521|459684077|FG007|Booster Phase|Adverse Event|0|||
127742450|NCT00937521|459684070|FG000|Booster Phase|Withdrawal by Subject|1|||
127742451|NCT00937521|459684071|FG001|Booster Phase|Withdrawal by Subject|0|||
127742452|NCT00937521|459684072|FG002|Booster Phase|Withdrawal by Subject|0|||
127742453|NCT00937521|459684073|FG003|Booster Phase|Withdrawal by Subject|1|||
127742454|NCT00937521|459684074|FG004|Booster Phase|Withdrawal by Subject|0|||
127742455|NCT00937521|459684075|FG005|Booster Phase|Withdrawal by Subject|0|||
127742456|NCT00937521|459684076|FG006|Booster Phase|Withdrawal by Subject|0|||
127742457|NCT00937521|459684077|FG007|Booster Phase|Withdrawal by Subject|2|||
127742458|NCT00937521|459684070|FG000|Booster Phase|Lost to Follow-up|2|||
127742459|NCT00937521|459684071|FG001|Booster Phase|Lost to Follow-up|2|||
127742460|NCT00937521|459684072|FG002|Booster Phase|Lost to Follow-up|4|||
127742461|NCT00937521|459684073|FG003|Booster Phase|Lost to Follow-up|2|||
127742462|NCT00937521|459684074|FG004|Booster Phase|Lost to Follow-up|4|||
127742463|NCT00937521|459684075|FG005|Booster Phase|Lost to Follow-up|4|||
127742464|NCT00937521|459684076|FG006|Booster Phase|Lost to Follow-up|3|||
127742465|NCT00937521|459684077|FG007|Booster Phase|Lost to Follow-up|0|||
127893378|NCT01498484|460231397|FG000|Overall Study|Death|6|||
127893379|NCT01498484|460231398|FG001|Overall Study|Death|3|||
127893380|NCT01498484|460231399|FG002|Overall Study|Death|1|||
127893381|NCT01498484|460231400|FG003|Overall Study|Death|1|||
127893382|NCT01498484|460231401|FG004|Overall Study|Death|0|||
127893383|NCT01498484|460231402|FG005|Overall Study|Death|0|||
127893384|NCT01498484|460231403|FG006|Overall Study|Death|10|||
127893385|NCT01498484|460231404|FG007|Overall Study|Death|1|||
127893386|NCT01498484|460231405|FG008|Overall Study|Death|0|||
127893387|NCT01498484|460231397|FG000|Overall Study|Physician Decision|3|||
127893388|NCT01498484|460231398|FG001|Overall Study|Physician Decision|2|||
127893389|NCT01498484|460231399|FG002|Overall Study|Physician Decision|1|||
127893390|NCT01498484|460231400|FG003|Overall Study|Physician Decision|1|||
127893391|NCT01498484|460231401|FG004|Overall Study|Physician Decision|0|||
127893392|NCT01498484|460231402|FG005|Overall Study|Physician Decision|0|||
127893393|NCT01498484|460231403|FG006|Overall Study|Physician Decision|8|||
127893394|NCT01498484|460231404|FG007|Overall Study|Physician Decision|13|||
127893395|NCT01498484|460231405|FG008|Overall Study|Physician Decision|1|||
127893396|NCT01498484|460231397|FG000|Overall Study|Adverse Event|0|||
127893397|NCT01498484|460231398|FG001|Overall Study|Adverse Event|0|||
127893398|NCT01498484|460231399|FG002|Overall Study|Adverse Event|0|||
127893399|NCT01498484|460231400|FG003|Overall Study|Adverse Event|0|||
127893400|NCT01498484|460231401|FG004|Overall Study|Adverse Event|0|||
127893401|NCT01498484|460231402|FG005|Overall Study|Adverse Event|1|||
127893402|NCT01498484|460231403|FG006|Overall Study|Adverse Event|0|||
127893403|NCT01498484|460231404|FG007|Overall Study|Adverse Event|0|||
127893404|NCT01498484|460231405|FG008|Overall Study|Adverse Event|0|||
127893405|NCT01498484|460231397|FG000|Overall Study|Withdrawal by Subject|0|||
127893406|NCT01498484|460231398|FG001|Overall Study|Withdrawal by Subject|0|||
127893407|NCT01498484|460231399|FG002|Overall Study|Withdrawal by Subject|0|||
127893408|NCT01498484|460231400|FG003|Overall Study|Withdrawal by Subject|1|||
127893409|NCT01498484|460231401|FG004|Overall Study|Withdrawal by Subject|0|||
127893410|NCT01498484|460231402|FG005|Overall Study|Withdrawal by Subject|0|||
127893411|NCT01498484|460231403|FG006|Overall Study|Withdrawal by Subject|1|||
127893412|NCT01498484|460231404|FG007|Overall Study|Withdrawal by Subject|0|||
127893413|NCT01498484|460231405|FG008|Overall Study|Withdrawal by Subject|0|||
127742466|NCT00937521|459684070|FG000|Booster Phase|Administrative Reason|0|||
127742467|NCT00937521|459684071|FG001|Booster Phase|Administrative Reason|0|||
127742468|NCT00937521|459684072|FG002|Booster Phase|Administrative Reason|1|||
127742469|NCT00937521|459684073|FG003|Booster Phase|Administrative Reason|0|||
127742470|NCT00937521|459684074|FG004|Booster Phase|Administrative Reason|1|||
127742471|NCT00937521|459684075|FG005|Booster Phase|Administrative Reason|1|||
127742472|NCT00937521|459684076|FG006|Booster Phase|Administrative Reason|0|||
127742473|NCT00937521|459684077|FG007|Booster Phase|Administrative Reason|0|||
127742474|NCT00937521|459684070|FG000|Booster Phase|Protocol Deviation|0|||
127742475|NCT00937521|459684071|FG001|Booster Phase|Protocol Deviation|0|||
127742476|NCT00937521|459684072|FG002|Booster Phase|Protocol Deviation|0|||
127742477|NCT00937521|459684073|FG003|Booster Phase|Protocol Deviation|0|||
127742478|NCT00937521|459684074|FG004|Booster Phase|Protocol Deviation|0|||
127742479|NCT00937521|459684075|FG005|Booster Phase|Protocol Deviation|0|||
127742480|NCT00937521|459684076|FG006|Booster Phase|Protocol Deviation|1|||
127742481|NCT00937521|459684077|FG007|Booster Phase|Protocol Deviation|0|||
127742482|NCT01721746|459684078|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
127742483|NCT01721746|459684079|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
127742484|NCT01721746|459684078|FG000|Pre-Treatment|Withdrawal by Subject|1|||
127742485|NCT01721746|459684079|FG001|Pre-Treatment|Withdrawal by Subject|16|||
127742486|NCT01721746|459684078|FG000|Pre-Treatment|Poor/Non-compliance|1|||
127742487|NCT01721746|459684079|FG001|Pre-Treatment|Poor/Non-compliance|0|||
127742488|NCT01721746|459684078|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
127742489|NCT01721746|459684079|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
127893414|NCT01498484|460231397|FG000|Overall Study|Other|5|||
127893415|NCT01498484|460231398|FG001|Overall Study|Other|2|||
127893416|NCT01498484|460231399|FG002|Overall Study|Other|0|||
127893417|NCT01498484|460231400|FG003|Overall Study|Other|0|||
127893418|NCT01498484|460231401|FG004|Overall Study|Other|1|||
127893419|NCT01498484|460231402|FG005|Overall Study|Other|0|||
127893420|NCT01498484|460231403|FG006|Overall Study|Other|3|||
127893421|NCT01498484|460231404|FG007|Overall Study|Other|0|||
127742490|NCT01721746|459684078|FG000|Treatment|Disease Progression|192|||
127742491|NCT01721746|459684079|FG001|Treatment|Disease Progression|74|||
127742492|NCT01721746|459684078|FG000|Treatment|Study Drug Toxicity|19|||
127742493|NCT01721746|459684079|FG001|Treatment|Study Drug Toxicity|11|||
127893422|NCT01498484|460231405|FG008|Overall Study|Other|1|||
127893423|NCT00319956|460231406|FG000|Overall Study|Death|20|||
127893424|NCT00319956|460231407|FG001|Overall Study|Death|24|||
127893425|NCT00753714|460231409|FG000|Overall Study|Lack of Efficacy|21|||
127893426|NCT00753714|460231410|FG001|Overall Study|Lack of Efficacy|34|||
127893427|NCT00753714|460231409|FG000|Overall Study|Adverse Event|26|||
127893428|NCT00753714|460231410|FG001|Overall Study|Adverse Event|18|||
127742494|NCT01721746|459684078|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
127742495|NCT01721746|459684079|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
127742496|NCT01721746|459684078|FG000|Treatment|Participant request to discontinue Study treatment|26|||
127742497|NCT01721746|459684079|FG001|Treatment|Participant request to discontinue Study treatment|7|||
127742498|NCT01721746|459684078|FG000|Treatment|Participant withdrew consent|4|||
127742499|NCT01721746|459684079|FG001|Treatment|Participant withdrew consent|2|||
127742500|NCT01721746|459684078|FG000|Treatment|Maximum Clinical Benefit|9|||
127742501|NCT01721746|459684079|FG001|Treatment|Maximum Clinical Benefit|3|||
127742502|NCT01721746|459684078|FG000|Treatment|Poor/Non-compliance|2|||
127742503|NCT01721746|459684079|FG001|Treatment|Poor/Non-compliance|0|||
127742504|NCT01721746|459684078|FG000|Treatment|Participant no longer met Study criteria|4|||
127742505|NCT01721746|459684079|FG001|Treatment|Participant no longer met Study criteria|0|||
127742506|NCT01721746|459684078|FG000|Treatment|Other reasons|6|||
127742507|NCT01721746|459684079|FG001|Treatment|Other reasons|2|||
127742508|NCT04358068|459684080|FG000|Overall Study|Did not initiate study treatment|2|||
127742509|NCT04358068|459684081|FG001|Overall Study|Did not initiate study treatment|2|||
127742510|NCT00239681|459684082|FG000|Overall Study|Adverse Event|100|||
127742511|NCT00239681|459684083|FG001|Overall Study|Adverse Event|99|||
127742512|NCT00239681|459684082|FG000|Overall Study|Withdrawal by Subject|458|||
127742513|NCT00239681|459684083|FG001|Overall Study|Withdrawal by Subject|489|||
127742514|NCT00239681|459684082|FG000|Overall Study|Lost to Follow-up|28|||
127742515|NCT00239681|459684083|FG001|Overall Study|Lost to Follow-up|22|||
127742516|NCT00239681|459684082|FG000|Overall Study|Protocol Violation|4|||
127742517|NCT00239681|459684083|FG001|Overall Study|Protocol Violation|4|||
127742518|NCT00239681|459684082|FG000|Overall Study|Physician Decision|13|||
127742519|NCT00239681|459684083|FG001|Overall Study|Physician Decision|17|||
127742520|NCT00239681|459684082|FG000|Overall Study|No information chacked on CaseReportForm|90|||
127742521|NCT00239681|459684083|FG001|Overall Study|No information chacked on CaseReportForm|84|||
127742522|NCT02447718|459684084|FG000|Overall Study|Lost to Follow-up|8|||
127742523|NCT02447718|459684085|FG001|Overall Study|Lost to Follow-up|0|||
127742524|NCT02447718|459684084|FG000|Overall Study|Withdrawal by Subject|3|||
127742525|NCT02447718|459684085|FG001|Overall Study|Withdrawal by Subject|0|||
127742526|NCT02447718|459684084|FG000|Overall Study|Screen Failure|1|||
127742527|NCT02447718|459684085|FG001|Overall Study|Screen Failure|0|||
127742528|NCT03599622|459684086|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
127742529|NCT03599622|459684087|FG001|Pre-Treatment Period|Withdrawal by Subject|1|||
127742530|NCT03599622|459684088|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
127742531|NCT03599622|459684089|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
127742532|NCT03599622|459684086|FG000|Pre-Treatment Period|Other reasons|1|||
127742533|NCT03599622|459684087|FG001|Pre-Treatment Period|Other reasons|1|||
127742534|NCT03599622|459684088|FG002|Pre-Treatment Period|Other reasons|1|||
127742535|NCT03599622|459684089|FG003|Pre-Treatment Period|Other reasons|0|||
127742536|NCT03599622|459684086|FG000|Treatment Period|Adverse Event|11|||
127742537|NCT03599622|459684087|FG001|Treatment Period|Adverse Event|20|||
127742538|NCT03599622|459684088|FG002|Treatment Period|Adverse Event|18|||
127742539|NCT03599622|459684089|FG003|Treatment Period|Adverse Event|2|||
127742540|NCT03599622|459684086|FG000|Treatment Period|Lack of Efficacy|18|||
127742541|NCT03599622|459684087|FG001|Treatment Period|Lack of Efficacy|12|||
127742542|NCT03599622|459684088|FG002|Treatment Period|Lack of Efficacy|13|||
127742543|NCT03599622|459684089|FG003|Treatment Period|Lack of Efficacy|2|||
127742544|NCT03599622|459684086|FG000|Treatment Period|Withdrawal by Subject|5|||
127742545|NCT03599622|459684087|FG001|Treatment Period|Withdrawal by Subject|11|||
127807585|NCT02388295|459915754|FG002|Dose Escalation Week 1|Adverse Event|1|||
127807586|NCT02388295|459915752|FG000|Dose Escalation Week 1|Determined not eligible|1|||
127807587|NCT02388295|459915753|FG001|Dose Escalation Week 1|Determined not eligible|1|||
127807588|NCT02388295|459915754|FG002|Dose Escalation Week 1|Determined not eligible|1|||
127807589|NCT02388295|459915752|FG000|Dose Escalation Week 2|Protocol Violation|0|||
127807590|NCT02388295|459915753|FG001|Dose Escalation Week 2|Protocol Violation|1|||
127807591|NCT02388295|459915754|FG002|Dose Escalation Week 2|Protocol Violation|0|||
127807592|NCT02388295|459915752|FG000|Dose Escalation Week 2|Determined not eligible|1|||
127807593|NCT02388295|459915753|FG001|Dose Escalation Week 2|Determined not eligible|1|||
127807594|NCT02388295|459915754|FG002|Dose Escalation Week 2|Determined not eligible|1|||
127807595|NCT02388295|459915752|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
127807596|NCT02388295|459915753|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
127807597|NCT02388295|459915754|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
127807598|NCT04007159|459915755|FG000|Induction Phase|(missed study visits)|16|||
127807599|NCT04007159|459915755|FG000|Induction Phase|Withdrawal by Subject|4|||
127807600|NCT04007159|459915755|FG000|Induction Phase|Adverse Event|2|||
127807601|NCT04007159|459915755|FG000|Challenge Phase|missed study visits|3|||
127807602|NCT02076165|459915756|FG000|Overall Study|Lost to Follow-up|7|||
127807603|NCT02076165|459915757|FG001|Overall Study|Lost to Follow-up|5|||
127742546|NCT03599622|459684088|FG002|Treatment Period|Withdrawal by Subject|16|||
127742547|NCT03599622|459684089|FG003|Treatment Period|Withdrawal by Subject|1|||
127807604|NCT02076165|459915756|FG000|Overall Study|Refused follow-up assessment|1|||
127807605|NCT02076165|459915757|FG001|Overall Study|Refused follow-up assessment|1|||
127742548|NCT03599622|459684086|FG000|Treatment Period|Other reasons|4|||
127742549|NCT03599622|459684087|FG001|Treatment Period|Other reasons|6|||
127742550|NCT03599622|459684088|FG002|Treatment Period|Other reasons|7|||
127742551|NCT03599622|459684089|FG003|Treatment Period|Other reasons|0|||
127742552|NCT03599622|459684086|FG000|Treatment Period|Lost to Follow-up|1|||
127742553|NCT03599622|459684087|FG001|Treatment Period|Lost to Follow-up|0|||
127742554|NCT03599622|459684088|FG002|Treatment Period|Lost to Follow-up|0|||
127742555|NCT03599622|459684089|FG003|Treatment Period|Lost to Follow-up|0|||
127893429|NCT00753714|460231409|FG000|Overall Study|Protocol Violation|1|||
127893430|NCT00753714|460231410|FG001|Overall Study|Protocol Violation|0|||
127893431|NCT00753714|460231409|FG000|Overall Study|Lost to Follow-up|0|||
127742556|NCT03599622|459684086|FG000|Treatment Period|Study terminated by sponsor|7|||
127742557|NCT03599622|459684087|FG001|Treatment Period|Study terminated by sponsor|20|||
127742558|NCT03599622|459684088|FG002|Treatment Period|Study terminated by sponsor|15|||
127742559|NCT03599622|459684089|FG003|Treatment Period|Study terminated by sponsor|0|||
127742560|NCT03599622|459684086|FG000|Treatment Period|Site terminated by sponsor|0|||
127742561|NCT03599622|459684087|FG001|Treatment Period|Site terminated by sponsor|1|||
127742562|NCT03599622|459684088|FG002|Treatment Period|Site terminated by sponsor|0|||
127742563|NCT03599622|459684089|FG003|Treatment Period|Site terminated by sponsor|0|||
127742564|NCT00770588|459684090|FG000|Overall Study|Adverse Event|9|||
127742565|NCT00770588|459684091|FG001|Overall Study|Adverse Event|2|||
127742566|NCT00770588|459684090|FG000|Overall Study|Death caused by progression of disease|70|||
127742567|NCT00770588|459684091|FG001|Overall Study|Death caused by progression of disease|91|||
127742568|NCT00770588|459684090|FG000|Overall Study|Lost to Follow-up|1|||
127742569|NCT00770588|459684091|FG001|Overall Study|Lost to Follow-up|1|||
127742570|NCT00770588|459684090|FG000|Overall Study|Withdrawal by Subject|1|||
127742571|NCT00770588|459684091|FG001|Overall Study|Withdrawal by Subject|1|||
127742572|NCT00468130|459684093|FG000|Overall Study|Adverse Event|2|||
127742573|NCT00468130|459684094|FG001|Overall Study|Adverse Event|1|||
127742574|NCT00468130|459684093|FG000|Overall Study|Withdrawal by Subject|0|||
127742575|NCT00468130|459684094|FG001|Overall Study|Withdrawal by Subject|1|||
127742576|NCT00436956|459684095|FG000|Overall Study|Not evaluable|1|||
127742577|NCT00436956|459684096|FG001|Overall Study|Not evaluable|0|||
127742578|NCT01006889|459684097|FG000|Overall Study|Withdrawal by Subject|3|||
127742579|NCT02143063|459684098|FG000|Overall Study|Lost to Follow-up|16|||
127742580|NCT02143063|459684099|FG001|Overall Study|Lost to Follow-up|28|||
127742581|NCT02143063|459684100|FG002|Overall Study|Lost to Follow-up|29|||
127742582|NCT02143063|459684098|FG000|Overall Study|Withdrawal by Subject|0|||
127742583|NCT02143063|459684099|FG001|Overall Study|Withdrawal by Subject|1|||
127742584|NCT02143063|459684100|FG002|Overall Study|Withdrawal by Subject|0|||
127742585|NCT02143063|459684098|FG000|Overall Study|Death|0|||
127742586|NCT02143063|459684099|FG001|Overall Study|Death|1|||
127742587|NCT02143063|459684100|FG002|Overall Study|Death|1|||
127742588|NCT00623363|459684103|FG000|Overall Study|Adverse Event|2|||
127742589|NCT00623363|459684104|FG001|Overall Study|Adverse Event|2|||
127742590|NCT01130168|459684106|FG000|Period 1|Withdrawal by Subject|0|||
127742591|NCT01130168|459684107|FG001|Period 1|Withdrawal by Subject|1|||
127742592|NCT01130168|459684108|FG002|Period 1|Withdrawal by Subject|0|||
127742593|NCT01130168|459684109|FG003|Period 1|Withdrawal by Subject|1|||
127742594|NCT01130168|459684110|FG004|Period 1|Withdrawal by Subject|0|||
127742595|NCT01130168|459684111|FG005|Period 1|Withdrawal by Subject|0|||
127742596|NCT01130168|459684106|FG000|Period 1|Discontinued For Other Reason|0|||
127742597|NCT01130168|459684107|FG001|Period 1|Discontinued For Other Reason|0|||
127742598|NCT01130168|459684108|FG002|Period 1|Discontinued For Other Reason|1|||
127742599|NCT01130168|459684109|FG003|Period 1|Discontinued For Other Reason|1|||
127742600|NCT01130168|459684110|FG004|Period 1|Discontinued For Other Reason|0|||
127742601|NCT01130168|459684111|FG005|Period 1|Discontinued For Other Reason|0|||
127742602|NCT01130168|459684106|FG000|Period 1|Adverse Event|0|||
127742603|NCT01130168|459684107|FG001|Period 1|Adverse Event|0|||
127742604|NCT01130168|459684108|FG002|Period 1|Adverse Event|0|||
127742605|NCT01130168|459684109|FG003|Period 1|Adverse Event|1|||
127742606|NCT01130168|459684110|FG004|Period 1|Adverse Event|0|||
127742607|NCT01130168|459684111|FG005|Period 1|Adverse Event|0|||
127742608|NCT01157377|459684114|FG000|Overall Study|Lost to Follow-up|0|||
127742609|NCT01157377|459684115|FG001|Overall Study|Lost to Follow-up|0|||
127742610|NCT01157377|459684116|FG002|Overall Study|Lost to Follow-up|1|||
127742611|NCT01157377|459684117|FG003|Overall Study|Lost to Follow-up|0|||
127742612|NCT01157377|459684118|FG004|Overall Study|Lost to Follow-up|1|||
127742613|NCT01157377|459684119|FG005|Overall Study|Lost to Follow-up|1|||
127742614|NCT01157377|459684120|FG006|Overall Study|Lost to Follow-up|0|||
127742615|NCT01157377|459684114|FG000|Overall Study|Personal Reasons|2|||
127742616|NCT01157377|459684115|FG001|Overall Study|Personal Reasons|1|||
127742617|NCT01157377|459684116|FG002|Overall Study|Personal Reasons|0|||
127742618|NCT01157377|459684117|FG003|Overall Study|Personal Reasons|1|||
127742619|NCT01157377|459684118|FG004|Overall Study|Personal Reasons|0|||
127742620|NCT01157377|459684119|FG005|Overall Study|Personal Reasons|0|||
127742621|NCT01157377|459684120|FG006|Overall Study|Personal Reasons|0|||
127893432|NCT00753714|460231410|FG001|Overall Study|Lost to Follow-up|1|||
127742622|NCT01157377|459684114|FG000|Overall Study|Protocol Violation|0|||
127742623|NCT01157377|459684115|FG001|Overall Study|Protocol Violation|0|||
127742624|NCT01157377|459684116|FG002|Overall Study|Protocol Violation|0|||
127742625|NCT01157377|459684117|FG003|Overall Study|Protocol Violation|0|||
127742626|NCT01157377|459684118|FG004|Overall Study|Protocol Violation|0|||
127742627|NCT01157377|459684119|FG005|Overall Study|Protocol Violation|1|||
127742628|NCT01157377|459684120|FG006|Overall Study|Protocol Violation|0|||
127742629|NCT01157377|459684114|FG000|Overall Study|Lack of Efficacy|0|||
127742630|NCT01157377|459684115|FG001|Overall Study|Lack of Efficacy|0|||
127742631|NCT01157377|459684116|FG002|Overall Study|Lack of Efficacy|0|||
127742632|NCT01157377|459684117|FG003|Overall Study|Lack of Efficacy|0|||
127742633|NCT01157377|459684118|FG004|Overall Study|Lack of Efficacy|0|||
127742634|NCT01157377|459684119|FG005|Overall Study|Lack of Efficacy|0|||
127742635|NCT01157377|459684120|FG006|Overall Study|Lack of Efficacy|1|||
127742636|NCT01157377|459684114|FG000|Overall Study|Other Miscellaneous Reasons|0|||
127742637|NCT01157377|459684115|FG001|Overall Study|Other Miscellaneous Reasons|2|||
127742638|NCT01157377|459684116|FG002|Overall Study|Other Miscellaneous Reasons|0|||
127742639|NCT01157377|459684117|FG003|Overall Study|Other Miscellaneous Reasons|0|||
127742640|NCT01157377|459684118|FG004|Overall Study|Other Miscellaneous Reasons|1|||
127742641|NCT01157377|459684119|FG005|Overall Study|Other Miscellaneous Reasons|1|||
127742642|NCT01157377|459684120|FG006|Overall Study|Other Miscellaneous Reasons|1|||
127742643|NCT02261285|459684121|FG000|Overall Study|Disease progression|0|||
127742644|NCT02261285|459684122|FG001|Overall Study|Disease progression|0|||
127742645|NCT02261285|459684123|FG002|Overall Study|Disease progression|1|||
127742646|NCT02760485|459684124|FG000|Phase 1|Death|3|||
127742647|NCT02760485|459684125|FG001|Phase 1|Death|6|||
127742648|NCT02760485|459684126|FG002|Phase 1|Death|0|||
127742649|NCT02760485|459684124|FG000|Phase 1|Withdrawal by Subject|2|||
127742650|NCT02760485|459684125|FG001|Phase 1|Withdrawal by Subject|0|||
127742651|NCT02760485|459684126|FG002|Phase 1|Withdrawal by Subject|0|||
127742652|NCT02760485|459684124|FG000|Phase 1|Progressive Disease|1|||
127742653|NCT02760485|459684125|FG001|Phase 1|Progressive Disease|0|||
127742654|NCT02760485|459684126|FG002|Phase 1|Progressive Disease|0|||
127742655|NCT02760485|459684124|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
127742656|NCT02760485|459684125|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
127742657|NCT02760485|459684126|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
127742658|NCT02760485|459684124|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
127742659|NCT02760485|459684125|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
127742660|NCT02760485|459684126|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
127742661|NCT02760485|459684124|FG000|Phase 2|Death|0|||
127742662|NCT02760485|459684125|FG001|Phase 2|Death|0|||
127742663|NCT02760485|459684126|FG002|Phase 2|Death|12|||
127742664|NCT02760485|459684124|FG000|Phase 2|Withdrawal by Subject|0|||
127742665|NCT02760485|459684125|FG001|Phase 2|Withdrawal by Subject|0|||
127742666|NCT02760485|459684126|FG002|Phase 2|Withdrawal by Subject|3|||
127742667|NCT02760485|459684124|FG000|Phase 2|Progressive Disease|0|||
127742668|NCT02760485|459684125|FG001|Phase 2|Progressive Disease|0|||
127742669|NCT02760485|459684126|FG002|Phase 2|Progressive Disease|1|||
127742670|NCT02760485|459684124|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
127742671|NCT02760485|459684125|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
127742672|NCT02760485|459684126|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
127742673|NCT01702519|459684127|FG000|Washout Period|Lost to Follow-up|1|||
127742674|NCT01702519|459684128|FG001|Washout Period|Lost to Follow-up|0|||
127742675|NCT01702519|459684127|FG000|Washout Period|Withdrawal by Subject|0|||
127742676|NCT01702519|459684128|FG001|Washout Period|Withdrawal by Subject|2|||
127742677|NCT03738397|459684129|FG000|Overall Study|Adverse Event|3|||
127742678|NCT03738397|459684130|FG001|Overall Study|Adverse Event|7|||
127742679|NCT03738397|459684129|FG000|Overall Study|Withdrawal by Subject|8|||
127742680|NCT03738397|459684130|FG001|Overall Study|Withdrawal by Subject|11|||
127742681|NCT03738397|459684129|FG000|Overall Study|Lost to Follow-up|7|||
127742682|NCT03738397|459684130|FG001|Overall Study|Lost to Follow-up|5|||
127742683|NCT03738397|459684129|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
127742684|NCT03738397|459684130|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
127742685|NCT03738397|459684129|FG000|Overall Study|Other|4|||
127742686|NCT03738397|459684130|FG001|Overall Study|Other|6|||
127742687|NCT00904722|459684133|FG000|Overall Study|Physician Decision|1|||
127742688|NCT01087814|459684134|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
127742689|NCT01087814|459684135|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
127742690|NCT01087814|459684134|FG000|Second Intervention (5 Days)|Physician Decision|1|||
127742691|NCT01087814|459684135|FG001|Second Intervention (5 Days)|Physician Decision|0|||
127742692|NCT01891890|459684136|FG000|Overall Study|Lost to Follow-up|0|||
127742693|NCT01891890|459684137|FG001|Overall Study|Lost to Follow-up|0|||
127742694|NCT01891890|459684138|FG002|Overall Study|Lost to Follow-up|1|||
127742695|NCT01891890|459684136|FG000|Overall Study|Study ended before endpoint reached|7|||
127742696|NCT01891890|459684137|FG001|Overall Study|Study ended before endpoint reached|3|||
127742697|NCT01891890|459684138|FG002|Overall Study|Study ended before endpoint reached|6|||
127742698|NCT01263925|459684145|FG000|Overall Study|Protocol Violation|1|||
127742699|NCT01263925|459684146|FG001|Overall Study|Protocol Violation|0|||
127742700|NCT01263925|459684145|FG000|Overall Study|Lack of Efficacy|0|||
127742701|NCT01263925|459684146|FG001|Overall Study|Lack of Efficacy|1|||
127742702|NCT01263925|459684145|FG000|Overall Study|Adverse Event|23|||
127742703|NCT01263925|459684146|FG001|Overall Study|Adverse Event|22|||
127742704|NCT01263925|459684145|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
127742705|NCT01263925|459684146|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
127742706|NCT01263925|459684145|FG000|Overall Study|Withdrawal by Subject|6|||
127742707|NCT01263925|459684146|FG001|Overall Study|Withdrawal by Subject|8|||
127742708|NCT01263925|459684145|FG000|Overall Study|Other|4|||
127742709|NCT01263925|459684146|FG001|Overall Study|Other|4|||
127742710|NCT01263925|459684145|FG000|Overall Study|Lost to Follow-up|3|||
127742711|NCT01263925|459684146|FG001|Overall Study|Lost to Follow-up|1|||
127742712|NCT01263925|459684145|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
127742713|NCT01263925|459684146|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
127742714|NCT01263925|459684145|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
127742715|NCT01263925|459684146|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
127742716|NCT01263925|459684145|FG000|Overall Study|AE/ Withdrawal|1|||
127742717|NCT01263925|459684146|FG001|Overall Study|AE/ Withdrawal|4|||
127742718|NCT01263925|459684145|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
127742719|NCT01263925|459684146|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
127742720|NCT01263925|459684145|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
127742721|NCT01263925|459684146|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
127742722|NCT01263925|459684145|FG000|Overall Study|Withdrawal/ Not specified|0|||
127742723|NCT01263925|459684146|FG001|Overall Study|Withdrawal/ Not specified|1|||
127742724|NCT03765164|459684151|FG000|Pre-intervention|Withdrawal by Subject|5|||
127742725|NCT03765164|459684152|FG001|Pre-intervention|Withdrawal by Subject|6|||
127742726|NCT03448536|459684154|FG000|Overall Study|Protocol Violation|2|||
127742727|NCT03448536|459684155|FG001|Overall Study|Protocol Violation|0|||
127742728|NCT03448536|459684154|FG000|Overall Study|Pregnancy|1|||
127742729|NCT03448536|459684155|FG001|Overall Study|Pregnancy|0|||
127742730|NCT03448536|459684154|FG000|Overall Study|Withdrawal by Subject|1|||
127742731|NCT03448536|459684155|FG001|Overall Study|Withdrawal by Subject|2|||
127742732|NCT03448536|459684154|FG000|Overall Study|Lost to Follow-up|3|||
127742733|NCT03448536|459684155|FG001|Overall Study|Lost to Follow-up|2|||
127742734|NCT03448536|459684154|FG000|Overall Study|Inadequate pain reporter|1|||
127742735|NCT03448536|459684155|FG001|Overall Study|Inadequate pain reporter|0|||
127742736|NCT03448536|459684154|FG000|Overall Study|Other|3|||
127742737|NCT03448536|459684155|FG001|Overall Study|Other|0|||
127742738|NCT03448536|459684154|FG000|Overall Study|Physician Decision|1|||
127742739|NCT03448536|459684155|FG001|Overall Study|Physician Decision|0|||
127742740|NCT04811339|459684165|FG000|Overall Study|lack of transportation not wanting to return|4|||
127742741|NCT04811339|459684166|FG001|Overall Study|lack of transportation not wanting to return|8|||
127742742|NCT04811339|459684167|FG002|Overall Study|lack of transportation not wanting to return|0|||
127742743|NCT04811339|459684165|FG000|Overall Study|Adverse Event|3|||
127742744|NCT04811339|459684166|FG001|Overall Study|Adverse Event|0|||
127742745|NCT04811339|459684167|FG002|Overall Study|Adverse Event|0|||
127742746|NCT04811339|459684165|FG000|Overall Study|Lost to Follow-up|1|||
127742747|NCT04811339|459684166|FG001|Overall Study|Lost to Follow-up|0|||
127742748|NCT04811339|459684167|FG002|Overall Study|Lost to Follow-up|0|||
127742749|NCT04811339|459684165|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
127742750|NCT04811339|459684166|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
127742751|NCT04811339|459684167|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
127742752|NCT04811339|459684165|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
127742753|NCT04811339|459684166|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
127742754|NCT04811339|459684167|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
127742755|NCT04811339|459684165|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
127742756|NCT04811339|459684166|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
127742757|NCT04811339|459684167|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
127742758|NCT04811339|459684165|FG000|Overall Study|Withdrawal by Subject|0|||
127742759|NCT04811339|459684166|FG001|Overall Study|Withdrawal by Subject|3|||
127742760|NCT04811339|459684167|FG002|Overall Study|Withdrawal by Subject|0|||
127742761|NCT04811339|459684165|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
127742762|NCT04811339|459684166|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
127742763|NCT04811339|459684167|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
127742764|NCT04811339|459684165|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
127742765|NCT04811339|459684166|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
127742766|NCT04811339|459684167|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
127742767|NCT00497874|459686107|FG000|Overall Study|Withdrawal by Subject|48|||
127742768|NCT00497874|459686108|FG001|Overall Study|Withdrawal by Subject|17|||
127742769|NCT00497874|459686107|FG000|Overall Study|Illness|8|||
127893433|NCT00753714|460231409|FG000|Overall Study|Withdrawal by Subject|2|||
127893434|NCT00753714|460231410|FG001|Overall Study|Withdrawal by Subject|1|||
127893435|NCT00753714|460231409|FG000|Overall Study|Death|3|||
127893436|NCT00753714|460231410|FG001|Overall Study|Death|3|||
127893437|NCT00753714|460231409|FG000|Overall Study|Other|7|||
127893438|NCT00753714|460231410|FG001|Overall Study|Other|5|||
127893439|NCT02607800|460231411|FG000|Overall Study|Lost to Follow-up|7|||
127893440|NCT02607800|460231412|FG001|Overall Study|Lost to Follow-up|10|||
127893441|NCT02607800|460231411|FG000|Overall Study|Withdrew Consent|2|||
127893442|NCT02607800|460231412|FG001|Overall Study|Withdrew Consent|0|||
127893443|NCT02607800|460231411|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
127893444|NCT02607800|460231412|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
127893445|NCT02486796|460231413|FG000|Overall Study|Withdrawal by Subject|1|||
127893446|NCT02486796|460231414|FG001|Overall Study|Withdrawal by Subject|1|||
127893447|NCT02486796|460231413|FG000|Overall Study|Physician Decision|1|||
127893448|NCT02486796|460231414|FG001|Overall Study|Physician Decision|0|||
127893449|NCT01185288|460231415|FG000|Overall Study|Adverse Event|7|||
127893450|NCT01185288|460231416|FG001|Overall Study|Adverse Event|6|||
127893451|NCT01185288|460231415|FG000|Overall Study|Withdrawal by Subject|6|||
127893452|NCT01185288|460231416|FG001|Overall Study|Withdrawal by Subject|4|||
127893453|NCT01185288|460231415|FG000|Overall Study|Lost to Follow-up|2|||
127742770|NCT00497874|459686108|FG001|Overall Study|Illness|4|||
127742771|NCT00497874|459686107|FG000|Overall Study|Death|2|||
127742772|NCT00497874|459686108|FG001|Overall Study|Death|4|||
127742773|NCT00497874|459686107|FG000|Overall Study|Unable to contact|52|||
127742774|NCT00497874|459686108|FG001|Overall Study|Unable to contact|67|||
127742775|NCT00497874|459686107|FG000|Overall Study|Unable to schedule|37|||
127742776|NCT00497874|459686108|FG001|Overall Study|Unable to schedule|24|||
127742777|NCT01256671|459686112|FG000|Overall Study|Adverse Event|29|||
127742778|NCT01256671|459686112|FG000|Overall Study|Lost to Follow-up|16|||
127742779|NCT01256671|459686112|FG000|Overall Study|Withdrawal by Subject|31|||
127742780|NCT01256671|459686112|FG000|Overall Study|Physician Decision|3|||
127742781|NCT01256671|459686112|FG000|Overall Study|Lack of Efficacy|4|||
127742782|NCT01256671|459686112|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
127742783|NCT04843579|459686119|FG000|Overall Study|Adverse Event|1|||
127742784|NCT04843579|459686119|FG000|Overall Study|Disease Progression|1|||
127742785|NCT04009629|459686120|FG000|Overall Study|Withdrawal by Subject|2|||
127742786|NCT04009629|459686121|FG001|Overall Study|Withdrawal by Subject|0|||
127742787|NCT02808975|459686123|FG000|Overall Study|Adverse Event|3|||
127893454|NCT01185288|460231416|FG001|Overall Study|Lost to Follow-up|5|||
127893455|NCT01185288|460231415|FG000|Overall Study|Lack of Efficacy|2|||
127893456|NCT01185288|460231416|FG001|Overall Study|Lack of Efficacy|0|||
127893457|NCT01185288|460231415|FG000|Overall Study|Investigator discretion|1|||
127893458|NCT01185288|460231416|FG001|Overall Study|Investigator discretion|0|||
127893459|NCT01185288|460231415|FG000|Overall Study|Did not meet inclusion criteria|1|||
127893460|NCT01185288|460231416|FG001|Overall Study|Did not meet inclusion criteria|0|||
127742788|NCT02808975|459686124|FG001|Overall Study|Adverse Event|4|||
127742789|NCT02808975|459686123|FG000|Overall Study|Withdrew consent|9|||
127742790|NCT02808975|459686124|FG001|Overall Study|Withdrew consent|8|||
127742791|NCT02808975|459686123|FG000|Overall Study|Lost to Follow-up|4|||
127742792|NCT02808975|459686124|FG001|Overall Study|Lost to Follow-up|6|||
127742793|NCT02808975|459686123|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
127742794|NCT02808975|459686124|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
127742795|NCT02808975|459686123|FG000|Overall Study|Other, not specified|5|||
127742796|NCT02808975|459686124|FG001|Overall Study|Other, not specified|1|||
127742797|NCT03602586|459686125|FG000|Overall Study|Withdrawal by Subject|3|||
127742798|NCT00030823|459686128|FG000|Overall Study|Withdrawal by Subject|1|||
127742799|NCT04333147|459686130|FG000|Overall Study|Adverse Event|43|||
127742800|NCT04333147|459686131|FG001|Overall Study|Adverse Event|40|||
127742801|NCT04333147|459686130|FG000|Overall Study|Lack of Efficacy|49|||
127742802|NCT04333147|459686131|FG001|Overall Study|Lack of Efficacy|48|||
127742803|NCT04333147|459686130|FG000|Overall Study|Lost to Follow-up|19|||
127742804|NCT04333147|459686131|FG001|Overall Study|Lost to Follow-up|16|||
127742805|NCT04333147|459686130|FG000|Overall Study|Physician Decision|17|||
127742806|NCT04333147|459686131|FG001|Overall Study|Physician Decision|20|||
127742807|NCT04333147|459686130|FG000|Overall Study|Withdrawal by Subject|65|||
127893461|NCT01185288|460231415|FG000|Overall Study|Noncompliance|0|||
127893462|NCT01185288|460231416|FG001|Overall Study|Noncompliance|1|||
127893463|NCT00278512|460231417|FG000|Overall Study|Death|1|||
127893464|NCT00278512|460231418|FG001|Overall Study|Death|0|||
127893465|NCT01202747|460231419|FG000|Overall Study|Withdrawal by Subject|1|||
127742808|NCT04333147|459686131|FG001|Overall Study|Withdrawal by Subject|68|||
127742809|NCT04333147|459686130|FG000|Overall Study|INVESTIGATOR SITE CLOSED|6|||
127742810|NCT04333147|459686131|FG001|Overall Study|INVESTIGATOR SITE CLOSED|2|||
127742811|NCT04333147|459686130|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|6|||
127893466|NCT01620177|460231420|FG000|Overall Study|Failure at Screening Visit|43|||
127893467|NCT01620177|460231420|FG000|Overall Study|Withdrawal by Subject|26|||
127893468|NCT01620177|460231420|FG000|Overall Study|Lost to Follow-up|7|||
127893469|NCT01620177|460231420|FG000|Overall Study|Physician Decision|2|||
127742812|NCT04333147|459686131|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|9|||
127742813|NCT04333147|459686130|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|1251|||
127893470|NCT01620177|460231420|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
127893471|NCT01626885|460231426|FG000|Overall Study|Adverse Event|8|||
127893472|NCT01626885|460231426|FG000|Overall Study|Withdrawal by Subject|4|||
127742814|NCT04333147|459686131|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1256|||
127742815|NCT03062449|459686132|FG000|Overall Study|Withdrawal by Subject|7|||
127742816|NCT03062449|459686133|FG001|Overall Study|Withdrawal by Subject|1|||
127742817|NCT04702893|459686135|FG000|Overall Study|Other reasons than listed|11|||
127742818|NCT04702893|459686135|FG000|Overall Study|Withdrawal by Subject|3|||
127742819|NCT04702893|459686135|FG000|Overall Study|Lost to Follow-up|7|||
127742820|NCT04702893|459686135|FG000|Overall Study|Death|10|||
127742821|NCT04702893|459686135|FG000|Overall Study|Not treated|6|||
127742822|NCT00408928|459686136|FG000|Overall Study|Withdrawal by Subject|1|||
127742823|NCT00408928|459686136|FG000|Overall Study|Death|1|||
127742824|NCT00408928|459686136|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
127742825|NCT04014790|459686137|FG000|Overall Study|Death|4|||
127893473|NCT00673790|460231427|FG000|Overall Study|Adverse Event|23|||
127893474|NCT00673790|460231428|FG001|Overall Study|Adverse Event|14|||
127893475|NCT00673790|460231429|FG002|Overall Study|Adverse Event|2|||
127893476|NCT00673790|460231427|FG000|Overall Study|Lack of Efficacy|2|||
127742826|NCT04014790|459686137|FG000|Overall Study|Adverse Event|1|||
127742827|NCT04014790|459686137|FG000|Overall Study|Withdrawal by Subject|1|||
127742828|NCT00816556|459686138|FG000|Overall Study|Adverse Event|1|||
127742829|NCT00816556|459686139|FG001|Overall Study|Adverse Event|1|||
127742830|NCT00816556|459686140|FG002|Overall Study|Adverse Event|1|||
127742831|NCT00816556|459686138|FG000|Overall Study|Withdrawal by Subject|1|||
127742832|NCT00816556|459686139|FG001|Overall Study|Withdrawal by Subject|1|||
127742833|NCT00816556|459686140|FG002|Overall Study|Withdrawal by Subject|1|||
127742834|NCT00816556|459686138|FG000|Overall Study|Lost to Follow-up|0|||
127742835|NCT00816556|459686139|FG001|Overall Study|Lost to Follow-up|0|||
127742836|NCT00816556|459686140|FG002|Overall Study|Lost to Follow-up|1|||
127742837|NCT03546816|459686141|FG000|Overall Study|Adverse Event|5|||
127742838|NCT03546816|459686142|FG001|Overall Study|Adverse Event|3|||
127742839|NCT03546816|459686141|FG000|Overall Study|Lack of Efficacy|2|||
127742840|NCT03546816|459686142|FG001|Overall Study|Lack of Efficacy|4|||
127742841|NCT03546816|459686141|FG000|Overall Study|Pregnancy|1|||
127742842|NCT03546816|459686142|FG001|Overall Study|Pregnancy|0|||
127742843|NCT03546816|459686141|FG000|Overall Study|Physician Decision|2|||
127742844|NCT03546816|459686142|FG001|Overall Study|Physician Decision|0|||
127742845|NCT03546816|459686141|FG000|Overall Study|Withdrawal by Subject|8|||
127742846|NCT03546816|459686142|FG001|Overall Study|Withdrawal by Subject|10|||
127742847|NCT03546816|459686141|FG000|Overall Study|Lost to Follow-up|3|||
127742848|NCT03546816|459686142|FG001|Overall Study|Lost to Follow-up|2|||
127742849|NCT02438371|459686143|FG000|Overall Study|Lost to Follow-up|3|||
127742850|NCT02438371|459686144|FG001|Overall Study|Lost to Follow-up|2|||
127742851|NCT02438371|459686143|FG000|Overall Study|Withdrawal by Subject|1|||
127742852|NCT02438371|459686144|FG001|Overall Study|Withdrawal by Subject|1|||
127742853|NCT01161446|459686145|FG000|Overall Study|Lost to Follow-up|18|||
127742854|NCT01161446|459686146|FG001|Overall Study|Lost to Follow-up|14|||
127742855|NCT01161446|459686145|FG000|Overall Study|Withdrawal by Subject|0|||
127742856|NCT01161446|459686146|FG001|Overall Study|Withdrawal by Subject|1|||
127742857|NCT02330562|459686147|FG000|Overall Study|Adverse Event|0|||
127742858|NCT02330562|459686148|FG001|Overall Study|Adverse Event|0|||
127742859|NCT02330562|459686149|FG002|Overall Study|Adverse Event|3|||
127742860|NCT02330562|459686150|FG003|Overall Study|Adverse Event|0|||
127742861|NCT02330562|459686151|FG004|Overall Study|Adverse Event|3|||
127807606|NCT03157531|459915758|FG000|Overall Study|Death|2|||
127807607|NCT03157531|459915758|FG000|Overall Study|Lost to Follow-up|4|||
127807608|NCT03417440|459915765|FG000|Overall Study|Lost to Follow-up|0|||
127807609|NCT03417440|459915766|FG001|Overall Study|Lost to Follow-up|1|||
127807610|NCT03417440|459915767|FG002|Overall Study|Lost to Follow-up|0|||
127807611|NCT03417440|459915768|FG003|Overall Study|Lost to Follow-up|0|||
127807612|NCT03417440|459915769|FG004|Overall Study|Lost to Follow-up|1|||
127742862|NCT02330562|459686152|FG005|Overall Study|Adverse Event|1|||
127742863|NCT02330562|459686153|FG006|Overall Study|Adverse Event|0|||
127742864|NCT02330562|459686154|FG007|Overall Study|Adverse Event|0|||
127742865|NCT02330562|459686155|FG008|Overall Study|Adverse Event|0|||
127742866|NCT02330562|459686156|FG009|Overall Study|Adverse Event|1|||
127742867|NCT02330562|459686157|FG010|Overall Study|Adverse Event|1|||
127742868|NCT02330562|459686147|FG000|Overall Study|Participant decision|1|||
127742869|NCT02330562|459686148|FG001|Overall Study|Participant decision|0|||
127742870|NCT02330562|459686149|FG002|Overall Study|Participant decision|4|||
127742871|NCT02330562|459686150|FG003|Overall Study|Participant decision|1|||
127742872|NCT02330562|459686151|FG004|Overall Study|Participant decision|5|||
127742873|NCT02330562|459686152|FG005|Overall Study|Participant decision|2|||
127807613|NCT03417440|459915770|FG005|Overall Study|Lost to Follow-up|0|||
127807614|NCT03417440|459915771|FG006|Overall Study|Lost to Follow-up|0|||
127893477|NCT00673790|460231428|FG001|Overall Study|Lack of Efficacy|2|||
127893478|NCT00673790|460231429|FG002|Overall Study|Lack of Efficacy|2|||
127893479|NCT00673790|460231427|FG000|Overall Study|Protocol Violation|6|||
127893480|NCT00673790|460231428|FG001|Overall Study|Protocol Violation|9|||
127893481|NCT00673790|460231429|FG002|Overall Study|Protocol Violation|1|||
127893482|NCT00673790|460231427|FG000|Overall Study|Withdrawal by Subject|7|||
127893483|NCT00673790|460231428|FG001|Overall Study|Withdrawal by Subject|4|||
127893484|NCT00673790|460231429|FG002|Overall Study|Withdrawal by Subject|1|||
127893485|NCT00673790|460231427|FG000|Overall Study|Lost to Follow-up|6|||
127893486|NCT00673790|460231428|FG001|Overall Study|Lost to Follow-up|6|||
127742874|NCT02330562|459686153|FG006|Overall Study|Participant decision|0|||
127742875|NCT02330562|459686154|FG007|Overall Study|Participant decision|0|||
127742876|NCT02330562|459686155|FG008|Overall Study|Participant decision|0|||
127742877|NCT02330562|459686156|FG009|Overall Study|Participant decision|3|||
127742878|NCT02330562|459686157|FG010|Overall Study|Participant decision|0|||
127742879|NCT02330562|459686147|FG000|Overall Study|Disease progression|5|||
127742880|NCT02330562|459686148|FG001|Overall Study|Disease progression|3|||
127742881|NCT02330562|459686149|FG002|Overall Study|Disease progression|20|||
127742882|NCT02330562|459686150|FG003|Overall Study|Disease progression|28|||
127742883|NCT02330562|459686151|FG004|Overall Study|Disease progression|23|||
127742884|NCT02330562|459686152|FG005|Overall Study|Disease progression|7|||
127742885|NCT02330562|459686153|FG006|Overall Study|Disease progression|1|||
127742886|NCT02330562|459686154|FG007|Overall Study|Disease progression|1|||
127742887|NCT02330562|459686155|FG008|Overall Study|Disease progression|1|||
127742888|NCT02330562|459686156|FG009|Overall Study|Disease progression|0|||
127742889|NCT02330562|459686157|FG010|Overall Study|Disease progression|5|||
127742890|NCT02330562|459686147|FG000|Overall Study|Other reasons|0|||
127742891|NCT02330562|459686148|FG001|Overall Study|Other reasons|0|||
127742892|NCT02330562|459686149|FG002|Overall Study|Other reasons|0|||
127742893|NCT02330562|459686150|FG003|Overall Study|Other reasons|1|||
127742894|NCT02330562|459686151|FG004|Overall Study|Other reasons|0|||
127742895|NCT02330562|459686152|FG005|Overall Study|Other reasons|0|||
127742896|NCT02330562|459686153|FG006|Overall Study|Other reasons|0|||
127742897|NCT02330562|459686154|FG007|Overall Study|Other reasons|0|||
127742898|NCT02330562|459686155|FG008|Overall Study|Other reasons|0|||
127742899|NCT02330562|459686156|FG009|Overall Study|Other reasons|0|||
127742900|NCT02330562|459686157|FG010|Overall Study|Other reasons|0|||
127742901|NCT02330562|459686147|FG000|Overall Study|Withdrawal by Subject|0|||
127742902|NCT02330562|459686148|FG001|Overall Study|Withdrawal by Subject|0|||
127742903|NCT02330562|459686149|FG002|Overall Study|Withdrawal by Subject|0|||
127742904|NCT02330562|459686150|FG003|Overall Study|Withdrawal by Subject|0|||
127742905|NCT02330562|459686151|FG004|Overall Study|Withdrawal by Subject|0|||
127742906|NCT02330562|459686152|FG005|Overall Study|Withdrawal by Subject|0|||
127742907|NCT02330562|459686153|FG006|Overall Study|Withdrawal by Subject|0|||
127742908|NCT02330562|459686154|FG007|Overall Study|Withdrawal by Subject|0|||
127742909|NCT02330562|459686155|FG008|Overall Study|Withdrawal by Subject|0|||
127742910|NCT02330562|459686156|FG009|Overall Study|Withdrawal by Subject|1|||
127742911|NCT02330562|459686157|FG010|Overall Study|Withdrawal by Subject|0|||
127742912|NCT01162135|459686162|FG000|Overall Study|Withdrawal by Subject|1|||
127742913|NCT01162135|459686162|FG000|Overall Study|Severe back pain|1|||
127742914|NCT01162135|459686162|FG000|Overall Study|Ineligible|1|||
127742915|NCT02088554|459686163|FG000|Overall Study|Exited before procedure|130|||
127742916|NCT02088554|459686163|FG000|Overall Study|Attempted but not implanted|31|||
127742917|NCT02088554|459686163|FG000|Overall Study|Implant not attempted|19|||
127742918|NCT02088554|459686163|FG000|Overall Study|Pending next visit|532|||
127742919|NCT02088554|459686163|FG000|Overall Study|Death|170|||
127742920|NCT02088554|459686163|FG000|Overall Study|Subject Withdrew + Physician Withdrew + Subject Not Implanted With Study Valve|96|||
127893487|NCT00673790|460231429|FG002|Overall Study|Lost to Follow-up|5|||
127893488|NCT00673790|460231427|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
127893489|NCT00673790|460231428|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
127893490|NCT00673790|460231429|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
127893491|NCT00673790|460231427|FG000|Overall Study|Poor compliance|1|||
127893492|NCT00673790|460231428|FG001|Overall Study|Poor compliance|0|||
127742921|NCT02088554|459686163|FG000|Overall Study|Lost to Follow-up|23|||
127742922|NCT02088554|459686163|FG000|Overall Study|Explanted|32|||
127742923|NCT02088554|459686163|FG000|Overall Study|Any other reason not covered by previous categories|11|||
127742924|NCT03898960|459686166|FG000|Overall Study|Death|10|||
127742925|NCT00548847|459686167|FG000|Overall Study|Disease progression|7|||
127742926|NCT01379703|459686168|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
127893493|NCT00673790|460231429|FG002|Overall Study|Poor compliance|0|||
127893494|NCT00673790|460231427|FG000|Overall Study|Participated in two Nebivolol studies|0|||
127742927|NCT01379703|459686169|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
127742928|NCT01379703|459686170|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
127742929|NCT01379703|459686168|FG000|Study Start Through 9 Months|Adverse Event|0|||
127742930|NCT01379703|459686169|FG001|Study Start Through 9 Months|Adverse Event|14|||
127742931|NCT01379703|459686170|FG002|Study Start Through 9 Months|Adverse Event|10|||
127893495|NCT00673790|460231428|FG001|Overall Study|Participated in two Nebivolol studies|0|||
127742932|NCT01379703|459686168|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
127742933|NCT01379703|459686169|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
127742934|NCT01379703|459686170|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
127742935|NCT01379703|459686168|FG000|Study Start Through 9 Months|Treatment Failure|0|||
127742936|NCT01379703|459686169|FG001|Study Start Through 9 Months|Treatment Failure|2|||
127742937|NCT01379703|459686170|FG002|Study Start Through 9 Months|Treatment Failure|2|||
127742938|NCT01379703|459686168|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
127742939|NCT01379703|459686169|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
127742940|NCT01379703|459686170|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
127742941|NCT01379703|459686168|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
127742942|NCT01379703|459686169|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
127742943|NCT01379703|459686170|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
127742944|NCT01379703|459686168|FG000|Study Start Through 9 Months|Medication not available|0|||
127742945|NCT01379703|459686169|FG001|Study Start Through 9 Months|Medication not available|2|||
127742946|NCT01379703|459686170|FG002|Study Start Through 9 Months|Medication not available|1|||
127742947|NCT01379703|459686168|FG000|Study Start Through 9 Months|Poor general condition|0|||
127742948|NCT01379703|459686169|FG001|Study Start Through 9 Months|Poor general condition|1|||
127742949|NCT01379703|459686170|FG002|Study Start Through 9 Months|Poor general condition|0|||
127742950|NCT01379703|459686168|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
127742951|NCT01379703|459686169|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
127742952|NCT01379703|459686170|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
127742953|NCT01379703|459686168|FG000|Study Start Through 9 Months|Reason unknown|2|||
127742954|NCT01379703|459686169|FG001|Study Start Through 9 Months|Reason unknown|31|||
127742955|NCT01379703|459686170|FG002|Study Start Through 9 Months|Reason unknown|24|||
127742956|NCT01379703|459686168|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
127742957|NCT01379703|459686169|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
127742958|NCT01379703|459686170|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
127742959|NCT01379703|459686168|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
127742960|NCT01379703|459686169|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
127742961|NCT01379703|459686170|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
127742962|NCT01379703|459686168|FG000|9 Months Through 18 Months|Adverse Event|0|||
127742963|NCT01379703|459686169|FG001|9 Months Through 18 Months|Adverse Event|6|||
127742964|NCT01379703|459686170|FG002|9 Months Through 18 Months|Adverse Event|0|||
127742965|NCT01379703|459686168|FG000|9 Months Through 18 Months|Treatment failure|0|||
127742966|NCT01379703|459686169|FG001|9 Months Through 18 Months|Treatment failure|5|||
127742967|NCT01379703|459686170|FG002|9 Months Through 18 Months|Treatment failure|0|||
127742968|NCT01379703|459686168|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
127742969|NCT01379703|459686169|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
127742970|NCT01379703|459686170|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
127742971|NCT01379703|459686168|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
127742972|NCT01379703|459686169|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
127742973|NCT01379703|459686170|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
127742974|NCT01379703|459686168|FG000|9 Months Through 18 Months|Fatigue|0|||
127742975|NCT01379703|459686169|FG001|9 Months Through 18 Months|Fatigue|1|||
127742976|NCT01379703|459686170|FG002|9 Months Through 18 Months|Fatigue|0|||
127742977|NCT01379703|459686168|FG000|9 Months Through 18 Months|Reason Unknown|0|||
127742978|NCT01379703|459686169|FG001|9 Months Through 18 Months|Reason Unknown|23|||
127742979|NCT01379703|459686170|FG002|9 Months Through 18 Months|Reason Unknown|0|||
127742980|NCT01316887|459686171|FG000|Overall Study|Adverse Event|13|||
127742981|NCT01316887|459686172|FG001|Overall Study|Adverse Event|21|||
127742982|NCT01316887|459686173|FG002|Overall Study|Adverse Event|17|||
127742983|NCT01316887|459686171|FG000|Overall Study|Lack of Efficacy|9|||
127742984|NCT01316887|459686172|FG001|Overall Study|Lack of Efficacy|3|||
127742985|NCT01316887|459686173|FG002|Overall Study|Lack of Efficacy|1|||
127742986|NCT01316887|459686171|FG000|Overall Study|Protocol Violation|2|||
127742987|NCT01316887|459686172|FG001|Overall Study|Protocol Violation|6|||
127742988|NCT01316887|459686173|FG002|Overall Study|Protocol Violation|6|||
127742989|NCT01316887|459686171|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
127742990|NCT01316887|459686172|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
127742991|NCT01316887|459686173|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
127742992|NCT01316887|459686171|FG000|Overall Study|Study Closed/Terminated|2|||
127742993|NCT01316887|459686172|FG001|Overall Study|Study Closed/Terminated|4|||
127742994|NCT01316887|459686173|FG002|Overall Study|Study Closed/Terminated|3|||
127742995|NCT01316887|459686171|FG000|Overall Study|Lost to Follow-up|1|||
127742996|NCT01316887|459686172|FG001|Overall Study|Lost to Follow-up|7|||
127742997|NCT01316887|459686173|FG002|Overall Study|Lost to Follow-up|5|||
127742998|NCT01316887|459686171|FG000|Overall Study|Withdrawal by Subject|8|||
127742999|NCT01316887|459686172|FG001|Overall Study|Withdrawal by Subject|16|||
127743000|NCT01316887|459686173|FG002|Overall Study|Withdrawal by Subject|15|||
127743001|NCT00813098|459686176|FG000|Overall Study|Adverse Event|2|||
127743002|NCT00813098|459686177|FG001|Overall Study|Adverse Event|4|||
127743003|NCT00813098|459686178|FG002|Overall Study|Adverse Event|1|||
127743004|NCT00813098|459686176|FG000|Overall Study|Withdrawal by Subject|0|||
127743005|NCT00813098|459686177|FG001|Overall Study|Withdrawal by Subject|1|||
127743006|NCT00813098|459686178|FG002|Overall Study|Withdrawal by Subject|0|||
127743007|NCT00813098|459686176|FG000|Overall Study|Inability to complete study procedures|1|||
127743008|NCT00813098|459686177|FG001|Overall Study|Inability to complete study procedures|0|||
127743009|NCT00813098|459686178|FG002|Overall Study|Inability to complete study procedures|0|||
127743010|NCT00813098|459686176|FG000|Overall Study|Lost to Follow-up|0|||
127743011|NCT00813098|459686177|FG001|Overall Study|Lost to Follow-up|1|||
127743012|NCT00813098|459686178|FG002|Overall Study|Lost to Follow-up|0|||
127743013|NCT00813098|459686176|FG000|Overall Study|Protocol Violation|0|||
127743014|NCT00813098|459686177|FG001|Overall Study|Protocol Violation|0|||
127743015|NCT00813098|459686178|FG002|Overall Study|Protocol Violation|1|||
127743016|NCT00813098|459686176|FG000|Overall Study|Principal Investigator decision|0|||
127743017|NCT00813098|459686177|FG001|Overall Study|Principal Investigator decision|1|||
127743018|NCT00813098|459686178|FG002|Overall Study|Principal Investigator decision|0|||
127743019|NCT00813098|459686176|FG000|Overall Study|Withdrew Consent|0|||
127743020|NCT00813098|459686177|FG001|Overall Study|Withdrew Consent|1|||
127743021|NCT00813098|459686178|FG002|Overall Study|Withdrew Consent|0|||
127743022|NCT03470545|459686181|FG000|Overall Study|Death|0|||
127743023|NCT03470545|459686182|FG001|Overall Study|Death|1|||
127743024|NCT03470545|459686181|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
127743025|NCT03470545|459686182|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
127743026|NCT03470545|459686181|FG000|Overall Study|Adverse Event|2|||
127743027|NCT03470545|459686182|FG001|Overall Study|Adverse Event|0|||
127743028|NCT03470545|459686181|FG000|Overall Study|Withdrawal by Subject|1|||
127743029|NCT03470545|459686182|FG001|Overall Study|Withdrawal by Subject|1|||
127743030|NCT03470545|459686181|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
127743031|NCT03470545|459686182|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
127743032|NCT01192776|459686183|FG000|Overall Study|Death|8|||
127743033|NCT01192776|459686184|FG001|Overall Study|Death|15|||
127743034|NCT01192776|459686185|FG002|Overall Study|Death|18|||
127743035|NCT01192776|459686186|FG003|Overall Study|Death|15|||
127743036|NCT01192776|459686183|FG000|Overall Study|Lost to Follow-up|3|||
127743037|NCT01192776|459686184|FG001|Overall Study|Lost to Follow-up|6|||
127743038|NCT01192776|459686185|FG002|Overall Study|Lost to Follow-up|3|||
127743039|NCT01192776|459686186|FG003|Overall Study|Lost to Follow-up|5|||
127743040|NCT02250534|459686191|FG000|Overall Study|Lost to Follow-up|18|||
127743041|NCT02250534|459686192|FG001|Overall Study|Lost to Follow-up|28|||
127743042|NCT02250534|459686193|FG002|Overall Study|Lost to Follow-up|33|||
127743043|NCT02250534|459686191|FG000|Overall Study|Personal reasons|7|||
127743044|NCT02250534|459686192|FG001|Overall Study|Personal reasons|8|||
127743045|NCT02250534|459686193|FG002|Overall Study|Personal reasons|14|||
127743046|NCT02250534|459686191|FG000|Overall Study|Adverse Event|6|||
127743047|NCT02250534|459686192|FG001|Overall Study|Adverse Event|3|||
127743048|NCT02250534|459686193|FG002|Overall Study|Adverse Event|8|||
127743049|NCT02250534|459686191|FG000|Overall Study|incarcerated|2|||
127743050|NCT02250534|459686192|FG001|Overall Study|incarcerated|1|||
127743051|NCT02250534|459686193|FG002|Overall Study|incarcerated|2|||
127743052|NCT02250534|459686191|FG000|Overall Study|Withdrawal by Subject|0|||
127743053|NCT02250534|459686192|FG001|Overall Study|Withdrawal by Subject|1|||
127743054|NCT02250534|459686193|FG002|Overall Study|Withdrawal by Subject|2|||
127743055|NCT02250534|459686191|FG000|Overall Study|Death|0|||
127743056|NCT02250534|459686192|FG001|Overall Study|Death|1|||
127743057|NCT02250534|459686193|FG002|Overall Study|Death|1|||
127743058|NCT02250534|459686191|FG000|Overall Study|Physician Decision|1|||
127743059|NCT02250534|459686192|FG001|Overall Study|Physician Decision|3|||
127743060|NCT02250534|459686193|FG002|Overall Study|Physician Decision|1|||
127743061|NCT02250534|459686191|FG000|Overall Study|Protocol Violation|1|||
127743062|NCT02250534|459686192|FG001|Overall Study|Protocol Violation|0|||
127743063|NCT02250534|459686193|FG002|Overall Study|Protocol Violation|1|||
127743064|NCT02250534|459686191|FG000|Overall Study|Reason unknown|1|||
127743065|NCT02250534|459686192|FG001|Overall Study|Reason unknown|0|||
127743066|NCT02250534|459686193|FG002|Overall Study|Reason unknown|0|||
127743067|NCT00217022|459686195|FG000|Overall Study|Withdrawal by Subject|1|||
127743068|NCT00217022|459686196|FG001|Overall Study|Withdrawal by Subject|1|||
127743069|NCT00832000|459686197|FG000|Overall Study|Adverse Event|2|||
127743070|NCT00832000|459686198|FG001|Overall Study|Adverse Event|0|||
127743071|NCT00832000|459686197|FG000|Overall Study|Withdrawal by Subject|1|||
127743072|NCT00832000|459686198|FG001|Overall Study|Withdrawal by Subject|0|||
127743073|NCT00832000|459686197|FG000|Overall Study|No calls to IVR in either period|1|||
127743074|NCT00832000|459686198|FG001|Overall Study|No calls to IVR in either period|1|||
127743075|NCT00832000|459686197|FG000|Overall Study|No calls to IVR in period 2|2|||
127743076|NCT00832000|459686198|FG001|Overall Study|No calls to IVR in period 2|0|||
127743077|NCT00817336|459686202|FG000|Overall Study|Withdrawal by Subject|1|||
127743078|NCT00817336|459686203|FG001|Overall Study|Withdrawal by Subject|1|||
127743079|NCT02108652|459686204|FG000|Overall Study|Death|253|||
127743080|NCT02108652|459686204|FG000|Overall Study|Lost to Follow-up|2|||
127743081|NCT02108652|459686204|FG000|Overall Study|Withdrawal by Subject|16|||
127743082|NCT02108652|459686204|FG000|Overall Study|Study Terminated By Sponsor|31|||
127743083|NCT02108652|459686204|FG000|Overall Study|Non-Compliance|1|||
127743084|NCT02108652|459686204|FG000|Overall Study|Physician Decision|6|||
127743085|NCT02108652|459686204|FG000|Overall Study|Progression Of Disease|1|||
127743086|NCT01182181|459686205|FG000|First Intervention|Adverse Event|1|||
127743087|NCT01182181|459686206|FG001|First Intervention|Adverse Event|0|||
127743088|NCT01182181|459686205|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
127743089|NCT01182181|459686206|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
127743090|NCT01121913|459686207|FG000|First Intervention Period|Adverse Event|0|||
127743091|NCT01121913|459686208|FG001|First Intervention Period|Adverse Event|0|||
127743092|NCT01121913|459686209|FG002|First Intervention Period|Adverse Event|1|||
127743093|NCT01121913|459686210|FG003|First Intervention Period|Adverse Event|0|||
127743094|NCT01121913|459686207|FG000|First Washout Period|Withdrawal by Subject|1|||
127743095|NCT01121913|459686208|FG001|First Washout Period|Withdrawal by Subject|0|||
127743096|NCT01121913|459686209|FG002|First Washout Period|Withdrawal by Subject|0|||
127743097|NCT01121913|459686210|FG003|First Washout Period|Withdrawal by Subject|0|||
127743098|NCT01121913|459686207|FG000|Second Intervention Period|Adverse Event|0|||
127743099|NCT01121913|459686208|FG001|Second Intervention Period|Adverse Event|0|||
127743100|NCT01121913|459686209|FG002|Second Intervention Period|Adverse Event|1|||
127743101|NCT01121913|459686210|FG003|Second Intervention Period|Adverse Event|0|||
127743102|NCT01121913|459686207|FG000|Second Washout Period|Withdrawal by Subject|0|||
127743103|NCT01121913|459686208|FG001|Second Washout Period|Withdrawal by Subject|0|||
127743104|NCT01121913|459686209|FG002|Second Washout Period|Withdrawal by Subject|1|||
127743105|NCT01121913|459686210|FG003|Second Washout Period|Withdrawal by Subject|0|||
127743106|NCT01121913|459686207|FG000|Third Washout Period|Adverse Event|1|||
127743107|NCT01121913|459686208|FG001|Third Washout Period|Adverse Event|0|||
127743108|NCT01121913|459686209|FG002|Third Washout Period|Adverse Event|0|||
127743109|NCT01121913|459686210|FG003|Third Washout Period|Adverse Event|0|||
127743110|NCT02564718|459686213|FG000|Overall Study|Withdrew from treatment|0|||
127743111|NCT02564718|459686214|FG001|Overall Study|Withdrew from treatment|1|||
127743112|NCT03845075|459686215|FG000|Part 1 - DB|Withdrawal by Subject|1|||
127743113|NCT03845075|459686216|FG001|Part 1 - DB|Withdrawal by Subject|1|||
127743114|NCT03845075|459686217|FG002|Part 1 - DB|Withdrawal by Subject|0|||
127743115|NCT03845075|459686218|FG003|Part 1 - DB|Withdrawal by Subject|0|||
127743116|NCT03845075|459686215|FG000|Part 1 - DB|Adverse Event|0|||
127743117|NCT03845075|459686216|FG001|Part 1 - DB|Adverse Event|1|||
127743118|NCT03845075|459686217|FG002|Part 1 - DB|Adverse Event|0|||
127743119|NCT03845075|459686218|FG003|Part 1 - DB|Adverse Event|0|||
127743120|NCT03845075|459686215|FG000|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|1|||
127743121|NCT03845075|459686216|FG001|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
127743122|NCT03845075|459686217|FG002|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
127743123|NCT03845075|459686218|FG003|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
127743124|NCT00935259|459686219|FG000|Period 1|Administrative (scheduling conflict)|1|||
127743125|NCT00935259|459686220|FG001|Period 1|Administrative (scheduling conflict)|1|||
127743126|NCT01017263|459686221|FG000|Overall Study|not eligible|12|||
127743127|NCT02980705|459686222|FG000|Overall Study|Adverse Event|0|||
127743128|NCT02980705|459686223|FG001|Overall Study|Adverse Event|1|||
127743129|NCT02980705|459686222|FG000|Overall Study|Withdrawal by Subject|6|||
127743130|NCT02980705|459686223|FG001|Overall Study|Withdrawal by Subject|9|||
127743131|NCT02980705|459686222|FG000|Overall Study|withdrew participation|0|||
127743132|NCT02980705|459686223|FG001|Overall Study|withdrew participation|1|||
127743133|NCT02980705|459686222|FG000|Overall Study|Lost to Follow-up|2|||
127743134|NCT02980705|459686223|FG001|Overall Study|Lost to Follow-up|0|||
127743135|NCT04353817|459686224|FG000|Overall Study|Adverse Event|0|||
127743136|NCT04353817|459686225|FG001|Overall Study|Adverse Event|1|||
127743137|NCT00002597|459686226|FG000|Overall Study|Protocol Violation|19|||
127743138|NCT00002597|459686227|FG001|Overall Study|Protocol Violation|17|||
127743139|NCT00002597|459686226|FG000|Overall Study|Withdrawal by Subject|7|||
127743140|NCT00002597|459686227|FG001|Overall Study|Withdrawal by Subject|6|||
127743141|NCT02654132|459686228|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
127743142|NCT02654132|459686229|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
127743143|NCT02654132|459686228|FG000|Treatment Period|Disease progression|43|||
127743144|NCT02654132|459686229|FG001|Treatment Period|Disease progression|38|||
127743145|NCT02654132|459686228|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
127743146|NCT02654132|459686229|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
127743147|NCT02654132|459686228|FG000|Treatment Period|Other reasons|4|||
127743148|NCT02654132|459686229|FG001|Treatment Period|Other reasons|2|||
127743149|NCT02654132|459686228|FG000|Treatment Period|Study drug toxicity|2|||
127743150|NCT02654132|459686229|FG001|Treatment Period|Study drug toxicity|2|||
127743151|NCT02654132|459686228|FG000|Treatment Period|Withdrawal by Subject|2|||
127743152|NCT02654132|459686229|FG001|Treatment Period|Withdrawal by Subject|1|||
127743153|NCT02654132|459686228|FG000|Treatment Period|Maximum Clinical Benefit|0|||
127743154|NCT02654132|459686229|FG001|Treatment Period|Maximum Clinical Benefit|2|||
127743155|NCT02654132|459686228|FG000|Treatment Period|Participant request to discontinue|2|||
127743156|NCT02654132|459686229|FG001|Treatment Period|Participant request to discontinue|0|||
127743157|NCT02654132|459686228|FG000|Treatment Period|Administrative reasons by sponsor|0|||
127743158|NCT02654132|459686229|FG001|Treatment Period|Administrative reasons by sponsor|1|||
127743159|NCT02654132|459686228|FG000|Treatment Period|Death|1|||
127743160|NCT02654132|459686229|FG001|Treatment Period|Death|0|||
127743161|NCT02485899|459686231|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
127743162|NCT02485899|459686232|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
127743163|NCT02485899|459686231|FG000|Overall Study|Withdrawal by Subject|1|||
127743164|NCT02485899|459686232|FG001|Overall Study|Withdrawal by Subject|0|||
127743165|NCT02485899|459686231|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
127743166|NCT02485899|459686232|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
127743167|NCT01918371|459686233|FG000|Overall Study|Missing Data|1|||
127743168|NCT01918371|459686234|FG001|Overall Study|Missing Data|1|||
127743169|NCT01880437|459686235|FG000|Overall Study|Death|12|||
127743170|NCT01880437|459686236|FG001|Overall Study|Death|4|||
127807615|NCT03417440|459915772|FG007|Overall Study|Lost to Follow-up|0|||
127807616|NCT03417440|459915765|FG000|Overall Study|Withdrawal by Subject|2|||
127807617|NCT03417440|459915766|FG001|Overall Study|Withdrawal by Subject|0|||
127807618|NCT03417440|459915767|FG002|Overall Study|Withdrawal by Subject|2|||
127743171|NCT01880437|459686237|FG002|Overall Study|Death|17|||
127743172|NCT01880437|459686235|FG000|Overall Study|Study terminated by Sponsor|3|||
127743173|NCT01880437|459686236|FG001|Overall Study|Study terminated by Sponsor|0|||
127743174|NCT01880437|459686237|FG002|Overall Study|Study terminated by Sponsor|2|||
127743175|NCT00823836|459686238|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
127743176|NCT00823836|459686239|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
127743177|NCT00823836|459686238|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
127743178|NCT00823836|459686239|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
127743179|NCT00823836|459686238|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
127743180|NCT00823836|459686239|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
127743181|NCT00823836|459686238|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
127743182|NCT00823836|459686239|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
127743183|NCT00823836|459686238|FG000|Long-term Phase|Adverse Event|3|||
127743184|NCT00823836|459686239|FG001|Long-term Phase|Adverse Event|2|||
127743185|NCT00823836|459686238|FG000|Long-term Phase|Physician Decision|1|||
127743186|NCT00823836|459686239|FG001|Long-term Phase|Physician Decision|2|||
127743187|NCT00823836|459686238|FG000|Long-term Phase|Withdrawal by Subject|1|||
127743188|NCT00823836|459686239|FG001|Long-term Phase|Withdrawal by Subject|1|||
127743189|NCT04354168|459686244|FG000|Overall Study|Lost to Follow-up|22|||
127743190|NCT01438840|459686247|FG000|Core Study|Adverse Event|0|||
127807619|NCT03417440|459915768|FG003|Overall Study|Withdrawal by Subject|1|||
127807620|NCT03417440|459915769|FG004|Overall Study|Withdrawal by Subject|1|||
127807621|NCT03417440|459915770|FG005|Overall Study|Withdrawal by Subject|0|||
127807622|NCT03417440|459915771|FG006|Overall Study|Withdrawal by Subject|0|||
127807623|NCT03417440|459915772|FG007|Overall Study|Withdrawal by Subject|1|||
127807624|NCT00238264|459915775|FG000|Overall Study|Death|7|||
127807625|NCT00238264|459915775|FG000|Overall Study|Lost to Follow-up|18|||
127807626|NCT00238264|459915775|FG000|Overall Study|Withdrawal by Subject|4|||
127807627|NCT00238264|459915775|FG000|Overall Study|Ineligible|7|||
127807628|NCT02706938|459915776|FG000|First Period, 6 Weeks|Adverse Event|8|||
127807629|NCT02706938|459915777|FG001|First Period, 6 Weeks|Adverse Event|0|||
127807630|NCT02706938|459915776|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
127807631|NCT02706938|459915777|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
127807632|NCT02706938|459915776|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
127807633|NCT02706938|459915777|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
127807634|NCT02706938|459915776|FG000|Second Period, 6 Weeks|Adverse Event|0|||
127893496|NCT00673790|460231429|FG002|Overall Study|Participated in two Nebivolol studies|1|||
127893497|NCT00673790|460231427|FG000|Overall Study|Unconfirmed pregnancy|0|||
127893498|NCT00673790|460231428|FG001|Overall Study|Unconfirmed pregnancy|1|||
127893499|NCT00673790|460231429|FG002|Overall Study|Unconfirmed pregnancy|0|||
127893500|NCT00673790|460231427|FG000|Overall Study|Randomization criteria not met|0|||
127893501|NCT00673790|460231428|FG001|Overall Study|Randomization criteria not met|1|||
127893502|NCT00673790|460231429|FG002|Overall Study|Randomization criteria not met|0|||
127893503|NCT01533428|460231432|FG000|Overall Study|Adverse Event|0|||
127743191|NCT01438840|459686248|FG001|Core Study|Adverse Event|3|||
127743192|NCT01438840|459686249|FG002|Core Study|Adverse Event|0|||
127743193|NCT01438840|459686247|FG000|Core Study|Lack of Efficacy|15|||
127743194|NCT01438840|459686248|FG001|Core Study|Lack of Efficacy|7|||
127743195|NCT01438840|459686249|FG002|Core Study|Lack of Efficacy|0|||
127743196|NCT01438840|459686247|FG000|Core Study|Withdrawal of consent|1|||
127743197|NCT01438840|459686248|FG001|Core Study|Withdrawal of consent|0|||
127807635|NCT02706938|459915777|FG001|Second Period, 6 Weeks|Adverse Event|7|||
127807636|NCT02706938|459915776|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
127807637|NCT02706938|459915777|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
127807638|NCT01838044|459915778|FG000|Overall Study|Adverse Event|4|||
127743198|NCT01438840|459686249|FG002|Core Study|Withdrawal of consent|0|||
127743199|NCT01438840|459686247|FG000|Extension Phase|Adverse Event|0|||
127743200|NCT01438840|459686248|FG001|Extension Phase|Adverse Event|0|||
127743201|NCT01438840|459686249|FG002|Extension Phase|Adverse Event|3|||
127743202|NCT01438840|459686247|FG000|Extension Phase|Lost to Follow-up|0|||
127743203|NCT01438840|459686248|FG001|Extension Phase|Lost to Follow-up|0|||
127743204|NCT01438840|459686249|FG002|Extension Phase|Lost to Follow-up|1|||
127743205|NCT01438840|459686247|FG000|Extension Phase|Withdrawal by Subject|0|||
127743206|NCT01438840|459686248|FG001|Extension Phase|Withdrawal by Subject|0|||
127743207|NCT01438840|459686249|FG002|Extension Phase|Withdrawal by Subject|3|||
127743208|NCT01438840|459686247|FG000|Extension Phase|Lack of Efficacy|0|||
127743209|NCT01438840|459686248|FG001|Extension Phase|Lack of Efficacy|0|||
127743210|NCT01438840|459686249|FG002|Extension Phase|Lack of Efficacy|2|||
127743211|NCT01438840|459686247|FG000|Extension Phase|Other|0|||
127743212|NCT01438840|459686248|FG001|Extension Phase|Other|0|||
127743213|NCT01438840|459686249|FG002|Extension Phase|Other|1|||
127743214|NCT02062645|459686252|FG000|Overall Study|Adverse Event|2|||
127743215|NCT02062645|459686252|FG000|Overall Study|Protocol Violation|8|||
127743216|NCT02062645|459686252|FG000|Overall Study|Lost to Follow-up|5|||
127743217|NCT02804399|459686253|FG000|Period 2|Adverse Event|0|||
127743218|NCT02804399|459686254|FG001|Period 2|Adverse Event|1|||
127743219|NCT01774305|459686255|FG000|Overall Study|Physician Decision|1|||
127743220|NCT01774305|459686256|FG001|Overall Study|Physician Decision|0|||
127743221|NCT04211389|459686257|FG000|Overall Study|Adverse Event|1|||
127743222|NCT04211389|459686258|FG001|Overall Study|Adverse Event|2|||
127743223|NCT04211389|459686257|FG000|Overall Study|Lost to Follow-up|15|||
127743224|NCT04211389|459686258|FG001|Overall Study|Lost to Follow-up|7|||
127743225|NCT04211389|459686257|FG000|Overall Study|Protocol Violation|0|||
127743226|NCT04211389|459686258|FG001|Overall Study|Protocol Violation|1|||
127743227|NCT04211389|459686257|FG000|Overall Study|Withdrawal by Subject|10|||
127743228|NCT04211389|459686258|FG001|Overall Study|Withdrawal by Subject|11|||
127743229|NCT01062971|459686264|FG000|Overall Study|Protocol Violation|1|||
127743230|NCT01062971|459686265|FG001|Overall Study|Protocol Violation|3|||
127743231|NCT01062971|459686264|FG000|Overall Study|Lost to Follow-up|3|||
127743232|NCT01062971|459686265|FG001|Overall Study|Lost to Follow-up|4|||
127743233|NCT01530087|459686266|FG000|Overall Study|Physician Decision|2|||
127743234|NCT05523219|459686267|FG000|Overall Study|Wrong inclusion|1|||
127743235|NCT05523219|459686267|FG000|Overall Study|Lost to Follow-up|7|||
127743236|NCT01182207|459686268|FG000|First Intervention|Positive Hepatitis Results|0|||
127743237|NCT01182207|459686269|FG001|First Intervention|Positive Hepatitis Results|1|||
127743238|NCT01182207|459686268|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
127743239|NCT01182207|459686269|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
127743240|NCT04680637|459686270|FG000|Overall Study|Lost to Follow-up|0|||
127743241|NCT04680637|459686271|FG001|Overall Study|Lost to Follow-up|1|||
127743242|NCT04680637|459686272|FG002|Overall Study|Lost to Follow-up|0|||
127743243|NCT04680637|459686273|FG003|Overall Study|Lost to Follow-up|1|||
127743244|NCT04680637|459686270|FG000|Overall Study|Death|1|||
127743245|NCT04680637|459686271|FG001|Overall Study|Death|0|||
127743246|NCT04680637|459686272|FG002|Overall Study|Death|0|||
127743247|NCT04680637|459686273|FG003|Overall Study|Death|0|||
127743248|NCT04680637|459686270|FG000|Overall Study|Withdrawal by Subject|7|||
127743249|NCT04680637|459686271|FG001|Overall Study|Withdrawal by Subject|10|||
127743250|NCT04680637|459686272|FG002|Overall Study|Withdrawal by Subject|17|||
127743251|NCT04680637|459686273|FG003|Overall Study|Withdrawal by Subject|15|||
127743252|NCT04680637|459686270|FG000|Overall Study|Decision by Sponsor|21|||
127743253|NCT04680637|459686271|FG001|Overall Study|Decision by Sponsor|15|||
127743254|NCT04680637|459686272|FG002|Overall Study|Decision by Sponsor|7|||
127743255|NCT04680637|459686273|FG003|Overall Study|Decision by Sponsor|32|||
127743256|NCT02037256|459686276|FG000|Overall Study|Protocol Violation|0|||
127743257|NCT02037256|459686277|FG001|Overall Study|Protocol Violation|1|||
127743258|NCT02037256|459686276|FG000|Overall Study|Withdrawn prior to Velcade|0|||
127743259|NCT02037256|459686277|FG001|Overall Study|Withdrawn prior to Velcade|2|||
127743260|NCT04398368|459688056|FG000|Overall Study|Withdrawal by Subject|2|||
127743261|NCT00891046|459688061|FG000|Overall Study|Protocol Violation|1|||
127743262|NCT00891046|459688062|FG001|Overall Study|Protocol Violation|1|||
127743263|NCT00891046|459688063|FG002|Overall Study|Protocol Violation|0|||
127743264|NCT00891046|459688064|FG003|Overall Study|Protocol Violation|0|||
127743265|NCT00891046|459688065|FG004|Overall Study|Protocol Violation|1|||
127743266|NCT00891046|459688061|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
127743267|NCT00891046|459688062|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
127743268|NCT00891046|459688063|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
127743269|NCT00891046|459688064|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
127743270|NCT00891046|459688065|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
127743271|NCT00891046|459688061|FG000|Overall Study|Administrative problems|0|||
127743272|NCT00891046|459688062|FG001|Overall Study|Administrative problems|0|||
127743273|NCT00891046|459688063|FG002|Overall Study|Administrative problems|0|||
127893504|NCT01533428|460231433|FG001|Overall Study|Adverse Event|1|||
127893505|NCT01533428|460231432|FG000|Overall Study|Lost to Follow-up|2|||
127893506|NCT01533428|460231433|FG001|Overall Study|Lost to Follow-up|1|||
127893507|NCT01533428|460231432|FG000|Overall Study|Withdrawal by Subject|7|||
127893508|NCT01533428|460231433|FG001|Overall Study|Withdrawal by Subject|6|||
127893509|NCT01364870|460231434|FG000|Overall Study|Withdrawal by Subject|13|||
127893510|NCT01364870|460231435|FG001|Overall Study|Withdrawal by Subject|24|||
127743274|NCT00891046|459688064|FG003|Overall Study|Administrative problems|0|||
127743275|NCT00891046|459688065|FG004|Overall Study|Administrative problems|1|||
127743276|NCT00891046|459688061|FG000|Overall Study|Participant no longer required drug|0|||
127743277|NCT00891046|459688062|FG001|Overall Study|Participant no longer required drug|2|||
127743278|NCT00891046|459688063|FG002|Overall Study|Participant no longer required drug|0|||
127743279|NCT00891046|459688064|FG003|Overall Study|Participant no longer required drug|0|||
127743280|NCT00891046|459688065|FG004|Overall Study|Participant no longer required drug|1|||
127743281|NCT00891046|459688061|FG000|Overall Study|Adverse Event|4|||
127743282|NCT00891046|459688062|FG001|Overall Study|Adverse Event|3|||
127743283|NCT00891046|459688063|FG002|Overall Study|Adverse Event|2|||
127743284|NCT00891046|459688064|FG003|Overall Study|Adverse Event|0|||
127743285|NCT00891046|459688065|FG004|Overall Study|Adverse Event|14|||
127743286|NCT00891046|459688061|FG000|Overall Study|Withdrawal by Subject|2|||
127743287|NCT00891046|459688062|FG001|Overall Study|Withdrawal by Subject|1|||
127743288|NCT00891046|459688063|FG002|Overall Study|Withdrawal by Subject|2|||
127743289|NCT00891046|459688064|FG003|Overall Study|Withdrawal by Subject|1|||
127743290|NCT00891046|459688065|FG004|Overall Study|Withdrawal by Subject|1|||
127743291|NCT00891046|459688061|FG000|Overall Study|Lost to Follow-up|0|||
127743292|NCT00891046|459688062|FG001|Overall Study|Lost to Follow-up|0|||
127743293|NCT00891046|459688063|FG002|Overall Study|Lost to Follow-up|0|||
127743294|NCT00891046|459688064|FG003|Overall Study|Lost to Follow-up|0|||
127743295|NCT00891046|459688065|FG004|Overall Study|Lost to Follow-up|1|||
127743296|NCT04523207|459688068|FG000|Overall Study|Adverse Event|5|||
127743297|NCT04523207|459688069|FG001|Overall Study|Adverse Event|1|||
127743298|NCT04523207|459688068|FG000|Overall Study|Lost to Follow-up|2|||
127743299|NCT04523207|459688069|FG001|Overall Study|Lost to Follow-up|0|||
127743300|NCT04523207|459688068|FG000|Overall Study|Withdrawal by Subject|2|||
127743301|NCT04523207|459688069|FG001|Overall Study|Withdrawal by Subject|0|||
127743302|NCT04523207|459688068|FG000|Overall Study|Progressive Disease|2|||
127743303|NCT04523207|459688069|FG001|Overall Study|Progressive Disease|1|||
127743304|NCT04523207|459688068|FG000|Overall Study|Other|7|||
127743305|NCT04523207|459688069|FG001|Overall Study|Other|1|||
127743306|NCT03113383|459688070|FG000|Overall Study|Death|4|||
127743307|NCT03113383|459688071|FG001|Overall Study|Death|0|||
127743308|NCT01010204|459688075|FG000|Overall Study|Lost to Follow-up|2|||
127743309|NCT01010204|459688076|FG001|Overall Study|Lost to Follow-up|2|||
127743310|NCT01010204|459688075|FG000|Overall Study|Adverse Event|1|||
127743311|NCT01010204|459688076|FG001|Overall Study|Adverse Event|3|||
127743312|NCT01010204|459688075|FG000|Overall Study|Withdrawal by Subject|2|||
127743313|NCT01010204|459688076|FG001|Overall Study|Withdrawal by Subject|3|||
127743314|NCT01010204|459688075|FG000|Overall Study|psychiatric hospitalization|2|||
127743315|NCT01010204|459688076|FG001|Overall Study|psychiatric hospitalization|1|||
127743316|NCT01519778|459688077|FG000|Overall Study|Withdrawal by Subject|3|||
127743317|NCT01519778|459688077|FG000|Overall Study|Lost to Follow-up|10|||
127743318|NCT01519778|459688077|FG000|Overall Study|Physician Decision|1|||
127743319|NCT01657799|459688078|FG000|Overall Study|Adverse Event Related to progression|6|||
127743320|NCT01657799|459688079|FG001|Overall Study|Adverse Event Related to progression|8|||
127743321|NCT01657799|459688080|FG002|Overall Study|Adverse Event Related to progression|12|||
127743322|NCT01657799|459688078|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
127743323|NCT01657799|459688079|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
127743324|NCT01657799|459688080|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
127743325|NCT01657799|459688078|FG000|Overall Study|Withdrawal by Subject|13|||
127743326|NCT01657799|459688079|FG001|Overall Study|Withdrawal by Subject|10|||
127743327|NCT01657799|459688080|FG002|Overall Study|Withdrawal by Subject|10|||
127743328|NCT01657799|459688078|FG000|Overall Study|Lost to Follow-up|1|||
127743329|NCT01657799|459688079|FG001|Overall Study|Lost to Follow-up|0|||
127893511|NCT01364870|460231436|FG002|Overall Study|Withdrawal by Subject|10|||
127893512|NCT01364870|460231434|FG000|Overall Study|Adverse Event|8|||
127743330|NCT01657799|459688080|FG002|Overall Study|Lost to Follow-up|1|||
127743331|NCT01657799|459688078|FG000|Overall Study|Disease Progression|2|||
127743332|NCT01657799|459688079|FG001|Overall Study|Disease Progression|4|||
127743333|NCT01657799|459688080|FG002|Overall Study|Disease Progression|4|||
127743334|NCT01657799|459688078|FG000|Overall Study|Progressive Disease Clinical|7|||
127743335|NCT01657799|459688079|FG001|Overall Study|Progressive Disease Clinical|4|||
127743336|NCT01657799|459688080|FG002|Overall Study|Progressive Disease Clinical|7|||
127743337|NCT01657799|459688078|FG000|Overall Study|Radiographic & Clinical Progression|16|||
127743338|NCT01657799|459688079|FG001|Overall Study|Radiographic & Clinical Progression|11|||
127743339|NCT01657799|459688080|FG002|Overall Study|Radiographic & Clinical Progression|15|||
127743340|NCT01657799|459688078|FG000|Overall Study|Other|52|||
127743341|NCT01657799|459688079|FG001|Overall Study|Other|62|||
127893513|NCT01364870|460231435|FG001|Overall Study|Adverse Event|6|||
127893514|NCT01364870|460231436|FG002|Overall Study|Adverse Event|4|||
127893515|NCT01364870|460231434|FG000|Overall Study|Protocol Violation|1|||
127893516|NCT01364870|460231435|FG001|Overall Study|Protocol Violation|0|||
127743342|NCT01657799|459688080|FG002|Overall Study|Other|49|||
127743343|NCT03021551|459688081|FG000|Overall Study|Equipment Issues|2|||
127743344|NCT03021551|459688081|FG000|Overall Study|Protocol Violation|1|||
127743345|NCT00412880|459688082|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
127743346|NCT00412880|459688082|FG000|Overall Study|Consent withdrawn|1|||
127743347|NCT00412880|459688082|FG000|Overall Study|Adverse Event|1|||
127743348|NCT00412880|459688082|FG000|Overall Study|Progressive disease|20|||
127743349|NCT04599855|459688091|FG000|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
127743350|NCT04599855|459688092|FG001|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|2|||
127743351|NCT04599855|459688093|FG002|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
127743352|NCT04599855|459688091|FG000|Double Blind Period (Day 1 to Day 28)|Adverse Event|2|||
127743353|NCT04599855|459688092|FG001|Double Blind Period (Day 1 to Day 28)|Adverse Event|1|||
127743354|NCT04599855|459688093|FG002|Double Blind Period (Day 1 to Day 28)|Adverse Event|5|||
127743355|NCT04599855|459688091|FG000|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
127743356|NCT04599855|459688092|FG001|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|0|||
127743357|NCT04599855|459688093|FG002|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
127743358|NCT04599855|459688091|FG000|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
127743359|NCT04599855|459688092|FG001|Double Blind Period (Day 1 to Day 28)|Protocol Violation|0|||
127743360|NCT04599855|459688093|FG002|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
127743361|NCT04599855|459688091|FG000|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
127743362|NCT04599855|459688092|FG001|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|1|||
127743363|NCT04599855|459688093|FG002|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
127743364|NCT04599855|459688091|FG000|Double Blind Period (Day 1 to Day 28)|Pregnancy|1|||
127743365|NCT04599855|459688092|FG001|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
127893517|NCT01364870|460231436|FG002|Overall Study|Protocol Violation|0|||
127893518|NCT01200394|460231437|FG000|Overall Study|Adverse Event|0|||
127893519|NCT01200394|460231438|FG001|Overall Study|Adverse Event|14|||
127893520|NCT01200394|460231437|FG000|Overall Study|Death|1|||
127893521|NCT01200394|460231438|FG001|Overall Study|Death|0|||
127893522|NCT01200394|460231437|FG000|Overall Study|Lost to Follow-up|0|||
127893523|NCT01200394|460231438|FG001|Overall Study|Lost to Follow-up|1|||
127893524|NCT01200394|460231437|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
127893525|NCT01200394|460231438|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
127893526|NCT01200394|460231437|FG000|Overall Study|Protocol Violation|0|||
127893527|NCT01200394|460231438|FG001|Overall Study|Protocol Violation|3|||
127893528|NCT01200394|460231437|FG000|Overall Study|Withdrawal by Subject|0|||
127893529|NCT01200394|460231438|FG001|Overall Study|Withdrawal by Subject|5|||
127893530|NCT01200394|460231437|FG000|Overall Study|Other|0|||
127743366|NCT04599855|459688093|FG002|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
127743367|NCT04599855|459688091|FG000|Double Blind Period (Day 1 to Day 28)|Other|1|||
127743368|NCT04599855|459688092|FG001|Double Blind Period (Day 1 to Day 28)|Other|0|||
127893531|NCT01200394|460231438|FG001|Overall Study|Other|1|||
127893532|NCT02666430|460231439|FG000|Period 1|Lost to Follow-up|1|||
127893533|NCT02666430|460231440|FG001|Period 1|Lost to Follow-up|0|||
127893534|NCT02666430|460231439|FG000|Period 1|Adverse Event|0|||
127893535|NCT02666430|460231440|FG001|Period 1|Adverse Event|1|||
127893536|NCT02666430|460231439|FG000|Period 2|Withdrawal by Subject|1|||
127893537|NCT02666430|460231440|FG001|Period 2|Withdrawal by Subject|4|||
127893538|NCT02666430|460231439|FG000|Period 3|Lost to Follow-up|1|||
127893539|NCT02666430|460231440|FG001|Period 3|Lost to Follow-up|0|||
127893540|NCT03828461|460231441|FG000|Overall Study|Lost to Follow-up|1|||
127893541|NCT03828461|460231441|FG000|Overall Study|Withdrawal by Subject|3|||
127893542|NCT00576199|460231442|FG000|Overall Study|Adverse Event|12|||
127893543|NCT00576199|460231442|FG000|Overall Study|Insufficient Therapeutic Response|14|||
127893544|NCT00576199|460231442|FG000|Overall Study|Refused Treatment|2|||
127893545|NCT00576199|460231442|FG000|Overall Study|Reason Unspecified|2|||
127893546|NCT04317053|460231443|FG000|Overall Study|Withdrawn (screen failure)|4|||
127893547|NCT04317053|460231444|FG001|Overall Study|Withdrawn (screen failure)|2|||
127893548|NCT00506753|460233202|FG000|Overall Study|Lost to Follow-up|21|||
127893549|NCT00506753|460233203|FG001|Overall Study|Lost to Follow-up|15|||
127893550|NCT00125359|460233204|FG000|Overall Study|Death|4|||
127893551|NCT00125359|460233204|FG000|Overall Study|Adverse Event|5|||
127893552|NCT00125359|460233204|FG000|Overall Study|Physician Decision|14|||
127893553|NCT02451670|460233205|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
127893554|NCT02451670|460233206|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
127893555|NCT01513551|460233207|FG000|Overall Study|Death|0|||
127743369|NCT04599855|459688093|FG002|Double Blind Period (Day 1 to Day 28)|Other|1|||
127743370|NCT04599855|459688091|FG000|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
127743371|NCT04599855|459688092|FG001|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|1|||
127743372|NCT04599855|459688093|FG002|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
127893556|NCT01513551|460233208|FG001|Overall Study|Death|1|||
127807639|NCT01838044|459915779|FG001|Overall Study|Adverse Event|6|||
127807640|NCT01838044|459915778|FG000|Overall Study|Protocol Violation|3|||
127807641|NCT01838044|459915779|FG001|Overall Study|Protocol Violation|3|||
127807642|NCT01838044|459915778|FG000|Overall Study|Withdrawal by Subject|0|||
127807643|NCT01838044|459915779|FG001|Overall Study|Withdrawal by Subject|2|||
127807644|NCT01838044|459915778|FG000|Overall Study|Insufficient clinical response|1|||
127807645|NCT01838044|459915779|FG001|Overall Study|Insufficient clinical response|2|||
127807646|NCT01838044|459915778|FG000|Overall Study|Medication error without associated AE|0|||
127807647|NCT01838044|459915779|FG001|Overall Study|Medication error without associated AE|1|||
127807648|NCT01838044|459915778|FG000|Overall Study|Lost to Follow-up|0|||
127807649|NCT01838044|459915779|FG001|Overall Study|Lost to Follow-up|2|||
127807650|NCT00860470|459915783|FG000|Overall Study|Death|6|||
127807651|NCT00860470|459915784|FG001|Overall Study|Death|10|||
127807652|NCT00860470|459915783|FG000|Overall Study|Moved away|8|||
127807653|NCT00860470|459915784|FG001|Overall Study|Moved away|10|||
127807654|NCT00860470|459915783|FG000|Overall Study|Lost to Follow-up|34|||
127807655|NCT00860470|459915784|FG001|Overall Study|Lost to Follow-up|39|||
127807656|NCT00723957|459915786|FG000|Overall Study|Adverse event unrelated to study drug|1|||
127807657|NCT00723957|459915787|FG001|Overall Study|Adverse event unrelated to study drug|4|||
127807658|NCT00723957|459915786|FG000|Overall Study|Death|3|||
127807659|NCT00723957|459915787|FG001|Overall Study|Death|4|||
127807660|NCT00723957|459915786|FG000|Overall Study|Disease progression|27|||
127807661|NCT00723957|459915787|FG001|Overall Study|Disease progression|25|||
127807662|NCT00723957|459915786|FG000|Overall Study|Maximum clinical benefit|4|||
127807663|NCT00723957|459915787|FG001|Overall Study|Maximum clinical benefit|5|||
127807664|NCT00723957|459915786|FG000|Overall Study|Investigator decision|1|||
127807665|NCT00723957|459915787|FG001|Overall Study|Investigator decision|1|||
127807666|NCT00723957|459915786|FG000|Overall Study|Study drug toxicity|4|||
127807667|NCT00723957|459915787|FG001|Overall Study|Study drug toxicity|6|||
127807668|NCT00723957|459915786|FG000|Overall Study|Withdrawal by Subject|7|||
127807669|NCT00723957|459915787|FG001|Overall Study|Withdrawal by Subject|5|||
127807670|NCT00723957|459915786|FG000|Overall Study|Reason not analyzed|1|||
127807671|NCT00723957|459915787|FG001|Overall Study|Reason not analyzed|0|||
127807672|NCT00723957|459915786|FG000|Overall Study|Never received treatment|3|||
127807673|NCT00723957|459915787|FG001|Overall Study|Never received treatment|3|||
127807674|NCT00706628|459915789|FG000|Overall Study|Other Adverse Event|16|||
127807675|NCT00706628|459915790|FG001|Overall Study|Other Adverse Event|5|||
127807676|NCT00706628|459915791|FG002|Overall Study|Other Adverse Event|5|||
127807677|NCT00706628|459915792|FG003|Overall Study|Other Adverse Event|2|||
127807678|NCT00706628|459915789|FG000|Overall Study|Non compliant with protocol|0|||
127807679|NCT00706628|459915790|FG001|Overall Study|Non compliant with protocol|1|||
127807680|NCT00706628|459915791|FG002|Overall Study|Non compliant with protocol|0|||
127807681|NCT00706628|459915792|FG003|Overall Study|Non compliant with protocol|0|||
127807682|NCT00706628|459915789|FG000|Overall Study|Consent withdrawn|6|||
127807683|NCT00706628|459915790|FG001|Overall Study|Consent withdrawn|1|||
127807684|NCT00706628|459915791|FG002|Overall Study|Consent withdrawn|3|||
127807685|NCT00706628|459915792|FG003|Overall Study|Consent withdrawn|0|||
127807686|NCT00706628|459915789|FG000|Overall Study|Progressive disease|20|||
127807687|NCT00706628|459915790|FG001|Overall Study|Progressive disease|13|||
127807688|NCT00706628|459915791|FG002|Overall Study|Progressive disease|8|||
127807689|NCT00706628|459915792|FG003|Overall Study|Progressive disease|1|||
127807690|NCT00706628|459915789|FG000|Overall Study|Other than those stated above|4|||
127807691|NCT00706628|459915790|FG001|Overall Study|Other than those stated above|0|||
127807692|NCT00706628|459915791|FG002|Overall Study|Other than those stated above|0|||
127807693|NCT00706628|459915792|FG003|Overall Study|Other than those stated above|0|||
127807694|NCT00706628|459915789|FG000|Overall Study|Not treated|1|||
127807695|NCT00706628|459915790|FG001|Overall Study|Not treated|1|||
127807696|NCT00706628|459915791|FG002|Overall Study|Not treated|0|||
127807697|NCT00706628|459915792|FG003|Overall Study|Not treated|0|||
127807698|NCT01264939|459915793|FG000|Overall Study|Adverse Event|1|||
127807699|NCT01264939|459915794|FG001|Overall Study|Adverse Event|3|||
127807700|NCT01264939|459915793|FG000|Overall Study|Lost to Follow-up|0|||
127807701|NCT01264939|459915794|FG001|Overall Study|Lost to Follow-up|3|||
127807702|NCT01264939|459915793|FG000|Overall Study|Physician Decision|1|||
127807703|NCT01264939|459915794|FG001|Overall Study|Physician Decision|1|||
127807704|NCT01264939|459915793|FG000|Overall Study|Patient/Guardian Decision|8|||
127807705|NCT01264939|459915794|FG001|Overall Study|Patient/Guardian Decision|10|||
127807706|NCT01264939|459915793|FG000|Overall Study|Disease Progression|8|||
127807707|NCT01264939|459915794|FG001|Overall Study|Disease Progression|11|||
127807708|NCT01285349|459915803|FG000|Overall Study|Lost to Follow-up|27|||
127807709|NCT01285349|459915804|FG001|Overall Study|Lost to Follow-up|20|||
127807710|NCT01285349|459915805|FG002|Overall Study|Lost to Follow-up|27|||
127807711|NCT01145560|459915806|FG000|Overall Study|Withdrawal by Subject|2|||
127807712|NCT01145560|459915807|FG001|Overall Study|Withdrawal by Subject|1|||
127807713|NCT01145560|459915808|FG002|Overall Study|Withdrawal by Subject|0|||
127807714|NCT01145560|459915806|FG000|Overall Study|Lost to Follow-up|1|||
127807715|NCT01145560|459915807|FG001|Overall Study|Lost to Follow-up|1|||
127807716|NCT01145560|459915808|FG002|Overall Study|Lost to Follow-up|1|||
127893557|NCT01513551|460233209|FG002|Overall Study|Death|0|||
127807717|NCT01145560|459915806|FG000|Overall Study|No study drug by 24h after organ failure|1|||
127807718|NCT01145560|459915807|FG001|Overall Study|No study drug by 24h after organ failure|0|||
127807719|NCT01145560|459915808|FG002|Overall Study|No study drug by 24h after organ failure|0|||
127807720|NCT01145560|459915806|FG000|Overall Study|Accidental unblinding of study treatment|0|||
127807721|NCT01145560|459915807|FG001|Overall Study|Accidental unblinding of study treatment|1|||
127807722|NCT01145560|459915808|FG002|Overall Study|Accidental unblinding of study treatment|0|||
127807723|NCT01145560|459915806|FG000|Overall Study|False insurance information|0|||
127807724|NCT01145560|459915807|FG001|Overall Study|False insurance information|1|||
127807725|NCT01145560|459915808|FG002|Overall Study|False insurance information|0|||
127807726|NCT01145560|459915806|FG000|Overall Study|Withdrawal of therapy|0|||
127807727|NCT01145560|459915807|FG001|Overall Study|Withdrawal of therapy|0|||
127807728|NCT01145560|459915808|FG002|Overall Study|Withdrawal of therapy|1|||
127807729|NCT02452762|459915814|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
127807730|NCT02452762|459915815|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
127807731|NCT02452762|459915814|FG000|Overall Study|Withdrawal by Subject|1|||
127807732|NCT02452762|459915815|FG001|Overall Study|Withdrawal by Subject|0|||
127807733|NCT00584870|459915816|FG000|Overall Study|Adverse Event|4|||
127807734|NCT00584870|459915817|FG001|Overall Study|Adverse Event|3|||
127807735|NCT00584870|459915818|FG002|Overall Study|Adverse Event|2|||
127807736|NCT00584870|459915816|FG000|Overall Study|Lost to Follow-up|4|||
127807737|NCT00584870|459915817|FG001|Overall Study|Lost to Follow-up|1|||
127807738|NCT00584870|459915818|FG002|Overall Study|Lost to Follow-up|1|||
127807739|NCT00584870|459915816|FG000|Overall Study|Lack of Efficacy|7|||
127807740|NCT00584870|459915817|FG001|Overall Study|Lack of Efficacy|14|||
127807741|NCT00584870|459915818|FG002|Overall Study|Lack of Efficacy|8|||
127807742|NCT00584870|459915816|FG000|Overall Study|Withdrawal by Subject|10|||
127807743|NCT00584870|459915817|FG001|Overall Study|Withdrawal by Subject|5|||
127807744|NCT00584870|459915818|FG002|Overall Study|Withdrawal by Subject|3|||
127807745|NCT00584870|459915816|FG000|Overall Study|Protocol Violation|1|||
127807746|NCT00584870|459915817|FG001|Overall Study|Protocol Violation|1|||
127807747|NCT00584870|459915818|FG002|Overall Study|Protocol Violation|2|||
127807748|NCT00584870|459915816|FG000|Overall Study|Did not met entrance criteria|1|||
127807749|NCT00584870|459915817|FG001|Overall Study|Did not met entrance criteria|0|||
127807750|NCT00584870|459915818|FG002|Overall Study|Did not met entrance criteria|0|||
127807751|NCT00584870|459915816|FG000|Overall Study|Other|2|||
127807752|NCT00584870|459915817|FG001|Overall Study|Other|0|||
127807753|NCT00584870|459915818|FG002|Overall Study|Other|0|||
127807754|NCT00584870|459915816|FG000|Overall Study|Randomized but not treated|0|||
127807755|NCT00584870|459915817|FG001|Overall Study|Randomized but not treated|1|||
127807756|NCT00584870|459915818|FG002|Overall Study|Randomized but not treated|2|||
127807757|NCT02292212|459915819|FG000|ViE Phase|Withdrawal by Subject|1|||
127807758|NCT02292212|459915819|FG000|ViE Phase|Protocol Violation|2|||
127807759|NCT02675075|459915820|FG000|Overall Study|Lost to Follow-up|3|||
127807760|NCT02675075|459915821|FG001|Overall Study|Lost to Follow-up|0|||
127807761|NCT00675597|459915822|FG000|Overall Study|Withdrawal by Subject|3|||
127807762|NCT00631137|459915823|FG000|Overall Study|Withdrawal by Subject|1|||
127807763|NCT00631137|459915824|FG001|Overall Study|Withdrawal by Subject|0|||
127807764|NCT03682120|459915825|FG000|Overall Study|Lost to Follow-up|11|||
127807765|NCT03682120|459915826|FG001|Overall Study|Lost to Follow-up|4|||
127807766|NCT03682120|459915827|FG002|Overall Study|Lost to Follow-up|5|||
127807767|NCT03682120|459915828|FG003|Overall Study|Lost to Follow-up|2|||
127807768|NCT03682120|459915825|FG000|Overall Study|Physician Decision|1|||
127807769|NCT03682120|459915826|FG001|Overall Study|Physician Decision|0|||
127807770|NCT03682120|459915827|FG002|Overall Study|Physician Decision|0|||
127807771|NCT03682120|459915828|FG003|Overall Study|Physician Decision|0|||
127807772|NCT03682120|459915825|FG000|Overall Study|Withdrawal by Subject|1|||
127807773|NCT03682120|459915826|FG001|Overall Study|Withdrawal by Subject|2|||
127807774|NCT03682120|459915827|FG002|Overall Study|Withdrawal by Subject|3|||
127807775|NCT03682120|459915828|FG003|Overall Study|Withdrawal by Subject|0|||
127807776|NCT03682120|459915825|FG000|Overall Study|Death|0|||
127893558|NCT01513551|460233207|FG000|Overall Study|Lost to Follow-up|3|||
127893559|NCT01513551|460233208|FG001|Overall Study|Lost to Follow-up|5|||
127807777|NCT03682120|459915826|FG001|Overall Study|Death|1|||
127807778|NCT03682120|459915827|FG002|Overall Study|Death|0|||
127807779|NCT03682120|459915828|FG003|Overall Study|Death|0|||
127807780|NCT03682120|459915825|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
127807781|NCT03682120|459915826|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
127807782|NCT03682120|459915827|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
127807783|NCT03682120|459915828|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
127807784|NCT01791855|459915829|FG000|Overall Study|Adverse Event|0|||
127807785|NCT01791855|459915830|FG001|Overall Study|Adverse Event|0|||
127807786|NCT01791855|459915831|FG002|Overall Study|Adverse Event|0|||
127807787|NCT01791855|459915832|FG003|Overall Study|Adverse Event|1|||
127807788|NCT01791855|459915829|FG000|Overall Study|Randomized, not treated|0|||
127807789|NCT01791855|459915830|FG001|Overall Study|Randomized, not treated|1|||
127743373|NCT04599855|459688091|FG000|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|8|||
127743374|NCT04599855|459688092|FG001|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|5|||
127743375|NCT04599855|459688093|FG002|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|6|||
127743376|NCT04599855|459688091|FG000|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|10|||
127743377|NCT04599855|459688092|FG001|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|3|||
127743378|NCT04599855|459688093|FG002|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|2|||
127743379|NCT04599855|459688091|FG000|Period Title: OL Period (Week 5 to 16)|Adverse Event|4|||
127743380|NCT04599855|459688092|FG001|Period Title: OL Period (Week 5 to 16)|Adverse Event|2|||
127743381|NCT04599855|459688093|FG002|Period Title: OL Period (Week 5 to 16)|Adverse Event|1|||
127743382|NCT04599855|459688091|FG000|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|4|||
127743383|NCT04599855|459688092|FG001|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|1|||
127743384|NCT04599855|459688093|FG002|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|2|||
127743385|NCT04599855|459688091|FG000|Period Title: OL Period (Week 5 to 16)|Protocol Violation|2|||
127743386|NCT04599855|459688092|FG001|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
127743387|NCT04599855|459688093|FG002|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
127743388|NCT04599855|459688091|FG000|Period Title: OL Period (Week 5 to 16)|Other|5|||
127743389|NCT04599855|459688092|FG001|Period Title: OL Period (Week 5 to 16)|Other|1|||
127743390|NCT04599855|459688093|FG002|Period Title: OL Period (Week 5 to 16)|Other|0|||
127743391|NCT02165397|459688094|FG000|Overall Study|Death|7|||
127743392|NCT02165397|459688095|FG001|Overall Study|Death|10|||
127743393|NCT02165397|459688096|FG002|Overall Study|Death|8|||
127743394|NCT02165397|459688094|FG000|Overall Study|Lost to Follow-up|1|||
127743395|NCT02165397|459688095|FG001|Overall Study|Lost to Follow-up|3|||
127743396|NCT02165397|459688096|FG002|Overall Study|Lost to Follow-up|0|||
127743397|NCT02165397|459688094|FG000|Overall Study|Withdrawal by Subject|6|||
127743398|NCT02165397|459688095|FG001|Overall Study|Withdrawal by Subject|6|||
127743399|NCT02165397|459688096|FG002|Overall Study|Withdrawal by Subject|1|||
127743400|NCT02165397|459688094|FG000|Overall Study|Other, Not Specified|0|||
127743401|NCT02165397|459688095|FG001|Overall Study|Other, Not Specified|0|||
127743402|NCT02165397|459688096|FG002|Overall Study|Other, Not Specified|1|||
127743403|NCT03297398|459688097|FG000|Overall Study|Sponsor's decision|6|||
127743404|NCT03297398|459688098|FG001|Overall Study|Sponsor's decision|9|||
127743405|NCT03297398|459688099|FG002|Overall Study|Sponsor's decision|7|||
127743406|NCT03297398|459688097|FG000|Overall Study|Adverse Event|1|||
127743407|NCT03297398|459688098|FG001|Overall Study|Adverse Event|4|||
127743408|NCT03297398|459688099|FG002|Overall Study|Adverse Event|4|||
127743409|NCT03297398|459688097|FG000|Overall Study|Withdrawal by Subject|1|||
127743410|NCT03297398|459688098|FG001|Overall Study|Withdrawal by Subject|2|||
127743411|NCT03297398|459688099|FG002|Overall Study|Withdrawal by Subject|2|||
127743412|NCT03297398|459688097|FG000|Overall Study|Protocol Violation|0|||
127743413|NCT03297398|459688098|FG001|Overall Study|Protocol Violation|2|||
127743414|NCT03297398|459688099|FG002|Overall Study|Protocol Violation|0|||
127743415|NCT03297398|459688097|FG000|Overall Study|Physician Decision|0|||
127743416|NCT03297398|459688098|FG001|Overall Study|Physician Decision|0|||
127743417|NCT03297398|459688099|FG002|Overall Study|Physician Decision|1|||
127743418|NCT03297398|459688097|FG000|Overall Study|Lost to Follow-up|0|||
127743419|NCT03297398|459688098|FG001|Overall Study|Lost to Follow-up|0|||
127743420|NCT03297398|459688099|FG002|Overall Study|Lost to Follow-up|1|||
127743421|NCT00236184|459688102|FG000|Overall Study|Adverse Event|5|||
127743422|NCT00236184|459688103|FG001|Overall Study|Adverse Event|2|||
127743423|NCT00236184|459688102|FG000|Overall Study|Lack of Efficacy|0|||
127743424|NCT00236184|459688103|FG001|Overall Study|Lack of Efficacy|1|||
127743425|NCT00236184|459688102|FG000|Overall Study|Lost to Follow-up|3|||
127743426|NCT00236184|459688103|FG001|Overall Study|Lost to Follow-up|4|||
127743427|NCT00236184|459688102|FG000|Overall Study|Physician Decision|1|||
127743428|NCT00236184|459688103|FG001|Overall Study|Physician Decision|1|||
127743429|NCT00236184|459688102|FG000|Overall Study|Withdrawal by Subject|3|||
127743430|NCT00236184|459688103|FG001|Overall Study|Withdrawal by Subject|0|||
127743431|NCT00236184|459688102|FG000|Overall Study|Protocol Violation|3|||
127743432|NCT00236184|459688103|FG001|Overall Study|Protocol Violation|0|||
127743433|NCT00236184|459688102|FG000|Overall Study|non-compliance with study drug|2|||
127743434|NCT00236184|459688103|FG001|Overall Study|non-compliance with study drug|1|||
127743435|NCT00236184|459688102|FG000|Overall Study|other|1|||
127743436|NCT00236184|459688103|FG001|Overall Study|other|2|||
127807790|NCT01791855|459915831|FG002|Overall Study|Randomized, not treated|0|||
127807791|NCT01791855|459915832|FG003|Overall Study|Randomized, not treated|0|||
127743437|NCT02312206|459688104|FG000|Overall Study|Adverse Event|3|||
127743438|NCT02312206|459688105|FG001|Overall Study|Adverse Event|6|||
127743439|NCT02312206|459688104|FG000|Overall Study|Withdrawal by Subject|6|||
127743440|NCT02312206|459688105|FG001|Overall Study|Withdrawal by Subject|6|||
127743441|NCT02312206|459688104|FG000|Overall Study|Physician Decision|7|||
127743442|NCT02312206|459688105|FG001|Overall Study|Physician Decision|6|||
127743443|NCT02312206|459688104|FG000|Overall Study|Death|31|||
127743444|NCT02312206|459688105|FG001|Overall Study|Death|36|||
127743445|NCT02312206|459688104|FG000|Overall Study|Study Terminated by Sponsor|81|||
127807792|NCT03437447|459915833|FG000|Treatment Period 1|Withdrawal by Subject|0|||
127893560|NCT01513551|460233209|FG002|Overall Study|Lost to Follow-up|2|||
127893561|NCT01513551|460233207|FG000|Overall Study|Withdrawal by Subject|1|||
127893562|NCT01513551|460233208|FG001|Overall Study|Withdrawal by Subject|0|||
127893563|NCT01513551|460233209|FG002|Overall Study|Withdrawal by Subject|2|||
127893564|NCT01513551|460233207|FG000|Overall Study|Randomized but not vaccinated|0|||
127893565|NCT01513551|460233208|FG001|Overall Study|Randomized but not vaccinated|0|||
127893566|NCT01513551|460233209|FG002|Overall Study|Randomized but not vaccinated|1|||
127893567|NCT00094302|460233211|FG000|Overall Study|Lost to Follow-up|43|||
127893568|NCT00094302|460233212|FG001|Overall Study|Lost to Follow-up|41|||
127893569|NCT00094302|460233211|FG000|Overall Study|Physician Decision|5|||
127893570|NCT00094302|460233212|FG001|Overall Study|Physician Decision|8|||
127893571|NCT00094302|460233211|FG000|Overall Study|Withdrawal by Subject|103|||
127893572|NCT00094302|460233212|FG001|Overall Study|Withdrawal by Subject|111|||
127893573|NCT00094302|460233211|FG000|Overall Study|Death|266|||
127893574|NCT00094302|460233212|FG001|Overall Study|Death|246|||
127893575|NCT02058628|460233217|FG000|Overall Study|Adverse Event|1|||
127807793|NCT03437447|459915834|FG001|Treatment Period 1|Withdrawal by Subject|0|||
127893576|NCT02058628|460233218|FG001|Overall Study|Adverse Event|0|||
127893577|NCT02058628|460233217|FG000|Overall Study|Withdrawal by Subject|2|||
127893578|NCT02058628|460233218|FG001|Overall Study|Withdrawal by Subject|2|||
127893579|NCT02058628|460233217|FG000|Overall Study|Lost to Follow-up|2|||
127893580|NCT02058628|460233218|FG001|Overall Study|Lost to Follow-up|4|||
127893581|NCT02058628|460233217|FG000|Overall Study|Not in time schedule|0|||
127893582|NCT02058628|460233218|FG001|Overall Study|Not in time schedule|1|||
127893583|NCT02058628|460233217|FG000|Overall Study|The visit date was not in timeline|0|||
127893584|NCT02058628|460233218|FG001|Overall Study|The visit date was not in timeline|1|||
127893585|NCT02058628|460233217|FG000|Overall Study|A lot of time for study for participant|1|||
127893586|NCT02058628|460233218|FG001|Overall Study|A lot of time for study for participant|0|||
127893587|NCT02058628|460233217|FG000|Overall Study|Non compliance|1|||
127893588|NCT02058628|460233218|FG001|Overall Study|Non compliance|0|||
127893589|NCT03355742|460233219|FG000|Overall Study|Lost to Follow-up|4|||
127893590|NCT03355742|460233219|FG000|Overall Study|Withdrawal by Subject|29|||
127893591|NCT03355742|460233219|FG000|Overall Study|Physician Decision|6|||
127893592|NCT03355742|460233219|FG000|Overall Study|Death|55|||
127893593|NCT03355742|460233219|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
127893594|NCT04527471|460233222|FG000|Overall Study|Adverse Event|1|||
127893595|NCT04527471|460233223|FG001|Overall Study|Adverse Event|0|||
127893596|NCT04527471|460233222|FG000|Overall Study|Lost to Follow-up|1|||
127893597|NCT04527471|460233223|FG001|Overall Study|Lost to Follow-up|0|||
127893598|NCT00096265|460233231|FG000|Overall Study|Ineligible|1|||
127893599|NCT00096265|460233232|FG001|Overall Study|Ineligible|0|||
127893600|NCT00096265|460233233|FG002|Overall Study|Ineligible|0|||
127893601|NCT01506323|460233234|FG000|Overall Study|Lost to Follow-up|5|||
127893602|NCT01506323|460233235|FG001|Overall Study|Lost to Follow-up|4|||
127893603|NCT01506323|460233234|FG000|Overall Study|Withdrawal by Subject|4|||
127893604|NCT01506323|460233235|FG001|Overall Study|Withdrawal by Subject|4|||
127893605|NCT01506323|460233234|FG000|Overall Study|Lack of Efficacy|1|||
127893606|NCT01506323|460233235|FG001|Overall Study|Lack of Efficacy|3|||
127893607|NCT01506323|460233234|FG000|Overall Study|Moved out of area|5|||
127893608|NCT01506323|460233235|FG001|Overall Study|Moved out of area|2|||
127893609|NCT01506323|460233234|FG000|Overall Study|Schedule or Transportation conflict|8|||
127893610|NCT01506323|460233235|FG001|Overall Study|Schedule or Transportation conflict|0|||
127893611|NCT01506323|460233234|FG000|Overall Study|Started another treatment|1|||
127893612|NCT01506323|460233235|FG001|Overall Study|Started another treatment|0|||
127893613|NCT02891200|460233236|FG000|Overall Study|Lost to Follow-up|31|||
127893614|NCT02891200|460233237|FG001|Overall Study|Lost to Follow-up|36|||
127893615|NCT02891200|460233236|FG000|Overall Study|Death|10|||
127893616|NCT02891200|460233237|FG001|Overall Study|Death|9|||
127807794|NCT03437447|459915835|FG002|Treatment Period 1|Withdrawal by Subject|1|||
127807795|NCT02764541|459915836|FG000|Overall Study|Withdrawal by Subject|0|||
127807796|NCT02764541|459915837|FG001|Overall Study|Withdrawal by Subject|0|||
127807797|NCT02764541|459915838|FG002|Overall Study|Withdrawal by Subject|0|||
127807798|NCT02764541|459915839|FG003|Overall Study|Withdrawal by Subject|0|||
127807799|NCT02764541|459915840|FG004|Overall Study|Withdrawal by Subject|1|||
127807800|NCT02764541|459915841|FG005|Overall Study|Withdrawal by Subject|1|||
127807801|NCT02764541|459915842|FG006|Overall Study|Withdrawal by Subject|0|||
127807802|NCT02764541|459915843|FG007|Overall Study|Withdrawal by Subject|1|||
127807803|NCT02764541|459915836|FG000|Overall Study|Adverse Event|1|||
127893617|NCT02891200|460233236|FG000|Overall Study|Withdrawal by Subject|1|||
127893618|NCT02891200|460233237|FG001|Overall Study|Withdrawal by Subject|4|||
127893619|NCT00444795|460233239|FG000|Overall Study|Not Treated|1|||
127893620|NCT00444795|460233239|FG000|Overall Study|Treated Prior to the Contract Date|2|||
127807804|NCT02764541|459915837|FG001|Overall Study|Adverse Event|0|||
127807805|NCT02764541|459915838|FG002|Overall Study|Adverse Event|0|||
127807806|NCT02764541|459915839|FG003|Overall Study|Adverse Event|0|||
127893621|NCT00988169|460233240|FG000|Overall Study|Withdrawal by Subject|1|||
127893622|NCT02710071|460233245|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
127893623|NCT02710071|460233246|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
127893624|NCT02710071|460233245|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
127893625|NCT02710071|460233246|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
127893626|NCT02637557|460233253|FG000|Overall Study|Adverse Event|3|||
127893627|NCT02637557|460233254|FG001|Overall Study|Adverse Event|1|||
127893628|NCT02637557|460233255|FG002|Overall Study|Adverse Event|3|||
127893629|NCT02637557|460233256|FG003|Overall Study|Adverse Event|3|||
127893630|NCT02637557|460233253|FG000|Overall Study|Lost to Follow-up|1|||
127893631|NCT02637557|460233254|FG001|Overall Study|Lost to Follow-up|1|||
127893632|NCT02637557|460233255|FG002|Overall Study|Lost to Follow-up|0|||
127893633|NCT02637557|460233256|FG003|Overall Study|Lost to Follow-up|1|||
127893634|NCT02637557|460233253|FG000|Overall Study|Physician Decision|1|||
127893635|NCT02637557|460233254|FG001|Overall Study|Physician Decision|0|||
127893636|NCT02637557|460233255|FG002|Overall Study|Physician Decision|0|||
127893637|NCT02637557|460233256|FG003|Overall Study|Physician Decision|0|||
127893638|NCT02637557|460233253|FG000|Overall Study|Protocol Violation|2|||
127743446|NCT02312206|459688105|FG001|Overall Study|Study Terminated by Sponsor|74|||
127743447|NCT02312206|459688104|FG000|Overall Study|Patient transferred to hospice|0|||
127743448|NCT02312206|459688105|FG001|Overall Study|Patient transferred to hospice|1|||
127893639|NCT02637557|460233254|FG001|Overall Study|Protocol Violation|0|||
127893640|NCT02637557|460233255|FG002|Overall Study|Protocol Violation|2|||
127893641|NCT02637557|460233256|FG003|Overall Study|Protocol Violation|1|||
127893642|NCT02637557|460233253|FG000|Overall Study|Withdrawal by Subject|1|||
127893643|NCT02637557|460233254|FG001|Overall Study|Withdrawal by Subject|3|||
127893644|NCT02637557|460233255|FG002|Overall Study|Withdrawal by Subject|4|||
127893645|NCT02637557|460233256|FG003|Overall Study|Withdrawal by Subject|2|||
127893646|NCT00613574|460233257|FG000|Overall Study|Adverse Event|3|||
127893647|NCT00613574|460233257|FG000|Overall Study|Lost to Follow-up|2|||
127893648|NCT00613574|460233257|FG000|Overall Study|Other|1|||
127893649|NCT04604184|460233264|FG000|Overall Study|Adverse Event|5|||
127893650|NCT04604184|460233265|FG001|Overall Study|Adverse Event|5|||
127893651|NCT04604184|460233264|FG000|Overall Study|Death|2|||
127893652|NCT04604184|460233265|FG001|Overall Study|Death|1|||
127893653|NCT04604184|460233264|FG000|Overall Study|Withdrawal by Subject|1|||
127893654|NCT04604184|460233265|FG001|Overall Study|Withdrawal by Subject|3|||
127893655|NCT04604184|460233264|FG000|Overall Study|Not treated|2|||
127893656|NCT04604184|460233265|FG001|Overall Study|Not treated|2|||
127893657|NCT04604184|460233264|FG000|Overall Study|Due to sponsor decision|9|||
127893658|NCT04604184|460233265|FG001|Overall Study|Due to sponsor decision|7|||
127893659|NCT04604184|460233264|FG000|Overall Study|Physician Decision|0|||
127893660|NCT04604184|460233265|FG001|Overall Study|Physician Decision|1|||
127893661|NCT04604184|460233264|FG000|Overall Study|Transfer to healthcare|1|||
127893662|NCT04604184|460233265|FG001|Overall Study|Transfer to healthcare|0|||
127893663|NCT01751412|460233266|FG000|Overall Study|Disease Progression Before Treatment|1|||
127893664|NCT01844583|460233269|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
127893665|NCT01844583|460233270|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
127893666|NCT01625377|460233271|FG000|Overall Study|Death|1|||
127893667|NCT01625377|460233272|FG001|Overall Study|Death|1|||
127893668|NCT01625377|460233271|FG000|Overall Study|Administrative Problem|1|||
127893669|NCT01625377|460233272|FG001|Overall Study|Administrative Problem|1|||
127893670|NCT01625377|460233271|FG000|Overall Study|Protocol Violation|0|||
127893671|NCT01625377|460233272|FG001|Overall Study|Protocol Violation|3|||
127893672|NCT01625377|460233271|FG000|Overall Study|Adverse Event|3|||
127893673|NCT01625377|460233272|FG001|Overall Study|Adverse Event|16|||
127743449|NCT02312206|459688104|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
127743450|NCT02312206|459688105|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
127743451|NCT02312206|459688104|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
127743452|NCT02312206|459688105|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
127743453|NCT02312206|459688104|FG000|Overall Study|Disease Progression|1|||
127743454|NCT02312206|459688105|FG001|Overall Study|Disease Progression|0|||
127743455|NCT03082612|459688106|FG000|Overall Study|Lost to Follow-up|2|||
127743456|NCT03082612|459688107|FG001|Overall Study|Lost to Follow-up|0|||
127893674|NCT01625377|460233271|FG000|Overall Study|Graft loss|1|||
127893675|NCT01625377|460233272|FG001|Overall Study|Graft loss|0|||
127893676|NCT01625377|460233271|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
127893677|NCT01625377|460233272|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
127893678|NCT01625377|460233271|FG000|Overall Study|Abnormal laboratory values|1|||
127893679|NCT01625377|460233272|FG001|Overall Study|Abnormal laboratory values|0|||
127893680|NCT03294538|460233277|FG000|Overall Study|Adverse Event|0|||
127743457|NCT01772563|459688110|FG000|Cycle 1|Dose limiting toxicity|2|||
127743458|NCT01772563|459688110|FG000|Cycle 1|Progressive disease|2|||
127743459|NCT01772563|459688110|FG000|Cycle 2 and Beyond|Progressive disease|17|||
127893681|NCT03294538|460233278|FG001|Overall Study|Adverse Event|1|||
127893682|NCT03294538|460233279|FG002|Overall Study|Adverse Event|1|||
127893683|NCT03294538|460233277|FG000|Overall Study|Lost to Follow-up|1|||
127893684|NCT03294538|460233278|FG001|Overall Study|Lost to Follow-up|0|||
127893685|NCT03294538|460233279|FG002|Overall Study|Lost to Follow-up|0|||
127743460|NCT01772563|459688110|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
127743461|NCT01772563|459688110|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
127743462|NCT01086384|459688117|FG000|2-week Run-in Period|Adverse Event|1|||
127743463|NCT01086384|459688118|FG001|2-week Run-in Period|Adverse Event|0|||
127743464|NCT01086384|459688119|FG002|2-week Run-in Period|Adverse Event|0|||
127743465|NCT01086384|459688117|FG000|2-week Run-in Period|Protocol Violation|1|||
127743466|NCT01086384|459688118|FG001|2-week Run-in Period|Protocol Violation|0|||
127743467|NCT01086384|459688119|FG002|2-week Run-in Period|Protocol Violation|0|||
127743468|NCT01086384|459688117|FG000|2-week Run-in Period|Lost to Follow-up|1|||
127743469|NCT01086384|459688118|FG001|2-week Run-in Period|Lost to Follow-up|0|||
127743470|NCT01086384|459688119|FG002|2-week Run-in Period|Lost to Follow-up|0|||
127743471|NCT01086384|459688117|FG000|2-week Run-in Period|Physician Decision|6|||
127743472|NCT01086384|459688118|FG001|2-week Run-in Period|Physician Decision|0|||
127743473|NCT01086384|459688119|FG002|2-week Run-in Period|Physician Decision|0|||
127743474|NCT01086384|459688117|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
127743475|NCT01086384|459688118|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
127743476|NCT01086384|459688119|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
127743477|NCT01086384|459688117|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
127743478|NCT01086384|459688118|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
127743479|NCT01086384|459688119|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
127743480|NCT01086384|459688117|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
127743481|NCT01086384|459688118|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
127743482|NCT01086384|459688119|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
127743483|NCT01086384|459688117|FG000|2-week Run-in Period|Randomized in Error|1|||
127743484|NCT01086384|459688118|FG001|2-week Run-in Period|Randomized in Error|0|||
127743485|NCT01086384|459688119|FG002|2-week Run-in Period|Randomized in Error|0|||
127743486|NCT01086384|459688117|FG000|Treatment Period|Withdrawal by Subject|0|||
127743487|NCT01086384|459688118|FG001|Treatment Period|Withdrawal by Subject|53|||
127743488|NCT01086384|459688119|FG002|Treatment Period|Withdrawal by Subject|55|||
127743489|NCT01086384|459688117|FG000|Treatment Period|Protocol Violation|0|||
127743490|NCT01086384|459688118|FG001|Treatment Period|Protocol Violation|26|||
127743491|NCT01086384|459688119|FG002|Treatment Period|Protocol Violation|17|||
127743492|NCT01086384|459688117|FG000|Treatment Period|Lack of Efficacy|0|||
127743493|NCT01086384|459688118|FG001|Treatment Period|Lack of Efficacy|22|||
127743494|NCT01086384|459688119|FG002|Treatment Period|Lack of Efficacy|13|||
127743495|NCT01086384|459688117|FG000|Treatment Period|Adverse Event|0|||
127743496|NCT01086384|459688118|FG001|Treatment Period|Adverse Event|19|||
127743497|NCT01086384|459688119|FG002|Treatment Period|Adverse Event|15|||
127743498|NCT01086384|459688117|FG000|Treatment Period|Lost to Follow-up|0|||
127743499|NCT01086384|459688118|FG001|Treatment Period|Lost to Follow-up|11|||
127743500|NCT01086384|459688119|FG002|Treatment Period|Lost to Follow-up|9|||
127743501|NCT01086384|459688117|FG000|Treatment Period|Physician Decision|0|||
127743502|NCT01086384|459688118|FG001|Treatment Period|Physician Decision|9|||
127743503|NCT01086384|459688119|FG002|Treatment Period|Physician Decision|6|||
127743504|NCT01086384|459688117|FG000|Treatment Period|Study Closed/Terminated|0|||
127743505|NCT01086384|459688118|FG001|Treatment Period|Study Closed/Terminated|7|||
127743506|NCT01086384|459688119|FG002|Treatment Period|Study Closed/Terminated|8|||
127743507|NCT01086384|459688117|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
127743508|NCT01086384|459688118|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
127743509|NCT01086384|459688119|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
127743510|NCT01086384|459688117|FG000|Treatment Period|Received Treatment in Error|0|||
127743511|NCT01086384|459688118|FG001|Treatment Period|Received Treatment in Error|1|||
127743512|NCT01086384|459688119|FG002|Treatment Period|Received Treatment in Error|0|||
127743513|NCT03732820|459688122|FG000|Overall Study|Death|168|||
127743514|NCT03732820|459688123|FG001|Overall Study|Death|203|||
127743515|NCT03732820|459688122|FG000|Overall Study|Other|2|||
127743516|NCT03732820|459688123|FG001|Overall Study|Other|2|||
127743517|NCT03732820|459688122|FG000|Overall Study|Failure to meet randomisation criteria|1|||
127743518|NCT03732820|459688123|FG001|Overall Study|Failure to meet randomisation criteria|1|||
127743519|NCT03732820|459688122|FG000|Overall Study|Patient decision|14|||
127743520|NCT03732820|459688123|FG001|Overall Study|Patient decision|10|||
127743521|NCT03732820|459688122|FG000|Overall Study|Screen failure|0|||
127743522|NCT03732820|459688123|FG001|Overall Study|Screen failure|1|||
127743523|NCT03732820|459688122|FG000|Overall Study|Patients ongoing study at data cut off|210|||
127807807|NCT02764541|459915840|FG004|Overall Study|Adverse Event|0|||
127807808|NCT02764541|459915841|FG005|Overall Study|Adverse Event|0|||
127743524|NCT03732820|459688123|FG001|Overall Study|Patients ongoing study at data cut off|178|||
127743525|NCT03732820|459688122|FG000|Overall Study|Lost to Follow-up|4|||
127743526|NCT03732820|459688123|FG001|Overall Study|Lost to Follow-up|2|||
127743527|NCT00992992|459688124|FG000|Overall Study|Lost to Follow-up|3|||
127743528|NCT00992992|459688124|FG000|Overall Study|Death|16|||
127743529|NCT00992992|459688124|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
127743530|NCT00992992|459688124|FG000|Overall Study|Sponsor Closed the Study|4|||
127743531|NCT02725567|459688125|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
127807809|NCT02764541|459915842|FG006|Overall Study|Adverse Event|1|||
127893686|NCT03294538|460233277|FG000|Overall Study|Outside of Visit Window|4|||
127893687|NCT03294538|460233278|FG001|Overall Study|Outside of Visit Window|4|||
127893688|NCT03294538|460233279|FG002|Overall Study|Outside of Visit Window|1|||
127893689|NCT01338636|460233280|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
127893690|NCT02385526|460233281|FG000|Overall Study|Withdrawal by Subject|0|||
127893691|NCT02385526|460233282|FG001|Overall Study|Withdrawal by Subject|2|||
127893692|NCT02385526|460233283|FG002|Overall Study|Withdrawal by Subject|0|||
127893693|NCT02385526|460233281|FG000|Overall Study|Lost to Follow-up|0|||
127893694|NCT02385526|460233282|FG001|Overall Study|Lost to Follow-up|1|||
127893695|NCT02385526|460233283|FG002|Overall Study|Lost to Follow-up|0|||
127893696|NCT02385526|460233281|FG000|Overall Study|Physician Decision|1|||
127893697|NCT02385526|460233282|FG001|Overall Study|Physician Decision|0|||
127893698|NCT02385526|460233283|FG002|Overall Study|Physician Decision|0|||
127893699|NCT02385526|460233281|FG000|Overall Study|Protocol Violation|1|||
127893700|NCT02385526|460233282|FG001|Overall Study|Protocol Violation|0|||
127893701|NCT02385526|460233283|FG002|Overall Study|Protocol Violation|0|||
127893702|NCT03532009|460233284|FG000|Overall Study|Other|1|||
127893703|NCT03532009|460233285|FG001|Overall Study|Other|1|||
127893704|NCT03532009|460233284|FG000|Overall Study|Death|1|||
127893705|NCT03532009|460233285|FG001|Overall Study|Death|1|||
127893706|NCT03532009|460233284|FG000|Overall Study|Withdrawal by Patient|0|||
127893707|NCT03532009|460233285|FG001|Overall Study|Withdrawal by Patient|2|||
127893708|NCT02035137|460233286|FG000|Overall Study|Physician Decision|0|||
127893709|NCT02035137|460233287|FG001|Overall Study|Physician Decision|0|||
127893710|NCT02035137|460233288|FG002|Overall Study|Physician Decision|1|||
127893711|NCT02035137|460233286|FG000|Overall Study|Withdrawal by Subject|0|||
127893712|NCT02035137|460233287|FG001|Overall Study|Withdrawal by Subject|1|||
127893713|NCT02035137|460233288|FG002|Overall Study|Withdrawal by Subject|2|||
127893714|NCT02035137|460233286|FG000|Overall Study|Ineligible|0|||
127893715|NCT02035137|460233287|FG001|Overall Study|Ineligible|1|||
127893716|NCT02035137|460233288|FG002|Overall Study|Ineligible|2|||
127893717|NCT02035137|460233286|FG000|Overall Study|Disease progression prior to treatment start|2|||
127893718|NCT02035137|460233287|FG001|Overall Study|Disease progression prior to treatment start|0|||
127893719|NCT02035137|460233288|FG002|Overall Study|Disease progression prior to treatment start|0|||
127893720|NCT01006707|460233295|FG000|Study Session 1|Lost to Follow-up|2|||
127893721|NCT01006707|460233296|FG001|Study Session 1|Lost to Follow-up|0|||
127893722|NCT01006707|460233297|FG002|Study Session 1|Lost to Follow-up|0|||
127893723|NCT01006707|460233295|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
127893724|NCT01006707|460233296|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
127893725|NCT01006707|460233297|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
127893726|NCT05034731|460233298|FG000|Overall Study|Screen fail|1|||
127893727|NCT05034731|460233299|FG001|Overall Study|Screen fail|1|||
127893728|NCT00283686|460233301|FG000|Overall Study|Death|1|||
127893729|NCT00283686|460233302|FG001|Overall Study|Death|1|||
127893730|NCT00283686|460233303|FG002|Overall Study|Death|1|||
127893731|NCT00283686|460233304|FG003|Overall Study|Death|0|||
127893732|NCT00283686|460233301|FG000|Overall Study|Lost to Follow-up|21|||
127893733|NCT00283686|460233302|FG001|Overall Study|Lost to Follow-up|31|||
127893734|NCT00283686|460233303|FG002|Overall Study|Lost to Follow-up|26|||
127807810|NCT02764541|459915843|FG007|Overall Study|Adverse Event|0|||
127807811|NCT02764541|459915836|FG000|Overall Study|Metastasis|1|||
127807812|NCT02764541|459915837|FG001|Overall Study|Metastasis|0|||
127807813|NCT02764541|459915838|FG002|Overall Study|Metastasis|0|||
127807814|NCT02764541|459915839|FG003|Overall Study|Metastasis|0|||
127807815|NCT02764541|459915840|FG004|Overall Study|Metastasis|0|||
127807816|NCT02764541|459915841|FG005|Overall Study|Metastasis|0|||
127807817|NCT02764541|459915842|FG006|Overall Study|Metastasis|0|||
127807818|NCT02764541|459915843|FG007|Overall Study|Metastasis|0|||
127807819|NCT02764541|459915836|FG000|Overall Study|Disease progression|1|||
127807820|NCT02764541|459915837|FG001|Overall Study|Disease progression|1|||
127893735|NCT00283686|460233304|FG003|Overall Study|Lost to Follow-up|20|||
127893736|NCT00283686|460233301|FG000|Overall Study|Less than full participation|7|||
127893737|NCT00283686|460233302|FG001|Overall Study|Less than full participation|9|||
127893738|NCT00283686|460233303|FG002|Overall Study|Less than full participation|6|||
127893739|NCT00283686|460233304|FG003|Overall Study|Less than full participation|12|||
127893740|NCT02970669|460233305|FG000|Double-blind Period|Adverse Event|4|||
127807821|NCT02764541|459915838|FG002|Overall Study|Disease progression|0|||
127807822|NCT02764541|459915839|FG003|Overall Study|Disease progression|0|||
127807823|NCT02764541|459915840|FG004|Overall Study|Disease progression|0|||
127807824|NCT02764541|459915841|FG005|Overall Study|Disease progression|0|||
127893741|NCT02970669|460233306|FG001|Double-blind Period|Adverse Event|0|||
127893742|NCT02970669|460233305|FG000|Double-blind Period|Death|1|||
127743532|NCT02725567|459688126|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
127743533|NCT02725567|459688125|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
127743534|NCT02725567|459688126|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
127743535|NCT02725567|459688125|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
127743536|NCT02725567|459688126|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
127743537|NCT00255944|459688127|FG000|Overall Study|Lost to Follow-up|797|||
127743538|NCT00255944|459688128|FG001|Overall Study|Lost to Follow-up|834|||
127743539|NCT01129115|459688129|FG000|Overall Study|Adverse Event|1|||
127743540|NCT01129115|459688130|FG001|Overall Study|Adverse Event|2|||
127743541|NCT01129115|459688131|FG002|Overall Study|Adverse Event|3|||
127743542|NCT01129115|459688132|FG003|Overall Study|Adverse Event|3|||
127743543|NCT01129115|459688129|FG000|Overall Study|Withdrawal by Subject|1|||
127743544|NCT01129115|459688130|FG001|Overall Study|Withdrawal by Subject|3|||
127743545|NCT01129115|459688131|FG002|Overall Study|Withdrawal by Subject|1|||
127743546|NCT01129115|459688132|FG003|Overall Study|Withdrawal by Subject|4|||
127743547|NCT01129115|459688129|FG000|Overall Study|Protocol Violation|0|||
127743548|NCT01129115|459688130|FG001|Overall Study|Protocol Violation|2|||
127743549|NCT01129115|459688131|FG002|Overall Study|Protocol Violation|2|||
127743550|NCT01129115|459688132|FG003|Overall Study|Protocol Violation|2|||
127743551|NCT03856047|459688133|FG000|Overall Study|Withdrawal by Subject|0|||
127743552|NCT03856047|459688134|FG001|Overall Study|Withdrawal by Subject|1|||
127743553|NCT03856047|459688135|FG002|Overall Study|Withdrawal by Subject|1|||
127743554|NCT03856047|459688136|FG003|Overall Study|Withdrawal by Subject|0|||
127743555|NCT03856047|459688137|FG004|Overall Study|Withdrawal by Subject|3|||
127743556|NCT03856047|459688138|FG005|Overall Study|Withdrawal by Subject|0|||
127743557|NCT03856047|459688139|FG006|Overall Study|Withdrawal by Subject|2|||
127743558|NCT03856047|459688133|FG000|Overall Study|Lost to Follow-up|4|||
127743559|NCT03856047|459688134|FG001|Overall Study|Lost to Follow-up|2|||
127743560|NCT03856047|459688135|FG002|Overall Study|Lost to Follow-up|3|||
127743561|NCT03856047|459688136|FG003|Overall Study|Lost to Follow-up|1|||
127743562|NCT03856047|459688137|FG004|Overall Study|Lost to Follow-up|4|||
127743563|NCT03856047|459688138|FG005|Overall Study|Lost to Follow-up|4|||
127743564|NCT03856047|459688139|FG006|Overall Study|Lost to Follow-up|4|||
127743565|NCT00874497|459688143|FG000|Overall Study|Lost to Follow-up|2|||
127743566|NCT00874497|459688144|FG001|Overall Study|Lost to Follow-up|4|||
127743567|NCT00874497|459688143|FG000|Overall Study|Adverse Event|9|||
127743568|NCT00874497|459688144|FG001|Overall Study|Adverse Event|4|||
127743569|NCT00874497|459688143|FG000|Overall Study|Sponsor Discontinued Trial|7|||
127743570|NCT00874497|459688144|FG001|Overall Study|Sponsor Discontinued Trial|3|||
127743571|NCT00874497|459688143|FG000|Overall Study|Met Withdrawal Criteria|4|||
127743572|NCT00874497|459688144|FG001|Overall Study|Met Withdrawal Criteria|2|||
127743573|NCT00874497|459688143|FG000|Overall Study|Physician Decision|1|||
127743574|NCT00874497|459688144|FG001|Overall Study|Physician Decision|1|||
127743575|NCT00874497|459688143|FG000|Overall Study|Withdrawal by Subject|5|||
127743576|NCT00874497|459688144|FG001|Overall Study|Withdrawal by Subject|4|||
127743577|NCT00665223|459688147|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
127743578|NCT00665223|459688148|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
127743579|NCT00665223|459688149|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
127743580|NCT00665223|459688147|FG000|Randomized Phase (26 Weeks)|Death|0|||
127743581|NCT00665223|459688148|FG001|Randomized Phase (26 Weeks)|Death|0|||
127743582|NCT00665223|459688149|FG002|Randomized Phase (26 Weeks)|Death|1|||
127743583|NCT00665223|459688147|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
127743584|NCT00665223|459688148|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
127743585|NCT00665223|459688149|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
127743586|NCT00665223|459688147|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
127743587|NCT00665223|459688148|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
127743588|NCT00665223|459688149|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
127743589|NCT00665223|459688147|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
127893743|NCT02970669|460233306|FG001|Double-blind Period|Death|0|||
127743590|NCT00665223|459688148|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
127743591|NCT00665223|459688149|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
127743592|NCT00665223|459688147|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
127743593|NCT00665223|459688148|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
127743594|NCT00665223|459688149|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
127743595|NCT00665223|459688147|FG000|Open-Label Period (26 Weeks)|Death|0|||
127743596|NCT00665223|459688148|FG001|Open-Label Period (26 Weeks)|Death|1|||
127743597|NCT00665223|459688149|FG002|Open-Label Period (26 Weeks)|Death|0|||
127743598|NCT00665223|459688147|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
127743599|NCT00665223|459688148|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
127743600|NCT00665223|459688149|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
127743601|NCT00665223|459688147|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
127743602|NCT00665223|459688148|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
127743603|NCT00665223|459688149|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
127743604|NCT00665223|459688147|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
127743605|NCT00665223|459688148|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
127743606|NCT00665223|459688149|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
127743607|NCT00665223|459688147|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
127743608|NCT00665223|459688148|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
127743609|NCT00665223|459688149|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
127743610|NCT00905359|459688150|FG000|Overall Study|Lost to Follow-up|17|||
127743611|NCT00905359|459688151|FG001|Overall Study|Lost to Follow-up|10|||
127743612|NCT00905359|459688150|FG000|Overall Study|Death|2|||
127743613|NCT00905359|459688151|FG001|Overall Study|Death|0|||
127743614|NCT00905359|459688150|FG000|Overall Study|Withdrawal consent|5|||
127743615|NCT00905359|459688151|FG001|Overall Study|Withdrawal consent|6|||
127743616|NCT02138253|459688152|FG000|Overall Study|Adverse Event|3|||
127743617|NCT02138253|459688153|FG001|Overall Study|Adverse Event|3|||
127743618|NCT02138253|459688152|FG000|Overall Study|Lost to Follow-up|2|||
127743619|NCT02138253|459688153|FG001|Overall Study|Lost to Follow-up|1|||
127743620|NCT02138253|459688152|FG000|Overall Study|Physician Decision|2|||
127743621|NCT02138253|459688153|FG001|Overall Study|Physician Decision|0|||
127743622|NCT02138253|459688152|FG000|Overall Study|Non compliance|1|||
127743623|NCT02138253|459688153|FG001|Overall Study|Non compliance|0|||
127743624|NCT02138253|459688152|FG000|Overall Study|Withdrawal by Subject|1|||
127743625|NCT02138253|459688153|FG001|Overall Study|Withdrawal by Subject|0|||
127743626|NCT01728623|459688154|FG000|Overall Study|Disease progression|26|||
127743627|NCT01728623|459688154|FG000|Overall Study|Adverse Event|1|||
127743628|NCT01728623|459688154|FG000|Overall Study|Withdrawal by Subject|1|||
127743629|NCT00243022|459688155|FG000|Overall Study|Withdrawal by Subject|1|||
127743630|NCT00243022|459688156|FG001|Overall Study|Withdrawal by Subject|0|||
127743631|NCT00243022|459688155|FG000|Overall Study|Death|1|||
127743632|NCT00243022|459688156|FG001|Overall Study|Death|0|||
127743633|NCT00243022|459688155|FG000|Overall Study|Difficult Travel Distance|0|||
127743634|NCT00243022|459688156|FG001|Overall Study|Difficult Travel Distance|1|||
127743635|NCT03517111|459688157|FG000|Enrolled|Withdrawal by Subject|0|||
127743636|NCT03517111|459688158|FG001|Enrolled|Withdrawal by Subject|1|||
127743637|NCT03517111|459688159|FG002|Enrolled|Withdrawal by Subject|0|||
127743638|NCT03517111|459688157|FG000|T2 Survey (Week 10-12)|Intervention workshops cancelled|83|||
127743639|NCT03517111|459688158|FG001|T2 Survey (Week 10-12)|Intervention workshops cancelled|78|||
127743640|NCT03517111|459688159|FG002|T2 Survey (Week 10-12)|Intervention workshops cancelled|60|||
127743641|NCT03517111|459688157|FG000|T2 Survey (Week 10-12)|Lost to Follow-up|36|||
127743642|NCT03517111|459688158|FG001|T2 Survey (Week 10-12)|Lost to Follow-up|12|||
127743643|NCT03517111|459688159|FG002|T2 Survey (Week 10-12)|Lost to Follow-up|23|||
127743644|NCT03517111|459688157|FG000|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|9|||
127743645|NCT03517111|459688158|FG001|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|3|||
127743646|NCT03517111|459688159|FG002|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|4|||
127743647|NCT03517111|459688157|FG000|T3 Survey (Weeks 24-26)|Lost to Follow-up|27|||
127743648|NCT03517111|459688158|FG001|T3 Survey (Weeks 24-26)|Lost to Follow-up|6|||
127893744|NCT02970669|460233305|FG000|Double-blind Period|Study terminated by sponsor|1|||
127893745|NCT02970669|460233306|FG001|Double-blind Period|Study terminated by sponsor|2|||
127743649|NCT03517111|459688159|FG002|T3 Survey (Weeks 24-26)|Lost to Follow-up|15|||
127743650|NCT00621192|459688160|FG000|Overall Study|Withdrawal by Subject|0|||
127743651|NCT00621192|459688161|FG001|Overall Study|Withdrawal by Subject|0|||
127743652|NCT00621192|459688162|FG002|Overall Study|Withdrawal by Subject|2|||
127743653|NCT00621192|459688163|FG003|Overall Study|Withdrawal by Subject|0|||
127743654|NCT00621192|459688160|FG000|Overall Study|Physician Decision|1|||
127743655|NCT00621192|459688161|FG001|Overall Study|Physician Decision|3|||
127743656|NCT00621192|459688162|FG002|Overall Study|Physician Decision|0|||
127743657|NCT00621192|459688163|FG003|Overall Study|Physician Decision|0|||
127743658|NCT00621192|459688160|FG000|Overall Study|Protocol Violation|1|||
127743659|NCT00621192|459688161|FG001|Overall Study|Protocol Violation|0|||
127743660|NCT00621192|459688162|FG002|Overall Study|Protocol Violation|0|||
127743661|NCT00621192|459688163|FG003|Overall Study|Protocol Violation|1|||
127743662|NCT00621192|459688160|FG000|Overall Study|Adverse Event|0|||
127743663|NCT00621192|459688161|FG001|Overall Study|Adverse Event|1|||
127743664|NCT00621192|459688162|FG002|Overall Study|Adverse Event|0|||
127743665|NCT00621192|459688163|FG003|Overall Study|Adverse Event|1|||
127743666|NCT00621192|459688160|FG000|Overall Study|Death|2|||
127743667|NCT00621192|459688161|FG001|Overall Study|Death|5|||
127743668|NCT00621192|459688162|FG002|Overall Study|Death|0|||
127743669|NCT00621192|459688163|FG003|Overall Study|Death|0|||
127743670|NCT00621192|459688160|FG000|Overall Study|Final Assessments not Completed|0|||
127743671|NCT00621192|459688161|FG001|Overall Study|Final Assessments not Completed|0|||
127743672|NCT00621192|459688162|FG002|Overall Study|Final Assessments not Completed|3|||
127743673|NCT00621192|459688163|FG003|Overall Study|Final Assessments not Completed|1|||
127743674|NCT04706793|459688164|FG000|Treatment|Disease worsening|10|||
127743675|NCT04706793|459688165|FG001|Treatment|Disease worsening|10|||
127743676|NCT04706793|459688164|FG000|Follow-up|Lack of Efficacy|1|||
127743677|NCT04706793|459688165|FG001|Follow-up|Lack of Efficacy|0|||
127743678|NCT04706793|459688164|FG000|Follow-up|Disease worsening|8|||
127743679|NCT04706793|459688165|FG001|Follow-up|Disease worsening|10|||
127743680|NCT04706793|459688164|FG000|Follow-up|Adverse Event|1|||
127743681|NCT04706793|459688165|FG001|Follow-up|Adverse Event|0|||
127743682|NCT03713320|459688168|FG000|Randomized Period|Adverse Event|1|||
127743683|NCT03713320|459688169|FG001|Randomized Period|Adverse Event|5|||
127743684|NCT03713320|459688170|FG002|Randomized Period|Adverse Event|0|||
127743685|NCT03713320|459688168|FG000|Randomized Period|Physician Decision|1|||
127743686|NCT03713320|459688169|FG001|Randomized Period|Physician Decision|1|||
127743687|NCT03713320|459688170|FG002|Randomized Period|Physician Decision|0|||
127743688|NCT03713320|459688168|FG000|Randomized Period|Withdrawal by Subject|4|||
127743689|NCT03713320|459688169|FG001|Randomized Period|Withdrawal by Subject|0|||
127807825|NCT02764541|459915842|FG006|Overall Study|Disease progression|0|||
127807826|NCT02764541|459915843|FG007|Overall Study|Disease progression|1|||
127807827|NCT02764541|459915836|FG000|Overall Study|Protocol Violation|0|||
127807828|NCT02764541|459915837|FG001|Overall Study|Protocol Violation|0|||
127807829|NCT02764541|459915838|FG002|Overall Study|Protocol Violation|0|||
127807830|NCT02764541|459915839|FG003|Overall Study|Protocol Violation|1|||
127807831|NCT02764541|459915840|FG004|Overall Study|Protocol Violation|0|||
127807832|NCT02764541|459915841|FG005|Overall Study|Protocol Violation|1|||
127807833|NCT02764541|459915842|FG006|Overall Study|Protocol Violation|0|||
127807834|NCT02764541|459915843|FG007|Overall Study|Protocol Violation|0|||
127893746|NCT02970669|460233305|FG000|Double-blind Period|Physician Decision|0|||
127893747|NCT02970669|460233306|FG001|Double-blind Period|Physician Decision|2|||
127893748|NCT02970669|460233305|FG000|Double-blind Period|Withdrawal by Subject|2|||
127893749|NCT02970669|460233306|FG001|Double-blind Period|Withdrawal by Subject|2|||
127893750|NCT02970669|460233305|FG000|Open-label Period|Withdrawal by Subject|2|||
127893751|NCT02970669|460233306|FG001|Open-label Period|Withdrawal by Subject|2|||
127743690|NCT03713320|459688170|FG002|Randomized Period|Withdrawal by Subject|0|||
127743691|NCT03713320|459688168|FG000|Randomized Period|Participant decision|3|||
127743692|NCT03713320|459688169|FG001|Randomized Period|Participant decision|1|||
127743693|NCT03713320|459688170|FG002|Randomized Period|Participant decision|0|||
127743694|NCT03713320|459688168|FG000|Randomized Period|Study terminated by sponsor|6|||
127743695|NCT03713320|459688169|FG001|Randomized Period|Study terminated by sponsor|3|||
127743696|NCT03713320|459688170|FG002|Randomized Period|Study terminated by sponsor|0|||
127807835|NCT02764541|459915836|FG000|Overall Study|Physician Decision|0|||
127807836|NCT02764541|459915837|FG001|Overall Study|Physician Decision|0|||
127807837|NCT02764541|459915838|FG002|Overall Study|Physician Decision|0|||
127743697|NCT03713320|459688168|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
127743698|NCT03713320|459688169|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
127743699|NCT03713320|459688170|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
127743700|NCT03713320|459688168|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
127743701|NCT03713320|459688169|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
127743702|NCT03713320|459688170|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
127743703|NCT02725528|459688171|FG000|Overall Study|Lost to Follow-up|1|||
127743704|NCT02725528|459688172|FG001|Overall Study|Lost to Follow-up|4|||
127743705|NCT02725528|459688171|FG000|Overall Study|Withdrawal by Subject|0|||
127743706|NCT02725528|459688172|FG001|Overall Study|Withdrawal by Subject|1|||
127743707|NCT02569957|459688174|FG000|Overall Study|Withdrawal by Subject|0|||
127743708|NCT02569957|459688175|FG001|Overall Study|Withdrawal by Subject|1|||
127743709|NCT01781832|459688177|FG000|Overall Study|Withdrawal by Subject|1|||
127743710|NCT02719743|459688178|FG000|Overall Study|Consent withdrawal|0|||
127743711|NCT02719743|459688179|FG001|Overall Study|Consent withdrawal|2|||
127743712|NCT02719743|459688180|FG002|Overall Study|Consent withdrawal|0|||
127743713|NCT02719743|459688181|FG003|Overall Study|Consent withdrawal|1|||
127743714|NCT02719743|459688182|FG004|Overall Study|Consent withdrawal|0|||
127743715|NCT02719743|459688178|FG000|Overall Study|Migrated/moved from study area|0|||
127743716|NCT02719743|459688179|FG001|Overall Study|Migrated/moved from study area|0|||
127743717|NCT02719743|459688180|FG002|Overall Study|Migrated/moved from study area|0|||
127743718|NCT02719743|459688181|FG003|Overall Study|Migrated/moved from study area|0|||
127743719|NCT02719743|459688182|FG004|Overall Study|Migrated/moved from study area|2|||
127743720|NCT02719743|459688178|FG000|Overall Study|Lost to Follow-up|1|||
127743721|NCT02719743|459688179|FG001|Overall Study|Lost to Follow-up|1|||
127743722|NCT02719743|459688180|FG002|Overall Study|Lost to Follow-up|0|||
127743723|NCT02719743|459688181|FG003|Overall Study|Lost to Follow-up|0|||
127743724|NCT02719743|459688182|FG004|Overall Study|Lost to Follow-up|0|||
127743725|NCT01209598|459688183|FG000|Overall Study|Withdrawal by Subject|1|||
127743726|NCT01209598|459688184|FG001|Overall Study|Withdrawal by Subject|0|||
127743727|NCT02601209|459688185|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
127743728|NCT02601209|459688186|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
127743729|NCT02601209|459688187|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
127743730|NCT02601209|459688188|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
127743731|NCT02601209|459688189|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
127743732|NCT02601209|459688190|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
127743733|NCT02601209|459688191|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
127743734|NCT02601209|459688192|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
127743735|NCT02601209|459688193|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
127743736|NCT02601209|459688185|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
127743737|NCT02601209|459688186|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
127743738|NCT02601209|459688187|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
127743739|NCT02601209|459688188|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
127743740|NCT02601209|459688189|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
127743741|NCT02601209|459688190|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
127743742|NCT02601209|459688191|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
127743743|NCT02601209|459688192|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
127743744|NCT02601209|459688193|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
127743745|NCT03636373|459688194|FG000|Overall Study|Study closure due to Covid-19|1|||
127743746|NCT03636373|459688195|FG001|Overall Study|Study closure due to Covid-19|0|||
127743747|NCT00572533|459688196|FG000|Overall Study|Death|4|||
127743748|NCT00572533|459688197|FG001|Overall Study|Death|1|||
127743749|NCT00572533|459688196|FG000|Overall Study|Received Kidney Transplant|2|||
127743750|NCT00572533|459688197|FG001|Overall Study|Received Kidney Transplant|1|||
127743751|NCT00572533|459688196|FG000|Overall Study|Social Issues|1|||
127743752|NCT00572533|459688197|FG001|Overall Study|Social Issues|0|||
127743753|NCT00572533|459688196|FG000|Overall Study|Transfer out of Facility|0|||
127743754|NCT00572533|459688197|FG001|Overall Study|Transfer out of Facility|1|||
127743755|NCT00798304|459688198|FG000|Overall Study|Adverse Event|0|||
127743756|NCT00798304|459688199|FG001|Overall Study|Adverse Event|1|||
127743757|NCT00798304|459688200|FG002|Overall Study|Adverse Event|1|||
127743758|NCT00798304|459688198|FG000|Overall Study|Discontinuation by Sponsor|14|||
127743759|NCT00798304|459688199|FG001|Overall Study|Discontinuation by Sponsor|21|||
127743760|NCT00798304|459688200|FG002|Overall Study|Discontinuation by Sponsor|9|||
127743761|NCT01161628|459688207|FG000|Overall Study|Death|6|||
127743762|NCT01161628|459688207|FG000|Overall Study|Lack of Efficacy|2|||
127743763|NCT00715117|459688208|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
127743764|NCT00715117|459688209|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
127807838|NCT02764541|459915839|FG003|Overall Study|Physician Decision|1|||
127743765|NCT01482429|459688210|FG000|Care Usual|Protocol Violation|0|||
127743766|NCT01482429|459688211|FG001|Care Usual|Protocol Violation|172|||
127743767|NCT01482429|459688210|FG000|Care Usual|Lost to Follow-up|0|||
127743768|NCT01482429|459688211|FG001|Care Usual|Lost to Follow-up|1|||
127743769|NCT01482429|459688210|FG000|Protocol|Protocol Violation|275|||
127743770|NCT01482429|459688211|FG001|Protocol|Protocol Violation|0|||
127743771|NCT00416598|459689961|FG000|Induction & Intensification|Adverse Event|38|||
127743772|NCT00416598|459689961|FG000|Induction & Intensification|Death|32|||
127743773|NCT00416598|459689961|FG000|Induction & Intensification|Withdrawal by Subject|46|||
127807839|NCT02764541|459915840|FG004|Overall Study|Physician Decision|0|||
127807840|NCT02764541|459915841|FG005|Overall Study|Physician Decision|0|||
127807841|NCT02764541|459915842|FG006|Overall Study|Physician Decision|0|||
127807842|NCT02764541|459915843|FG007|Overall Study|Physician Decision|1|||
127807843|NCT02764541|459915836|FG000|Overall Study|Three Cycles completed before surgery|0|||
127807844|NCT02764541|459915837|FG001|Overall Study|Three Cycles completed before surgery|0|||
127807845|NCT02764541|459915838|FG002|Overall Study|Three Cycles completed before surgery|0|||
127807846|NCT02764541|459915839|FG003|Overall Study|Three Cycles completed before surgery|1|||
127807847|NCT02764541|459915840|FG004|Overall Study|Three Cycles completed before surgery|0|||
127807848|NCT02764541|459915841|FG005|Overall Study|Three Cycles completed before surgery|0|||
127743774|NCT00416598|459689961|FG000|Induction & Intensification|Alternative Treatment|135|||
127743775|NCT00416598|459689961|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
127743776|NCT00416598|459689961|FG000|Induction & Intensification|Relapse/progression|29|||
127743777|NCT00416598|459689961|FG000|Induction & Intensification|Failed induction|87|||
127743778|NCT00416598|459689961|FG000|Decitabine Maintenance|Adverse Event|5|||
127743779|NCT00416598|459689961|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
127743780|NCT00416598|459689961|FG000|Decitabine Maintenance|Progression/relapse|38|||
127743781|NCT00416598|459689961|FG000|Decitabine Maintenance|Alternative treatment|2|||
127743782|NCT00416598|459689961|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
127743783|NCT02166476|459689968|FG000|Overall Study|Withdrawal by Subject|5|||
127743784|NCT02166476|459689969|FG001|Overall Study|Withdrawal by Subject|7|||
127743785|NCT02166476|459689968|FG000|Overall Study|Adverse Event|3|||
127743786|NCT02166476|459689969|FG001|Overall Study|Adverse Event|3|||
127743787|NCT02166476|459689968|FG000|Overall Study|Lost to Follow-up|5|||
127743788|NCT02166476|459689969|FG001|Overall Study|Lost to Follow-up|10|||
127743789|NCT02166476|459689968|FG000|Overall Study|Physician Decision|1|||
127743790|NCT02166476|459689969|FG001|Overall Study|Physician Decision|0|||
127743791|NCT02166476|459689968|FG000|Overall Study|Unable to Come for Visit|0|||
127743792|NCT02166476|459689969|FG001|Overall Study|Unable to Come for Visit|3|||
127743793|NCT02053610|459689973|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
127743794|NCT02053610|459689974|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
127743795|NCT02053610|459689973|FG000|Overall Study|Withdrew Consent|2|||
127743796|NCT02053610|459689974|FG001|Overall Study|Withdrew Consent|9|||
127743797|NCT02053610|459689973|FG000|Overall Study|Death|5|||
127743798|NCT02053610|459689974|FG001|Overall Study|Death|5|||
127743799|NCT02053610|459689973|FG000|Overall Study|Administrative/Other|1|||
127743800|NCT02053610|459689974|FG001|Overall Study|Administrative/Other|1|||
127743801|NCT02053610|459689973|FG000|Overall Study|Disease Progression|2|||
127743802|NCT02053610|459689974|FG001|Overall Study|Disease Progression|3|||
127743803|NCT02053610|459689973|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
127743804|NCT02053610|459689974|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
127743805|NCT02053610|459689973|FG000|Overall Study|Did not Receive Treatment|4|||
127807849|NCT02764541|459915842|FG006|Overall Study|Three Cycles completed before surgery|0|||
127807850|NCT02764541|459915843|FG007|Overall Study|Three Cycles completed before surgery|0|||
127807851|NCT02764541|459915836|FG000|Overall Study|Patient Compliance|0|||
127807852|NCT02764541|459915837|FG001|Overall Study|Patient Compliance|0|||
127807853|NCT02764541|459915838|FG002|Overall Study|Patient Compliance|1|||
127807854|NCT02764541|459915839|FG003|Overall Study|Patient Compliance|0|||
127893752|NCT02970669|460233305|FG000|Open-label Period|Adverse Event|1|||
127743806|NCT02053610|459689974|FG001|Overall Study|Did not Receive Treatment|2|||
127743807|NCT02053610|459689973|FG000|Overall Study|Insufficient Therapeutic Response|1|||
127743808|NCT02053610|459689974|FG001|Overall Study|Insufficient Therapeutic Response|1|||
127743809|NCT02053610|459689973|FG000|Overall Study|Violation of Selection Criteria|1|||
127743810|NCT02053610|459689974|FG001|Overall Study|Violation of Selection Criteria|0|||
127893753|NCT02970669|460233306|FG001|Open-label Period|Adverse Event|0|||
127893754|NCT02970669|460233305|FG000|Open-label Period|Physician Decision|1|||
127893755|NCT02970669|460233306|FG001|Open-label Period|Physician Decision|0|||
127743811|NCT00543062|459689980|FG000|Overall Study|Withdrawal by Subject|1|||
127893756|NCT03521999|460233307|FG000|Completed 1 Month Up|Lost to Follow-up|59|||
127743812|NCT00543062|459689981|FG001|Overall Study|Withdrawal by Subject|0|||
127743813|NCT00543062|459689982|FG002|Overall Study|Withdrawal by Subject|2|||
127743814|NCT00543062|459689983|FG003|Overall Study|Withdrawal by Subject|0|||
127743815|NCT00543062|459689980|FG000|Overall Study|Adverse Event|0|||
127743816|NCT00543062|459689981|FG001|Overall Study|Adverse Event|1|||
127807855|NCT02764541|459915840|FG004|Overall Study|Patient Compliance|0|||
127807856|NCT02764541|459915841|FG005|Overall Study|Patient Compliance|0|||
127743817|NCT00543062|459689982|FG002|Overall Study|Adverse Event|1|||
127743818|NCT00543062|459689983|FG003|Overall Study|Adverse Event|1|||
127743819|NCT00543062|459689980|FG000|Overall Study|Protocol Violation|1|||
127743820|NCT00543062|459689981|FG001|Overall Study|Protocol Violation|0|||
127743821|NCT00543062|459689982|FG002|Overall Study|Protocol Violation|0|||
127743822|NCT00543062|459689983|FG003|Overall Study|Protocol Violation|0|||
127743823|NCT00328562|459689986|FG000|Overall Study|Disease progression|1|||
127743824|NCT01513330|459689987|FG000|SenSura Mio First,|Adverse Event|2|||
127743825|NCT01513330|459689988|FG001|SenSura Mio First,|Adverse Event|0|||
127743826|NCT01513330|459689987|FG000|SenSura Mio First,|Lack of Efficacy|0|||
127743827|NCT01513330|459689988|FG001|SenSura Mio First,|Lack of Efficacy|1|||
127743828|NCT01513330|459689987|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
127743829|NCT01513330|459689988|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
127743830|NCT01513330|459689987|FG000|SenSura Mio First,|Other|1|||
127743831|NCT01513330|459689988|FG001|SenSura Mio First,|Other|0|||
127743832|NCT01513330|459689987|FG000|Standard Care First,|Lack of Efficacy|2|||
127743833|NCT01513330|459689988|FG001|Standard Care First,|Lack of Efficacy|2|||
127743834|NCT01513330|459689987|FG000|Standard Care First,|Withdrawal by Subject|1|||
127743835|NCT01513330|459689988|FG001|Standard Care First,|Withdrawal by Subject|2|||
127743836|NCT01513330|459689987|FG000|Standard Care First,|Other|1|||
127743837|NCT01513330|459689988|FG001|Standard Care First,|Other|0|||
127743838|NCT04486313|459689989|FG000|Overall Study|Lost to Follow-up|7|||
127743839|NCT04486313|459689990|FG001|Overall Study|Lost to Follow-up|9|||
127743840|NCT04486313|459689989|FG000|Overall Study|Withdrawal by Subject|8|||
127743841|NCT04486313|459689990|FG001|Overall Study|Withdrawal by Subject|6|||
127743842|NCT04486313|459689989|FG000|Overall Study|Physician Decision|1|||
127743843|NCT04486313|459689990|FG001|Overall Study|Physician Decision|1|||
127743844|NCT04486313|459689989|FG000|Overall Study|Death|2|||
127743845|NCT04486313|459689990|FG001|Overall Study|Death|0|||
127743846|NCT04486313|459689989|FG000|Overall Study|Protocol Violation|1|||
127743847|NCT04486313|459689990|FG001|Overall Study|Protocol Violation|1|||
127743848|NCT01496365|459689995|FG000|Overall Study|Adverse Event|2|||
127743849|NCT01496365|459689996|FG001|Overall Study|Adverse Event|3|||
127743850|NCT01496365|459689997|FG002|Overall Study|Adverse Event|3|||
127743851|NCT01496365|459689998|FG003|Overall Study|Adverse Event|2|||
127743852|NCT01496365|459689999|FG004|Overall Study|Adverse Event|5|||
127743853|NCT01496365|459690000|FG005|Overall Study|Adverse Event|6|||
127743854|NCT01496365|459690001|FG006|Overall Study|Adverse Event|4|||
127743855|NCT01496365|459689995|FG000|Overall Study|Withdrawal by Subject|6|||
127743856|NCT01496365|459689996|FG001|Overall Study|Withdrawal by Subject|6|||
127743857|NCT01496365|459689997|FG002|Overall Study|Withdrawal by Subject|0|||
127743858|NCT01496365|459689998|FG003|Overall Study|Withdrawal by Subject|1|||
127743859|NCT01496365|459689999|FG004|Overall Study|Withdrawal by Subject|3|||
127807857|NCT02764541|459915842|FG006|Overall Study|Patient Compliance|0|||
127807858|NCT02764541|459915843|FG007|Overall Study|Patient Compliance|0|||
127807859|NCT02764541|459915836|FG000|Overall Study|Death|0|||
127807860|NCT02764541|459915837|FG001|Overall Study|Death|0|||
127807861|NCT02764541|459915838|FG002|Overall Study|Death|0|||
127807862|NCT02764541|459915839|FG003|Overall Study|Death|0|||
127807863|NCT02764541|459915840|FG004|Overall Study|Death|0|||
127807864|NCT02764541|459915841|FG005|Overall Study|Death|0|||
127807865|NCT02764541|459915842|FG006|Overall Study|Death|1|||
127807866|NCT02764541|459915843|FG007|Overall Study|Death|0|||
127807867|NCT02764541|459915836|FG000|Overall Study|Insurance reasons|0|||
127807868|NCT02764541|459915837|FG001|Overall Study|Insurance reasons|0|||
127807869|NCT02764541|459915838|FG002|Overall Study|Insurance reasons|0|||
127807870|NCT02764541|459915839|FG003|Overall Study|Insurance reasons|0|||
127807871|NCT02764541|459915840|FG004|Overall Study|Insurance reasons|0|||
127807872|NCT02764541|459915841|FG005|Overall Study|Insurance reasons|0|||
127807873|NCT02764541|459915842|FG006|Overall Study|Insurance reasons|1|||
127807874|NCT02764541|459915843|FG007|Overall Study|Insurance reasons|0|||
127807875|NCT00749190|459915844|FG000|Overall Study|Adverse Event|0|||
127743860|NCT01496365|459690000|FG005|Overall Study|Withdrawal by Subject|2|||
127743861|NCT01496365|459690001|FG006|Overall Study|Withdrawal by Subject|1|||
127743862|NCT01496365|459689995|FG000|Overall Study|Protocol Violation|2|||
127743863|NCT01496365|459689996|FG001|Overall Study|Protocol Violation|1|||
127743864|NCT01496365|459689997|FG002|Overall Study|Protocol Violation|1|||
127743865|NCT01496365|459689998|FG003|Overall Study|Protocol Violation|0|||
127743866|NCT01496365|459689999|FG004|Overall Study|Protocol Violation|0|||
127743867|NCT01496365|459690000|FG005|Overall Study|Protocol Violation|1|||
127743868|NCT01496365|459690001|FG006|Overall Study|Protocol Violation|0|||
127743869|NCT01496365|459689995|FG000|Overall Study|Lack of Efficacy|1|||
127743870|NCT01496365|459689996|FG001|Overall Study|Lack of Efficacy|0|||
127743871|NCT01496365|459689997|FG002|Overall Study|Lack of Efficacy|0|||
127743872|NCT01496365|459689998|FG003|Overall Study|Lack of Efficacy|0|||
127807876|NCT00749190|459915845|FG001|Overall Study|Adverse Event|2|||
127807877|NCT00749190|459915846|FG002|Overall Study|Adverse Event|0|||
127807878|NCT00749190|459915847|FG003|Overall Study|Adverse Event|4|||
127807879|NCT00749190|459915848|FG004|Overall Study|Adverse Event|0|||
127807880|NCT00749190|459915849|FG005|Overall Study|Adverse Event|3|||
127807881|NCT00749190|459915850|FG006|Overall Study|Adverse Event|0|||
127743873|NCT01496365|459689999|FG004|Overall Study|Lack of Efficacy|0|||
127743874|NCT01496365|459690000|FG005|Overall Study|Lack of Efficacy|1|||
127743875|NCT01496365|459690001|FG006|Overall Study|Lack of Efficacy|0|||
127743876|NCT01496365|459689995|FG000|Overall Study|Lost to Follow-up|0|||
127743877|NCT01496365|459689996|FG001|Overall Study|Lost to Follow-up|1|||
127743878|NCT01496365|459689997|FG002|Overall Study|Lost to Follow-up|0|||
127743879|NCT01496365|459689998|FG003|Overall Study|Lost to Follow-up|0|||
127743880|NCT01496365|459689999|FG004|Overall Study|Lost to Follow-up|2|||
127743881|NCT01496365|459690000|FG005|Overall Study|Lost to Follow-up|0|||
127743882|NCT01496365|459690001|FG006|Overall Study|Lost to Follow-up|0|||
127743883|NCT01496365|459689995|FG000|Overall Study|Other|4|||
127743884|NCT01496365|459689996|FG001|Overall Study|Other|4|||
127743885|NCT01496365|459689997|FG002|Overall Study|Other|2|||
127743886|NCT01496365|459689998|FG003|Overall Study|Other|1|||
127743887|NCT01496365|459689999|FG004|Overall Study|Other|3|||
127743888|NCT01496365|459690000|FG005|Overall Study|Other|0|||
127743889|NCT01496365|459690001|FG006|Overall Study|Other|1|||
127743890|NCT01288209|459690002|FG000|Overall Study|Withdrawal by Subject|1|||
127743891|NCT01288209|459690003|FG001|Overall Study|Withdrawal by Subject|3|||
127743892|NCT01288209|459690002|FG000|Overall Study|Other|1|||
127743893|NCT01288209|459690003|FG001|Overall Study|Other|0|||
127743894|NCT01015677|459690004|FG000|Overall Study|Adverse Event|0|||
127743895|NCT01015677|459690005|FG001|Overall Study|Adverse Event|1|||
127743896|NCT01015677|459690006|FG002|Overall Study|Adverse Event|0|||
127743897|NCT01015677|459690004|FG000|Overall Study|Lack of Efficacy|0|||
127743898|NCT01015677|459690005|FG001|Overall Study|Lack of Efficacy|1|||
127743899|NCT01015677|459690006|FG002|Overall Study|Lack of Efficacy|0|||
127743900|NCT01015677|459690004|FG000|Overall Study|Protocol Violation|0|||
127743901|NCT01015677|459690005|FG001|Overall Study|Protocol Violation|1|||
127743902|NCT01015677|459690006|FG002|Overall Study|Protocol Violation|0|||
127743903|NCT01015677|459690004|FG000|Overall Study|Withdrawal by Subject|1|||
127743904|NCT01015677|459690005|FG001|Overall Study|Withdrawal by Subject|1|||
127743905|NCT01015677|459690006|FG002|Overall Study|Withdrawal by Subject|0|||
127743906|NCT02232399|459690007|FG000|Overall Study|Adverse Event|1|||
127743907|NCT02232399|459690008|FG001|Overall Study|Adverse Event|0|||
127743908|NCT02232399|459690007|FG000|Overall Study|Withdrawal by Subject|0|||
127743909|NCT02232399|459690008|FG001|Overall Study|Withdrawal by Subject|1|||
127743910|NCT01646385|459690011|FG000|Overall Study|Death|202|||
127743911|NCT01646385|459690012|FG001|Overall Study|Death|222|||
127743912|NCT01646385|459690011|FG000|Overall Study|Switched to alternate biologic|636|||
127743913|NCT01646385|459690012|FG001|Overall Study|Switched to alternate biologic|649|||
127743914|NCT01843777|459690013|FG000|Overall Study|Withdrawal by Subject|1|||
127743915|NCT01843777|459690014|FG001|Overall Study|Withdrawal by Subject|0|||
127743916|NCT01777334|459690015|FG000|Overall Study|Adverse Event|18|||
127743917|NCT01777334|459690016|FG001|Overall Study|Adverse Event|14|||
127743918|NCT01777334|459690015|FG000|Overall Study|Lack of Efficacy|15|||
127743919|NCT01777334|459690016|FG001|Overall Study|Lack of Efficacy|29|||
127743920|NCT01777334|459690015|FG000|Overall Study|Protocol Violation|3|||
127743921|NCT01777334|459690016|FG001|Overall Study|Protocol Violation|7|||
127743922|NCT01777334|459690015|FG000|Overall Study|Lost to Follow-up|3|||
127743923|NCT01777334|459690016|FG001|Overall Study|Lost to Follow-up|2|||
127743924|NCT01777334|459690015|FG000|Overall Study|Withdrawal by Subject|14|||
127743925|NCT01777334|459690016|FG001|Overall Study|Withdrawal by Subject|11|||
127743926|NCT04799418|459690020|FG000|Overall Study|Death|1|||
127743927|NCT04799418|459690021|FG001|Overall Study|Death|1|||
127743928|NCT04799418|459690020|FG000|Overall Study|Lack of Efficacy|14|||
127743929|NCT04799418|459690021|FG001|Overall Study|Lack of Efficacy|14|||
127743930|NCT04799418|459690020|FG000|Overall Study|Withdrawal by Subject|10|||
127807882|NCT00749190|459915844|FG000|Overall Study|Lack of Efficacy|3|||
127807883|NCT00749190|459915845|FG001|Overall Study|Lack of Efficacy|1|||
127807884|NCT00749190|459915846|FG002|Overall Study|Lack of Efficacy|1|||
127743931|NCT04799418|459690021|FG001|Overall Study|Withdrawal by Subject|7|||
127743932|NCT04799418|459690020|FG000|Overall Study|Adverse Event|3|||
127743933|NCT04799418|459690021|FG001|Overall Study|Adverse Event|2|||
127743934|NCT00632021|459690034|FG000|Overall Study|Withdrawal/death|4|||
127743935|NCT00632021|459690035|FG001|Overall Study|Withdrawal/death|7|||
127743936|NCT00952848|459690038|FG000|Overall Study|Withdrawal by Subject|4|||
127743937|NCT00458393|459690039|FG000|Overall Study|Withdrawal by Subject|67|||
127743938|NCT00458393|459690040|FG001|Overall Study|Withdrawal by Subject|80|||
127743939|NCT00458393|459690039|FG000|Overall Study|Physician Decision|31|||
127743940|NCT00458393|459690040|FG001|Overall Study|Physician Decision|22|||
127743941|NCT00458393|459690039|FG000|Overall Study|Relocated|77|||
127743942|NCT00458393|459690040|FG001|Overall Study|Relocated|81|||
127743943|NCT00458393|459690039|FG000|Overall Study|Lost to Follow-up|115|||
127743944|NCT00458393|459690040|FG001|Overall Study|Lost to Follow-up|92|||
127743945|NCT00458393|459690039|FG000|Overall Study|Sites marked other on the form.|19|||
127743946|NCT00458393|459690040|FG001|Overall Study|Sites marked other on the form.|20|||
127743947|NCT00857233|459690043|FG000|Overall Study|Adverse Event|24|||
127743948|NCT00857233|459690043|FG000|Overall Study|Lack of Efficacy|1|||
127743949|NCT00857233|459690043|FG000|Overall Study|Non-compliance|1|||
127743950|NCT00857233|459690043|FG000|Overall Study|Withdrawal of Consent|9|||
127743951|NCT00857233|459690043|FG000|Overall Study|Lost to Follow-up|4|||
127743952|NCT00857233|459690043|FG000|Overall Study|Nursing Home Placement|14|||
127743953|NCT00857233|459690043|FG000|Overall Study|Other Reasons|2|||
127743954|NCT01587118|459690044|FG000|Overall Study|Adverse Event|3|||
127743955|NCT01587118|459690044|FG000|Overall Study|Lost to Follow-up|2|||
127743956|NCT01587118|459690044|FG000|Overall Study|Relocation|1|||
127743957|NCT01587118|459690044|FG000|Overall Study|nonresponse|1|||
127743958|NCT00263575|459690045|FG000|Titration Period|Adverse Event|14|||
127743959|NCT00263575|459690045|FG000|Titration Period|Withdrawal by Subject|10|||
127743960|NCT00263575|459690045|FG000|Titration Period|Protocol Violation|9|||
127743961|NCT00263575|459690045|FG000|Titration Period|Sponsor Decision|2|||
127743962|NCT00263575|459690045|FG000|Titration Period|Other|2|||
127743963|NCT00263575|459690045|FG000|Titration Period|Lack of Efficacy|6|||
127743964|NCT00263575|459690045|FG000|Maintence Period|Adverse Event|23|||
127743965|NCT00263575|459690045|FG000|Maintence Period|Withdrawal by Subject|8|||
127743966|NCT00263575|459690045|FG000|Maintence Period|Protocol Violation|4|||
127743967|NCT00263575|459690045|FG000|Maintence Period|Lack of Efficacy|4|||
127743968|NCT00263575|459690045|FG000|Maintence Period|Physician Decision|6|||
127743969|NCT00263575|459690045|FG000|Maintence Period|Lost to Follow-up|1|||
127743970|NCT00263575|459690045|FG000|Maintence Period|Sponsor Decision|24|||
127743971|NCT00263575|459690045|FG000|Maintence Period|Other|7|||
127743972|NCT00537329|459690046|FG000|Overall Study|Death|10|||
127743973|NCT00537329|459690046|FG000|Overall Study|Adverse Event|3|||
127743974|NCT00537329|459690046|FG000|Overall Study|Lack of Efficacy|2|||
127743975|NCT00537329|459690046|FG000|Overall Study|Lost to Follow-up|6|||
127743976|NCT00537329|459690046|FG000|Overall Study|Withdrawal by Subject|4|||
127743977|NCT00537329|459690046|FG000|Overall Study|Other|1|||
127743978|NCT01278615|459690049|FG000|Overall Study|Withdrawal by Subject|2|||
127743979|NCT01426113|459690050|FG000|Overall Study|Study Discontinued|1|||
127743980|NCT01426113|459690051|FG001|Overall Study|Study Discontinued|1|||
127743981|NCT01426113|459690050|FG000|Overall Study|Adverse Event|0|||
127743982|NCT01426113|459690051|FG001|Overall Study|Adverse Event|1|||
127743983|NCT02872012|459690052|FG000|Overall Study|Withdrawal by Subject|1|||
127743984|NCT02872012|459690053|FG001|Overall Study|Withdrawal by Subject|0|||
127743985|NCT02872012|459690054|FG002|Overall Study|Withdrawal by Subject|0|||
127743986|NCT02872012|459690055|FG003|Overall Study|Withdrawal by Subject|0|||
127743987|NCT02872012|459690056|FG004|Overall Study|Withdrawal by Subject|0|||
127743988|NCT01390441|459690061|FG000|Treatment Period|Protocol Violation|0|||
127743989|NCT01390441|459690062|FG001|Treatment Period|Protocol Violation|1|||
127743990|NCT01390441|459690063|FG002|Treatment Period|Protocol Violation|0|||
127743991|NCT01390441|459690064|FG003|Treatment Period|Protocol Violation|0|||
127743992|NCT01390441|459690065|FG004|Treatment Period|Protocol Violation|0|||
127743993|NCT01390441|459690061|FG000|Treatment Period|Physician Decision|0|||
127743994|NCT01390441|459690062|FG001|Treatment Period|Physician Decision|0|||
127743995|NCT01390441|459690063|FG002|Treatment Period|Physician Decision|0|||
127743996|NCT01390441|459690064|FG003|Treatment Period|Physician Decision|1|||
127743997|NCT01390441|459690065|FG004|Treatment Period|Physician Decision|0|||
127743998|NCT01390441|459690061|FG000|Treatment Period|Lack of Efficacy|0|||
127743999|NCT01390441|459690062|FG001|Treatment Period|Lack of Efficacy|0|||
127744000|NCT01390441|459690063|FG002|Treatment Period|Lack of Efficacy|0|||
127893757|NCT03521999|460233308|FG001|Completed 1 Month Up|Lost to Follow-up|58|||
127893758|NCT03521999|460233307|FG000|Completed 3 Month Follow up|Lost to Follow-up|64|||
127893759|NCT03521999|460233308|FG001|Completed 3 Month Follow up|Lost to Follow-up|59|||
127893760|NCT03521999|460233307|FG000|Completed 3 Month Follow up|Death|0|||
127744001|NCT01390441|459690064|FG003|Treatment Period|Lack of Efficacy|0|||
127744002|NCT01390441|459690065|FG004|Treatment Period|Lack of Efficacy|1|||
127744003|NCT01390441|459690061|FG000|Treatment Period|Unknown due to early stopping of study|0|||
127744004|NCT01390441|459690062|FG001|Treatment Period|Unknown due to early stopping of study|0|||
127744005|NCT01390441|459690063|FG002|Treatment Period|Unknown due to early stopping of study|8|||
127893761|NCT03521999|460233308|FG001|Completed 3 Month Follow up|Death|1|||
127893762|NCT03521999|460233307|FG000|Completed 6 Month Follow|Lost to Follow-up|66|||
127744006|NCT01390441|459690064|FG003|Treatment Period|Unknown due to early stopping of study|11|||
127744007|NCT01390441|459690065|FG004|Treatment Period|Unknown due to early stopping of study|7|||
127744008|NCT01390441|459690061|FG000|Treatment Period|Adverse Event|0|||
127744009|NCT01390441|459690062|FG001|Treatment Period|Adverse Event|0|||
127744010|NCT01390441|459690063|FG002|Treatment Period|Adverse Event|1|||
127893763|NCT03521999|460233308|FG001|Completed 6 Month Follow|Lost to Follow-up|70|||
127893764|NCT00249821|460233309|FG000|Overall Study|Technical problem|0|||
127893765|NCT00249821|460233310|FG001|Overall Study|Technical problem|1|||
127893766|NCT00467584|460233315|FG000|Overall Study|Withdrawal by Subject|4|||
127893767|NCT00467584|460233316|FG001|Overall Study|Withdrawal by Subject|5|||
127893768|NCT00467584|460233317|FG002|Overall Study|Withdrawal by Subject|1|||
127893769|NCT02292238|460233321|FG000|Overall Study|Protocol Violation|1|||
127744011|NCT01390441|459690064|FG003|Treatment Period|Adverse Event|1|||
127744012|NCT01390441|459690065|FG004|Treatment Period|Adverse Event|2|||
127744013|NCT01390441|459690061|FG000|Treatment Period|Withdrawal by Subject|0|||
127744014|NCT01390441|459690062|FG001|Treatment Period|Withdrawal by Subject|0|||
127744015|NCT01390441|459690063|FG002|Treatment Period|Withdrawal by Subject|1|||
127744016|NCT01390441|459690064|FG003|Treatment Period|Withdrawal by Subject|0|||
127744017|NCT01390441|459690065|FG004|Treatment Period|Withdrawal by Subject|1|||
127744018|NCT01390441|459690061|FG000|Treatment Period|Lost to Follow-up|1|||
127744019|NCT01390441|459690062|FG001|Treatment Period|Lost to Follow-up|0|||
127744020|NCT01390441|459690063|FG002|Treatment Period|Lost to Follow-up|0|||
127744021|NCT01390441|459690064|FG003|Treatment Period|Lost to Follow-up|0|||
127744022|NCT01390441|459690065|FG004|Treatment Period|Lost to Follow-up|0|||
127744023|NCT01390441|459690061|FG000|Extension Period|Protocol Violation|3|||
127744024|NCT01390441|459690062|FG001|Extension Period|Protocol Violation|1|||
127744025|NCT01390441|459690063|FG002|Extension Period|Protocol Violation|0|||
127744026|NCT01390441|459690064|FG003|Extension Period|Protocol Violation|1|||
127744027|NCT01390441|459690065|FG004|Extension Period|Protocol Violation|0|||
127744028|NCT02287233|459690067|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
127744029|NCT02287233|459690068|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
127744030|NCT02287233|459690069|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
127744031|NCT02287233|459690067|FG000|Overall Study|Adverse Event Related to Progression|0|||
127744032|NCT02287233|459690068|FG001|Overall Study|Adverse Event Related to Progression|2|||
127744033|NCT02287233|459690069|FG002|Overall Study|Adverse Event Related to Progression|8|||
127744034|NCT02287233|459690067|FG000|Overall Study|Physician Decision|1|||
127744035|NCT02287233|459690068|FG001|Overall Study|Physician Decision|2|||
127744036|NCT02287233|459690069|FG002|Overall Study|Physician Decision|4|||
127744037|NCT02287233|459690067|FG000|Overall Study|Progressive Disease with Death|0|||
127744038|NCT02287233|459690068|FG001|Overall Study|Progressive Disease with Death|0|||
127744039|NCT02287233|459690069|FG002|Overall Study|Progressive Disease with Death|10|||
127744040|NCT02287233|459690067|FG000|Overall Study|Progressive Disease Without Death|2|||
127744041|NCT02287233|459690068|FG001|Overall Study|Progressive Disease Without Death|3|||
127893770|NCT02292238|460233322|FG001|Overall Study|Protocol Violation|2|||
127893771|NCT02292238|460233321|FG000|Overall Study|Withdrawal by Subject|2|||
127893772|NCT02292238|460233322|FG001|Overall Study|Withdrawal by Subject|1|||
127893773|NCT02292238|460233321|FG000|Overall Study|Lost to Follow-up|1|||
127893774|NCT02292238|460233322|FG001|Overall Study|Lost to Follow-up|0|||
127893775|NCT02292238|460233321|FG000|Overall Study|Physician Decision|0|||
127893776|NCT02292238|460233322|FG001|Overall Study|Physician Decision|1|||
127893777|NCT01789320|460233323|FG000|Overall Study|Re-enrolled into study|1|||
127893778|NCT01789320|460233323|FG000|Overall Study|Lost to Follow-up|1|||
127893779|NCT00814320|460233326|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
127893780|NCT00814320|460233327|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
127893781|NCT00814320|460233326|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
127893782|NCT00814320|460233327|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
127893783|NCT00814320|460233326|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
127893784|NCT00814320|460233327|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
127744042|NCT02287233|459690069|FG002|Overall Study|Progressive Disease Without Death|20|||
127744043|NCT02287233|459690067|FG000|Overall Study|Withdrawal by Subject|1|||
127744044|NCT02287233|459690068|FG001|Overall Study|Withdrawal by Subject|1|||
127744045|NCT02287233|459690069|FG002|Overall Study|Withdrawal by Subject|7|||
127744046|NCT02287233|459690067|FG000|Overall Study|Other|3|||
127744047|NCT02287233|459690068|FG001|Overall Study|Other|0|||
127744048|NCT02287233|459690069|FG002|Overall Study|Other|15|||
127744049|NCT02287233|459690067|FG000|Overall Study|Did Not Receive Treatment|0|||
127744050|NCT02287233|459690068|FG001|Overall Study|Did Not Receive Treatment|0|||
127744051|NCT02287233|459690069|FG002|Overall Study|Did Not Receive Treatment|2|||
127744052|NCT03432390|459690072|FG000|Apnea Period|Protocol Violation|2|||
127744053|NCT03432390|459690073|FG001|Apnea Period|Protocol Violation|2|||
127744054|NCT02168478|459690075|FG000|Overall Study|Withdrawal by Subject|1|||
127744055|NCT02168478|459690075|FG000|Overall Study|Did Not Consent to Participation|2|||
127744056|NCT02168478|459690075|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
127744057|NCT00661713|459690084|FG000|Overall Study|Death|1|||
127744058|NCT00661713|459690085|FG001|Overall Study|Death|0|||
127744059|NCT00661713|459690086|FG002|Overall Study|Death|0|||
127744060|NCT00661713|459690087|FG003|Overall Study|Death|0|||
127744061|NCT00661713|459690088|FG004|Overall Study|Death|1|||
127744062|NCT00661713|459690089|FG005|Overall Study|Death|0|||
127744063|NCT00661713|459690090|FG006|Overall Study|Death|0|||
127744064|NCT00661713|459690091|FG007|Overall Study|Death|0|||
127744065|NCT00661713|459690084|FG000|Overall Study|Unable to Classify|1|||
127744066|NCT00661713|459690085|FG001|Overall Study|Unable to Classify|0|||
127744067|NCT00661713|459690086|FG002|Overall Study|Unable to Classify|0|||
127744068|NCT00661713|459690087|FG003|Overall Study|Unable to Classify|0|||
127744069|NCT00661713|459690088|FG004|Overall Study|Unable to Classify|0|||
127744070|NCT00661713|459690089|FG005|Overall Study|Unable to Classify|0|||
127744071|NCT00661713|459690090|FG006|Overall Study|Unable to Classify|0|||
127744072|NCT00661713|459690091|FG007|Overall Study|Unable to Classify|0|||
127744073|NCT00661713|459690084|FG000|Overall Study|Protocol Violation|1|||
127744074|NCT00661713|459690085|FG001|Overall Study|Protocol Violation|6|||
127744075|NCT00661713|459690086|FG002|Overall Study|Protocol Violation|3|||
127744076|NCT00661713|459690087|FG003|Overall Study|Protocol Violation|3|||
127744077|NCT00661713|459690088|FG004|Overall Study|Protocol Violation|0|||
127744078|NCT00661713|459690089|FG005|Overall Study|Protocol Violation|2|||
127744079|NCT00661713|459690090|FG006|Overall Study|Protocol Violation|2|||
127744080|NCT00661713|459690091|FG007|Overall Study|Protocol Violation|1|||
127744081|NCT00661713|459690084|FG000|Overall Study|Withdrawal by Subject|11|||
127744082|NCT00661713|459690085|FG001|Overall Study|Withdrawal by Subject|25|||
127744083|NCT00661713|459690086|FG002|Overall Study|Withdrawal by Subject|12|||
127744084|NCT00661713|459690087|FG003|Overall Study|Withdrawal by Subject|21|||
127744085|NCT00661713|459690088|FG004|Overall Study|Withdrawal by Subject|12|||
127744086|NCT00661713|459690089|FG005|Overall Study|Withdrawal by Subject|26|||
127744087|NCT00661713|459690090|FG006|Overall Study|Withdrawal by Subject|45|||
127744088|NCT00661713|459690091|FG007|Overall Study|Withdrawal by Subject|9|||
127744089|NCT00661713|459690084|FG000|Overall Study|Lost to Follow-up|2|||
127744090|NCT00661713|459690085|FG001|Overall Study|Lost to Follow-up|7|||
127744091|NCT00661713|459690086|FG002|Overall Study|Lost to Follow-up|2|||
127744092|NCT00661713|459690087|FG003|Overall Study|Lost to Follow-up|2|||
127744093|NCT00661713|459690088|FG004|Overall Study|Lost to Follow-up|5|||
127744094|NCT00661713|459690089|FG005|Overall Study|Lost to Follow-up|7|||
127744095|NCT00661713|459690090|FG006|Overall Study|Lost to Follow-up|14|||
127744096|NCT00661713|459690091|FG007|Overall Study|Lost to Follow-up|1|||
127744097|NCT00661713|459690084|FG000|Overall Study|Administrative Reason|0|||
127744098|NCT00661713|459690085|FG001|Overall Study|Administrative Reason|1|||
127744099|NCT00661713|459690086|FG002|Overall Study|Administrative Reason|0|||
127744100|NCT00661713|459690087|FG003|Overall Study|Administrative Reason|2|||
127744101|NCT00661713|459690088|FG004|Overall Study|Administrative Reason|2|||
127744102|NCT00661713|459690089|FG005|Overall Study|Administrative Reason|2|||
127744103|NCT00661713|459690090|FG006|Overall Study|Administrative Reason|1|||
127744104|NCT00661713|459690091|FG007|Overall Study|Administrative Reason|0|||
127744105|NCT00661713|459690084|FG000|Overall Study|Adverse Event|0|||
127744106|NCT00661713|459690085|FG001|Overall Study|Adverse Event|0|||
127744107|NCT00661713|459690086|FG002|Overall Study|Adverse Event|0|||
127744108|NCT00661713|459690087|FG003|Overall Study|Adverse Event|0|||
127744109|NCT00661713|459690088|FG004|Overall Study|Adverse Event|0|||
127744110|NCT00661713|459690089|FG005|Overall Study|Adverse Event|0|||
127744111|NCT00661713|459690090|FG006|Overall Study|Adverse Event|1|||
127744112|NCT00661713|459690091|FG007|Overall Study|Adverse Event|0|||
127744113|NCT00661713|459690084|FG000|Overall Study|Inappropriate Enrollment|0|||
127744114|NCT00661713|459690085|FG001|Overall Study|Inappropriate Enrollment|0|||
127744115|NCT00661713|459690086|FG002|Overall Study|Inappropriate Enrollment|0|||
127744116|NCT00661713|459690087|FG003|Overall Study|Inappropriate Enrollment|0|||
127744117|NCT00661713|459690088|FG004|Overall Study|Inappropriate Enrollment|0|||
127744118|NCT00661713|459690089|FG005|Overall Study|Inappropriate Enrollment|0|||
127744119|NCT00661713|459690090|FG006|Overall Study|Inappropriate Enrollment|1|||
127744120|NCT00661713|459690091|FG007|Overall Study|Inappropriate Enrollment|0|||
127893785|NCT00814320|460233326|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
127744121|NCT02918292|459690095|FG000|Study Enrollment Prior to Transplant|Death|1|||
127744122|NCT02918292|459690095|FG000|Study Follow up After Transplant|Death|6|||
127744123|NCT01801982|459690096|FG000|Overall Study|Lost to Follow-up|1|||
127744124|NCT01185171|459690097|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
127744125|NCT01185171|459690097|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
127744126|NCT01185171|459690097|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
127744127|NCT01185171|459690097|FG000|Maintenance|Elevated liver transaminases|3|||
127744128|NCT01185171|459690097|FG000|Maintenance|Rush|2|||
127744129|NCT01185171|459690097|FG000|Maintenance|Diarrhea|1|||
127744130|NCT01185171|459690097|FG000|Maintenance|Xerostomia|1|||
127744131|NCT01185171|459690097|FG000|Maintenance|Nausea|1|||
127744132|NCT01185171|459690097|FG000|Maintenance|Comorbid Illness|2|||
127744133|NCT01185171|459690097|FG000|Maintenance|Withdrawal by Subject|1|||
127744134|NCT01185171|459690097|FG000|Maintenance|Disease Recurrence|1|||
127744135|NCT00727506|459690098|FG000|Overall Study|Adverse Event|0|||
127744136|NCT00727506|459690099|FG001|Overall Study|Adverse Event|0|||
127744137|NCT00727506|459690100|FG002|Overall Study|Adverse Event|4|||
127744138|NCT00727506|459690101|FG003|Overall Study|Adverse Event|4|||
127744139|NCT00727506|459690102|FG004|Overall Study|Adverse Event|1|||
127744140|NCT00727506|459690103|FG005|Overall Study|Adverse Event|8|||
127744141|NCT00727506|459690098|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
127744142|NCT00727506|459690099|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
127744143|NCT00727506|459690100|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
127744144|NCT00727506|459690101|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
127744145|NCT00727506|459690102|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
127744146|NCT00727506|459690103|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
127744147|NCT00727506|459690098|FG000|Overall Study|Progressive disease|4|||
127744148|NCT00727506|459690099|FG001|Overall Study|Progressive disease|7|||
127744149|NCT00727506|459690100|FG002|Overall Study|Progressive disease|9|||
127744150|NCT00727506|459690101|FG003|Overall Study|Progressive disease|28|||
127744151|NCT00727506|459690102|FG004|Overall Study|Progressive disease|38|||
127744152|NCT00727506|459690103|FG005|Overall Study|Progressive disease|28|||
127744153|NCT00727506|459690098|FG000|Overall Study|Refused to continue medication|0|||
127744154|NCT00727506|459690099|FG001|Overall Study|Refused to continue medication|1|||
127744155|NCT00727506|459690100|FG002|Overall Study|Refused to continue medication|2|||
127744156|NCT00727506|459690101|FG003|Overall Study|Refused to continue medication|3|||
127744157|NCT00727506|459690102|FG004|Overall Study|Refused to continue medication|1|||
127744158|NCT00727506|459690103|FG005|Overall Study|Refused to continue medication|2|||
127744159|NCT00727506|459690098|FG000|Overall Study|Other reason not described above|0|||
127744160|NCT00727506|459690099|FG001|Overall Study|Other reason not described above|0|||
127744161|NCT00727506|459690100|FG002|Overall Study|Other reason not described above|1|||
127744162|NCT00727506|459690101|FG003|Overall Study|Other reason not described above|4|||
127744163|NCT00727506|459690102|FG004|Overall Study|Other reason not described above|1|||
127744164|NCT00727506|459690103|FG005|Overall Study|Other reason not described above|1|||
127744165|NCT03561597|459690104|FG000|Overall Study|Lost to Follow-up|20|||
127744166|NCT03783689|459690106|FG000|Overall Study|Adverse Event|2|||
127744167|NCT03783689|459690107|FG001|Overall Study|Adverse Event|0|||
127744168|NCT03783689|459690106|FG000|Overall Study|Lost to Follow-up|2|||
127744169|NCT03783689|459690107|FG001|Overall Study|Lost to Follow-up|1|||
127744170|NCT03783689|459690106|FG000|Overall Study|Physician Decision|2|||
127744171|NCT03783689|459690107|FG001|Overall Study|Physician Decision|1|||
127744172|NCT03783689|459690106|FG000|Overall Study|Withdrawal by Subject|3|||
127744173|NCT03783689|459690107|FG001|Overall Study|Withdrawal by Subject|3|||
127744174|NCT03783871|459690115|FG000|Overall Study|Withdrawal by Subject|15|||
127744175|NCT03783871|459690115|FG000|Overall Study|Death|13|||
127744176|NCT03783871|459690115|FG000|Overall Study|Lost to Follow-up|2|||
127744177|NCT04594733|459690117|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
127744178|NCT04594733|459690118|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
127744179|NCT04594733|459690117|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
127744180|NCT04594733|459690118|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
127744181|NCT04594733|459690117|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
127744182|NCT04594733|459690118|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
127744183|NCT02647645|459690121|FG000|Overall Study|Lost to Follow-up|2|||
127744184|NCT02647645|459690122|FG001|Overall Study|Lost to Follow-up|1|||
127744185|NCT00356811|459690123|FG000|Overall Study|Death|35|||
127744186|NCT00356811|459690123|FG000|Overall Study|Lost to Follow-up|2|||
127744187|NCT00356811|459690123|FG000|Overall Study|Withdrawal by Subject|6|||
127744188|NCT00356811|459690123|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
127744189|NCT00356811|459690123|FG000|Overall Study|Study Is Terminating|3|||
127744190|NCT00356811|459690123|FG000|Overall Study|Site Closed during Follow-up|2|||
127744191|NCT02386839|459690124|FG000|Overall Study|Death|1|||
127744192|NCT02386839|459690125|FG001|Overall Study|Death|0|||
127744193|NCT02386839|459690124|FG000|Overall Study|Withdrawal by Subject|9|||
127744194|NCT02386839|459690125|FG001|Overall Study|Withdrawal by Subject|10|||
127744195|NCT02386839|459690124|FG000|Overall Study|Lost to Follow-up|4|||
127744196|NCT02386839|459690125|FG001|Overall Study|Lost to Follow-up|4|||
127744197|NCT02386839|459690124|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
127744198|NCT02386839|459690125|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
127744199|NCT02386839|459690124|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
127744200|NCT02386839|459690125|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
127744201|NCT02386839|459690124|FG000|Overall Study|Other (unspecified)|1|||
127744202|NCT02386839|459690125|FG001|Overall Study|Other (unspecified)|0|||
127744203|NCT02101983|459690126|FG000|Overall Study|Physician Decision|1|||
127744204|NCT02101983|459690127|FG001|Overall Study|Physician Decision|0|||
127744205|NCT00826228|459691741|FG000|Overall Study|Withdrawal by Subject|1|||
127744206|NCT03614676|459691742|FG000|Overall Study|Delivery before planned visit|2|||
127744207|NCT03614676|459691743|FG001|Overall Study|Delivery before planned visit|0|||
127744208|NCT03614676|459691742|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
127744209|NCT03614676|459691743|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
127744210|NCT03614676|459691742|FG000|Overall Study|Migrated / moved from the study area|30|||
127744211|NCT03614676|459691743|FG001|Overall Study|Migrated / moved from the study area|22|||
127744212|NCT03614676|459691742|FG000|Overall Study|Lost to Follow-up|17|||
127744213|NCT03614676|459691743|FG001|Overall Study|Lost to Follow-up|42|||
127744214|NCT03614676|459691742|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
127744215|NCT03614676|459691743|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
127744216|NCT03614676|459691742|FG000|Overall Study|Other|16|||
127744217|NCT03614676|459691743|FG001|Overall Study|Other|47|||
127744218|NCT03614676|459691742|FG000|Overall Study|Protocol Violation|0|||
127807885|NCT00749190|459915847|FG003|Overall Study|Lack of Efficacy|0|||
127807886|NCT00749190|459915848|FG004|Overall Study|Lack of Efficacy|0|||
127807887|NCT00749190|459915849|FG005|Overall Study|Lack of Efficacy|1|||
127807888|NCT00749190|459915850|FG006|Overall Study|Lack of Efficacy|0|||
127807889|NCT00749190|459915844|FG000|Overall Study|Withdrawal by Subject|2|||
127807890|NCT00749190|459915845|FG001|Overall Study|Withdrawal by Subject|1|||
127807891|NCT00749190|459915846|FG002|Overall Study|Withdrawal by Subject|0|||
127807892|NCT00749190|459915847|FG003|Overall Study|Withdrawal by Subject|0|||
127807893|NCT00749190|459915848|FG004|Overall Study|Withdrawal by Subject|0|||
127807894|NCT00749190|459915849|FG005|Overall Study|Withdrawal by Subject|1|||
127807895|NCT00749190|459915850|FG006|Overall Study|Withdrawal by Subject|0|||
127807896|NCT00749190|459915844|FG000|Overall Study|Protocol Violation|0|||
127807897|NCT00749190|459915845|FG001|Overall Study|Protocol Violation|1|||
127807898|NCT00749190|459915846|FG002|Overall Study|Protocol Violation|0|||
127807899|NCT00749190|459915847|FG003|Overall Study|Protocol Violation|0|||
127807900|NCT00749190|459915848|FG004|Overall Study|Protocol Violation|0|||
127807901|NCT00749190|459915849|FG005|Overall Study|Protocol Violation|0|||
127807902|NCT00749190|459915850|FG006|Overall Study|Protocol Violation|1|||
127807903|NCT00749190|459915844|FG000|Overall Study|Other reason not defined above|0|||
127807904|NCT00749190|459915845|FG001|Overall Study|Other reason not defined above|0|||
127807905|NCT00749190|459915846|FG002|Overall Study|Other reason not defined above|0|||
127807906|NCT00749190|459915847|FG003|Overall Study|Other reason not defined above|1|||
127807907|NCT00749190|459915848|FG004|Overall Study|Other reason not defined above|0|||
127807908|NCT00749190|459915849|FG005|Overall Study|Other reason not defined above|0|||
127807909|NCT00749190|459915850|FG006|Overall Study|Other reason not defined above|0|||
127807910|NCT01245673|459915851|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
127807911|NCT00355121|459915853|FG000|Overall Study|Did not receive study vaccine|1|||
127807912|NCT00355121|459915854|FG001|Overall Study|Did not receive study vaccine|0|||
127807913|NCT00355121|459915855|FG002|Overall Study|Did not receive study vaccine|1|||
127807914|NCT00355121|459915853|FG000|Overall Study|Adverse Event|0|||
127807915|NCT00355121|459915854|FG001|Overall Study|Adverse Event|1|||
127807916|NCT00355121|459915855|FG002|Overall Study|Adverse Event|0|||
127807917|NCT00355121|459915853|FG000|Overall Study|Protocol Violation|7|||
127807918|NCT00355121|459915854|FG001|Overall Study|Protocol Violation|9|||
127807919|NCT00355121|459915855|FG002|Overall Study|Protocol Violation|1|||
127807920|NCT00355121|459915853|FG000|Overall Study|Lost to Follow-up|4|||
127807921|NCT00355121|459915854|FG001|Overall Study|Lost to Follow-up|7|||
127807922|NCT00355121|459915855|FG002|Overall Study|Lost to Follow-up|1|||
127807923|NCT00355121|459915853|FG000|Overall Study|Withdrawal by Subject|9|||
127807924|NCT00355121|459915854|FG001|Overall Study|Withdrawal by Subject|10|||
127807925|NCT00355121|459915855|FG002|Overall Study|Withdrawal by Subject|2|||
127807926|NCT00355121|459915853|FG000|Overall Study|Serious adverse events|0|||
127807927|NCT00355121|459915854|FG001|Overall Study|Serious adverse events|2|||
127807928|NCT00355121|459915855|FG002|Overall Study|Serious adverse events|0|||
127807929|NCT02040142|459915857|FG000|Overall Study|Lost to Follow-up|5|||
127807930|NCT02040142|459915857|FG000|Overall Study|Death|17|||
127807931|NCT02040142|459915857|FG000|Overall Study|Not Evaluable (Surgery and/or Treatment aborted but still enrolled)|14|||
127807932|NCT01565980|459915859|FG000|Overall Study|Death|1|||
127744219|NCT03614676|459691743|FG001|Overall Study|Protocol Violation|2|||
127744220|NCT03614676|459691742|FG000|Overall Study|Neonatal event of interest|0|||
127744221|NCT03614676|459691743|FG001|Overall Study|Neonatal event of interest|6|||
127744222|NCT03614676|459691742|FG000|Overall Study|Death in infant greater than 28 days old|0|||
127744223|NCT03614676|459691743|FG001|Overall Study|Death in infant greater than 28 days old|12|||
127744224|NCT03614676|459691742|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
127744225|NCT03614676|459691743|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
127744226|NCT00903760|459691744|FG000|Overall Study|Disease Progression/Death|8|||
127744227|NCT00903760|459691745|FG001|Overall Study|Disease Progression/Death|6|||
127744228|NCT00903760|459691744|FG000|Overall Study|Stem Cell Transplant|8|||
127744229|NCT00903760|459691745|FG001|Overall Study|Stem Cell Transplant|4|||
127744230|NCT00903760|459691744|FG000|Overall Study|Physician Decision|1|||
127744231|NCT00903760|459691745|FG001|Overall Study|Physician Decision|2|||
127744232|NCT00903760|459691744|FG000|Overall Study|Death|0|||
127744233|NCT00903760|459691745|FG001|Overall Study|Death|1|||
127744234|NCT00903760|459691744|FG000|Overall Study|Lost to Follow-up|1|||
127744235|NCT00903760|459691745|FG001|Overall Study|Lost to Follow-up|0|||
127744236|NCT00903760|459691744|FG000|Overall Study|Withdrawal by Subject|1|||
127744237|NCT00903760|459691745|FG001|Overall Study|Withdrawal by Subject|2|||
127744238|NCT00903760|459691744|FG000|Overall Study|Off treatment for long period|0|||
127744239|NCT00903760|459691745|FG001|Overall Study|Off treatment for long period|1|||
127744240|NCT02388347|459691746|FG000|Overall Study|Withdrawal by Subject|0|||
127744241|NCT02388347|459691747|FG001|Overall Study|Withdrawal by Subject|0|||
127744242|NCT02388347|459691748|FG002|Overall Study|Withdrawal by Subject|1|||
127744243|NCT02388347|459691749|FG003|Overall Study|Withdrawal by Subject|0|||
127744244|NCT02388347|459691750|FG004|Overall Study|Withdrawal by Subject|0|||
127744245|NCT02825251|459691752|FG000|Overall Study|Adverse Event|0|||
127744246|NCT02825251|459691753|FG001|Overall Study|Adverse Event|1|||
127744247|NCT02825251|459691752|FG000|Overall Study|Lost to Follow-up|0|||
127744248|NCT02825251|459691753|FG001|Overall Study|Lost to Follow-up|1|||
127744249|NCT02825251|459691752|FG000|Overall Study|Withdrawal by Subject|1|||
127893786|NCT00814320|460233327|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
127893787|NCT00814320|460233326|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
127893788|NCT00814320|460233327|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
127893789|NCT00814320|460233326|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
127893790|NCT00814320|460233327|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
127893791|NCT00814320|460233326|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
127893792|NCT00814320|460233327|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
127893793|NCT00814320|460233326|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
127893794|NCT00814320|460233327|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
127893795|NCT00814320|460233326|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
127893796|NCT00814320|460233327|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
127893797|NCT00814320|460233326|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
127893798|NCT00814320|460233327|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
127893799|NCT00491504|460233328|FG000|Overall Study|Adverse Event|0|||
127893800|NCT00491504|460233329|FG001|Overall Study|Adverse Event|1|||
127893801|NCT00491504|460233330|FG002|Overall Study|Adverse Event|0|||
127893802|NCT00491504|460233331|FG003|Overall Study|Adverse Event|0|||
127893803|NCT00491504|460233328|FG000|Overall Study|Withdrawal by Subject|0|||
127893804|NCT00491504|460233329|FG001|Overall Study|Withdrawal by Subject|0|||
127893805|NCT00491504|460233330|FG002|Overall Study|Withdrawal by Subject|1|||
127893806|NCT00491504|460233331|FG003|Overall Study|Withdrawal by Subject|2|||
127893807|NCT00491504|460233328|FG000|Overall Study|Protocol Violation|0|||
127893808|NCT00491504|460233329|FG001|Overall Study|Protocol Violation|0|||
127893809|NCT00491504|460233330|FG002|Overall Study|Protocol Violation|3|||
127893810|NCT00491504|460233331|FG003|Overall Study|Protocol Violation|2|||
127893811|NCT02789111|460233334|FG000|Overall Study|Withdrawal by Subject|1|||
127893812|NCT02789111|460233335|FG001|Overall Study|Withdrawal by Subject|4|||
127893813|NCT00601484|460233341|FG000|Overall Study|Adverse Event|0|||
127893814|NCT00601484|460233342|FG001|Overall Study|Adverse Event|1|||
127893815|NCT00601484|460233341|FG000|Overall Study|Lost to Follow-up|4|||
127893816|NCT00601484|460233342|FG001|Overall Study|Lost to Follow-up|3|||
127893817|NCT00601484|460233341|FG000|Overall Study|Lack of Efficacy|0|||
127744250|NCT02825251|459691753|FG001|Overall Study|Withdrawal by Subject|4|||
127744251|NCT02825251|459691752|FG000|Overall Study|Unclassified|2|||
127893818|NCT00601484|460233342|FG001|Overall Study|Lack of Efficacy|2|||
127893819|NCT00601484|460233341|FG000|Overall Study|Withdrawal by Subject|1|||
127893820|NCT00601484|460233342|FG001|Overall Study|Withdrawal by Subject|1|||
127893821|NCT00601484|460233341|FG000|Overall Study|Randomized, but not treated|0|||
127744252|NCT02825251|459691753|FG001|Overall Study|Unclassified|0|||
127744253|NCT01845805|459691754|FG000|Overall Study|Withdrawal by Subject|1|||
127744254|NCT01845805|459691755|FG001|Overall Study|Withdrawal by Subject|2|||
127744255|NCT01845805|459691754|FG000|Overall Study|Disease Progression|13|||
127744256|NCT01845805|459691755|FG001|Overall Study|Disease Progression|14|||
127744257|NCT01845805|459691754|FG000|Overall Study|Drug-related Toxicity|4|||
127744258|NCT01845805|459691755|FG001|Overall Study|Drug-related Toxicity|0|||
127744259|NCT02820597|459691757|FG000|Overall Study|Lost to Follow-up|12|||
127744260|NCT00575042|459691758|FG000|Overall Study|Adverse Event|2|||
127744261|NCT00575042|459691758|FG000|Overall Study|Lost to Follow-up|1|||
127744262|NCT04795336|459691759|FG000|Overall Study|Withdrawal by Subject|3|||
127744263|NCT04795336|459691760|FG001|Overall Study|Withdrawal by Subject|4|||
127744264|NCT04795336|459691761|FG002|Overall Study|Withdrawal by Subject|3|||
127744265|NCT04795336|459691762|FG003|Overall Study|Withdrawal by Subject|12|||
127744266|NCT04795336|459691759|FG000|Overall Study|Lost study logs|0|||
127744267|NCT04795336|459691760|FG001|Overall Study|Lost study logs|1|||
127744268|NCT04795336|459691761|FG002|Overall Study|Lost study logs|0|||
127744269|NCT04795336|459691762|FG003|Overall Study|Lost study logs|2|||
127744270|NCT04795336|459691759|FG000|Overall Study|Did not take study medication|2|||
127744271|NCT04795336|459691760|FG001|Overall Study|Did not take study medication|0|||
127744272|NCT04795336|459691761|FG002|Overall Study|Did not take study medication|0|||
127744273|NCT04795336|459691762|FG003|Overall Study|Did not take study medication|0|||
127744274|NCT00810342|459691766|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
127744275|NCT00810342|459691767|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
127744276|NCT00810342|459691766|FG000|Month 1 Follow-up|Pregnancy|1|||
127744277|NCT00810342|459691767|FG001|Month 1 Follow-up|Pregnancy|0|||
127744278|NCT00810342|459691766|FG000|6-month Follow-up|Lost to Follow-up|18|||
127744279|NCT00810342|459691767|FG001|6-month Follow-up|Lost to Follow-up|6|||
127744280|NCT00810342|459691766|FG000|6-month Follow-up|Pregnancy|6|||
127744281|NCT00810342|459691767|FG001|6-month Follow-up|Pregnancy|2|||
127744282|NCT00810342|459691766|FG000|12-month Followup|Pregnancy|9|||
127744283|NCT00810342|459691767|FG001|12-month Followup|Pregnancy|10|||
127744284|NCT00810342|459691766|FG000|12-month Followup|Lost to Follow-up|3|||
127744285|NCT00810342|459691767|FG001|12-month Followup|Lost to Follow-up|1|||
127744286|NCT04504630|459691768|FG000|Assigned to Treatment|Withdrawal by Subject|2|||
127744287|NCT04504630|459691769|FG001|Assigned to Treatment|Withdrawal by Subject|0|||
127744288|NCT04504630|459691768|FG000|Follow-Up at 3 Months|Lost to Follow-up|3|||
127744289|NCT04504630|459691769|FG001|Follow-Up at 3 Months|Lost to Follow-up|1|||
127744290|NCT02229578|459691789|FG000|Overall Study|Withdrawal by Subject|1|||
127744291|NCT02229578|459691790|FG001|Overall Study|Withdrawal by Subject|3|||
127744292|NCT02229578|459691789|FG000|Overall Study|Protocol Violation|2|||
127744293|NCT02229578|459691790|FG001|Overall Study|Protocol Violation|0|||
127744294|NCT00943787|459691792|FG000|Overall Study|Physician Decision|4|||
127744295|NCT00943787|459691792|FG000|Overall Study|Withdrawal by Subject|3|||
127744296|NCT02706951|459691793|FG000|Period 1|Adverse Event|1|||
127744297|NCT02706951|459691794|FG001|Period 1|Adverse Event|5|||
127744298|NCT02706951|459691795|FG002|Period 1|Adverse Event|3|||
127744299|NCT02706951|459691796|FG003|Period 1|Adverse Event|0|||
127744300|NCT02706951|459691797|FG004|Period 1|Adverse Event|0|||
127744301|NCT02706951|459691793|FG000|Period 1|Withdrawal by Subject|10|||
127744302|NCT02706951|459691794|FG001|Period 1|Withdrawal by Subject|6|||
127744303|NCT02706951|459691795|FG002|Period 1|Withdrawal by Subject|6|||
127744304|NCT02706951|459691796|FG003|Period 1|Withdrawal by Subject|0|||
127744305|NCT02706951|459691797|FG004|Period 1|Withdrawal by Subject|0|||
127744306|NCT02706951|459691793|FG000|Period 1|Lost to Follow-up|0|||
127744307|NCT02706951|459691794|FG001|Period 1|Lost to Follow-up|4|||
127744308|NCT02706951|459691795|FG002|Period 1|Lost to Follow-up|1|||
127744309|NCT02706951|459691796|FG003|Period 1|Lost to Follow-up|0|||
127744310|NCT02706951|459691797|FG004|Period 1|Lost to Follow-up|0|||
127744311|NCT02706951|459691793|FG000|Period 1|Other|2|||
127744312|NCT02706951|459691794|FG001|Period 1|Other|1|||
127744313|NCT02706951|459691795|FG002|Period 1|Other|0|||
127744314|NCT02706951|459691796|FG003|Period 1|Other|0|||
127744315|NCT02706951|459691797|FG004|Period 1|Other|0|||
127744316|NCT02706951|459691793|FG000|Period 2|Adverse Event|0|||
127744317|NCT02706951|459691794|FG001|Period 2|Adverse Event|0|||
127744318|NCT02706951|459691795|FG002|Period 2|Adverse Event|0|||
127744319|NCT02706951|459691796|FG003|Period 2|Adverse Event|25|||
127744320|NCT02706951|459691797|FG004|Period 2|Adverse Event|34|||
127744321|NCT02706951|459691793|FG000|Period 2|Withdrawal by Subject|0|||
127744322|NCT02706951|459691794|FG001|Period 2|Withdrawal by Subject|0|||
127744323|NCT02706951|459691795|FG002|Period 2|Withdrawal by Subject|0|||
127744324|NCT02706951|459691796|FG003|Period 2|Withdrawal by Subject|38|||
127744325|NCT02706951|459691797|FG004|Period 2|Withdrawal by Subject|44|||
127744326|NCT02706951|459691793|FG000|Period 2|Lost to Follow-up|0|||
127744327|NCT02706951|459691794|FG001|Period 2|Lost to Follow-up|0|||
127744328|NCT02706951|459691795|FG002|Period 2|Lost to Follow-up|0|||
127744329|NCT02706951|459691796|FG003|Period 2|Lost to Follow-up|17|||
127744330|NCT02706951|459691797|FG004|Period 2|Lost to Follow-up|9|||
127744331|NCT02706951|459691793|FG000|Period 2|COVID-19 Related|0|||
127744332|NCT02706951|459691794|FG001|Period 2|COVID-19 Related|0|||
127744333|NCT02706951|459691795|FG002|Period 2|COVID-19 Related|0|||
127744334|NCT02706951|459691796|FG003|Period 2|COVID-19 Related|1|||
127744335|NCT02706951|459691797|FG004|Period 2|COVID-19 Related|2|||
127744336|NCT02706951|459691793|FG000|Period 2|Other|0|||
127744337|NCT02706951|459691794|FG001|Period 2|Other|0|||
127744338|NCT02706951|459691795|FG002|Period 2|Other|0|||
127744339|NCT02706951|459691796|FG003|Period 2|Other|37|||
127744340|NCT02706951|459691797|FG004|Period 2|Other|31|||
127744341|NCT04294667|459691798|FG000|Overall Study|Lack of Efficacy|4|||
127744342|NCT04294667|459691799|FG001|Overall Study|Lack of Efficacy|4|||
127744343|NCT04294667|459691798|FG000|Overall Study|Consent Withdrawal by Study Participant|9|||
127744344|NCT04294667|459691799|FG001|Overall Study|Consent Withdrawal by Study Participant|7|||
127744345|NCT04294667|459691798|FG000|Overall Study|Patient has a Renal Flare|1|||
127744346|NCT04294667|459691799|FG001|Overall Study|Patient has a Renal Flare|0|||
127744347|NCT04294667|459691798|FG000|Overall Study|SLE Worsening|0|||
127744348|NCT04294667|459691799|FG001|Overall Study|SLE Worsening|1|||
127744349|NCT04294667|459691798|FG000|Overall Study|Subject Decision due to Personal Reason|0|||
127744350|NCT04294667|459691799|FG001|Overall Study|Subject Decision due to Personal Reason|1|||
127744351|NCT04294667|459691798|FG000|Overall Study|PI closed Site - Subject Early Withdrawal|0|||
127744352|NCT04294667|459691799|FG001|Overall Study|PI closed Site - Subject Early Withdrawal|1|||
127744353|NCT04294667|459691798|FG000|Overall Study|Subject Withdrew due to Personal Reason|0|||
127744354|NCT04294667|459691799|FG001|Overall Study|Subject Withdrew due to Personal Reason|1|||
127744355|NCT04294667|459691798|FG000|Overall Study|Subject Moved to Another State|0|||
127744356|NCT04294667|459691799|FG001|Overall Study|Subject Moved to Another State|1|||
127744357|NCT04294667|459691798|FG000|Overall Study|Adverse event, serious fatal|0|||
127744358|NCT04294667|459691799|FG001|Overall Study|Adverse event, serious fatal|1|||
127744359|NCT04294667|459691798|FG000|Overall Study|Adverse event, non-fatal|3|||
127744360|NCT04294667|459691799|FG001|Overall Study|Adverse event, non-fatal|4|||
127744361|NCT02599688|459691800|FG000|Overall Study|Lack of Efficacy|1|||
127744362|NCT02599688|459691800|FG000|Overall Study|Withdrawal by Subject|1|||
127744363|NCT02599688|459691800|FG000|Overall Study|Termination by Sponsor|2|||
127744364|NCT01841697|459691801|FG000|Overall Study|Death|0|||
127744365|NCT01841697|459691802|FG001|Overall Study|Death|1|||
127744366|NCT01841697|459691801|FG000|Overall Study|Lost to Follow-up|4|||
127744367|NCT01841697|459691802|FG001|Overall Study|Lost to Follow-up|1|||
127744368|NCT01841697|459691801|FG000|Overall Study|Withdrawal by Subject|16|||
127744369|NCT01841697|459691802|FG001|Overall Study|Withdrawal by Subject|16|||
127744370|NCT00756457|459691803|FG000|Overall Study|Lost to Follow-up|1|||
127744371|NCT00756457|459691804|FG001|Overall Study|Lost to Follow-up|2|||
127744372|NCT02635386|459691805|FG000|Overall Study|Pregnancy|2|||
127744373|NCT02635386|459691806|FG001|Overall Study|Pregnancy|0|||
127744374|NCT02635386|459691807|FG002|Overall Study|Pregnancy|0|||
127744375|NCT02635386|459691808|FG003|Overall Study|Pregnancy|0|||
127744376|NCT02635386|459691809|FG004|Overall Study|Pregnancy|2|||
127744377|NCT02635386|459691805|FG000|Overall Study|Withdrawal by Subject|1|||
127744378|NCT02635386|459691806|FG001|Overall Study|Withdrawal by Subject|1|||
127744379|NCT02635386|459691807|FG002|Overall Study|Withdrawal by Subject|0|||
127744380|NCT02635386|459691808|FG003|Overall Study|Withdrawal by Subject|1|||
127744381|NCT02635386|459691809|FG004|Overall Study|Withdrawal by Subject|0|||
127744382|NCT02635386|459691805|FG000|Overall Study|Physician Decision|0|||
127744383|NCT02635386|459691806|FG001|Overall Study|Physician Decision|1|||
127744384|NCT02635386|459691807|FG002|Overall Study|Physician Decision|0|||
127744385|NCT02635386|459691808|FG003|Overall Study|Physician Decision|0|||
127744386|NCT02635386|459691809|FG004|Overall Study|Physician Decision|0|||
127744387|NCT02635386|459691805|FG000|Overall Study|Moved Out of State|0|||
127744388|NCT02635386|459691806|FG001|Overall Study|Moved Out of State|1|||
127744389|NCT02635386|459691807|FG002|Overall Study|Moved Out of State|0|||
127744390|NCT02635386|459691808|FG003|Overall Study|Moved Out of State|0|||
127744391|NCT02635386|459691809|FG004|Overall Study|Moved Out of State|0|||
127744392|NCT02635386|459691805|FG000|Overall Study|Noncompliant|0|||
127807933|NCT01565980|459915860|FG001|Overall Study|Death|0|||
127807934|NCT01565980|459915859|FG000|Overall Study|Lost to Follow-up|1|||
127807935|NCT01565980|459915860|FG001|Overall Study|Lost to Follow-up|0|||
127807936|NCT01565980|459915859|FG000|Overall Study|health complications|1|||
127807937|NCT01565980|459915860|FG001|Overall Study|health complications|1|||
127807938|NCT01565980|459915859|FG000|Overall Study|stopped medical treatment|1|||
127807939|NCT01565980|459915860|FG001|Overall Study|stopped medical treatment|0|||
127807940|NCT01565980|459915859|FG000|Overall Study|Withdrawal by Subject|0|||
127807941|NCT01565980|459915860|FG001|Overall Study|Withdrawal by Subject|3|||
127807942|NCT03219164|459917715|FG000|Overall Study|Study Terminated by Sponsor|16|||
127807943|NCT03219164|459917716|FG001|Overall Study|Study Terminated by Sponsor|12|||
127807944|NCT03219164|459917715|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
127744393|NCT02635386|459691806|FG001|Overall Study|Noncompliant|2|||
127744394|NCT02635386|459691807|FG002|Overall Study|Noncompliant|1|||
127744395|NCT02635386|459691808|FG003|Overall Study|Noncompliant|1|||
127744396|NCT02635386|459691809|FG004|Overall Study|Noncompliant|1|||
127807945|NCT03219164|459917716|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
127744397|NCT02635386|459691805|FG000|Overall Study|side effects|0|||
127744398|NCT02635386|459691806|FG001|Overall Study|side effects|0|||
127744399|NCT02635386|459691807|FG002|Overall Study|side effects|1|||
127744400|NCT02635386|459691808|FG003|Overall Study|side effects|4|||
127744401|NCT02635386|459691809|FG004|Overall Study|side effects|6|||
127744402|NCT02635386|459691805|FG000|Overall Study|needed other major surgery|0|||
127744403|NCT02635386|459691806|FG001|Overall Study|needed other major surgery|1|||
127807946|NCT03219164|459917715|FG000|Overall Study|Lost to Follow-up|1|||
127744404|NCT02635386|459691807|FG002|Overall Study|needed other major surgery|0|||
127744405|NCT02635386|459691808|FG003|Overall Study|needed other major surgery|0|||
127744406|NCT02635386|459691809|FG004|Overall Study|needed other major surgery|0|||
127744407|NCT02635386|459691805|FG000|Overall Study|Other medical problems not drug related|0|||
127744408|NCT02635386|459691806|FG001|Overall Study|Other medical problems not drug related|0|||
127744409|NCT02635386|459691807|FG002|Overall Study|Other medical problems not drug related|0|||
127744410|NCT02635386|459691808|FG003|Overall Study|Other medical problems not drug related|1|||
127744411|NCT02635386|459691809|FG004|Overall Study|Other medical problems not drug related|0|||
127744412|NCT00085566|459691813|FG000|Overall Study|Adverse Event|0|||
127744413|NCT00085566|459691814|FG001|Overall Study|Adverse Event|0|||
127744414|NCT00085566|459691815|FG002|Overall Study|Adverse Event|10|||
127744415|NCT00085566|459691813|FG000|Overall Study|Patient Not treated|0|||
127744416|NCT00085566|459691814|FG001|Overall Study|Patient Not treated|0|||
127744417|NCT00085566|459691815|FG002|Overall Study|Patient Not treated|3|||
127744418|NCT00085566|459691813|FG000|Overall Study|Clinical progression|0|||
127744419|NCT00085566|459691814|FG001|Overall Study|Clinical progression|0|||
127744420|NCT00085566|459691815|FG002|Overall Study|Clinical progression|1|||
127744421|NCT03174782|459691816|FG000|Overall Study|Protocol Violation|1|||
127744422|NCT03174782|459691817|FG001|Overall Study|Protocol Violation|0|||
127744423|NCT03174782|459691816|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
127744424|NCT03174782|459691817|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
127744425|NCT03178045|459691818|FG000|Overall Study|Withdrawal by Subject|5|||
127744426|NCT03178045|459691819|FG001|Overall Study|Withdrawal by Subject|7|||
127744427|NCT03178045|459691818|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
127744428|NCT03178045|459691819|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
127744429|NCT03178045|459691818|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
127744430|NCT03178045|459691819|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
127744431|NCT01163474|459691820|FG000|Overall Study|Withdrawal by Subject|1|||
127744432|NCT01163474|459691820|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
127744433|NCT01163474|459691820|FG000|Overall Study|Lost to Follow-up|3|||
127744434|NCT01078922|459691821|FG000|Overall Study|Adverse Event|1|||
127744435|NCT02706847|459691824|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
127744436|NCT02706847|459691825|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
127744437|NCT02706847|459691826|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
127744438|NCT02706847|459691827|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
127744439|NCT02706847|459691824|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
127744440|NCT02706847|459691825|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
127744441|NCT02706847|459691826|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
127744442|NCT02706847|459691827|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
127744443|NCT02706847|459691824|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
127744444|NCT02706847|459691825|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
127744445|NCT02706847|459691826|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
127744446|NCT02706847|459691827|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
127744447|NCT02706847|459691824|FG000|Period 1: Day 1 to Week 12|Other|4|||
127744448|NCT02706847|459691825|FG001|Period 1: Day 1 to Week 12|Other|4|||
127744449|NCT02706847|459691826|FG002|Period 1: Day 1 to Week 12|Other|2|||
127744450|NCT02706847|459691827|FG003|Period 1: Day 1 to Week 12|Other|2|||
127744451|NCT02706847|459691824|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
127744452|NCT02706847|459691825|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
127744453|NCT02706847|459691826|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
127744454|NCT02706847|459691827|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
127744455|NCT02706847|459691824|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
127744456|NCT02706847|459691825|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
127744457|NCT02706847|459691826|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
127807947|NCT03219164|459917716|FG001|Overall Study|Lost to Follow-up|1|||
127807948|NCT03219164|459917715|FG000|Overall Study|Adverse Event|1|||
127807949|NCT03219164|459917716|FG001|Overall Study|Adverse Event|0|||
127744458|NCT02706847|459691827|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
127744459|NCT02706847|459691824|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
127744460|NCT02706847|459691825|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
127744461|NCT02706847|459691826|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
127744462|NCT02706847|459691827|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
127744463|NCT02706847|459691824|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
127744464|NCT02706847|459691825|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
127744465|NCT02706847|459691826|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
127744466|NCT02706847|459691827|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
127744467|NCT02706847|459691824|FG000|Period 1: Week 12 to Week 24|Other|1|||
127744468|NCT02706847|459691825|FG001|Period 1: Week 12 to Week 24|Other|0|||
127744469|NCT02706847|459691826|FG002|Period 1: Week 12 to Week 24|Other|1|||
127744470|NCT02706847|459691827|FG003|Period 1: Week 12 to Week 24|Other|4|||
127744471|NCT02706847|459691824|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
127807950|NCT03219164|459917715|FG000|Overall Study|Non-Compliance with Study Drug|1|||
127744472|NCT02706847|459691825|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
127744473|NCT02706847|459691826|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
127744474|NCT02706847|459691827|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
127744475|NCT02706847|459691824|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
127744476|NCT02706847|459691825|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
127744477|NCT02706847|459691826|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
127744478|NCT02706847|459691827|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
127744479|NCT02706847|459691824|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
127744480|NCT02706847|459691825|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
127744481|NCT02706847|459691826|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
127744482|NCT02706847|459691827|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
127744483|NCT02706847|459691824|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
127744484|NCT02706847|459691825|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
127744485|NCT02706847|459691826|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
127744486|NCT02706847|459691827|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
127744487|NCT02706847|459691824|FG000|Period 2: Week 24 to Week 260|Other|8|||
127744488|NCT02706847|459691825|FG001|Period 2: Week 24 to Week 260|Other|5|||
127744489|NCT02706847|459691826|FG002|Period 2: Week 24 to Week 260|Other|15|||
127744490|NCT02706847|459691827|FG003|Period 2: Week 24 to Week 260|Other|15|||
127744491|NCT02689453|459691834|FG000|Overall Study|Progressive disease|0|||
127744492|NCT02689453|459691835|FG001|Overall Study|Progressive disease|1|||
127744493|NCT02689453|459691836|FG002|Overall Study|Progressive disease|1|||
127744494|NCT04206085|459691837|FG000|Overall Study|Lost to Follow-up|0|||
127744495|NCT04206085|459691838|FG001|Overall Study|Lost to Follow-up|1|||
127744496|NCT04206085|459691839|FG002|Overall Study|Lost to Follow-up|0|||
127744497|NCT04206085|459691837|FG000|Overall Study|Lost to Follow-up|0|||
127744498|NCT04206085|459691838|FG001|Overall Study|Lost to Follow-up|0|||
127744499|NCT04206085|459691839|FG002|Overall Study|Lost to Follow-up|1|||
127744500|NCT00763451|459691840|FG000|Overall Study|Adverse Event|4|||
127744501|NCT00763451|459691841|FG001|Overall Study|Adverse Event|6|||
127744502|NCT00763451|459691842|FG002|Overall Study|Adverse Event|19|||
127744503|NCT00763451|459691843|FG003|Overall Study|Adverse Event|14|||
127744504|NCT00763451|459691840|FG000|Overall Study|Lack of Efficacy|1|||
127744505|NCT00763451|459691841|FG001|Overall Study|Lack of Efficacy|4|||
127744506|NCT00763451|459691842|FG002|Overall Study|Lack of Efficacy|3|||
127744507|NCT00763451|459691843|FG003|Overall Study|Lack of Efficacy|2|||
127744508|NCT00763451|459691840|FG000|Overall Study|Withdrawal by Subject|1|||
127744509|NCT00763451|459691841|FG001|Overall Study|Withdrawal by Subject|6|||
127744510|NCT00763451|459691842|FG002|Overall Study|Withdrawal by Subject|9|||
127744511|NCT00763451|459691843|FG003|Overall Study|Withdrawal by Subject|7|||
127744512|NCT00763451|459691840|FG000|Overall Study|Protocol Violation|0|||
127744513|NCT00763451|459691841|FG001|Overall Study|Protocol Violation|0|||
127744514|NCT00763451|459691842|FG002|Overall Study|Protocol Violation|1|||
127744515|NCT00763451|459691843|FG003|Overall Study|Protocol Violation|0|||
127744516|NCT00763451|459691840|FG000|Overall Study|Poor Compliance to Protocol|1|||
127744517|NCT00763451|459691841|FG001|Overall Study|Poor Compliance to Protocol|1|||
127744518|NCT00763451|459691842|FG002|Overall Study|Poor Compliance to Protocol|2|||
127744519|NCT00763451|459691843|FG003|Overall Study|Poor Compliance to Protocol|2|||
127744520|NCT00763451|459691840|FG000|Overall Study|Familial and Personal Reasons|5|||
127744521|NCT00763451|459691841|FG001|Overall Study|Familial and Personal Reasons|3|||
127744522|NCT00763451|459691842|FG002|Overall Study|Familial and Personal Reasons|5|||
127744523|NCT00763451|459691843|FG003|Overall Study|Familial and Personal Reasons|4|||
127744524|NCT00763451|459691840|FG000|Overall Study|Randomized but not Treated|1|||
127744525|NCT00763451|459691841|FG001|Overall Study|Randomized but not Treated|1|||
127744526|NCT00763451|459691842|FG002|Overall Study|Randomized but not Treated|0|||
127744527|NCT00763451|459691843|FG003|Overall Study|Randomized but not Treated|0|||
127744528|NCT00763451|459691840|FG000|Overall Study|Study Site Reason|0|||
127744529|NCT00763451|459691841|FG001|Overall Study|Study Site Reason|1|||
127744530|NCT00763451|459691842|FG002|Overall Study|Study Site Reason|1|||
127744531|NCT00763451|459691843|FG003|Overall Study|Study Site Reason|1|||
127744532|NCT00725543|459691847|FG000|Overall Study|Adverse Event|10|||
127744533|NCT00725543|459691847|FG000|Overall Study|Lack of Efficacy|3|||
127744534|NCT00725543|459691847|FG000|Overall Study|Withdrawal by Subject|10|||
127744535|NCT00725543|459691847|FG000|Overall Study|Physician Decision|5|||
127744536|NCT00725543|459691847|FG000|Overall Study|Lost to Follow-up|4|||
127744537|NCT00725543|459691847|FG000|Overall Study|Non-compliance|2|||
127744538|NCT00725543|459691847|FG000|Overall Study|Other|119|||
127744539|NCT05594589|459691848|FG000|Overall Study|Other|0|||
127744540|NCT05594589|459691849|FG001|Overall Study|Other|1|||
127744541|NCT05594589|459691850|FG002|Overall Study|Other|0|||
127744542|NCT00087555|459691857|FG000|Overall Study|Adverse Event|3|||
127744543|NCT00087555|459691858|FG001|Overall Study|Adverse Event|6|||
127744544|NCT00087555|459691859|FG002|Overall Study|Adverse Event|14|||
127744545|NCT00087555|459691857|FG000|Overall Study|Lost to Follow-up|0|||
127744546|NCT00087555|459691858|FG001|Overall Study|Lost to Follow-up|1|||
127744547|NCT00087555|459691859|FG002|Overall Study|Lost to Follow-up|1|||
127744548|NCT00087555|459691857|FG000|Overall Study|Non - Compliance|1|||
127744549|NCT00087555|459691858|FG001|Overall Study|Non - Compliance|0|||
127744550|NCT00087555|459691859|FG002|Overall Study|Non - Compliance|0|||
127744551|NCT00087555|459691857|FG000|Overall Study|Protocol Violation|0|||
127744552|NCT00087555|459691858|FG001|Overall Study|Protocol Violation|0|||
127744553|NCT00087555|459691859|FG002|Overall Study|Protocol Violation|2|||
127744554|NCT00087555|459691857|FG000|Overall Study|Screen Failure|1|||
127744555|NCT00087555|459691858|FG001|Overall Study|Screen Failure|1|||
127744556|NCT00087555|459691859|FG002|Overall Study|Screen Failure|0|||
127744557|NCT00087555|459691857|FG000|Overall Study|Pregnancy|0|||
127744558|NCT00087555|459691858|FG001|Overall Study|Pregnancy|1|||
127744559|NCT00087555|459691859|FG002|Overall Study|Pregnancy|1|||
127744560|NCT00087555|459691857|FG000|Overall Study|Withdrawal by Subject|3|||
127744561|NCT00087555|459691858|FG001|Overall Study|Withdrawal by Subject|2|||
127744562|NCT00087555|459691859|FG002|Overall Study|Withdrawal by Subject|1|||
127744563|NCT00087555|459691857|FG000|Overall Study|Lack of Efficacy|2|||
127744564|NCT00087555|459691858|FG001|Overall Study|Lack of Efficacy|0|||
127744565|NCT00087555|459691859|FG002|Overall Study|Lack of Efficacy|1|||
127744566|NCT00087555|459691857|FG000|Overall Study|Non Compliance|0|||
127744567|NCT00087555|459691858|FG001|Overall Study|Non Compliance|0|||
127744568|NCT00087555|459691859|FG002|Overall Study|Non Compliance|1|||
127744569|NCT00087555|459691857|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
127744570|NCT00087555|459691858|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
127744571|NCT00087555|459691859|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
127744572|NCT00087555|459691857|FG000|Overall Study|Patient wanted to go back on Med|1|||
127744573|NCT00087555|459691858|FG001|Overall Study|Patient wanted to go back on Med|0|||
127744574|NCT00087555|459691859|FG002|Overall Study|Patient wanted to go back on Med|0|||
127744575|NCT02344173|459691860|FG000|Procedure|Ablation Procedure Not Performed|7|||
127744576|NCT02344173|459691860|FG000|12-month Visit|Death|8|||
127744577|NCT02344173|459691860|FG000|12-month Visit|Withdrawal by Subject|30|||
127744578|NCT02344173|459691860|FG000|12-month Visit|Lost to Follow-up|58|||
127744579|NCT03845023|459691861|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
127744580|NCT03845023|459691862|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
127744581|NCT03845023|459691863|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
127744582|NCT03845023|459691864|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
127744583|NCT03845023|459691861|FG000|Follow-Up (14 Days)|Adverse Event|0|||
127744584|NCT03845023|459691862|FG001|Follow-Up (14 Days)|Adverse Event|0|||
127744585|NCT03845023|459691863|FG002|Follow-Up (14 Days)|Adverse Event|1|||
127744586|NCT03845023|459691864|FG003|Follow-Up (14 Days)|Adverse Event|1|||
127744587|NCT03772613|459691865|FG000|Overall Study|Lost to Follow-up|0|||
127744588|NCT03772613|459691866|FG001|Overall Study|Lost to Follow-up|1|||
127807951|NCT03219164|459917716|FG001|Overall Study|Non-Compliance with Study Drug|0|||
127807952|NCT03219164|459917715|FG000|Overall Study|Protocol Violation|0|||
127807953|NCT03219164|459917716|FG001|Overall Study|Protocol Violation|1|||
127807954|NCT03219164|459917715|FG000|Overall Study|Withdrew Assent|1|||
127807955|NCT03219164|459917716|FG001|Overall Study|Withdrew Assent|0|||
127744589|NCT03772613|459691867|FG002|Overall Study|Lost to Follow-up|1|||
127744590|NCT01427738|459691868|FG000|Overall Study|Death|12|||
127744591|NCT01427738|459691869|FG001|Overall Study|Death|9|||
127744592|NCT01427738|459691868|FG000|Overall Study|Severe debilitation, unable to continue|0|||
127744593|NCT01427738|459691869|FG001|Overall Study|Severe debilitation, unable to continue|1|||
127744594|NCT01427738|459691868|FG000|Overall Study|Subject unable to get to clinic|5|||
127744595|NCT01427738|459691869|FG001|Overall Study|Subject unable to get to clinic|2|||
127744596|NCT01427738|459691868|FG000|Overall Study|Withdrawal by Subject|0|||
127744597|NCT01427738|459691869|FG001|Overall Study|Withdrawal by Subject|2|||
127744598|NCT01427738|459691868|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
127744599|NCT01427738|459691869|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
127744600|NCT01427738|459691868|FG000|Overall Study|Lost to Follow-up|1|||
127744601|NCT01427738|459691869|FG001|Overall Study|Lost to Follow-up|5|||
127744602|NCT05314374|459691870|FG000|Overall Study|Adverse Event|2|||
127744603|NCT05314374|459691871|FG001|Overall Study|Adverse Event|2|||
127744604|NCT02658175|459691872|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
127744605|NCT02658175|459691873|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
127744606|NCT02658175|459691874|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
127744607|NCT02658175|459691872|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
127807956|NCT02689492|459917717|FG000|Overall Study|Lost to Follow-up|61|||
127744608|NCT02658175|459691873|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
127744609|NCT02658175|459691874|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
127744610|NCT02658175|459691872|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
127744611|NCT02658175|459691873|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
127744612|NCT02658175|459691874|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
127744613|NCT02658175|459691872|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
127744614|NCT02658175|459691873|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
127744615|NCT02658175|459691874|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
127744616|NCT02658175|459691872|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
127744617|NCT02658175|459691873|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
127744618|NCT02658175|459691874|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
127744619|NCT02658175|459691872|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
127744620|NCT02658175|459691873|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
127744621|NCT02658175|459691874|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
127744622|NCT02658175|459691872|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
127744623|NCT02658175|459691873|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
127744624|NCT02658175|459691874|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
127744625|NCT02658175|459691872|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
127744626|NCT02658175|459691873|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
127744627|NCT02658175|459691874|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
127744628|NCT02658175|459691872|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
127744629|NCT02658175|459691873|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
127744630|NCT02658175|459691874|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
127744631|NCT02658175|459691872|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
127744632|NCT02658175|459691873|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
127744633|NCT02658175|459691874|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
127744634|NCT02554383|459691875|FG000|Overall Study|Ineligible|3|||
127744635|NCT02554383|459691876|FG001|Overall Study|Ineligible|2|||
127744636|NCT02554383|459691875|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
127744637|NCT02554383|459691876|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
127744638|NCT02554383|459691875|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
127744639|NCT02554383|459691876|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
127744640|NCT02554383|459691875|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
127744641|NCT02554383|459691876|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
127744642|NCT01214421|459691879|FG000|Overall Study|Lost to Follow-up|7|||
127744643|NCT01214421|459691880|FG001|Overall Study|Lost to Follow-up|3|||
127744644|NCT01214421|459691881|FG002|Overall Study|Lost to Follow-up|7|||
127744645|NCT01214421|459691882|FG003|Overall Study|Lost to Follow-up|3|||
127744646|NCT01214421|459691879|FG000|Overall Study|Adverse Event|16|||
127744647|NCT01214421|459691880|FG001|Overall Study|Adverse Event|35|||
127744648|NCT01214421|459691881|FG002|Overall Study|Adverse Event|14|||
127744649|NCT01214421|459691882|FG003|Overall Study|Adverse Event|3|||
127744650|NCT01214421|459691879|FG000|Overall Study|Sponsor Discontinued Site|1|||
127744651|NCT01214421|459691880|FG001|Overall Study|Sponsor Discontinued Site|2|||
127744652|NCT01214421|459691881|FG002|Overall Study|Sponsor Discontinued Site|0|||
127744653|NCT01214421|459691882|FG003|Overall Study|Sponsor Discontinued Site|0|||
127744654|NCT01214421|459691879|FG000|Overall Study|Withdrawal Criteria Met|3|||
127744655|NCT01214421|459691880|FG001|Overall Study|Withdrawal Criteria Met|0|||
127744656|NCT01214421|459691881|FG002|Overall Study|Withdrawal Criteria Met|2|||
127744657|NCT01214421|459691882|FG003|Overall Study|Withdrawal Criteria Met|1|||
127744658|NCT01214421|459691879|FG000|Overall Study|Physician Decision|2|||
127744659|NCT01214421|459691880|FG001|Overall Study|Physician Decision|0|||
127744660|NCT01214421|459691881|FG002|Overall Study|Physician Decision|4|||
127744661|NCT01214421|459691882|FG003|Overall Study|Physician Decision|0|||
127744662|NCT01214421|459691879|FG000|Overall Study|Withdrawal by Subject|21|||
127744663|NCT01214421|459691880|FG001|Overall Study|Withdrawal by Subject|18|||
127744664|NCT01214421|459691881|FG002|Overall Study|Withdrawal by Subject|11|||
127744665|NCT01214421|459691882|FG003|Overall Study|Withdrawal by Subject|2|||
127744666|NCT02581059|459691885|FG000|Study Treatment|Disease Progression|1|||
127744667|NCT02581059|459691886|FG001|Study Treatment|Disease Progression|1|||
127893822|NCT00601484|460233342|FG001|Overall Study|Randomized, but not treated|1|||
127893823|NCT01463683|460233346|FG000|Overall Study|Adverse Event|2|||
127893824|NCT01463683|460233347|FG001|Overall Study|Adverse Event|0|||
127744668|NCT02581059|459691885|FG000|Study Treatment|Adverse Event|2|||
127744669|NCT02581059|459691886|FG001|Study Treatment|Adverse Event|1|||
127744670|NCT02581059|459691885|FG000|Study Treatment|Death|1|||
127744671|NCT02581059|459691886|FG001|Study Treatment|Death|1|||
127744672|NCT02581059|459691885|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
127744673|NCT02581059|459691886|FG001|Study Treatment|Patient Withdrawal After Therapy Start|1|||
127744674|NCT02581059|459691885|FG000|Study Treatment|Screen Failure Before Therapy Start|0|||
127744675|NCT02581059|459691886|FG001|Study Treatment|Screen Failure Before Therapy Start|1|||
127744676|NCT02581059|459691885|FG000|Follow up|Death|1|||
127744677|NCT02581059|459691886|FG001|Follow up|Death|3|||
127744678|NCT02581059|459691885|FG000|Follow up|study terminated|1|||
127744679|NCT02581059|459691886|FG001|Follow up|study terminated|1|||
127744680|NCT02581059|459691885|FG000|Follow up|screen failure|0|||
127744681|NCT02581059|459691886|FG001|Follow up|screen failure|1|||
127744682|NCT02581059|459691885|FG000|Follow up|Patient started new clinical trial|1|||
127744683|NCT02581059|459691886|FG001|Follow up|Patient started new clinical trial|0|||
127744684|NCT02392104|459691887|FG000|Overall Study|discontinuation of warfarin|3|||
127744685|NCT02392104|459691887|FG000|Overall Study|bleeding event|1|||
127744686|NCT02392104|459691887|FG000|Overall Study|transferred care to another doctor|2|||
127744687|NCT02392104|459691887|FG000|Overall Study|INR goal range changed|1|||
127744688|NCT02392104|459691887|FG000|Overall Study|admitted to skilled nursing facility|3|||
127744689|NCT02392104|459691887|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
127744690|NCT04887506|459691890|FG000|Overall Study|Death|1|||
127744691|NCT04887506|459691891|FG001|Overall Study|Death|1|||
127744692|NCT04887506|459691890|FG000|Overall Study|Withdrawal by Subject|0|||
127744693|NCT04887506|459691891|FG001|Overall Study|Withdrawal by Subject|3|||
127744694|NCT04887506|459691890|FG000|Overall Study|Adverse Event|4|||
127744695|NCT04887506|459691891|FG001|Overall Study|Adverse Event|3|||
127744696|NCT04887506|459691890|FG000|Overall Study|Other - Not Reported|1|||
127744697|NCT04887506|459691891|FG001|Overall Study|Other - Not Reported|1|||
127744698|NCT02394665|459691894|FG000|Overall Study|Physician Decision|1|||
127744699|NCT02394665|459691895|FG001|Overall Study|Physician Decision|0|||
127744700|NCT02394665|459691896|FG002|Overall Study|Physician Decision|0|||
127744701|NCT02636608|459691897|FG000|Overall Study|Failure to Return|4|||
127744702|NCT02636608|459691897|FG000|Overall Study|Insufficient Virological Response|1|||
127744703|NCT02636608|459691897|FG000|Overall Study|Death|3|||
127744704|NCT02636608|459691897|FG000|Overall Study|Other|2|||
127744705|NCT02636608|459691897|FG000|Overall Study|Did Not Receive Treatment|1|||
127744706|NCT01255761|459691898|FG000|Overall Study|Adverse Event|29|||
127744707|NCT01255761|459691899|FG001|Overall Study|Adverse Event|43|||
127744708|NCT01255761|459691898|FG000|Overall Study|Lack of Efficacy|86|||
127744709|NCT01255761|459691899|FG001|Overall Study|Lack of Efficacy|74|||
127744710|NCT01255761|459691898|FG000|Overall Study|Protocol Violation|9|||
127744711|NCT01255761|459691899|FG001|Overall Study|Protocol Violation|5|||
127744712|NCT01255761|459691898|FG000|Overall Study|Lost to Follow-up|10|||
127744713|NCT01255761|459691899|FG001|Overall Study|Lost to Follow-up|8|||
127744714|NCT01255761|459691898|FG000|Overall Study|Withdrawal by Subject|11|||
127744715|NCT01255761|459691899|FG001|Overall Study|Withdrawal by Subject|27|||
127744716|NCT01255761|459691898|FG000|Overall Study|Other Reasons|37|||
127744717|NCT01255761|459691899|FG001|Overall Study|Other Reasons|18|||
127744718|NCT05613088|459691902|FG000|Treatment|Ongoing Study Treatment|9|||
127744719|NCT05613088|459691903|FG001|Treatment|Ongoing Study Treatment|2|||
127744720|NCT05613088|459691902|FG000|Treatment|Adverse Event|3|||
127744721|NCT05613088|459691903|FG001|Treatment|Adverse Event|1|||
127744722|NCT05613088|459691902|FG000|Treatment|Other Reasons|0|||
127744723|NCT05613088|459691903|FG001|Treatment|Other Reasons|1|||
127744724|NCT05613088|459691902|FG000|Treatment|Progressive Disease|58|||
127744725|NCT05613088|459691903|FG001|Treatment|Progressive Disease|26|||
127744726|NCT05613088|459691902|FG000|Treatment|Withdrawal by Subject|0|||
127744727|NCT05613088|459691903|FG001|Treatment|Withdrawal by Subject|4|||
127744728|NCT03912532|459691904|FG000|Overall Study|Adverse Event|3|||
127807957|NCT02689492|459917717|FG000|Overall Study|Withdrawal by Subject|11|||
127807958|NCT02689492|459917717|FG000|Overall Study|Death|9|||
127807959|NCT02689492|459917717|FG000|Overall Study|Physician Decision|2|||
127807960|NCT02689492|459917717|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
127807961|NCT02689492|459917717|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
127807962|NCT02689492|459917717|FG000|Overall Study|Other than listed|1|||
127744729|NCT03912532|459691905|FG001|Overall Study|Adverse Event|3|||
127807963|NCT02029976|459917718|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
127744730|NCT03912532|459691906|FG002|Overall Study|Adverse Event|2|||
127744731|NCT03912532|459691907|FG003|Overall Study|Adverse Event|2|||
127744732|NCT03912532|459691904|FG000|Overall Study|Lost to Follow-up|3|||
127744733|NCT03912532|459691905|FG001|Overall Study|Lost to Follow-up|2|||
127744734|NCT03912532|459691906|FG002|Overall Study|Lost to Follow-up|1|||
127744735|NCT03912532|459691907|FG003|Overall Study|Lost to Follow-up|2|||
127744736|NCT03912532|459691904|FG000|Overall Study|Withdrawal by Subject|1|||
127744737|NCT03912532|459691905|FG001|Overall Study|Withdrawal by Subject|1|||
127744738|NCT03912532|459691906|FG002|Overall Study|Withdrawal by Subject|2|||
127744739|NCT03912532|459691907|FG003|Overall Study|Withdrawal by Subject|0|||
127744740|NCT03912532|459691904|FG000|Overall Study|Physician Decision|1|||
127744741|NCT03912532|459691905|FG001|Overall Study|Physician Decision|0|||
127744742|NCT03912532|459691906|FG002|Overall Study|Physician Decision|0|||
127744743|NCT03912532|459691907|FG003|Overall Study|Physician Decision|3|||
127744744|NCT03912532|459691904|FG000|Overall Study|Other|0|||
127744745|NCT03912532|459691905|FG001|Overall Study|Other|1|||
127744746|NCT03912532|459691906|FG002|Overall Study|Other|1|||
127744747|NCT03912532|459691907|FG003|Overall Study|Other|0|||
127744748|NCT03569891|459691908|FG000|Lead-in|Ineligible during lead-in|8|||
127744749|NCT03569891|459691908|FG000|Lead-in|Withdrawal by Subject|3|||
127744750|NCT03569891|459691908|FG000|Lead-in|Risks related to COVID-19|2|||
127744751|NCT03569891|459691908|FG000|AMT-061|Adverse Event|1|||
127744752|NCT04650698|459693614|FG000|Overall Study|Protocol Violation|2|||
127744753|NCT04650698|459693615|FG001|Overall Study|Protocol Violation|1|||
127744754|NCT04650698|459693614|FG000|Overall Study|Withdrawal by Subject|0|||
127744755|NCT04650698|459693615|FG001|Overall Study|Withdrawal by Subject|1|||
127744756|NCT03778294|459693616|FG000|Overall Study|Death|1|||
127744757|NCT03778294|459693616|FG000|Overall Study|Issues with insurance|1|||
127744758|NCT03778294|459693616|FG000|Overall Study|disease progression before treatment|2|||
127744759|NCT00487825|459693620|FG000|Overall Study|Adverse Event|2|||
127744760|NCT00487825|459693621|FG001|Overall Study|Adverse Event|2|||
127744761|NCT00487825|459693620|FG000|Overall Study|Lack of Efficacy|1|||
127744762|NCT00487825|459693621|FG001|Overall Study|Lack of Efficacy|1|||
127744763|NCT00487825|459693620|FG000|Overall Study|Other|3|||
127744764|NCT00487825|459693621|FG001|Overall Study|Other|2|||
127744765|NCT01639742|459693624|FG000|Overall Study|Study Ongoing|17|||
127744766|NCT01639742|459693624|FG000|Overall Study|Lost to Follow-up|1|||
127744767|NCT01190644|459693625|FG000|Overall Study|Death|2|||
127744768|NCT01190644|459693625|FG000|Overall Study|Disease progression|1|||
127744769|NCT02366143|459693626|FG000|Overall Study|Death|307|||
127744770|NCT02366143|459693627|FG001|Overall Study|Death|278|||
127744771|NCT02366143|459693628|FG002|Overall Study|Death|280|||
127744772|NCT02366143|459693626|FG000|Overall Study|Lost to Follow-up|2|||
127744773|NCT02366143|459693627|FG001|Overall Study|Lost to Follow-up|4|||
127744774|NCT02366143|459693628|FG002|Overall Study|Lost to Follow-up|2|||
127744775|NCT02366143|459693626|FG000|Overall Study|Physician Decision|1|||
127744776|NCT02366143|459693627|FG001|Overall Study|Physician Decision|2|||
127744777|NCT02366143|459693628|FG002|Overall Study|Physician Decision|1|||
127744778|NCT02366143|459693626|FG000|Overall Study|Protocol Violation|0|||
127744779|NCT02366143|459693627|FG001|Overall Study|Protocol Violation|0|||
127744780|NCT02366143|459693628|FG002|Overall Study|Protocol Violation|2|||
127744781|NCT02366143|459693626|FG000|Overall Study|Withdrawal by Subject|16|||
127744782|NCT02366143|459693627|FG001|Overall Study|Withdrawal by Subject|17|||
127744783|NCT02366143|459693628|FG002|Overall Study|Withdrawal by Subject|22|||
127744784|NCT02366143|459693626|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
127744785|NCT02366143|459693627|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
127744786|NCT02366143|459693628|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
127744787|NCT02366143|459693626|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
127744788|NCT02366143|459693627|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
127744789|NCT02366143|459693628|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
127744790|NCT02366143|459693626|FG000|Overall Study|Randomization Error|1|||
127744791|NCT02366143|459693627|FG001|Overall Study|Randomization Error|0|||
127744792|NCT02366143|459693628|FG002|Overall Study|Randomization Error|0|||
127744793|NCT02366143|459693626|FG000|Overall Study|PI Move and Site Closure|1|||
127744794|NCT02366143|459693627|FG001|Overall Study|PI Move and Site Closure|0|||
127744795|NCT02366143|459693628|FG002|Overall Study|PI Move and Site Closure|1|||
127744796|NCT02366143|459693626|FG000|Overall Study|Study Terminated By Sponsor|0|||
127744797|NCT02366143|459693627|FG001|Overall Study|Study Terminated By Sponsor|0|||
127744798|NCT02366143|459693628|FG002|Overall Study|Study Terminated By Sponsor|2|||
127744799|NCT02366143|459693626|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
127744800|NCT02366143|459693627|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
127744801|NCT02366143|459693628|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
127744802|NCT02366143|459693626|FG000|Overall Study|Patient moved to roll-over study|1|||
127744803|NCT02366143|459693627|FG001|Overall Study|Patient moved to roll-over study|19|||
127807964|NCT02029976|459917719|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
127807965|NCT02029976|459917718|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
127807966|NCT02029976|459917719|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
127807967|NCT02029976|459917718|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
127807968|NCT02029976|459917719|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
127807969|NCT02029976|459917718|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
127807970|NCT02029976|459917719|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
127807971|NCT01341457|459917722|FG000|Overall Study|Adverse Event|2|||
127744804|NCT02366143|459693628|FG002|Overall Study|Patient moved to roll-over study|28|||
127744805|NCT02366143|459693626|FG000|Overall Study|Patient moved to commercial stock|0|||
127744806|NCT02366143|459693627|FG001|Overall Study|Patient moved to commercial stock|0|||
127744807|NCT02366143|459693628|FG002|Overall Study|Patient moved to commercial stock|1|||
127807972|NCT01341457|459917723|FG001|Overall Study|Adverse Event|0|||
127744808|NCT02366143|459693626|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
127744809|NCT02366143|459693627|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
127744810|NCT02366143|459693628|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
127744811|NCT02366143|459693626|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
127744812|NCT02366143|459693627|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
127744813|NCT02366143|459693628|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
127744814|NCT02366143|459693626|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
127744815|NCT02366143|459693627|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
127744816|NCT02366143|459693628|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
127744817|NCT02366143|459693626|FG000|Overall Study|Requester's instructions|1|||
127744818|NCT02366143|459693627|FG001|Overall Study|Requester's instructions|1|||
127744819|NCT02366143|459693628|FG002|Overall Study|Requester's instructions|1|||
127744820|NCT02366143|459693626|FG000|Overall Study|Uneligible|0|||
127744821|NCT02366143|459693627|FG001|Overall Study|Uneligible|1|||
127744822|NCT02366143|459693628|FG002|Overall Study|Uneligible|0|||
127744823|NCT02366143|459693626|FG000|Overall Study|Post Trial Migration|0|||
127744824|NCT02366143|459693627|FG001|Overall Study|Post Trial Migration|1|||
127744825|NCT02366143|459693628|FG002|Overall Study|Post Trial Migration|0|||
127744826|NCT02366143|459693626|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
127744827|NCT02366143|459693627|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
127744828|NCT02366143|459693628|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
127744829|NCT02366143|459693626|FG000|Overall Study|Patient switched to PTAP|0|||
127744830|NCT02366143|459693627|FG001|Overall Study|Patient switched to PTAP|1|||
127744831|NCT02366143|459693628|FG002|Overall Study|Patient switched to PTAP|0|||
127744832|NCT02366143|459693626|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
127744833|NCT02366143|459693627|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
127744834|NCT02366143|459693628|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
127744835|NCT04411186|459693629|FG000|Overall Study|Withdrawn due to protocol violation|0|||
127744836|NCT04411186|459693630|FG001|Overall Study|Withdrawn due to protocol violation|1|||
127744837|NCT01053247|459693631|FG000|Overall Study|Withdrawal by Subject|9|||
127744838|NCT01053247|459693632|FG001|Overall Study|Withdrawal by Subject|4|||
127744839|NCT01053247|459693633|FG002|Overall Study|Withdrawal by Subject|15|||
127744840|NCT01053247|459693631|FG000|Overall Study|Lack of Efficacy|1|||
127744841|NCT01053247|459693632|FG001|Overall Study|Lack of Efficacy|0|||
127744842|NCT01053247|459693633|FG002|Overall Study|Lack of Efficacy|1|||
127744843|NCT01053247|459693631|FG000|Overall Study|Protocol Violation|2|||
127744844|NCT01053247|459693632|FG001|Overall Study|Protocol Violation|1|||
127744845|NCT01053247|459693633|FG002|Overall Study|Protocol Violation|2|||
127744846|NCT01053247|459693631|FG000|Overall Study|Lost to Follow-up|8|||
127744847|NCT01053247|459693632|FG001|Overall Study|Lost to Follow-up|5|||
127744848|NCT01053247|459693633|FG002|Overall Study|Lost to Follow-up|7|||
127744849|NCT01053247|459693631|FG000|Overall Study|Adverse Event|0|||
127744850|NCT01053247|459693632|FG001|Overall Study|Adverse Event|9|||
127744851|NCT01053247|459693633|FG002|Overall Study|Adverse Event|3|||
127744852|NCT03898700|459693636|FG000|Overall Study|Withdrawal by Subject|2|||
127807973|NCT03124459|459917724|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
127807974|NCT03124459|459917725|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
127807975|NCT03124459|459917726|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
127807976|NCT03124459|459917727|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
127807977|NCT03124459|459917728|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
127807978|NCT03124459|459917729|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
127807979|NCT03124459|459917724|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
127807980|NCT03124459|459917725|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
127807981|NCT03124459|459917726|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
127807982|NCT03124459|459917727|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
127807983|NCT03124459|459917728|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
127807984|NCT03124459|459917729|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
127807985|NCT03124459|459917724|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
127807986|NCT03124459|459917725|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
127807987|NCT03124459|459917726|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
127807988|NCT03124459|459917727|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
127744853|NCT00701909|459693637|FG000|Overall Study|Withdrawal by Subject|0|||
127744854|NCT00701909|459693638|FG001|Overall Study|Withdrawal by Subject|1|||
127744855|NCT03023722|459693643|FG000|Overall Study|No follow-up assessment|4|||
127744856|NCT02666664|459693644|FG000|Overall Study|Physician Decision|0|||
127744857|NCT02666664|459693645|FG001|Overall Study|Physician Decision|1|||
127744858|NCT02666664|459693644|FG000|Overall Study|Protocol Violation|0|||
127744859|NCT02666664|459693645|FG001|Overall Study|Protocol Violation|2|||
127744860|NCT02666664|459693644|FG000|Overall Study|Other|0|||
127744861|NCT02666664|459693645|FG001|Overall Study|Other|1|||
127744862|NCT02666664|459693644|FG000|Overall Study|Adverse Event|12|||
127744863|NCT02666664|459693645|FG001|Overall Study|Adverse Event|37|||
127744864|NCT02666664|459693644|FG000|Overall Study|Withdrawal by participant|23|||
127744865|NCT02666664|459693645|FG001|Overall Study|Withdrawal by participant|40|||
127744866|NCT02666664|459693644|FG000|Overall Study|Sponsor decision|0|||
127744867|NCT02666664|459693645|FG001|Overall Study|Sponsor decision|1|||
127744868|NCT02666664|459693644|FG000|Overall Study|Lost to Follow-up|1|||
127744869|NCT02666664|459693645|FG001|Overall Study|Lost to Follow-up|2|||
127744870|NCT03616964|459693646|FG000|Overall Study|Adverse Event|15|||
127744871|NCT03616964|459693647|FG001|Overall Study|Adverse Event|10|||
127744872|NCT03616964|459693648|FG002|Overall Study|Adverse Event|16|||
127744873|NCT03616964|459693646|FG000|Overall Study|Death|3|||
127744874|NCT03616964|459693647|FG001|Overall Study|Death|0|||
127744875|NCT03616964|459693648|FG002|Overall Study|Death|4|||
127744876|NCT03616964|459693646|FG000|Overall Study|Lack of Efficacy|4|||
127744877|NCT03616964|459693647|FG001|Overall Study|Lack of Efficacy|8|||
127744878|NCT03616964|459693648|FG002|Overall Study|Lack of Efficacy|8|||
127744879|NCT03616964|459693646|FG000|Overall Study|Lost to Follow-up|2|||
127744880|NCT03616964|459693647|FG001|Overall Study|Lost to Follow-up|1|||
127744881|NCT03616964|459693648|FG002|Overall Study|Lost to Follow-up|3|||
127744882|NCT03616964|459693646|FG000|Overall Study|Withdrawal by Subject|18|||
127744883|NCT03616964|459693647|FG001|Overall Study|Withdrawal by Subject|14|||
127744884|NCT03616964|459693648|FG002|Overall Study|Withdrawal by Subject|21|||
127744885|NCT03616964|459693646|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
127744886|NCT03616964|459693647|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
127744887|NCT03616964|459693648|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
127744888|NCT03616964|459693646|FG000|Overall Study|Sponsor's Decision|1|||
127744889|NCT03616964|459693647|FG001|Overall Study|Sponsor's Decision|0|||
127744890|NCT03616964|459693648|FG002|Overall Study|Sponsor's Decision|0|||
127744891|NCT03616964|459693646|FG000|Overall Study|Physician Decision|0|||
127744892|NCT03616964|459693647|FG001|Overall Study|Physician Decision|2|||
127744893|NCT03616964|459693648|FG002|Overall Study|Physician Decision|0|||
127744894|NCT03616964|459693646|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
127744895|NCT03616964|459693647|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
127744896|NCT03616964|459693648|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
127744897|NCT03616964|459693646|FG000|Overall Study|Protocol Violation|0|||
127744898|NCT03616964|459693647|FG001|Overall Study|Protocol Violation|1|||
127744899|NCT03616964|459693648|FG002|Overall Study|Protocol Violation|0|||
127744900|NCT03616964|459693646|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
127744901|NCT03616964|459693647|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
127744902|NCT03616964|459693648|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
127744903|NCT03616964|459693646|FG000|Overall Study|Randomized but Never Treated|1|||
127744904|NCT03616964|459693647|FG001|Overall Study|Randomized but Never Treated|1|||
127744905|NCT03616964|459693648|FG002|Overall Study|Randomized but Never Treated|1|||
127744906|NCT00971997|459693649|FG000|Overall Study|Adverse Event|2|||
127744907|NCT00971997|459693649|FG000|Overall Study|Death|1|||
127744908|NCT00971997|459693649|FG000|Overall Study|Protocol Violation|4|||
127744909|NCT00971997|459693649|FG000|Overall Study|Withdrawal by Subject|5|||
127744910|NCT00971997|459693649|FG000|Overall Study|Physician Decision|7|||
127744911|NCT01385748|459693650|FG000|Overall Study|Withdrawal by Subject|7|||
127744912|NCT01385748|459693651|FG001|Overall Study|Withdrawal by Subject|4|||
127744913|NCT01385748|459693652|FG002|Overall Study|Withdrawal by Subject|5|||
127744914|NCT01385748|459693650|FG000|Overall Study|Noncompliance|3|||
127744915|NCT01385748|459693651|FG001|Overall Study|Noncompliance|1|||
127744916|NCT01385748|459693652|FG002|Overall Study|Noncompliance|6|||
127744917|NCT01385748|459693650|FG000|Overall Study|Other|1|||
127744918|NCT01385748|459693651|FG001|Overall Study|Other|7|||
127744919|NCT01385748|459693652|FG002|Overall Study|Other|1|||
127744920|NCT01385748|459693650|FG000|Overall Study|Adverse Event|4|||
127744921|NCT01385748|459693651|FG001|Overall Study|Adverse Event|2|||
127807989|NCT03124459|459917728|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
127744922|NCT01385748|459693652|FG002|Overall Study|Adverse Event|1|||
127744923|NCT01266018|459693657|FG000|Overall Study|Physician Decision|1|||
127744924|NCT01266018|459693658|FG001|Overall Study|Physician Decision|0|||
127744925|NCT01266018|459693657|FG000|Overall Study|Progressive disease|0|||
127744926|NCT01266018|459693658|FG001|Overall Study|Progressive disease|1|||
127744927|NCT03167151|459693659|FG000|Overall Study|Withdrawal by Subject|1|||
127744928|NCT03167151|459693660|FG001|Overall Study|Withdrawal by Subject|0|||
127744929|NCT03167151|459693661|FG002|Overall Study|Withdrawal by Subject|0|||
127744930|NCT03167151|459693659|FG000|Overall Study|No evidence of tumour at surgery|0|||
127744931|NCT03167151|459693660|FG001|Overall Study|No evidence of tumour at surgery|1|||
127744932|NCT03167151|459693661|FG002|Overall Study|No evidence of tumour at surgery|1|||
127744933|NCT01458522|459693662|FG000|Overall Study|Withdrawal by Subject|2|||
127744934|NCT01458522|459693663|FG001|Overall Study|Withdrawal by Subject|2|||
127744935|NCT01458522|459693662|FG000|Overall Study|Physician Decision|1|||
127744936|NCT01458522|459693663|FG001|Overall Study|Physician Decision|9|||
127893825|NCT01463683|460233348|FG002|Overall Study|Adverse Event|0|||
127893826|NCT01463683|460233346|FG000|Overall Study|Lost to Follow-up|10|||
127893827|NCT01463683|460233347|FG001|Overall Study|Lost to Follow-up|9|||
127744937|NCT02684123|459693664|FG000|Phase 1|Lack of Efficacy|5|||
127744938|NCT02684123|459693665|FG001|Phase 1|Lack of Efficacy|0|||
127744939|NCT02684123|459693664|FG000|Phase 1|Adverse Event|3|||
127744940|NCT02684123|459693665|FG001|Phase 1|Adverse Event|0|||
127744941|NCT02684123|459693664|FG000|Phase 1|Lost to Follow-up|0|||
127744942|NCT02684123|459693665|FG001|Phase 1|Lost to Follow-up|1|||
127744943|NCT02684123|459693664|FG000|Phase 2|Lack of Efficacy|1|||
127744944|NCT02684123|459693665|FG001|Phase 2|Lack of Efficacy|8|||
127807990|NCT03124459|459917729|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
127807991|NCT03124459|459917724|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
127807992|NCT03124459|459917725|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
127807993|NCT03124459|459917726|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
127807994|NCT03124459|459917727|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
127807995|NCT03124459|459917728|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
127807996|NCT03124459|459917729|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
127807997|NCT03124459|459917724|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
127807998|NCT03124459|459917725|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
127807999|NCT03124459|459917726|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
127808000|NCT03124459|459917727|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
127808001|NCT03124459|459917728|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
127808002|NCT03124459|459917729|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
127808003|NCT03124459|459917724|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
127808004|NCT03124459|459917725|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
127808005|NCT03124459|459917726|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
127808006|NCT03124459|459917727|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
127808007|NCT03124459|459917728|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
127808008|NCT03124459|459917729|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
127808009|NCT00496366|459917730|FG000|Overall Study|Death|1|||
127808010|NCT01717638|459917731|FG000|Overall Study|Lost to Follow-up|0|||
127808011|NCT01717638|459917732|FG001|Overall Study|Lost to Follow-up|0|||
127808012|NCT01717638|459917733|FG002|Overall Study|Lost to Follow-up|0|||
127808013|NCT01717638|459917734|FG003|Overall Study|Lost to Follow-up|0|||
127808014|NCT01717638|459917735|FG004|Overall Study|Lost to Follow-up|0|||
127808015|NCT01717638|459917736|FG005|Overall Study|Lost to Follow-up|1|||
127808016|NCT01717638|459917737|FG006|Overall Study|Lost to Follow-up|0|||
127808017|NCT01717638|459917738|FG007|Overall Study|Lost to Follow-up|0|||
127808018|NCT01717638|459917739|FG008|Overall Study|Lost to Follow-up|0|||
127808019|NCT01717638|459917740|FG009|Overall Study|Lost to Follow-up|0|||
127808020|NCT01717638|459917741|FG010|Overall Study|Lost to Follow-up|0|||
127744945|NCT00516139|459693666|FG000|Overall Study|Adverse Event|27|||
127744946|NCT00516139|459693666|FG000|Overall Study|Lost to Follow-up|1|||
127893828|NCT01463683|460233348|FG002|Overall Study|Lost to Follow-up|7|||
127744947|NCT00516139|459693666|FG000|Overall Study|Protocol Violation|1|||
127744948|NCT00516139|459693666|FG000|Overall Study|Withdrawal by Subject|8|||
127744949|NCT00516139|459693666|FG000|Overall Study|Lack of Efficacy|1|||
127744950|NCT04367480|459693667|FG000|Overall Study|Adverse Event|1|||
127744951|NCT04367480|459693668|FG001|Overall Study|Adverse Event|1|||
127744952|NCT04367480|459693667|FG000|Overall Study|Death|1|||
127744953|NCT04367480|459693668|FG001|Overall Study|Death|0|||
127744954|NCT04367480|459693667|FG000|Overall Study|Lost to Follow-up|1|||
127744955|NCT04367480|459693668|FG001|Overall Study|Lost to Follow-up|1|||
127744956|NCT04367480|459693667|FG000|Overall Study|Withdrawal by Subject|0|||
127744957|NCT04367480|459693668|FG001|Overall Study|Withdrawal by Subject|3|||
127744958|NCT04367480|459693667|FG000|Overall Study|App glitch during the study|1|||
127744959|NCT04367480|459693668|FG001|Overall Study|App glitch during the study|0|||
127744960|NCT04367480|459693667|FG000|Overall Study|Device Distribution Error|0|||
127744961|NCT04367480|459693668|FG001|Overall Study|Device Distribution Error|2|||
127744962|NCT04367480|459693667|FG000|Overall Study|Ineligible after Randomization|0|||
127744963|NCT04367480|459693668|FG001|Overall Study|Ineligible after Randomization|1|||
127744964|NCT04367480|459693667|FG000|Overall Study|Other Medical Reasons|0|||
127744965|NCT04367480|459693668|FG001|Overall Study|Other Medical Reasons|2|||
127744966|NCT00634842|459693669|FG000|Overall Study|Adverse Event|2|||
127744967|NCT00634842|459693670|FG001|Overall Study|Adverse Event|3|||
127744968|NCT00634842|459693669|FG000|Overall Study|Protocol Violation|8|||
127744969|NCT00634842|459693670|FG001|Overall Study|Protocol Violation|4|||
127744970|NCT00634842|459693669|FG000|Overall Study|Move to another state|1|||
127744971|NCT00634842|459693670|FG001|Overall Study|Move to another state|0|||
127744972|NCT00634842|459693669|FG000|Overall Study|Inclusion criteria were not met|1|||
127744973|NCT00634842|459693670|FG001|Overall Study|Inclusion criteria were not met|0|||
127744974|NCT00634842|459693669|FG000|Overall Study|Lost to Follow-up|1|||
127744975|NCT00634842|459693670|FG001|Overall Study|Lost to Follow-up|2|||
127744976|NCT00634842|459693669|FG000|Overall Study|Physician Decision|1|||
127744977|NCT00634842|459693670|FG001|Overall Study|Physician Decision|0|||
127744978|NCT00634842|459693669|FG000|Overall Study|Withdrawal by Subject|1|||
127744979|NCT00634842|459693670|FG001|Overall Study|Withdrawal by Subject|3|||
127744980|NCT00634842|459693669|FG000|Overall Study|Lack of time and intolerance to drug|0|||
127744981|NCT00634842|459693670|FG001|Overall Study|Lack of time and intolerance to drug|1|||
127744982|NCT00634842|459693669|FG000|Overall Study|Discontinued due to injection|0|||
127808021|NCT01717638|459917742|FG011|Overall Study|Lost to Follow-up|0|||
127808022|NCT01717638|459917743|FG012|Overall Study|Lost to Follow-up|0|||
127808023|NCT01717638|459917731|FG000|Overall Study|Father in hospital|0|||
127808024|NCT01717638|459917732|FG001|Overall Study|Father in hospital|0|||
127808025|NCT01717638|459917733|FG002|Overall Study|Father in hospital|0|||
127808026|NCT01717638|459917734|FG003|Overall Study|Father in hospital|0|||
127808027|NCT01717638|459917735|FG004|Overall Study|Father in hospital|0|||
127808028|NCT01717638|459917736|FG005|Overall Study|Father in hospital|0|||
127808029|NCT01717638|459917737|FG006|Overall Study|Father in hospital|0|||
127808030|NCT01717638|459917738|FG007|Overall Study|Father in hospital|0|||
127808031|NCT01717638|459917739|FG008|Overall Study|Father in hospital|0|||
127808032|NCT01717638|459917740|FG009|Overall Study|Father in hospital|0|||
127808033|NCT01717638|459917741|FG010|Overall Study|Father in hospital|0|||
127808034|NCT01717638|459917742|FG011|Overall Study|Father in hospital|0|||
127808035|NCT01717638|459917743|FG012|Overall Study|Father in hospital|1|||
127808036|NCT01717638|459917731|FG000|Overall Study|Withdrawal by Subject|0|||
127808037|NCT01717638|459917732|FG001|Overall Study|Withdrawal by Subject|1|||
127808038|NCT01717638|459917733|FG002|Overall Study|Withdrawal by Subject|1|||
127808039|NCT01717638|459917734|FG003|Overall Study|Withdrawal by Subject|0|||
127808040|NCT01717638|459917735|FG004|Overall Study|Withdrawal by Subject|1|||
127808041|NCT01717638|459917736|FG005|Overall Study|Withdrawal by Subject|0|||
127808042|NCT01717638|459917737|FG006|Overall Study|Withdrawal by Subject|2|||
127808043|NCT01717638|459917738|FG007|Overall Study|Withdrawal by Subject|1|||
127744983|NCT00634842|459693670|FG001|Overall Study|Discontinued due to injection|2|||
127744984|NCT00634842|459693669|FG000|Overall Study|No need of study drug to treat diabetes|0|||
127744985|NCT00634842|459693670|FG001|Overall Study|No need of study drug to treat diabetes|1|||
127744986|NCT00634842|459693669|FG000|Overall Study|No wish to keep taking Avandia|0|||
127744987|NCT00634842|459693670|FG001|Overall Study|No wish to keep taking Avandia|1|||
127744988|NCT00634842|459693669|FG000|Overall Study|Subject off study drug for too long|0|||
127744989|NCT00634842|459693670|FG001|Overall Study|Subject off study drug for too long|1|||
127744990|NCT04351269|459693674|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
127744991|NCT04351269|459693675|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
127744992|NCT04351269|459693676|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
127744993|NCT04351269|459693674|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
127808044|NCT01717638|459917739|FG008|Overall Study|Withdrawal by Subject|2|||
127808045|NCT01717638|459917740|FG009|Overall Study|Withdrawal by Subject|1|||
127808046|NCT01717638|459917741|FG010|Overall Study|Withdrawal by Subject|0|||
127808047|NCT01717638|459917742|FG011|Overall Study|Withdrawal by Subject|0|||
127808048|NCT01717638|459917743|FG012|Overall Study|Withdrawal by Subject|18|||
127808049|NCT05211336|459917748|FG000|Overall Study|Unacceptable adverse event - autoimmune hepatitis|1|||
127744994|NCT04351269|459693675|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
127744995|NCT04351269|459693676|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
127744996|NCT04351269|459693674|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
127744997|NCT04351269|459693675|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
127744998|NCT04351269|459693676|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
127744999|NCT04351269|459693674|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
127745000|NCT04351269|459693675|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
127745001|NCT04351269|459693676|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
127745002|NCT04351269|459693674|FG000|Overall Study|Lost to Follow-up|1|||
127745003|NCT04351269|459693675|FG001|Overall Study|Lost to Follow-up|3|||
127745004|NCT04351269|459693676|FG002|Overall Study|Lost to Follow-up|0|||
127745005|NCT01216072|459693681|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
127745006|NCT01216072|459693682|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
127745007|NCT01216072|459693681|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
127745008|NCT01216072|459693682|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
127745009|NCT01216072|459693681|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
127745010|NCT01216072|459693682|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
127745011|NCT01216072|459693681|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
127745012|NCT01216072|459693682|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
127745013|NCT01216072|459693681|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
127745014|NCT01216072|459693682|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
127745015|NCT01216072|459693681|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
127745016|NCT01216072|459693682|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
127745017|NCT01216072|459693681|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
127745018|NCT01216072|459693682|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
127745019|NCT01216072|459693681|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
127745020|NCT01216072|459693682|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
127745021|NCT01216072|459693681|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
127808050|NCT05211336|459917749|FG001|Overall Study|Unacceptable adverse event - autoimmune hepatitis|0|||
127808051|NCT05211336|459917748|FG000|Overall Study|Progressive disease|0|||
127808052|NCT05211336|459917749|FG001|Overall Study|Progressive disease|4|||
127808053|NCT05211336|459917748|FG000|Overall Study|Death due to myocardial infarction|0|||
127808054|NCT05211336|459917749|FG001|Overall Study|Death due to myocardial infarction|1|||
127808055|NCT05211336|459917748|FG000|Overall Study|Death due to unknown cause|0|||
127808056|NCT05211336|459917749|FG001|Overall Study|Death due to unknown cause|1|||
127808057|NCT05211336|459917748|FG000|Overall Study|Worsening kidney function and quality of response|0|||
127808058|NCT05211336|459917749|FG001|Overall Study|Worsening kidney function and quality of response|1|||
127808059|NCT03575104|459917751|FG000|Overall Study|Adverse Event|4|||
127808060|NCT03575104|459917752|FG001|Overall Study|Adverse Event|3|||
127808061|NCT03575104|459917753|FG002|Overall Study|Adverse Event|4|||
127808062|NCT03575104|459917751|FG000|Overall Study|Withdrawal by Subject|13|||
127808063|NCT03575104|459917752|FG001|Overall Study|Withdrawal by Subject|16|||
127893829|NCT01463683|460233346|FG000|Overall Study|Physician Decision|0|||
127745022|NCT01216072|459693682|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
127745023|NCT01216072|459693681|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
127745024|NCT01216072|459693682|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
127745025|NCT01777490|459693686|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
127745026|NCT01777490|459693687|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
127745027|NCT01777490|459693688|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
127745028|NCT01777490|459693689|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
127745029|NCT00822770|459693690|FG000|Overall Study|Not treated|1|||
127745030|NCT00822770|459693691|FG001|Overall Study|Not treated|0|||
127745031|NCT00822770|459693690|FG000|Overall Study|Complication/Incomplete treatment|1|||
127745032|NCT00822770|459693691|FG001|Overall Study|Complication/Incomplete treatment|0|||
127745033|NCT00822770|459693690|FG000|Overall Study|Death|1|||
127745034|NCT00822770|459693691|FG001|Overall Study|Death|1|||
127745035|NCT02818998|459693692|FG000|Overall Study|Adverse Event|3|||
127745036|NCT02818998|459693693|FG001|Overall Study|Adverse Event|2|||
127745037|NCT02818998|459693694|FG002|Overall Study|Adverse Event|1|||
127745038|NCT02818998|459693692|FG000|Overall Study|Lost to Follow-up|4|||
127745039|NCT02818998|459693693|FG001|Overall Study|Lost to Follow-up|1|||
127745040|NCT02818998|459693694|FG002|Overall Study|Lost to Follow-up|2|||
127745041|NCT02818998|459693692|FG000|Overall Study|Withdrawal by sponsor|0|||
127745042|NCT02818998|459693693|FG001|Overall Study|Withdrawal by sponsor|1|||
127745043|NCT02818998|459693694|FG002|Overall Study|Withdrawal by sponsor|1|||
127808064|NCT03575104|459917753|FG002|Overall Study|Withdrawal by Subject|11|||
127808065|NCT03575104|459917751|FG000|Overall Study|Other reasons|6|||
127893830|NCT01463683|460233347|FG001|Overall Study|Physician Decision|3|||
127893831|NCT01463683|460233348|FG002|Overall Study|Physician Decision|1|||
127745044|NCT02818998|459693692|FG000|Overall Study|Death|3|||
127745045|NCT02818998|459693693|FG001|Overall Study|Death|6|||
127745046|NCT02818998|459693694|FG002|Overall Study|Death|8|||
127745047|NCT02818998|459693692|FG000|Overall Study|Withdrawal by Subject|7|||
127745048|NCT02818998|459693693|FG001|Overall Study|Withdrawal by Subject|6|||
127745049|NCT02818998|459693694|FG002|Overall Study|Withdrawal by Subject|6|||
127745050|NCT02818998|459693692|FG000|Overall Study|Physician Decision|1|||
127745051|NCT02818998|459693693|FG001|Overall Study|Physician Decision|0|||
127745052|NCT02818998|459693694|FG002|Overall Study|Physician Decision|0|||
127745053|NCT01101061|459693695|FG000|Overall Study|Adverse Event|0|||
127745054|NCT01101061|459693696|FG001|Overall Study|Adverse Event|0|||
127745055|NCT01101061|459693697|FG002|Overall Study|Adverse Event|1|||
127745056|NCT01101061|459693698|FG003|Overall Study|Adverse Event|0|||
127745057|NCT01101061|459693699|FG004|Overall Study|Adverse Event|0|||
127808066|NCT03575104|459917752|FG001|Overall Study|Other reasons|8|||
127808067|NCT03575104|459917753|FG002|Overall Study|Other reasons|6|||
127808068|NCT03575104|459917751|FG000|Overall Study|Lost to Follow-up|1|||
127808069|NCT03575104|459917752|FG001|Overall Study|Lost to Follow-up|2|||
127808070|NCT03575104|459917753|FG002|Overall Study|Lost to Follow-up|1|||
127808071|NCT00434967|459917754|FG000|Overall Study|Adverse Event|2|||
127808072|NCT00434967|459917755|FG001|Overall Study|Adverse Event|4|||
127808073|NCT00434967|459917756|FG002|Overall Study|Adverse Event|3|||
127808074|NCT00434967|459917757|FG003|Overall Study|Adverse Event|3|||
127808075|NCT00434967|459917754|FG000|Overall Study|Lost to Follow-up|0|||
127808076|NCT00434967|459917755|FG001|Overall Study|Lost to Follow-up|0|||
127808077|NCT00434967|459917756|FG002|Overall Study|Lost to Follow-up|1|||
127808078|NCT00434967|459917757|FG003|Overall Study|Lost to Follow-up|0|||
127808079|NCT00434967|459917754|FG000|Overall Study|Withdrawal by Subject|2|||
127808080|NCT00434967|459917755|FG001|Overall Study|Withdrawal by Subject|2|||
127808081|NCT00434967|459917756|FG002|Overall Study|Withdrawal by Subject|4|||
127808082|NCT00434967|459917757|FG003|Overall Study|Withdrawal by Subject|6|||
127808083|NCT00434967|459917754|FG000|Overall Study|Randomized in error|0|||
127808084|NCT00434967|459917755|FG001|Overall Study|Randomized in error|0|||
127808085|NCT00434967|459917756|FG002|Overall Study|Randomized in error|0|||
127808086|NCT00434967|459917757|FG003|Overall Study|Randomized in error|1|||
127808087|NCT00434967|459917754|FG000|Overall Study|Protocol Violation|0|||
127808088|NCT00434967|459917755|FG001|Overall Study|Protocol Violation|1|||
127808089|NCT00434967|459917756|FG002|Overall Study|Protocol Violation|0|||
127808090|NCT00434967|459917757|FG003|Overall Study|Protocol Violation|1|||
127808091|NCT00434967|459917754|FG000|Overall Study|Physician Decision|1|||
127808092|NCT00434967|459917755|FG001|Overall Study|Physician Decision|1|||
127808093|NCT00434967|459917756|FG002|Overall Study|Physician Decision|1|||
127808094|NCT00434967|459917757|FG003|Overall Study|Physician Decision|0|||
127808095|NCT00434967|459917754|FG000|Overall Study|Patient Disposition Challenges|2|||
127808096|NCT00434967|459917755|FG001|Overall Study|Patient Disposition Challenges|0|||
127808097|NCT00434967|459917756|FG002|Overall Study|Patient Disposition Challenges|0|||
127808098|NCT00434967|459917757|FG003|Overall Study|Patient Disposition Challenges|3|||
127808099|NCT00408005|459917759|FG000|Induction|Adverse Event|19|||
127808100|NCT00408005|459917760|FG001|Induction|Adverse Event|3|||
127808101|NCT00408005|459917761|FG002|Induction|Adverse Event|0|||
127808102|NCT00408005|459917762|FG003|Induction|Adverse Event|0|||
127808103|NCT00408005|459917763|FG004|Induction|Adverse Event|0|||
127808104|NCT00408005|459917764|FG005|Induction|Adverse Event|0|||
127808105|NCT00408005|459917765|FG006|Induction|Adverse Event|0|||
127808106|NCT00408005|459917766|FG007|Induction|Adverse Event|0|||
127808107|NCT00408005|459917759|FG000|Induction|Death|6|||
127808108|NCT00408005|459917760|FG001|Induction|Death|0|||
127808109|NCT00408005|459917761|FG002|Induction|Death|0|||
127808110|NCT00408005|459917762|FG003|Induction|Death|0|||
127808111|NCT00408005|459917763|FG004|Induction|Death|0|||
127808112|NCT00408005|459917764|FG005|Induction|Death|0|||
127745058|NCT01101061|459693700|FG005|Overall Study|Adverse Event|0|||
127745059|NCT05043883|459693701|FG000|Overall Study|Minimum required measurements could not be taken|4|||
127745060|NCT02049515|459693702|FG000|Overall Study|Adverse Event|46|||
127745061|NCT02049515|459693703|FG001|Overall Study|Adverse Event|2|||
127745062|NCT02049515|459693702|FG000|Overall Study|Protocol-specified Disease Progression|23|||
127808113|NCT00408005|459917765|FG006|Induction|Death|0|||
127808114|NCT00408005|459917766|FG007|Induction|Death|0|||
127808115|NCT00408005|459917759|FG000|Induction|Physician Decision|83|||
127745063|NCT02049515|459693703|FG001|Overall Study|Protocol-specified Disease Progression|2|||
127745064|NCT02049515|459693702|FG000|Overall Study|Death|6|||
127808116|NCT00408005|459917760|FG001|Induction|Physician Decision|9|||
127808117|NCT00408005|459917761|FG002|Induction|Physician Decision|0|||
127808118|NCT00408005|459917762|FG003|Induction|Physician Decision|0|||
127808119|NCT00408005|459917763|FG004|Induction|Physician Decision|0|||
127808120|NCT00408005|459917764|FG005|Induction|Physician Decision|0|||
127808121|NCT00408005|459917765|FG006|Induction|Physician Decision|0|||
127808122|NCT00408005|459917766|FG007|Induction|Physician Decision|0|||
127808123|NCT00408005|459917759|FG000|Induction|Withdrawal by Subject|2|||
127808124|NCT00408005|459917760|FG001|Induction|Withdrawal by Subject|4|||
127808125|NCT00408005|459917761|FG002|Induction|Withdrawal by Subject|0|||
127745065|NCT02049515|459693703|FG001|Overall Study|Death|0|||
127745066|NCT02049515|459693702|FG000|Overall Study|Physician Decision|5|||
127745067|NCT02049515|459693703|FG001|Overall Study|Physician Decision|1|||
127745068|NCT02049515|459693702|FG000|Overall Study|Withdrawal by Subject|3|||
127745069|NCT02049515|459693703|FG001|Overall Study|Withdrawal by Subject|0|||
127745070|NCT02049515|459693702|FG000|Overall Study|Termination of the Study by Sponsor|2|||
127745071|NCT02049515|459693703|FG001|Overall Study|Termination of the Study by Sponsor|0|||
127745072|NCT02049515|459693702|FG000|Overall Study|Protocol Violation|1|||
127745073|NCT02049515|459693703|FG001|Overall Study|Protocol Violation|1|||
127745074|NCT02049515|459693702|FG000|Overall Study|Clinical Deterioration|1|||
127745075|NCT02049515|459693703|FG001|Overall Study|Clinical Deterioration|0|||
127808126|NCT00408005|459917762|FG003|Induction|Withdrawal by Subject|0|||
127808127|NCT00408005|459917763|FG004|Induction|Withdrawal by Subject|0|||
127808128|NCT00408005|459917764|FG005|Induction|Withdrawal by Subject|0|||
127808129|NCT00408005|459917765|FG006|Induction|Withdrawal by Subject|0|||
127808130|NCT00408005|459917766|FG007|Induction|Withdrawal by Subject|0|||
127808131|NCT00408005|459917759|FG000|Induction|Ineligible|33|||
127808132|NCT00408005|459917760|FG001|Induction|Ineligible|14|||
127808133|NCT00408005|459917761|FG002|Induction|Ineligible|0|||
127808134|NCT00408005|459917762|FG003|Induction|Ineligible|0|||
127808135|NCT00408005|459917763|FG004|Induction|Ineligible|0|||
127808136|NCT00408005|459917764|FG005|Induction|Ineligible|0|||
127808137|NCT00408005|459917765|FG006|Induction|Ineligible|0|||
127808138|NCT00408005|459917766|FG007|Induction|Ineligible|0|||
127808139|NCT00408005|459917759|FG000|Induction|Refusal of Further Protocol Therapy|225|||
127745076|NCT02049515|459693702|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
127745077|NCT02049515|459693703|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
127745078|NCT02049515|459693702|FG000|Overall Study|Treatment Interruption >42 Days|1|||
127808140|NCT00408005|459917760|FG001|Induction|Refusal of Further Protocol Therapy|44|||
127808141|NCT00408005|459917761|FG002|Induction|Refusal of Further Protocol Therapy|0|||
127808142|NCT00408005|459917762|FG003|Induction|Refusal of Further Protocol Therapy|0|||
127808143|NCT00408005|459917763|FG004|Induction|Refusal of Further Protocol Therapy|0|||
127745079|NCT02049515|459693703|FG001|Overall Study|Treatment Interruption >42 Days|0|||
127745080|NCT02049515|459693702|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
127745081|NCT02049515|459693703|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
127745082|NCT00224029|459693708|FG000|Overall Study|Lost to Follow-up|1|||
127745083|NCT00224029|459693708|FG000|Overall Study|Withdrawal by Subject|4|||
127745084|NCT00224029|459693708|FG000|Overall Study|Other|1|||
127745085|NCT01407276|459693709|FG000|Overall Study|Withdrawal by Subject|0|||
127745086|NCT01407276|459693710|FG001|Overall Study|Withdrawal by Subject|0|||
127745087|NCT01407276|459693711|FG002|Overall Study|Withdrawal by Subject|0|||
127745088|NCT01407276|459693712|FG003|Overall Study|Withdrawal by Subject|0|||
127745089|NCT01407276|459693713|FG004|Overall Study|Withdrawal by Subject|0|||
127745090|NCT01407276|459693714|FG005|Overall Study|Withdrawal by Subject|0|||
127745091|NCT01407276|459693715|FG006|Overall Study|Withdrawal by Subject|0|||
127745092|NCT01407276|459693716|FG007|Overall Study|Withdrawal by Subject|1|||
127745093|NCT00778921|459693717|FG000|Overall Study|Adverse Event|9|||
127745094|NCT00778921|459693718|FG001|Overall Study|Adverse Event|10|||
127745095|NCT00778921|459693719|FG002|Overall Study|Adverse Event|14|||
127745096|NCT00778921|459693717|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
127745097|NCT00778921|459693718|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
127745098|NCT00778921|459693719|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
127745099|NCT00778921|459693717|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
127745100|NCT00778921|459693718|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
127745101|NCT00778921|459693719|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
127745102|NCT00778921|459693717|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
127745103|NCT00778921|459693718|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
127745104|NCT00778921|459693719|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
127745105|NCT00778921|459693717|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
127745106|NCT00778921|459693718|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
127745107|NCT00778921|459693719|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
127745108|NCT00778921|459693717|FG000|Overall Study|Patient withdrew request|3|||
127745109|NCT00778921|459693718|FG001|Overall Study|Patient withdrew request|1|||
127745110|NCT00778921|459693719|FG002|Overall Study|Patient withdrew request|6|||
127745111|NCT00778921|459693717|FG000|Overall Study|Lost to Follow-up|0|||
127745112|NCT00778921|459693718|FG001|Overall Study|Lost to Follow-up|2|||
127745113|NCT00778921|459693719|FG002|Overall Study|Lost to Follow-up|1|||
127745114|NCT00778921|459693717|FG000|Overall Study|Administrative Problems|1|||
127745115|NCT00778921|459693718|FG001|Overall Study|Administrative Problems|2|||
127745116|NCT00778921|459693719|FG002|Overall Study|Administrative Problems|0|||
127745117|NCT00778921|459693717|FG000|Overall Study|Protocol Violation|3|||
127745118|NCT00778921|459693718|FG001|Overall Study|Protocol Violation|0|||
127745119|NCT00778921|459693719|FG002|Overall Study|Protocol Violation|2|||
127745120|NCT00778921|459693717|FG000|Overall Study|Not treated|0|||
127745121|NCT00778921|459693718|FG001|Overall Study|Not treated|2|||
127745122|NCT00778921|459693719|FG002|Overall Study|Not treated|2|||
127745123|NCT04805073|459693720|FG000|Overall Study|study personnel not available|2|||
127745124|NCT04805073|459693721|FG001|Overall Study|study personnel not available|0|||
127745125|NCT04805073|459693720|FG000|Overall Study|spinal anesthesia failure|0|||
127745126|NCT04805073|459693721|FG001|Overall Study|spinal anesthesia failure|1|||
127745127|NCT04805073|459693720|FG000|Overall Study|Lost to Follow-up|0|||
127745128|NCT04805073|459693721|FG001|Overall Study|Lost to Follow-up|2|||
127745129|NCT01174264|459693729|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
127745130|NCT01174264|459693730|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
127745131|NCT01174264|459693731|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
127745132|NCT01174264|459693729|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
127745133|NCT01174264|459693730|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
127745134|NCT01174264|459693731|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
127745135|NCT01174264|459693729|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
127745136|NCT01174264|459693730|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
127745137|NCT01174264|459693731|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
127745138|NCT02058836|459693735|FG000|Overall Study|Withdrawal by Subject|1|||
127745139|NCT02058836|459693736|FG001|Overall Study|Withdrawal by Subject|1|||
127745140|NCT00267098|459693737|FG000|Overall Study|Death|0|||
127745141|NCT00267098|459693738|FG001|Overall Study|Death|0|||
127745142|NCT00267098|459693739|FG002|Overall Study|Death|57|||
127745143|NCT00267098|459693740|FG003|Overall Study|Death|66|||
127745144|NCT00267098|459693741|FG004|Overall Study|Death|14|||
127745145|NCT00267098|459693742|FG005|Overall Study|Death|23|||
127745146|NCT00267098|459693743|FG006|Overall Study|Death|28|||
127745147|NCT00267098|459693744|FG007|Overall Study|Death|9|||
127745148|NCT00267098|459693737|FG000|Overall Study|Lost to Follow-up|0|||
127745149|NCT00267098|459693738|FG001|Overall Study|Lost to Follow-up|0|||
127745150|NCT00267098|459693739|FG002|Overall Study|Lost to Follow-up|6|||
127745151|NCT00267098|459693740|FG003|Overall Study|Lost to Follow-up|5|||
127745152|NCT00267098|459693741|FG004|Overall Study|Lost to Follow-up|2|||
127745153|NCT00267098|459693742|FG005|Overall Study|Lost to Follow-up|3|||
127745154|NCT00267098|459693743|FG006|Overall Study|Lost to Follow-up|1|||
127745155|NCT00267098|459693744|FG007|Overall Study|Lost to Follow-up|1|||
127745156|NCT00267098|459693737|FG000|Overall Study|Withdrawal by Subject|8|||
127745157|NCT00267098|459693738|FG001|Overall Study|Withdrawal by Subject|0|||
127745158|NCT00267098|459693739|FG002|Overall Study|Withdrawal by Subject|24|||
127745159|NCT00267098|459693740|FG003|Overall Study|Withdrawal by Subject|21|||
127745160|NCT00267098|459693741|FG004|Overall Study|Withdrawal by Subject|12|||
127745161|NCT00267098|459693742|FG005|Overall Study|Withdrawal by Subject|9|||
127745162|NCT00267098|459693743|FG006|Overall Study|Withdrawal by Subject|12|||
127745163|NCT00267098|459693744|FG007|Overall Study|Withdrawal by Subject|5|||
127745164|NCT00267098|459693737|FG000|Overall Study|Physician Decision|5|||
127745165|NCT00267098|459693738|FG001|Overall Study|Physician Decision|0|||
127745166|NCT00267098|459693739|FG002|Overall Study|Physician Decision|7|||
127745167|NCT00267098|459693740|FG003|Overall Study|Physician Decision|11|||
127745168|NCT00267098|459693741|FG004|Overall Study|Physician Decision|5|||
127745169|NCT00267098|459693742|FG005|Overall Study|Physician Decision|4|||
127745170|NCT00267098|459693743|FG006|Overall Study|Physician Decision|3|||
127745171|NCT00267098|459693744|FG007|Overall Study|Physician Decision|0|||
127745172|NCT00267098|459693737|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
127745173|NCT00267098|459693738|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
127745174|NCT00267098|459693739|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
127745175|NCT00267098|459693740|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
127745176|NCT00267098|459693741|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
127745177|NCT00267098|459693742|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
127745178|NCT00267098|459693743|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
127745179|NCT00267098|459693744|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
127745180|NCT00267098|459693737|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
127745181|NCT00267098|459693738|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
127745182|NCT00267098|459693739|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
127745183|NCT00267098|459693740|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
127745184|NCT00267098|459693741|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
127745185|NCT00267098|459693742|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
127745186|NCT00267098|459693743|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
127745187|NCT00267098|459693744|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
127745188|NCT00267098|459693737|FG000|Overall Study|Site closure|0|||
127745189|NCT00267098|459693738|FG001|Overall Study|Site closure|0|||
127745190|NCT00267098|459693739|FG002|Overall Study|Site closure|0|||
127745191|NCT00267098|459693740|FG003|Overall Study|Site closure|1|||
127745192|NCT00267098|459693741|FG004|Overall Study|Site closure|0|||
127745193|NCT00267098|459693742|FG005|Overall Study|Site closure|1|||
127745194|NCT00267098|459693743|FG006|Overall Study|Site closure|1|||
127745195|NCT00267098|459693744|FG007|Overall Study|Site closure|0|||
127745196|NCT00267098|459693737|FG000|Overall Study|Explanted Medtronic device|0|||
127745197|NCT00267098|459693738|FG001|Overall Study|Explanted Medtronic device|0|||
127745198|NCT00267098|459693739|FG002|Overall Study|Explanted Medtronic device|0|||
127745199|NCT00267098|459693740|FG003|Overall Study|Explanted Medtronic device|1|||
127745200|NCT00267098|459693741|FG004|Overall Study|Explanted Medtronic device|0|||
127745201|NCT00267098|459693742|FG005|Overall Study|Explanted Medtronic device|0|||
127745202|NCT00267098|459693743|FG006|Overall Study|Explanted Medtronic device|0|||
127745203|NCT00267098|459693744|FG007|Overall Study|Explanted Medtronic device|0|||
127745204|NCT00267098|459693737|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
127745205|NCT00267098|459693738|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
127745206|NCT00267098|459693739|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
127745207|NCT00267098|459693740|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
127745208|NCT00267098|459693741|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
127745209|NCT00267098|459693742|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
127745210|NCT00267098|459693743|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
127745211|NCT00267098|459693744|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
127745212|NCT00267098|459693737|FG000|Overall Study|Subject listed for heart transplant|0|||
127745213|NCT00267098|459693738|FG001|Overall Study|Subject listed for heart transplant|0|||
127745214|NCT00267098|459693739|FG002|Overall Study|Subject listed for heart transplant|0|||
127745215|NCT00267098|459693740|FG003|Overall Study|Subject listed for heart transplant|0|||
127745216|NCT00267098|459693741|FG004|Overall Study|Subject listed for heart transplant|0|||
127745217|NCT00267098|459693742|FG005|Overall Study|Subject listed for heart transplant|0|||
127745218|NCT00267098|459693743|FG006|Overall Study|Subject listed for heart transplant|1|||
127745219|NCT00267098|459693744|FG007|Overall Study|Subject listed for heart transplant|0|||
127745220|NCT00267098|459693737|FG000|Overall Study|Sponsor withdrew subject|0|||
127745221|NCT00267098|459693738|FG001|Overall Study|Sponsor withdrew subject|0|||
127745222|NCT00267098|459693739|FG002|Overall Study|Sponsor withdrew subject|0|||
127745223|NCT00267098|459693740|FG003|Overall Study|Sponsor withdrew subject|1|||
127745224|NCT00267098|459693741|FG004|Overall Study|Sponsor withdrew subject|0|||
127745225|NCT00267098|459693742|FG005|Overall Study|Sponsor withdrew subject|0|||
127745226|NCT00267098|459693743|FG006|Overall Study|Sponsor withdrew subject|0|||
127745227|NCT00267098|459693744|FG007|Overall Study|Sponsor withdrew subject|0|||
127745228|NCT00547534|459693745|FG000|Overall Study|Adverse Event|7|||
127745229|NCT00547534|459693745|FG000|Overall Study|Disease Progression|4|||
127745230|NCT02688530|459693747|FG000|Overall Study|Withdrawal by Subject|0|||
127745231|NCT02688530|459693748|FG001|Overall Study|Withdrawal by Subject|1|||
127745232|NCT02688530|459693749|FG002|Overall Study|Withdrawal by Subject|0|||
127745233|NCT02688530|459693750|FG003|Overall Study|Withdrawal by Subject|0|||
127745234|NCT02688530|459693747|FG000|Overall Study|Lost to Follow-up|0|||
127745235|NCT02688530|459693748|FG001|Overall Study|Lost to Follow-up|0|||
127808144|NCT00408005|459917764|FG005|Induction|Refusal of Further Protocol Therapy|0|||
127808145|NCT00408005|459917765|FG006|Induction|Refusal of Further Protocol Therapy|0|||
127808146|NCT00408005|459917766|FG007|Induction|Refusal of Further Protocol Therapy|0|||
127808147|NCT00408005|459917759|FG000|Induction|Entered another COG therapeutic protocol|4|||
127808148|NCT00408005|459917760|FG001|Induction|Entered another COG therapeutic protocol|0|||
127808149|NCT00408005|459917761|FG002|Induction|Entered another COG therapeutic protocol|0|||
127808150|NCT00408005|459917762|FG003|Induction|Entered another COG therapeutic protocol|0|||
127808151|NCT00408005|459917763|FG004|Induction|Entered another COG therapeutic protocol|0|||
127808152|NCT00408005|459917764|FG005|Induction|Entered another COG therapeutic protocol|0|||
127808153|NCT00408005|459917765|FG006|Induction|Entered another COG therapeutic protocol|0|||
127808154|NCT00408005|459917766|FG007|Induction|Entered another COG therapeutic protocol|0|||
127893832|NCT01463683|460233346|FG000|Overall Study|Pregnancy|2|||
127893833|NCT01463683|460233347|FG001|Overall Study|Pregnancy|2|||
127745236|NCT02688530|459693749|FG002|Overall Study|Lost to Follow-up|2|||
127745237|NCT02688530|459693750|FG003|Overall Study|Lost to Follow-up|0|||
127745238|NCT00115336|459693751|FG000|Overall Study|Hospital discharge before study drug|0|||
127745239|NCT00115336|459693752|FG001|Overall Study|Hospital discharge before study drug|1|||
127745240|NCT04199052|459693755|FG000|Overall Study|Lost to Follow-up|11|||
127745241|NCT04199052|459693756|FG001|Overall Study|Lost to Follow-up|18|||
127745242|NCT00815919|459693757|FG000|Overall Study|Unrelated Fungal Infection|1|||
127745243|NCT00815919|459693757|FG000|Overall Study|AML Relapse|1|||
127745244|NCT00815919|459693757|FG000|Overall Study|Lack of Efficacy|2|||
127745245|NCT04599907|459693760|FG000|Overall Study|Withdrawal by Subject|1|||
127745246|NCT04599907|459693761|FG001|Overall Study|Withdrawal by Subject|7|||
127745247|NCT04599907|459693762|FG002|Overall Study|Withdrawal by Subject|6|||
127745248|NCT04599907|459693760|FG000|Overall Study|Lost to Follow-up|0|||
127745249|NCT04599907|459693761|FG001|Overall Study|Lost to Follow-up|1|||
127745250|NCT04599907|459693762|FG002|Overall Study|Lost to Follow-up|0|||
127745251|NCT01466790|459693765|FG000|Overall Study|Adverse Event|1|||
127745252|NCT01466790|459693766|FG001|Overall Study|Adverse Event|0|||
127745253|NCT01466790|459693767|FG002|Overall Study|Adverse Event|0|||
127745254|NCT01466790|459693768|FG003|Overall Study|Adverse Event|0|||
127808155|NCT00408005|459917759|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
127808156|NCT00408005|459917760|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
127808157|NCT00408005|459917761|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
127893834|NCT01463683|460233348|FG002|Overall Study|Pregnancy|1|||
127893835|NCT01463683|460233346|FG000|Overall Study|Withdrawal by Subject|5|||
127893836|NCT01463683|460233347|FG001|Overall Study|Withdrawal by Subject|17|||
127745255|NCT01466790|459693769|FG004|Overall Study|Adverse Event|2|||
127745256|NCT01466790|459693770|FG005|Overall Study|Adverse Event|0|||
127745257|NCT01466790|459693771|FG006|Overall Study|Adverse Event|0|||
127745258|NCT01466790|459693772|FG007|Overall Study|Adverse Event|0|||
127745259|NCT01466790|459693765|FG000|Overall Study|Lost to Follow-up|2|||
127745260|NCT01466790|459693766|FG001|Overall Study|Lost to Follow-up|0|||
127745261|NCT01466790|459693767|FG002|Overall Study|Lost to Follow-up|0|||
127745262|NCT01466790|459693768|FG003|Overall Study|Lost to Follow-up|0|||
127745263|NCT01466790|459693769|FG004|Overall Study|Lost to Follow-up|0|||
127745264|NCT01466790|459693770|FG005|Overall Study|Lost to Follow-up|0|||
127808158|NCT00408005|459917762|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
127808159|NCT00408005|459917763|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
127893837|NCT01463683|460233348|FG002|Overall Study|Withdrawal by Subject|2|||
127893838|NCT04345471|460233353|FG000|Overall Study|Adverse Event|8|||
127745265|NCT01466790|459693771|FG006|Overall Study|Lost to Follow-up|0|||
127745266|NCT01466790|459693772|FG007|Overall Study|Lost to Follow-up|0|||
127745267|NCT01466790|459693765|FG000|Overall Study|Withdrawal by Subject|1|||
127745268|NCT01466790|459693766|FG001|Overall Study|Withdrawal by Subject|1|||
127745269|NCT01466790|459693767|FG002|Overall Study|Withdrawal by Subject|0|||
127745270|NCT01466790|459693768|FG003|Overall Study|Withdrawal by Subject|0|||
127745271|NCT01466790|459693769|FG004|Overall Study|Withdrawal by Subject|1|||
127745272|NCT01466790|459693770|FG005|Overall Study|Withdrawal by Subject|0|||
127745273|NCT01466790|459693771|FG006|Overall Study|Withdrawal by Subject|1|||
127745274|NCT01466790|459693772|FG007|Overall Study|Withdrawal by Subject|1|||
127745275|NCT01251887|459693774|FG000|Overall Study|Scheduling conflict|1|||
127745276|NCT01251887|459693775|FG001|Overall Study|Scheduling conflict|2|||
127745277|NCT01251887|459693776|FG002|Overall Study|Scheduling conflict|2|||
127745278|NCT01251887|459693774|FG000|Overall Study|Physician Decision|0|||
127745279|NCT01251887|459693775|FG001|Overall Study|Physician Decision|1|||
127745280|NCT01251887|459693776|FG002|Overall Study|Physician Decision|0|||
127745281|NCT03668223|459693777|FG000|Overall Study|Death|10|||
127745282|NCT03668223|459693778|FG001|Overall Study|Death|5|||
127745283|NCT03668223|459693777|FG000|Overall Study|Lost to Follow-up|12|||
127745284|NCT03668223|459693778|FG001|Overall Study|Lost to Follow-up|12|||
127745285|NCT03668223|459693777|FG000|Overall Study|Withdrawal by Subject|8|||
127745286|NCT03668223|459693778|FG001|Overall Study|Withdrawal by Subject|3|||
127745287|NCT01103232|459693779|FG000|Overall Study|Withdrawal by Subject|1|||
127745288|NCT01103232|459693780|FG001|Overall Study|Withdrawal by Subject|1|||
127745289|NCT01103232|459693779|FG000|Overall Study|Protocol Violation|0|||
127745290|NCT01103232|459693780|FG001|Overall Study|Protocol Violation|1|||
127745291|NCT00307047|459695343|FG000|Overall Study|Lost to Follow-up|35|||
127745292|NCT00307047|459695344|FG001|Overall Study|Lost to Follow-up|24|||
127745293|NCT00307047|459695343|FG000|Overall Study|Withdrawal by Subject|6|||
127745294|NCT00307047|459695344|FG001|Overall Study|Withdrawal by Subject|6|||
127745295|NCT00307047|459695343|FG000|Overall Study|Physician Decision|1|||
127745296|NCT00307047|459695344|FG001|Overall Study|Physician Decision|2|||
127745297|NCT00307047|459695343|FG000|Overall Study|Lost to follow-up for other reasons|0|||
127745298|NCT00307047|459695344|FG001|Overall Study|Lost to follow-up for other reasons|1|||
127745299|NCT00307047|459695343|FG000|Overall Study|All death, all MI, all Revascularization|27|||
127745300|NCT00307047|459695344|FG001|Overall Study|All death, all MI, all Revascularization|16|||
127745301|NCT02104505|459695345|FG000|First Intervention (14 Days)|Adverse Event|2|||
127745302|NCT02104505|459695346|FG001|First Intervention (14 Days)|Adverse Event|0|||
127745303|NCT02104505|459695345|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
127745304|NCT02104505|459695346|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
127745305|NCT02104505|459695345|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
127745306|NCT02104505|459695346|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
127745307|NCT02104505|459695345|FG000|First Intervention (14 Days)|exclusionary condition|0|||
127745308|NCT02104505|459695346|FG001|First Intervention (14 Days)|exclusionary condition|1|||
127745309|NCT02104505|459695345|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
127745310|NCT02104505|459695346|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
127808160|NCT00408005|459917764|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
127808161|NCT00408005|459917765|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
127808162|NCT00408005|459917766|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
127808163|NCT00408005|459917759|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
127808164|NCT00408005|459917760|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
127808165|NCT00408005|459917761|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
127808166|NCT00408005|459917762|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
127808167|NCT00408005|459917763|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
127808168|NCT00408005|459917764|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
127808169|NCT00408005|459917765|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
127808170|NCT00408005|459917766|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
127808171|NCT00408005|459917759|FG000|Induction|Progressive Disease|0|||
127745311|NCT02104505|459695345|FG000|Second Intervention (14 Days)|Adverse Event|2|||
127745312|NCT02104505|459695346|FG001|Second Intervention (14 Days)|Adverse Event|0|||
127745313|NCT00589303|459695351|FG000|Overall Study|Withdrawal by Subject|2|||
127745314|NCT00589303|459695352|FG001|Overall Study|Withdrawal by Subject|1|||
127745315|NCT00730015|459695356|FG000|Overall Study|Adverse Event|11|||
127745316|NCT00730015|459695357|FG001|Overall Study|Adverse Event|10|||
127745317|NCT00730015|459695358|FG002|Overall Study|Adverse Event|8|||
127808172|NCT00408005|459917760|FG001|Induction|Progressive Disease|1|||
127808173|NCT00408005|459917761|FG002|Induction|Progressive Disease|0|||
127808174|NCT00408005|459917762|FG003|Induction|Progressive Disease|0|||
127808175|NCT00408005|459917763|FG004|Induction|Progressive Disease|0|||
127808176|NCT00408005|459917764|FG005|Induction|Progressive Disease|0|||
127808177|NCT00408005|459917765|FG006|Induction|Progressive Disease|0|||
127808178|NCT00408005|459917766|FG007|Induction|Progressive Disease|0|||
127808179|NCT00408005|459917759|FG000|Induction|Inevaluable|18|||
127808180|NCT00408005|459917760|FG001|Induction|Inevaluable|14|||
127808181|NCT00408005|459917761|FG002|Induction|Inevaluable|0|||
127745318|NCT00730015|459695356|FG000|Overall Study|Protocol Violation|2|||
127745319|NCT00730015|459695357|FG001|Overall Study|Protocol Violation|6|||
127745320|NCT00730015|459695358|FG002|Overall Study|Protocol Violation|4|||
127745321|NCT00730015|459695356|FG000|Overall Study|Withdrawal by Subject|12|||
127745322|NCT00730015|459695357|FG001|Overall Study|Withdrawal by Subject|12|||
127745323|NCT00730015|459695358|FG002|Overall Study|Withdrawal by Subject|8|||
127745324|NCT00730015|459695356|FG000|Overall Study|Lost to Follow-up|4|||
127745325|NCT00730015|459695357|FG001|Overall Study|Lost to Follow-up|10|||
127745326|NCT00730015|459695358|FG002|Overall Study|Lost to Follow-up|3|||
127745327|NCT00730015|459695356|FG000|Overall Study|Lack of Efficacy|1|||
127745328|NCT00730015|459695357|FG001|Overall Study|Lack of Efficacy|2|||
127745329|NCT00730015|459695358|FG002|Overall Study|Lack of Efficacy|8|||
127745330|NCT00730015|459695356|FG000|Overall Study|Other Reason|1|||
127745331|NCT00730015|459695357|FG001|Overall Study|Other Reason|0|||
127745332|NCT00730015|459695358|FG002|Overall Study|Other Reason|1|||
127745333|NCT04120376|459695359|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
127745334|NCT04120376|459695360|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
127745335|NCT02641587|459695361|FG000|Confinement Period|Adverse Event|1|||
127745336|NCT02641587|459695362|FG001|Confinement Period|Adverse Event|0|||
127745337|NCT02641587|459695361|FG000|Confinement Period|Withdrawal by Subject|2|||
127745338|NCT02641587|459695362|FG001|Confinement Period|Withdrawal by Subject|1|||
127745339|NCT02641587|459695361|FG000|Ambulatory Period|Withdrawal by Subject|1|||
127745340|NCT02641587|459695362|FG001|Ambulatory Period|Withdrawal by Subject|0|||
127745341|NCT01165177|459695363|FG000|Overall Study|Serious Adverse Event|227|||
127745342|NCT01165177|459695364|FG001|Overall Study|Serious Adverse Event|235|||
127745343|NCT01165177|459695363|FG000|Overall Study|Withdrawal by Subject|368|||
127745344|NCT01165177|459695364|FG001|Overall Study|Withdrawal by Subject|354|||
127745345|NCT01165177|459695363|FG000|Overall Study|Protocol Violation|19|||
127745346|NCT01165177|459695364|FG001|Overall Study|Protocol Violation|21|||
127745347|NCT01165177|459695363|FG000|Overall Study|Non-serious adverse event|30|||
127745348|NCT01165177|459695364|FG001|Overall Study|Non-serious adverse event|18|||
127745349|NCT01165177|459695363|FG000|Overall Study|Other unspecified reasons|47|||
127745350|NCT01165177|459695364|FG001|Overall Study|Other unspecified reasons|35|||
127745351|NCT01165177|459695363|FG000|Overall Study|Suspected HZ episode|0|||
127745352|NCT01165177|459695364|FG001|Overall Study|Suspected HZ episode|2|||
127745353|NCT01165177|459695363|FG000|Overall Study|Lost to Follow-up|183|||
127745354|NCT01165177|459695364|FG001|Overall Study|Lost to Follow-up|194|||
127745355|NCT01165177|459695363|FG000|Overall Study|Migrated/ moved from study area|48|||
127745356|NCT01165177|459695364|FG001|Overall Study|Migrated/ moved from study area|43|||
127745357|NCT01663506|459695365|FG000|Overall Study|Lack of Efficacy|3|||
127745358|NCT01663506|459695365|FG000|Overall Study|Consent Withdrawal by Subject|1|||
127745359|NCT01663506|459695365|FG000|Overall Study|Lost to Follow-up|1|||
127745360|NCT01663506|459695365|FG000|Overall Study|Adverse Event|1|||
127745361|NCT01663506|459695365|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
127745362|NCT03210519|459695366|FG000|Overall Study|Adverse Event|2|||
127745363|NCT03210519|459695367|FG001|Overall Study|Adverse Event|0|||
127745364|NCT02270671|459695368|FG000|Overall Study|Withdrawal by Subject|1|||
127745365|NCT02270671|459695369|FG001|Overall Study|Withdrawal by Subject|1|||
127745366|NCT02270671|459695368|FG000|Overall Study|Protocol Violation|0|||
127745367|NCT02270671|459695369|FG001|Overall Study|Protocol Violation|1|||
127745368|NCT02270671|459695368|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
127745369|NCT02270671|459695369|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
127745370|NCT02270671|459695368|FG000|Overall Study|Lost to Follow-up|2|||
127745371|NCT02270671|459695369|FG001|Overall Study|Lost to Follow-up|1|||
127745372|NCT00174447|459695381|FG000|Overall Study|Adverse Event|19|||
127745373|NCT00174447|459695381|FG000|Overall Study|Withdrawal by Subject|15|||
127745374|NCT00174447|459695381|FG000|Overall Study|Protocol Violation|1|||
127745375|NCT00174447|459695381|FG000|Overall Study|Lack of Efficacy|1|||
127808182|NCT00408005|459917762|FG003|Induction|Inevaluable|0|||
127808183|NCT00408005|459917763|FG004|Induction|Inevaluable|0|||
127808184|NCT00408005|459917764|FG005|Induction|Inevaluable|0|||
127808185|NCT00408005|459917765|FG006|Induction|Inevaluable|0|||
127808186|NCT00408005|459917766|FG007|Induction|Inevaluable|0|||
127808187|NCT00408005|459917759|FG000|Induction|Failed to Complete Randomization|3|||
127745376|NCT00174447|459695381|FG000|Overall Study|Administrative reason/Other|2|||
127745377|NCT01437423|459695382|FG000|Overall Study|Lost to Follow-up|12|||
127745378|NCT01437423|459695382|FG000|Overall Study|Off label usage|3|||
127745379|NCT05878873|459695383|FG000|Overall Study|Lost to Follow-up|2|||
127745380|NCT05878873|459695384|FG001|Overall Study|Lost to Follow-up|0|||
127745381|NCT00633945|459695385|FG000|Overall Study|Physician Decision|2|||
127745382|NCT03865953|459695386|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
127808188|NCT00408005|459917760|FG001|Induction|Failed to Complete Randomization|2|||
127808189|NCT00408005|459917761|FG002|Induction|Failed to Complete Randomization|0|||
127745383|NCT03865953|459695387|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
127745384|NCT03865953|459695386|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
127745385|NCT03865953|459695387|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
127745386|NCT03865953|459695386|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
127745387|NCT03865953|459695387|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
127808190|NCT00408005|459917762|FG003|Induction|Failed to Complete Randomization|0|||
127808191|NCT00408005|459917763|FG004|Induction|Failed to Complete Randomization|0|||
127808192|NCT00408005|459917764|FG005|Induction|Failed to Complete Randomization|0|||
127808193|NCT00408005|459917765|FG006|Induction|Failed to Complete Randomization|0|||
127808194|NCT00408005|459917766|FG007|Induction|Failed to Complete Randomization|0|||
127808195|NCT00408005|459917759|FG000|Induction|Protocol Deviation|3|||
127808196|NCT00408005|459917760|FG001|Induction|Protocol Deviation|1|||
127808197|NCT00408005|459917761|FG002|Induction|Protocol Deviation|0|||
127745388|NCT00882115|459695388|FG000|Overall Study|Withdrawal by Subject|3|||
127745389|NCT00882115|459695388|FG000|Overall Study|did not respond to DEP challe|6|||
127745390|NCT01080326|459695389|FG000|Overall Study|Patient deterioration prior to procedure|3|||
127745391|NCT01080326|459695389|FG000|Overall Study|Surgeon decision|1|||
127745392|NCT01318876|459695390|FG000|Day 8 Survey|email address invalid|96|||
127745393|NCT01318876|459695390|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
127745394|NCT01318876|459695390|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
127745395|NCT01296555|459695391|FG000|Overall Study|Adverse Event|0|||
127745396|NCT01296555|459695392|FG001|Overall Study|Adverse Event|0|||
127745397|NCT01296555|459695393|FG002|Overall Study|Adverse Event|1|||
127745398|NCT01296555|459695394|FG003|Overall Study|Adverse Event|1|||
127745399|NCT01296555|459695395|FG004|Overall Study|Adverse Event|2|||
127745400|NCT01296555|459695396|FG005|Overall Study|Adverse Event|4|||
127745401|NCT01296555|459695397|FG006|Overall Study|Adverse Event|1|||
127745402|NCT01296555|459695398|FG007|Overall Study|Adverse Event|4|||
127745403|NCT01296555|459695399|FG008|Overall Study|Adverse Event|3|||
127745404|NCT01296555|459695400|FG009|Overall Study|Adverse Event|1|||
127745405|NCT01296555|459695401|FG010|Overall Study|Adverse Event|0|||
127745406|NCT01296555|459695402|FG011|Overall Study|Adverse Event|4|||
127745407|NCT01296555|459695403|FG012|Overall Study|Adverse Event|1|||
127745408|NCT01296555|459695404|FG013|Overall Study|Adverse Event|4|||
127745409|NCT01296555|459695405|FG014|Overall Study|Adverse Event|0|||
127745410|NCT01296555|459695406|FG015|Overall Study|Adverse Event|0|||
127745411|NCT01296555|459695407|FG016|Overall Study|Adverse Event|0|||
127745412|NCT01296555|459695408|FG017|Overall Study|Adverse Event|0|||
127745413|NCT01296555|459695409|FG018|Overall Study|Adverse Event|0|||
127745414|NCT01296555|459695410|FG019|Overall Study|Adverse Event|1|||
127745415|NCT01296555|459695411|FG020|Overall Study|Adverse Event|0|||
127745416|NCT01296555|459695412|FG021|Overall Study|Adverse Event|0|||
127745417|NCT01296555|459695413|FG022|Overall Study|Adverse Event|0|||
127745418|NCT01296555|459695414|FG023|Overall Study|Adverse Event|0|||
127745419|NCT01296555|459695415|FG024|Overall Study|Adverse Event|0|||
127745420|NCT01296555|459695416|FG025|Overall Study|Adverse Event|0|||
127745421|NCT01296555|459695417|FG026|Overall Study|Adverse Event|0|||
127745422|NCT01296555|459695418|FG027|Overall Study|Adverse Event|0|||
127745423|NCT01296555|459695419|FG028|Overall Study|Adverse Event|0|||
127745424|NCT01296555|459695391|FG000|Overall Study|Reason Not Specified|0|||
127745425|NCT01296555|459695392|FG001|Overall Study|Reason Not Specified|0|||
127808198|NCT00408005|459917762|FG003|Induction|Protocol Deviation|0|||
127808199|NCT00408005|459917763|FG004|Induction|Protocol Deviation|0|||
127808200|NCT00408005|459917764|FG005|Induction|Protocol Deviation|0|||
127808201|NCT00408005|459917765|FG006|Induction|Protocol Deviation|0|||
127808202|NCT00408005|459917766|FG007|Induction|Protocol Deviation|0|||
127808203|NCT00408005|459917759|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
127808204|NCT00408005|459917760|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
127808205|NCT00408005|459917761|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
127808206|NCT00408005|459917762|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
127808207|NCT00408005|459917763|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
127745426|NCT01296555|459695393|FG002|Overall Study|Reason Not Specified|0|||
127745427|NCT01296555|459695394|FG003|Overall Study|Reason Not Specified|0|||
127745428|NCT01296555|459695395|FG004|Overall Study|Reason Not Specified|0|||
127745429|NCT01296555|459695396|FG005|Overall Study|Reason Not Specified|0|||
127745430|NCT01296555|459695397|FG006|Overall Study|Reason Not Specified|0|||
127745431|NCT01296555|459695398|FG007|Overall Study|Reason Not Specified|0|||
127745432|NCT01296555|459695399|FG008|Overall Study|Reason Not Specified|0|||
127745433|NCT01296555|459695400|FG009|Overall Study|Reason Not Specified|0|||
127745434|NCT01296555|459695401|FG010|Overall Study|Reason Not Specified|0|||
127745435|NCT01296555|459695402|FG011|Overall Study|Reason Not Specified|0|||
127745436|NCT01296555|459695403|FG012|Overall Study|Reason Not Specified|0|||
127745437|NCT01296555|459695404|FG013|Overall Study|Reason Not Specified|1|||
127745438|NCT01296555|459695405|FG014|Overall Study|Reason Not Specified|2|||
127745439|NCT01296555|459695406|FG015|Overall Study|Reason Not Specified|3|||
127745440|NCT01296555|459695407|FG016|Overall Study|Reason Not Specified|7|||
127745441|NCT01296555|459695408|FG017|Overall Study|Reason Not Specified|4|||
127745442|NCT01296555|459695409|FG018|Overall Study|Reason Not Specified|3|||
127745443|NCT01296555|459695410|FG019|Overall Study|Reason Not Specified|7|||
127745444|NCT01296555|459695411|FG020|Overall Study|Reason Not Specified|11|||
127745445|NCT01296555|459695412|FG021|Overall Study|Reason Not Specified|5|||
127745446|NCT01296555|459695413|FG022|Overall Study|Reason Not Specified|5|||
127745447|NCT01296555|459695414|FG023|Overall Study|Reason Not Specified|7|||
127745448|NCT01296555|459695415|FG024|Overall Study|Reason Not Specified|2|||
127745449|NCT01296555|459695416|FG025|Overall Study|Reason Not Specified|2|||
127745450|NCT01296555|459695417|FG026|Overall Study|Reason Not Specified|19|||
127745451|NCT01296555|459695418|FG027|Overall Study|Reason Not Specified|11|||
127745452|NCT01296555|459695419|FG028|Overall Study|Reason Not Specified|9|||
127745453|NCT01296555|459695391|FG000|Overall Study|Physician Decision|0|||
127745454|NCT01296555|459695392|FG001|Overall Study|Physician Decision|0|||
127745455|NCT01296555|459695393|FG002|Overall Study|Physician Decision|0|||
127745456|NCT01296555|459695394|FG003|Overall Study|Physician Decision|0|||
127745457|NCT01296555|459695395|FG004|Overall Study|Physician Decision|1|||
127745458|NCT01296555|459695396|FG005|Overall Study|Physician Decision|0|||
127745459|NCT01296555|459695397|FG006|Overall Study|Physician Decision|0|||
127745460|NCT01296555|459695398|FG007|Overall Study|Physician Decision|0|||
127745461|NCT01296555|459695399|FG008|Overall Study|Physician Decision|0|||
127745462|NCT01296555|459695400|FG009|Overall Study|Physician Decision|0|||
127745463|NCT01296555|459695401|FG010|Overall Study|Physician Decision|0|||
127745464|NCT01296555|459695402|FG011|Overall Study|Physician Decision|0|||
127745465|NCT01296555|459695403|FG012|Overall Study|Physician Decision|0|||
127745466|NCT01296555|459695404|FG013|Overall Study|Physician Decision|1|||
127745467|NCT01296555|459695405|FG014|Overall Study|Physician Decision|0|||
127745468|NCT01296555|459695406|FG015|Overall Study|Physician Decision|0|||
127745469|NCT01296555|459695407|FG016|Overall Study|Physician Decision|0|||
127745470|NCT01296555|459695408|FG017|Overall Study|Physician Decision|0|||
127745471|NCT01296555|459695409|FG018|Overall Study|Physician Decision|0|||
127745472|NCT01296555|459695410|FG019|Overall Study|Physician Decision|1|||
127745473|NCT01296555|459695411|FG020|Overall Study|Physician Decision|0|||
127745474|NCT01296555|459695412|FG021|Overall Study|Physician Decision|0|||
127745475|NCT01296555|459695413|FG022|Overall Study|Physician Decision|0|||
127745476|NCT01296555|459695414|FG023|Overall Study|Physician Decision|0|||
127745477|NCT01296555|459695415|FG024|Overall Study|Physician Decision|0|||
127745478|NCT01296555|459695416|FG025|Overall Study|Physician Decision|0|||
127745479|NCT01296555|459695417|FG026|Overall Study|Physician Decision|0|||
127745480|NCT01296555|459695418|FG027|Overall Study|Physician Decision|0|||
127745481|NCT01296555|459695419|FG028|Overall Study|Physician Decision|0|||
127745482|NCT01296555|459695391|FG000|Overall Study|Progressive Disease|6|||
127745483|NCT01296555|459695392|FG001|Overall Study|Progressive Disease|3|||
127745484|NCT01296555|459695393|FG002|Overall Study|Progressive Disease|3|||
127745485|NCT01296555|459695394|FG003|Overall Study|Progressive Disease|7|||
127745486|NCT01296555|459695395|FG004|Overall Study|Progressive Disease|6|||
127745487|NCT01296555|459695396|FG005|Overall Study|Progressive Disease|16|||
127745488|NCT01296555|459695397|FG006|Overall Study|Progressive Disease|16|||
127745489|NCT01296555|459695398|FG007|Overall Study|Progressive Disease|8|||
127745490|NCT01296555|459695399|FG008|Overall Study|Progressive Disease|7|||
127745491|NCT01296555|459695400|FG009|Overall Study|Progressive Disease|18|||
127745492|NCT01296555|459695401|FG010|Overall Study|Progressive Disease|7|||
127745493|NCT01296555|459695402|FG011|Overall Study|Progressive Disease|14|||
127745494|NCT01296555|459695403|FG012|Overall Study|Progressive Disease|5|||
127745495|NCT01296555|459695404|FG013|Overall Study|Progressive Disease|12|||
127745496|NCT01296555|459695405|FG014|Overall Study|Progressive Disease|1|||
127745497|NCT01296555|459695406|FG015|Overall Study|Progressive Disease|1|||
127745498|NCT01296555|459695407|FG016|Overall Study|Progressive Disease|0|||
127745499|NCT01296555|459695408|FG017|Overall Study|Progressive Disease|0|||
127745500|NCT01296555|459695409|FG018|Overall Study|Progressive Disease|0|||
127745501|NCT01296555|459695410|FG019|Overall Study|Progressive Disease|1|||
127745502|NCT01296555|459695411|FG020|Overall Study|Progressive Disease|0|||
127745503|NCT01296555|459695412|FG021|Overall Study|Progressive Disease|0|||
127745504|NCT01296555|459695413|FG022|Overall Study|Progressive Disease|0|||
127745505|NCT01296555|459695414|FG023|Overall Study|Progressive Disease|0|||
127745506|NCT01296555|459695415|FG024|Overall Study|Progressive Disease|1|||
127745507|NCT01296555|459695416|FG025|Overall Study|Progressive Disease|0|||
127745508|NCT01296555|459695417|FG026|Overall Study|Progressive Disease|5|||
127745509|NCT01296555|459695418|FG027|Overall Study|Progressive Disease|1|||
127745510|NCT01296555|459695419|FG028|Overall Study|Progressive Disease|0|||
127745511|NCT01296555|459695391|FG000|Overall Study|Protocol Violation|0|||
127745512|NCT01296555|459695392|FG001|Overall Study|Protocol Violation|0|||
127745513|NCT01296555|459695393|FG002|Overall Study|Protocol Violation|0|||
127745514|NCT01296555|459695394|FG003|Overall Study|Protocol Violation|0|||
127745515|NCT01296555|459695395|FG004|Overall Study|Protocol Violation|0|||
127745516|NCT01296555|459695396|FG005|Overall Study|Protocol Violation|0|||
127745517|NCT01296555|459695397|FG006|Overall Study|Protocol Violation|0|||
127745518|NCT01296555|459695398|FG007|Overall Study|Protocol Violation|0|||
127745519|NCT01296555|459695399|FG008|Overall Study|Protocol Violation|0|||
127745520|NCT01296555|459695400|FG009|Overall Study|Protocol Violation|0|||
127745521|NCT01296555|459695401|FG010|Overall Study|Protocol Violation|0|||
127745522|NCT01296555|459695402|FG011|Overall Study|Protocol Violation|0|||
127745523|NCT01296555|459695403|FG012|Overall Study|Protocol Violation|0|||
127745524|NCT01296555|459695404|FG013|Overall Study|Protocol Violation|1|||
127745525|NCT01296555|459695405|FG014|Overall Study|Protocol Violation|0|||
127745526|NCT01296555|459695406|FG015|Overall Study|Protocol Violation|0|||
127745527|NCT01296555|459695407|FG016|Overall Study|Protocol Violation|0|||
127745528|NCT01296555|459695408|FG017|Overall Study|Protocol Violation|0|||
127745529|NCT01296555|459695409|FG018|Overall Study|Protocol Violation|0|||
127745530|NCT01296555|459695410|FG019|Overall Study|Protocol Violation|0|||
127745531|NCT01296555|459695411|FG020|Overall Study|Protocol Violation|0|||
127745532|NCT01296555|459695412|FG021|Overall Study|Protocol Violation|0|||
127745533|NCT01296555|459695413|FG022|Overall Study|Protocol Violation|0|||
127745534|NCT01296555|459695414|FG023|Overall Study|Protocol Violation|0|||
127745535|NCT01296555|459695415|FG024|Overall Study|Protocol Violation|0|||
127745536|NCT01296555|459695416|FG025|Overall Study|Protocol Violation|0|||
127745537|NCT01296555|459695417|FG026|Overall Study|Protocol Violation|0|||
127745538|NCT01296555|459695418|FG027|Overall Study|Protocol Violation|0|||
127745539|NCT01296555|459695419|FG028|Overall Study|Protocol Violation|0|||
127745540|NCT01296555|459695391|FG000|Overall Study|Study Terminated By Sponsor|0|||
127745541|NCT01296555|459695392|FG001|Overall Study|Study Terminated By Sponsor|0|||
127745542|NCT01296555|459695393|FG002|Overall Study|Study Terminated By Sponsor|0|||
127745543|NCT01296555|459695394|FG003|Overall Study|Study Terminated By Sponsor|0|||
127745544|NCT01296555|459695395|FG004|Overall Study|Study Terminated By Sponsor|0|||
127745545|NCT01296555|459695396|FG005|Overall Study|Study Terminated By Sponsor|0|||
127745546|NCT01296555|459695397|FG006|Overall Study|Study Terminated By Sponsor|0|||
127745547|NCT01296555|459695398|FG007|Overall Study|Study Terminated By Sponsor|0|||
127745548|NCT01296555|459695399|FG008|Overall Study|Study Terminated By Sponsor|0|||
127745549|NCT01296555|459695400|FG009|Overall Study|Study Terminated By Sponsor|0|||
127745550|NCT01296555|459695401|FG010|Overall Study|Study Terminated By Sponsor|0|||
127745551|NCT01296555|459695402|FG011|Overall Study|Study Terminated By Sponsor|0|||
127745552|NCT01296555|459695403|FG012|Overall Study|Study Terminated By Sponsor|0|||
127745553|NCT01296555|459695404|FG013|Overall Study|Study Terminated By Sponsor|0|||
127745554|NCT01296555|459695405|FG014|Overall Study|Study Terminated By Sponsor|0|||
127745555|NCT01296555|459695406|FG015|Overall Study|Study Terminated By Sponsor|0|||
127745556|NCT01296555|459695407|FG016|Overall Study|Study Terminated By Sponsor|0|||
127745557|NCT01296555|459695408|FG017|Overall Study|Study Terminated By Sponsor|0|||
127745558|NCT01296555|459695409|FG018|Overall Study|Study Terminated By Sponsor|0|||
127745559|NCT01296555|459695410|FG019|Overall Study|Study Terminated By Sponsor|0|||
127745560|NCT01296555|459695411|FG020|Overall Study|Study Terminated By Sponsor|0|||
127745561|NCT01296555|459695412|FG021|Overall Study|Study Terminated By Sponsor|0|||
127745562|NCT01296555|459695413|FG022|Overall Study|Study Terminated By Sponsor|0|||
127745563|NCT01296555|459695414|FG023|Overall Study|Study Terminated By Sponsor|0|||
127745564|NCT01296555|459695415|FG024|Overall Study|Study Terminated By Sponsor|0|||
127745565|NCT01296555|459695416|FG025|Overall Study|Study Terminated By Sponsor|1|||
127745566|NCT01296555|459695417|FG026|Overall Study|Study Terminated By Sponsor|0|||
127745567|NCT01296555|459695418|FG027|Overall Study|Study Terminated By Sponsor|0|||
127745568|NCT01296555|459695419|FG028|Overall Study|Study Terminated By Sponsor|0|||
127745569|NCT01296555|459695391|FG000|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
127745570|NCT01296555|459695392|FG001|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
127745571|NCT01296555|459695393|FG002|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
127745572|NCT01296555|459695394|FG003|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
127745573|NCT01296555|459695395|FG004|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
127745574|NCT01296555|459695396|FG005|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
127745575|NCT01296555|459695397|FG006|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
127745576|NCT01296555|459695398|FG007|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
127745577|NCT01296555|459695399|FG008|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
127745578|NCT01296555|459695400|FG009|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
127745579|NCT01296555|459695401|FG010|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
127745580|NCT01296555|459695402|FG011|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
127893839|NCT04345471|460233354|FG001|Overall Study|Adverse Event|5|||
127745581|NCT01296555|459695403|FG012|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
127745582|NCT01296555|459695404|FG013|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
127745583|NCT01296555|459695405|FG014|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
127745584|NCT01296555|459695406|FG015|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
127745585|NCT01296555|459695407|FG016|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
127745586|NCT01296555|459695408|FG017|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
127745587|NCT01296555|459695409|FG018|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
127745588|NCT01296555|459695410|FG019|Overall Study|Use Of Another Anti-Cancer Therapy|2|||
127745589|NCT01296555|459695411|FG020|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
127745590|NCT01296555|459695412|FG021|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
127745591|NCT01296555|459695413|FG022|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
127745592|NCT01296555|459695414|FG023|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
127745593|NCT01296555|459695415|FG024|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
127745594|NCT01296555|459695416|FG025|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
127745595|NCT01296555|459695417|FG026|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
127745596|NCT01296555|459695418|FG027|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
127745597|NCT01296555|459695419|FG028|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
127745598|NCT01296555|459695391|FG000|Overall Study|Death|0|||
127745599|NCT01296555|459695392|FG001|Overall Study|Death|0|||
127745600|NCT01296555|459695393|FG002|Overall Study|Death|0|||
127745601|NCT01296555|459695394|FG003|Overall Study|Death|2|||
127745602|NCT01296555|459695395|FG004|Overall Study|Death|1|||
127745603|NCT01296555|459695396|FG005|Overall Study|Death|0|||
127745604|NCT01296555|459695397|FG006|Overall Study|Death|2|||
127745605|NCT01296555|459695398|FG007|Overall Study|Death|0|||
127745606|NCT01296555|459695399|FG008|Overall Study|Death|0|||
127745607|NCT01296555|459695400|FG009|Overall Study|Death|1|||
127745608|NCT01296555|459695401|FG010|Overall Study|Death|0|||
127745609|NCT01296555|459695402|FG011|Overall Study|Death|1|||
127745610|NCT01296555|459695403|FG012|Overall Study|Death|0|||
127745611|NCT01296555|459695404|FG013|Overall Study|Death|2|||
127745612|NCT01296555|459695405|FG014|Overall Study|Death|27|||
127745613|NCT01296555|459695406|FG015|Overall Study|Death|15|||
127745614|NCT01296555|459695407|FG016|Overall Study|Death|11|||
127745615|NCT01296555|459695408|FG017|Overall Study|Death|11|||
127745616|NCT01296555|459695409|FG018|Overall Study|Death|17|||
127745617|NCT01296555|459695410|FG019|Overall Study|Death|12|||
127745618|NCT01296555|459695411|FG020|Overall Study|Death|13|||
127745619|NCT01296555|459695412|FG021|Overall Study|Death|12|||
127745620|NCT01296555|459695413|FG022|Overall Study|Death|12|||
127745621|NCT01296555|459695414|FG023|Overall Study|Death|13|||
127745622|NCT01296555|459695415|FG024|Overall Study|Death|7|||
127745623|NCT01296555|459695416|FG025|Overall Study|Death|7|||
127745624|NCT01296555|459695417|FG026|Overall Study|Death|35|||
127745625|NCT01296555|459695418|FG027|Overall Study|Death|92|||
127745626|NCT01296555|459695419|FG028|Overall Study|Death|44|||
127745627|NCT01296555|459695391|FG000|Overall Study|Lost to Follow-up|0|||
127745628|NCT01296555|459695392|FG001|Overall Study|Lost to Follow-up|0|||
127745629|NCT01296555|459695393|FG002|Overall Study|Lost to Follow-up|0|||
127745630|NCT01296555|459695394|FG003|Overall Study|Lost to Follow-up|0|||
127745631|NCT01296555|459695395|FG004|Overall Study|Lost to Follow-up|0|||
127745632|NCT01296555|459695396|FG005|Overall Study|Lost to Follow-up|0|||
127745633|NCT01296555|459695397|FG006|Overall Study|Lost to Follow-up|0|||
127745634|NCT01296555|459695398|FG007|Overall Study|Lost to Follow-up|0|||
127745635|NCT01296555|459695399|FG008|Overall Study|Lost to Follow-up|0|||
127745636|NCT01296555|459695400|FG009|Overall Study|Lost to Follow-up|0|||
127745637|NCT01296555|459695401|FG010|Overall Study|Lost to Follow-up|0|||
127745638|NCT01296555|459695402|FG011|Overall Study|Lost to Follow-up|0|||
127745639|NCT01296555|459695403|FG012|Overall Study|Lost to Follow-up|0|||
127745640|NCT01296555|459695404|FG013|Overall Study|Lost to Follow-up|0|||
127745641|NCT01296555|459695405|FG014|Overall Study|Lost to Follow-up|2|||
127745642|NCT01296555|459695406|FG015|Overall Study|Lost to Follow-up|1|||
127745643|NCT01296555|459695407|FG016|Overall Study|Lost to Follow-up|0|||
127745644|NCT01296555|459695408|FG017|Overall Study|Lost to Follow-up|2|||
127745645|NCT01296555|459695409|FG018|Overall Study|Lost to Follow-up|0|||
127745646|NCT01296555|459695410|FG019|Overall Study|Lost to Follow-up|2|||
127745647|NCT01296555|459695411|FG020|Overall Study|Lost to Follow-up|3|||
127745648|NCT01296555|459695412|FG021|Overall Study|Lost to Follow-up|2|||
127745649|NCT01296555|459695413|FG022|Overall Study|Lost to Follow-up|0|||
127745650|NCT01296555|459695414|FG023|Overall Study|Lost to Follow-up|0|||
127745651|NCT01296555|459695415|FG024|Overall Study|Lost to Follow-up|0|||
127745652|NCT01296555|459695416|FG025|Overall Study|Lost to Follow-up|0|||
127745653|NCT01296555|459695417|FG026|Overall Study|Lost to Follow-up|3|||
127745654|NCT01296555|459695418|FG027|Overall Study|Lost to Follow-up|13|||
127745655|NCT01296555|459695419|FG028|Overall Study|Lost to Follow-up|5|||
127745656|NCT01296555|459695391|FG000|Overall Study|Non-Compliance With Study Drug|0|||
127745657|NCT01296555|459695392|FG001|Overall Study|Non-Compliance With Study Drug|0|||
127745658|NCT01296555|459695393|FG002|Overall Study|Non-Compliance With Study Drug|0|||
127745659|NCT01296555|459695394|FG003|Overall Study|Non-Compliance With Study Drug|0|||
127745660|NCT01296555|459695395|FG004|Overall Study|Non-Compliance With Study Drug|0|||
127745661|NCT01296555|459695396|FG005|Overall Study|Non-Compliance With Study Drug|0|||
127745662|NCT01296555|459695397|FG006|Overall Study|Non-Compliance With Study Drug|0|||
127745663|NCT01296555|459695398|FG007|Overall Study|Non-Compliance With Study Drug|1|||
127745664|NCT01296555|459695399|FG008|Overall Study|Non-Compliance With Study Drug|0|||
127745665|NCT01296555|459695400|FG009|Overall Study|Non-Compliance With Study Drug|0|||
127745666|NCT01296555|459695401|FG010|Overall Study|Non-Compliance With Study Drug|0|||
127745667|NCT01296555|459695402|FG011|Overall Study|Non-Compliance With Study Drug|0|||
127745668|NCT01296555|459695403|FG012|Overall Study|Non-Compliance With Study Drug|0|||
127745669|NCT01296555|459695404|FG013|Overall Study|Non-Compliance With Study Drug|0|||
127745670|NCT01296555|459695405|FG014|Overall Study|Non-Compliance With Study Drug|0|||
127745671|NCT01296555|459695406|FG015|Overall Study|Non-Compliance With Study Drug|0|||
127745672|NCT01296555|459695407|FG016|Overall Study|Non-Compliance With Study Drug|0|||
127745673|NCT01296555|459695408|FG017|Overall Study|Non-Compliance With Study Drug|0|||
127745674|NCT01296555|459695409|FG018|Overall Study|Non-Compliance With Study Drug|0|||
127745675|NCT01296555|459695410|FG019|Overall Study|Non-Compliance With Study Drug|0|||
127745676|NCT01296555|459695411|FG020|Overall Study|Non-Compliance With Study Drug|0|||
127745677|NCT01296555|459695412|FG021|Overall Study|Non-Compliance With Study Drug|0|||
127745678|NCT01296555|459695413|FG022|Overall Study|Non-Compliance With Study Drug|0|||
127745679|NCT01296555|459695414|FG023|Overall Study|Non-Compliance With Study Drug|0|||
127745680|NCT01296555|459695415|FG024|Overall Study|Non-Compliance With Study Drug|0|||
127745681|NCT01296555|459695416|FG025|Overall Study|Non-Compliance With Study Drug|0|||
127745682|NCT01296555|459695417|FG026|Overall Study|Non-Compliance With Study Drug|0|||
127745683|NCT01296555|459695418|FG027|Overall Study|Non-Compliance With Study Drug|0|||
127745684|NCT01296555|459695419|FG028|Overall Study|Non-Compliance With Study Drug|0|||
127745685|NCT01296555|459695391|FG000|Overall Study|Withdrawal by Subject|0|||
127745686|NCT01296555|459695392|FG001|Overall Study|Withdrawal by Subject|0|||
127745687|NCT01296555|459695393|FG002|Overall Study|Withdrawal by Subject|0|||
127745688|NCT01296555|459695394|FG003|Overall Study|Withdrawal by Subject|0|||
127745689|NCT01296555|459695395|FG004|Overall Study|Withdrawal by Subject|1|||
127745690|NCT01296555|459695396|FG005|Overall Study|Withdrawal by Subject|0|||
127745691|NCT01296555|459695397|FG006|Overall Study|Withdrawal by Subject|1|||
127745692|NCT01296555|459695398|FG007|Overall Study|Withdrawal by Subject|0|||
127745693|NCT01296555|459695399|FG008|Overall Study|Withdrawal by Subject|0|||
127745694|NCT01296555|459695400|FG009|Overall Study|Withdrawal by Subject|0|||
127745695|NCT01296555|459695401|FG010|Overall Study|Withdrawal by Subject|1|||
127745696|NCT01296555|459695402|FG011|Overall Study|Withdrawal by Subject|1|||
127745697|NCT01296555|459695403|FG012|Overall Study|Withdrawal by Subject|0|||
127745698|NCT01296555|459695404|FG013|Overall Study|Withdrawal by Subject|0|||
127745699|NCT01296555|459695405|FG014|Overall Study|Withdrawal by Subject|3|||
127745700|NCT01296555|459695406|FG015|Overall Study|Withdrawal by Subject|0|||
127745701|NCT01296555|459695407|FG016|Overall Study|Withdrawal by Subject|2|||
127745702|NCT01296555|459695408|FG017|Overall Study|Withdrawal by Subject|1|||
127745703|NCT01296555|459695409|FG018|Overall Study|Withdrawal by Subject|0|||
127745704|NCT01296555|459695410|FG019|Overall Study|Withdrawal by Subject|1|||
127745705|NCT01296555|459695411|FG020|Overall Study|Withdrawal by Subject|1|||
127745706|NCT01296555|459695412|FG021|Overall Study|Withdrawal by Subject|1|||
127745707|NCT01296555|459695413|FG022|Overall Study|Withdrawal by Subject|3|||
127745708|NCT01296555|459695414|FG023|Overall Study|Withdrawal by Subject|0|||
127745709|NCT01296555|459695415|FG024|Overall Study|Withdrawal by Subject|0|||
127745710|NCT01296555|459695416|FG025|Overall Study|Withdrawal by Subject|0|||
127745711|NCT01296555|459695417|FG026|Overall Study|Withdrawal by Subject|8|||
127745712|NCT01296555|459695418|FG027|Overall Study|Withdrawal by Subject|4|||
127745713|NCT01296555|459695419|FG028|Overall Study|Withdrawal by Subject|2|||
127745714|NCT03000348|459695420|FG000|Overall Study|Adverse Event|1|||
127745715|NCT03000348|459695421|FG001|Overall Study|Adverse Event|1|||
127745716|NCT03000348|459695422|FG002|Overall Study|Adverse Event|1|||
127745717|NCT03000348|459695423|FG003|Overall Study|Adverse Event|1|||
127745718|NCT03000348|459695424|FG004|Overall Study|Adverse Event|1|||
127745719|NCT03000348|459695425|FG005|Overall Study|Adverse Event|1|||
127745720|NCT03000348|459695420|FG000|Overall Study|Lost to Follow-up|0|||
127745721|NCT03000348|459695421|FG001|Overall Study|Lost to Follow-up|0|||
127745722|NCT03000348|459695422|FG002|Overall Study|Lost to Follow-up|1|||
127745723|NCT03000348|459695423|FG003|Overall Study|Lost to Follow-up|0|||
127745724|NCT03000348|459695424|FG004|Overall Study|Lost to Follow-up|0|||
127745725|NCT03000348|459695425|FG005|Overall Study|Lost to Follow-up|0|||
127745726|NCT03000348|459695420|FG000|Overall Study|Withdrawal by Subject|0|||
127745727|NCT03000348|459695421|FG001|Overall Study|Withdrawal by Subject|1|||
127745728|NCT03000348|459695422|FG002|Overall Study|Withdrawal by Subject|0|||
127745729|NCT03000348|459695423|FG003|Overall Study|Withdrawal by Subject|0|||
127745730|NCT03000348|459695424|FG004|Overall Study|Withdrawal by Subject|0|||
127745731|NCT03000348|459695425|FG005|Overall Study|Withdrawal by Subject|0|||
127745732|NCT03000348|459695420|FG000|Overall Study|Consent|0|||
127745733|NCT03000348|459695421|FG001|Overall Study|Consent|0|||
127745734|NCT03000348|459695422|FG002|Overall Study|Consent|0|||
127745735|NCT03000348|459695423|FG003|Overall Study|Consent|0|||
127808208|NCT00408005|459917764|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
127808209|NCT00408005|459917765|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
127745736|NCT03000348|459695424|FG004|Overall Study|Consent|1|||
127745737|NCT03000348|459695425|FG005|Overall Study|Consent|0|||
127745738|NCT03000348|459695420|FG000|Overall Study|Failure to expectorate sputum|1|||
127745739|NCT03000348|459695421|FG001|Overall Study|Failure to expectorate sputum|0|||
127745740|NCT03000348|459695422|FG002|Overall Study|Failure to expectorate sputum|1|||
127745741|NCT03000348|459695423|FG003|Overall Study|Failure to expectorate sputum|0|||
127745742|NCT03000348|459695424|FG004|Overall Study|Failure to expectorate sputum|1|||
127745743|NCT03000348|459695425|FG005|Overall Study|Failure to expectorate sputum|0|||
127745744|NCT03000348|459695420|FG000|Overall Study|No gram negative|1|||
127893840|NCT04345471|460233355|FG002|Overall Study|Adverse Event|6|||
127745745|NCT03000348|459695421|FG001|Overall Study|No gram negative|2|||
127745746|NCT03000348|459695422|FG002|Overall Study|No gram negative|1|||
127745747|NCT03000348|459695423|FG003|Overall Study|No gram negative|1|||
127745748|NCT03000348|459695424|FG004|Overall Study|No gram negative|1|||
127745749|NCT03000348|459695425|FG005|Overall Study|No gram negative|1|||
127745750|NCT03000348|459695420|FG000|Overall Study|Patient had no transport|0|||
127745751|NCT03000348|459695421|FG001|Overall Study|Patient had no transport|0|||
127745752|NCT03000348|459695422|FG002|Overall Study|Patient had no transport|0|||
127745753|NCT03000348|459695423|FG003|Overall Study|Patient had no transport|1|||
127745754|NCT03000348|459695424|FG004|Overall Study|Patient had no transport|0|||
127745755|NCT03000348|459695425|FG005|Overall Study|Patient had no transport|0|||
127745756|NCT03000348|459695420|FG000|Overall Study|Dosing|0|||
127745757|NCT03000348|459695421|FG001|Overall Study|Dosing|0|||
127745758|NCT03000348|459695422|FG002|Overall Study|Dosing|0|||
127745759|NCT03000348|459695423|FG003|Overall Study|Dosing|0|||
127745760|NCT03000348|459695424|FG004|Overall Study|Dosing|1|||
127745761|NCT03000348|459695425|FG005|Overall Study|Dosing|0|||
127745762|NCT04042077|459695426|FG000|Overall Study|Adverse Event|0|||
127745763|NCT04042077|459695427|FG001|Overall Study|Adverse Event|1|||
127745764|NCT04042077|459695426|FG000|Overall Study|Death|2|||
127745765|NCT04042077|459695427|FG001|Overall Study|Death|1|||
127745766|NCT04042077|459695426|FG000|Overall Study|Physician Decision|2|||
127745767|NCT04042077|459695427|FG001|Overall Study|Physician Decision|0|||
127745768|NCT04042077|459695426|FG000|Overall Study|Withdrawal by Subject|3|||
127745769|NCT04042077|459695427|FG001|Overall Study|Withdrawal by Subject|2|||
127745770|NCT04042077|459695426|FG000|Overall Study|Lack of Efficacy|0|||
127745771|NCT04042077|459695427|FG001|Overall Study|Lack of Efficacy|1|||
127745772|NCT00745498|459695429|FG000|Overall Study|Lost to Follow-up|1|||
127745773|NCT00745498|459695430|FG001|Overall Study|Lost to Follow-up|1|||
127745774|NCT00745498|459695431|FG002|Overall Study|Lost to Follow-up|3|||
127745775|NCT00745498|459695429|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
127745776|NCT00745498|459695430|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
127745777|NCT00745498|459695431|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
127745778|NCT00745498|459695429|FG000|Overall Study|Non-PDR related VH|0|||
127745779|NCT00745498|459695430|FG001|Overall Study|Non-PDR related VH|1|||
127745780|NCT00745498|459695431|FG002|Overall Study|Non-PDR related VH|1|||
127745781|NCT00745498|459695429|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
127745782|NCT00745498|459695430|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
127745783|NCT00745498|459695431|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
127745784|NCT02031536|459695435|FG000|Overall Study|ineligible|1|||
127745785|NCT02031536|459695436|FG001|Overall Study|ineligible|0|||
127745786|NCT01658020|459695438|FG000|Overall Study|Adverse Event|3|||
127745787|NCT01658020|459695439|FG001|Overall Study|Adverse Event|3|||
127745788|NCT01658020|459695438|FG000|Overall Study|Lost to Follow-up|1|||
127745789|NCT01658020|459695439|FG001|Overall Study|Lost to Follow-up|0|||
127745790|NCT01658020|459695438|FG000|Overall Study|Withdrawal by Subject|4|||
127745791|NCT01658020|459695439|FG001|Overall Study|Withdrawal by Subject|5|||
127745792|NCT01658020|459695438|FG000|Overall Study|Protocol Violation|0|||
127745793|NCT01658020|459695439|FG001|Overall Study|Protocol Violation|1|||
127745794|NCT02353871|459695440|FG000|Overall Study|Protocol deviation|0|||
127745795|NCT02353871|459695441|FG001|Overall Study|Protocol deviation|1|||
127745796|NCT02353871|459695440|FG000|Overall Study|Consent withdrawn|1|||
127745797|NCT02353871|459695441|FG001|Overall Study|Consent withdrawn|8|||
127745798|NCT02353871|459695440|FG000|Overall Study|Lost to Follow-up|2|||
127745799|NCT02353871|459695441|FG001|Overall Study|Lost to Follow-up|0|||
127745800|NCT01191008|459695453|FG000|Overall Study|Protocol Violation|7|||
127745801|NCT01191008|459695453|FG000|Overall Study|Lost to Follow-up|8|||
127745802|NCT04905849|459695456|FG000|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|6|||
127745803|NCT04905849|459695457|FG001|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|0|||
127745804|NCT00838929|459695462|FG000|Overall Study|Protocol Violation|0|||
127745805|NCT00838929|459695463|FG001|Overall Study|Protocol Violation|1|||
127745806|NCT00838929|459695464|FG002|Overall Study|Protocol Violation|0|||
127745807|NCT00838929|459695462|FG000|Overall Study|Disease progression|0|||
127745808|NCT00838929|459695463|FG001|Overall Study|Disease progression|2|||
127745809|NCT00838929|459695464|FG002|Overall Study|Disease progression|1|||
127745810|NCT04913948|459695472|FG000|Overall Study|Withdrawal by Subject|2|||
127745811|NCT04913948|459695472|FG000|Overall Study|Sample processing issues|1|||
127745812|NCT04913948|459695472|FG000|Overall Study|Suspected to have COVID-19 at the time of delivery but was found to be negative upon RT-PCR testing|1|||
127745813|NCT01068210|459695475|FG000|Overall Study|Lost to Follow-up|1|||
127745814|NCT01068210|459695476|FG001|Overall Study|Lost to Follow-up|2|||
127745815|NCT01068210|459695477|FG002|Overall Study|Lost to Follow-up|2|||
127745816|NCT01068210|459695478|FG003|Overall Study|Lost to Follow-up|1|||
127745817|NCT01068210|459695475|FG000|Overall Study|Second cancer|0|||
127745818|NCT01068210|459695476|FG001|Overall Study|Second cancer|1|||
127745819|NCT01068210|459695477|FG002|Overall Study|Second cancer|0|||
127745820|NCT01068210|459695478|FG003|Overall Study|Second cancer|0|||
127808210|NCT00408005|459917766|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
127745821|NCT01068210|459695475|FG000|Overall Study|Disease progression|0|||
127745822|NCT01068210|459695476|FG001|Overall Study|Disease progression|0|||
127745823|NCT01068210|459695477|FG002|Overall Study|Disease progression|0|||
127745824|NCT01068210|459695478|FG003|Overall Study|Disease progression|2|||
127745825|NCT03522389|459695479|FG000|Overall Study|Lost to Follow-up|1|||
127745826|NCT03522389|459695480|FG001|Overall Study|Lost to Follow-up|1|||
127745827|NCT03522389|459695481|FG002|Overall Study|Lost to Follow-up|2|||
127745828|NCT03522389|459695479|FG000|Overall Study|had herniated nucleus pulposus|0|||
127745829|NCT03522389|459695480|FG001|Overall Study|had herniated nucleus pulposus|1|||
127745830|NCT03522389|459695481|FG002|Overall Study|had herniated nucleus pulposus|0|||
127745831|NCT03522389|459695479|FG000|Overall Study|go to work in other province|1|||
127745832|NCT03522389|459695480|FG001|Overall Study|go to work in other province|0|||
127745833|NCT03522389|459695481|FG002|Overall Study|go to work in other province|0|||
127745834|NCT02257918|459695482|FG000|Overall Study|Lost to Follow-up|4|||
127745835|NCT02257918|459695483|FG001|Overall Study|Lost to Follow-up|1|||
127745836|NCT02257918|459695484|FG002|Overall Study|Lost to Follow-up|0|||
127745837|NCT02257918|459695482|FG000|Overall Study|Withdrawal by Subject|0|||
127745838|NCT02257918|459695483|FG001|Overall Study|Withdrawal by Subject|0|||
127745839|NCT02257918|459695484|FG002|Overall Study|Withdrawal by Subject|1|||
127745840|NCT02257918|459695482|FG000|Overall Study|Pregnancy|0|||
127745841|NCT02257918|459695483|FG001|Overall Study|Pregnancy|0|||
127808211|NCT00408005|459917759|FG000|Induction|Recurrent leukemia|1|||
127808212|NCT00408005|459917760|FG001|Induction|Recurrent leukemia|0|||
127745842|NCT02257918|459695484|FG002|Overall Study|Pregnancy|1|||
127745843|NCT01263054|459695491|FG000|Overall Study|Death|1|||
127745844|NCT01263054|459695492|FG001|Overall Study|Death|0|||
127745845|NCT01263054|459695491|FG000|Overall Study|Lost to Follow-up|2|||
127745846|NCT01263054|459695492|FG001|Overall Study|Lost to Follow-up|2|||
127745847|NCT01263054|459695491|FG000|Overall Study|Withdrawal by Subject|1|||
127745848|NCT01263054|459695492|FG001|Overall Study|Withdrawal by Subject|3|||
127745849|NCT01263054|459695491|FG000|Overall Study|Qualification Violation|1|||
127808213|NCT00408005|459917761|FG002|Induction|Recurrent leukemia|0|||
127808214|NCT00408005|459917762|FG003|Induction|Recurrent leukemia|0|||
127808215|NCT00408005|459917763|FG004|Induction|Recurrent leukemia|0|||
127808216|NCT00408005|459917764|FG005|Induction|Recurrent leukemia|0|||
127808217|NCT00408005|459917765|FG006|Induction|Recurrent leukemia|0|||
127808218|NCT00408005|459917766|FG007|Induction|Recurrent leukemia|0|||
127808219|NCT00408005|459917759|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
127808220|NCT00408005|459917760|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
127808221|NCT00408005|459917761|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
127808222|NCT00408005|459917762|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
127808223|NCT00408005|459917763|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
127808224|NCT00408005|459917764|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
127808225|NCT00408005|459917765|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
127893841|NCT04345471|460233353|FG000|Overall Study|Lack of Efficacy|1|||
127893842|NCT04345471|460233354|FG001|Overall Study|Lack of Efficacy|1|||
127893843|NCT04345471|460233355|FG002|Overall Study|Lack of Efficacy|0|||
127893844|NCT04345471|460233353|FG000|Overall Study|Protocol Violation|0|||
127893845|NCT04345471|460233354|FG001|Overall Study|Protocol Violation|1|||
127893846|NCT04345471|460233355|FG002|Overall Study|Protocol Violation|2|||
127893847|NCT04345471|460233353|FG000|Overall Study|Withdrawal by Subject|10|||
127893848|NCT04345471|460233354|FG001|Overall Study|Withdrawal by Subject|5|||
127893849|NCT04345471|460233355|FG002|Overall Study|Withdrawal by Subject|10|||
127893850|NCT03896490|460233390|FG000|Overall Study|Withdrawal by Subject|1|||
127893851|NCT03896490|460233391|FG001|Overall Study|Withdrawal by Subject|1|||
127893852|NCT00003782|460233392|FG000|Overall Study|No follow up data|30|||
127893853|NCT00003782|460233393|FG001|Overall Study|No follow up data|31|||
127893854|NCT00003782|460233394|FG002|Overall Study|No follow up data|26|||
127893855|NCT01890707|460233395|FG000|Overall Study|Lost to Follow-up|1|||
127893856|NCT01890707|460233396|FG001|Overall Study|Lost to Follow-up|1|||
127893857|NCT01326026|460233398|FG000|Overall Study|Adverse Event|4|||
127745850|NCT01263054|459695492|FG001|Overall Study|Qualification Violation|0|||
127745851|NCT01263054|459695491|FG000|Overall Study|Other|0|||
127745852|NCT01263054|459695492|FG001|Overall Study|Other|1|||
127745853|NCT02242643|459695493|FG000|Overall Study|Protocol Violation|1|||
127745854|NCT02242643|459695494|FG001|Overall Study|Protocol Violation|2|||
127745855|NCT02242643|459695493|FG000|Overall Study|Withdrawal by Subject|15|||
127745856|NCT02242643|459695494|FG001|Overall Study|Withdrawal by Subject|10|||
127745857|NCT02242643|459695493|FG000|Overall Study|Migrated/moved from study area|1|||
127808226|NCT00408005|459917766|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
127893858|NCT01326026|460233399|FG001|Overall Study|Adverse Event|3|||
127893859|NCT01326026|460233398|FG000|Overall Study|Withdrawal Criteria|5|||
127893860|NCT01326026|460233399|FG001|Overall Study|Withdrawal Criteria|7|||
127745858|NCT02242643|459695494|FG001|Overall Study|Migrated/moved from study area|3|||
127893861|NCT01326026|460233398|FG000|Overall Study|Other|3|||
127893862|NCT01326026|460233399|FG001|Overall Study|Other|3|||
127893863|NCT03705351|460235144|FG000|Overall Study|Study termination|3|||
127745859|NCT02242643|459695493|FG000|Overall Study|Lost to Follow-up|54|||
127745860|NCT02242643|459695494|FG001|Overall Study|Lost to Follow-up|61|||
127745861|NCT02242643|459695493|FG000|Overall Study|Child placed in foster care by family|0|||
127745862|NCT02242643|459695494|FG001|Overall Study|Child placed in foster care by family|1|||
127745863|NCT02242643|459695493|FG000|Overall Study|Non-compliance|1|||
127745864|NCT02242643|459695494|FG001|Overall Study|Non-compliance|0|||
127745865|NCT02242643|459695493|FG000|Overall Study|Consent withdrawal by parent|1|||
127745866|NCT02242643|459695494|FG001|Overall Study|Consent withdrawal by parent|0|||
127745867|NCT02242643|459695493|FG000|Overall Study|Protocol requirements not followed|1|||
127745868|NCT02242643|459695494|FG001|Overall Study|Protocol requirements not followed|0|||
127745869|NCT02242643|459695493|FG000|Overall Study|Language barrier|1|||
127745870|NCT02242643|459695494|FG001|Overall Study|Language barrier|0|||
127745871|NCT02242643|459695493|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
127745872|NCT02242643|459695494|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
127745873|NCT02282059|459695501|FG000|Overall Study|Other|15|||
127745874|NCT02282059|459695502|FG001|Overall Study|Other|3|||
127745875|NCT02282059|459695501|FG000|Overall Study|Participant refused further follow-up|8|||
127745876|NCT02282059|459695502|FG001|Overall Study|Participant refused further follow-up|4|||
127745877|NCT02282059|459695501|FG000|Overall Study|Lost to Follow-up|19|||
127808227|NCT00408005|459917759|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
127808228|NCT00408005|459917760|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
127808229|NCT00408005|459917761|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
127808230|NCT00408005|459917762|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
127808231|NCT00408005|459917763|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
127808232|NCT00408005|459917764|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
127808233|NCT00408005|459917765|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
127808234|NCT00408005|459917766|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
127808235|NCT00408005|459917759|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
127808236|NCT00408005|459917760|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
127808237|NCT00408005|459917761|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
127808238|NCT00408005|459917762|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
127808239|NCT00408005|459917763|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
127808240|NCT00408005|459917764|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
127808241|NCT00408005|459917765|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
127808242|NCT00408005|459917766|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
127808243|NCT00408005|459917759|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
127808244|NCT00408005|459917760|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
127808245|NCT00408005|459917761|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
127808246|NCT00408005|459917762|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
127808247|NCT00408005|459917763|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
127808248|NCT00408005|459917764|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
127808249|NCT00408005|459917765|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
127808250|NCT00408005|459917766|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
127808251|NCT00408005|459917759|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
127808252|NCT00408005|459917760|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
127808253|NCT00408005|459917761|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
127808254|NCT00408005|459917762|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
127808255|NCT00408005|459917763|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
127808256|NCT00408005|459917764|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
127808257|NCT00408005|459917765|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
127808258|NCT00408005|459917766|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
127808259|NCT00408005|459917759|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
127808260|NCT00408005|459917760|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
127808261|NCT00408005|459917761|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
127808262|NCT00408005|459917762|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
127808263|NCT00408005|459917763|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
127808264|NCT00408005|459917764|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
127808265|NCT00408005|459917765|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
127808266|NCT00408005|459917766|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
127808267|NCT00408005|459917759|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
127808268|NCT00408005|459917760|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
127808269|NCT00408005|459917761|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
127868813|NCT01072175|460137387|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
127745878|NCT02282059|459695502|FG001|Overall Study|Lost to Follow-up|3|||
127745879|NCT02282059|459695501|FG000|Overall Study|Death|40|||
127745880|NCT02282059|459695502|FG001|Overall Study|Death|8|||
127745881|NCT05093504|459695503|FG000|Overall Study|Death|0|||
127745882|NCT05093504|459695504|FG001|Overall Study|Death|1|||
127745883|NCT05347485|459695511|FG000|Overall Study|Death|14|||
127745884|NCT05347485|459695511|FG000|Overall Study|Lost to Follow-up|2|||
127745885|NCT05347485|459695511|FG000|Overall Study|Withdrawal by Subject|13|||
127745886|NCT05347485|459695511|FG000|Overall Study|Progressive Disease|1|||
127745887|NCT05347485|459695511|FG000|Overall Study|Study Terminated by Sponsor|49|||
127745888|NCT05347485|459695511|FG000|Overall Study|Other|1|||
127745889|NCT05347485|459695511|FG000|Overall Study|Enrolled (consented) but not treated|4|||
127745890|NCT05347485|459695511|FG000|Overall Study|Disease Relapse|2|||
127745891|NCT04886518|459695512|FG000|Overall Study|Noncompliance with study drug|1|||
127745892|NCT04886518|459695513|FG001|Overall Study|Noncompliance with study drug|0|||
127745893|NCT04886518|459695514|FG002|Overall Study|Noncompliance with study drug|0|||
127745894|NCT04886518|459695512|FG000|Overall Study|Adverse Event|0|||
127745895|NCT04886518|459695513|FG001|Overall Study|Adverse Event|1|||
127745896|NCT04886518|459695514|FG002|Overall Study|Adverse Event|0|||
127745897|NCT04886518|459695512|FG000|Overall Study|Withdrawal by Subject|1|||
127745898|NCT04886518|459695513|FG001|Overall Study|Withdrawal by Subject|0|||
127745899|NCT04886518|459695514|FG002|Overall Study|Withdrawal by Subject|0|||
127745900|NCT03733899|459695515|FG000|Period 1|Protocol Violation|0|||
127745901|NCT03733899|459695516|FG001|Period 1|Protocol Violation|0|||
127745902|NCT03733899|459695517|FG002|Period 1|Protocol Violation|0|||
127745903|NCT03733899|459695518|FG003|Period 1|Protocol Violation|0|||
127745904|NCT03733899|459695519|FG004|Period 1|Protocol Violation|0|||
127745905|NCT03733899|459695520|FG005|Period 1|Protocol Violation|1|||
127745906|NCT03733899|459695515|FG000|Period 2|Unscuccessful Treatment|0|||
127745907|NCT03733899|459695516|FG001|Period 2|Unscuccessful Treatment|1|||
127745908|NCT03733899|459695517|FG002|Period 2|Unscuccessful Treatment|0|||
127745909|NCT03733899|459695518|FG003|Period 2|Unscuccessful Treatment|0|||
127745910|NCT03733899|459695519|FG004|Period 2|Unscuccessful Treatment|0|||
127745911|NCT03733899|459695520|FG005|Period 2|Unscuccessful Treatment|0|||
127745912|NCT03733899|459695515|FG000|Period 3|Withdrawal by Subject|1|||
127745913|NCT03733899|459695516|FG001|Period 3|Withdrawal by Subject|0|||
127745914|NCT03733899|459695517|FG002|Period 3|Withdrawal by Subject|0|||
127745915|NCT03733899|459695518|FG003|Period 3|Withdrawal by Subject|0|||
127745916|NCT03733899|459695519|FG004|Period 3|Withdrawal by Subject|0|||
127745917|NCT03733899|459695520|FG005|Period 3|Withdrawal by Subject|0|||
127745918|NCT02035696|459698004|FG000|Overall Study|Lost to Follow-up|0|||
127745919|NCT02035696|459698005|FG001|Overall Study|Lost to Follow-up|3|||
127745920|NCT02035696|459698006|FG002|Overall Study|Lost to Follow-up|1|||
127745921|NCT02035696|459698007|FG003|Overall Study|Lost to Follow-up|2|||
127745922|NCT02035696|459698004|FG000|Overall Study|Withdrawal by Subject|3|||
127745923|NCT02035696|459698005|FG001|Overall Study|Withdrawal by Subject|0|||
127745924|NCT02035696|459698006|FG002|Overall Study|Withdrawal by Subject|2|||
127745925|NCT02035696|459698007|FG003|Overall Study|Withdrawal by Subject|1|||
127745926|NCT01090011|459698008|FG000|Overall Study|Progressive disease|128|||
127745927|NCT01090011|459698008|FG000|Overall Study|Adverse Event|32|||
127745928|NCT01090011|459698008|FG000|Overall Study|Protocol Violation|1|||
127745929|NCT01090011|459698008|FG000|Overall Study|Refusal to start/continue medication|5|||
127745930|NCT01090011|459698008|FG000|Overall Study|Other reason not defined above|5|||
127745931|NCT00379769|459698009|FG000|Main Study|Death|57|||
127745932|NCT00379769|459698010|FG001|Main Study|Death|67|||
127745933|NCT00379769|459698011|FG002|Main Study|Death|54|||
127745934|NCT00379769|459698012|FG003|Main Study|Death|72|||
127745935|NCT00379769|459698013|FG004|Main Study|Death|0|||
127745936|NCT00379769|459698014|FG005|Main Study|Death|0|||
127745937|NCT00379769|459698009|FG000|Main Study|Adverse Event|5|||
127745938|NCT00379769|459698010|FG001|Main Study|Adverse Event|8|||
127745939|NCT00379769|459698011|FG002|Main Study|Adverse Event|10|||
127745940|NCT00379769|459698012|FG003|Main Study|Adverse Event|11|||
127745941|NCT00379769|459698013|FG004|Main Study|Adverse Event|0|||
127745942|NCT00379769|459698014|FG005|Main Study|Adverse Event|0|||
127745943|NCT00379769|459698009|FG000|Main Study|Lost to Follow-up|29|||
127745944|NCT00379769|459698010|FG001|Main Study|Lost to Follow-up|29|||
127745945|NCT00379769|459698011|FG002|Main Study|Lost to Follow-up|25|||
127745946|NCT00379769|459698012|FG003|Main Study|Lost to Follow-up|26|||
127745947|NCT00379769|459698013|FG004|Main Study|Lost to Follow-up|0|||
127745948|NCT00379769|459698014|FG005|Main Study|Lost to Follow-up|0|||
127745949|NCT00379769|459698009|FG000|Main Study|Withdrawal by Subject|46|||
127745950|NCT00379769|459698010|FG001|Main Study|Withdrawal by Subject|56|||
127745951|NCT00379769|459698011|FG002|Main Study|Withdrawal by Subject|72|||
127745952|NCT00379769|459698012|FG003|Main Study|Withdrawal by Subject|70|||
127745953|NCT00379769|459698013|FG004|Main Study|Withdrawal by Subject|0|||
127745954|NCT00379769|459698014|FG005|Main Study|Withdrawal by Subject|0|||
127745955|NCT00379769|459698009|FG000|Main Study|Moved to survival status follow-up only|27|||
127745956|NCT00379769|459698010|FG001|Main Study|Moved to survival status follow-up only|25|||
127745957|NCT00379769|459698011|FG002|Main Study|Moved to survival status follow-up only|32|||
127745958|NCT00379769|459698012|FG003|Main Study|Moved to survival status follow-up only|36|||
127745959|NCT00379769|459698013|FG004|Main Study|Moved to survival status follow-up only|0|||
127745960|NCT00379769|459698014|FG005|Main Study|Moved to survival status follow-up only|0|||
127745961|NCT00379769|459698009|FG000|Main Study|Participant moved|3|||
127745962|NCT00379769|459698010|FG001|Main Study|Participant moved|2|||
127745963|NCT00379769|459698011|FG002|Main Study|Participant moved|3|||
127745964|NCT00379769|459698012|FG003|Main Study|Participant moved|3|||
127745965|NCT00379769|459698013|FG004|Main Study|Participant moved|0|||
127745966|NCT00379769|459698014|FG005|Main Study|Participant moved|0|||
127745967|NCT00379769|459698009|FG000|Main Study|Poor compliance|3|||
127745968|NCT00379769|459698010|FG001|Main Study|Poor compliance|2|||
127745969|NCT00379769|459698011|FG002|Main Study|Poor compliance|2|||
127745970|NCT00379769|459698012|FG003|Main Study|Poor compliance|1|||
127745971|NCT00379769|459698013|FG004|Main Study|Poor compliance|0|||
127745972|NCT00379769|459698014|FG005|Main Study|Poor compliance|0|||
127745973|NCT00379769|459698009|FG000|Main Study|Prohibited glucose lowering medication|0|||
127745974|NCT00379769|459698010|FG001|Main Study|Prohibited glucose lowering medication|3|||
127745975|NCT00379769|459698011|FG002|Main Study|Prohibited glucose lowering medication|0|||
127745976|NCT00379769|459698012|FG003|Main Study|Prohibited glucose lowering medication|1|||
127745977|NCT00379769|459698013|FG004|Main Study|Prohibited glucose lowering medication|0|||
127745978|NCT00379769|459698014|FG005|Main Study|Prohibited glucose lowering medication|0|||
127745979|NCT00379769|459698009|FG000|Main Study|Site closed|4|||
127745980|NCT00379769|459698010|FG001|Main Study|Site closed|4|||
127745981|NCT00379769|459698011|FG002|Main Study|Site closed|4|||
127745982|NCT00379769|459698012|FG003|Main Study|Site closed|8|||
127745983|NCT00379769|459698013|FG004|Main Study|Site closed|0|||
127745984|NCT00379769|459698014|FG005|Main Study|Site closed|0|||
127745985|NCT00379769|459698009|FG000|Main Study|Entry criteria violation|0|||
127745986|NCT00379769|459698010|FG001|Main Study|Entry criteria violation|0|||
127745987|NCT00379769|459698011|FG002|Main Study|Entry criteria violation|1|||
127745988|NCT00379769|459698012|FG003|Main Study|Entry criteria violation|1|||
127745989|NCT00379769|459698013|FG004|Main Study|Entry criteria violation|0|||
127745990|NCT00379769|459698014|FG005|Main Study|Entry criteria violation|0|||
127745991|NCT00379769|459698009|FG000|Main Study|Participant did not take study drug|0|||
127745992|NCT00379769|459698010|FG001|Main Study|Participant did not take study drug|0|||
127745993|NCT00379769|459698011|FG002|Main Study|Participant did not take study drug|1|||
127745994|NCT00379769|459698012|FG003|Main Study|Participant did not take study drug|0|||
127745995|NCT00379769|459698013|FG004|Main Study|Participant did not take study drug|0|||
127745996|NCT00379769|459698014|FG005|Main Study|Participant did not take study drug|0|||
127745997|NCT00379769|459698009|FG000|Main Study|Physician Decision|2|||
127745998|NCT00379769|459698010|FG001|Main Study|Physician Decision|2|||
127745999|NCT00379769|459698011|FG002|Main Study|Physician Decision|1|||
127746000|NCT00379769|459698012|FG003|Main Study|Physician Decision|1|||
127746001|NCT00379769|459698013|FG004|Main Study|Physician Decision|0|||
127746002|NCT00379769|459698014|FG005|Main Study|Physician Decision|0|||
127746003|NCT00379769|459698009|FG000|Main Study|Participant completed study at visit 27|1|||
127746004|NCT00379769|459698010|FG001|Main Study|Participant completed study at visit 27|0|||
127746005|NCT00379769|459698011|FG002|Main Study|Participant completed study at visit 27|0|||
127746006|NCT00379769|459698012|FG003|Main Study|Participant completed study at visit 27|0|||
127746007|NCT00379769|459698013|FG004|Main Study|Participant completed study at visit 27|0|||
127746008|NCT00379769|459698014|FG005|Main Study|Participant completed study at visit 27|0|||
127746009|NCT00379769|459698009|FG000|Main Study|Personal reasons|1|||
127746010|NCT00379769|459698010|FG001|Main Study|Personal reasons|0|||
127746011|NCT00379769|459698011|FG002|Main Study|Personal reasons|0|||
127746012|NCT00379769|459698012|FG003|Main Study|Personal reasons|0|||
127746013|NCT00379769|459698013|FG004|Main Study|Personal reasons|0|||
127746014|NCT00379769|459698014|FG005|Main Study|Personal reasons|0|||
127746015|NCT00379769|459698009|FG000|Main Study|Risk of heart failure|0|||
127746016|NCT00379769|459698010|FG001|Main Study|Risk of heart failure|1|||
127746017|NCT00379769|459698011|FG002|Main Study|Risk of heart failure|0|||
127746018|NCT00379769|459698012|FG003|Main Study|Risk of heart failure|0|||
127746019|NCT00379769|459698013|FG004|Main Study|Risk of heart failure|0|||
127746020|NCT00379769|459698014|FG005|Main Study|Risk of heart failure|0|||
127746021|NCT00379769|459698009|FG000|Main Study|Investigator refused to log temperature|0|||
127808270|NCT00408005|459917762|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
127893864|NCT03705351|460235144|FG000|Overall Study|Death|1|||
127746022|NCT00379769|459698010|FG001|Main Study|Investigator refused to log temperature|0|||
127746023|NCT00379769|459698011|FG002|Main Study|Investigator refused to log temperature|1|||
127746024|NCT00379769|459698012|FG003|Main Study|Investigator refused to log temperature|0|||
127746025|NCT00379769|459698013|FG004|Main Study|Investigator refused to log temperature|0|||
127746026|NCT00379769|459698014|FG005|Main Study|Investigator refused to log temperature|0|||
127746027|NCT00379769|459698009|FG000|Main Study|Reason unspecified|0|||
127746028|NCT00379769|459698010|FG001|Main Study|Reason unspecified|0|||
127746029|NCT00379769|459698011|FG002|Main Study|Reason unspecified|1|||
127746030|NCT00379769|459698012|FG003|Main Study|Reason unspecified|0|||
127746031|NCT00379769|459698013|FG004|Main Study|Reason unspecified|0|||
127746032|NCT00379769|459698014|FG005|Main Study|Reason unspecified|0|||
127746033|NCT00379769|459698009|FG000|Observational Follow-up|Death|0|||
127746034|NCT00379769|459698010|FG001|Observational Follow-up|Death|0|||
127746035|NCT00379769|459698011|FG002|Observational Follow-up|Death|0|||
127746036|NCT00379769|459698012|FG003|Observational Follow-up|Death|0|||
127746037|NCT00379769|459698013|FG004|Observational Follow-up|Death|78|||
127746038|NCT00379769|459698014|FG005|Observational Follow-up|Death|70|||
127746039|NCT00379769|459698009|FG000|Observational Follow-up|Adverse Event|0|||
127746040|NCT00379769|459698010|FG001|Observational Follow-up|Adverse Event|0|||
127746041|NCT00379769|459698011|FG002|Observational Follow-up|Adverse Event|0|||
127746042|NCT00379769|459698012|FG003|Observational Follow-up|Adverse Event|0|||
127746043|NCT00379769|459698013|FG004|Observational Follow-up|Adverse Event|1|||
127746044|NCT00379769|459698014|FG005|Observational Follow-up|Adverse Event|0|||
127746045|NCT00379769|459698009|FG000|Observational Follow-up|Lost to Follow-up|0|||
127746046|NCT00379769|459698010|FG001|Observational Follow-up|Lost to Follow-up|0|||
127746047|NCT00379769|459698011|FG002|Observational Follow-up|Lost to Follow-up|0|||
127746048|NCT00379769|459698012|FG003|Observational Follow-up|Lost to Follow-up|0|||
127746049|NCT00379769|459698013|FG004|Observational Follow-up|Lost to Follow-up|25|||
127746050|NCT00379769|459698014|FG005|Observational Follow-up|Lost to Follow-up|27|||
127746051|NCT00379769|459698009|FG000|Observational Follow-up|Withdrawal by Subject|0|||
127746052|NCT00379769|459698010|FG001|Observational Follow-up|Withdrawal by Subject|0|||
127746053|NCT00379769|459698011|FG002|Observational Follow-up|Withdrawal by Subject|0|||
127746054|NCT00379769|459698012|FG003|Observational Follow-up|Withdrawal by Subject|0|||
127746055|NCT00379769|459698013|FG004|Observational Follow-up|Withdrawal by Subject|12|||
127746056|NCT00379769|459698014|FG005|Observational Follow-up|Withdrawal by Subject|12|||
127746057|NCT00379769|459698009|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
127746058|NCT00379769|459698010|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
127746059|NCT00379769|459698011|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
127746060|NCT00379769|459698012|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
127746061|NCT00379769|459698013|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
127746062|NCT00379769|459698014|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
127746063|NCT00379769|459698009|FG000|Observational Follow-up|Physician Decision|0|||
127746064|NCT00379769|459698010|FG001|Observational Follow-up|Physician Decision|0|||
127746065|NCT00379769|459698011|FG002|Observational Follow-up|Physician Decision|0|||
127746066|NCT00379769|459698012|FG003|Observational Follow-up|Physician Decision|0|||
127746067|NCT00379769|459698013|FG004|Observational Follow-up|Physician Decision|8|||
127746068|NCT00379769|459698014|FG005|Observational Follow-up|Physician Decision|8|||
127746069|NCT00379769|459698009|FG000|Observational Follow-up|Site Closed Early|0|||
127746070|NCT00379769|459698010|FG001|Observational Follow-up|Site Closed Early|0|||
127746071|NCT00379769|459698011|FG002|Observational Follow-up|Site Closed Early|0|||
127746072|NCT00379769|459698012|FG003|Observational Follow-up|Site Closed Early|0|||
127746073|NCT00379769|459698013|FG004|Observational Follow-up|Site Closed Early|6|||
127746074|NCT00379769|459698014|FG005|Observational Follow-up|Site Closed Early|7|||
127746075|NCT00379769|459698009|FG000|Observational Follow-up|Participant Moved|0|||
127746076|NCT00379769|459698010|FG001|Observational Follow-up|Participant Moved|0|||
127746077|NCT00379769|459698011|FG002|Observational Follow-up|Participant Moved|0|||
127746078|NCT00379769|459698012|FG003|Observational Follow-up|Participant Moved|0|||
127746079|NCT00379769|459698013|FG004|Observational Follow-up|Participant Moved|0|||
127746080|NCT00379769|459698014|FG005|Observational Follow-up|Participant Moved|1|||
127746081|NCT00379769|459698009|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
127746082|NCT00379769|459698010|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
127746083|NCT00379769|459698011|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
127746084|NCT00379769|459698012|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
127746085|NCT00379769|459698013|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
127746086|NCT00379769|459698014|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
127746087|NCT01689363|459698019|FG000|Overall Study|Protocol Violation|0|||
127746088|NCT01689363|459698020|FG001|Overall Study|Protocol Violation|1|||
127746089|NCT01689363|459698021|FG002|Overall Study|Protocol Violation|0|||
127746090|NCT01689363|459698022|FG003|Overall Study|Protocol Violation|0|||
127746091|NCT01689363|459698023|FG004|Overall Study|Protocol Violation|0|||
127746092|NCT01689363|459698024|FG005|Overall Study|Protocol Violation|0|||
127746093|NCT01689363|459698025|FG006|Overall Study|Protocol Violation|0|||
127746094|NCT01689363|459698026|FG007|Overall Study|Protocol Violation|0|||
127746095|NCT02859064|459698027|FG000|Overall Study|Progressive Disease|3|||
127746096|NCT02859064|459698027|FG000|Overall Study|Physician Decision|1|||
127746097|NCT02859064|459698027|FG000|Overall Study|Withdrawal by Subject|1|||
127746098|NCT02859064|459698027|FG000|Overall Study|Death|1|||
127746099|NCT00321685|459698028|FG000|Overall Study|Adverse Event|18|||
127746100|NCT00321685|459698028|FG000|Overall Study|Death|2|||
127746101|NCT00321685|459698028|FG000|Overall Study|Withdrawal by Subject|8|||
127746102|NCT00321685|459698028|FG000|Overall Study|Alternative therapy|1|||
127746103|NCT00321685|459698028|FG000|Overall Study|Complicating disese|1|||
127746104|NCT00321685|459698028|FG000|Overall Study|Other|5|||
127746105|NCT00321685|459698028|FG000|Overall Study|Not start protocol therapy|2|||
127746106|NCT00321685|459698028|FG000|Overall Study|Ineligible|2|||
127746107|NCT00127842|459698029|FG000|Overall Study|Adverse Event|15|||
127746108|NCT00127842|459698029|FG000|Overall Study|Withdrawal by Subject|3|||
127746109|NCT00127842|459698029|FG000|Overall Study|Lost to Follow-up|1|||
127746110|NCT00127842|459698029|FG000|Overall Study|Lack of Efficacy|12|||
127746111|NCT00127842|459698029|FG000|Overall Study|Noncompliance|2|||
127746112|NCT00127842|459698029|FG000|Overall Study|Protocol Violation|1|||
127746113|NCT00127842|459698029|FG000|Overall Study|Other|5|||
127746114|NCT01638390|459698032|FG000|Overall Study|screening failures|21|||
127746115|NCT01536587|459698033|FG000|Overall Study|Adverse Event|2|||
127746116|NCT02354651|459698034|FG000|Overall Study|Withdrawal by Subject|2|||
127746117|NCT02354651|459698034|FG000|Overall Study|Physician Decision|1|||
127746118|NCT01377389|459698035|FG000|Overall Study|Withdrawal by Subject|1|||
127746119|NCT01377389|459698035|FG000|Overall Study|Screen failure|2|||
127746120|NCT03382561|459698036|FG000|Overall Study|Disease progression|47|||
127746121|NCT03382561|459698037|FG001|Overall Study|Disease progression|6|||
127746122|NCT03382561|459698036|FG000|Overall Study|Adverse Event|10|||
127746123|NCT03382561|459698037|FG001|Overall Study|Adverse Event|2|||
127746124|NCT03382561|459698036|FG000|Overall Study|Death|8|||
127746125|NCT03382561|459698037|FG001|Overall Study|Death|3|||
127746126|NCT03382561|459698036|FG000|Overall Study|Withdrawal by Subject|6|||
127746127|NCT03382561|459698037|FG001|Overall Study|Withdrawal by Subject|5|||
127746128|NCT03382561|459698036|FG000|Overall Study|Alternative therapy|2|||
127746129|NCT03382561|459698037|FG001|Overall Study|Alternative therapy|8|||
127746130|NCT03382561|459698036|FG000|Overall Study|Never started treatment|3|||
127746131|NCT03382561|459698037|FG001|Overall Study|Never started treatment|6|||
127746132|NCT03382561|459698036|FG000|Overall Study|Lack of Efficacy|0|||
127746133|NCT03382561|459698037|FG001|Overall Study|Lack of Efficacy|1|||
127746134|NCT03382561|459698036|FG000|Overall Study|Physician Decision|0|||
127746135|NCT03382561|459698037|FG001|Overall Study|Physician Decision|1|||
127746136|NCT03382561|459698036|FG000|Overall Study|Other complicating disease|0|||
127746137|NCT03382561|459698037|FG001|Overall Study|Other complicating disease|1|||
127746138|NCT01131104|459698038|FG000|Overall Study|Withdrawal by Subject|3|||
127746139|NCT01131104|459698038|FG000|Overall Study|Physician Decision|4|||
127746140|NCT01131104|459698038|FG000|Overall Study|Information Not Available|5|||
127746141|NCT01131104|459698038|FG000|Overall Study|No Information on Index Date of Onset|1|||
127746142|NCT00334542|459698039|FG000|Overall Study|Adverse Event|3|||
127746143|NCT00334542|459698039|FG000|Overall Study|Withdrawal by Subject|1|||
127746144|NCT00334542|459698039|FG000|Overall Study|New cancer diagnosis|1|||
127746145|NCT02370251|459698040|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
127746146|NCT02370251|459698040|FG000|Overall Study|Death|4|||
127746147|NCT04698915|459698044|FG000|Overall Study|Adverse Event|2|||
127746148|NCT04698915|459698045|FG001|Overall Study|Adverse Event|0|||
127746149|NCT04698915|459698044|FG000|Overall Study|Death|23|||
127746150|NCT04698915|459698045|FG001|Overall Study|Death|20|||
127746151|NCT04698915|459698044|FG000|Overall Study|Physician Decision|1|||
127746152|NCT04698915|459698045|FG001|Overall Study|Physician Decision|1|||
127746153|NCT04698915|459698044|FG000|Overall Study|Lost to Follow-up|1|||
127746154|NCT04698915|459698045|FG001|Overall Study|Lost to Follow-up|0|||
127746155|NCT04698915|459698044|FG000|Overall Study|Study Terminated by Sponsor|55|||
127746156|NCT04698915|459698045|FG001|Overall Study|Study Terminated by Sponsor|60|||
127746157|NCT04698915|459698044|FG000|Overall Study|Withdrawal by Subject|2|||
127746158|NCT04698915|459698045|FG001|Overall Study|Withdrawal by Subject|3|||
127746159|NCT01150045|459698046|FG000|Overall Study|Protocol Violation|0|||
127746160|NCT01150045|459698047|FG001|Overall Study|Protocol Violation|1|||
127746161|NCT01150045|459698048|FG002|Overall Study|Protocol Violation|0|||
127746162|NCT01150045|459698049|FG003|Overall Study|Protocol Violation|1|||
127746163|NCT02094898|459698056|FG000|Overall Study|Clinical Worsening|2|||
127746164|NCT02094898|459698056|FG000|Overall Study|Adverse Event|2|||
127746165|NCT02094898|459698056|FG000|Overall Study|Lack of Efficacy|1|||
127746166|NCT03520075|459698057|FG000|Phase 1 (Dose Escalation)|Death|2|||
127746167|NCT03520075|459698058|FG001|Phase 1 (Dose Escalation)|Death|2|||
127746168|NCT03520075|459698059|FG002|Phase 1 (Dose Escalation)|Death|3|||
127746169|NCT03520075|459698060|FG003|Phase 1 (Dose Escalation)|Death|2|||
127746170|NCT03520075|459698061|FG004|Phase 1 (Dose Escalation)|Death|6|||
127746171|NCT03520075|459698062|FG005|Phase 1 (Dose Escalation)|Death|5|||
127746172|NCT03520075|459698063|FG006|Phase 1 (Dose Escalation)|Death|3|||
127746173|NCT03520075|459698064|FG007|Phase 1 (Dose Escalation)|Death|2|||
127746174|NCT03520075|459698065|FG008|Phase 1 (Dose Escalation)|Death|3|||
127746175|NCT03520075|459698066|FG009|Phase 1 (Dose Escalation)|Death|1|||
127746176|NCT03520075|459698067|FG010|Phase 1 (Dose Escalation)|Death|5|||
127746177|NCT03520075|459698068|FG011|Phase 1 (Dose Escalation)|Death|7|||
127746178|NCT03520075|459698069|FG012|Phase 1 (Dose Escalation)|Death|11|||
127746179|NCT03520075|459698070|FG013|Phase 1 (Dose Escalation)|Death|0|||
127746180|NCT03520075|459698071|FG014|Phase 1 (Dose Escalation)|Death|0|||
127746181|NCT03520075|459698072|FG015|Phase 1 (Dose Escalation)|Death|0|||
127746182|NCT03520075|459698073|FG016|Phase 1 (Dose Escalation)|Death|0|||
127746183|NCT03520075|459698074|FG017|Phase 1 (Dose Escalation)|Death|0|||
127746184|NCT03520075|459698075|FG018|Phase 1 (Dose Escalation)|Death|0|||
127746185|NCT03520075|459698057|FG000|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
127746186|NCT03520075|459698058|FG001|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
127746187|NCT03520075|459698059|FG002|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
127746188|NCT03520075|459698060|FG003|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
127746189|NCT03520075|459698061|FG004|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|3|||
127746190|NCT03520075|459698062|FG005|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
127746191|NCT03520075|459698063|FG006|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
127746192|NCT03520075|459698064|FG007|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
127746193|NCT03520075|459698065|FG008|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
127746194|NCT03520075|459698066|FG009|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
127746195|NCT03520075|459698067|FG010|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
127746196|NCT03520075|459698068|FG011|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
127746197|NCT03520075|459698069|FG012|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|4|||
127746198|NCT03520075|459698070|FG013|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
127746199|NCT03520075|459698071|FG014|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
127746200|NCT03520075|459698072|FG015|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
127746201|NCT03520075|459698073|FG016|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
127746202|NCT03520075|459698074|FG017|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
127746203|NCT03520075|459698075|FG018|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
127746204|NCT03520075|459698057|FG000|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
127746205|NCT03520075|459698058|FG001|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
127746206|NCT03520075|459698059|FG002|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
127746207|NCT03520075|459698060|FG003|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
127746208|NCT03520075|459698061|FG004|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
127746209|NCT03520075|459698062|FG005|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
127746210|NCT03520075|459698063|FG006|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
127746211|NCT03520075|459698064|FG007|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
127746212|NCT03520075|459698065|FG008|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
127808271|NCT00408005|459917763|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
127808272|NCT00408005|459917764|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
127808273|NCT00408005|459917765|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
127808274|NCT00408005|459917766|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
127808275|NCT00408005|459917759|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
127808276|NCT00408005|459917760|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
127808277|NCT00408005|459917761|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
127808278|NCT00408005|459917762|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
127808279|NCT00408005|459917763|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
127893865|NCT03705351|460235144|FG000|Overall Study|Lack of Efficacy|2|||
127893866|NCT03705351|460235144|FG000|Overall Study|Withdrawal by Subject|1|||
127893867|NCT00322556|460235152|FG000|Overall Study|Adverse Event|1|||
127893868|NCT00322556|460235152|FG000|Overall Study|Withdrawal by Subject|1|||
127893869|NCT00322556|460235152|FG000|Overall Study|Lost to Follow-up|3|||
127893870|NCT00322556|460235152|FG000|Overall Study|Other Reason|7|||
127893871|NCT02232074|460235153|FG000|Overall Study|Withdrawal by Subject|5|||
127746213|NCT03520075|459698066|FG009|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
127746214|NCT03520075|459698067|FG010|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
127746215|NCT03520075|459698068|FG011|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
127746216|NCT03520075|459698069|FG012|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
127746217|NCT03520075|459698070|FG013|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
127746218|NCT03520075|459698071|FG014|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
127893872|NCT02232074|460235154|FG001|Overall Study|Withdrawal by Subject|3|||
127893873|NCT02232074|460235153|FG000|Overall Study|No legal concerns at baseline|36|||
127893874|NCT02232074|460235154|FG001|Overall Study|No legal concerns at baseline|41|||
127746219|NCT03520075|459698072|FG015|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
127746220|NCT03520075|459698073|FG016|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
127746221|NCT03520075|459698074|FG017|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
127746222|NCT03520075|459698075|FG018|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
127746223|NCT03520075|459698057|FG000|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
127746224|NCT03520075|459698058|FG001|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
127746225|NCT03520075|459698059|FG002|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
127746226|NCT03520075|459698060|FG003|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
127746227|NCT03520075|459698061|FG004|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
127746228|NCT03520075|459698062|FG005|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
127746229|NCT03520075|459698063|FG006|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
127746230|NCT03520075|459698064|FG007|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
127746231|NCT03520075|459698065|FG008|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
127746232|NCT03520075|459698066|FG009|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|1|||
127746233|NCT03520075|459698067|FG010|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
127746234|NCT03520075|459698068|FG011|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
127746235|NCT03520075|459698069|FG012|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|3|||
127746236|NCT03520075|459698070|FG013|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
127746237|NCT03520075|459698071|FG014|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
127746238|NCT03520075|459698072|FG015|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
127746239|NCT03520075|459698073|FG016|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
127746240|NCT03520075|459698074|FG017|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
127746241|NCT03520075|459698075|FG018|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
127746242|NCT03520075|459698057|FG000|Phase 2 (Dose Expansion)|Death|0|||
127746243|NCT03520075|459698058|FG001|Phase 2 (Dose Expansion)|Death|0|||
127746244|NCT03520075|459698059|FG002|Phase 2 (Dose Expansion)|Death|0|||
127746245|NCT03520075|459698060|FG003|Phase 2 (Dose Expansion)|Death|0|||
127746246|NCT03520075|459698061|FG004|Phase 2 (Dose Expansion)|Death|0|||
127746247|NCT03520075|459698062|FG005|Phase 2 (Dose Expansion)|Death|0|||
127746248|NCT03520075|459698063|FG006|Phase 2 (Dose Expansion)|Death|0|||
127746249|NCT03520075|459698064|FG007|Phase 2 (Dose Expansion)|Death|0|||
127746250|NCT03520075|459698065|FG008|Phase 2 (Dose Expansion)|Death|0|||
127746251|NCT03520075|459698066|FG009|Phase 2 (Dose Expansion)|Death|0|||
127746252|NCT03520075|459698067|FG010|Phase 2 (Dose Expansion)|Death|0|||
127746253|NCT03520075|459698068|FG011|Phase 2 (Dose Expansion)|Death|0|||
127746254|NCT03520075|459698069|FG012|Phase 2 (Dose Expansion)|Death|0|||
127746255|NCT03520075|459698070|FG013|Phase 2 (Dose Expansion)|Death|20|||
127746256|NCT03520075|459698071|FG014|Phase 2 (Dose Expansion)|Death|13|||
127746257|NCT03520075|459698072|FG015|Phase 2 (Dose Expansion)|Death|9|||
127746258|NCT03520075|459698073|FG016|Phase 2 (Dose Expansion)|Death|5|||
127746259|NCT03520075|459698074|FG017|Phase 2 (Dose Expansion)|Death|14|||
127746260|NCT03520075|459698075|FG018|Phase 2 (Dose Expansion)|Death|12|||
127746261|NCT03520075|459698057|FG000|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
127746262|NCT03520075|459698058|FG001|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
127746263|NCT03520075|459698059|FG002|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
127746264|NCT03520075|459698060|FG003|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
127746265|NCT03520075|459698061|FG004|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
127746266|NCT03520075|459698062|FG005|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
127746267|NCT03520075|459698063|FG006|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
127746268|NCT03520075|459698064|FG007|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
127746269|NCT03520075|459698065|FG008|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
127746270|NCT03520075|459698066|FG009|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
127746271|NCT03520075|459698067|FG010|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
127746272|NCT03520075|459698068|FG011|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
127893875|NCT02232074|460235153|FG000|Overall Study|deemed ineligible|0|||
127893876|NCT02232074|460235154|FG001|Overall Study|deemed ineligible|1|||
127893877|NCT04480463|460235157|FG000|Overall Study|Death|0|||
127893878|NCT04480463|460235158|FG001|Overall Study|Death|1|||
127893879|NCT04480463|460235157|FG000|Overall Study|Adverse Event|6|||
127746273|NCT03520075|459698069|FG012|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
127746274|NCT03520075|459698070|FG013|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
127746275|NCT03520075|459698071|FG014|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
127746276|NCT03520075|459698072|FG015|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
127746277|NCT03520075|459698073|FG016|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
127746278|NCT03520075|459698074|FG017|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|3|||
127746279|NCT03520075|459698075|FG018|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
127746280|NCT03520075|459698057|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
127746281|NCT03520075|459698058|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
127746282|NCT03520075|459698059|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
127746283|NCT03520075|459698060|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
127746284|NCT03520075|459698061|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
127746285|NCT03520075|459698062|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
127746286|NCT03520075|459698063|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
127746287|NCT03520075|459698064|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
127746288|NCT03520075|459698065|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
127746289|NCT03520075|459698066|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
127746290|NCT03520075|459698067|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
127746291|NCT03520075|459698068|FG011|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
127746292|NCT03520075|459698069|FG012|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
127746293|NCT03520075|459698070|FG013|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
127746294|NCT03520075|459698071|FG014|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
127746295|NCT03520075|459698072|FG015|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
127746296|NCT03520075|459698073|FG016|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
127746297|NCT03520075|459698074|FG017|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
127746298|NCT03520075|459698075|FG018|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
127746299|NCT03520075|459698057|FG000|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
127746300|NCT03520075|459698058|FG001|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
127746301|NCT03520075|459698059|FG002|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
127746302|NCT03520075|459698060|FG003|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
127746303|NCT03520075|459698061|FG004|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
127746304|NCT03520075|459698062|FG005|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
127746305|NCT03520075|459698063|FG006|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
127746306|NCT03520075|459698064|FG007|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
127746307|NCT03520075|459698065|FG008|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
127746308|NCT03520075|459698066|FG009|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
127746309|NCT03520075|459698067|FG010|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
127746310|NCT03520075|459698068|FG011|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
127746311|NCT03520075|459698069|FG012|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
127746312|NCT03520075|459698070|FG013|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|6|||
127746313|NCT03520075|459698071|FG014|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
127746314|NCT03520075|459698072|FG015|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
127746315|NCT03520075|459698073|FG016|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|3|||
127746316|NCT03520075|459698074|FG017|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|10|||
127746317|NCT03520075|459698075|FG018|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
127746318|NCT01432626|459698076|FG000|Overall Study|LV function recovered|2|||
127746319|NCT01432626|459698076|FG000|Overall Study|Withdrawal by Subject|2|||
127746320|NCT01432626|459698076|FG000|Overall Study|Only 1 image competed|2|||
127746321|NCT01432626|459698076|FG000|Overall Study|Imaging agent not available|1|||
127746322|NCT05382039|459698077|FG000|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|5|||
127746323|NCT05382039|459698078|FG001|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
127746324|NCT05382039|459698079|FG002|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
127746325|NCT05382039|459698077|FG000|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
127746326|NCT05382039|459698078|FG001|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
127746327|NCT05382039|459698079|FG002|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|1|||
127746328|NCT05382039|459698077|FG000|Overall Study|waiting for confirmation|0|||
127746329|NCT05382039|459698078|FG001|Overall Study|waiting for confirmation|0|||
127746330|NCT05382039|459698079|FG002|Overall Study|waiting for confirmation|1|||
127746331|NCT01234883|459698080|FG000|Overall Study|Early treatment release|8|||
127746332|NCT01234883|459698081|FG001|Overall Study|Early treatment release|10|||
127746333|NCT01234883|459698080|FG000|Overall Study|Parent/guardian withdrew consent|1|||
127746334|NCT01234883|459698081|FG001|Overall Study|Parent/guardian withdrew consent|2|||
127746335|NCT01234883|459698080|FG000|Overall Study|Technical difficulties with IV infusion|0|||
127746336|NCT01234883|459698081|FG001|Overall Study|Technical difficulties with IV infusion|1|||
127808280|NCT00408005|459917764|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
127808281|NCT00408005|459917765|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
127746337|NCT01234883|459698080|FG000|Overall Study|Inclusion/exclusion failure|1|||
127746338|NCT01234883|459698081|FG001|Overall Study|Inclusion/exclusion failure|0|||
127808282|NCT00408005|459917766|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
127808283|NCT00408005|459917759|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
127746339|NCT00126659|459698084|FG000|Overall Study|Adverse Event|0|||
127746340|NCT00126659|459698085|FG001|Overall Study|Adverse Event|0|||
127746341|NCT00126659|459698086|FG002|Overall Study|Adverse Event|2|||
127746342|NCT02367352|459698087|FG000|Overall Study|Progressive disease|7|||
127746343|NCT02367352|459698088|FG001|Overall Study|Progressive disease|0|||
127746344|NCT02367352|459698089|FG002|Overall Study|Progressive disease|0|||
127746345|NCT02367352|459698087|FG000|Overall Study|Participant Received Alternative Therapy|1|||
127746346|NCT02367352|459698088|FG001|Overall Study|Participant Received Alternative Therapy|0|||
127746347|NCT02367352|459698089|FG002|Overall Study|Participant Received Alternative Therapy|0|||
127746348|NCT02367352|459698087|FG000|Overall Study|Adverse Event|1|||
127746349|NCT02367352|459698088|FG001|Overall Study|Adverse Event|0|||
127746350|NCT02367352|459698089|FG002|Overall Study|Adverse Event|0|||
127746351|NCT01375751|459698090|FG000|Overall Study|Other|0|||
127746352|NCT01375751|459698091|FG001|Overall Study|Other|1|||
127746353|NCT01375751|459698092|FG002|Overall Study|Other|0|||
127746354|NCT02980523|459698093|FG000|Overall Study|Lost to Follow-up|1|||
127746355|NCT02980523|459698094|FG001|Overall Study|Lost to Follow-up|4|||
127746356|NCT02980523|459698095|FG002|Overall Study|Lost to Follow-up|1|||
127746357|NCT02980523|459698096|FG003|Overall Study|Lost to Follow-up|2|||
127746358|NCT02980523|459698097|FG004|Overall Study|Lost to Follow-up|1|||
127746359|NCT02980523|459698093|FG000|Overall Study|Excluded from analysis|1|||
127746360|NCT02980523|459698094|FG001|Overall Study|Excluded from analysis|3|||
127746361|NCT02980523|459698095|FG002|Overall Study|Excluded from analysis|1|||
127746362|NCT02980523|459698096|FG003|Overall Study|Excluded from analysis|1|||
127746363|NCT02980523|459698097|FG004|Overall Study|Excluded from analysis|1|||
127746364|NCT02980523|459698093|FG000|Overall Study|Lack of Efficacy|1|||
127746365|NCT02980523|459698094|FG001|Overall Study|Lack of Efficacy|4|||
127746366|NCT02980523|459698095|FG002|Overall Study|Lack of Efficacy|4|||
127746367|NCT02980523|459698096|FG003|Overall Study|Lack of Efficacy|5|||
127746368|NCT02980523|459698097|FG004|Overall Study|Lack of Efficacy|8|||
127746369|NCT02980523|459698093|FG000|Overall Study|Did not receive intervention|0|||
127746370|NCT02980523|459698094|FG001|Overall Study|Did not receive intervention|0|||
127746371|NCT02980523|459698095|FG002|Overall Study|Did not receive intervention|0|||
127746372|NCT02980523|459698096|FG003|Overall Study|Did not receive intervention|1|||
127746373|NCT02980523|459698097|FG004|Overall Study|Did not receive intervention|0|||
127746374|NCT01271504|459698099|FG000|Overall Study|Death|7|||
127746375|NCT01271504|459698100|FG001|Overall Study|Death|6|||
127746376|NCT01271504|459698101|FG002|Overall Study|Death|32|||
127746377|NCT01271504|459698102|FG003|Overall Study|Death|32|||
127746378|NCT01271504|459698099|FG000|Overall Study|Lost to Follow-up|0|||
127746379|NCT01271504|459698100|FG001|Overall Study|Lost to Follow-up|1|||
127746380|NCT01271504|459698101|FG002|Overall Study|Lost to Follow-up|3|||
127746381|NCT01271504|459698102|FG003|Overall Study|Lost to Follow-up|1|||
127746382|NCT01271504|459698099|FG000|Overall Study|Protocol Violation|0|||
127746383|NCT01271504|459698100|FG001|Overall Study|Protocol Violation|0|||
127746384|NCT01271504|459698101|FG002|Overall Study|Protocol Violation|0|||
127746385|NCT01271504|459698102|FG003|Overall Study|Protocol Violation|2|||
127746386|NCT01271504|459698099|FG000|Overall Study|Administrative Reasons|0|||
127746387|NCT01271504|459698100|FG001|Overall Study|Administrative Reasons|0|||
127746388|NCT01271504|459698101|FG002|Overall Study|Administrative Reasons|6|||
127746389|NCT01271504|459698102|FG003|Overall Study|Administrative Reasons|5|||
127746390|NCT01271504|459698099|FG000|Overall Study|Withdrawal by Subject|0|||
127746391|NCT01271504|459698100|FG001|Overall Study|Withdrawal by Subject|0|||
127746392|NCT01271504|459698101|FG002|Overall Study|Withdrawal by Subject|1|||
127746393|NCT01271504|459698102|FG003|Overall Study|Withdrawal by Subject|3|||
127746394|NCT01271504|459698099|FG000|Overall Study|Other|0|||
127746395|NCT01271504|459698100|FG001|Overall Study|Other|1|||
127746396|NCT01271504|459698101|FG002|Overall Study|Other|2|||
127746397|NCT01271504|459698102|FG003|Overall Study|Other|0|||
127746398|NCT02375347|459698103|FG000|Overall Study|Protocol Violation|1|||
127746399|NCT02552147|459698104|FG000|First Intervention (7 Days)|Protocol Violation|1|||
127746400|NCT02552147|459698105|FG001|First Intervention (7 Days)|Protocol Violation|0|||
127746401|NCT02552147|459698104|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
127746402|NCT02552147|459698105|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
127746403|NCT01547598|459698106|FG000|Overall Study|Withdrew consent|1|||
127746404|NCT01547598|459698107|FG001|Overall Study|Withdrew consent|1|||
127746405|NCT01547598|459698106|FG000|Overall Study|Lost to Follow-up|1|||
127746406|NCT01547598|459698107|FG001|Overall Study|Lost to Follow-up|1|||
127746407|NCT01547598|459698106|FG000|Overall Study|Adverse Event|1|||
127746408|NCT01547598|459698107|FG001|Overall Study|Adverse Event|1|||
127746409|NCT01547598|459698106|FG000|Overall Study|Protocol Violation|1|||
127746410|NCT01547598|459698107|FG001|Overall Study|Protocol Violation|1|||
127746411|NCT01547598|459698106|FG000|Overall Study|Other Miscellaneous Reasons|2|||
127746412|NCT01547598|459698107|FG001|Overall Study|Other Miscellaneous Reasons|1|||
127746413|NCT02229227|459698110|FG000|Overall Study|Adverse Event|14|||
127746414|NCT02229227|459698111|FG001|Overall Study|Adverse Event|9|||
127746415|NCT02229227|459698110|FG000|Overall Study|Lack of Efficacy|3|||
127746416|NCT02229227|459698111|FG001|Overall Study|Lack of Efficacy|3|||
127746417|NCT02229227|459698110|FG000|Overall Study|Protocol Violation|6|||
127746418|NCT02229227|459698111|FG001|Overall Study|Protocol Violation|8|||
127746419|NCT02229227|459698110|FG000|Overall Study|Protocol defined stopping criteria|1|||
127746420|NCT02229227|459698111|FG001|Overall Study|Protocol defined stopping criteria|3|||
127746421|NCT02229227|459698110|FG000|Overall Study|Lost to Follow-up|3|||
127746422|NCT02229227|459698111|FG001|Overall Study|Lost to Follow-up|3|||
127746423|NCT02229227|459698110|FG000|Overall Study|Study terminated by sponsor|11|||
127746424|NCT02229227|459698111|FG001|Overall Study|Study terminated by sponsor|11|||
127746425|NCT02229227|459698110|FG000|Overall Study|Withdrawal by Subject|8|||
127746426|NCT02229227|459698111|FG001|Overall Study|Withdrawal by Subject|12|||
127746427|NCT02229227|459698110|FG000|Overall Study|Other|0|||
127746428|NCT02229227|459698111|FG001|Overall Study|Other|1|||
127746429|NCT02229227|459698110|FG000|Overall Study|Physician Decision|5|||
127746430|NCT02229227|459698111|FG001|Overall Study|Physician Decision|12|||
127746431|NCT04071301|459698112|FG000|Overall Study|Withdrawal by Subject|6|||
127746432|NCT04071301|459698112|FG000|Overall Study|Death|1|||
127746433|NCT05186311|459698113|FG000|Part A: Serum|Withdrawal by Subject|1|||
127746434|NCT02125279|459698114|FG000|Overall Study|Lack of Efficacy|2|||
127746435|NCT02125279|459698114|FG000|Overall Study|Withdrawal by Subject|6|||
127746436|NCT02125279|459698114|FG000|Overall Study|Protocol Violation|1|||
127746437|NCT02125279|459698114|FG000|Overall Study|Lost to Follow-up|4|||
127746438|NCT01850589|459698122|FG000|Overall Study|Withdrawal by Subject|8|||
127746439|NCT01850589|459698123|FG001|Overall Study|Withdrawal by Subject|0|||
127746440|NCT04468230|459698127|FG000|Overall Study|Adverse Event|2|||
127746441|NCT03721705|459698131|FG000|Overall Study|Adverse Event|2|||
127746442|NCT03721705|459698132|FG001|Overall Study|Adverse Event|0|||
127746443|NCT03721705|459698131|FG000|Overall Study|Withdrawal by Subject|4|||
127746444|NCT03721705|459698132|FG001|Overall Study|Withdrawal by Subject|10|||
127746445|NCT03721705|459698131|FG000|Overall Study|No Suitable Study Partner|1|||
127746446|NCT03721705|459698132|FG001|Overall Study|No Suitable Study Partner|0|||
127746447|NCT03721705|459698131|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
127746448|NCT03721705|459698132|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
127746449|NCT03721705|459698131|FG000|Overall Study|Death|0|||
127746450|NCT03721705|459698132|FG001|Overall Study|Death|1|||
127746451|NCT01790295|459698133|FG000|Overall Study|Adverse Event|1|||
127746452|NCT01790295|459698133|FG000|Overall Study|Death|4|||
127746453|NCT01790295|459698133|FG000|Overall Study|Lack of Efficacy|2|||
127746454|NCT01790295|459698133|FG000|Overall Study|Study closure|4|||
127746455|NCT03721172|459698136|FG000|Placebo-controlled Phase|Adverse Event|7|||
127746456|NCT03721172|459698137|FG001|Placebo-controlled Phase|Adverse Event|7|||
127746457|NCT03721172|459698138|FG002|Placebo-controlled Phase|Adverse Event|0|||
127746458|NCT03721172|459698136|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
127746459|NCT03721172|459698137|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
127746460|NCT03721172|459698138|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
127746461|NCT03721172|459698136|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
127746462|NCT03721172|459698137|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
127746463|NCT03721172|459698138|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
127746464|NCT03721172|459698136|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
127746465|NCT03721172|459698137|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
127746466|NCT03721172|459698138|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
127746467|NCT03721172|459698136|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
127746468|NCT03721172|459698137|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
127746469|NCT03721172|459698138|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
127746470|NCT03721172|459698136|FG000|Placebo-controlled Phase|Other|3|||
127746471|NCT03721172|459698137|FG001|Placebo-controlled Phase|Other|0|||
127746472|NCT03721172|459698138|FG002|Placebo-controlled Phase|Other|0|||
127746473|NCT03721172|459698136|FG000|Apremilast Extension Phase|Adverse Event|0|||
127746474|NCT03721172|459698137|FG001|Apremilast Extension Phase|Adverse Event|0|||
127746475|NCT03721172|459698138|FG002|Apremilast Extension Phase|Adverse Event|10|||
127746476|NCT03721172|459698136|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
127746477|NCT03721172|459698137|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
127808284|NCT00408005|459917760|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
127808285|NCT00408005|459917761|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
127746478|NCT03721172|459698138|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
127746479|NCT03721172|459698136|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
127746480|NCT03721172|459698137|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
127746481|NCT03721172|459698138|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
127808286|NCT00408005|459917762|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
127746482|NCT03721172|459698136|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
127746483|NCT03721172|459698137|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
127808287|NCT00408005|459917763|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
127746484|NCT03721172|459698138|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
127746485|NCT03721172|459698136|FG000|Apremilast Extension Phase|Protocol Violation|0|||
127746486|NCT03721172|459698137|FG001|Apremilast Extension Phase|Protocol Violation|0|||
127746487|NCT03721172|459698138|FG002|Apremilast Extension Phase|Protocol Violation|1|||
127746488|NCT03721172|459698136|FG000|Apremilast Extension Phase|Physician Decision|0|||
127746489|NCT03721172|459698137|FG001|Apremilast Extension Phase|Physician Decision|0|||
127746490|NCT03721172|459698138|FG002|Apremilast Extension Phase|Physician Decision|1|||
127746491|NCT03721172|459698136|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
127746492|NCT03721172|459698137|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
127746493|NCT03721172|459698138|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
127746494|NCT03721172|459698136|FG000|Apremilast Extension Phase|Other|0|||
127746495|NCT03721172|459698137|FG001|Apremilast Extension Phase|Other|0|||
127746496|NCT03721172|459698138|FG002|Apremilast Extension Phase|Other|3|||
127746497|NCT03721172|459698136|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
127746498|NCT03721172|459698137|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
127746499|NCT03721172|459698138|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
127746500|NCT02402322|459698142|FG000|Pretreatment|Withdrawal by Subject|3|||
127746501|NCT02402322|459698143|FG001|Pretreatment|Withdrawal by Subject|1|||
127746502|NCT02402322|459698144|FG002|Pretreatment|Withdrawal by Subject|1|||
127746503|NCT02402322|459698142|FG000|Follow-up|Withdrawal by Subject|6|||
127746504|NCT02402322|459698143|FG001|Follow-up|Withdrawal by Subject|3|||
127746505|NCT02402322|459698144|FG002|Follow-up|Withdrawal by Subject|24|||
127746506|NCT04593823|459698145|FG000|Overall Study|Withdrawal by Subject|1|||
127746507|NCT04593823|459698146|FG001|Overall Study|Withdrawal by Subject|1|||
127746508|NCT04593823|459698145|FG000|Overall Study|Lost to Follow-up|0|||
127746509|NCT04593823|459698146|FG001|Overall Study|Lost to Follow-up|1|||
127746510|NCT02472145|459698147|FG000|Overall Study|Death|10|||
127746511|NCT02472145|459698148|FG001|Overall Study|Death|101|||
127746512|NCT02472145|459698149|FG002|Overall Study|Death|99|||
127746513|NCT02472145|459698147|FG000|Overall Study|Lost to Follow-up|0|||
127746514|NCT02472145|459698148|FG001|Overall Study|Lost to Follow-up|1|||
127746515|NCT02472145|459698149|FG002|Overall Study|Lost to Follow-up|0|||
127746516|NCT02472145|459698147|FG000|Overall Study|Withdrawal by Subject|0|||
127746517|NCT02472145|459698148|FG001|Overall Study|Withdrawal by Subject|9|||
127746518|NCT02472145|459698149|FG002|Overall Study|Withdrawal by Subject|13|||
127746519|NCT02472145|459698147|FG000|Overall Study|Sponsor decision|0|||
127746520|NCT02472145|459698148|FG001|Overall Study|Sponsor decision|3|||
127746521|NCT02472145|459698149|FG002|Overall Study|Sponsor decision|2|||
127746522|NCT02472145|459698147|FG000|Overall Study|Other|0|||
127746523|NCT02472145|459698148|FG001|Overall Study|Other|45|||
127746524|NCT02472145|459698149|FG002|Overall Study|Other|43|||
127746525|NCT01236352|459698151|FG000|Overall Study|Death|0|||
127746526|NCT01236352|459698152|FG001|Overall Study|Death|0|||
127746527|NCT01236352|459698153|FG002|Overall Study|Death|0|||
127746528|NCT01236352|459698154|FG003|Overall Study|Death|0|||
127746529|NCT01236352|459698155|FG004|Overall Study|Death|0|||
127746530|NCT01236352|459698156|FG005|Overall Study|Death|0|||
127746531|NCT01236352|459698157|FG006|Overall Study|Death|0|||
127746532|NCT01236352|459698158|FG007|Overall Study|Death|1|||
127746533|NCT01236352|459698159|FG008|Overall Study|Death|0|||
127746534|NCT01236352|459698160|FG009|Overall Study|Death|0|||
127746535|NCT01236352|459698161|FG010|Overall Study|Death|0|||
127746536|NCT01236352|459698151|FG000|Overall Study|Withdrawal by Subject|0|||
127746537|NCT01236352|459698152|FG001|Overall Study|Withdrawal by Subject|0|||
127746538|NCT01236352|459698153|FG002|Overall Study|Withdrawal by Subject|0|||
127746539|NCT01236352|459698154|FG003|Overall Study|Withdrawal by Subject|0|||
127746540|NCT01236352|459698155|FG004|Overall Study|Withdrawal by Subject|0|||
127746541|NCT01236352|459698156|FG005|Overall Study|Withdrawal by Subject|0|||
127746542|NCT01236352|459698157|FG006|Overall Study|Withdrawal by Subject|0|||
127808288|NCT00408005|459917764|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
127808289|NCT00408005|459917765|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
127808290|NCT00408005|459917766|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
127808291|NCT00408005|459917759|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
127746543|NCT01236352|459698158|FG007|Overall Study|Withdrawal by Subject|0|||
127746544|NCT01236352|459698159|FG008|Overall Study|Withdrawal by Subject|0|||
127746545|NCT01236352|459698160|FG009|Overall Study|Withdrawal by Subject|2|||
127746546|NCT01236352|459698161|FG010|Overall Study|Withdrawal by Subject|1|||
127746547|NCT01236352|459698151|FG000|Overall Study|Adverse Event|0|||
127746548|NCT01236352|459698152|FG001|Overall Study|Adverse Event|0|||
127746549|NCT01236352|459698153|FG002|Overall Study|Adverse Event|0|||
127746550|NCT01236352|459698154|FG003|Overall Study|Adverse Event|0|||
127746551|NCT01236352|459698155|FG004|Overall Study|Adverse Event|0|||
127808292|NCT00408005|459917760|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
127746552|NCT01236352|459698156|FG005|Overall Study|Adverse Event|0|||
127746553|NCT01236352|459698157|FG006|Overall Study|Adverse Event|2|||
127746554|NCT01236352|459698158|FG007|Overall Study|Adverse Event|0|||
127746555|NCT01236352|459698159|FG008|Overall Study|Adverse Event|0|||
127893880|NCT04480463|460235158|FG001|Overall Study|Adverse Event|8|||
127893881|NCT04480463|460235157|FG000|Overall Study|Lost to Follow-up|3|||
127893882|NCT04480463|460235158|FG001|Overall Study|Lost to Follow-up|2|||
127893883|NCT04480463|460235157|FG000|Overall Study|Physician Decision|2|||
127893884|NCT04480463|460235158|FG001|Overall Study|Physician Decision|5|||
127893885|NCT04480463|460235157|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
127893886|NCT04480463|460235158|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
127893887|NCT04480463|460235157|FG000|Overall Study|Protocol Violation|2|||
127893888|NCT04480463|460235158|FG001|Overall Study|Protocol Violation|1|||
127893889|NCT04480463|460235157|FG000|Overall Study|Withdrawal by Subject|6|||
127893890|NCT04480463|460235158|FG001|Overall Study|Withdrawal by Subject|7|||
127893891|NCT04480463|460235157|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
127893892|NCT04480463|460235158|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
127893893|NCT04480463|460235157|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
127893894|NCT04480463|460235158|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
127893895|NCT04480463|460235157|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
127893896|NCT04480463|460235158|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
127893897|NCT04480463|460235157|FG000|Overall Study|Other|6|||
127893898|NCT04480463|460235158|FG001|Overall Study|Other|4|||
127893899|NCT00704418|460235159|FG000|Overall Study|Withdrawal by Subject|2|||
127893900|NCT00704418|460235160|FG001|Overall Study|Withdrawal by Subject|0|||
127893901|NCT00704418|460235159|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
127893902|NCT00704418|460235160|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
127893903|NCT02322879|460235162|FG000|First Intervention|Physician Decision|1|||
127893904|NCT02322879|460235163|FG001|First Intervention|Physician Decision|0|||
127893905|NCT01579474|460235164|FG000|Overall Study|Adverse Event|1|||
127893906|NCT01579474|460235165|FG001|Overall Study|Adverse Event|13|||
127893907|NCT01579474|460235166|FG002|Overall Study|Adverse Event|2|||
127893908|NCT01579474|460235167|FG003|Overall Study|Adverse Event|0|||
127893909|NCT01579474|460235168|FG004|Overall Study|Adverse Event|0|||
127893910|NCT01579474|460235169|FG005|Overall Study|Adverse Event|1|||
127893911|NCT01579474|460235164|FG000|Overall Study|Lack of Efficacy|1|||
127893912|NCT01579474|460235165|FG001|Overall Study|Lack of Efficacy|0|||
127893913|NCT01579474|460235166|FG002|Overall Study|Lack of Efficacy|0|||
127893914|NCT01579474|460235167|FG003|Overall Study|Lack of Efficacy|0|||
127893915|NCT01579474|460235168|FG004|Overall Study|Lack of Efficacy|1|||
127893916|NCT01579474|460235169|FG005|Overall Study|Lack of Efficacy|0|||
127893917|NCT01579474|460235164|FG000|Overall Study|Withdrawal by Subject|1|||
127893918|NCT01579474|460235165|FG001|Overall Study|Withdrawal by Subject|0|||
127893919|NCT01579474|460235166|FG002|Overall Study|Withdrawal by Subject|0|||
127893920|NCT01579474|460235167|FG003|Overall Study|Withdrawal by Subject|0|||
127893921|NCT01579474|460235168|FG004|Overall Study|Withdrawal by Subject|0|||
127746556|NCT01236352|459698160|FG009|Overall Study|Adverse Event|4|||
127746557|NCT01236352|459698161|FG010|Overall Study|Adverse Event|1|||
127746558|NCT01236352|459698151|FG000|Overall Study|Study drug toxicity|0|||
127746559|NCT01236352|459698152|FG001|Overall Study|Study drug toxicity|0|||
127746560|NCT01236352|459698153|FG002|Overall Study|Study drug toxicity|0|||
127746561|NCT01236352|459698154|FG003|Overall Study|Study drug toxicity|0|||
127746562|NCT01236352|459698155|FG004|Overall Study|Study drug toxicity|0|||
127746563|NCT01236352|459698156|FG005|Overall Study|Study drug toxicity|1|||
127746564|NCT01236352|459698157|FG006|Overall Study|Study drug toxicity|1|||
127746565|NCT01236352|459698158|FG007|Overall Study|Study drug toxicity|0|||
127746566|NCT01236352|459698159|FG008|Overall Study|Study drug toxicity|0|||
127746567|NCT01236352|459698160|FG009|Overall Study|Study drug toxicity|2|||
127893922|NCT01579474|460235169|FG005|Overall Study|Withdrawal by Subject|0|||
127746568|NCT01236352|459698161|FG010|Overall Study|Study drug toxicity|2|||
127746569|NCT01236352|459698151|FG000|Overall Study|Disease progression|1|||
127746570|NCT01236352|459698152|FG001|Overall Study|Disease progression|2|||
127746571|NCT01236352|459698153|FG002|Overall Study|Disease progression|1|||
127746572|NCT01236352|459698154|FG003|Overall Study|Disease progression|2|||
127746573|NCT01236352|459698155|FG004|Overall Study|Disease progression|2|||
127746574|NCT01236352|459698156|FG005|Overall Study|Disease progression|2|||
127746575|NCT01236352|459698157|FG006|Overall Study|Disease progression|1|||
127893923|NCT02637076|460235170|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
127976286|NCT03395184|460533176|FG003|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
127746576|NCT01236352|459698158|FG007|Overall Study|Disease progression|3|||
127746577|NCT01236352|459698159|FG008|Overall Study|Disease progression|2|||
127746578|NCT01236352|459698160|FG009|Overall Study|Disease progression|2|||
127746579|NCT01236352|459698161|FG010|Overall Study|Disease progression|2|||
127746580|NCT01236352|459698151|FG000|Overall Study|Poor/Non-compliance|1|||
127746581|NCT01236352|459698152|FG001|Overall Study|Poor/Non-compliance|0|||
127746582|NCT01236352|459698153|FG002|Overall Study|Poor/Non-compliance|0|||
127746583|NCT01236352|459698154|FG003|Overall Study|Poor/Non-compliance|0|||
127746584|NCT01236352|459698155|FG004|Overall Study|Poor/Non-compliance|0|||
127746585|NCT01236352|459698156|FG005|Overall Study|Poor/Non-compliance|0|||
127746586|NCT01236352|459698157|FG006|Overall Study|Poor/Non-compliance|0|||
127746587|NCT01236352|459698158|FG007|Overall Study|Poor/Non-compliance|0|||
127746588|NCT01236352|459698159|FG008|Overall Study|Poor/Non-compliance|0|||
127746589|NCT01236352|459698160|FG009|Overall Study|Poor/Non-compliance|0|||
127746590|NCT01236352|459698161|FG010|Overall Study|Poor/Non-compliance|0|||
127746591|NCT01236352|459698151|FG000|Overall Study|Maximum clinical benefit|1|||
127746592|NCT01236352|459698152|FG001|Overall Study|Maximum clinical benefit|1|||
127746593|NCT01236352|459698153|FG002|Overall Study|Maximum clinical benefit|1|||
127746594|NCT01236352|459698154|FG003|Overall Study|Maximum clinical benefit|0|||
127746595|NCT01236352|459698155|FG004|Overall Study|Maximum clinical benefit|2|||
127893924|NCT02637076|460235171|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
127893925|NCT02637076|460235170|FG000|Overall Study|Withdrawal by Subject|0|||
127893926|NCT02637076|460235171|FG001|Overall Study|Withdrawal by Subject|4|||
127893927|NCT00130520|460235172|FG000|Overall Study|Adverse Event|11|||
127893928|NCT00130520|460235172|FG000|Overall Study|Death|1|||
127746596|NCT01236352|459698156|FG005|Overall Study|Maximum clinical benefit|0|||
127746597|NCT01236352|459698157|FG006|Overall Study|Maximum clinical benefit|3|||
127746598|NCT01236352|459698158|FG007|Overall Study|Maximum clinical benefit|1|||
127746599|NCT01236352|459698159|FG008|Overall Study|Maximum clinical benefit|1|||
127746600|NCT01236352|459698160|FG009|Overall Study|Maximum clinical benefit|4|||
127746601|NCT01236352|459698161|FG010|Overall Study|Maximum clinical benefit|2|||
127746602|NCT01236352|459698151|FG000|Overall Study|Subject request to discontinue treatment|0|||
127746603|NCT01236352|459698152|FG001|Overall Study|Subject request to discontinue treatment|0|||
127746604|NCT01236352|459698153|FG002|Overall Study|Subject request to discontinue treatment|1|||
127746605|NCT01236352|459698154|FG003|Overall Study|Subject request to discontinue treatment|1|||
127746606|NCT01236352|459698155|FG004|Overall Study|Subject request to discontinue treatment|0|||
127746607|NCT01236352|459698156|FG005|Overall Study|Subject request to discontinue treatment|1|||
127746608|NCT01236352|459698157|FG006|Overall Study|Subject request to discontinue treatment|0|||
127746609|NCT01236352|459698158|FG007|Overall Study|Subject request to discontinue treatment|0|||
127746610|NCT01236352|459698159|FG008|Overall Study|Subject request to discontinue treatment|0|||
127746611|NCT01236352|459698160|FG009|Overall Study|Subject request to discontinue treatment|1|||
127746612|NCT01236352|459698161|FG010|Overall Study|Subject request to discontinue treatment|4|||
127746613|NCT01236352|459698151|FG000|Overall Study|Subject to receive drug via EAP|1|||
127746614|NCT01236352|459698152|FG001|Overall Study|Subject to receive drug via EAP|1|||
127746615|NCT01236352|459698153|FG002|Overall Study|Subject to receive drug via EAP|1|||
127746616|NCT01236352|459698154|FG003|Overall Study|Subject to receive drug via EAP|0|||
127746617|NCT01236352|459698155|FG004|Overall Study|Subject to receive drug via EAP|0|||
127746618|NCT01236352|459698156|FG005|Overall Study|Subject to receive drug via EAP|0|||
127746619|NCT01236352|459698157|FG006|Overall Study|Subject to receive drug via EAP|0|||
127746620|NCT01236352|459698158|FG007|Overall Study|Subject to receive drug via EAP|2|||
127746621|NCT01236352|459698159|FG008|Overall Study|Subject to receive drug via EAP|0|||
127746622|NCT01236352|459698160|FG009|Overall Study|Subject to receive drug via EAP|4|||
127746623|NCT01236352|459698161|FG010|Overall Study|Subject to receive drug via EAP|0|||
127746624|NCT01236352|459698151|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
127746625|NCT01236352|459698152|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
127746626|NCT01236352|459698153|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
127746627|NCT01236352|459698154|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
127746628|NCT01236352|459698155|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
127746629|NCT01236352|459698156|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
127746630|NCT01236352|459698157|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
127746631|NCT01236352|459698158|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
127746632|NCT01236352|459698159|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
127746633|NCT01236352|459698160|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
127746634|NCT01236352|459698161|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
127746635|NCT01236352|459698151|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
127746636|NCT01236352|459698152|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
127746637|NCT01236352|459698153|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
127746638|NCT01236352|459698154|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
127746639|NCT01236352|459698155|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
127746640|NCT01236352|459698156|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
127746641|NCT01236352|459698157|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
127746642|NCT01236352|459698158|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
127746643|NCT01236352|459698159|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
127746644|NCT01236352|459698160|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
127746645|NCT01236352|459698161|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
127746646|NCT01236352|459698151|FG000|Overall Study|Lack of response to drug|0|||
127746647|NCT01236352|459698152|FG001|Overall Study|Lack of response to drug|0|||
127746648|NCT01236352|459698153|FG002|Overall Study|Lack of response to drug|0|||
127746649|NCT01236352|459698154|FG003|Overall Study|Lack of response to drug|0|||
127746650|NCT01236352|459698155|FG004|Overall Study|Lack of response to drug|0|||
127746651|NCT01236352|459698156|FG005|Overall Study|Lack of response to drug|0|||
127746652|NCT01236352|459698157|FG006|Overall Study|Lack of response to drug|0|||
127746653|NCT01236352|459698158|FG007|Overall Study|Lack of response to drug|0|||
127746654|NCT01236352|459698159|FG008|Overall Study|Lack of response to drug|0|||
127746655|NCT01236352|459698160|FG009|Overall Study|Lack of response to drug|1|||
127746656|NCT01236352|459698161|FG010|Overall Study|Lack of response to drug|1|||
127746657|NCT01236352|459698151|FG000|Overall Study|Patient transferred to IST|0|||
127746658|NCT01236352|459698152|FG001|Overall Study|Patient transferred to IST|0|||
127746659|NCT01236352|459698153|FG002|Overall Study|Patient transferred to IST|0|||
127746660|NCT01236352|459698154|FG003|Overall Study|Patient transferred to IST|0|||
127746661|NCT01236352|459698155|FG004|Overall Study|Patient transferred to IST|0|||
127746662|NCT01236352|459698156|FG005|Overall Study|Patient transferred to IST|0|||
127746663|NCT01236352|459698157|FG006|Overall Study|Patient transferred to IST|0|||
127746664|NCT01236352|459698158|FG007|Overall Study|Patient transferred to IST|0|||
127746665|NCT01236352|459698159|FG008|Overall Study|Patient transferred to IST|0|||
127746666|NCT01236352|459698160|FG009|Overall Study|Patient transferred to IST|2|||
127746667|NCT01236352|459698161|FG010|Overall Study|Patient transferred to IST|6|||
127746668|NCT01827046|459698165|FG000|Overall Study|Lost to Follow-up|1|||
127746669|NCT01827046|459698166|FG001|Overall Study|Lost to Follow-up|5|||
127746670|NCT01827046|459698165|FG000|Overall Study|Withdrawal by Subject|0|||
127746671|NCT01827046|459698166|FG001|Overall Study|Withdrawal by Subject|4|||
127808293|NCT00408005|459917761|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
127808294|NCT00408005|459917762|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
127808295|NCT00408005|459917763|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
127808296|NCT00408005|459917764|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
127808297|NCT00408005|459917765|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
127808298|NCT00408005|459917766|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
127808299|NCT00408005|459917759|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
127808300|NCT00408005|459917760|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
127808301|NCT00408005|459917761|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
127808302|NCT00408005|459917762|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
127808303|NCT00408005|459917763|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
127808304|NCT00408005|459917764|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
127808305|NCT00408005|459917765|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
127808306|NCT00408005|459917766|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
127808307|NCT00408005|459917759|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
127808308|NCT00408005|459917760|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
127808309|NCT00408005|459917761|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
127808310|NCT00408005|459917762|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
127808311|NCT00408005|459917763|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
127808312|NCT00408005|459917764|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
127808313|NCT00408005|459917765|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
127808314|NCT00408005|459917766|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
127808315|NCT00408005|459917759|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
127808316|NCT00408005|459917760|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
127808317|NCT00408005|459917761|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
127808318|NCT00408005|459917762|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
127808319|NCT00408005|459917763|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
127808320|NCT00408005|459917764|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
127808321|NCT00408005|459917765|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
127808322|NCT00408005|459917766|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
127808323|NCT00408005|459917759|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
127808324|NCT00408005|459917760|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
127808325|NCT00408005|459917761|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
127808326|NCT00408005|459917762|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
127808327|NCT00408005|459917763|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
127746672|NCT02734004|459698167|FG000|Overall Study|Death|36|||
127746673|NCT02734004|459698168|FG001|Overall Study|Death|24|||
127746674|NCT02734004|459698169|FG002|Overall Study|Death|26|||
127746675|NCT02734004|459698170|FG003|Overall Study|Death|35|||
127746676|NCT02734004|459698171|FG004|Overall Study|Death|13|||
127746677|NCT02734004|459698172|FG005|Overall Study|Death|17|||
127746678|NCT02734004|459698173|FG006|Overall Study|Death|20|||
127893929|NCT00130520|460235172|FG000|Overall Study|Physician Decision|1|||
127893930|NCT00130520|460235172|FG000|Overall Study|Withdrawal by Subject|1|||
127893931|NCT00130520|460235172|FG000|Overall Study|Disease Progression|23|||
127893932|NCT00130520|460235172|FG000|Overall Study|Protocol non-compliance|1|||
127893933|NCT00130520|460235172|FG000|Overall Study|Did not meet re-treatment criteria|1|||
127893934|NCT03083483|460235179|FG000|Overall Study|Adverse Event|1|||
127746679|NCT02734004|459698167|FG000|Overall Study|Lost to Follow-up|1|||
127746680|NCT02734004|459698168|FG001|Overall Study|Lost to Follow-up|1|||
127746681|NCT02734004|459698169|FG002|Overall Study|Lost to Follow-up|0|||
127746682|NCT02734004|459698170|FG003|Overall Study|Lost to Follow-up|0|||
127746683|NCT02734004|459698171|FG004|Overall Study|Lost to Follow-up|1|||
127746684|NCT02734004|459698172|FG005|Overall Study|Lost to Follow-up|0|||
127746685|NCT02734004|459698173|FG006|Overall Study|Lost to Follow-up|0|||
127746686|NCT02734004|459698167|FG000|Overall Study|Withdrawal by Subject|3|||
127746687|NCT02734004|459698168|FG001|Overall Study|Withdrawal by Subject|1|||
127746688|NCT02734004|459698169|FG002|Overall Study|Withdrawal by Subject|1|||
127746689|NCT02734004|459698170|FG003|Overall Study|Withdrawal by Subject|1|||
127746690|NCT02734004|459698171|FG004|Overall Study|Withdrawal by Subject|3|||
127746691|NCT02734004|459698172|FG005|Overall Study|Withdrawal by Subject|0|||
127746692|NCT02734004|459698173|FG006|Overall Study|Withdrawal by Subject|2|||
127746693|NCT02734004|459698167|FG000|Overall Study|Other|0|||
127893935|NCT03083483|460235180|FG001|Overall Study|Adverse Event|1|||
127893936|NCT03083483|460235181|FG002|Overall Study|Adverse Event|1|||
127893937|NCT03083483|460235179|FG000|Overall Study|Lost to Follow-up|2|||
127893938|NCT03083483|460235180|FG001|Overall Study|Lost to Follow-up|1|||
127893939|NCT03083483|460235181|FG002|Overall Study|Lost to Follow-up|1|||
127893940|NCT03083483|460235179|FG000|Overall Study|technological issues|1|||
127893941|NCT03083483|460235180|FG001|Overall Study|technological issues|0|||
127893942|NCT03083483|460235181|FG002|Overall Study|technological issues|1|||
127893943|NCT02711956|460235182|FG000|Overall Study|Adverse Event|0|||
127893944|NCT02711956|460235183|FG001|Overall Study|Adverse Event|0|||
127893945|NCT02711956|460235184|FG002|Overall Study|Adverse Event|0|||
127893946|NCT02711956|460235185|FG003|Overall Study|Adverse Event|1|||
127893947|NCT02711956|460235186|FG004|Overall Study|Adverse Event|2|||
127893948|NCT02711956|460235187|FG005|Overall Study|Adverse Event|0|||
127893949|NCT02711956|460235188|FG006|Overall Study|Adverse Event|0|||
127893950|NCT02711956|460235189|FG007|Overall Study|Adverse Event|1|||
127893951|NCT02711956|460235190|FG008|Overall Study|Adverse Event|1|||
127893952|NCT02711956|460235191|FG009|Overall Study|Adverse Event|1|||
127893953|NCT02711956|460235192|FG010|Overall Study|Adverse Event|1|||
127893954|NCT02711956|460235193|FG011|Overall Study|Adverse Event|0|||
127893955|NCT02711956|460235194|FG012|Overall Study|Adverse Event|0|||
127893956|NCT02711956|460235195|FG013|Overall Study|Adverse Event|0|||
127893957|NCT02711956|460235196|FG014|Overall Study|Adverse Event|2|||
127893958|NCT02711956|460235182|FG000|Overall Study|Physician Decision|0|||
127893959|NCT02711956|460235183|FG001|Overall Study|Physician Decision|0|||
127893960|NCT02711956|460235184|FG002|Overall Study|Physician Decision|0|||
127893961|NCT02711956|460235185|FG003|Overall Study|Physician Decision|2|||
127893962|NCT02711956|460235186|FG004|Overall Study|Physician Decision|0|||
127893963|NCT02711956|460235187|FG005|Overall Study|Physician Decision|0|||
127893964|NCT02711956|460235188|FG006|Overall Study|Physician Decision|0|||
127893965|NCT02711956|460235189|FG007|Overall Study|Physician Decision|0|||
127893966|NCT02711956|460235190|FG008|Overall Study|Physician Decision|0|||
127893967|NCT02711956|460235191|FG009|Overall Study|Physician Decision|0|||
127893968|NCT02711956|460235192|FG010|Overall Study|Physician Decision|0|||
127893969|NCT02711956|460235193|FG011|Overall Study|Physician Decision|0|||
127893970|NCT02711956|460235194|FG012|Overall Study|Physician Decision|0|||
127893971|NCT02711956|460235195|FG013|Overall Study|Physician Decision|0|||
127893972|NCT02711956|460235196|FG014|Overall Study|Physician Decision|0|||
127893973|NCT02711956|460235182|FG000|Overall Study|Withdrawal by Subject|0|||
127893974|NCT02711956|460235183|FG001|Overall Study|Withdrawal by Subject|0|||
127893975|NCT02711956|460235184|FG002|Overall Study|Withdrawal by Subject|0|||
127893976|NCT02711956|460235185|FG003|Overall Study|Withdrawal by Subject|0|||
127893977|NCT02711956|460235186|FG004|Overall Study|Withdrawal by Subject|0|||
127893978|NCT02711956|460235187|FG005|Overall Study|Withdrawal by Subject|0|||
127893979|NCT02711956|460235188|FG006|Overall Study|Withdrawal by Subject|1|||
127746694|NCT02734004|459698168|FG001|Overall Study|Other|8|||
127746695|NCT02734004|459698169|FG002|Overall Study|Other|7|||
127893980|NCT02711956|460235189|FG007|Overall Study|Withdrawal by Subject|0|||
127893981|NCT02711956|460235190|FG008|Overall Study|Withdrawal by Subject|0|||
127893982|NCT02711956|460235191|FG009|Overall Study|Withdrawal by Subject|0|||
127893983|NCT02711956|460235192|FG010|Overall Study|Withdrawal by Subject|0|||
127893984|NCT02711956|460235193|FG011|Overall Study|Withdrawal by Subject|1|||
127893985|NCT02711956|460235194|FG012|Overall Study|Withdrawal by Subject|6|||
127893986|NCT02711956|460235195|FG013|Overall Study|Withdrawal by Subject|0|||
127746696|NCT02734004|459698170|FG003|Overall Study|Other|4|||
127746697|NCT02734004|459698171|FG004|Overall Study|Other|34|||
127893987|NCT02711956|460235196|FG014|Overall Study|Withdrawal by Subject|1|||
127746698|NCT02734004|459698172|FG005|Overall Study|Other|14|||
127746699|NCT02734004|459698173|FG006|Overall Study|Other|10|||
127746700|NCT01294436|459698174|FG000|Overall Study|Adverse Event|10|||
127746701|NCT01294436|459698175|FG001|Overall Study|Adverse Event|17|||
127746702|NCT01294436|459698174|FG000|Overall Study|Withdrawal by Subject|11|||
127746703|NCT01294436|459698175|FG001|Overall Study|Withdrawal by Subject|28|||
127746704|NCT01294436|459698174|FG000|Overall Study|subject no longer meets study criteria|5|||
127746705|NCT01294436|459698175|FG001|Overall Study|subject no longer meets study criteria|20|||
127746706|NCT01294436|459698174|FG000|Overall Study|poor/non-compliance|2|||
127746707|NCT01294436|459698175|FG001|Overall Study|poor/non-compliance|5|||
127746708|NCT01018732|459698178|FG000|Overall Study|Lost to Follow-up|0|||
127746709|NCT01018732|459698179|FG001|Overall Study|Lost to Follow-up|0|||
127746710|NCT01018732|459698180|FG002|Overall Study|Lost to Follow-up|3|||
127746711|NCT01018732|459698178|FG000|Overall Study|Protocol Violation|1|||
127746712|NCT01018732|459698179|FG001|Overall Study|Protocol Violation|1|||
127746713|NCT01018732|459698180|FG002|Overall Study|Protocol Violation|0|||
127746714|NCT01018732|459698178|FG000|Overall Study|Inappropriate Enrollment|0|||
127746715|NCT01018732|459698179|FG001|Overall Study|Inappropriate Enrollment|1|||
127746716|NCT01018732|459698180|FG002|Overall Study|Inappropriate Enrollment|0|||
127746717|NCT01018732|459698178|FG000|Overall Study|Unable to Classify|0|||
127746718|NCT01018732|459698179|FG001|Overall Study|Unable to Classify|0|||
127746719|NCT01018732|459698180|FG002|Overall Study|Unable to Classify|1|||
127746720|NCT01536171|459698181|FG000|Overall Study|Withdrawal by Subject|1|||
127746721|NCT00585078|459698182|FG000|Overall Study|Withdrawal by Subject|4|||
127746722|NCT00585078|459698182|FG000|Overall Study|Poor performance status|1|||
127746723|NCT00585078|459698182|FG000|Overall Study|Disease Progression|24|||
127746724|NCT00585078|459698182|FG000|Overall Study|Adverse Event|10|||
127746725|NCT00585078|459698182|FG000|Overall Study|Death|1|||
127746726|NCT01056263|459698185|FG000|Overall Study|Adverse Event|12|||
127746727|NCT01056263|459698185|FG000|Overall Study|Death|1|||
127746728|NCT01056263|459698185|FG000|Overall Study|Withdrawal by Subject|1|||
127746729|NCT01056263|459698185|FG000|Overall Study|Lack of Efficacy|29|||
127746730|NCT01056263|459698185|FG000|Overall Study|Progressive disease|2|||
127746731|NCT01056263|459698185|FG000|Overall Study|Neoplasm progression|1|||
127746732|NCT01056263|459698185|FG000|Overall Study|Objective progression or relapse|1|||
127746733|NCT01056263|459698185|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
127746734|NCT00699842|459698186|FG000|Overall Study|Death|0|||
127746735|NCT00699842|459698187|FG001|Overall Study|Death|1|||
127746736|NCT00699842|459698188|FG002|Overall Study|Death|0|||
127746737|NCT05990387|459698189|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|3|||
127746738|NCT05990387|459698190|FG001|Informed Consent/Screening Visit|Withdrawal by Subject|2|||
127746739|NCT04750577|459698191|FG000|Overall Study|Adverse Event|2|||
127746740|NCT04750577|459698192|FG001|Overall Study|Adverse Event|10|||
127746741|NCT04750577|459698193|FG002|Overall Study|Adverse Event|8|||
127746742|NCT04750577|459698194|FG003|Overall Study|Adverse Event|1|||
127746743|NCT04750577|459698191|FG000|Overall Study|Change of residence|0|||
127746744|NCT04750577|459698192|FG001|Overall Study|Change of residence|0|||
127746745|NCT04750577|459698193|FG002|Overall Study|Change of residence|1|||
127746746|NCT04750577|459698194|FG003|Overall Study|Change of residence|0|||
127746747|NCT04750577|459698191|FG000|Overall Study|Burden of study procedures|0|||
127746748|NCT04750577|459698192|FG001|Overall Study|Burden of study procedures|2|||
127746749|NCT04750577|459698193|FG002|Overall Study|Burden of study procedures|2|||
127746750|NCT04750577|459698194|FG003|Overall Study|Burden of study procedures|0|||
127746751|NCT04750577|459698191|FG000|Overall Study|Prematurely discontinued|0|||
127746752|NCT04750577|459698192|FG001|Overall Study|Prematurely discontinued|0|||
127746753|NCT04750577|459698193|FG002|Overall Study|Prematurely discontinued|0|||
127746754|NCT04750577|459698194|FG003|Overall Study|Prematurely discontinued|2|||
127808328|NCT00408005|459917764|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
127808329|NCT00408005|459917765|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
127808330|NCT00408005|459917766|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
127808331|NCT03155997|459917767|FG000|Overall Study|Withdrawal by Subject|119|||
127808332|NCT03155997|459917768|FG001|Overall Study|Withdrawal by Subject|134|||
127746755|NCT04750577|459698191|FG000|Overall Study|Protocol deviation|1|||
127746756|NCT04750577|459698192|FG001|Overall Study|Protocol deviation|1|||
127746757|NCT04750577|459698193|FG002|Overall Study|Protocol deviation|1|||
127746758|NCT04750577|459698194|FG003|Overall Study|Protocol deviation|1|||
127746759|NCT04750577|459698191|FG000|Overall Study|Other than listed|3|||
127746760|NCT04750577|459698192|FG001|Overall Study|Other than listed|2|||
127746761|NCT04750577|459698193|FG002|Overall Study|Other than listed|2|||
127746762|NCT04750577|459698194|FG003|Overall Study|Other than listed|1|||
127746763|NCT04750577|459698191|FG000|Overall Study|Not treated|0|||
127746764|NCT04750577|459698192|FG001|Overall Study|Not treated|0|||
127746765|NCT04750577|459698193|FG002|Overall Study|Not treated|0|||
127746766|NCT04750577|459698194|FG003|Overall Study|Not treated|2|||
127746767|NCT01806389|459698197|FG000|Overall Study|Withdrawal by Subject|4|||
127746768|NCT03371823|459698200|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
127746769|NCT03371823|459698201|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
127746770|NCT01310699|459698202|FG000|Overall Study|Patients did not complete tandem.|4|||
127746771|NCT01310699|459698203|FG001|Overall Study|Patients did not complete tandem.|6|||
127746772|NCT00936598|459698204|FG000|Overall Study|Withdrawal by Subject|1|||
127746773|NCT00936598|459698205|FG001|Overall Study|Withdrawal by Subject|0|||
127746774|NCT00936598|459698204|FG000|Overall Study|Ineligible after consent|1|||
127746775|NCT00936598|459698205|FG001|Overall Study|Ineligible after consent|0|||
127746776|NCT00926575|459698206|FG000|Overall Study|Adverse Event|1|||
127746777|NCT00926575|459698207|FG001|Overall Study|Adverse Event|1|||
127746778|NCT00926575|459698206|FG000|Overall Study|Death|4|||
127746779|NCT00926575|459698207|FG001|Overall Study|Death|4|||
127746780|NCT00926575|459698206|FG000|Overall Study|Lost to Follow-up|1|||
127746781|NCT00926575|459698207|FG001|Overall Study|Lost to Follow-up|1|||
127746782|NCT00926575|459698206|FG000|Overall Study|Physician Decision|1|||
127746783|NCT00926575|459698207|FG001|Overall Study|Physician Decision|2|||
127746784|NCT00926575|459698206|FG000|Overall Study|Protocol Violation|1|||
127746785|NCT00926575|459698207|FG001|Overall Study|Protocol Violation|0|||
127746786|NCT00926575|459698206|FG000|Overall Study|Withdrawal by Subject|8|||
127746787|NCT00926575|459698207|FG001|Overall Study|Withdrawal by Subject|9|||
127746788|NCT02633397|459698209|FG000|Overall Study|Adverse Event|8|||
127746789|NCT02633397|459698210|FG001|Overall Study|Adverse Event|8|||
127746790|NCT02633397|459698209|FG000|Overall Study|Study Burden|4|||
127746791|NCT02633397|459698210|FG001|Overall Study|Study Burden|1|||
127746792|NCT02633397|459698209|FG000|Overall Study|Treatment interruption|2|||
127746793|NCT02633397|459698210|FG001|Overall Study|Treatment interruption|5|||
127746794|NCT02633397|459698209|FG000|Overall Study|Death|2|||
127808333|NCT03155997|459917767|FG000|Overall Study|Lost to Follow-up|12|||
127808334|NCT03155997|459917768|FG001|Overall Study|Lost to Follow-up|13|||
127808335|NCT03155997|459917767|FG000|Overall Study|Missing disposition data|0|||
127808336|NCT03155997|459917768|FG001|Overall Study|Missing disposition data|1|||
127808337|NCT03155997|459917767|FG000|Overall Study|On study treatment|2027|||
127808338|NCT03155997|459917768|FG001|Overall Study|On study treatment|2074|||
127808339|NCT01848145|459917769|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
127808340|NCT01848145|459917769|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
127808341|NCT01848145|459917769|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
127808342|NCT01848145|459917769|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
127808343|NCT01848145|459917769|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
127808344|NCT01848145|459917769|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
127808345|NCT01848145|459917769|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
127746795|NCT02633397|459698210|FG001|Overall Study|Death|2|||
127746796|NCT02633397|459698209|FG000|Overall Study|Physician Decision|0|||
127746797|NCT02633397|459698210|FG001|Overall Study|Physician Decision|1|||
127746798|NCT03595878|459698211|FG000|Overall Study|Death|2|||
127746799|NCT03595878|459698212|FG001|Overall Study|Death|1|||
127746800|NCT03595878|459698213|FG002|Overall Study|Death|0|||
127746801|NCT03595878|459698211|FG000|Overall Study|Disease progression|2|||
127746802|NCT03595878|459698212|FG001|Overall Study|Disease progression|1|||
127746803|NCT03595878|459698213|FG002|Overall Study|Disease progression|2|||
127746804|NCT03494985|459698214|FG000|Overall Study|Adverse Event|3|||
127746805|NCT03494985|459698215|FG001|Overall Study|Adverse Event|2|||
127746806|NCT03494985|459698216|FG002|Overall Study|Adverse Event|3|||
127746807|NCT03494985|459698217|FG003|Overall Study|Adverse Event|0|||
127746808|NCT03494985|459698214|FG000|Overall Study|Other (Withdrawal of consent)|2|||
127808346|NCT02347631|459917770|FG000|First Intervention (2 Months)|Adverse Event|1|||
127746809|NCT03494985|459698215|FG001|Overall Study|Other (Withdrawal of consent)|3|||
127808347|NCT02347631|459917771|FG001|First Intervention (2 Months)|Adverse Event|1|||
127808348|NCT02347631|459917770|FG000|First Intervention (2 Months)|Pregnancy|1|||
127808349|NCT02347631|459917771|FG001|First Intervention (2 Months)|Pregnancy|0|||
127808350|NCT02347631|459917770|FG000|First Intervention (2 Months)|Moved out of area|0|||
127808351|NCT02347631|459917771|FG001|First Intervention (2 Months)|Moved out of area|2|||
127808352|NCT02347631|459917770|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
127808353|NCT02347631|459917771|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
127808354|NCT02347631|459917770|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
127808355|NCT02347631|459917771|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
127746810|NCT03494985|459698216|FG002|Overall Study|Other (Withdrawal of consent)|2|||
127746811|NCT03494985|459698217|FG003|Overall Study|Other (Withdrawal of consent)|5|||
127808356|NCT02347631|459917770|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
127808357|NCT02347631|459917771|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
127808358|NCT02347631|459917770|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
127746812|NCT03494985|459698214|FG000|Overall Study|Other (Not specified)|0|||
127746813|NCT03494985|459698215|FG001|Overall Study|Other (Not specified)|1|||
127746814|NCT03494985|459698216|FG002|Overall Study|Other (Not specified)|1|||
127746815|NCT03494985|459698217|FG003|Overall Study|Other (Not specified)|0|||
127746816|NCT03036124|459698218|FG000|Overall Study|Lost to Follow-up|0|||
127746817|NCT03036124|459698219|FG001|Overall Study|Lost to Follow-up|2|||
127746818|NCT03036124|459698218|FG000|Overall Study|Withdrawal by Subject|5|||
127746819|NCT03036124|459698219|FG001|Overall Study|Withdrawal by Subject|4|||
127746820|NCT02394925|459698220|FG000|Overall Study|Adverse Event|1|||
127746821|NCT02394925|459698220|FG000|Overall Study|Lens Discomfort|3|||
127746822|NCT02394925|459698220|FG000|Overall Study|Lens handling difficulities|5|||
127746823|NCT02394925|459698220|FG000|Overall Study|Lost to Follow-up|9|||
127746824|NCT02394925|459698220|FG000|Overall Study|Protocol Violation|5|||
127746825|NCT02394925|459698220|FG000|Overall Study|No longer meet eligibility criteria|1|||
127746826|NCT02394925|459698220|FG000|Overall Study|Unsatisfactory Visual Response|5|||
127746827|NCT01245140|459699810|FG000|Overall Study|Adverse Event|1|||
127746828|NCT01245140|459699811|FG001|Overall Study|Adverse Event|3|||
127746829|NCT01245140|459699810|FG000|Overall Study|Lack of Efficacy|2|||
127746830|NCT01245140|459699811|FG001|Overall Study|Lack of Efficacy|4|||
127746831|NCT01245140|459699810|FG000|Overall Study|Protocol Violation|0|||
127746832|NCT01245140|459699811|FG001|Overall Study|Protocol Violation|1|||
127746833|NCT01245140|459699810|FG000|Overall Study|Withdrawal by Subject|0|||
127746834|NCT01245140|459699811|FG001|Overall Study|Withdrawal by Subject|1|||
127746835|NCT01245140|459699810|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
127746836|NCT01245140|459699811|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
127746837|NCT04836559|459699812|FG000|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
127746838|NCT04836559|459699813|FG001|Double Blind Period (Day 1 to Day 85)|Adverse Event|4|||
127746839|NCT04836559|459699814|FG002|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
127746840|NCT04836559|459699815|FG003|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
127746841|NCT04836559|459699816|FG004|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
127746842|NCT04836559|459699817|FG005|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
127746843|NCT04836559|459699818|FG006|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
127746844|NCT04836559|459699819|FG007|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
127746845|NCT04836559|459699812|FG000|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
127746846|NCT04836559|459699813|FG001|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
127746847|NCT04836559|459699814|FG002|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
127746848|NCT04836559|459699815|FG003|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|3|||
127746849|NCT04836559|459699816|FG004|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
127746850|NCT04836559|459699817|FG005|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
127746851|NCT04836559|459699818|FG006|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
127746852|NCT04836559|459699819|FG007|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
127746853|NCT04836559|459699812|FG000|Double Blind Period (Day 1 to Day 85)|Protocol Violation|1|||
127746854|NCT04836559|459699813|FG001|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
127746855|NCT04836559|459699814|FG002|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
127746856|NCT04836559|459699815|FG003|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
127746857|NCT04836559|459699816|FG004|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
127746858|NCT04836559|459699817|FG005|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
127746859|NCT04836559|459699818|FG006|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
127746860|NCT04836559|459699819|FG007|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
127746861|NCT04836559|459699812|FG000|Double Blind Period (Day 1 to Day 85)|Other|1|||
127746862|NCT04836559|459699813|FG001|Double Blind Period (Day 1 to Day 85)|Other|0|||
127746863|NCT04836559|459699814|FG002|Double Blind Period (Day 1 to Day 85)|Other|0|||
127746864|NCT04836559|459699815|FG003|Double Blind Period (Day 1 to Day 85)|Other|0|||
127746865|NCT04836559|459699816|FG004|Double Blind Period (Day 1 to Day 85)|Other|0|||
127746866|NCT04836559|459699817|FG005|Double Blind Period (Day 1 to Day 85)|Other|0|||
127746867|NCT04836559|459699818|FG006|Double Blind Period (Day 1 to Day 85)|Other|0|||
127746868|NCT04836559|459699819|FG007|Double Blind Period (Day 1 to Day 85)|Other|0|||
127746869|NCT04836559|459699812|FG000|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
127746870|NCT04836559|459699813|FG001|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
127746871|NCT04836559|459699814|FG002|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
127746872|NCT04836559|459699815|FG003|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|1|||
127746873|NCT04836559|459699816|FG004|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
127746874|NCT04836559|459699817|FG005|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
127746875|NCT04836559|459699818|FG006|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
127746876|NCT04836559|459699819|FG007|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
127746877|NCT04836559|459699812|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
127808359|NCT02347631|459917771|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
127808360|NCT02347631|459917770|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
127746878|NCT04836559|459699813|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
127746879|NCT04836559|459699814|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
127746880|NCT04836559|459699815|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
127746881|NCT04836559|459699816|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|7|||
127808361|NCT02347631|459917771|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
127746882|NCT04836559|459699817|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|14|||
127746883|NCT04836559|459699818|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|4|||
127808362|NCT00501228|459917772|FG000|Overall Study|Withdrawal by Subject|1|||
127808363|NCT00331006|459917774|FG000|Screening Phase|Withdrawal by Subject|1|||
127808364|NCT00331006|459917774|FG000|Screening Phase|enrollment halted|1|||
127808365|NCT00331006|459917774|FG000|Screening Phase|Lost to Follow-up|1|||
127746884|NCT04836559|459699819|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|24|||
127746885|NCT04836559|459699812|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
127746886|NCT04836559|459699813|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
127746887|NCT04836559|459699814|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
127746888|NCT04836559|459699815|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
127746889|NCT04836559|459699816|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|1|||
127746890|NCT04836559|459699817|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|7|||
127746891|NCT04836559|459699818|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|3|||
127746892|NCT04836559|459699819|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|4|||
127746893|NCT04836559|459699812|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
127746894|NCT04836559|459699813|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
127746895|NCT04836559|459699814|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
127746896|NCT04836559|459699815|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
127746897|NCT04836559|459699816|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|4|||
127746898|NCT04836559|459699817|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
127746899|NCT04836559|459699818|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
127746900|NCT04836559|459699819|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
127746901|NCT04836559|459699812|FG000|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
127746902|NCT04836559|459699813|FG001|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
127746903|NCT04836559|459699814|FG002|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
127746904|NCT04836559|459699815|FG003|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
127746905|NCT04836559|459699816|FG004|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
127746906|NCT04836559|459699817|FG005|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
127746907|NCT04836559|459699818|FG006|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
127746908|NCT04836559|459699819|FG007|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|1|||
127746909|NCT05765435|459699822|FG000|Overall Study|Lost to Follow-up|0|||
127746910|NCT05765435|459699823|FG001|Overall Study|Lost to Follow-up|1|||
127746911|NCT05765435|459699824|FG002|Overall Study|Lost to Follow-up|0|||
127746912|NCT05765435|459699822|FG000|Overall Study|Withdrawal by Subject|0|||
127746913|NCT05765435|459699823|FG001|Overall Study|Withdrawal by Subject|0|||
127746914|NCT05765435|459699824|FG002|Overall Study|Withdrawal by Subject|1|||
127746915|NCT00781937|459699830|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
127746916|NCT00781937|459699831|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
127746917|NCT00781937|459699830|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
127746918|NCT00781937|459699831|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
127746919|NCT00781937|459699830|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
127746920|NCT00781937|459699831|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
127746921|NCT00781937|459699830|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
127746922|NCT00781937|459699831|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
127746923|NCT00781937|459699830|FG000|Main Trial Period Through Week 56|Unclassified|10|||
127746924|NCT00781937|459699831|FG001|Main Trial Period Through Week 56|Unclassified|15|||
127746925|NCT00781937|459699830|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
127746926|NCT00781937|459699831|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
127746927|NCT00781937|459699830|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
127746928|NCT00781937|459699831|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
127746929|NCT00013611|459699832|FG000|Overall Study|Lost to Follow-up|91|||
127746930|NCT00013611|459699833|FG001|Overall Study|Lost to Follow-up|100|||
127746931|NCT01013961|459699837|FG000|Overall Study|Adverse Event|2|||
127746932|NCT01013961|459699838|FG001|Overall Study|Adverse Event|2|||
127746933|NCT01013961|459699837|FG000|Overall Study|Withdrawal by Subject|1|||
127746934|NCT01013961|459699838|FG001|Overall Study|Withdrawal by Subject|0|||
127808366|NCT00331006|459917774|FG000|Screening Phase|Ineligible for treatment phase|4|||
127808367|NCT00331006|459917774|FG000|Treatment Phase|Withdrawal by Subject|1|||
127808368|NCT00331006|459917774|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
127808369|NCT00331006|459917774|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
127746935|NCT01013961|459699837|FG000|Overall Study|Physician Decision|0|||
127746936|NCT01013961|459699838|FG001|Overall Study|Physician Decision|1|||
127746937|NCT00420784|459699853|FG000|Overall Study|Adverse Event|11|||
127746938|NCT00420784|459699854|FG001|Overall Study|Adverse Event|29|||
127808370|NCT03804684|459917775|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
127868814|NCT01072175|460137388|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
127808371|NCT03804684|459917776|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
127746939|NCT00420784|459699855|FG002|Overall Study|Adverse Event|10|||
127746940|NCT00420784|459699856|FG003|Overall Study|Adverse Event|5|||
127746941|NCT00420784|459699853|FG000|Overall Study|Withdrawal by Subject|0|||
127746942|NCT00420784|459699854|FG001|Overall Study|Withdrawal by Subject|1|||
127746943|NCT00420784|459699855|FG002|Overall Study|Withdrawal by Subject|0|||
127746944|NCT00420784|459699856|FG003|Overall Study|Withdrawal by Subject|0|||
127746945|NCT00420784|459699853|FG000|Overall Study|Lost to Follow-up|0|||
127746946|NCT00420784|459699854|FG001|Overall Study|Lost to Follow-up|0|||
127746947|NCT00420784|459699855|FG002|Overall Study|Lost to Follow-up|2|||
127746948|NCT00420784|459699856|FG003|Overall Study|Lost to Follow-up|1|||
127746949|NCT00420784|459699853|FG000|Overall Study|Virologic Stopping Rule|17|||
127746950|NCT00420784|459699854|FG001|Overall Study|Virologic Stopping Rule|26|||
127746951|NCT00420784|459699855|FG002|Overall Study|Virologic Stopping Rule|41|||
127746952|NCT00420784|459699856|FG003|Overall Study|Virologic Stopping Rule|67|||
127746953|NCT00420784|459699853|FG000|Overall Study|Other|1|||
127746954|NCT00420784|459699854|FG001|Overall Study|Other|2|||
127746955|NCT00420784|459699855|FG002|Overall Study|Other|0|||
127746956|NCT00420784|459699856|FG003|Overall Study|Other|5|||
127746957|NCT02417441|459699859|FG000|Overall Study|Inconclusive due to missing data|52|||
127746958|NCT02417441|459699860|FG001|Overall Study|Inconclusive due to missing data|19|||
127746959|NCT00983853|459699863|FG000|Overall Study|Lost to Follow-up|1|||
127746960|NCT00983853|459699864|FG001|Overall Study|Lost to Follow-up|1|||
127746961|NCT00983853|459699865|FG002|Overall Study|Lost to Follow-up|2|||
127746962|NCT00983853|459699866|FG003|Overall Study|Lost to Follow-up|2|||
127746963|NCT00983853|459699867|FG004|Overall Study|Lost to Follow-up|2|||
127746964|NCT00983853|459699868|FG005|Overall Study|Lost to Follow-up|1|||
127746965|NCT00983853|459699863|FG000|Overall Study|Withdrawal by Subject|0|||
127746966|NCT00983853|459699864|FG001|Overall Study|Withdrawal by Subject|0|||
127746967|NCT00983853|459699865|FG002|Overall Study|Withdrawal by Subject|1|||
127746968|NCT00983853|459699866|FG003|Overall Study|Withdrawal by Subject|0|||
127746969|NCT00983853|459699867|FG004|Overall Study|Withdrawal by Subject|1|||
127746970|NCT00983853|459699868|FG005|Overall Study|Withdrawal by Subject|0|||
127746971|NCT00983853|459699863|FG000|Overall Study|Unable to come to study follow-up visits|0|||
127746972|NCT00983853|459699864|FG001|Overall Study|Unable to come to study follow-up visits|1|||
127746973|NCT00983853|459699865|FG002|Overall Study|Unable to come to study follow-up visits|0|||
127746974|NCT00983853|459699866|FG003|Overall Study|Unable to come to study follow-up visits|0|||
127746975|NCT00983853|459699867|FG004|Overall Study|Unable to come to study follow-up visits|0|||
127746976|NCT00983853|459699868|FG005|Overall Study|Unable to come to study follow-up visits|0|||
127746977|NCT03603639|459699869|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
127746978|NCT03603639|459699870|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
127746979|NCT03603639|459699871|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
127746980|NCT03603639|459699872|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
127746981|NCT03603639|459699873|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
127746982|NCT03603639|459699874|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
127746983|NCT03603639|459699869|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
127746984|NCT03603639|459699870|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
127746985|NCT03603639|459699871|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
127746986|NCT03603639|459699872|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
127746987|NCT03603639|459699873|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
127746988|NCT03603639|459699874|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
127746989|NCT03016598|459699882|FG000|Overall Study|Lost to Follow-up|0|||
127746990|NCT03016598|459699883|FG001|Overall Study|Lost to Follow-up|2|||
127746991|NCT02947100|459699884|FG000|Overall Study|study terminated early|3|||
127746992|NCT02947100|459699884|FG000|Overall Study|did not meet inclusion criteria|1|||
127746993|NCT00742326|459699887|FG000|Overall Study|Physician Decision|0|||
127808372|NCT03304522|459917780|FG000|Overall Study|Adverse Event|0|||
127808373|NCT03304522|459917781|FG001|Overall Study|Adverse Event|4|||
127808374|NCT03304522|459917780|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
127808375|NCT03304522|459917781|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
127808376|NCT03304522|459917780|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
127808377|NCT03304522|459917781|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
127746994|NCT00742326|459699888|FG001|Overall Study|Physician Decision|1|||
127746995|NCT00443209|459699890|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
127746996|NCT00443209|459699891|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
127746997|NCT00443209|459699890|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
127746998|NCT00443209|459699891|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
127746999|NCT00443209|459699890|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
127747000|NCT00443209|459699891|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
127747001|NCT00443209|459699890|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
127747002|NCT00443209|459699891|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
127747003|NCT00443209|459699890|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
127747004|NCT00443209|459699891|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
127747005|NCT00443209|459699890|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
127747006|NCT00443209|459699891|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
127747007|NCT00443209|459699890|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
127747008|NCT00443209|459699891|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
127747009|NCT00443209|459699890|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
127747010|NCT00443209|459699891|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
127747011|NCT00443209|459699890|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
127747012|NCT00443209|459699891|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
127747013|NCT00443209|459699890|FG000|Months 1 to 12 Treatment Period|Missing|2|||
127747014|NCT00443209|459699891|FG001|Months 1 to 12 Treatment Period|Missing|1|||
127747015|NCT00443209|459699890|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
127747016|NCT00443209|459699891|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
127747017|NCT00443209|459699890|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
127747018|NCT00443209|459699891|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
127747019|NCT00443209|459699890|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
127747020|NCT00443209|459699891|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
127747021|NCT00443209|459699890|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
127747022|NCT00443209|459699891|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
127747023|NCT00443209|459699890|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
127747024|NCT00443209|459699891|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
127747025|NCT00443209|459699890|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
127747026|NCT00443209|459699891|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
127747027|NCT00443209|459699890|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
127747028|NCT00443209|459699891|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
127747029|NCT01628692|459699892|FG000|Overall Study|Lack of Efficacy|4|||
127747030|NCT01628692|459699893|FG001|Overall Study|Lack of Efficacy|4|||
127747031|NCT01628692|459699894|FG002|Overall Study|Lack of Efficacy|5|||
127747032|NCT01628692|459699895|FG003|Overall Study|Lack of Efficacy|1|||
127747033|NCT01628692|459699896|FG004|Overall Study|Lack of Efficacy|4|||
127747034|NCT01628692|459699897|FG005|Overall Study|Lack of Efficacy|7|||
127747035|NCT01628692|459699892|FG000|Overall Study|Adverse Event|2|||
127747036|NCT01628692|459699893|FG001|Overall Study|Adverse Event|0|||
127747037|NCT01628692|459699894|FG002|Overall Study|Adverse Event|2|||
127747038|NCT01628692|459699895|FG003|Overall Study|Adverse Event|0|||
127747039|NCT01628692|459699896|FG004|Overall Study|Adverse Event|0|||
127747040|NCT01628692|459699897|FG005|Overall Study|Adverse Event|0|||
127747041|NCT01628692|459699892|FG000|Overall Study|Withdrawal by Subject|0|||
127747042|NCT01628692|459699893|FG001|Overall Study|Withdrawal by Subject|1|||
127747043|NCT01628692|459699894|FG002|Overall Study|Withdrawal by Subject|1|||
127747044|NCT01628692|459699895|FG003|Overall Study|Withdrawal by Subject|0|||
127747045|NCT01628692|459699896|FG004|Overall Study|Withdrawal by Subject|0|||
127747046|NCT01628692|459699897|FG005|Overall Study|Withdrawal by Subject|0|||
127747047|NCT01628692|459699892|FG000|Overall Study|Death|0|||
127747048|NCT01628692|459699893|FG001|Overall Study|Death|1|||
127747049|NCT01628692|459699894|FG002|Overall Study|Death|0|||
127747050|NCT01628692|459699895|FG003|Overall Study|Death|0|||
127747051|NCT01628692|459699896|FG004|Overall Study|Death|0|||
127747052|NCT01628692|459699897|FG005|Overall Study|Death|0|||
127747053|NCT01628692|459699892|FG000|Overall Study|Poor compliance/noncompliance|1|||
127747054|NCT01628692|459699893|FG001|Overall Study|Poor compliance/noncompliance|0|||
127747055|NCT01628692|459699894|FG002|Overall Study|Poor compliance/noncompliance|0|||
127747056|NCT01628692|459699895|FG003|Overall Study|Poor compliance/noncompliance|0|||
127747057|NCT01628692|459699896|FG004|Overall Study|Poor compliance/noncompliance|0|||
127808378|NCT03304522|459917780|FG000|Overall Study|Other|0|||
127808379|NCT03304522|459917781|FG001|Overall Study|Other|1|||
127808380|NCT00486603|459917786|FG000|Overall Study|Withdrawal by Subject|1|||
127808381|NCT00486603|459917787|FG001|Overall Study|Withdrawal by Subject|0|||
127808382|NCT00486603|459917788|FG002|Overall Study|Withdrawal by Subject|0|||
127747058|NCT01628692|459699897|FG005|Overall Study|Poor compliance/noncompliance|0|||
127747059|NCT01628692|459699892|FG000|Overall Study|Administrative reason by sponsor|0|||
127747060|NCT01628692|459699893|FG001|Overall Study|Administrative reason by sponsor|0|||
127747061|NCT01628692|459699894|FG002|Overall Study|Administrative reason by sponsor|0|||
127747062|NCT01628692|459699895|FG003|Overall Study|Administrative reason by sponsor|0|||
127747063|NCT01628692|459699896|FG004|Overall Study|Administrative reason by sponsor|0|||
127747064|NCT01628692|459699897|FG005|Overall Study|Administrative reason by sponsor|1|||
127747065|NCT01628692|459699892|FG000|Overall Study|Completed 12 Week only|0|||
127747066|NCT01628692|459699893|FG001|Overall Study|Completed 12 Week only|0|||
127747067|NCT01628692|459699894|FG002|Overall Study|Completed 12 Week only|0|||
127747068|NCT01628692|459699895|FG003|Overall Study|Completed 12 Week only|0|||
127747069|NCT01628692|459699896|FG004|Overall Study|Completed 12 Week only|0|||
127808383|NCT00486603|459917789|FG003|Overall Study|Withdrawal by Subject|0|||
127808384|NCT00486603|459917790|FG004|Overall Study|Withdrawal by Subject|0|||
127808385|NCT00486603|459917786|FG000|Overall Study|Physician Decision|0|||
127747070|NCT01628692|459699897|FG005|Overall Study|Completed 12 Week only|1|||
127747071|NCT00409409|459699898|FG000|Overall Study|Adverse Event|7|||
127747072|NCT00409409|459699899|FG001|Overall Study|Adverse Event|2|||
127747073|NCT00409409|459699898|FG000|Overall Study|Withdrawal by Subject|1|||
127747074|NCT00409409|459699899|FG001|Overall Study|Withdrawal by Subject|1|||
127747075|NCT00409409|459699898|FG000|Overall Study|Any other reason not above-mentioned|0|||
127747076|NCT00409409|459699899|FG001|Overall Study|Any other reason not above-mentioned|1|||
127747077|NCT03635086|459699904|FG000|Overall Study|Withdrawal of consent|0|||
127747078|NCT03635086|459699905|FG001|Overall Study|Withdrawal of consent|0|||
127747079|NCT03635086|459699906|FG002|Overall Study|Withdrawal of consent|1|||
127747080|NCT03635086|459699907|FG003|Overall Study|Withdrawal of consent|0|||
127747081|NCT03635086|459699908|FG004|Overall Study|Withdrawal of consent|0|||
127747082|NCT03635086|459699904|FG000|Overall Study|Adverse Event|0|||
127747083|NCT03635086|459699905|FG001|Overall Study|Adverse Event|1|||
127747084|NCT03635086|459699906|FG002|Overall Study|Adverse Event|0|||
127747085|NCT03635086|459699907|FG003|Overall Study|Adverse Event|0|||
127747086|NCT03635086|459699908|FG004|Overall Study|Adverse Event|0|||
127747087|NCT03635086|459699904|FG000|Overall Study|Lost to Follow-up|1|||
127747088|NCT03635086|459699905|FG001|Overall Study|Lost to Follow-up|0|||
127747089|NCT03635086|459699906|FG002|Overall Study|Lost to Follow-up|0|||
127747090|NCT03635086|459699907|FG003|Overall Study|Lost to Follow-up|0|||
127747091|NCT03635086|459699908|FG004|Overall Study|Lost to Follow-up|0|||
127747092|NCT02196077|459699909|FG000|Overall Study|Adverse Event|4|||
127747093|NCT02196077|459699909|FG000|Overall Study|Lack of Efficacy|1|||
127747094|NCT02196077|459699909|FG000|Overall Study|Withdrawal by Subject|14|||
127747095|NCT02196077|459699909|FG000|Overall Study|Physician Decision|1|||
127747096|NCT02196077|459699909|FG000|Overall Study|Lost to Follow-up|3|||
127747097|NCT02196077|459699909|FG000|Overall Study|Protocol Violation|24|||
127747098|NCT02638103|459699925|FG000|Overall Study|Adverse Event|13|||
127747099|NCT02638103|459699926|FG001|Overall Study|Adverse Event|12|||
127747100|NCT02638103|459699927|FG002|Overall Study|Adverse Event|19|||
127747101|NCT02638103|459699928|FG003|Overall Study|Adverse Event|12|||
127747102|NCT02638103|459699925|FG000|Overall Study|Withdrawal by Subject|43|||
127747103|NCT02638103|459699926|FG001|Overall Study|Withdrawal by Subject|53|||
127747104|NCT02638103|459699927|FG002|Overall Study|Withdrawal by Subject|30|||
127747105|NCT02638103|459699928|FG003|Overall Study|Withdrawal by Subject|61|||
127747106|NCT02638103|459699925|FG000|Overall Study|Protocol Violation|1|||
127747107|NCT02638103|459699926|FG001|Overall Study|Protocol Violation|2|||
127747108|NCT02638103|459699927|FG002|Overall Study|Protocol Violation|1|||
127747109|NCT02638103|459699928|FG003|Overall Study|Protocol Violation|4|||
127747110|NCT02638103|459699925|FG000|Overall Study|Pregnancy|2|||
127747111|NCT02638103|459699926|FG001|Overall Study|Pregnancy|3|||
127747112|NCT02638103|459699927|FG002|Overall Study|Pregnancy|0|||
127747113|NCT02638103|459699928|FG003|Overall Study|Pregnancy|1|||
127747114|NCT02638103|459699925|FG000|Overall Study|Non-compliance to Study Procedures|2|||
127747115|NCT02638103|459699926|FG001|Overall Study|Non-compliance to Study Procedures|1|||
127747116|NCT02638103|459699927|FG002|Overall Study|Non-compliance to Study Procedures|1|||
127747117|NCT02638103|459699928|FG003|Overall Study|Non-compliance to Study Procedures|1|||
127747118|NCT02638103|459699925|FG000|Overall Study|Lost to Follow-up|26|||
127747119|NCT02638103|459699926|FG001|Overall Study|Lost to Follow-up|33|||
127747120|NCT02638103|459699927|FG002|Overall Study|Lost to Follow-up|20|||
127747121|NCT02638103|459699928|FG003|Overall Study|Lost to Follow-up|37|||
127747122|NCT02638103|459699925|FG000|Overall Study|Lack of Efficacy|14|||
127747123|NCT02638103|459699926|FG001|Overall Study|Lack of Efficacy|10|||
127747124|NCT02638103|459699927|FG002|Overall Study|Lack of Efficacy|12|||
127747125|NCT02638103|459699928|FG003|Overall Study|Lack of Efficacy|22|||
127747126|NCT02638103|459699925|FG000|Overall Study|Other than specified|5|||
127747127|NCT02638103|459699926|FG001|Overall Study|Other than specified|4|||
127747128|NCT02638103|459699927|FG002|Overall Study|Other than specified|2|||
127747129|NCT02638103|459699928|FG003|Overall Study|Other than specified|4|||
127747130|NCT02781311|459699930|FG000|Overall Study|Adverse Event|2|||
127747131|NCT02781311|459699931|FG001|Overall Study|Adverse Event|6|||
127747132|NCT02781311|459699932|FG002|Overall Study|Adverse Event|1|||
127747133|NCT02781311|459699930|FG000|Overall Study|Withdrawal of Consent|11|||
127747134|NCT02781311|459699931|FG001|Overall Study|Withdrawal of Consent|12|||
127747135|NCT02781311|459699932|FG002|Overall Study|Withdrawal of Consent|2|||
127747136|NCT02781311|459699930|FG000|Overall Study|Lost to Follow-up|11|||
127747137|NCT02781311|459699931|FG001|Overall Study|Lost to Follow-up|8|||
127747138|NCT02781311|459699932|FG002|Overall Study|Lost to Follow-up|1|||
127747139|NCT02781311|459699930|FG000|Overall Study|Non-Compliance with Study Drug|2|||
127747140|NCT02781311|459699931|FG001|Overall Study|Non-Compliance with Study Drug|0|||
127747141|NCT02781311|459699932|FG002|Overall Study|Non-Compliance with Study Drug|0|||
127747142|NCT01262092|459699935|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
127747143|NCT01262092|459699936|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
127747144|NCT01262092|459699935|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
127747145|NCT01262092|459699936|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
127747146|NCT01262092|459699935|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
127893988|NCT02711956|460235182|FG000|Overall Study|Clinical progression|1|||
127747147|NCT01262092|459699936|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
127747148|NCT01262092|459699935|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
127893989|NCT02711956|460235183|FG001|Overall Study|Clinical progression|0|||
127747149|NCT01262092|459699936|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
127747150|NCT04147858|459699937|FG000|Overall Study|Adverse Event|6|||
127747151|NCT04147858|459699938|FG001|Overall Study|Adverse Event|6|||
127747152|NCT04147858|459699939|FG002|Overall Study|Adverse Event|6|||
127747153|NCT04147858|459699937|FG000|Overall Study|Lack of Efficacy|3|||
127747154|NCT04147858|459699938|FG001|Overall Study|Lack of Efficacy|3|||
127747155|NCT04147858|459699939|FG002|Overall Study|Lack of Efficacy|1|||
127747156|NCT04147858|459699937|FG000|Overall Study|Lost to Follow-up|1|||
127747157|NCT04147858|459699938|FG001|Overall Study|Lost to Follow-up|6|||
127747158|NCT04147858|459699939|FG002|Overall Study|Lost to Follow-up|2|||
127747159|NCT04147858|459699937|FG000|Overall Study|Withdrawal by Subject|3|||
127747160|NCT04147858|459699938|FG001|Overall Study|Withdrawal by Subject|4|||
127747161|NCT04147858|459699939|FG002|Overall Study|Withdrawal by Subject|10|||
127747162|NCT04147858|459699937|FG000|Overall Study|Subject Noncompliance, Other|4|||
127747163|NCT04147858|459699938|FG001|Overall Study|Subject Noncompliance, Other|3|||
127747164|NCT04147858|459699939|FG002|Overall Study|Subject Noncompliance, Other|1|||
127747165|NCT03512197|459699942|FG000|Overall Study|Guardian decision|1|||
127747166|NCT03512197|459699943|FG001|Overall Study|Guardian decision|1|||
127747167|NCT03512197|459699942|FG000|Overall Study|Lack of Efficacy|19|||
127747168|NCT03512197|459699943|FG001|Overall Study|Lack of Efficacy|11|||
127747169|NCT03512197|459699942|FG000|Overall Study|New Therapy for Study Indication|16|||
127747170|NCT03512197|459699943|FG001|Overall Study|New Therapy for Study Indication|16|||
127747171|NCT03512197|459699942|FG000|Overall Study|Physician Decision|60|||
127747172|NCT03512197|459699943|FG001|Overall Study|Physician Decision|60|||
127747173|NCT03512197|459699942|FG000|Overall Study|Protocol Violation|0|||
127747174|NCT03512197|459699943|FG001|Overall Study|Protocol Violation|2|||
127747175|NCT03512197|459699942|FG000|Overall Study|Terminated by Sponsored|46|||
127747176|NCT03512197|459699943|FG001|Overall Study|Terminated by Sponsored|50|||
127747177|NCT03512197|459699942|FG000|Overall Study|Subject Decision|15|||
127747178|NCT03512197|459699943|FG001|Overall Study|Subject Decision|12|||
127747179|NCT03512197|459699942|FG000|Overall Study|Withdrawal of informed consent|20|||
127747180|NCT03512197|459699943|FG001|Overall Study|Withdrawal of informed consent|14|||
127747181|NCT03512197|459699942|FG000|Overall Study|Adverse Event|30|||
127747182|NCT03512197|459699943|FG001|Overall Study|Adverse Event|34|||
127747183|NCT03512197|459699942|FG000|Overall Study|Death|14|||
127747184|NCT03512197|459699943|FG001|Overall Study|Death|9|||
127747185|NCT03512197|459699942|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
127747186|NCT03512197|459699943|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
127747187|NCT03512197|459699942|FG000|Overall Study|Missing|3|||
127747188|NCT03512197|459699943|FG001|Overall Study|Missing|13|||
127747189|NCT03842436|459699944|FG000|Overall Study|Lost to Follow-up|1|||
127747190|NCT02201901|459699947|FG000|Overall Study|Randomized but never treated|0|||
127808386|NCT00486603|459917787|FG001|Overall Study|Physician Decision|1|||
127808387|NCT00486603|459917788|FG002|Overall Study|Physician Decision|0|||
127808388|NCT00486603|459917789|FG003|Overall Study|Physician Decision|0|||
127808389|NCT00486603|459917790|FG004|Overall Study|Physician Decision|0|||
127808390|NCT01670994|459917791|FG000|Overall Study|Disease Progression and Switched to Alternative Treatment|0|||
127808391|NCT01670994|459917792|FG001|Overall Study|Disease Progression and Switched to Alternative Treatment|1|||
127808392|NCT01670994|459917791|FG000|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|0|||
127808393|NCT01670994|459917792|FG001|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|1|||
127808394|NCT01670994|459917791|FG000|Overall Study|Patient experienced DLT|0|||
127808395|NCT01670994|459917792|FG001|Overall Study|Patient experienced DLT|1|||
127808396|NCT02013544|459917793|FG000|Overall Study|Adverse Event|5|||
127808397|NCT02013544|459917794|FG001|Overall Study|Adverse Event|5|||
127808398|NCT02013544|459917793|FG000|Overall Study|Lost to Follow-up|2|||
127808399|NCT02013544|459917794|FG001|Overall Study|Lost to Follow-up|3|||
127747191|NCT02201901|459699948|FG001|Overall Study|Randomized but never treated|1|||
127747192|NCT02201901|459699949|FG002|Overall Study|Randomized but never treated|0|||
127747193|NCT02201901|459699947|FG000|Overall Study|Lack of Efficacy|7|||
127747194|NCT02201901|459699948|FG001|Overall Study|Lack of Efficacy|1|||
127747195|NCT02201901|459699949|FG002|Overall Study|Lack of Efficacy|6|||
127747196|NCT02201901|459699947|FG000|Overall Study|Death|3|||
127747197|NCT02201901|459699948|FG001|Overall Study|Death|3|||
127747198|NCT02201901|459699949|FG002|Overall Study|Death|3|||
127747199|NCT02201901|459699947|FG000|Overall Study|Lost to Follow-up|2|||
127808400|NCT02013544|459917793|FG000|Overall Study|Withdrawal by Subject|2|||
127893990|NCT02711956|460235184|FG002|Overall Study|Clinical progression|0|||
127747200|NCT02201901|459699948|FG001|Overall Study|Lost to Follow-up|3|||
127747201|NCT02201901|459699949|FG002|Overall Study|Lost to Follow-up|2|||
127747202|NCT02201901|459699947|FG000|Overall Study|Withdrew Consent|2|||
127747203|NCT02201901|459699948|FG001|Overall Study|Withdrew Consent|0|||
127808401|NCT02013544|459917794|FG001|Overall Study|Withdrawal by Subject|8|||
127808402|NCT02013544|459917793|FG000|Overall Study|Physician Decision|0|||
127808403|NCT02013544|459917794|FG001|Overall Study|Physician Decision|1|||
127808404|NCT02013544|459917793|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
127808405|NCT02013544|459917794|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
127808406|NCT01295125|459917795|FG000|Overall Study|Study stopped prematurely|9|||
127808407|NCT00885365|459917798|FG000|4 Weeks ON Treatment|Adverse Event|2|||
127808408|NCT00885365|459917799|FG001|4 Weeks ON Treatment|Adverse Event|4|||
127808409|NCT00885365|459917798|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
127808410|NCT00885365|459917799|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
127808411|NCT00885365|459917798|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
127808412|NCT00885365|459917799|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
127808413|NCT01824979|459917800|FG000|Overall Study|Withdrawal by Subject|5|||
127808414|NCT01824979|459917801|FG001|Overall Study|Withdrawal by Subject|0|||
127808415|NCT01824979|459917800|FG000|Overall Study|Physician Decision|2|||
127808416|NCT01824979|459917801|FG001|Overall Study|Physician Decision|0|||
127808417|NCT01824979|459917800|FG000|Overall Study|Protocol Violation|6|||
127808418|NCT01824979|459917801|FG001|Overall Study|Protocol Violation|13|||
127808419|NCT00888238|459917803|FG000|Washout Period After Period 2|Adverse Event|0|||
127808420|NCT00888238|459917804|FG001|Washout Period After Period 2|Adverse Event|0|||
127808421|NCT00888238|459917805|FG002|Washout Period After Period 2|Adverse Event|1|||
127808422|NCT03371355|459917814|FG000|Overall Study|Investigator judgment|0|||
127808423|NCT03371355|459917815|FG001|Overall Study|Investigator judgment|0|||
127808424|NCT03371355|459917816|FG002|Overall Study|Investigator judgment|1|||
127808425|NCT03371355|459917817|FG003|Overall Study|Investigator judgment|1|||
127808426|NCT03371355|459917814|FG000|Overall Study|Voluntary withdrawal|1|||
127808427|NCT03371355|459917815|FG001|Overall Study|Voluntary withdrawal|0|||
127808428|NCT03371355|459917816|FG002|Overall Study|Voluntary withdrawal|1|||
127808429|NCT03371355|459917817|FG003|Overall Study|Voluntary withdrawal|2|||
127808430|NCT03371355|459917814|FG000|Overall Study|Adverse Event|0|||
127808431|NCT03371355|459917815|FG001|Overall Study|Adverse Event|1|||
127808432|NCT03371355|459917816|FG002|Overall Study|Adverse Event|2|||
127808433|NCT03371355|459917817|FG003|Overall Study|Adverse Event|3|||
127808434|NCT03371355|459917814|FG000|Overall Study|Reason not Specified|0|||
127808435|NCT03371355|459917815|FG001|Overall Study|Reason not Specified|1|||
127808436|NCT03371355|459917816|FG002|Overall Study|Reason not Specified|0|||
127808437|NCT03371355|459917817|FG003|Overall Study|Reason not Specified|1|||
127808438|NCT01662648|459917818|FG000|Overall Study|Death|1|||
127808439|NCT01662648|459917819|FG001|Overall Study|Death|3|||
127808440|NCT01662648|459917818|FG000|Overall Study|Adverse Event|40|||
127808441|NCT01662648|459917819|FG001|Overall Study|Adverse Event|37|||
127808442|NCT01662648|459917818|FG000|Overall Study|Lack of Efficacy|17|||
127808443|NCT01662648|459917819|FG001|Overall Study|Lack of Efficacy|16|||
127808444|NCT01662648|459917818|FG000|Overall Study|Participant ineligible to continue trial|1|||
127808445|NCT01662648|459917819|FG001|Overall Study|Participant ineligible to continue trial|1|||
127808446|NCT01662648|459917818|FG000|Overall Study|Lost to Follow-up|24|||
127808447|NCT01662648|459917819|FG001|Overall Study|Lost to Follow-up|36|||
127808448|NCT01662648|459917818|FG000|Overall Study|Withdrawal by Subject|36|||
127808449|NCT01662648|459917819|FG001|Overall Study|Withdrawal by Subject|53|||
127808450|NCT01662648|459917818|FG000|Overall Study|Participant non-compliant|16|||
127808451|NCT01662648|459917819|FG001|Overall Study|Participant non-compliant|20|||
127808452|NCT01662648|459917818|FG000|Overall Study|Other|8|||
127808453|NCT01662648|459917819|FG001|Overall Study|Other|11|||
127808454|NCT01662648|459917818|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
127808455|NCT01662648|459917819|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
127808456|NCT01662648|459917818|FG000|Overall Study|LOE and other reason unspecified|1|||
127808457|NCT01662648|459917819|FG001|Overall Study|LOE and other reason unspecified|0|||
127808458|NCT01662648|459917818|FG000|Overall Study|LOE and Participant non-compliant|0|||
127808459|NCT01662648|459917819|FG001|Overall Study|LOE and Participant non-compliant|1|||
127808460|NCT03751111|459917821|FG000|Overall Study|Lack of Efficacy|9|||
127893991|NCT02711956|460235185|FG003|Overall Study|Clinical progression|0|||
127893992|NCT02711956|460235186|FG004|Overall Study|Clinical progression|0|||
127893993|NCT02711956|460235187|FG005|Overall Study|Clinical progression|0|||
127893994|NCT02711956|460235188|FG006|Overall Study|Clinical progression|1|||
127893995|NCT02711956|460235189|FG007|Overall Study|Clinical progression|0|||
127893996|NCT02711956|460235190|FG008|Overall Study|Clinical progression|1|||
127893997|NCT02711956|460235191|FG009|Overall Study|Clinical progression|0|||
127808461|NCT03751111|459917822|FG001|Overall Study|Lack of Efficacy|30|||
127808462|NCT03751111|459917821|FG000|Overall Study|Adverse Event|3|||
127808463|NCT03751111|459917822|FG001|Overall Study|Adverse Event|2|||
127808464|NCT03308188|459917823|FG000|Overall Study|Withdrawal by Subject|0|||
127808465|NCT03308188|459917824|FG001|Overall Study|Withdrawal by Subject|3|||
127808466|NCT03308188|459917823|FG000|Overall Study|Death|0|||
127893998|NCT02711956|460235192|FG010|Overall Study|Clinical progression|0|||
127893999|NCT02711956|460235193|FG011|Overall Study|Clinical progression|2|||
127808467|NCT03308188|459917824|FG001|Overall Study|Death|1|||
127747204|NCT02201901|459699949|FG002|Overall Study|Withdrew Consent|2|||
127747205|NCT02201901|459699947|FG000|Overall Study|Adverse Event|1|||
127747206|NCT02201901|459699948|FG001|Overall Study|Adverse Event|1|||
127747207|NCT02201901|459699949|FG002|Overall Study|Adverse Event|0|||
127747208|NCT00490698|459699950|FG000|Overall Study|Withdrawal by Subject|1|||
127747209|NCT00490698|459699950|FG000|Overall Study|Disease Progression|7|||
127747210|NCT00490698|459699950|FG000|Overall Study|Physician Decision|2|||
127747211|NCT01431950|459699952|FG000|Overall Study|Study Site Closed/Terminated|7|||
127747212|NCT01431950|459699953|FG001|Overall Study|Study Site Closed/Terminated|3|||
127747213|NCT01431950|459699952|FG000|Overall Study|Withdrawal by Subject|4|||
127747214|NCT01431950|459699953|FG001|Overall Study|Withdrawal by Subject|3|||
127747215|NCT01431950|459699952|FG000|Overall Study|Protocol Violation|2|||
127747216|NCT01431950|459699953|FG001|Overall Study|Protocol Violation|3|||
127747217|NCT01431950|459699952|FG000|Overall Study|Adverse Event|2|||
127747218|NCT01431950|459699953|FG001|Overall Study|Adverse Event|2|||
127747219|NCT01431950|459699952|FG000|Overall Study|Physician Decision|2|||
127747220|NCT01431950|459699953|FG001|Overall Study|Physician Decision|1|||
127747221|NCT01431950|459699952|FG000|Overall Study|Lack of Efficacy|2|||
127747222|NCT01431950|459699953|FG001|Overall Study|Lack of Efficacy|1|||
127747223|NCT01431950|459699952|FG000|Overall Study|Lost to Follow-up|0|||
127747224|NCT01431950|459699953|FG001|Overall Study|Lost to Follow-up|1|||
127747225|NCT01431950|459699952|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
127747226|NCT01431950|459699953|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
127747227|NCT00966264|459701490|FG000|Overall Study|Lost to Follow-up|4|||
127747228|NCT00966264|459701491|FG001|Overall Study|Lost to Follow-up|3|||
127747229|NCT01246999|459701492|FG000|Overall Study|Lost to Follow-up|0|||
127747230|NCT01246999|459701493|FG001|Overall Study|Lost to Follow-up|1|||
127747231|NCT01246999|459701494|FG002|Overall Study|Lost to Follow-up|0|||
127747232|NCT01246999|459701495|FG003|Overall Study|Lost to Follow-up|0|||
127747233|NCT01246999|459701492|FG000|Overall Study|Withdrawal by Subject|0|||
127747234|NCT01246999|459701493|FG001|Overall Study|Withdrawal by Subject|0|||
127747235|NCT01246999|459701494|FG002|Overall Study|Withdrawal by Subject|0|||
127747236|NCT01246999|459701495|FG003|Overall Study|Withdrawal by Subject|2|||
127747237|NCT01867047|459701496|FG000|Overall Study|Lost to Follow-up|3|||
127747238|NCT01867047|459701497|FG001|Overall Study|Lost to Follow-up|3|||
127747239|NCT01867047|459701496|FG000|Overall Study|Withdrawal by Subject|2|||
127747240|NCT01867047|459701497|FG001|Overall Study|Withdrawal by Subject|0|||
127747241|NCT01867047|459701496|FG000|Overall Study|Physician Decision|2|||
127747242|NCT01867047|459701497|FG001|Overall Study|Physician Decision|0|||
127747243|NCT01867047|459701496|FG000|Overall Study|surgery not indicated in protocol|1|||
127747244|NCT01867047|459701497|FG001|Overall Study|surgery not indicated in protocol|2|||
127747245|NCT04596995|459701502|FG000|Overall Study|Lack of Efficacy|8|||
127747246|NCT04596995|459701502|FG000|Overall Study|Lost to Follow-up|3|||
127747247|NCT04596995|459701502|FG000|Overall Study|Withdrawal by Subject|12|||
127747248|NCT04596995|459701502|FG000|Overall Study|Sponsor decision|3|||
127747249|NCT04596995|459701502|FG000|Overall Study|Enrolled in managed access program|3|||
127747250|NCT00590564|459701504|FG000|Overall Study|Withdrawal by Subject|4|||
127747251|NCT00590564|459701504|FG000|Overall Study|Lost to Follow-up|6|||
127747252|NCT00590564|459701504|FG000|Overall Study|Protocol Violation|1|||
127808468|NCT00772447|459917825|FG000|Overall Study|Withdrawal by Subject|9|||
127808469|NCT00772447|459917826|FG001|Overall Study|Withdrawal by Subject|5|||
127808470|NCT00772447|459917825|FG000|Overall Study|Physician Decision|4|||
127808471|NCT00772447|459917826|FG001|Overall Study|Physician Decision|8|||
127808472|NCT00772447|459917825|FG000|Overall Study|Lost to Follow-up|2|||
127808473|NCT00772447|459917826|FG001|Overall Study|Lost to Follow-up|4|||
127808474|NCT00772447|459917825|FG000|Overall Study|incorrect enrolment|3|||
127808475|NCT00772447|459917826|FG001|Overall Study|incorrect enrolment|4|||
127747253|NCT00590564|459701504|FG000|Overall Study|Patient Found to be Ineligible|1|||
127747254|NCT00590564|459701504|FG000|Overall Study|Patient Non-compliance|6|||
127747255|NCT01434680|459701505|FG000|Overall Study|Withdrawal by Subject|1|||
127747256|NCT01434680|459701506|FG001|Overall Study|Withdrawal by Subject|0|||
127747257|NCT01434680|459701507|FG002|Overall Study|Withdrawal by Subject|2|||
127747258|NCT01434680|459701508|FG003|Overall Study|Withdrawal by Subject|0|||
127747259|NCT01434680|459701505|FG000|Overall Study|Lost to Follow-up|1|||
127747260|NCT01434680|459701506|FG001|Overall Study|Lost to Follow-up|1|||
127747261|NCT01434680|459701507|FG002|Overall Study|Lost to Follow-up|0|||
127747262|NCT01434680|459701508|FG003|Overall Study|Lost to Follow-up|0|||
127808476|NCT00772447|459917825|FG000|Overall Study|Protocol Violation|0|||
127747263|NCT01434680|459701505|FG000|Overall Study|Protocol Violation|1|||
127747264|NCT01434680|459701506|FG001|Overall Study|Protocol Violation|1|||
127808477|NCT00772447|459917826|FG001|Overall Study|Protocol Violation|1|||
127808478|NCT00772447|459917825|FG000|Overall Study|all others|2|||
127808479|NCT00772447|459917826|FG001|Overall Study|all others|2|||
127747265|NCT01434680|459701507|FG002|Overall Study|Protocol Violation|0|||
127747266|NCT01434680|459701508|FG003|Overall Study|Protocol Violation|0|||
127747267|NCT03020069|459701509|FG000|Overall Study|Lost to Follow-up|0|||
127747268|NCT03020069|459701510|FG001|Overall Study|Lost to Follow-up|1|||
127747269|NCT01439867|459701511|FG000|Overall Study|Non-compliance|0|||
127747270|NCT01439867|459701512|FG001|Overall Study|Non-compliance|1|||
127747271|NCT01439867|459701511|FG000|Overall Study|Withdrawal by Subject|1|||
127747272|NCT01439867|459701512|FG001|Overall Study|Withdrawal by Subject|2|||
127747273|NCT01439867|459701511|FG000|Overall Study|Administrative Decision|4|||
127747274|NCT01439867|459701512|FG001|Overall Study|Administrative Decision|5|||
127747275|NCT01439867|459701511|FG000|Overall Study|Protocol-specified Criteria|1|||
127747276|NCT01439867|459701512|FG001|Overall Study|Protocol-specified Criteria|0|||
127808480|NCT01957137|459917830|FG000|Randomized Portion|Adverse Event|1|||
127808481|NCT01957137|459917830|FG000|Randomized Portion|Withdrawal by Subject|1|||
127808482|NCT03529409|459917831|FG000|Randomized|Lost to Follow-up|0|||
127808483|NCT03529409|459917832|FG001|Randomized|Lost to Follow-up|0|||
127808484|NCT03529409|459917833|FG002|Randomized|Lost to Follow-up|4|||
127808485|NCT03529409|459917831|FG000|Randomized|Excluded|0|||
127808486|NCT03529409|459917832|FG001|Randomized|Excluded|0|||
127808487|NCT03529409|459917833|FG002|Randomized|Excluded|1|||
127808488|NCT03529409|459917831|FG000|Post-treatment Assessment|Death|1|||
127808489|NCT03529409|459917832|FG001|Post-treatment Assessment|Death|0|||
127808490|NCT03529409|459917833|FG002|Post-treatment Assessment|Death|0|||
127894000|NCT02711956|460235194|FG012|Overall Study|Clinical progression|4|||
127894001|NCT02711956|460235195|FG013|Overall Study|Clinical progression|1|||
127894002|NCT02711956|460235196|FG014|Overall Study|Clinical progression|1|||
127808491|NCT03529409|459917831|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
127808492|NCT03529409|459917832|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
127808493|NCT03529409|459917833|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
127808494|NCT03529409|459917831|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
127808495|NCT03529409|459917832|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
127808496|NCT03529409|459917833|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
127808497|NCT03529409|459917831|FG000|Follow-up Assessment|Death|1|||
127808498|NCT03529409|459917832|FG001|Follow-up Assessment|Death|0|||
127808499|NCT03529409|459917833|FG002|Follow-up Assessment|Death|0|||
127808500|NCT03529409|459917831|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
127808501|NCT03529409|459917832|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
127808502|NCT03529409|459917833|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
127808503|NCT01497262|459917834|FG000|Overall Study|Abnormal Lab Values|4|||
127808504|NCT01497262|459917834|FG000|Overall Study|Abnormal Test Procedure Result|1|||
127808505|NCT01497262|459917834|FG000|Overall Study|Physician Decision|1|||
127808506|NCT01497262|459917834|FG000|Overall Study|Withdrawal by Subject|2|||
127808507|NCT01497262|459917834|FG000|Overall Study|Adverse Event|2|||
127808508|NCT01497262|459917834|FG000|Overall Study|Protocol Violation|1|||
127808509|NCT02497001|459917837|FG000|Overall Study|Lost to Follow-up|10|||
127808510|NCT02497001|459917838|FG001|Overall Study|Lost to Follow-up|2|||
127808511|NCT02497001|459917839|FG002|Overall Study|Lost to Follow-up|0|||
127808512|NCT02497001|459917840|FG003|Overall Study|Lost to Follow-up|2|||
127808513|NCT02497001|459917837|FG000|Overall Study|Adverse Event|28|||
127808514|NCT02497001|459917838|FG001|Overall Study|Adverse Event|30|||
127808515|NCT02497001|459917839|FG002|Overall Study|Adverse Event|11|||
127808516|NCT02497001|459917840|FG003|Overall Study|Adverse Event|11|||
127808517|NCT02497001|459917837|FG000|Overall Study|Withdrawal by Subject|14|||
127808518|NCT02497001|459917838|FG001|Overall Study|Withdrawal by Subject|37|||
127808519|NCT02497001|459917839|FG002|Overall Study|Withdrawal by Subject|19|||
127808520|NCT02497001|459917840|FG003|Overall Study|Withdrawal by Subject|15|||
127808521|NCT02497001|459917837|FG000|Overall Study|Physician Decision|5|||
127894003|NCT02711956|460235182|FG000|Overall Study|Radiographic progression|1|||
127894004|NCT02711956|460235183|FG001|Overall Study|Radiographic progression|1|||
127894005|NCT02711956|460235184|FG002|Overall Study|Radiographic progression|2|||
127894006|NCT02711956|460235185|FG003|Overall Study|Radiographic progression|0|||
127894007|NCT02711956|460235186|FG004|Overall Study|Radiographic progression|1|||
127894008|NCT02711956|460235187|FG005|Overall Study|Radiographic progression|0|||
127747277|NCT02635360|459701513|FG000|Overall Study|Adverse Event|0|||
127747278|NCT02635360|459701514|FG001|Overall Study|Adverse Event|3|||
127747279|NCT02635360|459701513|FG000|Overall Study|Withdrawal by Subject|2|||
127808522|NCT02497001|459917838|FG001|Overall Study|Physician Decision|11|||
127808523|NCT02497001|459917839|FG002|Overall Study|Physician Decision|5|||
127808524|NCT02497001|459917840|FG003|Overall Study|Physician Decision|1|||
127808525|NCT02497001|459917837|FG000|Overall Study|subjects that were not treated|1|||
127894009|NCT02711956|460235188|FG006|Overall Study|Radiographic progression|0|||
127894010|NCT02711956|460235189|FG007|Overall Study|Radiographic progression|0|||
127747280|NCT02635360|459701514|FG001|Overall Study|Withdrawal by Subject|0|||
127747281|NCT02635360|459701513|FG000|Overall Study|Non-Compliance|3|||
127894011|NCT02711956|460235190|FG008|Overall Study|Radiographic progression|2|||
127747282|NCT02635360|459701514|FG001|Overall Study|Non-Compliance|1|||
127747283|NCT02635360|459701513|FG000|Overall Study|Disease Progression|0|||
127808526|NCT02497001|459917838|FG001|Overall Study|subjects that were not treated|2|||
127808527|NCT02497001|459917839|FG002|Overall Study|subjects that were not treated|2|||
127808528|NCT02497001|459917840|FG003|Overall Study|subjects that were not treated|1|||
127808529|NCT02497001|459917837|FG000|Overall Study|Major Protocol Deviation|3|||
127747284|NCT02635360|459701514|FG001|Overall Study|Disease Progression|2|||
127747285|NCT02635360|459701513|FG000|Overall Study|Lost to Follow-up|1|||
127747286|NCT02635360|459701514|FG001|Overall Study|Lost to Follow-up|1|||
127747287|NCT04978350|459701515|FG000|Overall Study|Lost to Follow-up|6|||
127747288|NCT00983749|459701518|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
127747289|NCT00983749|459701519|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
127747290|NCT01952847|459701520|FG000|Overall Study|Ineligible|1|||
127747291|NCT01952847|459701521|FG001|Overall Study|Ineligible|0|||
127747292|NCT01952847|459701522|FG002|Overall Study|Ineligible|0|||
127747293|NCT01952847|459701523|FG003|Overall Study|Ineligible|0|||
127747294|NCT01952847|459701520|FG000|Overall Study|Lack of Insurance Coverage|0|||
127747295|NCT01952847|459701521|FG001|Overall Study|Lack of Insurance Coverage|1|||
127747296|NCT01952847|459701522|FG002|Overall Study|Lack of Insurance Coverage|0|||
127747297|NCT01952847|459701523|FG003|Overall Study|Lack of Insurance Coverage|0|||
127747298|NCT01952847|459701520|FG000|Overall Study|Withdrawal by Subject|1|||
127747299|NCT01952847|459701521|FG001|Overall Study|Withdrawal by Subject|1|||
127747300|NCT01952847|459701522|FG002|Overall Study|Withdrawal by Subject|0|||
127747301|NCT01952847|459701523|FG003|Overall Study|Withdrawal by Subject|1|||
127747302|NCT01907906|459701524|FG000|Overall Study|Withdrawal by Subject|1|||
127747303|NCT01907906|459701525|FG001|Overall Study|Withdrawal by Subject|0|||
127747304|NCT01907906|459701524|FG000|Overall Study|Physician Decision|3|||
127747305|NCT01907906|459701525|FG001|Overall Study|Physician Decision|1|||
127747306|NCT00490945|459701527|FG000|Overall Study|Adverse Event|0|||
127747307|NCT00490945|459701528|FG001|Overall Study|Adverse Event|1|||
127747308|NCT00490945|459701529|FG002|Overall Study|Adverse Event|0|||
127747309|NCT00490945|459701530|FG003|Overall Study|Adverse Event|0|||
127747310|NCT00490945|459701531|FG004|Overall Study|Adverse Event|0|||
127747311|NCT03334253|459701532|FG000|Overall Study|Withdrawal by Subject|1|||
127747312|NCT03334253|459701533|FG001|Overall Study|Withdrawal by Subject|0|||
127747313|NCT03334253|459701532|FG000|Overall Study|Lost to Follow-up|4|||
127747314|NCT03334253|459701533|FG001|Overall Study|Lost to Follow-up|3|||
127747315|NCT03334253|459701532|FG000|Overall Study|Moved residence|2|||
127747316|NCT03334253|459701533|FG001|Overall Study|Moved residence|2|||
127747317|NCT00203047|459701534|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
127747318|NCT00203047|459701535|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
127747319|NCT00203047|459701534|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
127747320|NCT00203047|459701535|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
127747321|NCT00203047|459701534|FG000|Overall Study|Withdrawal by Subject|13|||
127747322|NCT00203047|459701535|FG001|Overall Study|Withdrawal by Subject|47|||
127747323|NCT00203047|459701534|FG000|Overall Study|Teva requested participant withdrawal|1|||
127747324|NCT00203047|459701535|FG001|Overall Study|Teva requested participant withdrawal|1|||
127747325|NCT00203047|459701534|FG000|Overall Study|Physician Decision|8|||
127747326|NCT00203047|459701535|FG001|Overall Study|Physician Decision|7|||
127747327|NCT00203047|459701534|FG000|Overall Study|Non-compliance|4|||
127747328|NCT00203047|459701535|FG001|Overall Study|Non-compliance|8|||
127747329|NCT00203047|459701534|FG000|Overall Study|Protocol Violation|1|||
127747330|NCT00203047|459701535|FG001|Overall Study|Protocol Violation|0|||
127747331|NCT00203047|459701534|FG000|Overall Study|Lost to Follow-up|11|||
127747332|NCT00203047|459701535|FG001|Overall Study|Lost to Follow-up|5|||
127747333|NCT00203047|459701534|FG000|Overall Study|Adverse Event|8|||
127808530|NCT02497001|459917838|FG001|Overall Study|Major Protocol Deviation|4|||
127808531|NCT02497001|459917839|FG002|Overall Study|Major Protocol Deviation|4|||
127808532|NCT02497001|459917840|FG003|Overall Study|Major Protocol Deviation|4|||
127808533|NCT02497001|459917837|FG000|Overall Study|Lack of Efficacy|10|||
127808534|NCT02497001|459917838|FG001|Overall Study|Lack of Efficacy|16|||
127808535|NCT02497001|459917839|FG002|Overall Study|Lack of Efficacy|6|||
127747334|NCT00203047|459701535|FG001|Overall Study|Adverse Event|18|||
127747335|NCT00203047|459701534|FG000|Overall Study|Death|1|||
127747336|NCT00203047|459701535|FG001|Overall Study|Death|2|||
127747337|NCT00203047|459701534|FG000|Overall Study|Pregnancy|3|||
127747338|NCT00203047|459701535|FG001|Overall Study|Pregnancy|0|||
127747339|NCT00203047|459701534|FG000|Overall Study|Other|5|||
127747340|NCT00203047|459701535|FG001|Overall Study|Other|5|||
127747341|NCT00340704|459701538|FG000|PK Study|Adverse Event|0|||
127747342|NCT00340704|459701539|FG001|PK Study|Adverse Event|1|||
127747343|NCT00340704|459701540|FG002|PK Study|Adverse Event|0|||
127747344|NCT00340704|459701541|FG003|PK Study|Adverse Event|0|||
127747345|NCT00340704|459701542|FG004|PK Study|Adverse Event|0|||
127747346|NCT00340704|459701543|FG005|PK Study|Adverse Event|0|||
127747347|NCT00340704|459701544|FG006|PK Study|Adverse Event|0|||
127747348|NCT00340704|459701545|FG007|PK Study|Adverse Event|0|||
127747349|NCT00340704|459701546|FG008|PK Study|Adverse Event|0|||
127747350|NCT00340704|459701538|FG000|PK Study|Not treated|0|||
127747351|NCT00340704|459701539|FG001|PK Study|Not treated|0|||
127747352|NCT00340704|459701540|FG002|PK Study|Not treated|1|||
127747353|NCT00340704|459701541|FG003|PK Study|Not treated|0|||
127747354|NCT00340704|459701542|FG004|PK Study|Not treated|0|||
127747355|NCT00340704|459701543|FG005|PK Study|Not treated|0|||
127747356|NCT00340704|459701544|FG006|PK Study|Not treated|0|||
127747357|NCT00340704|459701545|FG007|PK Study|Not treated|0|||
127747358|NCT00340704|459701546|FG008|PK Study|Not treated|0|||
127747359|NCT00340704|459701538|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
127747360|NCT00340704|459701539|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
127747361|NCT00340704|459701540|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
127747362|NCT00340704|459701541|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
127747363|NCT00340704|459701542|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
127747364|NCT00340704|459701543|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
127747365|NCT00340704|459701544|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
127747366|NCT00340704|459701545|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
127747367|NCT00340704|459701546|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
127747368|NCT00340704|459701538|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
127747369|NCT00340704|459701539|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
127747370|NCT00340704|459701540|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
127747371|NCT00340704|459701541|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
127747372|NCT00340704|459701542|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
127747373|NCT00340704|459701543|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
127747374|NCT00340704|459701544|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
127747375|NCT00340704|459701545|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
127747376|NCT00340704|459701546|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
127747377|NCT00340704|459701538|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
127747378|NCT00340704|459701539|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
127747379|NCT00340704|459701540|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
127747380|NCT00340704|459701541|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
127747381|NCT00340704|459701542|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
127747382|NCT00340704|459701543|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
127747383|NCT00340704|459701544|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
127747384|NCT00340704|459701545|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
127747385|NCT00340704|459701546|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
127747386|NCT00340704|459701538|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
127747387|NCT00340704|459701539|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
127747388|NCT00340704|459701540|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
127747389|NCT00340704|459701541|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
127747390|NCT00340704|459701542|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
127747391|NCT00340704|459701543|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
127747392|NCT00340704|459701544|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
127747393|NCT00340704|459701545|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
127747394|NCT00340704|459701546|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
127747395|NCT00121667|459701547|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
127747396|NCT00121667|459701548|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
127747397|NCT00121667|459701549|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
127747398|NCT00121667|459701550|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
127747399|NCT00121667|459701547|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
127747400|NCT00121667|459701548|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
127747401|NCT00121667|459701549|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
127747402|NCT00121667|459701550|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
127747403|NCT00121667|459701547|FG000|Short Term (ST) Period|Adverse Event|5|||
127747404|NCT00121667|459701548|FG001|Short Term (ST) Period|Adverse Event|6|||
127747405|NCT00121667|459701549|FG002|Short Term (ST) Period|Adverse Event|5|||
127747406|NCT00121667|459701550|FG003|Short Term (ST) Period|Adverse Event|3|||
127747407|NCT00121667|459701547|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
127747408|NCT00121667|459701548|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
127747409|NCT00121667|459701549|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
127747410|NCT00121667|459701550|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
127747411|NCT00121667|459701547|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
127747412|NCT00121667|459701548|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
127747413|NCT00121667|459701549|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
127747414|NCT00121667|459701550|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
127747415|NCT00121667|459701547|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
127747416|NCT00121667|459701548|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
127747417|NCT00121667|459701549|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
127747418|NCT00121667|459701550|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
127747419|NCT00121667|459701547|FG000|Short Term (ST) Period|Other Reason|3|||
127747420|NCT00121667|459701548|FG001|Short Term (ST) Period|Other Reason|0|||
127747421|NCT00121667|459701549|FG002|Short Term (ST) Period|Other Reason|0|||
127747422|NCT00121667|459701550|FG003|Short Term (ST) Period|Other Reason|0|||
127747423|NCT00121667|459701547|FG000|Short Term (ST) Period|Death|0|||
127894012|NCT02711956|460235191|FG009|Overall Study|Radiographic progression|1|||
127894013|NCT02711956|460235192|FG010|Overall Study|Radiographic progression|0|||
127894014|NCT02711956|460235193|FG011|Overall Study|Radiographic progression|5|||
127894015|NCT02711956|460235194|FG012|Overall Study|Radiographic progression|3|||
127747424|NCT00121667|459701548|FG001|Short Term (ST) Period|Death|0|||
127747425|NCT00121667|459701549|FG002|Short Term (ST) Period|Death|0|||
127747426|NCT00121667|459701550|FG003|Short Term (ST) Period|Death|1|||
127747427|NCT00121667|459701547|FG000|Short Term (ST) Period|Pregnancy|0|||
127747428|NCT00121667|459701548|FG001|Short Term (ST) Period|Pregnancy|0|||
127747429|NCT00121667|459701549|FG002|Short Term (ST) Period|Pregnancy|0|||
127747430|NCT00121667|459701550|FG003|Short Term (ST) Period|Pregnancy|1|||
127747431|NCT00121667|459701547|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
127747432|NCT00121667|459701548|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
127747433|NCT00121667|459701549|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
127747434|NCT00121667|459701550|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
127747435|NCT00121667|459701547|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
127747436|NCT00121667|459701548|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
127747437|NCT00121667|459701549|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
127747438|NCT00121667|459701550|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
127747439|NCT00121667|459701547|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
127747440|NCT00121667|459701548|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
127747441|NCT00121667|459701549|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
127747442|NCT00121667|459701550|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
127747443|NCT00121667|459701547|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
127747444|NCT00121667|459701548|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
127747445|NCT00121667|459701549|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
127747446|NCT00121667|459701550|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
127747447|NCT00121667|459701547|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
127747448|NCT00121667|459701548|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
127747449|NCT00121667|459701549|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
127747450|NCT00121667|459701550|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
127747451|NCT00121667|459701547|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
127747452|NCT00121667|459701548|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
127747453|NCT00121667|459701549|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
127747454|NCT00121667|459701550|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
127747455|NCT00121667|459701547|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
127747456|NCT00121667|459701548|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
127747457|NCT00121667|459701549|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
127747458|NCT00121667|459701550|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
127747459|NCT00121667|459701547|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
127747460|NCT00121667|459701548|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
127747461|NCT00121667|459701549|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
127747462|NCT00121667|459701550|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
127747463|NCT00121667|459701547|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
127747464|NCT00121667|459701548|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
127747465|NCT00121667|459701549|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
127747466|NCT00121667|459701550|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
127747467|NCT01453023|459701551|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
127747468|NCT01453023|459701552|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
127747469|NCT01453023|459701551|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
127747470|NCT01453023|459701552|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
127747471|NCT01453023|459701551|FG000|Treatment Period 2|Protocol Violation|0|||
127747472|NCT01453023|459701552|FG001|Treatment Period 2|Protocol Violation|1|||
127747473|NCT02879383|459701553|FG000|First 24 Weeks|Physician Decision|0|||
127747474|NCT02879383|459701554|FG001|First 24 Weeks|Physician Decision|1|||
127747475|NCT02879383|459701555|FG002|First 24 Weeks|Physician Decision|0|||
127747476|NCT02879383|459701556|FG003|First 24 Weeks|Physician Decision|0|||
127747477|NCT02413593|459701570|FG000|Overall Study|Lost to Follow-up|3|||
127747478|NCT02413593|459701570|FG000|Overall Study|Adverse Event|1|||
127747479|NCT00723125|459701571|FG000|Overall Study|Met Dx|1|||
127747480|NCT00723125|459701572|FG001|Overall Study|Met Dx|0|||
127747481|NCT00723125|459701571|FG000|Overall Study|Withdrawal by Subject|15|||
127747482|NCT00723125|459701572|FG001|Overall Study|Withdrawal by Subject|6|||
127747483|NCT00723125|459701571|FG000|Overall Study|Adverse Event|2|||
127747484|NCT00723125|459701572|FG001|Overall Study|Adverse Event|0|||
127747485|NCT00003477|459701573|FG000|Overall Study|Not evalauable|4|||
127747486|NCT01575873|459701574|FG000|Overall Study|Withdrawal by Subject|15|||
127747487|NCT01575873|459701575|FG001|Overall Study|Withdrawal by Subject|20|||
127747488|NCT01575873|459701576|FG002|Overall Study|Withdrawal by Subject|34|||
127747489|NCT01575873|459701577|FG003|Overall Study|Withdrawal by Subject|34|||
127808536|NCT02497001|459917840|FG003|Overall Study|Lack of Efficacy|6|||
127808537|NCT02497001|459917837|FG000|Overall Study|Protocol Violation|3|||
127808538|NCT02497001|459917838|FG001|Overall Study|Protocol Violation|1|||
127808539|NCT02497001|459917839|FG002|Overall Study|Protocol Violation|3|||
127808540|NCT02497001|459917840|FG003|Overall Study|Protocol Violation|1|||
127808541|NCT03898063|459917841|FG000|Overall Study|Withdrawal by Subject|10|||
127808542|NCT03898063|459917842|FG001|Overall Study|Withdrawal by Subject|8|||
127808543|NCT00054132|459917843|FG000|Overall Study|Not Treated|1|||
127808544|NCT02949830|459917844|FG000|Overall Study|Adverse Event|1|||
127808545|NCT02949830|459917844|FG000|Overall Study|Withdrawal by Subject|1|||
127808546|NCT01290887|459917845|FG000|Overall Study|Adverse Event|6|||
127808547|NCT01290887|459917846|FG001|Overall Study|Adverse Event|11|||
127808548|NCT01290887|459917845|FG000|Overall Study|Lack of Efficacy|4|||
127808549|NCT01290887|459917846|FG001|Overall Study|Lack of Efficacy|5|||
127808550|NCT01290887|459917845|FG000|Overall Study|Withdrawal by Subject|26|||
127808551|NCT01290887|459917846|FG001|Overall Study|Withdrawal by Subject|32|||
127808552|NCT01290887|459917845|FG000|Overall Study|Protocol Violation|2|||
127808553|NCT01290887|459917846|FG001|Overall Study|Protocol Violation|1|||
127808554|NCT01290887|459917845|FG000|Overall Study|Lost to Follow-up|4|||
127808555|NCT01290887|459917846|FG001|Overall Study|Lost to Follow-up|4|||
127808556|NCT01290887|459917845|FG000|Overall Study|Non-compliance to study procedures|0|||
127808557|NCT01290887|459917846|FG001|Overall Study|Non-compliance to study procedures|1|||
127808558|NCT01290887|459917845|FG000|Overall Study|Non-compliance to study medications|1|||
127808559|NCT01290887|459917846|FG001|Overall Study|Non-compliance to study medications|0|||
127808560|NCT01290887|459917845|FG000|Overall Study|Sponsor closure of study|420|||
127808561|NCT01290887|459917846|FG001|Overall Study|Sponsor closure of study|476|||
127808562|NCT01290887|459917845|FG000|Overall Study|Other|3|||
127808563|NCT01290887|459917846|FG001|Overall Study|Other|6|||
127808564|NCT01795547|459917847|FG000|Overall Study|Adverse Event|16|||
127808565|NCT01795547|459917848|FG001|Overall Study|Adverse Event|27|||
127808566|NCT01795547|459917847|FG000|Overall Study|Lack of Efficacy|8|||
127808567|NCT01795547|459917848|FG001|Overall Study|Lack of Efficacy|3|||
127808568|NCT01795547|459917847|FG000|Overall Study|Protocol Violation|6|||
127808569|NCT01795547|459917848|FG001|Overall Study|Protocol Violation|4|||
127808570|NCT01795547|459917847|FG000|Overall Study|Lost to Follow-up|2|||
127808571|NCT01795547|459917848|FG001|Overall Study|Lost to Follow-up|5|||
127808572|NCT01795547|459917847|FG000|Overall Study|Withdrawal of consent|7|||
127808573|NCT01795547|459917848|FG001|Overall Study|Withdrawal of consent|12|||
127808574|NCT01795547|459917847|FG000|Overall Study|Not Treated|4|||
127808575|NCT01795547|459917848|FG001|Overall Study|Not Treated|10|||
127808576|NCT01795547|459917847|FG000|Overall Study|Non-compliance with IMP|1|||
127808577|NCT01795547|459917848|FG001|Overall Study|Non-compliance with IMP|1|||
127808578|NCT01795547|459917847|FG000|Overall Study|Others|4|||
127808579|NCT01795547|459917848|FG001|Overall Study|Others|1|||
127808580|NCT01795547|459917847|FG000|Overall Study|Not stated|0|||
127808581|NCT01795547|459917848|FG001|Overall Study|Not stated|1|||
127808582|NCT01551745|459917849|FG000|Overall Study|Withdrawal by Subject|1|||
127808583|NCT01551745|459917849|FG000|Overall Study|Disease Progression|2|||
127808584|NCT04752384|459917850|FG000|Overall Study|Withdrawal by Subject|1|||
127808585|NCT04752384|459917850|FG000|Overall Study|Death|1|||
127808586|NCT02330419|459917852|FG000|Overall Study|Lost to Follow-up|3|||
127808587|NCT02330419|459917853|FG001|Overall Study|Lost to Follow-up|7|||
127808588|NCT01813890|459917856|FG000|Overall Study|Adverse Event|0|||
127808589|NCT01813890|459917857|FG001|Overall Study|Adverse Event|3|||
127808590|NCT01813890|459917858|FG002|Overall Study|Adverse Event|4|||
127808591|NCT01813890|459917856|FG000|Overall Study|Lack of Efficacy|9|||
127808592|NCT01813890|459917857|FG001|Overall Study|Lack of Efficacy|1|||
127808593|NCT01813890|459917858|FG002|Overall Study|Lack of Efficacy|2|||
127808594|NCT03952559|459917859|FG000|Double Blind Treatment Period|Adverse Event|0|||
127808595|NCT03952559|459917860|FG001|Double Blind Treatment Period|Adverse Event|2|||
127808596|NCT03952559|459917861|FG002|Double Blind Treatment Period|Adverse Event|1|||
127808597|NCT03952559|459917862|FG003|Double Blind Treatment Period|Adverse Event|0|||
127808598|NCT03952559|459917863|FG004|Double Blind Treatment Period|Adverse Event|1|||
127808599|NCT03952559|459917859|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
127808600|NCT03952559|459917860|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
127808601|NCT03952559|459917861|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
127808602|NCT03952559|459917862|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
127808603|NCT03952559|459917863|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
127808604|NCT03952559|459917859|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
127808605|NCT03952559|459917860|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
127808606|NCT03952559|459917861|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
127808607|NCT03952559|459917862|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
127808608|NCT03952559|459917863|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
127808609|NCT03952559|459917859|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
127808610|NCT03952559|459917860|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
127808611|NCT03952559|459917861|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
127808612|NCT03952559|459917862|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
127747490|NCT01575873|459701574|FG000|Overall Study|Adverse Event|7|||
127747491|NCT01575873|459701575|FG001|Overall Study|Adverse Event|7|||
127747492|NCT01575873|459701576|FG002|Overall Study|Adverse Event|9|||
127747493|NCT01575873|459701577|FG003|Overall Study|Adverse Event|12|||
127747494|NCT01575873|459701574|FG000|Overall Study|Lost to Follow-up|1|||
127747495|NCT01575873|459701575|FG001|Overall Study|Lost to Follow-up|3|||
127747496|NCT01575873|459701576|FG002|Overall Study|Lost to Follow-up|13|||
127747497|NCT01575873|459701577|FG003|Overall Study|Lost to Follow-up|5|||
127747498|NCT01575873|459701574|FG000|Overall Study|Death|3|||
127747499|NCT01575873|459701575|FG001|Overall Study|Death|2|||
127747500|NCT01575873|459701576|FG002|Overall Study|Death|8|||
127747501|NCT01575873|459701577|FG003|Overall Study|Death|9|||
127747502|NCT01575873|459701574|FG000|Overall Study|Noncompliance|1|||
127747503|NCT01575873|459701575|FG001|Overall Study|Noncompliance|2|||
127747504|NCT01575873|459701576|FG002|Overall Study|Noncompliance|4|||
127747505|NCT01575873|459701577|FG003|Overall Study|Noncompliance|3|||
127747506|NCT01575873|459701574|FG000|Overall Study|Administrative decision|1|||
127747507|NCT01575873|459701575|FG001|Overall Study|Administrative decision|1|||
127747508|NCT01575873|459701576|FG002|Overall Study|Administrative decision|1|||
127747509|NCT01575873|459701577|FG003|Overall Study|Administrative decision|0|||
127747510|NCT01575873|459701574|FG000|Overall Study|Protocol deviation|0|||
127747511|NCT01575873|459701575|FG001|Overall Study|Protocol deviation|1|||
127747512|NCT01575873|459701576|FG002|Overall Study|Protocol deviation|0|||
127747513|NCT01575873|459701577|FG003|Overall Study|Protocol deviation|1|||
127747514|NCT01575873|459701574|FG000|Overall Study|Requirement for Alternative Therapy|0|||
127747515|NCT01575873|459701575|FG001|Overall Study|Requirement for Alternative Therapy|0|||
127747516|NCT01575873|459701576|FG002|Overall Study|Requirement for Alternative Therapy|1|||
127747517|NCT01575873|459701577|FG003|Overall Study|Requirement for Alternative Therapy|1|||
127747518|NCT01575873|459701574|FG000|Overall Study|Other|0|||
127747519|NCT01575873|459701575|FG001|Overall Study|Other|0|||
127747520|NCT01575873|459701576|FG002|Overall Study|Other|4|||
127808613|NCT03952559|459917863|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
127808614|NCT01870739|459917866|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
127808615|NCT01870739|459917867|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
127808616|NCT01870739|459917866|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
127808617|NCT01870739|459917867|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
127808618|NCT01870739|459917866|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
127808619|NCT01870739|459917867|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
127808620|NCT01870739|459917866|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
127808621|NCT01870739|459917867|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
127808622|NCT01870739|459917866|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
127808623|NCT01870739|459917867|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
127808624|NCT01870739|459917866|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
127808625|NCT01870739|459917867|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
127808626|NCT01870739|459917866|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
127808627|NCT01870739|459917867|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
127808628|NCT01986062|459917868|FG000|Overall Study|Lost to Follow-up|1|||
127808629|NCT01986062|459917869|FG001|Overall Study|Lost to Follow-up|0|||
127808630|NCT01986062|459917868|FG000|Overall Study|Withdrawal by Subject|0|||
127808631|NCT01986062|459917869|FG001|Overall Study|Withdrawal by Subject|1|||
127808632|NCT03538743|459917870|FG000|Overall Study|Adverse Event|0|||
127808633|NCT03538743|459917871|FG001|Overall Study|Adverse Event|0|||
127808634|NCT03538743|459917872|FG002|Overall Study|Adverse Event|1|||
127808635|NCT03538743|459917873|FG003|Overall Study|Adverse Event|1|||
127808636|NCT03538743|459917874|FG004|Overall Study|Adverse Event|0|||
127808637|NCT03538743|459917875|FG005|Overall Study|Adverse Event|0|||
127808638|NCT03538743|459917876|FG006|Overall Study|Adverse Event|0|||
127747521|NCT01575873|459701577|FG003|Overall Study|Other|2|||
127747522|NCT00965497|459701578|FG000|Overall Study|Physician Decision|1|||
127747523|NCT00246090|459701583|FG000|Overall Study|Adverse Event|25|||
127747524|NCT00246090|459701583|FG000|Overall Study|Withdrawal by Subject|7|||
127747525|NCT00246090|459701583|FG000|Overall Study|Progressive Disease|212|||
127747526|NCT00246090|459701583|FG000|Overall Study|Clinical Progression|30|||
127747527|NCT00246090|459701583|FG000|Overall Study|Physician Decision|11|||
127747528|NCT00246090|459701583|FG000|Overall Study|Not Otherwise Specified|10|||
127747529|NCT01299480|459701584|FG000|Overall Study|No longer willing to participate|19|||
127747530|NCT01299480|459701585|FG001|Overall Study|No longer willing to participate|17|||
127747531|NCT01299480|459701586|FG002|Overall Study|No longer willing to participate|14|||
127747532|NCT01299480|459701587|FG003|Overall Study|No longer willing to participate|13|||
127747533|NCT01299480|459701588|FG004|Overall Study|No longer willing to participate|10|||
127747534|NCT01299480|459701584|FG000|Overall Study|Protocol Violation|7|||
127747535|NCT01299480|459701585|FG001|Overall Study|Protocol Violation|5|||
127747536|NCT01299480|459701586|FG002|Overall Study|Protocol Violation|8|||
127808639|NCT03538743|459917877|FG007|Overall Study|Adverse Event|0|||
127808640|NCT03538743|459917878|FG008|Overall Study|Adverse Event|0|||
127808641|NCT03538743|459917870|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
127808642|NCT03538743|459917871|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
127808643|NCT03538743|459917872|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
127808644|NCT03538743|459917873|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
127808645|NCT03538743|459917874|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
127808646|NCT03538743|459917875|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
127808647|NCT03538743|459917876|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
127808648|NCT03538743|459917877|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
127808649|NCT03538743|459917878|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
127808650|NCT03538743|459917870|FG000|Overall Study|Withdrawal by Subject|0|||
127747537|NCT01299480|459701587|FG003|Overall Study|Protocol Violation|1|||
127747538|NCT01299480|459701588|FG004|Overall Study|Protocol Violation|1|||
127747539|NCT01299480|459701584|FG000|Overall Study|Withdrawal by Subject|3|||
127747540|NCT01299480|459701585|FG001|Overall Study|Withdrawal by Subject|4|||
127747541|NCT01299480|459701586|FG002|Overall Study|Withdrawal by Subject|7|||
127747542|NCT01299480|459701587|FG003|Overall Study|Withdrawal by Subject|3|||
127747543|NCT01299480|459701588|FG004|Overall Study|Withdrawal by Subject|4|||
127747544|NCT01299480|459701584|FG000|Overall Study|Adverse Event|6|||
127747545|NCT01299480|459701585|FG001|Overall Study|Adverse Event|4|||
127747546|NCT01299480|459701586|FG002|Overall Study|Adverse Event|5|||
127747547|NCT01299480|459701587|FG003|Overall Study|Adverse Event|4|||
127747548|NCT01299480|459701588|FG004|Overall Study|Adverse Event|0|||
127747549|NCT01299480|459701584|FG000|Overall Study|Withdrawal due to pregnancy|0|||
127747550|NCT01299480|459701585|FG001|Overall Study|Withdrawal due to pregnancy|1|||
127747551|NCT01299480|459701586|FG002|Overall Study|Withdrawal due to pregnancy|1|||
127747552|NCT01299480|459701587|FG003|Overall Study|Withdrawal due to pregnancy|0|||
127747553|NCT01299480|459701588|FG004|Overall Study|Withdrawal due to pregnancy|0|||
127747554|NCT01299480|459701584|FG000|Overall Study|Physician Decision|1|||
127747555|NCT01299480|459701585|FG001|Overall Study|Physician Decision|1|||
127747556|NCT01299480|459701586|FG002|Overall Study|Physician Decision|0|||
127747557|NCT01299480|459701587|FG003|Overall Study|Physician Decision|2|||
127808651|NCT03538743|459917871|FG001|Overall Study|Withdrawal by Subject|0|||
127808652|NCT03538743|459917872|FG002|Overall Study|Withdrawal by Subject|0|||
127808653|NCT03538743|459917873|FG003|Overall Study|Withdrawal by Subject|1|||
127808654|NCT03538743|459917874|FG004|Overall Study|Withdrawal by Subject|0|||
127808655|NCT03538743|459917875|FG005|Overall Study|Withdrawal by Subject|0|||
127808656|NCT03538743|459917876|FG006|Overall Study|Withdrawal by Subject|0|||
127808657|NCT03538743|459917877|FG007|Overall Study|Withdrawal by Subject|0|||
127808658|NCT03538743|459917878|FG008|Overall Study|Withdrawal by Subject|0|||
127808659|NCT00630331|459917879|FG000|Overall Study|Death|2|||
127808660|NCT00630331|459917880|FG001|Overall Study|Death|1|||
127808661|NCT00630331|459917881|FG002|Overall Study|Death|1|||
127808662|NCT00630331|459917879|FG000|Overall Study|Adverse Event|1|||
127808663|NCT00630331|459917880|FG001|Overall Study|Adverse Event|0|||
127808664|NCT00630331|459917881|FG002|Overall Study|Adverse Event|0|||
127808665|NCT00630331|459917879|FG000|Overall Study|Withdrawal by Subject|12|||
127808666|NCT00630331|459917880|FG001|Overall Study|Withdrawal by Subject|7|||
127808667|NCT00630331|459917881|FG002|Overall Study|Withdrawal by Subject|5|||
127808668|NCT00630331|459917879|FG000|Overall Study|Lost to Follow-up|175|||
127808669|NCT00630331|459917880|FG001|Overall Study|Lost to Follow-up|143|||
127808670|NCT00630331|459917881|FG002|Overall Study|Lost to Follow-up|170|||
127808671|NCT00630331|459917879|FG000|Overall Study|Inappropriate enrollment|3|||
127808672|NCT00630331|459917880|FG001|Overall Study|Inappropriate enrollment|6|||
127808673|NCT00630331|459917881|FG002|Overall Study|Inappropriate enrollment|3|||
127808674|NCT00630331|459917879|FG000|Overall Study|Unable to classify|9|||
127808675|NCT00630331|459917880|FG001|Overall Study|Unable to classify|4|||
127808676|NCT00630331|459917881|FG002|Overall Study|Unable to classify|3|||
127747558|NCT01299480|459701588|FG004|Overall Study|Physician Decision|0|||
127808677|NCT00630331|459917879|FG000|Overall Study|Protocol Violation|4|||
127808678|NCT00630331|459917880|FG001|Overall Study|Protocol Violation|5|||
127808679|NCT00630331|459917881|FG002|Overall Study|Protocol Violation|6|||
127808680|NCT04640766|459917882|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
127747559|NCT01299480|459701584|FG000|Overall Study|Lost to Follow-up|3|||
127747560|NCT01299480|459701585|FG001|Overall Study|Lost to Follow-up|1|||
127747561|NCT01299480|459701586|FG002|Overall Study|Lost to Follow-up|2|||
127747562|NCT01299480|459701587|FG003|Overall Study|Lost to Follow-up|1|||
127808681|NCT01827384|459917883|FG000|Overall Study|Switched to alternative treatment|0|||
127808682|NCT01827384|459917884|FG001|Overall Study|Switched to alternative treatment|0|||
127808683|NCT01827384|459917885|FG002|Overall Study|Switched to alternative treatment|0|||
127808684|NCT01827384|459917886|FG003|Overall Study|Switched to alternative treatment|0|||
127808685|NCT01827384|459917887|FG004|Overall Study|Switched to alternative treatment|0|||
127808686|NCT01827384|459917888|FG005|Overall Study|Switched to alternative treatment|0|||
127747563|NCT01299480|459701588|FG004|Overall Study|Lost to Follow-up|2|||
127747564|NCT01299480|459701584|FG000|Overall Study|Other|3|||
127747565|NCT01299480|459701585|FG001|Overall Study|Other|2|||
127747566|NCT01299480|459701586|FG002|Overall Study|Other|3|||
127747567|NCT01299480|459701587|FG003|Overall Study|Other|0|||
127747568|NCT01299480|459701588|FG004|Overall Study|Other|3|||
127747569|NCT01299480|459701584|FG000|Overall Study|Started, but not vaccinated|0|||
127747570|NCT01299480|459701585|FG001|Overall Study|Started, but not vaccinated|0|||
127747571|NCT01299480|459701586|FG002|Overall Study|Started, but not vaccinated|1|||
127747572|NCT01299480|459701587|FG003|Overall Study|Started, but not vaccinated|1|||
127747573|NCT01299480|459701588|FG004|Overall Study|Started, but not vaccinated|0|||
127747574|NCT02296892|459701595|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
127747575|NCT02296892|459701596|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
127747576|NCT02296892|459701597|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
127747577|NCT02296892|459701595|FG000|Overall Study|Lost to Follow-up|5|||
127747578|NCT02296892|459701596|FG001|Overall Study|Lost to Follow-up|0|||
127747579|NCT02296892|459701597|FG002|Overall Study|Lost to Follow-up|1|||
127747580|NCT02165826|459701599|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
127747581|NCT02165826|459701600|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
127747582|NCT02165826|459701601|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
127747583|NCT02165826|459701599|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
127747584|NCT02165826|459701600|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
127747585|NCT02165826|459701601|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
127747586|NCT02165826|459701599|FG000|Main Treatment Period|Lost to Follow-up|4|||
127747587|NCT02165826|459701600|FG001|Main Treatment Period|Lost to Follow-up|2|||
127747588|NCT02165826|459701601|FG002|Main Treatment Period|Lost to Follow-up|1|||
127747589|NCT02165826|459701599|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
127747590|NCT02165826|459701600|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
127747591|NCT02165826|459701601|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
127747592|NCT02165826|459701599|FG000|Main Treatment Period|Lack of Efficacy|2|||
127747593|NCT02165826|459701600|FG001|Main Treatment Period|Lack of Efficacy|0|||
127747594|NCT02165826|459701601|FG002|Main Treatment Period|Lack of Efficacy|0|||
127747595|NCT02165826|459701599|FG000|Main Treatment Period|Reason Not Specified|8|||
127747596|NCT02165826|459701600|FG001|Main Treatment Period|Reason Not Specified|5|||
127747597|NCT02165826|459701601|FG002|Main Treatment Period|Reason Not Specified|16|||
127747598|NCT02165826|459701599|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
127747599|NCT02165826|459701600|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
127747600|NCT02165826|459701601|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
127747601|NCT02165826|459701599|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
127747602|NCT02165826|459701600|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
127747603|NCT02165826|459701601|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
127747604|NCT02165826|459701599|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
127747605|NCT02165826|459701600|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
127747606|NCT02165826|459701601|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
127747607|NCT02165826|459701599|FG000|Down-Titration Period|Reason Not Specified|1|||
127747608|NCT02165826|459701600|FG001|Down-Titration Period|Reason Not Specified|0|||
127747609|NCT02165826|459701601|FG002|Down-Titration Period|Reason Not Specified|2|||
127747610|NCT04547023|459701606|FG000|Overall Study|Did Not Receive Intervention|3|||
127747611|NCT04547023|459701607|FG001|Overall Study|Did Not Receive Intervention|2|||
127747612|NCT04547023|459701606|FG000|Overall Study|Lost to Follow-up|1|||
127747613|NCT04547023|459701607|FG001|Overall Study|Lost to Follow-up|1|||
127747614|NCT00250432|459701608|FG000|Overall Study|Adverse Event|25|||
127747615|NCT00250432|459701609|FG001|Overall Study|Adverse Event|29|||
127747616|NCT00250432|459701608|FG000|Overall Study|Lack of Efficacy|2|||
127747617|NCT00250432|459701609|FG001|Overall Study|Lack of Efficacy|1|||
127747618|NCT00250432|459701608|FG000|Overall Study|Lost to Follow-up|6|||
127747619|NCT00250432|459701609|FG001|Overall Study|Lost to Follow-up|5|||
127747620|NCT00250432|459701608|FG000|Overall Study|Patient Moved|0|||
127747621|NCT00250432|459701609|FG001|Overall Study|Patient Moved|1|||
127747622|NCT00250432|459701608|FG000|Overall Study|Protocol Violation|0|||
127747623|NCT00250432|459701609|FG001|Overall Study|Protocol Violation|3|||
127747624|NCT00250432|459701608|FG000|Overall Study|Withdrawal by Subject|6|||
127747625|NCT00250432|459701609|FG001|Overall Study|Withdrawal by Subject|2|||
127747626|NCT00250432|459701608|FG000|Overall Study|Pt died out of posttherapy report period|6|||
127747627|NCT00250432|459701609|FG001|Overall Study|Pt died out of posttherapy report period|5|||
127747628|NCT00250432|459701608|FG000|Overall Study|Pt was considered untreatable|0|||
127747629|NCT00250432|459701609|FG001|Overall Study|Pt was considered untreatable|1|||
127747630|NCT03784820|459701610|FG000|Overall Study|Lost to Follow-up|5|||
127747631|NCT03784820|459701611|FG001|Overall Study|Lost to Follow-up|5|||
127747632|NCT03784820|459701612|FG002|Overall Study|Lost to Follow-up|3|||
127747633|NCT03784820|459701613|FG003|Overall Study|Lost to Follow-up|3|||
127747634|NCT00658606|459701616|FG000|Overall Study|Adverse Event|2|||
127747635|NCT00658606|459701617|FG001|Overall Study|Adverse Event|1|||
127747636|NCT00658606|459701616|FG000|Overall Study|Lack of Efficacy|6|||
127747637|NCT00658606|459701617|FG001|Overall Study|Lack of Efficacy|3|||
127747638|NCT00658606|459701616|FG000|Overall Study|Lost to Follow-up|1|||
127747639|NCT00658606|459701617|FG001|Overall Study|Lost to Follow-up|0|||
127747640|NCT00658606|459701616|FG000|Overall Study|Withdrawal by Subject|7|||
127747641|NCT00658606|459701617|FG001|Overall Study|Withdrawal by Subject|16|||
127747642|NCT00658606|459701616|FG000|Overall Study|Lack of Compliance|0|||
127747643|NCT00658606|459701617|FG001|Overall Study|Lack of Compliance|3|||
127747644|NCT00365547|459701620|FG000|Overall Study|Insurance did not cover Avastin|1|||
127747645|NCT00365547|459701620|FG000|Overall Study|Screen failure|1|||
127747646|NCT00365547|459701620|FG000|Overall Study|Withdrawal by Subject|1|||
127747647|NCT03170518|459701621|FG000|Overall Study|Lost to Follow-up|4|||
127747648|NCT03170518|459701622|FG001|Overall Study|Lost to Follow-up|1|||
127747649|NCT03170518|459701623|FG002|Overall Study|Lost to Follow-up|0|||
127747650|NCT03170518|459701621|FG000|Overall Study|Physician Decision|1|||
127747651|NCT03170518|459701622|FG001|Overall Study|Physician Decision|0|||
127747652|NCT03170518|459701623|FG002|Overall Study|Physician Decision|0|||
127747653|NCT03170518|459701621|FG000|Overall Study|Withdrawal by Subject|4|||
127747654|NCT03170518|459701622|FG001|Overall Study|Withdrawal by Subject|5|||
127747655|NCT03170518|459701623|FG002|Overall Study|Withdrawal by Subject|2|||
127747656|NCT03170518|459701621|FG000|Overall Study|Site terminated by sponsor|0|||
127747657|NCT03170518|459701622|FG001|Overall Study|Site terminated by sponsor|1|||
127747658|NCT03170518|459701623|FG002|Overall Study|Site terminated by sponsor|0|||
127747659|NCT03170518|459701621|FG000|Overall Study|Non-compliance with study drug|1|||
127747660|NCT03170518|459701622|FG001|Overall Study|Non-compliance with study drug|0|||
127747661|NCT03170518|459701623|FG002|Overall Study|Non-compliance with study drug|1|||
127747662|NCT03170518|459701621|FG000|Overall Study|Withdrawal by parent/guardian|2|||
127747663|NCT03170518|459701622|FG001|Overall Study|Withdrawal by parent/guardian|0|||
127747664|NCT03170518|459701623|FG002|Overall Study|Withdrawal by parent/guardian|0|||
127747665|NCT04428476|459701624|FG000|Overall Study|Withdrawal by Subject|1|||
127747666|NCT04428476|459701624|FG000|Overall Study|Still on treatment|12|||
127747667|NCT00546078|459701625|FG000|Overall Study|Lost to Follow-up|1|||
127747668|NCT00546078|459701626|FG001|Overall Study|Lost to Follow-up|3|||
127747669|NCT00546078|459701625|FG000|Overall Study|Withdrawal by Subject|2|||
127747670|NCT00546078|459701626|FG001|Overall Study|Withdrawal by Subject|3|||
127747671|NCT00546078|459701625|FG000|Overall Study|Other reason|1|||
127747672|NCT00546078|459701626|FG001|Overall Study|Other reason|1|||
127747673|NCT03023423|459701629|FG000|Overall Study|Death|5|||
127747674|NCT03023423|459701630|FG001|Overall Study|Death|12|||
127747675|NCT03023423|459701631|FG002|Overall Study|Death|20|||
127747676|NCT03023423|459701629|FG000|Overall Study|Other|0|||
127747677|NCT03023423|459701630|FG001|Overall Study|Other|2|||
127747678|NCT03023423|459701631|FG002|Overall Study|Other|2|||
127747679|NCT03023423|459701629|FG000|Overall Study|Ongoing|2|||
127747680|NCT03023423|459701630|FG001|Overall Study|Ongoing|32|||
127747681|NCT03023423|459701631|FG002|Overall Study|Ongoing|24|||
127747682|NCT03358238|459701634|FG000|Overall Study|Withdrawal by Subject|0|||
127747683|NCT03358238|459701635|FG001|Overall Study|Withdrawal by Subject|1|||
127747684|NCT00583947|459701638|FG000|Cross-over Period|Adverse Event|2|||
127747685|NCT00583947|459701639|FG001|Cross-over Period|Adverse Event|0|||
127747686|NCT00583947|459701638|FG000|Cross-over Period|Withdrawal by Subject|2|||
127747687|NCT00583947|459701639|FG001|Cross-over Period|Withdrawal by Subject|0|||
127747688|NCT00583947|459701638|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
127747689|NCT00583947|459701639|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
127747690|NCT00583947|459701638|FG000|Cross-over Period|Other|1|||
127747691|NCT00583947|459701639|FG001|Cross-over Period|Other|1|||
127747692|NCT01740154|459701641|FG000|Overall Study|Adverse Event|1|||
127747693|NCT00469859|459701642|FG000|Overall Study|Inevaluable|0|||
127747694|NCT00469859|459701643|FG001|Overall Study|Inevaluable|2|||
127747695|NCT05992922|459701647|FG000|Overall Study|Adverse Event|6|||
127747696|NCT05992922|459701648|FG001|Overall Study|Adverse Event|0|||
127747697|NCT05992922|459701647|FG000|Overall Study|Sponsor Termination of Study|14|||
127747698|NCT05992922|459701648|FG001|Overall Study|Sponsor Termination of Study|20|||
127747699|NCT02172911|459703405|FG000|Overall Study|Serious Adverse Event|0|||
127747700|NCT02172911|459703406|FG001|Overall Study|Serious Adverse Event|1|||
127747701|NCT02172911|459703405|FG000|Overall Study|Progression of Disease|0|||
127747702|NCT02172911|459703406|FG001|Overall Study|Progression of Disease|1|||
127747703|NCT02172911|459703405|FG000|Overall Study|Loss of insurance coverage|1|||
127747704|NCT02172911|459703406|FG001|Overall Study|Loss of insurance coverage|0|||
127747705|NCT02737826|459703407|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
127747706|NCT02737826|459703408|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
127747707|NCT02737826|459703409|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
127747708|NCT02056626|459703410|FG000|Overall Study|patient did not follow directions|3|||
127747709|NCT02056626|459703411|FG001|Overall Study|patient did not follow directions|1|||
127747710|NCT02056626|459703412|FG002|Overall Study|patient did not follow directions|0|||
127747711|NCT02056626|459703413|FG003|Overall Study|patient did not follow directions|0|||
127747712|NCT00863512|459703414|FG000|Overall Study|Adverse Event|2|||
127747713|NCT00863512|459703415|FG001|Overall Study|Adverse Event|0|||
127747714|NCT00863512|459703414|FG000|Overall Study|Withdrawal by Subject|11|||
127747715|NCT00863512|459703415|FG001|Overall Study|Withdrawal by Subject|0|||
127747716|NCT00863512|459703414|FG000|Overall Study|Physician Decision|1|||
127747717|NCT00863512|459703415|FG001|Overall Study|Physician Decision|0|||
127747718|NCT02037477|459703416|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
127747719|NCT02037477|459703417|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
127747720|NCT02037477|459703418|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
127747721|NCT02037477|459703419|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
127747722|NCT01454739|459703420|FG000|Overall Study|Protocol Violation|2|||
127747723|NCT01454739|459703421|FG001|Overall Study|Protocol Violation|3|||
127747724|NCT01454739|459703420|FG000|Overall Study|Withdrawal by Subject|2|||
127747725|NCT01454739|459703421|FG001|Overall Study|Withdrawal by Subject|6|||
127747726|NCT01454739|459703420|FG000|Overall Study|Other|3|||
127747727|NCT01454739|459703421|FG001|Overall Study|Other|5|||
127747728|NCT01454739|459703420|FG000|Overall Study|Physician Decision|0|||
127747729|NCT01454739|459703421|FG001|Overall Study|Physician Decision|5|||
127747730|NCT01454739|459703420|FG000|Overall Study|Lost to Follow-up|0|||
127747731|NCT01454739|459703421|FG001|Overall Study|Lost to Follow-up|1|||
127747732|NCT01454739|459703420|FG000|Overall Study|Adverse Event|0|||
127747733|NCT01454739|459703421|FG001|Overall Study|Adverse Event|1|||
127747734|NCT02577003|459703424|FG000|Overall Study|Adverse Event|2|||
127747735|NCT02577003|459703425|FG001|Overall Study|Adverse Event|4|||
127747736|NCT02577003|459703424|FG000|Overall Study|Withdrawal by Subject|0|||
127747737|NCT02577003|459703425|FG001|Overall Study|Withdrawal by Subject|1|||
127747738|NCT02786004|459703426|FG000|Overall Study|Withdrawal by Subject|0|||
127747739|NCT02786004|459703427|FG001|Overall Study|Withdrawal by Subject|1|||
127747740|NCT01677299|459703428|FG000|Overall Study|Adverse Event|0|||
127747741|NCT01677299|459703429|FG001|Overall Study|Adverse Event|2|||
127747742|NCT01677299|459703430|FG002|Overall Study|Adverse Event|1|||
127747743|NCT01677299|459703431|FG003|Overall Study|Adverse Event|0|||
127747744|NCT01677299|459703428|FG000|Overall Study|Withdrawal by Subject|0|||
127747745|NCT01677299|459703429|FG001|Overall Study|Withdrawal by Subject|1|||
127747746|NCT01677299|459703430|FG002|Overall Study|Withdrawal by Subject|0|||
127747747|NCT01677299|459703431|FG003|Overall Study|Withdrawal by Subject|1|||
127747748|NCT00193479|459703432|FG000|Induction Chemotherapy|Adverse Event|2|||
127747749|NCT00193479|459703432|FG000|Induction Chemotherapy|Disease Progression|1|||
127747750|NCT00193479|459703432|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
127747751|NCT00193479|459703432|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
127747752|NCT00559377|459703433|FG000|Overall Study|Withdrawal by Subject|9|||
127747753|NCT00940875|459703435|FG000|Treatment Phase|Adverse Event|9|||
127747754|NCT00940875|459703436|FG001|Treatment Phase|Adverse Event|3|||
127747755|NCT00940875|459703435|FG000|Treatment Phase|Death|3|||
127747756|NCT00940875|459703436|FG001|Treatment Phase|Death|5|||
127747757|NCT00940875|459703435|FG000|Treatment Phase|Lack of Efficacy|1|||
127747758|NCT00940875|459703436|FG001|Treatment Phase|Lack of Efficacy|0|||
127747759|NCT00940875|459703435|FG000|Treatment Phase|Withdrawal by Subject|3|||
127747760|NCT00940875|459703436|FG001|Treatment Phase|Withdrawal by Subject|0|||
127747761|NCT00940875|459703435|FG000|Treatment Phase|Disease progression|9|||
127747762|NCT00940875|459703436|FG001|Treatment Phase|Disease progression|11|||
127747763|NCT00940875|459703435|FG000|Treatment Phase|Physician Decision|1|||
127747764|NCT00940875|459703436|FG001|Treatment Phase|Physician Decision|0|||
127747765|NCT00940875|459703435|FG000|Post-Study Treatment|Death|0|||
127747766|NCT00940875|459703436|FG001|Post-Study Treatment|Death|1|||
127747767|NCT00940875|459703435|FG000|Post-Study Treatment|Disease Progression|0|||
127747768|NCT00940875|459703436|FG001|Post-Study Treatment|Disease Progression|2|||
127747769|NCT00872001|459703437|FG000|Overall Study|Adverse Event|34|||
127808687|NCT01827384|459917889|FG006|Overall Study|Switched to alternative treatment|0|||
127747770|NCT00872001|459703438|FG001|Overall Study|Adverse Event|23|||
127747771|NCT00872001|459703437|FG000|Overall Study|Protocol Defined Clinical Event|5|||
127747772|NCT00872001|459703438|FG001|Overall Study|Protocol Defined Clinical Event|7|||
127747773|NCT00872001|459703437|FG000|Overall Study|Lost to Follow-up|13|||
127747774|NCT00872001|459703438|FG001|Overall Study|Lost to Follow-up|12|||
127747775|NCT00872001|459703437|FG000|Overall Study|Withdrawal by Subject|18|||
127747776|NCT00872001|459703438|FG001|Overall Study|Withdrawal by Subject|30|||
127747777|NCT00872001|459703437|FG000|Overall Study|Protocol Violation|5|||
127747778|NCT00872001|459703438|FG001|Overall Study|Protocol Violation|8|||
127747779|NCT00872001|459703437|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
127747780|NCT00872001|459703438|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
127747781|NCT00872001|459703437|FG000|Overall Study|Administrative|23|||
127747782|NCT00872001|459703438|FG001|Overall Study|Administrative|15|||
127808688|NCT01827384|459917890|FG007|Overall Study|Switched to alternative treatment|0|||
127808689|NCT01827384|459917891|FG008|Overall Study|Switched to alternative treatment|0|||
127808690|NCT01827384|459917892|FG009|Overall Study|Switched to alternative treatment|0|||
127808691|NCT01827384|459917893|FG010|Overall Study|Switched to alternative treatment|0|||
127808692|NCT01827384|459917894|FG011|Overall Study|Switched to alternative treatment|0|||
127808693|NCT01827384|459917895|FG012|Overall Study|Switched to alternative treatment|0|||
127808694|NCT01827384|459917896|FG013|Overall Study|Switched to alternative treatment|2|||
127808695|NCT01827384|459917883|FG000|Overall Study|Disease progression before treatment|0|||
127808696|NCT01827384|459917884|FG001|Overall Study|Disease progression before treatment|0|||
127808697|NCT01827384|459917885|FG002|Overall Study|Disease progression before treatment|0|||
127808698|NCT01827384|459917886|FG003|Overall Study|Disease progression before treatment|0|||
127808699|NCT01827384|459917887|FG004|Overall Study|Disease progression before treatment|0|||
127808700|NCT01827384|459917888|FG005|Overall Study|Disease progression before treatment|0|||
127808701|NCT01827384|459917889|FG006|Overall Study|Disease progression before treatment|0|||
127808702|NCT01827384|459917890|FG007|Overall Study|Disease progression before treatment|0|||
127808703|NCT01827384|459917891|FG008|Overall Study|Disease progression before treatment|0|||
127808704|NCT01827384|459917892|FG009|Overall Study|Disease progression before treatment|0|||
127808705|NCT01827384|459917893|FG010|Overall Study|Disease progression before treatment|0|||
127808706|NCT01827384|459917894|FG011|Overall Study|Disease progression before treatment|0|||
127808707|NCT01827384|459917895|FG012|Overall Study|Disease progression before treatment|0|||
127808708|NCT01827384|459917896|FG013|Overall Study|Disease progression before treatment|4|||
127808709|NCT01827384|459917883|FG000|Overall Study|Ineligible|0|||
127808710|NCT01827384|459917884|FG001|Overall Study|Ineligible|0|||
127808711|NCT01827384|459917885|FG002|Overall Study|Ineligible|0|||
127808712|NCT01827384|459917886|FG003|Overall Study|Ineligible|0|||
127808713|NCT01827384|459917887|FG004|Overall Study|Ineligible|0|||
127808714|NCT01827384|459917888|FG005|Overall Study|Ineligible|0|||
127808715|NCT01827384|459917889|FG006|Overall Study|Ineligible|0|||
127808716|NCT01827384|459917890|FG007|Overall Study|Ineligible|0|||
127808717|NCT01827384|459917891|FG008|Overall Study|Ineligible|0|||
127808718|NCT01827384|459917892|FG009|Overall Study|Ineligible|0|||
127808719|NCT01827384|459917893|FG010|Overall Study|Ineligible|0|||
127808720|NCT01827384|459917894|FG011|Overall Study|Ineligible|0|||
127808721|NCT01827384|459917895|FG012|Overall Study|Ineligible|0|||
127808722|NCT01827384|459917896|FG013|Overall Study|Ineligible|19|||
127808723|NCT01827384|459917883|FG000|Overall Study|Participant died before treatment|0|||
127808724|NCT01827384|459917884|FG001|Overall Study|Participant died before treatment|0|||
127808725|NCT01827384|459917885|FG002|Overall Study|Participant died before treatment|0|||
127808726|NCT01827384|459917886|FG003|Overall Study|Participant died before treatment|0|||
127808727|NCT01827384|459917887|FG004|Overall Study|Participant died before treatment|0|||
127808728|NCT01827384|459917888|FG005|Overall Study|Participant died before treatment|0|||
127808729|NCT01827384|459917889|FG006|Overall Study|Participant died before treatment|0|||
127808730|NCT01827384|459917890|FG007|Overall Study|Participant died before treatment|0|||
127808731|NCT01827384|459917891|FG008|Overall Study|Participant died before treatment|0|||
127808732|NCT01827384|459917892|FG009|Overall Study|Participant died before treatment|0|||
127808733|NCT01827384|459917893|FG010|Overall Study|Participant died before treatment|0|||
127808734|NCT01827384|459917894|FG011|Overall Study|Participant died before treatment|0|||
127808735|NCT01827384|459917895|FG012|Overall Study|Participant died before treatment|0|||
127808736|NCT01827384|459917896|FG013|Overall Study|Participant died before treatment|5|||
127808737|NCT01827384|459917883|FG000|Overall Study|Insufficient tumor cells|0|||
127808738|NCT01827384|459917884|FG001|Overall Study|Insufficient tumor cells|0|||
127808739|NCT01827384|459917885|FG002|Overall Study|Insufficient tumor cells|0|||
127808740|NCT01827384|459917886|FG003|Overall Study|Insufficient tumor cells|0|||
127808741|NCT01827384|459917887|FG004|Overall Study|Insufficient tumor cells|0|||
127808742|NCT01827384|459917888|FG005|Overall Study|Insufficient tumor cells|0|||
127808743|NCT01827384|459917889|FG006|Overall Study|Insufficient tumor cells|0|||
127808744|NCT01827384|459917890|FG007|Overall Study|Insufficient tumor cells|0|||
127808745|NCT01827384|459917891|FG008|Overall Study|Insufficient tumor cells|0|||
127808746|NCT01827384|459917892|FG009|Overall Study|Insufficient tumor cells|0|||
127808747|NCT01827384|459917893|FG010|Overall Study|Insufficient tumor cells|0|||
127808748|NCT01827384|459917894|FG011|Overall Study|Insufficient tumor cells|0|||
127808749|NCT01827384|459917895|FG012|Overall Study|Insufficient tumor cells|0|||
127808750|NCT01827384|459917896|FG013|Overall Study|Insufficient tumor cells|13|||
127808751|NCT01827384|459917883|FG000|Overall Study|No actionable mutation|0|||
127808752|NCT01827384|459917884|FG001|Overall Study|No actionable mutation|0|||
127808753|NCT01827384|459917885|FG002|Overall Study|No actionable mutation|0|||
127808754|NCT01827384|459917886|FG003|Overall Study|No actionable mutation|0|||
127808755|NCT01827384|459917887|FG004|Overall Study|No actionable mutation|0|||
127808756|NCT01827384|459917888|FG005|Overall Study|No actionable mutation|0|||
127808757|NCT01827384|459917889|FG006|Overall Study|No actionable mutation|0|||
127808758|NCT01827384|459917890|FG007|Overall Study|No actionable mutation|0|||
127808759|NCT01827384|459917891|FG008|Overall Study|No actionable mutation|0|||
127747783|NCT02030002|459703439|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
127747784|NCT02030002|459703439|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
127747785|NCT02030002|459703439|FG000|Follow-up|Lost to Follow-up|2|||
127747786|NCT03482752|459703447|FG000|Overall Study|Withdrawal by Subject|2|||
127747787|NCT03482752|459703447|FG000|Overall Study|Lost to Follow-up|1|||
127747788|NCT03482752|459703447|FG000|Overall Study|1 participant died 24 days after last dose ie outside the definition of treatment-emergent|1|||
127747789|NCT01080300|459703448|FG000|Overall Study|Adverse Event|49|||
127747790|NCT01080300|459703449|FG001|Overall Study|Adverse Event|35|||
127747791|NCT01080300|459703448|FG000|Overall Study|Lack of Efficacy|12|||
127747792|NCT01080300|459703449|FG001|Overall Study|Lack of Efficacy|15|||
127747793|NCT01080300|459703448|FG000|Overall Study|Protocol Violation|7|||
127747794|NCT01080300|459703449|FG001|Overall Study|Protocol Violation|13|||
127747795|NCT01080300|459703448|FG000|Overall Study|Lost to Follow-up|10|||
127747796|NCT01080300|459703449|FG001|Overall Study|Lost to Follow-up|6|||
127747797|NCT01080300|459703448|FG000|Overall Study|Death|0|||
127747798|NCT01080300|459703449|FG001|Overall Study|Death|1|||
127747799|NCT01080300|459703448|FG000|Overall Study|Withdrawal by Subject|12|||
127747800|NCT01080300|459703449|FG001|Overall Study|Withdrawal by Subject|28|||
127747801|NCT01080300|459703448|FG000|Overall Study|Reasons not specified|4|||
127747802|NCT01080300|459703449|FG001|Overall Study|Reasons not specified|6|||
127747803|NCT01807182|459703451|FG000|Overall Study|Death|1|||
127747804|NCT01807182|459703451|FG000|Overall Study|New therapy|1|||
127747805|NCT01807182|459703451|FG000|Overall Study|Moved to hospice care|1|||
127747806|NCT04210843|459703452|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
127747807|NCT04210843|459703453|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
127747808|NCT04210843|459703452|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
127747809|NCT04210843|459703453|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
127747810|NCT04210843|459703452|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
127747811|NCT04210843|459703453|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
127747812|NCT04210843|459703452|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
127747813|NCT04210843|459703453|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
127747814|NCT04210843|459703452|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
127747815|NCT04210843|459703453|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
127747816|NCT04210843|459703452|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
127747817|NCT04210843|459703453|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
127747818|NCT04210843|459703452|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
127747819|NCT04210843|459703453|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
127747820|NCT04210843|459703452|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
127747821|NCT04210843|459703453|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
127747822|NCT04210843|459703452|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
127747823|NCT04210843|459703453|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
127747824|NCT04210843|459703452|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
127747825|NCT04210843|459703453|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
127747826|NCT04210843|459703452|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
127747827|NCT04210843|459703453|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
127747828|NCT04210843|459703452|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
127747829|NCT04210843|459703453|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
127894016|NCT02711956|460235195|FG013|Overall Study|Radiographic progression|0|||
127894017|NCT02711956|460235196|FG014|Overall Study|Radiographic progression|1|||
127747830|NCT04210843|459703452|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
127747831|NCT04210843|459703453|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
127747832|NCT04210843|459703452|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
127747833|NCT04210843|459703453|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
127747834|NCT04210843|459703452|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
127747835|NCT04210843|459703453|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
127747836|NCT04210843|459703452|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
127747837|NCT04210843|459703453|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
127747838|NCT04210843|459703452|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
127747839|NCT04210843|459703453|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
127894018|NCT02711956|460235182|FG000|Overall Study|PSA progression with clinical progression|0|||
127894019|NCT02711956|460235183|FG001|Overall Study|PSA progression with clinical progression|0|||
127894020|NCT02711956|460235184|FG002|Overall Study|PSA progression with clinical progression|0|||
127894021|NCT02711956|460235185|FG003|Overall Study|PSA progression with clinical progression|0|||
127747840|NCT04210843|459703452|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
127747841|NCT04210843|459703453|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
127747842|NCT04210843|459703452|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
127747843|NCT04210843|459703453|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
127747844|NCT04210843|459703452|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
127747845|NCT04210843|459703453|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
127747846|NCT04210843|459703452|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
127747847|NCT04210843|459703453|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
127747848|NCT04210843|459703452|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
127747849|NCT04210843|459703453|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
127747850|NCT04210843|459703452|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
127747851|NCT04210843|459703453|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
127747852|NCT04210843|459703452|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
127747853|NCT04210843|459703453|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
127747854|NCT01776008|459703454|FG000|Overall Study|ineligible|2|||
127747855|NCT03513068|459703457|FG000|Overall Study|Death|1|||
127747856|NCT03513068|459703458|FG001|Overall Study|Death|0|||
127747857|NCT03513068|459703457|FG000|Overall Study|Withdrawal by Subject|4|||
127747858|NCT03513068|459703458|FG001|Overall Study|Withdrawal by Subject|6|||
127747859|NCT00478205|459703459|FG000|Overall Study|Adverse Event|182|||
127747860|NCT00478205|459703460|FG001|Overall Study|Adverse Event|39|||
127747861|NCT00478205|459703459|FG000|Overall Study|Medication Non-compliance|9|||
127747862|NCT00478205|459703460|FG001|Overall Study|Medication Non-compliance|4|||
127747863|NCT00478205|459703459|FG000|Overall Study|Protocol Violation|15|||
127747864|NCT00478205|459703460|FG001|Overall Study|Protocol Violation|5|||
127747865|NCT00478205|459703459|FG000|Overall Study|Request of Investigator or Sponsor|4|||
127747866|NCT00478205|459703460|FG001|Overall Study|Request of Investigator or Sponsor|5|||
127747867|NCT00478205|459703459|FG000|Overall Study|Withdrawal by Subject|61|||
127747868|NCT00478205|459703460|FG001|Overall Study|Withdrawal by Subject|22|||
127747869|NCT00478205|459703459|FG000|Overall Study|Lack of Efficacy|1|||
127747870|NCT00478205|459703460|FG001|Overall Study|Lack of Efficacy|0|||
127747871|NCT00478205|459703459|FG000|Overall Study|Other|24|||
127747872|NCT00478205|459703460|FG001|Overall Study|Other|12|||
127747873|NCT01012947|459703461|FG000|Overall Study|Lost to Follow-up|131|||
127747874|NCT01012947|459703462|FG001|Overall Study|Lost to Follow-up|135|||
127747875|NCT01012947|459703463|FG002|Overall Study|Lost to Follow-up|130|||
127747876|NCT01012947|459703464|FG003|Overall Study|Lost to Follow-up|118|||
127747877|NCT01012947|459703465|FG004|Overall Study|Lost to Follow-up|142|||
127747878|NCT01791413|459703466|FG000|Overall Study|Lost to Follow-up|5|||
127747879|NCT01791413|459703467|FG001|Overall Study|Lost to Follow-up|1|||
127747880|NCT00825305|459703470|FG000|Overall Study|Adverse Event|1|||
127747881|NCT00825305|459703471|FG001|Overall Study|Adverse Event|1|||
127747882|NCT00825305|459703470|FG000|Overall Study|Withdrawal by Subject|6|||
127747883|NCT00825305|459703471|FG001|Overall Study|Withdrawal by Subject|12|||
127747884|NCT00825305|459703470|FG000|Overall Study|Inappropriate inclusion|1|||
127747885|NCT00825305|459703471|FG001|Overall Study|Inappropriate inclusion|0|||
127747886|NCT00825305|459703470|FG000|Overall Study|Protocol Violation|9|||
127747887|NCT00825305|459703471|FG001|Overall Study|Protocol Violation|9|||
127747888|NCT00825305|459703470|FG000|Overall Study|Can not be classified|0|||
127747889|NCT00825305|459703471|FG001|Overall Study|Can not be classified|1|||
127747890|NCT04016272|459703472|FG000|Overall Study|Withdrawal by Subject|1|||
127747891|NCT04016272|459703473|FG001|Overall Study|Withdrawal by Subject|2|||
127747892|NCT01850030|459703476|FG000|Overall Study|Adverse Event|64|||
127747893|NCT01850030|459703477|FG001|Overall Study|Adverse Event|82|||
127747894|NCT01850030|459703476|FG000|Overall Study|Lack of Efficacy|3|||
127747895|NCT01850030|459703477|FG001|Overall Study|Lack of Efficacy|1|||
127747896|NCT01850030|459703476|FG000|Overall Study|Lost to Follow-up|5|||
127747897|NCT01850030|459703477|FG001|Overall Study|Lost to Follow-up|5|||
127747898|NCT01850030|459703476|FG000|Overall Study|Withdrawal by Subject|3|||
127747899|NCT01850030|459703477|FG001|Overall Study|Withdrawal by Subject|4|||
127747900|NCT01850030|459703476|FG000|Overall Study|Protocol Violation|24|||
127747901|NCT01850030|459703477|FG001|Overall Study|Protocol Violation|28|||
127747902|NCT01850030|459703476|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
127747903|NCT01850030|459703477|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
127747904|NCT00762476|459703478|FG000|Overall Study|Adverse Event|7|||
127747905|NCT00762476|459703479|FG001|Overall Study|Adverse Event|1|||
127747906|NCT00762476|459703478|FG000|Overall Study|Lost to Follow-up|2|||
127808760|NCT01827384|459917892|FG009|Overall Study|No actionable mutation|0|||
127747907|NCT00762476|459703479|FG001|Overall Study|Lost to Follow-up|0|||
127808761|NCT01827384|459917893|FG010|Overall Study|No actionable mutation|0|||
127747908|NCT00762476|459703478|FG000|Overall Study|Protocol Violation|5|||
127808762|NCT01827384|459917894|FG011|Overall Study|No actionable mutation|0|||
127808763|NCT01827384|459917895|FG012|Overall Study|No actionable mutation|0|||
127747909|NCT00762476|459703479|FG001|Overall Study|Protocol Violation|6|||
127747910|NCT00762476|459703478|FG000|Overall Study|Physician Decision|2|||
127747911|NCT00762476|459703479|FG001|Overall Study|Physician Decision|14|||
127747912|NCT00762476|459703478|FG000|Overall Study|Withdrawal by Subject|6|||
127747913|NCT00762476|459703479|FG001|Overall Study|Withdrawal by Subject|12|||
127747914|NCT00762476|459703478|FG000|Overall Study|antibiotic use|0|||
127747915|NCT00762476|459703479|FG001|Overall Study|antibiotic use|1|||
127747916|NCT00762476|459703478|FG000|Overall Study|non-compliance with study visits|0|||
127747917|NCT00762476|459703479|FG001|Overall Study|non-compliance with study visits|2|||
127747918|NCT00762476|459703478|FG000|Overall Study|Seasonal allergies|1|||
127747919|NCT00762476|459703479|FG001|Overall Study|Seasonal allergies|0|||
127747920|NCT02878603|459703480|FG000|Overall Study|Lost to Follow-up|4|||
127747921|NCT02878603|459703481|FG001|Overall Study|Lost to Follow-up|1|||
127747922|NCT02878603|459703480|FG000|Overall Study|Withdrawal by Subject|1|||
127747923|NCT02878603|459703481|FG001|Overall Study|Withdrawal by Subject|1|||
127747924|NCT02878603|459703480|FG000|Overall Study|Death|1|||
127747925|NCT02878603|459703481|FG001|Overall Study|Death|0|||
127747926|NCT02878603|459703480|FG000|Overall Study|Physician Decision|0|||
127747927|NCT02878603|459703481|FG001|Overall Study|Physician Decision|3|||
127747928|NCT04674189|459703482|FG000|Overall Study|Adverse Event|0|||
127747929|NCT04674189|459703483|FG001|Overall Study|Adverse Event|0|||
127747930|NCT04674189|459703484|FG002|Overall Study|Adverse Event|1|||
127747931|NCT04674189|459703482|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
127747932|NCT04674189|459703483|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
127747933|NCT04674189|459703484|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
127747934|NCT04674189|459703482|FG000|Overall Study|Physician Decision|1|||
127747935|NCT04674189|459703483|FG001|Overall Study|Physician Decision|0|||
127747936|NCT04674189|459703484|FG002|Overall Study|Physician Decision|0|||
127747937|NCT04674189|459703482|FG000|Overall Study|Withdrawal by Participant|83|||
127747938|NCT04674189|459703483|FG001|Overall Study|Withdrawal by Participant|71|||
127747939|NCT04674189|459703484|FG002|Overall Study|Withdrawal by Participant|142|||
127747940|NCT04674189|459703482|FG000|Overall Study|Lost to Follow-up|55|||
127747941|NCT04674189|459703483|FG001|Overall Study|Lost to Follow-up|53|||
127747942|NCT04674189|459703484|FG002|Overall Study|Lost to Follow-up|44|||
127747943|NCT04674189|459703482|FG000|Overall Study|Miscellaneous|27|||
127747944|NCT04674189|459703483|FG001|Overall Study|Miscellaneous|23|||
127747945|NCT04674189|459703484|FG002|Overall Study|Miscellaneous|207|||
127747946|NCT04674189|459703482|FG000|Overall Study|Did Not Receive Treatment|3|||
127747947|NCT04674189|459703483|FG001|Overall Study|Did Not Receive Treatment|1|||
127747948|NCT04674189|459703484|FG002|Overall Study|Did Not Receive Treatment|2|||
127747949|NCT02838134|459703485|FG000|Overall Study|Lost to Follow-up|1|||
127747950|NCT02838134|459703486|FG001|Overall Study|Lost to Follow-up|2|||
127747951|NCT02838134|459703485|FG000|Overall Study|logistic problems|1|||
127747952|NCT02838134|459703486|FG001|Overall Study|logistic problems|1|||
127747953|NCT01564277|459703487|FG000|Overall Study|Protocol Violation|0|||
127747954|NCT01564277|459703488|FG001|Overall Study|Protocol Violation|1|||
127747955|NCT01564277|459703487|FG000|Overall Study|Physician Decision|1|||
127747956|NCT01564277|459703488|FG001|Overall Study|Physician Decision|0|||
127747957|NCT01637077|459703489|FG000|Overall Study|Cancel|1|||
127747958|NCT01637077|459703490|FG001|Overall Study|Cancel|1|||
127747959|NCT01637077|459703489|FG000|Overall Study|Withdrawal by Subject|1|||
127747960|NCT01637077|459703490|FG001|Overall Study|Withdrawal by Subject|0|||
127747961|NCT01637077|459703489|FG000|Overall Study|No cycle 1 questionnaire data|2|||
127747962|NCT01637077|459703490|FG001|Overall Study|No cycle 1 questionnaire data|0|||
127747963|NCT02595372|459703491|FG000|Overall Study|Adverse Event|6|||
127747964|NCT02595372|459703491|FG000|Overall Study|Physician Decision|2|||
127747965|NCT02595372|459703491|FG000|Overall Study|Disease Progression|1|||
127747966|NCT00794924|459703492|FG000|Overall Study|Lost to Follow-up|6|||
127747967|NCT00794924|459703493|FG001|Overall Study|Lost to Follow-up|8|||
127747968|NCT00794924|459703492|FG000|Overall Study|Withdrawal by Subject|48|||
127747969|NCT00794924|459703493|FG001|Overall Study|Withdrawal by Subject|60|||
127747970|NCT00794924|459703492|FG000|Overall Study|Adverse Event|6|||
127747971|NCT00794924|459703493|FG001|Overall Study|Adverse Event|2|||
127747972|NCT01594970|459703494|FG000|Overall Study|Non-Adverse Event Related|4|||
127747973|NCT01594970|459703495|FG001|Overall Study|Non-Adverse Event Related|5|||
127747974|NCT01594970|459703496|FG002|Overall Study|Non-Adverse Event Related|6|||
127747975|NCT01594970|459703494|FG000|Overall Study|Adverse Event|17|||
127747976|NCT01594970|459703495|FG001|Overall Study|Adverse Event|23|||
127747977|NCT01594970|459703496|FG002|Overall Study|Adverse Event|23|||
127747978|NCT01594970|459703494|FG000|Overall Study|Lost to Follow-up|54|||
127747979|NCT01594970|459703495|FG001|Overall Study|Lost to Follow-up|54|||
127747980|NCT01594970|459703496|FG002|Overall Study|Lost to Follow-up|37|||
127747981|NCT00953615|459703497|FG000|Overall Study|Adverse Event|1|||
127747982|NCT04277507|459703498|FG000|Overall Study|Lost to Follow-up|17|||
127747983|NCT04277507|459703498|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
127747984|NCT04277507|459703498|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
127747985|NCT04277507|459703498|FG000|Overall Study|Withdrawal by Subject|3|||
127747986|NCT04277507|459703498|FG000|Overall Study|Death due to COVID-19|1|||
127747987|NCT04277507|459703498|FG000|Overall Study|Data missing for full evaluation|5|||
127747988|NCT02559310|459703499|FG000|Overall Study|Death|4|||
127747989|NCT02559310|459703500|FG001|Overall Study|Death|3|||
127747990|NCT02559310|459703499|FG000|Overall Study|Lost to Follow-up|5|||
127747991|NCT02559310|459703500|FG001|Overall Study|Lost to Follow-up|3|||
127747992|NCT02559310|459703499|FG000|Overall Study|Physician Decision|2|||
127747993|NCT02559310|459703500|FG001|Overall Study|Physician Decision|1|||
127747994|NCT02559310|459703499|FG000|Overall Study|Withdrawal by Subject|13|||
127747995|NCT02559310|459703500|FG001|Overall Study|Withdrawal by Subject|9|||
127747996|NCT02559310|459703499|FG000|Overall Study|Sponsor Decision|0|||
127747997|NCT02559310|459703500|FG001|Overall Study|Sponsor Decision|1|||
127747998|NCT02559310|459703499|FG000|Overall Study|Randomized but not treated|3|||
127747999|NCT02559310|459703500|FG001|Overall Study|Randomized but not treated|2|||
127748000|NCT05226130|459703501|FG000|Overall Study|Lost to Follow-up|0|||
127748001|NCT05226130|459703502|FG001|Overall Study|Lost to Follow-up|1|||
127748002|NCT05226130|459703501|FG000|Overall Study|Not treatment adherent|0|||
127748003|NCT05226130|459703502|FG001|Overall Study|Not treatment adherent|2|||
127748004|NCT03358472|459703503|FG000|Overall Study|Death|6|||
127748005|NCT03358472|459703504|FG001|Overall Study|Death|3|||
127748006|NCT03358472|459703505|FG002|Overall Study|Death|10|||
127748007|NCT03358472|459703503|FG000|Overall Study|Physician Decision|0|||
127748008|NCT03358472|459703504|FG001|Overall Study|Physician Decision|1|||
127748009|NCT03358472|459703505|FG002|Overall Study|Physician Decision|0|||
127748010|NCT03358472|459703503|FG000|Overall Study|Withdrawal by Subject|0|||
127748011|NCT03358472|459703504|FG001|Overall Study|Withdrawal by Subject|0|||
127748012|NCT03358472|459703505|FG002|Overall Study|Withdrawal by Subject|1|||
127748013|NCT03358472|459703503|FG000|Overall Study|On-going at clinical cut off date|9|||
127808764|NCT01827384|459917896|FG013|Overall Study|No actionable mutation|73|||
127808765|NCT01827384|459917883|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
127808766|NCT01827384|459917884|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
127808767|NCT01827384|459917885|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
127808768|NCT01827384|459917886|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
127808769|NCT01827384|459917887|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
127808770|NCT01827384|459917888|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
127808771|NCT01827384|459917889|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
127808772|NCT01827384|459917890|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
127808773|NCT01827384|459917891|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
127808774|NCT01827384|459917892|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
127808775|NCT01827384|459917893|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
127808776|NCT01827384|459917894|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
127808777|NCT01827384|459917895|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
127808778|NCT01827384|459917896|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
127808779|NCT01955707|459917903|FG000|Overall Study|Adverse Event|1|||
127808780|NCT01955707|459917904|FG001|Overall Study|Adverse Event|2|||
127808781|NCT01955707|459917903|FG000|Overall Study|Lost to Follow-up|2|||
127808782|NCT01955707|459917904|FG001|Overall Study|Lost to Follow-up|1|||
127808783|NCT01955707|459917903|FG000|Overall Study|Withdrawal by Subject|0|||
127808784|NCT01955707|459917904|FG001|Overall Study|Withdrawal by Subject|3|||
127808785|NCT01955707|459917903|FG000|Overall Study|Death|13|||
127808786|NCT01955707|459917904|FG001|Overall Study|Death|14|||
127808787|NCT01955707|459917903|FG000|Overall Study|Other|4|||
127808788|NCT01955707|459917904|FG001|Overall Study|Other|2|||
127808789|NCT01817790|459917905|FG000|Overall Study|Adverse Event|0|||
127808790|NCT01817790|459917906|FG001|Overall Study|Adverse Event|2|||
127808791|NCT01817790|459917905|FG000|Overall Study|Lost to Follow-up|0|||
127808792|NCT01817790|459917906|FG001|Overall Study|Lost to Follow-up|1|||
127808793|NCT01817790|459917905|FG000|Overall Study|Protocol Violation|2|||
127808794|NCT01817790|459917906|FG001|Overall Study|Protocol Violation|1|||
127808795|NCT01817790|459917905|FG000|Overall Study|Withdrawal by Subject|1|||
127808796|NCT01817790|459917906|FG001|Overall Study|Withdrawal by Subject|3|||
127808797|NCT01817790|459917905|FG000|Overall Study|Other: Could not attend appointment|1|||
127808798|NCT01817790|459917906|FG001|Overall Study|Other: Could not attend appointment|1|||
127808799|NCT01671345|459917907|FG000|Overall Study|Lost to Follow-up|10|||
127808800|NCT01671345|459917908|FG001|Overall Study|Lost to Follow-up|6|||
127808801|NCT01671345|459917907|FG000|Overall Study|visit with non-participating physician|3|||
127808802|NCT01671345|459917908|FG001|Overall Study|visit with non-participating physician|3|||
127808803|NCT04280081|459917911|FG000|Overall Study|Adverse Event|4|||
127808804|NCT04280081|459917911|FG000|Overall Study|Death|2|||
127808805|NCT04280081|459917911|FG000|Overall Study|Progressive Disease|6|||
127748014|NCT03358472|459703504|FG001|Overall Study|On-going at clinical cut off date|6|||
127748015|NCT03358472|459703505|FG002|Overall Study|On-going at clinical cut off date|5|||
127748016|NCT03732677|459703506|FG000|Overall Study|Terminated the study|154|||
127748017|NCT03732677|459703507|FG001|Overall Study|Terminated the study|197|||
127748018|NCT03732677|459703506|FG000|Overall Study|Continuing study off treatment|379|||
127808806|NCT01468311|459917912|FG000|Overall Study|mobilization failure|1|||
127808807|NCT01468311|459917912|FG000|Overall Study|Withdrawal by Subject|1|||
127748019|NCT03732677|459703507|FG001|Overall Study|Continuing study off treatment|333|||
127748020|NCT02520310|459703508|FG000|At 6 Months Clinical Follow-up|Death|1|||
127748021|NCT02520310|459703508|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
127748022|NCT02520310|459703508|FG000|AT 3 Year Clinical Follow-up|Death|2|||
127748023|NCT02520310|459703508|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
127748024|NCT02520310|459703508|FG000|AT 4 Year Clinical Follow-up|Death|1|||
127748025|NCT02520310|459703508|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
127748026|NCT01340014|459703509|FG000|Period 1, First 7 Days|Adverse Event|1|||
127748027|NCT01340014|459703510|FG001|Period 1, First 7 Days|Adverse Event|0|||
127748028|NCT01340014|459703509|FG000|Period 1, First 7 Days|Personal Reasons|1|||
127748029|NCT01340014|459703510|FG001|Period 1, First 7 Days|Personal Reasons|0|||
127748030|NCT01340014|459703509|FG000|Period 2, Second 7 Days|Adverse Event|0|||
127748031|NCT01340014|459703510|FG001|Period 2, Second 7 Days|Adverse Event|1|||
127748032|NCT04535544|459703512|FG000|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
127748033|NCT04535544|459703513|FG001|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
127748034|NCT04535544|459703514|FG002|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|1|||
127748035|NCT04535544|459703515|FG003|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
127748036|NCT04535544|459703512|FG000|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|1|||
127748037|NCT04535544|459703513|FG001|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
127748038|NCT04535544|459703514|FG002|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|2|||
127748039|NCT04535544|459703515|FG003|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
127748040|NCT04535544|459703512|FG000|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
127748041|NCT04535544|459703513|FG001|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
127748042|NCT04535544|459703514|FG002|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
127748043|NCT04535544|459703515|FG003|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
127748044|NCT04535544|459703512|FG000|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
127748045|NCT04535544|459703513|FG001|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
127748046|NCT04535544|459703514|FG002|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
127748047|NCT04535544|459703515|FG003|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
127748048|NCT04535544|459703512|FG000|Open-label (Week 52 up to Week 148)|Ongoing|0|||
127748049|NCT04535544|459703513|FG001|Open-label (Week 52 up to Week 148)|Ongoing|1|||
127748050|NCT04535544|459703514|FG002|Open-label (Week 52 up to Week 148)|Ongoing|14|||
127748051|NCT04535544|459703515|FG003|Open-label (Week 52 up to Week 148)|Ongoing|4|||
127748052|NCT04535544|459703512|FG000|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|5|||
127748053|NCT04535544|459703513|FG001|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
127748054|NCT04535544|459703514|FG002|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|4|||
127748055|NCT04535544|459703515|FG003|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
127748056|NCT04535544|459703512|FG000|Follow-up (Week 148 up to Week 161)|Ongoing|4|||
127748057|NCT04535544|459703513|FG001|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
127748058|NCT04535544|459703514|FG002|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
127748059|NCT04535544|459703515|FG003|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
127748060|NCT04535544|459703512|FG000|Follow-up (Week 148 up to Week 161)|Other|0|||
127748061|NCT04535544|459703513|FG001|Follow-up (Week 148 up to Week 161)|Other|0|||
127748062|NCT04535544|459703514|FG002|Follow-up (Week 148 up to Week 161)|Other|1|||
127748063|NCT04535544|459703515|FG003|Follow-up (Week 148 up to Week 161)|Other|0|||
127748064|NCT05131477|459703522|FG000|PART 1|Withdrawal by Subject|2|||
127748065|NCT05131477|459703523|FG001|PART 1|Withdrawal by Subject|9|||
127748066|NCT05131477|459703524|FG002|PART 1|Withdrawal by Subject|6|||
127748067|NCT05131477|459703525|FG003|PART 1|Withdrawal by Subject|2|||
127748068|NCT05131477|459703526|FG004|PART 1|Withdrawal by Subject|8|||
127748069|NCT05131477|459703527|FG005|PART 1|Withdrawal by Subject|0|||
127748070|NCT05131477|459703528|FG006|PART 1|Withdrawal by Subject|0|||
127748071|NCT05131477|459703529|FG007|PART 1|Withdrawal by Subject|0|||
127748072|NCT05131477|459703530|FG008|PART 1|Withdrawal by Subject|0|||
127748073|NCT05131477|459703531|FG009|PART 1|Withdrawal by Subject|0|||
127748074|NCT05131477|459703532|FG010|PART 1|Withdrawal by Subject|0|||
127748075|NCT05131477|459703533|FG011|PART 1|Withdrawal by Subject|0|||
127748076|NCT05131477|459703534|FG012|PART 1|Withdrawal by Subject|0|||
127748077|NCT05131477|459703535|FG013|PART 1|Withdrawal by Subject|0|||
127748078|NCT05131477|459703522|FG000|PART 1|Physician Decision|1|||
127748079|NCT05131477|459703523|FG001|PART 1|Physician Decision|0|||
127748080|NCT05131477|459703524|FG002|PART 1|Physician Decision|0|||
127748081|NCT05131477|459703525|FG003|PART 1|Physician Decision|0|||
127748082|NCT05131477|459703526|FG004|PART 1|Physician Decision|0|||
127748083|NCT05131477|459703527|FG005|PART 1|Physician Decision|0|||
127748084|NCT05131477|459703528|FG006|PART 1|Physician Decision|0|||
127894022|NCT02711956|460235186|FG004|Overall Study|PSA progression with clinical progression|1|||
127748085|NCT05131477|459703529|FG007|PART 1|Physician Decision|0|||
127748086|NCT05131477|459703530|FG008|PART 1|Physician Decision|0|||
127894023|NCT02711956|460235187|FG005|Overall Study|PSA progression with clinical progression|0|||
127894024|NCT02711956|460235188|FG006|Overall Study|PSA progression with clinical progression|0|||
127894025|NCT02711956|460235189|FG007|Overall Study|PSA progression with clinical progression|0|||
127748087|NCT05131477|459703531|FG009|PART 1|Physician Decision|0|||
127748088|NCT05131477|459703532|FG010|PART 1|Physician Decision|0|||
127748089|NCT05131477|459703533|FG011|PART 1|Physician Decision|0|||
127748090|NCT05131477|459703534|FG012|PART 1|Physician Decision|0|||
127748091|NCT05131477|459703535|FG013|PART 1|Physician Decision|0|||
127748092|NCT05131477|459703522|FG000|PART 1|Adverse Event|3|||
127748093|NCT05131477|459703523|FG001|PART 1|Adverse Event|5|||
127748094|NCT05131477|459703524|FG002|PART 1|Adverse Event|1|||
127748095|NCT05131477|459703525|FG003|PART 1|Adverse Event|6|||
127748096|NCT05131477|459703526|FG004|PART 1|Adverse Event|4|||
127748097|NCT05131477|459703527|FG005|PART 1|Adverse Event|0|||
127748098|NCT05131477|459703528|FG006|PART 1|Adverse Event|0|||
127748099|NCT05131477|459703529|FG007|PART 1|Adverse Event|0|||
127748100|NCT05131477|459703530|FG008|PART 1|Adverse Event|0|||
127748101|NCT05131477|459703531|FG009|PART 1|Adverse Event|0|||
127748102|NCT05131477|459703532|FG010|PART 1|Adverse Event|0|||
127748103|NCT05131477|459703533|FG011|PART 1|Adverse Event|0|||
127748104|NCT05131477|459703534|FG012|PART 1|Adverse Event|0|||
127748105|NCT05131477|459703535|FG013|PART 1|Adverse Event|0|||
127748106|NCT05131477|459703522|FG000|PART 1|unclassified|1|||
127748107|NCT05131477|459703523|FG001|PART 1|unclassified|1|||
127748108|NCT05131477|459703524|FG002|PART 1|unclassified|0|||
127748109|NCT05131477|459703525|FG003|PART 1|unclassified|0|||
127748110|NCT05131477|459703526|FG004|PART 1|unclassified|4|||
127748111|NCT05131477|459703527|FG005|PART 1|unclassified|0|||
127748112|NCT05131477|459703528|FG006|PART 1|unclassified|0|||
127748113|NCT05131477|459703529|FG007|PART 1|unclassified|0|||
127748114|NCT05131477|459703530|FG008|PART 1|unclassified|0|||
127748115|NCT05131477|459703531|FG009|PART 1|unclassified|0|||
127748116|NCT05131477|459703532|FG010|PART 1|unclassified|0|||
127748117|NCT05131477|459703533|FG011|PART 1|unclassified|0|||
127748118|NCT05131477|459703534|FG012|PART 1|unclassified|0|||
127748119|NCT05131477|459703535|FG013|PART 1|unclassified|0|||
127748120|NCT05131477|459703522|FG000|PART 1|Randomized and not treated|0|||
127748121|NCT05131477|459703523|FG001|PART 1|Randomized and not treated|0|||
127748122|NCT05131477|459703524|FG002|PART 1|Randomized and not treated|0|||
127748123|NCT05131477|459703525|FG003|PART 1|Randomized and not treated|1|||
127748124|NCT05131477|459703526|FG004|PART 1|Randomized and not treated|1|||
127748125|NCT05131477|459703527|FG005|PART 1|Randomized and not treated|0|||
127748126|NCT05131477|459703528|FG006|PART 1|Randomized and not treated|0|||
127748127|NCT05131477|459703529|FG007|PART 1|Randomized and not treated|0|||
127748128|NCT05131477|459703530|FG008|PART 1|Randomized and not treated|0|||
127808808|NCT01750918|459919937|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
127808809|NCT01750918|459919938|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
127808810|NCT01750918|459919939|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
127808811|NCT01750918|459919940|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
127808812|NCT01750918|459919941|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
127808813|NCT01750918|459919942|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
127808814|NCT01750918|459919943|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
127808815|NCT01750918|459919944|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
127808816|NCT01750918|459919937|FG000|Overall Study|Lost to Follow-up|0|||
127808817|NCT01750918|459919938|FG001|Overall Study|Lost to Follow-up|0|||
127808818|NCT01750918|459919939|FG002|Overall Study|Lost to Follow-up|2|||
127808819|NCT01750918|459919940|FG003|Overall Study|Lost to Follow-up|2|||
127808820|NCT01750918|459919941|FG004|Overall Study|Lost to Follow-up|0|||
127808821|NCT01750918|459919942|FG005|Overall Study|Lost to Follow-up|0|||
127808822|NCT01750918|459919943|FG006|Overall Study|Lost to Follow-up|0|||
127808823|NCT01750918|459919944|FG007|Overall Study|Lost to Follow-up|1|||
127808824|NCT01750918|459919937|FG000|Overall Study|Withdrawal by Subject|0|||
127808825|NCT01750918|459919938|FG001|Overall Study|Withdrawal by Subject|0|||
127808826|NCT01750918|459919939|FG002|Overall Study|Withdrawal by Subject|1|||
127808827|NCT01750918|459919940|FG003|Overall Study|Withdrawal by Subject|2|||
127808828|NCT01750918|459919941|FG004|Overall Study|Withdrawal by Subject|1|||
127808829|NCT01750918|459919942|FG005|Overall Study|Withdrawal by Subject|1|||
127808830|NCT01750918|459919943|FG006|Overall Study|Withdrawal by Subject|2|||
127748129|NCT05131477|459703531|FG009|PART 1|Randomized and not treated|0|||
127748130|NCT05131477|459703532|FG010|PART 1|Randomized and not treated|0|||
127748131|NCT05131477|459703533|FG011|PART 1|Randomized and not treated|0|||
127748132|NCT05131477|459703534|FG012|PART 1|Randomized and not treated|0|||
127808831|NCT01750918|459919944|FG007|Overall Study|Withdrawal by Subject|2|||
127748133|NCT05131477|459703535|FG013|PART 1|Randomized and not treated|0|||
127748134|NCT05131477|459703522|FG000|PART 1|Protocol Violation|2|||
127748135|NCT05131477|459703523|FG001|PART 1|Protocol Violation|0|||
127748136|NCT05131477|459703524|FG002|PART 1|Protocol Violation|0|||
127748137|NCT05131477|459703525|FG003|PART 1|Protocol Violation|1|||
127748138|NCT05131477|459703526|FG004|PART 1|Protocol Violation|0|||
127748139|NCT05131477|459703527|FG005|PART 1|Protocol Violation|0|||
127748140|NCT05131477|459703528|FG006|PART 1|Protocol Violation|0|||
127748141|NCT05131477|459703529|FG007|PART 1|Protocol Violation|0|||
127748142|NCT05131477|459703530|FG008|PART 1|Protocol Violation|0|||
127748143|NCT05131477|459703531|FG009|PART 1|Protocol Violation|0|||
127748144|NCT05131477|459703532|FG010|PART 1|Protocol Violation|0|||
127748145|NCT05131477|459703533|FG011|PART 1|Protocol Violation|0|||
127748146|NCT05131477|459703534|FG012|PART 1|Protocol Violation|0|||
127808832|NCT02338843|459919950|FG000|Overall Study|Adverse Event|2|||
127808833|NCT02338843|459919951|FG001|Overall Study|Adverse Event|1|||
127808834|NCT02338843|459919950|FG000|Overall Study|Death|40|||
127808835|NCT02338843|459919951|FG001|Overall Study|Death|53|||
127808836|NCT02338843|459919950|FG000|Overall Study|Physician Decision|1|||
127748147|NCT05131477|459703535|FG013|PART 1|Protocol Violation|0|||
127748148|NCT05131477|459703522|FG000|PART 1|Lack of Efficacy|0|||
127748149|NCT05131477|459703523|FG001|PART 1|Lack of Efficacy|1|||
127748150|NCT05131477|459703524|FG002|PART 1|Lack of Efficacy|1|||
127748151|NCT05131477|459703525|FG003|PART 1|Lack of Efficacy|2|||
127748152|NCT05131477|459703526|FG004|PART 1|Lack of Efficacy|5|||
127748153|NCT05131477|459703527|FG005|PART 1|Lack of Efficacy|0|||
127748154|NCT05131477|459703528|FG006|PART 1|Lack of Efficacy|0|||
127748155|NCT05131477|459703529|FG007|PART 1|Lack of Efficacy|0|||
127748156|NCT05131477|459703530|FG008|PART 1|Lack of Efficacy|0|||
127748157|NCT05131477|459703531|FG009|PART 1|Lack of Efficacy|0|||
127748158|NCT05131477|459703532|FG010|PART 1|Lack of Efficacy|0|||
127748159|NCT05131477|459703533|FG011|PART 1|Lack of Efficacy|0|||
127748160|NCT05131477|459703534|FG012|PART 1|Lack of Efficacy|0|||
127748161|NCT05131477|459703535|FG013|PART 1|Lack of Efficacy|0|||
127748162|NCT05131477|459703522|FG000|PART 2|Withdrawal by Subject|0|||
127748163|NCT05131477|459703523|FG001|PART 2|Withdrawal by Subject|0|||
127748164|NCT05131477|459703524|FG002|PART 2|Withdrawal by Subject|0|||
127748165|NCT05131477|459703525|FG003|PART 2|Withdrawal by Subject|0|||
127748166|NCT05131477|459703526|FG004|PART 2|Withdrawal by Subject|0|||
127748167|NCT05131477|459703527|FG005|PART 2|Withdrawal by Subject|0|||
127748168|NCT05131477|459703528|FG006|PART 2|Withdrawal by Subject|2|||
127748169|NCT05131477|459703529|FG007|PART 2|Withdrawal by Subject|0|||
127748170|NCT05131477|459703530|FG008|PART 2|Withdrawal by Subject|0|||
127748171|NCT05131477|459703531|FG009|PART 2|Withdrawal by Subject|0|||
127748172|NCT05131477|459703532|FG010|PART 2|Withdrawal by Subject|2|||
127748173|NCT05131477|459703533|FG011|PART 2|Withdrawal by Subject|0|||
127748174|NCT05131477|459703534|FG012|PART 2|Withdrawal by Subject|2|||
127748175|NCT05131477|459703535|FG013|PART 2|Withdrawal by Subject|2|||
127748176|NCT05131477|459703522|FG000|PART 2|Other|0|||
127748177|NCT05131477|459703523|FG001|PART 2|Other|0|||
127748178|NCT05131477|459703524|FG002|PART 2|Other|0|||
127748179|NCT05131477|459703525|FG003|PART 2|Other|0|||
127748180|NCT05131477|459703526|FG004|PART 2|Other|0|||
127748181|NCT05131477|459703527|FG005|PART 2|Other|0|||
127748182|NCT05131477|459703528|FG006|PART 2|Other|0|||
127748183|NCT05131477|459703529|FG007|PART 2|Other|0|||
127748184|NCT05131477|459703530|FG008|PART 2|Other|1|||
127748185|NCT05131477|459703531|FG009|PART 2|Other|1|||
127748186|NCT05131477|459703532|FG010|PART 2|Other|0|||
127748187|NCT05131477|459703533|FG011|PART 2|Other|0|||
127748188|NCT05131477|459703534|FG012|PART 2|Other|1|||
127748189|NCT05131477|459703535|FG013|PART 2|Other|0|||
127748190|NCT05131477|459703522|FG000|PART 2|Lack of Efficacy|0|||
127748191|NCT05131477|459703523|FG001|PART 2|Lack of Efficacy|0|||
127748192|NCT05131477|459703524|FG002|PART 2|Lack of Efficacy|0|||
127748193|NCT05131477|459703525|FG003|PART 2|Lack of Efficacy|0|||
127748194|NCT05131477|459703526|FG004|PART 2|Lack of Efficacy|0|||
127748195|NCT05131477|459703527|FG005|PART 2|Lack of Efficacy|1|||
127748196|NCT05131477|459703528|FG006|PART 2|Lack of Efficacy|1|||
127748197|NCT05131477|459703529|FG007|PART 2|Lack of Efficacy|0|||
127808837|NCT02338843|459919951|FG001|Overall Study|Physician Decision|0|||
127808838|NCT02338843|459919950|FG000|Overall Study|Withdrawal by Subject|0|||
127808839|NCT02338843|459919951|FG001|Overall Study|Withdrawal by Subject|2|||
127808840|NCT02338843|459919950|FG000|Overall Study|Subject Recovered|0|||
127808841|NCT02338843|459919951|FG001|Overall Study|Subject Recovered|2|||
127808842|NCT02338843|459919950|FG000|Overall Study|Discontinued prior to randomizat|1|||
127748198|NCT05131477|459703530|FG008|PART 2|Lack of Efficacy|3|||
127748199|NCT05131477|459703531|FG009|PART 2|Lack of Efficacy|0|||
127748200|NCT05131477|459703532|FG010|PART 2|Lack of Efficacy|1|||
127748201|NCT05131477|459703533|FG011|PART 2|Lack of Efficacy|0|||
127748202|NCT05131477|459703534|FG012|PART 2|Lack of Efficacy|2|||
127748203|NCT05131477|459703535|FG013|PART 2|Lack of Efficacy|0|||
127748204|NCT05131477|459703522|FG000|PART 2|Unclassified|0|||
127748205|NCT05131477|459703523|FG001|PART 2|Unclassified|0|||
127808843|NCT02338843|459919951|FG001|Overall Study|Discontinued prior to randomizat|0|||
127808844|NCT00023322|459919952|FG000|Overall Study|Lost to Follow-up|1|||
127748206|NCT05131477|459703524|FG002|PART 2|Unclassified|0|||
127808845|NCT01793792|459919959|FG000|Overall Study|Death|5|||
127808846|NCT01793792|459919959|FG000|Overall Study|Lost to Follow-up|5|||
127808847|NCT01793792|459919959|FG000|Overall Study|Withdrawal by Subject|1|||
127748207|NCT05131477|459703525|FG003|PART 2|Unclassified|0|||
127748208|NCT05131477|459703526|FG004|PART 2|Unclassified|0|||
127748209|NCT05131477|459703527|FG005|PART 2|Unclassified|0|||
127748210|NCT05131477|459703528|FG006|PART 2|Unclassified|0|||
127748211|NCT05131477|459703529|FG007|PART 2|Unclassified|0|||
127748212|NCT05131477|459703530|FG008|PART 2|Unclassified|0|||
127748213|NCT05131477|459703531|FG009|PART 2|Unclassified|0|||
127748214|NCT05131477|459703532|FG010|PART 2|Unclassified|1|||
127748215|NCT05131477|459703533|FG011|PART 2|Unclassified|0|||
127748216|NCT05131477|459703534|FG012|PART 2|Unclassified|0|||
127748217|NCT05131477|459703535|FG013|PART 2|Unclassified|0|||
127748218|NCT05131477|459703522|FG000|PART 2|Re-randomized and not treated|0|||
127748219|NCT05131477|459703523|FG001|PART 2|Re-randomized and not treated|0|||
127748220|NCT05131477|459703524|FG002|PART 2|Re-randomized and not treated|0|||
127748221|NCT05131477|459703525|FG003|PART 2|Re-randomized and not treated|0|||
127748222|NCT05131477|459703526|FG004|PART 2|Re-randomized and not treated|0|||
127748223|NCT05131477|459703527|FG005|PART 2|Re-randomized and not treated|0|||
127748224|NCT05131477|459703528|FG006|PART 2|Re-randomized and not treated|0|||
127748225|NCT05131477|459703529|FG007|PART 2|Re-randomized and not treated|1|||
127748226|NCT05131477|459703530|FG008|PART 2|Re-randomized and not treated|0|||
127748227|NCT05131477|459703531|FG009|PART 2|Re-randomized and not treated|0|||
127748228|NCT05131477|459703532|FG010|PART 2|Re-randomized and not treated|1|||
127748229|NCT05131477|459703533|FG011|PART 2|Re-randomized and not treated|0|||
127748230|NCT05131477|459703534|FG012|PART 2|Re-randomized and not treated|1|||
127748231|NCT05131477|459703535|FG013|PART 2|Re-randomized and not treated|1|||
127748232|NCT02194829|459703536|FG000|Overall Study|Adverse Event|2|||
127748233|NCT02194829|459703537|FG001|Overall Study|Adverse Event|2|||
127748234|NCT02194829|459703536|FG000|Overall Study|Death|0|||
127748235|NCT02194829|459703537|FG001|Overall Study|Death|1|||
127748236|NCT02194829|459703536|FG000|Overall Study|Disease progression|0|||
127748237|NCT02194829|459703537|FG001|Overall Study|Disease progression|1|||
127748238|NCT02194829|459703536|FG000|Overall Study|Withdrawal by Subject|0|||
127748239|NCT02194829|459703537|FG001|Overall Study|Withdrawal by Subject|1|||
127748240|NCT02194829|459703536|FG000|Overall Study|Never started protocol therapy|0|||
127748241|NCT02194829|459703537|FG001|Overall Study|Never started protocol therapy|1|||
127748242|NCT05101993|459703540|FG000|Overall Study|Withdrawal by Subject|1|||
127748243|NCT04577573|459703541|FG000|Overall Study|Technical - invalid protocol|0|||
127748244|NCT04577573|459703542|FG001|Overall Study|Technical - invalid protocol|2|||
127748245|NCT04577573|459703543|FG002|Overall Study|Technical - invalid protocol|0|||
127748246|NCT01124838|459703544|FG000|Overall Study|Miscellaneous|4|||
127748247|NCT01124838|459703545|FG001|Overall Study|Miscellaneous|2|||
127748248|NCT01124838|459703544|FG000|Overall Study|Adverse Event|7|||
127748249|NCT01124838|459703545|FG001|Overall Study|Adverse Event|11|||
127748250|NCT01124838|459703544|FG000|Overall Study|Lack of Efficacy|2|||
127748251|NCT01124838|459703545|FG001|Overall Study|Lack of Efficacy|0|||
127748252|NCT01124838|459703544|FG000|Overall Study|Withdrawal by Subject|3|||
127748253|NCT01124838|459703545|FG001|Overall Study|Withdrawal by Subject|2|||
127748254|NCT01124838|459703544|FG000|Overall Study|Lost to Follow-up|2|||
127748255|NCT01124838|459703545|FG001|Overall Study|Lost to Follow-up|0|||
127748256|NCT04297618|459703546|FG000|Overall Study|Adverse Event|1|||
127748257|NCT04297618|459703546|FG000|Overall Study|Withdrawal by Subject|1|||
127748258|NCT06719986|459703547|FG000|Washout (up to 72 Hours)|Adverse Event|0|||
127748259|NCT06719986|459703548|FG001|Washout (up to 72 Hours)|Adverse Event|0|||
127748260|NCT06719986|459703549|FG002|Washout (up to 72 Hours)|Adverse Event|1|||
127748261|NCT06719986|459703547|FG000|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
127748262|NCT06719986|459703548|FG001|Washout (up to 72 Hours)|Withdrawal by Subject|1|||
127748263|NCT06719986|459703549|FG002|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
127748264|NCT02726945|459703551|FG000|Overall Study|Withdrawal by Subject|0|||
127748265|NCT02726945|459703552|FG001|Overall Study|Withdrawal by Subject|0|||
127748266|NCT02726945|459703553|FG002|Overall Study|Withdrawal by Subject|1|||
127748267|NCT02726945|459703551|FG000|Overall Study|Elected to have total knee replacement|0|||
127748268|NCT02726945|459703552|FG001|Overall Study|Elected to have total knee replacement|1|||
127748269|NCT02726945|459703553|FG002|Overall Study|Elected to have total knee replacement|0|||
127748270|NCT00129935|459705247|FG000|Overall Study|Adverse Event|18|||
127748271|NCT00129935|459705248|FG001|Overall Study|Adverse Event|56|||
127748272|NCT00129935|459705247|FG000|Overall Study|Death|1|||
127748273|NCT00129935|459705248|FG001|Overall Study|Death|1|||
127748274|NCT00129935|459705247|FG000|Overall Study|Withdrawal by Subject|7|||
127748275|NCT00129935|459705248|FG001|Overall Study|Withdrawal by Subject|20|||
127748276|NCT00129935|459705247|FG000|Overall Study|Protocol Violation|0|||
127748277|NCT00129935|459705248|FG001|Overall Study|Protocol Violation|4|||
127748278|NCT00129935|459705247|FG000|Overall Study|Physician Decision|3|||
127894026|NCT02711956|460235190|FG008|Overall Study|PSA progression with clinical progression|0|||
127894027|NCT02711956|460235191|FG009|Overall Study|PSA progression with clinical progression|0|||
127894028|NCT02711956|460235192|FG010|Overall Study|PSA progression with clinical progression|0|||
127894029|NCT02711956|460235193|FG011|Overall Study|PSA progression with clinical progression|0|||
127894030|NCT02711956|460235194|FG012|Overall Study|PSA progression with clinical progression|1|||
127748279|NCT00129935|459705248|FG001|Overall Study|Physician Decision|4|||
127748280|NCT00129935|459705247|FG000|Overall Study|Recurrence|1|||
127748281|NCT00129935|459705248|FG001|Overall Study|Recurrence|3|||
127748282|NCT00129935|459705247|FG000|Overall Study|Second primary|0|||
127748283|NCT00129935|459705248|FG001|Overall Study|Second primary|1|||
127748284|NCT00129935|459705247|FG000|Overall Study|Other|3|||
127748285|NCT00129935|459705248|FG001|Overall Study|Other|2|||
127894031|NCT02711956|460235195|FG013|Overall Study|PSA progression with clinical progression|1|||
127894032|NCT02711956|460235196|FG014|Overall Study|PSA progression with clinical progression|0|||
127748286|NCT00129935|459705247|FG000|Overall Study|Crossed to the other arm|2|||
127748287|NCT00129935|459705248|FG001|Overall Study|Crossed to the other arm|1|||
127748288|NCT00129935|459705247|FG000|Overall Study|Incorrect study treatment|1|||
127748289|NCT00129935|459705248|FG001|Overall Study|Incorrect study treatment|0|||
127748290|NCT02783573|459705249|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
127748291|NCT02783573|459705250|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
127748292|NCT02783573|459705251|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
127748293|NCT02783573|459705249|FG000|Placebo-Controlled Treatment Period|Death|4|||
127748294|NCT02783573|459705250|FG001|Placebo-Controlled Treatment Period|Death|2|||
127748295|NCT02783573|459705251|FG002|Placebo-Controlled Treatment Period|Death|3|||
127748296|NCT02783573|459705249|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
127748297|NCT02783573|459705250|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
127748298|NCT02783573|459705251|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
127748299|NCT02783573|459705249|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
127748300|NCT02783573|459705250|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
127748301|NCT02783573|459705251|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
127748302|NCT02783573|459705249|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
127748303|NCT02783573|459705250|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
127748304|NCT02783573|459705251|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
127748305|NCT02783573|459705249|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
127748306|NCT02783573|459705250|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
127748307|NCT02783573|459705251|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
127748308|NCT02783573|459705249|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
127748309|NCT02783573|459705250|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
127748310|NCT02783573|459705251|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
127748311|NCT02783573|459705249|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
127748312|NCT02783573|459705250|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
127748313|NCT02783573|459705251|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
127748314|NCT02783573|459705249|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
127748315|NCT02783573|459705250|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
127748316|NCT02783573|459705251|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
127748317|NCT02783573|459705249|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
127748318|NCT02783573|459705250|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
127748319|NCT02783573|459705251|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
127748320|NCT02783573|459705249|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
127748321|NCT02783573|459705250|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
127748322|NCT02783573|459705251|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
127748323|NCT02783573|459705249|FG000|Delayed-Start Period|Sponsor Decision|0|||
127748324|NCT02783573|459705250|FG001|Delayed-Start Period|Sponsor Decision|17|||
127748325|NCT02783573|459705251|FG002|Delayed-Start Period|Sponsor Decision|12|||
127748326|NCT00581893|459705252|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
127748327|NCT00581893|459705253|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
127748328|NCT00233480|459705254|FG000|Overall Study|Underwent status II heart transplant|0|||
127748329|NCT00233480|459705255|FG001|Overall Study|Underwent status II heart transplant|1|||
127748330|NCT02797522|459705263|FG000|Overall Study|Study Terminated by Sponsor|0|||
127748331|NCT02797522|459705264|FG001|Overall Study|Study Terminated by Sponsor|0|||
127748332|NCT02797522|459705265|FG002|Overall Study|Study Terminated by Sponsor|0|||
127748333|NCT02797522|459705266|FG003|Overall Study|Study Terminated by Sponsor|0|||
127748334|NCT02797522|459705267|FG004|Overall Study|Study Terminated by Sponsor|0|||
127748335|NCT02797522|459705268|FG005|Overall Study|Study Terminated by Sponsor|0|||
127748336|NCT02797522|459705269|FG006|Overall Study|Study Terminated by Sponsor|0|||
127748337|NCT02797522|459705270|FG007|Overall Study|Study Terminated by Sponsor|4|||
127748338|NCT02797522|459705271|FG008|Overall Study|Study Terminated by Sponsor|2|||
127748339|NCT02797522|459705272|FG009|Overall Study|Study Terminated by Sponsor|4|||
127748340|NCT02797522|459705273|FG010|Overall Study|Study Terminated by Sponsor|1|||
127748341|NCT00725712|459705274|FG000|Overall Study|Withdrawal by Subject|2|||
127748342|NCT00725712|459705275|FG001|Overall Study|Withdrawal by Subject|1|||
127748343|NCT00725712|459705274|FG000|Overall Study|Protocol Violation|1|||
127748344|NCT00725712|459705275|FG001|Overall Study|Protocol Violation|0|||
127748345|NCT00725712|459705274|FG000|Overall Study|Progressive disease|37|||
127748346|NCT00725712|459705275|FG001|Overall Study|Progressive disease|16|||
127748347|NCT00725712|459705274|FG000|Overall Study|Clinical progression not based on RECIST|0|||
127748348|NCT00725712|459705275|FG001|Overall Study|Clinical progression not based on RECIST|3|||
127748349|NCT00725712|459705274|FG000|Overall Study|Adverse Event|5|||
127748350|NCT00725712|459705275|FG001|Overall Study|Adverse Event|5|||
127748351|NCT00725712|459705274|FG000|Overall Study|Death|2|||
127748352|NCT00725712|459705275|FG001|Overall Study|Death|0|||
127748353|NCT00725712|459705274|FG000|Overall Study|Other: Death|1|||
127748354|NCT00725712|459705275|FG001|Overall Study|Other: Death|0|||
127748355|NCT00725712|459705274|FG000|Overall Study|Hospitalized, unable to continue|0|||
127748356|NCT00725712|459705275|FG001|Overall Study|Hospitalized, unable to continue|1|||
127748357|NCT00132678|459705278|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
127748358|NCT00132678|459705279|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
127748359|NCT00132678|459705280|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
127748360|NCT00132678|459705278|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
127748361|NCT00132678|459705279|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
127748362|NCT00132678|459705280|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
127748363|NCT00132678|459705278|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
127748364|NCT00132678|459705279|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
127748365|NCT00132678|459705280|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
127748366|NCT00132678|459705278|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
127748367|NCT00132678|459705279|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
127748368|NCT00132678|459705280|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
127748369|NCT00132678|459705278|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
127748370|NCT00132678|459705279|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
127748371|NCT00132678|459705280|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
127748372|NCT00132678|459705278|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
127748373|NCT00132678|459705279|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
127748374|NCT00132678|459705280|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
127748375|NCT00132678|459705278|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
127748376|NCT00132678|459705279|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
127748377|NCT00132678|459705280|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
127748378|NCT00132678|459705278|FG000|Period III (Open-Label Stabilization)|Death|2|||
127748379|NCT00132678|459705279|FG001|Period III (Open-Label Stabilization)|Death|0|||
127748380|NCT00132678|459705280|FG002|Period III (Open-Label Stabilization)|Death|0|||
127748381|NCT00132678|459705278|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
127748382|NCT00132678|459705279|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
127748383|NCT00132678|459705280|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
127748384|NCT00132678|459705278|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
127748385|NCT00132678|459705279|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
127748386|NCT00132678|459705280|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
127748387|NCT00132678|459705278|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
127748388|NCT00132678|459705279|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
127748389|NCT00132678|459705280|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
127748390|NCT00132678|459705278|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
127748391|NCT00132678|459705279|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
127748392|NCT00132678|459705280|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
127748393|NCT00132678|459705278|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
127748394|NCT00132678|459705279|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
127748395|NCT00132678|459705280|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
127748396|NCT00132678|459705278|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
127748397|NCT00132678|459705279|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
127748398|NCT00132678|459705280|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
127748399|NCT00132678|459705278|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
127748400|NCT00132678|459705279|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
127748401|NCT00132678|459705280|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
127748402|NCT00132678|459705278|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
127748403|NCT00132678|459705279|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
127748404|NCT00132678|459705280|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
127748405|NCT00132678|459705278|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
127748406|NCT00132678|459705279|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
127748407|NCT00132678|459705280|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
127748408|NCT00132678|459705278|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
127748409|NCT00132678|459705279|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
127748410|NCT00132678|459705280|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
127748411|NCT00132678|459705278|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
127748412|NCT00132678|459705279|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
127748413|NCT00132678|459705280|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
127748414|NCT00132678|459705278|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
127748415|NCT00132678|459705279|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
127748416|NCT00132678|459705280|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
127748417|NCT00132678|459705278|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
127748418|NCT00132678|459705279|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
127748419|NCT00132678|459705280|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
127748420|NCT00132678|459705278|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
127748421|NCT00132678|459705279|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
127748422|NCT00132678|459705280|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
127748423|NCT00132678|459705278|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
127748424|NCT00132678|459705279|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
127748425|NCT00132678|459705280|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
127748426|NCT01367847|459705281|FG000|Overall Study|Withdrawal by Subject|2|||
127748427|NCT01367847|459705282|FG001|Overall Study|Withdrawal by Subject|2|||
127748428|NCT00592293|459705283|FG000|Overall Study|Withdrawal by Subject|1|||
127748429|NCT01784523|459705286|FG000|Overall Study|Study closed early|7|||
127748430|NCT01784523|459705287|FG001|Overall Study|Study closed early|4|||
127748431|NCT04340947|459705288|FG000|7-day Washout Period|Lost to Follow-up|5|||
127748432|NCT04340947|459705289|FG001|7-day Washout Period|Lost to Follow-up|4|||
127748433|NCT01124097|459705294|FG000|Overall Study|Withdrawal by Subject|4|||
127748434|NCT01124097|459705295|FG001|Overall Study|Withdrawal by Subject|3|||
127748435|NCT01124097|459705296|FG002|Overall Study|Withdrawal by Subject|2|||
127748436|NCT01124097|459705297|FG003|Overall Study|Withdrawal by Subject|3|||
127748437|NCT01124097|459705294|FG000|Overall Study|Lack of Efficacy|2|||
127748438|NCT01124097|459705295|FG001|Overall Study|Lack of Efficacy|3|||
127748439|NCT01124097|459705296|FG002|Overall Study|Lack of Efficacy|1|||
127748440|NCT01124097|459705297|FG003|Overall Study|Lack of Efficacy|3|||
127748441|NCT01124097|459705294|FG000|Overall Study|Adverse Event|24|||
127748442|NCT01124097|459705295|FG001|Overall Study|Adverse Event|15|||
127748443|NCT01124097|459705296|FG002|Overall Study|Adverse Event|15|||
127748444|NCT01124097|459705297|FG003|Overall Study|Adverse Event|7|||
127748445|NCT01124097|459705294|FG000|Overall Study|Protocol Violation|2|||
127748446|NCT01124097|459705295|FG001|Overall Study|Protocol Violation|0|||
127748447|NCT01124097|459705296|FG002|Overall Study|Protocol Violation|2|||
127748448|NCT01124097|459705297|FG003|Overall Study|Protocol Violation|1|||
127748449|NCT01124097|459705294|FG000|Overall Study|Physician Decision|2|||
127748450|NCT01124097|459705295|FG001|Overall Study|Physician Decision|1|||
127748451|NCT01124097|459705296|FG002|Overall Study|Physician Decision|0|||
127748452|NCT01124097|459705297|FG003|Overall Study|Physician Decision|0|||
127748453|NCT01821937|459705298|FG000|Overall Study|Adverse Event|0|||
127748454|NCT01821937|459705299|FG001|Overall Study|Adverse Event|3|||
127748455|NCT00609947|459705300|FG000|Overall Study|Death|1|||
127748456|NCT02406248|459705301|FG000|Overall Study|Death|7|||
127748457|NCT02406248|459705301|FG000|Overall Study|Withdrawal by Subject|2|||
127748458|NCT01304498|459705302|FG000|Overall Study|Adverse Event|1|||
127748459|NCT01304498|459705303|FG001|Overall Study|Adverse Event|1|||
127748460|NCT01304498|459705302|FG000|Overall Study|Withdrawal by Subject|2|||
127748461|NCT01304498|459705303|FG001|Overall Study|Withdrawal by Subject|3|||
127748462|NCT01304498|459705302|FG000|Overall Study|Protocol Violation|1|||
127748463|NCT01304498|459705303|FG001|Overall Study|Protocol Violation|0|||
127748464|NCT01304498|459705302|FG000|Overall Study|Lost to Follow-up|2|||
127748465|NCT01304498|459705303|FG001|Overall Study|Lost to Follow-up|1|||
127748466|NCT01834586|459705305|FG000|Overall Study|Adverse Event|1|||
127748467|NCT01667549|459705306|FG000|Overall Study|Withdrawal by Subject|3|||
127748468|NCT01667549|459705307|FG001|Overall Study|Withdrawal by Subject|5|||
127748469|NCT01667549|459705308|FG002|Overall Study|Withdrawal by Subject|7|||
127748470|NCT01667549|459705309|FG003|Overall Study|Withdrawal by Subject|6|||
127748471|NCT01667549|459705310|FG004|Overall Study|Withdrawal by Subject|1|||
127748472|NCT02844777|459705311|FG000|Overall Study|Withdrawal by Subject|2|||
127748473|NCT02844777|459705312|FG001|Overall Study|Withdrawal by Subject|0|||
127748474|NCT02844777|459705313|FG002|Overall Study|Withdrawal by Subject|0|||
127748475|NCT00150618|459705314|FG000|Overall Study|Adverse Event|2|||
127748476|NCT00150618|459705315|FG001|Overall Study|Adverse Event|2|||
127748477|NCT00150618|459705316|FG002|Overall Study|Adverse Event|6|||
127748478|NCT00150618|459705317|FG003|Overall Study|Adverse Event|9|||
127808848|NCT01793792|459919959|FG000|Overall Study|Device Not Implanted|1|||
127808849|NCT02185521|459919960|FG000|Overall Study|Withdrawal by Subject|1|||
127808850|NCT02185521|459919960|FG000|Overall Study|Protocol Violation|1|||
127808851|NCT01756274|459919969|FG000|Overall Study|Protocol Violation|2|||
127808852|NCT01756274|459919969|FG000|Overall Study|Laboratory error|1|||
127808853|NCT01147926|459919970|FG000|Overall Study|Subject Withdrew Consent|9|||
127808854|NCT01147926|459919971|FG001|Overall Study|Subject Withdrew Consent|10|||
127808855|NCT01147926|459919970|FG000|Overall Study|Adverse Event|7|||
127808856|NCT01147926|459919971|FG001|Overall Study|Adverse Event|6|||
127808857|NCT01147926|459919970|FG000|Overall Study|Subject Non-Compliant|5|||
127808858|NCT01147926|459919971|FG001|Overall Study|Subject Non-Compliant|4|||
127808859|NCT01147926|459919970|FG000|Overall Study|Principal investigator left hospital|1|||
127808860|NCT01147926|459919971|FG001|Overall Study|Principal investigator left hospital|3|||
127808861|NCT01147926|459919970|FG000|Overall Study|Selection criteria not met|3|||
127808862|NCT01147926|459919971|FG001|Overall Study|Selection criteria not met|1|||
127894033|NCT02711956|460235182|FG000|Overall Study|PSA progression with radiographic progression|0|||
127894034|NCT02711956|460235183|FG001|Overall Study|PSA progression with radiographic progression|1|||
127894035|NCT02711956|460235184|FG002|Overall Study|PSA progression with radiographic progression|0|||
127894036|NCT02711956|460235185|FG003|Overall Study|PSA progression with radiographic progression|0|||
127894037|NCT02711956|460235186|FG004|Overall Study|PSA progression with radiographic progression|0|||
127894038|NCT02711956|460235187|FG005|Overall Study|PSA progression with radiographic progression|2|||
127748479|NCT00150618|459705318|FG004|Overall Study|Adverse Event|5|||
127748480|NCT00150618|459705314|FG000|Overall Study|Withdrawal by Subject|6|||
127748481|NCT00150618|459705315|FG001|Overall Study|Withdrawal by Subject|8|||
127748482|NCT00150618|459705316|FG002|Overall Study|Withdrawal by Subject|8|||
127748483|NCT00150618|459705317|FG003|Overall Study|Withdrawal by Subject|4|||
127748484|NCT00150618|459705318|FG004|Overall Study|Withdrawal by Subject|5|||
127748485|NCT00150618|459705314|FG000|Overall Study|Lost to Follow-up|4|||
127748486|NCT00150618|459705315|FG001|Overall Study|Lost to Follow-up|1|||
127748487|NCT00150618|459705316|FG002|Overall Study|Lost to Follow-up|5|||
127748488|NCT00150618|459705317|FG003|Overall Study|Lost to Follow-up|8|||
127748489|NCT00150618|459705318|FG004|Overall Study|Lost to Follow-up|4|||
127748490|NCT00150618|459705314|FG000|Overall Study|Protocol Violation|1|||
127748491|NCT00150618|459705315|FG001|Overall Study|Protocol Violation|0|||
127748492|NCT00150618|459705316|FG002|Overall Study|Protocol Violation|0|||
127748493|NCT00150618|459705317|FG003|Overall Study|Protocol Violation|0|||
127748494|NCT00150618|459705318|FG004|Overall Study|Protocol Violation|1|||
127748495|NCT00150618|459705314|FG000|Overall Study|Lack of Efficacy|1|||
127748496|NCT00150618|459705315|FG001|Overall Study|Lack of Efficacy|4|||
127748497|NCT00150618|459705316|FG002|Overall Study|Lack of Efficacy|7|||
127748498|NCT00150618|459705317|FG003|Overall Study|Lack of Efficacy|4|||
127748499|NCT00150618|459705318|FG004|Overall Study|Lack of Efficacy|6|||
127748500|NCT00150618|459705314|FG000|Overall Study|No study meds|0|||
127748501|NCT00150618|459705315|FG001|Overall Study|No study meds|0|||
127748502|NCT00150618|459705316|FG002|Overall Study|No study meds|0|||
127748503|NCT00150618|459705317|FG003|Overall Study|No study meds|0|||
127748504|NCT00150618|459705318|FG004|Overall Study|No study meds|2|||
127748505|NCT00150618|459705314|FG000|Overall Study|Physician Decision|0|||
127748506|NCT00150618|459705315|FG001|Overall Study|Physician Decision|2|||
127748507|NCT00150618|459705316|FG002|Overall Study|Physician Decision|0|||
127748508|NCT00150618|459705317|FG003|Overall Study|Physician Decision|0|||
127748509|NCT00150618|459705318|FG004|Overall Study|Physician Decision|1|||
127748510|NCT00150618|459705314|FG000|Overall Study|Lack of compliance|2|||
127748511|NCT00150618|459705315|FG001|Overall Study|Lack of compliance|1|||
127748512|NCT00150618|459705316|FG002|Overall Study|Lack of compliance|1|||
127748513|NCT00150618|459705317|FG003|Overall Study|Lack of compliance|0|||
127748514|NCT00150618|459705318|FG004|Overall Study|Lack of compliance|1|||
127748515|NCT00150618|459705314|FG000|Overall Study|Abnormal ECG|1|||
127748516|NCT00150618|459705315|FG001|Overall Study|Abnormal ECG|0|||
127894039|NCT02711956|460235188|FG006|Overall Study|PSA progression with radiographic progression|2|||
127894040|NCT02711956|460235189|FG007|Overall Study|PSA progression with radiographic progression|1|||
127748517|NCT00150618|459705316|FG002|Overall Study|Abnormal ECG|0|||
127748518|NCT00150618|459705317|FG003|Overall Study|Abnormal ECG|0|||
127748519|NCT00150618|459705318|FG004|Overall Study|Abnormal ECG|0|||
127808863|NCT01147926|459919970|FG000|Overall Study|Lost to Follow-up|0|||
127808864|NCT01147926|459919971|FG001|Overall Study|Lost to Follow-up|2|||
127808865|NCT01147926|459919970|FG000|Overall Study|Sponsor's Decision|0|||
127748520|NCT00150618|459705314|FG000|Overall Study|Sponsor's decision|0|||
127748521|NCT00150618|459705315|FG001|Overall Study|Sponsor's decision|0|||
127748522|NCT00150618|459705316|FG002|Overall Study|Sponsor's decision|0|||
127748523|NCT00150618|459705317|FG003|Overall Study|Sponsor's decision|1|||
127748524|NCT00150618|459705318|FG004|Overall Study|Sponsor's decision|0|||
127748525|NCT02493946|459705319|FG000|DB Period|Withdrawal by Subject|8|||
127748526|NCT02493946|459705320|FG001|DB Period|Withdrawal by Subject|5|||
127748527|NCT02493946|459705321|FG002|DB Period|Withdrawal by Subject|0|||
127748528|NCT02493946|459705319|FG000|Open Label Period|Withdrawal by Subject|0|||
127808866|NCT01147926|459919971|FG001|Overall Study|Sponsor's Decision|1|||
127748529|NCT02493946|459705320|FG001|Open Label Period|Withdrawal by Subject|0|||
127748530|NCT02493946|459705321|FG002|Open Label Period|Withdrawal by Subject|74|||
127748531|NCT02493946|459705319|FG000|Open Label Period|Adverse Event|0|||
127748532|NCT02493946|459705320|FG001|Open Label Period|Adverse Event|0|||
127748533|NCT02493946|459705321|FG002|Open Label Period|Adverse Event|4|||
127748534|NCT02493946|459705319|FG000|Open Label Period|Lost to Follow-up|0|||
127748535|NCT02493946|459705320|FG001|Open Label Period|Lost to Follow-up|0|||
127748536|NCT02493946|459705321|FG002|Open Label Period|Lost to Follow-up|1|||
127748537|NCT02493946|459705319|FG000|Open Label Period|Investigator decision, non-compliance|0|||
127748538|NCT02493946|459705320|FG001|Open Label Period|Investigator decision, non-compliance|0|||
127748539|NCT02493946|459705321|FG002|Open Label Period|Investigator decision, non-compliance|2|||
127748540|NCT02493946|459705319|FG000|Open Label Period|Investigator decision, non-availability|0|||
127748541|NCT02493946|459705320|FG001|Open Label Period|Investigator decision, non-availability|0|||
127748542|NCT02493946|459705321|FG002|Open Label Period|Investigator decision, non-availability|1|||
127748543|NCT02493946|459705319|FG000|Open Label Period|Pregnancy|0|||
127748544|NCT02493946|459705320|FG001|Open Label Period|Pregnancy|0|||
127748545|NCT02493946|459705321|FG002|Open Label Period|Pregnancy|3|||
127748546|NCT02493946|459705319|FG000|Open Label Period|Site error|0|||
127748547|NCT02493946|459705320|FG001|Open Label Period|Site error|0|||
127748548|NCT02493946|459705321|FG002|Open Label Period|Site error|1|||
127748549|NCT01727505|459705323|FG000|First 24 Hours|Adverse Event|0|||
127748550|NCT01727505|459705324|FG001|First 24 Hours|Adverse Event|1|||
127748551|NCT01727505|459705323|FG000|Second 24 Hours|Missing data|0|||
127748552|NCT01727505|459705324|FG001|Second 24 Hours|Missing data|1|||
127748553|NCT02389764|459705331|FG000|Overall Study|Lack of Efficacy|9|||
127748554|NCT01814072|459705332|FG000|Overall Study|Lost to Follow-up|2|||
127748555|NCT01814072|459705333|FG001|Overall Study|Lost to Follow-up|2|||
127748556|NCT01814072|459705334|FG002|Overall Study|Lost to Follow-up|2|||
127748557|NCT01814072|459705335|FG003|Overall Study|Lost to Follow-up|0|||
127748558|NCT01814072|459705336|FG004|Overall Study|Lost to Follow-up|2|||
127748559|NCT01814072|459705337|FG005|Overall Study|Lost to Follow-up|3|||
127748560|NCT01814072|459705338|FG006|Overall Study|Lost to Follow-up|3|||
127748561|NCT01814072|459705339|FG007|Overall Study|Lost to Follow-up|1|||
127748562|NCT01814072|459705340|FG008|Overall Study|Lost to Follow-up|2|||
127748563|NCT01814072|459705341|FG009|Overall Study|Lost to Follow-up|3|||
127748564|NCT01814072|459705342|FG010|Overall Study|Lost to Follow-up|1|||
127748565|NCT01814072|459705343|FG011|Overall Study|Lost to Follow-up|2|||
127748566|NCT01814072|459705344|FG012|Overall Study|Lost to Follow-up|2|||
127748567|NCT01814072|459705345|FG013|Overall Study|Lost to Follow-up|1|||
127748568|NCT01814072|459705346|FG014|Overall Study|Lost to Follow-up|2|||
127748569|NCT01814072|459705347|FG015|Overall Study|Lost to Follow-up|1|||
127748570|NCT01814072|459705348|FG016|Overall Study|Lost to Follow-up|3|||
127748571|NCT01814072|459705349|FG017|Overall Study|Lost to Follow-up|1|||
127748572|NCT01814072|459705350|FG018|Overall Study|Lost to Follow-up|3|||
127748573|NCT01814072|459705351|FG019|Overall Study|Lost to Follow-up|3|||
127748574|NCT01814072|459705352|FG020|Overall Study|Lost to Follow-up|2|||
127748575|NCT01814072|459705353|FG021|Overall Study|Lost to Follow-up|1|||
127748576|NCT01814072|459705354|FG022|Overall Study|Lost to Follow-up|3|||
127748577|NCT01814072|459705355|FG023|Overall Study|Lost to Follow-up|1|||
127748578|NCT01814072|459705356|FG024|Overall Study|Lost to Follow-up|4|||
127748579|NCT01814072|459705357|FG025|Overall Study|Lost to Follow-up|1|||
127748580|NCT01814072|459705358|FG026|Overall Study|Lost to Follow-up|1|||
127748581|NCT01814072|459705359|FG027|Overall Study|Lost to Follow-up|2|||
127748582|NCT01814072|459705360|FG028|Overall Study|Lost to Follow-up|3|||
127748583|NCT01814072|459705361|FG029|Overall Study|Lost to Follow-up|3|||
127748584|NCT01814072|459705362|FG030|Overall Study|Lost to Follow-up|2|||
127748585|NCT01814072|459705363|FG031|Overall Study|Lost to Follow-up|0|||
127748586|NCT01814072|459705332|FG000|Overall Study|Withdrawal by Subject|2|||
127748587|NCT01814072|459705333|FG001|Overall Study|Withdrawal by Subject|0|||
127748588|NCT01814072|459705334|FG002|Overall Study|Withdrawal by Subject|1|||
127748589|NCT01814072|459705335|FG003|Overall Study|Withdrawal by Subject|0|||
127748590|NCT01814072|459705336|FG004|Overall Study|Withdrawal by Subject|2|||
127748591|NCT01814072|459705337|FG005|Overall Study|Withdrawal by Subject|3|||
127748592|NCT01814072|459705338|FG006|Overall Study|Withdrawal by Subject|1|||
127748593|NCT01814072|459705339|FG007|Overall Study|Withdrawal by Subject|0|||
127748594|NCT01814072|459705340|FG008|Overall Study|Withdrawal by Subject|1|||
127748595|NCT01814072|459705341|FG009|Overall Study|Withdrawal by Subject|2|||
127748596|NCT01814072|459705342|FG010|Overall Study|Withdrawal by Subject|0|||
127748597|NCT01814072|459705343|FG011|Overall Study|Withdrawal by Subject|0|||
127748598|NCT01814072|459705344|FG012|Overall Study|Withdrawal by Subject|1|||
127748599|NCT01814072|459705345|FG013|Overall Study|Withdrawal by Subject|1|||
127748600|NCT01814072|459705346|FG014|Overall Study|Withdrawal by Subject|1|||
127748601|NCT01814072|459705347|FG015|Overall Study|Withdrawal by Subject|1|||
127748602|NCT01814072|459705348|FG016|Overall Study|Withdrawal by Subject|0|||
127748603|NCT01814072|459705349|FG017|Overall Study|Withdrawal by Subject|0|||
127748604|NCT01814072|459705350|FG018|Overall Study|Withdrawal by Subject|0|||
127748605|NCT01814072|459705351|FG019|Overall Study|Withdrawal by Subject|2|||
127748606|NCT01814072|459705352|FG020|Overall Study|Withdrawal by Subject|0|||
127748607|NCT01814072|459705353|FG021|Overall Study|Withdrawal by Subject|0|||
127748608|NCT01814072|459705354|FG022|Overall Study|Withdrawal by Subject|1|||
127748609|NCT01814072|459705355|FG023|Overall Study|Withdrawal by Subject|0|||
127748610|NCT01814072|459705356|FG024|Overall Study|Withdrawal by Subject|2|||
127748611|NCT01814072|459705357|FG025|Overall Study|Withdrawal by Subject|1|||
127748612|NCT01814072|459705358|FG026|Overall Study|Withdrawal by Subject|1|||
127748613|NCT01814072|459705359|FG027|Overall Study|Withdrawal by Subject|2|||
127748614|NCT01814072|459705360|FG028|Overall Study|Withdrawal by Subject|1|||
127748615|NCT01814072|459705361|FG029|Overall Study|Withdrawal by Subject|0|||
127748616|NCT01814072|459705362|FG030|Overall Study|Withdrawal by Subject|0|||
127748617|NCT01814072|459705363|FG031|Overall Study|Withdrawal by Subject|0|||
127748618|NCT01011868|459705364|FG000|After Week 18 Follow-up|Adverse Event|8|||
127748619|NCT01011868|459705365|FG001|After Week 18 Follow-up|Adverse Event|6|||
127748620|NCT01011868|459705366|FG002|After Week 18 Follow-up|Adverse Event|13|||
127748621|NCT01011868|459705364|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
127748622|NCT01011868|459705365|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
127748623|NCT01011868|459705366|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
127748624|NCT01011868|459705364|FG000|After Week 18 Follow-up|Protocol Violation|1|||
127748625|NCT01011868|459705365|FG001|After Week 18 Follow-up|Protocol Violation|1|||
127748626|NCT01011868|459705366|FG002|After Week 18 Follow-up|Protocol Violation|1|||
127748627|NCT01011868|459705364|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
127748628|NCT01011868|459705365|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
127748629|NCT01011868|459705366|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
127748630|NCT01011868|459705364|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
127748631|NCT01011868|459705365|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
127748632|NCT01011868|459705366|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
127748633|NCT01011868|459705364|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
127748634|NCT01011868|459705365|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
127748635|NCT01011868|459705366|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
127748636|NCT01011868|459705364|FG000|After Week 78 Follow-up|Adverse Event|14|||
127748637|NCT01011868|459705365|FG001|After Week 78 Follow-up|Adverse Event|18|||
127748638|NCT01011868|459705366|FG002|After Week 78 Follow-up|Adverse Event|21|||
127748639|NCT01011868|459705364|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
127748640|NCT01011868|459705365|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
127748641|NCT01011868|459705366|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
127748642|NCT01011868|459705364|FG000|After Week 78 Follow-up|Protocol Violation|9|||
127748643|NCT01011868|459705365|FG001|After Week 78 Follow-up|Protocol Violation|1|||
127748644|NCT01011868|459705366|FG002|After Week 78 Follow-up|Protocol Violation|2|||
127748645|NCT01011868|459705364|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
127748646|NCT01011868|459705365|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
127748647|NCT01011868|459705366|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
127748648|NCT01011868|459705364|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
127748649|NCT01011868|459705365|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
127748650|NCT01011868|459705366|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
127748651|NCT01011868|459705364|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
127748652|NCT01011868|459705365|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
127748653|NCT01011868|459705366|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
127808867|NCT01147926|459919970|FG000|Overall Study|Lack of Efficacy|1|||
127808868|NCT01147926|459919971|FG001|Overall Study|Lack of Efficacy|0|||
127808869|NCT01147926|459919970|FG000|Overall Study|Too busy, no time for study|1|||
127808870|NCT01147926|459919971|FG001|Overall Study|Too busy, no time for study|0|||
127808871|NCT01147926|459919970|FG000|Overall Study|Went on holiday|0|||
127808872|NCT01147926|459919971|FG001|Overall Study|Went on holiday|1|||
127808873|NCT01147926|459919970|FG000|Overall Study|Colonoscopy result|0|||
127808874|NCT01147926|459919971|FG001|Overall Study|Colonoscopy result|1|||
127808875|NCT03514914|459919973|FG000|Overall Study|Death|3|||
127808876|NCT03514914|459919974|FG001|Overall Study|Death|3|||
127808877|NCT03514914|459919973|FG000|Overall Study|Lost to Follow-up|117|||
127808878|NCT03514914|459919974|FG001|Overall Study|Lost to Follow-up|89|||
127808879|NCT01355289|459919976|FG000|Core Study|Adverse Event, Non-Fatal|1|||
127748654|NCT02336425|459705367|FG000|Overall Study|Study terminated.|2|||
127748655|NCT02336425|459705368|FG001|Overall Study|Study terminated.|2|||
127748656|NCT02336425|459705369|FG002|Overall Study|Study terminated.|3|||
127748657|NCT02336425|459705370|FG003|Overall Study|Study terminated.|3|||
127808880|NCT01355289|459919977|FG001|Core Study|Adverse Event, Non-Fatal|0|||
127748658|NCT00978562|459705371|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
127748659|NCT01782690|459705372|FG000|Overall Study|Not reported|7|||
127748660|NCT01782690|459705372|FG000|Overall Study|Toxicity of gemcitabine|1|||
127748661|NCT01782690|459705372|FG000|Overall Study|Toxicity of erlotinib|1|||
127748662|NCT01782690|459705372|FG000|Overall Study|Lost to Follow-up|31|||
127748663|NCT01782690|459705372|FG000|Overall Study|Withdrawal of informed consent|2|||
127808881|NCT01355289|459919978|FG002|Core Study|Adverse Event, Non-Fatal|0|||
127808882|NCT01355289|459919979|FG003|Core Study|Adverse Event, Non-Fatal|0|||
127748664|NCT01782690|459705372|FG000|Overall Study|Absent rash|9|||
127748665|NCT01782690|459705372|FG000|Overall Study|Physician Decision|13|||
127748666|NCT01782690|459705372|FG000|Overall Study|Patient's wish|21|||
127748667|NCT01782690|459705372|FG000|Overall Study|Tumor progression|74|||
127748668|NCT01782690|459705372|FG000|Overall Study|Death|133|||
127748669|NCT01782690|459705372|FG000|Overall Study|Study completion unknown|7|||
127748670|NCT04946942|459705374|FG000|Overall Study|Lost to Follow-up|6|||
127748671|NCT04946942|459705375|FG001|Overall Study|Lost to Follow-up|2|||
127748672|NCT04946942|459705376|FG002|Overall Study|Lost to Follow-up|0|||
127748673|NCT04907357|459705377|FG000|Overall Study|Death|0|||
127748674|NCT04907357|459705378|FG001|Overall Study|Death|1|||
127748675|NCT04907357|459705377|FG000|Overall Study|Lost to Follow-up|9|||
127748676|NCT04907357|459705378|FG001|Overall Study|Lost to Follow-up|18|||
127748677|NCT04907357|459705377|FG000|Overall Study|Physician Decision|1|||
127748678|NCT04907357|459705378|FG001|Overall Study|Physician Decision|0|||
127748679|NCT04907357|459705377|FG000|Overall Study|Withdrawal by Subject|0|||
127748680|NCT04907357|459705378|FG001|Overall Study|Withdrawal by Subject|1|||
127748681|NCT04907357|459705377|FG000|Overall Study|Unable to attend visits|1|||
127748682|NCT04907357|459705378|FG001|Overall Study|Unable to attend visits|0|||
127748683|NCT04907357|459705377|FG000|Overall Study|Incarcerated|1|||
127748684|NCT04907357|459705378|FG001|Overall Study|Incarcerated|1|||
127748685|NCT01948076|459705379|FG000|Overall Study|Withdrawal by Subject|0|||
127748686|NCT01948076|459705380|FG001|Overall Study|Withdrawal by Subject|1|||
127748687|NCT00738283|459705387|FG000|Overall Study|Death|1|||
127748688|NCT00738283|459705387|FG000|Overall Study|Transfer to another facility|2|||
127748689|NCT00738283|459705387|FG000|Overall Study|Discharge home prior to end of study|1|||
127748690|NCT00486252|459705390|FG000|Overall Study|Adverse Event|7|||
127748691|NCT00486252|459705390|FG000|Overall Study|Lack of Efficacy|9|||
127748692|NCT00486252|459705390|FG000|Overall Study|Lost to Follow-up|24|||
127748693|NCT00486252|459705390|FG000|Overall Study|Other|18|||
127748694|NCT01210651|459705391|FG000|Overall Study|Lost to Follow-up|1|||
127748695|NCT01210651|459705392|FG001|Overall Study|Lost to Follow-up|1|||
127748696|NCT01210651|459705391|FG000|Overall Study|schedule conflicts|1|||
127748697|NCT01210651|459705392|FG001|Overall Study|schedule conflicts|5|||
127748698|NCT01210651|459705391|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
127748699|NCT01210651|459705392|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
127748700|NCT01210651|459705391|FG000|Overall Study|Withdrawal by Subject|1|||
127748701|NCT01210651|459705392|FG001|Overall Study|Withdrawal by Subject|1|||
127748702|NCT01210651|459705391|FG000|Overall Study|Injury outside study|2|||
127748703|NCT01210651|459705392|FG001|Overall Study|Injury outside study|0|||
127748704|NCT01261247|459705393|FG000|Overall Study|Ineligible|2|||
127748705|NCT02592707|459705397|FG000|Overall Study|Consent Withdrawn|0|||
127748706|NCT02592707|459705398|FG001|Overall Study|Consent Withdrawn|1|||
127748707|NCT02592707|459705399|FG002|Overall Study|Consent Withdrawn|2|||
127748708|NCT02592707|459705400|FG003|Overall Study|Consent Withdrawn|0|||
127748709|NCT02592707|459705397|FG000|Overall Study|Death|1|||
127748710|NCT02592707|459705398|FG001|Overall Study|Death|0|||
127748711|NCT02592707|459705399|FG002|Overall Study|Death|0|||
127748712|NCT02592707|459705400|FG003|Overall Study|Death|0|||
127748713|NCT02592707|459705397|FG000|Overall Study|Progressive Disease|4|||
127748714|NCT02592707|459705398|FG001|Overall Study|Progressive Disease|4|||
127748715|NCT02592707|459705399|FG002|Overall Study|Progressive Disease|3|||
127748716|NCT02592707|459705400|FG003|Overall Study|Progressive Disease|3|||
127748717|NCT02592707|459705397|FG000|Overall Study|Other|0|||
127748718|NCT02592707|459705398|FG001|Overall Study|Other|0|||
127748719|NCT02592707|459705399|FG002|Overall Study|Other|1|||
127748720|NCT02592707|459705400|FG003|Overall Study|Other|2|||
127748721|NCT02592707|459705397|FG000|Overall Study|Never entered LTFU period|1|||
127808883|NCT01355289|459919980|FG004|Core Study|Adverse Event, Non-Fatal|0|||
127748722|NCT02592707|459705398|FG001|Overall Study|Never entered LTFU period|0|||
127748723|NCT02592707|459705399|FG002|Overall Study|Never entered LTFU period|0|||
127748724|NCT02592707|459705400|FG003|Overall Study|Never entered LTFU period|2|||
127748725|NCT04124471|459705401|FG000|Overall Study|screen failure|1|||
127748726|NCT04855734|459705402|FG000|Overall Study|Lost to Follow-up|2|||
127748727|NCT04855734|459705403|FG001|Overall Study|Lost to Follow-up|2|||
127748728|NCT04013971|459705404|FG000|Overall Study|Treadmill speed less than 0.50 miles per hour|2|||
127748729|NCT04013971|459705405|FG001|Overall Study|Treadmill speed less than 0.50 miles per hour|0|||
127748730|NCT04013971|459705404|FG000|Overall Study|Missing biomechanical data|0|||
127748731|NCT04013971|459705405|FG001|Overall Study|Missing biomechanical data|1|||
127748732|NCT00344032|459705411|FG000|Overall Study|Adverse Event|0|||
127748733|NCT00344032|459705412|FG001|Overall Study|Adverse Event|1|||
127748734|NCT00344032|459705411|FG000|Overall Study|Withdrawal by Subject|6|||
127748735|NCT00344032|459705412|FG001|Overall Study|Withdrawal by Subject|2|||
127748736|NCT00344032|459705411|FG000|Overall Study|Lost to Follow-up|4|||
127748737|NCT00344032|459705412|FG001|Overall Study|Lost to Follow-up|6|||
127748738|NCT00344032|459705411|FG000|Overall Study|Physician Decision|4|||
127748739|NCT00344032|459705412|FG001|Overall Study|Physician Decision|1|||
127748740|NCT02600897|459705413|FG000|Overall Study|Death|1|||
127748741|NCT02600897|459705414|FG001|Overall Study|Death|2|||
127808884|NCT01355289|459919976|FG000|Core Study|Inadequate Therapeutic Effect|0|||
127808885|NCT01355289|459919977|FG001|Core Study|Inadequate Therapeutic Effect|0|||
127808886|NCT01355289|459919978|FG002|Core Study|Inadequate Therapeutic Effect|0|||
127808887|NCT01355289|459919979|FG003|Core Study|Inadequate Therapeutic Effect|1|||
127808888|NCT01355289|459919980|FG004|Core Study|Inadequate Therapeutic Effect|0|||
127748742|NCT02600897|459705415|FG002|Overall Study|Death|1|||
127748743|NCT02600897|459705416|FG003|Overall Study|Death|2|||
127748744|NCT02600897|459705417|FG004|Overall Study|Death|3|||
127748745|NCT02600897|459705418|FG005|Overall Study|Death|2|||
127748746|NCT02600897|459705419|FG006|Overall Study|Death|10|||
127748747|NCT02600897|459705420|FG007|Overall Study|Death|7|||
127748748|NCT02600897|459705421|FG008|Overall Study|Death|20|||
127748749|NCT02600897|459705413|FG000|Overall Study|Lost to Follow-up|1|||
127748750|NCT02600897|459705414|FG001|Overall Study|Lost to Follow-up|0|||
127748751|NCT02600897|459705415|FG002|Overall Study|Lost to Follow-up|0|||
127748752|NCT02600897|459705416|FG003|Overall Study|Lost to Follow-up|0|||
127748753|NCT02600897|459705417|FG004|Overall Study|Lost to Follow-up|0|||
127748754|NCT02600897|459705418|FG005|Overall Study|Lost to Follow-up|0|||
127748755|NCT02600897|459705419|FG006|Overall Study|Lost to Follow-up|0|||
127748756|NCT02600897|459705420|FG007|Overall Study|Lost to Follow-up|1|||
127748757|NCT02600897|459705421|FG008|Overall Study|Lost to Follow-up|0|||
127748758|NCT02600897|459705413|FG000|Overall Study|Withdrawal by Subject|0|||
127748759|NCT02600897|459705414|FG001|Overall Study|Withdrawal by Subject|0|||
127748760|NCT02600897|459705415|FG002|Overall Study|Withdrawal by Subject|0|||
127748761|NCT02600897|459705416|FG003|Overall Study|Withdrawal by Subject|0|||
127748762|NCT02600897|459705417|FG004|Overall Study|Withdrawal by Subject|0|||
127748763|NCT02600897|459705418|FG005|Overall Study|Withdrawal by Subject|0|||
127748764|NCT02600897|459705419|FG006|Overall Study|Withdrawal by Subject|0|||
127748765|NCT02600897|459705420|FG007|Overall Study|Withdrawal by Subject|4|||
127748766|NCT02600897|459705421|FG008|Overall Study|Withdrawal by Subject|2|||
127748767|NCT02600897|459705413|FG000|Overall Study|Reason Not Specified|0|||
127748768|NCT02600897|459705414|FG001|Overall Study|Reason Not Specified|0|||
127748769|NCT02600897|459705415|FG002|Overall Study|Reason Not Specified|0|||
127748770|NCT02600897|459705416|FG003|Overall Study|Reason Not Specified|0|||
127748771|NCT02600897|459705417|FG004|Overall Study|Reason Not Specified|0|||
127748772|NCT02600897|459705418|FG005|Overall Study|Reason Not Specified|0|||
127748773|NCT02600897|459705419|FG006|Overall Study|Reason Not Specified|0|||
127748774|NCT02600897|459705420|FG007|Overall Study|Reason Not Specified|0|||
127748775|NCT02600897|459705421|FG008|Overall Study|Reason Not Specified|1|||
127748776|NCT06840769|459705422|FG000|Overall Study|Withdrawal by Subject|1|||
127748777|NCT06840769|459705423|FG001|Overall Study|Withdrawal by Subject|0|||
127748778|NCT06840769|459705424|FG002|Overall Study|Withdrawal by Subject|0|||
127808889|NCT01355289|459919976|FG000|Core Study|Other|0|||
127808890|NCT01355289|459919977|FG001|Core Study|Other|0|||
127808891|NCT01355289|459919978|FG002|Core Study|Other|0|||
127808892|NCT01355289|459919979|FG003|Core Study|Other|1|||
127808893|NCT01355289|459919980|FG004|Core Study|Other|0|||
127808894|NCT01355289|459919976|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
127808895|NCT01355289|459919977|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
127808896|NCT01355289|459919978|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
127808897|NCT01355289|459919979|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
127808898|NCT01355289|459919980|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
127808899|NCT01355289|459919976|FG000|Open Label Extension|Lost to Follow-up|0|||
127808900|NCT01355289|459919977|FG001|Open Label Extension|Lost to Follow-up|0|||
127808901|NCT01355289|459919978|FG002|Open Label Extension|Lost to Follow-up|0|||
127808902|NCT01355289|459919979|FG003|Open Label Extension|Lost to Follow-up|0|||
127808903|NCT01355289|459919980|FG004|Open Label Extension|Lost to Follow-up|1|||
127808904|NCT01355289|459919976|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
127808905|NCT01355289|459919977|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
127808906|NCT01355289|459919978|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
127808907|NCT01355289|459919979|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
127808908|NCT01355289|459919980|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
127808909|NCT01355289|459919976|FG000|Open Label Extension|Other|0|||
127748779|NCT06840769|459705425|FG003|Overall Study|Withdrawal by Subject|0|||
127748780|NCT06840769|459705426|FG004|Overall Study|Withdrawal by Subject|0|||
127894041|NCT02711956|460235190|FG008|Overall Study|PSA progression with radiographic progression|0|||
127748781|NCT03192462|459707873|FG000|Overall Study|Death|13|||
127748782|NCT03192462|459707874|FG001|Overall Study|Death|11|||
127748783|NCT03192462|459707875|FG002|Overall Study|Death|9|||
127748784|NCT03192462|459707873|FG000|Overall Study|Lost to Follow-up|0|||
127748785|NCT03192462|459707874|FG001|Overall Study|Lost to Follow-up|1|||
127748786|NCT03192462|459707875|FG002|Overall Study|Lost to Follow-up|0|||
127748787|NCT03192462|459707873|FG000|Overall Study|On follow up|0|||
127748788|NCT03192462|459707874|FG001|Overall Study|On follow up|0|||
127748789|NCT03192462|459707875|FG002|Overall Study|On follow up|3|||
127808910|NCT01355289|459919977|FG001|Open Label Extension|Other|0|||
127808911|NCT01355289|459919978|FG002|Open Label Extension|Other|0|||
127808912|NCT01355289|459919979|FG003|Open Label Extension|Other|0|||
127894042|NCT02711956|460235191|FG009|Overall Study|PSA progression with radiographic progression|1|||
127894043|NCT02711956|460235192|FG010|Overall Study|PSA progression with radiographic progression|0|||
127894044|NCT02711956|460235193|FG011|Overall Study|PSA progression with radiographic progression|1|||
127894045|NCT02711956|460235194|FG012|Overall Study|PSA progression with radiographic progression|2|||
127894046|NCT02711956|460235195|FG013|Overall Study|PSA progression with radiographic progression|3|||
127748790|NCT02419417|459707876|FG000|Overall Study|Disease progression|5|||
127748791|NCT02419417|459707877|FG001|Overall Study|Disease progression|4|||
127748792|NCT02419417|459707878|FG002|Overall Study|Disease progression|13|||
127748793|NCT02419417|459707879|FG003|Overall Study|Disease progression|10|||
127748794|NCT02419417|459707880|FG004|Overall Study|Disease progression|10|||
127748795|NCT02419417|459707881|FG005|Overall Study|Disease progression|3|||
127748796|NCT02419417|459707882|FG006|Overall Study|Disease progression|4|||
127748797|NCT02419417|459707883|FG007|Overall Study|Disease progression|5|||
127748798|NCT02419417|459707884|FG008|Overall Study|Disease progression|13|||
127748799|NCT02419417|459707885|FG009|Overall Study|Disease progression|9|||
127748800|NCT02419417|459707886|FG010|Overall Study|Disease progression|0|||
127748801|NCT02419417|459707876|FG000|Overall Study|Study drug toxicity|0|||
127748802|NCT02419417|459707877|FG001|Overall Study|Study drug toxicity|0|||
127748803|NCT02419417|459707878|FG002|Overall Study|Study drug toxicity|0|||
127748804|NCT02419417|459707879|FG003|Overall Study|Study drug toxicity|0|||
127748805|NCT02419417|459707880|FG004|Overall Study|Study drug toxicity|1|||
127748806|NCT02419417|459707881|FG005|Overall Study|Study drug toxicity|0|||
127748807|NCT02419417|459707882|FG006|Overall Study|Study drug toxicity|0|||
127748808|NCT02419417|459707883|FG007|Overall Study|Study drug toxicity|0|||
127748809|NCT02419417|459707884|FG008|Overall Study|Study drug toxicity|0|||
127748810|NCT02419417|459707885|FG009|Overall Study|Study drug toxicity|0|||
127748811|NCT02419417|459707886|FG010|Overall Study|Study drug toxicity|0|||
127748812|NCT02419417|459707876|FG000|Overall Study|Adverse event unrelated to study drug|0|||
127748813|NCT02419417|459707877|FG001|Overall Study|Adverse event unrelated to study drug|0|||
127748814|NCT02419417|459707878|FG002|Overall Study|Adverse event unrelated to study drug|0|||
127748815|NCT02419417|459707879|FG003|Overall Study|Adverse event unrelated to study drug|0|||
127748816|NCT02419417|459707880|FG004|Overall Study|Adverse event unrelated to study drug|2|||
127748817|NCT02419417|459707881|FG005|Overall Study|Adverse event unrelated to study drug|1|||
127748818|NCT02419417|459707882|FG006|Overall Study|Adverse event unrelated to study drug|0|||
127748819|NCT02419417|459707883|FG007|Overall Study|Adverse event unrelated to study drug|1|||
127748820|NCT02419417|459707884|FG008|Overall Study|Adverse event unrelated to study drug|0|||
127748821|NCT02419417|459707885|FG009|Overall Study|Adverse event unrelated to study drug|0|||
127748822|NCT02419417|459707886|FG010|Overall Study|Adverse event unrelated to study drug|0|||
127748823|NCT02419417|459707876|FG000|Overall Study|Participant request to discontinue|0|||
127748824|NCT02419417|459707877|FG001|Overall Study|Participant request to discontinue|0|||
127748825|NCT02419417|459707878|FG002|Overall Study|Participant request to discontinue|0|||
127748826|NCT02419417|459707879|FG003|Overall Study|Participant request to discontinue|0|||
127748827|NCT02419417|459707880|FG004|Overall Study|Participant request to discontinue|0|||
127748828|NCT02419417|459707881|FG005|Overall Study|Participant request to discontinue|0|||
127748829|NCT02419417|459707882|FG006|Overall Study|Participant request to discontinue|0|||
127748830|NCT02419417|459707883|FG007|Overall Study|Participant request to discontinue|0|||
127748831|NCT02419417|459707884|FG008|Overall Study|Participant request to discontinue|0|||
127748832|NCT02419417|459707885|FG009|Overall Study|Participant request to discontinue|1|||
127748833|NCT02419417|459707886|FG010|Overall Study|Participant request to discontinue|0|||
127748834|NCT02419417|459707876|FG000|Overall Study|Withdrawal by Subject|0|||
127748835|NCT02419417|459707877|FG001|Overall Study|Withdrawal by Subject|0|||
127748836|NCT02419417|459707878|FG002|Overall Study|Withdrawal by Subject|0|||
127748837|NCT02419417|459707879|FG003|Overall Study|Withdrawal by Subject|0|||
127748838|NCT02419417|459707880|FG004|Overall Study|Withdrawal by Subject|0|||
127748839|NCT02419417|459707881|FG005|Overall Study|Withdrawal by Subject|0|||
127748840|NCT02419417|459707882|FG006|Overall Study|Withdrawal by Subject|0|||
127748841|NCT02419417|459707883|FG007|Overall Study|Withdrawal by Subject|0|||
127748842|NCT02419417|459707884|FG008|Overall Study|Withdrawal by Subject|0|||
127748843|NCT02419417|459707885|FG009|Overall Study|Withdrawal by Subject|0|||
127748844|NCT02419417|459707886|FG010|Overall Study|Withdrawal by Subject|1|||
127748845|NCT00078377|459707887|FG000|Overall Study|Adverse Event|2|||
127748846|NCT00078377|459707888|FG001|Overall Study|Adverse Event|5|||
127748847|NCT00078377|459707889|FG002|Overall Study|Adverse Event|1|||
127748848|NCT00078377|459707887|FG000|Overall Study|Lack of Efficacy|2|||
127894047|NCT02711956|460235196|FG014|Overall Study|PSA progression with radiographic progression|3|||
127748849|NCT00078377|459707888|FG001|Overall Study|Lack of Efficacy|0|||
127748850|NCT00078377|459707889|FG002|Overall Study|Lack of Efficacy|2|||
127748851|NCT00078377|459707887|FG000|Overall Study|Lost to Follow-up|0|||
127748852|NCT00078377|459707888|FG001|Overall Study|Lost to Follow-up|1|||
127748853|NCT00078377|459707889|FG002|Overall Study|Lost to Follow-up|1|||
127748854|NCT00078377|459707887|FG000|Overall Study|Physician Decision|2|||
127748855|NCT00078377|459707888|FG001|Overall Study|Physician Decision|0|||
127748856|NCT00078377|459707889|FG002|Overall Study|Physician Decision|0|||
127748857|NCT00078377|459707887|FG000|Overall Study|Withdrawal by Subject|3|||
127808913|NCT01355289|459919980|FG004|Open Label Extension|Other|3|||
127808914|NCT04336163|459919981|FG000|Overall Study|Lost to Follow-up|55|||
127808915|NCT04336163|459919982|FG001|Overall Study|Lost to Follow-up|0|||
127808916|NCT01085682|459919983|FG000|Overall Study|Withdrawal by Subject|25|||
127808917|NCT01085682|459919984|FG001|Overall Study|Withdrawal by Subject|25|||
127808918|NCT00813995|459919989|FG000|Overall Study|Clinical adverse event|9|||
127808919|NCT00813995|459919990|FG001|Overall Study|Clinical adverse event|3|||
127808920|NCT00813995|459919989|FG000|Overall Study|Laboratory adverse event|0|||
127894048|NCT03734237|460235197|FG000|Overall Study|Lost to Follow-up|1|||
127894049|NCT03734237|460235198|FG001|Overall Study|Lost to Follow-up|3|||
127894050|NCT03734237|460235199|FG002|Overall Study|Lost to Follow-up|0|||
127894051|NCT03734237|460235197|FG000|Overall Study|Withdrawal by Subject|7|||
127894052|NCT03734237|460235198|FG001|Overall Study|Withdrawal by Subject|9|||
127894053|NCT03734237|460235199|FG002|Overall Study|Withdrawal by Subject|10|||
127894054|NCT01673009|460235200|FG000|Overall Study|Physician Decision|5|||
127894055|NCT01673009|460235200|FG000|Overall Study|Withdrawal by Subject|8|||
127894056|NCT02207621|460235203|FG000|Overall Study|Adverse Event|71|||
127894057|NCT02207621|460235204|FG001|Overall Study|Adverse Event|15|||
127894058|NCT02207621|460235205|FG002|Overall Study|Adverse Event|132|||
127894059|NCT02207621|460235203|FG000|Overall Study|Withdrawal by Subject|9|||
127894060|NCT02207621|460235204|FG001|Overall Study|Withdrawal by Subject|9|||
127894061|NCT02207621|460235205|FG002|Overall Study|Withdrawal by Subject|13|||
127894062|NCT02207621|460235203|FG000|Overall Study|Non-Compliant|3|||
127894063|NCT02207621|460235204|FG001|Overall Study|Non-Compliant|3|||
127894064|NCT02207621|460235205|FG002|Overall Study|Non-Compliant|1|||
127894065|NCT02207621|460235203|FG000|Overall Study|Lost to Follow-up|1|||
127894066|NCT02207621|460235204|FG001|Overall Study|Lost to Follow-up|0|||
127894067|NCT02207621|460235205|FG002|Overall Study|Lost to Follow-up|3|||
127894068|NCT02207621|460235203|FG000|Overall Study|Lack of Efficacy|10|||
127894069|NCT02207621|460235204|FG001|Overall Study|Lack of Efficacy|2|||
127894070|NCT02207621|460235205|FG002|Overall Study|Lack of Efficacy|4|||
127894071|NCT02207621|460235203|FG000|Overall Study|Disallowed Concurrent Medication|2|||
127894072|NCT02207621|460235204|FG001|Overall Study|Disallowed Concurrent Medication|5|||
127894073|NCT02207621|460235205|FG002|Overall Study|Disallowed Concurrent Medication|2|||
127894074|NCT02207621|460235203|FG000|Overall Study|Physician Decision|1|||
127894075|NCT02207621|460235204|FG001|Overall Study|Physician Decision|2|||
127748858|NCT00078377|459707888|FG001|Overall Study|Withdrawal by Subject|4|||
127748859|NCT00078377|459707889|FG002|Overall Study|Withdrawal by Subject|4|||
127748860|NCT00078377|459707887|FG000|Overall Study|Miscellaneous|2|||
127748861|NCT00078377|459707888|FG001|Overall Study|Miscellaneous|6|||
127748862|NCT00078377|459707889|FG002|Overall Study|Miscellaneous|1|||
127748863|NCT00953147|459707890|FG000|Overall Study|Adverse Event|8|||
127748864|NCT00953147|459707891|FG001|Overall Study|Adverse Event|16|||
127748865|NCT00953147|459707892|FG002|Overall Study|Adverse Event|6|||
127748866|NCT00953147|459707890|FG000|Overall Study|Protocol Violation|2|||
127748867|NCT00953147|459707891|FG001|Overall Study|Protocol Violation|8|||
127748868|NCT00953147|459707892|FG002|Overall Study|Protocol Violation|4|||
127748869|NCT00953147|459707890|FG000|Overall Study|Withdrawal by Subject|13|||
127748870|NCT00953147|459707891|FG001|Overall Study|Withdrawal by Subject|15|||
127748871|NCT00953147|459707892|FG002|Overall Study|Withdrawal by Subject|12|||
127748872|NCT00953147|459707890|FG000|Overall Study|Lost to Follow-up|8|||
127748873|NCT00953147|459707891|FG001|Overall Study|Lost to Follow-up|9|||
127748874|NCT00953147|459707892|FG002|Overall Study|Lost to Follow-up|4|||
127808921|NCT00813995|459919990|FG001|Overall Study|Laboratory adverse event|2|||
127808922|NCT00813995|459919989|FG000|Overall Study|Lack of Efficacy|1|||
127808923|NCT00813995|459919990|FG001|Overall Study|Lack of Efficacy|0|||
127894076|NCT02207621|460235205|FG002|Overall Study|Physician Decision|2|||
127748875|NCT00953147|459707890|FG000|Overall Study|Physician Decision|2|||
127748876|NCT00953147|459707891|FG001|Overall Study|Physician Decision|7|||
127748877|NCT00953147|459707892|FG002|Overall Study|Physician Decision|3|||
127808924|NCT00813995|459919989|FG000|Overall Study|Lost to Follow-up|4|||
127808925|NCT00813995|459919990|FG001|Overall Study|Lost to Follow-up|2|||
127808926|NCT00813995|459919989|FG000|Overall Study|Other reason|2|||
127894077|NCT02207621|460235203|FG000|Overall Study|Protocol Violation|4|||
127894078|NCT02207621|460235204|FG001|Overall Study|Protocol Violation|10|||
127894079|NCT02207621|460235205|FG002|Overall Study|Protocol Violation|6|||
127894080|NCT02207621|460235203|FG000|Overall Study|Death|2|||
127894081|NCT02207621|460235204|FG001|Overall Study|Death|0|||
127748878|NCT00953147|459707890|FG000|Overall Study|Other|4|||
127748879|NCT00953147|459707891|FG001|Overall Study|Other|11|||
127748880|NCT00953147|459707892|FG002|Overall Study|Other|13|||
127808927|NCT00813995|459919990|FG001|Overall Study|Other reason|2|||
127894082|NCT02207621|460235205|FG002|Overall Study|Death|0|||
127894083|NCT02207621|460235203|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
127808928|NCT00813995|459919989|FG000|Overall Study|Protocol Violation|3|||
127808929|NCT00813995|459919990|FG001|Overall Study|Protocol Violation|2|||
127808930|NCT00813995|459919989|FG000|Overall Study|Subject moved|4|||
127808931|NCT00813995|459919990|FG001|Overall Study|Subject moved|0|||
127808932|NCT00813995|459919989|FG000|Overall Study|Withdrawal by Subject|0|||
127808933|NCT00813995|459919990|FG001|Overall Study|Withdrawal by Subject|5|||
127808934|NCT02507349|459919991|FG000|Overall Study|Death|12|||
127808935|NCT02507349|459919992|FG001|Overall Study|Death|16|||
127808936|NCT02507349|459919991|FG000|Overall Study|Withdrawal by Subject|1|||
127808937|NCT02507349|459919992|FG001|Overall Study|Withdrawal by Subject|1|||
127808938|NCT02507349|459919991|FG000|Overall Study|Lost to Follow-up|174|||
127748881|NCT00790400|459707893|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
127748882|NCT00790400|459707894|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
127748883|NCT00790400|459707893|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
127748884|NCT00790400|459707894|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
127748885|NCT00790400|459707893|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
127748886|NCT00790400|459707894|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
127748887|NCT00790400|459707893|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
127748888|NCT00790400|459707894|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
127748889|NCT00790400|459707893|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
127748890|NCT00790400|459707894|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
127748891|NCT00790400|459707893|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
127748892|NCT00790400|459707894|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
127748893|NCT00790400|459707893|FG000|Double-blind Period (Core Phase)|Death|1|||
127748894|NCT00790400|459707894|FG001|Double-blind Period (Core Phase)|Death|0|||
127748895|NCT00790400|459707893|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
127748896|NCT00790400|459707894|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
127748897|NCT00790400|459707893|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
127748898|NCT00790400|459707894|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
127748899|NCT00790400|459707893|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
127748900|NCT00790400|459707894|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
127748901|NCT00790400|459707893|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
127748902|NCT00790400|459707894|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
127748903|NCT00790400|459707893|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
127748904|NCT00790400|459707894|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
127748905|NCT00790400|459707893|FG000|Everolimus Period (Core or Extension)|Death|1|||
127748906|NCT00790400|459707894|FG001|Everolimus Period (Core or Extension)|Death|0|||
127748907|NCT00790400|459707893|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
127748908|NCT00790400|459707894|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
127748909|NCT00790400|459707893|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
127748910|NCT00790400|459707894|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
127748911|NCT00790400|459707893|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
127748912|NCT00790400|459707894|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
127748913|NCT00078338|459707895|FG000|Overall Study|Adverse Event|31|||
127748914|NCT00078338|459707896|FG001|Overall Study|Adverse Event|24|||
127748915|NCT00078338|459707895|FG000|Overall Study|Lost to Follow-up|17|||
127748916|NCT00078338|459707896|FG001|Overall Study|Lost to Follow-up|2|||
127748917|NCT00078338|459707895|FG000|Overall Study|Protocol Violation|2|||
127748918|NCT00078338|459707896|FG001|Overall Study|Protocol Violation|2|||
127748919|NCT00078338|459707895|FG000|Overall Study|Disease Progression|4|||
127748920|NCT00078338|459707896|FG001|Overall Study|Disease Progression|7|||
127748921|NCT00078338|459707895|FG000|Overall Study|Other|28|||
127748922|NCT00078338|459707896|FG001|Overall Study|Other|16|||
127748923|NCT00078338|459707895|FG000|Overall Study|Subjects randomized, but not treated|3|||
127748924|NCT00078338|459707896|FG001|Overall Study|Subjects randomized, but not treated|3|||
127748925|NCT03258723|459707897|FG000|Overall Study|COVID Interruption of study|54|||
127748926|NCT03258723|459707897|FG000|Overall Study|Lost to Follow-up|8|||
127748927|NCT01606319|459707901|FG000|Overall Study|Lost to Follow-up|17|||
127748928|NCT01606319|459707902|FG001|Overall Study|Lost to Follow-up|14|||
127748929|NCT01606319|459707901|FG000|Overall Study|Withdrawal by Subject|9|||
127808939|NCT02507349|459919992|FG001|Overall Study|Lost to Follow-up|144|||
127808940|NCT01614964|459919993|FG000|Overall Study|Withdrawal by Subject|2|||
127748930|NCT01606319|459707902|FG001|Overall Study|Withdrawal by Subject|12|||
127748931|NCT01606319|459707901|FG000|Overall Study|Physician Decision|1|||
127748932|NCT01606319|459707902|FG001|Overall Study|Physician Decision|2|||
127748933|NCT01606319|459707901|FG000|Overall Study|Lack of Efficacy|6|||
127748934|NCT01606319|459707902|FG001|Overall Study|Lack of Efficacy|8|||
127748935|NCT01606319|459707901|FG000|Overall Study|Adverse Event|1|||
127748936|NCT01606319|459707902|FG001|Overall Study|Adverse Event|4|||
127748937|NCT01594827|459707906|FG000|Overall Study|Adverse Event|1|||
127748938|NCT01594827|459707907|FG001|Overall Study|Adverse Event|0|||
127748939|NCT01594827|459707906|FG000|Overall Study|Physician Decision|3|||
127748940|NCT01594827|459707907|FG001|Overall Study|Physician Decision|0|||
127748941|NCT02153905|459707908|FG000|Overall Study|Death|1|||
127748942|NCT02153905|459707909|FG001|Overall Study|Death|0|||
127748943|NCT01607879|459707914|FG000|Overall Study|Death|1|||
127748944|NCT01607879|459707915|FG001|Overall Study|Death|0|||
127748945|NCT01592045|459707918|FG000|Overall Study|Disease Progression|1|||
127748946|NCT01592045|459707919|FG001|Overall Study|Disease Progression|1|||
127748947|NCT01592045|459707918|FG000|Overall Study|Adverse Event|1|||
127748948|NCT01592045|459707919|FG001|Overall Study|Adverse Event|1|||
127748949|NCT01592045|459707918|FG000|Overall Study|Withdrawal by Subject|1|||
127748950|NCT01592045|459707919|FG001|Overall Study|Withdrawal by Subject|0|||
127748951|NCT01592045|459707918|FG000|Overall Study|Moved out of country|2|||
127748952|NCT01592045|459707919|FG001|Overall Study|Moved out of country|0|||
127748953|NCT03994731|459707920|FG000|Pegloticase + IMM Period|Death|2|||
127748954|NCT03994731|459707921|FG001|Pegloticase + IMM Period|Death|0|||
127748955|NCT03994731|459707920|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
127748956|NCT03994731|459707921|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
127748957|NCT03994731|459707920|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
127748958|NCT03994731|459707921|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
127748959|NCT03812029|459707929|FG000|Overall Study|Protocol Violation|1|||
127748960|NCT03812029|459707930|FG001|Overall Study|Protocol Violation|0|||
127748961|NCT03812029|459707931|FG002|Overall Study|Protocol Violation|0|||
127748962|NCT03812029|459707932|FG003|Overall Study|Protocol Violation|1|||
127748963|NCT03812029|459707933|FG004|Overall Study|Protocol Violation|0|||
127748964|NCT03812029|459707929|FG000|Overall Study|Withdrawal by Subject|1|||
127748965|NCT03812029|459707930|FG001|Overall Study|Withdrawal by Subject|0|||
127748966|NCT03812029|459707931|FG002|Overall Study|Withdrawal by Subject|0|||
127748967|NCT03812029|459707932|FG003|Overall Study|Withdrawal by Subject|2|||
127748968|NCT03812029|459707933|FG004|Overall Study|Withdrawal by Subject|2|||
127748969|NCT03812029|459707929|FG000|Overall Study|Stopping rules|0|||
127748970|NCT03812029|459707930|FG001|Overall Study|Stopping rules|1|||
127748971|NCT03812029|459707931|FG002|Overall Study|Stopping rules|0|||
127748972|NCT03812029|459707932|FG003|Overall Study|Stopping rules|0|||
127748973|NCT03812029|459707933|FG004|Overall Study|Stopping rules|0|||
127748974|NCT03812029|459707929|FG000|Overall Study|Adverse Event|0|||
127748975|NCT03812029|459707930|FG001|Overall Study|Adverse Event|9|||
127748976|NCT03812029|459707931|FG002|Overall Study|Adverse Event|0|||
127748977|NCT03812029|459707932|FG003|Overall Study|Adverse Event|3|||
127748978|NCT03812029|459707933|FG004|Overall Study|Adverse Event|5|||
127748979|NCT03812029|459707929|FG000|Overall Study|Lost to Follow-up|0|||
127748980|NCT03812029|459707930|FG001|Overall Study|Lost to Follow-up|0|||
127808941|NCT01614964|459919994|FG001|Overall Study|Withdrawal by Subject|0|||
127808942|NCT01614964|459919993|FG000|Overall Study|Lost to Follow-up|3|||
127808943|NCT01614964|459919994|FG001|Overall Study|Lost to Follow-up|0|||
127808944|NCT02700984|459920003|FG000|Overall Study|Death|2|||
127808945|NCT02700984|459920004|FG001|Overall Study|Death|1|||
127808946|NCT02700984|459920003|FG000|Overall Study|Lost to Follow-up|2|||
127808947|NCT02700984|459920004|FG001|Overall Study|Lost to Follow-up|1|||
127894084|NCT02207621|460235204|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
127894085|NCT02207621|460235205|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
127748981|NCT03812029|459707931|FG002|Overall Study|Lost to Follow-up|0|||
127748982|NCT03812029|459707932|FG003|Overall Study|Lost to Follow-up|0|||
127748983|NCT03812029|459707933|FG004|Overall Study|Lost to Follow-up|3|||
127748984|NCT03149042|459707934|FG000|Overall Study|Invasive FFR not performed|21|||
127748985|NCT03149042|459707934|FG000|Overall Study|Poor CT Image Quality|1|||
127894086|NCT01769378|460235210|FG000|Overall Study|Adverse Event|10|||
127894087|NCT01769378|460235211|FG001|Overall Study|Adverse Event|0|||
127894088|NCT01769378|460235210|FG000|Overall Study|Entry criteria not met|1|||
127748986|NCT03149042|459707934|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
127748987|NCT00790205|459707935|FG000|Overall Study|Lost to Follow-up|61|||
127748988|NCT00790205|459707936|FG001|Overall Study|Lost to Follow-up|71|||
127748989|NCT00790205|459707935|FG000|Overall Study|Withdrawal by Subject|299|||
127748990|NCT00790205|459707936|FG001|Overall Study|Withdrawal by Subject|363|||
127748991|NCT02643628|459707937|FG000|Overall Study|Lost to Follow-up|1|||
127748992|NCT02643628|459707938|FG001|Overall Study|Lost to Follow-up|4|||
127748993|NCT02643628|459707937|FG000|Overall Study|Withdrawal by Subject|0|||
127808948|NCT02700984|459920003|FG000|Overall Study|Physician Decision|0|||
127808949|NCT02700984|459920004|FG001|Overall Study|Physician Decision|1|||
127808950|NCT02700984|459920003|FG000|Overall Study|Withdrawal by Subject|8|||
127808951|NCT02700984|459920004|FG001|Overall Study|Withdrawal by Subject|9|||
127808952|NCT02700984|459920003|FG000|Overall Study|Reason not specified|3|||
127808953|NCT02700984|459920004|FG001|Overall Study|Reason not specified|2|||
127808954|NCT00473876|459920006|FG000|Overall Study|Lost to Follow-up|3|||
127808955|NCT00473876|459920007|FG001|Overall Study|Lost to Follow-up|1|||
127808956|NCT01032629|459920008|FG000|Overall Study|Closed Site|21|||
127808957|NCT01032629|459920009|FG001|Overall Study|Closed Site|18|||
127808958|NCT01032629|459920010|FG002|Overall Study|Closed Site|16|||
127748994|NCT02643628|459707938|FG001|Overall Study|Withdrawal by Subject|1|||
127808959|NCT01032629|459920008|FG000|Overall Study|Withdrawal by Subject|50|||
127748995|NCT02643628|459707937|FG000|Overall Study|Relocated out of state|0|||
127748996|NCT02643628|459707938|FG001|Overall Study|Relocated out of state|1|||
127748997|NCT04092452|459707954|FG000|Overall Study|Adverse Event|1|||
127748998|NCT04092452|459707955|FG001|Overall Study|Adverse Event|3|||
127748999|NCT04092452|459707956|FG002|Overall Study|Adverse Event|3|||
127749000|NCT04092452|459707957|FG003|Overall Study|Adverse Event|7|||
127749001|NCT04092452|459707954|FG000|Overall Study|Lack of Efficacy|1|||
127749002|NCT04092452|459707955|FG001|Overall Study|Lack of Efficacy|1|||
127749003|NCT04092452|459707956|FG002|Overall Study|Lack of Efficacy|1|||
127749004|NCT04092452|459707957|FG003|Overall Study|Lack of Efficacy|0|||
127749005|NCT04092452|459707954|FG000|Overall Study|Lost to Follow-up|4|||
127749006|NCT04092452|459707955|FG001|Overall Study|Lost to Follow-up|3|||
127749007|NCT04092452|459707956|FG002|Overall Study|Lost to Follow-up|5|||
127749008|NCT04092452|459707957|FG003|Overall Study|Lost to Follow-up|1|||
127749009|NCT04092452|459707954|FG000|Overall Study|Non-Compliance With Study Drug|0|||
127749010|NCT04092452|459707955|FG001|Overall Study|Non-Compliance With Study Drug|0|||
127749011|NCT04092452|459707956|FG002|Overall Study|Non-Compliance With Study Drug|1|||
127749012|NCT04092452|459707957|FG003|Overall Study|Non-Compliance With Study Drug|1|||
127749013|NCT04092452|459707954|FG000|Overall Study|Physician Decision|1|||
127749014|NCT04092452|459707955|FG001|Overall Study|Physician Decision|0|||
127749015|NCT04092452|459707956|FG002|Overall Study|Physician Decision|1|||
127749016|NCT04092452|459707957|FG003|Overall Study|Physician Decision|0|||
127749017|NCT04092452|459707954|FG000|Overall Study|Pregnancy|2|||
127749018|NCT04092452|459707955|FG001|Overall Study|Pregnancy|0|||
127749019|NCT04092452|459707956|FG002|Overall Study|Pregnancy|0|||
127749020|NCT04092452|459707957|FG003|Overall Study|Pregnancy|0|||
127749021|NCT04092452|459707954|FG000|Overall Study|Protocol Deviation|1|||
127749022|NCT04092452|459707955|FG001|Overall Study|Protocol Deviation|0|||
127749023|NCT04092452|459707956|FG002|Overall Study|Protocol Deviation|0|||
127749024|NCT04092452|459707957|FG003|Overall Study|Protocol Deviation|0|||
127749025|NCT04092452|459707954|FG000|Overall Study|Withdrawal by Subject|3|||
127749026|NCT04092452|459707955|FG001|Overall Study|Withdrawal by Subject|10|||
127749027|NCT04092452|459707956|FG002|Overall Study|Withdrawal by Subject|3|||
127749028|NCT04092452|459707957|FG003|Overall Study|Withdrawal by Subject|5|||
127749029|NCT04092452|459707954|FG000|Overall Study|Other|0|||
127749030|NCT04092452|459707955|FG001|Overall Study|Other|0|||
127749031|NCT04092452|459707956|FG002|Overall Study|Other|1|||
127749032|NCT04092452|459707957|FG003|Overall Study|Other|2|||
127749033|NCT02127125|459707958|FG000|Overall Study|Lost to Follow-up|0|||
127749034|NCT02127125|459707959|FG001|Overall Study|Lost to Follow-up|0|||
127749035|NCT02127125|459707960|FG002|Overall Study|Lost to Follow-up|0|||
127749036|NCT02127125|459707961|FG003|Overall Study|Lost to Follow-up|0|||
127749037|NCT02127125|459707962|FG004|Overall Study|Lost to Follow-up|2|||
127808960|NCT01032629|459920009|FG001|Overall Study|Withdrawal by Subject|36|||
127808961|NCT01032629|459920010|FG002|Overall Study|Withdrawal by Subject|35|||
127808962|NCT01032629|459920008|FG000|Overall Study|Lost to Follow-up|74|||
127808963|NCT01032629|459920009|FG001|Overall Study|Lost to Follow-up|47|||
127808964|NCT01032629|459920010|FG002|Overall Study|Lost to Follow-up|37|||
127808965|NCT00348140|459920011|FG000|Overall Study|Adverse Event|46|||
127894089|NCT01769378|460235211|FG001|Overall Study|Entry criteria not met|0|||
127894090|NCT01769378|460235210|FG000|Overall Study|Protocol Violation|1|||
127808966|NCT00348140|459920012|FG001|Overall Study|Adverse Event|49|||
127808967|NCT00348140|459920013|FG002|Overall Study|Adverse Event|78|||
127808968|NCT00348140|459920011|FG000|Overall Study|Lost to Follow-up|4|||
127749038|NCT02127125|459707963|FG005|Overall Study|Lost to Follow-up|1|||
127749039|NCT02127125|459707964|FG006|Overall Study|Lost to Follow-up|0|||
127749040|NCT02127125|459707965|FG007|Overall Study|Lost to Follow-up|0|||
127749041|NCT02127125|459707966|FG008|Overall Study|Lost to Follow-up|0|||
127749042|NCT02127125|459707958|FG000|Overall Study|Withdrawal by Subject|0|||
127749043|NCT02127125|459707959|FG001|Overall Study|Withdrawal by Subject|0|||
127749044|NCT02127125|459707960|FG002|Overall Study|Withdrawal by Subject|0|||
127749045|NCT02127125|459707961|FG003|Overall Study|Withdrawal by Subject|1|||
127749046|NCT02127125|459707962|FG004|Overall Study|Withdrawal by Subject|0|||
127749047|NCT02127125|459707963|FG005|Overall Study|Withdrawal by Subject|0|||
127749048|NCT02127125|459707964|FG006|Overall Study|Withdrawal by Subject|0|||
127808969|NCT00348140|459920012|FG001|Overall Study|Lost to Follow-up|4|||
127808970|NCT00348140|459920013|FG002|Overall Study|Lost to Follow-up|4|||
127749049|NCT02127125|459707965|FG007|Overall Study|Withdrawal by Subject|0|||
127749050|NCT02127125|459707966|FG008|Overall Study|Withdrawal by Subject|0|||
127749051|NCT02127125|459707958|FG000|Overall Study|Physician Decision|0|||
127749052|NCT02127125|459707959|FG001|Overall Study|Physician Decision|0|||
127749053|NCT02127125|459707960|FG002|Overall Study|Physician Decision|1|||
127749054|NCT02127125|459707961|FG003|Overall Study|Physician Decision|0|||
127749055|NCT02127125|459707962|FG004|Overall Study|Physician Decision|1|||
127749056|NCT02127125|459707963|FG005|Overall Study|Physician Decision|2|||
127749057|NCT02127125|459707964|FG006|Overall Study|Physician Decision|0|||
127749058|NCT02127125|459707965|FG007|Overall Study|Physician Decision|0|||
127749059|NCT02127125|459707966|FG008|Overall Study|Physician Decision|0|||
127749060|NCT02353468|459707968|FG000|Overall Study|Study terminated|3|||
127749061|NCT02344342|459707969|FG000|Overall Study|Industry partner dropped out|11|||
127749062|NCT02344342|459707970|FG001|Overall Study|Industry partner dropped out|9|||
127749063|NCT02344342|459707971|FG002|Overall Study|Industry partner dropped out|14|||
127749064|NCT02344342|459707972|FG003|Overall Study|Industry partner dropped out|10|||
127749065|NCT00848484|459707974|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
127749066|NCT00848484|459707975|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
127749067|NCT00848484|459707974|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
127749068|NCT00848484|459707975|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
127749069|NCT00848484|459707974|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
127749070|NCT00848484|459707975|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
127749071|NCT00848484|459707974|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
127749072|NCT00848484|459707975|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
127749073|NCT00848484|459707974|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
127749074|NCT00848484|459707975|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
127749075|NCT03355209|459707979|FG000|Part 1: Double-Blind Period|Adverse Event|0|||
127749076|NCT03355209|459707980|FG001|Part 1: Double-Blind Period|Adverse Event|4|||
127749077|NCT03355209|459707981|FG002|Part 1: Double-Blind Period|Adverse Event|4|||
127749078|NCT03355209|459707982|FG003|Part 1: Double-Blind Period|Adverse Event|0|||
127749079|NCT03355209|459707983|FG004|Part 1: Double-Blind Period|Adverse Event|1|||
127749080|NCT03355209|459707984|FG005|Part 1: Double-Blind Period|Adverse Event|0|||
127749081|NCT03355209|459707979|FG000|Part 1: Double-Blind Period|Death|0|||
127749082|NCT03355209|459707980|FG001|Part 1: Double-Blind Period|Death|0|||
127749083|NCT03355209|459707981|FG002|Part 1: Double-Blind Period|Death|1|||
127749084|NCT03355209|459707982|FG003|Part 1: Double-Blind Period|Death|0|||
127749085|NCT03355209|459707983|FG004|Part 1: Double-Blind Period|Death|0|||
127749086|NCT03355209|459707984|FG005|Part 1: Double-Blind Period|Death|0|||
127749087|NCT03355209|459707979|FG000|Part 1: Double-Blind Period|Physician Decision|0|||
127749088|NCT03355209|459707980|FG001|Part 1: Double-Blind Period|Physician Decision|1|||
127749089|NCT03355209|459707981|FG002|Part 1: Double-Blind Period|Physician Decision|0|||
127749090|NCT03355209|459707982|FG003|Part 1: Double-Blind Period|Physician Decision|0|||
127749091|NCT03355209|459707983|FG004|Part 1: Double-Blind Period|Physician Decision|0|||
127749092|NCT03355209|459707984|FG005|Part 1: Double-Blind Period|Physician Decision|0|||
127749093|NCT03355209|459707979|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
127808971|NCT00348140|459920011|FG000|Overall Study|Protocol Violation|12|||
127808972|NCT00348140|459920012|FG001|Overall Study|Protocol Violation|13|||
127808973|NCT00348140|459920013|FG002|Overall Study|Protocol Violation|14|||
127808974|NCT00348140|459920011|FG000|Overall Study|Withdrawal by Subject|32|||
127808975|NCT00348140|459920012|FG001|Overall Study|Withdrawal by Subject|40|||
127808976|NCT00348140|459920013|FG002|Overall Study|Withdrawal by Subject|40|||
127808977|NCT00348140|459920011|FG000|Overall Study|Non-compliance|8|||
127808978|NCT00348140|459920012|FG001|Overall Study|Non-compliance|13|||
127808979|NCT00348140|459920013|FG002|Overall Study|Non-compliance|5|||
127808980|NCT00348140|459920011|FG000|Overall Study|Participant at risk due to study drug|2|||
127808981|NCT00348140|459920012|FG001|Overall Study|Participant at risk due to study drug|0|||
127808982|NCT00348140|459920013|FG002|Overall Study|Participant at risk due to study drug|0|||
127808983|NCT00348140|459920011|FG000|Overall Study|Conditional medication increased dose|1|||
127749094|NCT03355209|459707980|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
127749095|NCT03355209|459707981|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
127749096|NCT03355209|459707982|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
127749097|NCT03355209|459707983|FG004|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
127749098|NCT03355209|459707984|FG005|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
127749099|NCT03355209|459707979|FG000|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
127749100|NCT03355209|459707980|FG001|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
127749101|NCT03355209|459707981|FG002|Part 2:Open-Label Extension (OLE) Period|Adverse Event|3|||
127808984|NCT00348140|459920012|FG001|Overall Study|Conditional medication increased dose|0|||
127749102|NCT03355209|459707982|FG003|Part 2:Open-Label Extension (OLE) Period|Adverse Event|0|||
127749103|NCT03355209|459707983|FG004|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
127749104|NCT03355209|459707984|FG005|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
127749105|NCT03355209|459707979|FG000|Part 2:Open-Label Extension (OLE) Period|Death|0|||
127749106|NCT03355209|459707980|FG001|Part 2:Open-Label Extension (OLE) Period|Death|1|||
127749107|NCT03355209|459707981|FG002|Part 2:Open-Label Extension (OLE) Period|Death|0|||
127749108|NCT03355209|459707982|FG003|Part 2:Open-Label Extension (OLE) Period|Death|0|||
127749109|NCT03355209|459707983|FG004|Part 2:Open-Label Extension (OLE) Period|Death|0|||
127749110|NCT03355209|459707984|FG005|Part 2:Open-Label Extension (OLE) Period|Death|0|||
127749111|NCT03355209|459707979|FG000|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|13|||
127749112|NCT03355209|459707980|FG001|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|21|||
127749113|NCT03355209|459707981|FG002|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|23|||
127749114|NCT03355209|459707982|FG003|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
127749115|NCT03355209|459707983|FG004|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
127749116|NCT03355209|459707984|FG005|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|1|||
127749117|NCT03355209|459707979|FG000|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
127749118|NCT03355209|459707980|FG001|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
127749119|NCT03355209|459707981|FG002|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
127749120|NCT03355209|459707982|FG003|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|5|||
127749121|NCT03355209|459707983|FG004|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|6|||
127749122|NCT03355209|459707984|FG005|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|3|||
127749123|NCT03355209|459707979|FG000|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|6|||
127749124|NCT03355209|459707980|FG001|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
127749125|NCT03355209|459707981|FG002|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|4|||
127749126|NCT03355209|459707982|FG003|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
127749127|NCT03355209|459707983|FG004|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
127749128|NCT03355209|459707984|FG005|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
127749129|NCT03355209|459707979|FG000|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
127749130|NCT03355209|459707980|FG001|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
127749131|NCT03355209|459707981|FG002|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
127749132|NCT03355209|459707982|FG003|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
127749133|NCT03355209|459707983|FG004|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
127749134|NCT03355209|459707984|FG005|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
127749135|NCT03355209|459707979|FG000|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|1|||
127749136|NCT03355209|459707980|FG001|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
127749137|NCT03355209|459707981|FG002|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|2|||
127749138|NCT03355209|459707982|FG003|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
127749139|NCT03355209|459707983|FG004|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
127749140|NCT03355209|459707984|FG005|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
127749141|NCT02975102|459707988|FG000|Overall Study|Adverse Event|2|||
127808985|NCT00348140|459920013|FG002|Overall Study|Conditional medication increased dose|0|||
127808986|NCT00348140|459920011|FG000|Overall Study|Caregiver related|4|||
127808987|NCT00348140|459920012|FG001|Overall Study|Caregiver related|7|||
127808988|NCT00348140|459920013|FG002|Overall Study|Caregiver related|3|||
127808989|NCT00348140|459920011|FG000|Overall Study|Participant hospitalised|3|||
127808990|NCT00348140|459920012|FG001|Overall Study|Participant hospitalised|0|||
127808991|NCT00348140|459920013|FG002|Overall Study|Participant hospitalised|0|||
127808992|NCT00348140|459920011|FG000|Overall Study|Efficacy related|1|||
127808993|NCT00348140|459920012|FG001|Overall Study|Efficacy related|1|||
127808994|NCT00348140|459920013|FG002|Overall Study|Efficacy related|0|||
127808995|NCT00348140|459920011|FG000|Overall Study|Administration related|3|||
127808996|NCT00348140|459920012|FG001|Overall Study|Administration related|1|||
127808997|NCT00348140|459920013|FG002|Overall Study|Administration related|1|||
127808998|NCT00348140|459920011|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
127808999|NCT00348140|459920012|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
127749142|NCT02975102|459707989|FG001|Overall Study|Adverse Event|1|||
127749143|NCT03017742|459707990|FG000|Overall Study|Protocol Violation|36|||
127749144|NCT03017742|459707990|FG000|Overall Study|Withdrawal by Subject|37|||
127749145|NCT01441635|459707995|FG000|Overall Study|Adverse Event|4|||
127749146|NCT01441635|459707996|FG001|Overall Study|Adverse Event|3|||
127749147|NCT01441635|459707997|FG002|Overall Study|Adverse Event|1|||
127749148|NCT01441635|459707998|FG003|Overall Study|Adverse Event|5|||
127749149|NCT01441635|459707999|FG004|Overall Study|Adverse Event|1|||
127749150|NCT01441635|459708000|FG005|Overall Study|Adverse Event|2|||
127809000|NCT00348140|459920013|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
127809001|NCT00348140|459920011|FG000|Overall Study|Participant unwell|1|||
127809002|NCT00348140|459920012|FG001|Overall Study|Participant unwell|0|||
127809003|NCT00348140|459920013|FG002|Overall Study|Participant unwell|0|||
127809004|NCT00348140|459920011|FG000|Overall Study|Screen failure|1|||
127749151|NCT01441635|459708001|FG006|Overall Study|Adverse Event|2|||
127749152|NCT01441635|459708002|FG007|Overall Study|Adverse Event|2|||
127749153|NCT01441635|459708003|FG008|Overall Study|Adverse Event|1|||
127749154|NCT01441635|459708004|FG009|Overall Study|Adverse Event|0|||
127749155|NCT01441635|459707995|FG000|Overall Study|Withdrawal by Subject|1|||
127749156|NCT01441635|459707996|FG001|Overall Study|Withdrawal by Subject|1|||
127749157|NCT01441635|459707997|FG002|Overall Study|Withdrawal by Subject|0|||
127749158|NCT01441635|459707998|FG003|Overall Study|Withdrawal by Subject|1|||
127749159|NCT01441635|459707999|FG004|Overall Study|Withdrawal by Subject|0|||
127749160|NCT01441635|459708000|FG005|Overall Study|Withdrawal by Subject|0|||
127749161|NCT01441635|459708001|FG006|Overall Study|Withdrawal by Subject|2|||
127749162|NCT01441635|459708002|FG007|Overall Study|Withdrawal by Subject|0|||
127749163|NCT01441635|459708003|FG008|Overall Study|Withdrawal by Subject|1|||
127749164|NCT01441635|459708004|FG009|Overall Study|Withdrawal by Subject|1|||
127749165|NCT01441635|459707995|FG000|Overall Study|Lost to Follow-up|0|||
127749166|NCT01441635|459707996|FG001|Overall Study|Lost to Follow-up|1|||
127749167|NCT01441635|459707997|FG002|Overall Study|Lost to Follow-up|1|||
127749168|NCT01441635|459707998|FG003|Overall Study|Lost to Follow-up|1|||
127749169|NCT01441635|459707999|FG004|Overall Study|Lost to Follow-up|1|||
127749170|NCT01441635|459708000|FG005|Overall Study|Lost to Follow-up|3|||
127749171|NCT01441635|459708001|FG006|Overall Study|Lost to Follow-up|1|||
127749172|NCT01441635|459708002|FG007|Overall Study|Lost to Follow-up|1|||
127749173|NCT01441635|459708003|FG008|Overall Study|Lost to Follow-up|0|||
127749174|NCT01441635|459708004|FG009|Overall Study|Lost to Follow-up|1|||
127749175|NCT01441635|459707995|FG000|Overall Study|Noncompliance|0|||
127749176|NCT01441635|459707996|FG001|Overall Study|Noncompliance|1|||
127749177|NCT01441635|459707997|FG002|Overall Study|Noncompliance|0|||
127749178|NCT01441635|459707998|FG003|Overall Study|Noncompliance|0|||
127749179|NCT01441635|459707999|FG004|Overall Study|Noncompliance|0|||
127749180|NCT01441635|459708000|FG005|Overall Study|Noncompliance|0|||
127749181|NCT01441635|459708001|FG006|Overall Study|Noncompliance|1|||
127749182|NCT01441635|459708002|FG007|Overall Study|Noncompliance|0|||
127749183|NCT01441635|459708003|FG008|Overall Study|Noncompliance|0|||
127749184|NCT01441635|459708004|FG009|Overall Study|Noncompliance|0|||
127749185|NCT01441635|459707995|FG000|Overall Study|Surgery or Invasive Intervention|0|||
127749186|NCT01441635|459707996|FG001|Overall Study|Surgery or Invasive Intervention|0|||
127749187|NCT01441635|459707997|FG002|Overall Study|Surgery or Invasive Intervention|1|||
127749188|NCT01441635|459707998|FG003|Overall Study|Surgery or Invasive Intervention|0|||
127749189|NCT01441635|459707999|FG004|Overall Study|Surgery or Invasive Intervention|0|||
127749190|NCT01441635|459708000|FG005|Overall Study|Surgery or Invasive Intervention|0|||
127749191|NCT01441635|459708001|FG006|Overall Study|Surgery or Invasive Intervention|0|||
127749192|NCT01441635|459708002|FG007|Overall Study|Surgery or Invasive Intervention|0|||
127749193|NCT01441635|459708003|FG008|Overall Study|Surgery or Invasive Intervention|0|||
127749194|NCT01441635|459708004|FG009|Overall Study|Surgery or Invasive Intervention|0|||
127749195|NCT01441635|459707995|FG000|Overall Study|Received Exclusionary Medication|1|||
127749196|NCT01441635|459707996|FG001|Overall Study|Received Exclusionary Medication|0|||
127749197|NCT01441635|459707997|FG002|Overall Study|Received Exclusionary Medication|0|||
127809005|NCT00348140|459920012|FG001|Overall Study|Screen failure|0|||
127809006|NCT00348140|459920013|FG002|Overall Study|Screen failure|0|||
127809007|NCT00348140|459920011|FG000|Overall Study|Investigator decided to discontinue|4|||
127809008|NCT00348140|459920012|FG001|Overall Study|Investigator decided to discontinue|1|||
127809009|NCT00348140|459920013|FG002|Overall Study|Investigator decided to discontinue|4|||
127749198|NCT01441635|459707998|FG003|Overall Study|Received Exclusionary Medication|0|||
127749199|NCT01441635|459707999|FG004|Overall Study|Received Exclusionary Medication|0|||
127749200|NCT01441635|459708000|FG005|Overall Study|Received Exclusionary Medication|0|||
127749201|NCT01441635|459708001|FG006|Overall Study|Received Exclusionary Medication|0|||
127749202|NCT01441635|459708002|FG007|Overall Study|Received Exclusionary Medication|0|||
127749203|NCT01441635|459708003|FG008|Overall Study|Received Exclusionary Medication|0|||
127749204|NCT01441635|459708004|FG009|Overall Study|Received Exclusionary Medication|0|||
127749205|NCT01441635|459707995|FG000|Overall Study|Other|0|||
127749206|NCT01441635|459707996|FG001|Overall Study|Other|0|||
127749207|NCT01441635|459707997|FG002|Overall Study|Other|0|||
127749208|NCT01441635|459707998|FG003|Overall Study|Other|0|||
127749209|NCT01441635|459707999|FG004|Overall Study|Other|0|||
127749210|NCT01441635|459708000|FG005|Overall Study|Other|0|||
127749211|NCT01441635|459708001|FG006|Overall Study|Other|0|||
127749212|NCT01441635|459708002|FG007|Overall Study|Other|1|||
127749213|NCT01441635|459708003|FG008|Overall Study|Other|0|||
127749214|NCT01441635|459708004|FG009|Overall Study|Other|0|||
127749215|NCT01825577|459708005|FG000|Overall Study|Physician Decision|2|||
127749216|NCT01825577|459708005|FG000|Overall Study|Withdrawal by Subject|1|||
127749217|NCT01825577|459708005|FG000|Overall Study|Withdrawn by family members|2|||
127749218|NCT01825577|459708005|FG000|Overall Study|Lack of Efficacy|3|||
127749219|NCT00358644|459708006|FG000|Overall Study|Progressive Disease|21|||
127749220|NCT00358644|459708006|FG000|Overall Study|Adverse Event|7|||
127749221|NCT00358644|459708006|FG000|Overall Study|Death|11|||
127749222|NCT00358644|459708006|FG000|Overall Study|Withdrawal by Subject|4|||
127749223|NCT00358644|459708006|FG000|Overall Study|Physician Decision|6|||
127749224|NCT00358644|459708006|FG000|Overall Study|Patient not eligible for study|1|||
127749225|NCT01358331|459708007|FG000|Overall Study|Lost to Follow-up|0|||
127749226|NCT01358331|459708008|FG001|Overall Study|Lost to Follow-up|0|||
127749227|NCT01358331|459708009|FG002|Overall Study|Lost to Follow-up|0|||
127749228|NCT01358331|459708010|FG003|Overall Study|Lost to Follow-up|1|||
127749229|NCT01358331|459708011|FG004|Overall Study|Lost to Follow-up|0|||
127749230|NCT01358331|459708012|FG005|Overall Study|Lost to Follow-up|0|||
127749231|NCT01358331|459708007|FG000|Overall Study|Withdrawal by Subject|0|||
127749232|NCT01358331|459708008|FG001|Overall Study|Withdrawal by Subject|0|||
127749233|NCT01358331|459708009|FG002|Overall Study|Withdrawal by Subject|0|||
127749234|NCT01358331|459708010|FG003|Overall Study|Withdrawal by Subject|1|||
127749235|NCT01358331|459708011|FG004|Overall Study|Withdrawal by Subject|1|||
127749236|NCT01358331|459708012|FG005|Overall Study|Withdrawal by Subject|1|||
127749237|NCT01358331|459708007|FG000|Overall Study|Adverse Events|1|||
127749238|NCT01358331|459708008|FG001|Overall Study|Adverse Events|1|||
127749239|NCT01358331|459708009|FG002|Overall Study|Adverse Events|1|||
127749240|NCT01358331|459708010|FG003|Overall Study|Adverse Events|0|||
127749241|NCT01358331|459708011|FG004|Overall Study|Adverse Events|1|||
127749242|NCT01358331|459708012|FG005|Overall Study|Adverse Events|5|||
127749243|NCT01358331|459708007|FG000|Overall Study|Symptomatic Deterioration|0|||
127749244|NCT01358331|459708008|FG001|Overall Study|Symptomatic Deterioration|0|||
127749245|NCT01358331|459708009|FG002|Overall Study|Symptomatic Deterioration|0|||
127749246|NCT01358331|459708010|FG003|Overall Study|Symptomatic Deterioration|0|||
127749247|NCT01358331|459708011|FG004|Overall Study|Symptomatic Deterioration|1|||
127749248|NCT01358331|459708012|FG005|Overall Study|Symptomatic Deterioration|0|||
127749249|NCT01358331|459708007|FG000|Overall Study|Participants did not wish to continue|0|||
127749250|NCT01358331|459708008|FG001|Overall Study|Participants did not wish to continue|0|||
127749251|NCT01358331|459708009|FG002|Overall Study|Participants did not wish to continue|0|||
127749252|NCT01358331|459708010|FG003|Overall Study|Participants did not wish to continue|0|||
127749253|NCT01358331|459708011|FG004|Overall Study|Participants did not wish to continue|1|||
127749254|NCT01358331|459708012|FG005|Overall Study|Participants did not wish to continue|0|||
127749255|NCT01358331|459708007|FG000|Overall Study|Progress of disease under investigation|1|||
127749256|NCT01358331|459708008|FG001|Overall Study|Progress of disease under investigation|2|||
127749257|NCT01358331|459708009|FG002|Overall Study|Progress of disease under investigation|3|||
127749258|NCT01358331|459708010|FG003|Overall Study|Progress of disease under investigation|1|||
127749259|NCT01358331|459708011|FG004|Overall Study|Progress of disease under investigation|3|||
127749260|NCT01358331|459708012|FG005|Overall Study|Progress of disease under investigation|0|||
127749261|NCT03327831|459708013|FG000|Overall Study|Lost to Follow-up|2|||
127749262|NCT03332784|459708016|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
127749263|NCT03332784|459708017|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
127749264|NCT03332784|459708018|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
127749265|NCT03332784|459708019|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
127749266|NCT03332784|459708020|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
127749267|NCT03332784|459708021|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
127749268|NCT03332784|459708022|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
127749269|NCT03332784|459708023|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
127749270|NCT03332784|459708024|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
127749271|NCT03332784|459708025|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
127749272|NCT03332784|459708026|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
127749273|NCT03332784|459708027|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
127809010|NCT00348140|459920011|FG000|Overall Study|Decided to discontinue on their own|1|||
127809011|NCT00348140|459920012|FG001|Overall Study|Decided to discontinue on their own|4|||
127809012|NCT00348140|459920013|FG002|Overall Study|Decided to discontinue on their own|1|||
127809013|NCT00348140|459920011|FG000|Overall Study|Use of prohibited drug|1|||
127809014|NCT00348140|459920012|FG001|Overall Study|Use of prohibited drug|0|||
127749274|NCT03332784|459708028|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
127749275|NCT03332784|459708029|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
127809015|NCT00348140|459920013|FG002|Overall Study|Use of prohibited drug|2|||
127749276|NCT03332784|459708030|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
127749277|NCT03332784|459708031|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
127749278|NCT03332784|459708032|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
127809016|NCT00348140|459920011|FG000|Overall Study|Disease progression|1|||
127749279|NCT03332784|459708033|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
127749280|NCT03332784|459708034|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
127749281|NCT03332784|459708035|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
127749282|NCT01969851|459708036|FG000|Overall Study|Adverse Event|0|||
127749283|NCT01969851|459708037|FG001|Overall Study|Adverse Event|0|||
127749284|NCT01969851|459708038|FG002|Overall Study|Adverse Event|3|||
127749285|NCT01969851|459708036|FG000|Overall Study|Lack of Efficacy|0|||
127749286|NCT01969851|459708037|FG001|Overall Study|Lack of Efficacy|3|||
127749287|NCT01969851|459708038|FG002|Overall Study|Lack of Efficacy|1|||
127749288|NCT01969851|459708036|FG000|Overall Study|Withdrawal by Subject|1|||
127749289|NCT01969851|459708037|FG001|Overall Study|Withdrawal by Subject|0|||
127749290|NCT01969851|459708038|FG002|Overall Study|Withdrawal by Subject|1|||
127749291|NCT01969851|459708036|FG000|Overall Study|No effective dose in Titration period|0|||
127749292|NCT01969851|459708037|FG001|Overall Study|No effective dose in Titration period|0|||
127749293|NCT01969851|459708038|FG002|Overall Study|No effective dose in Titration period|1|||
127749294|NCT01969851|459708036|FG000|Overall Study|Sponsor decision|0|||
127749295|NCT01969851|459708037|FG001|Overall Study|Sponsor decision|0|||
127749296|NCT01969851|459708038|FG002|Overall Study|Sponsor decision|1|||
127749297|NCT01430468|459708050|FG000|Overall Study|Physician Decision|2|||
127749298|NCT01430468|459708051|FG001|Overall Study|Physician Decision|1|||
127749299|NCT01430468|459708050|FG000|Overall Study|Withdrawal by Subject|5|||
127749300|NCT01430468|459708051|FG001|Overall Study|Withdrawal by Subject|5|||
127749301|NCT02498236|459708054|FG000|Overall Study|Did not show for testing|1|||
127749302|NCT02498236|459708055|FG001|Overall Study|Did not show for testing|0|||
127749303|NCT02498236|459708056|FG002|Overall Study|Did not show for testing|0|||
127749304|NCT02498236|459708057|FG003|Overall Study|Did not show for testing|0|||
127749305|NCT02498236|459708058|FG004|Overall Study|Did not show for testing|0|||
127749306|NCT02498236|459708059|FG005|Overall Study|Did not show for testing|0|||
127749307|NCT02498236|459708060|FG006|Overall Study|Did not show for testing|0|||
127749308|NCT02498236|459708061|FG007|Overall Study|Did not show for testing|1|||
127749309|NCT02498236|459708054|FG000|Overall Study|Equipment failure|0|||
127749310|NCT02498236|459708055|FG001|Overall Study|Equipment failure|0|||
127749311|NCT02498236|459708056|FG002|Overall Study|Equipment failure|0|||
127749312|NCT02498236|459708057|FG003|Overall Study|Equipment failure|0|||
127749313|NCT02498236|459708058|FG004|Overall Study|Equipment failure|0|||
127749314|NCT02498236|459708059|FG005|Overall Study|Equipment failure|0|||
127749315|NCT02498236|459708060|FG006|Overall Study|Equipment failure|1|||
127749316|NCT02498236|459708061|FG007|Overall Study|Equipment failure|0|||
127749317|NCT02498236|459708054|FG000|Overall Study|Withdrawal by Subject|0|||
127749318|NCT02498236|459708055|FG001|Overall Study|Withdrawal by Subject|0|||
127749319|NCT02498236|459708056|FG002|Overall Study|Withdrawal by Subject|0|||
127749320|NCT02498236|459708057|FG003|Overall Study|Withdrawal by Subject|0|||
127749321|NCT02498236|459708058|FG004|Overall Study|Withdrawal by Subject|1|||
127749322|NCT02498236|459708059|FG005|Overall Study|Withdrawal by Subject|0|||
127749323|NCT02498236|459708060|FG006|Overall Study|Withdrawal by Subject|0|||
127749324|NCT02498236|459708061|FG007|Overall Study|Withdrawal by Subject|0|||
127749325|NCT00383123|459708062|FG000|Overall Study|Adverse Event|1|||
127749326|NCT00383123|459708063|FG001|Overall Study|Adverse Event|0|||
127749327|NCT00383123|459708062|FG000|Overall Study|Lost to Follow-up|68|||
127749328|NCT00383123|459708063|FG001|Overall Study|Lost to Follow-up|61|||
127749329|NCT00383123|459708062|FG000|Overall Study|Protocol Violation|5|||
127749330|NCT00383123|459708063|FG001|Overall Study|Protocol Violation|1|||
127749331|NCT00383123|459708062|FG000|Overall Study|Withdrawal by Subject|27|||
127749332|NCT00383123|459708063|FG001|Overall Study|Withdrawal by Subject|18|||
127749333|NCT00383123|459708062|FG000|Overall Study|Other reason|10|||
127749334|NCT00383123|459708063|FG001|Overall Study|Other reason|6|||
127749335|NCT04982575|459708064|FG000|Overall Study|Withdrawal by Subject|2|||
127749336|NCT04982575|459708065|FG001|Overall Study|Withdrawal by Subject|0|||
127749337|NCT04982575|459708066|FG002|Overall Study|Withdrawal by Subject|2|||
127749338|NCT01151423|459708067|FG000|Overall Study|Study terminated by Sponsor|9|||
127749339|NCT01151423|459708068|FG001|Overall Study|Study terminated by Sponsor|10|||
127749340|NCT01151423|459708067|FG000|Overall Study|Protocol Violation|0|||
127749341|NCT01151423|459708068|FG001|Overall Study|Protocol Violation|1|||
127749342|NCT01151423|459708067|FG000|Overall Study|Physician Decision|1|||
127749343|NCT01151423|459708068|FG001|Overall Study|Physician Decision|1|||
127749344|NCT01151423|459708067|FG000|Overall Study|Pregnancy|0|||
127749345|NCT01151423|459708068|FG001|Overall Study|Pregnancy|1|||
127749346|NCT01151423|459708067|FG000|Overall Study|Death|0|||
127749347|NCT01151423|459708068|FG001|Overall Study|Death|1|||
127749348|NCT01151423|459708067|FG000|Overall Study|Adverse Event|3|||
127749349|NCT01151423|459708068|FG001|Overall Study|Adverse Event|0|||
127809017|NCT00348140|459920012|FG001|Overall Study|Disease progression|2|||
127809018|NCT00348140|459920013|FG002|Overall Study|Disease progression|5|||
127809019|NCT00348140|459920011|FG000|Overall Study|Increased risk of cardiac infarction|0|||
127809020|NCT00348140|459920012|FG001|Overall Study|Increased risk of cardiac infarction|1|||
127809021|NCT00348140|459920013|FG002|Overall Study|Increased risk of cardiac infarction|0|||
127809022|NCT00348140|459920011|FG000|Overall Study|Serious adverse event|0|||
127809023|NCT00348140|459920012|FG001|Overall Study|Serious adverse event|1|||
127809024|NCT00348140|459920013|FG002|Overall Study|Serious adverse event|0|||
127809025|NCT00348140|459920011|FG000|Overall Study|Abnormal ECG|0|||
127809026|NCT00348140|459920012|FG001|Overall Study|Abnormal ECG|1|||
127809027|NCT00348140|459920013|FG002|Overall Study|Abnormal ECG|3|||
127809028|NCT00348140|459920011|FG000|Overall Study|Participant died|0|||
127809029|NCT00348140|459920012|FG001|Overall Study|Participant died|1|||
127809030|NCT00348140|459920013|FG002|Overall Study|Participant died|0|||
127809031|NCT00348140|459920011|FG000|Overall Study|Exclusion criteria met|0|||
127809032|NCT00348140|459920012|FG001|Overall Study|Exclusion criteria met|0|||
127809033|NCT00348140|459920013|FG002|Overall Study|Exclusion criteria met|1|||
127809034|NCT00348140|459920011|FG000|Overall Study|Memory declined|0|||
127809035|NCT00348140|459920012|FG001|Overall Study|Memory declined|0|||
127809036|NCT00348140|459920013|FG002|Overall Study|Memory declined|1|||
127809037|NCT00977470|459920017|FG000|Overall Study|Lack of Efficacy|32|||
127809038|NCT00977470|459920018|FG001|Overall Study|Lack of Efficacy|30|||
127809039|NCT00977470|459920017|FG000|Overall Study|Physician Decision|2|||
127809040|NCT00977470|459920018|FG001|Overall Study|Physician Decision|0|||
127809041|NCT00977470|459920017|FG000|Overall Study|Adverse Event|1|||
127749350|NCT01151423|459708067|FG000|Overall Study|Withdrawal by Subject|1|||
127749351|NCT01151423|459708068|FG001|Overall Study|Withdrawal by Subject|3|||
127749352|NCT01151423|459708067|FG000|Overall Study|Lost to Follow-up|1|||
127749353|NCT01151423|459708068|FG001|Overall Study|Lost to Follow-up|0|||
127749354|NCT01151423|459708067|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
127749355|NCT01151423|459708068|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
127749356|NCT01151423|459708067|FG000|Overall Study|Participated in other clinical trial|1|||
127749357|NCT01151423|459708068|FG001|Overall Study|Participated in other clinical trial|0|||
127749358|NCT02065882|459708070|FG000|Part I: PK/PD|Screening failure|5|||
127749359|NCT02065882|459708070|FG000|Part I: PK/PD|Withdrawal by Subject|2|||
127749360|NCT02065882|459708070|FG000|Part I: PK/PD|Adverse Event|1|||
127749361|NCT02065882|459708070|FG000|Part II: Clinical Efficacy|Screening failure|7|||
127749362|NCT02065882|459708070|FG000|Part II: Clinical Efficacy|Withdrawal by Subject|2|||
127749363|NCT02065882|459708070|FG000|Part II: Clinical Efficacy|Adverse Event|5|||
127749364|NCT02065882|459708070|FG000|Part II: Clinical Efficacy|Regulatory Authority Decision|3|||
127749365|NCT02065882|459708070|FG000|Part II: Clinical Efficacy|No Bleeding Event|11|||
127749366|NCT02065882|459708070|FG000|Part II: Clinical Efficacy|Protocol Violation|3|||
127749367|NCT02763215|459709990|FG000|Overall Study|Participants withdrew from study|3|||
127749368|NCT02763215|459709990|FG000|Overall Study|Missed visit|1|||
127749369|NCT02763215|459709990|FG000|Overall Study|Visit outside visit-window|1|||
127749370|NCT02763215|459709990|FG000|Overall Study|Death|1|||
127749371|NCT02763215|459709990|FG000|Overall Study|Lost to Follow-up|1|||
127749372|NCT00475644|459709992|FG000|Overall Study|Protocol Violation|13|||
127749373|NCT01411241|459709993|FG000|Overall Study|Protocol Violation|0|||
127749374|NCT01411241|459709994|FG001|Overall Study|Protocol Violation|5|||
127749375|NCT01411241|459709993|FG000|Overall Study|Withdrawal by Subject|9|||
127749376|NCT01411241|459709994|FG001|Overall Study|Withdrawal by Subject|10|||
127749377|NCT01411241|459709993|FG000|Overall Study|Serious Adverse Event|0|||
127749378|NCT01411241|459709994|FG001|Overall Study|Serious Adverse Event|3|||
127749379|NCT01411241|459709993|FG000|Overall Study|Lost to Follow-up|2|||
127749380|NCT01411241|459709994|FG001|Overall Study|Lost to Follow-up|4|||
127749381|NCT01107899|459710000|FG000|Overall Study|Physician Decision|5|||
127749382|NCT01107899|459710001|FG001|Overall Study|Physician Decision|0|||
127749383|NCT01107899|459710002|FG002|Overall Study|Physician Decision|3|||
127749384|NCT01107899|459710000|FG000|Overall Study|Withdrawal by Subject|0|||
127809042|NCT00977470|459920018|FG001|Overall Study|Adverse Event|2|||
127809043|NCT00977470|459920017|FG000|Overall Study|Protocol Violation|1|||
127809044|NCT00977470|459920018|FG001|Overall Study|Protocol Violation|0|||
127749385|NCT01107899|459710001|FG001|Overall Study|Withdrawal by Subject|0|||
127749386|NCT01107899|459710002|FG002|Overall Study|Withdrawal by Subject|1|||
127749387|NCT00974259|459710003|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
127749388|NCT00974259|459710004|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
127749389|NCT00944229|459710007|FG000|Overall Study|Withdrawal by Subject|11|||
127749390|NCT00944229|459710007|FG000|Overall Study|Physician Decision|14|||
127809045|NCT00977470|459920017|FG000|Overall Study|Withdrawal by Subject|0|||
127809046|NCT00977470|459920018|FG001|Overall Study|Withdrawal by Subject|2|||
127809047|NCT00977470|459920017|FG000|Overall Study|Death|0|||
127809048|NCT00977470|459920018|FG001|Overall Study|Death|2|||
127809049|NCT00977470|459920017|FG000|Overall Study|clinical decline|0|||
127809050|NCT00977470|459920018|FG001|Overall Study|clinical decline|1|||
127894091|NCT01769378|460235211|FG001|Overall Study|Protocol Violation|1|||
127749391|NCT04292470|459710008|FG000|Overall Study|Withdrawal by Subject|0|||
127749392|NCT04292470|459710009|FG001|Overall Study|Withdrawal by Subject|1|||
127894092|NCT01769378|460235210|FG000|Overall Study|Withdrawal by Subject|10|||
127894093|NCT01769378|460235211|FG001|Overall Study|Withdrawal by Subject|3|||
127894094|NCT01769378|460235210|FG000|Overall Study|Sponsor Decision|1|||
127894095|NCT01769378|460235211|FG001|Overall Study|Sponsor Decision|0|||
127749393|NCT02906020|459710027|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
127749394|NCT02906020|459710028|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
127749395|NCT02906020|459710029|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
127749396|NCT02906020|459710030|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
127749397|NCT02906020|459710031|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
127749398|NCT02906020|459710032|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
127749399|NCT02906020|459710033|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
127749400|NCT02906020|459710034|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
127749401|NCT02906020|459710035|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
127749402|NCT02906020|459710036|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
127749403|NCT02906020|459710037|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
127749404|NCT02906020|459710038|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
127749405|NCT02906020|459710039|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
127749406|NCT02906020|459710040|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
127749407|NCT02906020|459710041|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
127749408|NCT02906020|459710042|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
127749409|NCT02906020|459710027|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
127749410|NCT02906020|459710028|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
127749411|NCT02906020|459710029|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
127749412|NCT02906020|459710030|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
127749413|NCT02906020|459710031|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
127749414|NCT02906020|459710032|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
127749415|NCT02906020|459710033|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
127749416|NCT02906020|459710034|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
127749417|NCT02906020|459710035|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
127749418|NCT02906020|459710036|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
127749419|NCT02906020|459710037|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
127749420|NCT02906020|459710038|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
127749421|NCT02906020|459710039|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
127749422|NCT02906020|459710040|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
127749423|NCT02906020|459710041|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
127749424|NCT02906020|459710042|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
127749425|NCT02906020|459710027|FG000|Part 2: Double-blind Treatment Period|Other|0|||
127749426|NCT02906020|459710028|FG001|Part 2: Double-blind Treatment Period|Other|0|||
127749427|NCT02906020|459710029|FG002|Part 2: Double-blind Treatment Period|Other|0|||
127749428|NCT02906020|459710030|FG003|Part 2: Double-blind Treatment Period|Other|0|||
127749429|NCT02906020|459710031|FG004|Part 2: Double-blind Treatment Period|Other|0|||
127749430|NCT02906020|459710032|FG005|Part 2: Double-blind Treatment Period|Other|0|||
127749431|NCT02906020|459710033|FG006|Part 2: Double-blind Treatment Period|Other|0|||
127749432|NCT02906020|459710034|FG007|Part 2: Double-blind Treatment Period|Other|0|||
127749433|NCT02906020|459710035|FG008|Part 2: Double-blind Treatment Period|Other|6|||
127749434|NCT02906020|459710036|FG009|Part 2: Double-blind Treatment Period|Other|10|||
127749435|NCT02906020|459710037|FG010|Part 2: Double-blind Treatment Period|Other|0|||
127749436|NCT02906020|459710038|FG011|Part 2: Double-blind Treatment Period|Other|0|||
127749437|NCT02906020|459710039|FG012|Part 2: Double-blind Treatment Period|Other|0|||
127749438|NCT02906020|459710040|FG013|Part 2: Double-blind Treatment Period|Other|0|||
127749439|NCT02906020|459710041|FG014|Part 2: Double-blind Treatment Period|Other|0|||
127749440|NCT02906020|459710042|FG015|Part 2: Double-blind Treatment Period|Other|0|||
127749441|NCT02906020|459710027|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
127749442|NCT02906020|459710028|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
127749443|NCT02906020|459710029|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
127749444|NCT02906020|459710030|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
127749445|NCT02906020|459710031|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
127749446|NCT02906020|459710032|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
127749447|NCT02906020|459710033|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
127749448|NCT02906020|459710034|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
127749449|NCT02906020|459710035|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
127749450|NCT02906020|459710036|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
127749451|NCT02906020|459710037|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
127749452|NCT02906020|459710038|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
127749453|NCT02906020|459710039|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
127749454|NCT02906020|459710040|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
127749455|NCT02906020|459710041|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
127894096|NCT01769378|460235210|FG000|Overall Study|Lost to Follow-up|2|||
127894097|NCT01769378|460235211|FG001|Overall Study|Lost to Follow-up|0|||
127894098|NCT01238848|460235216|FG000|Overall Study|Physician Decision|13|||
127749456|NCT02906020|459710042|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
127749457|NCT02906020|459710027|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
127749458|NCT02906020|459710028|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
127749459|NCT02906020|459710029|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
127749460|NCT02906020|459710030|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
127749461|NCT02906020|459710031|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
127749462|NCT02906020|459710032|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
127749463|NCT02906020|459710033|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
127749464|NCT02906020|459710034|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
127749465|NCT02906020|459710035|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
127749466|NCT02906020|459710036|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
127749467|NCT02906020|459710037|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
127749468|NCT02906020|459710038|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
127749469|NCT02906020|459710039|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
127749470|NCT02906020|459710040|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
127749471|NCT02906020|459710041|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
127749472|NCT02906020|459710042|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
127749473|NCT02906020|459710027|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
127749474|NCT02906020|459710028|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
127749475|NCT02906020|459710029|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
127749476|NCT02906020|459710030|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
127749477|NCT02906020|459710031|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
127749478|NCT02906020|459710032|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
127749479|NCT02906020|459710033|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
127749480|NCT02906020|459710034|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
127749481|NCT02906020|459710035|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
127749482|NCT02906020|459710036|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
127749483|NCT02906020|459710037|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
127749484|NCT02906020|459710038|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
127749485|NCT02906020|459710039|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
127749486|NCT02906020|459710040|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
127749487|NCT02906020|459710041|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
127749488|NCT02906020|459710042|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
127749489|NCT02906020|459710027|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
127749490|NCT02906020|459710028|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
127749491|NCT02906020|459710029|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
127749492|NCT02906020|459710030|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
127749493|NCT02906020|459710031|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
127749494|NCT02906020|459710032|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
127749495|NCT02906020|459710033|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
127749496|NCT02906020|459710034|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
127749497|NCT02906020|459710035|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
127749498|NCT02906020|459710036|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
127749499|NCT02906020|459710037|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
127749500|NCT02906020|459710038|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
127749501|NCT02906020|459710039|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
127749502|NCT02906020|459710040|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
127749503|NCT02906020|459710041|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
127749504|NCT02906020|459710042|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
127749505|NCT02906020|459710027|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
127749506|NCT02906020|459710028|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
127749507|NCT02906020|459710029|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
127894099|NCT01238848|460235217|FG001|Overall Study|Physician Decision|5|||
127894100|NCT00576901|460235218|FG000|Overall Study|Withdrawal by Subject|1|||
127749508|NCT02906020|459710030|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
127749509|NCT02906020|459710031|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
127749510|NCT02906020|459710032|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
127749511|NCT02906020|459710033|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
127749512|NCT02906020|459710034|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
127749513|NCT02906020|459710035|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
127749514|NCT02906020|459710036|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
127749515|NCT02906020|459710037|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
127749516|NCT02906020|459710038|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
127749517|NCT02906020|459710039|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
127749518|NCT02906020|459710040|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
127749519|NCT02906020|459710041|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
127749520|NCT02906020|459710042|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
127749521|NCT02906020|459710027|FG000|Part 2: Long-term Follow-up Period|Other|0|||
127749522|NCT02906020|459710028|FG001|Part 2: Long-term Follow-up Period|Other|0|||
127749523|NCT02906020|459710029|FG002|Part 2: Long-term Follow-up Period|Other|0|||
127749524|NCT02906020|459710030|FG003|Part 2: Long-term Follow-up Period|Other|0|||
127749525|NCT02906020|459710031|FG004|Part 2: Long-term Follow-up Period|Other|0|||
127749526|NCT02906020|459710032|FG005|Part 2: Long-term Follow-up Period|Other|0|||
127749527|NCT02906020|459710033|FG006|Part 2: Long-term Follow-up Period|Other|0|||
127749528|NCT02906020|459710034|FG007|Part 2: Long-term Follow-up Period|Other|0|||
127749529|NCT02906020|459710035|FG008|Part 2: Long-term Follow-up Period|Other|0|||
127749530|NCT02906020|459710036|FG009|Part 2: Long-term Follow-up Period|Other|0|||
127749531|NCT02906020|459710037|FG010|Part 2: Long-term Follow-up Period|Other|0|||
127749532|NCT02906020|459710038|FG011|Part 2: Long-term Follow-up Period|Other|0|||
127749533|NCT02906020|459710039|FG012|Part 2: Long-term Follow-up Period|Other|13|||
127749534|NCT02906020|459710040|FG013|Part 2: Long-term Follow-up Period|Other|8|||
127749535|NCT02906020|459710041|FG014|Part 2: Long-term Follow-up Period|Other|3|||
127749536|NCT02906020|459710042|FG015|Part 2: Long-term Follow-up Period|Other|2|||
127749537|NCT01810939|459710043|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
127749538|NCT01810939|459710044|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
127749539|NCT01810939|459710045|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
127749540|NCT01810939|459710043|FG000|Part A Treatment Period|Protocol Violation|2|||
127749541|NCT01810939|459710044|FG001|Part A Treatment Period|Protocol Violation|0|||
127749542|NCT01810939|459710045|FG002|Part A Treatment Period|Protocol Violation|0|||
127749543|NCT01810939|459710043|FG000|Part A Treatment Period|Adverse Event|10|||
127749544|NCT01810939|459710044|FG001|Part A Treatment Period|Adverse Event|0|||
127749545|NCT01810939|459710045|FG002|Part A Treatment Period|Adverse Event|0|||
127749546|NCT01810939|459710043|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
127749547|NCT01810939|459710044|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
127749548|NCT01810939|459710045|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
127749549|NCT01810939|459710043|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
127749550|NCT01810939|459710044|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
127749551|NCT01810939|459710045|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
127749552|NCT01810939|459710043|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
127749553|NCT01810939|459710044|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
127749554|NCT01810939|459710045|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
127749555|NCT01810939|459710043|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
127749556|NCT01810939|459710044|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
127749557|NCT01810939|459710045|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
127749558|NCT01810939|459710043|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
127749559|NCT01810939|459710044|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
127749560|NCT01810939|459710045|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
127749561|NCT01810939|459710043|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
127749562|NCT01810939|459710044|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
127749563|NCT01810939|459710045|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
127749564|NCT01810939|459710043|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
127749565|NCT01810939|459710044|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
127749566|NCT01810939|459710045|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
127749567|NCT01810939|459710043|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
127749568|NCT01810939|459710044|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
127749569|NCT01810939|459710045|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
127749570|NCT01810939|459710043|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
127749571|NCT01810939|459710044|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
127749572|NCT01810939|459710045|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
127749573|NCT01810939|459710043|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
127749574|NCT01810939|459710044|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
127749575|NCT01810939|459710045|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
127749576|NCT01810939|459710043|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
127749577|NCT01810939|459710044|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
127749578|NCT01810939|459710045|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
127749579|NCT01810939|459710043|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
127749580|NCT01810939|459710044|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
127749581|NCT01810939|459710045|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
127749582|NCT01810939|459710043|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
127749583|NCT01810939|459710044|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
127749584|NCT01810939|459710045|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
127749585|NCT01810939|459710043|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
127749586|NCT01810939|459710044|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
127749587|NCT01810939|459710045|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
127749588|NCT02963090|459710046|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
127749589|NCT02963090|459710047|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
127749590|NCT01375673|459710048|FG000|Overall Study|Withdrawal by Subject|0|||
127749591|NCT01375673|459710049|FG001|Overall Study|Withdrawal by Subject|1|||
127749592|NCT02179177|459710050|FG000|Overall Study|Lost to Follow-up|1|||
127749593|NCT02179177|459710051|FG001|Overall Study|Lost to Follow-up|1|||
127749594|NCT02179177|459710050|FG000|Overall Study|Withdrawal by Subject|1|||
127749595|NCT02179177|459710051|FG001|Overall Study|Withdrawal by Subject|1|||
127749596|NCT00884650|459710055|FG000|Overall Study|Did not return complete pain diaries|7|||
127749597|NCT00884650|459710056|FG001|Overall Study|Did not return complete pain diaries|7|||
127749598|NCT00884650|459710055|FG000|Overall Study|Admitted Post-Op|1|||
127749599|NCT00884650|459710056|FG001|Overall Study|Admitted Post-Op|0|||
127749600|NCT00884650|459710055|FG000|Overall Study|Femoral Stress Fracture|1|||
127749601|NCT00884650|459710056|FG001|Overall Study|Femoral Stress Fracture|0|||
127749602|NCT00884650|459710055|FG000|Overall Study|Pain Pump Complication|0|||
127749603|NCT00884650|459710056|FG001|Overall Study|Pain Pump Complication|1|||
127749604|NCT00979953|459710057|FG000|Overall Study|Adverse Event|5|||
127749605|NCT00979953|459710058|FG001|Overall Study|Adverse Event|2|||
127749606|NCT00979953|459710059|FG002|Overall Study|Adverse Event|17|||
127749607|NCT00979953|459710060|FG003|Overall Study|Adverse Event|4|||
127749608|NCT00979953|459710057|FG000|Overall Study|Lack of Efficacy|1|||
127749609|NCT00979953|459710058|FG001|Overall Study|Lack of Efficacy|2|||
127749610|NCT00979953|459710059|FG002|Overall Study|Lack of Efficacy|0|||
127749611|NCT00979953|459710060|FG003|Overall Study|Lack of Efficacy|0|||
127749612|NCT00979953|459710057|FG000|Overall Study|Lost to Follow-up|1|||
127749613|NCT00979953|459710058|FG001|Overall Study|Lost to Follow-up|1|||
127749614|NCT00979953|459710059|FG002|Overall Study|Lost to Follow-up|1|||
127749615|NCT00979953|459710060|FG003|Overall Study|Lost to Follow-up|0|||
127749616|NCT00979953|459710057|FG000|Overall Study|Withdrawal by Subject|0|||
127749617|NCT00979953|459710058|FG001|Overall Study|Withdrawal by Subject|0|||
127749618|NCT00979953|459710059|FG002|Overall Study|Withdrawal by Subject|2|||
127749619|NCT00979953|459710060|FG003|Overall Study|Withdrawal by Subject|1|||
127749620|NCT00979953|459710057|FG000|Overall Study|Protocol Violation|1|||
127749621|NCT00979953|459710058|FG001|Overall Study|Protocol Violation|0|||
127749622|NCT00979953|459710059|FG002|Overall Study|Protocol Violation|2|||
127749623|NCT00979953|459710060|FG003|Overall Study|Protocol Violation|2|||
127749624|NCT04829747|459710065|FG000|Overall Study|Protocol Violation|1|||
127749625|NCT02615509|459710068|FG000|Overall Study|Lost to Follow-up|134|||
127749626|NCT02615509|459710068|FG000|Overall Study|Death|4|||
127749627|NCT02615509|459710068|FG000|Overall Study|Withdrawal by Subject|8|||
127749628|NCT02563548|459710069|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
127749629|NCT02563548|459710070|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
127749630|NCT02563548|459710071|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
127749631|NCT02563548|459710072|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
127809051|NCT00977470|459920017|FG000|Overall Study|prolonged recovery post-surgery|0|||
127809052|NCT00977470|459920018|FG001|Overall Study|prolonged recovery post-surgery|1|||
127809053|NCT00977470|459920017|FG000|Overall Study|Still on-study|2|||
127809054|NCT00977470|459920018|FG001|Overall Study|Still on-study|0|||
127809055|NCT00737529|459920022|FG000|Overall Study|Disease Progression|95|||
127749632|NCT02563548|459710073|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
127749633|NCT02563548|459710074|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
127749634|NCT02563548|459710069|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
127749635|NCT02563548|459710070|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
127749636|NCT02563548|459710071|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
127749637|NCT02563548|459710072|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
127809056|NCT00737529|459920022|FG000|Overall Study|Adverse Event|24|||
127749638|NCT02563548|459710073|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
127749639|NCT02563548|459710074|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
127809057|NCT00737529|459920022|FG000|Overall Study|Withdrawal by Subject|5|||
127809058|NCT00737529|459920022|FG000|Overall Study|Death|4|||
127809059|NCT00737529|459920022|FG000|Overall Study|Protocol Violation|1|||
127809060|NCT00737529|459920022|FG000|Overall Study|Other|4|||
127809061|NCT01173653|459920029|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
127809062|NCT01173653|459920030|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
127809063|NCT01651780|459920038|FG000|Overall Study|Physician decision: No 30-day visit|2|||
127809064|NCT01651780|459920039|FG001|Overall Study|Physician decision: No 30-day visit|1|||
127809065|NCT01651780|459920038|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
127809066|NCT01651780|459920039|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
127809067|NCT01651780|459920038|FG000|Overall Study|Withdrawal by Subject|2|||
127809068|NCT01651780|459920039|FG001|Overall Study|Withdrawal by Subject|0|||
127809069|NCT01651780|459920038|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
127809070|NCT01651780|459920039|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
127809071|NCT01651780|459920038|FG000|Overall Study|Lost to Follow-up|1|||
127809072|NCT01651780|459920039|FG001|Overall Study|Lost to Follow-up|2|||
127809073|NCT01651780|459920038|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
127809074|NCT01651780|459920039|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
127809075|NCT01412229|459920040|FG000|Overall Study|Physician Decision|1|||
127809076|NCT00151892|459920047|FG000|Overall Study|Lack of Efficacy|50|||
127809077|NCT00151892|459920048|FG001|Overall Study|Lack of Efficacy|57|||
127809078|NCT00151892|459920047|FG000|Overall Study|Patient request|10|||
127809079|NCT00151892|459920048|FG001|Overall Study|Patient request|7|||
127809080|NCT00151892|459920047|FG000|Overall Study|Lost to Follow-up|5|||
127809081|NCT00151892|459920048|FG001|Overall Study|Lost to Follow-up|10|||
127809082|NCT00151892|459920047|FG000|Overall Study|Adverse Event|6|||
127809083|NCT00151892|459920048|FG001|Overall Study|Adverse Event|3|||
127809084|NCT00151892|459920047|FG000|Overall Study|Protocol Violation|3|||
127809085|NCT00151892|459920048|FG001|Overall Study|Protocol Violation|3|||
127809086|NCT00151892|459920047|FG000|Overall Study|Non-compliance|0|||
127809087|NCT00151892|459920048|FG001|Overall Study|Non-compliance|1|||
127809088|NCT00151892|459920047|FG000|Overall Study|Pregnancy|0|||
127749640|NCT02563548|459710069|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
127749641|NCT02563548|459710070|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
127749642|NCT02563548|459710071|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
127749643|NCT02563548|459710072|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
127749644|NCT02563548|459710073|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
127749645|NCT02563548|459710074|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
127749646|NCT02563548|459710069|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
127749647|NCT02563548|459710070|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
127749648|NCT02563548|459710071|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
127749649|NCT02563548|459710072|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
127749650|NCT02563548|459710073|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
127749651|NCT02563548|459710074|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
127749652|NCT02563548|459710069|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
127749653|NCT02563548|459710070|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
127749654|NCT02563548|459710071|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
127749655|NCT02563548|459710072|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
127749656|NCT02563548|459710073|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
127749657|NCT02563548|459710074|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
127749658|NCT02563548|459710069|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
127749659|NCT02563548|459710070|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
127749660|NCT02563548|459710071|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
127749661|NCT02563548|459710072|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
127749662|NCT02563548|459710073|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
127749663|NCT02563548|459710074|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
127749664|NCT02563548|459710069|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
127749665|NCT02563548|459710070|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
127809089|NCT00151892|459920048|FG001|Overall Study|Pregnancy|1|||
127894101|NCT00576901|460235218|FG000|Overall Study|Disease course|1|||
127749666|NCT02563548|459710071|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
127749667|NCT02563548|459710072|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
127749668|NCT02563548|459710073|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
127749669|NCT02563548|459710074|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
127749670|NCT02563548|459710069|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
127749671|NCT02563548|459710070|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
127809090|NCT00151892|459920047|FG000|Overall Study|Did not return for a visit|1|||
127809091|NCT00151892|459920048|FG001|Overall Study|Did not return for a visit|0|||
127809092|NCT00151892|459920047|FG000|Overall Study|Used prohibited corticosteroids|1|||
127809093|NCT00151892|459920048|FG001|Overall Study|Used prohibited corticosteroids|0|||
127809094|NCT00151892|459920047|FG000|Overall Study|Lack of study medication at center|0|||
127809095|NCT00151892|459920048|FG001|Overall Study|Lack of study medication at center|1|||
127809096|NCT02901431|459920049|FG000|PK Part|Adverse Event|0|||
127809097|NCT02901431|459920050|FG001|PK Part|Adverse Event|1|||
127809098|NCT02901431|459920051|FG002|PK Part|Adverse Event|0|||
127809099|NCT02901431|459920052|FG003|PK Part|Adverse Event|0|||
127809100|NCT02901431|459920053|FG004|PK Part|Adverse Event|0|||
127809101|NCT02901431|459920054|FG005|PK Part|Adverse Event|0|||
127809102|NCT02901431|459920055|FG006|PK Part|Adverse Event|0|||
127809103|NCT02901431|459920056|FG007|PK Part|Adverse Event|0|||
127809104|NCT02901431|459920057|FG008|PK Part|Adverse Event|0|||
127809105|NCT02901431|459920058|FG009|PK Part|Adverse Event|0|||
127809106|NCT02901431|459920059|FG010|PK Part|Adverse Event|0|||
127809107|NCT02901431|459920060|FG011|PK Part|Adverse Event|0|||
127809108|NCT02901431|459920061|FG012|PK Part|Adverse Event|0|||
127809109|NCT02901431|459920049|FG000|PK Part|Lost to Follow-up|0|||
127809110|NCT02901431|459920050|FG001|PK Part|Lost to Follow-up|0|||
127809111|NCT02901431|459920051|FG002|PK Part|Lost to Follow-up|1|||
127809112|NCT02901431|459920052|FG003|PK Part|Lost to Follow-up|0|||
127809113|NCT02901431|459920053|FG004|PK Part|Lost to Follow-up|0|||
127809114|NCT02901431|459920054|FG005|PK Part|Lost to Follow-up|0|||
127809115|NCT02901431|459920055|FG006|PK Part|Lost to Follow-up|0|||
127809116|NCT02901431|459920056|FG007|PK Part|Lost to Follow-up|0|||
127809117|NCT02901431|459920057|FG008|PK Part|Lost to Follow-up|0|||
127809118|NCT02901431|459920058|FG009|PK Part|Lost to Follow-up|0|||
127809119|NCT02901431|459920059|FG010|PK Part|Lost to Follow-up|0|||
127809120|NCT02901431|459920060|FG011|PK Part|Lost to Follow-up|0|||
127809121|NCT02901431|459920061|FG012|PK Part|Lost to Follow-up|0|||
127809122|NCT02901431|459920049|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
127809123|NCT02901431|459920050|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
127809124|NCT02901431|459920051|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
127809125|NCT02901431|459920052|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
127809126|NCT02901431|459920053|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
127809127|NCT02901431|459920054|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
127809128|NCT02901431|459920055|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
127809129|NCT02901431|459920056|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
127809130|NCT02901431|459920057|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
127809131|NCT02901431|459920058|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
127809132|NCT02901431|459920059|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
127809133|NCT02901431|459920060|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
127809134|NCT02901431|459920061|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
127809135|NCT02901431|459920049|FG000|PK Part|Pending dose confirmation|0|||
127809136|NCT02901431|459920050|FG001|PK Part|Pending dose confirmation|1|||
127809137|NCT02901431|459920051|FG002|PK Part|Pending dose confirmation|0|||
127809138|NCT02901431|459920052|FG003|PK Part|Pending dose confirmation|0|||
127809139|NCT02901431|459920053|FG004|PK Part|Pending dose confirmation|0|||
127809140|NCT02901431|459920054|FG005|PK Part|Pending dose confirmation|0|||
127809141|NCT02901431|459920055|FG006|PK Part|Pending dose confirmation|0|||
127809142|NCT02901431|459920056|FG007|PK Part|Pending dose confirmation|0|||
127809143|NCT02901431|459920057|FG008|PK Part|Pending dose confirmation|0|||
127809144|NCT02901431|459920058|FG009|PK Part|Pending dose confirmation|0|||
127809145|NCT02901431|459920059|FG010|PK Part|Pending dose confirmation|0|||
127809146|NCT02901431|459920060|FG011|PK Part|Pending dose confirmation|0|||
127809147|NCT02901431|459920061|FG012|PK Part|Pending dose confirmation|0|||
127809148|NCT02901431|459920049|FG000|PK Part|8 weeks of treatment ran out|2|||
127809149|NCT02901431|459920050|FG001|PK Part|8 weeks of treatment ran out|0|||
127809150|NCT02901431|459920051|FG002|PK Part|8 weeks of treatment ran out|0|||
127809151|NCT02901431|459920052|FG003|PK Part|8 weeks of treatment ran out|0|||
127894102|NCT00576901|460235218|FG000|Overall Study|Protocol Violation|1|||
127894103|NCT01755858|460235221|FG000|Overall Study|Adverse Event|1|||
127894104|NCT01755858|460235222|FG001|Overall Study|Adverse Event|1|||
127894105|NCT02398188|460235223|FG000|Overall Study|Adverse Event|2|||
127894106|NCT02398188|460235224|FG001|Overall Study|Adverse Event|3|||
127894107|NCT02398188|460235223|FG000|Overall Study|Lost to Follow-up|5|||
127894108|NCT02398188|460235224|FG001|Overall Study|Lost to Follow-up|0|||
127809152|NCT02901431|459920053|FG004|PK Part|8 weeks of treatment ran out|0|||
127809153|NCT02901431|459920054|FG005|PK Part|8 weeks of treatment ran out|0|||
127809154|NCT02901431|459920055|FG006|PK Part|8 weeks of treatment ran out|0|||
127809155|NCT02901431|459920056|FG007|PK Part|8 weeks of treatment ran out|0|||
127809156|NCT02901431|459920057|FG008|PK Part|8 weeks of treatment ran out|0|||
127809157|NCT02901431|459920058|FG009|PK Part|8 weeks of treatment ran out|0|||
127809158|NCT02901431|459920059|FG010|PK Part|8 weeks of treatment ran out|0|||
127809159|NCT02901431|459920060|FG011|PK Part|8 weeks of treatment ran out|0|||
127809160|NCT02901431|459920061|FG012|PK Part|8 weeks of treatment ran out|0|||
127809161|NCT02901431|459920049|FG000|PK Part|Stopped treatment after 8 weeks|1|||
127809162|NCT02901431|459920050|FG001|PK Part|Stopped treatment after 8 weeks|0|||
127894109|NCT02398188|460235223|FG000|Overall Study|Non-compliance|4|||
127894110|NCT02398188|460235224|FG001|Overall Study|Non-compliance|4|||
127894111|NCT02398188|460235223|FG000|Overall Study|Protocol Violation|6|||
127809163|NCT02901431|459920051|FG002|PK Part|Stopped treatment after 8 weeks|1|||
127809164|NCT02901431|459920052|FG003|PK Part|Stopped treatment after 8 weeks|0|||
127809165|NCT02901431|459920053|FG004|PK Part|Stopped treatment after 8 weeks|0|||
127809166|NCT02901431|459920054|FG005|PK Part|Stopped treatment after 8 weeks|0|||
127809167|NCT02901431|459920055|FG006|PK Part|Stopped treatment after 8 weeks|0|||
127809168|NCT02901431|459920056|FG007|PK Part|Stopped treatment after 8 weeks|0|||
127809169|NCT02901431|459920057|FG008|PK Part|Stopped treatment after 8 weeks|0|||
127809170|NCT02901431|459920058|FG009|PK Part|Stopped treatment after 8 weeks|0|||
127809171|NCT02901431|459920059|FG010|PK Part|Stopped treatment after 8 weeks|0|||
127809172|NCT02901431|459920060|FG011|PK Part|Stopped treatment after 8 weeks|0|||
127809173|NCT02901431|459920061|FG012|PK Part|Stopped treatment after 8 weeks|0|||
127809174|NCT02901431|459920049|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
127809175|NCT02901431|459920050|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
127809176|NCT02901431|459920051|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
127809177|NCT02901431|459920052|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
127809178|NCT02901431|459920053|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
127809179|NCT02901431|459920054|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
127809180|NCT02901431|459920055|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
127809181|NCT02901431|459920056|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
127809182|NCT02901431|459920057|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
127809183|NCT02901431|459920058|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
127809184|NCT02901431|459920059|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
127809185|NCT02901431|459920060|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
127809186|NCT02901431|459920061|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
127809187|NCT02901431|459920049|FG000|PK Part|Discontinued per Sponsor|0|||
127809188|NCT02901431|459920050|FG001|PK Part|Discontinued per Sponsor|3|||
127809189|NCT02901431|459920051|FG002|PK Part|Discontinued per Sponsor|0|||
127809190|NCT02901431|459920052|FG003|PK Part|Discontinued per Sponsor|0|||
127809191|NCT02901431|459920053|FG004|PK Part|Discontinued per Sponsor|0|||
127809192|NCT02901431|459920054|FG005|PK Part|Discontinued per Sponsor|0|||
127809193|NCT02901431|459920055|FG006|PK Part|Discontinued per Sponsor|0|||
127809194|NCT02901431|459920056|FG007|PK Part|Discontinued per Sponsor|0|||
127809195|NCT02901431|459920057|FG008|PK Part|Discontinued per Sponsor|0|||
127809196|NCT02901431|459920058|FG009|PK Part|Discontinued per Sponsor|0|||
127809197|NCT02901431|459920059|FG010|PK Part|Discontinued per Sponsor|0|||
127809198|NCT02901431|459920060|FG011|PK Part|Discontinued per Sponsor|0|||
127809199|NCT02901431|459920061|FG012|PK Part|Discontinued per Sponsor|0|||
127809200|NCT02901431|459920049|FG000|PK Part|Withdrawal by Subject|1|||
127809201|NCT02901431|459920050|FG001|PK Part|Withdrawal by Subject|1|||
127809202|NCT02901431|459920051|FG002|PK Part|Withdrawal by Subject|3|||
127809203|NCT02901431|459920052|FG003|PK Part|Withdrawal by Subject|0|||
127809204|NCT02901431|459920053|FG004|PK Part|Withdrawal by Subject|0|||
127809205|NCT02901431|459920054|FG005|PK Part|Withdrawal by Subject|0|||
127809206|NCT02901431|459920055|FG006|PK Part|Withdrawal by Subject|0|||
127809207|NCT02901431|459920056|FG007|PK Part|Withdrawal by Subject|0|||
127894112|NCT02398188|460235224|FG001|Overall Study|Protocol Violation|10|||
127894113|NCT02398188|460235223|FG000|Overall Study|Sponsor Decision|2|||
127894114|NCT02398188|460235224|FG001|Overall Study|Sponsor Decision|1|||
127894115|NCT02398188|460235223|FG000|Overall Study|Pregnancy|1|||
127894116|NCT02398188|460235224|FG001|Overall Study|Pregnancy|0|||
127894117|NCT02398188|460235223|FG000|Overall Study|Withdrawal by Subject|7|||
127894118|NCT02398188|460235224|FG001|Overall Study|Withdrawal by Subject|16|||
127809208|NCT02901431|459920057|FG008|PK Part|Withdrawal by Subject|0|||
127809209|NCT02901431|459920058|FG009|PK Part|Withdrawal by Subject|0|||
127809210|NCT02901431|459920059|FG010|PK Part|Withdrawal by Subject|0|||
127809211|NCT02901431|459920060|FG011|PK Part|Withdrawal by Subject|0|||
127809212|NCT02901431|459920061|FG012|PK Part|Withdrawal by Subject|0|||
127809213|NCT02901431|459920049|FG000|Main Treatment Part|Adverse Event|0|||
127809214|NCT02901431|459920050|FG001|Main Treatment Part|Adverse Event|0|||
127894119|NCT00782509|460235225|FG000|Overall Study|Adverse Event|20|||
127894120|NCT00782509|460235226|FG001|Overall Study|Adverse Event|10|||
127894121|NCT00782509|460235227|FG002|Overall Study|Adverse Event|20|||
127809215|NCT02901431|459920051|FG002|Main Treatment Part|Adverse Event|0|||
127809216|NCT02901431|459920052|FG003|Main Treatment Part|Adverse Event|3|||
127809217|NCT02901431|459920053|FG004|Main Treatment Part|Adverse Event|3|||
127809218|NCT02901431|459920054|FG005|Main Treatment Part|Adverse Event|4|||
127809219|NCT02901431|459920055|FG006|Main Treatment Part|Adverse Event|1|||
127894122|NCT00782509|460235225|FG000|Overall Study|Lost to Follow-up|1|||
127894123|NCT00782509|460235226|FG001|Overall Study|Lost to Follow-up|2|||
127894124|NCT00782509|460235227|FG002|Overall Study|Lost to Follow-up|3|||
127894125|NCT00782509|460235225|FG000|Overall Study|Withdrawal by Subject|3|||
127809220|NCT02901431|459920056|FG007|Main Treatment Part|Adverse Event|0|||
127809221|NCT02901431|459920057|FG008|Main Treatment Part|Adverse Event|0|||
127809222|NCT02901431|459920058|FG009|Main Treatment Part|Adverse Event|0|||
127809223|NCT02901431|459920059|FG010|Main Treatment Part|Adverse Event|0|||
127809224|NCT02901431|459920060|FG011|Main Treatment Part|Adverse Event|0|||
127894126|NCT00782509|460235226|FG001|Overall Study|Withdrawal by Subject|5|||
127894127|NCT00782509|460235227|FG002|Overall Study|Withdrawal by Subject|8|||
127749672|NCT02563548|459710071|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
127749673|NCT02563548|459710072|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
127749674|NCT02563548|459710073|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
127749675|NCT02563548|459710074|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
127749676|NCT02563548|459710069|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
127749677|NCT02563548|459710070|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
127749678|NCT02563548|459710071|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
127749679|NCT02563548|459710072|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
127749680|NCT02563548|459710073|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
127749681|NCT02563548|459710074|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
127749682|NCT02563548|459710069|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
127749683|NCT02563548|459710070|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
127749684|NCT02563548|459710071|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
127749685|NCT02563548|459710072|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
127749686|NCT02563548|459710073|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
127749687|NCT02563548|459710074|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
127749688|NCT02563548|459710069|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
127749689|NCT02563548|459710070|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
127749690|NCT02563548|459710071|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
127749691|NCT02563548|459710072|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
127749692|NCT02563548|459710073|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
127749693|NCT02563548|459710074|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
127749694|NCT02563548|459710069|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
127749695|NCT02563548|459710070|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
127749696|NCT02563548|459710071|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
127749697|NCT02563548|459710072|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
127749698|NCT02563548|459710073|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
127749699|NCT02563548|459710074|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
127749700|NCT03274453|459710075|FG000|Overall Study|Lost to Follow-up|2|||
127749701|NCT03274453|459710076|FG001|Overall Study|Lost to Follow-up|5|||
127749702|NCT03274453|459710077|FG002|Overall Study|Lost to Follow-up|4|||
127749703|NCT03274453|459710078|FG003|Overall Study|Lost to Follow-up|1|||
127749704|NCT03274453|459710075|FG000|Overall Study|Physician Decision|2|||
127749705|NCT03274453|459710076|FG001|Overall Study|Physician Decision|0|||
127749706|NCT03274453|459710077|FG002|Overall Study|Physician Decision|0|||
127749707|NCT03274453|459710078|FG003|Overall Study|Physician Decision|3|||
127749708|NCT03274453|459710075|FG000|Overall Study|Surgery Cancelled|0|||
127749709|NCT03274453|459710076|FG001|Overall Study|Surgery Cancelled|1|||
127749710|NCT03274453|459710077|FG002|Overall Study|Surgery Cancelled|0|||
127749711|NCT03274453|459710078|FG003|Overall Study|Surgery Cancelled|0|||
127749712|NCT01516749|459710080|FG000|Active Therapy|Lost to Follow-up|1|||
127749713|NCT01516749|459710080|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
127749714|NCT01732549|459710081|FG000|Overall Study|Adverse Event|13|||
127749715|NCT01732549|459710082|FG001|Overall Study|Adverse Event|3|||
127749716|NCT01732549|459710081|FG000|Overall Study|Consent withdrawn|13|||
127749717|NCT01732549|459710082|FG001|Overall Study|Consent withdrawn|6|||
127749718|NCT01732549|459710081|FG000|Overall Study|Disease progression|37|||
127749719|NCT01732549|459710082|FG001|Overall Study|Disease progression|50|||
127749720|NCT01732549|459710081|FG000|Overall Study|Other|8|||
127749721|NCT01732549|459710082|FG001|Overall Study|Other|14|||
127749722|NCT00351377|459710083|FG000|Overall Study|Adverse Event|5|||
127749723|NCT00351377|459710083|FG000|Overall Study|Death|1|||
127749724|NCT00351377|459710083|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
127749725|NCT03845140|459710085|FG000|Overall Study|Participant travelled outside study area|0|||
127749726|NCT03845140|459710086|FG001|Overall Study|Participant travelled outside study area|1|||
127749727|NCT03845140|459710087|FG002|Overall Study|Participant travelled outside study area|0|||
127749728|NCT03845140|459710088|FG003|Overall Study|Participant travelled outside study area|0|||
127809225|NCT02901431|459920061|FG012|Main Treatment Part|Adverse Event|0|||
127809226|NCT02901431|459920049|FG000|Main Treatment Part|Lack of Efficacy|0|||
127809227|NCT02901431|459920050|FG001|Main Treatment Part|Lack of Efficacy|0|||
127809228|NCT02901431|459920051|FG002|Main Treatment Part|Lack of Efficacy|0|||
127809229|NCT02901431|459920052|FG003|Main Treatment Part|Lack of Efficacy|1|||
127809230|NCT02901431|459920053|FG004|Main Treatment Part|Lack of Efficacy|0|||
127749729|NCT03845140|459710089|FG004|Overall Study|Participant travelled outside study area|0|||
127809231|NCT02901431|459920054|FG005|Main Treatment Part|Lack of Efficacy|0|||
127749730|NCT03845140|459710090|FG005|Overall Study|Participant travelled outside study area|0|||
127749731|NCT01681992|459710098|FG000|Overall Study|Adverse Event|3|||
127749732|NCT01681992|459710099|FG001|Overall Study|Adverse Event|2|||
127749733|NCT01681992|459710100|FG002|Overall Study|Adverse Event|3|||
127749734|NCT01681992|459710098|FG000|Overall Study|Lost to Follow-up|36|||
127809232|NCT02901431|459920055|FG006|Main Treatment Part|Lack of Efficacy|0|||
127809233|NCT02901431|459920056|FG007|Main Treatment Part|Lack of Efficacy|0|||
127809234|NCT02901431|459920057|FG008|Main Treatment Part|Lack of Efficacy|0|||
127809235|NCT02901431|459920058|FG009|Main Treatment Part|Lack of Efficacy|0|||
127809236|NCT02901431|459920059|FG010|Main Treatment Part|Lack of Efficacy|0|||
127809237|NCT02901431|459920060|FG011|Main Treatment Part|Lack of Efficacy|0|||
127809238|NCT02901431|459920061|FG012|Main Treatment Part|Lack of Efficacy|0|||
127809239|NCT02901431|459920049|FG000|Main Treatment Part|Lost to Follow-up|0|||
127809240|NCT02901431|459920050|FG001|Main Treatment Part|Lost to Follow-up|0|||
127809241|NCT02901431|459920051|FG002|Main Treatment Part|Lost to Follow-up|0|||
127809242|NCT02901431|459920052|FG003|Main Treatment Part|Lost to Follow-up|3|||
127809243|NCT02901431|459920053|FG004|Main Treatment Part|Lost to Follow-up|1|||
127809244|NCT02901431|459920054|FG005|Main Treatment Part|Lost to Follow-up|2|||
127809245|NCT02901431|459920055|FG006|Main Treatment Part|Lost to Follow-up|3|||
127809246|NCT02901431|459920056|FG007|Main Treatment Part|Lost to Follow-up|0|||
127809247|NCT02901431|459920057|FG008|Main Treatment Part|Lost to Follow-up|0|||
127809248|NCT02901431|459920058|FG009|Main Treatment Part|Lost to Follow-up|0|||
127809249|NCT02901431|459920059|FG010|Main Treatment Part|Lost to Follow-up|0|||
127809250|NCT02901431|459920060|FG011|Main Treatment Part|Lost to Follow-up|0|||
127894128|NCT00782509|460235225|FG000|Overall Study|Non compliance with protocol|2|||
127894129|NCT00782509|460235226|FG001|Overall Study|Non compliance with protocol|0|||
127894130|NCT00782509|460235227|FG002|Overall Study|Non compliance with protocol|0|||
127749735|NCT01681992|459710099|FG001|Overall Study|Lost to Follow-up|38|||
127749736|NCT01681992|459710100|FG002|Overall Study|Lost to Follow-up|53|||
127749737|NCT01681992|459710098|FG000|Overall Study|As Per Sponsor Decision|0|||
127749738|NCT01681992|459710099|FG001|Overall Study|As Per Sponsor Decision|0|||
127749739|NCT01681992|459710100|FG002|Overall Study|As Per Sponsor Decision|1|||
127749740|NCT01681992|459710098|FG000|Overall Study|Protocol Violation|0|||
127749741|NCT01681992|459710099|FG001|Overall Study|Protocol Violation|0|||
127749742|NCT01681992|459710100|FG002|Overall Study|Protocol Violation|1|||
127749743|NCT01681992|459710098|FG000|Overall Study|Withdrawal by Subject|27|||
127749744|NCT01681992|459710099|FG001|Overall Study|Withdrawal by Subject|30|||
127749745|NCT01681992|459710100|FG002|Overall Study|Withdrawal by Subject|25|||
127749746|NCT03690427|459710106|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
127749747|NCT03690427|459710107|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
127749748|NCT02609672|459710112|FG000|Overall Study|Lost to Follow-up|3|||
127749749|NCT02609672|459710113|FG001|Overall Study|Lost to Follow-up|1|||
127749750|NCT02956837|459710114|FG000|Overall Study|Serious Adverse Events|0|||
127749751|NCT02956837|459710115|FG001|Overall Study|Serious Adverse Events|1|||
127749752|NCT02956837|459710116|FG002|Overall Study|Serious Adverse Events|0|||
127749753|NCT02956837|459710117|FG003|Overall Study|Serious Adverse Events|0|||
127749754|NCT02956837|459710114|FG000|Overall Study|Withdrawal by Subject|0|||
127749755|NCT02956837|459710115|FG001|Overall Study|Withdrawal by Subject|1|||
127749756|NCT02956837|459710116|FG002|Overall Study|Withdrawal by Subject|0|||
127749757|NCT02956837|459710117|FG003|Overall Study|Withdrawal by Subject|3|||
127749758|NCT02956837|459710114|FG000|Overall Study|Lost to Follow-up|0|||
127749759|NCT02956837|459710115|FG001|Overall Study|Lost to Follow-up|1|||
127749760|NCT02956837|459710116|FG002|Overall Study|Lost to Follow-up|2|||
127749761|NCT02956837|459710117|FG003|Overall Study|Lost to Follow-up|0|||
127749762|NCT02597712|459710118|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
127749763|NCT02597712|459710119|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
127749764|NCT02597712|459710118|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
127749765|NCT02597712|459710119|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
127749766|NCT02597712|459710118|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
127749767|NCT02597712|459710119|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
127749768|NCT02637323|459710120|FG000|Overall Study|Lost to Follow-up|2|||
127749769|NCT02637323|459710121|FG001|Overall Study|Lost to Follow-up|0|||
127749770|NCT02637323|459710120|FG000|Overall Study|Protocol Violation|0|||
127749771|NCT02637323|459710121|FG001|Overall Study|Protocol Violation|1|||
127749772|NCT00513708|459710122|FG000|Overall Study|Lost to Follow-up|4|||
127749773|NCT00513708|459710123|FG001|Overall Study|Lost to Follow-up|4|||
127749774|NCT00513708|459710124|FG002|Overall Study|Lost to Follow-up|4|||
127749775|NCT03274895|459710127|FG000|Overall Study|Lack of Efficacy|1|||
127749776|NCT03274895|459710128|FG001|Overall Study|Lack of Efficacy|0|||
127749777|NCT03274895|459710127|FG000|Overall Study|Adverse Event|8|||
127809251|NCT02901431|459920061|FG012|Main Treatment Part|Lost to Follow-up|0|||
127809252|NCT02901431|459920049|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
127894131|NCT00782509|460235225|FG000|Overall Study|Other reasons not stated above|5|||
127749778|NCT03274895|459710128|FG001|Overall Study|Adverse Event|7|||
127749779|NCT03274895|459710127|FG000|Overall Study|Lost to Follow-up|1|||
127749780|NCT03274895|459710128|FG001|Overall Study|Lost to Follow-up|0|||
127749781|NCT03274895|459710127|FG000|Overall Study|Diagnosis not confirmed|3|||
127749782|NCT03274895|459710128|FG001|Overall Study|Diagnosis not confirmed|4|||
127749783|NCT00401258|459710132|FG000|Overall Study|Adverse Event|7|||
127809253|NCT02901431|459920050|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
127809254|NCT02901431|459920051|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
127809255|NCT02901431|459920052|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
127809256|NCT02901431|459920053|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
127809257|NCT02901431|459920054|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
127809258|NCT02901431|459920055|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
127809259|NCT02901431|459920056|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
127809260|NCT02901431|459920057|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
127809261|NCT02901431|459920058|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
127809262|NCT02901431|459920059|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
127809263|NCT02901431|459920060|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
127809264|NCT02901431|459920061|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
127809265|NCT02901431|459920049|FG000|Main Treatment Part|Physician Decision|0|||
127809266|NCT02901431|459920050|FG001|Main Treatment Part|Physician Decision|0|||
127809267|NCT02901431|459920051|FG002|Main Treatment Part|Physician Decision|0|||
127809268|NCT02901431|459920052|FG003|Main Treatment Part|Physician Decision|1|||
127809269|NCT02901431|459920053|FG004|Main Treatment Part|Physician Decision|0|||
127809270|NCT02901431|459920054|FG005|Main Treatment Part|Physician Decision|0|||
127809271|NCT02901431|459920055|FG006|Main Treatment Part|Physician Decision|1|||
127809272|NCT02901431|459920056|FG007|Main Treatment Part|Physician Decision|0|||
127809273|NCT02901431|459920057|FG008|Main Treatment Part|Physician Decision|0|||
127809274|NCT02901431|459920058|FG009|Main Treatment Part|Physician Decision|0|||
127809275|NCT02901431|459920059|FG010|Main Treatment Part|Physician Decision|0|||
127809276|NCT02901431|459920060|FG011|Main Treatment Part|Physician Decision|0|||
127809277|NCT02901431|459920061|FG012|Main Treatment Part|Physician Decision|0|||
127809278|NCT02901431|459920049|FG000|Main Treatment Part|Withdrawal by Subject|0|||
127809279|NCT02901431|459920050|FG001|Main Treatment Part|Withdrawal by Subject|0|||
127809280|NCT02901431|459920051|FG002|Main Treatment Part|Withdrawal by Subject|0|||
127809281|NCT02901431|459920052|FG003|Main Treatment Part|Withdrawal by Subject|18|||
127809282|NCT02901431|459920053|FG004|Main Treatment Part|Withdrawal by Subject|3|||
127809283|NCT02901431|459920054|FG005|Main Treatment Part|Withdrawal by Subject|5|||
127809284|NCT02901431|459920055|FG006|Main Treatment Part|Withdrawal by Subject|6|||
127809285|NCT02901431|459920056|FG007|Main Treatment Part|Withdrawal by Subject|0|||
127809286|NCT02901431|459920057|FG008|Main Treatment Part|Withdrawal by Subject|0|||
127809287|NCT02901431|459920058|FG009|Main Treatment Part|Withdrawal by Subject|0|||
127809288|NCT02901431|459920059|FG010|Main Treatment Part|Withdrawal by Subject|0|||
127809289|NCT02901431|459920060|FG011|Main Treatment Part|Withdrawal by Subject|0|||
127809290|NCT02901431|459920061|FG012|Main Treatment Part|Withdrawal by Subject|0|||
127809291|NCT02901431|459920049|FG000|Open Label Part|Adverse Event|0|||
127809292|NCT02901431|459920050|FG001|Open Label Part|Adverse Event|0|||
127809293|NCT02901431|459920051|FG002|Open Label Part|Adverse Event|0|||
127809294|NCT02901431|459920052|FG003|Open Label Part|Adverse Event|0|||
127809295|NCT02901431|459920053|FG004|Open Label Part|Adverse Event|0|||
127809296|NCT02901431|459920054|FG005|Open Label Part|Adverse Event|0|||
127809297|NCT02901431|459920055|FG006|Open Label Part|Adverse Event|0|||
127809298|NCT02901431|459920056|FG007|Open Label Part|Adverse Event|0|||
127809299|NCT02901431|459920057|FG008|Open Label Part|Adverse Event|4|||
127809300|NCT02901431|459920058|FG009|Open Label Part|Adverse Event|4|||
127809301|NCT02901431|459920059|FG010|Open Label Part|Adverse Event|0|||
127809302|NCT02901431|459920060|FG011|Open Label Part|Adverse Event|4|||
127809303|NCT02901431|459920061|FG012|Open Label Part|Adverse Event|1|||
127809304|NCT02901431|459920049|FG000|Open Label Part|Lost to Follow-up|0|||
127809305|NCT02901431|459920050|FG001|Open Label Part|Lost to Follow-up|0|||
127809306|NCT02901431|459920051|FG002|Open Label Part|Lost to Follow-up|0|||
127809307|NCT02901431|459920052|FG003|Open Label Part|Lost to Follow-up|0|||
127809308|NCT02901431|459920053|FG004|Open Label Part|Lost to Follow-up|0|||
127809309|NCT02901431|459920054|FG005|Open Label Part|Lost to Follow-up|0|||
127809310|NCT02901431|459920055|FG006|Open Label Part|Lost to Follow-up|0|||
127809311|NCT02901431|459920056|FG007|Open Label Part|Lost to Follow-up|0|||
127809312|NCT02901431|459920057|FG008|Open Label Part|Lost to Follow-up|2|||
127809313|NCT02901431|459920058|FG009|Open Label Part|Lost to Follow-up|2|||
127809314|NCT02901431|459920059|FG010|Open Label Part|Lost to Follow-up|1|||
127809315|NCT02901431|459920060|FG011|Open Label Part|Lost to Follow-up|1|||
127809316|NCT02901431|459920061|FG012|Open Label Part|Lost to Follow-up|1|||
127809317|NCT02901431|459920049|FG000|Open Label Part|Physician Decision|0|||
127809318|NCT02901431|459920050|FG001|Open Label Part|Physician Decision|0|||
127809319|NCT02901431|459920051|FG002|Open Label Part|Physician Decision|0|||
127809320|NCT02901431|459920052|FG003|Open Label Part|Physician Decision|0|||
127809321|NCT02901431|459920053|FG004|Open Label Part|Physician Decision|0|||
127894132|NCT00782509|460235226|FG001|Overall Study|Other reasons not stated above|2|||
127809322|NCT02901431|459920054|FG005|Open Label Part|Physician Decision|0|||
127809323|NCT02901431|459920055|FG006|Open Label Part|Physician Decision|0|||
127809324|NCT02901431|459920056|FG007|Open Label Part|Physician Decision|0|||
127809325|NCT02901431|459920057|FG008|Open Label Part|Physician Decision|1|||
127809326|NCT02901431|459920058|FG009|Open Label Part|Physician Decision|1|||
127809327|NCT02901431|459920059|FG010|Open Label Part|Physician Decision|0|||
127809328|NCT02901431|459920060|FG011|Open Label Part|Physician Decision|0|||
127749784|NCT00617929|459710138|FG000|Overall Study|Physician Decision|1|||
127749785|NCT00760747|459710143|FG000|Study Period II|Adverse Event|3|||
127749786|NCT00760747|459710144|FG001|Study Period II|Adverse Event|4|||
127749787|NCT00760747|459710143|FG000|Study Period II|Lack of Efficacy|0|||
127749788|NCT00760747|459710144|FG001|Study Period II|Lack of Efficacy|6|||
127749789|NCT00760747|459710143|FG000|Study Period II|Parent/Caregiver Decision|3|||
127749790|NCT00760747|459710144|FG001|Study Period II|Parent/Caregiver Decision|0|||
127749791|NCT00760747|459710143|FG000|Study Period II|Protocol Violation|6|||
127749792|NCT00760747|459710144|FG001|Study Period II|Protocol Violation|3|||
127749793|NCT00760747|459710143|FG000|Study Period II|Withdrawal by Subject|1|||
127749794|NCT00760747|459710144|FG001|Study Period II|Withdrawal by Subject|0|||
127749795|NCT00760747|459710143|FG000|Study Period II|No drug administered|0|||
127749796|NCT00760747|459710144|FG001|Study Period II|No drug administered|1|||
127749797|NCT00760747|459710143|FG000|Study Period III|Adverse Event|1|||
127749798|NCT00760747|459710144|FG001|Study Period III|Adverse Event|0|||
127749799|NCT00760747|459710143|FG000|Study Period III|Lack of Efficacy|1|||
127749800|NCT00760747|459710144|FG001|Study Period III|Lack of Efficacy|0|||
127749801|NCT00760747|459710143|FG000|Study Period III|Parent/Caregiver Decision|0|||
127749802|NCT00760747|459710144|FG001|Study Period III|Parent/Caregiver Decision|1|||
127749803|NCT00760747|459710143|FG000|Study Period III|Protocol Violation|1|||
127749804|NCT00760747|459710144|FG001|Study Period III|Protocol Violation|1|||
127749805|NCT00760747|459710143|FG000|Study Period III|Physician Decision|0|||
127749806|NCT00760747|459710144|FG001|Study Period III|Physician Decision|1|||
127749807|NCT01443923|459710145|FG000|Overall Study|Adverse Event|1|||
127749808|NCT01443923|459710146|FG001|Overall Study|Adverse Event|0|||
127749809|NCT03566979|459710147|FG000|Overall Study|Withdrawal by Subject|2|||
127749810|NCT03566979|459710148|FG001|Overall Study|Withdrawal by Subject|0|||
127749811|NCT03566979|459710149|FG002|Overall Study|Withdrawal by Subject|1|||
127749812|NCT03566979|459710150|FG003|Overall Study|Withdrawal by Subject|1|||
127749813|NCT03566979|459710147|FG000|Overall Study|Lost to Follow-up|2|||
127749814|NCT03566979|459710148|FG001|Overall Study|Lost to Follow-up|7|||
127749815|NCT03566979|459710149|FG002|Overall Study|Lost to Follow-up|9|||
127749816|NCT03566979|459710150|FG003|Overall Study|Lost to Follow-up|5|||
127749817|NCT03566979|459710147|FG000|Overall Study|Adverse Event|1|||
127749818|NCT03566979|459710148|FG001|Overall Study|Adverse Event|0|||
127749819|NCT03566979|459710149|FG002|Overall Study|Adverse Event|0|||
127749820|NCT03566979|459710150|FG003|Overall Study|Adverse Event|0|||
127749821|NCT00108745|459710151|FG000|Overall Study|Withdrawal by Subject|19|||
127749822|NCT00108745|459710152|FG001|Overall Study|Withdrawal by Subject|12|||
127749823|NCT00108745|459710153|FG002|Overall Study|Withdrawal by Subject|12|||
127749824|NCT00108745|459710151|FG000|Overall Study|Never Treated|8|||
127749825|NCT00108745|459710152|FG001|Overall Study|Never Treated|10|||
127749826|NCT00108745|459710153|FG002|Overall Study|Never Treated|12|||
127749827|NCT00108745|459710151|FG000|Overall Study|Ineligible|7|||
127749828|NCT00108745|459710152|FG001|Overall Study|Ineligible|13|||
127749829|NCT00108745|459710153|FG002|Overall Study|Ineligible|13|||
127749830|NCT01889069|459710154|FG000|Overall Study|Death|18|||
127749831|NCT01889069|459710154|FG000|Overall Study|Progression of Disease|14|||
127749832|NCT01889069|459710154|FG000|Overall Study|Lost to Follow-up|6|||
127749833|NCT01889069|459710154|FG000|Overall Study|Other|4|||
127749834|NCT01889069|459710154|FG000|Overall Study|Consent Withdrawal|3|||
127749835|NCT01426347|459710156|FG000|Overall Study|Lost to Follow-up|0|||
127749836|NCT01426347|459710157|FG001|Overall Study|Lost to Follow-up|3|||
127749837|NCT01426347|459710156|FG000|Overall Study|Protocol Violation|2|||
127749838|NCT01426347|459710157|FG001|Overall Study|Protocol Violation|0|||
127749839|NCT01426347|459710156|FG000|Overall Study|Withdrawal by Subject|5|||
127749840|NCT01426347|459710157|FG001|Overall Study|Withdrawal by Subject|0|||
127749841|NCT00455741|459710158|FG000|Overall Study|Physician Decision|0|||
127749842|NCT00455741|459710159|FG001|Overall Study|Physician Decision|1|||
127809329|NCT02901431|459920061|FG012|Open Label Part|Physician Decision|0|||
127809330|NCT02901431|459920049|FG000|Open Label Part|Study Terminated By Sponsor|0|||
127749843|NCT01245374|459710164|FG000|Overall Study|Protocol Violation|1|||
127749844|NCT01245374|459710164|FG000|Overall Study|Withdrawal by Subject|3|||
127749845|NCT00935532|459710165|FG000|Overall Study|Adverse Event|11|||
127809331|NCT02901431|459920050|FG001|Open Label Part|Study Terminated By Sponsor|0|||
127749846|NCT00935532|459710166|FG001|Overall Study|Adverse Event|6|||
127749847|NCT00935532|459710165|FG000|Overall Study|Death|1|||
127809332|NCT02901431|459920051|FG002|Open Label Part|Study Terminated By Sponsor|0|||
127809333|NCT02901431|459920052|FG003|Open Label Part|Study Terminated By Sponsor|0|||
127749848|NCT00935532|459710166|FG001|Overall Study|Death|0|||
127749849|NCT00935532|459710165|FG000|Overall Study|Lost to Follow-up|1|||
127749850|NCT00935532|459710166|FG001|Overall Study|Lost to Follow-up|0|||
127749851|NCT00935532|459710165|FG000|Overall Study|Physician Decision|1|||
127749852|NCT00935532|459710166|FG001|Overall Study|Physician Decision|2|||
127749853|NCT00935532|459710165|FG000|Overall Study|Protocol Violation|2|||
127809334|NCT02901431|459920053|FG004|Open Label Part|Study Terminated By Sponsor|0|||
127749854|NCT00935532|459710166|FG001|Overall Study|Protocol Violation|1|||
127749855|NCT00935532|459710165|FG000|Overall Study|Subject Decision|2|||
127749856|NCT00935532|459710166|FG001|Overall Study|Subject Decision|1|||
127749857|NCT00935532|459710165|FG000|Overall Study|Sponsor Decision|0|||
127749858|NCT00935532|459710166|FG001|Overall Study|Sponsor Decision|1|||
127749859|NCT00935532|459710165|FG000|Overall Study|Loss Glucose Control|4|||
127749860|NCT00935532|459710166|FG001|Overall Study|Loss Glucose Control|0|||
127749861|NCT04954326|459710167|FG000|Overall Study|Protocol Violation|0|||
127749862|NCT04954326|459710168|FG001|Overall Study|Protocol Violation|1|||
127749863|NCT04954326|459710167|FG000|Overall Study|Death|0|||
127749864|NCT04954326|459710168|FG001|Overall Study|Death|2|||
127749865|NCT04954326|459710167|FG000|Overall Study|Physician Decision|0|||
127749866|NCT04954326|459710168|FG001|Overall Study|Physician Decision|1|||
127749867|NCT00475228|459710169|FG000|Overall Study|Lost to Follow-up|17|||
127749868|NCT00475228|459710170|FG001|Overall Study|Lost to Follow-up|17|||
127749869|NCT04949802|459711949|FG000|Overall Study|Lost to Follow-up|3|||
127749870|NCT02473965|459711950|FG000|Overall Study|Adverse Event|6|||
127749871|NCT02473965|459711951|FG001|Overall Study|Adverse Event|4|||
127749872|NCT02473965|459711950|FG000|Overall Study|MG worsening|4|||
127749873|NCT02473965|459711951|FG001|Overall Study|MG worsening|1|||
127749874|NCT02473965|459711950|FG000|Overall Study|Withdrawal by Subject|2|||
127749875|NCT02473965|459711951|FG001|Overall Study|Withdrawal by Subject|3|||
127749876|NCT02473965|459711950|FG000|Overall Study|Physician Decision|0|||
127749877|NCT02473965|459711951|FG001|Overall Study|Physician Decision|2|||
127749878|NCT01183390|459711952|FG000|First Intervention|Adverse Event|0|||
127749879|NCT01183390|459711953|FG001|First Intervention|Adverse Event|1|||
127749880|NCT03816761|459711954|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
127749881|NCT03816761|459711955|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
127749882|NCT03816761|459711956|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
127749883|NCT03816761|459711957|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
127749884|NCT03816761|459711958|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
127749885|NCT03816761|459711959|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
127749886|NCT03816761|459711954|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
127749887|NCT03816761|459711955|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
127749888|NCT03816761|459711956|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
127809335|NCT02901431|459920054|FG005|Open Label Part|Study Terminated By Sponsor|0|||
127809336|NCT02901431|459920055|FG006|Open Label Part|Study Terminated By Sponsor|0|||
127809337|NCT02901431|459920056|FG007|Open Label Part|Study Terminated By Sponsor|0|||
127809338|NCT02901431|459920057|FG008|Open Label Part|Study Terminated By Sponsor|35|||
127809339|NCT02901431|459920058|FG009|Open Label Part|Study Terminated By Sponsor|12|||
127809340|NCT02901431|459920059|FG010|Open Label Part|Study Terminated By Sponsor|21|||
127809341|NCT02901431|459920060|FG011|Open Label Part|Study Terminated By Sponsor|31|||
127809342|NCT02901431|459920061|FG012|Open Label Part|Study Terminated By Sponsor|0|||
127809343|NCT02901431|459920049|FG000|Open Label Part|Withdrawal by Subject|0|||
127809344|NCT02901431|459920050|FG001|Open Label Part|Withdrawal by Subject|0|||
127809345|NCT02901431|459920051|FG002|Open Label Part|Withdrawal by Subject|0|||
127809346|NCT02901431|459920052|FG003|Open Label Part|Withdrawal by Subject|0|||
127809347|NCT02901431|459920053|FG004|Open Label Part|Withdrawal by Subject|0|||
127809348|NCT02901431|459920054|FG005|Open Label Part|Withdrawal by Subject|0|||
127809349|NCT02901431|459920055|FG006|Open Label Part|Withdrawal by Subject|0|||
127809350|NCT02901431|459920056|FG007|Open Label Part|Withdrawal by Subject|0|||
127809351|NCT02901431|459920057|FG008|Open Label Part|Withdrawal by Subject|6|||
127809352|NCT02901431|459920058|FG009|Open Label Part|Withdrawal by Subject|5|||
127809353|NCT02901431|459920059|FG010|Open Label Part|Withdrawal by Subject|7|||
127809354|NCT02901431|459920060|FG011|Open Label Part|Withdrawal by Subject|3|||
127809355|NCT02901431|459920061|FG012|Open Label Part|Withdrawal by Subject|1|||
127809356|NCT01889602|459920062|FG000|First Intervention|Adverse Event|1|||
127809357|NCT01889602|459920063|FG001|First Intervention|Adverse Event|1|||
127809358|NCT01889602|459920064|FG002|First Intervention|Adverse Event|1|||
127809359|NCT01889602|459920062|FG000|First Intervention|Protocol Violation|0|||
127809360|NCT01889602|459920063|FG001|First Intervention|Protocol Violation|1|||
127809361|NCT01889602|459920064|FG002|First Intervention|Protocol Violation|1|||
127809362|NCT01889602|459920062|FG000|First Intervention|Study ending|0|||
127809363|NCT01889602|459920063|FG001|First Intervention|Study ending|1|||
127809364|NCT01889602|459920064|FG002|First Intervention|Study ending|0|||
127809365|NCT01889602|459920062|FG000|Second Intervention|Adverse Event|0|||
127809366|NCT01889602|459920063|FG001|Second Intervention|Adverse Event|0|||
127809367|NCT01889602|459920064|FG002|Second Intervention|Adverse Event|1|||
127809368|NCT01889602|459920062|FG000|Second Intervention|Study ending|1|||
127809369|NCT01889602|459920063|FG001|Second Intervention|Study ending|0|||
127809370|NCT01889602|459920064|FG002|Second Intervention|Study ending|0|||
127749889|NCT03816761|459711957|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
127749890|NCT03816761|459711958|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
127749891|NCT03816761|459711959|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
127749892|NCT01240551|459711960|FG000|Overall Study|Refused further treatment|3|||
127749893|NCT01240551|459711961|FG001|Overall Study|Refused further treatment|2|||
127749894|NCT01240551|459711960|FG000|Overall Study|Lost to Follow-up|1|||
127749895|NCT01240551|459711961|FG001|Overall Study|Lost to Follow-up|1|||
127809371|NCT01889602|459920062|FG000|Second Intervention|Withdrawal by Subject|0|||
127809372|NCT01889602|459920063|FG001|Second Intervention|Withdrawal by Subject|0|||
127809373|NCT01889602|459920064|FG002|Second Intervention|Withdrawal by Subject|1|||
127809374|NCT01889602|459920062|FG000|Third Intervention|Protocol Violation|1|||
127809375|NCT01889602|459920063|FG001|Third Intervention|Protocol Violation|0|||
127809376|NCT01889602|459920064|FG002|Third Intervention|Protocol Violation|0|||
127809377|NCT01889602|459920062|FG000|Third Intervention|Withdrawal by Subject|2|||
127809378|NCT01889602|459920063|FG001|Third Intervention|Withdrawal by Subject|2|||
127809379|NCT01889602|459920064|FG002|Third Intervention|Withdrawal by Subject|0|||
127809380|NCT00404092|459920065|FG000|Overall Study|Death|1|||
127809381|NCT00404092|459920066|FG001|Overall Study|Death|0|||
127809382|NCT00404092|459920067|FG002|Overall Study|Death|0|||
127809383|NCT00404092|459920068|FG003|Overall Study|Death|0|||
127809384|NCT00404092|459920065|FG000|Overall Study|Adverse Event|0|||
127809385|NCT00404092|459920066|FG001|Overall Study|Adverse Event|0|||
127809386|NCT00404092|459920067|FG002|Overall Study|Adverse Event|1|||
127809387|NCT00404092|459920068|FG003|Overall Study|Adverse Event|0|||
127809388|NCT04223609|459920073|FG000|Overall Study|Adverse Event|0|||
127809389|NCT04223609|459920074|FG001|Overall Study|Adverse Event|1|||
127809390|NCT04223609|459920073|FG000|Overall Study|Missed last visit|0|||
127809391|NCT04223609|459920074|FG001|Overall Study|Missed last visit|1|||
127809392|NCT03440944|459920077|FG000|Overall Study|Physician Decision|1|||
127809393|NCT03440944|459920078|FG001|Overall Study|Physician Decision|0|||
127809394|NCT03440944|459920077|FG000|Overall Study|No Acceptable Vasculature|0|||
127809395|NCT03440944|459920078|FG001|Overall Study|No Acceptable Vasculature|1|||
127809396|NCT00484315|459920079|FG000|12-Month Clinical Follow-up|Death|6|||
127809397|NCT00484315|459920080|FG001|12-Month Clinical Follow-up|Death|2|||
127809398|NCT00484315|459920079|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
127809399|NCT00484315|459920080|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
127809400|NCT00484315|459920079|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
127809401|NCT00484315|459920080|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
127809402|NCT00484315|459920079|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
127809403|NCT00484315|459920080|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
127809404|NCT00484315|459920079|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
127809405|NCT00484315|459920080|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
127809406|NCT00484315|459920079|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
127809407|NCT00484315|459920080|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
127809408|NCT00484315|459920079|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
127809409|NCT00484315|459920080|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
127809410|NCT00943683|459920081|FG000|Overall Study|Adverse Event|3|||
127809411|NCT00943683|459920082|FG001|Overall Study|Adverse Event|3|||
127809412|NCT00943683|459920081|FG000|Overall Study|Lost to Follow-up|1|||
127809413|NCT00943683|459920082|FG001|Overall Study|Lost to Follow-up|1|||
127809414|NCT00943683|459920081|FG000|Overall Study|Protocol Violation|1|||
127809415|NCT00943683|459920082|FG001|Overall Study|Protocol Violation|2|||
127809416|NCT00943683|459920081|FG000|Overall Study|Withdrawal by Subject|1|||
127809417|NCT00943683|459920082|FG001|Overall Study|Withdrawal by Subject|0|||
127809418|NCT00943683|459920081|FG000|Overall Study|Patient Moved|1|||
127809419|NCT00943683|459920082|FG001|Overall Study|Patient Moved|0|||
127809420|NCT04439123|459920094|FG000|Overall Study|Adverse Event|11|||
127809421|NCT04439123|459920094|FG000|Overall Study|Death|1|||
127809422|NCT04439123|459920094|FG000|Overall Study|Disease progression|19|||
127809423|NCT04439123|459920094|FG000|Overall Study|Withdrawal by Subject|2|||
127894133|NCT00782509|460235227|FG002|Overall Study|Other reasons not stated above|3|||
127894134|NCT00782509|460235225|FG000|Overall Study|Lack of Efficacy|10|||
127894135|NCT00782509|460235226|FG001|Overall Study|Lack of Efficacy|5|||
127894136|NCT00782509|460235227|FG002|Overall Study|Lack of Efficacy|2|||
127894137|NCT01259869|460235228|FG000|Overall Study|Duplicated registration|1|||
127894138|NCT00175019|460235229|FG000|Overall Study|Adverse Event|54|||
127894139|NCT00175019|460235230|FG001|Overall Study|Adverse Event|22|||
127894140|NCT00175019|460235231|FG002|Overall Study|Adverse Event|2|||
127894141|NCT00175019|460235229|FG000|Overall Study|Protocol Violation|6|||
127894142|NCT00175019|460235230|FG001|Overall Study|Protocol Violation|3|||
127894143|NCT00175019|460235231|FG002|Overall Study|Protocol Violation|3|||
127809424|NCT04439123|459920094|FG000|Overall Study|Still on treatment|2|||
127809425|NCT03636906|459920103|FG000|Overall Study|Adverse Event|0|||
127809426|NCT03636906|459920104|FG001|Overall Study|Adverse Event|0|||
127809427|NCT03636906|459920105|FG002|Overall Study|Adverse Event|1|||
127894144|NCT00175019|460235229|FG000|Overall Study|Lost to Follow-up|42|||
127894145|NCT00175019|460235230|FG001|Overall Study|Lost to Follow-up|39|||
127809428|NCT03636906|459920103|FG000|Overall Study|Lost to Follow-up|1|||
127894146|NCT00175019|460235231|FG002|Overall Study|Lost to Follow-up|9|||
127894147|NCT00175019|460235229|FG000|Overall Study|Did not continue under Amendment 4|1|||
127894148|NCT00175019|460235230|FG001|Overall Study|Did not continue under Amendment 4|1|||
127894149|NCT00175019|460235231|FG002|Overall Study|Did not continue under Amendment 4|2|||
127894150|NCT00175019|460235229|FG000|Overall Study|Personal Reason(s)|39|||
127894151|NCT00175019|460235230|FG001|Overall Study|Personal Reason(s)|31|||
127749896|NCT01730950|459711967|FG000|Overall Study|Protocol Violation|6|||
127749897|NCT01730950|459711968|FG001|Overall Study|Protocol Violation|6|||
127749898|NCT00667459|459711969|FG000|Overall Study|Death|0|||
127749899|NCT00667459|459711970|FG001|Overall Study|Death|2|||
127749900|NCT00667459|459711969|FG000|Overall Study|Lost to Follow-up|8|||
127749901|NCT00667459|459711970|FG001|Overall Study|Lost to Follow-up|43|||
127749902|NCT02568397|459711971|FG000|Period 2|Withdrawal by Subject|0|||
127749903|NCT02568397|459711972|FG001|Period 2|Withdrawal by Subject|1|||
127749904|NCT02568397|459711971|FG000|Period 2|Physician Decision|0|||
127749905|NCT02568397|459711972|FG001|Period 2|Physician Decision|1|||
127749906|NCT01200342|459711973|FG000|Overall Study|Disease Progression|1|||
127749907|NCT04546217|459711976|FG000|Overall Study|Withdrawal by Subject|2|||
127749908|NCT04546217|459711977|FG001|Overall Study|Withdrawal by Subject|0|||
127749909|NCT04546217|459711976|FG000|Overall Study|Uncontrolled hypertension|1|||
127749910|NCT04546217|459711977|FG001|Overall Study|Uncontrolled hypertension|0|||
127749911|NCT02550938|459711978|FG000|Overall Study|Lost to Follow-up|8|||
127749912|NCT02550938|459711979|FG001|Overall Study|Lost to Follow-up|7|||
127749913|NCT02550938|459711980|FG002|Overall Study|Lost to Follow-up|12|||
127749914|NCT02550938|459711981|FG003|Overall Study|Lost to Follow-up|11|||
127749915|NCT01484431|459711982|FG000|Period 1: High Dose|Physician Decision|0|||
127749916|NCT01484431|459711983|FG001|Period 1: High Dose|Physician Decision|1|||
127749917|NCT01484431|459711984|FG002|Period 1: High Dose|Physician Decision|0|||
127749918|NCT01484431|459711982|FG000|Period 2|Death|0|||
127749919|NCT01484431|459711983|FG001|Period 2|Death|1|||
127749920|NCT01484431|459711984|FG002|Period 2|Death|1|||
127749921|NCT01484431|459711982|FG000|Period 2|Physician Decision|0|||
127749922|NCT01484431|459711983|FG001|Period 2|Physician Decision|0|||
127749923|NCT01484431|459711984|FG002|Period 2|Physician Decision|1|||
127749924|NCT01484431|459711982|FG000|Period 2|Non-Compliance with Study Drug|1|||
127749925|NCT01484431|459711983|FG001|Period 2|Non-Compliance with Study Drug|0|||
127749926|NCT01484431|459711984|FG002|Period 2|Non-Compliance with Study Drug|0|||
127749927|NCT02514239|459711988|FG000|Overall Study|Refused to continue trial medication|0|||
127749928|NCT02514239|459711989|FG001|Overall Study|Refused to continue trial medication|0|||
127749929|NCT02514239|459711990|FG002|Overall Study|Refused to continue trial medication|0|||
127749930|NCT02514239|459711991|FG003|Overall Study|Refused to continue trial medication|0|||
127749931|NCT02514239|459711992|FG004|Overall Study|Refused to continue trial medication|0|||
127749932|NCT02514239|459711993|FG005|Overall Study|Refused to continue trial medication|0|||
127749933|NCT02514239|459711994|FG006|Overall Study|Refused to continue trial medication|0|||
127749934|NCT02514239|459711995|FG007|Overall Study|Refused to continue trial medication|0|||
127749935|NCT02514239|459711996|FG008|Overall Study|Refused to continue trial medication|0|||
127749936|NCT02514239|459711997|FG009|Overall Study|Refused to continue trial medication|1|||
127749937|NCT02514239|459711988|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
127749938|NCT02514239|459711989|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
127749939|NCT02514239|459711990|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
127749940|NCT02514239|459711991|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
127749941|NCT02514239|459711992|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
127749942|NCT02514239|459711993|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
127749943|NCT02514239|459711994|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
127749944|NCT02514239|459711995|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
127749945|NCT02514239|459711996|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
127749946|NCT02514239|459711997|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
127749947|NCT02514239|459711988|FG000|Overall Study|Not treated|0|||
127749948|NCT02514239|459711989|FG001|Overall Study|Not treated|1|||
127749949|NCT02514239|459711990|FG002|Overall Study|Not treated|0|||
127749950|NCT02514239|459711991|FG003|Overall Study|Not treated|0|||
127749951|NCT02514239|459711992|FG004|Overall Study|Not treated|0|||
127749952|NCT02514239|459711993|FG005|Overall Study|Not treated|0|||
127749953|NCT02514239|459711994|FG006|Overall Study|Not treated|0|||
127749954|NCT02514239|459711995|FG007|Overall Study|Not treated|0|||
127749955|NCT02514239|459711996|FG008|Overall Study|Not treated|0|||
127749956|NCT02514239|459711997|FG009|Overall Study|Not treated|0|||
127749957|NCT02514239|459711988|FG000|Overall Study|Other Adverse Events|2|||
127749958|NCT02514239|459711989|FG001|Overall Study|Other Adverse Events|0|||
127749959|NCT02514239|459711990|FG002|Overall Study|Other Adverse Events|0|||
127749960|NCT02514239|459711991|FG003|Overall Study|Other Adverse Events|1|||
127749961|NCT02514239|459711992|FG004|Overall Study|Other Adverse Events|0|||
127749962|NCT02514239|459711993|FG005|Overall Study|Other Adverse Events|1|||
127749963|NCT02514239|459711994|FG006|Overall Study|Other Adverse Events|0|||
127749964|NCT02514239|459711995|FG007|Overall Study|Other Adverse Events|1|||
127749965|NCT02514239|459711996|FG008|Overall Study|Other Adverse Events|2|||
127749966|NCT02514239|459711997|FG009|Overall Study|Other Adverse Events|0|||
127749967|NCT02514239|459711988|FG000|Overall Study|Progressive disease|3|||
127749968|NCT02514239|459711989|FG001|Overall Study|Progressive disease|3|||
127749969|NCT02514239|459711990|FG002|Overall Study|Progressive disease|2|||
127749970|NCT02514239|459711991|FG003|Overall Study|Progressive disease|2|||
127749971|NCT02514239|459711992|FG004|Overall Study|Progressive disease|3|||
127749972|NCT02514239|459711993|FG005|Overall Study|Progressive disease|3|||
127749973|NCT02514239|459711994|FG006|Overall Study|Progressive disease|4|||
127749974|NCT02514239|459711995|FG007|Overall Study|Progressive disease|2|||
127749975|NCT02514239|459711996|FG008|Overall Study|Progressive disease|5|||
127749976|NCT02514239|459711997|FG009|Overall Study|Progressive disease|0|||
127749977|NCT01888874|459711998|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
127749978|NCT01888874|459711999|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
127749979|NCT01888874|459712000|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
127749980|NCT01888874|459712001|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
127749981|NCT01888874|459712002|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
127809429|NCT03636906|459920104|FG001|Overall Study|Lost to Follow-up|0|||
127809430|NCT03636906|459920105|FG002|Overall Study|Lost to Follow-up|0|||
127809431|NCT03636906|459920103|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
127809432|NCT03636906|459920104|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
127809433|NCT03636906|459920105|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
127809434|NCT03636906|459920103|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
127809435|NCT03636906|459920104|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
127809436|NCT03636906|459920105|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
127809437|NCT03636906|459920103|FG000|Overall Study|Other|0|||
127809438|NCT03636906|459920104|FG001|Overall Study|Other|0|||
127809439|NCT03636906|459920105|FG002|Overall Study|Other|1|||
127809440|NCT01291017|459920106|FG000|Overall Study|Lost to Follow-up|2|||
127809441|NCT01291017|459920106|FG000|Overall Study|Withdrawal by Subject|3|||
127809442|NCT04980391|459920107|FG000|Overall Study|Death|0|||
127809443|NCT04980391|459920108|FG001|Overall Study|Death|0|||
127809444|NCT04980391|459920109|FG002|Overall Study|Death|1|||
127809445|NCT04980391|459920110|FG003|Overall Study|Death|1|||
127809446|NCT04980391|459920107|FG000|Overall Study|Lost to Follow-up|3|||
127809447|NCT04980391|459920108|FG001|Overall Study|Lost to Follow-up|3|||
127809448|NCT04980391|459920109|FG002|Overall Study|Lost to Follow-up|2|||
127809449|NCT04980391|459920110|FG003|Overall Study|Lost to Follow-up|3|||
127809450|NCT04980391|459920107|FG000|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|2|||
127809451|NCT04980391|459920108|FG001|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
127809452|NCT04980391|459920109|FG002|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
127809453|NCT04980391|459920110|FG003|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
127809454|NCT04980391|459920107|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
127809455|NCT04980391|459920108|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
127809456|NCT04980391|459920109|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
127809457|NCT04980391|459920110|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
127809458|NCT04980391|459920107|FG000|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
127809459|NCT04980391|459920108|FG001|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
127809460|NCT04980391|459920109|FG002|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|3|||
127809461|NCT04980391|459920110|FG003|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
127809462|NCT03690869|459920111|FG000|Overall Study|Adverse Event|0|||
127809463|NCT03690869|459920112|FG001|Overall Study|Adverse Event|0|||
127809464|NCT03690869|459920113|FG002|Overall Study|Adverse Event|0|||
127809465|NCT03690869|459920114|FG003|Overall Study|Adverse Event|1|||
127809466|NCT03690869|459920115|FG004|Overall Study|Adverse Event|0|||
127809467|NCT03690869|459920116|FG005|Overall Study|Adverse Event|0|||
127809468|NCT03690869|459920117|FG006|Overall Study|Adverse Event|0|||
127809469|NCT03690869|459920118|FG007|Overall Study|Adverse Event|1|||
127809470|NCT03690869|459920119|FG008|Overall Study|Adverse Event|0|||
127809471|NCT03690869|459920120|FG009|Overall Study|Adverse Event|1|||
127809472|NCT03690869|459920111|FG000|Overall Study|Death|1|||
127809473|NCT03690869|459920112|FG001|Overall Study|Death|1|||
127809474|NCT03690869|459920113|FG002|Overall Study|Death|1|||
127809475|NCT03690869|459920114|FG003|Overall Study|Death|4|||
127809476|NCT03690869|459920115|FG004|Overall Study|Death|2|||
127809477|NCT03690869|459920116|FG005|Overall Study|Death|5|||
127809478|NCT03690869|459920117|FG006|Overall Study|Death|3|||
127749982|NCT01888874|459712003|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
127749983|NCT01888874|459712004|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
127749984|NCT01888874|459711998|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
127749985|NCT01888874|459711999|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
127749986|NCT01888874|459712000|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
127749987|NCT01888874|459712001|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
127749988|NCT01888874|459712002|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
127749989|NCT01888874|459712003|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
127749990|NCT01888874|459712004|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
127749991|NCT01888874|459711998|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
127749992|NCT01888874|459711999|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
127749993|NCT01888874|459712000|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
127749994|NCT01888874|459712001|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
127749995|NCT01888874|459712002|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
127749996|NCT01888874|459712003|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
127749997|NCT01888874|459712004|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
127749998|NCT01888874|459711998|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
127749999|NCT01888874|459711999|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
127750000|NCT01888874|459712000|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
127750001|NCT01888874|459712001|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
127750002|NCT01888874|459712002|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
127750003|NCT01888874|459712003|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
127750004|NCT01888874|459712004|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
127750005|NCT01888874|459711998|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
127750006|NCT01888874|459711999|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
127750007|NCT01888874|459712000|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
127750008|NCT01888874|459712001|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
127750009|NCT01888874|459712002|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
127750010|NCT01888874|459712003|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
127750011|NCT01888874|459712004|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
127750012|NCT01888874|459711998|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
127750013|NCT01888874|459711999|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
127750014|NCT01888874|459712000|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
127750015|NCT01888874|459712001|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
127750016|NCT01888874|459712002|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
127750017|NCT01888874|459712003|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
127750018|NCT01888874|459712004|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
127750019|NCT01888874|459711998|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
127750020|NCT01888874|459711999|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
127750021|NCT01888874|459712000|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
127750022|NCT01888874|459712001|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
127750023|NCT01888874|459712002|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
127750024|NCT01888874|459712003|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
127750025|NCT01888874|459712004|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
127750026|NCT01888874|459711998|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
127750027|NCT01888874|459711999|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
127750028|NCT01888874|459712000|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
127750029|NCT01888874|459712001|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
127750030|NCT01888874|459712002|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
127750031|NCT01888874|459712003|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
127750032|NCT01888874|459712004|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
127750033|NCT01888874|459711998|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
127750034|NCT01888874|459711999|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
127750035|NCT01888874|459712000|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
127750036|NCT01888874|459712001|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
127750037|NCT01888874|459712002|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
127750038|NCT01888874|459712003|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
127809479|NCT03690869|459920118|FG007|Overall Study|Death|2|||
127809480|NCT03690869|459920119|FG008|Overall Study|Death|0|||
127809481|NCT03690869|459920120|FG009|Overall Study|Death|3|||
127809482|NCT03690869|459920111|FG000|Overall Study|Lost to Follow-up|0|||
127809483|NCT03690869|459920112|FG001|Overall Study|Lost to Follow-up|0|||
127809484|NCT03690869|459920113|FG002|Overall Study|Lost to Follow-up|1|||
127809485|NCT03690869|459920114|FG003|Overall Study|Lost to Follow-up|0|||
127809486|NCT03690869|459920115|FG004|Overall Study|Lost to Follow-up|0|||
127809487|NCT03690869|459920116|FG005|Overall Study|Lost to Follow-up|0|||
127750039|NCT01888874|459712004|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
127750040|NCT01888874|459711998|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
127750041|NCT01888874|459711999|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
127750042|NCT01888874|459712000|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
127750043|NCT01888874|459712001|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
127750044|NCT01888874|459712002|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
127750045|NCT01888874|459712003|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
127750046|NCT01888874|459712004|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
127750047|NCT01888874|459711998|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
127750048|NCT01888874|459711999|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
127750049|NCT01888874|459712000|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
127750050|NCT01888874|459712001|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
127750051|NCT01888874|459712002|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
127750052|NCT01888874|459712003|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
127750053|NCT01888874|459712004|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
127750054|NCT01888874|459711998|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
127750055|NCT01888874|459711999|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
127750056|NCT01888874|459712000|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
127750057|NCT01888874|459712001|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
127750058|NCT01888874|459712002|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
127750059|NCT01888874|459712003|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
127750060|NCT01888874|459712004|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
127750061|NCT01888874|459711998|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
127750062|NCT01888874|459711999|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
127750063|NCT01888874|459712000|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
127750064|NCT01888874|459712001|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
127750065|NCT01888874|459712002|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
127750066|NCT01888874|459712003|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
127750067|NCT01888874|459712004|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
127750068|NCT02980042|459712007|FG000|Overall Study|Lost to Follow-up|5|||
127750069|NCT02980042|459712008|FG001|Overall Study|Lost to Follow-up|0|||
127750070|NCT02980042|459712007|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
127750071|NCT02980042|459712008|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
127750072|NCT01020877|459712016|FG000|Second Intervention|Withdrawal by Subject|1|||
127750073|NCT01020877|459712017|FG001|Second Intervention|Withdrawal by Subject|0|||
127750074|NCT01483144|459712019|FG000|Overall Study|Adverse Event|9|||
127750075|NCT01483144|459712020|FG001|Overall Study|Adverse Event|4|||
127750076|NCT01483144|459712021|FG002|Overall Study|Adverse Event|6|||
127750077|NCT01483144|459712019|FG000|Overall Study|Withdrawal by Subject|0|||
127750078|NCT01483144|459712020|FG001|Overall Study|Withdrawal by Subject|2|||
127750079|NCT01483144|459712021|FG002|Overall Study|Withdrawal by Subject|5|||
127750080|NCT01483144|459712019|FG000|Overall Study|Physician Decision|1|||
127750081|NCT01483144|459712020|FG001|Overall Study|Physician Decision|0|||
127750082|NCT01483144|459712021|FG002|Overall Study|Physician Decision|0|||
127750083|NCT01483144|459712019|FG000|Overall Study|Lost to Follow-up|2|||
127750084|NCT01483144|459712020|FG001|Overall Study|Lost to Follow-up|4|||
127750085|NCT01483144|459712021|FG002|Overall Study|Lost to Follow-up|1|||
127750086|NCT01483144|459712019|FG000|Overall Study|Protocol Violation|3|||
127750087|NCT01483144|459712020|FG001|Overall Study|Protocol Violation|3|||
127750088|NCT01483144|459712021|FG002|Overall Study|Protocol Violation|3|||
127750089|NCT02460575|459712022|FG000|Overall Study|Lost to Follow-up|1|||
127750090|NCT02460575|459712023|FG001|Overall Study|Lost to Follow-up|0|||
127750091|NCT04497389|459712024|FG000|Overall Study|Withdrawal by Subject|1|||
127750092|NCT04497389|459712025|FG001|Overall Study|Withdrawal by Subject|0|||
127750093|NCT03322540|459712026|FG000|Overall Study|Death|21|||
127750094|NCT03322540|459712027|FG001|Overall Study|Death|28|||
127750095|NCT03322540|459712026|FG000|Overall Study|Lost to Follow-up|0|||
127750096|NCT03322540|459712027|FG001|Overall Study|Lost to Follow-up|1|||
127750097|NCT03322540|459712026|FG000|Overall Study|Physician Decision|7|||
127809488|NCT03690869|459920117|FG006|Overall Study|Lost to Follow-up|0|||
127809489|NCT03690869|459920118|FG007|Overall Study|Lost to Follow-up|0|||
127809490|NCT03690869|459920119|FG008|Overall Study|Lost to Follow-up|0|||
127809491|NCT03690869|459920120|FG009|Overall Study|Lost to Follow-up|0|||
127809492|NCT03690869|459920111|FG000|Overall Study|Other Treatment|1|||
127809493|NCT03690869|459920112|FG001|Overall Study|Other Treatment|1|||
127750098|NCT03322540|459712027|FG001|Overall Study|Physician Decision|6|||
127750099|NCT03322540|459712026|FG000|Overall Study|Withdrawal by Subject|3|||
127750100|NCT03322540|459712027|FG001|Overall Study|Withdrawal by Subject|1|||
127750101|NCT03322540|459712026|FG000|Overall Study|Study terminated by sponsor|0|||
127750102|NCT03322540|459712027|FG001|Overall Study|Study terminated by sponsor|1|||
127750103|NCT04052425|459712028|FG000|24-Week Double-blind Period|Adverse Event|0|||
127750104|NCT04052425|459712029|FG001|24-Week Double-blind Period|Adverse Event|1|||
127750105|NCT04052425|459712030|FG002|24-Week Double-blind Period|Adverse Event|0|||
127894152|NCT00175019|460235231|FG002|Overall Study|Personal Reason(s)|8|||
127894153|NCT00175019|460235229|FG000|Overall Study|Therapeutic Failure|10|||
127894154|NCT00175019|460235230|FG001|Overall Study|Therapeutic Failure|38|||
127750106|NCT04052425|459712031|FG003|24-Week Double-blind Period|Adverse Event|0|||
127750107|NCT04052425|459712028|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
127750108|NCT04052425|459712029|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
127750109|NCT04052425|459712030|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
127750110|NCT04052425|459712031|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
127750111|NCT04052425|459712028|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
127750112|NCT04052425|459712029|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
127750113|NCT04052425|459712030|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
127750114|NCT04052425|459712031|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
127750115|NCT04052425|459712028|FG000|24-Week Double-blind Period|Physician Decision|1|||
127750116|NCT04052425|459712029|FG001|24-Week Double-blind Period|Physician Decision|0|||
127750117|NCT04052425|459712030|FG002|24-Week Double-blind Period|Physician Decision|0|||
127750118|NCT04052425|459712031|FG003|24-Week Double-blind Period|Physician Decision|0|||
127750119|NCT04052425|459712028|FG000|24-Week Double-blind Period|Protocol Violation|1|||
127750120|NCT04052425|459712029|FG001|24-Week Double-blind Period|Protocol Violation|0|||
127750121|NCT04052425|459712030|FG002|24-Week Double-blind Period|Protocol Violation|0|||
127750122|NCT04052425|459712031|FG003|24-Week Double-blind Period|Protocol Violation|0|||
127750123|NCT04052425|459712028|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
127750124|NCT04052425|459712029|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
127750125|NCT04052425|459712030|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
127750126|NCT04052425|459712031|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
127750127|NCT04052425|459712028|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
127750128|NCT04052425|459712029|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
127750129|NCT04052425|459712030|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
127750130|NCT04052425|459712031|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
127750131|NCT04052425|459712028|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
127750132|NCT04052425|459712029|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
127750133|NCT04052425|459712030|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
127750134|NCT04052425|459712031|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
127750135|NCT04052425|459712028|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
127750136|NCT04052425|459712029|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
127750137|NCT04052425|459712030|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
127750138|NCT04052425|459712031|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
127750139|NCT04052425|459712028|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
127750140|NCT04052425|459712029|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
127750141|NCT04052425|459712030|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
127750142|NCT04052425|459712031|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
127750143|NCT04052425|459712028|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
127750144|NCT04052425|459712029|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
127750145|NCT04052425|459712030|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
127750146|NCT04052425|459712031|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
127750147|NCT04052425|459712028|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
127750148|NCT04052425|459712029|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
127750149|NCT04052425|459712030|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
127750150|NCT04052425|459712031|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
127750151|NCT04052425|459712028|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
127750152|NCT04052425|459712029|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
127750153|NCT04052425|459712030|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
127750154|NCT04052425|459712031|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
127750155|NCT04052425|459712028|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
127750156|NCT04052425|459712029|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
127750157|NCT04052425|459712030|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
127750158|NCT04052425|459712031|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
127750159|NCT04334278|459712032|FG000|Overall Study|Lost to Follow-up|0|||
127750160|NCT04334278|459712033|FG001|Overall Study|Lost to Follow-up|3|||
127750161|NCT04334278|459712032|FG000|Overall Study|Withdrawal by Subject|4|||
127750162|NCT04334278|459712033|FG001|Overall Study|Withdrawal by Subject|2|||
127750163|NCT00425607|459712034|FG000|Overall Study|Death|1|||
127750164|NCT00425607|459712034|FG000|Overall Study|Withdrawal by Subject|1|||
127750165|NCT00079339|459712035|FG000|Overall Study|Adverse Event|1|||
127750166|NCT00079339|459712036|FG001|Overall Study|Adverse Event|7|||
127750167|NCT00079339|459712037|FG002|Overall Study|Adverse Event|2|||
127750168|NCT00079339|459712035|FG000|Overall Study|Death|1|||
127750169|NCT00079339|459712036|FG001|Overall Study|Death|0|||
127750170|NCT00079339|459712037|FG002|Overall Study|Death|0|||
127750171|NCT00079339|459712035|FG000|Overall Study|Non-compliance|0|||
127750172|NCT00079339|459712036|FG001|Overall Study|Non-compliance|0|||
127750173|NCT00079339|459712037|FG002|Overall Study|Non-compliance|1|||
127750174|NCT00079339|459712035|FG000|Overall Study|Withdrawal by Subject|0|||
127750175|NCT00079339|459712036|FG001|Overall Study|Withdrawal by Subject|4|||
127750176|NCT00079339|459712037|FG002|Overall Study|Withdrawal by Subject|1|||
127750177|NCT00079339|459712035|FG000|Overall Study|Disease progression|3|||
127750178|NCT00079339|459712036|FG001|Overall Study|Disease progression|28|||
127750179|NCT00079339|459712037|FG002|Overall Study|Disease progression|2|||
127750180|NCT00520845|459712038|FG000|Overall Study|Death|3|||
127750181|NCT00520845|459712038|FG000|Overall Study|Adverse Event|4|||
127750182|NCT00520845|459712038|FG000|Overall Study|Disease Progression, relapse|13|||
127750183|NCT00520845|459712038|FG000|Overall Study|Withdrawal by Subject|1|||
127750184|NCT00520845|459712038|FG000|Overall Study|Alternative Therapy|1|||
127750185|NCT00945672|459712042|FG000|Overall Study|Withdrawal by Subject|0|||
127750186|NCT00945672|459712043|FG001|Overall Study|Withdrawal by Subject|0|||
127750187|NCT00945672|459712044|FG002|Overall Study|Withdrawal by Subject|0|||
127750188|NCT00945672|459712045|FG003|Overall Study|Withdrawal by Subject|1|||
127750189|NCT03054337|459712046|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
127750190|NCT03054337|459712047|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
127750191|NCT03054337|459712048|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
127750192|NCT03054337|459712049|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
127750193|NCT03054337|459712050|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
127750194|NCT03054337|459712051|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
127750195|NCT00447590|459712053|FG000|Overall Study|Withdrawal by Subject|26|||
127750196|NCT00447590|459712053|FG000|Overall Study|Lost to Follow-up|24|||
127750197|NCT00447590|459712053|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
127750198|NCT01967069|459712054|FG000|Overall Study|Adverse Event|2|||
127750199|NCT01967069|459712055|FG001|Overall Study|Adverse Event|2|||
127750200|NCT01967069|459712054|FG000|Overall Study|Lost to Follow-up|5|||
127750201|NCT01967069|459712055|FG001|Overall Study|Lost to Follow-up|2|||
127750202|NCT01967069|459712054|FG000|Overall Study|Withdrawal by Subject|1|||
127750203|NCT01967069|459712055|FG001|Overall Study|Withdrawal by Subject|3|||
127750204|NCT01967069|459712054|FG000|Overall Study|Lack of Efficacy|0|||
127750205|NCT01967069|459712055|FG001|Overall Study|Lack of Efficacy|1|||
127750206|NCT01661205|459712058|FG000|Overall Study|Physician Decision|2|||
127750207|NCT03111095|459712063|FG000|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|3|||
127750208|NCT03111095|459712064|FG001|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|0|||
127750209|NCT03111095|459712063|FG000|Aims 2-5: Intervention|Withdrawal by Subject|19|||
127750210|NCT03111095|459712064|FG001|Aims 2-5: Intervention|Withdrawal by Subject|0|||
127750211|NCT00504075|459712065|FG000|Overall Study|Adverse Event|1|||
127750212|NCT00504075|459712065|FG000|Overall Study|Lost to Follow-up|5|||
127750213|NCT00504075|459712065|FG000|Overall Study|Withdrawal by Subject|1|||
127750214|NCT00504075|459712065|FG000|Overall Study|Required other therapeutic intervention|1|||
127750215|NCT04245345|459712073|FG000|Overall Study|Death|1|||
127750216|NCT04245345|459712073|FG000|Overall Study|Exited prior to implant|5|||
127750217|NCT04245345|459712073|FG000|Overall Study|Exited prior to 1-month|9|||
127750218|NCT04245345|459712073|FG000|Overall Study|Missed 1-month visit|3|||
127750219|NCT04245345|459712073|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
127750220|NCT04245345|459712073|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
127750221|NCT00706654|459712074|FG000|Conversion Phase|Lost to Follow-up|4|||
127750222|NCT00706654|459712075|FG001|Conversion Phase|Lost to Follow-up|0|||
127750223|NCT00706654|459712076|FG002|Conversion Phase|Lost to Follow-up|0|||
127750224|NCT00706654|459712077|FG003|Conversion Phase|Lost to Follow-up|0|||
127750225|NCT00706654|459712074|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
127750226|NCT00706654|459712075|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
127750227|NCT00706654|459712076|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
127750228|NCT00706654|459712077|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
127750229|NCT00706654|459712074|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
127750230|NCT00706654|459712075|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
127750231|NCT00706654|459712076|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
127750232|NCT00706654|459712077|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
127750233|NCT00706654|459712074|FG000|Conversion Phase|Withdrawn by Investigator|14|||
127750234|NCT00706654|459712075|FG001|Conversion Phase|Withdrawn by Investigator|0|||
127750235|NCT00706654|459712076|FG002|Conversion Phase|Withdrawn by Investigator|0|||
127750236|NCT00706654|459712077|FG003|Conversion Phase|Withdrawn by Investigator|0|||
127750237|NCT00706654|459712074|FG000|Conversion Phase|Withdrew Consent|38|||
127750238|NCT00706654|459712075|FG001|Conversion Phase|Withdrew Consent|0|||
127750239|NCT00706654|459712076|FG002|Conversion Phase|Withdrew Consent|0|||
127750240|NCT00706654|459712077|FG003|Conversion Phase|Withdrew Consent|0|||
127750241|NCT00706654|459712074|FG000|Conversion Phase|Adverse Event|18|||
127750242|NCT00706654|459712075|FG001|Conversion Phase|Adverse Event|0|||
127750243|NCT00706654|459712076|FG002|Conversion Phase|Adverse Event|0|||
127750244|NCT00706654|459712077|FG003|Conversion Phase|Adverse Event|0|||
127750245|NCT00706654|459712074|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
127750246|NCT00706654|459712075|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
127809494|NCT03690869|459920113|FG002|Overall Study|Other Treatment|1|||
127809495|NCT03690869|459920114|FG003|Overall Study|Other Treatment|2|||
127809496|NCT03690869|459920115|FG004|Overall Study|Other Treatment|3|||
127750247|NCT00706654|459712076|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
127750248|NCT00706654|459712077|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
127750249|NCT00706654|459712074|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
127750250|NCT00706654|459712075|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
127750251|NCT00706654|459712076|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
127750252|NCT00706654|459712077|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
127750253|NCT00706654|459712074|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
127750254|NCT00706654|459712075|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
127750255|NCT00706654|459712076|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
127750256|NCT00706654|459712077|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
127750257|NCT00706654|459712074|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
127750258|NCT00706654|459712075|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
127750259|NCT00706654|459712076|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
127750260|NCT00706654|459712077|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
127750261|NCT00706654|459712074|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
127750262|NCT00706654|459712075|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
127750263|NCT00706654|459712076|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
127750264|NCT00706654|459712077|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
127750265|NCT00706654|459712074|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
127750266|NCT00706654|459712075|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
127750267|NCT00706654|459712076|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
127750268|NCT00706654|459712077|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
127750269|NCT00706654|459712074|FG000|Oral Stabilization Phase|Withdrew consent|55|||
127750270|NCT00706654|459712075|FG001|Oral Stabilization Phase|Withdrew consent|0|||
127750271|NCT00706654|459712076|FG002|Oral Stabilization Phase|Withdrew consent|0|||
127750272|NCT00706654|459712077|FG003|Oral Stabilization Phase|Withdrew consent|0|||
127750273|NCT00706654|459712074|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
127750274|NCT00706654|459712075|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
127750275|NCT00706654|459712076|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
127750276|NCT00706654|459712077|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
127750277|NCT00706654|459712074|FG000|Oral Stabilization Phase|Adverse Event|21|||
127750278|NCT00706654|459712075|FG001|Oral Stabilization Phase|Adverse Event|0|||
127750279|NCT00706654|459712076|FG002|Oral Stabilization Phase|Adverse Event|0|||
127750280|NCT00706654|459712077|FG003|Oral Stabilization Phase|Adverse Event|0|||
127750281|NCT00706654|459712074|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
127750282|NCT00706654|459712075|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
127750283|NCT00706654|459712076|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
127750284|NCT00706654|459712077|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
127750285|NCT00706654|459712074|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
127750286|NCT00706654|459712075|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
127750287|NCT00706654|459712076|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
127750288|NCT00706654|459712077|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
127750289|NCT00706654|459712074|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
127750290|NCT00706654|459712075|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
127750291|NCT00706654|459712076|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
127750292|NCT00706654|459712077|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
127750293|NCT00706654|459712074|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
127750294|NCT00706654|459712075|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
127750295|NCT00706654|459712076|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
127750296|NCT00706654|459712077|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
127750297|NCT00706654|459712074|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
127750298|NCT00706654|459712075|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
127750299|NCT00706654|459712076|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
127750300|NCT00706654|459712077|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
127750301|NCT00706654|459712074|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
127809497|NCT03690869|459920116|FG005|Overall Study|Other Treatment|1|||
127750302|NCT00706654|459712075|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
127750303|NCT00706654|459712076|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
127750304|NCT00706654|459712077|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
127750305|NCT00706654|459712074|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
127750306|NCT00706654|459712075|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
127750307|NCT00706654|459712076|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
127750308|NCT00706654|459712077|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
127750309|NCT00706654|459712074|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
127750310|NCT00706654|459712075|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
127750311|NCT00706654|459712076|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
127750312|NCT00706654|459712077|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
127750313|NCT00706654|459712074|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
127750314|NCT00706654|459712075|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
127750315|NCT00706654|459712076|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
127750316|NCT00706654|459712077|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
127750317|NCT00706654|459712074|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
127750318|NCT00706654|459712075|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
127750319|NCT00706654|459712076|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
127750320|NCT00706654|459712077|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
127750321|NCT01001390|459712080|FG000|Overall Study|Failure to wear AFO device|2|||
127750322|NCT01001390|459712081|FG001|Overall Study|Failure to wear AFO device|0|||
127750323|NCT01151215|459712082|FG000|Overall Study|Worsening of condition under study|1|||
127750324|NCT01151215|459712083|FG001|Overall Study|Worsening of condition under study|1|||
127750325|NCT01151215|459712084|FG002|Overall Study|Worsening of condition under study|1|||
127750326|NCT01151215|459712082|FG000|Overall Study|Death|16|||
127750327|NCT01151215|459712083|FG001|Overall Study|Death|20|||
127750328|NCT01151215|459712084|FG002|Overall Study|Death|11|||
127750329|NCT01151215|459712082|FG000|Overall Study|Lost to Follow-up|0|||
127750330|NCT01151215|459712083|FG001|Overall Study|Lost to Follow-up|0|||
127750331|NCT01151215|459712084|FG002|Overall Study|Lost to Follow-up|3|||
127750332|NCT01151215|459712082|FG000|Overall Study|Withdrawal by Subject|3|||
127750333|NCT01151215|459712083|FG001|Overall Study|Withdrawal by Subject|1|||
127750334|NCT01151215|459712084|FG002|Overall Study|Withdrawal by Subject|2|||
127750335|NCT01151215|459712082|FG000|Overall Study|Disease progression|0|||
127750336|NCT01151215|459712083|FG001|Overall Study|Disease progression|1|||
127750337|NCT01151215|459712084|FG002|Overall Study|Disease progression|1|||
127750338|NCT01151215|459712082|FG000|Overall Study|Safety as judged by the investigator|0|||
127750339|NCT01151215|459712083|FG001|Overall Study|Safety as judged by the investigator|0|||
127750340|NCT01151215|459712084|FG002|Overall Study|Safety as judged by the investigator|1|||
127750341|NCT03392168|459712085|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
127750342|NCT03392168|459712086|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
127750343|NCT03392168|459712087|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
127750344|NCT03392168|459712088|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
127750345|NCT03392168|459712085|FG000|Period 2: Cohort 2|Other|0|||
127750346|NCT03392168|459712086|FG001|Period 2: Cohort 2|Other|1|||
127750347|NCT03392168|459712087|FG002|Period 2: Cohort 2|Other|0|||
127750348|NCT03392168|459712088|FG003|Period 2: Cohort 2|Other|0|||
127750349|NCT01721954|459712089|FG000|Overall Study|Death|58|||
127750350|NCT01721954|459712090|FG001|Overall Study|Death|64|||
127750351|NCT01721954|459712089|FG000|Overall Study|Withdrawal by Subject|8|||
127809498|NCT03690869|459920117|FG006|Overall Study|Other Treatment|2|||
127809499|NCT03690869|459920118|FG007|Overall Study|Other Treatment|7|||
127809500|NCT03690869|459920119|FG008|Overall Study|Other Treatment|0|||
127809501|NCT03690869|459920120|FG009|Overall Study|Other Treatment|3|||
127809502|NCT03690869|459920111|FG000|Overall Study|Physician Decision|0|||
127809503|NCT03690869|459920112|FG001|Overall Study|Physician Decision|1|||
127809504|NCT03690869|459920113|FG002|Overall Study|Physician Decision|0|||
127809505|NCT03690869|459920114|FG003|Overall Study|Physician Decision|0|||
127809506|NCT03690869|459920115|FG004|Overall Study|Physician Decision|0|||
127809507|NCT03690869|459920116|FG005|Overall Study|Physician Decision|0|||
127809508|NCT03690869|459920117|FG006|Overall Study|Physician Decision|0|||
127809509|NCT03690869|459920118|FG007|Overall Study|Physician Decision|0|||
127809510|NCT03690869|459920119|FG008|Overall Study|Physician Decision|0|||
127809511|NCT03690869|459920120|FG009|Overall Study|Physician Decision|0|||
127809512|NCT03690869|459920111|FG000|Overall Study|Progressive Disease|1|||
127750352|NCT01721954|459712090|FG001|Overall Study|Withdrawal by Subject|4|||
127750353|NCT01721954|459712089|FG000|Overall Study|Adverse Event|2|||
127809513|NCT03690869|459920112|FG001|Overall Study|Progressive Disease|2|||
127809514|NCT03690869|459920113|FG002|Overall Study|Progressive Disease|0|||
127809515|NCT03690869|459920114|FG003|Overall Study|Progressive Disease|1|||
127750354|NCT01721954|459712090|FG001|Overall Study|Adverse Event|0|||
127750355|NCT01721954|459712089|FG000|Overall Study|Lost to Follow-up|2|||
127750356|NCT01721954|459712090|FG001|Overall Study|Lost to Follow-up|1|||
127750357|NCT01162486|459712097|FG000|Overall Study|low ANC|1|||
127750358|NCT01162486|459712098|FG001|Overall Study|low ANC|0|||
127750359|NCT01162486|459712099|FG002|Overall Study|low ANC|0|||
127750360|NCT01162486|459712100|FG003|Overall Study|low ANC|0|||
127750361|NCT01162486|459712101|FG004|Overall Study|low ANC|0|||
127750362|NCT01162486|459712097|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
127750363|NCT01162486|459712098|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
127750364|NCT01162486|459712099|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
127750365|NCT01162486|459712100|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
127750366|NCT01162486|459712101|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
127750367|NCT01162486|459712097|FG000|Overall Study|elevated LFTs|0|||
127750368|NCT01162486|459712098|FG001|Overall Study|elevated LFTs|0|||
127750369|NCT01162486|459712099|FG002|Overall Study|elevated LFTs|1|||
127750370|NCT01162486|459712100|FG003|Overall Study|elevated LFTs|0|||
127750371|NCT01162486|459712101|FG004|Overall Study|elevated LFTs|0|||
127750372|NCT01162486|459712097|FG000|Overall Study|Pregnancy|0|||
127750373|NCT01162486|459712098|FG001|Overall Study|Pregnancy|0|||
127750374|NCT01162486|459712099|FG002|Overall Study|Pregnancy|0|||
127750375|NCT01162486|459712100|FG003|Overall Study|Pregnancy|1|||
127750376|NCT01162486|459712101|FG004|Overall Study|Pregnancy|0|||
127750377|NCT00844597|459712104|FG000|Overall Study|Adverse Event|0|||
127750378|NCT00844597|459712105|FG001|Overall Study|Adverse Event|0|||
127750379|NCT00844597|459712106|FG002|Overall Study|Adverse Event|0|||
127750380|NCT00844597|459712107|FG003|Overall Study|Adverse Event|1|||
127750381|NCT00844597|459712108|FG004|Overall Study|Adverse Event|0|||
127750382|NCT00844597|459712109|FG005|Overall Study|Adverse Event|0|||
127750383|NCT02762903|459712113|FG000|Overall Study|Lost to Follow-up|0|||
127750384|NCT02762903|459712114|FG001|Overall Study|Lost to Follow-up|1|||
127750385|NCT01228175|459712115|FG000|Overall Study|Lost to Follow-up|64|||
127750386|NCT01228175|459712116|FG001|Overall Study|Lost to Follow-up|50|||
127750387|NCT01228175|459712115|FG000|Overall Study|Withdrawal by Subject|1|||
127750388|NCT01228175|459712116|FG001|Overall Study|Withdrawal by Subject|2|||
127750389|NCT01228175|459712115|FG000|Overall Study|Physician Decision|1|||
127750390|NCT01228175|459712116|FG001|Overall Study|Physician Decision|1|||
127750391|NCT02227992|459712117|FG000|Overall Study|Lost to Follow-up|1|||
127750392|NCT02227992|459712118|FG001|Overall Study|Lost to Follow-up|1|||
127750393|NCT02358668|459714589|FG000|Overall Study|Adverse Event|2|||
127750394|NCT02358668|459714590|FG001|Overall Study|Adverse Event|0|||
127750395|NCT02358668|459714591|FG002|Overall Study|Adverse Event|0|||
127750396|NCT02358668|459714589|FG000|Overall Study|Withdrawal by Subject|0|||
127750397|NCT02358668|459714590|FG001|Overall Study|Withdrawal by Subject|1|||
127750398|NCT02358668|459714591|FG002|Overall Study|Withdrawal by Subject|0|||
127750399|NCT04057573|459714592|FG000|24-Week Double-Blind Period|Adverse Event|2|||
127750400|NCT04057573|459714593|FG001|24-Week Double-Blind Period|Adverse Event|0|||
127750401|NCT04057573|459714594|FG002|24-Week Double-Blind Period|Adverse Event|0|||
127750402|NCT04057573|459714595|FG003|24-Week Double-Blind Period|Adverse Event|0|||
127750403|NCT04057573|459714592|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
127750404|NCT04057573|459714593|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
127750405|NCT04057573|459714594|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
127750406|NCT04057573|459714595|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
127750407|NCT04057573|459714592|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
127750408|NCT04057573|459714593|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
127750409|NCT04057573|459714594|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
127750410|NCT04057573|459714595|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
127750411|NCT04057573|459714592|FG000|24-Week Double-Blind Period|Physician Decision|1|||
127750412|NCT04057573|459714593|FG001|24-Week Double-Blind Period|Physician Decision|0|||
127750413|NCT04057573|459714594|FG002|24-Week Double-Blind Period|Physician Decision|0|||
127750414|NCT04057573|459714595|FG003|24-Week Double-Blind Period|Physician Decision|0|||
127750415|NCT04057573|459714592|FG000|24-Week Double-Blind Period|Pregnancy|1|||
127894155|NCT00175019|460235231|FG002|Overall Study|Therapeutic Failure|22|||
127750416|NCT04057573|459714593|FG001|24-Week Double-Blind Period|Pregnancy|0|||
127750417|NCT04057573|459714594|FG002|24-Week Double-Blind Period|Pregnancy|0|||
127750418|NCT04057573|459714595|FG003|24-Week Double-Blind Period|Pregnancy|0|||
127750419|NCT04057573|459714592|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
127750420|NCT04057573|459714593|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
127750421|NCT04057573|459714594|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
127750422|NCT04057573|459714595|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
127750423|NCT04057573|459714592|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
127750424|NCT04057573|459714593|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
127750425|NCT04057573|459714594|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
127750426|NCT04057573|459714595|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
127750427|NCT04057573|459714592|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
127750428|NCT04057573|459714593|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
127750429|NCT04057573|459714594|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
127750430|NCT04057573|459714595|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
127750431|NCT04057573|459714592|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
127750432|NCT04057573|459714593|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
127750433|NCT04057573|459714594|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
127750434|NCT04057573|459714595|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
127750435|NCT04057573|459714592|FG000|24-Week Double-Blind Period|Not Treated|1|||
127750436|NCT04057573|459714593|FG001|24-Week Double-Blind Period|Not Treated|0|||
127750437|NCT04057573|459714594|FG002|24-Week Double-Blind Period|Not Treated|0|||
127750438|NCT04057573|459714595|FG003|24-Week Double-Blind Period|Not Treated|0|||
127750439|NCT04057573|459714592|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
127750440|NCT04057573|459714593|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
127750441|NCT04057573|459714594|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
127750442|NCT04057573|459714595|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
127750443|NCT04057573|459714592|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
127750444|NCT04057573|459714593|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
127750445|NCT04057573|459714594|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
127750446|NCT04057573|459714595|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
127750447|NCT04057573|459714592|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
127750448|NCT04057573|459714593|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
127750449|NCT04057573|459714594|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
127750450|NCT04057573|459714595|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
127750451|NCT04057573|459714592|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
127750452|NCT04057573|459714593|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
127750453|NCT04057573|459714594|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
127750454|NCT04057573|459714595|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
127750455|NCT04057573|459714592|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
127750456|NCT04057573|459714593|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
127750457|NCT04057573|459714594|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
127750458|NCT04057573|459714595|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
127750459|NCT01317875|459714598|FG000|Overall Study|Other|0|||
127750460|NCT01317875|459714599|FG001|Overall Study|Other|0|||
127750461|NCT01317875|459714600|FG002|Overall Study|Other|1|||
127750462|NCT01317875|459714601|FG003|Overall Study|Other|0|||
127809516|NCT03690869|459920115|FG004|Overall Study|Progressive Disease|0|||
127809517|NCT03690869|459920116|FG005|Overall Study|Progressive Disease|0|||
127809518|NCT03690869|459920117|FG006|Overall Study|Progressive Disease|0|||
127809519|NCT03690869|459920118|FG007|Overall Study|Progressive Disease|0|||
127809520|NCT03690869|459920119|FG008|Overall Study|Progressive Disease|1|||
127809521|NCT03690869|459920120|FG009|Overall Study|Progressive Disease|1|||
127809522|NCT03690869|459920111|FG000|Overall Study|Subject Decision|0|||
127809523|NCT03690869|459920112|FG001|Overall Study|Subject Decision|0|||
127809524|NCT03690869|459920113|FG002|Overall Study|Subject Decision|0|||
127809525|NCT03690869|459920114|FG003|Overall Study|Subject Decision|1|||
127809526|NCT03690869|459920115|FG004|Overall Study|Subject Decision|0|||
127809527|NCT03690869|459920116|FG005|Overall Study|Subject Decision|0|||
127809528|NCT03690869|459920117|FG006|Overall Study|Subject Decision|0|||
127809529|NCT03690869|459920118|FG007|Overall Study|Subject Decision|1|||
127809530|NCT03690869|459920119|FG008|Overall Study|Subject Decision|0|||
127809531|NCT03690869|459920120|FG009|Overall Study|Subject Decision|0|||
127809532|NCT03658889|459921380|FG000|Overall Study|Protocol Violation|2|||
127809533|NCT03658889|459921381|FG001|Overall Study|Protocol Violation|0|||
127809534|NCT01903876|459921388|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
127809535|NCT01903876|459921389|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
127809536|NCT01903876|459921388|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
127809537|NCT01903876|459921389|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
127809538|NCT04317690|459921392|FG000|Overall Study|did not have complete information for primary outcome|0|||
127809539|NCT04317690|459921393|FG001|Overall Study|did not have complete information for primary outcome|4|||
127809540|NCT04317690|459921394|FG002|Overall Study|did not have complete information for primary outcome|0|||
127809541|NCT04317690|459921395|FG003|Overall Study|did not have complete information for primary outcome|2|||
127809542|NCT04317690|459921396|FG004|Overall Study|did not have complete information for primary outcome|0|||
127750463|NCT01317875|459714602|FG004|Overall Study|Other|0|||
127750464|NCT01317875|459714603|FG005|Overall Study|Other|0|||
127750465|NCT01317875|459714604|FG006|Overall Study|Other|0|||
127750466|NCT01317875|459714605|FG007|Overall Study|Other|0|||
127750467|NCT01317875|459714606|FG008|Overall Study|Other|0|||
127750468|NCT01317875|459714607|FG009|Overall Study|Other|0|||
127750469|NCT01317875|459714598|FG000|Overall Study|Noncompliance with study drug|0|||
127750470|NCT01317875|459714599|FG001|Overall Study|Noncompliance with study drug|0|||
127750471|NCT01317875|459714600|FG002|Overall Study|Noncompliance with study drug|1|||
127750472|NCT01317875|459714601|FG003|Overall Study|Noncompliance with study drug|0|||
127750473|NCT01317875|459714602|FG004|Overall Study|Noncompliance with study drug|0|||
127750474|NCT01317875|459714603|FG005|Overall Study|Noncompliance with study drug|0|||
127750475|NCT01317875|459714604|FG006|Overall Study|Noncompliance with study drug|0|||
127750476|NCT01317875|459714605|FG007|Overall Study|Noncompliance with study drug|0|||
127750477|NCT01317875|459714606|FG008|Overall Study|Noncompliance with study drug|0|||
127750478|NCT01317875|459714607|FG009|Overall Study|Noncompliance with study drug|0|||
127750479|NCT01317875|459714598|FG000|Overall Study|Progressive Disease|1|||
127750480|NCT01317875|459714599|FG001|Overall Study|Progressive Disease|0|||
127750481|NCT01317875|459714600|FG002|Overall Study|Progressive Disease|2|||
127750482|NCT01317875|459714601|FG003|Overall Study|Progressive Disease|0|||
127750483|NCT01317875|459714602|FG004|Overall Study|Progressive Disease|1|||
127750484|NCT01317875|459714603|FG005|Overall Study|Progressive Disease|0|||
127750485|NCT01317875|459714604|FG006|Overall Study|Progressive Disease|0|||
127750486|NCT01317875|459714605|FG007|Overall Study|Progressive Disease|1|||
127750487|NCT01317875|459714606|FG008|Overall Study|Progressive Disease|0|||
127750488|NCT01317875|459714607|FG009|Overall Study|Progressive Disease|0|||
127750489|NCT01317875|459714598|FG000|Overall Study|Withdrawal by Subject|0|||
127750490|NCT01317875|459714599|FG001|Overall Study|Withdrawal by Subject|0|||
127750491|NCT01317875|459714600|FG002|Overall Study|Withdrawal by Subject|0|||
127750492|NCT01317875|459714601|FG003|Overall Study|Withdrawal by Subject|0|||
127750493|NCT01317875|459714602|FG004|Overall Study|Withdrawal by Subject|1|||
127750494|NCT01317875|459714603|FG005|Overall Study|Withdrawal by Subject|0|||
127750495|NCT01317875|459714604|FG006|Overall Study|Withdrawal by Subject|0|||
127750496|NCT01317875|459714605|FG007|Overall Study|Withdrawal by Subject|3|||
127750497|NCT01317875|459714606|FG008|Overall Study|Withdrawal by Subject|0|||
127750498|NCT01317875|459714607|FG009|Overall Study|Withdrawal by Subject|0|||
127750499|NCT01317875|459714598|FG000|Overall Study|Physician Decision|0|||
127750500|NCT01317875|459714599|FG001|Overall Study|Physician Decision|1|||
127750501|NCT01317875|459714600|FG002|Overall Study|Physician Decision|1|||
127750502|NCT01317875|459714601|FG003|Overall Study|Physician Decision|0|||
127750503|NCT01317875|459714602|FG004|Overall Study|Physician Decision|2|||
127750504|NCT01317875|459714603|FG005|Overall Study|Physician Decision|0|||
127750505|NCT01317875|459714604|FG006|Overall Study|Physician Decision|0|||
127750506|NCT01317875|459714605|FG007|Overall Study|Physician Decision|2|||
127750507|NCT01317875|459714606|FG008|Overall Study|Physician Decision|0|||
127750508|NCT01317875|459714607|FG009|Overall Study|Physician Decision|0|||
127750509|NCT01317875|459714598|FG000|Overall Study|Death|0|||
127750510|NCT01317875|459714599|FG001|Overall Study|Death|0|||
127750511|NCT01317875|459714600|FG002|Overall Study|Death|2|||
127750512|NCT01317875|459714601|FG003|Overall Study|Death|1|||
127750513|NCT01317875|459714602|FG004|Overall Study|Death|0|||
127750514|NCT01317875|459714603|FG005|Overall Study|Death|1|||
127750515|NCT01317875|459714604|FG006|Overall Study|Death|0|||
127750516|NCT01317875|459714605|FG007|Overall Study|Death|4|||
127750517|NCT01317875|459714606|FG008|Overall Study|Death|0|||
127750518|NCT01317875|459714607|FG009|Overall Study|Death|0|||
127750519|NCT01317875|459714598|FG000|Overall Study|Adverse Event|2|||
127750520|NCT01317875|459714599|FG001|Overall Study|Adverse Event|1|||
127750521|NCT01317875|459714600|FG002|Overall Study|Adverse Event|2|||
127809543|NCT01901224|459921402|FG000|Overall Study|study was not funded and terminated|2|||
127809544|NCT03902080|459921404|FG000|Overall Study|Adverse Event|17|||
127809545|NCT03902080|459921405|FG001|Overall Study|Adverse Event|15|||
127809546|NCT03902080|459921404|FG000|Overall Study|Withdrawal by Subject|28|||
127809547|NCT03902080|459921405|FG001|Overall Study|Withdrawal by Subject|35|||
127809548|NCT03902080|459921404|FG000|Overall Study|Lost to Follow-up|6|||
127750522|NCT01317875|459714601|FG003|Overall Study|Adverse Event|1|||
127750523|NCT01317875|459714602|FG004|Overall Study|Adverse Event|5|||
127750524|NCT01317875|459714603|FG005|Overall Study|Adverse Event|1|||
127809549|NCT03902080|459921405|FG001|Overall Study|Lost to Follow-up|7|||
127809550|NCT03902080|459921404|FG000|Overall Study|Other|3|||
127750525|NCT01317875|459714604|FG006|Overall Study|Adverse Event|2|||
127750526|NCT01317875|459714605|FG007|Overall Study|Adverse Event|5|||
127750527|NCT01317875|459714606|FG008|Overall Study|Adverse Event|0|||
127750528|NCT01317875|459714607|FG009|Overall Study|Adverse Event|0|||
127750529|NCT01381575|459714608|FG000|Overall Study|Serious Adverse Event|1|||
127750530|NCT01381575|459714609|FG001|Overall Study|Serious Adverse Event|0|||
127750531|NCT01381575|459714610|FG002|Overall Study|Serious Adverse Event|0|||
127750532|NCT01381575|459714608|FG000|Overall Study|Non-Serious Adverse Event|0|||
127809551|NCT03902080|459921405|FG001|Overall Study|Other|5|||
127809552|NCT03902080|459921404|FG000|Overall Study|Non compliance|4|||
127750533|NCT01381575|459714609|FG001|Overall Study|Non-Serious Adverse Event|0|||
127750534|NCT01381575|459714610|FG002|Overall Study|Non-Serious Adverse Event|1|||
127750535|NCT01381575|459714608|FG000|Overall Study|Protocol Violation|0|||
127750536|NCT01381575|459714609|FG001|Overall Study|Protocol Violation|1|||
127750537|NCT01381575|459714610|FG002|Overall Study|Protocol Violation|1|||
127750538|NCT01381575|459714608|FG000|Overall Study|Withdrawal by Subject|15|||
127750539|NCT01381575|459714609|FG001|Overall Study|Withdrawal by Subject|9|||
127750540|NCT01381575|459714610|FG002|Overall Study|Withdrawal by Subject|7|||
127750541|NCT01381575|459714608|FG000|Overall Study|Migrated/moved from study area|2|||
127750542|NCT01381575|459714609|FG001|Overall Study|Migrated/moved from study area|12|||
127750543|NCT01381575|459714610|FG002|Overall Study|Migrated/moved from study area|2|||
127750544|NCT01381575|459714608|FG000|Overall Study|Lost to Follow-up|8|||
127750545|NCT01381575|459714609|FG001|Overall Study|Lost to Follow-up|17|||
127750546|NCT01381575|459714610|FG002|Overall Study|Lost to Follow-up|9|||
127750547|NCT01443403|459714611|FG000|Overall Study|Adverse Event|1|||
127750548|NCT01443403|459714612|FG001|Overall Study|Adverse Event|1|||
127750549|NCT01443403|459714613|FG002|Overall Study|Adverse Event|4|||
127750550|NCT01443403|459714614|FG003|Overall Study|Adverse Event|5|||
127750551|NCT01443403|459714611|FG000|Overall Study|Withdrawal by Subject|0|||
127750552|NCT01443403|459714612|FG001|Overall Study|Withdrawal by Subject|1|||
127750553|NCT01443403|459714613|FG002|Overall Study|Withdrawal by Subject|2|||
127750554|NCT01443403|459714614|FG003|Overall Study|Withdrawal by Subject|1|||
127750555|NCT01443403|459714611|FG000|Overall Study|Lost to Follow-up|0|||
127750556|NCT01443403|459714612|FG001|Overall Study|Lost to Follow-up|0|||
127750557|NCT01443403|459714613|FG002|Overall Study|Lost to Follow-up|0|||
127750558|NCT01443403|459714614|FG003|Overall Study|Lost to Follow-up|1|||
127750559|NCT01443403|459714611|FG000|Overall Study|Protocol Violation|2|||
127750560|NCT01443403|459714612|FG001|Overall Study|Protocol Violation|1|||
127750561|NCT01443403|459714613|FG002|Overall Study|Protocol Violation|1|||
127750562|NCT01443403|459714614|FG003|Overall Study|Protocol Violation|1|||
127750563|NCT01443403|459714611|FG000|Overall Study|Use of Prohibited Treatment|2|||
127750564|NCT01443403|459714612|FG001|Overall Study|Use of Prohibited Treatment|3|||
127750565|NCT01443403|459714613|FG002|Overall Study|Use of Prohibited Treatment|0|||
127809553|NCT03902080|459921405|FG001|Overall Study|Non compliance|3|||
127809554|NCT03902080|459921404|FG000|Overall Study|Physician Decision|5|||
127809555|NCT03902080|459921405|FG001|Overall Study|Physician Decision|1|||
127809556|NCT03902080|459921404|FG000|Overall Study|Protocol Violation|3|||
127809557|NCT03902080|459921405|FG001|Overall Study|Protocol Violation|3|||
127809558|NCT03902080|459921404|FG000|Overall Study|Lack of Efficacy|1|||
127809559|NCT03902080|459921405|FG001|Overall Study|Lack of Efficacy|3|||
127809560|NCT03902080|459921404|FG000|Overall Study|Withdrawn prior to dosing|0|||
127809561|NCT03902080|459921405|FG001|Overall Study|Withdrawn prior to dosing|1|||
127809562|NCT01919307|459921410|FG000|Overall Study|Withdrawal by Subject|9|||
127809563|NCT01701258|459921412|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
127809564|NCT01701258|459921413|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
127809565|NCT01701258|459921414|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
127809566|NCT01701258|459921415|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
127809567|NCT01701258|459921416|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
127809568|NCT01701258|459921417|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
127809569|NCT01701258|459921418|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
127809570|NCT01701258|459921419|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
127809571|NCT01701258|459921420|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
127809572|NCT01701258|459921421|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
127809573|NCT01701258|459921422|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
127809574|NCT01701258|459921423|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
127809575|NCT01701258|459921424|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
127809576|NCT01701258|459921412|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
127809577|NCT01701258|459921413|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
127809578|NCT01701258|459921414|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
127809579|NCT01701258|459921415|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
127809580|NCT01701258|459921416|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
127809581|NCT01701258|459921417|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
127809582|NCT01701258|459921418|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
127809583|NCT01701258|459921419|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
127809584|NCT01701258|459921420|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
127809585|NCT01701258|459921421|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
127809586|NCT01701258|459921422|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
127809587|NCT01701258|459921423|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
127809588|NCT01701258|459921424|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
127809589|NCT01701258|459921412|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
127809590|NCT01701258|459921413|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
127750566|NCT01443403|459714614|FG003|Overall Study|Use of Prohibited Treatment|0|||
127894156|NCT00175019|460235229|FG000|Overall Study|Gout Flare|2|||
127750567|NCT01443403|459714611|FG000|Overall Study|Other - Miscellaneous|1|||
127750568|NCT01443403|459714612|FG001|Overall Study|Other - Miscellaneous|0|||
127750569|NCT01443403|459714613|FG002|Overall Study|Other - Miscellaneous|0|||
127750570|NCT01443403|459714614|FG003|Overall Study|Other - Miscellaneous|1|||
127750571|NCT00474526|459714615|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
127750572|NCT00474526|459714616|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
127750573|NCT00474526|459714617|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
127750574|NCT00474526|459714618|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
127750575|NCT00474526|459714619|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
127750576|NCT00474526|459714620|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
127750577|NCT00474526|459714621|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
127809591|NCT01701258|459921414|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
127809592|NCT01701258|459921415|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
127809593|NCT01701258|459921416|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
127809594|NCT01701258|459921417|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
127809595|NCT01701258|459921418|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
127809596|NCT01701258|459921419|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
127809597|NCT01701258|459921420|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
127809598|NCT01701258|459921421|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
127809599|NCT01701258|459921422|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
127809600|NCT01701258|459921423|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
127809601|NCT01701258|459921424|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
127809602|NCT01701258|459921412|FG000|Assessment and Scheduling|Investigator Terminated|2|||
127809603|NCT01701258|459921413|FG001|Assessment and Scheduling|Investigator Terminated|0|||
127809604|NCT01701258|459921414|FG002|Assessment and Scheduling|Investigator Terminated|0|||
127809605|NCT01701258|459921415|FG003|Assessment and Scheduling|Investigator Terminated|0|||
127809606|NCT01701258|459921416|FG004|Assessment and Scheduling|Investigator Terminated|0|||
127809607|NCT01701258|459921417|FG005|Assessment and Scheduling|Investigator Terminated|0|||
127809608|NCT01701258|459921418|FG006|Assessment and Scheduling|Investigator Terminated|0|||
127809609|NCT01701258|459921419|FG007|Assessment and Scheduling|Investigator Terminated|0|||
127809610|NCT01701258|459921420|FG008|Assessment and Scheduling|Investigator Terminated|0|||
127809611|NCT01701258|459921421|FG009|Assessment and Scheduling|Investigator Terminated|0|||
127809612|NCT01701258|459921422|FG010|Assessment and Scheduling|Investigator Terminated|0|||
127809613|NCT01701258|459921423|FG011|Assessment and Scheduling|Investigator Terminated|0|||
127809614|NCT01701258|459921424|FG012|Assessment and Scheduling|Investigator Terminated|0|||
127809615|NCT02429856|459921427|FG000|Overall Study|Death|12|||
127809616|NCT02429856|459921428|FG001|Overall Study|Death|13|||
127809617|NCT02429856|459921427|FG000|Overall Study|Lost to Follow-up|6|||
127809618|NCT02429856|459921428|FG001|Overall Study|Lost to Follow-up|5|||
127809619|NCT02429856|459921427|FG000|Overall Study|Withdrawal by Subject|1|||
127809620|NCT02429856|459921428|FG001|Overall Study|Withdrawal by Subject|1|||
127809621|NCT01451645|459921440|FG000|Overall Study|Protocol Violation|1|||
127809622|NCT01451645|459921441|FG001|Overall Study|Protocol Violation|0|||
127809623|NCT01451645|459921440|FG000|Overall Study|Adverse Event|0|||
127809624|NCT01451645|459921441|FG001|Overall Study|Adverse Event|3|||
127809625|NCT01451645|459921440|FG000|Overall Study|Withdrawal by Subject|4|||
127809626|NCT01451645|459921441|FG001|Overall Study|Withdrawal by Subject|2|||
127809627|NCT01451645|459921440|FG000|Overall Study|Lost to Follow-up|4|||
127809628|NCT01451645|459921441|FG001|Overall Study|Lost to Follow-up|3|||
127809629|NCT02978222|459921444|FG000|Overall Study|Withdrawal by Subject|2|||
127809630|NCT02978222|459921445|FG001|Overall Study|Withdrawal by Subject|2|||
127809631|NCT02978222|459921444|FG000|Overall Study|Physician Decision|2|||
127809632|NCT02978222|459921445|FG001|Overall Study|Physician Decision|0|||
127809633|NCT02978222|459921444|FG000|Overall Study|Adverse Event|0|||
127809634|NCT02978222|459921445|FG001|Overall Study|Adverse Event|1|||
127809635|NCT02978222|459921444|FG000|Overall Study|Death|1|||
127809636|NCT02978222|459921445|FG001|Overall Study|Death|0|||
127809637|NCT02978222|459921444|FG000|Overall Study|Disease Progression|32|||
127809638|NCT02978222|459921445|FG001|Overall Study|Disease Progression|32|||
127809639|NCT02978222|459921444|FG000|Overall Study|Early Study Termination|24|||
127809640|NCT02978222|459921445|FG001|Overall Study|Early Study Termination|21|||
127809641|NCT01686568|459921446|FG000|Main Study|Withdrawal by Subject|1|||
127809642|NCT01686568|459921447|FG001|Main Study|Withdrawal by Subject|3|||
127809643|NCT01686568|459921446|FG000|Main Study|Noncompliance with protocol|0|||
127809644|NCT01686568|459921447|FG001|Main Study|Noncompliance with protocol|1|||
127809645|NCT01686568|459921446|FG000|Main Study|Liver enzymes above range of exclusion|1|||
127809646|NCT01686568|459921447|FG001|Main Study|Liver enzymes above range of exclusion|0|||
127809647|NCT01686568|459921446|FG000|Sub-Study|Not consented for sub-study|2|||
127809648|NCT01686568|459921447|FG001|Sub-Study|Not consented for sub-study|2|||
127809649|NCT03838484|459921448|FG000|Overall Study|Lost to Follow-up|0|||
127809650|NCT03838484|459921449|FG001|Overall Study|Lost to Follow-up|1|||
127809651|NCT03838484|459921450|FG002|Overall Study|Lost to Follow-up|0|||
127809652|NCT03838484|459921451|FG003|Overall Study|Lost to Follow-up|0|||
127809653|NCT02868892|459921456|FG000|Overall Study|Investigator left site and no follow-up|6|||
127809654|NCT02393209|459921460|FG000|Overall Study|Study Terminated by Sponsor|1|||
127809655|NCT02393209|459921461|FG001|Overall Study|Study Terminated by Sponsor|1|||
127809656|NCT02393209|459921462|FG002|Overall Study|Study Terminated by Sponsor|0|||
127809657|NCT02393209|459921463|FG003|Overall Study|Study Terminated by Sponsor|0|||
127809658|NCT02393209|459921460|FG000|Overall Study|Withdrawal by Patient|1|||
127809659|NCT02393209|459921461|FG001|Overall Study|Withdrawal by Patient|0|||
127809660|NCT02393209|459921462|FG002|Overall Study|Withdrawal by Patient|0|||
127809661|NCT02393209|459921463|FG003|Overall Study|Withdrawal by Patient|0|||
127809662|NCT02393209|459921460|FG000|Overall Study|Death|2|||
127809663|NCT02393209|459921461|FG001|Overall Study|Death|2|||
127809664|NCT02393209|459921462|FG002|Overall Study|Death|0|||
127809665|NCT02393209|459921463|FG003|Overall Study|Death|0|||
127809666|NCT02393209|459921460|FG000|Overall Study|Death due to Disease Progression|2|||
127809667|NCT02393209|459921461|FG001|Overall Study|Death due to Disease Progression|2|||
127809668|NCT02393209|459921462|FG002|Overall Study|Death due to Disease Progression|0|||
127809669|NCT02393209|459921463|FG003|Overall Study|Death due to Disease Progression|0|||
127809670|NCT02393209|459921460|FG000|Overall Study|Death from Legionella Infection|0|||
127809671|NCT02393209|459921461|FG001|Overall Study|Death from Legionella Infection|1|||
127809672|NCT02393209|459921462|FG002|Overall Study|Death from Legionella Infection|0|||
127809673|NCT02393209|459921463|FG003|Overall Study|Death from Legionella Infection|0|||
127809674|NCT02393209|459921460|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
127809675|NCT02393209|459921461|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
127809676|NCT02393209|459921462|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
127809677|NCT02393209|459921463|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
127809678|NCT02393209|459921460|FG000|Overall Study|Lost to Follow-up|0|||
127894157|NCT00175019|460235230|FG001|Overall Study|Gout Flare|3|||
127894158|NCT00175019|460235231|FG002|Overall Study|Gout Flare|0|||
127750578|NCT00474526|459714622|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
127750579|NCT00474526|459714623|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
127750580|NCT00474526|459714624|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
127750581|NCT00474526|459714625|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
127750582|NCT00474526|459714626|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
127750583|NCT00474526|459714627|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
127750584|NCT00474526|459714628|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
127750585|NCT00474526|459714629|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
127750586|NCT00474526|459714630|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
127750587|NCT00474526|459714631|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
127750588|NCT00474526|459714615|FG000|Overall Study|Adverse Event|2|||
127750589|NCT00474526|459714616|FG001|Overall Study|Adverse Event|0|||
127750590|NCT00474526|459714617|FG002|Overall Study|Adverse Event|2|||
127750591|NCT00474526|459714618|FG003|Overall Study|Adverse Event|4|||
127750592|NCT00474526|459714619|FG004|Overall Study|Adverse Event|2|||
127750593|NCT00474526|459714620|FG005|Overall Study|Adverse Event|1|||
127750594|NCT00474526|459714621|FG006|Overall Study|Adverse Event|1|||
127750595|NCT00474526|459714622|FG007|Overall Study|Adverse Event|0|||
127750596|NCT00474526|459714623|FG008|Overall Study|Adverse Event|0|||
127750597|NCT00474526|459714624|FG009|Overall Study|Adverse Event|0|||
127750598|NCT00474526|459714625|FG010|Overall Study|Adverse Event|0|||
127750599|NCT00474526|459714626|FG011|Overall Study|Adverse Event|0|||
127809679|NCT02393209|459921461|FG001|Overall Study|Lost to Follow-up|1|||
127894159|NCT00175019|460235229|FG000|Overall Study|Reason Not Specified|40|||
127750600|NCT00474526|459714627|FG012|Overall Study|Adverse Event|0|||
127750601|NCT00474526|459714628|FG013|Overall Study|Adverse Event|0|||
127750602|NCT00474526|459714629|FG014|Overall Study|Adverse Event|1|||
127750603|NCT00474526|459714630|FG015|Overall Study|Adverse Event|1|||
127750604|NCT00474526|459714631|FG016|Overall Study|Adverse Event|0|||
127750605|NCT00474526|459714615|FG000|Overall Study|Death|0|||
127809680|NCT02393209|459921462|FG002|Overall Study|Lost to Follow-up|0|||
127809681|NCT02393209|459921463|FG003|Overall Study|Lost to Follow-up|0|||
127809682|NCT00619957|459921464|FG000|Month 24 Double-Blind|Adverse Event|9|||
127750606|NCT00474526|459714616|FG001|Overall Study|Death|0|||
127809683|NCT00619957|459921465|FG001|Month 24 Double-Blind|Adverse Event|7|||
127894160|NCT00175019|460235230|FG001|Overall Study|Reason Not Specified|34|||
127750607|NCT00474526|459714617|FG002|Overall Study|Death|0|||
127750608|NCT00474526|459714618|FG003|Overall Study|Death|0|||
127894161|NCT00175019|460235231|FG002|Overall Study|Reason Not Specified|11|||
127894162|NCT03209570|460235232|FG000|Overall Study|Death|1|||
127894163|NCT03209570|460235233|FG001|Overall Study|Death|0|||
127894164|NCT03209570|460235232|FG000|Overall Study|Incomplete Data|8|||
127750609|NCT00474526|459714619|FG004|Overall Study|Death|0|||
127750610|NCT00474526|459714620|FG005|Overall Study|Death|0|||
127750611|NCT00474526|459714621|FG006|Overall Study|Death|0|||
127750612|NCT00474526|459714622|FG007|Overall Study|Death|0|||
127750613|NCT00474526|459714623|FG008|Overall Study|Death|0|||
127750614|NCT00474526|459714624|FG009|Overall Study|Death|0|||
127750615|NCT00474526|459714625|FG010|Overall Study|Death|0|||
127750616|NCT00474526|459714626|FG011|Overall Study|Death|0|||
127750617|NCT00474526|459714627|FG012|Overall Study|Death|0|||
127750618|NCT00474526|459714628|FG013|Overall Study|Death|3|||
127750619|NCT00474526|459714629|FG014|Overall Study|Death|0|||
127750620|NCT00474526|459714630|FG015|Overall Study|Death|0|||
127750621|NCT00474526|459714631|FG016|Overall Study|Death|0|||
127750622|NCT00474526|459714615|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
127750623|NCT00474526|459714616|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
127750624|NCT00474526|459714617|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
127750625|NCT00474526|459714618|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
127750626|NCT00474526|459714619|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
127750627|NCT00474526|459714620|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
127750628|NCT00474526|459714621|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
127750629|NCT00474526|459714622|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
127750630|NCT00474526|459714623|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
127750631|NCT00474526|459714624|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
127750632|NCT00474526|459714625|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
127750633|NCT00474526|459714626|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
127750634|NCT00474526|459714627|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
127750635|NCT00474526|459714628|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
127750636|NCT00474526|459714629|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
127750637|NCT00474526|459714630|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
127750638|NCT00474526|459714631|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
127750639|NCT00474526|459714615|FG000|Overall Study|Lost to Follow-up|8|||
127750640|NCT00474526|459714616|FG001|Overall Study|Lost to Follow-up|6|||
127750641|NCT00474526|459714617|FG002|Overall Study|Lost to Follow-up|13|||
127750642|NCT00474526|459714618|FG003|Overall Study|Lost to Follow-up|29|||
127750643|NCT00474526|459714619|FG004|Overall Study|Lost to Follow-up|11|||
127750644|NCT00474526|459714620|FG005|Overall Study|Lost to Follow-up|5|||
127750645|NCT00474526|459714621|FG006|Overall Study|Lost to Follow-up|8|||
127750646|NCT00474526|459714622|FG007|Overall Study|Lost to Follow-up|1|||
127750647|NCT00474526|459714623|FG008|Overall Study|Lost to Follow-up|0|||
127750648|NCT00474526|459714624|FG009|Overall Study|Lost to Follow-up|6|||
127750649|NCT00474526|459714625|FG010|Overall Study|Lost to Follow-up|2|||
127750650|NCT00474526|459714626|FG011|Overall Study|Lost to Follow-up|4|||
127750651|NCT00474526|459714627|FG012|Overall Study|Lost to Follow-up|6|||
127750652|NCT00474526|459714628|FG013|Overall Study|Lost to Follow-up|74|||
127750653|NCT00474526|459714629|FG014|Overall Study|Lost to Follow-up|29|||
127750654|NCT00474526|459714630|FG015|Overall Study|Lost to Follow-up|4|||
127750655|NCT00474526|459714631|FG016|Overall Study|Lost to Follow-up|5|||
127750656|NCT00474526|459714615|FG000|Overall Study|Protocol Violation|2|||
127750657|NCT00474526|459714616|FG001|Overall Study|Protocol Violation|6|||
127894165|NCT03209570|460235233|FG001|Overall Study|Incomplete Data|10|||
127894166|NCT03209570|460235232|FG000|Overall Study|Protocol Violation|1|||
127894167|NCT03209570|460235233|FG001|Overall Study|Protocol Violation|0|||
127750658|NCT00474526|459714617|FG002|Overall Study|Protocol Violation|4|||
127750659|NCT00474526|459714618|FG003|Overall Study|Protocol Violation|12|||
127750660|NCT00474526|459714619|FG004|Overall Study|Protocol Violation|3|||
127750661|NCT00474526|459714620|FG005|Overall Study|Protocol Violation|1|||
127894168|NCT03209570|460235232|FG000|Overall Study|Withdrawal by Subject|0|||
127894169|NCT03209570|460235233|FG001|Overall Study|Withdrawal by Subject|3|||
127894170|NCT00220701|460235244|FG000|Overall Study|Lost to Follow-up|5|||
127750662|NCT00474526|459714621|FG006|Overall Study|Protocol Violation|3|||
127750663|NCT00474526|459714622|FG007|Overall Study|Protocol Violation|0|||
127750664|NCT00474526|459714623|FG008|Overall Study|Protocol Violation|0|||
127750665|NCT00474526|459714624|FG009|Overall Study|Protocol Violation|4|||
127750666|NCT00474526|459714625|FG010|Overall Study|Protocol Violation|2|||
127750667|NCT00474526|459714626|FG011|Overall Study|Protocol Violation|2|||
127750668|NCT00474526|459714627|FG012|Overall Study|Protocol Violation|4|||
127750669|NCT00474526|459714628|FG013|Overall Study|Protocol Violation|19|||
127750670|NCT00474526|459714629|FG014|Overall Study|Protocol Violation|9|||
127750671|NCT00474526|459714630|FG015|Overall Study|Protocol Violation|6|||
127750672|NCT00474526|459714631|FG016|Overall Study|Protocol Violation|2|||
127750673|NCT00474526|459714615|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
127750674|NCT00474526|459714616|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
127750675|NCT00474526|459714617|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
127894171|NCT00220701|460235245|FG001|Overall Study|Lost to Follow-up|4|||
127750676|NCT00474526|459714618|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
127750677|NCT00474526|459714619|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
127894172|NCT00755326|460235247|FG000|Overall Study|Lost to Follow-up|2|||
127750678|NCT00474526|459714620|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
127750679|NCT00474526|459714621|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
127750680|NCT00474526|459714622|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
127750681|NCT00474526|459714623|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
127750682|NCT00474526|459714624|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
127750683|NCT00474526|459714625|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
127750684|NCT00474526|459714626|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
127750685|NCT00474526|459714627|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
127750686|NCT00474526|459714628|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
127750687|NCT00474526|459714629|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
127750688|NCT00474526|459714630|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
127750689|NCT00474526|459714631|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
127750690|NCT00474526|459714615|FG000|Overall Study|Withdrawal by Subject|9|||
127750691|NCT00474526|459714616|FG001|Overall Study|Withdrawal by Subject|24|||
127750692|NCT00474526|459714617|FG002|Overall Study|Withdrawal by Subject|21|||
127750693|NCT00474526|459714618|FG003|Overall Study|Withdrawal by Subject|52|||
127750694|NCT00474526|459714619|FG004|Overall Study|Withdrawal by Subject|38|||
127750695|NCT00474526|459714620|FG005|Overall Study|Withdrawal by Subject|6|||
127750696|NCT00474526|459714621|FG006|Overall Study|Withdrawal by Subject|12|||
127750697|NCT00474526|459714622|FG007|Overall Study|Withdrawal by Subject|4|||
127750698|NCT00474526|459714623|FG008|Overall Study|Withdrawal by Subject|4|||
127750699|NCT00474526|459714624|FG009|Overall Study|Withdrawal by Subject|13|||
127750700|NCT00474526|459714625|FG010|Overall Study|Withdrawal by Subject|5|||
127750701|NCT00474526|459714626|FG011|Overall Study|Withdrawal by Subject|4|||
127750702|NCT00474526|459714627|FG012|Overall Study|Withdrawal by Subject|4|||
127750703|NCT00474526|459714628|FG013|Overall Study|Withdrawal by Subject|37|||
127750704|NCT00474526|459714629|FG014|Overall Study|Withdrawal by Subject|22|||
127750705|NCT00474526|459714630|FG015|Overall Study|Withdrawal by Subject|1|||
127750706|NCT00474526|459714631|FG016|Overall Study|Withdrawal by Subject|1|||
127750707|NCT01251770|459714635|FG000|Overall Study|Protocol Violation|13|||
127750708|NCT01251770|459714636|FG001|Overall Study|Protocol Violation|7|||
127750709|NCT04307940|459714637|FG000|Overall Study|Adverse Event|1|||
127750710|NCT04307940|459714638|FG001|Overall Study|Adverse Event|0|||
127750711|NCT04307940|459714639|FG002|Overall Study|Adverse Event|0|||
127750712|NCT04307940|459714637|FG000|Overall Study|Withdrawal by Subject|2|||
127894173|NCT00755326|460235248|FG001|Overall Study|Lost to Follow-up|3|||
127894174|NCT04041570|460235254|FG000|Overall Study|Moved from Area|0|||
127894175|NCT04041570|460235255|FG001|Overall Study|Moved from Area|2|||
127750713|NCT04307940|459714638|FG001|Overall Study|Withdrawal by Subject|3|||
127750714|NCT04307940|459714639|FG002|Overall Study|Withdrawal by Subject|1|||
127750715|NCT04307940|459714637|FG000|Overall Study|Lost to Follow-up|2|||
127750716|NCT04307940|459714638|FG001|Overall Study|Lost to Follow-up|0|||
127750717|NCT04307940|459714639|FG002|Overall Study|Lost to Follow-up|1|||
127750718|NCT05543174|459714640|FG000|Overall Study|Ongoing|7|||
127750719|NCT00953771|459714641|FG000|Overall Study|Death|1|||
127750720|NCT00953771|459714642|FG001|Overall Study|Death|0|||
127750721|NCT04896008|459714643|FG000|Overall Study|Ongoing|70|||
127750722|NCT04896008|459714644|FG001|Overall Study|Ongoing|38|||
127750723|NCT04896008|459714643|FG000|Overall Study|Adverse Event|0|||
127750724|NCT04896008|459714644|FG001|Overall Study|Adverse Event|2|||
127750725|NCT04896008|459714643|FG000|Overall Study|Death|5|||
127750726|NCT04896008|459714644|FG001|Overall Study|Death|10|||
127750727|NCT04896008|459714643|FG000|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|1|||
127750728|NCT04896008|459714644|FG001|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|0|||
127750729|NCT04896008|459714643|FG000|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|0|||
127750730|NCT04896008|459714644|FG001|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|1|||
127750731|NCT04896008|459714643|FG000|Overall Study|Unwillingness Or Inability To Comply With Protocol|1|||
127750732|NCT04896008|459714644|FG001|Overall Study|Unwillingness Or Inability To Comply With Protocol|0|||
127750733|NCT04896008|459714643|FG000|Overall Study|Withdrawal by Subject|1|||
127750734|NCT04896008|459714644|FG001|Overall Study|Withdrawal by Subject|4|||
127750735|NCT04896008|459714643|FG000|Overall Study|Investigator Decision|2|||
127750736|NCT04896008|459714644|FG001|Overall Study|Investigator Decision|0|||
127750737|NCT04896008|459714643|FG000|Overall Study|Transitioned to Commercial Sotatercept|2|||
127750738|NCT04896008|459714644|FG001|Overall Study|Transitioned to Commercial Sotatercept|1|||
127750739|NCT01270828|459714645|FG000|Pregabalin CR SB|Reason Unspecified|0|||
127750740|NCT01270828|459714646|FG001|Pregabalin CR SB|Reason Unspecified|0|||
127750741|NCT01270828|459714647|FG002|Pregabalin CR SB|Reason Unspecified|8|||
127750742|NCT01270828|459714645|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
127750743|NCT01270828|459714646|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
127750744|NCT01270828|459714647|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
127750745|NCT01270828|459714645|FG000|Pregabalin CR SB|Related adverse event|0|||
127750746|NCT01270828|459714646|FG001|Pregabalin CR SB|Related adverse event|0|||
127750747|NCT01270828|459714647|FG002|Pregabalin CR SB|Related adverse event|46|||
127750748|NCT01270828|459714645|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
127750749|NCT01270828|459714646|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
127894176|NCT00384033|460235266|FG000|Overall Study|Adverse Event|10|||
127809684|NCT00619957|459921464|FG000|Month 24 Double-Blind|Protocol Violation|1|||
127809685|NCT00619957|459921465|FG001|Month 24 Double-Blind|Protocol Violation|0|||
127809686|NCT00619957|459921464|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
127809687|NCT00619957|459921465|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
127809688|NCT00619957|459921464|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
127809689|NCT00619957|459921465|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
127809690|NCT00619957|459921464|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
127809691|NCT00619957|459921465|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
127809692|NCT00619957|459921464|FG000|Month 48 Open-Label|Adverse Event|4|||
127809693|NCT00619957|459921465|FG001|Month 48 Open-Label|Adverse Event|4|||
127809694|NCT00619957|459921464|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
127809695|NCT00619957|459921465|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
127809696|NCT00619957|459921464|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
127809697|NCT00619957|459921465|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
127809698|NCT00755079|459921466|FG000|Overall Study|Lost to Follow-up|1|||
127809699|NCT00755079|459921467|FG001|Overall Study|Lost to Follow-up|3|||
127809700|NCT00755079|459921466|FG000|Overall Study|Adverse Event|0|||
127809701|NCT00755079|459921467|FG001|Overall Study|Adverse Event|1|||
127809702|NCT00755079|459921466|FG000|Overall Study|Withdrawal by Subject|0|||
127809703|NCT00755079|459921467|FG001|Overall Study|Withdrawal by Subject|2|||
127809704|NCT03545282|459921468|FG000|Overall Study|Lost to Follow-up|15|||
127809705|NCT03545282|459921469|FG001|Overall Study|Lost to Follow-up|10|||
127809706|NCT03545282|459921468|FG000|Overall Study|Withdrawal by Subject|2|||
127809707|NCT03545282|459921469|FG001|Overall Study|Withdrawal by Subject|2|||
127809708|NCT00868790|459921470|FG000|Period 1|Adverse Event|1|||
127809709|NCT00868790|459921471|FG001|Period 1|Adverse Event|0|||
127809710|NCT00868790|459921472|FG002|Period 1|Adverse Event|0|||
127809711|NCT00868790|459921473|FG003|Period 1|Adverse Event|0|||
127809712|NCT00868790|459921474|FG004|Period 1|Adverse Event|0|||
127809713|NCT00868790|459921475|FG005|Period 1|Adverse Event|0|||
127809714|NCT00868790|459921476|FG006|Period 1|Adverse Event|0|||
127809715|NCT00868790|459921477|FG007|Period 1|Adverse Event|3|||
127809716|NCT00868790|459921478|FG008|Period 1|Adverse Event|1|||
127809717|NCT00868790|459921479|FG009|Period 1|Adverse Event|0|||
127809718|NCT00868790|459921480|FG010|Period 1|Adverse Event|0|||
127809719|NCT00868790|459921481|FG011|Period 1|Adverse Event|0|||
127809720|NCT00868790|459921482|FG012|Period 1|Adverse Event|0|||
127809721|NCT00868790|459921483|FG013|Period 1|Adverse Event|1|||
127809722|NCT00868790|459921470|FG000|Period 1|Protocol Violation|1|||
127809723|NCT00868790|459921471|FG001|Period 1|Protocol Violation|0|||
127809724|NCT00868790|459921472|FG002|Period 1|Protocol Violation|0|||
127809725|NCT00868790|459921473|FG003|Period 1|Protocol Violation|0|||
127809726|NCT00868790|459921474|FG004|Period 1|Protocol Violation|0|||
127809727|NCT00868790|459921475|FG005|Period 1|Protocol Violation|0|||
127809728|NCT00868790|459921476|FG006|Period 1|Protocol Violation|0|||
127809729|NCT00868790|459921477|FG007|Period 1|Protocol Violation|0|||
127809730|NCT00868790|459921478|FG008|Period 1|Protocol Violation|0|||
127809731|NCT00868790|459921479|FG009|Period 1|Protocol Violation|0|||
127809732|NCT00868790|459921480|FG010|Period 1|Protocol Violation|0|||
127809733|NCT00868790|459921481|FG011|Period 1|Protocol Violation|0|||
127809734|NCT00868790|459921482|FG012|Period 1|Protocol Violation|0|||
127809735|NCT00868790|459921483|FG013|Period 1|Protocol Violation|0|||
127809736|NCT00868790|459921470|FG000|Period 1|Withdrawal by Subject|0|||
127809737|NCT00868790|459921471|FG001|Period 1|Withdrawal by Subject|1|||
127809738|NCT00868790|459921472|FG002|Period 1|Withdrawal by Subject|0|||
127809739|NCT00868790|459921473|FG003|Period 1|Withdrawal by Subject|0|||
127809740|NCT00868790|459921474|FG004|Period 1|Withdrawal by Subject|0|||
127809741|NCT00868790|459921475|FG005|Period 1|Withdrawal by Subject|0|||
127809742|NCT00868790|459921476|FG006|Period 1|Withdrawal by Subject|0|||
127809743|NCT00868790|459921477|FG007|Period 1|Withdrawal by Subject|0|||
127809744|NCT00868790|459921478|FG008|Period 1|Withdrawal by Subject|0|||
127809745|NCT00868790|459921479|FG009|Period 1|Withdrawal by Subject|0|||
127809746|NCT00868790|459921480|FG010|Period 1|Withdrawal by Subject|0|||
127809747|NCT00868790|459921481|FG011|Period 1|Withdrawal by Subject|0|||
127809748|NCT00868790|459921482|FG012|Period 1|Withdrawal by Subject|0|||
127809749|NCT00868790|459921483|FG013|Period 1|Withdrawal by Subject|1|||
127809750|NCT00868790|459921470|FG000|Period 1|Abnormal Triglycerides|0|||
127809751|NCT00868790|459921471|FG001|Period 1|Abnormal Triglycerides|0|||
127809752|NCT00868790|459921472|FG002|Period 1|Abnormal Triglycerides|0|||
127809753|NCT00868790|459921473|FG003|Period 1|Abnormal Triglycerides|0|||
127809754|NCT00868790|459921474|FG004|Period 1|Abnormal Triglycerides|1|||
127809755|NCT00868790|459921475|FG005|Period 1|Abnormal Triglycerides|0|||
127809756|NCT00868790|459921476|FG006|Period 1|Abnormal Triglycerides|0|||
127809757|NCT00868790|459921477|FG007|Period 1|Abnormal Triglycerides|0|||
127809758|NCT00868790|459921478|FG008|Period 1|Abnormal Triglycerides|0|||
127809759|NCT00868790|459921479|FG009|Period 1|Abnormal Triglycerides|0|||
127809760|NCT00868790|459921480|FG010|Period 1|Abnormal Triglycerides|0|||
127809761|NCT00868790|459921481|FG011|Period 1|Abnormal Triglycerides|0|||
127809762|NCT00868790|459921482|FG012|Period 1|Abnormal Triglycerides|0|||
127809763|NCT00868790|459921483|FG013|Period 1|Abnormal Triglycerides|0|||
127809764|NCT00868790|459921470|FG000|Period 1|Lost to Follow-up|0|||
127750750|NCT01270828|459714647|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
127750751|NCT01270828|459714645|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
127750752|NCT01270828|459714646|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
127750753|NCT01270828|459714647|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
127750754|NCT01270828|459714645|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
127750755|NCT01270828|459714646|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
127809765|NCT00868790|459921471|FG001|Period 1|Lost to Follow-up|0|||
127809766|NCT00868790|459921472|FG002|Period 1|Lost to Follow-up|0|||
127809767|NCT00868790|459921473|FG003|Period 1|Lost to Follow-up|0|||
127809768|NCT00868790|459921474|FG004|Period 1|Lost to Follow-up|0|||
127809769|NCT00868790|459921475|FG005|Period 1|Lost to Follow-up|1|||
127809770|NCT00868790|459921476|FG006|Period 1|Lost to Follow-up|0|||
127809771|NCT00868790|459921477|FG007|Period 1|Lost to Follow-up|0|||
127809772|NCT00868790|459921478|FG008|Period 1|Lost to Follow-up|0|||
127809773|NCT00868790|459921479|FG009|Period 1|Lost to Follow-up|0|||
127809774|NCT00868790|459921480|FG010|Period 1|Lost to Follow-up|0|||
127809775|NCT00868790|459921481|FG011|Period 1|Lost to Follow-up|0|||
127809776|NCT00868790|459921482|FG012|Period 1|Lost to Follow-up|0|||
127809777|NCT00868790|459921483|FG013|Period 1|Lost to Follow-up|0|||
127809778|NCT00868790|459921470|FG000|Period 2|Adverse Event|0|||
127809779|NCT00868790|459921471|FG001|Period 2|Adverse Event|0|||
127809780|NCT00868790|459921472|FG002|Period 2|Adverse Event|0|||
127809781|NCT00868790|459921473|FG003|Period 2|Adverse Event|0|||
127809782|NCT00868790|459921474|FG004|Period 2|Adverse Event|0|||
127809783|NCT00868790|459921475|FG005|Period 2|Adverse Event|0|||
127809784|NCT00868790|459921476|FG006|Period 2|Adverse Event|0|||
127809785|NCT00868790|459921477|FG007|Period 2|Adverse Event|0|||
127809786|NCT00868790|459921478|FG008|Period 2|Adverse Event|1|||
127809787|NCT00868790|459921479|FG009|Period 2|Adverse Event|0|||
127809788|NCT00868790|459921480|FG010|Period 2|Adverse Event|0|||
127809789|NCT00868790|459921481|FG011|Period 2|Adverse Event|0|||
127809790|NCT00868790|459921482|FG012|Period 2|Adverse Event|0|||
127809791|NCT00868790|459921483|FG013|Period 2|Adverse Event|0|||
127809792|NCT00868790|459921470|FG000|Period 2|Lost to Follow-up|0|||
127809793|NCT00868790|459921471|FG001|Period 2|Lost to Follow-up|1|||
127809794|NCT00868790|459921472|FG002|Period 2|Lost to Follow-up|0|||
127809795|NCT00868790|459921473|FG003|Period 2|Lost to Follow-up|0|||
127809796|NCT00868790|459921474|FG004|Period 2|Lost to Follow-up|0|||
127809797|NCT00868790|459921475|FG005|Period 2|Lost to Follow-up|1|||
127809798|NCT00868790|459921476|FG006|Period 2|Lost to Follow-up|0|||
127809799|NCT00868790|459921477|FG007|Period 2|Lost to Follow-up|0|||
127809800|NCT00868790|459921478|FG008|Period 2|Lost to Follow-up|0|||
127809801|NCT00868790|459921479|FG009|Period 2|Lost to Follow-up|0|||
127809802|NCT00868790|459921480|FG010|Period 2|Lost to Follow-up|0|||
127809803|NCT00868790|459921481|FG011|Period 2|Lost to Follow-up|0|||
127809804|NCT00868790|459921482|FG012|Period 2|Lost to Follow-up|0|||
127809805|NCT00868790|459921483|FG013|Period 2|Lost to Follow-up|0|||
127809806|NCT00868790|459921470|FG000|Period 2|Withdrawal by Subject|0|||
127809807|NCT00868790|459921471|FG001|Period 2|Withdrawal by Subject|0|||
127809808|NCT00868790|459921472|FG002|Period 2|Withdrawal by Subject|0|||
127809809|NCT00868790|459921473|FG003|Period 2|Withdrawal by Subject|0|||
127809810|NCT00868790|459921474|FG004|Period 2|Withdrawal by Subject|0|||
127809811|NCT00868790|459921475|FG005|Period 2|Withdrawal by Subject|0|||
127809812|NCT00868790|459921476|FG006|Period 2|Withdrawal by Subject|0|||
127809813|NCT00868790|459921477|FG007|Period 2|Withdrawal by Subject|0|||
127809814|NCT00868790|459921478|FG008|Period 2|Withdrawal by Subject|1|||
127809815|NCT00868790|459921479|FG009|Period 2|Withdrawal by Subject|0|||
127809816|NCT00868790|459921480|FG010|Period 2|Withdrawal by Subject|0|||
127809817|NCT00868790|459921481|FG011|Period 2|Withdrawal by Subject|0|||
127809818|NCT00868790|459921482|FG012|Period 2|Withdrawal by Subject|0|||
127809819|NCT00868790|459921483|FG013|Period 2|Withdrawal by Subject|1|||
127809820|NCT00868790|459921470|FG000|Period 3|Adverse Event|0|||
127750756|NCT01270828|459714647|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
127809821|NCT00868790|459921471|FG001|Period 3|Adverse Event|0|||
127809822|NCT00868790|459921472|FG002|Period 3|Adverse Event|0|||
127809823|NCT00868790|459921473|FG003|Period 3|Adverse Event|0|||
127809824|NCT00868790|459921474|FG004|Period 3|Adverse Event|0|||
127809825|NCT00868790|459921475|FG005|Period 3|Adverse Event|0|||
127809826|NCT00868790|459921476|FG006|Period 3|Adverse Event|0|||
127809827|NCT00868790|459921477|FG007|Period 3|Adverse Event|0|||
127750757|NCT01270828|459714645|FG000|Pregabalin CR SB|Unrelated AE|0|||
127750758|NCT01270828|459714646|FG001|Pregabalin CR SB|Unrelated AE|0|||
127750759|NCT01270828|459714647|FG002|Pregabalin CR SB|Unrelated AE|8|||
127809828|NCT00868790|459921478|FG008|Period 3|Adverse Event|0|||
127809829|NCT00868790|459921479|FG009|Period 3|Adverse Event|1|||
127809830|NCT00868790|459921480|FG010|Period 3|Adverse Event|0|||
127809831|NCT00868790|459921481|FG011|Period 3|Adverse Event|0|||
127809832|NCT00868790|459921482|FG012|Period 3|Adverse Event|0|||
127809833|NCT00868790|459921483|FG013|Period 3|Adverse Event|0|||
127809834|NCT00868790|459921470|FG000|Period 3|Protocol Violation|0|||
127809835|NCT00868790|459921471|FG001|Period 3|Protocol Violation|0|||
127809836|NCT00868790|459921472|FG002|Period 3|Protocol Violation|0|||
127809837|NCT00868790|459921473|FG003|Period 3|Protocol Violation|0|||
127750760|NCT01270828|459714645|FG000|Pregabalin CR SB|Protocol Violation|0|||
127750761|NCT01270828|459714646|FG001|Pregabalin CR SB|Protocol Violation|0|||
127750762|NCT01270828|459714647|FG002|Pregabalin CR SB|Protocol Violation|8|||
127750763|NCT01270828|459714645|FG000|Double Blind Phase|Death|0|||
127750764|NCT01270828|459714646|FG001|Double Blind Phase|Death|1|||
127750765|NCT01270828|459714647|FG002|Double Blind Phase|Death|0|||
127750766|NCT01270828|459714645|FG000|Double Blind Phase|Protocol Violation|0|||
127750767|NCT01270828|459714646|FG001|Double Blind Phase|Protocol Violation|1|||
127750768|NCT01270828|459714647|FG002|Double Blind Phase|Protocol Violation|0|||
127750769|NCT01270828|459714645|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
127750770|NCT01270828|459714646|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
127750771|NCT01270828|459714647|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
127750772|NCT01270828|459714645|FG000|Double Blind Phase|Reason Unspecified|7|||
127750773|NCT01270828|459714646|FG001|Double Blind Phase|Reason Unspecified|4|||
127750774|NCT01270828|459714647|FG002|Double Blind Phase|Reason Unspecified|0|||
127750775|NCT01270828|459714645|FG000|Double Blind Phase|Withdrawal by Subject|6|||
127750776|NCT01270828|459714646|FG001|Double Blind Phase|Withdrawal by Subject|15|||
127750777|NCT01270828|459714647|FG002|Double Blind Phase|Withdrawal by Subject|0|||
127750778|NCT01270828|459714645|FG000|Double Blind Phase|Lost to Follow-up|1|||
127750779|NCT01270828|459714646|FG001|Double Blind Phase|Lost to Follow-up|2|||
127750780|NCT01270828|459714647|FG002|Double Blind Phase|Lost to Follow-up|0|||
127750781|NCT01270828|459714645|FG000|Double Blind Phase|Lack of Efficacy|2|||
127750782|NCT01270828|459714646|FG001|Double Blind Phase|Lack of Efficacy|11|||
127750783|NCT01270828|459714647|FG002|Double Blind Phase|Lack of Efficacy|0|||
127750784|NCT01270828|459714645|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
127750785|NCT01270828|459714646|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
127750786|NCT01270828|459714647|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
127750787|NCT01270828|459714645|FG000|Double Blind Phase|Adverse event related to study drug|5|||
127750788|NCT01270828|459714646|FG001|Double Blind Phase|Adverse event related to study drug|7|||
127750789|NCT01270828|459714647|FG002|Double Blind Phase|Adverse event related to study drug|0|||
127750790|NCT00709228|459714653|FG000|Overall Study|Not treated|14|||
127750791|NCT00709228|459714653|FG000|Overall Study|Eligibility criteria not met|281|||
127750792|NCT00709228|459714653|FG000|Overall Study|Adverse events|2|||
127750793|NCT00709228|459714653|FG000|Overall Study|Discontinued treatment|14|||
127750794|NCT00709228|459714653|FG000|Overall Study|Did not enter follow-up|4|||
127750795|NCT00709228|459714653|FG000|Overall Study|Discontinued follow-up|5|||
127750796|NCT00709228|459714653|FG000|Overall Study|Disease progression|1|||
127750797|NCT00709228|459714653|FG000|Overall Study|Lost to Follow-up|6|||
127750798|NCT00709228|459714653|FG000|Overall Study|Non-compliance|5|||
127750799|NCT02870972|459714656|FG000|Overall Study|Adverse Event|1|||
127750800|NCT02870972|459714657|FG001|Overall Study|Adverse Event|0|||
127750801|NCT02870972|459714658|FG002|Overall Study|Adverse Event|0|||
127750802|NCT02870972|459714659|FG003|Overall Study|Adverse Event|0|||
127750803|NCT02870972|459714660|FG004|Overall Study|Adverse Event|0|||
127750804|NCT02493062|459714664|FG000|Overall Study|Physician Decision|12|||
127750805|NCT01327612|459714666|FG000|Overall Study|Withdrawal by Subject|0|||
127750806|NCT01327612|459714667|FG001|Overall Study|Withdrawal by Subject|0|||
127750807|NCT01327612|459714668|FG002|Overall Study|Withdrawal by Subject|0|||
127750808|NCT01327612|459714669|FG003|Overall Study|Withdrawal by Subject|0|||
127750809|NCT01327612|459714670|FG004|Overall Study|Withdrawal by Subject|0|||
127750810|NCT01327612|459714671|FG005|Overall Study|Withdrawal by Subject|1|||
127750811|NCT01327612|459714672|FG006|Overall Study|Withdrawal by Subject|0|||
127750812|NCT01327612|459714666|FG000|Overall Study|Disease Progression|1|||
127750813|NCT01327612|459714667|FG001|Overall Study|Disease Progression|1|||
127750814|NCT01327612|459714668|FG002|Overall Study|Disease Progression|1|||
127809838|NCT00868790|459921474|FG004|Period 3|Protocol Violation|0|||
127809839|NCT00868790|459921475|FG005|Period 3|Protocol Violation|0|||
127809840|NCT00868790|459921476|FG006|Period 3|Protocol Violation|0|||
127809841|NCT00868790|459921477|FG007|Period 3|Protocol Violation|0|||
127809842|NCT00868790|459921478|FG008|Period 3|Protocol Violation|0|||
127809843|NCT00868790|459921479|FG009|Period 3|Protocol Violation|0|||
127809844|NCT00868790|459921480|FG010|Period 3|Protocol Violation|1|||
127750815|NCT01327612|459714669|FG003|Overall Study|Disease Progression|0|||
127750816|NCT01327612|459714670|FG004|Overall Study|Disease Progression|1|||
127750817|NCT01327612|459714671|FG005|Overall Study|Disease Progression|2|||
127750818|NCT01327612|459714672|FG006|Overall Study|Disease Progression|2|||
127750819|NCT01327612|459714666|FG000|Overall Study|Administrative Decision|0|||
127750820|NCT01327612|459714667|FG001|Overall Study|Administrative Decision|0|||
127750821|NCT01327612|459714668|FG002|Overall Study|Administrative Decision|0|||
127750822|NCT01327612|459714669|FG003|Overall Study|Administrative Decision|1|||
127809845|NCT00868790|459921481|FG011|Period 3|Protocol Violation|0|||
127750823|NCT01327612|459714670|FG004|Overall Study|Administrative Decision|0|||
127750824|NCT01327612|459714671|FG005|Overall Study|Administrative Decision|0|||
127750825|NCT01327612|459714672|FG006|Overall Study|Administrative Decision|0|||
127750826|NCT01327612|459714666|FG000|Overall Study|Death|0|||
127809846|NCT00868790|459921482|FG012|Period 3|Protocol Violation|0|||
127750827|NCT01327612|459714667|FG001|Overall Study|Death|0|||
127750828|NCT01327612|459714668|FG002|Overall Study|Death|0|||
127750829|NCT01327612|459714669|FG003|Overall Study|Death|0|||
127750830|NCT01327612|459714670|FG004|Overall Study|Death|1|||
127750831|NCT01327612|459714671|FG005|Overall Study|Death|0|||
127750832|NCT01327612|459714672|FG006|Overall Study|Death|0|||
127750833|NCT05569421|459714673|FG000|Overall Study|Withdrawal by Subject|1|||
127750834|NCT05569421|459714674|FG001|Overall Study|Withdrawal by Subject|0|||
127750835|NCT05569421|459714675|FG002|Overall Study|Withdrawal by Subject|0|||
127750836|NCT01689857|459714676|FG000|Overall Study|Lost to Follow-up|5|||
127750837|NCT01689857|459714677|FG001|Overall Study|Lost to Follow-up|2|||
127750838|NCT05105087|459714678|FG000|Overall Study|Withdrawal by Subject|2|||
127750839|NCT05105087|459714678|FG000|Overall Study|Ineligible for surgery due to advanced disease|2|||
127750840|NCT03738475|459714679|FG000|Overall Study|Participant Non-Compliance|1|||
127750841|NCT03738475|459714680|FG001|Overall Study|Participant Non-Compliance|0|||
127750842|NCT00737477|459714681|FG000|Overall Study|Adverse Event|9|||
127750843|NCT00737477|459714681|FG000|Overall Study|Death|9|||
127750844|NCT00737477|459714681|FG000|Overall Study|Treatment Refusal|1|||
127750845|NCT00737477|459714681|FG000|Overall Study|Withdrawal by Subject|1|||
127750846|NCT00737477|459714681|FG000|Overall Study|Renal Transplantation|10|||
127750847|NCT00737477|459714681|FG000|Overall Study|Other|4|||
127750848|NCT00581477|459714682|FG000|Overall Study|Physician Decision|2|||
127750849|NCT03106753|459714683|FG000|Overall Study|Withdrawal by Subject|0|||
127750850|NCT03106753|459714684|FG001|Overall Study|Withdrawal by Subject|1|||
127750851|NCT01853475|459714685|FG000|Overall Study|Withdrawal by Subject|0|||
127750852|NCT01853475|459714686|FG001|Overall Study|Withdrawal by Subject|1|||
127750853|NCT01853475|459714687|FG002|Overall Study|Withdrawal by Subject|0|||
127750854|NCT02803593|459714691|FG000|Overall Study|Lost to Follow-up|17|||
127750855|NCT02803593|459714692|FG001|Overall Study|Lost to Follow-up|35|||
127750856|NCT05143138|459714693|FG000|Overall Study|Death|5|||
127750857|NCT05143138|459714694|FG001|Overall Study|Death|35|||
127750858|NCT05143138|459714695|FG002|Overall Study|Death|1|||
127750859|NCT05143138|459714693|FG000|Overall Study|Lost to Follow-up|2|||
127750860|NCT05143138|459714694|FG001|Overall Study|Lost to Follow-up|4|||
127750861|NCT05143138|459714695|FG002|Overall Study|Lost to Follow-up|0|||
127750862|NCT05143138|459714693|FG000|Overall Study|withdrawal|1|||
127750863|NCT05143138|459714694|FG001|Overall Study|withdrawal|1|||
127750864|NCT05143138|459714695|FG002|Overall Study|withdrawal|0|||
127750865|NCT03443414|459714698|FG000|Overall Study|Adverse Event|6|||
127750866|NCT03443414|459714699|FG001|Overall Study|Adverse Event|0|||
127750867|NCT03443414|459714700|FG002|Overall Study|Adverse Event|4|||
127750868|NCT03443414|459714701|FG003|Overall Study|Adverse Event|2|||
127750869|NCT03443414|459714702|FG004|Overall Study|Adverse Event|3|||
127750870|NCT03443414|459714698|FG000|Overall Study|Withdrawal by Subject|3|||
127750871|NCT03443414|459714699|FG001|Overall Study|Withdrawal by Subject|2|||
127809847|NCT00868790|459921483|FG013|Period 3|Protocol Violation|0|||
127809848|NCT00868790|459921470|FG000|Period 3|Study Terminated by Sponsor|0|||
127809849|NCT00868790|459921471|FG001|Period 3|Study Terminated by Sponsor|0|||
127809850|NCT00868790|459921472|FG002|Period 3|Study Terminated by Sponsor|0|||
127809851|NCT00868790|459921473|FG003|Period 3|Study Terminated by Sponsor|1|||
127809852|NCT00868790|459921474|FG004|Period 3|Study Terminated by Sponsor|0|||
127750872|NCT03443414|459714700|FG002|Overall Study|Withdrawal by Subject|2|||
127750873|NCT03443414|459714701|FG003|Overall Study|Withdrawal by Subject|2|||
127750874|NCT03443414|459714702|FG004|Overall Study|Withdrawal by Subject|1|||
127750875|NCT03443414|459714698|FG000|Overall Study|Death|0|||
127750876|NCT03443414|459714699|FG001|Overall Study|Death|1|||
127750877|NCT03443414|459714700|FG002|Overall Study|Death|0|||
127750878|NCT03443414|459714701|FG003|Overall Study|Death|1|||
127809853|NCT00868790|459921475|FG005|Period 3|Study Terminated by Sponsor|0|||
127809854|NCT00868790|459921476|FG006|Period 3|Study Terminated by Sponsor|0|||
127809855|NCT00868790|459921477|FG007|Period 3|Study Terminated by Sponsor|0|||
127894177|NCT00384033|460235267|FG001|Overall Study|Adverse Event|8|||
127894178|NCT00384033|460235268|FG002|Overall Study|Adverse Event|11|||
127894179|NCT00384033|460235269|FG003|Overall Study|Adverse Event|20|||
127750879|NCT03443414|459714702|FG004|Overall Study|Death|0|||
127750880|NCT03443414|459714698|FG000|Overall Study|Reason not specified|2|||
127750881|NCT03443414|459714699|FG001|Overall Study|Reason not specified|0|||
127750882|NCT03443414|459714700|FG002|Overall Study|Reason not specified|0|||
127750883|NCT03443414|459714701|FG003|Overall Study|Reason not specified|0|||
127750884|NCT03443414|459714702|FG004|Overall Study|Reason not specified|1|||
127750885|NCT00732992|459714703|FG000|Overall Study|Adverse Event|1|||
127809856|NCT00868790|459921478|FG008|Period 3|Study Terminated by Sponsor|0|||
127894180|NCT00384033|460235266|FG000|Overall Study|Failed to return|1|||
127750886|NCT00732992|459714704|FG001|Overall Study|Adverse Event|1|||
127750887|NCT00732992|459714703|FG000|Overall Study|Objective Progression or Relapse|3|||
127750888|NCT00732992|459714704|FG001|Overall Study|Objective Progression or Relapse|5|||
127750889|NCT00732992|459714703|FG000|Overall Study|Global Deterioration of Health Status|1|||
127750890|NCT00732992|459714704|FG001|Overall Study|Global Deterioration of Health Status|0|||
127894181|NCT00384033|460235267|FG001|Overall Study|Failed to return|3|||
127894182|NCT00384033|460235268|FG002|Overall Study|Failed to return|2|||
127894183|NCT00384033|460235269|FG003|Overall Study|Failed to return|2|||
127894184|NCT00384033|460235266|FG000|Overall Study|Physician Decision|1|||
127894185|NCT00384033|460235267|FG001|Overall Study|Physician Decision|0|||
127894186|NCT00384033|460235268|FG002|Overall Study|Physician Decision|0|||
127894187|NCT00384033|460235269|FG003|Overall Study|Physician Decision|0|||
127894188|NCT00384033|460235266|FG000|Overall Study|Lost to Follow-up|6|||
127894189|NCT00384033|460235267|FG001|Overall Study|Lost to Follow-up|12|||
127894190|NCT00384033|460235268|FG002|Overall Study|Lost to Follow-up|7|||
127750891|NCT00732992|459714703|FG000|Overall Study|Withdrawal by Subject|1|||
127750892|NCT00732992|459714704|FG001|Overall Study|Withdrawal by Subject|0|||
127750893|NCT03004404|459714707|FG000|Period 2|Adverse Event|0|||
127750894|NCT03004404|459714708|FG001|Period 2|Adverse Event|0|||
127750895|NCT03004404|459714709|FG002|Period 2|Adverse Event|0|||
127750896|NCT03004404|459714710|FG003|Period 2|Adverse Event|0|||
127750897|NCT03004404|459714711|FG004|Period 2|Adverse Event|0|||
127750898|NCT03004404|459714712|FG005|Period 2|Adverse Event|0|||
127750899|NCT03004404|459714713|FG006|Period 2|Adverse Event|0|||
127750900|NCT03004404|459714714|FG007|Period 2|Adverse Event|0|||
127750901|NCT03004404|459714715|FG008|Period 2|Adverse Event|1|||
127750902|NCT03004404|459714716|FG009|Period 2|Adverse Event|0|||
127750903|NCT03004404|459714717|FG010|Period 2|Adverse Event|0|||
127750904|NCT03004404|459714718|FG011|Period 2|Adverse Event|0|||
127750905|NCT03004404|459714719|FG012|Period 2|Adverse Event|0|||
127750906|NCT03004404|459714720|FG013|Period 2|Adverse Event|0|||
127750907|NCT03004404|459714721|FG014|Period 2|Adverse Event|0|||
127750908|NCT03004404|459714722|FG015|Period 2|Adverse Event|1|||
127750909|NCT03933462|459714723|FG000|Overall Study|Adverse Event|2|||
127750910|NCT03933462|459714724|FG001|Overall Study|Adverse Event|0|||
127750911|NCT02522728|459714729|FG000|Overall Study|Withdrawal by Subject|6|||
127750912|NCT02522728|459714730|FG001|Overall Study|Withdrawal by Subject|6|||
127750913|NCT02522728|459714729|FG000|Overall Study|Death|4|||
127750914|NCT02522728|459714730|FG001|Overall Study|Death|3|||
127750915|NCT02522728|459714729|FG000|Overall Study|Adverse Event|2|||
127750916|NCT02522728|459714730|FG001|Overall Study|Adverse Event|1|||
127750917|NCT02522728|459714729|FG000|Overall Study|Did not receive randomized study device|0|||
127750918|NCT02522728|459714730|FG001|Overall Study|Did not receive randomized study device|1|||
127750919|NCT01099917|459714731|FG000|Overall Study|Adverse Event|3|||
127750920|NCT01099917|459714731|FG000|Overall Study|Not Treated|24|||
127750921|NCT00422734|459714743|FG000|Overall Study|Physician Decision|1|||
127750922|NCT00422734|459714744|FG001|Overall Study|Physician Decision|1|||
127750923|NCT00422734|459714743|FG000|Overall Study|Protocol Violation|1|||
127750924|NCT00422734|459714744|FG001|Overall Study|Protocol Violation|6|||
127750925|NCT00422734|459714743|FG000|Overall Study|Withdrawal by Subject|12|||
127750926|NCT00422734|459714744|FG001|Overall Study|Withdrawal by Subject|8|||
127750927|NCT00422734|459714743|FG000|Overall Study|Adverse Event|0|||
127750928|NCT00422734|459714744|FG001|Overall Study|Adverse Event|3|||
127750929|NCT00422734|459714743|FG000|Overall Study|Partner Decision|0|||
127750930|NCT00422734|459714744|FG001|Overall Study|Partner Decision|3|||
127750931|NCT00368875|459714748|FG000|Overall Study|Adverse Event|0|||
127750932|NCT00368875|459714749|FG001|Overall Study|Adverse Event|12|||
127750933|NCT00368875|459714748|FG000|Overall Study|Progressive disease|3|||
127750934|NCT00368875|459714749|FG001|Overall Study|Progressive disease|27|||
127750935|NCT00368875|459714748|FG000|Overall Study|Withdrawal by Subject|2|||
127750936|NCT00368875|459714749|FG001|Overall Study|Withdrawal by Subject|6|||
127750937|NCT00368875|459714748|FG000|Overall Study|Other Reason|0|||
127750938|NCT00368875|459714749|FG001|Overall Study|Other Reason|2|||
127750939|NCT00368875|459714748|FG000|Overall Study|Alternative Therapy|1|||
127750940|NCT00368875|459714749|FG001|Overall Study|Alternative Therapy|1|||
127750941|NCT01305239|459714750|FG000|Overall Study|Adverse Event|22|||
127750942|NCT01305239|459714750|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
127750943|NCT03229486|459714751|FG000|Overall Study|Protocol Violation|0|||
127750944|NCT03229486|459714752|FG001|Overall Study|Protocol Violation|1|||
127750945|NCT01461005|459714756|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
127750946|NCT04160988|459714759|FG000|Overall Study|poor image quality|28|||
127750947|NCT02670122|459714760|FG000|Overall Study|Lost to Follow-up|4|||
127750948|NCT00243074|459714763|FG000|Overall Study|Ineligible|6|||
127750949|NCT00243074|459714763|FG000|Overall Study|Adverse Event|6|||
127894191|NCT00384033|460235269|FG003|Overall Study|Lost to Follow-up|7|||
127750950|NCT00243074|459714763|FG000|Overall Study|Withdrawal by Subject|2|||
127750951|NCT00243074|459714763|FG000|Overall Study|Lack of Efficacy|36|||
127750952|NCT00243074|459714763|FG000|Overall Study|Death|2|||
127750953|NCT00243074|459714763|FG000|Overall Study|not protocol specified|1|||
127750954|NCT00243074|459714763|FG000|Overall Study|Did not receive any treatment|1|||
127750955|NCT00664534|459714764|FG000|Overall Study|Adverse Event|2|||
127894192|NCT00384033|460235266|FG000|Overall Study|Other|2|||
127750956|NCT00664534|459714765|FG001|Overall Study|Adverse Event|3|||
127750957|NCT00664534|459714764|FG000|Overall Study|Lost to Follow-up|6|||
127750958|NCT00664534|459714765|FG001|Overall Study|Lost to Follow-up|10|||
127894193|NCT00384033|460235267|FG001|Overall Study|Other|0|||
127894194|NCT00384033|460235268|FG002|Overall Study|Other|0|||
127750959|NCT00664534|459714764|FG000|Overall Study|Protocol Violation|10|||
127750960|NCT00664534|459714765|FG001|Overall Study|Protocol Violation|8|||
127750961|NCT00664534|459714764|FG000|Overall Study|Withdrawal by Subject|7|||
127750962|NCT00664534|459714765|FG001|Overall Study|Withdrawal by Subject|6|||
127750963|NCT00664534|459714764|FG000|Overall Study|Physician Decision|8|||
127750964|NCT00664534|459714765|FG001|Overall Study|Physician Decision|0|||
127750965|NCT00664534|459714764|FG000|Overall Study|Sponsor decision|8|||
127750966|NCT00664534|459714765|FG001|Overall Study|Sponsor decision|6|||
127750967|NCT03041792|459714766|FG000|Overall Study|Adverse Event|4|||
127750968|NCT03041792|459714767|FG001|Overall Study|Adverse Event|0|||
127750969|NCT03041792|459714766|FG000|Overall Study|Death in the family|0|||
127750970|NCT03041792|459714767|FG001|Overall Study|Death in the family|2|||
127750971|NCT03041792|459714766|FG000|Overall Study|Randomized but not treated|0|||
127750972|NCT03041792|459714767|FG001|Overall Study|Randomized but not treated|1|||
127750973|NCT04978090|459714770|FG000|Overall Study|unable to adequately fit device|2|||
127750974|NCT00996606|459714773|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
127750975|NCT00996606|459714773|FG000|Overall Study|Insufficient Therapeutic Response|2|||
127750976|NCT00996606|459714773|FG000|Overall Study|Protocol Violation|1|||
127750977|NCT00996606|459714773|FG000|Overall Study|Withdrawal by Subject|3|||
127750978|NCT00632502|459714775|FG000|Overall Study|Adverse Event|0|||
127750979|NCT00632502|459714776|FG001|Overall Study|Adverse Event|1|||
127750980|NCT00632502|459714775|FG000|Overall Study|Randomized not treated|3|||
127750981|NCT00632502|459714776|FG001|Overall Study|Randomized not treated|0|||
127750982|NCT03075527|459714777|FG000|Overall Study|Death|1|||
127750983|NCT03075527|459714777|FG000|Overall Study|Withdrawal by Subject|1|||
127750984|NCT03075527|459714777|FG000|Overall Study|Physician Decision|3|||
127750985|NCT03075527|459714777|FG000|Overall Study|Progression/Relapse|14|||
127750986|NCT00681668|459714778|FG000|Overall Study|Protocol Violation|1|||
127750987|NCT00681668|459714778|FG000|Overall Study|Withdrawal by Subject|1|||
127750988|NCT02209181|459714779|FG000|Overall Study|Adverse Event|1|||
127750989|NCT02209181|459714780|FG001|Overall Study|Adverse Event|0|||
127750990|NCT02209181|459714781|FG002|Overall Study|Adverse Event|1|||
127750991|NCT02209181|459714782|FG003|Overall Study|Adverse Event|0|||
127750992|NCT02209181|459714779|FG000|Overall Study|Withdrawal by Subject|0|||
127750993|NCT02209181|459714780|FG001|Overall Study|Withdrawal by Subject|1|||
127750994|NCT02209181|459714781|FG002|Overall Study|Withdrawal by Subject|0|||
127750995|NCT02209181|459714782|FG003|Overall Study|Withdrawal by Subject|0|||
127750996|NCT04641962|459714788|FG000|DBT Period: Up to 52 Weeks|Miscellaneous|5|||
127750997|NCT04641962|459714789|FG001|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
127750998|NCT04641962|459714790|FG002|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
127750999|NCT04641962|459714791|FG003|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
127751000|NCT04641962|459714792|FG004|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
127751001|NCT04641962|459714788|FG000|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
127751002|NCT04641962|459714789|FG001|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
127751003|NCT04641962|459714790|FG002|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
127751004|NCT04641962|459714791|FG003|DBT Period: Up to 52 Weeks|Withdrawal by Subject|1|||
127751005|NCT04641962|459714792|FG004|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
127751006|NCT04641962|459714788|FG000|DBT Period: Up to 52 Weeks|Protocol deviation|1|||
127809857|NCT00868790|459921479|FG009|Period 3|Study Terminated by Sponsor|0|||
127809858|NCT00868790|459921480|FG010|Period 3|Study Terminated by Sponsor|0|||
127809859|NCT00868790|459921481|FG011|Period 3|Study Terminated by Sponsor|0|||
127809860|NCT00868790|459921482|FG012|Period 3|Study Terminated by Sponsor|0|||
127809861|NCT00868790|459921483|FG013|Period 3|Study Terminated by Sponsor|0|||
127809862|NCT00868790|459921470|FG000|Period 4|Adverse Event|0|||
127809863|NCT00868790|459921471|FG001|Period 4|Adverse Event|0|||
127809864|NCT00868790|459921472|FG002|Period 4|Adverse Event|0|||
127809865|NCT00868790|459921473|FG003|Period 4|Adverse Event|0|||
127809866|NCT00868790|459921474|FG004|Period 4|Adverse Event|0|||
127751007|NCT04641962|459714789|FG001|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
127751008|NCT04641962|459714790|FG002|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
127751009|NCT04641962|459714791|FG003|DBT Period: Up to 52 Weeks|Protocol deviation|2|||
127809867|NCT00868790|459921475|FG005|Period 4|Adverse Event|0|||
127809868|NCT00868790|459921476|FG006|Period 4|Adverse Event|0|||
127809869|NCT00868790|459921477|FG007|Period 4|Adverse Event|1|||
127751010|NCT04641962|459714792|FG004|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
127751011|NCT04641962|459714788|FG000|DBT Period: Up to 52 Weeks|Death|1|||
127751012|NCT04641962|459714789|FG001|DBT Period: Up to 52 Weeks|Death|0|||
127751013|NCT04641962|459714790|FG002|DBT Period: Up to 52 Weeks|Death|0|||
127751014|NCT04641962|459714791|FG003|DBT Period: Up to 52 Weeks|Death|0|||
127751015|NCT04641962|459714792|FG004|DBT Period: Up to 52 Weeks|Death|0|||
127809870|NCT00868790|459921478|FG008|Period 4|Adverse Event|0|||
127809871|NCT00868790|459921479|FG009|Period 4|Adverse Event|0|||
127809872|NCT00868790|459921480|FG010|Period 4|Adverse Event|1|||
127809873|NCT00868790|459921481|FG011|Period 4|Adverse Event|0|||
127751016|NCT04641962|459714788|FG000|DBT Period: Up to 52 Weeks|Adverse Event|0|||
127751017|NCT04641962|459714789|FG001|DBT Period: Up to 52 Weeks|Adverse Event|3|||
127751018|NCT04641962|459714790|FG002|DBT Period: Up to 52 Weeks|Adverse Event|0|||
127751019|NCT04641962|459714791|FG003|DBT Period: Up to 52 Weeks|Adverse Event|2|||
127751020|NCT04641962|459714792|FG004|DBT Period: Up to 52 Weeks|Adverse Event|0|||
127751021|NCT04641962|459714788|FG000|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
127751022|NCT04641962|459714789|FG001|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
127751023|NCT04641962|459714790|FG002|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|4|||
127751024|NCT04641962|459714791|FG003|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
127751025|NCT04641962|459714792|FG004|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|1|||
127751026|NCT04641962|459714788|FG000|OLE Treatment Period: Up to 76 Weeks|Death|0|||
127751027|NCT04641962|459714789|FG001|OLE Treatment Period: Up to 76 Weeks|Death|0|||
127751028|NCT04641962|459714790|FG002|OLE Treatment Period: Up to 76 Weeks|Death|1|||
127751029|NCT04641962|459714791|FG003|OLE Treatment Period: Up to 76 Weeks|Death|0|||
127751030|NCT04641962|459714792|FG004|OLE Treatment Period: Up to 76 Weeks|Death|0|||
127751031|NCT06926673|459714793|FG000|Overall Study|Lost to Follow-up|0|||
127751032|NCT06926673|459714794|FG001|Overall Study|Lost to Follow-up|0|||
127751033|NCT06926673|459714795|FG002|Overall Study|Lost to Follow-up|0|||
127751034|NCT06926673|459714796|FG003|Overall Study|Lost to Follow-up|1|||
127751035|NCT06926673|459714797|FG004|Overall Study|Lost to Follow-up|0|||
127751036|NCT06926673|459714798|FG005|Overall Study|Lost to Follow-up|0|||
127751037|NCT06926673|459714799|FG006|Overall Study|Lost to Follow-up|0|||
127751038|NCT06926673|459714793|FG000|Overall Study|Physician Decision|0|||
127751039|NCT06926673|459714794|FG001|Overall Study|Physician Decision|0|||
127751040|NCT06926673|459714795|FG002|Overall Study|Physician Decision|0|||
127751041|NCT06926673|459714796|FG003|Overall Study|Physician Decision|0|||
127751042|NCT06926673|459714797|FG004|Overall Study|Physician Decision|0|||
127751043|NCT06926673|459714798|FG005|Overall Study|Physician Decision|0|||
127751044|NCT06926673|459714799|FG006|Overall Study|Physician Decision|1|||
127751045|NCT06926673|459714793|FG000|Overall Study|Withdrawal by Subject|0|||
127751046|NCT06926673|459714794|FG001|Overall Study|Withdrawal by Subject|3|||
127751047|NCT06926673|459714795|FG002|Overall Study|Withdrawal by Subject|2|||
127809874|NCT00868790|459921482|FG012|Period 4|Adverse Event|1|||
127809875|NCT00868790|459921483|FG013|Period 4|Adverse Event|0|||
127809876|NCT00868790|459921470|FG000|Period 4|Lost to Follow-up|0|||
127809877|NCT00868790|459921471|FG001|Period 4|Lost to Follow-up|0|||
127809878|NCT00868790|459921472|FG002|Period 4|Lost to Follow-up|0|||
127809879|NCT00868790|459921473|FG003|Period 4|Lost to Follow-up|0|||
127809880|NCT00868790|459921474|FG004|Period 4|Lost to Follow-up|0|||
127809881|NCT00868790|459921475|FG005|Period 4|Lost to Follow-up|0|||
127809882|NCT00868790|459921476|FG006|Period 4|Lost to Follow-up|0|||
127809883|NCT00868790|459921477|FG007|Period 4|Lost to Follow-up|1|||
127809884|NCT00868790|459921478|FG008|Period 4|Lost to Follow-up|0|||
127809885|NCT00868790|459921479|FG009|Period 4|Lost to Follow-up|0|||
127809886|NCT00868790|459921480|FG010|Period 4|Lost to Follow-up|0|||
127809887|NCT00868790|459921481|FG011|Period 4|Lost to Follow-up|0|||
127809888|NCT00868790|459921482|FG012|Period 4|Lost to Follow-up|0|||
127809889|NCT00868790|459921483|FG013|Period 4|Lost to Follow-up|0|||
127809890|NCT00868790|459921470|FG000|Period 4|Study Terminated by Sponsor|2|||
127809891|NCT00868790|459921471|FG001|Period 4|Study Terminated by Sponsor|0|||
127809892|NCT00868790|459921472|FG002|Period 4|Study Terminated by Sponsor|0|||
127809893|NCT00868790|459921473|FG003|Period 4|Study Terminated by Sponsor|0|||
127809894|NCT00868790|459921474|FG004|Period 4|Study Terminated by Sponsor|0|||
127751048|NCT06926673|459714796|FG003|Overall Study|Withdrawal by Subject|1|||
127751049|NCT06926673|459714797|FG004|Overall Study|Withdrawal by Subject|0|||
127751050|NCT06926673|459714798|FG005|Overall Study|Withdrawal by Subject|2|||
127751051|NCT06926673|459714799|FG006|Overall Study|Withdrawal by Subject|0|||
127751052|NCT01920477|459716502|FG000|Overall Study|Adverse Event|0|||
127751053|NCT01920477|459716503|FG001|Overall Study|Adverse Event|1|||
127751054|NCT01920477|459716502|FG000|Overall Study|Lack of Efficacy|1|||
127751055|NCT01920477|459716503|FG001|Overall Study|Lack of Efficacy|0|||
127751056|NCT01920477|459716502|FG000|Overall Study|Study closed/terminated|14|||
127751057|NCT01920477|459716503|FG001|Overall Study|Study closed/terminated|15|||
127751058|NCT01920477|459716502|FG000|Overall Study|Withdrawal by Subject|0|||
127751059|NCT01920477|459716503|FG001|Overall Study|Withdrawal by Subject|1|||
127751060|NCT01681277|459716504|FG000|Overall Study|Adverse Event|1|||
127751061|NCT01681277|459716505|FG001|Overall Study|Adverse Event|0|||
127751062|NCT01681277|459716506|FG002|Overall Study|Adverse Event|0|||
127751063|NCT01681277|459716507|FG003|Overall Study|Adverse Event|0|||
127751064|NCT01681277|459716508|FG004|Overall Study|Adverse Event|0|||
127751065|NCT02113124|459716509|FG000|Overall Study|Unable to retrieve blood sample|1|||
127751066|NCT02113124|459716510|FG001|Overall Study|Unable to retrieve blood sample|1|||
127751067|NCT02271984|459716516|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
127751068|NCT02271984|459716517|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
127751069|NCT02271984|459716518|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
127751070|NCT02271984|459716519|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
127751071|NCT02271984|459716520|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
127751072|NCT02271984|459716521|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
127751073|NCT02271984|459716522|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
127751074|NCT02271984|459716523|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
127751075|NCT02271984|459716524|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
127751076|NCT02271984|459716525|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
127751077|NCT02271984|459716526|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
127751078|NCT02271984|459716527|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
127751079|NCT04624243|459716528|FG000|Overall Study|Death|0|||
127751080|NCT04624243|459716529|FG001|Overall Study|Death|1|||
127751081|NCT04624243|459716530|FG002|Overall Study|Death|0|||
127751082|NCT04624243|459716531|FG003|Overall Study|Death|0|||
127751083|NCT04624243|459716532|FG004|Overall Study|Death|0|||
127751084|NCT04624243|459716528|FG000|Overall Study|Lost to Follow-up|2|||
127751085|NCT04624243|459716529|FG001|Overall Study|Lost to Follow-up|3|||
127751086|NCT04624243|459716530|FG002|Overall Study|Lost to Follow-up|7|||
127751087|NCT04624243|459716531|FG003|Overall Study|Lost to Follow-up|1|||
127751088|NCT04624243|459716532|FG004|Overall Study|Lost to Follow-up|3|||
127751089|NCT04624243|459716528|FG000|Overall Study|Physician Decision|3|||
127751090|NCT04624243|459716529|FG001|Overall Study|Physician Decision|8|||
127751091|NCT04624243|459716530|FG002|Overall Study|Physician Decision|15|||
127751092|NCT04624243|459716531|FG003|Overall Study|Physician Decision|2|||
127751093|NCT04624243|459716532|FG004|Overall Study|Physician Decision|11|||
127751094|NCT04624243|459716528|FG000|Overall Study|Withdrawal by Subject|19|||
127751095|NCT04624243|459716529|FG001|Overall Study|Withdrawal by Subject|44|||
127751096|NCT04624243|459716530|FG002|Overall Study|Withdrawal by Subject|40|||
127751097|NCT04624243|459716531|FG003|Overall Study|Withdrawal by Subject|21|||
127751098|NCT04624243|459716532|FG004|Overall Study|Withdrawal by Subject|39|||
127751099|NCT04624243|459716528|FG000|Overall Study|Miscellaneous|3|||
127751100|NCT04624243|459716529|FG001|Overall Study|Miscellaneous|12|||
127751101|NCT04624243|459716530|FG002|Overall Study|Miscellaneous|9|||
127751102|NCT04624243|459716531|FG003|Overall Study|Miscellaneous|4|||
127751103|NCT04624243|459716532|FG004|Overall Study|Miscellaneous|6|||
127751104|NCT03374488|459716533|FG000|Overall Study|Death|13|||
127751105|NCT03374488|459716534|FG001|Overall Study|Death|13|||
127751106|NCT03374488|459716533|FG000|Overall Study|Withdrawal by Subject|3|||
127751107|NCT03374488|459716534|FG001|Overall Study|Withdrawal by Subject|1|||
127751108|NCT03374488|459716533|FG000|Overall Study|Physician Decision|3|||
127751109|NCT03374488|459716534|FG001|Overall Study|Physician Decision|0|||
127751110|NCT03104075|459716535|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
127751111|NCT03104075|459716536|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
127751112|NCT04024462|459716537|FG000|Overall Study|Withdrawal by Subject|6|||
127751113|NCT04024462|459716538|FG001|Overall Study|Withdrawal by Subject|7|||
127751114|NCT04024462|459716537|FG000|Overall Study|Progressive Disease|0|||
127751115|NCT04024462|459716538|FG001|Overall Study|Progressive Disease|1|||
127751116|NCT04024462|459716537|FG000|Overall Study|Adverse Event|0|||
127751117|NCT04024462|459716538|FG001|Overall Study|Adverse Event|1|||
127751118|NCT04024462|459716537|FG000|Overall Study|Death|0|||
127751119|NCT04024462|459716538|FG001|Overall Study|Death|1|||
127751120|NCT04024462|459716537|FG000|Overall Study|Lost to Follow-up|1|||
127751121|NCT04024462|459716538|FG001|Overall Study|Lost to Follow-up|0|||
127751122|NCT04024462|459716537|FG000|Overall Study|Ongoing in the Study|94|||
127751123|NCT04024462|459716538|FG001|Overall Study|Ongoing in the Study|89|||
127751124|NCT00789360|459716547|FG000|Overall Study|Protocol Violation|3|||
127751125|NCT00789360|459716548|FG001|Overall Study|Protocol Violation|1|||
127751126|NCT04400487|459716549|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
127751127|NCT04400487|459716549|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
127751128|NCT04400487|459716549|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
127751129|NCT00022659|459716550|FG000|Overall Study|Ineligible: wrong primary|1|||
127751130|NCT00022659|459716550|FG000|Overall Study|Never treated|1|||
127751131|NCT03559062|459716551|FG000|Overall Study|Other|0|||
127751132|NCT03559062|459716552|FG001|Overall Study|Other|1|||
127751133|NCT03559062|459716553|FG002|Overall Study|Other|0|||
127751134|NCT03445533|459716554|FG000|Overall Study|Progressive Disease|48|||
127751135|NCT03445533|459716555|FG001|Overall Study|Progressive Disease|81|||
127751136|NCT03445533|459716554|FG000|Overall Study|Adverse Event|60|||
127751137|NCT03445533|459716555|FG001|Overall Study|Adverse Event|64|||
127751138|NCT03445533|459716554|FG000|Overall Study|Death|9|||
127809895|NCT00868790|459921475|FG005|Period 4|Study Terminated by Sponsor|0|||
127809896|NCT00868790|459921476|FG006|Period 4|Study Terminated by Sponsor|0|||
127809897|NCT00868790|459921477|FG007|Period 4|Study Terminated by Sponsor|1|||
127809898|NCT00868790|459921478|FG008|Period 4|Study Terminated by Sponsor|2|||
127809899|NCT00868790|459921479|FG009|Period 4|Study Terminated by Sponsor|0|||
127809900|NCT00868790|459921480|FG010|Period 4|Study Terminated by Sponsor|2|||
127809901|NCT00868790|459921481|FG011|Period 4|Study Terminated by Sponsor|1|||
127809902|NCT00868790|459921482|FG012|Period 4|Study Terminated by Sponsor|0|||
127809903|NCT00868790|459921483|FG013|Period 4|Study Terminated by Sponsor|1|||
127809904|NCT00868790|459921470|FG000|Period 4|Abnormal ALT/AST|0|||
127809905|NCT00868790|459921471|FG001|Period 4|Abnormal ALT/AST|0|||
127809906|NCT00868790|459921472|FG002|Period 4|Abnormal ALT/AST|1|||
127809907|NCT00868790|459921473|FG003|Period 4|Abnormal ALT/AST|0|||
127809908|NCT00868790|459921474|FG004|Period 4|Abnormal ALT/AST|0|||
127809909|NCT00868790|459921475|FG005|Period 4|Abnormal ALT/AST|0|||
127809910|NCT00868790|459921476|FG006|Period 4|Abnormal ALT/AST|0|||
127809911|NCT00868790|459921477|FG007|Period 4|Abnormal ALT/AST|0|||
127809912|NCT00868790|459921478|FG008|Period 4|Abnormal ALT/AST|0|||
127809913|NCT00868790|459921479|FG009|Period 4|Abnormal ALT/AST|0|||
127809914|NCT00868790|459921480|FG010|Period 4|Abnormal ALT/AST|0|||
127809915|NCT00868790|459921481|FG011|Period 4|Abnormal ALT/AST|0|||
127809916|NCT00868790|459921482|FG012|Period 4|Abnormal ALT/AST|0|||
127809917|NCT00868790|459921483|FG013|Period 4|Abnormal ALT/AST|0|||
127809918|NCT00868790|459921470|FG000|Post-study|Withdrawal by Subject|0|||
127809919|NCT00868790|459921471|FG001|Post-study|Withdrawal by Subject|0|||
127809920|NCT00868790|459921472|FG002|Post-study|Withdrawal by Subject|0|||
127809921|NCT00868790|459921473|FG003|Post-study|Withdrawal by Subject|0|||
127809922|NCT00868790|459921474|FG004|Post-study|Withdrawal by Subject|1|||
127809923|NCT00868790|459921475|FG005|Post-study|Withdrawal by Subject|0|||
127809924|NCT00868790|459921476|FG006|Post-study|Withdrawal by Subject|0|||
127809925|NCT00868790|459921477|FG007|Post-study|Withdrawal by Subject|0|||
127809926|NCT00868790|459921478|FG008|Post-study|Withdrawal by Subject|0|||
127809927|NCT00868790|459921479|FG009|Post-study|Withdrawal by Subject|0|||
127809928|NCT00868790|459921480|FG010|Post-study|Withdrawal by Subject|0|||
127809929|NCT00868790|459921481|FG011|Post-study|Withdrawal by Subject|0|||
127809930|NCT00868790|459921482|FG012|Post-study|Withdrawal by Subject|0|||
127809931|NCT00868790|459921483|FG013|Post-study|Withdrawal by Subject|0|||
127809932|NCT00868790|459921470|FG000|Post-study|Excluded Medication|0|||
127809933|NCT00868790|459921471|FG001|Post-study|Excluded Medication|0|||
127809934|NCT00868790|459921472|FG002|Post-study|Excluded Medication|0|||
127809935|NCT00868790|459921473|FG003|Post-study|Excluded Medication|0|||
127809936|NCT00868790|459921474|FG004|Post-study|Excluded Medication|0|||
127809937|NCT00868790|459921475|FG005|Post-study|Excluded Medication|0|||
127809938|NCT00868790|459921476|FG006|Post-study|Excluded Medication|0|||
127751139|NCT03445533|459716555|FG001|Overall Study|Death|19|||
127751140|NCT03445533|459716554|FG000|Overall Study|Miscellaneous|0|||
127809939|NCT00868790|459921477|FG007|Post-study|Excluded Medication|2|||
127809940|NCT00868790|459921478|FG008|Post-study|Excluded Medication|0|||
127809941|NCT00868790|459921479|FG009|Post-study|Excluded Medication|1|||
127809942|NCT00868790|459921480|FG010|Post-study|Excluded Medication|0|||
127809943|NCT00868790|459921481|FG011|Post-study|Excluded Medication|0|||
127809944|NCT00868790|459921482|FG012|Post-study|Excluded Medication|0|||
127809945|NCT00868790|459921483|FG013|Post-study|Excluded Medication|0|||
127751141|NCT03445533|459716555|FG001|Overall Study|Miscellaneous|16|||
127751142|NCT03445533|459716554|FG000|Overall Study|Withdrawal by Subject|3|||
127809946|NCT03377634|459921487|FG000|Study Period|Adverse Event|1|||
127809947|NCT03377634|459921488|FG001|Study Period|Adverse Event|0|||
127809948|NCT03377634|459921487|FG000|Study Period|Withdrawal by Subject|1|||
127809949|NCT03377634|459921488|FG001|Study Period|Withdrawal by Subject|0|||
127751143|NCT03445533|459716555|FG001|Overall Study|Withdrawal by Subject|4|||
127751144|NCT03445533|459716554|FG000|Overall Study|Physician Decision|1|||
127809950|NCT03040024|459921490|FG000|Overall Study|Adverse Event|0|||
127809951|NCT03040024|459921491|FG001|Overall Study|Adverse Event|1|||
127751145|NCT03445533|459716555|FG001|Overall Study|Physician Decision|3|||
127751146|NCT03445533|459716554|FG000|Overall Study|Sponsor Decision|0|||
127751147|NCT03445533|459716555|FG001|Overall Study|Sponsor Decision|1|||
127751148|NCT03445533|459716554|FG000|Overall Study|Lost to Follow-up|0|||
127751149|NCT03445533|459716555|FG001|Overall Study|Lost to Follow-up|1|||
127751150|NCT03445533|459716554|FG000|Overall Study|Never Received any Study Treatment|7|||
127751151|NCT03445533|459716555|FG001|Overall Study|Never Received any Study Treatment|4|||
127809952|NCT03040024|459921492|FG002|Overall Study|Adverse Event|0|||
127809953|NCT03040024|459921490|FG000|Overall Study|Death|0|||
127809954|NCT03040024|459921491|FG001|Overall Study|Death|1|||
127809955|NCT03040024|459921492|FG002|Overall Study|Death|0|||
127809956|NCT03040024|459921490|FG000|Overall Study|Physician Decision|0|||
127809957|NCT03040024|459921491|FG001|Overall Study|Physician Decision|0|||
127809958|NCT03040024|459921492|FG002|Overall Study|Physician Decision|1|||
127809959|NCT01526148|459921494|FG000|Overall Study|Adverse Event|6|||
127809960|NCT01526148|459921495|FG001|Overall Study|Adverse Event|5|||
127809961|NCT01526148|459921494|FG000|Overall Study|Lost to Follow-up|3|||
127809962|NCT01526148|459921495|FG001|Overall Study|Lost to Follow-up|6|||
127809963|NCT01526148|459921494|FG000|Overall Study|Withdrawal by Subject|2|||
127809964|NCT01526148|459921495|FG001|Overall Study|Withdrawal by Subject|0|||
127809965|NCT01526148|459921494|FG000|Overall Study|Unstable Medical Condition|1|||
127809966|NCT01526148|459921495|FG001|Overall Study|Unstable Medical Condition|0|||
127809967|NCT01526148|459921494|FG000|Overall Study|Unable to discontinue concomitant med|1|||
127809968|NCT01526148|459921495|FG001|Overall Study|Unable to discontinue concomitant med|0|||
127809969|NCT01526148|459921494|FG000|Overall Study|Moved out of state|1|||
127809970|NCT01526148|459921495|FG001|Overall Study|Moved out of state|0|||
127809971|NCT01526148|459921494|FG000|Overall Study|Incarcerated|0|||
127809972|NCT01526148|459921495|FG001|Overall Study|Incarcerated|2|||
127809973|NCT01818297|459921496|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
127809974|NCT01818297|459921497|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
127809975|NCT01818297|459921496|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
127809976|NCT01818297|459921497|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
127809977|NCT01818297|459921496|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
127809978|NCT01818297|459921497|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
127809979|NCT03029832|459921498|FG000|Overall Study|Safety Follow-Up Completed|2|||
127751152|NCT00968526|459716556|FG000|Overall Study|Adverse Event|2|||
127751153|NCT00968526|459716557|FG001|Overall Study|Adverse Event|0|||
127751154|NCT00968526|459716556|FG000|Overall Study|Migrated/moved from study area|1|||
127751155|NCT00968526|459716557|FG001|Overall Study|Migrated/moved from study area|0|||
127809980|NCT03029832|459921499|FG001|Overall Study|Safety Follow-Up Completed|0|||
127809981|NCT03029832|459921498|FG000|Overall Study|Death due to Disease Progression|1|||
127809982|NCT03029832|459921499|FG001|Overall Study|Death due to Disease Progression|0|||
127809983|NCT03029832|459921498|FG000|Overall Study|Study Terminated By Sponsor|1|||
127751156|NCT03926195|459716558|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
127751157|NCT03926195|459716559|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
127809984|NCT03029832|459921499|FG001|Overall Study|Study Terminated By Sponsor|1|||
127809985|NCT01628926|459921500|FG000|Overall Study|Adverse Event|13|||
127809986|NCT01628926|459921501|FG001|Overall Study|Adverse Event|11|||
127809987|NCT01628926|459921502|FG002|Overall Study|Adverse Event|9|||
127809988|NCT01628926|459921500|FG000|Overall Study|Lack of Efficacy|2|||
127809989|NCT01628926|459921501|FG001|Overall Study|Lack of Efficacy|1|||
127809990|NCT01628926|459921502|FG002|Overall Study|Lack of Efficacy|5|||
127809991|NCT01628926|459921500|FG000|Overall Study|Withdrawal by Subject|6|||
127809992|NCT01628926|459921501|FG001|Overall Study|Withdrawal by Subject|4|||
127751158|NCT03926195|459716558|FG000|EXT Phase (Through Week 156)|Adverse Event|5|||
127751159|NCT03926195|459716559|FG001|EXT Phase (Through Week 156)|Adverse Event|1|||
127751160|NCT03926195|459716558|FG000|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|16|||
127751161|NCT03926195|459716559|FG001|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|17|||
127751162|NCT03926195|459716558|FG000|EXT Phase (Through Week 156)|Withdrawal by Subject|1|||
127894195|NCT00384033|460235269|FG003|Overall Study|Other|0|||
127894196|NCT00384033|460235266|FG000|Overall Study|Protocol Violation|5|||
127894197|NCT00384033|460235267|FG001|Overall Study|Protocol Violation|0|||
127894198|NCT00384033|460235268|FG002|Overall Study|Protocol Violation|5|||
127894199|NCT00384033|460235269|FG003|Overall Study|Protocol Violation|6|||
127894200|NCT00384033|460235266|FG000|Overall Study|Withdrawal by Subject|6|||
127894201|NCT00384033|460235267|FG001|Overall Study|Withdrawal by Subject|2|||
127894202|NCT00384033|460235268|FG002|Overall Study|Withdrawal by Subject|5|||
127894203|NCT00384033|460235269|FG003|Overall Study|Withdrawal by Subject|2|||
127894204|NCT00384033|460235266|FG000|Overall Study|Lack of Efficacy|7|||
127894205|NCT00384033|460235267|FG001|Overall Study|Lack of Efficacy|3|||
127894206|NCT00384033|460235268|FG002|Overall Study|Lack of Efficacy|3|||
127894207|NCT00384033|460235269|FG003|Overall Study|Lack of Efficacy|1|||
127894208|NCT00384033|460235266|FG000|Overall Study|Randomized but not treated|3|||
127894209|NCT00384033|460235267|FG001|Overall Study|Randomized but not treated|7|||
127894210|NCT00384033|460235268|FG002|Overall Study|Randomized but not treated|10|||
127894211|NCT00384033|460235269|FG003|Overall Study|Randomized but not treated|2|||
127894212|NCT00290745|460235270|FG000|Overall Study|Withdrawal by Subject|4|||
127894213|NCT00290745|460235270|FG000|Overall Study|Physician Decision|2|||
127894214|NCT00290745|460235270|FG000|Overall Study|Surgery after 3 months for progression|3|||
127894215|NCT00290745|460235270|FG000|Overall Study|Baseline MRI not available|3|||
127894216|NCT02750306|460235271|FG000|Overall Study|Withdrawal by Subject|5|||
127894217|NCT02750306|460235272|FG001|Overall Study|Withdrawal by Subject|2|||
127894218|NCT02750306|460235271|FG000|Overall Study|Protocol Violation|1|||
127894219|NCT02750306|460235272|FG001|Overall Study|Protocol Violation|0|||
127894220|NCT02737306|460235273|FG000|Overall Study|Adverse Event|3|||
127894221|NCT02737306|460235274|FG001|Overall Study|Adverse Event|0|||
127894222|NCT02737306|460235273|FG000|Overall Study|Enrolment and treatment halted by sponsor.|1|||
127894223|NCT02737306|460235274|FG001|Overall Study|Enrolment and treatment halted by sponsor.|0|||
127894224|NCT03361423|460235275|FG000|Overall Study|Withdrawal by Subject|4|||
127751163|NCT03926195|459716559|FG001|EXT Phase (Through Week 156)|Withdrawal by Subject|3|||
127751164|NCT03926195|459716558|FG000|EXT Phase (Through Week 156)|Physician Decision|0|||
127751165|NCT03926195|459716559|FG001|EXT Phase (Through Week 156)|Physician Decision|2|||
127751166|NCT03926195|459716558|FG000|Monitoring Phase (52 Weeks)|Withdrawal by Subject|0|||
127751167|NCT03926195|459716559|FG001|Monitoring Phase (52 Weeks)|Withdrawal by Subject|1|||
127751168|NCT00426127|459716561|FG000|Overall Study|Adverse Event|1|||
127751169|NCT00426127|459716561|FG000|Overall Study|Removed due to disease progression|1|||
127751170|NCT05048238|459716564|FG000|Overall Study|Withdrawal by Subject|1|||
127751171|NCT01730378|459716565|FG000|Overall Study|Lost to Follow-up|1|||
127751172|NCT01730378|459716566|FG001|Overall Study|Lost to Follow-up|0|||
127751173|NCT00955708|459716567|FG000|Overall Study|Death|269|||
127751174|NCT00955708|459716567|FG000|Overall Study|Lost to Follow-up|72|||
127751175|NCT00955708|459716567|FG000|Overall Study|Physician Decision|36|||
127809993|NCT01628926|459921502|FG002|Overall Study|Withdrawal by Subject|2|||
127809994|NCT01628926|459921500|FG000|Overall Study|Protocol Violation|0|||
127809995|NCT01628926|459921501|FG001|Overall Study|Protocol Violation|1|||
127809996|NCT01628926|459921502|FG002|Overall Study|Protocol Violation|0|||
127809997|NCT01628926|459921500|FG000|Overall Study|Discontinuation criteria|3|||
127809998|NCT01628926|459921501|FG001|Overall Study|Discontinuation criteria|4|||
127809999|NCT01628926|459921502|FG002|Overall Study|Discontinuation criteria|0|||
127810000|NCT01628926|459921500|FG000|Overall Study|Physician Decision|2|||
127810001|NCT01628926|459921501|FG001|Overall Study|Physician Decision|2|||
127810002|NCT01628926|459921502|FG002|Overall Study|Physician Decision|1|||
127810003|NCT01275222|459921503|FG000|Phase l by Treatment|Adverse Event|1|||
127751176|NCT00955708|459716567|FG000|Overall Study|Protocol Violation|134|||
127894225|NCT03361423|460235276|FG001|Overall Study|Withdrawal by Subject|3|||
127894226|NCT03361423|460235275|FG000|Overall Study|Did not treat|19|||
127894227|NCT03361423|460235276|FG001|Overall Study|Did not treat|18|||
127894228|NCT03361423|460235275|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
127894229|NCT03361423|460235276|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
127894230|NCT03361423|460235275|FG000|Overall Study|Missing data|4|||
127894231|NCT03361423|460235276|FG001|Overall Study|Missing data|1|||
127810004|NCT01275222|459921504|FG001|Phase l by Treatment|Adverse Event|4|||
127810005|NCT01275222|459921505|FG002|Phase l by Treatment|Adverse Event|2|||
127810006|NCT01275222|459921506|FG003|Phase l by Treatment|Adverse Event|3|||
127810007|NCT01275222|459921507|FG004|Phase l by Treatment|Adverse Event|0|||
127810008|NCT01275222|459921508|FG005|Phase l by Treatment|Adverse Event|0|||
127810009|NCT01275222|459921503|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
127810010|NCT01275222|459921504|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
127810011|NCT01275222|459921505|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
127751177|NCT00955708|459716567|FG000|Overall Study|Registry Conclusion|186|||
127751178|NCT00955708|459716567|FG000|Overall Study|Product removed from service|94|||
127751179|NCT00955708|459716567|FG000|Overall Study|Patient Refused to participate further|116|||
127751180|NCT00955708|459716567|FG000|Overall Study|Closure of study location|60|||
127751181|NCT00955708|459716567|FG000|Overall Study|Patient changed care provider/moved|91|||
127751182|NCT01016262|459716568|FG000|Double-blind Phase|Adverse Event|0|||
127751183|NCT01016262|459716569|FG001|Double-blind Phase|Adverse Event|0|||
127751184|NCT01016262|459716570|FG002|Double-blind Phase|Adverse Event|1|||
127751185|NCT01016262|459716571|FG003|Double-blind Phase|Adverse Event|0|||
127751186|NCT01016262|459716572|FG004|Double-blind Phase|Adverse Event|0|||
127751187|NCT01016262|459716573|FG005|Double-blind Phase|Adverse Event|0|||
127751188|NCT01016262|459716568|FG000|Double-blind Phase|Lack of Efficacy|1|||
127751189|NCT01016262|459716569|FG001|Double-blind Phase|Lack of Efficacy|0|||
127751190|NCT01016262|459716570|FG002|Double-blind Phase|Lack of Efficacy|5|||
127751191|NCT01016262|459716571|FG003|Double-blind Phase|Lack of Efficacy|0|||
127751192|NCT01016262|459716572|FG004|Double-blind Phase|Lack of Efficacy|0|||
127751193|NCT01016262|459716573|FG005|Double-blind Phase|Lack of Efficacy|0|||
127751194|NCT01016262|459716568|FG000|Double-blind Phase|Disease Progression|0|||
127751195|NCT01016262|459716569|FG001|Double-blind Phase|Disease Progression|1|||
127751196|NCT01016262|459716570|FG002|Double-blind Phase|Disease Progression|2|||
127751197|NCT01016262|459716571|FG003|Double-blind Phase|Disease Progression|0|||
127751198|NCT01016262|459716572|FG004|Double-blind Phase|Disease Progression|0|||
127751199|NCT01016262|459716573|FG005|Double-blind Phase|Disease Progression|0|||
127751200|NCT01016262|459716568|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
127751201|NCT01016262|459716569|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
127751202|NCT01016262|459716570|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
127751203|NCT01016262|459716571|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
127810012|NCT01275222|459921506|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
127810013|NCT01275222|459921507|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
127810014|NCT01275222|459921508|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
127810015|NCT01275222|459921503|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
127810016|NCT01275222|459921504|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
127810017|NCT01275222|459921505|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
127810018|NCT01275222|459921506|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
127810019|NCT01275222|459921507|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
127810020|NCT01275222|459921508|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
127810021|NCT01275222|459921503|FG000|Phase l by Treatment|Disease progression|12|||
127810022|NCT01275222|459921504|FG001|Phase l by Treatment|Disease progression|8|||
127810023|NCT01275222|459921505|FG002|Phase l by Treatment|Disease progression|2|||
127810024|NCT01275222|459921506|FG003|Phase l by Treatment|Disease progression|5|||
127810025|NCT01275222|459921507|FG004|Phase l by Treatment|Disease progression|0|||
127810026|NCT01275222|459921508|FG005|Phase l by Treatment|Disease progression|0|||
127810027|NCT01275222|459921503|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
127810028|NCT01275222|459921504|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
127810029|NCT01275222|459921505|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
127810030|NCT01275222|459921506|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
127810031|NCT01275222|459921507|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
127810032|NCT01275222|459921508|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
127810033|NCT01275222|459921503|FG000|Phase l by Treatment|Death|0|||
127810034|NCT01275222|459921504|FG001|Phase l by Treatment|Death|1|||
127810035|NCT01275222|459921505|FG002|Phase l by Treatment|Death|0|||
127810036|NCT01275222|459921506|FG003|Phase l by Treatment|Death|1|||
127810037|NCT01275222|459921507|FG004|Phase l by Treatment|Death|0|||
127810038|NCT01275222|459921508|FG005|Phase l by Treatment|Death|0|||
127810039|NCT01275222|459921503|FG000|Phase ll by Stratum|Adverse Event|0|||
127810040|NCT01275222|459921504|FG001|Phase ll by Stratum|Adverse Event|0|||
127894232|NCT01336894|460235277|FG000|Follow-up|Study terminated prematurely|2|||
127894233|NCT01336894|460235278|FG001|Follow-up|Study terminated prematurely|7|||
127810041|NCT01275222|459921505|FG002|Phase ll by Stratum|Adverse Event|0|||
127894234|NCT00622908|460235279|FG000|Overall Study|Protocol Violation|1|||
127894235|NCT00622908|460235280|FG001|Overall Study|Protocol Violation|0|||
127810042|NCT01275222|459921506|FG003|Phase ll by Stratum|Adverse Event|0|||
127810043|NCT01275222|459921507|FG004|Phase ll by Stratum|Adverse Event|2|||
127810044|NCT01275222|459921508|FG005|Phase ll by Stratum|Adverse Event|10|||
127751204|NCT01016262|459716572|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
127751205|NCT01016262|459716573|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
127751206|NCT01016262|459716568|FG000|Open-Label Phase|Adverse Event|0|||
127751207|NCT01016262|459716569|FG001|Open-Label Phase|Adverse Event|0|||
127751208|NCT01016262|459716570|FG002|Open-Label Phase|Adverse Event|0|||
127751209|NCT01016262|459716571|FG003|Open-Label Phase|Adverse Event|1|||
127751210|NCT01016262|459716572|FG004|Open-Label Phase|Adverse Event|0|||
127751211|NCT01016262|459716573|FG005|Open-Label Phase|Adverse Event|0|||
127751212|NCT01016262|459716568|FG000|Open-Label Phase|Lost to Follow-up|0|||
127751213|NCT01016262|459716569|FG001|Open-Label Phase|Lost to Follow-up|0|||
127751214|NCT01016262|459716570|FG002|Open-Label Phase|Lost to Follow-up|0|||
127751215|NCT01016262|459716571|FG003|Open-Label Phase|Lost to Follow-up|0|||
127751216|NCT01016262|459716572|FG004|Open-Label Phase|Lost to Follow-up|1|||
127751217|NCT01016262|459716573|FG005|Open-Label Phase|Lost to Follow-up|0|||
127751218|NCT01016262|459716568|FG000|Open-Label Phase|Lack of Efficacy|0|||
127751219|NCT01016262|459716569|FG001|Open-Label Phase|Lack of Efficacy|0|||
127751220|NCT01016262|459716570|FG002|Open-Label Phase|Lack of Efficacy|0|||
127751221|NCT01016262|459716571|FG003|Open-Label Phase|Lack of Efficacy|1|||
127751222|NCT01016262|459716572|FG004|Open-Label Phase|Lack of Efficacy|0|||
127751223|NCT01016262|459716573|FG005|Open-Label Phase|Lack of Efficacy|0|||
127751224|NCT01016262|459716568|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
127751225|NCT01016262|459716569|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
127751226|NCT01016262|459716570|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
127751227|NCT01016262|459716571|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
127751228|NCT01016262|459716572|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
127751229|NCT01016262|459716573|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
127751230|NCT01736540|459716574|FG000|Overall Study|Did not complete scan within 45 days|2|||
127751231|NCT01736540|459716574|FG000|Overall Study|Death|1|||
127751232|NCT01736540|459716574|FG000|Overall Study|Abnormal test procedure|1|||
127751233|NCT01736540|459716574|FG000|Overall Study|Withdrawal by Subject|5|||
127751234|NCT01736540|459716574|FG000|Overall Study|Protocol Violation|1|||
127751235|NCT01736540|459716574|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
127751236|NCT01736540|459716574|FG000|Overall Study|No show for MRI appointment|1|||
127751237|NCT01736540|459716574|FG000|Overall Study|Unable to make MRI appointment|3|||
127751238|NCT00479882|459716575|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
127751239|NCT00479882|459716576|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
127751240|NCT00479882|459716577|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
127751241|NCT00479882|459716578|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
127751242|NCT00479882|459716575|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
127751243|NCT00479882|459716576|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
127751244|NCT00479882|459716577|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
127751245|NCT00479882|459716578|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
127751246|NCT00479882|459716575|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
127751247|NCT00479882|459716576|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
127751248|NCT00479882|459716577|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
127751249|NCT00479882|459716578|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
127751250|NCT00479882|459716575|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
127751251|NCT00479882|459716576|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
127751252|NCT00479882|459716577|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
127751253|NCT00479882|459716578|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
127751254|NCT00479882|459716575|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
127751255|NCT00479882|459716576|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
127751256|NCT00479882|459716577|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
127751257|NCT00479882|459716578|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
127751258|NCT00479882|459716575|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
127751259|NCT00479882|459716576|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
127751260|NCT00479882|459716577|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
127751261|NCT00479882|459716578|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
127751262|NCT00479882|459716575|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
127751263|NCT00479882|459716576|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
127751264|NCT00479882|459716577|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
127751265|NCT00479882|459716578|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
127751266|NCT00479882|459716575|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
127751267|NCT00479882|459716576|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
127751268|NCT00479882|459716577|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
127751269|NCT00479882|459716578|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
127751270|NCT00479882|459716575|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
127810045|NCT01275222|459921503|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
127810046|NCT01275222|459921504|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
127751271|NCT00479882|459716576|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
127751272|NCT00479882|459716577|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
127751273|NCT00479882|459716578|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
127751274|NCT00479882|459716575|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
127751275|NCT00479882|459716576|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
127751276|NCT00479882|459716577|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
127751277|NCT00479882|459716578|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
127751278|NCT00479882|459716575|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
127751279|NCT00479882|459716576|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
127751280|NCT00479882|459716577|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
127751281|NCT00479882|459716578|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
127751282|NCT00479882|459716575|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
127751283|NCT00479882|459716576|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
127751284|NCT00479882|459716577|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
127751285|NCT00479882|459716578|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
127751286|NCT00479882|459716575|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
127751287|NCT00479882|459716576|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
127751288|NCT00479882|459716577|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
127751289|NCT00479882|459716578|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
127751290|NCT00479882|459716575|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
127751291|NCT00479882|459716576|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
127751292|NCT00479882|459716577|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
127751293|NCT00479882|459716578|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
127751294|NCT01370655|459716579|FG000|Period 1|Adverse Event|2|||
127751295|NCT01370655|459716580|FG001|Period 1|Adverse Event|0|||
127751296|NCT01370655|459716581|FG002|Period 1|Adverse Event|0|||
127751297|NCT01370655|459716582|FG003|Period 1|Adverse Event|0|||
127751298|NCT01370655|459716583|FG004|Period 1|Adverse Event|0|||
127751299|NCT01370655|459716584|FG005|Period 1|Adverse Event|0|||
127751300|NCT01370655|459716585|FG006|Period 1|Adverse Event|1|||
127751301|NCT01370655|459716586|FG007|Period 1|Adverse Event|0|||
127751302|NCT01370655|459716587|FG008|Period 1|Adverse Event|0|||
127751303|NCT01370655|459716588|FG009|Period 1|Adverse Event|0|||
127751304|NCT01370655|459716589|FG010|Period 1|Adverse Event|0|||
127751305|NCT01370655|459716590|FG011|Period 1|Adverse Event|0|||
127751306|NCT01370655|459716579|FG000|Period 2|Adverse Event|0|||
127751307|NCT01370655|459716580|FG001|Period 2|Adverse Event|0|||
127751308|NCT01370655|459716581|FG002|Period 2|Adverse Event|1|||
127751309|NCT01370655|459716582|FG003|Period 2|Adverse Event|0|||
127751310|NCT01370655|459716583|FG004|Period 2|Adverse Event|1|||
127751311|NCT01370655|459716584|FG005|Period 2|Adverse Event|0|||
127751312|NCT01370655|459716585|FG006|Period 2|Adverse Event|0|||
127751313|NCT01370655|459716586|FG007|Period 2|Adverse Event|1|||
127751314|NCT01370655|459716587|FG008|Period 2|Adverse Event|0|||
127751315|NCT01370655|459716588|FG009|Period 2|Adverse Event|0|||
127751316|NCT01370655|459716589|FG010|Period 2|Adverse Event|0|||
127751317|NCT01370655|459716590|FG011|Period 2|Adverse Event|0|||
127751318|NCT01370655|459716579|FG000|Period 2|met protocol specified stopping criteria|0|||
127751319|NCT01370655|459716580|FG001|Period 2|met protocol specified stopping criteria|0|||
127751320|NCT01370655|459716581|FG002|Period 2|met protocol specified stopping criteria|1|||
127751321|NCT01370655|459716582|FG003|Period 2|met protocol specified stopping criteria|0|||
127751322|NCT01370655|459716583|FG004|Period 2|met protocol specified stopping criteria|0|||
127751323|NCT01370655|459716584|FG005|Period 2|met protocol specified stopping criteria|0|||
127751324|NCT01370655|459716585|FG006|Period 2|met protocol specified stopping criteria|1|||
127751325|NCT01370655|459716586|FG007|Period 2|met protocol specified stopping criteria|0|||
127751326|NCT01370655|459716587|FG008|Period 2|met protocol specified stopping criteria|1|||
127751327|NCT01370655|459716588|FG009|Period 2|met protocol specified stopping criteria|0|||
127751328|NCT01370655|459716589|FG010|Period 2|met protocol specified stopping criteria|1|||
127751329|NCT01370655|459716590|FG011|Period 2|met protocol specified stopping criteria|0|||
127751330|NCT01370655|459716579|FG000|Period 2|Withdrawal by Subject|0|||
127751331|NCT01370655|459716580|FG001|Period 2|Withdrawal by Subject|0|||
127894236|NCT00622908|460235279|FG000|Overall Study|Adverse Event|0|||
127894237|NCT00622908|460235280|FG001|Overall Study|Adverse Event|1|||
127751332|NCT01370655|459716581|FG002|Period 2|Withdrawal by Subject|0|||
127751333|NCT01370655|459716582|FG003|Period 2|Withdrawal by Subject|0|||
127751334|NCT01370655|459716583|FG004|Period 2|Withdrawal by Subject|0|||
127751335|NCT01370655|459716584|FG005|Period 2|Withdrawal by Subject|0|||
127751336|NCT01370655|459716585|FG006|Period 2|Withdrawal by Subject|0|||
127751337|NCT01370655|459716586|FG007|Period 2|Withdrawal by Subject|0|||
127751338|NCT01370655|459716587|FG008|Period 2|Withdrawal by Subject|1|||
127751339|NCT01370655|459716588|FG009|Period 2|Withdrawal by Subject|0|||
127751340|NCT01370655|459716589|FG010|Period 2|Withdrawal by Subject|0|||
127751341|NCT01370655|459716590|FG011|Period 2|Withdrawal by Subject|0|||
127751342|NCT02057575|459716595|FG000|Overall Study|Adverse Event|0|||
127751343|NCT02057575|459716596|FG001|Overall Study|Adverse Event|2|||
127751344|NCT02057575|459716597|FG002|Overall Study|Adverse Event|0|||
127810047|NCT01275222|459921505|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
127810048|NCT01275222|459921506|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
127810049|NCT01275222|459921507|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
127810050|NCT01275222|459921508|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
127810051|NCT01275222|459921503|FG000|Phase ll by Stratum|Disease progression|0|||
127810052|NCT01275222|459921504|FG001|Phase ll by Stratum|Disease progression|0|||
127810053|NCT01275222|459921505|FG002|Phase ll by Stratum|Disease progression|0|||
127810054|NCT01275222|459921506|FG003|Phase ll by Stratum|Disease progression|0|||
127810055|NCT01275222|459921507|FG004|Phase ll by Stratum|Disease progression|23|||
127810056|NCT01275222|459921508|FG005|Phase ll by Stratum|Disease progression|31|||
127810057|NCT01275222|459921503|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
127810058|NCT01275222|459921504|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
127810059|NCT01275222|459921505|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
127810060|NCT01275222|459921506|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
127810061|NCT01275222|459921507|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
127810062|NCT01275222|459921508|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
127810063|NCT01275222|459921503|FG000|Phase ll by Stratum|Death|0|||
127810064|NCT01275222|459921504|FG001|Phase ll by Stratum|Death|0|||
127810065|NCT01275222|459921505|FG002|Phase ll by Stratum|Death|0|||
127810066|NCT01275222|459921506|FG003|Phase ll by Stratum|Death|0|||
127810067|NCT01275222|459921507|FG004|Phase ll by Stratum|Death|1|||
127810068|NCT01275222|459921508|FG005|Phase ll by Stratum|Death|1|||
127810069|NCT00591734|459921509|FG000|Overall Study|Lack of Efficacy|35|||
127810070|NCT00591734|459921509|FG000|Overall Study|Adverse Event|5|||
127810071|NCT00591734|459921509|FG000|Overall Study|Physician Decision|5|||
127810072|NCT00591734|459921509|FG000|Overall Study|Intercurrent Illness|8|||
127810073|NCT04672083|459921510|FG000|Overall Study|Lost to Follow-up|1|||
127810074|NCT04672083|459921511|FG001|Overall Study|Lost to Follow-up|0|||
127810075|NCT04672083|459921512|FG002|Overall Study|Lost to Follow-up|0|||
127810076|NCT04672083|459921513|FG003|Overall Study|Lost to Follow-up|0|||
127810077|NCT04672083|459921514|FG004|Overall Study|Lost to Follow-up|0|||
127810078|NCT02500537|459921515|FG000|Overall Study|Death|2|||
127810079|NCT02500537|459921516|FG001|Overall Study|Death|0|||
127810080|NCT02500537|459921515|FG000|Overall Study|Lost to Follow-up|0|||
127810081|NCT02500537|459921516|FG001|Overall Study|Lost to Follow-up|1|||
127810082|NCT02500537|459921515|FG000|Overall Study|Withdrawal by Subject|1|||
127810083|NCT02500537|459921516|FG001|Overall Study|Withdrawal by Subject|0|||
127810084|NCT01661790|459921517|FG000|Overall Study|Lost to Follow-up|0|||
127810085|NCT01661790|459921518|FG001|Overall Study|Lost to Follow-up|2|||
127810086|NCT02048904|459921519|FG000|Overall Study|Withdrawal by Subject|7|||
127810087|NCT02048904|459921519|FG000|Overall Study|Physician Decision|70|||
127810088|NCT00784758|459921520|FG000|Overall Study|Withdrawal by Subject|3|||
127810089|NCT00784758|459921521|FG001|Overall Study|Withdrawal by Subject|0|||
127810090|NCT00784758|459921520|FG000|Overall Study|Adverse Event|1|||
127810091|NCT00784758|459921521|FG001|Overall Study|Adverse Event|0|||
127810092|NCT06119191|459921524|FG000|Overall Study|Adverse Event|0|||
127810093|NCT06119191|459921525|FG001|Overall Study|Adverse Event|1|||
127810094|NCT06119191|459921524|FG000|Overall Study|Protocol Violation|1|||
127810095|NCT06119191|459921525|FG001|Overall Study|Protocol Violation|0|||
127810096|NCT02732951|459923723|FG000|Overall Study|Other than listed|1|||
127810097|NCT02732951|459923724|FG001|Overall Study|Other than listed|0|||
127810098|NCT02732951|459923723|FG000|Overall Study|Lost to Follow-up|0|||
127810099|NCT02732951|459923724|FG001|Overall Study|Lost to Follow-up|1|||
127810100|NCT02732951|459923723|FG000|Overall Study|Adverse Event|4|||
127810101|NCT02732951|459923724|FG001|Overall Study|Adverse Event|4|||
127810102|NCT02732951|459923723|FG000|Overall Study|Protocol Violation|0|||
127810103|NCT02732951|459923724|FG001|Overall Study|Protocol Violation|1|||
127810104|NCT03263806|459923726|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
127810105|NCT03263806|459923727|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
127810106|NCT03263806|459923726|FG000|Overall Study|Withdrawal by Subject|0|||
127810107|NCT03263806|459923727|FG001|Overall Study|Withdrawal by Subject|1|||
127751345|NCT02057575|459716598|FG003|Overall Study|Adverse Event|1|||
127751346|NCT02057575|459716595|FG000|Overall Study|Withdrawal by Subject|1|||
127751347|NCT02057575|459716596|FG001|Overall Study|Withdrawal by Subject|0|||
127751348|NCT02057575|459716597|FG002|Overall Study|Withdrawal by Subject|0|||
127751349|NCT02057575|459716598|FG003|Overall Study|Withdrawal by Subject|0|||
127751350|NCT02057575|459716595|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
127751351|NCT02057575|459716596|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
127751352|NCT02057575|459716597|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
127751353|NCT02057575|459716598|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
127751354|NCT02057575|459716595|FG000|Overall Study|Protocol Violation|0|||
127751355|NCT02057575|459716596|FG001|Overall Study|Protocol Violation|1|||
127751356|NCT02057575|459716597|FG002|Overall Study|Protocol Violation|0|||
127751357|NCT02057575|459716598|FG003|Overall Study|Protocol Violation|0|||
127751358|NCT00332462|459716599|FG000|Overall Study|Adverse Event|5|||
127810108|NCT03263806|459923726|FG000|Overall Study|Study Termination|5|||
127810109|NCT03263806|459923727|FG001|Overall Study|Study Termination|6|||
127810110|NCT01412879|459923730|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
127751359|NCT00332462|459716599|FG000|Overall Study|Abnormal Lab Value|1|||
127751360|NCT00332462|459716599|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
127751361|NCT00332462|459716599|FG000|Overall Study|no longer requires study drug|1|||
127751362|NCT00332462|459716599|FG000|Overall Study|Death|3|||
127751363|NCT00332462|459716599|FG000|Overall Study|Graft Loss|2|||
127751364|NCT01643044|459716600|FG000|Overall Study|Lost to Follow-up|1|||
127751365|NCT01643044|459716601|FG001|Overall Study|Lost to Follow-up|1|||
127751366|NCT01643044|459716600|FG000|Overall Study|Miscarried baby|2|||
127751367|NCT01643044|459716601|FG001|Overall Study|Miscarried baby|2|||
127751368|NCT01643044|459716600|FG000|Overall Study|Delivered outside of hospital|1|||
127751369|NCT01643044|459716601|FG001|Overall Study|Delivered outside of hospital|2|||
127751370|NCT01735175|459716605|FG000|Overall Study|Withdrawal by Subject|9|||
127751371|NCT01735175|459716606|FG001|Overall Study|Withdrawal by Subject|2|||
127751372|NCT01735175|459716605|FG000|Overall Study|Lost to Follow-up|4|||
127751373|NCT01735175|459716606|FG001|Overall Study|Lost to Follow-up|2|||
127751374|NCT01735175|459716605|FG000|Overall Study|Death|3|||
127751375|NCT01735175|459716606|FG001|Overall Study|Death|2|||
127751376|NCT01735175|459716605|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
127751377|NCT01735175|459716606|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
127751378|NCT01023958|459716609|FG000|Overall Study|Progressive disease|48|||
127751379|NCT01023958|459716609|FG000|Overall Study|Other adverse event|1|||
127751380|NCT01023958|459716609|FG000|Overall Study|Refused to continue medication|1|||
127751381|NCT02159040|459716610|FG000|Overall Study|Death|1|||
127751382|NCT03080493|459716611|FG000|Overall Study|Did not provide NRS pain results|1|||
127751383|NCT03080493|459716612|FG001|Overall Study|Did not provide NRS pain results|0|||
127751384|NCT03080493|459716611|FG000|Overall Study|Adverse Event|0|||
127751385|NCT03080493|459716612|FG001|Overall Study|Adverse Event|1|||
127751386|NCT03080493|459716611|FG000|Overall Study|Randomization error (parity group)|0|||
127751387|NCT03080493|459716612|FG001|Overall Study|Randomization error (parity group)|1|||
127751388|NCT00755417|459716613|FG000|Overall Study|Adverse Event|28|||
127751389|NCT00755417|459716614|FG001|Overall Study|Adverse Event|20|||
127751390|NCT00755417|459716615|FG002|Overall Study|Adverse Event|7|||
127751391|NCT00755417|459716613|FG000|Overall Study|Lack of Efficacy|8|||
127751392|NCT00755417|459716614|FG001|Overall Study|Lack of Efficacy|4|||
127751393|NCT00755417|459716615|FG002|Overall Study|Lack of Efficacy|9|||
127751394|NCT00755417|459716613|FG000|Overall Study|Protocol Violation|2|||
127751395|NCT00755417|459716614|FG001|Overall Study|Protocol Violation|1|||
127751396|NCT00755417|459716615|FG002|Overall Study|Protocol Violation|1|||
127751397|NCT00755417|459716613|FG000|Overall Study|Lost to Follow-up|3|||
127751398|NCT00755417|459716614|FG001|Overall Study|Lost to Follow-up|0|||
127751399|NCT00755417|459716615|FG002|Overall Study|Lost to Follow-up|1|||
127751400|NCT00755417|459716613|FG000|Overall Study|Withdrawal by Subject|12|||
127751401|NCT00755417|459716614|FG001|Overall Study|Withdrawal by Subject|12|||
127751402|NCT00755417|459716615|FG002|Overall Study|Withdrawal by Subject|12|||
127751403|NCT00755417|459716613|FG000|Overall Study|Not specified or missing data|9|||
127751404|NCT00755417|459716614|FG001|Overall Study|Not specified or missing data|18|||
127751405|NCT00755417|459716615|FG002|Overall Study|Not specified or missing data|12|||
127751406|NCT02362503|459716617|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
127751407|NCT02362503|459716618|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
127751408|NCT02362503|459716619|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
127751409|NCT02362503|459716617|FG000|Double-blind Period-Up to 8 Days|Death|1|||
127751410|NCT02362503|459716618|FG001|Double-blind Period-Up to 8 Days|Death|0|||
127751411|NCT02362503|459716619|FG002|Double-blind Period-Up to 8 Days|Death|0|||
127751412|NCT02362503|459716617|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
127751413|NCT02362503|459716618|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
127751414|NCT02362503|459716619|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
127751415|NCT02362503|459716617|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
127751416|NCT02362503|459716618|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
127751417|NCT02362503|459716619|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
127751418|NCT02362503|459716617|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
127751419|NCT02362503|459716618|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
127751420|NCT02362503|459716619|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
127751421|NCT02362503|459716617|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
127751422|NCT02362503|459716618|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
127894238|NCT00622908|460235279|FG000|Overall Study|Lack of Efficacy|1|||
127751423|NCT02362503|459716619|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
127810111|NCT01412879|459923731|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
127751424|NCT02362503|459716617|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
127751425|NCT02362503|459716618|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
127751426|NCT02362503|459716619|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
127751427|NCT02362503|459716617|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
127751428|NCT02362503|459716618|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
127751429|NCT02362503|459716619|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
127751430|NCT02362503|459716617|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
127751431|NCT02362503|459716618|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
127751432|NCT02362503|459716619|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
127751433|NCT02362503|459716617|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
127810112|NCT01412879|459923732|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
127810113|NCT01412879|459923730|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
127810114|NCT01412879|459923731|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
127810115|NCT01412879|459923732|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
127810116|NCT01412879|459923730|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
127810117|NCT01412879|459923731|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
127810118|NCT01412879|459923732|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
127810119|NCT01412879|459923730|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
127810120|NCT01412879|459923731|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
127810121|NCT01412879|459923732|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
127810122|NCT01412879|459923730|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
127810123|NCT01412879|459923731|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
127810124|NCT01412879|459923732|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
127810125|NCT04840667|459923733|FG000|Overall Study|Screen failures/ Failure to meet inclusion criteria|17|||
127810126|NCT01445171|459923740|FG000|Overall Study|Lost to Follow-up|11|||
127810127|NCT01445171|459923740|FG000|Overall Study|Withdrawal by Subject|16|||
127810128|NCT01445171|459923740|FG000|Overall Study|Death|51|||
127810129|NCT01445171|459923740|FG000|Overall Study|Subjects declined to return for followup|9|||
127810130|NCT01445171|459923740|FG000|Overall Study|Consented but did not receive device|8|||
127810131|NCT03195894|459923741|FG000|Overall Study|"An example is Started other treatment."|4|||
127810132|NCT03195894|459923742|FG001|Overall Study|"An example is Started other treatment."|5|||
127810133|NCT03195894|459923741|FG000|Overall Study|Withdrawal by Subject|15|||
127810134|NCT03195894|459923742|FG001|Overall Study|Withdrawal by Subject|4|||
127810135|NCT03195894|459923741|FG000|Overall Study|Lost to Follow-up|14|||
127810136|NCT03195894|459923742|FG001|Overall Study|Lost to Follow-up|19|||
127810137|NCT00162773|459923746|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
127810138|NCT05047523|459923757|FG000|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
127810139|NCT05047523|459923758|FG001|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
127810140|NCT05047523|459923759|FG002|Primary Evaluation Period (48 Weeks)|Physician Decision|1|||
127810141|NCT05047523|459923760|FG003|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
127810142|NCT05047523|459923761|FG004|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
127810143|NCT05047523|459923762|FG005|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
127810144|NCT05047523|459923757|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
127810145|NCT05047523|459923758|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
127810146|NCT05047523|459923759|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
127810147|NCT05047523|459923760|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
127810148|NCT05047523|459923761|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
127810149|NCT05047523|459923762|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
127810150|NCT05047523|459923757|FG000|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|2|||
127810151|NCT05047523|459923758|FG001|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
127810152|NCT05047523|459923759|FG002|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|3|||
127810153|NCT05047523|459923760|FG003|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
127810154|NCT05047523|459923761|FG004|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
127810155|NCT05047523|459923762|FG005|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
127810156|NCT05047523|459923757|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
127810157|NCT05047523|459923758|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
127810158|NCT05047523|459923759|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
127810159|NCT05047523|459923760|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
127810160|NCT05047523|459923761|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
127894239|NCT00622908|460235280|FG001|Overall Study|Lack of Efficacy|7|||
127894240|NCT00622908|460235279|FG000|Overall Study|Lost to Follow-up|1|||
127894241|NCT00622908|460235280|FG001|Overall Study|Lost to Follow-up|0|||
127894242|NCT00622908|460235279|FG000|Overall Study|Refusal|0|||
127894243|NCT00622908|460235280|FG001|Overall Study|Refusal|1|||
127810161|NCT05047523|459923762|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
127810162|NCT05047523|459923757|FG000|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
127810163|NCT05047523|459923758|FG001|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
127810164|NCT05047523|459923759|FG002|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
127810165|NCT05047523|459923760|FG003|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
127810166|NCT05047523|459923761|FG004|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
127810167|NCT05047523|459923762|FG005|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
127810168|NCT05047523|459923757|FG000|Extension Period (24 Weeks)|Adverse Event|0|||
127810169|NCT05047523|459923758|FG001|Extension Period (24 Weeks)|Adverse Event|0|||
127810170|NCT05047523|459923759|FG002|Extension Period (24 Weeks)|Adverse Event|0|||
127810171|NCT05047523|459923760|FG003|Extension Period (24 Weeks)|Adverse Event|0|||
127810172|NCT05047523|459923761|FG004|Extension Period (24 Weeks)|Adverse Event|1|||
127810173|NCT05047523|459923762|FG005|Extension Period (24 Weeks)|Adverse Event|1|||
127810174|NCT00224016|459923763|FG000|Titration Period|Withdrawal by Subject|0|||
127810175|NCT00224016|459923764|FG001|Titration Period|Withdrawal by Subject|1|||
127810176|NCT00224016|459923763|FG000|Titration Period|Lost to Follow-up|1|||
127810177|NCT00224016|459923764|FG001|Titration Period|Lost to Follow-up|0|||
127810178|NCT00224016|459923763|FG000|Maintenance Period|Withdrawal by Subject|2|||
127810179|NCT00224016|459923764|FG001|Maintenance Period|Withdrawal by Subject|0|||
127810180|NCT00224016|459923763|FG000|Maintenance Period|Lost to Follow-up|0|||
127810181|NCT00224016|459923764|FG001|Maintenance Period|Lost to Follow-up|1|||
127810182|NCT01609933|459923765|FG000|Overall Study|Adverse Event|1|||
127810183|NCT01609933|459923765|FG000|Overall Study|Withdrawal by Subject|3|||
127810184|NCT01252966|459923766|FG000|Overall Study|Lost to Follow-up|16|||
127810185|NCT01252966|459923767|FG001|Overall Study|Lost to Follow-up|10|||
127810186|NCT01252966|459923766|FG000|Overall Study|Withdrawal by Subject|7|||
127810187|NCT01252966|459923767|FG001|Overall Study|Withdrawal by Subject|3|||
127751434|NCT02362503|459716618|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
127751435|NCT02362503|459716619|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
127810188|NCT00206726|459923775|FG000|Overall Study|Delayed recovery of blood counts|1|||
127810189|NCT00206726|459923775|FG000|Overall Study|Progressive disease or relapsed disease|18|||
127810190|NCT00206726|459923775|FG000|Overall Study|Placed on new protocol|1|||
127810191|NCT00206726|459923775|FG000|Overall Study|Bone marrow transplant|1|||
127810192|NCT00206726|459923775|FG000|Overall Study|Adverse Event|17|||
127810193|NCT00206726|459923775|FG000|Overall Study|Death|4|||
127810194|NCT00206726|459923775|FG000|Overall Study|Protocol Violation|1|||
127810195|NCT00206726|459923775|FG000|Overall Study|Withdrawal by Subject|8|||
127810196|NCT02612909|459923776|FG000|Phase 2|Withdrawal by Subject|2|||
127810197|NCT02612909|459923777|FG001|Phase 2|Withdrawal by Subject|5|||
127810198|NCT02612909|459923778|FG002|Phase 2|Withdrawal by Subject|0|||
127810199|NCT02612909|459923779|FG003|Phase 2|Withdrawal by Subject|0|||
127810200|NCT02612909|459923780|FG004|Phase 2|Withdrawal by Subject|0|||
127810201|NCT02612909|459923776|FG000|Phase 2|Pregnancy|0|||
127810202|NCT02612909|459923777|FG001|Phase 2|Pregnancy|0|||
127810203|NCT02612909|459923778|FG002|Phase 2|Pregnancy|1|||
127810204|NCT02612909|459923779|FG003|Phase 2|Pregnancy|0|||
127810205|NCT02612909|459923780|FG004|Phase 2|Pregnancy|0|||
127810206|NCT02612909|459923776|FG000|Phase 3|Withdrawal by Subject|0|||
127894244|NCT00622908|460235279|FG000|Overall Study|Termination by study sponser|0|||
127751436|NCT02362503|459716617|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
127751437|NCT02362503|459716618|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
127751438|NCT02362503|459716619|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
127751439|NCT02362503|459716617|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
127751440|NCT02362503|459716618|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
127751441|NCT02362503|459716619|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
127751442|NCT02362503|459716617|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
127751443|NCT02362503|459716618|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
127751444|NCT02362503|459716619|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
127751445|NCT02362503|459716617|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
127751446|NCT02362503|459716618|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
127810207|NCT02612909|459923777|FG001|Phase 3|Withdrawal by Subject|0|||
127810208|NCT02612909|459923778|FG002|Phase 3|Withdrawal by Subject|0|||
127810209|NCT02612909|459923779|FG003|Phase 3|Withdrawal by Subject|1|||
127810210|NCT02612909|459923780|FG004|Phase 3|Withdrawal by Subject|0|||
127810211|NCT01719757|459923782|FG000|Overall Study|Adverse Event|38|||
127810212|NCT01719757|459923782|FG000|Overall Study|Withdrawal by Subject|15|||
127810213|NCT01719757|459923782|FG000|Overall Study|Lost to Follow-up|20|||
127810214|NCT01719757|459923782|FG000|Overall Study|Protocol Violation|1|||
127810215|NCT01719757|459923782|FG000|Overall Study|well controlled pain|27|||
127810216|NCT02626338|459923783|FG000|Overall Study|Lack of Efficacy|3|||
127810217|NCT02626338|459923784|FG001|Overall Study|Lack of Efficacy|2|||
127810218|NCT02626338|459923785|FG002|Overall Study|Lack of Efficacy|0|||
127810219|NCT00450580|459923786|FG000|Overall Study|Adverse Event|5|||
127810220|NCT00450580|459923787|FG001|Overall Study|Adverse Event|7|||
127810221|NCT00450580|459923786|FG000|Overall Study|Lost to Follow-up|4|||
127751447|NCT02362503|459716619|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
127751448|NCT02195479|459716620|FG000|Overall Study|Lost to Follow-up|18|||
127751449|NCT02195479|459716621|FG001|Overall Study|Lost to Follow-up|15|||
127751450|NCT02195479|459716620|FG000|Overall Study|Death|217|||
127751451|NCT02195479|459716621|FG001|Overall Study|Death|171|||
127751452|NCT02195479|459716620|FG000|Overall Study|Physician Decision|1|||
127751453|NCT02195479|459716621|FG001|Overall Study|Physician Decision|0|||
127751454|NCT02195479|459716620|FG000|Overall Study|Withdrawal by Subject|30|||
127751455|NCT02195479|459716621|FG001|Overall Study|Withdrawal by Subject|30|||
127751456|NCT02195479|459716620|FG000|Overall Study|Other|3|||
127751457|NCT02195479|459716621|FG001|Overall Study|Other|4|||
127751458|NCT02195479|459716620|FG000|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|87|||
127751459|NCT02195479|459716621|FG001|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|130|||
127751460|NCT03325777|459716626|FG000|Overall Study|Lost to Follow-up|9|||
127751461|NCT03325777|459716627|FG001|Overall Study|Lost to Follow-up|12|||
127751462|NCT01266161|459716630|FG000|Overall Study|Ineligible|1|||
127751463|NCT01266161|459716631|FG001|Overall Study|Ineligible|0|||
127751464|NCT01266161|459716630|FG000|Overall Study|Lack of Efficacy|0|||
127751465|NCT01266161|459716631|FG001|Overall Study|Lack of Efficacy|1|||
127751466|NCT01266161|459716630|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
127751467|NCT01266161|459716631|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
127751468|NCT01436305|459716633|FG000|Overall Study|Death|1|||
127751469|NCT01436305|459716634|FG001|Overall Study|Death|0|||
127751470|NCT01436305|459716635|FG002|Overall Study|Death|0|||
127751471|NCT01436305|459716633|FG000|Overall Study|Lost to Follow-up|0|||
127751472|NCT01436305|459716634|FG001|Overall Study|Lost to Follow-up|1|||
127751473|NCT01436305|459716635|FG002|Overall Study|Lost to Follow-up|0|||
127751474|NCT01436305|459716633|FG000|Overall Study|Withdrawal by Subject|1|||
127751475|NCT01436305|459716634|FG001|Overall Study|Withdrawal by Subject|3|||
127751476|NCT01436305|459716635|FG002|Overall Study|Withdrawal by Subject|0|||
127751477|NCT01485120|459716636|FG000|Overall Study|Withdrawal by Subject|2|||
127751478|NCT01081886|459716637|FG000|Overall Study|Study termination|11|||
127751479|NCT01081886|459716638|FG001|Overall Study|Study termination|13|||
127751480|NCT02567708|459716639|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
127751481|NCT02567708|459716640|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
127751482|NCT02567708|459716639|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
127751483|NCT02567708|459716640|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
127751484|NCT02567708|459716639|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
127751485|NCT02567708|459716640|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
127751486|NCT02567708|459716639|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
127751487|NCT02567708|459716640|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
127751488|NCT04148651|459716643|FG000|Overall Study|Lost to Follow-up|2|||
127751489|NCT05262751|459716644|FG000|Washout Period 2|Adverse Event|1|||
127751490|NCT05262751|459716645|FG001|Washout Period 2|Adverse Event|0|||
127751491|NCT05262751|459716646|FG002|Washout Period 2|Adverse Event|0|||
127751492|NCT05262751|459716647|FG003|Washout Period 2|Adverse Event|0|||
127751493|NCT05262751|459716648|FG004|Washout Period 2|Adverse Event|0|||
127751494|NCT05262751|459716649|FG005|Washout Period 2|Adverse Event|0|||
127751495|NCT05262751|459716644|FG000|Treatment Period 3|Not treated because of an adverse event|0|||
127751496|NCT05262751|459716645|FG001|Treatment Period 3|Not treated because of an adverse event|1|||
127751497|NCT05262751|459716646|FG002|Treatment Period 3|Not treated because of an adverse event|0|||
127751498|NCT05262751|459716647|FG003|Treatment Period 3|Not treated because of an adverse event|0|||
127751499|NCT05262751|459716648|FG004|Treatment Period 3|Not treated because of an adverse event|0|||
127751500|NCT05262751|459716649|FG005|Treatment Period 3|Not treated because of an adverse event|0|||
127751501|NCT01154140|459716650|FG000|Overall Study|Death|71|||
127751502|NCT01154140|459716651|FG001|Overall Study|Death|81|||
127751503|NCT01154140|459716650|FG000|Overall Study|Lost to Follow-up|4|||
127751504|NCT01154140|459716651|FG001|Overall Study|Lost to Follow-up|5|||
127751505|NCT01154140|459716650|FG000|Overall Study|Withdrawal by Subject|12|||
127751506|NCT01154140|459716651|FG001|Overall Study|Withdrawal by Subject|13|||
127751507|NCT01154140|459716650|FG000|Overall Study|Other|3|||
127751508|NCT01154140|459716651|FG001|Overall Study|Other|1|||
127751509|NCT01154140|459716650|FG000|Overall Study|Randomized but not treated|1|||
127751510|NCT01154140|459716651|FG001|Overall Study|Randomized but not treated|2|||
127751511|NCT00862836|459716655|FG000|Overall Study|Withdrawal by Subject|1|||
127751512|NCT04463680|459716656|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
127751513|NCT04463680|459716656|FG000|Overall Study|Not eligible due to implant duration of use|1|||
127751514|NCT04463680|459716656|FG000|Overall Study|Withdrawal by Subject|3|||
127751515|NCT05239598|459716659|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
127751516|NCT05239598|459716660|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
127751517|NCT05239598|459716659|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
127751518|NCT05239598|459716660|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
127751519|NCT04147195|459716663|FG000|Overall Study|Adverse Event|0|||
127751520|NCT04147195|459716664|FG001|Overall Study|Adverse Event|3|||
127751521|NCT04147195|459716663|FG000|Overall Study|Study Terminated by Sponsor|4|||
127751522|NCT04147195|459716664|FG001|Overall Study|Study Terminated by Sponsor|2|||
127751523|NCT04147195|459716663|FG000|Overall Study|Withdrawal by Subject|0|||
127751524|NCT04147195|459716664|FG001|Overall Study|Withdrawal by Subject|1|||
127751525|NCT01424813|459716665|FG000|Overall Study|Withdrawal by Subject|3|||
127751526|NCT01424813|459716666|FG001|Overall Study|Withdrawal by Subject|0|||
127751527|NCT01424813|459716665|FG000|Overall Study|Protocol Violation|1|||
127751528|NCT01424813|459716666|FG001|Overall Study|Protocol Violation|0|||
127751529|NCT01424813|459716665|FG000|Overall Study|Other|1|||
127751530|NCT01424813|459716666|FG001|Overall Study|Other|2|||
127751531|NCT04991753|459718278|FG000|Overall Study|Withdrawal by Subject|0|||
127751532|NCT04991753|459718279|FG001|Overall Study|Withdrawal by Subject|1|||
127751533|NCT03299049|459718282|FG000|Overall Study|On-going|486|||
127751534|NCT03299049|459718283|FG001|Overall Study|On-going|481|||
127751535|NCT03299049|459718282|FG000|Overall Study|Withdrawal by Subject|6|||
127751536|NCT03299049|459718283|FG001|Overall Study|Withdrawal by Subject|21|||
127751537|NCT03299049|459718282|FG000|Overall Study|Physician Decision|5|||
127751538|NCT03299049|459718283|FG001|Overall Study|Physician Decision|1|||
127751539|NCT03299049|459718282|FG000|Overall Study|Lost to Follow-up|2|||
127751540|NCT03299049|459718283|FG001|Overall Study|Lost to Follow-up|0|||
127751541|NCT03299049|459718282|FG000|Overall Study|Pregnancy|1|||
127751542|NCT03299049|459718283|FG001|Overall Study|Pregnancy|3|||
127751543|NCT03299049|459718282|FG000|Overall Study|Protocol Violation|1|||
127751544|NCT03299049|459718283|FG001|Overall Study|Protocol Violation|1|||
127751545|NCT03299049|459718282|FG000|Overall Study|Lack of Efficacy|9|||
127751546|NCT03299049|459718283|FG001|Overall Study|Lack of Efficacy|3|||
127751547|NCT03299049|459718282|FG000|Overall Study|Adverse Event|12|||
127751548|NCT03299049|459718283|FG001|Overall Study|Adverse Event|13|||
127751549|NCT01901419|459718284|FG000|Overall Study|Protocol Violation|2|||
127751550|NCT01901419|459718285|FG001|Overall Study|Protocol Violation|6|||
127751551|NCT01901419|459718284|FG000|Overall Study|unavailable researchers|6|||
127751552|NCT01901419|459718285|FG001|Overall Study|unavailable researchers|3|||
127751553|NCT01667926|459718290|FG000|Overall Study|Withdrawal by Subject|1|||
127751554|NCT01667926|459718291|FG001|Overall Study|Withdrawal by Subject|2|||
127751555|NCT01667926|459718292|FG002|Overall Study|Withdrawal by Subject|2|||
127751556|NCT01667926|459718290|FG000|Overall Study|Physician Decision|0|||
127751557|NCT01667926|459718291|FG001|Overall Study|Physician Decision|0|||
127751558|NCT01667926|459718292|FG002|Overall Study|Physician Decision|1|||
127751559|NCT01667926|459718290|FG000|Overall Study|Time committment|0|||
127751560|NCT01667926|459718291|FG001|Overall Study|Time committment|0|||
127751561|NCT01667926|459718292|FG002|Overall Study|Time committment|2|||
127751562|NCT01667926|459718290|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
127751563|NCT01667926|459718291|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
127751564|NCT01667926|459718292|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
127751565|NCT01667926|459718290|FG000|Overall Study|Lost to Follow-up|1|||
127751566|NCT01667926|459718291|FG001|Overall Study|Lost to Follow-up|2|||
127751567|NCT01667926|459718292|FG002|Overall Study|Lost to Follow-up|1|||
127751568|NCT01667926|459718290|FG000|Overall Study|Side effects|3|||
127751569|NCT01667926|459718291|FG001|Overall Study|Side effects|0|||
127751570|NCT01667926|459718292|FG002|Overall Study|Side effects|0|||
127751571|NCT02412735|459718293|FG000|Overall Study|Adverse Event|0|||
127751572|NCT02412735|459718294|FG001|Overall Study|Adverse Event|1|||
127751573|NCT02412735|459718295|FG002|Overall Study|Adverse Event|2|||
127751574|NCT02412735|459718293|FG000|Overall Study|Withdrawal by Subject|23|||
127751575|NCT02412735|459718294|FG001|Overall Study|Withdrawal by Subject|27|||
127751576|NCT02412735|459718295|FG002|Overall Study|Withdrawal by Subject|22|||
127810222|NCT00450580|459923787|FG001|Overall Study|Lost to Follow-up|5|||
127810223|NCT00450580|459923786|FG000|Overall Study|Withdrawal by Subject|2|||
127810224|NCT00450580|459923787|FG001|Overall Study|Withdrawal by Subject|2|||
127751577|NCT02412735|459718293|FG000|Overall Study|Investigator Decision|3|||
127751578|NCT02412735|459718294|FG001|Overall Study|Investigator Decision|3|||
127751579|NCT02412735|459718295|FG002|Overall Study|Investigator Decision|2|||
127751580|NCT02412735|459718293|FG000|Overall Study|Lost to Follow-up|17|||
127810225|NCT00450580|459923786|FG000|Overall Study|Protocol Violation|1|||
127810226|NCT00450580|459923787|FG001|Overall Study|Protocol Violation|1|||
127751581|NCT02412735|459718294|FG001|Overall Study|Lost to Follow-up|11|||
127751582|NCT02412735|459718295|FG002|Overall Study|Lost to Follow-up|18|||
127751583|NCT02412735|459718293|FG000|Overall Study|Reason not Specified|3|||
127751584|NCT02412735|459718294|FG001|Overall Study|Reason not Specified|2|||
127751585|NCT02412735|459718295|FG002|Overall Study|Reason not Specified|2|||
127751586|NCT04043143|459718296|FG000|Overall Study|Lost to Follow-up|5|||
127810227|NCT00450580|459923786|FG000|Overall Study|Protocol-defined virologic failure|1|||
127751587|NCT04043143|459718297|FG001|Overall Study|Lost to Follow-up|5|||
127751588|NCT04043143|459718296|FG000|Overall Study|screen failure|1|||
127751589|NCT04043143|459718297|FG001|Overall Study|screen failure|0|||
127751590|NCT02521363|459718298|FG000|Overall Study|Withdrawal by Subject|1|||
127751591|NCT02521363|459718299|FG001|Overall Study|Withdrawal by Subject|2|||
127751592|NCT05071053|459718300|FG000|Overall Study|Progressive disease|30|||
127751593|NCT05071053|459718300|FG000|Overall Study|Adverse Event|5|||
127751594|NCT01602510|459718301|FG000|Open Label Phase|Adverse Event|46|||
127751595|NCT01602510|459718302|FG001|Open Label Phase|Adverse Event|0|||
127751596|NCT01602510|459718303|FG002|Open Label Phase|Adverse Event|0|||
127751597|NCT01602510|459718301|FG000|Open Label Phase|Lack of Efficacy|22|||
127751598|NCT01602510|459718302|FG001|Open Label Phase|Lack of Efficacy|0|||
127751599|NCT01602510|459718303|FG002|Open Label Phase|Lack of Efficacy|0|||
127751600|NCT01602510|459718301|FG000|Open Label Phase|Protocol Violation|15|||
127751601|NCT01602510|459718302|FG001|Open Label Phase|Protocol Violation|0|||
127751602|NCT01602510|459718303|FG002|Open Label Phase|Protocol Violation|0|||
127751603|NCT01602510|459718301|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
127751604|NCT01602510|459718302|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
127751605|NCT01602510|459718303|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
127751606|NCT01602510|459718301|FG000|Open Label Phase|Lost to Follow-up|22|||
127751607|NCT01602510|459718302|FG001|Open Label Phase|Lost to Follow-up|0|||
127751608|NCT01602510|459718303|FG002|Open Label Phase|Lost to Follow-up|0|||
127751609|NCT01602510|459718301|FG000|Open Label Phase|Physician Decision|19|||
127751610|NCT01602510|459718302|FG001|Open Label Phase|Physician Decision|0|||
127751611|NCT01602510|459718303|FG002|Open Label Phase|Physician Decision|0|||
127751612|NCT01602510|459718301|FG000|Open Label Phase|Withdrawal by Subject|57|||
127751613|NCT01602510|459718302|FG001|Open Label Phase|Withdrawal by Subject|0|||
127751614|NCT01602510|459718303|FG002|Open Label Phase|Withdrawal by Subject|0|||
127751615|NCT01602510|459718301|FG000|Randomized Phase|Adverse Event|0|||
127751616|NCT01602510|459718302|FG001|Randomized Phase|Adverse Event|2|||
127751617|NCT01602510|459718303|FG002|Randomized Phase|Adverse Event|6|||
127751618|NCT01602510|459718301|FG000|Randomized Phase|Lack of Efficacy|0|||
127751619|NCT01602510|459718302|FG001|Randomized Phase|Lack of Efficacy|4|||
127751620|NCT01602510|459718303|FG002|Randomized Phase|Lack of Efficacy|4|||
127751621|NCT01602510|459718301|FG000|Randomized Phase|Protocol Violation|0|||
127751622|NCT01602510|459718302|FG001|Randomized Phase|Protocol Violation|3|||
127751623|NCT01602510|459718303|FG002|Randomized Phase|Protocol Violation|3|||
127751624|NCT01602510|459718301|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
127751625|NCT01602510|459718302|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
127751626|NCT01602510|459718303|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
127751627|NCT01602510|459718301|FG000|Randomized Phase|Lost to Follow-up|0|||
127751628|NCT01602510|459718302|FG001|Randomized Phase|Lost to Follow-up|1|||
127751629|NCT01602510|459718303|FG002|Randomized Phase|Lost to Follow-up|3|||
127751630|NCT01602510|459718301|FG000|Randomized Phase|Physician Decision|0|||
127751631|NCT01602510|459718302|FG001|Randomized Phase|Physician Decision|0|||
127751632|NCT01602510|459718303|FG002|Randomized Phase|Physician Decision|2|||
127751633|NCT01602510|459718301|FG000|Randomized Phase|Withdrawal by Subject|0|||
127751634|NCT01602510|459718302|FG001|Randomized Phase|Withdrawal by Subject|6|||
127751635|NCT01602510|459718303|FG002|Randomized Phase|Withdrawal by Subject|7|||
127751636|NCT03519204|459718304|FG000|Overall Study|Lost to Follow-up|3|||
127751637|NCT03519204|459718305|FG001|Overall Study|Lost to Follow-up|8|||
127751638|NCT03519204|459718304|FG000|Overall Study|Withdrawal by Subject|9|||
127751639|NCT03519204|459718305|FG001|Overall Study|Withdrawal by Subject|7|||
127751640|NCT03519204|459718304|FG000|Overall Study|Other Miscellaneous Reasons|1|||
127751641|NCT03519204|459718305|FG001|Overall Study|Other Miscellaneous Reasons|0|||
127751642|NCT01572740|459718307|FG000|Overall Study|Adverse Event|1|||
127751643|NCT01572740|459718308|FG001|Overall Study|Adverse Event|1|||
127751644|NCT01572740|459718307|FG000|Overall Study|Withdrawal by Subject|1|||
127751645|NCT01572740|459718308|FG001|Overall Study|Withdrawal by Subject|1|||
127751646|NCT01572740|459718307|FG000|Overall Study|unclassified|4|||
127751647|NCT01572740|459718308|FG001|Overall Study|unclassified|3|||
127751648|NCT01289210|459718309|FG000|Overall Study|Adverse Event|1|||
127751649|NCT01818531|459718310|FG000|Overall Study|Withdrawn for case delay after block|1|||
127751650|NCT01818531|459718311|FG001|Overall Study|Withdrawn for case delay after block|0|||
127751651|NCT01818531|459718310|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
127751652|NCT01818531|459718311|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
127751653|NCT01818531|459718310|FG000|Overall Study|Withdrawn for failure to place block|0|||
127751654|NCT01818531|459718311|FG001|Overall Study|Withdrawn for failure to place block|1|||
127751655|NCT00477490|459718312|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
127751656|NCT00477490|459718313|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
127751657|NCT00477490|459718314|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
127751658|NCT00477490|459718315|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
127751659|NCT00477490|459718316|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
127751660|NCT00477490|459718317|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
127751661|NCT00477490|459718318|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
127751662|NCT00477490|459718319|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
127751663|NCT00477490|459718320|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
127751664|NCT00477490|459718312|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
127751665|NCT00477490|459718313|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
127751666|NCT00477490|459718314|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
127751667|NCT00477490|459718315|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
127751668|NCT00477490|459718316|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
127751669|NCT00477490|459718317|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
127751670|NCT00477490|459718318|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
127751671|NCT00477490|459718319|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
127751672|NCT00477490|459718320|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
127751673|NCT00477490|459718312|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
127751674|NCT00477490|459718313|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
127751675|NCT00477490|459718314|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
127751676|NCT00477490|459718315|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
127751677|NCT00477490|459718316|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
127751678|NCT00477490|459718317|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
127751679|NCT00477490|459718318|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
127810228|NCT00450580|459923787|FG001|Overall Study|Protocol-defined virologic failure|0|||
127810229|NCT00450580|459923786|FG000|Overall Study|Could not comply with scheduled visits|1|||
127810230|NCT00450580|459923787|FG001|Overall Study|Could not comply with scheduled visits|0|||
127810231|NCT00450580|459923786|FG000|Overall Study|Patient went to Brazil|1|||
127810232|NCT00450580|459923787|FG001|Overall Study|Patient went to Brazil|0|||
127810233|NCT00450580|459923786|FG000|Overall Study|Patient could not swallow Norvir|1|||
127810234|NCT00450580|459923787|FG001|Overall Study|Patient could not swallow Norvir|0|||
127810235|NCT00450580|459923786|FG000|Overall Study|Withdrawal due to pregnancy|0|||
127810236|NCT00450580|459923787|FG001|Overall Study|Withdrawal due to pregnancy|1|||
127810237|NCT00393718|459923788|FG000|Overall Study|Adverse Event|20|||
127810238|NCT00393718|459923789|FG001|Overall Study|Adverse Event|8|||
127810239|NCT00393718|459923788|FG000|Overall Study|Protocol Violation|1|||
127810240|NCT00393718|459923789|FG001|Overall Study|Protocol Violation|2|||
127810241|NCT00393718|459923788|FG000|Overall Study|Lack of Efficacy|10|||
127810242|NCT00393718|459923789|FG001|Overall Study|Lack of Efficacy|9|||
127810243|NCT00393718|459923788|FG000|Overall Study|Hypoglycaemia|3|||
127810244|NCT00393718|459923789|FG001|Overall Study|Hypoglycaemia|2|||
127810245|NCT00393718|459923788|FG000|Overall Study|Subject decision|5|||
127810246|NCT00393718|459923789|FG001|Overall Study|Subject decision|0|||
127810247|NCT00393718|459923788|FG000|Overall Study|Withdrawal of consent|2|||
127810248|NCT00393718|459923789|FG001|Overall Study|Withdrawal of consent|1|||
127810249|NCT00393718|459923788|FG000|Overall Study|Missed measurement|1|||
127810250|NCT00393718|459923789|FG001|Overall Study|Missed measurement|0|||
127810251|NCT00393718|459923788|FG000|Overall Study|Move|1|||
127810252|NCT00393718|459923789|FG001|Overall Study|Move|0|||
127810253|NCT03293654|459923790|FG000|Overall Study|Lost to Follow-up|0|||
127810254|NCT03293654|459923791|FG001|Overall Study|Lost to Follow-up|1|||
127810255|NCT03293654|459923792|FG002|Overall Study|Lost to Follow-up|0|||
127810256|NCT00391976|459923793|FG000|Overall Study|Adverse Event|0|||
127810257|NCT00391976|459923794|FG001|Overall Study|Adverse Event|0|||
127810258|NCT00391976|459923795|FG002|Overall Study|Adverse Event|1|||
127810259|NCT00391976|459923793|FG000|Overall Study|Withdrawal of consent|0|||
127810260|NCT00391976|459923794|FG001|Overall Study|Withdrawal of consent|1|||
127810261|NCT00391976|459923795|FG002|Overall Study|Withdrawal of consent|1|||
127810262|NCT00391976|459923793|FG000|Overall Study|Lost to Follow-up|1|||
127810263|NCT00391976|459923794|FG001|Overall Study|Lost to Follow-up|2|||
127810264|NCT00391976|459923795|FG002|Overall Study|Lost to Follow-up|0|||
127810265|NCT00391976|459923793|FG000|Overall Study|Inappropriate enrollment|1|||
127810266|NCT00391976|459923794|FG001|Overall Study|Inappropriate enrollment|1|||
127810267|NCT00391976|459923795|FG002|Overall Study|Inappropriate enrollment|0|||
127751680|NCT00477490|459718319|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
127751681|NCT00477490|459718320|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
127810268|NCT00391976|459923793|FG000|Overall Study|Protocol deviation/violation|4|||
127810269|NCT00391976|459923794|FG001|Overall Study|Protocol deviation/violation|2|||
127810270|NCT00391976|459923795|FG002|Overall Study|Protocol deviation/violation|1|||
127810271|NCT00391976|459923793|FG000|Overall Study|Recurrence/no eradication of infection|21|||
127810272|NCT00391976|459923794|FG001|Overall Study|Recurrence/no eradication of infection|19|||
127810273|NCT00391976|459923795|FG002|Overall Study|Recurrence/no eradication of infection|0|||
127810274|NCT00391976|459923793|FG000|Overall Study|Unable to classify|0|||
127810275|NCT00391976|459923794|FG001|Overall Study|Unable to classify|0|||
127810276|NCT00391976|459923795|FG002|Overall Study|Unable to classify|1|||
127810277|NCT00391976|459923793|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
127810278|NCT00391976|459923794|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
127810279|NCT00391976|459923795|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
127810280|NCT03093402|459923800|FG000|Overall Study|Lost to Follow-up|1|||
127810281|NCT03093402|459923801|FG001|Overall Study|Lost to Follow-up|0|||
127810282|NCT03093402|459923802|FG002|Overall Study|Lost to Follow-up|0|||
127810283|NCT03093402|459923803|FG003|Overall Study|Lost to Follow-up|0|||
127810284|NCT03093402|459923800|FG000|Overall Study|Withdrawal by Subject|3|||
127810285|NCT03093402|459923801|FG001|Overall Study|Withdrawal by Subject|3|||
127810286|NCT03093402|459923802|FG002|Overall Study|Withdrawal by Subject|0|||
127810287|NCT03093402|459923803|FG003|Overall Study|Withdrawal by Subject|1|||
127810288|NCT03093402|459923800|FG000|Overall Study|Withdrew prior to dosing|2|||
127810289|NCT03093402|459923801|FG001|Overall Study|Withdrew prior to dosing|1|||
127810290|NCT03093402|459923802|FG002|Overall Study|Withdrew prior to dosing|2|||
127810291|NCT03093402|459923803|FG003|Overall Study|Withdrew prior to dosing|3|||
127810292|NCT03093402|459923800|FG000|Overall Study|Ineligible for study|1|||
127810293|NCT03093402|459923801|FG001|Overall Study|Ineligible for study|0|||
127810294|NCT03093402|459923802|FG002|Overall Study|Ineligible for study|0|||
127810295|NCT03093402|459923803|FG003|Overall Study|Ineligible for study|0|||
127810296|NCT03093402|459923800|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
127810297|NCT03093402|459923801|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
127810298|NCT03093402|459923802|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
127810299|NCT03093402|459923803|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
127810300|NCT02886702|459923804|FG000|Overall Study|Other|4|||
127810301|NCT02886702|459923805|FG001|Overall Study|Other|3|||
127810302|NCT02886702|459923806|FG002|Overall Study|Other|9|||
127810303|NCT02886702|459923804|FG000|Overall Study|Withdrawal by Subject|24|||
127810304|NCT02886702|459923805|FG001|Overall Study|Withdrawal by Subject|18|||
127810305|NCT02886702|459923806|FG002|Overall Study|Withdrawal by Subject|22|||
127810306|NCT02886702|459923804|FG000|Overall Study|Significant Worsening of Condition|0|||
127810307|NCT02886702|459923805|FG001|Overall Study|Significant Worsening of Condition|1|||
127810308|NCT02886702|459923806|FG002|Overall Study|Significant Worsening of Condition|0|||
127810309|NCT02886702|459923804|FG000|Overall Study|Protocol Violation|2|||
127810310|NCT02886702|459923805|FG001|Overall Study|Protocol Violation|2|||
127810311|NCT02886702|459923806|FG002|Overall Study|Protocol Violation|1|||
127810312|NCT02886702|459923804|FG000|Overall Study|Non-Compliance With Study Drug|0|||
127810313|NCT02886702|459923805|FG001|Overall Study|Non-Compliance With Study Drug|1|||
127810314|NCT02886702|459923806|FG002|Overall Study|Non-Compliance With Study Drug|4|||
127810315|NCT02886702|459923804|FG000|Overall Study|Lost to Follow-up|11|||
127810316|NCT02886702|459923805|FG001|Overall Study|Lost to Follow-up|13|||
127810317|NCT02886702|459923806|FG002|Overall Study|Lost to Follow-up|8|||
127810318|NCT02886702|459923804|FG000|Overall Study|Lack of Efficacy|3|||
127810319|NCT02886702|459923805|FG001|Overall Study|Lack of Efficacy|4|||
127810320|NCT02886702|459923806|FG002|Overall Study|Lack of Efficacy|5|||
127810321|NCT02886702|459923804|FG000|Overall Study|Adverse Event|4|||
127810322|NCT02886702|459923805|FG001|Overall Study|Adverse Event|9|||
127810323|NCT02886702|459923806|FG002|Overall Study|Adverse Event|3|||
127810324|NCT02886702|459923804|FG000|Overall Study|Administrative Reasons|0|||
127810325|NCT02886702|459923805|FG001|Overall Study|Administrative Reasons|0|||
127810326|NCT02886702|459923806|FG002|Overall Study|Administrative Reasons|1|||
127810327|NCT00763009|459923807|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
127810328|NCT00891735|459923808|FG000|Overall Study|Adverse Event|2|||
127810329|NCT00891735|459923809|FG001|Overall Study|Adverse Event|0|||
127810330|NCT00891735|459923810|FG002|Overall Study|Adverse Event|2|||
127810331|NCT00891735|459923811|FG003|Overall Study|Adverse Event|0|||
127810332|NCT00891735|459923808|FG000|Overall Study|Death|8|||
127810333|NCT00891735|459923809|FG001|Overall Study|Death|5|||
127810334|NCT00891735|459923810|FG002|Overall Study|Death|4|||
127810335|NCT00891735|459923811|FG003|Overall Study|Death|5|||
127810336|NCT00891735|459923808|FG000|Overall Study|Lost to Follow-up|2|||
127810337|NCT00891735|459923809|FG001|Overall Study|Lost to Follow-up|2|||
127810338|NCT00891735|459923810|FG002|Overall Study|Lost to Follow-up|2|||
127810339|NCT00891735|459923811|FG003|Overall Study|Lost to Follow-up|2|||
127810340|NCT00891735|459923808|FG000|Overall Study|Physician's decision to withdraw patient|1|||
127810341|NCT00891735|459923809|FG001|Overall Study|Physician's decision to withdraw patient|0|||
127810342|NCT00891735|459923810|FG002|Overall Study|Physician's decision to withdraw patient|0|||
127810343|NCT00891735|459923811|FG003|Overall Study|Physician's decision to withdraw patient|0|||
127810344|NCT00891735|459923808|FG000|Overall Study|Patient's decision to withdraw|4|||
127810345|NCT00891735|459923809|FG001|Overall Study|Patient's decision to withdraw|9|||
127810346|NCT00891735|459923810|FG002|Overall Study|Patient's decision to withdraw|4|||
127810347|NCT00891735|459923811|FG003|Overall Study|Patient's decision to withdraw|8|||
127810348|NCT03663166|459923814|FG000|Overall Study|Withdrawal by Subject|1|||
127810349|NCT00158184|459923820|FG000|Overall Study|personal issues|3|||
127810350|NCT00158184|459923821|FG001|Overall Study|personal issues|1|||
127894245|NCT00622908|460235280|FG001|Overall Study|Termination by study sponser|1|||
127810351|NCT00158184|459923820|FG000|Overall Study|failed for follow unit/study rules|2|||
127751682|NCT00477490|459718312|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
127751683|NCT00477490|459718313|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
127751684|NCT00477490|459718314|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
127751685|NCT00477490|459718315|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
127751686|NCT00477490|459718316|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
127751687|NCT00477490|459718317|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
127751688|NCT00477490|459718318|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
127751689|NCT00477490|459718319|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
127751690|NCT00477490|459718320|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
127751691|NCT00477490|459718312|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
127751692|NCT00477490|459718313|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
127751693|NCT00477490|459718314|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
127751694|NCT00477490|459718315|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
127751695|NCT00477490|459718316|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
127751696|NCT00477490|459718317|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
127751697|NCT00477490|459718318|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
127751698|NCT00477490|459718319|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
127751699|NCT00477490|459718320|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
127751700|NCT00477490|459718312|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
127751701|NCT00477490|459718313|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
127751702|NCT00477490|459718314|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
127751703|NCT00477490|459718315|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
127751704|NCT00477490|459718316|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
127751705|NCT00477490|459718317|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
127751706|NCT00477490|459718318|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
127751707|NCT00477490|459718319|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
127751708|NCT00477490|459718320|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
127751709|NCT00477490|459718312|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
127751710|NCT00477490|459718313|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
127751711|NCT00477490|459718314|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
127751712|NCT00477490|459718315|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
127751713|NCT00477490|459718316|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
127751714|NCT00477490|459718317|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
127751715|NCT00477490|459718318|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
127751716|NCT00477490|459718319|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
127751717|NCT00477490|459718320|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
127751718|NCT00477490|459718312|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
127751719|NCT00477490|459718313|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
127751720|NCT00477490|459718314|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
127751721|NCT00477490|459718315|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
127751722|NCT00477490|459718316|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
127751723|NCT00477490|459718317|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
127751724|NCT00477490|459718318|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
127751725|NCT00477490|459718319|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
127751726|NCT00477490|459718320|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
127751727|NCT00477490|459718312|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
127751728|NCT00477490|459718313|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
127751729|NCT00477490|459718314|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
127751730|NCT00477490|459718315|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
127751731|NCT00477490|459718316|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
127810352|NCT00158184|459923821|FG001|Overall Study|failed for follow unit/study rules|0|||
127810353|NCT00158184|459923820|FG000|Overall Study|Adverse Event|1|||
127810354|NCT00158184|459923821|FG001|Overall Study|Adverse Event|1|||
127810355|NCT05340504|459923822|FG000|Overall Study|Withdrawal by Subject|1|||
127810356|NCT05340504|459923823|FG001|Overall Study|Withdrawal by Subject|0|||
127810357|NCT02582671|459923824|FG000|Overall Study|Failure to return|1|||
127810358|NCT02582671|459923824|FG000|Overall Study|Other, not specified|1|||
127810359|NCT03068715|459923825|FG000|Overall Study|No longer met inclusion criteria|1|||
127810360|NCT03068715|459923826|FG001|Overall Study|No longer met inclusion criteria|0|||
127810361|NCT00481065|459923827|FG000|Overall Study|Adverse event or death|1|||
127810362|NCT00481065|459923828|FG001|Overall Study|Adverse event or death|1|||
127810363|NCT00481065|459923829|FG002|Overall Study|Adverse event or death|3|||
127810364|NCT00481065|459923830|FG003|Overall Study|Adverse event or death|0|||
127751732|NCT00477490|459718317|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
127751733|NCT00477490|459718318|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
127751734|NCT00477490|459718319|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
127810365|NCT00481065|459923831|FG004|Overall Study|Adverse event or death|2|||
127810366|NCT00481065|459923832|FG005|Overall Study|Adverse event or death|0|||
127810367|NCT00481065|459923833|FG006|Overall Study|Adverse event or death|1|||
127894246|NCT03937466|460235281|FG000|Overall Study|not eligbile after the 2-week diary|9|||
127894247|NCT03937466|460235281|FG000|Overall Study|never returned their diary|6|||
127894248|NCT03937466|460235281|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
127894249|NCT03937466|460235281|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
127751735|NCT00477490|459718320|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
127751736|NCT00477490|459718312|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
127751737|NCT00477490|459718313|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
127751738|NCT00477490|459718314|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
127751739|NCT00477490|459718315|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
127751740|NCT00477490|459718316|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
127751741|NCT00477490|459718317|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
127751742|NCT00477490|459718318|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
127751743|NCT00477490|459718319|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
127751744|NCT00477490|459718320|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
127751745|NCT00477490|459718312|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
127751746|NCT00477490|459718313|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
127751747|NCT00477490|459718314|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
127751748|NCT00477490|459718315|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
127751749|NCT00477490|459718316|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
127751750|NCT00477490|459718317|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
127751751|NCT00477490|459718318|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
127751752|NCT00477490|459718319|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
127751753|NCT00477490|459718320|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
127751754|NCT00477490|459718312|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
127751755|NCT00477490|459718313|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
127751756|NCT00477490|459718314|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
127751757|NCT00477490|459718315|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
127751758|NCT00477490|459718316|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
127751759|NCT00477490|459718317|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
127751760|NCT00477490|459718318|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
127751761|NCT00477490|459718319|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
127751762|NCT00477490|459718320|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
127751763|NCT00477490|459718312|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
127751764|NCT00477490|459718313|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
127751765|NCT00477490|459718314|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
127751766|NCT00477490|459718315|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
127751767|NCT00477490|459718316|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
127751768|NCT00477490|459718317|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
127751769|NCT00477490|459718318|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
127751770|NCT00477490|459718319|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
127751771|NCT00477490|459718320|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
127751772|NCT00477490|459718312|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
127751773|NCT00477490|459718313|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
127751774|NCT00477490|459718314|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
127751775|NCT00477490|459718315|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
127751776|NCT00477490|459718316|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
127751777|NCT00477490|459718317|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
127751778|NCT00477490|459718318|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
127751779|NCT00477490|459718319|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
127751780|NCT00477490|459718320|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
127751781|NCT01110408|459718323|FG000|Overall Study|Protocol Violation|1|||
127751782|NCT01110408|459718324|FG001|Overall Study|Protocol Violation|0|||
127751783|NCT01646177|459718325|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
127751784|NCT01646177|459718326|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
127751785|NCT01646177|459718327|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
127751786|NCT01646177|459718328|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
127751787|NCT01646177|459718329|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
127751788|NCT01646177|459718330|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
127751789|NCT01646177|459718331|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
127751790|NCT01646177|459718332|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
127751791|NCT01646177|459718333|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
127894250|NCT00113490|460235282|FG000|Overall Study|Withdrawal by Subject|1|||
127751792|NCT01646177|459718334|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
127894251|NCT00113490|460235283|FG001|Overall Study|Withdrawal by Subject|3|||
127894252|NCT00113490|460235282|FG000|Overall Study|Lost to Follow-up|1|||
127810368|NCT00481065|459923834|FG007|Overall Study|Adverse event or death|1|||
127810369|NCT00481065|459923827|FG000|Overall Study|Withdrawal by Subject|11|||
127810370|NCT00481065|459923828|FG001|Overall Study|Withdrawal by Subject|12|||
127810371|NCT00481065|459923829|FG002|Overall Study|Withdrawal by Subject|7|||
127810372|NCT00481065|459923830|FG003|Overall Study|Withdrawal by Subject|11|||
127810373|NCT00481065|459923831|FG004|Overall Study|Withdrawal by Subject|13|||
127810374|NCT00481065|459923832|FG005|Overall Study|Withdrawal by Subject|12|||
127810375|NCT00481065|459923833|FG006|Overall Study|Withdrawal by Subject|9|||
127810376|NCT00481065|459923834|FG007|Overall Study|Withdrawal by Subject|10|||
127810377|NCT00481065|459923827|FG000|Overall Study|Lost to Follow-up|4|||
127810378|NCT00481065|459923828|FG001|Overall Study|Lost to Follow-up|2|||
127810379|NCT00481065|459923829|FG002|Overall Study|Lost to Follow-up|4|||
127810380|NCT00481065|459923830|FG003|Overall Study|Lost to Follow-up|3|||
127810381|NCT00481065|459923831|FG004|Overall Study|Lost to Follow-up|3|||
127810382|NCT00481065|459923832|FG005|Overall Study|Lost to Follow-up|3|||
127810383|NCT00481065|459923833|FG006|Overall Study|Lost to Follow-up|2|||
127810384|NCT00481065|459923834|FG007|Overall Study|Lost to Follow-up|5|||
127810385|NCT00481065|459923827|FG000|Overall Study|Inappropriate enrollment|4|||
127810386|NCT00481065|459923828|FG001|Overall Study|Inappropriate enrollment|0|||
127810387|NCT00481065|459923829|FG002|Overall Study|Inappropriate enrollment|2|||
127810388|NCT00481065|459923830|FG003|Overall Study|Inappropriate enrollment|0|||
127810389|NCT00481065|459923831|FG004|Overall Study|Inappropriate enrollment|2|||
127810390|NCT00481065|459923832|FG005|Overall Study|Inappropriate enrollment|1|||
127810391|NCT00481065|459923833|FG006|Overall Study|Inappropriate enrollment|0|||
127810392|NCT00481065|459923834|FG007|Overall Study|Inappropriate enrollment|1|||
127810393|NCT00481065|459923827|FG000|Overall Study|Administrative reason|0|||
127810394|NCT00481065|459923828|FG001|Overall Study|Administrative reason|0|||
127810395|NCT00481065|459923829|FG002|Overall Study|Administrative reason|0|||
127810396|NCT00481065|459923830|FG003|Overall Study|Administrative reason|0|||
127810397|NCT00481065|459923831|FG004|Overall Study|Administrative reason|0|||
127810398|NCT00481065|459923832|FG005|Overall Study|Administrative reason|2|||
127810399|NCT00481065|459923833|FG006|Overall Study|Administrative reason|1|||
127810400|NCT00481065|459923834|FG007|Overall Study|Administrative reason|0|||
127810401|NCT00481065|459923827|FG000|Overall Study|Protocol Violation|2|||
127810402|NCT00481065|459923828|FG001|Overall Study|Protocol Violation|1|||
127810403|NCT00481065|459923829|FG002|Overall Study|Protocol Violation|1|||
127810404|NCT00481065|459923830|FG003|Overall Study|Protocol Violation|1|||
127810405|NCT00481065|459923831|FG004|Overall Study|Protocol Violation|2|||
127810406|NCT00481065|459923832|FG005|Overall Study|Protocol Violation|6|||
127810407|NCT00481065|459923833|FG006|Overall Study|Protocol Violation|3|||
127810408|NCT00481065|459923834|FG007|Overall Study|Protocol Violation|2|||
127810409|NCT00481065|459923827|FG000|Overall Study|Unable to classify|0|||
127810410|NCT00481065|459923828|FG001|Overall Study|Unable to classify|1|||
127810411|NCT00481065|459923829|FG002|Overall Study|Unable to classify|2|||
127810412|NCT00481065|459923830|FG003|Overall Study|Unable to classify|0|||
127810413|NCT00481065|459923831|FG004|Overall Study|Unable to classify|1|||
127810414|NCT00481065|459923832|FG005|Overall Study|Unable to classify|0|||
127810415|NCT00481065|459923833|FG006|Overall Study|Unable to classify|0|||
127810416|NCT00481065|459923834|FG007|Overall Study|Unable to classify|0|||
127810417|NCT01709331|459923837|FG000|Overall Study|Adverse Event|1|||
127810418|NCT02875223|459923844|FG000|Overall Study|Other reasons|0|||
127810419|NCT02875223|459923845|FG001|Overall Study|Other reasons|0|||
127810420|NCT02875223|459923846|FG002|Overall Study|Other reasons|1|||
127810421|NCT02875223|459923847|FG003|Overall Study|Other reasons|0|||
127810422|NCT02875223|459923848|FG004|Overall Study|Other reasons|1|||
127810423|NCT02875223|459923849|FG005|Overall Study|Other reasons|2|||
127810424|NCT02875223|459923850|FG006|Overall Study|Other reasons|0|||
127810425|NCT02875223|459923851|FG007|Overall Study|Other reasons|2|||
127810426|NCT02875223|459923852|FG008|Overall Study|Other reasons|0|||
127810427|NCT02875223|459923853|FG009|Overall Study|Other reasons|0|||
127810428|NCT02875223|459923854|FG010|Overall Study|Other reasons|0|||
127810429|NCT02875223|459923855|FG011|Overall Study|Other reasons|0|||
127810430|NCT02875223|459923856|FG012|Overall Study|Other reasons|0|||
127810431|NCT02875223|459923844|FG000|Overall Study|Withdrawal by Subject|0|||
127810432|NCT02875223|459923845|FG001|Overall Study|Withdrawal by Subject|0|||
127810433|NCT02875223|459923846|FG002|Overall Study|Withdrawal by Subject|0|||
127810434|NCT02875223|459923847|FG003|Overall Study|Withdrawal by Subject|0|||
127810435|NCT02875223|459923848|FG004|Overall Study|Withdrawal by Subject|1|||
127810436|NCT02875223|459923849|FG005|Overall Study|Withdrawal by Subject|1|||
127810437|NCT02875223|459923850|FG006|Overall Study|Withdrawal by Subject|0|||
127810438|NCT02875223|459923851|FG007|Overall Study|Withdrawal by Subject|0|||
127810439|NCT02875223|459923852|FG008|Overall Study|Withdrawal by Subject|1|||
127810440|NCT02875223|459923853|FG009|Overall Study|Withdrawal by Subject|0|||
127810441|NCT02875223|459923854|FG010|Overall Study|Withdrawal by Subject|0|||
127810442|NCT02875223|459923855|FG011|Overall Study|Withdrawal by Subject|0|||
127810443|NCT02875223|459923856|FG012|Overall Study|Withdrawal by Subject|0|||
127810444|NCT02875223|459923844|FG000|Overall Study|Progressive disease|0|||
127810445|NCT02875223|459923845|FG001|Overall Study|Progressive disease|0|||
127751793|NCT01646177|459718335|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
127751794|NCT01646177|459718336|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
127751795|NCT01646177|459718325|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
127751796|NCT01646177|459718326|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
127751797|NCT01646177|459718327|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
127751798|NCT01646177|459718328|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
127751799|NCT01646177|459718329|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
127751800|NCT01646177|459718330|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
127751801|NCT01646177|459718331|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
127751802|NCT01646177|459718332|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
127751803|NCT01646177|459718333|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
127751804|NCT01646177|459718334|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
127751805|NCT01646177|459718335|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
127751806|NCT01646177|459718336|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
127751807|NCT01646177|459718325|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
127751808|NCT01646177|459718326|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
127751809|NCT01646177|459718327|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
127751810|NCT01646177|459718328|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
127751811|NCT01646177|459718329|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
127751812|NCT01646177|459718330|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
127751813|NCT01646177|459718331|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
127751814|NCT01646177|459718332|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
127751815|NCT01646177|459718333|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
127751816|NCT01646177|459718334|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
127751817|NCT01646177|459718335|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
127751818|NCT01646177|459718336|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
127751819|NCT01646177|459718325|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
127751820|NCT01646177|459718326|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
127751821|NCT01646177|459718327|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
127751822|NCT01646177|459718328|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
127751823|NCT01646177|459718329|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
127751824|NCT01646177|459718330|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
127751825|NCT01646177|459718331|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
127751826|NCT01646177|459718332|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
127751827|NCT01646177|459718333|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
127751828|NCT01646177|459718334|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
127751829|NCT01646177|459718335|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
127751830|NCT01646177|459718336|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
127751831|NCT01646177|459718325|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
127751832|NCT01646177|459718326|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
127751833|NCT01646177|459718327|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
127751834|NCT01646177|459718328|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
127751835|NCT01646177|459718329|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
127751836|NCT01646177|459718330|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
127751837|NCT01646177|459718331|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
127751838|NCT01646177|459718332|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
127751839|NCT01646177|459718333|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
127751840|NCT01646177|459718334|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
127751841|NCT01646177|459718335|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
127751842|NCT01646177|459718336|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
127751843|NCT01646177|459718325|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
127751844|NCT01646177|459718326|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
127751845|NCT01646177|459718327|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
127751846|NCT01646177|459718328|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
127751847|NCT01646177|459718329|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
127751848|NCT01646177|459718330|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
127751849|NCT01646177|459718331|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
127751850|NCT01646177|459718332|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
127751851|NCT01646177|459718333|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
127751852|NCT01646177|459718334|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
127751853|NCT01646177|459718335|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
127751854|NCT01646177|459718336|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
127810446|NCT02875223|459923846|FG002|Overall Study|Progressive disease|1|||
127810447|NCT02875223|459923847|FG003|Overall Study|Progressive disease|0|||
127810448|NCT02875223|459923848|FG004|Overall Study|Progressive disease|0|||
127810449|NCT02875223|459923849|FG005|Overall Study|Progressive disease|0|||
127810450|NCT02875223|459923850|FG006|Overall Study|Progressive disease|0|||
127810451|NCT02875223|459923851|FG007|Overall Study|Progressive disease|0|||
127810452|NCT02875223|459923852|FG008|Overall Study|Progressive disease|0|||
127810453|NCT02875223|459923853|FG009|Overall Study|Progressive disease|12|||
127810454|NCT02875223|459923854|FG010|Overall Study|Progressive disease|2|||
127810455|NCT02875223|459923855|FG011|Overall Study|Progressive disease|3|||
127810456|NCT02875223|459923856|FG012|Overall Study|Progressive disease|6|||
127810457|NCT02875223|459923844|FG000|Overall Study|Death|4|||
127810458|NCT02875223|459923845|FG001|Overall Study|Death|4|||
127810459|NCT02875223|459923846|FG002|Overall Study|Death|3|||
127810460|NCT02875223|459923847|FG003|Overall Study|Death|4|||
127810461|NCT02875223|459923848|FG004|Overall Study|Death|2|||
127810462|NCT02875223|459923849|FG005|Overall Study|Death|3|||
127810463|NCT02875223|459923850|FG006|Overall Study|Death|5|||
127810464|NCT02875223|459923851|FG007|Overall Study|Death|7|||
127810465|NCT02875223|459923852|FG008|Overall Study|Death|3|||
127810466|NCT02875223|459923853|FG009|Overall Study|Death|2|||
127810467|NCT02875223|459923854|FG010|Overall Study|Death|0|||
127810468|NCT02875223|459923855|FG011|Overall Study|Death|0|||
127810469|NCT02875223|459923856|FG012|Overall Study|Death|0|||
127810470|NCT02875223|459923844|FG000|Overall Study|Lost to Follow-up|0|||
127810471|NCT02875223|459923845|FG001|Overall Study|Lost to Follow-up|1|||
127810472|NCT02875223|459923846|FG002|Overall Study|Lost to Follow-up|1|||
127810473|NCT02875223|459923847|FG003|Overall Study|Lost to Follow-up|0|||
127810474|NCT02875223|459923848|FG004|Overall Study|Lost to Follow-up|1|||
127810475|NCT02875223|459923849|FG005|Overall Study|Lost to Follow-up|0|||
127810476|NCT02875223|459923850|FG006|Overall Study|Lost to Follow-up|1|||
127810477|NCT02875223|459923851|FG007|Overall Study|Lost to Follow-up|1|||
127810478|NCT02875223|459923852|FG008|Overall Study|Lost to Follow-up|0|||
127810479|NCT02875223|459923853|FG009|Overall Study|Lost to Follow-up|0|||
127810480|NCT02875223|459923854|FG010|Overall Study|Lost to Follow-up|0|||
127810481|NCT02875223|459923855|FG011|Overall Study|Lost to Follow-up|0|||
127810482|NCT02875223|459923856|FG012|Overall Study|Lost to Follow-up|0|||
127810483|NCT01707992|459923859|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
127810484|NCT01707992|459923860|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
127810485|NCT01707992|459923861|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
127810486|NCT01707992|459923862|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
127810487|NCT01707992|459923863|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
127810488|NCT01707992|459923864|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
127810489|NCT01707992|459923859|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
127810490|NCT01707992|459923860|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
127810491|NCT01707992|459923861|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
127810492|NCT01707992|459923862|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
127810493|NCT01707992|459923863|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
127810494|NCT01707992|459923864|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
127810495|NCT01707992|459923859|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
127810496|NCT01707992|459923860|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
127810497|NCT01707992|459923861|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
127810498|NCT01707992|459923862|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
127810499|NCT01707992|459923863|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
127810500|NCT01707992|459923864|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
127810501|NCT01707992|459923859|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
127810502|NCT01707992|459923860|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
127810503|NCT01707992|459923861|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
127810504|NCT01707992|459923862|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
127810505|NCT01707992|459923863|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
127810506|NCT01707992|459923864|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
127810507|NCT01707992|459923859|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
127810508|NCT01707992|459923860|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
127810509|NCT01707992|459923861|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
127810510|NCT01707992|459923862|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
127810511|NCT01707992|459923863|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
127810512|NCT01707992|459923864|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
127810513|NCT01707992|459923859|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
127810514|NCT01707992|459923860|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
127810515|NCT01707992|459923861|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
127810516|NCT01707992|459923862|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
127810517|NCT01707992|459923863|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
127810518|NCT01707992|459923864|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
127810519|NCT01707992|459923859|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
127810520|NCT01707992|459923860|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
127810521|NCT01707992|459923861|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
127810522|NCT01707992|459923862|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
127810523|NCT01707992|459923863|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
127810524|NCT01707992|459923864|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
127810525|NCT01707992|459923859|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
127810526|NCT01707992|459923860|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
127810527|NCT01707992|459923861|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
127810528|NCT01707992|459923862|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
127810529|NCT01707992|459923863|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
127810530|NCT01707992|459923864|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
127810531|NCT01707992|459923859|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
127810532|NCT01707992|459923860|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
127810533|NCT01707992|459923861|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
127810534|NCT01707992|459923862|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
127810535|NCT01707992|459923863|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
127810536|NCT01707992|459923864|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
127810537|NCT01707992|459923859|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
127810538|NCT01707992|459923860|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
127810539|NCT01707992|459923861|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
127810540|NCT01707992|459923862|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
127810541|NCT01707992|459923863|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
127810542|NCT01707992|459923864|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
127810543|NCT01707992|459923859|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
127810544|NCT01707992|459923860|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
127810545|NCT01707992|459923861|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
127810546|NCT01707992|459923862|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
127810547|NCT01707992|459923863|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
127810548|NCT01707992|459923864|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
127810549|NCT01707992|459923859|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
127810550|NCT01707992|459923860|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
127810551|NCT01707992|459923861|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
127810552|NCT01707992|459923862|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
127810553|NCT01707992|459923863|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
127810554|NCT01707992|459923864|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
127810555|NCT01707992|459923859|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
127810556|NCT01707992|459923860|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
127810557|NCT01707992|459923861|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
127810558|NCT01707992|459923862|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
127810559|NCT01707992|459923863|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
127810560|NCT01707992|459923864|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
127810561|NCT01707992|459923859|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
127810562|NCT01707992|459923860|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
127810563|NCT01707992|459923861|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
127810564|NCT01707992|459923862|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
127810565|NCT01707992|459923863|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
127810566|NCT01707992|459923864|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
127810567|NCT01707992|459923859|FG000|Active Treatment Phase (24 Months)|Death|0|||
127810568|NCT01707992|459923860|FG001|Active Treatment Phase (24 Months)|Death|0|||
127810569|NCT01707992|459923861|FG002|Active Treatment Phase (24 Months)|Death|0|||
127810570|NCT01707992|459923862|FG003|Active Treatment Phase (24 Months)|Death|2|||
127810571|NCT01707992|459923863|FG004|Active Treatment Phase (24 Months)|Death|0|||
127810572|NCT01707992|459923864|FG005|Active Treatment Phase (24 Months)|Death|0|||
127810573|NCT01707992|459923859|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
127810574|NCT01707992|459923860|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
127810575|NCT01707992|459923861|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
127810576|NCT01707992|459923862|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
127810577|NCT01707992|459923863|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
127810578|NCT01707992|459923864|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
127810579|NCT01707992|459923859|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
127810580|NCT01707992|459923860|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
127810581|NCT01707992|459923861|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
127810582|NCT01707992|459923862|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
127810583|NCT01707992|459923863|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
127810584|NCT01707992|459923864|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
127810585|NCT01707992|459923859|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
127810586|NCT01707992|459923860|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
127810587|NCT01707992|459923861|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
127810588|NCT01707992|459923862|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
127810589|NCT01707992|459923863|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
127810590|NCT01707992|459923864|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
127810591|NCT01707992|459923859|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
127810592|NCT01707992|459923860|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
127810593|NCT01707992|459923861|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
127810594|NCT01707992|459923862|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
127810595|NCT01707992|459923863|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
127810596|NCT01707992|459923864|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
127810597|NCT02654002|459923868|FG000|Overall Study|Adverse Event|0|||
127810598|NCT02654002|459923869|FG001|Overall Study|Adverse Event|0|||
127810599|NCT02654002|459923870|FG002|Overall Study|Adverse Event|0|||
127810600|NCT02654002|459923871|FG003|Overall Study|Adverse Event|0|||
127810601|NCT02654002|459923872|FG004|Overall Study|Adverse Event|0|||
127810602|NCT02654002|459923873|FG005|Overall Study|Adverse Event|0|||
127810603|NCT02654002|459923874|FG006|Overall Study|Adverse Event|1|||
127810604|NCT02654002|459923875|FG007|Overall Study|Adverse Event|0|||
127810605|NCT02654002|459923876|FG008|Overall Study|Adverse Event|0|||
127810606|NCT02654002|459923868|FG000|Overall Study|Withdrew Consent|0|||
127810607|NCT02654002|459923869|FG001|Overall Study|Withdrew Consent|0|||
127810608|NCT02654002|459923870|FG002|Overall Study|Withdrew Consent|0|||
127810609|NCT02654002|459923871|FG003|Overall Study|Withdrew Consent|0|||
127810610|NCT02654002|459923872|FG004|Overall Study|Withdrew Consent|0|||
127810611|NCT02654002|459923873|FG005|Overall Study|Withdrew Consent|1|||
127810612|NCT02654002|459923874|FG006|Overall Study|Withdrew Consent|0|||
127810613|NCT02654002|459923875|FG007|Overall Study|Withdrew Consent|1|||
127810614|NCT02654002|459923876|FG008|Overall Study|Withdrew Consent|0|||
127810615|NCT01523873|459923877|FG000|Overall Study|Protocol Violation|422|||
127810616|NCT00891202|459923878|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
127810617|NCT00891202|459923879|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
127810618|NCT00891202|459923880|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
127810619|NCT00891202|459923881|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
127810620|NCT00891202|459923878|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
127810621|NCT00891202|459923879|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
127810622|NCT00891202|459923880|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
127810623|NCT00891202|459923881|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
127810624|NCT00891202|459923878|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
127810625|NCT00891202|459923879|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
127810626|NCT00891202|459923880|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
127810627|NCT00891202|459923881|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
127810628|NCT00891202|459923878|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
127810629|NCT00891202|459923879|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
127810630|NCT00891202|459923880|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
127810631|NCT00891202|459923881|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
127810632|NCT03313050|459923885|FG000|Stage 2: 12 Months|Adverse Event|0|||
127810633|NCT03313050|459923886|FG001|Stage 2: 12 Months|Adverse Event|0|||
127810634|NCT03313050|459923887|FG002|Stage 2: 12 Months|Adverse Event|0|||
127810635|NCT03313050|459923888|FG003|Stage 2: 12 Months|Adverse Event|1|||
127810636|NCT03313050|459923885|FG000|Stage 2: 12 Months|Death|0|||
127810637|NCT03313050|459923886|FG001|Stage 2: 12 Months|Death|0|||
127810638|NCT03313050|459923887|FG002|Stage 2: 12 Months|Death|3|||
127810639|NCT03313050|459923888|FG003|Stage 2: 12 Months|Death|0|||
127810640|NCT03313050|459923885|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
127810641|NCT03313050|459923886|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
127810642|NCT03313050|459923887|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
127810643|NCT03313050|459923888|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
127810644|NCT03313050|459923885|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
127810645|NCT03313050|459923886|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
127810646|NCT03313050|459923887|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
127810647|NCT03313050|459923888|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
127810648|NCT03313050|459923885|FG000|Stage 2: 12 Months|Protocol deviation|0|||
127810649|NCT03313050|459923886|FG001|Stage 2: 12 Months|Protocol deviation|0|||
127810650|NCT03313050|459923887|FG002|Stage 2: 12 Months|Protocol deviation|7|||
127810651|NCT03313050|459923888|FG003|Stage 2: 12 Months|Protocol deviation|7|||
127810652|NCT03313050|459923885|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
127810653|NCT03313050|459923886|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
127810654|NCT03313050|459923887|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
127810655|NCT03313050|459923888|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
127810656|NCT03313050|459923885|FG000|Stage 2: 12 Months|Other|0|||
127810657|NCT03313050|459923886|FG001|Stage 2: 12 Months|Other|0|||
127810658|NCT03313050|459923887|FG002|Stage 2: 12 Months|Other|0|||
127810659|NCT03313050|459923888|FG003|Stage 2: 12 Months|Other|1|||
127810660|NCT04211337|459923889|FG000|Overall Study|On Treatment|175|||
127810661|NCT04211337|459923890|FG001|Overall Study|On Treatment|40|||
127810662|NCT04211337|459923889|FG000|Overall Study|Withdrawal by Subject|0|||
127810663|NCT04211337|459923890|FG001|Overall Study|Withdrawal by Subject|2|||
127810664|NCT02847598|459923901|FG000|Overall Study|Adverse Event|0|||
127810665|NCT02847598|459923902|FG001|Overall Study|Adverse Event|0|||
127810666|NCT02847598|459923903|FG002|Overall Study|Adverse Event|0|||
127810667|NCT02847598|459923904|FG003|Overall Study|Adverse Event|0|||
127810668|NCT02847598|459923905|FG004|Overall Study|Adverse Event|0|||
127810669|NCT02847598|459923906|FG005|Overall Study|Adverse Event|0|||
127810670|NCT02847598|459923907|FG006|Overall Study|Adverse Event|0|||
127810671|NCT02847598|459923908|FG007|Overall Study|Adverse Event|1|||
127810672|NCT02847598|459923901|FG000|Overall Study|Consent withdrawn|2|||
127810673|NCT02847598|459923902|FG001|Overall Study|Consent withdrawn|0|||
127810674|NCT02847598|459923903|FG002|Overall Study|Consent withdrawn|0|||
127810675|NCT02847598|459923904|FG003|Overall Study|Consent withdrawn|4|||
127810676|NCT02847598|459923905|FG004|Overall Study|Consent withdrawn|3|||
127810677|NCT02847598|459923906|FG005|Overall Study|Consent withdrawn|2|||
127810678|NCT02847598|459923907|FG006|Overall Study|Consent withdrawn|1|||
127810679|NCT02847598|459923908|FG007|Overall Study|Consent withdrawn|3|||
127810680|NCT02847598|459923901|FG000|Overall Study|Death|3|||
127810681|NCT02847598|459923902|FG001|Overall Study|Death|0|||
127810682|NCT02847598|459923903|FG002|Overall Study|Death|0|||
127810683|NCT02847598|459923904|FG003|Overall Study|Death|0|||
127810684|NCT02847598|459923905|FG004|Overall Study|Death|0|||
127810685|NCT02847598|459923906|FG005|Overall Study|Death|0|||
127810686|NCT02847598|459923907|FG006|Overall Study|Death|0|||
127810687|NCT02847598|459923908|FG007|Overall Study|Death|0|||
127810688|NCT02847598|459923901|FG000|Overall Study|Lost to Follow-up|0|||
127810689|NCT02847598|459923902|FG001|Overall Study|Lost to Follow-up|0|||
127810690|NCT02847598|459923903|FG002|Overall Study|Lost to Follow-up|0|||
127810691|NCT02847598|459923904|FG003|Overall Study|Lost to Follow-up|0|||
127810692|NCT02847598|459923905|FG004|Overall Study|Lost to Follow-up|0|||
127810693|NCT02847598|459923906|FG005|Overall Study|Lost to Follow-up|1|||
127810694|NCT02847598|459923907|FG006|Overall Study|Lost to Follow-up|1|||
127810695|NCT02847598|459923908|FG007|Overall Study|Lost to Follow-up|0|||
127810696|NCT02848833|459923909|FG000|Overall Study|subject who are duplicated|1|||
127810697|NCT02848833|459923909|FG000|Overall Study|have not taken the study drug|11|||
127810698|NCT02848833|459923909|FG000|Overall Study|follow-up failure|6|||
127810699|NCT02848833|459923909|FG000|Overall Study|Protocol Violation|119|||
127810700|NCT04167345|459923910|FG000|Overall Study|Other|1|||
127810701|NCT04167345|459923911|FG001|Overall Study|Other|1|||
127810702|NCT04167345|459923912|FG002|Overall Study|Other|0|||
127810703|NCT04167345|459923913|FG003|Overall Study|Other|0|||
127810704|NCT04167345|459923914|FG004|Overall Study|Other|0|||
127810705|NCT00960076|459926392|FG000|Overall Study|Adverse Event|1|||
127810706|NCT00960076|459926393|FG001|Overall Study|Adverse Event|7|||
127810707|NCT00960076|459926392|FG000|Overall Study|No longer met study criteria|1|||
127810708|NCT00960076|459926393|FG001|Overall Study|No longer met study criteria|5|||
127810709|NCT00960076|459926392|FG000|Overall Study|Withdrawal by Subject|1|||
127810710|NCT00960076|459926393|FG001|Overall Study|Withdrawal by Subject|2|||
127810711|NCT00960076|459926392|FG000|Overall Study|Lost to Follow-up|3|||
127810712|NCT00960076|459926393|FG001|Overall Study|Lost to Follow-up|3|||
127810713|NCT00960076|459926392|FG000|Overall Study|Severe non-compliance to protocol|1|||
127810714|NCT00960076|459926393|FG001|Overall Study|Severe non-compliance to protocol|2|||
127810715|NCT00960076|459926392|FG000|Overall Study|Hyperglycemia|1|||
127810716|NCT00960076|459926393|FG001|Overall Study|Hyperglycemia|5|||
127810717|NCT00960076|459926392|FG000|Overall Study|Did not attend the termination visit|0|||
127810718|NCT00960076|459926393|FG001|Overall Study|Did not attend the termination visit|1|||
127810719|NCT00500266|459926394|FG000|Overall Study|Death|3|||
127810720|NCT00500266|459926394|FG000|Overall Study|Lost to Follow-up|3|||
127751855|NCT01646177|459718325|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
127751856|NCT01646177|459718326|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
127751857|NCT01646177|459718327|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
127751858|NCT01646177|459718328|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
127751859|NCT01646177|459718329|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
127751860|NCT01646177|459718330|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
127751861|NCT01646177|459718331|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
127751862|NCT01646177|459718332|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
127751863|NCT01646177|459718333|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
127751864|NCT01646177|459718334|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
127751865|NCT01646177|459718335|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
127751866|NCT01646177|459718336|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
127751867|NCT01646177|459718325|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
127751868|NCT01646177|459718326|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
127751869|NCT01646177|459718327|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
127751870|NCT01646177|459718328|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
127751871|NCT01646177|459718329|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
127751872|NCT01646177|459718330|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
127751873|NCT01646177|459718331|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
127751874|NCT01646177|459718332|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
127751875|NCT01646177|459718333|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
127751876|NCT01646177|459718334|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
127751877|NCT01646177|459718335|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
127751878|NCT01646177|459718336|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
127751879|NCT01646177|459718325|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
127751880|NCT01646177|459718326|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
127751881|NCT01646177|459718327|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
127751882|NCT01646177|459718328|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
127751883|NCT01646177|459718329|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
127751884|NCT01646177|459718330|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
127751885|NCT01646177|459718331|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
127751886|NCT01646177|459718332|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
127751887|NCT01646177|459718333|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
127751888|NCT01646177|459718334|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
127751889|NCT01646177|459718335|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
127751890|NCT01646177|459718336|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
127751891|NCT01646177|459718325|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
127751892|NCT01646177|459718326|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
127751893|NCT01646177|459718327|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
127751894|NCT01646177|459718328|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
127751895|NCT01646177|459718329|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
127751896|NCT01646177|459718330|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
127751897|NCT01646177|459718331|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
127751898|NCT01646177|459718332|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
127751899|NCT01646177|459718333|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
127751900|NCT01646177|459718334|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
127751901|NCT01646177|459718335|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
127751902|NCT01646177|459718336|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
127751903|NCT01646177|459718325|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
127751904|NCT01646177|459718326|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
127751905|NCT01646177|459718327|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
127751906|NCT01646177|459718328|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
127751907|NCT01646177|459718329|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
127751908|NCT01646177|459718330|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
127751909|NCT01646177|459718331|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
127751910|NCT01646177|459718332|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
127751911|NCT01646177|459718333|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
127751912|NCT01646177|459718334|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
127751913|NCT01646177|459718335|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
127751914|NCT01646177|459718336|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
127751915|NCT01646177|459718325|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
127810721|NCT00500266|459926394|FG000|Overall Study|Withdrawal by Subject|3|||
127810722|NCT00500266|459926394|FG000|Overall Study|Assigned, not treated|4|||
127810723|NCT01431287|459926395|FG000|Overall Study|not treated|0|||
127751916|NCT01646177|459718326|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
127751917|NCT01646177|459718327|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
127751918|NCT01646177|459718328|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
127751919|NCT01646177|459718329|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
127751920|NCT01646177|459718330|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
127751921|NCT01646177|459718331|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
127751922|NCT01646177|459718332|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
127751923|NCT01646177|459718333|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
127751924|NCT01646177|459718334|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
127751925|NCT01646177|459718335|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
127751926|NCT01646177|459718336|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
127751927|NCT01646177|459718325|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
127751928|NCT01646177|459718326|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
127751929|NCT01646177|459718327|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
127751930|NCT01646177|459718328|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
127751931|NCT01646177|459718329|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
127751932|NCT01646177|459718330|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
127751933|NCT01646177|459718331|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
127751934|NCT01646177|459718332|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
127751935|NCT01646177|459718333|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
127751936|NCT01646177|459718334|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
127751937|NCT01646177|459718335|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
127751938|NCT01646177|459718336|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
127751939|NCT01646177|459718325|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
127751940|NCT01646177|459718326|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
127751941|NCT01646177|459718327|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
127751942|NCT01646177|459718328|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
127751943|NCT01646177|459718329|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
127751944|NCT01646177|459718330|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
127751945|NCT01646177|459718331|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
127751946|NCT01646177|459718332|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
127751947|NCT01646177|459718333|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
127751948|NCT01646177|459718334|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
127751949|NCT01646177|459718335|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
127751950|NCT01646177|459718336|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
127751951|NCT01646177|459718325|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
127751952|NCT01646177|459718326|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
127751953|NCT01646177|459718327|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
127751954|NCT01646177|459718328|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
127751955|NCT01646177|459718329|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
127751956|NCT01646177|459718330|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
127751957|NCT01646177|459718331|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
127751958|NCT01646177|459718332|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
127751959|NCT01646177|459718333|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
127751960|NCT01646177|459718334|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
127751961|NCT01646177|459718335|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
127751962|NCT01646177|459718336|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
127751963|NCT01646177|459718325|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
127751964|NCT01646177|459718326|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
127751965|NCT01646177|459718327|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
127751966|NCT01646177|459718328|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
127751967|NCT01646177|459718329|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
127751968|NCT01646177|459718330|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
127751969|NCT01646177|459718331|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
127751970|NCT01646177|459718332|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
127751971|NCT01646177|459718333|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
127751972|NCT01646177|459718334|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
127751973|NCT01646177|459718335|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
127751974|NCT01646177|459718336|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
127751975|NCT01646177|459718325|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
127810724|NCT01431287|459926396|FG001|Overall Study|not treated|0|||
127810725|NCT01431287|459926397|FG002|Overall Study|not treated|1|||
127810726|NCT01431287|459926398|FG003|Overall Study|not treated|0|||
127810727|NCT01431287|459926399|FG004|Overall Study|not treated|0|||
127810728|NCT01431287|459926395|FG000|Overall Study|Adverse Event|59|||
127751976|NCT01646177|459718326|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
127751977|NCT01646177|459718327|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
127751978|NCT01646177|459718328|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
127751979|NCT01646177|459718329|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
127751980|NCT01646177|459718330|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
127751981|NCT01646177|459718331|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
127751982|NCT01646177|459718332|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
127751983|NCT01646177|459718333|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
127751984|NCT01646177|459718334|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
127751985|NCT01646177|459718335|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
127751986|NCT01646177|459718336|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
127751987|NCT01646177|459718325|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
127810729|NCT01431287|459926396|FG001|Overall Study|Adverse Event|57|||
127810730|NCT01431287|459926397|FG002|Overall Study|Adverse Event|53|||
127810731|NCT01431287|459926398|FG003|Overall Study|Adverse Event|33|||
127810732|NCT01431287|459926399|FG004|Overall Study|Adverse Event|41|||
127810733|NCT01431287|459926395|FG000|Overall Study|Non compliant with protocol|6|||
127810734|NCT01431287|459926396|FG001|Overall Study|Non compliant with protocol|6|||
127810735|NCT01431287|459926397|FG002|Overall Study|Non compliant with protocol|5|||
127810736|NCT01431287|459926398|FG003|Overall Study|Non compliant with protocol|6|||
127810737|NCT01431287|459926399|FG004|Overall Study|Non compliant with protocol|5|||
127810738|NCT01431287|459926395|FG000|Overall Study|Lost to Follow-up|0|||
127810739|NCT01431287|459926396|FG001|Overall Study|Lost to Follow-up|3|||
127810740|NCT01431287|459926397|FG002|Overall Study|Lost to Follow-up|2|||
127810741|NCT01431287|459926398|FG003|Overall Study|Lost to Follow-up|3|||
127810742|NCT01431287|459926399|FG004|Overall Study|Lost to Follow-up|1|||
127810743|NCT01431287|459926395|FG000|Overall Study|Consent withdrawn not due to AE|29|||
127810744|NCT01431287|459926396|FG001|Overall Study|Consent withdrawn not due to AE|30|||
127810745|NCT01431287|459926397|FG002|Overall Study|Consent withdrawn not due to AE|34|||
127810746|NCT01431287|459926398|FG003|Overall Study|Consent withdrawn not due to AE|19|||
127810747|NCT01431287|459926399|FG004|Overall Study|Consent withdrawn not due to AE|29|||
127810748|NCT01431287|459926395|FG000|Overall Study|not stated above|4|||
127810749|NCT01431287|459926396|FG001|Overall Study|not stated above|2|||
127810750|NCT01431287|459926397|FG002|Overall Study|not stated above|2|||
127810751|NCT01431287|459926398|FG003|Overall Study|not stated above|2|||
127810752|NCT01431287|459926399|FG004|Overall Study|not stated above|1|||
127810753|NCT02109029|459926400|FG000|Part B|Adverse Event|0|||
127810754|NCT02109029|459926401|FG001|Part B|Adverse Event|0|||
127810755|NCT02109029|459926402|FG002|Part B|Adverse Event|0|||
127810756|NCT02109029|459926403|FG003|Part B|Adverse Event|0|||
127810757|NCT02109029|459926404|FG004|Part B|Adverse Event|1|||
127810758|NCT02109029|459926405|FG005|Part B|Adverse Event|1|||
127810759|NCT00110305|459926406|FG000|Overall Study|Adverse Event|46|||
127810760|NCT00110305|459926407|FG001|Overall Study|Adverse Event|13|||
127810761|NCT00110305|459926406|FG000|Overall Study|Sponsors Decision|1|||
127810762|NCT00110305|459926407|FG001|Overall Study|Sponsors Decision|0|||
127810763|NCT00110305|459926406|FG000|Overall Study|Subject Non-Compliant|9|||
127810764|NCT00110305|459926407|FG001|Overall Study|Subject Non-Compliant|2|||
127810765|NCT00110305|459926406|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
127810766|NCT00110305|459926407|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
127810767|NCT00110305|459926406|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
127810768|NCT00110305|459926407|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
127810769|NCT00110305|459926406|FG000|Overall Study|Protocol Violation|0|||
127810770|NCT00110305|459926407|FG001|Overall Study|Protocol Violation|1|||
127810771|NCT00110305|459926406|FG000|Overall Study|Withdrawal by Subject|7|||
127810772|NCT00110305|459926407|FG001|Overall Study|Withdrawal by Subject|7|||
127810773|NCT00110305|459926406|FG000|Overall Study|Lost to Follow-up|20|||
127810774|NCT00110305|459926407|FG001|Overall Study|Lost to Follow-up|3|||
127810775|NCT00110305|459926406|FG000|Overall Study|Other|8|||
127810776|NCT00110305|459926407|FG001|Overall Study|Other|2|||
127810777|NCT01028352|459926412|FG000|Overall Study|Ineligible due to baseline average pain|5|||
127810778|NCT01028352|459926412|FG000|Overall Study|Withdrawal by Subject|1|||
127810779|NCT03323749|459926413|FG000|Double-blind Period|Lost to Follow-up|4|||
127894253|NCT00113490|460235283|FG001|Overall Study|Lost to Follow-up|0|||
127894254|NCT02162758|460235284|FG000|Overall Study|Study termination|0|||
127894255|NCT02162758|460235285|FG001|Overall Study|Study termination|1|||
127894256|NCT04471935|460235286|FG000|Overall Study|Withdrawal by Subject|1|||
127894257|NCT04471935|460235286|FG000|Overall Study|Deemed ineligible to participate|1|||
127894258|NCT03213210|460235289|FG000|Overall Study|Lost to Follow-up|2|||
127894259|NCT03213210|460235289|FG000|Overall Study|Study termination|3|||
127894260|NCT01325207|460235297|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
127810780|NCT03323749|459926414|FG001|Double-blind Period|Lost to Follow-up|5|||
127810781|NCT03323749|459926413|FG000|Double-blind Period|Adverse Event|3|||
127810782|NCT03323749|459926414|FG001|Double-blind Period|Adverse Event|1|||
127751988|NCT01646177|459718326|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
127751989|NCT01646177|459718327|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
127751990|NCT01646177|459718328|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
127751991|NCT01646177|459718329|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
127751992|NCT01646177|459718330|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
127751993|NCT01646177|459718331|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
127751994|NCT01646177|459718332|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
127751995|NCT01646177|459718333|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
127751996|NCT01646177|459718334|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
127751997|NCT01646177|459718335|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
127751998|NCT01646177|459718336|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
127751999|NCT01646177|459718325|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
127752000|NCT01646177|459718326|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
127752001|NCT01646177|459718327|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
127752002|NCT01646177|459718328|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
127752003|NCT01646177|459718329|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
127752004|NCT01646177|459718330|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
127752005|NCT01646177|459718331|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
127752006|NCT01646177|459718332|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
127752007|NCT01646177|459718333|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
127752008|NCT01646177|459718334|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
127752009|NCT01646177|459718335|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
127752010|NCT01646177|459718336|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
127752011|NCT01646177|459718325|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
127752012|NCT01646177|459718326|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
127752013|NCT01646177|459718327|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
127752014|NCT01646177|459718328|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
127752015|NCT01646177|459718329|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
127752016|NCT01646177|459718330|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
127752017|NCT01646177|459718331|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
127752018|NCT01646177|459718332|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
127752019|NCT01646177|459718333|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
127752020|NCT01646177|459718334|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
127752021|NCT01646177|459718335|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
127752022|NCT01646177|459718336|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
127752023|NCT01646177|459718325|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
127752024|NCT01646177|459718326|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
127752025|NCT01646177|459718327|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
127752026|NCT01646177|459718328|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
127752027|NCT01646177|459718329|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
127752028|NCT01646177|459718330|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
127810783|NCT03323749|459926413|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
127810784|NCT03323749|459926414|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
127810785|NCT03323749|459926413|FG000|Open-Label Period|Adverse Event|3|||
127810786|NCT03323749|459926414|FG001|Open-Label Period|Adverse Event|10|||
127810787|NCT03323749|459926413|FG000|Open-Label Period|Withdrawal by Subject|7|||
127810788|NCT03323749|459926414|FG001|Open-Label Period|Withdrawal by Subject|5|||
127810789|NCT02468193|459926415|FG000|Overall Study|Adverse Event|4|||
127810790|NCT02468193|459926415|FG000|Overall Study|Subject/ Guardian decision|2|||
127810791|NCT03312218|459926416|FG000|Overall Study|Never signed in to access the app|54|||
127810792|NCT03312218|459926417|FG001|Overall Study|Never signed in to access the app|58|||
127810793|NCT01887912|459926418|FG000|Overall Study|Serious adverse event|400|||
127810794|NCT01887912|459926419|FG001|Overall Study|Serious adverse event|198|||
127810795|NCT01887912|459926418|FG000|Overall Study|Other Adverse Event|34|||
127810796|NCT01887912|459926419|FG001|Overall Study|Other Adverse Event|15|||
127810797|NCT01887912|459926418|FG000|Overall Study|Protocol Violation|67|||
127810798|NCT01887912|459926419|FG001|Overall Study|Protocol Violation|37|||
127810799|NCT01887912|459926418|FG000|Overall Study|Lost to Follow-up|163|||
127810800|NCT01887912|459926419|FG001|Overall Study|Lost to Follow-up|74|||
127810801|NCT01887912|459926418|FG000|Overall Study|Withdrawal by Subject|606|||
127810802|NCT01887912|459926419|FG001|Overall Study|Withdrawal by Subject|349|||
127810803|NCT01887912|459926418|FG000|Overall Study|Other|122|||
127810804|NCT01887912|459926419|FG001|Overall Study|Other|58|||
127810805|NCT05067127|459926422|FG000|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
127810806|NCT05067127|459926423|FG001|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|1|||
127810807|NCT05067127|459926424|FG002|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
127810808|NCT05067127|459926425|FG003|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
127810809|NCT05067127|459926422|FG000|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
127810810|NCT05067127|459926423|FG001|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
127810811|NCT05067127|459926424|FG002|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
127810812|NCT05067127|459926425|FG003|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
127810813|NCT05067127|459926422|FG000|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
127810814|NCT05067127|459926423|FG001|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
127810815|NCT05067127|459926424|FG002|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
127810816|NCT05067127|459926425|FG003|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
127810817|NCT05067127|459926422|FG000|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
127810818|NCT05067127|459926423|FG001|Randomized Controlled Period (26 Weeks)|Pregnancy|1|||
127810819|NCT05067127|459926424|FG002|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
127810820|NCT05067127|459926425|FG003|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
127810821|NCT05067127|459926422|FG000|Randomized Controlled Period (26 Weeks)|Death|1|||
127810822|NCT05067127|459926423|FG001|Randomized Controlled Period (26 Weeks)|Death|0|||
127810823|NCT05067127|459926424|FG002|Randomized Controlled Period (26 Weeks)|Death|0|||
127810824|NCT05067127|459926425|FG003|Randomized Controlled Period (26 Weeks)|Death|0|||
127810825|NCT05067127|459926422|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
127810826|NCT05067127|459926423|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
127810827|NCT05067127|459926424|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
127810828|NCT05067127|459926425|FG003|Open-Label Period (26 Weeks)|Withdrawal by Subject|1|||
127810829|NCT05067127|459926422|FG000|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
127810830|NCT05067127|459926423|FG001|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
127810831|NCT05067127|459926424|FG002|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|2|||
127810832|NCT05067127|459926425|FG003|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
127810833|NCT04462536|459926426|FG000|Overall Study|Withdrawal by Subject|3|||
127810834|NCT04462536|459926427|FG001|Overall Study|Withdrawal by Subject|9|||
127810835|NCT04462536|459926426|FG000|Overall Study|Lost to Follow-up|2|||
127810836|NCT04462536|459926427|FG001|Overall Study|Lost to Follow-up|4|||
127810837|NCT01154101|459926433|FG000|Overall Study|Adverse Event|0|||
127810838|NCT01154101|459926434|FG001|Overall Study|Adverse Event|2|||
127810839|NCT01154101|459926435|FG002|Overall Study|Adverse Event|1|||
127810840|NCT01154101|459926436|FG003|Overall Study|Adverse Event|1|||
127810841|NCT01154101|459926437|FG004|Overall Study|Adverse Event|0|||
127810842|NCT01154101|459926433|FG000|Overall Study|Lost to Follow-up|0|||
127810843|NCT01154101|459926434|FG001|Overall Study|Lost to Follow-up|1|||
127810844|NCT01154101|459926435|FG002|Overall Study|Lost to Follow-up|0|||
127810845|NCT01154101|459926436|FG003|Overall Study|Lost to Follow-up|1|||
127810846|NCT01154101|459926437|FG004|Overall Study|Lost to Follow-up|0|||
127810847|NCT01154101|459926433|FG000|Overall Study|Withdrawal by Subject|0|||
127810848|NCT01154101|459926434|FG001|Overall Study|Withdrawal by Subject|1|||
127810849|NCT01154101|459926435|FG002|Overall Study|Withdrawal by Subject|2|||
127810850|NCT01154101|459926436|FG003|Overall Study|Withdrawal by Subject|0|||
127810851|NCT01154101|459926437|FG004|Overall Study|Withdrawal by Subject|1|||
127810852|NCT04125680|459926439|FG000|Overall Study|Lost to Follow-up|15|||
127810853|NCT01562028|459926440|FG000|Overall Study|Withdrawal by Subject|1|||
127810854|NCT01562028|459926441|FG001|Overall Study|Withdrawal by Subject|1|||
127810855|NCT01562028|459926440|FG000|Overall Study|Lost to Follow-up|2|||
127810856|NCT01562028|459926441|FG001|Overall Study|Lost to Follow-up|1|||
127810857|NCT02360098|459926442|FG000|Overall Study|Physician Decision|7|||
127810858|NCT04938648|459926443|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
127810859|NCT04938648|459926444|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
127810860|NCT04938648|459926443|FG000|Overall Study|Patient too ill|0|||
127810861|NCT04938648|459926444|FG001|Overall Study|Patient too ill|1|||
127810862|NCT04938648|459926443|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
127810863|NCT04938648|459926444|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
127810864|NCT04938648|459926443|FG000|Overall Study|Patient did not have memory problems|1|||
127810865|NCT04938648|459926444|FG001|Overall Study|Patient did not have memory problems|1|||
127810866|NCT04938648|459926443|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
127810867|NCT04938648|459926444|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
127810868|NCT04938648|459926443|FG000|Overall Study|Care partner could not be reached|0|||
127810869|NCT04938648|459926444|FG001|Overall Study|Care partner could not be reached|1|||
127810870|NCT04938648|459926443|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
127810871|NCT04938648|459926444|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
127810872|NCT04938648|459926443|FG000|Overall Study|Withdrawal by Subject|2|||
127810873|NCT04938648|459926444|FG001|Overall Study|Withdrawal by Subject|1|||
127810874|NCT03619213|459926445|FG000|Overall Study|Lost to Follow-up|2|||
127810875|NCT03619213|459926446|FG001|Overall Study|Lost to Follow-up|1|||
127752029|NCT01646177|459718331|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
127752030|NCT01646177|459718332|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
127752031|NCT01646177|459718333|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
127752032|NCT01646177|459718334|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
127752033|NCT01646177|459718335|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
127752034|NCT01646177|459718336|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
127752035|NCT01646177|459718325|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
127752036|NCT01646177|459718326|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
127752037|NCT01646177|459718327|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
127752038|NCT01646177|459718328|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
127752039|NCT01646177|459718329|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
127752040|NCT01646177|459718330|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
127752041|NCT01646177|459718331|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
127752042|NCT01646177|459718332|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
127752043|NCT01646177|459718333|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
127752044|NCT01646177|459718334|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
127752045|NCT01646177|459718335|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
127752046|NCT01646177|459718336|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
127752047|NCT01646177|459718325|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
127752048|NCT01646177|459718326|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
127752049|NCT01646177|459718327|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
127752050|NCT01646177|459718328|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
127752051|NCT01646177|459718329|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
127752052|NCT01646177|459718330|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
127752053|NCT01646177|459718331|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
127752054|NCT01646177|459718332|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
127752055|NCT01646177|459718333|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
127752056|NCT01646177|459718334|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
127752057|NCT01646177|459718335|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
127752058|NCT01646177|459718336|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
127752059|NCT01646177|459718325|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
127752060|NCT01646177|459718326|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
127752061|NCT01646177|459718327|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
127752062|NCT01646177|459718328|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
127752063|NCT01646177|459718329|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
127752064|NCT01646177|459718330|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
127752065|NCT01646177|459718331|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
127752066|NCT01646177|459718332|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
127752067|NCT01646177|459718333|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
127752068|NCT01646177|459718334|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
127752069|NCT01646177|459718335|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
127752070|NCT01646177|459718336|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
127752071|NCT01646177|459718325|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
127752072|NCT01646177|459718326|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
127752073|NCT01646177|459718327|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
127752074|NCT01646177|459718328|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
127752075|NCT01646177|459718329|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
127752076|NCT01646177|459718330|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
127752077|NCT01646177|459718331|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
127752078|NCT01646177|459718332|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
127752079|NCT01646177|459718333|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
127752080|NCT01646177|459718334|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
127752081|NCT01646177|459718335|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
127752082|NCT01646177|459718336|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
127752083|NCT01646177|459718325|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
127752084|NCT01646177|459718326|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
127752085|NCT01646177|459718327|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
127752086|NCT01646177|459718328|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
127752087|NCT01646177|459718329|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
127752088|NCT01646177|459718330|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
127752089|NCT01646177|459718331|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
127752090|NCT01646177|459718332|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
127752091|NCT01646177|459718333|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
127752092|NCT01646177|459718334|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
127752093|NCT01646177|459718335|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
127752094|NCT01646177|459718336|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
127894261|NCT01325207|460235298|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
127894262|NCT01325207|460235299|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
127894263|NCT01325207|460235300|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
127752095|NCT01646177|459718325|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
127752096|NCT01646177|459718326|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
127752097|NCT01646177|459718327|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
127752098|NCT01646177|459718328|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
127752099|NCT01646177|459718329|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
127752100|NCT01646177|459718330|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
127752101|NCT01646177|459718331|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
127752102|NCT01646177|459718332|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
127752103|NCT01646177|459718333|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
127752104|NCT01646177|459718334|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
127752105|NCT01646177|459718335|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
127752106|NCT01646177|459718336|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
127752107|NCT01465763|459718337|FG000|Overall Study|Withdrawal by Subject|4|||
127752108|NCT01465763|459718338|FG001|Overall Study|Withdrawal by Subject|0|||
127752109|NCT01465763|459718339|FG002|Overall Study|Withdrawal by Subject|1|||
127752110|NCT01465763|459718337|FG000|Overall Study|Insufficient Clinical Response|11|||
127752111|NCT01465763|459718338|FG001|Overall Study|Insufficient Clinical Response|0|||
127810876|NCT03619213|459926445|FG000|Overall Study|Withdrawal by Subject|8|||
127810877|NCT03619213|459926446|FG001|Overall Study|Withdrawal by Subject|10|||
127810878|NCT02542267|459926447|FG000|Overall Study|Withdrawal by Subject|10|||
127810879|NCT02542267|459926447|FG000|Overall Study|Physician Decision|6|||
127810880|NCT02542267|459926447|FG000|Overall Study|Lost to Follow-up|4|||
127810881|NCT02542267|459926447|FG000|Overall Study|Death|13|||
127810882|NCT02542267|459926447|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
127810883|NCT02542267|459926447|FG000|Overall Study|Other|9|||
127810884|NCT03093155|459926450|FG000|Overall Study|Not Eligible|1|||
127810885|NCT03093155|459926451|FG001|Overall Study|Not Eligible|0|||
127810886|NCT03093155|459926450|FG000|Overall Study|Withdrawal by Subject|0|||
127810887|NCT03093155|459926451|FG001|Overall Study|Withdrawal by Subject|1|||
127810888|NCT00619229|459926452|FG000|Overall Study|Withdrawal by Subject|1|||
127810889|NCT00619229|459926453|FG001|Overall Study|Withdrawal by Subject|1|||
127810890|NCT00619229|459926452|FG000|Overall Study|Lost to Follow-up|1|||
127810891|NCT00619229|459926453|FG001|Overall Study|Lost to Follow-up|0|||
127810892|NCT00619229|459926452|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
127810893|NCT00619229|459926453|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
127810894|NCT00619229|459926452|FG000|Overall Study|Investigator planned Cataract Operation|1|||
127810895|NCT00619229|459926453|FG001|Overall Study|Investigator planned Cataract Operation|0|||
127810896|NCT02786901|459926454|FG000|Overall Study|Adverse Event|1|||
127810897|NCT02786901|459926455|FG001|Overall Study|Adverse Event|1|||
127810898|NCT02786901|459926456|FG002|Overall Study|Adverse Event|2|||
127810899|NCT02786901|459926454|FG000|Overall Study|Physician Decision|1|||
127810900|NCT02786901|459926455|FG001|Overall Study|Physician Decision|0|||
127810901|NCT02786901|459926456|FG002|Overall Study|Physician Decision|0|||
127810902|NCT02786901|459926454|FG000|Overall Study|Rescue Therapy Use|71|||
127810903|NCT02786901|459926455|FG001|Overall Study|Rescue Therapy Use|49|||
127810904|NCT02786901|459926456|FG002|Overall Study|Rescue Therapy Use|33|||
127810905|NCT02786901|459926454|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
127810906|NCT02786901|459926455|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
127810907|NCT02786901|459926456|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
127810908|NCT02786901|459926454|FG000|Overall Study|Disallowed medication|1|||
127810909|NCT02786901|459926455|FG001|Overall Study|Disallowed medication|1|||
127810910|NCT02786901|459926456|FG002|Overall Study|Disallowed medication|0|||
127810911|NCT02786901|459926454|FG000|Overall Study|Randomized in error|2|||
127810912|NCT02786901|459926455|FG001|Overall Study|Randomized in error|0|||
127810913|NCT02786901|459926456|FG002|Overall Study|Randomized in error|1|||
127810914|NCT03367871|459926457|FG000|Overall Study|Lost to Follow-up|1|||
127810915|NCT01075178|459926458|FG000|Subject Matching|eligible but not matched|130|||
127810916|NCT01075178|459926459|FG001|Subject Matching|eligible but not matched|403|||
127752112|NCT01465763|459718339|FG002|Overall Study|Insufficient Clinical Response|1|||
127752113|NCT01465763|459718337|FG000|Overall Study|Adverse Event|9|||
127752114|NCT01465763|459718338|FG001|Overall Study|Adverse Event|0|||
127752115|NCT01465763|459718339|FG002|Overall Study|Adverse Event|1|||
127752116|NCT01465763|459718337|FG000|Overall Study|Other|2|||
127810917|NCT01075178|459926458|FG000|Subject Chart Review|died before chart review period|0|||
127810918|NCT01075178|459926459|FG001|Subject Chart Review|died before chart review period|2|||
127810919|NCT01075178|459926458|FG000|Subject Chart Review|no data collected due to site closure|3|||
127894264|NCT01325207|460235301|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
127810920|NCT01075178|459926459|FG001|Subject Chart Review|no data collected due to site closure|4|||
127810921|NCT01075178|459926458|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
127810922|NCT01075178|459926459|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
127810923|NCT02983604|459926460|FG000|Overall Study|Enrolled but not Treated|0|||
127810924|NCT02983604|459926461|FG001|Overall Study|Enrolled but not Treated|0|||
127810925|NCT02983604|459926462|FG002|Overall Study|Enrolled but not Treated|1|||
127810926|NCT02983604|459926463|FG003|Overall Study|Enrolled but not Treated|0|||
127810927|NCT01111604|459926464|FG000|Overall Study|Lost to Follow-up|0|||
127810928|NCT01111604|459926465|FG001|Overall Study|Lost to Follow-up|0|||
127810929|NCT01111604|459926466|FG002|Overall Study|Lost to Follow-up|1|||
127810930|NCT01111604|459926464|FG000|Overall Study|Withdrew Consent|3|||
127810931|NCT01111604|459926465|FG001|Overall Study|Withdrew Consent|0|||
127810932|NCT01111604|459926466|FG002|Overall Study|Withdrew Consent|2|||
127810933|NCT01111604|459926464|FG000|Overall Study|Withdrawal by Subject|2|||
127810934|NCT01111604|459926465|FG001|Overall Study|Withdrawal by Subject|0|||
127810935|NCT01111604|459926466|FG002|Overall Study|Withdrawal by Subject|0|||
127810936|NCT01111604|459926464|FG000|Overall Study|Death|1|||
127810937|NCT01111604|459926465|FG001|Overall Study|Death|0|||
127810938|NCT01111604|459926466|FG002|Overall Study|Death|0|||
127810939|NCT01111604|459926464|FG000|Overall Study|Met Exclusion Criteria|2|||
127810940|NCT01111604|459926465|FG001|Overall Study|Met Exclusion Criteria|0|||
127810941|NCT01111604|459926466|FG002|Overall Study|Met Exclusion Criteria|0|||
127810942|NCT00316264|459926468|FG000|Overall Study|Lost to Follow-up|0|||
127810943|NCT00316264|459926469|FG001|Overall Study|Lost to Follow-up|1|||
127810944|NCT00316264|459926470|FG002|Overall Study|Lost to Follow-up|0|||
127810945|NCT00316264|459926468|FG000|Overall Study|Withdrawal of Consent|3|||
127810946|NCT00316264|459926469|FG001|Overall Study|Withdrawal of Consent|5|||
127810947|NCT00316264|459926470|FG002|Overall Study|Withdrawal of Consent|6|||
127810948|NCT00316264|459926468|FG000|Overall Study|Death|2|||
127810949|NCT00316264|459926469|FG001|Overall Study|Death|0|||
127810950|NCT00316264|459926470|FG002|Overall Study|Death|0|||
127810951|NCT00316264|459926468|FG000|Overall Study|Other|1|||
127810952|NCT00316264|459926469|FG001|Overall Study|Other|1|||
127810953|NCT00316264|459926470|FG002|Overall Study|Other|0|||
127810954|NCT00607048|459926471|FG000|Overall Study|Adverse Event|0|||
127810955|NCT00607048|459926472|FG001|Overall Study|Adverse Event|1|||
127810956|NCT00607048|459926473|FG002|Overall Study|Adverse Event|0|||
127810957|NCT00607048|459926474|FG003|Overall Study|Adverse Event|0|||
127810958|NCT00607048|459926475|FG004|Overall Study|Adverse Event|4|||
127810959|NCT00607048|459926476|FG005|Overall Study|Adverse Event|0|||
127810960|NCT00607048|459926471|FG000|Overall Study|Global deterioration of health|1|||
127810961|NCT00607048|459926472|FG001|Overall Study|Global deterioration of health|0|||
127810962|NCT00607048|459926473|FG002|Overall Study|Global deterioration of health|0|||
127810963|NCT00607048|459926474|FG003|Overall Study|Global deterioration of health|0|||
127810964|NCT00607048|459926475|FG004|Overall Study|Global deterioration of health|0|||
127810965|NCT00607048|459926476|FG005|Overall Study|Global deterioration of health|0|||
127810966|NCT00607048|459926471|FG000|Overall Study|Objective disease progression - relapse|1|||
127810967|NCT00607048|459926472|FG001|Overall Study|Objective disease progression - relapse|2|||
127810968|NCT00607048|459926473|FG002|Overall Study|Objective disease progression - relapse|4|||
127810969|NCT00607048|459926474|FG003|Overall Study|Objective disease progression - relapse|2|||
127810970|NCT00607048|459926475|FG004|Overall Study|Objective disease progression - relapse|2|||
127810971|NCT00607048|459926476|FG005|Overall Study|Objective disease progression - relapse|2|||
127810972|NCT00607048|459926471|FG000|Overall Study|Withdrawal by Subject|0|||
127810973|NCT00607048|459926472|FG001|Overall Study|Withdrawal by Subject|0|||
127810974|NCT00607048|459926473|FG002|Overall Study|Withdrawal by Subject|0|||
127810975|NCT00607048|459926474|FG003|Overall Study|Withdrawal by Subject|1|||
127810976|NCT00607048|459926475|FG004|Overall Study|Withdrawal by Subject|0|||
127810977|NCT00607048|459926476|FG005|Overall Study|Withdrawal by Subject|2|||
127810978|NCT00607048|459926471|FG000|Overall Study|Other|1|||
127810979|NCT00607048|459926472|FG001|Overall Study|Other|1|||
127810980|NCT00607048|459926473|FG002|Overall Study|Other|0|||
127810981|NCT00607048|459926474|FG003|Overall Study|Other|0|||
127810982|NCT00607048|459926475|FG004|Overall Study|Other|0|||
127810983|NCT00607048|459926476|FG005|Overall Study|Other|1|||
127810984|NCT00355264|459926477|FG000|Extension (Variable Duration)|Adverse Event|1|||
127810985|NCT00355264|459926477|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
127810986|NCT01157117|459926478|FG000|Overall Study|Dosing Symptoms|0|||
127810987|NCT01157117|459926479|FG001|Overall Study|Dosing Symptoms|4|||
127810988|NCT01157117|459926480|FG002|Overall Study|Dosing Symptoms|0|||
127810989|NCT01157117|459926478|FG000|Overall Study|Withdrawal by Subject|4|||
127810990|NCT01157117|459926479|FG001|Overall Study|Withdrawal by Subject|1|||
127894265|NCT01325207|460235302|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
127810991|NCT01157117|459926480|FG002|Overall Study|Withdrawal by Subject|1|||
127810992|NCT01157117|459926478|FG000|Overall Study|Lack of Efficacy|1|||
127810993|NCT01157117|459926479|FG001|Overall Study|Lack of Efficacy|1|||
127810994|NCT01157117|459926480|FG002|Overall Study|Lack of Efficacy|0|||
127810995|NCT01157117|459926478|FG000|Overall Study|Lost to Follow-up|0|||
127810996|NCT01157117|459926479|FG001|Overall Study|Lost to Follow-up|0|||
127810997|NCT01157117|459926480|FG002|Overall Study|Lost to Follow-up|1|||
127752117|NCT01465763|459718338|FG001|Overall Study|Other|0|||
127752118|NCT01465763|459718339|FG002|Overall Study|Other|0|||
127752119|NCT01465763|459718337|FG000|Overall Study|Protocol Violation|4|||
127752120|NCT01465763|459718338|FG001|Overall Study|Protocol Violation|1|||
127752121|NCT01465763|459718339|FG002|Overall Study|Protocol Violation|1|||
127752122|NCT01465763|459718337|FG000|Overall Study|Death|1|||
127752123|NCT01465763|459718338|FG001|Overall Study|Death|0|||
127752124|NCT01465763|459718339|FG002|Overall Study|Death|0|||
127752125|NCT02920970|459718340|FG000|First Intervention|Protocol Violation|0|||
127752126|NCT02920970|459718341|FG001|First Intervention|Protocol Violation|1|||
127752127|NCT02920970|459718340|FG000|First Intervention|Adverse Event|0|||
127752128|NCT02920970|459718341|FG001|First Intervention|Adverse Event|1|||
127752129|NCT02920970|459718340|FG000|Second Intervention|Poor Lens Fit|1|||
127752130|NCT02920970|459718341|FG001|Second Intervention|Poor Lens Fit|0|||
127752131|NCT01711853|459718345|FG000|Overall Study|Not treated|3|||
127752132|NCT02992691|459718349|FG000|Overall Study|Adverse Event|2|||
127752133|NCT02992691|459718349|FG000|Overall Study|Withdrawal by Subject|1|||
127752134|NCT04276051|459718350|FG000|Overall Study|Lost to Follow-up|0|||
127752135|NCT04276051|459718351|FG001|Overall Study|Lost to Follow-up|1|||
127752136|NCT04276051|459718350|FG000|Overall Study|Physician Decision|0|||
127752137|NCT04276051|459718351|FG001|Overall Study|Physician Decision|1|||
127752138|NCT04276051|459718350|FG000|Overall Study|Withdrawal by Subject|1|||
127752139|NCT04276051|459718351|FG001|Overall Study|Withdrawal by Subject|1|||
127752140|NCT00392925|459718353|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
127752141|NCT00392925|459718354|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
127752142|NCT00392925|459718355|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
127752143|NCT00392925|459718356|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
127752144|NCT00392925|459718353|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
127752145|NCT00392925|459718354|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
127752146|NCT00392925|459718355|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
127752147|NCT00392925|459718356|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
127752148|NCT00392925|459718353|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
127752149|NCT00392925|459718354|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
127752150|NCT00392925|459718355|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
127752151|NCT00392925|459718356|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
127752152|NCT00392925|459718353|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
127752153|NCT00392925|459718354|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
127752154|NCT00392925|459718355|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
127752155|NCT00392925|459718356|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
127752156|NCT00392925|459718353|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
127752157|NCT00392925|459718354|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
127752158|NCT00392925|459718355|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
127752159|NCT00392925|459718356|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
127810998|NCT01157117|459926478|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
127810999|NCT01157117|459926479|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
127811000|NCT01157117|459926480|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
127811001|NCT00826514|459926481|FG000|Overall Study|Adverse Event|1|||
127811002|NCT00826514|459926482|FG001|Overall Study|Adverse Event|1|||
127811003|NCT00826514|459926481|FG000|Overall Study|Lack of Efficacy|0|||
127811004|NCT00826514|459926482|FG001|Overall Study|Lack of Efficacy|1|||
127811005|NCT00826514|459926481|FG000|Overall Study|Withdrawal by Subject|2|||
127811006|NCT00826514|459926482|FG001|Overall Study|Withdrawal by Subject|3|||
127811007|NCT03926143|459926484|FG000|Overall Study|Physician Decision|3|||
127811008|NCT03926143|459926484|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
127811009|NCT03926143|459926484|FG000|Overall Study|Adverse Event|2|||
127811010|NCT03926143|459926484|FG000|Overall Study|Progressive disease|3|||
127894266|NCT01325207|460235297|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
127894267|NCT01325207|460235298|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
127752160|NCT00392925|459718353|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
127752161|NCT00392925|459718354|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
127752162|NCT00392925|459718355|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
127752163|NCT00392925|459718356|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
127752164|NCT00392925|459718353|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
127811011|NCT02207907|459926490|FG000|Overall Study|Lost to Follow-up|3|||
127811012|NCT02207907|459926491|FG001|Overall Study|Lost to Follow-up|1|||
127752165|NCT00392925|459718354|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
127752166|NCT00392925|459718355|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
127752167|NCT00392925|459718356|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
127752168|NCT00392925|459718353|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
127752169|NCT00392925|459718354|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
127752170|NCT00392925|459718355|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
127752171|NCT00392925|459718356|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
127752172|NCT00392925|459718353|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
127752173|NCT00392925|459718354|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
127752174|NCT00392925|459718355|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
127752175|NCT00392925|459718356|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
127752176|NCT00755105|459718359|FG000|Overall Study|Withdrawal by Subject|9|||
127752177|NCT00755105|459718360|FG001|Overall Study|Withdrawal by Subject|11|||
127752178|NCT00755105|459718361|FG002|Overall Study|Withdrawal by Subject|4|||
127752179|NCT01281839|459718362|FG000|Overall Study|Lost to Follow-up|6|||
127752180|NCT01281839|459718363|FG001|Overall Study|Lost to Follow-up|3|||
127752181|NCT01281839|459718362|FG000|Overall Study|Withdrawal by Subject|4|||
127752182|NCT01281839|459718363|FG001|Overall Study|Withdrawal by Subject|10|||
127752183|NCT01281839|459718362|FG000|Overall Study|Reason not specified|0|||
127752184|NCT01281839|459718363|FG001|Overall Study|Reason not specified|1|||
127752185|NCT01509547|459718368|FG000|Overall Study|Lost to Follow-up|24|||
127752186|NCT01509547|459718369|FG001|Overall Study|Lost to Follow-up|14|||
127752187|NCT01509547|459718368|FG000|Overall Study|Withdrawal by Subject|11|||
127752188|NCT01509547|459718369|FG001|Overall Study|Withdrawal by Subject|24|||
127752189|NCT01509547|459718368|FG000|Overall Study|Physician Decision|0|||
127752190|NCT01509547|459718369|FG001|Overall Study|Physician Decision|1|||
127752191|NCT00402051|459718370|FG000|Overall Study|Progressive Disease|13|||
127752192|NCT00402051|459718371|FG001|Overall Study|Progressive Disease|20|||
127752193|NCT00402051|459718370|FG000|Overall Study|Adverse Event|11|||
127752194|NCT00402051|459718371|FG001|Overall Study|Adverse Event|4|||
127752195|NCT00402051|459718370|FG000|Overall Study|Physician Decision|7|||
127752196|NCT00402051|459718371|FG001|Overall Study|Physician Decision|3|||
127752197|NCT00402051|459718370|FG000|Overall Study|Withdrawal by Subject|3|||
127752198|NCT00402051|459718371|FG001|Overall Study|Withdrawal by Subject|3|||
127752199|NCT00402051|459718370|FG000|Overall Study|Death - Related to Study Drug|1|||
127752200|NCT00402051|459718371|FG001|Overall Study|Death - Related to Study Drug|2|||
127752201|NCT00402051|459718370|FG000|Overall Study|Death Due to Study Disease|2|||
127752202|NCT00402051|459718371|FG001|Overall Study|Death Due to Study Disease|1|||
127752203|NCT00402051|459718370|FG000|Overall Study|Death Due to Adverse Event|0|||
127752204|NCT00402051|459718371|FG001|Overall Study|Death Due to Adverse Event|2|||
127752205|NCT00402051|459718370|FG000|Overall Study|Lost to Follow-up|1|||
127752206|NCT00402051|459718371|FG001|Overall Study|Lost to Follow-up|0|||
127752207|NCT00570908|459718386|FG000|Overall Study|Adverse Event|5|||
127752208|NCT00570908|459718386|FG000|Overall Study|Withdrawal by Subject|2|||
127752209|NCT01213524|459718387|FG000|Baseline|Withdrawal by Subject|5|||
127752210|NCT01213524|459718387|FG000|Baseline|high breath alcohol levels|1|||
127752211|NCT01213524|459718387|FG000|Baseline|Physician Decision|1|||
127752212|NCT01213524|459718387|FG000|Session 2|Withdrawal by Subject|5|||
127752213|NCT01213524|459718387|FG000|Session 3|Withdrawal by Subject|4|||
127752214|NCT01213524|459718387|FG000|Session 4|Physician Decision|1|||
127752215|NCT01213524|459718387|FG000|Session 4|Withdrawal by Subject|2|||
127752216|NCT06152224|459718393|FG000|Overall Study|Withdrawal by Subject|1|||
127752217|NCT06152224|459718394|FG001|Overall Study|Withdrawal by Subject|0|||
127752218|NCT06152224|459718393|FG000|Overall Study|Lost to Follow-up|0|||
127752219|NCT06152224|459718394|FG001|Overall Study|Lost to Follow-up|1|||
127752220|NCT06152224|459718393|FG000|Overall Study|On Follow Up|18|||
127752221|NCT06152224|459718394|FG001|Overall Study|On Follow Up|18|||
127752222|NCT00281320|459718397|FG000|Overall Study|Adverse Event|12|||
127752223|NCT00281320|459718398|FG001|Overall Study|Adverse Event|9|||
127752224|NCT00281320|459718397|FG000|Overall Study|Lack of Efficacy|4|||
127752225|NCT00281320|459718398|FG001|Overall Study|Lack of Efficacy|3|||
127752226|NCT00281320|459718397|FG000|Overall Study|Withdrawal by Subject|5|||
127752227|NCT00281320|459718398|FG001|Overall Study|Withdrawal by Subject|6|||
127752228|NCT00281320|459718397|FG000|Overall Study|Lost to Follow-up|1|||
127752229|NCT00281320|459718398|FG001|Overall Study|Lost to Follow-up|2|||
127752230|NCT00281320|459718397|FG000|Overall Study|Other|3|||
127752231|NCT00281320|459718398|FG001|Overall Study|Other|1|||
127752232|NCT01447576|459718407|FG000|Overall Study|Lost to Follow-up|52|||
127752233|NCT01447576|459718407|FG000|Overall Study|Adverse Event|127|||
127752234|NCT01447576|459718407|FG000|Overall Study|Participant met withdrawal criteria|40|||
127752235|NCT01447576|459718407|FG000|Overall Study|Withdrawal by Subject|100|||
127752236|NCT01447576|459718407|FG000|Overall Study|Protocol deviation|83|||
127752237|NCT01447576|459718407|FG000|Overall Study|Lack of Efficacy|68|||
127752238|NCT01447576|459718407|FG000|Overall Study|Physician Decision|6|||
127752239|NCT00975676|459718408|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
127752240|NCT00975676|459718409|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
127752241|NCT02548078|459718410|FG000|Overall Study|Serious adverse event/Adverse event|1|||
127752242|NCT02548078|459718411|FG001|Overall Study|Serious adverse event/Adverse event|0|||
127752243|NCT02548078|459718410|FG000|Overall Study|Moved from study area|3|||
127752244|NCT02548078|459718411|FG001|Overall Study|Moved from study area|3|||
127752245|NCT02548078|459718410|FG000|Overall Study|Lost to Follow-up|1|||
127752246|NCT02548078|459718411|FG001|Overall Study|Lost to Follow-up|3|||
127752247|NCT02579772|459718412|FG000|Overall Study|Withdrawal by Subject|0|||
127752248|NCT02579772|459718413|FG001|Overall Study|Withdrawal by Subject|1|||
127752249|NCT02579772|459718412|FG000|Overall Study|Usage of additional antioxidants|1|||
127752250|NCT02579772|459718413|FG001|Overall Study|Usage of additional antioxidants|0|||
127752251|NCT02579772|459718412|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
127752252|NCT02579772|459718413|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
127752253|NCT03128671|459718414|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
127752254|NCT03128671|459718415|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
127752255|NCT03128671|459718414|FG000|Allocation|Death|1|||
127752256|NCT03128671|459718415|FG001|Allocation|Death|0|||
127752257|NCT03128671|459718414|FG000|Allocation|Withdrawal by Subject|4|||
127752258|NCT03128671|459718415|FG001|Allocation|Withdrawal by Subject|0|||
127752259|NCT03128671|459718414|FG000|Intervention|Withdrawal by Subject|11|||
127752260|NCT03128671|459718415|FG001|Intervention|Withdrawal by Subject|10|||
127752261|NCT03128671|459718414|FG000|Intervention|Palliative/hospice care initiated|9|||
127752262|NCT03128671|459718415|FG001|Intervention|Palliative/hospice care initiated|10|||
127752263|NCT03128671|459718414|FG000|Intervention|Death|13|||
127752264|NCT03128671|459718415|FG001|Intervention|Death|11|||
127752265|NCT03128671|459718414|FG000|Intervention|Interrupted by hurricane|1|||
127752266|NCT03128671|459718415|FG001|Intervention|Interrupted by hurricane|0|||
127752267|NCT03128671|459718414|FG000|Intervention|Physician Decision|2|||
127752268|NCT03128671|459718415|FG001|Intervention|Physician Decision|3|||
127752269|NCT05823012|459718419|FG000|Titration Period|Adverse Event|1|||
127752270|NCT05823012|459718419|FG000|Titration Period|Inability to Achieve a tolerable replacement dosage|3|||
127752271|NCT05823012|459718419|FG000|Maintenance Period|Adverse Event|1|||
127752272|NCT05823012|459718419|FG000|Maintenance Period|Inability to achieve a tolerable replacement dosage|1|||
127752273|NCT05823012|459718419|FG000|Maintenance Period|Inability to achieve an adequate replacement dosage|1|||
127752274|NCT02614183|459718420|FG000|Double Blind Treatment Phase|Adverse Event|10|||
127752275|NCT02614183|459718421|FG001|Double Blind Treatment Phase|Adverse Event|9|||
127752276|NCT02614183|459718422|FG002|Double Blind Treatment Phase|Adverse Event|7|||
127752277|NCT02614183|459718420|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
127752278|NCT02614183|459718421|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
127752279|NCT02614183|459718422|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
127752280|NCT02614183|459718420|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
127752281|NCT02614183|459718421|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
127752282|NCT02614183|459718422|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
127752283|NCT02614183|459718420|FG000|Double Blind Treatment Phase|Physician Decision|7|||
127752284|NCT02614183|459718421|FG001|Double Blind Treatment Phase|Physician Decision|3|||
127752285|NCT02614183|459718422|FG002|Double Blind Treatment Phase|Physician Decision|2|||
127752286|NCT02614183|459718420|FG000|Double Blind Treatment Phase|Pregnancy|2|||
127752287|NCT02614183|459718421|FG001|Double Blind Treatment Phase|Pregnancy|1|||
127752288|NCT02614183|459718422|FG002|Double Blind Treatment Phase|Pregnancy|3|||
127752289|NCT02614183|459718420|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
127752290|NCT02614183|459718421|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
127752291|NCT02614183|459718422|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
127752292|NCT02614183|459718420|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
127752293|NCT02614183|459718421|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
127752294|NCT02614183|459718422|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
127752295|NCT02614183|459718420|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
127752296|NCT02614183|459718421|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
127752297|NCT02614183|459718422|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
127752298|NCT02614183|459718420|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
127752299|NCT02614183|459718421|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
127752300|NCT02614183|459718422|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
127752301|NCT02614183|459718420|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
127752302|NCT02614183|459718421|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
127752303|NCT02614183|459718422|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
127752304|NCT02614183|459718420|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
127752305|NCT02614183|459718421|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
127752306|NCT02614183|459718422|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
127752307|NCT02614183|459718420|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
127752308|NCT02614183|459718421|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
127752309|NCT02614183|459718422|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
127752310|NCT01088984|459720492|FG000|Phase 1|Death|2|||
127752311|NCT01088984|459720493|FG001|Phase 1|Death|1|||
127811013|NCT02207907|459926490|FG000|Overall Study|Withdrawal by Subject|5|||
127811014|NCT02207907|459926491|FG001|Overall Study|Withdrawal by Subject|6|||
127811015|NCT02207907|459926490|FG000|Overall Study|Did not meet study criteria|3|||
127811016|NCT02207907|459926491|FG001|Overall Study|Did not meet study criteria|0|||
127811017|NCT02207907|459926490|FG000|Overall Study|Pregnancy|0|||
127811018|NCT02207907|459926491|FG001|Overall Study|Pregnancy|1|||
127811019|NCT02620020|459926492|FG000|Overall Study|Adverse Event|8|||
127811020|NCT02620020|459926493|FG001|Overall Study|Adverse Event|4|||
127811021|NCT02620020|459926494|FG002|Overall Study|Adverse Event|3|||
127811022|NCT02620020|459926495|FG003|Overall Study|Adverse Event|5|||
127811023|NCT02620020|459926492|FG000|Overall Study|Lost to Follow-up|4|||
127811024|NCT02620020|459926493|FG001|Overall Study|Lost to Follow-up|8|||
127811025|NCT02620020|459926494|FG002|Overall Study|Lost to Follow-up|1|||
127811026|NCT02620020|459926495|FG003|Overall Study|Lost to Follow-up|4|||
127811027|NCT02620020|459926492|FG000|Overall Study|Physician Decision|7|||
127811028|NCT02620020|459926493|FG001|Overall Study|Physician Decision|4|||
127811029|NCT02620020|459926494|FG002|Overall Study|Physician Decision|3|||
127811030|NCT02620020|459926495|FG003|Overall Study|Physician Decision|4|||
127811031|NCT02620020|459926492|FG000|Overall Study|Protocol Violation|5|||
127811032|NCT02620020|459926493|FG001|Overall Study|Protocol Violation|2|||
127811033|NCT02620020|459926494|FG002|Overall Study|Protocol Violation|1|||
127811034|NCT02620020|459926495|FG003|Overall Study|Protocol Violation|1|||
127811035|NCT02620020|459926492|FG000|Overall Study|Withdrawal by Subject|20|||
127811036|NCT02620020|459926493|FG001|Overall Study|Withdrawal by Subject|16|||
127811037|NCT02620020|459926494|FG002|Overall Study|Withdrawal by Subject|17|||
127811038|NCT02620020|459926495|FG003|Overall Study|Withdrawal by Subject|12|||
127811039|NCT02620020|459926492|FG000|Overall Study|Death|0|||
127811040|NCT02620020|459926493|FG001|Overall Study|Death|1|||
127811041|NCT02620020|459926494|FG002|Overall Study|Death|0|||
127811042|NCT02620020|459926495|FG003|Overall Study|Death|0|||
127811043|NCT01287104|459926496|FG000|Overall Study|Patient developed progressive disease|1|||
127811044|NCT01287104|459926497|FG001|Overall Study|Patient developed progressive disease|1|||
127811045|NCT01287104|459926498|FG002|Overall Study|Patient developed progressive disease|3|||
127811046|NCT01287104|459926499|FG003|Overall Study|Patient developed progressive disease|2|||
127811047|NCT01287104|459926496|FG000|Overall Study|Donor anaphylaxis|0|||
127811048|NCT01287104|459926497|FG001|Overall Study|Donor anaphylaxis|1|||
127752312|NCT01088984|459720492|FG000|Phase 1|Disease Progression|2|||
127752313|NCT01088984|459720493|FG001|Phase 1|Disease Progression|4|||
127752314|NCT01088984|459720492|FG000|Phase 1|Other|1|||
127752315|NCT01088984|459720493|FG001|Phase 1|Other|1|||
127752316|NCT01088984|459720492|FG000|Phase 2|Death|0|||
127752317|NCT01088984|459720493|FG001|Phase 2|Death|5|||
127752318|NCT01088984|459720492|FG000|Phase 2|Withdrawal by Subject|0|||
127752319|NCT01088984|459720493|FG001|Phase 2|Withdrawal by Subject|1|||
127752320|NCT01088984|459720492|FG000|Phase 2|DIsease Progression|0|||
127752321|NCT01088984|459720493|FG001|Phase 2|DIsease Progression|25|||
127752322|NCT01088984|459720492|FG000|Phase 2|Other|0|||
127752323|NCT01088984|459720493|FG001|Phase 2|Other|1|||
127752324|NCT04707664|459720494|FG000|Overall Study|Adverse Event|2|||
127752325|NCT04707664|459720495|FG001|Overall Study|Adverse Event|0|||
127752326|NCT04707664|459720494|FG000|Overall Study|Death|1|||
127752327|NCT04707664|459720495|FG001|Overall Study|Death|2|||
127752328|NCT04707664|459720494|FG000|Overall Study|Withdrawal by Subject|13|||
127752329|NCT04707664|459720495|FG001|Overall Study|Withdrawal by Subject|21|||
127752330|NCT04707664|459720494|FG000|Overall Study|Lost to Follow-up|11|||
127752331|NCT04707664|459720495|FG001|Overall Study|Lost to Follow-up|13|||
127752332|NCT04707664|459720494|FG000|Overall Study|Not treated|2|||
127752333|NCT04707664|459720495|FG001|Overall Study|Not treated|0|||
127752334|NCT00699153|459720496|FG000|Overall Study|Lost to Follow-up|1|||
127752335|NCT00699153|459720497|FG001|Overall Study|Lost to Follow-up|0|||
127752336|NCT00699153|459720496|FG000|Overall Study|Adverse Event|0|||
127752337|NCT00699153|459720497|FG001|Overall Study|Adverse Event|2|||
127811049|NCT01287104|459926498|FG002|Overall Study|Donor anaphylaxis|0|||
127811050|NCT01287104|459926499|FG003|Overall Study|Donor anaphylaxis|1|||
127811051|NCT01287104|459926496|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
127811052|NCT01287104|459926497|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
127811053|NCT01287104|459926498|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
127811054|NCT01287104|459926499|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
127811055|NCT01287104|459926496|FG000|Overall Study|Low donor chimerism|0|||
127811056|NCT01287104|459926497|FG001|Overall Study|Low donor chimerism|1|||
127811057|NCT01287104|459926498|FG002|Overall Study|Low donor chimerism|0|||
127811058|NCT01287104|459926499|FG003|Overall Study|Low donor chimerism|0|||
127811059|NCT01287104|459926496|FG000|Overall Study|NK cells did not meet release criteria|0|||
127752338|NCT00699153|459720496|FG000|Overall Study|Protocol Violation|1|||
127752339|NCT00699153|459720497|FG001|Overall Study|Protocol Violation|0|||
127752340|NCT00699153|459720496|FG000|Overall Study|Travel Problem|1|||
127752341|NCT00699153|459720497|FG001|Overall Study|Travel Problem|0|||
127752342|NCT01006980|459720500|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
127752343|NCT01006980|459720501|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
127752344|NCT01006980|459720500|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
127752345|NCT01006980|459720501|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
127752346|NCT01006980|459720500|FG000|Vemurafenib and Dacarbazine|Death|13|||
127752347|NCT01006980|459720501|FG001|Vemurafenib and Dacarbazine|Death|12|||
127752348|NCT01006980|459720500|FG000|Vemurafenib and Dacarbazine|Progression|257|||
127752349|NCT01006980|459720501|FG001|Vemurafenib and Dacarbazine|Progression|218|||
127752350|NCT01006980|459720500|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
127752351|NCT01006980|459720501|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
127752352|NCT01006980|459720500|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
127752353|NCT01006980|459720501|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
127752354|NCT01006980|459720500|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
127752355|NCT01006980|459720501|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
127752356|NCT01006980|459720500|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
127752357|NCT01006980|459720501|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
127752358|NCT01006980|459720500|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
127752359|NCT01006980|459720501|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
127752360|NCT01006980|459720500|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
127752361|NCT01006980|459720501|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
127752362|NCT01006980|459720500|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
127752363|NCT01006980|459720501|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
127752364|NCT01006980|459720500|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
127752365|NCT01006980|459720501|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
127752366|NCT01006980|459720500|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
127752367|NCT01006980|459720501|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
127752368|NCT02706405|459720506|FG000|Overall Study|Death|3|||
127752369|NCT02706405|459720507|FG001|Overall Study|Death|2|||
127752370|NCT02706405|459720508|FG002|Overall Study|Death|0|||
127752371|NCT02706405|459720509|FG003|Overall Study|Death|1|||
127752372|NCT02706405|459720510|FG004|Overall Study|Death|0|||
127752373|NCT02706405|459720511|FG005|Overall Study|Death|0|||
127752374|NCT02706405|459720512|FG006|Overall Study|Death|3|||
127752375|NCT02706405|459720513|FG007|Overall Study|Death|4|||
127752376|NCT02706405|459720506|FG000|Overall Study|Disease progression|0|||
127752377|NCT02706405|459720507|FG001|Overall Study|Disease progression|0|||
127752378|NCT02706405|459720508|FG002|Overall Study|Disease progression|0|||
127752379|NCT02706405|459720509|FG003|Overall Study|Disease progression|0|||
127752380|NCT02706405|459720510|FG004|Overall Study|Disease progression|0|||
127752381|NCT02706405|459720511|FG005|Overall Study|Disease progression|0|||
127752382|NCT02706405|459720512|FG006|Overall Study|Disease progression|0|||
127752383|NCT02706405|459720513|FG007|Overall Study|Disease progression|1|||
127752384|NCT02706405|459720506|FG000|Overall Study|Pt moved to new therapy|0|||
127752385|NCT02706405|459720507|FG001|Overall Study|Pt moved to new therapy|0|||
127752386|NCT02706405|459720508|FG002|Overall Study|Pt moved to new therapy|0|||
127752387|NCT02706405|459720509|FG003|Overall Study|Pt moved to new therapy|0|||
127752388|NCT02706405|459720510|FG004|Overall Study|Pt moved to new therapy|0|||
127752389|NCT02706405|459720511|FG005|Overall Study|Pt moved to new therapy|1|||
127752390|NCT02706405|459720512|FG006|Overall Study|Pt moved to new therapy|0|||
127752391|NCT02706405|459720513|FG007|Overall Study|Pt moved to new therapy|1|||
127752392|NCT02706405|459720506|FG000|Overall Study|Physician Decision|1|||
127752393|NCT02706405|459720507|FG001|Overall Study|Physician Decision|0|||
127752394|NCT02706405|459720508|FG002|Overall Study|Physician Decision|0|||
127752395|NCT02706405|459720509|FG003|Overall Study|Physician Decision|0|||
127752396|NCT02706405|459720510|FG004|Overall Study|Physician Decision|0|||
127752397|NCT02706405|459720511|FG005|Overall Study|Physician Decision|0|||
127752398|NCT02706405|459720512|FG006|Overall Study|Physician Decision|0|||
127752399|NCT02706405|459720513|FG007|Overall Study|Physician Decision|0|||
127752400|NCT01228318|459720514|FG000|Overall Study|Clinic no show to receive intervention|1|||
127752401|NCT01228318|459720515|FG001|Overall Study|Clinic no show to receive intervention|0|||
127752402|NCT01228318|459720514|FG000|Overall Study|Unable to contact|2|||
127752403|NCT01228318|459720515|FG001|Overall Study|Unable to contact|5|||
127752404|NCT01228318|459720514|FG000|Overall Study|Moved|0|||
127752405|NCT01228318|459720515|FG001|Overall Study|Moved|2|||
127811060|NCT01287104|459926497|FG001|Overall Study|NK cells did not meet release criteria|1|||
127811061|NCT01287104|459926498|FG002|Overall Study|NK cells did not meet release criteria|0|||
127752406|NCT01228318|459720514|FG000|Overall Study|Incarcerated|1|||
127752407|NCT01228318|459720515|FG001|Overall Study|Incarcerated|0|||
127752408|NCT01182441|459720520|FG000|Overall Study|Patient Still in Follow-up|152|||
127752409|NCT01182441|459720521|FG001|Overall Study|Patient Still in Follow-up|72|||
127752410|NCT01182441|459720520|FG000|Overall Study|Death|37|||
127752411|NCT01182441|459720521|FG001|Overall Study|Death|25|||
127752412|NCT01182441|459720520|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
127752413|NCT01182441|459720521|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
127752414|NCT01182441|459720520|FG000|Overall Study|Lost to Follow-up|5|||
127752415|NCT01182441|459720521|FG001|Overall Study|Lost to Follow-up|8|||
127752416|NCT01182441|459720520|FG000|Overall Study|Withdrawal by Subject|6|||
127752417|NCT01182441|459720521|FG001|Overall Study|Withdrawal by Subject|13|||
127752418|NCT01182441|459720520|FG000|Overall Study|Implant Not Attempted|4|||
127752419|NCT01182441|459720521|FG001|Overall Study|Implant Not Attempted|0|||
127752420|NCT01182441|459720520|FG000|Overall Study|Adverse Event|2|||
127752421|NCT01182441|459720521|FG001|Overall Study|Adverse Event|0|||
127752422|NCT01182441|459720520|FG000|Overall Study|Physician Decision|1|||
127752423|NCT01182441|459720521|FG001|Overall Study|Physician Decision|1|||
127752424|NCT00603525|459720522|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
127752425|NCT00603525|459720523|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
127752426|NCT00603525|459720524|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
127752427|NCT00603525|459720522|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
127752428|NCT00603525|459720523|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
127752429|NCT00603525|459720524|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
127752430|NCT00603525|459720522|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
127752431|NCT00603525|459720523|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
127752432|NCT00603525|459720524|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
127752433|NCT00603525|459720522|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
127752434|NCT00603525|459720523|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
127752435|NCT00603525|459720524|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
127752436|NCT00603525|459720522|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
127752437|NCT00603525|459720523|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
127752438|NCT00603525|459720524|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
127752439|NCT00603525|459720522|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
127752440|NCT00603525|459720523|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
127752441|NCT00603525|459720524|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
127752442|NCT00603525|459720522|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
127752443|NCT00603525|459720523|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
127752444|NCT00603525|459720524|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
127752445|NCT00603525|459720522|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
127752446|NCT00603525|459720523|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
127752447|NCT00603525|459720524|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
127752448|NCT00603525|459720522|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
127752449|NCT00603525|459720523|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
127752450|NCT00603525|459720524|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
127752451|NCT00603525|459720522|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
127752452|NCT00603525|459720523|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
127752453|NCT00603525|459720524|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
127752454|NCT00603525|459720522|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
127752455|NCT00603525|459720523|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
127752456|NCT00603525|459720524|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
127752457|NCT00603525|459720522|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
127752458|NCT00603525|459720523|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
127752459|NCT00603525|459720524|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
127752460|NCT00603525|459720522|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
127752461|NCT00603525|459720523|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
127752462|NCT00603525|459720524|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
127752463|NCT00603525|459720522|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
127752464|NCT00603525|459720523|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
127752465|NCT00603525|459720524|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
127752466|NCT00603525|459720522|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
127752467|NCT00603525|459720523|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
127752468|NCT00603525|459720524|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
127752469|NCT02304705|459720525|FG000|Overall Study|Withdrawal by Subject|2|||
127752470|NCT02304705|459720526|FG001|Overall Study|Withdrawal by Subject|0|||
127752471|NCT02304705|459720525|FG000|Overall Study|Physician Decision|2|||
127811062|NCT01287104|459926499|FG003|Overall Study|NK cells did not meet release criteria|0|||
127752472|NCT02304705|459720526|FG001|Overall Study|Physician Decision|4|||
127752473|NCT02304705|459720525|FG000|Overall Study|Death|0|||
127752474|NCT02304705|459720526|FG001|Overall Study|Death|1|||
127752475|NCT02304705|459720525|FG000|Overall Study|Lost to Follow-up|0|||
127752476|NCT02304705|459720526|FG001|Overall Study|Lost to Follow-up|2|||
127752477|NCT02124811|459720527|FG000|Overall Study|Early termination|2|||
127752478|NCT02124811|459720528|FG001|Overall Study|Early termination|2|||
127752479|NCT02124811|459720527|FG000|Overall Study|Withdrawal by Subject|1|||
127752480|NCT02124811|459720528|FG001|Overall Study|Withdrawal by Subject|0|||
127752481|NCT03480932|459720529|FG000|Overall Study|Death|1|||
127752482|NCT03480932|459720530|FG001|Overall Study|Death|1|||
127811063|NCT01276288|459926504|FG000|Overall Study|Adverse Event|1|||
127811064|NCT01276288|459926505|FG001|Overall Study|Adverse Event|1|||
127752483|NCT03480932|459720531|FG002|Overall Study|Death|0|||
127752484|NCT03480932|459720529|FG000|Overall Study|Lost to Follow-up|0|||
127752485|NCT03480932|459720530|FG001|Overall Study|Lost to Follow-up|2|||
127752486|NCT03480932|459720531|FG002|Overall Study|Lost to Follow-up|3|||
127752487|NCT03480932|459720529|FG000|Overall Study|Incarcerated|2|||
127752488|NCT03480932|459720530|FG001|Overall Study|Incarcerated|2|||
127752489|NCT03480932|459720531|FG002|Overall Study|Incarcerated|2|||
127752490|NCT01757197|459720537|FG000|Overall Study|Death|2|||
127752491|NCT01174446|459720541|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
127752492|NCT01174446|459720542|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
127752493|NCT01174446|459720543|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
127752494|NCT01174446|459720544|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
127752495|NCT01174446|459720541|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
127752496|NCT01174446|459720542|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
127752497|NCT01174446|459720543|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
127752498|NCT01174446|459720544|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
127752499|NCT01174446|459720541|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
127752500|NCT01174446|459720542|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
127752501|NCT01174446|459720543|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
127752502|NCT01174446|459720544|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
127752503|NCT01174446|459720541|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
127752504|NCT01174446|459720542|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
127752505|NCT01174446|459720543|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
127752506|NCT01174446|459720544|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
127752507|NCT01077128|459720545|FG000|Overall Study|Adverse Event|8|||
127752508|NCT01077128|459720545|FG000|Overall Study|Lack of Efficacy|1|||
127752509|NCT01077128|459720545|FG000|Overall Study|Disease exacerbation|1|||
127752510|NCT01077128|459720545|FG000|Overall Study|Adverse event and consent withdrawal|1|||
127752511|NCT01077128|459720545|FG000|Overall Study|Adverse event and disease exacerbation|1|||
127752512|NCT01077128|459720545|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
127752513|NCT01077128|459720545|FG000|Overall Study|Other|54|||
127752514|NCT00847626|459720548|FG000|Overall Study|Adverse Event|10|||
127752515|NCT00847626|459720549|FG001|Overall Study|Adverse Event|10|||
127752516|NCT00847626|459720550|FG002|Overall Study|Adverse Event|6|||
127752517|NCT00847626|459720551|FG003|Overall Study|Adverse Event|19|||
127752518|NCT00847626|459720552|FG004|Overall Study|Adverse Event|11|||
127752519|NCT00847626|459720553|FG005|Overall Study|Adverse Event|22|||
127752520|NCT00847626|459720554|FG006|Overall Study|Adverse Event|4|||
127752521|NCT00847626|459720555|FG007|Overall Study|Adverse Event|6|||
127752522|NCT00847626|459720556|FG008|Overall Study|Adverse Event|3|||
127752523|NCT00847626|459720557|FG009|Overall Study|Adverse Event|6|||
127752524|NCT00847626|459720558|FG010|Overall Study|Adverse Event|6|||
127752525|NCT00847626|459720548|FG000|Overall Study|Protocol Violation|2|||
127752526|NCT00847626|459720549|FG001|Overall Study|Protocol Violation|1|||
127752527|NCT00847626|459720550|FG002|Overall Study|Protocol Violation|2|||
127752528|NCT00847626|459720551|FG003|Overall Study|Protocol Violation|1|||
127752529|NCT00847626|459720552|FG004|Overall Study|Protocol Violation|1|||
127752530|NCT00847626|459720553|FG005|Overall Study|Protocol Violation|1|||
127752531|NCT00847626|459720554|FG006|Overall Study|Protocol Violation|1|||
127752532|NCT00847626|459720555|FG007|Overall Study|Protocol Violation|1|||
127752533|NCT00847626|459720556|FG008|Overall Study|Protocol Violation|0|||
127752534|NCT00847626|459720557|FG009|Overall Study|Protocol Violation|1|||
127752535|NCT00847626|459720558|FG010|Overall Study|Protocol Violation|1|||
127752536|NCT00847626|459720548|FG000|Overall Study|Lost to Follow-up|0|||
127752537|NCT00847626|459720549|FG001|Overall Study|Lost to Follow-up|1|||
127811065|NCT01276288|459926506|FG002|Overall Study|Adverse Event|0|||
127811066|NCT01276288|459926507|FG003|Overall Study|Adverse Event|0|||
127752538|NCT00847626|459720550|FG002|Overall Study|Lost to Follow-up|1|||
127752539|NCT00847626|459720551|FG003|Overall Study|Lost to Follow-up|1|||
127752540|NCT00847626|459720552|FG004|Overall Study|Lost to Follow-up|0|||
127752541|NCT00847626|459720553|FG005|Overall Study|Lost to Follow-up|3|||
127752542|NCT00847626|459720554|FG006|Overall Study|Lost to Follow-up|1|||
127752543|NCT00847626|459720555|FG007|Overall Study|Lost to Follow-up|3|||
127752544|NCT00847626|459720556|FG008|Overall Study|Lost to Follow-up|1|||
127752545|NCT00847626|459720557|FG009|Overall Study|Lost to Follow-up|0|||
127752546|NCT00847626|459720558|FG010|Overall Study|Lost to Follow-up|1|||
127752547|NCT00847626|459720548|FG000|Overall Study|Withdrawal by Subject|5|||
127752548|NCT00847626|459720549|FG001|Overall Study|Withdrawal by Subject|5|||
127811067|NCT01276288|459926504|FG000|Overall Study|not treated|1|||
127752549|NCT00847626|459720550|FG002|Overall Study|Withdrawal by Subject|3|||
127752550|NCT00847626|459720551|FG003|Overall Study|Withdrawal by Subject|8|||
127752551|NCT00847626|459720552|FG004|Overall Study|Withdrawal by Subject|12|||
127752552|NCT00847626|459720553|FG005|Overall Study|Withdrawal by Subject|9|||
127752553|NCT00847626|459720554|FG006|Overall Study|Withdrawal by Subject|8|||
127811068|NCT01276288|459926505|FG001|Overall Study|not treated|0|||
127752554|NCT00847626|459720555|FG007|Overall Study|Withdrawal by Subject|4|||
127752555|NCT00847626|459720556|FG008|Overall Study|Withdrawal by Subject|4|||
127752556|NCT00847626|459720557|FG009|Overall Study|Withdrawal by Subject|5|||
127752557|NCT00847626|459720558|FG010|Overall Study|Withdrawal by Subject|2|||
127752558|NCT00847626|459720548|FG000|Overall Study|Lack of Efficacy|3|||
127752559|NCT00847626|459720549|FG001|Overall Study|Lack of Efficacy|1|||
127752560|NCT00847626|459720550|FG002|Overall Study|Lack of Efficacy|0|||
127752561|NCT00847626|459720551|FG003|Overall Study|Lack of Efficacy|1|||
127752562|NCT00847626|459720552|FG004|Overall Study|Lack of Efficacy|2|||
127752563|NCT00847626|459720553|FG005|Overall Study|Lack of Efficacy|0|||
127752564|NCT00847626|459720554|FG006|Overall Study|Lack of Efficacy|6|||
127752565|NCT00847626|459720555|FG007|Overall Study|Lack of Efficacy|2|||
127752566|NCT00847626|459720556|FG008|Overall Study|Lack of Efficacy|5|||
127752567|NCT00847626|459720557|FG009|Overall Study|Lack of Efficacy|1|||
127752568|NCT00847626|459720558|FG010|Overall Study|Lack of Efficacy|7|||
127752569|NCT00847626|459720548|FG000|Overall Study|Other|1|||
127752570|NCT00847626|459720549|FG001|Overall Study|Other|5|||
127752571|NCT00847626|459720550|FG002|Overall Study|Other|4|||
127752572|NCT00847626|459720551|FG003|Overall Study|Other|1|||
127752573|NCT00847626|459720552|FG004|Overall Study|Other|2|||
127752574|NCT00847626|459720553|FG005|Overall Study|Other|2|||
127752575|NCT00847626|459720554|FG006|Overall Study|Other|2|||
127752576|NCT00847626|459720555|FG007|Overall Study|Other|3|||
127752577|NCT00847626|459720556|FG008|Overall Study|Other|1|||
127752578|NCT00847626|459720557|FG009|Overall Study|Other|1|||
127752579|NCT00847626|459720558|FG010|Overall Study|Other|3|||
127752580|NCT03057847|459720559|FG000|Overall Study|Lost to Follow-up|16|||
127752581|NCT01706705|459720560|FG000|Overall Study|Death|1|||
127752582|NCT01706705|459720560|FG000|Overall Study|Lack of Efficacy|13|||
127752583|NCT01706705|459720560|FG000|Overall Study|Non-clinical|6|||
127752584|NCT04703192|459720561|FG000|Overall Study|Withdrawal by Subject|2|||
127752585|NCT04703192|459720562|FG001|Overall Study|Withdrawal by Subject|0|||
127752586|NCT04703192|459720561|FG000|Overall Study|Death|3|||
127752587|NCT04703192|459720562|FG001|Overall Study|Death|1|||
127752588|NCT04703192|459720561|FG000|Overall Study|Adverse Event|13|||
127752589|NCT04703192|459720562|FG001|Overall Study|Adverse Event|2|||
127752590|NCT04703192|459720561|FG000|Overall Study|Progressive or Relapsed Disease|46|||
127752591|NCT04703192|459720562|FG001|Overall Study|Progressive or Relapsed Disease|7|||
127752592|NCT04703192|459720561|FG000|Overall Study|Clinical Progression|19|||
127752593|NCT04703192|459720562|FG001|Overall Study|Clinical Progression|8|||
127752594|NCT04703192|459720561|FG000|Overall Study|Lost to Follow-up|1|||
127752595|NCT04703192|459720562|FG001|Overall Study|Lost to Follow-up|0|||
127752596|NCT04703192|459720561|FG000|Overall Study|Hematopoietic Cell Transplantation|12|||
127752597|NCT04703192|459720562|FG001|Overall Study|Hematopoietic Cell Transplantation|1|||
127752598|NCT04703192|459720561|FG000|Overall Study|Other|5|||
127752599|NCT04703192|459720562|FG001|Overall Study|Other|1|||
127752600|NCT02138786|459720563|FG000|Overall Study|Adverse Event|0|||
127752601|NCT02138786|459720564|FG001|Overall Study|Adverse Event|2|||
127752602|NCT02138786|459720565|FG002|Overall Study|Adverse Event|1|||
127752603|NCT02138786|459720563|FG000|Overall Study|Death|1|||
127752604|NCT02138786|459720564|FG001|Overall Study|Death|7|||
127752605|NCT02138786|459720565|FG002|Overall Study|Death|2|||
127752606|NCT02138786|459720563|FG000|Overall Study|Disease Progression|1|||
127752607|NCT02138786|459720564|FG001|Overall Study|Disease Progression|1|||
127811069|NCT01276288|459926506|FG002|Overall Study|not treated|0|||
127811070|NCT01276288|459926507|FG003|Overall Study|not treated|0|||
127811071|NCT03168867|459926508|FG000|Overall Study|Withdrawal by Subject|1|||
127811072|NCT03168867|459926509|FG001|Overall Study|Withdrawal by Subject|5|||
127811073|NCT04348851|459926510|FG000|Post-Test 1|Withdrawal by Subject|0|||
127811074|NCT04348851|459926511|FG001|Post-Test 1|Withdrawal by Subject|1|||
127811075|NCT04348851|459926512|FG002|Post-Test 1|Withdrawal by Subject|0|||
127811076|NCT04348851|459926513|FG003|Post-Test 1|Withdrawal by Subject|0|||
127811077|NCT04348851|459926510|FG000|Post-Test 1|Lost to Follow-up|0|||
127811078|NCT04348851|459926511|FG001|Post-Test 1|Lost to Follow-up|1|||
127811079|NCT04348851|459926512|FG002|Post-Test 1|Lost to Follow-up|0|||
127752608|NCT02138786|459720565|FG002|Overall Study|Disease Progression|3|||
127752609|NCT02138786|459720563|FG000|Overall Study|Withdrawal by Subject|1|||
127752610|NCT02138786|459720564|FG001|Overall Study|Withdrawal by Subject|2|||
127752611|NCT02138786|459720565|FG002|Overall Study|Withdrawal by Subject|0|||
127752612|NCT02138786|459720563|FG000|Overall Study|Patient's Wish|0|||
127752613|NCT02138786|459720564|FG001|Overall Study|Patient's Wish|2|||
127752614|NCT02138786|459720565|FG002|Overall Study|Patient's Wish|0|||
127752615|NCT02138786|459720563|FG000|Overall Study|Sponsor Terminated Study|0|||
127752616|NCT02138786|459720564|FG001|Overall Study|Sponsor Terminated Study|1|||
127752617|NCT02138786|459720565|FG002|Overall Study|Sponsor Terminated Study|1|||
127752618|NCT02138786|459720563|FG000|Overall Study|Non-Compliance|0|||
127752619|NCT02138786|459720564|FG001|Overall Study|Non-Compliance|0|||
127811080|NCT04348851|459926513|FG003|Post-Test 1|Lost to Follow-up|0|||
127811081|NCT04348851|459926510|FG000|Post-Test 2|Stroke survivor death|0|||
127811082|NCT04348851|459926511|FG001|Post-Test 2|Stroke survivor death|1|||
127811083|NCT04348851|459926512|FG002|Post-Test 2|Stroke survivor death|0|||
127752620|NCT02138786|459720565|FG002|Overall Study|Non-Compliance|1|||
127752621|NCT02088957|459720566|FG000|Overall Study|Lack of Efficacy|1|||
127752622|NCT02088957|459720567|FG001|Overall Study|Lack of Efficacy|0|||
127752623|NCT01923662|459720568|FG000|Overall Study|Withdrawal by Subject|1|||
127752624|NCT01939353|459720569|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
127752625|NCT01939353|459720569|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
127752626|NCT01939353|459720569|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
127752627|NCT01939353|459720569|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
127752628|NCT01939353|459720569|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
127752629|NCT00874731|459720577|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
127752630|NCT00874731|459720578|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
127752631|NCT00874731|459720579|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
127752632|NCT00874731|459720577|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
127752633|NCT00874731|459720578|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
127752634|NCT00874731|459720579|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
127752635|NCT00874731|459720577|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
127752636|NCT00874731|459720578|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
127752637|NCT00874731|459720579|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
127752638|NCT01132820|459720584|FG000|Overall Study|Ineligible: wrong cell type|1|||
127752639|NCT01132820|459720584|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
127752640|NCT01132820|459720584|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
127752641|NCT01132820|459720584|FG000|Overall Study|Never treated|1|||
127752642|NCT01132820|459720584|FG000|Overall Study|Inadequate data|1|||
127752643|NCT00667394|459720588|FG000|Overall Study|Adverse Event|3|||
127752644|NCT00667394|459720589|FG001|Overall Study|Adverse Event|0|||
127752645|NCT00667394|459720588|FG000|Overall Study|Progressive disease|1|||
127752646|NCT00667394|459720589|FG001|Overall Study|Progressive disease|0|||
127752647|NCT05000216|459720590|FG000|Stage 1|Lost to Follow-up|0|||
127752648|NCT05000216|459720591|FG001|Stage 1|Lost to Follow-up|0|||
127752649|NCT05000216|459720592|FG002|Stage 1|Lost to Follow-up|0|||
127752650|NCT05000216|459720593|FG003|Stage 1|Lost to Follow-up|0|||
127752651|NCT05000216|459720594|FG004|Stage 1|Lost to Follow-up|0|||
127752652|NCT05000216|459720595|FG005|Stage 1|Lost to Follow-up|0|||
127752653|NCT05000216|459720596|FG006|Stage 1|Lost to Follow-up|1|||
127752654|NCT05000216|459720597|FG007|Stage 1|Lost to Follow-up|1|||
127752655|NCT05000216|459720598|FG008|Stage 1|Lost to Follow-up|0|||
127752656|NCT05000216|459720599|FG009|Stage 1|Lost to Follow-up|2|||
127752657|NCT05000216|459720600|FG010|Stage 1|Lost to Follow-up|3|||
127752658|NCT05000216|459720601|FG011|Stage 1|Lost to Follow-up|0|||
127752659|NCT05000216|459720602|FG012|Stage 1|Lost to Follow-up|0|||
127752660|NCT05000216|459720603|FG013|Stage 1|Lost to Follow-up|0|||
127752661|NCT05000216|459720604|FG014|Stage 1|Lost to Follow-up|0|||
127752662|NCT05000216|459720605|FG015|Stage 1|Lost to Follow-up|0|||
127752663|NCT05000216|459720606|FG016|Stage 1|Lost to Follow-up|0|||
127752664|NCT05000216|459720607|FG017|Stage 1|Lost to Follow-up|0|||
127752665|NCT05000216|459720608|FG018|Stage 1|Lost to Follow-up|0|||
127752666|NCT05000216|459720609|FG019|Stage 1|Lost to Follow-up|0|||
127752667|NCT05000216|459720610|FG020|Stage 1|Lost to Follow-up|0|||
127752668|NCT05000216|459720611|FG021|Stage 1|Lost to Follow-up|0|||
127752669|NCT05000216|459720590|FG000|Stage 1|Physician Decision|0|||
127752670|NCT05000216|459720591|FG001|Stage 1|Physician Decision|0|||
127752671|NCT05000216|459720592|FG002|Stage 1|Physician Decision|0|||
127752672|NCT05000216|459720593|FG003|Stage 1|Physician Decision|0|||
127752673|NCT05000216|459720594|FG004|Stage 1|Physician Decision|0|||
127752674|NCT05000216|459720595|FG005|Stage 1|Physician Decision|0|||
127752675|NCT05000216|459720596|FG006|Stage 1|Physician Decision|0|||
127752676|NCT05000216|459720597|FG007|Stage 1|Physician Decision|1|||
127752677|NCT05000216|459720598|FG008|Stage 1|Physician Decision|1|||
127752678|NCT05000216|459720599|FG009|Stage 1|Physician Decision|0|||
127752679|NCT05000216|459720600|FG010|Stage 1|Physician Decision|0|||
127752680|NCT05000216|459720601|FG011|Stage 1|Physician Decision|0|||
127752681|NCT05000216|459720602|FG012|Stage 1|Physician Decision|0|||
127752682|NCT05000216|459720603|FG013|Stage 1|Physician Decision|0|||
127752683|NCT05000216|459720604|FG014|Stage 1|Physician Decision|0|||
127752684|NCT05000216|459720605|FG015|Stage 1|Physician Decision|0|||
127752685|NCT05000216|459720606|FG016|Stage 1|Physician Decision|0|||
127752686|NCT05000216|459720607|FG017|Stage 1|Physician Decision|0|||
127752687|NCT05000216|459720608|FG018|Stage 1|Physician Decision|0|||
127752688|NCT05000216|459720609|FG019|Stage 1|Physician Decision|0|||
127752689|NCT05000216|459720610|FG020|Stage 1|Physician Decision|0|||
127752690|NCT05000216|459720611|FG021|Stage 1|Physician Decision|0|||
127752691|NCT05000216|459720590|FG000|Stage 1|Withdrawal by Subject|0|||
127752692|NCT05000216|459720591|FG001|Stage 1|Withdrawal by Subject|1|||
127752693|NCT05000216|459720592|FG002|Stage 1|Withdrawal by Subject|0|||
127752694|NCT05000216|459720593|FG003|Stage 1|Withdrawal by Subject|0|||
127752695|NCT05000216|459720594|FG004|Stage 1|Withdrawal by Subject|0|||
127752696|NCT05000216|459720595|FG005|Stage 1|Withdrawal by Subject|0|||
127752697|NCT05000216|459720596|FG006|Stage 1|Withdrawal by Subject|0|||
127752698|NCT05000216|459720597|FG007|Stage 1|Withdrawal by Subject|0|||
127752699|NCT05000216|459720598|FG008|Stage 1|Withdrawal by Subject|0|||
127752700|NCT05000216|459720599|FG009|Stage 1|Withdrawal by Subject|3|||
127752701|NCT05000216|459720600|FG010|Stage 1|Withdrawal by Subject|10|||
127752702|NCT05000216|459720601|FG011|Stage 1|Withdrawal by Subject|0|||
127752703|NCT05000216|459720602|FG012|Stage 1|Withdrawal by Subject|0|||
127752704|NCT05000216|459720603|FG013|Stage 1|Withdrawal by Subject|0|||
127752705|NCT05000216|459720604|FG014|Stage 1|Withdrawal by Subject|0|||
127752706|NCT05000216|459720605|FG015|Stage 1|Withdrawal by Subject|0|||
127752707|NCT05000216|459720606|FG016|Stage 1|Withdrawal by Subject|0|||
127752708|NCT05000216|459720607|FG017|Stage 1|Withdrawal by Subject|0|||
127752709|NCT05000216|459720608|FG018|Stage 1|Withdrawal by Subject|0|||
127752710|NCT05000216|459720609|FG019|Stage 1|Withdrawal by Subject|0|||
127752711|NCT05000216|459720610|FG020|Stage 1|Withdrawal by Subject|0|||
127752712|NCT05000216|459720611|FG021|Stage 1|Withdrawal by Subject|0|||
127752713|NCT05000216|459720590|FG000|Stage 1|Did not receive vaccine at Week 0|0|||
127811084|NCT04348851|459926513|FG003|Post-Test 2|Stroke survivor death|1|||
127811085|NCT02965378|459926514|FG000|Overall Study|Progression|16|||
127811086|NCT02965378|459926515|FG001|Overall Study|Progression|4|||
127811087|NCT02965378|459926514|FG000|Overall Study|Adverse Event|5|||
127811088|NCT02965378|459926515|FG001|Overall Study|Adverse Event|2|||
127752714|NCT05000216|459720591|FG001|Stage 1|Did not receive vaccine at Week 0|0|||
127752715|NCT05000216|459720592|FG002|Stage 1|Did not receive vaccine at Week 0|1|||
127752716|NCT05000216|459720593|FG003|Stage 1|Did not receive vaccine at Week 0|1|||
127752717|NCT05000216|459720594|FG004|Stage 1|Did not receive vaccine at Week 0|0|||
127752718|NCT05000216|459720595|FG005|Stage 1|Did not receive vaccine at Week 0|0|||
127752719|NCT05000216|459720596|FG006|Stage 1|Did not receive vaccine at Week 0|0|||
127752720|NCT05000216|459720597|FG007|Stage 1|Did not receive vaccine at Week 0|0|||
127752721|NCT05000216|459720598|FG008|Stage 1|Did not receive vaccine at Week 0|0|||
127752722|NCT05000216|459720599|FG009|Stage 1|Did not receive vaccine at Week 0|1|||
127752723|NCT05000216|459720600|FG010|Stage 1|Did not receive vaccine at Week 0|0|||
127752724|NCT05000216|459720601|FG011|Stage 1|Did not receive vaccine at Week 0|0|||
127752725|NCT05000216|459720602|FG012|Stage 1|Did not receive vaccine at Week 0|0|||
127752726|NCT05000216|459720603|FG013|Stage 1|Did not receive vaccine at Week 0|0|||
127811089|NCT02965378|459926514|FG000|Overall Study|Death|2|||
127811090|NCT02965378|459926515|FG001|Overall Study|Death|0|||
127811091|NCT02965378|459926514|FG000|Overall Study|Refusal|2|||
127811092|NCT02965378|459926515|FG001|Overall Study|Refusal|1|||
127811093|NCT02965378|459926514|FG000|Overall Study|Not protocol specified|0|||
127811094|NCT02965378|459926515|FG001|Overall Study|Not protocol specified|2|||
127811095|NCT00629083|459926520|FG000|Overall Study|Adverse Event|0|||
127811096|NCT00629083|459926521|FG001|Overall Study|Adverse Event|2|||
127811097|NCT00629083|459926520|FG000|Overall Study|Lack of Efficacy|3|||
127811098|NCT00629083|459926521|FG001|Overall Study|Lack of Efficacy|1|||
127811099|NCT00629083|459926520|FG000|Overall Study|Withdrawal by Subject|10|||
127811100|NCT00629083|459926521|FG001|Overall Study|Withdrawal by Subject|2|||
127752727|NCT05000216|459720604|FG014|Stage 1|Did not receive vaccine at Week 0|0|||
127752728|NCT05000216|459720605|FG015|Stage 1|Did not receive vaccine at Week 0|0|||
127752729|NCT05000216|459720606|FG016|Stage 1|Did not receive vaccine at Week 0|0|||
127752730|NCT05000216|459720607|FG017|Stage 1|Did not receive vaccine at Week 0|0|||
127811101|NCT00629083|459926520|FG000|Overall Study|Lost to Follow-up|12|||
127811102|NCT00629083|459926521|FG001|Overall Study|Lost to Follow-up|8|||
127811103|NCT00629083|459926520|FG000|Overall Study|Moved out of country/state|2|||
127811104|NCT00629083|459926521|FG001|Overall Study|Moved out of country/state|1|||
127811105|NCT00629083|459926520|FG000|Overall Study|Refused to return for 12 month visit|1|||
127811106|NCT00629083|459926521|FG001|Overall Study|Refused to return for 12 month visit|0|||
127811107|NCT02909153|459926522|FG000|Overall Study|Withdrawal by Subject|0|||
127811108|NCT02909153|459926523|FG001|Overall Study|Withdrawal by Subject|1|||
127811109|NCT02909153|459926524|FG002|Overall Study|Withdrawal by Subject|0|||
127811110|NCT02909153|459926525|FG003|Overall Study|Withdrawal by Subject|0|||
127811111|NCT02909153|459926526|FG004|Overall Study|Withdrawal by Subject|0|||
127811112|NCT01147809|459926527|FG000|Phase I (168 Days)|Adverse Event|0|||
127752731|NCT05000216|459720608|FG018|Stage 1|Did not receive vaccine at Week 0|0|||
127752732|NCT05000216|459720609|FG019|Stage 1|Did not receive vaccine at Week 0|0|||
127752733|NCT05000216|459720610|FG020|Stage 1|Did not receive vaccine at Week 0|0|||
127752734|NCT05000216|459720611|FG021|Stage 1|Did not receive vaccine at Week 0|0|||
127752735|NCT05000216|459720590|FG000|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
127811113|NCT01147809|459926528|FG001|Phase I (168 Days)|Adverse Event|0|||
127752736|NCT05000216|459720591|FG001|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
127752737|NCT05000216|459720592|FG002|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
127752738|NCT05000216|459720593|FG003|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
127811114|NCT01147809|459926529|FG002|Phase I (168 Days)|Adverse Event|0|||
127752739|NCT05000216|459720594|FG004|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
127752740|NCT05000216|459720595|FG005|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
127752741|NCT05000216|459720596|FG006|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
127752742|NCT05000216|459720597|FG007|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
127752743|NCT05000216|459720598|FG008|Stage 1|Received a SARS-CoV-2 vaccine off study|1|||
127752744|NCT05000216|459720599|FG009|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
127752745|NCT05000216|459720600|FG010|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
127752746|NCT05000216|459720601|FG011|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
127752747|NCT05000216|459720602|FG012|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
127752748|NCT05000216|459720603|FG013|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
127752749|NCT05000216|459720604|FG014|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
127752750|NCT05000216|459720605|FG015|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
127752751|NCT05000216|459720606|FG016|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
127752752|NCT05000216|459720607|FG017|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
127752753|NCT05000216|459720608|FG018|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
127752754|NCT05000216|459720609|FG019|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
127752755|NCT05000216|459720610|FG020|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
127752756|NCT05000216|459720611|FG021|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
127752757|NCT05000216|459720590|FG000|Stage 1|Other|0|||
127752758|NCT05000216|459720591|FG001|Stage 1|Other|0|||
127752759|NCT05000216|459720592|FG002|Stage 1|Other|0|||
127752760|NCT05000216|459720593|FG003|Stage 1|Other|0|||
127752761|NCT05000216|459720594|FG004|Stage 1|Other|1|||
127752762|NCT05000216|459720595|FG005|Stage 1|Other|0|||
127752763|NCT05000216|459720596|FG006|Stage 1|Other|0|||
127752764|NCT05000216|459720597|FG007|Stage 1|Other|2|||
127752765|NCT05000216|459720598|FG008|Stage 1|Other|0|||
127752766|NCT05000216|459720599|FG009|Stage 1|Other|0|||
127752767|NCT05000216|459720600|FG010|Stage 1|Other|1|||
127752768|NCT05000216|459720601|FG011|Stage 1|Other|1|||
127752769|NCT05000216|459720602|FG012|Stage 1|Other|0|||
127752770|NCT05000216|459720603|FG013|Stage 1|Other|0|||
127752771|NCT05000216|459720604|FG014|Stage 1|Other|0|||
127752772|NCT05000216|459720605|FG015|Stage 1|Other|0|||
127752773|NCT05000216|459720606|FG016|Stage 1|Other|0|||
127752774|NCT05000216|459720607|FG017|Stage 1|Other|0|||
127752775|NCT05000216|459720608|FG018|Stage 1|Other|0|||
127752776|NCT05000216|459720609|FG019|Stage 1|Other|0|||
127752777|NCT05000216|459720610|FG020|Stage 1|Other|0|||
127752778|NCT05000216|459720611|FG021|Stage 1|Other|0|||
127752779|NCT05000216|459720590|FG000|Stage 1|Rolled over to Stage 2 of the study|1|||
127752780|NCT05000216|459720591|FG001|Stage 1|Rolled over to Stage 2 of the study|0|||
127752781|NCT05000216|459720592|FG002|Stage 1|Rolled over to Stage 2 of the study|3|||
127752782|NCT05000216|459720593|FG003|Stage 1|Rolled over to Stage 2 of the study|3|||
127752783|NCT05000216|459720594|FG004|Stage 1|Rolled over to Stage 2 of the study|0|||
127752784|NCT05000216|459720595|FG005|Stage 1|Rolled over to Stage 2 of the study|1|||
127752785|NCT05000216|459720596|FG006|Stage 1|Rolled over to Stage 2 of the study|0|||
127752786|NCT05000216|459720597|FG007|Stage 1|Rolled over to Stage 2 of the study|2|||
127752787|NCT05000216|459720598|FG008|Stage 1|Rolled over to Stage 2 of the study|0|||
127752788|NCT05000216|459720599|FG009|Stage 1|Rolled over to Stage 2 of the study|13|||
127752789|NCT05000216|459720600|FG010|Stage 1|Rolled over to Stage 2 of the study|18|||
127752790|NCT05000216|459720601|FG011|Stage 1|Rolled over to Stage 2 of the study|2|||
127752791|NCT05000216|459720602|FG012|Stage 1|Rolled over to Stage 2 of the study|0|||
127752792|NCT05000216|459720603|FG013|Stage 1|Rolled over to Stage 2 of the study|0|||
127752793|NCT05000216|459720604|FG014|Stage 1|Rolled over to Stage 2 of the study|0|||
127752794|NCT05000216|459720605|FG015|Stage 1|Rolled over to Stage 2 of the study|0|||
127752795|NCT05000216|459720606|FG016|Stage 1|Rolled over to Stage 2 of the study|0|||
127752796|NCT05000216|459720607|FG017|Stage 1|Rolled over to Stage 2 of the study|0|||
127752797|NCT05000216|459720608|FG018|Stage 1|Rolled over to Stage 2 of the study|0|||
127894268|NCT01325207|460235299|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
127752798|NCT05000216|459720609|FG019|Stage 1|Rolled over to Stage 2 of the study|0|||
127752799|NCT05000216|459720610|FG020|Stage 1|Rolled over to Stage 2 of the study|0|||
127752800|NCT05000216|459720611|FG021|Stage 1|Rolled over to Stage 2 of the study|0|||
127752801|NCT05000216|459720590|FG000|Stage 2|Lost to Follow-up|0|||
127752802|NCT05000216|459720591|FG001|Stage 2|Lost to Follow-up|0|||
127752803|NCT05000216|459720592|FG002|Stage 2|Lost to Follow-up|0|||
127752804|NCT05000216|459720593|FG003|Stage 2|Lost to Follow-up|0|||
127752805|NCT05000216|459720594|FG004|Stage 2|Lost to Follow-up|0|||
127752806|NCT05000216|459720595|FG005|Stage 2|Lost to Follow-up|0|||
127752807|NCT05000216|459720596|FG006|Stage 2|Lost to Follow-up|0|||
127752808|NCT05000216|459720597|FG007|Stage 2|Lost to Follow-up|0|||
127752809|NCT05000216|459720598|FG008|Stage 2|Lost to Follow-up|0|||
127752810|NCT05000216|459720599|FG009|Stage 2|Lost to Follow-up|0|||
127894269|NCT01325207|460235300|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
127752811|NCT05000216|459720600|FG010|Stage 2|Lost to Follow-up|0|||
127752812|NCT05000216|459720601|FG011|Stage 2|Lost to Follow-up|0|||
127752813|NCT05000216|459720602|FG012|Stage 2|Lost to Follow-up|0|||
127752814|NCT05000216|459720603|FG013|Stage 2|Lost to Follow-up|0|||
127752815|NCT05000216|459720604|FG014|Stage 2|Lost to Follow-up|0|||
127811115|NCT01147809|459926530|FG003|Phase I (168 Days)|Adverse Event|1|||
127811116|NCT01147809|459926531|FG004|Phase I (168 Days)|Adverse Event|0|||
127811117|NCT01147809|459926532|FG005|Phase I (168 Days)|Adverse Event|0|||
127752816|NCT05000216|459720605|FG015|Stage 2|Lost to Follow-up|0|||
127752817|NCT05000216|459720606|FG016|Stage 2|Lost to Follow-up|4|||
127752818|NCT05000216|459720607|FG017|Stage 2|Lost to Follow-up|0|||
127752819|NCT05000216|459720608|FG018|Stage 2|Lost to Follow-up|0|||
127752820|NCT05000216|459720609|FG019|Stage 2|Lost to Follow-up|0|||
127752821|NCT05000216|459720610|FG020|Stage 2|Lost to Follow-up|0|||
127752822|NCT05000216|459720611|FG021|Stage 2|Lost to Follow-up|0|||
127752823|NCT05000216|459720590|FG000|Stage 2|Physician Decision|0|||
127752824|NCT05000216|459720591|FG001|Stage 2|Physician Decision|0|||
127752825|NCT05000216|459720592|FG002|Stage 2|Physician Decision|0|||
127752826|NCT05000216|459720593|FG003|Stage 2|Physician Decision|0|||
127752827|NCT05000216|459720594|FG004|Stage 2|Physician Decision|0|||
127752828|NCT05000216|459720595|FG005|Stage 2|Physician Decision|0|||
127752829|NCT05000216|459720596|FG006|Stage 2|Physician Decision|0|||
127752830|NCT05000216|459720597|FG007|Stage 2|Physician Decision|0|||
127752831|NCT05000216|459720598|FG008|Stage 2|Physician Decision|0|||
127752832|NCT05000216|459720599|FG009|Stage 2|Physician Decision|0|||
127752833|NCT05000216|459720600|FG010|Stage 2|Physician Decision|0|||
127752834|NCT05000216|459720601|FG011|Stage 2|Physician Decision|0|||
127752835|NCT05000216|459720602|FG012|Stage 2|Physician Decision|1|||
127752836|NCT05000216|459720603|FG013|Stage 2|Physician Decision|0|||
127752837|NCT05000216|459720604|FG014|Stage 2|Physician Decision|0|||
127752838|NCT05000216|459720605|FG015|Stage 2|Physician Decision|0|||
127752839|NCT05000216|459720606|FG016|Stage 2|Physician Decision|0|||
127752840|NCT05000216|459720607|FG017|Stage 2|Physician Decision|0|||
127752841|NCT05000216|459720608|FG018|Stage 2|Physician Decision|0|||
127752842|NCT05000216|459720609|FG019|Stage 2|Physician Decision|0|||
127752843|NCT05000216|459720610|FG020|Stage 2|Physician Decision|0|||
127752844|NCT05000216|459720611|FG021|Stage 2|Physician Decision|0|||
127752845|NCT05000216|459720590|FG000|Stage 2|Withdrawal by Subject|0|||
127752846|NCT05000216|459720591|FG001|Stage 2|Withdrawal by Subject|0|||
127752847|NCT05000216|459720592|FG002|Stage 2|Withdrawal by Subject|0|||
127752848|NCT05000216|459720593|FG003|Stage 2|Withdrawal by Subject|0|||
127752849|NCT05000216|459720594|FG004|Stage 2|Withdrawal by Subject|0|||
127752850|NCT05000216|459720595|FG005|Stage 2|Withdrawal by Subject|0|||
127752851|NCT05000216|459720596|FG006|Stage 2|Withdrawal by Subject|0|||
127752852|NCT05000216|459720597|FG007|Stage 2|Withdrawal by Subject|0|||
127752853|NCT05000216|459720598|FG008|Stage 2|Withdrawal by Subject|0|||
127752854|NCT05000216|459720599|FG009|Stage 2|Withdrawal by Subject|0|||
127752855|NCT05000216|459720600|FG010|Stage 2|Withdrawal by Subject|0|||
127752856|NCT05000216|459720601|FG011|Stage 2|Withdrawal by Subject|0|||
127752857|NCT05000216|459720602|FG012|Stage 2|Withdrawal by Subject|0|||
127752858|NCT05000216|459720603|FG013|Stage 2|Withdrawal by Subject|0|||
127752859|NCT05000216|459720604|FG014|Stage 2|Withdrawal by Subject|2|||
127752860|NCT05000216|459720605|FG015|Stage 2|Withdrawal by Subject|0|||
127752861|NCT05000216|459720606|FG016|Stage 2|Withdrawal by Subject|9|||
127752862|NCT05000216|459720607|FG017|Stage 2|Withdrawal by Subject|0|||
127752863|NCT05000216|459720608|FG018|Stage 2|Withdrawal by Subject|0|||
127752864|NCT05000216|459720609|FG019|Stage 2|Withdrawal by Subject|0|||
127752865|NCT05000216|459720610|FG020|Stage 2|Withdrawal by Subject|0|||
127752866|NCT05000216|459720611|FG021|Stage 2|Withdrawal by Subject|0|||
127752867|NCT05000216|459720590|FG000|Stage 2|Did not receive vaccine at Week 0|0|||
127752868|NCT05000216|459720591|FG001|Stage 2|Did not receive vaccine at Week 0|0|||
127752869|NCT05000216|459720592|FG002|Stage 2|Did not receive vaccine at Week 0|0|||
127811118|NCT01147809|459926527|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
127811119|NCT01147809|459926528|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
127811120|NCT01147809|459926529|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
127811121|NCT01147809|459926530|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
127752870|NCT05000216|459720593|FG003|Stage 2|Did not receive vaccine at Week 0|0|||
127811122|NCT01147809|459926531|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
127752871|NCT05000216|459720594|FG004|Stage 2|Did not receive vaccine at Week 0|0|||
127752872|NCT05000216|459720595|FG005|Stage 2|Did not receive vaccine at Week 0|0|||
127752873|NCT05000216|459720596|FG006|Stage 2|Did not receive vaccine at Week 0|0|||
127752874|NCT05000216|459720597|FG007|Stage 2|Did not receive vaccine at Week 0|0|||
127752875|NCT05000216|459720598|FG008|Stage 2|Did not receive vaccine at Week 0|0|||
127752876|NCT05000216|459720599|FG009|Stage 2|Did not receive vaccine at Week 0|0|||
127752877|NCT05000216|459720600|FG010|Stage 2|Did not receive vaccine at Week 0|0|||
127752878|NCT05000216|459720601|FG011|Stage 2|Did not receive vaccine at Week 0|0|||
127752879|NCT05000216|459720602|FG012|Stage 2|Did not receive vaccine at Week 0|0|||
127752880|NCT05000216|459720603|FG013|Stage 2|Did not receive vaccine at Week 0|0|||
127752881|NCT05000216|459720604|FG014|Stage 2|Did not receive vaccine at Week 0|0|||
127752882|NCT05000216|459720605|FG015|Stage 2|Did not receive vaccine at Week 0|0|||
127752883|NCT05000216|459720606|FG016|Stage 2|Did not receive vaccine at Week 0|4|||
127752884|NCT05000216|459720607|FG017|Stage 2|Did not receive vaccine at Week 0|0|||
127752885|NCT05000216|459720608|FG018|Stage 2|Did not receive vaccine at Week 0|0|||
127811123|NCT01147809|459926532|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
127752886|NCT05000216|459720609|FG019|Stage 2|Did not receive vaccine at Week 0|1|||
127752887|NCT05000216|459720610|FG020|Stage 2|Did not receive vaccine at Week 0|0|||
127752888|NCT05000216|459720611|FG021|Stage 2|Did not receive vaccine at Week 0|0|||
127752889|NCT05000216|459720590|FG000|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
127752890|NCT05000216|459720591|FG001|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
127752891|NCT05000216|459720592|FG002|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
127752892|NCT05000216|459720593|FG003|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
127752893|NCT05000216|459720594|FG004|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
127752894|NCT05000216|459720595|FG005|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
127752895|NCT05000216|459720596|FG006|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
127752896|NCT05000216|459720597|FG007|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
127752897|NCT05000216|459720598|FG008|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
127752898|NCT05000216|459720599|FG009|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
127752899|NCT05000216|459720600|FG010|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
127752900|NCT05000216|459720601|FG011|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
127752901|NCT05000216|459720602|FG012|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
127752902|NCT05000216|459720603|FG013|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
127752903|NCT05000216|459720604|FG014|Stage 2|Received a SARS-CoV-2 vaccine off study|1|||
127752904|NCT05000216|459720605|FG015|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
127752905|NCT05000216|459720606|FG016|Stage 2|Received a SARS-CoV-2 vaccine off study|6|||
127752906|NCT05000216|459720607|FG017|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
127752907|NCT05000216|459720608|FG018|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
127752908|NCT05000216|459720609|FG019|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
127752909|NCT05000216|459720610|FG020|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
127752910|NCT05000216|459720611|FG021|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
127752911|NCT05000216|459720590|FG000|Stage 2|Other reason|0|||
127752912|NCT05000216|459720591|FG001|Stage 2|Other reason|0|||
127752913|NCT05000216|459720592|FG002|Stage 2|Other reason|0|||
127752914|NCT05000216|459720593|FG003|Stage 2|Other reason|0|||
127752915|NCT05000216|459720594|FG004|Stage 2|Other reason|0|||
127752916|NCT05000216|459720595|FG005|Stage 2|Other reason|0|||
127752917|NCT05000216|459720596|FG006|Stage 2|Other reason|0|||
127752918|NCT05000216|459720597|FG007|Stage 2|Other reason|0|||
127752919|NCT05000216|459720598|FG008|Stage 2|Other reason|0|||
127752920|NCT05000216|459720599|FG009|Stage 2|Other reason|0|||
127752921|NCT05000216|459720600|FG010|Stage 2|Other reason|0|||
127752922|NCT05000216|459720601|FG011|Stage 2|Other reason|0|||
127752923|NCT05000216|459720602|FG012|Stage 2|Other reason|0|||
127752924|NCT05000216|459720603|FG013|Stage 2|Other reason|0|||
127752925|NCT05000216|459720604|FG014|Stage 2|Other reason|0|||
127752926|NCT05000216|459720605|FG015|Stage 2|Other reason|0|||
127752927|NCT05000216|459720606|FG016|Stage 2|Other reason|1|||
127752928|NCT05000216|459720607|FG017|Stage 2|Other reason|0|||
127752929|NCT05000216|459720608|FG018|Stage 2|Other reason|0|||
127752930|NCT05000216|459720609|FG019|Stage 2|Other reason|0|||
127752931|NCT05000216|459720610|FG020|Stage 2|Other reason|0|||
127752932|NCT05000216|459720611|FG021|Stage 2|Other reason|0|||
127752933|NCT05000216|459720590|FG000|Stage 2 Sanofi|Lost to Follow-up|0|||
127752934|NCT05000216|459720591|FG001|Stage 2 Sanofi|Lost to Follow-up|0|||
127752935|NCT05000216|459720592|FG002|Stage 2 Sanofi|Lost to Follow-up|0|||
127752936|NCT05000216|459720593|FG003|Stage 2 Sanofi|Lost to Follow-up|0|||
127752937|NCT05000216|459720594|FG004|Stage 2 Sanofi|Lost to Follow-up|0|||
127752938|NCT05000216|459720595|FG005|Stage 2 Sanofi|Lost to Follow-up|0|||
127752939|NCT05000216|459720596|FG006|Stage 2 Sanofi|Lost to Follow-up|0|||
127752940|NCT05000216|459720597|FG007|Stage 2 Sanofi|Lost to Follow-up|0|||
127752941|NCT05000216|459720598|FG008|Stage 2 Sanofi|Lost to Follow-up|0|||
127752942|NCT05000216|459720599|FG009|Stage 2 Sanofi|Lost to Follow-up|0|||
127752943|NCT05000216|459720600|FG010|Stage 2 Sanofi|Lost to Follow-up|0|||
127752944|NCT05000216|459720601|FG011|Stage 2 Sanofi|Lost to Follow-up|0|||
127752945|NCT05000216|459720602|FG012|Stage 2 Sanofi|Lost to Follow-up|0|||
127752946|NCT05000216|459720603|FG013|Stage 2 Sanofi|Lost to Follow-up|0|||
127752947|NCT05000216|459720604|FG014|Stage 2 Sanofi|Lost to Follow-up|0|||
127752948|NCT05000216|459720605|FG015|Stage 2 Sanofi|Lost to Follow-up|0|||
127811124|NCT01147809|459926527|FG000|Phase I (168 Days)|Physician Decision|0|||
127811125|NCT01147809|459926528|FG001|Phase I (168 Days)|Physician Decision|1|||
127752949|NCT05000216|459720606|FG016|Stage 2 Sanofi|Lost to Follow-up|0|||
127752950|NCT05000216|459720607|FG017|Stage 2 Sanofi|Lost to Follow-up|0|||
127752951|NCT05000216|459720608|FG018|Stage 2 Sanofi|Lost to Follow-up|1|||
127752952|NCT05000216|459720609|FG019|Stage 2 Sanofi|Lost to Follow-up|0|||
127752953|NCT05000216|459720610|FG020|Stage 2 Sanofi|Lost to Follow-up|0|||
127752954|NCT05000216|459720611|FG021|Stage 2 Sanofi|Lost to Follow-up|0|||
127752955|NCT05000216|459720590|FG000|Stage 2 Sanofi|Withdrawal by Subject|0|||
127752956|NCT05000216|459720591|FG001|Stage 2 Sanofi|Withdrawal by Subject|0|||
127752957|NCT05000216|459720592|FG002|Stage 2 Sanofi|Withdrawal by Subject|0|||
127752958|NCT05000216|459720593|FG003|Stage 2 Sanofi|Withdrawal by Subject|0|||
127752959|NCT05000216|459720594|FG004|Stage 2 Sanofi|Withdrawal by Subject|0|||
127752960|NCT05000216|459720595|FG005|Stage 2 Sanofi|Withdrawal by Subject|0|||
127752961|NCT05000216|459720596|FG006|Stage 2 Sanofi|Withdrawal by Subject|0|||
127752962|NCT05000216|459720597|FG007|Stage 2 Sanofi|Withdrawal by Subject|0|||
127752963|NCT05000216|459720598|FG008|Stage 2 Sanofi|Withdrawal by Subject|0|||
127752964|NCT05000216|459720599|FG009|Stage 2 Sanofi|Withdrawal by Subject|0|||
127752965|NCT05000216|459720600|FG010|Stage 2 Sanofi|Withdrawal by Subject|0|||
127752966|NCT05000216|459720601|FG011|Stage 2 Sanofi|Withdrawal by Subject|0|||
127752967|NCT05000216|459720602|FG012|Stage 2 Sanofi|Withdrawal by Subject|0|||
127752968|NCT05000216|459720603|FG013|Stage 2 Sanofi|Withdrawal by Subject|0|||
127752969|NCT05000216|459720604|FG014|Stage 2 Sanofi|Withdrawal by Subject|0|||
127752970|NCT05000216|459720605|FG015|Stage 2 Sanofi|Withdrawal by Subject|1|||
127752971|NCT05000216|459720606|FG016|Stage 2 Sanofi|Withdrawal by Subject|0|||
127752972|NCT05000216|459720607|FG017|Stage 2 Sanofi|Withdrawal by Subject|0|||
127752973|NCT05000216|459720608|FG018|Stage 2 Sanofi|Withdrawal by Subject|0|||
127752974|NCT05000216|459720609|FG019|Stage 2 Sanofi|Withdrawal by Subject|0|||
127752975|NCT05000216|459720610|FG020|Stage 2 Sanofi|Withdrawal by Subject|0|||
127752976|NCT05000216|459720611|FG021|Stage 2 Sanofi|Withdrawal by Subject|0|||
127752977|NCT05000216|459720590|FG000|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
127752978|NCT05000216|459720591|FG001|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
127752979|NCT05000216|459720592|FG002|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
127752980|NCT05000216|459720593|FG003|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
127752981|NCT05000216|459720594|FG004|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
127752982|NCT05000216|459720595|FG005|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
127752983|NCT05000216|459720596|FG006|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
127752984|NCT05000216|459720597|FG007|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
127752985|NCT05000216|459720598|FG008|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
127752986|NCT05000216|459720599|FG009|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
127752987|NCT05000216|459720600|FG010|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
127752988|NCT05000216|459720601|FG011|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
127752989|NCT05000216|459720602|FG012|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
127752990|NCT05000216|459720603|FG013|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|1|||
127752991|NCT05000216|459720604|FG014|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
127752992|NCT05000216|459720605|FG015|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
127752993|NCT05000216|459720606|FG016|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
127752994|NCT05000216|459720607|FG017|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
127752995|NCT05000216|459720608|FG018|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
127752996|NCT05000216|459720609|FG019|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
127752997|NCT05000216|459720610|FG020|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
127752998|NCT05000216|459720611|FG021|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
127752999|NCT02224703|459720617|FG000|Overall Study|Adverse Event|0|||
127753000|NCT02224703|459720618|FG001|Overall Study|Adverse Event|5|||
127753001|NCT02224703|459720619|FG002|Overall Study|Adverse Event|0|||
127753002|NCT02224703|459720617|FG000|Overall Study|Withdrawn by investigator|1|||
127753003|NCT02224703|459720618|FG001|Overall Study|Withdrawn by investigator|0|||
127753004|NCT02224703|459720619|FG002|Overall Study|Withdrawn by investigator|0|||
127753005|NCT02224703|459720617|FG000|Overall Study|Advised by medical monitor|1|||
127753006|NCT02224703|459720618|FG001|Overall Study|Advised by medical monitor|0|||
127753007|NCT02224703|459720619|FG002|Overall Study|Advised by medical monitor|0|||
127753008|NCT02224703|459720617|FG000|Overall Study|Withdrawn by parent/guardian|0|||
127753009|NCT02224703|459720618|FG001|Overall Study|Withdrawn by parent/guardian|1|||
127753010|NCT02224703|459720619|FG002|Overall Study|Withdrawn by parent/guardian|0|||
127753011|NCT02224703|459720617|FG000|Overall Study|Lack of Efficacy|1|||
127753012|NCT02224703|459720618|FG001|Overall Study|Lack of Efficacy|0|||
127753013|NCT02224703|459720619|FG002|Overall Study|Lack of Efficacy|0|||
127753014|NCT02922023|459720620|FG000|Overall Study|Lost to Follow-up|2|||
127811126|NCT01147809|459926529|FG002|Phase I (168 Days)|Physician Decision|2|||
127753015|NCT02922023|459720621|FG001|Overall Study|Lost to Follow-up|0|||
127753016|NCT00659880|459720622|FG000|Overall Study|Lost to Follow-up|5|||
127753017|NCT01886287|459720629|FG000|Overall Study|Radiographic disease progression|1|||
127753018|NCT01886287|459720629|FG000|Overall Study|Clinical progression due to disease|1|||
127753019|NCT02990468|459720630|FG000|Phase 2: MTD|Change in treatment|0|||
127753020|NCT02990468|459720631|FG001|Phase 2: MTD|Change in treatment|0|||
127753021|NCT02990468|459720632|FG002|Phase 2: MTD|Change in treatment|1|||
127753022|NCT00669877|459720637|FG000|Overall Study|Disease Progression/Death|4|||
127753023|NCT01427725|459720640|FG000|Overall Study|Lost to Follow-up|17|||
127753024|NCT01427725|459720640|FG000|Overall Study|Protocol Violation|1|||
127753025|NCT01427725|459720640|FG000|Overall Study|Drug not administered|1|||
127753026|NCT01427725|459720640|FG000|Overall Study|Failure to visit|7|||
127753027|NCT01427725|459720640|FG000|Overall Study|Adverse Event|46|||
127753028|NCT01427725|459720640|FG000|Overall Study|Failure to visit after administration|40|||
127753029|NCT01427725|459720640|FG000|Overall Study|Patient's rejection|27|||
127753030|NCT01427725|459720640|FG000|Overall Study|Transfer to a different hospital|17|||
127753031|NCT01427725|459720640|FG000|Overall Study|Lack of Efficacy|8|||
127753032|NCT01427725|459720640|FG000|Overall Study|Death|7|||
127753033|NCT01427725|459720640|FG000|Overall Study|Symptom improvement|6|||
127753034|NCT01427725|459720640|FG000|Overall Study|AE and Patient's rejection|5|||
127753035|NCT01427725|459720640|FG000|Overall Study|Physician Decision|5|||
127753036|NCT01427725|459720640|FG000|Overall Study|Exacerbation of underlying disease|5|||
127753037|NCT01427725|459720640|FG000|Overall Study|Oral feeding difficulty|5|||
127753038|NCT01427725|459720640|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
127753039|NCT01427725|459720640|FG000|Overall Study|Forgetting prescription|1|||
127753040|NCT01427725|459720640|FG000|Overall Study|Other|2|||
127753041|NCT02269423|459720644|FG000|Overall Study|Discontinued due to change in residence|0|||
127753042|NCT02269423|459720645|FG001|Overall Study|Discontinued due to change in residence|1|||
127753043|NCT02269423|459720646|FG002|Overall Study|Discontinued due to change in residence|0|||
127753044|NCT02269423|459720647|FG003|Overall Study|Discontinued due to change in residence|1|||
127753045|NCT01277887|459720649|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
127753046|NCT01277887|459720650|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
127753047|NCT01277887|459720649|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
127753048|NCT01277887|459720650|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
127753049|NCT01277887|459720649|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
127753050|NCT01277887|459720650|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
127753051|NCT00415051|459720651|FG000|Overall Study|Protocol Violation|1|||
127753052|NCT00203268|459720652|FG000|Early Treatment|only treated one headache|2|||
127753053|NCT00203268|459720652|FG000|Early Treatment|Lost to Follow-up|1|||
127753054|NCT00203268|459720652|FG000|Early Treatment|Withdrawal by Subject|1|||
127753055|NCT00600613|459720653|FG000|Overall Study|Protocol Deviation|1|||
127753056|NCT02514551|459720656|FG000|Overall Study|Lost to Follow-up|0|||
127753057|NCT02514551|459720657|FG001|Overall Study|Lost to Follow-up|1|||
127753058|NCT02514551|459720656|FG000|Overall Study|Participant Never Treated|0|||
127753059|NCT02514551|459720657|FG001|Overall Study|Participant Never Treated|2|||
127753060|NCT05415748|459720663|FG000|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
127753061|NCT05415748|459720664|FG001|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
127753062|NCT05415748|459720665|FG002|Wash-out #1 (1 Week)|Withdrawal by Subject|2|||
127753063|NCT05415748|459720666|FG003|Wash-out #1 (1 Week)|Withdrawal by Subject|0|||
127753064|NCT05415748|459720663|FG000|Intervention #2 (2 Weeks)|Withdrawal by Subject|1|||
127753065|NCT05415748|459720664|FG001|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
127753066|NCT05415748|459720665|FG002|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
127753067|NCT05415748|459720666|FG003|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
127753068|NCT03838731|459722306|FG000|Overall Study|Pregnancy|0|||
127753069|NCT03838731|459722307|FG001|Overall Study|Pregnancy|1|||
127753070|NCT03838731|459722306|FG000|Overall Study|Withdrawal of consent|1|||
127753071|NCT03838731|459722307|FG001|Overall Study|Withdrawal of consent|0|||
127753072|NCT00770029|459722311|FG000|Overall Study|Lost to Follow-up|2|||
127753073|NCT00770029|459722312|FG001|Overall Study|Lost to Follow-up|0|||
127753074|NCT00770029|459722311|FG000|Overall Study|Withdrawal by Subject|3|||
127753075|NCT00770029|459722312|FG001|Overall Study|Withdrawal by Subject|3|||
127753076|NCT00770029|459722311|FG000|Overall Study|Adverse Event|1|||
127753077|NCT00770029|459722312|FG001|Overall Study|Adverse Event|0|||
127753078|NCT05627258|459722313|FG000|Overall Study|Lost to Follow-up|1|||
127753079|NCT05627258|459722314|FG001|Overall Study|Lost to Follow-up|0|||
127753080|NCT05627258|459722315|FG002|Overall Study|Lost to Follow-up|0|||
127753081|NCT05627258|459722316|FG003|Overall Study|Lost to Follow-up|0|||
127753082|NCT05627258|459722317|FG004|Overall Study|Lost to Follow-up|0|||
127753083|NCT05627258|459722318|FG005|Overall Study|Lost to Follow-up|0|||
127753084|NCT05627258|459722313|FG000|Overall Study|Withdrawal by Subject|0|||
127753085|NCT05627258|459722314|FG001|Overall Study|Withdrawal by Subject|0|||
127753086|NCT05627258|459722315|FG002|Overall Study|Withdrawal by Subject|0|||
127753087|NCT05627258|459722316|FG003|Overall Study|Withdrawal by Subject|0|||
127753088|NCT05627258|459722317|FG004|Overall Study|Withdrawal by Subject|2|||
127753089|NCT05627258|459722318|FG005|Overall Study|Withdrawal by Subject|0|||
127753090|NCT05627258|459722313|FG000|Overall Study|Enrolled, but product not administered|1|||
127753091|NCT05627258|459722314|FG001|Overall Study|Enrolled, but product not administered|0|||
127753092|NCT05627258|459722315|FG002|Overall Study|Enrolled, but product not administered|0|||
127753093|NCT05627258|459722316|FG003|Overall Study|Enrolled, but product not administered|0|||
127753094|NCT05627258|459722317|FG004|Overall Study|Enrolled, but product not administered|0|||
127753095|NCT05627258|459722318|FG005|Overall Study|Enrolled, but product not administered|0|||
127753096|NCT05627258|459722313|FG000|Overall Study|Other subject illness/injury|1|||
127753097|NCT05627258|459722314|FG001|Overall Study|Other subject illness/injury|0|||
127753098|NCT05627258|459722315|FG002|Overall Study|Other subject illness/injury|0|||
127753099|NCT05627258|459722316|FG003|Overall Study|Other subject illness/injury|0|||
127753100|NCT05627258|459722317|FG004|Overall Study|Other subject illness/injury|0|||
127753101|NCT05627258|459722318|FG005|Overall Study|Other subject illness/injury|0|||
127753102|NCT05627258|459722313|FG000|Overall Study|Subject moved from area|0|||
127753103|NCT05627258|459722314|FG001|Overall Study|Subject moved from area|0|||
127753104|NCT05627258|459722315|FG002|Overall Study|Subject moved from area|1|||
127753105|NCT05627258|459722316|FG003|Overall Study|Subject moved from area|0|||
127753106|NCT05627258|459722317|FG004|Overall Study|Subject moved from area|0|||
127753107|NCT05627258|459722318|FG005|Overall Study|Subject moved from area|0|||
127753108|NCT01199068|459722319|FG000|Overall Study|Unacceptable toxicity|0|||
127753109|NCT01199068|459722320|FG001|Overall Study|Unacceptable toxicity|0|||
127753110|NCT01199068|459722321|FG002|Overall Study|Unacceptable toxicity|2|||
127753111|NCT01199068|459722319|FG000|Overall Study|Progressive disease|3|||
127753112|NCT01199068|459722320|FG001|Overall Study|Progressive disease|3|||
127753113|NCT01199068|459722321|FG002|Overall Study|Progressive disease|6|||
127753114|NCT01199068|459722319|FG000|Overall Study|Withdrawal by Subject|0|||
127753115|NCT01199068|459722320|FG001|Overall Study|Withdrawal by Subject|0|||
127753116|NCT01199068|459722321|FG002|Overall Study|Withdrawal by Subject|1|||
127753117|NCT01294397|459722322|FG000|Overall Study|Withdrawal by Subject|1|||
127753118|NCT01294397|459722322|FG000|Overall Study|Administrative Decision|1|||
127753119|NCT00678301|459722323|FG000|Overall Study|Non-compliance with study procedures|0|||
127753120|NCT00678301|459722324|FG001|Overall Study|Non-compliance with study procedures|1|||
127753121|NCT00678301|459722323|FG000|Overall Study|Adverse Event|1|||
127753122|NCT00678301|459722324|FG001|Overall Study|Adverse Event|0|||
127753123|NCT00678301|459722323|FG000|Overall Study|Withdrawal by Subject|4|||
127753124|NCT00678301|459722324|FG001|Overall Study|Withdrawal by Subject|0|||
127753125|NCT00678301|459722323|FG000|Overall Study|Lost to Follow-up|3|||
127753126|NCT00678301|459722324|FG001|Overall Study|Lost to Follow-up|1|||
127753127|NCT02687035|459722327|FG000|Overall Study|Withdrawal by Subject|1|||
127753128|NCT02687035|459722327|FG000|Overall Study|Death|87|||
127753129|NCT02687035|459722327|FG000|Overall Study|Lost to Follow-up|1|||
127753130|NCT02687035|459722327|FG000|Overall Study|Missed Visit|87|||
127753131|NCT02687035|459722327|FG000|Overall Study|Did not receive Study Device|8|||
127753132|NCT04076943|459722329|FG000|Overall Study|Withdrawal by Subject|12|||
127753133|NCT04076943|459722329|FG000|Overall Study|Adverse Event|1|||
127753134|NCT04076943|459722329|FG000|Overall Study|Progressive Disease|2|||
127753135|NCT04076943|459722329|FG000|Overall Study|Death|13|||
127753136|NCT04076943|459722329|FG000|Overall Study|Other than specified|6|||
127753137|NCT03596762|459722330|FG000|Overall Study|Protocol Violation|0|||
127753138|NCT03596762|459722331|FG001|Overall Study|Protocol Violation|0|||
127753139|NCT03596762|459722332|FG002|Overall Study|Protocol Violation|0|||
127753140|NCT03596762|459722333|FG003|Overall Study|Protocol Violation|0|||
127753141|NCT03596762|459722334|FG004|Overall Study|Protocol Violation|1|||
127753142|NCT03596762|459722330|FG000|Overall Study|Adverse Event|2|||
127753143|NCT03596762|459722331|FG001|Overall Study|Adverse Event|0|||
127753144|NCT03596762|459722332|FG002|Overall Study|Adverse Event|1|||
127753145|NCT03596762|459722333|FG003|Overall Study|Adverse Event|0|||
127753146|NCT03596762|459722334|FG004|Overall Study|Adverse Event|5|||
127753147|NCT03596762|459722330|FG000|Overall Study|Withdrawal by Subject|2|||
127753148|NCT03596762|459722331|FG001|Overall Study|Withdrawal by Subject|1|||
127753149|NCT03596762|459722332|FG002|Overall Study|Withdrawal by Subject|0|||
127753150|NCT03596762|459722333|FG003|Overall Study|Withdrawal by Subject|1|||
127753151|NCT03596762|459722334|FG004|Overall Study|Withdrawal by Subject|1|||
127753152|NCT01031628|459722335|FG000|Overall Study|Study terminated early|0|||
127753153|NCT01031628|459722336|FG001|Overall Study|Study terminated early|1|||
127753154|NCT01031628|459722337|FG002|Overall Study|Study terminated early|3|||
127753155|NCT01031628|459722338|FG003|Overall Study|Study terminated early|0|||
127753156|NCT01263509|459722339|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
127753157|NCT01263509|459722340|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
127753158|NCT01263509|459722341|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
127753159|NCT01263509|459722342|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
127753160|NCT01263509|459722339|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
127753161|NCT01263509|459722340|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
127753162|NCT01263509|459722341|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
127753163|NCT01263509|459722342|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
127753164|NCT01263509|459722339|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
127753165|NCT01263509|459722340|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
127753166|NCT01263509|459722341|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
127753167|NCT01263509|459722342|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
127753168|NCT01263509|459722339|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
127753169|NCT01263509|459722340|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
127753170|NCT01263509|459722341|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
127753171|NCT01263509|459722342|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
127753172|NCT01263509|459722339|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
127753173|NCT01263509|459722340|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
127753174|NCT01263509|459722341|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
127753175|NCT01263509|459722342|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
127753176|NCT02593123|459722343|FG000|Overall Study|Physician Decision|2|||
127753177|NCT02593123|459722344|FG001|Overall Study|Physician Decision|1|||
127753178|NCT02593123|459722343|FG000|Overall Study|Relapse|1|||
127753179|NCT02593123|459722344|FG001|Overall Study|Relapse|1|||
127753180|NCT00895895|459722345|FG000|Period 1|Adverse Event|7|||
127753181|NCT00895895|459722346|FG001|Period 1|Adverse Event|6|||
127753182|NCT00895895|459722347|FG002|Period 1|Adverse Event|4|||
127753183|NCT00895895|459722348|FG003|Period 1|Adverse Event|6|||
127753184|NCT00895895|459722349|FG004|Period 1|Adverse Event|7|||
127753185|NCT00895895|459722345|FG000|Period 1|Death|0|||
127753186|NCT00895895|459722346|FG001|Period 1|Death|0|||
127753187|NCT00895895|459722347|FG002|Period 1|Death|0|||
127753188|NCT00895895|459722348|FG003|Period 1|Death|0|||
127753189|NCT00895895|459722349|FG004|Period 1|Death|1|||
127811127|NCT01147809|459926530|FG003|Phase I (168 Days)|Physician Decision|0|||
127811128|NCT01147809|459926531|FG004|Phase I (168 Days)|Physician Decision|0|||
127811129|NCT01147809|459926532|FG005|Phase I (168 Days)|Physician Decision|0|||
127811130|NCT01147809|459926527|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
127811131|NCT01147809|459926528|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
127753190|NCT00895895|459722345|FG000|Period 1|discontinued by sponsor|2|||
127753191|NCT00895895|459722346|FG001|Period 1|discontinued by sponsor|1|||
127753192|NCT00895895|459722347|FG002|Period 1|discontinued by sponsor|2|||
127753193|NCT00895895|459722348|FG003|Period 1|discontinued by sponsor|1|||
127753194|NCT00895895|459722349|FG004|Period 1|discontinued by sponsor|1|||
127753195|NCT00895895|459722345|FG000|Period 1|failed to return|0|||
127753196|NCT00895895|459722346|FG001|Period 1|failed to return|0|||
127811132|NCT01147809|459926529|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
127811133|NCT01147809|459926530|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
127811134|NCT01147809|459926531|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
127811135|NCT01147809|459926532|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
127811136|NCT01147809|459926527|FG000|Phase II (168 Days)|Adverse Event|0|||
127811137|NCT01147809|459926528|FG001|Phase II (168 Days)|Adverse Event|0|||
127811138|NCT01147809|459926529|FG002|Phase II (168 Days)|Adverse Event|0|||
127811139|NCT01147809|459926530|FG003|Phase II (168 Days)|Adverse Event|0|||
127811140|NCT01147809|459926531|FG004|Phase II (168 Days)|Adverse Event|3|||
127811141|NCT01147809|459926532|FG005|Phase II (168 Days)|Adverse Event|6|||
127811142|NCT01147809|459926527|FG000|Phase II (168 Days)|Protocol Violation|0|||
127811143|NCT01147809|459926528|FG001|Phase II (168 Days)|Protocol Violation|0|||
127811144|NCT01147809|459926529|FG002|Phase II (168 Days)|Protocol Violation|0|||
127811145|NCT01147809|459926530|FG003|Phase II (168 Days)|Protocol Violation|0|||
127811146|NCT01147809|459926531|FG004|Phase II (168 Days)|Protocol Violation|0|||
127811147|NCT01147809|459926532|FG005|Phase II (168 Days)|Protocol Violation|1|||
127811148|NCT01147809|459926527|FG000|Phase II (168 Days)|Physician Decision|0|||
127811149|NCT01147809|459926528|FG001|Phase II (168 Days)|Physician Decision|0|||
127811150|NCT01147809|459926529|FG002|Phase II (168 Days)|Physician Decision|0|||
127811151|NCT01147809|459926530|FG003|Phase II (168 Days)|Physician Decision|0|||
127811152|NCT01147809|459926531|FG004|Phase II (168 Days)|Physician Decision|5|||
127811153|NCT01147809|459926532|FG005|Phase II (168 Days)|Physician Decision|11|||
127811154|NCT01147809|459926527|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
127811155|NCT01147809|459926528|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
127811156|NCT01147809|459926529|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
127811157|NCT01147809|459926530|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
127811158|NCT01147809|459926531|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
127811159|NCT01147809|459926532|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
127753197|NCT00895895|459722347|FG002|Period 1|failed to return|1|||
127753198|NCT00895895|459722348|FG003|Period 1|failed to return|0|||
127753199|NCT00895895|459722349|FG004|Period 1|failed to return|1|||
127753200|NCT00895895|459722345|FG000|Period 1|investigator request|0|||
127753201|NCT00895895|459722346|FG001|Period 1|investigator request|1|||
127753202|NCT00895895|459722347|FG002|Period 1|investigator request|0|||
127753203|NCT00895895|459722348|FG003|Period 1|investigator request|0|||
127753204|NCT00895895|459722349|FG004|Period 1|investigator request|0|||
127753205|NCT00895895|459722345|FG000|Period 1|Lost to Follow-up|2|||
127753206|NCT00895895|459722346|FG001|Period 1|Lost to Follow-up|1|||
127753207|NCT00895895|459722347|FG002|Period 1|Lost to Follow-up|3|||
127753208|NCT00895895|459722348|FG003|Period 1|Lost to Follow-up|2|||
127753209|NCT00895895|459722349|FG004|Period 1|Lost to Follow-up|3|||
127753210|NCT00895895|459722345|FG000|Period 1|Other|1|||
127753211|NCT00895895|459722346|FG001|Period 1|Other|2|||
127753212|NCT00895895|459722347|FG002|Period 1|Other|1|||
127753213|NCT00895895|459722348|FG003|Period 1|Other|1|||
127753214|NCT00895895|459722349|FG004|Period 1|Other|1|||
127753215|NCT00895895|459722345|FG000|Period 1|Protocol Violation|0|||
127753216|NCT00895895|459722346|FG001|Period 1|Protocol Violation|1|||
127753217|NCT00895895|459722347|FG002|Period 1|Protocol Violation|0|||
127753218|NCT00895895|459722348|FG003|Period 1|Protocol Violation|0|||
127753219|NCT00895895|459722349|FG004|Period 1|Protocol Violation|0|||
127753220|NCT00895895|459722345|FG000|Period 1|Withdrawal by Subject|6|||
127753221|NCT00895895|459722346|FG001|Period 1|Withdrawal by Subject|6|||
127753222|NCT00895895|459722347|FG002|Period 1|Withdrawal by Subject|8|||
127753223|NCT00895895|459722348|FG003|Period 1|Withdrawal by Subject|2|||
127753224|NCT00895895|459722349|FG004|Period 1|Withdrawal by Subject|4|||
127753225|NCT00895895|459722345|FG000|Period 1|unsatisfactory response-efficacy|2|||
127753226|NCT00895895|459722346|FG001|Period 1|unsatisfactory response-efficacy|0|||
127753227|NCT00895895|459722347|FG002|Period 1|unsatisfactory response-efficacy|0|||
127753228|NCT00895895|459722348|FG003|Period 1|unsatisfactory response-efficacy|0|||
127753229|NCT00895895|459722349|FG004|Period 1|unsatisfactory response-efficacy|0|||
127753230|NCT00895895|459722345|FG000|Period 1|randomized and not treated|1|||
127753231|NCT00895895|459722346|FG001|Period 1|randomized and not treated|3|||
127753232|NCT00895895|459722347|FG002|Period 1|randomized and not treated|1|||
127753233|NCT00895895|459722348|FG003|Period 1|randomized and not treated|1|||
127753234|NCT00895895|459722349|FG004|Period 1|randomized and not treated|2|||
127753235|NCT00895895|459722345|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
127753236|NCT00895895|459722346|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
127753237|NCT00895895|459722347|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
127753238|NCT00895895|459722348|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
127753239|NCT00895895|459722349|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
127753240|NCT00895895|459722345|FG000|After Period 1, Prior to Period 2|Other|0|||
127753241|NCT00895895|459722346|FG001|After Period 1, Prior to Period 2|Other|0|||
127753242|NCT00895895|459722347|FG002|After Period 1, Prior to Period 2|Other|1|||
127753243|NCT00895895|459722348|FG003|After Period 1, Prior to Period 2|Other|0|||
127753244|NCT00895895|459722349|FG004|After Period 1, Prior to Period 2|Other|0|||
127753245|NCT00895895|459722345|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
127753246|NCT00895895|459722346|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
127753247|NCT00895895|459722347|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
127753248|NCT00895895|459722348|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
127753249|NCT00895895|459722349|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
127753250|NCT00895895|459722345|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
127753251|NCT00895895|459722346|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
127753252|NCT00895895|459722347|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
127753253|NCT00895895|459722348|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
127753254|NCT00895895|459722349|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
127753255|NCT00895895|459722345|FG000|Period 2|Adverse Event|3|||
127753256|NCT00895895|459722346|FG001|Period 2|Adverse Event|3|||
127753257|NCT00895895|459722347|FG002|Period 2|Adverse Event|5|||
127753258|NCT00895895|459722348|FG003|Period 2|Adverse Event|2|||
127753259|NCT00895895|459722349|FG004|Period 2|Adverse Event|5|||
127811160|NCT01147809|459926527|FG000|Phase II (168 Days)|Ongoing|0|||
127811161|NCT01147809|459926528|FG001|Phase II (168 Days)|Ongoing|0|||
127811162|NCT01147809|459926529|FG002|Phase II (168 Days)|Ongoing|0|||
127811163|NCT01147809|459926530|FG003|Phase II (168 Days)|Ongoing|0|||
127811164|NCT01147809|459926531|FG004|Phase II (168 Days)|Ongoing|1|||
127753260|NCT00895895|459722345|FG000|Period 2|Death|0|||
127753261|NCT00895895|459722346|FG001|Period 2|Death|0|||
127753262|NCT00895895|459722347|FG002|Period 2|Death|1|||
127753263|NCT00895895|459722348|FG003|Period 2|Death|0|||
127753264|NCT00895895|459722349|FG004|Period 2|Death|0|||
127753265|NCT00895895|459722345|FG000|Period 2|discontinued by sponsor|44|||
127753266|NCT00895895|459722346|FG001|Period 2|discontinued by sponsor|44|||
127753267|NCT00895895|459722347|FG002|Period 2|discontinued by sponsor|38|||
127753268|NCT00895895|459722348|FG003|Period 2|discontinued by sponsor|46|||
127753269|NCT00895895|459722349|FG004|Period 2|discontinued by sponsor|37|||
127753270|NCT00895895|459722345|FG000|Period 2|failed to return|2|||
127894270|NCT01325207|460235301|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
127894271|NCT01325207|460235302|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
127894272|NCT01325207|460235297|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
127894273|NCT01325207|460235298|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
127894274|NCT01325207|460235299|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
127894275|NCT01325207|460235300|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
127894276|NCT01325207|460235301|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
127894277|NCT01325207|460235302|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
127894278|NCT01325207|460235297|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
127894279|NCT01325207|460235298|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
127894280|NCT01325207|460235299|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
127894281|NCT01325207|460235300|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
127894282|NCT01325207|460235301|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
127894283|NCT01325207|460235302|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
127894284|NCT01325207|460235297|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
127894285|NCT01325207|460235298|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
127894286|NCT01325207|460235299|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
127894287|NCT01325207|460235300|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
127894288|NCT01325207|460235301|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
127894289|NCT01325207|460235302|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
127894290|NCT01325207|460235297|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
127894291|NCT01325207|460235298|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
127894292|NCT01325207|460235299|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
127894293|NCT01325207|460235300|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
127894294|NCT01325207|460235301|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
127894295|NCT01325207|460235302|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
127894296|NCT01325207|460235297|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
127894297|NCT01325207|460235298|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
127894298|NCT01325207|460235299|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
127894299|NCT01325207|460235300|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
127894300|NCT01325207|460235301|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
127894301|NCT01325207|460235302|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
127894302|NCT00708422|460235303|FG000|Overall Study|Adverse Event|3|||
127753271|NCT00895895|459722346|FG001|Period 2|failed to return|0|||
127753272|NCT00895895|459722347|FG002|Period 2|failed to return|0|||
127753273|NCT00895895|459722348|FG003|Period 2|failed to return|0|||
127753274|NCT00895895|459722349|FG004|Period 2|failed to return|0|||
127753275|NCT00895895|459722345|FG000|Period 2|investigator request|2|||
127753276|NCT00895895|459722346|FG001|Period 2|investigator request|0|||
127753277|NCT00895895|459722347|FG002|Period 2|investigator request|0|||
127753278|NCT00895895|459722348|FG003|Period 2|investigator request|0|||
127753279|NCT00895895|459722349|FG004|Period 2|investigator request|0|||
127753280|NCT00895895|459722345|FG000|Period 2|Lost to Follow-up|1|||
127753281|NCT00895895|459722346|FG001|Period 2|Lost to Follow-up|2|||
127753282|NCT00895895|459722347|FG002|Period 2|Lost to Follow-up|1|||
127753283|NCT00895895|459722348|FG003|Period 2|Lost to Follow-up|1|||
127753284|NCT00895895|459722349|FG004|Period 2|Lost to Follow-up|0|||
127753285|NCT00895895|459722345|FG000|Period 2|Other|1|||
127753286|NCT00895895|459722346|FG001|Period 2|Other|1|||
127753287|NCT00895895|459722347|FG002|Period 2|Other|3|||
127753288|NCT00895895|459722348|FG003|Period 2|Other|1|||
127753289|NCT00895895|459722349|FG004|Period 2|Other|1|||
127753290|NCT00895895|459722345|FG000|Period 2|Protocol Violation|1|||
127753291|NCT00895895|459722346|FG001|Period 2|Protocol Violation|0|||
127753292|NCT00895895|459722347|FG002|Period 2|Protocol Violation|1|||
127753293|NCT00895895|459722348|FG003|Period 2|Protocol Violation|1|||
127753294|NCT00895895|459722349|FG004|Period 2|Protocol Violation|1|||
127753295|NCT00895895|459722345|FG000|Period 2|Withdrawal by Subject|0|||
127753296|NCT00895895|459722346|FG001|Period 2|Withdrawal by Subject|2|||
127753297|NCT00895895|459722347|FG002|Period 2|Withdrawal by Subject|0|||
127753298|NCT00895895|459722348|FG003|Period 2|Withdrawal by Subject|3|||
127753299|NCT00895895|459722349|FG004|Period 2|Withdrawal by Subject|5|||
127753300|NCT00895895|459722345|FG000|Period 2|unsatisfactory response-efficacy|2|||
127753301|NCT00895895|459722346|FG001|Period 2|unsatisfactory response-efficacy|1|||
127753302|NCT00895895|459722347|FG002|Period 2|unsatisfactory response-efficacy|0|||
127753303|NCT00895895|459722348|FG003|Period 2|unsatisfactory response-efficacy|0|||
127753304|NCT00895895|459722349|FG004|Period 2|unsatisfactory response-efficacy|0|||
127753305|NCT01261000|459722350|FG000|Overall Study|Screen failure|1|||
127753306|NCT00504777|459722351|FG000|Overall Study|Adverse Event|1|||
127753307|NCT01374568|459722354|FG000|Overall Study|Lab unable to analyze BTM|0|||
127753308|NCT01374568|459722355|FG001|Overall Study|Lab unable to analyze BTM|2|||
127753309|NCT01912404|459722356|FG000|Overall Study|Due to personal reasons|1|||
127753310|NCT01912404|459722357|FG001|Overall Study|Due to personal reasons|0|||
127753311|NCT00820170|459722359|FG000|Overall Study|Adverse Event|0|||
127753312|NCT00820170|459722360|FG001|Overall Study|Adverse Event|0|||
127753313|NCT00820170|459722361|FG002|Overall Study|Adverse Event|0|||
127753314|NCT00820170|459722362|FG003|Overall Study|Adverse Event|0|||
127753315|NCT00820170|459722363|FG004|Overall Study|Adverse Event|2|||
127753316|NCT00820170|459722359|FG000|Overall Study|Progressive Disease|0|||
127753317|NCT00820170|459722360|FG001|Overall Study|Progressive Disease|0|||
127753318|NCT00820170|459722361|FG002|Overall Study|Progressive Disease|0|||
127753319|NCT00820170|459722362|FG003|Overall Study|Progressive Disease|0|||
127753320|NCT00820170|459722363|FG004|Overall Study|Progressive Disease|2|||
127753321|NCT03995316|459722364|FG000|Overall Study|Lost to Follow-up|10|||
127753322|NCT03995316|459722365|FG001|Overall Study|Lost to Follow-up|3|||
127753323|NCT01361594|459722366|FG000|Overall Study|Withdrawal by Subject|1|||
127753324|NCT01361594|459722367|FG001|Overall Study|Withdrawal by Subject|2|||
127753325|NCT00780559|459722371|FG000|Overall Study|Lost to Follow-up|2|||
127753326|NCT00780559|459722372|FG001|Overall Study|Lost to Follow-up|7|||
127753327|NCT00780559|459722371|FG000|Overall Study|Death|1|||
127753328|NCT00780559|459722372|FG001|Overall Study|Death|0|||
127753329|NCT04462289|459722375|FG000|Overall Study|Lost to Follow-up|4|||
127753330|NCT04462289|459722376|FG001|Overall Study|Lost to Follow-up|5|||
127753331|NCT04462289|459722375|FG000|Overall Study|Death|0|||
127753332|NCT04462289|459722376|FG001|Overall Study|Death|3|||
127753333|NCT04462289|459722375|FG000|Overall Study|Withdrawal by Subject|1|||
127753334|NCT04462289|459722376|FG001|Overall Study|Withdrawal by Subject|3|||
127753335|NCT01518153|459722377|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
127753336|NCT01518153|459722378|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
127753337|NCT01518153|459722379|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
127753338|NCT01518153|459722377|FG000|Stem Cell Transplant|Death|2|||
127753339|NCT01518153|459722378|FG001|Stem Cell Transplant|Death|0|||
127753340|NCT01518153|459722379|FG002|Stem Cell Transplant|Death|0|||
127753341|NCT01518153|459722377|FG000|Stem Cell Transplant|Secondary graft failure|1|||
127753342|NCT01518153|459722378|FG001|Stem Cell Transplant|Secondary graft failure|0|||
127753343|NCT01518153|459722379|FG002|Stem Cell Transplant|Secondary graft failure|0|||
127753344|NCT01518153|459722377|FG000|Stem Cell Transplant|Adverse Event|1|||
127753345|NCT01518153|459722378|FG001|Stem Cell Transplant|Adverse Event|0|||
127753346|NCT01518153|459722379|FG002|Stem Cell Transplant|Adverse Event|0|||
127753347|NCT01518153|459722377|FG000|Donor Lymphocyte Infusion|Death|0|||
127753348|NCT01518153|459722378|FG001|Donor Lymphocyte Infusion|Death|2|||
127753349|NCT01518153|459722379|FG002|Donor Lymphocyte Infusion|Death|1|||
127753350|NCT01754753|459722380|FG000|Overall Study|Study close|43|||
127753351|NCT01754753|459722381|FG001|Overall Study|Study close|44|||
127753352|NCT01754753|459722380|FG000|Overall Study|Lost to Follow-up|9|||
127753353|NCT01754753|459722381|FG001|Overall Study|Lost to Follow-up|5|||
127753354|NCT00856245|459722384|FG000|Overall Study|Was not transplanted|5|||
127753355|NCT01250509|459722385|FG000|Overall Study|Lost to Follow-up|5|||
127753356|NCT01250509|459722386|FG001|Overall Study|Lost to Follow-up|2|||
127811165|NCT01147809|459926532|FG005|Phase II (168 Days)|Ongoing|0|||
127811166|NCT01307423|459926533|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
127811167|NCT01307423|459926534|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
127811168|NCT01307423|459926535|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
127753357|NCT00839956|459722398|FG000|Overall Study|Adverse Event|2|||
127753358|NCT00839956|459722398|FG000|Overall Study|Lack of Efficacy|6|||
127753359|NCT00839956|459722398|FG000|Overall Study|Physician Decision|1|||
127753360|NCT00839956|459722398|FG000|Overall Study|Withdrawal by Subject|3|||
127753361|NCT02807883|459722399|FG000|Overall Study|Withdrawal by Subject|2|||
127894303|NCT00708422|460235304|FG001|Overall Study|Adverse Event|1|||
127753362|NCT01399918|459722401|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
127753363|NCT03197766|459722402|FG000|Overall Study|Withdrawal by Subject|2|||
127753364|NCT03197766|459722403|FG001|Overall Study|Withdrawal by Subject|0|||
127753365|NCT00972322|459722405|FG000|Overall Study|Adverse Event|2|||
127753366|NCT00972322|459722406|FG001|Overall Study|Adverse Event|1|||
127753367|NCT00972322|459722405|FG000|Overall Study|Positive drug screen|0|||
127753368|NCT00972322|459722406|FG001|Overall Study|Positive drug screen|1|||
127753369|NCT00972322|459722405|FG000|Overall Study|Lost to Follow-up|0|||
127753370|NCT00972322|459722406|FG001|Overall Study|Lost to Follow-up|1|||
127753371|NCT00972322|459722405|FG000|Overall Study|Consistently high glucose values|1|||
127753372|NCT00972322|459722406|FG001|Overall Study|Consistently high glucose values|0|||
127753373|NCT00277095|459722409|FG000|Overall Study|Death|2|||
127753374|NCT00277095|459722409|FG000|Overall Study|Explanted|7|||
127753375|NCT00277095|459722409|FG000|Overall Study|Lost to Follow-up|2|||
127753376|NCT00277095|459722409|FG000|Overall Study|Missed Follow-up|9|||
127753377|NCT00277095|459722409|FG000|Overall Study|Physician Decision|1|||
127753378|NCT04520659|459722411|FG000|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
127753379|NCT04520659|459722412|FG001|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
127753380|NCT04520659|459722413|FG002|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
127753381|NCT04520659|459722414|FG003|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
127753382|NCT03361865|459722419|FG000|Overall Study|Death|17|||
127753383|NCT03361865|459722420|FG001|Overall Study|Death|18|||
127753384|NCT03361865|459722419|FG000|Overall Study|Physician Decision|1|||
127753385|NCT03361865|459722420|FG001|Overall Study|Physician Decision|9|||
127753386|NCT03361865|459722419|FG000|Overall Study|Withdrawal by Subject|1|||
127753387|NCT03361865|459722420|FG001|Overall Study|Withdrawal by Subject|0|||
127753388|NCT03852719|459722421|FG000|Overall Study|Withdrawal of consent|8|||
127753389|NCT03852719|459722422|FG001|Overall Study|Withdrawal of consent|8|||
127753390|NCT03852719|459722423|FG002|Overall Study|Withdrawal of consent|9|||
127753391|NCT03852719|459722421|FG000|Overall Study|Physician Decision|5|||
127753392|NCT03852719|459722422|FG001|Overall Study|Physician Decision|4|||
127753393|NCT03852719|459722423|FG002|Overall Study|Physician Decision|1|||
127753394|NCT03852719|459722421|FG000|Overall Study|Pregnancy|2|||
127753395|NCT03852719|459722422|FG001|Overall Study|Pregnancy|1|||
127753396|NCT03852719|459722423|FG002|Overall Study|Pregnancy|0|||
127753397|NCT03852719|459722421|FG000|Overall Study|Death|1|||
127753398|NCT03852719|459722422|FG001|Overall Study|Death|0|||
127753399|NCT03852719|459722423|FG002|Overall Study|Death|0|||
127753400|NCT03852719|459722421|FG000|Overall Study|Reason not Specified|3|||
127753401|NCT03852719|459722422|FG001|Overall Study|Reason not Specified|3|||
127753402|NCT03852719|459722423|FG002|Overall Study|Reason not Specified|5|||
127753403|NCT03852719|459722421|FG000|Overall Study|Adverse Event|2|||
127753404|NCT03852719|459722422|FG001|Overall Study|Adverse Event|1|||
127753405|NCT03852719|459722423|FG002|Overall Study|Adverse Event|4|||
127753406|NCT03852719|459722421|FG000|Overall Study|Progressive disease|1|||
127753407|NCT03852719|459722422|FG001|Overall Study|Progressive disease|4|||
127753408|NCT03852719|459722423|FG002|Overall Study|Progressive disease|1|||
127753409|NCT03852719|459722421|FG000|Overall Study|Lost to Follow-up|1|||
127753410|NCT03852719|459722422|FG001|Overall Study|Lost to Follow-up|0|||
127753411|NCT03852719|459722423|FG002|Overall Study|Lost to Follow-up|0|||
127753412|NCT05543187|459722424|FG000|Overall Study|Ongoing|3|||
127753413|NCT05543187|459722425|FG001|Overall Study|Ongoing|2|||
127753414|NCT02819024|459722427|FG000|Overall Study|Withdrawal by Subject|1|||
127753415|NCT00792948|459722428|FG000|Overall Study|Adverse Event|6|||
127753416|NCT00792948|459722428|FG000|Overall Study|Death|4|||
127753417|NCT00792948|459722428|FG000|Overall Study|Withdrawal by Subject|3|||
127753418|NCT00792948|459722428|FG000|Overall Study|Ineligible|2|||
127753419|NCT00792948|459722428|FG000|Overall Study|Insurance denial - not treated|1|||
127753420|NCT00792948|459722428|FG000|Overall Study|Physician Decision|11|||
127894304|NCT00708422|460235303|FG000|Overall Study|Withdrawal by Subject|1|||
127753421|NCT00792948|459722428|FG000|Overall Study|Protocol Violation|1|||
127753422|NCT02998476|459722429|FG000|Overall Study|Lost to Follow-up|1|||
127753423|NCT02998476|459722430|FG001|Overall Study|Lost to Follow-up|0|||
127753424|NCT02998476|459722429|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
127753425|NCT02998476|459722430|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
127753426|NCT02998476|459722429|FG000|Overall Study|Withdrawal by Subject|1|||
127753427|NCT02998476|459722430|FG001|Overall Study|Withdrawal by Subject|2|||
127753428|NCT02998476|459722429|FG000|Overall Study|Death|45|||
127753429|NCT02998476|459722430|FG001|Overall Study|Death|2|||
127753430|NCT02998476|459722429|FG000|Overall Study|Other|6|||
127753431|NCT02998476|459722430|FG001|Overall Study|Other|1|||
127753432|NCT03832595|459722431|FG000|Overall Study|Death|142|||
127753433|NCT03832595|459722432|FG001|Overall Study|Death|130|||
127894305|NCT00708422|460235304|FG001|Overall Study|Withdrawal by Subject|0|||
127753434|NCT03832595|459722431|FG000|Overall Study|Medical management without dialysis|37|||
127753435|NCT03832595|459722432|FG001|Overall Study|Medical management without dialysis|1|||
127753436|NCT03277352|459722433|FG000|Overall Study|Study Terminated By Sponsor|2|||
127753437|NCT03277352|459722433|FG000|Overall Study|Withdrawal by Subject|4|||
127753438|NCT03277352|459722433|FG000|Overall Study|Death|4|||
127753439|NCT02397447|459722434|FG000|Overall Study|Lost to Follow-up|2|||
127753440|NCT02397447|459722435|FG001|Overall Study|Lost to Follow-up|2|||
127753441|NCT01435772|459722436|FG000|Overall Study|Adverse Event|1|||
127753442|NCT01435772|459722437|FG001|Overall Study|Adverse Event|0|||
127753443|NCT01435772|459722438|FG002|Overall Study|Adverse Event|2|||
127753444|NCT01435772|459722436|FG000|Overall Study|Withdrawal by Subject|0|||
127753445|NCT01435772|459722437|FG001|Overall Study|Withdrawal by Subject|1|||
127753446|NCT01435772|459722438|FG002|Overall Study|Withdrawal by Subject|3|||
127753447|NCT01435772|459722436|FG000|Overall Study|Other - study termination|2|||
127753448|NCT01435772|459722437|FG001|Overall Study|Other - study termination|2|||
127753449|NCT01435772|459722438|FG002|Overall Study|Other - study termination|10|||
127753450|NCT03238963|459722439|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
127753451|NCT03238963|459722440|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
127753452|NCT03238963|459722439|FG000|Overall Study|Withdrawal by Subject|1|||
127753453|NCT03238963|459722440|FG001|Overall Study|Withdrawal by Subject|1|||
127753454|NCT03238963|459722439|FG000|Overall Study|Lost to Follow-up|1|||
127753455|NCT03238963|459722440|FG001|Overall Study|Lost to Follow-up|0|||
127753456|NCT03238963|459722439|FG000|Overall Study|Protocol Violation|1|||
127753457|NCT03238963|459722440|FG001|Overall Study|Protocol Violation|1|||
127753458|NCT03238963|459722439|FG000|Overall Study|Adverse Event|1|||
127753459|NCT03238963|459722440|FG001|Overall Study|Adverse Event|0|||
127753460|NCT01195948|459724552|FG000|Overall Study|Lost to Follow-up|0|||
127753461|NCT01195948|459724553|FG001|Overall Study|Lost to Follow-up|1|||
127753462|NCT01195948|459724554|FG002|Overall Study|Lost to Follow-up|2|||
127753463|NCT03809039|459724558|FG000|Part 1|Withdrawal by Subject|1|||
127753464|NCT03809039|459724559|FG001|Part 1|Withdrawal by Subject|0|||
127753465|NCT03809039|459724560|FG002|Part 1|Withdrawal by Subject|0|||
127753466|NCT03809039|459724561|FG003|Part 1|Withdrawal by Subject|1|||
127753467|NCT03809039|459724562|FG004|Part 1|Withdrawal by Subject|0|||
127753468|NCT03809039|459724563|FG005|Part 1|Withdrawal by Subject|0|||
127753469|NCT03809039|459724564|FG006|Part 1|Withdrawal by Subject|0|||
127753470|NCT03809039|459724565|FG007|Part 1|Withdrawal by Subject|0|||
127753471|NCT03809039|459724566|FG008|Part 1|Withdrawal by Subject|0|||
127753472|NCT03809039|459724558|FG000|Part 3|Withdrawn by study termination|0|||
127753473|NCT03809039|459724559|FG001|Part 3|Withdrawn by study termination|0|||
127753474|NCT03809039|459724560|FG002|Part 3|Withdrawn by study termination|0|||
127753475|NCT03809039|459724561|FG003|Part 3|Withdrawn by study termination|0|||
127753476|NCT03809039|459724562|FG004|Part 3|Withdrawn by study termination|0|||
127753477|NCT03809039|459724563|FG005|Part 3|Withdrawn by study termination|0|||
127753478|NCT03809039|459724564|FG006|Part 3|Withdrawn by study termination|0|||
127753479|NCT03809039|459724565|FG007|Part 3|Withdrawn by study termination|2|||
127753480|NCT03809039|459724566|FG008|Part 3|Withdrawn by study termination|6|||
127753481|NCT01250925|459724569|FG000|Overall Study|Lost to Follow-up|1|||
127753482|NCT01250925|459724570|FG001|Overall Study|Lost to Follow-up|1|||
127753483|NCT01250925|459724571|FG002|Overall Study|Lost to Follow-up|0|||
127753484|NCT01250925|459724569|FG000|Overall Study|Withdrawal by Subject|2|||
127753485|NCT01250925|459724570|FG001|Overall Study|Withdrawal by Subject|0|||
127753486|NCT01250925|459724571|FG002|Overall Study|Withdrawal by Subject|0|||
127753487|NCT01250925|459724569|FG000|Overall Study|Protocol Violation|2|||
127753488|NCT01250925|459724570|FG001|Overall Study|Protocol Violation|0|||
127753489|NCT01250925|459724571|FG002|Overall Study|Protocol Violation|0|||
127753490|NCT01250925|459724569|FG000|Overall Study|Physician Decision|0|||
127753491|NCT01250925|459724570|FG001|Overall Study|Physician Decision|2|||
127753492|NCT01250925|459724571|FG002|Overall Study|Physician Decision|1|||
127753493|NCT01250925|459724569|FG000|Overall Study|Adverse Event|0|||
127753494|NCT01250925|459724570|FG001|Overall Study|Adverse Event|0|||
127753495|NCT01250925|459724571|FG002|Overall Study|Adverse Event|1|||
127753496|NCT03338296|459724572|FG000|Overall Study|Adverse Event|0|||
127753497|NCT03338296|459724573|FG001|Overall Study|Adverse Event|1|||
127753498|NCT03338296|459724572|FG000|Overall Study|Withdrawal by Subject|14|||
127753499|NCT03338296|459724573|FG001|Overall Study|Withdrawal by Subject|13|||
127753500|NCT03338296|459724572|FG000|Overall Study|Lost to Follow-up|10|||
127753501|NCT03338296|459724573|FG001|Overall Study|Lost to Follow-up|10|||
127753502|NCT03338296|459724572|FG000|Overall Study|Study Terminated by Sponsor|77|||
127753503|NCT03338296|459724573|FG001|Overall Study|Study Terminated by Sponsor|76|||
127753504|NCT03338296|459724572|FG000|Overall Study|Other|2|||
127753505|NCT03338296|459724573|FG001|Overall Study|Other|7|||
127753506|NCT03338296|459724572|FG000|Overall Study|Missing|0|||
127753507|NCT03338296|459724573|FG001|Overall Study|Missing|1|||
127753508|NCT04421950|459724574|FG000|Overall Study|Dropped or lost to follow up|4|||
127753509|NCT04421950|459724575|FG001|Overall Study|Dropped or lost to follow up|2|||
127753510|NCT01252355|459724576|FG000|Overall Study|Adverse Event|9|||
127753511|NCT01252355|459724577|FG001|Overall Study|Adverse Event|17|||
127753512|NCT01252355|459724578|FG002|Overall Study|Adverse Event|22|||
127753513|NCT01252355|459724576|FG000|Overall Study|Lack of Efficacy|6|||
127753514|NCT01252355|459724577|FG001|Overall Study|Lack of Efficacy|4|||
127753515|NCT01252355|459724578|FG002|Overall Study|Lack of Efficacy|2|||
127753516|NCT01252355|459724576|FG000|Overall Study|Lost to Follow-up|0|||
127753517|NCT01252355|459724577|FG001|Overall Study|Lost to Follow-up|0|||
127753518|NCT01252355|459724578|FG002|Overall Study|Lost to Follow-up|1|||
127753519|NCT01252355|459724576|FG000|Overall Study|Poor Compliance to Protocol|1|||
127753520|NCT01252355|459724577|FG001|Overall Study|Poor Compliance to Protocol|1|||
127753521|NCT01252355|459724578|FG002|Overall Study|Poor Compliance to Protocol|1|||
127753522|NCT01252355|459724576|FG000|Overall Study|Progressive Disease|2|||
127753523|NCT01252355|459724577|FG001|Overall Study|Progressive Disease|0|||
127753524|NCT01252355|459724578|FG002|Overall Study|Progressive Disease|0|||
127753525|NCT01252355|459724576|FG000|Overall Study|Sponsor Early Termination of Study|149|||
127753526|NCT01252355|459724577|FG001|Overall Study|Sponsor Early Termination of Study|149|||
127753527|NCT01252355|459724578|FG002|Overall Study|Sponsor Early Termination of Study|146|||
127753528|NCT01252355|459724576|FG000|Overall Study|Randomized but not Treated|2|||
127753529|NCT01252355|459724577|FG001|Overall Study|Randomized but not Treated|0|||
127753530|NCT01252355|459724578|FG002|Overall Study|Randomized but not Treated|0|||
127753531|NCT01252355|459724576|FG000|Overall Study|Other Than Above|8|||
127753532|NCT01252355|459724577|FG001|Overall Study|Other Than Above|7|||
127753533|NCT01252355|459724578|FG002|Overall Study|Other Than Above|7|||
127753534|NCT01725126|459724579|FG000|Overall Study|Protocol Violation|0|||
127753535|NCT01725126|459724580|FG001|Overall Study|Protocol Violation|1|||
127753536|NCT01725126|459724581|FG002|Overall Study|Protocol Violation|0|||
127753537|NCT01725126|459724582|FG003|Overall Study|Protocol Violation|0|||
127753538|NCT01725126|459724583|FG004|Overall Study|Protocol Violation|0|||
127753539|NCT01725126|459724584|FG005|Overall Study|Protocol Violation|0|||
127753540|NCT01725126|459724579|FG000|Overall Study|Withdrawal by Subject|0|||
127753541|NCT01725126|459724580|FG001|Overall Study|Withdrawal by Subject|0|||
127753542|NCT01725126|459724581|FG002|Overall Study|Withdrawal by Subject|0|||
127753543|NCT01725126|459724582|FG003|Overall Study|Withdrawal by Subject|1|||
127753544|NCT01725126|459724583|FG004|Overall Study|Withdrawal by Subject|0|||
127753545|NCT01725126|459724584|FG005|Overall Study|Withdrawal by Subject|0|||
127753546|NCT00677534|459724588|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
127753547|NCT00677534|459724588|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
127753548|NCT00677534|459724588|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
127753549|NCT00863681|459724598|FG000|Overall Study|Other|2|||
127753550|NCT00863681|459724599|FG001|Overall Study|Other|0|||
127753551|NCT00863681|459724600|FG002|Overall Study|Other|0|||
127753552|NCT00863681|459724598|FG000|Overall Study|Missing|1|||
127753553|NCT00863681|459724599|FG001|Overall Study|Missing|0|||
127753554|NCT00863681|459724600|FG002|Overall Study|Missing|0|||
127753555|NCT00863681|459724598|FG000|Overall Study|Death|40|||
127753556|NCT00863681|459724599|FG001|Overall Study|Death|23|||
127753557|NCT00863681|459724600|FG002|Overall Study|Death|6|||
127753558|NCT00863681|459724598|FG000|Overall Study|Withdrawal by Subject|12|||
127753559|NCT00863681|459724599|FG001|Overall Study|Withdrawal by Subject|5|||
127753560|NCT00863681|459724600|FG002|Overall Study|Withdrawal by Subject|2|||
127753561|NCT00863681|459724598|FG000|Overall Study|Protocol Violation|2|||
127753562|NCT00863681|459724599|FG001|Overall Study|Protocol Violation|0|||
127753563|NCT00863681|459724600|FG002|Overall Study|Protocol Violation|0|||
127753564|NCT00863681|459724598|FG000|Overall Study|Lost to Follow-up|3|||
127753565|NCT00863681|459724599|FG001|Overall Study|Lost to Follow-up|0|||
127753566|NCT00863681|459724600|FG002|Overall Study|Lost to Follow-up|3|||
127753567|NCT00863681|459724598|FG000|Overall Study|Adverse Event|28|||
127753568|NCT00863681|459724599|FG001|Overall Study|Adverse Event|10|||
127753569|NCT00863681|459724600|FG002|Overall Study|Adverse Event|6|||
127753570|NCT00863681|459724598|FG000|Overall Study|Lack of Efficacy|2|||
127753571|NCT00863681|459724599|FG001|Overall Study|Lack of Efficacy|2|||
127753572|NCT00863681|459724600|FG002|Overall Study|Lack of Efficacy|1|||
127753573|NCT00863681|459724598|FG000|Overall Study|Non-compliance with study drug|1|||
127753574|NCT00863681|459724599|FG001|Overall Study|Non-compliance with study drug|3|||
127753575|NCT00863681|459724600|FG002|Overall Study|Non-compliance with study drug|0|||
127753576|NCT03031496|459724601|FG000|Period 1|Adverse Event|2|||
127753577|NCT03031496|459724602|FG001|Period 1|Adverse Event|0|||
127753578|NCT03031496|459724601|FG000|Period 1|Withdrawal by Subject|0|||
127753579|NCT03031496|459724602|FG001|Period 1|Withdrawal by Subject|2|||
127753580|NCT02766777|459724608|FG000|Overall Study|Adverse Event|12|||
127753581|NCT02766777|459724608|FG000|Overall Study|Lost to Follow-up|16|||
127753582|NCT02766777|459724608|FG000|Overall Study|Non-Compliance With Study Drug|1|||
127753583|NCT02766777|459724608|FG000|Overall Study|Protocol Violation|1|||
127753584|NCT02766777|459724608|FG000|Overall Study|Withdrawal by Subject|4|||
127753585|NCT00967005|459724611|FG000|Overall Study|Lost to Follow-up|7|||
127753586|NCT00967005|459724612|FG001|Overall Study|Lost to Follow-up|10|||
127753587|NCT01371825|459724613|FG000|Overall Study|Death|4|||
127753588|NCT03019640|459724614|FG000|Overall Study|Screen Failures|4|||
127753589|NCT03019640|459724614|FG000|Overall Study|Adverse Event|3|||
127753590|NCT03019640|459724614|FG000|Overall Study|Participant Relapsed|1|||
127753591|NCT01162863|459724615|FG000|Overall Study|Lack of Efficacy|1|||
127753592|NCT01162863|459724616|FG001|Overall Study|Lack of Efficacy|0|||
127753593|NCT01162863|459724617|FG002|Overall Study|Lack of Efficacy|0|||
127753594|NCT01162863|459724615|FG000|Overall Study|Adverse Event|0|||
127753595|NCT01162863|459724616|FG001|Overall Study|Adverse Event|1|||
127753596|NCT01162863|459724617|FG002|Overall Study|Adverse Event|0|||
127753597|NCT00588692|459724618|FG000|Overall Study|Withdrawal by Subject|4|||
127753598|NCT00588692|459724619|FG001|Overall Study|Withdrawal by Subject|2|||
127753599|NCT00588692|459724618|FG000|Overall Study|Hip Surgery|0|||
127753600|NCT00588692|459724619|FG001|Overall Study|Hip Surgery|1|||
127753601|NCT00588692|459724618|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
127753602|NCT00588692|459724619|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
127753603|NCT00588692|459724618|FG000|Overall Study|Cancer|1|||
127753604|NCT00588692|459724619|FG001|Overall Study|Cancer|0|||
127753605|NCT00588692|459724618|FG000|Overall Study|Death|1|||
127753606|NCT00588692|459724619|FG001|Overall Study|Death|0|||
127753607|NCT03552523|459724620|FG000|Overall Study|Withdrawal by Subject|1|||
127753608|NCT03552523|459724621|FG001|Overall Study|Withdrawal by Subject|1|||
127753609|NCT03538938|459724622|FG000|Overall Study|Death|0|||
127753610|NCT03538938|459724623|FG001|Overall Study|Death|0|||
127753611|NCT03538938|459724624|FG002|Overall Study|Death|2|||
127753612|NCT03538938|459724625|FG003|Overall Study|Death|0|||
127753613|NCT03538938|459724626|FG004|Overall Study|Death|0|||
127753614|NCT03538938|459724627|FG005|Overall Study|Death|1|||
127753615|NCT03538938|459724628|FG006|Overall Study|Death|0|||
127753616|NCT03538938|459724629|FG007|Overall Study|Death|1|||
127753617|NCT03538938|459724630|FG008|Overall Study|Death|1|||
127753618|NCT03538938|459724631|FG009|Overall Study|Death|1|||
127753619|NCT03538938|459724632|FG010|Overall Study|Death|0|||
127753620|NCT03538938|459724633|FG011|Overall Study|Death|0|||
127753621|NCT03538938|459724634|FG012|Overall Study|Death|1|||
127753622|NCT03538938|459724635|FG013|Overall Study|Death|1|||
127753623|NCT03538938|459724636|FG014|Overall Study|Death|0|||
127753624|NCT03538938|459724637|FG015|Overall Study|Death|1|||
127753625|NCT03538938|459724622|FG000|Overall Study|Withdrawal by Subject|4|||
127753626|NCT03538938|459724623|FG001|Overall Study|Withdrawal by Subject|6|||
127753627|NCT03538938|459724624|FG002|Overall Study|Withdrawal by Subject|5|||
127753628|NCT03538938|459724625|FG003|Overall Study|Withdrawal by Subject|3|||
127753629|NCT03538938|459724626|FG004|Overall Study|Withdrawal by Subject|0|||
127753630|NCT03538938|459724627|FG005|Overall Study|Withdrawal by Subject|0|||
127753631|NCT03538938|459724628|FG006|Overall Study|Withdrawal by Subject|3|||
127753632|NCT03538938|459724629|FG007|Overall Study|Withdrawal by Subject|1|||
127753633|NCT03538938|459724630|FG008|Overall Study|Withdrawal by Subject|5|||
127753634|NCT03538938|459724631|FG009|Overall Study|Withdrawal by Subject|1|||
127753635|NCT03538938|459724632|FG010|Overall Study|Withdrawal by Subject|2|||
127753636|NCT03538938|459724633|FG011|Overall Study|Withdrawal by Subject|1|||
127753637|NCT03538938|459724634|FG012|Overall Study|Withdrawal by Subject|3|||
127753638|NCT03538938|459724635|FG013|Overall Study|Withdrawal by Subject|0|||
127753639|NCT03538938|459724636|FG014|Overall Study|Withdrawal by Subject|2|||
127753640|NCT03538938|459724637|FG015|Overall Study|Withdrawal by Subject|4|||
127753641|NCT03538938|459724622|FG000|Overall Study|Incarcerated|0|||
127753642|NCT03538938|459724623|FG001|Overall Study|Incarcerated|0|||
127753643|NCT03538938|459724624|FG002|Overall Study|Incarcerated|0|||
127753644|NCT03538938|459724625|FG003|Overall Study|Incarcerated|0|||
127753645|NCT03538938|459724626|FG004|Overall Study|Incarcerated|0|||
127753646|NCT03538938|459724627|FG005|Overall Study|Incarcerated|0|||
127753647|NCT03538938|459724628|FG006|Overall Study|Incarcerated|0|||
127753648|NCT03538938|459724629|FG007|Overall Study|Incarcerated|0|||
127753649|NCT03538938|459724630|FG008|Overall Study|Incarcerated|0|||
127753650|NCT03538938|459724631|FG009|Overall Study|Incarcerated|0|||
127753651|NCT03538938|459724632|FG010|Overall Study|Incarcerated|0|||
127753652|NCT03538938|459724633|FG011|Overall Study|Incarcerated|1|||
127753653|NCT03538938|459724634|FG012|Overall Study|Incarcerated|0|||
127753654|NCT03538938|459724635|FG013|Overall Study|Incarcerated|0|||
127811169|NCT01307423|459926536|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
127894306|NCT01254409|460235305|FG000|Overall Study|Adverse Event|0|||
127753655|NCT03538938|459724636|FG014|Overall Study|Incarcerated|0|||
127753656|NCT03538938|459724637|FG015|Overall Study|Incarcerated|0|||
127753657|NCT01371708|459724638|FG000|Overall Study|Insufficient clinical response|3|||
127753658|NCT01371708|459724639|FG001|Overall Study|Insufficient clinical response|2|||
127753659|NCT01371708|459724640|FG002|Overall Study|Insufficient clinical response|0|||
127753660|NCT01371708|459724638|FG000|Overall Study|Lost to Follow-up|5|||
127753661|NCT01371708|459724639|FG001|Overall Study|Lost to Follow-up|9|||
127753662|NCT01371708|459724640|FG002|Overall Study|Lost to Follow-up|7|||
127753663|NCT01371708|459724638|FG000|Overall Study|Protocol Violation|2|||
127753664|NCT01371708|459724639|FG001|Overall Study|Protocol Violation|1|||
127753665|NCT01371708|459724640|FG002|Overall Study|Protocol Violation|2|||
127753666|NCT01371708|459724638|FG000|Overall Study|No longer willing to participate|7|||
127753667|NCT01371708|459724639|FG001|Overall Study|No longer willing to participate|7|||
127753668|NCT01371708|459724640|FG002|Overall Study|No longer willing to participate|13|||
127753669|NCT01371708|459724638|FG000|Overall Study|Medication error/not related to AE|0|||
127753670|NCT01371708|459724639|FG001|Overall Study|Medication error/not related to AE|1|||
127753671|NCT01371708|459724640|FG002|Overall Study|Medication error/not related to AE|0|||
127753672|NCT01371708|459724638|FG000|Overall Study|Other|3|||
127753673|NCT01371708|459724639|FG001|Overall Study|Other|2|||
127753674|NCT01371708|459724640|FG002|Overall Study|Other|4|||
127753675|NCT01371708|459724638|FG000|Overall Study|Adverse Event|5|||
127753676|NCT01371708|459724639|FG001|Overall Study|Adverse Event|8|||
127753677|NCT01371708|459724640|FG002|Overall Study|Adverse Event|12|||
127753678|NCT01371708|459724638|FG000|Overall Study|Started but did not receive treatment|1|||
127753679|NCT01371708|459724639|FG001|Overall Study|Started but did not receive treatment|0|||
127753680|NCT01371708|459724640|FG002|Overall Study|Started but did not receive treatment|1|||
127753681|NCT01067846|459724647|FG000|Overall Study|Lost to Follow-up|17|||
127811170|NCT01307423|459926537|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
127811171|NCT01307423|459926538|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
127811172|NCT01307423|459926539|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
127811173|NCT01307423|459926540|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
127753682|NCT01067846|459724648|FG001|Overall Study|Lost to Follow-up|19|||
127753683|NCT01067846|459724647|FG000|Overall Study|Withdrawal by Subject|1|||
127753684|NCT01067846|459724648|FG001|Overall Study|Withdrawal by Subject|0|||
127753685|NCT01067846|459724647|FG000|Overall Study|participation in other tx study|1|||
127753686|NCT01067846|459724648|FG001|Overall Study|participation in other tx study|0|||
127753687|NCT01077518|459724649|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
127753688|NCT01077518|459724650|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
127753689|NCT01077518|459724651|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
127753690|NCT01077518|459724649|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
127753691|NCT01077518|459724650|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
127753692|NCT01077518|459724651|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
127753693|NCT01077518|459724649|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
127753694|NCT01077518|459724650|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
127753695|NCT01077518|459724651|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
127753696|NCT01077518|459724649|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
127753697|NCT01077518|459724650|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
127753698|NCT01077518|459724651|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
127753699|NCT01077518|459724649|FG000|Optional Ofa Phase|Physician Decision|0|||
127753700|NCT01077518|459724650|FG001|Optional Ofa Phase|Physician Decision|0|||
127753701|NCT01077518|459724651|FG002|Optional Ofa Phase|Physician Decision|1|||
127811174|NCT01307423|459926541|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
127811175|NCT01307423|459926533|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
127811176|NCT01307423|459926534|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
127811177|NCT01307423|459926535|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
127811178|NCT01307423|459926536|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
127811179|NCT01307423|459926537|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
127811180|NCT01307423|459926538|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
127811181|NCT01307423|459926539|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
127894307|NCT01254409|460235306|FG001|Overall Study|Adverse Event|1|||
127753702|NCT01077518|459724649|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
127753703|NCT01077518|459724650|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
127811182|NCT01307423|459926540|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
127753704|NCT01077518|459724651|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
127753705|NCT01077518|459724649|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
127753706|NCT01077518|459724650|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
127753707|NCT01077518|459724651|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
127753708|NCT01495598|459724652|FG000|Overall Study|Death during follow up period|2|||
127753709|NCT01495598|459724652|FG000|Overall Study|Death on study|1|||
127753710|NCT01495598|459724652|FG000|Overall Study|Lost to Follow-up|3|||
127753711|NCT01495598|459724652|FG000|Overall Study|Physician Decision|8|||
127753712|NCT05511038|459724656|FG000|Overall|Withdrawal by Subject|5|||
127753713|NCT05511038|459724657|FG001|Overall|Withdrawal by Subject|3|||
127753714|NCT05511038|459724656|FG000|Overall|Screen Failure|20|||
127753715|NCT05511038|459724657|FG001|Overall|Screen Failure|1|||
127753716|NCT05511038|459724656|FG000|Overall|Physician Decision|3|||
127753717|NCT05511038|459724657|FG001|Overall|Physician Decision|0|||
127753718|NCT05511038|459724656|FG000|Overall|Lost to Follow-up|3|||
127753719|NCT05511038|459724657|FG001|Overall|Lost to Follow-up|0|||
127753720|NCT05511038|459724656|FG000|Overall|Death|1|||
127753721|NCT05511038|459724657|FG001|Overall|Death|0|||
127753722|NCT05511038|459724656|FG000|Screening|Withdrawal by Subject|1|||
127753723|NCT05511038|459724657|FG001|Screening|Withdrawal by Subject|0|||
127753724|NCT05511038|459724656|FG000|Screening|Lost to Follow Up (1 participant)|1|||
127753725|NCT05511038|459724657|FG001|Screening|Lost to Follow Up (1 participant)|0|||
127753726|NCT05511038|459724656|FG000|Screening|Screen Failure|3|||
127753727|NCT05511038|459724657|FG001|Screening|Screen Failure|0|||
127753728|NCT05511038|459724656|FG000|Screening|Screen Failure that was identified after screening (1 participant)|1|||
127753729|NCT05511038|459724657|FG001|Screening|Screen Failure that was identified after screening (1 participant)|0|||
127753730|NCT05511038|459724656|FG000|Treatment|Withdrawal by Subject|5|||
127753731|NCT05511038|459724657|FG001|Treatment|Withdrawal by Subject|3|||
127753732|NCT05511038|459724656|FG000|Treatment|Physician Decision|4|||
127753733|NCT05511038|459724657|FG001|Treatment|Physician Decision|0|||
127753734|NCT05511038|459724656|FG000|Treatment|Lost to Follow-up|2|||
127753735|NCT05511038|459724657|FG001|Treatment|Lost to Follow-up|0|||
127753736|NCT05511038|459724656|FG000|Treatment|Death|1|||
127753737|NCT05511038|459724657|FG001|Treatment|Death|0|||
127753738|NCT05511038|459724656|FG000|Treatment|Subject did nod visit the site despite multiple follow-up|3|||
127753739|NCT05511038|459724657|FG001|Treatment|Subject did nod visit the site despite multiple follow-up|1|||
127753740|NCT05511038|459724656|FG000|Treatment|Refuse by subject|1|||
127753741|NCT05511038|459724657|FG001|Treatment|Refuse by subject|0|||
127753742|NCT05511038|459724656|FG000|Treatment|Subject did not go to the site for visit|1|||
127753743|NCT05511038|459724657|FG001|Treatment|Subject did not go to the site for visit|0|||
127753744|NCT05140915|459724658|FG000|Overall Study|Lost to Follow-up|2|||
127753745|NCT05140915|459724659|FG001|Overall Study|Lost to Follow-up|1|||
127753746|NCT04485611|459724660|FG000|Prehabilitation|Physician Decision|1|||
127753747|NCT04879849|459724661|FG000|Overall Study|Lost to Follow-up|0|||
127753748|NCT04879849|459724662|FG001|Overall Study|Lost to Follow-up|0|||
127753749|NCT04879849|459724663|FG002|Overall Study|Lost to Follow-up|0|||
127753750|NCT04879849|459724664|FG003|Overall Study|Lost to Follow-up|1|||
127753751|NCT04879849|459724665|FG004|Overall Study|Lost to Follow-up|0|||
127753752|NCT04879849|459724666|FG005|Overall Study|Lost to Follow-up|0|||
127753753|NCT04879849|459724667|FG006|Overall Study|Lost to Follow-up|0|||
127753754|NCT04879849|459724668|FG007|Overall Study|Lost to Follow-up|0|||
127753755|NCT04879849|459724661|FG000|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
127753756|NCT04879849|459724662|FG001|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
127753757|NCT04879849|459724663|FG002|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
127753758|NCT04879849|459724664|FG003|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
127753759|NCT04879849|459724665|FG004|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
127753760|NCT04879849|459724666|FG005|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
127753761|NCT04879849|459724667|FG006|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
127753762|NCT04879849|459724668|FG007|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
127753763|NCT04879849|459724661|FG000|Overall Study|Withdrawal by Subject|0|||
127753764|NCT04879849|459724662|FG001|Overall Study|Withdrawal by Subject|0|||
127753765|NCT04879849|459724663|FG002|Overall Study|Withdrawal by Subject|0|||
127753766|NCT04879849|459724664|FG003|Overall Study|Withdrawal by Subject|0|||
127753767|NCT04879849|459724665|FG004|Overall Study|Withdrawal by Subject|2|||
127753768|NCT04879849|459724666|FG005|Overall Study|Withdrawal by Subject|0|||
127753769|NCT04879849|459724667|FG006|Overall Study|Withdrawal by Subject|1|||
127753770|NCT04879849|459724668|FG007|Overall Study|Withdrawal by Subject|0|||
127753771|NCT04879849|459724661|FG000|Overall Study|Progressive Disease|0|||
127753772|NCT04879849|459724662|FG001|Overall Study|Progressive Disease|0|||
127753773|NCT04879849|459724663|FG002|Overall Study|Progressive Disease|1|||
127753774|NCT04879849|459724664|FG003|Overall Study|Progressive Disease|0|||
127753775|NCT04879849|459724665|FG004|Overall Study|Progressive Disease|0|||
127753776|NCT04879849|459724666|FG005|Overall Study|Progressive Disease|0|||
127811183|NCT01307423|459926541|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
127753777|NCT04879849|459724667|FG006|Overall Study|Progressive Disease|0|||
127753778|NCT04879849|459724668|FG007|Overall Study|Progressive Disease|0|||
127753779|NCT04879849|459724661|FG000|Overall Study|Death|0|||
127753780|NCT04879849|459724662|FG001|Overall Study|Death|0|||
127753781|NCT04879849|459724663|FG002|Overall Study|Death|1|||
127753782|NCT04879849|459724664|FG003|Overall Study|Death|1|||
127753783|NCT04879849|459724665|FG004|Overall Study|Death|1|||
127753784|NCT04879849|459724666|FG005|Overall Study|Death|2|||
127753785|NCT04879849|459724667|FG006|Overall Study|Death|1|||
127753786|NCT04879849|459724668|FG007|Overall Study|Death|2|||
127753787|NCT04879849|459724661|FG000|Overall Study|Completion of Follow-up Period and Assessments|0|||
127753788|NCT04879849|459724662|FG001|Overall Study|Completion of Follow-up Period and Assessments|1|||
127753789|NCT04879849|459724663|FG002|Overall Study|Completion of Follow-up Period and Assessments|0|||
127753790|NCT04879849|459724664|FG003|Overall Study|Completion of Follow-up Period and Assessments|1|||
127753791|NCT04879849|459724665|FG004|Overall Study|Completion of Follow-up Period and Assessments|3|||
127753792|NCT04879849|459724666|FG005|Overall Study|Completion of Follow-up Period and Assessments|2|||
127753793|NCT04879849|459724667|FG006|Overall Study|Completion of Follow-up Period and Assessments|0|||
127753794|NCT04879849|459724668|FG007|Overall Study|Completion of Follow-up Period and Assessments|0|||
127753795|NCT04879849|459724661|FG000|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
127753796|NCT04879849|459724662|FG001|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
127753797|NCT04879849|459724663|FG002|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
127753798|NCT04879849|459724664|FG003|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
127753799|NCT04879849|459724665|FG004|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
127753800|NCT04879849|459724666|FG005|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
127753801|NCT04879849|459724667|FG006|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|1|||
127753802|NCT04879849|459724668|FG007|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
127753803|NCT04879849|459724661|FG000|Overall Study|Reason Not Specified|1|||
127753804|NCT04879849|459724662|FG001|Overall Study|Reason Not Specified|0|||
127753805|NCT04879849|459724663|FG002|Overall Study|Reason Not Specified|0|||
127753806|NCT04879849|459724664|FG003|Overall Study|Reason Not Specified|0|||
127753807|NCT04879849|459724665|FG004|Overall Study|Reason Not Specified|0|||
127753808|NCT04879849|459724666|FG005|Overall Study|Reason Not Specified|0|||
127753809|NCT04879849|459724667|FG006|Overall Study|Reason Not Specified|0|||
127753810|NCT04879849|459724668|FG007|Overall Study|Reason Not Specified|0|||
127753811|NCT03810235|459724671|FG000|Overall Study|Withdrawal by Subject|2|||
127753812|NCT03810235|459724672|FG001|Overall Study|Withdrawal by Subject|0|||
127753813|NCT04777864|459724673|FG000|Overall Study|Lost to Follow-up|8|||
127753814|NCT04777864|459724674|FG001|Overall Study|Lost to Follow-up|19|||
127753815|NCT01647542|459724675|FG000|Overall Study|Major Protocol Deviation|1|||
127753816|NCT01647542|459724676|FG001|Overall Study|Major Protocol Deviation|0|||
127753817|NCT01647542|459724677|FG002|Overall Study|Major Protocol Deviation|0|||
127753818|NCT01647542|459724675|FG000|Overall Study|Adverse Event|4|||
127753819|NCT01647542|459724676|FG001|Overall Study|Adverse Event|5|||
127753820|NCT01647542|459724677|FG002|Overall Study|Adverse Event|4|||
127753821|NCT01647542|459724675|FG000|Overall Study|Lost to Follow-up|0|||
127753822|NCT01647542|459724676|FG001|Overall Study|Lost to Follow-up|2|||
127753823|NCT01647542|459724677|FG002|Overall Study|Lost to Follow-up|2|||
127753824|NCT01647542|459724675|FG000|Overall Study|Withdrawal by Subject|6|||
127753825|NCT01647542|459724676|FG001|Overall Study|Withdrawal by Subject|4|||
127753826|NCT01647542|459724677|FG002|Overall Study|Withdrawal by Subject|0|||
127753827|NCT01647542|459724675|FG000|Overall Study|Study Termination|64|||
127753828|NCT01647542|459724676|FG001|Overall Study|Study Termination|61|||
127753829|NCT01647542|459724677|FG002|Overall Study|Study Termination|65|||
127753830|NCT01647542|459724675|FG000|Overall Study|Lack of Efficacy|1|||
127753831|NCT01647542|459724676|FG001|Overall Study|Lack of Efficacy|1|||
127753832|NCT01647542|459724677|FG002|Overall Study|Lack of Efficacy|0|||
127753833|NCT01647542|459724675|FG000|Overall Study|Death|0|||
127753834|NCT01647542|459724676|FG001|Overall Study|Death|0|||
127753835|NCT01647542|459724677|FG002|Overall Study|Death|1|||
127753836|NCT03086655|459724678|FG000|3 Month Follow-up Assessment|Lost to Follow-up|5|||
127753837|NCT03086655|459724679|FG001|3 Month Follow-up Assessment|Lost to Follow-up|4|||
127753838|NCT03086655|459724678|FG000|3 Month Follow-up Assessment|Withdrawal by Subject|2|||
127753839|NCT03086655|459724679|FG001|3 Month Follow-up Assessment|Withdrawal by Subject|0|||
127753840|NCT03086655|459724678|FG000|6 Month Follow-up Assessment|Lost to Follow-up|7|||
127753841|NCT03086655|459724679|FG001|6 Month Follow-up Assessment|Lost to Follow-up|6|||
127753842|NCT03086655|459724678|FG000|6 Month Follow-up Assessment|Withdrawal by Subject|2|||
127753843|NCT03086655|459724679|FG001|6 Month Follow-up Assessment|Withdrawal by Subject|1|||
127753844|NCT03086655|459724678|FG000|9 Month Follow-up Assessment|Lost to Follow-up|9|||
127753845|NCT03086655|459724679|FG001|9 Month Follow-up Assessment|Lost to Follow-up|4|||
127753846|NCT03086655|459724678|FG000|12 Month Follow-up = Final Assessment|Lost to Follow-up|7|||
127753847|NCT03086655|459724679|FG001|12 Month Follow-up = Final Assessment|Lost to Follow-up|3|||
127753848|NCT03086655|459724678|FG000|12 Month Follow-up = Final Assessment|Death|0|||
127753849|NCT03086655|459724679|FG001|12 Month Follow-up = Final Assessment|Death|1|||
127753850|NCT05576662|459724680|FG000|Overall Study|Withdrawn by site within 15-day treatment period|0|||
127753851|NCT05576662|459724681|FG001|Overall Study|Withdrawn by site within 15-day treatment period|1|||
127753852|NCT05576662|459724680|FG000|Overall Study|Requested to withdraw within 15-day treatment period|0|||
127753853|NCT05576662|459724681|FG001|Overall Study|Requested to withdraw within 15-day treatment period|1|||
127753854|NCT05576662|459724680|FG000|Overall Study|Lost to follow-up within 15-day treatment period|2|||
127753855|NCT05576662|459724681|FG001|Overall Study|Lost to follow-up within 15-day treatment period|0|||
127753856|NCT05576662|459724680|FG000|Overall Study|Requested to withdraw after 15-day treatment period|2|||
127753857|NCT05576662|459724681|FG001|Overall Study|Requested to withdraw after 15-day treatment period|2|||
127753858|NCT03008005|459724682|FG000|Overall Study|Physician Decision|1|||
127753859|NCT03008005|459724683|FG001|Overall Study|Physician Decision|0|||
127753860|NCT03008005|459724684|FG002|Overall Study|Physician Decision|0|||
127753861|NCT03008005|459724682|FG000|Overall Study|Withdrawal by Subject|1|||
127753862|NCT03008005|459724683|FG001|Overall Study|Withdrawal by Subject|0|||
127753863|NCT03008005|459724684|FG002|Overall Study|Withdrawal by Subject|0|||
127753864|NCT03008005|459724682|FG000|Overall Study|Ineligible|0|||
127753865|NCT03008005|459724683|FG001|Overall Study|Ineligible|1|||
127753866|NCT03008005|459724684|FG002|Overall Study|Ineligible|0|||
127753867|NCT01040169|459724700|FG000|Overall Study|Lost to Follow-up|3|||
127753868|NCT01040169|459724701|FG001|Overall Study|Lost to Follow-up|8|||
127753869|NCT00350727|459724702|FG000|Phase I: Dose Escalation|Adverse Event|4|||
127753870|NCT00350727|459724703|FG001|Phase I: Dose Escalation|Adverse Event|0|||
127753871|NCT00350727|459724704|FG002|Phase I: Dose Escalation|Adverse Event|0|||
127753872|NCT00350727|459724702|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
127753873|NCT00350727|459724703|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
127753874|NCT00350727|459724704|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
127753875|NCT00350727|459724702|FG000|Phase I: Dose Escalation|Death|1|||
127753876|NCT00350727|459724703|FG001|Phase I: Dose Escalation|Death|0|||
127753877|NCT00350727|459724704|FG002|Phase I: Dose Escalation|Death|0|||
127753878|NCT00350727|459724702|FG000|Phase I: Dose Escalation|Physician Decision|1|||
127753879|NCT00350727|459724703|FG001|Phase I: Dose Escalation|Physician Decision|0|||
127753880|NCT00350727|459724704|FG002|Phase I: Dose Escalation|Physician Decision|0|||
127753881|NCT00350727|459724702|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
127753882|NCT00350727|459724703|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
127753883|NCT00350727|459724704|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
127753884|NCT00350727|459724702|FG000|Phase II|Disease Progression|0|||
127753885|NCT00350727|459724703|FG001|Phase II|Disease Progression|15|||
127753886|NCT00350727|459724704|FG002|Phase II|Disease Progression|16|||
127753887|NCT00350727|459724702|FG000|Phase II|Clinical Deterioration|0|||
127753888|NCT00350727|459724703|FG001|Phase II|Clinical Deterioration|1|||
127753889|NCT00350727|459724704|FG002|Phase II|Clinical Deterioration|0|||
127753890|NCT00350727|459724702|FG000|Phase II|Withdrawal by Subject|0|||
127753891|NCT00350727|459724703|FG001|Phase II|Withdrawal by Subject|2|||
127753892|NCT00350727|459724704|FG002|Phase II|Withdrawal by Subject|1|||
127753893|NCT00350727|459724702|FG000|Phase II|Adverse Event|0|||
127753894|NCT00350727|459724703|FG001|Phase II|Adverse Event|1|||
127753895|NCT00350727|459724704|FG002|Phase II|Adverse Event|1|||
127753896|NCT00350727|459724702|FG000|Phase II|Death|0|||
127753897|NCT00350727|459724703|FG001|Phase II|Death|0|||
127753898|NCT00350727|459724704|FG002|Phase II|Death|2|||
127753899|NCT00350727|459724702|FG000|Phase II|Sponsor Terminated Study|0|||
127753900|NCT00350727|459724703|FG001|Phase II|Sponsor Terminated Study|0|||
127753901|NCT00350727|459724704|FG002|Phase II|Sponsor Terminated Study|1|||
127753902|NCT00350727|459724702|FG000|Phase II|Enrolled in Rollover Study|0|||
127753903|NCT00350727|459724703|FG001|Phase II|Enrolled in Rollover Study|0|||
127753904|NCT00350727|459724704|FG002|Phase II|Enrolled in Rollover Study|1|||
127753905|NCT03633799|459724709|FG000|Overall Study|Adverse Event|349|||
127753906|NCT03633799|459724709|FG000|Overall Study|Withdrawal by Subject|288|||
127753907|NCT03633799|459724709|FG000|Overall Study|Lost to Follow-up|97|||
127753908|NCT03633799|459724709|FG000|Overall Study|Physician Decision|9|||
127753909|NCT03633799|459724709|FG000|Overall Study|Protocol Violation|4|||
127753910|NCT03633799|459724709|FG000|Overall Study|Pregnancy|20|||
127753911|NCT03633799|459724709|FG000|Overall Study|other|39|||
127753912|NCT03633799|459724709|FG000|Overall Study|ongoing within third year of study|106|||
127753913|NCT03633799|459724709|FG000|Overall Study|unsuccessful study drug placement|19|||
127753914|NCT03551691|459724710|FG000|Overall Study|Withdrawal by Subject|3|||
127753915|NCT03551691|459724711|FG001|Overall Study|Withdrawal by Subject|3|||
127753916|NCT03520712|459724712|FG000|Overall Study|Early termination of the study by Sponsor|2|||
127753917|NCT05855967|459724713|FG000|Overall Study|Withdrawal by Subject|7|||
127753918|NCT05855967|459724714|FG001|Overall Study|Withdrawal by Subject|5|||
127753919|NCT05855967|459724713|FG000|Overall Study|Lost to Follow-up|2|||
127753920|NCT05855967|459724714|FG001|Overall Study|Lost to Follow-up|1|||
127753921|NCT02446821|459724715|FG000|Overall Study|Adverse Event|28|||
127753922|NCT02446821|459724715|FG000|Overall Study|Withdrawal by Subject|6|||
127753923|NCT02446821|459724715|FG000|Overall Study|Lost to Follow-up|22|||
127753924|NCT02446821|459724715|FG000|Overall Study|other|9|||
127753925|NCT02446821|459724715|FG000|Overall Study|insertion failure|3|||
127753926|NCT02284009|459724717|FG000|Overall Study|Adverse Event|3|||
127753927|NCT02284009|459724718|FG001|Overall Study|Adverse Event|0|||
127753928|NCT02284009|459724717|FG000|Overall Study|Lost to Follow-up|1|||
127753929|NCT02284009|459724718|FG001|Overall Study|Lost to Follow-up|3|||
127753930|NCT02284009|459724717|FG000|Overall Study|Physician Decision|0|||
127753931|NCT02284009|459724718|FG001|Overall Study|Physician Decision|2|||
127753932|NCT02284009|459724717|FG000|Overall Study|Withdrawal by Subject|2|||
127753933|NCT02284009|459724718|FG001|Overall Study|Withdrawal by Subject|5|||
127753934|NCT04942366|459726132|FG000|Overall Study|Withdrawal by Subject|5|||
127753935|NCT04942366|459726133|FG001|Overall Study|Withdrawal by Subject|5|||
127753936|NCT04996004|459726134|FG000|Phase I|Death|1|||
127753937|NCT04996004|459726135|FG001|Phase I|Death|2|||
127753938|NCT04996004|459726136|FG002|Phase I|Death|1|||
127753939|NCT04996004|459726137|FG003|Phase I|Death|0|||
127753940|NCT04996004|459726138|FG004|Phase I|Death|0|||
127753941|NCT04996004|459726139|FG005|Phase I|Death|0|||
127753942|NCT04996004|459726134|FG000|Phase I|Study terminated by sponsor|2|||
127753943|NCT04996004|459726135|FG001|Phase I|Study terminated by sponsor|1|||
127753944|NCT04996004|459726136|FG002|Phase I|Study terminated by sponsor|2|||
127753945|NCT04996004|459726137|FG003|Phase I|Study terminated by sponsor|0|||
127753946|NCT04996004|459726138|FG004|Phase I|Study terminated by sponsor|0|||
127753947|NCT04996004|459726139|FG005|Phase I|Study terminated by sponsor|0|||
127753948|NCT04996004|459726134|FG000|Phase II|Study terminated by sponsor|0|||
127753949|NCT04996004|459726135|FG001|Phase II|Study terminated by sponsor|0|||
127753950|NCT04996004|459726136|FG002|Phase II|Study terminated by sponsor|0|||
127753951|NCT04996004|459726137|FG003|Phase II|Study terminated by sponsor|20|||
127753952|NCT04996004|459726138|FG004|Phase II|Study terminated by sponsor|10|||
127753953|NCT04996004|459726139|FG005|Phase II|Study terminated by sponsor|10|||
127753954|NCT04996004|459726134|FG000|Phase II|Withdrawal by Subject|0|||
127753955|NCT04996004|459726135|FG001|Phase II|Withdrawal by Subject|0|||
127753956|NCT04996004|459726136|FG002|Phase II|Withdrawal by Subject|0|||
127753957|NCT04996004|459726137|FG003|Phase II|Withdrawal by Subject|0|||
127753958|NCT04996004|459726138|FG004|Phase II|Withdrawal by Subject|1|||
127753959|NCT04996004|459726139|FG005|Phase II|Withdrawal by Subject|2|||
127753960|NCT04996004|459726134|FG000|Phase II|Death|0|||
127753961|NCT04996004|459726135|FG001|Phase II|Death|0|||
127753962|NCT04996004|459726136|FG002|Phase II|Death|0|||
127753963|NCT04996004|459726137|FG003|Phase II|Death|12|||
127753964|NCT04996004|459726138|FG004|Phase II|Death|2|||
127753965|NCT04996004|459726139|FG005|Phase II|Death|9|||
127753966|NCT04996004|459726134|FG000|Phase II|Other|0|||
127753967|NCT04996004|459726135|FG001|Phase II|Other|0|||
127753968|NCT04996004|459726136|FG002|Phase II|Other|0|||
127753969|NCT04996004|459726137|FG003|Phase II|Other|0|||
127753970|NCT04996004|459726138|FG004|Phase II|Other|0|||
127753971|NCT04996004|459726139|FG005|Phase II|Other|1|||
127753972|NCT02942277|459726140|FG000|Year 1|Withdrawal by Subject|0|||
127753973|NCT02942277|459726141|FG001|Year 1|Withdrawal by Subject|0|||
127753974|NCT02942277|459726142|FG002|Year 1|Withdrawal by Subject|0|||
127753975|NCT02942277|459726143|FG003|Year 1|Withdrawal by Subject|0|||
127753976|NCT02942277|459726144|FG004|Year 1|Withdrawal by Subject|1|||
127753977|NCT02942277|459726145|FG005|Year 1|Withdrawal by Subject|3|||
127753978|NCT02942277|459726146|FG006|Year 1|Withdrawal by Subject|0|||
127753979|NCT02942277|459726147|FG007|Year 1|Withdrawal by Subject|1|||
127753980|NCT02942277|459726148|FG008|Year 1|Withdrawal by Subject|0|||
127753981|NCT02942277|459726149|FG009|Year 1|Withdrawal by Subject|0|||
127753982|NCT02942277|459726150|FG010|Year 1|Withdrawal by Subject|3|||
127753983|NCT02942277|459726140|FG000|Year 1|Travel|0|||
127753984|NCT02942277|459726141|FG001|Year 1|Travel|1|||
127753985|NCT02942277|459726142|FG002|Year 1|Travel|0|||
127753986|NCT02942277|459726143|FG003|Year 1|Travel|0|||
127753987|NCT02942277|459726144|FG004|Year 1|Travel|4|||
127753988|NCT02942277|459726145|FG005|Year 1|Travel|5|||
127753989|NCT02942277|459726146|FG006|Year 1|Travel|0|||
127753990|NCT02942277|459726147|FG007|Year 1|Travel|0|||
127753991|NCT02942277|459726148|FG008|Year 1|Travel|0|||
127753992|NCT02942277|459726149|FG009|Year 1|Travel|0|||
127753993|NCT02942277|459726150|FG010|Year 1|Travel|8|||
127753994|NCT02942277|459726140|FG000|Year 1|Joined Army|0|||
127753995|NCT02942277|459726141|FG001|Year 1|Joined Army|1|||
127753996|NCT02942277|459726142|FG002|Year 1|Joined Army|0|||
127753997|NCT02942277|459726143|FG003|Year 1|Joined Army|0|||
127753998|NCT02942277|459726144|FG004|Year 1|Joined Army|0|||
127753999|NCT02942277|459726145|FG005|Year 1|Joined Army|0|||
127754000|NCT02942277|459726146|FG006|Year 1|Joined Army|0|||
127754001|NCT02942277|459726147|FG007|Year 1|Joined Army|0|||
127754002|NCT02942277|459726148|FG008|Year 1|Joined Army|0|||
127754003|NCT02942277|459726149|FG009|Year 1|Joined Army|0|||
127754004|NCT02942277|459726150|FG010|Year 1|Joined Army|0|||
127754005|NCT02942277|459726140|FG000|Year 1|Subject met withdrawal criteria|0|||
127754006|NCT02942277|459726141|FG001|Year 1|Subject met withdrawal criteria|0|||
127754007|NCT02942277|459726142|FG002|Year 1|Subject met withdrawal criteria|0|||
127754008|NCT02942277|459726143|FG003|Year 1|Subject met withdrawal criteria|1|||
127754009|NCT02942277|459726144|FG004|Year 1|Subject met withdrawal criteria|0|||
127754010|NCT02942277|459726145|FG005|Year 1|Subject met withdrawal criteria|0|||
127754011|NCT02942277|459726146|FG006|Year 1|Subject met withdrawal criteria|0|||
127754012|NCT02942277|459726147|FG007|Year 1|Subject met withdrawal criteria|0|||
127754013|NCT02942277|459726148|FG008|Year 1|Subject met withdrawal criteria|0|||
127754014|NCT02942277|459726149|FG009|Year 1|Subject met withdrawal criteria|0|||
127754015|NCT02942277|459726150|FG010|Year 1|Subject met withdrawal criteria|0|||
127754016|NCT02942277|459726140|FG000|Year 1|Lost to Follow-up|0|||
127754017|NCT02942277|459726141|FG001|Year 1|Lost to Follow-up|0|||
127754018|NCT02942277|459726142|FG002|Year 1|Lost to Follow-up|0|||
127754019|NCT02942277|459726143|FG003|Year 1|Lost to Follow-up|0|||
127754020|NCT02942277|459726144|FG004|Year 1|Lost to Follow-up|1|||
127754021|NCT02942277|459726145|FG005|Year 1|Lost to Follow-up|0|||
127754022|NCT02942277|459726146|FG006|Year 1|Lost to Follow-up|0|||
127754023|NCT02942277|459726147|FG007|Year 1|Lost to Follow-up|0|||
127754024|NCT02942277|459726148|FG008|Year 1|Lost to Follow-up|0|||
127754025|NCT02942277|459726149|FG009|Year 1|Lost to Follow-up|0|||
127754026|NCT02942277|459726150|FG010|Year 1|Lost to Follow-up|2|||
127754027|NCT02942277|459726140|FG000|Year 1|Protocol Violation|0|||
127754028|NCT02942277|459726141|FG001|Year 1|Protocol Violation|0|||
127754029|NCT02942277|459726142|FG002|Year 1|Protocol Violation|0|||
127754030|NCT02942277|459726143|FG003|Year 1|Protocol Violation|0|||
127754031|NCT02942277|459726144|FG004|Year 1|Protocol Violation|1|||
127754032|NCT02942277|459726145|FG005|Year 1|Protocol Violation|1|||
127754033|NCT02942277|459726146|FG006|Year 1|Protocol Violation|0|||
127754034|NCT02942277|459726147|FG007|Year 1|Protocol Violation|0|||
127754035|NCT02942277|459726148|FG008|Year 1|Protocol Violation|0|||
127754036|NCT02942277|459726149|FG009|Year 1|Protocol Violation|0|||
127754037|NCT02942277|459726150|FG010|Year 1|Protocol Violation|2|||
127754038|NCT02942277|459726140|FG000|Year 1|Pregnancy|0|||
127754039|NCT02942277|459726141|FG001|Year 1|Pregnancy|0|||
127754040|NCT02942277|459726142|FG002|Year 1|Pregnancy|0|||
127754041|NCT02942277|459726143|FG003|Year 1|Pregnancy|0|||
127754042|NCT02942277|459726144|FG004|Year 1|Pregnancy|0|||
127754043|NCT02942277|459726145|FG005|Year 1|Pregnancy|1|||
127754044|NCT02942277|459726146|FG006|Year 1|Pregnancy|0|||
127754045|NCT02942277|459726147|FG007|Year 1|Pregnancy|0|||
127754046|NCT02942277|459726148|FG008|Year 1|Pregnancy|0|||
127754047|NCT02942277|459726149|FG009|Year 1|Pregnancy|0|||
127754048|NCT02942277|459726150|FG010|Year 1|Pregnancy|0|||
127754049|NCT02942277|459726140|FG000|Year 2|Lost to Follow-up|0|||
127754050|NCT02942277|459726141|FG001|Year 2|Lost to Follow-up|0|||
127754051|NCT02942277|459726142|FG002|Year 2|Lost to Follow-up|0|||
127754052|NCT02942277|459726143|FG003|Year 2|Lost to Follow-up|0|||
127754053|NCT02942277|459726144|FG004|Year 2|Lost to Follow-up|2|||
127754054|NCT02942277|459726145|FG005|Year 2|Lost to Follow-up|1|||
127754055|NCT02942277|459726146|FG006|Year 2|Lost to Follow-up|0|||
127754056|NCT02942277|459726147|FG007|Year 2|Lost to Follow-up|0|||
127754057|NCT02942277|459726148|FG008|Year 2|Lost to Follow-up|0|||
127754058|NCT02942277|459726149|FG009|Year 2|Lost to Follow-up|0|||
127754059|NCT02942277|459726150|FG010|Year 2|Lost to Follow-up|0|||
127754060|NCT02942277|459726140|FG000|Year 2|Did not rescreen|0|||
127754061|NCT02942277|459726141|FG001|Year 2|Did not rescreen|0|||
127754062|NCT02942277|459726142|FG002|Year 2|Did not rescreen|1|||
127754063|NCT02942277|459726143|FG003|Year 2|Did not rescreen|1|||
127754064|NCT02942277|459726144|FG004|Year 2|Did not rescreen|9|||
127754065|NCT02942277|459726145|FG005|Year 2|Did not rescreen|6|||
127754066|NCT02942277|459726146|FG006|Year 2|Did not rescreen|0|||
127754067|NCT02942277|459726147|FG007|Year 2|Did not rescreen|1|||
127754068|NCT02942277|459726148|FG008|Year 2|Did not rescreen|0|||
127754069|NCT02942277|459726149|FG009|Year 2|Did not rescreen|0|||
127754070|NCT02942277|459726150|FG010|Year 2|Did not rescreen|21|||
127754071|NCT02942277|459726140|FG000|Year 2|Met withdrawal criteria|0|||
127754072|NCT02942277|459726141|FG001|Year 2|Met withdrawal criteria|0|||
127754073|NCT02942277|459726142|FG002|Year 2|Met withdrawal criteria|0|||
127754074|NCT02942277|459726143|FG003|Year 2|Met withdrawal criteria|0|||
127754075|NCT02942277|459726144|FG004|Year 2|Met withdrawal criteria|1|||
127754076|NCT02942277|459726145|FG005|Year 2|Met withdrawal criteria|2|||
127754077|NCT02942277|459726146|FG006|Year 2|Met withdrawal criteria|0|||
127754078|NCT02942277|459726147|FG007|Year 2|Met withdrawal criteria|0|||
127754079|NCT02942277|459726148|FG008|Year 2|Met withdrawal criteria|0|||
127754080|NCT02942277|459726149|FG009|Year 2|Met withdrawal criteria|0|||
127754081|NCT02942277|459726150|FG010|Year 2|Met withdrawal criteria|1|||
127754082|NCT02942277|459726140|FG000|Year 2|Travel|0|||
127754083|NCT02942277|459726141|FG001|Year 2|Travel|1|||
127754084|NCT02942277|459726142|FG002|Year 2|Travel|0|||
127754085|NCT02942277|459726143|FG003|Year 2|Travel|0|||
127754086|NCT02942277|459726144|FG004|Year 2|Travel|0|||
127754087|NCT02942277|459726145|FG005|Year 2|Travel|1|||
127754088|NCT02942277|459726146|FG006|Year 2|Travel|0|||
127754089|NCT02942277|459726147|FG007|Year 2|Travel|0|||
127754090|NCT02942277|459726148|FG008|Year 2|Travel|0|||
127754091|NCT02942277|459726149|FG009|Year 2|Travel|1|||
127754092|NCT02942277|459726150|FG010|Year 2|Travel|3|||
127754093|NCT02942277|459726140|FG000|Year 2|Non-compliant|0|||
127754094|NCT02942277|459726141|FG001|Year 2|Non-compliant|0|||
127754095|NCT02942277|459726142|FG002|Year 2|Non-compliant|0|||
127754096|NCT02942277|459726143|FG003|Year 2|Non-compliant|0|||
127754097|NCT02942277|459726144|FG004|Year 2|Non-compliant|1|||
127754098|NCT02942277|459726145|FG005|Year 2|Non-compliant|1|||
127754099|NCT02942277|459726146|FG006|Year 2|Non-compliant|0|||
127754100|NCT02942277|459726147|FG007|Year 2|Non-compliant|0|||
127754101|NCT02942277|459726148|FG008|Year 2|Non-compliant|0|||
127754102|NCT02942277|459726149|FG009|Year 2|Non-compliant|0|||
127754103|NCT02942277|459726150|FG010|Year 2|Non-compliant|0|||
127754104|NCT02942277|459726140|FG000|Year 2|Withdrawal by Subject|0|||
127754105|NCT02942277|459726141|FG001|Year 2|Withdrawal by Subject|0|||
127754106|NCT02942277|459726142|FG002|Year 2|Withdrawal by Subject|0|||
127754107|NCT02942277|459726143|FG003|Year 2|Withdrawal by Subject|0|||
127754108|NCT02942277|459726144|FG004|Year 2|Withdrawal by Subject|0|||
127754109|NCT02942277|459726145|FG005|Year 2|Withdrawal by Subject|0|||
127754110|NCT02942277|459726146|FG006|Year 2|Withdrawal by Subject|1|||
127754111|NCT02942277|459726147|FG007|Year 2|Withdrawal by Subject|0|||
127754112|NCT02942277|459726148|FG008|Year 2|Withdrawal by Subject|0|||
127754113|NCT02942277|459726149|FG009|Year 2|Withdrawal by Subject|0|||
127754114|NCT02942277|459726150|FG010|Year 2|Withdrawal by Subject|0|||
127754115|NCT05577715|459726151|FG000|Overall Study|Withdrawal by Subject|1|||
127754116|NCT05577715|459726151|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|16|||
127754117|NCT05577715|459726151|FG000|Overall Study|Lost to Follow-up|1|||
127754118|NCT05577715|459726151|FG000|Overall Study|Death|6|||
127754119|NCT05282121|459726155|FG000|Overall Study|Adverse Event|1|||
127754120|NCT05282121|459726156|FG001|Overall Study|Adverse Event|1|||
127754121|NCT05282121|459726157|FG002|Overall Study|Adverse Event|4|||
127754122|NCT05282121|459726158|FG003|Overall Study|Adverse Event|1|||
127754123|NCT05282121|459726155|FG000|Overall Study|Study Terminated by Sponsor|1|||
127754124|NCT05282121|459726156|FG001|Overall Study|Study Terminated by Sponsor|2|||
127754125|NCT05282121|459726157|FG002|Overall Study|Study Terminated by Sponsor|2|||
127754126|NCT05282121|459726158|FG003|Overall Study|Study Terminated by Sponsor|2|||
127754127|NCT05282121|459726155|FG000|Overall Study|Other than listed|0|||
127894308|NCT01254409|460235307|FG002|Overall Study|Adverse Event|0|||
127894309|NCT01254409|460235308|FG003|Overall Study|Adverse Event|0|||
127754128|NCT05282121|459726156|FG001|Overall Study|Other than listed|0|||
127754129|NCT05282121|459726157|FG002|Overall Study|Other than listed|1|||
127754130|NCT05282121|459726158|FG003|Overall Study|Other than listed|0|||
127754131|NCT05282121|459726155|FG000|Overall Study|No reason available|0|||
127754132|NCT05282121|459726156|FG001|Overall Study|No reason available|0|||
127754133|NCT05282121|459726157|FG002|Overall Study|No reason available|1|||
127754134|NCT05282121|459726158|FG003|Overall Study|No reason available|0|||
127754135|NCT01736189|459726159|FG000|Overall Study|Violation of registration criteria|41|||
127754136|NCT01736189|459726159|FG000|Overall Study|Protocol Violation|4|||
127754137|NCT01736189|459726159|FG000|Overall Study|Criteria and protocol violations|1|||
127754138|NCT03301155|459726160|FG000|Overall Study|Сompliance with exclusion criteria|8|||
127754139|NCT03301155|459726161|FG001|Overall Study|Сompliance with exclusion criteria|7|||
127754140|NCT00384189|459726162|FG000|Overall Study|Reason Not Specified|50|||
127754141|NCT00384189|459726163|FG001|Overall Study|Reason Not Specified|57|||
127754142|NCT00384189|459726164|FG002|Overall Study|Reason Not Specified|58|||
127754143|NCT00384189|459726165|FG003|Overall Study|Reason Not Specified|40|||
127754144|NCT00608868|459726166|FG000|Overall Study|Withdrawal by Subject|7|||
127754145|NCT00608868|459726166|FG000|Overall Study|Protocol Violation|3|||
127754146|NCT00608868|459726166|FG000|Overall Study|Lost to Follow-up|2|||
127754147|NCT00608868|459726166|FG000|Overall Study|Adverse Event|1|||
127754148|NCT00608868|459726166|FG000|Overall Study|Physician Decision|2|||
127754149|NCT00335140|459726169|FG000|Overall Study|Ineligible|1|||
127754150|NCT04546425|459726170|FG000|Overall Study|Protocol Violation|1|||
127754151|NCT04546425|459726171|FG001|Overall Study|Protocol Violation|1|||
127754152|NCT04546425|459726172|FG002|Overall Study|Protocol Violation|0|||
127754153|NCT04546425|459726173|FG003|Overall Study|Protocol Violation|0|||
127754154|NCT04546425|459726170|FG000|Overall Study|Adverse Event|3|||
127754155|NCT04546425|459726171|FG001|Overall Study|Adverse Event|0|||
127754156|NCT04546425|459726172|FG002|Overall Study|Adverse Event|0|||
127754157|NCT04546425|459726173|FG003|Overall Study|Adverse Event|0|||
127754158|NCT04546425|459726170|FG000|Overall Study|Lost to Follow-up|5|||
127754159|NCT04546425|459726171|FG001|Overall Study|Lost to Follow-up|4|||
127754160|NCT04546425|459726172|FG002|Overall Study|Lost to Follow-up|0|||
127754161|NCT04546425|459726173|FG003|Overall Study|Lost to Follow-up|0|||
127754162|NCT04546425|459726170|FG000|Overall Study|No Longer met eligibility criteria|3|||
127754163|NCT04546425|459726171|FG001|Overall Study|No Longer met eligibility criteria|3|||
127754164|NCT04546425|459726172|FG002|Overall Study|No Longer met eligibility criteria|1|||
127754165|NCT04546425|459726173|FG003|Overall Study|No Longer met eligibility criteria|1|||
127754166|NCT04546425|459726170|FG000|Overall Study|Withdrawal by parent/guardian|6|||
127754167|NCT04546425|459726171|FG001|Overall Study|Withdrawal by parent/guardian|5|||
127754168|NCT04546425|459726172|FG002|Overall Study|Withdrawal by parent/guardian|1|||
127754169|NCT04546425|459726173|FG003|Overall Study|Withdrawal by parent/guardian|1|||
127754170|NCT02979249|459726176|FG000|Overall Study|Lost to Follow-up|2|||
127754171|NCT02979249|459726176|FG000|Overall Study|Withdrawal by Subject|4|||
127894310|NCT00299156|460235311|FG000|Period 2 (Randomized)|Screen Failure|0|||
127754172|NCT01125046|459726177|FG000|First 6 Months of Treatment|Death|1|||
127754173|NCT01125046|459726177|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
127894311|NCT00299156|460235312|FG001|Period 2 (Randomized)|Screen Failure|1|||
127754174|NCT01125046|459726177|FG000|First 6 Months of Treatment|Non-compliance|1|||
127754175|NCT01125046|459726177|FG000|First 6 Months of Treatment|Surgery|1|||
127754176|NCT01125046|459726177|FG000|First 6 Months of Treatment|Progressive Disease|7|||
127754177|NCT01125046|459726177|FG000|First 6 Months of Treatment|Adverse Event|2|||
127754178|NCT01125046|459726177|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
127754179|NCT01125046|459726177|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
127754180|NCT01125046|459726177|FG000|Follow-up/Data Cut Off Point|Death|29|||
127754181|NCT01125046|459726177|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
127754182|NCT03868787|459726179|FG000|Overall Study|Withdrawal by Subject|2|||
127754183|NCT03868787|459726180|FG001|Overall Study|Withdrawal by Subject|1|||
127754184|NCT01685229|459726181|FG000|Overall Study|Subjects missing Study Exit form|3|||
127754185|NCT01685229|459726182|FG001|Overall Study|Subjects missing Study Exit form|1|||
127754186|NCT01685229|459726181|FG000|Overall Study|Lost to Follow-up|16|||
127754187|NCT01685229|459726182|FG001|Overall Study|Lost to Follow-up|10|||
127754188|NCT01685229|459726181|FG000|Overall Study|Withdrawal by Subject|6|||
127754189|NCT01685229|459726182|FG001|Overall Study|Withdrawal by Subject|5|||
127754190|NCT01685229|459726181|FG000|Overall Study|Death|1|||
127754191|NCT01685229|459726182|FG001|Overall Study|Death|0|||
127754192|NCT01399697|459726195|FG000|Overall Study|Adverse Event|13|||
127754193|NCT01399697|459726196|FG001|Overall Study|Adverse Event|3|||
127754194|NCT01399697|459726197|FG002|Overall Study|Adverse Event|1|||
127754195|NCT01399697|459726195|FG000|Overall Study|Lost to Follow-up|2|||
127754196|NCT01399697|459726196|FG001|Overall Study|Lost to Follow-up|0|||
127754197|NCT01399697|459726197|FG002|Overall Study|Lost to Follow-up|0|||
127754198|NCT01399697|459726195|FG000|Overall Study|Withdrawal by Subject|8|||
127754199|NCT01399697|459726196|FG001|Overall Study|Withdrawal by Subject|0|||
127754200|NCT01399697|459726197|FG002|Overall Study|Withdrawal by Subject|0|||
127754201|NCT01399697|459726195|FG000|Overall Study|Investigator Decisión|1|||
127754202|NCT01399697|459726196|FG001|Overall Study|Investigator Decisión|0|||
127754203|NCT01399697|459726197|FG002|Overall Study|Investigator Decisión|2|||
127754204|NCT01399697|459726195|FG000|Overall Study|Lack of Efficacy|9|||
127754205|NCT01399697|459726196|FG001|Overall Study|Lack of Efficacy|0|||
127754206|NCT01399697|459726197|FG002|Overall Study|Lack of Efficacy|1|||
127754207|NCT01399697|459726195|FG000|Overall Study|Protocol Violation|2|||
127754208|NCT01399697|459726196|FG001|Overall Study|Protocol Violation|0|||
127754209|NCT01399697|459726197|FG002|Overall Study|Protocol Violation|0|||
127754210|NCT01399697|459726195|FG000|Overall Study|Non-Compliant|1|||
127754211|NCT01399697|459726196|FG001|Overall Study|Non-Compliant|0|||
127754212|NCT01399697|459726197|FG002|Overall Study|Non-Compliant|0|||
127754213|NCT01399697|459726195|FG000|Overall Study|Inclusion Error|2|||
127754214|NCT01399697|459726196|FG001|Overall Study|Inclusion Error|0|||
127754215|NCT01399697|459726197|FG002|Overall Study|Inclusion Error|0|||
127754216|NCT01399697|459726195|FG000|Overall Study|Positive result for hepatitis B|1|||
127754217|NCT01399697|459726196|FG001|Overall Study|Positive result for hepatitis B|0|||
127754218|NCT01399697|459726197|FG002|Overall Study|Positive result for hepatitis B|0|||
127754219|NCT01399697|459726195|FG000|Overall Study|Clinical RA remission|1|||
127754220|NCT01399697|459726196|FG001|Overall Study|Clinical RA remission|0|||
127754221|NCT01399697|459726197|FG002|Overall Study|Clinical RA remission|0|||
127754222|NCT01399697|459726195|FG000|Overall Study|Sponsor Decision|1|||
127754223|NCT01399697|459726196|FG001|Overall Study|Sponsor Decision|0|||
127754224|NCT01399697|459726197|FG002|Overall Study|Sponsor Decision|0|||
127754225|NCT04313608|459726198|FG000|Overall Study|Death|12|||
127754226|NCT04313608|459726199|FG001|Overall Study|Death|3|||
127754227|NCT02440425|459726206|FG000|Overall Study|Death likely due to disease progression|1|||
127754228|NCT02440425|459726206|FG000|Overall Study|Withdrawal by Subject|2|||
127754229|NCT02440425|459726206|FG000|Overall Study|Adverse Event|1|||
127754230|NCT02440425|459726206|FG000|Overall Study|Adverse Event/Ineligible|1|||
127754231|NCT02807272|459726207|FG000|Overall Study|Death|9|||
127754232|NCT02807272|459726208|FG001|Overall Study|Death|5|||
127754233|NCT02807272|459726209|FG002|Overall Study|Death|2|||
127754234|NCT02807272|459726210|FG003|Overall Study|Death|0|||
127754235|NCT02807272|459726211|FG004|Overall Study|Death|1|||
127754236|NCT02807272|459726207|FG000|Overall Study|Lost to Follow-up|1|||
127754237|NCT02807272|459726208|FG001|Overall Study|Lost to Follow-up|0|||
127754238|NCT02807272|459726209|FG002|Overall Study|Lost to Follow-up|0|||
127754239|NCT02807272|459726210|FG003|Overall Study|Lost to Follow-up|0|||
127754240|NCT02807272|459726211|FG004|Overall Study|Lost to Follow-up|0|||
127754241|NCT02807272|459726207|FG000|Overall Study|Permanent Withdrawal of Consent|8|||
127754242|NCT02807272|459726208|FG001|Overall Study|Permanent Withdrawal of Consent|2|||
127754243|NCT02807272|459726209|FG002|Overall Study|Permanent Withdrawal of Consent|0|||
127754244|NCT02807272|459726210|FG003|Overall Study|Permanent Withdrawal of Consent|2|||
127754245|NCT02807272|459726211|FG004|Overall Study|Permanent Withdrawal of Consent|1|||
127754246|NCT02807272|459726207|FG000|Overall Study|Protocol-defined Disease Progression|0|||
127754247|NCT02807272|459726208|FG001|Overall Study|Protocol-defined Disease Progression|1|||
127754248|NCT02807272|459726209|FG002|Overall Study|Protocol-defined Disease Progression|0|||
127754249|NCT02807272|459726210|FG003|Overall Study|Protocol-defined Disease Progression|0|||
127754250|NCT02807272|459726211|FG004|Overall Study|Protocol-defined Disease Progression|1|||
127754251|NCT02807272|459726207|FG000|Overall Study|Study Terminated by Sponsor|1|||
127754252|NCT02807272|459726208|FG001|Overall Study|Study Terminated by Sponsor|0|||
127754253|NCT02807272|459726209|FG002|Overall Study|Study Terminated by Sponsor|0|||
127754254|NCT02807272|459726210|FG003|Overall Study|Study Terminated by Sponsor|1|||
127754255|NCT02807272|459726211|FG004|Overall Study|Study Terminated by Sponsor|0|||
127754256|NCT02807272|459726207|FG000|Overall Study|Other|1|||
127754257|NCT02807272|459726208|FG001|Overall Study|Other|0|||
127754258|NCT02807272|459726209|FG002|Overall Study|Other|0|||
127754259|NCT02807272|459726210|FG003|Overall Study|Other|0|||
127754260|NCT02807272|459726211|FG004|Overall Study|Other|1|||
127754261|NCT01038427|459726212|FG000|Overall Study|Lost to follow up|1|||
127754262|NCT01038427|459726213|FG001|Overall Study|Lost to follow up|1|||
127754263|NCT01038427|459726214|FG002|Overall Study|Lost to follow up|0|||
127754264|NCT01038427|459726212|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
127754265|NCT01038427|459726213|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
127754266|NCT01038427|459726214|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
127754267|NCT01038427|459726212|FG000|Overall Study|Withdrew consent|0|||
127754268|NCT01038427|459726213|FG001|Overall Study|Withdrew consent|0|||
127754269|NCT01038427|459726214|FG002|Overall Study|Withdrew consent|1|||
127754270|NCT01038427|459726212|FG000|Overall Study|Adverse Event|2|||
127754271|NCT01038427|459726213|FG001|Overall Study|Adverse Event|2|||
127754272|NCT01038427|459726214|FG002|Overall Study|Adverse Event|1|||
127754273|NCT01038427|459726212|FG000|Overall Study|Enrolled in error|0|||
127754274|NCT01038427|459726213|FG001|Overall Study|Enrolled in error|1|||
127754275|NCT01038427|459726214|FG002|Overall Study|Enrolled in error|1|||
127754276|NCT01038427|459726212|FG000|Overall Study|Other|0|||
127754277|NCT01038427|459726213|FG001|Overall Study|Other|2|||
127754278|NCT01038427|459726214|FG002|Overall Study|Other|0|||
127754279|NCT00604708|459726215|FG000|Overall Study|Withdrawal by Subject|9|||
127754280|NCT00604708|459726216|FG001|Overall Study|Withdrawal by Subject|10|||
127754281|NCT00604708|459726215|FG000|Overall Study|Protocol Violation|2|||
127754282|NCT00604708|459726216|FG001|Overall Study|Protocol Violation|8|||
127754283|NCT00604708|459726215|FG000|Overall Study|Lost to Follow-up|5|||
127754284|NCT00604708|459726216|FG001|Overall Study|Lost to Follow-up|5|||
127754285|NCT00604708|459726215|FG000|Overall Study|administrative reasons|9|||
127754286|NCT00604708|459726216|FG001|Overall Study|administrative reasons|11|||
127754287|NCT00604708|459726215|FG000|Overall Study|Adverse Event|6|||
127754288|NCT00604708|459726216|FG001|Overall Study|Adverse Event|6|||
127754289|NCT01327846|459726219|FG000|Core Phase|Subject decision (vital status: missing)|1|||
127754290|NCT01327846|459726220|FG001|Core Phase|Subject decision (vital status: missing)|2|||
127754291|NCT01327846|459726221|FG002|Core Phase|Subject decision (vital status: missing)|2|||
127754292|NCT01327846|459726222|FG003|Core Phase|Subject decision (vital status: missing)|1|||
127754293|NCT01327846|459726219|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
127754294|NCT01327846|459726220|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
127754295|NCT01327846|459726221|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
127754296|NCT01327846|459726222|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
127754297|NCT01327846|459726219|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
127754298|NCT01327846|459726220|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
127754299|NCT01327846|459726221|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
127754300|NCT01327846|459726222|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
127754301|NCT01327846|459726219|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
127754302|NCT01327846|459726220|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
127754303|NCT01327846|459726221|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
127754304|NCT01327846|459726222|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
127754305|NCT01327846|459726219|FG000|Core Phase|Lost to Follow-up|3|||
127754306|NCT01327846|459726220|FG001|Core Phase|Lost to Follow-up|3|||
127754307|NCT01327846|459726221|FG002|Core Phase|Lost to Follow-up|4|||
127754308|NCT01327846|459726222|FG003|Core Phase|Lost to Follow-up|5|||
127754309|NCT01327846|459726219|FG000|Extension Phase|Study terminated by sponsor|1073|||
127754310|NCT01327846|459726220|FG001|Extension Phase|Study terminated by sponsor|1124|||
127754311|NCT01327846|459726221|FG002|Extension Phase|Study terminated by sponsor|1067|||
127754312|NCT01327846|459726222|FG003|Extension Phase|Study terminated by sponsor|1660|||
127754313|NCT01327846|459726219|FG000|Extension Phase|Withdrawal by Subject|20|||
127754314|NCT01327846|459726220|FG001|Extension Phase|Withdrawal by Subject|13|||
127811184|NCT01307423|459926533|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
127811185|NCT01307423|459926534|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
127811186|NCT01307423|459926535|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
127754315|NCT01327846|459726221|FG002|Extension Phase|Withdrawal by Subject|19|||
127754316|NCT01327846|459726222|FG003|Extension Phase|Withdrawal by Subject|37|||
127754317|NCT01327846|459726219|FG000|Extension Phase|Lost to Follow-up|4|||
127754318|NCT01327846|459726220|FG001|Extension Phase|Lost to Follow-up|3|||
127754319|NCT01327846|459726221|FG002|Extension Phase|Lost to Follow-up|4|||
127754320|NCT01327846|459726222|FG003|Extension Phase|Lost to Follow-up|7|||
127754321|NCT01327846|459726219|FG000|Extension Phase|Technical Problems|2|||
127754322|NCT01327846|459726220|FG001|Extension Phase|Technical Problems|4|||
127754323|NCT01327846|459726221|FG002|Extension Phase|Technical Problems|2|||
127754324|NCT01327846|459726222|FG003|Extension Phase|Technical Problems|2|||
127754325|NCT04343976|459726223|FG000|Overall Study|Withdrawal by Subject|0|||
127754326|NCT04343976|459726224|FG001|Overall Study|Withdrawal by Subject|1|||
127754327|NCT00594880|459726225|FG000|Overall Study|Withdrawal by Subject|1|||
127754328|NCT00594880|459726226|FG001|Overall Study|Withdrawal by Subject|1|||
127754329|NCT00594880|459726225|FG000|Overall Study|Lost to Follow-up|1|||
127754330|NCT00594880|459726226|FG001|Overall Study|Lost to Follow-up|0|||
127754331|NCT00694109|459726227|FG000|Overall Study|Physician Decision|3|||
127754332|NCT00694109|459726227|FG000|Overall Study|Adverse Event|74|||
127754333|NCT00694109|459726227|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
127754334|NCT00694109|459726227|FG000|Overall Study|Lack of Efficacy|2|||
127754335|NCT00694109|459726227|FG000|Overall Study|Withdrawal by Subject|13|||
127754336|NCT00694109|459726227|FG000|Overall Study|Pregnancy|1|||
127754337|NCT00694109|459726227|FG000|Overall Study|Enrolled but not treated|1|||
127754338|NCT00694109|459726227|FG000|Overall Study|Other|2|||
127754339|NCT00694109|459726227|FG000|Overall Study|Consented but no additional treatment|3|||
127754340|NCT00846807|459726228|FG000|Overall Study|Adverse Event|270|||
127754341|NCT00846807|459726228|FG000|Overall Study|Lost to Follow-up|94|||
127754342|NCT00846807|459726228|FG000|Overall Study|Withdrawal by Subject|56|||
127754343|NCT00846807|459726228|FG000|Overall Study|Non compliant with European label|7|||
127754344|NCT00846807|459726228|FG000|Overall Study|Switch to other anticoagulants|89|||
127754345|NCT00846807|459726228|FG000|Overall Study|No prescription after hospital discharge|56|||
127754346|NCT00846807|459726228|FG000|Overall Study|Other|60|||
127754347|NCT02817906|459726229|FG000|Overall Study|Adverse Event|3|||
127754348|NCT02817906|459726230|FG001|Overall Study|Adverse Event|0|||
127754349|NCT02817906|459726229|FG000|Overall Study|Lack of Efficacy|1|||
127754350|NCT02817906|459726230|FG001|Overall Study|Lack of Efficacy|0|||
127754351|NCT02817906|459726229|FG000|Overall Study|Protocol Violation|1|||
127754352|NCT02817906|459726230|FG001|Overall Study|Protocol Violation|1|||
127754353|NCT02817906|459726229|FG000|Overall Study|Study Terminated by Sponsor|2|||
127754354|NCT02817906|459726230|FG001|Overall Study|Study Terminated by Sponsor|2|||
127754355|NCT02817906|459726229|FG000|Overall Study|Withdrawal by Subject|7|||
127754356|NCT02817906|459726230|FG001|Overall Study|Withdrawal by Subject|0|||
127754357|NCT02817906|459726229|FG000|Overall Study|Other|2|||
127754358|NCT02817906|459726230|FG001|Overall Study|Other|2|||
127754359|NCT03686423|459726231|FG000|Overall Study|Withdrawal by Subject|9|||
127754360|NCT03686423|459726231|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
127754361|NCT02833077|459726232|FG000|Overall Study|Adverse Event|1|||
127754362|NCT02833077|459726233|FG001|Overall Study|Adverse Event|2|||
127754363|NCT02833077|459726232|FG000|Overall Study|Lost to Follow-up|10|||
127754364|NCT02833077|459726233|FG001|Overall Study|Lost to Follow-up|1|||
127754365|NCT02833077|459726232|FG000|Overall Study|Personal Reasons|6|||
127754366|NCT02833077|459726233|FG001|Overall Study|Personal Reasons|4|||
127754367|NCT02833077|459726232|FG000|Overall Study|Protocol Deviation|0|||
127754368|NCT02833077|459726233|FG001|Overall Study|Protocol Deviation|1|||
127754369|NCT01436253|459726236|FG000|Overall Study|Lost to Follow-up|182|||
127754370|NCT01436253|459726236|FG000|Overall Study|Not meeting all eligibility criteria|117|||
127754371|NCT03682185|459726241|FG000|Overall Study|Lost to Follow-up|4|||
127754372|NCT03682185|459726242|FG001|Overall Study|Lost to Follow-up|7|||
127754373|NCT03682185|459726243|FG002|Overall Study|Lost to Follow-up|4|||
127754374|NCT03682185|459726244|FG003|Overall Study|Lost to Follow-up|7|||
127754375|NCT03682185|459726245|FG004|Overall Study|Lost to Follow-up|1|||
127754376|NCT03682185|459726241|FG000|Overall Study|Withdrawal by Subject|7|||
127754377|NCT03682185|459726242|FG001|Overall Study|Withdrawal by Subject|3|||
127754378|NCT03682185|459726243|FG002|Overall Study|Withdrawal by Subject|7|||
127754379|NCT03682185|459726244|FG003|Overall Study|Withdrawal by Subject|3|||
127754380|NCT03682185|459726245|FG004|Overall Study|Withdrawal by Subject|0|||
127754381|NCT04908631|459726246|FG000|Overall Study|Lost to Follow-up|1|||
127754382|NCT04908631|459726246|FG000|Overall Study|Physician Decision|1|||
127754383|NCT04908631|459726246|FG000|Overall Study|Received a second implant after the 1 month visit|1|||
127754384|NCT04531982|459726247|FG000|Overall Study|Withdrawal by Subject|10|||
127754385|NCT04531982|459726248|FG001|Overall Study|Withdrawal by Subject|11|||
127754386|NCT04531982|459726247|FG000|Overall Study|Adverse Event|6|||
127754387|NCT04531982|459726248|FG001|Overall Study|Adverse Event|14|||
127754388|NCT04531982|459726247|FG000|Overall Study|Protocol Violation|6|||
127754389|NCT04531982|459726248|FG001|Overall Study|Protocol Violation|9|||
127754390|NCT04531982|459726247|FG000|Overall Study|Non-compliance with study drug|3|||
127754391|NCT04531982|459726248|FG001|Overall Study|Non-compliance with study drug|2|||
127754392|NCT04531982|459726247|FG000|Overall Study|Use of prohibited medication|2|||
127754393|NCT04531982|459726248|FG001|Overall Study|Use of prohibited medication|0|||
127754394|NCT04531982|459726247|FG000|Overall Study|Lost to Follow-up|0|||
127754395|NCT04531982|459726248|FG001|Overall Study|Lost to Follow-up|1|||
127754396|NCT04531982|459726247|FG000|Overall Study|Geopolitical conflict|2|||
127754397|NCT04531982|459726248|FG001|Overall Study|Geopolitical conflict|0|||
127754398|NCT04531982|459726247|FG000|Overall Study|Lack of Efficacy|3|||
127754399|NCT04531982|459726248|FG001|Overall Study|Lack of Efficacy|1|||
127754400|NCT04047862|459726252|FG000|Overall Study|Death|0|||
127754401|NCT04047862|459726253|FG001|Overall Study|Death|0|||
127754402|NCT04047862|459726254|FG002|Overall Study|Death|4|||
127754403|NCT04047862|459726255|FG003|Overall Study|Death|7|||
127754404|NCT04047862|459726256|FG004|Overall Study|Death|2|||
127754405|NCT04047862|459726257|FG005|Overall Study|Death|4|||
127754406|NCT04047862|459726258|FG006|Overall Study|Death|3|||
127754407|NCT04047862|459726259|FG007|Overall Study|Death|24|||
127754408|NCT04047862|459726260|FG008|Overall Study|Death|24|||
127754409|NCT04047862|459726261|FG009|Overall Study|Death|22|||
127754410|NCT04047862|459726262|FG010|Overall Study|Death|35|||
127754411|NCT04047862|459726263|FG011|Overall Study|Death|18|||
127754412|NCT04047862|459726264|FG012|Overall Study|Death|14|||
127754413|NCT04047862|459726265|FG013|Overall Study|Death|6|||
127754414|NCT04047862|459726266|FG014|Overall Study|Death|19|||
127754415|NCT04047862|459726267|FG015|Overall Study|Death|42|||
127754416|NCT04047862|459726268|FG016|Overall Study|Death|9|||
127754417|NCT04047862|459726269|FG017|Overall Study|Death|8|||
127754418|NCT04047862|459726270|FG018|Overall Study|Death|10|||
127754419|NCT04047862|459726252|FG000|Overall Study|Withdrawal by Subject|0|||
127754420|NCT04047862|459726253|FG001|Overall Study|Withdrawal by Subject|0|||
127754421|NCT04047862|459726254|FG002|Overall Study|Withdrawal by Subject|0|||
127754422|NCT04047862|459726255|FG003|Overall Study|Withdrawal by Subject|5|||
127754423|NCT04047862|459726256|FG004|Overall Study|Withdrawal by Subject|2|||
127754424|NCT04047862|459726257|FG005|Overall Study|Withdrawal by Subject|0|||
127754425|NCT04047862|459726258|FG006|Overall Study|Withdrawal by Subject|1|||
127754426|NCT04047862|459726259|FG007|Overall Study|Withdrawal by Subject|0|||
127754427|NCT04047862|459726260|FG008|Overall Study|Withdrawal by Subject|4|||
127754428|NCT04047862|459726261|FG009|Overall Study|Withdrawal by Subject|4|||
127754429|NCT04047862|459726262|FG010|Overall Study|Withdrawal by Subject|4|||
127754430|NCT04047862|459726263|FG011|Overall Study|Withdrawal by Subject|2|||
127754431|NCT04047862|459726264|FG012|Overall Study|Withdrawal by Subject|3|||
127754432|NCT04047862|459726265|FG013|Overall Study|Withdrawal by Subject|0|||
127754433|NCT04047862|459726266|FG014|Overall Study|Withdrawal by Subject|9|||
127754434|NCT04047862|459726267|FG015|Overall Study|Withdrawal by Subject|5|||
127754435|NCT04047862|459726268|FG016|Overall Study|Withdrawal by Subject|1|||
127754436|NCT04047862|459726269|FG017|Overall Study|Withdrawal by Subject|3|||
127754437|NCT04047862|459726270|FG018|Overall Study|Withdrawal by Subject|1|||
127754438|NCT04047862|459726252|FG000|Overall Study|Lost to Follow-up|0|||
127754439|NCT04047862|459726253|FG001|Overall Study|Lost to Follow-up|0|||
127754440|NCT04047862|459726254|FG002|Overall Study|Lost to Follow-up|1|||
127754441|NCT04047862|459726255|FG003|Overall Study|Lost to Follow-up|0|||
127754442|NCT04047862|459726256|FG004|Overall Study|Lost to Follow-up|0|||
127754443|NCT04047862|459726257|FG005|Overall Study|Lost to Follow-up|0|||
127754444|NCT04047862|459726258|FG006|Overall Study|Lost to Follow-up|0|||
127754445|NCT04047862|459726259|FG007|Overall Study|Lost to Follow-up|1|||
127754446|NCT04047862|459726260|FG008|Overall Study|Lost to Follow-up|0|||
127754447|NCT04047862|459726261|FG009|Overall Study|Lost to Follow-up|1|||
127754448|NCT04047862|459726262|FG010|Overall Study|Lost to Follow-up|0|||
127754449|NCT04047862|459726263|FG011|Overall Study|Lost to Follow-up|3|||
127754450|NCT04047862|459726264|FG012|Overall Study|Lost to Follow-up|0|||
127754451|NCT04047862|459726265|FG013|Overall Study|Lost to Follow-up|0|||
127754452|NCT04047862|459726266|FG014|Overall Study|Lost to Follow-up|2|||
127754453|NCT04047862|459726267|FG015|Overall Study|Lost to Follow-up|2|||
127754454|NCT04047862|459726268|FG016|Overall Study|Lost to Follow-up|1|||
127754455|NCT04047862|459726269|FG017|Overall Study|Lost to Follow-up|0|||
127754456|NCT04047862|459726270|FG018|Overall Study|Lost to Follow-up|0|||
127754457|NCT04047862|459726252|FG000|Overall Study|Physician Decision|0|||
127754458|NCT04047862|459726253|FG001|Overall Study|Physician Decision|0|||
127754459|NCT04047862|459726254|FG002|Overall Study|Physician Decision|0|||
127754460|NCT04047862|459726255|FG003|Overall Study|Physician Decision|1|||
127754461|NCT04047862|459726256|FG004|Overall Study|Physician Decision|0|||
127754462|NCT04047862|459726257|FG005|Overall Study|Physician Decision|0|||
127754463|NCT04047862|459726258|FG006|Overall Study|Physician Decision|0|||
127754464|NCT04047862|459726259|FG007|Overall Study|Physician Decision|0|||
127754465|NCT04047862|459726260|FG008|Overall Study|Physician Decision|0|||
127754466|NCT04047862|459726261|FG009|Overall Study|Physician Decision|0|||
127754467|NCT04047862|459726262|FG010|Overall Study|Physician Decision|0|||
127754468|NCT04047862|459726263|FG011|Overall Study|Physician Decision|0|||
127754469|NCT04047862|459726264|FG012|Overall Study|Physician Decision|0|||
127754470|NCT04047862|459726265|FG013|Overall Study|Physician Decision|0|||
127754471|NCT04047862|459726266|FG014|Overall Study|Physician Decision|1|||
127754472|NCT04047862|459726267|FG015|Overall Study|Physician Decision|0|||
127754473|NCT04047862|459726268|FG016|Overall Study|Physician Decision|1|||
127754474|NCT04047862|459726269|FG017|Overall Study|Physician Decision|0|||
127754475|NCT04047862|459726270|FG018|Overall Study|Physician Decision|0|||
127754476|NCT04047862|459726252|FG000|Overall Study|Completed all Assessments|1|||
127754477|NCT04047862|459726253|FG001|Overall Study|Completed all Assessments|3|||
127754478|NCT04047862|459726254|FG002|Overall Study|Completed all Assessments|1|||
127754479|NCT04047862|459726255|FG003|Overall Study|Completed all Assessments|3|||
127754480|NCT04047862|459726256|FG004|Overall Study|Completed all Assessments|2|||
127754481|NCT04047862|459726257|FG005|Overall Study|Completed all Assessments|5|||
127754482|NCT04047862|459726258|FG006|Overall Study|Completed all Assessments|7|||
127754483|NCT04047862|459726259|FG007|Overall Study|Completed all Assessments|0|||
127754484|NCT04047862|459726260|FG008|Overall Study|Completed all Assessments|0|||
127754485|NCT04047862|459726261|FG009|Overall Study|Completed all Assessments|0|||
127754486|NCT04047862|459726262|FG010|Overall Study|Completed all Assessments|0|||
127754487|NCT04047862|459726263|FG011|Overall Study|Completed all Assessments|0|||
127754488|NCT04047862|459726264|FG012|Overall Study|Completed all Assessments|0|||
127754489|NCT04047862|459726265|FG013|Overall Study|Completed all Assessments|0|||
127754490|NCT04047862|459726266|FG014|Overall Study|Completed all Assessments|0|||
127754491|NCT04047862|459726267|FG015|Overall Study|Completed all Assessments|0|||
127754492|NCT04047862|459726268|FG016|Overall Study|Completed all Assessments|0|||
127754493|NCT04047862|459726269|FG017|Overall Study|Completed all Assessments|0|||
127754494|NCT04047862|459726270|FG018|Overall Study|Completed all Assessments|0|||
127754495|NCT04047862|459726252|FG000|Overall Study|Sponsor Decision|0|||
127754496|NCT04047862|459726253|FG001|Overall Study|Sponsor Decision|0|||
127754497|NCT04047862|459726254|FG002|Overall Study|Sponsor Decision|0|||
127754498|NCT04047862|459726255|FG003|Overall Study|Sponsor Decision|0|||
127754499|NCT04047862|459726256|FG004|Overall Study|Sponsor Decision|0|||
127754500|NCT04047862|459726257|FG005|Overall Study|Sponsor Decision|0|||
127754501|NCT04047862|459726258|FG006|Overall Study|Sponsor Decision|0|||
127754502|NCT04047862|459726259|FG007|Overall Study|Sponsor Decision|13|||
127754503|NCT04047862|459726260|FG008|Overall Study|Sponsor Decision|10|||
127754504|NCT04047862|459726261|FG009|Overall Study|Sponsor Decision|18|||
127754505|NCT04047862|459726262|FG010|Overall Study|Sponsor Decision|3|||
127754506|NCT04047862|459726263|FG011|Overall Study|Sponsor Decision|3|||
127754507|NCT04047862|459726264|FG012|Overall Study|Sponsor Decision|4|||
127754508|NCT04047862|459726265|FG013|Overall Study|Sponsor Decision|0|||
127754509|NCT04047862|459726266|FG014|Overall Study|Sponsor Decision|7|||
127754510|NCT04047862|459726267|FG015|Overall Study|Sponsor Decision|8|||
127754511|NCT04047862|459726268|FG016|Overall Study|Sponsor Decision|9|||
127754512|NCT04047862|459726269|FG017|Overall Study|Sponsor Decision|7|||
127754513|NCT04047862|459726270|FG018|Overall Study|Sponsor Decision|8|||
127754514|NCT04047862|459726252|FG000|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
127754515|NCT04047862|459726253|FG001|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
127754516|NCT04047862|459726254|FG002|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
127754517|NCT04047862|459726255|FG003|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
127754518|NCT04047862|459726256|FG004|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
127754519|NCT04047862|459726257|FG005|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
127754520|NCT04047862|459726258|FG006|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
127754521|NCT04047862|459726259|FG007|Overall Study|Transfer to a Company Sponsored Clinical Trial|3|||
127754522|NCT04047862|459726260|FG008|Overall Study|Transfer to a Company Sponsored Clinical Trial|5|||
127754523|NCT04047862|459726261|FG009|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
127754524|NCT04047862|459726262|FG010|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
127754525|NCT04047862|459726263|FG011|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
127754526|NCT04047862|459726264|FG012|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
127754527|NCT04047862|459726265|FG013|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
127754528|NCT04047862|459726266|FG014|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
127754529|NCT04047862|459726267|FG015|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
127754530|NCT04047862|459726268|FG016|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
127754531|NCT04047862|459726269|FG017|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
127754532|NCT04047862|459726270|FG018|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
127754533|NCT04047862|459726252|FG000|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
127754534|NCT04047862|459726253|FG001|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
127754535|NCT04047862|459726254|FG002|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
127754536|NCT04047862|459726255|FG003|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
127754537|NCT04047862|459726256|FG004|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
127754538|NCT04047862|459726257|FG005|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
127754539|NCT04047862|459726258|FG006|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
127754540|NCT04047862|459726259|FG007|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
127754541|NCT04047862|459726260|FG008|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
127754542|NCT04047862|459726261|FG009|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
127754543|NCT04047862|459726262|FG010|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
127754544|NCT04047862|459726263|FG011|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
127754545|NCT04047862|459726264|FG012|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
127754546|NCT04047862|459726265|FG013|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
127811187|NCT01307423|459926536|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
127811188|NCT01307423|459926537|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
127811189|NCT01307423|459926538|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
127754547|NCT04047862|459726266|FG014|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
127754548|NCT04047862|459726267|FG015|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|1|||
127754549|NCT04047862|459726268|FG016|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
127754550|NCT04047862|459726269|FG017|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
127754551|NCT04047862|459726270|FG018|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|2|||
127754552|NCT04047862|459726252|FG000|Overall Study|Other|0|||
127754553|NCT04047862|459726253|FG001|Overall Study|Other|0|||
127754554|NCT04047862|459726254|FG002|Overall Study|Other|0|||
127754555|NCT04047862|459726255|FG003|Overall Study|Other|0|||
127754556|NCT04047862|459726256|FG004|Overall Study|Other|0|||
127754557|NCT04047862|459726257|FG005|Overall Study|Other|0|||
127754558|NCT04047862|459726258|FG006|Overall Study|Other|0|||
127754559|NCT04047862|459726259|FG007|Overall Study|Other|0|||
127754560|NCT04047862|459726260|FG008|Overall Study|Other|0|||
127754561|NCT04047862|459726261|FG009|Overall Study|Other|0|||
127754562|NCT04047862|459726262|FG010|Overall Study|Other|0|||
127754563|NCT04047862|459726263|FG011|Overall Study|Other|0|||
127754564|NCT04047862|459726264|FG012|Overall Study|Other|0|||
127754565|NCT04047862|459726265|FG013|Overall Study|Other|0|||
127754566|NCT04047862|459726266|FG014|Overall Study|Other|2|||
127754567|NCT04047862|459726267|FG015|Overall Study|Other|1|||
127754568|NCT04047862|459726268|FG016|Overall Study|Other|1|||
127754569|NCT04047862|459726269|FG017|Overall Study|Other|1|||
127754570|NCT04047862|459726270|FG018|Overall Study|Other|0|||
127754571|NCT01876082|459727824|FG000|Overall Study|Withdrawal by Subject|0|||
127754572|NCT01876082|459727825|FG001|Overall Study|Withdrawal by Subject|2|||
127754573|NCT01876082|459727824|FG000|Overall Study|Protocol Violation|1|||
127754574|NCT01876082|459727825|FG001|Overall Study|Protocol Violation|0|||
127754575|NCT01876082|459727824|FG000|Overall Study|Adverse Event|1|||
127754576|NCT01876082|459727825|FG001|Overall Study|Adverse Event|1|||
127754577|NCT01876082|459727824|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
127754578|NCT01876082|459727825|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
127754579|NCT04427280|459727827|FG000|Overall Study|Withdrawal by Subject|0|||
127754580|NCT04427280|459727828|FG001|Overall Study|Withdrawal by Subject|2|||
127754581|NCT03829501|459727831|FG000|Overall Study|Withdrawal of Consent|2|||
127754582|NCT03829501|459727832|FG001|Overall Study|Withdrawal of Consent|0|||
127754583|NCT03829501|459727833|FG002|Overall Study|Withdrawal of Consent|3|||
127754584|NCT03829501|459727834|FG003|Overall Study|Withdrawal of Consent|0|||
127754585|NCT03829501|459727835|FG004|Overall Study|Withdrawal of Consent|1|||
127754586|NCT03829501|459727836|FG005|Overall Study|Withdrawal of Consent|1|||
127754587|NCT03829501|459727837|FG006|Overall Study|Withdrawal of Consent|0|||
127754588|NCT03829501|459727838|FG007|Overall Study|Withdrawal of Consent|10|||
127754589|NCT03829501|459727839|FG008|Overall Study|Withdrawal of Consent|10|||
127754590|NCT03829501|459727840|FG009|Overall Study|Withdrawal of Consent|3|||
127754591|NCT03829501|459727841|FG010|Overall Study|Withdrawal of Consent|4|||
127754592|NCT03829501|459727842|FG011|Overall Study|Withdrawal of Consent|4|||
127754593|NCT03829501|459727843|FG012|Overall Study|Withdrawal of Consent|4|||
127754594|NCT03829501|459727844|FG013|Overall Study|Withdrawal of Consent|0|||
127754595|NCT03829501|459727845|FG014|Overall Study|Withdrawal of Consent|3|||
127754596|NCT03829501|459727846|FG015|Overall Study|Withdrawal of Consent|0|||
127754597|NCT03829501|459727847|FG016|Overall Study|Withdrawal of Consent|1|||
127754598|NCT03829501|459727848|FG017|Overall Study|Withdrawal of Consent|1|||
127754599|NCT03829501|459727849|FG018|Overall Study|Withdrawal of Consent|0|||
127754600|NCT03829501|459727850|FG019|Overall Study|Withdrawal of Consent|0|||
127754601|NCT03829501|459727851|FG020|Overall Study|Withdrawal of Consent|3|||
127754602|NCT03829501|459727852|FG021|Overall Study|Withdrawal of Consent|0|||
127754603|NCT03829501|459727853|FG022|Overall Study|Withdrawal of Consent|1|||
127754604|NCT03829501|459727831|FG000|Overall Study|PD|0|||
127754605|NCT03829501|459727832|FG001|Overall Study|PD|0|||
127754606|NCT03829501|459727833|FG002|Overall Study|PD|0|||
127754607|NCT03829501|459727834|FG003|Overall Study|PD|2|||
127754608|NCT03829501|459727835|FG004|Overall Study|PD|0|||
127754609|NCT03829501|459727836|FG005|Overall Study|PD|0|||
127754610|NCT03829501|459727837|FG006|Overall Study|PD|0|||
127754611|NCT03829501|459727838|FG007|Overall Study|PD|0|||
127754612|NCT03829501|459727839|FG008|Overall Study|PD|0|||
127754613|NCT03829501|459727840|FG009|Overall Study|PD|0|||
127754614|NCT03829501|459727841|FG010|Overall Study|PD|0|||
127754615|NCT03829501|459727842|FG011|Overall Study|PD|0|||
127754616|NCT03829501|459727843|FG012|Overall Study|PD|0|||
127754617|NCT03829501|459727844|FG013|Overall Study|PD|0|||
127754618|NCT03829501|459727845|FG014|Overall Study|PD|0|||
127754619|NCT03829501|459727846|FG015|Overall Study|PD|1|||
127754620|NCT03829501|459727847|FG016|Overall Study|PD|0|||
127754621|NCT03829501|459727848|FG017|Overall Study|PD|0|||
127754622|NCT03829501|459727849|FG018|Overall Study|PD|0|||
127754623|NCT03829501|459727850|FG019|Overall Study|PD|0|||
127754624|NCT03829501|459727851|FG020|Overall Study|PD|1|||
127754625|NCT03829501|459727852|FG021|Overall Study|PD|0|||
127754626|NCT03829501|459727853|FG022|Overall Study|PD|0|||
127754627|NCT03829501|459727831|FG000|Overall Study|Study Terminated by Sponsor|0|||
127754628|NCT03829501|459727832|FG001|Overall Study|Study Terminated by Sponsor|0|||
127754629|NCT03829501|459727833|FG002|Overall Study|Study Terminated by Sponsor|0|||
127754630|NCT03829501|459727834|FG003|Overall Study|Study Terminated by Sponsor|0|||
127754631|NCT03829501|459727835|FG004|Overall Study|Study Terminated by Sponsor|0|||
127754632|NCT03829501|459727836|FG005|Overall Study|Study Terminated by Sponsor|0|||
127754633|NCT03829501|459727837|FG006|Overall Study|Study Terminated by Sponsor|0|||
127754634|NCT03829501|459727838|FG007|Overall Study|Study Terminated by Sponsor|3|||
127754635|NCT03829501|459727839|FG008|Overall Study|Study Terminated by Sponsor|1|||
127754636|NCT03829501|459727840|FG009|Overall Study|Study Terminated by Sponsor|0|||
127754637|NCT03829501|459727841|FG010|Overall Study|Study Terminated by Sponsor|0|||
127754638|NCT03829501|459727842|FG011|Overall Study|Study Terminated by Sponsor|0|||
127754639|NCT03829501|459727843|FG012|Overall Study|Study Terminated by Sponsor|0|||
127754640|NCT03829501|459727844|FG013|Overall Study|Study Terminated by Sponsor|0|||
127754641|NCT03829501|459727845|FG014|Overall Study|Study Terminated by Sponsor|3|||
127754642|NCT03829501|459727846|FG015|Overall Study|Study Terminated by Sponsor|2|||
127754643|NCT03829501|459727847|FG016|Overall Study|Study Terminated by Sponsor|2|||
127754644|NCT03829501|459727848|FG017|Overall Study|Study Terminated by Sponsor|0|||
127754645|NCT03829501|459727849|FG018|Overall Study|Study Terminated by Sponsor|0|||
127754646|NCT03829501|459727850|FG019|Overall Study|Study Terminated by Sponsor|0|||
127754647|NCT03829501|459727851|FG020|Overall Study|Study Terminated by Sponsor|1|||
127754648|NCT03829501|459727852|FG021|Overall Study|Study Terminated by Sponsor|0|||
127754649|NCT03829501|459727853|FG022|Overall Study|Study Terminated by Sponsor|3|||
127754650|NCT03829501|459727831|FG000|Overall Study|Lost to Follow Up|0|||
127754651|NCT03829501|459727832|FG001|Overall Study|Lost to Follow Up|0|||
127754652|NCT03829501|459727833|FG002|Overall Study|Lost to Follow Up|0|||
127754653|NCT03829501|459727834|FG003|Overall Study|Lost to Follow Up|0|||
127754654|NCT03829501|459727835|FG004|Overall Study|Lost to Follow Up|1|||
127754655|NCT03829501|459727836|FG005|Overall Study|Lost to Follow Up|0|||
127754656|NCT03829501|459727837|FG006|Overall Study|Lost to Follow Up|0|||
127754657|NCT03829501|459727838|FG007|Overall Study|Lost to Follow Up|2|||
127754658|NCT03829501|459727839|FG008|Overall Study|Lost to Follow Up|2|||
127754659|NCT03829501|459727840|FG009|Overall Study|Lost to Follow Up|0|||
127754660|NCT03829501|459727841|FG010|Overall Study|Lost to Follow Up|2|||
127754661|NCT03829501|459727842|FG011|Overall Study|Lost to Follow Up|1|||
127754662|NCT03829501|459727843|FG012|Overall Study|Lost to Follow Up|0|||
127754663|NCT03829501|459727844|FG013|Overall Study|Lost to Follow Up|1|||
127754664|NCT03829501|459727845|FG014|Overall Study|Lost to Follow Up|1|||
127754665|NCT03829501|459727846|FG015|Overall Study|Lost to Follow Up|0|||
127754666|NCT03829501|459727847|FG016|Overall Study|Lost to Follow Up|0|||
127754667|NCT03829501|459727848|FG017|Overall Study|Lost to Follow Up|0|||
127754668|NCT03829501|459727849|FG018|Overall Study|Lost to Follow Up|0|||
127754669|NCT03829501|459727850|FG019|Overall Study|Lost to Follow Up|0|||
127754670|NCT03829501|459727851|FG020|Overall Study|Lost to Follow Up|0|||
127754671|NCT03829501|459727852|FG021|Overall Study|Lost to Follow Up|0|||
127754672|NCT03829501|459727853|FG022|Overall Study|Lost to Follow Up|1|||
127754673|NCT03829501|459727831|FG000|Overall Study|Death|2|||
127754674|NCT03829501|459727832|FG001|Overall Study|Death|4|||
127754675|NCT03829501|459727833|FG002|Overall Study|Death|5|||
127754676|NCT03829501|459727834|FG003|Overall Study|Death|6|||
127754677|NCT03829501|459727835|FG004|Overall Study|Death|5|||
127754678|NCT03829501|459727836|FG005|Overall Study|Death|4|||
127754679|NCT03829501|459727837|FG006|Overall Study|Death|5|||
127754680|NCT03829501|459727838|FG007|Overall Study|Death|24|||
127754681|NCT03829501|459727839|FG008|Overall Study|Death|22|||
127754682|NCT03829501|459727840|FG009|Overall Study|Death|6|||
127754683|NCT03829501|459727841|FG010|Overall Study|Death|3|||
127754684|NCT03829501|459727842|FG011|Overall Study|Death|10|||
127754685|NCT03829501|459727843|FG012|Overall Study|Death|10|||
127754686|NCT03829501|459727844|FG013|Overall Study|Death|5|||
127754687|NCT03829501|459727845|FG014|Overall Study|Death|7|||
127754688|NCT03829501|459727846|FG015|Overall Study|Death|2|||
127754689|NCT03829501|459727847|FG016|Overall Study|Death|2|||
127754690|NCT03829501|459727848|FG017|Overall Study|Death|1|||
127754691|NCT03829501|459727849|FG018|Overall Study|Death|1|||
127754692|NCT03829501|459727850|FG019|Overall Study|Death|1|||
127754693|NCT03829501|459727851|FG020|Overall Study|Death|1|||
127754694|NCT03829501|459727852|FG021|Overall Study|Death|2|||
127754695|NCT03829501|459727853|FG022|Overall Study|Death|3|||
127754696|NCT03829501|459727831|FG000|Overall Study|Miscellaneous|0|||
127754697|NCT03829501|459727832|FG001|Overall Study|Miscellaneous|0|||
127754698|NCT03829501|459727833|FG002|Overall Study|Miscellaneous|1|||
127754699|NCT03829501|459727834|FG003|Overall Study|Miscellaneous|0|||
127754700|NCT03829501|459727835|FG004|Overall Study|Miscellaneous|0|||
127754701|NCT03829501|459727836|FG005|Overall Study|Miscellaneous|0|||
127754702|NCT03829501|459727837|FG006|Overall Study|Miscellaneous|0|||
127754703|NCT03829501|459727838|FG007|Overall Study|Miscellaneous|1|||
127754704|NCT03829501|459727839|FG008|Overall Study|Miscellaneous|0|||
127754705|NCT03829501|459727840|FG009|Overall Study|Miscellaneous|0|||
127754706|NCT03829501|459727841|FG010|Overall Study|Miscellaneous|0|||
127754707|NCT03829501|459727842|FG011|Overall Study|Miscellaneous|0|||
127754708|NCT03829501|459727843|FG012|Overall Study|Miscellaneous|0|||
127754709|NCT03829501|459727844|FG013|Overall Study|Miscellaneous|0|||
127754710|NCT03829501|459727845|FG014|Overall Study|Miscellaneous|0|||
127754711|NCT03829501|459727846|FG015|Overall Study|Miscellaneous|0|||
127754712|NCT03829501|459727847|FG016|Overall Study|Miscellaneous|0|||
127754713|NCT03829501|459727848|FG017|Overall Study|Miscellaneous|0|||
127754714|NCT03829501|459727849|FG018|Overall Study|Miscellaneous|0|||
127754715|NCT03829501|459727850|FG019|Overall Study|Miscellaneous|0|||
127754716|NCT03829501|459727851|FG020|Overall Study|Miscellaneous|0|||
127754717|NCT03829501|459727852|FG021|Overall Study|Miscellaneous|0|||
127754718|NCT03829501|459727853|FG022|Overall Study|Miscellaneous|1|||
127754719|NCT01123070|459727854|FG000|Part B Double Blind Period|Protocol Violation|0|||
127754720|NCT01123070|459727855|FG001|Part B Double Blind Period|Protocol Violation|0|||
127754721|NCT01123070|459727856|FG002|Part B Double Blind Period|Protocol Violation|0|||
127754722|NCT01123070|459727857|FG003|Part B Double Blind Period|Protocol Violation|1|||
127754723|NCT01123070|459727854|FG000|Part B Double Blind Period|Adverse Event|0|||
127754724|NCT01123070|459727855|FG001|Part B Double Blind Period|Adverse Event|0|||
127754725|NCT01123070|459727856|FG002|Part B Double Blind Period|Adverse Event|2|||
127754726|NCT01123070|459727857|FG003|Part B Double Blind Period|Adverse Event|0|||
127754727|NCT01123070|459727854|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
127754728|NCT01123070|459727855|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
127754729|NCT01123070|459727856|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
127754730|NCT01123070|459727857|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
127754731|NCT03284229|459727858|FG000|Overall Study|Lost to Follow-up|3|||
127754732|NCT00626197|459727862|FG000|Overall Study|Did not cooperate|2|||
127754733|NCT00626197|459727863|FG001|Overall Study|Did not cooperate|6|||
127754734|NCT00626197|459727864|FG002|Overall Study|Did not cooperate|1|||
127754735|NCT00626197|459727862|FG000|Overall Study|Failure to return|6|||
127754736|NCT00626197|459727863|FG001|Overall Study|Failure to return|5|||
127754737|NCT00626197|459727864|FG002|Overall Study|Failure to return|6|||
127754738|NCT00626197|459727862|FG000|Overall Study|Adverse event, serious fatal|3|||
127754739|NCT00626197|459727863|FG001|Overall Study|Adverse event, serious fatal|6|||
127754740|NCT00626197|459727864|FG002|Overall Study|Adverse event, serious fatal|6|||
127754741|NCT00626197|459727862|FG000|Overall Study|Adverse Event|1|||
127754742|NCT00626197|459727863|FG001|Overall Study|Adverse Event|1|||
127754743|NCT00626197|459727864|FG002|Overall Study|Adverse Event|2|||
127754744|NCT00626197|459727862|FG000|Overall Study|Withdrawal by Subject|17|||
127754745|NCT00626197|459727863|FG001|Overall Study|Withdrawal by Subject|17|||
127754746|NCT00626197|459727864|FG002|Overall Study|Withdrawal by Subject|7|||
127754747|NCT00626197|459727862|FG000|Overall Study|Administrative reasons|15|||
127754748|NCT00626197|459727863|FG001|Overall Study|Administrative reasons|19|||
127754749|NCT00626197|459727864|FG002|Overall Study|Administrative reasons|55|||
127754750|NCT04833127|459727865|FG000|Overall Study|Lost to Follow-up|1|||
127754751|NCT04833127|459727866|FG001|Overall Study|Lost to Follow-up|1|||
127754752|NCT04552899|459727869|FG000|Overall Study|Adverse Event|4|||
127754753|NCT04552899|459727870|FG001|Overall Study|Adverse Event|3|||
127754754|NCT04552899|459727869|FG000|Overall Study|Death|4|||
127754755|NCT04552899|459727870|FG001|Overall Study|Death|4|||
127754756|NCT04552899|459727869|FG000|Overall Study|Lost to Follow-up|8|||
127754757|NCT04552899|459727870|FG001|Overall Study|Lost to Follow-up|13|||
127754758|NCT04552899|459727869|FG000|Overall Study|Lung Transplant|4|||
127754759|NCT04552899|459727870|FG001|Overall Study|Lung Transplant|3|||
127811190|NCT01307423|459926539|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
127811191|NCT01307423|459926540|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
127811192|NCT01307423|459926541|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
127754760|NCT04552899|459727869|FG000|Overall Study|Participant and physician wanted to withdraw participant from study|0|||
127754761|NCT04552899|459727870|FG001|Overall Study|Participant and physician wanted to withdraw participant from study|1|||
127754762|NCT04552899|459727869|FG000|Overall Study|Physician Decision|3|||
127754763|NCT04552899|459727870|FG001|Overall Study|Physician Decision|4|||
127754764|NCT04552899|459727869|FG000|Overall Study|Study Terminated By Sponsor|237|||
127754765|NCT04552899|459727870|FG001|Overall Study|Study Terminated By Sponsor|239|||
127754766|NCT04552899|459727869|FG000|Overall Study|Withdrawal by Subject|15|||
127754767|NCT04552899|459727870|FG001|Overall Study|Withdrawal by Subject|17|||
127754768|NCT00461981|459727874|FG000|Overall Study|Lost to Follow-up|9|||
127754769|NCT00461981|459727875|FG001|Overall Study|Lost to Follow-up|6|||
127754770|NCT00461981|459727874|FG000|Overall Study|Withdrawal by Subject|2|||
127754771|NCT00461981|459727875|FG001|Overall Study|Withdrawal by Subject|3|||
127754772|NCT00731133|459727879|FG000|Overall Study|Withdrawal by Subject|10|||
127754773|NCT03510455|459727880|FG000|Overall Study|Physician Decision|1|||
127754774|NCT04958642|459727887|FG000|Overall Study|Transferred to OLEX program|3|||
127754775|NCT04958642|459727888|FG001|Overall Study|Transferred to OLEX program|0|||
127754776|NCT04958642|459727889|FG002|Overall Study|Transferred to OLEX program|5|||
127754777|NCT04958642|459727887|FG000|Overall Study|Death|0|||
127754778|NCT04958642|459727888|FG001|Overall Study|Death|0|||
127754779|NCT04958642|459727889|FG002|Overall Study|Death|1|||
127754780|NCT04958642|459727887|FG000|Overall Study|Withdrawal by Subject|4|||
127754781|NCT04958642|459727888|FG001|Overall Study|Withdrawal by Subject|9|||
127754782|NCT04958642|459727889|FG002|Overall Study|Withdrawal by Subject|13|||
127754783|NCT04958642|459727887|FG000|Overall Study|Investigator's Decision|0|||
127754784|NCT04958642|459727888|FG001|Overall Study|Investigator's Decision|0|||
127754785|NCT04958642|459727889|FG002|Overall Study|Investigator's Decision|1|||
127754786|NCT04958642|459727887|FG000|Overall Study|Adverse Event|1|||
127754787|NCT04958642|459727888|FG001|Overall Study|Adverse Event|0|||
127754788|NCT04958642|459727889|FG002|Overall Study|Adverse Event|1|||
127754789|NCT04958642|459727887|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
127754790|NCT04958642|459727888|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
127754791|NCT04958642|459727889|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
127754792|NCT04958642|459727887|FG000|Overall Study|Lost to Follow-up|1|||
127754793|NCT04958642|459727888|FG001|Overall Study|Lost to Follow-up|0|||
127754794|NCT04958642|459727889|FG002|Overall Study|Lost to Follow-up|0|||
127754795|NCT04958642|459727887|FG000|Overall Study|Transferred to EAP following study termination|0|||
127754796|NCT04958642|459727888|FG001|Overall Study|Transferred to EAP following study termination|0|||
127754797|NCT04958642|459727889|FG002|Overall Study|Transferred to EAP following study termination|1|||
127754798|NCT04958642|459727887|FG000|Overall Study|Transferred to Expanded Access Program|1|||
127754799|NCT04958642|459727888|FG001|Overall Study|Transferred to Expanded Access Program|0|||
127754800|NCT04958642|459727889|FG002|Overall Study|Transferred to Expanded Access Program|0|||
127754801|NCT03853551|459727893|FG000|Overall Study|Death|2|||
127754802|NCT03853551|459727893|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
127754803|NCT02476175|459727894|FG000|Overall Study|Adverse Event|2|||
127754804|NCT02964325|459727897|FG000|Overall Study|Lost to Follow-up|3|||
127754805|NCT02964325|459727898|FG001|Overall Study|Lost to Follow-up|3|||
127754806|NCT02964325|459727897|FG000|Overall Study|Physician Decision|5|||
127754807|NCT02964325|459727898|FG001|Overall Study|Physician Decision|4|||
127754808|NCT02964325|459727897|FG000|Overall Study|Death|1|||
127754809|NCT02964325|459727898|FG001|Overall Study|Death|3|||
127754810|NCT02964325|459727897|FG000|Overall Study|Withdrawal by Subject|2|||
127754811|NCT02964325|459727898|FG001|Overall Study|Withdrawal by Subject|1|||
127754812|NCT02964325|459727897|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
127754813|NCT02964325|459727898|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
127754814|NCT02510040|459727899|FG000|Overall Study|Deemed no longer eligible|18|||
127754815|NCT02510040|459727900|FG001|Overall Study|Deemed no longer eligible|3|||
127754816|NCT02510040|459727901|FG002|Overall Study|Deemed no longer eligible|1|||
127754817|NCT00534495|459727908|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
127754818|NCT00534495|459727909|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
127754819|NCT00534495|459727910|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
127754820|NCT00534495|459727908|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
127754821|NCT00534495|459727909|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
127754822|NCT00534495|459727910|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
127754823|NCT00534495|459727908|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
127754824|NCT00534495|459727909|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
127754825|NCT00534495|459727910|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
127754826|NCT00534495|459727908|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
127754827|NCT00534495|459727909|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
127754828|NCT00534495|459727910|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
127754829|NCT00534495|459727908|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
127754830|NCT00534495|459727909|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
127754831|NCT00534495|459727910|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
127754832|NCT00534495|459727908|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
127754833|NCT00534495|459727909|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
127754834|NCT00534495|459727910|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
127811193|NCT01307423|459926533|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
127811194|NCT01307423|459926534|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
127811195|NCT01307423|459926535|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
127811196|NCT01307423|459926536|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
127811197|NCT01307423|459926537|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
127754835|NCT00534495|459727908|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
127754836|NCT00534495|459727909|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
127754837|NCT00534495|459727910|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
127754838|NCT00534495|459727908|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
127754839|NCT00534495|459727909|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
127754840|NCT00534495|459727910|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
127754841|NCT00534495|459727908|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
127754842|NCT00534495|459727909|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
127754843|NCT00534495|459727910|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
127754844|NCT01068665|459727911|FG000|Overall Study|Adverse Event|5|||
127754845|NCT01068665|459727912|FG001|Overall Study|Adverse Event|4|||
127754846|NCT01068665|459727911|FG000|Overall Study|Lack of Efficacy|0|||
127754847|NCT01068665|459727912|FG001|Overall Study|Lack of Efficacy|2|||
127754848|NCT01068665|459727911|FG000|Overall Study|Protocol Violation|5|||
127754849|NCT01068665|459727912|FG001|Overall Study|Protocol Violation|2|||
127754850|NCT01068665|459727911|FG000|Overall Study|Withdrawal Criteria|3|||
127754851|NCT01068665|459727912|FG001|Overall Study|Withdrawal Criteria|9|||
127754852|NCT01068665|459727911|FG000|Overall Study|Other|17|||
127754853|NCT01068665|459727912|FG001|Overall Study|Other|12|||
127754854|NCT04230122|459727913|FG000|Overall Study|Lost to Follow-up|1|||
127754855|NCT04230122|459727914|FG001|Overall Study|Lost to Follow-up|0|||
127754856|NCT02202785|459727915|FG000|Overall Study|Study Terminated by Sponsor|1|||
127754857|NCT02202785|459727916|FG001|Overall Study|Study Terminated by Sponsor|6|||
127754858|NCT02202785|459727917|FG002|Overall Study|Study Terminated by Sponsor|4|||
127754859|NCT02202785|459727915|FG000|Overall Study|Withdrawal by Subject|0|||
127754860|NCT02202785|459727916|FG001|Overall Study|Withdrawal by Subject|1|||
127754861|NCT02202785|459727917|FG002|Overall Study|Withdrawal by Subject|0|||
127754862|NCT02202785|459727915|FG000|Overall Study|Lost to Follow-up|0|||
127754863|NCT02202785|459727916|FG001|Overall Study|Lost to Follow-up|1|||
127754864|NCT02202785|459727917|FG002|Overall Study|Lost to Follow-up|0|||
127754865|NCT02202785|459727915|FG000|Overall Study|Reason not Specified|10|||
127754866|NCT02202785|459727916|FG001|Overall Study|Reason not Specified|7|||
127754867|NCT02202785|459727917|FG002|Overall Study|Reason not Specified|13|||
127754868|NCT01137578|459727918|FG000|Overall Study|Participant requested to Discontinue|3|||
127754869|NCT01137578|459727919|FG001|Overall Study|Participant requested to Discontinue|0|||
127754870|NCT01137578|459727920|FG002|Overall Study|Participant requested to Discontinue|0|||
127754871|NCT01137578|459727918|FG000|Overall Study|Withdrawal by Subject|1|||
127754872|NCT01137578|459727919|FG001|Overall Study|Withdrawal by Subject|0|||
127754873|NCT01137578|459727920|FG002|Overall Study|Withdrawal by Subject|0|||
127754874|NCT01137578|459727918|FG000|Overall Study|Other|12|||
127754875|NCT01137578|459727919|FG001|Overall Study|Other|2|||
127754876|NCT01137578|459727920|FG002|Overall Study|Other|6|||
127754877|NCT04145700|459727921|FG000|Overall Study|Withdrawal by Subject|8|||
127754878|NCT04145700|459727922|FG001|Overall Study|Withdrawal by Subject|3|||
127754879|NCT00818779|459727923|FG000|Overall Study|Protocol Violation|1|||
127754880|NCT00818779|459727924|FG001|Overall Study|Protocol Violation|0|||
127754881|NCT00818779|459727923|FG000|Overall Study|Lost to Follow-up|1|||
127754882|NCT00818779|459727924|FG001|Overall Study|Lost to Follow-up|0|||
127754883|NCT00818779|459727923|FG000|Overall Study|Adverse Event|4|||
127754884|NCT00818779|459727924|FG001|Overall Study|Adverse Event|1|||
127754885|NCT04978493|459727925|FG000|Overall Study|No reason available|0|||
127754886|NCT04978493|459727926|FG001|Overall Study|No reason available|1|||
127754887|NCT04978493|459727925|FG000|Overall Study|Adverse Event|1|||
127754888|NCT04978493|459727926|FG001|Overall Study|Adverse Event|0|||
127754889|NCT01254747|459727927|FG000|Overall Study|Unacceptable subjective vision|0|||
127754890|NCT01254747|459727928|FG001|Overall Study|Unacceptable subjective vision|0|||
127754891|NCT01254747|459727929|FG002|Overall Study|Unacceptable subjective vision|0|||
127754892|NCT01254747|459727930|FG003|Overall Study|Unacceptable subjective vision|2|||
127754893|NCT01254747|459727927|FG000|Overall Study|Difficult removal handling|0|||
127754894|NCT01254747|459727928|FG001|Overall Study|Difficult removal handling|0|||
127754895|NCT01254747|459727929|FG002|Overall Study|Difficult removal handling|1|||
127754896|NCT01254747|459727930|FG003|Overall Study|Difficult removal handling|0|||
127754897|NCT01254747|459727927|FG000|Overall Study|Symptoms and problems|0|||
127754898|NCT01254747|459727928|FG001|Overall Study|Symptoms and problems|2|||
127754899|NCT01254747|459727929|FG002|Overall Study|Symptoms and problems|1|||
127754900|NCT01254747|459727930|FG003|Overall Study|Symptoms and problems|0|||
127754901|NCT01254747|459727927|FG000|Overall Study|Lost to Follow-up|0|||
127754902|NCT01254747|459727928|FG001|Overall Study|Lost to Follow-up|0|||
127754903|NCT01254747|459727929|FG002|Overall Study|Lost to Follow-up|1|||
127754904|NCT01254747|459727930|FG003|Overall Study|Lost to Follow-up|0|||
127754905|NCT01254747|459727927|FG000|Overall Study|Biomicroscopy|0|||
127754906|NCT01254747|459727928|FG001|Overall Study|Biomicroscopy|0|||
127754907|NCT01254747|459727929|FG002|Overall Study|Biomicroscopy|1|||
127754908|NCT01254747|459727930|FG003|Overall Study|Biomicroscopy|0|||
127754909|NCT01254747|459727927|FG000|Overall Study|Discomfort|0|||
127754910|NCT01254747|459727928|FG001|Overall Study|Discomfort|4|||
127754911|NCT01254747|459727929|FG002|Overall Study|Discomfort|0|||
127754912|NCT01254747|459727930|FG003|Overall Study|Discomfort|0|||
127754913|NCT00245960|459727931|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
127754914|NCT00245960|459727932|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
127754915|NCT00245960|459727931|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
127754916|NCT00245960|459727932|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
127754917|NCT00245960|459727931|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
127754918|NCT00245960|459727932|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
127754919|NCT00245960|459727931|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
127754920|NCT00245960|459727932|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
127754921|NCT00245960|459727931|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
127754922|NCT00245960|459727932|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
127754923|NCT00245960|459727931|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
127754924|NCT00245960|459727932|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
127754925|NCT00245960|459727931|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
127754926|NCT00245960|459727932|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
127754927|NCT00245960|459727931|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
127754928|NCT00245960|459727932|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
127754929|NCT00245960|459727931|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
127754930|NCT00245960|459727932|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
127754931|NCT00245960|459727931|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
127754932|NCT00245960|459727932|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
127754933|NCT00245960|459727931|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
127754934|NCT00245960|459727932|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
127754935|NCT00245960|459727931|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
127754936|NCT00245960|459727932|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
127754937|NCT00737698|459727933|FG000|Overall Study|Withdrawal by Subject|6|||
127754938|NCT00737698|459727934|FG001|Overall Study|Withdrawal by Subject|5|||
127754939|NCT00737698|459727935|FG002|Overall Study|Withdrawal by Subject|3|||
127754940|NCT00737698|459727933|FG000|Overall Study|Death|0|||
127754941|NCT00737698|459727934|FG001|Overall Study|Death|0|||
127754942|NCT00737698|459727935|FG002|Overall Study|Death|1|||
127754943|NCT04608773|459727937|FG000|First Wash Out (1 Week)|Withdrawal by Subject|12|||
127754944|NCT04608773|459727938|FG001|First Wash Out (1 Week)|Withdrawal by Subject|6|||
127754945|NCT04608773|459727937|FG000|First Intervention (2 Weeks)|Lost to Follow-up|3|||
127754946|NCT04608773|459727938|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
127754947|NCT04608773|459727937|FG000|First Intervention (2 Weeks)|mild adverse effects|1|||
127754948|NCT04608773|459727938|FG001|First Intervention (2 Weeks)|mild adverse effects|3|||
127754949|NCT04608773|459727937|FG000|Second Intervention (2 Week)|Lost to Follow-up|2|||
127754950|NCT04608773|459727938|FG001|Second Intervention (2 Week)|Lost to Follow-up|4|||
127754951|NCT04608773|459727937|FG000|Second Intervention (2 Week)|mild adverse effect|0|||
127754952|NCT04608773|459727938|FG001|Second Intervention (2 Week)|mild adverse effect|1|||
127754953|NCT02387970|459727939|FG000|Overall Study|Did not complete 1-year follow up|1|||
127754954|NCT02387970|459727940|FG001|Overall Study|Did not complete 1-year follow up|2|||
127754955|NCT00316017|459727944|FG000|Overall Study|Protocol Violation|11|||
127754956|NCT00316017|459727945|FG001|Overall Study|Protocol Violation|13|||
127754957|NCT00316017|459727946|FG002|Overall Study|Protocol Violation|19|||
127754958|NCT02671500|459727947|FG000|Overall Study|Lack of Efficacy|12|||
127754959|NCT02671500|459727947|FG000|Overall Study|Lost to Follow-up|2|||
127754960|NCT05292586|459727948|FG000|Overall Study|Withdrawal by Subject|3|||
127754961|NCT05292586|459727949|FG001|Overall Study|Withdrawal by Subject|10|||
127754962|NCT05292586|459727948|FG000|Overall Study|Randomization error|3|||
127754963|NCT05292586|459727949|FG001|Overall Study|Randomization error|7|||
127754964|NCT05292586|459727948|FG000|Overall Study|Adverse Event|3|||
127754965|NCT05292586|459727949|FG001|Overall Study|Adverse Event|0|||
127754966|NCT05292586|459727948|FG000|Overall Study|Lost to Follow-up|0|||
127754967|NCT05292586|459727949|FG001|Overall Study|Lost to Follow-up|1|||
127754968|NCT05292586|459727948|FG000|Overall Study|Patient refused treatment|1|||
127754969|NCT05292586|459727949|FG001|Overall Study|Patient refused treatment|0|||
127754970|NCT05292586|459727948|FG000|Overall Study|Patient could not travel to the study site|1|||
127754971|NCT05292586|459727949|FG001|Overall Study|Patient could not travel to the study site|0|||
127754972|NCT05292586|459727948|FG000|Overall Study|Technical issues with the masterscope|0|||
127754973|NCT05292586|459727949|FG001|Overall Study|Technical issues with the masterscope|3|||
127754974|NCT05292586|459727948|FG000|Overall Study|Patient moved to a different state|0|||
127754975|NCT05292586|459727949|FG001|Overall Study|Patient moved to a different state|1|||
127754976|NCT01217437|459727950|FG000|Overall Study|Adverse Event|0|||
127754977|NCT01217437|459727951|FG001|Overall Study|Adverse Event|8|||
127754978|NCT01217437|459727950|FG000|Overall Study|Death|5|||
127754979|NCT01217437|459727951|FG001|Overall Study|Death|0|||
127754980|NCT01217437|459727950|FG000|Overall Study|Lack of Efficacy|29|||
127811198|NCT01307423|459926538|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
127811199|NCT01307423|459926539|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
127811200|NCT01307423|459926540|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
127754981|NCT01217437|459727951|FG001|Overall Study|Lack of Efficacy|25|||
127754982|NCT01217437|459727950|FG000|Overall Study|Physician Decision|8|||
127754983|NCT01217437|459727951|FG001|Overall Study|Physician Decision|5|||
127754984|NCT01217437|459727950|FG000|Overall Study|Withdrawal by Subject|0|||
127754985|NCT01217437|459727951|FG001|Overall Study|Withdrawal by Subject|2|||
127754986|NCT01217437|459727950|FG000|Overall Study|Ineligible|1|||
127754987|NCT01217437|459727951|FG001|Overall Study|Ineligible|1|||
127754988|NCT03841526|459727955|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
127754989|NCT03841526|459727956|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
127754990|NCT03841526|459727957|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
127754991|NCT03841526|459727958|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
127754992|NCT03841526|459727959|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
127754993|NCT03841526|459727960|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
127754994|NCT03841526|459727955|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
127754995|NCT03841526|459727956|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
127754996|NCT03841526|459727957|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
127754997|NCT03841526|459727958|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
127754998|NCT03841526|459727959|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
127754999|NCT03841526|459727960|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
127755000|NCT03841526|459727955|FG000|Outpatient Phase Treatment|Physician Decision|0|||
127755001|NCT03841526|459727956|FG001|Outpatient Phase Treatment|Physician Decision|1|||
127755002|NCT03841526|459727957|FG002|Outpatient Phase Treatment|Physician Decision|0|||
127755003|NCT03841526|459727958|FG003|Outpatient Phase Treatment|Physician Decision|0|||
127755004|NCT03841526|459727959|FG004|Outpatient Phase Treatment|Physician Decision|0|||
127755005|NCT03841526|459727960|FG005|Outpatient Phase Treatment|Physician Decision|0|||
127755006|NCT03841526|459727955|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
127755007|NCT03841526|459727956|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
127755008|NCT03841526|459727957|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
127755009|NCT03841526|459727958|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
127755010|NCT03841526|459727959|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
127755011|NCT03841526|459727960|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
127755030|NCT01332630|459728911|FG000|Overall Study|Withdrawal by Subject|3|||
127755031|NCT03140280|459728912|FG000|Overall Study|Physician Decision|5|||
127755032|NCT00663702|459728923|FG000|Overall Study|Adverse Event|8|||
127755033|NCT00663702|459728924|FG001|Overall Study|Adverse Event|4|||
127755034|NCT00663702|459728923|FG000|Overall Study|Withdrawal by Subject|3|||
127755035|NCT00663702|459728924|FG001|Overall Study|Withdrawal by Subject|1|||
127755036|NCT00663702|459728923|FG000|Overall Study|Pregnancy|0|||
127755037|NCT00663702|459728924|FG001|Overall Study|Pregnancy|1|||
127755038|NCT00663702|459728923|FG000|Overall Study|Lost to Follow-up|3|||
127755039|NCT00663702|459728924|FG001|Overall Study|Lost to Follow-up|0|||
127755040|NCT00663702|459728923|FG000|Overall Study|Death|1|||
127755041|NCT00663702|459728924|FG001|Overall Study|Death|1|||
127755042|NCT00663702|459728923|FG000|Overall Study|Lack of Efficacy|3|||
127755043|NCT00663702|459728924|FG001|Overall Study|Lack of Efficacy|3|||
127755044|NCT01977677|459728925|FG000|Overall Study|Unrelated Adverse Event|0|||
127755045|NCT01977677|459728926|FG001|Overall Study|Unrelated Adverse Event|0|||
127755046|NCT01977677|459728927|FG002|Overall Study|Unrelated Adverse Event|1|||
127755047|NCT01498887|459728928|FG000|Overall Study|Administrative problems|1|||
127755048|NCT01498887|459728929|FG001|Overall Study|Administrative problems|0|||
127755049|NCT01498887|459728928|FG000|Overall Study|Lost to Follow-up|1|||
127755050|NCT01498887|459728929|FG001|Overall Study|Lost to Follow-up|1|||
127755051|NCT01498887|459728928|FG000|Overall Study|Withdrawal by Subject|1|||
127755052|NCT01498887|459728929|FG001|Overall Study|Withdrawal by Subject|0|||
127755053|NCT01498887|459728928|FG000|Overall Study|Protocol Violation|1|||
127755054|NCT01498887|459728929|FG001|Overall Study|Protocol Violation|3|||
127755055|NCT01498887|459728928|FG000|Overall Study|Lack of Efficacy|5|||
127755056|NCT01498887|459728929|FG001|Overall Study|Lack of Efficacy|3|||
127755057|NCT01498887|459728928|FG000|Overall Study|Abnormal result from test procedure|1|||
127755058|NCT01498887|459728929|FG001|Overall Study|Abnormal result from test procedure|1|||
127755059|NCT01498887|459728928|FG000|Overall Study|Abnormal laboratory value|2|||
127755060|NCT01498887|459728929|FG001|Overall Study|Abnormal laboratory value|2|||
127755061|NCT01498887|459728928|FG000|Overall Study|Adverse Event|4|||
127755062|NCT01498887|459728929|FG001|Overall Study|Adverse Event|1|||
127755063|NCT00667225|459728932|FG000|Overall Study|Subject had no more lesions to treat.|1|||
127755064|NCT00667225|459728933|FG001|Overall Study|Subject had no more lesions to treat.|0|||
127755065|NCT00667225|459728932|FG000|Overall Study|Lost to Follow-up|0|||
127755066|NCT00667225|459728933|FG001|Overall Study|Lost to Follow-up|1|||
127755067|NCT02993406|459728934|FG000|Overall Study|Withdrawal by Subject|170|||
127755068|NCT02993406|459728935|FG001|Overall Study|Withdrawal by Subject|196|||
127755069|NCT02993406|459728934|FG000|Overall Study|Physician Decision|3|||
127755070|NCT02993406|459728935|FG001|Overall Study|Physician Decision|5|||
127755071|NCT02993406|459728934|FG000|Overall Study|Lost to Follow-up|12|||
127755072|NCT02993406|459728935|FG001|Overall Study|Lost to Follow-up|13|||
127755073|NCT02993406|459728934|FG000|Overall Study|Unclassifiable Response|105|||
127755074|NCT02993406|459728935|FG001|Overall Study|Unclassifiable Response|139|||
127755075|NCT02993406|459728934|FG000|Overall Study|Administrative decision|1|||
127755076|NCT02993406|459728935|FG001|Overall Study|Administrative decision|0|||
127755077|NCT02993406|459728934|FG000|Overall Study|Sponsor decision|4|||
127755078|NCT02993406|459728935|FG001|Overall Study|Sponsor decision|5|||
127755079|NCT05262517|459728936|FG000|Overall Study|Randomized but not treated|5|||
127755080|NCT05262517|459728937|FG001|Overall Study|Randomized but not treated|11|||
127755081|NCT04325282|459728938|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
127755082|NCT04325282|459728939|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
127755083|NCT04325282|459728938|FG000|Second Intervention (1 Day)|Withdrawal by Subject|0|||
127755084|NCT04325282|459728939|FG001|Second Intervention (1 Day)|Withdrawal by Subject|1|||
127755085|NCT02672852|459728940|FG000|Part A1|Disease Worsening|1|||
127755086|NCT02672852|459728941|FG001|Part A1|Disease Worsening|0|||
127755087|NCT02672852|459728942|FG002|Part A1|Disease Worsening|0|||
127755088|NCT02672852|459728943|FG003|Part A1|Disease Worsening|0|||
127755089|NCT02672852|459728944|FG004|Part A1|Disease Worsening|0|||
127755090|NCT02672852|459728945|FG005|Part A1|Disease Worsening|0|||
127755091|NCT02672852|459728946|FG006|Part A1|Disease Worsening|0|||
127755092|NCT02672852|459728940|FG000|Part A1|Adverse Event|0|||
127755093|NCT02672852|459728941|FG001|Part A1|Adverse Event|1|||
127755094|NCT02672852|459728942|FG002|Part A1|Adverse Event|0|||
127755095|NCT02672852|459728943|FG003|Part A1|Adverse Event|0|||
127755096|NCT02672852|459728944|FG004|Part A1|Adverse Event|0|||
127755097|NCT02672852|459728945|FG005|Part A1|Adverse Event|0|||
127755098|NCT02672852|459728946|FG006|Part A1|Adverse Event|0|||
127755099|NCT02672852|459728940|FG000|Part A1|Lost to Follow-up|1|||
127755100|NCT02672852|459728941|FG001|Part A1|Lost to Follow-up|2|||
127755101|NCT02672852|459728942|FG002|Part A1|Lost to Follow-up|0|||
127755102|NCT02672852|459728943|FG003|Part A1|Lost to Follow-up|0|||
127755103|NCT02672852|459728944|FG004|Part A1|Lost to Follow-up|0|||
127755104|NCT02672852|459728945|FG005|Part A1|Lost to Follow-up|0|||
127755105|NCT02672852|459728946|FG006|Part A1|Lost to Follow-up|0|||
127755106|NCT02672852|459728940|FG000|Part A1|Withdrawal by Subject|1|||
127755107|NCT02672852|459728941|FG001|Part A1|Withdrawal by Subject|1|||
127755108|NCT02672852|459728942|FG002|Part A1|Withdrawal by Subject|0|||
127755109|NCT02672852|459728943|FG003|Part A1|Withdrawal by Subject|0|||
127755110|NCT02672852|459728944|FG004|Part A1|Withdrawal by Subject|0|||
127755111|NCT02672852|459728945|FG005|Part A1|Withdrawal by Subject|0|||
127755112|NCT02672852|459728946|FG006|Part A1|Withdrawal by Subject|0|||
127755113|NCT02672852|459728940|FG000|Part A2|Disease worsening|0|||
127755114|NCT02672852|459728941|FG001|Part A2|Disease worsening|0|||
127755115|NCT02672852|459728942|FG002|Part A2|Disease worsening|1|||
127755116|NCT02672852|459728943|FG003|Part A2|Disease worsening|0|||
127755117|NCT02672852|459728944|FG004|Part A2|Disease worsening|0|||
127755118|NCT02672852|459728945|FG005|Part A2|Disease worsening|0|||
127755119|NCT02672852|459728946|FG006|Part A2|Disease worsening|0|||
127755120|NCT02672852|459728940|FG000|Part A2|Adverse Event|0|||
127811201|NCT01307423|459926541|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
127755121|NCT02672852|459728941|FG001|Part A2|Adverse Event|0|||
127755122|NCT02672852|459728942|FG002|Part A2|Adverse Event|3|||
127755123|NCT02672852|459728943|FG003|Part A2|Adverse Event|0|||
127755124|NCT02672852|459728944|FG004|Part A2|Adverse Event|0|||
127755125|NCT02672852|459728945|FG005|Part A2|Adverse Event|0|||
127755126|NCT02672852|459728946|FG006|Part A2|Adverse Event|0|||
127755127|NCT02672852|459728940|FG000|Part A2|Lost to Follow-up|0|||
127755128|NCT02672852|459728941|FG001|Part A2|Lost to Follow-up|0|||
127811202|NCT01307423|459926533|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
127755129|NCT02672852|459728942|FG002|Part A2|Lost to Follow-up|2|||
127755130|NCT02672852|459728943|FG003|Part A2|Lost to Follow-up|0|||
127755131|NCT02672852|459728944|FG004|Part A2|Lost to Follow-up|0|||
127755132|NCT02672852|459728945|FG005|Part A2|Lost to Follow-up|0|||
127755133|NCT02672852|459728946|FG006|Part A2|Lost to Follow-up|0|||
127755134|NCT02672852|459728940|FG000|Part A2|Withdrawal by Subject|0|||
127755135|NCT02672852|459728941|FG001|Part A2|Withdrawal by Subject|0|||
127755136|NCT02672852|459728942|FG002|Part A2|Withdrawal by Subject|1|||
127755137|NCT02672852|459728943|FG003|Part A2|Withdrawal by Subject|0|||
127755138|NCT02672852|459728944|FG004|Part A2|Withdrawal by Subject|0|||
127755139|NCT02672852|459728945|FG005|Part A2|Withdrawal by Subject|0|||
127755140|NCT02672852|459728946|FG006|Part A2|Withdrawal by Subject|0|||
127755141|NCT02672852|459728940|FG000|Part A2|Other|0|||
127755142|NCT02672852|459728941|FG001|Part A2|Other|0|||
127755143|NCT02672852|459728942|FG002|Part A2|Other|3|||
127755144|NCT02672852|459728943|FG003|Part A2|Other|0|||
127755145|NCT02672852|459728944|FG004|Part A2|Other|0|||
127755146|NCT02672852|459728945|FG005|Part A2|Other|0|||
127755147|NCT02672852|459728946|FG006|Part A2|Other|0|||
127755148|NCT02672852|459728940|FG000|Part A2|Not entered in Part B|0|||
127755149|NCT02672852|459728941|FG001|Part A2|Not entered in Part B|0|||
127755150|NCT02672852|459728942|FG002|Part A2|Not entered in Part B|0|||
127755151|NCT02672852|459728943|FG003|Part A2|Not entered in Part B|4|||
127755152|NCT02672852|459728944|FG004|Part A2|Not entered in Part B|0|||
127755153|NCT02672852|459728945|FG005|Part A2|Not entered in Part B|0|||
127755154|NCT02672852|459728946|FG006|Part A2|Not entered in Part B|0|||
127755155|NCT02672852|459728940|FG000|Part B|Disease worsening|0|||
127755156|NCT02672852|459728941|FG001|Part B|Disease worsening|0|||
127755157|NCT02672852|459728942|FG002|Part B|Disease worsening|0|||
127755158|NCT02672852|459728943|FG003|Part B|Disease worsening|0|||
127755159|NCT02672852|459728944|FG004|Part B|Disease worsening|1|||
127755160|NCT02672852|459728945|FG005|Part B|Disease worsening|0|||
127755161|NCT02672852|459728946|FG006|Part B|Disease worsening|1|||
127755162|NCT02672852|459728940|FG000|Part B|Worsening pre-existing condition|0|||
127755163|NCT02672852|459728941|FG001|Part B|Worsening pre-existing condition|0|||
127755164|NCT02672852|459728942|FG002|Part B|Worsening pre-existing condition|0|||
127755165|NCT02672852|459728943|FG003|Part B|Worsening pre-existing condition|0|||
127755166|NCT02672852|459728944|FG004|Part B|Worsening pre-existing condition|0|||
127755167|NCT02672852|459728945|FG005|Part B|Worsening pre-existing condition|1|||
127755168|NCT02672852|459728946|FG006|Part B|Worsening pre-existing condition|0|||
127755169|NCT02672852|459728940|FG000|Part B|Other adverse event|0|||
127755170|NCT02672852|459728941|FG001|Part B|Other adverse event|0|||
127755171|NCT02672852|459728942|FG002|Part B|Other adverse event|0|||
127755172|NCT02672852|459728943|FG003|Part B|Other adverse event|0|||
127755173|NCT02672852|459728944|FG004|Part B|Other adverse event|3|||
127755174|NCT02672852|459728945|FG005|Part B|Other adverse event|5|||
127755175|NCT02672852|459728946|FG006|Part B|Other adverse event|1|||
127755176|NCT02672852|459728940|FG000|Part B|Lost to Follow-up|0|||
127755177|NCT02672852|459728941|FG001|Part B|Lost to Follow-up|0|||
127755178|NCT02672852|459728942|FG002|Part B|Lost to Follow-up|0|||
127755179|NCT02672852|459728943|FG003|Part B|Lost to Follow-up|0|||
127755180|NCT02672852|459728944|FG004|Part B|Lost to Follow-up|3|||
127755181|NCT02672852|459728945|FG005|Part B|Lost to Follow-up|4|||
127755182|NCT02672852|459728946|FG006|Part B|Lost to Follow-up|1|||
127755183|NCT02672852|459728940|FG000|Part B|Withdrawal by Subject|0|||
127755184|NCT02672852|459728941|FG001|Part B|Withdrawal by Subject|0|||
127755185|NCT02672852|459728942|FG002|Part B|Withdrawal by Subject|0|||
127755186|NCT02672852|459728943|FG003|Part B|Withdrawal by Subject|0|||
127755187|NCT02672852|459728944|FG004|Part B|Withdrawal by Subject|5|||
127755188|NCT02672852|459728945|FG005|Part B|Withdrawal by Subject|0|||
127755189|NCT02672852|459728946|FG006|Part B|Withdrawal by Subject|7|||
127755190|NCT02672852|459728940|FG000|Part B|Other|0|||
127755191|NCT02672852|459728941|FG001|Part B|Other|0|||
127755192|NCT02672852|459728942|FG002|Part B|Other|0|||
127755193|NCT02672852|459728943|FG003|Part B|Other|0|||
127755194|NCT02672852|459728944|FG004|Part B|Other|4|||
127755195|NCT02672852|459728945|FG005|Part B|Other|1|||
127755196|NCT02672852|459728946|FG006|Part B|Other|2|||
127755197|NCT01876901|459728948|FG000|Overall Study|Protocol Violation|10|||
127755198|NCT01876901|459728949|FG001|Overall Study|Protocol Violation|2|||
127755199|NCT01876901|459728948|FG000|Overall Study|No or other surgical intervention|7|||
127755200|NCT01876901|459728949|FG001|Overall Study|No or other surgical intervention|5|||
127755201|NCT01598662|459728950|FG000|Overall Study|Lost to Follow-up|10|||
127755202|NCT01598662|459728951|FG001|Overall Study|Lost to Follow-up|17|||
127755203|NCT01598662|459728950|FG000|Overall Study|Physician Decision|1|||
127755204|NCT01598662|459728951|FG001|Overall Study|Physician Decision|2|||
127755205|NCT01598662|459728950|FG000|Overall Study|IUD expelled before month 6|0|||
127755206|NCT01598662|459728951|FG001|Overall Study|IUD expelled before month 6|2|||
127755207|NCT00643617|459728952|FG000|Overall Study|Death|6|||
127755208|NCT00643617|459728953|FG001|Overall Study|Death|9|||
127811203|NCT01307423|459926534|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
127811204|NCT01307423|459926535|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
127755209|NCT00643617|459728952|FG000|Overall Study|Lost to Follow-up|42|||
127755210|NCT00643617|459728953|FG001|Overall Study|Lost to Follow-up|51|||
127755211|NCT02683785|459728956|FG000|Overall Study|Withdrawal by Subject|1|||
127755212|NCT02683785|459728957|FG001|Overall Study|Withdrawal by Subject|1|||
127755213|NCT02683785|459728956|FG000|Overall Study|Lost to Follow-up|0|||
127755214|NCT02683785|459728957|FG001|Overall Study|Lost to Follow-up|1|||
127755215|NCT02683785|459728956|FG000|Overall Study|Adverse Event|0|||
127755216|NCT02683785|459728957|FG001|Overall Study|Adverse Event|2|||
127755217|NCT02233803|459728962|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
127755218|NCT02233803|459728963|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
127755219|NCT02233803|459728962|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
127755220|NCT02233803|459728963|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
127755221|NCT02233803|459728962|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
127755222|NCT02233803|459728963|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
127755223|NCT02233803|459728962|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
127755224|NCT02233803|459728963|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
127811205|NCT01307423|459926536|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
127811206|NCT01307423|459926537|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
127811207|NCT01307423|459926538|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
127811208|NCT01307423|459926539|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
127811209|NCT01307423|459926540|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
127811210|NCT01307423|459926541|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
127811211|NCT01307423|459926533|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
127811212|NCT01307423|459926534|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
127811213|NCT01307423|459926535|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
127811214|NCT01307423|459926536|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
127811215|NCT01307423|459926537|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
127894312|NCT00299156|460235313|FG002|Period 2 (Randomized)|Screen Failure|0|||
127894313|NCT01564758|460235319|FG000|Overall Study|Death|8|||
127894314|NCT01564758|460235319|FG000|Overall Study|Adverse Event|3|||
127894315|NCT01564758|460235319|FG000|Overall Study|Other|3|||
127755225|NCT02233803|459728962|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
127755226|NCT02233803|459728963|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
127755227|NCT02233803|459728962|FG000|Washout Period (4-Wks)|Physician Decision|1|||
127755228|NCT02233803|459728963|FG001|Washout Period (4-Wks)|Physician Decision|0|||
127755229|NCT02233803|459728962|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
127755230|NCT02233803|459728963|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
127755231|NCT02233803|459728962|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
127755232|NCT02233803|459728963|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
127755233|NCT02233803|459728962|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
127755234|NCT02233803|459728963|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
127755235|NCT03635099|459728964|FG000|Period 1|Adverse Event|1|||
127755236|NCT03635099|459728965|FG001|Period 1|Adverse Event|0|||
127755237|NCT03635099|459728966|FG002|Period 1|Adverse Event|0|||
127755238|NCT03635099|459728967|FG003|Period 1|Adverse Event|1|||
127755239|NCT03635099|459728968|FG004|Period 1|Adverse Event|0|||
127755240|NCT03635099|459728969|FG005|Period 1|Adverse Event|0|||
127755241|NCT03635099|459728970|FG006|Period 1|Adverse Event|0|||
127755242|NCT03635099|459728971|FG007|Period 1|Adverse Event|0|||
127755243|NCT03635099|459728964|FG000|Period 1|Protocol Violation|0|||
127755244|NCT03635099|459728965|FG001|Period 1|Protocol Violation|0|||
127755245|NCT03635099|459728966|FG002|Period 1|Protocol Violation|1|||
127755246|NCT03635099|459728967|FG003|Period 1|Protocol Violation|0|||
127755247|NCT03635099|459728968|FG004|Period 1|Protocol Violation|0|||
127755248|NCT03635099|459728969|FG005|Period 1|Protocol Violation|0|||
127755249|NCT03635099|459728970|FG006|Period 1|Protocol Violation|0|||
127755250|NCT03635099|459728971|FG007|Period 1|Protocol Violation|0|||
127755251|NCT03635099|459728964|FG000|Period 1|Lost to Follow-up|0|||
127755252|NCT03635099|459728965|FG001|Period 1|Lost to Follow-up|0|||
127755253|NCT03635099|459728966|FG002|Period 1|Lost to Follow-up|1|||
127755254|NCT03635099|459728967|FG003|Period 1|Lost to Follow-up|2|||
127755255|NCT03635099|459728968|FG004|Period 1|Lost to Follow-up|1|||
127755256|NCT03635099|459728969|FG005|Period 1|Lost to Follow-up|0|||
127755257|NCT03635099|459728970|FG006|Period 1|Lost to Follow-up|1|||
127755258|NCT03635099|459728971|FG007|Period 1|Lost to Follow-up|2|||
127755259|NCT03635099|459728964|FG000|Period 1|Withdrawal by Subject|3|||
127755260|NCT03635099|459728965|FG001|Period 1|Withdrawal by Subject|3|||
127755261|NCT03635099|459728966|FG002|Period 1|Withdrawal by Subject|5|||
127755262|NCT03635099|459728967|FG003|Period 1|Withdrawal by Subject|2|||
127755263|NCT03635099|459728968|FG004|Period 1|Withdrawal by Subject|2|||
127894316|NCT02482571|460235320|FG000|Overall Study|Adverse Event|1|||
127894317|NCT02482571|460235320|FG000|Overall Study|Scanner or Respiract failure|3|||
127894318|NCT02482571|460235320|FG000|Overall Study|Withdrawal by Subject|4|||
127894319|NCT01446913|460235321|FG000|Overall Study|Significant illness|1|||
127894320|NCT01446913|460235322|FG001|Overall Study|Significant illness|1|||
127755264|NCT03635099|459728969|FG005|Period 1|Withdrawal by Subject|0|||
127894321|NCT01446913|460235323|FG002|Overall Study|Significant illness|1|||
127755265|NCT03635099|459728970|FG006|Period 1|Withdrawal by Subject|3|||
127755266|NCT03635099|459728971|FG007|Period 1|Withdrawal by Subject|0|||
127755267|NCT03635099|459728964|FG000|Period 1|History of suicidal ideation|0|||
127894322|NCT01446913|460235321|FG000|Overall Study|Withdrawal by Subject|5|||
127894323|NCT01446913|460235322|FG001|Overall Study|Withdrawal by Subject|3|||
127755268|NCT03635099|459728965|FG001|Period 1|History of suicidal ideation|0|||
127894324|NCT01446913|460235323|FG002|Overall Study|Withdrawal by Subject|5|||
127755269|NCT03635099|459728966|FG002|Period 1|History of suicidal ideation|1|||
127755270|NCT03635099|459728967|FG003|Period 1|History of suicidal ideation|0|||
127755271|NCT03635099|459728968|FG004|Period 1|History of suicidal ideation|0|||
127755272|NCT03635099|459728969|FG005|Period 1|History of suicidal ideation|0|||
127755273|NCT03635099|459728970|FG006|Period 1|History of suicidal ideation|0|||
127755274|NCT03635099|459728971|FG007|Period 1|History of suicidal ideation|0|||
127755275|NCT03635099|459728964|FG000|Period 1|pursue other treatment options|0|||
127755276|NCT03635099|459728965|FG001|Period 1|pursue other treatment options|0|||
127755277|NCT03635099|459728966|FG002|Period 1|pursue other treatment options|0|||
127755278|NCT03635099|459728967|FG003|Period 1|pursue other treatment options|0|||
127755279|NCT03635099|459728968|FG004|Period 1|pursue other treatment options|0|||
127755280|NCT03635099|459728969|FG005|Period 1|pursue other treatment options|1|||
127755281|NCT03635099|459728970|FG006|Period 1|pursue other treatment options|0|||
127755282|NCT03635099|459728971|FG007|Period 1|pursue other treatment options|0|||
127755283|NCT03635099|459728964|FG000|Not Eligible for Period 2|Pregnancy|0|||
127755284|NCT03635099|459728965|FG001|Not Eligible for Period 2|Pregnancy|0|||
127755285|NCT03635099|459728966|FG002|Not Eligible for Period 2|Pregnancy|0|||
127755286|NCT03635099|459728967|FG003|Not Eligible for Period 2|Pregnancy|1|||
127755287|NCT03635099|459728968|FG004|Not Eligible for Period 2|Pregnancy|0|||
127755288|NCT03635099|459728969|FG005|Not Eligible for Period 2|Pregnancy|0|||
127755289|NCT03635099|459728970|FG006|Not Eligible for Period 2|Pregnancy|0|||
127755290|NCT03635099|459728971|FG007|Not Eligible for Period 2|Pregnancy|0|||
127755291|NCT03635099|459728964|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
127755292|NCT03635099|459728965|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
127755293|NCT03635099|459728966|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
127755294|NCT03635099|459728967|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
127755295|NCT03635099|459728968|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
127755296|NCT03635099|459728969|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
127755297|NCT03635099|459728970|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
127755298|NCT03635099|459728971|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
127755299|NCT03635099|459728964|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
127755300|NCT03635099|459728965|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
127755301|NCT03635099|459728966|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
127755302|NCT03635099|459728967|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
127755303|NCT03635099|459728968|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
127755304|NCT03635099|459728969|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
127755305|NCT03635099|459728970|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
127755306|NCT03635099|459728971|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
127755307|NCT03635099|459728964|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
127755308|NCT03635099|459728965|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
127755309|NCT03635099|459728966|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
127755310|NCT03635099|459728967|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
127755311|NCT03635099|459728968|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
127755312|NCT03635099|459728969|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
127811216|NCT01307423|459926538|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
127811217|NCT01307423|459926539|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
127811218|NCT01307423|459926540|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
127811219|NCT01307423|459926541|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
127811220|NCT01307423|459926533|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
127811221|NCT01307423|459926534|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
127811222|NCT01307423|459926535|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
127811223|NCT01307423|459926536|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
127811224|NCT01307423|459926537|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
127811225|NCT01307423|459926538|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
127811226|NCT01307423|459926539|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
127811227|NCT01307423|459926540|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
127811228|NCT01307423|459926541|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
127811229|NCT01307423|459926533|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
127811230|NCT01307423|459926534|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
127811231|NCT01307423|459926535|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
127811232|NCT01307423|459926536|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
127811233|NCT01307423|459926537|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
127811234|NCT01307423|459926538|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
127811235|NCT01307423|459926539|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
127811236|NCT01307423|459926540|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
127811237|NCT01307423|459926541|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
127755313|NCT03635099|459728970|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
127755314|NCT03635099|459728971|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
127755315|NCT03635099|459728964|FG000|Period 2|Adverse Event|0|||
127755316|NCT03635099|459728965|FG001|Period 2|Adverse Event|0|||
127755317|NCT03635099|459728966|FG002|Period 2|Adverse Event|1|||
127755318|NCT03635099|459728967|FG003|Period 2|Adverse Event|0|||
127755319|NCT03635099|459728968|FG004|Period 2|Adverse Event|1|||
127755320|NCT03635099|459728969|FG005|Period 2|Adverse Event|0|||
127755321|NCT03635099|459728970|FG006|Period 2|Adverse Event|0|||
127755322|NCT03635099|459728971|FG007|Period 2|Adverse Event|0|||
127755323|NCT03635099|459728964|FG000|Period 2|Lost to Follow-up|0|||
127755324|NCT03635099|459728965|FG001|Period 2|Lost to Follow-up|0|||
127755325|NCT03635099|459728966|FG002|Period 2|Lost to Follow-up|1|||
127755326|NCT03635099|459728967|FG003|Period 2|Lost to Follow-up|0|||
127755327|NCT03635099|459728968|FG004|Period 2|Lost to Follow-up|4|||
127755328|NCT03635099|459728969|FG005|Period 2|Lost to Follow-up|0|||
127755329|NCT03635099|459728970|FG006|Period 2|Lost to Follow-up|0|||
127755330|NCT03635099|459728971|FG007|Period 2|Lost to Follow-up|0|||
127755331|NCT03635099|459728964|FG000|Period 2|Withdrawal by Subject|0|||
127755332|NCT03635099|459728965|FG001|Period 2|Withdrawal by Subject|0|||
127755333|NCT03635099|459728966|FG002|Period 2|Withdrawal by Subject|7|||
127755334|NCT03635099|459728967|FG003|Period 2|Withdrawal by Subject|4|||
127755335|NCT03635099|459728968|FG004|Period 2|Withdrawal by Subject|7|||
127755336|NCT03635099|459728969|FG005|Period 2|Withdrawal by Subject|0|||
127755337|NCT03635099|459728970|FG006|Period 2|Withdrawal by Subject|0|||
127755338|NCT03635099|459728971|FG007|Period 2|Withdrawal by Subject|0|||
127755339|NCT04191616|459728974|FG000|Pre-assignment Period|Did not receive study treatment|2|||
127755340|NCT04191616|459728974|FG000|Treatment Period|Death|37|||
127755341|NCT04191616|459728974|FG000|Treatment Period|Sponsor decision|11|||
127755342|NCT04191616|459728974|FG000|Treatment Period|Withdrawal by Subject|4|||
127755343|NCT02180243|459728975|FG000|Overall Study|Withdrawal by Subject|12|||
127755344|NCT02180243|459728976|FG001|Overall Study|Withdrawal by Subject|12|||
127755345|NCT02180243|459728975|FG000|Overall Study|Lost to Follow-up|12|||
127755346|NCT02180243|459728976|FG001|Overall Study|Lost to Follow-up|2|||
127755347|NCT01840410|459728980|FG000|Overall Study|Physician Decision|1|||
127755348|NCT01840410|459728981|FG001|Overall Study|Physician Decision|2|||
127755349|NCT01840410|459728980|FG000|Overall Study|Pregnancy|1|||
127755350|NCT01840410|459728981|FG001|Overall Study|Pregnancy|0|||
127755351|NCT01840410|459728980|FG000|Overall Study|Protocol deviation|1|||
127755352|NCT01840410|459728981|FG001|Overall Study|Protocol deviation|0|||
127755353|NCT01840410|459728980|FG000|Overall Study|Lost to Follow-up|1|||
127755354|NCT01840410|459728981|FG001|Overall Study|Lost to Follow-up|0|||
127755355|NCT01840410|459728980|FG000|Overall Study|Withdrawal by Subject|2|||
127755356|NCT01840410|459728981|FG001|Overall Study|Withdrawal by Subject|1|||
127755357|NCT01840410|459728980|FG000|Overall Study|Adverse Event|1|||
127755358|NCT01840410|459728981|FG001|Overall Study|Adverse Event|1|||
127755359|NCT05235269|459728992|FG000|Overall Study|Adverse Event|1|||
127755360|NCT05235269|459728992|FG000|Overall Study|Participant elected to drop out (i.e., not undergo second scan) but did not withdraw consent|1|||
127755361|NCT05235269|459728992|FG000|Overall Study|Protocol-specified withdrawal criterion met|5|||
127755362|NCT00798434|459728993|FG000|Double-Blind|Adverse Event|22|||
127755363|NCT00798434|459728994|FG001|Double-Blind|Adverse Event|46|||
127755364|NCT00798434|459728993|FG000|Double-Blind|Death|0|||
127755365|NCT00798434|459728994|FG001|Double-Blind|Death|1|||
127755366|NCT00798434|459728993|FG000|Double-Blind|Lost to Follow-up|1|||
127755367|NCT00798434|459728994|FG001|Double-Blind|Lost to Follow-up|0|||
127755368|NCT00798434|459728993|FG000|Double-Blind|Lack of Efficacy|8|||
127755369|NCT00798434|459728994|FG001|Double-Blind|Lack of Efficacy|12|||
127755370|NCT00798434|459728993|FG000|Double-Blind|Withdrawal by Subject|17|||
127755371|NCT00798434|459728994|FG001|Double-Blind|Withdrawal by Subject|14|||
127755372|NCT00798434|459728993|FG000|Double-Blind|Protocol Violation|1|||
127755373|NCT00798434|459728994|FG001|Double-Blind|Protocol Violation|4|||
127755374|NCT00798434|459728993|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
127755375|NCT00798434|459728994|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
127755376|NCT00798434|459728993|FG000|Double-Blind|Other|1|||
127755377|NCT00798434|459728994|FG001|Double-Blind|Other|0|||
127755378|NCT00798434|459728993|FG000|Double-Blind|Not Treated|3|||
127755379|NCT00798434|459728994|FG001|Double-Blind|Not Treated|6|||
127755380|NCT00798434|459728993|FG000|Open-Label|Adverse Event|33|||
127755381|NCT00798434|459728994|FG001|Open-Label|Adverse Event|11|||
127755382|NCT00798434|459728993|FG000|Open-Label|Lack of Efficacy|5|||
127755383|NCT00798434|459728994|FG001|Open-Label|Lack of Efficacy|11|||
127755384|NCT00798434|459728993|FG000|Open-Label|Withdrawal by Subject|2|||
127755385|NCT00798434|459728994|FG001|Open-Label|Withdrawal by Subject|7|||
127755386|NCT00798434|459728993|FG000|Open-Label|Protocol Violation|1|||
127755387|NCT00798434|459728994|FG001|Open-Label|Protocol Violation|0|||
127755388|NCT00798434|459728993|FG000|Open-Label|Other|1|||
127755389|NCT00798434|459728994|FG001|Open-Label|Other|2|||
127755390|NCT00798434|459728993|FG000|Open-Label|Not Treated|0|||
127755391|NCT00798434|459728994|FG001|Open-Label|Not Treated|1|||
127755392|NCT03898167|459728995|FG000|Overall Study|Terminated phone call early|7|||
127755393|NCT03898167|459728996|FG001|Overall Study|Terminated phone call early|0|||
127894325|NCT01446913|460235321|FG000|Overall Study|Physician Decision|0|||
127755394|NCT03898167|459728997|FG002|Overall Study|Terminated phone call early|0|||
127755395|NCT03898167|459728995|FG000|Overall Study|Terminated phone call early or requested to not receive a kit|0|||
127755396|NCT03898167|459728996|FG001|Overall Study|Terminated phone call early or requested to not receive a kit|91|||
127755397|NCT03898167|459728997|FG002|Overall Study|Terminated phone call early or requested to not receive a kit|103|||
127755398|NCT05177354|459728998|FG000|Implant to 30-day Visit|Physician Decision|1|||
127755399|NCT05177354|459728998|FG000|Implant to 30-day Visit|Withdrawal by Subject|1|||
127755400|NCT05177354|459728998|FG000|Implant to 30-day Visit|Lack of compliance to the protocol including phone calls & optimisation visits.|1|||
127755401|NCT05177354|459728998|FG000|30-day Visit to 3-Month Visit|Adverse Event|1|||
127755402|NCT03548220|459729000|FG000|Overall Study|Lost to Follow-up|1|||
127755403|NCT03548220|459729001|FG001|Overall Study|Lost to Follow-up|0|||
127755404|NCT03548220|459729002|FG002|Overall Study|Lost to Follow-up|0|||
127755405|NCT03548220|459729003|FG003|Overall Study|Lost to Follow-up|0|||
127755406|NCT03570892|459729004|FG000|Overall Study|Death|51|||
127755407|NCT03570892|459729005|FG001|Overall Study|Death|45|||
127755408|NCT03570892|459729004|FG000|Overall Study|Subject decision|5|||
127755409|NCT03570892|459729005|FG001|Overall Study|Subject decision|3|||
127755410|NCT03570892|459729004|FG000|Overall Study|Protocol Violation|1|||
127755411|NCT03570892|459729005|FG001|Overall Study|Protocol Violation|4|||
127755412|NCT03570892|459729004|FG000|Overall Study|Physician Decision|0|||
127755413|NCT03570892|459729005|FG001|Overall Study|Physician Decision|2|||
127755414|NCT06748729|459729010|FG000|Overall Study|Withdrawal by Subject|1|||
127755415|NCT01099215|459730519|FG000|Overall Study|Withdrawal by Subject|1|||
127755416|NCT01099215|459730520|FG001|Overall Study|Withdrawal by Subject|0|||
127755417|NCT01099215|459730519|FG000|Overall Study|Adverse Event|0|||
127755418|NCT01099215|459730520|FG001|Overall Study|Adverse Event|1|||
127755419|NCT00747227|459730522|FG000|Overall Study|Death|3|||
127755420|NCT00747227|459730523|FG001|Overall Study|Death|1|||
127755421|NCT00747227|459730522|FG000|Overall Study|Withdrawal by Subject|1|||
127755422|NCT00747227|459730523|FG001|Overall Study|Withdrawal by Subject|0|||
127755423|NCT00747227|459730522|FG000|Overall Study|Lost to Follow-up|1|||
127755424|NCT00747227|459730523|FG001|Overall Study|Lost to Follow-up|2|||
127755425|NCT00747227|459730522|FG000|Overall Study|Illness|1|||
127755426|NCT00747227|459730523|FG001|Overall Study|Illness|1|||
127755427|NCT03554629|459730524|FG000|Overall Study|Inadequate data|6|||
127755428|NCT00515671|459730531|FG000|Overall Study|Lost to Follow-up|13|||
127755429|NCT00515671|459730532|FG001|Overall Study|Lost to Follow-up|10|||
127755430|NCT00515671|459730531|FG000|Overall Study|Withdrawal by Subject|3|||
127755431|NCT00515671|459730532|FG001|Overall Study|Withdrawal by Subject|5|||
127755432|NCT00515671|459730531|FG000|Overall Study|incarcerated|1|||
127755433|NCT00515671|459730532|FG001|Overall Study|incarcerated|2|||
127755434|NCT00288639|459730535|FG000|Overall Study|Adverse Event|5|||
127755435|NCT00288639|459730535|FG000|Overall Study|Lack of Efficacy|4|||
127755436|NCT00288639|459730535|FG000|Overall Study|Withdrawal by Subject|2|||
127755437|NCT00288639|459730535|FG000|Overall Study|Other|1|||
127755438|NCT01014208|459730544|FG000|Overall Study|Lost to Follow-up|2|||
127755439|NCT01014208|459730545|FG001|Overall Study|Lost to Follow-up|5|||
127755440|NCT01014208|459730544|FG000|Overall Study|Participant Withdrew Consent|12|||
127755441|NCT01014208|459730545|FG001|Overall Study|Participant Withdrew Consent|12|||
127755442|NCT01014208|459730544|FG000|Overall Study|Did Not Receive Study Drug|2|||
127755443|NCT01014208|459730545|FG001|Overall Study|Did Not Receive Study Drug|0|||
127755444|NCT01014208|459730544|FG000|Overall Study|Study Closed/terminated|78|||
127755445|NCT01014208|459730545|FG001|Overall Study|Study Closed/terminated|83|||
127755446|NCT04165031|459730546|FG000|Overall Study|Adverse Event|1|||
127755447|NCT04165031|459730547|FG001|Overall Study|Adverse Event|1|||
127755448|NCT04165031|459730548|FG002|Overall Study|Adverse Event|0|||
127755449|NCT04165031|459730549|FG003|Overall Study|Adverse Event|0|||
127755450|NCT04165031|459730550|FG004|Overall Study|Adverse Event|0|||
127755451|NCT04165031|459730551|FG005|Overall Study|Adverse Event|0|||
127755452|NCT04165031|459730546|FG000|Overall Study|Withdrawal by Subject|0|||
127755453|NCT04165031|459730547|FG001|Overall Study|Withdrawal by Subject|0|||
127755454|NCT04165031|459730548|FG002|Overall Study|Withdrawal by Subject|1|||
127755455|NCT04165031|459730549|FG003|Overall Study|Withdrawal by Subject|0|||
127755456|NCT04165031|459730550|FG004|Overall Study|Withdrawal by Subject|0|||
127755457|NCT04165031|459730551|FG005|Overall Study|Withdrawal by Subject|0|||
127755458|NCT02248818|459730556|FG000|Screening|Protocol Violation|0|||
127755459|NCT02248818|459730557|FG001|Screening|Protocol Violation|0|||
127755460|NCT02248818|459730558|FG002|Screening|Protocol Violation|0|||
127755461|NCT02248818|459730559|FG003|Screening|Protocol Violation|0|||
127755462|NCT02248818|459730560|FG004|Screening|Protocol Violation|0|||
127755463|NCT02248818|459730561|FG005|Screening|Protocol Violation|0|||
127755464|NCT02248818|459730562|FG006|Screening|Protocol Violation|0|||
127755465|NCT02248818|459730563|FG007|Screening|Protocol Violation|0|||
127755466|NCT02248818|459730564|FG008|Screening|Protocol Violation|7|||
127755467|NCT02248818|459730556|FG000|Screening|Study fully enrolled|0|||
127811238|NCT01307423|459926533|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
127811239|NCT01307423|459926534|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
127811240|NCT01307423|459926535|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
127755468|NCT02248818|459730557|FG001|Screening|Study fully enrolled|0|||
127755469|NCT02248818|459730558|FG002|Screening|Study fully enrolled|0|||
127755470|NCT02248818|459730559|FG003|Screening|Study fully enrolled|0|||
127755471|NCT02248818|459730560|FG004|Screening|Study fully enrolled|0|||
127755472|NCT02248818|459730561|FG005|Screening|Study fully enrolled|0|||
127755473|NCT02248818|459730562|FG006|Screening|Study fully enrolled|0|||
127755474|NCT02248818|459730563|FG007|Screening|Study fully enrolled|0|||
127755475|NCT02248818|459730564|FG008|Screening|Study fully enrolled|14|||
127755476|NCT02248818|459730556|FG000|Screening|Physician Decision|0|||
127755477|NCT02248818|459730557|FG001|Screening|Physician Decision|0|||
127755478|NCT02248818|459730558|FG002|Screening|Physician Decision|0|||
127755479|NCT02248818|459730559|FG003|Screening|Physician Decision|0|||
127755480|NCT02248818|459730560|FG004|Screening|Physician Decision|0|||
127755481|NCT02248818|459730561|FG005|Screening|Physician Decision|0|||
127755482|NCT02248818|459730562|FG006|Screening|Physician Decision|0|||
127755483|NCT02248818|459730563|FG007|Screening|Physician Decision|0|||
127755484|NCT02248818|459730564|FG008|Screening|Physician Decision|73|||
127755485|NCT02248818|459730556|FG000|Screening|Withdrawal by Subject|0|||
127755486|NCT02248818|459730557|FG001|Screening|Withdrawal by Subject|0|||
127755487|NCT02248818|459730558|FG002|Screening|Withdrawal by Subject|0|||
127755488|NCT02248818|459730559|FG003|Screening|Withdrawal by Subject|0|||
127755489|NCT02248818|459730560|FG004|Screening|Withdrawal by Subject|0|||
127755490|NCT02248818|459730561|FG005|Screening|Withdrawal by Subject|0|||
127755491|NCT02248818|459730562|FG006|Screening|Withdrawal by Subject|0|||
127811241|NCT01307423|459926536|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
127811242|NCT01307423|459926537|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
127811243|NCT01307423|459926538|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
127811244|NCT01307423|459926539|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
127811245|NCT01307423|459926540|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
127811246|NCT01307423|459926541|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
127811247|NCT01307423|459926533|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
127811248|NCT01307423|459926534|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
127811249|NCT01307423|459926535|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
127811250|NCT01307423|459926536|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
127811251|NCT01307423|459926537|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
127811252|NCT01307423|459926538|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
127811253|NCT01307423|459926539|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
127811254|NCT01307423|459926540|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
127811255|NCT01307423|459926541|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
127811256|NCT01307423|459926533|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
127811257|NCT01307423|459926534|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
127811258|NCT01307423|459926535|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
127811259|NCT01307423|459926536|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
127811260|NCT01307423|459926537|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
127811261|NCT01307423|459926538|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
127811262|NCT01307423|459926539|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
127755492|NCT02248818|459730563|FG007|Screening|Withdrawal by Subject|0|||
127755493|NCT02248818|459730564|FG008|Screening|Withdrawal by Subject|6|||
127755494|NCT02248818|459730556|FG000|Screening|Lost to Follow-up|0|||
127755495|NCT02248818|459730557|FG001|Screening|Lost to Follow-up|0|||
127755496|NCT02248818|459730558|FG002|Screening|Lost to Follow-up|0|||
127755497|NCT02248818|459730559|FG003|Screening|Lost to Follow-up|0|||
127811263|NCT01307423|459926540|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
127811264|NCT01307423|459926541|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
127811265|NCT01307423|459926533|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
127811266|NCT01307423|459926534|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
127811267|NCT01307423|459926535|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
127811268|NCT01307423|459926536|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
127811269|NCT01307423|459926537|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
127811270|NCT01307423|459926538|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
127811271|NCT01307423|459926539|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
127811272|NCT01307423|459926540|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
127811273|NCT01307423|459926541|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
127811274|NCT01307423|459926533|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
127811275|NCT01307423|459926534|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
127894326|NCT01446913|460235322|FG001|Overall Study|Physician Decision|0|||
127894327|NCT01446913|460235323|FG002|Overall Study|Physician Decision|2|||
127894328|NCT01446913|460235321|FG000|Overall Study|Lost to Follow-up|3|||
127894329|NCT01446913|460235322|FG001|Overall Study|Lost to Follow-up|5|||
127894330|NCT01446913|460235323|FG002|Overall Study|Lost to Follow-up|3|||
127755498|NCT02248818|459730560|FG004|Screening|Lost to Follow-up|0|||
127755499|NCT02248818|459730561|FG005|Screening|Lost to Follow-up|0|||
127755500|NCT02248818|459730562|FG006|Screening|Lost to Follow-up|0|||
127755501|NCT02248818|459730563|FG007|Screening|Lost to Follow-up|0|||
127894331|NCT00745251|460235324|FG000|Overall Study|Adverse Event|1|||
127894332|NCT00745251|460235325|FG001|Overall Study|Adverse Event|2|||
127894333|NCT00745251|460235324|FG000|Overall Study|Withdrawal by Subject|1|||
127894334|NCT00745251|460235325|FG001|Overall Study|Withdrawal by Subject|1|||
127894335|NCT01618305|460235327|FG000|Overall Study|Death|0|||
127894336|NCT01618305|460235328|FG001|Overall Study|Death|1|||
127894337|NCT01618305|460235327|FG000|Overall Study|Lost to Follow-up|11|||
127894338|NCT01618305|460235328|FG001|Overall Study|Lost to Follow-up|7|||
127894339|NCT01618305|460235327|FG000|Overall Study|Protocol Violation|1|||
127894340|NCT01618305|460235328|FG001|Overall Study|Protocol Violation|0|||
127894341|NCT01618305|460235327|FG000|Overall Study|Withdrawal by Subject|3|||
127894342|NCT01618305|460235328|FG001|Overall Study|Withdrawal by Subject|2|||
127894343|NCT02708277|460235329|FG000|Overall Study|Lost to Follow-up|7|||
127894344|NCT02708277|460235330|FG001|Overall Study|Lost to Follow-up|4|||
127894345|NCT01960816|460235331|FG000|Overall Study|Lost to Follow-up|1|||
127894346|NCT01118728|460235332|FG000|Overall Study|Adverse Event|17|||
127894347|NCT01118728|460235332|FG000|Overall Study|Lack of Efficacy|27|||
127894348|NCT01118728|460235332|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
127894349|NCT01118728|460235332|FG000|Overall Study|Withdrawal by Subject|3|||
127894350|NCT01118728|460235332|FG000|Overall Study|Lost to Follow-up|4|||
127894351|NCT00385541|460235333|FG000|Overall Study|severe pain, clinician requested unblind|0|||
127894352|NCT00385541|460235334|FG001|Overall Study|severe pain, clinician requested unblind|1|||
127894353|NCT00929708|460235335|FG000|Overall Study|Protocol Violation|2|||
127894354|NCT00929708|460235336|FG001|Overall Study|Protocol Violation|1|||
127894355|NCT00929708|460235337|FG002|Overall Study|Protocol Violation|1|||
127894356|NCT00929708|460235338|FG003|Overall Study|Protocol Violation|1|||
127894357|NCT00929708|460235339|FG004|Overall Study|Protocol Violation|1|||
127894358|NCT00929708|460235335|FG000|Overall Study|Withdrawal by Subject|2|||
127894359|NCT00929708|460235336|FG001|Overall Study|Withdrawal by Subject|0|||
127894360|NCT00929708|460235337|FG002|Overall Study|Withdrawal by Subject|0|||
127755502|NCT02248818|459730564|FG008|Screening|Lost to Follow-up|7|||
127755503|NCT02248818|459730556|FG000|Randomised Study|Administrative - randomization error|0|||
127755504|NCT02248818|459730557|FG001|Randomised Study|Administrative - randomization error|0|||
127755505|NCT02248818|459730558|FG002|Randomised Study|Administrative - randomization error|0|||
127755506|NCT02248818|459730559|FG003|Randomised Study|Administrative - randomization error|0|||
127755507|NCT02248818|459730560|FG004|Randomised Study|Administrative - randomization error|0|||
127755508|NCT02248818|459730561|FG005|Randomised Study|Administrative - randomization error|8|||
127755509|NCT02248818|459730562|FG006|Randomised Study|Administrative - randomization error|0|||
127755510|NCT02248818|459730563|FG007|Randomised Study|Administrative - randomization error|0|||
127755511|NCT02248818|459730564|FG008|Randomised Study|Administrative - randomization error|0|||
127755512|NCT01283152|459730568|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
127894361|NCT00929708|460235338|FG003|Overall Study|Withdrawal by Subject|2|||
127755513|NCT01283152|459730569|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
127894362|NCT00929708|460235339|FG004|Overall Study|Withdrawal by Subject|1|||
127894363|NCT00929708|460235335|FG000|Overall Study|Adverse Event|0|||
127894364|NCT00929708|460235336|FG001|Overall Study|Adverse Event|0|||
127894365|NCT00929708|460235337|FG002|Overall Study|Adverse Event|0|||
127894366|NCT00929708|460235338|FG003|Overall Study|Adverse Event|0|||
127894367|NCT00929708|460235339|FG004|Overall Study|Adverse Event|3|||
127894368|NCT00929708|460235335|FG000|Overall Study|Physician Decision|0|||
127755514|NCT01283152|459730568|FG000|Overall Study|Refused HESA|1|||
127755515|NCT01283152|459730569|FG001|Overall Study|Refused HESA|0|||
127755516|NCT04020185|459730574|FG000|Overall Study|Death|0|||
127755517|NCT04020185|459730575|FG001|Overall Study|Death|0|||
127755518|NCT04020185|459730576|FG002|Overall Study|Death|1|||
127755519|NCT04020185|459730577|FG003|Overall Study|Death|2|||
127755520|NCT04020185|459730578|FG004|Overall Study|Death|1|||
127755521|NCT04020185|459730579|FG005|Overall Study|Death|0|||
127755522|NCT04020185|459730580|FG006|Overall Study|Death|1|||
127755523|NCT04020185|459730581|FG007|Overall Study|Death|0|||
127755524|NCT04020185|459730574|FG000|Overall Study|Consent withdrawn|1|||
127755525|NCT04020185|459730575|FG001|Overall Study|Consent withdrawn|0|||
127755526|NCT04020185|459730576|FG002|Overall Study|Consent withdrawn|0|||
127755527|NCT04020185|459730577|FG003|Overall Study|Consent withdrawn|0|||
127755528|NCT04020185|459730578|FG004|Overall Study|Consent withdrawn|2|||
127755529|NCT04020185|459730579|FG005|Overall Study|Consent withdrawn|0|||
127755530|NCT04020185|459730580|FG006|Overall Study|Consent withdrawn|1|||
127755531|NCT04020185|459730581|FG007|Overall Study|Consent withdrawn|1|||
127755532|NCT04020185|459730574|FG000|Overall Study|Patient in hospice|0|||
127755533|NCT04020185|459730575|FG001|Overall Study|Patient in hospice|1|||
127755534|NCT04020185|459730576|FG002|Overall Study|Patient in hospice|0|||
127755535|NCT04020185|459730577|FG003|Overall Study|Patient in hospice|0|||
127755536|NCT04020185|459730578|FG004|Overall Study|Patient in hospice|0|||
127755537|NCT04020185|459730579|FG005|Overall Study|Patient in hospice|0|||
127755538|NCT04020185|459730580|FG006|Overall Study|Patient in hospice|0|||
127755539|NCT04020185|459730581|FG007|Overall Study|Patient in hospice|0|||
127755540|NCT04020185|459730574|FG000|Overall Study|Continuing on expanded access|0|||
127755541|NCT04020185|459730575|FG001|Overall Study|Continuing on expanded access|0|||
127755542|NCT04020185|459730576|FG002|Overall Study|Continuing on expanded access|0|||
127755543|NCT04020185|459730577|FG003|Overall Study|Continuing on expanded access|0|||
127755544|NCT04020185|459730578|FG004|Overall Study|Continuing on expanded access|0|||
127811276|NCT01307423|459926535|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
127811277|NCT01307423|459926536|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
127811278|NCT01307423|459926537|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
127811279|NCT01307423|459926538|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
127811280|NCT01307423|459926539|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
127811281|NCT01307423|459926540|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
127811282|NCT01307423|459926541|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
127811283|NCT01307423|459926533|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
127811284|NCT01307423|459926534|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
127811285|NCT01307423|459926535|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
127811286|NCT01307423|459926536|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
127811287|NCT01307423|459926537|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
127811288|NCT01307423|459926538|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
127811289|NCT01307423|459926539|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
127811290|NCT01307423|459926540|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
127811291|NCT01307423|459926541|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
127811292|NCT01307423|459926533|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
127811293|NCT01307423|459926534|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
127811294|NCT01307423|459926535|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
127811295|NCT01307423|459926536|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
127811296|NCT01307423|459926537|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
127811297|NCT01307423|459926538|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
127811298|NCT01307423|459926539|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
127755545|NCT04020185|459730579|FG005|Overall Study|Continuing on expanded access|0|||
127755546|NCT04020185|459730580|FG006|Overall Study|Continuing on expanded access|1|||
127755547|NCT04020185|459730581|FG007|Overall Study|Continuing on expanded access|1|||
127755548|NCT00527787|459730583|FG000|Overall Study|Adverse Event|14|||
127755549|NCT00527787|459730584|FG001|Overall Study|Adverse Event|24|||
127755550|NCT00527787|459730583|FG000|Overall Study|Withdrawal by Subject|13|||
127755551|NCT00527787|459730584|FG001|Overall Study|Withdrawal by Subject|25|||
127755552|NCT00527787|459730583|FG000|Overall Study|Lost to Follow-up|5|||
127755553|NCT00527787|459730584|FG001|Overall Study|Lost to Follow-up|2|||
127755554|NCT00527787|459730583|FG000|Overall Study|Duodenal Ulcer|1|||
127755555|NCT00527787|459730584|FG001|Overall Study|Duodenal Ulcer|10|||
127755556|NCT00527787|459730583|FG000|Overall Study|misc|5|||
127755557|NCT00527787|459730584|FG001|Overall Study|misc|2|||
127755558|NCT03433677|459730585|FG000|Period 1|Protocol Violation|1|||
127811299|NCT01307423|459926540|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
127755559|NCT03433677|459730586|FG001|Period 1|Protocol Violation|0|||
127811300|NCT01307423|459926541|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
127811301|NCT01307423|459926533|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
127811302|NCT01307423|459926534|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
127755560|NCT03433677|459730585|FG000|Period 2|Withdrawal by Subject|1|||
127755561|NCT03433677|459730586|FG001|Period 2|Withdrawal by Subject|1|||
127755562|NCT03330405|459730587|FG000|Overall Study|Other|1|||
127755563|NCT03330405|459730588|FG001|Overall Study|Other|3|||
127755564|NCT03330405|459730589|FG002|Overall Study|Other|1|||
127755565|NCT03330405|459730590|FG003|Overall Study|Other|0|||
127755566|NCT03330405|459730591|FG004|Overall Study|Other|2|||
127755567|NCT03330405|459730592|FG005|Overall Study|Other|0|||
127755568|NCT03330405|459730593|FG006|Overall Study|Other|1|||
127755569|NCT03330405|459730594|FG007|Overall Study|Other|0|||
127755570|NCT03330405|459730595|FG008|Overall Study|Other|0|||
127755571|NCT03330405|459730596|FG009|Overall Study|Other|0|||
127755572|NCT03330405|459730597|FG010|Overall Study|Other|0|||
127755573|NCT03330405|459730587|FG000|Overall Study|Progressive disease|8|||
127811303|NCT01307423|459926535|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
127811304|NCT01307423|459926536|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
127811305|NCT01307423|459926537|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
127811306|NCT01307423|459926538|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
127811307|NCT01307423|459926539|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
127811308|NCT01307423|459926540|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
127811309|NCT01307423|459926541|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
127811310|NCT01307423|459926533|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
127811311|NCT01307423|459926534|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
127811312|NCT01307423|459926535|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
127811313|NCT01307423|459926536|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
127811314|NCT01307423|459926537|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
127811315|NCT01307423|459926538|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
127811316|NCT01307423|459926539|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
127811317|NCT01307423|459926540|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
127811318|NCT01307423|459926541|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
127811319|NCT01307423|459926533|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
127811320|NCT01307423|459926534|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
127811321|NCT01307423|459926535|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
127811322|NCT01307423|459926536|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
127811323|NCT01307423|459926537|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
127811324|NCT01307423|459926538|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
127811325|NCT01307423|459926539|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
127811326|NCT01307423|459926540|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
127811327|NCT01307423|459926541|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
127811328|NCT01307423|459926533|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
127811329|NCT01307423|459926534|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
127811330|NCT01307423|459926535|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
127811331|NCT01307423|459926536|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
127811332|NCT01307423|459926537|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
127811333|NCT01307423|459926538|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
127811334|NCT01307423|459926539|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
127811335|NCT01307423|459926540|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
127811336|NCT01307423|459926541|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
127811337|NCT01307423|459926533|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
127811338|NCT01307423|459926534|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
127811339|NCT01307423|459926535|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
127811340|NCT01307423|459926536|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
127811341|NCT01307423|459926537|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
127811342|NCT01307423|459926538|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
127811343|NCT01307423|459926539|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
127811344|NCT01307423|459926540|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
127811345|NCT01307423|459926541|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
127811346|NCT01307423|459926533|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
127811347|NCT01307423|459926534|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
127811348|NCT01307423|459926535|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
127755574|NCT03330405|459730588|FG001|Overall Study|Progressive disease|27|||
127755575|NCT03330405|459730589|FG002|Overall Study|Progressive disease|4|||
127755576|NCT03330405|459730590|FG003|Overall Study|Progressive disease|18|||
127755577|NCT03330405|459730591|FG004|Overall Study|Progressive disease|16|||
127755578|NCT03330405|459730592|FG005|Overall Study|Progressive disease|14|||
127755579|NCT03330405|459730593|FG006|Overall Study|Progressive disease|7|||
127755580|NCT03330405|459730594|FG007|Overall Study|Progressive disease|29|||
127755581|NCT03330405|459730595|FG008|Overall Study|Progressive disease|9|||
127755582|NCT03330405|459730596|FG009|Overall Study|Progressive disease|11|||
127755583|NCT03330405|459730597|FG010|Overall Study|Progressive disease|5|||
127755584|NCT03330405|459730587|FG000|Overall Study|Withdrawal by Subject|1|||
127755585|NCT03330405|459730588|FG001|Overall Study|Withdrawal by Subject|4|||
127755586|NCT03330405|459730589|FG002|Overall Study|Withdrawal by Subject|0|||
127755587|NCT03330405|459730590|FG003|Overall Study|Withdrawal by Subject|1|||
127755588|NCT03330405|459730591|FG004|Overall Study|Withdrawal by Subject|1|||
127755589|NCT03330405|459730592|FG005|Overall Study|Withdrawal by Subject|1|||
127755590|NCT03330405|459730593|FG006|Overall Study|Withdrawal by Subject|0|||
127755591|NCT03330405|459730594|FG007|Overall Study|Withdrawal by Subject|2|||
127755592|NCT03330405|459730595|FG008|Overall Study|Withdrawal by Subject|2|||
127755593|NCT03330405|459730596|FG009|Overall Study|Withdrawal by Subject|1|||
127755594|NCT03330405|459730597|FG010|Overall Study|Withdrawal by Subject|1|||
127755595|NCT03330405|459730587|FG000|Overall Study|Global deterioration of health status|2|||
127755596|NCT03330405|459730588|FG001|Overall Study|Global deterioration of health status|3|||
127755597|NCT03330405|459730589|FG002|Overall Study|Global deterioration of health status|0|||
127755598|NCT03330405|459730590|FG003|Overall Study|Global deterioration of health status|2|||
127755599|NCT03330405|459730591|FG004|Overall Study|Global deterioration of health status|3|||
127755600|NCT03330405|459730592|FG005|Overall Study|Global deterioration of health status|3|||
127755601|NCT03330405|459730593|FG006|Overall Study|Global deterioration of health status|0|||
127755602|NCT03330405|459730594|FG007|Overall Study|Global deterioration of health status|2|||
127755603|NCT03330405|459730595|FG008|Overall Study|Global deterioration of health status|8|||
127755604|NCT03330405|459730596|FG009|Overall Study|Global deterioration of health status|4|||
127755605|NCT03330405|459730597|FG010|Overall Study|Global deterioration of health status|1|||
127755606|NCT03330405|459730587|FG000|Overall Study|Adverse Event|0|||
127755607|NCT03330405|459730588|FG001|Overall Study|Adverse Event|1|||
127755608|NCT03330405|459730589|FG002|Overall Study|Adverse Event|0|||
127755609|NCT03330405|459730590|FG003|Overall Study|Adverse Event|1|||
127755610|NCT03330405|459730591|FG004|Overall Study|Adverse Event|1|||
127755611|NCT03330405|459730592|FG005|Overall Study|Adverse Event|1|||
127755612|NCT03330405|459730593|FG006|Overall Study|Adverse Event|3|||
127755613|NCT03330405|459730594|FG007|Overall Study|Adverse Event|4|||
127755614|NCT03330405|459730595|FG008|Overall Study|Adverse Event|2|||
127755615|NCT03330405|459730596|FG009|Overall Study|Adverse Event|2|||
127755616|NCT03330405|459730597|FG010|Overall Study|Adverse Event|2|||
127755617|NCT03330405|459730587|FG000|Overall Study|Death|0|||
127755618|NCT03330405|459730588|FG001|Overall Study|Death|4|||
127755619|NCT03330405|459730589|FG002|Overall Study|Death|0|||
127755620|NCT03330405|459730590|FG003|Overall Study|Death|0|||
127755621|NCT03330405|459730591|FG004|Overall Study|Death|0|||
127755622|NCT03330405|459730592|FG005|Overall Study|Death|1|||
127755623|NCT03330405|459730593|FG006|Overall Study|Death|0|||
127755624|NCT03330405|459730594|FG007|Overall Study|Death|2|||
127755625|NCT03330405|459730595|FG008|Overall Study|Death|0|||
127755626|NCT03330405|459730596|FG009|Overall Study|Death|0|||
127755627|NCT03330405|459730597|FG010|Overall Study|Death|0|||
127894369|NCT00929708|460235336|FG001|Overall Study|Physician Decision|2|||
127755628|NCT03330405|459730587|FG000|Overall Study|Physician Decision|0|||
127755629|NCT03330405|459730588|FG001|Overall Study|Physician Decision|0|||
127755630|NCT03330405|459730589|FG002|Overall Study|Physician Decision|0|||
127755631|NCT03330405|459730590|FG003|Overall Study|Physician Decision|0|||
127755632|NCT03330405|459730591|FG004|Overall Study|Physician Decision|0|||
127894370|NCT00929708|460235337|FG002|Overall Study|Physician Decision|2|||
127755633|NCT03330405|459730592|FG005|Overall Study|Physician Decision|0|||
127755634|NCT03330405|459730593|FG006|Overall Study|Physician Decision|0|||
127755635|NCT03330405|459730594|FG007|Overall Study|Physician Decision|1|||
127755636|NCT03330405|459730595|FG008|Overall Study|Physician Decision|0|||
127755637|NCT03330405|459730596|FG009|Overall Study|Physician Decision|0|||
127755638|NCT03330405|459730597|FG010|Overall Study|Physician Decision|0|||
127755639|NCT02643303|459730598|FG000|Overall Study|Progressive Disease|4|||
127755640|NCT02643303|459730599|FG001|Overall Study|Progressive Disease|4|||
127755641|NCT02643303|459730600|FG002|Overall Study|Progressive Disease|1|||
127755642|NCT02643303|459730601|FG003|Overall Study|Progressive Disease|12|||
127755643|NCT02643303|459730602|FG004|Overall Study|Progressive Disease|6|||
127755644|NCT02643303|459730603|FG005|Overall Study|Progressive Disease|4|||
127755645|NCT02643303|459730604|FG006|Overall Study|Progressive Disease|8|||
127755646|NCT02643303|459730605|FG007|Overall Study|Progressive Disease|2|||
127755647|NCT02643303|459730606|FG008|Overall Study|Progressive Disease|6|||
127755648|NCT02643303|459730598|FG000|Overall Study|Adverse Event|0|||
127755649|NCT02643303|459730599|FG001|Overall Study|Adverse Event|1|||
127755650|NCT02643303|459730600|FG002|Overall Study|Adverse Event|0|||
127755651|NCT02643303|459730601|FG003|Overall Study|Adverse Event|0|||
127755652|NCT02643303|459730602|FG004|Overall Study|Adverse Event|1|||
127755653|NCT02643303|459730603|FG005|Overall Study|Adverse Event|0|||
127755654|NCT02643303|459730604|FG006|Overall Study|Adverse Event|0|||
127755655|NCT02643303|459730605|FG007|Overall Study|Adverse Event|0|||
127755656|NCT02643303|459730606|FG008|Overall Study|Adverse Event|0|||
127755657|NCT02643303|459730598|FG000|Overall Study|Withdrawal by Subject|0|||
127755658|NCT02643303|459730599|FG001|Overall Study|Withdrawal by Subject|0|||
127755659|NCT02643303|459730600|FG002|Overall Study|Withdrawal by Subject|0|||
127755660|NCT02643303|459730601|FG003|Overall Study|Withdrawal by Subject|1|||
127755661|NCT02643303|459730602|FG004|Overall Study|Withdrawal by Subject|0|||
127755662|NCT02643303|459730603|FG005|Overall Study|Withdrawal by Subject|0|||
127755663|NCT02643303|459730604|FG006|Overall Study|Withdrawal by Subject|1|||
127755664|NCT02643303|459730605|FG007|Overall Study|Withdrawal by Subject|1|||
127755665|NCT02643303|459730606|FG008|Overall Study|Withdrawal by Subject|1|||
127755666|NCT01499303|459730613|FG000|Overall Study|Ongoing|2|||
127755667|NCT01499303|459730614|FG001|Overall Study|Ongoing|1|||
127755668|NCT01499303|459730613|FG000|Overall Study|Withdrawal by Subject|0|||
127755669|NCT01499303|459730614|FG001|Overall Study|Withdrawal by Subject|1|||
127755670|NCT01499303|459730613|FG000|Overall Study|Adverse Event|1|||
127755671|NCT01499303|459730614|FG001|Overall Study|Adverse Event|4|||
127755672|NCT01499303|459730613|FG000|Overall Study|Other|0|||
127755673|NCT01499303|459730614|FG001|Overall Study|Other|1|||
127755674|NCT04939701|459730617|FG000|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
127755675|NCT04939701|459730618|FG001|Phase 1: Dose Escalation (168 Days)|Progressive disease|5|||
127755676|NCT04939701|459730619|FG002|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
127755677|NCT04939701|459730617|FG000|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
127755678|NCT04939701|459730618|FG001|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|1|||
127755679|NCT04939701|459730619|FG002|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
127755680|NCT04939701|459730617|FG000|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|2|||
127755681|NCT04939701|459730618|FG001|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
127755682|NCT04939701|459730619|FG002|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
127755683|NCT04939701|459730617|FG000|Phase 1: Dose Escalation (168 Days)|Death|1|||
127755684|NCT04939701|459730618|FG001|Phase 1: Dose Escalation (168 Days)|Death|0|||
127755685|NCT04939701|459730619|FG002|Phase 1: Dose Escalation (168 Days)|Death|0|||
127755686|NCT04939701|459730617|FG000|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
127755687|NCT04939701|459730618|FG001|Phase 1: Dose Escalation (168 Days)|Adverse Event|1|||
127755688|NCT04939701|459730619|FG002|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
127755689|NCT04939701|459730617|FG000|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
127755690|NCT04939701|459730618|FG001|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
127755691|NCT04939701|459730619|FG002|Phase 2: Dose Expansion (168 Days)|Progressive disease|3|||
127755692|NCT04939701|459730617|FG000|Phase 2: Dose Expansion (168 Days)|Death|0|||
127755693|NCT04939701|459730618|FG001|Phase 2: Dose Expansion (168 Days)|Death|0|||
127755694|NCT04939701|459730619|FG002|Phase 2: Dose Expansion (168 Days)|Death|1|||
127755695|NCT02383940|459730620|FG000|Overall Study|Adverse Event|1|||
127755696|NCT02383940|459730621|FG001|Overall Study|Adverse Event|0|||
127755697|NCT02383940|459730620|FG000|Overall Study|Lost to Follow-up|2|||
127755698|NCT02383940|459730621|FG001|Overall Study|Lost to Follow-up|2|||
127755699|NCT02383940|459730620|FG000|Overall Study|Physician Decision|2|||
127755700|NCT02383940|459730621|FG001|Overall Study|Physician Decision|0|||
127755701|NCT02383940|459730620|FG000|Overall Study|Withdrawal by Subject|1|||
127755702|NCT02383940|459730621|FG001|Overall Study|Withdrawal by Subject|1|||
127755703|NCT02383940|459730620|FG000|Overall Study|Randomized but not treated|2|||
127755704|NCT02383940|459730621|FG001|Overall Study|Randomized but not treated|0|||
127755705|NCT02383940|459730620|FG000|Overall Study|Other than specified above|1|||
127755706|NCT02383940|459730621|FG001|Overall Study|Other than specified above|0|||
127755707|NCT04308590|459730623|FG000|Overall Study|Adverse Event|12|||
127755708|NCT04308590|459730624|FG001|Overall Study|Adverse Event|2|||
127755709|NCT04308590|459730623|FG000|Overall Study|Withdrawal by Subject|10|||
127755710|NCT04308590|459730624|FG001|Overall Study|Withdrawal by Subject|4|||
127755711|NCT04308590|459730623|FG000|Overall Study|Death|1|||
127755712|NCT04308590|459730624|FG001|Overall Study|Death|0|||
127755713|NCT04308590|459730623|FG000|Overall Study|Lost to Follow-up|1|||
127755714|NCT04308590|459730624|FG001|Overall Study|Lost to Follow-up|1|||
127755715|NCT04308590|459730623|FG000|Overall Study|Physician Decision|1|||
127755716|NCT04308590|459730624|FG001|Overall Study|Physician Decision|0|||
127755717|NCT04308590|459730623|FG000|Overall Study|Subject does not want to continue with Pi|0|||
127755718|NCT04308590|459730624|FG001|Overall Study|Subject does not want to continue with Pi|1|||
127755719|NCT05487586|459730625|FG000|Overall Study|Death|22|||
127755720|NCT05487586|459730625|FG000|Overall Study|Physician Decision|1|||
127755721|NCT05487586|459730625|FG000|Overall Study|Transfer to another hospital|4|||
127755722|NCT05487586|459730625|FG000|Overall Study|Other|1|||
127755723|NCT00565773|459730626|FG000|Overall Study|Withdrawal by Subject|1|||
127755724|NCT00565773|459730626|FG000|Overall Study|Physician Decision|1|||
127755725|NCT04798781|459730627|FG000|Overall Study|Withdrawal by Subject|1|||
127755726|NCT00702962|459730628|FG000|Overall Study|Progressive disease|0|||
127755727|NCT00702962|459730629|FG001|Overall Study|Progressive disease|1|||
127755728|NCT00702962|459730628|FG000|Overall Study|Hospitalized for other health disorder|1|||
127755729|NCT00702962|459730629|FG001|Overall Study|Hospitalized for other health disorder|0|||
127755730|NCT02175641|459730632|FG000|Overall Study|Death|3|||
127755731|NCT02175641|459730633|FG001|Overall Study|Death|4|||
127755732|NCT02175641|459730632|FG000|Overall Study|Lost to Follow-up|4|||
127755733|NCT02175641|459730633|FG001|Overall Study|Lost to Follow-up|4|||
127755734|NCT02175641|459730632|FG000|Overall Study|Withdrawal by Subject|7|||
127755735|NCT02175641|459730633|FG001|Overall Study|Withdrawal by Subject|4|||
127755736|NCT02175641|459730632|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
127755737|NCT02175641|459730633|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
127755738|NCT02175641|459730632|FG000|Overall Study|Developed Contraindicated Condition|8|||
127755739|NCT02175641|459730633|FG001|Overall Study|Developed Contraindicated Condition|0|||
127755740|NCT01923467|459730634|FG000|Overall Study|Lost to Follow-up|62|||
127755741|NCT01923467|459730634|FG000|Overall Study|Subject non-interest|479|||
127755742|NCT03921723|459730635|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
127755743|NCT03921723|459730635|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
127755744|NCT03015129|459730636|FG000|Overall Study|Death|2|||
127755745|NCT03015129|459730637|FG001|Overall Study|Death|2|||
127755746|NCT03015129|459730636|FG000|Overall Study|Lost to Follow-up|0|||
127755747|NCT03015129|459730637|FG001|Overall Study|Lost to Follow-up|1|||
127755748|NCT03015129|459730636|FG000|Overall Study|Progression of disease|38|||
127755749|NCT03015129|459730637|FG001|Overall Study|Progression of disease|33|||
127755750|NCT03015129|459730636|FG000|Overall Study|Adverse Event|0|||
127755751|NCT03015129|459730637|FG001|Overall Study|Adverse Event|4|||
127755752|NCT02242097|459730638|FG000|Ibrutinib Treatment|Adverse Event|16|||
127755753|NCT02242097|459730638|FG000|Ibrutinib Treatment|Physician Decision|1|||
127755754|NCT02242097|459730638|FG000|Ibrutinib Treatment|Lack of Efficacy|1|||
127755755|NCT02242097|459730638|FG000|Ibrutinib Treatment|Death|1|||
127755756|NCT02242097|459730638|FG000|Ibrutinib Treatment|Patient Ineligible to start treatment|1|||
127755757|NCT02242097|459730638|FG000|Post Therapy Follow Up|Death|3|||
127755758|NCT02242097|459730638|FG000|Post Therapy Follow Up|Lost to Follow-up|1|||
127755759|NCT02574845|459730641|FG000|Overall Study|Consent withdrawn further participation|0|||
127755760|NCT02574845|459730642|FG001|Overall Study|Consent withdrawn further participation|0|||
127755761|NCT02574845|459730643|FG002|Overall Study|Consent withdrawn further participation|0|||
127755762|NCT02574845|459730644|FG003|Overall Study|Consent withdrawn further participation|0|||
127755763|NCT02574845|459730645|FG004|Overall Study|Consent withdrawn further participation|1|||
127755764|NCT02574845|459730646|FG005|Overall Study|Consent withdrawn further participation|0|||
127755765|NCT02574845|459730641|FG000|Overall Study|Adverse Event|0|||
127755766|NCT02574845|459730642|FG001|Overall Study|Adverse Event|1|||
127755767|NCT02574845|459730643|FG002|Overall Study|Adverse Event|0|||
127755768|NCT02574845|459730644|FG003|Overall Study|Adverse Event|0|||
127755769|NCT02574845|459730645|FG004|Overall Study|Adverse Event|0|||
127755770|NCT02574845|459730646|FG005|Overall Study|Adverse Event|1|||
127755771|NCT03435692|459730648|FG000|Overall Study|Lack of Efficacy|2|||
127755772|NCT03435692|459730649|FG001|Overall Study|Lack of Efficacy|2|||
127755773|NCT03435692|459730650|FG002|Overall Study|Lack of Efficacy|0|||
127755774|NCT01946529|459730657|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
127755775|NCT01946529|459730658|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
127755776|NCT01946529|459730659|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
127755777|NCT01946529|459730657|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
127755778|NCT01946529|459730658|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
127755779|NCT01946529|459730659|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
127755780|NCT03578887|459730668|FG000|Overall Study|Withdrawal by Subject|7|||
127755781|NCT03578887|459730669|FG001|Overall Study|Withdrawal by Subject|2|||
127755782|NCT03578887|459730670|FG002|Overall Study|Withdrawal by Subject|1|||
127755783|NCT03578887|459730668|FG000|Overall Study|Lost to Follow-up|13|||
127755784|NCT03578887|459730669|FG001|Overall Study|Lost to Follow-up|1|||
127755785|NCT03578887|459730670|FG002|Overall Study|Lost to Follow-up|4|||
127755786|NCT03578887|459730668|FG000|Overall Study|Physician Decision|0|||
127755787|NCT03578887|459730669|FG001|Overall Study|Physician Decision|1|||
127755788|NCT03578887|459730670|FG002|Overall Study|Physician Decision|1|||
127755789|NCT05602727|459732442|FG000|Overall Study|Physician Decision|0|||
127755790|NCT05602727|459732443|FG001|Overall Study|Physician Decision|1|||
127755791|NCT05602727|459732444|FG002|Overall Study|Physician Decision|0|||
127755792|NCT05602727|459732442|FG000|Overall Study|Randomized by mistake without study medication|1|||
127755793|NCT05602727|459732443|FG001|Overall Study|Randomized by mistake without study medication|0|||
127755794|NCT05602727|459732444|FG002|Overall Study|Randomized by mistake without study medication|0|||
127755795|NCT05602727|459732442|FG000|Overall Study|Study termination by Sponsor|18|||
127755796|NCT05602727|459732443|FG001|Overall Study|Study termination by Sponsor|15|||
127755797|NCT05602727|459732444|FG002|Overall Study|Study termination by Sponsor|19|||
127755798|NCT05602727|459732442|FG000|Overall Study|Withdrawal by Subject|2|||
127755799|NCT05602727|459732443|FG001|Overall Study|Withdrawal by Subject|1|||
127755800|NCT05602727|459732444|FG002|Overall Study|Withdrawal by Subject|1|||
127755801|NCT05602727|459732442|FG000|Overall Study|Various reasons|1|||
127755802|NCT05602727|459732443|FG001|Overall Study|Various reasons|6|||
127755803|NCT05602727|459732444|FG002|Overall Study|Various reasons|1|||
127755804|NCT03889704|459732445|FG000|Overall Study|Study terminated due to pandemic|1|||
127755805|NCT03482466|459732446|FG000|Overall Study|Protocol Violation|2|||
127755806|NCT03268603|459732447|FG000|Overall Study|Withdrawal by Subject|6|||
127755807|NCT03268603|459732447|FG000|Overall Study|Physician Decision|1|||
127755808|NCT03268603|459732447|FG000|Overall Study|Withdrawn due to disease progression|2|||
127755809|NCT02060370|459732448|FG000|Overall Study|Physician Decision|1|||
127755810|NCT00356408|459732449|FG000|Overall Study|Adverse Event|9|||
127755811|NCT00356408|459732449|FG000|Overall Study|Lack of Efficacy|36|||
127755812|NCT00356408|459732449|FG000|Overall Study|Lost to Follow-up|2|||
127755813|NCT00356408|459732449|FG000|Overall Study|Withdrawal by Subject|6|||
127755814|NCT00356408|459732449|FG000|Overall Study|Other: Principal investigator discretion|3|||
127755815|NCT00356408|459732449|FG000|Overall Study|Other: Sponsor request|1|||
127755816|NCT00356408|459732449|FG000|Overall Study|Other: Azathioprine stopped|1|||
127755817|NCT00356408|459732449|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
127755818|NCT00356408|459732449|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
127755819|NCT01493427|459732451|FG000|Overall Study|Adverse Event|10|||
127755820|NCT01493427|459732451|FG000|Overall Study|Personal Reasons|4|||
127755821|NCT01493427|459732451|FG000|Overall Study|Lost to Follow-up|2|||
127755822|NCT01493427|459732451|FG000|Overall Study|Inability to Follow Instructions|2|||
127755823|NCT01493427|459732451|FG000|Overall Study|Other|2|||
127811349|NCT01307423|459926536|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
127811350|NCT01307423|459926537|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
127811351|NCT01307423|459926538|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
127755824|NCT05775991|459732452|FG000|Overall Study|Withdrawal by Subject|0|||
127755825|NCT05775991|459732453|FG001|Overall Study|Withdrawal by Subject|0|||
127755826|NCT05775991|459732454|FG002|Overall Study|Withdrawal by Subject|2|||
127755827|NCT01461811|459732455|FG000|Overall Study|Adverse Event|2|||
127755828|NCT01461811|459732456|FG001|Overall Study|Adverse Event|1|||
127755829|NCT01461811|459732455|FG000|Overall Study|Subject decision unrelated to an AE|1|||
127755830|NCT01461811|459732456|FG001|Overall Study|Subject decision unrelated to an AE|1|||
127755831|NCT01461811|459732455|FG000|Overall Study|Noncompliance|1|||
127755832|NCT01461811|459732456|FG001|Overall Study|Noncompliance|1|||
127755833|NCT01075958|459732457|FG000|Overall Study|Blood sample could not be obtained|44|||
127755834|NCT03733314|459732458|FG000|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|2|||
127755835|NCT03733314|459732459|FG001|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|0|||
127755836|NCT03733314|459732458|FG000|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|1|||
127811352|NCT01307423|459926539|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
127755837|NCT03733314|459732459|FG001|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|2|||
127755838|NCT03733314|459732458|FG000|Rescue Period: (Weeks 12 to 24)|Progressive disease|0|||
127755839|NCT03733314|459732459|FG001|Rescue Period: (Weeks 12 to 24)|Progressive disease|2|||
127811353|NCT01307423|459926540|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
127755840|NCT03733314|459732458|FG000|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
127755841|NCT03733314|459732459|FG001|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
127755842|NCT03733314|459732458|FG000|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|1|||
127755843|NCT03733314|459732459|FG001|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|0|||
127755844|NCT03733314|459732458|FG000|Extension Period:(Week 12-52/Week 24-64)|Other|3|||
127755845|NCT03733314|459732459|FG001|Extension Period:(Week 12-52/Week 24-64)|Other|2|||
127755846|NCT01240915|459732460|FG000|Overall Study|Adverse Event|0|||
127755847|NCT01240915|459732461|FG001|Overall Study|Adverse Event|0|||
127755848|NCT01240915|459732462|FG002|Overall Study|Adverse Event|0|||
127755849|NCT01240915|459732463|FG003|Overall Study|Adverse Event|1|||
127755850|NCT01240915|459732464|FG004|Overall Study|Adverse Event|0|||
127755851|NCT01240915|459732465|FG005|Overall Study|Adverse Event|2|||
127755852|NCT01240915|459732466|FG006|Overall Study|Adverse Event|0|||
127755853|NCT01240915|459732467|FG007|Overall Study|Adverse Event|0|||
127755854|NCT01240915|459732468|FG008|Overall Study|Adverse Event|1|||
127755855|NCT01240915|459732460|FG000|Overall Study|Lost to Follow-up|0|||
127755856|NCT01240915|459732461|FG001|Overall Study|Lost to Follow-up|0|||
127755857|NCT01240915|459732462|FG002|Overall Study|Lost to Follow-up|0|||
127755858|NCT01240915|459732463|FG003|Overall Study|Lost to Follow-up|0|||
127755859|NCT01240915|459732464|FG004|Overall Study|Lost to Follow-up|1|||
127755860|NCT01240915|459732465|FG005|Overall Study|Lost to Follow-up|1|||
127755861|NCT01240915|459732466|FG006|Overall Study|Lost to Follow-up|0|||
127755862|NCT01240915|459732467|FG007|Overall Study|Lost to Follow-up|1|||
127755863|NCT01240915|459732468|FG008|Overall Study|Lost to Follow-up|1|||
127755864|NCT01240915|459732460|FG000|Overall Study|Withdrawal by Subject|2|||
127755865|NCT01240915|459732461|FG001|Overall Study|Withdrawal by Subject|1|||
127755866|NCT01240915|459732462|FG002|Overall Study|Withdrawal by Subject|0|||
127755867|NCT01240915|459732463|FG003|Overall Study|Withdrawal by Subject|2|||
127755868|NCT01240915|459732464|FG004|Overall Study|Withdrawal by Subject|0|||
127755869|NCT01240915|459732465|FG005|Overall Study|Withdrawal by Subject|4|||
127755870|NCT01240915|459732466|FG006|Overall Study|Withdrawal by Subject|2|||
127755871|NCT01240915|459732467|FG007|Overall Study|Withdrawal by Subject|3|||
127755872|NCT01240915|459732468|FG008|Overall Study|Withdrawal by Subject|3|||
127755873|NCT01240915|459732460|FG000|Overall Study|Other|0|||
127755874|NCT01240915|459732461|FG001|Overall Study|Other|0|||
127755875|NCT01240915|459732462|FG002|Overall Study|Other|0|||
127755876|NCT01240915|459732463|FG003|Overall Study|Other|0|||
127755877|NCT01240915|459732464|FG004|Overall Study|Other|2|||
127755878|NCT01240915|459732465|FG005|Overall Study|Other|0|||
127755879|NCT01240915|459732466|FG006|Overall Study|Other|0|||
127755880|NCT01240915|459732467|FG007|Overall Study|Other|0|||
127755881|NCT01240915|459732468|FG008|Overall Study|Other|0|||
127755882|NCT01240915|459732460|FG000|Overall Study|Insufficient Clinical Response|0|||
127755883|NCT01240915|459732461|FG001|Overall Study|Insufficient Clinical Response|0|||
127755884|NCT01240915|459732462|FG002|Overall Study|Insufficient Clinical Response|0|||
127755885|NCT01240915|459732463|FG003|Overall Study|Insufficient Clinical Response|0|||
127755886|NCT01240915|459732464|FG004|Overall Study|Insufficient Clinical Response|1|||
127755887|NCT01240915|459732465|FG005|Overall Study|Insufficient Clinical Response|3|||
127755888|NCT01240915|459732466|FG006|Overall Study|Insufficient Clinical Response|6|||
127755889|NCT01240915|459732467|FG007|Overall Study|Insufficient Clinical Response|0|||
127755890|NCT01240915|459732468|FG008|Overall Study|Insufficient Clinical Response|3|||
127755891|NCT04514510|459732469|FG000|Overall Study|Lost to Follow-up|0|||
127755892|NCT04514510|459732470|FG001|Overall Study|Lost to Follow-up|1|||
127755893|NCT04514510|459732469|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
127755894|NCT04514510|459732470|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
127755895|NCT00406692|459732471|FG000|Overall Study|Withdrawal by Subject|4|||
127755896|NCT00406692|459732471|FG000|Overall Study|Physician Decision|1|||
127755897|NCT00406692|459732471|FG000|Overall Study|Adverse Event|1|||
127755898|NCT00406692|459732471|FG000|Overall Study|Lack of Efficacy|1|||
127755899|NCT00821587|459732472|FG000|Overall Study|Physician Decision|0|||
127755900|NCT00821587|459732473|FG001|Overall Study|Physician Decision|1|||
127755901|NCT02781090|459732476|FG000|3-Month Follow-Up|Missed Visit|20|||
127755902|NCT02781090|459732477|FG001|3-Month Follow-Up|Missed Visit|20|||
127755903|NCT02781090|459732476|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
127755904|NCT02781090|459732477|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
127755905|NCT02781090|459732476|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
127755906|NCT02781090|459732477|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
127755907|NCT02781090|459732476|FG000|3-Month Follow-Up|Death|1|||
127755908|NCT02781090|459732477|FG001|3-Month Follow-Up|Death|0|||
127755909|NCT02781090|459732476|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
127755910|NCT02781090|459732477|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
127755911|NCT02781090|459732476|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
127755912|NCT02781090|459732477|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
127755913|NCT02781090|459732476|FG000|6-Month Follow-Up|Death|0|||
127755914|NCT02781090|459732477|FG001|6-Month Follow-Up|Death|1|||
127811354|NCT01307423|459926541|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
127811355|NCT01307423|459926533|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
127811356|NCT01307423|459926534|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
127811357|NCT01307423|459926535|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
127811358|NCT01307423|459926536|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
127811359|NCT01307423|459926537|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
127811360|NCT01307423|459926538|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
127811361|NCT01307423|459926539|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
127811362|NCT01307423|459926540|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
127811363|NCT01307423|459926541|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
127811364|NCT01307423|459926533|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
127811365|NCT01307423|459926534|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
127811366|NCT01307423|459926535|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
127811367|NCT01307423|459926536|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
127811368|NCT01307423|459926537|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
127755915|NCT01145898|459732478|FG000|3-year Treatment|medication change by treating physician|3|||
127755916|NCT01145898|459732479|FG001|3-year Treatment|medication change by treating physician|16|||
127755917|NCT01712061|459732480|FG000|Overall Study|Adverse Event|4|||
127755918|NCT01712061|459732481|FG001|Overall Study|Adverse Event|9|||
127755919|NCT01712061|459732482|FG002|Overall Study|Adverse Event|5|||
127755920|NCT01712061|459732480|FG000|Overall Study|Death|0|||
127755921|NCT01712061|459732481|FG001|Overall Study|Death|0|||
127755922|NCT01712061|459732482|FG002|Overall Study|Death|1|||
127811369|NCT01307423|459926538|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
127811370|NCT01307423|459926539|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
127811371|NCT01307423|459926540|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
127755923|NCT01712061|459732480|FG000|Overall Study|Lost to Follow-up|1|||
127755924|NCT01712061|459732481|FG001|Overall Study|Lost to Follow-up|0|||
127755925|NCT01712061|459732482|FG002|Overall Study|Lost to Follow-up|1|||
127755926|NCT01712061|459732480|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
127755927|NCT01712061|459732481|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
127755928|NCT01712061|459732482|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
127755929|NCT01712061|459732480|FG000|Overall Study|Medication Error Without Associated AE|0|||
127755930|NCT01712061|459732481|FG001|Overall Study|Medication Error Without Associated AE|1|||
127755931|NCT01712061|459732482|FG002|Overall Study|Medication Error Without Associated AE|0|||
127755932|NCT01712061|459732480|FG000|Overall Study|Withdrawal by Subject|1|||
127755933|NCT01712061|459732481|FG001|Overall Study|Withdrawal by Subject|7|||
127755934|NCT01712061|459732482|FG002|Overall Study|Withdrawal by Subject|1|||
127755935|NCT01712061|459732480|FG000|Overall Study|Other|0|||
127755936|NCT01712061|459732481|FG001|Overall Study|Other|3|||
127755937|NCT01712061|459732482|FG002|Overall Study|Other|0|||
127755938|NCT00879775|459732485|FG000|Overall Study|Lost to Follow-up|2|||
127755939|NCT00879775|459732486|FG001|Overall Study|Lost to Follow-up|1|||
127755940|NCT01195623|459732487|FG000|Overall Study|Lost to Follow-up|35|||
127755941|NCT01195623|459732488|FG001|Overall Study|Lost to Follow-up|37|||
127755942|NCT01401153|459732490|FG000|First Test Day|Learning disabilities; illness|1|||
127755943|NCT01401153|459732491|FG001|First Test Day|Learning disabilities; illness|10|||
127755944|NCT01401153|459732490|FG000|Second Test Day|illness|0|||
127755945|NCT01401153|459732491|FG001|Second Test Day|illness|5|||
127755946|NCT00214019|459732492|FG000|Overall Study|Lost to Follow-up|11|||
127755947|NCT00214019|459732492|FG000|Overall Study|Withdrawal by Subject|2|||
127755948|NCT00214019|459732492|FG000|Overall Study|Screen Failed prior to randomization|17|||
127755949|NCT01677767|459732495|FG000|Overall Study|Adverse Event|1|||
127755950|NCT01677767|459732495|FG000|Overall Study|Death|4|||
127755951|NCT01677767|459732495|FG000|Overall Study|Protocol Violation|4|||
127811372|NCT01307423|459926541|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
127755952|NCT01677767|459732495|FG000|Overall Study|Withdrawal by Subject|10|||
127755953|NCT01677767|459732495|FG000|Overall Study|Non-compliance by the participants|3|||
127755954|NCT00757627|459732496|FG000|Overall Study|Adverse Event|15|||
127755955|NCT00757627|459732496|FG000|Overall Study|Lack of Efficacy|10|||
127755956|NCT00757627|459732496|FG000|Overall Study|Lost to Follow-up|28|||
127755957|NCT00757627|459732496|FG000|Overall Study|Withdrawal by Subject|27|||
127755958|NCT00757627|459732496|FG000|Overall Study|Other|1|||
127755959|NCT03846453|459732497|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
127755960|NCT03846453|459732498|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
127755961|NCT03846453|459732499|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
127755962|NCT03846453|459732497|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
127755963|NCT03846453|459732498|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
127755964|NCT03846453|459732499|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
127755965|NCT03846453|459732497|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
127755966|NCT03846453|459732498|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
127755967|NCT03846453|459732499|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
127755968|NCT03846453|459732497|FG000|Placebo Run-in (14 Days)|Other|2|||
127755969|NCT03846453|459732498|FG001|Placebo Run-in (14 Days)|Other|0|||
127755970|NCT03846453|459732499|FG002|Placebo Run-in (14 Days)|Other|0|||
127755971|NCT03846453|459732497|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
127755972|NCT03846453|459732498|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
127755973|NCT03846453|459732499|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
127755974|NCT03846453|459732497|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
127755975|NCT03846453|459732498|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
127755976|NCT03846453|459732499|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
127755977|NCT03846453|459732497|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
127755978|NCT03846453|459732498|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
127755979|NCT03846453|459732499|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
127755980|NCT03846453|459732497|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
127755981|NCT03846453|459732498|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
127755982|NCT03846453|459732499|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
127755983|NCT03846453|459732497|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
127755984|NCT03846453|459732498|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
127755985|NCT03846453|459732499|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
127755986|NCT00468143|459732500|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
127755987|NCT00468143|459732501|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
127755988|NCT00468143|459732500|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
127755989|NCT00468143|459732501|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
127755990|NCT01606670|459732502|FG000|Overall Study|Adverse Event|6|||
127755991|NCT01606670|459732502|FG000|Overall Study|Lack of Efficacy|2|||
127755992|NCT01606670|459732502|FG000|Overall Study|Lost to Follow-up|3|||
127755993|NCT01606670|459732502|FG000|Overall Study|Withdrawal by Subject|3|||
127755994|NCT01606670|459732502|FG000|Overall Study|Other Reason|2|||
127755995|NCT02636725|459732504|FG000|Overall Study|Adverse Event|1|||
127755996|NCT05330676|459732505|FG000|Overall Study|Inadequate imaging quality for final analysis|2|||
127755997|NCT05330676|459732506|FG001|Overall Study|Inadequate imaging quality for final analysis|9|||
127755998|NCT01559129|459732508|FG000|Treatment Phase|Adverse Event|0|||
127755999|NCT01559129|459732509|FG001|Treatment Phase|Adverse Event|2|||
127756000|NCT01559129|459732508|FG000|Treatment Phase|Progressive Disease|1|||
127756001|NCT01559129|459732509|FG001|Treatment Phase|Progressive Disease|1|||
127756002|NCT01559129|459732508|FG000|Treatment Phase|Lack of Efficacy|0|||
127756003|NCT01559129|459732509|FG001|Treatment Phase|Lack of Efficacy|1|||
127756004|NCT01559129|459732508|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
127756005|NCT01559129|459732509|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
127756006|NCT01559129|459732508|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
127756007|NCT01559129|459732509|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
127756008|NCT01559129|459732508|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
127756009|NCT01559129|459732509|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
127756010|NCT01559129|459732508|FG000|Open-label Extension Period|Adverse Event|1|||
127756011|NCT01559129|459732509|FG001|Open-label Extension Period|Adverse Event|0|||
127756012|NCT01559129|459732508|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
127756013|NCT01559129|459732509|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
127756014|NCT00368927|459732510|FG000|Overall Study|Lost to Follow-up|2|||
127756015|NCT00368927|459732511|FG001|Overall Study|Lost to Follow-up|0|||
127756016|NCT00368927|459732510|FG000|Overall Study|Adverse Event|1|||
127756017|NCT00368927|459732511|FG001|Overall Study|Adverse Event|1|||
127756018|NCT00368927|459732510|FG000|Overall Study|Withdrawal by Subject|1|||
127756019|NCT00368927|459732511|FG001|Overall Study|Withdrawal by Subject|2|||
127756020|NCT00368927|459732510|FG000|Overall Study|Physician Decision|1|||
127756021|NCT00368927|459732511|FG001|Overall Study|Physician Decision|0|||
127756022|NCT03525392|459732512|FG000|Overall Study|Adverse Event|1|||
127756023|NCT03525392|459732513|FG001|Overall Study|Adverse Event|0|||
127756024|NCT03525392|459732514|FG002|Overall Study|Adverse Event|2|||
127756025|NCT03525392|459732515|FG003|Overall Study|Adverse Event|0|||
127756026|NCT03525392|459732516|FG004|Overall Study|Adverse Event|0|||
127756027|NCT03525392|459732512|FG000|Overall Study|Progressive disease|0|||
127756028|NCT03525392|459732513|FG001|Overall Study|Progressive disease|1|||
127756029|NCT03525392|459732514|FG002|Overall Study|Progressive disease|1|||
127756030|NCT03525392|459732515|FG003|Overall Study|Progressive disease|3|||
127756031|NCT03525392|459732516|FG004|Overall Study|Progressive disease|1|||
127756032|NCT03284203|459732519|FG000|Overall Study|Lost to Follow-up|3|||
127756033|NCT02229851|459732520|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
127756034|NCT02229851|459732521|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
127756035|NCT02229851|459732522|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
127756036|NCT02229851|459732523|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
127756037|NCT02229851|459732524|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
127756038|NCT02229851|459732525|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
127756039|NCT02229851|459732526|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
127756040|NCT02229851|459732520|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
127756041|NCT02229851|459732521|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
127756042|NCT02229851|459732522|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
127756043|NCT02229851|459732523|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
127756044|NCT02229851|459732524|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
127756045|NCT02229851|459732525|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
127756046|NCT02229851|459732526|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
127756047|NCT02229851|459732520|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
127756048|NCT02229851|459732521|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
127756049|NCT02229851|459732522|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
127756050|NCT02229851|459732523|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
127756051|NCT02229851|459732524|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
127756052|NCT02229851|459732525|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
127756053|NCT02229851|459732526|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
127756054|NCT02229851|459732520|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
127756055|NCT02229851|459732521|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
127756056|NCT02229851|459732522|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
127756057|NCT02229851|459732523|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
127756058|NCT02229851|459732524|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
127756059|NCT02229851|459732525|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
127756060|NCT02229851|459732526|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
127756061|NCT02229851|459732520|FG000|Main Phase (Double-blind Phase)|Death|1|||
127756062|NCT02229851|459732521|FG001|Main Phase (Double-blind Phase)|Death|1|||
127756063|NCT02229851|459732522|FG002|Main Phase (Double-blind Phase)|Death|0|||
127756064|NCT02229851|459732523|FG003|Main Phase (Double-blind Phase)|Death|0|||
127756065|NCT02229851|459732524|FG004|Main Phase (Double-blind Phase)|Death|0|||
127756066|NCT02229851|459732525|FG005|Main Phase (Double-blind Phase)|Death|0|||
127756067|NCT02229851|459732526|FG006|Main Phase (Double-blind Phase)|Death|0|||
127756068|NCT02229851|459732520|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
127756069|NCT02229851|459732521|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
127756070|NCT02229851|459732522|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
127756071|NCT02229851|459732523|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
127756072|NCT02229851|459732524|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
127756073|NCT02229851|459732525|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
127756074|NCT02229851|459732526|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
127756075|NCT02229851|459732520|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
127756076|NCT02229851|459732521|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
127756077|NCT02229851|459732522|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
127756078|NCT02229851|459732523|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
127756079|NCT02229851|459732524|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
127756080|NCT02229851|459732525|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
127756081|NCT02229851|459732526|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
127756082|NCT02229851|459732520|FG000|Extension Phase (Open-label Phase)|Death|0|||
127756083|NCT02229851|459732521|FG001|Extension Phase (Open-label Phase)|Death|0|||
127756084|NCT02229851|459732522|FG002|Extension Phase (Open-label Phase)|Death|0|||
127756085|NCT02229851|459732523|FG003|Extension Phase (Open-label Phase)|Death|1|||
127756086|NCT02229851|459732524|FG004|Extension Phase (Open-label Phase)|Death|0|||
127756087|NCT02229851|459732525|FG005|Extension Phase (Open-label Phase)|Death|1|||
127756088|NCT02229851|459732526|FG006|Extension Phase (Open-label Phase)|Death|1|||
127756089|NCT01111240|459732527|FG000|Overall Study|Adverse Event|190|||
127756090|NCT01111240|459732527|FG000|Overall Study|Lack of Efficacy|545|||
127756091|NCT01111240|459732527|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
127894371|NCT00929708|460235338|FG003|Overall Study|Physician Decision|2|||
127756092|NCT01111240|459732527|FG000|Overall Study|Other|312|||
127756093|NCT04187326|459732528|FG000|Overall Study|Lost to Follow-up|2|||
127756094|NCT04187326|459732529|FG001|Overall Study|Lost to Follow-up|1|||
127756095|NCT04187326|459732528|FG000|Overall Study|Computer error- task was only partially completed.|0|||
127756096|NCT04187326|459732529|FG001|Overall Study|Computer error- task was only partially completed.|1|||
127756097|NCT01607476|459732530|FG000|Overall Study|Withdrawal by Subject|1|||
127756098|NCT01607476|459732531|FG001|Overall Study|Withdrawal by Subject|0|||
127756099|NCT01607476|459732532|FG002|Overall Study|Withdrawal by Subject|1|||
127894372|NCT00929708|460235339|FG004|Overall Study|Physician Decision|1|||
127756100|NCT01607476|459732530|FG000|Overall Study|Lost to Follow-up|0|||
127756101|NCT01607476|459732531|FG001|Overall Study|Lost to Follow-up|0|||
127756102|NCT01607476|459732532|FG002|Overall Study|Lost to Follow-up|2|||
127756103|NCT04958200|459732535|FG000|Overall Study|Withdrawal by Subject|0|||
127756104|NCT04958200|459732536|FG001|Overall Study|Withdrawal by Subject|2|||
127756105|NCT04958200|459732535|FG000|Overall Study|Lost to Follow-up|3|||
127756106|NCT04958200|459732536|FG001|Overall Study|Lost to Follow-up|2|||
127756107|NCT00623805|459732537|FG000|Overall Study|Adverse Event|9|||
127756108|NCT00623805|459732538|FG001|Overall Study|Adverse Event|6|||
127756109|NCT00623805|459732537|FG000|Overall Study|Death|2|||
127756110|NCT00623805|459732538|FG001|Overall Study|Death|0|||
127756111|NCT00623805|459732537|FG000|Overall Study|Lack of Efficacy|3|||
127756112|NCT00623805|459732538|FG001|Overall Study|Lack of Efficacy|7|||
127756113|NCT00623805|459732537|FG000|Overall Study|Lost to Follow-up|2|||
127756114|NCT00623805|459732538|FG001|Overall Study|Lost to Follow-up|2|||
127756115|NCT00623805|459732537|FG000|Overall Study|Protocol Violation|1|||
127756116|NCT00623805|459732538|FG001|Overall Study|Protocol Violation|1|||
127756117|NCT00623805|459732537|FG000|Overall Study|Reason not Specified|3|||
127756118|NCT00623805|459732538|FG001|Overall Study|Reason not Specified|6|||
127756119|NCT04655027|459732553|FG000|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|1|||
127756120|NCT04655027|459732554|FG001|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|0|||
127756121|NCT03519997|459732557|FG000|Overall Study|Adverse Event|4|||
127756122|NCT03519997|459732557|FG000|Overall Study|Withdrawal by Subject|2|||
127756123|NCT03519997|459732557|FG000|Overall Study|Protocol Violation|1|||
127756124|NCT02906007|459732558|FG000|Overall Study|Physician Decision|0|||
127756125|NCT02906007|459732559|FG001|Overall Study|Physician Decision|0|||
127756126|NCT02906007|459732560|FG002|Overall Study|Physician Decision|1|||
127756127|NCT02906007|459732558|FG000|Overall Study|Died|1|||
127756128|NCT02906007|459732559|FG001|Overall Study|Died|0|||
127756129|NCT02906007|459732560|FG002|Overall Study|Died|0|||
127756130|NCT06655558|459732564|FG000|Overall Study|Protocol Violation|1|||
127756131|NCT05718466|459734233|FG000|Overall Study|Withdrawal by Subject|1|||
127756132|NCT05718466|459734234|FG001|Overall Study|Withdrawal by Subject|2|||
127756133|NCT05718466|459734233|FG000|Overall Study|Death|0|||
127756134|NCT05718466|459734234|FG001|Overall Study|Death|1|||
127756135|NCT00387426|459734236|FG000|Overall Study|Lack of Response|7|||
127756136|NCT00387426|459734236|FG000|Overall Study|Toxicities|4|||
127756137|NCT00387426|459734236|FG000|Overall Study|Disease Progression|3|||
127756138|NCT01253135|459734243|FG000|Original Protocol|Protocol Amendment|15|||
127756139|NCT01253135|459734243|FG000|Amended Protocol|Non-compliance|1|||
127756140|NCT01901432|459734248|FG000|Overall Study|Adverse Event|0|||
127756141|NCT01901432|459734249|FG001|Overall Study|Adverse Event|1|||
127756142|NCT01901432|459734250|FG002|Overall Study|Adverse Event|1|||
127756143|NCT01901432|459734251|FG003|Overall Study|Adverse Event|0|||
127756144|NCT01901432|459734252|FG004|Overall Study|Adverse Event|1|||
127756145|NCT01901432|459734248|FG000|Overall Study|Withdrawal by Subject|0|||
127756146|NCT01901432|459734249|FG001|Overall Study|Withdrawal by Subject|0|||
127756147|NCT01901432|459734250|FG002|Overall Study|Withdrawal by Subject|1|||
127756148|NCT01901432|459734251|FG003|Overall Study|Withdrawal by Subject|0|||
127756149|NCT01901432|459734252|FG004|Overall Study|Withdrawal by Subject|5|||
127756150|NCT01901432|459734248|FG000|Overall Study|Physician Decision|0|||
127756151|NCT01901432|459734249|FG001|Overall Study|Physician Decision|0|||
127756152|NCT01901432|459734250|FG002|Overall Study|Physician Decision|0|||
127756153|NCT01901432|459734251|FG003|Overall Study|Physician Decision|0|||
127756154|NCT01901432|459734252|FG004|Overall Study|Physician Decision|2|||
127756155|NCT01901432|459734248|FG000|Overall Study|Patient decision to stop study drug|0|||
127756156|NCT01901432|459734249|FG001|Overall Study|Patient decision to stop study drug|0|||
127756157|NCT01901432|459734250|FG002|Overall Study|Patient decision to stop study drug|0|||
127756158|NCT01901432|459734251|FG003|Overall Study|Patient decision to stop study drug|0|||
127756159|NCT01901432|459734252|FG004|Overall Study|Patient decision to stop study drug|1|||
127756160|NCT00379288|459734255|FG000|Overall Study|Adverse Event|5|||
127756161|NCT00379288|459734256|FG001|Overall Study|Adverse Event|6|||
127756162|NCT00379288|459734257|FG002|Overall Study|Adverse Event|2|||
127756163|NCT00379288|459734258|FG003|Overall Study|Adverse Event|0|||
127756164|NCT00379288|459734255|FG000|Overall Study|Treatment Failure|0|||
127756165|NCT00379288|459734256|FG001|Overall Study|Treatment Failure|1|||
127756166|NCT00379288|459734257|FG002|Overall Study|Treatment Failure|0|||
127756167|NCT00379288|459734258|FG003|Overall Study|Treatment Failure|1|||
127756168|NCT00379288|459734255|FG000|Overall Study|Lost to Follow-up|3|||
127756169|NCT00379288|459734256|FG001|Overall Study|Lost to Follow-up|3|||
127756170|NCT00379288|459734257|FG002|Overall Study|Lost to Follow-up|2|||
127756171|NCT00379288|459734258|FG003|Overall Study|Lost to Follow-up|0|||
127756172|NCT00379288|459734255|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
127756173|NCT00379288|459734256|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
127756174|NCT00379288|459734257|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
127756175|NCT00379288|459734258|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
127756176|NCT00379288|459734255|FG000|Overall Study|Subject withdrew-related to study drug|1|||
127894373|NCT00929708|460235335|FG000|Overall Study|Lost to Follow-up|0|||
127756177|NCT00379288|459734256|FG001|Overall Study|Subject withdrew-related to study drug|0|||
127756178|NCT00379288|459734257|FG002|Overall Study|Subject withdrew-related to study drug|0|||
127756179|NCT00379288|459734258|FG003|Overall Study|Subject withdrew-related to study drug|1|||
127756180|NCT00379288|459734255|FG000|Overall Study|Noncompliance with protocol|8|||
127756181|NCT00379288|459734256|FG001|Overall Study|Noncompliance with protocol|6|||
127756182|NCT00379288|459734257|FG002|Overall Study|Noncompliance with protocol|2|||
127756183|NCT00379288|459734258|FG003|Overall Study|Noncompliance with protocol|1|||
127756184|NCT00379288|459734255|FG000|Overall Study|Did not meet protocol eligibility|0|||
127756185|NCT00379288|459734256|FG001|Overall Study|Did not meet protocol eligibility|1|||
127756186|NCT00379288|459734257|FG002|Overall Study|Did not meet protocol eligibility|0|||
127756187|NCT00379288|459734258|FG003|Overall Study|Did not meet protocol eligibility|2|||
127756188|NCT00379288|459734255|FG000|Overall Study|Administrative|2|||
127756189|NCT00379288|459734256|FG001|Overall Study|Administrative|2|||
127756190|NCT00379288|459734257|FG002|Overall Study|Administrative|0|||
127756191|NCT00379288|459734258|FG003|Overall Study|Administrative|1|||
127756192|NCT00918879|459734259|FG000|Overall Study|Withdrawal by Subject|4|||
127756193|NCT00918879|459734260|FG001|Overall Study|Withdrawal by Subject|4|||
127756194|NCT00918879|459734259|FG000|Overall Study|Lost to Follow-up|1|||
127756195|NCT00918879|459734260|FG001|Overall Study|Lost to Follow-up|1|||
127756196|NCT00918879|459734259|FG000|Overall Study|Severe non-compliance to protocol|1|||
127756197|NCT00918879|459734260|FG001|Overall Study|Severe non-compliance to protocol|1|||
127756198|NCT00833261|459734263|FG000|Overall Study|Withdrawal by Subject|4|||
127756199|NCT00357110|459734264|FG000|Overall Study|Early study termination|5|||
127756200|NCT00357110|459734265|FG001|Overall Study|Early study termination|5|||
127756201|NCT01531673|459734266|FG000|Overall Study|Non-Compliance|0|||
127756202|NCT01531673|459734267|FG001|Overall Study|Non-Compliance|0|||
127756203|NCT01531673|459734268|FG002|Overall Study|Non-Compliance|0|||
127756204|NCT01531673|459734269|FG003|Overall Study|Non-Compliance|0|||
127756205|NCT01531673|459734270|FG004|Overall Study|Non-Compliance|0|||
127756206|NCT01531673|459734271|FG005|Overall Study|Non-Compliance|1|||
127756207|NCT01531673|459734272|FG006|Overall Study|Non-Compliance|0|||
127756208|NCT01531673|459734273|FG007|Overall Study|Non-Compliance|0|||
127756209|NCT01531673|459734274|FG008|Overall Study|Non-Compliance|0|||
127756210|NCT01531673|459734275|FG009|Overall Study|Non-Compliance|0|||
127756211|NCT01531673|459734276|FG010|Overall Study|Non-Compliance|0|||
127756212|NCT01531673|459734277|FG011|Overall Study|Non-Compliance|0|||
127756213|NCT01531673|459734278|FG012|Overall Study|Non-Compliance|0|||
127756214|NCT01531673|459734266|FG000|Overall Study|Adverse Event|0|||
127756215|NCT01531673|459734267|FG001|Overall Study|Adverse Event|1|||
127756216|NCT01531673|459734268|FG002|Overall Study|Adverse Event|0|||
127756217|NCT01531673|459734269|FG003|Overall Study|Adverse Event|0|||
127756218|NCT01531673|459734270|FG004|Overall Study|Adverse Event|0|||
127756219|NCT01531673|459734271|FG005|Overall Study|Adverse Event|0|||
127756220|NCT01531673|459734272|FG006|Overall Study|Adverse Event|0|||
127756221|NCT01531673|459734273|FG007|Overall Study|Adverse Event|0|||
127756222|NCT01531673|459734274|FG008|Overall Study|Adverse Event|0|||
127756223|NCT01531673|459734275|FG009|Overall Study|Adverse Event|0|||
127756224|NCT01531673|459734276|FG010|Overall Study|Adverse Event|0|||
127756225|NCT01531673|459734277|FG011|Overall Study|Adverse Event|0|||
127756226|NCT01531673|459734278|FG012|Overall Study|Adverse Event|0|||
127756227|NCT01531673|459734266|FG000|Overall Study|Lost to Follow-up|0|||
127756228|NCT01531673|459734267|FG001|Overall Study|Lost to Follow-up|0|||
127756229|NCT01531673|459734268|FG002|Overall Study|Lost to Follow-up|0|||
127756230|NCT01531673|459734269|FG003|Overall Study|Lost to Follow-up|0|||
127756231|NCT01531673|459734270|FG004|Overall Study|Lost to Follow-up|1|||
127756232|NCT01531673|459734271|FG005|Overall Study|Lost to Follow-up|0|||
127756233|NCT01531673|459734272|FG006|Overall Study|Lost to Follow-up|0|||
127756234|NCT01531673|459734273|FG007|Overall Study|Lost to Follow-up|0|||
127756235|NCT01531673|459734274|FG008|Overall Study|Lost to Follow-up|0|||
127756236|NCT01531673|459734275|FG009|Overall Study|Lost to Follow-up|0|||
127756237|NCT01531673|459734276|FG010|Overall Study|Lost to Follow-up|0|||
127756238|NCT01531673|459734277|FG011|Overall Study|Lost to Follow-up|0|||
127756239|NCT01531673|459734278|FG012|Overall Study|Lost to Follow-up|0|||
127756240|NCT01531673|459734266|FG000|Overall Study|Other|0|||
127756241|NCT01531673|459734267|FG001|Overall Study|Other|0|||
127756242|NCT01531673|459734268|FG002|Overall Study|Other|0|||
127756243|NCT01531673|459734269|FG003|Overall Study|Other|1|||
127756244|NCT01531673|459734270|FG004|Overall Study|Other|0|||
127756245|NCT01531673|459734271|FG005|Overall Study|Other|0|||
127756246|NCT01531673|459734272|FG006|Overall Study|Other|0|||
127756247|NCT01531673|459734273|FG007|Overall Study|Other|0|||
127756248|NCT01531673|459734274|FG008|Overall Study|Other|0|||
127756249|NCT01531673|459734275|FG009|Overall Study|Other|1|||
127756250|NCT01531673|459734276|FG010|Overall Study|Other|0|||
127756251|NCT01531673|459734277|FG011|Overall Study|Other|0|||
127756252|NCT01531673|459734278|FG012|Overall Study|Other|0|||
127756253|NCT01008553|459734279|FG000|Period 1 (Titration Period)|Physician Decision|2|||
127756254|NCT01008553|459734280|FG001|Period 1 (Titration Period)|Physician Decision|0|||
127756255|NCT01008553|459734281|FG002|Period 1 (Titration Period)|Physician Decision|0|||
127756256|NCT01008553|459734279|FG000|Period 1 (Titration Period)|Adverse Event|33|||
127756257|NCT01008553|459734280|FG001|Period 1 (Titration Period)|Adverse Event|0|||
127756258|NCT01008553|459734281|FG002|Period 1 (Titration Period)|Adverse Event|0|||
127756259|NCT01008553|459734279|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
127756260|NCT01008553|459734280|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
127756261|NCT01008553|459734281|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
127756262|NCT01008553|459734279|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
127756263|NCT01008553|459734280|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
127756264|NCT01008553|459734281|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
127756265|NCT01008553|459734279|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
127756266|NCT01008553|459734280|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
127756267|NCT01008553|459734281|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
127756268|NCT01008553|459734279|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
127756269|NCT01008553|459734280|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
127756270|NCT01008553|459734281|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
127756271|NCT01008553|459734279|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
127756272|NCT01008553|459734280|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
127756273|NCT01008553|459734281|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
127756274|NCT01008553|459734279|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
127756275|NCT01008553|459734280|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
127756276|NCT01008553|459734281|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
127756277|NCT01008553|459734279|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
127756278|NCT01008553|459734280|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
127756279|NCT01008553|459734281|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
127756280|NCT01008553|459734279|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
127756281|NCT01008553|459734280|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
127756282|NCT01008553|459734281|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
127756283|NCT01008553|459734279|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
127756284|NCT01008553|459734280|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
127756285|NCT01008553|459734281|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
127756286|NCT01008553|459734279|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
127756287|NCT01008553|459734280|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
127756288|NCT01008553|459734281|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
127756289|NCT01008553|459734279|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
127756290|NCT01008553|459734280|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
127756291|NCT01008553|459734281|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
127756292|NCT01008553|459734279|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
127756293|NCT01008553|459734280|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
127756294|NCT01008553|459734281|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
127756295|NCT03563157|459734288|FG000|Overall Study|Progressive Disease|2|||
127756296|NCT02187159|459734289|FG000|Overall Study|Protocol Violation|4|||
127756297|NCT02187159|459734290|FG001|Overall Study|Protocol Violation|6|||
127756298|NCT02187159|459734291|FG002|Overall Study|Protocol Violation|3|||
127756299|NCT02187159|459734292|FG003|Overall Study|Protocol Violation|4|||
127756300|NCT02187159|459734289|FG000|Overall Study|Lack of Efficacy|10|||
127756301|NCT02187159|459734290|FG001|Overall Study|Lack of Efficacy|5|||
127756302|NCT02187159|459734291|FG002|Overall Study|Lack of Efficacy|4|||
127756303|NCT02187159|459734292|FG003|Overall Study|Lack of Efficacy|7|||
127756304|NCT02187159|459734289|FG000|Overall Study|Adverse Event|28|||
127756305|NCT02187159|459734290|FG001|Overall Study|Adverse Event|33|||
127756306|NCT02187159|459734291|FG002|Overall Study|Adverse Event|42|||
127756307|NCT02187159|459734292|FG003|Overall Study|Adverse Event|50|||
127756308|NCT02187159|459734289|FG000|Overall Study|Withdrawal by Subject|24|||
127756309|NCT02187159|459734290|FG001|Overall Study|Withdrawal by Subject|28|||
127756310|NCT02187159|459734291|FG002|Overall Study|Withdrawal by Subject|25|||
127756311|NCT02187159|459734292|FG003|Overall Study|Withdrawal by Subject|26|||
127756312|NCT02187159|459734289|FG000|Overall Study|Other|3|||
127756313|NCT02187159|459734290|FG001|Overall Study|Other|7|||
127756314|NCT02187159|459734291|FG002|Overall Study|Other|3|||
127756315|NCT02187159|459734292|FG003|Overall Study|Other|9|||
127756316|NCT00567567|459734293|FG000|Overall Study|Adverse Event|0|||
127756317|NCT00567567|459734294|FG001|Overall Study|Adverse Event|2|||
127756318|NCT00567567|459734295|FG002|Overall Study|Adverse Event|5|||
127756319|NCT00567567|459734293|FG000|Overall Study|Death|8|||
127756320|NCT00567567|459734294|FG001|Overall Study|Death|1|||
127756321|NCT00567567|459734295|FG002|Overall Study|Death|5|||
127756322|NCT00567567|459734293|FG000|Overall Study|Lack of Efficacy|16|||
127756323|NCT00567567|459734294|FG001|Overall Study|Lack of Efficacy|17|||
127811373|NCT01307423|459926533|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
127756324|NCT00567567|459734295|FG002|Overall Study|Lack of Efficacy|48|||
127811374|NCT01307423|459926534|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
127811375|NCT01307423|459926535|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
127811376|NCT01307423|459926536|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
127811377|NCT01307423|459926537|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
127811378|NCT01307423|459926538|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
127811379|NCT01307423|459926539|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
127811380|NCT01307423|459926540|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
127811381|NCT01307423|459926541|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
127811382|NCT01307423|459926533|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
127811383|NCT01307423|459926534|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
127811384|NCT01307423|459926535|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
127811385|NCT01307423|459926536|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
127811386|NCT01307423|459926537|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
127811387|NCT01307423|459926538|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
127811388|NCT01307423|459926539|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
127811389|NCT01307423|459926540|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
127811390|NCT01307423|459926541|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
127811391|NCT01307423|459926533|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
127811392|NCT01307423|459926534|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
127811393|NCT01307423|459926535|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
127811394|NCT01307423|459926536|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
127811395|NCT01307423|459926537|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
127811396|NCT01307423|459926538|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
127811397|NCT01307423|459926539|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
127811398|NCT01307423|459926540|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
127811399|NCT01307423|459926541|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
127811400|NCT01307423|459926533|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
127811401|NCT01307423|459926534|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
127811402|NCT01307423|459926535|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
127811403|NCT01307423|459926536|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
127811404|NCT01307423|459926537|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
127811405|NCT01307423|459926538|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
127811406|NCT01307423|459926539|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
127811407|NCT01307423|459926540|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
127811408|NCT01307423|459926541|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
127811409|NCT01307423|459926533|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
127811410|NCT01307423|459926534|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
127811411|NCT01307423|459926535|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
127811412|NCT01307423|459926536|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
127811413|NCT01307423|459926537|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
127811414|NCT01307423|459926538|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
127811415|NCT01307423|459926539|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
127811416|NCT01307423|459926540|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
127811417|NCT01307423|459926541|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
127811418|NCT01307423|459926533|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
127811419|NCT01307423|459926534|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
127811420|NCT01307423|459926535|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
127811421|NCT01307423|459926536|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
127811422|NCT01307423|459926537|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
127756325|NCT00567567|459734293|FG000|Overall Study|Lost to Follow-up|0|||
127756326|NCT00567567|459734294|FG001|Overall Study|Lost to Follow-up|0|||
127756327|NCT00567567|459734295|FG002|Overall Study|Lost to Follow-up|1|||
127756328|NCT00567567|459734293|FG000|Overall Study|Physician Decision|16|||
127756329|NCT00567567|459734294|FG001|Overall Study|Physician Decision|18|||
127756330|NCT00567567|459734295|FG002|Overall Study|Physician Decision|84|||
127756331|NCT00567567|459734293|FG000|Overall Study|Withdrawal by Subject|0|||
127756332|NCT00567567|459734294|FG001|Overall Study|Withdrawal by Subject|0|||
127756333|NCT00567567|459734295|FG002|Overall Study|Withdrawal by Subject|2|||
127756334|NCT00567567|459734293|FG000|Overall Study|Ineligible|4|||
127756335|NCT00567567|459734294|FG001|Overall Study|Ineligible|0|||
127756336|NCT00567567|459734295|FG002|Overall Study|Ineligible|9|||
127756337|NCT00567567|459734293|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
127756338|NCT00567567|459734294|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
127811423|NCT01307423|459926538|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
127811424|NCT01307423|459926539|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
127811425|NCT01307423|459926540|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
127811426|NCT01307423|459926541|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
127811427|NCT01307423|459926533|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
127756339|NCT00567567|459734295|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
127756340|NCT00567567|459734293|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
127811428|NCT01307423|459926534|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
127811429|NCT01307423|459926535|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
127756341|NCT00567567|459734294|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
127756342|NCT00567567|459734295|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
127756343|NCT00567567|459734293|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
127756344|NCT00567567|459734294|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
127756345|NCT00567567|459734295|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
127756346|NCT04335591|459734296|FG000|Overall Study|Adverse Event|5|||
127756347|NCT04335591|459734297|FG001|Overall Study|Adverse Event|2|||
127756348|NCT04335591|459734298|FG002|Overall Study|Adverse Event|3|||
127756349|NCT04335591|459734299|FG003|Overall Study|Adverse Event|2|||
127756350|NCT04335591|459734296|FG000|Overall Study|Protocol Violation|1|||
127756351|NCT04335591|459734297|FG001|Overall Study|Protocol Violation|0|||
127756352|NCT04335591|459734298|FG002|Overall Study|Protocol Violation|0|||
127756353|NCT04335591|459734299|FG003|Overall Study|Protocol Violation|0|||
127756354|NCT04335591|459734296|FG000|Overall Study|Withdrawal by Subject|8|||
127756355|NCT04335591|459734297|FG001|Overall Study|Withdrawal by Subject|4|||
127756356|NCT04335591|459734298|FG002|Overall Study|Withdrawal by Subject|4|||
127756357|NCT04335591|459734299|FG003|Overall Study|Withdrawal by Subject|5|||
127756358|NCT04335591|459734296|FG000|Overall Study|Subject planning pregnancy|0|||
127756359|NCT04335591|459734297|FG001|Overall Study|Subject planning pregnancy|1|||
127756360|NCT04335591|459734298|FG002|Overall Study|Subject planning pregnancy|0|||
127756361|NCT04335591|459734299|FG003|Overall Study|Subject planning pregnancy|0|||
127756362|NCT04335591|459734296|FG000|Overall Study|Ukrainian Russian war conflict|4|||
127756363|NCT04335591|459734297|FG001|Overall Study|Ukrainian Russian war conflict|5|||
127811430|NCT01307423|459926536|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
127811431|NCT01307423|459926537|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
127811432|NCT01307423|459926538|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
127811433|NCT01307423|459926539|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
127811434|NCT01307423|459926540|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
127811435|NCT01307423|459926541|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
127811436|NCT01307423|459926533|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
127811437|NCT01307423|459926534|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
127811438|NCT01307423|459926535|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
127811439|NCT01307423|459926536|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
127811440|NCT01307423|459926537|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
127811441|NCT01307423|459926538|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
127811442|NCT01307423|459926539|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
127811443|NCT01307423|459926540|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
127811444|NCT01307423|459926541|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
127811445|NCT01307423|459926533|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
127811446|NCT01307423|459926534|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
127811447|NCT01307423|459926535|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
127811448|NCT01307423|459926536|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
127811449|NCT01307423|459926537|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
127811450|NCT01307423|459926538|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
127756364|NCT04335591|459734298|FG002|Overall Study|Ukrainian Russian war conflict|2|||
127756365|NCT04335591|459734299|FG003|Overall Study|Ukrainian Russian war conflict|0|||
127756366|NCT01867333|459734300|FG000|Overall Study|Withdrawal by Subject|1|||
127756367|NCT01867333|459734301|FG001|Overall Study|Withdrawal by Subject|0|||
127756368|NCT01867333|459734300|FG000|Overall Study|Adverse Event|1|||
127756369|NCT01867333|459734301|FG001|Overall Study|Adverse Event|0|||
127756370|NCT01867333|459734300|FG000|Overall Study|Participant choice|1|||
127756371|NCT01867333|459734301|FG001|Overall Study|Participant choice|2|||
127756372|NCT01867333|459734300|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
127756373|NCT01867333|459734301|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
127811451|NCT01307423|459926539|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
127894374|NCT00929708|460235336|FG001|Overall Study|Lost to Follow-up|0|||
127756374|NCT01867333|459734300|FG000|Overall Study|Death|0|||
127756375|NCT01867333|459734301|FG001|Overall Study|Death|1|||
127756376|NCT01867333|459734300|FG000|Overall Study|Physician Decision|3|||
127811452|NCT01307423|459926540|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
127811453|NCT01307423|459926541|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
127811454|NCT01307423|459926533|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
127894375|NCT00929708|460235337|FG002|Overall Study|Lost to Follow-up|0|||
127894376|NCT00929708|460235338|FG003|Overall Study|Lost to Follow-up|1|||
127894377|NCT00929708|460235339|FG004|Overall Study|Lost to Follow-up|0|||
127756377|NCT01867333|459734301|FG001|Overall Study|Physician Decision|2|||
127756378|NCT01867333|459734300|FG000|Overall Study|Switched to alternative treatment|1|||
127756379|NCT01867333|459734301|FG001|Overall Study|Switched to alternative treatment|0|||
127756380|NCT00842244|459734302|FG000|Overall Study|Death|3|||
127756381|NCT00842244|459734302|FG000|Overall Study|Withdrawal by Subject|1|||
127756382|NCT00842244|459734302|FG000|Overall Study|Other|17|||
127811455|NCT01307423|459926534|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
127811456|NCT01307423|459926535|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
127811457|NCT01307423|459926536|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
127811458|NCT01307423|459926537|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
127811459|NCT01307423|459926538|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
127811460|NCT01307423|459926539|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
127811461|NCT01307423|459926540|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
127811462|NCT01307423|459926541|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
127811463|NCT01307423|459926533|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
127811464|NCT01307423|459926534|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
127811465|NCT01307423|459926535|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
127811466|NCT01307423|459926536|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
127811467|NCT01307423|459926537|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
127811468|NCT01307423|459926538|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
127811469|NCT01307423|459926539|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
127811470|NCT01307423|459926540|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
127811471|NCT01307423|459926541|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
127811472|NCT01307423|459926533|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
127811473|NCT01307423|459926534|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
127811474|NCT01307423|459926535|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
127811475|NCT01307423|459926536|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
127811476|NCT01307423|459926537|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
127811477|NCT01307423|459926538|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
127811478|NCT01307423|459926539|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
127811479|NCT01307423|459926540|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
127811480|NCT01307423|459926541|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
127811481|NCT01307423|459926533|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
127811482|NCT01307423|459926534|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
127811483|NCT01307423|459926535|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
127811484|NCT01307423|459926536|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
127811485|NCT01307423|459926537|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
127811486|NCT01307423|459926538|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
127811487|NCT01307423|459926539|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
127811488|NCT01307423|459926540|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
127811489|NCT01307423|459926541|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
127811490|NCT00190775|459926542|FG000|Overall Study|Adverse Event|57|||
127811491|NCT00190775|459926543|FG001|Overall Study|Adverse Event|22|||
127811492|NCT00190775|459926542|FG000|Overall Study|Satisfactory Response|1|||
127811493|NCT00190775|459926543|FG001|Overall Study|Satisfactory Response|0|||
127756383|NCT00635661|459734308|FG000|Overall Study|Withdrawal by Subject|4|||
127756384|NCT00403767|459734313|FG000|Overall Study|Adverse Event|993|||
127756385|NCT00403767|459734314|FG001|Overall Study|Adverse Event|919|||
127756386|NCT00403767|459734313|FG000|Overall Study|Non-compliant with study medication|134|||
127756387|NCT00403767|459734314|FG001|Overall Study|Non-compliant with study medication|164|||
127756388|NCT00403767|459734313|FG000|Overall Study|Consent withdrawn|671|||
127756389|NCT00403767|459734314|FG001|Overall Study|Consent withdrawn|673|||
127756390|NCT00403767|459734313|FG000|Overall Study|Investigator dec./not protocol-related|191|||
127756391|NCT00403767|459734314|FG001|Overall Study|Investigator dec./not protocol-related|178|||
127756392|NCT00403767|459734313|FG000|Overall Study|Lost to Follow-up|6|||
127756393|NCT00403767|459734314|FG001|Overall Study|Lost to Follow-up|8|||
127756394|NCT00403767|459734313|FG000|Overall Study|Protocol Violation|142|||
127756395|NCT00403767|459734314|FG001|Overall Study|Protocol Violation|124|||
127756396|NCT00403767|459734313|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
127756397|NCT00403767|459734314|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
127756398|NCT00403767|459734313|FG000|Overall Study|Study terminated by sponsor|82|||
127756399|NCT00403767|459734314|FG001|Overall Study|Study terminated by sponsor|69|||
127756400|NCT00403767|459734313|FG000|Overall Study|Missing/incomplete data|1|||
127756401|NCT00403767|459734314|FG001|Overall Study|Missing/incomplete data|1|||
127756402|NCT03192475|459734315|FG000|Overall Study|Death|0|||
127756403|NCT03192475|459734316|FG001|Overall Study|Death|1|||
127811494|NCT00190775|459926542|FG000|Overall Study|Lack of Efficacy|28|||
127811495|NCT00190775|459926543|FG001|Overall Study|Lack of Efficacy|32|||
127811496|NCT00190775|459926542|FG000|Overall Study|Lost to Follow-up|31|||
127811497|NCT00190775|459926543|FG001|Overall Study|Lost to Follow-up|23|||
127756404|NCT03192475|459734315|FG000|Overall Study|Lost to Follow-up|13|||
127756405|NCT03192475|459734316|FG001|Overall Study|Lost to Follow-up|8|||
127756406|NCT00436605|459734317|FG000|Overall Study|Protocol Violation|3|||
127811498|NCT00190775|459926542|FG000|Overall Study|Participant Moved|0|||
127811499|NCT00190775|459926543|FG001|Overall Study|Participant Moved|1|||
127811500|NCT00190775|459926542|FG000|Overall Study|Withdrawal by Subject|24|||
127811501|NCT00190775|459926543|FG001|Overall Study|Withdrawal by Subject|13|||
127811502|NCT00190775|459926542|FG000|Overall Study|Sponsor Decision|1|||
127756407|NCT01696045|459734318|FG000|Overall Study|Study drug toxicity|1|||
127756408|NCT01696045|459734319|FG001|Overall Study|Study drug toxicity|5|||
127756409|NCT01696045|459734318|FG000|Overall Study|Disease progression|2|||
127756410|NCT01696045|459734319|FG001|Overall Study|Disease progression|2|||
127756411|NCT01204710|459734329|FG000|Randomization Treatment|Lost to Follow-up|1|||
127756412|NCT01204710|459734330|FG001|Randomization Treatment|Lost to Follow-up|0|||
127756413|NCT01204710|459734329|FG000|Randomization Treatment|Withdrawal by Subject|6|||
127756414|NCT01204710|459734330|FG001|Randomization Treatment|Withdrawal by Subject|5|||
127756415|NCT01204710|459734329|FG000|Randomization Treatment|Physician Decision|3|||
127756416|NCT01204710|459734330|FG001|Randomization Treatment|Physician Decision|2|||
127756417|NCT01204710|459734329|FG000|Randomization Treatment|Entry criteria not met|0|||
127756418|NCT01204710|459734330|FG001|Randomization Treatment|Entry criteria not met|1|||
127756419|NCT01204710|459734329|FG000|Randomization Treatment|Adverse Event|4|||
127756420|NCT01204710|459734330|FG001|Randomization Treatment|Adverse Event|2|||
127756421|NCT01204710|459734329|FG000|Randomization Treatment|Sponsor Decision|0|||
127756422|NCT01204710|459734330|FG001|Randomization Treatment|Sponsor Decision|1|||
127756423|NCT01204710|459734329|FG000|Randomization Treatment|Worsening of General condition|0|||
127756424|NCT01204710|459734330|FG001|Randomization Treatment|Worsening of General condition|1|||
127756425|NCT01204710|459734329|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
127756426|NCT01204710|459734330|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
127756427|NCT01204710|459734329|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
127756428|NCT01204710|459734330|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
127756429|NCT01204710|459734329|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
127756430|NCT01204710|459734330|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
127756431|NCT01204710|459734329|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
127756432|NCT01204710|459734330|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
127756433|NCT01276379|459734331|FG000|Overall Study|Screening failure|40|||
127756434|NCT00864253|459734332|FG000|Overall Study|Adverse Event|56|||
127756435|NCT00864253|459734333|FG001|Overall Study|Adverse Event|11|||
127756436|NCT00864253|459734332|FG000|Overall Study|Unrelated Adverse Event|3|||
127756437|NCT00864253|459734333|FG001|Overall Study|Unrelated Adverse Event|1|||
127756438|NCT00864253|459734332|FG000|Overall Study|Physician Decision|11|||
127756439|NCT00864253|459734333|FG001|Overall Study|Physician Decision|15|||
127756440|NCT00864253|459734332|FG000|Overall Study|Protocol Violation|0|||
127756441|NCT00864253|459734333|FG001|Overall Study|Protocol Violation|2|||
127756442|NCT00864253|459734332|FG000|Overall Study|Lost to Follow-up|1|||
127756443|NCT00864253|459734333|FG001|Overall Study|Lost to Follow-up|1|||
127756444|NCT00864253|459734332|FG000|Overall Study|Withdrawal by Subject|18|||
127756445|NCT00864253|459734333|FG001|Overall Study|Withdrawal by Subject|18|||
127756446|NCT00864253|459734332|FG000|Overall Study|Death|1|||
127756447|NCT00864253|459734333|FG001|Overall Study|Death|0|||
127756448|NCT00864253|459734332|FG000|Overall Study|Ongoing|2|||
127756449|NCT00864253|459734333|FG001|Overall Study|Ongoing|3|||
127756450|NCT00864253|459734332|FG000|Overall Study|Untreated|7|||
127756451|NCT00864253|459734333|FG001|Overall Study|Untreated|7|||
127756452|NCT01896726|459734334|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
127756453|NCT01896726|459734334|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
127756454|NCT01128114|459734335|FG000|Overall Study|Treatment Withdrawn|6|||
127756455|NCT01128114|459734335|FG000|Overall Study|Screening Failed|2|||
127756456|NCT02206061|459734336|FG000|Overall Study|Withdrawal by Subject|4|||
127756457|NCT02206061|459734337|FG001|Overall Study|Withdrawal by Subject|7|||
127756458|NCT02206061|459734338|FG002|Overall Study|Withdrawal by Subject|1|||
127756459|NCT02206061|459734336|FG000|Overall Study|Lost to Follow-up|14|||
127756460|NCT02206061|459734337|FG001|Overall Study|Lost to Follow-up|7|||
127756461|NCT02206061|459734338|FG002|Overall Study|Lost to Follow-up|20|||
127756462|NCT04445987|459734339|FG000|Overall Study|Adverse Event|0|||
127811503|NCT00190775|459926543|FG001|Overall Study|Sponsor Decision|0|||
127811504|NCT00190775|459926542|FG000|Overall Study|Physician Decision|3|||
127811505|NCT00190775|459926543|FG001|Overall Study|Physician Decision|0|||
127811506|NCT00190775|459926542|FG000|Overall Study|Noncompliance|3|||
127811507|NCT00190775|459926543|FG001|Overall Study|Noncompliance|5|||
127811508|NCT00190775|459926542|FG000|Overall Study|Protocol Violation|0|||
127811509|NCT00190775|459926543|FG001|Overall Study|Protocol Violation|1|||
127811510|NCT00190775|459926542|FG000|Overall Study|Exclusion Criteria Met|1|||
127811511|NCT00190775|459926543|FG001|Overall Study|Exclusion Criteria Met|3|||
127811512|NCT00519077|459926544|FG000|Overall Study|Death|6|||
127811513|NCT00519077|459926544|FG000|Overall Study|Other|2|||
127811514|NCT01967225|459926545|FG000|Overall Study|Adverse Event|3|||
127811515|NCT01967225|459926546|FG001|Overall Study|Adverse Event|1|||
127756463|NCT04445987|459734340|FG001|Overall Study|Adverse Event|0|||
127756464|NCT04445987|459734341|FG002|Overall Study|Adverse Event|1|||
127756465|NCT04445987|459734342|FG003|Overall Study|Adverse Event|0|||
127756466|NCT04445987|459734343|FG004|Overall Study|Adverse Event|4|||
127756467|NCT04445987|459734344|FG005|Overall Study|Adverse Event|0|||
127756468|NCT04445987|459734339|FG000|Overall Study|Lost to Follow-up|4|||
127756469|NCT04445987|459734340|FG001|Overall Study|Lost to Follow-up|3|||
127811516|NCT01967225|459926545|FG000|Overall Study|Withdrawal by Subject|2|||
127756470|NCT04445987|459734341|FG002|Overall Study|Lost to Follow-up|1|||
127756471|NCT04445987|459734342|FG003|Overall Study|Lost to Follow-up|1|||
127756472|NCT04445987|459734343|FG004|Overall Study|Lost to Follow-up|29|||
127756473|NCT04445987|459734344|FG005|Overall Study|Lost to Follow-up|0|||
127756474|NCT04445987|459734339|FG000|Overall Study|Physician Decision|0|||
127756475|NCT04445987|459734340|FG001|Overall Study|Physician Decision|0|||
127756476|NCT04445987|459734341|FG002|Overall Study|Physician Decision|0|||
127756477|NCT04445987|459734342|FG003|Overall Study|Physician Decision|0|||
127756478|NCT04445987|459734343|FG004|Overall Study|Physician Decision|1|||
127756479|NCT04445987|459734344|FG005|Overall Study|Physician Decision|0|||
127756480|NCT04445987|459734339|FG000|Overall Study|Protocol Violation|1|||
127756481|NCT04445987|459734340|FG001|Overall Study|Protocol Violation|0|||
127756482|NCT04445987|459734341|FG002|Overall Study|Protocol Violation|0|||
127756483|NCT04445987|459734342|FG003|Overall Study|Protocol Violation|0|||
127756484|NCT04445987|459734343|FG004|Overall Study|Protocol Violation|2|||
127756485|NCT04445987|459734344|FG005|Overall Study|Protocol Violation|0|||
127756486|NCT04445987|459734339|FG000|Overall Study|Withdrawal by Subject|4|||
127756487|NCT04445987|459734340|FG001|Overall Study|Withdrawal by Subject|0|||
127756488|NCT04445987|459734341|FG002|Overall Study|Withdrawal by Subject|1|||
127756489|NCT04445987|459734342|FG003|Overall Study|Withdrawal by Subject|0|||
127756490|NCT04445987|459734343|FG004|Overall Study|Withdrawal by Subject|18|||
127756491|NCT04445987|459734344|FG005|Overall Study|Withdrawal by Subject|1|||
127756492|NCT04445987|459734339|FG000|Overall Study|Other reason|0|||
127756493|NCT04445987|459734340|FG001|Overall Study|Other reason|0|||
127756494|NCT04445987|459734341|FG002|Overall Study|Other reason|1|||
127756495|NCT04445987|459734342|FG003|Overall Study|Other reason|0|||
127756496|NCT04445987|459734343|FG004|Overall Study|Other reason|2|||
127756497|NCT04445987|459734344|FG005|Overall Study|Other reason|0|||
127756498|NCT04531098|459734354|FG000|Stage I|Adverse Event|0|||
127756499|NCT04531098|459734355|FG001|Stage I|Adverse Event|0|||
127756500|NCT04531098|459734356|FG002|Stage I|Adverse Event|3|||
127756501|NCT04531098|459734354|FG000|Stage I|Protocol Violation|0|||
127756502|NCT04531098|459734355|FG001|Stage I|Protocol Violation|0|||
127756503|NCT04531098|459734356|FG002|Stage I|Protocol Violation|5|||
127756504|NCT04531098|459734354|FG000|Stage I|Withdrawal by Subject|0|||
127756505|NCT04531098|459734355|FG001|Stage I|Withdrawal by Subject|5|||
127756506|NCT04531098|459734356|FG002|Stage I|Withdrawal by Subject|10|||
127756507|NCT04531098|459734354|FG000|Stage II|Adverse Event|1|||
127811517|NCT01967225|459926546|FG001|Overall Study|Withdrawal by Subject|1|||
127811518|NCT01967225|459926545|FG000|Overall Study|Lack of Efficacy|1|||
127811519|NCT01967225|459926546|FG001|Overall Study|Lack of Efficacy|1|||
127811520|NCT01967225|459926545|FG000|Overall Study|Switching to other therapy|2|||
127756508|NCT04531098|459734355|FG001|Stage II|Adverse Event|2|||
127756509|NCT04531098|459734356|FG002|Stage II|Adverse Event|0|||
127756510|NCT04531098|459734354|FG000|Stage II|Protocol Violation|1|||
127756511|NCT04531098|459734355|FG001|Stage II|Protocol Violation|2|||
127756512|NCT04531098|459734356|FG002|Stage II|Protocol Violation|0|||
127756513|NCT04531098|459734354|FG000|Stage II|Withdrawal by Subject|3|||
127756514|NCT04531098|459734355|FG001|Stage II|Withdrawal by Subject|1|||
127756515|NCT04531098|459734356|FG002|Stage II|Withdrawal by Subject|0|||
127756516|NCT04531098|459734354|FG000|Stage II|Moved from study area|8|||
127756517|NCT04531098|459734355|FG001|Stage II|Moved from study area|5|||
127756518|NCT04531098|459734356|FG002|Stage II|Moved from study area|0|||
127756519|NCT02628028|459734357|FG000|Dosing Period|Withdrawal by Subject|0|||
127756520|NCT02628028|459734358|FG001|Dosing Period|Withdrawal by Subject|0|||
127756521|NCT02628028|459734359|FG002|Dosing Period|Withdrawal by Subject|1|||
127756522|NCT02628028|459734360|FG003|Dosing Period|Withdrawal by Subject|0|||
127756523|NCT02628028|459734361|FG004|Dosing Period|Withdrawal by Subject|2|||
127756524|NCT02628028|459734362|FG005|Dosing Period|Withdrawal by Subject|4|||
127756525|NCT02628028|459734363|FG006|Dosing Period|Withdrawal by Subject|1|||
127811521|NCT01967225|459926546|FG001|Overall Study|Switching to other therapy|0|||
127811522|NCT01967225|459926545|FG000|Overall Study|Protocol driven decision point|1|||
127811523|NCT01967225|459926546|FG001|Overall Study|Protocol driven decision point|0|||
127811524|NCT01967225|459926545|FG000|Overall Study|Logistical difficulties|1|||
127756526|NCT02628028|459734364|FG007|Dosing Period|Withdrawal by Subject|1|||
127756527|NCT02628028|459734357|FG000|Dosing Period|Adverse Event|0|||
127756528|NCT02628028|459734358|FG001|Dosing Period|Adverse Event|0|||
127756529|NCT02628028|459734359|FG002|Dosing Period|Adverse Event|0|||
127756530|NCT02628028|459734360|FG003|Dosing Period|Adverse Event|0|||
127756531|NCT02628028|459734361|FG004|Dosing Period|Adverse Event|2|||
127756532|NCT02628028|459734362|FG005|Dosing Period|Adverse Event|1|||
127756533|NCT02628028|459734363|FG006|Dosing Period|Adverse Event|3|||
127756534|NCT02628028|459734364|FG007|Dosing Period|Adverse Event|2|||
127756535|NCT02628028|459734357|FG000|Dosing Period|Death|0|||
127756536|NCT02628028|459734358|FG001|Dosing Period|Death|0|||
127756537|NCT02628028|459734359|FG002|Dosing Period|Death|0|||
127756538|NCT02628028|459734360|FG003|Dosing Period|Death|0|||
127756539|NCT02628028|459734361|FG004|Dosing Period|Death|0|||
127756540|NCT02628028|459734362|FG005|Dosing Period|Death|0|||
127756541|NCT02628028|459734363|FG006|Dosing Period|Death|0|||
127756542|NCT02628028|459734364|FG007|Dosing Period|Death|1|||
127756543|NCT02628028|459734357|FG000|Dosing Period|Lack of Efficacy|0|||
127756544|NCT02628028|459734358|FG001|Dosing Period|Lack of Efficacy|0|||
127756545|NCT02628028|459734359|FG002|Dosing Period|Lack of Efficacy|0|||
127756546|NCT02628028|459734360|FG003|Dosing Period|Lack of Efficacy|0|||
127756547|NCT02628028|459734361|FG004|Dosing Period|Lack of Efficacy|3|||
127756548|NCT02628028|459734362|FG005|Dosing Period|Lack of Efficacy|0|||
127756549|NCT02628028|459734363|FG006|Dosing Period|Lack of Efficacy|1|||
127756550|NCT02628028|459734364|FG007|Dosing Period|Lack of Efficacy|0|||
127756551|NCT02628028|459734357|FG000|Dosing Period|Study Terminated by Sponsor|0|||
127756552|NCT02628028|459734358|FG001|Dosing Period|Study Terminated by Sponsor|0|||
127756553|NCT02628028|459734359|FG002|Dosing Period|Study Terminated by Sponsor|0|||
127756554|NCT02628028|459734360|FG003|Dosing Period|Study Terminated by Sponsor|0|||
127756555|NCT02628028|459734361|FG004|Dosing Period|Study Terminated by Sponsor|7|||
127756556|NCT02628028|459734362|FG005|Dosing Period|Study Terminated by Sponsor|6|||
127756557|NCT02628028|459734363|FG006|Dosing Period|Study Terminated by Sponsor|7|||
127756558|NCT02628028|459734364|FG007|Dosing Period|Study Terminated by Sponsor|7|||
127756559|NCT02628028|459734357|FG000|Dosing Period|Physician Decision|0|||
127756560|NCT02628028|459734358|FG001|Dosing Period|Physician Decision|0|||
127756561|NCT02628028|459734359|FG002|Dosing Period|Physician Decision|0|||
127756562|NCT02628028|459734360|FG003|Dosing Period|Physician Decision|0|||
127756563|NCT02628028|459734361|FG004|Dosing Period|Physician Decision|0|||
127756564|NCT02628028|459734362|FG005|Dosing Period|Physician Decision|1|||
127756565|NCT02628028|459734363|FG006|Dosing Period|Physician Decision|0|||
127756566|NCT02628028|459734364|FG007|Dosing Period|Physician Decision|0|||
127756567|NCT02628028|459734357|FG000|Dosing Period|Site Terminated by Sponsor|0|||
127756568|NCT02628028|459734358|FG001|Dosing Period|Site Terminated by Sponsor|0|||
127756569|NCT02628028|459734359|FG002|Dosing Period|Site Terminated by Sponsor|0|||
127756570|NCT02628028|459734360|FG003|Dosing Period|Site Terminated by Sponsor|0|||
127756571|NCT02628028|459734361|FG004|Dosing Period|Site Terminated by Sponsor|0|||
127756572|NCT02628028|459734362|FG005|Dosing Period|Site Terminated by Sponsor|1|||
127756573|NCT02628028|459734363|FG006|Dosing Period|Site Terminated by Sponsor|1|||
127756574|NCT02628028|459734364|FG007|Dosing Period|Site Terminated by Sponsor|0|||
127756575|NCT02628028|459734357|FG000|Dosing Period|Lost to Follow-up|0|||
127756576|NCT02628028|459734358|FG001|Dosing Period|Lost to Follow-up|0|||
127756577|NCT02628028|459734359|FG002|Dosing Period|Lost to Follow-up|0|||
127756578|NCT02628028|459734360|FG003|Dosing Period|Lost to Follow-up|0|||
127756579|NCT02628028|459734361|FG004|Dosing Period|Lost to Follow-up|0|||
127756580|NCT02628028|459734362|FG005|Dosing Period|Lost to Follow-up|0|||
127756581|NCT02628028|459734363|FG006|Dosing Period|Lost to Follow-up|1|||
127756582|NCT02628028|459734364|FG007|Dosing Period|Lost to Follow-up|0|||
127756583|NCT02628028|459734357|FG000|Dosing Period|Other|0|||
127756584|NCT02628028|459734358|FG001|Dosing Period|Other|0|||
127756585|NCT02628028|459734359|FG002|Dosing Period|Other|0|||
127756586|NCT02628028|459734360|FG003|Dosing Period|Other|0|||
127756587|NCT02628028|459734361|FG004|Dosing Period|Other|2|||
127756588|NCT02628028|459734362|FG005|Dosing Period|Other|1|||
127756589|NCT02628028|459734363|FG006|Dosing Period|Other|2|||
127756590|NCT02628028|459734364|FG007|Dosing Period|Other|4|||
127756591|NCT02628028|459734357|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
127756592|NCT02628028|459734358|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
127756593|NCT02628028|459734359|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
127756594|NCT02628028|459734360|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
127756595|NCT02628028|459734361|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
127756596|NCT02628028|459734362|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
127756597|NCT02628028|459734363|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
127756598|NCT02628028|459734364|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
127756599|NCT02628028|459734357|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
127756600|NCT02628028|459734358|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
127756601|NCT02628028|459734359|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
127756602|NCT02628028|459734360|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
127756603|NCT02628028|459734361|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
127756604|NCT02628028|459734362|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
127756605|NCT02628028|459734363|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
127756606|NCT02628028|459734364|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
127811525|NCT01967225|459926546|FG001|Overall Study|Logistical difficulties|0|||
127811526|NCT01967225|459926545|FG000|Overall Study|Protocol Violation|2|||
127756607|NCT02628028|459734357|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
127756608|NCT02628028|459734358|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
127756609|NCT02628028|459734359|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
127756610|NCT02628028|459734360|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
127756611|NCT02628028|459734361|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
127756612|NCT02628028|459734362|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
127756613|NCT02628028|459734363|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
127756614|NCT02628028|459734364|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
127756615|NCT02628028|459734357|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
127756616|NCT02628028|459734358|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
127756617|NCT02628028|459734359|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
127756618|NCT02628028|459734360|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
127756619|NCT02628028|459734361|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
127756620|NCT02628028|459734362|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
127756621|NCT02628028|459734363|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
127756622|NCT02628028|459734364|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
127756623|NCT02628028|459734357|FG000|Long-term Extension (LTE) Period|Other|0|||
127756624|NCT02628028|459734358|FG001|Long-term Extension (LTE) Period|Other|0|||
127756625|NCT02628028|459734359|FG002|Long-term Extension (LTE) Period|Other|0|||
127756626|NCT02628028|459734360|FG003|Long-term Extension (LTE) Period|Other|0|||
127756627|NCT02628028|459734361|FG004|Long-term Extension (LTE) Period|Other|0|||
127756628|NCT02628028|459734362|FG005|Long-term Extension (LTE) Period|Other|3|||
127756629|NCT02628028|459734363|FG006|Long-term Extension (LTE) Period|Other|4|||
127756630|NCT02628028|459734364|FG007|Long-term Extension (LTE) Period|Other|3|||
127756631|NCT02145468|459734365|FG000|Overall Study|Withdrawal by Subject|5|||
127756632|NCT02145468|459734366|FG001|Overall Study|Withdrawal by Subject|8|||
127756633|NCT04157400|459734367|FG000|Overall Study|Withdrawal by Subject|1|||
127756634|NCT04157400|459734367|FG000|Overall Study|Lost to Follow-up|3|||
127756635|NCT05543707|459734369|FG000|Overall Study|Study drug non-compliance/|5|||
127756636|NCT05543707|459734370|FG001|Overall Study|Study drug non-compliance/|0|||
127756637|NCT05543707|459734369|FG000|Overall Study|Withdrawal by Subject|1|||
127756638|NCT05543707|459734370|FG001|Overall Study|Withdrawal by Subject|1|||
127756639|NCT05543707|459734369|FG000|Overall Study|Adverse Event|1|||
127756640|NCT05543707|459734370|FG001|Overall Study|Adverse Event|0|||
127756641|NCT05543707|459734369|FG000|Overall Study|concurrent illness|0|||
127756642|NCT05543707|459734370|FG001|Overall Study|concurrent illness|1|||
127756643|NCT05543707|459734369|FG000|Overall Study|Pregnancy|1|||
127756644|NCT05543707|459734370|FG001|Overall Study|Pregnancy|1|||
127756645|NCT00186888|459734371|FG000|Overall Study|Toxicity|0|||
127756646|NCT00186888|459734372|FG001|Overall Study|Toxicity|1|||
127756647|NCT00186888|459734373|FG002|Overall Study|Toxicity|0|||
127756648|NCT00186888|459734371|FG000|Overall Study|Relapse or progression of disease|4|||
127756649|NCT00186888|459734372|FG001|Overall Study|Relapse or progression of disease|2|||
127756650|NCT00186888|459734373|FG002|Overall Study|Relapse or progression of disease|0|||
127756651|NCT02336451|459734376|FG000|Overall Study|Adverse Event|1|||
127756652|NCT02336451|459734377|FG001|Overall Study|Adverse Event|2|||
127756653|NCT02336451|459734378|FG002|Overall Study|Adverse Event|0|||
127756654|NCT02336451|459734379|FG003|Overall Study|Adverse Event|6|||
127756655|NCT02336451|459734380|FG004|Overall Study|Adverse Event|4|||
127756656|NCT02336451|459734376|FG000|Overall Study|Death|6|||
127756657|NCT02336451|459734377|FG001|Overall Study|Death|2|||
127756658|NCT02336451|459734378|FG002|Overall Study|Death|3|||
127756659|NCT02336451|459734379|FG003|Overall Study|Death|6|||
127756660|NCT02336451|459734380|FG004|Overall Study|Death|6|||
127756661|NCT02336451|459734376|FG000|Overall Study|Physician Decision|9|||
127756662|NCT02336451|459734377|FG001|Overall Study|Physician Decision|6|||
127756663|NCT02336451|459734378|FG002|Overall Study|Physician Decision|7|||
127756664|NCT02336451|459734379|FG003|Overall Study|Physician Decision|16|||
127756665|NCT02336451|459734380|FG004|Overall Study|Physician Decision|3|||
127756666|NCT02336451|459734376|FG000|Overall Study|Progressive disease|23|||
127756667|NCT02336451|459734377|FG001|Overall Study|Progressive disease|26|||
127756668|NCT02336451|459734378|FG002|Overall Study|Progressive disease|2|||
127756669|NCT02336451|459734379|FG003|Overall Study|Progressive disease|14|||
127756670|NCT02336451|459734380|FG004|Overall Study|Progressive disease|4|||
127756671|NCT02336451|459734376|FG000|Overall Study|Protocol Violation|1|||
127756672|NCT02336451|459734377|FG001|Overall Study|Protocol Violation|0|||
127756673|NCT02336451|459734378|FG002|Overall Study|Protocol Violation|0|||
127756674|NCT02336451|459734379|FG003|Overall Study|Protocol Violation|0|||
127756675|NCT02336451|459734380|FG004|Overall Study|Protocol Violation|0|||
127756676|NCT02336451|459734376|FG000|Overall Study|Patient/guardian decision|2|||
127756677|NCT02336451|459734377|FG001|Overall Study|Patient/guardian decision|4|||
127756678|NCT02336451|459734378|FG002|Overall Study|Patient/guardian decision|0|||
127756679|NCT02336451|459734379|FG003|Overall Study|Patient/guardian decision|2|||
127756680|NCT02336451|459734380|FG004|Overall Study|Patient/guardian decision|1|||
127756681|NCT02344290|459734385|FG000|Overall Study|Withdrawal by Subject|315|||
127756682|NCT02344290|459734386|FG001|Overall Study|Withdrawal by Subject|324|||
127756683|NCT02344290|459734385|FG000|Overall Study|Lost to Follow-up|258|||
127756684|NCT02344290|459734386|FG001|Overall Study|Lost to Follow-up|249|||
127756685|NCT02344290|459734385|FG000|Overall Study|Unable to get to clinic|69|||
127756686|NCT02344290|459734386|FG001|Overall Study|Unable to get to clinic|60|||
127756687|NCT02344290|459734385|FG000|Overall Study|Physician Decision|25|||
127756688|NCT02344290|459734386|FG001|Overall Study|Physician Decision|25|||
127756689|NCT02344290|459734385|FG000|Overall Study|Site Closure|15|||
127756690|NCT02344290|459734386|FG001|Overall Study|Site Closure|19|||
127756691|NCT02344290|459734385|FG000|Overall Study|Other|5|||
127756692|NCT02344290|459734386|FG001|Overall Study|Other|3|||
127756693|NCT04998812|459734387|FG000|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|1|||
127756694|NCT04998812|459734388|FG001|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|0|||
127756695|NCT04998812|459734387|FG000|Pregnancy and Early Post-Partum Period|Lost to Follow-up|1|||
127756696|NCT04998812|459734388|FG001|Pregnancy and Early Post-Partum Period|Lost to Follow-up|0|||
127756697|NCT04998812|459734387|FG000|Pregnancy and Early Post-Partum Period|Other|0|||
127756698|NCT04998812|459734388|FG001|Pregnancy and Early Post-Partum Period|Other|1|||
127756699|NCT04998812|459734387|FG000|Vaccination Period|Ongoing in study|23|||
127756700|NCT04998812|459734388|FG001|Vaccination Period|Ongoing in study|23|||
127756701|NCT03826030|459734389|FG000|Overall Study|Withdrawal by Subject|2|||
127756702|NCT03826030|459734390|FG001|Overall Study|Withdrawal by Subject|0|||
127756703|NCT03826030|459734391|FG002|Overall Study|Withdrawal by Subject|1|||
127756704|NCT03826030|459734389|FG000|Overall Study|Lost to Follow-up|1|||
127756705|NCT03826030|459734390|FG001|Overall Study|Lost to Follow-up|1|||
127756706|NCT03826030|459734391|FG002|Overall Study|Lost to Follow-up|1|||
127756707|NCT03826030|459734389|FG000|Overall Study|Too busy to return for visits|1|||
127811527|NCT01967225|459926546|FG001|Overall Study|Protocol Violation|0|||
127756708|NCT03826030|459734390|FG001|Overall Study|Too busy to return for visits|0|||
127756709|NCT03826030|459734391|FG002|Overall Study|Too busy to return for visits|0|||
127756710|NCT04893460|459734396|FG000|Overall Study|Lost to Follow-up|18|||
127756711|NCT03820947|459734399|FG000|Overall Study|Physician Decision|0|||
127756712|NCT03820947|459734400|FG001|Overall Study|Physician Decision|1|||
127756713|NCT03820947|459734401|FG002|Overall Study|Physician Decision|1|||
127756714|NCT03820947|459734402|FG003|Overall Study|Physician Decision|0|||
127756715|NCT03820947|459734403|FG004|Overall Study|Physician Decision|3|||
127756716|NCT03820947|459734399|FG000|Overall Study|Withdrawal by Subject|6|||
127756717|NCT03820947|459734400|FG001|Overall Study|Withdrawal by Subject|10|||
127756718|NCT03820947|459734401|FG002|Overall Study|Withdrawal by Subject|3|||
127756719|NCT03820947|459734402|FG003|Overall Study|Withdrawal by Subject|8|||
127756720|NCT03820947|459734403|FG004|Overall Study|Withdrawal by Subject|5|||
127756721|NCT03820947|459734399|FG000|Overall Study|Procedure Not Attempted|0|||
127756722|NCT03820947|459734400|FG001|Overall Study|Procedure Not Attempted|2|||
127756723|NCT03820947|459734401|FG002|Overall Study|Procedure Not Attempted|1|||
127756724|NCT03820947|459734402|FG003|Overall Study|Procedure Not Attempted|0|||
127756725|NCT03820947|459734403|FG004|Overall Study|Procedure Not Attempted|0|||
127756726|NCT03820947|459734399|FG000|Overall Study|Other Exit|1|||
127756727|NCT03820947|459734400|FG001|Overall Study|Other Exit|3|||
127756728|NCT03820947|459734401|FG002|Overall Study|Other Exit|3|||
127756729|NCT03820947|459734402|FG003|Overall Study|Other Exit|3|||
127756730|NCT03820947|459734403|FG004|Overall Study|Other Exit|0|||
127756731|NCT03820947|459734399|FG000|Overall Study|Follow-up Not Done|10|||
127756732|NCT03820947|459734400|FG001|Overall Study|Follow-up Not Done|13|||
127756733|NCT03820947|459734401|FG002|Overall Study|Follow-up Not Done|2|||
127756734|NCT03820947|459734402|FG003|Overall Study|Follow-up Not Done|3|||
127756735|NCT03820947|459734403|FG004|Overall Study|Follow-up Not Done|12|||
127756736|NCT03820947|459734399|FG000|Overall Study|Death|0|||
127756737|NCT03820947|459734400|FG001|Overall Study|Death|0|||
127756738|NCT03820947|459734401|FG002|Overall Study|Death|0|||
127756739|NCT03820947|459734402|FG003|Overall Study|Death|0|||
127756740|NCT03820947|459734403|FG004|Overall Study|Death|9|||
127756741|NCT03820947|459734399|FG000|Overall Study|Lost to Follow-up|4|||
127756742|NCT03820947|459734400|FG001|Overall Study|Lost to Follow-up|6|||
127756743|NCT03820947|459734401|FG002|Overall Study|Lost to Follow-up|0|||
127756744|NCT03820947|459734402|FG003|Overall Study|Lost to Follow-up|0|||
127756745|NCT03820947|459734403|FG004|Overall Study|Lost to Follow-up|9|||
127756746|NCT02218606|459736589|FG000|Overall Study|Adverse Event|1|||
127756747|NCT02218606|459736590|FG001|Overall Study|Adverse Event|1|||
127756748|NCT02218606|459736589|FG000|Overall Study|Death|15|||
127756749|NCT02218606|459736590|FG001|Overall Study|Death|28|||
127756750|NCT02218606|459736589|FG000|Overall Study|Physician Decision|0|||
127756751|NCT02218606|459736590|FG001|Overall Study|Physician Decision|1|||
127756752|NCT02218606|459736589|FG000|Overall Study|Withdrawal by Subject|4|||
127756753|NCT02218606|459736590|FG001|Overall Study|Withdrawal by Subject|0|||
127756754|NCT02218606|459736589|FG000|Overall Study|Noncompliance|1|||
127756755|NCT02218606|459736590|FG001|Overall Study|Noncompliance|0|||
127756756|NCT02218606|459736589|FG000|Overall Study|Initiation of new drug for prostate cancer|2|||
127811528|NCT03896295|459926547|FG000|Overall Study|Adverse Event|0|||
127756757|NCT02218606|459736590|FG001|Overall Study|Initiation of new drug for prostate cancer|0|||
127756758|NCT02218606|459736589|FG000|Overall Study|Other|2|||
127756759|NCT02218606|459736590|FG001|Overall Study|Other|1|||
127756760|NCT02218606|459736589|FG000|Overall Study|Never started treatment|0|||
127756761|NCT02218606|459736590|FG001|Overall Study|Never started treatment|1|||
127756762|NCT03203473|459736591|FG000|Induction Phase|Never started primary treatment|2|||
127756763|NCT03203473|459736592|FG001|Induction Phase|Never started primary treatment|0|||
127756764|NCT03203473|459736593|FG002|Induction Phase|Never started primary treatment|0|||
127756765|NCT03203473|459736591|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
127756766|NCT03203473|459736592|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
127756767|NCT03203473|459736593|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
127756768|NCT03203473|459736591|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
127756769|NCT03203473|459736592|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
127756770|NCT03203473|459736593|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
127756771|NCT03203473|459736591|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
127756772|NCT03203473|459736592|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
127756773|NCT03203473|459736593|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
127756774|NCT03203473|459736591|FG000|Arm Allocation Phase|started salvage therapy|0|||
127756775|NCT03203473|459736592|FG001|Arm Allocation Phase|started salvage therapy|5|||
127756776|NCT03203473|459736593|FG002|Arm Allocation Phase|started salvage therapy|0|||
127756777|NCT03203473|459736591|FG000|Arm Allocation Phase|Disease progression|0|||
127756778|NCT03203473|459736592|FG001|Arm Allocation Phase|Disease progression|0|||
127756779|NCT03203473|459736593|FG002|Arm Allocation Phase|Disease progression|37|||
127756780|NCT03203473|459736591|FG000|Arm Allocation Phase|Adverse Event|0|||
127756781|NCT03203473|459736592|FG001|Arm Allocation Phase|Adverse Event|0|||
127756782|NCT03203473|459736593|FG002|Arm Allocation Phase|Adverse Event|11|||
127756783|NCT03203473|459736591|FG000|Arm Allocation Phase|Physician Decision|0|||
127756784|NCT03203473|459736592|FG001|Arm Allocation Phase|Physician Decision|0|||
127756785|NCT03203473|459736593|FG002|Arm Allocation Phase|Physician Decision|3|||
127756786|NCT03203473|459736591|FG000|Arm Allocation Phase|Death|0|||
127756787|NCT03203473|459736592|FG001|Arm Allocation Phase|Death|0|||
127756788|NCT03203473|459736593|FG002|Arm Allocation Phase|Death|1|||
127756789|NCT03203473|459736591|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
127756790|NCT03203473|459736592|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
127756791|NCT03203473|459736593|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
127756792|NCT03203473|459736591|FG000|Arm Allocation Phase|Intercurrent illness|0|||
127756793|NCT03203473|459736592|FG001|Arm Allocation Phase|Intercurrent illness|0|||
127756794|NCT03203473|459736593|FG002|Arm Allocation Phase|Intercurrent illness|1|||
127756795|NCT03203473|459736591|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
127756796|NCT03203473|459736592|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
127756797|NCT03203473|459736593|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
127756798|NCT00890695|459736594|FG000|Overall Study|Protocol Violation|1|||
127756799|NCT00890695|459736595|FG001|Overall Study|Protocol Violation|0|||
127756800|NCT01732822|459736600|FG000|Overall Study|Withdrawal by Subject|123|||
127756801|NCT01732822|459736601|FG001|Overall Study|Withdrawal by Subject|113|||
127756802|NCT01183260|459736602|FG000|Overall Study|Intraop screen failure|2|||
127756803|NCT01183260|459736603|FG001|Overall Study|Intraop screen failure|0|||
127756804|NCT01183260|459736602|FG000|Overall Study|Withdrawal by Subject|1|||
127756805|NCT01183260|459736603|FG001|Overall Study|Withdrawal by Subject|1|||
127756806|NCT01183260|459736602|FG000|Overall Study|Revised within 30 days|0|||
127756807|NCT01183260|459736603|FG001|Overall Study|Revised within 30 days|1|||
127756808|NCT01183260|459736602|FG000|Overall Study|Death|1|||
127756809|NCT01183260|459736603|FG001|Overall Study|Death|0|||
127756810|NCT01255631|459736604|FG000|Overall Study|poor enrollment, no data analyzed|9|||
127756811|NCT01255631|459736605|FG001|Overall Study|poor enrollment, no data analyzed|6|||
127756812|NCT00568178|459736615|FG000|Double Blind Base Study|Adverse Event|0|||
127756813|NCT00568178|459736616|FG001|Double Blind Base Study|Adverse Event|2|||
127756814|NCT00568178|459736617|FG002|Double Blind Base Study|Adverse Event|1|||
127756815|NCT00568178|459736618|FG003|Double Blind Base Study|Adverse Event|2|||
127756816|NCT00568178|459736619|FG004|Double Blind Base Study|Adverse Event|0|||
127756817|NCT00568178|459736620|FG005|Double Blind Base Study|Adverse Event|0|||
127756818|NCT00568178|459736615|FG000|Double Blind Base Study|Lost to Follow-up|1|||
127756819|NCT00568178|459736616|FG001|Double Blind Base Study|Lost to Follow-up|0|||
127756820|NCT00568178|459736617|FG002|Double Blind Base Study|Lost to Follow-up|0|||
127756821|NCT00568178|459736618|FG003|Double Blind Base Study|Lost to Follow-up|1|||
127756822|NCT00568178|459736619|FG004|Double Blind Base Study|Lost to Follow-up|0|||
127756823|NCT00568178|459736620|FG005|Double Blind Base Study|Lost to Follow-up|0|||
127756824|NCT00568178|459736615|FG000|Double Blind Base Study|Physician Decision|1|||
127756825|NCT00568178|459736616|FG001|Double Blind Base Study|Physician Decision|1|||
127756826|NCT00568178|459736617|FG002|Double Blind Base Study|Physician Decision|0|||
127756827|NCT00568178|459736618|FG003|Double Blind Base Study|Physician Decision|1|||
127756828|NCT00568178|459736619|FG004|Double Blind Base Study|Physician Decision|0|||
127756829|NCT00568178|459736620|FG005|Double Blind Base Study|Physician Decision|0|||
127811529|NCT03896295|459926548|FG001|Overall Study|Adverse Event|1|||
127811530|NCT03896295|459926547|FG000|Overall Study|COVID-19|7|||
127756830|NCT00568178|459736615|FG000|Double Blind Base Study|Protocol Violation|3|||
127756831|NCT00568178|459736616|FG001|Double Blind Base Study|Protocol Violation|2|||
127756832|NCT00568178|459736617|FG002|Double Blind Base Study|Protocol Violation|0|||
127756833|NCT00568178|459736618|FG003|Double Blind Base Study|Protocol Violation|0|||
127756834|NCT00568178|459736619|FG004|Double Blind Base Study|Protocol Violation|0|||
127756835|NCT00568178|459736620|FG005|Double Blind Base Study|Protocol Violation|0|||
127756836|NCT00568178|459736615|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
127756837|NCT00568178|459736616|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
127756838|NCT00568178|459736617|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
127756839|NCT00568178|459736618|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
127756840|NCT00568178|459736619|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
127756841|NCT00568178|459736620|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
127756842|NCT00568178|459736615|FG000|Double Blind Base Study|Progressive Disease|0|||
127756843|NCT00568178|459736616|FG001|Double Blind Base Study|Progressive Disease|0|||
127756844|NCT00568178|459736617|FG002|Double Blind Base Study|Progressive Disease|0|||
127756845|NCT00568178|459736618|FG003|Double Blind Base Study|Progressive Disease|1|||
127756846|NCT00568178|459736619|FG004|Double Blind Base Study|Progressive Disease|0|||
127756847|NCT00568178|459736620|FG005|Double Blind Base Study|Progressive Disease|0|||
127756848|NCT00568178|459736615|FG000|Open Label Extension|Adverse Event|0|||
127756849|NCT00568178|459736616|FG001|Open Label Extension|Adverse Event|0|||
127756850|NCT00568178|459736617|FG002|Open Label Extension|Adverse Event|0|||
127756851|NCT00568178|459736618|FG003|Open Label Extension|Adverse Event|0|||
127756852|NCT00568178|459736619|FG004|Open Label Extension|Adverse Event|11|||
127756853|NCT00568178|459736620|FG005|Open Label Extension|Adverse Event|8|||
127756854|NCT00568178|459736615|FG000|Open Label Extension|Protocol Violation|0|||
127756855|NCT00568178|459736616|FG001|Open Label Extension|Protocol Violation|0|||
127756856|NCT00568178|459736617|FG002|Open Label Extension|Protocol Violation|0|||
127756857|NCT00568178|459736618|FG003|Open Label Extension|Protocol Violation|0|||
127756858|NCT00568178|459736619|FG004|Open Label Extension|Protocol Violation|1|||
127756859|NCT00568178|459736620|FG005|Open Label Extension|Protocol Violation|0|||
127756860|NCT00568178|459736615|FG000|Open Label Extension|Lost to Follow-up|0|||
127756861|NCT00568178|459736616|FG001|Open Label Extension|Lost to Follow-up|0|||
127756862|NCT00568178|459736617|FG002|Open Label Extension|Lost to Follow-up|0|||
127756863|NCT00568178|459736618|FG003|Open Label Extension|Lost to Follow-up|0|||
127756864|NCT00568178|459736619|FG004|Open Label Extension|Lost to Follow-up|6|||
127756865|NCT00568178|459736620|FG005|Open Label Extension|Lost to Follow-up|11|||
127756866|NCT00568178|459736615|FG000|Open Label Extension|Physician Decision|0|||
127756867|NCT00568178|459736616|FG001|Open Label Extension|Physician Decision|0|||
127756868|NCT00568178|459736617|FG002|Open Label Extension|Physician Decision|0|||
127756869|NCT00568178|459736618|FG003|Open Label Extension|Physician Decision|0|||
127756870|NCT00568178|459736619|FG004|Open Label Extension|Physician Decision|9|||
127756871|NCT00568178|459736620|FG005|Open Label Extension|Physician Decision|8|||
127756872|NCT00568178|459736615|FG000|Open Label Extension|Pregnancy|0|||
127756873|NCT00568178|459736616|FG001|Open Label Extension|Pregnancy|0|||
127756874|NCT00568178|459736617|FG002|Open Label Extension|Pregnancy|0|||
127756875|NCT00568178|459736618|FG003|Open Label Extension|Pregnancy|0|||
127756876|NCT00568178|459736619|FG004|Open Label Extension|Pregnancy|0|||
127756877|NCT00568178|459736620|FG005|Open Label Extension|Pregnancy|1|||
127756878|NCT00568178|459736615|FG000|Open Label Extension|Progressive Disease|0|||
127756879|NCT00568178|459736616|FG001|Open Label Extension|Progressive Disease|0|||
127756880|NCT00568178|459736617|FG002|Open Label Extension|Progressive Disease|0|||
127756881|NCT00568178|459736618|FG003|Open Label Extension|Progressive Disease|0|||
127756882|NCT00568178|459736619|FG004|Open Label Extension|Progressive Disease|3|||
127756883|NCT00568178|459736620|FG005|Open Label Extension|Progressive Disease|1|||
127756884|NCT00568178|459736615|FG000|Open Label Extension|Termination of Trial|0|||
127756885|NCT00568178|459736616|FG001|Open Label Extension|Termination of Trial|0|||
127756886|NCT00568178|459736617|FG002|Open Label Extension|Termination of Trial|0|||
127756887|NCT00568178|459736618|FG003|Open Label Extension|Termination of Trial|0|||
127811531|NCT03896295|459926548|FG001|Overall Study|COVID-19|29|||
127811532|NCT00700804|459926549|FG000|Overall Study|Withdrawal by Subject|1|||
127811533|NCT00700804|459926550|FG001|Overall Study|Withdrawal by Subject|2|||
127756888|NCT00568178|459736619|FG004|Open Label Extension|Termination of Trial|45|||
127756889|NCT00568178|459736620|FG005|Open Label Extension|Termination of Trial|47|||
127756890|NCT00568178|459736615|FG000|Open Label Extension|Withdrawal by Subject|0|||
127756891|NCT00568178|459736616|FG001|Open Label Extension|Withdrawal by Subject|0|||
127756892|NCT00568178|459736617|FG002|Open Label Extension|Withdrawal by Subject|0|||
127756893|NCT00568178|459736618|FG003|Open Label Extension|Withdrawal by Subject|0|||
127756894|NCT00568178|459736619|FG004|Open Label Extension|Withdrawal by Subject|4|||
127756895|NCT00568178|459736620|FG005|Open Label Extension|Withdrawal by Subject|4|||
127756896|NCT02815579|459736621|FG000|Overall Study|Non-payment of loan down-payment|16|||
127756897|NCT02815579|459736622|FG001|Overall Study|Non-payment of loan down-payment|0|||
127756898|NCT02815579|459736621|FG000|Overall Study|Withdrawal by Subject|7|||
127756899|NCT02815579|459736622|FG001|Overall Study|Withdrawal by Subject|1|||
127756900|NCT02815579|459736621|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
127756901|NCT02815579|459736622|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
127756902|NCT02815579|459736621|FG000|Overall Study|Lost to Follow-up|7|||
127756903|NCT02815579|459736622|FG001|Overall Study|Lost to Follow-up|4|||
127756904|NCT02815579|459736621|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
127756905|NCT02815579|459736622|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
127756906|NCT02815579|459736621|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
127756907|NCT02815579|459736622|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
127756908|NCT02815579|459736621|FG000|Overall Study|Death|5|||
127756909|NCT02815579|459736622|FG001|Overall Study|Death|4|||
127756910|NCT02815579|459736621|FG000|Overall Study|Imprisoned|0|||
127756911|NCT02815579|459736622|FG001|Overall Study|Imprisoned|2|||
127756912|NCT02815579|459736621|FG000|Overall Study|Did not meet enrollment criteria|0|||
127756913|NCT02815579|459736622|FG001|Overall Study|Did not meet enrollment criteria|1|||
127756914|NCT00264303|459736623|FG000|Overall Study|Adverse Event|4|||
127756915|NCT00264303|459736624|FG001|Overall Study|Adverse Event|3|||
127756916|NCT00264303|459736623|FG000|Overall Study|Lack of Efficacy|10|||
127756917|NCT00264303|459736624|FG001|Overall Study|Lack of Efficacy|13|||
127756918|NCT00264303|459736623|FG000|Overall Study|Lost to Follow-up|3|||
127756919|NCT00264303|459736624|FG001|Overall Study|Lost to Follow-up|3|||
127756920|NCT00264303|459736623|FG000|Overall Study|Withdrawal by Subject|2|||
127756921|NCT00264303|459736624|FG001|Overall Study|Withdrawal by Subject|3|||
127756922|NCT00264303|459736623|FG000|Overall Study|Various reasons listed in study report|6|||
127756923|NCT00264303|459736624|FG001|Overall Study|Various reasons listed in study report|7|||
127756924|NCT02389452|459736625|FG000|Overall Study|Lost to Follow-up|13|||
127756925|NCT02389452|459736625|FG000|Overall Study|Adverse Event|1|||
127756926|NCT02389452|459736625|FG000|Overall Study|Withdrawal by Subject|5|||
127756927|NCT02389452|459736625|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
127756928|NCT02311673|459736626|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
127756929|NCT02311673|459736627|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
127756930|NCT02311673|459736628|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
127756931|NCT02311673|459736629|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
127756932|NCT00414908|459736639|FG000|Overall Study|Protocol Violation|1|||
127756933|NCT00414908|459736640|FG001|Overall Study|Protocol Violation|1|||
127756934|NCT01076153|459736641|FG000|Overall Study|Symptoms improved/resolved|10|||
127756935|NCT01076153|459736641|FG000|Overall Study|Adverse Event|1|||
127756936|NCT00818168|459736642|FG000|Overall Study|Lack of Efficacy|18|||
127756937|NCT00818168|459736642|FG000|Overall Study|Pregnancy|2|||
127756938|NCT00818168|459736642|FG000|Overall Study|Withdrawal by Subject|16|||
127756939|NCT00818168|459736642|FG000|Overall Study|Lost to Follow-up|7|||
127756940|NCT00818168|459736642|FG000|Overall Study|Adverse Event|19|||
127756941|NCT00818168|459736642|FG000|Overall Study|Reason for Non-completion Not reported|6|||
127756942|NCT00818168|459736642|FG000|Overall Study|Participant Moved|2|||
127756943|NCT02040259|459736643|FG000|Overall Study|Death|280|||
127756944|NCT02040259|459736643|FG000|Overall Study|Lost to Follow-up|76|||
127756945|NCT02040259|459736643|FG000|Overall Study|Assessment not completed|3|||
127756946|NCT02040259|459736643|FG000|Overall Study|Withdrawal by Subject|4|||
127756947|NCT04476251|459736644|FG000|Overall Study|Not treated|1|||
127756948|NCT00316602|459736655|FG000|Overall Study|Withdrawal by Subject|3|||
127756949|NCT00316602|459736656|FG001|Overall Study|Withdrawal by Subject|2|||
127756950|NCT00316602|459736655|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
127756951|NCT00316602|459736656|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
127756952|NCT00316602|459736655|FG000|Overall Study|Adverse Event|1|||
127756953|NCT00316602|459736656|FG001|Overall Study|Adverse Event|0|||
127756954|NCT00316602|459736655|FG000|Overall Study|Other|3|||
127756955|NCT00316602|459736656|FG001|Overall Study|Other|6|||
127756956|NCT00626990|459736659|FG000|Overall Study|Lack of Efficacy|6|||
127756957|NCT00626990|459736660|FG001|Overall Study|Lack of Efficacy|7|||
127756958|NCT00626990|459736661|FG002|Overall Study|Lack of Efficacy|49|||
127756959|NCT00626990|459736662|FG003|Overall Study|Lack of Efficacy|40|||
127756960|NCT00626990|459736659|FG000|Overall Study|Adverse Event|1|||
127894378|NCT01893138|460235340|FG000|Double-Blind Period|Withdrawal by Subject|1|||
127894379|NCT01893138|460235341|FG001|Double-Blind Period|Withdrawal by Subject|1|||
127756961|NCT00626990|459736660|FG001|Overall Study|Adverse Event|7|||
127756962|NCT00626990|459736661|FG002|Overall Study|Adverse Event|14|||
127756963|NCT00626990|459736662|FG003|Overall Study|Adverse Event|28|||
127756964|NCT00626990|459736659|FG000|Overall Study|Death|0|||
127756965|NCT00626990|459736660|FG001|Overall Study|Death|1|||
127756966|NCT00626990|459736661|FG002|Overall Study|Death|0|||
127756967|NCT00626990|459736662|FG003|Overall Study|Death|0|||
127756968|NCT00626990|459736659|FG000|Overall Study|Withdrawal by Subject|3|||
127756969|NCT00626990|459736660|FG001|Overall Study|Withdrawal by Subject|1|||
127756970|NCT00626990|459736661|FG002|Overall Study|Withdrawal by Subject|5|||
127756971|NCT00626990|459736662|FG003|Overall Study|Withdrawal by Subject|11|||
127756972|NCT00626990|459736659|FG000|Overall Study|Protocol Violation|0|||
127756973|NCT00626990|459736660|FG001|Overall Study|Protocol Violation|1|||
127756974|NCT00626990|459736661|FG002|Overall Study|Protocol Violation|1|||
127756975|NCT00626990|459736662|FG003|Overall Study|Protocol Violation|0|||
127756976|NCT00626990|459736659|FG000|Overall Study|Various different reasons/missing|4|||
127756977|NCT00626990|459736660|FG001|Overall Study|Various different reasons/missing|8|||
127756978|NCT00626990|459736661|FG002|Overall Study|Various different reasons/missing|8|||
127756979|NCT00626990|459736662|FG003|Overall Study|Various different reasons/missing|16|||
127756980|NCT04138576|459736667|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
127756981|NCT01008410|459736669|FG000|Overall Study|Adverse Event|13|||
127756982|NCT01008410|459736670|FG001|Overall Study|Adverse Event|7|||
127756983|NCT01008410|459736669|FG000|Overall Study|Withdrawal by Subject|6|||
127756984|NCT01008410|459736670|FG001|Overall Study|Withdrawal by Subject|2|||
127756985|NCT01008410|459736669|FG000|Overall Study|Lost to Follow-up|1|||
127756986|NCT01008410|459736670|FG001|Overall Study|Lost to Follow-up|0|||
127756987|NCT01008410|459736669|FG000|Overall Study|Noncompliance|1|||
127756988|NCT01008410|459736670|FG001|Overall Study|Noncompliance|0|||
127756989|NCT01008410|459736669|FG000|Overall Study|Low Cortisol|2|||
127756990|NCT01008410|459736670|FG001|Overall Study|Low Cortisol|0|||
127756991|NCT01008410|459736669|FG000|Overall Study|Lack of Efficacy|2|||
127756992|NCT01008410|459736670|FG001|Overall Study|Lack of Efficacy|6|||
127756993|NCT01008410|459736669|FG000|Overall Study|Met Exclusion Criterion|0|||
127756994|NCT01008410|459736670|FG001|Overall Study|Met Exclusion Criterion|1|||
127756995|NCT00297427|459736673|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
127756996|NCT00297427|459736674|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
127756997|NCT00297427|459736673|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
127756998|NCT00297427|459736674|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
127756999|NCT00297427|459736673|FG000|Phase 1: Initial Intervention|Death|0|||
127757000|NCT00297427|459736674|FG001|Phase 1: Initial Intervention|Death|1|||
127757001|NCT00297427|459736673|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
127757002|NCT00297427|459736674|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
127757003|NCT00297427|459736673|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
127757004|NCT00297427|459736674|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
127757005|NCT00297427|459736673|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
127757006|NCT00297427|459736674|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
127757007|NCT00297427|459736673|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
127757008|NCT00297427|459736674|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
127757009|NCT00297427|459736673|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
127757010|NCT00297427|459736674|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
127757011|NCT03056300|459736675|FG000|Overall Study|Surgical reason per study protocol|3|||
127757012|NCT03248882|459736676|FG000|Overall Study|Adverse Event|3|||
127757013|NCT03248882|459736677|FG001|Overall Study|Adverse Event|3|||
127757014|NCT03248882|459736678|FG002|Overall Study|Adverse Event|2|||
127757015|NCT03248882|459736679|FG003|Overall Study|Adverse Event|6|||
127757016|NCT03248882|459736680|FG004|Overall Study|Adverse Event|9|||
127757017|NCT03248882|459736676|FG000|Overall Study|Lost to Follow-up|0|||
127757018|NCT03248882|459736677|FG001|Overall Study|Lost to Follow-up|0|||
127757019|NCT03248882|459736678|FG002|Overall Study|Lost to Follow-up|0|||
127757020|NCT03248882|459736679|FG003|Overall Study|Lost to Follow-up|0|||
127894380|NCT01893138|460235340|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
127757021|NCT03248882|459736680|FG004|Overall Study|Lost to Follow-up|1|||
127757022|NCT03248882|459736676|FG000|Overall Study|Protocol Violation|2|||
127757023|NCT03248882|459736677|FG001|Overall Study|Protocol Violation|0|||
127757024|NCT03248882|459736678|FG002|Overall Study|Protocol Violation|2|||
127894381|NCT01893138|460235341|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
127894382|NCT01893138|460235340|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
127894383|NCT01893138|460235341|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
127894384|NCT01893138|460235340|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
127757025|NCT03248882|459736679|FG003|Overall Study|Protocol Violation|0|||
127757026|NCT03248882|459736680|FG004|Overall Study|Protocol Violation|1|||
127757027|NCT03248882|459736676|FG000|Overall Study|Withdrawal by Subject|2|||
127757028|NCT03248882|459736677|FG001|Overall Study|Withdrawal by Subject|2|||
127757029|NCT03248882|459736678|FG002|Overall Study|Withdrawal by Subject|3|||
127757030|NCT03248882|459736679|FG003|Overall Study|Withdrawal by Subject|4|||
127757031|NCT03248882|459736680|FG004|Overall Study|Withdrawal by Subject|2|||
127757032|NCT01656200|459736681|FG000|Overall Study|Withdrawal by Subject|1|||
127757033|NCT01156376|459736687|FG000|Overall Study|Adverse Event|1|||
127757034|NCT01156376|459736688|FG001|Overall Study|Adverse Event|0|||
127757035|NCT01156376|459736689|FG002|Overall Study|Adverse Event|1|||
127757036|NCT01156376|459736687|FG000|Overall Study|Withdrawal by Subject|0|||
127757037|NCT01156376|459736688|FG001|Overall Study|Withdrawal by Subject|0|||
127894385|NCT01893138|460235341|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
127757038|NCT01156376|459736689|FG002|Overall Study|Withdrawal by Subject|3|||
127757039|NCT03174431|459736692|FG000|Overall Study|Withdrawal by Subject|14|||
127757040|NCT03174431|459736693|FG001|Overall Study|Withdrawal by Subject|11|||
127757041|NCT03174431|459736692|FG000|Overall Study|alternative treatment|2|||
127757042|NCT03174431|459736693|FG001|Overall Study|alternative treatment|0|||
127757043|NCT03174431|459736692|FG000|Overall Study|Lost to Follow-up|1|||
127757044|NCT03174431|459736693|FG001|Overall Study|Lost to Follow-up|5|||
127757045|NCT02075073|459736694|FG000|Overall Study|Withdrawal by Subject|0|||
127757046|NCT02075073|459736695|FG001|Overall Study|Withdrawal by Subject|1|||
127757047|NCT02075073|459736696|FG002|Overall Study|Withdrawal by Subject|0|||
127757048|NCT02797080|459736701|FG000|Overall Study|Lost to Follow-up|1|||
127757049|NCT02797080|459736701|FG000|Overall Study|Withdrawal by Subject|1|||
127757050|NCT00951015|459736704|FG000|Randomization Phase 96 Week|Adverse Event|1|||
127757051|NCT00951015|459736705|FG001|Randomization Phase 96 Week|Adverse Event|1|||
127757052|NCT00951015|459736706|FG002|Randomization Phase 96 Week|Adverse Event|2|||
127757053|NCT00951015|459736707|FG003|Randomization Phase 96 Week|Adverse Event|5|||
127757054|NCT00951015|459736708|FG004|Randomization Phase 96 Week|Adverse Event|0|||
127757055|NCT00951015|459736704|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
127757056|NCT00951015|459736705|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
127757057|NCT00951015|459736706|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
127757058|NCT00951015|459736707|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
127757059|NCT00951015|459736708|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
127757060|NCT00951015|459736704|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
127757061|NCT00951015|459736705|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
127757062|NCT00951015|459736706|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
127757063|NCT00951015|459736707|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
127757064|NCT00951015|459736708|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
127757065|NCT00951015|459736704|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
127757066|NCT00951015|459736705|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
127757067|NCT00951015|459736706|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
127757068|NCT00951015|459736707|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
127757069|NCT00951015|459736708|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
127757070|NCT00951015|459736704|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
127757071|NCT00951015|459736705|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
127757072|NCT00951015|459736706|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
127757073|NCT00951015|459736707|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
127757074|NCT00951015|459736708|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
127757075|NCT00951015|459736704|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
127757076|NCT00951015|459736705|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
127757077|NCT00951015|459736706|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
127757078|NCT00951015|459736707|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
127757079|NCT00951015|459736708|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
127757080|NCT00951015|459736704|FG000|Open-label Phase|Adverse Event|0|||
127757081|NCT00951015|459736705|FG001|Open-label Phase|Adverse Event|0|||
127757082|NCT00951015|459736706|FG002|Open-label Phase|Adverse Event|0|||
127757083|NCT00951015|459736707|FG003|Open-label Phase|Adverse Event|0|||
127757084|NCT00951015|459736708|FG004|Open-label Phase|Adverse Event|3|||
127757085|NCT00951015|459736704|FG000|Open-label Phase|Lack of Efficacy|0|||
127757086|NCT00951015|459736705|FG001|Open-label Phase|Lack of Efficacy|0|||
127757087|NCT00951015|459736706|FG002|Open-label Phase|Lack of Efficacy|0|||
127757088|NCT00951015|459736707|FG003|Open-label Phase|Lack of Efficacy|0|||
127757089|NCT00951015|459736708|FG004|Open-label Phase|Lack of Efficacy|1|||
127757090|NCT00951015|459736704|FG000|Open-label Phase|Protocol Violation|0|||
127757091|NCT00951015|459736705|FG001|Open-label Phase|Protocol Violation|0|||
127757092|NCT00951015|459736706|FG002|Open-label Phase|Protocol Violation|0|||
127757093|NCT00951015|459736707|FG003|Open-label Phase|Protocol Violation|0|||
127757094|NCT00951015|459736708|FG004|Open-label Phase|Protocol Violation|12|||
127757095|NCT00951015|459736704|FG000|Open-label Phase|Lost to Follow-up|0|||
127757096|NCT00951015|459736705|FG001|Open-label Phase|Lost to Follow-up|0|||
127757097|NCT00951015|459736706|FG002|Open-label Phase|Lost to Follow-up|0|||
127757098|NCT00951015|459736707|FG003|Open-label Phase|Lost to Follow-up|0|||
127757099|NCT00951015|459736708|FG004|Open-label Phase|Lost to Follow-up|12|||
127757100|NCT00951015|459736704|FG000|Open-label Phase|Withdrawal by Subject|0|||
127757101|NCT00951015|459736705|FG001|Open-label Phase|Withdrawal by Subject|0|||
127757102|NCT00951015|459736706|FG002|Open-label Phase|Withdrawal by Subject|0|||
127757103|NCT00951015|459736707|FG003|Open-label Phase|Withdrawal by Subject|0|||
127757104|NCT00951015|459736708|FG004|Open-label Phase|Withdrawal by Subject|14|||
127757105|NCT00951015|459736704|FG000|Open-label Phase|Physician Decision|0|||
127757106|NCT00951015|459736705|FG001|Open-label Phase|Physician Decision|0|||
127757107|NCT00951015|459736706|FG002|Open-label Phase|Physician Decision|0|||
127757108|NCT00951015|459736707|FG003|Open-label Phase|Physician Decision|0|||
127757109|NCT00951015|459736708|FG004|Open-label Phase|Physician Decision|8|||
127757110|NCT03819634|459736710|FG000|Overall Study|Physician Decision|2|||
127757111|NCT01208103|459736711|FG000|Overall Study|Adverse Event|1|||
127757112|NCT01208103|459736711|FG000|Overall Study|Withdrawal by Subject|1|||
127757113|NCT00299494|459736712|FG000|Overall Study|Withdrawal by Subject|0|||
127757114|NCT00299494|459736713|FG001|Overall Study|Withdrawal by Subject|0|||
127757115|NCT00299494|459736714|FG002|Overall Study|Withdrawal by Subject|0|||
127757116|NCT00299494|459736715|FG003|Overall Study|Withdrawal by Subject|3|||
127757117|NCT00299494|459736716|FG004|Overall Study|Withdrawal by Subject|1|||
127757118|NCT00299494|459736717|FG005|Overall Study|Withdrawal by Subject|4|||
127757119|NCT00299494|459736712|FG000|Overall Study|Physician Decision|0|||
127757120|NCT00299494|459736713|FG001|Overall Study|Physician Decision|0|||
127757121|NCT00299494|459736714|FG002|Overall Study|Physician Decision|0|||
127757122|NCT00299494|459736715|FG003|Overall Study|Physician Decision|0|||
127757123|NCT00299494|459736716|FG004|Overall Study|Physician Decision|1|||
127757124|NCT00299494|459736717|FG005|Overall Study|Physician Decision|0|||
127757125|NCT00299494|459736712|FG000|Overall Study|Death|3|||
127757126|NCT00299494|459736713|FG001|Overall Study|Death|1|||
127757127|NCT00299494|459736714|FG002|Overall Study|Death|4|||
127757128|NCT00299494|459736715|FG003|Overall Study|Death|6|||
127757129|NCT00299494|459736716|FG004|Overall Study|Death|18|||
127757130|NCT00299494|459736717|FG005|Overall Study|Death|19|||
127757131|NCT00299494|459736712|FG000|Overall Study|Lost to Follow-up|0|||
127757132|NCT00299494|459736713|FG001|Overall Study|Lost to Follow-up|0|||
127757133|NCT00299494|459736714|FG002|Overall Study|Lost to Follow-up|0|||
127757134|NCT00299494|459736715|FG003|Overall Study|Lost to Follow-up|0|||
127757135|NCT00299494|459736716|FG004|Overall Study|Lost to Follow-up|3|||
127757136|NCT00299494|459736717|FG005|Overall Study|Lost to Follow-up|1|||
127757137|NCT00299494|459736712|FG000|Overall Study|Other - Unspecified|0|||
127757138|NCT00299494|459736713|FG001|Overall Study|Other - Unspecified|0|||
127757139|NCT00299494|459736714|FG002|Overall Study|Other - Unspecified|0|||
127757140|NCT00299494|459736715|FG003|Overall Study|Other - Unspecified|0|||
127757141|NCT00299494|459736716|FG004|Overall Study|Other - Unspecified|3|||
127757142|NCT00299494|459736717|FG005|Overall Study|Other - Unspecified|1|||
127757143|NCT00299494|459736712|FG000|Overall Study|Other - site closure|0|||
127757144|NCT00299494|459736713|FG001|Overall Study|Other - site closure|0|||
127757145|NCT00299494|459736714|FG002|Overall Study|Other - site closure|0|||
127757146|NCT00299494|459736715|FG003|Overall Study|Other - site closure|1|||
127757147|NCT00299494|459736716|FG004|Overall Study|Other - site closure|1|||
127757148|NCT00299494|459736717|FG005|Overall Study|Other - site closure|1|||
127757149|NCT03101462|459736718|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
127757150|NCT03101462|459736719|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
127757151|NCT01696955|459736720|FG000|Main Study|Protocol Violation|1|||
127757152|NCT01696955|459736721|FG001|Main Study|Protocol Violation|0|||
127757153|NCT01696955|459736720|FG000|Main Study|Withdrawal by Subject|1|||
127757154|NCT01696955|459736721|FG001|Main Study|Withdrawal by Subject|1|||
127757155|NCT00573859|459736726|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
127757156|NCT00573859|459736726|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
127757157|NCT03541200|459736727|FG000|Overall Study|Adverse Event|19|||
127757158|NCT03541200|459736727|FG000|Overall Study|Death|1|||
127757159|NCT03541200|459736727|FG000|Overall Study|Lost to Follow-up|10|||
127757160|NCT03541200|459736727|FG000|Overall Study|Physician Decision|1|||
127757161|NCT03541200|459736727|FG000|Overall Study|Protocol Violation|51|||
127757162|NCT03541200|459736727|FG000|Overall Study|Withdrawal by Subject|23|||
127757163|NCT03541200|459736727|FG000|Overall Study|other|8|||
127757164|NCT00208325|459736728|FG000|Overall Study|Death|18|||
127757165|NCT00208325|459736729|FG001|Overall Study|Death|19|||
127757166|NCT00208325|459736730|FG002|Overall Study|Death|7|||
127757167|NCT00208325|459736731|FG003|Overall Study|Death|5|||
127757168|NCT00208325|459736728|FG000|Overall Study|Withdrawal by Subject|0|||
127757169|NCT00208325|459736729|FG001|Overall Study|Withdrawal by Subject|1|||
127757170|NCT00208325|459736730|FG002|Overall Study|Withdrawal by Subject|0|||
127757171|NCT00208325|459736731|FG003|Overall Study|Withdrawal by Subject|0|||
127757172|NCT00208325|459736728|FG000|Overall Study|Revision|4|||
127757173|NCT00208325|459736729|FG001|Overall Study|Revision|1|||
127757174|NCT00208325|459736730|FG002|Overall Study|Revision|0|||
127757175|NCT00208325|459736731|FG003|Overall Study|Revision|4|||
127757176|NCT00208325|459736728|FG000|Overall Study|Lost to Follow-up|1|||
127757177|NCT00208325|459736729|FG001|Overall Study|Lost to Follow-up|0|||
127757178|NCT00208325|459736730|FG002|Overall Study|Lost to Follow-up|2|||
127757179|NCT00208325|459736731|FG003|Overall Study|Lost to Follow-up|0|||
127757180|NCT00208325|459736728|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
127757181|NCT00208325|459736729|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
127757182|NCT00208325|459736730|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
127757183|NCT00208325|459736731|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
127757184|NCT00208325|459736728|FG000|Overall Study|Does not wish to Continue in Study|5|||
127757185|NCT00208325|459736729|FG001|Overall Study|Does not wish to Continue in Study|8|||
127757186|NCT00208325|459736730|FG002|Overall Study|Does not wish to Continue in Study|3|||
127757187|NCT00208325|459736731|FG003|Overall Study|Does not wish to Continue in Study|2|||
127757188|NCT00208325|459736728|FG000|Overall Study|Other|2|||
127757189|NCT00208325|459736729|FG001|Overall Study|Other|1|||
127757190|NCT00208325|459736730|FG002|Overall Study|Other|1|||
127757191|NCT00208325|459736731|FG003|Overall Study|Other|0|||
127757192|NCT00208325|459736728|FG000|Overall Study|Mis-Randomized|17|||
127757193|NCT00208325|459736729|FG001|Overall Study|Mis-Randomized|20|||
127757194|NCT00208325|459736730|FG002|Overall Study|Mis-Randomized|0|||
127757195|NCT00208325|459736731|FG003|Overall Study|Mis-Randomized|0|||
127757196|NCT02001064|459736732|FG000|Overall Study|Withdrawal by Subject|2|||
127811534|NCT00700804|459926549|FG000|Overall Study|Protocol Violation|1|||
127811535|NCT00700804|459926550|FG001|Overall Study|Protocol Violation|1|||
127811536|NCT00700804|459926549|FG000|Overall Study|Loose Stools|1|||
127811537|NCT00700804|459926550|FG001|Overall Study|Loose Stools|1|||
127811538|NCT01511445|459926551|FG000|Overall Study|Lost to Follow-up|3|||
127811539|NCT01511445|459926552|FG001|Overall Study|Lost to Follow-up|1|||
127811540|NCT01511445|459926551|FG000|Overall Study|Protocol Violation|1|||
127811541|NCT01511445|459926552|FG001|Overall Study|Protocol Violation|3|||
127811542|NCT01511445|459926551|FG000|Overall Study|Protocol Violation|1|||
127811543|NCT01511445|459926552|FG001|Overall Study|Protocol Violation|0|||
127811544|NCT04696861|459926553|FG000|Overall Study|Death|1|||
127811545|NCT04696861|459926554|FG001|Overall Study|Death|0|||
127811546|NCT04696861|459926553|FG000|Overall Study|Lost to Follow-up|3|||
127811547|NCT04696861|459926554|FG001|Overall Study|Lost to Follow-up|0|||
127811548|NCT01926626|459926555|FG000|Overall Study|Withdrawal by Subject|15|||
127811549|NCT01926626|459926555|FG000|Overall Study|Lost to Follow-up|7|||
127811550|NCT02382133|459926556|FG000|Overall Study|Death|22|||
127811551|NCT02382133|459926556|FG000|Overall Study|transfer out of ICU|4|||
127811552|NCT02382133|459926556|FG000|Overall Study|Physician Decision|2|||
127811553|NCT02382133|459926556|FG000|Overall Study|arterial catheter loss|4|||
127811554|NCT02382133|459926556|FG000|Overall Study|pressure injury both sites|1|||
127811555|NCT00655928|459926557|FG000|Overall Study|Withdrawal by Subject|2|||
127811556|NCT00655928|459926558|FG001|Overall Study|Withdrawal by Subject|1|||
127811557|NCT00655928|459926557|FG000|Overall Study|Physician Decision|1|||
127811558|NCT00655928|459926558|FG001|Overall Study|Physician Decision|1|||
127811559|NCT04906707|459926559|FG000|Overall Study|Withdrawal by Subject|2|||
127757197|NCT02001064|459736733|FG001|Overall Study|Withdrawal by Subject|1|||
127757198|NCT02108964|459736736|FG000|Overall Study|Progressive disease|15|||
127757199|NCT02108964|459736737|FG001|Overall Study|Progressive disease|31|||
127757200|NCT02108964|459736738|FG002|Overall Study|Progressive disease|54|||
127757201|NCT02108964|459736739|FG003|Overall Study|Progressive disease|7|||
127757202|NCT02108964|459736740|FG004|Overall Study|Progressive disease|20|||
127757203|NCT02108964|459736741|FG005|Overall Study|Progressive disease|4|||
127757204|NCT02108964|459736742|FG006|Overall Study|Progressive disease|6|||
127757205|NCT02108964|459736743|FG007|Overall Study|Progressive disease|33|||
127757206|NCT02108964|459736736|FG000|Overall Study|Physician Decision|1|||
127757207|NCT02108964|459736737|FG001|Overall Study|Physician Decision|5|||
127757208|NCT02108964|459736738|FG002|Overall Study|Physician Decision|7|||
127757209|NCT02108964|459736739|FG003|Overall Study|Physician Decision|1|||
127757210|NCT02108964|459736740|FG004|Overall Study|Physician Decision|2|||
127757211|NCT02108964|459736741|FG005|Overall Study|Physician Decision|1|||
127757212|NCT02108964|459736742|FG006|Overall Study|Physician Decision|1|||
127757213|NCT02108964|459736743|FG007|Overall Study|Physician Decision|3|||
127757214|NCT02108964|459736736|FG000|Overall Study|Adverse Event|0|||
127757215|NCT02108964|459736737|FG001|Overall Study|Adverse Event|0|||
127757216|NCT02108964|459736738|FG002|Overall Study|Adverse Event|4|||
127757217|NCT02108964|459736739|FG003|Overall Study|Adverse Event|0|||
127757218|NCT02108964|459736740|FG004|Overall Study|Adverse Event|1|||
127757219|NCT02108964|459736741|FG005|Overall Study|Adverse Event|0|||
127811560|NCT04906707|459926560|FG001|Overall Study|Withdrawal by Subject|0|||
127811561|NCT04906707|459926559|FG000|Overall Study|Withdrawal due to PI decision|1|||
127757220|NCT02108964|459736742|FG006|Overall Study|Adverse Event|3|||
127757221|NCT02108964|459736743|FG007|Overall Study|Adverse Event|2|||
127757222|NCT02108964|459736736|FG000|Overall Study|Death|1|||
127757223|NCT02108964|459736737|FG001|Overall Study|Death|1|||
127811562|NCT04906707|459926560|FG001|Overall Study|Withdrawal due to PI decision|0|||
127811563|NCT04906707|459926559|FG000|Overall Study|Lost to Follow-up|0|||
127811564|NCT04906707|459926560|FG001|Overall Study|Lost to Follow-up|1|||
127811565|NCT01976806|459926561|FG000|Overall Study|Lost to Follow-up|1|||
127811566|NCT01976806|459926562|FG001|Overall Study|Lost to Follow-up|4|||
127757224|NCT02108964|459736738|FG002|Overall Study|Death|4|||
127757225|NCT02108964|459736739|FG003|Overall Study|Death|0|||
127757226|NCT02108964|459736740|FG004|Overall Study|Death|3|||
127757227|NCT02108964|459736741|FG005|Overall Study|Death|0|||
127757228|NCT02108964|459736742|FG006|Overall Study|Death|0|||
127811567|NCT01976806|459926561|FG000|Overall Study|Adverse Event|1|||
127811568|NCT01976806|459926562|FG001|Overall Study|Adverse Event|1|||
127811569|NCT01976806|459926561|FG000|Overall Study|Withdrawal by Subject|1|||
127811570|NCT01976806|459926562|FG001|Overall Study|Withdrawal by Subject|1|||
127811571|NCT00998738|459926567|FG000|Overall Study|Uknown|1|||
127757229|NCT02108964|459736743|FG007|Overall Study|Death|2|||
127757230|NCT02108964|459736736|FG000|Overall Study|Subject/Guardian decision|0|||
127757231|NCT02108964|459736737|FG001|Overall Study|Subject/Guardian decision|1|||
127757232|NCT02108964|459736738|FG002|Overall Study|Subject/Guardian decision|4|||
127757233|NCT02108964|459736739|FG003|Overall Study|Subject/Guardian decision|0|||
127757234|NCT02108964|459736740|FG004|Overall Study|Subject/Guardian decision|2|||
127757235|NCT02108964|459736741|FG005|Overall Study|Subject/Guardian decision|0|||
127757236|NCT02108964|459736742|FG006|Overall Study|Subject/Guardian decision|1|||
127757237|NCT02108964|459736743|FG007|Overall Study|Subject/Guardian decision|2|||
127757238|NCT02108964|459736736|FG000|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
127757239|NCT02108964|459736737|FG001|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
127757240|NCT02108964|459736738|FG002|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
127757241|NCT02108964|459736739|FG003|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
127757242|NCT02108964|459736740|FG004|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
127757243|NCT02108964|459736741|FG005|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
127757244|NCT02108964|459736742|FG006|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
127757245|NCT02108964|459736743|FG007|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|3|||
127757246|NCT03006848|459736744|FG000|Overall Study|Adverse Event|1|||
127757247|NCT03006848|459736744|FG000|Overall Study|Physician Decision|1|||
127757248|NCT03006848|459736744|FG000|Overall Study|Lack of Efficacy|16|||
127757249|NCT01214642|459736745|FG000|Overall Study|Progressive Disease|3|||
127757250|NCT01214642|459736746|FG001|Overall Study|Progressive Disease|2|||
127757251|NCT01214642|459736747|FG002|Overall Study|Progressive Disease|3|||
127757252|NCT01214642|459736748|FG003|Overall Study|Progressive Disease|5|||
127757253|NCT01214642|459736749|FG004|Overall Study|Progressive Disease|5|||
127757254|NCT01214642|459736750|FG005|Overall Study|Progressive Disease|3|||
127757255|NCT01214642|459736751|FG006|Overall Study|Progressive Disease|5|||
127757256|NCT01214642|459736752|FG007|Overall Study|Progressive Disease|3|||
127757257|NCT01214642|459736753|FG008|Overall Study|Progressive Disease|10|||
127757258|NCT01214642|459736754|FG009|Overall Study|Progressive Disease|2|||
127757259|NCT01214642|459736755|FG010|Overall Study|Progressive Disease|1|||
127757260|NCT01214642|459736756|FG011|Overall Study|Progressive Disease|4|||
127757261|NCT01214642|459736745|FG000|Overall Study|Adverse Event|0|||
127757262|NCT01214642|459736746|FG001|Overall Study|Adverse Event|1|||
127757263|NCT01214642|459736747|FG002|Overall Study|Adverse Event|0|||
127757264|NCT01214642|459736748|FG003|Overall Study|Adverse Event|0|||
127757265|NCT01214642|459736749|FG004|Overall Study|Adverse Event|0|||
127757266|NCT01214642|459736750|FG005|Overall Study|Adverse Event|0|||
127757267|NCT01214642|459736751|FG006|Overall Study|Adverse Event|1|||
127757268|NCT01214642|459736752|FG007|Overall Study|Adverse Event|0|||
127757269|NCT01214642|459736753|FG008|Overall Study|Adverse Event|0|||
127757270|NCT01214642|459736754|FG009|Overall Study|Adverse Event|1|||
127757271|NCT01214642|459736755|FG010|Overall Study|Adverse Event|1|||
127757272|NCT01214642|459736756|FG011|Overall Study|Adverse Event|0|||
127757273|NCT01214642|459736745|FG000|Overall Study|Death|0|||
127757274|NCT01214642|459736746|FG001|Overall Study|Death|0|||
127757275|NCT01214642|459736747|FG002|Overall Study|Death|1|||
127757276|NCT01214642|459736748|FG003|Overall Study|Death|0|||
127757277|NCT01214642|459736749|FG004|Overall Study|Death|0|||
127757278|NCT01214642|459736750|FG005|Overall Study|Death|0|||
127757279|NCT01214642|459736751|FG006|Overall Study|Death|0|||
127811572|NCT03946449|459926568|FG000|Treatment Extension II|Rolled over to another study|0|||
127811573|NCT03946449|459926569|FG001|Treatment Extension II|Rolled over to another study|0|||
127757280|NCT01214642|459736752|FG007|Overall Study|Death|0|||
127757281|NCT01214642|459736753|FG008|Overall Study|Death|0|||
127757282|NCT01214642|459736754|FG009|Overall Study|Death|0|||
127757283|NCT01214642|459736755|FG010|Overall Study|Death|1|||
127757284|NCT01214642|459736756|FG011|Overall Study|Death|0|||
127757285|NCT01214642|459736745|FG000|Overall Study|Withdrawal by Subject|0|||
127757286|NCT01214642|459736746|FG001|Overall Study|Withdrawal by Subject|0|||
127757287|NCT01214642|459736747|FG002|Overall Study|Withdrawal by Subject|1|||
127757288|NCT01214642|459736748|FG003|Overall Study|Withdrawal by Subject|0|||
127757289|NCT01214642|459736749|FG004|Overall Study|Withdrawal by Subject|0|||
127757290|NCT01214642|459736750|FG005|Overall Study|Withdrawal by Subject|0|||
127757291|NCT01214642|459736751|FG006|Overall Study|Withdrawal by Subject|0|||
127757292|NCT01214642|459736752|FG007|Overall Study|Withdrawal by Subject|0|||
127757293|NCT01214642|459736753|FG008|Overall Study|Withdrawal by Subject|3|||
127757294|NCT01214642|459736754|FG009|Overall Study|Withdrawal by Subject|1|||
127757295|NCT01214642|459736755|FG010|Overall Study|Withdrawal by Subject|1|||
127757296|NCT01214642|459736756|FG011|Overall Study|Withdrawal by Subject|0|||
127757297|NCT01214642|459736745|FG000|Overall Study|Physician Decision|0|||
127757298|NCT01214642|459736746|FG001|Overall Study|Physician Decision|0|||
127757299|NCT01214642|459736747|FG002|Overall Study|Physician Decision|1|||
127757300|NCT01214642|459736748|FG003|Overall Study|Physician Decision|1|||
127757301|NCT01214642|459736749|FG004|Overall Study|Physician Decision|1|||
127757302|NCT01214642|459736750|FG005|Overall Study|Physician Decision|0|||
127757303|NCT01214642|459736751|FG006|Overall Study|Physician Decision|0|||
127757304|NCT01214642|459736752|FG007|Overall Study|Physician Decision|0|||
127757305|NCT01214642|459736753|FG008|Overall Study|Physician Decision|0|||
127757306|NCT01214642|459736754|FG009|Overall Study|Physician Decision|0|||
127757307|NCT01214642|459736755|FG010|Overall Study|Physician Decision|0|||
127757308|NCT01214642|459736756|FG011|Overall Study|Physician Decision|2|||
127757309|NCT04500769|459738501|FG000|Overall Study|Withdrawal by Subject|5|||
127757310|NCT01967147|459738502|FG000|Overall Study|Adverse Event|5|||
127757311|NCT01967147|459738503|FG001|Overall Study|Adverse Event|2|||
127757312|NCT01967147|459738502|FG000|Overall Study|Lack of Efficacy|1|||
127757313|NCT01967147|459738503|FG001|Overall Study|Lack of Efficacy|4|||
127757314|NCT01967147|459738502|FG000|Overall Study|Lost to Follow-up|1|||
127757315|NCT01967147|459738503|FG001|Overall Study|Lost to Follow-up|2|||
127757316|NCT01967147|459738502|FG000|Overall Study|Withdrawal by Subject|2|||
127757317|NCT01967147|459738503|FG001|Overall Study|Withdrawal by Subject|4|||
127757318|NCT01967147|459738502|FG000|Overall Study|Non-compliance with Study Drug|0|||
127757319|NCT01967147|459738503|FG001|Overall Study|Non-compliance with Study Drug|3|||
127757320|NCT01967147|459738502|FG000|Overall Study|Other|4|||
127757321|NCT01967147|459738503|FG001|Overall Study|Other|5|||
127757322|NCT02314780|459738504|FG000|Overall Study|organizational reasons|0|||
127757323|NCT02314780|459738505|FG001|Overall Study|organizational reasons|2|||
127757324|NCT02314780|459738506|FG002|Overall Study|organizational reasons|0|||
127757325|NCT02314780|459738504|FG000|Overall Study|Adverse Event|0|||
127757326|NCT02314780|459738505|FG001|Overall Study|Adverse Event|1|||
127757327|NCT02314780|459738506|FG002|Overall Study|Adverse Event|0|||
127757328|NCT00215137|459738510|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
127894386|NCT01893138|460235340|FG000|Open Label - Unblinded Period|Adverse Event|1|||
127757329|NCT00215137|459738511|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
127757330|NCT00215137|459738512|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
127757331|NCT00215137|459738510|FG000|Randomization Period|Lost to Follow-up|0|||
127757332|NCT00215137|459738511|FG001|Randomization Period|Lost to Follow-up|1|||
127757333|NCT00215137|459738512|FG002|Randomization Period|Lost to Follow-up|0|||
127757334|NCT00215137|459738510|FG000|Randomization Period|Withdrawal by Subject|0|||
127757335|NCT00215137|459738511|FG001|Randomization Period|Withdrawal by Subject|1|||
127757336|NCT00215137|459738512|FG002|Randomization Period|Withdrawal by Subject|0|||
127757337|NCT01142232|459738517|FG000|Overall Study|Adverse Event|1|||
127757338|NCT01142232|459738518|FG001|Overall Study|Adverse Event|2|||
127757339|NCT01142232|459738519|FG002|Overall Study|Adverse Event|1|||
127757340|NCT01142232|459738520|FG003|Overall Study|Adverse Event|0|||
127757341|NCT01142232|459738521|FG004|Overall Study|Adverse Event|4|||
127757342|NCT01142232|459738517|FG000|Overall Study|Death|0|||
127757343|NCT01142232|459738518|FG001|Overall Study|Death|0|||
127757344|NCT01142232|459738519|FG002|Overall Study|Death|0|||
127757345|NCT01142232|459738520|FG003|Overall Study|Death|0|||
127757346|NCT01142232|459738521|FG004|Overall Study|Death|1|||
127757347|NCT01142232|459738517|FG000|Overall Study|Disease Progression|2|||
127757348|NCT01142232|459738518|FG001|Overall Study|Disease Progression|0|||
127757349|NCT01142232|459738519|FG002|Overall Study|Disease Progression|1|||
127757350|NCT01142232|459738520|FG003|Overall Study|Disease Progression|2|||
127757351|NCT01142232|459738521|FG004|Overall Study|Disease Progression|12|||
127757352|NCT01142232|459738517|FG000|Overall Study|Withdrawal by Subject|0|||
127757353|NCT01142232|459738518|FG001|Overall Study|Withdrawal by Subject|0|||
127757354|NCT01142232|459738519|FG002|Overall Study|Withdrawal by Subject|0|||
127757355|NCT01142232|459738520|FG003|Overall Study|Withdrawal by Subject|1|||
127757356|NCT01142232|459738521|FG004|Overall Study|Withdrawal by Subject|3|||
127757357|NCT01142232|459738517|FG000|Overall Study|Physician Decision|0|||
127757358|NCT01142232|459738518|FG001|Overall Study|Physician Decision|1|||
127757359|NCT01142232|459738519|FG002|Overall Study|Physician Decision|0|||
127894387|NCT01893138|460235341|FG001|Open Label - Unblinded Period|Adverse Event|0|||
127894388|NCT05188521|460237115|FG000|Baricitinib 2mg Initial Study|Travel issues|1|||
127894389|NCT05188521|460237116|FG001|Baricitinib 2mg Initial Study|Travel issues|0|||
127894390|NCT01341639|460237117|FG000|Infant Series|Protocol Violation|1|||
127894391|NCT01341639|460237118|FG001|Infant Series|Protocol Violation|0|||
127894392|NCT01341639|460237117|FG000|Infant Series|Not Vaccinated|0|||
127894393|NCT01341639|460237118|FG001|Infant Series|Not Vaccinated|1|||
127757360|NCT01142232|459738520|FG003|Overall Study|Physician Decision|2|||
127757361|NCT01142232|459738521|FG004|Overall Study|Physician Decision|10|||
127757362|NCT01142232|459738517|FG000|Overall Study|Alternative Therapy|0|||
127757363|NCT01142232|459738518|FG001|Overall Study|Alternative Therapy|1|||
127757364|NCT01142232|459738519|FG002|Overall Study|Alternative Therapy|1|||
127757365|NCT01142232|459738520|FG003|Overall Study|Alternative Therapy|0|||
127757366|NCT01142232|459738521|FG004|Overall Study|Alternative Therapy|1|||
127894394|NCT01341639|460237117|FG000|Infant Series|Adverse Event|0|||
127757367|NCT01142232|459738517|FG000|Overall Study|Off Trt for other complicating disease|0|||
127757368|NCT01142232|459738518|FG001|Overall Study|Off Trt for other complicating disease|0|||
127757369|NCT01142232|459738519|FG002|Overall Study|Off Trt for other complicating disease|0|||
127757370|NCT01142232|459738520|FG003|Overall Study|Off Trt for other complicating disease|0|||
127757371|NCT01142232|459738521|FG004|Overall Study|Off Trt for other complicating disease|1|||
127757372|NCT01142232|459738517|FG000|Overall Study|Noncompliance|0|||
127757373|NCT01142232|459738518|FG001|Overall Study|Noncompliance|0|||
127757374|NCT01142232|459738519|FG002|Overall Study|Noncompliance|0|||
127757375|NCT01142232|459738520|FG003|Overall Study|Noncompliance|0|||
127757376|NCT01142232|459738521|FG004|Overall Study|Noncompliance|2|||
127757377|NCT02787044|459738524|FG000|Overall Study|Lost to Follow-up|15|||
127757378|NCT02787044|459738525|FG001|Overall Study|Lost to Follow-up|19|||
127757379|NCT02182947|459738526|FG000|Overall Study|Withdrawal by Subject|7|||
127757380|NCT02182947|459738526|FG000|Overall Study|Lost to Follow-up|3|||
127757381|NCT02182947|459738526|FG000|Overall Study|Failed screening activities|8|||
127757382|NCT00730275|459738529|FG000|Overall Study|Withdrawal by Subject|0|||
127757383|NCT00730275|459738530|FG001|Overall Study|Withdrawal by Subject|0|||
127757384|NCT00730275|459738531|FG002|Overall Study|Withdrawal by Subject|0|||
127757385|NCT00730275|459738532|FG003|Overall Study|Withdrawal by Subject|1|||
127757386|NCT03046121|459738533|FG000|Overall Study|Death|32|||
127757387|NCT03046121|459738534|FG001|Overall Study|Death|60|||
127757388|NCT03046121|459738533|FG000|Overall Study|Withdrawal by Subject|14|||
127757389|NCT03046121|459738534|FG001|Overall Study|Withdrawal by Subject|12|||
127757390|NCT04155047|459738537|FG000|Overall Study|Adverse Event|1|||
127757391|NCT04155047|459738538|FG001|Overall Study|Adverse Event|0|||
127757392|NCT04155047|459738537|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
127757393|NCT04155047|459738538|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
127757394|NCT04488770|459738542|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
127757395|NCT04488770|459738543|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
127757396|NCT04488770|459738544|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
127757397|NCT04488770|459738545|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
127757398|NCT04488770|459738546|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
127757399|NCT04488770|459738547|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
127757400|NCT04488770|459738548|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
127757401|NCT04488770|459738549|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
127757402|NCT04488770|459738550|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
127757403|NCT04488770|459738551|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
127757404|NCT04488770|459738552|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
127757405|NCT04488770|459738553|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
127757406|NCT04488770|459738554|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
127757407|NCT04488770|459738542|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
127757408|NCT04488770|459738543|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
127757409|NCT04488770|459738544|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
127757410|NCT04488770|459738545|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
127757411|NCT04488770|459738546|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
127757412|NCT04488770|459738547|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
127757413|NCT04488770|459738548|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
127757414|NCT04488770|459738549|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
127757415|NCT04488770|459738550|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
127757416|NCT04488770|459738551|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
127757417|NCT04488770|459738552|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
127757418|NCT04488770|459738553|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
127757419|NCT04488770|459738554|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
127757420|NCT04488770|459738542|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
127757421|NCT04488770|459738543|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
127757422|NCT04488770|459738544|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
127757423|NCT04488770|459738545|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
127757424|NCT04488770|459738546|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
127757425|NCT04488770|459738547|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
127757426|NCT04488770|459738548|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
127757427|NCT04488770|459738549|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
127757428|NCT04488770|459738550|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
127757429|NCT04488770|459738551|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
127757430|NCT04488770|459738552|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
127811574|NCT03946449|459926570|FG002|Treatment Extension II|Rolled over to another study|2|||
127757431|NCT04488770|459738553|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
127757432|NCT04488770|459738554|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
127757433|NCT04488770|459738542|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
127757434|NCT04488770|459738543|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
127894395|NCT01341639|460237118|FG001|Infant Series|Adverse Event|5|||
127894396|NCT01341639|460237117|FG000|Infant Series|Withdrawal by Subject|11|||
127894397|NCT01341639|460237118|FG001|Infant Series|Withdrawal by Subject|8|||
127894398|NCT01341639|460237117|FG000|Infant Series|Lost to Follow-up|0|||
127894399|NCT01341639|460237118|FG001|Infant Series|Lost to Follow-up|2|||
127757435|NCT04488770|459738544|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
127757436|NCT04488770|459738545|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
127757437|NCT04488770|459738546|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
127757438|NCT04488770|459738547|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
127757439|NCT04488770|459738548|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
127757440|NCT04488770|459738549|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
127757441|NCT04488770|459738550|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
127757442|NCT04488770|459738551|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
127757443|NCT04488770|459738552|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
127757444|NCT04488770|459738553|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
127757445|NCT04488770|459738554|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
127757446|NCT00416195|459738556|FG000|Overall Study|Adverse Event|1|||
127757447|NCT00416195|459738557|FG001|Overall Study|Adverse Event|2|||
127757448|NCT00416195|459738556|FG000|Overall Study|Protocol Violation|1|||
127757449|NCT00416195|459738557|FG001|Overall Study|Protocol Violation|1|||
127757450|NCT00416195|459738556|FG000|Overall Study|Other|0|||
127757451|NCT00416195|459738557|FG001|Overall Study|Other|1|||
127757452|NCT01417104|459738565|FG000|Overall Study|Withdrawal by Subject|5|||
127757453|NCT01417104|459738566|FG001|Overall Study|Withdrawal by Subject|1|||
127757454|NCT01417104|459738565|FG000|Overall Study|Failure to make contact|0|||
127757455|NCT01417104|459738566|FG001|Overall Study|Failure to make contact|1|||
127757456|NCT01417104|459738565|FG000|Overall Study|Adverse Event|1|||
127757457|NCT01417104|459738566|FG001|Overall Study|Adverse Event|0|||
127757458|NCT03361605|459738567|FG000|Overall Study|Analyzable data not available|3|||
127757459|NCT01305408|459738568|FG000|Overall Study|Adverse Event|10|||
127757460|NCT01305408|459738569|FG001|Overall Study|Adverse Event|7|||
127757461|NCT01305408|459738568|FG000|Overall Study|Lack of Efficacy|3|||
127757462|NCT01305408|459738569|FG001|Overall Study|Lack of Efficacy|4|||
127757463|NCT01305408|459738568|FG000|Overall Study|Withdrawal by Subject|9|||
127757464|NCT01305408|459738569|FG001|Overall Study|Withdrawal by Subject|9|||
127757465|NCT01305408|459738568|FG000|Overall Study|Protocol Violation|4|||
127757466|NCT01305408|459738569|FG001|Overall Study|Protocol Violation|6|||
127757467|NCT01305408|459738568|FG000|Overall Study|Lost to Follow-up|5|||
127757468|NCT01305408|459738569|FG001|Overall Study|Lost to Follow-up|3|||
127757469|NCT01305408|459738568|FG000|Overall Study|Noncompliance with study medication|0|||
127757470|NCT01305408|459738569|FG001|Overall Study|Noncompliance with study medication|1|||
127757471|NCT01305408|459738568|FG000|Overall Study|Noncompliance with study procedures|0|||
127757472|NCT01305408|459738569|FG001|Overall Study|Noncompliance with study procedures|1|||
127757473|NCT01305408|459738568|FG000|Overall Study|Other|1|||
127757474|NCT01305408|459738569|FG001|Overall Study|Other|0|||
127757475|NCT01641159|459738581|FG000|Overall Study|Lost to Follow-up|2|||
127757476|NCT01641159|459738582|FG001|Overall Study|Lost to Follow-up|1|||
127757477|NCT01641159|459738581|FG000|Overall Study|Withdrawal by Subject|0|||
127811575|NCT03946449|459926568|FG000|Treatment Extension II|Withdrawal by Subject|0|||
127811576|NCT03946449|459926569|FG001|Treatment Extension II|Withdrawal by Subject|0|||
127811577|NCT03946449|459926570|FG002|Treatment Extension II|Withdrawal by Subject|1|||
127811578|NCT03896581|459928750|FG000|Overall Study|Other (Covid-19 Pandemic Circumstances)|1|||
127811579|NCT03896581|459928751|FG001|Overall Study|Other (Covid-19 Pandemic Circumstances)|0|||
127811580|NCT03896581|459928750|FG000|Overall Study|Withdrawal by Subject|4|||
127811581|NCT03896581|459928751|FG001|Overall Study|Withdrawal by Subject|1|||
127811582|NCT03896581|459928750|FG000|Overall Study|Lost to Follow-up|1|||
127811583|NCT03896581|459928751|FG001|Overall Study|Lost to Follow-up|0|||
127811584|NCT03896581|459928750|FG000|Overall Study|Lack of Efficacy|2|||
127811585|NCT03896581|459928751|FG001|Overall Study|Lack of Efficacy|1|||
127811586|NCT03896581|459928750|FG000|Overall Study|Adverse event, non-fatal|0|||
127757478|NCT01641159|459738582|FG001|Overall Study|Withdrawal by Subject|1|||
127757479|NCT03653208|459738586|FG000|Overall Study|Withdrawal by Subject|0|||
127757480|NCT03653208|459738587|FG001|Overall Study|Withdrawal by Subject|0|||
127757481|NCT03653208|459738588|FG002|Overall Study|Withdrawal by Subject|0|||
127757482|NCT03653208|459738589|FG003|Overall Study|Withdrawal by Subject|0|||
127757483|NCT03653208|459738590|FG004|Overall Study|Withdrawal by Subject|1|||
127811587|NCT03896581|459928751|FG001|Overall Study|Adverse event, non-fatal|2|||
127894400|NCT01341639|460237117|FG000|Infant Series|Site 0048 Participants|17|||
127757484|NCT03653208|459738591|FG005|Overall Study|Withdrawal by Subject|0|||
127757485|NCT03653208|459738592|FG006|Overall Study|Withdrawal by Subject|0|||
127757486|NCT03653208|459738593|FG007|Overall Study|Withdrawal by Subject|1|||
127757487|NCT03653208|459738594|FG008|Overall Study|Withdrawal by Subject|1|||
127757488|NCT03752970|459738596|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
127757489|NCT03752970|459738597|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|1|||
127757490|NCT03752970|459738598|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
127757491|NCT03752970|459738596|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
127757492|NCT03752970|459738597|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
127757493|NCT03752970|459738598|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|1|||
127757494|NCT03752970|459738596|FG000|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
127757495|NCT03752970|459738597|FG001|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
127757496|NCT03752970|459738598|FG002|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|1|||
127757497|NCT03752970|459738596|FG000|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
127757498|NCT03752970|459738597|FG001|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|4|||
127757499|NCT03752970|459738598|FG002|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
127757500|NCT03752970|459738596|FG000|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
127757501|NCT03752970|459738597|FG001|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
127757502|NCT03752970|459738598|FG002|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|1|||
127757503|NCT01152814|459738600|FG000|Overall Study|Lost to Follow-up|2|||
127757504|NCT00831129|459738604|FG000|Overall Study|Adverse Event|0|||
127757505|NCT00831129|459738605|FG001|Overall Study|Adverse Event|1|||
127757506|NCT00831129|459738604|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
127757507|NCT00831129|459738605|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
127757508|NCT01877239|459738606|FG000|Overall Study|Adverse Event|4|||
127757509|NCT01877239|459738606|FG000|Overall Study|Disease Remission|1|||
127757510|NCT01877239|459738606|FG000|Overall Study|Withdrawal by Subject|4|||
127757511|NCT01877239|459738606|FG000|Overall Study|Other|2|||
127757512|NCT01877239|459738606|FG000|Overall Study|Lack of Efficacy|4|||
127757513|NCT01877239|459738606|FG000|Overall Study|Data not available|35|||
127757514|NCT01669577|459738610|FG000|Overall Study|Death|22|||
127757515|NCT01669577|459738610|FG000|Overall Study|Lost to Follow-up|78|||
127757516|NCT01669577|459738610|FG000|Overall Study|Physician Decision|34|||
127757517|NCT01283516|459738611|FG000|Overall Study|Adverse Event|0|||
127757518|NCT01283516|459738612|FG001|Overall Study|Adverse Event|0|||
127757519|NCT01283516|459738613|FG002|Overall Study|Adverse Event|0|||
127757520|NCT01283516|459738614|FG003|Overall Study|Adverse Event|0|||
127757521|NCT01283516|459738615|FG004|Overall Study|Adverse Event|0|||
127757522|NCT01283516|459738616|FG005|Overall Study|Adverse Event|0|||
127757523|NCT01283516|459738617|FG006|Overall Study|Adverse Event|2|||
127757524|NCT01283516|459738618|FG007|Overall Study|Adverse Event|0|||
127757525|NCT01283516|459738619|FG008|Overall Study|Adverse Event|28|||
127757526|NCT01283516|459738611|FG000|Overall Study|Death|0|||
127757527|NCT01283516|459738612|FG001|Overall Study|Death|0|||
127757528|NCT01283516|459738613|FG002|Overall Study|Death|0|||
127757529|NCT01283516|459738614|FG003|Overall Study|Death|0|||
127757530|NCT01283516|459738615|FG004|Overall Study|Death|0|||
127757531|NCT01283516|459738616|FG005|Overall Study|Death|1|||
127757532|NCT01283516|459738617|FG006|Overall Study|Death|0|||
127757533|NCT01283516|459738618|FG007|Overall Study|Death|1|||
127757534|NCT01283516|459738619|FG008|Overall Study|Death|12|||
127757535|NCT01283516|459738611|FG000|Overall Study|Disease Progression|2|||
127757536|NCT01283516|459738612|FG001|Overall Study|Disease Progression|2|||
127757537|NCT01283516|459738613|FG002|Overall Study|Disease Progression|3|||
127757538|NCT01283516|459738614|FG003|Overall Study|Disease Progression|3|||
127757539|NCT01283516|459738615|FG004|Overall Study|Disease Progression|13|||
127757540|NCT01283516|459738616|FG005|Overall Study|Disease Progression|8|||
127757541|NCT01283516|459738617|FG006|Overall Study|Disease Progression|6|||
127757542|NCT01283516|459738618|FG007|Overall Study|Disease Progression|3|||
127757543|NCT01283516|459738619|FG008|Overall Study|Disease Progression|139|||
127757544|NCT01283516|459738611|FG000|Overall Study|Withdrawal by Subject|0|||
127757545|NCT01283516|459738612|FG001|Overall Study|Withdrawal by Subject|0|||
127757546|NCT01283516|459738613|FG002|Overall Study|Withdrawal by Subject|0|||
127757547|NCT01283516|459738614|FG003|Overall Study|Withdrawal by Subject|0|||
127757548|NCT01283516|459738615|FG004|Overall Study|Withdrawal by Subject|1|||
127757549|NCT01283516|459738616|FG005|Overall Study|Withdrawal by Subject|0|||
127757550|NCT01283516|459738617|FG006|Overall Study|Withdrawal by Subject|1|||
127757551|NCT01283516|459738618|FG007|Overall Study|Withdrawal by Subject|0|||
127757552|NCT01283516|459738619|FG008|Overall Study|Withdrawal by Subject|36|||
127757553|NCT01283516|459738611|FG000|Overall Study|Administrative problems|0|||
127757554|NCT01283516|459738612|FG001|Overall Study|Administrative problems|0|||
127757555|NCT01283516|459738613|FG002|Overall Study|Administrative problems|0|||
127757556|NCT01283516|459738614|FG003|Overall Study|Administrative problems|0|||
127757557|NCT01283516|459738615|FG004|Overall Study|Administrative problems|0|||
127757558|NCT01283516|459738616|FG005|Overall Study|Administrative problems|1|||
127757559|NCT01283516|459738617|FG006|Overall Study|Administrative problems|1|||
127757560|NCT01283516|459738618|FG007|Overall Study|Administrative problems|1|||
127757561|NCT01283516|459738619|FG008|Overall Study|Administrative problems|39|||
127757562|NCT01283516|459738611|FG000|Overall Study|Lost to Follow-up|0|||
127757563|NCT01283516|459738612|FG001|Overall Study|Lost to Follow-up|0|||
127757564|NCT01283516|459738613|FG002|Overall Study|Lost to Follow-up|0|||
127757565|NCT01283516|459738614|FG003|Overall Study|Lost to Follow-up|0|||
127757566|NCT01283516|459738615|FG004|Overall Study|Lost to Follow-up|0|||
127757567|NCT01283516|459738616|FG005|Overall Study|Lost to Follow-up|0|||
127757568|NCT01283516|459738617|FG006|Overall Study|Lost to Follow-up|0|||
127757569|NCT01283516|459738618|FG007|Overall Study|Lost to Follow-up|0|||
127757570|NCT01283516|459738619|FG008|Overall Study|Lost to Follow-up|1|||
127757571|NCT00132873|459738628|FG000|Overall Study|Adverse Event|3|||
127757572|NCT00132873|459738628|FG000|Overall Study|Lost to Follow-up|1|||
127757573|NCT00132873|459738628|FG000|Overall Study|Lack of Efficacy|1|||
127757574|NCT00132873|459738628|FG000|Overall Study|Withdrawal by Subject|3|||
127757575|NCT00132873|459738628|FG000|Overall Study|Planned Pregnancy|1|||
127757576|NCT00444275|459738629|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
127757577|NCT00444275|459738630|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
127757578|NCT00444275|459738631|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
127757579|NCT00444275|459738632|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
127757580|NCT00444275|459738633|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
127757581|NCT00444275|459738629|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
127757582|NCT00444275|459738630|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
127757583|NCT00444275|459738631|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
127757584|NCT00444275|459738632|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
127757585|NCT00444275|459738633|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
127757586|NCT00444275|459738629|FG000|Maintenance Treatment Phase|Adverse Event|0|||
127757587|NCT00444275|459738630|FG001|Maintenance Treatment Phase|Adverse Event|0|||
127757588|NCT00444275|459738631|FG002|Maintenance Treatment Phase|Adverse Event|3|||
127757589|NCT00444275|459738632|FG003|Maintenance Treatment Phase|Adverse Event|2|||
127757590|NCT00444275|459738633|FG004|Maintenance Treatment Phase|Adverse Event|13|||
127757591|NCT00444275|459738629|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
127757592|NCT00444275|459738630|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
127757593|NCT00444275|459738631|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
127757594|NCT00444275|459738632|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
127757595|NCT00444275|459738633|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
127757596|NCT00444275|459738629|FG000|Maintenance Treatment Phase|Patient's wish|0|||
127757597|NCT00444275|459738630|FG001|Maintenance Treatment Phase|Patient's wish|0|||
127757598|NCT00444275|459738631|FG002|Maintenance Treatment Phase|Patient's wish|19|||
127757599|NCT00444275|459738632|FG003|Maintenance Treatment Phase|Patient's wish|9|||
127757600|NCT00444275|459738633|FG004|Maintenance Treatment Phase|Patient's wish|20|||
127757601|NCT00444275|459738629|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
127757602|NCT00444275|459738630|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
127757603|NCT00444275|459738631|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
127757604|NCT00444275|459738632|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
127757605|NCT00444275|459738633|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
127757606|NCT00444275|459738629|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
127757607|NCT00444275|459738630|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
127757608|NCT00444275|459738631|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
127757609|NCT00444275|459738632|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
127757610|NCT00444275|459738633|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
127757611|NCT02045875|459738634|FG000|Overall Study|Lost to Follow-up|3|||
127757612|NCT02045875|459738635|FG001|Overall Study|Lost to Follow-up|0|||
127757613|NCT02045875|459738634|FG000|Overall Study|Withdrawal by Subject|4|||
127757614|NCT02045875|459738635|FG001|Overall Study|Withdrawal by Subject|3|||
127757615|NCT01114880|459738639|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
127757616|NCT01114880|459738640|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
127757617|NCT01114880|459738639|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
127757618|NCT01114880|459738640|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
127757619|NCT01114880|459738639|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
127757620|NCT01114880|459738640|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
127757621|NCT01114880|459738639|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
127757622|NCT01114880|459738640|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
127757623|NCT01114880|459738639|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
127757624|NCT01114880|459738640|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
127811588|NCT04375761|459928752|FG000|Overall Study|Death|1|||
127757625|NCT01114880|459738639|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
127757626|NCT01114880|459738640|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
127757627|NCT00586612|459738641|FG000|Primary Phase|Protocol Violation|1|||
127757628|NCT00586612|459738642|FG001|Primary Phase|Protocol Violation|0|||
127757629|NCT00586612|459738641|FG000|Primary Phase|Lost to Follow-up|0|||
127757630|NCT00586612|459738642|FG001|Primary Phase|Lost to Follow-up|1|||
127757631|NCT00586612|459738641|FG000|Primary Phase|Withdrawal by Subject|0|||
127757632|NCT00586612|459738642|FG001|Primary Phase|Withdrawal by Subject|2|||
127757633|NCT00586612|459738641|FG000|Booster Phase|Lost to Follow-up|3|||
127757634|NCT00586612|459738642|FG001|Booster Phase|Lost to Follow-up|1|||
127757635|NCT01609062|459738645|FG000|Extension Phase|Terminated by Sponsor|14|||
127757636|NCT01609062|459738646|FG001|Extension Phase|Terminated by Sponsor|9|||
127757637|NCT01609062|459738645|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
127757638|NCT01609062|459738646|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
127757639|NCT01609062|459738645|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
127757640|NCT01609062|459738646|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
127757641|NCT02738853|459738647|FG000|Enrollment|Inclusion/Exclusion not met|21|||
127757642|NCT02738853|459738647|FG000|Enrollment|Withdrawal by Subject|3|||
127757643|NCT02738853|459738647|FG000|Enrollment|Subject treated with commercially available device|6|||
127757644|NCT02738853|459738647|FG000|Enrollment|Study Enrollment Closed|3|||
127757645|NCT02738853|459738647|FG000|Procedure|Death|1|||
127811589|NCT04375761|459928753|FG001|Overall Study|Death|2|||
127811590|NCT04375761|459928752|FG000|Overall Study|Lost to Follow-up|203|||
127811591|NCT04375761|459928753|FG001|Overall Study|Lost to Follow-up|380|||
127811592|NCT04375761|459928752|FG000|Overall Study|Withdrawal by Subject|47|||
127811593|NCT04375761|459928753|FG001|Overall Study|Withdrawal by Subject|98|||
127811594|NCT04375761|459928752|FG000|Overall Study|Noncompliance with study procedure|121|||
127811595|NCT04375761|459928753|FG001|Overall Study|Noncompliance with study procedure|251|||
127811596|NCT04375761|459928752|FG000|Overall Study|Reimbursement not enough|1|||
127811597|NCT04375761|459928753|FG001|Overall Study|Reimbursement not enough|2|||
127811598|NCT04375761|459928752|FG000|Overall Study|Unforeseen family circumstances|1|||
127811599|NCT04375761|459928753|FG001|Overall Study|Unforeseen family circumstances|3|||
127811600|NCT04375761|459928752|FG000|Overall Study|Test too painful|1|||
127811601|NCT04375761|459928753|FG001|Overall Study|Test too painful|1|||
127811602|NCT04375761|459928752|FG000|Overall Study|Moved|0|||
127811603|NCT04375761|459928753|FG001|Overall Study|Moved|2|||
127811604|NCT04375761|459928752|FG000|Overall Study|Nonresponsive|0|||
127811605|NCT04375761|459928753|FG001|Overall Study|Nonresponsive|5|||
127811606|NCT03797001|459928754|FG000|Overall Study|Withdrawn due to COVID19|4|||
127811607|NCT03797001|459928755|FG001|Overall Study|Withdrawn due to COVID19|0|||
127811608|NCT03797001|459928754|FG000|Overall Study|Withdrawal by Subject|7|||
127811609|NCT03797001|459928755|FG001|Overall Study|Withdrawal by Subject|6|||
127811610|NCT03797001|459928754|FG000|Overall Study|Adverse Event|0|||
127811611|NCT03797001|459928755|FG001|Overall Study|Adverse Event|1|||
127811612|NCT05630846|459928758|FG000|Overall Study|Death|1|||
127811613|NCT05630846|459928759|FG001|Overall Study|Death|0|||
127811614|NCT05630846|459928760|FG002|Overall Study|Death|0|||
127811615|NCT05630846|459928761|FG003|Overall Study|Death|0|||
127811616|NCT05630846|459928758|FG000|Overall Study|Withdrawal by Subject|3|||
127811617|NCT05630846|459928759|FG001|Overall Study|Withdrawal by Subject|3|||
127811618|NCT05630846|459928760|FG002|Overall Study|Withdrawal by Subject|4|||
127811619|NCT05630846|459928761|FG003|Overall Study|Withdrawal by Subject|1|||
127811620|NCT05630846|459928758|FG000|Overall Study|Lost to Follow-up|6|||
127811621|NCT05630846|459928759|FG001|Overall Study|Lost to Follow-up|5|||
127811622|NCT05630846|459928760|FG002|Overall Study|Lost to Follow-up|2|||
127811623|NCT05630846|459928761|FG003|Overall Study|Lost to Follow-up|5|||
127811624|NCT05630846|459928758|FG000|Overall Study|Other|1|||
127811625|NCT05630846|459928759|FG001|Overall Study|Other|0|||
127811626|NCT05630846|459928760|FG002|Overall Study|Other|0|||
127811627|NCT05630846|459928761|FG003|Overall Study|Other|0|||
127811628|NCT02224664|459928762|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
127811629|NCT02224664|459928763|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
127811630|NCT02224664|459928764|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
127811631|NCT02224664|459928765|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
127811632|NCT02224664|459928766|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
127811633|NCT02224664|459928762|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
127811634|NCT02224664|459928763|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
127811635|NCT02224664|459928764|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
127811636|NCT02224664|459928765|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
127811637|NCT02224664|459928766|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
127811638|NCT02224664|459928762|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
127811639|NCT02224664|459928763|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
127811640|NCT02224664|459928764|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
127811641|NCT02224664|459928765|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
127811642|NCT02224664|459928766|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
127811643|NCT02251743|459928770|FG000|Overall Study|Withdrawal by Subject|1|||
127811644|NCT02251743|459928771|FG001|Overall Study|Withdrawal by Subject|1|||
127811645|NCT00215150|459928772|FG000|Open Label Phase|Lost to Follow-up|7|||
127811646|NCT00215150|459928772|FG000|Open Label Phase|Withdrawal by Subject|1|||
127811647|NCT00215150|459928772|FG000|Open Label Phase|Did not complete a post base visit|13|||
127811648|NCT00215150|459928772|FG000|Open Label Phase|Did not meet randomization criteria|9|||
127811649|NCT00215150|459928772|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
127811650|NCT00215150|459928772|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
127811651|NCT00215150|459928772|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
127811652|NCT00260208|459928776|FG000|Overall Study|Subject withdrew consent|11|||
127811653|NCT00260208|459928777|FG001|Overall Study|Subject withdrew consent|7|||
127811654|NCT00260208|459928776|FG000|Overall Study|Lost to Follow-up|6|||
127811655|NCT00260208|459928777|FG001|Overall Study|Lost to Follow-up|1|||
127811656|NCT00260208|459928776|FG000|Overall Study|Death|12|||
127811657|NCT00260208|459928777|FG001|Overall Study|Death|10|||
127811658|NCT00260208|459928776|FG000|Overall Study|Missing|18|||
127811659|NCT00260208|459928777|FG001|Overall Study|Missing|16|||
127811660|NCT02091440|459928778|FG000|Overall Study|Death|2|||
127811661|NCT00768222|459928779|FG000|Overall Study|Lost to Follow-up|1|||
127811662|NCT00768222|459928780|FG001|Overall Study|Lost to Follow-up|1|||
127811663|NCT00768222|459928779|FG000|Overall Study|Withdrawal by Subject|3|||
127811664|NCT00768222|459928780|FG001|Overall Study|Withdrawal by Subject|1|||
127811665|NCT00768222|459928779|FG000|Overall Study|Protocol Violation|0|||
127811666|NCT00768222|459928780|FG001|Overall Study|Protocol Violation|2|||
127811667|NCT00278629|459928787|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
127811668|NCT00826748|459928789|FG000|Overall Study|Withdrawal by Subject|0|||
127811669|NCT00826748|459928790|FG001|Overall Study|Withdrawal by Subject|0|||
127811670|NCT00826748|459928791|FG002|Overall Study|Withdrawal by Subject|2|||
127811671|NCT00826748|459928789|FG000|Overall Study|Physician Decision|0|||
127811672|NCT00826748|459928790|FG001|Overall Study|Physician Decision|0|||
127811673|NCT00826748|459928791|FG002|Overall Study|Physician Decision|1|||
127811674|NCT00826748|459928789|FG000|Overall Study|Samples Did Not pass QC|0|||
127811675|NCT00826748|459928790|FG001|Overall Study|Samples Did Not pass QC|0|||
127811676|NCT00826748|459928791|FG002|Overall Study|Samples Did Not pass QC|1|||
127811677|NCT06161012|459928796|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
127811678|NCT06161012|459928797|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
127811679|NCT02601950|459928798|FG000|Overall Study|Participant enrolled in rollover study|0|||
127811680|NCT02601950|459928799|FG001|Overall Study|Participant enrolled in rollover study|0|||
127811681|NCT02601950|459928800|FG002|Overall Study|Participant enrolled in rollover study|1|||
127811682|NCT02601950|459928801|FG003|Overall Study|Participant enrolled in rollover study|0|||
127811683|NCT02601950|459928802|FG004|Overall Study|Participant enrolled in rollover study|1|||
127811684|NCT02601950|459928803|FG005|Overall Study|Participant enrolled in rollover study|1|||
127811685|NCT02601950|459928804|FG006|Overall Study|Participant enrolled in rollover study|1|||
127811686|NCT02601950|459928805|FG007|Overall Study|Participant enrolled in rollover study|0|||
127811687|NCT02601950|459928798|FG000|Overall Study|Disease progression - radiological|21|||
127811688|NCT02601950|459928799|FG001|Overall Study|Disease progression - radiological|26|||
127811689|NCT02601950|459928800|FG002|Overall Study|Disease progression - radiological|22|||
127811690|NCT02601950|459928801|FG003|Overall Study|Disease progression - radiological|11|||
127811691|NCT02601950|459928802|FG004|Overall Study|Disease progression - radiological|46|||
127811692|NCT02601950|459928803|FG005|Overall Study|Disease progression - radiological|52|||
127811693|NCT02601950|459928804|FG006|Overall Study|Disease progression - radiological|7|||
127811694|NCT02601950|459928805|FG007|Overall Study|Disease progression - radiological|5|||
127811695|NCT02601950|459928798|FG000|Overall Study|Disease progression - clinical|3|||
127811696|NCT02601950|459928799|FG001|Overall Study|Disease progression - clinical|5|||
127811697|NCT02601950|459928800|FG002|Overall Study|Disease progression - clinical|4|||
127811698|NCT02601950|459928801|FG003|Overall Study|Disease progression - clinical|2|||
127811699|NCT02601950|459928802|FG004|Overall Study|Disease progression - clinical|6|||
127811700|NCT02601950|459928803|FG005|Overall Study|Disease progression - clinical|6|||
127811701|NCT02601950|459928804|FG006|Overall Study|Disease progression - clinical|5|||
127811702|NCT02601950|459928805|FG007|Overall Study|Disease progression - clinical|1|||
127811703|NCT02601950|459928798|FG000|Overall Study|Death|6|||
127811704|NCT02601950|459928799|FG001|Overall Study|Death|0|||
127811705|NCT02601950|459928800|FG002|Overall Study|Death|3|||
127811706|NCT02601950|459928801|FG003|Overall Study|Death|1|||
127811707|NCT02601950|459928802|FG004|Overall Study|Death|4|||
127811708|NCT02601950|459928803|FG005|Overall Study|Death|1|||
127811709|NCT02601950|459928804|FG006|Overall Study|Death|0|||
127811710|NCT02601950|459928805|FG007|Overall Study|Death|0|||
127811711|NCT02601950|459928798|FG000|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
127811712|NCT02601950|459928799|FG001|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
127811713|NCT02601950|459928800|FG002|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
127811714|NCT02601950|459928801|FG003|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
127811715|NCT02601950|459928802|FG004|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
127811716|NCT02601950|459928803|FG005|Overall Study|Unacceptable toxicity (related to study treatment)|1|||
127811717|NCT02601950|459928804|FG006|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
127811718|NCT02601950|459928805|FG007|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
127811719|NCT02601950|459928798|FG000|Overall Study|Adverse event (not related to study treatment)|1|||
127811720|NCT02601950|459928799|FG001|Overall Study|Adverse event (not related to study treatment)|0|||
127811721|NCT02601950|459928800|FG002|Overall Study|Adverse event (not related to study treatment)|0|||
127811722|NCT02601950|459928801|FG003|Overall Study|Adverse event (not related to study treatment)|0|||
127811723|NCT02601950|459928802|FG004|Overall Study|Adverse event (not related to study treatment)|0|||
127811724|NCT02601950|459928803|FG005|Overall Study|Adverse event (not related to study treatment)|2|||
127811725|NCT02601950|459928804|FG006|Overall Study|Adverse event (not related to study treatment)|0|||
127811726|NCT02601950|459928805|FG007|Overall Study|Adverse event (not related to study treatment)|0|||
127811727|NCT02601950|459928798|FG000|Overall Study|Non-compliance|0|||
127811728|NCT02601950|459928799|FG001|Overall Study|Non-compliance|1|||
127811729|NCT02601950|459928800|FG002|Overall Study|Non-compliance|0|||
127811730|NCT02601950|459928801|FG003|Overall Study|Non-compliance|0|||
127811731|NCT02601950|459928802|FG004|Overall Study|Non-compliance|0|||
127811732|NCT02601950|459928803|FG005|Overall Study|Non-compliance|1|||
127811733|NCT02601950|459928804|FG006|Overall Study|Non-compliance|1|||
127811734|NCT02601950|459928805|FG007|Overall Study|Non-compliance|0|||
127811735|NCT02601950|459928798|FG000|Overall Study|Participant refused further study treatment|0|||
127811736|NCT02601950|459928799|FG001|Overall Study|Participant refused further study treatment|1|||
127811737|NCT02601950|459928800|FG002|Overall Study|Participant refused further study treatment|1|||
127811738|NCT02601950|459928801|FG003|Overall Study|Participant refused further study treatment|0|||
127811739|NCT02601950|459928802|FG004|Overall Study|Participant refused further study treatment|2|||
127811740|NCT02601950|459928803|FG005|Overall Study|Participant refused further study treatment|2|||
127811741|NCT02601950|459928804|FG006|Overall Study|Participant refused further study treatment|2|||
127811742|NCT02601950|459928805|FG007|Overall Study|Participant refused further study treatment|1|||
127811743|NCT02601950|459928798|FG000|Overall Study|Investigator discretion|1|||
127811744|NCT02601950|459928799|FG001|Overall Study|Investigator discretion|0|||
127811745|NCT02601950|459928800|FG002|Overall Study|Investigator discretion|1|||
127811746|NCT02601950|459928801|FG003|Overall Study|Investigator discretion|0|||
127811747|NCT02601950|459928802|FG004|Overall Study|Investigator discretion|1|||
127811748|NCT02601950|459928803|FG005|Overall Study|Investigator discretion|1|||
127811749|NCT02601950|459928804|FG006|Overall Study|Investigator discretion|1|||
127811750|NCT02601950|459928805|FG007|Overall Study|Investigator discretion|0|||
127811751|NCT02601950|459928798|FG000|Overall Study|Other|0|||
127811752|NCT02601950|459928799|FG001|Overall Study|Other|0|||
127811753|NCT02601950|459928800|FG002|Overall Study|Other|0|||
127811754|NCT02601950|459928801|FG003|Overall Study|Other|0|||
127811755|NCT02601950|459928802|FG004|Overall Study|Other|2|||
127811756|NCT02601950|459928803|FG005|Overall Study|Other|2|||
127811757|NCT02601950|459928804|FG006|Overall Study|Other|1|||
127811758|NCT02601950|459928805|FG007|Overall Study|Other|0|||
127811759|NCT05817045|459928806|FG000|Overall Study|Protocol Violation|0|||
127811760|NCT05817045|459928807|FG001|Overall Study|Protocol Violation|3|||
127811761|NCT05817045|459928806|FG000|Overall Study|Withdrawal by Subject|10|||
127811762|NCT05817045|459928807|FG001|Overall Study|Withdrawal by Subject|7|||
127811763|NCT05817045|459928806|FG000|Overall Study|Physician Decision|3|||
127811764|NCT05817045|459928807|FG001|Overall Study|Physician Decision|0|||
127811765|NCT05817045|459928806|FG000|Overall Study|Lost to Follow-up|0|||
127811766|NCT05817045|459928807|FG001|Overall Study|Lost to Follow-up|1|||
127811767|NCT05817045|459928806|FG000|Overall Study|Device Deficiency|1|||
127811768|NCT05817045|459928807|FG001|Overall Study|Device Deficiency|0|||
127811769|NCT05817045|459928806|FG000|Overall Study|System Error|1|||
127811770|NCT05817045|459928807|FG001|Overall Study|System Error|0|||
127811771|NCT01725165|459928810|FG000|Overall Study|Death|11|||
127811772|NCT01725165|459928811|FG001|Overall Study|Death|18|||
127811773|NCT05113940|459928812|FG000|Part A (18 Days)|Adverse Event|0|||
127811774|NCT05113940|459928813|FG001|Part A (18 Days)|Adverse Event|0|||
127811775|NCT05113940|459928814|FG002|Part A (18 Days)|Adverse Event|1|||
127811776|NCT05113940|459928815|FG003|Part A (18 Days)|Adverse Event|1|||
127811777|NCT05113940|459928816|FG004|Part A (18 Days)|Adverse Event|1|||
127811778|NCT05113940|459928817|FG005|Part A (18 Days)|Adverse Event|0|||
127811779|NCT05113940|459928818|FG006|Part A (18 Days)|Adverse Event|0|||
127811780|NCT05113940|459928819|FG007|Part A (18 Days)|Adverse Event|0|||
127811781|NCT05113940|459928820|FG008|Part A (18 Days)|Adverse Event|0|||
127811782|NCT05113940|459928821|FG009|Part A (18 Days)|Adverse Event|0|||
127811783|NCT05113940|459928822|FG010|Part A (18 Days)|Adverse Event|0|||
127811784|NCT05113940|459928823|FG011|Part A (18 Days)|Adverse Event|2|||
127757646|NCT02738853|459738647|FG000|1 Month|Death|2|||
127757647|NCT02738853|459738647|FG000|6 Month|Death|4|||
127757648|NCT02738853|459738647|FG000|6 Month|Withdrawal by Subject|2|||
127757649|NCT02738853|459738647|FG000|1 Year|Death|6|||
127757650|NCT02738853|459738647|FG000|1 Year|Withdrawal by Subject|1|||
127757651|NCT02738853|459738647|FG000|2 Year|Death|2|||
127757652|NCT02738853|459738647|FG000|2 Year|Lost to Follow-up|1|||
127757653|NCT02738853|459738647|FG000|3 Year|Death|2|||
127757654|NCT02738853|459738647|FG000|3 Year|Withdrawal by Subject|1|||
127757655|NCT02738853|459738647|FG000|4 Year|Death|9|||
127757656|NCT02738853|459738647|FG000|5 Year|Lost to Follow-up|4|||
127757657|NCT01803282|459738648|FG000|Overall Study|Progressive Disease|4|||
127757658|NCT01803282|459738649|FG001|Overall Study|Progressive Disease|3|||
127757659|NCT01803282|459738650|FG002|Overall Study|Progressive Disease|6|||
127757660|NCT01803282|459738651|FG003|Overall Study|Progressive Disease|22|||
127757661|NCT01803282|459738652|FG004|Overall Study|Progressive Disease|5|||
127757662|NCT01803282|459738653|FG005|Overall Study|Progressive Disease|8|||
127757663|NCT01803282|459738654|FG006|Overall Study|Progressive Disease|23|||
127757664|NCT01803282|459738655|FG007|Overall Study|Progressive Disease|24|||
127757665|NCT01803282|459738656|FG008|Overall Study|Progressive Disease|3|||
127757666|NCT01803282|459738657|FG009|Overall Study|Progressive Disease|29|||
127757667|NCT01803282|459738658|FG010|Overall Study|Progressive Disease|6|||
127757668|NCT01803282|459738659|FG011|Overall Study|Progressive Disease|11|||
127757669|NCT01803282|459738648|FG000|Overall Study|Death|0|||
127757670|NCT01803282|459738649|FG001|Overall Study|Death|0|||
127757671|NCT01803282|459738650|FG002|Overall Study|Death|0|||
127757672|NCT01803282|459738651|FG003|Overall Study|Death|0|||
127757673|NCT01803282|459738652|FG004|Overall Study|Death|2|||
127757674|NCT01803282|459738653|FG005|Overall Study|Death|1|||
127757675|NCT01803282|459738654|FG006|Overall Study|Death|1|||
127757676|NCT01803282|459738655|FG007|Overall Study|Death|5|||
127757677|NCT01803282|459738656|FG008|Overall Study|Death|1|||
127757678|NCT01803282|459738657|FG009|Overall Study|Death|1|||
127757679|NCT01803282|459738658|FG010|Overall Study|Death|0|||
127757680|NCT01803282|459738659|FG011|Overall Study|Death|0|||
127757681|NCT01803282|459738648|FG000|Overall Study|Withdrew Consent|0|||
127757682|NCT01803282|459738649|FG001|Overall Study|Withdrew Consent|0|||
127757683|NCT01803282|459738650|FG002|Overall Study|Withdrew Consent|0|||
127757684|NCT01803282|459738651|FG003|Overall Study|Withdrew Consent|6|||
127757685|NCT01803282|459738652|FG004|Overall Study|Withdrew Consent|1|||
127757686|NCT01803282|459738653|FG005|Overall Study|Withdrew Consent|0|||
127757687|NCT01803282|459738654|FG006|Overall Study|Withdrew Consent|8|||
127757688|NCT01803282|459738655|FG007|Overall Study|Withdrew Consent|3|||
127757689|NCT01803282|459738656|FG008|Overall Study|Withdrew Consent|1|||
127757690|NCT01803282|459738657|FG009|Overall Study|Withdrew Consent|5|||
127757691|NCT01803282|459738658|FG010|Overall Study|Withdrew Consent|0|||
127757692|NCT01803282|459738659|FG011|Overall Study|Withdrew Consent|1|||
127757693|NCT01803282|459738648|FG000|Overall Study|Investigator's Discretion|0|||
127757694|NCT01803282|459738649|FG001|Overall Study|Investigator's Discretion|0|||
127757695|NCT01803282|459738650|FG002|Overall Study|Investigator's Discretion|0|||
127757696|NCT01803282|459738651|FG003|Overall Study|Investigator's Discretion|7|||
127757697|NCT01803282|459738652|FG004|Overall Study|Investigator's Discretion|2|||
127757698|NCT01803282|459738653|FG005|Overall Study|Investigator's Discretion|1|||
127757699|NCT01803282|459738654|FG006|Overall Study|Investigator's Discretion|7|||
127757700|NCT01803282|459738655|FG007|Overall Study|Investigator's Discretion|10|||
127757701|NCT01803282|459738656|FG008|Overall Study|Investigator's Discretion|6|||
127757702|NCT01803282|459738657|FG009|Overall Study|Investigator's Discretion|7|||
127811785|NCT05113940|459928824|FG012|Part A (18 Days)|Adverse Event|0|||
127811786|NCT05113940|459928825|FG013|Part A (18 Days)|Adverse Event|0|||
127811787|NCT05113940|459928826|FG014|Part A (18 Days)|Adverse Event|0|||
127811788|NCT05113940|459928812|FG000|Part B- Period 2 (8 Days)|Adverse Event|0|||
127811789|NCT05113940|459928813|FG001|Part B- Period 2 (8 Days)|Adverse Event|0|||
127811790|NCT05113940|459928814|FG002|Part B- Period 2 (8 Days)|Adverse Event|0|||
127811791|NCT05113940|459928815|FG003|Part B- Period 2 (8 Days)|Adverse Event|0|||
127811792|NCT05113940|459928816|FG004|Part B- Period 2 (8 Days)|Adverse Event|0|||
127811793|NCT05113940|459928817|FG005|Part B- Period 2 (8 Days)|Adverse Event|0|||
127811794|NCT05113940|459928818|FG006|Part B- Period 2 (8 Days)|Adverse Event|0|||
127811795|NCT05113940|459928819|FG007|Part B- Period 2 (8 Days)|Adverse Event|0|||
127811796|NCT05113940|459928820|FG008|Part B- Period 2 (8 Days)|Adverse Event|0|||
127811797|NCT05113940|459928821|FG009|Part B- Period 2 (8 Days)|Adverse Event|0|||
127811798|NCT05113940|459928822|FG010|Part B- Period 2 (8 Days)|Adverse Event|0|||
127811799|NCT05113940|459928823|FG011|Part B- Period 2 (8 Days)|Adverse Event|0|||
127811800|NCT05113940|459928824|FG012|Part B- Period 2 (8 Days)|Adverse Event|0|||
127811801|NCT05113940|459928825|FG013|Part B- Period 2 (8 Days)|Adverse Event|0|||
127811802|NCT05113940|459928826|FG014|Part B- Period 2 (8 Days)|Adverse Event|2|||
127811803|NCT02688647|459928829|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
127811804|NCT02688647|459928830|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
127811805|NCT02688647|459928829|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
127811806|NCT02688647|459928830|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
127811807|NCT02688647|459928829|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
127811808|NCT02688647|459928830|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
127811809|NCT02688647|459928829|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
127811810|NCT02688647|459928830|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
127811811|NCT02688647|459928829|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
127811812|NCT02688647|459928830|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
127811813|NCT02688647|459928829|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
127811814|NCT02688647|459928830|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
127811815|NCT02688647|459928829|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
127811816|NCT02688647|459928830|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
127811817|NCT00382967|459928831|FG000|Overall Study|Protocol Violation|1|||
127811818|NCT00382967|459928832|FG001|Overall Study|Protocol Violation|1|||
127811819|NCT03049449|459928836|FG000|Overall Study|Did not receive treatment.|0|||
127811820|NCT03049449|459928837|FG001|Overall Study|Did not receive treatment.|0|||
127811821|NCT03049449|459928838|FG002|Overall Study|Did not receive treatment.|0|||
127811822|NCT03049449|459928839|FG003|Overall Study|Did not receive treatment.|0|||
127811823|NCT03049449|459928840|FG004|Overall Study|Did not receive treatment.|0|||
127811824|NCT03049449|459928841|FG005|Overall Study|Did not receive treatment.|0|||
127811825|NCT03049449|459928842|FG006|Overall Study|Did not receive treatment.|0|||
127811826|NCT03049449|459928843|FG007|Overall Study|Did not receive treatment.|0|||
127811827|NCT03049449|459928844|FG008|Overall Study|Did not receive treatment.|1|||
127811828|NCT03049449|459928845|FG009|Overall Study|Did not receive treatment.|0|||
127811829|NCT03049449|459928836|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
127811830|NCT03049449|459928837|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
127811831|NCT03049449|459928838|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
127811832|NCT03049449|459928839|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
127811833|NCT03049449|459928840|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
127811834|NCT03049449|459928841|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
127811835|NCT03049449|459928842|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
127811836|NCT03049449|459928843|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
127811837|NCT03049449|459928844|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
127811838|NCT03049449|459928845|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
127811839|NCT03049449|459928836|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
127811840|NCT03049449|459928837|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
127811841|NCT03049449|459928838|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
127811842|NCT03049449|459928839|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
127811843|NCT03049449|459928840|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
127811844|NCT03049449|459928841|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
127811845|NCT03049449|459928842|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
127811846|NCT03049449|459928843|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
127811847|NCT03049449|459928844|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
127811848|NCT03049449|459928845|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
127811849|NCT00474240|459928846|FG000|Overall Study|Withdrawal by Subject|1|||
127811850|NCT00474240|459928847|FG001|Overall Study|Withdrawal by Subject|1|||
127811851|NCT00474240|459928848|FG002|Overall Study|Withdrawal by Subject|0|||
127811852|NCT00474240|459928849|FG003|Overall Study|Withdrawal by Subject|2|||
127811853|NCT00474240|459928850|FG004|Overall Study|Withdrawal by Subject|3|||
127811854|NCT00474240|459928851|FG005|Overall Study|Withdrawal by Subject|1|||
127811855|NCT00474240|459928846|FG000|Overall Study|Adverse Event|0|||
127811856|NCT00474240|459928847|FG001|Overall Study|Adverse Event|0|||
127811857|NCT00474240|459928848|FG002|Overall Study|Adverse Event|9|||
127811858|NCT00474240|459928849|FG003|Overall Study|Adverse Event|14|||
127811859|NCT00474240|459928850|FG004|Overall Study|Adverse Event|5|||
127811860|NCT00474240|459928851|FG005|Overall Study|Adverse Event|16|||
127811861|NCT00474240|459928846|FG000|Overall Study|Removed due to lab value|0|||
127811862|NCT00474240|459928847|FG001|Overall Study|Removed due to lab value|0|||
127811863|NCT00474240|459928848|FG002|Overall Study|Removed due to lab value|0|||
127811864|NCT00474240|459928849|FG003|Overall Study|Removed due to lab value|0|||
127811865|NCT00474240|459928850|FG004|Overall Study|Removed due to lab value|0|||
127811866|NCT00474240|459928851|FG005|Overall Study|Removed due to lab value|1|||
127811867|NCT01147497|459928852|FG000|Overall Study|failed insertion|2|||
127811868|NCT01147497|459928853|FG001|Overall Study|failed insertion|0|||
127811869|NCT01262898|459928856|FG000|Overall Study|Protocol Violation|1|||
127811870|NCT01262898|459928857|FG001|Overall Study|Protocol Violation|1|||
127811871|NCT01262898|459928858|FG002|Overall Study|Protocol Violation|0|||
127811872|NCT01262898|459928859|FG003|Overall Study|Protocol Violation|0|||
127811873|NCT01262898|459928856|FG000|Overall Study|Lost to Follow-up|1|||
127811874|NCT01262898|459928857|FG001|Overall Study|Lost to Follow-up|0|||
127811875|NCT01262898|459928858|FG002|Overall Study|Lost to Follow-up|0|||
127811876|NCT01262898|459928859|FG003|Overall Study|Lost to Follow-up|0|||
127811877|NCT01262898|459928856|FG000|Overall Study|Withdrawal by Subject|1|||
127811878|NCT01262898|459928857|FG001|Overall Study|Withdrawal by Subject|1|||
127811879|NCT01262898|459928858|FG002|Overall Study|Withdrawal by Subject|0|||
127811880|NCT01262898|459928859|FG003|Overall Study|Withdrawal by Subject|0|||
127811881|NCT02731742|459928860|FG000|Overall Study|Death|1|||
127811882|NCT02731742|459928861|FG001|Overall Study|Death|2|||
127811883|NCT02731742|459928862|FG002|Overall Study|Death|5|||
127811884|NCT02731742|459928863|FG003|Overall Study|Death|0|||
127811885|NCT02731742|459928860|FG000|Overall Study|Physician Decision|0|||
127811886|NCT02731742|459928861|FG001|Overall Study|Physician Decision|0|||
127811887|NCT02731742|459928862|FG002|Overall Study|Physician Decision|0|||
127811888|NCT02731742|459928863|FG003|Overall Study|Physician Decision|1|||
127811889|NCT02731742|459928860|FG000|Overall Study|Study Terminated by Sponsor|2|||
127811890|NCT02731742|459928861|FG001|Overall Study|Study Terminated by Sponsor|1|||
127811891|NCT02731742|459928862|FG002|Overall Study|Study Terminated by Sponsor|1|||
127811892|NCT02731742|459928863|FG003|Overall Study|Study Terminated by Sponsor|1|||
127811893|NCT04026568|459928866|FG000|Overall Study|study terminated|0|||
127811894|NCT04026568|459928867|FG001|Overall Study|study terminated|1|||
127811895|NCT00502840|459928868|FG000|Overall Study|Adverse Event|5|||
127811896|NCT00502840|459928868|FG000|Overall Study|Additional or changed therapy|48|||
127811897|NCT00502840|459928868|FG000|Overall Study|Lack of Efficacy|11|||
127811898|NCT00502840|459928868|FG000|Overall Study|Protocol Violation|4|||
127811899|NCT00502840|459928868|FG000|Overall Study|Withdrawal by Subject|5|||
127811900|NCT00502840|459928868|FG000|Overall Study|Lost to Follow-up|6|||
127811901|NCT00502840|459928868|FG000|Overall Study|Administrative problems|1|||
127811902|NCT00502840|459928868|FG000|Overall Study|Other|20|||
127811903|NCT02197377|459928869|FG000|Overall Study|Insertion Failure|0|||
127811904|NCT02197377|459928870|FG001|Overall Study|Insertion Failure|3|||
127811905|NCT01974323|459928871|FG000|Overall Study|Other Reasons|25|||
127811906|NCT01974323|459928872|FG001|Overall Study|Other Reasons|28|||
127811907|NCT01974323|459928871|FG000|Overall Study|Protocol Violation|2|||
127811908|NCT01974323|459928872|FG001|Overall Study|Protocol Violation|2|||
127811909|NCT01974323|459928871|FG000|Overall Study|Personal Reasons|15|||
127811910|NCT01974323|459928872|FG001|Overall Study|Personal Reasons|19|||
127811911|NCT01974323|459928871|FG000|Overall Study|Lost to Follow-up|45|||
127894401|NCT01341639|460237118|FG001|Infant Series|Site 0048 Participants|16|||
127894402|NCT01341639|460237117|FG000|Interim Period|Withdrawal by Subject|6|||
127894403|NCT01341639|460237118|FG001|Interim Period|Withdrawal by Subject|7|||
127894404|NCT01341639|460237117|FG000|Interim Period|Lost to Follow-up|2|||
127894405|NCT01341639|460237118|FG001|Interim Period|Lost to Follow-up|0|||
127894406|NCT01341639|460237117|FG000|Interim Period|Physician Decision|0|||
127811912|NCT01974323|459928872|FG001|Overall Study|Lost to Follow-up|40|||
127811913|NCT01974323|459928871|FG000|Overall Study|Pregnancy|2|||
127811914|NCT01974323|459928872|FG001|Overall Study|Pregnancy|1|||
127811915|NCT01974323|459928871|FG000|Overall Study|Lack of Efficacy|1|||
127811916|NCT01974323|459928872|FG001|Overall Study|Lack of Efficacy|1|||
127811917|NCT01974323|459928871|FG000|Overall Study|Adverse Event|2|||
127811918|NCT01974323|459928872|FG001|Overall Study|Adverse Event|2|||
127811919|NCT00331760|459928873|FG000|Overall Study|Ineligible / no protocol treatment|15|||
127811920|NCT00331760|459928874|FG001|Overall Study|Ineligible / no protocol treatment|8|||
127811921|NCT00461175|459928875|FG000|Overall Study|Protocol Violation|522|||
127811922|NCT00461175|459928876|FG001|Overall Study|Protocol Violation|365|||
127811923|NCT01700829|459928878|FG000|Overall Study|Withdrawal by Subject|1|||
127811924|NCT01700829|459928879|FG001|Overall Study|Withdrawal by Subject|1|||
127811925|NCT02561156|459928880|FG000|Part 2|Adverse Event|0|||
127811926|NCT02561156|459928881|FG001|Part 2|Adverse Event|0|||
127811927|NCT02561156|459928882|FG002|Part 2|Adverse Event|0|||
127811928|NCT02561156|459928883|FG003|Part 2|Adverse Event|0|||
127811929|NCT02561156|459928884|FG004|Part 2|Adverse Event|0|||
127811930|NCT02561156|459928885|FG005|Part 2|Adverse Event|0|||
127811931|NCT02561156|459928886|FG006|Part 2|Adverse Event|0|||
127811932|NCT02561156|459928887|FG007|Part 2|Adverse Event|0|||
127811933|NCT02561156|459928888|FG008|Part 2|Adverse Event|0|||
127811934|NCT02561156|459928889|FG009|Part 2|Adverse Event|0|||
127811935|NCT02561156|459928890|FG010|Part 2|Adverse Event|0|||
127811936|NCT02561156|459928891|FG011|Part 2|Adverse Event|1|||
127811937|NCT02561156|459928892|FG012|Part 2|Adverse Event|0|||
127811938|NCT01071070|459928893|FG000|Overall Study|Adverse Event|0|||
127811939|NCT01071070|459928894|FG001|Overall Study|Adverse Event|3|||
127811940|NCT01071070|459928893|FG000|Overall Study|Withdrawal by Subject|1|||
127811941|NCT01071070|459928894|FG001|Overall Study|Withdrawal by Subject|0|||
127811942|NCT01071070|459928893|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
127811943|NCT01071070|459928894|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
127811944|NCT01071070|459928893|FG000|Overall Study|Hypercalcemia|1|||
127811945|NCT01071070|459928894|FG001|Overall Study|Hypercalcemia|0|||
127811946|NCT02209506|459928903|FG000|Overall Study|Withdrawal by Subject|0|||
127811947|NCT02209506|459928904|FG001|Overall Study|Withdrawal by Subject|0|||
127811948|NCT02209506|459928905|FG002|Overall Study|Withdrawal by Subject|0|||
127811949|NCT02209506|459928906|FG003|Overall Study|Withdrawal by Subject|0|||
127811950|NCT02209506|459928907|FG004|Overall Study|Withdrawal by Subject|1|||
127811951|NCT00098787|459928908|FG000|Overall Study|Never started treatment|3|||
127811952|NCT00098787|459928909|FG001|Overall Study|Never started treatment|2|||
127811953|NCT00098787|459928910|FG002|Overall Study|Never started treatment|1|||
127811954|NCT00098787|459928908|FG000|Overall Study|Ineligible|9|||
127811955|NCT00098787|459928909|FG001|Overall Study|Ineligible|7|||
127811956|NCT00098787|459928910|FG002|Overall Study|Ineligible|3|||
127811957|NCT00098787|459928908|FG000|Overall Study|Disease progression|28|||
127811958|NCT00098787|459928909|FG001|Overall Study|Disease progression|17|||
127811959|NCT00098787|459928910|FG002|Overall Study|Disease progression|23|||
127811960|NCT00098787|459928908|FG000|Overall Study|Adverse Event|8|||
127811961|NCT00098787|459928909|FG001|Overall Study|Adverse Event|17|||
127811962|NCT00098787|459928910|FG002|Overall Study|Adverse Event|8|||
127811963|NCT00098787|459928908|FG000|Overall Study|Death|6|||
127811964|NCT00098787|459928909|FG001|Overall Study|Death|1|||
127811965|NCT00098787|459928910|FG002|Overall Study|Death|0|||
127811966|NCT00098787|459928908|FG000|Overall Study|Withdrawal by Subject|4|||
127811967|NCT00098787|459928909|FG001|Overall Study|Withdrawal by Subject|12|||
127811968|NCT00098787|459928910|FG002|Overall Study|Withdrawal by Subject|6|||
127811969|NCT00098787|459928908|FG000|Overall Study|Alternative therapy|8|||
127811970|NCT00098787|459928909|FG001|Overall Study|Alternative therapy|13|||
127811971|NCT00098787|459928910|FG002|Overall Study|Alternative therapy|13|||
127811972|NCT00098787|459928908|FG000|Overall Study|Other|7|||
127811973|NCT00098787|459928909|FG001|Overall Study|Other|6|||
127811974|NCT00098787|459928910|FG002|Overall Study|Other|9|||
127811975|NCT02203149|459928913|FG000|Part 1|Adverse Event|0|||
127811976|NCT02203149|459928914|FG001|Part 1|Adverse Event|1|||
127811977|NCT02203149|459928915|FG002|Part 1|Adverse Event|0|||
127811978|NCT02203149|459928916|FG003|Part 1|Adverse Event|0|||
127811979|NCT02203149|459928917|FG004|Part 1|Adverse Event|0|||
127811980|NCT02203149|459928913|FG000|Part 2|Death|0|||
127811981|NCT02203149|459928914|FG001|Part 2|Death|0|||
127811982|NCT02203149|459928915|FG002|Part 2|Death|1|||
127811983|NCT02203149|459928916|FG003|Part 2|Death|1|||
127811984|NCT02203149|459928917|FG004|Part 2|Death|0|||
127811985|NCT02203149|459928913|FG000|Part 2|Withdrawal by Subject|0|||
127811986|NCT02203149|459928914|FG001|Part 2|Withdrawal by Subject|0|||
127811987|NCT02203149|459928915|FG002|Part 2|Withdrawal by Subject|0|||
127811988|NCT02203149|459928916|FG003|Part 2|Withdrawal by Subject|1|||
127811989|NCT02203149|459928917|FG004|Part 2|Withdrawal by Subject|0|||
127811990|NCT02203149|459928913|FG000|Part 2|Adverse Event|0|||
127811991|NCT02203149|459928914|FG001|Part 2|Adverse Event|0|||
127811992|NCT02203149|459928915|FG002|Part 2|Adverse Event|0|||
127811993|NCT02203149|459928916|FG003|Part 2|Adverse Event|1|||
127811994|NCT02203149|459928917|FG004|Part 2|Adverse Event|1|||
127811995|NCT02537678|459928918|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
127811996|NCT02537678|459928919|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
127811997|NCT02537678|459928918|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
127811998|NCT02537678|459928919|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
127811999|NCT02537678|459928918|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
127812000|NCT02537678|459928919|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
127894407|NCT01341639|460237118|FG001|Interim Period|Physician Decision|1|||
127812001|NCT02537678|459928918|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
127812002|NCT02537678|459928919|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
127812003|NCT02537678|459928918|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
127812004|NCT02537678|459928919|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
127812005|NCT02537678|459928918|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
127812006|NCT02537678|459928919|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
127812007|NCT02537678|459928918|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
127812008|NCT02537678|459928919|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
127812009|NCT01360996|459928920|FG000|Overall Study|Withdrawal by Subject|4|||
127812010|NCT01360996|459928921|FG001|Overall Study|Withdrawal by Subject|3|||
127812011|NCT01360996|459928922|FG002|Overall Study|Withdrawal by Subject|2|||
127812012|NCT01360996|459928920|FG000|Overall Study|Noncompliant|2|||
127812013|NCT01360996|459928921|FG001|Overall Study|Noncompliant|0|||
127812014|NCT01360996|459928922|FG002|Overall Study|Noncompliant|0|||
127812015|NCT01454076|459928924|FG000|Overall Study|Other|2|||
127812016|NCT01454076|459928925|FG001|Overall Study|Other|0|||
127812017|NCT01454076|459928926|FG002|Overall Study|Other|0|||
127812018|NCT01454076|459928927|FG003|Overall Study|Other|1|||
127812019|NCT01454076|459928928|FG004|Overall Study|Other|2|||
127812020|NCT01454076|459928924|FG000|Overall Study|Withdrawal by Subject|3|||
127812021|NCT01454076|459928925|FG001|Overall Study|Withdrawal by Subject|4|||
127812022|NCT01454076|459928926|FG002|Overall Study|Withdrawal by Subject|2|||
127812023|NCT01454076|459928927|FG003|Overall Study|Withdrawal by Subject|1|||
127812024|NCT01454076|459928928|FG004|Overall Study|Withdrawal by Subject|2|||
127812025|NCT01454076|459928924|FG000|Overall Study|Adverse Event|8|||
127812026|NCT01454076|459928925|FG001|Overall Study|Adverse Event|2|||
127812027|NCT01454076|459928926|FG002|Overall Study|Adverse Event|7|||
127812028|NCT01454076|459928927|FG003|Overall Study|Adverse Event|0|||
127812029|NCT01454076|459928928|FG004|Overall Study|Adverse Event|2|||
127812030|NCT04964258|459928929|FG000|Overall Study|Lost to Follow-up|1|||
127812031|NCT04964258|459928930|FG001|Overall Study|Lost to Follow-up|0|||
127812032|NCT04964258|459928931|FG002|Overall Study|Lost to Follow-up|0|||
127812033|NCT04964258|459928932|FG003|Overall Study|Lost to Follow-up|0|||
127812034|NCT04964258|459928933|FG004|Overall Study|Lost to Follow-up|0|||
127812035|NCT04964258|459928934|FG005|Overall Study|Lost to Follow-up|1|||
127812036|NCT04964258|459928935|FG006|Overall Study|Lost to Follow-up|0|||
127812037|NCT04964258|459928936|FG007|Overall Study|Lost to Follow-up|0|||
127812038|NCT04964258|459928937|FG008|Overall Study|Lost to Follow-up|0|||
127812039|NCT04964258|459928938|FG009|Overall Study|Lost to Follow-up|0|||
127812040|NCT04964258|459928939|FG010|Overall Study|Lost to Follow-up|0|||
127812041|NCT01478958|459928940|FG000|Overall Study|Withdrawal by Subject|1|||
127812042|NCT01478958|459928941|FG001|Overall Study|Withdrawal by Subject|1|||
127812043|NCT01478958|459928942|FG002|Overall Study|Withdrawal by Subject|1|||
127812044|NCT01478958|459928940|FG000|Overall Study|Weight loss|1|||
127812045|NCT01478958|459928941|FG001|Overall Study|Weight loss|0|||
127812046|NCT01478958|459928942|FG002|Overall Study|Weight loss|0|||
127812047|NCT01478958|459928940|FG000|Overall Study|Re-located|0|||
127812048|NCT01478958|459928941|FG001|Overall Study|Re-located|1|||
127812049|NCT01478958|459928942|FG002|Overall Study|Re-located|0|||
127812050|NCT01478958|459928940|FG000|Overall Study|Unable to comply|0|||
127812051|NCT01478958|459928941|FG001|Overall Study|Unable to comply|0|||
127812052|NCT01478958|459928942|FG002|Overall Study|Unable to comply|2|||
127812053|NCT03401749|459928943|FG000|Overall Study|Lost to Follow-up|20|||
127812054|NCT03401749|459928944|FG001|Overall Study|Lost to Follow-up|16|||
127812055|NCT03401749|459928945|FG002|Overall Study|Lost to Follow-up|26|||
127812056|NCT01193686|459928946|FG000|Overall Study|Withdrawal by Subject|4|||
127812057|NCT01193686|459928947|FG001|Overall Study|Withdrawal by Subject|1|||
127812058|NCT01193686|459928946|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
127812059|NCT01193686|459928947|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
127812060|NCT03075839|459928950|FG000|Overall Study|Lost to Follow-up|4|||
127812061|NCT01499290|459928951|FG000|Overall Study|Withdrawal by Subject|22|||
127812062|NCT01499290|459928952|FG001|Overall Study|Withdrawal by Subject|15|||
127812063|NCT01499290|459928951|FG000|Overall Study|Not specified in study report|11|||
127894408|NCT01341639|460237117|FG000|Interim Period|Protocol Violation|0|||
127894409|NCT01341639|460237118|FG001|Interim Period|Protocol Violation|1|||
127894410|NCT01341639|460237117|FG000|Post-Treatment|Withdrawal by Subject|0|||
127894411|NCT01341639|460237118|FG001|Post-Treatment|Withdrawal by Subject|1|||
127894412|NCT01341639|460237117|FG000|Post-Treatment|Adverse Event|0|||
127812064|NCT01499290|459928952|FG001|Overall Study|Not specified in study report|5|||
127812065|NCT01499290|459928951|FG000|Overall Study|Condition improved/subject recovered|1|||
127812066|NCT01499290|459928952|FG001|Overall Study|Condition improved/subject recovered|0|||
127812067|NCT01499290|459928951|FG000|Overall Study|Lack of Efficacy|7|||
127812068|NCT01499290|459928952|FG001|Overall Study|Lack of Efficacy|8|||
127812069|NCT01499290|459928951|FG000|Overall Study|Adverse Event|14|||
127812070|NCT01499290|459928952|FG001|Overall Study|Adverse Event|7|||
127894413|NCT01341639|460237118|FG001|Post-Treatment|Adverse Event|2|||
127812071|NCT04052139|459928953|FG000|Overall Study|Lost to Follow-up|2|||
127812072|NCT04052139|459928954|FG001|Overall Study|Lost to Follow-up|0|||
127812073|NCT04052139|459928955|FG002|Overall Study|Lost to Follow-up|0|||
127812074|NCT04052139|459928953|FG000|Overall Study|Withdrawal by Subject|1|||
127812075|NCT04052139|459928954|FG001|Overall Study|Withdrawal by Subject|0|||
127812076|NCT04052139|459928955|FG002|Overall Study|Withdrawal by Subject|0|||
127812077|NCT03406962|459928956|FG000|Overall Study|Death|2|||
127812078|NCT03406962|459928956|FG000|Overall Study|Adverse Event|1|||
127812079|NCT00327444|459928957|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
127812080|NCT00327444|459928958|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
127812081|NCT00327444|459928957|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
127812082|NCT00327444|459928958|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
127812083|NCT00327444|459928957|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
127812084|NCT00327444|459928958|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
127812085|NCT00327444|459928957|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
127812086|NCT00327444|459928958|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
127812087|NCT00327444|459928957|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
127812088|NCT00327444|459928958|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
127812089|NCT00327444|459928957|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
127812090|NCT00327444|459928958|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
127812091|NCT00327444|459928957|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
127812092|NCT00327444|459928958|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
127812093|NCT00327444|459928957|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
127812094|NCT00327444|459928958|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
127812095|NCT04439344|459928959|FG000|Overall Study|Never started threapy|3|||
127812096|NCT04439344|459928959|FG000|Overall Study|Ineligible|3|||
127812097|NCT04439344|459928959|FG000|Overall Study|Adverse Event|13|||
127812098|NCT04439344|459928959|FG000|Overall Study|Death|2|||
127812099|NCT04439344|459928959|FG000|Overall Study|Disease progression|29|||
127812100|NCT04439344|459928959|FG000|Overall Study|Withdrawal by Subject|2|||
127812101|NCT04439344|459928959|FG000|Overall Study|Alternative therapy|1|||
127812102|NCT00552110|459928960|FG000|Overall Study|Serious or Life-Threatening AE|0|||
127812103|NCT00552110|459928961|FG001|Overall Study|Serious or Life-Threatening AE|0|||
127812104|NCT00552110|459928962|FG002|Overall Study|Serious or Life-Threatening AE|1|||
127812105|NCT00552110|459928963|FG003|Overall Study|Serious or Life-Threatening AE|0|||
127812106|NCT00552110|459928964|FG004|Overall Study|Serious or Life-Threatening AE|0|||
127812107|NCT00552110|459928960|FG000|Overall Study|Lack of Efficacy|1|||
127812108|NCT00552110|459928961|FG001|Overall Study|Lack of Efficacy|0|||
127812109|NCT00552110|459928962|FG002|Overall Study|Lack of Efficacy|0|||
127812110|NCT00552110|459928963|FG003|Overall Study|Lack of Efficacy|1|||
127812111|NCT00552110|459928964|FG004|Overall Study|Lack of Efficacy|4|||
127812112|NCT00552110|459928960|FG000|Overall Study|Withdrawal by Subject|0|||
127812113|NCT00552110|459928961|FG001|Overall Study|Withdrawal by Subject|2|||
127812114|NCT00552110|459928962|FG002|Overall Study|Withdrawal by Subject|0|||
127812115|NCT00552110|459928963|FG003|Overall Study|Withdrawal by Subject|3|||
127812116|NCT00552110|459928964|FG004|Overall Study|Withdrawal by Subject|2|||
127812117|NCT00552110|459928960|FG000|Overall Study|Lost to Follow-up|0|||
127812118|NCT00552110|459928961|FG001|Overall Study|Lost to Follow-up|0|||
127812119|NCT00552110|459928962|FG002|Overall Study|Lost to Follow-up|0|||
127812120|NCT00552110|459928963|FG003|Overall Study|Lost to Follow-up|1|||
127812121|NCT00552110|459928964|FG004|Overall Study|Lost to Follow-up|1|||
127812122|NCT00552110|459928960|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
127812123|NCT00552110|459928961|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
127812124|NCT00552110|459928962|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
127812125|NCT00552110|459928963|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
127812126|NCT00552110|459928964|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
127812127|NCT00552110|459928960|FG000|Overall Study|Withdrawn per Sponsor|0|||
127812128|NCT00552110|459928961|FG001|Overall Study|Withdrawn per Sponsor|1|||
127812129|NCT00552110|459928962|FG002|Overall Study|Withdrawn per Sponsor|0|||
127812130|NCT00552110|459928963|FG003|Overall Study|Withdrawn per Sponsor|0|||
127812131|NCT00552110|459928964|FG004|Overall Study|Withdrawn per Sponsor|1|||
127812132|NCT00552110|459928960|FG000|Overall Study|Use of Prohibited Medication|1|||
127812133|NCT00552110|459928961|FG001|Overall Study|Use of Prohibited Medication|1|||
127812134|NCT00552110|459928962|FG002|Overall Study|Use of Prohibited Medication|0|||
127812135|NCT00552110|459928963|FG003|Overall Study|Use of Prohibited Medication|0|||
127812136|NCT00552110|459928964|FG004|Overall Study|Use of Prohibited Medication|0|||
127812137|NCT00552110|459928960|FG000|Overall Study|Delay of Study due to Relabeling|0|||
127812138|NCT00552110|459928961|FG001|Overall Study|Delay of Study due to Relabeling|0|||
127812139|NCT00552110|459928962|FG002|Overall Study|Delay of Study due to Relabeling|0|||
127812140|NCT00552110|459928963|FG003|Overall Study|Delay of Study due to Relabeling|1|||
127812141|NCT00552110|459928964|FG004|Overall Study|Delay of Study due to Relabeling|0|||
127812142|NCT00552110|459928960|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
127812143|NCT00552110|459928961|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
127812144|NCT00552110|459928962|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
127812145|NCT00552110|459928963|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
127812146|NCT00552110|459928964|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
127812147|NCT00552110|459928960|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
127812148|NCT00552110|459928961|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
127812149|NCT00552110|459928962|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
127812150|NCT00552110|459928963|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
127812151|NCT00552110|459928964|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
127812152|NCT05556616|459931242|FG000|Overall Study|Withdrawal by Subject|1|||
127812153|NCT05556616|459931243|FG001|Overall Study|Withdrawal by Subject|0|||
127812154|NCT05556616|459931244|FG002|Overall Study|Withdrawal by Subject|0|||
127812155|NCT05556616|459931245|FG003|Overall Study|Withdrawal by Subject|0|||
127812156|NCT05556616|459931246|FG004|Overall Study|Withdrawal by Subject|0|||
127812157|NCT05556616|459931247|FG005|Overall Study|Withdrawal by Subject|0|||
127812158|NCT05556616|459931248|FG006|Overall Study|Withdrawal by Subject|0|||
127812159|NCT05556616|459931242|FG000|Overall Study|Death|0|||
127812160|NCT05556616|459931243|FG001|Overall Study|Death|0|||
127812161|NCT05556616|459931244|FG002|Overall Study|Death|2|||
127812162|NCT05556616|459931245|FG003|Overall Study|Death|1|||
127812163|NCT05556616|459931246|FG004|Overall Study|Death|0|||
127812164|NCT05556616|459931247|FG005|Overall Study|Death|0|||
127812165|NCT05556616|459931248|FG006|Overall Study|Death|0|||
127812166|NCT05556616|459931242|FG000|Overall Study|Study Terminated by Sponsor|0|||
127812167|NCT05556616|459931243|FG001|Overall Study|Study Terminated by Sponsor|3|||
127812168|NCT05556616|459931244|FG002|Overall Study|Study Terminated by Sponsor|0|||
127812169|NCT05556616|459931245|FG003|Overall Study|Study Terminated by Sponsor|0|||
127812170|NCT05556616|459931246|FG004|Overall Study|Study Terminated by Sponsor|0|||
127812171|NCT05556616|459931247|FG005|Overall Study|Study Terminated by Sponsor|0|||
127812172|NCT05556616|459931248|FG006|Overall Study|Study Terminated by Sponsor|0|||
127812173|NCT00075881|459931249|FG000|Overall Study|Lack of Efficacy|18|||
127812174|NCT00075881|459931249|FG000|Overall Study|Adverse Event|7|||
127812175|NCT00075881|459931249|FG000|Overall Study|Death|1|||
127812176|NCT00075881|459931249|FG000|Overall Study|Withdrawal by Subject|2|||
127812177|NCT00075881|459931249|FG000|Overall Study|Protocol Violation|4|||
127812178|NCT00075881|459931249|FG000|Overall Study|other complicating disease|3|||
127812179|NCT00075881|459931249|FG000|Overall Study|other|4|||
127812180|NCT00075881|459931249|FG000|Overall Study|missing data|2|||
127812181|NCT00075881|459931249|FG000|Overall Study|Ineligible|1|||
127812182|NCT00075881|459931249|FG000|Overall Study|never start protocol therapy|1|||
127812183|NCT03019549|459931250|FG000|Washout|DId not meet genotype criteria|11|||
127812184|NCT03019549|459931250|FG000|Period 2|Adverse Event|2|||
127812185|NCT03019549|459931250|FG000|Period 2|Physician Decision|2|||
127812186|NCT03019549|459931250|FG000|Period 2|Withdrawal by Subject|1|||
127812187|NCT03263091|459931251|FG000|OL Component|Withdrawal by Subject|1|||
127812188|NCT03263091|459931252|FG001|OL Component|Withdrawal by Subject|1|||
127812189|NCT03263091|459931253|FG002|OL Component|Withdrawal by Subject|0|||
127812190|NCT03263091|459931254|FG003|OL Component|Withdrawal by Subject|0|||
127812191|NCT03263091|459931255|FG004|OL Component|Withdrawal by Subject|0|||
127812192|NCT03263091|459931256|FG005|OL Component|Withdrawal by Subject|0|||
127812193|NCT03263091|459931251|FG000|OL Component|Physician Decision|0|||
127812194|NCT03263091|459931252|FG001|OL Component|Physician Decision|1|||
127812195|NCT03263091|459931253|FG002|OL Component|Physician Decision|2|||
127812196|NCT03263091|459931254|FG003|OL Component|Physician Decision|0|||
127812197|NCT03263091|459931255|FG004|OL Component|Physician Decision|0|||
127812198|NCT03263091|459931256|FG005|OL Component|Physician Decision|0|||
127812199|NCT03263091|459931251|FG000|OL Component|Death|1|||
127812200|NCT03263091|459931252|FG001|OL Component|Death|0|||
127812201|NCT03263091|459931253|FG002|OL Component|Death|0|||
127812202|NCT03263091|459931254|FG003|OL Component|Death|0|||
127812203|NCT03263091|459931255|FG004|OL Component|Death|0|||
127812204|NCT03263091|459931256|FG005|OL Component|Death|0|||
127812205|NCT03263091|459931251|FG000|OL High-EPO Component|Withdrawal by Subject|0|||
127812206|NCT03263091|459931252|FG001|OL High-EPO Component|Withdrawal by Subject|0|||
127812207|NCT03263091|459931253|FG002|OL High-EPO Component|Withdrawal by Subject|0|||
127812208|NCT03263091|459931254|FG003|OL High-EPO Component|Withdrawal by Subject|6|||
127812209|NCT03263091|459931255|FG004|OL High-EPO Component|Withdrawal by Subject|0|||
127812210|NCT03263091|459931256|FG005|OL High-EPO Component|Withdrawal by Subject|0|||
127812211|NCT03263091|459931251|FG000|OL High-EPO Component|Physician Decision|0|||
127812212|NCT03263091|459931252|FG001|OL High-EPO Component|Physician Decision|0|||
127812213|NCT03263091|459931253|FG002|OL High-EPO Component|Physician Decision|0|||
127812214|NCT03263091|459931254|FG003|OL High-EPO Component|Physician Decision|1|||
127812215|NCT03263091|459931255|FG004|OL High-EPO Component|Physician Decision|0|||
127812216|NCT03263091|459931256|FG005|OL High-EPO Component|Physician Decision|0|||
127812217|NCT03263091|459931251|FG000|OL High-EPO Component|Death|0|||
127812218|NCT03263091|459931252|FG001|OL High-EPO Component|Death|0|||
127812219|NCT03263091|459931253|FG002|OL High-EPO Component|Death|0|||
127812220|NCT03263091|459931254|FG003|OL High-EPO Component|Death|3|||
127812221|NCT03263091|459931255|FG004|OL High-EPO Component|Death|0|||
127812222|NCT03263091|459931256|FG005|OL High-EPO Component|Death|0|||
127812223|NCT03263091|459931251|FG000|DB Component|Withdrawal by Subject|0|||
127812224|NCT03263091|459931252|FG001|DB Component|Withdrawal by Subject|0|||
127812225|NCT03263091|459931253|FG002|DB Component|Withdrawal by Subject|0|||
127812226|NCT03263091|459931254|FG003|DB Component|Withdrawal by Subject|0|||
127812227|NCT03263091|459931255|FG004|DB Component|Withdrawal by Subject|22|||
127812228|NCT03263091|459931256|FG005|DB Component|Withdrawal by Subject|8|||
127812229|NCT03263091|459931251|FG000|DB Component|Physician Decision|0|||
127812230|NCT03263091|459931252|FG001|DB Component|Physician Decision|0|||
127812231|NCT03263091|459931253|FG002|DB Component|Physician Decision|0|||
127812232|NCT03263091|459931254|FG003|DB Component|Physician Decision|0|||
127812233|NCT03263091|459931255|FG004|DB Component|Physician Decision|3|||
127812234|NCT03263091|459931256|FG005|DB Component|Physician Decision|1|||
127812235|NCT03263091|459931251|FG000|DB Component|Adverse Event|0|||
127812236|NCT03263091|459931252|FG001|DB Component|Adverse Event|0|||
127812237|NCT03263091|459931253|FG002|DB Component|Adverse Event|0|||
127812238|NCT03263091|459931254|FG003|DB Component|Adverse Event|0|||
127812239|NCT03263091|459931255|FG004|DB Component|Adverse Event|2|||
127812240|NCT03263091|459931256|FG005|DB Component|Adverse Event|1|||
127812241|NCT03263091|459931251|FG000|DB Component|Lost to Follow-up|0|||
127812242|NCT03263091|459931252|FG001|DB Component|Lost to Follow-up|0|||
127812243|NCT03263091|459931253|FG002|DB Component|Lost to Follow-up|0|||
127812244|NCT03263091|459931254|FG003|DB Component|Lost to Follow-up|0|||
127812245|NCT03263091|459931255|FG004|DB Component|Lost to Follow-up|2|||
127812246|NCT03263091|459931256|FG005|DB Component|Lost to Follow-up|1|||
127812247|NCT03263091|459931251|FG000|DB Component|Death|0|||
127812248|NCT03263091|459931252|FG001|DB Component|Death|0|||
127812249|NCT03263091|459931253|FG002|DB Component|Death|0|||
127812250|NCT03263091|459931254|FG003|DB Component|Death|0|||
127812251|NCT03263091|459931255|FG004|DB Component|Death|7|||
127812252|NCT03263091|459931256|FG005|DB Component|Death|4|||
127812253|NCT03263091|459931251|FG000|DB Component|Other than specified|0|||
127812254|NCT03263091|459931252|FG001|DB Component|Other than specified|0|||
127812255|NCT03263091|459931253|FG002|DB Component|Other than specified|0|||
127812256|NCT03263091|459931254|FG003|DB Component|Other than specified|0|||
127812257|NCT03263091|459931255|FG004|DB Component|Other than specified|8|||
127812258|NCT03263091|459931256|FG005|DB Component|Other than specified|6|||
127812259|NCT00742781|459931257|FG000|Overall Study|Withdrawal by Subject|3|||
127812260|NCT03539432|459931264|FG000|Overall Study|Lost to Follow-up|0|||
127812261|NCT03539432|459931265|FG001|Overall Study|Lost to Follow-up|1|||
127812262|NCT00824564|459931275|FG000|Overall Study|Lost to Follow-up|5|||
127812263|NCT00824564|459931276|FG001|Overall Study|Lost to Follow-up|7|||
127812264|NCT00824564|459931275|FG000|Overall Study|Withdrawal by Subject|1|||
127812265|NCT00824564|459931276|FG001|Overall Study|Withdrawal by Subject|1|||
127812266|NCT00824564|459931275|FG000|Overall Study|Other|1|||
127812267|NCT00824564|459931276|FG001|Overall Study|Other|2|||
127812268|NCT00824564|459931275|FG000|Overall Study|Randomized, but not treated|1|||
127894414|NCT04582266|460237119|FG000|Overall Study|Lost to Follow-up|7|||
127812269|NCT00824564|459931276|FG001|Overall Study|Randomized, but not treated|0|||
127812270|NCT01552057|459931283|FG000|Overall Study|Adverse Event|14|||
127812271|NCT01552057|459931284|FG001|Overall Study|Adverse Event|15|||
127812272|NCT01552057|459931283|FG000|Overall Study|Lack of Efficacy|8|||
127812273|NCT01552057|459931284|FG001|Overall Study|Lack of Efficacy|23|||
127812274|NCT01552057|459931283|FG000|Overall Study|Withdrawal by Subject|5|||
127812275|NCT01552057|459931284|FG001|Overall Study|Withdrawal by Subject|8|||
127812276|NCT01552057|459931283|FG000|Overall Study|Entry Criteria Not Met|2|||
127812277|NCT01552057|459931284|FG001|Overall Study|Entry Criteria Not Met|2|||
127812278|NCT01552057|459931283|FG000|Overall Study|Physician Decision|1|||
127812279|NCT01552057|459931284|FG001|Overall Study|Physician Decision|0|||
127812280|NCT05127486|459931286|FG000|Overall Study|Adverse Event|2|||
127812281|NCT05127486|459931287|FG001|Overall Study|Adverse Event|4|||
127812282|NCT05127486|459931286|FG000|Overall Study|Lack of Efficacy|1|||
127812283|NCT05127486|459931287|FG001|Overall Study|Lack of Efficacy|0|||
127812284|NCT05127486|459931286|FG000|Overall Study|Pregnancy|0|||
127812285|NCT05127486|459931287|FG001|Overall Study|Pregnancy|1|||
127812286|NCT05127486|459931286|FG000|Overall Study|Physician Decision|4|||
127812287|NCT05127486|459931287|FG001|Overall Study|Physician Decision|1|||
127812288|NCT05127486|459931286|FG000|Overall Study|Withdrawal by Subject|14|||
127812289|NCT05127486|459931287|FG001|Overall Study|Withdrawal by Subject|13|||
127812290|NCT05127486|459931286|FG000|Overall Study|Lost to Follow-up|5|||
127812291|NCT05127486|459931287|FG001|Overall Study|Lost to Follow-up|8|||
127812292|NCT01287754|459931288|FG000|Overall Study|Death|2|||
127812293|NCT01287754|459931289|FG001|Overall Study|Death|12|||
127812294|NCT01287754|459931288|FG000|Overall Study|Lost to Follow-up|1|||
127812295|NCT01287754|459931289|FG001|Overall Study|Lost to Follow-up|6|||
127812296|NCT01287754|459931288|FG000|Overall Study|Protocol Violation|0|||
127812297|NCT01287754|459931289|FG001|Overall Study|Protocol Violation|3|||
127812298|NCT04439266|459931300|FG000|Overall Study|Ineligible|1|||
127812299|NCT04439266|459931300|FG000|Overall Study|Adverse Event|1|||
127812300|NCT04439266|459931300|FG000|Overall Study|Death|1|||
127812301|NCT04439266|459931300|FG000|Overall Study|Disease progression|1|||
127812302|NCT04439266|459931300|FG000|Overall Study|Still on treatment|1|||
127812303|NCT04971226|459931301|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
127812304|NCT04971226|459931302|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
127812305|NCT04971226|459931303|FG002|Overall Study|Unsatisfactory therapeutic effect|21|||
127812306|NCT04971226|459931304|FG003|Overall Study|Unsatisfactory therapeutic effect|10|||
127812307|NCT04971226|459931301|FG000|Overall Study|Adverse Event|6|||
127812308|NCT04971226|459931302|FG001|Overall Study|Adverse Event|5|||
127812309|NCT04971226|459931303|FG002|Overall Study|Adverse Event|11|||
127812310|NCT04971226|459931304|FG003|Overall Study|Adverse Event|10|||
127812311|NCT04971226|459931301|FG000|Overall Study|Progressive disease|2|||
127812312|NCT04971226|459931302|FG001|Overall Study|Progressive disease|0|||
127812313|NCT04971226|459931303|FG002|Overall Study|Progressive disease|3|||
127812314|NCT04971226|459931304|FG003|Overall Study|Progressive disease|1|||
127812315|NCT04971226|459931301|FG000|Overall Study|Protocol Deviation|1|||
127812316|NCT04971226|459931302|FG001|Overall Study|Protocol Deviation|0|||
127812317|NCT04971226|459931303|FG002|Overall Study|Protocol Deviation|1|||
127812318|NCT04971226|459931304|FG003|Overall Study|Protocol Deviation|1|||
127812319|NCT04971226|459931301|FG000|Overall Study|Subject Decision|0|||
127812320|NCT04971226|459931302|FG001|Overall Study|Subject Decision|1|||
127812321|NCT04971226|459931303|FG002|Overall Study|Subject Decision|1|||
127812322|NCT04971226|459931304|FG003|Overall Study|Subject Decision|1|||
127812323|NCT04971226|459931301|FG000|Overall Study|Pregnancy|0|||
127812324|NCT04971226|459931302|FG001|Overall Study|Pregnancy|0|||
127812325|NCT04971226|459931303|FG002|Overall Study|Pregnancy|0|||
127812326|NCT04971226|459931304|FG003|Overall Study|Pregnancy|1|||
127812327|NCT04971226|459931301|FG000|Overall Study|Participants not treated|1|||
127812328|NCT04971226|459931302|FG001|Overall Study|Participants not treated|0|||
127812329|NCT04971226|459931303|FG002|Overall Study|Participants not treated|2|||
127812330|NCT04971226|459931304|FG003|Overall Study|Participants not treated|1|||
127812331|NCT00001337|459931306|FG000|Overall Study|Switched to alternate treatment|2|||
127812332|NCT00001337|459931307|FG001|Overall Study|Switched to alternate treatment|2|||
127812333|NCT00001337|459931308|FG002|Overall Study|Switched to alternate treatment|0|||
127812334|NCT00001337|459931306|FG000|Overall Study|Refused further treatment|2|||
127812335|NCT00001337|459931307|FG001|Overall Study|Refused further treatment|1|||
127812336|NCT00001337|459931308|FG002|Overall Study|Refused further treatment|0|||
127812337|NCT00001337|459931306|FG000|Overall Study|Began other Tx|1|||
127812338|NCT00001337|459931307|FG001|Overall Study|Began other Tx|0|||
127812339|NCT00001337|459931308|FG002|Overall Study|Began other Tx|0|||
127812340|NCT00001337|459931306|FG000|Overall Study|Physician Decision|3|||
127812341|NCT00001337|459931307|FG001|Overall Study|Physician Decision|1|||
127812342|NCT00001337|459931308|FG002|Overall Study|Physician Decision|0|||
127812343|NCT00001337|459931306|FG000|Overall Study|Doesn't have NHL|0|||
127812344|NCT00001337|459931307|FG001|Overall Study|Doesn't have NHL|1|||
127812345|NCT00001337|459931308|FG002|Overall Study|Doesn't have NHL|0|||
127812346|NCT00001337|459931306|FG000|Overall Study|Non protocol tx needed|3|||
127812347|NCT00001337|459931307|FG001|Overall Study|Non protocol tx needed|1|||
127812348|NCT00001337|459931308|FG002|Overall Study|Non protocol tx needed|0|||
127812349|NCT00001337|459931306|FG000|Overall Study|Protocol change|1|||
127812350|NCT00001337|459931307|FG001|Overall Study|Protocol change|0|||
127812351|NCT00001337|459931308|FG002|Overall Study|Protocol change|0|||
127812352|NCT00001337|459931306|FG000|Overall Study|2nd primary disease|0|||
127812353|NCT00001337|459931307|FG001|Overall Study|2nd primary disease|0|||
127812354|NCT00001337|459931308|FG002|Overall Study|2nd primary disease|1|||
127812355|NCT00001337|459931306|FG000|Overall Study|Death during follow up period|9|||
127812356|NCT00001337|459931307|FG001|Overall Study|Death during follow up period|4|||
127812357|NCT00001337|459931308|FG002|Overall Study|Death during follow up period|0|||
127812358|NCT00001337|459931306|FG000|Overall Study|Death on study|19|||
127812359|NCT00001337|459931307|FG001|Overall Study|Death on study|9|||
127812360|NCT00001337|459931308|FG002|Overall Study|Death on study|0|||
127812361|NCT00001337|459931306|FG000|Overall Study|Disease progression during follow-up period|3|||
127812362|NCT00001337|459931307|FG001|Overall Study|Disease progression during follow-up period|1|||
127812363|NCT00001337|459931308|FG002|Overall Study|Disease progression during follow-up period|0|||
127812364|NCT00001337|459931306|FG000|Overall Study|Disease progression on study|33|||
127812365|NCT00001337|459931307|FG001|Overall Study|Disease progression on study|41|||
127812366|NCT00001337|459931308|FG002|Overall Study|Disease progression on study|0|||
127812367|NCT00001337|459931306|FG000|Overall Study|Lost to further follow-up|10|||
127812368|NCT00001337|459931307|FG001|Overall Study|Lost to further follow-up|6|||
127812369|NCT00001337|459931308|FG002|Overall Study|Lost to further follow-up|0|||
127812370|NCT00001337|459931306|FG000|Overall Study|2nd malignancy|1|||
127812371|NCT00001337|459931307|FG001|Overall Study|2nd malignancy|0|||
127812372|NCT00001337|459931308|FG002|Overall Study|2nd malignancy|0|||
127812373|NCT00001337|459931306|FG000|Overall Study|Treatment for second lymphoma|0|||
127812374|NCT00001337|459931307|FG001|Overall Study|Treatment for second lymphoma|1|||
127812375|NCT00001337|459931308|FG002|Overall Study|Treatment for second lymphoma|0|||
127812376|NCT00001337|459931306|FG000|Overall Study|Transfer to transplant|0|||
127812377|NCT00001337|459931307|FG001|Overall Study|Transfer to transplant|1|||
127812378|NCT00001337|459931308|FG002|Overall Study|Transfer to transplant|0|||
127812379|NCT05040971|459931309|FG000|Overall Study|Withdrawal by Subject|0|||
127812380|NCT05040971|459931310|FG001|Overall Study|Withdrawal by Subject|2|||
127812381|NCT05040971|459931309|FG000|Overall Study|Lost to Follow-up|8|||
127812382|NCT05040971|459931310|FG001|Overall Study|Lost to Follow-up|3|||
127812383|NCT05040971|459931309|FG000|Overall Study|Death|2|||
127812384|NCT05040971|459931310|FG001|Overall Study|Death|0|||
127812385|NCT04889209|459931317|FG000|All Cohorts Except 15E|Adverse Event|0|||
127812386|NCT04889209|459931318|FG001|All Cohorts Except 15E|Adverse Event|0|||
127812387|NCT04889209|459931319|FG002|All Cohorts Except 15E|Adverse Event|0|||
127812388|NCT04889209|459931320|FG003|All Cohorts Except 15E|Adverse Event|0|||
127812389|NCT04889209|459931321|FG004|All Cohorts Except 15E|Adverse Event|0|||
127812390|NCT04889209|459931322|FG005|All Cohorts Except 15E|Adverse Event|0|||
127812391|NCT04889209|459931323|FG006|All Cohorts Except 15E|Adverse Event|1|||
127812392|NCT04889209|459931324|FG007|All Cohorts Except 15E|Adverse Event|0|||
127812393|NCT04889209|459931325|FG008|All Cohorts Except 15E|Adverse Event|0|||
127812394|NCT04889209|459931326|FG009|All Cohorts Except 15E|Adverse Event|0|||
127812395|NCT04889209|459931327|FG010|All Cohorts Except 15E|Adverse Event|0|||
127812396|NCT04889209|459931328|FG011|All Cohorts Except 15E|Adverse Event|0|||
127812397|NCT04889209|459931329|FG012|All Cohorts Except 15E|Adverse Event|0|||
127812398|NCT04889209|459931330|FG013|All Cohorts Except 15E|Adverse Event|0|||
127812399|NCT04889209|459931331|FG014|All Cohorts Except 15E|Adverse Event|0|||
127812400|NCT04889209|459931332|FG015|All Cohorts Except 15E|Adverse Event|0|||
127812401|NCT04889209|459931333|FG016|All Cohorts Except 15E|Adverse Event|0|||
127812402|NCT04889209|459931334|FG017|All Cohorts Except 15E|Adverse Event|0|||
127812403|NCT04889209|459931317|FG000|All Cohorts Except 15E|Death|0|||
127812404|NCT04889209|459931318|FG001|All Cohorts Except 15E|Death|1|||
127812405|NCT04889209|459931319|FG002|All Cohorts Except 15E|Death|0|||
127812406|NCT04889209|459931320|FG003|All Cohorts Except 15E|Death|0|||
127812407|NCT04889209|459931321|FG004|All Cohorts Except 15E|Death|0|||
127812408|NCT04889209|459931322|FG005|All Cohorts Except 15E|Death|0|||
127812409|NCT04889209|459931323|FG006|All Cohorts Except 15E|Death|0|||
127812410|NCT04889209|459931324|FG007|All Cohorts Except 15E|Death|0|||
127812411|NCT04889209|459931325|FG008|All Cohorts Except 15E|Death|0|||
127812412|NCT04889209|459931326|FG009|All Cohorts Except 15E|Death|0|||
127812413|NCT04889209|459931327|FG010|All Cohorts Except 15E|Death|0|||
127812414|NCT04889209|459931328|FG011|All Cohorts Except 15E|Death|0|||
127812415|NCT04889209|459931329|FG012|All Cohorts Except 15E|Death|0|||
127812416|NCT04889209|459931330|FG013|All Cohorts Except 15E|Death|0|||
127812417|NCT04889209|459931331|FG014|All Cohorts Except 15E|Death|0|||
127812418|NCT04889209|459931332|FG015|All Cohorts Except 15E|Death|0|||
127812419|NCT04889209|459931333|FG016|All Cohorts Except 15E|Death|0|||
127812420|NCT04889209|459931334|FG017|All Cohorts Except 15E|Death|0|||
127812421|NCT04889209|459931317|FG000|All Cohorts Except 15E|Lost to Follow-up|0|||
127812422|NCT04889209|459931318|FG001|All Cohorts Except 15E|Lost to Follow-up|0|||
127812423|NCT04889209|459931319|FG002|All Cohorts Except 15E|Lost to Follow-up|1|||
127812424|NCT04889209|459931320|FG003|All Cohorts Except 15E|Lost to Follow-up|2|||
127812425|NCT04889209|459931321|FG004|All Cohorts Except 15E|Lost to Follow-up|4|||
127812426|NCT04889209|459931322|FG005|All Cohorts Except 15E|Lost to Follow-up|1|||
127812427|NCT04889209|459931323|FG006|All Cohorts Except 15E|Lost to Follow-up|0|||
127812428|NCT04889209|459931324|FG007|All Cohorts Except 15E|Lost to Follow-up|1|||
127812429|NCT04889209|459931325|FG008|All Cohorts Except 15E|Lost to Follow-up|2|||
127812430|NCT04889209|459931326|FG009|All Cohorts Except 15E|Lost to Follow-up|2|||
127812431|NCT04889209|459931327|FG010|All Cohorts Except 15E|Lost to Follow-up|2|||
127812432|NCT04889209|459931328|FG011|All Cohorts Except 15E|Lost to Follow-up|4|||
127812433|NCT04889209|459931329|FG012|All Cohorts Except 15E|Lost to Follow-up|2|||
127812434|NCT04889209|459931330|FG013|All Cohorts Except 15E|Lost to Follow-up|2|||
127812435|NCT04889209|459931331|FG014|All Cohorts Except 15E|Lost to Follow-up|0|||
127812436|NCT04889209|459931332|FG015|All Cohorts Except 15E|Lost to Follow-up|5|||
127812437|NCT04889209|459931333|FG016|All Cohorts Except 15E|Lost to Follow-up|5|||
127812438|NCT04889209|459931334|FG017|All Cohorts Except 15E|Lost to Follow-up|28|||
127812439|NCT04889209|459931317|FG000|All Cohorts Except 15E|Physician Decision|0|||
127812440|NCT04889209|459931318|FG001|All Cohorts Except 15E|Physician Decision|0|||
127812441|NCT04889209|459931319|FG002|All Cohorts Except 15E|Physician Decision|0|||
127812442|NCT04889209|459931320|FG003|All Cohorts Except 15E|Physician Decision|0|||
127812443|NCT04889209|459931321|FG004|All Cohorts Except 15E|Physician Decision|1|||
127812444|NCT04889209|459931322|FG005|All Cohorts Except 15E|Physician Decision|0|||
127812445|NCT04889209|459931323|FG006|All Cohorts Except 15E|Physician Decision|0|||
127812446|NCT04889209|459931324|FG007|All Cohorts Except 15E|Physician Decision|1|||
127812447|NCT04889209|459931325|FG008|All Cohorts Except 15E|Physician Decision|0|||
127812448|NCT04889209|459931326|FG009|All Cohorts Except 15E|Physician Decision|1|||
127812449|NCT04889209|459931327|FG010|All Cohorts Except 15E|Physician Decision|0|||
127812450|NCT04889209|459931328|FG011|All Cohorts Except 15E|Physician Decision|1|||
127812451|NCT04889209|459931329|FG012|All Cohorts Except 15E|Physician Decision|1|||
127812452|NCT04889209|459931330|FG013|All Cohorts Except 15E|Physician Decision|0|||
127812453|NCT04889209|459931331|FG014|All Cohorts Except 15E|Physician Decision|0|||
127812454|NCT04889209|459931332|FG015|All Cohorts Except 15E|Physician Decision|0|||
127812455|NCT04889209|459931333|FG016|All Cohorts Except 15E|Physician Decision|0|||
127812456|NCT04889209|459931334|FG017|All Cohorts Except 15E|Physician Decision|0|||
127812457|NCT04889209|459931317|FG000|All Cohorts Except 15E|Withdrawal by Subject|1|||
127812458|NCT04889209|459931318|FG001|All Cohorts Except 15E|Withdrawal by Subject|1|||
127812459|NCT04889209|459931319|FG002|All Cohorts Except 15E|Withdrawal by Subject|2|||
127812460|NCT04889209|459931320|FG003|All Cohorts Except 15E|Withdrawal by Subject|5|||
127812461|NCT04889209|459931321|FG004|All Cohorts Except 15E|Withdrawal by Subject|2|||
127812462|NCT04889209|459931322|FG005|All Cohorts Except 15E|Withdrawal by Subject|3|||
127812463|NCT04889209|459931323|FG006|All Cohorts Except 15E|Withdrawal by Subject|3|||
127812464|NCT04889209|459931324|FG007|All Cohorts Except 15E|Withdrawal by Subject|1|||
127812465|NCT04889209|459931325|FG008|All Cohorts Except 15E|Withdrawal by Subject|3|||
127812466|NCT04889209|459931326|FG009|All Cohorts Except 15E|Withdrawal by Subject|3|||
127812467|NCT04889209|459931327|FG010|All Cohorts Except 15E|Withdrawal by Subject|3|||
127812468|NCT04889209|459931328|FG011|All Cohorts Except 15E|Withdrawal by Subject|3|||
127812469|NCT04889209|459931329|FG012|All Cohorts Except 15E|Withdrawal by Subject|3|||
127812470|NCT04889209|459931330|FG013|All Cohorts Except 15E|Withdrawal by Subject|0|||
127812471|NCT04889209|459931331|FG014|All Cohorts Except 15E|Withdrawal by Subject|0|||
127812472|NCT04889209|459931332|FG015|All Cohorts Except 15E|Withdrawal by Subject|1|||
127812473|NCT04889209|459931333|FG016|All Cohorts Except 15E|Withdrawal by Subject|3|||
127812474|NCT04889209|459931334|FG017|All Cohorts Except 15E|Withdrawal by Subject|16|||
127812475|NCT04889209|459931317|FG000|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
127812476|NCT04889209|459931318|FG001|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
127812477|NCT04889209|459931319|FG002|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
127812478|NCT04889209|459931320|FG003|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
127812479|NCT04889209|459931321|FG004|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
127812480|NCT04889209|459931322|FG005|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
127812481|NCT04889209|459931323|FG006|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
127812482|NCT04889209|459931324|FG007|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
127812483|NCT04889209|459931325|FG008|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
127812484|NCT04889209|459931326|FG009|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
127812485|NCT04889209|459931327|FG010|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
127812486|NCT04889209|459931328|FG011|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
127812487|NCT04889209|459931329|FG012|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
127812488|NCT04889209|459931330|FG013|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
127812489|NCT04889209|459931331|FG014|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
127812490|NCT04889209|459931332|FG015|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
127812491|NCT04889209|459931333|FG016|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
127812492|NCT04889209|459931334|FG017|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
127812493|NCT04889209|459931317|FG000|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
127812494|NCT04889209|459931318|FG001|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
127812495|NCT04889209|459931319|FG002|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
127812496|NCT04889209|459931320|FG003|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|12|||
127812497|NCT04889209|459931321|FG004|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
127894415|NCT04582266|460237120|FG001|Overall Study|Lost to Follow-up|5|||
127894416|NCT04582266|460237119|FG000|Overall Study|Withdrawal by Subject|1|||
127812498|NCT04889209|459931322|FG005|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
127812499|NCT04889209|459931323|FG006|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
127894417|NCT04582266|460237120|FG001|Overall Study|Withdrawal by Subject|0|||
127812500|NCT04889209|459931324|FG007|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
127812501|NCT04889209|459931325|FG008|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
127812502|NCT04889209|459931326|FG009|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
127812503|NCT04889209|459931327|FG010|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
127812504|NCT04889209|459931328|FG011|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
127812505|NCT04889209|459931329|FG012|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
127812506|NCT04889209|459931330|FG013|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
127812507|NCT04889209|459931331|FG014|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
127812508|NCT04889209|459931332|FG015|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
127812509|NCT04889209|459931333|FG016|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
127812510|NCT04889209|459931334|FG017|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
127812511|NCT04889209|459931317|FG000|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
127812512|NCT04889209|459931318|FG001|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
127812513|NCT04889209|459931319|FG002|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
127812514|NCT04889209|459931320|FG003|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
127812515|NCT04889209|459931321|FG004|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
127812516|NCT04889209|459931322|FG005|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
127812517|NCT04889209|459931323|FG006|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
127812518|NCT04889209|459931324|FG007|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
127812519|NCT04889209|459931325|FG008|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
127812520|NCT04889209|459931326|FG009|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
127812521|NCT04889209|459931327|FG010|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
127812522|NCT04889209|459931328|FG011|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
127812523|NCT04889209|459931329|FG012|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
127812524|NCT04889209|459931330|FG013|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
127812525|NCT04889209|459931331|FG014|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
127812526|NCT04889209|459931332|FG015|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
127812527|NCT04889209|459931333|FG016|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
127812528|NCT04889209|459931334|FG017|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
127812529|NCT04889209|459931317|FG000|All Cohorts Except 15E|Became ineligible after enrollment|0|||
127812530|NCT04889209|459931318|FG001|All Cohorts Except 15E|Became ineligible after enrollment|0|||
127812531|NCT04889209|459931319|FG002|All Cohorts Except 15E|Became ineligible after enrollment|0|||
127812532|NCT04889209|459931320|FG003|All Cohorts Except 15E|Became ineligible after enrollment|0|||
127812533|NCT04889209|459931321|FG004|All Cohorts Except 15E|Became ineligible after enrollment|0|||
127812534|NCT04889209|459931322|FG005|All Cohorts Except 15E|Became ineligible after enrollment|0|||
127812535|NCT04889209|459931323|FG006|All Cohorts Except 15E|Became ineligible after enrollment|0|||
127812536|NCT04889209|459931324|FG007|All Cohorts Except 15E|Became ineligible after enrollment|0|||
127812537|NCT04889209|459931325|FG008|All Cohorts Except 15E|Became ineligible after enrollment|0|||
127812538|NCT04889209|459931326|FG009|All Cohorts Except 15E|Became ineligible after enrollment|0|||
127812539|NCT04889209|459931327|FG010|All Cohorts Except 15E|Became ineligible after enrollment|0|||
127812540|NCT04889209|459931328|FG011|All Cohorts Except 15E|Became ineligible after enrollment|0|||
127812541|NCT04889209|459931329|FG012|All Cohorts Except 15E|Became ineligible after enrollment|0|||
127812542|NCT04889209|459931330|FG013|All Cohorts Except 15E|Became ineligible after enrollment|0|||
127812543|NCT04889209|459931331|FG014|All Cohorts Except 15E|Became ineligible after enrollment|0|||
127812544|NCT04889209|459931332|FG015|All Cohorts Except 15E|Became ineligible after enrollment|0|||
127812545|NCT04889209|459931333|FG016|All Cohorts Except 15E|Became ineligible after enrollment|0|||
127812546|NCT04889209|459931334|FG017|All Cohorts Except 15E|Became ineligible after enrollment|1|||
127812547|NCT04889209|459931317|FG000|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
127812548|NCT04889209|459931318|FG001|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
127894418|NCT04582266|460237119|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
127894419|NCT04582266|460237120|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
127894420|NCT01241461|460237121|FG000|Overall Study|Progressive Disease|3|||
127894421|NCT01241461|460237122|FG001|Overall Study|Progressive Disease|6|||
127894422|NCT01132118|460237123|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
127894423|NCT01132118|460237124|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
127894424|NCT01132118|460237123|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
127894425|NCT01132118|460237124|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
127894426|NCT01132118|460237123|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
127894427|NCT01132118|460237124|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
127894428|NCT01299038|460237127|FG000|Overall Study|Withdrawal by Subject|1|||
127894429|NCT01299038|460237128|FG001|Overall Study|Withdrawal by Subject|0|||
127812549|NCT04889209|459931319|FG002|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
127812550|NCT04889209|459931320|FG003|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
127812551|NCT04889209|459931321|FG004|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
127812552|NCT04889209|459931322|FG005|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
127812553|NCT04889209|459931323|FG006|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
127812554|NCT04889209|459931324|FG007|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
127812555|NCT04889209|459931325|FG008|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
127812556|NCT04889209|459931326|FG009|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
127812557|NCT04889209|459931327|FG010|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
127812558|NCT04889209|459931328|FG011|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
127812559|NCT04889209|459931329|FG012|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
127812560|NCT04889209|459931330|FG013|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
127812561|NCT04889209|459931331|FG014|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
127812562|NCT04889209|459931332|FG015|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
127812563|NCT04889209|459931333|FG016|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
127812564|NCT04889209|459931334|FG017|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|4|||
127812565|NCT04889209|459931317|FG000|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
127812566|NCT04889209|459931318|FG001|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
127812567|NCT04889209|459931319|FG002|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
127812568|NCT04889209|459931320|FG003|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
127812569|NCT04889209|459931321|FG004|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
127812570|NCT04889209|459931322|FG005|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
127812571|NCT04889209|459931323|FG006|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
127812572|NCT04889209|459931324|FG007|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
127812573|NCT04889209|459931325|FG008|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
127812574|NCT04889209|459931326|FG009|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
127812575|NCT04889209|459931327|FG010|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
127812576|NCT04889209|459931328|FG011|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
127812577|NCT04889209|459931329|FG012|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
127812578|NCT04889209|459931330|FG013|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
127812579|NCT04889209|459931331|FG014|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|2|||
127812580|NCT04889209|459931332|FG015|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
127812581|NCT04889209|459931333|FG016|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
127812582|NCT04889209|459931334|FG017|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
127812583|NCT00442598|459931341|FG000|Overall Study|Adverse Event|1|||
127812584|NCT00442598|459931342|FG001|Overall Study|Adverse Event|0|||
127812585|NCT00442598|459931343|FG002|Overall Study|Adverse Event|0|||
127812586|NCT00442598|459931341|FG000|Overall Study|Tumor progression|3|||
127812587|NCT00442598|459931342|FG001|Overall Study|Tumor progression|4|||
127812588|NCT00442598|459931343|FG002|Overall Study|Tumor progression|0|||
127812589|NCT00442598|459931341|FG000|Overall Study|Clinical deterioration|1|||
127812590|NCT00442598|459931342|FG001|Overall Study|Clinical deterioration|2|||
127812591|NCT00442598|459931343|FG002|Overall Study|Clinical deterioration|0|||
127812592|NCT00442598|459931341|FG000|Overall Study|CA125 progression|0|||
127812593|NCT00442598|459931342|FG001|Overall Study|CA125 progression|1|||
127812594|NCT00442598|459931343|FG002|Overall Study|CA125 progression|0|||
127812595|NCT00442598|459931341|FG000|Overall Study|Reduced creatinine clearance|1|||
127812596|NCT00442598|459931342|FG001|Overall Study|Reduced creatinine clearance|0|||
127812597|NCT00442598|459931343|FG002|Overall Study|Reduced creatinine clearance|0|||
127812598|NCT00442598|459931341|FG000|Overall Study|Death|0|||
127812599|NCT00442598|459931342|FG001|Overall Study|Death|1|||
127812600|NCT00442598|459931343|FG002|Overall Study|Death|0|||
127812601|NCT02305563|459931347|FG000|Treatment Period|Disease progression|0|||
127812602|NCT02305563|459931348|FG001|Treatment Period|Disease progression|0|||
127812603|NCT02305563|459931349|FG002|Treatment Period|Disease progression|15|||
127812604|NCT02305563|459931350|FG003|Treatment Period|Disease progression|6|||
127812605|NCT02305563|459931351|FG004|Treatment Period|Disease progression|6|||
127812606|NCT02305563|459931347|FG000|Treatment Period|Study drug toxicity|0|||
127812607|NCT02305563|459931348|FG001|Treatment Period|Study drug toxicity|0|||
127812608|NCT02305563|459931349|FG002|Treatment Period|Study drug toxicity|0|||
127812609|NCT02305563|459931350|FG003|Treatment Period|Study drug toxicity|1|||
127812610|NCT02305563|459931351|FG004|Treatment Period|Study drug toxicity|2|||
127812611|NCT02305563|459931347|FG000|Treatment Period|Death|0|||
127812612|NCT02305563|459931348|FG001|Treatment Period|Death|0|||
127812613|NCT02305563|459931349|FG002|Treatment Period|Death|1|||
127812614|NCT02305563|459931350|FG003|Treatment Period|Death|2|||
127812615|NCT02305563|459931351|FG004|Treatment Period|Death|1|||
127812616|NCT02305563|459931347|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
127812617|NCT02305563|459931348|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
127812618|NCT02305563|459931349|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
127812619|NCT02305563|459931350|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
127812620|NCT02305563|459931351|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
127812621|NCT02305563|459931347|FG000|Treatment Period|Participant request to stop therapy|0|||
127812622|NCT02305563|459931348|FG001|Treatment Period|Participant request to stop therapy|2|||
127812623|NCT02305563|459931349|FG002|Treatment Period|Participant request to stop therapy|0|||
127812624|NCT02305563|459931350|FG003|Treatment Period|Participant request to stop therapy|1|||
127812625|NCT02305563|459931351|FG004|Treatment Period|Participant request to stop therapy|0|||
127812626|NCT02305563|459931347|FG000|Treatment Period|Participant withdrew consent|0|||
127812627|NCT02305563|459931348|FG001|Treatment Period|Participant withdrew consent|0|||
127812628|NCT02305563|459931349|FG002|Treatment Period|Participant withdrew consent|1|||
127812629|NCT02305563|459931350|FG003|Treatment Period|Participant withdrew consent|1|||
127812630|NCT02305563|459931351|FG004|Treatment Period|Participant withdrew consent|1|||
127812631|NCT02305563|459931347|FG000|Treatment Period|Maximum clinical benefit|0|||
127812632|NCT02305563|459931348|FG001|Treatment Period|Maximum clinical benefit|0|||
127812633|NCT02305563|459931349|FG002|Treatment Period|Maximum clinical benefit|0|||
127812634|NCT02305563|459931350|FG003|Treatment Period|Maximum clinical benefit|0|||
127812635|NCT02305563|459931351|FG004|Treatment Period|Maximum clinical benefit|1|||
127812636|NCT02305563|459931347|FG000|Treatment Period|Poor/non-compliance|0|||
127812637|NCT02305563|459931348|FG001|Treatment Period|Poor/non-compliance|0|||
127812638|NCT02305563|459931349|FG002|Treatment Period|Poor/non-compliance|0|||
127812639|NCT02305563|459931350|FG003|Treatment Period|Poor/non-compliance|0|||
127812640|NCT02305563|459931351|FG004|Treatment Period|Poor/non-compliance|1|||
127812641|NCT02305563|459931347|FG000|Treatment Period|Administrative reason by Sponsor|0|||
127812642|NCT02305563|459931348|FG001|Treatment Period|Administrative reason by Sponsor|0|||
127812643|NCT02305563|459931349|FG002|Treatment Period|Administrative reason by Sponsor|0|||
127812644|NCT02305563|459931350|FG003|Treatment Period|Administrative reason by Sponsor|0|||
127812645|NCT02305563|459931351|FG004|Treatment Period|Administrative reason by Sponsor|1|||
127812646|NCT02305563|459931347|FG000|Treatment Period|other reason|2|||
127812647|NCT02305563|459931348|FG001|Treatment Period|other reason|0|||
127812648|NCT02305563|459931349|FG002|Treatment Period|other reason|2|||
127812649|NCT02305563|459931350|FG003|Treatment Period|other reason|2|||
127812650|NCT02305563|459931351|FG004|Treatment Period|other reason|1|||
127812651|NCT02305563|459931347|FG000|Treatment Period|Randomized but not treated|0|||
127812652|NCT02305563|459931348|FG001|Treatment Period|Randomized but not treated|0|||
127812653|NCT02305563|459931349|FG002|Treatment Period|Randomized but not treated|0|||
127812654|NCT02305563|459931350|FG003|Treatment Period|Randomized but not treated|0|||
127812655|NCT02305563|459931351|FG004|Treatment Period|Randomized but not treated|2|||
127812656|NCT02305563|459931347|FG000|Treatment Period|added ULO, then disease progression|0|||
127812657|NCT02305563|459931348|FG001|Treatment Period|added ULO, then disease progression|0|||
127812658|NCT02305563|459931349|FG002|Treatment Period|added ULO, then disease progression|0|||
127812659|NCT02305563|459931350|FG003|Treatment Period|added ULO, then disease progression|0|||
127812660|NCT02305563|459931351|FG004|Treatment Period|added ULO, then disease progression|4|||
127812661|NCT02305563|459931347|FG000|Treatment Period|added ULO; then other reason|0|||
127812662|NCT02305563|459931348|FG001|Treatment Period|added ULO; then other reason|0|||
127812663|NCT02305563|459931349|FG002|Treatment Period|added ULO; then other reason|0|||
127812664|NCT02305563|459931350|FG003|Treatment Period|added ULO; then other reason|0|||
127812665|NCT02305563|459931351|FG004|Treatment Period|added ULO; then other reason|1|||
127812666|NCT02305563|459931347|FG000|Treatment Period|added ULO, then request to stop|0|||
127812667|NCT02305563|459931348|FG001|Treatment Period|added ULO, then request to stop|0|||
127812668|NCT02305563|459931349|FG002|Treatment Period|added ULO, then request to stop|0|||
127812669|NCT02305563|459931350|FG003|Treatment Period|added ULO, then request to stop|0|||
127812670|NCT02305563|459931351|FG004|Treatment Period|added ULO, then request to stop|1|||
127812671|NCT02305563|459931347|FG000|Follow-up Period|Death|0|||
127812672|NCT02305563|459931348|FG001|Follow-up Period|Death|0|||
127812673|NCT02305563|459931349|FG002|Follow-up Period|Death|5|||
127812674|NCT02305563|459931350|FG003|Follow-up Period|Death|4|||
127812675|NCT02305563|459931351|FG004|Follow-up Period|Death|7|||
127812676|NCT02305563|459931347|FG000|Follow-up Period|Participant withdrew consent|0|||
127812677|NCT02305563|459931348|FG001|Follow-up Period|Participant withdrew consent|0|||
127812678|NCT02305563|459931349|FG002|Follow-up Period|Participant withdrew consent|2|||
127812679|NCT02305563|459931350|FG003|Follow-up Period|Participant withdrew consent|1|||
127812680|NCT02305563|459931351|FG004|Follow-up Period|Participant withdrew consent|0|||
127812681|NCT02305563|459931347|FG000|Follow-up Period|other reason|0|||
127812682|NCT02305563|459931348|FG001|Follow-up Period|other reason|0|||
127812683|NCT02305563|459931349|FG002|Follow-up Period|other reason|0|||
127812684|NCT02305563|459931350|FG003|Follow-up Period|other reason|0|||
127812685|NCT02305563|459931351|FG004|Follow-up Period|other reason|1|||
127812686|NCT02305563|459931347|FG000|Follow-up Period|Followup no longer required per protocol|3|||
127812687|NCT02305563|459931348|FG001|Follow-up Period|Followup no longer required per protocol|3|||
127812688|NCT02305563|459931349|FG002|Follow-up Period|Followup no longer required per protocol|4|||
127812689|NCT02305563|459931350|FG003|Follow-up Period|Followup no longer required per protocol|1|||
127812690|NCT02305563|459931351|FG004|Follow-up Period|Followup no longer required per protocol|4|||
127812691|NCT02700451|459931352|FG000|Overall Study|Protocol Violation|2|||
127812692|NCT02700451|459931353|FG001|Overall Study|Protocol Violation|2|||
127812693|NCT02700451|459931354|FG002|Overall Study|Protocol Violation|3|||
127812694|NCT02700451|459931352|FG000|Overall Study|Discontinued intervention|14|||
127812695|NCT02700451|459931353|FG001|Overall Study|Discontinued intervention|15|||
127812696|NCT02700451|459931354|FG002|Overall Study|Discontinued intervention|14|||
127812697|NCT04373460|459931355|FG000|Overall Study|Did not receive tranfusion|18|||
127812698|NCT04373460|459931356|FG001|Overall Study|Did not receive tranfusion|26|||
127812699|NCT00454207|459931357|FG000|Overall Study|Adverse Event|3|||
127812700|NCT00454207|459931358|FG001|Overall Study|Adverse Event|1|||
127812701|NCT00454207|459931357|FG000|Overall Study|Lack of Efficacy|1|||
127812702|NCT00454207|459931358|FG001|Overall Study|Lack of Efficacy|0|||
127812703|NCT00454207|459931357|FG000|Overall Study|Protocol Violation|0|||
127812704|NCT00454207|459931358|FG001|Overall Study|Protocol Violation|1|||
127812705|NCT01672957|459931359|FG000|Overall Study|Protocol Violation|48|||
127812706|NCT01672957|459931359|FG000|Overall Study|Death|2|||
127812707|NCT01672957|459931359|FG000|Overall Study|ICF Signed After Transplantation|5|||
127812708|NCT02115308|459931361|FG000|Overall Study|Safety Screening|2|||
127812709|NCT02115308|459931362|FG001|Overall Study|Safety Screening|2|||
127812710|NCT00642642|459931363|FG000|Treatment & Follow Up|Adverse Event|2|||
127812711|NCT00642642|459931363|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
127812712|NCT00642642|459931363|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
127812713|NCT02337387|459931366|FG000|Overall Study|Adverse Event|0|||
127812714|NCT02337387|459931367|FG001|Overall Study|Adverse Event|1|||
127812715|NCT02337387|459931368|FG002|Overall Study|Adverse Event|0|||
127812716|NCT02337387|459931369|FG003|Overall Study|Adverse Event|0|||
127812717|NCT02337387|459931366|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
127812718|NCT02337387|459931367|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
127812719|NCT02337387|459931368|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
127812720|NCT02337387|459931369|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
127812721|NCT02272790|459931370|FG000|Overall Study|Physician Decision|0|||
127812722|NCT02272790|459931371|FG001|Overall Study|Physician Decision|1|||
127812723|NCT02272790|459931372|FG002|Overall Study|Physician Decision|0|||
127812724|NCT02272790|459931373|FG003|Overall Study|Physician Decision|0|||
127812725|NCT02272790|459931374|FG004|Overall Study|Physician Decision|0|||
127812726|NCT02272790|459931375|FG005|Overall Study|Physician Decision|0|||
127812727|NCT00332202|459931376|FG000|Overall Study|Adverse Event|72|||
127812728|NCT00332202|459931377|FG001|Overall Study|Adverse Event|28|||
127812729|NCT00332202|459931376|FG000|Overall Study|Lost to Follow-up|2|||
127812730|NCT00332202|459931377|FG001|Overall Study|Lost to Follow-up|1|||
127812731|NCT00332202|459931376|FG000|Overall Study|Physician Decision|6|||
127812732|NCT00332202|459931377|FG001|Overall Study|Physician Decision|8|||
127812733|NCT00332202|459931376|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
127812734|NCT00332202|459931377|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
127812735|NCT00332202|459931376|FG000|Overall Study|Protocol Violation|7|||
127812736|NCT00332202|459931377|FG001|Overall Study|Protocol Violation|2|||
127812737|NCT00332202|459931376|FG000|Overall Study|Sponsor Decision|1|||
127812738|NCT00332202|459931377|FG001|Overall Study|Sponsor Decision|2|||
127812739|NCT00332202|459931376|FG000|Overall Study|Withdrawal by Subject|36|||
127812740|NCT00332202|459931377|FG001|Overall Study|Withdrawal by Subject|17|||
127812741|NCT00332202|459931376|FG000|Overall Study|Progressive Disease|106|||
127812742|NCT00332202|459931377|FG001|Overall Study|Progressive Disease|60|||
127812743|NCT00332202|459931376|FG000|Overall Study|Death|5|||
127812744|NCT00332202|459931377|FG001|Overall Study|Death|2|||
127812745|NCT03871491|459931378|FG000|Overall Study|Withdrawal by Subject|14|||
127812746|NCT03871491|459931379|FG001|Overall Study|Withdrawal by Subject|14|||
127812747|NCT03871491|459931380|FG002|Overall Study|Withdrawal by Subject|14|||
127812748|NCT03871491|459931381|FG003|Overall Study|Withdrawal by Subject|14|||
127812749|NCT03871491|459931378|FG000|Overall Study|Physician Decision|0|||
127812750|NCT03871491|459931379|FG001|Overall Study|Physician Decision|0|||
127812751|NCT03871491|459931380|FG002|Overall Study|Physician Decision|1|||
127812752|NCT03871491|459931381|FG003|Overall Study|Physician Decision|1|||
127812753|NCT03871491|459931378|FG000|Overall Study|Lost to Follow-up|50|||
127812754|NCT03871491|459931379|FG001|Overall Study|Lost to Follow-up|15|||
127812755|NCT03871491|459931380|FG002|Overall Study|Lost to Follow-up|36|||
127812756|NCT03871491|459931381|FG003|Overall Study|Lost to Follow-up|11|||
127812757|NCT05202808|459931382|FG000|Overall Study|Lost to Follow-up|3|||
127812758|NCT05202808|459931383|FG001|Overall Study|Lost to Follow-up|1|||
127812759|NCT04439331|459931384|FG000|Overall Study|Never Start Protocol Therapy|2|||
127812760|NCT04439331|459931384|FG000|Overall Study|Ineligible|2|||
127812761|NCT04439331|459931384|FG000|Overall Study|Mutation Status Not Confirmed|1|||
127812762|NCT04439331|459931384|FG000|Overall Study|Adverse Event|1|||
127812763|NCT04439331|459931384|FG000|Overall Study|Death|1|||
127812764|NCT04439331|459931384|FG000|Overall Study|Disease Progression|20|||
127812765|NCT04439331|459931384|FG000|Overall Study|Withdrawal by Subject|6|||
127812766|NCT04439331|459931384|FG000|Overall Study|Physician Decision|1|||
127812767|NCT04439331|459931384|FG000|Overall Study|Other Complicating Disease|1|||
127812768|NCT02495948|459931387|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
127812769|NCT02495948|459931388|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
127812770|NCT02495948|459931387|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
127812771|NCT02495948|459931388|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
127812772|NCT02747004|459931390|FG000|Overall Study|Withdrawal by Subject|8|||
127812773|NCT02747004|459931391|FG001|Overall Study|Withdrawal by Subject|5|||
127812774|NCT02747004|459931392|FG002|Overall Study|Withdrawal by Subject|4|||
127812775|NCT02747004|459931390|FG000|Overall Study|Lost to Follow-up|1|||
127812776|NCT02747004|459931391|FG001|Overall Study|Lost to Follow-up|2|||
127812777|NCT02747004|459931392|FG002|Overall Study|Lost to Follow-up|2|||
127812778|NCT02747004|459931390|FG000|Overall Study|on study treatment/follow-up|48|||
127812779|NCT02747004|459931391|FG001|Overall Study|on study treatment/follow-up|42|||
127812780|NCT02747004|459931392|FG002|Overall Study|on study treatment/follow-up|41|||
127812781|NCT06218251|459931393|FG000|Overall Study|Lost to Follow-up|4|||
127812782|NCT05087030|459931394|FG000|Main Period (Week 0 to Week 52)|Withdrawal by Subject|8|||
127812783|NCT05087030|459931395|FG001|Main Period (Week 0 to Week 52)|Withdrawal by Subject|13|||
127812784|NCT05087030|459931396|FG002|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
127812785|NCT05087030|459931397|FG003|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
127812786|NCT05087030|459931398|FG004|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
127812787|NCT05087030|459931394|FG000|Main Period (Week 0 to Week 52)|Adverse Event|2|||
127812788|NCT05087030|459931395|FG001|Main Period (Week 0 to Week 52)|Adverse Event|2|||
127812789|NCT05087030|459931396|FG002|Main Period (Week 0 to Week 52)|Adverse Event|0|||
127812790|NCT05087030|459931397|FG003|Main Period (Week 0 to Week 52)|Adverse Event|0|||
127812791|NCT05087030|459931398|FG004|Main Period (Week 0 to Week 52)|Adverse Event|0|||
127812792|NCT05087030|459931394|FG000|Main Period (Week 0 to Week 52)|Lost to Follow-up|3|||
127812793|NCT05087030|459931395|FG001|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
127812794|NCT05087030|459931396|FG002|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
127812795|NCT05087030|459931397|FG003|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
127812796|NCT05087030|459931398|FG004|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
127812797|NCT05087030|459931394|FG000|Main Period (Week 0 to Week 52)|Protocol Deviation|1|||
127812798|NCT05087030|459931395|FG001|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
127812799|NCT05087030|459931396|FG002|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
127812800|NCT05087030|459931397|FG003|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
127812801|NCT05087030|459931398|FG004|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
127812802|NCT05087030|459931394|FG000|Main Period (Week 0 to Week 52)|Death|0|||
127812803|NCT05087030|459931395|FG001|Main Period (Week 0 to Week 52)|Death|1|||
127812804|NCT05087030|459931396|FG002|Main Period (Week 0 to Week 52)|Death|0|||
127812805|NCT05087030|459931397|FG003|Main Period (Week 0 to Week 52)|Death|0|||
127812806|NCT05087030|459931398|FG004|Main Period (Week 0 to Week 52)|Death|0|||
127812807|NCT05087030|459931394|FG000|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
127812808|NCT05087030|459931395|FG001|Main Period (Week 0 to Week 52)|Subject's Personal Reason|2|||
127812809|NCT05087030|459931396|FG002|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
127812810|NCT05087030|459931397|FG003|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
127812811|NCT05087030|459931398|FG004|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
127812812|NCT05087030|459931394|FG000|Main Period (Week 0 to Week 52)|Exclusion criteria met|1|||
127812813|NCT05087030|459931395|FG001|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
127812814|NCT05087030|459931396|FG002|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
127812815|NCT05087030|459931397|FG003|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
127812816|NCT05087030|459931398|FG004|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
127812817|NCT05087030|459931394|FG000|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|1|||
127812818|NCT05087030|459931395|FG001|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
127812819|NCT05087030|459931396|FG002|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
127812820|NCT05087030|459931397|FG003|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
127812821|NCT05087030|459931398|FG004|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
127812822|NCT05087030|459931394|FG000|Main Period (Week 0 to Week 52)|Other|1|||
127812823|NCT05087030|459931395|FG001|Main Period (Week 0 to Week 52)|Other|2|||
127812824|NCT05087030|459931396|FG002|Main Period (Week 0 to Week 52)|Other|0|||
127812825|NCT05087030|459931397|FG003|Main Period (Week 0 to Week 52)|Other|0|||
127812826|NCT05087030|459931398|FG004|Main Period (Week 0 to Week 52)|Other|0|||
127812827|NCT05087030|459931394|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
127812828|NCT05087030|459931395|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
127812829|NCT05087030|459931396|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
127812830|NCT05087030|459931397|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
127812831|NCT05087030|459931398|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
127812832|NCT01444300|459931399|FG000|Overall Study|Adverse Event|4|||
127812833|NCT01444300|459931400|FG001|Overall Study|Adverse Event|0|||
127812834|NCT00490542|459931401|FG000|Overall Study|Lost to Follow-up|3|||
127812835|NCT00490542|459931402|FG001|Overall Study|Lost to Follow-up|0|||
127812836|NCT00490542|459931401|FG000|Overall Study|Adverse Event|3|||
127812837|NCT00490542|459931402|FG001|Overall Study|Adverse Event|3|||
127812838|NCT00490542|459931401|FG000|Overall Study|Lack of Efficacy|1|||
127812839|NCT00490542|459931402|FG001|Overall Study|Lack of Efficacy|1|||
127812840|NCT00818259|459931406|FG000|Part I|Withdrawal by Subject|1|||
127812841|NCT00818259|459931407|FG001|Part I|Withdrawal by Subject|0|||
127812842|NCT00818259|459931408|FG002|Part I|Withdrawal by Subject|0|||
127812843|NCT00818259|459931409|FG003|Part I|Withdrawal by Subject|0|||
127812844|NCT00818259|459931410|FG004|Part I|Withdrawal by Subject|0|||
127812845|NCT00818259|459931411|FG005|Part I|Withdrawal by Subject|0|||
127812846|NCT00818259|459931412|FG006|Part I|Withdrawal by Subject|0|||
127812847|NCT00818259|459931413|FG007|Part I|Withdrawal by Subject|0|||
127812848|NCT00818259|459931414|FG008|Part I|Withdrawal by Subject|0|||
127812849|NCT00818259|459931406|FG000|Part II|Physician Decision|0|||
127812850|NCT00818259|459931407|FG001|Part II|Physician Decision|0|||
127812851|NCT00818259|459931408|FG002|Part II|Physician Decision|1|||
127812852|NCT00818259|459931409|FG003|Part II|Physician Decision|0|||
127812853|NCT00818259|459931410|FG004|Part II|Physician Decision|0|||
127812854|NCT00818259|459931411|FG005|Part II|Physician Decision|0|||
127812855|NCT00818259|459931412|FG006|Part II|Physician Decision|0|||
127812856|NCT00818259|459931413|FG007|Part II|Physician Decision|0|||
127812857|NCT00818259|459931414|FG008|Part II|Physician Decision|0|||
127812858|NCT00818259|459931406|FG000|Part II|Lack of Efficacy|0|||
127812859|NCT00818259|459931407|FG001|Part II|Lack of Efficacy|0|||
127812860|NCT00818259|459931408|FG002|Part II|Lack of Efficacy|0|||
127812861|NCT00818259|459931409|FG003|Part II|Lack of Efficacy|1|||
127812862|NCT00818259|459931410|FG004|Part II|Lack of Efficacy|0|||
127812863|NCT00818259|459931411|FG005|Part II|Lack of Efficacy|0|||
127812864|NCT00818259|459931412|FG006|Part II|Lack of Efficacy|0|||
127812865|NCT00818259|459931413|FG007|Part II|Lack of Efficacy|0|||
127812866|NCT00818259|459931414|FG008|Part II|Lack of Efficacy|0|||
127812867|NCT00818259|459931406|FG000|Part II|Not Treated|0|||
127812868|NCT00818259|459931407|FG001|Part II|Not Treated|0|||
127812869|NCT00818259|459931408|FG002|Part II|Not Treated|0|||
127812870|NCT00818259|459931409|FG003|Part II|Not Treated|1|||
127812871|NCT00818259|459931410|FG004|Part II|Not Treated|0|||
127812872|NCT00818259|459931411|FG005|Part II|Not Treated|0|||
127812873|NCT00818259|459931412|FG006|Part II|Not Treated|0|||
127812874|NCT00818259|459931413|FG007|Part II|Not Treated|0|||
127812875|NCT00818259|459931414|FG008|Part II|Not Treated|0|||
127812876|NCT00818259|459931406|FG000|Part IV|Physician Decision|0|||
127812877|NCT00818259|459931407|FG001|Part IV|Physician Decision|0|||
127812878|NCT00818259|459931408|FG002|Part IV|Physician Decision|0|||
127812879|NCT00818259|459931409|FG003|Part IV|Physician Decision|0|||
127812880|NCT00818259|459931410|FG004|Part IV|Physician Decision|0|||
127812881|NCT00818259|459931411|FG005|Part IV|Physician Decision|1|||
127812882|NCT00818259|459931412|FG006|Part IV|Physician Decision|0|||
127812883|NCT00818259|459931413|FG007|Part IV|Physician Decision|0|||
127812884|NCT00818259|459931414|FG008|Part IV|Physician Decision|0|||
127812885|NCT00818259|459931406|FG000|Part V|Adverse Event|0|||
127812886|NCT00818259|459931407|FG001|Part V|Adverse Event|0|||
127812887|NCT00818259|459931408|FG002|Part V|Adverse Event|0|||
127812888|NCT00818259|459931409|FG003|Part V|Adverse Event|0|||
127812889|NCT00818259|459931410|FG004|Part V|Adverse Event|0|||
127812890|NCT00818259|459931411|FG005|Part V|Adverse Event|0|||
127812891|NCT00818259|459931412|FG006|Part V|Adverse Event|0|||
127812892|NCT00818259|459931413|FG007|Part V|Adverse Event|1|||
127812893|NCT00818259|459931414|FG008|Part V|Adverse Event|0|||
127812894|NCT01237951|459931420|FG000|Overall Study|Death|1|||
127812895|NCT01053429|459931421|FG000|Overall Study|Adverse Event|64|||
127812896|NCT01053429|459931421|FG000|Overall Study|Other|309|||
127812897|NCT00752986|459931422|FG000|Overall Study|Withdrawal by Subject|2|||
127812898|NCT00752986|459931423|FG001|Overall Study|Withdrawal by Subject|1|||
127812899|NCT00752986|459931424|FG002|Overall Study|Withdrawal by Subject|2|||
127812900|NCT00752986|459931422|FG000|Overall Study|Protocol Violation|3|||
127812901|NCT00752986|459931423|FG001|Overall Study|Protocol Violation|0|||
127812902|NCT00752986|459931424|FG002|Overall Study|Protocol Violation|0|||
127812903|NCT00924703|459931428|FG000|Overall Study|Withdrawal by Subject|11|||
127812904|NCT00924703|459931428|FG000|Overall Study|Physician Decision|5|||
127812905|NCT00924703|459931428|FG000|Overall Study|Lost to Follow-up|3|||
127812906|NCT00924703|459931428|FG000|Overall Study|Adverse Event|2|||
127812907|NCT00924703|459931428|FG000|Overall Study|Withdrawal by Sponsor|1|||
127812908|NCT00666562|459931429|FG000|Overall Study|Withdrawal by Subject|0|||
127812909|NCT00666562|459931430|FG001|Overall Study|Withdrawal by Subject|1|||
127812910|NCT00666562|459931431|FG002|Overall Study|Withdrawal by Subject|0|||
127812911|NCT00666562|459931429|FG000|Overall Study|Concomitant Medication|0|||
127812912|NCT00666562|459931430|FG001|Overall Study|Concomitant Medication|1|||
127812913|NCT00666562|459931431|FG002|Overall Study|Concomitant Medication|0|||
127812914|NCT01587989|459931433|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
127812915|NCT01587989|459931434|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
127812916|NCT01587989|459931435|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
127812917|NCT01587989|459931433|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
127812918|NCT01587989|459931434|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
127812919|NCT01587989|459931435|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
127812920|NCT01587989|459931433|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
127812921|NCT01587989|459931434|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
127812922|NCT01587989|459931435|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
127812923|NCT01587989|459931433|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
127812924|NCT01587989|459931434|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
127812925|NCT01587989|459931435|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
127812926|NCT01587989|459931433|FG000|Randomized Study Treatment|Screening failure|0|||
127812927|NCT01587989|459931434|FG001|Randomized Study Treatment|Screening failure|1|||
127812928|NCT01587989|459931435|FG002|Randomized Study Treatment|Screening failure|0|||
127812929|NCT01587989|459931433|FG000|Randomized Study Treatment|Physician Decision|0|||
127812930|NCT01587989|459931434|FG001|Randomized Study Treatment|Physician Decision|0|||
127812931|NCT01587989|459931435|FG002|Randomized Study Treatment|Physician Decision|1|||
127812932|NCT00275561|459931438|FG000|Overall Study|Withdrawal by Subject|0|||
127812933|NCT00275561|459931439|FG001|Overall Study|Withdrawal by Subject|1|||
127812934|NCT00275561|459931438|FG000|Overall Study|Travel|1|||
127812935|NCT00275561|459931439|FG001|Overall Study|Travel|1|||
127812936|NCT00275561|459931438|FG000|Overall Study|Scheduling|1|||
127812937|NCT00275561|459931439|FG001|Overall Study|Scheduling|2|||
127812938|NCT00275561|459931438|FG000|Overall Study|Family Issues|0|||
127812939|NCT00275561|459931439|FG001|Overall Study|Family Issues|2|||
127812940|NCT00684177|459931447|FG000|Overall Study|Adverse Event|4|||
127812941|NCT00684177|459931448|FG001|Overall Study|Adverse Event|3|||
127812942|NCT00684177|459931447|FG000|Overall Study|Lack of Efficacy|10|||
127812943|NCT00684177|459931448|FG001|Overall Study|Lack of Efficacy|15|||
127812944|NCT00684177|459931447|FG000|Overall Study|Protocol Violation|1|||
127812945|NCT00684177|459931448|FG001|Overall Study|Protocol Violation|0|||
127812946|NCT00684177|459931447|FG000|Overall Study|Lost to Follow-up|2|||
127812947|NCT00684177|459931448|FG001|Overall Study|Lost to Follow-up|1|||
127812948|NCT00684177|459931447|FG000|Overall Study|Physician Decision|2|||
127812949|NCT00684177|459931448|FG001|Overall Study|Physician Decision|0|||
127812950|NCT00684177|459931447|FG000|Overall Study|Withdrawal by Subject|1|||
127812951|NCT00684177|459931448|FG001|Overall Study|Withdrawal by Subject|2|||
127812952|NCT00684177|459931447|FG000|Overall Study|Other|1|||
127812953|NCT00684177|459931448|FG001|Overall Study|Other|2|||
127812954|NCT02031679|459933246|FG000|Overall Study|Protocol Violation|0|||
127812955|NCT02031679|459933247|FG001|Overall Study|Protocol Violation|1|||
127812956|NCT02031679|459933246|FG000|Overall Study|Lack of Efficacy|0|||
127812957|NCT02031679|459933247|FG001|Overall Study|Lack of Efficacy|1|||
127812958|NCT04030195|459933248|FG000|Overall Study|Withdrawal by Subject|2|||
127812959|NCT04030195|459933249|FG001|Overall Study|Withdrawal by Subject|0|||
127812960|NCT04030195|459933250|FG002|Overall Study|Withdrawal by Subject|0|||
127812961|NCT02443402|459933251|FG000|Overall Study|Withdrawal by Subject|3|||
127812962|NCT02443402|459933252|FG001|Overall Study|Withdrawal by Subject|1|||
127812963|NCT02443402|459933251|FG000|Overall Study|Screen Failure|1|||
127812964|NCT02443402|459933252|FG001|Overall Study|Screen Failure|2|||
127812965|NCT00476086|459933255|FG000|Overall Study|Alternative therapy|1|||
127812966|NCT00476086|459933255|FG000|Overall Study|Progressive Disease|4|||
127812967|NCT04178590|459933256|FG000|Overall Study|Pregnancy|1|||
127812968|NCT04178590|459933256|FG000|Overall Study|Lost to Follow-up|1|||
127812969|NCT01389245|459933257|FG000|Overall Study|Protocol Violation|10|||
127812970|NCT01389245|459933257|FG000|Overall Study|Lost to Follow-up|3|||
127812971|NCT01389245|459933257|FG000|Overall Study|Withdrawal by Subject|2|||
127812972|NCT02292849|459933258|FG000|Overall Study|Lost to Follow-up|0|||
127812973|NCT02292849|459933259|FG001|Overall Study|Lost to Follow-up|2|||
127812974|NCT02292849|459933260|FG002|Overall Study|Lost to Follow-up|2|||
127812975|NCT02292849|459933258|FG000|Overall Study|Physician Decision|4|||
127812976|NCT02292849|459933259|FG001|Overall Study|Physician Decision|0|||
127812977|NCT02292849|459933260|FG002|Overall Study|Physician Decision|0|||
127812978|NCT00886938|459933261|FG000|Overall Study|Adverse Event|1|||
127812979|NCT00886938|459933261|FG000|Overall Study|Withdrawal by Subject|1|||
127812980|NCT00364793|459933262|FG000|Overall Study|Adverse Event|2|||
127812981|NCT00364793|459933263|FG001|Overall Study|Adverse Event|0|||
127812982|NCT00364793|459933264|FG002|Overall Study|Adverse Event|0|||
127812983|NCT00364793|459933265|FG003|Overall Study|Adverse Event|0|||
127812984|NCT00364793|459933262|FG000|Overall Study|Death|1|||
127812985|NCT00364793|459933263|FG001|Overall Study|Death|0|||
127812986|NCT00364793|459933264|FG002|Overall Study|Death|1|||
127812987|NCT00364793|459933265|FG003|Overall Study|Death|0|||
127812988|NCT00364793|459933262|FG000|Overall Study|Lack of Efficacy|3|||
127812989|NCT00364793|459933263|FG001|Overall Study|Lack of Efficacy|3|||
127812990|NCT00364793|459933264|FG002|Overall Study|Lack of Efficacy|1|||
127812991|NCT00364793|459933265|FG003|Overall Study|Lack of Efficacy|1|||
127812992|NCT00364793|459933262|FG000|Overall Study|Lost to Follow-up|1|||
127812993|NCT00364793|459933263|FG001|Overall Study|Lost to Follow-up|0|||
127812994|NCT00364793|459933264|FG002|Overall Study|Lost to Follow-up|2|||
127812995|NCT00364793|459933265|FG003|Overall Study|Lost to Follow-up|0|||
127812996|NCT00364793|459933262|FG000|Overall Study|Poor or non-compliance|1|||
127812997|NCT00364793|459933263|FG001|Overall Study|Poor or non-compliance|1|||
127812998|NCT00364793|459933264|FG002|Overall Study|Poor or non-compliance|0|||
127812999|NCT00364793|459933265|FG003|Overall Study|Poor or non-compliance|1|||
127813000|NCT00364793|459933262|FG000|Overall Study|No longer meets criteria|0|||
127813001|NCT00364793|459933263|FG001|Overall Study|No longer meets criteria|0|||
127813002|NCT00364793|459933264|FG002|Overall Study|No longer meets criteria|0|||
127813003|NCT00364793|459933265|FG003|Overall Study|No longer meets criteria|1|||
127813004|NCT00364793|459933262|FG000|Overall Study|Withdrawal by Subject|0|||
127813005|NCT00364793|459933263|FG001|Overall Study|Withdrawal by Subject|1|||
127813006|NCT00364793|459933264|FG002|Overall Study|Withdrawal by Subject|0|||
127813007|NCT00364793|459933265|FG003|Overall Study|Withdrawal by Subject|0|||
127813008|NCT00363415|459933268|FG000|Overall Study|Progressive Disease|196|||
127813009|NCT00363415|459933269|FG001|Overall Study|Progressive Disease|107|||
127813010|NCT00363415|459933268|FG000|Overall Study|Sponsor Decision|67|||
127813011|NCT00363415|459933269|FG001|Overall Study|Sponsor Decision|31|||
127813012|NCT00363415|459933268|FG000|Overall Study|Death|32|||
127813013|NCT00363415|459933269|FG001|Overall Study|Death|29|||
127813014|NCT00363415|459933268|FG000|Overall Study|Adverse Event|24|||
127813015|NCT00363415|459933269|FG001|Overall Study|Adverse Event|15|||
127813016|NCT00363415|459933268|FG000|Overall Study|Physician Decision|18|||
127813017|NCT00363415|459933269|FG001|Overall Study|Physician Decision|35|||
127813018|NCT00363415|459933268|FG000|Overall Study|Entry Criteria Not Met|11|||
127813019|NCT00363415|459933269|FG001|Overall Study|Entry Criteria Not Met|10|||
127813020|NCT00363415|459933268|FG000|Overall Study|Withdrawal by Subject|9|||
127813021|NCT00363415|459933269|FG001|Overall Study|Withdrawal by Subject|15|||
127813022|NCT00363415|459933268|FG000|Overall Study|Lost to Follow-up|3|||
127813023|NCT00363415|459933269|FG001|Overall Study|Lost to Follow-up|3|||
127813024|NCT00363415|459933268|FG000|Overall Study|Protocol Violation|1|||
127813025|NCT00363415|459933269|FG001|Overall Study|Protocol Violation|4|||
127813026|NCT05027802|459933272|FG000|Overall Study|Adverse Event|2|||
127813027|NCT05027802|459933272|FG000|Overall Study|Withdrawal by Subject|18|||
127813028|NCT05027802|459933272|FG000|Overall Study|Death|2|||
127813029|NCT05027802|459933272|FG000|Overall Study|Other|1|||
127813030|NCT02725788|459933273|FG000|Overall Study|Lost to Follow-up|1|||
127813031|NCT02725788|459933274|FG001|Overall Study|Lost to Follow-up|1|||
127813032|NCT02725788|459933273|FG000|Overall Study|Protocol Violation|0|||
127813033|NCT02725788|459933274|FG001|Overall Study|Protocol Violation|1|||
127813034|NCT05590377|459933275|FG000|Overall Study|Death|1|||
127813035|NCT05590377|459933276|FG001|Overall Study|Death|1|||
127813036|NCT05590377|459933277|FG002|Overall Study|Death|2|||
127813037|NCT05590377|459933278|FG003|Overall Study|Death|0|||
127813038|NCT05590377|459933279|FG004|Overall Study|Death|0|||
127813039|NCT05590377|459933275|FG000|Overall Study|Study Terminated by Sponsor|1|||
127813040|NCT05590377|459933276|FG001|Overall Study|Study Terminated by Sponsor|5|||
127813041|NCT05590377|459933277|FG002|Overall Study|Study Terminated by Sponsor|4|||
127813042|NCT05590377|459933278|FG003|Overall Study|Study Terminated by Sponsor|0|||
127813043|NCT05590377|459933279|FG004|Overall Study|Study Terminated by Sponsor|0|||
127813044|NCT05590377|459933275|FG000|Overall Study|Withdrawal by Subject|1|||
127813045|NCT05590377|459933276|FG001|Overall Study|Withdrawal by Subject|0|||
127813046|NCT05590377|459933277|FG002|Overall Study|Withdrawal by Subject|0|||
127813047|NCT05590377|459933278|FG003|Overall Study|Withdrawal by Subject|0|||
127813048|NCT05590377|459933279|FG004|Overall Study|Withdrawal by Subject|0|||
127813049|NCT00828464|459933280|FG000|Overall Study|Withdrawal by Subject|1|||
127813050|NCT00809133|459933281|FG000|Overall Study|Progressive disease|2|||
127813051|NCT00809133|459933282|FG001|Overall Study|Progressive disease|5|||
127813052|NCT00809133|459933283|FG002|Overall Study|Progressive disease|5|||
127813053|NCT00809133|459933284|FG003|Overall Study|Progressive disease|3|||
127813054|NCT00809133|459933285|FG004|Overall Study|Progressive disease|4|||
127813055|NCT00809133|459933286|FG005|Overall Study|Progressive disease|1|||
127813056|NCT00809133|459933287|FG006|Overall Study|Progressive disease|3|||
127813057|NCT00809133|459933288|FG007|Overall Study|Progressive disease|3|||
127813058|NCT00809133|459933289|FG008|Overall Study|Progressive disease|3|||
127813059|NCT00809133|459933290|FG009|Overall Study|Progressive disease|9|||
127813060|NCT00809133|459933291|FG010|Overall Study|Progressive disease|5|||
127894430|NCT00832078|460237129|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
127894431|NCT00832078|460237130|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
127894432|NCT00832078|460237129|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
127894433|NCT00832078|460237130|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
127894434|NCT01767597|460237131|FG000|Overall Study|Incomplete intervention|3|||
127894435|NCT01767597|460237132|FG001|Overall Study|Incomplete intervention|1|||
127894436|NCT01767597|460237131|FG000|Overall Study|Withdrawal by Subject|1|||
127894437|NCT01767597|460237132|FG001|Overall Study|Withdrawal by Subject|0|||
127894438|NCT02961920|460237133|FG000|Overall Study|did not achive stydy protocol schedule|1|||
127894439|NCT02961920|460237134|FG001|Overall Study|did not achive stydy protocol schedule|1|||
127894440|NCT01628120|460237137|FG000|Overall Study|Withdrawal by Subject|7|||
127894441|NCT01628120|460237137|FG000|Overall Study|Adverse Event|12|||
127894442|NCT01628120|460237137|FG000|Overall Study|Lost to Follow-up|1|||
127894443|NCT01628120|460237137|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
127894444|NCT01628120|460237137|FG000|Overall Study|Non-compliant with Study Procedures|1|||
127894445|NCT01628120|460237137|FG000|Overall Study|Not Treated|3|||
127894446|NCT01628120|460237137|FG000|Overall Study|Sponsor Decision|5|||
127894447|NCT01628120|460237137|FG000|Overall Study|Switched Dialysis Method|2|||
127894448|NCT01628120|460237137|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
127894449|NCT01628120|460237137|FG000|Overall Study|Moved or Relocated|5|||
127894450|NCT01628120|460237137|FG000|Overall Study|Kidney Transplant|2|||
127894451|NCT01628120|460237137|FG000|Overall Study|Use of Standard of Care|1|||
127894452|NCT02192905|460237140|FG000|Overall Study|Lost to Follow-up|1|||
127894453|NCT02173704|460237141|FG000|Overall Study|Adverse Event|1|||
127894454|NCT02173704|460237142|FG001|Overall Study|Adverse Event|0|||
127894455|NCT02173704|460237141|FG000|Overall Study|Lost to Follow-up|1|||
127894456|NCT02173704|460237142|FG001|Overall Study|Lost to Follow-up|0|||
127894457|NCT02173704|460237141|FG000|Overall Study|Other|1|||
127894458|NCT02173704|460237142|FG001|Overall Study|Other|0|||
127894459|NCT02173704|460237141|FG000|Overall Study|Protocol Violation|1|||
127894460|NCT02173704|460237142|FG001|Overall Study|Protocol Violation|0|||
127894461|NCT02173704|460237141|FG000|Overall Study|Withdrawal by Subject|9|||
127894462|NCT02173704|460237142|FG001|Overall Study|Withdrawal by Subject|4|||
127894463|NCT00419926|460237143|FG000|Overall Study|Withdrawal by Subject|7|||
127894464|NCT00419926|460237144|FG001|Overall Study|Withdrawal by Subject|3|||
127894465|NCT00419926|460237143|FG000|Overall Study|Administrative Problem|4|||
127894466|NCT00419926|460237144|FG001|Overall Study|Administrative Problem|4|||
127813061|NCT00809133|459933292|FG011|Overall Study|Progressive disease|7|||
127813062|NCT00809133|459933293|FG012|Overall Study|Progressive disease|5|||
127813063|NCT00809133|459933294|FG013|Overall Study|Progressive disease|4|||
127813064|NCT00809133|459933281|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
127813065|NCT00809133|459933282|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
127813066|NCT00809133|459933283|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
127813067|NCT00809133|459933284|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
127813068|NCT00809133|459933285|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
127813069|NCT00809133|459933286|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
127813070|NCT00809133|459933287|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
127813071|NCT00809133|459933288|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
127813072|NCT00809133|459933289|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
127813073|NCT00809133|459933290|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
127813074|NCT00809133|459933291|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
127813075|NCT00809133|459933292|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
127894467|NCT00419926|460237143|FG000|Overall Study|Lost to Follow-up|1|||
127894468|NCT00419926|460237144|FG001|Overall Study|Lost to Follow-up|2|||
127894469|NCT00419926|460237143|FG000|Overall Study|Death|2|||
127894470|NCT00419926|460237144|FG001|Overall Study|Death|1|||
127894471|NCT02374918|460237149|FG000|Overall Study|Protocol Violation|2|||
127894472|NCT02374918|460237150|FG001|Overall Study|Protocol Violation|0|||
127813076|NCT00809133|459933293|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
127813077|NCT00809133|459933294|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
127813078|NCT00809133|459933281|FG000|Overall Study|Other adverse event|1|||
127813079|NCT00809133|459933282|FG001|Overall Study|Other adverse event|1|||
127813080|NCT00809133|459933283|FG002|Overall Study|Other adverse event|1|||
127813081|NCT00809133|459933284|FG003|Overall Study|Other adverse event|0|||
127813082|NCT00809133|459933285|FG004|Overall Study|Other adverse event|0|||
127813083|NCT00809133|459933286|FG005|Overall Study|Other adverse event|3|||
127813084|NCT00809133|459933287|FG006|Overall Study|Other adverse event|2|||
127813085|NCT00809133|459933288|FG007|Overall Study|Other adverse event|4|||
127813086|NCT00809133|459933289|FG008|Overall Study|Other adverse event|0|||
127813087|NCT00809133|459933290|FG009|Overall Study|Other adverse event|0|||
127813088|NCT00809133|459933291|FG010|Overall Study|Other adverse event|1|||
127813089|NCT00809133|459933292|FG011|Overall Study|Other adverse event|1|||
127813090|NCT00809133|459933293|FG012|Overall Study|Other adverse event|0|||
127813091|NCT00809133|459933294|FG013|Overall Study|Other adverse event|1|||
127813092|NCT00809133|459933281|FG000|Overall Study|Lost to Follow-up|0|||
127813093|NCT00809133|459933282|FG001|Overall Study|Lost to Follow-up|0|||
127813094|NCT00809133|459933283|FG002|Overall Study|Lost to Follow-up|0|||
127813095|NCT00809133|459933284|FG003|Overall Study|Lost to Follow-up|0|||
127813096|NCT00809133|459933285|FG004|Overall Study|Lost to Follow-up|0|||
127813097|NCT00809133|459933286|FG005|Overall Study|Lost to Follow-up|1|||
127813098|NCT00809133|459933287|FG006|Overall Study|Lost to Follow-up|0|||
127813099|NCT00809133|459933288|FG007|Overall Study|Lost to Follow-up|0|||
127813100|NCT00809133|459933289|FG008|Overall Study|Lost to Follow-up|0|||
127813101|NCT00809133|459933290|FG009|Overall Study|Lost to Follow-up|0|||
127813102|NCT00809133|459933291|FG010|Overall Study|Lost to Follow-up|0|||
127813103|NCT00809133|459933292|FG011|Overall Study|Lost to Follow-up|0|||
127813104|NCT00809133|459933293|FG012|Overall Study|Lost to Follow-up|0|||
127813105|NCT00809133|459933294|FG013|Overall Study|Lost to Follow-up|0|||
127813106|NCT00809133|459933281|FG000|Overall Study|Consent withdrawn|0|||
127813107|NCT00809133|459933282|FG001|Overall Study|Consent withdrawn|0|||
127813108|NCT00809133|459933283|FG002|Overall Study|Consent withdrawn|0|||
127813109|NCT00809133|459933284|FG003|Overall Study|Consent withdrawn|0|||
127813110|NCT00809133|459933285|FG004|Overall Study|Consent withdrawn|1|||
127813111|NCT00809133|459933286|FG005|Overall Study|Consent withdrawn|0|||
127813112|NCT00809133|459933287|FG006|Overall Study|Consent withdrawn|0|||
127813113|NCT00809133|459933288|FG007|Overall Study|Consent withdrawn|0|||
127813114|NCT00809133|459933289|FG008|Overall Study|Consent withdrawn|0|||
127813115|NCT00809133|459933290|FG009|Overall Study|Consent withdrawn|0|||
127813116|NCT00809133|459933291|FG010|Overall Study|Consent withdrawn|0|||
127813117|NCT00809133|459933292|FG011|Overall Study|Consent withdrawn|0|||
127813118|NCT00809133|459933293|FG012|Overall Study|Consent withdrawn|0|||
127813119|NCT00809133|459933294|FG013|Overall Study|Consent withdrawn|0|||
127813120|NCT00809133|459933281|FG000|Overall Study|Other not mentioned above|0|||
127813121|NCT00809133|459933282|FG001|Overall Study|Other not mentioned above|1|||
127813122|NCT00809133|459933283|FG002|Overall Study|Other not mentioned above|0|||
127813123|NCT00809133|459933284|FG003|Overall Study|Other not mentioned above|0|||
127813124|NCT00809133|459933285|FG004|Overall Study|Other not mentioned above|0|||
127813125|NCT00809133|459933286|FG005|Overall Study|Other not mentioned above|1|||
127813126|NCT00809133|459933287|FG006|Overall Study|Other not mentioned above|0|||
127813127|NCT00809133|459933288|FG007|Overall Study|Other not mentioned above|0|||
127813128|NCT00809133|459933289|FG008|Overall Study|Other not mentioned above|0|||
127813129|NCT00809133|459933290|FG009|Overall Study|Other not mentioned above|0|||
127813130|NCT00809133|459933291|FG010|Overall Study|Other not mentioned above|0|||
127813131|NCT00809133|459933292|FG011|Overall Study|Other not mentioned above|0|||
127813132|NCT00809133|459933293|FG012|Overall Study|Other not mentioned above|0|||
127813133|NCT00809133|459933294|FG013|Overall Study|Other not mentioned above|0|||
127813134|NCT00833092|459933295|FG000|Overall Study|Withdrawal by Subject|2|||
127813135|NCT00833092|459933296|FG001|Overall Study|Withdrawal by Subject|3|||
127813136|NCT00833092|459933295|FG000|Overall Study|Protocol Violation|2|||
127813137|NCT00833092|459933296|FG001|Overall Study|Protocol Violation|1|||
127813138|NCT00833092|459933295|FG000|Overall Study|Diarrhea|0|||
127813139|NCT00833092|459933296|FG001|Overall Study|Diarrhea|2|||
127813140|NCT00833092|459933295|FG000|Overall Study|constipation|0|||
127813141|NCT00833092|459933296|FG001|Overall Study|constipation|1|||
127813142|NCT00699192|459933297|FG000|Overall Study|Missing|1|||
127813143|NCT00699192|459933298|FG001|Overall Study|Missing|1|||
127813144|NCT00699192|459933299|FG002|Overall Study|Missing|1|||
127813145|NCT00699192|459933297|FG000|Overall Study|Adverse Event|9|||
127813146|NCT00699192|459933298|FG001|Overall Study|Adverse Event|4|||
127813147|NCT00699192|459933299|FG002|Overall Study|Adverse Event|3|||
127813148|NCT00699192|459933297|FG000|Overall Study|Abnormal test procedure result(s)|0|||
127813149|NCT00699192|459933298|FG001|Overall Study|Abnormal test procedure result(s)|0|||
127813150|NCT00699192|459933299|FG002|Overall Study|Abnormal test procedure result(s)|1|||
127813151|NCT00699192|459933297|FG000|Overall Study|Lack of Efficacy|0|||
127813152|NCT00699192|459933298|FG001|Overall Study|Lack of Efficacy|0|||
127813153|NCT00699192|459933299|FG002|Overall Study|Lack of Efficacy|1|||
127813154|NCT00699192|459933297|FG000|Overall Study|Withdrawal by Subject|3|||
127813155|NCT00699192|459933298|FG001|Overall Study|Withdrawal by Subject|2|||
127813156|NCT00699192|459933299|FG002|Overall Study|Withdrawal by Subject|4|||
127813157|NCT00699192|459933297|FG000|Overall Study|Administrative problems|1|||
127813158|NCT00699192|459933298|FG001|Overall Study|Administrative problems|3|||
127813159|NCT00699192|459933299|FG002|Overall Study|Administrative problems|1|||
127813160|NCT00699192|459933297|FG000|Overall Study|Protocol Violation|2|||
127813161|NCT00699192|459933298|FG001|Overall Study|Protocol Violation|2|||
127813162|NCT00699192|459933299|FG002|Overall Study|Protocol Violation|0|||
127813163|NCT01025635|459933311|FG000|Overall Study|Withdrawal by Subject|6|||
127813164|NCT01025635|459933312|FG001|Overall Study|Withdrawal by Subject|7|||
127813165|NCT01025635|459933311|FG000|Overall Study|Protocol Violation|4|||
127813166|NCT01025635|459933312|FG001|Overall Study|Protocol Violation|2|||
127813167|NCT01025635|459933311|FG000|Overall Study|Lack of Efficacy|0|||
127813168|NCT01025635|459933312|FG001|Overall Study|Lack of Efficacy|1|||
127813169|NCT01025635|459933311|FG000|Overall Study|Lost to Follow-up|9|||
127813170|NCT01025635|459933312|FG001|Overall Study|Lost to Follow-up|13|||
127813171|NCT01025635|459933311|FG000|Overall Study|Reason not known|4|||
127813172|NCT01025635|459933312|FG001|Overall Study|Reason not known|2|||
127813173|NCT00727402|459933313|FG000|Overall Study|Physician Decision|116|||
127813174|NCT00929240|459933314|FG000|Initial Treatment Phase|Adverse Event|31|||
127813175|NCT00929240|459933315|FG001|Initial Treatment Phase|Adverse Event|0|||
127813176|NCT00929240|459933316|FG002|Initial Treatment Phase|Adverse Event|0|||
127813177|NCT00929240|459933314|FG000|Initial Treatment Phase|Disease progression|41|||
127813178|NCT00929240|459933315|FG001|Initial Treatment Phase|Disease progression|0|||
127813179|NCT00929240|459933316|FG002|Initial Treatment Phase|Disease progression|0|||
127813180|NCT00929240|459933314|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
127813181|NCT00929240|459933315|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
127813182|NCT00929240|459933316|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
127813183|NCT00929240|459933314|FG000|Initial Treatment Phase|Protocol Violation|5|||
127813184|NCT00929240|459933315|FG001|Initial Treatment Phase|Protocol Violation|0|||
127813185|NCT00929240|459933316|FG002|Initial Treatment Phase|Protocol Violation|0|||
127813186|NCT00929240|459933314|FG000|Initial Treatment Phase|Death|2|||
127813187|NCT00929240|459933315|FG001|Initial Treatment Phase|Death|0|||
127813188|NCT00929240|459933316|FG002|Initial Treatment Phase|Death|0|||
127813189|NCT00929240|459933314|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
127813190|NCT00929240|459933315|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
127813191|NCT00929240|459933316|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
127813192|NCT00929240|459933314|FG000|Initial Treatment Phase|Physician Decision|4|||
127813193|NCT00929240|459933315|FG001|Initial Treatment Phase|Physician Decision|0|||
127813194|NCT00929240|459933316|FG002|Initial Treatment Phase|Physician Decision|0|||
127813195|NCT00929240|459933314|FG000|Maintenance Phase|Disease progression|0|||
127813196|NCT00929240|459933315|FG001|Maintenance Phase|Disease progression|73|||
127813197|NCT00929240|459933316|FG002|Maintenance Phase|Disease progression|60|||
127813198|NCT00929240|459933314|FG000|Maintenance Phase|Adverse Event|0|||
127813199|NCT00929240|459933315|FG001|Maintenance Phase|Adverse Event|9|||
127813200|NCT00929240|459933316|FG002|Maintenance Phase|Adverse Event|12|||
127813201|NCT00929240|459933314|FG000|Maintenance Phase|Withdrawal by Subject|0|||
127813202|NCT00929240|459933315|FG001|Maintenance Phase|Withdrawal by Subject|2|||
127813203|NCT00929240|459933316|FG002|Maintenance Phase|Withdrawal by Subject|6|||
127813204|NCT00929240|459933314|FG000|Maintenance Phase|Protocol Violation|0|||
127813205|NCT00929240|459933315|FG001|Maintenance Phase|Protocol Violation|1|||
127813206|NCT00929240|459933316|FG002|Maintenance Phase|Protocol Violation|0|||
127813207|NCT00929240|459933314|FG000|Maintenance Phase|Health authority/Study termination|0|||
127813208|NCT00929240|459933315|FG001|Maintenance Phase|Health authority/Study termination|1|||
127813209|NCT00929240|459933316|FG002|Maintenance Phase|Health authority/Study termination|2|||
127813210|NCT00929240|459933314|FG000|Maintenance Phase|Physician Decision|0|||
127813211|NCT00929240|459933315|FG001|Maintenance Phase|Physician Decision|2|||
127813212|NCT00929240|459933316|FG002|Maintenance Phase|Physician Decision|1|||
127813213|NCT00929240|459933314|FG000|Maintenance Phase|Change of treatment|0|||
127813214|NCT00929240|459933315|FG001|Maintenance Phase|Change of treatment|4|||
127813215|NCT00929240|459933316|FG002|Maintenance Phase|Change of treatment|0|||
127813216|NCT00929240|459933314|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
127813217|NCT00929240|459933315|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
127813218|NCT00929240|459933316|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
127813219|NCT00929240|459933314|FG000|Maintenance Phase|Participant not treated|0|||
127813220|NCT00929240|459933315|FG001|Maintenance Phase|Participant not treated|2|||
127813221|NCT00929240|459933316|FG002|Maintenance Phase|Participant not treated|0|||
127813222|NCT05292755|459933317|FG000|Overall Study|Lost to Follow-up|5|||
127813223|NCT05292755|459933318|FG001|Overall Study|Lost to Follow-up|9|||
127813224|NCT00432809|459933319|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
127813225|NCT00432809|459933320|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
127813226|NCT00432809|459933321|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
127813227|NCT00432809|459933319|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
127813228|NCT00432809|459933320|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
127813229|NCT00432809|459933321|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
127813230|NCT04433117|459933322|FG000|Overall Study|Withdrawal by Subject|1|||
127813231|NCT04433117|459933323|FG001|Overall Study|Withdrawal by Subject|0|||
127813232|NCT01051739|459933324|FG000|Overall Study|Death|3|||
127813233|NCT01051739|459933325|FG001|Overall Study|Death|3|||
127813234|NCT01051739|459933324|FG000|Overall Study|Withdrawal by Subject|25|||
127813235|NCT01051739|459933325|FG001|Overall Study|Withdrawal by Subject|10|||
127813236|NCT00707577|459933326|FG000|Overall Study|Withdrawal by Subject|3|||
127813237|NCT00707577|459933327|FG001|Overall Study|Withdrawal by Subject|2|||
127813238|NCT00707577|459933326|FG000|Overall Study|Lost to Follow-up|34|||
127813239|NCT00707577|459933327|FG001|Overall Study|Lost to Follow-up|25|||
127813240|NCT00707577|459933326|FG000|Overall Study|Left employment|13|||
127813241|NCT00707577|459933327|FG001|Overall Study|Left employment|10|||
127813242|NCT00707577|459933326|FG000|Overall Study|Pregnancy|4|||
127813243|NCT00707577|459933327|FG001|Overall Study|Pregnancy|1|||
127813244|NCT03853694|459933328|FG000|Overall Study|Protocol Violation|3|||
127813245|NCT03853694|459933329|FG001|Overall Study|Protocol Violation|5|||
127813246|NCT03853694|459933330|FG002|Overall Study|Protocol Violation|3|||
127813247|NCT03853694|459933328|FG000|Overall Study|Delivered early|0|||
127813248|NCT03853694|459933329|FG001|Overall Study|Delivered early|1|||
127813249|NCT03853694|459933330|FG002|Overall Study|Delivered early|0|||
127813250|NCT03853694|459933328|FG000|Overall Study|not suitable to proceed|0|||
127813251|NCT03853694|459933329|FG001|Overall Study|not suitable to proceed|1|||
127813252|NCT03853694|459933330|FG002|Overall Study|not suitable to proceed|0|||
127813253|NCT03853694|459933328|FG000|Overall Study|difficult surgery|0|||
127813254|NCT03853694|459933329|FG001|Overall Study|difficult surgery|0|||
127813255|NCT03853694|459933330|FG002|Overall Study|difficult surgery|1|||
127813256|NCT03853694|459933328|FG000|Overall Study|Lost to Follow-up|0|||
127813257|NCT03853694|459933329|FG001|Overall Study|Lost to Follow-up|1|||
127813258|NCT03853694|459933330|FG002|Overall Study|Lost to Follow-up|0|||
127813259|NCT03853694|459933328|FG000|Overall Study|Withdrawal by Subject|0|||
127813260|NCT03853694|459933329|FG001|Overall Study|Withdrawal by Subject|1|||
127813261|NCT03853694|459933330|FG002|Overall Study|Withdrawal by Subject|0|||
127813262|NCT02499952|459933331|FG000|Overall Study|Lost to Follow-up|1|||
127813263|NCT02499952|459933331|FG000|Overall Study|Death|9|||
127813264|NCT05089708|459933332|FG000|Overall Study|Lost to Follow-up|9|||
127813265|NCT05089708|459933333|FG001|Overall Study|Lost to Follow-up|7|||
127813266|NCT05089708|459933332|FG000|Overall Study|Withdrawal by Subject|3|||
127813267|NCT05089708|459933333|FG001|Overall Study|Withdrawal by Subject|1|||
127813268|NCT05089708|459933332|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
127813269|NCT05089708|459933333|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
127813270|NCT05089708|459933332|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
127813271|NCT05089708|459933333|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
127813272|NCT02209766|459933335|FG000|Overall Study|Withdrawal by Subject|0|||
127813273|NCT02209766|459933336|FG001|Overall Study|Withdrawal by Subject|0|||
127813274|NCT02209766|459933337|FG002|Overall Study|Withdrawal by Subject|0|||
127813275|NCT02209766|459933338|FG003|Overall Study|Withdrawal by Subject|1|||
127813276|NCT02209766|459933339|FG004|Overall Study|Withdrawal by Subject|0|||
127813277|NCT00805207|459933340|FG000|Overall Study|Protocol Violation|0|||
127813278|NCT00805207|459933341|FG001|Overall Study|Protocol Violation|0|||
127813279|NCT00805207|459933342|FG002|Overall Study|Protocol Violation|1|||
127813280|NCT00805207|459933343|FG003|Overall Study|Protocol Violation|0|||
127813281|NCT00805207|459933344|FG004|Overall Study|Protocol Violation|0|||
127813282|NCT00805207|459933345|FG005|Overall Study|Protocol Violation|0|||
127813283|NCT00805207|459933346|FG006|Overall Study|Protocol Violation|0|||
127813284|NCT00805207|459933347|FG007|Overall Study|Protocol Violation|0|||
127813285|NCT00805207|459933348|FG008|Overall Study|Protocol Violation|0|||
127813286|NCT00805207|459933340|FG000|Overall Study|Physician Decision|0|||
127813287|NCT00805207|459933341|FG001|Overall Study|Physician Decision|1|||
127813288|NCT00805207|459933342|FG002|Overall Study|Physician Decision|0|||
127813289|NCT00805207|459933343|FG003|Overall Study|Physician Decision|0|||
127813290|NCT00805207|459933344|FG004|Overall Study|Physician Decision|0|||
127813291|NCT00805207|459933345|FG005|Overall Study|Physician Decision|1|||
127813292|NCT00805207|459933346|FG006|Overall Study|Physician Decision|0|||
127813293|NCT00805207|459933347|FG007|Overall Study|Physician Decision|0|||
127813294|NCT00805207|459933348|FG008|Overall Study|Physician Decision|0|||
127813295|NCT00805207|459933340|FG000|Overall Study|Withdrawal by Subject|0|||
127813296|NCT00805207|459933341|FG001|Overall Study|Withdrawal by Subject|1|||
127813297|NCT00805207|459933342|FG002|Overall Study|Withdrawal by Subject|0|||
127813298|NCT00805207|459933343|FG003|Overall Study|Withdrawal by Subject|0|||
127813299|NCT00805207|459933344|FG004|Overall Study|Withdrawal by Subject|1|||
127813300|NCT00805207|459933345|FG005|Overall Study|Withdrawal by Subject|2|||
127813301|NCT00805207|459933346|FG006|Overall Study|Withdrawal by Subject|0|||
127813302|NCT00805207|459933347|FG007|Overall Study|Withdrawal by Subject|0|||
127813303|NCT00805207|459933348|FG008|Overall Study|Withdrawal by Subject|0|||
127813304|NCT00064701|459933349|FG000|One Year Post-transplant|Did not receive study drug|7|||
127813305|NCT00064701|459933350|FG001|One Year Post-transplant|Did not receive study drug|12|||
127813306|NCT00064701|459933351|FG002|One Year Post-transplant|Did not receive study drug|11|||
127813307|NCT00064701|459933349|FG000|One Year Post-transplant|Adverse Event|23|||
127813308|NCT00064701|459933350|FG001|One Year Post-transplant|Adverse Event|19|||
127813309|NCT00064701|459933351|FG002|One Year Post-transplant|Adverse Event|37|||
127813310|NCT00064701|459933349|FG000|One Year Post-transplant|Rejection|0|||
127813311|NCT00064701|459933350|FG001|One Year Post-transplant|Rejection|1|||
127813312|NCT00064701|459933351|FG002|One Year Post-transplant|Rejection|16|||
127813313|NCT00064701|459933349|FG000|One Year Post-transplant|Non-compliance|4|||
127813314|NCT00064701|459933350|FG001|One Year Post-transplant|Non-compliance|2|||
127813315|NCT00064701|459933351|FG002|One Year Post-transplant|Non-compliance|5|||
127813316|NCT00064701|459933349|FG000|One Year Post-transplant|Graft Failure|3|||
127813317|NCT00064701|459933350|FG001|One Year Post-transplant|Graft Failure|2|||
127813318|NCT00064701|459933351|FG002|One Year Post-transplant|Graft Failure|1|||
127813319|NCT00064701|459933349|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
127813320|NCT00064701|459933350|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
127813321|NCT00064701|459933351|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
127813322|NCT00064701|459933349|FG000|One Year Post-transplant|Lost to Follow-up|1|||
127813323|NCT00064701|459933350|FG001|One Year Post-transplant|Lost to Follow-up|0|||
127813324|NCT00064701|459933351|FG002|One Year Post-transplant|Lost to Follow-up|0|||
127813325|NCT00064701|459933349|FG000|One Year Post-transplant|Converted to rapamycin|1|||
127813326|NCT00064701|459933350|FG001|One Year Post-transplant|Converted to rapamycin|0|||
127813327|NCT00064701|459933351|FG002|One Year Post-transplant|Converted to rapamycin|0|||
127813328|NCT00064701|459933349|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
127813329|NCT00064701|459933350|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
127813330|NCT00064701|459933351|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
127813331|NCT00064701|459933349|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
127813332|NCT00064701|459933350|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
127813333|NCT00064701|459933351|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
127813334|NCT00064701|459933349|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
127813335|NCT00064701|459933350|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
127813336|NCT00064701|459933351|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
127813337|NCT00064701|459933349|FG000|One Year Post-transplant|Poor absorption|0|||
127813338|NCT00064701|459933350|FG001|One Year Post-transplant|Poor absorption|1|||
127813339|NCT00064701|459933351|FG002|One Year Post-transplant|Poor absorption|0|||
127813340|NCT00064701|459933349|FG000|One Year Post-transplant|Pancreas transplant|0|||
127813341|NCT00064701|459933350|FG001|One Year Post-transplant|Pancreas transplant|0|||
127813342|NCT00064701|459933351|FG002|One Year Post-transplant|Pancreas transplant|1|||
127813343|NCT00064701|459933349|FG000|Clinical Continuation Phase|Adverse Event|12|||
127813344|NCT00064701|459933350|FG001|Clinical Continuation Phase|Adverse Event|21|||
127813345|NCT00064701|459933351|FG002|Clinical Continuation Phase|Adverse Event|14|||
127813346|NCT00064701|459933349|FG000|Clinical Continuation Phase|Non-compliance|8|||
127813347|NCT00064701|459933350|FG001|Clinical Continuation Phase|Non-compliance|6|||
127813348|NCT00064701|459933351|FG002|Clinical Continuation Phase|Non-compliance|7|||
127813349|NCT00064701|459933349|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
127813350|NCT00064701|459933350|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
127813351|NCT00064701|459933351|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
127813352|NCT00064701|459933349|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
127813353|NCT00064701|459933350|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
127813354|NCT00064701|459933351|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
127813355|NCT00064701|459933349|FG000|Clinical Continuation Phase|Graft Failure|5|||
127813356|NCT00064701|459933350|FG001|Clinical Continuation Phase|Graft Failure|5|||
127813357|NCT00064701|459933351|FG002|Clinical Continuation Phase|Graft Failure|2|||
127813358|NCT00064701|459933349|FG000|Clinical Continuation Phase|Rejection|1|||
127813359|NCT00064701|459933350|FG001|Clinical Continuation Phase|Rejection|2|||
127813360|NCT00064701|459933351|FG002|Clinical Continuation Phase|Rejection|2|||
127813361|NCT00064701|459933349|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
127813362|NCT00064701|459933350|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
127813363|NCT00064701|459933351|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
127813364|NCT00064701|459933349|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
127813365|NCT00064701|459933350|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
127813366|NCT00064701|459933351|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
127813367|NCT00064701|459933349|FG000|Clinical Continuation Phase|Physician Decision|1|||
127813368|NCT00064701|459933350|FG001|Clinical Continuation Phase|Physician Decision|3|||
127813369|NCT00064701|459933351|FG002|Clinical Continuation Phase|Physician Decision|0|||
127813370|NCT00064701|459933349|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
127813371|NCT00064701|459933350|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
127813372|NCT00064701|459933351|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
127813373|NCT00064701|459933349|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
127813374|NCT00064701|459933350|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
127813375|NCT00064701|459933351|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
127813376|NCT00064701|459933349|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
127813377|NCT00064701|459933350|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
127813378|NCT00064701|459933351|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
127813379|NCT00064701|459933349|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
127813380|NCT00064701|459933350|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
127813381|NCT00064701|459933351|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
127813382|NCT00064701|459933349|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
127813383|NCT00064701|459933350|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
127813384|NCT00064701|459933351|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
127813385|NCT00064701|459933349|FG000|Clinical Continuation Phase|Patient opted out|0|||
127813386|NCT00064701|459933350|FG001|Clinical Continuation Phase|Patient opted out|0|||
127813387|NCT00064701|459933351|FG002|Clinical Continuation Phase|Patient opted out|1|||
127813388|NCT01491945|459933353|FG000|Overall Study|Death|30|||
127813389|NCT01491945|459933353|FG000|Overall Study|Withdrwan/LTF|16|||
127813390|NCT01491945|459933353|FG000|Overall Study|Conversion|4|||
127813391|NCT01491945|459933353|FG000|Overall Study|Missed Visit|1|||
127813392|NCT05681715|459933354|FG000|Training Period (6-weeks)|Adverse Event|3|||
127813393|NCT05681715|459933355|FG001|Training Period (6-weeks)|Adverse Event|0|||
127813394|NCT05681715|459933356|FG002|Training Period (6-weeks)|Adverse Event|0|||
127813395|NCT05681715|459933354|FG000|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|1|||
127813396|NCT05681715|459933355|FG001|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
127813397|NCT05681715|459933356|FG002|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
127813398|NCT05681715|459933354|FG000|Training Period (6-weeks)|Not Eligible for SA but continued in study|3|||
127813399|NCT05681715|459933355|FG001|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
127813400|NCT05681715|459933356|FG002|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
127813401|NCT05681715|459933354|FG000|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
127813402|NCT05681715|459933355|FG001|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|1|||
127813403|NCT05681715|459933356|FG002|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
127813404|NCT05681715|459933354|FG000|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
127868815|NCT01072175|460137389|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
127813405|NCT05681715|459933355|FG001|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
127813406|NCT05681715|459933356|FG002|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|1|||
127813407|NCT05681715|459933354|FG000|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
127813408|NCT05681715|459933355|FG001|Self-administration Period 1 (6 Weeks)|Adverse Event|1|||
127813409|NCT05681715|459933356|FG002|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
127813410|NCT05681715|459933354|FG000|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
127813411|NCT05681715|459933355|FG001|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|1|||
127813412|NCT05681715|459933356|FG002|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
127813413|NCT05681715|459933354|FG000|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
127813414|NCT05681715|459933355|FG001|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|2|||
127813415|NCT05681715|459933356|FG002|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
127813416|NCT03770403|459933357|FG000|Overall Study|Adverse Event|8|||
127813417|NCT03770403|459933357|FG000|Overall Study|Death|5|||
127813418|NCT03770403|459933357|FG000|Overall Study|Physician Decision|1|||
127813419|NCT03770403|459933357|FG000|Overall Study|Sponsor decision|1|||
127813420|NCT03770403|459933357|FG000|Overall Study|Study terminated by Sponsor|1|||
127813421|NCT03770403|459933357|FG000|Overall Study|Withdrawal by Subject|13|||
127813422|NCT03770403|459933357|FG000|Overall Study|Other|88|||
127813423|NCT02344576|459933388|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
127813424|NCT02344576|459933389|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
127813425|NCT02344576|459933390|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
127813426|NCT02344576|459933391|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
127813427|NCT02344576|459933388|FG000|1-Month Follow-Up|Death|13|||
127813428|NCT02344576|459933389|FG001|1-Month Follow-Up|Death|8|||
127813429|NCT02344576|459933390|FG002|1-Month Follow-Up|Death|0|||
127813430|NCT02344576|459933391|FG003|1-Month Follow-Up|Death|0|||
127813431|NCT02344576|459933388|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
127813432|NCT02344576|459933389|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
127813433|NCT02344576|459933390|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
127813434|NCT02344576|459933391|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
127813435|NCT02344576|459933388|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
127813436|NCT02344576|459933389|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
127813437|NCT02344576|459933390|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
127813438|NCT02344576|459933391|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
127813439|NCT02344576|459933388|FG000|6-Month Follow-Up|Death|14|||
127813440|NCT02344576|459933389|FG001|6-Month Follow-Up|Death|14|||
127813441|NCT02344576|459933390|FG002|6-Month Follow-Up|Death|0|||
127813442|NCT02344576|459933391|FG003|6-Month Follow-Up|Death|0|||
127813443|NCT02344576|459933388|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
127813444|NCT02344576|459933389|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
127813445|NCT02344576|459933390|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
127813446|NCT02344576|459933391|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
127813447|NCT02344576|459933388|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
127813448|NCT02344576|459933389|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
127813449|NCT02344576|459933390|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
127813450|NCT02344576|459933391|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
127813451|NCT04325503|459933405|FG000|Overall Study|Withdrawal by Subject|1|||
127813452|NCT04325503|459933405|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
127813453|NCT01856114|459933406|FG000|Overall Study|Withdrawal by Subject|1|||
127813454|NCT01856114|459933407|FG001|Overall Study|Withdrawal by Subject|0|||
127813455|NCT01856114|459933406|FG000|Overall Study|Adverse Event|1|||
127813456|NCT01856114|459933407|FG001|Overall Study|Adverse Event|0|||
127813457|NCT00981526|459933408|FG000|Overall Study|Withdrawal by Subject|0|||
127813458|NCT00981526|459933409|FG001|Overall Study|Withdrawal by Subject|2|||
127894473|NCT02374918|460237151|FG002|Overall Study|Protocol Violation|2|||
127894474|NCT02374918|460237152|FG003|Overall Study|Protocol Violation|1|||
127894475|NCT02374918|460237149|FG000|Overall Study|Withdrawal by Subject|1|||
127813459|NCT00981526|459933408|FG000|Overall Study|Physician Decision|4|||
127813460|NCT00981526|459933409|FG001|Overall Study|Physician Decision|4|||
127813461|NCT01564784|459933410|FG000|Overall Study|Other|1|||
127813462|NCT01564784|459933411|FG001|Overall Study|Other|0|||
127813463|NCT01564784|459933410|FG000|Overall Study|Subject refused further follow-up|1|||
127813464|NCT01564784|459933411|FG001|Overall Study|Subject refused further follow-up|6|||
127813465|NCT01564784|459933410|FG000|Overall Study|Lost to Follow-up|1|||
127813466|NCT01564784|459933411|FG001|Overall Study|Lost to Follow-up|1|||
127813467|NCT01564784|459933410|FG000|Overall Study|Death|131|||
127813468|NCT01564784|459933411|FG001|Overall Study|Death|126|||
127813469|NCT02370121|459933412|FG000|Overall Study|Lost to Follow-up|1|||
127813470|NCT02370121|459933413|FG001|Overall Study|Lost to Follow-up|1|||
127813471|NCT04429022|459933415|FG000|Overall Study|Protocol Violation|18|||
127894476|NCT02374918|460237150|FG001|Overall Study|Withdrawal by Subject|1|||
127813472|NCT04429022|459933416|FG001|Overall Study|Protocol Violation|1|||
127813473|NCT01769105|459933417|FG000|First Intervention|Protocol Violation|2|||
127813474|NCT01769105|459933418|FG001|First Intervention|Protocol Violation|2|||
127813475|NCT01769105|459933417|FG000|Cross-over|Lost to Follow-up|5|||
127813476|NCT01769105|459933418|FG001|Cross-over|Lost to Follow-up|0|||
127813477|NCT00963807|459933419|FG000|Overall Study|Physician Decision|2|||
127813478|NCT00963807|459933419|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
127813479|NCT00963807|459933419|FG000|Overall Study|Disease progression|15|||
127813480|NCT02582658|459933421|FG000|Overall Study|Failure to Return|10|||
127813481|NCT02582658|459933421|FG000|Overall Study|Insufficient Virological Response|2|||
127813482|NCT02582658|459933421|FG000|Overall Study|Withdrawn Consent|1|||
127813483|NCT02582658|459933421|FG000|Overall Study|Death|1|||
127813484|NCT02582658|459933421|FG000|Overall Study|Not further specified|11|||
127813485|NCT01024244|459936184|FG000|Overall Study|Adverse Event|1|||
127813486|NCT01024244|459936185|FG001|Overall Study|Adverse Event|2|||
127813487|NCT01024244|459936186|FG002|Overall Study|Adverse Event|0|||
127813488|NCT01024244|459936187|FG003|Overall Study|Adverse Event|1|||
127813489|NCT01024244|459936188|FG004|Overall Study|Adverse Event|2|||
127813490|NCT01024244|459936184|FG000|Overall Study|Entry Criteria Not Met|0|||
127813491|NCT01024244|459936185|FG001|Overall Study|Entry Criteria Not Met|1|||
127813492|NCT01024244|459936186|FG002|Overall Study|Entry Criteria Not Met|0|||
127813493|NCT01024244|459936187|FG003|Overall Study|Entry Criteria Not Met|0|||
127813494|NCT01024244|459936188|FG004|Overall Study|Entry Criteria Not Met|0|||
127813495|NCT01024244|459936184|FG000|Overall Study|Lack of Efficacy|1|||
127813496|NCT01024244|459936185|FG001|Overall Study|Lack of Efficacy|0|||
127813497|NCT01024244|459936186|FG002|Overall Study|Lack of Efficacy|0|||
127813498|NCT01024244|459936187|FG003|Overall Study|Lack of Efficacy|0|||
127813499|NCT01024244|459936188|FG004|Overall Study|Lack of Efficacy|0|||
127813500|NCT01024244|459936184|FG000|Overall Study|Protocol Violation|1|||
127813501|NCT01024244|459936185|FG001|Overall Study|Protocol Violation|0|||
127813502|NCT01024244|459936186|FG002|Overall Study|Protocol Violation|0|||
127813503|NCT01024244|459936187|FG003|Overall Study|Protocol Violation|0|||
127813504|NCT01024244|459936188|FG004|Overall Study|Protocol Violation|2|||
127813505|NCT01024244|459936184|FG000|Overall Study|Sponsor Decision|14|||
127813506|NCT01024244|459936185|FG001|Overall Study|Sponsor Decision|7|||
127813507|NCT01024244|459936186|FG002|Overall Study|Sponsor Decision|14|||
127813508|NCT01024244|459936187|FG003|Overall Study|Sponsor Decision|12|||
127813509|NCT01024244|459936188|FG004|Overall Study|Sponsor Decision|10|||
127813510|NCT01024244|459936184|FG000|Overall Study|Withdrawal by Subject|0|||
127813511|NCT01024244|459936185|FG001|Overall Study|Withdrawal by Subject|1|||
127813512|NCT01024244|459936186|FG002|Overall Study|Withdrawal by Subject|0|||
127813513|NCT01024244|459936187|FG003|Overall Study|Withdrawal by Subject|0|||
127813514|NCT01024244|459936188|FG004|Overall Study|Withdrawal by Subject|0|||
127813515|NCT02660580|459936192|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
127813516|NCT02660580|459936193|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
127813517|NCT02660580|459936194|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
127813518|NCT02660580|459936195|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
127813519|NCT02660580|459936196|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
127813520|NCT02660580|459936192|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
127813521|NCT02660580|459936193|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
127813522|NCT02660580|459936194|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
127813523|NCT02660580|459936195|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
127813524|NCT02660580|459936196|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
127813525|NCT02660580|459936192|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
127813526|NCT02660580|459936193|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
127813527|NCT02660580|459936194|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
127813528|NCT02660580|459936195|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
127813529|NCT02660580|459936196|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
127813530|NCT02660580|459936192|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
127813531|NCT02660580|459936193|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
127813532|NCT02660580|459936194|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
127813533|NCT02660580|459936195|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
127813534|NCT02660580|459936196|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
127813535|NCT02660580|459936192|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
127813536|NCT02660580|459936193|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
127813537|NCT02660580|459936194|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
127813538|NCT02660580|459936195|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
127813539|NCT02660580|459936196|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
127813540|NCT02660580|459936192|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
127813541|NCT02660580|459936193|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
127813542|NCT02660580|459936194|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
127813543|NCT02660580|459936195|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
127813544|NCT02660580|459936196|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
127813545|NCT02660580|459936192|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
127813546|NCT02660580|459936193|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
127813547|NCT02660580|459936194|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
127813548|NCT02660580|459936195|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
127813549|NCT02660580|459936196|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
127813550|NCT02660580|459936192|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
127813551|NCT02660580|459936193|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
127813552|NCT02660580|459936194|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
127813553|NCT02660580|459936195|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
127813554|NCT02660580|459936196|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
127813555|NCT02660580|459936192|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
127813556|NCT02660580|459936193|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
127813557|NCT02660580|459936194|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
127813558|NCT02660580|459936195|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
127813559|NCT02660580|459936196|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
127813560|NCT02660580|459936192|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
127813561|NCT02660580|459936193|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
127813562|NCT02660580|459936194|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
127813563|NCT02660580|459936195|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
127813564|NCT02660580|459936196|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
127813565|NCT02660580|459936192|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
127813566|NCT02660580|459936193|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
127813567|NCT02660580|459936194|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
127813568|NCT02660580|459936195|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
127813569|NCT02660580|459936196|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
127813570|NCT02660580|459936192|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
127813571|NCT02660580|459936193|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
127813572|NCT02660580|459936194|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
127813573|NCT02660580|459936195|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
127813574|NCT02660580|459936196|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
127813575|NCT02660580|459936192|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
127813576|NCT02660580|459936193|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
127813577|NCT02660580|459936194|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
127813578|NCT02660580|459936195|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
127813579|NCT02660580|459936196|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
127813580|NCT00377962|459936197|FG000|Core Study: 0-12 Months|Adverse Event|18|||
127813581|NCT00377962|459936198|FG001|Core Study: 0-12 Months|Adverse Event|2|||
127813582|NCT00377962|459936197|FG000|Core Study: 0-12 Months|Death|3|||
127813583|NCT00377962|459936198|FG001|Core Study: 0-12 Months|Death|0|||
127813584|NCT00377962|459936197|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
127813585|NCT00377962|459936198|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
127813586|NCT00377962|459936197|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
127813587|NCT00377962|459936198|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
127813588|NCT00377962|459936197|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
127813589|NCT00377962|459936198|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
127813590|NCT00377962|459936197|FG000|Extension Study: 12-24 Months|Death|1|||
127813591|NCT00377962|459936198|FG001|Extension Study: 12-24 Months|Death|1|||
127813592|NCT00377962|459936197|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
127813593|NCT00377962|459936198|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
127813594|NCT00377962|459936197|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
127813595|NCT00377962|459936198|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
127813596|NCT00377962|459936197|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
127813597|NCT00377962|459936198|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
127813598|NCT01381094|459936204|FG000|Overall Study|Adverse Event|1|||
127813599|NCT01381094|459936205|FG001|Overall Study|Adverse Event|2|||
127813600|NCT01381094|459936206|FG002|Overall Study|Adverse Event|0|||
127813601|NCT01381094|459936207|FG003|Overall Study|Adverse Event|1|||
127813602|NCT01381094|459936208|FG004|Overall Study|Adverse Event|0|||
127813603|NCT01381094|459936204|FG000|Overall Study|Lost to Follow-up|0|||
127813604|NCT01381094|459936205|FG001|Overall Study|Lost to Follow-up|0|||
127813605|NCT01381094|459936206|FG002|Overall Study|Lost to Follow-up|0|||
127813606|NCT01381094|459936207|FG003|Overall Study|Lost to Follow-up|0|||
127813607|NCT01381094|459936208|FG004|Overall Study|Lost to Follow-up|1|||
127813608|NCT01381094|459936204|FG000|Overall Study|Withdrawal of informed consent|0|||
127813609|NCT01381094|459936205|FG001|Overall Study|Withdrawal of informed consent|1|||
127813610|NCT01381094|459936206|FG002|Overall Study|Withdrawal of informed consent|0|||
127813611|NCT01381094|459936207|FG003|Overall Study|Withdrawal of informed consent|0|||
127813612|NCT01381094|459936208|FG004|Overall Study|Withdrawal of informed consent|0|||
127813613|NCT01381094|459936204|FG000|Overall Study|Participant given Aranesp injection|1|||
127813614|NCT01381094|459936205|FG001|Overall Study|Participant given Aranesp injection|0|||
127813615|NCT01381094|459936206|FG002|Overall Study|Participant given Aranesp injection|0|||
127813616|NCT01381094|459936207|FG003|Overall Study|Participant given Aranesp injection|0|||
127813617|NCT01381094|459936208|FG004|Overall Study|Participant given Aranesp injection|0|||
127813618|NCT02665689|459936209|FG000|Overall Study|Adverse Event|1|||
127813619|NCT02665689|459936210|FG001|Overall Study|Adverse Event|0|||
127813620|NCT02665689|459936209|FG000|Overall Study|Trial termination|1|||
127813621|NCT02665689|459936210|FG001|Overall Study|Trial termination|1|||
127813622|NCT02665689|459936209|FG000|Overall Study|Lost to Follow-up|0|||
127813623|NCT02665689|459936210|FG001|Overall Study|Lost to Follow-up|1|||
127813624|NCT00486902|459936211|FG000|Overall Study|Withdrawal by Subject|1|||
127813625|NCT00486902|459936212|FG001|Overall Study|Withdrawal by Subject|2|||
127813626|NCT00486902|459936211|FG000|Overall Study|decision for postpartum tubal ligation|3|||
127813627|NCT00486902|459936212|FG001|Overall Study|decision for postpartum tubal ligation|1|||
127813628|NCT00486902|459936211|FG000|Overall Study|spinal anesthetic protocal violation|1|||
127813629|NCT00486902|459936212|FG001|Overall Study|spinal anesthetic protocal violation|1|||
127813630|NCT00486902|459936211|FG000|Overall Study|Did not meet inclusion criteria|1|||
127813631|NCT00486902|459936212|FG001|Overall Study|Did not meet inclusion criteria|0|||
127813632|NCT00486902|459936211|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
127813633|NCT00486902|459936212|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
127813634|NCT00541307|459936215|FG000|Overall Study|Death|5|||
127813635|NCT00541307|459936215|FG000|Overall Study|Physician Decision|3|||
127813636|NCT00541307|459936215|FG000|Overall Study|Withdrawal by Subject|6|||
127813637|NCT00541307|459936215|FG000|Overall Study|Lost to Follow-up|4|||
127813638|NCT00541307|459936215|FG000|Overall Study|Subject returned early (outside window)|1|||
127813639|NCT00541307|459936215|FG000|Overall Study|Surgical Bypass|5|||
127813640|NCT03615222|459936216|FG000|Overall Study|Ineligible|26|||
127813641|NCT03615222|459936216|FG000|Overall Study|Withdrawal by Subject|7|||
127813642|NCT03615222|459936216|FG000|Overall Study|Death|1|||
127813643|NCT02900092|459936217|FG000|Overall Study|Adverse Event|1|||
127813644|NCT03895203|459936218|FG000|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
127813645|NCT03895203|459936219|FG001|Double-Blind Treatment Period: 16 Weeks|Adverse Event|8|||
127813646|NCT03895203|459936220|FG002|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
127813647|NCT03895203|459936221|FG003|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
127813648|NCT03895203|459936222|FG004|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
127813649|NCT03895203|459936223|FG005|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
127813650|NCT03895203|459936218|FG000|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|2|||
127813651|NCT03895203|459936219|FG001|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
127813652|NCT03895203|459936220|FG002|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
127813653|NCT03895203|459936221|FG003|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
127813654|NCT03895203|459936222|FG004|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
127813655|NCT03895203|459936223|FG005|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
127813656|NCT03895203|459936218|FG000|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|2|||
127813657|NCT03895203|459936219|FG001|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
127813658|NCT03895203|459936220|FG002|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
127813659|NCT03895203|459936221|FG003|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
127813660|NCT03895203|459936222|FG004|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
127813661|NCT03895203|459936223|FG005|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
127813662|NCT03895203|459936218|FG000|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|4|||
127813663|NCT03895203|459936219|FG001|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|6|||
127813664|NCT03895203|459936220|FG002|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|1|||
127813665|NCT03895203|459936221|FG003|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
127813666|NCT03895203|459936222|FG004|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
127813667|NCT03895203|459936223|FG005|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
127813668|NCT03895203|459936218|FG000|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
127813669|NCT03895203|459936219|FG001|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|1|||
127813670|NCT03895203|459936220|FG002|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
127813671|NCT03895203|459936221|FG003|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
127813672|NCT03895203|459936222|FG004|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
127813673|NCT03895203|459936223|FG005|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
127813674|NCT03895203|459936218|FG000|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
127813675|NCT03895203|459936219|FG001|Double-Blind Treatment Period: 16 Weeks|Site terminated|1|||
127813676|NCT03895203|459936220|FG002|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
127813677|NCT03895203|459936221|FG003|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
127813678|NCT03895203|459936222|FG004|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
127813679|NCT03895203|459936223|FG005|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
127813680|NCT03895203|459936218|FG000|Active Treatment-Blind Period: 36 Weeks|Death|0|||
127813681|NCT03895203|459936219|FG001|Active Treatment-Blind Period: 36 Weeks|Death|0|||
127813682|NCT03895203|459936220|FG002|Active Treatment-Blind Period: 36 Weeks|Death|0|||
127813683|NCT03895203|459936221|FG003|Active Treatment-Blind Period: 36 Weeks|Death|1|||
127813684|NCT03895203|459936222|FG004|Active Treatment-Blind Period: 36 Weeks|Death|0|||
127813685|NCT03895203|459936223|FG005|Active Treatment-Blind Period: 36 Weeks|Death|0|||
127813686|NCT03895203|459936218|FG000|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
127813687|NCT03895203|459936219|FG001|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
127813688|NCT03895203|459936220|FG002|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
127813689|NCT03895203|459936221|FG003|Active Treatment-Blind Period: 36 Weeks|Adverse Event|5|||
127813690|NCT03895203|459936222|FG004|Active Treatment-Blind Period: 36 Weeks|Adverse Event|9|||
127813691|NCT03895203|459936223|FG005|Active Treatment-Blind Period: 36 Weeks|Adverse Event|4|||
127813692|NCT03895203|459936218|FG000|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
127813693|NCT03895203|459936219|FG001|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
127813694|NCT03895203|459936220|FG002|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
127813695|NCT03895203|459936221|FG003|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|1|||
127813696|NCT03895203|459936222|FG004|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|6|||
127813697|NCT03895203|459936223|FG005|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|4|||
127813698|NCT03895203|459936218|FG000|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
127813699|NCT03895203|459936219|FG001|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
127813700|NCT03895203|459936220|FG002|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
127813701|NCT03895203|459936221|FG003|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|1|||
127813702|NCT03895203|459936222|FG004|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|3|||
127813703|NCT03895203|459936223|FG005|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
127813704|NCT03895203|459936218|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
127813705|NCT03895203|459936219|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
127813706|NCT03895203|459936220|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
127813707|NCT03895203|459936221|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|4|||
127813708|NCT03895203|459936222|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|9|||
127813709|NCT03895203|459936223|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|2|||
127813710|NCT03895203|459936218|FG000|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
127813711|NCT03895203|459936219|FG001|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
127813712|NCT03895203|459936220|FG002|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
127813713|NCT03895203|459936221|FG003|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|1|||
127813714|NCT03895203|459936222|FG004|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
127813715|NCT03895203|459936223|FG005|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
127813716|NCT03895203|459936218|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
127813717|NCT03895203|459936219|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
127813718|NCT03895203|459936220|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
127813719|NCT03895203|459936221|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|1|||
127813720|NCT03895203|459936222|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
127813721|NCT03895203|459936223|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
127813722|NCT03895203|459936218|FG000|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
127813723|NCT03895203|459936219|FG001|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
127813724|NCT03895203|459936220|FG002|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
127813725|NCT03895203|459936221|FG003|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
127813726|NCT03895203|459936222|FG004|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
127813727|NCT03895203|459936223|FG005|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|1|||
127813728|NCT00996840|459936224|FG000|Overall Study|Adverse Event|0|||
127813729|NCT00996840|459936225|FG001|Overall Study|Adverse Event|1|||
127813730|NCT00996840|459936226|FG002|Overall Study|Adverse Event|0|||
127813731|NCT00996840|459936227|FG003|Overall Study|Adverse Event|0|||
127813732|NCT00996840|459936228|FG004|Overall Study|Adverse Event|0|||
127813733|NCT00996840|459936224|FG000|Overall Study|Physician Decision|0|||
127813734|NCT00996840|459936225|FG001|Overall Study|Physician Decision|0|||
127813735|NCT00996840|459936226|FG002|Overall Study|Physician Decision|1|||
127813736|NCT00996840|459936227|FG003|Overall Study|Physician Decision|1|||
127813737|NCT00996840|459936228|FG004|Overall Study|Physician Decision|2|||
127813738|NCT00996840|459936224|FG000|Overall Study|Withdrawal by Subject|1|||
127813739|NCT00996840|459936225|FG001|Overall Study|Withdrawal by Subject|1|||
127813740|NCT00996840|459936226|FG002|Overall Study|Withdrawal by Subject|0|||
127813741|NCT00996840|459936227|FG003|Overall Study|Withdrawal by Subject|0|||
127813742|NCT00996840|459936228|FG004|Overall Study|Withdrawal by Subject|0|||
127813743|NCT04645797|459936229|FG000|Overall Study|Disease Progression|3|||
127813744|NCT04645797|459936230|FG001|Overall Study|Disease Progression|3|||
127813745|NCT04645797|459936231|FG002|Overall Study|Disease Progression|1|||
127813746|NCT04645797|459936232|FG003|Overall Study|Disease Progression|0|||
127813747|NCT04645797|459936233|FG004|Overall Study|Disease Progression|0|||
127813748|NCT04645797|459936234|FG005|Overall Study|Disease Progression|0|||
127813749|NCT04645797|459936235|FG006|Overall Study|Disease Progression|0|||
127813750|NCT04645797|459936229|FG000|Overall Study|Death|3|||
127813751|NCT04645797|459936230|FG001|Overall Study|Death|1|||
127813752|NCT04645797|459936231|FG002|Overall Study|Death|0|||
127813753|NCT04645797|459936232|FG003|Overall Study|Death|0|||
127813754|NCT04645797|459936233|FG004|Overall Study|Death|0|||
127813755|NCT04645797|459936234|FG005|Overall Study|Death|0|||
127813756|NCT04645797|459936235|FG006|Overall Study|Death|0|||
127813757|NCT01485614|459936237|FG000|Randomization|Not Treated|1|||
127813758|NCT01485614|459936238|FG001|Randomization|Not Treated|0|||
127813759|NCT01485614|459936239|FG002|Randomization|Not Treated|0|||
127813760|NCT01485614|459936240|FG003|Randomization|Not Treated|0|||
127813761|NCT01485614|459936237|FG000|Weeks 0-20|Lost to Follow-up|2|||
127813762|NCT01485614|459936238|FG001|Weeks 0-20|Lost to Follow-up|0|||
127813763|NCT01485614|459936239|FG002|Weeks 0-20|Lost to Follow-up|0|||
127813764|NCT01485614|459936240|FG003|Weeks 0-20|Lost to Follow-up|0|||
127813765|NCT01485614|459936237|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
127813766|NCT01485614|459936238|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
127813767|NCT01485614|459936239|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
127813768|NCT01485614|459936240|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
127813769|NCT01485614|459936237|FG000|Weeks 0-20|Withdrawal by Subject|3|||
127813770|NCT01485614|459936238|FG001|Weeks 0-20|Withdrawal by Subject|2|||
127813771|NCT01485614|459936239|FG002|Weeks 0-20|Withdrawal by Subject|1|||
127813772|NCT01485614|459936240|FG003|Weeks 0-20|Withdrawal by Subject|0|||
127813773|NCT01485614|459936237|FG000|Weeks 20-54|Lost to Follow-up|4|||
127813774|NCT01485614|459936238|FG001|Weeks 20-54|Lost to Follow-up|3|||
127813775|NCT01485614|459936239|FG002|Weeks 20-54|Lost to Follow-up|1|||
127813776|NCT01485614|459936240|FG003|Weeks 20-54|Lost to Follow-up|0|||
127813777|NCT01485614|459936237|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
127813778|NCT01485614|459936238|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
127813779|NCT01485614|459936239|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
127813780|NCT01485614|459936240|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
127813781|NCT01485614|459936237|FG000|Weeks 20-54|Withdrawal by Subject|5|||
127813782|NCT01485614|459936238|FG001|Weeks 20-54|Withdrawal by Subject|3|||
127813783|NCT01485614|459936239|FG002|Weeks 20-54|Withdrawal by Subject|0|||
127813784|NCT01485614|459936240|FG003|Weeks 20-54|Withdrawal by Subject|0|||
127813785|NCT00733902|459936241|FG000|Overall Study|Death|0|||
127813786|NCT00733902|459936242|FG001|Overall Study|Death|0|||
127813787|NCT00733902|459936243|FG002|Overall Study|Death|0|||
127813788|NCT00733902|459936244|FG003|Overall Study|Death|1|||
127813789|NCT00733902|459936241|FG000|Overall Study|Adverse Event|3|||
127813790|NCT00733902|459936242|FG001|Overall Study|Adverse Event|4|||
127813791|NCT00733902|459936243|FG002|Overall Study|Adverse Event|7|||
127813792|NCT00733902|459936244|FG003|Overall Study|Adverse Event|11|||
127813793|NCT00733902|459936241|FG000|Overall Study|Lack of Efficacy|56|||
127813794|NCT00733902|459936242|FG001|Overall Study|Lack of Efficacy|21|||
127813795|NCT00733902|459936243|FG002|Overall Study|Lack of Efficacy|34|||
127813796|NCT00733902|459936244|FG003|Overall Study|Lack of Efficacy|23|||
127813797|NCT00733902|459936241|FG000|Overall Study|Protocol Violation|4|||
127813798|NCT00733902|459936242|FG001|Overall Study|Protocol Violation|6|||
127813799|NCT00733902|459936243|FG002|Overall Study|Protocol Violation|3|||
127813800|NCT00733902|459936244|FG003|Overall Study|Protocol Violation|3|||
127813801|NCT00733902|459936241|FG000|Overall Study|Withdrawal by Subject|10|||
127813802|NCT00733902|459936242|FG001|Overall Study|Withdrawal by Subject|5|||
127813803|NCT00733902|459936243|FG002|Overall Study|Withdrawal by Subject|4|||
127813804|NCT00733902|459936244|FG003|Overall Study|Withdrawal by Subject|16|||
127813805|NCT00733902|459936241|FG000|Overall Study|Entered extension study|89|||
127813806|NCT00733902|459936242|FG001|Overall Study|Entered extension study|124|||
127813807|NCT00733902|459936243|FG002|Overall Study|Entered extension study|111|||
127813808|NCT00733902|459936244|FG003|Overall Study|Entered extension study|109|||
127813809|NCT00733902|459936241|FG000|Overall Study|Randomized but not treated|2|||
127813810|NCT00733902|459936242|FG001|Overall Study|Randomized but not treated|2|||
127813811|NCT00733902|459936243|FG002|Overall Study|Randomized but not treated|2|||
127813812|NCT00733902|459936244|FG003|Overall Study|Randomized but not treated|1|||
127813813|NCT02582515|459936245|FG000|Overall Study|Withdrawal by Subject|0|||
127813814|NCT02582515|459936246|FG001|Overall Study|Withdrawal by Subject|1|||
127813815|NCT00775021|459936247|FG000|First Intervention|Lost to Follow-up|1|||
127813816|NCT00775021|459936248|FG001|First Intervention|Lost to Follow-up|0|||
127813817|NCT00775021|459936247|FG000|Second Intervention|Adverse Event|0|||
127813818|NCT00775021|459936248|FG001|Second Intervention|Adverse Event|1|||
127813819|NCT00870688|459936249|FG000|Overall Study|Lost to Follow-up|2|||
127813820|NCT00870688|459936249|FG000|Overall Study|Death, Unrelated|1|||
127813821|NCT00870688|459936249|FG000|Overall Study|Granules in the Stools|1|||
127813822|NCT03872180|459936258|FG000|Overall Study|Adverse Event|4|||
127813823|NCT03872180|459936258|FG000|Overall Study|Lack of Efficacy|2|||
127813824|NCT01506141|459936259|FG000|Overall Study|Adverse Event|0|||
127813825|NCT01506141|459936260|FG001|Overall Study|Adverse Event|2|||
127813826|NCT01506141|459936259|FG000|Overall Study|Participation Terminated by Investigator|1|||
127813827|NCT01506141|459936260|FG001|Overall Study|Participation Terminated by Investigator|1|||
127813828|NCT01506141|459936259|FG000|Overall Study|Site Terminated by Sponsor|2|||
127813829|NCT01506141|459936260|FG001|Overall Study|Site Terminated by Sponsor|0|||
127813830|NCT01506141|459936259|FG000|Overall Study|Reason Not Specified|4|||
127813831|NCT01506141|459936260|FG001|Overall Study|Reason Not Specified|2|||
127813832|NCT04607408|459936261|FG000|Overall Study|Lost to Follow-up|0|||
127813833|NCT04607408|459936262|FG001|Overall Study|Lost to Follow-up|0|||
127813834|NCT04607408|459936263|FG002|Overall Study|Lost to Follow-up|0|||
127813835|NCT04607408|459936264|FG003|Overall Study|Lost to Follow-up|1|||
127813836|NCT04607408|459936265|FG004|Overall Study|Lost to Follow-up|0|||
127813837|NCT04607408|459936261|FG000|Overall Study|Withdrawal by Subject|0|||
127813838|NCT04607408|459936262|FG001|Overall Study|Withdrawal by Subject|1|||
127813839|NCT04607408|459936263|FG002|Overall Study|Withdrawal by Subject|0|||
127813840|NCT04607408|459936264|FG003|Overall Study|Withdrawal by Subject|1|||
127813841|NCT04607408|459936265|FG004|Overall Study|Withdrawal by Subject|0|||
127813842|NCT02599402|459936270|FG000|Overall Study|Disease progression|153|||
127813843|NCT02599402|459936270|FG000|Overall Study|Study drug toxicity|201|||
127813844|NCT02599402|459936270|FG000|Overall Study|Death|26|||
127813845|NCT02599402|459936270|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
127813846|NCT02599402|459936270|FG000|Overall Study|Participant request to discontinue study treatment|13|||
127813847|NCT02599402|459936270|FG000|Overall Study|Participant withdrew consent|5|||
127813848|NCT02599402|459936270|FG000|Overall Study|Lost to Follow-up|1|||
127813849|NCT02599402|459936270|FG000|Overall Study|Maximum Clinical Benefit|7|||
127813850|NCT02599402|459936270|FG000|Overall Study|Poor/non-compliance|1|||
127813851|NCT02599402|459936270|FG000|Overall Study|Pregnancy|1|||
127813852|NCT02599402|459936270|FG000|Overall Study|Participant no longer met study criteria|7|||
127813853|NCT02599402|459936270|FG000|Overall Study|Other Reasons|95|||
127813854|NCT01773473|459936271|FG000|Overall Study|Adverse Event|3|||
127813855|NCT01773473|459936272|FG001|Overall Study|Adverse Event|2|||
127813856|NCT01773473|459936271|FG000|Overall Study|Protocol Violation|0|||
127813857|NCT01773473|459936272|FG001|Overall Study|Protocol Violation|4|||
127813858|NCT01773473|459936271|FG000|Overall Study|Physician Decision|3|||
127813859|NCT01773473|459936272|FG001|Overall Study|Physician Decision|5|||
127813860|NCT01773473|459936271|FG000|Overall Study|Sponsor Decision|2|||
127813861|NCT01773473|459936272|FG001|Overall Study|Sponsor Decision|0|||
127813862|NCT01773473|459936271|FG000|Overall Study|Lack of Efficacy|0|||
127813863|NCT01773473|459936272|FG001|Overall Study|Lack of Efficacy|1|||
127813864|NCT01773473|459936271|FG000|Overall Study|Non-Compliance with study drug|1|||
127813865|NCT01773473|459936272|FG001|Overall Study|Non-Compliance with study drug|4|||
127813866|NCT01773473|459936271|FG000|Overall Study|Withdrawal by Subject|5|||
127813867|NCT01773473|459936272|FG001|Overall Study|Withdrawal by Subject|3|||
127813868|NCT01773473|459936271|FG000|Overall Study|Lost to Follow-up|2|||
127813869|NCT01773473|459936272|FG001|Overall Study|Lost to Follow-up|0|||
127813870|NCT04927312|459936273|FG000|Overall Study|Adverse Event|1|||
127813871|NCT04927312|459936273|FG000|Overall Study|Death|1|||
127813872|NCT04927312|459936273|FG000|Overall Study|Withdrawal by Subject|1|||
127813873|NCT04927312|459936273|FG000|Overall Study|Other|1|||
127813874|NCT04919564|459936274|FG000|Overall Study|Lost to Follow-up|1|||
127813875|NCT04919564|459936275|FG001|Overall Study|Lost to Follow-up|0|||
127813876|NCT04919564|459936274|FG000|Overall Study|Physician Decision|1|||
127813877|NCT04919564|459936275|FG001|Overall Study|Physician Decision|1|||
127813878|NCT01241786|459936276|FG000|Overall Study|Lack of Efficacy|5|||
127813879|NCT02371629|459936278|FG000|Overall Study|Patient decision|14|||
127813880|NCT02371629|459936279|FG001|Overall Study|Patient decision|10|||
127813881|NCT02371629|459936278|FG000|Overall Study|Adverse Event|8|||
127813882|NCT02371629|459936279|FG001|Overall Study|Adverse Event|8|||
127813883|NCT02371629|459936278|FG000|Overall Study|Physician Decision|2|||
127813884|NCT02371629|459936279|FG001|Overall Study|Physician Decision|3|||
127813885|NCT02371629|459936278|FG000|Overall Study|Death|1|||
127813886|NCT02371629|459936279|FG001|Overall Study|Death|1|||
127813887|NCT02371629|459936278|FG000|Overall Study|Noncompliance with study treatment|1|||
127813888|NCT02371629|459936279|FG001|Overall Study|Noncompliance with study treatment|0|||
127813889|NCT02371629|459936278|FG000|Overall Study|Lack of Efficacy|0|||
127813890|NCT02371629|459936279|FG001|Overall Study|Lack of Efficacy|2|||
127813891|NCT02371629|459936278|FG000|Overall Study|Protocol deviation|0|||
127813892|NCT02371629|459936279|FG001|Overall Study|Protocol deviation|1|||
127813893|NCT01440101|459936280|FG000|Overall Study|Adverse Event|2|||
127813894|NCT01440101|459936281|FG001|Overall Study|Adverse Event|0|||
127813895|NCT01440101|459936282|FG002|Overall Study|Adverse Event|0|||
127813896|NCT01440101|459936280|FG000|Overall Study|Withdrawal by Subject|0|||
127813897|NCT01440101|459936281|FG001|Overall Study|Withdrawal by Subject|3|||
127813898|NCT01440101|459936282|FG002|Overall Study|Withdrawal by Subject|1|||
127813899|NCT01440101|459936280|FG000|Overall Study|Other|0|||
127813900|NCT01440101|459936281|FG001|Overall Study|Other|1|||
127813901|NCT01440101|459936282|FG002|Overall Study|Other|0|||
127813902|NCT03832387|459936286|FG000|Overall Study|Protocol Violation|2|||
127813903|NCT03832387|459936287|FG001|Overall Study|Protocol Violation|6|||
127813904|NCT03832387|459936286|FG000|Overall Study|EXCLUSION CRITERIA|3|||
127813905|NCT03832387|459936287|FG001|Overall Study|EXCLUSION CRITERIA|1|||
127813906|NCT00144170|459936288|FG000|Overall Study|Adverse Event|84|||
127813907|NCT00144170|459936289|FG001|Overall Study|Adverse Event|41|||
127813908|NCT00144170|459936288|FG000|Overall Study|Protocol Violation|23|||
127813909|NCT00144170|459936289|FG001|Overall Study|Protocol Violation|16|||
127813910|NCT00144170|459936288|FG000|Overall Study|Lost to Follow-up|5|||
127813911|NCT00144170|459936289|FG001|Overall Study|Lost to Follow-up|10|||
127813912|NCT00144170|459936288|FG000|Overall Study|Withdrawal by Subject|29|||
127813913|NCT00144170|459936289|FG001|Overall Study|Withdrawal by Subject|13|||
127813914|NCT00144170|459936288|FG000|Overall Study|Other reason not defined above|211|||
127813915|NCT00144170|459936289|FG001|Overall Study|Other reason not defined above|316|||
127813916|NCT00045032|459936301|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
127813917|NCT00045032|459936302|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
127813918|NCT00045032|459936303|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
127813919|NCT00045032|459936301|FG000|Overall Study|Death|22|||
127813920|NCT00045032|459936302|FG001|Overall Study|Death|24|||
127813921|NCT00045032|459936303|FG002|Overall Study|Death|17|||
127813922|NCT00045032|459936301|FG000|Overall Study|Insufficient Therapeutic Response|542|||
127813923|NCT00045032|459936302|FG001|Overall Study|Insufficient Therapeutic Response|437|||
127813924|NCT00045032|459936303|FG002|Overall Study|Insufficient Therapeutic Response|445|||
127813925|NCT00045032|459936301|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
127813926|NCT00045032|459936302|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
127813927|NCT00045032|459936303|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
127813928|NCT00045032|459936301|FG000|Overall Study|Other Protocol Violation|2|||
127813929|NCT00045032|459936302|FG001|Overall Study|Other Protocol Violation|0|||
127813930|NCT00045032|459936303|FG002|Overall Study|Other Protocol Violation|1|||
127813931|NCT00045032|459936301|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
127813932|NCT00045032|459936302|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
127813933|NCT00045032|459936303|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
127813934|NCT00045032|459936301|FG000|Overall Study|Failure to Return|57|||
127813935|NCT00045032|459936302|FG001|Overall Study|Failure to Return|62|||
127813936|NCT00045032|459936303|FG002|Overall Study|Failure to Return|61|||
127813937|NCT00045032|459936301|FG000|Overall Study|Other|93|||
127813938|NCT00045032|459936302|FG001|Overall Study|Other|84|||
127813939|NCT00045032|459936303|FG002|Overall Study|Other|105|||
127813940|NCT02581995|459936311|FG000|Overall Study|Unspecified other|3|||
127813941|NCT02581995|459936311|FG000|Overall Study|Adverse Event|6|||
127813942|NCT02581995|459936311|FG000|Overall Study|Lost to Follow-up|5|||
127813943|NCT02581995|459936311|FG000|Overall Study|Withdrawal by participant|12|||
127813944|NCT02581995|459936311|FG000|Overall Study|Physician Decision|1|||
127813945|NCT02581995|459936311|FG000|Overall Study|Death|4|||
127813946|NCT03095703|459937939|FG000|Overall Study|Withdrawal by Subject|1|||
127813947|NCT01934504|459937942|FG000|Overall Study|Protocol Deviation|0|||
127813948|NCT01934504|459937943|FG001|Overall Study|Protocol Deviation|0|||
127813949|NCT01934504|459937944|FG002|Overall Study|Protocol Deviation|0|||
127813950|NCT01934504|459937945|FG003|Overall Study|Protocol Deviation|2|||
127813951|NCT01934504|459937942|FG000|Overall Study|Study Terminated by Sponsor|1|||
127813952|NCT01934504|459937943|FG001|Overall Study|Study Terminated by Sponsor|0|||
127813953|NCT01934504|459937944|FG002|Overall Study|Study Terminated by Sponsor|5|||
127813954|NCT01934504|459937945|FG003|Overall Study|Study Terminated by Sponsor|5|||
127813955|NCT02455557|459937946|FG000|Overall Study|Withdrawal by Subject|2|||
127813956|NCT02210780|459937947|FG000|Overall Study|Adverse Event|0|||
127813957|NCT02210780|459937948|FG001|Overall Study|Adverse Event|5|||
127813958|NCT02210780|459937947|FG000|Overall Study|Lost to Follow-up|2|||
127813959|NCT02210780|459937948|FG001|Overall Study|Lost to Follow-up|1|||
127813960|NCT02210780|459937947|FG000|Overall Study|Withdrawal by Subject|1|||
127813961|NCT02210780|459937948|FG001|Overall Study|Withdrawal by Subject|1|||
127813962|NCT02210780|459937947|FG000|Overall Study|Physician Decision|1|||
127813963|NCT02210780|459937948|FG001|Overall Study|Physician Decision|0|||
127813964|NCT02210780|459937947|FG000|Overall Study|Protocol Violation|1|||
127813965|NCT02210780|459937948|FG001|Overall Study|Protocol Violation|0|||
127813966|NCT02210780|459937947|FG000|Overall Study|Other than specified above|0|||
127813967|NCT02210780|459937948|FG001|Overall Study|Other than specified above|1|||
127813968|NCT00049127|459937949|FG000|Overall Study|Withdrawal by Subject|0|||
127813969|NCT00049127|459937950|FG001|Overall Study|Withdrawal by Subject|0|||
127813970|NCT00049127|459937951|FG002|Overall Study|Withdrawal by Subject|1|||
127813971|NCT00049127|459937952|FG003|Overall Study|Withdrawal by Subject|0|||
127813972|NCT00049127|459937953|FG004|Overall Study|Withdrawal by Subject|0|||
127813973|NCT01122927|459937954|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
127813974|NCT01122927|459937955|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
127813975|NCT01122927|459937954|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
127813976|NCT01122927|459937955|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
127813977|NCT01122927|459937954|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
127813978|NCT01122927|459937955|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
127813979|NCT01122927|459937954|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
127813980|NCT01122927|459937955|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
127813981|NCT01122927|459937954|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
127813982|NCT01122927|459937955|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
127813983|NCT01122927|459937954|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
127813984|NCT01122927|459937955|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
127813985|NCT01122927|459937954|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
127813986|NCT01122927|459937955|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
127813987|NCT01122927|459937954|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
127813988|NCT01122927|459937955|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
127813989|NCT01122927|459937954|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
127813990|NCT01122927|459937955|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
127813991|NCT01122927|459937954|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
127813992|NCT01122927|459937955|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
127813993|NCT01122927|459937954|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
127813994|NCT01122927|459937955|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
127813995|NCT01122927|459937954|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
127813996|NCT01122927|459937955|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
127813997|NCT00684814|459937956|FG000|Washout Period of 7 Days|Adverse Event|1|||
127813998|NCT00684814|459937957|FG001|Washout Period of 7 Days|Adverse Event|2|||
127813999|NCT00684814|459937956|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
127814000|NCT00684814|459937957|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
127814001|NCT00684814|459937956|FG000|Second Intervention|Adverse Event|1|||
127814002|NCT00684814|459937957|FG001|Second Intervention|Adverse Event|0|||
127814003|NCT01676961|459937960|FG000|Overall Study|Death|3|||
127814004|NCT01676961|459937960|FG000|Overall Study|Lost to Follow-up|1|||
127814005|NCT01676961|459937960|FG000|Overall Study|Withdrawal by Subject|1|||
127814006|NCT00117312|459937961|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
127814007|NCT00117312|459937962|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
127814008|NCT00117312|459937963|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
127814009|NCT00117312|459937964|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
127814010|NCT00117312|459937961|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
127814011|NCT00117312|459937962|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
127814012|NCT00117312|459937963|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
127814013|NCT00117312|459937964|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
127814014|NCT00117312|459937961|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
127814015|NCT00117312|459937962|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
127814016|NCT00117312|459937963|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
127814017|NCT00117312|459937964|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
127814018|NCT00117312|459937961|FG000|Overall Study|Other|0|||
127814019|NCT00117312|459937962|FG001|Overall Study|Other|1|||
127814020|NCT00117312|459937963|FG002|Overall Study|Other|3|||
127814021|NCT00117312|459937964|FG003|Overall Study|Other|1|||
127814022|NCT00117312|459937961|FG000|Overall Study|Patient choice|0|||
127814023|NCT00117312|459937962|FG001|Overall Study|Patient choice|0|||
127814024|NCT00117312|459937963|FG002|Overall Study|Patient choice|2|||
127814025|NCT00117312|459937964|FG003|Overall Study|Patient choice|1|||
127814026|NCT00117312|459937961|FG000|Overall Study|Adverse Event|0|||
127814027|NCT00117312|459937962|FG001|Overall Study|Adverse Event|2|||
127814028|NCT00117312|459937963|FG002|Overall Study|Adverse Event|0|||
127814029|NCT00117312|459937964|FG003|Overall Study|Adverse Event|0|||
127814030|NCT00117312|459937961|FG000|Overall Study|Protocol Violation|0|||
127814031|NCT00117312|459937962|FG001|Overall Study|Protocol Violation|1|||
127814032|NCT00117312|459937963|FG002|Overall Study|Protocol Violation|3|||
127814033|NCT00117312|459937964|FG003|Overall Study|Protocol Violation|0|||
127814034|NCT00117312|459937961|FG000|Overall Study|PSA decrease <=50%|0|||
127814035|NCT00117312|459937962|FG001|Overall Study|PSA decrease <=50%|2|||
127814036|NCT00117312|459937963|FG002|Overall Study|PSA decrease <=50%|2|||
127814037|NCT00117312|459937964|FG003|Overall Study|PSA decrease <=50%|4|||
127814038|NCT00117312|459937961|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
127814039|NCT00117312|459937962|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
127814040|NCT00117312|459937963|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
127814041|NCT00117312|459937964|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
127814042|NCT00117312|459937961|FG000|Overall Study|Hepatic abnormality|0|||
127814043|NCT00117312|459937962|FG001|Overall Study|Hepatic abnormality|1|||
127814044|NCT00117312|459937963|FG002|Overall Study|Hepatic abnormality|0|||
127814045|NCT00117312|459937964|FG003|Overall Study|Hepatic abnormality|1|||
127814046|NCT00117312|459937961|FG000|Overall Study|Withdrawal by Subject|0|||
127814047|NCT00117312|459937962|FG001|Overall Study|Withdrawal by Subject|2|||
127814048|NCT00117312|459937963|FG002|Overall Study|Withdrawal by Subject|0|||
127814049|NCT00117312|459937964|FG003|Overall Study|Withdrawal by Subject|0|||
127814050|NCT00195650|459937965|FG000|Overall Study|Adverse Event|194|||
127814051|NCT00195650|459937965|FG000|Overall Study|Lack of Efficacy|99|||
127814052|NCT00195650|459937965|FG000|Overall Study|Withdrawal by Subject|67|||
127814053|NCT00195650|459937965|FG000|Overall Study|Lost to Follow-up|44|||
127814054|NCT00195650|459937965|FG000|Overall Study|Death|23|||
127814055|NCT00195650|459937965|FG000|Overall Study|Protocol Violation|15|||
127814056|NCT00195650|459937965|FG000|Overall Study|Administrative reasons|83|||
127814057|NCT00201851|459937967|FG000|Overall Study|Lost to Follow-up|2|||
127814058|NCT00201851|459937968|FG001|Overall Study|Lost to Follow-up|1|||
127814059|NCT00201851|459937969|FG002|Overall Study|Lost to Follow-up|0|||
127814060|NCT00201851|459937967|FG000|Overall Study|Ineligible post enrollment|6|||
127814061|NCT00201851|459937968|FG001|Overall Study|Ineligible post enrollment|1|||
127814062|NCT00201851|459937969|FG002|Overall Study|Ineligible post enrollment|1|||
127814063|NCT02469246|459937970|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
127814064|NCT02469246|459937971|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
127814065|NCT02469246|459937970|FG000|Double-Blind Phase|Adverse Event|12|||
127814066|NCT02469246|459937971|FG001|Double-Blind Phase|Adverse Event|9|||
127814067|NCT02469246|459937970|FG000|Double-Blind Phase|Death|2|||
127814068|NCT02469246|459937971|FG001|Double-Blind Phase|Death|0|||
127814069|NCT02469246|459937970|FG000|Double-Blind Phase|Lack of Efficacy|2|||
127814070|NCT02469246|459937971|FG001|Double-Blind Phase|Lack of Efficacy|1|||
127814071|NCT02469246|459937970|FG000|Double-Blind Phase|Investigator's Discretion|8|||
127814072|NCT02469246|459937971|FG001|Double-Blind Phase|Investigator's Discretion|8|||
127814073|NCT02469246|459937970|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
127814074|NCT02469246|459937971|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
127814075|NCT02469246|459937970|FG000|Double-Blind Phase|Protocol Violation|1|||
127814076|NCT02469246|459937971|FG001|Double-Blind Phase|Protocol Violation|1|||
127814077|NCT02469246|459937970|FG000|Double-Blind Phase|Withdrew Consent|25|||
127814078|NCT02469246|459937971|FG001|Double-Blind Phase|Withdrew Consent|25|||
127814079|NCT02469246|459937970|FG000|Double-Blind Phase|Lost to Follow-up|9|||
127814080|NCT02469246|459937971|FG001|Double-Blind Phase|Lost to Follow-up|5|||
127814081|NCT00636818|459937975|FG000|Overall Study|Adverse Event|1|||
127814082|NCT00636818|459937975|FG000|Overall Study|Lost to Follow-up|2|||
127814083|NCT00636818|459937975|FG000|Overall Study|Entry Criteria Exclusion|3|||
127814084|NCT00636818|459937975|FG000|Overall Study|Protocol Violation|1|||
127814085|NCT00636818|459937975|FG000|Overall Study|Withdrawal by Subject|4|||
127814086|NCT00074958|459937976|FG000|Overall Study|Adverse Event|1|||
127814087|NCT01658514|459937980|FG000|Overall Study|Protocol Violation|1|||
127814088|NCT01658514|459937981|FG001|Overall Study|Protocol Violation|0|||
127814089|NCT01658514|459937982|FG002|Overall Study|Protocol Violation|2|||
127814090|NCT00749203|459937983|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
127814091|NCT00749203|459937984|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
127814092|NCT00749203|459937983|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
127814093|NCT00749203|459937984|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
127814094|NCT00749203|459937983|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
127814095|NCT00749203|459937984|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
127814096|NCT00749203|459937983|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
127814097|NCT00749203|459937984|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
127814098|NCT00749203|459937983|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
127894477|NCT02374918|460237151|FG002|Overall Study|Withdrawal by Subject|1|||
127894478|NCT02374918|460237152|FG003|Overall Study|Withdrawal by Subject|0|||
127894479|NCT02374918|460237149|FG000|Overall Study|Lack of Efficacy|0|||
127894480|NCT02374918|460237150|FG001|Overall Study|Lack of Efficacy|0|||
127894481|NCT02374918|460237151|FG002|Overall Study|Lack of Efficacy|1|||
127894482|NCT02374918|460237152|FG003|Overall Study|Lack of Efficacy|1|||
127894483|NCT01180244|460237153|FG000|Overall Study|Lack of Efficacy|0|||
127894484|NCT01180244|460237154|FG001|Overall Study|Lack of Efficacy|7|||
127894485|NCT01180244|460237153|FG000|Overall Study|Physician Decision|3|||
127894486|NCT01180244|460237154|FG001|Overall Study|Physician Decision|0|||
127894487|NCT01180244|460237153|FG000|Overall Study|Adverse Event|1|||
127894488|NCT01180244|460237154|FG001|Overall Study|Adverse Event|0|||
127894489|NCT01180244|460237153|FG000|Overall Study|Withdrawal by Subject|0|||
127894490|NCT01180244|460237154|FG001|Overall Study|Withdrawal by Subject|1|||
127894491|NCT01180244|460237153|FG000|Overall Study|Protocol Violation|1|||
127894492|NCT01180244|460237154|FG001|Overall Study|Protocol Violation|0|||
127894493|NCT01180244|460237153|FG000|Overall Study|Lost to Follow-up|1|||
127894494|NCT01180244|460237154|FG001|Overall Study|Lost to Follow-up|0|||
127894495|NCT00729859|460237155|FG000|Overall Study|Adverse Event|0|||
127894496|NCT00729859|460237156|FG001|Overall Study|Adverse Event|1|||
127894497|NCT00729859|460237157|FG002|Overall Study|Adverse Event|0|||
127894498|NCT00729859|460237155|FG000|Overall Study|Withdrawal by Subject|0|||
127894499|NCT00729859|460237156|FG001|Overall Study|Withdrawal by Subject|1|||
127894500|NCT00729859|460237157|FG002|Overall Study|Withdrawal by Subject|0|||
127894501|NCT02623829|460237160|FG000|Overall Study|Lost to Follow-up|1|||
127894502|NCT02623829|460237161|FG001|Overall Study|Lost to Follow-up|1|||
127894503|NCT03349333|460237162|FG000|Overall Study|Progression of Disease|36|||
127894504|NCT03349333|460237162|FG000|Overall Study|Adverse Event|11|||
127894505|NCT03349333|460237162|FG000|Overall Study|Other|6|||
127894506|NCT03349333|460237162|FG000|Overall Study|Withdrawal by Subject|5|||
127894507|NCT03349333|460237162|FG000|Overall Study|Conditions interfere with participation|2|||
127894508|NCT03349333|460237162|FG000|Overall Study|Physician Decision|2|||
127814099|NCT00749203|459937984|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
127814100|NCT00749203|459937983|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
127814101|NCT00749203|459937984|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
127894509|NCT03349333|460237162|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
127894510|NCT03349333|460237162|FG000|Overall Study|Patients in treatment less than 24 month|8|||
127814102|NCT02853760|459937986|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
127814103|NCT02853760|459937987|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
127814104|NCT02853760|459937988|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
127814105|NCT02853760|459937989|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
127814106|NCT02853760|459937990|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
127814107|NCT02853760|459937991|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
127814108|NCT01642212|459937992|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
127814109|NCT01642212|459937993|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
127814110|NCT01642212|459937994|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
127814111|NCT01642212|459937995|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
127814112|NCT01642212|459937996|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
127814113|NCT01642212|459937992|FG000|Double-blind Treatment|Other|0|||
127814114|NCT01642212|459937993|FG001|Double-blind Treatment|Other|2|||
127814115|NCT01642212|459937994|FG002|Double-blind Treatment|Other|1|||
127814116|NCT01642212|459937995|FG003|Double-blind Treatment|Other|0|||
127814117|NCT01642212|459937996|FG004|Double-blind Treatment|Other|0|||
127814118|NCT01642212|459937992|FG000|Double-blind Treatment|Non-compliance|0|||
127814119|NCT01642212|459937993|FG001|Double-blind Treatment|Non-compliance|1|||
127814120|NCT01642212|459937994|FG002|Double-blind Treatment|Non-compliance|0|||
127814121|NCT01642212|459937995|FG003|Double-blind Treatment|Non-compliance|0|||
127814122|NCT01642212|459937996|FG004|Double-blind Treatment|Non-compliance|0|||
127814123|NCT01642212|459937992|FG000|Double-blind Treatment|Adverse Event|0|||
127814124|NCT01642212|459937993|FG001|Double-blind Treatment|Adverse Event|0|||
127814125|NCT01642212|459937994|FG002|Double-blind Treatment|Adverse Event|1|||
127814126|NCT01642212|459937995|FG003|Double-blind Treatment|Adverse Event|0|||
127814127|NCT01642212|459937996|FG004|Double-blind Treatment|Adverse Event|0|||
127814128|NCT01642212|459937992|FG000|Open-label Extension|Adverse Event|0|||
127814129|NCT01642212|459937993|FG001|Open-label Extension|Adverse Event|0|||
127814130|NCT01642212|459937994|FG002|Open-label Extension|Adverse Event|0|||
127814131|NCT01642212|459937995|FG003|Open-label Extension|Adverse Event|3|||
127814132|NCT01642212|459937996|FG004|Open-label Extension|Adverse Event|0|||
127814133|NCT01642212|459937992|FG000|Open-label Extension|Sponsor Decision|0|||
127814134|NCT01642212|459937993|FG001|Open-label Extension|Sponsor Decision|0|||
127814135|NCT01642212|459937994|FG002|Open-label Extension|Sponsor Decision|0|||
127814136|NCT01642212|459937995|FG003|Open-label Extension|Sponsor Decision|7|||
127814137|NCT01642212|459937996|FG004|Open-label Extension|Sponsor Decision|4|||
127814138|NCT01642212|459937992|FG000|Open-label Extension|Consent Withdrawn|0|||
127814139|NCT01642212|459937993|FG001|Open-label Extension|Consent Withdrawn|0|||
127814140|NCT01642212|459937994|FG002|Open-label Extension|Consent Withdrawn|0|||
127814141|NCT01642212|459937995|FG003|Open-label Extension|Consent Withdrawn|0|||
127814142|NCT01642212|459937996|FG004|Open-label Extension|Consent Withdrawn|2|||
127814143|NCT01642212|459937992|FG000|Open-label Extension|Lost to Follow-up|0|||
127814144|NCT01642212|459937993|FG001|Open-label Extension|Lost to Follow-up|0|||
127814145|NCT01642212|459937994|FG002|Open-label Extension|Lost to Follow-up|0|||
127894511|NCT00783796|460237163|FG000|Overall Study|Did not receive any stent|4|||
127894512|NCT00783796|460237163|FG000|Overall Study|Received non-XIENCE V stent|1|||
127894513|NCT00783796|460237163|FG000|Overall Study|Received commercial XIENCE V stent|1|||
127894514|NCT03267264|460237165|FG000|Overall Study|Withdrawal by Subject|1|||
127894515|NCT03267264|460237166|FG001|Overall Study|Withdrawal by Subject|0|||
127894516|NCT03267264|460237167|FG002|Overall Study|Withdrawal by Subject|2|||
127894517|NCT03267264|460237168|FG003|Overall Study|Withdrawal by Subject|4|||
127894518|NCT01766921|460237169|FG000|Overall Study|Administrative Reason|5|||
127894519|NCT01766921|460237170|FG001|Overall Study|Administrative Reason|5|||
127894520|NCT01766921|460237169|FG000|Overall Study|Death|1|||
127894521|NCT01766921|460237170|FG001|Overall Study|Death|1|||
127894522|NCT01766921|460237169|FG000|Overall Study|Lost to Follow-up|1|||
127894523|NCT01766921|460237170|FG001|Overall Study|Lost to Follow-up|3|||
127894524|NCT01766921|460237169|FG000|Overall Study|Unclassified|2|||
127894525|NCT01766921|460237170|FG001|Overall Study|Unclassified|2|||
127894526|NCT01766921|460237169|FG000|Overall Study|Protocol Violation|1|||
127894527|NCT01766921|460237170|FG001|Overall Study|Protocol Violation|1|||
127894528|NCT01766921|460237169|FG000|Overall Study|Withdrawal by Subject|14|||
127894529|NCT01766921|460237170|FG001|Overall Study|Withdrawal by Subject|5|||
127894530|NCT01659567|460237173|FG000|Overall Study|Lack of Efficacy|22|||
127894531|NCT01659567|460237173|FG000|Overall Study|Switched to Pegferon|6|||
127894532|NCT01659567|460237173|FG000|Overall Study|Adverse Event|12|||
127814146|NCT01642212|459937995|FG003|Open-label Extension|Lost to Follow-up|0|||
127814147|NCT01642212|459937996|FG004|Open-label Extension|Lost to Follow-up|1|||
127814148|NCT01642212|459937992|FG000|Open-label Extension|Other|0|||
127814149|NCT01642212|459937993|FG001|Open-label Extension|Other|0|||
127814150|NCT01642212|459937994|FG002|Open-label Extension|Other|0|||
127814151|NCT01642212|459937995|FG003|Open-label Extension|Other|0|||
127814152|NCT01642212|459937996|FG004|Open-label Extension|Other|1|||
127814153|NCT01243268|459937997|FG000|Overall Study|Lost to Follow-up|4|||
127814154|NCT01243268|459937997|FG000|Overall Study|Protocol Violation|51|||
127814155|NCT01243268|459937997|FG000|Overall Study|Deviation with contract date|7|||
127814156|NCT01243268|459937997|FG000|Overall Study|Duplicate subject|2|||
127814157|NCT00957853|459937998|FG000|Overall Study|Withdrawal by Subject|1|||
127814158|NCT00957853|459937999|FG001|Overall Study|Withdrawal by Subject|0|||
127814159|NCT00957853|459938000|FG002|Overall Study|Withdrawal by Subject|0|||
127814160|NCT00004980|459938001|FG000|Overall Study|Withdrawal by Subject|1|||
127814161|NCT00004980|459938002|FG001|Overall Study|Withdrawal by Subject|0|||
127814162|NCT00004980|459938001|FG000|Overall Study|memory difficulties|1|||
127814163|NCT00004980|459938002|FG001|Overall Study|memory difficulties|1|||
127814164|NCT00004980|459938001|FG000|Overall Study|Physician Decision|0|||
127814165|NCT00004980|459938002|FG001|Overall Study|Physician Decision|1|||
127814166|NCT00702143|459938003|FG000|Overall Study|Lost to Follow-up|0|||
127814167|NCT00702143|459938004|FG001|Overall Study|Lost to Follow-up|0|||
127814168|NCT00702143|459938005|FG002|Overall Study|Lost to Follow-up|1|||
127814169|NCT03577990|459938006|FG000|Overall Study|Lost to Follow-up|4|||
127814170|NCT03577990|459938007|FG001|Overall Study|Lost to Follow-up|6|||
127814171|NCT03577990|459938006|FG000|Overall Study|Withdrawal by Subject|4|||
127814172|NCT03577990|459938007|FG001|Overall Study|Withdrawal by Subject|7|||
127814173|NCT04996797|459938012|FG000|Overall Study|Adverse Event|0|||
127814174|NCT04996797|459938013|FG001|Overall Study|Adverse Event|2|||
127814175|NCT04996797|459938014|FG002|Overall Study|Adverse Event|0|||
127814176|NCT04996797|459938015|FG003|Overall Study|Adverse Event|1|||
127814177|NCT04996797|459938012|FG000|Overall Study|Lack of Efficacy|0|||
127814178|NCT04996797|459938013|FG001|Overall Study|Lack of Efficacy|2|||
127814179|NCT04996797|459938014|FG002|Overall Study|Lack of Efficacy|0|||
127814180|NCT04996797|459938015|FG003|Overall Study|Lack of Efficacy|0|||
127814181|NCT04996797|459938012|FG000|Overall Study|Prohibited Medication|0|||
127814182|NCT04996797|459938013|FG001|Overall Study|Prohibited Medication|1|||
127814183|NCT04996797|459938014|FG002|Overall Study|Prohibited Medication|0|||
127814184|NCT04996797|459938015|FG003|Overall Study|Prohibited Medication|0|||
127814185|NCT04996797|459938012|FG000|Overall Study|Ongoing|68|||
127814186|NCT04996797|459938013|FG001|Overall Study|Ongoing|60|||
127814187|NCT04996797|459938014|FG002|Overall Study|Ongoing|22|||
127814188|NCT04996797|459938015|FG003|Overall Study|Ongoing|20|||
127814189|NCT04996797|459938012|FG000|Overall Study|Withdrawal by Subject|0|||
127814190|NCT04996797|459938013|FG001|Overall Study|Withdrawal by Subject|2|||
127814191|NCT04996797|459938014|FG002|Overall Study|Withdrawal by Subject|0|||
127814192|NCT04996797|459938015|FG003|Overall Study|Withdrawal by Subject|0|||
127814193|NCT02793544|459938016|FG000|Overall Study|Death|10|||
127814194|NCT02793544|459938017|FG001|Overall Study|Death|8|||
127814195|NCT02793544|459938016|FG000|Overall Study|Lost to Follow-up|2|||
127814196|NCT02793544|459938017|FG001|Overall Study|Lost to Follow-up|0|||
127814197|NCT02793544|459938016|FG000|Overall Study|Withdrawal by Subject|1|||
127814198|NCT02793544|459938017|FG001|Overall Study|Withdrawal by Subject|0|||
127814199|NCT00100048|459938020|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
127814200|NCT00100048|459938021|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
127814201|NCT00100048|459938022|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
127814202|NCT00100048|459938023|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
127814203|NCT00100048|459938024|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
127814204|NCT00100048|459938025|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
127814205|NCT00100048|459938020|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
127814206|NCT00100048|459938021|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
127814207|NCT00100048|459938022|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
127814208|NCT00100048|459938023|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
127814209|NCT00100048|459938024|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
127814210|NCT00100048|459938025|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
127814211|NCT00100048|459938020|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
127814212|NCT00100048|459938021|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
127814213|NCT00100048|459938022|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
127814214|NCT00100048|459938023|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
127814215|NCT00100048|459938024|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
127814216|NCT00100048|459938025|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
127814217|NCT00100048|459938020|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
127814218|NCT00100048|459938021|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
127814219|NCT00100048|459938022|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
127814220|NCT00100048|459938023|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
127814221|NCT00100048|459938024|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
127814222|NCT00100048|459938025|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
127814223|NCT00100048|459938020|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
127814224|NCT00100048|459938021|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
127814225|NCT00100048|459938022|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
127814226|NCT00100048|459938023|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
127814227|NCT00100048|459938024|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
127814228|NCT00100048|459938025|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
127814229|NCT00100048|459938020|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
127814230|NCT00100048|459938021|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
127814231|NCT00100048|459938022|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
127814232|NCT00100048|459938023|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
127814233|NCT00100048|459938024|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
127814234|NCT00100048|459938025|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
127814235|NCT00100048|459938020|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
127814236|NCT00100048|459938021|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
127814237|NCT00100048|459938022|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
127814238|NCT00100048|459938023|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
127814239|NCT00100048|459938024|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
127814240|NCT00100048|459938025|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
127814241|NCT00100048|459938020|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
127814242|NCT00100048|459938021|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
127814243|NCT00100048|459938022|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
127814244|NCT00100048|459938023|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
127814245|NCT00100048|459938024|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
127814246|NCT00100048|459938025|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
127814247|NCT01822561|459938027|FG000|Overall Study|Withdrawal by Subject|2|||
127814248|NCT01624142|459938028|FG000|Overall Study|Withdrawal by Subject|14|||
127814249|NCT01624142|459938029|FG001|Overall Study|Withdrawal by Subject|4|||
127814250|NCT01624142|459938028|FG000|Overall Study|Death|3|||
127814251|NCT01624142|459938029|FG001|Overall Study|Death|6|||
127814252|NCT01624142|459938028|FG000|Overall Study|Study Closure|12|||
127814253|NCT01624142|459938029|FG001|Overall Study|Study Closure|6|||
127814254|NCT01624142|459938028|FG000|Overall Study|Lost to Follow-up|2|||
127814255|NCT01624142|459938029|FG001|Overall Study|Lost to Follow-up|0|||
127814256|NCT01624142|459938028|FG000|Overall Study|Other|1|||
127814257|NCT01624142|459938029|FG001|Overall Study|Other|0|||
127814258|NCT04826900|459938032|FG000|Overall Study|Family factor|1|||
127814259|NCT04826900|459938033|FG001|Overall Study|Family factor|1|||
127814260|NCT03372941|459938034|FG000|Overall Study|Lost to Follow-up|2|||
127814261|NCT03372941|459938035|FG001|Overall Study|Lost to Follow-up|4|||
127814262|NCT00741819|459938036|FG000|Overall Study|Adverse Event|3|||
127814263|NCT00741819|459938036|FG000|Overall Study|Withdrawal by Subject|3|||
127814264|NCT00741819|459938036|FG000|Overall Study|Death|1|||
127814265|NCT00741819|459938036|FG000|Overall Study|Disease progression|1|||
127814266|NCT01126580|459938037|FG000|Overall Study|Adverse Event|14|||
127814267|NCT01126580|459938038|FG001|Overall Study|Adverse Event|8|||
127814268|NCT01126580|459938039|FG002|Overall Study|Adverse Event|12|||
127814269|NCT01126580|459938037|FG000|Overall Study|Withdrawal by Subject|11|||
127814270|NCT01126580|459938038|FG001|Overall Study|Withdrawal by Subject|19|||
127814271|NCT01126580|459938039|FG002|Overall Study|Withdrawal by Subject|14|||
127814272|NCT01126580|459938037|FG000|Overall Study|Sponsor Decision|5|||
127814273|NCT01126580|459938038|FG001|Overall Study|Sponsor Decision|4|||
127814274|NCT01126580|459938039|FG002|Overall Study|Sponsor Decision|7|||
127814275|NCT01126580|459938037|FG000|Overall Study|Physician Decision|1|||
127814276|NCT01126580|459938038|FG001|Overall Study|Physician Decision|1|||
127814277|NCT01126580|459938039|FG002|Overall Study|Physician Decision|2|||
127814278|NCT01126580|459938037|FG000|Overall Study|Entry Criteria Not Met|1|||
127814279|NCT01126580|459938038|FG001|Overall Study|Entry Criteria Not Met|1|||
127814280|NCT01126580|459938039|FG002|Overall Study|Entry Criteria Not Met|2|||
127814281|NCT01126580|459938037|FG000|Overall Study|Lack of Efficacy|2|||
127814282|NCT01126580|459938038|FG001|Overall Study|Lack of Efficacy|3|||
127814283|NCT01126580|459938039|FG002|Overall Study|Lack of Efficacy|4|||
127814284|NCT01126580|459938037|FG000|Overall Study|Protocol Violation|0|||
127814285|NCT01126580|459938038|FG001|Overall Study|Protocol Violation|1|||
127814286|NCT01126580|459938039|FG002|Overall Study|Protocol Violation|2|||
127814287|NCT01126580|459938037|FG000|Overall Study|Lost to Follow-up|15|||
127814288|NCT01126580|459938038|FG001|Overall Study|Lost to Follow-up|13|||
127814289|NCT01126580|459938039|FG002|Overall Study|Lost to Follow-up|9|||
127814290|NCT01126580|459938037|FG000|Overall Study|Treatment Non-compliance|0|||
127814291|NCT01126580|459938038|FG001|Overall Study|Treatment Non-compliance|2|||
127814292|NCT01126580|459938039|FG002|Overall Study|Treatment Non-compliance|3|||
127814293|NCT00686543|459938040|FG000|Overall Study|Adverse Event|9|||
127814294|NCT00686543|459938041|FG001|Overall Study|Adverse Event|1|||
127814295|NCT00686543|459938042|FG002|Overall Study|Adverse Event|3|||
127814296|NCT00686543|459938043|FG003|Overall Study|Adverse Event|2|||
127814297|NCT00686543|459938040|FG000|Overall Study|Withdrawal by Subject|2|||
127814298|NCT00686543|459938041|FG001|Overall Study|Withdrawal by Subject|0|||
127814299|NCT00686543|459938042|FG002|Overall Study|Withdrawal by Subject|0|||
127814300|NCT00686543|459938043|FG003|Overall Study|Withdrawal by Subject|0|||
127814301|NCT00686543|459938040|FG000|Overall Study|Protocol Violation|3|||
127814302|NCT00686543|459938041|FG001|Overall Study|Protocol Violation|0|||
127814303|NCT00686543|459938042|FG002|Overall Study|Protocol Violation|2|||
127814304|NCT00686543|459938043|FG003|Overall Study|Protocol Violation|1|||
127814305|NCT00609622|459938044|FG000|Overall Study|Adverse Event|14|||
127814306|NCT00609622|459938045|FG001|Overall Study|Adverse Event|10|||
127814307|NCT00609622|459938044|FG000|Overall Study|Withdrawal by Subject|4|||
127814308|NCT00609622|459938045|FG001|Overall Study|Withdrawal by Subject|20|||
127814309|NCT00609622|459938044|FG000|Overall Study|Death|1|||
127814310|NCT00609622|459938045|FG001|Overall Study|Death|4|||
127814311|NCT00609622|459938044|FG000|Overall Study|Protocol Violation|1|||
127814312|NCT00609622|459938045|FG001|Overall Study|Protocol Violation|1|||
127814313|NCT00609622|459938044|FG000|Overall Study|Objective progression or relapse|47|||
127814314|NCT00609622|459938045|FG001|Overall Study|Objective progression or relapse|41|||
127814315|NCT00609622|459938044|FG000|Overall Study|Study terminated by sponsor|16|||
127814316|NCT00609622|459938045|FG001|Overall Study|Study terminated by sponsor|3|||
127814317|NCT00609622|459938044|FG000|Overall Study|Other|7|||
127814318|NCT00609622|459938045|FG001|Overall Study|Other|14|||
127814319|NCT00609622|459938044|FG000|Overall Study|Global deterioration of health status|6|||
127814320|NCT00609622|459938045|FG001|Overall Study|Global deterioration of health status|2|||
127814321|NCT01708057|459938049|FG000|Overall Study|Withdrawal due to study termination.|1|||
127814322|NCT01708057|459938050|FG001|Overall Study|Withdrawal due to study termination.|1|||
127814323|NCT01708057|459938051|FG002|Overall Study|Withdrawal due to study termination.|1|||
127814324|NCT00947349|459938054|FG000|Triple Treatment Combination Period|Adverse Event|0|||
127814325|NCT00947349|459938055|FG001|Triple Treatment Combination Period|Adverse Event|1|||
127814326|NCT00947349|459938056|FG002|Triple Treatment Combination Period|Adverse Event|0|||
127814327|NCT00947349|459938057|FG003|Triple Treatment Combination Period|Adverse Event|0|||
127814328|NCT00947349|459938054|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
127814329|NCT00947349|459938055|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
127814330|NCT00947349|459938056|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
127814331|NCT00947349|459938057|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
127814332|NCT00947349|459938054|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
127814333|NCT00947349|459938055|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
127814334|NCT00947349|459938056|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
127814335|NCT00947349|459938057|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
127814336|NCT00947349|459938054|FG000|Overall Study Standard of Care|Other|0|||
127814337|NCT00947349|459938055|FG001|Overall Study Standard of Care|Other|0|||
127814338|NCT00947349|459938056|FG002|Overall Study Standard of Care|Other|0|||
127814339|NCT00947349|459938057|FG003|Overall Study Standard of Care|Other|1|||
127814340|NCT00538681|459938058|FG000|Overall Study|Progressive Disease|7|||
127814341|NCT00538681|459938059|FG001|Overall Study|Progressive Disease|0|||
127814342|NCT00538681|459938060|FG002|Overall Study|Progressive Disease|1|||
127814343|NCT00538681|459938061|FG003|Overall Study|Progressive Disease|0|||
127814344|NCT00538681|459938058|FG000|Overall Study|Sponsor Decision|1|||
127814345|NCT00538681|459938059|FG001|Overall Study|Sponsor Decision|3|||
127814346|NCT00538681|459938060|FG002|Overall Study|Sponsor Decision|8|||
127814347|NCT00538681|459938061|FG003|Overall Study|Sponsor Decision|9|||
127814348|NCT00538681|459938058|FG000|Overall Study|Adverse Event|1|||
127814349|NCT00538681|459938059|FG001|Overall Study|Adverse Event|1|||
127814350|NCT00538681|459938060|FG002|Overall Study|Adverse Event|1|||
127814351|NCT00538681|459938061|FG003|Overall Study|Adverse Event|0|||
127814352|NCT00538681|459938058|FG000|Overall Study|Death|0|||
127814353|NCT00538681|459938059|FG001|Overall Study|Death|0|||
127814354|NCT00538681|459938060|FG002|Overall Study|Death|1|||
127814355|NCT00538681|459938061|FG003|Overall Study|Death|1|||
127814356|NCT00538681|459938058|FG000|Overall Study|Investigator Decision|0|||
127814357|NCT00538681|459938059|FG001|Overall Study|Investigator Decision|0|||
127814358|NCT00538681|459938060|FG002|Overall Study|Investigator Decision|0|||
127814359|NCT00538681|459938061|FG003|Overall Study|Investigator Decision|1|||
127814360|NCT02970929|459938062|FG000|Overall Study|Adverse Event|18|||
127814361|NCT02970929|459938062|FG000|Overall Study|Lack of Efficacy|8|||
127814362|NCT02970929|459938062|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
127814363|NCT02970929|459938062|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
127814364|NCT02970929|459938062|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
127814365|NCT02970929|459938062|FG000|Overall Study|LOST TO FOLLOWUP|6|||
127814366|NCT02970929|459938062|FG000|Overall Study|MOVED OUT OF STATE|1|||
127814367|NCT02970929|459938062|FG000|Overall Study|Withdrawal by Subject|16|||
127814368|NCT03929250|459938071|FG000|Overall Study|Blood draws could not be successfully obtained|0|||
127814369|NCT03929250|459938072|FG001|Overall Study|Blood draws could not be successfully obtained|1|||
127814370|NCT04321343|459938077|FG000|Overall Study|Adverse Event|0|||
127814371|NCT04321343|459938078|FG001|Overall Study|Adverse Event|0|||
127814372|NCT04321343|459938079|FG002|Overall Study|Adverse Event|1|||
127814373|NCT04321343|459938080|FG003|Overall Study|Adverse Event|0|||
127814374|NCT04321343|459938077|FG000|Overall Study|Death|0|||
127814375|NCT04321343|459938078|FG001|Overall Study|Death|0|||
127814376|NCT04321343|459938079|FG002|Overall Study|Death|0|||
127814377|NCT04321343|459938080|FG003|Overall Study|Death|1|||
127814378|NCT04321343|459938077|FG000|Overall Study|Pregnancy|1|||
127814379|NCT04321343|459938078|FG001|Overall Study|Pregnancy|0|||
127814380|NCT04321343|459938079|FG002|Overall Study|Pregnancy|0|||
127814381|NCT04321343|459938080|FG003|Overall Study|Pregnancy|0|||
127814382|NCT04321343|459938077|FG000|Overall Study|Protocol Violation|1|||
127814383|NCT04321343|459938078|FG001|Overall Study|Protocol Violation|1|||
127814384|NCT04321343|459938079|FG002|Overall Study|Protocol Violation|1|||
127814385|NCT04321343|459938080|FG003|Overall Study|Protocol Violation|1|||
127814386|NCT04321343|459938077|FG000|Overall Study|Withdrawal by Subject|0|||
127814387|NCT04321343|459938078|FG001|Overall Study|Withdrawal by Subject|6|||
127814388|NCT04321343|459938079|FG002|Overall Study|Withdrawal by Subject|0|||
127814389|NCT04321343|459938080|FG003|Overall Study|Withdrawal by Subject|2|||
127814390|NCT04321343|459938077|FG000|Overall Study|Lost to Follow-up|2|||
127814391|NCT04321343|459938078|FG001|Overall Study|Lost to Follow-up|2|||
127814392|NCT04321343|459938079|FG002|Overall Study|Lost to Follow-up|1|||
127814393|NCT04321343|459938080|FG003|Overall Study|Lost to Follow-up|3|||
127814394|NCT04194944|459938081|FG000|Overall Study|Lost to Follow-up|3|||
127814395|NCT04194944|459938082|FG001|Overall Study|Lost to Follow-up|0|||
127814396|NCT04194944|459938081|FG000|Overall Study|Withdrawal by Subject|2|||
127814397|NCT04194944|459938082|FG001|Overall Study|Withdrawal by Subject|2|||
127814398|NCT04194944|459938081|FG000|Overall Study|On Treatment|93|||
127814399|NCT04194944|459938082|FG001|Overall Study|On Treatment|30|||
127868816|NCT01072175|460137390|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
127868817|NCT01072175|460137391|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
127868818|NCT01072175|460137392|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
127868819|NCT01072175|460137393|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
127868820|NCT01072175|460137394|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
127868821|NCT01072175|460137395|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
127868822|NCT01072175|460137383|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
127868823|NCT01072175|460137384|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
127868824|NCT01072175|460137385|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
127868825|NCT01072175|460137386|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
127868826|NCT01072175|460137387|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
127868827|NCT01072175|460137388|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
127868828|NCT01072175|460137389|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
127868829|NCT01072175|460137390|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
127868830|NCT01072175|460137391|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
127868831|NCT01072175|460137392|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
127868832|NCT01072175|460137393|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
127868833|NCT01072175|460137394|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
127868834|NCT01072175|460137395|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
127868835|NCT00682539|460137396|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
127868836|NCT00682539|460137397|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
127868837|NCT00682539|460137398|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
127868838|NCT00682539|460137396|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
127868839|NCT00682539|460137397|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
127868840|NCT00682539|460137398|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
127868841|NCT02477215|460137401|FG000|Dose Escalation Phase|Physician Decision|1|||
127868842|NCT02477215|460137402|FG001|Dose Escalation Phase|Physician Decision|2|||
127868843|NCT02477215|460137403|FG002|Dose Escalation Phase|Physician Decision|0|||
127868844|NCT02477215|460137401|FG000|Fixed Dose Phase|Physician Decision|0|||
127868845|NCT02477215|460137402|FG001|Fixed Dose Phase|Physician Decision|7|||
127868846|NCT02477215|460137403|FG002|Fixed Dose Phase|Physician Decision|0|||
127868847|NCT01911546|460137406|FG000|Overall Study|Lost to Follow-up|1|||
127868848|NCT01911546|460137406|FG000|Overall Study|Everolimus was discontinued|5|||
127814400|NCT00473694|459939487|FG000|Overall Study|Adverse Event|0|||
127814401|NCT00473694|459939488|FG001|Overall Study|Adverse Event|1|||
127814402|NCT00473694|459939489|FG002|Overall Study|Adverse Event|0|||
127814403|NCT00473694|459939490|FG003|Overall Study|Adverse Event|0|||
127814404|NCT00473694|459939487|FG000|Overall Study|Participants did not receive treatment|11|||
127814405|NCT00473694|459939488|FG001|Overall Study|Participants did not receive treatment|3|||
127814406|NCT00473694|459939489|FG002|Overall Study|Participants did not receive treatment|5|||
127814407|NCT00473694|459939490|FG003|Overall Study|Participants did not receive treatment|6|||
127814408|NCT00473694|459939487|FG000|Overall Study|Lost to Follow-up|0|||
127814409|NCT00473694|459939488|FG001|Overall Study|Lost to Follow-up|0|||
127814410|NCT00473694|459939489|FG002|Overall Study|Lost to Follow-up|0|||
127814411|NCT00473694|459939490|FG003|Overall Study|Lost to Follow-up|1|||
127814412|NCT03874234|459939498|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
127814413|NCT03874234|459939499|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
127814414|NCT03874234|459939500|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
127814415|NCT03874234|459939501|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
127814416|NCT03874234|459939502|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
127814417|NCT03874234|459939503|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
127814418|NCT03874234|459939504|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
127814419|NCT03874234|459939505|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
127814420|NCT03874234|459939506|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
127814421|NCT03874234|459939507|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
127814422|NCT03874234|459939508|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
127814423|NCT03874234|459939509|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
127814424|NCT03874234|459939510|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
127814425|NCT03874234|459939498|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
127814426|NCT03874234|459939499|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
127814427|NCT03874234|459939500|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
127814428|NCT03874234|459939501|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
127814429|NCT03874234|459939502|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
127814430|NCT03874234|459939503|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
127814431|NCT03874234|459939504|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
127814432|NCT03874234|459939505|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
127814433|NCT03874234|459939506|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
127814434|NCT03874234|459939507|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
127814435|NCT03874234|459939508|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
127814436|NCT03874234|459939509|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
127814437|NCT03874234|459939510|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
127814438|NCT03874234|459939498|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
127814439|NCT03874234|459939499|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
127814440|NCT03874234|459939500|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
127814441|NCT03874234|459939501|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
127814442|NCT03874234|459939502|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
127814443|NCT03874234|459939503|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
127814444|NCT03874234|459939504|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
127814445|NCT03874234|459939505|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
127814446|NCT03874234|459939506|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
127814447|NCT03874234|459939507|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
127814448|NCT03874234|459939508|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
127814449|NCT03874234|459939509|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
127814450|NCT03874234|459939510|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
127814451|NCT03874234|459939498|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
127814452|NCT03874234|459939499|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
127814453|NCT03874234|459939500|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
127814454|NCT03874234|459939501|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
127814455|NCT03874234|459939502|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
127814456|NCT03874234|459939503|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
127814457|NCT03874234|459939504|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
127814458|NCT03874234|459939505|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
127814459|NCT03874234|459939506|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
127814460|NCT03874234|459939507|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
127814461|NCT03874234|459939508|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
127814462|NCT03874234|459939509|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
127814463|NCT03874234|459939510|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
127814464|NCT03874234|459939498|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
127814465|NCT03874234|459939499|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
127814466|NCT03874234|459939500|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
127814467|NCT03874234|459939501|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
127814468|NCT03874234|459939502|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
127814469|NCT03874234|459939503|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
127814470|NCT03874234|459939504|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
127814471|NCT03874234|459939505|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
127814472|NCT03874234|459939506|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
127814473|NCT03874234|459939507|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
127814474|NCT03874234|459939508|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
127814475|NCT03874234|459939509|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
127814476|NCT03874234|459939510|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
127814477|NCT03874234|459939498|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
127814478|NCT03874234|459939499|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
127814479|NCT03874234|459939500|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
127814480|NCT03874234|459939501|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
127814481|NCT03874234|459939502|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
127814482|NCT03874234|459939503|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
127814483|NCT03874234|459939504|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
127814484|NCT03874234|459939505|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
127814485|NCT03874234|459939506|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
127814486|NCT03874234|459939507|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
127814487|NCT03874234|459939508|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
127814488|NCT03874234|459939509|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
127814489|NCT03874234|459939510|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
127814490|NCT03874234|459939498|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
127814491|NCT03874234|459939499|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
127814492|NCT03874234|459939500|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
127814493|NCT03874234|459939501|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
127814494|NCT03874234|459939502|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
127814495|NCT03874234|459939503|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
127814496|NCT03874234|459939504|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
127814497|NCT03874234|459939505|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
127814498|NCT03874234|459939506|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
127814499|NCT03874234|459939507|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
127814500|NCT03874234|459939508|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
127814501|NCT03874234|459939509|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
127814502|NCT03874234|459939510|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
127814503|NCT03874234|459939498|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
127814504|NCT03874234|459939499|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
127814505|NCT03874234|459939500|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
127814506|NCT03874234|459939501|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
127814507|NCT03874234|459939502|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
127814508|NCT03874234|459939503|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
127814509|NCT03874234|459939504|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
127814510|NCT03874234|459939505|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
127814511|NCT03874234|459939506|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
127814512|NCT03874234|459939507|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
127814513|NCT03874234|459939508|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
127814514|NCT03874234|459939509|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
127814515|NCT03874234|459939510|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
127814516|NCT00783289|459939511|FG000|Overall Study|Protocol Violation|0|||
127814517|NCT00783289|459939512|FG001|Overall Study|Protocol Violation|1|||
127814518|NCT00783289|459939513|FG002|Overall Study|Protocol Violation|0|||
127814519|NCT00783289|459939514|FG003|Overall Study|Protocol Violation|0|||
127814520|NCT00506389|459939515|FG000|In-treatment Period|Other|3|||
127814521|NCT00506389|459939516|FG001|In-treatment Period|Other|3|||
127814522|NCT00506389|459939517|FG002|In-treatment Period|Other|4|||
127814523|NCT00506389|459939515|FG000|In-treatment Period|Lost to Follow-up|0|||
127814524|NCT00506389|459939516|FG001|In-treatment Period|Lost to Follow-up|0|||
127814525|NCT00506389|459939517|FG002|In-treatment Period|Lost to Follow-up|1|||
127814526|NCT00506389|459939515|FG000|In-treatment Period|Lack of compliance|1|||
127814527|NCT00506389|459939516|FG001|In-treatment Period|Lack of compliance|0|||
127814528|NCT00506389|459939517|FG002|In-treatment Period|Lack of compliance|0|||
127814529|NCT00506389|459939515|FG000|In-treatment Period|Reasons not related to trial|4|||
127814530|NCT00506389|459939516|FG001|In-treatment Period|Reasons not related to trial|1|||
127814531|NCT00506389|459939517|FG002|In-treatment Period|Reasons not related to trial|0|||
127814532|NCT00506389|459939515|FG000|In-treatment Period|Withdrawal by Subject|3|||
127814533|NCT00506389|459939516|FG001|In-treatment Period|Withdrawal by Subject|3|||
127814534|NCT00506389|459939517|FG002|In-treatment Period|Withdrawal by Subject|4|||
127814535|NCT00506389|459939515|FG000|In-treatment Period|Lack of Efficacy|0|||
127814536|NCT00506389|459939516|FG001|In-treatment Period|Lack of Efficacy|2|||
127814537|NCT00506389|459939517|FG002|In-treatment Period|Lack of Efficacy|0|||
127814538|NCT00506389|459939515|FG000|In-treatment Period|Adverse Event|11|||
127814539|NCT00506389|459939516|FG001|In-treatment Period|Adverse Event|5|||
127814540|NCT00506389|459939517|FG002|In-treatment Period|Adverse Event|2|||
127814541|NCT00506389|459939515|FG000|In-treatment Period|Randomized but not treated|4|||
127814542|NCT00506389|459939516|FG001|In-treatment Period|Randomized but not treated|1|||
127814543|NCT00506389|459939517|FG002|In-treatment Period|Randomized but not treated|1|||
127814544|NCT05224258|459939518|FG000|Overall Study|Withdrawal by Subject|1|||
127814545|NCT05224258|459939519|FG001|Overall Study|Withdrawal by Subject|1|||
127814546|NCT05224258|459939518|FG000|Overall Study|Physician Decision|1|||
127814547|NCT05224258|459939519|FG001|Overall Study|Physician Decision|1|||
127814548|NCT05224258|459939518|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
127814549|NCT05224258|459939519|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
127814550|NCT05224258|459939518|FG000|Overall Study|Study Product No Longer in Use|1|||
127814551|NCT05224258|459939519|FG001|Overall Study|Study Product No Longer in Use|0|||
127814552|NCT05224258|459939518|FG000|Overall Study|Adverse Event|0|||
127814553|NCT05224258|459939519|FG001|Overall Study|Adverse Event|1|||
127814554|NCT05224258|459939518|FG000|Overall Study|Protocol Deviation|0|||
127814555|NCT05224258|459939519|FG001|Overall Study|Protocol Deviation|1|||
127814556|NCT03812510|459939536|FG000|Overall Study|Lost to Follow-up|39|||
127814557|NCT03812510|459939536|FG000|Overall Study|Withdrawal by Subject|42|||
127814558|NCT03812510|459939536|FG000|Overall Study|Physician Decision|2|||
127814559|NCT03812510|459939536|FG000|Overall Study|Study Terminated by Sponsor|9|||
127814560|NCT03812510|459939536|FG000|Overall Study|Did Not Start Study Medication|55|||
127814561|NCT03812510|459939536|FG000|Overall Study|Adverse Event|5|||
127814562|NCT00768560|459939537|FG000|Intervention Set 1|Adverse Event|0|||
127814563|NCT00768560|459939538|FG001|Intervention Set 1|Adverse Event|1|||
127814564|NCT00768560|459939539|FG002|Intervention Set 1|Adverse Event|0|||
127814565|NCT00768560|459939540|FG003|Intervention Set 1|Adverse Event|0|||
127814566|NCT00768560|459939541|FG004|Intervention Set 1|Adverse Event|0|||
127814567|NCT00768560|459939542|FG005|Intervention Set 1|Adverse Event|0|||
127894533|NCT01659567|460237173|FG000|Overall Study|Good result at early stage of treatment|5|||
127814604|NCT01120626|459939547|FG000|Overall Study|Withdrawal by Subject|1|||
127814605|NCT01120626|459939548|FG001|Overall Study|Withdrawal by Subject|0|||
127814606|NCT01128387|459939549|FG000|Overall Study|Physician Decision|0|||
127814607|NCT01128387|459939550|FG001|Overall Study|Physician Decision|1|||
127814608|NCT02635204|459939551|FG000|Overall Study|Adverse Event|1|||
127814609|NCT02635204|459939552|FG001|Overall Study|Adverse Event|0|||
127814610|NCT02635204|459939551|FG000|Overall Study|Lost to Follow-up|1|||
127814611|NCT02635204|459939552|FG001|Overall Study|Lost to Follow-up|1|||
127814612|NCT01535235|459939553|FG000|Overall Study|Adverse Event|1|||
127814613|NCT01535235|459939554|FG001|Overall Study|Adverse Event|0|||
127814614|NCT00858832|459939556|FG000|Overall Study|became ineligible: delivered vaginally|1|||
127814615|NCT00858832|459939557|FG001|Overall Study|became ineligible: delivered vaginally|0|||
127814616|NCT00858832|459939556|FG000|Overall Study|Adverse Event|0|||
127814617|NCT00858832|459939557|FG001|Overall Study|Adverse Event|1|||
127814618|NCT00389207|459939558|FG000|Overall Study|Adverse Event|26|||
127814619|NCT00389207|459939559|FG001|Overall Study|Adverse Event|32|||
127814620|NCT00389207|459939560|FG002|Overall Study|Adverse Event|10|||
127814621|NCT00389207|459939558|FG000|Overall Study|Protocol Violation|3|||
127814622|NCT00389207|459939559|FG001|Overall Study|Protocol Violation|1|||
127814623|NCT00389207|459939560|FG002|Overall Study|Protocol Violation|4|||
127814624|NCT00389207|459939558|FG000|Overall Study|Lost to Follow-up|12|||
127814625|NCT00389207|459939559|FG001|Overall Study|Lost to Follow-up|9|||
127814626|NCT00389207|459939560|FG002|Overall Study|Lost to Follow-up|7|||
127814627|NCT00389207|459939558|FG000|Overall Study|Withdrawal by Subject|5|||
127814628|NCT00389207|459939559|FG001|Overall Study|Withdrawal by Subject|7|||
127814629|NCT00389207|459939560|FG002|Overall Study|Withdrawal by Subject|11|||
127814630|NCT00389207|459939558|FG000|Overall Study|Other|17|||
127814631|NCT00389207|459939559|FG001|Overall Study|Other|23|||
127814632|NCT00389207|459939560|FG002|Overall Study|Other|9|||
127814633|NCT01794780|459939565|FG000|Overall Study|Adverse Event|0|||
127814634|NCT01794780|459939566|FG001|Overall Study|Adverse Event|1|||
127814635|NCT01794780|459939567|FG002|Overall Study|Adverse Event|2|||
127814636|NCT01794780|459939568|FG003|Overall Study|Adverse Event|0|||
127814637|NCT01794780|459939569|FG004|Overall Study|Adverse Event|0|||
127814638|NCT01794780|459939570|FG005|Overall Study|Adverse Event|0|||
127814639|NCT01794780|459939571|FG006|Overall Study|Adverse Event|0|||
127814640|NCT01794780|459939572|FG007|Overall Study|Adverse Event|0|||
127814641|NCT01794780|459939565|FG000|Overall Study|Death|0|||
127814642|NCT01794780|459939566|FG001|Overall Study|Death|2|||
127814643|NCT01794780|459939567|FG002|Overall Study|Death|14|||
127814644|NCT01794780|459939568|FG003|Overall Study|Death|1|||
127814645|NCT01794780|459939569|FG004|Overall Study|Death|0|||
127814646|NCT01794780|459939570|FG005|Overall Study|Death|9|||
127814647|NCT01794780|459939571|FG006|Overall Study|Death|4|||
127814648|NCT01794780|459939572|FG007|Overall Study|Death|0|||
127814649|NCT01794780|459939565|FG000|Overall Study|Lost to Follow-up|10|||
127814650|NCT01794780|459939566|FG001|Overall Study|Lost to Follow-up|64|||
127814651|NCT01794780|459939567|FG002|Overall Study|Lost to Follow-up|165|||
127814652|NCT01794780|459939568|FG003|Overall Study|Lost to Follow-up|53|||
127814653|NCT01794780|459939569|FG004|Overall Study|Lost to Follow-up|2|||
127814654|NCT01794780|459939570|FG005|Overall Study|Lost to Follow-up|99|||
127814655|NCT01794780|459939571|FG006|Overall Study|Lost to Follow-up|30|||
127814656|NCT01794780|459939572|FG007|Overall Study|Lost to Follow-up|5|||
127814657|NCT01794780|459939565|FG000|Overall Study|Withdrew informed consent|7|||
127814658|NCT01794780|459939566|FG001|Overall Study|Withdrew informed consent|17|||
127814659|NCT01794780|459939567|FG002|Overall Study|Withdrew informed consent|36|||
127814660|NCT01794780|459939568|FG003|Overall Study|Withdrew informed consent|9|||
127814661|NCT01794780|459939569|FG004|Overall Study|Withdrew informed consent|0|||
127814662|NCT01794780|459939570|FG005|Overall Study|Withdrew informed consent|48|||
127814663|NCT01794780|459939571|FG006|Overall Study|Withdrew informed consent|4|||
127814664|NCT01794780|459939572|FG007|Overall Study|Withdrew informed consent|3|||
127814665|NCT01794780|459939565|FG000|Overall Study|Other|0|||
127814666|NCT01794780|459939566|FG001|Overall Study|Other|12|||
127814667|NCT01794780|459939567|FG002|Overall Study|Other|25|||
127814668|NCT01794780|459939568|FG003|Overall Study|Other|20|||
127814669|NCT01794780|459939569|FG004|Overall Study|Other|1|||
127814670|NCT01794780|459939570|FG005|Overall Study|Other|24|||
127814671|NCT01794780|459939571|FG006|Overall Study|Other|4|||
127814672|NCT01794780|459939572|FG007|Overall Study|Other|1|||
127814673|NCT02286102|459939573|FG000|Overall Study|Screen Failure|1|||
127814674|NCT02286102|459939574|FG001|Overall Study|Screen Failure|1|||
127814675|NCT03293680|459939576|FG000|Overall Study|Death|1|||
127814676|NCT03293680|459939576|FG000|Overall Study|Did not meet inclusion criteria|8|||
127814677|NCT02201940|459939577|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
127814678|NCT02201940|459939578|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
127814679|NCT02201940|459939577|FG000|Overall Study|Lack of Efficacy|2|||
127814680|NCT02201940|459939578|FG001|Overall Study|Lack of Efficacy|113|||
127814681|NCT02201940|459939577|FG000|Overall Study|Lost to Follow-up|5|||
127814682|NCT02201940|459939578|FG001|Overall Study|Lost to Follow-up|0|||
127814683|NCT02201940|459939577|FG000|Overall Study|Withdrew Consent|2|||
127814684|NCT02201940|459939578|FG001|Overall Study|Withdrew Consent|1|||
127814685|NCT02201940|459939577|FG000|Overall Study|Investigator's Discretion|1|||
127814686|NCT02201940|459939578|FG001|Overall Study|Investigator's Discretion|1|||
127814687|NCT02201940|459939577|FG000|Overall Study|Death|1|||
127814688|NCT02201940|459939578|FG001|Overall Study|Death|0|||
127814689|NCT02201940|459939577|FG000|Overall Study|Adverse Event|0|||
127814690|NCT02201940|459939578|FG001|Overall Study|Adverse Event|1|||
127814691|NCT03192904|459939579|FG000|Overall Study|Physician Decision|3|||
127814692|NCT03192904|459939580|FG001|Overall Study|Physician Decision|1|||
127814693|NCT03192904|459939579|FG000|Overall Study|Lost to Follow-up|0|||
127814694|NCT03192904|459939580|FG001|Overall Study|Lost to Follow-up|1|||
127814695|NCT02690701|459939583|FG000|Treatment Period 1|Adverse Event|2|||
127814696|NCT02690701|459939584|FG001|Treatment Period 1|Adverse Event|2|||
127814697|NCT02690701|459939583|FG000|Treatment Period 1|Withdrawal by Subject|0|||
127814698|NCT02690701|459939584|FG001|Treatment Period 1|Withdrawal by Subject|1|||
127814699|NCT02690701|459939583|FG000|Treatment Period 2|Adverse Event|2|||
127814700|NCT02690701|459939584|FG001|Treatment Period 2|Adverse Event|0|||
127814701|NCT02690701|459939583|FG000|Treatment Period 2|Lack of Efficacy|1|||
127814702|NCT02690701|459939584|FG001|Treatment Period 2|Lack of Efficacy|0|||
127814703|NCT02690701|459939583|FG000|Treatment Period 2|Lost to Follow-up|0|||
127814704|NCT02690701|459939584|FG001|Treatment Period 2|Lost to Follow-up|2|||
127814705|NCT02690701|459939583|FG000|Treatment Period 2|Withdrawal by Subject|0|||
127814706|NCT02690701|459939584|FG001|Treatment Period 2|Withdrawal by Subject|2|||
127814707|NCT02690701|459939583|FG000|Treatment Period 2|Protocol Violation|0|||
127814708|NCT02690701|459939584|FG001|Treatment Period 2|Protocol Violation|1|||
127814709|NCT01309737|459939585|FG000|Week 0 to 16|Death|1|||
127814710|NCT01309737|459939586|FG001|Week 0 to 16|Death|0|||
127814711|NCT01309737|459939587|FG002|Week 0 to 16|Death|1|||
127814712|NCT01309737|459939588|FG003|Week 0 to 16|Death|0|||
127814713|NCT01309737|459939589|FG004|Week 0 to 16|Death|0|||
127814714|NCT01309737|459939585|FG000|Week 0 to 16|Adverse Event|11|||
127814715|NCT01309737|459939586|FG001|Week 0 to 16|Adverse Event|10|||
127814716|NCT01309737|459939587|FG002|Week 0 to 16|Adverse Event|5|||
127814717|NCT01309737|459939588|FG003|Week 0 to 16|Adverse Event|0|||
127814718|NCT01309737|459939589|FG004|Week 0 to 16|Adverse Event|0|||
127814719|NCT01309737|459939585|FG000|Week 0 to 16|Lack of Efficacy|15|||
127814720|NCT01309737|459939586|FG001|Week 0 to 16|Lack of Efficacy|2|||
127814721|NCT01309737|459939587|FG002|Week 0 to 16|Lack of Efficacy|24|||
127814722|NCT01309737|459939588|FG003|Week 0 to 16|Lack of Efficacy|0|||
127814723|NCT01309737|459939589|FG004|Week 0 to 16|Lack of Efficacy|0|||
127814724|NCT01309737|459939585|FG000|Week 0 to 16|Lost to Follow-up|7|||
127814725|NCT01309737|459939586|FG001|Week 0 to 16|Lost to Follow-up|8|||
127814726|NCT01309737|459939587|FG002|Week 0 to 16|Lost to Follow-up|3|||
127814727|NCT01309737|459939588|FG003|Week 0 to 16|Lost to Follow-up|0|||
127814728|NCT01309737|459939589|FG004|Week 0 to 16|Lost to Follow-up|0|||
127814729|NCT01309737|459939585|FG000|Week 0 to 16|Withdrawal by Subject|7|||
127814730|NCT01309737|459939586|FG001|Week 0 to 16|Withdrawal by Subject|6|||
127814731|NCT01309737|459939587|FG002|Week 0 to 16|Withdrawal by Subject|7|||
127814732|NCT01309737|459939588|FG003|Week 0 to 16|Withdrawal by Subject|0|||
127814733|NCT01309737|459939589|FG004|Week 0 to 16|Withdrawal by Subject|0|||
127814734|NCT01309737|459939585|FG000|Week 0 to 16|Other|10|||
127814735|NCT01309737|459939586|FG001|Week 0 to 16|Other|14|||
127814736|NCT01309737|459939587|FG002|Week 0 to 16|Other|4|||
127814737|NCT01309737|459939588|FG003|Week 0 to 16|Other|0|||
127814738|NCT01309737|459939589|FG004|Week 0 to 16|Other|0|||
127814739|NCT01309737|459939585|FG000|Week 0 to 16|Randomized, but not treated|1|||
127814740|NCT01309737|459939586|FG001|Week 0 to 16|Randomized, but not treated|0|||
127814741|NCT01309737|459939587|FG002|Week 0 to 16|Randomized, but not treated|0|||
127814742|NCT01309737|459939588|FG003|Week 0 to 16|Randomized, but not treated|0|||
127814743|NCT01309737|459939589|FG004|Week 0 to 16|Randomized, but not treated|0|||
127814744|NCT01309737|459939585|FG000|Week 16 to 52|Death|0|||
127814745|NCT01309737|459939586|FG001|Week 16 to 52|Death|0|||
127814746|NCT01309737|459939587|FG002|Week 16 to 52|Death|0|||
127814747|NCT01309737|459939588|FG003|Week 16 to 52|Death|0|||
127814748|NCT01309737|459939589|FG004|Week 16 to 52|Death|1|||
127814749|NCT01309737|459939585|FG000|Week 16 to 52|Adverse Event|7|||
127814750|NCT01309737|459939586|FG001|Week 16 to 52|Adverse Event|7|||
127814751|NCT01309737|459939587|FG002|Week 16 to 52|Adverse Event|0|||
127814752|NCT01309737|459939588|FG003|Week 16 to 52|Adverse Event|6|||
127814753|NCT01309737|459939589|FG004|Week 16 to 52|Adverse Event|5|||
127814754|NCT01309737|459939585|FG000|Week 16 to 52|Lack of Efficacy|107|||
127814755|NCT01309737|459939586|FG001|Week 16 to 52|Lack of Efficacy|76|||
127814756|NCT01309737|459939587|FG002|Week 16 to 52|Lack of Efficacy|0|||
127814757|NCT01309737|459939588|FG003|Week 16 to 52|Lack of Efficacy|25|||
127814758|NCT01309737|459939589|FG004|Week 16 to 52|Lack of Efficacy|21|||
127814759|NCT01309737|459939585|FG000|Week 16 to 52|Lost to Follow-up|4|||
127814760|NCT01309737|459939586|FG001|Week 16 to 52|Lost to Follow-up|2|||
127814761|NCT01309737|459939587|FG002|Week 16 to 52|Lost to Follow-up|0|||
127814762|NCT01309737|459939588|FG003|Week 16 to 52|Lost to Follow-up|1|||
127814763|NCT01309737|459939589|FG004|Week 16 to 52|Lost to Follow-up|4|||
127814764|NCT01309737|459939585|FG000|Week 16 to 52|Withdrawal by Subject|5|||
127814765|NCT01309737|459939586|FG001|Week 16 to 52|Withdrawal by Subject|6|||
127814766|NCT01309737|459939587|FG002|Week 16 to 52|Withdrawal by Subject|0|||
127814767|NCT01309737|459939588|FG003|Week 16 to 52|Withdrawal by Subject|0|||
127814768|NCT01309737|459939589|FG004|Week 16 to 52|Withdrawal by Subject|2|||
127814769|NCT01309737|459939585|FG000|Week 16 to 52|Other|10|||
127814770|NCT01309737|459939586|FG001|Week 16 to 52|Other|12|||
127814771|NCT01309737|459939587|FG002|Week 16 to 52|Other|0|||
127814772|NCT01309737|459939588|FG003|Week 16 to 52|Other|2|||
127814773|NCT01309737|459939589|FG004|Week 16 to 52|Other|0|||
127814774|NCT01442181|459939590|FG000|Overall Study|patient refused surgery|1|||
127814775|NCT01442181|459939591|FG001|Overall Study|patient refused surgery|0|||
127814776|NCT01442181|459939590|FG000|Overall Study|no insurance for surgery|1|||
127814777|NCT01442181|459939591|FG001|Overall Study|no insurance for surgery|0|||
127814778|NCT01442181|459939590|FG000|Overall Study|low ejection factor|0|||
127814779|NCT01442181|459939591|FG001|Overall Study|low ejection factor|1|||
127814780|NCT01442181|459939590|FG000|Overall Study|Lost to Follow-up|1|||
127814781|NCT01442181|459939591|FG001|Overall Study|Lost to Follow-up|1|||
127814782|NCT01442181|459939590|FG000|Overall Study|patient in an additional study|1|||
127814783|NCT01442181|459939591|FG001|Overall Study|patient in an additional study|0|||
127814784|NCT01442181|459939590|FG000|Overall Study|atrial fibrillation not noted|0|||
127814785|NCT01442181|459939591|FG001|Overall Study|atrial fibrillation not noted|1|||
127814786|NCT00709202|459939592|FG000|Overall Study|Withdrawal by Subject|6|||
127814787|NCT00709202|459939593|FG001|Overall Study|Withdrawal by Subject|6|||
127814788|NCT02597062|459939594|FG000|Overall Study|Ineligible|1|||
127814789|NCT05369806|459939595|FG000|Overall Study|Lost to Follow-up|1|||
127814790|NCT01392183|459939596|FG000|First Drug Administration|Adverse Event|3|||
127814791|NCT01392183|459939597|FG001|First Drug Administration|Adverse Event|2|||
127814792|NCT01392183|459939596|FG000|First Drug Administration|Death|1|||
127814793|NCT01392183|459939597|FG001|First Drug Administration|Death|0|||
127814794|NCT01392183|459939596|FG000|First Drug Administration|Withdrawal by Subject|10|||
127814795|NCT01392183|459939597|FG001|First Drug Administration|Withdrawal by Subject|17|||
127814796|NCT03430310|459939598|FG000|Overall Study|Protocol Violation|2|||
127814797|NCT03430310|459939599|FG001|Overall Study|Protocol Violation|0|||
127814798|NCT03430310|459939598|FG000|Overall Study|Withdrawal by Subject|3|||
127814799|NCT03430310|459939599|FG001|Overall Study|Withdrawal by Subject|2|||
127814800|NCT03430310|459939598|FG000|Overall Study|COVID shutdown March 2020|0|||
127814801|NCT03430310|459939599|FG001|Overall Study|COVID shutdown March 2020|1|||
127814802|NCT03476239|459939601|FG000|Overall Study|Withdrawal by Subject|10|||
127814803|NCT03476239|459939601|FG000|Overall Study|Death|80|||
127814804|NCT03476239|459939601|FG000|Overall Study|Lost to Follow-up|8|||
127814805|NCT01097044|459939605|FG000|Overall Study|Withdrawal by Subject|4|||
127814806|NCT01097044|459939606|FG001|Overall Study|Withdrawal by Subject|4|||
127814807|NCT01097044|459939605|FG000|Overall Study|Lost to Follow-up|1|||
127814808|NCT01097044|459939606|FG001|Overall Study|Lost to Follow-up|0|||
127814809|NCT01097044|459939605|FG000|Overall Study|Withdrawal by Sponsor|0|||
127814810|NCT01097044|459939606|FG001|Overall Study|Withdrawal by Sponsor|1|||
127814811|NCT01331161|459939607|FG000|Overall Study|Physician Decision|1|||
127814812|NCT01331161|459939608|FG001|Overall Study|Physician Decision|0|||
127814813|NCT01331161|459939607|FG000|Overall Study|Lost to Follow-up|0|||
127814814|NCT01331161|459939608|FG001|Overall Study|Lost to Follow-up|1|||
127814815|NCT01331161|459939607|FG000|Overall Study|Pregnancy|0|||
127814816|NCT01331161|459939608|FG001|Overall Study|Pregnancy|1|||
127814817|NCT01682044|459939609|FG000|Overall Study|Death|1|||
127814818|NCT01682044|459939609|FG000|Overall Study|Progression|3|||
127814819|NCT03277196|459939610|FG000|Overall Study|Commercial Drug is Available for Participants|20|||
127814820|NCT03277196|459939610|FG000|Overall Study|Lost to Follow-up|3|||
127814821|NCT03277196|459939610|FG000|Overall Study|Withdrawal of Consent (not due to AE)|3|||
127814822|NCT03277196|459939610|FG000|Overall Study|Other|2|||
127814823|NCT01826214|459940996|FG000|Overall Study|Adverse Event|7|||
127814824|NCT01826214|459940997|FG001|Overall Study|Adverse Event|6|||
127814825|NCT01826214|459940996|FG000|Overall Study|Death|3|||
127814826|NCT01826214|459940997|FG001|Overall Study|Death|1|||
127814827|NCT01826214|459940996|FG000|Overall Study|Lost to Follow-up|1|||
127814828|NCT01826214|459940997|FG001|Overall Study|Lost to Follow-up|0|||
127814829|NCT01826214|459940996|FG000|Overall Study|Physician Decision|0|||
127814830|NCT01826214|459940997|FG001|Overall Study|Physician Decision|2|||
127814831|NCT01826214|459940996|FG000|Overall Study|Progressive disease|22|||
127814832|NCT01826214|459940997|FG001|Overall Study|Progressive disease|21|||
127814833|NCT01826214|459940996|FG000|Overall Study|Study terminated by Sponsor|0|||
127814834|NCT01826214|459940997|FG001|Overall Study|Study terminated by Sponsor|1|||
127814835|NCT01826214|459940996|FG000|Overall Study|Subject/guardian decision|2|||
127814836|NCT01826214|459940997|FG001|Overall Study|Subject/guardian decision|3|||
127814837|NCT01056107|459941000|FG000|Overall Study|Withdrawal by Subject|0|||
127814838|NCT01056107|459941001|FG001|Overall Study|Withdrawal by Subject|1|||
127814839|NCT01056107|459941002|FG002|Overall Study|Withdrawal by Subject|3|||
127814840|NCT01056107|459941003|FG003|Overall Study|Withdrawal by Subject|0|||
127814841|NCT02017444|459941004|FG000|Overall Study|Physician Decision|1|||
127814842|NCT02017444|459941005|FG001|Overall Study|Physician Decision|0|||
127814843|NCT02017444|459941004|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
127814844|NCT02017444|459941005|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
127814845|NCT01614457|459941006|FG000|Overall Study|Non-Compliance|1|||
127814846|NCT01614457|459941007|FG001|Overall Study|Non-Compliance|0|||
127814847|NCT01614457|459941006|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
127814848|NCT01614457|459941007|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
127814849|NCT01821963|459941013|FG000|Overall Study|Adverse Event|1|||
127814850|NCT03952130|459941014|FG000|Overall Study|Adverse Event|0|||
127814851|NCT03952130|459941015|FG001|Overall Study|Adverse Event|1|||
127814852|NCT03952130|459941014|FG000|Overall Study|Lost to Follow-up|1|||
127814853|NCT03952130|459941015|FG001|Overall Study|Lost to Follow-up|0|||
127814854|NCT03952130|459941014|FG000|Overall Study|Withdrawal by Subject|1|||
127814855|NCT03952130|459941015|FG001|Overall Study|Withdrawal by Subject|5|||
127814856|NCT01713348|459941016|FG000|Overall Study|Withdrawal by Subject|3|||
127814857|NCT01713348|459941017|FG001|Overall Study|Withdrawal by Subject|2|||
127814858|NCT01713348|459941018|FG002|Overall Study|Withdrawal by Subject|2|||
127814859|NCT01713348|459941019|FG003|Overall Study|Withdrawal by Subject|0|||
127814860|NCT01713348|459941016|FG000|Overall Study|Lost to Follow-up|1|||
127814861|NCT01713348|459941017|FG001|Overall Study|Lost to Follow-up|0|||
127814862|NCT01713348|459941018|FG002|Overall Study|Lost to Follow-up|0|||
127814863|NCT01713348|459941019|FG003|Overall Study|Lost to Follow-up|0|||
127814864|NCT01896232|459941020|FG000|Overall Study|Death|6|||
127814865|NCT01896232|459941021|FG001|Overall Study|Death|10|||
127814866|NCT01896232|459941020|FG000|Overall Study|Withdrawal by Subject|32|||
127814867|NCT01896232|459941021|FG001|Overall Study|Withdrawal by Subject|31|||
127814868|NCT01896232|459941020|FG000|Overall Study|Sponsor Decision|2|||
127814869|NCT01896232|459941021|FG001|Overall Study|Sponsor Decision|0|||
127814870|NCT01896232|459941020|FG000|Overall Study|Lost to Follow-up|9|||
127814871|NCT01896232|459941021|FG001|Overall Study|Lost to Follow-up|12|||
127814872|NCT00686205|459941028|FG000|Overall Study|Protocol Violation|127|||
127814873|NCT00686205|459941029|FG001|Overall Study|Protocol Violation|0|||
127814874|NCT00686205|459941028|FG000|Overall Study|Withdrawal by Subject|2|||
127814875|NCT00686205|459941029|FG001|Overall Study|Withdrawal by Subject|0|||
127814876|NCT00686205|459941028|FG000|Overall Study|Specimen handling procedure altered|5878|||
127814877|NCT00686205|459941029|FG001|Overall Study|Specimen handling procedure altered|0|||
127814878|NCT00686205|459941028|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
127814879|NCT00686205|459941029|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
127814880|NCT00265941|459941030|FG000|Overall Study|Protocol Violation|22|||
127814881|NCT00265941|459941031|FG001|Overall Study|Protocol Violation|25|||
127814882|NCT00265941|459941030|FG000|Overall Study|Lost to Follow-up|1|||
127814883|NCT00265941|459941031|FG001|Overall Study|Lost to Follow-up|1|||
127814884|NCT03816995|459941034|FG000|Overall Study|Withdrawal by Subject|3|||
127814885|NCT03816995|459941035|FG001|Overall Study|Withdrawal by Subject|1|||
127814886|NCT03816995|459941034|FG000|Overall Study|Cancelled Surgery|8|||
127814887|NCT03816995|459941035|FG001|Overall Study|Cancelled Surgery|12|||
127814888|NCT03816995|459941034|FG000|Overall Study|No wound protector used|11|||
127814889|NCT03816995|459941035|FG001|Overall Study|No wound protector used|17|||
127814890|NCT03816995|459941034|FG000|Overall Study|Protocol Violation|2|||
127814891|NCT03816995|459941035|FG001|Overall Study|Protocol Violation|3|||
127814892|NCT01324830|459941037|FG000|Overall Study|Progressive Disease|3|||
127814893|NCT01324830|459941038|FG001|Overall Study|Progressive Disease|2|||
127814894|NCT01324830|459941039|FG002|Overall Study|Progressive Disease|3|||
127814895|NCT01324830|459941040|FG003|Overall Study|Progressive Disease|3|||
127814896|NCT01324830|459941041|FG004|Overall Study|Progressive Disease|6|||
127814897|NCT01324830|459941042|FG005|Overall Study|Progressive Disease|6|||
127814898|NCT01324830|459941043|FG006|Overall Study|Progressive Disease|3|||
127814899|NCT01324830|459941044|FG007|Overall Study|Progressive Disease|3|||
127814900|NCT01324830|459941045|FG008|Overall Study|Progressive Disease|3|||
127814901|NCT01324830|459941046|FG009|Overall Study|Progressive Disease|6|||
127814902|NCT01324830|459941047|FG010|Overall Study|Progressive Disease|2|||
127814903|NCT01324830|459941048|FG011|Overall Study|Progressive Disease|1|||
127814904|NCT01324830|459941049|FG012|Overall Study|Progressive Disease|1|||
127814905|NCT01324830|459941050|FG013|Overall Study|Progressive Disease|1|||
127814906|NCT01324830|459941051|FG014|Overall Study|Progressive Disease|1|||
127814907|NCT01324830|459941052|FG015|Overall Study|Progressive Disease|3|||
127814908|NCT01324830|459941053|FG016|Overall Study|Progressive Disease|2|||
127814909|NCT01324830|459941054|FG017|Overall Study|Progressive Disease|3|||
127814910|NCT01324830|459941055|FG018|Overall Study|Progressive Disease|4|||
127814911|NCT01324830|459941037|FG000|Overall Study|Dose limiting toxicity|0|||
127814912|NCT01324830|459941038|FG001|Overall Study|Dose limiting toxicity|0|||
127814913|NCT01324830|459941039|FG002|Overall Study|Dose limiting toxicity|0|||
127814914|NCT01324830|459941040|FG003|Overall Study|Dose limiting toxicity|0|||
127814915|NCT01324830|459941041|FG004|Overall Study|Dose limiting toxicity|1|||
127814916|NCT01324830|459941042|FG005|Overall Study|Dose limiting toxicity|0|||
127814917|NCT01324830|459941043|FG006|Overall Study|Dose limiting toxicity|0|||
127814918|NCT01324830|459941044|FG007|Overall Study|Dose limiting toxicity|0|||
127814919|NCT01324830|459941045|FG008|Overall Study|Dose limiting toxicity|0|||
127814920|NCT01324830|459941046|FG009|Overall Study|Dose limiting toxicity|0|||
127814921|NCT01324830|459941047|FG010|Overall Study|Dose limiting toxicity|0|||
127814922|NCT01324830|459941048|FG011|Overall Study|Dose limiting toxicity|0|||
127814923|NCT01324830|459941049|FG012|Overall Study|Dose limiting toxicity|0|||
127814924|NCT01324830|459941050|FG013|Overall Study|Dose limiting toxicity|0|||
127814925|NCT01324830|459941051|FG014|Overall Study|Dose limiting toxicity|0|||
127814926|NCT01324830|459941052|FG015|Overall Study|Dose limiting toxicity|0|||
127814927|NCT01324830|459941053|FG016|Overall Study|Dose limiting toxicity|1|||
127814928|NCT01324830|459941054|FG017|Overall Study|Dose limiting toxicity|1|||
127814929|NCT01324830|459941055|FG018|Overall Study|Dose limiting toxicity|1|||
127814930|NCT01324830|459941037|FG000|Overall Study|Reason not mentioned above|0|||
127814931|NCT01324830|459941038|FG001|Overall Study|Reason not mentioned above|0|||
127814932|NCT01324830|459941039|FG002|Overall Study|Reason not mentioned above|0|||
127814933|NCT01324830|459941040|FG003|Overall Study|Reason not mentioned above|0|||
127814934|NCT01324830|459941041|FG004|Overall Study|Reason not mentioned above|0|||
127814935|NCT01324830|459941042|FG005|Overall Study|Reason not mentioned above|0|||
127814936|NCT01324830|459941043|FG006|Overall Study|Reason not mentioned above|0|||
127814937|NCT01324830|459941044|FG007|Overall Study|Reason not mentioned above|0|||
127814938|NCT01324830|459941045|FG008|Overall Study|Reason not mentioned above|0|||
127814939|NCT01324830|459941046|FG009|Overall Study|Reason not mentioned above|0|||
127814940|NCT01324830|459941047|FG010|Overall Study|Reason not mentioned above|0|||
127814941|NCT01324830|459941048|FG011|Overall Study|Reason not mentioned above|0|||
127814942|NCT01324830|459941049|FG012|Overall Study|Reason not mentioned above|0|||
127814943|NCT01324830|459941050|FG013|Overall Study|Reason not mentioned above|0|||
127814944|NCT01324830|459941051|FG014|Overall Study|Reason not mentioned above|0|||
127814945|NCT01324830|459941052|FG015|Overall Study|Reason not mentioned above|0|||
127814946|NCT01324830|459941053|FG016|Overall Study|Reason not mentioned above|0|||
127814947|NCT01324830|459941054|FG017|Overall Study|Reason not mentioned above|1|||
127814948|NCT01324830|459941055|FG018|Overall Study|Reason not mentioned above|0|||
127814949|NCT01324830|459941037|FG000|Overall Study|Adverse Event, serious fatal|0|||
127814950|NCT01324830|459941038|FG001|Overall Study|Adverse Event, serious fatal|1|||
127814951|NCT01324830|459941039|FG002|Overall Study|Adverse Event, serious fatal|0|||
127814952|NCT01324830|459941040|FG003|Overall Study|Adverse Event, serious fatal|0|||
127814953|NCT01324830|459941041|FG004|Overall Study|Adverse Event, serious fatal|0|||
127814954|NCT01324830|459941042|FG005|Overall Study|Adverse Event, serious fatal|0|||
127814955|NCT01324830|459941043|FG006|Overall Study|Adverse Event, serious fatal|0|||
127814956|NCT01324830|459941044|FG007|Overall Study|Adverse Event, serious fatal|0|||
127814957|NCT01324830|459941045|FG008|Overall Study|Adverse Event, serious fatal|0|||
127814958|NCT01324830|459941046|FG009|Overall Study|Adverse Event, serious fatal|0|||
127814959|NCT01324830|459941047|FG010|Overall Study|Adverse Event, serious fatal|0|||
127814960|NCT01324830|459941048|FG011|Overall Study|Adverse Event, serious fatal|0|||
127814961|NCT01324830|459941049|FG012|Overall Study|Adverse Event, serious fatal|0|||
127814962|NCT01324830|459941050|FG013|Overall Study|Adverse Event, serious fatal|0|||
127814963|NCT01324830|459941051|FG014|Overall Study|Adverse Event, serious fatal|0|||
127814964|NCT01324830|459941052|FG015|Overall Study|Adverse Event, serious fatal|0|||
127814965|NCT01324830|459941053|FG016|Overall Study|Adverse Event, serious fatal|0|||
127814966|NCT01324830|459941054|FG017|Overall Study|Adverse Event, serious fatal|0|||
127814967|NCT01324830|459941055|FG018|Overall Study|Adverse Event, serious fatal|0|||
127814968|NCT01324830|459941037|FG000|Overall Study|Adverse Event, non-fatal|0|||
127814969|NCT01324830|459941038|FG001|Overall Study|Adverse Event, non-fatal|0|||
127814970|NCT01324830|459941039|FG002|Overall Study|Adverse Event, non-fatal|0|||
127814971|NCT01324830|459941040|FG003|Overall Study|Adverse Event, non-fatal|0|||
127814972|NCT01324830|459941041|FG004|Overall Study|Adverse Event, non-fatal|0|||
127814973|NCT01324830|459941042|FG005|Overall Study|Adverse Event, non-fatal|0|||
127814974|NCT01324830|459941043|FG006|Overall Study|Adverse Event, non-fatal|0|||
127814975|NCT01324830|459941044|FG007|Overall Study|Adverse Event, non-fatal|0|||
127814976|NCT01324830|459941045|FG008|Overall Study|Adverse Event, non-fatal|2|||
127814977|NCT01324830|459941046|FG009|Overall Study|Adverse Event, non-fatal|0|||
127814978|NCT01324830|459941047|FG010|Overall Study|Adverse Event, non-fatal|1|||
127814979|NCT01324830|459941048|FG011|Overall Study|Adverse Event, non-fatal|0|||
127814980|NCT01324830|459941049|FG012|Overall Study|Adverse Event, non-fatal|0|||
127814981|NCT01324830|459941050|FG013|Overall Study|Adverse Event, non-fatal|0|||
127814982|NCT01324830|459941051|FG014|Overall Study|Adverse Event, non-fatal|0|||
127814983|NCT01324830|459941052|FG015|Overall Study|Adverse Event, non-fatal|0|||
127814984|NCT01324830|459941053|FG016|Overall Study|Adverse Event, non-fatal|0|||
127814985|NCT01324830|459941054|FG017|Overall Study|Adverse Event, non-fatal|1|||
127814986|NCT01324830|459941055|FG018|Overall Study|Adverse Event, non-fatal|0|||
127814987|NCT01324830|459941037|FG000|Overall Study|Withdrawal by Subject|0|||
127814988|NCT01324830|459941038|FG001|Overall Study|Withdrawal by Subject|0|||
127814989|NCT01324830|459941039|FG002|Overall Study|Withdrawal by Subject|0|||
127814990|NCT01324830|459941040|FG003|Overall Study|Withdrawal by Subject|0|||
127814991|NCT01324830|459941041|FG004|Overall Study|Withdrawal by Subject|0|||
127814992|NCT01324830|459941042|FG005|Overall Study|Withdrawal by Subject|1|||
127814993|NCT01324830|459941043|FG006|Overall Study|Withdrawal by Subject|0|||
127814994|NCT01324830|459941044|FG007|Overall Study|Withdrawal by Subject|0|||
127814995|NCT01324830|459941045|FG008|Overall Study|Withdrawal by Subject|0|||
127814996|NCT01324830|459941046|FG009|Overall Study|Withdrawal by Subject|0|||
127814997|NCT01324830|459941047|FG010|Overall Study|Withdrawal by Subject|1|||
127814998|NCT01324830|459941048|FG011|Overall Study|Withdrawal by Subject|0|||
127814999|NCT01324830|459941049|FG012|Overall Study|Withdrawal by Subject|0|||
127815000|NCT01324830|459941050|FG013|Overall Study|Withdrawal by Subject|0|||
127815001|NCT01324830|459941051|FG014|Overall Study|Withdrawal by Subject|0|||
127815002|NCT01324830|459941052|FG015|Overall Study|Withdrawal by Subject|0|||
127815003|NCT01324830|459941053|FG016|Overall Study|Withdrawal by Subject|0|||
127815004|NCT01324830|459941054|FG017|Overall Study|Withdrawal by Subject|0|||
127815005|NCT01324830|459941055|FG018|Overall Study|Withdrawal by Subject|1|||
127815006|NCT00942409|459941056|FG000|Overall Study|Lack of Efficacy|1|||
127815007|NCT00942409|459941056|FG000|Overall Study|study drug unavailable|2|||
127815008|NCT01503021|459941061|FG000|Overall Study|Adverse Event|7|||
127815009|NCT01503021|459941062|FG001|Overall Study|Adverse Event|6|||
127815010|NCT01503021|459941061|FG000|Overall Study|Death|0|||
127815011|NCT01503021|459941062|FG001|Overall Study|Death|2|||
127815012|NCT01503021|459941061|FG000|Overall Study|Lost to Follow-up|2|||
127815013|NCT01503021|459941062|FG001|Overall Study|Lost to Follow-up|0|||
127815014|NCT01503021|459941061|FG000|Overall Study|Physician Decision|3|||
127815015|NCT01503021|459941062|FG001|Overall Study|Physician Decision|0|||
127815016|NCT01503021|459941061|FG000|Overall Study|Protocol Violation|1|||
127815017|NCT01503021|459941062|FG001|Overall Study|Protocol Violation|3|||
127815018|NCT01503021|459941061|FG000|Overall Study|Withdrawal by Subject|9|||
127815019|NCT01503021|459941062|FG001|Overall Study|Withdrawal by Subject|8|||
127815020|NCT01503021|459941061|FG000|Overall Study|Moved, received transplant, etc.|5|||
127815021|NCT01503021|459941062|FG001|Overall Study|Moved, received transplant, etc.|7|||
127815022|NCT00817414|459941063|FG000|Overall Study|Adverse Event|1|||
127815023|NCT00817414|459941064|FG001|Overall Study|Adverse Event|1|||
127815024|NCT00817414|459941065|FG002|Overall Study|Adverse Event|1|||
127815025|NCT00817414|459941066|FG003|Overall Study|Adverse Event|0|||
127815026|NCT00817414|459941067|FG004|Overall Study|Adverse Event|0|||
127815027|NCT00817414|459941063|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
127815028|NCT00817414|459941064|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
127815029|NCT00817414|459941065|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
127815030|NCT00817414|459941066|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
127815031|NCT00817414|459941067|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
127815032|NCT00817414|459941063|FG000|Overall Study|Withdrawal by Subject|1|||
127815033|NCT00817414|459941064|FG001|Overall Study|Withdrawal by Subject|1|||
127815034|NCT00817414|459941065|FG002|Overall Study|Withdrawal by Subject|0|||
127815035|NCT00817414|459941066|FG003|Overall Study|Withdrawal by Subject|0|||
127815036|NCT00817414|459941067|FG004|Overall Study|Withdrawal by Subject|0|||
127815037|NCT00817414|459941063|FG000|Overall Study|Lost to Follow-up|0|||
127815038|NCT00817414|459941064|FG001|Overall Study|Lost to Follow-up|0|||
127815039|NCT00817414|459941065|FG002|Overall Study|Lost to Follow-up|1|||
127815040|NCT00817414|459941066|FG003|Overall Study|Lost to Follow-up|1|||
127815041|NCT00817414|459941067|FG004|Overall Study|Lost to Follow-up|1|||
127815042|NCT00817414|459941063|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
127815043|NCT00817414|459941064|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
127815044|NCT00817414|459941065|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
127815045|NCT00817414|459941066|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
127815046|NCT00817414|459941067|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
127815047|NCT00817414|459941063|FG000|Overall Study|Protocol Violation|0|||
127815048|NCT00817414|459941064|FG001|Overall Study|Protocol Violation|0|||
127815049|NCT00817414|459941065|FG002|Overall Study|Protocol Violation|0|||
127815050|NCT00817414|459941066|FG003|Overall Study|Protocol Violation|0|||
127815051|NCT00817414|459941067|FG004|Overall Study|Protocol Violation|1|||
127815052|NCT00097539|459941068|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
127815053|NCT00097539|459941069|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
127815054|NCT00097539|459941070|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
127815055|NCT00097539|459941071|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
127815056|NCT00097539|459941072|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
127815057|NCT00097539|459941073|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
127815058|NCT00097539|459941074|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
127815059|NCT00097539|459941068|FG000|Overall Study|Withdrawal by Subject|925|||
127815060|NCT00097539|459941069|FG001|Overall Study|Withdrawal by Subject|323|||
127815061|NCT00097539|459941070|FG002|Overall Study|Withdrawal by Subject|346|||
127815062|NCT00097539|459941071|FG003|Overall Study|Withdrawal by Subject|217|||
127815063|NCT00097539|459941072|FG004|Overall Study|Withdrawal by Subject|68|||
127815064|NCT00097539|459941073|FG005|Overall Study|Withdrawal by Subject|229|||
127815065|NCT00097539|459941074|FG006|Overall Study|Withdrawal by Subject|3|||
127815066|NCT00097539|459941068|FG000|Overall Study|Participant Non-compliant|2140|||
127815067|NCT00097539|459941069|FG001|Overall Study|Participant Non-compliant|567|||
127815068|NCT00097539|459941070|FG002|Overall Study|Participant Non-compliant|1067|||
127815069|NCT00097539|459941071|FG003|Overall Study|Participant Non-compliant|353|||
127815070|NCT00097539|459941072|FG004|Overall Study|Participant Non-compliant|136|||
127815071|NCT00097539|459941073|FG005|Overall Study|Participant Non-compliant|543|||
127815072|NCT00097539|459941074|FG006|Overall Study|Participant Non-compliant|18|||
127815073|NCT00097539|459941068|FG000|Overall Study|Lack of Efficacy|249|||
127815074|NCT00097539|459941069|FG001|Overall Study|Lack of Efficacy|122|||
127815075|NCT00097539|459941070|FG002|Overall Study|Lack of Efficacy|202|||
127815076|NCT00097539|459941071|FG003|Overall Study|Lack of Efficacy|105|||
127815077|NCT00097539|459941072|FG004|Overall Study|Lack of Efficacy|45|||
127815078|NCT00097539|459941073|FG005|Overall Study|Lack of Efficacy|228|||
127815079|NCT00097539|459941074|FG006|Overall Study|Lack of Efficacy|5|||
127815080|NCT00097539|459941068|FG000|Overall Study|Adverse Event|78|||
127815081|NCT00097539|459941069|FG001|Overall Study|Adverse Event|133|||
127815082|NCT00097539|459941070|FG002|Overall Study|Adverse Event|37|||
127815083|NCT00097539|459941071|FG003|Overall Study|Adverse Event|27|||
127815084|NCT00097539|459941072|FG004|Overall Study|Adverse Event|30|||
127815085|NCT00097539|459941073|FG005|Overall Study|Adverse Event|59|||
127815086|NCT00097539|459941074|FG006|Overall Study|Adverse Event|1|||
127815087|NCT00097539|459941068|FG000|Overall Study|Death|2|||
127815088|NCT00097539|459941069|FG001|Overall Study|Death|7|||
127815089|NCT00097539|459941070|FG002|Overall Study|Death|0|||
127815090|NCT00097539|459941071|FG003|Overall Study|Death|0|||
127815091|NCT00097539|459941072|FG004|Overall Study|Death|1|||
127815092|NCT00097539|459941073|FG005|Overall Study|Death|3|||
127815093|NCT00097539|459941074|FG006|Overall Study|Death|0|||
127815094|NCT00097539|459941068|FG000|Overall Study|Reasons Other Than Above|3602|||
127815095|NCT00097539|459941069|FG001|Overall Study|Reasons Other Than Above|1382|||
127815096|NCT00097539|459941070|FG002|Overall Study|Reasons Other Than Above|1757|||
127815097|NCT00097539|459941071|FG003|Overall Study|Reasons Other Than Above|692|||
127815098|NCT00097539|459941072|FG004|Overall Study|Reasons Other Than Above|361|||
127815099|NCT00097539|459941073|FG005|Overall Study|Reasons Other Than Above|1244|||
127815100|NCT00097539|459941074|FG006|Overall Study|Reasons Other Than Above|34|||
127815101|NCT00097539|459941068|FG000|Overall Study|Reason not Specified|111|||
127815102|NCT00097539|459941069|FG001|Overall Study|Reason not Specified|49|||
127815103|NCT00097539|459941070|FG002|Overall Study|Reason not Specified|53|||
127815104|NCT00097539|459941071|FG003|Overall Study|Reason not Specified|21|||
127815105|NCT00097539|459941072|FG004|Overall Study|Reason not Specified|11|||
127815106|NCT00097539|459941073|FG005|Overall Study|Reason not Specified|40|||
127815107|NCT00097539|459941074|FG006|Overall Study|Reason not Specified|2|||
127815108|NCT02015819|459941077|FG000|Overall Study|Rickham catheter was misaligned|0|||
127815109|NCT02015819|459941078|FG001|Overall Study|Rickham catheter was misaligned|0|||
127815110|NCT02015819|459941079|FG002|Overall Study|Rickham catheter was misaligned|0|||
127815111|NCT02015819|459941080|FG003|Overall Study|Rickham catheter was misaligned|1|||
127815112|NCT02945657|459941081|FG000|Overall Study|Adverse Event|1|||
127815113|NCT02945657|459941081|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
127815114|NCT00283387|459941083|FG000|First Intervention|Subject non-compliant|1|||
127894534|NCT01659567|460237173|FG000|Overall Study|Withdrawal by Subject|64|||
127815115|NCT00283387|459941084|FG001|First Intervention|Subject non-compliant|1|||
127815116|NCT00283387|459941083|FG000|First Intervention|Withdrawal by Subject|0|||
127815117|NCT00283387|459941084|FG001|First Intervention|Withdrawal by Subject|1|||
127815118|NCT03584009|459941086|FG000|Overall Study|Death|25|||
127815119|NCT03584009|459941087|FG001|Overall Study|Death|18|||
127815120|NCT03584009|459941086|FG000|Overall Study|Lost to Follow-up|0|||
127815121|NCT03584009|459941087|FG001|Overall Study|Lost to Follow-up|1|||
127815122|NCT03584009|459941086|FG000|Overall Study|Physician Decision|1|||
127815123|NCT03584009|459941087|FG001|Overall Study|Physician Decision|1|||
127815124|NCT03584009|459941086|FG000|Overall Study|Study Terminated by Sponsor|22|||
127815125|NCT03584009|459941087|FG001|Overall Study|Study Terminated by Sponsor|30|||
127815126|NCT03584009|459941086|FG000|Overall Study|Withdrawal by Subject|3|||
127815127|NCT03584009|459941087|FG001|Overall Study|Withdrawal by Subject|2|||
127815128|NCT00446030|459941088|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
127815129|NCT00446030|459941089|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
127815130|NCT00446030|459941088|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
127815131|NCT00446030|459941089|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
127815132|NCT00446030|459941088|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
127815133|NCT00446030|459941089|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
127815134|NCT00446030|459941088|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
127815135|NCT00446030|459941089|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
127815136|NCT00446030|459941088|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
127815137|NCT00446030|459941089|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
127815138|NCT00446030|459941088|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
127815139|NCT00446030|459941089|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
127815140|NCT00446030|459941088|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
127815141|NCT00446030|459941089|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
127815142|NCT00446030|459941088|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
127815143|NCT00446030|459941089|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
127815144|NCT00446030|459941088|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
127815145|NCT00446030|459941089|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
127815146|NCT00446030|459941088|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
127815147|NCT00446030|459941089|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
127815148|NCT00446030|459941088|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
127815149|NCT00446030|459941089|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
127815150|NCT00446030|459941088|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
127815151|NCT00446030|459941089|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
127815152|NCT00446030|459941088|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
127815153|NCT00446030|459941089|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
127815154|NCT00446030|459941088|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
127894535|NCT01659567|460237173|FG000|Overall Study|Progression of the main disease|1|||
127894536|NCT01659567|460237173|FG000|Overall Study|Other|13|||
127815155|NCT00446030|459941089|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
127815156|NCT00446030|459941088|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
127815157|NCT00446030|459941089|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
127815158|NCT00446030|459941088|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
127894537|NCT03019965|460237174|FG000|Overall Study|Withdrawal by Subject|1|||
127815159|NCT00446030|459941089|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
127815160|NCT00446030|459941088|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
127894538|NCT03019965|460237175|FG001|Overall Study|Withdrawal by Subject|0|||
127815161|NCT00446030|459941089|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
127815162|NCT00446030|459941088|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
127815163|NCT00446030|459941089|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
127815164|NCT00446030|459941088|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
127815165|NCT00446030|459941089|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
127815166|NCT02886715|459941090|FG000|Overall Study|Non-Compliance With Study Drug|0|||
127815167|NCT02886715|459941091|FG001|Overall Study|Non-Compliance With Study Drug|2|||
127815168|NCT02886715|459941092|FG002|Overall Study|Non-Compliance With Study Drug|0|||
127815169|NCT02886715|459941090|FG000|Overall Study|Adverse Event|4|||
127815170|NCT02886715|459941091|FG001|Overall Study|Adverse Event|2|||
127815171|NCT02886715|459941092|FG002|Overall Study|Adverse Event|0|||
127815172|NCT02886715|459941090|FG000|Overall Study|Lack of Efficacy|0|||
127815173|NCT02886715|459941091|FG001|Overall Study|Lack of Efficacy|2|||
127815174|NCT02886715|459941092|FG002|Overall Study|Lack of Efficacy|1|||
127815175|NCT02886715|459941090|FG000|Overall Study|Lost to Follow-up|29|||
127815176|NCT02886715|459941091|FG001|Overall Study|Lost to Follow-up|26|||
127815177|NCT02886715|459941092|FG002|Overall Study|Lost to Follow-up|10|||
127815178|NCT02886715|459941090|FG000|Overall Study|Pregnancy|1|||
127815179|NCT02886715|459941091|FG001|Overall Study|Pregnancy|1|||
127815180|NCT02886715|459941092|FG002|Overall Study|Pregnancy|1|||
127815181|NCT02886715|459941090|FG000|Overall Study|Protocol Violation|3|||
127815182|NCT02886715|459941091|FG001|Overall Study|Protocol Violation|2|||
127815183|NCT02886715|459941092|FG002|Overall Study|Protocol Violation|1|||
127815184|NCT02886715|459941090|FG000|Overall Study|Withdrawal by Subject|20|||
127815185|NCT02886715|459941091|FG001|Overall Study|Withdrawal by Subject|18|||
127815186|NCT02886715|459941092|FG002|Overall Study|Withdrawal by Subject|5|||
127815187|NCT02886715|459941090|FG000|Overall Study|missing|7|||
127815188|NCT02886715|459941091|FG001|Overall Study|missing|2|||
127815189|NCT02886715|459941092|FG002|Overall Study|missing|2|||
127815190|NCT00222105|459941093|FG000|Overall Study|Removed due to wrong diagnosis|1|||
127815191|NCT00222105|459941093|FG000|Overall Study|Withdrawal by Subject|1|||
127815192|NCT00222105|459941093|FG000|Overall Study|Adverse Event|8|||
127815193|NCT00222105|459941093|FG000|Overall Study|Treatment delays|2|||
127815194|NCT00222105|459941093|FG000|Overall Study|Death|2|||
127815195|NCT00503399|459941094|FG000|Overall Study|Death|2|||
127815196|NCT00503399|459941095|FG001|Overall Study|Death|1|||
127815197|NCT00503399|459941094|FG000|Overall Study|Protocol Violation|1|||
127815198|NCT00503399|459941095|FG001|Overall Study|Protocol Violation|0|||
127815199|NCT00503399|459941094|FG000|Overall Study|Withdrawal by Subject|4|||
127815200|NCT00503399|459941095|FG001|Overall Study|Withdrawal by Subject|2|||
127815201|NCT00503399|459941094|FG000|Overall Study|Adverse Event|0|||
127815202|NCT00503399|459941095|FG001|Overall Study|Adverse Event|3|||
127815203|NCT00503399|459941094|FG000|Overall Study|Lost to Follow-up|0|||
127815204|NCT00503399|459941095|FG001|Overall Study|Lost to Follow-up|2|||
127815205|NCT01073943|459941119|FG000|Overall Study|Withdrawal by Subject|8|||
127815206|NCT01073943|459941120|FG001|Overall Study|Withdrawal by Subject|2|||
127815207|NCT01073943|459941119|FG000|Overall Study|Protocol Violation|2|||
127815208|NCT01073943|459941120|FG001|Overall Study|Protocol Violation|1|||
127815209|NCT01073943|459941119|FG000|Overall Study|Adverse Event|1|||
127815210|NCT01073943|459941120|FG001|Overall Study|Adverse Event|1|||
127815211|NCT01073943|459941119|FG000|Overall Study|Lost to Follow-up|0|||
127815212|NCT01073943|459941120|FG001|Overall Study|Lost to Follow-up|2|||
127815213|NCT01073943|459941119|FG000|Overall Study|Power outage; colonoscopy not done|1|||
127815214|NCT01073943|459941120|FG001|Overall Study|Power outage; colonoscopy not done|0|||
127815215|NCT01073943|459941119|FG000|Overall Study|Subject forgot|0|||
127815216|NCT01073943|459941120|FG001|Overall Study|Subject forgot|1|||
127815217|NCT01073943|459941119|FG000|Overall Study|Unable to return for follow-up|0|||
127815218|NCT01073943|459941120|FG001|Overall Study|Unable to return for follow-up|1|||
127815219|NCT01073943|459941119|FG000|Overall Study|Could not tolerate prep|1|||
127815220|NCT01073943|459941120|FG001|Overall Study|Could not tolerate prep|0|||
127815221|NCT03527043|459941121|FG000|Overall Study|Withdrawal by Subject|1|||
127815222|NCT03527043|459941122|FG001|Overall Study|Withdrawal by Subject|0|||
127815223|NCT03830281|459941123|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
127815224|NCT03830281|459941124|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
127815225|NCT03830281|459941123|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
127815226|NCT03830281|459941124|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
127815227|NCT03830281|459941123|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
127815228|NCT03830281|459941124|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
127815229|NCT03830281|459941123|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
127815230|NCT03830281|459941124|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
127815231|NCT03830281|459941123|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
127815232|NCT03830281|459941124|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
127815233|NCT03830281|459941123|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
127815234|NCT03830281|459941124|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
127815235|NCT03830281|459941123|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
127815236|NCT03830281|459941124|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
127815237|NCT03830281|459941123|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
127815238|NCT03830281|459941124|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
127815239|NCT03830281|459941123|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
127815240|NCT03830281|459941124|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
127815241|NCT01985321|459941125|FG000|Overall Study|Protocol Violation|4|||
127815242|NCT01985321|459941126|FG001|Overall Study|Protocol Violation|3|||
127815243|NCT01985321|459941125|FG000|Overall Study|Withdrawal by Subject|1|||
127815244|NCT01985321|459941126|FG001|Overall Study|Withdrawal by Subject|0|||
127815245|NCT01985321|459941125|FG000|Overall Study|Lost to Follow-up|5|||
127815246|NCT01985321|459941126|FG001|Overall Study|Lost to Follow-up|2|||
127815247|NCT01985321|459941125|FG000|Overall Study|Subject treated wrong type of sore|1|||
127815248|NCT01985321|459941126|FG001|Overall Study|Subject treated wrong type of sore|0|||
127815249|NCT01299025|459941130|FG000|Overall Study|Withdrawal by Subject|2|||
127815250|NCT01299025|459941131|FG001|Overall Study|Withdrawal by Subject|1|||
127815251|NCT01299025|459941130|FG000|Overall Study|Lost to Follow-up|1|||
127815252|NCT01299025|459941131|FG001|Overall Study|Lost to Follow-up|0|||
127815253|NCT03934684|459941132|FG000|Overall Study|Participants continuing in study|11|||
127815254|NCT03934684|459941133|FG001|Overall Study|Participants continuing in study|4|||
127815255|NCT03934684|459941132|FG000|Overall Study|Discontinuation of carfilzomib|20|||
127815256|NCT03934684|459941133|FG001|Overall Study|Discontinuation of carfilzomib|30|||
127815257|NCT03934684|459941132|FG000|Overall Study|Death|2|||
127815258|NCT03934684|459941133|FG001|Overall Study|Death|2|||
127815259|NCT03934684|459941132|FG000|Overall Study|Lost to Follow-up|2|||
127815260|NCT03934684|459941133|FG001|Overall Study|Lost to Follow-up|5|||
127815261|NCT03934684|459941132|FG000|Overall Study|Withdrawal by Subject|7|||
127815262|NCT03934684|459941133|FG001|Overall Study|Withdrawal by Subject|8|||
127815263|NCT04091217|459941134|FG000|Overall Study|Lost to Follow-up|2|||
127815264|NCT05662332|459941135|FG000|Overall Study|Death|3|||
127815265|NCT05662332|459941136|FG001|Overall Study|Death|3|||
127815266|NCT05662332|459941135|FG000|Overall Study|Lost to Follow-up|3|||
127815267|NCT05662332|459941136|FG001|Overall Study|Lost to Follow-up|8|||
127815268|NCT05662332|459941135|FG000|Overall Study|Physician Decision|1|||
127815269|NCT05662332|459941136|FG001|Overall Study|Physician Decision|2|||
127815270|NCT05662332|459941135|FG000|Overall Study|Protocol Deviation|2|||
127815271|NCT05662332|459941136|FG001|Overall Study|Protocol Deviation|1|||
127815272|NCT05662332|459941135|FG000|Overall Study|Withdrawal by Subject|14|||
127815273|NCT05662332|459941136|FG001|Overall Study|Withdrawal by Subject|14|||
127815274|NCT05662332|459941135|FG000|Overall Study|Assigned Treatment by Mistake|5|||
127815275|NCT05662332|459941136|FG001|Overall Study|Assigned Treatment by Mistake|7|||
127815276|NCT05662332|459941135|FG000|Overall Study|Non-compliance with study drug|4|||
127815277|NCT05662332|459941136|FG001|Overall Study|Non-compliance with study drug|1|||
127815278|NCT05662332|459941135|FG000|Overall Study|Due to Bariatric surgery|1|||
127815279|NCT05662332|459941136|FG001|Overall Study|Due to Bariatric surgery|0|||
127815280|NCT05662332|459941135|FG000|Overall Study|Subject Moving out of State|0|||
127815281|NCT05662332|459941136|FG001|Overall Study|Subject Moving out of State|1|||
127815282|NCT05662332|459941135|FG000|Overall Study|Subject Missed the Schedule|1|||
127815283|NCT05662332|459941136|FG001|Overall Study|Subject Missed the Schedule|0|||
127815284|NCT05662332|459941135|FG000|Overall Study|The Patient Moved to Another City|1|||
127815285|NCT05662332|459941136|FG001|Overall Study|The Patient Moved to Another City|0|||
127815286|NCT04885257|459941137|FG000|Overall Study|Withdrawal by Subject|1|||
127815287|NCT04885257|459941138|FG001|Overall Study|Withdrawal by Subject|0|||
127815288|NCT00256295|459941139|FG000|Overall Study|Withdrawal by Subject|3|||
127815289|NCT00256295|459941139|FG000|Overall Study|Death|1|||
127815290|NCT01697345|459941142|FG000|Overall Study|Withdrawal by Subject|1|||
127815291|NCT00140855|459941143|FG000|Overall Study|Progressive disease|2|||
127815292|NCT05262764|459941145|FG000|Overall Study|Case report form not collected|9|||
127815293|NCT05262764|459941145|FG000|Overall Study|No patient visits after entry|23|||
127815294|NCT05262764|459941145|FG000|Overall Study|Registration rule not followed|2|||
127815295|NCT05262764|459941145|FG000|Overall Study|Patient of non-chronic heart failure|1|||
127815296|NCT01446809|459941146|FG000|Overall Study|Adverse Event|0|||
127815297|NCT01446809|459941147|FG001|Overall Study|Adverse Event|0|||
127815298|NCT01446809|459941148|FG002|Overall Study|Adverse Event|1|||
127815299|NCT01446809|459941146|FG000|Overall Study|Failure to complete study procedures|0|||
127815300|NCT01446809|459941147|FG001|Overall Study|Failure to complete study procedures|0|||
127815301|NCT01446809|459941148|FG002|Overall Study|Failure to complete study procedures|1|||
127815302|NCT00785577|459941149|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
127815303|NCT00785577|459941150|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
127815304|NCT00785577|459941151|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
127815305|NCT00785577|459941152|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
127815306|NCT00785577|459941153|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
127815307|NCT00785577|459941149|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
127815308|NCT00785577|459941150|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
127815309|NCT00785577|459941151|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
127815310|NCT00785577|459941152|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
127815311|NCT00785577|459941153|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
127815312|NCT00785577|459941149|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
127815313|NCT00785577|459941150|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
127815314|NCT00785577|459941151|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
127815315|NCT00785577|459941152|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
127815316|NCT00785577|459941153|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
127815317|NCT00785577|459941149|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
127815318|NCT00785577|459941150|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
127815319|NCT00785577|459941151|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
127815320|NCT00785577|459941152|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
127815321|NCT00785577|459941153|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
127815322|NCT00785577|459941149|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
127815323|NCT00785577|459941150|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
127815324|NCT00785577|459941151|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
127815325|NCT00785577|459941152|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
127815326|NCT00785577|459941153|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
127815327|NCT00785577|459941149|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
127815328|NCT00785577|459941150|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
127815329|NCT00785577|459941151|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
127815330|NCT00785577|459941152|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
127815331|NCT00785577|459941153|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
127815332|NCT00785577|459941149|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
127815333|NCT00785577|459941150|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
127815334|NCT00785577|459941151|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
127815335|NCT00785577|459941152|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
127815336|NCT00785577|459941153|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
127815337|NCT00785577|459941149|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
127815338|NCT00785577|459941150|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
127815339|NCT00785577|459941151|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
127815340|NCT00785577|459941152|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
127815341|NCT00785577|459941153|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
127815342|NCT00785577|459941149|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
127815343|NCT00785577|459941150|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
127815344|NCT00785577|459941151|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
127815345|NCT00785577|459941152|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
127815346|NCT00785577|459941153|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
127815347|NCT00785577|459941149|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
127815348|NCT00785577|459941150|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
127815349|NCT00785577|459941151|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
127815350|NCT00785577|459941152|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
127815351|NCT00785577|459941153|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
127815352|NCT01659151|459941157|FG000|Overall Study|Inadequate TIL growth|1|||
127815353|NCT03972488|459941158|FG000|Overall Study|Progressive disease|42|||
127815354|NCT03972488|459941159|FG001|Overall Study|Progressive disease|44|||
127815355|NCT03972488|459941158|FG000|Overall Study|Physician Decision|13|||
127815356|NCT03972488|459941159|FG001|Overall Study|Physician Decision|7|||
127815357|NCT03972488|459941158|FG000|Overall Study|Adverse Event|8|||
127815358|NCT03972488|459941159|FG001|Overall Study|Adverse Event|1|||
127815359|NCT03972488|459941158|FG000|Overall Study|Death|4|||
127815360|NCT03972488|459941159|FG001|Overall Study|Death|4|||
127815361|NCT03972488|459941158|FG000|Overall Study|Withdrawal by Subject|3|||
127815362|NCT03972488|459941159|FG001|Overall Study|Withdrawal by Subject|4|||
127868849|NCT02210559|460137407|FG000|Overall Study|Progressive Disease|3|||
127815363|NCT03972488|459941158|FG000|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|3|||
127815364|NCT03972488|459941159|FG001|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|0|||
127815365|NCT04865731|459941160|FG000|Overall Study|Physician Decision|2|||
127815366|NCT04865731|459941161|FG001|Overall Study|Physician Decision|1|||
127815367|NCT04865731|459941160|FG000|Overall Study|Adverse Event|1|||
127815368|NCT04865731|459941161|FG001|Overall Study|Adverse Event|0|||
127815369|NCT04865731|459941160|FG000|Overall Study|Withdrawal by Subject|0|||
127815370|NCT04865731|459941161|FG001|Overall Study|Withdrawal by Subject|1|||
127815371|NCT02770807|459941162|FG000|Overall Study|Adverse Event|3|||
127815372|NCT02770807|459941163|FG001|Overall Study|Adverse Event|3|||
127815373|NCT02770807|459941164|FG002|Overall Study|Adverse Event|1|||
127815374|NCT02770807|459941162|FG000|Overall Study|Withdrawal by Subject|7|||
127815375|NCT02770807|459941163|FG001|Overall Study|Withdrawal by Subject|3|||
127815376|NCT02770807|459941164|FG002|Overall Study|Withdrawal by Subject|4|||
127815377|NCT02770807|459941162|FG000|Overall Study|Other|0|||
127815378|NCT02770807|459941163|FG001|Overall Study|Other|1|||
127815379|NCT02770807|459941164|FG002|Overall Study|Other|0|||
127815380|NCT02770807|459941162|FG000|Overall Study|Covid-Related Treatment/Visit Delay|15|||
127815381|NCT02770807|459941163|FG001|Overall Study|Covid-Related Treatment/Visit Delay|13|||
127815382|NCT02770807|459941164|FG002|Overall Study|Covid-Related Treatment/Visit Delay|17|||
127815383|NCT02770807|459941162|FG000|Overall Study|Physician Decision|0|||
127815384|NCT02770807|459941163|FG001|Overall Study|Physician Decision|0|||
127815385|NCT02770807|459941164|FG002|Overall Study|Physician Decision|1|||
127815386|NCT00374556|459942813|FG000|Overall Study|Lost to Follow-up|1|||
127815387|NCT00374556|459942814|FG001|Overall Study|Lost to Follow-up|0|||
127815388|NCT00374556|459942813|FG000|Overall Study|Removed at baseline due to medical cond|0|||
127815389|NCT00374556|459942814|FG001|Overall Study|Removed at baseline due to medical cond|1|||
127815390|NCT00942162|459942815|FG000|Overall Study|Death|45|||
127815391|NCT00942162|459942816|FG001|Overall Study|Death|35|||
127815392|NCT00942162|459942817|FG002|Overall Study|Death|0|||
127815393|NCT00942162|459942815|FG000|Overall Study|Withdrawal by Subject|7|||
127815394|NCT00942162|459942816|FG001|Overall Study|Withdrawal by Subject|2|||
127815395|NCT00942162|459942817|FG002|Overall Study|Withdrawal by Subject|0|||
127815396|NCT00942162|459942815|FG000|Overall Study|Lost to Follow-up|4|||
127815397|NCT00942162|459942816|FG001|Overall Study|Lost to Follow-up|0|||
127815398|NCT00942162|459942817|FG002|Overall Study|Lost to Follow-up|0|||
127815399|NCT00942162|459942815|FG000|Overall Study|Other|14|||
127815400|NCT00942162|459942816|FG001|Overall Study|Other|13|||
127815401|NCT00942162|459942817|FG002|Overall Study|Other|2|||
127815402|NCT02799381|459942827|FG000|Overall Study|Withdrew consent|3|||
127815403|NCT02799381|459942828|FG001|Overall Study|Withdrew consent|2|||
127815404|NCT02799381|459942827|FG000|Overall Study|Adverse Event|0|||
127815405|NCT02799381|459942828|FG001|Overall Study|Adverse Event|1|||
127815406|NCT02799381|459942827|FG000|Overall Study|Participant did not take any study drug|1|||
127815407|NCT02799381|459942828|FG001|Overall Study|Participant did not take any study drug|0|||
127815408|NCT05882890|459942831|FG000|Overall Study|Exclusion was due to a score in xerostomia VASscale < 4.|1|||
127815409|NCT00613314|459942834|FG000|Overall Study|Adverse Event|5|||
127815410|NCT00613314|459942834|FG000|Overall Study|Protocol Violation|14|||
127815411|NCT00613314|459942834|FG000|Overall Study|Lost to Follow-up|46|||
127815412|NCT00613314|459942834|FG000|Overall Study|Other reason not defined above|90|||
127815413|NCT03090191|459942839|FG000|Overall Study|Adverse Event|90|||
127815414|NCT03090191|459942840|FG001|Overall Study|Adverse Event|72|||
127815415|NCT03090191|459942839|FG000|Overall Study|Death|365|||
127815416|NCT03090191|459942840|FG001|Overall Study|Death|358|||
127815417|NCT03090191|459942839|FG000|Overall Study|Lost to Follow-up|382|||
127815418|NCT03090191|459942840|FG001|Overall Study|Lost to Follow-up|394|||
127815419|NCT03090191|459942839|FG000|Overall Study|Physician Decision|77|||
127815420|NCT03090191|459942840|FG001|Overall Study|Physician Decision|66|||
127815421|NCT03090191|459942839|FG000|Overall Study|Protocol Violation|43|||
127815422|NCT03090191|459942840|FG001|Overall Study|Protocol Violation|52|||
127815423|NCT03090191|459942839|FG000|Overall Study|Withdrawal by Subject|2160|||
127815424|NCT03090191|459942840|FG001|Overall Study|Withdrawal by Subject|2133|||
127815425|NCT03090191|459942839|FG000|Overall Study|Site terminated|7|||
127815426|NCT03090191|459942840|FG001|Overall Study|Site terminated|8|||
127815427|NCT03090191|459942839|FG000|Overall Study|Other|66|||
127815428|NCT03090191|459942840|FG001|Overall Study|Other|60|||
127815429|NCT03090191|459942839|FG000|Overall Study|Withdrawn before any study vaccination|43|||
127815430|NCT03090191|459942840|FG001|Overall Study|Withdrawn before any study vaccination|52|||
127815431|NCT04723537|459942841|FG000|Overall Study|Withdrawal by Subject|3|||
127815432|NCT04723537|459942842|FG001|Overall Study|Withdrawal by Subject|0|||
127815433|NCT04723537|459942843|FG002|Overall Study|Withdrawal by Subject|0|||
127815434|NCT04723537|459942841|FG000|Overall Study|Physician Decision|0|||
127815435|NCT04723537|459942842|FG001|Overall Study|Physician Decision|0|||
127815436|NCT04723537|459942843|FG002|Overall Study|Physician Decision|1|||
127815437|NCT04723537|459942841|FG000|Overall Study|Medical monitor decision, sponsor decision and other|1|||
127815438|NCT04723537|459942842|FG001|Overall Study|Medical monitor decision, sponsor decision and other|1|||
127815439|NCT04723537|459942843|FG002|Overall Study|Medical monitor decision, sponsor decision and other|1|||
127815440|NCT02432807|459942844|FG000|Overall Study|Adverse Event|0|||
127815441|NCT02432807|459942845|FG001|Overall Study|Adverse Event|2|||
127815442|NCT02432807|459942844|FG000|Overall Study|Lost to Follow-up|1|||
127815443|NCT02432807|459942845|FG001|Overall Study|Lost to Follow-up|0|||
127815444|NCT02432807|459942844|FG000|Overall Study|Withdrawal by Subject|1|||
127815445|NCT02432807|459942845|FG001|Overall Study|Withdrawal by Subject|1|||
127815446|NCT02432807|459942844|FG000|Overall Study|Other|1|||
127815447|NCT02432807|459942845|FG001|Overall Study|Other|1|||
127815448|NCT04419506|459942846|FG000|Overall Study|Adverse Event|0|||
127815449|NCT04419506|459942847|FG001|Overall Study|Adverse Event|10|||
127815450|NCT04419506|459942848|FG002|Overall Study|Adverse Event|0|||
127815451|NCT04419506|459942849|FG003|Overall Study|Adverse Event|3|||
127815452|NCT04419506|459942846|FG000|Overall Study|Withdrawal by Subject|0|||
127815453|NCT04419506|459942847|FG001|Overall Study|Withdrawal by Subject|0|||
127815454|NCT04419506|459942848|FG002|Overall Study|Withdrawal by Subject|0|||
127815455|NCT04419506|459942849|FG003|Overall Study|Withdrawal by Subject|1|||
127815456|NCT04419506|459942846|FG000|Overall Study|poor-compliance|0|||
127815457|NCT04419506|459942847|FG001|Overall Study|poor-compliance|0|||
127815458|NCT04419506|459942848|FG002|Overall Study|poor-compliance|0|||
127815459|NCT04419506|459942849|FG003|Overall Study|poor-compliance|1|||
127815460|NCT01845025|459942850|FG000|Overall Study|Adverse Event|6|||
127815461|NCT01845025|459942851|FG001|Overall Study|Adverse Event|3|||
127815462|NCT01845025|459942850|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
127815463|NCT01845025|459942851|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
127815464|NCT01845025|459942850|FG000|Overall Study|Withdrawal by Subject|48|||
127815465|NCT01845025|459942851|FG001|Overall Study|Withdrawal by Subject|44|||
127815466|NCT01845025|459942850|FG000|Overall Study|Lost to Follow-up|13|||
127815467|NCT01845025|459942851|FG001|Overall Study|Lost to Follow-up|13|||
127815468|NCT01845025|459942850|FG000|Overall Study|Administrative problems|8|||
127815469|NCT01845025|459942851|FG001|Overall Study|Administrative problems|8|||
127815470|NCT01845025|459942850|FG000|Overall Study|Death|2|||
127815471|NCT01845025|459942851|FG001|Overall Study|Death|0|||
127815472|NCT01845025|459942850|FG000|Overall Study|Protocol deviation|3|||
127815473|NCT01845025|459942851|FG001|Overall Study|Protocol deviation|6|||
127815474|NCT01845025|459942850|FG000|Overall Study|Missing|1|||
127815475|NCT01845025|459942851|FG001|Overall Study|Missing|1|||
127815476|NCT03976401|459942858|FG000|Overall Study|Adverse Event|2|||
127815477|NCT03976401|459942859|FG001|Overall Study|Adverse Event|0|||
127815478|NCT03976401|459942860|FG002|Overall Study|Adverse Event|4|||
127815479|NCT03976401|459942861|FG003|Overall Study|Adverse Event|1|||
127815480|NCT03976401|459942862|FG004|Overall Study|Adverse Event|1|||
127815481|NCT03976401|459942863|FG005|Overall Study|Adverse Event|0|||
127815482|NCT03976401|459942858|FG000|Overall Study|Withdrawal by Subject|0|||
127815483|NCT03976401|459942859|FG001|Overall Study|Withdrawal by Subject|1|||
127815484|NCT03976401|459942860|FG002|Overall Study|Withdrawal by Subject|0|||
127815485|NCT03976401|459942861|FG003|Overall Study|Withdrawal by Subject|0|||
127815486|NCT03976401|459942862|FG004|Overall Study|Withdrawal by Subject|0|||
127815487|NCT03976401|459942863|FG005|Overall Study|Withdrawal by Subject|1|||
127815488|NCT03976401|459942858|FG000|Overall Study|Physician Decision|0|||
127815489|NCT03976401|459942859|FG001|Overall Study|Physician Decision|0|||
127815490|NCT03976401|459942860|FG002|Overall Study|Physician Decision|1|||
127815491|NCT03976401|459942861|FG003|Overall Study|Physician Decision|0|||
127815492|NCT03976401|459942862|FG004|Overall Study|Physician Decision|0|||
127815493|NCT03976401|459942863|FG005|Overall Study|Physician Decision|0|||
127815494|NCT03976401|459942858|FG000|Overall Study|Lost to Follow-up|1|||
127815495|NCT03976401|459942859|FG001|Overall Study|Lost to Follow-up|2|||
127815496|NCT03976401|459942860|FG002|Overall Study|Lost to Follow-up|0|||
127815497|NCT03976401|459942861|FG003|Overall Study|Lost to Follow-up|0|||
127815498|NCT03976401|459942862|FG004|Overall Study|Lost to Follow-up|0|||
127815499|NCT03976401|459942863|FG005|Overall Study|Lost to Follow-up|0|||
127815500|NCT03976401|459942858|FG000|Overall Study|Protocol Violation|0|||
127815501|NCT03976401|459942859|FG001|Overall Study|Protocol Violation|1|||
127815502|NCT03976401|459942860|FG002|Overall Study|Protocol Violation|0|||
127815503|NCT03976401|459942861|FG003|Overall Study|Protocol Violation|0|||
127815504|NCT03976401|459942862|FG004|Overall Study|Protocol Violation|0|||
127815505|NCT03976401|459942863|FG005|Overall Study|Protocol Violation|0|||
127815506|NCT03976401|459942858|FG000|Overall Study|Withdrew Consent|0|||
127815507|NCT03976401|459942859|FG001|Overall Study|Withdrew Consent|0|||
127815508|NCT03976401|459942860|FG002|Overall Study|Withdrew Consent|0|||
127815509|NCT03976401|459942861|FG003|Overall Study|Withdrew Consent|1|||
127815510|NCT03976401|459942862|FG004|Overall Study|Withdrew Consent|0|||
127815511|NCT03976401|459942863|FG005|Overall Study|Withdrew Consent|0|||
127815512|NCT01973283|459942865|FG000|Overall Study|Lost to Follow-up|4|||
127815513|NCT02966314|459942866|FG000|Overall Study|Lost to Follow-up|1|||
127815514|NCT02966314|459942867|FG001|Overall Study|Lost to Follow-up|0|||
127815515|NCT03941548|459942869|FG000|Overall Study|Adverse Event|0|||
127815516|NCT03941548|459942870|FG001|Overall Study|Adverse Event|1|||
127815517|NCT03941548|459942869|FG000|Overall Study|Lost to Follow-up|0|||
127815518|NCT03941548|459942870|FG001|Overall Study|Lost to Follow-up|1|||
127815519|NCT03941548|459942869|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
127815520|NCT03941548|459942870|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
127815521|NCT00811252|459942880|FG000|Overall Study|Adverse Event|6|||
127815522|NCT00811252|459942881|FG001|Overall Study|Adverse Event|10|||
127815523|NCT00811252|459942882|FG002|Overall Study|Adverse Event|15|||
127815524|NCT00811252|459942880|FG000|Overall Study|Lack of Efficacy|7|||
127815525|NCT00811252|459942881|FG001|Overall Study|Lack of Efficacy|2|||
127815526|NCT00811252|459942882|FG002|Overall Study|Lack of Efficacy|0|||
127815527|NCT00811252|459942880|FG000|Overall Study|Protocol Violation|3|||
127815528|NCT00811252|459942881|FG001|Overall Study|Protocol Violation|3|||
127815529|NCT00811252|459942882|FG002|Overall Study|Protocol Violation|2|||
127815530|NCT00811252|459942880|FG000|Overall Study|Withdrawal of Consent|1|||
127815531|NCT00811252|459942881|FG001|Overall Study|Withdrawal of Consent|2|||
127815532|NCT00811252|459942882|FG002|Overall Study|Withdrawal of Consent|2|||
127815533|NCT00811252|459942880|FG000|Overall Study|Lost to Follow-up|0|||
127815534|NCT00811252|459942881|FG001|Overall Study|Lost to Follow-up|0|||
127815535|NCT00811252|459942882|FG002|Overall Study|Lost to Follow-up|2|||
127815536|NCT00811252|459942880|FG000|Overall Study|Administrative or Other Reasons|0|||
127815537|NCT00811252|459942881|FG001|Overall Study|Administrative or Other Reasons|3|||
127815538|NCT00811252|459942882|FG002|Overall Study|Administrative or Other Reasons|2|||
127815539|NCT01486264|459942883|FG000|Overall Study|Death|1|||
127815540|NCT01486264|459942884|FG001|Overall Study|Death|1|||
127815541|NCT01486264|459942883|FG000|Overall Study|Adverse Event|3|||
127815542|NCT01486264|459942884|FG001|Overall Study|Adverse Event|3|||
127815543|NCT01486264|459942883|FG000|Overall Study|Lack of Efficacy|6|||
127815544|NCT01486264|459942884|FG001|Overall Study|Lack of Efficacy|10|||
127815545|NCT01486264|459942883|FG000|Overall Study|Withdrawal by Subject|7|||
127815546|NCT01486264|459942884|FG001|Overall Study|Withdrawal by Subject|18|||
127815547|NCT01486264|459942883|FG000|Overall Study|Physician Decision|1|||
127815548|NCT01486264|459942884|FG001|Overall Study|Physician Decision|1|||
127815549|NCT01486264|459942883|FG000|Overall Study|Protocol Violation|3|||
127815550|NCT01486264|459942884|FG001|Overall Study|Protocol Violation|0|||
127815551|NCT01486264|459942883|FG000|Overall Study|Lost to Follow-up|3|||
127815552|NCT01486264|459942884|FG001|Overall Study|Lost to Follow-up|2|||
127815553|NCT01486264|459942883|FG000|Overall Study|Other|5|||
127815554|NCT01486264|459942884|FG001|Overall Study|Other|11|||
127815555|NCT01486264|459942883|FG000|Overall Study|Not treated|0|||
127815556|NCT01486264|459942884|FG001|Overall Study|Not treated|1|||
127815557|NCT00813748|459942885|FG000|Skin Test Substudy|Physician Decision|0|||
127815558|NCT00813748|459942886|FG001|Skin Test Substudy|Physician Decision|1|||
127815559|NCT01931865|459942887|FG000|Overall Study|Lost to Follow-up|2|||
127815560|NCT01931865|459942887|FG000|Overall Study|Withdrawal by Subject|2|||
127815561|NCT00824421|459942892|FG000|Overall Study|Adverse Event|6|||
127815562|NCT00824421|459942893|FG001|Overall Study|Adverse Event|6|||
127815563|NCT00824421|459942894|FG002|Overall Study|Adverse Event|6|||
127815564|NCT00824421|459942892|FG000|Overall Study|Death|0|||
127815565|NCT00824421|459942893|FG001|Overall Study|Death|1|||
127815566|NCT00824421|459942894|FG002|Overall Study|Death|0|||
127815567|NCT00824421|459942892|FG000|Overall Study|Lack of Efficacy|5|||
127815568|NCT00824421|459942893|FG001|Overall Study|Lack of Efficacy|7|||
127815569|NCT00824421|459942894|FG002|Overall Study|Lack of Efficacy|4|||
127815570|NCT00824421|459942892|FG000|Overall Study|Lost to Follow-up|2|||
127815571|NCT00824421|459942893|FG001|Overall Study|Lost to Follow-up|3|||
127815572|NCT00824421|459942894|FG002|Overall Study|Lost to Follow-up|0|||
127815573|NCT00824421|459942892|FG000|Overall Study|Pregnancy|1|||
127815574|NCT00824421|459942893|FG001|Overall Study|Pregnancy|0|||
127815575|NCT00824421|459942894|FG002|Overall Study|Pregnancy|1|||
127815576|NCT00824421|459942892|FG000|Overall Study|Withdrawal by Subject|2|||
127815577|NCT00824421|459942893|FG001|Overall Study|Withdrawal by Subject|3|||
127815578|NCT00824421|459942894|FG002|Overall Study|Withdrawal by Subject|3|||
127815579|NCT00824421|459942892|FG000|Overall Study|Randomized but not Treated|1|||
127815580|NCT00824421|459942893|FG001|Overall Study|Randomized but not Treated|1|||
127815581|NCT00824421|459942894|FG002|Overall Study|Randomized but not Treated|0|||
127815582|NCT00824421|459942892|FG000|Overall Study|Other|0|||
127815583|NCT00824421|459942893|FG001|Overall Study|Other|1|||
127815584|NCT00824421|459942894|FG002|Overall Study|Other|0|||
127815585|NCT02120417|459942896|FG000|Overall Study|Death|5|||
127815586|NCT02120417|459942897|FG001|Overall Study|Death|1|||
127815587|NCT02120417|459942896|FG000|Overall Study|Adverse Event|3|||
127815588|NCT02120417|459942897|FG001|Overall Study|Adverse Event|9|||
127815589|NCT02120417|459942896|FG000|Overall Study|Participant decision|4|||
127815590|NCT02120417|459942897|FG001|Overall Study|Participant decision|4|||
127815591|NCT02120417|459942896|FG000|Overall Study|Disease progression|41|||
127815592|NCT02120417|459942897|FG001|Overall Study|Disease progression|45|||
127815593|NCT02120417|459942896|FG000|Overall Study|Noncompliance with study treatment|0|||
127815594|NCT02120417|459942897|FG001|Overall Study|Noncompliance with study treatment|2|||
127815595|NCT02120417|459942896|FG000|Overall Study|Physician Decision|2|||
127815596|NCT02120417|459942897|FG001|Overall Study|Physician Decision|3|||
127815597|NCT02120417|459942896|FG000|Overall Study|Other unspecified|5|||
127815598|NCT02120417|459942897|FG001|Overall Study|Other unspecified|4|||
127815599|NCT00594399|459942898|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
127815600|NCT00594399|459942899|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
127815601|NCT00594399|459942900|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
127815602|NCT00594399|459942898|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
127815603|NCT00594399|459942899|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
127815604|NCT00594399|459942900|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
127815605|NCT00594399|459942898|FG000|Initial 3 Month Counseling|Personal issues|2|||
127815606|NCT00594399|459942899|FG001|Initial 3 Month Counseling|Personal issues|0|||
127815607|NCT00594399|459942900|FG002|Initial 3 Month Counseling|Personal issues|0|||
127815608|NCT00594399|459942898|FG000|Initial 3 Month Counseling|Too busy|7|||
127815609|NCT00594399|459942899|FG001|Initial 3 Month Counseling|Too busy|1|||
127815610|NCT00594399|459942900|FG002|Initial 3 Month Counseling|Too busy|0|||
127815611|NCT00594399|459942898|FG000|Initial 3 Month Counseling|Pain|2|||
127815612|NCT00594399|459942899|FG001|Initial 3 Month Counseling|Pain|0|||
127815613|NCT00594399|459942900|FG002|Initial 3 Month Counseling|Pain|0|||
127815614|NCT00594399|459942898|FG000|Initial 3 Month Counseling|Moved|1|||
127815615|NCT00594399|459942899|FG001|Initial 3 Month Counseling|Moved|0|||
127815616|NCT00594399|459942900|FG002|Initial 3 Month Counseling|Moved|0|||
127815617|NCT00594399|459942898|FG000|Initial 3 Month Counseling|Family illness|1|||
127815618|NCT00594399|459942899|FG001|Initial 3 Month Counseling|Family illness|0|||
127815619|NCT00594399|459942900|FG002|Initial 3 Month Counseling|Family illness|0|||
127815620|NCT00594399|459942898|FG000|Rerandomization Arm 1 Only|Death|2|||
127815621|NCT00594399|459942899|FG001|Rerandomization Arm 1 Only|Death|1|||
127815622|NCT00594399|459942900|FG002|Rerandomization Arm 1 Only|Death|0|||
127815623|NCT00594399|459942898|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
127815624|NCT00594399|459942899|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
127815625|NCT00594399|459942900|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
127815626|NCT00424398|459942901|FG000|Overall Study|Withdrawal by Subject|2|||
127815627|NCT00424398|459942902|FG001|Overall Study|Withdrawal by Subject|1|||
127815628|NCT00424398|459942903|FG002|Overall Study|Withdrawal by Subject|0|||
127815629|NCT00424398|459942901|FG000|Overall Study|Subject met exclusion criteria|1|||
127815630|NCT00424398|459942902|FG001|Overall Study|Subject met exclusion criteria|0|||
127815631|NCT00424398|459942903|FG002|Overall Study|Subject met exclusion criteria|0|||
127815632|NCT01023789|459942904|FG000|3 - Year Visit|Death|29|||
127815633|NCT01023789|459942904|FG000|3 - Year Visit|Withdrawal of consent|1|||
127815634|NCT01023789|459942904|FG000|3 - Year Visit|Lost to Follow-up|13|||
127815635|NCT02034123|459942909|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
127815636|NCT02034123|459942910|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
127815637|NCT02034123|459942911|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
127815638|NCT02034123|459942912|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
127815639|NCT02034123|459942913|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
127815640|NCT02034123|459942914|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
127815641|NCT02034123|459942915|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
127815642|NCT02034123|459942916|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
127815643|NCT02034123|459942917|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
127815644|NCT02034123|459942918|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
127815645|NCT02034123|459942919|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
127815646|NCT02034123|459942920|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
127815647|NCT02034123|459942921|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
127815648|NCT02034123|459942922|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
127815649|NCT02034123|459942923|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
127815650|NCT02034123|459942924|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
127815651|NCT02034123|459942925|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
127815652|NCT02034123|459942926|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
127815653|NCT02034123|459942909|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
127815654|NCT02034123|459942910|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
127815655|NCT02034123|459942911|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
127815656|NCT02034123|459942912|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
127815657|NCT02034123|459942913|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
127815658|NCT02034123|459942914|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
127815659|NCT02034123|459942915|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
127868850|NCT02210559|460137408|FG001|Overall Study|Progressive Disease|2|||
127815660|NCT02034123|459942916|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
127815661|NCT02034123|459942917|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
127815662|NCT02034123|459942918|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
127815663|NCT02034123|459942919|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
127815664|NCT02034123|459942920|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
127815665|NCT02034123|459942921|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
127815666|NCT02034123|459942922|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
127815667|NCT02034123|459942923|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
127815668|NCT02034123|459942924|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
127815669|NCT02034123|459942925|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
127815670|NCT02034123|459942926|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
127815671|NCT02034123|459942909|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
127815672|NCT02034123|459942910|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
127815673|NCT02034123|459942911|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
127815674|NCT02034123|459942912|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
127815675|NCT02034123|459942913|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
127815676|NCT02034123|459942914|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
127815677|NCT02034123|459942915|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
127815678|NCT02034123|459942916|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
127815679|NCT02034123|459942917|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
127815680|NCT02034123|459942918|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
127815681|NCT02034123|459942919|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
127815682|NCT02034123|459942920|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
127815683|NCT02034123|459942921|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
127815684|NCT02034123|459942922|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
127815685|NCT02034123|459942923|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
127815686|NCT02034123|459942924|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
127815687|NCT02034123|459942925|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
127815688|NCT02034123|459942926|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
127815689|NCT02034123|459942909|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
127815690|NCT02034123|459942910|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
127815691|NCT02034123|459942911|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
127815692|NCT02034123|459942912|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
127815693|NCT02034123|459942913|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
127815694|NCT02034123|459942914|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
127815695|NCT02034123|459942915|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
127815696|NCT02034123|459942916|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
127815697|NCT02034123|459942917|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
127815698|NCT02034123|459942918|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
127815699|NCT02034123|459942919|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
127815700|NCT02034123|459942920|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
127815701|NCT02034123|459942921|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
127815702|NCT02034123|459942922|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
127815703|NCT02034123|459942923|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
127815704|NCT02034123|459942924|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
127815705|NCT02034123|459942925|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
127815706|NCT02034123|459942926|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
127815707|NCT02240706|459942930|FG000|Overall Study|Lack of Efficacy|2|||
127815708|NCT02240706|459942931|FG001|Overall Study|Lack of Efficacy|2|||
127815709|NCT02240706|459942932|FG002|Overall Study|Lack of Efficacy|2|||
127815710|NCT02240706|459942933|FG003|Overall Study|Lack of Efficacy|2|||
127815711|NCT02240706|459942934|FG004|Overall Study|Lack of Efficacy|5|||
127815712|NCT02240706|459942935|FG005|Overall Study|Lack of Efficacy|0|||
127815713|NCT02240706|459942936|FG006|Overall Study|Lack of Efficacy|0|||
127815714|NCT02240706|459942930|FG000|Overall Study|Adverse Event|1|||
127815715|NCT02240706|459942931|FG001|Overall Study|Adverse Event|0|||
127815716|NCT02240706|459942932|FG002|Overall Study|Adverse Event|1|||
127815717|NCT02240706|459942933|FG003|Overall Study|Adverse Event|0|||
127815718|NCT02240706|459942934|FG004|Overall Study|Adverse Event|2|||
127815719|NCT02240706|459942935|FG005|Overall Study|Adverse Event|0|||
127815720|NCT02240706|459942936|FG006|Overall Study|Adverse Event|0|||
127815721|NCT02240706|459942930|FG000|Overall Study|Progressive disease|0|||
127815722|NCT02240706|459942931|FG001|Overall Study|Progressive disease|0|||
127815723|NCT02240706|459942932|FG002|Overall Study|Progressive disease|0|||
127815724|NCT02240706|459942933|FG003|Overall Study|Progressive disease|0|||
127815725|NCT02240706|459942934|FG004|Overall Study|Progressive disease|1|||
127815726|NCT02240706|459942935|FG005|Overall Study|Progressive disease|0|||
127815727|NCT02240706|459942936|FG006|Overall Study|Progressive disease|0|||
127815728|NCT02240706|459942930|FG000|Overall Study|Dose limiting toxicity|0|||
127815729|NCT02240706|459942931|FG001|Overall Study|Dose limiting toxicity|0|||
127815730|NCT02240706|459942932|FG002|Overall Study|Dose limiting toxicity|0|||
127815731|NCT02240706|459942933|FG003|Overall Study|Dose limiting toxicity|0|||
127815732|NCT02240706|459942934|FG004|Overall Study|Dose limiting toxicity|1|||
127815733|NCT02240706|459942935|FG005|Overall Study|Dose limiting toxicity|0|||
127815734|NCT02240706|459942936|FG006|Overall Study|Dose limiting toxicity|0|||
127815735|NCT02240706|459942930|FG000|Overall Study|Refused to continue taking medication|0|||
127815736|NCT02240706|459942931|FG001|Overall Study|Refused to continue taking medication|1|||
127815737|NCT02240706|459942932|FG002|Overall Study|Refused to continue taking medication|3|||
127815738|NCT02240706|459942933|FG003|Overall Study|Refused to continue taking medication|1|||
127815739|NCT02240706|459942934|FG004|Overall Study|Refused to continue taking medication|2|||
127815740|NCT02240706|459942935|FG005|Overall Study|Refused to continue taking medication|0|||
127815741|NCT02240706|459942936|FG006|Overall Study|Refused to continue taking medication|0|||
127815742|NCT02240706|459942930|FG000|Overall Study|Insurance billing concerns|0|||
127815743|NCT02240706|459942931|FG001|Overall Study|Insurance billing concerns|0|||
127815744|NCT02240706|459942932|FG002|Overall Study|Insurance billing concerns|0|||
127815745|NCT02240706|459942933|FG003|Overall Study|Insurance billing concerns|1|||
127815746|NCT02240706|459942934|FG004|Overall Study|Insurance billing concerns|0|||
127815747|NCT02240706|459942935|FG005|Overall Study|Insurance billing concerns|0|||
127815748|NCT02240706|459942936|FG006|Overall Study|Insurance billing concerns|0|||
127815749|NCT03301857|459942937|FG000|Overall Study|Death|0|||
127815750|NCT03301857|459942938|FG001|Overall Study|Death|2|||
127815751|NCT03301857|459942937|FG000|Overall Study|Lost to Follow-up|4|||
127815752|NCT03301857|459942938|FG001|Overall Study|Lost to Follow-up|2|||
127815753|NCT03301857|459942937|FG000|Overall Study|Decision by Sponsor|6|||
127815754|NCT03301857|459942938|FG001|Overall Study|Decision by Sponsor|0|||
127815755|NCT03301857|459942937|FG000|Overall Study|Withdrawal by Subject|12|||
127815756|NCT03301857|459942938|FG001|Overall Study|Withdrawal by Subject|4|||
127815757|NCT00613626|459942942|FG000|Overall Study|Ineligible|0|||
127815758|NCT00613626|459942943|FG001|Overall Study|Ineligible|1|||
127815759|NCT00613626|459942944|FG002|Overall Study|Ineligible|0|||
127815760|NCT01731002|459942954|FG000|Overall Study|Adverse Event|0|||
127815761|NCT01731002|459942955|FG001|Overall Study|Adverse Event|2|||
127815762|NCT01731002|459942956|FG002|Overall Study|Adverse Event|2|||
127815763|NCT01731002|459942954|FG000|Overall Study|Non-Compliant|0|||
127815764|NCT01731002|459942955|FG001|Overall Study|Non-Compliant|1|||
127815765|NCT01731002|459942956|FG002|Overall Study|Non-Compliant|0|||
127815766|NCT01731002|459942954|FG000|Overall Study|Lost to Follow-up|1|||
127815767|NCT01731002|459942955|FG001|Overall Study|Lost to Follow-up|0|||
127815768|NCT01731002|459942956|FG002|Overall Study|Lost to Follow-up|0|||
127815769|NCT01731002|459942954|FG000|Overall Study|Test Agent Discontinuation|0|||
127815770|NCT01731002|459942955|FG001|Overall Study|Test Agent Discontinuation|1|||
127815771|NCT01731002|459942956|FG002|Overall Study|Test Agent Discontinuation|0|||
127815772|NCT01731002|459942954|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
127815773|NCT01731002|459942955|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
127815774|NCT01731002|459942956|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
127815775|NCT01731002|459942954|FG000|Overall Study|Elevated IOP|1|||
127815776|NCT01731002|459942955|FG001|Overall Study|Elevated IOP|0|||
127815777|NCT01731002|459942956|FG002|Overall Study|Elevated IOP|0|||
127815778|NCT01731002|459942954|FG000|Overall Study|Inappropriate use of study medications|0|||
127815779|NCT01731002|459942955|FG001|Overall Study|Inappropriate use of study medications|0|||
127815780|NCT01731002|459942956|FG002|Overall Study|Inappropriate use of study medications|1|||
127815781|NCT00628355|459942959|FG000|Overall Study|Withdrawal by Subject|1|||
127815782|NCT00628355|459942960|FG001|Overall Study|Withdrawal by Subject|1|||
127815783|NCT03542682|459942961|FG000|Overall Study|COVID-19 Protocol|0|||
127815784|NCT03542682|459942962|FG001|Overall Study|COVID-19 Protocol|1|||
127815785|NCT03232073|459942965|FG000|Overall Study|Death|1|||
127815786|NCT03232073|459942966|FG001|Overall Study|Death|0|||
127815787|NCT03232073|459942965|FG000|Overall Study|Adverse Event|7|||
127815788|NCT03232073|459942966|FG001|Overall Study|Adverse Event|12|||
127815789|NCT03232073|459942965|FG000|Overall Study|Lost to Follow-up|6|||
127815790|NCT03232073|459942966|FG001|Overall Study|Lost to Follow-up|6|||
127815791|NCT03232073|459942965|FG000|Overall Study|Lack of Efficacy|10|||
127815792|NCT03232073|459942966|FG001|Overall Study|Lack of Efficacy|8|||
127815793|NCT03232073|459942965|FG000|Overall Study|Physician Decision|9|||
127815794|NCT03232073|459942966|FG001|Overall Study|Physician Decision|2|||
127815795|NCT03232073|459942965|FG000|Overall Study|Withdrawal by Subject|54|||
127815796|NCT03232073|459942966|FG001|Overall Study|Withdrawal by Subject|39|||
127815797|NCT00853632|459944045|FG000|Overall Study|Death|88|||
127815798|NCT00853632|459944045|FG000|Overall Study|Withdrawal by Subject|45|||
127815799|NCT00853632|459944045|FG000|Overall Study|Lost to Follow-up|30|||
127815800|NCT00853632|459944045|FG000|Overall Study|Reoperation/Explant|17|||
127815801|NCT00853632|459944045|FG000|Overall Study|Exit with other reason|22|||
127815802|NCT01672892|459944046|FG000|Overall Study|Protocol Violation|7|||
127815803|NCT01672892|459944047|FG001|Overall Study|Protocol Violation|3|||
127815804|NCT00886821|459944058|FG000|Stage 2|Adverse Event|0|||
127815805|NCT00886821|459944059|FG001|Stage 2|Adverse Event|0|||
127815806|NCT00886821|459944060|FG002|Stage 2|Adverse Event|0|||
127815807|NCT00886821|459944061|FG003|Stage 2|Adverse Event|0|||
127815808|NCT00886821|459944062|FG004|Stage 2|Adverse Event|0|||
127815809|NCT00886821|459944063|FG005|Stage 2|Adverse Event|0|||
127815810|NCT00886821|459944064|FG006|Stage 2|Adverse Event|0|||
127815811|NCT00886821|459944065|FG007|Stage 2|Adverse Event|0|||
127815812|NCT00886821|459944066|FG008|Stage 2|Adverse Event|0|||
127815813|NCT00886821|459944067|FG009|Stage 2|Adverse Event|0|||
127815814|NCT00886821|459944068|FG010|Stage 2|Adverse Event|0|||
127815815|NCT00886821|459944069|FG011|Stage 2|Adverse Event|1|||
127815816|NCT00886821|459944070|FG012|Stage 2|Adverse Event|3|||
127815817|NCT00886821|459944071|FG013|Stage 2|Adverse Event|0|||
127815818|NCT00886821|459944058|FG000|Stage 2|Lost to Follow-up|0|||
127815819|NCT00886821|459944059|FG001|Stage 2|Lost to Follow-up|0|||
127815820|NCT00886821|459944060|FG002|Stage 2|Lost to Follow-up|0|||
127815821|NCT00886821|459944061|FG003|Stage 2|Lost to Follow-up|0|||
127815822|NCT00886821|459944062|FG004|Stage 2|Lost to Follow-up|0|||
127815823|NCT00886821|459944063|FG005|Stage 2|Lost to Follow-up|0|||
127815824|NCT00886821|459944064|FG006|Stage 2|Lost to Follow-up|0|||
127815825|NCT00886821|459944065|FG007|Stage 2|Lost to Follow-up|0|||
127815826|NCT00886821|459944066|FG008|Stage 2|Lost to Follow-up|0|||
127815827|NCT00886821|459944067|FG009|Stage 2|Lost to Follow-up|0|||
127815828|NCT00886821|459944068|FG010|Stage 2|Lost to Follow-up|0|||
127815829|NCT00886821|459944069|FG011|Stage 2|Lost to Follow-up|0|||
127815830|NCT00886821|459944070|FG012|Stage 2|Lost to Follow-up|2|||
127815831|NCT00886821|459944071|FG013|Stage 2|Lost to Follow-up|1|||
127815832|NCT00914628|459944072|FG000|Overall Study|Death|35|||
127815833|NCT00914628|459944073|FG001|Overall Study|Death|17|||
127815834|NCT00914628|459944072|FG000|Overall Study|Medical decision|4|||
127815835|NCT00914628|459944073|FG001|Overall Study|Medical decision|0|||
127815836|NCT00914628|459944072|FG000|Overall Study|Protocol Violation|1|||
127815837|NCT00914628|459944073|FG001|Overall Study|Protocol Violation|0|||
127815838|NCT00914628|459944072|FG000|Overall Study|Lack of Efficacy|1|||
127815839|NCT00914628|459944073|FG001|Overall Study|Lack of Efficacy|0|||
127815840|NCT00914628|459944072|FG000|Overall Study|non-randomized|1|||
127815841|NCT00914628|459944073|FG001|Overall Study|non-randomized|0|||
127815842|NCT00914628|459944072|FG000|Overall Study|Relapse|1|||
127815843|NCT00914628|459944073|FG001|Overall Study|Relapse|2|||
127815844|NCT00914628|459944072|FG000|Overall Study|Study terminated by Sponsor|14|||
127815845|NCT00914628|459944073|FG001|Overall Study|Study terminated by Sponsor|8|||
127815846|NCT00914628|459944072|FG000|Overall Study|Patients who did not receive a single dose|7|||
127815847|NCT00914628|459944073|FG001|Overall Study|Patients who did not receive a single dose|1|||
127815848|NCT03404960|459944074|FG000|Overall Study|Adverse Event|0|||
127815849|NCT03404960|459944075|FG001|Overall Study|Adverse Event|2|||
127815850|NCT03404960|459944074|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
127815851|NCT03404960|459944075|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
127815852|NCT03404960|459944074|FG000|Overall Study|Bowel obstruction|0|||
127815853|NCT03404960|459944075|FG001|Overall Study|Bowel obstruction|1|||
127815854|NCT03404960|459944074|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
127815855|NCT03404960|459944075|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
127815856|NCT03311126|459944076|FG000|Induction|Death|1|||
127815857|NCT03311126|459944076|FG000|Restaging Imaging|Radiographic Complete Response moved to Observation rather than Maintenance|10|||
127815858|NCT02579603|459944077|FG000|Overall Study|Not treated|1|||
127815859|NCT02579603|459944078|FG001|Overall Study|Not treated|0|||
127815860|NCT02579603|459944077|FG000|Overall Study|Adverse Event|2|||
127815861|NCT02579603|459944078|FG001|Overall Study|Adverse Event|2|||
127815862|NCT02579603|459944077|FG000|Overall Study|Other than stated|1|||
127815863|NCT02579603|459944078|FG001|Overall Study|Other than stated|0|||
127815864|NCT00469079|459944079|FG000|Overall Study|Lack of Efficacy|3|||
127815865|NCT00469079|459944080|FG001|Overall Study|Lack of Efficacy|8|||
127815866|NCT00469079|459944081|FG002|Overall Study|Lack of Efficacy|5|||
127815867|NCT00469079|459944079|FG000|Overall Study|Adverse Event|1|||
127815868|NCT00469079|459944080|FG001|Overall Study|Adverse Event|3|||
127815869|NCT00469079|459944081|FG002|Overall Study|Adverse Event|2|||
127815870|NCT00469079|459944079|FG000|Overall Study|Lost to Follow-up|4|||
127815871|NCT00469079|459944080|FG001|Overall Study|Lost to Follow-up|8|||
127815872|NCT00469079|459944081|FG002|Overall Study|Lost to Follow-up|10|||
127815873|NCT00469079|459944079|FG000|Overall Study|Withdrawal by Subject|1|||
127815874|NCT00469079|459944080|FG001|Overall Study|Withdrawal by Subject|2|||
127815875|NCT00469079|459944081|FG002|Overall Study|Withdrawal by Subject|2|||
127815876|NCT00469079|459944079|FG000|Overall Study|Ineligible|0|||
127815877|NCT00469079|459944080|FG001|Overall Study|Ineligible|1|||
127815878|NCT00469079|459944081|FG002|Overall Study|Ineligible|0|||
127815879|NCT01006356|459944082|FG000|Overall Study|Adverse Event|6|||
127815880|NCT01006356|459944082|FG000|Overall Study|Physician Decision|1|||
127815881|NCT01006356|459944082|FG000|Overall Study|Paticipants did not cooperate|6|||
127815882|NCT01006356|459944082|FG000|Overall Study|Withdrawal by Subject|1|||
127815883|NCT01006356|459944082|FG000|Overall Study|Choice by participants|2|||
127815884|NCT01006356|459944082|FG000|Overall Study|Protocol Violation|3|||
127815885|NCT01006356|459944082|FG000|Overall Study|Other|23|||
127815886|NCT01756157|459944087|FG000|First Intervention Period|Withdrawal by Subject|1|||
127815887|NCT01756157|459944088|FG001|First Intervention Period|Withdrawal by Subject|0|||
127815888|NCT01756157|459944087|FG000|First Intervention Period|Lost to Follow-up|0|||
127815889|NCT01756157|459944088|FG001|First Intervention Period|Lost to Follow-up|2|||
127815890|NCT03368859|459944089|FG000|Overall Study|Withdrew Consent|5|||
127815891|NCT03368859|459944090|FG001|Overall Study|Withdrew Consent|4|||
127815892|NCT03368859|459944089|FG000|Overall Study|Death|12|||
127815893|NCT03368859|459944090|FG001|Overall Study|Death|6|||
127815894|NCT03368859|459944089|FG000|Overall Study|Study terminated by Sponsor|18|||
127815895|NCT03368859|459944090|FG001|Overall Study|Study terminated by Sponsor|23|||
127815896|NCT03368859|459944089|FG000|Overall Study|Other|1|||
127815897|NCT03368859|459944090|FG001|Overall Study|Other|1|||
127815898|NCT02698410|459944091|FG000|Overall Study|Adverse Event|2|||
127815899|NCT02698410|459944091|FG000|Overall Study|Withdrawal by Subject|1|||
127815900|NCT02698410|459944091|FG000|Overall Study|Other|1|||
127815901|NCT01584024|459944092|FG000|Overall Study|Lost to Follow-up|10|||
127815902|NCT01584024|459944092|FG000|Overall Study|Withdrawal by Subject|3|||
127815903|NCT01217606|459944093|FG000|Initial Treatment Phase|Other Reasons|0|||
127815904|NCT01217606|459944094|FG001|Initial Treatment Phase|Other Reasons|2|||
127815905|NCT01217606|459944093|FG000|Initial Treatment Phase|Protocol Violation|3|||
127868851|NCT02210559|460137407|FG000|Overall Study|Adverse Event|2|||
127815906|NCT01217606|459944094|FG001|Initial Treatment Phase|Protocol Violation|2|||
127815907|NCT01217606|459944093|FG000|Initial Treatment Phase|Personal Reasons|0|||
127815908|NCT01217606|459944094|FG001|Initial Treatment Phase|Personal Reasons|2|||
127815909|NCT01217606|459944093|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
127815910|NCT01217606|459944094|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
127815911|NCT01217606|459944093|FG000|Initial Treatment Phase|Adverse Event|10|||
127815912|NCT01217606|459944094|FG001|Initial Treatment Phase|Adverse Event|6|||
127815913|NCT01217606|459944093|FG000|9-Month Masked Extension|Adverse Event|3|||
127815914|NCT01217606|459944094|FG001|9-Month Masked Extension|Adverse Event|6|||
127815915|NCT01217606|459944093|FG000|9-Month Masked Extension|Other Reasons|4|||
127815916|NCT01217606|459944094|FG001|9-Month Masked Extension|Other Reasons|4|||
127815917|NCT01217606|459944093|FG000|9-Month Masked Extension|Personal Reasons|2|||
127815918|NCT01217606|459944094|FG001|9-Month Masked Extension|Personal Reasons|1|||
127815919|NCT01217606|459944093|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
127815920|NCT01217606|459944094|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
127815921|NCT01217606|459944093|FG000|9-Month Masked Extension|Pregnancy|1|||
127815922|NCT01217606|459944094|FG001|9-Month Masked Extension|Pregnancy|0|||
127815923|NCT01217606|459944093|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
127815924|NCT01217606|459944094|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
127815925|NCT00719810|459944102|FG000|Overall Study|Adverse Event|0|||
127815926|NCT00719810|459944103|FG001|Overall Study|Adverse Event|2|||
127815927|NCT00719810|459944104|FG002|Overall Study|Adverse Event|3|||
127815928|NCT00719810|459944102|FG000|Overall Study|Lost to Follow-up|2|||
127815929|NCT00719810|459944103|FG001|Overall Study|Lost to Follow-up|0|||
127815930|NCT00719810|459944104|FG002|Overall Study|Lost to Follow-up|3|||
127815931|NCT00719810|459944102|FG000|Overall Study|Physician Decision|0|||
127815932|NCT00719810|459944103|FG001|Overall Study|Physician Decision|1|||
127815933|NCT00719810|459944104|FG002|Overall Study|Physician Decision|0|||
127815934|NCT00719810|459944102|FG000|Overall Study|Withdrawal by Subject|1|||
127815935|NCT00719810|459944103|FG001|Overall Study|Withdrawal by Subject|1|||
127815936|NCT00719810|459944104|FG002|Overall Study|Withdrawal by Subject|2|||
127815937|NCT04893265|459944105|FG000|Overall Study|Withdrawal by Subject|2|||
127815938|NCT04893265|459944106|FG001|Overall Study|Withdrawal by Subject|5|||
127815939|NCT04893265|459944105|FG000|Overall Study|Lost to Follow-up|0|||
127815940|NCT04893265|459944106|FG001|Overall Study|Lost to Follow-up|4|||
127815941|NCT00573131|459944107|FG000|Overall Study|Withdrawal by Subject|10|||
127815942|NCT00573131|459944108|FG001|Overall Study|Withdrawal by Subject|8|||
127815943|NCT00893789|459944110|FG000|Overall Study|Withdrawal by Subject|3|||
127815944|NCT00893789|459944111|FG001|Overall Study|Withdrawal by Subject|1|||
127815945|NCT00893789|459944112|FG002|Overall Study|Withdrawal by Subject|3|||
127815946|NCT00893789|459944113|FG003|Overall Study|Withdrawal by Subject|1|||
127815947|NCT00893789|459944110|FG000|Overall Study|Noncompliance With Study Drug|1|||
127815948|NCT00893789|459944111|FG001|Overall Study|Noncompliance With Study Drug|0|||
127815949|NCT00893789|459944112|FG002|Overall Study|Noncompliance With Study Drug|1|||
127815950|NCT00893789|459944113|FG003|Overall Study|Noncompliance With Study Drug|2|||
127815951|NCT00893789|459944110|FG000|Overall Study|Noncompliance With Study Procedures|1|||
127815952|NCT00893789|459944111|FG001|Overall Study|Noncompliance With Study Procedures|0|||
127815953|NCT00893789|459944112|FG002|Overall Study|Noncompliance With Study Procedures|0|||
127815954|NCT00893789|459944113|FG003|Overall Study|Noncompliance With Study Procedures|0|||
127815955|NCT00893789|459944110|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
127815956|NCT00893789|459944111|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
127815957|NCT00893789|459944112|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
127815958|NCT00893789|459944113|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
127815959|NCT00893789|459944110|FG000|Overall Study|Adverse Event|0|||
127815960|NCT00893789|459944111|FG001|Overall Study|Adverse Event|2|||
127815961|NCT00893789|459944112|FG002|Overall Study|Adverse Event|1|||
127815962|NCT00893789|459944113|FG003|Overall Study|Adverse Event|5|||
127815963|NCT00893789|459944110|FG000|Overall Study|Protocol Violation|0|||
127815964|NCT00893789|459944111|FG001|Overall Study|Protocol Violation|1|||
127815965|NCT00893789|459944112|FG002|Overall Study|Protocol Violation|1|||
127815966|NCT00893789|459944113|FG003|Overall Study|Protocol Violation|4|||
127815967|NCT00893789|459944110|FG000|Overall Study|Lost to Follow-up|0|||
127815968|NCT00893789|459944111|FG001|Overall Study|Lost to Follow-up|0|||
127815969|NCT00893789|459944112|FG002|Overall Study|Lost to Follow-up|0|||
127815970|NCT00893789|459944113|FG003|Overall Study|Lost to Follow-up|1|||
127815971|NCT02024464|459944114|FG000|Overall Study|Discontinued|5|||
127815972|NCT02024464|459944115|FG001|Overall Study|Discontinued|4|||
127815973|NCT02024464|459944114|FG000|Overall Study|Missed Visits|1|||
127815974|NCT02024464|459944115|FG001|Overall Study|Missed Visits|0|||
127815975|NCT02024464|459944114|FG000|Overall Study|Lost to Follow-up|4|||
127815976|NCT02024464|459944115|FG001|Overall Study|Lost to Follow-up|7|||
127815977|NCT01242111|459944120|FG000|Overall Study|Adverse Event|1|||
127815978|NCT01242111|459944120|FG000|Overall Study|Withdrawal by Subject|1|||
127815979|NCT01242111|459944120|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
127815980|NCT01021007|459944123|FG000|Overall Study|Lost to Follow-up|1|||
127815981|NCT01021007|459944124|FG001|Overall Study|Lost to Follow-up|1|||
127815982|NCT01021007|459944123|FG000|Overall Study|Adverse Event|1|||
127815983|NCT01021007|459944124|FG001|Overall Study|Adverse Event|3|||
127815984|NCT00087438|459944125|FG000|Overall Study|Ineligible / No protocol treatment|4|||
127815985|NCT00466505|459944126|FG000|Overall Study|disease progression|13|||
127815986|NCT00466505|459944126|FG000|Overall Study|Adverse Event|4|||
127815987|NCT00927485|459944129|FG000|Overall Study|Adverse Event|4|||
127815988|NCT00927485|459944130|FG001|Overall Study|Adverse Event|2|||
127815989|NCT00927485|459944129|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
127815990|NCT00927485|459944130|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
127815991|NCT03953118|459944131|FG000|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
127815992|NCT03953118|459944132|FG001|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
127815993|NCT02604264|459944135|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
127815994|NCT02604264|459944136|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
127815995|NCT00246259|459944137|FG000|Overall Study|Other|3|||
127815996|NCT00246259|459944138|FG001|Overall Study|Other|3|||
127815997|NCT00246259|459944137|FG000|Overall Study|Not stable by Week 18|2|||
127815998|NCT00246259|459944138|FG001|Overall Study|Not stable by Week 18|1|||
127815999|NCT00246259|459944137|FG000|Overall Study|Participant non-compliant|4|||
127816000|NCT00246259|459944138|FG001|Overall Study|Participant non-compliant|9|||
127816001|NCT00246259|459944137|FG000|Overall Study|Lack of Efficacy|2|||
127816002|NCT00246259|459944138|FG001|Overall Study|Lack of Efficacy|2|||
127816003|NCT00246259|459944137|FG000|Overall Study|Investigator withdrew participant|2|||
127816004|NCT00246259|459944138|FG001|Overall Study|Investigator withdrew participant|0|||
127816005|NCT00246259|459944137|FG000|Overall Study|Adverse Event|5|||
127816006|NCT00246259|459944138|FG001|Overall Study|Adverse Event|0|||
127816007|NCT00246259|459944137|FG000|Overall Study|Lost to Follow-up|3|||
127816008|NCT00246259|459944138|FG001|Overall Study|Lost to Follow-up|4|||
127816009|NCT00246259|459944137|FG000|Overall Study|Withdrawal by Subject|5|||
127816010|NCT00246259|459944138|FG001|Overall Study|Withdrawal by Subject|1|||
127816011|NCT00246259|459944137|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
127816012|NCT00246259|459944138|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
127816013|NCT03133767|459944139|FG000|Overall Study|Lost to Follow-up|38|||
127816014|NCT03133767|459944140|FG001|Overall Study|Lost to Follow-up|24|||
127816015|NCT03133767|459944139|FG000|Overall Study|Protocol Violation|0|||
127816016|NCT03133767|459944140|FG001|Overall Study|Protocol Violation|1|||
127816017|NCT00855439|459944145|FG000|Overall Study|Withdrawal by Subject|2|||
127816018|NCT00855439|459944146|FG001|Overall Study|Withdrawal by Subject|0|||
127816019|NCT00855439|459944145|FG000|Overall Study|Pregnancy|1|||
127816020|NCT00855439|459944146|FG001|Overall Study|Pregnancy|0|||
127816021|NCT05480514|459944149|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
127816022|NCT05480514|459944150|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
127816023|NCT05480514|459944149|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
127816024|NCT05480514|459944150|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
127816025|NCT05480514|459944149|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
127816026|NCT05480514|459944150|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
127816027|NCT05480514|459944149|FG000|Period 1|Covid-19 Related|1|||
127816028|NCT05480514|459944150|FG001|Period 1|Covid-19 Related|0|||
127816029|NCT05480514|459944149|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
127816030|NCT05480514|459944150|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
127816031|NCT00457639|459944151|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
127816032|NCT00457639|459944152|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
127816033|NCT00457639|459944151|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
127816034|NCT00457639|459944152|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
127816035|NCT00457639|459944151|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
127816036|NCT00457639|459944152|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
127816037|NCT01901328|459944153|FG000|Overall Study|Lost to Follow-up|1|||
127816038|NCT01901328|459944154|FG001|Overall Study|Lost to Follow-up|0|||
127816039|NCT01901328|459944153|FG000|Overall Study|Physician Decision|0|||
127816040|NCT01901328|459944154|FG001|Overall Study|Physician Decision|1|||
127816041|NCT01901328|459944153|FG000|Overall Study|Protocol Violation|1|||
127816042|NCT01901328|459944154|FG001|Overall Study|Protocol Violation|1|||
127816043|NCT01901328|459944153|FG000|Overall Study|Study Terminated by Sponsor|19|||
127816044|NCT01901328|459944154|FG001|Overall Study|Study Terminated by Sponsor|16|||
127816045|NCT01901328|459944153|FG000|Overall Study|Withdrawal by Subject|1|||
127816046|NCT01901328|459944154|FG001|Overall Study|Withdrawal by Subject|2|||
127816047|NCT01901328|459944153|FG000|Overall Study|Lack of Efficacy|0|||
127816048|NCT01901328|459944154|FG001|Overall Study|Lack of Efficacy|1|||
127816049|NCT00621023|459945978|FG000|Overall Study|Death|5|||
127816050|NCT00621023|459945978|FG000|Overall Study|Follow up discontinued|1|||
127816051|NCT02559505|459945983|FG000|Overall Study|Lost to Follow-up|23|||
127816052|NCT02559505|459945984|FG001|Overall Study|Lost to Follow-up|20|||
127816053|NCT02559505|459945983|FG000|Overall Study|Withdrawal by Subject|4|||
127816054|NCT02559505|459945984|FG001|Overall Study|Withdrawal by Subject|2|||
127816055|NCT04331899|459945991|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
127816056|NCT04331899|459945992|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
127816057|NCT02424539|459945995|FG000|Overall Study|Adverse Event|0|||
127816058|NCT02424539|459945996|FG001|Overall Study|Adverse Event|0|||
127816059|NCT02424539|459945997|FG002|Overall Study|Adverse Event|1|||
127816060|NCT02424539|459945995|FG000|Overall Study|Physician Decision|0|||
127816061|NCT02424539|459945996|FG001|Overall Study|Physician Decision|0|||
127816062|NCT02424539|459945997|FG002|Overall Study|Physician Decision|1|||
127816063|NCT02424539|459945995|FG000|Overall Study|Withdrawal by Subject|3|||
127816064|NCT02424539|459945996|FG001|Overall Study|Withdrawal by Subject|1|||
127816065|NCT02424539|459945997|FG002|Overall Study|Withdrawal by Subject|0|||
127816066|NCT02424539|459945995|FG000|Overall Study|Other: Reached stopping criteria|11|||
127816067|NCT02424539|459945996|FG001|Overall Study|Other: Reached stopping criteria|7|||
127816068|NCT02424539|459945997|FG002|Overall Study|Other: Reached stopping criteria|6|||
127816069|NCT05408858|459946000|FG000|Overall Study|no longer met eligibility criteria|1|||
127816070|NCT02037919|459946004|FG000|Overall Study|Lost to Follow-up|30|||
127816071|NCT02037919|459946005|FG001|Overall Study|Lost to Follow-up|45|||
127816072|NCT03717922|459946013|FG000|Overall Study|Lost to Follow-up|2|||
127816073|NCT03717922|459946014|FG001|Overall Study|Lost to Follow-up|2|||
127816074|NCT01697215|459946024|FG000|Overall Study|Physician Decision|5|||
127816075|NCT01697215|459946024|FG000|Overall Study|Malfunction|9|||
127816076|NCT01697215|459946024|FG000|Overall Study|CXR not available|9|||
127816077|NCT01929083|459946025|FG000|Intervention 1|Lost to Follow-up|2|||
127816078|NCT01929083|459946026|FG001|Intervention 1|Lost to Follow-up|0|||
127816079|NCT01929083|459946025|FG000|Intervention 1|Nonadherent to study medications|1|||
127816080|NCT01929083|459946026|FG001|Intervention 1|Nonadherent to study medications|0|||
127816081|NCT01929083|459946025|FG000|Intervention 2|Adverse Event|0|||
127816082|NCT01929083|459946026|FG001|Intervention 2|Adverse Event|1|||
127816083|NCT02586805|459946031|FG000|Overall Study|Withdrawal by Subject|3|||
127816084|NCT02586805|459946032|FG001|Overall Study|Withdrawal by Subject|1|||
127816085|NCT02586805|459946033|FG002|Overall Study|Withdrawal by Subject|1|||
127816086|NCT02586805|459946034|FG003|Overall Study|Withdrawal by Subject|2|||
127816087|NCT02586805|459946031|FG000|Overall Study|Adverse Event|2|||
127816088|NCT02586805|459946032|FG001|Overall Study|Adverse Event|0|||
127816089|NCT02586805|459946033|FG002|Overall Study|Adverse Event|1|||
127816090|NCT02586805|459946034|FG003|Overall Study|Adverse Event|0|||
127816091|NCT02586805|459946031|FG000|Overall Study|Lost to Follow-up|0|||
127816092|NCT02586805|459946032|FG001|Overall Study|Lost to Follow-up|0|||
127816093|NCT02586805|459946033|FG002|Overall Study|Lost to Follow-up|1|||
127816094|NCT02586805|459946034|FG003|Overall Study|Lost to Follow-up|0|||
127816095|NCT02586805|459946031|FG000|Overall Study|Physician Decision|1|||
127816096|NCT02586805|459946032|FG001|Overall Study|Physician Decision|0|||
127816097|NCT02586805|459946033|FG002|Overall Study|Physician Decision|0|||
127816098|NCT02586805|459946034|FG003|Overall Study|Physician Decision|0|||
127816099|NCT01829048|459946035|FG000|Overall Study|Withdrawal by Subject|0|||
127816100|NCT01829048|459946036|FG001|Overall Study|Withdrawal by Subject|0|||
127816101|NCT01829048|459946037|FG002|Overall Study|Withdrawal by Subject|0|||
127816102|NCT01829048|459946038|FG003|Overall Study|Withdrawal by Subject|2|||
127816103|NCT01829048|459946039|FG004|Overall Study|Withdrawal by Subject|0|||
127816104|NCT00504257|459946040|FG000|Overall Study|Withdrawal by Subject|2|||
127816105|NCT00504257|459946040|FG000|Overall Study|ineligible histology|2|||
127816106|NCT02504541|459946041|FG000|Overall Study|Adverse Event|4|||
127816107|NCT02504541|459946041|FG000|Overall Study|Withdrawal by Subject|4|||
127816108|NCT02504541|459946041|FG000|Overall Study|Lost to Follow-up|1|||
127816109|NCT02504541|459946041|FG000|Overall Study|Met Stopping Criteria|1|||
127816110|NCT02504541|459946041|FG000|Overall Study|Protocol Violation|2|||
127816111|NCT02504541|459946041|FG000|Overall Study|Termination by Sponsor|1|||
127816112|NCT02504541|459946041|FG000|Overall Study|Other|2|||
127816113|NCT02504541|459946041|FG000|Overall Study|Multiple|5|||
127816114|NCT02317510|459946045|FG000|Overall Study|Adverse Event|0|||
127816115|NCT02317510|459946046|FG001|Overall Study|Adverse Event|1|||
127816116|NCT00500071|459946047|FG000|Screening and Washout Phase|Protocol Violation|1|||
127816117|NCT00500071|459946047|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
127816118|NCT00500071|459946047|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
127816119|NCT00500071|459946047|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
127816120|NCT00500071|459946047|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
127816121|NCT00500071|459946047|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
127816122|NCT00500071|459946047|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
127816123|NCT00472303|459946048|FG000|Titration Phase|Adverse Event|22|||
127816124|NCT00472303|459946049|FG001|Titration Phase|Adverse Event|12|||
127816125|NCT00472303|459946050|FG002|Titration Phase|Adverse Event|0|||
127816126|NCT00472303|459946048|FG000|Titration Phase|Death|4|||
127816127|NCT00472303|459946049|FG001|Titration Phase|Death|2|||
127816128|NCT00472303|459946050|FG002|Titration Phase|Death|0|||
127816129|NCT00472303|459946048|FG000|Titration Phase|Lack of Efficacy|10|||
127816130|NCT00472303|459946049|FG001|Titration Phase|Lack of Efficacy|0|||
127816131|NCT00472303|459946050|FG002|Titration Phase|Lack of Efficacy|0|||
127816132|NCT00472303|459946048|FG000|Titration Phase|Withdrawal by Subject|16|||
127816133|NCT00472303|459946049|FG001|Titration Phase|Withdrawal by Subject|13|||
127816134|NCT00472303|459946050|FG002|Titration Phase|Withdrawal by Subject|0|||
127816135|NCT00472303|459946048|FG000|Titration Phase|Trial Medication non-compliant|4|||
127816136|NCT00472303|459946049|FG001|Titration Phase|Trial Medication non-compliant|1|||
127816137|NCT00472303|459946050|FG002|Titration Phase|Trial Medication non-compliant|0|||
127816138|NCT00472303|459946048|FG000|Titration Phase|Other|3|||
127816139|NCT00472303|459946049|FG001|Titration Phase|Other|1|||
127816140|NCT00472303|459946050|FG002|Titration Phase|Other|0|||
127816141|NCT00472303|459946048|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
127816142|NCT00472303|459946049|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
127816143|NCT00472303|459946050|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
127816144|NCT00472303|459946048|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
127816145|NCT00472303|459946049|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
127816146|NCT00472303|459946050|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
127816147|NCT00472303|459946048|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
127816148|NCT00472303|459946049|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
127816149|NCT00472303|459946050|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
127816150|NCT00472303|459946048|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
127816151|NCT00472303|459946049|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
127816152|NCT00472303|459946050|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
127816153|NCT00472303|459946048|FG000|Discontinuations After Titration Phase|Other|5|||
127816154|NCT00472303|459946049|FG001|Discontinuations After Titration Phase|Other|0|||
127816155|NCT00472303|459946050|FG002|Discontinuations After Titration Phase|Other|0|||
127816156|NCT00472303|459946048|FG000|Maintenance Phase|Adverse Event|5|||
127816157|NCT00472303|459946049|FG001|Maintenance Phase|Adverse Event|6|||
127816158|NCT00472303|459946050|FG002|Maintenance Phase|Adverse Event|6|||
127816159|NCT00472303|459946048|FG000|Maintenance Phase|Death|3|||
127816160|NCT00472303|459946049|FG001|Maintenance Phase|Death|0|||
127816161|NCT00472303|459946050|FG002|Maintenance Phase|Death|2|||
127816162|NCT00472303|459946048|FG000|Maintenance Phase|Lack of Efficacy|2|||
127816163|NCT00472303|459946049|FG001|Maintenance Phase|Lack of Efficacy|2|||
127816164|NCT00472303|459946050|FG002|Maintenance Phase|Lack of Efficacy|4|||
127816165|NCT00472303|459946048|FG000|Maintenance Phase|Withdrawal by Subject|6|||
127816166|NCT00472303|459946049|FG001|Maintenance Phase|Withdrawal by Subject|7|||
127816167|NCT00472303|459946050|FG002|Maintenance Phase|Withdrawal by Subject|3|||
127816168|NCT00472303|459946048|FG000|Maintenance Phase|Trial medication non-compliant|0|||
127816169|NCT00472303|459946049|FG001|Maintenance Phase|Trial medication non-compliant|0|||
127816170|NCT00472303|459946050|FG002|Maintenance Phase|Trial medication non-compliant|1|||
127816171|NCT00472303|459946048|FG000|Maintenance Phase|Resolution of pain|0|||
127816172|NCT00472303|459946049|FG001|Maintenance Phase|Resolution of pain|0|||
127816173|NCT00472303|459946050|FG002|Maintenance Phase|Resolution of pain|1|||
127816174|NCT00472303|459946048|FG000|Maintenance Phase|Other|1|||
127816175|NCT00472303|459946049|FG001|Maintenance Phase|Other|1|||
127816176|NCT00472303|459946050|FG002|Maintenance Phase|Other|0|||
127816177|NCT03182738|459946059|FG000|Overall Study|Lost to Follow-up|9|||
127816178|NCT03182738|459946060|FG001|Overall Study|Lost to Follow-up|3|||
127816179|NCT03182738|459946059|FG000|Overall Study|Pregnancy|0|||
127816180|NCT03182738|459946060|FG001|Overall Study|Pregnancy|1|||
127816181|NCT03182738|459946059|FG000|Overall Study|Withdrawal by Subject|0|||
127816182|NCT03182738|459946060|FG001|Overall Study|Withdrawal by Subject|1|||
127816183|NCT00728416|459946062|FG000|Overall Study|Adverse Event|1|||
127816184|NCT00728416|459946063|FG001|Overall Study|Adverse Event|1|||
127816185|NCT00728416|459946062|FG000|Overall Study|Treatment Failure|0|||
127816186|NCT00728416|459946063|FG001|Overall Study|Treatment Failure|1|||
127816187|NCT00728416|459946062|FG000|Overall Study|Withdrawal by Subject|1|||
127816188|NCT00728416|459946063|FG001|Overall Study|Withdrawal by Subject|0|||
127816189|NCT01244737|459946073|FG000|Overall Study|Physician Decision|2|||
127816190|NCT01244737|459946074|FG001|Overall Study|Physician Decision|18|||
127816191|NCT01244737|459946075|FG002|Overall Study|Physician Decision|5|||
127816192|NCT01244737|459946073|FG000|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
127816193|NCT01244737|459946074|FG001|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
127816194|NCT01244737|459946075|FG002|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|0|||
127816195|NCT01244737|459946073|FG000|Overall Study|Surgical pathology did not confirm evaluable brain tumor|2|||
127816196|NCT01244737|459946074|FG001|Overall Study|Surgical pathology did not confirm evaluable brain tumor|1|||
127816197|NCT01244737|459946075|FG002|Overall Study|Surgical pathology did not confirm evaluable brain tumor|0|||
127816198|NCT01244737|459946073|FG000|Overall Study|MIB immunopathology results not available|3|||
127816199|NCT01244737|459946074|FG001|Overall Study|MIB immunopathology results not available|2|||
127816200|NCT01244737|459946075|FG002|Overall Study|MIB immunopathology results not available|0|||
127816201|NCT01244737|459946073|FG000|Overall Study|PET data failure|0|||
127816202|NCT01244737|459946074|FG001|Overall Study|PET data failure|1|||
127816203|NCT01244737|459946075|FG002|Overall Study|PET data failure|0|||
127816204|NCT01244737|459946073|FG000|Overall Study|Withdrawal by Subject|0|||
127816205|NCT01244737|459946074|FG001|Overall Study|Withdrawal by Subject|0|||
127816206|NCT01244737|459946075|FG002|Overall Study|Withdrawal by Subject|1|||
127816207|NCT00356915|459946078|FG000|Overall Study|Non compliance|1|||
127816208|NCT00356915|459946079|FG001|Overall Study|Non compliance|2|||
127816209|NCT00356915|459946080|FG002|Overall Study|Non compliance|1|||
127816210|NCT00356915|459946078|FG000|Overall Study|Protocol Violation|2|||
127816211|NCT00356915|459946079|FG001|Overall Study|Protocol Violation|3|||
127816212|NCT00356915|459946080|FG002|Overall Study|Protocol Violation|2|||
127816213|NCT00356915|459946078|FG000|Overall Study|Withdrawal by Subject|14|||
127816214|NCT00356915|459946079|FG001|Overall Study|Withdrawal by Subject|14|||
127816215|NCT00356915|459946080|FG002|Overall Study|Withdrawal by Subject|10|||
127816216|NCT00356915|459946078|FG000|Overall Study|Lack of Efficacy|0|||
127816217|NCT00356915|459946079|FG001|Overall Study|Lack of Efficacy|0|||
127816218|NCT00356915|459946080|FG002|Overall Study|Lack of Efficacy|3|||
127816219|NCT00356915|459946078|FG000|Overall Study|Lost to Follow-up|27|||
127816220|NCT00356915|459946079|FG001|Overall Study|Lost to Follow-up|34|||
127816221|NCT00356915|459946080|FG002|Overall Study|Lost to Follow-up|14|||
127816222|NCT00356915|459946078|FG000|Overall Study|Administrative Decision|0|||
127816223|NCT00356915|459946079|FG001|Overall Study|Administrative Decision|0|||
127816224|NCT00356915|459946080|FG002|Overall Study|Administrative Decision|1|||
127816225|NCT00356915|459946078|FG000|Overall Study|Physician Decision|0|||
127816226|NCT00356915|459946079|FG001|Overall Study|Physician Decision|2|||
127816227|NCT00356915|459946080|FG002|Overall Study|Physician Decision|0|||
127816228|NCT00356915|459946078|FG000|Overall Study|Adverse Event|21|||
127816229|NCT00356915|459946079|FG001|Overall Study|Adverse Event|31|||
127816230|NCT00356915|459946080|FG002|Overall Study|Adverse Event|8|||
127816231|NCT00356915|459946078|FG000|Overall Study|Miscellaneous reasons|11|||
127816232|NCT00356915|459946079|FG001|Overall Study|Miscellaneous reasons|8|||
127816233|NCT00356915|459946080|FG002|Overall Study|Miscellaneous reasons|3|||
127816234|NCT00509106|459946082|FG000|Overall Study|Adverse Event|3|||
127816235|NCT00509106|459946083|FG001|Overall Study|Adverse Event|2|||
127816236|NCT00509106|459946082|FG000|Overall Study|Noncompliance|0|||
127816237|NCT00509106|459946083|FG001|Overall Study|Noncompliance|1|||
127816238|NCT00509106|459946082|FG000|Overall Study|At the request of sponsor/investigator|1|||
127816239|NCT00509106|459946083|FG001|Overall Study|At the request of sponsor/investigator|2|||
127816240|NCT00509106|459946082|FG000|Overall Study|Withdrew consent|4|||
127816241|NCT00509106|459946083|FG001|Overall Study|Withdrew consent|8|||
127816242|NCT00509106|459946082|FG000|Overall Study|Lost to Follow-up|16|||
127816243|NCT00509106|459946083|FG001|Overall Study|Lost to Follow-up|10|||
127816244|NCT00509106|459946082|FG000|Overall Study|Other|1|||
127816245|NCT00509106|459946083|FG001|Overall Study|Other|0|||
127816246|NCT00509106|459946082|FG000|Overall Study|Death|6|||
127816247|NCT00509106|459946083|FG001|Overall Study|Death|6|||
127816248|NCT00488631|459946084|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
127816249|NCT00488631|459946085|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
127816250|NCT00488631|459946086|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
127816251|NCT00488631|459946087|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
127816252|NCT00488631|459946088|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
127816253|NCT00488631|459946089|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
127816254|NCT00488631|459946090|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
127816255|NCT00488631|459946091|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
127816256|NCT00488631|459946092|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
127816257|NCT00488631|459946093|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
127816258|NCT00488631|459946084|FG000|Double Blind Period (Week 0-54)|Death|0|||
127816259|NCT00488631|459946085|FG001|Double Blind Period (Week 0-54)|Death|0|||
127816260|NCT00488631|459946086|FG002|Double Blind Period (Week 0-54)|Death|0|||
127816261|NCT00488631|459946087|FG003|Double Blind Period (Week 0-54)|Death|0|||
127816262|NCT00488631|459946088|FG004|Double Blind Period (Week 0-54)|Death|0|||
127816263|NCT00488631|459946089|FG005|Double Blind Period (Week 0-54)|Death|1|||
127816264|NCT00488631|459946090|FG006|Double Blind Period (Week 0-54)|Death|0|||
127816265|NCT00488631|459946091|FG007|Double Blind Period (Week 0-54)|Death|0|||
127816266|NCT00488631|459946092|FG008|Double Blind Period (Week 0-54)|Death|0|||
127816267|NCT00488631|459946093|FG009|Double Blind Period (Week 0-54)|Death|0|||
127816268|NCT00488631|459946084|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
127816269|NCT00488631|459946085|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
127816270|NCT00488631|459946086|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
127816271|NCT00488631|459946087|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
127816272|NCT00488631|459946088|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
127816273|NCT00488631|459946089|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
127816274|NCT00488631|459946090|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
127816275|NCT00488631|459946091|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
127816276|NCT00488631|459946092|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
127816277|NCT00488631|459946093|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
127816278|NCT00488631|459946084|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
127816279|NCT00488631|459946085|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
127816280|NCT00488631|459946086|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
127816281|NCT00488631|459946087|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
127816282|NCT00488631|459946088|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
127816283|NCT00488631|459946089|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
127816284|NCT00488631|459946090|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
127816285|NCT00488631|459946091|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
127816286|NCT00488631|459946092|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
127816287|NCT00488631|459946093|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
127816288|NCT00488631|459946084|FG000|Double Blind Period (Week 0-54)|Other|6|||
127816289|NCT00488631|459946085|FG001|Double Blind Period (Week 0-54)|Other|12|||
127816290|NCT00488631|459946086|FG002|Double Blind Period (Week 0-54)|Other|10|||
127816291|NCT00488631|459946087|FG003|Double Blind Period (Week 0-54)|Other|11|||
127816292|NCT00488631|459946088|FG004|Double Blind Period (Week 0-54)|Other|14|||
127816293|NCT00488631|459946089|FG005|Double Blind Period (Week 0-54)|Other|34|||
127816294|NCT00488631|459946090|FG006|Double Blind Period (Week 0-54)|Other|0|||
127816295|NCT00488631|459946091|FG007|Double Blind Period (Week 0-54)|Other|0|||
127816296|NCT00488631|459946092|FG008|Double Blind Period (Week 0-54)|Other|0|||
127816297|NCT00488631|459946093|FG009|Double Blind Period (Week 0-54)|Other|0|||
127816298|NCT00488631|459946084|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
127816299|NCT00488631|459946085|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
127816300|NCT00488631|459946086|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
127816301|NCT00488631|459946087|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
127816302|NCT00488631|459946088|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
127816303|NCT00488631|459946089|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
127816304|NCT00488631|459946090|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
127816305|NCT00488631|459946091|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
127816306|NCT00488631|459946092|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
127816307|NCT00488631|459946093|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
127816308|NCT00488631|459946084|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
127816309|NCT00488631|459946085|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
127816310|NCT00488631|459946086|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
127816311|NCT00488631|459946087|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
127816312|NCT00488631|459946088|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
127816313|NCT00488631|459946089|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
127816314|NCT00488631|459946090|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
127816315|NCT00488631|459946091|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
127816316|NCT00488631|459946092|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
127816317|NCT00488631|459946093|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
127868852|NCT02210559|460137408|FG001|Overall Study|Adverse Event|2|||
127816318|NCT00488631|459946084|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
127816319|NCT00488631|459946085|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
127816320|NCT00488631|459946086|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
127816321|NCT00488631|459946087|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
127816322|NCT00488631|459946088|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
127816323|NCT00488631|459946089|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
127816324|NCT00488631|459946090|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
127816325|NCT00488631|459946091|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
127816326|NCT00488631|459946092|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
127816327|NCT00488631|459946093|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
127816328|NCT00488631|459946084|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
127816329|NCT00488631|459946085|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
127816330|NCT00488631|459946086|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
127816331|NCT00488631|459946087|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
127816332|NCT00488631|459946088|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
127816333|NCT00488631|459946089|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
127816334|NCT00488631|459946090|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
127816335|NCT00488631|459946091|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
127816336|NCT00488631|459946092|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
127816337|NCT00488631|459946093|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
127816338|NCT00488631|459946084|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
127816339|NCT00488631|459946085|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
127816340|NCT00488631|459946086|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
127816341|NCT00488631|459946087|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
127816342|NCT00488631|459946088|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
127816343|NCT00488631|459946089|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
127816344|NCT00488631|459946090|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
127816345|NCT00488631|459946091|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
127816346|NCT00488631|459946092|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
127816347|NCT00488631|459946093|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
127816348|NCT01873950|459946094|FG000|Period 5|Withdrawal by Subject|0|||
127816349|NCT01873950|459946095|FG001|Period 5|Withdrawal by Subject|0|||
127816350|NCT01873950|459946096|FG002|Period 5|Withdrawal by Subject|0|||
127816351|NCT01873950|459946097|FG003|Period 5|Withdrawal by Subject|1|||
127816352|NCT01873950|459946098|FG004|Period 5|Withdrawal by Subject|0|||
127816353|NCT00730236|459946099|FG000|Overall Study|Adverse Event|4|||
127816354|NCT00730236|459946099|FG000|Overall Study|Withdrawal by Subject|1|||
127816355|NCT00730236|459946099|FG000|Overall Study|Non-compliance|1|||
127816356|NCT01772134|459946104|FG000|Overall Study|Adverse Event|6|||
127816357|NCT01772134|459946105|FG001|Overall Study|Adverse Event|5|||
127816358|NCT01772134|459946106|FG002|Overall Study|Adverse Event|10|||
127816359|NCT01772134|459946104|FG000|Overall Study|Withdrew Consent|3|||
127816360|NCT01772134|459946105|FG001|Overall Study|Withdrew Consent|1|||
127816361|NCT01772134|459946106|FG002|Overall Study|Withdrew Consent|5|||
127816362|NCT01772134|459946104|FG000|Overall Study|Lost to Follow-up|2|||
127816363|NCT01772134|459946105|FG001|Overall Study|Lost to Follow-up|0|||
127816364|NCT01772134|459946106|FG002|Overall Study|Lost to Follow-up|0|||
127816365|NCT01772134|459946104|FG000|Overall Study|Protocol Deviation|4|||
127816366|NCT01772134|459946105|FG001|Overall Study|Protocol Deviation|3|||
127816367|NCT01772134|459946106|FG002|Overall Study|Protocol Deviation|3|||
127816368|NCT01772134|459946104|FG000|Overall Study|Lack of Efficacy|11|||
127816369|NCT01772134|459946105|FG001|Overall Study|Lack of Efficacy|5|||
127816370|NCT01772134|459946106|FG002|Overall Study|Lack of Efficacy|3|||
127816371|NCT01772134|459946104|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
127816372|NCT01772134|459946105|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
127816373|NCT01772134|459946106|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
127816374|NCT01772134|459946104|FG000|Overall Study|Randomized Study Medication Not Received|2|||
127816375|NCT01772134|459946105|FG001|Overall Study|Randomized Study Medication Not Received|0|||
127816376|NCT01772134|459946106|FG002|Overall Study|Randomized Study Medication Not Received|1|||
127816377|NCT03486314|459946111|FG000|Part A|Adverse Event|1|||
127816378|NCT03486314|459946112|FG001|Part A|Adverse Event|0|||
127816379|NCT03486314|459946113|FG002|Part A|Adverse Event|0|||
127816380|NCT03486314|459946111|FG000|Part A|Symptomatic Deterioration|2|||
127816381|NCT03486314|459946112|FG001|Part A|Symptomatic Deterioration|0|||
127816382|NCT03486314|459946113|FG002|Part A|Symptomatic Deterioration|0|||
127816383|NCT00659438|459946114|FG000|Overall Study|Withdrawal by Subject|2|||
127894539|NCT03019965|460237174|FG000|Overall Study|Protocol Violation|1|||
127894540|NCT03019965|460237175|FG001|Overall Study|Protocol Violation|3|||
127894541|NCT03019965|460237174|FG000|Overall Study|viral or fungal infection|3|||
127816384|NCT00659438|459946115|FG001|Overall Study|Withdrawal by Subject|2|||
127816385|NCT00659438|459946114|FG000|Overall Study|Death|11|||
127816386|NCT00659438|459946115|FG001|Overall Study|Death|6|||
127816387|NCT00659438|459946114|FG000|Overall Study|Lost to Follow-up|1|||
127816388|NCT00659438|459946115|FG001|Overall Study|Lost to Follow-up|0|||
127816389|NCT04003610|459946117|FG000|Overall Study|Lost to Follow-up|0|||
127816390|NCT04003610|459946118|FG001|Overall Study|Lost to Follow-up|1|||
127816391|NCT04003610|459946119|FG002|Overall Study|Lost to Follow-up|0|||
127816392|NCT04003610|459946117|FG000|Overall Study|Death|0|||
127816393|NCT04003610|459946118|FG001|Overall Study|Death|0|||
127816394|NCT04003610|459946119|FG002|Overall Study|Death|3|||
127816395|NCT04003610|459946117|FG000|Overall Study|Study Terminated by Sponsor|0|||
127816396|NCT04003610|459946118|FG001|Overall Study|Study Terminated by Sponsor|0|||
127816397|NCT04003610|459946119|FG002|Overall Study|Study Terminated by Sponsor|3|||
127894542|NCT03019965|460237175|FG001|Overall Study|viral or fungal infection|4|||
127816398|NCT02698189|459946132|FG000|Overall Study|Physician Decision|3|||
127816399|NCT02698189|459946133|FG001|Overall Study|Physician Decision|0|||
127894543|NCT03019965|460237174|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
127894544|NCT03019965|460237175|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
127894545|NCT03019965|460237174|FG000|Overall Study|Physician Decision|1|||
127816400|NCT02698189|459946132|FG000|Overall Study|Progressive disease|0|||
127816401|NCT02698189|459946133|FG001|Overall Study|Progressive disease|5|||
127816402|NCT02698189|459946132|FG000|Overall Study|Study terminated by sponsor|0|||
127816403|NCT02698189|459946133|FG001|Overall Study|Study terminated by sponsor|1|||
127816404|NCT05502289|459946134|FG000|Period 1|Out Of Window|1|||
127816405|NCT05502289|459946135|FG001|Period 1|Out Of Window|0|||
127816406|NCT02333227|459946141|FG000|Overall Study|Lost to Follow-up|137|||
127816407|NCT02333227|459946142|FG001|Overall Study|Lost to Follow-up|106|||
127816408|NCT02333227|459946141|FG000|Overall Study|Pregnancy Interrupted|42|||
127816409|NCT02333227|459946142|FG001|Overall Study|Pregnancy Interrupted|89|||
127816410|NCT02333227|459946141|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
127816411|NCT02333227|459946142|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
127816412|NCT00816036|459946143|FG000|Overall Study|Death|47|||
127816413|NCT00816036|459946144|FG001|Overall Study|Death|28|||
127816414|NCT00816036|459946143|FG000|Overall Study|Lost to Follow-up|75|||
127816415|NCT00816036|459946144|FG001|Overall Study|Lost to Follow-up|57|||
127816416|NCT00816036|459946143|FG000|Overall Study|Withdrawal by Subject|54|||
127816417|NCT00816036|459946144|FG001|Overall Study|Withdrawal by Subject|23|||
127816418|NCT01624194|459946145|FG000|Overall Study|Lost to Follow-up|1|||
127816419|NCT01624194|459946146|FG001|Overall Study|Lost to Follow-up|0|||
127816420|NCT01624194|459946145|FG000|Overall Study|Withdrawal by Subject|1|||
127816421|NCT01624194|459946146|FG001|Overall Study|Withdrawal by Subject|0|||
127816422|NCT03212261|459946147|FG000|Overall Study|Became ineligible d/t tech|2|||
127816423|NCT03212261|459946147|FG000|Overall Study|Tech Trouble- No first study visit|1|||
127816424|NCT03212261|459946147|FG000|Overall Study|Lost to Follow-up|7|||
127816425|NCT03212261|459946147|FG000|Overall Study|Family Emergency|1|||
127816426|NCT03212261|459946147|FG000|Overall Study|Too busy/ No time|5|||
127816427|NCT01076179|459946148|FG000|Overall Study|Withdrawal by Subject|1|||
127816428|NCT01084252|459948412|FG000|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
127816429|NCT01084252|459948413|FG001|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
127816430|NCT01084252|459948414|FG002|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
127816431|NCT01084252|459948415|FG003|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
127816432|NCT01084252|459948416|FG004|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
127816433|NCT01084252|459948417|FG005|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
127816434|NCT01084252|459948418|FG006|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
127816435|NCT01084252|459948419|FG007|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
127816436|NCT01084252|459948420|FG008|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
127816437|NCT01084252|459948421|FG009|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
127816438|NCT01084252|459948422|FG010|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
127816439|NCT01084252|459948423|FG011|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
127816440|NCT01084252|459948424|FG012|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|1|||
127816441|NCT01084252|459948425|FG013|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
127816442|NCT04909463|459948426|FG000|Overall Study|Withdrawal by Subject|0|||
127816443|NCT04909463|459948427|FG001|Overall Study|Withdrawal by Subject|1|||
127816444|NCT04909463|459948428|FG002|Overall Study|Withdrawal by Subject|0|||
127816445|NCT04909463|459948429|FG003|Overall Study|Withdrawal by Subject|0|||
127816446|NCT04909463|459948426|FG000|Overall Study|Lost to Follow-up|2|||
127816447|NCT04909463|459948427|FG001|Overall Study|Lost to Follow-up|1|||
127816448|NCT04909463|459948428|FG002|Overall Study|Lost to Follow-up|1|||
127816449|NCT04909463|459948429|FG003|Overall Study|Lost to Follow-up|0|||
127816450|NCT03528681|459948430|FG000|Open-Label Phase|Physician Decision|2|||
127816451|NCT03528681|459948431|FG001|Open-Label Phase|Physician Decision|0|||
127816452|NCT03528681|459948432|FG002|Open-Label Phase|Physician Decision|0|||
127816453|NCT03528681|459948433|FG003|Open-Label Phase|Physician Decision|0|||
127816454|NCT03528681|459948430|FG000|Open-Label Phase|Withdrawal by Subject|8|||
127816455|NCT03528681|459948431|FG001|Open-Label Phase|Withdrawal by Subject|0|||
127816456|NCT03528681|459948432|FG002|Open-Label Phase|Withdrawal by Subject|0|||
127816457|NCT03528681|459948433|FG003|Open-Label Phase|Withdrawal by Subject|0|||
127816458|NCT03528681|459948430|FG000|Open-Label Phase|(Not collected)|4|||
127816459|NCT03528681|459948431|FG001|Open-Label Phase|(Not collected)|0|||
127816460|NCT03528681|459948432|FG002|Open-Label Phase|(Not collected)|0|||
127816461|NCT03528681|459948433|FG003|Open-Label Phase|(Not collected)|0|||
127816462|NCT03528681|459948430|FG000|Randomized Treatment Phase|Lost to Follow-up|0|||
127816463|NCT03528681|459948431|FG001|Randomized Treatment Phase|Lost to Follow-up|0|||
127816464|NCT03528681|459948432|FG002|Randomized Treatment Phase|Lost to Follow-up|1|||
127816465|NCT03528681|459948433|FG003|Randomized Treatment Phase|Lost to Follow-up|0|||
127816466|NCT03528681|459948430|FG000|Randomized Treatment Phase|Physician Decision|0|||
127816467|NCT03528681|459948431|FG001|Randomized Treatment Phase|Physician Decision|5|||
127816468|NCT03528681|459948432|FG002|Randomized Treatment Phase|Physician Decision|1|||
127816469|NCT03528681|459948433|FG003|Randomized Treatment Phase|Physician Decision|2|||
127816470|NCT03528681|459948430|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
127816471|NCT03528681|459948431|FG001|Randomized Treatment Phase|Withdrawal by Subject|7|||
127816472|NCT03528681|459948432|FG002|Randomized Treatment Phase|Withdrawal by Subject|4|||
127816473|NCT03528681|459948433|FG003|Randomized Treatment Phase|Withdrawal by Subject|1|||
127816474|NCT03528681|459948430|FG000|Randomized Treatment Phase|(Study specific withdrawal criteria)|0|||
127816475|NCT03528681|459948431|FG001|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
127816476|NCT03528681|459948432|FG002|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
127816477|NCT03528681|459948433|FG003|Randomized Treatment Phase|(Study specific withdrawal criteria)|4|||
127816478|NCT03528681|459948430|FG000|Randomized Treatment Phase|(Not collected)|0|||
127816479|NCT03528681|459948431|FG001|Randomized Treatment Phase|(Not collected)|4|||
127816480|NCT03528681|459948432|FG002|Randomized Treatment Phase|(Not collected)|6|||
127816481|NCT03528681|459948433|FG003|Randomized Treatment Phase|(Not collected)|5|||
127816482|NCT00955110|459948434|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
127816483|NCT00955110|459948434|FG000|Treatment Phase|Adverse Event|2|||
127816484|NCT00955110|459948434|FG000|Treatment Phase|Administrative reasons|2|||
127816485|NCT00955110|459948434|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
127816486|NCT00955110|459948434|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
127816487|NCT02981472|459948442|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
127816488|NCT02981472|459948443|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
127816489|NCT02981472|459948442|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
127816490|NCT02981472|459948443|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
127816491|NCT02981472|459948442|FG000|Treatment Period|Adverse Event|6|||
127816492|NCT02981472|459948443|FG001|Treatment Period|Adverse Event|1|||
127816493|NCT02981472|459948442|FG000|Treatment Period|Participant withdrew consent|1|||
127816494|NCT02981472|459948443|FG001|Treatment Period|Participant withdrew consent|0|||
127816495|NCT02981472|459948442|FG000|Treatment Period|Lost to Follow-up|0|||
127816496|NCT02981472|459948443|FG001|Treatment Period|Lost to Follow-up|1|||
127816497|NCT04430348|459948449|FG000|Overall Study|Death|3|||
127816498|NCT04430348|459948450|FG001|Overall Study|Death|2|||
127816499|NCT04430348|459948451|FG002|Overall Study|Death|2|||
127816500|NCT04430348|459948452|FG003|Overall Study|Death|2|||
127816501|NCT04430348|459948453|FG004|Overall Study|Death|2|||
127816502|NCT04430348|459948454|FG005|Overall Study|Death|3|||
127816503|NCT04430348|459948449|FG000|Overall Study|Lost to Follow-up|0|||
127816504|NCT04430348|459948450|FG001|Overall Study|Lost to Follow-up|0|||
127816505|NCT04430348|459948451|FG002|Overall Study|Lost to Follow-up|0|||
127816506|NCT04430348|459948452|FG003|Overall Study|Lost to Follow-up|1|||
127816507|NCT04430348|459948453|FG004|Overall Study|Lost to Follow-up|0|||
127816508|NCT04430348|459948454|FG005|Overall Study|Lost to Follow-up|0|||
127816509|NCT04430348|459948449|FG000|Overall Study|Adverse Event|0|||
127816510|NCT04430348|459948450|FG001|Overall Study|Adverse Event|0|||
127816511|NCT04430348|459948451|FG002|Overall Study|Adverse Event|0|||
127816512|NCT04430348|459948452|FG003|Overall Study|Adverse Event|0|||
127816513|NCT04430348|459948453|FG004|Overall Study|Adverse Event|0|||
127816514|NCT04430348|459948454|FG005|Overall Study|Adverse Event|1|||
127816515|NCT04430348|459948449|FG000|Overall Study|Withdrawal by Subject|0|||
127816516|NCT04430348|459948450|FG001|Overall Study|Withdrawal by Subject|1|||
127816517|NCT04430348|459948451|FG002|Overall Study|Withdrawal by Subject|0|||
127816518|NCT04430348|459948452|FG003|Overall Study|Withdrawal by Subject|0|||
127816519|NCT04430348|459948453|FG004|Overall Study|Withdrawal by Subject|0|||
127816520|NCT04430348|459948454|FG005|Overall Study|Withdrawal by Subject|1|||
127816521|NCT04430348|459948449|FG000|Overall Study|Study Terminated by Sponsor|0|||
127816522|NCT04430348|459948450|FG001|Overall Study|Study Terminated by Sponsor|0|||
127816523|NCT04430348|459948451|FG002|Overall Study|Study Terminated by Sponsor|2|||
127816524|NCT04430348|459948452|FG003|Overall Study|Study Terminated by Sponsor|0|||
127816525|NCT04430348|459948453|FG004|Overall Study|Study Terminated by Sponsor|1|||
127816526|NCT04430348|459948454|FG005|Overall Study|Study Terminated by Sponsor|1|||
127816527|NCT03715465|459948455|FG000|Overall Study|Withdrawal by Subject|1|||
127816528|NCT03715465|459948456|FG001|Overall Study|Withdrawal by Subject|2|||
127816529|NCT00756002|459948460|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
127816530|NCT00756002|459948461|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
127816531|NCT00756002|459948460|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
127816532|NCT00756002|459948461|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
127816533|NCT00756002|459948460|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
127816534|NCT00756002|459948461|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
127894546|NCT03019965|460237175|FG001|Overall Study|Physician Decision|1|||
127816535|NCT00756002|459948460|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
127816536|NCT00756002|459948461|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
127816537|NCT00756002|459948460|FG000|Double-Blind Treatment Period|Other|2|||
127894547|NCT01915732|460237176|FG000|Overall Study|Withdrawal by Subject|18|||
127816538|NCT00756002|459948461|FG001|Double-Blind Treatment Period|Other|2|||
127816539|NCT04899271|459948466|FG000|Overall Study|Lost to Follow-up|1|||
127816540|NCT04899271|459948467|FG001|Overall Study|Lost to Follow-up|0|||
127816541|NCT04899271|459948466|FG000|Overall Study|Subject request/consent withdrawal|2|||
127816542|NCT04899271|459948467|FG001|Overall Study|Subject request/consent withdrawal|0|||
127816543|NCT00900796|459948472|FG000|Phase 1|Lacked sufficient information|4|||
127816544|NCT00900796|459948472|FG000|Phase 1|Missing information at Week 16|7|||
127816545|NCT00900796|459948472|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
127816546|NCT00900796|459948472|FG000|Phase 2|Lost to Follow-up|5|||
127816547|NCT01859403|459948473|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
127816548|NCT01859403|459948474|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
127816549|NCT01859403|459948473|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
127816550|NCT01859403|459948474|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
127816551|NCT01859403|459948473|FG000|Primary Endpoint Measure|Physician Decision|0|||
127816552|NCT01859403|459948474|FG001|Primary Endpoint Measure|Physician Decision|1|||
127816553|NCT01859403|459948473|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
127816554|NCT01859403|459948474|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
127816555|NCT02750410|459948480|FG000|Double-Blind Treatment Period|Adverse Event|2|||
127816556|NCT02750410|459948481|FG001|Double-Blind Treatment Period|Adverse Event|2|||
127816557|NCT02750410|459948480|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
127816558|NCT02750410|459948481|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
127816559|NCT02750410|459948480|FG000|Open-Label Extension Period|Adverse Event|5|||
127816560|NCT02750410|459948481|FG001|Open-Label Extension Period|Adverse Event|3|||
127816561|NCT02750410|459948480|FG000|Open-Label Extension Period|Protocol Violation|0|||
127816562|NCT02750410|459948481|FG001|Open-Label Extension Period|Protocol Violation|1|||
127816563|NCT02750410|459948480|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
127816564|NCT02750410|459948481|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
127816565|NCT01531725|459948485|FG000|Overall Study|Protocol Violation|5|||
127816566|NCT03596164|459948487|FG000|Overall Study|Adverse Event|0|||
127816567|NCT03596164|459948488|FG001|Overall Study|Adverse Event|1|||
127816568|NCT03596164|459948487|FG000|Overall Study|Death|1|||
127816569|NCT03596164|459948488|FG001|Overall Study|Death|0|||
127816570|NCT04112914|459948489|FG000|Overall Study|Lost to Follow-up|13|||
127816571|NCT04112914|459948490|FG001|Overall Study|Lost to Follow-up|9|||
127816572|NCT04112914|459948489|FG000|Overall Study|Withdrawal by Subject|1|||
127816573|NCT04112914|459948490|FG001|Overall Study|Withdrawal by Subject|0|||
127816574|NCT03427073|459948491|FG000|Overall Study|Disease Progression|1|||
127816575|NCT03427073|459948492|FG001|Overall Study|Disease Progression|1|||
127816576|NCT03427073|459948493|FG002|Overall Study|Disease Progression|1|||
127816577|NCT03427073|459948494|FG003|Overall Study|Disease Progression|3|||
127816578|NCT03427073|459948495|FG004|Overall Study|Disease Progression|3|||
127816579|NCT03427073|459948496|FG005|Overall Study|Disease Progression|4|||
127816580|NCT03427073|459948497|FG006|Overall Study|Disease Progression|2|||
127816581|NCT03427073|459948498|FG007|Overall Study|Disease Progression|3|||
127816582|NCT03427073|459948491|FG000|Overall Study|Physician Decision|0|||
127816583|NCT03427073|459948492|FG001|Overall Study|Physician Decision|0|||
127816584|NCT03427073|459948493|FG002|Overall Study|Physician Decision|0|||
127816585|NCT03427073|459948494|FG003|Overall Study|Physician Decision|0|||
127816586|NCT03427073|459948495|FG004|Overall Study|Physician Decision|0|||
127816587|NCT03427073|459948496|FG005|Overall Study|Physician Decision|0|||
127816588|NCT03427073|459948497|FG006|Overall Study|Physician Decision|1|||
127816589|NCT03427073|459948498|FG007|Overall Study|Physician Decision|1|||
127816590|NCT01486238|459948502|FG000|Overall Study|Death|0|||
127816591|NCT01486238|459948503|FG001|Overall Study|Death|2|||
127816592|NCT01486238|459948502|FG000|Overall Study|Withdrawal by Subject|2|||
127816593|NCT01486238|459948503|FG001|Overall Study|Withdrawal by Subject|1|||
127816594|NCT01486238|459948502|FG000|Overall Study|Lost to Follow-up|0|||
127816595|NCT01486238|459948503|FG001|Overall Study|Lost to Follow-up|3|||
127816596|NCT02835495|459948505|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
127816597|NCT02835495|459948506|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
127816598|NCT02835495|459948505|FG000|Overall Study|Declined in-person follow-up visit|4|||
127816599|NCT02835495|459948506|FG001|Overall Study|Declined in-person follow-up visit|2|||
127816600|NCT02318602|459948507|FG000|Overall Study|Adverse Event|0|||
127816601|NCT02318602|459948508|FG001|Overall Study|Adverse Event|1|||
127816602|NCT02318602|459948509|FG002|Overall Study|Adverse Event|1|||
127816603|NCT02318602|459948507|FG000|Overall Study|Withdrawal by Subject|0|||
127816604|NCT02318602|459948508|FG001|Overall Study|Withdrawal by Subject|3|||
127816605|NCT02318602|459948509|FG002|Overall Study|Withdrawal by Subject|0|||
127816606|NCT02318602|459948507|FG000|Overall Study|Death|1|||
127816607|NCT02318602|459948508|FG001|Overall Study|Death|0|||
127816608|NCT02318602|459948509|FG002|Overall Study|Death|0|||
127816609|NCT02318602|459948507|FG000|Overall Study|Guardian decision to withdraw|0|||
127816610|NCT02318602|459948508|FG001|Overall Study|Guardian decision to withdraw|0|||
127894548|NCT01915732|460237177|FG001|Overall Study|Withdrawal by Subject|18|||
127894549|NCT01915732|460237176|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
127816611|NCT02318602|459948509|FG002|Overall Study|Guardian decision to withdraw|1|||
127816612|NCT00693706|459948510|FG000|Overall Study|Protocol Violation|0|||
127816613|NCT00693706|459948511|FG001|Overall Study|Protocol Violation|1|||
127816614|NCT05421754|459948512|FG000|Overall Study|Technical issue with sensor|1|||
127816615|NCT02580058|459948513|FG000|Overall Study|Adverse Event|16|||
127816616|NCT02580058|459948514|FG001|Overall Study|Adverse Event|30|||
127894550|NCT01915732|460237177|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
127894551|NCT01915732|460237176|FG000|Overall Study|Adverse Event|12|||
127816617|NCT02580058|459948515|FG002|Overall Study|Adverse Event|20|||
127816618|NCT02580058|459948513|FG000|Overall Study|Death|4|||
127816619|NCT02580058|459948514|FG001|Overall Study|Death|4|||
127816620|NCT02580058|459948515|FG002|Overall Study|Death|5|||
127816621|NCT02580058|459948513|FG000|Overall Study|Physician Decision|1|||
127816622|NCT02580058|459948514|FG001|Overall Study|Physician Decision|3|||
127816623|NCT02580058|459948515|FG002|Overall Study|Physician Decision|11|||
127816624|NCT02580058|459948513|FG000|Overall Study|Other|5|||
127816625|NCT02580058|459948514|FG001|Overall Study|Other|1|||
127816626|NCT02580058|459948515|FG002|Overall Study|Other|3|||
127816627|NCT02580058|459948513|FG000|Overall Study|Withdrawal by Subject|4|||
127816628|NCT02580058|459948514|FG001|Overall Study|Withdrawal by Subject|7|||
127816629|NCT02580058|459948515|FG002|Overall Study|Withdrawal by Subject|31|||
127816630|NCT02580058|459948513|FG000|Overall Study|Global Deterioration of Health Status|19|||
127816631|NCT02580058|459948514|FG001|Overall Study|Global Deterioration of Health Status|18|||
127816632|NCT02580058|459948515|FG002|Overall Study|Global Deterioration of Health Status|24|||
127816633|NCT02580058|459948513|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
127816634|NCT02580058|459948514|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
127816635|NCT02580058|459948515|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
127816636|NCT02580058|459948513|FG000|Overall Study|Progressive Disease|137|||
127816637|NCT02580058|459948514|FG001|Overall Study|Progressive Disease|125|||
127816638|NCT02580058|459948515|FG002|Overall Study|Progressive Disease|94|||
127816639|NCT02580058|459948513|FG000|Overall Study|Non-Compliance With Study Drug|1|||
127816640|NCT02580058|459948514|FG001|Overall Study|Non-Compliance With Study Drug|0|||
127816641|NCT02580058|459948515|FG002|Overall Study|Non-Compliance With Study Drug|0|||
127816642|NCT01193335|459948516|FG000|After Infant Series|Lost to Follow-up|1|||
127816643|NCT01193335|459948517|FG001|After Infant Series|Lost to Follow-up|2|||
127816644|NCT01193335|459948516|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
127816645|NCT01193335|459948517|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
127816646|NCT01193335|459948516|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
127816647|NCT01193335|459948517|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
127816648|NCT01193335|459948516|FG000|1-Year Follow-up|Lost to Follow-up|4|||
127816649|NCT01193335|459948517|FG001|1-Year Follow-up|Lost to Follow-up|0|||
127816650|NCT01193335|459948516|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
127816651|NCT01193335|459948517|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
127816652|NCT01193335|459948516|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
127816653|NCT01193335|459948517|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
127816654|NCT01733329|459948519|FG000|Overall Study|Protocol Violation|1|||
127816655|NCT01733329|459948520|FG001|Overall Study|Protocol Violation|1|||
127816656|NCT01733329|459948519|FG000|Overall Study|Uterine artery injury|1|||
127816657|NCT01733329|459948520|FG001|Overall Study|Uterine artery injury|0|||
127816658|NCT00542828|459948521|FG000|Overall Study|Physician Decision|1|||
127816659|NCT00542828|459948521|FG000|Overall Study|Need for Prohibited Treatment|3|||
127816660|NCT00542828|459948521|FG000|Overall Study|Study Prematurely Discontinued|7|||
127816661|NCT00542828|459948521|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
127816662|NCT03228186|459948522|FG000|Overall Study|Patient never started treatment|1|||
127816663|NCT04246047|459948523|FG000|Overall Study|Death|50|||
127816664|NCT04246047|459948524|FG001|Overall Study|Death|77|||
127816665|NCT04246047|459948523|FG000|Overall Study|Lost to Follow-up|1|||
127816666|NCT04246047|459948524|FG001|Overall Study|Lost to Follow-up|3|||
127816667|NCT04246047|459948523|FG000|Overall Study|Physician Decision|4|||
127816668|NCT04246047|459948524|FG001|Overall Study|Physician Decision|10|||
127816669|NCT04246047|459948523|FG000|Overall Study|Withdrawal by Subject|19|||
127816670|NCT04246047|459948524|FG001|Overall Study|Withdrawal by Subject|26|||
127816671|NCT04246047|459948523|FG000|Overall Study|Ongoing|169|||
127816672|NCT04246047|459948524|FG001|Overall Study|Ongoing|135|||
127816673|NCT05139030|459948528|FG000|Overall Study|Withdrawal by Subject|1|||
127816674|NCT05139030|459948529|FG001|Overall Study|Withdrawal by Subject|3|||
127816675|NCT05139030|459948528|FG000|Overall Study|Adverse Event|0|||
127816676|NCT05139030|459948529|FG001|Overall Study|Adverse Event|1|||
127816677|NCT05139030|459948528|FG000|Overall Study|Failure to meet continuation criteria|0|||
127816678|NCT05139030|459948529|FG001|Overall Study|Failure to meet continuation criteria|1|||
127816679|NCT02502864|459948532|FG000|Overall Study|Withdrawal by Subject|1|||
127816680|NCT03772327|459948533|FG000|Overall Study|Lost to Follow-up|3|||
127816681|NCT03772327|459948534|FG001|Overall Study|Lost to Follow-up|4|||
127816682|NCT03772327|459948533|FG000|Overall Study|Withdrawal by Subject|2|||
127816683|NCT03772327|459948534|FG001|Overall Study|Withdrawal by Subject|3|||
127816684|NCT04233424|459948535|FG000|Overall Study|Death|15|||
127816685|NCT04233424|459948536|FG001|Overall Study|Death|16|||
127816686|NCT04233424|459948535|FG000|Overall Study|Withdrawal by Subject|2|||
127816687|NCT04233424|459948536|FG001|Overall Study|Withdrawal by Subject|8|||
127816688|NCT04233424|459948535|FG000|Overall Study|Physician Decision|1|||
127816689|NCT04233424|459948536|FG001|Overall Study|Physician Decision|3|||
127816690|NCT04233424|459948535|FG000|Overall Study|Protocol Violation|3|||
127816691|NCT04233424|459948536|FG001|Overall Study|Protocol Violation|1|||
127816692|NCT04233424|459948535|FG000|Overall Study|Lost to Follow-up|1|||
127816693|NCT04233424|459948536|FG001|Overall Study|Lost to Follow-up|3|||
127816694|NCT04233424|459948535|FG000|Overall Study|subject refuse to visit site|2|||
127816695|NCT04233424|459948536|FG001|Overall Study|subject refuse to visit site|0|||
127816696|NCT03517436|459948537|FG000|Overall Study|Death|3|||
127816697|NCT03517436|459948537|FG000|Overall Study|Withdrawal by Subject|4|||
127816698|NCT03517436|459948537|FG000|Overall Study|Did not receive study valve.|1|||
127816699|NCT01254344|459948540|FG000|Overall Study|Adverse Event|2|||
127816700|NCT01254344|459948541|FG001|Overall Study|Adverse Event|5|||
127816701|NCT01254344|459948540|FG000|Overall Study|Physician Decision|7|||
127816702|NCT01254344|459948541|FG001|Overall Study|Physician Decision|4|||
127816703|NCT01254344|459948540|FG000|Overall Study|Protocol Violation|1|||
127816704|NCT01254344|459948541|FG001|Overall Study|Protocol Violation|4|||
127816705|NCT01254344|459948540|FG000|Overall Study|Withdrawal by Subject|3|||
127816706|NCT01254344|459948541|FG001|Overall Study|Withdrawal by Subject|6|||
127816707|NCT03022461|459948542|FG000|Overall Study|Death|3|||
127816708|NCT01982630|459948543|FG000|Overall Study|Adverse Event|2|||
127816709|NCT01982630|459948544|FG001|Overall Study|Adverse Event|0|||
127816710|NCT01982630|459948545|FG002|Overall Study|Adverse Event|1|||
127816711|NCT01982630|459948546|FG003|Overall Study|Adverse Event|0|||
127816712|NCT01982630|459948547|FG004|Overall Study|Adverse Event|1|||
127816713|NCT01982630|459948548|FG005|Overall Study|Adverse Event|2|||
127816714|NCT01982630|459948549|FG006|Overall Study|Adverse Event|1|||
127816715|NCT01982630|459948550|FG007|Overall Study|Adverse Event|0|||
127816716|NCT01982630|459948543|FG000|Overall Study|Physician Decision|1|||
127816717|NCT01982630|459948544|FG001|Overall Study|Physician Decision|0|||
127816718|NCT01982630|459948545|FG002|Overall Study|Physician Decision|2|||
127816719|NCT01982630|459948546|FG003|Overall Study|Physician Decision|1|||
127816720|NCT01982630|459948547|FG004|Overall Study|Physician Decision|2|||
127816721|NCT01982630|459948548|FG005|Overall Study|Physician Decision|0|||
127816722|NCT01982630|459948549|FG006|Overall Study|Physician Decision|0|||
127816723|NCT01982630|459948550|FG007|Overall Study|Physician Decision|0|||
127816724|NCT01982630|459948543|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
127816725|NCT01982630|459948544|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
127816726|NCT01982630|459948545|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
127816727|NCT01982630|459948546|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
127816728|NCT01982630|459948547|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
127816729|NCT01982630|459948548|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
127816730|NCT01982630|459948549|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
127816731|NCT01982630|459948550|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
127816732|NCT01982630|459948543|FG000|Overall Study|Withdrawal by Subject|0|||
127816733|NCT01982630|459948544|FG001|Overall Study|Withdrawal by Subject|0|||
127816734|NCT01982630|459948545|FG002|Overall Study|Withdrawal by Subject|0|||
127816735|NCT01982630|459948546|FG003|Overall Study|Withdrawal by Subject|0|||
127816736|NCT01982630|459948547|FG004|Overall Study|Withdrawal by Subject|0|||
127816737|NCT01982630|459948548|FG005|Overall Study|Withdrawal by Subject|1|||
127816738|NCT01982630|459948549|FG006|Overall Study|Withdrawal by Subject|0|||
127816739|NCT01982630|459948550|FG007|Overall Study|Withdrawal by Subject|0|||
127816740|NCT03459040|459948551|FG000|Overall Study|Death|8|||
127816741|NCT03459040|459948551|FG000|Overall Study|Withdrawal by Subject|1|||
127816742|NCT00986349|459948554|FG000|Overall Study|Unsuccessful implant procedure|3|||
127816743|NCT00986349|459948554|FG000|Overall Study|Adverse Event|2|||
127816744|NCT00986349|459948554|FG000|Overall Study|Physician Decision|1|||
127816745|NCT00986349|459948554|FG000|Overall Study|device migration|1|||
127816746|NCT02299934|459948555|FG000|Overall Study|Termination of study|13|||
127816747|NCT00561353|459948556|FG000|Overall Study|Subject reached a virologic endpoint|2|||
127816748|NCT00561353|459948557|FG001|Overall Study|Subject reached a virologic endpoint|1|||
127816749|NCT00561353|459948558|FG002|Overall Study|Subject reached a virologic endpoint|1|||
127816750|NCT00561353|459948559|FG003|Overall Study|Subject reached a virologic endpoint|4|||
127816751|NCT00561353|459948560|FG004|Overall Study|Subject reached a virologic endpoint|1|||
127894552|NCT01915732|460237177|FG001|Overall Study|Adverse Event|4|||
127816752|NCT00561353|459948561|FG005|Overall Study|Subject reached a virologic endpoint|3|||
127816753|NCT00561353|459948562|FG006|Overall Study|Subject reached a virologic endpoint|4|||
127816754|NCT00561353|459948563|FG007|Overall Study|Subject reached a virologic endpoint|4|||
127816755|NCT00561353|459948564|FG008|Overall Study|Subject reached a virologic endpoint|5|||
127816756|NCT00561353|459948565|FG009|Overall Study|Subject reached a virologic endpoint|0|||
127816757|NCT00561353|459948556|FG000|Overall Study|Subject ineligible to continue the trial|0|||
127816758|NCT00561353|459948557|FG001|Overall Study|Subject ineligible to continue the trial|0|||
127816759|NCT00561353|459948558|FG002|Overall Study|Subject ineligible to continue the trial|0|||
127816760|NCT00561353|459948559|FG003|Overall Study|Subject ineligible to continue the trial|0|||
127816761|NCT00561353|459948560|FG004|Overall Study|Subject ineligible to continue the trial|0|||
127816762|NCT00561353|459948561|FG005|Overall Study|Subject ineligible to continue the trial|1|||
127816763|NCT00561353|459948562|FG006|Overall Study|Subject ineligible to continue the trial|1|||
127816764|NCT00561353|459948563|FG007|Overall Study|Subject ineligible to continue the trial|0|||
127816765|NCT00561353|459948564|FG008|Overall Study|Subject ineligible to continue the trial|2|||
127816766|NCT00561353|459948565|FG009|Overall Study|Subject ineligible to continue the trial|1|||
127816767|NCT00561353|459948556|FG000|Overall Study|Other|1|||
127816768|NCT00561353|459948557|FG001|Overall Study|Other|0|||
127816769|NCT00561353|459948558|FG002|Overall Study|Other|1|||
127816770|NCT00561353|459948559|FG003|Overall Study|Other|0|||
127816771|NCT00561353|459948560|FG004|Overall Study|Other|0|||
127816772|NCT00561353|459948561|FG005|Overall Study|Other|2|||
127816773|NCT00561353|459948562|FG006|Overall Study|Other|0|||
127816774|NCT00561353|459948563|FG007|Overall Study|Other|0|||
127816775|NCT00561353|459948564|FG008|Overall Study|Other|0|||
127816776|NCT00561353|459948565|FG009|Overall Study|Other|0|||
127816777|NCT00561353|459948556|FG000|Overall Study|Adverse Event|0|||
127816778|NCT00561353|459948557|FG001|Overall Study|Adverse Event|0|||
127816779|NCT00561353|459948558|FG002|Overall Study|Adverse Event|0|||
127816780|NCT00561353|459948559|FG003|Overall Study|Adverse Event|2|||
127816781|NCT00561353|459948560|FG004|Overall Study|Adverse Event|0|||
127816782|NCT00561353|459948561|FG005|Overall Study|Adverse Event|0|||
127816783|NCT00561353|459948562|FG006|Overall Study|Adverse Event|1|||
127816784|NCT00561353|459948563|FG007|Overall Study|Adverse Event|0|||
127816785|NCT00561353|459948564|FG008|Overall Study|Adverse Event|0|||
127816786|NCT00561353|459948565|FG009|Overall Study|Adverse Event|1|||
127816787|NCT00561353|459948556|FG000|Overall Study|Lost to Follow-up|2|||
127816788|NCT00561353|459948557|FG001|Overall Study|Lost to Follow-up|0|||
127816789|NCT00561353|459948558|FG002|Overall Study|Lost to Follow-up|1|||
127816790|NCT00561353|459948559|FG003|Overall Study|Lost to Follow-up|0|||
127816791|NCT00561353|459948560|FG004|Overall Study|Lost to Follow-up|0|||
127816792|NCT00561353|459948561|FG005|Overall Study|Lost to Follow-up|0|||
127816793|NCT00561353|459948562|FG006|Overall Study|Lost to Follow-up|0|||
127816794|NCT00561353|459948563|FG007|Overall Study|Lost to Follow-up|0|||
127816795|NCT00561353|459948564|FG008|Overall Study|Lost to Follow-up|0|||
127816796|NCT00561353|459948565|FG009|Overall Study|Lost to Follow-up|0|||
127816797|NCT00561353|459948556|FG000|Overall Study|Withdrawal by Subject|0|||
127816798|NCT00561353|459948557|FG001|Overall Study|Withdrawal by Subject|2|||
127816799|NCT00561353|459948558|FG002|Overall Study|Withdrawal by Subject|0|||
127816800|NCT00561353|459948559|FG003|Overall Study|Withdrawal by Subject|0|||
127816801|NCT00561353|459948560|FG004|Overall Study|Withdrawal by Subject|0|||
127816802|NCT00561353|459948561|FG005|Overall Study|Withdrawal by Subject|0|||
127816803|NCT00561353|459948562|FG006|Overall Study|Withdrawal by Subject|0|||
127816804|NCT00561353|459948563|FG007|Overall Study|Withdrawal by Subject|0|||
127816805|NCT00561353|459948564|FG008|Overall Study|Withdrawal by Subject|0|||
127816806|NCT00561353|459948565|FG009|Overall Study|Withdrawal by Subject|0|||
127816807|NCT01273818|459948566|FG000|Overall Study|Physician Decision|13|||
127816808|NCT01273818|459948567|FG001|Overall Study|Physician Decision|2|||
127816809|NCT01273818|459948568|FG002|Overall Study|Physician Decision|9|||
127816810|NCT03815175|459948569|FG000|Overall Study|Subject Lost to Follow-up|6|||
127816811|NCT03815175|459948569|FG000|Overall Study|Subject Withdrew Consent|48|||
127816812|NCT03815175|459948569|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
127816813|NCT03815175|459948569|FG000|Overall Study|Death|86|||
127816814|NCT03815175|459948569|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
127816815|NCT03815175|459948569|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
127816816|NCT03815175|459948569|FG000|Overall Study|Other Status Change Reason|1|||
127816817|NCT03815175|459948569|FG000|Overall Study|Missed Visit|12|||
127816818|NCT00820040|459948570|FG000|Overall Study|Death|1|||
127816819|NCT00820040|459948570|FG000|Overall Study|Sponsor terminated study|1|||
127816820|NCT00820040|459948570|FG000|Overall Study|Screen failure|1|||
127816821|NCT02493751|459948571|FG000|Overall Study|Withdrawal by Subject|2|||
127816822|NCT02493751|459948572|FG001|Overall Study|Withdrawal by Subject|8|||
127816823|NCT02493751|459948571|FG000|Overall Study|Death|6|||
127816824|NCT02493751|459948572|FG001|Overall Study|Death|13|||
127816825|NCT02493751|459948571|FG000|Overall Study|Lost to Follow-up|2|||
127816826|NCT02493751|459948572|FG001|Overall Study|Lost to Follow-up|3|||
127816827|NCT02493751|459948571|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
127816828|NCT02493751|459948572|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
127816829|NCT01824602|459948575|FG000|Overall Study|Withdrawal by Subject|0|||
127816830|NCT01824602|459948576|FG001|Overall Study|Withdrawal by Subject|0|||
127816831|NCT01824602|459948577|FG002|Overall Study|Withdrawal by Subject|1|||
127816832|NCT01824602|459948578|FG003|Overall Study|Withdrawal by Subject|2|||
127816833|NCT01824602|459948575|FG000|Overall Study|Patient non-compliance|0|||
127816834|NCT01824602|459948576|FG001|Overall Study|Patient non-compliance|0|||
127816835|NCT01824602|459948577|FG002|Overall Study|Patient non-compliance|1|||
127816836|NCT01824602|459948578|FG003|Overall Study|Patient non-compliance|0|||
127816837|NCT01824602|459948575|FG000|Overall Study|Adverse Event|1|||
127816838|NCT01824602|459948576|FG001|Overall Study|Adverse Event|0|||
127816839|NCT01824602|459948577|FG002|Overall Study|Adverse Event|2|||
127816840|NCT01824602|459948578|FG003|Overall Study|Adverse Event|2|||
127816841|NCT01824602|459948575|FG000|Overall Study|Treatment failure|0|||
127816842|NCT01824602|459948576|FG001|Overall Study|Treatment failure|0|||
127816843|NCT01824602|459948577|FG002|Overall Study|Treatment failure|0|||
127816844|NCT01824602|459948578|FG003|Overall Study|Treatment failure|1|||
127816845|NCT02485717|459948581|FG000|Overall Study|Lost to Follow-up|6|||
127816846|NCT02485717|459948582|FG001|Overall Study|Lost to Follow-up|0|||
127816847|NCT02485717|459948583|FG002|Overall Study|Lost to Follow-up|0|||
127816848|NCT02485717|459948581|FG000|Overall Study|Withdrawal by Subject|0|||
127816849|NCT02485717|459948582|FG001|Overall Study|Withdrawal by Subject|0|||
127816850|NCT02485717|459948583|FG002|Overall Study|Withdrawal by Subject|1|||
127816851|NCT02485717|459948581|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
127816852|NCT02485717|459948582|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
127816853|NCT02485717|459948583|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
127816854|NCT02485717|459948581|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
127816855|NCT02485717|459948582|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
127816856|NCT02485717|459948583|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
127816857|NCT03822468|459948584|FG000|Treatment Period|Progressive disease|98|||
127816858|NCT03822468|459948585|FG001|Treatment Period|Progressive disease|94|||
127816859|NCT03822468|459948584|FG000|Treatment Period|Adverse Event|21|||
127816860|NCT03822468|459948585|FG001|Treatment Period|Adverse Event|24|||
127816861|NCT03822468|459948584|FG000|Treatment Period|Withdrawal by Subject|9|||
127816862|NCT03822468|459948585|FG001|Treatment Period|Withdrawal by Subject|5|||
127816863|NCT03822468|459948584|FG000|Treatment Period|Physician Decision|9|||
127816864|NCT03822468|459948585|FG001|Treatment Period|Physician Decision|7|||
127816865|NCT03822468|459948584|FG000|Treatment Period|Protocol Violation|2|||
127816866|NCT03822468|459948585|FG001|Treatment Period|Protocol Violation|1|||
127816867|NCT03822468|459948584|FG000|Treatment Period|Death|2|||
127816868|NCT03822468|459948585|FG001|Treatment Period|Death|3|||
127816869|NCT03822468|459948584|FG000|Treatment Period|Lost to Follow-up|1|||
127816870|NCT03822468|459948585|FG001|Treatment Period|Lost to Follow-up|1|||
127816871|NCT03822468|459948584|FG000|Treatment Period|Sponsor decision|46|||
127816872|NCT03822468|459948585|FG001|Treatment Period|Sponsor decision|53|||
127816873|NCT03822468|459948584|FG000|Post-treatment Efficacy Follow-up|Progressive disease|11|||
127816874|NCT03822468|459948585|FG001|Post-treatment Efficacy Follow-up|Progressive disease|14|||
127816875|NCT03822468|459948584|FG000|Post-treatment Efficacy Follow-up|Withdrawal by Subject|4|||
127816876|NCT03822468|459948585|FG001|Post-treatment Efficacy Follow-up|Withdrawal by Subject|3|||
127816877|NCT03822468|459948584|FG000|Post-treatment Efficacy Follow-up|Death|1|||
127816878|NCT03822468|459948585|FG001|Post-treatment Efficacy Follow-up|Death|0|||
127816879|NCT03822468|459948584|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
127816880|NCT03822468|459948585|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
127816881|NCT03822468|459948584|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
127816882|NCT03822468|459948585|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
127816883|NCT03822468|459948584|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
127816884|NCT03822468|459948585|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
127816885|NCT03822468|459948584|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|3|||
127816886|NCT03822468|459948585|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|7|||
127816887|NCT02722044|459948586|FG000|Overall Study|Adverse Event|2|||
127816888|NCT02722044|459948586|FG000|Overall Study|Physician Decision|1|||
127816889|NCT02722044|459948586|FG000|Overall Study|Withdrawal by Subject|1|||
127816890|NCT02722044|459948586|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
127816891|NCT02117687|459948587|FG000|Overall Study|Lost to Follow-up|0|||
127816892|NCT02117687|459948588|FG001|Overall Study|Lost to Follow-up|1|||
127816893|NCT02117687|459948587|FG000|Overall Study|Adverse Event|0|||
127816894|NCT02117687|459948588|FG001|Overall Study|Adverse Event|2|||
127816895|NCT02117687|459948587|FG000|Overall Study|Other Reasons|1|||
127816896|NCT02117687|459948588|FG001|Overall Study|Other Reasons|1|||
127816897|NCT00002850|459948589|FG000|Overall Study|Death|4|||
127816898|NCT00002850|459948590|FG001|Overall Study|Death|1|||
127816899|NCT00002850|459948591|FG002|Overall Study|Death|3|||
127816900|NCT00002850|459948589|FG000|Overall Study|Protocol Violation|1|||
127816901|NCT00002850|459948590|FG001|Overall Study|Protocol Violation|0|||
127816902|NCT00002850|459948591|FG002|Overall Study|Protocol Violation|1|||
127816903|NCT00002850|459948589|FG000|Overall Study|Withdrawal by Subject|0|||
127816904|NCT00002850|459948590|FG001|Overall Study|Withdrawal by Subject|1|||
127816905|NCT00002850|459948591|FG002|Overall Study|Withdrawal by Subject|0|||
127816906|NCT01416181|459949954|FG000|Part 1|Other|10|||
127816907|NCT01416181|459949955|FG001|Part 1|Other|24|||
127816908|NCT01416181|459949954|FG000|Part 1|Death|0|||
127816909|NCT01416181|459949955|FG001|Part 1|Death|1|||
127816910|NCT01416181|459949954|FG000|Part 1|Investigator Decision|7|||
127816911|NCT01416181|459949955|FG001|Part 1|Investigator Decision|6|||
127816912|NCT01416181|459949954|FG000|Part 1|Withdrawal by Subject|74|||
127816913|NCT01416181|459949955|FG001|Part 1|Withdrawal by Subject|48|||
127816914|NCT01416181|459949954|FG000|Part 1|Lack of Efficacy|16|||
127816915|NCT01416181|459949955|FG001|Part 1|Lack of Efficacy|8|||
127816916|NCT01416181|459949954|FG000|Part 1|Lost to Follow-up|1|||
127816917|NCT01416181|459949955|FG001|Part 1|Lost to Follow-up|1|||
127816918|NCT01416181|459949954|FG000|Part 1|Adverse Event|15|||
127816919|NCT01416181|459949955|FG001|Part 1|Adverse Event|18|||
127816920|NCT01416181|459949954|FG000|Part 1|Ongoing in Follow-Up|14|||
127816921|NCT01416181|459949955|FG001|Part 1|Ongoing in Follow-Up|8|||
127816922|NCT01416181|459949954|FG000|Part 2|Adverse Event|11|||
127816923|NCT01416181|459949955|FG001|Part 2|Adverse Event|4|||
127816924|NCT01416181|459949954|FG000|Part 2|Other|234|||
127816925|NCT01416181|459949955|FG001|Part 2|Other|267|||
127816926|NCT01416181|459949954|FG000|Part 2|Investigator Decision|6|||
127816927|NCT01416181|459949955|FG001|Part 2|Investigator Decision|7|||
127816928|NCT01416181|459949954|FG000|Part 2|Withdrawal by Subject|14|||
127816929|NCT01416181|459949955|FG001|Part 2|Withdrawal by Subject|5|||
127816930|NCT01416181|459949954|FG000|Part 2|Lack of Efficacy|4|||
127816931|NCT01416181|459949955|FG001|Part 2|Lack of Efficacy|1|||
127816932|NCT01416181|459949954|FG000|Part 2|Lost to Follow-up|2|||
127816933|NCT01416181|459949955|FG001|Part 2|Lost to Follow-up|2|||
127816934|NCT00698516|459949958|FG000|Overall Study|Study Termination|2|||
127816935|NCT00698516|459949958|FG000|Overall Study|Withdrawal by Subject|3|||
127816936|NCT02158533|459949969|FG000|Stage 1|Adverse Event|6|||
127816937|NCT02158533|459949970|FG001|Stage 1|Adverse Event|4|||
127816938|NCT02158533|459949971|FG002|Stage 1|Adverse Event|7|||
127816939|NCT02158533|459949972|FG003|Stage 1|Adverse Event|0|||
127816940|NCT02158533|459949973|FG004|Stage 1|Adverse Event|0|||
127816941|NCT02158533|459949974|FG005|Stage 1|Adverse Event|0|||
127816942|NCT02158533|459949969|FG000|Stage 1|Withdrawal by Subject|3|||
127816943|NCT02158533|459949970|FG001|Stage 1|Withdrawal by Subject|2|||
127816944|NCT02158533|459949971|FG002|Stage 1|Withdrawal by Subject|1|||
127816945|NCT02158533|459949972|FG003|Stage 1|Withdrawal by Subject|0|||
127816946|NCT02158533|459949973|FG004|Stage 1|Withdrawal by Subject|0|||
127816947|NCT02158533|459949974|FG005|Stage 1|Withdrawal by Subject|0|||
127816948|NCT02158533|459949969|FG000|Stage 1|Lack of Efficacy|1|||
127816949|NCT02158533|459949970|FG001|Stage 1|Lack of Efficacy|0|||
127816950|NCT02158533|459949971|FG002|Stage 1|Lack of Efficacy|0|||
127816951|NCT02158533|459949972|FG003|Stage 1|Lack of Efficacy|0|||
127816952|NCT02158533|459949973|FG004|Stage 1|Lack of Efficacy|0|||
127816953|NCT02158533|459949974|FG005|Stage 1|Lack of Efficacy|0|||
127816954|NCT02158533|459949969|FG000|Stage 1|Lost to Follow-up|3|||
127816955|NCT02158533|459949970|FG001|Stage 1|Lost to Follow-up|1|||
127816956|NCT02158533|459949971|FG002|Stage 1|Lost to Follow-up|0|||
127816957|NCT02158533|459949972|FG003|Stage 1|Lost to Follow-up|0|||
127816958|NCT02158533|459949973|FG004|Stage 1|Lost to Follow-up|0|||
127816959|NCT02158533|459949974|FG005|Stage 1|Lost to Follow-up|0|||
127816960|NCT02158533|459949969|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
127816961|NCT02158533|459949970|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
127816962|NCT02158533|459949971|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
127816963|NCT02158533|459949972|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
127816964|NCT02158533|459949973|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
127816965|NCT02158533|459949974|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
127816966|NCT02158533|459949969|FG000|Stage 1|Non-compliance with study visits|1|||
127816967|NCT02158533|459949970|FG001|Stage 1|Non-compliance with study visits|0|||
127816968|NCT02158533|459949971|FG002|Stage 1|Non-compliance with study visits|0|||
127816969|NCT02158533|459949972|FG003|Stage 1|Non-compliance with study visits|0|||
127816970|NCT02158533|459949973|FG004|Stage 1|Non-compliance with study visits|0|||
127816971|NCT02158533|459949974|FG005|Stage 1|Non-compliance with study visits|0|||
127816972|NCT02158533|459949969|FG000|Stage 2|Adverse Event|0|||
127816973|NCT02158533|459949970|FG001|Stage 2|Adverse Event|0|||
127816974|NCT02158533|459949971|FG002|Stage 2|Adverse Event|0|||
127816975|NCT02158533|459949972|FG003|Stage 2|Adverse Event|0|||
127816976|NCT02158533|459949973|FG004|Stage 2|Adverse Event|0|||
127816977|NCT02158533|459949974|FG005|Stage 2|Adverse Event|1|||
127816978|NCT02158533|459949969|FG000|Stage 2|Lack of Efficacy|0|||
127816979|NCT02158533|459949970|FG001|Stage 2|Lack of Efficacy|0|||
127816980|NCT02158533|459949971|FG002|Stage 2|Lack of Efficacy|0|||
127816981|NCT02158533|459949972|FG003|Stage 2|Lack of Efficacy|0|||
127816982|NCT02158533|459949973|FG004|Stage 2|Lack of Efficacy|1|||
127816983|NCT02158533|459949974|FG005|Stage 2|Lack of Efficacy|0|||
127816984|NCT02158533|459949969|FG000|Stage 2|Lost to Follow-up|0|||
127816985|NCT02158533|459949970|FG001|Stage 2|Lost to Follow-up|0|||
127816986|NCT02158533|459949971|FG002|Stage 2|Lost to Follow-up|0|||
127816987|NCT02158533|459949972|FG003|Stage 2|Lost to Follow-up|1|||
127816988|NCT02158533|459949973|FG004|Stage 2|Lost to Follow-up|1|||
127816989|NCT02158533|459949974|FG005|Stage 2|Lost to Follow-up|2|||
127816990|NCT02158533|459949969|FG000|Stage 2|Withdrawal by Subject|0|||
127816991|NCT02158533|459949970|FG001|Stage 2|Withdrawal by Subject|0|||
127816992|NCT02158533|459949971|FG002|Stage 2|Withdrawal by Subject|0|||
127816993|NCT02158533|459949972|FG003|Stage 2|Withdrawal by Subject|0|||
127816994|NCT02158533|459949973|FG004|Stage 2|Withdrawal by Subject|1|||
127816995|NCT02158533|459949974|FG005|Stage 2|Withdrawal by Subject|2|||
127816996|NCT02158533|459949969|FG000|Stage 2|Physician Decision|0|||
127816997|NCT02158533|459949970|FG001|Stage 2|Physician Decision|0|||
127816998|NCT02158533|459949971|FG002|Stage 2|Physician Decision|0|||
127816999|NCT02158533|459949972|FG003|Stage 2|Physician Decision|0|||
127817000|NCT02158533|459949973|FG004|Stage 2|Physician Decision|1|||
127817001|NCT02158533|459949974|FG005|Stage 2|Physician Decision|0|||
127817002|NCT02158533|459949969|FG000|Stage 2|Pregnancy|0|||
127817003|NCT02158533|459949970|FG001|Stage 2|Pregnancy|0|||
127817004|NCT02158533|459949971|FG002|Stage 2|Pregnancy|0|||
127817005|NCT02158533|459949972|FG003|Stage 2|Pregnancy|1|||
127817006|NCT02158533|459949973|FG004|Stage 2|Pregnancy|0|||
127817007|NCT02158533|459949974|FG005|Stage 2|Pregnancy|0|||
127817008|NCT02158533|459949969|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
127817009|NCT02158533|459949970|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
127817010|NCT02158533|459949971|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
127817011|NCT02158533|459949972|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
127817012|NCT02158533|459949973|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
127817013|NCT02158533|459949974|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
127817014|NCT02158533|459949969|FG000|Stage 2|Non-adherence with study visits|0|||
127817015|NCT02158533|459949970|FG001|Stage 2|Non-adherence with study visits|0|||
127817016|NCT02158533|459949971|FG002|Stage 2|Non-adherence with study visits|0|||
127817017|NCT02158533|459949972|FG003|Stage 2|Non-adherence with study visits|0|||
127817018|NCT02158533|459949973|FG004|Stage 2|Non-adherence with study visits|0|||
127817019|NCT02158533|459949974|FG005|Stage 2|Non-adherence with study visits|1|||
127817020|NCT00917384|459949981|FG000|Overall Study|Lost to Follow-up|4|||
127817021|NCT00917384|459949982|FG001|Overall Study|Lost to Follow-up|2|||
127817022|NCT00917384|459949981|FG000|Overall Study|Withdrawal by Subject|10|||
127817023|NCT00917384|459949982|FG001|Overall Study|Withdrawal by Subject|2|||
127817024|NCT00149214|459949984|FG000|Overall Study|Adverse Event|12|||
127817025|NCT00149214|459949985|FG001|Overall Study|Adverse Event|9|||
127817026|NCT00149214|459949984|FG000|Overall Study|Withdrawal by Subject|4|||
127817027|NCT00149214|459949985|FG001|Overall Study|Withdrawal by Subject|1|||
127817028|NCT00149214|459949984|FG000|Overall Study|Physician Decision|3|||
127817029|NCT00149214|459949985|FG001|Overall Study|Physician Decision|3|||
127817030|NCT00149214|459949984|FG000|Overall Study|Sponsor Decision|0|||
127817031|NCT00149214|459949985|FG001|Overall Study|Sponsor Decision|1|||
127817032|NCT00149214|459949984|FG000|Overall Study|Progressive Disease|7|||
127817033|NCT00149214|459949985|FG001|Overall Study|Progressive Disease|3|||
127817034|NCT00174941|459949991|FG000|Overall Study|Adverse Event|1|||
127817035|NCT00174941|459949992|FG001|Overall Study|Adverse Event|10|||
127817036|NCT00174941|459949993|FG002|Overall Study|Adverse Event|2|||
127817037|NCT00174941|459949994|FG003|Overall Study|Adverse Event|13|||
127817038|NCT00174941|459949991|FG000|Overall Study|Protocol Violation|0|||
127817039|NCT00174941|459949992|FG001|Overall Study|Protocol Violation|1|||
127817040|NCT00174941|459949993|FG002|Overall Study|Protocol Violation|0|||
127817041|NCT00174941|459949994|FG003|Overall Study|Protocol Violation|1|||
127817042|NCT00174941|459949991|FG000|Overall Study|Lost to Follow-up|0|||
127817043|NCT00174941|459949992|FG001|Overall Study|Lost to Follow-up|3|||
127817044|NCT00174941|459949993|FG002|Overall Study|Lost to Follow-up|2|||
127817045|NCT00174941|459949994|FG003|Overall Study|Lost to Follow-up|5|||
127817046|NCT00174941|459949991|FG000|Overall Study|Personal Reason(s)|0|||
127817047|NCT00174941|459949992|FG001|Overall Study|Personal Reason(s)|14|||
127817048|NCT00174941|459949993|FG002|Overall Study|Personal Reason(s)|8|||
127817049|NCT00174941|459949994|FG003|Overall Study|Personal Reason(s)|22|||
127817050|NCT00174941|459949991|FG000|Overall Study|Gout Flare|0|||
127817051|NCT00174941|459949992|FG001|Overall Study|Gout Flare|4|||
127817052|NCT00174941|459949993|FG002|Overall Study|Gout Flare|4|||
127817053|NCT00174941|459949994|FG003|Overall Study|Gout Flare|8|||
127817054|NCT00174941|459949991|FG000|Overall Study|Reason Not Specified|1|||
127817055|NCT00174941|459949992|FG001|Overall Study|Reason Not Specified|6|||
127817056|NCT00174941|459949993|FG002|Overall Study|Reason Not Specified|2|||
127817057|NCT00174941|459949994|FG003|Overall Study|Reason Not Specified|9|||
127817058|NCT03126227|459949995|FG000|Overall Study|Adverse Event|43|||
127817059|NCT03126227|459949996|FG001|Overall Study|Adverse Event|4|||
127817060|NCT03126227|459949995|FG000|Overall Study|Death|0|||
127817061|NCT03126227|459949996|FG001|Overall Study|Death|1|||
127817062|NCT03126227|459949995|FG000|Overall Study|Lost to Follow-up|0|||
127817063|NCT03126227|459949996|FG001|Overall Study|Lost to Follow-up|1|||
127817064|NCT03126227|459949995|FG000|Overall Study|Physician Decision|2|||
127817065|NCT03126227|459949996|FG001|Overall Study|Physician Decision|0|||
127817066|NCT03126227|459949995|FG000|Overall Study|Protocol Violation|1|||
127817067|NCT03126227|459949996|FG001|Overall Study|Protocol Violation|0|||
127817068|NCT03126227|459949995|FG000|Overall Study|Withdrawal by Subject|19|||
127817069|NCT03126227|459949996|FG001|Overall Study|Withdrawal by Subject|3|||
127817070|NCT03126227|459949995|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
127817071|NCT03126227|459949996|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
127817072|NCT03126227|459949995|FG000|Overall Study|Lack of dosing compliance|2|||
127817073|NCT03126227|459949996|FG001|Overall Study|Lack of dosing compliance|0|||
127817074|NCT03126227|459949995|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
127817075|NCT03126227|459949996|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
127817076|NCT03126227|459949995|FG000|Overall Study|Scheduling conflict|1|||
127817077|NCT03126227|459949996|FG001|Overall Study|Scheduling conflict|0|||
127817078|NCT03230097|459950000|FG000|Overall Study|Adverse Event|2|||
127817079|NCT03230097|459950001|FG001|Overall Study|Adverse Event|1|||
127817080|NCT03230097|459950000|FG000|Overall Study|non-compliance|0|||
127817081|NCT03230097|459950001|FG001|Overall Study|non-compliance|1|||
127817082|NCT03230097|459950000|FG000|Overall Study|Lost to Follow-up|2|||
127817083|NCT03230097|459950001|FG001|Overall Study|Lost to Follow-up|4|||
127817084|NCT03230097|459950000|FG000|Overall Study|Withdrawal by Subject|7|||
127817085|NCT03230097|459950001|FG001|Overall Study|Withdrawal by Subject|3|||
127817086|NCT03230097|459950000|FG000|Overall Study|Trial termination|4|||
127817087|NCT03230097|459950001|FG001|Overall Study|Trial termination|5|||
127817088|NCT03230097|459950000|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
127817089|NCT03230097|459950001|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
127817090|NCT03230097|459950000|FG000|Overall Study|outcome event|0|||
127817091|NCT03230097|459950001|FG001|Overall Study|outcome event|1|||
127817092|NCT01121406|459950006|FG000|Overall Study|Progressive disease RECIST|44|||
127817093|NCT01121406|459950007|FG001|Overall Study|Progressive disease RECIST|28|||
127817094|NCT01121406|459950006|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
127817095|NCT01121406|459950007|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
127817096|NCT01121406|459950006|FG000|Overall Study|Other AE|3|||
127817097|NCT01121406|459950007|FG001|Overall Study|Other AE|10|||
127817098|NCT01121406|459950006|FG000|Overall Study|Non-compliant with protocol|0|||
127817099|NCT01121406|459950007|FG001|Overall Study|Non-compliant with protocol|2|||
127817100|NCT01121406|459950006|FG000|Overall Study|Lost to Follow-up|0|||
127817101|NCT01121406|459950007|FG001|Overall Study|Lost to Follow-up|1|||
127817102|NCT01121406|459950006|FG000|Overall Study|Refused continuation of study med.|1|||
127817103|NCT01121406|459950007|FG001|Overall Study|Refused continuation of study med.|2|||
127817104|NCT01121406|459950006|FG000|Overall Study|Reason other than specified above|2|||
127817105|NCT01121406|459950007|FG001|Overall Study|Reason other than specified above|6|||
127817106|NCT01121406|459950006|FG000|Overall Study|Not treated|1|||
127817107|NCT01121406|459950007|FG001|Overall Study|Not treated|0|||
127817108|NCT02500550|459950014|FG000|Overall Study|Death|7|||
127817109|NCT02388776|459950015|FG000|Overall Study|Death|1|||
127817110|NCT02388776|459950015|FG000|Overall Study|Lost to Follow-up|1|||
127817111|NCT03826914|459950016|FG000|Overall Study|Withdrawal by Subject|1|||
127817112|NCT03826914|459950017|FG001|Overall Study|Withdrawal by Subject|1|||
127817113|NCT04334148|459950018|FG000|Overall Study|positive nasal swab at baseline|0|||
127817114|NCT04334148|459950019|FG001|Overall Study|positive nasal swab at baseline|1|||
127817115|NCT04283461|459950026|FG000|Overall Study|Enrolled in separate trial|0|||
127817116|NCT04283461|459950027|FG001|Overall Study|Enrolled in separate trial|0|||
127817117|NCT04283461|459950028|FG002|Overall Study|Enrolled in separate trial|8|||
127817118|NCT04283461|459950029|FG003|Overall Study|Enrolled in separate trial|13|||
127817119|NCT04283461|459950030|FG004|Overall Study|Enrolled in separate trial|12|||
127817120|NCT04283461|459950031|FG005|Overall Study|Enrolled in separate trial|0|||
127817121|NCT04283461|459950032|FG006|Overall Study|Enrolled in separate trial|0|||
127817122|NCT04283461|459950033|FG007|Overall Study|Enrolled in separate trial|8|||
127817123|NCT04283461|459950034|FG008|Overall Study|Enrolled in separate trial|0|||
127817124|NCT04283461|459950035|FG009|Overall Study|Enrolled in separate trial|0|||
127817125|NCT04283461|459950036|FG010|Overall Study|Enrolled in separate trial|0|||
127817126|NCT04283461|459950037|FG011|Overall Study|Enrolled in separate trial|7|||
127817127|NCT04283461|459950038|FG012|Overall Study|Enrolled in separate trial|0|||
127817128|NCT04375878|459950045|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
127817129|NCT04375878|459950046|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
127817130|NCT04375878|459950047|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
127817131|NCT04375878|459950048|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
127868853|NCT02210559|460137407|FG000|Overall Study|Physician Decision|1|||
127817132|NCT04375878|459950049|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
127817133|NCT04375878|459950050|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
127817134|NCT04375878|459950045|FG000|Crossover First and Second Interventions|Adverse Event|0|||
127817135|NCT04375878|459950046|FG001|Crossover First and Second Interventions|Adverse Event|0|||
127817136|NCT04375878|459950047|FG002|Crossover First and Second Interventions|Adverse Event|1|||
127817137|NCT04375878|459950048|FG003|Crossover First and Second Interventions|Adverse Event|0|||
127817138|NCT04375878|459950049|FG004|Crossover First and Second Interventions|Adverse Event|0|||
127817139|NCT04375878|459950050|FG005|Crossover First and Second Interventions|Adverse Event|0|||
127817140|NCT04375878|459950045|FG000|Extension Phase|Withdrawal by Subject|0|||
127817141|NCT04375878|459950046|FG001|Extension Phase|Withdrawal by Subject|0|||
127817142|NCT04375878|459950047|FG002|Extension Phase|Withdrawal by Subject|0|||
127817143|NCT04375878|459950048|FG003|Extension Phase|Withdrawal by Subject|0|||
127817144|NCT04375878|459950049|FG004|Extension Phase|Withdrawal by Subject|1|||
127817145|NCT04375878|459950050|FG005|Extension Phase|Withdrawal by Subject|0|||
127817146|NCT00195351|459950051|FG000|Overall Study|Lost to Follow-up|9|||
127817147|NCT00195351|459950052|FG001|Overall Study|Lost to Follow-up|9|||
127817148|NCT00195351|459950051|FG000|Overall Study|Withdrawal by Subject|6|||
127817149|NCT00195351|459950052|FG001|Overall Study|Withdrawal by Subject|3|||
127817150|NCT00195351|459950051|FG000|Overall Study|Protocol Deviation|3|||
127817151|NCT00195351|459950052|FG001|Overall Study|Protocol Deviation|2|||
127817152|NCT00195351|459950051|FG000|Overall Study|Death|3|||
127817153|NCT00195351|459950052|FG001|Overall Study|Death|1|||
127817154|NCT00195351|459950051|FG000|Overall Study|Lack of Efficacy|0|||
127817155|NCT00195351|459950052|FG001|Overall Study|Lack of Efficacy|1|||
127817156|NCT01259466|459950053|FG000|Overall Study|Withdrawal by Subject|1|||
127817157|NCT01259466|459950054|FG001|Overall Study|Withdrawal by Subject|9|||
127817158|NCT05300087|459950057|FG000|Overall Study|Withdrawal by Subject|0|||
127817159|NCT05300087|459950058|FG001|Overall Study|Withdrawal by Subject|1|||
127817160|NCT03248128|459950059|FG000|Overall Study|Lost to Follow-up|1|||
127817161|NCT03248128|459950060|FG001|Overall Study|Lost to Follow-up|0|||
127817162|NCT03248128|459950059|FG000|Overall Study|Withdrawal by Subject|16|||
127817163|NCT03248128|459950060|FG001|Overall Study|Withdrawal by Subject|14|||
127817164|NCT03248128|459950059|FG000|Overall Study|Site Closed|4|||
127817165|NCT03248128|459950060|FG001|Overall Study|Site Closed|3|||
127817166|NCT03248128|459950059|FG000|Overall Study|Randomized, but did not receive treatment|1|||
127817167|NCT03248128|459950060|FG001|Overall Study|Randomized, but did not receive treatment|3|||
127817168|NCT01914679|459950061|FG000|Overall Study|Lack of Efficacy|1|||
127817169|NCT01914679|459950061|FG000|Overall Study|Sponsor terminated study|4|||
127817170|NCT03875235|459950069|FG000|Overall Study|Ongoing study treatment|63|||
127817171|NCT03875235|459950070|FG001|Overall Study|Ongoing study treatment|20|||
127817172|NCT03875235|459950069|FG000|Overall Study|Off treatment|77|||
127817173|NCT03875235|459950070|FG001|Overall Study|Off treatment|91|||
127817174|NCT03875235|459950069|FG000|Overall Study|Withdrawal by Subject|3|||
127817175|NCT03875235|459950070|FG001|Overall Study|Withdrawal by Subject|10|||
127817176|NCT03875235|459950069|FG000|Overall Study|Death|198|||
127817177|NCT03875235|459950070|FG001|Overall Study|Death|223|||
127817178|NCT01877655|459950074|FG000|Overall Study|Death|57|||
127817179|NCT01877655|459950075|FG001|Overall Study|Death|52|||
127817180|NCT01877655|459950074|FG000|Overall Study|Withdrawal by Subject|18|||
127817181|NCT01877655|459950075|FG001|Overall Study|Withdrawal by Subject|26|||
127817182|NCT01877655|459950074|FG000|Overall Study|Physician Decision|11|||
127817183|NCT01877655|459950075|FG001|Overall Study|Physician Decision|10|||
127817184|NCT01877655|459950074|FG000|Overall Study|Miscellaneous|4|||
127817185|NCT01877655|459950075|FG001|Overall Study|Miscellaneous|4|||
127817186|NCT01877655|459950074|FG000|Overall Study|Randomized but Never Received Drug|8|||
127817187|NCT01877655|459950075|FG001|Overall Study|Randomized but Never Received Drug|5|||
127817188|NCT02332915|459950076|FG000|Overall Study|Moved out of region|3|||
127817189|NCT02332915|459950077|FG001|Overall Study|Moved out of region|0|||
127817190|NCT02332915|459950076|FG000|Overall Study|Unrelated illness|1|||
127817191|NCT02332915|459950077|FG001|Overall Study|Unrelated illness|1|||
127817192|NCT02332915|459950076|FG000|Overall Study|Travel distance prohibitive|0|||
127817193|NCT02332915|459950077|FG001|Overall Study|Travel distance prohibitive|1|||
127817194|NCT02332915|459950076|FG000|Overall Study|did not meet inclusion criteria|2|||
127817195|NCT02332915|459950077|FG001|Overall Study|did not meet inclusion criteria|4|||
127817196|NCT05847881|459950078|FG000|Overall Study|Principal Investigator Decision|8|||
127817197|NCT05847881|459950078|FG000|Overall Study|Withdrawal by Subject|2|||
127817198|NCT04513158|459950081|FG000|Overall Study|Screen Failure|1|||
127817199|NCT05635838|459951286|FG000|16-Week DBVC Period|Adverse Event|2|||
127817200|NCT05635838|459951287|FG001|16-Week DBVC Period|Adverse Event|0|||
127817201|NCT05635838|459951288|FG002|16-Week DBVC Period|Adverse Event|0|||
127817202|NCT05635838|459951289|FG003|16-Week DBVC Period|Adverse Event|0|||
127817203|NCT05635838|459951286|FG000|16-Week DBVC Period|Lost to Follow-up|5|||
127817204|NCT05635838|459951287|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
127817205|NCT05635838|459951288|FG002|16-Week DBVC Period|Lost to Follow-up|0|||
127817206|NCT05635838|459951289|FG003|16-Week DBVC Period|Lost to Follow-up|0|||
127817207|NCT05635838|459951286|FG000|16-Week DBVC Period|Physician Decision|0|||
127817208|NCT05635838|459951287|FG001|16-Week DBVC Period|Physician Decision|1|||
127817209|NCT05635838|459951288|FG002|16-Week DBVC Period|Physician Decision|0|||
127817210|NCT05635838|459951289|FG003|16-Week DBVC Period|Physician Decision|0|||
127817211|NCT05635838|459951286|FG000|16-Week DBVC Period|Protocol Violation|1|||
127817212|NCT05635838|459951287|FG001|16-Week DBVC Period|Protocol Violation|0|||
127817213|NCT05635838|459951288|FG002|16-Week DBVC Period|Protocol Violation|0|||
127817214|NCT05635838|459951289|FG003|16-Week DBVC Period|Protocol Violation|0|||
127817215|NCT05635838|459951286|FG000|16-Week DBVC Period|Withdrawal by Subject|1|||
127817216|NCT05635838|459951287|FG001|16-Week DBVC Period|Withdrawal by Subject|0|||
127817217|NCT05635838|459951288|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
127817218|NCT05635838|459951289|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
127817219|NCT05635838|459951286|FG000|16-Week DBVC Period|Presence of Disease Tunnel|1|||
127817220|NCT05635838|459951287|FG001|16-Week DBVC Period|Presence of Disease Tunnel|0|||
127817221|NCT05635838|459951288|FG002|16-Week DBVC Period|Presence of Disease Tunnel|0|||
127817222|NCT05635838|459951289|FG003|16-Week DBVC Period|Presence of Disease Tunnel|0|||
127817223|NCT05635838|459951286|FG000|16-Week DBVC Period|Developed Draining Fistula|0|||
127817224|NCT05635838|459951287|FG001|16-Week DBVC Period|Developed Draining Fistula|1|||
127817225|NCT05635838|459951288|FG002|16-Week DBVC Period|Developed Draining Fistula|0|||
127817226|NCT05635838|459951289|FG003|16-Week DBVC Period|Developed Draining Fistula|0|||
127817227|NCT05635838|459951286|FG000|16-Week OLE Period|Adverse Event|0|||
127817228|NCT05635838|459951287|FG001|16-Week OLE Period|Adverse Event|0|||
127817229|NCT05635838|459951288|FG002|16-Week OLE Period|Adverse Event|0|||
127817230|NCT05635838|459951289|FG003|16-Week OLE Period|Adverse Event|2|||
127817231|NCT05635838|459951286|FG000|16-Week OLE Period|Lost to Follow-up|0|||
127817232|NCT05635838|459951287|FG001|16-Week OLE Period|Lost to Follow-up|0|||
127817233|NCT05635838|459951288|FG002|16-Week OLE Period|Lost to Follow-up|1|||
127817234|NCT05635838|459951289|FG003|16-Week OLE Period|Lost to Follow-up|3|||
127817235|NCT05635838|459951286|FG000|16-Week OLE Period|Physician Decision|0|||
127817236|NCT05635838|459951287|FG001|16-Week OLE Period|Physician Decision|0|||
127817237|NCT05635838|459951288|FG002|16-Week OLE Period|Physician Decision|0|||
127817238|NCT05635838|459951289|FG003|16-Week OLE Period|Physician Decision|1|||
127817239|NCT05635838|459951286|FG000|16-Week OLE Period|Protocol Violation|0|||
127817240|NCT05635838|459951287|FG001|16-Week OLE Period|Protocol Violation|0|||
127817241|NCT05635838|459951288|FG002|16-Week OLE Period|Protocol Violation|1|||
127817242|NCT05635838|459951289|FG003|16-Week OLE Period|Protocol Violation|1|||
127817243|NCT05635838|459951286|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
127817244|NCT05635838|459951287|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
127817245|NCT05635838|459951288|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
127817246|NCT05635838|459951289|FG003|16-Week OLE Period|Withdrawal by Subject|1|||
127817247|NCT05635838|459951286|FG000|16-Week OLE Period|Pregnancy|0|||
127817248|NCT05635838|459951287|FG001|16-Week OLE Period|Pregnancy|0|||
127817249|NCT05635838|459951288|FG002|16-Week OLE Period|Pregnancy|1|||
127817250|NCT05635838|459951289|FG003|16-Week OLE Period|Pregnancy|0|||
127817251|NCT04493619|459951291|FG000|Overall Study|Death|4|||
127817252|NCT04493619|459951292|FG001|Overall Study|Death|3|||
127817253|NCT04493619|459951293|FG002|Overall Study|Death|3|||
127817254|NCT04493619|459951294|FG003|Overall Study|Death|4|||
127817255|NCT04493619|459951291|FG000|Overall Study|Study discontinued early|10|||
127817256|NCT04493619|459951292|FG001|Overall Study|Study discontinued early|0|||
127817257|NCT04493619|459951293|FG002|Overall Study|Study discontinued early|4|||
127817258|NCT04493619|459951294|FG003|Overall Study|Study discontinued early|8|||
127817259|NCT04493619|459951291|FG000|Overall Study|Lost to Follow-up|0|||
127817260|NCT04493619|459951292|FG001|Overall Study|Lost to Follow-up|0|||
127817261|NCT04493619|459951293|FG002|Overall Study|Lost to Follow-up|0|||
127817262|NCT04493619|459951294|FG003|Overall Study|Lost to Follow-up|1|||
127817263|NCT02128490|459951296|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
127817264|NCT02128490|459951297|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
127817265|NCT02128490|459951298|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
127817266|NCT02128490|459951299|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
127817267|NCT02128490|459951300|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
127817268|NCT02128490|459951296|FG000|Overall Study|Major Protocol Deviation|1|||
127817269|NCT02128490|459951297|FG001|Overall Study|Major Protocol Deviation|2|||
127817270|NCT02128490|459951298|FG002|Overall Study|Major Protocol Deviation|0|||
127817271|NCT02128490|459951299|FG003|Overall Study|Major Protocol Deviation|2|||
127817272|NCT02128490|459951300|FG004|Overall Study|Major Protocol Deviation|2|||
127817273|NCT02128490|459951296|FG000|Overall Study|Lost to Follow-up|0|||
127817274|NCT02128490|459951297|FG001|Overall Study|Lost to Follow-up|0|||
127817275|NCT02128490|459951298|FG002|Overall Study|Lost to Follow-up|1|||
127894553|NCT01915732|460237176|FG000|Overall Study|Protocol Violation|5|||
127894554|NCT01915732|460237177|FG001|Overall Study|Protocol Violation|5|||
127817276|NCT02128490|459951299|FG003|Overall Study|Lost to Follow-up|1|||
127817277|NCT02128490|459951300|FG004|Overall Study|Lost to Follow-up|1|||
127817278|NCT02128490|459951296|FG000|Overall Study|Voluntary Withdrawal|3|||
127817279|NCT02128490|459951297|FG001|Overall Study|Voluntary Withdrawal|3|||
127817280|NCT02128490|459951298|FG002|Overall Study|Voluntary Withdrawal|1|||
127817281|NCT02128490|459951299|FG003|Overall Study|Voluntary Withdrawal|1|||
127817282|NCT02128490|459951300|FG004|Overall Study|Voluntary Withdrawal|2|||
127817283|NCT02128490|459951296|FG000|Overall Study|Lack of Efficacy|0|||
127817284|NCT02128490|459951297|FG001|Overall Study|Lack of Efficacy|1|||
127817285|NCT02128490|459951298|FG002|Overall Study|Lack of Efficacy|0|||
127817286|NCT02128490|459951299|FG003|Overall Study|Lack of Efficacy|0|||
127817287|NCT02128490|459951300|FG004|Overall Study|Lack of Efficacy|0|||
127817288|NCT02128490|459951296|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
127817289|NCT02128490|459951297|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
127817290|NCT02128490|459951298|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
127817291|NCT02128490|459951299|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
127817292|NCT02128490|459951300|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
127817293|NCT02128490|459951296|FG000|Overall Study|Other Miscellaneous Reasons|0|||
127817294|NCT02128490|459951297|FG001|Overall Study|Other Miscellaneous Reasons|0|||
127817295|NCT02128490|459951298|FG002|Overall Study|Other Miscellaneous Reasons|2|||
127817296|NCT02128490|459951299|FG003|Overall Study|Other Miscellaneous Reasons|1|||
127817297|NCT02128490|459951300|FG004|Overall Study|Other Miscellaneous Reasons|1|||
127817298|NCT02243176|459951301|FG000|Overall Study|Other reason|1|||
127817299|NCT02243176|459951302|FG001|Overall Study|Other reason|2|||
127817300|NCT02243176|459951301|FG000|Overall Study|protocol specified withdrawal critera|1|||
127817301|NCT02243176|459951302|FG001|Overall Study|protocol specified withdrawal critera|3|||
127817302|NCT02243176|459951301|FG000|Overall Study|Protocol Violation|2|||
127817303|NCT02243176|459951302|FG001|Overall Study|Protocol Violation|1|||
127817304|NCT02243176|459951301|FG000|Overall Study|Withdrawal by Subject|8|||
127817305|NCT02243176|459951302|FG001|Overall Study|Withdrawal by Subject|7|||
127817306|NCT02243176|459951301|FG000|Overall Study|Adverse Event|2|||
127817307|NCT02243176|459951302|FG001|Overall Study|Adverse Event|2|||
127817308|NCT02342171|459951306|FG000|Overall Study|Death|4|||
127817309|NCT02342171|459951307|FG001|Overall Study|Death|87|||
127817310|NCT02342171|459951306|FG000|Overall Study|Received favipiravir|10|||
127817311|NCT02342171|459951307|FG001|Overall Study|Received favipiravir|0|||
127817312|NCT02342171|459951306|FG000|Overall Study|Missing cycle treshold value|1|||
127817313|NCT02342171|459951307|FG001|Overall Study|Missing cycle treshold value|0|||
127817314|NCT02342171|459951306|FG000|Overall Study|Unknown outcome|0|||
127817315|NCT02342171|459951307|FG001|Overall Study|Unknown outcome|1|||
127817316|NCT02342171|459951306|FG000|Overall Study|Missing age data|0|||
127817317|NCT02342171|459951307|FG001|Overall Study|Missing age data|1|||
127817318|NCT03704051|459951308|FG000|Overall Study|Withdrawal by Subject|4|||
127817319|NCT03704051|459951309|FG001|Overall Study|Withdrawal by Subject|0|||
127817320|NCT02629393|459951310|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
127817321|NCT02629393|459951310|FG000|Overall Study|Physician Decision|1|||
127817322|NCT01943539|459951311|FG000|Overall Study|Non-compliance with at-home intervention|4|||
127817323|NCT01943539|459951312|FG001|Overall Study|Non-compliance with at-home intervention|0|||
127817324|NCT00345605|459951314|FG000|Arm 1|Adverse Event|0|||
127817325|NCT00345605|459951315|FG001|Arm 1|Adverse Event|1|||
127817326|NCT00345605|459951314|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
127817327|NCT00345605|459951315|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
127817328|NCT01335971|459951316|FG000|Overall Study|Withdrawal by Subject|1|||
127817329|NCT01335971|459951317|FG001|Overall Study|Withdrawal by Subject|0|||
127817330|NCT01335971|459951318|FG002|Overall Study|Withdrawal by Subject|0|||
127817331|NCT01335971|459951316|FG000|Overall Study|Did not complete bronchoscopy|1|||
127817332|NCT01335971|459951317|FG001|Overall Study|Did not complete bronchoscopy|1|||
127817333|NCT01335971|459951318|FG002|Overall Study|Did not complete bronchoscopy|1|||
127817334|NCT00384956|459951319|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
127817335|NCT01126619|459951322|FG000|Overall Study|Not eligible for the study|2|||
127817336|NCT01126619|459951322|FG000|Overall Study|Investigator decision|4|||
127817337|NCT01126619|459951322|FG000|Overall Study|Serious adverse event|1|||
127817338|NCT01126619|459951322|FG000|Overall Study|Withdrawal by Subject|9|||
127817339|NCT01126619|459951322|FG000|Overall Study|Non-compliance|1|||
127817340|NCT03351244|459951323|FG000|Overall Study|Adverse Event|7|||
127817341|NCT03351244|459951324|FG001|Overall Study|Adverse Event|11|||
127817342|NCT03351244|459951325|FG002|Overall Study|Adverse Event|12|||
127894555|NCT01915732|460237176|FG000|Overall Study|Lack of Efficacy|6|||
127894556|NCT01915732|460237177|FG001|Overall Study|Lack of Efficacy|11|||
127817343|NCT03351244|459951323|FG000|Overall Study|Investigator's decision|0|||
127817344|NCT03351244|459951324|FG001|Overall Study|Investigator's decision|0|||
127817345|NCT03351244|459951325|FG002|Overall Study|Investigator's decision|2|||
127817346|NCT03351244|459951323|FG000|Overall Study|System error|0|||
127817347|NCT03351244|459951324|FG001|Overall Study|System error|0|||
127817348|NCT03351244|459951325|FG002|Overall Study|System error|2|||
127817349|NCT03351244|459951323|FG000|Overall Study|COVID-19 restrictions|3|||
127817350|NCT03351244|459951324|FG001|Overall Study|COVID-19 restrictions|0|||
127817351|NCT03351244|459951325|FG002|Overall Study|COVID-19 restrictions|1|||
127817352|NCT03351244|459951323|FG000|Overall Study|Non-compliance|2|||
127817353|NCT03351244|459951324|FG001|Overall Study|Non-compliance|5|||
127817354|NCT03351244|459951325|FG002|Overall Study|Non-compliance|0|||
127817355|NCT03351244|459951323|FG000|Overall Study|Withdrawal by Subject|11|||
127817356|NCT03351244|459951324|FG001|Overall Study|Withdrawal by Subject|16|||
127817357|NCT03351244|459951325|FG002|Overall Study|Withdrawal by Subject|13|||
127817358|NCT03351244|459951323|FG000|Overall Study|Lost to Follow-up|2|||
127817359|NCT03351244|459951324|FG001|Overall Study|Lost to Follow-up|6|||
127817360|NCT03351244|459951325|FG002|Overall Study|Lost to Follow-up|4|||
127817361|NCT03351244|459951323|FG000|Overall Study|Protocol Violation|2|||
127817362|NCT03351244|459951324|FG001|Overall Study|Protocol Violation|2|||
127817363|NCT03351244|459951325|FG002|Overall Study|Protocol Violation|0|||
127817364|NCT00892437|459951326|FG000|Randomized Phase|Randomized but not treated|6|||
127817365|NCT00892437|459951327|FG001|Randomized Phase|Randomized but not treated|0|||
127817366|NCT00892437|459951326|FG000|Randomized Phase|Adverse Event|2|||
127817367|NCT00892437|459951327|FG001|Randomized Phase|Adverse Event|2|||
127817368|NCT00892437|459951326|FG000|Randomized Phase|Lost to Follow-up|1|||
127817369|NCT00892437|459951327|FG001|Randomized Phase|Lost to Follow-up|3|||
127817370|NCT00892437|459951326|FG000|Randomized Phase|Investigator's Discretion|1|||
127817371|NCT00892437|459951327|FG001|Randomized Phase|Investigator's Discretion|0|||
127817372|NCT00892437|459951326|FG000|Randomized Phase|Withdrew Consent|1|||
127817373|NCT00892437|459951327|FG001|Randomized Phase|Withdrew Consent|0|||
127817374|NCT00892437|459951326|FG000|Open-Label Extension Phase|Adverse Event|4|||
127817375|NCT00892437|459951327|FG001|Open-Label Extension Phase|Adverse Event|2|||
127817376|NCT00892437|459951326|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
127817377|NCT00892437|459951327|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
127817378|NCT00892437|459951326|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
127817379|NCT00892437|459951327|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
127817380|NCT00892437|459951326|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
127817381|NCT00892437|459951327|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
127817382|NCT00892437|459951326|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
127817383|NCT00892437|459951327|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
127817384|NCT03185130|459951329|FG000|Overall Study|Withdrawal by Subject|0|||
127817385|NCT03185130|459951330|FG001|Overall Study|Withdrawal by Subject|2|||
127817386|NCT01925703|459951331|FG000|Overall Study|Physician Decision|1|||
127817387|NCT01925703|459951331|FG000|Overall Study|Lost to Follow-up|2|||
127817388|NCT01925703|459951331|FG000|Overall Study|Discharge prior to full iron repletion|1|||
127817389|NCT03215277|459951333|FG000|Overall Study|Adverse Event|2|||
127817390|NCT03215277|459951334|FG001|Overall Study|Adverse Event|3|||
127817391|NCT03215277|459951333|FG000|Overall Study|Death|1|||
127817392|NCT03215277|459951334|FG001|Overall Study|Death|0|||
127817393|NCT03215277|459951333|FG000|Overall Study|Lost to Follow-up|0|||
127817394|NCT03215277|459951334|FG001|Overall Study|Lost to Follow-up|1|||
127817395|NCT03215277|459951333|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
127817396|NCT03215277|459951334|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
127817397|NCT03794986|459951335|FG000|Overall Study|0 Sessions Attended|34|||
127817398|NCT03794986|459951336|FG001|Overall Study|0 Sessions Attended|37|||
127817399|NCT03794986|459951335|FG000|Overall Study|Withdrawal by Subject|4|||
127817400|NCT03794986|459951336|FG001|Overall Study|Withdrawal by Subject|6|||
127817401|NCT03794986|459951335|FG000|Overall Study|Protocol Violation|1|||
127817402|NCT03794986|459951336|FG001|Overall Study|Protocol Violation|0|||
127817403|NCT01238120|459951339|FG000|Overall Study|Withdrawal by Subject|4|||
127817404|NCT01238120|459951340|FG001|Overall Study|Withdrawal by Subject|1|||
127817405|NCT01238120|459951341|FG002|Overall Study|Withdrawal by Subject|2|||
127817406|NCT01238120|459951342|FG003|Overall Study|Withdrawal by Subject|5|||
127817407|NCT01238120|459951339|FG000|Overall Study|Lost to Follow-up|2|||
127817408|NCT01238120|459951340|FG001|Overall Study|Lost to Follow-up|0|||
127817409|NCT01238120|459951341|FG002|Overall Study|Lost to Follow-up|1|||
127817410|NCT01238120|459951342|FG003|Overall Study|Lost to Follow-up|1|||
127817411|NCT01238120|459951339|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
127817412|NCT01238120|459951340|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
127817413|NCT01238120|459951341|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
127817414|NCT01238120|459951342|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
127817415|NCT02498652|459951347|FG000|Overall Study|Protocol Violation|0|||
127817416|NCT02498652|459951348|FG001|Overall Study|Protocol Violation|1|||
127817417|NCT00465569|459951350|FG000|Overall Study|persistent eczema during dose escalation|1|||
127817418|NCT00465569|459951351|FG001|Overall Study|persistent eczema during dose escalation|0|||
127817419|NCT04786210|459951352|FG000|Overall Study|Lost to Follow-up|2|||
127817420|NCT04786210|459951352|FG000|Overall Study|Withdrawal by Subject|4|||
127817421|NCT00922935|459951353|FG000|Overall Study|Protocol Violation|0|||
127817422|NCT00922935|459951354|FG001|Overall Study|Protocol Violation|3|||
127894557|NCT01915732|460237176|FG000|Overall Study|Lost to Follow-up|22|||
127817423|NCT00922935|459951355|FG002|Overall Study|Protocol Violation|0|||
127817424|NCT00922935|459951353|FG000|Overall Study|Physician Decision|1|||
127817425|NCT00922935|459951354|FG001|Overall Study|Physician Decision|1|||
127817426|NCT00922935|459951355|FG002|Overall Study|Physician Decision|0|||
127817427|NCT00922935|459951353|FG000|Overall Study|Lost to Follow-up|0|||
127817428|NCT00922935|459951354|FG001|Overall Study|Lost to Follow-up|1|||
127817429|NCT00922935|459951355|FG002|Overall Study|Lost to Follow-up|0|||
127817430|NCT00849212|459951356|FG000|Overall Study|Lack of Efficacy|1|||
127817431|NCT00849212|459951356|FG000|Overall Study|Withdrawal by Subject|3|||
127817432|NCT00849212|459951356|FG000|Overall Study|Adverse Event|2|||
127817433|NCT00849212|459951356|FG000|Overall Study|Miscellaneous|1|||
127817434|NCT00095303|459951357|FG000|Main Study|Lost to Follow-up|91|||
127817435|NCT00095303|459951358|FG001|Main Study|Lost to Follow-up|87|||
127817436|NCT00095303|459951357|FG000|Follow Up Study|Lost to Follow-up|59|||
127817437|NCT00095303|459951358|FG001|Follow Up Study|Lost to Follow-up|58|||
127817438|NCT01364467|459951359|FG000|Overall Study|Lost to Follow-up|1|||
127817439|NCT01364467|459951360|FG001|Overall Study|Lost to Follow-up|2|||
127817440|NCT01499576|459951361|FG000|Overall Study|Physician Decision|12|||
127817441|NCT01499576|459951361|FG000|Overall Study|Withdrawal by Subject|9|||
127817442|NCT01634243|459951362|FG000|Overall Study|Adverse Event|5|||
127817443|NCT01634243|459951363|FG001|Overall Study|Adverse Event|5|||
127817444|NCT01634243|459951362|FG000|Overall Study|Lack of Efficacy|1|||
127817445|NCT01634243|459951363|FG001|Overall Study|Lack of Efficacy|0|||
127817446|NCT02111369|459951366|FG000|Overall Study|Lost to Follow-up|2|||
127817447|NCT02111369|459951366|FG000|Overall Study|Withdrawal by Subject|1|||
127817448|NCT00971321|459951371|FG000|Up to Month 7|Withdrawal by Subject|1|||
127817449|NCT00971321|459951372|FG001|Up to Month 7|Withdrawal by Subject|0|||
127817450|NCT00971321|459951371|FG000|Up to Month 7|Migrated/moved from study area|3|||
127894558|NCT01915732|460237177|FG001|Overall Study|Lost to Follow-up|26|||
127894559|NCT01915732|460237176|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
127894560|NCT01915732|460237177|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
127817451|NCT00971321|459951372|FG001|Up to Month 7|Migrated/moved from study area|2|||
127817452|NCT00971321|459951371|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
127817453|NCT00971321|459951372|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
127817454|NCT00971321|459951371|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
127817455|NCT00971321|459951372|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
127817456|NCT00971321|459951371|FG000|Up to Month 11-12|Lost to Follow-up|1|||
127817457|NCT00971321|459951372|FG001|Up to Month 11-12|Lost to Follow-up|0|||
127817458|NCT00519623|459951375|FG000|Overall Study|Adverse Event|1|||
127817459|NCT02296840|459951379|FG000|Overall Study|Adverse Event|1|||
127817460|NCT02296840|459951380|FG001|Overall Study|Adverse Event|1|||
127817461|NCT02296840|459951379|FG000|Overall Study|Protocol Violation|2|||
127817462|NCT02296840|459951380|FG001|Overall Study|Protocol Violation|1|||
127817463|NCT02296840|459951379|FG000|Overall Study|Lost to Follow-up|6|||
127817464|NCT02296840|459951380|FG001|Overall Study|Lost to Follow-up|17|||
127817465|NCT00104871|459951383|FG000|Overall Study|Not evaluable|1|||
127817466|NCT00761215|459951384|FG000|Overall Study|Randomized but didn't receive drug|1|||
127817467|NCT00761215|459951385|FG001|Overall Study|Randomized but didn't receive drug|1|||
127817468|NCT00761215|459951386|FG002|Overall Study|Randomized but didn't receive drug|2|||
127817469|NCT00761215|459951384|FG000|Overall Study|Lost to Follow-up|6|||
127817470|NCT00761215|459951385|FG001|Overall Study|Lost to Follow-up|3|||
127817471|NCT00761215|459951386|FG002|Overall Study|Lost to Follow-up|6|||
127817472|NCT00761215|459951384|FG000|Overall Study|Withdrawal by Subject|1|||
127817473|NCT00761215|459951385|FG001|Overall Study|Withdrawal by Subject|0|||
127817474|NCT00761215|459951386|FG002|Overall Study|Withdrawal by Subject|0|||
127817475|NCT00761215|459951384|FG000|Overall Study|Bacteremia|1|||
127817476|NCT00761215|459951385|FG001|Overall Study|Bacteremia|0|||
127817477|NCT00761215|459951386|FG002|Overall Study|Bacteremia|0|||
127817478|NCT01687673|459951393|FG000|Overall Study|Physician Decision|1|||
127817479|NCT02234622|459951394|FG000|Overall Study|Withdrawal by Subject|16|||
127817480|NCT02234622|459951395|FG001|Overall Study|Withdrawal by Subject|22|||
127817481|NCT02234622|459951394|FG000|Overall Study|Lost to Follow-up|27|||
127817482|NCT02234622|459951395|FG001|Overall Study|Lost to Follow-up|14|||
127817483|NCT00618956|459951396|FG000|Overall Study|Adverse Event|10|||
127817484|NCT00618956|459951397|FG001|Overall Study|Adverse Event|34|||
127817485|NCT00618956|459951396|FG000|Overall Study|Lack of Efficacy|2|||
127817486|NCT00618956|459951397|FG001|Overall Study|Lack of Efficacy|1|||
127817487|NCT00618956|459951396|FG000|Overall Study|Withdrawal by Subject|5|||
127817488|NCT00618956|459951397|FG001|Overall Study|Withdrawal by Subject|7|||
127817489|NCT00618956|459951396|FG000|Overall Study|Lost to Follow-up|4|||
127817490|NCT00618956|459951397|FG001|Overall Study|Lost to Follow-up|5|||
127817491|NCT00618956|459951396|FG000|Overall Study|Protocol Violation|2|||
127817492|NCT00618956|459951397|FG001|Overall Study|Protocol Violation|2|||
127817493|NCT00618956|459951396|FG000|Overall Study|did not meet criteria, non-compliance|2|||
127817494|NCT00618956|459951397|FG001|Overall Study|did not meet criteria, non-compliance|1|||
127817495|NCT02006576|459951398|FG000|Overall Study|Withdrawal by Subject|4|||
127817496|NCT02006576|459951399|FG001|Overall Study|Withdrawal by Subject|6|||
127817497|NCT02006576|459951400|FG002|Overall Study|Withdrawal by Subject|2|||
127817498|NCT02006576|459951398|FG000|Overall Study|Death|0|||
127817499|NCT02006576|459951399|FG001|Overall Study|Death|0|||
127817500|NCT02006576|459951400|FG002|Overall Study|Death|1|||
127817501|NCT02006576|459951398|FG000|Overall Study|Lost to Follow-up|1|||
127817502|NCT02006576|459951399|FG001|Overall Study|Lost to Follow-up|0|||
127817503|NCT02006576|459951400|FG002|Overall Study|Lost to Follow-up|1|||
127817504|NCT02006576|459951398|FG000|Overall Study|Screen Failure, too sick, other|13|||
127817505|NCT02006576|459951399|FG001|Overall Study|Screen Failure, too sick, other|1|||
127817506|NCT02006576|459951400|FG002|Overall Study|Screen Failure, too sick, other|13|||
127817507|NCT03478683|459951401|FG000|Overall Study|Adverse Event|5|||
127817508|NCT03478683|459951402|FG001|Overall Study|Adverse Event|3|||
127817509|NCT03478683|459951401|FG000|Overall Study|Lost to Follow-up|0|||
127817510|NCT03478683|459951402|FG001|Overall Study|Lost to Follow-up|5|||
127817511|NCT03478683|459951401|FG000|Overall Study|Physician Decision|1|||
127817512|NCT03478683|459951402|FG001|Overall Study|Physician Decision|3|||
127817513|NCT03478683|459951401|FG000|Overall Study|Withdrawal by Subject|7|||
127817514|NCT03478683|459951402|FG001|Overall Study|Withdrawal by Subject|7|||
127817515|NCT04090164|459951405|FG000|Overall Study|incomplete data on file|245|||
127817516|NCT04090164|459951406|FG001|Overall Study|incomplete data on file|0|||
127817517|NCT01650805|459951407|FG000|Overall Study|Withdrawal by Subject|1|||
127817518|NCT01650805|459951408|FG001|Overall Study|Withdrawal by Subject|0|||
127817519|NCT02452359|459951409|FG000|Overall Study|Adverse Event|1|||
127817520|NCT02452359|459951409|FG000|Overall Study|Lost to Follow-up|15|||
127817521|NCT02452359|459951409|FG000|Overall Study|Pregnancy|1|||
127817522|NCT02452359|459951409|FG000|Overall Study|Withdrawal by Subject|4|||
127817523|NCT01887210|459951410|FG000|Overall Study|Withdrawal by Subject|1|||
127817524|NCT01887210|459951411|FG001|Overall Study|Withdrawal by Subject|3|||
127817525|NCT01887210|459951410|FG000|Overall Study|Lost to Follow-up|0|||
127817526|NCT01887210|459951411|FG001|Overall Study|Lost to Follow-up|1|||
127817527|NCT00630032|459951420|FG000|Overall Study|Death|55|||
127817528|NCT00630032|459951421|FG001|Overall Study|Death|49|||
127817529|NCT00630032|459951420|FG000|Overall Study|Withdrawal by Subject|3|||
127817530|NCT00630032|459951421|FG001|Overall Study|Withdrawal by Subject|2|||
127817531|NCT00630032|459951420|FG000|Overall Study|Lost to Follow-up|18|||
127894561|NCT01915732|460237176|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
127817532|NCT00630032|459951421|FG001|Overall Study|Lost to Follow-up|31|||
127817533|NCT00630032|459951420|FG000|Overall Study|Protocol Violation|1|||
127817534|NCT00630032|459951421|FG001|Overall Study|Protocol Violation|0|||
127817535|NCT00630032|459951420|FG000|Overall Study|Patient has moved|1|||
127817536|NCT00630032|459951421|FG001|Overall Study|Patient has moved|1|||
127817537|NCT00630032|459951420|FG000|Overall Study|Disease progression|1|||
127817538|NCT00630032|459951421|FG001|Overall Study|Disease progression|1|||
127817539|NCT00630032|459951420|FG000|Overall Study|End of monitoring in US centers|11|||
127817540|NCT00630032|459951421|FG001|Overall Study|End of monitoring in US centers|11|||
127817541|NCT03497689|459951425|FG000|Overall Study|Adverse Event|2|||
127817542|NCT03497689|459951425|FG000|Overall Study|Death|1|||
127817543|NCT03497689|459951425|FG000|Overall Study|Physician Decision|1|||
127817544|NCT03497689|459951425|FG000|Overall Study|Withdrawal by Subject|1|||
127817545|NCT03497689|459951425|FG000|Overall Study|Protocol Violation|2|||
127817546|NCT03191786|459951426|FG000|Overall Study|Death|236|||
127817547|NCT03191786|459951427|FG001|Overall Study|Death|127|||
127817548|NCT03191786|459951426|FG000|Overall Study|Lost to Follow-up|9|||
127817549|NCT03191786|459951427|FG001|Overall Study|Lost to Follow-up|3|||
127817550|NCT03191786|459951426|FG000|Overall Study|Physician Decision|1|||
127817551|NCT03191786|459951427|FG001|Overall Study|Physician Decision|0|||
127817552|NCT03191786|459951426|FG000|Overall Study|Moved to Post Trial Access Program|30|||
127817553|NCT03191786|459951427|FG001|Overall Study|Moved to Post Trial Access Program|5|||
127817554|NCT03191786|459951426|FG000|Overall Study|Withdrawal by Subject|26|||
127817555|NCT03191786|459951427|FG001|Overall Study|Withdrawal by Subject|16|||
127817556|NCT03518840|459953507|FG000|Overall Study|Lost to Follow-up|6|||
127817557|NCT00875420|459953509|FG000|Overall Study|Adverse Event|0|||
127817558|NCT00875420|459953510|FG001|Overall Study|Adverse Event|1|||
127817559|NCT00875420|459953511|FG002|Overall Study|Adverse Event|1|||
127817560|NCT00875420|459953512|FG003|Overall Study|Adverse Event|0|||
127817561|NCT00875420|459953513|FG004|Overall Study|Adverse Event|0|||
127817562|NCT00875420|459953509|FG000|Overall Study|Inability to complete study procedures|1|||
127817563|NCT00875420|459953510|FG001|Overall Study|Inability to complete study procedures|0|||
127817564|NCT00875420|459953511|FG002|Overall Study|Inability to complete study procedures|1|||
127817565|NCT00875420|459953512|FG003|Overall Study|Inability to complete study procedures|1|||
127817566|NCT00875420|459953513|FG004|Overall Study|Inability to complete study procedures|1|||
127817567|NCT00875420|459953509|FG000|Overall Study|Lost to Follow-up|1|||
127817568|NCT00875420|459953510|FG001|Overall Study|Lost to Follow-up|0|||
127817569|NCT00875420|459953511|FG002|Overall Study|Lost to Follow-up|0|||
127817570|NCT00875420|459953512|FG003|Overall Study|Lost to Follow-up|0|||
127817571|NCT00875420|459953513|FG004|Overall Study|Lost to Follow-up|0|||
127817572|NCT00875420|459953509|FG000|Overall Study|Personal reason|0|||
127817573|NCT00875420|459953510|FG001|Overall Study|Personal reason|0|||
127817574|NCT00875420|459953511|FG002|Overall Study|Personal reason|0|||
127817575|NCT00875420|459953512|FG003|Overall Study|Personal reason|0|||
127817576|NCT00875420|459953513|FG004|Overall Study|Personal reason|1|||
127817577|NCT00875420|459953509|FG000|Overall Study|Prohibited medication|0|||
127817578|NCT00875420|459953510|FG001|Overall Study|Prohibited medication|0|||
127817579|NCT00875420|459953511|FG002|Overall Study|Prohibited medication|0|||
127817580|NCT00875420|459953512|FG003|Overall Study|Prohibited medication|1|||
127817581|NCT00875420|459953513|FG004|Overall Study|Prohibited medication|0|||
127817582|NCT00875420|459953509|FG000|Overall Study|Sponsor decision|0|||
127817583|NCT00875420|459953510|FG001|Overall Study|Sponsor decision|1|||
127817584|NCT00875420|459953511|FG002|Overall Study|Sponsor decision|0|||
127817585|NCT00875420|459953512|FG003|Overall Study|Sponsor decision|0|||
127817586|NCT00875420|459953513|FG004|Overall Study|Sponsor decision|0|||
127817587|NCT00875420|459953509|FG000|Overall Study|Withdrawal by Subject|0|||
127817588|NCT00875420|459953510|FG001|Overall Study|Withdrawal by Subject|0|||
127817589|NCT00875420|459953511|FG002|Overall Study|Withdrawal by Subject|1|||
127817590|NCT00875420|459953512|FG003|Overall Study|Withdrawal by Subject|0|||
127817591|NCT00875420|459953513|FG004|Overall Study|Withdrawal by Subject|0|||
127817592|NCT00001259|459953516|FG000|Study 2|Adverse Event|0|||
127817593|NCT00001259|459953517|FG001|Study 2|Adverse Event|0|||
127817594|NCT00001259|459953518|FG002|Study 2|Adverse Event|0|||
127817595|NCT00001259|459953519|FG003|Study 2|Adverse Event|0|||
127817596|NCT00001259|459953520|FG004|Study 2|Adverse Event|2|||
127817597|NCT00001259|459953521|FG005|Study 2|Adverse Event|0|||
127817598|NCT00001259|459953522|FG006|Study 2|Adverse Event|0|||
127817599|NCT03705494|459953523|FG000|Overall Study|Lost to Follow-up|2|||
127817600|NCT03705494|459953524|FG001|Overall Study|Lost to Follow-up|1|||
127817601|NCT03705494|459953523|FG000|Overall Study|Withdrawal by Subject|5|||
127817602|NCT03705494|459953524|FG001|Overall Study|Withdrawal by Subject|2|||
127817603|NCT03716726|459953528|FG000|Completed Baseline Assessment|Did not complete baseline assessment|10|||
127817604|NCT03716726|459953529|FG001|Completed Baseline Assessment|Did not complete baseline assessment|12|||
127817605|NCT03716726|459953528|FG000|12 Months Followup|Lost to Follow-up|10|||
127817606|NCT03716726|459953529|FG001|12 Months Followup|Lost to Follow-up|17|||
127817607|NCT01981187|459953532|FG000|Overall Study|Participant/guardian decision|2|||
127817608|NCT01981187|459953532|FG000|Overall Study|Physician Decision|1|||
127817609|NCT01981187|459953532|FG000|Overall Study|Disease progression|2|||
127817610|NCT01981187|459953532|FG000|Overall Study|Adverse Event|7|||
127817611|NCT03199911|459953536|FG000|Overall Study|Lost to Follow-up|5|||
127817612|NCT03199911|459953537|FG001|Overall Study|Lost to Follow-up|5|||
127817613|NCT03199911|459953536|FG000|Overall Study|Did not proceed with surgery|2|||
127817614|NCT03199911|459953537|FG001|Overall Study|Did not proceed with surgery|1|||
127817615|NCT01009463|459953538|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
127817616|NCT01009463|459953539|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
127817617|NCT01009463|459953540|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
127817618|NCT01009463|459953541|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
127817619|NCT01009463|459953542|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
127817620|NCT01009463|459953538|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
127817621|NCT01009463|459953539|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
127817622|NCT01009463|459953540|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
127817623|NCT01009463|459953541|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
127817624|NCT01009463|459953542|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
127817625|NCT01009463|459953538|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
127817626|NCT01009463|459953539|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
127817627|NCT01009463|459953540|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
127817628|NCT01009463|459953541|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
127817629|NCT01009463|459953542|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
127817630|NCT01009463|459953538|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
127817631|NCT01009463|459953539|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
127817632|NCT01009463|459953540|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
127817633|NCT01009463|459953541|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
127817634|NCT01009463|459953542|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
127817635|NCT01009463|459953538|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
127817636|NCT01009463|459953539|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
127817637|NCT01009463|459953540|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
127817638|NCT01009463|459953541|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
127817639|NCT01009463|459953542|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
127817640|NCT01009463|459953538|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
127817641|NCT01009463|459953539|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
127817642|NCT01009463|459953540|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
127817643|NCT01009463|459953541|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
127817644|NCT01009463|459953542|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
127817645|NCT01009463|459953538|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
127817646|NCT01009463|459953539|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
127817647|NCT01009463|459953540|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
127817648|NCT01009463|459953541|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
127817649|NCT01009463|459953542|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
127817650|NCT01009463|459953538|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
127817651|NCT01009463|459953539|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
127817652|NCT01009463|459953540|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
127817653|NCT01009463|459953541|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
127817654|NCT01009463|459953542|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
127817655|NCT01009463|459953538|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
127817656|NCT01009463|459953539|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
127817657|NCT01009463|459953540|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
127817658|NCT01009463|459953541|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
127817659|NCT01009463|459953542|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
127817660|NCT01009463|459953538|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
127817661|NCT01009463|459953539|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
127817662|NCT01009463|459953540|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
127817663|NCT01009463|459953541|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
127817664|NCT01009463|459953542|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
127817665|NCT01009463|459953538|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
127817666|NCT01009463|459953539|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
127817667|NCT01009463|459953540|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
127817668|NCT01009463|459953541|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
127817669|NCT01009463|459953542|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
127817670|NCT01009463|459953538|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
127817671|NCT01009463|459953539|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
127817672|NCT01009463|459953540|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
127817673|NCT01009463|459953541|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
127817674|NCT01009463|459953542|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
127817675|NCT01009463|459953538|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
127817676|NCT01009463|459953539|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
127817677|NCT01009463|459953540|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
127817678|NCT01009463|459953541|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
127817679|NCT01009463|459953542|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
127817680|NCT02413255|459953543|FG000|Overall Study|Voluntary Withdrawal|0|||
127817681|NCT02413255|459953544|FG001|Overall Study|Voluntary Withdrawal|0|||
127817682|NCT02413255|459953545|FG002|Overall Study|Voluntary Withdrawal|0|||
127817683|NCT02413255|459953546|FG003|Overall Study|Voluntary Withdrawal|0|||
127817684|NCT02413255|459953547|FG004|Overall Study|Voluntary Withdrawal|0|||
127817685|NCT02413255|459953548|FG005|Overall Study|Voluntary Withdrawal|0|||
127817686|NCT02413255|459953549|FG006|Overall Study|Voluntary Withdrawal|0|||
127817687|NCT02413255|459953550|FG007|Overall Study|Voluntary Withdrawal|0|||
127817688|NCT02413255|459953551|FG008|Overall Study|Voluntary Withdrawal|0|||
127817689|NCT02413255|459953552|FG009|Overall Study|Voluntary Withdrawal|0|||
127817690|NCT02413255|459953553|FG010|Overall Study|Voluntary Withdrawal|0|||
127817691|NCT02413255|459953554|FG011|Overall Study|Voluntary Withdrawal|0|||
127817692|NCT02413255|459953555|FG012|Overall Study|Voluntary Withdrawal|0|||
127817693|NCT02413255|459953556|FG013|Overall Study|Voluntary Withdrawal|0|||
127817694|NCT02413255|459953557|FG014|Overall Study|Voluntary Withdrawal|1|||
127817695|NCT02413255|459953558|FG015|Overall Study|Voluntary Withdrawal|0|||
127817696|NCT02413255|459953559|FG016|Overall Study|Voluntary Withdrawal|0|||
127817697|NCT02333331|459953560|FG000|Overall Study|Adverse Event|1|||
127817698|NCT02333331|459953561|FG001|Overall Study|Adverse Event|0|||
127817699|NCT02333331|459953562|FG002|Overall Study|Adverse Event|4|||
127817700|NCT02333331|459953563|FG003|Overall Study|Adverse Event|1|||
127817701|NCT02333331|459953560|FG000|Overall Study|Death|0|||
127817702|NCT02333331|459953561|FG001|Overall Study|Death|0|||
127817703|NCT02333331|459953562|FG002|Overall Study|Death|2|||
127817704|NCT02333331|459953563|FG003|Overall Study|Death|0|||
127817705|NCT02333331|459953560|FG000|Overall Study|Lost to Follow-up|0|||
127817706|NCT02333331|459953561|FG001|Overall Study|Lost to Follow-up|0|||
127817707|NCT02333331|459953562|FG002|Overall Study|Lost to Follow-up|1|||
127817708|NCT02333331|459953563|FG003|Overall Study|Lost to Follow-up|0|||
127817709|NCT02333331|459953560|FG000|Overall Study|Physician Decision|0|||
127817710|NCT02333331|459953561|FG001|Overall Study|Physician Decision|1|||
127817711|NCT02333331|459953562|FG002|Overall Study|Physician Decision|0|||
127817712|NCT02333331|459953563|FG003|Overall Study|Physician Decision|0|||
127817713|NCT02333331|459953560|FG000|Overall Study|Protocol Deviation|0|||
127817714|NCT02333331|459953561|FG001|Overall Study|Protocol Deviation|3|||
127817715|NCT02333331|459953562|FG002|Overall Study|Protocol Deviation|2|||
127817716|NCT02333331|459953563|FG003|Overall Study|Protocol Deviation|1|||
127817717|NCT02333331|459953560|FG000|Overall Study|Patient/Guardian Decision|1|||
127817718|NCT02333331|459953561|FG001|Overall Study|Patient/Guardian Decision|2|||
127817719|NCT02333331|459953562|FG002|Overall Study|Patient/Guardian Decision|9|||
127817720|NCT02333331|459953563|FG003|Overall Study|Patient/Guardian Decision|1|||
127817721|NCT01494038|459953564|FG000|Overall Study|Protocol Violation|1|||
127817722|NCT01494038|459953565|FG001|Overall Study|Protocol Violation|1|||
127817723|NCT01494038|459953564|FG000|Overall Study|Lost to Follow-up|18|||
127817724|NCT01494038|459953565|FG001|Overall Study|Lost to Follow-up|20|||
127817725|NCT01494038|459953564|FG000|Overall Study|Withdrawal by Subject|44|||
127817726|NCT01494038|459953565|FG001|Overall Study|Withdrawal by Subject|34|||
127817727|NCT01494038|459953564|FG000|Overall Study|Not able to get to clinic|21|||
127817728|NCT01494038|459953565|FG001|Overall Study|Not able to get to clinic|15|||
127817729|NCT01494038|459953564|FG000|Overall Study|Not willing to adhere to reqs|2|||
127817730|NCT01494038|459953565|FG001|Overall Study|Not willing to adhere to reqs|9|||
127817731|NCT01494038|459953564|FG000|Overall Study|Death|2|||
127817732|NCT01494038|459953565|FG001|Overall Study|Death|4|||
127817733|NCT05309668|459953566|FG000|Overall Study|Ongoing at data cut-off|14|||
127817734|NCT05309668|459953567|FG001|Overall Study|Ongoing at data cut-off|17|||
127817735|NCT05309668|459953568|FG002|Overall Study|Ongoing at data cut-off|4|||
127817736|NCT02401256|459953571|FG000|Overall Study|Adverse Event|5|||
127817737|NCT02401256|459953571|FG000|Overall Study|Withdrawal by Subject|12|||
127817738|NCT00430781|459953572|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
127817739|NCT00430781|459953573|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
127817740|NCT00430781|459953574|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
127817741|NCT00430781|459953572|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
127817742|NCT00430781|459953573|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
127817743|NCT00430781|459953574|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
127817744|NCT00430781|459953572|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
127817745|NCT00430781|459953573|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
127817746|NCT00430781|459953574|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
127817747|NCT00430781|459953572|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
127817748|NCT00430781|459953573|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
127817749|NCT00430781|459953574|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
127817750|NCT00430781|459953572|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
127817751|NCT00430781|459953573|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
127817752|NCT00430781|459953574|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
127817753|NCT00430781|459953572|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
127817754|NCT00430781|459953573|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
127817755|NCT00430781|459953574|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
127817756|NCT00430781|459953572|FG000|Interim Analysis; 11 February 2008|Death|0|||
127817757|NCT00430781|459953573|FG001|Interim Analysis; 11 February 2008|Death|1|||
127817758|NCT00430781|459953574|FG002|Interim Analysis; 11 February 2008|Death|0|||
127817759|NCT00430781|459953572|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
127817760|NCT00430781|459953573|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
127817761|NCT00430781|459953574|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
127817762|NCT00430781|459953572|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
127817763|NCT00430781|459953573|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
127817764|NCT00430781|459953574|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
127817765|NCT00430781|459953572|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
127817766|NCT00430781|459953573|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
127817767|NCT00430781|459953574|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
127817768|NCT00430781|459953572|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
127817769|NCT00430781|459953573|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
127817770|NCT00430781|459953574|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
127817771|NCT00430781|459953572|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
127817772|NCT00430781|459953573|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
127817773|NCT00430781|459953574|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
127817774|NCT00430781|459953572|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
127817775|NCT00430781|459953573|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
127817776|NCT00430781|459953574|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
127817777|NCT00430781|459953572|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
127817778|NCT00430781|459953573|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
127817779|NCT00430781|459953574|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
127817780|NCT00430781|459953572|FG000|Final Analysis; 31 July 2008|Other|0|||
127817781|NCT00430781|459953573|FG001|Final Analysis; 31 July 2008|Other|1|||
127817782|NCT00430781|459953574|FG002|Final Analysis; 31 July 2008|Other|0|||
127817783|NCT00430781|459953572|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
127817784|NCT00430781|459953573|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
127817785|NCT00430781|459953574|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
127817786|NCT00430781|459953572|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
127817787|NCT00430781|459953573|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
127817788|NCT00430781|459953574|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
127817789|NCT00430781|459953572|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
127817790|NCT00430781|459953573|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
127817791|NCT00430781|459953574|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
127817792|NCT00430781|459953572|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
127817793|NCT00430781|459953573|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
127817794|NCT00430781|459953574|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
127817795|NCT00430781|459953572|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
127817796|NCT00430781|459953573|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
127817797|NCT00430781|459953574|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
127817798|NCT00430781|459953572|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
127817799|NCT00430781|459953573|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
127817800|NCT00430781|459953574|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
127817801|NCT00430781|459953572|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
127817802|NCT00430781|459953573|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
127817803|NCT00430781|459953574|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
127817804|NCT04329949|459953578|FG000|Overall Study|Death|36|||
127817805|NCT04329949|459953578|FG000|Overall Study|Withdrawal by Subject|4|||
127817806|NCT04329949|459953578|FG000|Overall Study|Termination of study by sponsor|3|||
127817807|NCT03180736|459953581|FG000|Overall Study|Adverse Event|3|||
127817808|NCT03180736|459953582|FG001|Overall Study|Adverse Event|4|||
127817809|NCT03180736|459953581|FG000|Overall Study|Death|10|||
127817810|NCT03180736|459953582|FG001|Overall Study|Death|7|||
127817811|NCT03180736|459953581|FG000|Overall Study|Withdrawal by Subject|5|||
127817812|NCT03180736|459953582|FG001|Overall Study|Withdrawal by Subject|12|||
127894562|NCT01915732|460237177|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
127894563|NCT01915732|460237176|FG000|Overall Study|Drug Release Error|1|||
127817813|NCT03180736|459953581|FG000|Overall Study|Lost to Follow-up|1|||
127817814|NCT03180736|459953582|FG001|Overall Study|Lost to Follow-up|0|||
127817815|NCT03180736|459953581|FG000|Overall Study|Lack of Efficacy|66|||
127817816|NCT03180736|459953582|FG001|Overall Study|Lack of Efficacy|87|||
127817817|NCT03180736|459953581|FG000|Overall Study|Physician Decision|4|||
127817818|NCT03180736|459953582|FG001|Overall Study|Physician Decision|7|||
127817819|NCT03180736|459953581|FG000|Overall Study|randomized but not treated|2|||
127817820|NCT03180736|459953582|FG001|Overall Study|randomized but not treated|3|||
127817821|NCT01059812|459953583|FG000|Overall Study|Adverse Event|9|||
127817822|NCT01059812|459953584|FG001|Overall Study|Adverse Event|5|||
127817823|NCT01059812|459953583|FG000|Overall Study|Lack of Efficacy|2|||
127817824|NCT01059812|459953584|FG001|Overall Study|Lack of Efficacy|2|||
127817825|NCT01059812|459953583|FG000|Overall Study|Protocol Violation|3|||
127817826|NCT01059812|459953584|FG001|Overall Study|Protocol Violation|1|||
127817827|NCT01059812|459953583|FG000|Overall Study|Withdrawal Criteria|9|||
127817828|NCT01059812|459953584|FG001|Overall Study|Withdrawal Criteria|4|||
127817829|NCT01059812|459953583|FG000|Overall Study|Unclassified|14|||
127817830|NCT01059812|459953584|FG001|Overall Study|Unclassified|4|||
127817831|NCT01451515|459953587|FG000|Overall Study|Death|0|||
127817832|NCT01451515|459953588|FG001|Overall Study|Death|1|||
127817833|NCT01451515|459953589|FG002|Overall Study|Death|0|||
127817834|NCT01451515|459953587|FG000|Overall Study|Withdrawal by Subject|0|||
127817835|NCT01451515|459953588|FG001|Overall Study|Withdrawal by Subject|1|||
127817836|NCT01451515|459953589|FG002|Overall Study|Withdrawal by Subject|0|||
127817837|NCT01451515|459953587|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
127817838|NCT01451515|459953588|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
127817839|NCT01451515|459953589|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
127817840|NCT01451515|459953587|FG000|Overall Study|Relapse (except CNS)|1|||
127817841|NCT01451515|459953588|FG001|Overall Study|Relapse (except CNS)|1|||
127817842|NCT01451515|459953589|FG002|Overall Study|Relapse (except CNS)|0|||
127817843|NCT01458340|459953592|FG000|Overall Study|Adverse Event|5|||
127817844|NCT01458340|459953593|FG001|Overall Study|Adverse Event|4|||
127817845|NCT01458340|459953594|FG002|Overall Study|Adverse Event|2|||
127817846|NCT01458340|459953592|FG000|Overall Study|Lost to Follow-up|3|||
127817847|NCT01458340|459953593|FG001|Overall Study|Lost to Follow-up|3|||
127817848|NCT01458340|459953594|FG002|Overall Study|Lost to Follow-up|10|||
127817849|NCT01458340|459953592|FG000|Overall Study|Miscellaneous|0|||
127817850|NCT01458340|459953593|FG001|Overall Study|Miscellaneous|1|||
127817851|NCT01458340|459953594|FG002|Overall Study|Miscellaneous|0|||
127817852|NCT01458340|459953592|FG000|Overall Study|Physician Decision|1|||
127817853|NCT01458340|459953593|FG001|Overall Study|Physician Decision|1|||
127817854|NCT01458340|459953594|FG002|Overall Study|Physician Decision|2|||
127817855|NCT01458340|459953592|FG000|Overall Study|Protocol Violation|6|||
127817856|NCT01458340|459953593|FG001|Overall Study|Protocol Violation|6|||
127817857|NCT01458340|459953594|FG002|Overall Study|Protocol Violation|5|||
127817858|NCT01458340|459953592|FG000|Overall Study|Withdrawal by Subject|12|||
127817859|NCT01458340|459953593|FG001|Overall Study|Withdrawal by Subject|6|||
127817860|NCT01458340|459953594|FG002|Overall Study|Withdrawal by Subject|4|||
127817861|NCT03056287|459953595|FG000|Overall Study|Withdrawal by Subject|0|||
127817862|NCT03056287|459953596|FG001|Overall Study|Withdrawal by Subject|1|||
127817863|NCT03056287|459953597|FG002|Overall Study|Withdrawal by Subject|0|||
127817864|NCT03056287|459953598|FG003|Overall Study|Withdrawal by Subject|0|||
127817865|NCT03056287|459953595|FG000|Overall Study|move out of area|0|||
127817866|NCT03056287|459953596|FG001|Overall Study|move out of area|0|||
127817867|NCT03056287|459953597|FG002|Overall Study|move out of area|1|||
127817868|NCT03056287|459953598|FG003|Overall Study|move out of area|1|||
127817869|NCT00091793|459953600|FG000|Overall Study|Adverse Event|1|||
127817870|NCT00091793|459953601|FG001|Overall Study|Adverse Event|2|||
127817871|NCT00091793|459953600|FG000|Overall Study|Withdrawal by Subject|10|||
127817872|NCT00091793|459953601|FG001|Overall Study|Withdrawal by Subject|15|||
127817873|NCT00091793|459953600|FG000|Overall Study|Ineligibility determined|2|||
127817874|NCT00091793|459953601|FG001|Overall Study|Ineligibility determined|0|||
127817875|NCT00091793|459953600|FG000|Overall Study|Lost to Follow-up|7|||
127817876|NCT00091793|459953601|FG001|Overall Study|Lost to Follow-up|5|||
127817877|NCT00091793|459953600|FG000|Overall Study|Noncompliance|2|||
127817878|NCT00091793|459953601|FG001|Overall Study|Noncompliance|0|||
127817879|NCT00091793|459953600|FG000|Overall Study|Other|2|||
127817880|NCT00091793|459953601|FG001|Overall Study|Other|0|||
127817881|NCT05309083|459953603|FG000|Overall Study|Withdrawal by Subject|2|||
127817882|NCT01165229|459953604|FG000|Overall Study|Serious Adverse Event|456|||
127817883|NCT01165229|459953605|FG001|Overall Study|Serious Adverse Event|487|||
127894564|NCT01915732|460237177|FG001|Overall Study|Drug Release Error|0|||
127894565|NCT01915732|460237176|FG000|Overall Study|Recovered|1|||
127894566|NCT01915732|460237177|FG001|Overall Study|Recovered|0|||
127817884|NCT01165229|459953604|FG000|Overall Study|Non-Serious Adverse Event|47|||
127894567|NCT01915732|460237176|FG000|Overall Study|Pregnancy|1|||
127817885|NCT01165229|459953605|FG001|Overall Study|Non-Serious Adverse Event|15|||
127817886|NCT01165229|459953604|FG000|Overall Study|Protocol Violation|6|||
127817887|NCT01165229|459953605|FG001|Overall Study|Protocol Violation|8|||
127817888|NCT01165229|459953604|FG000|Overall Study|Withdrawal by Subject|387|||
127817889|NCT01165229|459953605|FG001|Overall Study|Withdrawal by Subject|396|||
127817890|NCT01165229|459953604|FG000|Overall Study|Migrated/moved from study area|51|||
127817891|NCT01165229|459953605|FG001|Overall Study|Migrated/moved from study area|46|||
127817892|NCT01165229|459953604|FG000|Overall Study|Lost to Follow-up|123|||
127817893|NCT01165229|459953605|FG001|Overall Study|Lost to Follow-up|133|||
127817894|NCT01165229|459953604|FG000|Overall Study|Suspected HZ Episode|2|||
127817895|NCT01165229|459953605|FG001|Overall Study|Suspected HZ Episode|2|||
127817896|NCT01165229|459953604|FG000|Overall Study|No reason from the subject|108|||
127817897|NCT01165229|459953605|FG001|Overall Study|No reason from the subject|102|||
127817898|NCT01165229|459953604|FG000|Overall Study|Unknown completion status|0|||
127817899|NCT01165229|459953605|FG001|Overall Study|Unknown completion status|1|||
127817900|NCT00881205|459953609|FG000|Overall Study|Adverse Event|8|||
127817901|NCT00881205|459953610|FG001|Overall Study|Adverse Event|3|||
127817902|NCT00881205|459953609|FG000|Overall Study|Withdrawal by Subject|1|||
127817903|NCT00881205|459953610|FG001|Overall Study|Withdrawal by Subject|2|||
127817904|NCT00881205|459953609|FG000|Overall Study|Lost to Follow-up|0|||
127817905|NCT00881205|459953610|FG001|Overall Study|Lost to Follow-up|1|||
127817906|NCT00881205|459953609|FG000|Overall Study|Administrative problems|1|||
127817907|NCT00881205|459953610|FG001|Overall Study|Administrative problems|1|||
127817908|NCT00881205|459953609|FG000|Overall Study|Condition no longer requires drug|1|||
127817909|NCT00881205|459953610|FG001|Overall Study|Condition no longer requires drug|0|||
127817910|NCT00845429|459953618|FG000|Overall Study|Protocol Violation|5|||
127817911|NCT00845429|459953619|FG001|Overall Study|Protocol Violation|4|||
127817912|NCT00845429|459953620|FG002|Overall Study|Protocol Violation|7|||
127817913|NCT00845429|459953618|FG000|Overall Study|Lost to Follow-up|7|||
127817914|NCT00845429|459953619|FG001|Overall Study|Lost to Follow-up|9|||
127817915|NCT00845429|459953620|FG002|Overall Study|Lost to Follow-up|10|||
127817916|NCT00845429|459953618|FG000|Overall Study|Withdrawal by Subject|2|||
127817917|NCT00845429|459953619|FG001|Overall Study|Withdrawal by Subject|2|||
127817918|NCT00845429|459953620|FG002|Overall Study|Withdrawal by Subject|2|||
127817919|NCT00845429|459953618|FG000|Overall Study|Serious adverse event|0|||
127817920|NCT00845429|459953619|FG001|Overall Study|Serious adverse event|0|||
127817921|NCT00845429|459953620|FG002|Overall Study|Serious adverse event|1|||
127817922|NCT00587223|459953624|FG000|Overall Study|Adverse Event|1|||
127817923|NCT03240081|459953628|FG000|Overall Study|Withdrawal by Subject|0|||
127817924|NCT03240081|459953629|FG001|Overall Study|Withdrawal by Subject|2|||
127817925|NCT03240081|459953628|FG000|Overall Study|Lost to Follow-up|0|||
127817926|NCT03240081|459953629|FG001|Overall Study|Lost to Follow-up|1|||
127817927|NCT00883753|459953630|FG000|Overall Study|Adverse Event|37|||
127817928|NCT00883753|459953630|FG000|Overall Study|Death|2|||
127817929|NCT00883753|459953630|FG000|Overall Study|Insufficient therapeutic response|16|||
127817930|NCT00883753|459953630|FG000|Overall Study|Lost to Follow-up|4|||
127817931|NCT00883753|459953630|FG000|Overall Study|Violation of selection criteria at entry|7|||
127817932|NCT00883753|459953630|FG000|Overall Study|Protocol Violation|2|||
127817933|NCT00883753|459953630|FG000|Overall Study|Refused treatment|4|||
127817934|NCT00883753|459953630|FG000|Overall Study|Withdrew consent|10|||
127817935|NCT00883753|459953630|FG000|Overall Study|Investigator's decision|17|||
127817936|NCT00883753|459953630|FG000|Overall Study|Administrative/Other|8|||
127817937|NCT01480180|459953631|FG000|Main Phase|Withdrawal criteria|12|||
127817938|NCT01480180|459953632|FG001|Main Phase|Withdrawal criteria|1|||
127817939|NCT01480180|459953633|FG002|Main Phase|Withdrawal criteria|0|||
127817940|NCT01480180|459953634|FG003|Main Phase|Withdrawal criteria|0|||
127817941|NCT01480180|459953635|FG004|Main Phase|Withdrawal criteria|0|||
127817942|NCT01480180|459953636|FG005|Main Phase|Withdrawal criteria|0|||
127817943|NCT01480180|459953631|FG000|Main Phase|Lack of Efficacy|1|||
127817944|NCT01480180|459953632|FG001|Main Phase|Lack of Efficacy|0|||
127817945|NCT01480180|459953633|FG002|Main Phase|Lack of Efficacy|0|||
127817946|NCT01480180|459953634|FG003|Main Phase|Lack of Efficacy|0|||
127817947|NCT01480180|459953635|FG004|Main Phase|Lack of Efficacy|0|||
127817948|NCT01480180|459953636|FG005|Main Phase|Lack of Efficacy|0|||
127817949|NCT01480180|459953631|FG000|Main Phase|Non-compliance|3|||
127817950|NCT01480180|459953632|FG001|Main Phase|Non-compliance|0|||
127817951|NCT01480180|459953633|FG002|Main Phase|Non-compliance|0|||
127817952|NCT01480180|459953634|FG003|Main Phase|Non-compliance|0|||
127817953|NCT01480180|459953635|FG004|Main Phase|Non-compliance|0|||
127817954|NCT01480180|459953636|FG005|Main Phase|Non-compliance|0|||
127817955|NCT01480180|459953631|FG000|Main Phase|Unclassified|3|||
127817956|NCT01480180|459953632|FG001|Main Phase|Unclassified|0|||
127817957|NCT01480180|459953633|FG002|Main Phase|Unclassified|0|||
127817958|NCT01480180|459953634|FG003|Main Phase|Unclassified|0|||
127817959|NCT01480180|459953635|FG004|Main Phase|Unclassified|0|||
127817960|NCT01480180|459953636|FG005|Main Phase|Unclassified|0|||
127817961|NCT01480180|459953631|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
127817962|NCT01480180|459953632|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
127817963|NCT01480180|459953633|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
127817964|NCT01480180|459953634|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
127817965|NCT01480180|459953635|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
127817966|NCT01480180|459953636|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
127817967|NCT01480180|459953631|FG000|Extension Phase, Part 1|Unclassified|0|||
127817968|NCT01480180|459953632|FG001|Extension Phase, Part 1|Unclassified|0|||
127817969|NCT01480180|459953633|FG002|Extension Phase, Part 1|Unclassified|1|||
127817970|NCT01480180|459953634|FG003|Extension Phase, Part 1|Unclassified|0|||
127817971|NCT01480180|459953635|FG004|Extension Phase, Part 1|Unclassified|0|||
127817972|NCT01480180|459953636|FG005|Extension Phase, Part 1|Unclassified|0|||
127817973|NCT01480180|459953631|FG000|Extension Phase, Part 1|Adverse Event|0|||
127817974|NCT01480180|459953632|FG001|Extension Phase, Part 1|Adverse Event|0|||
127817975|NCT01480180|459953633|FG002|Extension Phase, Part 1|Adverse Event|4|||
127817976|NCT01480180|459953634|FG003|Extension Phase, Part 1|Adverse Event|1|||
127817977|NCT01480180|459953635|FG004|Extension Phase, Part 1|Adverse Event|0|||
127817978|NCT01480180|459953636|FG005|Extension Phase, Part 1|Adverse Event|0|||
127817979|NCT01480180|459953631|FG000|Extension Phase, Part 1|Change of treatment|0|||
127817980|NCT01480180|459953632|FG001|Extension Phase, Part 1|Change of treatment|0|||
127817981|NCT01480180|459953633|FG002|Extension Phase, Part 1|Change of treatment|0|||
127817982|NCT01480180|459953634|FG003|Extension Phase, Part 1|Change of treatment|9|||
127817983|NCT01480180|459953635|FG004|Extension Phase, Part 1|Change of treatment|0|||
127817984|NCT01480180|459953636|FG005|Extension Phase, Part 1|Change of treatment|0|||
127817985|NCT01480180|459953631|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
127817986|NCT01480180|459953632|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
127817987|NCT01480180|459953633|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
127817988|NCT01480180|459953634|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
127817989|NCT01480180|459953635|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
127817990|NCT01480180|459953636|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
127817991|NCT01480180|459953631|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
127817992|NCT01480180|459953632|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
127817993|NCT01480180|459953633|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
127817994|NCT01480180|459953634|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
127817995|NCT01480180|459953635|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
127817996|NCT01480180|459953636|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
127817997|NCT01480180|459953631|FG000|Extension Phase, Part 2|Unclassified|0|||
127817998|NCT01480180|459953632|FG001|Extension Phase, Part 2|Unclassified|0|||
127817999|NCT01480180|459953633|FG002|Extension Phase, Part 2|Unclassified|3|||
127818000|NCT01480180|459953634|FG003|Extension Phase, Part 2|Unclassified|1|||
127818001|NCT01480180|459953635|FG004|Extension Phase, Part 2|Unclassified|1|||
127818002|NCT01480180|459953636|FG005|Extension Phase, Part 2|Unclassified|0|||
127818003|NCT00667277|459953641|FG000|Overall Study|Withdrawal by Subject|2|||
127818004|NCT05121103|459953642|FG000|Overall Study|Progressive disease|2|||
127818005|NCT05121103|459953643|FG001|Overall Study|Progressive disease|1|||
127818006|NCT05121103|459953644|FG002|Overall Study|Progressive disease|6|||
127818007|NCT05121103|459953642|FG000|Overall Study|Physician Decision|2|||
127818008|NCT05121103|459953643|FG001|Overall Study|Physician Decision|1|||
127818009|NCT05121103|459953644|FG002|Overall Study|Physician Decision|0|||
127818010|NCT05121103|459953642|FG000|Overall Study|Withdrawal by Subject|0|||
127818011|NCT05121103|459953643|FG001|Overall Study|Withdrawal by Subject|1|||
127818012|NCT05121103|459953644|FG002|Overall Study|Withdrawal by Subject|0|||
127818013|NCT03138564|459953647|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
127818014|NCT03138564|459953648|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
127818015|NCT03138564|459953647|FG000|Overall Study|Lost to Follow-up|16|||
127818016|NCT03138564|459953648|FG001|Overall Study|Lost to Follow-up|2|||
127818017|NCT03138564|459953647|FG000|Overall Study|Withdrawal by Subject|48|||
127818018|NCT03138564|459953648|FG001|Overall Study|Withdrawal by Subject|4|||
127818019|NCT03138564|459953647|FG000|Overall Study|No longer met eligibility criteria|2|||
127818020|NCT03138564|459953648|FG001|Overall Study|No longer met eligibility criteria|0|||
127818021|NCT03138564|459953647|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
127818022|NCT03138564|459953648|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
127818023|NCT03138564|459953647|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
127818024|NCT03138564|459953648|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
127818025|NCT03138564|459953647|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
127894568|NCT01915732|460237177|FG001|Overall Study|Pregnancy|0|||
127818026|NCT03138564|459953648|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
127818027|NCT03138564|459953647|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
127818028|NCT03138564|459953648|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
127818029|NCT00814710|459953649|FG000|Overall Study|Adverse Event|1|||
127818030|NCT00814710|459953650|FG001|Overall Study|Adverse Event|0|||
127818031|NCT00814710|459953649|FG000|Overall Study|Lost to Follow-up|7|||
127818032|NCT00814710|459953650|FG001|Overall Study|Lost to Follow-up|3|||
127818033|NCT03885284|459953657|FG000|Overall Study|Disease Progression|1|||
127818034|NCT03885284|459953658|FG001|Overall Study|Disease Progression|3|||
127818035|NCT03885284|459953657|FG000|Overall Study|Physician Decision|0|||
127818036|NCT03885284|459953658|FG001|Overall Study|Physician Decision|1|||
127818037|NCT01476787|459953663|FG000|Treatment|Progression|64|||
127818038|NCT01476787|459953664|FG001|Treatment|Progression|71|||
127818039|NCT01476787|459953663|FG000|Treatment|Toxicity|44|||
127818040|NCT01476787|459953664|FG001|Treatment|Toxicity|16|||
127818041|NCT01476787|459953663|FG000|Treatment|Death|0|||
127818042|NCT01476787|459953664|FG001|Treatment|Death|1|||
127818043|NCT01476787|459953663|FG000|Treatment|Withdrawal by Subject|3|||
127818044|NCT01476787|459953664|FG001|Treatment|Withdrawal by Subject|14|||
127818045|NCT01476787|459953663|FG000|Treatment|Major protocol violation|1|||
127818046|NCT01476787|459953664|FG001|Treatment|Major protocol violation|6|||
127818047|NCT01476787|459953663|FG000|Treatment|Other reasons|10|||
127818048|NCT01476787|459953664|FG001|Treatment|Other reasons|22|||
127818049|NCT01476787|459953663|FG000|Treatment|Concurrent illness|12|||
127818050|NCT01476787|459953664|FG001|Treatment|Concurrent illness|9|||
127818051|NCT01476787|459953663|FG000|Treatment|Insufficient response|15|||
127818052|NCT01476787|459953664|FG001|Treatment|Insufficient response|3|||
127818053|NCT01476787|459953663|FG000|Treatment|Voluntary treatment discontinuation|8|||
127818054|NCT01476787|459953664|FG001|Treatment|Voluntary treatment discontinuation|4|||
127818055|NCT01450137|459953665|FG000|Up to Week 12|Adverse Event|2|||
127818056|NCT01450137|459953666|FG001|Up to Week 12|Adverse Event|1|||
127818057|NCT01450137|459953665|FG000|Up to Week 12|Withdrawal by Subject|0|||
127818058|NCT01450137|459953666|FG001|Up to Week 12|Withdrawal by Subject|2|||
127818059|NCT01450137|459953665|FG000|Week 12 to Study End|Death|0|||
127818060|NCT01450137|459953666|FG001|Week 12 to Study End|Death|1|||
127818061|NCT01450137|459953665|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
127818062|NCT01450137|459953666|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
127818063|NCT01450540|459953668|FG000|Overall Study|Withdrawal by Subject|19|||
127818064|NCT01450540|459953669|FG001|Overall Study|Withdrawal by Subject|13|||
127818065|NCT01450540|459953668|FG000|Overall Study|protocol deviation|3|||
127818066|NCT01450540|459953669|FG001|Overall Study|protocol deviation|23|||
127818067|NCT01926886|459953670|FG000|Overall Study|Administrative/other|1|||
127818068|NCT01926886|459953671|FG001|Overall Study|Administrative/other|0|||
127818069|NCT01926886|459953670|FG000|Overall Study|Adverse event/intercurrent illness|4|||
127818070|NCT01926886|459953671|FG001|Overall Study|Adverse event/intercurrent illness|0|||
127818071|NCT01926886|459953670|FG000|Overall Study|Disease progression/recurrence|4|||
127818072|NCT01926886|459953671|FG001|Overall Study|Disease progression/recurrence|0|||
127818073|NCT01926886|459953670|FG000|Overall Study|Withdrawal by Subject|15|||
127818074|NCT01926886|459953671|FG001|Overall Study|Withdrawal by Subject|0|||
127818075|NCT01926886|459953670|FG000|Overall Study|Failure to return|3|||
127818076|NCT01926886|459953671|FG001|Overall Study|Failure to return|0|||
127818077|NCT01926886|459953670|FG000|Overall Study|Recurrence of disease|1|||
127818078|NCT01926886|459953671|FG001|Overall Study|Recurrence of disease|0|||
127818079|NCT01926886|459953670|FG000|Overall Study|Progression of disease|2|||
127818080|NCT01926886|459953671|FG001|Overall Study|Progression of disease|0|||
127818081|NCT01926886|459953670|FG000|Overall Study|Death|1|||
127818082|NCT01926886|459953671|FG001|Overall Study|Death|0|||
127818083|NCT01926886|459953670|FG000|Overall Study|Did not cooperate|1|||
127818084|NCT01926886|459953671|FG001|Overall Study|Did not cooperate|0|||
127818085|NCT01662999|459953680|FG000|Period 3|Withdrawal by Subject|0|||
127818086|NCT01662999|459953681|FG001|Period 3|Withdrawal by Subject|1|||
127818087|NCT01662999|459953682|FG002|Period 3|Withdrawal by Subject|0|||
127818088|NCT01662999|459953683|FG003|Period 3|Withdrawal by Subject|0|||
127818089|NCT01662999|459953684|FG004|Period 3|Withdrawal by Subject|0|||
127818090|NCT01662999|459953685|FG005|Period 3|Withdrawal by Subject|0|||
127818091|NCT02932267|459953688|FG000|Overall Study|Withdrawal by Subject|3|||
127818092|NCT02932267|459953688|FG000|Overall Study|Lost to Follow-up|4|||
127818093|NCT02932267|459953688|FG000|Overall Study|Pregnancy|1|||
127818094|NCT02453841|459953689|FG000|Overall Study|Protocol Violation|1|||
127818095|NCT02453841|459953689|FG000|Overall Study|Unable to obtain blood samples|2|||
127818096|NCT03851510|459953690|FG000|Overall Study|Screen Fail|1|||
127818097|NCT03851510|459953690|FG000|Overall Study|Adverse Event|1|||
127818098|NCT03851510|459953690|FG000|Overall Study|Withdrawal by Subject|1|||
127818099|NCT01151137|459953691|FG000|Overall Study|Death|15|||
127818100|NCT01151137|459953692|FG001|Overall Study|Death|27|||
127818101|NCT01151137|459953691|FG000|Overall Study|Lost to Follow-up|1|||
127818102|NCT01151137|459953692|FG001|Overall Study|Lost to Follow-up|1|||
127818103|NCT03439345|459955317|FG000|Overall Study|Lost to Follow-up|0|||
127818104|NCT03439345|459955318|FG001|Overall Study|Lost to Follow-up|1|||
127818105|NCT03439345|459955317|FG000|Overall Study|Consent withdrawn|0|||
127818106|NCT03439345|459955318|FG001|Overall Study|Consent withdrawn|1|||
127818107|NCT05165394|459955322|FG000|Overall Study|Withdrawal by Subject|5|||
127818108|NCT05165394|459955323|FG001|Overall Study|Withdrawal by Subject|1|||
127818109|NCT05165394|459955322|FG000|Overall Study|Lost to Follow-up|1|||
127818110|NCT05165394|459955323|FG001|Overall Study|Lost to Follow-up|2|||
127818111|NCT05165394|459955322|FG000|Overall Study|Other Than Specified|0|||
127818112|NCT05165394|459955323|FG001|Overall Study|Other Than Specified|1|||
127818113|NCT02517515|459955329|FG000|Overall Study|Adverse Event|0|||
127818114|NCT02517515|459955330|FG001|Overall Study|Adverse Event|1|||
127818115|NCT02517515|459955329|FG000|Overall Study|Withdrew Consent|0|||
127818116|NCT02517515|459955330|FG001|Overall Study|Withdrew Consent|1|||
127818117|NCT02517515|459955329|FG000|Overall Study|Lost to Follow-up|1|||
127818118|NCT02517515|459955330|FG001|Overall Study|Lost to Follow-up|0|||
127818119|NCT02517515|459955329|FG000|Overall Study|Other|1|||
127818120|NCT02517515|459955330|FG001|Overall Study|Other|0|||
127818121|NCT02786537|459955331|FG000|As Randomized|Adverse Event|0|||
127818122|NCT02786537|459955332|FG001|As Randomized|Adverse Event|11|||
127818123|NCT02786537|459955333|FG002|As Randomized|Adverse Event|0|||
127818124|NCT02786537|459955334|FG003|As Randomized|Adverse Event|4|||
127818125|NCT02786537|459955335|FG004|As Randomized|Adverse Event|6|||
127818126|NCT02786537|459955336|FG005|As Randomized|Adverse Event|2|||
127818127|NCT02786537|459955331|FG000|As Randomized|Lack of Efficacy|0|||
127818128|NCT02786537|459955332|FG001|As Randomized|Lack of Efficacy|0|||
127818129|NCT02786537|459955333|FG002|As Randomized|Lack of Efficacy|0|||
127818130|NCT02786537|459955334|FG003|As Randomized|Lack of Efficacy|1|||
127818131|NCT02786537|459955335|FG004|As Randomized|Lack of Efficacy|0|||
127818132|NCT02786537|459955336|FG005|As Randomized|Lack of Efficacy|0|||
127818133|NCT02786537|459955331|FG000|As Randomized|Withdrawal by Subject|1|||
127868854|NCT02210559|460137408|FG001|Overall Study|Physician Decision|0|||
127868855|NCT02210559|460137407|FG000|Overall Study|Withdrawal by Subject|0|||
127868856|NCT02210559|460137408|FG001|Overall Study|Withdrawal by Subject|1|||
127868857|NCT02210559|460137407|FG000|Overall Study|Other than specified|0|||
127868858|NCT02210559|460137408|FG001|Overall Study|Other than specified|1|||
127868859|NCT02546193|460137409|FG000|Overall Study|Withdrawal by Subject|2|||
127868860|NCT02546193|460137410|FG001|Overall Study|Withdrawal by Subject|0|||
127868861|NCT02546193|460137411|FG002|Overall Study|Withdrawal by Subject|1|||
127868862|NCT02546193|460137412|FG003|Overall Study|Withdrawal by Subject|0|||
127868863|NCT02546193|460137409|FG000|Overall Study|Not eligible at time of induction|4|||
127868864|NCT02546193|460137410|FG001|Overall Study|Not eligible at time of induction|6|||
127868865|NCT02546193|460137411|FG002|Overall Study|Not eligible at time of induction|1|||
127818134|NCT02786537|459955332|FG001|As Randomized|Withdrawal by Subject|2|||
127818135|NCT02786537|459955333|FG002|As Randomized|Withdrawal by Subject|0|||
127818136|NCT02786537|459955334|FG003|As Randomized|Withdrawal by Subject|1|||
127818137|NCT02786537|459955335|FG004|As Randomized|Withdrawal by Subject|1|||
127818138|NCT02786537|459955336|FG005|As Randomized|Withdrawal by Subject|0|||
127818139|NCT02786537|459955331|FG000|As Randomized|Death|0|||
127818140|NCT02786537|459955332|FG001|As Randomized|Death|2|||
127818141|NCT02786537|459955333|FG002|As Randomized|Death|0|||
127818142|NCT02786537|459955334|FG003|As Randomized|Death|3|||
127818143|NCT02786537|459955335|FG004|As Randomized|Death|1|||
127818144|NCT02786537|459955336|FG005|As Randomized|Death|0|||
127818145|NCT02786537|459955331|FG000|As Randomized|Non-compliance with study drug|1|||
127818146|NCT02786537|459955332|FG001|As Randomized|Non-compliance with study drug|11|||
127818147|NCT02786537|459955333|FG002|As Randomized|Non-compliance with study drug|0|||
127818148|NCT02786537|459955334|FG003|As Randomized|Non-compliance with study drug|1|||
127818149|NCT02786537|459955335|FG004|As Randomized|Non-compliance with study drug|0|||
127818150|NCT02786537|459955336|FG005|As Randomized|Non-compliance with study drug|1|||
127818151|NCT02786537|459955331|FG000|As Randomized|Lost to treatment follow-up|4|||
127818152|NCT02786537|459955332|FG001|As Randomized|Lost to treatment follow-up|32|||
127818153|NCT02786537|459955333|FG002|As Randomized|Lost to treatment follow-up|0|||
127818154|NCT02786537|459955334|FG003|As Randomized|Lost to treatment follow-up|24|||
127818155|NCT02786537|459955335|FG004|As Randomized|Lost to treatment follow-up|4|||
127818156|NCT02786537|459955336|FG005|As Randomized|Lost to treatment follow-up|4|||
127818157|NCT02786537|459955331|FG000|As Randomized|Incarceration|0|||
127818158|NCT02786537|459955332|FG001|As Randomized|Incarceration|1|||
127818159|NCT02786537|459955333|FG002|As Randomized|Incarceration|0|||
127818160|NCT02786537|459955334|FG003|As Randomized|Incarceration|0|||
127818161|NCT02786537|459955335|FG004|As Randomized|Incarceration|0|||
127818162|NCT02786537|459955336|FG005|As Randomized|Incarceration|0|||
127818163|NCT02786537|459955331|FG000|As Randomized|Opiate Dependency Relapse|0|||
127818164|NCT02786537|459955332|FG001|As Randomized|Opiate Dependency Relapse|1|||
127818165|NCT02786537|459955333|FG002|As Randomized|Opiate Dependency Relapse|0|||
127818166|NCT02786537|459955334|FG003|As Randomized|Opiate Dependency Relapse|0|||
127818167|NCT02786537|459955335|FG004|As Randomized|Opiate Dependency Relapse|0|||
127818168|NCT02786537|459955336|FG005|As Randomized|Opiate Dependency Relapse|0|||
127818169|NCT02786537|459955331|FG000|As Randomized|HCV drugs stolen from pt|0|||
127818170|NCT02786537|459955332|FG001|As Randomized|HCV drugs stolen from pt|1|||
127818171|NCT02786537|459955333|FG002|As Randomized|HCV drugs stolen from pt|0|||
127818172|NCT02786537|459955334|FG003|As Randomized|HCV drugs stolen from pt|0|||
127818173|NCT02786537|459955335|FG004|As Randomized|HCV drugs stolen from pt|0|||
127818174|NCT02786537|459955336|FG005|As Randomized|HCV drugs stolen from pt|0|||
127818175|NCT02786537|459955331|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
127818176|NCT02786537|459955332|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
127818177|NCT02786537|459955333|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
127818178|NCT02786537|459955334|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
127818179|NCT02786537|459955335|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
127818180|NCT02786537|459955336|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
127818181|NCT02786537|459955331|FG000|As Randomized|Subject lost insurance|0|||
127818182|NCT02786537|459955332|FG001|As Randomized|Subject lost insurance|0|||
127818183|NCT02786537|459955333|FG002|As Randomized|Subject lost insurance|0|||
127818184|NCT02786537|459955334|FG003|As Randomized|Subject lost insurance|1|||
127818185|NCT02786537|459955335|FG004|As Randomized|Subject lost insurance|0|||
127818186|NCT02786537|459955336|FG005|As Randomized|Subject lost insurance|0|||
127818187|NCT02786537|459955331|FG000|As Treated|Adverse Event|0|||
127818188|NCT02786537|459955332|FG001|As Treated|Adverse Event|11|||
127818189|NCT02786537|459955333|FG002|As Treated|Adverse Event|0|||
127818190|NCT02786537|459955334|FG003|As Treated|Adverse Event|4|||
127818191|NCT02786537|459955335|FG004|As Treated|Adverse Event|6|||
127818192|NCT02786537|459955336|FG005|As Treated|Adverse Event|2|||
127818193|NCT02786537|459955331|FG000|As Treated|Death|0|||
127818194|NCT02786537|459955332|FG001|As Treated|Death|2|||
127818195|NCT02786537|459955333|FG002|As Treated|Death|0|||
127818196|NCT02786537|459955334|FG003|As Treated|Death|3|||
127818197|NCT02786537|459955335|FG004|As Treated|Death|1|||
127818198|NCT02786537|459955336|FG005|As Treated|Death|0|||
127818199|NCT02786537|459955331|FG000|As Treated|Lack of Efficacy|0|||
127818200|NCT02786537|459955332|FG001|As Treated|Lack of Efficacy|0|||
127818201|NCT02786537|459955333|FG002|As Treated|Lack of Efficacy|0|||
127818202|NCT02786537|459955334|FG003|As Treated|Lack of Efficacy|1|||
127818203|NCT02786537|459955335|FG004|As Treated|Lack of Efficacy|0|||
127818204|NCT02786537|459955336|FG005|As Treated|Lack of Efficacy|0|||
127818205|NCT02786537|459955331|FG000|As Treated|Lost to Follow-up|4|||
127818206|NCT02786537|459955332|FG001|As Treated|Lost to Follow-up|32|||
127818207|NCT02786537|459955333|FG002|As Treated|Lost to Follow-up|0|||
127818208|NCT02786537|459955334|FG003|As Treated|Lost to Follow-up|25|||
127818209|NCT02786537|459955335|FG004|As Treated|Lost to Follow-up|4|||
127818210|NCT02786537|459955336|FG005|As Treated|Lost to Follow-up|4|||
127818211|NCT02786537|459955331|FG000|As Treated|Non-compliance with study drug|1|||
127818212|NCT02786537|459955332|FG001|As Treated|Non-compliance with study drug|11|||
127818213|NCT02786537|459955333|FG002|As Treated|Non-compliance with study drug|0|||
127818214|NCT02786537|459955334|FG003|As Treated|Non-compliance with study drug|1|||
127818215|NCT02786537|459955335|FG004|As Treated|Non-compliance with study drug|0|||
127818216|NCT02786537|459955336|FG005|As Treated|Non-compliance with study drug|1|||
127818217|NCT02786537|459955331|FG000|As Treated|Lost insurance|0|||
127818218|NCT02786537|459955332|FG001|As Treated|Lost insurance|0|||
127818219|NCT02786537|459955333|FG002|As Treated|Lost insurance|0|||
127818220|NCT02786537|459955334|FG003|As Treated|Lost insurance|1|||
127818221|NCT02786537|459955335|FG004|As Treated|Lost insurance|0|||
127818222|NCT02786537|459955336|FG005|As Treated|Lost insurance|0|||
127818223|NCT02786537|459955331|FG000|As Treated|Withdrawal by Subject|1|||
127818224|NCT02786537|459955332|FG001|As Treated|Withdrawal by Subject|2|||
127818225|NCT02786537|459955333|FG002|As Treated|Withdrawal by Subject|0|||
127818226|NCT02786537|459955334|FG003|As Treated|Withdrawal by Subject|0|||
127818227|NCT02786537|459955335|FG004|As Treated|Withdrawal by Subject|1|||
127818228|NCT02786537|459955336|FG005|As Treated|Withdrawal by Subject|0|||
127818229|NCT02786537|459955331|FG000|As Treated|Incarceration|0|||
127818230|NCT02786537|459955332|FG001|As Treated|Incarceration|1|||
127818231|NCT02786537|459955333|FG002|As Treated|Incarceration|0|||
127818232|NCT02786537|459955334|FG003|As Treated|Incarceration|0|||
127818233|NCT02786537|459955335|FG004|As Treated|Incarceration|0|||
127818234|NCT02786537|459955336|FG005|As Treated|Incarceration|0|||
127818235|NCT02786537|459955331|FG000|As Treated|Opiate dependency relapse|0|||
127818236|NCT02786537|459955332|FG001|As Treated|Opiate dependency relapse|1|||
127818237|NCT02786537|459955333|FG002|As Treated|Opiate dependency relapse|0|||
127818238|NCT02786537|459955334|FG003|As Treated|Opiate dependency relapse|0|||
127818239|NCT02786537|459955335|FG004|As Treated|Opiate dependency relapse|0|||
127818240|NCT02786537|459955336|FG005|As Treated|Opiate dependency relapse|0|||
127818241|NCT02786537|459955331|FG000|As Treated|Drugs stolen from patient|0|||
127818242|NCT02786537|459955332|FG001|As Treated|Drugs stolen from patient|1|||
127818243|NCT02786537|459955333|FG002|As Treated|Drugs stolen from patient|0|||
127818244|NCT02786537|459955334|FG003|As Treated|Drugs stolen from patient|0|||
127818245|NCT02786537|459955335|FG004|As Treated|Drugs stolen from patient|0|||
127818246|NCT02786537|459955336|FG005|As Treated|Drugs stolen from patient|0|||
127818247|NCT02786537|459955331|FG000|As Treated|Advised to stop tx after loss of meds|0|||
127818248|NCT02786537|459955332|FG001|As Treated|Advised to stop tx after loss of meds|1|||
127818249|NCT02786537|459955333|FG002|As Treated|Advised to stop tx after loss of meds|0|||
127818250|NCT02786537|459955334|FG003|As Treated|Advised to stop tx after loss of meds|0|||
127818251|NCT02786537|459955335|FG004|As Treated|Advised to stop tx after loss of meds|0|||
127818252|NCT02786537|459955336|FG005|As Treated|Advised to stop tx after loss of meds|0|||
127818253|NCT02638012|459955337|FG000|Overall Study|Lost to Follow-up|1|||
127818254|NCT00443560|459955338|FG000|Overall Study|No intrathecal dose|58|||
127818255|NCT00443560|459955339|FG001|Overall Study|No intrathecal dose|26|||
127818256|NCT00443560|459955338|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
127818257|NCT00443560|459955339|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
127818258|NCT01389128|459955342|FG000|Overall Study|Fetal distress|1|||
127818259|NCT01389128|459955343|FG001|Overall Study|Fetal distress|0|||
127818260|NCT01389128|459955342|FG000|Overall Study|Cervix dilation stop|1|||
127818261|NCT01389128|459955343|FG001|Overall Study|Cervix dilation stop|2|||
127818262|NCT01389128|459955342|FG000|Overall Study|Rapid labor evolution|3|||
127818263|NCT01389128|459955343|FG001|Overall Study|Rapid labor evolution|2|||
127818264|NCT01389128|459955342|FG000|Overall Study|Intolerance to procedure|0|||
127818265|NCT01389128|459955343|FG001|Overall Study|Intolerance to procedure|2|||
127818266|NCT00947154|459955347|FG000|Overall Study|Lost to Follow-up|1|||
127818267|NCT02286960|459955356|FG000|Overall Study|Lost to Follow-up|3|||
127818268|NCT02286960|459955357|FG001|Overall Study|Lost to Follow-up|3|||
127818269|NCT00440401|459955358|FG000|Overall Study|Adverse Event|2|||
127818270|NCT00440401|459955359|FG001|Overall Study|Adverse Event|1|||
127818271|NCT00440401|459955358|FG000|Overall Study|Other|2|||
127818272|NCT00440401|459955359|FG001|Overall Study|Other|5|||
127818273|NCT00550238|459955360|FG000|Overall Study|Adverse Event|88|||
127818274|NCT00550238|459955360|FG000|Overall Study|Death|34|||
127818275|NCT00550238|459955360|FG000|Overall Study|Disease progression|46|||
127818276|NCT00550238|459955360|FG000|Overall Study|Withdrawal by Subject|167|||
127818277|NCT00550238|459955360|FG000|Overall Study|Physician Decision|31|||
127818278|NCT00550238|459955360|FG000|Overall Study|Patient noncompliance|25|||
127818279|NCT00550238|459955360|FG000|Overall Study|Lost to Follow-up|13|||
127818280|NCT00550238|459955360|FG000|Overall Study|Sponsor decision|55|||
127818281|NCT00779038|459955361|FG000|Overall Study|Study Prematurely Terminated|13|||
127818282|NCT00537745|459955362|FG000|Overall Study|Did not meet eligibility criteria|2|||
127818283|NCT00537745|459955362|FG000|Overall Study|Withdrawal by Subject|2|||
127818284|NCT00537745|459955362|FG000|Overall Study|Subject unable to provide Interlock info|1|||
127818285|NCT05370157|459955363|FG000|Participants Entering at Baseline|Lost to Follow-up|11|||
127818286|NCT05370157|459955364|FG001|Participants Entering at Baseline|Lost to Follow-up|11|||
127818287|NCT05370157|459955363|FG000|Participants Entering at Baseline|Not eligible for followup - no longer member of team|17|||
127818288|NCT05370157|459955364|FG001|Participants Entering at Baseline|Not eligible for followup - no longer member of team|4|||
127818289|NCT03700892|459955365|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
127818290|NCT03700892|459955366|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
127818291|NCT03700892|459955367|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
127818292|NCT00184054|459955377|FG000|Overall Study|Adverse Event|1|||
127818293|NCT00828451|459955378|FG000|Overall Study|Death|2|||
127818294|NCT00828451|459955378|FG000|Overall Study|Lack of intravenous line|7|||
127818295|NCT00828451|459955378|FG000|Overall Study|Withdrawal by Subject|1|||
127818296|NCT00828451|459955378|FG000|Overall Study|Deterioration in clinical status|1|||
127818297|NCT05593432|459955380|FG000|16-Week DBVC Period|Withdrawal by Subject|2|||
127818298|NCT05593432|459955381|FG001|16-Week DBVC Period|Withdrawal by Subject|3|||
127818299|NCT05593432|459955382|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
127818300|NCT05593432|459955383|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
127818301|NCT05593432|459955380|FG000|16-Week OLE Period|Lack of Efficacy|0|||
127818302|NCT05593432|459955381|FG001|16-Week OLE Period|Lack of Efficacy|0|||
127818303|NCT05593432|459955382|FG002|16-Week OLE Period|Lack of Efficacy|0|||
127818304|NCT05593432|459955383|FG003|16-Week OLE Period|Lack of Efficacy|1|||
127818305|NCT05593432|459955380|FG000|16-Week OLE Period|Lost to Follow-up|0|||
127818306|NCT05593432|459955381|FG001|16-Week OLE Period|Lost to Follow-up|0|||
127818307|NCT05593432|459955382|FG002|16-Week OLE Period|Lost to Follow-up|1|||
127818308|NCT05593432|459955383|FG003|16-Week OLE Period|Lost to Follow-up|2|||
127818309|NCT05593432|459955380|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
127818310|NCT05593432|459955381|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
127818311|NCT05593432|459955382|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
127818312|NCT05593432|459955383|FG003|16-Week OLE Period|Withdrawal by Subject|3|||
127818313|NCT01591330|459955386|FG000|Period 1|Adverse Event|1|||
127818314|NCT01591330|459955387|FG001|Period 1|Adverse Event|0|||
127818315|NCT01591330|459955388|FG002|Period 1|Adverse Event|0|||
127818316|NCT01591330|459955389|FG003|Period 1|Adverse Event|0|||
127818317|NCT01591330|459955386|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
127818318|NCT01591330|459955387|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
127818319|NCT01591330|459955388|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
127818320|NCT01591330|459955389|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
127818321|NCT01591330|459955386|FG000|Period 2|Adverse Event|1|||
127818322|NCT01591330|459955387|FG001|Period 2|Adverse Event|0|||
127818323|NCT01591330|459955388|FG002|Period 2|Adverse Event|0|||
127818324|NCT01591330|459955389|FG003|Period 2|Adverse Event|0|||
127818325|NCT04800315|459955393|FG000|Randomization|Did not receive study treatment|1|||
127818326|NCT04800315|459955394|FG001|Randomization|Did not receive study treatment|0|||
127818327|NCT04800315|459955395|FG002|Randomization|Did not receive study treatment|0|||
127818328|NCT04800315|459955396|FG003|Randomization|Did not receive study treatment|0|||
127818329|NCT04800315|459955393|FG000|Treatment Period|Adverse Event|4|||
127818330|NCT04800315|459955394|FG001|Treatment Period|Adverse Event|2|||
127818331|NCT04800315|459955395|FG002|Treatment Period|Adverse Event|1|||
127818332|NCT04800315|459955396|FG003|Treatment Period|Adverse Event|2|||
127818333|NCT04800315|459955393|FG000|Treatment Period|Lack of Efficacy|1|||
127818334|NCT04800315|459955394|FG001|Treatment Period|Lack of Efficacy|0|||
127818335|NCT04800315|459955395|FG002|Treatment Period|Lack of Efficacy|0|||
127818336|NCT04800315|459955396|FG003|Treatment Period|Lack of Efficacy|3|||
127818337|NCT04800315|459955393|FG000|Treatment Period|Lost to Follow-up|0|||
127818338|NCT04800315|459955394|FG001|Treatment Period|Lost to Follow-up|1|||
127818339|NCT04800315|459955395|FG002|Treatment Period|Lost to Follow-up|2|||
127818340|NCT04800315|459955396|FG003|Treatment Period|Lost to Follow-up|2|||
127818341|NCT04800315|459955393|FG000|Treatment Period|Withdrawal by participant|0|||
127818342|NCT04800315|459955394|FG001|Treatment Period|Withdrawal by participant|0|||
127818343|NCT04800315|459955395|FG002|Treatment Period|Withdrawal by participant|0|||
127818344|NCT04800315|459955396|FG003|Treatment Period|Withdrawal by participant|4|||
127818345|NCT04800315|459955393|FG000|Treatment Period|Other Reasons|0|||
127818346|NCT04800315|459955394|FG001|Treatment Period|Other Reasons|2|||
127818347|NCT04800315|459955395|FG002|Treatment Period|Other Reasons|0|||
127818348|NCT04800315|459955396|FG003|Treatment Period|Other Reasons|1|||
127818349|NCT00753922|459955397|FG000|Overall Study|Lost to Follow-up|155|||
127818350|NCT00753922|459955398|FG001|Overall Study|Lost to Follow-up|24|||
127818351|NCT00753922|459955399|FG002|Overall Study|Lost to Follow-up|28|||
127818352|NCT00753922|459955400|FG003|Overall Study|Lost to Follow-up|5|||
127818353|NCT00753922|459955397|FG000|Overall Study|Withdrawal by Subject|9|||
127818354|NCT00753922|459955398|FG001|Overall Study|Withdrawal by Subject|11|||
127818355|NCT00753922|459955399|FG002|Overall Study|Withdrawal by Subject|4|||
127818356|NCT00753922|459955400|FG003|Overall Study|Withdrawal by Subject|2|||
127818357|NCT00753922|459955397|FG000|Overall Study|Patient Non-compliance|55|||
127818358|NCT00753922|459955398|FG001|Overall Study|Patient Non-compliance|22|||
127818359|NCT00753922|459955399|FG002|Overall Study|Patient Non-compliance|14|||
127818360|NCT00753922|459955400|FG003|Overall Study|Patient Non-compliance|11|||
127818361|NCT00753922|459955397|FG000|Overall Study|Patients Not Completing Visit|11|||
127818362|NCT00753922|459955398|FG001|Overall Study|Patients Not Completing Visit|0|||
127818363|NCT00753922|459955399|FG002|Overall Study|Patients Not Completing Visit|1|||
127818364|NCT00753922|459955400|FG003|Overall Study|Patients Not Completing Visit|0|||
127818365|NCT00753922|459955397|FG000|Overall Study|Death|2|||
127818366|NCT00753922|459955398|FG001|Overall Study|Death|23|||
127818367|NCT00753922|459955399|FG002|Overall Study|Death|2|||
127818368|NCT00753922|459955400|FG003|Overall Study|Death|1|||
127818369|NCT00753922|459955397|FG000|Overall Study|Discontinuation Due to Explantation|14|||
127818370|NCT00753922|459955398|FG001|Overall Study|Discontinuation Due to Explantation|14|||
127818371|NCT00753922|459955399|FG002|Overall Study|Discontinuation Due to Explantation|14|||
127818372|NCT00753922|459955400|FG003|Overall Study|Discontinuation Due to Explantation|4|||
127818373|NCT01919411|459955403|FG000|Overall Study|Lost to Follow-up|2|||
127818374|NCT01919411|459955404|FG001|Overall Study|Lost to Follow-up|4|||
127818375|NCT01919411|459955403|FG000|Overall Study|Physician Decision|1|||
127818376|NCT01919411|459955404|FG001|Overall Study|Physician Decision|0|||
127818377|NCT01919411|459955403|FG000|Overall Study|Protocol Violation|2|||
127818378|NCT01919411|459955404|FG001|Overall Study|Protocol Violation|1|||
127818379|NCT02426086|459955408|FG000|Overall Study|Death|33|||
127818380|NCT02426086|459955409|FG001|Overall Study|Death|36|||
127818381|NCT02426086|459955408|FG000|Overall Study|Lost to Follow-up|2|||
127818382|NCT02426086|459955409|FG001|Overall Study|Lost to Follow-up|0|||
127818383|NCT02426086|459955408|FG000|Overall Study|Study Terminated by Sponsor|5|||
127818384|NCT02426086|459955409|FG001|Overall Study|Study Terminated by Sponsor|14|||
127818385|NCT02426086|459955408|FG000|Overall Study|Withdrawal by Subject|8|||
127818386|NCT02426086|459955409|FG001|Overall Study|Withdrawal by Subject|9|||
127818387|NCT00524303|459955410|FG000|Overall Study|Lost to Follow-up|6|||
127818388|NCT00524303|459955411|FG001|Overall Study|Lost to Follow-up|0|||
127818389|NCT00524303|459955412|FG002|Overall Study|Lost to Follow-up|3|||
127818390|NCT00524303|459955410|FG000|Overall Study|Protocol Violation|0|||
127818391|NCT00524303|459955411|FG001|Overall Study|Protocol Violation|1|||
127818392|NCT00524303|459955412|FG002|Overall Study|Protocol Violation|1|||
127818393|NCT00524303|459955410|FG000|Overall Study|Withdrawal by Subject|3|||
127818394|NCT00524303|459955411|FG001|Overall Study|Withdrawal by Subject|0|||
127818395|NCT00524303|459955412|FG002|Overall Study|Withdrawal by Subject|4|||
127818396|NCT00524303|459955410|FG000|Overall Study|Death|0|||
127818397|NCT00524303|459955411|FG001|Overall Study|Death|2|||
127818398|NCT00524303|459955412|FG002|Overall Study|Death|3|||
127818399|NCT00524303|459955410|FG000|Overall Study|Adverse Event|1|||
127818400|NCT00524303|459955411|FG001|Overall Study|Adverse Event|2|||
127818401|NCT00524303|459955412|FG002|Overall Study|Adverse Event|3|||
127818402|NCT00524303|459955410|FG000|Overall Study|Did not Complete Study Dosing|1|||
127818403|NCT00524303|459955411|FG001|Overall Study|Did not Complete Study Dosing|0|||
127818404|NCT00524303|459955412|FG002|Overall Study|Did not Complete Study Dosing|0|||
127818405|NCT00524303|459955410|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
127818406|NCT00524303|459955411|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
127818407|NCT00524303|459955412|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
127818408|NCT00524303|459955410|FG000|Overall Study|Disease Progression|0|||
127818409|NCT00524303|459955411|FG001|Overall Study|Disease Progression|4|||
127818410|NCT00524303|459955412|FG002|Overall Study|Disease Progression|1|||
127818411|NCT00524303|459955410|FG000|Overall Study|Disease Recurrence|0|||
127818412|NCT00524303|459955411|FG001|Overall Study|Disease Recurrence|1|||
127818413|NCT00524303|459955412|FG002|Overall Study|Disease Recurrence|0|||
127818414|NCT00524303|459955410|FG000|Overall Study|Sponsor Request|0|||
127818415|NCT00524303|459955411|FG001|Overall Study|Sponsor Request|0|||
127818416|NCT00524303|459955412|FG002|Overall Study|Sponsor Request|1|||
127818417|NCT00524303|459955410|FG000|Overall Study|Physician Decision|0|||
127818418|NCT00524303|459955411|FG001|Overall Study|Physician Decision|0|||
127894569|NCT01915732|460237176|FG000|Overall Study|Poor Perceived Efficacy|1|||
127818419|NCT00524303|459955412|FG002|Overall Study|Physician Decision|1|||
127818420|NCT00524303|459955410|FG000|Overall Study|Completed 5 years|0|||
127818421|NCT00524303|459955411|FG001|Overall Study|Completed 5 years|0|||
127818422|NCT00524303|459955412|FG002|Overall Study|Completed 5 years|1|||
127818423|NCT00840463|459955416|FG000|Overall Study|Adverse Event|1|||
127818424|NCT00840463|459955417|FG001|Overall Study|Adverse Event|0|||
127818425|NCT01739595|459955420|FG000|Overall Study|Adverse Event|3|||
127818426|NCT01739595|459955421|FG001|Overall Study|Adverse Event|0|||
127818427|NCT01739595|459955422|FG002|Overall Study|Adverse Event|0|||
127818428|NCT01739595|459955420|FG000|Overall Study|Lost to Follow-up|2|||
127818429|NCT01739595|459955421|FG001|Overall Study|Lost to Follow-up|0|||
127818430|NCT01739595|459955422|FG002|Overall Study|Lost to Follow-up|0|||
127818431|NCT01739595|459955420|FG000|Overall Study|Withdrawal by Subject|2|||
127818432|NCT01739595|459955421|FG001|Overall Study|Withdrawal by Subject|1|||
127818433|NCT01739595|459955422|FG002|Overall Study|Withdrawal by Subject|2|||
127818434|NCT01739595|459955420|FG000|Overall Study|Eligibility issue|3|||
127818435|NCT01739595|459955421|FG001|Overall Study|Eligibility issue|0|||
127818436|NCT01739595|459955422|FG002|Overall Study|Eligibility issue|0|||
127818437|NCT01739595|459955420|FG000|Overall Study|Protocol Violation|1|||
127818438|NCT01739595|459955421|FG001|Overall Study|Protocol Violation|0|||
127818439|NCT01739595|459955422|FG002|Overall Study|Protocol Violation|0|||
127818440|NCT01739595|459955420|FG000|Overall Study|Lab assessment|1|||
127818441|NCT01739595|459955421|FG001|Overall Study|Lab assessment|0|||
127818442|NCT01739595|459955422|FG002|Overall Study|Lab assessment|0|||
127818443|NCT01739595|459955420|FG000|Overall Study|Drug discrepancy|1|||
127818444|NCT01739595|459955421|FG001|Overall Study|Drug discrepancy|0|||
127818445|NCT01739595|459955422|FG002|Overall Study|Drug discrepancy|0|||
127818446|NCT02515669|459955423|FG000|228 Week Open-Label Phase|Other|0|||
127818447|NCT02515669|459955424|FG001|228 Week Open-Label Phase|Other|0|||
127818448|NCT02515669|459955425|FG002|228 Week Open-Label Phase|Other|1|||
127818449|NCT02515669|459955426|FG003|228 Week Open-Label Phase|Other|4|||
127818450|NCT02515669|459955423|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
127818451|NCT02515669|459955424|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
127818452|NCT02515669|459955425|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
127818453|NCT02515669|459955426|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
127818454|NCT02515669|459955423|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
127818455|NCT02515669|459955424|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
127818456|NCT02515669|459955425|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
127818457|NCT02515669|459955426|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
127818458|NCT02515669|459955423|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
127818459|NCT02515669|459955424|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
127818460|NCT02515669|459955425|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
127818461|NCT02515669|459955426|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
127818462|NCT02515669|459955423|FG000|228 Week Open-Label Phase|Missing|0|||
127818463|NCT02515669|459955424|FG001|228 Week Open-Label Phase|Missing|2|||
127818464|NCT02515669|459955425|FG002|228 Week Open-Label Phase|Missing|2|||
127818465|NCT02515669|459955426|FG003|228 Week Open-Label Phase|Missing|2|||
127818466|NCT03750838|459955429|FG000|Overall Study|Lost to Follow-up|10|||
127818467|NCT03750838|459955430|FG001|Overall Study|Lost to Follow-up|6|||
127818468|NCT01676116|459955432|FG000|Overall Study|Withdrawal criteria|2|||
127818469|NCT01676116|459955433|FG001|Overall Study|Withdrawal criteria|14|||
127818470|NCT01676116|459955432|FG000|Overall Study|Adverse Event|1|||
127818471|NCT01676116|459955433|FG001|Overall Study|Adverse Event|2|||
127818472|NCT01676116|459955432|FG000|Overall Study|Unclassified|4|||
127818473|NCT01676116|459955433|FG001|Overall Study|Unclassified|10|||
127818474|NCT01676116|459955432|FG000|Overall Study|Protocol Violation|9|||
127818475|NCT01676116|459955433|FG001|Overall Study|Protocol Violation|3|||
127818476|NCT01287117|459955434|FG000|Overall Study|Adverse Event|2|||
127818477|NCT01287117|459955435|FG001|Overall Study|Adverse Event|1|||
127818478|NCT01287117|459955436|FG002|Overall Study|Adverse Event|1|||
127818479|NCT01287117|459955437|FG003|Overall Study|Adverse Event|1|||
127818480|NCT01287117|459955434|FG000|Overall Study|Lost to Follow-up|1|||
127818481|NCT01287117|459955435|FG001|Overall Study|Lost to Follow-up|1|||
127818482|NCT01287117|459955436|FG002|Overall Study|Lost to Follow-up|0|||
127818483|NCT01287117|459955437|FG003|Overall Study|Lost to Follow-up|0|||
127818484|NCT01287117|459955434|FG000|Overall Study|Physician Decision|0|||
127818485|NCT01287117|459955435|FG001|Overall Study|Physician Decision|1|||
127818486|NCT01287117|459955436|FG002|Overall Study|Physician Decision|1|||
127894570|NCT01915732|460237177|FG001|Overall Study|Poor Perceived Efficacy|0|||
127818487|NCT01287117|459955437|FG003|Overall Study|Physician Decision|1|||
127818488|NCT01287117|459955434|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
127818489|NCT01287117|459955435|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
127818490|NCT01287117|459955436|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
127818491|NCT01287117|459955437|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
127818492|NCT01287117|459955434|FG000|Overall Study|Disease Progression|10|||
127818493|NCT01287117|459955435|FG001|Overall Study|Disease Progression|5|||
127818494|NCT01287117|459955436|FG002|Overall Study|Disease Progression|6|||
127818495|NCT01287117|459955437|FG003|Overall Study|Disease Progression|5|||
127818496|NCT01769404|459955442|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
127818497|NCT01769404|459955443|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
127818498|NCT01769404|459955442|FG000|Treatment Period 1|Withdrawal by Subject|3|||
127818499|NCT01769404|459955443|FG001|Treatment Period 1|Withdrawal by Subject|0|||
127818500|NCT01769404|459955442|FG000|Treatment Period 1|Sponsor decision|1|||
127818501|NCT01769404|459955443|FG001|Treatment Period 1|Sponsor decision|0|||
127818502|NCT01769404|459955442|FG000|Treatment Period 2|Sponsor decision|7|||
127818503|NCT01769404|459955443|FG001|Treatment Period 2|Sponsor decision|0|||
127818504|NCT00538733|459955444|FG000|Overall Study|Adverse Event|8|||
127818505|NCT00538733|459955444|FG000|Overall Study|Death|1|||
127818506|NCT00538733|459955444|FG000|Overall Study|declined to participate|2|||
127818507|NCT00538733|459955444|FG000|Overall Study|still on therapy|1|||
127818508|NCT00095121|459955449|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
127818509|NCT00095121|459955450|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
127818510|NCT00095121|459955449|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
127818511|NCT00095121|459955450|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
127818512|NCT02975349|459955457|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
127818513|NCT02975349|459955458|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
127818514|NCT02975349|459955459|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
127818515|NCT02975349|459955460|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
127818516|NCT02975349|459955461|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
127818517|NCT02975349|459955462|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
127818518|NCT02975349|459955463|FG006|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
127818519|NCT02975349|459955457|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
127818520|NCT02975349|459955458|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
127818521|NCT02975349|459955459|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
127818522|NCT02975349|459955460|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
127818523|NCT02975349|459955461|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
127818524|NCT02975349|459955462|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
127818525|NCT02975349|459955463|FG006|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
127818526|NCT02975349|459955457|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
127818527|NCT02975349|459955458|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
127818528|NCT02975349|459955459|FG002|Active Treatment Period (24 Weeks)|Adverse Event|0|||
127818529|NCT02975349|459955460|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
127818530|NCT02975349|459955461|FG004|Active Treatment Period (24 Weeks)|Adverse Event|2|||
127818531|NCT02975349|459955462|FG005|Active Treatment Period (24 Weeks)|Adverse Event|6|||
127818532|NCT02975349|459955463|FG006|Active Treatment Period (24 Weeks)|Adverse Event|2|||
127818533|NCT02975349|459955457|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
127818534|NCT02975349|459955458|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
127818535|NCT02975349|459955459|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
127818536|NCT02975349|459955460|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
127818537|NCT02975349|459955461|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|3|||
127818538|NCT02975349|459955462|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
127818539|NCT02975349|459955463|FG006|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
127818540|NCT02975349|459955457|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
127818541|NCT02975349|459955458|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
127818542|NCT02975349|459955459|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
127818543|NCT02975349|459955460|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
127818544|NCT02975349|459955461|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
127818545|NCT02975349|459955462|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
127818546|NCT02975349|459955463|FG006|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
127818547|NCT02975349|459955457|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
127818548|NCT02975349|459955458|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
127818549|NCT02975349|459955459|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
127818550|NCT02975349|459955460|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
127818551|NCT02975349|459955461|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
127818552|NCT02975349|459955462|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
127818553|NCT02975349|459955463|FG006|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
127818554|NCT02975349|459955457|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
127818555|NCT02975349|459955458|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
127818556|NCT02975349|459955459|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
127818557|NCT02975349|459955460|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
127818558|NCT02975349|459955461|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
127818559|NCT02975349|459955462|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
127818560|NCT02975349|459955463|FG006|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
127818561|NCT02975349|459955457|FG000|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
127818562|NCT02975349|459955458|FG001|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
127818563|NCT02975349|459955459|FG002|Open-label Extension Period (336 Weeks)|Adverse Event|3|||
127818564|NCT02975349|459955460|FG003|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
127818565|NCT02975349|459955461|FG004|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
127818566|NCT02975349|459955462|FG005|Open-label Extension Period (336 Weeks)|Adverse Event|1|||
127818567|NCT02975349|459955463|FG006|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
127818568|NCT02975349|459955457|FG000|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
127818569|NCT02975349|459955458|FG001|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
127818570|NCT02975349|459955459|FG002|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
127818571|NCT02975349|459955460|FG003|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
127818572|NCT02975349|459955461|FG004|Open-label Extension Period (336 Weeks)|Study reached its predefined end|1|||
127818573|NCT02975349|459955462|FG005|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
127818574|NCT02975349|459955463|FG006|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
127818575|NCT02975349|459955457|FG000|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
127818576|NCT02975349|459955458|FG001|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
127818577|NCT02975349|459955459|FG002|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
127818578|NCT02975349|459955460|FG003|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
127818579|NCT02975349|459955461|FG004|Open-label Extension Period (336 Weeks)|Lack of Efficacy|2|||
127818580|NCT02975349|459955462|FG005|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
127818581|NCT02975349|459955463|FG006|Open-label Extension Period (336 Weeks)|Lack of Efficacy|1|||
127818582|NCT02975349|459955457|FG000|Open-label Extension Period (336 Weeks)|Death|0|||
127818583|NCT02975349|459955458|FG001|Open-label Extension Period (336 Weeks)|Death|0|||
127818584|NCT02975349|459955459|FG002|Open-label Extension Period (336 Weeks)|Death|0|||
127818585|NCT02975349|459955460|FG003|Open-label Extension Period (336 Weeks)|Death|1|||
127818586|NCT02975349|459955461|FG004|Open-label Extension Period (336 Weeks)|Death|0|||
127818587|NCT02975349|459955462|FG005|Open-label Extension Period (336 Weeks)|Death|0|||
127818588|NCT02975349|459955463|FG006|Open-label Extension Period (336 Weeks)|Death|0|||
127818589|NCT02975349|459955457|FG000|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
127818590|NCT02975349|459955458|FG001|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
127818591|NCT02975349|459955459|FG002|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
127818592|NCT02975349|459955460|FG003|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
127818593|NCT02975349|459955461|FG004|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
127818594|NCT02975349|459955462|FG005|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
127818595|NCT02975349|459955463|FG006|Open-label Extension Period (336 Weeks)|COVID-19 Related|2|||
127818596|NCT02975349|459955457|FG000|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
127818597|NCT02975349|459955458|FG001|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
127818598|NCT02975349|459955459|FG002|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
127818599|NCT02975349|459955460|FG003|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
127818600|NCT02975349|459955461|FG004|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
127818601|NCT02975349|459955462|FG005|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
127818602|NCT02975349|459955463|FG006|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
127818603|NCT02975349|459955457|FG000|Open-label Extension Period (336 Weeks)|Other|0|||
127818604|NCT02975349|459955458|FG001|Open-label Extension Period (336 Weeks)|Other|0|||
127818605|NCT02975349|459955459|FG002|Open-label Extension Period (336 Weeks)|Other|3|||
127818606|NCT02975349|459955460|FG003|Open-label Extension Period (336 Weeks)|Other|3|||
127818607|NCT02975349|459955461|FG004|Open-label Extension Period (336 Weeks)|Other|1|||
127818608|NCT02975349|459955462|FG005|Open-label Extension Period (336 Weeks)|Other|2|||
127818609|NCT02975349|459955463|FG006|Open-label Extension Period (336 Weeks)|Other|3|||
127818610|NCT02975349|459955457|FG000|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
127818611|NCT02975349|459955458|FG001|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
127818612|NCT02975349|459955459|FG002|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
127818613|NCT02975349|459955460|FG003|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|7|||
127818614|NCT02975349|459955461|FG004|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
127818615|NCT02975349|459955462|FG005|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
127818616|NCT02975349|459955463|FG006|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
127818617|NCT01266148|459957210|FG000|Overall Study|Adverse Event|2|||
127818618|NCT01266148|459957211|FG001|Overall Study|Adverse Event|0|||
127818619|NCT01266148|459957210|FG000|Overall Study|Ongoing rejection|1|||
127818620|NCT01266148|459957211|FG001|Overall Study|Ongoing rejection|0|||
127818621|NCT01266148|459957210|FG000|Overall Study|2 2R rejections|1|||
127818622|NCT01266148|459957211|FG001|Overall Study|2 2R rejections|0|||
127818623|NCT01266148|459957210|FG000|Overall Study|Death|2|||
127818624|NCT01266148|459957211|FG001|Overall Study|Death|3|||
127818625|NCT01266148|459957210|FG000|Overall Study|missing mGFR value + AE|1|||
127818626|NCT01266148|459957211|FG001|Overall Study|missing mGFR value + AE|0|||
127818627|NCT01853228|459957212|FG000|Phase 1|Lack of Efficacy|8|||
127818628|NCT01853228|459957213|FG001|Phase 1|Lack of Efficacy|0|||
127818629|NCT01853228|459957212|FG000|Phase 1|Other|1|||
127894571|NCT01915732|460237176|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
127894572|NCT01915732|460237177|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
127894573|NCT01915732|460237176|FG000|Overall Study|Got Well|0|||
127894574|NCT01915732|460237177|FG001|Overall Study|Got Well|1|||
127894575|NCT01915732|460237176|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
127894576|NCT01915732|460237177|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
127894577|NCT01915732|460237176|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
127894578|NCT01915732|460237177|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
127894579|NCT01915732|460237176|FG000|Overall Study|Job Transfer|0|||
127894580|NCT01915732|460237177|FG001|Overall Study|Job Transfer|1|||
127894581|NCT01915732|460237176|FG000|Overall Study|Improper Facial Procedure|0|||
127894582|NCT01915732|460237177|FG001|Overall Study|Improper Facial Procedure|1|||
127894583|NCT01915732|460237176|FG000|Overall Study|Poor Conscious Effect|0|||
127894584|NCT01915732|460237177|FG001|Overall Study|Poor Conscious Effect|1|||
127894585|NCT01166568|460237191|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
127894586|NCT01166568|460237192|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
127894587|NCT01166568|460237193|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
127894588|NCT01166568|460237191|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
127894589|NCT01166568|460237192|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
127894590|NCT01166568|460237193|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
127818630|NCT01853228|459957213|FG001|Phase 1|Other|0|||
127818631|NCT01853228|459957212|FG000|Phase 2|Physician Decision|0|||
127818632|NCT01853228|459957213|FG001|Phase 2|Physician Decision|1|||
127818633|NCT01853228|459957212|FG000|Phase 2|Proceed To Transplant|0|||
127818634|NCT01853228|459957213|FG001|Phase 2|Proceed To Transplant|3|||
127818635|NCT01853228|459957212|FG000|Phase 2|Lack of Efficacy|0|||
127818636|NCT01853228|459957213|FG001|Phase 2|Lack of Efficacy|4|||
127818637|NCT03167619|459957214|FG000|Overall Study|Death|11|||
127818638|NCT03167619|459957215|FG001|Overall Study|Death|8|||
127818639|NCT03167619|459957214|FG000|Overall Study|Withdrawal by Subject|1|||
127818640|NCT03167619|459957215|FG001|Overall Study|Withdrawal by Subject|2|||
127818641|NCT03167619|459957214|FG000|Overall Study|Physician Decision|0|||
127818642|NCT03167619|459957215|FG001|Overall Study|Physician Decision|1|||
127818643|NCT01348919|459957217|FG000|Overall Study|Adverse Event|3|||
127818644|NCT01348919|459957218|FG001|Overall Study|Adverse Event|1|||
127818645|NCT01348919|459957219|FG002|Overall Study|Adverse Event|0|||
127818646|NCT01348919|459957217|FG000|Overall Study|Withdrawal by Subject|0|||
127818647|NCT01348919|459957218|FG001|Overall Study|Withdrawal by Subject|1|||
127818648|NCT01348919|459957219|FG002|Overall Study|Withdrawal by Subject|0|||
127818649|NCT01348919|459957217|FG000|Overall Study|Disease progression|0|||
127818650|NCT01348919|459957218|FG001|Overall Study|Disease progression|1|||
127818651|NCT01348919|459957219|FG002|Overall Study|Disease progression|1|||
127818652|NCT02089737|459957220|FG000|Overall Study|Survey form not completed|5|||
127818653|NCT02089737|459957220|FG000|Overall Study|Not treated|1|||
127818654|NCT02082184|459957222|FG000|Overall Study|Adverse Event|1|||
127818655|NCT02082184|459957223|FG001|Overall Study|Adverse Event|0|||
127818656|NCT02082184|459957222|FG000|Overall Study|Medical diagnosis|1|||
127818657|NCT02082184|459957223|FG001|Overall Study|Medical diagnosis|2|||
127818658|NCT02082184|459957222|FG000|Overall Study|Device associated symptoms|5|||
127818659|NCT02082184|459957223|FG001|Overall Study|Device associated symptoms|0|||
127818660|NCT02082184|459957222|FG000|Overall Study|Withdrawal by Subject|3|||
127818661|NCT02082184|459957223|FG001|Overall Study|Withdrawal by Subject|2|||
127818662|NCT02082184|459957222|FG000|Overall Study|Protocol Violation|0|||
127818663|NCT02082184|459957223|FG001|Overall Study|Protocol Violation|6|||
127818664|NCT02082184|459957222|FG000|Overall Study|Lost to Follow-up|0|||
127818665|NCT02082184|459957223|FG001|Overall Study|Lost to Follow-up|2|||
127818666|NCT02082184|459957222|FG000|Overall Study|Subject non-compliance|0|||
127818667|NCT02082184|459957223|FG001|Overall Study|Subject non-compliance|1|||
127818668|NCT02413398|459957234|FG000|Overall Study|Lost to Follow-up|2|||
127818669|NCT02413398|459957235|FG001|Overall Study|Lost to Follow-up|4|||
127818670|NCT02413398|459957234|FG000|Overall Study|Withdrawal by Subject|1|||
127818671|NCT02413398|459957235|FG001|Overall Study|Withdrawal by Subject|1|||
127818672|NCT02413398|459957234|FG000|Overall Study|Other Eligibility criteria|1|||
127818673|NCT02413398|459957235|FG001|Overall Study|Other Eligibility criteria|2|||
127818674|NCT02874794|459957238|FG000|Overall Study|Physician Decision|3|||
127818675|NCT02874794|459957239|FG001|Overall Study|Physician Decision|2|||
127818676|NCT02874794|459957238|FG000|Overall Study|Withdrawal by Subject|2|||
127818677|NCT02874794|459957239|FG001|Overall Study|Withdrawal by Subject|8|||
127818678|NCT02874794|459957238|FG000|Overall Study|Death|2|||
127818679|NCT02874794|459957239|FG001|Overall Study|Death|1|||
127818680|NCT00537940|459957240|FG000|Overall Study|Adverse Event|20|||
127818681|NCT00537940|459957241|FG001|Overall Study|Adverse Event|19|||
127818682|NCT00537940|459957240|FG000|Overall Study|Lack of Efficacy|8|||
127818683|NCT00537940|459957241|FG001|Overall Study|Lack of Efficacy|16|||
127818684|NCT00537940|459957240|FG000|Overall Study|Lost to Follow-up|23|||
127818685|NCT00537940|459957241|FG001|Overall Study|Lost to Follow-up|29|||
127818686|NCT00537940|459957240|FG000|Overall Study|Withdrawal by Subject|113|||
127818687|NCT00537940|459957241|FG001|Overall Study|Withdrawal by Subject|95|||
127818688|NCT00537940|459957240|FG000|Overall Study|Protocol Violation|6|||
127818689|NCT00537940|459957241|FG001|Overall Study|Protocol Violation|4|||
127818690|NCT00537940|459957240|FG000|Overall Study|Pregnancy|1|||
127818691|NCT00537940|459957241|FG001|Overall Study|Pregnancy|1|||
127818692|NCT00537940|459957240|FG000|Overall Study|Study terminated by sponsor|2|||
127818693|NCT00537940|459957241|FG001|Overall Study|Study terminated by sponsor|3|||
127818694|NCT00537940|459957240|FG000|Overall Study|Other|10|||
127818695|NCT00537940|459957241|FG001|Overall Study|Other|12|||
127818696|NCT01062399|459957242|FG000|Overall Study|Protocol Violation|0|||
127818697|NCT01062399|459957243|FG001|Overall Study|Protocol Violation|1|||
127818698|NCT01062399|459957244|FG002|Overall Study|Protocol Violation|0|||
127818699|NCT01062399|459957245|FG003|Overall Study|Protocol Violation|6|||
127818700|NCT01062399|459957246|FG004|Overall Study|Protocol Violation|4|||
127818701|NCT00634543|459957248|FG000|Overall Study|Other|1|||
127818702|NCT00634543|459957249|FG001|Overall Study|Other|2|||
127818703|NCT00634543|459957248|FG000|Overall Study|Protocol Violation|3|||
127818704|NCT00634543|459957249|FG001|Overall Study|Protocol Violation|3|||
127818705|NCT00634543|459957248|FG000|Overall Study|Adverse Event|11|||
127818706|NCT00634543|459957249|FG001|Overall Study|Adverse Event|11|||
127818707|NCT00634543|459957248|FG000|Overall Study|Withdrawal by Subject|4|||
127818708|NCT00634543|459957249|FG001|Overall Study|Withdrawal by Subject|4|||
127818709|NCT00634543|459957248|FG000|Overall Study|Lost to Follow-up|0|||
127818710|NCT00634543|459957249|FG001|Overall Study|Lost to Follow-up|1|||
127818711|NCT02465034|459957252|FG000|Overall Study|Withdrawal by Subject|1|||
127818712|NCT02465034|459957253|FG001|Overall Study|Withdrawal by Subject|1|||
127818713|NCT02465034|459957252|FG000|Overall Study|Screen fail|2|||
127818714|NCT02465034|459957253|FG001|Overall Study|Screen fail|0|||
127818715|NCT02465034|459957252|FG000|Overall Study|Could not be scheduled for study visit|0|||
127818716|NCT02465034|459957253|FG001|Overall Study|Could not be scheduled for study visit|5|||
127818717|NCT05299892|459957254|FG000|Overall Study|Withdrawal by Subject|2|||
127818718|NCT02397655|459957255|FG000|Overall Study|data not completed|1301|||
127818719|NCT01736683|459957256|FG000|Overall Study|Disease Relapse|0|||
127818720|NCT01736683|459957257|FG001|Overall Study|Disease Relapse|0|||
127818721|NCT01736683|459957258|FG002|Overall Study|Disease Relapse|2|||
127818722|NCT01736683|459957259|FG003|Overall Study|Disease Relapse|1|||
127818723|NCT01736683|459957260|FG004|Overall Study|Disease Relapse|0|||
127818724|NCT01736683|459957256|FG000|Overall Study|Adverse Event|0|||
127818725|NCT01736683|459957257|FG001|Overall Study|Adverse Event|2|||
127818726|NCT01736683|459957258|FG002|Overall Study|Adverse Event|2|||
127818727|NCT01736683|459957259|FG003|Overall Study|Adverse Event|3|||
127818728|NCT01736683|459957260|FG004|Overall Study|Adverse Event|2|||
127818729|NCT01736683|459957256|FG000|Overall Study|Withdrawal by Subject|0|||
127818730|NCT01736683|459957257|FG001|Overall Study|Withdrawal by Subject|0|||
127818731|NCT01736683|459957258|FG002|Overall Study|Withdrawal by Subject|3|||
127818732|NCT01736683|459957259|FG003|Overall Study|Withdrawal by Subject|1|||
127818733|NCT01736683|459957260|FG004|Overall Study|Withdrawal by Subject|1|||
127818734|NCT01736683|459957256|FG000|Overall Study|Lack of Therapeutic Effect|7|||
127818735|NCT01736683|459957257|FG001|Overall Study|Lack of Therapeutic Effect|4|||
127818736|NCT01736683|459957258|FG002|Overall Study|Lack of Therapeutic Effect|13|||
127818737|NCT01736683|459957259|FG003|Overall Study|Lack of Therapeutic Effect|20|||
127818738|NCT01736683|459957260|FG004|Overall Study|Lack of Therapeutic Effect|1|||
127818739|NCT01736683|459957256|FG000|Overall Study|Progressive Disease|0|||
127818740|NCT01736683|459957257|FG001|Overall Study|Progressive Disease|0|||
127818741|NCT01736683|459957258|FG002|Overall Study|Progressive Disease|0|||
127818742|NCT01736683|459957259|FG003|Overall Study|Progressive Disease|1|||
127818743|NCT01736683|459957260|FG004|Overall Study|Progressive Disease|0|||
127818744|NCT01736683|459957256|FG000|Overall Study|Other|0|||
127818745|NCT01736683|459957257|FG001|Overall Study|Other|0|||
127818746|NCT01736683|459957258|FG002|Overall Study|Other|1|||
127818747|NCT01736683|459957259|FG003|Overall Study|Other|9|||
127818748|NCT01736683|459957260|FG004|Overall Study|Other|1|||
127818749|NCT01588197|459957261|FG000|Overall Study|Lack of Efficacy|0|||
127818750|NCT01588197|459957262|FG001|Overall Study|Lack of Efficacy|1|||
127818751|NCT01588197|459957261|FG000|Overall Study|No MRI|1|||
127818752|NCT01588197|459957262|FG001|Overall Study|No MRI|0|||
127818753|NCT01844076|459957265|FG000|Overall Study|Adverse Event|1|||
127818754|NCT01844076|459957266|FG001|Overall Study|Adverse Event|0|||
127818755|NCT01844076|459957267|FG002|Overall Study|Adverse Event|0|||
127818756|NCT01844076|459957268|FG003|Overall Study|Adverse Event|0|||
127818757|NCT01844076|459957265|FG000|Overall Study|Withdrawal by Subject|1|||
127818758|NCT01844076|459957266|FG001|Overall Study|Withdrawal by Subject|0|||
127818759|NCT01844076|459957267|FG002|Overall Study|Withdrawal by Subject|0|||
127818760|NCT01844076|459957268|FG003|Overall Study|Withdrawal by Subject|0|||
127818761|NCT01937312|459957271|FG000|Overall Study|Adverse Event|10|||
127818762|NCT01937312|459957272|FG001|Overall Study|Adverse Event|1|||
127818763|NCT01937312|459957271|FG000|Overall Study|Lack of Efficacy|0|||
127818764|NCT01937312|459957272|FG001|Overall Study|Lack of Efficacy|1|||
127818765|NCT01937312|459957271|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
127818766|NCT01937312|459957272|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
127818767|NCT00474253|459957273|FG000|Overall Study|Withdrew consent|2|||
127818768|NCT00474253|459957274|FG001|Overall Study|Withdrew consent|0|||
127818769|NCT00474253|459957273|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
127818770|NCT00474253|459957274|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
127818771|NCT00474253|459957273|FG000|Overall Study|Lost to Follow-up|1|||
127818772|NCT00474253|459957274|FG001|Overall Study|Lost to Follow-up|0|||
127818773|NCT00474253|459957273|FG000|Overall Study|Discharged prior to study completion|0|||
127818774|NCT00474253|459957274|FG001|Overall Study|Discharged prior to study completion|1|||
127818775|NCT00593112|459957279|FG000|Overall Study|Scan Anxiety|3|||
127894591|NCT01166568|460237191|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
127818776|NCT00593112|459957280|FG001|Overall Study|Scan Anxiety|0|||
127818777|NCT00593112|459957279|FG000|Overall Study|Abnormal Scan|1|||
127818778|NCT00593112|459957280|FG001|Overall Study|Abnormal Scan|0|||
127894592|NCT01166568|460237192|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
127818779|NCT00593112|459957279|FG000|Overall Study|Unreadable Scan|1|||
127818780|NCT00593112|459957280|FG001|Overall Study|Unreadable Scan|0|||
127818781|NCT00593112|459957279|FG000|Overall Study|Withdrawal by Subject|5|||
127818782|NCT00593112|459957280|FG001|Overall Study|Withdrawal by Subject|0|||
127818783|NCT00482001|459957281|FG000|Overall Study|Protocol Violation|1|||
127818784|NCT00482001|459957282|FG001|Overall Study|Protocol Violation|1|||
127818785|NCT00258154|459957283|FG000|Overall Study|Adverse Event|1|||
127818786|NCT00258154|459957284|FG001|Overall Study|Adverse Event|0|||
127818787|NCT00258154|459957283|FG000|Overall Study|Lost to Follow-up|0|||
127818788|NCT00258154|459957284|FG001|Overall Study|Lost to Follow-up|1|||
127818789|NCT00258154|459957283|FG000|Overall Study|Protocol Violation|2|||
127818790|NCT00258154|459957284|FG001|Overall Study|Protocol Violation|1|||
127818791|NCT00258154|459957283|FG000|Overall Study|Withdrawal by Subject|3|||
127818792|NCT00258154|459957284|FG001|Overall Study|Withdrawal by Subject|4|||
127818793|NCT00258154|459957283|FG000|Overall Study|Patient Moved|3|||
127818794|NCT00258154|459957284|FG001|Overall Study|Patient Moved|1|||
127818795|NCT00847613|459957289|FG000|Overall Study|Ongoing at cut-off date|250|||
127818796|NCT00847613|459957290|FG001|Overall Study|Ongoing at cut-off date|265|||
127818797|NCT00847613|459957291|FG002|Overall Study|Ongoing at cut-off date|64|||
127818798|NCT00847613|459957292|FG003|Overall Study|Ongoing at cut-off date|64|||
127818799|NCT00847613|459957289|FG000|Overall Study|Death|1|||
127818800|NCT00847613|459957290|FG001|Overall Study|Death|1|||
127818801|NCT00847613|459957291|FG002|Overall Study|Death|0|||
127818802|NCT00847613|459957292|FG003|Overall Study|Death|0|||
127818803|NCT00847613|459957289|FG000|Overall Study|Adverse Event|36|||
127818804|NCT00847613|459957290|FG001|Overall Study|Adverse Event|26|||
127818805|NCT00847613|459957291|FG002|Overall Study|Adverse Event|5|||
127818806|NCT00847613|459957292|FG003|Overall Study|Adverse Event|6|||
127818807|NCT00847613|459957289|FG000|Overall Study|Lack of Efficacy|7|||
127818808|NCT00847613|459957290|FG001|Overall Study|Lack of Efficacy|3|||
127818809|NCT00847613|459957291|FG002|Overall Study|Lack of Efficacy|3|||
127818810|NCT00847613|459957292|FG003|Overall Study|Lack of Efficacy|1|||
127818811|NCT00847613|459957289|FG000|Overall Study|Study terminated by Sponsor|1|||
127818812|NCT00847613|459957290|FG001|Overall Study|Study terminated by Sponsor|0|||
127818813|NCT00847613|459957291|FG002|Overall Study|Study terminated by Sponsor|2|||
127818814|NCT00847613|459957292|FG003|Overall Study|Study terminated by Sponsor|1|||
127818815|NCT00847613|459957289|FG000|Overall Study|Lost to Follow-up|5|||
127818816|NCT00847613|459957290|FG001|Overall Study|Lost to Follow-up|0|||
127818817|NCT00847613|459957291|FG002|Overall Study|Lost to Follow-up|0|||
127818818|NCT00847613|459957292|FG003|Overall Study|Lost to Follow-up|3|||
127818819|NCT00847613|459957289|FG000|Overall Study|Protocol Violation|6|||
127818820|NCT00847613|459957290|FG001|Overall Study|Protocol Violation|6|||
127818821|NCT00847613|459957291|FG002|Overall Study|Protocol Violation|3|||
127818822|NCT00847613|459957292|FG003|Overall Study|Protocol Violation|1|||
127818823|NCT00847613|459957289|FG000|Overall Study|Pregnancy|1|||
127818824|NCT00847613|459957290|FG001|Overall Study|Pregnancy|1|||
127818825|NCT00847613|459957291|FG002|Overall Study|Pregnancy|0|||
127818826|NCT00847613|459957292|FG003|Overall Study|Pregnancy|0|||
127818827|NCT00847613|459957289|FG000|Overall Study|Site closure|1|||
127818828|NCT00847613|459957290|FG001|Overall Study|Site closure|0|||
127818829|NCT00847613|459957291|FG002|Overall Study|Site closure|0|||
127818830|NCT00847613|459957292|FG003|Overall Study|Site closure|1|||
127818831|NCT00847613|459957289|FG000|Overall Study|Withdrawal by Subject|8|||
127818832|NCT00847613|459957290|FG001|Overall Study|Withdrawal by Subject|11|||
127818833|NCT00847613|459957291|FG002|Overall Study|Withdrawal by Subject|2|||
127818834|NCT00847613|459957292|FG003|Overall Study|Withdrawal by Subject|2|||
127818835|NCT00847613|459957289|FG000|Overall Study|Participant moved|4|||
127818836|NCT00847613|459957290|FG001|Overall Study|Participant moved|1|||
127818837|NCT00847613|459957291|FG002|Overall Study|Participant moved|0|||
127818838|NCT00847613|459957292|FG003|Overall Study|Participant moved|0|||
127818839|NCT00847613|459957289|FG000|Overall Study|Sponsor request|0|||
127818840|NCT00847613|459957290|FG001|Overall Study|Sponsor request|1|||
127818841|NCT00847613|459957291|FG002|Overall Study|Sponsor request|0|||
127818842|NCT00847613|459957292|FG003|Overall Study|Sponsor request|0|||
127818843|NCT00847613|459957289|FG000|Overall Study|Randomized, but not treated|0|||
127818844|NCT00847613|459957290|FG001|Overall Study|Randomized, but not treated|3|||
127818845|NCT00847613|459957291|FG002|Overall Study|Randomized, but not treated|0|||
127894593|NCT01166568|460237193|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
127894594|NCT01654380|460237194|FG000|Part B, Period 1|Physician Decision|0|||
127894595|NCT01654380|460237195|FG001|Part B, Period 1|Physician Decision|0|||
127894596|NCT01654380|460237196|FG002|Part B, Period 1|Physician Decision|1|||
127894597|NCT01654380|460237197|FG003|Part B, Period 1|Physician Decision|0|||
127818846|NCT00847613|459957292|FG003|Overall Study|Randomized, but not treated|0|||
127818847|NCT00847613|459957289|FG000|Overall Study|Other|1|||
127818848|NCT00847613|459957290|FG001|Overall Study|Other|1|||
127818849|NCT00847613|459957291|FG002|Overall Study|Other|2|||
127818850|NCT00847613|459957292|FG003|Overall Study|Other|0|||
127818851|NCT00754390|459957293|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
127818852|NCT00754390|459957293|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
127818853|NCT00754390|459957293|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
127818854|NCT00754390|459957293|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
127818855|NCT01009294|459957294|FG000|Overall Study|Study discontinued by Sponsor|6|||
127818856|NCT01856673|459957295|FG000|Overall Study|Withdrawal by Subject|44|||
127818857|NCT01856673|459957296|FG001|Overall Study|Withdrawal by Subject|50|||
127818858|NCT01856673|459957297|FG002|Overall Study|Withdrawal by Subject|33|||
127818859|NCT01856673|459957295|FG000|Overall Study|Lost to Follow-up|31|||
127818860|NCT01856673|459957296|FG001|Overall Study|Lost to Follow-up|34|||
127818861|NCT01856673|459957297|FG002|Overall Study|Lost to Follow-up|0|||
127818862|NCT01856673|459957295|FG000|Overall Study|Unknown reasons|9|||
127818863|NCT01856673|459957296|FG001|Overall Study|Unknown reasons|0|||
127818864|NCT01856673|459957297|FG002|Overall Study|Unknown reasons|0|||
127818865|NCT01856673|459957295|FG000|Overall Study|Psychologist decision|1|||
127818866|NCT01856673|459957296|FG001|Overall Study|Psychologist decision|0|||
127818867|NCT01856673|459957297|FG002|Overall Study|Psychologist decision|0|||
127818868|NCT01856673|459957295|FG000|Overall Study|Paperwork errors|8|||
127818869|NCT01856673|459957296|FG001|Overall Study|Paperwork errors|0|||
127818870|NCT01856673|459957297|FG002|Overall Study|Paperwork errors|0|||
127818871|NCT01856673|459957295|FG000|Overall Study|Death|1|||
127818872|NCT01856673|459957296|FG001|Overall Study|Death|1|||
127818873|NCT01856673|459957297|FG002|Overall Study|Death|0|||
127818874|NCT01856673|459957295|FG000|Overall Study|Protocol Violation|1|||
127818875|NCT01856673|459957296|FG001|Overall Study|Protocol Violation|0|||
127818876|NCT01856673|459957297|FG002|Overall Study|Protocol Violation|1|||
127818877|NCT04332419|459957298|FG000|Overall Study|Withdrawal by Subject|1|||
127818878|NCT02436239|459957299|FG000|Open-Lable Treatment Period|Adverse Event|12|||
127818879|NCT02436239|459957300|FG001|Open-Lable Treatment Period|Adverse Event|3|||
127818880|NCT02436239|459957301|FG002|Open-Lable Treatment Period|Adverse Event|4|||
127818881|NCT02436239|459957302|FG003|Open-Lable Treatment Period|Adverse Event|2|||
127818882|NCT02436239|459957299|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
127818883|NCT02436239|459957300|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
127818884|NCT02436239|459957301|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
127818885|NCT02436239|459957302|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
127818886|NCT02436239|459957299|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
127818887|NCT02436239|459957300|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
127818888|NCT02436239|459957301|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
127818889|NCT02436239|459957302|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
127818890|NCT02436239|459957299|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
127818891|NCT02436239|459957300|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
127818892|NCT02436239|459957301|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
127818893|NCT02436239|459957302|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
127818894|NCT02436239|459957299|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
127818895|NCT02436239|459957300|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
127818896|NCT02436239|459957301|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
127818897|NCT02436239|459957302|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
127818898|NCT02436239|459957299|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
127818899|NCT02436239|459957300|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
127818900|NCT02436239|459957301|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
127818901|NCT02436239|459957302|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
127818902|NCT02436239|459957299|FG000|Open-Lable Treatment Period|Other Reason|1|||
127818903|NCT02436239|459957300|FG001|Open-Lable Treatment Period|Other Reason|1|||
127818904|NCT02436239|459957301|FG002|Open-Lable Treatment Period|Other Reason|0|||
127818905|NCT02436239|459957302|FG003|Open-Lable Treatment Period|Other Reason|0|||
127818906|NCT02436239|459957299|FG000|Down-Taper Period|Withdrawal by Subject|4|||
127818907|NCT02436239|459957300|FG001|Down-Taper Period|Withdrawal by Subject|4|||
127818908|NCT02436239|459957301|FG002|Down-Taper Period|Withdrawal by Subject|1|||
127818909|NCT02436239|459957302|FG003|Down-Taper Period|Withdrawal by Subject|2|||
127818910|NCT04925570|459957303|FG000|Overall Study|Protocol Violation|24|||
127818911|NCT04925570|459957304|FG001|Overall Study|Protocol Violation|30|||
127818912|NCT04925570|459957303|FG000|Overall Study|Withdrawal by Subject|0|||
127818913|NCT04925570|459957304|FG001|Overall Study|Withdrawal by Subject|2|||
127818914|NCT00658333|459957305|FG000|Overall Study|Adverse Event|2|||
127818915|NCT00658333|459957306|FG001|Overall Study|Adverse Event|1|||
127818916|NCT00519532|459957309|FG000|Overall Study|Adverse Event|11|||
127818917|NCT00519532|459957309|FG000|Overall Study|Withdrawal by Subject|5|||
127818918|NCT00519532|459957309|FG000|Overall Study|Lost to Follow-up|2|||
127818919|NCT00624338|459957310|FG000|Overall Study|Adverse Event|14|||
127818920|NCT00624338|459957311|FG001|Overall Study|Adverse Event|14|||
127818921|NCT00624338|459957312|FG002|Overall Study|Adverse Event|18|||
127818922|NCT00624338|459957310|FG000|Overall Study|Lost to Follow-up|1|||
127818923|NCT00624338|459957311|FG001|Overall Study|Lost to Follow-up|0|||
127818924|NCT00624338|459957312|FG002|Overall Study|Lost to Follow-up|0|||
127818925|NCT00624338|459957310|FG000|Overall Study|Lack of Efficacy|11|||
127818926|NCT00624338|459957311|FG001|Overall Study|Lack of Efficacy|3|||
127818927|NCT00624338|459957312|FG002|Overall Study|Lack of Efficacy|14|||
127818928|NCT00624338|459957310|FG000|Overall Study|Protocol Violation|3|||
127818929|NCT00624338|459957311|FG001|Overall Study|Protocol Violation|3|||
127818930|NCT00624338|459957312|FG002|Overall Study|Protocol Violation|2|||
127818931|NCT00624338|459957310|FG000|Overall Study|Death|0|||
127818932|NCT00624338|459957311|FG001|Overall Study|Death|2|||
127818933|NCT00624338|459957312|FG002|Overall Study|Death|0|||
127894598|NCT00684671|460237198|FG000|Overall Study|Adverse Event|1|||
127818934|NCT00624338|459957310|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
127818935|NCT00624338|459957311|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
127818936|NCT00624338|459957312|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
127818937|NCT00624338|459957310|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
127818938|NCT00624338|459957311|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
127818939|NCT00624338|459957312|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
127818940|NCT00624338|459957310|FG000|Overall Study|Other|15|||
127818941|NCT00624338|459957311|FG001|Overall Study|Other|5|||
127818942|NCT00624338|459957312|FG002|Overall Study|Other|9|||
127818943|NCT00624338|459957310|FG000|Overall Study|Randomized but not treated|2|||
127818944|NCT00624338|459957311|FG001|Overall Study|Randomized but not treated|1|||
127818945|NCT00624338|459957312|FG002|Overall Study|Randomized but not treated|3|||
127818946|NCT01548638|459957313|FG000|Overall Study|Protocol Violation|3|||
127818947|NCT01548638|459957313|FG000|Overall Study|Withdrawal by Subject|1|||
127818948|NCT02609399|459957314|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
127818949|NCT02609399|459957315|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
127818950|NCT02609399|459957314|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
127818951|NCT02609399|459957315|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
127818952|NCT02609399|459957314|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
127818953|NCT02609399|459957315|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
127818954|NCT02190591|459957319|FG000|Overall Study|Withdrawal by Subject|1|||
127818955|NCT02190591|459957320|FG001|Overall Study|Withdrawal by Subject|8|||
127818956|NCT02190591|459957319|FG000|Overall Study|Protocol Violation|1|||
127818957|NCT02190591|459957320|FG001|Overall Study|Protocol Violation|0|||
127818958|NCT02190591|459957319|FG000|Overall Study|did not use peanut ball as instructed|0|||
127818959|NCT02190591|459957320|FG001|Overall Study|did not use peanut ball as instructed|2|||
127818960|NCT02190591|459957319|FG000|Overall Study|face presentation so she was ineligible|0|||
127818961|NCT02190591|459957320|FG001|Overall Study|face presentation so she was ineligible|1|||
127818962|NCT03598777|459957321|FG000|Overall Study|Study Terminated by Sponsor|3|||
127818963|NCT03598777|459957322|FG001|Overall Study|Study Terminated by Sponsor|0|||
127818964|NCT03598777|459957323|FG002|Overall Study|Study Terminated by Sponsor|0|||
127818965|NCT03598777|459957324|FG003|Overall Study|Study Terminated by Sponsor|0|||
127818966|NCT03598777|459957325|FG004|Overall Study|Study Terminated by Sponsor|15|||
127818967|NCT03598777|459957321|FG000|Overall Study|Withdrawal by Subject|1|||
127818968|NCT03598777|459957322|FG001|Overall Study|Withdrawal by Subject|1|||
127818969|NCT03598777|459957323|FG002|Overall Study|Withdrawal by Subject|0|||
127818970|NCT03598777|459957324|FG003|Overall Study|Withdrawal by Subject|0|||
127818971|NCT03598777|459957325|FG004|Overall Study|Withdrawal by Subject|0|||
127818972|NCT03598777|459957321|FG000|Overall Study|Adverse Event|1|||
127818973|NCT03598777|459957322|FG001|Overall Study|Adverse Event|0|||
127818974|NCT03598777|459957323|FG002|Overall Study|Adverse Event|0|||
127818975|NCT03598777|459957324|FG003|Overall Study|Adverse Event|0|||
127818976|NCT03598777|459957325|FG004|Overall Study|Adverse Event|0|||
127818977|NCT03598777|459957321|FG000|Overall Study|Lost to Follow-up|1|||
127818978|NCT03598777|459957322|FG001|Overall Study|Lost to Follow-up|0|||
127818979|NCT03598777|459957323|FG002|Overall Study|Lost to Follow-up|0|||
127818980|NCT03598777|459957324|FG003|Overall Study|Lost to Follow-up|0|||
127818981|NCT03598777|459957325|FG004|Overall Study|Lost to Follow-up|0|||
127818982|NCT00072189|459957326|FG000|Overall Study|Withdrawal by Subject|1|||
127818983|NCT00144300|459957327|FG000|Overall Study|Adverse Event|18|||
127818984|NCT00144300|459957328|FG001|Overall Study|Adverse Event|16|||
127818985|NCT00144300|459957327|FG000|Overall Study|Protocol Violation|1|||
127818986|NCT00144300|459957328|FG001|Overall Study|Protocol Violation|3|||
127818987|NCT00144300|459957327|FG000|Overall Study|Lost to Follow-up|3|||
127818988|NCT00144300|459957328|FG001|Overall Study|Lost to Follow-up|0|||
127818989|NCT00144300|459957327|FG000|Overall Study|Withdrawal by Subject|6|||
127818990|NCT00144300|459957328|FG001|Overall Study|Withdrawal by Subject|6|||
127818991|NCT00144300|459957327|FG000|Overall Study|Other reason (not specified)|1|||
127818992|NCT00144300|459957328|FG001|Overall Study|Other reason (not specified)|3|||
127818993|NCT01933672|459957329|FG000|Metformin Run-in Period|Adverse Event|1|||
127818994|NCT01933672|459957330|FG001|Metformin Run-in Period|Adverse Event|0|||
127818995|NCT01933672|459957331|FG002|Metformin Run-in Period|Adverse Event|0|||
127818996|NCT01933672|459957332|FG003|Metformin Run-in Period|Adverse Event|0|||
127818997|NCT01933672|459957333|FG004|Metformin Run-in Period|Adverse Event|0|||
127818998|NCT01933672|459957334|FG005|Metformin Run-in Period|Adverse Event|0|||
127818999|NCT01933672|459957335|FG006|Metformin Run-in Period|Adverse Event|0|||
127819000|NCT01933672|459957329|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
127819001|NCT01933672|459957330|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
127819002|NCT01933672|459957331|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
127819003|NCT01933672|459957332|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
127819004|NCT01933672|459957333|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
127819005|NCT01933672|459957334|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
127819006|NCT01933672|459957335|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
127819007|NCT01933672|459957329|FG000|Metformin Run-in Period|Other|5|||
127819008|NCT01933672|459957330|FG001|Metformin Run-in Period|Other|0|||
127819009|NCT01933672|459957331|FG002|Metformin Run-in Period|Other|0|||
127819010|NCT01933672|459957332|FG003|Metformin Run-in Period|Other|0|||
127819011|NCT01933672|459957333|FG004|Metformin Run-in Period|Other|0|||
127819012|NCT01933672|459957334|FG005|Metformin Run-in Period|Other|0|||
127819013|NCT01933672|459957335|FG006|Metformin Run-in Period|Other|0|||
127819014|NCT01933672|459957329|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
127819015|NCT01933672|459957330|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
127819016|NCT01933672|459957331|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
127819017|NCT01933672|459957332|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
127819018|NCT01933672|459957333|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
127819019|NCT01933672|459957334|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
127819020|NCT01933672|459957335|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
127819021|NCT01933672|459957329|FG000|First Intervention Period (12-16 Days)|Other|0|||
127819022|NCT01933672|459957330|FG001|First Intervention Period (12-16 Days)|Other|0|||
127819023|NCT01933672|459957331|FG002|First Intervention Period (12-16 Days)|Other|1|||
127819024|NCT01933672|459957332|FG003|First Intervention Period (12-16 Days)|Other|0|||
127819025|NCT01933672|459957333|FG004|First Intervention Period (12-16 Days)|Other|0|||
127819026|NCT01933672|459957334|FG005|First Intervention Period (12-16 Days)|Other|1|||
127819027|NCT01933672|459957335|FG006|First Intervention Period (12-16 Days)|Other|0|||
127819028|NCT01933672|459957329|FG000|Second Intervention Period (12-16 Days)|Other|0|||
127819029|NCT01933672|459957330|FG001|Second Intervention Period (12-16 Days)|Other|1|||
127819030|NCT01933672|459957331|FG002|Second Intervention Period (12-16 Days)|Other|1|||
127819031|NCT01933672|459957332|FG003|Second Intervention Period (12-16 Days)|Other|0|||
127819032|NCT01933672|459957333|FG004|Second Intervention Period (12-16 Days)|Other|0|||
127819033|NCT01933672|459957334|FG005|Second Intervention Period (12-16 Days)|Other|0|||
127819034|NCT01933672|459957335|FG006|Second Intervention Period (12-16 Days)|Other|0|||
127819035|NCT01933672|459957329|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
127819036|NCT01933672|459957330|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
127819037|NCT01933672|459957331|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
127819038|NCT01933672|459957332|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
127819039|NCT01933672|459957333|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
127819040|NCT01933672|459957334|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
127819041|NCT01933672|459957335|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
127819042|NCT01933672|459957329|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
127819043|NCT01933672|459957330|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
127819044|NCT01933672|459957331|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
127819045|NCT01933672|459957332|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
127819046|NCT01933672|459957333|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
127819047|NCT01933672|459957334|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
127819048|NCT01933672|459957335|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
127819049|NCT00778999|459957339|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
127819050|NCT00778999|459957340|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
127819051|NCT00778999|459957339|FG000|Overall Study|Did not receive recFSH|14|||
127819052|NCT00778999|459957340|FG001|Overall Study|Did not receive recFSH|20|||
127819053|NCT02032524|459957341|FG000|Period 1: TDR12857 Study|Adverse Event|1|||
127819054|NCT02032524|459957342|FG001|Period 1: TDR12857 Study|Adverse Event|0|||
127819055|NCT02032524|459957343|FG002|Period 1: TDR12857 Study|Adverse Event|0|||
127819056|NCT02032524|459957344|FG003|Period 1: TDR12857 Study|Adverse Event|0|||
127819057|NCT02032524|459957345|FG004|Period 1: TDR12857 Study|Adverse Event|0|||
127819058|NCT02032524|459957346|FG005|Period 1: TDR12857 Study|Adverse Event|0|||
127819059|NCT02032524|459957341|FG000|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
127819060|NCT02032524|459957342|FG001|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
127819061|NCT02032524|459957343|FG002|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
127819062|NCT02032524|459957344|FG003|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
127894599|NCT00684671|460237199|FG001|Overall Study|Adverse Event|0|||
127819063|NCT02032524|459957345|FG004|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
127819064|NCT02032524|459957346|FG005|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
127819065|NCT02032524|459957341|FG000|Period 2: LTS13769 Study|Adverse Event|0|||
127819066|NCT02032524|459957342|FG001|Period 2: LTS13769 Study|Adverse Event|0|||
127819067|NCT02032524|459957343|FG002|Period 2: LTS13769 Study|Adverse Event|1|||
127819068|NCT02032524|459957344|FG003|Period 2: LTS13769 Study|Adverse Event|0|||
127819069|NCT02032524|459957345|FG004|Period 2: LTS13769 Study|Adverse Event|0|||
127819070|NCT02032524|459957346|FG005|Period 2: LTS13769 Study|Adverse Event|0|||
127819071|NCT02032524|459957341|FG000|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
127819072|NCT02032524|459957342|FG001|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
127819073|NCT02032524|459957343|FG002|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
127819074|NCT02032524|459957344|FG003|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
127819075|NCT02032524|459957345|FG004|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
127819076|NCT02032524|459957346|FG005|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
127819077|NCT02032524|459957341|FG000|Period 2: LTS13769 Study|Other|0|||
127819078|NCT02032524|459957342|FG001|Period 2: LTS13769 Study|Other|0|||
127819079|NCT02032524|459957343|FG002|Period 2: LTS13769 Study|Other|0|||
127819080|NCT02032524|459957344|FG003|Period 2: LTS13769 Study|Other|0|||
127819081|NCT02032524|459957345|FG004|Period 2: LTS13769 Study|Other|0|||
127819082|NCT02032524|459957346|FG005|Period 2: LTS13769 Study|Other|1|||
127819083|NCT03567187|459957347|FG000|Overall Study|Lost to Follow-up|18|||
127819084|NCT02032875|459957350|FG000|Treatment Period|Adverse Event|1|||
127819085|NCT02032875|459957351|FG001|Treatment Period|Adverse Event|0|||
127819086|NCT02032875|459957350|FG000|Treatment Period|Liver transplant, No extension needed|0|||
127819087|NCT02032875|459957351|FG001|Treatment Period|Liver transplant, No extension needed|1|||
127819088|NCT02032875|459957350|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
127819089|NCT02032875|459957351|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
127819090|NCT02032875|459957350|FG000|Follow-up Period|Death|0|||
127819091|NCT02032875|459957351|FG001|Follow-up Period|Death|1|||
127819092|NCT02032875|459957350|FG000|Follow-up Period|Virologic Relapse|3|||
127819093|NCT02032875|459957351|FG001|Follow-up Period|Virologic Relapse|10|||
127819094|NCT04358458|459957352|FG000|Overall Study|Death|1|||
127819095|NCT04358458|459957353|FG001|Overall Study|Death|1|||
127819096|NCT04358458|459957354|FG002|Overall Study|Death|3|||
127819097|NCT04358458|459957355|FG003|Overall Study|Death|8|||
127819098|NCT04358458|459957356|FG004|Overall Study|Death|1|||
127819099|NCT04358458|459957357|FG005|Overall Study|Death|6|||
127819100|NCT04358458|459957358|FG006|Overall Study|Death|2|||
127819101|NCT04358458|459957359|FG007|Overall Study|Death|3|||
127819102|NCT04358458|459957352|FG000|Overall Study|Lost to Follow-up|0|||
127819103|NCT04358458|459957353|FG001|Overall Study|Lost to Follow-up|0|||
127819104|NCT04358458|459957354|FG002|Overall Study|Lost to Follow-up|0|||
127819105|NCT04358458|459957355|FG003|Overall Study|Lost to Follow-up|0|||
127819106|NCT04358458|459957356|FG004|Overall Study|Lost to Follow-up|0|||
127819107|NCT04358458|459957357|FG005|Overall Study|Lost to Follow-up|0|||
127819108|NCT04358458|459957358|FG006|Overall Study|Lost to Follow-up|0|||
127819109|NCT04358458|459957359|FG007|Overall Study|Lost to Follow-up|1|||
127819110|NCT04358458|459957352|FG000|Overall Study|Site is closing study participation|0|||
127819111|NCT04358458|459957353|FG001|Overall Study|Site is closing study participation|0|||
127819112|NCT04358458|459957354|FG002|Overall Study|Site is closing study participation|0|||
127819113|NCT04358458|459957355|FG003|Overall Study|Site is closing study participation|1|||
127819114|NCT04358458|459957356|FG004|Overall Study|Site is closing study participation|0|||
127819115|NCT04358458|459957357|FG005|Overall Study|Site is closing study participation|0|||
127819116|NCT04358458|459957358|FG006|Overall Study|Site is closing study participation|0|||
127819117|NCT04358458|459957359|FG007|Overall Study|Site is closing study participation|0|||
127819118|NCT04358458|459957352|FG000|Overall Study|Sponsor request|2|||
127819119|NCT04358458|459957353|FG001|Overall Study|Sponsor request|3|||
127819120|NCT04358458|459957354|FG002|Overall Study|Sponsor request|3|||
127819121|NCT04358458|459957355|FG003|Overall Study|Sponsor request|0|||
127819122|NCT04358458|459957356|FG004|Overall Study|Sponsor request|2|||
127819123|NCT04358458|459957357|FG005|Overall Study|Sponsor request|3|||
127819124|NCT04358458|459957358|FG006|Overall Study|Sponsor request|1|||
127819125|NCT04358458|459957359|FG007|Overall Study|Sponsor request|1|||
127819126|NCT04358458|459957352|FG000|Overall Study|Withdrawal by Subject|0|||
127819127|NCT04358458|459957353|FG001|Overall Study|Withdrawal by Subject|0|||
127819128|NCT04358458|459957354|FG002|Overall Study|Withdrawal by Subject|1|||
127819129|NCT04358458|459957355|FG003|Overall Study|Withdrawal by Subject|1|||
127819130|NCT04358458|459957356|FG004|Overall Study|Withdrawal by Subject|0|||
127819131|NCT04358458|459957357|FG005|Overall Study|Withdrawal by Subject|1|||
127819132|NCT04358458|459957358|FG006|Overall Study|Withdrawal by Subject|0|||
127819133|NCT04358458|459957359|FG007|Overall Study|Withdrawal by Subject|1|||
127819134|NCT02031146|459958640|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
127819135|NCT02031146|459958641|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
127819136|NCT02031146|459958642|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
127819137|NCT02031146|459958643|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
127819138|NCT02031146|459958644|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
127819139|NCT02031146|459958645|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
127819140|NCT02031146|459958646|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
127819141|NCT02114203|459958654|FG000|Overall Study|Adverse Event|0|||
127819142|NCT02114203|459958655|FG001|Overall Study|Adverse Event|1|||
127819143|NCT02114203|459958656|FG002|Overall Study|Adverse Event|0|||
127819144|NCT02114203|459958654|FG000|Overall Study|Withdrawal by Subject|0|||
127819145|NCT02114203|459958655|FG001|Overall Study|Withdrawal by Subject|1|||
127819146|NCT02114203|459958656|FG002|Overall Study|Withdrawal by Subject|0|||
127819147|NCT01518699|459958657|FG000|Period 2|Protocol Violation|1|||
127819148|NCT01518699|459958658|FG001|Period 2|Protocol Violation|1|||
127819149|NCT01518699|459958659|FG002|Period 2|Protocol Violation|0|||
127819150|NCT01518699|459958660|FG003|Period 2|Protocol Violation|0|||
127819151|NCT01518699|459958661|FG004|Period 2|Protocol Violation|0|||
127819152|NCT01518699|459958662|FG005|Period 2|Protocol Violation|0|||
127819153|NCT01518699|459958657|FG000|Period 2|Lost to Follow-up|0|||
127819154|NCT01518699|459958658|FG001|Period 2|Lost to Follow-up|1|||
127819155|NCT01518699|459958659|FG002|Period 2|Lost to Follow-up|0|||
127819156|NCT01518699|459958660|FG003|Period 2|Lost to Follow-up|0|||
127819157|NCT01518699|459958661|FG004|Period 2|Lost to Follow-up|0|||
127819158|NCT01518699|459958662|FG005|Period 2|Lost to Follow-up|0|||
127819159|NCT01518699|459958657|FG000|Period 2|Adverse Event|1|||
127819160|NCT01518699|459958658|FG001|Period 2|Adverse Event|0|||
127819161|NCT01518699|459958659|FG002|Period 2|Adverse Event|0|||
127819162|NCT01518699|459958660|FG003|Period 2|Adverse Event|0|||
127819163|NCT01518699|459958661|FG004|Period 2|Adverse Event|0|||
127819164|NCT01518699|459958662|FG005|Period 2|Adverse Event|0|||
127819165|NCT02839746|459958663|FG000|Overall Study|Not met selection criteria|12|||
127819166|NCT02767570|459958664|FG000|Overall Study|Lost to Follow-up|3|||
127819167|NCT02767570|459958665|FG001|Overall Study|Lost to Follow-up|0|||
127819168|NCT02767570|459958664|FG000|Overall Study|COVID shutdown|2|||
127819169|NCT02767570|459958665|FG001|Overall Study|COVID shutdown|5|||
127819170|NCT02767570|459958664|FG000|Overall Study|Increased pain|2|||
127819171|NCT02767570|459958665|FG001|Overall Study|Increased pain|0|||
127819172|NCT02767570|459958664|FG000|Overall Study|Withdrawal by Subject|1|||
127819173|NCT02767570|459958665|FG001|Overall Study|Withdrawal by Subject|3|||
127819174|NCT02767570|459958664|FG000|Overall Study|Unrelated medical issue|1|||
127819175|NCT02767570|459958665|FG001|Overall Study|Unrelated medical issue|1|||
127819176|NCT02767570|459958664|FG000|Overall Study|Received intra-articular injection|0|||
127819177|NCT02767570|459958665|FG001|Overall Study|Received intra-articular injection|1|||
127819178|NCT00151411|459958666|FG000|Overall Study|Lost to Follow-up|15|||
127819179|NCT00151411|459958667|FG001|Overall Study|Lost to Follow-up|19|||
127819180|NCT00151411|459958666|FG000|Overall Study|Withdrawal by Subject|12|||
127819181|NCT00151411|459958667|FG001|Overall Study|Withdrawal by Subject|20|||
127819182|NCT00151411|459958666|FG000|Overall Study|Adverse Event|6|||
127819183|NCT00151411|459958667|FG001|Overall Study|Adverse Event|0|||
127819184|NCT00151411|459958666|FG000|Overall Study|Pregnancy|0|||
127819185|NCT00151411|459958667|FG001|Overall Study|Pregnancy|4|||
127819186|NCT01712438|459958668|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
127819187|NCT01712438|459958668|FG000|Overall Study|Ongoing ITI treatment|6|||
127819188|NCT01712438|459958668|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
127819189|NCT01712438|459958668|FG000|Overall Study|Prematurely Discontinued|25|||
127819190|NCT04426630|459958669|FG000|Overall Study|Death|4|||
127819191|NCT04426630|459958669|FG000|Overall Study|Lost to Follow-up|2|||
127819192|NCT01157169|459958672|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
127819193|NCT01157169|459958673|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
127819194|NCT01157169|459958672|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
127819195|NCT01157169|459958673|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
127819196|NCT01123889|459958674|FG000|Overall Study|Lost to Follow-up|3|||
127819197|NCT01123889|459958675|FG001|Overall Study|Lost to Follow-up|1|||
127819198|NCT03846947|459958680|FG000|Overall Study|technical issues with imaging sequence|2|||
127819199|NCT01362322|459958683|FG000|Overall Study|Withdrawal by Subject|3|||
127819200|NCT01362322|459958684|FG001|Overall Study|Withdrawal by Subject|1|||
127819201|NCT01362322|459958683|FG000|Overall Study|Lost to Follow-up|2|||
127819202|NCT01362322|459958684|FG001|Overall Study|Lost to Follow-up|6|||
127819203|NCT03334214|459958690|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
127819204|NCT03334214|459958691|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
127819205|NCT03334214|459958690|FG000|Overall Study|Withdrawal by Subject|0|||
127819206|NCT03334214|459958691|FG001|Overall Study|Withdrawal by Subject|1|||
127819207|NCT03334214|459958690|FG000|Overall Study|Other|1|||
127819208|NCT03334214|459958691|FG001|Overall Study|Other|0|||
127819209|NCT01260181|459958694|FG000|Overall Study|Decision of Investigator|1|||
127819210|NCT01025336|459958700|FG000|Overall Study|Protocol Violation|0|||
127819211|NCT01025336|459958701|FG001|Overall Study|Protocol Violation|0|||
127819212|NCT01025336|459958702|FG002|Overall Study|Protocol Violation|0|||
127819213|NCT01025336|459958703|FG003|Overall Study|Protocol Violation|2|||
127819214|NCT01025336|459958704|FG004|Overall Study|Protocol Violation|0|||
127819215|NCT03133481|459958705|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
127819216|NCT03133481|459958706|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
127819217|NCT00637728|459958713|FG000|Double-blind Phase|Adverse Event|1|||
127819218|NCT00637728|459958714|FG001|Double-blind Phase|Adverse Event|0|||
127819219|NCT00637728|459958715|FG002|Double-blind Phase|Adverse Event|0|||
127819220|NCT00637728|459958713|FG000|Double-blind Phase|Non-compliance|2|||
127819221|NCT00637728|459958714|FG001|Double-blind Phase|Non-compliance|0|||
127819222|NCT00637728|459958715|FG002|Double-blind Phase|Non-compliance|0|||
127819223|NCT00637728|459958713|FG000|Double-blind Phase|Study Discontinued|1|||
127819224|NCT00637728|459958714|FG001|Double-blind Phase|Study Discontinued|1|||
127819225|NCT00637728|459958715|FG002|Double-blind Phase|Study Discontinued|0|||
127819226|NCT02723630|459958718|FG000|Intervention Period 1|Adverse Event|1|||
127819227|NCT02723630|459958719|FG001|Intervention Period 1|Adverse Event|0|||
127819228|NCT02723630|459958720|FG002|Intervention Period 1|Adverse Event|0|||
127819229|NCT02723630|459958721|FG003|Intervention Period 1|Adverse Event|0|||
127819230|NCT02723630|459958722|FG004|Intervention Period 1|Adverse Event|0|||
127819231|NCT02723630|459958723|FG005|Intervention Period 1|Adverse Event|0|||
127819232|NCT02723630|459958718|FG000|Intervention Period 3|consumption of restricted item|0|||
127819233|NCT02723630|459958719|FG001|Intervention Period 3|consumption of restricted item|1|||
127819234|NCT02723630|459958720|FG002|Intervention Period 3|consumption of restricted item|0|||
127819235|NCT02723630|459958721|FG003|Intervention Period 3|consumption of restricted item|0|||
127819236|NCT02723630|459958722|FG004|Intervention Period 3|consumption of restricted item|0|||
127819237|NCT02723630|459958723|FG005|Intervention Period 3|consumption of restricted item|0|||
127819238|NCT01184989|459958724|FG000|Overall Study|Adverse Event|11|||
127819239|NCT01184989|459958724|FG000|Overall Study|Withdrawal by Subject|1|||
127819240|NCT01570491|459958725|FG000|Overall Study|Lost to Follow-up|3|||
127819241|NCT01570491|459958726|FG001|Overall Study|Lost to Follow-up|1|||
127819242|NCT01570491|459958725|FG000|Overall Study|treatment: not given or discontinued|2|||
127819243|NCT01570491|459958726|FG001|Overall Study|treatment: not given or discontinued|0|||
127819244|NCT03047213|459958727|FG000|Overall Study|Withdrawal by Subject|2|||
127819245|NCT03047213|459958728|FG001|Overall Study|Withdrawal by Subject|0|||
127819246|NCT03047213|459958727|FG000|Overall Study|Adverse Event|2|||
127819247|NCT03047213|459958728|FG001|Overall Study|Adverse Event|0|||
127819248|NCT04407507|459958731|FG000|Overall Study|Withdrawal by Subject|0|||
127819249|NCT04407507|459958732|FG001|Overall Study|Withdrawal by Subject|1|||
127819250|NCT03633331|459958733|FG000|Overall Study|Withdrawal by Subject|1|||
127819251|NCT04222725|459958738|FG000|Overall Study|Adverse Event|0|||
127819252|NCT04222725|459958739|FG001|Overall Study|Adverse Event|1|||
127819253|NCT04222725|459958740|FG002|Overall Study|Adverse Event|0|||
127819254|NCT04222725|459958741|FG003|Overall Study|Adverse Event|0|||
127819255|NCT03443024|459958744|FG000|Overall Study|Adverse Event|2|||
127819256|NCT03443024|459958745|FG001|Overall Study|Adverse Event|4|||
127819257|NCT03443024|459958746|FG002|Overall Study|Adverse Event|3|||
127819258|NCT03443024|459958747|FG003|Overall Study|Adverse Event|1|||
127819259|NCT03443024|459958744|FG000|Overall Study|Lost to Follow-up|9|||
127819260|NCT03443024|459958745|FG001|Overall Study|Lost to Follow-up|9|||
127819261|NCT03443024|459958746|FG002|Overall Study|Lost to Follow-up|7|||
127819262|NCT03443024|459958747|FG003|Overall Study|Lost to Follow-up|5|||
127819263|NCT03443024|459958744|FG000|Overall Study|Withdrawal by Subject|8|||
127819264|NCT03443024|459958745|FG001|Overall Study|Withdrawal by Subject|15|||
127819265|NCT03443024|459958746|FG002|Overall Study|Withdrawal by Subject|9|||
127819266|NCT03443024|459958747|FG003|Overall Study|Withdrawal by Subject|23|||
127819267|NCT03443024|459958744|FG000|Overall Study|Physician Decision|1|||
127819268|NCT03443024|459958745|FG001|Overall Study|Physician Decision|2|||
127819269|NCT03443024|459958746|FG002|Overall Study|Physician Decision|0|||
127819270|NCT03443024|459958747|FG003|Overall Study|Physician Decision|1|||
127819271|NCT03443024|459958744|FG000|Overall Study|Sponsor Decision|1|||
127819272|NCT03443024|459958745|FG001|Overall Study|Sponsor Decision|1|||
127819273|NCT03443024|459958746|FG002|Overall Study|Sponsor Decision|0|||
127819274|NCT03443024|459958747|FG003|Overall Study|Sponsor Decision|0|||
127819275|NCT03443024|459958744|FG000|Overall Study|Protocol Deviation|0|||
127819276|NCT03443024|459958745|FG001|Overall Study|Protocol Deviation|0|||
127819277|NCT03443024|459958746|FG002|Overall Study|Protocol Deviation|0|||
127819278|NCT03443024|459958747|FG003|Overall Study|Protocol Deviation|2|||
127819279|NCT02986373|459958748|FG000|Overall Study|Adverse Event|4|||
127819280|NCT02986373|459958748|FG000|Overall Study|Lost to Follow-up|1|||
127819281|NCT02986373|459958748|FG000|Overall Study|Withdrawal by Subject|10|||
127819282|NCT02986373|459958748|FG000|Overall Study|Other|24|||
127819283|NCT00995371|459958754|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
127819284|NCT00995371|459958755|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
127819285|NCT04725682|459958756|FG000|Overall Study|Withdrawal by Subject|7|||
127819286|NCT04725682|459958757|FG001|Overall Study|Withdrawal by Subject|5|||
127819287|NCT04725682|459958756|FG000|Overall Study|Failed to comply with the requirements|2|||
127819288|NCT04725682|459958757|FG001|Overall Study|Failed to comply with the requirements|1|||
127819289|NCT04725682|459958756|FG000|Overall Study|Adverse Event|1|||
127819290|NCT04725682|459958757|FG001|Overall Study|Adverse Event|1|||
127819291|NCT04725682|459958756|FG000|Overall Study|Death|0|||
127819292|NCT04725682|459958757|FG001|Overall Study|Death|1|||
127819293|NCT01607892|459958759|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
127819294|NCT01607892|459958760|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
127819295|NCT01607892|459958761|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
127819296|NCT01607892|459958762|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
127819297|NCT01607892|459958763|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
127819298|NCT01607892|459958759|FG000|Overall Study|Death|4|||
127819299|NCT01607892|459958760|FG001|Overall Study|Death|2|||
127819300|NCT01607892|459958761|FG002|Overall Study|Death|8|||
127819301|NCT01607892|459958762|FG003|Overall Study|Death|10|||
127819302|NCT01607892|459958763|FG004|Overall Study|Death|3|||
127819303|NCT01607892|459958759|FG000|Overall Study|Investigator discretion|2|||
127819304|NCT01607892|459958760|FG001|Overall Study|Investigator discretion|4|||
127819305|NCT01607892|459958761|FG002|Overall Study|Investigator discretion|4|||
127819306|NCT01607892|459958762|FG003|Overall Study|Investigator discretion|8|||
127819307|NCT01607892|459958763|FG004|Overall Study|Investigator discretion|0|||
127819308|NCT01607892|459958759|FG000|Overall Study|Other treatments became available|1|||
127819309|NCT01607892|459958760|FG001|Overall Study|Other treatments became available|1|||
127819310|NCT01607892|459958761|FG002|Overall Study|Other treatments became available|0|||
127819311|NCT01607892|459958762|FG003|Overall Study|Other treatments became available|0|||
127819312|NCT01607892|459958763|FG004|Overall Study|Other treatments became available|2|||
127819313|NCT01607892|459958759|FG000|Overall Study|Intercurrent illness|1|||
127819314|NCT01607892|459958760|FG001|Overall Study|Intercurrent illness|0|||
127819315|NCT01607892|459958761|FG002|Overall Study|Intercurrent illness|0|||
127819316|NCT01607892|459958762|FG003|Overall Study|Intercurrent illness|3|||
127819317|NCT01607892|459958763|FG004|Overall Study|Intercurrent illness|0|||
127819318|NCT01607892|459958759|FG000|Overall Study|Non-Compliance with study procedures|0|||
127819319|NCT01607892|459958760|FG001|Overall Study|Non-Compliance with study procedures|0|||
127819320|NCT01607892|459958761|FG002|Overall Study|Non-Compliance with study procedures|1|||
127819321|NCT01607892|459958762|FG003|Overall Study|Non-Compliance with study procedures|0|||
127819322|NCT01607892|459958763|FG004|Overall Study|Non-Compliance with study procedures|0|||
127819323|NCT01607892|459958759|FG000|Overall Study|Consent withdrawn by participant|9|||
127819324|NCT01607892|459958760|FG001|Overall Study|Consent withdrawn by participant|4|||
127819325|NCT01607892|459958761|FG002|Overall Study|Consent withdrawn by participant|24|||
127819326|NCT01607892|459958762|FG003|Overall Study|Consent withdrawn by participant|14|||
127819327|NCT01607892|459958763|FG004|Overall Study|Consent withdrawn by participant|4|||
127819328|NCT01607892|459958759|FG000|Overall Study|Disease progression|38|||
127819329|NCT01607892|459958760|FG001|Overall Study|Disease progression|13|||
127819330|NCT01607892|459958761|FG002|Overall Study|Disease progression|37|||
127894600|NCT00684671|460237200|FG002|Overall Study|Adverse Event|0|||
127819331|NCT01607892|459958762|FG003|Overall Study|Disease progression|57|||
127819332|NCT01607892|459958763|FG004|Overall Study|Disease progression|9|||
127819333|NCT01607892|459958759|FG000|Overall Study|Incidence or severity of Adverse events|3|||
127819334|NCT01607892|459958760|FG001|Overall Study|Incidence or severity of Adverse events|3|||
127819335|NCT01607892|459958761|FG002|Overall Study|Incidence or severity of Adverse events|7|||
127819336|NCT01607892|459958762|FG003|Overall Study|Incidence or severity of Adverse events|2|||
127819337|NCT01607892|459958763|FG004|Overall Study|Incidence or severity of Adverse events|6|||
127819338|NCT03414359|459958766|FG000|Overall Study|Lack of Efficacy|1|||
127819339|NCT03414359|459958767|FG001|Overall Study|Lack of Efficacy|1|||
127819340|NCT03414359|459958766|FG000|Overall Study|Protocol Violation|0|||
127819341|NCT03414359|459958767|FG001|Overall Study|Protocol Violation|1|||
127819342|NCT02273973|459958768|FG000|Overall Study|Adverse Event|4|||
127819343|NCT02273973|459958769|FG001|Overall Study|Adverse Event|0|||
127819344|NCT02273973|459958768|FG000|Overall Study|Withdrawal by Subject|2|||
127819345|NCT02273973|459958769|FG001|Overall Study|Withdrawal by Subject|3|||
127819346|NCT02273973|459958768|FG000|Overall Study|Death|1|||
127819347|NCT02273973|459958769|FG001|Overall Study|Death|0|||
127819348|NCT02273973|459958768|FG000|Overall Study|Non-compliance|1|||
127819349|NCT02273973|459958769|FG001|Overall Study|Non-compliance|0|||
127819350|NCT02273973|459958768|FG000|Overall Study|Protocol Violation|1|||
127819351|NCT02273973|459958769|FG001|Overall Study|Protocol Violation|0|||
127819352|NCT02273973|459958768|FG000|Overall Study|Progression of disease|0|||
127819353|NCT02273973|459958769|FG001|Overall Study|Progression of disease|2|||
127819354|NCT02273973|459958768|FG000|Overall Study|Lost to Follow-up|0|||
127819355|NCT02273973|459958769|FG001|Overall Study|Lost to Follow-up|1|||
127819356|NCT02273973|459958768|FG000|Overall Study|Physician Decision|0|||
127819357|NCT02273973|459958769|FG001|Overall Study|Physician Decision|1|||
127819358|NCT02273973|459958768|FG000|Overall Study|Reason not specified|0|||
127819359|NCT02273973|459958769|FG001|Overall Study|Reason not specified|1|||
127819360|NCT03022422|459958771|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
127819361|NCT03022422|459958772|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
127819362|NCT03022422|459958773|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
127819363|NCT03022422|459958774|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
127819364|NCT03022422|459958775|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
127819365|NCT03022422|459958776|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
127819366|NCT01282814|459958778|FG000|First Intervention|Emesis During Dosing Interval|0|||
127819367|NCT01282814|459958779|FG001|First Intervention|Emesis During Dosing Interval|3|||
127819368|NCT01282814|459958778|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
127819369|NCT01282814|459958779|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
127819370|NCT02403206|459958780|FG000|Overall Study|Lost to Follow-up|4|||
127819371|NCT02403206|459958781|FG001|Overall Study|Lost to Follow-up|3|||
127819372|NCT02403206|459958780|FG000|Overall Study|Physician Decision|2|||
127819373|NCT02403206|459958781|FG001|Overall Study|Physician Decision|0|||
127819374|NCT02403206|459958780|FG000|Overall Study|Withdrawal by Subject|3|||
127819375|NCT02403206|459958781|FG001|Overall Study|Withdrawal by Subject|3|||
127819376|NCT02403206|459958780|FG000|Overall Study|Reason not given|2|||
127819377|NCT02403206|459958781|FG001|Overall Study|Reason not given|4|||
127819378|NCT00957372|459958782|FG000|PART I|Lost to Follow-up|0|||
127819379|NCT00957372|459958783|FG001|PART I|Lost to Follow-up|0|||
127819380|NCT00957372|459958784|FG002|PART I|Lost to Follow-up|1|||
127819381|NCT00957372|459958785|FG003|PART I|Lost to Follow-up|0|||
127819382|NCT00957372|459958782|FG000|PART II|Withdrawal by Subject|0|||
127819383|NCT00957372|459958783|FG001|PART II|Withdrawal by Subject|0|||
127819384|NCT00957372|459958784|FG002|PART II|Withdrawal by Subject|0|||
127819385|NCT00957372|459958785|FG003|PART II|Withdrawal by Subject|8|||
127819386|NCT00957372|459958782|FG000|PART II|Physician Decision|0|||
127819387|NCT00957372|459958783|FG001|PART II|Physician Decision|0|||
127819388|NCT00957372|459958784|FG002|PART II|Physician Decision|0|||
127819389|NCT00957372|459958785|FG003|PART II|Physician Decision|1|||
127819390|NCT00957372|459958782|FG000|PART II|Pregnancy|0|||
127819391|NCT00957372|459958783|FG001|PART II|Pregnancy|0|||
127819392|NCT00957372|459958784|FG002|PART II|Pregnancy|0|||
127819393|NCT00957372|459958785|FG003|PART II|Pregnancy|1|||
127819394|NCT00957372|459958782|FG000|PART II|Not Know|0|||
127894601|NCT00684671|460237198|FG000|Overall Study|Lost to Follow-up|1|||
127819395|NCT00957372|459958783|FG001|PART II|Not Know|0|||
127819396|NCT00957372|459958784|FG002|PART II|Not Know|0|||
127819397|NCT00957372|459958785|FG003|PART II|Not Know|20|||
127819398|NCT00957372|459958782|FG000|PART II|Adverse Event|0|||
127819399|NCT00957372|459958783|FG001|PART II|Adverse Event|0|||
127819400|NCT00957372|459958784|FG002|PART II|Adverse Event|0|||
127819401|NCT00957372|459958785|FG003|PART II|Adverse Event|10|||
127819402|NCT00957372|459958782|FG000|PART II|Patient non-compliance|0|||
127819403|NCT00957372|459958783|FG001|PART II|Patient non-compliance|0|||
127819404|NCT00957372|459958784|FG002|PART II|Patient non-compliance|0|||
127819405|NCT00957372|459958785|FG003|PART II|Patient non-compliance|4|||
127819406|NCT01444391|459958786|FG000|Overall Study|Death|1|||
127819407|NCT02209597|459958789|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
127819408|NCT02209597|459958789|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
127819409|NCT02209597|459958789|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
127819410|NCT02209597|459958789|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
127819411|NCT01855789|459958791|FG000|1) Baseline up to Week 24|Adverse Event|37|||
127819412|NCT01855789|459958792|FG001|1) Baseline up to Week 24|Adverse Event|0|||
127819413|NCT01855789|459958793|FG002|1) Baseline up to Week 24|Adverse Event|0|||
127819414|NCT01855789|459958794|FG003|1) Baseline up to Week 24|Adverse Event|0|||
127819415|NCT01855789|459958791|FG000|1) Baseline up to Week 24|Death|2|||
127819416|NCT01855789|459958792|FG001|1) Baseline up to Week 24|Death|0|||
127819417|NCT01855789|459958793|FG002|1) Baseline up to Week 24|Death|0|||
127819418|NCT01855789|459958794|FG003|1) Baseline up to Week 24|Death|0|||
127819419|NCT01855789|459958791|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
127819420|NCT01855789|459958792|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
127819421|NCT01855789|459958793|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
127819422|NCT01855789|459958794|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
127819423|NCT01855789|459958791|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
127819424|NCT01855789|459958792|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
127819425|NCT01855789|459958793|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
127819426|NCT01855789|459958794|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
127819427|NCT01855789|459958791|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
127819428|NCT01855789|459958792|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
127819429|NCT01855789|459958793|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
127819430|NCT01855789|459958794|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
127819431|NCT01855789|459958791|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
127819432|NCT01855789|459958792|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
127819433|NCT01855789|459958793|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
127819434|NCT01855789|459958794|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
127819435|NCT01855789|459958791|FG000|1) Baseline up to Week 24|Physician Decision|4|||
127819436|NCT01855789|459958792|FG001|1) Baseline up to Week 24|Physician Decision|0|||
127819437|NCT01855789|459958793|FG002|1) Baseline up to Week 24|Physician Decision|0|||
127819438|NCT01855789|459958794|FG003|1) Baseline up to Week 24|Physician Decision|0|||
127819439|NCT01855789|459958791|FG000|1) Baseline up to Week 24|Pregnancy|1|||
127819440|NCT01855789|459958792|FG001|1) Baseline up to Week 24|Pregnancy|0|||
127819441|NCT01855789|459958793|FG002|1) Baseline up to Week 24|Pregnancy|0|||
127819442|NCT01855789|459958794|FG003|1) Baseline up to Week 24|Pregnancy|0|||
127819443|NCT01855789|459958791|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
127819444|NCT01855789|459958792|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
127819445|NCT01855789|459958793|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
127819446|NCT01855789|459958794|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
127819447|NCT01855789|459958791|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
127819448|NCT01855789|459958792|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
127819449|NCT01855789|459958793|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
127819450|NCT01855789|459958794|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
127819451|NCT01855789|459958791|FG000|1) Baseline up to Week 24|Other|4|||
127819452|NCT01855789|459958792|FG001|1) Baseline up to Week 24|Other|0|||
127819453|NCT01855789|459958793|FG002|1) Baseline up to Week 24|Other|0|||
127819454|NCT01855789|459958794|FG003|1) Baseline up to Week 24|Other|0|||
127819455|NCT01855789|459958791|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
127819456|NCT01855789|459958792|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
127819457|NCT01855789|459958793|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
127819458|NCT01855789|459958794|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
127819459|NCT01855789|459958791|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
127819460|NCT01855789|459958792|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
127819461|NCT01855789|459958793|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
127819462|NCT01855789|459958794|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
127819463|NCT01855789|459958791|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
127819464|NCT01855789|459958792|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
127819465|NCT01855789|459958793|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
127819466|NCT01855789|459958794|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
127819467|NCT01855789|459958791|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
127819468|NCT01855789|459958792|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
127819469|NCT01855789|459958793|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
127819470|NCT01855789|459958794|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
127819471|NCT01855789|459958791|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
127819472|NCT01855789|459958792|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
127819473|NCT01855789|459958793|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
127819474|NCT01855789|459958794|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
127819475|NCT01855789|459958791|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
127819476|NCT01855789|459958792|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
127819477|NCT01855789|459958793|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
127819478|NCT01855789|459958794|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
127819479|NCT01855789|459958791|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
127819480|NCT01855789|459958792|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
127819481|NCT01855789|459958793|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
127819482|NCT01855789|459958794|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
127819483|NCT01855789|459958791|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
127819484|NCT01855789|459958792|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
127819485|NCT01855789|459958793|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
127819486|NCT01855789|459958794|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
127819487|NCT01855789|459958791|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
127819488|NCT01855789|459958792|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
127819489|NCT01855789|459958793|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
127819490|NCT01855789|459958794|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
127819491|NCT01855789|459958791|FG000|2) Week 24 up to End of Study|Other|0|||
127819492|NCT01855789|459958792|FG001|2) Week 24 up to End of Study|Other|0|||
127819493|NCT01855789|459958793|FG002|2) Week 24 up to End of Study|Other|0|||
127819494|NCT01855789|459958794|FG003|2) Week 24 up to End of Study|Other|1|||
127819495|NCT03067311|459958795|FG000|Overall Study|Lost to Follow-up|1|||
127819496|NCT03067311|459958796|FG001|Overall Study|Lost to Follow-up|1|||
127819497|NCT03067311|459958795|FG000|Overall Study|Moved away|1|||
127819498|NCT03067311|459958796|FG001|Overall Study|Moved away|1|||
127819499|NCT03937986|459960444|FG000|Overall Study|COVID-19 Pandemic|1|||
127819500|NCT00744055|459960446|FG000|Overall Study|Withdrawal by Subject|6|||
127819501|NCT00744055|459960447|FG001|Overall Study|Withdrawal by Subject|9|||
127819502|NCT00744055|459960446|FG000|Overall Study|Lack of Efficacy|0|||
127819503|NCT00744055|459960447|FG001|Overall Study|Lack of Efficacy|1|||
127819504|NCT00744055|459960446|FG000|Overall Study|Physician Decision|0|||
127819505|NCT00744055|459960447|FG001|Overall Study|Physician Decision|2|||
127819506|NCT00744055|459960446|FG000|Overall Study|Protocol Violation|1|||
127819507|NCT00744055|459960447|FG001|Overall Study|Protocol Violation|1|||
127819508|NCT00744055|459960446|FG000|Overall Study|Lost to Follow-up|0|||
127819509|NCT00744055|459960447|FG001|Overall Study|Lost to Follow-up|1|||
127819510|NCT04328623|459960452|FG000|Overall Study|Protocol Violation|0|||
127819511|NCT04328623|459960453|FG001|Overall Study|Protocol Violation|1|||
127819512|NCT00849693|459960454|FG000|Acute Treatment Phase|Adverse Event|12|||
127819513|NCT00849693|459960455|FG001|Acute Treatment Phase|Adverse Event|7|||
127819514|NCT00849693|459960456|FG002|Acute Treatment Phase|Adverse Event|6|||
127819515|NCT00849693|459960457|FG003|Acute Treatment Phase|Adverse Event|4|||
127819516|NCT00849693|459960454|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
127819517|NCT00849693|459960455|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
127819518|NCT00849693|459960456|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
127819519|NCT00849693|459960457|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
127819520|NCT00849693|459960454|FG000|Acute Treatment Phase|Protocol Violation|1|||
127819521|NCT00849693|459960455|FG001|Acute Treatment Phase|Protocol Violation|5|||
127819522|NCT00849693|459960456|FG002|Acute Treatment Phase|Protocol Violation|2|||
127819523|NCT00849693|459960457|FG003|Acute Treatment Phase|Protocol Violation|6|||
127819524|NCT00849693|459960454|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
127819525|NCT00849693|459960455|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
127819526|NCT00849693|459960456|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
127819527|NCT00849693|459960457|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
127819528|NCT00849693|459960454|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
127819529|NCT00849693|459960455|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
127819530|NCT00849693|459960456|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
127819531|NCT00849693|459960457|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
127819532|NCT00849693|459960454|FG000|Acute Treatment Phase|Physician Decision|2|||
127819533|NCT00849693|459960455|FG001|Acute Treatment Phase|Physician Decision|1|||
127819534|NCT00849693|459960456|FG002|Acute Treatment Phase|Physician Decision|2|||
127819535|NCT00849693|459960457|FG003|Acute Treatment Phase|Physician Decision|1|||
127819536|NCT00849693|459960454|FG000|Acute Treatment Phase|Sponsor decision|0|||
127819537|NCT00849693|459960455|FG001|Acute Treatment Phase|Sponsor decision|0|||
127819538|NCT00849693|459960456|FG002|Acute Treatment Phase|Sponsor decision|1|||
127819539|NCT00849693|459960457|FG003|Acute Treatment Phase|Sponsor decision|0|||
127819540|NCT00849693|459960454|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
127819541|NCT00849693|459960455|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
127819542|NCT00849693|459960456|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
127819543|NCT00849693|459960457|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
127819544|NCT00849693|459960454|FG000|Extension Phase|Adverse Event|4|||
127819545|NCT00849693|459960455|FG001|Extension Phase|Adverse Event|6|||
127819546|NCT00849693|459960456|FG002|Extension Phase|Adverse Event|3|||
127819547|NCT00849693|459960457|FG003|Extension Phase|Adverse Event|7|||
127819548|NCT00849693|459960454|FG000|Extension Phase|Lost to Follow-up|7|||
127819549|NCT00849693|459960455|FG001|Extension Phase|Lost to Follow-up|5|||
127819550|NCT00849693|459960456|FG002|Extension Phase|Lost to Follow-up|6|||
127819551|NCT00849693|459960457|FG003|Extension Phase|Lost to Follow-up|6|||
127819552|NCT00849693|459960454|FG000|Extension Phase|Protocol Violation|0|||
127819553|NCT00849693|459960455|FG001|Extension Phase|Protocol Violation|3|||
127819554|NCT00849693|459960456|FG002|Extension Phase|Protocol Violation|2|||
127819555|NCT00849693|459960457|FG003|Extension Phase|Protocol Violation|3|||
127819556|NCT00849693|459960454|FG000|Extension Phase|Withdrawal by Subject|6|||
127819557|NCT00849693|459960455|FG001|Extension Phase|Withdrawal by Subject|9|||
127819558|NCT00849693|459960456|FG002|Extension Phase|Withdrawal by Subject|10|||
127819559|NCT00849693|459960457|FG003|Extension Phase|Withdrawal by Subject|15|||
127819560|NCT00849693|459960454|FG000|Extension Phase|Parent or caregiver decision|9|||
127819561|NCT00849693|459960455|FG001|Extension Phase|Parent or caregiver decision|4|||
127819562|NCT00849693|459960456|FG002|Extension Phase|Parent or caregiver decision|10|||
127819563|NCT00849693|459960457|FG003|Extension Phase|Parent or caregiver decision|5|||
127819564|NCT00849693|459960454|FG000|Extension Phase|Physician Decision|1|||
127819565|NCT00849693|459960455|FG001|Extension Phase|Physician Decision|1|||
127819566|NCT00849693|459960456|FG002|Extension Phase|Physician Decision|2|||
127819567|NCT00849693|459960457|FG003|Extension Phase|Physician Decision|0|||
127819568|NCT00849693|459960454|FG000|Extension Phase|Sponsor decision|1|||
127819569|NCT00849693|459960455|FG001|Extension Phase|Sponsor decision|0|||
127819570|NCT00849693|459960456|FG002|Extension Phase|Sponsor decision|0|||
127819571|NCT00849693|459960457|FG003|Extension Phase|Sponsor decision|1|||
127819572|NCT00849693|459960454|FG000|Extension Phase|Lack of Efficacy|2|||
127819573|NCT00849693|459960455|FG001|Extension Phase|Lack of Efficacy|2|||
127819574|NCT00849693|459960456|FG002|Extension Phase|Lack of Efficacy|2|||
127819575|NCT00849693|459960457|FG003|Extension Phase|Lack of Efficacy|1|||
127819576|NCT01408537|459960461|FG000|Overall Study|Withdrawal by Subject|2|||
127819577|NCT01408537|459960461|FG000|Overall Study|Protocol Violation|3|||
127819578|NCT01408537|459960461|FG000|Overall Study|Lost to Follow-up|3|||
127819579|NCT02760602|459960464|FG000|Overall Study|Withdrawal by Subject|1|||
127819580|NCT02760602|459960465|FG001|Overall Study|Withdrawal by Subject|0|||
127819581|NCT02760602|459960464|FG000|Overall Study|Terminated by sponsor|12|||
127819582|NCT02760602|459960465|FG001|Overall Study|Terminated by sponsor|13|||
127819583|NCT02046564|459960477|FG000|Overall Study|Adverse Event|6|||
127819584|NCT02046564|459960478|FG001|Overall Study|Adverse Event|3|||
127819585|NCT02046564|459960477|FG000|Overall Study|Physician Decision|0|||
127819586|NCT02046564|459960478|FG001|Overall Study|Physician Decision|1|||
127819587|NCT02046564|459960477|FG000|Overall Study|Protocol Violation|3|||
127819588|NCT02046564|459960478|FG001|Overall Study|Protocol Violation|1|||
127894602|NCT00684671|460237199|FG001|Overall Study|Lost to Follow-up|0|||
127894603|NCT00684671|460237200|FG002|Overall Study|Lost to Follow-up|0|||
127819589|NCT02046564|459960477|FG000|Overall Study|Withdrawal by Subject|4|||
127819590|NCT02046564|459960478|FG001|Overall Study|Withdrawal by Subject|10|||
127819591|NCT02046564|459960477|FG000|Overall Study|Subject met withdrawal criteria|2|||
127819592|NCT02046564|459960478|FG001|Overall Study|Subject met withdrawal criteria|5|||
127894604|NCT00684671|460237198|FG000|Overall Study|Alcoholic dependance|1|||
127819593|NCT00984659|459960479|FG000|2-week Run-in Period|Adverse Event|8|||
127819594|NCT00984659|459960480|FG001|2-week Run-in Period|Adverse Event|0|||
127819595|NCT00984659|459960481|FG002|2-week Run-in Period|Adverse Event|0|||
127819596|NCT00984659|459960482|FG003|2-week Run-in Period|Adverse Event|0|||
127819597|NCT00984659|459960479|FG000|2-week Run-in Period|Protocol Violation|5|||
127819598|NCT00984659|459960480|FG001|2-week Run-in Period|Protocol Violation|0|||
127819599|NCT00984659|459960481|FG002|2-week Run-in Period|Protocol Violation|0|||
127819600|NCT00984659|459960482|FG003|2-week Run-in Period|Protocol Violation|0|||
127819601|NCT00984659|459960479|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
127819602|NCT00984659|459960480|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
127819603|NCT00984659|459960481|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
127819604|NCT00984659|459960482|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
127819605|NCT00984659|459960479|FG000|2-week Run-in Period|Lost to Follow-up|3|||
127819606|NCT00984659|459960480|FG001|2-week Run-in Period|Lost to Follow-up|0|||
127819607|NCT00984659|459960481|FG002|2-week Run-in Period|Lost to Follow-up|0|||
127819608|NCT00984659|459960482|FG003|2-week Run-in Period|Lost to Follow-up|0|||
127819609|NCT00984659|459960479|FG000|2-week Run-in Period|Physician Decision|10|||
127819610|NCT00984659|459960480|FG001|2-week Run-in Period|Physician Decision|0|||
127819611|NCT00984659|459960481|FG002|2-week Run-in Period|Physician Decision|0|||
127819612|NCT00984659|459960482|FG003|2-week Run-in Period|Physician Decision|0|||
127819613|NCT00984659|459960479|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
127819614|NCT00984659|459960480|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
127819615|NCT00984659|459960481|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
127819616|NCT00984659|459960482|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
127819617|NCT00984659|459960479|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
127819618|NCT00984659|459960480|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
127819619|NCT00984659|459960481|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
127819620|NCT00984659|459960482|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
127819621|NCT00984659|459960479|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
127819622|NCT00984659|459960480|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
127819623|NCT00984659|459960481|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
127819624|NCT00984659|459960482|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
127819625|NCT00984659|459960479|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
127819626|NCT00984659|459960480|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
127819627|NCT00984659|459960481|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
127819628|NCT00984659|459960482|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
127819629|NCT00984659|459960479|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
127819630|NCT00984659|459960480|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
127819631|NCT00984659|459960481|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
127819632|NCT00984659|459960482|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
127819633|NCT00984659|459960479|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
127819634|NCT00984659|459960480|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
127819635|NCT00984659|459960481|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
127819636|NCT00984659|459960482|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
127819637|NCT00984659|459960479|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
127819638|NCT00984659|459960480|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
127819639|NCT00984659|459960481|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
127819640|NCT00984659|459960482|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
127819641|NCT00635102|459960485|FG000|Overall Study|Withdrawal by Subject|7|||
127819642|NCT00635102|459960486|FG001|Overall Study|Withdrawal by Subject|8|||
127819643|NCT01938625|459960487|FG000|Overall Study|Withdrawal by Subject|0|||
127819644|NCT01938625|459960488|FG001|Overall Study|Withdrawal by Subject|1|||
127819645|NCT01938625|459960487|FG000|Overall Study|Adverse Event|0|||
127819646|NCT01938625|459960488|FG001|Overall Study|Adverse Event|1|||
127819647|NCT02088034|459960489|FG000|Overall Study|Lost to Follow-up|1|||
127819648|NCT02088034|459960490|FG001|Overall Study|Lost to Follow-up|1|||
127819649|NCT02088034|459960491|FG002|Overall Study|Lost to Follow-up|0|||
127819650|NCT02088034|459960489|FG000|Overall Study|Pregnancy|2|||
127819651|NCT02088034|459960490|FG001|Overall Study|Pregnancy|1|||
127819652|NCT02088034|459960491|FG002|Overall Study|Pregnancy|2|||
127819653|NCT00546351|459960492|FG000|Overall Study|Adverse Event|76|||
127819654|NCT00546351|459960492|FG000|Overall Study|Lack of Efficacy|15|||
127819655|NCT00546351|459960492|FG000|Overall Study|Withdrawal by Subject|109|||
127819656|NCT00546351|459960492|FG000|Overall Study|Lost to Follow-up|9|||
127819657|NCT00546351|459960492|FG000|Overall Study|Protocol Deviation|1|||
127819658|NCT00546351|459960492|FG000|Overall Study|Unsatisfactory compliance|9|||
127819659|NCT00546351|459960492|FG000|Overall Study|Other reasons for premature termination|17|||
127819660|NCT03952650|459960493|FG000|Overall Study|TRAVEL|0|||
127819661|NCT03952650|459960494|FG001|Overall Study|TRAVEL|4|||
127819662|NCT03952650|459960495|FG002|Overall Study|TRAVEL|0|||
127819663|NCT03952650|459960496|FG003|Overall Study|TRAVEL|4|||
127819664|NCT03952650|459960497|FG004|Overall Study|TRAVEL|0|||
127819665|NCT03952650|459960498|FG005|Overall Study|TRAVEL|3|||
127819666|NCT03952650|459960499|FG006|Overall Study|TRAVEL|2|||
127819667|NCT03952650|459960493|FG000|Overall Study|Withdrawal by Subject|0|||
127819668|NCT03952650|459960494|FG001|Overall Study|Withdrawal by Subject|2|||
127819669|NCT03952650|459960495|FG002|Overall Study|Withdrawal by Subject|0|||
127819670|NCT03952650|459960496|FG003|Overall Study|Withdrawal by Subject|3|||
127819671|NCT03952650|459960497|FG004|Overall Study|Withdrawal by Subject|0|||
127819672|NCT03952650|459960498|FG005|Overall Study|Withdrawal by Subject|1|||
127819673|NCT03952650|459960499|FG006|Overall Study|Withdrawal by Subject|1|||
127819674|NCT03952650|459960493|FG000|Overall Study|Lost to Follow-up|0|||
127819675|NCT03952650|459960494|FG001|Overall Study|Lost to Follow-up|1|||
127819676|NCT03952650|459960495|FG002|Overall Study|Lost to Follow-up|0|||
127819677|NCT03952650|459960496|FG003|Overall Study|Lost to Follow-up|0|||
127819678|NCT03952650|459960497|FG004|Overall Study|Lost to Follow-up|0|||
127819679|NCT03952650|459960498|FG005|Overall Study|Lost to Follow-up|1|||
127819680|NCT03952650|459960499|FG006|Overall Study|Lost to Follow-up|1|||
127819681|NCT03952650|459960493|FG000|Overall Study|Received wrong vaccine and travelled|0|||
127819682|NCT03952650|459960494|FG001|Overall Study|Received wrong vaccine and travelled|0|||
127819683|NCT03952650|459960495|FG002|Overall Study|Received wrong vaccine and travelled|0|||
127819684|NCT03952650|459960496|FG003|Overall Study|Received wrong vaccine and travelled|0|||
127819685|NCT03952650|459960497|FG004|Overall Study|Received wrong vaccine and travelled|0|||
127819686|NCT03952650|459960498|FG005|Overall Study|Received wrong vaccine and travelled|1|||
127819687|NCT03952650|459960499|FG006|Overall Study|Received wrong vaccine and travelled|0|||
127819688|NCT03952650|459960493|FG000|Overall Study|Unable to make study visit|0|||
127819689|NCT03952650|459960494|FG001|Overall Study|Unable to make study visit|0|||
127819690|NCT03952650|459960495|FG002|Overall Study|Unable to make study visit|0|||
127819691|NCT03952650|459960496|FG003|Overall Study|Unable to make study visit|0|||
127819692|NCT03952650|459960497|FG004|Overall Study|Unable to make study visit|0|||
127819693|NCT03952650|459960498|FG005|Overall Study|Unable to make study visit|1|||
127819694|NCT03952650|459960499|FG006|Overall Study|Unable to make study visit|0|||
127819695|NCT02424149|459960500|FG000|Overall Study|surgery cancelled|2|||
127819696|NCT02424149|459960501|FG001|Overall Study|surgery cancelled|0|||
127819697|NCT02424149|459960500|FG000|Overall Study|Withdrawal by Subject|0|||
127819698|NCT02424149|459960501|FG001|Overall Study|Withdrawal by Subject|1|||
127819699|NCT00592683|459960504|FG000|Overall Study|Found ineligible|0|||
127819700|NCT00592683|459960505|FG001|Overall Study|Found ineligible|1|||
127819701|NCT00592683|459960504|FG000|Overall Study|Withdrawal by Subject|1|||
127819702|NCT00592683|459960505|FG001|Overall Study|Withdrawal by Subject|0|||
127819703|NCT00592683|459960504|FG000|Overall Study|Adverse Event|0|||
127819704|NCT00592683|459960505|FG001|Overall Study|Adverse Event|2|||
127819705|NCT00592683|459960504|FG000|Overall Study|Protocol Violation|1|||
127819706|NCT00592683|459960505|FG001|Overall Study|Protocol Violation|0|||
127819707|NCT00592683|459960504|FG000|Overall Study|Study drug expired|1|||
127819708|NCT00592683|459960505|FG001|Overall Study|Study drug expired|0|||
127819709|NCT00592683|459960504|FG000|Overall Study|Other|1|||
127819710|NCT00592683|459960505|FG001|Overall Study|Other|0|||
127819711|NCT00592683|459960504|FG000|Overall Study|Lost to Follow-up|0|||
127819712|NCT00592683|459960505|FG001|Overall Study|Lost to Follow-up|1|||
127819713|NCT00545818|459960506|FG000|Overall Study|Protocol Violation|1|||
127819714|NCT00545818|459960507|FG001|Overall Study|Protocol Violation|0|||
127819715|NCT00545818|459960506|FG000|Overall Study|Adverse Event|1|||
127819716|NCT00545818|459960507|FG001|Overall Study|Adverse Event|1|||
127819717|NCT00545818|459960506|FG000|Overall Study|Lost to Follow-up|1|||
127819718|NCT00545818|459960507|FG001|Overall Study|Lost to Follow-up|6|||
127819719|NCT03043365|459960508|FG000|Weeks 0 to Week 8|Adverse Event|1|||
127819720|NCT03043365|459960509|FG001|Weeks 0 to Week 8|Adverse Event|3|||
127819721|NCT03043365|459960508|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
127819722|NCT03043365|459960509|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
127819723|NCT03043365|459960508|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
127819724|NCT03043365|459960509|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
127819725|NCT03455543|459960510|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
127819726|NCT03455543|459960511|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
127894605|NCT00684671|460237199|FG001|Overall Study|Alcoholic dependance|0|||
127894606|NCT00684671|460237200|FG002|Overall Study|Alcoholic dependance|0|||
127894607|NCT03335371|460237201|FG000|Overall Study|Lost to Follow-up|0|||
127894608|NCT03335371|460237202|FG001|Overall Study|Lost to Follow-up|0|||
127819727|NCT03455543|459960512|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
127819728|NCT03455543|459960510|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
127819729|NCT03455543|459960511|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
127819730|NCT03455543|459960512|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
127819731|NCT03455543|459960510|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
127819732|NCT03455543|459960511|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
127819733|NCT03455543|459960512|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
127819734|NCT03455543|459960510|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
127894609|NCT03335371|460237203|FG002|Overall Study|Lost to Follow-up|0|||
127819735|NCT03455543|459960511|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
127819736|NCT03455543|459960512|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
127819737|NCT03455543|459960510|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
127819738|NCT03455543|459960511|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
127819739|NCT03455543|459960512|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
127819740|NCT03455543|459960510|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
127819741|NCT03455543|459960511|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
127819742|NCT03455543|459960512|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
127819743|NCT03455543|459960510|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
127819744|NCT03455543|459960511|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
127819745|NCT03455543|459960512|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
127819746|NCT03455543|459960510|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
127819747|NCT03455543|459960511|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
127819748|NCT03455543|459960512|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
127819749|NCT03455543|459960510|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
127819750|NCT03455543|459960511|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
127819751|NCT03455543|459960512|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
127819752|NCT02873221|459960513|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
127819753|NCT02873221|459960514|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
127819754|NCT02873221|459960515|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
127819755|NCT02873221|459960513|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
127819756|NCT02873221|459960514|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
127819757|NCT02873221|459960515|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
127819758|NCT02873221|459960513|FG000|Treatment Period|Protocol Violation|2|||
127819759|NCT02873221|459960514|FG001|Treatment Period|Protocol Violation|5|||
127819760|NCT02873221|459960515|FG002|Treatment Period|Protocol Violation|8|||
127819761|NCT02873221|459960513|FG000|Treatment Period|Pregnancy|4|||
127819762|NCT02873221|459960514|FG001|Treatment Period|Pregnancy|6|||
127819763|NCT02873221|459960515|FG002|Treatment Period|Pregnancy|3|||
127819764|NCT02873221|459960513|FG000|Treatment Period|Lack of Qualifying Event|0|||
127819765|NCT02873221|459960514|FG001|Treatment Period|Lack of Qualifying Event|3|||
127819766|NCT02873221|459960515|FG002|Treatment Period|Lack of Qualifying Event|1|||
127819767|NCT02873221|459960513|FG000|Treatment Period|Withdrawal of Consent|52|||
127819768|NCT02873221|459960514|FG001|Treatment Period|Withdrawal of Consent|51|||
127819769|NCT02873221|459960515|FG002|Treatment Period|Withdrawal of Consent|41|||
127819770|NCT02873221|459960513|FG000|Treatment Period|Lack of Efficacy|0|||
127819771|NCT02873221|459960514|FG001|Treatment Period|Lack of Efficacy|17|||
127819772|NCT02873221|459960515|FG002|Treatment Period|Lack of Efficacy|12|||
127819773|NCT02873221|459960513|FG000|Treatment Period|Adverse Event|4|||
127819774|NCT02873221|459960514|FG001|Treatment Period|Adverse Event|9|||
127819775|NCT02873221|459960515|FG002|Treatment Period|Adverse Event|11|||
127819776|NCT02873221|459960513|FG000|Treatment Period|Lost to Follow-up|26|||
127819777|NCT02873221|459960514|FG001|Treatment Period|Lost to Follow-up|30|||
127819778|NCT02873221|459960515|FG002|Treatment Period|Lost to Follow-up|26|||
127819779|NCT02873221|459960513|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
127819780|NCT02873221|459960514|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
127819781|NCT02873221|459960515|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
127819782|NCT02873221|459960513|FG000|Safety Follow-up Period|Protocol Violation|0|||
127819783|NCT02873221|459960514|FG001|Safety Follow-up Period|Protocol Violation|0|||
127819784|NCT02873221|459960515|FG002|Safety Follow-up Period|Protocol Violation|1|||
127819785|NCT02873221|459960513|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
127819786|NCT02873221|459960514|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
127819787|NCT02873221|459960515|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
127819788|NCT02873221|459960513|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
127819789|NCT02873221|459960514|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
127819790|NCT02873221|459960515|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
127819791|NCT01325493|459960518|FG000|Overall Study|Protocol Violation|0|||
127819792|NCT01325493|459960519|FG001|Overall Study|Protocol Violation|1|||
127819793|NCT01325493|459960518|FG000|Overall Study|loss of neuromonitoring signals|0|||
127819794|NCT01325493|459960519|FG001|Overall Study|loss of neuromonitoring signals|2|||
127819795|NCT01325493|459960518|FG000|Overall Study|Allergy|1|||
127819796|NCT01325493|459960519|FG001|Overall Study|Allergy|0|||
127819797|NCT05372315|459960522|FG000|Overall Study|Withdrawal by Subject|1|||
127819798|NCT05372315|459960523|FG001|Overall Study|Withdrawal by Subject|0|||
127819799|NCT01508676|459960526|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
127819800|NCT01508676|459960527|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
127894610|NCT03335371|460237204|FG003|Overall Study|Lost to Follow-up|0|||
127819801|NCT01508676|459960526|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
127819802|NCT01508676|459960527|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
127819803|NCT01508676|459960526|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
127819804|NCT01508676|459960527|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
127819805|NCT01508676|459960526|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
127819806|NCT01508676|459960527|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
127819807|NCT01508676|459960526|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
127819808|NCT01508676|459960527|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
127819809|NCT00650585|459960528|FG000|Overall Study|Lost to Follow-up|505|||
127819810|NCT00650585|459960529|FG001|Overall Study|Lost to Follow-up|482|||
127819811|NCT00650585|459960528|FG000|Overall Study|No parental consent|935|||
127819812|NCT00650585|459960529|FG001|Overall Study|No parental consent|866|||
127819813|NCT00650585|459960528|FG000|Overall Study|Excluded/ruled ineligible|357|||
127819814|NCT00650585|459960529|FG001|Overall Study|Excluded/ruled ineligible|129|||
127819815|NCT02532543|459960531|FG000|Overall Study|Lost to Follow-up|0|||
127819816|NCT02532543|459960532|FG001|Overall Study|Lost to Follow-up|0|||
127819817|NCT02532543|459960533|FG002|Overall Study|Lost to Follow-up|1|||
127819818|NCT02532543|459960534|FG003|Overall Study|Lost to Follow-up|0|||
127819819|NCT02614794|459960537|FG000|Overall Study|Death|258|||
127819820|NCT02614794|459960538|FG001|Overall Study|Death|151|||
127819821|NCT02614794|459960537|FG000|Overall Study|Study closure by Sponsor|119|||
127819822|NCT02614794|459960538|FG001|Overall Study|Study closure by Sponsor|45|||
127819823|NCT02614794|459960537|FG000|Overall Study|Withdrawal by Subject|24|||
127819824|NCT02614794|459960538|FG001|Overall Study|Withdrawal by Subject|5|||
127819825|NCT02614794|459960537|FG000|Overall Study|Lost to Follow-up|7|||
127819826|NCT02614794|459960538|FG001|Overall Study|Lost to Follow-up|0|||
127819827|NCT02614794|459960537|FG000|Overall Study|Physician Decision|1|||
127819828|NCT02614794|459960538|FG001|Overall Study|Physician Decision|1|||
127819829|NCT02614794|459960537|FG000|Overall Study|Hospital closure|1|||
127819830|NCT02614794|459960538|FG001|Overall Study|Hospital closure|0|||
127819831|NCT00923091|459960542|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
127819832|NCT00923091|459960543|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
127819833|NCT00923091|459960544|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
127819834|NCT00923091|459960545|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
127819835|NCT00923091|459960546|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
127819836|NCT00923091|459960547|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
127819837|NCT00923091|459960548|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
127819838|NCT00923091|459960549|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
127819839|NCT00923091|459960550|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
127819840|NCT00923091|459960551|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
127819841|NCT00923091|459960552|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
127819842|NCT00923091|459960553|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
127819843|NCT00923091|459960554|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
127819844|NCT00923091|459960542|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
127819845|NCT00923091|459960543|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
127819846|NCT00923091|459960544|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
127819847|NCT00923091|459960545|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
127819848|NCT00923091|459960546|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
127819849|NCT00923091|459960547|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
127819850|NCT00923091|459960548|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
127819851|NCT00923091|459960549|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
127819852|NCT00923091|459960550|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
127819853|NCT00923091|459960551|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
127819854|NCT00923091|459960552|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
127819855|NCT00923091|459960553|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
127819856|NCT00923091|459960554|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
127819857|NCT00923091|459960542|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
127819858|NCT00923091|459960543|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
127819859|NCT00923091|459960544|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
127819860|NCT00923091|459960545|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
127819861|NCT00923091|459960546|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
127819862|NCT00923091|459960547|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
127819863|NCT00923091|459960548|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
127819864|NCT00923091|459960549|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
127819865|NCT00923091|459960550|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
127819866|NCT00923091|459960551|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
127819867|NCT00923091|459960552|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
127819868|NCT00923091|459960553|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
127819869|NCT00923091|459960554|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
127819870|NCT00923091|459960542|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
127819871|NCT00923091|459960543|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
127819872|NCT00923091|459960544|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
127819873|NCT00923091|459960545|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
127819874|NCT00923091|459960546|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
127819875|NCT00923091|459960547|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
127819876|NCT00923091|459960548|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
127819877|NCT00923091|459960549|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
127819878|NCT00923091|459960550|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
127819879|NCT00923091|459960551|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
127819880|NCT00923091|459960552|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
127819881|NCT00923091|459960553|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
127819882|NCT00923091|459960554|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
127819883|NCT00923091|459960542|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
127819884|NCT00923091|459960543|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
127819885|NCT00923091|459960544|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
127819886|NCT00923091|459960545|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
127819887|NCT00923091|459960546|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
127819888|NCT00923091|459960547|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
127819889|NCT00923091|459960548|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
127819890|NCT00923091|459960549|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
127819891|NCT00923091|459960550|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
127819892|NCT00923091|459960551|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
127819893|NCT00923091|459960552|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
127819894|NCT00923091|459960553|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
127819895|NCT00923091|459960554|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
127819896|NCT00923091|459960542|FG000|Period III (Single-Blind)|Adverse Event|5|||
127819897|NCT00923091|459960543|FG001|Period III (Single-Blind)|Adverse Event|0|||
127819898|NCT00923091|459960544|FG002|Period III (Single-Blind)|Adverse Event|0|||
127819899|NCT00923091|459960545|FG003|Period III (Single-Blind)|Adverse Event|0|||
127819900|NCT00923091|459960546|FG004|Period III (Single-Blind)|Adverse Event|0|||
127819901|NCT00923091|459960547|FG005|Period III (Single-Blind)|Adverse Event|0|||
127819902|NCT00923091|459960548|FG006|Period III (Single-Blind)|Adverse Event|0|||
127819903|NCT00923091|459960549|FG007|Period III (Single-Blind)|Adverse Event|0|||
127819904|NCT00923091|459960550|FG008|Period III (Single-Blind)|Adverse Event|0|||
127819905|NCT00923091|459960551|FG009|Period III (Single-Blind)|Adverse Event|0|||
127819906|NCT00923091|459960552|FG010|Period III (Single-Blind)|Adverse Event|0|||
127819907|NCT00923091|459960553|FG011|Period III (Single-Blind)|Adverse Event|0|||
127819908|NCT00923091|459960554|FG012|Period III (Single-Blind)|Adverse Event|0|||
127819909|NCT00923091|459960542|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
127819910|NCT00923091|459960543|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
127819911|NCT00923091|459960544|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
127819912|NCT00923091|459960545|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
127819913|NCT00923091|459960546|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
127819914|NCT00923091|459960547|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
127819915|NCT00923091|459960548|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
127819916|NCT00923091|459960549|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
127819917|NCT00923091|459960550|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
127819918|NCT00923091|459960551|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
127819919|NCT00923091|459960552|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
127819920|NCT00923091|459960553|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
127819921|NCT00923091|459960554|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
127819922|NCT00923091|459960542|FG000|Period III (Single-Blind)|Protocol Violation|3|||
127819923|NCT00923091|459960543|FG001|Period III (Single-Blind)|Protocol Violation|0|||
127819924|NCT00923091|459960544|FG002|Period III (Single-Blind)|Protocol Violation|0|||
127819925|NCT00923091|459960545|FG003|Period III (Single-Blind)|Protocol Violation|0|||
127819926|NCT00923091|459960546|FG004|Period III (Single-Blind)|Protocol Violation|0|||
127819927|NCT00923091|459960547|FG005|Period III (Single-Blind)|Protocol Violation|0|||
127819928|NCT00923091|459960548|FG006|Period III (Single-Blind)|Protocol Violation|0|||
127819929|NCT00923091|459960549|FG007|Period III (Single-Blind)|Protocol Violation|0|||
127819930|NCT00923091|459960550|FG008|Period III (Single-Blind)|Protocol Violation|0|||
127819931|NCT00923091|459960551|FG009|Period III (Single-Blind)|Protocol Violation|0|||
127819932|NCT00923091|459960552|FG010|Period III (Single-Blind)|Protocol Violation|0|||
127819933|NCT00923091|459960553|FG011|Period III (Single-Blind)|Protocol Violation|0|||
127819934|NCT00923091|459960554|FG012|Period III (Single-Blind)|Protocol Violation|0|||
127819935|NCT00923091|459960542|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
127819936|NCT00923091|459960543|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
127819937|NCT00923091|459960544|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
127819938|NCT00923091|459960545|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
127819939|NCT00923091|459960546|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
127819940|NCT00923091|459960547|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
127819941|NCT00923091|459960548|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
127819942|NCT00923091|459960549|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
127819943|NCT00923091|459960550|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
127819944|NCT00923091|459960551|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
127819945|NCT00923091|459960552|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
127819946|NCT00923091|459960553|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
127819947|NCT00923091|459960554|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
127819948|NCT00923091|459960542|FG000|Period IV (Double-Blind)|Adverse Event|2|||
127819949|NCT00923091|459960543|FG001|Period IV (Double-Blind)|Adverse Event|0|||
127819950|NCT00923091|459960544|FG002|Period IV (Double-Blind)|Adverse Event|0|||
127819951|NCT00923091|459960545|FG003|Period IV (Double-Blind)|Adverse Event|0|||
127819952|NCT00923091|459960546|FG004|Period IV (Double-Blind)|Adverse Event|0|||
127819953|NCT00923091|459960547|FG005|Period IV (Double-Blind)|Adverse Event|0|||
127819954|NCT00923091|459960548|FG006|Period IV (Double-Blind)|Adverse Event|0|||
127819955|NCT00923091|459960549|FG007|Period IV (Double-Blind)|Adverse Event|0|||
127819956|NCT00923091|459960550|FG008|Period IV (Double-Blind)|Adverse Event|0|||
127819957|NCT00923091|459960551|FG009|Period IV (Double-Blind)|Adverse Event|0|||
127819958|NCT00923091|459960552|FG010|Period IV (Double-Blind)|Adverse Event|0|||
127819959|NCT00923091|459960553|FG011|Period IV (Double-Blind)|Adverse Event|0|||
127819960|NCT00923091|459960554|FG012|Period IV (Double-Blind)|Adverse Event|0|||
127819961|NCT00923091|459960542|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
127819962|NCT00923091|459960543|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
127819963|NCT00923091|459960544|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
127819964|NCT00923091|459960545|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
127819965|NCT00923091|459960546|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
127819966|NCT00923091|459960547|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
127819967|NCT00923091|459960548|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
127819968|NCT00923091|459960549|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
127819969|NCT00923091|459960550|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
127819970|NCT00923091|459960551|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
127819971|NCT00923091|459960552|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
127819972|NCT00923091|459960553|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
127819973|NCT00923091|459960554|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
127819974|NCT00923091|459960542|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
127819975|NCT00923091|459960543|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
127819976|NCT00923091|459960544|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
127819977|NCT00923091|459960545|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
127819978|NCT00923091|459960546|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
127819979|NCT00923091|459960547|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
127819980|NCT00923091|459960548|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
127819981|NCT00923091|459960549|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
127819982|NCT00923091|459960550|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
127819983|NCT00923091|459960551|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
127819984|NCT00923091|459960552|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
127819985|NCT00923091|459960553|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
127819986|NCT00923091|459960554|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
127819987|NCT00923091|459960542|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
127819988|NCT00923091|459960543|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
127819989|NCT00923091|459960544|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
127819990|NCT00923091|459960545|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
127819991|NCT00923091|459960546|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
127819992|NCT00923091|459960547|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
127819993|NCT00923091|459960548|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
127819994|NCT00923091|459960549|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
127819995|NCT00923091|459960550|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
127819996|NCT00923091|459960551|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
127819997|NCT00923091|459960552|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
127819998|NCT00923091|459960553|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
127819999|NCT00923091|459960554|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
127820000|NCT00923091|459960542|FG000|Period V (Double -Blind)|Protocol Violation|0|||
127820001|NCT00923091|459960543|FG001|Period V (Double -Blind)|Protocol Violation|0|||
127820002|NCT00923091|459960544|FG002|Period V (Double -Blind)|Protocol Violation|0|||
127820003|NCT00923091|459960545|FG003|Period V (Double -Blind)|Protocol Violation|0|||
127820004|NCT00923091|459960546|FG004|Period V (Double -Blind)|Protocol Violation|0|||
127820005|NCT00923091|459960547|FG005|Period V (Double -Blind)|Protocol Violation|0|||
127820006|NCT00923091|459960548|FG006|Period V (Double -Blind)|Protocol Violation|0|||
127820007|NCT00923091|459960549|FG007|Period V (Double -Blind)|Protocol Violation|0|||
127820008|NCT00923091|459960550|FG008|Period V (Double -Blind)|Protocol Violation|0|||
127820009|NCT00923091|459960551|FG009|Period V (Double -Blind)|Protocol Violation|0|||
127820010|NCT00923091|459960552|FG010|Period V (Double -Blind)|Protocol Violation|0|||
127820011|NCT00923091|459960553|FG011|Period V (Double -Blind)|Protocol Violation|0|||
127820012|NCT00923091|459960554|FG012|Period V (Double -Blind)|Protocol Violation|1|||
127820013|NCT00923091|459960542|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
127820014|NCT00923091|459960543|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
127820015|NCT00923091|459960544|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
127820016|NCT00923091|459960545|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
127820017|NCT00923091|459960546|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
127820018|NCT00923091|459960547|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
127820019|NCT00923091|459960548|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
127820020|NCT00923091|459960549|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
127820021|NCT00923091|459960550|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
127820022|NCT00923091|459960551|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
127820023|NCT00923091|459960552|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
127820024|NCT00923091|459960553|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
127820025|NCT00923091|459960554|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
127820026|NCT00923091|459960542|FG000|Period VI (Open-Label)|Adverse Event|17|||
127820027|NCT00923091|459960543|FG001|Period VI (Open-Label)|Adverse Event|0|||
127820028|NCT00923091|459960544|FG002|Period VI (Open-Label)|Adverse Event|4|||
127820029|NCT00923091|459960545|FG003|Period VI (Open-Label)|Adverse Event|1|||
127820030|NCT00923091|459960546|FG004|Period VI (Open-Label)|Adverse Event|1|||
127820031|NCT00923091|459960547|FG005|Period VI (Open-Label)|Adverse Event|0|||
127820032|NCT00923091|459960548|FG006|Period VI (Open-Label)|Adverse Event|0|||
127820033|NCT00923091|459960549|FG007|Period VI (Open-Label)|Adverse Event|0|||
127820034|NCT00923091|459960550|FG008|Period VI (Open-Label)|Adverse Event|0|||
127820035|NCT00923091|459960551|FG009|Period VI (Open-Label)|Adverse Event|0|||
127820036|NCT00923091|459960552|FG010|Period VI (Open-Label)|Adverse Event|0|||
127820037|NCT00923091|459960553|FG011|Period VI (Open-Label)|Adverse Event|0|||
127820038|NCT00923091|459960554|FG012|Period VI (Open-Label)|Adverse Event|0|||
127820039|NCT00923091|459960542|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
127820040|NCT00923091|459960543|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
127820041|NCT00923091|459960544|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
127820042|NCT00923091|459960545|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
127820043|NCT00923091|459960546|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
127820044|NCT00923091|459960547|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
127820045|NCT00923091|459960548|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
127820046|NCT00923091|459960549|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
127820047|NCT00923091|459960550|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
127820048|NCT00923091|459960551|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
127820049|NCT00923091|459960552|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
127820050|NCT00923091|459960553|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
127820051|NCT00923091|459960554|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
127820052|NCT00923091|459960542|FG000|Period VI (Open-Label)|Protocol Violation|6|||
127820053|NCT00923091|459960543|FG001|Period VI (Open-Label)|Protocol Violation|1|||
127820054|NCT00923091|459960544|FG002|Period VI (Open-Label)|Protocol Violation|3|||
127820055|NCT00923091|459960545|FG003|Period VI (Open-Label)|Protocol Violation|1|||
127820056|NCT00923091|459960546|FG004|Period VI (Open-Label)|Protocol Violation|4|||
127820057|NCT00923091|459960547|FG005|Period VI (Open-Label)|Protocol Violation|0|||
127820058|NCT00923091|459960548|FG006|Period VI (Open-Label)|Protocol Violation|0|||
127820059|NCT00923091|459960549|FG007|Period VI (Open-Label)|Protocol Violation|0|||
127820060|NCT00923091|459960550|FG008|Period VI (Open-Label)|Protocol Violation|0|||
127820061|NCT00923091|459960551|FG009|Period VI (Open-Label)|Protocol Violation|0|||
127820062|NCT00923091|459960552|FG010|Period VI (Open-Label)|Protocol Violation|0|||
127820063|NCT00923091|459960553|FG011|Period VI (Open-Label)|Protocol Violation|0|||
127820064|NCT00923091|459960554|FG012|Period VI (Open-Label)|Protocol Violation|0|||
127820065|NCT00923091|459960542|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
127894611|NCT03335371|460237205|FG004|Overall Study|Lost to Follow-up|1|||
127894612|NCT03335371|460237201|FG000|Overall Study|Withdrawal by Subject|0|||
127894613|NCT03335371|460237202|FG001|Overall Study|Withdrawal by Subject|0|||
127820066|NCT00923091|459960543|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
127820067|NCT00923091|459960544|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
127820068|NCT00923091|459960545|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
127894614|NCT03335371|460237203|FG002|Overall Study|Withdrawal by Subject|0|||
127820069|NCT00923091|459960546|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
127820070|NCT00923091|459960547|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
127820071|NCT00923091|459960548|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
127820072|NCT00923091|459960549|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
127820073|NCT00923091|459960550|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
127820074|NCT00923091|459960551|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
127820075|NCT00923091|459960552|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
127820076|NCT00923091|459960553|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
127820077|NCT00923091|459960554|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
127820078|NCT00923091|459960542|FG000|Period VI (Open-Label)|Other Reason|0|||
127820079|NCT00923091|459960543|FG001|Period VI (Open-Label)|Other Reason|0|||
127820080|NCT00923091|459960544|FG002|Period VI (Open-Label)|Other Reason|0|||
127820081|NCT00923091|459960545|FG003|Period VI (Open-Label)|Other Reason|1|||
127820082|NCT00923091|459960546|FG004|Period VI (Open-Label)|Other Reason|1|||
127820083|NCT00923091|459960547|FG005|Period VI (Open-Label)|Other Reason|0|||
127820084|NCT00923091|459960548|FG006|Period VI (Open-Label)|Other Reason|0|||
127820085|NCT00923091|459960549|FG007|Period VI (Open-Label)|Other Reason|0|||
127820086|NCT00923091|459960550|FG008|Period VI (Open-Label)|Other Reason|0|||
127820087|NCT00923091|459960551|FG009|Period VI (Open-Label)|Other Reason|0|||
127820088|NCT00923091|459960552|FG010|Period VI (Open-Label)|Other Reason|0|||
127820089|NCT00923091|459960553|FG011|Period VI (Open-Label)|Other Reason|0|||
127820090|NCT00923091|459960554|FG012|Period VI (Open-Label)|Other Reason|0|||
127820091|NCT00467649|459960558|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
127820092|NCT00467649|459960559|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
127820093|NCT00467649|459960560|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
127820094|NCT00467649|459960561|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
127820095|NCT00467649|459960562|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
127820096|NCT00467649|459960563|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
127820097|NCT00467649|459960558|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
127820098|NCT00467649|459960559|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
127820099|NCT00467649|459960560|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
127820100|NCT00467649|459960561|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
127820101|NCT00467649|459960562|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
127820102|NCT00467649|459960563|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
127820103|NCT00467649|459960558|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
127820104|NCT00467649|459960559|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
127820105|NCT00467649|459960560|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
127820106|NCT00467649|459960561|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
127820107|NCT00467649|459960562|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
127820108|NCT00467649|459960563|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
127820109|NCT00467649|459960558|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
127820110|NCT00467649|459960559|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
127820111|NCT00467649|459960560|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
127820112|NCT00467649|459960561|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
127820113|NCT00467649|459960562|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
127820114|NCT00467649|459960563|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
127820115|NCT00467649|459960558|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
127820116|NCT00467649|459960559|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
127820117|NCT00467649|459960560|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
127820118|NCT00467649|459960561|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
127820119|NCT00467649|459960562|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
127820120|NCT00467649|459960563|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
127820121|NCT00467649|459960558|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
127820122|NCT00467649|459960559|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
127820123|NCT00467649|459960560|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
127820124|NCT00467649|459960561|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
127820125|NCT00467649|459960562|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
127820126|NCT00467649|459960563|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
127820127|NCT00467649|459960558|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
127820128|NCT00467649|459960559|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
127820129|NCT00467649|459960560|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
127820130|NCT00467649|459960561|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
127820131|NCT00467649|459960562|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
127820132|NCT00467649|459960563|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
127820133|NCT03233048|459960566|FG000|Overall Study|Withdrawal by Subject|1|||
127820134|NCT05897853|459960575|FG000|Overall Study|Lost to Follow-up|2|||
127820135|NCT05897853|459960576|FG001|Overall Study|Lost to Follow-up|0|||
127820136|NCT05897853|459960575|FG000|Overall Study|Diagnostic criteria not met at baseline|0|||
127820137|NCT05897853|459960576|FG001|Overall Study|Diagnostic criteria not met at baseline|8|||
127820138|NCT02782715|459960581|FG000|Overall Study|Withdrawal by Subject|1|||
127820139|NCT04458857|459960582|FG000|Overall Study|Adverse Event|0|||
127820140|NCT04458857|459960583|FG001|Overall Study|Adverse Event|1|||
127820141|NCT04458857|459960584|FG002|Overall Study|Adverse Event|0|||
127820142|NCT04458857|459960582|FG000|Overall Study|Withdrawal by Subject|2|||
127820143|NCT04458857|459960583|FG001|Overall Study|Withdrawal by Subject|0|||
127820144|NCT04458857|459960584|FG002|Overall Study|Withdrawal by Subject|0|||
127820145|NCT04458857|459960582|FG000|Overall Study|Withdrawal by parent/guardian|0|||
127820146|NCT04458857|459960583|FG001|Overall Study|Withdrawal by parent/guardian|0|||
127820147|NCT04458857|459960584|FG002|Overall Study|Withdrawal by parent/guardian|1|||
127820148|NCT04458857|459960582|FG000|Overall Study|Non-compliance with study drug|0|||
127820149|NCT04458857|459960583|FG001|Overall Study|Non-compliance with study drug|1|||
127820150|NCT04458857|459960584|FG002|Overall Study|Non-compliance with study drug|0|||
127820151|NCT04458857|459960582|FG000|Overall Study|Lost to Follow-up|4|||
127820152|NCT04458857|459960583|FG001|Overall Study|Lost to Follow-up|1|||
127820153|NCT04458857|459960584|FG002|Overall Study|Lost to Follow-up|0|||
127820154|NCT03368404|459960587|FG000|Overall Study|Adverse Event|2|||
127820155|NCT03368404|459960588|FG001|Overall Study|Adverse Event|1|||
127820156|NCT03368404|459960587|FG000|Overall Study|Withdrawal by Subject|1|||
127820157|NCT03368404|459960588|FG001|Overall Study|Withdrawal by Subject|1|||
127820158|NCT02983292|459960589|FG000|Overall Study|Participant unwell & cannot travel|2|||
127820159|NCT02983292|459960589|FG000|Overall Study|Lost to Follow-up|3|||
127820160|NCT02983292|459960589|FG000|Overall Study|Participant withdrew consent|2|||
127820161|NCT02983292|459960589|FG000|Overall Study|Revision|7|||
127820162|NCT02983292|459960589|FG000|Overall Study|Death|1|||
127820163|NCT02983292|459960589|FG000|Overall Study|Participant did not return due to COVID-19 related lockdown|30|||
127820164|NCT02983292|459960589|FG000|Overall Study|Participant failed to return for follow-up visits|6|||
127820165|NCT02983292|459960589|FG000|Overall Study|Participant relocation|1|||
127820166|NCT00964795|459960590|FG000|Overall Study|Withdrawal by Subject|79|||
127820167|NCT00964795|459960590|FG000|Overall Study|Adverse Event|12|||
127820168|NCT00964795|459960590|FG000|Overall Study|Death|14|||
127820169|NCT00964795|459960590|FG000|Overall Study|Lost to Follow-up|7|||
127820170|NCT00964795|459960590|FG000|Overall Study|Termination of Study by Sponsor|169|||
127820171|NCT00964795|459960590|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
127820172|NCT00964795|459960590|FG000|Overall Study|Other|23|||
127820173|NCT00586690|459960595|FG000|Overall Study|Death|2|||
127820174|NCT00586690|459960596|FG001|Overall Study|Death|0|||
127820175|NCT00586690|459960595|FG000|Overall Study|Disease Progression|10|||
127820176|NCT00586690|459960596|FG001|Overall Study|Disease Progression|0|||
127820177|NCT00586690|459960595|FG000|Overall Study|Adverse Event|1|||
127820178|NCT00586690|459960596|FG001|Overall Study|Adverse Event|0|||
127820179|NCT00586690|459960595|FG000|Overall Study|Lack of Efficacy|2|||
127820180|NCT00586690|459960596|FG001|Overall Study|Lack of Efficacy|0|||
127820181|NCT00586690|459960595|FG000|Overall Study|Lab can't accommodate|1|||
127820182|NCT00586690|459960596|FG001|Overall Study|Lab can't accommodate|0|||
127820183|NCT00857246|459960597|FG000|Induction Regimen|Adverse Event|1|||
127820184|NCT00857246|459960597|FG000|Induction Regimen|disease-related complications|1|||
127820185|NCT00857246|459960597|FG000|Induction Regimen|Withdrawal by Subject|1|||
127820186|NCT00857246|459960597|FG000|Surgery (Curative)|disease progression|6|||
127820187|NCT00857246|459960597|FG000|ChemoRT|Withdrawal by Subject|1|||
127820188|NCT00857246|459960597|FG000|ChemoRT|Adverse Event|2|||
127820189|NCT02104180|459960600|FG000|Overall Study|Protocol Violation|1|||
127820190|NCT02104180|459960601|FG001|Overall Study|Protocol Violation|0|||
127820191|NCT01524289|459960602|FG000|Overall Study|Lost to Follow-up|0|||
127820192|NCT01524289|459960603|FG001|Overall Study|Lost to Follow-up|1|||
127820193|NCT01524289|459960602|FG000|Overall Study|Physician Decision|1|||
127820194|NCT01524289|459960603|FG001|Overall Study|Physician Decision|0|||
127820195|NCT01524289|459960602|FG000|Overall Study|Protocol Violation|5|||
127820196|NCT01524289|459960603|FG001|Overall Study|Protocol Violation|1|||
127820197|NCT01524289|459960602|FG000|Overall Study|Withdrawal by Subject|11|||
127820198|NCT01524289|459960603|FG001|Overall Study|Withdrawal by Subject|7|||
127820199|NCT01524289|459960602|FG000|Overall Study|Adverse Event|12|||
127820200|NCT01524289|459960603|FG001|Overall Study|Adverse Event|5|||
127820201|NCT01524289|459960602|FG000|Overall Study|Did not take study medication|1|||
127820202|NCT01524289|459960603|FG001|Overall Study|Did not take study medication|0|||
127820203|NCT02704429|459960604|FG000|Part A: 24 Weeks|Adverse Event|3|||
127820204|NCT02704429|459960605|FG001|Part A: 24 Weeks|Adverse Event|0|||
127820205|NCT02704429|459960604|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
127820206|NCT02704429|459960605|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
127820207|NCT01821677|459960606|FG000|Overall Study|Adverse Event|4|||
127820208|NCT01821677|459960607|FG001|Overall Study|Adverse Event|6|||
127820209|NCT01821677|459960608|FG002|Overall Study|Adverse Event|5|||
127820210|NCT01821677|459960606|FG000|Overall Study|Physician Decision|1|||
127820211|NCT01821677|459960607|FG001|Overall Study|Physician Decision|4|||
127820212|NCT01821677|459960608|FG002|Overall Study|Physician Decision|1|||
127820213|NCT01821677|459960606|FG000|Overall Study|Non-compliance|0|||
127820214|NCT01821677|459960607|FG001|Overall Study|Non-compliance|1|||
127820215|NCT01821677|459960608|FG002|Overall Study|Non-compliance|2|||
127820216|NCT01821677|459960606|FG000|Overall Study|Lost to Follow-up|2|||
127820217|NCT01821677|459960607|FG001|Overall Study|Lost to Follow-up|1|||
127820218|NCT01821677|459960608|FG002|Overall Study|Lost to Follow-up|3|||
127820219|NCT01821677|459960606|FG000|Overall Study|Protocol Violation|0|||
127820220|NCT01821677|459960607|FG001|Overall Study|Protocol Violation|0|||
127820221|NCT01821677|459960608|FG002|Overall Study|Protocol Violation|2|||
127820222|NCT01821677|459960606|FG000|Overall Study|Withdrawal by Subject|7|||
127820223|NCT01821677|459960607|FG001|Overall Study|Withdrawal by Subject|3|||
127820224|NCT01821677|459960608|FG002|Overall Study|Withdrawal by Subject|2|||
127820225|NCT01821677|459960606|FG000|Overall Study|Other|9|||
127820226|NCT01821677|459960607|FG001|Overall Study|Other|0|||
127820227|NCT01821677|459960608|FG002|Overall Study|Other|0|||
127820228|NCT00907738|459960609|FG000|Overall Study|Adverse Event|2|||
127820229|NCT00907738|459960610|FG001|Overall Study|Adverse Event|0|||
127820230|NCT00907738|459960611|FG002|Overall Study|Adverse Event|1|||
127820231|NCT00907738|459960612|FG003|Overall Study|Adverse Event|0|||
127820232|NCT00907738|459960613|FG004|Overall Study|Adverse Event|0|||
127820233|NCT00907738|459960609|FG000|Overall Study|not specified or withdrew consent|3|||
127820234|NCT00907738|459960610|FG001|Overall Study|not specified or withdrew consent|0|||
127820235|NCT00907738|459960611|FG002|Overall Study|not specified or withdrew consent|0|||
127820236|NCT00907738|459960612|FG003|Overall Study|not specified or withdrew consent|0|||
127820237|NCT00907738|459960613|FG004|Overall Study|not specified or withdrew consent|0|||
127820238|NCT00907738|459960609|FG000|Overall Study|Disease progression|8|||
127820239|NCT00907738|459960610|FG001|Overall Study|Disease progression|1|||
127820240|NCT00907738|459960611|FG002|Overall Study|Disease progression|6|||
127820241|NCT00907738|459960612|FG003|Overall Study|Disease progression|4|||
127820242|NCT00907738|459960613|FG004|Overall Study|Disease progression|2|||
127820243|NCT01089725|459960614|FG000|Overall Study|Adverse Event|1|||
127820244|NCT01089725|459960615|FG001|Overall Study|Adverse Event|1|||
127820245|NCT01089725|459960616|FG002|Overall Study|Adverse Event|0|||
127820246|NCT01089725|459960617|FG003|Overall Study|Adverse Event|0|||
127820247|NCT01089725|459960618|FG004|Overall Study|Adverse Event|2|||
127820248|NCT01089725|459960614|FG000|Overall Study|Lack of Efficacy|4|||
127820249|NCT01089725|459960615|FG001|Overall Study|Lack of Efficacy|3|||
127820250|NCT01089725|459960616|FG002|Overall Study|Lack of Efficacy|1|||
127894615|NCT03335371|460237204|FG003|Overall Study|Withdrawal by Subject|0|||
127894616|NCT03335371|460237205|FG004|Overall Study|Withdrawal by Subject|1|||
127894617|NCT03335371|460237201|FG000|Overall Study|Randomization Error|0|||
127894618|NCT03335371|460237202|FG001|Overall Study|Randomization Error|0|||
127894619|NCT03335371|460237203|FG002|Overall Study|Randomization Error|1|||
127894620|NCT03335371|460237204|FG003|Overall Study|Randomization Error|0|||
127894621|NCT03335371|460237205|FG004|Overall Study|Randomization Error|0|||
127894622|NCT01725451|460237207|FG000|Period 1|Withdrawal by Subject|1|||
127894623|NCT01725451|460237208|FG001|Period 1|Withdrawal by Subject|0|||
127894624|NCT01725451|460237209|FG002|Period 1|Withdrawal by Subject|0|||
127894625|NCT01725451|460237210|FG003|Period 1|Withdrawal by Subject|0|||
127894626|NCT01725451|460237207|FG000|Washout From Period 3|Protocol Violation|0|||
127894627|NCT01725451|460237208|FG001|Washout From Period 3|Protocol Violation|0|||
127894628|NCT01725451|460237209|FG002|Washout From Period 3|Protocol Violation|1|||
127894629|NCT01725451|460237210|FG003|Washout From Period 3|Protocol Violation|0|||
127894630|NCT01725451|460237207|FG000|Washout From Period 3|Adverse Event|0|||
127894631|NCT01725451|460237208|FG001|Washout From Period 3|Adverse Event|1|||
127894632|NCT01725451|460237209|FG002|Washout From Period 3|Adverse Event|0|||
127894633|NCT01725451|460237210|FG003|Washout From Period 3|Adverse Event|0|||
127894634|NCT01725451|460237207|FG000|Period 4|Adverse Event|0|||
127894635|NCT01725451|460237208|FG001|Period 4|Adverse Event|0|||
127894636|NCT01725451|460237209|FG002|Period 4|Adverse Event|1|||
127820251|NCT01089725|459960617|FG003|Overall Study|Lack of Efficacy|0|||
127820252|NCT01089725|459960618|FG004|Overall Study|Lack of Efficacy|4|||
127820253|NCT01089725|459960614|FG000|Overall Study|Lost to Follow-up|2|||
127820254|NCT01089725|459960615|FG001|Overall Study|Lost to Follow-up|2|||
127820255|NCT01089725|459960616|FG002|Overall Study|Lost to Follow-up|0|||
127820256|NCT01089725|459960617|FG003|Overall Study|Lost to Follow-up|3|||
127820257|NCT01089725|459960618|FG004|Overall Study|Lost to Follow-up|0|||
127820258|NCT01089725|459960614|FG000|Overall Study|Protocol Violation|0|||
127820259|NCT01089725|459960615|FG001|Overall Study|Protocol Violation|0|||
127820260|NCT01089725|459960616|FG002|Overall Study|Protocol Violation|1|||
127820261|NCT01089725|459960617|FG003|Overall Study|Protocol Violation|1|||
127820262|NCT01089725|459960618|FG004|Overall Study|Protocol Violation|0|||
127894637|NCT01725451|460237210|FG003|Period 4|Adverse Event|0|||
127820263|NCT01089725|459960614|FG000|Overall Study|Withdrawal by Subject|5|||
127820264|NCT01089725|459960615|FG001|Overall Study|Withdrawal by Subject|5|||
127820265|NCT01089725|459960616|FG002|Overall Study|Withdrawal by Subject|4|||
127820266|NCT01089725|459960617|FG003|Overall Study|Withdrawal by Subject|5|||
127820267|NCT01089725|459960618|FG004|Overall Study|Withdrawal by Subject|4|||
127820268|NCT01089725|459960614|FG000|Overall Study|Study Terminated by Sponsor|51|||
127820269|NCT01089725|459960615|FG001|Overall Study|Study Terminated by Sponsor|56|||
127820270|NCT01089725|459960616|FG002|Overall Study|Study Terminated by Sponsor|53|||
127820271|NCT01089725|459960617|FG003|Overall Study|Study Terminated by Sponsor|68|||
127820272|NCT01089725|459960618|FG004|Overall Study|Study Terminated by Sponsor|68|||
127894638|NCT02015793|460237213|FG000|Overall Study|Adverse Event|3|||
127894639|NCT02015793|460237214|FG001|Overall Study|Adverse Event|3|||
127894640|NCT02015793|460237213|FG000|Overall Study|Withdrawal by Subject|1|||
127894641|NCT02015793|460237214|FG001|Overall Study|Withdrawal by Subject|1|||
127894642|NCT00437281|460237215|FG000|Overall Study|Adverse Event|0|||
127820273|NCT01089725|459960614|FG000|Overall Study|Randomized, but not treated|0|||
127820274|NCT01089725|459960615|FG001|Overall Study|Randomized, but not treated|1|||
127820275|NCT01089725|459960616|FG002|Overall Study|Randomized, but not treated|2|||
127820276|NCT01089725|459960617|FG003|Overall Study|Randomized, but not treated|1|||
127820277|NCT01089725|459960618|FG004|Overall Study|Randomized, but not treated|2|||
127820278|NCT01089725|459960614|FG000|Overall Study|Other|3|||
127820279|NCT01089725|459960615|FG001|Overall Study|Other|0|||
127820280|NCT01089725|459960616|FG002|Overall Study|Other|0|||
127820281|NCT01089725|459960617|FG003|Overall Study|Other|1|||
127820282|NCT01089725|459960618|FG004|Overall Study|Other|0|||
127820283|NCT01582282|459962293|FG000|Overall Study|Adverse Event|1|||
127820284|NCT01582282|459962294|FG001|Overall Study|Adverse Event|1|||
127820285|NCT01582282|459962295|FG002|Overall Study|Adverse Event|0|||
127820286|NCT01582282|459962293|FG000|Overall Study|Lost to Follow-up|1|||
127820287|NCT01582282|459962294|FG001|Overall Study|Lost to Follow-up|0|||
127820288|NCT01582282|459962295|FG002|Overall Study|Lost to Follow-up|0|||
127820289|NCT01582282|459962293|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
127820290|NCT01582282|459962294|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
127820291|NCT01582282|459962295|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
127820292|NCT01486316|459962296|FG000|Overall Study|Device explanted with/without re-implant|3|||
127820293|NCT01486316|459962297|FG001|Overall Study|Device explanted with/without re-implant|2|||
127820294|NCT01486316|459962298|FG002|Overall Study|Device explanted with/without re-implant|0|||
127820295|NCT01486316|459962299|FG003|Overall Study|Device explanted with/without re-implant|2|||
127820296|NCT01486316|459962296|FG000|Overall Study|Not meeting eligibility criteria|0|||
127820297|NCT01486316|459962297|FG001|Overall Study|Not meeting eligibility criteria|0|||
127820298|NCT01486316|459962298|FG002|Overall Study|Not meeting eligibility criteria|1|||
127820299|NCT01486316|459962299|FG003|Overall Study|Not meeting eligibility criteria|0|||
127820300|NCT01486316|459962296|FG000|Overall Study|Withdrawal by Subject|1|||
127820301|NCT01486316|459962297|FG001|Overall Study|Withdrawal by Subject|0|||
127820302|NCT01486316|459962298|FG002|Overall Study|Withdrawal by Subject|3|||
127820303|NCT01486316|459962299|FG003|Overall Study|Withdrawal by Subject|0|||
127820304|NCT01486316|459962296|FG000|Overall Study|Physician Decision|0|||
127820305|NCT01486316|459962297|FG001|Overall Study|Physician Decision|0|||
127820306|NCT01486316|459962298|FG002|Overall Study|Physician Decision|1|||
127820307|NCT01486316|459962299|FG003|Overall Study|Physician Decision|0|||
127820308|NCT01486316|459962296|FG000|Overall Study|Death|0|||
127820309|NCT01486316|459962297|FG001|Overall Study|Death|1|||
127820310|NCT01486316|459962298|FG002|Overall Study|Death|0|||
127820311|NCT01486316|459962299|FG003|Overall Study|Death|0|||
127820312|NCT02495077|459962308|FG000|Overall Study|Adverse Event|0|||
127820313|NCT02495077|459962309|FG001|Overall Study|Adverse Event|1|||
127820314|NCT02495077|459962310|FG002|Overall Study|Adverse Event|1|||
127820315|NCT02495077|459962311|FG003|Overall Study|Adverse Event|0|||
127820316|NCT02495077|459962308|FG000|Overall Study|Death|3|||
127820317|NCT02495077|459962309|FG001|Overall Study|Death|5|||
127820318|NCT02495077|459962310|FG002|Overall Study|Death|0|||
127820319|NCT02495077|459962311|FG003|Overall Study|Death|0|||
127820320|NCT02495077|459962308|FG000|Overall Study|Lost to Follow-up|6|||
127820321|NCT02495077|459962309|FG001|Overall Study|Lost to Follow-up|4|||
127894643|NCT00437281|460237216|FG001|Overall Study|Adverse Event|0|||
127894644|NCT00437281|460237217|FG002|Overall Study|Adverse Event|0|||
127894645|NCT00437281|460237218|FG003|Overall Study|Adverse Event|1|||
127894646|NCT00437281|460237219|FG004|Overall Study|Adverse Event|0|||
127894647|NCT00437281|460237220|FG005|Overall Study|Adverse Event|1|||
127894648|NCT00437281|460237221|FG006|Overall Study|Adverse Event|0|||
127894649|NCT00437281|460237222|FG007|Overall Study|Adverse Event|0|||
127894650|NCT00437281|460237223|FG008|Overall Study|Adverse Event|0|||
127894651|NCT00437281|460237224|FG009|Overall Study|Adverse Event|1|||
127894652|NCT00437281|460237225|FG010|Overall Study|Adverse Event|0|||
127894653|NCT00437281|460237226|FG011|Overall Study|Adverse Event|0|||
127894654|NCT00437281|460237227|FG012|Overall Study|Adverse Event|0|||
127894655|NCT00437281|460237228|FG013|Overall Study|Adverse Event|1|||
127894656|NCT00437281|460237229|FG014|Overall Study|Adverse Event|1|||
127894657|NCT00437281|460237230|FG015|Overall Study|Adverse Event|0|||
127894658|NCT00437281|460237231|FG016|Overall Study|Adverse Event|0|||
127820322|NCT02495077|459962310|FG002|Overall Study|Lost to Follow-up|0|||
127820323|NCT02495077|459962311|FG003|Overall Study|Lost to Follow-up|0|||
127820324|NCT02495077|459962308|FG000|Overall Study|Physician Decision|2|||
127820325|NCT02495077|459962309|FG001|Overall Study|Physician Decision|1|||
127820326|NCT02495077|459962310|FG002|Overall Study|Physician Decision|4|||
127820327|NCT02495077|459962311|FG003|Overall Study|Physician Decision|0|||
127820328|NCT02495077|459962308|FG000|Overall Study|Protocol Violation|0|||
127820329|NCT02495077|459962309|FG001|Overall Study|Protocol Violation|1|||
127820330|NCT02495077|459962310|FG002|Overall Study|Protocol Violation|0|||
127820331|NCT02495077|459962311|FG003|Overall Study|Protocol Violation|0|||
127894659|NCT00437281|460237232|FG017|Overall Study|Adverse Event|0|||
127894660|NCT00437281|460237233|FG018|Overall Study|Adverse Event|1|||
127894661|NCT00437281|460237234|FG019|Overall Study|Adverse Event|0|||
127820332|NCT02495077|459962308|FG000|Overall Study|Screen Failure|0|||
127820333|NCT02495077|459962309|FG001|Overall Study|Screen Failure|0|||
127820334|NCT02495077|459962310|FG002|Overall Study|Screen Failure|0|||
127820335|NCT02495077|459962311|FG003|Overall Study|Screen Failure|48|||
127820336|NCT02495077|459962308|FG000|Overall Study|Withdrawal by Subject|7|||
127820337|NCT02495077|459962309|FG001|Overall Study|Withdrawal by Subject|7|||
127820338|NCT02495077|459962310|FG002|Overall Study|Withdrawal by Subject|7|||
127820339|NCT02495077|459962311|FG003|Overall Study|Withdrawal by Subject|0|||
127820340|NCT02495077|459962308|FG000|Overall Study|Covid-19 research restrictions|1|||
127820341|NCT02495077|459962309|FG001|Overall Study|Covid-19 research restrictions|0|||
127820342|NCT02495077|459962310|FG002|Overall Study|Covid-19 research restrictions|0|||
127820343|NCT02495077|459962311|FG003|Overall Study|Covid-19 research restrictions|0|||
127820344|NCT02495077|459962308|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
127820345|NCT02495077|459962309|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
127820346|NCT02495077|459962310|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
127820347|NCT02495077|459962311|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
127820348|NCT02495077|459962308|FG000|Overall Study|Incarcerated|0|||
127820349|NCT02495077|459962309|FG001|Overall Study|Incarcerated|1|||
127820350|NCT02495077|459962310|FG002|Overall Study|Incarcerated|0|||
127820351|NCT02495077|459962311|FG003|Overall Study|Incarcerated|0|||
127820352|NCT02495077|459962308|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
127820353|NCT02495077|459962309|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
127820354|NCT02495077|459962310|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
127820355|NCT02495077|459962311|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
127820356|NCT02495077|459962308|FG000|Overall Study|Timing of transplant and randomization|0|||
127820357|NCT02495077|459962309|FG001|Overall Study|Timing of transplant and randomization|0|||
127820358|NCT02495077|459962310|FG002|Overall Study|Timing of transplant and randomization|5|||
127820359|NCT02495077|459962311|FG003|Overall Study|Timing of transplant and randomization|0|||
127820360|NCT02742649|459962312|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
127820361|NCT02742649|459962313|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
127820362|NCT02742649|459962314|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
127820363|NCT02742649|459962315|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
127820364|NCT02742649|459962316|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
127820365|NCT02742649|459962312|FG000|Double-Blind Treatment Period|Adverse Event|0|||
127820366|NCT02742649|459962313|FG001|Double-Blind Treatment Period|Adverse Event|1|||
127820367|NCT02742649|459962314|FG002|Double-Blind Treatment Period|Adverse Event|0|||
127820368|NCT02742649|459962315|FG003|Double-Blind Treatment Period|Adverse Event|0|||
127820369|NCT02742649|459962316|FG004|Double-Blind Treatment Period|Adverse Event|0|||
127820370|NCT02742649|459962312|FG000|Open-Label Period|Lost to Follow-up|0|||
127820371|NCT02742649|459962313|FG001|Open-Label Period|Lost to Follow-up|0|||
127820372|NCT02742649|459962314|FG002|Open-Label Period|Lost to Follow-up|0|||
127820373|NCT02742649|459962315|FG003|Open-Label Period|Lost to Follow-up|0|||
127820374|NCT02742649|459962316|FG004|Open-Label Period|Lost to Follow-up|1|||
127820375|NCT00417612|459962327|FG000|Overall Study|Errant diagnosis|0|||
127820376|NCT00417612|459962328|FG001|Overall Study|Errant diagnosis|1|||
127820377|NCT00417612|459962327|FG000|Overall Study|Adverse Event|2|||
127820378|NCT00417612|459962328|FG001|Overall Study|Adverse Event|0|||
127820379|NCT00417612|459962327|FG000|Overall Study|Protocol Violation|0|||
127820380|NCT00417612|459962328|FG001|Overall Study|Protocol Violation|2|||
127820381|NCT00417612|459962327|FG000|Overall Study|Lost to Follow-up|1|||
127820382|NCT00417612|459962328|FG001|Overall Study|Lost to Follow-up|0|||
127820383|NCT00224107|459962329|FG000|Overall Study|Adverse Event|20|||
127820384|NCT00224107|459962330|FG001|Overall Study|Adverse Event|6|||
127820385|NCT00224107|459962329|FG000|Overall Study|Protocol Violation|2|||
127820386|NCT00224107|459962330|FG001|Overall Study|Protocol Violation|3|||
127894662|NCT00437281|460237215|FG000|Overall Study|Lost to Follow-up|0|||
127894663|NCT00437281|460237216|FG001|Overall Study|Lost to Follow-up|0|||
127894664|NCT00437281|460237217|FG002|Overall Study|Lost to Follow-up|0|||
127894665|NCT00437281|460237218|FG003|Overall Study|Lost to Follow-up|0|||
127894666|NCT00437281|460237219|FG004|Overall Study|Lost to Follow-up|0|||
127820387|NCT00224107|459962329|FG000|Overall Study|Withdrawal by Subject|1|||
127820388|NCT00224107|459962330|FG001|Overall Study|Withdrawal by Subject|4|||
127820389|NCT00224107|459962329|FG000|Overall Study|Lack of Efficacy|2|||
127820390|NCT00224107|459962330|FG001|Overall Study|Lack of Efficacy|0|||
127820391|NCT00224107|459962329|FG000|Overall Study|Lost to Follow-up|4|||
127820392|NCT00224107|459962330|FG001|Overall Study|Lost to Follow-up|0|||
127820393|NCT00224107|459962329|FG000|Overall Study|Physician Decision|1|||
127820394|NCT00224107|459962330|FG001|Overall Study|Physician Decision|0|||
127820395|NCT00224107|459962329|FG000|Overall Study|Other|1|||
127820396|NCT00224107|459962330|FG001|Overall Study|Other|1|||
127820397|NCT00685178|459962331|FG000|Overall Study|Adverse Event|1|||
127820398|NCT00685178|459962332|FG001|Overall Study|Adverse Event|5|||
127820399|NCT00685178|459962333|FG002|Overall Study|Adverse Event|2|||
127820400|NCT00685178|459962334|FG003|Overall Study|Adverse Event|4|||
127894667|NCT00437281|460237220|FG005|Overall Study|Lost to Follow-up|0|||
127820401|NCT00685178|459962331|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
127820402|NCT00685178|459962332|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
127820403|NCT00685178|459962333|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
127820404|NCT00685178|459962334|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
127820405|NCT00685178|459962331|FG000|Overall Study|voluntary study discharge|4|||
127820406|NCT00685178|459962332|FG001|Overall Study|voluntary study discharge|5|||
127820407|NCT00685178|459962333|FG002|Overall Study|voluntary study discharge|1|||
127820408|NCT00685178|459962334|FG003|Overall Study|voluntary study discharge|1|||
127820409|NCT00685178|459962331|FG000|Overall Study|incarcerated|1|||
127820410|NCT00685178|459962332|FG001|Overall Study|incarcerated|3|||
127820411|NCT00685178|459962333|FG002|Overall Study|incarcerated|7|||
127820412|NCT00685178|459962334|FG003|Overall Study|incarcerated|0|||
127820413|NCT00685178|459962331|FG000|Overall Study|administrative (disciplinary) discharge|0|||
127820414|NCT00685178|459962332|FG001|Overall Study|administrative (disciplinary) discharge|1|||
127820415|NCT00685178|459962333|FG002|Overall Study|administrative (disciplinary) discharge|0|||
127820416|NCT00685178|459962334|FG003|Overall Study|administrative (disciplinary) discharge|2|||
127820417|NCT00685178|459962331|FG000|Overall Study|Pregnancy|0|||
127820418|NCT00685178|459962332|FG001|Overall Study|Pregnancy|0|||
127820419|NCT00685178|459962333|FG002|Overall Study|Pregnancy|0|||
127820420|NCT00685178|459962334|FG003|Overall Study|Pregnancy|1|||
127820421|NCT00077623|459962335|FG000|Overall Study|Adverse Event|1|||
127820422|NCT00077623|459962336|FG001|Overall Study|Adverse Event|0|||
127820423|NCT00077623|459962337|FG002|Overall Study|Adverse Event|1|||
127820424|NCT00077623|459962335|FG000|Overall Study|Withdrawal by Subject|2|||
127820425|NCT00077623|459962336|FG001|Overall Study|Withdrawal by Subject|10|||
127820426|NCT00077623|459962337|FG002|Overall Study|Withdrawal by Subject|1|||
127820427|NCT00077623|459962335|FG000|Overall Study|Other-Non safety reason|18|||
127820428|NCT00077623|459962336|FG001|Overall Study|Other-Non safety reason|15|||
127820429|NCT00077623|459962337|FG002|Overall Study|Other-Non safety reason|19|||
127820430|NCT00077623|459962335|FG000|Overall Study|Insufficient therapeutic response|2|||
127820431|NCT00077623|459962336|FG001|Overall Study|Insufficient therapeutic response|0|||
127820432|NCT00077623|459962337|FG002|Overall Study|Insufficient therapeutic response|0|||
127820433|NCT00077623|459962335|FG000|Overall Study|Death|12|||
127820434|NCT00077623|459962336|FG001|Overall Study|Death|18|||
127820435|NCT00077623|459962337|FG002|Overall Study|Death|11|||
127820436|NCT00077623|459962335|FG000|Overall Study|Failure to return|1|||
127820437|NCT00077623|459962336|FG001|Overall Study|Failure to return|0|||
127820438|NCT00077623|459962337|FG002|Overall Study|Failure to return|0|||
127820439|NCT04220866|459962340|FG000|Overall Study|Death|4|||
127820440|NCT04220866|459962341|FG001|Overall Study|Death|5|||
127820441|NCT04220866|459962340|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
127820442|NCT04220866|459962341|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
127820443|NCT04220866|459962340|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
127820444|NCT04220866|459962341|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
127820445|NCT04220866|459962340|FG000|Overall Study|Withdrawal by Subject|0|||
127820446|NCT04220866|459962341|FG001|Overall Study|Withdrawal by Subject|1|||
127820447|NCT02138110|459962342|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
127820448|NCT02138110|459962342|FG000|Overall Scaffold Implantation|Death|3|||
127820449|NCT00882713|459962343|FG000|Overall Study|Adverse Event|2|||
127820450|NCT00882713|459962343|FG000|Overall Study|Death|3|||
127820451|NCT00882713|459962343|FG000|Overall Study|Administrative reasons|4|||
127820452|NCT00882713|459962343|FG000|Overall Study|refused treatment/withdrew consent|4|||
127820453|NCT00882713|459962343|FG000|Overall Study|Blood transfusion|2|||
127820454|NCT00882713|459962343|FG000|Overall Study|Insufficient therapeutic response|3|||
127820455|NCT00882713|459962343|FG000|Overall Study|Failure to return|2|||
127820456|NCT00882713|459962343|FG000|Overall Study|Other - Reasons|2|||
127820457|NCT05523362|459962344|FG000|Phase 1- Blinded (10 Days)|Unable to contact|2|||
127894668|NCT00437281|460237221|FG006|Overall Study|Lost to Follow-up|0|||
127894669|NCT00437281|460237222|FG007|Overall Study|Lost to Follow-up|0|||
127894670|NCT00437281|460237223|FG008|Overall Study|Lost to Follow-up|0|||
127894671|NCT00437281|460237224|FG009|Overall Study|Lost to Follow-up|0|||
127894672|NCT00437281|460237225|FG010|Overall Study|Lost to Follow-up|0|||
127894673|NCT00437281|460237226|FG011|Overall Study|Lost to Follow-up|0|||
127894674|NCT00437281|460237227|FG012|Overall Study|Lost to Follow-up|0|||
127820458|NCT05523362|459962344|FG000|Phase 1- Blinded (10 Days)|High stress, did not want to continue|1|||
127820459|NCT05523362|459962344|FG000|Phase 1- Blinded (10 Days)|Technical issues with device|4|||
127820460|NCT05523362|459962344|FG000|Phase 1- Blinded (10 Days)|did not meet eligibility criteria|2|||
127820461|NCT03515538|459962345|FG000|Overall Study|Lack of Efficacy|2|||
127820462|NCT03515538|459962346|FG001|Overall Study|Lack of Efficacy|0|||
127820463|NCT03515538|459962347|FG002|Overall Study|Lack of Efficacy|2|||
127820464|NCT03515538|459962348|FG003|Overall Study|Lack of Efficacy|0|||
127820465|NCT03515538|459962345|FG000|Overall Study|Death|0|||
127820466|NCT03515538|459962346|FG001|Overall Study|Death|0|||
127820467|NCT03515538|459962347|FG002|Overall Study|Death|1|||
127894675|NCT00437281|460237228|FG013|Overall Study|Lost to Follow-up|0|||
127894676|NCT00437281|460237229|FG014|Overall Study|Lost to Follow-up|0|||
127820468|NCT03515538|459962348|FG003|Overall Study|Death|0|||
127820469|NCT03515538|459962345|FG000|Overall Study|Protocol Violation|0|||
127820470|NCT03515538|459962346|FG001|Overall Study|Protocol Violation|0|||
127820471|NCT03515538|459962347|FG002|Overall Study|Protocol Violation|0|||
127820472|NCT03515538|459962348|FG003|Overall Study|Protocol Violation|1|||
127820473|NCT03515538|459962345|FG000|Overall Study|Screen failure (baseline dropout)|0|||
127820474|NCT03515538|459962346|FG001|Overall Study|Screen failure (baseline dropout)|1|||
127820475|NCT03515538|459962347|FG002|Overall Study|Screen failure (baseline dropout)|0|||
127820476|NCT03515538|459962348|FG003|Overall Study|Screen failure (baseline dropout)|0|||
127820477|NCT03515538|459962345|FG000|Overall Study|Withdrawal by Subject|2|||
127820478|NCT03515538|459962346|FG001|Overall Study|Withdrawal by Subject|2|||
127820479|NCT03515538|459962347|FG002|Overall Study|Withdrawal by Subject|1|||
127820480|NCT03515538|459962348|FG003|Overall Study|Withdrawal by Subject|3|||
127820481|NCT03515538|459962345|FG000|Overall Study|Physician Decision|1|||
127820482|NCT03515538|459962346|FG001|Overall Study|Physician Decision|0|||
127820483|NCT03515538|459962347|FG002|Overall Study|Physician Decision|0|||
127820484|NCT03515538|459962348|FG003|Overall Study|Physician Decision|1|||
127820485|NCT01295905|459962359|FG000|Overall Study|Did not meet inclusion criteria|1|||
127820486|NCT01295905|459962360|FG001|Overall Study|Did not meet inclusion criteria|0|||
127820487|NCT01295905|459962359|FG000|Overall Study|Met exclusion criteria|1|||
127820488|NCT01295905|459962360|FG001|Overall Study|Met exclusion criteria|0|||
127820489|NCT03842709|459962362|FG000|Overall Study|Withdrawal by Subject|3|||
127820490|NCT03842709|459962363|FG001|Overall Study|Withdrawal by Subject|3|||
127820491|NCT03842709|459962362|FG000|Overall Study|Lost to Follow-up|1|||
127820492|NCT03842709|459962363|FG001|Overall Study|Lost to Follow-up|0|||
127820493|NCT00791128|459962364|FG000|Overall Study|Adverse Event|4|||
127820494|NCT00791128|459962364|FG000|Overall Study|Device migration|2|||
127820495|NCT00791128|459962364|FG000|Overall Study|non-compliance by subject|2|||
127820496|NCT00791128|459962364|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
127820497|NCT00308620|459962365|FG000|Overall Study|Death|1|||
127820498|NCT00308620|459962366|FG001|Overall Study|Death|1|||
127820499|NCT00308620|459962367|FG002|Overall Study|Death|0|||
127820500|NCT00308620|459962365|FG000|Overall Study|Lost to Follow-up|0|||
127820501|NCT00308620|459962366|FG001|Overall Study|Lost to Follow-up|0|||
127820502|NCT00308620|459962367|FG002|Overall Study|Lost to Follow-up|1|||
127820503|NCT01357239|459962371|FG000|Stratum: All Patients|Adverse Event|0|||
127820504|NCT01357239|459962372|FG001|Stratum: All Patients|Adverse Event|0|||
127820505|NCT01357239|459962373|FG002|Stratum: All Patients|Adverse Event|1|||
127820506|NCT01357239|459962374|FG003|Stratum: All Patients|Adverse Event|1|||
127820507|NCT01357239|459962371|FG000|Stratum: All Patients|Subject withdrew consent|0|||
127820508|NCT01357239|459962372|FG001|Stratum: All Patients|Subject withdrew consent|0|||
127820509|NCT01357239|459962373|FG002|Stratum: All Patients|Subject withdrew consent|1|||
127820510|NCT01357239|459962374|FG003|Stratum: All Patients|Subject withdrew consent|1|||
127820511|NCT01357239|459962371|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
127820512|NCT01357239|459962372|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
127820513|NCT01357239|459962373|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
127820514|NCT01357239|459962374|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
127820515|NCT01357239|459962371|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
127820516|NCT01357239|459962372|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
127820517|NCT01357239|459962373|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
127820518|NCT01357239|459962374|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
127820519|NCT01357239|459962371|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
127820520|NCT01357239|459962372|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
127820521|NCT01357239|459962373|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
127820522|NCT01357239|459962374|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
127820523|NCT00609609|459962381|FG000|Overall Study|Withdrawal by Subject|2|||
127820524|NCT00609609|459962382|FG001|Overall Study|Withdrawal by Subject|0|||
127820525|NCT00609609|459962381|FG000|Overall Study|Progression|4|||
127820526|NCT00609609|459962382|FG001|Overall Study|Progression|2|||
127820527|NCT01050062|459962383|FG000|Overall Study|Adverse Event|75|||
127820528|NCT01050062|459962384|FG001|Overall Study|Adverse Event|22|||
127820529|NCT01050062|459962383|FG000|Overall Study|Lost to Follow-up|83|||
127820530|NCT01050062|459962384|FG001|Overall Study|Lost to Follow-up|35|||
127820531|NCT01050062|459962383|FG000|Overall Study|Lack of Efficacy|22|||
127820532|NCT01050062|459962384|FG001|Overall Study|Lack of Efficacy|35|||
127820533|NCT01050062|459962383|FG000|Overall Study|Physician Decision|74|||
127820534|NCT01050062|459962384|FG001|Overall Study|Physician Decision|9|||
127820535|NCT01050062|459962383|FG000|Overall Study|Others|17|||
127820536|NCT01050062|459962384|FG001|Overall Study|Others|11|||
127820537|NCT00670111|459962387|FG000|Enrollment to One Month|Testing Failure|0|||
127820538|NCT00670111|459962388|FG001|Enrollment to One Month|Testing Failure|0|||
127820539|NCT00670111|459962389|FG002|Enrollment to One Month|Testing Failure|13|||
127820540|NCT00670111|459962387|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
127820541|NCT00670111|459962388|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
127820542|NCT00670111|459962389|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
127820543|NCT00670111|459962387|FG000|Enrollment to One Month|Physician Decision|1|||
127820544|NCT00670111|459962388|FG001|Enrollment to One Month|Physician Decision|0|||
127820545|NCT00670111|459962389|FG002|Enrollment to One Month|Physician Decision|0|||
127820546|NCT03988751|459962390|FG000|Overall Study|Withdrawal by Subject|1|||
127820547|NCT03988751|459962391|FG001|Overall Study|Withdrawal by Subject|0|||
127820548|NCT03988751|459962390|FG000|Overall Study|Protocol Violation|0|||
127820549|NCT03988751|459962391|FG001|Overall Study|Protocol Violation|1|||
127820550|NCT02623361|459962392|FG000|Overall Study|Protocol Violation|0|||
127820551|NCT02623361|459962393|FG001|Overall Study|Protocol Violation|1|||
127820552|NCT02623361|459962392|FG000|Overall Study|Withdrawal by Subject|0|||
127820553|NCT02623361|459962393|FG001|Overall Study|Withdrawal by Subject|1|||
127820554|NCT00844883|459962394|FG000|Overall Study|Bridged to liver transplant|3|||
127820555|NCT00844883|459962394|FG000|Overall Study|Bridged to resection|1|||
127820556|NCT03894540|459962398|FG000|Overall Study|Adverse Event|0|||
127820557|NCT03894540|459962399|FG001|Overall Study|Adverse Event|0|||
127820558|NCT03894540|459962400|FG002|Overall Study|Adverse Event|0|||
127820559|NCT03894540|459962401|FG003|Overall Study|Adverse Event|0|||
127820560|NCT03894540|459962402|FG004|Overall Study|Adverse Event|1|||
127820561|NCT03894540|459962403|FG005|Overall Study|Adverse Event|0|||
127820562|NCT03894540|459962398|FG000|Overall Study|Withdrawal by Subject|0|||
127820563|NCT03894540|459962399|FG001|Overall Study|Withdrawal by Subject|0|||
127820564|NCT03894540|459962400|FG002|Overall Study|Withdrawal by Subject|0|||
127820565|NCT03894540|459962401|FG003|Overall Study|Withdrawal by Subject|0|||
127820566|NCT03894540|459962402|FG004|Overall Study|Withdrawal by Subject|1|||
127820567|NCT03894540|459962403|FG005|Overall Study|Withdrawal by Subject|0|||
127820568|NCT03894540|459962398|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
127820569|NCT03894540|459962399|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
127820570|NCT03894540|459962400|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
127820571|NCT03894540|459962401|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
127820572|NCT03894540|459962402|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
127820573|NCT03894540|459962403|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
127820574|NCT03894540|459962398|FG000|Overall Study|Progressive Disease Clinical|1|||
127820575|NCT03894540|459962399|FG001|Overall Study|Progressive Disease Clinical|1|||
127820576|NCT03894540|459962400|FG002|Overall Study|Progressive Disease Clinical|0|||
127820577|NCT03894540|459962401|FG003|Overall Study|Progressive Disease Clinical|1|||
127820578|NCT03894540|459962402|FG004|Overall Study|Progressive Disease Clinical|5|||
127820579|NCT03894540|459962403|FG005|Overall Study|Progressive Disease Clinical|1|||
127820580|NCT03894540|459962398|FG000|Overall Study|Study termination by sponsor|0|||
127820581|NCT03894540|459962399|FG001|Overall Study|Study termination by sponsor|0|||
127820582|NCT03894540|459962400|FG002|Overall Study|Study termination by sponsor|0|||
127820583|NCT03894540|459962401|FG003|Overall Study|Study termination by sponsor|0|||
127820584|NCT03894540|459962402|FG004|Overall Study|Study termination by sponsor|2|||
127820585|NCT03894540|459962403|FG005|Overall Study|Study termination by sponsor|0|||
127820586|NCT03000452|459962405|FG000|Treatment Period|Death|1|||
127820587|NCT03000452|459962405|FG000|Treatment Period|Progressive Disease (PD)|14|||
127820588|NCT03000452|459962405|FG000|Treatment Period|Physician Decision|1|||
127820589|NCT03000452|459962405|FG000|Treatment Period|Miscellaneous|2|||
127820590|NCT03000452|459962405|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
127820591|NCT03000452|459962405|FG000|Follow-Up Period|Death|3|||
127820592|NCT03000452|459962405|FG000|Follow-Up Period|Withdrawal by Subject|3|||
127820593|NCT00537823|459962408|FG000|Overall Study|Adverse Event|2|||
127820594|NCT00537823|459962409|FG001|Overall Study|Adverse Event|0|||
127820595|NCT03065530|459962410|FG000|Overall Study|Lack of Efficacy|1|||
127820596|NCT03065530|459962411|FG001|Overall Study|Lack of Efficacy|1|||
127820597|NCT03065530|459962412|FG002|Overall Study|Lack of Efficacy|0|||
127820598|NCT03065530|459962413|FG003|Overall Study|Lack of Efficacy|1|||
127820599|NCT03065530|459962410|FG000|Overall Study|Protocol Violation|1|||
127820600|NCT03065530|459962411|FG001|Overall Study|Protocol Violation|0|||
127820601|NCT03065530|459962412|FG002|Overall Study|Protocol Violation|1|||
127820602|NCT03065530|459962413|FG003|Overall Study|Protocol Violation|1|||
127820603|NCT00852930|459962414|FG000|Overall Study|Withdrawal by Subject|1|||
127820604|NCT00852930|459962415|FG001|Overall Study|Withdrawal by Subject|1|||
127894677|NCT00437281|460237230|FG015|Overall Study|Lost to Follow-up|0|||
127820605|NCT00852930|459962416|FG002|Overall Study|Withdrawal by Subject|1|||
127820606|NCT00852930|459962414|FG000|Overall Study|Physician Decision|0|||
127820607|NCT00852930|459962415|FG001|Overall Study|Physician Decision|0|||
127820608|NCT00852930|459962416|FG002|Overall Study|Physician Decision|1|||
127820609|NCT00479466|459962417|FG000|Overall Study|Adverse Event|5|||
127820610|NCT00479466|459962418|FG001|Overall Study|Adverse Event|1|||
127820611|NCT00479466|459962419|FG002|Overall Study|Adverse Event|0|||
127820612|NCT00479466|459962420|FG003|Overall Study|Adverse Event|1|||
127820613|NCT00479466|459962421|FG004|Overall Study|Adverse Event|2|||
127820614|NCT00479466|459962422|FG005|Overall Study|Adverse Event|0|||
127820615|NCT00479466|459962417|FG000|Overall Study|Hyperglycemia|0|||
127820616|NCT00479466|459962418|FG001|Overall Study|Hyperglycemia|0|||
127820617|NCT00479466|459962419|FG002|Overall Study|Hyperglycemia|0|||
127820618|NCT00479466|459962420|FG003|Overall Study|Hyperglycemia|0|||
127820619|NCT00479466|459962421|FG004|Overall Study|Hyperglycemia|0|||
127820620|NCT00479466|459962422|FG005|Overall Study|Hyperglycemia|1|||
127820621|NCT00479466|459962417|FG000|Overall Study|Lack of Efficacy|2|||
127820622|NCT00479466|459962418|FG001|Overall Study|Lack of Efficacy|0|||
127820623|NCT00479466|459962419|FG002|Overall Study|Lack of Efficacy|1|||
127820624|NCT00479466|459962420|FG003|Overall Study|Lack of Efficacy|0|||
127820625|NCT00479466|459962421|FG004|Overall Study|Lack of Efficacy|0|||
127820626|NCT00479466|459962422|FG005|Overall Study|Lack of Efficacy|0|||
127820627|NCT00479466|459962417|FG000|Overall Study|Lost to Follow-up|0|||
127820628|NCT00479466|459962418|FG001|Overall Study|Lost to Follow-up|1|||
127820629|NCT00479466|459962419|FG002|Overall Study|Lost to Follow-up|1|||
127820630|NCT00479466|459962420|FG003|Overall Study|Lost to Follow-up|0|||
127820631|NCT00479466|459962421|FG004|Overall Study|Lost to Follow-up|2|||
127820632|NCT00479466|459962422|FG005|Overall Study|Lost to Follow-up|2|||
127820633|NCT00479466|459962417|FG000|Overall Study|Physician Decision|2|||
127820634|NCT00479466|459962418|FG001|Overall Study|Physician Decision|1|||
127820635|NCT00479466|459962419|FG002|Overall Study|Physician Decision|1|||
127820636|NCT00479466|459962420|FG003|Overall Study|Physician Decision|0|||
127820637|NCT00479466|459962421|FG004|Overall Study|Physician Decision|0|||
127820638|NCT00479466|459962422|FG005|Overall Study|Physician Decision|0|||
127820639|NCT00479466|459962417|FG000|Overall Study|Pregnancy|0|||
127820640|NCT00479466|459962418|FG001|Overall Study|Pregnancy|0|||
127820641|NCT00479466|459962419|FG002|Overall Study|Pregnancy|0|||
127820642|NCT00479466|459962420|FG003|Overall Study|Pregnancy|0|||
127820643|NCT00479466|459962421|FG004|Overall Study|Pregnancy|1|||
127820644|NCT00479466|459962422|FG005|Overall Study|Pregnancy|0|||
127820645|NCT00479466|459962417|FG000|Overall Study|Protocol Violation|1|||
127820646|NCT00479466|459962418|FG001|Overall Study|Protocol Violation|0|||
127820647|NCT00479466|459962419|FG002|Overall Study|Protocol Violation|0|||
127820648|NCT00479466|459962420|FG003|Overall Study|Protocol Violation|0|||
127820649|NCT00479466|459962421|FG004|Overall Study|Protocol Violation|0|||
127820650|NCT00479466|459962422|FG005|Overall Study|Protocol Violation|0|||
127820651|NCT00479466|459962417|FG000|Overall Study|Withdrawal by Subject|3|||
127820652|NCT00479466|459962418|FG001|Overall Study|Withdrawal by Subject|5|||
127820653|NCT00479466|459962419|FG002|Overall Study|Withdrawal by Subject|0|||
127820654|NCT00479466|459962420|FG003|Overall Study|Withdrawal by Subject|2|||
127820655|NCT00479466|459962421|FG004|Overall Study|Withdrawal by Subject|3|||
127820656|NCT00479466|459962422|FG005|Overall Study|Withdrawal by Subject|1|||
127820657|NCT01633060|459962430|FG000|Randomization Phase|Protocol deviation|1|||
127820658|NCT01633060|459962431|FG001|Randomization Phase|Protocol deviation|2|||
127820659|NCT01633060|459962430|FG000|Randomization Phase|Technical problem|0|||
127820660|NCT01633060|459962431|FG001|Randomization Phase|Technical problem|1|||
127820661|NCT01633060|459962430|FG000|Treatment Phase|Adverse Event|24|||
127820662|NCT01633060|459962431|FG001|Treatment Phase|Adverse Event|3|||
127820663|NCT01633060|459962430|FG000|Treatment Phase|Lost to Follow-up|1|||
127820664|NCT01633060|459962431|FG001|Treatment Phase|Lost to Follow-up|0|||
127820665|NCT01633060|459962430|FG000|Treatment Phase|Physician Decision|16|||
127820666|NCT01633060|459962431|FG001|Treatment Phase|Physician Decision|7|||
127820667|NCT01633060|459962430|FG000|Treatment Phase|Progressive Disease|210|||
127820668|NCT01633060|459962431|FG001|Treatment Phase|Progressive Disease|120|||
127820669|NCT01633060|459962430|FG000|Treatment Phase|Protocol Deviation|1|||
127820670|NCT01633060|459962431|FG001|Treatment Phase|Protocol Deviation|0|||
127820671|NCT01633060|459962430|FG000|Treatment Phase|Study Terminated by sponsor|7|||
127820672|NCT01633060|459962431|FG001|Treatment Phase|Study Terminated by sponsor|3|||
127820673|NCT01633060|459962430|FG000|Treatment Phase|Subject/guardian decision|25|||
127820674|NCT01633060|459962431|FG001|Treatment Phase|Subject/guardian decision|4|||
127820675|NCT01633060|459962430|FG000|Treatment Phase|Death|4|||
127820676|NCT01633060|459962431|FG001|Treatment Phase|Death|3|||
127820677|NCT01633060|459962430|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
127820678|NCT01633060|459962431|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
127820679|NCT01633060|459962430|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
127820680|NCT01633060|459962431|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
127820681|NCT01633060|459962430|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
127820682|NCT01633060|459962431|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
127820683|NCT01633060|459962430|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
127820684|NCT01633060|459962431|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
127820685|NCT01633060|459962430|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
127820686|NCT01633060|459962431|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
127820687|NCT01633060|459962430|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
127820688|NCT01633060|459962431|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
127820689|NCT01396525|459962432|FG000|Overall Study|Withdrawal by Subject|8|||
127820690|NCT01396525|459962432|FG000|Overall Study|Death|14|||
127820691|NCT01396525|459962432|FG000|Overall Study|Lost to Follow-up|4|||
127820692|NCT03114969|459962433|FG000|Overall Study|Lost to Follow-up|0|||
127820693|NCT03114969|459962434|FG001|Overall Study|Lost to Follow-up|0|||
127820694|NCT03114969|459962435|FG002|Overall Study|Lost to Follow-up|3|||
127820695|NCT03114969|459962436|FG003|Overall Study|Lost to Follow-up|2|||
127820696|NCT03114969|459962437|FG004|Overall Study|Lost to Follow-up|0|||
127820697|NCT03114969|459962438|FG005|Overall Study|Lost to Follow-up|0|||
127820698|NCT03114969|459962439|FG006|Overall Study|Lost to Follow-up|0|||
127820699|NCT03114969|459962440|FG007|Overall Study|Lost to Follow-up|0|||
127820700|NCT03114969|459962441|FG008|Overall Study|Lost to Follow-up|0|||
127820701|NCT03114969|459962433|FG000|Overall Study|Adverse Event|0|||
127820702|NCT03114969|459962434|FG001|Overall Study|Adverse Event|0|||
127820703|NCT03114969|459962435|FG002|Overall Study|Adverse Event|1|||
127820704|NCT03114969|459962436|FG003|Overall Study|Adverse Event|0|||
127820705|NCT03114969|459962437|FG004|Overall Study|Adverse Event|0|||
127820706|NCT03114969|459962438|FG005|Overall Study|Adverse Event|1|||
127820707|NCT03114969|459962439|FG006|Overall Study|Adverse Event|1|||
127820708|NCT03114969|459962440|FG007|Overall Study|Adverse Event|0|||
127820709|NCT03114969|459962441|FG008|Overall Study|Adverse Event|2|||
127820710|NCT01743027|459962447|FG000|Overall Study|Adverse Event|2|||
127820711|NCT01743027|459962448|FG001|Overall Study|Adverse Event|0|||
127820712|NCT01743027|459962449|FG002|Overall Study|Adverse Event|0|||
127820713|NCT01743027|459962450|FG003|Overall Study|Adverse Event|0|||
127820714|NCT01743027|459962447|FG000|Overall Study|Lost to Follow-up|0|||
127820715|NCT01743027|459962448|FG001|Overall Study|Lost to Follow-up|0|||
127820716|NCT01743027|459962449|FG002|Overall Study|Lost to Follow-up|2|||
127820717|NCT01743027|459962450|FG003|Overall Study|Lost to Follow-up|0|||
127820718|NCT01743027|459962447|FG000|Overall Study|Progressive Disease|1|||
127820719|NCT01743027|459962448|FG001|Overall Study|Progressive Disease|4|||
127820720|NCT01743027|459962449|FG002|Overall Study|Progressive Disease|3|||
127820721|NCT01743027|459962450|FG003|Overall Study|Progressive Disease|0|||
127820722|NCT01743027|459962447|FG000|Overall Study|Protocol Violation|1|||
127820723|NCT01743027|459962448|FG001|Overall Study|Protocol Violation|1|||
127820724|NCT01743027|459962449|FG002|Overall Study|Protocol Violation|1|||
127820725|NCT01743027|459962450|FG003|Overall Study|Protocol Violation|0|||
127820726|NCT01743027|459962447|FG000|Overall Study|Withdrawal by Subject|1|||
127820727|NCT01743027|459962448|FG001|Overall Study|Withdrawal by Subject|0|||
127820728|NCT01743027|459962449|FG002|Overall Study|Withdrawal by Subject|3|||
127820729|NCT01743027|459962450|FG003|Overall Study|Withdrawal by Subject|1|||
127820730|NCT00069121|459962455|FG000|Overall Study|Death|286|||
127820731|NCT00069121|459962456|FG001|Overall Study|Death|242|||
127820732|NCT00069121|459962455|FG000|Overall Study|Withdrawal by Subject|18|||
127820733|NCT00069121|459962456|FG001|Overall Study|Withdrawal by Subject|20|||
127820734|NCT00069121|459962455|FG000|Overall Study|Lost to Follow-up|63|||
127820735|NCT00069121|459962456|FG001|Overall Study|Lost to Follow-up|63|||
127820736|NCT00231478|459962462|FG000|Overall Study|Protocol Violation|3|||
127820737|NCT00231478|459962463|FG001|Overall Study|Protocol Violation|2|||
127820738|NCT00231478|459962462|FG000|Overall Study|Refused Treatment|1|||
127820739|NCT00231478|459962463|FG001|Overall Study|Refused Treatment|1|||
127820740|NCT00231478|459962462|FG000|Overall Study|Withdrawal by Subject|1|||
127820741|NCT00231478|459962463|FG001|Overall Study|Withdrawal by Subject|0|||
127820742|NCT00231478|459962462|FG000|Overall Study|Adverse Event|0|||
127820743|NCT00231478|459962463|FG001|Overall Study|Adverse Event|1|||
127820744|NCT00231478|459962462|FG000|Overall Study|Administrative|3|||
127820745|NCT00231478|459962463|FG001|Overall Study|Administrative|2|||
127820746|NCT00393458|459962470|FG000|Overall Study|Adverse Event|35|||
127820747|NCT00393458|459962471|FG001|Overall Study|Adverse Event|24|||
127820748|NCT00393458|459962472|FG002|Overall Study|Adverse Event|40|||
127820749|NCT00393458|459962473|FG003|Overall Study|Adverse Event|35|||
127820750|NCT00393458|459962470|FG000|Overall Study|Subject withdrew consent|27|||
127820751|NCT00393458|459962471|FG001|Overall Study|Subject withdrew consent|40|||
127820752|NCT00393458|459962472|FG002|Overall Study|Subject withdrew consent|33|||
127820753|NCT00393458|459962473|FG003|Overall Study|Subject withdrew consent|50|||
127820754|NCT00393458|459962470|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
127820755|NCT00393458|459962471|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
127820756|NCT00393458|459962472|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
127820757|NCT00393458|459962473|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
127820758|NCT00393458|459962470|FG000|Overall Study|Protocol deviation|11|||
127820759|NCT00393458|459962471|FG001|Overall Study|Protocol deviation|11|||
127820760|NCT00393458|459962472|FG002|Overall Study|Protocol deviation|11|||
127820761|NCT00393458|459962473|FG003|Overall Study|Protocol deviation|10|||
127820762|NCT00393458|459962470|FG000|Overall Study|Administrative problems|7|||
127820763|NCT00393458|459962471|FG001|Overall Study|Administrative problems|8|||
127820764|NCT00393458|459962472|FG002|Overall Study|Administrative problems|5|||
127820765|NCT00393458|459962473|FG003|Overall Study|Administrative problems|2|||
127820766|NCT00393458|459962470|FG000|Overall Study|Lost to Follow-up|5|||
127820767|NCT00393458|459962471|FG001|Overall Study|Lost to Follow-up|6|||
127820768|NCT00393458|459962472|FG002|Overall Study|Lost to Follow-up|5|||
127820769|NCT00393458|459962473|FG003|Overall Study|Lost to Follow-up|3|||
127820770|NCT00393458|459962470|FG000|Overall Study|Abnormal laboratory value(s)|1|||
127820771|NCT00393458|459962471|FG001|Overall Study|Abnormal laboratory value(s)|1|||
127820772|NCT00393458|459962472|FG002|Overall Study|Abnormal laboratory value(s)|0|||
127820773|NCT00393458|459962473|FG003|Overall Study|Abnormal laboratory value(s)|0|||
127820774|NCT00393458|459962470|FG000|Overall Study|Death|1|||
127820775|NCT00393458|459962471|FG001|Overall Study|Death|1|||
127820776|NCT00393458|459962472|FG002|Overall Study|Death|5|||
127820777|NCT00393458|459962473|FG003|Overall Study|Death|5|||
127820778|NCT00393458|459962470|FG000|Overall Study|Abnormal test procedure result(s)|0|||
127820779|NCT00393458|459962471|FG001|Overall Study|Abnormal test procedure result(s)|1|||
127820780|NCT00393458|459962472|FG002|Overall Study|Abnormal test procedure result(s)|1|||
127820781|NCT00393458|459962473|FG003|Overall Study|Abnormal test procedure result(s)|2|||
127820782|NCT00393458|459962470|FG000|Overall Study|Subject no longer requires study drug|0|||
127820783|NCT00393458|459962471|FG001|Overall Study|Subject no longer requires study drug|1|||
127820784|NCT00393458|459962472|FG002|Overall Study|Subject no longer requires study drug|0|||
127820785|NCT00393458|459962473|FG003|Overall Study|Subject no longer requires study drug|0|||
127820786|NCT00104104|459962482|FG000|Overall Study|Adverse Event|8|||
127820787|NCT00104104|459962483|FG001|Overall Study|Adverse Event|8|||
127820788|NCT00104104|459962482|FG000|Overall Study|Abnormal laboratory value(s)|20|||
127820789|NCT00104104|459962483|FG001|Overall Study|Abnormal laboratory value(s)|14|||
127820790|NCT00104104|459962482|FG000|Overall Study|Lack of Efficacy|0|||
127820791|NCT00104104|459962483|FG001|Overall Study|Lack of Efficacy|3|||
127820792|NCT00104104|459962482|FG000|Overall Study|Condition no longer requires study drug|7|||
127820793|NCT00104104|459962483|FG001|Overall Study|Condition no longer requires study drug|4|||
127820794|NCT00104104|459962482|FG000|Overall Study|Protocol Violation|5|||
127820795|NCT00104104|459962483|FG001|Overall Study|Protocol Violation|2|||
127820796|NCT00104104|459962482|FG000|Overall Study|Withdrawal by Subject|11|||
127820797|NCT00104104|459962483|FG001|Overall Study|Withdrawal by Subject|15|||
127820798|NCT00104104|459962482|FG000|Overall Study|Lost to Follow-up|3|||
127820799|NCT00104104|459962483|FG001|Overall Study|Lost to Follow-up|7|||
127820800|NCT00104104|459962482|FG000|Overall Study|Administrative problems|12|||
127820801|NCT00104104|459962483|FG001|Overall Study|Administrative problems|13|||
127820802|NCT00104104|459962482|FG000|Overall Study|Death|9|||
127820803|NCT00104104|459962483|FG001|Overall Study|Death|6|||
127820804|NCT00035815|459962487|FG000|Overall Study|Withdrawal by Subject|17|||
127820805|NCT00035815|459962488|FG001|Overall Study|Withdrawal by Subject|11|||
127820806|NCT01894516|459964297|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
127820807|NCT01894516|459964298|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
127820808|NCT01894516|459964299|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
127820809|NCT01894516|459964300|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
127820810|NCT01894516|459964297|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
127820811|NCT01894516|459964298|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
127820812|NCT01894516|459964299|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
127820813|NCT01894516|459964300|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
127820814|NCT01894516|459964297|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
127820815|NCT01894516|459964298|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
127820816|NCT01894516|459964299|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
127820817|NCT01894516|459964300|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
127820818|NCT01894516|459964297|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
127820819|NCT01894516|459964298|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
127820820|NCT01894516|459964299|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
127820821|NCT01894516|459964300|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
127820822|NCT01894516|459964297|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
127820823|NCT01894516|459964298|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
127820824|NCT01894516|459964299|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
127820825|NCT01894516|459964300|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
127820826|NCT01894516|459964297|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
127820827|NCT01894516|459964298|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
127820828|NCT01894516|459964299|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
127820829|NCT01894516|459964300|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
127820830|NCT01894516|459964297|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
127820831|NCT01894516|459964298|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
127820832|NCT01894516|459964299|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
127820833|NCT01894516|459964300|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
127820834|NCT01894516|459964297|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
127820835|NCT01894516|459964298|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
127820836|NCT01894516|459964299|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
127820837|NCT01894516|459964300|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
127820838|NCT03191396|459964302|FG000|Overall Study|Lost to Follow-up|0|||
127820839|NCT03191396|459964303|FG001|Overall Study|Lost to Follow-up|3|||
127820840|NCT03191396|459964302|FG000|Overall Study|Withdrawal by Subject|3|||
127820841|NCT03191396|459964303|FG001|Overall Study|Withdrawal by Subject|2|||
127820842|NCT03635190|459964305|FG000|Overall Study|Lost to Follow-up|4|||
127820843|NCT03635190|459964305|FG000|Overall Study|Death|3|||
127820844|NCT03635190|459964305|FG000|Overall Study|Withdrawal by Subject|1|||
127820845|NCT03635190|459964305|FG000|Overall Study|Patient moved and did not return for follow up|1|||
127820846|NCT03692910|459964306|FG000|Overall Study|Lost to Follow-up|4|||
127820847|NCT03692910|459964307|FG001|Overall Study|Lost to Follow-up|0|||
127820848|NCT03692910|459964308|FG002|Overall Study|Lost to Follow-up|0|||
127820849|NCT03692910|459964306|FG000|Overall Study|Withdrawal by Subject|2|||
127820850|NCT03692910|459964307|FG001|Overall Study|Withdrawal by Subject|0|||
127820851|NCT03692910|459964308|FG002|Overall Study|Withdrawal by Subject|0|||
127820852|NCT01981122|459964311|FG000|Overall Study|Withdrawal by Subject|0|||
127820853|NCT01981122|459964312|FG001|Overall Study|Withdrawal by Subject|2|||
127820854|NCT01981122|459964311|FG000|Overall Study|Protocol Violation|0|||
127820855|NCT01981122|459964312|FG001|Overall Study|Protocol Violation|1|||
127820856|NCT01981122|459964311|FG000|Overall Study|Lost to Follow-up|0|||
127820857|NCT01981122|459964312|FG001|Overall Study|Lost to Follow-up|1|||
127820858|NCT01981122|459964311|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
127820859|NCT01981122|459964312|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
127820860|NCT01981122|459964311|FG000|Overall Study|Death|14|||
127820861|NCT01981122|459964312|FG001|Overall Study|Death|15|||
127820862|NCT01330381|459964313|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
127820863|NCT01330381|459964314|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
127820864|NCT01330381|459964315|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
127820865|NCT01330381|459964313|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
127820866|NCT01330381|459964314|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
127820867|NCT01330381|459964315|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
127820868|NCT01330381|459964313|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
127820869|NCT01330381|459964314|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
127820870|NCT01330381|459964315|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
127820871|NCT01330381|459964313|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
127820872|NCT01330381|459964314|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
127820873|NCT01330381|459964315|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
127820874|NCT01330381|459964313|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
127820875|NCT01330381|459964314|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
127820876|NCT01330381|459964315|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
127820877|NCT01330381|459964313|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
127820878|NCT01330381|459964314|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
127820879|NCT01330381|459964315|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
127820880|NCT01330381|459964313|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
127820881|NCT01330381|459964314|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
127820882|NCT01330381|459964315|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
127820883|NCT01330381|459964313|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
127820884|NCT01330381|459964314|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
127820885|NCT01330381|459964315|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
127820886|NCT01330381|459964313|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
127820887|NCT01330381|459964314|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
127820888|NCT01330381|459964315|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
127820889|NCT01330381|459964313|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
127820890|NCT01330381|459964314|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
127820891|NCT01330381|459964315|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
127820892|NCT03060577|459964316|FG000|Overall Study|Withdrawal by Subject|25|||
127820893|NCT03060577|459964317|FG001|Overall Study|Withdrawal by Subject|5|||
127820894|NCT03060577|459964316|FG000|Overall Study|Physician Decision|4|||
127820895|NCT03060577|459964317|FG001|Overall Study|Physician Decision|3|||
127820896|NCT03060577|459964316|FG000|Overall Study|Lost to Follow-up|3|||
127820897|NCT03060577|459964317|FG001|Overall Study|Lost to Follow-up|0|||
127820898|NCT03060577|459964316|FG000|Overall Study|Death|7|||
127820899|NCT03060577|459964317|FG001|Overall Study|Death|1|||
127820900|NCT03060577|459964316|FG000|Overall Study|Adverse Event|9|||
127820901|NCT03060577|459964317|FG001|Overall Study|Adverse Event|1|||
127820902|NCT03060577|459964316|FG000|Overall Study|Inclusion/Exclusion|1|||
127820903|NCT03060577|459964317|FG001|Overall Study|Inclusion/Exclusion|0|||
127820904|NCT03060577|459964316|FG000|Overall Study|Other|8|||
127820905|NCT03060577|459964317|FG001|Overall Study|Other|2|||
127820906|NCT03216265|459964321|FG000|Overall Study|Adverse Event|2|||
127820907|NCT03216265|459964322|FG001|Overall Study|Adverse Event|0|||
127820908|NCT03216265|459964323|FG002|Overall Study|Adverse Event|2|||
127820909|NCT03216265|459964321|FG000|Overall Study|Lost to Follow-up|0|||
127820910|NCT03216265|459964322|FG001|Overall Study|Lost to Follow-up|1|||
127820911|NCT03216265|459964323|FG002|Overall Study|Lost to Follow-up|0|||
127820912|NCT03216265|459964321|FG000|Overall Study|Withdrawal by Subject|0|||
127820913|NCT03216265|459964322|FG001|Overall Study|Withdrawal by Subject|0|||
127820914|NCT03216265|459964323|FG002|Overall Study|Withdrawal by Subject|1|||
127820915|NCT01277289|459964325|FG000|Overall Study|fragile vein|1|||
127820916|NCT01277289|459964326|FG001|Overall Study|fragile vein|0|||
127820917|NCT01277289|459964325|FG000|Overall Study|Physician Decision|1|||
127820918|NCT01277289|459964326|FG001|Overall Study|Physician Decision|0|||
127820919|NCT01277289|459964325|FG000|Overall Study|therapy failure and/or Crohn's surgery|13|||
127820920|NCT01277289|459964326|FG001|Overall Study|therapy failure and/or Crohn's surgery|16|||
127820921|NCT01277289|459964325|FG000|Overall Study|Protocol Violation|1|||
127820922|NCT01277289|459964326|FG001|Overall Study|Protocol Violation|1|||
127820923|NCT01277289|459964325|FG000|Overall Study|Adverse Event|2|||
127820924|NCT01277289|459964326|FG001|Overall Study|Adverse Event|1|||
127820925|NCT01277289|459964325|FG000|Overall Study|consent withdrawn|1|||
127820926|NCT01277289|459964326|FG001|Overall Study|consent withdrawn|1|||
127820927|NCT01277289|459964325|FG000|Overall Study|premature closure of the study|4|||
127820928|NCT01277289|459964326|FG001|Overall Study|premature closure of the study|2|||
127820929|NCT00092547|459964327|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
127820930|NCT00092547|459964328|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
127820931|NCT00092547|459964329|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
127820932|NCT00092547|459964327|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
127820933|NCT00092547|459964328|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
127820934|NCT00092547|459964329|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
127820935|NCT00092547|459964327|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
127820936|NCT00092547|459964328|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
127820937|NCT00092547|459964329|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
127820938|NCT00092547|459964327|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
127820939|NCT00092547|459964328|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
127820940|NCT00092547|459964329|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
127820941|NCT00092547|459964327|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
127820942|NCT00092547|459964328|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
127820943|NCT00092547|459964329|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
127820944|NCT00092547|459964327|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
127820945|NCT00092547|459964328|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
127820946|NCT00092547|459964329|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
127820947|NCT00092547|459964327|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
127820948|NCT00092547|459964328|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
127820949|NCT00092547|459964329|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
127820950|NCT00092547|459964327|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
127820951|NCT00092547|459964328|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
127820952|NCT00092547|459964329|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
127820953|NCT00092547|459964327|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
127820954|NCT00092547|459964328|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
127820955|NCT00092547|459964329|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
127820956|NCT00092547|459964327|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
127820957|NCT00092547|459964328|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
127820958|NCT00092547|459964329|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
127820959|NCT00092547|459964327|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
127820960|NCT00092547|459964328|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
127820961|NCT00092547|459964329|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
127820962|NCT00092547|459964327|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
127820963|NCT00092547|459964328|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
127820964|NCT00092547|459964329|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
127820965|NCT00092547|459964327|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
127820966|NCT00092547|459964328|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
127820967|NCT00092547|459964329|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
127820968|NCT00092547|459964327|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
127820969|NCT00092547|459964328|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
127820970|NCT00092547|459964329|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
127820971|NCT00092547|459964327|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
127820972|NCT00092547|459964328|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
127820973|NCT00092547|459964329|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
127820974|NCT00092547|459964327|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
127820975|NCT00092547|459964328|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
127820976|NCT00092547|459964329|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
127820977|NCT00092547|459964327|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
127820978|NCT00092547|459964328|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
127820979|NCT00092547|459964329|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
127820980|NCT00092547|459964327|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
127820981|NCT00092547|459964328|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
127820982|NCT00092547|459964329|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
127820983|NCT00092547|459964327|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
127820984|NCT00092547|459964328|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
127820985|NCT00092547|459964329|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
127820986|NCT00092547|459964327|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
127820987|NCT00092547|459964328|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
127820988|NCT00092547|459964329|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
127820989|NCT00092547|459964327|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
127820990|NCT00092547|459964328|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
127820991|NCT00092547|459964329|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
127820992|NCT01539837|459964330|FG000|Overall Study|reduce neutrophil level|0|||
127820993|NCT01539837|459964331|FG001|Overall Study|reduce neutrophil level|1|||
127820994|NCT01539837|459964332|FG002|Overall Study|reduce neutrophil level|1|||
127820995|NCT01539837|459964330|FG000|Overall Study|bad compliance|0|||
127820996|NCT01539837|459964331|FG001|Overall Study|bad compliance|0|||
127820997|NCT01539837|459964332|FG002|Overall Study|bad compliance|1|||
127820998|NCT01978912|459964334|FG000|Overall Study|Adverse Event|0|||
127820999|NCT01978912|459964335|FG001|Overall Study|Adverse Event|1|||
127821000|NCT01978912|459964336|FG002|Overall Study|Adverse Event|0|||
127821001|NCT01978912|459964337|FG003|Overall Study|Adverse Event|0|||
127821002|NCT01978912|459964334|FG000|Overall Study|Lost to Follow-up|1|||
127821003|NCT01978912|459964335|FG001|Overall Study|Lost to Follow-up|1|||
127821004|NCT01978912|459964336|FG002|Overall Study|Lost to Follow-up|0|||
127821005|NCT01978912|459964337|FG003|Overall Study|Lost to Follow-up|1|||
127821006|NCT01978912|459964334|FG000|Overall Study|Withdrawal by Subject|1|||
127821007|NCT01978912|459964335|FG001|Overall Study|Withdrawal by Subject|0|||
127821008|NCT01978912|459964336|FG002|Overall Study|Withdrawal by Subject|2|||
127821009|NCT01978912|459964337|FG003|Overall Study|Withdrawal by Subject|2|||
127821010|NCT01978912|459964334|FG000|Overall Study|Lumbar Surgery|1|||
127821011|NCT01978912|459964335|FG001|Overall Study|Lumbar Surgery|0|||
127821012|NCT01978912|459964336|FG002|Overall Study|Lumbar Surgery|1|||
127821013|NCT01978912|459964337|FG003|Overall Study|Lumbar Surgery|0|||
127821014|NCT01978912|459964334|FG000|Overall Study|Intradiscal Steroid Injection|0|||
127821015|NCT01978912|459964335|FG001|Overall Study|Intradiscal Steroid Injection|1|||
127821016|NCT01978912|459964336|FG002|Overall Study|Intradiscal Steroid Injection|0|||
127821017|NCT01978912|459964337|FG003|Overall Study|Intradiscal Steroid Injection|0|||
127821018|NCT00401973|459964338|FG000|Overall Study|Adverse Event|2|||
127821019|NCT00401973|459964339|FG001|Overall Study|Adverse Event|8|||
127821020|NCT00401973|459964340|FG002|Overall Study|Adverse Event|4|||
127821021|NCT00401973|459964338|FG000|Overall Study|Clinical Relapse|0|||
127821022|NCT00401973|459964339|FG001|Overall Study|Clinical Relapse|1|||
127821023|NCT00401973|459964340|FG002|Overall Study|Clinical Relapse|1|||
127821024|NCT00401973|459964338|FG000|Overall Study|Lack of Efficacy|0|||
127821025|NCT00401973|459964339|FG001|Overall Study|Lack of Efficacy|0|||
127821026|NCT00401973|459964340|FG002|Overall Study|Lack of Efficacy|3|||
127821027|NCT00401973|459964338|FG000|Overall Study|Lost to Follow-up|2|||
127821028|NCT00401973|459964339|FG001|Overall Study|Lost to Follow-up|2|||
127821029|NCT00401973|459964340|FG002|Overall Study|Lost to Follow-up|2|||
127821030|NCT00401973|459964338|FG000|Overall Study|Physician Decision|2|||
127821031|NCT00401973|459964339|FG001|Overall Study|Physician Decision|0|||
127821032|NCT00401973|459964340|FG002|Overall Study|Physician Decision|1|||
127821033|NCT00401973|459964338|FG000|Overall Study|Protocol Violation|1|||
127821034|NCT00401973|459964339|FG001|Overall Study|Protocol Violation|2|||
127821035|NCT00401973|459964340|FG002|Overall Study|Protocol Violation|3|||
127821036|NCT00401973|459964338|FG000|Overall Study|Sponsor Decision|0|||
127821037|NCT00401973|459964339|FG001|Overall Study|Sponsor Decision|1|||
127821038|NCT00401973|459964340|FG002|Overall Study|Sponsor Decision|0|||
127821039|NCT00401973|459964338|FG000|Overall Study|Withdrawal by Subject|4|||
127821040|NCT00401973|459964339|FG001|Overall Study|Withdrawal by Subject|12|||
127821041|NCT00401973|459964340|FG002|Overall Study|Withdrawal by Subject|9|||
127821042|NCT04075604|459964341|FG000|Overall Study|Adverse Event|0|||
127821043|NCT04075604|459964342|FG001|Overall Study|Adverse Event|0|||
127821044|NCT04075604|459964343|FG002|Overall Study|Adverse Event|3|||
127821045|NCT04075604|459964341|FG000|Overall Study|Participant request to discontinue study treatment|0|||
127821046|NCT04075604|459964342|FG001|Overall Study|Participant request to discontinue study treatment|0|||
127821047|NCT04075604|459964343|FG002|Overall Study|Participant request to discontinue study treatment|1|||
127821048|NCT04075604|459964341|FG000|Overall Study|Participant withdrew consent|0|||
127821049|NCT04075604|459964342|FG001|Overall Study|Participant withdrew consent|0|||
127821050|NCT04075604|459964343|FG002|Overall Study|Participant withdrew consent|1|||
127821051|NCT04075604|459964341|FG000|Overall Study|Other reasons|1|||
127821052|NCT04075604|459964342|FG001|Overall Study|Other reasons|0|||
127821053|NCT04075604|459964343|FG002|Overall Study|Other reasons|0|||
127821054|NCT04075604|459964341|FG000|Overall Study|Disease progression|0|||
127821055|NCT04075604|459964342|FG001|Overall Study|Disease progression|1|||
127821056|NCT04075604|459964343|FG002|Overall Study|Disease progression|0|||
127821057|NCT04075604|459964341|FG000|Overall Study|Study drug toxicity|0|||
127821058|NCT04075604|459964342|FG001|Overall Study|Study drug toxicity|5|||
127821059|NCT04075604|459964343|FG002|Overall Study|Study drug toxicity|1|||
127821060|NCT01650779|459964344|FG000|Overall Study|Withdrawal by Subject|1|||
127821061|NCT03666143|459964345|FG000|Overall Study|Death|158|||
127821062|NCT03666143|459964345|FG000|Overall Study|Sponsor Decision|31|||
127821063|NCT03666143|459964345|FG000|Overall Study|Withdrawal by Subject|11|||
127821064|NCT03666143|459964345|FG000|Overall Study|Lost to Follow-up|5|||
127821065|NCT03666143|459964345|FG000|Overall Study|Physician Decision|1|||
127821066|NCT03666143|459964345|FG000|Overall Study|Rolled into extension study|9|||
127821067|NCT03666143|459964345|FG000|Overall Study|Progressive Disease|1|||
127821068|NCT00283712|459964346|FG000|Overall Study|Death|0|||
127821069|NCT00283712|459964347|FG001|Overall Study|Death|1|||
127821070|NCT04329923|459964348|FG000|Overall Study|Withdrawal by Subject|1|||
127821071|NCT04329923|459964349|FG001|Overall Study|Withdrawal by Subject|4|||
127821072|NCT04329923|459964350|FG002|Overall Study|Withdrawal by Subject|1|||
127821073|NCT04329923|459964351|FG003|Overall Study|Withdrawal by Subject|1|||
127821074|NCT04329923|459964352|FG004|Overall Study|Withdrawal by Subject|1|||
127821075|NCT04329923|459964353|FG005|Overall Study|Withdrawal by Subject|1|||
127821076|NCT04329923|459964348|FG000|Overall Study|early termination of study|0|||
127821077|NCT04329923|459964349|FG001|Overall Study|early termination of study|0|||
127821078|NCT04329923|459964350|FG002|Overall Study|early termination of study|0|||
127821079|NCT04329923|459964351|FG003|Overall Study|early termination of study|0|||
127821080|NCT04329923|459964352|FG004|Overall Study|early termination of study|1|||
127821081|NCT04329923|459964353|FG005|Overall Study|early termination of study|2|||
127821082|NCT04329923|459964348|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
127821083|NCT04329923|459964349|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
127821084|NCT04329923|459964350|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
127821085|NCT04329923|459964351|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
127821086|NCT04329923|459964352|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
127821087|NCT04329923|459964353|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
127821088|NCT01272180|459964354|FG000|Overall Study|Adverse Event|0|||
127821089|NCT01272180|459964355|FG001|Overall Study|Adverse Event|0|||
127821090|NCT01272180|459964356|FG002|Overall Study|Adverse Event|1|||
127821091|NCT01272180|459964357|FG003|Overall Study|Adverse Event|0|||
127821092|NCT01272180|459964354|FG000|Overall Study|Withdrawal by Subject|2|||
127821093|NCT01272180|459964355|FG001|Overall Study|Withdrawal by Subject|6|||
127821094|NCT01272180|459964356|FG002|Overall Study|Withdrawal by Subject|3|||
127821095|NCT01272180|459964357|FG003|Overall Study|Withdrawal by Subject|2|||
127821096|NCT01272180|459964354|FG000|Overall Study|Lost to Follow-up|15|||
127821097|NCT01272180|459964355|FG001|Overall Study|Lost to Follow-up|14|||
127821098|NCT01272180|459964356|FG002|Overall Study|Lost to Follow-up|8|||
127821099|NCT01272180|459964357|FG003|Overall Study|Lost to Follow-up|10|||
127821100|NCT01272180|459964354|FG000|Overall Study|Inappropriate enrollment|0|||
127821101|NCT01272180|459964355|FG001|Overall Study|Inappropriate enrollment|0|||
127821102|NCT01272180|459964356|FG002|Overall Study|Inappropriate enrollment|1|||
127821103|NCT01272180|459964357|FG003|Overall Study|Inappropriate enrollment|1|||
127821104|NCT01272180|459964354|FG000|Overall Study|Protocol Violation|0|||
127821105|NCT01272180|459964355|FG001|Overall Study|Protocol Violation|1|||
127821106|NCT01272180|459964356|FG002|Overall Study|Protocol Violation|0|||
127821107|NCT01272180|459964357|FG003|Overall Study|Protocol Violation|1|||
127821108|NCT01183858|459964358|FG000|Overall Study|Death not related to Progressive Disease|5|||
127821109|NCT01183858|459964359|FG001|Overall Study|Death not related to Progressive Disease|6|||
127821110|NCT01183858|459964358|FG000|Overall Study|Adverse Event|14|||
127821111|NCT01183858|459964359|FG001|Overall Study|Adverse Event|11|||
127821112|NCT01183858|459964358|FG000|Overall Study|Investigator's Decision|0|||
127821113|NCT01183858|459964359|FG001|Overall Study|Investigator's Decision|3|||
127821114|NCT01183858|459964358|FG000|Overall Study|Insufficient Therapeutic Response|2|||
127821115|NCT01183858|459964359|FG001|Overall Study|Insufficient Therapeutic Response|0|||
127821116|NCT01183858|459964358|FG000|Overall Study|Refused Treatment|1|||
127821117|NCT01183858|459964359|FG001|Overall Study|Refused Treatment|4|||
127821118|NCT01183858|459964358|FG000|Overall Study|Withdrew Consent|4|||
127821119|NCT01183858|459964359|FG001|Overall Study|Withdrew Consent|4|||
127821120|NCT01183858|459964358|FG000|Overall Study|Discontinued Smoking|3|||
127821121|NCT01183858|459964359|FG001|Overall Study|Discontinued Smoking|1|||
127821122|NCT01183858|459964358|FG000|Overall Study|Protocol Violation|1|||
127821123|NCT01183858|459964359|FG001|Overall Study|Protocol Violation|0|||
127821124|NCT01183858|459964358|FG000|Overall Study|Administrative/Other|6|||
127821125|NCT01183858|459964359|FG001|Overall Study|Administrative/Other|6|||
127821126|NCT01183858|459964358|FG000|Overall Study|Progressive Disease|112|||
127821127|NCT01183858|459964359|FG001|Overall Study|Progressive Disease|115|||
127821128|NCT01183858|459964358|FG000|Overall Study|Death related to Progressive Disease|4|||
127821129|NCT01183858|459964359|FG001|Overall Study|Death related to Progressive Disease|5|||
127821130|NCT01183858|459964358|FG000|Overall Study|Lost to Follow-up|1|||
127821131|NCT01183858|459964359|FG001|Overall Study|Lost to Follow-up|1|||
127821132|NCT02747043|459964362|FG000|Overall Study|Other|1|||
127821133|NCT02747043|459964363|FG001|Overall Study|Other|1|||
127821134|NCT02747043|459964362|FG000|Overall Study|Adverse Event|3|||
127821135|NCT02747043|459964363|FG001|Overall Study|Adverse Event|1|||
127821136|NCT02747043|459964362|FG000|Overall Study|Withdrawal by Subject|1|||
127821137|NCT02747043|459964363|FG001|Overall Study|Withdrawal by Subject|1|||
127821138|NCT02747043|459964362|FG000|Overall Study|Physician Decision|1|||
127821139|NCT02747043|459964363|FG001|Overall Study|Physician Decision|1|||
127821140|NCT02747043|459964362|FG000|Overall Study|Protocol Violation|0|||
127821141|NCT02747043|459964363|FG001|Overall Study|Protocol Violation|1|||
127821142|NCT02747043|459964362|FG000|Overall Study|Disease progression|4|||
127821143|NCT02747043|459964363|FG001|Overall Study|Disease progression|0|||
127821144|NCT01629667|459964370|FG000|Overall Study|Lost to Follow-up|0|||
127821145|NCT01629667|459964371|FG001|Overall Study|Lost to Follow-up|1|||
127821146|NCT01629667|459964372|FG002|Overall Study|Lost to Follow-up|1|||
127821147|NCT01629667|459964370|FG000|Overall Study|Withdrawal by Subject|31|||
127821148|NCT01629667|459964371|FG001|Overall Study|Withdrawal by Subject|20|||
127821149|NCT01629667|459964372|FG002|Overall Study|Withdrawal by Subject|28|||
127821150|NCT01629667|459964370|FG000|Overall Study|Death|1|||
127821151|NCT01629667|459964371|FG001|Overall Study|Death|5|||
127821152|NCT01629667|459964372|FG002|Overall Study|Death|3|||
127821153|NCT01629667|459964370|FG000|Overall Study|Randomized, not treated|2|||
127821154|NCT01629667|459964371|FG001|Overall Study|Randomized, not treated|1|||
127821155|NCT01629667|459964372|FG002|Overall Study|Randomized, not treated|0|||
127821156|NCT01629667|459964370|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
127821157|NCT01629667|459964371|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
127821158|NCT01629667|459964372|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
127821159|NCT01629667|459964370|FG000|Overall Study|Requiring lung transplant|2|||
127821160|NCT01629667|459964371|FG001|Overall Study|Requiring lung transplant|1|||
127821161|NCT01629667|459964372|FG002|Overall Study|Requiring lung transplant|3|||
127821162|NCT01629667|459964370|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
127821163|NCT01629667|459964371|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
127821164|NCT01629667|459964372|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
127821165|NCT01629667|459964370|FG000|Overall Study|Started other medicine|1|||
127821166|NCT01629667|459964371|FG001|Overall Study|Started other medicine|0|||
127821167|NCT01629667|459964372|FG002|Overall Study|Started other medicine|1|||
127821168|NCT01629667|459964370|FG000|Overall Study|Site error in safety follow-up|0|||
127821169|NCT01629667|459964371|FG001|Overall Study|Site error in safety follow-up|0|||
127821170|NCT01629667|459964372|FG002|Overall Study|Site error in safety follow-up|1|||
127821171|NCT01629667|459964370|FG000|Overall Study|Enrolled in another clinical study|0|||
127821172|NCT01629667|459964371|FG001|Overall Study|Enrolled in another clinical study|1|||
127821173|NCT01629667|459964372|FG002|Overall Study|Enrolled in another clinical study|0|||
127821174|NCT01629667|459964370|FG000|Overall Study|Code break|1|||
127821175|NCT01629667|459964371|FG001|Overall Study|Code break|0|||
127821176|NCT01629667|459964372|FG002|Overall Study|Code break|0|||
127821177|NCT01512368|459964376|FG000|Overall Study|Protocol Violation|3|||
127821178|NCT02717546|459964378|FG000|Overall Study|Lost to Follow-up|12|||
127821179|NCT02460822|459964384|FG000|Overall Study|Withdrawal by Subject|1|||
127821180|NCT00949650|459964387|FG000|Overall Study|Progressive disease|188|||
127821181|NCT00949650|459964388|FG001|Overall Study|Progressive disease|19|||
127821182|NCT00949650|459964387|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
127821183|NCT00949650|459964388|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
127821184|NCT00949650|459964387|FG000|Overall Study|Other Adverse Event (AE)|28|||
127821185|NCT00949650|459964388|FG001|Overall Study|Other Adverse Event (AE)|17|||
127821186|NCT00949650|459964387|FG000|Overall Study|Protocol Violation|1|||
127821187|NCT00949650|459964388|FG001|Overall Study|Protocol Violation|4|||
127821188|NCT00949650|459964387|FG000|Overall Study|Refusal to continue medication|7|||
127821189|NCT00949650|459964388|FG001|Overall Study|Refusal to continue medication|11|||
127821190|NCT00949650|459964387|FG000|Overall Study|Not treated|1|||
127821191|NCT00949650|459964388|FG001|Overall Study|Not treated|4|||
127821192|NCT00949650|459964387|FG000|Overall Study|Other not specified above|5|||
127821193|NCT00949650|459964388|FG001|Overall Study|Other not specified above|0|||
127821194|NCT04601272|459964389|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
127821195|NCT04601272|459964390|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
127821196|NCT04601272|459964391|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
127821197|NCT00414440|459964392|FG000|Core Period|Withdrawal by Subject|70|||
127821198|NCT00414440|459964393|FG001|Core Period|Withdrawal by Subject|32|||
127821199|NCT00414440|459964392|FG000|Extension Period|Lost to Follow-up|44|||
127821200|NCT00414440|459964393|FG001|Extension Period|Lost to Follow-up|52|||
127821201|NCT00414440|459964392|FG000|Extension Period|Did not consent to continue follow up|61|||
127821202|NCT00414440|459964393|FG001|Extension Period|Did not consent to continue follow up|54|||
127821203|NCT00414440|459964392|FG000|Extension Period|Other|1|||
127821204|NCT00414440|459964393|FG001|Extension Period|Other|1|||
127821205|NCT00414440|459964392|FG000|Extension Period|Administrative|16|||
127821206|NCT00414440|459964393|FG001|Extension Period|Administrative|16|||
127821207|NCT00414440|459964392|FG000|Extension Period|Death|1|||
127821208|NCT00414440|459964393|FG001|Extension Period|Death|2|||
127821209|NCT00414440|459964392|FG000|Extension Period|Withdrawal by Subject|9|||
127821210|NCT00414440|459964393|FG001|Extension Period|Withdrawal by Subject|7|||
127821211|NCT00414440|459964392|FG000|Extension Period|Not included in follow up period|18|||
127821212|NCT00414440|459964393|FG001|Extension Period|Not included in follow up period|8|||
127821213|NCT02168946|459964394|FG000|Overall Study|Adverse Event|8|||
127821214|NCT02168946|459964395|FG001|Overall Study|Adverse Event|5|||
127821215|NCT02168946|459964394|FG000|Overall Study|Lost to Follow-up|3|||
127821216|NCT02168946|459964395|FG001|Overall Study|Lost to Follow-up|0|||
127821217|NCT02168946|459964394|FG000|Overall Study|Subject unable to come back for visits|1|||
127821218|NCT02168946|459964395|FG001|Overall Study|Subject unable to come back for visits|0|||
127821219|NCT02498821|459964396|FG000|Overall Study|Screen failure|3|||
127821220|NCT02498821|459964397|FG001|Overall Study|Screen failure|5|||
127821221|NCT02111811|459964398|FG000|Treatment Phase|Lost to Follow-up|22|||
127821222|NCT02111811|459964399|FG001|Treatment Phase|Lost to Follow-up|18|||
127821223|NCT02111811|459964398|FG000|Treatment Phase|Death|2|||
127821224|NCT02111811|459964399|FG001|Treatment Phase|Death|0|||
127821225|NCT02111811|459964398|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
127821226|NCT02111811|459964399|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
127821227|NCT02111811|459964398|FG000|Follow up Period (Aim 2)|Death|2|||
127821228|NCT02111811|459964399|FG001|Follow up Period (Aim 2)|Death|0|||
127821231|NCT01478347|459964412|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
127821232|NCT01478347|459964412|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
127821233|NCT01478347|459964412|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
127821234|NCT00196937|459964413|FG000|Overall Study|Serious Adverse Event|1|||
127821235|NCT00196937|459964414|FG001|Overall Study|Serious Adverse Event|0|||
127821236|NCT00196937|459964415|FG002|Overall Study|Serious Adverse Event|0|||
127821237|NCT00196937|459964413|FG000|Overall Study|Non-serious adverse event|1|||
127821238|NCT00196937|459964414|FG001|Overall Study|Non-serious adverse event|1|||
127821239|NCT00196937|459964415|FG002|Overall Study|Non-serious adverse event|1|||
127821240|NCT00196937|459964413|FG000|Overall Study|Withdrawal by Subject|0|||
127821241|NCT00196937|459964414|FG001|Overall Study|Withdrawal by Subject|0|||
127821242|NCT00196937|459964415|FG002|Overall Study|Withdrawal by Subject|2|||
127821243|NCT00196937|459964413|FG000|Overall Study|Lost to Follow-up|4|||
127821244|NCT00196937|459964414|FG001|Overall Study|Lost to Follow-up|3|||
127821245|NCT00196937|459964415|FG002|Overall Study|Lost to Follow-up|3|||
127821246|NCT00196937|459964413|FG000|Overall Study|Other|3|||
127821247|NCT00196937|459964414|FG001|Overall Study|Other|1|||
127821248|NCT00196937|459964415|FG002|Overall Study|Other|1|||
127821249|NCT02973815|459964425|FG000|Post Intervention|Death|1|||
127821250|NCT02973815|459964426|FG001|Post Intervention|Death|0|||
127821251|NCT02973815|459964425|FG000|Post Intervention|Lost to Follow-up|7|||
127821252|NCT02973815|459964426|FG001|Post Intervention|Lost to Follow-up|24|||
127821253|NCT02973815|459964425|FG000|Follow-up|Lost to Follow-up|2|||
127821254|NCT02973815|459964426|FG001|Follow-up|Lost to Follow-up|0|||
127821255|NCT05258058|459964435|FG000|Overall Study|Withdrawal by Subject|2|||
127821256|NCT04579393|459964440|FG000|Overall Study|Withdrawal by Subject|2|||
127821257|NCT04579393|459964441|FG001|Overall Study|Withdrawal by Subject|2|||
127821258|NCT04579393|459964440|FG000|Overall Study|Death|1|||
127821259|NCT04579393|459964441|FG001|Overall Study|Death|3|||
127821260|NCT01787591|459964449|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
127821261|NCT01787591|459964450|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
127821262|NCT01787591|459964451|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
127821263|NCT01787591|459964452|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
127821264|NCT02725177|459964453|FG000|Overall Study|Physician Decision|4|||
127821265|NCT02725177|459964453|FG000|Overall Study|Adverse Event|1|||
127821266|NCT00793585|459964456|FG000|Overall Study|Adverse Event|1|||
127821267|NCT00793585|459964457|FG001|Overall Study|Adverse Event|1|||
127821268|NCT00793585|459964456|FG000|Overall Study|Protocol Violation|1|||
127821269|NCT00793585|459964457|FG001|Overall Study|Protocol Violation|2|||
127821270|NCT00377299|459964458|FG000|Overall Study|Lost to Follow-up|14|||
127821271|NCT00377299|459964459|FG001|Overall Study|Lost to Follow-up|19|||
127821272|NCT00377299|459964458|FG000|Overall Study|Adverse Event|0|||
127821273|NCT00377299|459964459|FG001|Overall Study|Adverse Event|1|||
127821274|NCT00377299|459964458|FG000|Overall Study|Withdrawal by Subject|5|||
127821275|NCT00377299|459964459|FG001|Overall Study|Withdrawal by Subject|4|||
127821276|NCT02699515|459966302|FG000|Overall Study|Death|3|||
127821277|NCT02699515|459966303|FG001|Overall Study|Death|3|||
127821278|NCT02699515|459966304|FG002|Overall Study|Death|3|||
127821279|NCT02699515|459966305|FG003|Overall Study|Death|23|||
127821280|NCT02699515|459966306|FG004|Overall Study|Death|22|||
127821281|NCT02699515|459966307|FG005|Overall Study|Death|23|||
127821282|NCT02699515|459966308|FG006|Overall Study|Death|3|||
127821283|NCT02699515|459966309|FG007|Overall Study|Death|5|||
127821284|NCT02699515|459966302|FG000|Overall Study|Withdrawal by Subject|0|||
127821285|NCT02699515|459966303|FG001|Overall Study|Withdrawal by Subject|0|||
127821286|NCT02699515|459966304|FG002|Overall Study|Withdrawal by Subject|3|||
127821287|NCT02699515|459966305|FG003|Overall Study|Withdrawal by Subject|1|||
127821288|NCT02699515|459966306|FG004|Overall Study|Withdrawal by Subject|5|||
127821289|NCT02699515|459966307|FG005|Overall Study|Withdrawal by Subject|3|||
127821290|NCT02699515|459966308|FG006|Overall Study|Withdrawal by Subject|0|||
127821291|NCT02699515|459966309|FG007|Overall Study|Withdrawal by Subject|1|||
127821292|NCT02699515|459966302|FG000|Overall Study|Other|1|||
127821293|NCT02699515|459966303|FG001|Overall Study|Other|0|||
127821294|NCT02699515|459966304|FG002|Overall Study|Other|1|||
127821295|NCT02699515|459966305|FG003|Overall Study|Other|6|||
127821296|NCT02699515|459966306|FG004|Overall Study|Other|4|||
127821297|NCT02699515|459966307|FG005|Overall Study|Other|3|||
127821298|NCT02699515|459966308|FG006|Overall Study|Other|0|||
127821299|NCT02699515|459966309|FG007|Overall Study|Other|0|||
127821300|NCT00375934|459966310|FG000|Overall Study|Adverse Event|1|||
127821301|NCT00375934|459966311|FG001|Overall Study|Adverse Event|1|||
127821302|NCT00375934|459966310|FG000|Overall Study|Withdrawal by Subject|2|||
127821303|NCT00375934|459966311|FG001|Overall Study|Withdrawal by Subject|2|||
127821304|NCT00375934|459966310|FG000|Overall Study|Lack of Efficacy|0|||
127821305|NCT00375934|459966311|FG001|Overall Study|Lack of Efficacy|2|||
127821306|NCT00375934|459966310|FG000|Overall Study|Physician Decision|0|||
127821307|NCT00375934|459966311|FG001|Overall Study|Physician Decision|1|||
127821308|NCT01300286|459966312|FG000|Overall Study|did not get dosed|1|||
127821309|NCT02584634|459966319|FG000|Overall Study|Adverse Event|3|||
127821310|NCT02584634|459966320|FG001|Overall Study|Adverse Event|5|||
127821311|NCT02584634|459966319|FG000|Overall Study|Death|0|||
127821312|NCT02584634|459966320|FG001|Overall Study|Death|1|||
127821313|NCT02584634|459966319|FG000|Overall Study|Lost to Follow-up|0|||
127821314|NCT02584634|459966320|FG001|Overall Study|Lost to Follow-up|1|||
127821315|NCT02584634|459966319|FG000|Overall Study|Physician Decision|1|||
127821316|NCT02584634|459966320|FG001|Overall Study|Physician Decision|2|||
127821317|NCT02584634|459966319|FG000|Overall Study|Progressive disease|7|||
127821318|NCT02584634|459966320|FG001|Overall Study|Progressive disease|15|||
127821319|NCT02584634|459966319|FG000|Overall Study|Withdrawal by Subject|1|||
127821320|NCT02584634|459966320|FG001|Overall Study|Withdrawal by Subject|1|||
127821321|NCT02584634|459966319|FG000|Overall Study|Other|0|||
127821322|NCT02584634|459966320|FG001|Overall Study|Other|6|||
127821323|NCT03707977|459966321|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
127821324|NCT03707977|459966322|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
127821325|NCT03707977|459966323|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
127821326|NCT03707977|459966321|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
127821327|NCT03707977|459966322|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
127821328|NCT03707977|459966323|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
127821329|NCT02564120|459966324|FG000|Overall Study|Did not return release forms|160|||
127821330|NCT02564120|459966324|FG000|Overall Study|Death|58|||
127821331|NCT02564120|459966324|FG000|Overall Study|Withdrawal by Subject|204|||
127821332|NCT02564120|459966324|FG000|Overall Study|Other medical condition|24|||
127821333|NCT00641147|459966325|FG000|Completed 4 Months.|Physician Decision|1|||
127821334|NCT00641147|459966326|FG001|Completed 4 Months.|Physician Decision|0|||
127821335|NCT00641147|459966325|FG000|Completed 4 Months.|Adverse Event|1|||
127821336|NCT00641147|459966326|FG001|Completed 4 Months.|Adverse Event|0|||
127821337|NCT00641147|459966325|FG000|Completed 8 Months.|Physician Decision|2|||
127821338|NCT00641147|459966326|FG001|Completed 8 Months.|Physician Decision|1|||
127821339|NCT00641147|459966325|FG000|Completed 8 Months.|non compliance|1|||
127821340|NCT00641147|459966326|FG001|Completed 8 Months.|non compliance|0|||
127821341|NCT00641147|459966325|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
127821342|NCT00641147|459966326|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
127821343|NCT00641147|459966325|FG000|Completed 12 Months.|Physician Decision|1|||
127821344|NCT00641147|459966326|FG001|Completed 12 Months.|Physician Decision|1|||
127821345|NCT00641147|459966325|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
127821346|NCT00641147|459966326|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
127821347|NCT00641147|459966325|FG000|Completed 16 Months.|Physician Decision|1|||
127821348|NCT00641147|459966326|FG001|Completed 16 Months.|Physician Decision|0|||
127821349|NCT00641147|459966325|FG000|Completed 16 Months.|Lost to Follow-up|1|||
127821350|NCT00641147|459966326|FG001|Completed 16 Months.|Lost to Follow-up|0|||
127821351|NCT01966731|459966327|FG000|Overall Study|Death|2|||
127821352|NCT01966731|459966327|FG000|Overall Study|Lost to Follow-up|1|||
127821353|NCT01966731|459966327|FG000|Overall Study|Physician Decision|2|||
127821354|NCT01966731|459966327|FG000|Overall Study|Follow up is not complete|600|||
127821355|NCT01966731|459966327|FG000|Overall Study|Screening Failure|29|||
127821356|NCT01966731|459966327|FG000|Overall Study|Found to be ineligible|1|||
127821357|NCT01380093|459966329|FG000|Naloxone Challenge Phase|Screen failures|21|||
127821358|NCT01380093|459966330|FG001|Naloxone Challenge Phase|Screen failures|0|||
127821359|NCT01380093|459966331|FG002|Naloxone Challenge Phase|Screen failures|0|||
127821360|NCT01380093|459966332|FG003|Naloxone Challenge Phase|Screen failures|0|||
127821361|NCT01380093|459966333|FG004|Naloxone Challenge Phase|Screen failures|0|||
127821362|NCT01380093|459966334|FG005|Naloxone Challenge Phase|Screen failures|0|||
127821363|NCT01380093|459966335|FG006|Naloxone Challenge Phase|Screen failures|0|||
127821364|NCT01380093|459966336|FG007|Naloxone Challenge Phase|Screen failures|0|||
127821365|NCT01380093|459966337|FG008|Naloxone Challenge Phase|Screen failures|0|||
127821366|NCT01380093|459966329|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
127821367|NCT01380093|459966330|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
127821368|NCT01380093|459966331|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
127821369|NCT01380093|459966332|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
127821370|NCT01380093|459966333|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
127821371|NCT01380093|459966334|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
127821372|NCT01380093|459966335|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
127821373|NCT01380093|459966336|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
127821374|NCT01380093|459966337|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
127821375|NCT01380093|459966329|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
127894678|NCT00437281|460237231|FG016|Overall Study|Lost to Follow-up|0|||
127894679|NCT00437281|460237232|FG017|Overall Study|Lost to Follow-up|0|||
127821376|NCT01380093|459966330|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
127894680|NCT00437281|460237233|FG018|Overall Study|Lost to Follow-up|0|||
127821377|NCT01380093|459966331|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
127821378|NCT01380093|459966332|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
127821379|NCT01380093|459966333|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
127821380|NCT01380093|459966334|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
127821381|NCT01380093|459966335|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
127821382|NCT01380093|459966336|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
127821383|NCT01380093|459966337|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
127821384|NCT01380093|459966329|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
127821385|NCT01380093|459966330|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
127821386|NCT01380093|459966331|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
127821387|NCT01380093|459966332|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
127821388|NCT01380093|459966333|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
127821389|NCT01380093|459966334|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
127821390|NCT01380093|459966335|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
127821391|NCT01380093|459966336|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
127821392|NCT01380093|459966337|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
127821393|NCT01380093|459966329|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
127821394|NCT01380093|459966330|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
127821395|NCT01380093|459966331|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
127821396|NCT01380093|459966332|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
127821397|NCT01380093|459966333|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
127821398|NCT01380093|459966334|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
127821399|NCT01380093|459966335|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
127821400|NCT01380093|459966336|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
127821401|NCT01380093|459966337|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
127821402|NCT01380093|459966329|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
127821403|NCT01380093|459966330|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
127821404|NCT01380093|459966331|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
127821405|NCT01380093|459966332|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
127821406|NCT01380093|459966333|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
127821407|NCT01380093|459966334|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
127821408|NCT01380093|459966335|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
127821409|NCT01380093|459966336|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
127821410|NCT01380093|459966337|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
127821411|NCT01380093|459966329|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
127821412|NCT01380093|459966330|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
127821413|NCT01380093|459966331|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
127821414|NCT01380093|459966332|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
127821415|NCT01380093|459966333|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
127821416|NCT01380093|459966334|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
127821417|NCT01380093|459966335|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
127821418|NCT01380093|459966336|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
127821419|NCT01380093|459966337|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
127821420|NCT01380093|459966329|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
127821421|NCT01380093|459966330|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
127821422|NCT01380093|459966331|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
127821423|NCT01380093|459966332|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
127821424|NCT01380093|459966333|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
127821425|NCT01380093|459966334|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
127821426|NCT01380093|459966335|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
127821427|NCT01380093|459966336|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
127821428|NCT01380093|459966337|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
127821429|NCT01380093|459966329|FG000|Treatment Phase: Second Intervention|Other|0|||
127894681|NCT00437281|460237234|FG019|Overall Study|Lost to Follow-up|1|||
127821430|NCT01380093|459966330|FG001|Treatment Phase: Second Intervention|Other|0|||
127821431|NCT01380093|459966331|FG002|Treatment Phase: Second Intervention|Other|0|||
127821432|NCT01380093|459966332|FG003|Treatment Phase: Second Intervention|Other|1|||
127821433|NCT01380093|459966333|FG004|Treatment Phase: Second Intervention|Other|0|||
127821434|NCT01380093|459966334|FG005|Treatment Phase: Second Intervention|Other|0|||
127821435|NCT01380093|459966335|FG006|Treatment Phase: Second Intervention|Other|0|||
127821436|NCT01380093|459966336|FG007|Treatment Phase: Second Intervention|Other|0|||
127821437|NCT01380093|459966337|FG008|Treatment Phase: Second Intervention|Other|0|||
127821438|NCT01380093|459966329|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
127821439|NCT01380093|459966330|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
127821440|NCT01380093|459966331|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
127821441|NCT01380093|459966332|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
127821442|NCT01380093|459966333|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
127821443|NCT01380093|459966334|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
127821444|NCT01380093|459966335|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
127821445|NCT01380093|459966336|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
127821446|NCT01380093|459966337|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
127821447|NCT01380093|459966329|FG000|Treatment Phase: Third Intervention|Other|0|||
127821448|NCT01380093|459966330|FG001|Treatment Phase: Third Intervention|Other|0|||
127821449|NCT01380093|459966331|FG002|Treatment Phase: Third Intervention|Other|0|||
127821450|NCT01380093|459966332|FG003|Treatment Phase: Third Intervention|Other|0|||
127821451|NCT01380093|459966333|FG004|Treatment Phase: Third Intervention|Other|0|||
127821452|NCT01380093|459966334|FG005|Treatment Phase: Third Intervention|Other|0|||
127821453|NCT01380093|459966335|FG006|Treatment Phase: Third Intervention|Other|0|||
127821454|NCT01380093|459966336|FG007|Treatment Phase: Third Intervention|Other|0|||
127821455|NCT01380093|459966337|FG008|Treatment Phase: Third Intervention|Other|1|||
127821456|NCT04734873|459966338|FG000|Overall Study|Lost to Follow-up|1|||
127821457|NCT04734873|459966339|FG001|Overall Study|Lost to Follow-up|3|||
127821458|NCT04734873|459966340|FG002|Overall Study|Lost to Follow-up|2|||
127821459|NCT04734873|459966338|FG000|Overall Study|Randomized but not dosed|1|||
127821460|NCT04734873|459966339|FG001|Overall Study|Randomized but not dosed|0|||
127821461|NCT04734873|459966340|FG002|Overall Study|Randomized but not dosed|1|||
127821462|NCT02441803|459966344|FG000|Overall Study|Physician Decision|0|||
127821463|NCT02441803|459966345|FG001|Overall Study|Physician Decision|2|||
127821464|NCT02441803|459966346|FG002|Overall Study|Physician Decision|2|||
127821465|NCT00328198|459966350|FG000|Treatment|Adverse Event|21|||
127821466|NCT00328198|459966350|FG000|Treatment|Death|1|||
127821467|NCT00328198|459966350|FG000|Treatment|Physician Decision|5|||
127821468|NCT00328198|459966350|FG000|Treatment|Withdrawal by Subject|5|||
127821469|NCT00328198|459966350|FG000|Treatment|Evidence of disease progression|2|||
127821470|NCT00328198|459966350|FG000|Treatment|Non-compliance|1|||
127821471|NCT00328198|459966350|FG000|Treatment|Confirmed complete response, MRD -|3|||
127821472|NCT00328198|459966350|FG000|Follow-up|Lost to Follow-up|4|||
127821473|NCT00328198|459966350|FG000|Follow-up|Death|31|||
127821474|NCT03396471|459966351|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
127821475|NCT03396471|459966351|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
127821476|NCT03396471|459966351|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
127821477|NCT03396471|459966351|FG000|Study Treatment - Up to 22 Months|Death|2|||
127821478|NCT03396471|459966351|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
127821479|NCT03396471|459966351|FG000|Follow up - Up to 2 Years|Death|9|||
127821480|NCT03396471|459966351|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
127821481|NCT03396471|459966351|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
127821482|NCT03396471|459966351|FG000|Follow up - Up to 2 Years|study terminated|1|||
127821483|NCT03396471|459966351|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
127894682|NCT00601354|460237235|FG000|Overall Study|Lost to Follow-up|4|||
127821484|NCT03396471|459966351|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
127821485|NCT00718861|459966352|FG000|Overall Study|Withdrawal by Subject|15|||
127821486|NCT00718861|459966353|FG001|Overall Study|Withdrawal by Subject|10|||
127821487|NCT00718861|459966352|FG000|Overall Study|Adverse Event|2|||
127821488|NCT00718861|459966353|FG001|Overall Study|Adverse Event|1|||
127821489|NCT00718861|459966352|FG000|Overall Study|Lost to Follow-up|2|||
127821490|NCT00718861|459966353|FG001|Overall Study|Lost to Follow-up|1|||
127821491|NCT00718861|459966352|FG000|Overall Study|Administrative Problems|1|||
127821492|NCT00718861|459966353|FG001|Overall Study|Administrative Problems|1|||
127821493|NCT00718861|459966352|FG000|Overall Study|Death|1|||
127821494|NCT00718861|459966353|FG001|Overall Study|Death|5|||
127821495|NCT03237845|459966354|FG000|Overall Study|Adverse Event|0|||
127821496|NCT03237845|459966355|FG001|Overall Study|Adverse Event|1|||
127821497|NCT03237845|459966354|FG000|Overall Study|Lost to Follow-up|13|||
127821498|NCT03237845|459966355|FG001|Overall Study|Lost to Follow-up|10|||
127821499|NCT03237845|459966354|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
127821500|NCT03237845|459966355|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
127821501|NCT03237845|459966354|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
127821502|NCT03237845|459966355|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
127821503|NCT03237845|459966354|FG000|Overall Study|Physician Decision|1|||
127821504|NCT03237845|459966355|FG001|Overall Study|Physician Decision|2|||
127821505|NCT03237845|459966354|FG000|Overall Study|Pregnancy|1|||
127821506|NCT03237845|459966355|FG001|Overall Study|Pregnancy|0|||
127821507|NCT03237845|459966354|FG000|Overall Study|Protocol Deviation|0|||
127821508|NCT03237845|459966355|FG001|Overall Study|Protocol Deviation|1|||
127821509|NCT03237845|459966354|FG000|Overall Study|Technical Problems|8|||
127821510|NCT03237845|459966355|FG001|Overall Study|Technical Problems|1|||
127821511|NCT03237845|459966354|FG000|Overall Study|Withdrawal by Subject|3|||
127821512|NCT03237845|459966355|FG001|Overall Study|Withdrawal by Subject|3|||
127821513|NCT03237845|459966354|FG000|Overall Study|Other Reasons|4|||
127821514|NCT03237845|459966355|FG001|Overall Study|Other Reasons|0|||
127821515|NCT03865407|459966359|FG000|Overall Study|Adverse Event|1|||
127821516|NCT03865407|459966360|FG001|Overall Study|Adverse Event|0|||
127821517|NCT03865407|459966359|FG000|Overall Study|Withdrawal by Subject|1|||
127821518|NCT03865407|459966360|FG001|Overall Study|Withdrawal by Subject|0|||
127821519|NCT03865407|459966359|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
127821520|NCT03865407|459966360|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
127821521|NCT02117050|459966361|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
127821522|NCT01645280|459966362|FG000|Overall Study|Death|0|||
127821523|NCT01645280|459966363|FG001|Overall Study|Death|1|||
127821524|NCT01645280|459966364|FG002|Overall Study|Death|0|||
127821525|NCT01645280|459966365|FG003|Overall Study|Death|0|||
127821526|NCT01645280|459966366|FG004|Overall Study|Death|0|||
127821527|NCT01645280|459966362|FG000|Overall Study|Withdrawal by Subject|4|||
127821528|NCT01645280|459966363|FG001|Overall Study|Withdrawal by Subject|0|||
127821529|NCT01645280|459966364|FG002|Overall Study|Withdrawal by Subject|2|||
127821530|NCT01645280|459966365|FG003|Overall Study|Withdrawal by Subject|4|||
127821531|NCT01645280|459966366|FG004|Overall Study|Withdrawal by Subject|5|||
127821532|NCT01645280|459966362|FG000|Overall Study|Lost to Follow-up|0|||
127821533|NCT01645280|459966363|FG001|Overall Study|Lost to Follow-up|0|||
127821534|NCT01645280|459966364|FG002|Overall Study|Lost to Follow-up|0|||
127821535|NCT01645280|459966365|FG003|Overall Study|Lost to Follow-up|2|||
127821536|NCT01645280|459966366|FG004|Overall Study|Lost to Follow-up|1|||
127821537|NCT01645280|459966362|FG000|Overall Study|Other|1|||
127821538|NCT01645280|459966363|FG001|Overall Study|Other|1|||
127821539|NCT01645280|459966364|FG002|Overall Study|Other|2|||
127821540|NCT01645280|459966365|FG003|Overall Study|Other|0|||
127821541|NCT01645280|459966366|FG004|Overall Study|Other|0|||
127821542|NCT01645280|459966362|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
127821543|NCT01645280|459966363|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
127821544|NCT01645280|459966364|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
127821545|NCT01645280|459966365|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
127821546|NCT01645280|459966366|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
127821547|NCT00234104|459966371|FG000|Overall Study|Adverse Event|4|||
127821548|NCT00234104|459966372|FG001|Overall Study|Adverse Event|0|||
127821549|NCT00234104|459966373|FG002|Overall Study|Adverse Event|3|||
127821550|NCT00234104|459966374|FG003|Overall Study|Adverse Event|5|||
127821551|NCT00234104|459966371|FG000|Overall Study|Protocol Violation|0|||
127821552|NCT00234104|459966372|FG001|Overall Study|Protocol Violation|0|||
127821553|NCT00234104|459966373|FG002|Overall Study|Protocol Violation|0|||
127821554|NCT00234104|459966374|FG003|Overall Study|Protocol Violation|1|||
127821555|NCT00234104|459966371|FG000|Overall Study|Physician Decision|0|||
127821556|NCT00234104|459966372|FG001|Overall Study|Physician Decision|1|||
127821557|NCT00234104|459966373|FG002|Overall Study|Physician Decision|2|||
127821558|NCT00234104|459966374|FG003|Overall Study|Physician Decision|2|||
127821559|NCT00546819|459966377|FG000|Overall Study|Adverse Event|2|||
127821560|NCT00546819|459966378|FG001|Overall Study|Adverse Event|3|||
127821561|NCT00546819|459966377|FG000|Overall Study|Lost to Follow-up|2|||
127821562|NCT00546819|459966378|FG001|Overall Study|Lost to Follow-up|1|||
127821563|NCT00546819|459966377|FG000|Overall Study|Withdrawal by Subject|4|||
127821564|NCT00546819|459966378|FG001|Overall Study|Withdrawal by Subject|2|||
127821565|NCT02052960|459966380|FG000|Overall Study|Adverse Event|19|||
127821566|NCT02052960|459966381|FG001|Overall Study|Adverse Event|17|||
127821567|NCT02052960|459966380|FG000|Overall Study|Protocol Violation|4|||
127821568|NCT02052960|459966381|FG001|Overall Study|Protocol Violation|3|||
127821569|NCT02052960|459966380|FG000|Overall Study|Withdrawal by Subject|6|||
127821570|NCT02052960|459966381|FG001|Overall Study|Withdrawal by Subject|11|||
127821571|NCT02052960|459966380|FG000|Overall Study|Other|25|||
127821572|NCT02052960|459966381|FG001|Overall Study|Other|15|||
127821573|NCT03849560|459966382|FG000|Overall Study|Withdrawal by Subject|1|||
127821574|NCT03849560|459966383|FG001|Overall Study|Withdrawal by Subject|0|||
127821575|NCT03849560|459966384|FG002|Overall Study|Withdrawal by Subject|0|||
127821576|NCT04045613|459966385|FG000|Overall Study|Adverse Event|2|||
127821577|NCT04045613|459966386|FG001|Overall Study|Adverse Event|2|||
127821578|NCT04045613|459966387|FG002|Overall Study|Adverse Event|1|||
127821579|NCT04045613|459966388|FG003|Overall Study|Adverse Event|1|||
127821580|NCT04045613|459966389|FG004|Overall Study|Adverse Event|0|||
127821581|NCT04045613|459966390|FG005|Overall Study|Adverse Event|0|||
127821582|NCT04045613|459966391|FG006|Overall Study|Adverse Event|1|||
127821583|NCT04045613|459966385|FG000|Overall Study|Withdrawal by Subject|0|||
127821584|NCT04045613|459966386|FG001|Overall Study|Withdrawal by Subject|5|||
127821585|NCT04045613|459966387|FG002|Overall Study|Withdrawal by Subject|0|||
127821586|NCT04045613|459966388|FG003|Overall Study|Withdrawal by Subject|0|||
127821587|NCT04045613|459966389|FG004|Overall Study|Withdrawal by Subject|0|||
127821588|NCT04045613|459966390|FG005|Overall Study|Withdrawal by Subject|1|||
127821589|NCT04045613|459966391|FG006|Overall Study|Withdrawal by Subject|0|||
127821590|NCT04045613|459966385|FG000|Overall Study|Physician Decision|2|||
127821591|NCT04045613|459966386|FG001|Overall Study|Physician Decision|0|||
127821592|NCT04045613|459966387|FG002|Overall Study|Physician Decision|0|||
127821593|NCT04045613|459966388|FG003|Overall Study|Physician Decision|0|||
127821594|NCT04045613|459966389|FG004|Overall Study|Physician Decision|1|||
127821595|NCT04045613|459966390|FG005|Overall Study|Physician Decision|0|||
127821596|NCT04045613|459966391|FG006|Overall Study|Physician Decision|0|||
127821597|NCT04045613|459966385|FG000|Overall Study|Death|3|||
127821598|NCT04045613|459966386|FG001|Overall Study|Death|0|||
127821599|NCT04045613|459966387|FG002|Overall Study|Death|0|||
127821600|NCT04045613|459966388|FG003|Overall Study|Death|0|||
127821601|NCT04045613|459966389|FG004|Overall Study|Death|0|||
127821602|NCT04045613|459966390|FG005|Overall Study|Death|0|||
127821603|NCT04045613|459966391|FG006|Overall Study|Death|1|||
127821604|NCT04045613|459966385|FG000|Overall Study|Other reasons|0|||
127821605|NCT04045613|459966386|FG001|Overall Study|Other reasons|1|||
127821606|NCT04045613|459966387|FG002|Overall Study|Other reasons|0|||
127821607|NCT04045613|459966388|FG003|Overall Study|Other reasons|0|||
127821608|NCT04045613|459966389|FG004|Overall Study|Other reasons|0|||
127821609|NCT04045613|459966390|FG005|Overall Study|Other reasons|0|||
127821610|NCT04045613|459966391|FG006|Overall Study|Other reasons|1|||
127821611|NCT04045613|459966385|FG000|Overall Study|Progressive disease: Clinical progression|1|||
127821612|NCT04045613|459966386|FG001|Overall Study|Progressive disease: Clinical progression|0|||
127821613|NCT04045613|459966387|FG002|Overall Study|Progressive disease: Clinical progression|3|||
127821614|NCT04045613|459966388|FG003|Overall Study|Progressive disease: Clinical progression|1|||
127821615|NCT04045613|459966389|FG004|Overall Study|Progressive disease: Clinical progression|1|||
127821616|NCT04045613|459966390|FG005|Overall Study|Progressive disease: Clinical progression|3|||
127821617|NCT04045613|459966391|FG006|Overall Study|Progressive disease: Clinical progression|3|||
127821618|NCT04045613|459966385|FG000|Overall Study|Progressive disease: Radiological progression|24|||
127821619|NCT04045613|459966386|FG001|Overall Study|Progressive disease: Radiological progression|6|||
127821620|NCT04045613|459966387|FG002|Overall Study|Progressive disease: Radiological progression|8|||
127821621|NCT04045613|459966388|FG003|Overall Study|Progressive disease: Radiological progression|0|||
127821622|NCT04045613|459966389|FG004|Overall Study|Progressive disease: Radiological progression|6|||
127821623|NCT04045613|459966390|FG005|Overall Study|Progressive disease: Radiological progression|6|||
127821624|NCT04045613|459966391|FG006|Overall Study|Progressive disease: Radiological progression|11|||
127821625|NCT04983901|459966392|FG000|Overall Study|Death|1|||
127821626|NCT04983901|459966393|FG001|Overall Study|Death|4|||
127821627|NCT04983901|459966392|FG000|Overall Study|Lost to Follow-up|3|||
127821628|NCT04983901|459966393|FG001|Overall Study|Lost to Follow-up|0|||
127821629|NCT04983901|459966392|FG000|Overall Study|Protocol Violation|1|||
127821630|NCT04983901|459966393|FG001|Overall Study|Protocol Violation|0|||
127821631|NCT04983901|459966392|FG000|Overall Study|Withdrawal by Subject|1|||
127821632|NCT04983901|459966393|FG001|Overall Study|Withdrawal by Subject|2|||
127821633|NCT02859415|459966401|FG000|Overall Study|Physician Decision|1|||
127821634|NCT02859415|459966402|FG001|Overall Study|Physician Decision|0|||
127821635|NCT02859415|459966401|FG000|Overall Study|Off treatment due to cardiac event|0|||
127821636|NCT02859415|459966402|FG001|Overall Study|Off treatment due to cardiac event|1|||
127821637|NCT01174784|459966403|FG000|Overall Study|Screen fails|4|||
127821638|NCT00450866|459966409|FG000|Overall Study|Adverse Event|0|||
127821639|NCT00450866|459966410|FG001|Overall Study|Adverse Event|1|||
127821640|NCT00450866|459966409|FG000|Overall Study|Withdrawal by Subject|5|||
127821641|NCT00450866|459966410|FG001|Overall Study|Withdrawal by Subject|2|||
127821642|NCT00450866|459966409|FG000|Overall Study|Death|1|||
127821643|NCT00450866|459966410|FG001|Overall Study|Death|0|||
127821644|NCT00450866|459966409|FG000|Overall Study|Physician Decision|1|||
127821645|NCT00450866|459966410|FG001|Overall Study|Physician Decision|0|||
127821650|NCT01716169|459966413|FG000|Overall Study|Adverse Event|1|||
127821651|NCT01716169|459966413|FG000|Overall Study|Lost to Follow-up|1|||
127821652|NCT01716169|459966413|FG000|Overall Study|Withdrawal by Subject|1|||
127821653|NCT01716169|459966413|FG000|Overall Study|inconsistent dressing application|1|||
127821654|NCT00553787|459966414|FG000|Overall Study|Adverse Event|34|||
127821655|NCT00553787|459966415|FG001|Overall Study|Adverse Event|21|||
127821656|NCT00553787|459966416|FG002|Overall Study|Adverse Event|67|||
127821657|NCT00553787|459966414|FG000|Overall Study|Lost to Follow-up|132|||
127821658|NCT00553787|459966415|FG001|Overall Study|Lost to Follow-up|44|||
127821659|NCT00553787|459966416|FG002|Overall Study|Lost to Follow-up|78|||
127821660|NCT00553787|459966414|FG000|Overall Study|Withdrawal by Subject|151|||
127821661|NCT00553787|459966415|FG001|Overall Study|Withdrawal by Subject|40|||
127821662|NCT00553787|459966416|FG002|Overall Study|Withdrawal by Subject|83|||
127821663|NCT00553787|459966414|FG000|Overall Study|Lack of Efficacy|31|||
127821664|NCT00553787|459966415|FG001|Overall Study|Lack of Efficacy|1|||
127821665|NCT00553787|459966416|FG002|Overall Study|Lack of Efficacy|3|||
127821666|NCT00553787|459966414|FG000|Overall Study|Pregnancy|0|||
127821667|NCT00553787|459966415|FG001|Overall Study|Pregnancy|1|||
127821668|NCT00553787|459966416|FG002|Overall Study|Pregnancy|2|||
127821669|NCT00553787|459966414|FG000|Overall Study|non compliance|4|||
127821670|NCT00553787|459966415|FG001|Overall Study|non compliance|0|||
127821671|NCT00553787|459966416|FG002|Overall Study|non compliance|11|||
127821672|NCT00553787|459966414|FG000|Overall Study|Requirement for restricted medication|8|||
127894683|NCT00601354|460237236|FG001|Overall Study|Lost to Follow-up|5|||
127894684|NCT01862328|460237237|FG000|Overall Study|Progressive Disease|3|||
127821673|NCT00553787|459966415|FG001|Overall Study|Requirement for restricted medication|7|||
127821674|NCT00553787|459966416|FG002|Overall Study|Requirement for restricted medication|5|||
127821675|NCT00553787|459966414|FG000|Overall Study|Other|18|||
127821676|NCT00553787|459966415|FG001|Overall Study|Other|10|||
127821677|NCT00553787|459966416|FG002|Overall Study|Other|13|||
127821678|NCT01088412|459966417|FG000|Overall Study|Adverse Event|38|||
127821679|NCT01088412|459966418|FG001|Overall Study|Adverse Event|0|||
127821680|NCT01088412|459966419|FG002|Overall Study|Adverse Event|0|||
127821681|NCT01088412|459966417|FG000|Overall Study|Death|42|||
127821682|NCT01088412|459966418|FG001|Overall Study|Death|6|||
127821683|NCT01088412|459966419|FG002|Overall Study|Death|0|||
127821684|NCT01088412|459966417|FG000|Overall Study|Other Reason per Case Report Form|2089|||
127821685|NCT01088412|459966418|FG001|Overall Study|Other Reason per Case Report Form|103|||
127821686|NCT01088412|459966419|FG002|Overall Study|Other Reason per Case Report Form|9|||
127821687|NCT01088412|459966417|FG000|Overall Study|Withdrawal by Subject|1761|||
127821688|NCT01088412|459966418|FG001|Overall Study|Withdrawal by Subject|25|||
127821689|NCT01088412|459966419|FG002|Overall Study|Withdrawal by Subject|1|||
127821690|NCT01088412|459966417|FG000|Overall Study|Received Another GH Product|79|||
127821691|NCT01088412|459966418|FG001|Overall Study|Received Another GH Product|0|||
127821692|NCT01088412|459966419|FG002|Overall Study|Received Another GH Product|0|||
127821693|NCT01088412|459966417|FG000|Overall Study|Participant Moved|601|||
127821694|NCT01088412|459966418|FG001|Overall Study|Participant Moved|21|||
127821695|NCT01088412|459966419|FG002|Overall Study|Participant Moved|2|||
127821696|NCT01088412|459966417|FG000|Overall Study|Physician Decision|1041|||
127821697|NCT01088412|459966418|FG001|Overall Study|Physician Decision|8|||
127821698|NCT01088412|459966419|FG002|Overall Study|Physician Decision|4|||
127821699|NCT01088412|459966417|FG000|Overall Study|Sponsor Decision|4467|||
127821700|NCT01088412|459966418|FG001|Overall Study|Sponsor Decision|79|||
127821701|NCT01088412|459966419|FG002|Overall Study|Sponsor Decision|23|||
127821702|NCT01088412|459966417|FG000|Overall Study|Third Party Required to Change Brand|487|||
127821703|NCT01088412|459966418|FG001|Overall Study|Third Party Required to Change Brand|0|||
127821704|NCT01088412|459966419|FG002|Overall Study|Third Party Required to Change Brand|0|||
127821705|NCT01088412|459966417|FG000|Overall Study|Lost to Follow-up|3052|||
127821706|NCT01088412|459966418|FG001|Overall Study|Lost to Follow-up|130|||
127821707|NCT01088412|459966419|FG002|Overall Study|Lost to Follow-up|11|||
127821708|NCT01088412|459966417|FG000|Overall Study|Study Summary Not Completed|4360|||
127821709|NCT01088412|459966418|FG001|Overall Study|Study Summary Not Completed|64|||
127821710|NCT01088412|459966419|FG002|Overall Study|Study Summary Not Completed|22|||
127821711|NCT02285010|459966420|FG000|Overall Study|not abdominal hysterectomy|2|||
127821712|NCT02285010|459966421|FG001|Overall Study|not abdominal hysterectomy|0|||
127821713|NCT02285010|459966420|FG000|Overall Study|Not spinal anesthesia|3|||
127821714|NCT02285010|459966421|FG001|Overall Study|Not spinal anesthesia|1|||
127821715|NCT01333189|459966424|FG000|Overall Study|Time constraints|1|||
127821716|NCT01333189|459966425|FG001|Overall Study|Time constraints|0|||
127821717|NCT01333189|459966424|FG000|Overall Study|Adverse Event|1|||
127821718|NCT01333189|459966425|FG001|Overall Study|Adverse Event|0|||
127821719|NCT01333189|459966424|FG000|Overall Study|Transportation difficulties|0|||
127821720|NCT01333189|459966425|FG001|Overall Study|Transportation difficulties|1|||
127821721|NCT01333189|459966424|FG000|Overall Study|Moved from region|0|||
127821722|NCT01333189|459966425|FG001|Overall Study|Moved from region|1|||
127821723|NCT02489630|459966428|FG000|Overall Study|Oversedation|1|||
127821724|NCT02489630|459966429|FG001|Overall Study|Oversedation|1|||
127821725|NCT02489630|459966428|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
127821726|NCT02489630|459966429|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
127821727|NCT03429556|459966430|FG000|Overall Study|Lost to Follow-up|0|||
127821728|NCT03429556|459966431|FG001|Overall Study|Lost to Follow-up|1|||
127821729|NCT03429556|459966432|FG002|Overall Study|Lost to Follow-up|0|||
127821730|NCT03429556|459966433|FG003|Overall Study|Lost to Follow-up|0|||
127821731|NCT01863758|459966438|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
127821732|NCT01863758|459966438|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
127821733|NCT02369510|459966439|FG000|Overall Study|Spilled Medication|1|||
127821734|NCT02369510|459966440|FG001|Overall Study|Spilled Medication|2|||
127821735|NCT02369510|459966441|FG002|Overall Study|Spilled Medication|1|||
127821736|NCT02369510|459966439|FG000|Overall Study|Epidural Activation|1|||
127821737|NCT02369510|459966440|FG001|Overall Study|Epidural Activation|1|||
127821738|NCT02369510|459966441|FG002|Overall Study|Epidural Activation|5|||
127821739|NCT02050048|459966442|FG000|Overall Study|Lost to Follow-up|0|||
127821740|NCT02050048|459966443|FG001|Overall Study|Lost to Follow-up|1|||
127821741|NCT02050048|459966442|FG000|Overall Study|Death|1|||
127821742|NCT02050048|459966443|FG001|Overall Study|Death|0|||
127821743|NCT02050048|459966442|FG000|Overall Study|Ineligible after ERCP|4|||
127821744|NCT02050048|459966443|FG001|Overall Study|Ineligible after ERCP|1|||
127821745|NCT04285723|459966447|FG000|Overall Study|Subject decision|1|||
127821746|NCT04285723|459966448|FG001|Overall Study|Subject decision|2|||
127821747|NCT04285723|459966447|FG000|Overall Study|Physician Decision|1|||
127821748|NCT04285723|459966448|FG001|Overall Study|Physician Decision|0|||
127821749|NCT04285723|459966447|FG000|Overall Study|No efficiency|1|||
127821750|NCT04285723|459966448|FG001|Overall Study|No efficiency|0|||
127821751|NCT02903511|459966453|FG000|Overall Study|Withdrawal by Subject|1|||
127821752|NCT02903511|459966454|FG001|Overall Study|Withdrawal by Subject|0|||
127821753|NCT02903511|459966453|FG000|Overall Study|Lost to Follow-up|3|||
127821754|NCT02903511|459966454|FG001|Overall Study|Lost to Follow-up|2|||
127821755|NCT00969618|459966455|FG000|Overall Study|Adverse Event|29|||
127821756|NCT00969618|459966455|FG000|Overall Study|Entry Criteria Not Met|3|||
127821757|NCT00969618|459966455|FG000|Overall Study|Lack of Efficacy|2|||
127821758|NCT00969618|459966455|FG000|Overall Study|Lost to Follow-up|7|||
127821759|NCT00969618|459966455|FG000|Overall Study|Physician Decision|1|||
127821760|NCT00969618|459966455|FG000|Overall Study|Protocol Violation|9|||
127821761|NCT00969618|459966455|FG000|Overall Study|Withdrawal by Subject|27|||
127821762|NCT05363293|459966460|FG000|Overall Study|Withdrawal by Subject|1|||
127821763|NCT05363293|459966461|FG001|Overall Study|Withdrawal by Subject|0|||
127821764|NCT05363293|459966462|FG002|Overall Study|Withdrawal by Subject|0|||
127821765|NCT05363293|459966463|FG003|Overall Study|Withdrawal by Subject|0|||
127821766|NCT05363293|459966464|FG004|Overall Study|Withdrawal by Subject|0|||
127821767|NCT05363293|459966465|FG005|Overall Study|Withdrawal by Subject|0|||
127821768|NCT05363293|459966466|FG006|Overall Study|Withdrawal by Subject|0|||
127821769|NCT05363293|459966467|FG007|Overall Study|Withdrawal by Subject|0|||
127821770|NCT05363293|459966468|FG008|Overall Study|Withdrawal by Subject|0|||
127821771|NCT05363293|459966469|FG009|Overall Study|Withdrawal by Subject|0|||
127821772|NCT01318902|459966470|FG000|Overall Study|Symptomatic Deterioration|0|||
127821773|NCT01318902|459966471|FG001|Overall Study|Symptomatic Deterioration|1|||
127821774|NCT01318902|459966472|FG002|Overall Study|Symptomatic Deterioration|1|||
127821775|NCT01318902|459966473|FG003|Overall Study|Symptomatic Deterioration|2|||
127821776|NCT01318902|459966470|FG000|Overall Study|Withdrawal by Patient|0|||
127821777|NCT01318902|459966471|FG001|Overall Study|Withdrawal by Patient|1|||
127821778|NCT01318902|459966472|FG002|Overall Study|Withdrawal by Patient|0|||
127821779|NCT01318902|459966473|FG003|Overall Study|Withdrawal by Patient|3|||
127821780|NCT01318902|459966470|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
127821781|NCT01318902|459966471|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
127821782|NCT01318902|459966472|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
127821783|NCT01318902|459966473|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
127821784|NCT01318902|459966470|FG000|Overall Study|Adverse Event|0|||
127821785|NCT01318902|459966471|FG001|Overall Study|Adverse Event|1|||
127821786|NCT01318902|459966472|FG002|Overall Study|Adverse Event|0|||
127821787|NCT01318902|459966473|FG003|Overall Study|Adverse Event|0|||
127821788|NCT01318902|459966470|FG000|Overall Study|Terminated by Sponsor|0|||
127821789|NCT01318902|459966471|FG001|Overall Study|Terminated by Sponsor|0|||
127821790|NCT01318902|459966472|FG002|Overall Study|Terminated by Sponsor|1|||
127821791|NCT01318902|459966473|FG003|Overall Study|Terminated by Sponsor|0|||
127821792|NCT03270085|459968416|FG000|Overall Study|Withdrawal by Subject|1|||
127821793|NCT03270085|459968417|FG001|Overall Study|Withdrawal by Subject|0|||
127821794|NCT02400346|459968418|FG000|Overall Study|Adverse Event|24|||
127821795|NCT02400346|459968418|FG000|Overall Study|Lack of Efficacy|9|||
127821796|NCT02400346|459968418|FG000|Overall Study|Non-compliance with IMP|1|||
127821797|NCT02400346|459968418|FG000|Overall Study|Withdrawal by Subject|7|||
127821798|NCT02400346|459968418|FG000|Overall Study|Administrative or other reason(s)|2|||
127821799|NCT02400346|459968418|FG000|Overall Study|Lost to Follow-up|1|||
127821800|NCT01269125|459968420|FG000|Overall Study|Adverse Event|3|||
127821801|NCT01269125|459968421|FG001|Overall Study|Adverse Event|5|||
127821802|NCT01269125|459968422|FG002|Overall Study|Adverse Event|0|||
127821803|NCT01269125|459968420|FG000|Overall Study|Lost to Follow-up|4|||
127821804|NCT01269125|459968421|FG001|Overall Study|Lost to Follow-up|0|||
127821805|NCT01269125|459968422|FG002|Overall Study|Lost to Follow-up|0|||
127821806|NCT01283581|459968424|FG000|Overall Study|Lost to Follow-up|8|||
127821807|NCT01283581|459968425|FG001|Overall Study|Lost to Follow-up|6|||
127821808|NCT01283581|459968426|FG002|Overall Study|Lost to Follow-up|8|||
127821809|NCT01283581|459968424|FG000|Overall Study|Withdrawal by Subject|2|||
127821810|NCT01283581|459968425|FG001|Overall Study|Withdrawal by Subject|5|||
127821811|NCT01283581|459968426|FG002|Overall Study|Withdrawal by Subject|2|||
127821812|NCT01283581|459968424|FG000|Overall Study|Adverse Event|1|||
127821813|NCT01283581|459968425|FG001|Overall Study|Adverse Event|1|||
127821814|NCT01283581|459968426|FG002|Overall Study|Adverse Event|4|||
127821815|NCT01283581|459968424|FG000|Overall Study|Physician Decision|0|||
127821816|NCT01283581|459968425|FG001|Overall Study|Physician Decision|1|||
127821817|NCT01283581|459968426|FG002|Overall Study|Physician Decision|2|||
127821818|NCT01283581|459968424|FG000|Overall Study|Protocol Violation|0|||
127821819|NCT01283581|459968425|FG001|Overall Study|Protocol Violation|1|||
127821820|NCT01283581|459968426|FG002|Overall Study|Protocol Violation|2|||
127821821|NCT01283581|459968424|FG000|Overall Study|Noncompliance|1|||
127821822|NCT01283581|459968425|FG001|Overall Study|Noncompliance|0|||
127821823|NCT01283581|459968426|FG002|Overall Study|Noncompliance|0|||
127821824|NCT01283581|459968424|FG000|Overall Study|Investigator unblinded|0|||
127821825|NCT01283581|459968425|FG001|Overall Study|Investigator unblinded|0|||
127821826|NCT01283581|459968426|FG002|Overall Study|Investigator unblinded|1|||
127821827|NCT01283581|459968424|FG000|Overall Study|"Early termination"|0|||
127821828|NCT01283581|459968425|FG001|Overall Study|"Early termination"|0|||
127821829|NCT01283581|459968426|FG002|Overall Study|"Early termination"|1|||
127821830|NCT00486226|459968427|FG000|Overall Study|Death|3|||
127821831|NCT00486226|459968427|FG000|Overall Study|Adverse Event|1|||
127821832|NCT00486226|459968427|FG000|Overall Study|Withdrawal by Subject|1|||
127821833|NCT00486226|459968427|FG000|Overall Study|Lost to Follow-up|8|||
127821834|NCT01259492|459968428|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
127821835|NCT01259492|459968429|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
127821836|NCT01259492|459968430|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
127821837|NCT01259492|459968431|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
127821838|NCT01259492|459968428|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
127821839|NCT01259492|459968429|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
127821840|NCT01259492|459968430|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
127821841|NCT01259492|459968431|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
127821842|NCT01259492|459968428|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
127821843|NCT01259492|459968429|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
127821844|NCT01259492|459968430|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
127821845|NCT01259492|459968431|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
127821846|NCT01259492|459968428|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
127821847|NCT01259492|459968429|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
127821848|NCT01259492|459968430|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
127821849|NCT01259492|459968431|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
127821850|NCT01259492|459968428|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
127821851|NCT01259492|459968429|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
127821852|NCT01259492|459968430|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
127821853|NCT01259492|459968431|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
127821854|NCT01259492|459968428|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
127821855|NCT01259492|459968429|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
127821856|NCT01259492|459968430|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
127821857|NCT01259492|459968431|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
127821858|NCT01259492|459968428|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
127821859|NCT01259492|459968429|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
127821860|NCT01259492|459968430|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
127821861|NCT01259492|459968431|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
127821862|NCT01259492|459968428|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
127821863|NCT01259492|459968429|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
127821864|NCT01259492|459968430|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
127821865|NCT01259492|459968431|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
127821866|NCT01259492|459968428|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
127821867|NCT01259492|459968429|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
127821868|NCT01259492|459968430|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
127821869|NCT01259492|459968431|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
127821870|NCT01259492|459968428|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
127821871|NCT01259492|459968429|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
127821872|NCT01259492|459968430|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
127821873|NCT01259492|459968431|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
127821874|NCT01259492|459968428|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
127821875|NCT01259492|459968429|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
127821876|NCT01259492|459968430|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
127821877|NCT01259492|459968431|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
127821878|NCT01259492|459968428|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
127821879|NCT01259492|459968429|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
127821880|NCT01259492|459968430|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
127821881|NCT01259492|459968431|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
127821882|NCT01259492|459968428|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
127821883|NCT01259492|459968429|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
127821884|NCT01259492|459968430|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
127821885|NCT01259492|459968431|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
127821886|NCT01259492|459968428|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
127821887|NCT01259492|459968429|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
127821888|NCT01259492|459968430|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
127821889|NCT01259492|459968431|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
127821890|NCT01259492|459968428|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
127821891|NCT01259492|459968429|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
127821892|NCT01259492|459968430|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
127821893|NCT01259492|459968431|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
127821894|NCT01259492|459968428|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
127821895|NCT01259492|459968429|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
127821896|NCT01259492|459968430|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
127821897|NCT01259492|459968431|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
127821898|NCT01259492|459968428|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
127821899|NCT01259492|459968429|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
127821900|NCT01259492|459968430|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
127821901|NCT01259492|459968431|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
127821902|NCT01259492|459968428|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
127821903|NCT01259492|459968429|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
127821904|NCT01259492|459968430|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
127821905|NCT01259492|459968431|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
127821906|NCT01259492|459968428|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
127821907|NCT01259492|459968429|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
127821908|NCT01259492|459968430|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
127821909|NCT01259492|459968431|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
127821910|NCT01259492|459968428|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
127821911|NCT01259492|459968429|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
127821912|NCT01259492|459968430|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
127821913|NCT01259492|459968431|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
127821914|NCT00663858|459968434|FG000|Overall Study|Adverse Event|9|||
127821915|NCT00663858|459968435|FG001|Overall Study|Adverse Event|1|||
127821916|NCT00663858|459968436|FG002|Overall Study|Adverse Event|6|||
127821917|NCT00663858|459968434|FG000|Overall Study|Lack of Efficacy|5|||
127821918|NCT00663858|459968435|FG001|Overall Study|Lack of Efficacy|1|||
127821919|NCT00663858|459968436|FG002|Overall Study|Lack of Efficacy|3|||
127821920|NCT00663858|459968434|FG000|Overall Study|Withdrawal by Subject|7|||
127821921|NCT00663858|459968435|FG001|Overall Study|Withdrawal by Subject|3|||
127821922|NCT00663858|459968436|FG002|Overall Study|Withdrawal by Subject|3|||
127821923|NCT00663858|459968434|FG000|Overall Study|Protocol Violation|5|||
127821924|NCT00663858|459968435|FG001|Overall Study|Protocol Violation|3|||
127821925|NCT00663858|459968436|FG002|Overall Study|Protocol Violation|4|||
127821926|NCT00663858|459968434|FG000|Overall Study|Other|8|||
127821927|NCT00663858|459968435|FG001|Overall Study|Other|2|||
127821928|NCT00663858|459968436|FG002|Overall Study|Other|4|||
127821929|NCT01166659|459968443|FG000|Overall Study|Subject Decision|8|||
127821930|NCT01166659|459968443|FG000|Overall Study|Investigator Decision|2|||
127821931|NCT01166659|459968443|FG000|Overall Study|Death|1|||
127821932|NCT01166659|459968443|FG000|Overall Study|Lost to Follow-up|1|||
127821933|NCT01166659|459968443|FG000|Overall Study|Study Closed at Site|1|||
127821934|NCT01371838|459968457|FG000|Overall Study|Withdrawal by Subject|27|||
127821935|NCT01371838|459968458|FG001|Overall Study|Withdrawal by Subject|33|||
127894685|NCT01862328|460237238|FG001|Overall Study|Progressive Disease|11|||
127894686|NCT01862328|460237239|FG002|Overall Study|Progressive Disease|5|||
127821936|NCT01371838|459968457|FG000|Overall Study|Lost to Follow-up|10|||
127821937|NCT01371838|459968458|FG001|Overall Study|Lost to Follow-up|20|||
127821938|NCT01371838|459968457|FG000|Overall Study|Death|3|||
127821939|NCT01371838|459968458|FG001|Overall Study|Death|4|||
127894687|NCT01862328|460237240|FG003|Overall Study|Progressive Disease|6|||
127821940|NCT01371838|459968457|FG000|Overall Study|Protocol Violation|3|||
127821941|NCT01371838|459968458|FG001|Overall Study|Protocol Violation|0|||
127821942|NCT01371838|459968457|FG000|Overall Study|Investigator Decision|3|||
127821943|NCT01371838|459968458|FG001|Overall Study|Investigator Decision|8|||
127821944|NCT01371838|459968457|FG000|Overall Study|Last follow-up visit not conducted|2|||
127821945|NCT01371838|459968458|FG001|Overall Study|Last follow-up visit not conducted|0|||
127821946|NCT01371838|459968457|FG000|Overall Study|Lack of therapeutic response|0|||
127821947|NCT01371838|459968458|FG001|Overall Study|Lack of therapeutic response|1|||
127821948|NCT01371838|459968457|FG000|Overall Study|Surgery|1|||
127821949|NCT01371838|459968458|FG001|Overall Study|Surgery|0|||
127821950|NCT01334125|459968459|FG000|Overall Study|Lost to Follow-up|3|||
127821951|NCT01334125|459968460|FG001|Overall Study|Lost to Follow-up|3|||
127821952|NCT00641043|459968465|FG000|Overall Study|Adverse Event|6|||
127821953|NCT00641043|459968466|FG001|Overall Study|Adverse Event|4|||
127821954|NCT00641043|459968465|FG000|Overall Study|Protocol Violation|2|||
127821955|NCT00641043|459968466|FG001|Overall Study|Protocol Violation|3|||
127821956|NCT00641043|459968465|FG000|Overall Study|Lost to Follow-up|3|||
127821957|NCT00641043|459968466|FG001|Overall Study|Lost to Follow-up|2|||
127821958|NCT00641043|459968465|FG000|Overall Study|Withdrawal by Subject|4|||
127821959|NCT00641043|459968466|FG001|Overall Study|Withdrawal by Subject|4|||
127821960|NCT00641043|459968465|FG000|Overall Study|Other incl. lack of efficacy|4|||
127821961|NCT00641043|459968466|FG001|Overall Study|Other incl. lack of efficacy|2|||
127821962|NCT04275310|459968467|FG000|Overall Study|Non-randomized due to running out of funding|4|||
127821963|NCT04275310|459968468|FG001|Overall Study|Non-randomized due to running out of funding|0|||
127821964|NCT00098345|459968470|FG000|Overall Study|Adverse Event|7|||
127821965|NCT00098345|459968470|FG000|Overall Study|Withdrawal by Subject|2|||
127821966|NCT00098345|459968470|FG000|Overall Study|progression|4|||
127821967|NCT01936649|459968471|FG000|Overall Study|Withdrawal by Subject|4|||
127821968|NCT01936649|459968471|FG000|Overall Study|Physician Decision|2|||
127821969|NCT01936649|459968471|FG000|Overall Study|Protocol Violation|2|||
127821970|NCT01936649|459968471|FG000|Overall Study|Other than specified above|5|||
127821971|NCT04655586|459968480|FG000|Overall Study|Physician Decision|1|||
127821972|NCT04655586|459968481|FG001|Overall Study|Physician Decision|3|||
127821973|NCT04655586|459968482|FG002|Overall Study|Physician Decision|4|||
127821974|NCT04655586|459968480|FG000|Overall Study|Withdrawal by Subject|1|||
127821975|NCT04655586|459968481|FG001|Overall Study|Withdrawal by Subject|3|||
127821976|NCT04655586|459968482|FG002|Overall Study|Withdrawal by Subject|1|||
127821977|NCT00201201|459968485|FG000|Overall Study|Death|0|||
127821978|NCT00201201|459968486|FG001|Overall Study|Death|2|||
127821979|NCT00201201|459968485|FG000|Overall Study|Withdrawal by Subject|5|||
127821980|NCT00201201|459968486|FG001|Overall Study|Withdrawal by Subject|5|||
127821981|NCT01342640|459968488|FG000|Overall Study|Adverse Event|3|||
127821982|NCT01342640|459968488|FG000|Overall Study|Protocol Violation|16|||
127821983|NCT01342640|459968488|FG000|Overall Study|Lost to Follow-up|21|||
127821984|NCT01342640|459968488|FG000|Overall Study|Other|1|||
127821985|NCT04101422|459968490|FG000|Overall Study|Ineligible|1|||
127821986|NCT04101422|459968491|FG001|Overall Study|Ineligible|0|||
127821987|NCT04101422|459968492|FG002|Overall Study|Ineligible|9|||
127821988|NCT04101422|459968493|FG003|Overall Study|Ineligible|0|||
127821989|NCT04101422|459968490|FG000|Overall Study|Withdrawal by Subject|0|||
127821990|NCT04101422|459968491|FG001|Overall Study|Withdrawal by Subject|0|||
127821991|NCT04101422|459968492|FG002|Overall Study|Withdrawal by Subject|1|||
127821992|NCT04101422|459968493|FG003|Overall Study|Withdrawal by Subject|0|||
127821993|NCT04101422|459968490|FG000|Overall Study|Not attending to the stimuli|0|||
127821994|NCT04101422|459968491|FG001|Overall Study|Not attending to the stimuli|0|||
127821995|NCT04101422|459968492|FG002|Overall Study|Not attending to the stimuli|4|||
127821996|NCT04101422|459968493|FG003|Overall Study|Not attending to the stimuli|0|||
127821997|NCT04101422|459968490|FG000|Overall Study|Did not download app|0|||
127821998|NCT04101422|459968491|FG001|Overall Study|Did not download app|0|||
127821999|NCT04101422|459968492|FG002|Overall Study|Did not download app|0|||
127822000|NCT04101422|459968493|FG003|Overall Study|Did not download app|17|||
127822001|NCT04101422|459968490|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
127822002|NCT04101422|459968491|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
127822003|NCT04101422|459968492|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
127822004|NCT04101422|459968493|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
127822005|NCT02640612|459968494|FG000|Overall Study|Adverse Event|6|||
127822006|NCT02640612|459968495|FG001|Overall Study|Adverse Event|7|||
127822007|NCT02640612|459968496|FG002|Overall Study|Adverse Event|2|||
127822008|NCT02640612|459968494|FG000|Overall Study|Death|1|||
127822009|NCT02640612|459968495|FG001|Overall Study|Death|0|||
127822010|NCT02640612|459968496|FG002|Overall Study|Death|0|||
127822011|NCT02640612|459968494|FG000|Overall Study|Withdrawal by Subject|10|||
127822012|NCT02640612|459968495|FG001|Overall Study|Withdrawal by Subject|3|||
127822013|NCT02640612|459968496|FG002|Overall Study|Withdrawal by Subject|3|||
127822014|NCT02640612|459968494|FG000|Overall Study|Lost to Follow-up|4|||
127822015|NCT02640612|459968495|FG001|Overall Study|Lost to Follow-up|1|||
127822016|NCT02640612|459968496|FG002|Overall Study|Lost to Follow-up|1|||
127822017|NCT02640612|459968494|FG000|Overall Study|Protocol Violation|0|||
127822018|NCT02640612|459968495|FG001|Overall Study|Protocol Violation|2|||
127822019|NCT02640612|459968496|FG002|Overall Study|Protocol Violation|0|||
127822020|NCT02640612|459968494|FG000|Overall Study|Lack of Efficacy|1|||
127822021|NCT02640612|459968495|FG001|Overall Study|Lack of Efficacy|1|||
127822022|NCT02640612|459968496|FG002|Overall Study|Lack of Efficacy|0|||
127822023|NCT01720667|459968497|FG000|Overall Study|Adverse Event|1|||
127822024|NCT01720667|459968498|FG001|Overall Study|Adverse Event|1|||
127822025|NCT01720667|459968497|FG000|Overall Study|Withdrawal by Subject|3|||
127822026|NCT01720667|459968498|FG001|Overall Study|Withdrawal by Subject|0|||
127822027|NCT03472534|459968499|FG000|Overall Study|Withdrawal by Subject|9|||
127822028|NCT03472534|459968499|FG000|Overall Study|Adverse Event|2|||
127822029|NCT01319929|459968505|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
127822030|NCT01319929|459968506|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
127822031|NCT01319929|459968505|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
127822032|NCT01319929|459968506|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
127822033|NCT01319929|459968505|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
127822034|NCT01319929|459968506|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
127822035|NCT01319929|459968505|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
127822036|NCT01319929|459968506|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
127822037|NCT01319929|459968505|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
127822038|NCT01319929|459968506|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
127822039|NCT01749735|459968508|FG000|Overall Study|Withdrawal by Subject|1|||
127822040|NCT01749735|459968509|FG001|Overall Study|Withdrawal by Subject|0|||
127822041|NCT01221233|459968510|FG000|Overall Study|Withdrawal by Subject|3|||
127822042|NCT01221233|459968511|FG001|Overall Study|Withdrawal by Subject|1|||
127822043|NCT00611455|459968514|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
127822044|NCT00611455|459968515|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
127822045|NCT00611455|459968516|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
127822046|NCT00611455|459968514|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
127822047|NCT00611455|459968515|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
127822048|NCT00611455|459968516|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
127822049|NCT00611455|459968514|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
127822050|NCT00611455|459968515|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
127822051|NCT00611455|459968516|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
127894688|NCT01862328|460237241|FG004|Overall Study|Progressive Disease|7|||
127822052|NCT00611455|459968514|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
127822053|NCT00611455|459968515|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
127822054|NCT00611455|459968516|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
127822055|NCT00611455|459968514|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
127822056|NCT00611455|459968515|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
127822057|NCT00611455|459968516|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
127822058|NCT00611455|459968514|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
127822059|NCT00611455|459968515|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
127822060|NCT00611455|459968516|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
127822061|NCT00611455|459968514|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
127822062|NCT00611455|459968515|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
127822063|NCT00611455|459968516|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
127822064|NCT00611455|459968514|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
127822065|NCT00611455|459968515|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
127822066|NCT00611455|459968516|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
127822067|NCT00611455|459968514|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
127822068|NCT00611455|459968515|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
127822069|NCT00611455|459968516|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
127822070|NCT00611455|459968514|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
127822071|NCT00611455|459968515|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
127822072|NCT00611455|459968516|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
127822073|NCT00611455|459968514|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
127822074|NCT00611455|459968515|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
127822075|NCT00611455|459968516|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
127822076|NCT00611455|459968514|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
127822077|NCT00611455|459968515|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
127822078|NCT00611455|459968516|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
127822079|NCT00611455|459968514|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
127822080|NCT00611455|459968515|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
127822081|NCT00611455|459968516|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
127822082|NCT00611455|459968514|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
127822083|NCT00611455|459968515|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
127822084|NCT00611455|459968516|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
127822085|NCT00611455|459968514|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
127822086|NCT00611455|459968515|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
127822087|NCT00611455|459968516|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
127822088|NCT00611455|459968514|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
127822089|NCT00611455|459968515|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
127822090|NCT00611455|459968516|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
127822091|NCT00611455|459968514|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
127822092|NCT00611455|459968515|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
127822093|NCT00611455|459968516|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
127822094|NCT00611455|459968514|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
127822095|NCT00611455|459968515|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
127822096|NCT00611455|459968516|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
127822097|NCT00611455|459968514|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
127822098|NCT00611455|459968515|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
127822099|NCT00611455|459968516|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
127822100|NCT00611455|459968514|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
127822101|NCT00611455|459968515|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
127822102|NCT00611455|459968516|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
127822103|NCT00611455|459968514|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
127822104|NCT00611455|459968515|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
127822105|NCT00611455|459968516|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
127822106|NCT00491530|459968517|FG000|Overall Study|Adverse Event|6|||
127822107|NCT00491530|459968518|FG001|Overall Study|Adverse Event|1|||
127822108|NCT00491530|459968519|FG002|Overall Study|Adverse Event|2|||
127822109|NCT00491530|459968517|FG000|Overall Study|Withdrawal by Subject|3|||
127822110|NCT00491530|459968518|FG001|Overall Study|Withdrawal by Subject|0|||
127822111|NCT00491530|459968519|FG002|Overall Study|Withdrawal by Subject|0|||
127822112|NCT00491530|459968517|FG000|Overall Study|Lost to Follow-up|3|||
127822113|NCT00491530|459968518|FG001|Overall Study|Lost to Follow-up|2|||
127822114|NCT00491530|459968519|FG002|Overall Study|Lost to Follow-up|2|||
127894689|NCT01862328|460237242|FG005|Overall Study|Progressive Disease|4|||
127822115|NCT00491530|459968517|FG000|Overall Study|Lack of Efficacy|0|||
127822116|NCT00491530|459968518|FG001|Overall Study|Lack of Efficacy|1|||
127822117|NCT00491530|459968519|FG002|Overall Study|Lack of Efficacy|0|||
127822118|NCT00491530|459968517|FG000|Overall Study|Investigator Discretion|0|||
127822119|NCT00491530|459968518|FG001|Overall Study|Investigator Discretion|1|||
127822120|NCT00491530|459968519|FG002|Overall Study|Investigator Discretion|0|||
127822121|NCT00491530|459968517|FG000|Overall Study|Patient Request|0|||
127822122|NCT00491530|459968518|FG001|Overall Study|Patient Request|1|||
127822123|NCT00491530|459968519|FG002|Overall Study|Patient Request|0|||
127822124|NCT00491530|459968517|FG000|Overall Study|Use of Prohibited Medication|0|||
127822125|NCT00491530|459968518|FG001|Overall Study|Use of Prohibited Medication|0|||
127822126|NCT00491530|459968519|FG002|Overall Study|Use of Prohibited Medication|1|||
127822127|NCT03671369|459968522|FG000|Overall Study|Other|1|||
127822128|NCT03671369|459968522|FG000|Overall Study|Withdrawal by Subject|289|||
127822129|NCT03671369|459968522|FG000|Overall Study|Not willing to be vaccinated|1|||
127822130|NCT02732912|459968523|FG000|Overall Study|Discharged before night|2|||
127822131|NCT02732912|459968524|FG001|Overall Study|Discharged before night|6|||
127822132|NCT02732912|459968523|FG000|Overall Study|Incomplete completion of questionnaire|2|||
127822133|NCT02732912|459968524|FG001|Overall Study|Incomplete completion of questionnaire|3|||
127822134|NCT02732912|459968523|FG000|Overall Study|No outcome; discharged or refused|6|||
127822135|NCT02732912|459968524|FG001|Overall Study|No outcome; discharged or refused|9|||
127822136|NCT04382651|459968525|FG000|Overall Study|Death|26|||
127822137|NCT04382651|459968526|FG001|Overall Study|Death|23|||
127822138|NCT04382651|459968525|FG000|Overall Study|Lost to Follow-up|3|||
127822139|NCT04382651|459968526|FG001|Overall Study|Lost to Follow-up|4|||
127822140|NCT04382651|459968525|FG000|Overall Study|Withdrawal by Subject|2|||
127822141|NCT04382651|459968526|FG001|Overall Study|Withdrawal by Subject|0|||
127822142|NCT04382651|459968525|FG000|Overall Study|Physician Decision|0|||
127822143|NCT04382651|459968526|FG001|Overall Study|Physician Decision|1|||
127822144|NCT01507545|459968527|FG000|Overall Study|Withdrawal by Subject|6|||
127822145|NCT01507545|459968528|FG001|Overall Study|Withdrawal by Subject|2|||
127822146|NCT01507545|459968527|FG000|Overall Study|Lost to Follow-up|1|||
127822147|NCT01507545|459968528|FG001|Overall Study|Lost to Follow-up|0|||
127822148|NCT01507545|459968527|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
127822149|NCT01507545|459968528|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
127822150|NCT01507545|459968527|FG000|Overall Study|Progressive disease|60|||
127822151|NCT01507545|459968528|FG001|Overall Study|Progressive disease|27|||
127822152|NCT01507545|459968527|FG000|Overall Study|Other|6|||
127822153|NCT01507545|459968528|FG001|Overall Study|Other|4|||
127822154|NCT01873742|459968529|FG000|Overall Study|Lost to Follow-up|68|||
127822155|NCT01873742|459968530|FG001|Overall Study|Lost to Follow-up|76|||
127822156|NCT00790296|459968532|FG000|Overall Study|Did not meet study eligibility criteria|1|||
127822157|NCT00790296|459968533|FG001|Overall Study|Did not meet study eligibility criteria|1|||
127822158|NCT00790296|459968532|FG000|Overall Study|Adverse Event|0|||
127822159|NCT00790296|459968533|FG001|Overall Study|Adverse Event|1|||
127822160|NCT01671488|459968534|FG000|Overall Study|Withdrawal by Subject|1|||
127822161|NCT02612077|459968535|FG000|Overall Study|Adverse Event|3|||
127822162|NCT02612077|459968535|FG000|Overall Study|Withdrawal by Subject|9|||
127822163|NCT02612077|459968535|FG000|Overall Study|Protocol Violation|28|||
127822164|NCT02612077|459968535|FG000|Overall Study|Lost to Follow-up|20|||
127822165|NCT02612077|459968535|FG000|Overall Study|Death|377|||
127822166|NCT02612077|459968535|FG000|Overall Study|Moved or Changed Medical Team|23|||
127822167|NCT02612077|459968535|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
127822168|NCT02612077|459968535|FG000|Overall Study|Disease Progression|3|||
127822169|NCT02612077|459968535|FG000|Overall Study|Unknown reason|2|||
127822170|NCT01022853|459968536|FG000|Overall Study|Progressive disease|2|||
127822171|NCT01022853|459968537|FG001|Overall Study|Progressive disease|3|||
127822172|NCT01022853|459968538|FG002|Overall Study|Progressive disease|11|||
127822173|NCT01022853|459968539|FG003|Overall Study|Progressive disease|7|||
127822174|NCT01022853|459968540|FG004|Overall Study|Progressive disease|1|||
127822175|NCT01022853|459968536|FG000|Overall Study|Dose-limiting toxicity|0|||
127822176|NCT01022853|459968537|FG001|Overall Study|Dose-limiting toxicity|0|||
127822177|NCT01022853|459968538|FG002|Overall Study|Dose-limiting toxicity|0|||
127822178|NCT01022853|459968539|FG003|Overall Study|Dose-limiting toxicity|0|||
127822179|NCT01022853|459968540|FG004|Overall Study|Dose-limiting toxicity|1|||
127822180|NCT01022853|459968536|FG000|Overall Study|Withdrawal by Subject|0|||
127822181|NCT01022853|459968537|FG001|Overall Study|Withdrawal by Subject|1|||
127822182|NCT01022853|459968538|FG002|Overall Study|Withdrawal by Subject|1|||
127822183|NCT01022853|459968539|FG003|Overall Study|Withdrawal by Subject|1|||
127822184|NCT01022853|459968540|FG004|Overall Study|Withdrawal by Subject|0|||
127822185|NCT01022853|459968536|FG000|Overall Study|Other not stated above|1|||
127822186|NCT01022853|459968537|FG001|Overall Study|Other not stated above|0|||
127822187|NCT01022853|459968538|FG002|Overall Study|Other not stated above|1|||
127822188|NCT01022853|459968539|FG003|Overall Study|Other not stated above|0|||
127822189|NCT01022853|459968540|FG004|Overall Study|Other not stated above|0|||
127822190|NCT01753518|459968541|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
127822191|NCT01753518|459968542|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
127822192|NCT01753518|459968541|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
127822193|NCT01753518|459968542|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
127822194|NCT01753518|459968541|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
127822195|NCT01753518|459968542|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
127822196|NCT01753518|459968541|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
127822197|NCT01753518|459968542|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
127822198|NCT01971476|459968543|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
127822199|NCT01971476|459968544|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
127822200|NCT01971476|459968545|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
127822201|NCT01971476|459968543|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
127822202|NCT01971476|459968544|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
127822203|NCT01971476|459968545|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
127822204|NCT01971476|459968543|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
127822205|NCT01971476|459968544|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
127822206|NCT01971476|459968545|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
127822207|NCT02075255|459968546|FG000|Overall Study|Study specific withdrawal criteria|0|||
127822208|NCT02075255|459968547|FG001|Overall Study|Study specific withdrawal criteria|1|||
127822209|NCT02075255|459968548|FG002|Overall Study|Study specific withdrawal criteria|1|||
127822210|NCT02075255|459968546|FG000|Overall Study|Withdrawal by Subject|4|||
127822211|NCT02075255|459968547|FG001|Overall Study|Withdrawal by Subject|1|||
127822212|NCT02075255|459968548|FG002|Overall Study|Withdrawal by Subject|0|||
127822213|NCT02075255|459968546|FG000|Overall Study|Lost to Follow-up|0|||
127822214|NCT02075255|459968547|FG001|Overall Study|Lost to Follow-up|0|||
127822215|NCT02075255|459968548|FG002|Overall Study|Lost to Follow-up|1|||
127822216|NCT02075255|459968546|FG000|Overall Study|Adverse Event|0|||
127822217|NCT02075255|459968547|FG001|Overall Study|Adverse Event|0|||
127822218|NCT02075255|459968548|FG002|Overall Study|Adverse Event|1|||
127822219|NCT02075255|459968546|FG000|Overall Study|Death|0|||
127822220|NCT02075255|459968547|FG001|Overall Study|Death|2|||
127822221|NCT02075255|459968548|FG002|Overall Study|Death|0|||
127822222|NCT01426386|459968550|FG000|Overall Study|Adverse Event|0|||
127822223|NCT01426386|459968551|FG001|Overall Study|Adverse Event|1|||
127822224|NCT01426386|459968552|FG002|Overall Study|Adverse Event|0|||
127822225|NCT01426386|459968553|FG003|Overall Study|Adverse Event|0|||
127822226|NCT01426386|459968554|FG004|Overall Study|Adverse Event|0|||
127822227|NCT01426386|459968555|FG005|Overall Study|Adverse Event|0|||
127822228|NCT01426386|459968550|FG000|Overall Study|Did not attend scheduled visit|1|||
127822229|NCT01426386|459968551|FG001|Overall Study|Did not attend scheduled visit|4|||
127822230|NCT01426386|459968552|FG002|Overall Study|Did not attend scheduled visit|0|||
127822231|NCT01426386|459968553|FG003|Overall Study|Did not attend scheduled visit|0|||
127822232|NCT01426386|459968554|FG004|Overall Study|Did not attend scheduled visit|2|||
127822233|NCT01426386|459968555|FG005|Overall Study|Did not attend scheduled visit|1|||
127822234|NCT01426386|459968550|FG000|Overall Study|Poor response|2|||
127822235|NCT01426386|459968551|FG001|Overall Study|Poor response|1|||
127822236|NCT01426386|459968552|FG002|Overall Study|Poor response|2|||
127822237|NCT01426386|459968553|FG003|Overall Study|Poor response|0|||
127822238|NCT01426386|459968554|FG004|Overall Study|Poor response|1|||
127822239|NCT01426386|459968555|FG005|Overall Study|Poor response|0|||
127822240|NCT01426386|459968550|FG000|Overall Study|Personal reasons|0|||
127822241|NCT01426386|459968551|FG001|Overall Study|Personal reasons|0|||
127822242|NCT01426386|459968552|FG002|Overall Study|Personal reasons|0|||
127822243|NCT01426386|459968553|FG003|Overall Study|Personal reasons|0|||
127822244|NCT01426386|459968554|FG004|Overall Study|Personal reasons|1|||
127822245|NCT01426386|459968555|FG005|Overall Study|Personal reasons|0|||
127822246|NCT01096667|459968556|FG000|Overall Study|Lost to Follow-up|1|||
127822247|NCT01096667|459968557|FG001|Overall Study|Lost to Follow-up|1|||
127822248|NCT01096667|459968558|FG002|Overall Study|Lost to Follow-up|1|||
127822249|NCT01096667|459968559|FG003|Overall Study|Lost to Follow-up|0|||
127822250|NCT01096667|459968560|FG004|Overall Study|Lost to Follow-up|0|||
127822251|NCT01096667|459968556|FG000|Overall Study|Withdrawal by Subject|1|||
127822252|NCT01096667|459968557|FG001|Overall Study|Withdrawal by Subject|0|||
127822253|NCT01096667|459968558|FG002|Overall Study|Withdrawal by Subject|0|||
127822254|NCT01096667|459968559|FG003|Overall Study|Withdrawal by Subject|1|||
127822255|NCT01096667|459968560|FG004|Overall Study|Withdrawal by Subject|0|||
127822256|NCT01096667|459968556|FG000|Overall Study|Reason not available|0|||
127822257|NCT01096667|459968557|FG001|Overall Study|Reason not available|1|||
127822258|NCT01096667|459968558|FG002|Overall Study|Reason not available|1|||
127822259|NCT01096667|459968559|FG003|Overall Study|Reason not available|1|||
127822260|NCT01096667|459968560|FG004|Overall Study|Reason not available|0|||
127822261|NCT01096667|459968556|FG000|Overall Study|Protocol Violation|0|||
127822262|NCT01096667|459968557|FG001|Overall Study|Protocol Violation|0|||
127822263|NCT01096667|459968558|FG002|Overall Study|Protocol Violation|0|||
127822264|NCT01096667|459968559|FG003|Overall Study|Protocol Violation|1|||
127822265|NCT01096667|459968560|FG004|Overall Study|Protocol Violation|0|||
127822266|NCT01096667|459968556|FG000|Overall Study|Not treated|1|||
127822267|NCT01096667|459968557|FG001|Overall Study|Not treated|0|||
127822268|NCT01096667|459968558|FG002|Overall Study|Not treated|0|||
127822269|NCT01096667|459968559|FG003|Overall Study|Not treated|0|||
127822270|NCT01096667|459968560|FG004|Overall Study|Not treated|0|||
127822271|NCT01751646|459968561|FG000|Overall Study|Lost to Follow-up|5|||
127822272|NCT01751646|459968562|FG001|Overall Study|Lost to Follow-up|1|||
127822273|NCT01751646|459968561|FG000|Overall Study|Withdrawal by Subject|0|||
127822274|NCT01751646|459968562|FG001|Overall Study|Withdrawal by Subject|4|||
127822275|NCT01751646|459968561|FG000|Overall Study|Starting hormone therapy|1|||
127822276|NCT01751646|459968562|FG001|Overall Study|Starting hormone therapy|0|||
127822277|NCT01751646|459968561|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
127822278|NCT01751646|459968562|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
127822279|NCT01751646|459968561|FG000|Overall Study|Inadvertent enrollment|1|||
127822280|NCT01751646|459968562|FG001|Overall Study|Inadvertent enrollment|1|||
127822281|NCT01751646|459968561|FG000|Overall Study|Moved out of the area|1|||
127822282|NCT01751646|459968562|FG001|Overall Study|Moved out of the area|5|||
127822283|NCT01751646|459968561|FG000|Overall Study|Inability to attend required visits|0|||
127822284|NCT01751646|459968562|FG001|Overall Study|Inability to attend required visits|1|||
127822285|NCT01751646|459968561|FG000|Overall Study|Off study due to multiple obligations|0|||
127822286|NCT01751646|459968562|FG001|Overall Study|Off study due to multiple obligations|1|||
127822287|NCT01751646|459968561|FG000|Overall Study|Fails to comply with study requirements|0|||
127822288|NCT01751646|459968562|FG001|Overall Study|Fails to comply with study requirements|1|||
127822289|NCT01751646|459968561|FG000|Overall Study|Childcare issues|1|||
127822290|NCT01751646|459968562|FG001|Overall Study|Childcare issues|1|||
127822291|NCT02335450|459968563|FG000|Overall Study|Pregnancy|1|||
127822292|NCT02613572|459968564|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
127822293|NCT02613572|459968565|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
127822294|NCT02613572|459968566|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
127822295|NCT02613572|459968564|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
127822296|NCT02613572|459968565|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
127822297|NCT02613572|459968566|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
127822298|NCT04542291|459968567|FG000|Overall Study|Adverse Event|1|||
127822299|NCT04542291|459968567|FG000|Overall Study|Physician Decision|2|||
127822300|NCT00853905|459968568|FG000|Overall Study|Lost to Follow-up|1|||
127822301|NCT00853905|459968569|FG001|Overall Study|Lost to Follow-up|3|||
127822302|NCT00853905|459968568|FG000|Overall Study|Withdrawal by Subject|0|||
127822303|NCT00853905|459968569|FG001|Overall Study|Withdrawal by Subject|1|||
127822304|NCT00853905|459968568|FG000|Overall Study|never had surgery|1|||
127822305|NCT00853905|459968569|FG001|Overall Study|never had surgery|0|||
127822306|NCT00970294|459968572|FG000|Overall Study|Physician Decision|4|||
127822307|NCT00970294|459968572|FG000|Overall Study|Withdrawal by Subject|1|||
127822308|NCT00847561|459968573|FG000|Overall Study|Withdrawal by Subject|4|||
127822309|NCT00847561|459968574|FG001|Overall Study|Withdrawal by Subject|3|||
127822310|NCT00847561|459968573|FG000|Overall Study|Unable to schedule|9|||
127822311|NCT00847561|459968574|FG001|Overall Study|Unable to schedule|1|||
127822312|NCT00465738|459968575|FG000|Overall Study|Lost to Follow-up|2|||
127822313|NCT00465738|459968576|FG001|Overall Study|Lost to Follow-up|0|||
127822314|NCT00465738|459968575|FG000|Overall Study|Adverse Event|0|||
127822315|NCT00465738|459968576|FG001|Overall Study|Adverse Event|1|||
127822316|NCT00465738|459968575|FG000|Overall Study|Withdrawal by Subject|2|||
127822317|NCT00465738|459968576|FG001|Overall Study|Withdrawal by Subject|0|||
127822318|NCT00465738|459968575|FG000|Overall Study|Other|2|||
127822319|NCT00465738|459968576|FG001|Overall Study|Other|5|||
127822320|NCT01326962|459968578|FG000|Overall Study|Adverse Event|1|||
127822321|NCT01326962|459968578|FG000|Overall Study|Withdrawal by Subject|1|||
127822322|NCT01326962|459968578|FG000|Overall Study|Lost to Follow-up|3|||
127822323|NCT01326962|459968578|FG000|Overall Study|Other|2|||
127822324|NCT01056523|459968579|FG000|Overall Study|Death|1|||
127822325|NCT01056523|459968580|FG001|Overall Study|Death|0|||
127822326|NCT01056523|459968581|FG002|Overall Study|Death|2|||
127822327|NCT01056523|459968582|FG003|Overall Study|Death|3|||
127822328|NCT01056523|459968583|FG004|Overall Study|Death|0|||
127822329|NCT01056523|459968584|FG005|Overall Study|Death|0|||
127822330|NCT01056523|459968585|FG006|Overall Study|Death|1|||
127822331|NCT04952389|459968588|FG000|Overall Study|Withdrawal by Subject|8|||
127822332|NCT04952389|459968589|FG001|Overall Study|Withdrawal by Subject|4|||
127822333|NCT01507246|459968590|FG000|Overall Study|Required different surgical procedures|2|||
127822334|NCT01507246|459968591|FG001|Overall Study|Required different surgical procedures|1|||
127822335|NCT05243550|459970141|FG000|Overall Study|Ongoing in the Study|171|||
127822336|NCT05243550|459970141|FG000|Overall Study|Withdrawal by Subject|10|||
127822337|NCT05243550|459970141|FG000|Overall Study|Lost to Follow-up|7|||
127822338|NCT05243550|459970141|FG000|Overall Study|Adverse Event|3|||
127822339|NCT05243550|459970141|FG000|Overall Study|Noncompliance|1|||
127822340|NCT05243550|459970141|FG000|Overall Study|Physician Decision|1|||
127822341|NCT05243550|459970141|FG000|Overall Study|Other Reason|4|||
127822342|NCT02452970|459970152|FG000|Overall Study|Adverse Event|1|||
127822343|NCT00893113|459970153|FG000|Overall Study|Lost to Follow-up|4|||
127822344|NCT00893113|459970154|FG001|Overall Study|Lost to Follow-up|8|||
127822345|NCT00893113|459970153|FG000|Overall Study|Early Termination|1|||
127822346|NCT00893113|459970154|FG001|Overall Study|Early Termination|1|||
127822347|NCT00893113|459970153|FG000|Overall Study|Withdrew Consent|8|||
127822348|NCT00893113|459970154|FG001|Overall Study|Withdrew Consent|7|||
127822349|NCT00128206|459970163|FG000|Overall Study|Lost to Follow-up|137|||
127822350|NCT00128206|459970164|FG001|Overall Study|Lost to Follow-up|118|||
127822351|NCT00128206|459970163|FG000|Overall Study|Adverse Event|0|||
127822352|NCT00128206|459970164|FG001|Overall Study|Adverse Event|2|||
127822353|NCT01040832|459970165|FG000|Overall Study|Adverse Event|4|||
127822354|NCT01040832|459970166|FG001|Overall Study|Adverse Event|5|||
127822355|NCT01040832|459970165|FG000|Overall Study|Death|4|||
127822356|NCT01040832|459970166|FG001|Overall Study|Death|6|||
127822357|NCT01040832|459970165|FG000|Overall Study|Withdrawal by Subject|2|||
127822358|NCT01040832|459970166|FG001|Overall Study|Withdrawal by Subject|3|||
127822359|NCT01040832|459970165|FG000|Overall Study|Progressive disease|32|||
127822360|NCT01040832|459970166|FG001|Overall Study|Progressive disease|17|||
127822361|NCT01040832|459970165|FG000|Overall Study|Symptomatic deterioration|2|||
127822362|NCT01040832|459970166|FG001|Overall Study|Symptomatic deterioration|5|||
127822363|NCT01040832|459970165|FG000|Overall Study|Other|2|||
127822364|NCT01040832|459970166|FG001|Overall Study|Other|1|||
127822365|NCT02940886|459970167|FG000|Overall Study|Adverse Event|7|||
127822366|NCT02940886|459970168|FG001|Overall Study|Adverse Event|3|||
127822367|NCT02940886|459970167|FG000|Overall Study|Protocol Violation|0|||
127822368|NCT02940886|459970168|FG001|Overall Study|Protocol Violation|2|||
127822369|NCT02940886|459970167|FG000|Overall Study|Withdrawal by Subject|28|||
127822370|NCT02940886|459970168|FG001|Overall Study|Withdrawal by Subject|20|||
127822371|NCT02940886|459970167|FG000|Overall Study|Death|1|||
127822372|NCT02940886|459970168|FG001|Overall Study|Death|0|||
127822373|NCT02940886|459970167|FG000|Overall Study|Lack of Efficacy|1|||
127822374|NCT02940886|459970168|FG001|Overall Study|Lack of Efficacy|0|||
127822375|NCT02940886|459970167|FG000|Overall Study|Lost to Follow-up|49|||
127822376|NCT02940886|459970168|FG001|Overall Study|Lost to Follow-up|21|||
127822377|NCT02940886|459970167|FG000|Overall Study|Physician Decision|9|||
127822378|NCT02940886|459970168|FG001|Overall Study|Physician Decision|4|||
127822379|NCT02940886|459970167|FG000|Overall Study|Sponsor decision|0|||
127822380|NCT02940886|459970168|FG001|Overall Study|Sponsor decision|1|||
127822381|NCT02940886|459970167|FG000|Overall Study|No treatment|7|||
127822382|NCT02940886|459970168|FG001|Overall Study|No treatment|2|||
127822383|NCT02940886|459970167|FG000|Overall Study|Enrolment error|0|||
127822384|NCT02940886|459970168|FG001|Overall Study|Enrolment error|1|||
127822385|NCT01306058|459970169|FG000|Overall Study|Death|1|||
127822386|NCT01306058|459970169|FG000|Overall Study|Enrolled but did not get treatment|1|||
127822387|NCT01666444|459970170|FG000|Overall Study|Did not initiate treatment|2|||
127822388|NCT01666444|459970171|FG001|Overall Study|Did not initiate treatment|1|||
127822389|NCT00592358|459970172|FG000|Overall Study|Withdrawal by Subject|2|||
127822390|NCT00592358|459970172|FG000|Overall Study|Adverse Event|1|||
127822391|NCT00592358|459970172|FG000|Overall Study|Lack of Efficacy|2|||
127822392|NCT00592358|459970172|FG000|Overall Study|Inability to swallow pills|1|||
127822393|NCT00084682|459970173|FG000|Overall Study|Withdrawal by Subject|1|||
127822394|NCT03238248|459970181|FG000|Overall Study|Death|5|||
127822395|NCT03238248|459970181|FG000|Overall Study|Withdrawal by Subject|7|||
127822396|NCT03238248|459970181|FG000|Overall Study|Participant proceeding to transplant|10|||
127822397|NCT03238248|459970181|FG000|Overall Study|Lack of Efficacy|4|||
127822398|NCT03238248|459970181|FG000|Overall Study|Physician Decision|3|||
127822399|NCT03238248|459970181|FG000|Overall Study|Transitioning to another study|1|||
127822400|NCT03238248|459970181|FG000|Overall Study|No longer benefiting|1|||
127822401|NCT03238248|459970181|FG000|Overall Study|Other complicating disease|1|||
127822402|NCT03238248|459970181|FG000|Overall Study|Adverse Event|5|||
127822403|NCT03238248|459970181|FG000|Overall Study|Disease progression|26|||
127822404|NCT03238248|459970181|FG000|Overall Study|N/A participant is still on treatment|1|||
127822405|NCT03238248|459970181|FG000|Overall Study|Decline in condition|1|||
127822406|NCT03238248|459970181|FG000|Overall Study|Alternative therapy|2|||
127894690|NCT01862328|460237243|FG006|Overall Study|Progressive Disease|3|||
127822407|NCT01013883|459970183|FG000|Overall Study|Lost to Follow-up|2|||
127822408|NCT01013883|459970184|FG001|Overall Study|Lost to Follow-up|2|||
127822409|NCT02241512|459970185|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
127822410|NCT02241512|459970186|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
127822411|NCT00474630|459970189|FG000|Overall Study|Adverse Event|98|||
127822412|NCT00474630|459970190|FG001|Overall Study|Adverse Event|26|||
127822413|NCT00474630|459970189|FG000|Overall Study|Lost to Follow-up|22|||
127822414|NCT00474630|459970190|FG001|Overall Study|Lost to Follow-up|15|||
127822415|NCT00474630|459970189|FG000|Overall Study|Withdrawal by Subject|21|||
127822416|NCT00474630|459970190|FG001|Overall Study|Withdrawal by Subject|15|||
127822417|NCT00474630|459970189|FG000|Overall Study|Protocol Violation|3|||
127822418|NCT00474630|459970190|FG001|Overall Study|Protocol Violation|4|||
127822419|NCT00474630|459970189|FG000|Overall Study|Lack of Efficacy|5|||
127822420|NCT00474630|459970190|FG001|Overall Study|Lack of Efficacy|6|||
127822421|NCT00474630|459970189|FG000|Overall Study|Drug noncompliance, other|11|||
127822422|NCT00474630|459970190|FG001|Overall Study|Drug noncompliance, other|4|||
127822423|NCT03088605|459970191|FG000|Overall Study|Withdrawal by Subject|1|||
127822424|NCT03088605|459970192|FG001|Overall Study|Withdrawal by Subject|0|||
127822425|NCT02225223|459970194|FG000|Overall Study|Death|10|||
127822426|NCT02225223|459970195|FG001|Overall Study|Death|1|||
127822427|NCT02225223|459970194|FG000|Overall Study|Lost to Follow-up|5|||
127822428|NCT02225223|459970195|FG001|Overall Study|Lost to Follow-up|0|||
127822429|NCT02225223|459970194|FG000|Overall Study|Other|1|||
127822430|NCT02225223|459970195|FG001|Overall Study|Other|2|||
127822431|NCT02225223|459970194|FG000|Overall Study|Physician Decision|1|||
127822432|NCT02225223|459970195|FG001|Overall Study|Physician Decision|0|||
127822433|NCT02225223|459970194|FG000|Overall Study|Withdrawal by Subject|2|||
127822434|NCT02225223|459970195|FG001|Overall Study|Withdrawal by Subject|2|||
127822435|NCT00958568|459970196|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
127822436|NCT00958568|459970197|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
127822437|NCT00958568|459970198|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
127822438|NCT00958568|459970199|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
127822439|NCT00958568|459970196|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
127822440|NCT00958568|459970197|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
127822441|NCT00958568|459970198|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
127822442|NCT00958568|459970199|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
127822443|NCT00958568|459970196|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
127822444|NCT00958568|459970197|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
127822445|NCT00958568|459970198|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
127822446|NCT00958568|459970199|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
127822447|NCT00958568|459970196|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
127822448|NCT00958568|459970197|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
127822449|NCT00958568|459970198|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
127822450|NCT00958568|459970199|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
127822451|NCT00958568|459970196|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
127822452|NCT00958568|459970197|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
127822453|NCT00958568|459970198|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
127822454|NCT00958568|459970199|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
127822455|NCT00958568|459970196|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
127822456|NCT00958568|459970197|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
127822457|NCT00958568|459970198|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
127822458|NCT00958568|459970199|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
127822459|NCT00958568|459970196|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
127822460|NCT00958568|459970197|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
127822461|NCT00958568|459970198|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
127822462|NCT00958568|459970199|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
127822463|NCT00958568|459970196|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
127822464|NCT00958568|459970197|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
127822465|NCT00958568|459970198|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
127822466|NCT00958568|459970199|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
127822467|NCT00958568|459970196|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
127822468|NCT00958568|459970197|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
127822469|NCT00958568|459970198|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
127822470|NCT00958568|459970199|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
127822471|NCT00958568|459970196|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
127822472|NCT00958568|459970197|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
127822473|NCT00958568|459970198|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
127822474|NCT00958568|459970199|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
127822475|NCT00958568|459970196|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
127822476|NCT00958568|459970197|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
127822477|NCT00958568|459970198|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
127822478|NCT00958568|459970199|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
127822479|NCT00958568|459970196|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
127822480|NCT00958568|459970197|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
127822481|NCT00958568|459970198|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
127822482|NCT00958568|459970199|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
127822483|NCT00958568|459970196|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
127894691|NCT01862328|460237237|FG000|Overall Study|Adverse Event|0|||
127894692|NCT01862328|460237238|FG001|Overall Study|Adverse Event|4|||
127894693|NCT01862328|460237239|FG002|Overall Study|Adverse Event|0|||
127822484|NCT00958568|459970197|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
127822485|NCT00958568|459970198|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
127822486|NCT00958568|459970199|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
127822487|NCT00958568|459970196|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
127822488|NCT00958568|459970197|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
127822489|NCT00958568|459970198|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
127822490|NCT00958568|459970199|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
127822491|NCT00958568|459970196|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
127822492|NCT00958568|459970197|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
127822493|NCT00958568|459970198|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
127822494|NCT00958568|459970199|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
127822495|NCT00958568|459970196|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
127822496|NCT00958568|459970197|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
127822497|NCT00958568|459970198|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
127822498|NCT00958568|459970199|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
127822499|NCT00958568|459970196|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
127822500|NCT00958568|459970197|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
127822501|NCT00958568|459970198|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
127822502|NCT00958568|459970199|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
127822503|NCT00958568|459970196|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
127822504|NCT00958568|459970197|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
127822505|NCT00958568|459970198|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
127822506|NCT00958568|459970199|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
127822507|NCT00958568|459970196|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
127822508|NCT00958568|459970197|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
127822509|NCT00958568|459970198|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
127822510|NCT00958568|459970199|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
127822511|NCT00958568|459970196|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
127822512|NCT00958568|459970197|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
127822513|NCT00958568|459970198|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
127822514|NCT00958568|459970199|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
127822515|NCT00958568|459970196|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
127822516|NCT00958568|459970197|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
127822517|NCT00958568|459970198|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
127822518|NCT00958568|459970199|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
127822519|NCT00958568|459970196|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
127822520|NCT00958568|459970197|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
127822521|NCT00958568|459970198|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
127822522|NCT00958568|459970199|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
127822523|NCT00958568|459970196|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
127822524|NCT00958568|459970197|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
127822525|NCT00958568|459970198|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
127822526|NCT00958568|459970199|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
127822527|NCT00958568|459970196|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
127822528|NCT00958568|459970197|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
127822529|NCT00958568|459970198|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
127822530|NCT00958568|459970199|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
127822531|NCT00958568|459970196|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
127822532|NCT00958568|459970197|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
127822533|NCT00958568|459970198|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
127822534|NCT00958568|459970199|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
127822535|NCT00958568|459970196|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
127822536|NCT00958568|459970197|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
127822537|NCT00958568|459970198|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
127822538|NCT00958568|459970199|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
127822539|NCT00958568|459970196|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
127822540|NCT00958568|459970197|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
127822541|NCT00958568|459970198|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
127822542|NCT00958568|459970199|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
127822543|NCT00958568|459970196|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
127822544|NCT00958568|459970197|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
127822545|NCT00958568|459970198|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
127822546|NCT00958568|459970199|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
127822547|NCT00958568|459970196|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
127822548|NCT00958568|459970197|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
127822549|NCT00958568|459970198|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
127822550|NCT00958568|459970199|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
127822551|NCT02927171|459970214|FG000|Overall Study|Lost to Follow-up|0|||
127822552|NCT02927171|459970215|FG001|Overall Study|Lost to Follow-up|1|||
127822553|NCT00552305|459970221|FG000|Overall Study|Adverse Event|43|||
127822554|NCT00552305|459970221|FG000|Overall Study|Lack of Efficacy|120|||
127822555|NCT00552305|459970221|FG000|Overall Study|Lost to Follow-up|4|||
127822556|NCT00552305|459970221|FG000|Overall Study|Protocol Violation|3|||
127822557|NCT00552305|459970221|FG000|Overall Study|Withdrawal by Subject|44|||
127822558|NCT00552305|459970221|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
127822559|NCT00552305|459970221|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
127822560|NCT00552305|459970221|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
127822561|NCT00552305|459970221|FG000|Overall Study|Unsatisfactory compliance|11|||
127822562|NCT00552305|459970221|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
127822563|NCT00552305|459970221|FG000|Overall Study|AE/Other: prohibited drug required|1|||
127822564|NCT00552305|459970221|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
127822565|NCT00552305|459970221|FG000|Overall Study|Other: Site closed|4|||
127822566|NCT00552305|459970221|FG000|Overall Study|Other: Personal problems|1|||
127822567|NCT00552305|459970221|FG000|Overall Study|Other: Unable to attend visits|1|||
127822568|NCT00552305|459970221|FG000|Overall Study|Other: Subject underwent surgery|4|||
127822569|NCT00552305|459970221|FG000|Overall Study|Other: Subject became pregnant|1|||
127822570|NCT00552305|459970221|FG000|Overall Study|Other: Health problems, not drug related|1|||
127822571|NCT00552305|459970221|FG000|Overall Study|Other: Subject moved from area|2|||
127822572|NCT00552305|459970221|FG000|Overall Study|Other: Subject incarcerated|1|||
127822573|NCT00552305|459970221|FG000|Overall Study|Other: Subject went to rehab|1|||
127822574|NCT03503773|459970222|FG000|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|0|||
127822575|NCT03503773|459970223|FG001|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|2|||
127822576|NCT03503773|459970222|FG000|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|8|||
127822577|NCT03503773|459970223|FG001|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|4|||
127822578|NCT03503773|459970222|FG000|Overall Study|Not completing the primary ABPM|3|||
127822579|NCT03503773|459970223|FG001|Overall Study|Not completing the primary ABPM|1|||
127822580|NCT03503773|459970222|FG000|Overall Study|Not meeting inclusion/exclusion criteria|1|||
127822581|NCT03503773|459970223|FG001|Overall Study|Not meeting inclusion/exclusion criteria|0|||
127822582|NCT02675517|459970226|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
127822583|NCT02675517|459970226|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
127822584|NCT00425438|459970227|FG000|Overall Study|Termination by Sponsor|25|||
127822585|NCT00425438|459970228|FG001|Overall Study|Termination by Sponsor|27|||
127822586|NCT02619253|459970229|FG000|Overall Study|Adverse Event|0|||
127822587|NCT02619253|459970230|FG001|Overall Study|Adverse Event|0|||
127822588|NCT02619253|459970231|FG002|Overall Study|Adverse Event|1|||
127822589|NCT02619253|459970232|FG003|Overall Study|Adverse Event|1|||
127822590|NCT02619253|459970233|FG004|Overall Study|Adverse Event|3|||
127822591|NCT02619253|459970229|FG000|Overall Study|Alternative Therapy|0|||
127822592|NCT02619253|459970230|FG001|Overall Study|Alternative Therapy|0|||
127894694|NCT01862328|460237240|FG003|Overall Study|Adverse Event|1|||
127894695|NCT01862328|460237241|FG004|Overall Study|Adverse Event|0|||
127894696|NCT01862328|460237242|FG005|Overall Study|Adverse Event|2|||
127894697|NCT01862328|460237243|FG006|Overall Study|Adverse Event|4|||
127894698|NCT01862328|460237237|FG000|Overall Study|Other|0|||
127894699|NCT01862328|460237238|FG001|Overall Study|Other|2|||
127894700|NCT01862328|460237239|FG002|Overall Study|Other|1|||
127894701|NCT01862328|460237240|FG003|Overall Study|Other|0|||
127894702|NCT01862328|460237241|FG004|Overall Study|Other|4|||
127894703|NCT01862328|460237242|FG005|Overall Study|Other|0|||
127894704|NCT01862328|460237243|FG006|Overall Study|Other|1|||
127894705|NCT01862328|460237237|FG000|Overall Study|Withdrawal by Subject|1|||
127894706|NCT01862328|460237238|FG001|Overall Study|Withdrawal by Subject|1|||
127894707|NCT01862328|460237239|FG002|Overall Study|Withdrawal by Subject|0|||
127894708|NCT01862328|460237240|FG003|Overall Study|Withdrawal by Subject|0|||
127894709|NCT01862328|460237241|FG004|Overall Study|Withdrawal by Subject|1|||
127894710|NCT01862328|460237242|FG005|Overall Study|Withdrawal by Subject|1|||
127894711|NCT01862328|460237243|FG006|Overall Study|Withdrawal by Subject|1|||
127894712|NCT01862328|460237237|FG000|Overall Study|Symptomatic Deterioration|0|||
127894713|NCT01862328|460237238|FG001|Overall Study|Symptomatic Deterioration|0|||
127894714|NCT01862328|460237239|FG002|Overall Study|Symptomatic Deterioration|0|||
127894715|NCT01862328|460237240|FG003|Overall Study|Symptomatic Deterioration|0|||
127894716|NCT01862328|460237241|FG004|Overall Study|Symptomatic Deterioration|0|||
127894717|NCT01862328|460237242|FG005|Overall Study|Symptomatic Deterioration|0|||
127894718|NCT01862328|460237243|FG006|Overall Study|Symptomatic Deterioration|1|||
127894719|NCT01656889|460237245|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
127894720|NCT01656889|460237246|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
127894721|NCT01656889|460237245|FG000|Treatment Period, 12 Weeks|Death|0|||
127894722|NCT01656889|460237246|FG001|Treatment Period, 12 Weeks|Death|1|||
127894723|NCT01656889|460237245|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
127894724|NCT01656889|460237246|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
127894725|NCT01656889|460237245|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
127894726|NCT01656889|460237246|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
127822593|NCT02619253|459970231|FG002|Overall Study|Alternative Therapy|1|||
127822594|NCT02619253|459970232|FG003|Overall Study|Alternative Therapy|0|||
127822595|NCT02619253|459970233|FG004|Overall Study|Alternative Therapy|0|||
127822596|NCT02619253|459970229|FG000|Overall Study|Death|0|||
127894727|NCT01656889|460237245|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
127894728|NCT01656889|460237246|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
127894729|NCT01656889|460237245|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
127894730|NCT01656889|460237246|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
127894731|NCT01656889|460237245|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
127822597|NCT02619253|459970230|FG001|Overall Study|Death|0|||
127822598|NCT02619253|459970231|FG002|Overall Study|Death|0|||
127822599|NCT02619253|459970232|FG003|Overall Study|Death|1|||
127822600|NCT02619253|459970233|FG004|Overall Study|Death|0|||
127822601|NCT02619253|459970229|FG000|Overall Study|Disease Progression|4|||
127822602|NCT02619253|459970230|FG001|Overall Study|Disease Progression|2|||
127822603|NCT02619253|459970231|FG002|Overall Study|Disease Progression|8|||
127822604|NCT02619253|459970232|FG003|Overall Study|Disease Progression|9|||
127822605|NCT02619253|459970233|FG004|Overall Study|Disease Progression|10|||
127822606|NCT02619253|459970229|FG000|Overall Study|Needed a disqualifying therapy|0|||
127822607|NCT02619253|459970230|FG001|Overall Study|Needed a disqualifying therapy|0|||
127822608|NCT02619253|459970231|FG002|Overall Study|Needed a disqualifying therapy|1|||
127822609|NCT02619253|459970232|FG003|Overall Study|Needed a disqualifying therapy|0|||
127822610|NCT02619253|459970233|FG004|Overall Study|Needed a disqualifying therapy|0|||
127822611|NCT02619253|459970229|FG000|Overall Study|Transferred to hospice|0|||
127822612|NCT02619253|459970230|FG001|Overall Study|Transferred to hospice|0|||
127822613|NCT02619253|459970231|FG002|Overall Study|Transferred to hospice|1|||
127822614|NCT02619253|459970232|FG003|Overall Study|Transferred to hospice|0|||
127822615|NCT02619253|459970233|FG004|Overall Study|Transferred to hospice|0|||
127822616|NCT02619253|459970229|FG000|Overall Study|Physician Decision|0|||
127822617|NCT02619253|459970230|FG001|Overall Study|Physician Decision|1|||
127822618|NCT02619253|459970231|FG002|Overall Study|Physician Decision|2|||
127822619|NCT02619253|459970232|FG003|Overall Study|Physician Decision|3|||
127822620|NCT02619253|459970233|FG004|Overall Study|Physician Decision|0|||
127822621|NCT02619253|459970229|FG000|Overall Study|Withdrawal by Subject|0|||
127822622|NCT02619253|459970230|FG001|Overall Study|Withdrawal by Subject|1|||
127822623|NCT02619253|459970231|FG002|Overall Study|Withdrawal by Subject|0|||
127822624|NCT02619253|459970232|FG003|Overall Study|Withdrawal by Subject|0|||
127822625|NCT02619253|459970233|FG004|Overall Study|Withdrawal by Subject|2|||
127822626|NCT00514449|459970234|FG000|Overall Study|Withdrawal by Subject|1|||
127822627|NCT00514449|459970235|FG001|Overall Study|Withdrawal by Subject|2|||
127822628|NCT00514449|459970234|FG000|Overall Study|Protocol Violation|1|||
127822629|NCT00514449|459970235|FG001|Overall Study|Protocol Violation|2|||
127822630|NCT00514449|459970234|FG000|Overall Study|Lost to Follow-up|1|||
127822631|NCT00514449|459970235|FG001|Overall Study|Lost to Follow-up|0|||
127822632|NCT00301067|459970239|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
127822633|NCT00301067|459970240|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
127822634|NCT00301067|459970241|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
127822635|NCT00301067|459970242|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
127822636|NCT00301067|459970239|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
127822637|NCT00301067|459970240|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
127822638|NCT00301067|459970241|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
127822639|NCT00301067|459970242|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
127822640|NCT00301067|459970239|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
127822641|NCT00301067|459970240|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
127822642|NCT00301067|459970241|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
127822643|NCT00301067|459970242|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
127822644|NCT00301067|459970239|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
127822645|NCT00301067|459970240|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
127822646|NCT00301067|459970241|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
127822647|NCT00301067|459970242|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
127822648|NCT00301067|459970239|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
127822649|NCT00301067|459970240|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
127822650|NCT00301067|459970241|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
127822651|NCT00301067|459970242|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
127822652|NCT00301067|459970239|FG000|Follow up Until Death|Alive at last data cut point|1|||
127822653|NCT00301067|459970240|FG001|Follow up Until Death|Alive at last data cut point|0|||
127822654|NCT00301067|459970241|FG002|Follow up Until Death|Alive at last data cut point|0|||
127822655|NCT00301067|459970242|FG003|Follow up Until Death|Alive at last data cut point|1|||
127822656|NCT00149825|459970243|FG000|Overall Study|Intolerance to medication side effects|1|||
127822657|NCT00149825|459970244|FG001|Overall Study|Intolerance to medication side effects|2|||
127822658|NCT00149825|459970243|FG000|Overall Study|Time commitments|2|||
127822659|NCT00149825|459970244|FG001|Overall Study|Time commitments|1|||
127822660|NCT00149825|459970243|FG000|Overall Study|Not liking insomnia therapy|1|||
127822661|NCT00149825|459970244|FG001|Overall Study|Not liking insomnia therapy|0|||
127822662|NCT00149825|459970243|FG000|Overall Study|Other|1|||
127822663|NCT00149825|459970244|FG001|Overall Study|Other|0|||
127822664|NCT01359982|459970245|FG000|Overall Study|Adverse Event|2|||
127822665|NCT01359982|459970246|FG001|Overall Study|Adverse Event|0|||
127822666|NCT01359982|459970247|FG002|Overall Study|Adverse Event|0|||
127822667|NCT01359982|459970248|FG003|Overall Study|Adverse Event|1|||
127822668|NCT01359982|459970249|FG004|Overall Study|Adverse Event|0|||
127822669|NCT01359982|459970250|FG005|Overall Study|Adverse Event|0|||
127822670|NCT01359982|459970245|FG000|Overall Study|Death|1|||
127822671|NCT01359982|459970246|FG001|Overall Study|Death|0|||
127822672|NCT01359982|459970247|FG002|Overall Study|Death|0|||
127822673|NCT01359982|459970248|FG003|Overall Study|Death|0|||
127822674|NCT01359982|459970249|FG004|Overall Study|Death|0|||
127822675|NCT01359982|459970250|FG005|Overall Study|Death|0|||
127822676|NCT01208181|459970251|FG000|Part 1|Withdrawal by Subject|11|||
127822677|NCT01208181|459970252|FG001|Part 1|Withdrawal by Subject|10|||
127822678|NCT01208181|459970253|FG002|Part 1|Withdrawal by Subject|0|||
127822679|NCT01208181|459970254|FG003|Part 1|Withdrawal by Subject|0|||
127822680|NCT01208181|459970255|FG004|Part 1|Withdrawal by Subject|0|||
127822681|NCT01208181|459970251|FG000|Part 1|Technical problem|5|||
127822682|NCT01208181|459970252|FG001|Part 1|Technical problem|0|||
127822683|NCT01208181|459970253|FG002|Part 1|Technical problem|0|||
127822684|NCT01208181|459970254|FG003|Part 1|Technical problem|0|||
127822685|NCT01208181|459970255|FG004|Part 1|Technical problem|0|||
127822686|NCT01208181|459970251|FG000|Part 1|Protocol Violation|10|||
127822687|NCT01208181|459970252|FG001|Part 1|Protocol Violation|5|||
127822688|NCT01208181|459970253|FG002|Part 1|Protocol Violation|0|||
127822689|NCT01208181|459970254|FG003|Part 1|Protocol Violation|0|||
127822690|NCT01208181|459970255|FG004|Part 1|Protocol Violation|0|||
127822691|NCT01208181|459970251|FG000|Part 1|Physician Decision|4|||
127822692|NCT01208181|459970252|FG001|Part 1|Physician Decision|0|||
127822693|NCT01208181|459970253|FG002|Part 1|Physician Decision|0|||
127822694|NCT01208181|459970254|FG003|Part 1|Physician Decision|0|||
127822695|NCT01208181|459970255|FG004|Part 1|Physician Decision|0|||
127822696|NCT01208181|459970251|FG000|Part 1|Non-compliance with study drug|1|||
127822697|NCT01208181|459970252|FG001|Part 1|Non-compliance with study drug|1|||
127822698|NCT01208181|459970253|FG002|Part 1|Non-compliance with study drug|0|||
127822699|NCT01208181|459970254|FG003|Part 1|Non-compliance with study drug|0|||
127822700|NCT01208181|459970255|FG004|Part 1|Non-compliance with study drug|0|||
127822701|NCT01208181|459970251|FG000|Part 1|Lost to Follow-up|5|||
127822702|NCT01208181|459970252|FG001|Part 1|Lost to Follow-up|3|||
127822703|NCT01208181|459970253|FG002|Part 1|Lost to Follow-up|0|||
127822704|NCT01208181|459970254|FG003|Part 1|Lost to Follow-up|0|||
127822705|NCT01208181|459970255|FG004|Part 1|Lost to Follow-up|1|||
127822706|NCT01208181|459970251|FG000|Part 1|Lack of Efficacy|37|||
127822707|NCT01208181|459970252|FG001|Part 1|Lack of Efficacy|12|||
127822708|NCT01208181|459970253|FG002|Part 1|Lack of Efficacy|0|||
127822709|NCT01208181|459970254|FG003|Part 1|Lack of Efficacy|0|||
127822710|NCT01208181|459970255|FG004|Part 1|Lack of Efficacy|17|||
127822711|NCT01208181|459970251|FG000|Part 1|Adverse Event|26|||
127822712|NCT01208181|459970252|FG001|Part 1|Adverse Event|24|||
127822713|NCT01208181|459970253|FG002|Part 1|Adverse Event|0|||
127822714|NCT01208181|459970254|FG003|Part 1|Adverse Event|0|||
127822715|NCT01208181|459970255|FG004|Part 1|Adverse Event|4|||
127822716|NCT01208181|459970251|FG000|Part 2|Adverse Event|0|||
127822717|NCT01208181|459970252|FG001|Part 2|Adverse Event|0|||
127822718|NCT01208181|459970253|FG002|Part 2|Adverse Event|6|||
127822719|NCT01208181|459970254|FG003|Part 2|Adverse Event|7|||
127822720|NCT01208181|459970255|FG004|Part 2|Adverse Event|0|||
127822721|NCT01208181|459970251|FG000|Part 2|Withdrawal by Subject|0|||
127822722|NCT01208181|459970252|FG001|Part 2|Withdrawal by Subject|0|||
127822723|NCT01208181|459970253|FG002|Part 2|Withdrawal by Subject|1|||
127822724|NCT01208181|459970254|FG003|Part 2|Withdrawal by Subject|1|||
127822725|NCT01208181|459970255|FG004|Part 2|Withdrawal by Subject|0|||
127822726|NCT01208181|459970251|FG000|Part 2|Protocol Violation|0|||
127822727|NCT01208181|459970252|FG001|Part 2|Protocol Violation|0|||
127822728|NCT01208181|459970253|FG002|Part 2|Protocol Violation|1|||
127822729|NCT01208181|459970254|FG003|Part 2|Protocol Violation|0|||
127822730|NCT01208181|459970255|FG004|Part 2|Protocol Violation|0|||
127822731|NCT01208181|459970251|FG000|Part 2|Physician Decision|0|||
127822732|NCT01208181|459970252|FG001|Part 2|Physician Decision|0|||
127822733|NCT01208181|459970253|FG002|Part 2|Physician Decision|1|||
127822734|NCT01208181|459970254|FG003|Part 2|Physician Decision|2|||
127822735|NCT01208181|459970255|FG004|Part 2|Physician Decision|0|||
127822736|NCT01208181|459970251|FG000|Part 2|Non-compliance with study drug|0|||
127822737|NCT01208181|459970252|FG001|Part 2|Non-compliance with study drug|0|||
127822738|NCT01208181|459970253|FG002|Part 2|Non-compliance with study drug|1|||
127822739|NCT01208181|459970254|FG003|Part 2|Non-compliance with study drug|1|||
127822740|NCT01208181|459970255|FG004|Part 2|Non-compliance with study drug|0|||
127822741|NCT01208181|459970251|FG000|Part 2|Lost to Follow-up|0|||
127822742|NCT01208181|459970252|FG001|Part 2|Lost to Follow-up|0|||
127822743|NCT01208181|459970253|FG002|Part 2|Lost to Follow-up|1|||
127822744|NCT01208181|459970254|FG003|Part 2|Lost to Follow-up|2|||
127822745|NCT01208181|459970255|FG004|Part 2|Lost to Follow-up|0|||
127822746|NCT01208181|459970251|FG000|Part 2|Lack of Efficacy|0|||
127822747|NCT01208181|459970252|FG001|Part 2|Lack of Efficacy|0|||
127822748|NCT01208181|459970253|FG002|Part 2|Lack of Efficacy|5|||
127822749|NCT01208181|459970254|FG003|Part 2|Lack of Efficacy|7|||
127822750|NCT01208181|459970255|FG004|Part 2|Lack of Efficacy|0|||
127822751|NCT00942708|459970256|FG000|Overall Study|Withdrawal by Subject|1|||
127822752|NCT01457339|459970261|FG000|Period 3 (100 mg)|Adverse Event|0|||
127822753|NCT01457339|459970262|FG001|Period 3 (100 mg)|Adverse Event|1|||
127822754|NCT01457339|459970261|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
127822755|NCT01457339|459970262|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
127822756|NCT01457339|459970261|FG000|Period 6 (250 mg)|Family Emergency|1|||
127822757|NCT01457339|459970262|FG001|Period 6 (250 mg)|Family Emergency|0|||
127822758|NCT01457339|459970261|FG000|Period 6 (250 mg)|Personal appointment|0|||
127822759|NCT01457339|459970262|FG001|Period 6 (250 mg)|Personal appointment|1|||
127822760|NCT03694522|459970264|FG000|Overall Study|Withdrawal by Subject|8|||
127822761|NCT03694522|459970265|FG001|Overall Study|Withdrawal by Subject|10|||
127822762|NCT03694522|459970264|FG000|Overall Study|Physician Decision|53|||
127822763|NCT03694522|459970265|FG001|Overall Study|Physician Decision|54|||
127822764|NCT03694522|459970264|FG000|Overall Study|Other|1|||
127822765|NCT03694522|459970265|FG001|Overall Study|Other|1|||
127822766|NCT03694522|459970264|FG000|Overall Study|Lost to Follow-up|0|||
127822767|NCT03694522|459970265|FG001|Overall Study|Lost to Follow-up|1|||
127822768|NCT01164501|459970266|FG000|Overall Study|Not treated|2|||
127822769|NCT01164501|459970267|FG001|Overall Study|Not treated|0|||
127822770|NCT01164501|459970268|FG002|Overall Study|Not treated|1|||
127822771|NCT01164501|459970266|FG000|Overall Study|Adverse Event|18|||
127822772|NCT01164501|459970267|FG001|Overall Study|Adverse Event|4|||
127822773|NCT01164501|459970268|FG002|Overall Study|Adverse Event|21|||
127822774|NCT01164501|459970266|FG000|Overall Study|Lack of Efficacy|0|||
127822775|NCT01164501|459970267|FG001|Overall Study|Lack of Efficacy|0|||
127822776|NCT01164501|459970268|FG002|Overall Study|Lack of Efficacy|1|||
127822777|NCT01164501|459970266|FG000|Overall Study|Non compliant with protocol|1|||
127822778|NCT01164501|459970267|FG001|Overall Study|Non compliant with protocol|1|||
127822779|NCT01164501|459970268|FG002|Overall Study|Non compliant with protocol|4|||
127822780|NCT01164501|459970266|FG000|Overall Study|Lost to Follow-up|3|||
127822781|NCT01164501|459970267|FG001|Overall Study|Lost to Follow-up|0|||
127822782|NCT01164501|459970268|FG002|Overall Study|Lost to Follow-up|3|||
127822783|NCT01164501|459970266|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
127822784|NCT01164501|459970267|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
127822785|NCT01164501|459970268|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
127822786|NCT01164501|459970266|FG000|Overall Study|Other reason not defined above|9|||
127822787|NCT01164501|459970267|FG001|Overall Study|Other reason not defined above|1|||
127822788|NCT01164501|459970268|FG002|Overall Study|Other reason not defined above|4|||
127822789|NCT00306891|459970269|FG000|Part A|Withdrawal by Subject|1|||
127822790|NCT00306891|459970270|FG001|Part A|Withdrawal by Subject|1|||
127822791|NCT00306891|459970271|FG002|Part A|Withdrawal by Subject|0|||
127822792|NCT00306891|459970272|FG003|Part A|Withdrawal by Subject|0|||
127822793|NCT00306891|459970269|FG000|Part A|Condition under investigation worsened|2|||
127822794|NCT00306891|459970270|FG001|Part A|Condition under investigation worsened|2|||
127822795|NCT00306891|459970271|FG002|Part A|Condition under investigation worsened|0|||
127822796|NCT00306891|459970272|FG003|Part A|Condition under investigation worsened|0|||
127822797|NCT00306891|459970269|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
127822798|NCT00306891|459970270|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
127822799|NCT00306891|459970271|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
127822800|NCT00306891|459970272|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
127822801|NCT00306891|459970269|FG000|Part A|Partial bowel obstruction|1|||
127822802|NCT00306891|459970270|FG001|Part A|Partial bowel obstruction|0|||
127822803|NCT00306891|459970271|FG002|Part A|Partial bowel obstruction|0|||
127822804|NCT00306891|459970272|FG003|Part A|Partial bowel obstruction|0|||
127822805|NCT00306891|459970269|FG000|Part A|Reaccumul. of ascites following drainage|0|||
127822806|NCT00306891|459970270|FG001|Part A|Reaccumul. of ascites following drainage|1|||
127822807|NCT00306891|459970271|FG002|Part A|Reaccumul. of ascites following drainage|0|||
127822808|NCT00306891|459970272|FG003|Part A|Reaccumul. of ascites following drainage|0|||
127822809|NCT00306891|459970269|FG000|Part A|Suspicion of second malignancy|0|||
127822810|NCT00306891|459970270|FG001|Part A|Suspicion of second malignancy|1|||
127822811|NCT00306891|459970271|FG002|Part A|Suspicion of second malignancy|0|||
127822812|NCT00306891|459970272|FG003|Part A|Suspicion of second malignancy|0|||
127822813|NCT00306891|459970269|FG000|Part A|QTC interval outwith elig. criteria|1|||
127822814|NCT00306891|459970270|FG001|Part A|QTC interval outwith elig. criteria|0|||
127822815|NCT00306891|459970271|FG002|Part A|QTC interval outwith elig. criteria|0|||
127822816|NCT00306891|459970272|FG003|Part A|QTC interval outwith elig. criteria|0|||
127822817|NCT00306891|459970269|FG000|Part B|Death|0|||
127822818|NCT00306891|459970270|FG001|Part B|Death|0|||
127822819|NCT00306891|459970271|FG002|Part B|Death|1|||
127822820|NCT00306891|459970272|FG003|Part B|Death|2|||
127822821|NCT00306891|459970269|FG000|Part B|Adverse Event|0|||
127822822|NCT00306891|459970270|FG001|Part B|Adverse Event|0|||
127822823|NCT00306891|459970271|FG002|Part B|Adverse Event|5|||
127822824|NCT00306891|459970272|FG003|Part B|Adverse Event|5|||
127822825|NCT00306891|459970269|FG000|Part B|Withdrawal by Subject|0|||
127822826|NCT00306891|459970270|FG001|Part B|Withdrawal by Subject|0|||
127822827|NCT00306891|459970271|FG002|Part B|Withdrawal by Subject|3|||
127822828|NCT00306891|459970272|FG003|Part B|Withdrawal by Subject|1|||
127822829|NCT00306891|459970269|FG000|Part B|Condition under investigation worsened|0|||
127822830|NCT00306891|459970270|FG001|Part B|Condition under investigation worsened|0|||
127822831|NCT00306891|459970271|FG002|Part B|Condition under investigation worsened|2|||
127822832|NCT00306891|459970272|FG003|Part B|Condition under investigation worsened|8|||
127822833|NCT00306891|459970269|FG000|Part B|Development of study specific disc crit.|0|||
127822834|NCT00306891|459970270|FG001|Part B|Development of study specific disc crit.|0|||
127822835|NCT00306891|459970271|FG002|Part B|Development of study specific disc crit.|0|||
127822836|NCT00306891|459970272|FG003|Part B|Development of study specific disc crit.|1|||
127822837|NCT00673673|459970273|FG000|Overall Study|Progressive disease|27|||
127822838|NCT00673673|459970273|FG000|Overall Study|Adverse Event|4|||
127894732|NCT01656889|460237246|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
127894733|NCT01656889|460237245|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
127894734|NCT01656889|460237246|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
127894735|NCT01656889|460237245|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
127894736|NCT01656889|460237246|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
127822839|NCT00673673|459970273|FG000|Overall Study|Withdrawal by Subject|3|||
127822840|NCT00673673|459970273|FG000|Overall Study|Investigators' discretion|2|||
127822841|NCT04538950|459970274|FG000|Overall Study|Pulmonary Issues|2|||
127822842|NCT04538950|459970274|FG000|Overall Study|illness|2|||
127822843|NCT02792777|459970275|FG000|Overall Study|Withdrawal by Subject|2|||
127822844|NCT02792777|459970276|FG001|Overall Study|Withdrawal by Subject|0|||
127822845|NCT02792777|459970275|FG000|Overall Study|Recording malfunction|2|||
127822846|NCT02792777|459970276|FG001|Overall Study|Recording malfunction|0|||
127822847|NCT02792777|459970275|FG000|Overall Study|Later determined to be ineligible|2|||
127822848|NCT02792777|459970276|FG001|Overall Study|Later determined to be ineligible|0|||
127822849|NCT02792777|459970275|FG000|Overall Study|Participant interviewed twice|1|||
127822850|NCT02792777|459970276|FG001|Overall Study|Participant interviewed twice|0|||
127822851|NCT04799782|459970277|FG000|Washout|Physician Decision|2|||
127822852|NCT04799782|459970278|FG001|Washout|Physician Decision|0|||
127822853|NCT04799782|459970277|FG000|Washout|Withdrawal by Subject|0|||
127822854|NCT04799782|459970278|FG001|Washout|Withdrawal by Subject|2|||
127822855|NCT04799782|459970277|FG000|Washout|Lost to Follow-up|0|||
127894737|NCT01656889|460237245|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
127822856|NCT04799782|459970278|FG001|Washout|Lost to Follow-up|1|||
127822857|NCT02606877|459970279|FG000|Overall Study|Adverse Event|3|||
127822858|NCT02606877|459970280|FG001|Overall Study|Adverse Event|0|||
127822859|NCT02606877|459970279|FG000|Overall Study|Non-compliance with protocol|0|||
127822860|NCT02606877|459970280|FG001|Overall Study|Non-compliance with protocol|1|||
127822861|NCT02606877|459970279|FG000|Overall Study|Other than listed above|1|||
127822862|NCT02606877|459970280|FG001|Overall Study|Other than listed above|0|||
127822863|NCT00515463|459970292|FG000|Overall Study|Physician Decision|4|||
127822864|NCT00515463|459970293|FG001|Overall Study|Physician Decision|2|||
127822865|NCT00515463|459970292|FG000|Overall Study|Adverse Event|1|||
127822866|NCT00515463|459970293|FG001|Overall Study|Adverse Event|2|||
127822867|NCT00515463|459970292|FG000|Overall Study|Withdrawal by Subject|3|||
127822868|NCT00515463|459970293|FG001|Overall Study|Withdrawal by Subject|4|||
127822869|NCT00515463|459970292|FG000|Overall Study|Lost to Follow-up|6|||
127822870|NCT00515463|459970293|FG001|Overall Study|Lost to Follow-up|5|||
127822871|NCT00515463|459970292|FG000|Overall Study|Other|0|||
127822872|NCT00515463|459970293|FG001|Overall Study|Other|1|||
127822873|NCT01058369|459971504|FG000|Overall Study|Adverse Event|1|||
127822874|NCT01058369|459971504|FG000|Overall Study|Early termination study|1|||
127822875|NCT03268746|459971510|FG000|Overall Study|Withdrawal by Subject|1|||
127822876|NCT00891657|459971515|FG000|Overall Study|Withdrawal by Subject|1|||
127822877|NCT00891657|459971516|FG001|Overall Study|Withdrawal by Subject|1|||
127822878|NCT04530825|459971517|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
127822879|NCT04530825|459971518|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
127822880|NCT04530825|459971519|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
127822881|NCT04530825|459971520|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
127822882|NCT04530825|459971517|FG000|Overall Study|Did not complete follow-up|3|||
127822883|NCT04530825|459971518|FG001|Overall Study|Did not complete follow-up|0|||
127822884|NCT04530825|459971519|FG002|Overall Study|Did not complete follow-up|0|||
127822885|NCT04530825|459971520|FG003|Overall Study|Did not complete follow-up|0|||
127822886|NCT00850499|459971521|FG000|Overall Study|Adverse Event|3|||
127822887|NCT00850499|459971522|FG001|Overall Study|Adverse Event|1|||
127822888|NCT00850499|459971521|FG000|Overall Study|Lack of Efficacy|0|||
127822889|NCT00850499|459971522|FG001|Overall Study|Lack of Efficacy|1|||
127822890|NCT04498910|459971523|FG000|Overall Study|Lost to Follow-up|0|||
127822891|NCT04498910|459971524|FG001|Overall Study|Lost to Follow-up|1|||
127822892|NCT04498910|459971523|FG000|Overall Study|Withdrawal by Subject|2|||
127822893|NCT04498910|459971524|FG001|Overall Study|Withdrawal by Subject|1|||
127822894|NCT04498910|459971523|FG000|Overall Study|Adverse Event|1|||
127822895|NCT04498910|459971524|FG001|Overall Study|Adverse Event|0|||
127822896|NCT01849848|459971525|FG000|Overall Study|Physician Decision|1|||
127822897|NCT01849848|459971525|FG000|Overall Study|Progression of the primary disease|3|||
127822898|NCT00909090|459971526|FG000|Overall Study|Lost to Follow-up|17|||
127822899|NCT00909090|459971527|FG001|Overall Study|Lost to Follow-up|17|||
127822900|NCT02926573|459971529|FG000|Overall Study|Nausea|1|||
127822901|NCT02926573|459971530|FG001|Overall Study|Nausea|0|||
127822902|NCT02926573|459971529|FG000|Overall Study|Remain intubated|2|||
127822903|NCT02926573|459971530|FG001|Overall Study|Remain intubated|2|||
127822904|NCT02926573|459971529|FG000|Overall Study|Change in surgery plan|3|||
127822905|NCT02926573|459971530|FG001|Overall Study|Change in surgery plan|1|||
127822906|NCT02926573|459971529|FG000|Overall Study|Change to outpatient status|5|||
127822907|NCT02926573|459971530|FG001|Overall Study|Change to outpatient status|1|||
127822908|NCT02926573|459971529|FG000|Overall Study|Withdrawal by Subject|0|||
127822909|NCT02926573|459971530|FG001|Overall Study|Withdrawal by Subject|2|||
127822910|NCT02926573|459971529|FG000|Overall Study|Return to operating room|0|||
127822911|NCT02926573|459971530|FG001|Overall Study|Return to operating room|2|||
127822912|NCT02926573|459971529|FG000|Overall Study|Delirium|0|||
127822913|NCT02926573|459971530|FG001|Overall Study|Delirium|1|||
127822914|NCT00858702|459971533|FG000|Overall Study|Lack of Efficacy|1|||
127822915|NCT00858702|459971534|FG001|Overall Study|Lack of Efficacy|0|||
127822916|NCT00858702|459971533|FG000|Overall Study|Protocol Violation|1|||
127822917|NCT00858702|459971534|FG001|Overall Study|Protocol Violation|1|||
127822918|NCT00858702|459971533|FG000|Overall Study|Other|2|||
127822919|NCT00858702|459971534|FG001|Overall Study|Other|1|||
127822920|NCT00858702|459971533|FG000|Overall Study|Withdrawal by Subject|1|||
127822921|NCT00858702|459971534|FG001|Overall Study|Withdrawal by Subject|0|||
127822922|NCT01214434|459971543|FG000|Overall Study|Withdrawal by Subject|1|||
127822923|NCT01214434|459971544|FG001|Overall Study|Withdrawal by Subject|0|||
127822924|NCT01214434|459971543|FG000|Overall Study|Lost to Follow-up|2|||
127894738|NCT01656889|460237246|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
127822925|NCT01214434|459971544|FG001|Overall Study|Lost to Follow-up|2|||
127822926|NCT01214434|459971543|FG000|Overall Study|Site error|1|||
127822927|NCT01214434|459971544|FG001|Overall Study|Site error|0|||
127822928|NCT03792750|459971546|FG000|Overall Study|Death|3|||
127822929|NCT00138151|459971547|FG000|Overall Study|Withdrawal by Subject|3|||
127822930|NCT00138151|459971547|FG000|Overall Study|Physician Decision|1|||
127822931|NCT02902809|459971551|FG000|Overall Study|Discontinuation of asthma program|28|||
127822932|NCT00532259|459971552|FG000|Overall Study|Withdrawal by Subject|2|||
127822933|NCT00532259|459971552|FG000|Overall Study|Adverse Event|1|||
127822934|NCT00532259|459971552|FG000|Overall Study|Death|1|||
127822935|NCT00532259|459971552|FG000|Overall Study|Lack of Efficacy|21|||
127822936|NCT00532259|459971552|FG000|Overall Study|Lost to Follow-up|3|||
127822937|NCT00532259|459971552|FG000|Overall Study|Physician Decision|3|||
127822938|NCT00532259|459971552|FG000|Overall Study|Protocol Violation|1|||
127822939|NCT00793104|459971553|FG000|Overall Study|Lost to Follow-up|1|||
127822940|NCT01302769|459971554|FG000|Overall Study|Lost to Follow-up|1|||
127822941|NCT01302769|459971555|FG001|Overall Study|Lost to Follow-up|1|||
127822942|NCT03494725|459971556|FG000|Overall Study|Withdrawal by Subject|0|||
127822943|NCT03494725|459971557|FG001|Overall Study|Withdrawal by Subject|2|||
127822944|NCT03494725|459971556|FG000|Overall Study|Antibiotic use|1|||
127822945|NCT03494725|459971557|FG001|Overall Study|Antibiotic use|0|||
127822946|NCT04983940|459971558|FG000|Overall Study|Lost to Follow-up|14|||
127822947|NCT04983940|459971558|FG000|Overall Study|Lack of Efficacy|2|||
127822948|NCT02760407|459971561|FG000|Overall Study|Death|2|||
127822949|NCT02760407|459971562|FG001|Overall Study|Death|3|||
127822950|NCT02760407|459971563|FG002|Overall Study|Death|1|||
127822951|NCT02760407|459971564|FG003|Overall Study|Death|1|||
127822952|NCT02760407|459971561|FG000|Overall Study|Lost to Follow-up|1|||
127822953|NCT02760407|459971562|FG001|Overall Study|Lost to Follow-up|7|||
127822954|NCT02760407|459971563|FG002|Overall Study|Lost to Follow-up|4|||
127822955|NCT02760407|459971564|FG003|Overall Study|Lost to Follow-up|6|||
127822956|NCT02760407|459971561|FG000|Overall Study|Withdrawal by Subject|25|||
127822957|NCT02760407|459971562|FG001|Overall Study|Withdrawal by Subject|31|||
127822958|NCT02760407|459971563|FG002|Overall Study|Withdrawal by Subject|37|||
127822959|NCT02760407|459971564|FG003|Overall Study|Withdrawal by Subject|25|||
127822960|NCT02760407|459971561|FG000|Overall Study|Violation of Eligibility criteria|0|||
127822961|NCT02760407|459971562|FG001|Overall Study|Violation of Eligibility criteria|0|||
127822962|NCT02760407|459971563|FG002|Overall Study|Violation of Eligibility criteria|1|||
127822963|NCT02760407|459971564|FG003|Overall Study|Violation of Eligibility criteria|1|||
127822964|NCT02760407|459971561|FG000|Overall Study|Personal reasons|0|||
127822965|NCT02760407|459971562|FG001|Overall Study|Personal reasons|0|||
127822966|NCT02760407|459971563|FG002|Overall Study|Personal reasons|0|||
127822967|NCT02760407|459971564|FG003|Overall Study|Personal reasons|1|||
127822968|NCT02760407|459971561|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
127822969|NCT02760407|459971562|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
127822970|NCT02760407|459971563|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
127822971|NCT02760407|459971564|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
127822972|NCT02760407|459971561|FG000|Overall Study|Use of prohibited Medication|0|||
127822973|NCT02760407|459971562|FG001|Overall Study|Use of prohibited Medication|0|||
127822974|NCT02760407|459971563|FG002|Overall Study|Use of prohibited Medication|1|||
127822975|NCT02760407|459971564|FG003|Overall Study|Use of prohibited Medication|0|||
127822976|NCT02760407|459971561|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
127822977|NCT02760407|459971562|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
127822978|NCT02760407|459971563|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
127822979|NCT02760407|459971564|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
127822980|NCT02760407|459971561|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
127822981|NCT02760407|459971562|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
127822982|NCT02760407|459971563|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
127822983|NCT02760407|459971564|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
127822984|NCT02760407|459971561|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
127822985|NCT02760407|459971562|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
127822986|NCT02760407|459971563|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
127822987|NCT02760407|459971564|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
127822988|NCT02760407|459971561|FG000|Overall Study|Inadequately Enrolled|0|||
127822989|NCT02760407|459971562|FG001|Overall Study|Inadequately Enrolled|0|||
127822990|NCT02760407|459971563|FG002|Overall Study|Inadequately Enrolled|0|||
127822991|NCT02760407|459971564|FG003|Overall Study|Inadequately Enrolled|1|||
127822992|NCT02760407|459971561|FG000|Overall Study|Withdrawal By PI's Decision|0|||
127822993|NCT02760407|459971562|FG001|Overall Study|Withdrawal By PI's Decision|1|||
127822994|NCT02760407|459971563|FG002|Overall Study|Withdrawal By PI's Decision|0|||
127822995|NCT02760407|459971564|FG003|Overall Study|Withdrawal By PI's Decision|0|||
127822996|NCT02760407|459971561|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
127822997|NCT02760407|459971562|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
127822998|NCT02760407|459971563|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
127822999|NCT02760407|459971564|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
127823000|NCT02760407|459971561|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
127823001|NCT02760407|459971562|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
127823002|NCT02760407|459971563|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
127823003|NCT02760407|459971564|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
127823004|NCT02760407|459971561|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
127823005|NCT02760407|459971562|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
127823006|NCT02760407|459971563|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
127823007|NCT02760407|459971564|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
127823008|NCT02760407|459971561|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
127823009|NCT02760407|459971562|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
127823010|NCT02760407|459971563|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
127823011|NCT02760407|459971564|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
127823012|NCT02760407|459971561|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
127823013|NCT02760407|459971562|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
127823014|NCT02760407|459971563|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
127823015|NCT02760407|459971564|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
127823016|NCT02760407|459971561|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
127823017|NCT02760407|459971562|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
127823018|NCT02760407|459971563|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
127823019|NCT02760407|459971564|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
127823020|NCT02760407|459971561|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
127823021|NCT02760407|459971562|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
127823022|NCT02760407|459971563|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
127823023|NCT02760407|459971564|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
127823024|NCT02760407|459971561|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
127823025|NCT02760407|459971562|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
127823026|NCT02760407|459971563|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
127823027|NCT02760407|459971564|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
127823028|NCT02760407|459971561|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
127823029|NCT02760407|459971562|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
127823030|NCT02760407|459971563|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
127823031|NCT02760407|459971564|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
127823032|NCT01645930|459971565|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
127823033|NCT01645930|459971565|FG000|Overall Study|Progressive Disease|12|||
127823034|NCT01645930|459971565|FG000|Overall Study|Adverse Event|4|||
127823035|NCT01645930|459971565|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
127823036|NCT01645930|459971565|FG000|Overall Study|Withdrawal by Participant|2|||
127823037|NCT01645930|459971565|FG000|Overall Study|Reason not Defined|1|||
127823038|NCT01748760|459971566|FG000|Overall Study|Withdrawal by Subject|1|||
127823039|NCT01748760|459971567|FG001|Overall Study|Withdrawal by Subject|1|||
127823040|NCT01748760|459971566|FG000|Overall Study|Lost to Follow-up|5|||
127823041|NCT01748760|459971567|FG001|Overall Study|Lost to Follow-up|1|||
127823042|NCT03245814|459971568|FG000|Overall Study|Lost to Follow-up|5|||
127823043|NCT03245814|459971569|FG001|Overall Study|Lost to Follow-up|8|||
127823044|NCT03245814|459971568|FG000|Overall Study|Excluded (did not receive allocated condition)|10|||
127823045|NCT03245814|459971569|FG001|Overall Study|Excluded (did not receive allocated condition)|4|||
127823046|NCT02522377|459971573|FG000|Overall Study|Withdrawal by Subject|1|||
127823047|NCT02522377|459971574|FG001|Overall Study|Withdrawal by Subject|0|||
127823048|NCT02522377|459971573|FG000|Overall Study|Remission Achieved|3|||
127823049|NCT02522377|459971574|FG001|Overall Study|Remission Achieved|0|||
127823050|NCT01158950|459971575|FG000|1st Intervention (1 Day)|Physician Decision|1|||
127823051|NCT01158950|459971576|FG001|1st Intervention (1 Day)|Physician Decision|2|||
127823052|NCT02263365|459971577|FG000|Overall Study|Physician Decision|22|||
127823053|NCT02263365|459971578|FG001|Overall Study|Physician Decision|18|||
127823054|NCT00945191|459971579|FG000|Overall Study|Did not achieve a complete response|18|||
127823055|NCT00945191|459971579|FG000|Overall Study|Participant relocated to another state|1|||
127823056|NCT00945191|459971579|FG000|Overall Study|Disease progression|3|||
127823057|NCT00945191|459971579|FG000|Overall Study|Serious adverse event or adverse event|1|||
127823058|NCT00945191|459971579|FG000|Overall Study|Investigator's discretion|1|||
127823059|NCT00206518|459971580|FG000|Overall Study|Lack of Efficacy|6|||
127823060|NCT00206518|459971581|FG001|Overall Study|Lack of Efficacy|4|||
127823061|NCT00206518|459971580|FG000|Overall Study|Adverse Event|2|||
127823062|NCT00206518|459971581|FG001|Overall Study|Adverse Event|1|||
127823063|NCT00206518|459971580|FG000|Overall Study|Physician Decision|1|||
127823064|NCT00206518|459971581|FG001|Overall Study|Physician Decision|0|||
127823065|NCT00206518|459971580|FG000|Overall Study|Protocol Violation|1|||
127823066|NCT00206518|459971581|FG001|Overall Study|Protocol Violation|1|||
127823067|NCT01004146|459971582|FG000|Overall Study|Withdrawal by Subject|4|||
127823068|NCT01004146|459971583|FG001|Overall Study|Withdrawal by Subject|5|||
127823069|NCT01001494|459971584|FG000|Overall Study|Adverse Event|8|||
127823070|NCT01001494|459971585|FG001|Overall Study|Adverse Event|4|||
127823071|NCT01001494|459971586|FG002|Overall Study|Adverse Event|6|||
127823072|NCT01001494|459971584|FG000|Overall Study|Protocol Violation|0|||
127823073|NCT01001494|459971585|FG001|Overall Study|Protocol Violation|1|||
127823074|NCT01001494|459971586|FG002|Overall Study|Protocol Violation|1|||
127823075|NCT01001494|459971584|FG000|Overall Study|Lost to Follow-up|2|||
127823076|NCT01001494|459971585|FG001|Overall Study|Lost to Follow-up|0|||
127823077|NCT01001494|459971586|FG002|Overall Study|Lost to Follow-up|1|||
127823078|NCT01001494|459971584|FG000|Overall Study|Withdrawal by Subject|9|||
127823079|NCT01001494|459971585|FG001|Overall Study|Withdrawal by Subject|7|||
127823080|NCT01001494|459971586|FG002|Overall Study|Withdrawal by Subject|17|||
127823081|NCT01001494|459971584|FG000|Overall Study|COPD exacerbation|3|||
127823082|NCT01001494|459971585|FG001|Overall Study|COPD exacerbation|4|||
127823083|NCT01001494|459971586|FG002|Overall Study|COPD exacerbation|5|||
127823084|NCT01001494|459971584|FG000|Overall Study|Lack of Efficacy|2|||
127823085|NCT01001494|459971585|FG001|Overall Study|Lack of Efficacy|0|||
127823086|NCT01001494|459971586|FG002|Overall Study|Lack of Efficacy|8|||
127823087|NCT01001494|459971584|FG000|Overall Study|Other|0|||
127823088|NCT01001494|459971585|FG001|Overall Study|Other|1|||
127823089|NCT01001494|459971586|FG002|Overall Study|Other|3|||
127823090|NCT02179398|459971587|FG000|Overall Study|Lack of obligatory data|3|||
127823091|NCT02179398|459971588|FG001|Overall Study|Lack of obligatory data|3|||
127823092|NCT02179398|459971587|FG000|Overall Study|Lost to Follow-up|0|||
127823093|NCT02179398|459971588|FG001|Overall Study|Lost to Follow-up|1|||
127823094|NCT00408681|459971595|FG000|Overall Study|Lack of Efficacy|2|||
127823095|NCT00408681|459971595|FG000|Overall Study|Adverse Event|7|||
127823096|NCT02519231|459971598|FG000|Overall Study|Lost to Follow-up|2|||
127823097|NCT02519231|459971599|FG001|Overall Study|Lost to Follow-up|5|||
127823098|NCT02519231|459971598|FG000|Overall Study|Withdrawal by Subject|0|||
127823099|NCT02519231|459971599|FG001|Overall Study|Withdrawal by Subject|1|||
127823100|NCT00447421|459971600|FG000|Overall Study|Lack of Efficacy|1|||
127823101|NCT00447421|459971600|FG000|Overall Study|Adverse Event|3|||
127823102|NCT00447421|459971600|FG000|Overall Study|Sponsor Decision|2|||
127823103|NCT02124798|459971601|FG000|Overall Study|Adverse Event|3|||
127823104|NCT02124798|459971601|FG000|Overall Study|Lost to Follow-up|1|||
127823105|NCT01707147|459971605|FG000|Overall Study|Administered Trajenta prior to contract|5|||
127823106|NCT01707147|459971605|FG000|Overall Study|Patients who have not taken Trajenta|1|||
127823107|NCT01707147|459971605|FG000|Overall Study|Follow-up failure|17|||
127823108|NCT01707147|459971605|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
127823109|NCT02053246|459971606|FG000|Overall Study|Withdrawal by Subject|3|||
127823110|NCT02053246|459971606|FG000|Overall Study|Physician Decision|1|||
127823111|NCT02795156|459971607|FG000|Overall Study|Progressive Disease|22|||
127823112|NCT02795156|459971608|FG001|Overall Study|Progressive Disease|7|||
127823113|NCT02795156|459971609|FG002|Overall Study|Progressive Disease|34|||
127823114|NCT02795156|459971610|FG003|Overall Study|Progressive Disease|7|||
127823115|NCT02795156|459971607|FG000|Overall Study|Adverse Event|13|||
127823116|NCT02795156|459971608|FG001|Overall Study|Adverse Event|2|||
127823117|NCT02795156|459971609|FG002|Overall Study|Adverse Event|3|||
127823118|NCT02795156|459971610|FG003|Overall Study|Adverse Event|2|||
127823119|NCT02795156|459971607|FG000|Overall Study|Death|1|||
127823120|NCT02795156|459971608|FG001|Overall Study|Death|1|||
127823121|NCT02795156|459971609|FG002|Overall Study|Death|1|||
127823122|NCT02795156|459971610|FG003|Overall Study|Death|0|||
127823123|NCT02795156|459971607|FG000|Overall Study|Physician Decision|1|||
127823124|NCT02795156|459971608|FG001|Overall Study|Physician Decision|0|||
127823125|NCT02795156|459971609|FG002|Overall Study|Physician Decision|1|||
127823126|NCT02795156|459971610|FG003|Overall Study|Physician Decision|0|||
127823127|NCT02795156|459971607|FG000|Overall Study|Withdrawal by Subject|2|||
127823128|NCT02795156|459971608|FG001|Overall Study|Withdrawal by Subject|0|||
127823129|NCT02795156|459971609|FG002|Overall Study|Withdrawal by Subject|3|||
127823130|NCT02795156|459971610|FG003|Overall Study|Withdrawal by Subject|0|||
127823131|NCT00815308|459971611|FG000|Overall Study|Adverse Event|4|||
127823132|NCT00815308|459971611|FG000|Overall Study|Withdrawal by Subject|0|||
127823133|NCT00815308|459971611|FG000|Overall Study|Protocol Violation|6|||
127823134|NCT00638846|459971615|FG000|Overall Study|Adverse Event|0|||
127823135|NCT00638846|459971616|FG001|Overall Study|Adverse Event|1|||
127823136|NCT00638846|459971615|FG000|Overall Study|Lost to Follow-up|3|||
127823137|NCT00638846|459971616|FG001|Overall Study|Lost to Follow-up|2|||
127823138|NCT00638846|459971615|FG000|Overall Study|lens issue|1|||
127823139|NCT00638846|459971616|FG001|Overall Study|lens issue|3|||
127823140|NCT01171521|459971620|FG000|Overall Study|Lost to Follow-up|5|||
127823141|NCT01171521|459971620|FG000|Overall Study|screen failure|1|||
127823142|NCT00734929|459971625|FG000|Overall Study|Lost to Follow-up|1|||
127823143|NCT00734929|459971626|FG001|Overall Study|Lost to Follow-up|2|||
127823144|NCT00734929|459971625|FG000|Overall Study|No intervention/ screen fail|5|||
127823145|NCT00734929|459971626|FG001|Overall Study|No intervention/ screen fail|3|||
127823146|NCT01422304|459971627|FG000|Overall Study|Adverse Event|0|||
127823147|NCT01422304|459971628|FG001|Overall Study|Adverse Event|1|||
127823148|NCT01422304|459971627|FG000|Overall Study|Lost to Follow-up|14|||
127823149|NCT01422304|459971628|FG001|Overall Study|Lost to Follow-up|20|||
127823150|NCT01422304|459971627|FG000|Overall Study|Never Entered Follow-up|2|||
127823151|NCT01422304|459971628|FG001|Overall Study|Never Entered Follow-up|1|||
127823152|NCT01422304|459971627|FG000|Overall Study|Protocol Violation|1|||
127823153|NCT01422304|459971628|FG001|Overall Study|Protocol Violation|0|||
127823154|NCT01422304|459971627|FG000|Overall Study|Withdrawal by Subject|4|||
127894739|NCT02521948|460237247|FG000|Overall Study|Adverse Event|2|||
127823155|NCT01422304|459971628|FG001|Overall Study|Withdrawal by Subject|2|||
127823156|NCT01422304|459971627|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
127823157|NCT01422304|459971628|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
127823158|NCT01422304|459971627|FG000|Overall Study|Not Treated|3|||
127823159|NCT01422304|459971628|FG001|Overall Study|Not Treated|11|||
127823160|NCT02190435|459971629|FG000|Overall Study|First 12 patients were lead-ins|12|||
127823161|NCT02190435|459971630|FG001|Overall Study|First 12 patients were lead-ins|0|||
127823162|NCT02190435|459971629|FG000|Overall Study|3 consented screen fails|3|||
127823163|NCT02190435|459971630|FG001|Overall Study|3 consented screen fails|0|||
127823164|NCT02269319|459971631|FG000|Overall Study|Lost to Follow-up|4|||
127823165|NCT02269319|459971632|FG001|Overall Study|Lost to Follow-up|3|||
127823166|NCT02269319|459971631|FG000|Overall Study|Adverse Event|0|||
127823167|NCT02269319|459971632|FG001|Overall Study|Adverse Event|1|||
127823168|NCT02269319|459971631|FG000|Overall Study|Instructions not followed|1|||
127823169|NCT02269319|459971632|FG001|Overall Study|Instructions not followed|0|||
127823170|NCT01589094|459971633|FG000|Overall Study|Did not receive treatment|2|||
127823171|NCT03575468|459971634|FG000|Overall Study|Withdrawal by Subject|3|||
127823172|NCT03575468|459971635|FG001|Overall Study|Withdrawal by Subject|0|||
127823173|NCT03575468|459971634|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
127823174|NCT03575468|459971635|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
127823175|NCT03575468|459971634|FG000|Overall Study|Lost to Follow-up|13|||
127823176|NCT03575468|459971635|FG001|Overall Study|Lost to Follow-up|17|||
127823177|NCT05270694|459972985|FG000|Overall Study|Death|1|||
127823178|NCT05270694|459972985|FG000|Overall Study|Medical issues impacted ability to participate|2|||
127823179|NCT05270694|459972985|FG000|Overall Study|Lost to Follow-up|3|||
127823180|NCT05270694|459972985|FG000|Overall Study|Withdrawal by Subject|3|||
127823181|NCT01991977|459972986|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
127823182|NCT01991977|459972986|FG000|Overall Study|Withdrew after start of treatment|5|||
127823183|NCT02531035|459972993|FG000|Overall Study|Death|0|||
127823184|NCT02531035|459972994|FG001|Overall Study|Death|1|||
127823185|NCT02531035|459972993|FG000|Overall Study|Protocol Violation|1|||
127823186|NCT02531035|459972994|FG001|Overall Study|Protocol Violation|1|||
127823187|NCT02531035|459972993|FG000|Overall Study|Noncompliance with study drug|8|||
127823188|NCT02531035|459972994|FG001|Overall Study|Noncompliance with study drug|3|||
127823189|NCT02531035|459972993|FG000|Overall Study|Physician Decision|1|||
127823190|NCT02531035|459972994|FG001|Overall Study|Physician Decision|0|||
127823191|NCT02531035|459972993|FG000|Overall Study|Adverse Event|16|||
127823192|NCT02531035|459972994|FG001|Overall Study|Adverse Event|45|||
127823193|NCT02531035|459972993|FG000|Overall Study|Other|3|||
127823194|NCT02531035|459972994|FG001|Overall Study|Other|2|||
127823195|NCT02531035|459972993|FG000|Overall Study|Withdrawal by Subject|42|||
127823196|NCT02531035|459972994|FG001|Overall Study|Withdrawal by Subject|32|||
127823197|NCT02531035|459972993|FG000|Overall Study|Lost to Follow-up|8|||
127823198|NCT02531035|459972994|FG001|Overall Study|Lost to Follow-up|10|||
127823199|NCT02531035|459972993|FG000|Overall Study|Randomized, not treated|2|||
127823200|NCT02531035|459972994|FG001|Overall Study|Randomized, not treated|1|||
127823201|NCT03032068|459973004|FG000|Overall Study|Adverse Event|1|||
127823202|NCT01597622|459973005|FG000|Overall Study|Adverse Event|7|||
127823203|NCT01597622|459973005|FG000|Overall Study|Lack of Efficacy|3|||
127823204|NCT01597622|459973005|FG000|Overall Study|Protocol Violation|1|||
127823205|NCT01597622|459973005|FG000|Overall Study|Lost to Follow-up|1|||
127823206|NCT01597622|459973005|FG000|Overall Study|Investigator Discretion|5|||
127823207|NCT01597622|459973005|FG000|Overall Study|Withdrawal by Subject|20|||
127823208|NCT01597622|459973005|FG000|Overall Study|Death|1|||
127823209|NCT03042611|459973010|FG000|Core Phase|Withdrawal by Subject|13|||
127823210|NCT03042611|459973011|FG001|Core Phase|Withdrawal by Subject|4|||
127823211|NCT03042611|459973012|FG002|Core Phase|Withdrawal by Subject|0|||
127823212|NCT03042611|459973013|FG003|Core Phase|Withdrawal by Subject|0|||
127823213|NCT03042611|459973010|FG000|Core Phase|Death|232|||
127823214|NCT03042611|459973011|FG001|Core Phase|Death|110|||
127823215|NCT03042611|459973012|FG002|Core Phase|Death|0|||
127823216|NCT03042611|459973013|FG003|Core Phase|Death|0|||
127823217|NCT03042611|459973010|FG000|Core Phase|Lost to Follow-up|4|||
127823218|NCT03042611|459973011|FG001|Core Phase|Lost to Follow-up|7|||
127823219|NCT03042611|459973012|FG002|Core Phase|Lost to Follow-up|0|||
127823220|NCT03042611|459973013|FG003|Core Phase|Lost to Follow-up|0|||
127823221|NCT03042611|459973010|FG000|Core Phase|Physician Decision|7|||
127823222|NCT03042611|459973011|FG001|Core Phase|Physician Decision|2|||
127823223|NCT03042611|459973012|FG002|Core Phase|Physician Decision|0|||
127894740|NCT02521948|460237247|FG000|Overall Study|Death|4|||
127823224|NCT03042611|459973013|FG003|Core Phase|Physician Decision|0|||
127823225|NCT03042611|459973010|FG000|Core Phase|Study Closed|0|||
127823226|NCT03042611|459973011|FG001|Core Phase|Study Closed|1|||
127823227|NCT03042611|459973012|FG002|Core Phase|Study Closed|0|||
127823228|NCT03042611|459973013|FG003|Core Phase|Study Closed|0|||
127894741|NCT02521948|460237247|FG000|Overall Study|Lost to Follow-up|1|||
127823229|NCT03042611|459973010|FG000|Extension Phase|Death|0|||
127823230|NCT03042611|459973011|FG001|Extension Phase|Death|0|||
127823231|NCT03042611|459973012|FG002|Extension Phase|Death|34|||
127823232|NCT03042611|459973013|FG003|Extension Phase|Death|16|||
127823233|NCT03042611|459973010|FG000|Extension Phase|Lost to Follow-up|0|||
127823234|NCT03042611|459973011|FG001|Extension Phase|Lost to Follow-up|0|||
127823235|NCT03042611|459973012|FG002|Extension Phase|Lost to Follow-up|1|||
127823236|NCT03042611|459973013|FG003|Extension Phase|Lost to Follow-up|1|||
127823237|NCT03042611|459973010|FG000|Extension Phase|Study Closed|0|||
127823238|NCT03042611|459973011|FG001|Extension Phase|Study Closed|0|||
127823239|NCT03042611|459973012|FG002|Extension Phase|Study Closed|17|||
127823240|NCT03042611|459973013|FG003|Extension Phase|Study Closed|11|||
127823241|NCT03567291|459973018|FG000|Period I|Adverse Event|14|||
127823242|NCT03567291|459973019|FG001|Period I|Adverse Event|0|||
127823243|NCT03567291|459973020|FG002|Period I|Adverse Event|0|||
127823244|NCT03567291|459973021|FG003|Period I|Adverse Event|0|||
127823245|NCT03567291|459973018|FG000|Period I|Protocol Violation|1|||
127823246|NCT03567291|459973019|FG001|Period I|Protocol Violation|0|||
127894742|NCT02521948|460237247|FG000|Overall Study|Did not attend one or both follow-ups|6|||
127894743|NCT02427607|460237248|FG000|Overall Study|Withdrawal by Subject|1|||
127894744|NCT00423800|460237249|FG000|Overall Study|Protocol Violation|0|||
127894745|NCT00423800|460237250|FG001|Overall Study|Protocol Violation|1|||
127894746|NCT04000009|460237251|FG000|Overall Study|Adverse Event|13|||
127894747|NCT04000009|460237251|FG000|Overall Study|Lack of Efficacy|7|||
127894748|NCT04000009|460237251|FG000|Overall Study|Lost to Follow-up|8|||
127894749|NCT04000009|460237251|FG000|Overall Study|Noncompliance with study drug|4|||
127894750|NCT04000009|460237251|FG000|Overall Study|Physician Decision|1|||
127894751|NCT04000009|460237251|FG000|Overall Study|Use of prohibited medication|3|||
127894752|NCT04000009|460237251|FG000|Overall Study|Pregnancy|1|||
127894753|NCT04000009|460237251|FG000|Overall Study|Withdrawal by Subject|22|||
127894754|NCT04000009|460237251|FG000|Overall Study|Study terminated by sponsor|98|||
127894755|NCT04000009|460237251|FG000|Overall Study|Not further specified|8|||
127894756|NCT00679783|460237253|FG000|Overall Study|Adverse Event|0|||
127894757|NCT00679783|460237254|FG001|Overall Study|Adverse Event|0|||
127894758|NCT00679783|460237255|FG002|Overall Study|Adverse Event|0|||
127894759|NCT00679783|460237256|FG003|Overall Study|Adverse Event|3|||
127894760|NCT00679783|460237257|FG004|Overall Study|Adverse Event|0|||
127894761|NCT00679783|460237258|FG005|Overall Study|Adverse Event|0|||
127894762|NCT00679783|460237259|FG006|Overall Study|Adverse Event|1|||
127894763|NCT00679783|460237253|FG000|Overall Study|Lack of Efficacy|0|||
127894764|NCT00679783|460237254|FG001|Overall Study|Lack of Efficacy|1|||
127894765|NCT00679783|460237255|FG002|Overall Study|Lack of Efficacy|0|||
127894766|NCT00679783|460237256|FG003|Overall Study|Lack of Efficacy|2|||
127894767|NCT00679783|460237257|FG004|Overall Study|Lack of Efficacy|0|||
127894768|NCT00679783|460237258|FG005|Overall Study|Lack of Efficacy|0|||
127894769|NCT00679783|460237259|FG006|Overall Study|Lack of Efficacy|0|||
127894770|NCT00679783|460237253|FG000|Overall Study|Withdrawal by Subject|0|||
127894771|NCT00679783|460237254|FG001|Overall Study|Withdrawal by Subject|0|||
127894772|NCT00679783|460237255|FG002|Overall Study|Withdrawal by Subject|1|||
127894773|NCT00679783|460237256|FG003|Overall Study|Withdrawal by Subject|1|||
127894774|NCT00679783|460237257|FG004|Overall Study|Withdrawal by Subject|0|||
127894775|NCT00679783|460237258|FG005|Overall Study|Withdrawal by Subject|0|||
127894776|NCT00679783|460237259|FG006|Overall Study|Withdrawal by Subject|0|||
127894777|NCT00679783|460237253|FG000|Overall Study|Not Captured|0|||
127894778|NCT00679783|460237254|FG001|Overall Study|Not Captured|0|||
127894779|NCT00679783|460237255|FG002|Overall Study|Not Captured|0|||
127894780|NCT00679783|460237256|FG003|Overall Study|Not Captured|5|||
127894781|NCT00679783|460237257|FG004|Overall Study|Not Captured|0|||
127894782|NCT00679783|460237258|FG005|Overall Study|Not Captured|0|||
127894783|NCT00679783|460237259|FG006|Overall Study|Not Captured|0|||
127894784|NCT00679783|460237253|FG000|Overall Study|Ongoing at data cut-off|2|||
127823247|NCT03567291|459973020|FG002|Period I|Protocol Violation|0|||
127823248|NCT03567291|459973021|FG003|Period I|Protocol Violation|0|||
127823249|NCT03567291|459973018|FG000|Period I|Withdrawal by Subject|23|||
127823250|NCT03567291|459973019|FG001|Period I|Withdrawal by Subject|0|||
127823251|NCT03567291|459973020|FG002|Period I|Withdrawal by Subject|0|||
127823252|NCT03567291|459973021|FG003|Period I|Withdrawal by Subject|0|||
127823253|NCT03567291|459973018|FG000|Period I|Lost to Follow-up|2|||
127823254|NCT03567291|459973019|FG001|Period I|Lost to Follow-up|0|||
127823255|NCT03567291|459973020|FG002|Period I|Lost to Follow-up|0|||
127823256|NCT03567291|459973021|FG003|Period I|Lost to Follow-up|0|||
127894785|NCT00679783|460237254|FG001|Overall Study|Ongoing at data cut-off|2|||
127894786|NCT00679783|460237255|FG002|Overall Study|Ongoing at data cut-off|0|||
127894787|NCT00679783|460237256|FG003|Overall Study|Ongoing at data cut-off|9|||
127894788|NCT00679783|460237257|FG004|Overall Study|Ongoing at data cut-off|1|||
127894789|NCT00679783|460237258|FG005|Overall Study|Ongoing at data cut-off|0|||
127894790|NCT00679783|460237259|FG006|Overall Study|Ongoing at data cut-off|0|||
127894791|NCT01754259|460237262|FG000|Overall Study|Withdrawal by Subject|2|||
127894792|NCT01754259|460237263|FG001|Overall Study|Withdrawal by Subject|4|||
127894793|NCT01754259|460237262|FG000|Overall Study|Adverse Event|3|||
127894794|NCT01754259|460237263|FG001|Overall Study|Adverse Event|1|||
127894795|NCT01754259|460237262|FG000|Overall Study|Lost to Follow-up|0|||
127894796|NCT01754259|460237263|FG001|Overall Study|Lost to Follow-up|1|||
127894797|NCT00619385|460237266|FG000|Overall Study|Adverse Event|0|||
127894798|NCT00619385|460237267|FG001|Overall Study|Adverse Event|0|||
127894799|NCT00619385|460237268|FG002|Overall Study|Adverse Event|3|||
127894800|NCT00619385|460237266|FG000|Overall Study|Other|1|||
127894801|NCT00619385|460237267|FG001|Overall Study|Other|2|||
127894802|NCT00619385|460237268|FG002|Overall Study|Other|1|||
127894803|NCT02041702|460237271|FG000|Overall Study|Lost to Follow-up|1|||
127894804|NCT02041702|460237272|FG001|Overall Study|Lost to Follow-up|6|||
127894805|NCT02041702|460237271|FG000|Overall Study|Death|4|||
127894806|NCT02041702|460237272|FG001|Overall Study|Death|0|||
127894807|NCT02041702|460237271|FG000|Overall Study|Withdrawal by Subject|4|||
127894808|NCT02041702|460237272|FG001|Overall Study|Withdrawal by Subject|3|||
127894809|NCT02041702|460237271|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
127894810|NCT02041702|460237272|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
127894811|NCT02041702|460237271|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
127894812|NCT02041702|460237272|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
127894813|NCT00717756|460237274|FG000|Overall Study|Withdrawal by Subject|1|||
127894814|NCT00306384|460237275|FG000|Overall Study|Adverse Event|103|||
127894815|NCT00306384|460237276|FG001|Overall Study|Adverse Event|87|||
127894816|NCT00306384|460237277|FG002|Overall Study|Adverse Event|40|||
127894817|NCT00306384|460237275|FG000|Overall Study|Major protocol deviation|43|||
127894818|NCT00306384|460237276|FG001|Overall Study|Major protocol deviation|51|||
127894819|NCT00306384|460237277|FG002|Overall Study|Major protocol deviation|18|||
127894820|NCT00306384|460237275|FG000|Overall Study|Lost to Follow-up|57|||
127894821|NCT00306384|460237276|FG001|Overall Study|Lost to Follow-up|41|||
127894822|NCT00306384|460237277|FG002|Overall Study|Lost to Follow-up|35|||
127894823|NCT00306384|460237275|FG000|Overall Study|Voluntary withdrawal|199|||
127894824|NCT00306384|460237276|FG001|Overall Study|Voluntary withdrawal|187|||
127894825|NCT00306384|460237277|FG002|Overall Study|Voluntary withdrawal|91|||
127894826|NCT00306384|460237275|FG000|Overall Study|Study termination|1|||
127894827|NCT00306384|460237276|FG001|Overall Study|Study termination|0|||
127894828|NCT00306384|460237277|FG002|Overall Study|Study termination|1|||
127894829|NCT00306384|460237275|FG000|Overall Study|Pregnancy|3|||
127894830|NCT00306384|460237276|FG001|Overall Study|Pregnancy|1|||
127894831|NCT00306384|460237277|FG002|Overall Study|Pregnancy|1|||
127894832|NCT00306384|460237275|FG000|Overall Study|Lack of Efficacy|26|||
127894833|NCT00306384|460237276|FG001|Overall Study|Lack of Efficacy|40|||
127894834|NCT00306384|460237277|FG002|Overall Study|Lack of Efficacy|38|||
127823257|NCT03567291|459973018|FG000|Period I|Terminated by sponsor|44|||
127823258|NCT03567291|459973019|FG001|Period I|Terminated by sponsor|0|||
127823259|NCT03567291|459973020|FG002|Period I|Terminated by sponsor|0|||
127823260|NCT03567291|459973021|FG003|Period I|Terminated by sponsor|0|||
127823261|NCT03567291|459973018|FG000|Period I|Missing or unknown|7|||
127823262|NCT03567291|459973019|FG001|Period I|Missing or unknown|0|||
127823263|NCT03567291|459973020|FG002|Period I|Missing or unknown|0|||
127823264|NCT03567291|459973021|FG003|Period I|Missing or unknown|0|||
127823265|NCT03567291|459973018|FG000|Period II|Adverse Event|0|||
127823266|NCT03567291|459973019|FG001|Period II|Adverse Event|1|||
127823267|NCT03567291|459973020|FG002|Period II|Adverse Event|0|||
127823268|NCT03567291|459973021|FG003|Period II|Adverse Event|0|||
127823269|NCT03567291|459973018|FG000|Period II|Missing or unknown|0|||
127823270|NCT03567291|459973019|FG001|Period II|Missing or unknown|2|||
127823271|NCT03567291|459973020|FG002|Period II|Missing or unknown|1|||
127823272|NCT03567291|459973021|FG003|Period II|Missing or unknown|0|||
127823273|NCT03567291|459973018|FG000|Period III|Adverse Event|0|||
127823274|NCT03567291|459973019|FG001|Period III|Adverse Event|0|||
127823275|NCT03567291|459973020|FG002|Period III|Adverse Event|0|||
127823276|NCT03567291|459973021|FG003|Period III|Adverse Event|4|||
127823277|NCT03567291|459973018|FG000|Period III|Withdrawal by Subject|0|||
127823278|NCT03567291|459973019|FG001|Period III|Withdrawal by Subject|0|||
127823279|NCT03567291|459973020|FG002|Period III|Withdrawal by Subject|0|||
127823280|NCT03567291|459973021|FG003|Period III|Withdrawal by Subject|4|||
127823281|NCT03567291|459973018|FG000|Period III|Lost to Follow-up|0|||
127823282|NCT03567291|459973019|FG001|Period III|Lost to Follow-up|0|||
127823283|NCT03567291|459973020|FG002|Period III|Lost to Follow-up|0|||
127823284|NCT03567291|459973021|FG003|Period III|Lost to Follow-up|1|||
127823285|NCT03567291|459973018|FG000|Period III|Terminated by sponsor|0|||
127823286|NCT03567291|459973019|FG001|Period III|Terminated by sponsor|0|||
127823287|NCT03567291|459973020|FG002|Period III|Terminated by sponsor|0|||
127823288|NCT03567291|459973021|FG003|Period III|Terminated by sponsor|68|||
127894835|NCT00306384|460237275|FG000|Overall Study|Investigator discretion|28|||
127894836|NCT00306384|460237276|FG001|Overall Study|Investigator discretion|31|||
127894837|NCT00306384|460237277|FG002|Overall Study|Investigator discretion|21|||
127894838|NCT00306384|460237275|FG000|Overall Study|Other|80|||
127823289|NCT03567291|459973018|FG000|Period III|Missing or unknown|0|||
127823290|NCT03567291|459973019|FG001|Period III|Missing or unknown|0|||
127894839|NCT00306384|460237276|FG001|Overall Study|Other|70|||
127894840|NCT00306384|460237277|FG002|Overall Study|Other|32|||
127823291|NCT03567291|459973020|FG002|Period III|Missing or unknown|0|||
127823292|NCT03567291|459973021|FG003|Period III|Missing or unknown|8|||
127823293|NCT01103349|459973022|FG000|Overall Study|Adverse Event|8|||
127823294|NCT01103349|459973023|FG001|Overall Study|Adverse Event|5|||
127823295|NCT01103349|459973024|FG002|Overall Study|Adverse Event|3|||
127823296|NCT01103349|459973022|FG000|Overall Study|Consent withdrawn|1|||
127823297|NCT01103349|459973023|FG001|Overall Study|Consent withdrawn|0|||
127823298|NCT01103349|459973024|FG002|Overall Study|Consent withdrawn|0|||
127823299|NCT01103349|459973022|FG000|Overall Study|Incorrectly included in the trial|1|||
127823300|NCT01103349|459973023|FG001|Overall Study|Incorrectly included in the trial|0|||
127823301|NCT01103349|459973024|FG002|Overall Study|Incorrectly included in the trial|0|||
127823302|NCT01103349|459973022|FG000|Overall Study|Withdrawal by Subject|1|||
127823303|NCT01103349|459973023|FG001|Overall Study|Withdrawal by Subject|1|||
127823304|NCT01103349|459973024|FG002|Overall Study|Withdrawal by Subject|0|||
127823305|NCT01103349|459973022|FG000|Overall Study|did not want to take trial medication|0|||
127823306|NCT01103349|459973023|FG001|Overall Study|did not want to take trial medication|1|||
127823307|NCT01103349|459973024|FG002|Overall Study|did not want to take trial medication|0|||
127823308|NCT01103349|459973022|FG000|Overall Study|forgot to take medication|0|||
127823309|NCT01103349|459973023|FG001|Overall Study|forgot to take medication|0|||
127823310|NCT01103349|459973024|FG002|Overall Study|forgot to take medication|1|||
127823311|NCT00090285|459973025|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
127823312|NCT00090285|459973026|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
127823313|NCT00090285|459973027|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
127823314|NCT00090285|459973028|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
127823315|NCT00090285|459973029|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
127823316|NCT00090285|459973030|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
127823317|NCT00090285|459973025|FG000|Base Study Vaccination Period|Adverse Event|2|||
127823318|NCT00090285|459973026|FG001|Base Study Vaccination Period|Adverse Event|4|||
127823319|NCT00090285|459973027|FG002|Base Study Vaccination Period|Adverse Event|0|||
127823320|NCT00090285|459973028|FG003|Base Study Vaccination Period|Adverse Event|0|||
127823321|NCT00090285|459973029|FG004|Base Study Vaccination Period|Adverse Event|0|||
127823322|NCT00090285|459973030|FG005|Base Study Vaccination Period|Adverse Event|0|||
127823323|NCT00090285|459973025|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
127823324|NCT00090285|459973026|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
127823325|NCT00090285|459973027|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
127823326|NCT00090285|459973028|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
127823327|NCT00090285|459973029|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
127894841|NCT00306384|460237275|FG000|Overall Study|Site closure|2|||
127894842|NCT00306384|460237276|FG001|Overall Study|Site closure|0|||
127894843|NCT00306384|460237277|FG002|Overall Study|Site closure|0|||
127894844|NCT01379781|460238511|FG000|Overall Study|Lost to Follow-up|11|||
127894845|NCT01379781|460238512|FG001|Overall Study|Lost to Follow-up|8|||
127894846|NCT03329027|460238515|FG000|Overall Study|Lost to Follow-up|1|||
127894847|NCT03329027|460238516|FG001|Overall Study|Lost to Follow-up|0|||
127894848|NCT03329027|460238517|FG002|Overall Study|Lost to Follow-up|1|||
127894849|NCT03329027|460238515|FG000|Overall Study|Protocol Violation|9|||
127894850|NCT03329027|460238516|FG001|Overall Study|Protocol Violation|5|||
127894851|NCT03329027|460238517|FG002|Overall Study|Protocol Violation|7|||
127894852|NCT02742090|460238529|FG000|Overall Study|Adverse Event|10|||
127894853|NCT02742090|460238529|FG000|Overall Study|Death|3|||
127894854|NCT02742090|460238529|FG000|Overall Study|Disease Progression|25|||
127894855|NCT02742090|460238529|FG000|Overall Study|Investigator's Decision|1|||
127894856|NCT02742090|460238529|FG000|Overall Study|Lost to Follow-up|1|||
127894857|NCT02742090|460238529|FG000|Overall Study|Non-compliance with Study|1|||
127894858|NCT02742090|460238529|FG000|Overall Study|Sponsor Discontinuation of the Study|5|||
127823328|NCT00090285|459973030|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
127823329|NCT00090285|459973025|FG000|Base Study Vaccination Period|Protocol Violation|2|||
127823330|NCT00090285|459973026|FG001|Base Study Vaccination Period|Protocol Violation|3|||
127823331|NCT00090285|459973027|FG002|Base Study Vaccination Period|Protocol Violation|0|||
127823332|NCT00090285|459973028|FG003|Base Study Vaccination Period|Protocol Violation|0|||
127823333|NCT00090285|459973029|FG004|Base Study Vaccination Period|Protocol Violation|0|||
127823334|NCT00090285|459973030|FG005|Base Study Vaccination Period|Protocol Violation|0|||
127823335|NCT00090285|459973025|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
127823336|NCT00090285|459973026|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
127823337|NCT00090285|459973027|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
127823338|NCT00090285|459973028|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
127823339|NCT00090285|459973029|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
127823340|NCT00090285|459973030|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
127823341|NCT00090285|459973025|FG000|Base Study Vaccination Period|Uncooperative|2|||
127823342|NCT00090285|459973026|FG001|Base Study Vaccination Period|Uncooperative|2|||
127894859|NCT02742090|460238529|FG000|Overall Study|Withdrawal by Subject|4|||
127894860|NCT02742090|460238529|FG000|Overall Study|Reason Not Specified|1|||
127894861|NCT00836927|460238530|FG000|Overall Study|Progressive disease|2|||
127823343|NCT00090285|459973027|FG002|Base Study Vaccination Period|Uncooperative|0|||
127823344|NCT00090285|459973028|FG003|Base Study Vaccination Period|Uncooperative|0|||
127823345|NCT00090285|459973029|FG004|Base Study Vaccination Period|Uncooperative|0|||
127823346|NCT00090285|459973030|FG005|Base Study Vaccination Period|Uncooperative|0|||
127823347|NCT00090285|459973025|FG000|Base Study Vaccination Period|Moved|20|||
127823348|NCT00090285|459973026|FG001|Base Study Vaccination Period|Moved|21|||
127823349|NCT00090285|459973027|FG002|Base Study Vaccination Period|Moved|0|||
127823350|NCT00090285|459973028|FG003|Base Study Vaccination Period|Moved|0|||
127823351|NCT00090285|459973029|FG004|Base Study Vaccination Period|Moved|0|||
127823352|NCT00090285|459973030|FG005|Base Study Vaccination Period|Moved|0|||
127823353|NCT00090285|459973025|FG000|Base Study Vaccination Period|Site Terminated|1|||
127823354|NCT00090285|459973026|FG001|Base Study Vaccination Period|Site Terminated|0|||
127823355|NCT00090285|459973027|FG002|Base Study Vaccination Period|Site Terminated|0|||
127823356|NCT00090285|459973028|FG003|Base Study Vaccination Period|Site Terminated|0|||
127823357|NCT00090285|459973029|FG004|Base Study Vaccination Period|Site Terminated|0|||
127823358|NCT00090285|459973030|FG005|Base Study Vaccination Period|Site Terminated|0|||
127823359|NCT00090285|459973025|FG000|Base Study Vaccination Period|Other|2|||
127823360|NCT00090285|459973026|FG001|Base Study Vaccination Period|Other|2|||
127823361|NCT00090285|459973027|FG002|Base Study Vaccination Period|Other|0|||
127823362|NCT00090285|459973028|FG003|Base Study Vaccination Period|Other|0|||
127823363|NCT00090285|459973029|FG004|Base Study Vaccination Period|Other|0|||
127823364|NCT00090285|459973030|FG005|Base Study Vaccination Period|Other|0|||
127823365|NCT00090285|459973025|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
127823366|NCT00090285|459973026|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
127823367|NCT00090285|459973027|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
127823368|NCT00090285|459973028|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
127823369|NCT00090285|459973029|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
127823370|NCT00090285|459973030|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
127823371|NCT00090285|459973025|FG000|Base Study Vaccination Period|HIV positive|1|||
127823372|NCT00090285|459973026|FG001|Base Study Vaccination Period|HIV positive|1|||
127823373|NCT00090285|459973027|FG002|Base Study Vaccination Period|HIV positive|0|||
127823374|NCT00090285|459973028|FG003|Base Study Vaccination Period|HIV positive|0|||
127823375|NCT00090285|459973029|FG004|Base Study Vaccination Period|HIV positive|0|||
127823376|NCT00090285|459973030|FG005|Base Study Vaccination Period|HIV positive|0|||
127823377|NCT00090285|459973025|FG000|Base Study Follow-up Period|Adverse Event|3|||
127823378|NCT00090285|459973026|FG001|Base Study Follow-up Period|Adverse Event|10|||
127823379|NCT00090285|459973027|FG002|Base Study Follow-up Period|Adverse Event|0|||
127823380|NCT00090285|459973028|FG003|Base Study Follow-up Period|Adverse Event|0|||
127823381|NCT00090285|459973029|FG004|Base Study Follow-up Period|Adverse Event|0|||
127823382|NCT00090285|459973030|FG005|Base Study Follow-up Period|Adverse Event|0|||
127823383|NCT00090285|459973025|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
127823384|NCT00090285|459973026|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
127823385|NCT00090285|459973027|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
127823386|NCT00090285|459973028|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
127823387|NCT00090285|459973029|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
127823388|NCT00090285|459973030|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
127823389|NCT00090285|459973025|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
127823390|NCT00090285|459973026|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
127823391|NCT00090285|459973027|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
127823392|NCT00090285|459973028|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
127823393|NCT00090285|459973029|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
127823394|NCT00090285|459973030|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
127823395|NCT00090285|459973025|FG000|Base Study Follow-up Period|Moved|41|||
127823396|NCT00090285|459973026|FG001|Base Study Follow-up Period|Moved|36|||
127823397|NCT00090285|459973027|FG002|Base Study Follow-up Period|Moved|0|||
127823398|NCT00090285|459973028|FG003|Base Study Follow-up Period|Moved|0|||
127823399|NCT00090285|459973029|FG004|Base Study Follow-up Period|Moved|0|||
127823400|NCT00090285|459973030|FG005|Base Study Follow-up Period|Moved|0|||
127823401|NCT00090285|459973025|FG000|Base Study Follow-up Period|Other|2|||
127823402|NCT00090285|459973026|FG001|Base Study Follow-up Period|Other|0|||
127823403|NCT00090285|459973027|FG002|Base Study Follow-up Period|Other|0|||
127823404|NCT00090285|459973028|FG003|Base Study Follow-up Period|Other|0|||
127823405|NCT00090285|459973029|FG004|Base Study Follow-up Period|Other|0|||
127823406|NCT00090285|459973030|FG005|Base Study Follow-up Period|Other|0|||
127823407|NCT00090285|459973025|FG000|Base Study Follow-up Period|Protocol Violation|1|||
127823408|NCT00090285|459973026|FG001|Base Study Follow-up Period|Protocol Violation|0|||
127823409|NCT00090285|459973027|FG002|Base Study Follow-up Period|Protocol Violation|0|||
127823410|NCT00090285|459973028|FG003|Base Study Follow-up Period|Protocol Violation|0|||
127823411|NCT00090285|459973029|FG004|Base Study Follow-up Period|Protocol Violation|0|||
127823412|NCT00090285|459973030|FG005|Base Study Follow-up Period|Protocol Violation|0|||
127823413|NCT00090285|459973025|FG000|Base Study Follow-up Period|Uncooperative|3|||
127823414|NCT00090285|459973026|FG001|Base Study Follow-up Period|Uncooperative|4|||
127823415|NCT00090285|459973027|FG002|Base Study Follow-up Period|Uncooperative|0|||
127823416|NCT00090285|459973028|FG003|Base Study Follow-up Period|Uncooperative|0|||
127823417|NCT00090285|459973029|FG004|Base Study Follow-up Period|Uncooperative|0|||
127823418|NCT00090285|459973030|FG005|Base Study Follow-up Period|Uncooperative|0|||
127823419|NCT00090285|459973025|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
127823420|NCT00090285|459973026|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
127823421|NCT00090285|459973027|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
127823422|NCT00090285|459973028|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
127823423|NCT00090285|459973029|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
127823424|NCT00090285|459973030|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
127823425|NCT00090285|459973025|FG000|Extension 1|Adverse Event|0|||
127823426|NCT00090285|459973026|FG001|Extension 1|Adverse Event|0|||
127823427|NCT00090285|459973027|FG002|Extension 1|Adverse Event|2|||
127823428|NCT00090285|459973028|FG003|Extension 1|Adverse Event|0|||
127823429|NCT00090285|459973029|FG004|Extension 1|Adverse Event|0|||
127823430|NCT00090285|459973030|FG005|Extension 1|Adverse Event|0|||
127823431|NCT00090285|459973025|FG000|Extension 1|Lost to Follow-up|0|||
127823432|NCT00090285|459973026|FG001|Extension 1|Lost to Follow-up|0|||
127823433|NCT00090285|459973027|FG002|Extension 1|Lost to Follow-up|35|||
127823434|NCT00090285|459973028|FG003|Extension 1|Lost to Follow-up|0|||
127823435|NCT00090285|459973029|FG004|Extension 1|Lost to Follow-up|0|||
127823436|NCT00090285|459973030|FG005|Extension 1|Lost to Follow-up|0|||
127823437|NCT00090285|459973025|FG000|Extension 1|Withdrawal by Subject|0|||
127823438|NCT00090285|459973026|FG001|Extension 1|Withdrawal by Subject|0|||
127823439|NCT00090285|459973027|FG002|Extension 1|Withdrawal by Subject|13|||
127823440|NCT00090285|459973028|FG003|Extension 1|Withdrawal by Subject|1|||
127823441|NCT00090285|459973029|FG004|Extension 1|Withdrawal by Subject|0|||
127823442|NCT00090285|459973030|FG005|Extension 1|Withdrawal by Subject|0|||
127823443|NCT00090285|459973025|FG000|Extension 1|Other|0|||
127823444|NCT00090285|459973026|FG001|Extension 1|Other|0|||
127823445|NCT00090285|459973027|FG002|Extension 1|Other|4|||
127823446|NCT00090285|459973028|FG003|Extension 1|Other|0|||
127823447|NCT00090285|459973029|FG004|Extension 1|Other|0|||
127823448|NCT00090285|459973030|FG005|Extension 1|Other|0|||
127823449|NCT00090285|459973025|FG000|Extension 1|Moved|0|||
127823450|NCT00090285|459973026|FG001|Extension 1|Moved|0|||
127823451|NCT00090285|459973027|FG002|Extension 1|Moved|3|||
127823452|NCT00090285|459973028|FG003|Extension 1|Moved|0|||
127823453|NCT00090285|459973029|FG004|Extension 1|Moved|0|||
127823454|NCT00090285|459973030|FG005|Extension 1|Moved|0|||
127823455|NCT00090285|459973025|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
127823456|NCT00090285|459973026|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
127823457|NCT00090285|459973027|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
127823458|NCT00090285|459973028|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
127823459|NCT00090285|459973029|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
127823460|NCT00090285|459973030|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
127823461|NCT00090285|459973025|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
127823462|NCT00090285|459973026|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
127823463|NCT00090285|459973027|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
127823464|NCT00090285|459973028|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
127823465|NCT00090285|459973029|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
127823466|NCT00090285|459973030|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
127823467|NCT00090285|459973025|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
127823468|NCT00090285|459973026|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
127823469|NCT00090285|459973027|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
127823470|NCT00090285|459973028|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
127823471|NCT00090285|459973029|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
127823472|NCT00090285|459973030|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
127823473|NCT00090285|459973025|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
127823474|NCT00090285|459973026|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
127823475|NCT00090285|459973027|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
127823476|NCT00090285|459973028|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
127823477|NCT00090285|459973029|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
127823478|NCT00090285|459973030|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
127823479|NCT00907478|459973031|FG000|Overall Study|Ineligibility determined|0|||
127823480|NCT00907478|459973032|FG001|Overall Study|Ineligibility determined|0|||
127823481|NCT00907478|459973033|FG002|Overall Study|Ineligibility determined|1|||
127823482|NCT00907478|459973031|FG000|Overall Study|Noncompliance|0|||
127823483|NCT00907478|459973032|FG001|Overall Study|Noncompliance|0|||
127823484|NCT00907478|459973033|FG002|Overall Study|Noncompliance|1|||
127823485|NCT00907478|459973031|FG000|Overall Study|Adverse Event|3|||
127823486|NCT00907478|459973032|FG001|Overall Study|Adverse Event|1|||
127823487|NCT00907478|459973033|FG002|Overall Study|Adverse Event|2|||
127823488|NCT00907478|459973031|FG000|Overall Study|Withdrawal by Subject|8|||
127823489|NCT00907478|459973032|FG001|Overall Study|Withdrawal by Subject|9|||
127823490|NCT00907478|459973033|FG002|Overall Study|Withdrawal by Subject|6|||
127823491|NCT00907478|459973031|FG000|Overall Study|Requirement for alternative therapy|1|||
127823492|NCT00907478|459973032|FG001|Overall Study|Requirement for alternative therapy|2|||
127823493|NCT00907478|459973033|FG002|Overall Study|Requirement for alternative therapy|3|||
127823494|NCT00907478|459973031|FG000|Overall Study|Physician Decision|2|||
127823495|NCT00907478|459973032|FG001|Overall Study|Physician Decision|0|||
127823496|NCT00907478|459973033|FG002|Overall Study|Physician Decision|3|||
127823497|NCT00907478|459973031|FG000|Overall Study|Death|4|||
127823498|NCT00907478|459973032|FG001|Overall Study|Death|2|||
127823499|NCT00907478|459973033|FG002|Overall Study|Death|1|||
127823500|NCT00907478|459973031|FG000|Overall Study|Protocol-specified criteria|5|||
127823501|NCT00907478|459973032|FG001|Overall Study|Protocol-specified criteria|2|||
127823502|NCT00907478|459973033|FG002|Overall Study|Protocol-specified criteria|3|||
127823503|NCT00907478|459973031|FG000|Overall Study|Pregnancy|0|||
127823504|NCT00907478|459973032|FG001|Overall Study|Pregnancy|1|||
127823505|NCT00907478|459973033|FG002|Overall Study|Pregnancy|1|||
127823506|NCT00907478|459973031|FG000|Overall Study|Lost to Follow-up|1|||
127823507|NCT00907478|459973032|FG001|Overall Study|Lost to Follow-up|0|||
127823508|NCT00907478|459973033|FG002|Overall Study|Lost to Follow-up|0|||
127823509|NCT00907478|459973031|FG000|Overall Study|Other|3|||
127823510|NCT00907478|459973032|FG001|Overall Study|Other|0|||
127823511|NCT00907478|459973033|FG002|Overall Study|Other|1|||
127823512|NCT02639182|459973034|FG000|Overall Study|Disease Progression|50|||
127823513|NCT02639182|459973035|FG001|Overall Study|Disease Progression|49|||
127823514|NCT02639182|459973034|FG000|Overall Study|Adverse Event|7|||
127823515|NCT02639182|459973035|FG001|Overall Study|Adverse Event|5|||
127823516|NCT02639182|459973034|FG000|Overall Study|Physician Decision|3|||
127823517|NCT02639182|459973035|FG001|Overall Study|Physician Decision|3|||
127823518|NCT02639182|459973034|FG000|Overall Study|Withdrew Consent|5|||
127823519|NCT02639182|459973035|FG001|Overall Study|Withdrew Consent|4|||
127823520|NCT02639182|459973034|FG000|Overall Study|Lost to Follow-up|0|||
127823521|NCT02639182|459973035|FG001|Overall Study|Lost to Follow-up|1|||
127823522|NCT02639182|459973034|FG000|Overall Study|Study Closure|1|||
127823523|NCT02639182|459973035|FG001|Overall Study|Study Closure|2|||
127823524|NCT02639182|459973034|FG000|Overall Study|Sponsor Ended Study|0|||
127823525|NCT02639182|459973035|FG001|Overall Study|Sponsor Ended Study|1|||
127823526|NCT02639182|459973034|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
127823527|NCT02639182|459973035|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
127823528|NCT03069690|459973036|FG000|Pregnancy Intervention|Pregnancy loss|9|||
127823529|NCT03069690|459973037|FG001|Pregnancy Intervention|Pregnancy loss|4|||
127823530|NCT03069690|459973038|FG002|Pregnancy Intervention|Pregnancy loss|0|||
127823531|NCT03069690|459973039|FG003|Pregnancy Intervention|Pregnancy loss|0|||
127823532|NCT03069690|459973040|FG004|Pregnancy Intervention|Pregnancy loss|0|||
127823533|NCT03069690|459973041|FG005|Pregnancy Intervention|Pregnancy loss|0|||
127823534|NCT03069690|459973036|FG000|Pregnancy Intervention|Lost to Follow-up|16|||
127823535|NCT03069690|459973037|FG001|Pregnancy Intervention|Lost to Follow-up|14|||
127823536|NCT03069690|459973038|FG002|Pregnancy Intervention|Lost to Follow-up|0|||
127823537|NCT03069690|459973039|FG003|Pregnancy Intervention|Lost to Follow-up|0|||
127823538|NCT03069690|459973040|FG004|Pregnancy Intervention|Lost to Follow-up|0|||
127823539|NCT03069690|459973041|FG005|Pregnancy Intervention|Lost to Follow-up|0|||
127823540|NCT03069690|459973036|FG000|Postpartum Intervention|Lost to Follow-up|0|||
127823541|NCT03069690|459973037|FG001|Postpartum Intervention|Lost to Follow-up|0|||
127823542|NCT03069690|459973038|FG002|Postpartum Intervention|Lost to Follow-up|5|||
127823543|NCT03069690|459973039|FG003|Postpartum Intervention|Lost to Follow-up|5|||
127823544|NCT03069690|459973040|FG004|Postpartum Intervention|Lost to Follow-up|2|||
127823545|NCT03069690|459973041|FG005|Postpartum Intervention|Lost to Follow-up|4|||
127823546|NCT01372878|459973042|FG000|Overall Study|Withdrawal by Subject|63|||
127823547|NCT01372878|459973042|FG000|Overall Study|Protocol Violation|17|||
127823548|NCT01372878|459973042|FG000|Overall Study|incomplete study procedure|104|||
127823549|NCT02385123|459973043|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
127823550|NCT01070303|459973044|FG000|Overall Study|Adverse Event|39|||
127823551|NCT01070303|459973044|FG000|Overall Study|Withdrawal by Subject|20|||
127823552|NCT01070303|459973044|FG000|Overall Study|Lost to Follow-up|9|||
127823553|NCT01070303|459973044|FG000|Overall Study|Protocol Violation|0|||
127823554|NCT01070303|459973044|FG000|Overall Study|Lack of Efficacy|2|||
127823555|NCT01070303|459973044|FG000|Overall Study|Administrative Reason|1|||
127823556|NCT01070303|459973044|FG000|Overall Study|Other|18|||
127823557|NCT02345434|459973045|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
127823558|NCT02345434|459973046|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
127823559|NCT04504032|459973050|FG000|Overall Study|Adverse Event|1|||
127823560|NCT04504032|459973051|FG001|Overall Study|Adverse Event|2|||
127823561|NCT04504032|459973050|FG000|Overall Study|Lost to Follow-up|6|||
127823562|NCT04504032|459973051|FG001|Overall Study|Lost to Follow-up|9|||
127823563|NCT04504032|459973050|FG000|Overall Study|Protocol Violation|2|||
127823564|NCT04504032|459973051|FG001|Overall Study|Protocol Violation|0|||
127823565|NCT04504032|459973050|FG000|Overall Study|Study terminated by sponsor|1|||
127823566|NCT04504032|459973051|FG001|Overall Study|Study terminated by sponsor|2|||
127823567|NCT04504032|459973050|FG000|Overall Study|Withdrawal by Subject|9|||
127823568|NCT04504032|459973051|FG001|Overall Study|Withdrawal by Subject|11|||
127823569|NCT04504032|459973050|FG000|Overall Study|Disease progression prior to dosing|15|||
127823570|NCT04504032|459973051|FG001|Overall Study|Disease progression prior to dosing|3|||
127823571|NCT04504032|459973050|FG000|Overall Study|Drug supply issues|1|||
127823572|NCT04504032|459973051|FG001|Overall Study|Drug supply issues|1|||
127823573|NCT04504032|459973050|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
127823574|NCT04504032|459973051|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
127823575|NCT01839188|459973052|FG000|Overall Study|Withdrawal by Subject|1|||
127823576|NCT00394914|459973070|FG000|Treatment Period|Adverse Event|0|||
127823577|NCT00394914|459973071|FG001|Treatment Period|Adverse Event|3|||
127823578|NCT00394914|459973072|FG002|Treatment Period|Adverse Event|1|||
127823579|NCT00394914|459973070|FG000|Treatment Period|Lost to Follow-up|0|||
127823580|NCT00394914|459973071|FG001|Treatment Period|Lost to Follow-up|1|||
127823581|NCT00394914|459973072|FG002|Treatment Period|Lost to Follow-up|0|||
127823582|NCT00394914|459973070|FG000|Treatment Period|Withdrawal by Subject|0|||
127823583|NCT00394914|459973071|FG001|Treatment Period|Withdrawal by Subject|2|||
127823584|NCT00394914|459973072|FG002|Treatment Period|Withdrawal by Subject|2|||
127823585|NCT00394914|459973070|FG000|Treatment Period|Noncompliance with protocol|0|||
127823586|NCT00394914|459973071|FG001|Treatment Period|Noncompliance with protocol|3|||
127823587|NCT00394914|459973072|FG002|Treatment Period|Noncompliance with protocol|2|||
127823588|NCT00394914|459973070|FG000|Treatment Period|Did not meet protocol eligibility|0|||
127823589|NCT00394914|459973071|FG001|Treatment Period|Did not meet protocol eligibility|1|||
127823590|NCT00394914|459973072|FG002|Treatment Period|Did not meet protocol eligibility|1|||
127823591|NCT00312377|459973078|FG000|Overall Study|Death|403|||
127823592|NCT00312377|459973079|FG001|Overall Study|Death|418|||
127823593|NCT00312377|459973078|FG000|Overall Study|Withdrawal by Subject|23|||
127823594|NCT00312377|459973079|FG001|Overall Study|Withdrawal by Subject|30|||
127823595|NCT00312377|459973078|FG000|Overall Study|Lost to Follow-up|9|||
127823596|NCT00312377|459973079|FG001|Overall Study|Lost to Follow-up|12|||
127823597|NCT00312377|459973078|FG000|Overall Study|Non-compliance|0|||
127823598|NCT00312377|459973079|FG001|Overall Study|Non-compliance|2|||
127823599|NCT00312377|459973078|FG000|Overall Study|Randomised but never received treatment|6|||
127823600|NCT00312377|459973079|FG001|Overall Study|Randomised but never received treatment|6|||
127823601|NCT00312377|459973078|FG000|Overall Study|Discontinue treatment survival follow up|202|||
127823602|NCT00312377|459973079|FG001|Overall Study|Discontinue treatment survival follow up|200|||
127823603|NCT00312377|459973078|FG000|Overall Study|Site ended participation in study|1|||
127823604|NCT00312377|459973079|FG001|Overall Study|Site ended participation in study|0|||
127823605|NCT00872898|459973080|FG000|Part Two - Double Blind|Adverse Event|4|||
127823606|NCT00872898|459973081|FG001|Part Two - Double Blind|Adverse Event|3|||
127823607|NCT00872898|459973080|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
127823608|NCT00872898|459973081|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
127823609|NCT00872898|459973080|FG000|Part Two - Double Blind|Protocol Violation|1|||
127823610|NCT00872898|459973081|FG001|Part Two - Double Blind|Protocol Violation|0|||
127823611|NCT00872898|459973080|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
127823612|NCT00872898|459973081|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
127823613|NCT00872898|459973080|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
127823614|NCT00872898|459973081|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
127823615|NCT00872898|459973080|FG000|Part Two - Double Blind|Other reasons|2|||
127823616|NCT00872898|459973081|FG001|Part Two - Double Blind|Other reasons|0|||
127823617|NCT02707757|459973097|FG000|Overall Study|Protocol Violation|3|||
127823618|NCT02707757|459973098|FG001|Overall Study|Protocol Violation|2|||
127823619|NCT02707757|459973097|FG000|Overall Study|Withdrawal by Subject|2|||
127823620|NCT02707757|459973098|FG001|Overall Study|Withdrawal by Subject|0|||
127823621|NCT02707757|459973097|FG000|Overall Study|Death|0|||
127823622|NCT02707757|459973098|FG001|Overall Study|Death|1|||
127823623|NCT02707757|459973097|FG000|Overall Study|Adverse Event|6|||
127823624|NCT02707757|459973098|FG001|Overall Study|Adverse Event|4|||
127823625|NCT02707757|459973097|FG000|Overall Study|Renal transplant/elective operation|1|||
127823626|NCT02707757|459973098|FG001|Overall Study|Renal transplant/elective operation|5|||
127823627|NCT00652093|459973099|FG000|Overall Study|Withdrawal by Subject|0|||
127823628|NCT00652093|459973100|FG001|Overall Study|Withdrawal by Subject|0|||
127823629|NCT00652093|459973101|FG002|Overall Study|Withdrawal by Subject|1|||
127823630|NCT00652093|459973102|FG003|Overall Study|Withdrawal by Subject|0|||
127823631|NCT00652093|459973103|FG004|Overall Study|Withdrawal by Subject|1|||
127823632|NCT00652093|459973104|FG005|Overall Study|Withdrawal by Subject|0|||
127823633|NCT00652093|459973099|FG000|Overall Study|Physician Decision|0|||
127823634|NCT00652093|459973100|FG001|Overall Study|Physician Decision|0|||
127823635|NCT00652093|459973101|FG002|Overall Study|Physician Decision|0|||
127823636|NCT00652093|459973102|FG003|Overall Study|Physician Decision|0|||
127823637|NCT00652093|459973103|FG004|Overall Study|Physician Decision|1|||
127823638|NCT00652093|459973104|FG005|Overall Study|Physician Decision|0|||
127823639|NCT03176966|459973108|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
127823640|NCT03176966|459973109|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
127823641|NCT03176966|459973108|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
127823642|NCT03176966|459973109|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
127823643|NCT03176966|459973108|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
127823644|NCT03176966|459973109|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
127823645|NCT03176966|459973108|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
127823646|NCT03176966|459973109|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
127823647|NCT03176966|459973108|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
127823648|NCT03176966|459973109|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
127823649|NCT03176966|459973108|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
127823650|NCT03176966|459973109|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
127823651|NCT03176966|459973108|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
127823652|NCT03176966|459973109|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
127823653|NCT02955186|459973110|FG000|Overall Study|Withdrawal by Subject|6|||
127823654|NCT02955186|459973111|FG001|Overall Study|Withdrawal by Subject|2|||
127823655|NCT02955186|459973110|FG000|Overall Study|Protocol Violation|1|||
127823656|NCT02955186|459973111|FG001|Overall Study|Protocol Violation|0|||
127823657|NCT01696877|459973114|FG000|Overall Study|Adverse Event|0|||
127823658|NCT01696877|459973115|FG001|Overall Study|Adverse Event|1|||
127823659|NCT02961764|459973116|FG000|Overall Study|Protocol Violation|0|||
127823660|NCT02961764|459973117|FG001|Overall Study|Protocol Violation|1|||
127823661|NCT02961764|459973116|FG000|Overall Study|Death|2|||
127823662|NCT02961764|459973117|FG001|Overall Study|Death|0|||
127823663|NCT02961764|459973116|FG000|Overall Study|Lost to Follow-up|35|||
127823664|NCT02961764|459973117|FG001|Overall Study|Lost to Follow-up|24|||
127823665|NCT02961764|459973116|FG000|Overall Study|Withdrawal by Subject|2|||
127823666|NCT02961764|459973117|FG001|Overall Study|Withdrawal by Subject|0|||
127823667|NCT00469014|459973118|FG000|Initial Phase Randomization|Disease Progression|0|||
127823668|NCT00469014|459973119|FG001|Initial Phase Randomization|Disease Progression|1|||
127823669|NCT00469014|459973120|FG002|Initial Phase Randomization|Disease Progression|1|||
127823670|NCT00469014|459973121|FG003|Initial Phase Randomization|Disease Progression|0|||
127823671|NCT00469014|459973118|FG000|Initial Phase Randomization|No Response|1|||
127823672|NCT00469014|459973119|FG001|Initial Phase Randomization|No Response|0|||
127823673|NCT00469014|459973120|FG002|Initial Phase Randomization|No Response|0|||
127823674|NCT00469014|459973121|FG003|Initial Phase Randomization|No Response|1|||
127823675|NCT00469014|459973118|FG000|Adaptive Randomization|Not Evaluable|1|||
127823676|NCT00469014|459973119|FG001|Adaptive Randomization|Not Evaluable|0|||
127823677|NCT00469014|459973120|FG002|Adaptive Randomization|Not Evaluable|0|||
127823678|NCT00469014|459973121|FG003|Adaptive Randomization|Not Evaluable|1|||
127823679|NCT00469014|459973118|FG000|Adaptive Randomization|No Response|0|||
127823680|NCT00469014|459973119|FG001|Adaptive Randomization|No Response|1|||
127823681|NCT00469014|459973120|FG002|Adaptive Randomization|No Response|0|||
127823682|NCT00469014|459973121|FG003|Adaptive Randomization|No Response|0|||
127823683|NCT00469014|459973118|FG000|Adaptive Randomization|Death|0|||
127823684|NCT00469014|459973119|FG001|Adaptive Randomization|Death|0|||
127823685|NCT00469014|459973120|FG002|Adaptive Randomization|Death|1|||
127823686|NCT00469014|459973121|FG003|Adaptive Randomization|Death|0|||
127823687|NCT00866294|459973122|FG000|Overall Study|Adverse Event|12|||
127823688|NCT00866294|459973123|FG001|Overall Study|Adverse Event|13|||
127823689|NCT00866294|459973124|FG002|Overall Study|Adverse Event|9|||
127823690|NCT00866294|459973122|FG000|Overall Study|Lack of Efficacy|7|||
127823691|NCT00866294|459973123|FG001|Overall Study|Lack of Efficacy|1|||
127823692|NCT00866294|459973124|FG002|Overall Study|Lack of Efficacy|0|||
127823693|NCT00866294|459973122|FG000|Overall Study|Protocol Violation|2|||
127823694|NCT00866294|459973123|FG001|Overall Study|Protocol Violation|0|||
127823695|NCT00866294|459973124|FG002|Overall Study|Protocol Violation|0|||
127823696|NCT00866294|459973122|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
127823697|NCT00866294|459973123|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
127823698|NCT00866294|459973124|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
127823699|NCT00866294|459973122|FG000|Overall Study|Lost to Follow-up|1|||
127823700|NCT00866294|459973123|FG001|Overall Study|Lost to Follow-up|3|||
127823701|NCT00866294|459973124|FG002|Overall Study|Lost to Follow-up|0|||
127823702|NCT00866294|459973122|FG000|Overall Study|Physician Decision|6|||
127823703|NCT00866294|459973123|FG001|Overall Study|Physician Decision|2|||
127823704|NCT00866294|459973124|FG002|Overall Study|Physician Decision|1|||
127823705|NCT01632878|459973125|FG000|Screening|Physician Decision|268|||
127823706|NCT01632878|459973125|FG000|Treatment|Lost to Follow-up|41|||
127823707|NCT01632878|459973125|FG000|Treatment|Withdrawal by Subject|36|||
127823708|NCT01632878|459973125|FG000|Treatment|Physician Decision|34|||
127823709|NCT01632878|459973125|FG000|Treatment|missing information|4|||
127823710|NCT01632878|459973125|FG000|Treatment|no information on study completion|43|||
127823711|NCT01558089|459973126|FG000|Overall Study|Adverse Event|1|||
127823712|NCT01558089|459973126|FG000|Overall Study|Lack of Efficacy|1|||
127823713|NCT01558089|459973126|FG000|Overall Study|Lost to Follow-up|5|||
127823714|NCT01558089|459973126|FG000|Overall Study|Withdrawal by Subject|6|||
127823715|NCT00916721|459973127|FG000|Overall Study|Lost to Follow-up|0|||
127823716|NCT00916721|459973128|FG001|Overall Study|Lost to Follow-up|1|||
127823717|NCT00916721|459973127|FG000|Overall Study|Adverse Event|6|||
127823718|NCT00916721|459973128|FG001|Overall Study|Adverse Event|3|||
127823719|NCT00916721|459973127|FG000|Overall Study|Withdrawal by Subject|2|||
127823720|NCT00916721|459973128|FG001|Overall Study|Withdrawal by Subject|2|||
127823721|NCT00916721|459973127|FG000|Overall Study|Protocol Violation|2|||
127823722|NCT00916721|459973128|FG001|Overall Study|Protocol Violation|4|||
127823723|NCT01903434|459973132|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
127823724|NCT01903434|459973133|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
127823725|NCT01903434|459973132|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
127823726|NCT01903434|459973133|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
127823727|NCT01469052|459973136|FG000|Overall Study|Adverse Event|2|||
127823728|NCT01469052|459973137|FG001|Overall Study|Adverse Event|3|||
127823729|NCT01469052|459973138|FG002|Overall Study|Adverse Event|0|||
127823730|NCT01469052|459973139|FG003|Overall Study|Adverse Event|2|||
127823731|NCT01469052|459973140|FG004|Overall Study|Adverse Event|0|||
127823732|NCT01469052|459973141|FG005|Overall Study|Adverse Event|1|||
127823733|NCT01469052|459973136|FG000|Overall Study|Progressive disease|3|||
127823734|NCT01469052|459973137|FG001|Overall Study|Progressive disease|0|||
127823735|NCT01469052|459973138|FG002|Overall Study|Progressive disease|5|||
127823736|NCT01469052|459973139|FG003|Overall Study|Progressive disease|3|||
127823737|NCT01469052|459973140|FG004|Overall Study|Progressive disease|7|||
127823738|NCT01469052|459973141|FG005|Overall Study|Progressive disease|2|||
127823739|NCT01469052|459973136|FG000|Overall Study|Lack of Efficacy|0|||
127823740|NCT01469052|459973137|FG001|Overall Study|Lack of Efficacy|0|||
127823741|NCT01469052|459973138|FG002|Overall Study|Lack of Efficacy|0|||
127823742|NCT01469052|459973139|FG003|Overall Study|Lack of Efficacy|0|||
127823743|NCT01469052|459973140|FG004|Overall Study|Lack of Efficacy|0|||
127823744|NCT01469052|459973141|FG005|Overall Study|Lack of Efficacy|2|||
127823745|NCT01469052|459973136|FG000|Overall Study|Moved to rollover protocol|1|||
127823746|NCT01469052|459973137|FG001|Overall Study|Moved to rollover protocol|0|||
127823747|NCT01469052|459973138|FG002|Overall Study|Moved to rollover protocol|1|||
127823748|NCT01469052|459973139|FG003|Overall Study|Moved to rollover protocol|0|||
127823749|NCT01469052|459973140|FG004|Overall Study|Moved to rollover protocol|0|||
127823750|NCT01469052|459973141|FG005|Overall Study|Moved to rollover protocol|1|||
127823751|NCT01469052|459973136|FG000|Overall Study|Other|0|||
127823752|NCT01469052|459973137|FG001|Overall Study|Other|1|||
127823753|NCT01469052|459973138|FG002|Overall Study|Other|0|||
127823754|NCT01469052|459973139|FG003|Overall Study|Other|0|||
127823755|NCT01469052|459973140|FG004|Overall Study|Other|1|||
127823756|NCT01469052|459973141|FG005|Overall Study|Other|0|||
127823757|NCT01519427|459973146|FG000|Overall Study|disease progression|2|||
127823758|NCT03894904|459973147|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
127823759|NCT03894904|459973148|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
127823760|NCT03894904|459973147|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
127823761|NCT03894904|459973148|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
127823762|NCT01781026|459973149|FG000|Overall Study|Lack of Efficacy|2|||
127823763|NCT01118143|459973150|FG000|Overall Study|Withdrawal by Subject|2|||
127823764|NCT01118143|459973151|FG001|Overall Study|Withdrawal by Subject|5|||
127823765|NCT02112448|459973152|FG000|Overall Study|lab values precluding use of ketorolac|2|||
127823766|NCT02112448|459973153|FG001|Overall Study|lab values precluding use of ketorolac|2|||
127823767|NCT02112448|459973152|FG000|Overall Study|Protocol Violation|1|||
127823768|NCT02112448|459973153|FG001|Overall Study|Protocol Violation|2|||
127823769|NCT02112448|459973152|FG000|Overall Study|Physician Decision|4|||
127823770|NCT02112448|459973153|FG001|Overall Study|Physician Decision|6|||
127823771|NCT02112448|459973152|FG000|Overall Study|required heparin so could not use ketoro|1|||
127823772|NCT02112448|459973153|FG001|Overall Study|required heparin so could not use ketoro|0|||
127823773|NCT05094154|459974600|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
127823774|NCT05094154|459974601|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
127823775|NCT05094154|459974600|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
127823776|NCT05094154|459974601|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
127823777|NCT01240811|459974604|FG000|Overall Study|Physician Decision|0|||
127823778|NCT01240811|459974605|FG001|Overall Study|Physician Decision|1|||
127823779|NCT01240811|459974606|FG002|Overall Study|Physician Decision|0|||
127823780|NCT01240811|459974604|FG000|Overall Study|Withdrawal by Subject|0|||
127823781|NCT01240811|459974605|FG001|Overall Study|Withdrawal by Subject|0|||
127823782|NCT01240811|459974606|FG002|Overall Study|Withdrawal by Subject|1|||
127823783|NCT01543490|459974610|FG000|Overall Study|Adverse Event|4|||
127823784|NCT01543490|459974611|FG001|Overall Study|Adverse Event|0|||
127823785|NCT01543490|459974610|FG000|Overall Study|Physician Decision|1|||
127823786|NCT01543490|459974611|FG001|Overall Study|Physician Decision|0|||
127823787|NCT01543490|459974610|FG000|Overall Study|Lack of Efficacy|3|||
127823788|NCT01543490|459974611|FG001|Overall Study|Lack of Efficacy|3|||
127823789|NCT01543490|459974610|FG000|Overall Study|Lost to Follow-up|5|||
127823790|NCT01543490|459974611|FG001|Overall Study|Lost to Follow-up|0|||
127823791|NCT01543490|459974610|FG000|Overall Study|Withdrawal by Subject|2|||
127823792|NCT01543490|459974611|FG001|Overall Study|Withdrawal by Subject|0|||
127823793|NCT01543490|459974610|FG000|Overall Study|Other-Various Administrative Reasons|1|||
127823794|NCT01543490|459974611|FG001|Overall Study|Other-Various Administrative Reasons|2|||
127823795|NCT04168645|459974613|FG000|Overall Study|Lost to Follow-up|23|||
127823796|NCT04168645|459974614|FG001|Overall Study|Lost to Follow-up|28|||
127823797|NCT04168645|459974615|FG002|Overall Study|Lost to Follow-up|15|||
127823798|NCT04168645|459974616|FG003|Overall Study|Lost to Follow-up|12|||
127823799|NCT04168645|459974613|FG000|Overall Study|Death|1|||
127823800|NCT04168645|459974614|FG001|Overall Study|Death|1|||
127823801|NCT04168645|459974615|FG002|Overall Study|Death|0|||
127823802|NCT04168645|459974616|FG003|Overall Study|Death|0|||
127823803|NCT04168645|459974613|FG000|Overall Study|Withdrawal by Subject|5|||
127823804|NCT04168645|459974614|FG001|Overall Study|Withdrawal by Subject|2|||
127823805|NCT04168645|459974615|FG002|Overall Study|Withdrawal by Subject|2|||
127823806|NCT04168645|459974616|FG003|Overall Study|Withdrawal by Subject|2|||
127823807|NCT04168645|459974613|FG000|Overall Study|Administrative Withdrawal|3|||
127823808|NCT04168645|459974614|FG001|Overall Study|Administrative Withdrawal|1|||
127823809|NCT04168645|459974615|FG002|Overall Study|Administrative Withdrawal|1|||
127823810|NCT04168645|459974616|FG003|Overall Study|Administrative Withdrawal|3|||
127823811|NCT03132805|459974619|FG000|Overall Study|Lost to Follow-up|142|||
127823812|NCT03132805|459974620|FG001|Overall Study|Lost to Follow-up|141|||
127823813|NCT03132805|459974621|FG002|Overall Study|Lost to Follow-up|113|||
127823814|NCT03918642|459974622|FG000|Overall Study|Lost to Follow-up|12|||
127823815|NCT03918642|459974623|FG001|Overall Study|Lost to Follow-up|10|||
127823816|NCT03825042|459974624|FG000|Overall Study|Adverse Event|1|||
127823817|NCT03825042|459974625|FG001|Overall Study|Adverse Event|0|||
127823818|NCT03825042|459974624|FG000|Overall Study|Withdrawal by Subject|1|||
127823819|NCT03825042|459974625|FG001|Overall Study|Withdrawal by Subject|0|||
127823820|NCT00500149|459974632|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
127823821|NCT00500149|459974633|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
127823822|NCT00500149|459974632|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
127823823|NCT00500149|459974633|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
127823824|NCT00500149|459974632|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
127823825|NCT00500149|459974633|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
127823826|NCT00500149|459974632|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
127823827|NCT00500149|459974633|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
127823828|NCT00500149|459974632|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
127823829|NCT00500149|459974633|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
127823830|NCT00500149|459974632|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
127823831|NCT00500149|459974633|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
127823832|NCT00500149|459974632|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
127823833|NCT00500149|459974633|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
127823834|NCT01158534|459974634|FG000|Overall Study|Withdrawal by Subject|1|||
127823835|NCT01158534|459974634|FG000|Overall Study|Death|1|||
127823836|NCT01158534|459974634|FG000|Overall Study|Other|1|||
127823837|NCT01988012|459974635|FG000|Overall Study|Adverse Event|5|||
127823838|NCT01988012|459974635|FG000|Overall Study|Insufficient Therapeutic Response|3|||
127823839|NCT01988012|459974635|FG000|Overall Study|Patient Withdrawal of Consent|4|||
127823840|NCT01988012|459974635|FG000|Overall Study|Lost to Follow-up|1|||
127823841|NCT01988012|459974635|FG000|Overall Study|Physician Decision|1|||
127823842|NCT01988012|459974635|FG000|Overall Study|Protocol Violation|1|||
127823843|NCT00521339|459974636|FG000|Treatment Phase|Adverse Event|2|||
127823844|NCT00521339|459974637|FG001|Treatment Phase|Adverse Event|0|||
127823845|NCT00521339|459974638|FG002|Treatment Phase|Adverse Event|0|||
127823846|NCT00521339|459974636|FG000|Treatment Phase|Intolerability to study drug|2|||
127823847|NCT00521339|459974637|FG001|Treatment Phase|Intolerability to study drug|0|||
127823848|NCT00521339|459974638|FG002|Treatment Phase|Intolerability to study drug|0|||
127823849|NCT00521339|459974636|FG000|Treatment Phase|Lack of Efficacy|3|||
127823850|NCT00521339|459974637|FG001|Treatment Phase|Lack of Efficacy|0|||
127823851|NCT00521339|459974638|FG002|Treatment Phase|Lack of Efficacy|0|||
127823852|NCT00521339|459974636|FG000|Treatment Phase|Withdrawal by Subject|3|||
127823853|NCT00521339|459974637|FG001|Treatment Phase|Withdrawal by Subject|0|||
127823854|NCT00521339|459974638|FG002|Treatment Phase|Withdrawal by Subject|0|||
127823855|NCT00521339|459974636|FG000|Treatment Phase|Lost to Follow-up|1|||
127823856|NCT00521339|459974637|FG001|Treatment Phase|Lost to Follow-up|0|||
127823857|NCT00521339|459974638|FG002|Treatment Phase|Lost to Follow-up|0|||
127823858|NCT00521339|459974636|FG000|Treatment Phase|Protocol Violation|1|||
127823859|NCT00521339|459974637|FG001|Treatment Phase|Protocol Violation|0|||
127823860|NCT00521339|459974638|FG002|Treatment Phase|Protocol Violation|0|||
127823861|NCT00521339|459974636|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
127823862|NCT00521339|459974637|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
127823863|NCT00521339|459974638|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
127823864|NCT00521339|459974636|FG000|Treatment Extension Phase|Death|0|||
127823865|NCT00521339|459974637|FG001|Treatment Extension Phase|Death|0|||
127823866|NCT00521339|459974638|FG002|Treatment Extension Phase|Death|1|||
127823867|NCT00089843|459974639|FG000|Overall Study|Withdrawal by Subject|1|||
127823868|NCT00089843|459974640|FG001|Overall Study|Withdrawal by Subject|4|||
127823869|NCT00089843|459974641|FG002|Overall Study|Withdrawal by Subject|5|||
127823870|NCT00089843|459974642|FG003|Overall Study|Withdrawal by Subject|6|||
127823871|NCT00089843|459974639|FG000|Overall Study|Physician Decision|1|||
127823872|NCT00089843|459974640|FG001|Overall Study|Physician Decision|0|||
127823873|NCT00089843|459974641|FG002|Overall Study|Physician Decision|0|||
127823874|NCT00089843|459974642|FG003|Overall Study|Physician Decision|1|||
127823875|NCT02240628|459974643|FG000|Overall Study|Physician Decision|6|||
127823876|NCT02240628|459974644|FG001|Overall Study|Physician Decision|5|||
127823877|NCT00859898|459974648|FG000|Overall Study|Lack of Efficacy|0|||
127823878|NCT00859898|459974649|FG001|Overall Study|Lack of Efficacy|1|||
127823879|NCT00859898|459974650|FG002|Overall Study|Lack of Efficacy|1|||
127823880|NCT00859898|459974648|FG000|Overall Study|Adverse Event|4|||
127823881|NCT00859898|459974649|FG001|Overall Study|Adverse Event|9|||
127823882|NCT00859898|459974650|FG002|Overall Study|Adverse Event|8|||
127823883|NCT00859898|459974648|FG000|Overall Study|Withdrawal by Subject|11|||
127823884|NCT00859898|459974649|FG001|Overall Study|Withdrawal by Subject|8|||
127823885|NCT00859898|459974650|FG002|Overall Study|Withdrawal by Subject|11|||
127823886|NCT00859898|459974648|FG000|Overall Study|Death|0|||
127823887|NCT00859898|459974649|FG001|Overall Study|Death|0|||
127823888|NCT00859898|459974650|FG002|Overall Study|Death|1|||
127823889|NCT00859898|459974648|FG000|Overall Study|Lost to Follow-up|10|||
127823890|NCT00859898|459974649|FG001|Overall Study|Lost to Follow-up|11|||
127823891|NCT00859898|459974650|FG002|Overall Study|Lost to Follow-up|5|||
127823892|NCT00859898|459974648|FG000|Overall Study|poor/non-compliance|2|||
127823893|NCT00859898|459974649|FG001|Overall Study|poor/non-compliance|0|||
127823894|NCT00859898|459974650|FG002|Overall Study|poor/non-compliance|0|||
127823895|NCT00859898|459974648|FG000|Overall Study|No longer meets criteria|0|||
127823896|NCT00859898|459974649|FG001|Overall Study|No longer meets criteria|1|||
127823897|NCT00859898|459974650|FG002|Overall Study|No longer meets criteria|0|||
127823898|NCT00859898|459974648|FG000|Overall Study|non-specified|1|||
127823899|NCT00859898|459974649|FG001|Overall Study|non-specified|1|||
127823900|NCT00859898|459974650|FG002|Overall Study|non-specified|1|||
127823901|NCT01302041|459974651|FG000|Overall Study|Death|5|||
127823902|NCT01302041|459974651|FG000|Overall Study|Withdrawal by Subject|4|||
127823903|NCT01302041|459974651|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
127823904|NCT01302041|459974651|FG000|Overall Study|Other-Miscellaneous Reason|2|||
127823905|NCT00771030|459974652|FG000|Overall Study|Adverse Event|0|||
127823906|NCT00771030|459974653|FG001|Overall Study|Adverse Event|1|||
127823907|NCT00771030|459974654|FG002|Overall Study|Adverse Event|0|||
127823908|NCT00771030|459974655|FG003|Overall Study|Adverse Event|0|||
127823909|NCT00771030|459974656|FG004|Overall Study|Adverse Event|0|||
127823910|NCT00771030|459974657|FG005|Overall Study|Adverse Event|0|||
127823911|NCT00771030|459974658|FG006|Overall Study|Adverse Event|0|||
127823912|NCT02416908|459974659|FG000|Dose Escalation Phase|Adverse Event|0|||
127823913|NCT02416908|459974660|FG001|Dose Escalation Phase|Adverse Event|0|||
127823914|NCT02416908|459974661|FG002|Dose Escalation Phase|Adverse Event|3|||
127823915|NCT02416908|459974662|FG003|Dose Escalation Phase|Adverse Event|0|||
127823916|NCT02416908|459974659|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
127823917|NCT02416908|459974660|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
127823918|NCT02416908|459974661|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
127823919|NCT02416908|459974662|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
127823920|NCT00940342|459974663|FG000|Overall Study|Adverse Event|0|||
127823921|NCT00940342|459974664|FG001|Overall Study|Adverse Event|2|||
127823922|NCT00940342|459974665|FG002|Overall Study|Adverse Event|1|||
127823923|NCT01327339|459974666|FG000|Overall Study|Protocol Violation|8|||
127823924|NCT00700752|459974671|FG000|First Intervention|Withdrawal by Subject|0|||
127823925|NCT00700752|459974672|FG001|First Intervention|Withdrawal by Subject|2|||
127823926|NCT01097330|459974675|FG000|Overall Study|Study terminated early|7|||
127823927|NCT01097330|459974676|FG001|Overall Study|Study terminated early|5|||
127823928|NCT00510692|459974678|FG000|Overall Study|Adverse Event|1|||
127823929|NCT00510692|459974679|FG001|Overall Study|Adverse Event|3|||
127823930|NCT00510692|459974678|FG000|Overall Study|Withdrawal by Subject|1|||
127823931|NCT00510692|459974679|FG001|Overall Study|Withdrawal by Subject|0|||
127823932|NCT01845077|459974680|FG000|Washout Period|Lost to Follow-up|0|||
127823933|NCT01845077|459974681|FG001|Washout Period|Lost to Follow-up|1|||
127823934|NCT01845077|459974682|FG002|Washout Period|Lost to Follow-up|0|||
127823935|NCT01845077|459974683|FG003|Washout Period|Lost to Follow-up|1|||
127823936|NCT01845077|459974684|FG004|Washout Period|Lost to Follow-up|0|||
127823937|NCT01845077|459974685|FG005|Washout Period|Lost to Follow-up|1|||
127823938|NCT01845077|459974680|FG000|Washout Period|Adverse Event|1|||
127823939|NCT01845077|459974681|FG001|Washout Period|Adverse Event|0|||
127823940|NCT01845077|459974682|FG002|Washout Period|Adverse Event|0|||
127823941|NCT01845077|459974683|FG003|Washout Period|Adverse Event|0|||
127823942|NCT01845077|459974684|FG004|Washout Period|Adverse Event|0|||
127823943|NCT01845077|459974685|FG005|Washout Period|Adverse Event|0|||
127823944|NCT01845077|459974680|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
127823945|NCT01845077|459974681|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
127823946|NCT01845077|459974682|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
127823947|NCT01845077|459974683|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
127823948|NCT01845077|459974684|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
127823949|NCT01845077|459974685|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
127823950|NCT01845077|459974680|FG000|Washout Period|Protocol Violation|0|||
127823951|NCT01845077|459974681|FG001|Washout Period|Protocol Violation|0|||
127823952|NCT01845077|459974682|FG002|Washout Period|Protocol Violation|0|||
127823953|NCT01845077|459974683|FG003|Washout Period|Protocol Violation|1|||
127823954|NCT01845077|459974684|FG004|Washout Period|Protocol Violation|1|||
127823955|NCT01845077|459974685|FG005|Washout Period|Protocol Violation|0|||
127823956|NCT01797432|459974686|FG000|Overall Study|Lost to Follow-up|1|||
127823957|NCT01797432|459974686|FG000|Overall Study|Adverse Event|1|||
127823958|NCT01797432|459974686|FG000|Overall Study|Withdrawal by Subject|1|||
127823959|NCT01797432|459974686|FG000|Overall Study|lived too far from study site|1|||
127823960|NCT01137435|459974687|FG000|Overall Study|Lost to Follow-up|24|||
127823961|NCT01137435|459974687|FG000|Overall Study|Off label usage|4|||
127823962|NCT02746679|459974696|FG000|Overall Study|Lost to Follow-up|4|||
127823963|NCT02746679|459974697|FG001|Overall Study|Lost to Follow-up|6|||
127823964|NCT00487279|459974698|FG000|Overall Study|Death|1|||
127823965|NCT00487279|459974699|FG001|Overall Study|Death|0|||
127823966|NCT00487279|459974698|FG000|Overall Study|Withdrawal by Subject|0|||
127823967|NCT00487279|459974699|FG001|Overall Study|Withdrawal by Subject|2|||
127823968|NCT00501852|459974700|FG000|Overall Study|Adverse Event|3|||
127823969|NCT00501852|459974700|FG000|Overall Study|Withdrawal by Subject|2|||
127823970|NCT01416610|459974703|FG000|Overall Study|Adverse Event|4|||
127823971|NCT01416610|459974703|FG000|Overall Study|Adverse Event -Patient decision|3|||
127823972|NCT01416610|459974703|FG000|Overall Study|Lack of Efficacy|4|||
127823973|NCT01416610|459974703|FG000|Overall Study|No reason given|5|||
127823974|NCT01416610|459974703|FG000|Overall Study|Withdrawal by Subject|13|||
127823975|NCT01416610|459974703|FG000|Overall Study|Lost to Follow-up|7|||
127823976|NCT01416610|459974703|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
127823977|NCT01927562|459974705|FG000|Overall Study|Lost to Follow-up|30|||
127823978|NCT01927562|459974705|FG000|Overall Study|Withdrawal by Subject|3|||
127823979|NCT01927562|459974705|FG000|Overall Study|Physician Decision|5|||
127823980|NCT00642616|459974706|FG000|Overall Study|Adverse Event|2|||
127823981|NCT00642616|459974707|FG001|Overall Study|Adverse Event|0|||
127823982|NCT00642616|459974708|FG002|Overall Study|Adverse Event|1|||
127823983|NCT00642616|459974709|FG003|Overall Study|Adverse Event|0|||
127823984|NCT00642616|459974706|FG000|Overall Study|Study Terminated by Sponsor|7|||
127823985|NCT00642616|459974707|FG001|Overall Study|Study Terminated by Sponsor|6|||
127823986|NCT00642616|459974708|FG002|Overall Study|Study Terminated by Sponsor|4|||
127823987|NCT00642616|459974709|FG003|Overall Study|Study Terminated by Sponsor|5|||
127823988|NCT00642616|459974706|FG000|Overall Study|Withdrawal by Subject|0|||
127823989|NCT00642616|459974707|FG001|Overall Study|Withdrawal by Subject|1|||
127823990|NCT00642616|459974708|FG002|Overall Study|Withdrawal by Subject|1|||
127894862|NCT00836927|460238531|FG001|Overall Study|Progressive disease|0|||
127894863|NCT00836927|460238532|FG002|Overall Study|Progressive disease|0|||
127894864|NCT00836927|460238533|FG003|Overall Study|Progressive disease|1|||
127894865|NCT00836927|460238534|FG004|Overall Study|Progressive disease|1|||
127894866|NCT00836927|460238530|FG000|Overall Study|Withdrawal by Subject|1|||
127823991|NCT00642616|459974709|FG003|Overall Study|Withdrawal by Subject|1|||
127823992|NCT00642616|459974706|FG000|Overall Study|Protocol Violation|0|||
127823993|NCT00642616|459974707|FG001|Overall Study|Protocol Violation|0|||
127823994|NCT00642616|459974708|FG002|Overall Study|Protocol Violation|2|||
127823995|NCT00642616|459974709|FG003|Overall Study|Protocol Violation|0|||
127823996|NCT00642616|459974706|FG000|Overall Study|Physician Decision|0|||
127823997|NCT00642616|459974707|FG001|Overall Study|Physician Decision|0|||
127823998|NCT00642616|459974708|FG002|Overall Study|Physician Decision|1|||
127823999|NCT00642616|459974709|FG003|Overall Study|Physician Decision|1|||
127824000|NCT00399802|459974710|FG000|Overall Study|Adverse Event|0|||
127824001|NCT00399802|459974711|FG001|Overall Study|Adverse Event|2|||
127894867|NCT00836927|460238531|FG001|Overall Study|Withdrawal by Subject|0|||
127894868|NCT00836927|460238532|FG002|Overall Study|Withdrawal by Subject|0|||
127894869|NCT00836927|460238533|FG003|Overall Study|Withdrawal by Subject|0|||
127894870|NCT00836927|460238534|FG004|Overall Study|Withdrawal by Subject|0|||
127824002|NCT00399802|459974710|FG000|Overall Study|Participant discontinued by mistake|0|||
127824003|NCT00399802|459974711|FG001|Overall Study|Participant discontinued by mistake|1|||
127824004|NCT00492921|459974712|FG000|Overall Study|Death|1|||
127824005|NCT00492921|459974713|FG001|Overall Study|Death|0|||
127824006|NCT00492921|459974714|FG002|Overall Study|Death|1|||
127824007|NCT00542815|459974715|FG000|Overall Study|Adverse Event|19|||
127824008|NCT00542815|459974716|FG001|Overall Study|Adverse Event|6|||
127824009|NCT00542815|459974717|FG002|Overall Study|Adverse Event|9|||
127824010|NCT00542815|459974715|FG000|Overall Study|Death|10|||
127824011|NCT00542815|459974716|FG001|Overall Study|Death|7|||
127824012|NCT00542815|459974717|FG002|Overall Study|Death|3|||
127824013|NCT00542815|459974715|FG000|Overall Study|Lack of Efficacy|9|||
127824014|NCT00542815|459974716|FG001|Overall Study|Lack of Efficacy|2|||
127824015|NCT00542815|459974717|FG002|Overall Study|Lack of Efficacy|0|||
127824016|NCT00542815|459974715|FG000|Overall Study|Physician Decision|2|||
127824017|NCT00542815|459974716|FG001|Overall Study|Physician Decision|1|||
127824018|NCT00542815|459974717|FG002|Overall Study|Physician Decision|0|||
127824019|NCT00542815|459974715|FG000|Overall Study|Protocol Violation|1|||
127824020|NCT00542815|459974716|FG001|Overall Study|Protocol Violation|1|||
127824021|NCT00542815|459974717|FG002|Overall Study|Protocol Violation|2|||
127824022|NCT00542815|459974715|FG000|Overall Study|Withdrawal by Subject|41|||
127824023|NCT00542815|459974716|FG001|Overall Study|Withdrawal by Subject|5|||
127824024|NCT00542815|459974717|FG002|Overall Study|Withdrawal by Subject|8|||
127824025|NCT00542815|459974715|FG000|Overall Study|Other reasons|24|||
127824026|NCT00542815|459974716|FG001|Overall Study|Other reasons|10|||
127824027|NCT00542815|459974717|FG002|Overall Study|Other reasons|10|||
127824028|NCT00081289|459974718|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
127824029|NCT00081289|459974719|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
127824030|NCT00081289|459974718|FG000|Overall Study|Ineligible / no protocol treatment|3|||
127824031|NCT00081289|459974719|FG001|Overall Study|Ineligible / no protocol treatment|4|||
127824032|NCT02749370|459974720|FG000|Overall Study|Withdrawal by Subject|11|||
127824033|NCT02749370|459974720|FG000|Overall Study|Lost to Follow-up|3|||
127824034|NCT03242759|459974721|FG000|Overall Study|Adverse Event|5|||
127824035|NCT03242759|459974722|FG001|Overall Study|Adverse Event|1|||
127824036|NCT03242759|459974721|FG000|Overall Study|Withdrawal by Subject|4|||
127824037|NCT03242759|459974722|FG001|Overall Study|Withdrawal by Subject|3|||
127824038|NCT03242759|459974721|FG000|Overall Study|Lost to Follow-up|3|||
127824039|NCT03242759|459974722|FG001|Overall Study|Lost to Follow-up|1|||
127824040|NCT03242759|459974721|FG000|Overall Study|Administrative problems|1|||
127824041|NCT03242759|459974722|FG001|Overall Study|Administrative problems|1|||
127824042|NCT03242759|459974721|FG000|Overall Study|Death|22|||
127824043|NCT03242759|459974722|FG001|Overall Study|Death|0|||
127824044|NCT03242759|459974721|FG000|Overall Study|Change visit schedule|0|||
127824045|NCT03242759|459974722|FG001|Overall Study|Change visit schedule|1|||
127824046|NCT00336492|459974731|FG000|Overall Study|Adverse Event|4|||
127824047|NCT00336492|459974732|FG001|Overall Study|Adverse Event|3|||
127824048|NCT00336492|459974733|FG002|Overall Study|Adverse Event|6|||
127824049|NCT00336492|459974731|FG000|Overall Study|Lack of Efficacy|6|||
127824050|NCT00336492|459974732|FG001|Overall Study|Lack of Efficacy|1|||
127824051|NCT00336492|459974733|FG002|Overall Study|Lack of Efficacy|4|||
127824052|NCT00336492|459974731|FG000|Overall Study|Other|5|||
127824053|NCT00336492|459974732|FG001|Overall Study|Other|0|||
127824054|NCT00336492|459974733|FG002|Overall Study|Other|1|||
127824055|NCT00227877|459974734|FG000|Pre-visit Assessment|Technical difficulties|7|||
127824056|NCT00227877|459974735|FG001|Pre-visit Assessment|Technical difficulties|3|||
127824057|NCT00227877|459974736|FG002|Pre-visit Assessment|Technical difficulties|0|||
127824058|NCT00227877|459974737|FG003|Pre-visit Assessment|Technical difficulties|0|||
127824059|NCT00227877|459974734|FG000|Post-visit Checklist|Lost to Follow-up|24|||
127824060|NCT00227877|459974735|FG001|Post-visit Checklist|Lost to Follow-up|13|||
127824061|NCT00227877|459974736|FG002|Post-visit Checklist|Lost to Follow-up|1|||
127824062|NCT00227877|459974737|FG003|Post-visit Checklist|Lost to Follow-up|0|||
127824063|NCT00227877|459974734|FG000|3-months Follow-up|Completed late|135|||
127824064|NCT00227877|459974735|FG001|3-months Follow-up|Completed late|128|||
127824065|NCT00227877|459974736|FG002|3-months Follow-up|Completed late|34|||
127824066|NCT00227877|459974737|FG003|3-months Follow-up|Completed late|8|||
127824067|NCT00227877|459974734|FG000|3-months Follow-up|Lost to Follow-up|178|||
127824068|NCT00227877|459974735|FG001|3-months Follow-up|Lost to Follow-up|139|||
127824069|NCT00227877|459974736|FG002|3-months Follow-up|Lost to Follow-up|18|||
127824070|NCT00227877|459974737|FG003|3-months Follow-up|Lost to Follow-up|13|||
127824071|NCT00227877|459974734|FG000|12-months Follow-up|Completed late|78|||
127824072|NCT00227877|459974735|FG001|12-months Follow-up|Completed late|74|||
127824073|NCT00227877|459974736|FG002|12-months Follow-up|Completed late|1|||
127824074|NCT00227877|459974737|FG003|12-months Follow-up|Completed late|0|||
127824075|NCT00227877|459974734|FG000|12-months Follow-up|Lost to Follow-up|232|||
127824076|NCT00227877|459974735|FG001|12-months Follow-up|Lost to Follow-up|189|||
127824077|NCT00227877|459974736|FG002|12-months Follow-up|Lost to Follow-up|30|||
127824078|NCT00227877|459974737|FG003|12-months Follow-up|Lost to Follow-up|26|||
127824079|NCT02522481|459974740|FG000|Overall Study|discontinued|1|||
127824080|NCT02522481|459974740|FG000|Overall Study|Not dosed|2|||
127824081|NCT00404768|459974743|FG000|Part A and B|Withdrawn due to labor progression|1|||
127824082|NCT00404768|459974744|FG001|Part A and B|Withdrawn due to labor progression|0|||
127824083|NCT00404768|459974745|FG002|Part A and B|Withdrawn due to labor progression|0|||
127824084|NCT00404768|459974746|FG003|Part A and B|Withdrawn due to labor progression|0|||
127824085|NCT00404768|459974743|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
127824086|NCT00404768|459974744|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
127824087|NCT00404768|459974745|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
127824088|NCT00404768|459974746|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
127824089|NCT00404768|459974743|FG000|Part C|Adverse Event|0|||
127824090|NCT00404768|459974744|FG001|Part C|Adverse Event|0|||
127824091|NCT00404768|459974745|FG002|Part C|Adverse Event|0|||
127824092|NCT00404768|459974746|FG003|Part C|Adverse Event|3|||
127824093|NCT00404768|459974743|FG000|Part C|Lost to Follow-up|0|||
127824094|NCT00404768|459974744|FG001|Part C|Lost to Follow-up|0|||
127824095|NCT00404768|459974745|FG002|Part C|Lost to Follow-up|3|||
127824096|NCT00404768|459974746|FG003|Part C|Lost to Follow-up|1|||
127824097|NCT00404768|459974743|FG000|Part C|Withdrawal by Subject|0|||
127824098|NCT00404768|459974744|FG001|Part C|Withdrawal by Subject|0|||
127824099|NCT00404768|459974745|FG002|Part C|Withdrawal by Subject|2|||
127824100|NCT00404768|459974746|FG003|Part C|Withdrawal by Subject|1|||
127824101|NCT00404768|459974743|FG000|Part C|Early withdrawal from study medication|0|||
127824102|NCT00404768|459974744|FG001|Part C|Early withdrawal from study medication|0|||
127824103|NCT00404768|459974745|FG002|Part C|Early withdrawal from study medication|1|||
127824104|NCT00404768|459974746|FG003|Part C|Early withdrawal from study medication|0|||
127824105|NCT00404768|459974743|FG000|Part C|Participant did not respond to therapy|0|||
127824106|NCT00404768|459974744|FG001|Part C|Participant did not respond to therapy|0|||
127824107|NCT00404768|459974745|FG002|Part C|Participant did not respond to therapy|1|||
127824108|NCT00404768|459974746|FG003|Part C|Participant did not respond to therapy|1|||
127824109|NCT00404768|459974743|FG000|Part C|Physician withdrew the study medication|0|||
127824110|NCT00404768|459974744|FG001|Part C|Physician withdrew the study medication|0|||
127824111|NCT00404768|459974745|FG002|Part C|Physician withdrew the study medication|1|||
127824112|NCT00404768|459974746|FG003|Part C|Physician withdrew the study medication|0|||
127824113|NCT00404768|459974743|FG000|Part C|Participant delivered baby|0|||
127824114|NCT00404768|459974744|FG001|Part C|Participant delivered baby|0|||
127824115|NCT00404768|459974745|FG002|Part C|Participant delivered baby|0|||
127824116|NCT00404768|459974746|FG003|Part C|Participant delivered baby|1|||
127824117|NCT00404768|459974743|FG000|Part C|Unsatisfactory uterine response to IP|0|||
127824118|NCT00404768|459974744|FG001|Part C|Unsatisfactory uterine response to IP|0|||
127824119|NCT00404768|459974745|FG002|Part C|Unsatisfactory uterine response to IP|0|||
127824120|NCT00404768|459974746|FG003|Part C|Unsatisfactory uterine response to IP|1|||
127824121|NCT00404768|459974743|FG000|Part C|Active labor|0|||
127824122|NCT00404768|459974744|FG001|Part C|Active labor|0|||
127824123|NCT00404768|459974745|FG002|Part C|Active labor|0|||
127824124|NCT00404768|459974746|FG003|Part C|Active labor|1|||
127824125|NCT00404768|459974743|FG000|Part C|Lack of Efficacy|0|||
127824126|NCT00404768|459974744|FG001|Part C|Lack of Efficacy|0|||
127824127|NCT00404768|459974745|FG002|Part C|Lack of Efficacy|0|||
127824128|NCT00404768|459974746|FG003|Part C|Lack of Efficacy|2|||
127824129|NCT00404768|459974743|FG000|Part C|Treatment failure|0|||
127824130|NCT00404768|459974744|FG001|Part C|Treatment failure|0|||
127824131|NCT00404768|459974745|FG002|Part C|Treatment failure|0|||
127824132|NCT00404768|459974746|FG003|Part C|Treatment failure|1|||
127824133|NCT00404768|459974743|FG000|Part C|Investigator discretion|0|||
127824134|NCT00404768|459974744|FG001|Part C|Investigator discretion|0|||
127824135|NCT00404768|459974745|FG002|Part C|Investigator discretion|0|||
127824136|NCT00404768|459974746|FG003|Part C|Investigator discretion|1|||
127824137|NCT00404768|459974743|FG000|Part C|Researcher suspended study medication|0|||
127824138|NCT00404768|459974744|FG001|Part C|Researcher suspended study medication|0|||
127824139|NCT00404768|459974745|FG002|Part C|Researcher suspended study medication|0|||
127824140|NCT00404768|459974746|FG003|Part C|Researcher suspended study medication|1|||
127824141|NCT03123939|459974747|FG000|Overall Study|Lack of Efficacy|6|||
127824142|NCT03123939|459974747|FG000|Overall Study|Death|5|||
127824143|NCT03123939|459974747|FG000|Overall Study|Physician Decision|2|||
127824144|NCT03123939|459974747|FG000|Overall Study|Subject/guardian decision|2|||
127824145|NCT03123939|459974747|FG000|Overall Study|Lost to Follow-up|1|||
127824146|NCT03123939|459974747|FG000|Overall Study|New therapy for study indication|1|||
127824147|NCT03123939|459974747|FG000|Overall Study|Protocol deviation|1|||
127824148|NCT03123939|459974747|FG000|Overall Study|Progressive disease|18|||
127824149|NCT03123939|459974747|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
127824150|NCT03123939|459974747|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
127824151|NCT01937130|459976134|FG000|Overall Study|Withdrawal by Subject|0|||
127824152|NCT01937130|459976135|FG001|Overall Study|Withdrawal by Subject|0|||
127824153|NCT01937130|459976136|FG002|Overall Study|Withdrawal by Subject|0|||
127824154|NCT01937130|459976137|FG003|Overall Study|Withdrawal by Subject|1|||
127824155|NCT01937130|459976134|FG000|Overall Study|Adverse Event|0|||
127824156|NCT01937130|459976135|FG001|Overall Study|Adverse Event|1|||
127824157|NCT01937130|459976136|FG002|Overall Study|Adverse Event|0|||
127824158|NCT01937130|459976137|FG003|Overall Study|Adverse Event|1|||
127824159|NCT01937130|459976134|FG000|Overall Study|Death|1|||
127824160|NCT01937130|459976135|FG001|Overall Study|Death|1|||
127824161|NCT01937130|459976136|FG002|Overall Study|Death|1|||
127824162|NCT01937130|459976137|FG003|Overall Study|Death|0|||
127824163|NCT01937130|459976134|FG000|Overall Study|Lost to Follow-up|2|||
127824164|NCT01937130|459976135|FG001|Overall Study|Lost to Follow-up|0|||
127824165|NCT01937130|459976136|FG002|Overall Study|Lost to Follow-up|2|||
127824166|NCT01937130|459976137|FG003|Overall Study|Lost to Follow-up|0|||
127824167|NCT01937130|459976134|FG000|Overall Study|Physician Decision|0|||
127824168|NCT01937130|459976135|FG001|Overall Study|Physician Decision|1|||
127824169|NCT01937130|459976136|FG002|Overall Study|Physician Decision|0|||
127824170|NCT01937130|459976137|FG003|Overall Study|Physician Decision|0|||
127824171|NCT01937130|459976134|FG000|Overall Study|Patients unable to swallow|0|||
127824172|NCT01937130|459976135|FG001|Overall Study|Patients unable to swallow|1|||
127824173|NCT01937130|459976136|FG002|Overall Study|Patients unable to swallow|0|||
127824174|NCT01937130|459976137|FG003|Overall Study|Patients unable to swallow|0|||
127824175|NCT01937130|459976134|FG000|Overall Study|Patient lost to FU due to death|2|||
127824176|NCT01937130|459976135|FG001|Overall Study|Patient lost to FU due to death|0|||
127824177|NCT01937130|459976136|FG002|Overall Study|Patient lost to FU due to death|0|||
127824178|NCT01937130|459976137|FG003|Overall Study|Patient lost to FU due to death|0|||
127824179|NCT02115815|459976138|FG000|Overall Study|Withdrawal by Subject|2|||
127824180|NCT02115815|459976139|FG001|Overall Study|Withdrawal by Subject|0|||
127824181|NCT02115815|459976140|FG002|Overall Study|Withdrawal by Subject|0|||
127824182|NCT02115815|459976141|FG003|Overall Study|Withdrawal by Subject|0|||
127824183|NCT02115815|459976142|FG004|Overall Study|Withdrawal by Subject|0|||
127824184|NCT02115815|459976143|FG005|Overall Study|Withdrawal by Subject|0|||
127824185|NCT02115815|459976144|FG006|Overall Study|Withdrawal by Subject|0|||
127824186|NCT02115815|459976138|FG000|Overall Study|Not enough drug to dose participant|0|||
127824187|NCT02115815|459976139|FG001|Overall Study|Not enough drug to dose participant|0|||
127824188|NCT02115815|459976140|FG002|Overall Study|Not enough drug to dose participant|0|||
127824189|NCT02115815|459976141|FG003|Overall Study|Not enough drug to dose participant|0|||
127824190|NCT02115815|459976142|FG004|Overall Study|Not enough drug to dose participant|0|||
127824191|NCT02115815|459976143|FG005|Overall Study|Not enough drug to dose participant|1|||
127824192|NCT02115815|459976144|FG006|Overall Study|Not enough drug to dose participant|0|||
127824193|NCT02115815|459976138|FG000|Overall Study|Missed appointment, randomized in error|0|||
127824194|NCT02115815|459976139|FG001|Overall Study|Missed appointment, randomized in error|0|||
127824195|NCT02115815|459976140|FG002|Overall Study|Missed appointment, randomized in error|0|||
127824196|NCT02115815|459976141|FG003|Overall Study|Missed appointment, randomized in error|0|||
127824197|NCT02115815|459976142|FG004|Overall Study|Missed appointment, randomized in error|0|||
127824198|NCT02115815|459976143|FG005|Overall Study|Missed appointment, randomized in error|1|||
127824199|NCT02115815|459976144|FG006|Overall Study|Missed appointment, randomized in error|0|||
127824200|NCT01228071|459976145|FG000|Overall Study|Protocol Violation|1|||
127824201|NCT01228071|459976145|FG000|Overall Study|Withdrawal by Subject|1|||
127824202|NCT03314519|459976146|FG000|Overall Study|Protocol Violation|3|||
127824203|NCT03314519|459976147|FG001|Overall Study|Protocol Violation|2|||
127824204|NCT04003155|459976148|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
127824205|NCT04003155|459976149|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
127824206|NCT04003155|459976150|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
127824207|NCT04003155|459976151|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
127824208|NCT04003155|459976152|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
127824209|NCT04003155|459976148|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
127824210|NCT04003155|459976149|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
127824211|NCT04003155|459976150|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
127824212|NCT04003155|459976151|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
127824213|NCT04003155|459976152|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
127824214|NCT04003155|459976148|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
127824215|NCT04003155|459976149|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
127824216|NCT04003155|459976150|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
127824217|NCT04003155|459976151|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
127824218|NCT04003155|459976152|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
127824219|NCT04003155|459976148|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
127824220|NCT04003155|459976149|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
127824221|NCT04003155|459976150|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
127824222|NCT04003155|459976151|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
127824223|NCT04003155|459976152|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
127824224|NCT04003155|459976148|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
127894871|NCT02688400|460238544|FG000|Overall Study|Protocol Violation|2|||
127824225|NCT04003155|459976149|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
127824226|NCT04003155|459976150|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
127824227|NCT04003155|459976151|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
127824228|NCT04003155|459976152|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
127824229|NCT04003155|459976148|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
127824230|NCT04003155|459976149|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
127824231|NCT04003155|459976150|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
127824232|NCT04003155|459976151|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
127824233|NCT04003155|459976152|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
127824234|NCT04003155|459976148|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
127824235|NCT04003155|459976149|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
127824236|NCT04003155|459976150|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
127824237|NCT04003155|459976151|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
127824238|NCT04003155|459976152|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
127824239|NCT04003155|459976148|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
127824240|NCT04003155|459976149|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
127824241|NCT04003155|459976150|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
127824242|NCT04003155|459976151|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
127824243|NCT04003155|459976152|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
127824244|NCT04003155|459976148|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
127824245|NCT04003155|459976149|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
127824246|NCT04003155|459976150|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
127824247|NCT04003155|459976151|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
127824248|NCT04003155|459976152|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
127824249|NCT01912872|459976153|FG000|Overall Study|Lost to Follow-up|2|||
127824250|NCT01912872|459976154|FG001|Overall Study|Lost to Follow-up|3|||
127824251|NCT01912872|459976155|FG002|Overall Study|Lost to Follow-up|5|||
127824252|NCT01912872|459976156|FG003|Overall Study|Lost to Follow-up|5|||
127824253|NCT01912872|459976153|FG000|Overall Study|Other unspecified|3|||
127824254|NCT01912872|459976154|FG001|Overall Study|Other unspecified|1|||
127824255|NCT01912872|459976155|FG002|Overall Study|Other unspecified|3|||
127824256|NCT01912872|459976156|FG003|Overall Study|Other unspecified|0|||
127824257|NCT01912872|459976153|FG000|Overall Study|Informed consent withdrawn|0|||
127824258|NCT01912872|459976154|FG001|Overall Study|Informed consent withdrawn|0|||
127824259|NCT01912872|459976155|FG002|Overall Study|Informed consent withdrawn|1|||
127824260|NCT01912872|459976156|FG003|Overall Study|Informed consent withdrawn|1|||
127824261|NCT01912872|459976153|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
127824262|NCT01912872|459976154|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
127824263|NCT01912872|459976155|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
127824264|NCT01912872|459976156|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
127824265|NCT01912872|459976153|FG000|Overall Study|Protocol Violation|0|||
127824266|NCT01912872|459976154|FG001|Overall Study|Protocol Violation|0|||
127824267|NCT01912872|459976155|FG002|Overall Study|Protocol Violation|1|||
127824268|NCT01912872|459976156|FG003|Overall Study|Protocol Violation|0|||
127824269|NCT01912872|459976153|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
127824270|NCT01912872|459976154|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
127824271|NCT01912872|459976155|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
127824272|NCT01912872|459976156|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
127824273|NCT01912872|459976153|FG000|Overall Study|Withdrawal of study medication|0|||
127824274|NCT01912872|459976154|FG001|Overall Study|Withdrawal of study medication|0|||
127824275|NCT01912872|459976155|FG002|Overall Study|Withdrawal of study medication|0|||
127824276|NCT01912872|459976156|FG003|Overall Study|Withdrawal of study medication|2|||
127824277|NCT01912872|459976153|FG000|Overall Study|Missing|0|||
127824278|NCT01912872|459976154|FG001|Overall Study|Missing|0|||
127824279|NCT01912872|459976155|FG002|Overall Study|Missing|0|||
127824280|NCT01912872|459976156|FG003|Overall Study|Missing|1|||
127824281|NCT00950690|459976157|FG000|Overall Study|Death|4|||
127824282|NCT00950690|459976157|FG000|Overall Study|Adverse Event|15|||
127824283|NCT00950690|459976157|FG000|Overall Study|Lack of Efficacy|22|||
127824284|NCT00950690|459976157|FG000|Overall Study|Lost to Follow-up|40|||
127824285|NCT00950690|459976157|FG000|Overall Study|Other|163|||
127824286|NCT01713036|459976158|FG000|Overall Study|Death|1|||
127824287|NCT02546856|459976163|FG000|4 Months Evaluation|Death|2|||
127824288|NCT02546856|459976164|FG001|4 Months Evaluation|Death|3|||
127824289|NCT02546856|459976163|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
127824290|NCT02546856|459976164|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
127824291|NCT02546856|459976163|FG000|4 Months Evaluation|Lost to Follow-up|3|||
127824292|NCT02546856|459976164|FG001|4 Months Evaluation|Lost to Follow-up|3|||
127824293|NCT02546856|459976163|FG000|4 Months Evaluation|Physician Decision|3|||
127824294|NCT02546856|459976164|FG001|4 Months Evaluation|Physician Decision|0|||
127824295|NCT02546856|459976163|FG000|4 Months Evaluation|Working or living abroad|5|||
127824296|NCT02546856|459976164|FG001|4 Months Evaluation|Working or living abroad|1|||
127824297|NCT02546856|459976163|FG000|4 Months Evaluation|reasons not due to titration|4|||
127824298|NCT02546856|459976164|FG001|4 Months Evaluation|reasons not due to titration|1|||
127824299|NCT02546856|459976163|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
127824300|NCT02546856|459976164|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
127824301|NCT02546856|459976163|FG000|6 Months Evaluation|Death|1|||
127824302|NCT02546856|459976164|FG001|6 Months Evaluation|Death|1|||
127824303|NCT02546856|459976163|FG000|6 Months Evaluation|Lost to Follow-up|1|||
127824304|NCT02546856|459976164|FG001|6 Months Evaluation|Lost to Follow-up|1|||
127824305|NCT02546856|459976163|FG000|6 Months Evaluation|Working or living abroad|6|||
127824306|NCT02546856|459976164|FG001|6 Months Evaluation|Working or living abroad|4|||
127824307|NCT02546856|459976163|FG000|6 Months Evaluation|reasons not due to titration|0|||
127824308|NCT02546856|459976164|FG001|6 Months Evaluation|reasons not due to titration|1|||
127824309|NCT01097616|459976166|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
127824310|NCT01097616|459976167|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
127824311|NCT01097616|459976168|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
127824312|NCT01097616|459976169|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
127824313|NCT01097616|459976170|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
127824314|NCT01097616|459976171|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
127824315|NCT01097616|459976172|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
127824316|NCT01097616|459976173|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
127824317|NCT01097616|459976166|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
127824318|NCT01097616|459976167|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
127824319|NCT01097616|459976168|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
127824320|NCT01097616|459976169|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
127824321|NCT01097616|459976170|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
127824322|NCT01097616|459976171|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
127824323|NCT01097616|459976172|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
127824324|NCT01097616|459976173|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
127824325|NCT01097616|459976166|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
127824326|NCT01097616|459976167|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
127824327|NCT01097616|459976168|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
127824328|NCT01097616|459976169|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
127824329|NCT01097616|459976170|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
127824330|NCT01097616|459976171|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
127824331|NCT01097616|459976172|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
127824332|NCT01097616|459976173|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
127824333|NCT01097616|459976166|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
127824334|NCT01097616|459976167|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
127824335|NCT01097616|459976168|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
127824336|NCT01097616|459976169|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
127824337|NCT01097616|459976170|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
127824338|NCT01097616|459976171|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
127824339|NCT01097616|459976172|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
127824340|NCT01097616|459976173|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
127824341|NCT01097616|459976166|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
127824342|NCT01097616|459976167|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
127824343|NCT01097616|459976168|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
127824344|NCT01097616|459976169|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
127824345|NCT01097616|459976170|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
127824346|NCT01097616|459976171|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
127824347|NCT01097616|459976172|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
127824348|NCT01097616|459976173|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
127824349|NCT01097616|459976166|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
127824350|NCT01097616|459976167|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
127824351|NCT01097616|459976168|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
127824352|NCT01097616|459976169|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
127824353|NCT01097616|459976170|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
127824354|NCT01097616|459976171|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
127824355|NCT01097616|459976172|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
127824356|NCT01097616|459976173|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
127824357|NCT01097616|459976166|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
127824358|NCT01097616|459976167|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
127824359|NCT01097616|459976168|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
127824360|NCT01097616|459976169|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
127824361|NCT01097616|459976170|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
127824362|NCT01097616|459976171|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
127824363|NCT01097616|459976172|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
127824364|NCT01097616|459976173|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
127824365|NCT01097616|459976166|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
127824366|NCT01097616|459976167|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
127824367|NCT01097616|459976168|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
127824368|NCT01097616|459976169|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
127824369|NCT01097616|459976170|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
127824370|NCT01097616|459976171|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
127824371|NCT01097616|459976172|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
127824372|NCT01097616|459976173|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
127824373|NCT01097616|459976166|FG000|Optional DB EXT Phase|Adverse Event|0|||
127824374|NCT01097616|459976167|FG001|Optional DB EXT Phase|Adverse Event|7|||
127824375|NCT01097616|459976168|FG002|Optional DB EXT Phase|Adverse Event|2|||
127824376|NCT01097616|459976169|FG003|Optional DB EXT Phase|Adverse Event|0|||
127824377|NCT01097616|459976170|FG004|Optional DB EXT Phase|Adverse Event|0|||
127824378|NCT01097616|459976171|FG005|Optional DB EXT Phase|Adverse Event|0|||
127824379|NCT01097616|459976172|FG006|Optional DB EXT Phase|Adverse Event|0|||
127824380|NCT01097616|459976173|FG007|Optional DB EXT Phase|Adverse Event|0|||
127824381|NCT01097616|459976166|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
127824382|NCT01097616|459976167|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
127824383|NCT01097616|459976168|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
127824384|NCT01097616|459976169|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
127824385|NCT01097616|459976170|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
127824386|NCT01097616|459976171|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
127824387|NCT01097616|459976172|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
127824388|NCT01097616|459976173|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
127824389|NCT01097616|459976166|FG000|Optional DB EXT Phase|Protocol Violation|0|||
127824390|NCT01097616|459976167|FG001|Optional DB EXT Phase|Protocol Violation|2|||
127824391|NCT01097616|459976168|FG002|Optional DB EXT Phase|Protocol Violation|3|||
127824392|NCT01097616|459976169|FG003|Optional DB EXT Phase|Protocol Violation|0|||
127824393|NCT01097616|459976170|FG004|Optional DB EXT Phase|Protocol Violation|0|||
127824394|NCT01097616|459976171|FG005|Optional DB EXT Phase|Protocol Violation|0|||
127824395|NCT01097616|459976172|FG006|Optional DB EXT Phase|Protocol Violation|0|||
127824396|NCT01097616|459976173|FG007|Optional DB EXT Phase|Protocol Violation|0|||
127824397|NCT01097616|459976166|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
127824398|NCT01097616|459976167|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
127824399|NCT01097616|459976168|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
127824400|NCT01097616|459976169|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
127824401|NCT01097616|459976170|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
127824402|NCT01097616|459976171|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
127824403|NCT01097616|459976172|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
127824404|NCT01097616|459976173|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
127824405|NCT01097616|459976166|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
127824406|NCT01097616|459976167|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
127824407|NCT01097616|459976168|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
127824408|NCT01097616|459976169|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
127824409|NCT01097616|459976170|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
127824410|NCT01097616|459976171|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
127824411|NCT01097616|459976172|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
127824412|NCT01097616|459976173|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
127824413|NCT01097616|459976166|FG000|Optional DB EXT Phase|Physician Decision|1|||
127824414|NCT01097616|459976167|FG001|Optional DB EXT Phase|Physician Decision|0|||
127824415|NCT01097616|459976168|FG002|Optional DB EXT Phase|Physician Decision|0|||
127824416|NCT01097616|459976169|FG003|Optional DB EXT Phase|Physician Decision|0|||
127824417|NCT01097616|459976170|FG004|Optional DB EXT Phase|Physician Decision|0|||
127824418|NCT01097616|459976171|FG005|Optional DB EXT Phase|Physician Decision|0|||
127824419|NCT01097616|459976172|FG006|Optional DB EXT Phase|Physician Decision|0|||
127824420|NCT01097616|459976173|FG007|Optional DB EXT Phase|Physician Decision|0|||
127824421|NCT01097616|459976166|FG000|DB RO Phase|Adverse Event|0|||
127824422|NCT01097616|459976167|FG001|DB RO Phase|Adverse Event|0|||
127824423|NCT01097616|459976168|FG002|DB RO Phase|Adverse Event|0|||
127824424|NCT01097616|459976169|FG003|DB RO Phase|Adverse Event|0|||
127824425|NCT01097616|459976170|FG004|DB RO Phase|Adverse Event|0|||
127824426|NCT01097616|459976171|FG005|DB RO Phase|Adverse Event|0|||
127824427|NCT01097616|459976172|FG006|DB RO Phase|Adverse Event|1|||
127824428|NCT01097616|459976173|FG007|DB RO Phase|Adverse Event|0|||
127824429|NCT01097616|459976166|FG000|DB RO Phase|Withdrawal by Subject|0|||
127824430|NCT01097616|459976167|FG001|DB RO Phase|Withdrawal by Subject|0|||
127824431|NCT01097616|459976168|FG002|DB RO Phase|Withdrawal by Subject|0|||
127824432|NCT01097616|459976169|FG003|DB RO Phase|Withdrawal by Subject|0|||
127824433|NCT01097616|459976170|FG004|DB RO Phase|Withdrawal by Subject|0|||
127824434|NCT01097616|459976171|FG005|DB RO Phase|Withdrawal by Subject|1|||
127824435|NCT01097616|459976172|FG006|DB RO Phase|Withdrawal by Subject|0|||
127824436|NCT01097616|459976173|FG007|DB RO Phase|Withdrawal by Subject|0|||
127824437|NCT01097616|459976166|FG000|DB RO Phase|Lost to Follow-up|0|||
127824438|NCT01097616|459976167|FG001|DB RO Phase|Lost to Follow-up|0|||
127824439|NCT01097616|459976168|FG002|DB RO Phase|Lost to Follow-up|0|||
127824440|NCT01097616|459976169|FG003|DB RO Phase|Lost to Follow-up|1|||
127824441|NCT01097616|459976170|FG004|DB RO Phase|Lost to Follow-up|1|||
127824442|NCT01097616|459976171|FG005|DB RO Phase|Lost to Follow-up|0|||
127824443|NCT01097616|459976172|FG006|DB RO Phase|Lost to Follow-up|0|||
127824444|NCT01097616|459976173|FG007|DB RO Phase|Lost to Follow-up|1|||
127824445|NCT01097616|459976166|FG000|DB RO Phase|Not Treated in RO|0|||
127824446|NCT01097616|459976167|FG001|DB RO Phase|Not Treated in RO|0|||
127824447|NCT01097616|459976168|FG002|DB RO Phase|Not Treated in RO|0|||
127824448|NCT01097616|459976169|FG003|DB RO Phase|Not Treated in RO|0|||
127824449|NCT01097616|459976170|FG004|DB RO Phase|Not Treated in RO|0|||
127824450|NCT01097616|459976171|FG005|DB RO Phase|Not Treated in RO|1|||
127824451|NCT01097616|459976172|FG006|DB RO Phase|Not Treated in RO|0|||
127824452|NCT01097616|459976173|FG007|DB RO Phase|Not Treated in RO|0|||
127824453|NCT01996319|459976174|FG000|Overall Study|Protocol Violation|1|||
127824454|NCT01996319|459976175|FG001|Overall Study|Protocol Violation|0|||
127824455|NCT01996319|459976174|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
127824456|NCT01996319|459976175|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
127824457|NCT01996319|459976174|FG000|Overall Study|Adverse Event|2|||
127824458|NCT01996319|459976175|FG001|Overall Study|Adverse Event|2|||
127824459|NCT00130208|459976178|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
127824460|NCT00130208|459976179|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
127824461|NCT00130208|459976178|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
127824462|NCT00130208|459976179|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
127824463|NCT00130208|459976178|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
127824464|NCT00130208|459976179|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
127894872|NCT02688400|460238545|FG001|Overall Study|Protocol Violation|5|||
127824465|NCT00130208|459976178|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
127824466|NCT00130208|459976179|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
127824467|NCT00130208|459976178|FG000|Maintenance Period (26 Weeks)|Other|1|||
127824468|NCT00130208|459976179|FG001|Maintenance Period (26 Weeks)|Other|1|||
127824469|NCT00130208|459976178|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
127824470|NCT00130208|459976179|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
127824471|NCT00130208|459976178|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
127824472|NCT00130208|459976179|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
127824473|NCT00130208|459976178|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
127824474|NCT00130208|459976179|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
127824475|NCT00130208|459976178|FG000|Washout Period (8 Weeks)|Other|1|||
127824476|NCT00130208|459976179|FG001|Washout Period (8 Weeks)|Other|1|||
127824477|NCT00589472|459976181|FG000|Overall Study|Adverse Event|1|||
127824478|NCT00553059|459976182|FG000|Overall Study|Deemed ineligible|1|||
127824479|NCT00553059|459976183|FG001|Overall Study|Deemed ineligible|1|||
127824480|NCT00553059|459976182|FG000|Overall Study|Drug supply not available|0|||
127824481|NCT00553059|459976183|FG001|Overall Study|Drug supply not available|1|||
127824482|NCT00117338|459976184|FG000|Overall Study|Adverse Event|0|||
127824483|NCT00117338|459976185|FG001|Overall Study|Adverse Event|1|||
127824484|NCT00117338|459976184|FG000|Overall Study|Protocol Violation|3|||
127824485|NCT00117338|459976185|FG001|Overall Study|Protocol Violation|2|||
127824486|NCT00117338|459976184|FG000|Overall Study|Withdrawal by Subject|1|||
127824487|NCT00117338|459976185|FG001|Overall Study|Withdrawal by Subject|0|||
127824488|NCT00117338|459976184|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
127824489|NCT00117338|459976185|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
127824490|NCT00117338|459976184|FG000|Overall Study|Lack of Efficacy|0|||
127824491|NCT00117338|459976185|FG001|Overall Study|Lack of Efficacy|1|||
127824492|NCT01703819|459976190|FG000|Overall Study|Adverse Event|0|||
127824493|NCT01703819|459976191|FG001|Overall Study|Adverse Event|1|||
127824494|NCT01703819|459976190|FG000|Overall Study|Withdrawal by Subject|0|||
127824495|NCT01703819|459976191|FG001|Overall Study|Withdrawal by Subject|1|||
127824496|NCT02145156|459976192|FG000|Overall Study|No match to vaccination records|60|||
127824497|NCT02145156|459976193|FG001|Overall Study|No match to vaccination records|52|||
127824498|NCT02145156|459976194|FG002|Overall Study|No match to vaccination records|41|||
127824499|NCT01797783|459976195|FG000|Overall Study|Adverse Event|1|||
127824500|NCT01797783|459976196|FG001|Overall Study|Adverse Event|1|||
127824501|NCT01797783|459976195|FG000|Overall Study|Withdrawal by Subject|1|||
127824502|NCT01797783|459976196|FG001|Overall Study|Withdrawal by Subject|0|||
127824503|NCT00532883|459976197|FG000|Overall Study|Adverse Event|1|||
127824504|NCT00532883|459976198|FG001|Overall Study|Adverse Event|0|||
127824505|NCT00532883|459976199|FG002|Overall Study|Adverse Event|0|||
127824506|NCT00532883|459976200|FG003|Overall Study|Adverse Event|1|||
127824507|NCT00532883|459976197|FG000|Overall Study|Lost to Follow-up|1|||
127824508|NCT00532883|459976198|FG001|Overall Study|Lost to Follow-up|1|||
127824509|NCT00532883|459976199|FG002|Overall Study|Lost to Follow-up|1|||
127824510|NCT00532883|459976200|FG003|Overall Study|Lost to Follow-up|0|||
127824511|NCT00532883|459976197|FG000|Overall Study|Withdrawal by Subject|0|||
127824512|NCT00532883|459976198|FG001|Overall Study|Withdrawal by Subject|1|||
127824513|NCT00532883|459976199|FG002|Overall Study|Withdrawal by Subject|1|||
127824514|NCT00532883|459976200|FG003|Overall Study|Withdrawal by Subject|0|||
127824515|NCT00532883|459976197|FG000|Overall Study|Subject was Nonadherent|0|||
127824516|NCT00532883|459976198|FG001|Overall Study|Subject was Nonadherent|1|||
127824517|NCT00532883|459976199|FG002|Overall Study|Subject was Nonadherent|1|||
127824518|NCT00532883|459976200|FG003|Overall Study|Subject was Nonadherent|0|||
127824519|NCT00532883|459976197|FG000|Overall Study|Early Study Termination|4|||
127824520|NCT00532883|459976198|FG001|Overall Study|Early Study Termination|4|||
127824521|NCT00532883|459976199|FG002|Overall Study|Early Study Termination|1|||
127824522|NCT00532883|459976200|FG003|Overall Study|Early Study Termination|4|||
127824523|NCT05232097|459976203|FG000|Overall Study|Physician Decision|1|||
127824524|NCT01172288|459976204|FG000|Overall Study|Adverse Event|1|||
127824525|NCT01172288|459976205|FG001|Overall Study|Adverse Event|0|||
127824526|NCT01172288|459976204|FG000|Overall Study|Protocol Violation|0|||
127824527|NCT01172288|459976205|FG001|Overall Study|Protocol Violation|1|||
127824528|NCT00871858|459976208|FG000|Overall Study|Protocol Violation|3|||
127824529|NCT00871858|459976209|FG001|Overall Study|Protocol Violation|4|||
127824530|NCT00871858|459976208|FG000|Overall Study|Adverse Event|1|||
127824531|NCT00871858|459976209|FG001|Overall Study|Adverse Event|1|||
127824532|NCT00871858|459976208|FG000|Overall Study|Withdrawal by Subject|1|||
127824533|NCT00871858|459976209|FG001|Overall Study|Withdrawal by Subject|1|||
127824534|NCT00871858|459976208|FG000|Overall Study|Lost to Follow-up|0|||
127824535|NCT00871858|459976209|FG001|Overall Study|Lost to Follow-up|1|||
127824536|NCT03662334|459976210|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
127824537|NCT03662334|459976211|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
127824538|NCT02853331|459976222|FG000|Overall Study|Death|59|||
127824539|NCT02853331|459976223|FG001|Overall Study|Death|95|||
127824540|NCT02853331|459976222|FG000|Overall Study|Withdrawal by Subject|5|||
127824541|NCT02853331|459976223|FG001|Overall Study|Withdrawal by Subject|9|||
127824542|NCT02853331|459976222|FG000|Overall Study|Ongoing in study|368|||
127824543|NCT02853331|459976223|FG001|Overall Study|Ongoing in study|325|||
127824544|NCT03290300|459976230|FG000|Overall Study|Lost to Follow-up|3|||
127824545|NCT01520922|459976231|FG000|Treatment Phase|Physician Decision|2|||
127824546|NCT01520922|459976232|FG001|Treatment Phase|Physician Decision|1|||
127824547|NCT01520922|459976231|FG000|Treatment Phase|Progression|0|||
127824548|NCT01520922|459976232|FG001|Treatment Phase|Progression|2|||
127824549|NCT01520922|459976231|FG000|Treatment Phase|Adverse Event|3|||
127824550|NCT01520922|459976232|FG001|Treatment Phase|Adverse Event|5|||
127824551|NCT01520922|459976231|FG000|Follow up|Lost to Follow-up|0|||
127824552|NCT01520922|459976232|FG001|Follow up|Lost to Follow-up|1|||
127824553|NCT01520922|459976231|FG000|Survival Follow-up|Withdrawal by Subject|1|||
127824554|NCT01520922|459976232|FG001|Survival Follow-up|Withdrawal by Subject|0|||
127824555|NCT01618656|459976234|FG000|Overall Study|Withdrawal by Subject|7|||
127824556|NCT01618656|459976235|FG001|Overall Study|Withdrawal by Subject|3|||
127824557|NCT01618656|459976234|FG000|Overall Study|Physician Decision|1|||
127824558|NCT01618656|459976235|FG001|Overall Study|Physician Decision|1|||
127824559|NCT01899144|459976236|FG000|Treatment Period 2|Other|1|||
127824560|NCT01899144|459976236|FG000|Treatment Period 3|Other|2|||
127824561|NCT01899144|459976236|FG000|Treatment Period 5|Other|1|||
127824562|NCT04770155|459976243|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
127824563|NCT04770155|459976244|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
127824564|NCT04770155|459976245|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
127824565|NCT04770155|459976246|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
127824566|NCT04770155|459976247|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
127824567|NCT04770155|459976248|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
127824568|NCT04770155|459976249|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
127824569|NCT04770155|459976250|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
127824570|NCT00864227|459976252|FG000|Overall Study|Withdrawal by Subject|1|||
127824571|NCT00864227|459976252|FG000|Overall Study|Disease Relapse/Progression|3|||
127824572|NCT03461289|459976255|FG000|Overall Study|Death|1|||
127824573|NCT03321929|459976256|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
127824574|NCT00633139|459976264|FG000|Overall Study|Non compliance|0|||
127824575|NCT00633139|459976265|FG001|Overall Study|Non compliance|0|||
127824576|NCT00633139|459976266|FG002|Overall Study|Non compliance|1|||
127824577|NCT00633139|459976264|FG000|Overall Study|Withdrawal by Subject|0|||
127824578|NCT00633139|459976265|FG001|Overall Study|Withdrawal by Subject|1|||
127824579|NCT00633139|459976266|FG002|Overall Study|Withdrawal by Subject|0|||
127824580|NCT04773041|459976270|FG000|Overall Study|Unable to data match|1|||
127824581|NCT04773041|459976271|FG001|Overall Study|Unable to data match|0|||
127824582|NCT04773041|459976272|FG002|Overall Study|Unable to data match|0|||
127824583|NCT01522651|459976273|FG000|Overall Study|Adverse Event|3|||
127824584|NCT01522651|459976274|FG001|Overall Study|Adverse Event|4|||
127824585|NCT01522651|459976275|FG002|Overall Study|Adverse Event|4|||
127824586|NCT01522651|459976276|FG003|Overall Study|Adverse Event|5|||
127824587|NCT01522651|459976277|FG004|Overall Study|Adverse Event|4|||
127824588|NCT01522651|459976273|FG000|Overall Study|Cardioversion|1|||
127824589|NCT01522651|459976274|FG001|Overall Study|Cardioversion|0|||
127824590|NCT01522651|459976275|FG002|Overall Study|Cardioversion|0|||
127824591|NCT01522651|459976276|FG003|Overall Study|Cardioversion|0|||
127824592|NCT01522651|459976277|FG004|Overall Study|Cardioversion|0|||
127824593|NCT01522651|459976273|FG000|Overall Study|Device Malfunction|0|||
127824594|NCT01522651|459976274|FG001|Overall Study|Device Malfunction|1|||
127824595|NCT01522651|459976275|FG002|Overall Study|Device Malfunction|0|||
127824596|NCT01522651|459976276|FG003|Overall Study|Device Malfunction|0|||
127824597|NCT01522651|459976277|FG004|Overall Study|Device Malfunction|0|||
127824598|NCT01522651|459976273|FG000|Overall Study|Investigator's Discretion|0|||
127824599|NCT01522651|459976274|FG001|Overall Study|Investigator's Discretion|1|||
127824600|NCT01522651|459976275|FG002|Overall Study|Investigator's Discretion|0|||
127824601|NCT01522651|459976276|FG003|Overall Study|Investigator's Discretion|0|||
127824602|NCT01522651|459976277|FG004|Overall Study|Investigator's Discretion|0|||
127824603|NCT01522651|459976273|FG000|Overall Study|Protocol Violation|3|||
127824604|NCT01522651|459976274|FG001|Overall Study|Protocol Violation|0|||
127824605|NCT01522651|459976275|FG002|Overall Study|Protocol Violation|0|||
127824606|NCT01522651|459976276|FG003|Overall Study|Protocol Violation|0|||
127824607|NCT01522651|459976277|FG004|Overall Study|Protocol Violation|0|||
127824608|NCT01522651|459976273|FG000|Overall Study|Reason Not Specified|0|||
127824609|NCT01522651|459976274|FG001|Overall Study|Reason Not Specified|0|||
127824610|NCT01522651|459976275|FG002|Overall Study|Reason Not Specified|0|||
127824611|NCT01522651|459976276|FG003|Overall Study|Reason Not Specified|1|||
127824612|NCT01522651|459976277|FG004|Overall Study|Reason Not Specified|0|||
127824613|NCT01522651|459976273|FG000|Overall Study|Participant Non-Compliance|1|||
127824614|NCT01522651|459976274|FG001|Overall Study|Participant Non-Compliance|0|||
127824615|NCT01522651|459976275|FG002|Overall Study|Participant Non-Compliance|0|||
127824616|NCT01522651|459976276|FG003|Overall Study|Participant Non-Compliance|0|||
127824617|NCT01522651|459976277|FG004|Overall Study|Participant Non-Compliance|0|||
127824618|NCT01522651|459976273|FG000|Overall Study|Withdrew Consent|1|||
127824619|NCT01522651|459976274|FG001|Overall Study|Withdrew Consent|1|||
127824620|NCT01522651|459976275|FG002|Overall Study|Withdrew Consent|0|||
127824621|NCT01522651|459976276|FG003|Overall Study|Withdrew Consent|1|||
127824622|NCT01522651|459976277|FG004|Overall Study|Withdrew Consent|1|||
127824623|NCT01522651|459976273|FG000|Overall Study|Randomized but Never Treated|0|||
127824624|NCT01522651|459976274|FG001|Overall Study|Randomized but Never Treated|1|||
127824625|NCT01522651|459976275|FG002|Overall Study|Randomized but Never Treated|0|||
127824626|NCT01522651|459976276|FG003|Overall Study|Randomized but Never Treated|1|||
127824627|NCT01522651|459976277|FG004|Overall Study|Randomized but Never Treated|1|||
127824628|NCT02658656|459976278|FG000|Screening|Failed eligibility criteria|0|||
127824629|NCT02658656|459976279|FG001|Screening|Failed eligibility criteria|0|||
127824630|NCT02658656|459976280|FG002|Screening|Failed eligibility criteria|263|||
127824631|NCT02658656|459976278|FG000|Randomization|Withdrawal by Subject|8|||
127824632|NCT02658656|459976279|FG001|Randomization|Withdrawal by Subject|7|||
127824633|NCT02658656|459976280|FG002|Randomization|Withdrawal by Subject|0|||
127824634|NCT02658656|459976278|FG000|Randomization|Lost to Follow-up|1|||
127824635|NCT02658656|459976279|FG001|Randomization|Lost to Follow-up|3|||
127824636|NCT02658656|459976280|FG002|Randomization|Lost to Follow-up|0|||
127824637|NCT02658656|459976278|FG000|Randomization|Adverse Event|4|||
127824638|NCT02658656|459976279|FG001|Randomization|Adverse Event|0|||
127824639|NCT02658656|459976280|FG002|Randomization|Adverse Event|0|||
127824640|NCT02658656|459976278|FG000|Randomization|Administrative Termination|3|||
127824641|NCT02658656|459976279|FG001|Randomization|Administrative Termination|1|||
127824642|NCT02658656|459976280|FG002|Randomization|Administrative Termination|0|||
127824643|NCT02658656|459976278|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
127824644|NCT02658656|459976279|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
127824645|NCT02658656|459976280|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
127824646|NCT02658656|459976278|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
127824647|NCT02658656|459976279|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
127824648|NCT02658656|459976280|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
127824649|NCT02658656|459976278|FG000|Randomization|Not eligible for Randomization|1|||
127824650|NCT02658656|459976279|FG001|Randomization|Not eligible for Randomization|0|||
127824651|NCT02658656|459976280|FG002|Randomization|Not eligible for Randomization|0|||
127824652|NCT02658656|459976278|FG000|Randomization|Protocol Violation|1|||
127824653|NCT02658656|459976279|FG001|Randomization|Protocol Violation|0|||
127824654|NCT02658656|459976280|FG002|Randomization|Protocol Violation|0|||
127824655|NCT02100657|459977907|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
127824656|NCT02100657|459977908|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
127824657|NCT02100657|459977909|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
127824658|NCT02100657|459977907|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
127824659|NCT02100657|459977908|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
127824660|NCT02100657|459977909|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
127824661|NCT02100657|459977907|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
127824662|NCT02100657|459977908|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
127824663|NCT02100657|459977909|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
127824664|NCT02100657|459977907|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
127824665|NCT02100657|459977908|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
127824666|NCT02100657|459977909|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
127824667|NCT02100657|459977907|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
127824668|NCT02100657|459977908|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
127824669|NCT02100657|459977909|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
127824670|NCT02100657|459977907|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
127824671|NCT02100657|459977908|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
127824672|NCT02100657|459977909|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
127824673|NCT02100657|459977907|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
127824674|NCT02100657|459977908|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
127824675|NCT02100657|459977909|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
127824676|NCT02100657|459977907|FG000|Cohort 3: Dose Level 3|Death|0|||
127824677|NCT02100657|459977908|FG001|Cohort 3: Dose Level 3|Death|0|||
127824678|NCT02100657|459977909|FG002|Cohort 3: Dose Level 3|Death|1|||
127824679|NCT02100657|459977907|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
127824680|NCT02100657|459977908|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
127824681|NCT02100657|459977909|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
127824682|NCT02100657|459977907|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
127824683|NCT02100657|459977908|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
127824684|NCT02100657|459977909|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
127824685|NCT02100657|459977907|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
127824686|NCT02100657|459977908|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
127824687|NCT02100657|459977909|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
127824688|NCT02100657|459977907|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
127824689|NCT02100657|459977908|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
127824690|NCT02100657|459977909|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
127824691|NCT02100657|459977907|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
127824692|NCT02100657|459977908|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
127824693|NCT02100657|459977909|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
127824694|NCT01850563|459977910|FG000|Overall Study|Not eligible|3|||
127824695|NCT01850563|459977911|FG001|Overall Study|Not eligible|0|||
127824696|NCT02322892|459977912|FG000|Overall Study|Surgery cancelled|1|||
127824697|NCT02322892|459977913|FG001|Overall Study|Surgery cancelled|2|||
127824698|NCT02322892|459977912|FG000|Overall Study|Met exclusion criteria|0|||
127824699|NCT02322892|459977913|FG001|Overall Study|Met exclusion criteria|1|||
127824700|NCT02322892|459977912|FG000|Overall Study|Protocol Violation|1|||
127824701|NCT02322892|459977913|FG001|Overall Study|Protocol Violation|0|||
127824702|NCT02125331|459977916|FG000|Overall Study|Protocol Violation|1|||
127824703|NCT02125331|459977917|FG001|Overall Study|Protocol Violation|0|||
127824704|NCT02125331|459977916|FG000|Overall Study|technical problem|2|||
127824705|NCT02125331|459977917|FG001|Overall Study|technical problem|0|||
127824706|NCT02125331|459977916|FG000|Overall Study|screen failure|2|||
127824707|NCT02125331|459977917|FG001|Overall Study|screen failure|0|||
127824708|NCT00710034|459977918|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
127824709|NCT00710034|459977919|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
127824710|NCT00710034|459977918|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
127824711|NCT00710034|459977919|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
127824712|NCT00710034|459977918|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
127824713|NCT00710034|459977919|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
127824714|NCT00710034|459977918|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
127824715|NCT00710034|459977919|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
127824716|NCT00710034|459977918|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
127824717|NCT00710034|459977919|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
127824718|NCT00710034|459977918|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
127824719|NCT00710034|459977919|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
127824720|NCT00710034|459977918|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
127824721|NCT00710034|459977919|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
127824722|NCT00710034|459977918|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
127824723|NCT00710034|459977919|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
127824724|NCT00710034|459977918|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
127824725|NCT00710034|459977919|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
127824726|NCT00710034|459977918|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
127824727|NCT00710034|459977919|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
127824728|NCT00710034|459977918|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
127824729|NCT00710034|459977919|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
127824730|NCT02601001|459977920|FG000|Dosing Period 2|Adverse Event|0|||
127824731|NCT02601001|459977921|FG001|Dosing Period 2|Adverse Event|0|||
127824732|NCT02601001|459977922|FG002|Dosing Period 2|Adverse Event|0|||
127824733|NCT02601001|459977923|FG003|Dosing Period 2|Adverse Event|0|||
127824734|NCT02601001|459977924|FG004|Dosing Period 2|Adverse Event|0|||
127824735|NCT02601001|459977925|FG005|Dosing Period 2|Adverse Event|0|||
127824736|NCT02601001|459977926|FG006|Dosing Period 2|Adverse Event|1|||
127824737|NCT02778867|459977927|FG000|Phase 1|Withdrawal by Subject|2|||
127824738|NCT02778867|459977928|FG001|Phase 1|Withdrawal by Subject|3|||
127824739|NCT02778867|459977929|FG002|Phase 1|Withdrawal by Subject|0|||
127824740|NCT02778867|459977930|FG003|Phase 1|Withdrawal by Subject|0|||
127824741|NCT02778867|459977927|FG000|Phase 2|Withdrawal by Subject|0|||
127824742|NCT02778867|459977928|FG001|Phase 2|Withdrawal by Subject|0|||
127824743|NCT02778867|459977929|FG002|Phase 2|Withdrawal by Subject|1|||
127824744|NCT02778867|459977930|FG003|Phase 2|Withdrawal by Subject|0|||
127824745|NCT02778867|459977927|FG000|Phase 2|Physician Decision|0|||
127824746|NCT02778867|459977928|FG001|Phase 2|Physician Decision|0|||
127824747|NCT02778867|459977929|FG002|Phase 2|Physician Decision|0|||
127824748|NCT02778867|459977930|FG003|Phase 2|Physician Decision|1|||
127824749|NCT02778867|459977927|FG000|Phase 2|Adverse Event|0|||
127824750|NCT02778867|459977928|FG001|Phase 2|Adverse Event|0|||
127824751|NCT02778867|459977929|FG002|Phase 2|Adverse Event|0|||
127824752|NCT02778867|459977930|FG003|Phase 2|Adverse Event|1|||
127824753|NCT03504774|459977931|FG000|Overall Study|Adverse Event|2|||
127824754|NCT03504774|459977932|FG001|Overall Study|Adverse Event|0|||
127824755|NCT03504774|459977931|FG000|Overall Study|Lost to Follow-up|0|||
127824756|NCT03504774|459977932|FG001|Overall Study|Lost to Follow-up|1|||
127824757|NCT03504774|459977931|FG000|Overall Study|Protocol Violation|11|||
127824758|NCT03504774|459977932|FG001|Overall Study|Protocol Violation|3|||
127824759|NCT03504774|459977931|FG000|Overall Study|failed wk 52 DBPCFC|1|||
127824760|NCT03504774|459977932|FG001|Overall Study|failed wk 52 DBPCFC|0|||
127824761|NCT00915005|459977939|FG000|Overall Study|Withdrawal by Subject|4|||
127824762|NCT00915005|459977940|FG001|Overall Study|Withdrawal by Subject|4|||
127824763|NCT00915005|459977939|FG000|Overall Study|Patient preferred protons therapy|6|||
127824764|NCT00915005|459977940|FG001|Overall Study|Patient preferred protons therapy|0|||
127824765|NCT00915005|459977939|FG000|Overall Study|Insurance denial|3|||
127824766|NCT00915005|459977940|FG001|Overall Study|Insurance denial|15|||
127824767|NCT00305006|459977945|FG000|Overall Study|Withdrawal by Subject|1|||
127824768|NCT00305006|459977946|FG001|Overall Study|Withdrawal by Subject|0|||
127824769|NCT00305006|459977945|FG000|Overall Study|Failure to complete pretest|0|||
127824770|NCT00305006|459977946|FG001|Overall Study|Failure to complete pretest|1|||
127824771|NCT00631488|459977950|FG000|Overall Study|Adverse Event|1|||
127824772|NCT00631488|459977951|FG001|Overall Study|Adverse Event|0|||
127824773|NCT00631488|459977952|FG002|Overall Study|Adverse Event|0|||
127824774|NCT00631488|459977950|FG000|Overall Study|Lost to Follow-up|2|||
127824775|NCT00631488|459977951|FG001|Overall Study|Lost to Follow-up|2|||
127824776|NCT00631488|459977952|FG002|Overall Study|Lost to Follow-up|0|||
127824777|NCT00631488|459977950|FG000|Overall Study|Physician Decision|1|||
127824778|NCT00631488|459977951|FG001|Overall Study|Physician Decision|0|||
127824779|NCT00631488|459977952|FG002|Overall Study|Physician Decision|1|||
127824780|NCT00631488|459977950|FG000|Overall Study|Protocol Violation|0|||
127824781|NCT00631488|459977951|FG001|Overall Study|Protocol Violation|0|||
127824782|NCT00631488|459977952|FG002|Overall Study|Protocol Violation|1|||
127824783|NCT03648476|459977954|FG000|Overall Study|Withdrawal by Subject|2|||
127824784|NCT03648476|459977955|FG001|Overall Study|Withdrawal by Subject|1|||
127824785|NCT02855411|459977956|FG000|Overall Study|Study terminated by sponsor|21|||
127824786|NCT02855411|459977956|FG000|Overall Study|Does not meet entrance criteria|14|||
127824787|NCT01671085|459977959|FG000|Overall Study|Withdrawal by Subject|1|||
127824788|NCT01671085|459977960|FG001|Overall Study|Withdrawal by Subject|0|||
127824789|NCT00637273|459977961|FG000|Overall Study|Adverse Event|11|||
127824790|NCT00637273|459977962|FG001|Overall Study|Adverse Event|5|||
127824791|NCT00637273|459977963|FG002|Overall Study|Adverse Event|7|||
127824792|NCT00637273|459977961|FG000|Overall Study|Lost to Follow-up|8|||
127824793|NCT00637273|459977962|FG001|Overall Study|Lost to Follow-up|9|||
127824794|NCT00637273|459977963|FG002|Overall Study|Lost to Follow-up|13|||
127824795|NCT00637273|459977961|FG000|Overall Study|Protocol Violation|2|||
127824796|NCT00637273|459977962|FG001|Overall Study|Protocol Violation|4|||
127824797|NCT00637273|459977963|FG002|Overall Study|Protocol Violation|1|||
127824798|NCT00637273|459977961|FG000|Overall Study|Withdrawal of Consent|18|||
127824799|NCT00637273|459977962|FG001|Overall Study|Withdrawal of Consent|6|||
127824800|NCT00637273|459977963|FG002|Overall Study|Withdrawal of Consent|18|||
127824801|NCT00637273|459977961|FG000|Overall Study|Investigator Decision|1|||
127824802|NCT00637273|459977962|FG001|Overall Study|Investigator Decision|3|||
127824803|NCT00637273|459977963|FG002|Overall Study|Investigator Decision|1|||
127824804|NCT00637273|459977961|FG000|Overall Study|Administrative|2|||
127824805|NCT00637273|459977962|FG001|Overall Study|Administrative|0|||
127824806|NCT00637273|459977963|FG002|Overall Study|Administrative|0|||
127824807|NCT00637273|459977961|FG000|Overall Study|Loss of Glucose Control|1|||
127824808|NCT00637273|459977962|FG001|Overall Study|Loss of Glucose Control|1|||
127824809|NCT00637273|459977963|FG002|Overall Study|Loss of Glucose Control|1|||
127824810|NCT00986258|459977964|FG000|Observation Period|Not eligible to be dosed|11|||
127824811|NCT00986258|459977964|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
127824812|NCT00986258|459977964|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
127824813|NCT00986258|459977964|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
127824814|NCT00986258|459977964|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
127824815|NCT00986258|459977964|FG000|Titration and Optimal Dose Period|Other|1|||
127824816|NCT00986258|459977964|FG000|Maintenance Period|Adverse Event|5|||
127824817|NCT00986258|459977964|FG000|Maintenance Period|Lack of Efficacy|2|||
127824818|NCT00986258|459977964|FG000|Maintenance Period|Withdrawal by Subject|2|||
127824819|NCT02616029|459977966|FG000|Overall Study|Adverse Event|1|||
127824820|NCT02616029|459977967|FG001|Overall Study|Adverse Event|0|||
127824821|NCT02616029|459977966|FG000|Overall Study|Death|0|||
127824822|NCT02616029|459977967|FG001|Overall Study|Death|1|||
127824823|NCT02616029|459977966|FG000|Overall Study|Protocol Violation|1|||
127824824|NCT02616029|459977967|FG001|Overall Study|Protocol Violation|0|||
127824825|NCT02616029|459977966|FG000|Overall Study|Withdrew Consent|1|||
127824826|NCT02616029|459977967|FG001|Overall Study|Withdrew Consent|0|||
127824827|NCT02616029|459977966|FG000|Overall Study|Enrolled and Never Treated|1|||
127824828|NCT02616029|459977967|FG001|Overall Study|Enrolled and Never Treated|1|||
127824829|NCT04230486|459977969|FG000|Overall Study|Screen Failure|1|||
127824830|NCT02234583|459977972|FG000|Overall Study|Adverse Event|172|||
127824831|NCT02234583|459977973|FG001|Overall Study|Adverse Event|156|||
127824832|NCT02234583|459977972|FG000|Overall Study|Withdrawal by Subject|109|||
127824833|NCT02234583|459977973|FG001|Overall Study|Withdrawal by Subject|157|||
127824834|NCT02234583|459977972|FG000|Overall Study|Lost to Follow-up|0|||
127824835|NCT02234583|459977973|FG001|Overall Study|Lost to Follow-up|1|||
127824836|NCT02234583|459977972|FG000|Overall Study|Lack of Efficacy|58|||
127824837|NCT02234583|459977973|FG001|Overall Study|Lack of Efficacy|103|||
127824838|NCT02234583|459977972|FG000|Overall Study|Protocol Violation|35|||
127824839|NCT02234583|459977973|FG001|Overall Study|Protocol Violation|42|||
127824840|NCT02234583|459977972|FG000|Overall Study|Other|39|||
127824841|NCT02234583|459977973|FG001|Overall Study|Other|97|||
127824842|NCT02805907|459977974|FG000|Overall Study|Lost to Follow-up|3|||
127824843|NCT02805907|459977975|FG001|Overall Study|Lost to Follow-up|3|||
127824844|NCT01264965|459977976|FG000|Overall Study|Withdrawal by Subject|10|||
127824845|NCT02202031|459977977|FG000|Overall Study|Lost to Follow-up|1|||
127824846|NCT02202031|459977978|FG001|Overall Study|Lost to Follow-up|0|||
127824847|NCT02202031|459977977|FG000|Overall Study|Too Busy|1|||
127824848|NCT02202031|459977978|FG001|Overall Study|Too Busy|3|||
127824849|NCT02202031|459977977|FG000|Overall Study|Illness/Medical Reason|0|||
127824850|NCT02202031|459977978|FG001|Overall Study|Illness/Medical Reason|2|||
127824851|NCT02202031|459977977|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
127824852|NCT02202031|459977978|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
127824853|NCT01188798|459977981|FG000|Overall Study|Death|0|||
127824854|NCT01188798|459977982|FG001|Overall Study|Death|1|||
127824855|NCT01188798|459977981|FG000|Overall Study|Required additional transplant|1|||
127824856|NCT01188798|459977982|FG001|Overall Study|Required additional transplant|1|||
127824857|NCT01188798|459977981|FG000|Overall Study|Protocol closure|1|||
127824858|NCT01188798|459977982|FG001|Overall Study|Protocol closure|1|||
127824859|NCT02795767|459977983|FG000|Overall Study|Received Commercial Emicizumab|1|||
127824860|NCT02795767|459977984|FG001|Overall Study|Received Commercial Emicizumab|0|||
127824861|NCT02795767|459977985|FG002|Overall Study|Received Commercial Emicizumab|0|||
127824862|NCT04156646|459977991|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
127824863|NCT04156646|459977992|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
127824864|NCT00751881|459977993|FG000|Core Treatment Period|Not treated|1|||
127824865|NCT00751881|459977994|FG001|Core Treatment Period|Not treated|1|||
127824866|NCT00751881|459977995|FG002|Core Treatment Period|Not treated|2|||
127824867|NCT00751881|459977993|FG000|Core Treatment Period|Adverse Event|26|||
127824868|NCT00751881|459977994|FG001|Core Treatment Period|Adverse Event|54|||
127824869|NCT00751881|459977995|FG002|Core Treatment Period|Adverse Event|58|||
127824870|NCT00751881|459977993|FG000|Core Treatment Period|Lack of Efficacy|37|||
127824871|NCT00751881|459977994|FG001|Core Treatment Period|Lack of Efficacy|30|||
127824872|NCT00751881|459977995|FG002|Core Treatment Period|Lack of Efficacy|20|||
127824873|NCT00751881|459977993|FG000|Core Treatment Period|Poor compliance to protocol|15|||
127824874|NCT00751881|459977994|FG001|Core Treatment Period|Poor compliance to protocol|3|||
127824875|NCT00751881|459977995|FG002|Core Treatment Period|Poor compliance to protocol|4|||
127824876|NCT00751881|459977993|FG000|Core Treatment Period|Lost to Follow-up|6|||
127824877|NCT00751881|459977994|FG001|Core Treatment Period|Lost to Follow-up|4|||
127824878|NCT00751881|459977995|FG002|Core Treatment Period|Lost to Follow-up|3|||
127824879|NCT00751881|459977993|FG000|Core Treatment Period|Other: protocol deviation|3|||
127824880|NCT00751881|459977994|FG001|Core Treatment Period|Other: protocol deviation|3|||
127824881|NCT00751881|459977995|FG002|Core Treatment Period|Other: protocol deviation|7|||
127824882|NCT00751881|459977993|FG000|Core Treatment Period|Other: wish to parent|5|||
127824883|NCT00751881|459977994|FG001|Core Treatment Period|Other: wish to parent|7|||
127824884|NCT00751881|459977995|FG002|Core Treatment Period|Other: wish to parent|4|||
127824885|NCT00751881|459977993|FG000|Core Treatment Period|Other: personal/family constraints|6|||
127824886|NCT00751881|459977994|FG001|Core Treatment Period|Other: personal/family constraints|7|||
127824887|NCT00751881|459977995|FG002|Core Treatment Period|Other: personal/family constraints|10|||
127824888|NCT00751881|459977993|FG000|Core Treatment Period|Other: MS treatment change|6|||
127824889|NCT00751881|459977994|FG001|Core Treatment Period|Other: MS treatment change|4|||
127824890|NCT00751881|459977995|FG002|Core Treatment Period|Other: MS treatment change|4|||
127824891|NCT00751881|459977993|FG000|Core Treatment Period|Other: tolerability complaints|2|||
127824892|NCT00751881|459977994|FG001|Core Treatment Period|Other: tolerability complaints|0|||
127824893|NCT00751881|459977995|FG002|Core Treatment Period|Other: tolerability complaints|0|||
127824894|NCT00751881|459977993|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
127824895|NCT00751881|459977994|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
127824896|NCT00751881|459977995|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
127824897|NCT00751881|459977993|FG000|Extension Study Period|Adverse Event|18|||
127824898|NCT00751881|459977994|FG001|Extension Study Period|Adverse Event|20|||
127824899|NCT00751881|459977995|FG002|Extension Study Period|Adverse Event|21|||
127824900|NCT00751881|459977993|FG000|Extension Study Period|Lack of Efficacy|14|||
127824901|NCT00751881|459977994|FG001|Extension Study Period|Lack of Efficacy|10|||
127824902|NCT00751881|459977995|FG002|Extension Study Period|Lack of Efficacy|20|||
127824903|NCT00751881|459977993|FG000|Extension Study Period|Lost to Follow-up|4|||
127824904|NCT00751881|459977994|FG001|Extension Study Period|Lost to Follow-up|9|||
127824905|NCT00751881|459977995|FG002|Extension Study Period|Lost to Follow-up|6|||
127824906|NCT00751881|459977993|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
127824907|NCT00751881|459977994|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
127824908|NCT00751881|459977995|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
127824909|NCT00751881|459977993|FG000|Extension Study Period|Other than specified above|26|||
127824910|NCT00751881|459977994|FG001|Extension Study Period|Other than specified above|30|||
127824911|NCT00751881|459977995|FG002|Extension Study Period|Other than specified above|18|||
127824912|NCT01765764|459977996|FG000|Treatment Period|Adverse Event|1|||
127824913|NCT01765764|459977997|FG001|Treatment Period|Adverse Event|2|||
127824914|NCT01765764|459977998|FG002|Treatment Period|Adverse Event|1|||
127824915|NCT01765764|459977996|FG000|Treatment Period|Lost to Follow-up|0|||
127824916|NCT01765764|459977997|FG001|Treatment Period|Lost to Follow-up|3|||
127824917|NCT01765764|459977998|FG002|Treatment Period|Lost to Follow-up|2|||
127824918|NCT01765764|459977996|FG000|Treatment Period|Personal Reasons|1|||
127824919|NCT01765764|459977997|FG001|Treatment Period|Personal Reasons|2|||
127824920|NCT01765764|459977998|FG002|Treatment Period|Personal Reasons|1|||
127824921|NCT01765764|459977996|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
127824922|NCT01765764|459977997|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
127824923|NCT01765764|459977998|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
127824924|NCT00530712|459978000|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
127824925|NCT00530712|459978000|FG000|30 Day Follow-up Visit|Missed Visit|5|||
127824926|NCT00530712|459978000|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
127824927|NCT00530712|459978000|FG000|6 Month Follow-up Visit|Missed Visit|3|||
127824928|NCT00530712|459978000|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
127824929|NCT00530712|459978000|FG000|6 Month Follow-up Visit|Death|2|||
127824930|NCT00530712|459978000|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
127824931|NCT00530712|459978000|FG000|12 Month Follow-up Visit|Missed Visit|3|||
127824932|NCT00530712|459978000|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
127824933|NCT00530712|459978000|FG000|12 Month Follow-up Visit|Death|9|||
127824934|NCT00651118|459978008|FG000|Overall Study|Adverse Event|4|||
127824935|NCT00651118|459978009|FG001|Overall Study|Adverse Event|0|||
127824936|NCT00651118|459978010|FG002|Overall Study|Adverse Event|1|||
127824937|NCT00651118|459978011|FG003|Overall Study|Adverse Event|1|||
127824938|NCT00651118|459978008|FG000|Overall Study|Protocol Violation|2|||
127824939|NCT00651118|459978009|FG001|Overall Study|Protocol Violation|2|||
127824940|NCT00651118|459978010|FG002|Overall Study|Protocol Violation|6|||
127824941|NCT00651118|459978011|FG003|Overall Study|Protocol Violation|2|||
127824942|NCT00651118|459978008|FG000|Overall Study|Lost to Follow-up|2|||
127824943|NCT00651118|459978009|FG001|Overall Study|Lost to Follow-up|0|||
127824944|NCT00651118|459978010|FG002|Overall Study|Lost to Follow-up|1|||
127824945|NCT00651118|459978011|FG003|Overall Study|Lost to Follow-up|2|||
127824946|NCT00651118|459978008|FG000|Overall Study|administrative|1|||
127824947|NCT00651118|459978009|FG001|Overall Study|administrative|4|||
127824948|NCT00651118|459978010|FG002|Overall Study|administrative|2|||
127824949|NCT00651118|459978011|FG003|Overall Study|administrative|1|||
127824950|NCT00651118|459978008|FG000|Overall Study|Withdrawal by Subject|0|||
127824951|NCT00651118|459978009|FG001|Overall Study|Withdrawal by Subject|1|||
127824952|NCT00651118|459978010|FG002|Overall Study|Withdrawal by Subject|1|||
127824953|NCT00651118|459978011|FG003|Overall Study|Withdrawal by Subject|1|||
127824954|NCT03117049|459978012|FG000|Overall Study|Continued the follow-up period|109|||
127824955|NCT03117049|459978013|FG001|Overall Study|Continued the follow-up period|129|||
127824956|NCT03117049|459978012|FG000|Overall Study|Died|82|||
127824957|NCT03117049|459978013|FG001|Overall Study|Died|93|||
127824958|NCT03117049|459978012|FG000|Overall Study|Consent withdrawal|7|||
127824959|NCT03117049|459978013|FG001|Overall Study|Consent withdrawal|6|||
127824960|NCT03117049|459978012|FG000|Overall Study|Missing contact|3|||
127824961|NCT03117049|459978013|FG001|Overall Study|Missing contact|3|||
127824962|NCT00839098|459978014|FG000|Overall Study|Withdrawal by Subject|2|||
127824963|NCT00839098|459978015|FG001|Overall Study|Withdrawal by Subject|1|||
127824964|NCT00839098|459978016|FG002|Overall Study|Withdrawal by Subject|7|||
127824965|NCT00365976|459978019|FG000|Overall Study|Withdrawal by Subject|1|||
127824966|NCT00365976|459978020|FG001|Overall Study|Withdrawal by Subject|5|||
127824967|NCT02260193|459978021|FG000|Overall Study|Lack of Efficacy|0|||
127824968|NCT02260193|459978022|FG001|Overall Study|Lack of Efficacy|1|||
127824969|NCT02260193|459978023|FG002|Overall Study|Lack of Efficacy|6|||
127824970|NCT02260193|459978021|FG000|Overall Study|Adverse Event|3|||
127824971|NCT02260193|459978022|FG001|Overall Study|Adverse Event|4|||
127824972|NCT02260193|459978023|FG002|Overall Study|Adverse Event|1|||
127824973|NCT02260193|459978021|FG000|Overall Study|Protocol Violation|0|||
127824974|NCT02260193|459978022|FG001|Overall Study|Protocol Violation|4|||
127824975|NCT02260193|459978023|FG002|Overall Study|Protocol Violation|0|||
127824976|NCT02260193|459978021|FG000|Overall Study|Withdrawal by Subject|3|||
127824977|NCT02260193|459978022|FG001|Overall Study|Withdrawal by Subject|0|||
127824978|NCT02260193|459978023|FG002|Overall Study|Withdrawal by Subject|2|||
127824979|NCT02260193|459978021|FG000|Overall Study|Kidney Transplantation|0|||
127824980|NCT02260193|459978022|FG001|Overall Study|Kidney Transplantation|0|||
127824981|NCT02260193|459978023|FG002|Overall Study|Kidney Transplantation|1|||
127824982|NCT00935220|459978024|FG000|Overall Study|Adverse Event|1|||
127824983|NCT00935220|459978024|FG000|Overall Study|Other reason (not specified)|1|||
127824984|NCT00798967|459978027|FG000|Overall Study|Adverse Event|2|||
127824985|NCT00798967|459978028|FG001|Overall Study|Adverse Event|3|||
127824986|NCT00798967|459978027|FG000|Overall Study|Withdrawal by Subject|0|||
127824987|NCT00798967|459978028|FG001|Overall Study|Withdrawal by Subject|1|||
127824988|NCT00798967|459978027|FG000|Overall Study|Physician Decision|1|||
127824989|NCT00798967|459978028|FG001|Overall Study|Physician Decision|0|||
127824990|NCT00798967|459978027|FG000|Overall Study|Randomized in error by site|1|||
127824991|NCT00798967|459978028|FG001|Overall Study|Randomized in error by site|0|||
127824992|NCT01415440|459978031|FG000|Overall Study|Lost to Follow-up|0|||
127824993|NCT01415440|459978032|FG001|Overall Study|Lost to Follow-up|1|||
127824994|NCT01415440|459978033|FG002|Overall Study|Lost to Follow-up|2|||
127824995|NCT01415440|459978031|FG000|Overall Study|Physician Decision|3|||
127824996|NCT01415440|459978032|FG001|Overall Study|Physician Decision|0|||
127824997|NCT01415440|459978033|FG002|Overall Study|Physician Decision|0|||
127824998|NCT01415440|459978031|FG000|Overall Study|Withdrawal by Subject|1|||
127824999|NCT01415440|459978032|FG001|Overall Study|Withdrawal by Subject|0|||
127825000|NCT01415440|459978033|FG002|Overall Study|Withdrawal by Subject|0|||
127825001|NCT02160977|459978036|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
127825002|NCT02160977|459978037|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
127825003|NCT02160977|459978036|FG000|Three Months After Surgery|Lost to Follow-up|0|||
127825004|NCT02160977|459978037|FG001|Three Months After Surgery|Lost to Follow-up|2|||
127825005|NCT02160977|459978036|FG000|Six Months After Surgery|Lost to Follow-up|2|||
127825006|NCT02160977|459978037|FG001|Six Months After Surgery|Lost to Follow-up|1|||
127825007|NCT04359823|459979557|FG000|Overall Study|Lost to Follow-up|0|||
127825008|NCT04359823|459979558|FG001|Overall Study|Lost to Follow-up|1|||
127825009|NCT04359823|459979557|FG000|Overall Study|Withdrawal by Subject|0|||
127825010|NCT04359823|459979558|FG001|Overall Study|Withdrawal by Subject|1|||
127825011|NCT00408421|459979562|FG000|Treatment Initial Randomization|Adverse Event|5|||
127825012|NCT00408421|459979563|FG001|Treatment Initial Randomization|Adverse Event|9|||
127825013|NCT00408421|459979564|FG002|Treatment Initial Randomization|Adverse Event|0|||
127825014|NCT00408421|459979562|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
127825015|NCT00408421|459979563|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
127825016|NCT00408421|459979564|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
127825017|NCT00408421|459979562|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
127825018|NCT00408421|459979563|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
127825019|NCT00408421|459979564|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
127825020|NCT00408421|459979562|FG000|Treatment Initial Randomization|Physician Decision|1|||
127825021|NCT00408421|459979563|FG001|Treatment Initial Randomization|Physician Decision|0|||
127825022|NCT00408421|459979564|FG002|Treatment Initial Randomization|Physician Decision|0|||
127825023|NCT00408421|459979562|FG000|Treatment Initial Randomization|Protocol Violation|0|||
127825024|NCT00408421|459979563|FG001|Treatment Initial Randomization|Protocol Violation|1|||
127825025|NCT00408421|459979564|FG002|Treatment Initial Randomization|Protocol Violation|0|||
127825026|NCT00408421|459979562|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
127825027|NCT00408421|459979563|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
127825028|NCT00408421|459979564|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
127825029|NCT00408421|459979562|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
127825030|NCT00408421|459979563|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
127825031|NCT00408421|459979564|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
127825032|NCT00408421|459979562|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
127825033|NCT00408421|459979563|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
127825034|NCT00408421|459979564|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
127825035|NCT00408421|459979562|FG000|Treatment Re-Randomization|Adverse Event|2|||
127825036|NCT00408421|459979563|FG001|Treatment Re-Randomization|Adverse Event|2|||
127825037|NCT00408421|459979564|FG002|Treatment Re-Randomization|Adverse Event|4|||
127825038|NCT00408421|459979562|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
127825039|NCT00408421|459979563|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
127825040|NCT00408421|459979564|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
127825041|NCT00408421|459979562|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
127825042|NCT00408421|459979563|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
127825043|NCT00408421|459979564|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
127825044|NCT00408421|459979562|FG000|Treatment Re-Randomization|Physician Decision|1|||
127825045|NCT00408421|459979563|FG001|Treatment Re-Randomization|Physician Decision|3|||
127825046|NCT00408421|459979564|FG002|Treatment Re-Randomization|Physician Decision|0|||
127825047|NCT00408421|459979562|FG000|Treatment Re-Randomization|Protocol Violation|1|||
127825048|NCT00408421|459979563|FG001|Treatment Re-Randomization|Protocol Violation|1|||
127825049|NCT00408421|459979564|FG002|Treatment Re-Randomization|Protocol Violation|0|||
127825050|NCT00408421|459979562|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
127825051|NCT00408421|459979563|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
127825052|NCT00408421|459979564|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
127825053|NCT01614769|459979570|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
127825054|NCT01614769|459979571|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
127825055|NCT01614769|459979572|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
127825056|NCT01614769|459979573|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
127825057|NCT01614769|459979574|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
127825058|NCT01614769|459979575|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
127825059|NCT01614769|459979570|FG000|Period 1|Protocol Violation|0|||
127825060|NCT01614769|459979571|FG001|Period 1|Protocol Violation|0|||
127825061|NCT01614769|459979572|FG002|Period 1|Protocol Violation|0|||
127825062|NCT01614769|459979573|FG003|Period 1|Protocol Violation|1|||
127825063|NCT01614769|459979574|FG004|Period 1|Protocol Violation|0|||
127825064|NCT01614769|459979575|FG005|Period 1|Protocol Violation|0|||
127825065|NCT01614769|459979570|FG000|Period 1|Withdrawal by Subject|1|||
127825066|NCT01614769|459979571|FG001|Period 1|Withdrawal by Subject|0|||
127825067|NCT01614769|459979572|FG002|Period 1|Withdrawal by Subject|0|||
127825068|NCT01614769|459979573|FG003|Period 1|Withdrawal by Subject|0|||
127825069|NCT01614769|459979574|FG004|Period 1|Withdrawal by Subject|0|||
127825070|NCT01614769|459979575|FG005|Period 1|Withdrawal by Subject|0|||
127825071|NCT01614769|459979570|FG000|Period 3|Withdrawal by Subject|0|||
127825072|NCT01614769|459979571|FG001|Period 3|Withdrawal by Subject|0|||
127825073|NCT01614769|459979572|FG002|Period 3|Withdrawal by Subject|1|||
127825074|NCT01614769|459979573|FG003|Period 3|Withdrawal by Subject|0|||
127825075|NCT01614769|459979574|FG004|Period 3|Withdrawal by Subject|0|||
127825076|NCT01614769|459979575|FG005|Period 3|Withdrawal by Subject|0|||
127825077|NCT03123354|459979576|FG000|Overall Study|Physician Decision|6|||
127825078|NCT00960440|459979579|FG000|Overall Study|Death|0|||
127825079|NCT00960440|459979580|FG001|Overall Study|Death|0|||
127825080|NCT00960440|459979581|FG002|Overall Study|Death|0|||
127825081|NCT00960440|459979582|FG003|Overall Study|Death|1|||
127825082|NCT00960440|459979579|FG000|Overall Study|Adverse Event|12|||
127825083|NCT00960440|459979580|FG001|Overall Study|Adverse Event|12|||
127825084|NCT00960440|459979581|FG002|Overall Study|Adverse Event|4|||
127825085|NCT00960440|459979582|FG003|Overall Study|Adverse Event|4|||
127825086|NCT00960440|459979579|FG000|Overall Study|Lack of Efficacy|2|||
127825087|NCT00960440|459979580|FG001|Overall Study|Lack of Efficacy|5|||
127825088|NCT00960440|459979581|FG002|Overall Study|Lack of Efficacy|3|||
127825089|NCT00960440|459979582|FG003|Overall Study|Lack of Efficacy|8|||
127825090|NCT00960440|459979579|FG000|Overall Study|Protocol Violation|2|||
127825091|NCT00960440|459979580|FG001|Overall Study|Protocol Violation|8|||
127825092|NCT00960440|459979581|FG002|Overall Study|Protocol Violation|3|||
127825093|NCT00960440|459979582|FG003|Overall Study|Protocol Violation|4|||
127825094|NCT00960440|459979579|FG000|Overall Study|Withdrawal by Subject|9|||
127825095|NCT00960440|459979580|FG001|Overall Study|Withdrawal by Subject|5|||
127825096|NCT00960440|459979581|FG002|Overall Study|Withdrawal by Subject|2|||
127825097|NCT00960440|459979582|FG003|Overall Study|Withdrawal by Subject|1|||
127825098|NCT00960440|459979579|FG000|Overall Study|Other|1|||
127825099|NCT00960440|459979580|FG001|Overall Study|Other|1|||
127825100|NCT00960440|459979581|FG002|Overall Study|Other|1|||
127825101|NCT00960440|459979582|FG003|Overall Study|Other|0|||
127825102|NCT02421120|459979583|FG000|Overall Study|Adverse Event|1|||
127825103|NCT02345161|459979584|FG000|Overall Study|Withdrawal by Subject|25|||
127825104|NCT02345161|459979585|FG001|Overall Study|Withdrawal by Subject|33|||
127825105|NCT02345161|459979584|FG000|Overall Study|Adverse Event|16|||
127825106|NCT02345161|459979585|FG001|Overall Study|Adverse Event|19|||
127825107|NCT02345161|459979584|FG000|Overall Study|Physician Decision|4|||
127825108|NCT02345161|459979585|FG001|Overall Study|Physician Decision|4|||
127825109|NCT02345161|459979584|FG000|Overall Study|Lost to Follow-up|0|||
127825110|NCT02345161|459979585|FG001|Overall Study|Lost to Follow-up|1|||
127825111|NCT03554005|459979586|FG000|Overall Study|Not in participant's best interest|0|||
127825112|NCT03554005|459979587|FG001|Overall Study|Not in participant's best interest|0|||
127825113|NCT03554005|459979588|FG002|Overall Study|Not in participant's best interest|0|||
127825114|NCT03554005|459979589|FG003|Overall Study|Not in participant's best interest|0|||
127825115|NCT03554005|459979590|FG004|Overall Study|Not in participant's best interest|0|||
127825116|NCT03554005|459979591|FG005|Overall Study|Not in participant's best interest|1|||
127825117|NCT03554005|459979586|FG000|Overall Study|Disease Progression|1|||
127825118|NCT03554005|459979587|FG001|Overall Study|Disease Progression|1|||
127825119|NCT03554005|459979588|FG002|Overall Study|Disease Progression|1|||
127825120|NCT03554005|459979589|FG003|Overall Study|Disease Progression|1|||
127894873|NCT02688400|460238544|FG000|Overall Study|Lack of Efficacy|7|||
127894874|NCT02688400|460238545|FG001|Overall Study|Lack of Efficacy|7|||
127825121|NCT03554005|459979590|FG004|Overall Study|Disease Progression|5|||
127825122|NCT03554005|459979591|FG005|Overall Study|Disease Progression|6|||
127825123|NCT03554005|459979586|FG000|Overall Study|Adverse Event|0|||
127825124|NCT03554005|459979587|FG001|Overall Study|Adverse Event|0|||
127825125|NCT03554005|459979588|FG002|Overall Study|Adverse Event|0|||
127825126|NCT03554005|459979589|FG003|Overall Study|Adverse Event|0|||
127825127|NCT03554005|459979590|FG004|Overall Study|Adverse Event|0|||
127825128|NCT03554005|459979591|FG005|Overall Study|Adverse Event|3|||
127825129|NCT03554005|459979586|FG000|Overall Study|Physician Decision|0|||
127825130|NCT03554005|459979587|FG001|Overall Study|Physician Decision|0|||
127825131|NCT03554005|459979588|FG002|Overall Study|Physician Decision|0|||
127825132|NCT03554005|459979589|FG003|Overall Study|Physician Decision|0|||
127825133|NCT03554005|459979590|FG004|Overall Study|Physician Decision|1|||
127825134|NCT03554005|459979591|FG005|Overall Study|Physician Decision|0|||
127825135|NCT03554005|459979586|FG000|Overall Study|Other|0|||
127825136|NCT03554005|459979587|FG001|Overall Study|Other|0|||
127825137|NCT03554005|459979588|FG002|Overall Study|Other|0|||
127825138|NCT03554005|459979589|FG003|Overall Study|Other|0|||
127825139|NCT03554005|459979590|FG004|Overall Study|Other|0|||
127825140|NCT03554005|459979591|FG005|Overall Study|Other|1|||
127825141|NCT02606045|459979592|FG000|Overall Study|Study closed before treament could begin|1|||
127825142|NCT02606045|459979593|FG001|Overall Study|Study closed before treament could begin|2|||
127825143|NCT00907881|459979594|FG000|Overall Study|Lost to Follow-up|59|||
127825144|NCT00907881|459979594|FG000|Overall Study|Noncompliance|5|||
127825145|NCT00907881|459979594|FG000|Overall Study|Withdrawal by Subject|5|||
127825146|NCT00907881|459979594|FG000|Overall Study|Protocol Violation|1|||
127825147|NCT00907881|459979594|FG000|Overall Study|Missing discontinuation information|15|||
127825148|NCT03215264|459979601|FG000|Dose Level 2|Adverse Event|0|||
127825149|NCT03215264|459979602|FG001|Dose Level 2|Adverse Event|1|||
127825150|NCT03215264|459979603|FG002|Dose Level 2|Adverse Event|0|||
127825151|NCT03215264|459979601|FG000|Dose Level 3|Withdrawal by Subject|0|||
127825152|NCT03215264|459979602|FG001|Dose Level 3|Withdrawal by Subject|0|||
127825153|NCT03215264|459979603|FG002|Dose Level 3|Withdrawal by Subject|1|||
127825154|NCT01740440|459979604|FG000|Overall Study|Lost to Follow-up|3|||
127825155|NCT03408873|459979610|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
127825156|NCT03408873|459979610|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
127825157|NCT03408873|459979610|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
127825158|NCT03408873|459979610|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
127825159|NCT03408873|459979610|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
127825160|NCT03408873|459979610|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
127825161|NCT03799718|459979613|FG000|Overall Study|Adverse Event|2|||
127825162|NCT02214186|459979615|FG000|Overall Study|Lost to Follow-up|1|||
127825163|NCT02214186|459979616|FG001|Overall Study|Lost to Follow-up|1|||
127825164|NCT02214186|459979615|FG000|Overall Study|Protocol Violation|1|||
127825165|NCT02214186|459979616|FG001|Overall Study|Protocol Violation|1|||
127825166|NCT01651052|459979617|FG000|Overall Study|Death|21|||
127825167|NCT01651052|459979617|FG000|Overall Study|Explant|1|||
127825168|NCT01651052|459979617|FG000|Overall Study|Withdrawal by Subject|1|||
127825169|NCT01651052|459979617|FG000|Overall Study|Lost to Follow-up|3|||
127825170|NCT01024465|459979628|FG000|Overall Study|Adverse Event|2|||
127825171|NCT01024465|459979628|FG000|Overall Study|Physician Decision|1|||
127825172|NCT03078608|459979629|FG000|Overall Study|Death|1|||
127825173|NCT03078608|459979630|FG001|Overall Study|Death|2|||
127825174|NCT03078608|459979631|FG002|Overall Study|Death|0|||
127825175|NCT03078608|459979632|FG003|Overall Study|Death|0|||
127825176|NCT03078608|459979629|FG000|Overall Study|Withdrawal by Subject|8|||
127825177|NCT03078608|459979630|FG001|Overall Study|Withdrawal by Subject|1|||
127825178|NCT03078608|459979631|FG002|Overall Study|Withdrawal by Subject|0|||
127825179|NCT03078608|459979632|FG003|Overall Study|Withdrawal by Subject|0|||
127825180|NCT03078608|459979629|FG000|Overall Study|Lost to Follow-up|5|||
127825181|NCT03078608|459979630|FG001|Overall Study|Lost to Follow-up|8|||
127825182|NCT03078608|459979631|FG002|Overall Study|Lost to Follow-up|4|||
127825183|NCT03078608|459979632|FG003|Overall Study|Lost to Follow-up|1|||
127825184|NCT00723840|459979633|FG000|Overall Study|Lost to Follow-up|2|||
127825185|NCT00723840|459979633|FG000|Overall Study|Failure to return|18|||
127825186|NCT00723840|459979633|FG000|Overall Study|Withdrawal by Subject|55|||
127825187|NCT00723840|459979633|FG000|Overall Study|Serious Adverse Events|3|||
127825188|NCT00723840|459979633|FG000|Overall Study|Other Medical Event|2|||
127825189|NCT00723840|459979633|FG000|Overall Study|Unspecified reason|2|||
127825190|NCT02086565|459979637|FG000|Overall Study|Lost to Follow-up|9|||
127825191|NCT02086565|459979638|FG001|Overall Study|Lost to Follow-up|7|||
127894875|NCT02688400|460238544|FG000|Overall Study|Adverse Event|21|||
127825192|NCT02086565|459979637|FG000|Overall Study|Withdrawal by Subject|2|||
127825193|NCT02086565|459979638|FG001|Overall Study|Withdrawal by Subject|1|||
127825194|NCT02086565|459979637|FG000|Overall Study|Death|3|||
127825195|NCT02086565|459979638|FG001|Overall Study|Death|2|||
127825196|NCT02086565|459979637|FG000|Overall Study|withdrawn by research team|2|||
127825197|NCT02086565|459979638|FG001|Overall Study|withdrawn by research team|2|||
127825198|NCT00751101|459979639|FG000|Overall Study|Withdrawal by Subject|1|||
127825199|NCT00751101|459979640|FG001|Overall Study|Withdrawal by Subject|0|||
127825200|NCT00751101|459979639|FG000|Overall Study|No HFS / Never Started Patch/|0|||
127825201|NCT00751101|459979640|FG001|Overall Study|No HFS / Never Started Patch/|4|||
127825202|NCT00751101|459979639|FG000|Overall Study|Never began capecitabine|1|||
127825203|NCT00751101|459979640|FG001|Overall Study|Never began capecitabine|0|||
127825204|NCT00751101|459979639|FG000|Overall Study|Physician Decision|0|||
127825205|NCT00751101|459979640|FG001|Overall Study|Physician Decision|1|||
127825206|NCT02116972|459979641|FG000|Overall Study|Adverse Event|4|||
127825207|NCT02116972|459979642|FG001|Overall Study|Adverse Event|4|||
127825208|NCT02116972|459979643|FG002|Overall Study|Adverse Event|1|||
127825209|NCT02116972|459979641|FG000|Overall Study|Withdrawal by Subject|1|||
127825210|NCT02116972|459979642|FG001|Overall Study|Withdrawal by Subject|1|||
127825211|NCT02116972|459979643|FG002|Overall Study|Withdrawal by Subject|5|||
127825212|NCT02116972|459979641|FG000|Overall Study|Protocol Violation|1|||
127825213|NCT02116972|459979642|FG001|Overall Study|Protocol Violation|0|||
127825214|NCT02116972|459979643|FG002|Overall Study|Protocol Violation|1|||
127825215|NCT02116972|459979641|FG000|Overall Study|Lost to Follow-up|4|||
127825216|NCT02116972|459979642|FG001|Overall Study|Lost to Follow-up|3|||
127825217|NCT02116972|459979643|FG002|Overall Study|Lost to Follow-up|1|||
127825218|NCT02116972|459979641|FG000|Overall Study|Lack of Efficacy|6|||
127825219|NCT02116972|459979642|FG001|Overall Study|Lack of Efficacy|6|||
127825220|NCT02116972|459979643|FG002|Overall Study|Lack of Efficacy|5|||
127825221|NCT02116972|459979641|FG000|Overall Study|scheduling conflicts and relocation|3|||
127825222|NCT02116972|459979642|FG001|Overall Study|scheduling conflicts and relocation|3|||
127825223|NCT02116972|459979643|FG002|Overall Study|scheduling conflicts and relocation|6|||
127825224|NCT00784784|459979644|FG000|Overall Study|Withdrawal by Subject|2|||
127825225|NCT00784784|459979645|FG001|Overall Study|Withdrawal by Subject|2|||
127825226|NCT01400971|459979646|FG000|Overall Study|Death|82|||
127825227|NCT01400971|459979646|FG000|Overall Study|Lost to Follow-up|196|||
127825228|NCT01400971|459979646|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
127825229|NCT01400971|459979646|FG000|Overall Study|Physician Decision|57|||
127825230|NCT01400971|459979646|FG000|Overall Study|Withdrawal by Subject|158|||
127825231|NCT01400971|459979646|FG000|Overall Study|Other|422|||
127825232|NCT01905397|459979647|FG000|Overall Study|Death|0|||
127825233|NCT01905397|459979648|FG001|Overall Study|Death|1|||
127825234|NCT01905397|459979647|FG000|Overall Study|Withdrawal by Subject|2|||
127825235|NCT01905397|459979648|FG001|Overall Study|Withdrawal by Subject|0|||
127825236|NCT01905397|459979647|FG000|Overall Study|Surgery canceled/aborted|9|||
127825237|NCT01905397|459979648|FG001|Overall Study|Surgery canceled/aborted|5|||
127825238|NCT01905397|459979647|FG000|Overall Study|Incision < 7 cm|2|||
127825239|NCT01905397|459979648|FG001|Overall Study|Incision < 7 cm|0|||
127825240|NCT01905397|459979647|FG000|Overall Study|Wrong treatment|1|||
127825241|NCT01905397|459979648|FG001|Overall Study|Wrong treatment|1|||
127825242|NCT01905397|459979647|FG000|Overall Study|Device not applied|3|||
127825243|NCT01905397|459979648|FG001|Overall Study|Device not applied|0|||
127825244|NCT01905397|459979647|FG000|Overall Study|Dressing not applied in operating room|1|||
127825245|NCT01905397|459979648|FG001|Overall Study|Dressing not applied in operating room|0|||
127825246|NCT01905397|459979647|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
127825247|NCT01905397|459979648|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
127825248|NCT00844428|459979649|FG000|Screening Period|Screen Failure|3|||
127825249|NCT00844428|459979649|FG000|Extension Treatment Period|Death|1|||
127825250|NCT00844428|459979649|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
127825251|NCT00789477|459979650|FG000|Overall Study|Withdrawal by Subject|2|||
127825252|NCT00789477|459979651|FG001|Overall Study|Withdrawal by Subject|1|||
127825253|NCT00789477|459979652|FG002|Overall Study|Withdrawal by Subject|3|||
127825254|NCT00789477|459979653|FG003|Overall Study|Withdrawal by Subject|2|||
127825255|NCT00789477|459979654|FG004|Overall Study|Withdrawal by Subject|3|||
127825256|NCT00789477|459979650|FG000|Overall Study|Protocol Violation|1|||
127894876|NCT02688400|460238545|FG001|Overall Study|Adverse Event|12|||
127894877|NCT02688400|460238544|FG000|Overall Study|Withdrawal by Subject|15|||
127825257|NCT00789477|459979651|FG001|Overall Study|Protocol Violation|0|||
127825258|NCT00789477|459979652|FG002|Overall Study|Protocol Violation|0|||
127825259|NCT00789477|459979653|FG003|Overall Study|Protocol Violation|1|||
127825260|NCT00789477|459979654|FG004|Overall Study|Protocol Violation|0|||
127825261|NCT00789477|459979650|FG000|Overall Study|Adverse Event|3|||
127825262|NCT00789477|459979651|FG001|Overall Study|Adverse Event|3|||
127825263|NCT00789477|459979652|FG002|Overall Study|Adverse Event|1|||
127825264|NCT00789477|459979653|FG003|Overall Study|Adverse Event|0|||
127825265|NCT00789477|459979654|FG004|Overall Study|Adverse Event|0|||
127825266|NCT00789477|459979650|FG000|Overall Study|Death|1|||
127825267|NCT00789477|459979651|FG001|Overall Study|Death|1|||
127825268|NCT00789477|459979652|FG002|Overall Study|Death|2|||
127825269|NCT00789477|459979653|FG003|Overall Study|Death|2|||
127825270|NCT00789477|459979654|FG004|Overall Study|Death|0|||
127825271|NCT00789477|459979650|FG000|Overall Study|Lost to Follow-up|0|||
127825272|NCT00789477|459979651|FG001|Overall Study|Lost to Follow-up|1|||
127825273|NCT00789477|459979652|FG002|Overall Study|Lost to Follow-up|4|||
127825274|NCT00789477|459979653|FG003|Overall Study|Lost to Follow-up|2|||
127825275|NCT00789477|459979654|FG004|Overall Study|Lost to Follow-up|4|||
127825276|NCT00789477|459979650|FG000|Overall Study|Lack of Efficacy|2|||
127825277|NCT00789477|459979651|FG001|Overall Study|Lack of Efficacy|0|||
127825278|NCT00789477|459979652|FG002|Overall Study|Lack of Efficacy|0|||
127825279|NCT00789477|459979653|FG003|Overall Study|Lack of Efficacy|0|||
127825280|NCT00789477|459979654|FG004|Overall Study|Lack of Efficacy|0|||
127825281|NCT00789477|459979650|FG000|Overall Study|Other|2|||
127825282|NCT00789477|459979651|FG001|Overall Study|Other|0|||
127825283|NCT00789477|459979652|FG002|Overall Study|Other|1|||
127825284|NCT00789477|459979653|FG003|Overall Study|Other|3|||
127825285|NCT00789477|459979654|FG004|Overall Study|Other|0|||
127825286|NCT00863928|459979657|FG000|Overall Study|Protocol Violation|26|||
127825287|NCT00863928|459979658|FG001|Overall Study|Protocol Violation|0|||
127825288|NCT00863928|459979657|FG000|Overall Study|Withdrawal by Subject|3|||
127825289|NCT00863928|459979658|FG001|Overall Study|Withdrawal by Subject|0|||
127825290|NCT00863928|459979657|FG000|Overall Study|surgery cancellation|4|||
127825291|NCT00863928|459979658|FG001|Overall Study|surgery cancellation|0|||
127825292|NCT00863928|459979657|FG000|Overall Study|medication allergy|3|||
127825293|NCT00863928|459979658|FG001|Overall Study|medication allergy|0|||
127825294|NCT00772967|459979659|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
127825295|NCT00772967|459979660|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
127825296|NCT00772967|459979661|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
127825297|NCT00772967|459979662|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
127825298|NCT00772967|459979663|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
127825299|NCT00772967|459979664|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
127825300|NCT00772967|459979659|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
127825301|NCT00772967|459979660|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
127825302|NCT00772967|459979661|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
127825303|NCT00772967|459979662|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
127825304|NCT00772967|459979663|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
127825305|NCT00772967|459979664|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
127825306|NCT00772967|459979659|FG000|Crossover Treatment 3|Adverse Event|0|||
127825307|NCT00772967|459979660|FG001|Crossover Treatment 3|Adverse Event|0|||
127825308|NCT00772967|459979661|FG002|Crossover Treatment 3|Adverse Event|0|||
127825309|NCT00772967|459979662|FG003|Crossover Treatment 3|Adverse Event|0|||
127825310|NCT00772967|459979663|FG004|Crossover Treatment 3|Adverse Event|1|||
127825311|NCT00772967|459979664|FG005|Crossover Treatment 3|Adverse Event|0|||
127825312|NCT01595646|459979665|FG000|Overall Study|Withdrawal by Subject|1|||
127825313|NCT01595646|459979666|FG001|Overall Study|Withdrawal by Subject|0|||
127825314|NCT01595646|459979667|FG002|Overall Study|Withdrawal by Subject|0|||
127825315|NCT04172831|459979671|FG000|Overall Study|Adverse Event|21|||
127825316|NCT04172831|459979672|FG001|Overall Study|Adverse Event|9|||
127825317|NCT04172831|459979671|FG000|Overall Study|Lack of Efficacy|2|||
127825318|NCT04172831|459979672|FG001|Overall Study|Lack of Efficacy|8|||
127825319|NCT04172831|459979671|FG000|Overall Study|Physician Decision|0|||
127825320|NCT04172831|459979672|FG001|Overall Study|Physician Decision|1|||
127825321|NCT04172831|459979671|FG000|Overall Study|Withdrawal by Subject|12|||
127825322|NCT04172831|459979672|FG001|Overall Study|Withdrawal by Subject|11|||
127825323|NCT04172831|459979671|FG000|Overall Study|Lost to Follow-up|4|||
127825324|NCT04172831|459979672|FG001|Overall Study|Lost to Follow-up|9|||
127825325|NCT04172831|459979671|FG000|Overall Study|COVID-19 related crisis|3|||
127825326|NCT04172831|459979672|FG001|Overall Study|COVID-19 related crisis|3|||
127825327|NCT04172831|459979671|FG000|Overall Study|Subject non-compliance|1|||
127825328|NCT04172831|459979672|FG001|Overall Study|Subject non-compliance|1|||
127825329|NCT04172831|459979671|FG000|Overall Study|Family emergency|1|||
127825330|NCT04172831|459979672|FG001|Overall Study|Family emergency|0|||
127825331|NCT01041573|459979673|FG000|Overall Study|Withdrawal by Subject|2|||
127825332|NCT01041573|459979674|FG001|Overall Study|Withdrawal by Subject|5|||
127825333|NCT01041573|459979675|FG002|Overall Study|Withdrawal by Subject|2|||
127825334|NCT01041573|459979676|FG003|Overall Study|Withdrawal by Subject|0|||
127825335|NCT01041573|459979673|FG000|Overall Study|Death|1|||
127825336|NCT01041573|459979674|FG001|Overall Study|Death|0|||
127825337|NCT01041573|459979675|FG002|Overall Study|Death|0|||
127825338|NCT01041573|459979676|FG003|Overall Study|Death|0|||
127825339|NCT01041573|459979673|FG000|Overall Study|Lost to Follow-up|0|||
127825340|NCT01041573|459979674|FG001|Overall Study|Lost to Follow-up|1|||
127825341|NCT01041573|459979675|FG002|Overall Study|Lost to Follow-up|2|||
127825342|NCT01041573|459979676|FG003|Overall Study|Lost to Follow-up|1|||
127825343|NCT01041573|459979673|FG000|Overall Study|Adverse Event|0|||
127825344|NCT01041573|459979674|FG001|Overall Study|Adverse Event|2|||
127825345|NCT01041573|459979675|FG002|Overall Study|Adverse Event|0|||
127825346|NCT01041573|459979676|FG003|Overall Study|Adverse Event|0|||
127825347|NCT01041573|459979673|FG000|Overall Study|relocation|1|||
127825348|NCT01041573|459979674|FG001|Overall Study|relocation|4|||
127825349|NCT01041573|459979675|FG002|Overall Study|relocation|3|||
127825350|NCT01041573|459979676|FG003|Overall Study|relocation|1|||
127825351|NCT01041573|459979673|FG000|Overall Study|further blood extraction|0|||
127825352|NCT01041573|459979674|FG001|Overall Study|further blood extraction|1|||
127825353|NCT01041573|459979675|FG002|Overall Study|further blood extraction|0|||
127825354|NCT01041573|459979676|FG003|Overall Study|further blood extraction|0|||
127825355|NCT01041573|459979673|FG000|Overall Study|positive to anti-HCV|1|||
127825356|NCT01041573|459979674|FG001|Overall Study|positive to anti-HCV|0|||
127825357|NCT01041573|459979675|FG002|Overall Study|positive to anti-HCV|0|||
127825358|NCT01041573|459979676|FG003|Overall Study|positive to anti-HCV|0|||
127825359|NCT01276847|459979680|FG000|Overall Study|Withdrawal by Subject|1|||
127825360|NCT01276847|459979681|FG001|Overall Study|Withdrawal by Subject|0|||
127825361|NCT01276847|459979682|FG002|Overall Study|Withdrawal by Subject|0|||
127825362|NCT02119104|459979683|FG000|Overall Study|Protocol Violation|16|||
127825363|NCT02239094|459979685|FG000|Overall Study|Withdrawal by Subject|1|||
127825364|NCT02239094|459979685|FG000|Overall Study|Remitted before started|1|||
127825365|NCT03184701|459979686|FG000|Overall Study|Death|3|||
127825366|NCT03184701|459979686|FG000|Overall Study|Physician Decision|3|||
127825367|NCT03184701|459979686|FG000|Overall Study|Withdrawal by Subject|6|||
127825368|NCT03184701|459979686|FG000|Overall Study|Lost to Follow-up|5|||
127825369|NCT02399475|459979692|FG000|Overall Study|Physician Decision|1|||
127825370|NCT02399475|459979693|FG001|Overall Study|Physician Decision|0|||
127825371|NCT01963117|459979701|FG000|Overall Study|Death|1|||
127825372|NCT01000064|459979702|FG000|Overall Study|Withdrawal by Subject|1|||
127825373|NCT01000064|459979703|FG001|Overall Study|Withdrawal by Subject|1|||
127825374|NCT01518192|459979704|FG000|Overall Study|Lost to Follow-up|29|||
127825375|NCT01518192|459979705|FG001|Overall Study|Lost to Follow-up|26|||
127825376|NCT01518192|459979706|FG002|Overall Study|Lost to Follow-up|35|||
127825377|NCT03090737|459979707|FG000|Overall Study|Other reasons|1|||
127825378|NCT03090737|459979707|FG000|Overall Study|Completed treatment as per protocol|17|||
127825379|NCT03090737|459979707|FG000|Overall Study|Maximum clinical benefit|2|||
127825380|NCT03090737|459979707|FG000|Overall Study|Adverse event unrelated to study drug|7|||
127757703|NCT01803282|459738658|FG010|Overall Study|Investigator's Discretion|1|||
127757704|NCT01803282|459738659|FG011|Overall Study|Investigator's Discretion|0|||
127757705|NCT01803282|459738648|FG000|Overall Study|Adverse Event|0|||
127757706|NCT01803282|459738649|FG001|Overall Study|Adverse Event|0|||
127757707|NCT01803282|459738650|FG002|Overall Study|Adverse Event|0|||
127757708|NCT01803282|459738651|FG003|Overall Study|Adverse Event|0|||
127757709|NCT01803282|459738652|FG004|Overall Study|Adverse Event|0|||
127757710|NCT01803282|459738653|FG005|Overall Study|Adverse Event|0|||
127757711|NCT01803282|459738654|FG006|Overall Study|Adverse Event|1|||
127757712|NCT01803282|459738655|FG007|Overall Study|Adverse Event|2|||
127757713|NCT01803282|459738656|FG008|Overall Study|Adverse Event|0|||
127757714|NCT01803282|459738657|FG009|Overall Study|Adverse Event|1|||
127825381|NCT03090737|459979707|FG000|Overall Study|Study drug toxicity|4|||
127825382|NCT03090737|459979707|FG000|Overall Study|Disease progression|98|||
127825383|NCT03141307|459979708|FG000|In-Hospital|Withdrawal by Subject|0|||
127825384|NCT03141307|459979709|FG001|In-Hospital|Withdrawal by Subject|2|||
127825385|NCT03141307|459979708|FG000|In-Hospital|Protocol Violation|4|||
127825386|NCT03141307|459979709|FG001|In-Hospital|Protocol Violation|0|||
127825387|NCT03141307|459979708|FG000|Follow-Up|Lost to Follow-up|97|||
127825388|NCT03141307|459979709|FG001|Follow-Up|Lost to Follow-up|54|||
127825389|NCT04430582|459979712|FG000|Overall Study|Found to meet exclusionary criteria|1|||
127825390|NCT04430582|459979713|FG001|Overall Study|Found to meet exclusionary criteria|0|||
127825391|NCT04430582|459979712|FG000|Overall Study|Withdrawal by Subject|0|||
127825392|NCT04430582|459979713|FG001|Overall Study|Withdrawal by Subject|1|||
127825393|NCT03009539|459981378|FG000|Overall Study|Lost to Follow-up|132|||
127825394|NCT03009539|459981379|FG001|Overall Study|Lost to Follow-up|113|||
127757715|NCT01803282|459738658|FG010|Overall Study|Adverse Event|0|||
127825395|NCT03009539|459981380|FG002|Overall Study|Lost to Follow-up|132|||
127825396|NCT03009539|459981381|FG003|Overall Study|Lost to Follow-up|113|||
127825397|NCT03151148|459981382|FG000|Overall Study|Lost to Follow-up|1|||
127825398|NCT03151148|459981383|FG001|Overall Study|Lost to Follow-up|0|||
127825399|NCT03151148|459981382|FG000|Overall Study|Withdrawal by Subject|1|||
127825400|NCT03151148|459981383|FG001|Overall Study|Withdrawal by Subject|0|||
127825401|NCT00494871|459981384|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
127825402|NCT00494871|459981385|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
127825403|NCT00494871|459981384|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
127825404|NCT00494871|459981385|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
127825405|NCT00494871|459981384|FG000|Double-blind (DB) Treatment Period|Death|8|||
127825406|NCT00494871|459981385|FG001|Double-blind (DB) Treatment Period|Death|3|||
127825407|NCT00494871|459981384|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
127825408|NCT00494871|459981385|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
127825409|NCT00494871|459981384|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
127825410|NCT00494871|459981385|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
127825411|NCT00494871|459981384|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
127825412|NCT00494871|459981385|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
127825413|NCT00494871|459981384|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
127825414|NCT00494871|459981385|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
127825415|NCT00494871|459981384|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
127825416|NCT00494871|459981385|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
127825417|NCT00494871|459981384|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
127825418|NCT00494871|459981385|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
127825419|NCT00494871|459981384|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
127825420|NCT00494871|459981385|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
127825421|NCT00494871|459981384|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
127825422|NCT00494871|459981385|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
127825423|NCT00494871|459981384|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
127825424|NCT00494871|459981385|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
127825425|NCT00494871|459981384|FG000|Follow-up (FU) Period|Adverse Event|1|||
127825426|NCT00494871|459981385|FG001|Follow-up (FU) Period|Adverse Event|1|||
127825427|NCT00494871|459981384|FG000|Follow-up (FU) Period|Death|13|||
127825428|NCT00494871|459981385|FG001|Follow-up (FU) Period|Death|12|||
127825429|NCT00494871|459981384|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
127825430|NCT00494871|459981385|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
127825431|NCT00494871|459981384|FG000|Follow-up (FU) Period|Physician Decision|0|||
127825432|NCT00494871|459981385|FG001|Follow-up (FU) Period|Physician Decision|1|||
127825433|NCT00494871|459981384|FG000|Follow-up (FU) Period|Protocol Violation|1|||
127825434|NCT00494871|459981385|FG001|Follow-up (FU) Period|Protocol Violation|0|||
127825435|NCT00494871|459981384|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
127825436|NCT00494871|459981385|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
127825437|NCT00494871|459981384|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
127825438|NCT00494871|459981385|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
127825439|NCT04543955|459981386|FG000|Overall Study|Company cancelled study|1|||
127825440|NCT04543955|459981387|FG001|Overall Study|Company cancelled study|0|||
127825442|NCT02433210|459981393|FG000|Overall Study|Physician Decision|1|||
127825443|NCT02433210|459981394|FG001|Overall Study|Physician Decision|0|||
127825444|NCT02433210|459981395|FG002|Overall Study|Physician Decision|0|||
127825445|NCT01958671|459981400|FG000|Overall Study|Adverse Event|1|||
127825446|NCT01958671|459981401|FG001|Overall Study|Adverse Event|1|||
127825447|NCT01958671|459981402|FG002|Overall Study|Adverse Event|5|||
127825448|NCT01958671|459981400|FG000|Overall Study|Death|1|||
127825449|NCT01958671|459981401|FG001|Overall Study|Death|0|||
127825450|NCT01958671|459981402|FG002|Overall Study|Death|0|||
127825451|NCT01958671|459981400|FG000|Overall Study|Excluded medication|0|||
127825452|NCT01958671|459981401|FG001|Overall Study|Excluded medication|0|||
127825453|NCT01958671|459981402|FG002|Overall Study|Excluded medication|1|||
127825454|NCT01958671|459981400|FG000|Overall Study|Hyperglycemia|0|||
127825455|NCT01958671|459981401|FG001|Overall Study|Hyperglycemia|0|||
127825456|NCT01958671|459981402|FG002|Overall Study|Hyperglycemia|2|||
127825457|NCT01958671|459981400|FG000|Overall Study|Lost to Follow-up|7|||
127825458|NCT01958671|459981401|FG001|Overall Study|Lost to Follow-up|11|||
127825459|NCT01958671|459981402|FG002|Overall Study|Lost to Follow-up|7|||
127825460|NCT01958671|459981400|FG000|Overall Study|Non-compliance with study drug|1|||
127825461|NCT01958671|459981401|FG001|Overall Study|Non-compliance with study drug|1|||
127825462|NCT01958671|459981402|FG002|Overall Study|Non-compliance with study drug|1|||
127825463|NCT01958671|459981400|FG000|Overall Study|Pregnancy|0|||
127825464|NCT01958671|459981401|FG001|Overall Study|Pregnancy|0|||
127825465|NCT01958671|459981402|FG002|Overall Study|Pregnancy|1|||
127825466|NCT01958671|459981400|FG000|Overall Study|Protocol Violation|0|||
127825467|NCT01958671|459981401|FG001|Overall Study|Protocol Violation|1|||
127825468|NCT01958671|459981402|FG002|Overall Study|Protocol Violation|0|||
127825469|NCT01958671|459981400|FG000|Overall Study|Study site terminated by sponsor|1|||
127825470|NCT01958671|459981401|FG001|Overall Study|Study site terminated by sponsor|0|||
127825471|NCT01958671|459981402|FG002|Overall Study|Study site terminated by sponsor|1|||
127825472|NCT01958671|459981400|FG000|Overall Study|Participant moved|0|||
127825473|NCT01958671|459981401|FG001|Overall Study|Participant moved|0|||
127825474|NCT01958671|459981402|FG002|Overall Study|Participant moved|1|||
127825475|NCT01958671|459981400|FG000|Overall Study|Withdrawal by Subject|8|||
127825476|NCT01958671|459981401|FG001|Overall Study|Withdrawal by Subject|10|||
127825477|NCT01958671|459981402|FG002|Overall Study|Withdrawal by Subject|13|||
127825478|NCT04760314|459981403|FG000|Induction Period|Withdrawal by Subject|0|||
127825479|NCT04760314|459981404|FG001|Induction Period|Withdrawal by Subject|1|||
127825480|NCT04760314|459981405|FG002|Induction Period|Withdrawal by Subject|1|||
127825481|NCT04760314|459981406|FG003|Induction Period|Withdrawal by Subject|0|||
127825482|NCT04760314|459981407|FG004|Induction Period|Withdrawal by Subject|0|||
127825483|NCT04760314|459981408|FG005|Induction Period|Withdrawal by Subject|0|||
127825484|NCT04760314|459981409|FG006|Induction Period|Withdrawal by Subject|0|||
127825485|NCT04760314|459981410|FG007|Induction Period|Withdrawal by Subject|0|||
127825486|NCT04760314|459981411|FG008|Induction Period|Withdrawal by Subject|0|||
127825487|NCT04760314|459981412|FG009|Induction Period|Withdrawal by Subject|0|||
127825488|NCT04760314|459981413|FG010|Induction Period|Withdrawal by Subject|0|||
127825489|NCT04760314|459981403|FG000|Induction Period|Adverse Event|0|||
127825490|NCT04760314|459981404|FG001|Induction Period|Adverse Event|0|||
127825491|NCT04760314|459981405|FG002|Induction Period|Adverse Event|2|||
127825492|NCT04760314|459981406|FG003|Induction Period|Adverse Event|0|||
127825493|NCT04760314|459981407|FG004|Induction Period|Adverse Event|0|||
127825494|NCT04760314|459981408|FG005|Induction Period|Adverse Event|0|||
127825495|NCT04760314|459981409|FG006|Induction Period|Adverse Event|0|||
127825496|NCT04760314|459981410|FG007|Induction Period|Adverse Event|0|||
127825497|NCT04760314|459981411|FG008|Induction Period|Adverse Event|0|||
127825498|NCT04760314|459981412|FG009|Induction Period|Adverse Event|0|||
127825499|NCT04760314|459981413|FG010|Induction Period|Adverse Event|0|||
127825500|NCT04760314|459981403|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
127825501|NCT04760314|459981404|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
127825502|NCT04760314|459981405|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
127825503|NCT04760314|459981406|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
127825504|NCT04760314|459981407|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
127825505|NCT04760314|459981408|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
127825506|NCT04760314|459981409|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
127825507|NCT04760314|459981410|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
127825508|NCT04760314|459981411|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
127825509|NCT04760314|459981412|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
127825510|NCT04760314|459981413|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
127825511|NCT04760314|459981403|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
127825512|NCT04760314|459981404|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
127825513|NCT04760314|459981405|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
127825514|NCT04760314|459981406|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
127825515|NCT04760314|459981407|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
127825516|NCT04760314|459981408|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
127825517|NCT04760314|459981409|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
127825518|NCT04760314|459981410|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
127825519|NCT04760314|459981411|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
127825520|NCT04760314|459981412|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
127825521|NCT04760314|459981413|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
127825522|NCT04760314|459981403|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
127825523|NCT04760314|459981404|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
127825524|NCT04760314|459981405|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
127825525|NCT04760314|459981406|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
127825526|NCT04760314|459981407|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
127825527|NCT04760314|459981408|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
127825528|NCT04760314|459981409|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
127825529|NCT04760314|459981410|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
127825530|NCT04760314|459981411|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
127825531|NCT04760314|459981412|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
127825532|NCT04760314|459981413|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
127825533|NCT04760314|459981403|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
127825534|NCT04760314|459981404|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
127894878|NCT02688400|460238545|FG001|Overall Study|Withdrawal by Subject|13|||
127825535|NCT04760314|459981405|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
127825536|NCT04760314|459981406|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
127825537|NCT04760314|459981407|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
127825538|NCT04760314|459981408|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
127825539|NCT04760314|459981409|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
127825540|NCT04760314|459981410|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
127825541|NCT04760314|459981411|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
127825542|NCT04760314|459981412|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
127825543|NCT04760314|459981413|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
127825544|NCT04760314|459981403|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
127825545|NCT04760314|459981404|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
127825546|NCT04760314|459981405|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
127825547|NCT04760314|459981406|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
127825548|NCT04760314|459981407|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
127825549|NCT04760314|459981408|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
127825550|NCT04760314|459981409|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
127825551|NCT04760314|459981410|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
127825552|NCT04760314|459981411|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
127825553|NCT04760314|459981412|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
127825554|NCT04760314|459981413|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
127825555|NCT04760314|459981403|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
127825556|NCT04760314|459981404|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
127825557|NCT04760314|459981405|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
127825558|NCT04760314|459981406|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
127825559|NCT04760314|459981407|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
127825560|NCT04760314|459981408|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
127825561|NCT04760314|459981409|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
127825562|NCT04760314|459981410|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
127825563|NCT04760314|459981411|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
127825564|NCT04760314|459981412|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
127825565|NCT04760314|459981413|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
127825566|NCT04760314|459981403|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
127825567|NCT04760314|459981404|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
127825568|NCT04760314|459981405|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
127825569|NCT04760314|459981406|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
127825570|NCT04760314|459981407|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
127825571|NCT04760314|459981408|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
127825572|NCT04760314|459981409|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
127825573|NCT04760314|459981410|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
127825574|NCT04760314|459981411|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
127825575|NCT04760314|459981412|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
127825576|NCT04760314|459981413|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
127825577|NCT04760314|459981403|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
127825578|NCT04760314|459981404|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
127825579|NCT04760314|459981405|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
127825580|NCT04760314|459981406|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
127825581|NCT04760314|459981407|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
127825582|NCT04760314|459981408|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
127825583|NCT04760314|459981409|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
127825584|NCT04760314|459981410|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
127825585|NCT04760314|459981411|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
127825586|NCT04760314|459981412|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
127825587|NCT04760314|459981413|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
127825588|NCT02207530|459981415|FG000|Overall Study|Worsening condition under investigation|78|||
127825589|NCT02207530|459981415|FG000|Overall Study|Patient decision to stop study treatment|5|||
127825590|NCT02207530|459981415|FG000|Overall Study|Adverse Event|8|||
127825591|NCT01505491|459981422|FG000|Overall Study|Other reason not listed|1|||
127825592|NCT01505491|459981423|FG001|Overall Study|Other reason not listed|0|||
127825593|NCT01505491|459981424|FG002|Overall Study|Other reason not listed|0|||
127825594|NCT01505491|459981422|FG000|Overall Study|Withdrawal by Subject|1|||
127825595|NCT01505491|459981423|FG001|Overall Study|Withdrawal by Subject|1|||
127825596|NCT01505491|459981424|FG002|Overall Study|Withdrawal by Subject|4|||
127825597|NCT01505491|459981422|FG000|Overall Study|Lost to Follow-up|0|||
127825598|NCT01505491|459981423|FG001|Overall Study|Lost to Follow-up|0|||
127825599|NCT01505491|459981424|FG002|Overall Study|Lost to Follow-up|1|||
127825600|NCT00406315|459981433|FG000|Overall Study|Death|1|||
127825601|NCT00406315|459981433|FG000|Overall Study|Adverse Event|39|||
127825602|NCT00406315|459981433|FG000|Overall Study|Laboratory Abnormality|4|||
127825603|NCT00406315|459981433|FG000|Overall Study|Lack of Efficacy|13|||
127825604|NCT00406315|459981433|FG000|Overall Study|Other|33|||
127825605|NCT00406315|459981433|FG000|Overall Study|Lost to Follow-up|21|||
127825606|NCT00406315|459981433|FG000|Overall Study|Withdrawal by Subject|30|||
127825607|NCT01312428|459981434|FG000|Overall Study|Study Termination|3|||
127825608|NCT01312428|459981435|FG001|Overall Study|Study Termination|4|||
127825609|NCT00339183|459981439|FG000|Overall Study|Adverse Event|5|||
127825610|NCT00339183|459981440|FG001|Overall Study|Adverse Event|3|||
127825611|NCT00339183|459981439|FG000|Overall Study|Withdrawal by Subject|16|||
127825612|NCT00339183|459981440|FG001|Overall Study|Withdrawal by Subject|19|||
127825613|NCT00339183|459981439|FG000|Overall Study|Physician Decision|2|||
127825614|NCT00339183|459981440|FG001|Overall Study|Physician Decision|4|||
127825615|NCT00339183|459981439|FG000|Overall Study|Lost to Follow-up|17|||
127825616|NCT00339183|459981440|FG001|Overall Study|Lost to Follow-up|17|||
127825617|NCT00339183|459981439|FG000|Overall Study|Protocol-specified criteria|12|||
127825618|NCT00339183|459981440|FG001|Overall Study|Protocol-specified criteria|8|||
127825619|NCT00339183|459981439|FG000|Overall Study|Missing reason|3|||
127825620|NCT00339183|459981440|FG001|Overall Study|Missing reason|1|||
127825621|NCT00339183|459981439|FG000|Overall Study|Other|46|||
127825622|NCT00339183|459981440|FG001|Overall Study|Other|40|||
127825623|NCT00339183|459981439|FG000|Overall Study|Ongoing|20|||
127825624|NCT00339183|459981440|FG001|Overall Study|Ongoing|13|||
127825625|NCT00611130|459981443|FG000|Overall Study|Lost to Follow-up|25|||
127825626|NCT00611130|459981444|FG001|Overall Study|Lost to Follow-up|29|||
127825627|NCT00611130|459981443|FG000|Overall Study|Protocol noncompliance|7|||
127825628|NCT00611130|459981444|FG001|Overall Study|Protocol noncompliance|6|||
127825629|NCT00611130|459981443|FG000|Overall Study|Withdrawal by Subject|6|||
127825630|NCT00611130|459981444|FG001|Overall Study|Withdrawal by Subject|5|||
127825631|NCT00611130|459981443|FG000|Overall Study|Other|5|||
127825632|NCT00611130|459981444|FG001|Overall Study|Other|4|||
127825633|NCT00611130|459981443|FG000|Overall Study|Incarceration|3|||
127825634|NCT00611130|459981444|FG001|Overall Study|Incarceration|2|||
127825635|NCT00611130|459981443|FG000|Overall Study|Administrative|1|||
127825636|NCT00611130|459981444|FG001|Overall Study|Administrative|1|||
127825637|NCT00611130|459981443|FG000|Overall Study|Adverse Event|1|||
127825638|NCT00611130|459981444|FG001|Overall Study|Adverse Event|0|||
127825639|NCT00611130|459981443|FG000|Overall Study|Death|1|||
127825640|NCT00611130|459981444|FG001|Overall Study|Death|0|||
127825641|NCT03964415|459981446|FG000|Overall Study|Sponsor's decision|1563|||
127825642|NCT03964415|459981447|FG001|Overall Study|Sponsor's decision|1528|||
127825643|NCT03964415|459981446|FG000|Overall Study|Lost to Follow-up|139|||
127825644|NCT03964415|459981447|FG001|Overall Study|Lost to Follow-up|146|||
127825645|NCT03964415|459981446|FG000|Overall Study|Withdrawal by Subject|68|||
127825646|NCT03964415|459981447|FG001|Overall Study|Withdrawal by Subject|72|||
127825647|NCT03964415|459981446|FG000|Overall Study|Physician Decision|34|||
127825648|NCT03964415|459981447|FG001|Overall Study|Physician Decision|48|||
127825649|NCT03964415|459981446|FG000|Overall Study|Adverse Event|3|||
127825650|NCT03964415|459981447|FG001|Overall Study|Adverse Event|0|||
127825651|NCT03964415|459981446|FG000|Overall Study|Death|4|||
127825652|NCT03964415|459981447|FG001|Overall Study|Death|6|||
127825653|NCT03964415|459981446|FG000|Overall Study|Protocol Violation|1|||
127825654|NCT03964415|459981447|FG001|Overall Study|Protocol Violation|4|||
127825655|NCT03964415|459981446|FG000|Overall Study|Other|35|||
127825656|NCT03964415|459981447|FG001|Overall Study|Other|38|||
127825657|NCT03964415|459981446|FG000|Overall Study|Randomized but not treated|6|||
127825658|NCT03964415|459981447|FG001|Overall Study|Randomized but not treated|7|||
127825659|NCT01734993|459981448|FG000|Overall Study|Adverse Event|1|||
127825660|NCT01734993|459981448|FG000|Overall Study|Lack of Efficacy|1|||
127825661|NCT01455428|459981452|FG000|Overall Study|Protocol Violation|2|||
127825662|NCT01455428|459981453|FG001|Overall Study|Protocol Violation|1|||
127825663|NCT01455428|459981452|FG000|Overall Study|Adverse Event|6|||
127825664|NCT01455428|459981453|FG001|Overall Study|Adverse Event|2|||
127825665|NCT01455428|459981452|FG000|Overall Study|Lost to Follow-up|1|||
127825666|NCT01455428|459981453|FG001|Overall Study|Lost to Follow-up|1|||
127825667|NCT01455428|459981452|FG000|Overall Study|Withdrawal by Subject|2|||
127825668|NCT01455428|459981453|FG001|Overall Study|Withdrawal by Subject|5|||
127825669|NCT01455428|459981452|FG000|Overall Study|Did not meet entrance criteria|0|||
127825670|NCT01455428|459981453|FG001|Overall Study|Did not meet entrance criteria|2|||
127825671|NCT01455428|459981452|FG000|Overall Study|Insufficient clinical response|0|||
127825672|NCT01455428|459981453|FG001|Overall Study|Insufficient clinical response|2|||
127825673|NCT01455428|459981452|FG000|Overall Study|Did not receive treatment|1|||
127825674|NCT01455428|459981453|FG001|Overall Study|Did not receive treatment|1|||
127825675|NCT01455428|459981452|FG000|Overall Study|Other|2|||
127825676|NCT01455428|459981453|FG001|Overall Study|Other|4|||
127825677|NCT03303339|459981454|FG000|Overall Study|Death|2|||
127825678|NCT03303339|459981455|FG001|Overall Study|Death|2|||
127825679|NCT03303339|459981456|FG002|Overall Study|Death|2|||
127825680|NCT03303339|459981457|FG003|Overall Study|Death|1|||
127825681|NCT03303339|459981458|FG004|Overall Study|Death|4|||
127825682|NCT03303339|459981459|FG005|Overall Study|Death|2|||
127825683|NCT03303339|459981460|FG006|Overall Study|Death|2|||
127825684|NCT03303339|459981461|FG007|Overall Study|Death|2|||
127825685|NCT03303339|459981462|FG008|Overall Study|Death|3|||
127825686|NCT03303339|459981463|FG009|Overall Study|Death|3|||
127825687|NCT03303339|459981464|FG010|Overall Study|Death|4|||
127825688|NCT03303339|459981465|FG011|Overall Study|Death|24|||
127825689|NCT03303339|459981454|FG000|Overall Study|Study Terminated by Sponsor|0|||
127825690|NCT03303339|459981455|FG001|Overall Study|Study Terminated by Sponsor|0|||
127825691|NCT03303339|459981456|FG002|Overall Study|Study Terminated by Sponsor|0|||
127825692|NCT03303339|459981457|FG003|Overall Study|Study Terminated by Sponsor|0|||
127825693|NCT03303339|459981458|FG004|Overall Study|Study Terminated by Sponsor|0|||
127825694|NCT03303339|459981459|FG005|Overall Study|Study Terminated by Sponsor|0|||
127825695|NCT03303339|459981460|FG006|Overall Study|Study Terminated by Sponsor|0|||
127825696|NCT03303339|459981461|FG007|Overall Study|Study Terminated by Sponsor|0|||
127825697|NCT03303339|459981462|FG008|Overall Study|Study Terminated by Sponsor|1|||
127825698|NCT03303339|459981463|FG009|Overall Study|Study Terminated by Sponsor|0|||
127825699|NCT03303339|459981464|FG010|Overall Study|Study Terminated by Sponsor|1|||
127825700|NCT03303339|459981465|FG011|Overall Study|Study Terminated by Sponsor|1|||
127825701|NCT03303339|459981454|FG000|Overall Study|Withdrawal by Subject|1|||
127825702|NCT03303339|459981455|FG001|Overall Study|Withdrawal by Subject|0|||
127825703|NCT03303339|459981456|FG002|Overall Study|Withdrawal by Subject|0|||
127825704|NCT03303339|459981457|FG003|Overall Study|Withdrawal by Subject|0|||
127825705|NCT03303339|459981458|FG004|Overall Study|Withdrawal by Subject|0|||
127825706|NCT03303339|459981459|FG005|Overall Study|Withdrawal by Subject|1|||
127825707|NCT03303339|459981460|FG006|Overall Study|Withdrawal by Subject|1|||
127825708|NCT03303339|459981461|FG007|Overall Study|Withdrawal by Subject|0|||
127825709|NCT03303339|459981462|FG008|Overall Study|Withdrawal by Subject|0|||
127825710|NCT03303339|459981463|FG009|Overall Study|Withdrawal by Subject|0|||
127825711|NCT03303339|459981464|FG010|Overall Study|Withdrawal by Subject|0|||
127825712|NCT03303339|459981465|FG011|Overall Study|Withdrawal by Subject|2|||
127825713|NCT03303339|459981454|FG000|Overall Study|Physician Decision|0|||
127825714|NCT03303339|459981455|FG001|Overall Study|Physician Decision|0|||
127825715|NCT03303339|459981456|FG002|Overall Study|Physician Decision|0|||
127825716|NCT03303339|459981457|FG003|Overall Study|Physician Decision|0|||
127825717|NCT03303339|459981458|FG004|Overall Study|Physician Decision|1|||
127825718|NCT03303339|459981459|FG005|Overall Study|Physician Decision|0|||
127825719|NCT03303339|459981460|FG006|Overall Study|Physician Decision|0|||
127825720|NCT03303339|459981461|FG007|Overall Study|Physician Decision|0|||
127825721|NCT03303339|459981462|FG008|Overall Study|Physician Decision|0|||
127825722|NCT03303339|459981463|FG009|Overall Study|Physician Decision|0|||
127825723|NCT03303339|459981464|FG010|Overall Study|Physician Decision|0|||
127825724|NCT03303339|459981465|FG011|Overall Study|Physician Decision|0|||
127825725|NCT03303339|459981454|FG000|Overall Study|Safety/Non-compliance|0|||
127825726|NCT03303339|459981455|FG001|Overall Study|Safety/Non-compliance|0|||
127825727|NCT03303339|459981456|FG002|Overall Study|Safety/Non-compliance|0|||
127825728|NCT03303339|459981457|FG003|Overall Study|Safety/Non-compliance|0|||
127825729|NCT03303339|459981458|FG004|Overall Study|Safety/Non-compliance|0|||
127825730|NCT03303339|459981459|FG005|Overall Study|Safety/Non-compliance|0|||
127825731|NCT03303339|459981460|FG006|Overall Study|Safety/Non-compliance|0|||
127825732|NCT03303339|459981461|FG007|Overall Study|Safety/Non-compliance|0|||
127825733|NCT03303339|459981462|FG008|Overall Study|Safety/Non-compliance|0|||
127825734|NCT03303339|459981463|FG009|Overall Study|Safety/Non-compliance|0|||
127825735|NCT03303339|459981464|FG010|Overall Study|Safety/Non-compliance|0|||
127825736|NCT03303339|459981465|FG011|Overall Study|Safety/Non-compliance|1|||
127825737|NCT01921270|459981470|FG000|Overall Study|Withdrawal by Subject|1|||
127825738|NCT00455858|459981472|FG000|Overall Study|Lost to Follow-up|2|||
127825739|NCT00455858|459981472|FG000|Overall Study|Protocol Violation|1|||
127825740|NCT00455858|459981472|FG000|Overall Study|Lack of Efficacy|1|||
127825741|NCT00455858|459981472|FG000|Overall Study|Well controlled FPG without insulin|1|||
127825742|NCT00455858|459981472|FG000|Overall Study|Withdrawal|1|||
127825743|NCT02092389|459981473|FG000|Overall Study|Adverse Event|1|||
127825744|NCT02092389|459981473|FG000|Overall Study|Other|5|||
127825745|NCT01242020|459981474|FG000|Overall Study|Withdrawal by Subject|2|||
127825746|NCT01242020|459981475|FG001|Overall Study|Withdrawal by Subject|0|||
127825747|NCT01242020|459981474|FG000|Overall Study|Failed screening|1|||
127825748|NCT01242020|459981475|FG001|Overall Study|Failed screening|0|||
127825749|NCT01161524|459981477|FG000|Core Study (23 Weeks)|Adverse Event|3|||
127825750|NCT01161524|459981478|FG001|Core Study (23 Weeks)|Adverse Event|0|||
127825751|NCT01161524|459981479|FG002|Core Study (23 Weeks)|Adverse Event|0|||
127825752|NCT01161524|459981477|FG000|Core Study (23 Weeks)|Other|1|||
127825753|NCT01161524|459981478|FG001|Core Study (23 Weeks)|Other|0|||
127825754|NCT01161524|459981479|FG002|Core Study (23 Weeks)|Other|0|||
127825755|NCT01161524|459981477|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
127825756|NCT01161524|459981478|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
127825757|NCT01161524|459981479|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
127825758|NCT01161524|459981477|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
127825759|NCT01161524|459981478|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
127825760|NCT01161524|459981479|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
127825761|NCT01161524|459981477|FG000|Core Study (23 Weeks)|Subject Choice|3|||
127825762|NCT01161524|459981478|FG001|Core Study (23 Weeks)|Subject Choice|2|||
127825763|NCT01161524|459981479|FG002|Core Study (23 Weeks)|Subject Choice|0|||
127825764|NCT01161524|459981477|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
127825765|NCT01161524|459981478|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
127825766|NCT01161524|459981479|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
127825767|NCT01161524|459981477|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
127825768|NCT01161524|459981478|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
127825769|NCT01161524|459981479|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
127825770|NCT01161524|459981477|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
127825771|NCT01161524|459981478|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
127825772|NCT01161524|459981479|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
127825773|NCT01161524|459981477|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
127825774|NCT01161524|459981478|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
127825775|NCT01161524|459981479|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
127825776|NCT01161524|459981477|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
127825777|NCT01161524|459981478|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
127825778|NCT01161524|459981479|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
127825779|NCT00231062|459981486|FG000|Overall Study|Physician Decision|6|||
127825780|NCT01052012|459981487|FG000|Overall Study|Not treated|2|||
127825781|NCT01052012|459981488|FG001|Overall Study|Not treated|5|||
127825782|NCT01052012|459981489|FG002|Overall Study|Not treated|0|||
127825783|NCT01052012|459981490|FG003|Overall Study|Not treated|0|||
127825784|NCT01052012|459981491|FG004|Overall Study|Not treated|11|||
127825785|NCT01052012|459981492|FG005|Overall Study|Not treated|8|||
127825786|NCT01052012|459981487|FG000|Overall Study|Adverse Event|1|||
127825787|NCT01052012|459981488|FG001|Overall Study|Adverse Event|0|||
127825788|NCT01052012|459981489|FG002|Overall Study|Adverse Event|0|||
127825789|NCT01052012|459981490|FG003|Overall Study|Adverse Event|1|||
127825790|NCT01052012|459981491|FG004|Overall Study|Adverse Event|0|||
127825791|NCT01052012|459981492|FG005|Overall Study|Adverse Event|0|||
127825792|NCT01052012|459981487|FG000|Overall Study|Lost to Follow-up|0|||
127825793|NCT01052012|459981488|FG001|Overall Study|Lost to Follow-up|0|||
127825794|NCT01052012|459981489|FG002|Overall Study|Lost to Follow-up|0|||
127825795|NCT01052012|459981490|FG003|Overall Study|Lost to Follow-up|0|||
127825796|NCT01052012|459981491|FG004|Overall Study|Lost to Follow-up|1|||
127825797|NCT01052012|459981492|FG005|Overall Study|Lost to Follow-up|0|||
127825798|NCT01052012|459981487|FG000|Overall Study|Withdrawal by Subject|1|||
127825799|NCT01052012|459981488|FG001|Overall Study|Withdrawal by Subject|1|||
127825800|NCT01052012|459981489|FG002|Overall Study|Withdrawal by Subject|0|||
127825801|NCT01052012|459981490|FG003|Overall Study|Withdrawal by Subject|0|||
127825802|NCT01052012|459981491|FG004|Overall Study|Withdrawal by Subject|3|||
127894879|NCT02688400|460238544|FG000|Overall Study|No study medication intake|1|||
127825803|NCT01052012|459981492|FG005|Overall Study|Withdrawal by Subject|1|||
127825804|NCT01052012|459981487|FG000|Overall Study|Physician Decision|0|||
127825805|NCT01052012|459981488|FG001|Overall Study|Physician Decision|0|||
127825806|NCT01052012|459981489|FG002|Overall Study|Physician Decision|0|||
127825807|NCT01052012|459981490|FG003|Overall Study|Physician Decision|0|||
127825808|NCT01052012|459981491|FG004|Overall Study|Physician Decision|0|||
127825809|NCT01052012|459981492|FG005|Overall Study|Physician Decision|1|||
127825810|NCT01052012|459981487|FG000|Overall Study|Other|0|||
127825811|NCT01052012|459981488|FG001|Overall Study|Other|0|||
127825812|NCT01052012|459981489|FG002|Overall Study|Other|0|||
127825813|NCT01052012|459981490|FG003|Overall Study|Other|0|||
127825814|NCT01052012|459981491|FG004|Overall Study|Other|1|||
127825815|NCT01052012|459981492|FG005|Overall Study|Other|0|||
127825816|NCT02873715|459981493|FG000|Overall Study|Lost to Follow-up|84|||
127825817|NCT02873715|459981494|FG001|Overall Study|Lost to Follow-up|94|||
127825818|NCT02873715|459981493|FG000|Overall Study|Withdrawal by Subject|7|||
127825819|NCT02873715|459981494|FG001|Overall Study|Withdrawal by Subject|26|||
127825820|NCT02698423|459981501|FG000|Overall Study|Lost to Follow-up|19|||
127825821|NCT02698423|459981502|FG001|Overall Study|Lost to Follow-up|24|||
127825822|NCT01651260|459981503|FG000|Overall Study|unable to apply product|3|||
127825823|NCT01952015|459981506|FG000|Induction|Protocol Violation|1|||
127825824|NCT01952015|459981506|FG000|Maintenance|Adverse Event|2|||
127825825|NCT01952015|459981506|FG000|Treatment Period 3|Physician Decision|9|||
127825826|NCT01597193|459981507|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
127825827|NCT01597193|459981508|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
127825828|NCT01597193|459981509|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
127825829|NCT01597193|459981510|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
127825830|NCT01597193|459981511|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
127825831|NCT01597193|459981512|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
127825832|NCT01597193|459981513|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
127825833|NCT01597193|459981507|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
127825834|NCT01597193|459981508|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
127757716|NCT01803282|459738659|FG011|Overall Study|Adverse Event|3|||
127757717|NCT01803282|459738648|FG000|Overall Study|Non-Compliance with Study Drug|0|||
127757718|NCT01803282|459738649|FG001|Overall Study|Non-Compliance with Study Drug|0|||
127757719|NCT01803282|459738650|FG002|Overall Study|Non-Compliance with Study Drug|0|||
127757720|NCT01803282|459738651|FG003|Overall Study|Non-Compliance with Study Drug|1|||
127757721|NCT01803282|459738652|FG004|Overall Study|Non-Compliance with Study Drug|0|||
127757722|NCT01803282|459738653|FG005|Overall Study|Non-Compliance with Study Drug|0|||
127757723|NCT01803282|459738654|FG006|Overall Study|Non-Compliance with Study Drug|0|||
127757724|NCT01803282|459738655|FG007|Overall Study|Non-Compliance with Study Drug|0|||
127757725|NCT01803282|459738656|FG008|Overall Study|Non-Compliance with Study Drug|0|||
127757726|NCT01803282|459738657|FG009|Overall Study|Non-Compliance with Study Drug|0|||
127757727|NCT01803282|459738658|FG010|Overall Study|Non-Compliance with Study Drug|0|||
127757728|NCT01803282|459738659|FG011|Overall Study|Non-Compliance with Study Drug|0|||
127757729|NCT01803282|459738648|FG000|Overall Study|Unknown Reason|0|||
127757730|NCT01803282|459738649|FG001|Overall Study|Unknown Reason|0|||
127757731|NCT01803282|459738650|FG002|Overall Study|Unknown Reason|0|||
127757732|NCT01803282|459738651|FG003|Overall Study|Unknown Reason|0|||
127757733|NCT01803282|459738652|FG004|Overall Study|Unknown Reason|0|||
127757734|NCT01803282|459738653|FG005|Overall Study|Unknown Reason|0|||
127757735|NCT01803282|459738654|FG006|Overall Study|Unknown Reason|0|||
127757736|NCT01803282|459738655|FG007|Overall Study|Unknown Reason|1|||
127757737|NCT01803282|459738656|FG008|Overall Study|Unknown Reason|0|||
127757738|NCT01803282|459738657|FG009|Overall Study|Unknown Reason|0|||
127757739|NCT01803282|459738658|FG010|Overall Study|Unknown Reason|0|||
127757740|NCT01803282|459738659|FG011|Overall Study|Unknown Reason|0|||
127757741|NCT01803282|459738648|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
127757742|NCT01803282|459738649|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
127757743|NCT01803282|459738650|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
127757744|NCT01803282|459738651|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
127757745|NCT01803282|459738652|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
127757746|NCT01803282|459738653|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
127757747|NCT01803282|459738654|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
127757748|NCT01803282|459738655|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
127757749|NCT01803282|459738656|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
127757750|NCT01803282|459738657|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
127757751|NCT01803282|459738658|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
127757752|NCT01803282|459738659|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
127757753|NCT01803282|459738648|FG000|Overall Study|Enrolled but Never Treated|0|||
127757754|NCT01803282|459738649|FG001|Overall Study|Enrolled but Never Treated|0|||
127757755|NCT01803282|459738650|FG002|Overall Study|Enrolled but Never Treated|0|||
127757756|NCT01803282|459738651|FG003|Overall Study|Enrolled but Never Treated|0|||
127757757|NCT01803282|459738652|FG004|Overall Study|Enrolled but Never Treated|1|||
127757758|NCT01803282|459738653|FG005|Overall Study|Enrolled but Never Treated|0|||
127757759|NCT01803282|459738654|FG006|Overall Study|Enrolled but Never Treated|1|||
127757760|NCT01803282|459738655|FG007|Overall Study|Enrolled but Never Treated|1|||
127757761|NCT01803282|459738656|FG008|Overall Study|Enrolled but Never Treated|0|||
127757762|NCT01803282|459738657|FG009|Overall Study|Enrolled but Never Treated|1|||
127825835|NCT01597193|459981509|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
127825836|NCT01597193|459981510|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
127825837|NCT01597193|459981511|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
127825838|NCT01597193|459981512|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
127825839|NCT01597193|459981513|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
127825840|NCT01597193|459981507|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
127825841|NCT01597193|459981508|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
127825842|NCT01597193|459981509|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
127825843|NCT01597193|459981510|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
127825844|NCT01597193|459981511|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
127825845|NCT01597193|459981512|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
127825846|NCT01597193|459981513|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
127825847|NCT01597193|459981507|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
127825848|NCT01597193|459981508|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
127825849|NCT01597193|459981509|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
127825850|NCT01597193|459981510|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
127825851|NCT01597193|459981511|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
127825852|NCT01597193|459981512|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
127825853|NCT01597193|459981513|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
127825854|NCT01597193|459981507|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
127825855|NCT01597193|459981508|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
127825856|NCT01597193|459981509|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
127825857|NCT01597193|459981510|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
127825858|NCT01597193|459981511|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
127825859|NCT01597193|459981512|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
127825860|NCT01597193|459981513|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
127825861|NCT02508701|459981514|FG000|Overall Study|Lost to Follow-up|9|||
127825862|NCT02508701|459981515|FG001|Overall Study|Lost to Follow-up|5|||
127825863|NCT02508701|459981516|FG002|Overall Study|Lost to Follow-up|5|||
127825864|NCT02508701|459981517|FG003|Overall Study|Lost to Follow-up|3|||
127825865|NCT01259297|459981518|FG000|Double Blind Randomized Period|Death|1|||
127825866|NCT01259297|459981519|FG001|Double Blind Randomized Period|Death|1|||
127825867|NCT01259297|459981520|FG002|Double Blind Randomized Period|Death|1|||
127825868|NCT01259297|459981521|FG003|Double Blind Randomized Period|Death|2|||
127825869|NCT01259297|459981522|FG004|Double Blind Randomized Period|Death|1|||
127825870|NCT01259297|459981523|FG005|Double Blind Randomized Period|Death|5|||
127825871|NCT01259297|459981524|FG006|Double Blind Randomized Period|Death|2|||
127825872|NCT01259297|459981525|FG007|Double Blind Randomized Period|Death|1|||
127825873|NCT01259297|459981518|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
127825874|NCT01259297|459981519|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
127825875|NCT01259297|459981520|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
127825876|NCT01259297|459981521|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
127825877|NCT01259297|459981522|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
127825878|NCT01259297|459981523|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
127825879|NCT01259297|459981524|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
127825880|NCT01259297|459981525|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
127825881|NCT01259297|459981518|FG000|Double Blind Randomized Period|Other reasons|0|||
127825882|NCT01259297|459981519|FG001|Double Blind Randomized Period|Other reasons|1|||
127825883|NCT01259297|459981520|FG002|Double Blind Randomized Period|Other reasons|0|||
127825884|NCT01259297|459981521|FG003|Double Blind Randomized Period|Other reasons|0|||
127825885|NCT01259297|459981522|FG004|Double Blind Randomized Period|Other reasons|1|||
127825886|NCT01259297|459981523|FG005|Double Blind Randomized Period|Other reasons|2|||
127825887|NCT01259297|459981524|FG006|Double Blind Randomized Period|Other reasons|3|||
127825888|NCT01259297|459981525|FG007|Double Blind Randomized Period|Other reasons|1|||
127825889|NCT00592501|459981526|FG000|Overall Study|Withdrawal by Subject|1|||
127825890|NCT00592501|459981526|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
127825891|NCT03880227|459981530|FG000|First Visit|Withdrawal by Subject|1|||
127825892|NCT03880227|459981531|FG001|First Visit|Withdrawal by Subject|0|||
127825893|NCT03880227|459981532|FG002|First Visit|Withdrawal by Subject|0|||
127825894|NCT03880227|459981533|FG003|First Visit|Withdrawal by Subject|0|||
127825895|NCT03880227|459981530|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
127825896|NCT03880227|459981531|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
127825897|NCT03880227|459981532|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
127825898|NCT03880227|459981533|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
127825899|NCT03880227|459981530|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
127825900|NCT03880227|459981531|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
127825901|NCT03880227|459981532|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
127825902|NCT03880227|459981533|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
127825903|NCT03880227|459981530|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
127825904|NCT03880227|459981531|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
127825905|NCT03880227|459981532|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
127825906|NCT03880227|459981533|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
127825907|NCT01070784|459981534|FG000|Overall Study|Withdrawal by Subject|6|||
127825908|NCT01070784|459981535|FG001|Overall Study|Withdrawal by Subject|9|||
127825909|NCT01070784|459981534|FG000|Overall Study|Adverse Event|14|||
127825910|NCT01070784|459981535|FG001|Overall Study|Adverse Event|9|||
127825911|NCT02582749|459981537|FG000|Overall Study|Study terminated by funder|5|||
127825912|NCT02582749|459981538|FG001|Overall Study|Study terminated by funder|10|||
127825913|NCT02582749|459981537|FG000|Overall Study|Withdrawal by Subject|0|||
127825914|NCT02582749|459981538|FG001|Overall Study|Withdrawal by Subject|1|||
127825915|NCT02815397|459981539|FG000|Overall Study|Physician Decision|2|||
127825916|NCT02518620|459981540|FG000|Overall Study|Adverse Event|23|||
127825917|NCT02518620|459981541|FG001|Overall Study|Adverse Event|11|||
127825918|NCT02518620|459981540|FG000|Overall Study|Lack of Efficacy|2|||
127825919|NCT02518620|459981541|FG001|Overall Study|Lack of Efficacy|0|||
127825920|NCT02518620|459981540|FG000|Overall Study|Non-Compliance with Study Drug|1|||
127825921|NCT02518620|459981541|FG001|Overall Study|Non-Compliance with Study Drug|0|||
127825922|NCT02518620|459981540|FG000|Overall Study|Physician Decision|1|||
127825923|NCT02518620|459981541|FG001|Overall Study|Physician Decision|1|||
127825924|NCT02518620|459981540|FG000|Overall Study|Sponsor's Decision|0|||
127825925|NCT02518620|459981541|FG001|Overall Study|Sponsor's Decision|3|||
127825926|NCT02518620|459981540|FG000|Overall Study|Lost to Follow-up|1|||
127825927|NCT02518620|459981541|FG001|Overall Study|Lost to Follow-up|1|||
127825928|NCT02518620|459981540|FG000|Overall Study|Withdrawal by Subject|17|||
127825929|NCT02518620|459981541|FG001|Overall Study|Withdrawal by Subject|9|||
127825930|NCT02518620|459981540|FG000|Overall Study|Death|1|||
127825931|NCT02518620|459981541|FG001|Overall Study|Death|0|||
127825932|NCT02518620|459981540|FG000|Overall Study|Pregnancy Wish|3|||
127825933|NCT02518620|459981541|FG001|Overall Study|Pregnancy Wish|0|||
127825934|NCT02518620|459981540|FG000|Overall Study|Pregnancy|1|||
127825935|NCT02518620|459981541|FG001|Overall Study|Pregnancy|0|||
127825936|NCT02518620|459981540|FG000|Overall Study|Relocation|2|||
127825937|NCT02518620|459981541|FG001|Overall Study|Relocation|1|||
127825938|NCT00085540|459981542|FG000|Overall Study|Withdrawal by Subject|0|||
127825939|NCT00085540|459981543|FG001|Overall Study|Withdrawal by Subject|1|||
127825940|NCT00085540|459981542|FG000|Overall Study|Protocol Violation|0|||
127825941|NCT00085540|459981543|FG001|Overall Study|Protocol Violation|1|||
127825942|NCT01605396|459981544|FG000|Overall Study|Adverse Event|5|||
127825943|NCT01605396|459981545|FG001|Overall Study|Adverse Event|3|||
127825944|NCT01605396|459981544|FG000|Overall Study|Lost to Follow-up|1|||
127825945|NCT01605396|459981545|FG001|Overall Study|Lost to Follow-up|0|||
127825946|NCT01605396|459981544|FG000|Overall Study|Non-Compliance With Study Drug|1|||
127825947|NCT01605396|459981545|FG001|Overall Study|Non-Compliance With Study Drug|1|||
127825948|NCT01605396|459981544|FG000|Overall Study|Physician Decision|2|||
127825949|NCT01605396|459981545|FG001|Overall Study|Physician Decision|2|||
127825950|NCT01605396|459981544|FG000|Overall Study|Progressive Disease|23|||
127825951|NCT01605396|459981545|FG001|Overall Study|Progressive Disease|27|||
127825952|NCT01605396|459981544|FG000|Overall Study|Withdrawal by Subject|4|||
127825953|NCT01605396|459981545|FG001|Overall Study|Withdrawal by Subject|2|||
127825954|NCT01605396|459981544|FG000|Overall Study|Transfer Off Study|4|||
127825955|NCT01605396|459981545|FG001|Overall Study|Transfer Off Study|5|||
127825956|NCT01663740|459981548|FG000|Overall Study|Lost to Follow-up|1|||
127825957|NCT01663740|459981549|FG001|Overall Study|Lost to Follow-up|4|||
127825958|NCT01663740|459981548|FG000|Overall Study|Other|9|||
127825959|NCT01663740|459981549|FG001|Overall Study|Other|2|||
127825960|NCT01663740|459981548|FG000|Overall Study|Inclusion/Exclusion not met|1|||
127825961|NCT01663740|459981549|FG001|Overall Study|Inclusion/Exclusion not met|0|||
127825962|NCT01663740|459981548|FG000|Overall Study|Death|0|||
127825963|NCT01663740|459981549|FG001|Overall Study|Death|1|||
127825964|NCT01663740|459981548|FG000|Overall Study|Withdrawal by Subject|2|||
127825965|NCT01663740|459981549|FG001|Overall Study|Withdrawal by Subject|1|||
127825966|NCT01663740|459981548|FG000|Overall Study|No end of study status|3|||
127825967|NCT01663740|459981549|FG001|Overall Study|No end of study status|0|||
127825968|NCT03607682|459981550|FG000|Overall Study|Withdrawal by Subject|1|||
127825969|NCT03607682|459981550|FG000|Overall Study|Disease progression|1|||
127825970|NCT01770353|459981551|FG000|Overall Study|Progressive disease|2|||
127825971|NCT01770353|459981552|FG001|Overall Study|Progressive disease|1|||
127825972|NCT01770353|459981551|FG000|Overall Study|Adverse Event|0|||
127825973|NCT01770353|459981552|FG001|Overall Study|Adverse Event|1|||
127825974|NCT01770353|459981551|FG000|Overall Study|Protocol Violation|1|||
127825975|NCT01770353|459981552|FG001|Overall Study|Protocol Violation|0|||
127825976|NCT01770353|459981551|FG000|Overall Study|Physician Decision|0|||
127825977|NCT01770353|459981552|FG001|Overall Study|Physician Decision|3|||
127825978|NCT01770353|459981551|FG000|Overall Study|Clinical deterioration|3|||
127825979|NCT01770353|459981552|FG001|Overall Study|Clinical deterioration|6|||
127825980|NCT01770353|459981551|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
127825981|NCT01770353|459981552|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
127825982|NCT00376688|459981553|FG000|Overall Study|Adverse Event|3|||
127825983|NCT00376688|459981553|FG000|Overall Study|Death|1|||
127825984|NCT02574312|459981554|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
127825985|NCT02574312|459981555|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
127825986|NCT04267562|459983536|FG000|Assessed for Eligibility|Screen Failure|64|||
127825987|NCT04267562|459983536|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
127825988|NCT04267562|459983536|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
127825989|NCT04267562|459983536|FG000|Assessed for Eligibility|Site closure|6|||
127825990|NCT04267562|459983536|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
127825991|NCT04267562|459983536|FG000|Assessed for Eligibility|Physician Decision|1|||
127825992|NCT04267562|459983536|FG000|Month 24|Elective hysterectomy|1|||
127825993|NCT04267562|459983536|FG000|Month 24|Lost to Follow-up|1|||
127825994|NCT04267562|459983536|FG000|Month 36|Elective hysterectomy|2|||
127825995|NCT04267562|459983536|FG000|Month 36|Lost to Follow-up|3|||
127825996|NCT02078713|459983537|FG000|Overall Study|Lost to Follow-up|49|||
127825997|NCT02078713|459983538|FG001|Overall Study|Lost to Follow-up|55|||
127825998|NCT02078713|459983539|FG002|Overall Study|Lost to Follow-up|0|||
127825999|NCT02078713|459983540|FG003|Overall Study|Lost to Follow-up|0|||
127826000|NCT02078713|459983537|FG000|Overall Study|Pregnant at baseline|3|||
127826001|NCT02078713|459983538|FG001|Overall Study|Pregnant at baseline|5|||
127826002|NCT02078713|459983539|FG002|Overall Study|Pregnant at baseline|0|||
127826003|NCT02078713|459983540|FG003|Overall Study|Pregnant at baseline|0|||
127826004|NCT02078713|459983537|FG000|Overall Study|Enrolled twice|0|||
127826005|NCT02078713|459983538|FG001|Overall Study|Enrolled twice|1|||
127826006|NCT02078713|459983539|FG002|Overall Study|Enrolled twice|0|||
127826007|NCT02078713|459983540|FG003|Overall Study|Enrolled twice|0|||
127826008|NCT00696657|459983545|FG000|Overall Study|Protocol Violation|0|||
127826009|NCT00696657|459983546|FG001|Overall Study|Protocol Violation|0|||
127826010|NCT00696657|459983547|FG002|Overall Study|Protocol Violation|0|||
127826011|NCT00696657|459983548|FG003|Overall Study|Protocol Violation|0|||
127826012|NCT00696657|459983549|FG004|Overall Study|Protocol Violation|0|||
127826013|NCT00696657|459983550|FG005|Overall Study|Protocol Violation|1|||
127826014|NCT00696657|459983551|FG006|Overall Study|Protocol Violation|0|||
127826015|NCT00696657|459983552|FG007|Overall Study|Protocol Violation|0|||
127826016|NCT00696657|459983553|FG008|Overall Study|Protocol Violation|1|||
127826017|NCT00696657|459983545|FG000|Overall Study|Lack of Efficacy|0|||
127826018|NCT00696657|459983546|FG001|Overall Study|Lack of Efficacy|1|||
127826019|NCT00696657|459983547|FG002|Overall Study|Lack of Efficacy|0|||
127826020|NCT00696657|459983548|FG003|Overall Study|Lack of Efficacy|0|||
127826021|NCT00696657|459983549|FG004|Overall Study|Lack of Efficacy|0|||
127826022|NCT00696657|459983550|FG005|Overall Study|Lack of Efficacy|0|||
127826023|NCT00696657|459983551|FG006|Overall Study|Lack of Efficacy|0|||
127826024|NCT00696657|459983552|FG007|Overall Study|Lack of Efficacy|0|||
127826025|NCT00696657|459983553|FG008|Overall Study|Lack of Efficacy|0|||
127826026|NCT00696657|459983545|FG000|Overall Study|Withdrawal criteria|1|||
127826027|NCT00696657|459983546|FG001|Overall Study|Withdrawal criteria|3|||
127826028|NCT00696657|459983547|FG002|Overall Study|Withdrawal criteria|2|||
127826029|NCT00696657|459983548|FG003|Overall Study|Withdrawal criteria|2|||
127826030|NCT00696657|459983549|FG004|Overall Study|Withdrawal criteria|0|||
127826031|NCT00696657|459983550|FG005|Overall Study|Withdrawal criteria|0|||
127826032|NCT00696657|459983551|FG006|Overall Study|Withdrawal criteria|1|||
127826033|NCT00696657|459983552|FG007|Overall Study|Withdrawal criteria|1|||
127826034|NCT00696657|459983553|FG008|Overall Study|Withdrawal criteria|2|||
127826035|NCT00696657|459983545|FG000|Overall Study|Unclassified|0|||
127826036|NCT00696657|459983546|FG001|Overall Study|Unclassified|1|||
127826037|NCT00696657|459983547|FG002|Overall Study|Unclassified|3|||
127826038|NCT00696657|459983548|FG003|Overall Study|Unclassified|2|||
127826039|NCT00696657|459983549|FG004|Overall Study|Unclassified|4|||
127826040|NCT00696657|459983550|FG005|Overall Study|Unclassified|2|||
127826041|NCT00696657|459983551|FG006|Overall Study|Unclassified|0|||
127826042|NCT00696657|459983552|FG007|Overall Study|Unclassified|0|||
127826043|NCT00696657|459983553|FG008|Overall Study|Unclassified|1|||
127826044|NCT00696657|459983545|FG000|Overall Study|Adverse Event|0|||
127826045|NCT00696657|459983546|FG001|Overall Study|Adverse Event|0|||
127826046|NCT00696657|459983547|FG002|Overall Study|Adverse Event|3|||
127826047|NCT00696657|459983548|FG003|Overall Study|Adverse Event|7|||
127826048|NCT00696657|459983549|FG004|Overall Study|Adverse Event|6|||
127826049|NCT00696657|459983550|FG005|Overall Study|Adverse Event|9|||
127826050|NCT00696657|459983551|FG006|Overall Study|Adverse Event|14|||
127826051|NCT00696657|459983552|FG007|Overall Study|Adverse Event|2|||
127826052|NCT00696657|459983553|FG008|Overall Study|Adverse Event|5|||
127826053|NCT01790438|459983554|FG000|Overall Study|Adverse Event|3|||
127826054|NCT01790438|459983555|FG001|Overall Study|Adverse Event|2|||
127826055|NCT01790438|459983554|FG000|Overall Study|Death|4|||
127826056|NCT01790438|459983555|FG001|Overall Study|Death|0|||
127826057|NCT01790438|459983554|FG000|Overall Study|Lost to Follow-up|5|||
127826058|NCT01790438|459983555|FG001|Overall Study|Lost to Follow-up|2|||
127826059|NCT01790438|459983554|FG000|Overall Study|Withdrawal by Subject|13|||
127826060|NCT01790438|459983555|FG001|Overall Study|Withdrawal by Subject|2|||
127826061|NCT01790438|459983554|FG000|Overall Study|Physician Decision|3|||
127826062|NCT01790438|459983555|FG001|Overall Study|Physician Decision|1|||
127826063|NCT01790438|459983554|FG000|Overall Study|Sponsor Decision|0|||
127826064|NCT01790438|459983555|FG001|Overall Study|Sponsor Decision|3|||
127826065|NCT01790438|459983554|FG000|Overall Study|Protocol Required Discontinuation|7|||
127826066|NCT01790438|459983555|FG001|Overall Study|Protocol Required Discontinuation|1|||
127826067|NCT02090114|459983559|FG000|Overall Study|Withdrawal by Subject|3|||
127826068|NCT02090114|459983560|FG001|Overall Study|Withdrawal by Subject|6|||
127826069|NCT02090114|459983561|FG002|Overall Study|Withdrawal by Subject|2|||
127826070|NCT02090114|459983562|FG003|Overall Study|Withdrawal by Subject|1|||
127826071|NCT02090114|459983559|FG000|Overall Study|Physician Decision|5|||
127826072|NCT02090114|459983560|FG001|Overall Study|Physician Decision|0|||
127826073|NCT02090114|459983561|FG002|Overall Study|Physician Decision|1|||
127826074|NCT02090114|459983562|FG003|Overall Study|Physician Decision|1|||
127826075|NCT02090114|459983559|FG000|Overall Study|Adverse Event|1|||
127826076|NCT02090114|459983560|FG001|Overall Study|Adverse Event|2|||
127826077|NCT02090114|459983561|FG002|Overall Study|Adverse Event|2|||
127826078|NCT02090114|459983562|FG003|Overall Study|Adverse Event|0|||
127826079|NCT02090114|459983559|FG000|Overall Study|Progressive Disease|20|||
127826080|NCT02090114|459983560|FG001|Overall Study|Progressive Disease|21|||
127826081|NCT02090114|459983561|FG002|Overall Study|Progressive Disease|23|||
127826082|NCT02090114|459983562|FG003|Overall Study|Progressive Disease|6|||
127826083|NCT02090114|459983559|FG000|Overall Study|Death|1|||
127826084|NCT02090114|459983560|FG001|Overall Study|Death|0|||
127826085|NCT02090114|459983561|FG002|Overall Study|Death|1|||
127826086|NCT02090114|459983562|FG003|Overall Study|Death|0|||
127826087|NCT04439838|459983565|FG000|Overall Study|Withdrawal by Subject|0|||
127826088|NCT04439838|459983566|FG001|Overall Study|Withdrawal by Subject|0|||
127826089|NCT04439838|459983567|FG002|Overall Study|Withdrawal by Subject|0|||
127826090|NCT04439838|459983568|FG003|Overall Study|Withdrawal by Subject|0|||
127826091|NCT04439838|459983569|FG004|Overall Study|Withdrawal by Subject|0|||
127826092|NCT04439838|459983570|FG005|Overall Study|Withdrawal by Subject|0|||
127826093|NCT04439838|459983571|FG006|Overall Study|Withdrawal by Subject|0|||
127826094|NCT04439838|459983572|FG007|Overall Study|Withdrawal by Subject|0|||
127826095|NCT04439838|459983573|FG008|Overall Study|Withdrawal by Subject|1|||
127826096|NCT04494633|459983574|FG000|Overall Study|Lost to Follow-up|5|||
127826097|NCT04494633|459983575|FG001|Overall Study|Lost to Follow-up|3|||
127826098|NCT04494633|459983574|FG000|Overall Study|Protocol Violation|1|||
127826099|NCT04494633|459983575|FG001|Overall Study|Protocol Violation|1|||
127826100|NCT02948777|459983576|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
127826101|NCT02311478|459983577|FG000|Overall Study|Withdrawal by Subject|1|||
127826102|NCT02311478|459983577|FG000|Overall Study|Lost to Follow-up|5|||
127826103|NCT02311478|459983577|FG000|Overall Study|Failed IUD Insertion|1|||
127826104|NCT03242928|459983578|FG000|Overall Study|Adverse Event|2|||
127826105|NCT03242928|459983579|FG001|Overall Study|Adverse Event|1|||
127826106|NCT03242928|459983578|FG000|Overall Study|Lost to Follow-up|2|||
127826107|NCT03242928|459983579|FG001|Overall Study|Lost to Follow-up|0|||
127826108|NCT03242928|459983578|FG000|Overall Study|Physician Decision|0|||
127826109|NCT03242928|459983579|FG001|Overall Study|Physician Decision|1|||
127826110|NCT03242928|459983578|FG000|Overall Study|Withdrawal by Subject|5|||
127826111|NCT03242928|459983579|FG001|Overall Study|Withdrawal by Subject|3|||
127826112|NCT00390780|459983580|FG000|Overall Study|Not completed|10|||
127826113|NCT00390780|459983581|FG001|Overall Study|Not completed|4|||
127826114|NCT00390780|459983580|FG000|Overall Study|Protocol Violation|6|||
127826115|NCT00390780|459983581|FG001|Overall Study|Protocol Violation|4|||
127826116|NCT00390780|459983580|FG000|Overall Study|Lost to Follow-up|3|||
127826117|NCT00390780|459983581|FG001|Overall Study|Lost to Follow-up|6|||
127894880|NCT02688400|460238545|FG001|Overall Study|No study medication intake|4|||
127826118|NCT00390780|459983580|FG000|Overall Study|Adverse Event|2|||
127826119|NCT00390780|459983581|FG001|Overall Study|Adverse Event|3|||
127826120|NCT00390780|459983580|FG000|Overall Study|Death|1|||
127826121|NCT00390780|459983581|FG001|Overall Study|Death|3|||
127826122|NCT00390780|459983580|FG000|Overall Study|Withdrawal by Subject|1|||
127826123|NCT00390780|459983581|FG001|Overall Study|Withdrawal by Subject|2|||
127826124|NCT00390780|459983580|FG000|Overall Study|Inclusion criteria not satisfied|0|||
127826125|NCT00390780|459983581|FG001|Overall Study|Inclusion criteria not satisfied|2|||
127826126|NCT00390780|459983580|FG000|Overall Study|Lost to follow up and other reasons|0|||
127826127|NCT00390780|459983581|FG001|Overall Study|Lost to follow up and other reasons|1|||
127826128|NCT00390780|459983580|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
127826129|NCT00390780|459983581|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
127826130|NCT00390780|459983580|FG000|Overall Study|SAE, death|0|||
127826131|NCT00390780|459983581|FG001|Overall Study|SAE, death|1|||
127826132|NCT00109733|459983582|FG000|Overall Study|Protocol Violation|0|||
127826133|NCT00109733|459983583|FG001|Overall Study|Protocol Violation|1|||
127826134|NCT00109733|459983582|FG000|Overall Study|Stopped taking study drug|1|||
127826135|NCT00109733|459983583|FG001|Overall Study|Stopped taking study drug|1|||
127826136|NCT00109733|459983582|FG000|Overall Study|Non-compliant|0|||
127826137|NCT00109733|459983583|FG001|Overall Study|Non-compliant|1|||
127826138|NCT00109733|459983582|FG000|Overall Study|Could not commit time for study|1|||
127826139|NCT00109733|459983583|FG001|Overall Study|Could not commit time for study|1|||
127826140|NCT06094296|459983588|FG000|Overall Study|Progressive Disease|1|||
127826141|NCT06094296|459983589|FG001|Overall Study|Progressive Disease|0|||
127826142|NCT06094296|459983590|FG002|Overall Study|Progressive Disease|0|||
127826143|NCT06094296|459983591|FG003|Overall Study|Progressive Disease|0|||
127826144|NCT03332667|459983592|FG000|Overall Study|Adverse Event|0|||
127826145|NCT03332667|459983593|FG001|Overall Study|Adverse Event|0|||
127826146|NCT03332667|459983594|FG002|Overall Study|Adverse Event|2|||
127826147|NCT03332667|459983595|FG003|Overall Study|Adverse Event|1|||
127826148|NCT03332667|459983592|FG000|Overall Study|Withdrawal by Subject|2|||
127826149|NCT03332667|459983593|FG001|Overall Study|Withdrawal by Subject|1|||
127826150|NCT03332667|459983594|FG002|Overall Study|Withdrawal by Subject|5|||
127826151|NCT03332667|459983595|FG003|Overall Study|Withdrawal by Subject|1|||
127826152|NCT03332667|459983592|FG000|Overall Study|Disease Progression or Relapse|2|||
127826153|NCT03332667|459983593|FG001|Overall Study|Disease Progression or Relapse|1|||
127826154|NCT03332667|459983594|FG002|Overall Study|Disease Progression or Relapse|3|||
127826155|NCT03332667|459983595|FG003|Overall Study|Disease Progression or Relapse|0|||
127826156|NCT03332667|459983592|FG000|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
127826157|NCT03332667|459983593|FG001|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
127826158|NCT03332667|459983594|FG002|Overall Study|Initiation onto Another Anti-Cancer Therapy|3|||
127826159|NCT03332667|459983595|FG003|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
127826160|NCT03332667|459983592|FG000|Overall Study|No Treatment Received|0|||
127826161|NCT03332667|459983593|FG001|Overall Study|No Treatment Received|0|||
127826162|NCT03332667|459983594|FG002|Overall Study|No Treatment Received|1|||
127826163|NCT03332667|459983595|FG003|Overall Study|No Treatment Received|0|||
127826164|NCT04964063|459983596|FG000|Overall Study|Adverse Event|4|||
127826165|NCT04964063|459983596|FG000|Overall Study|Lost to Follow-up|47|||
127826166|NCT04964063|459983596|FG000|Overall Study|Withdrawal by Subject|5|||
127826167|NCT04964063|459983596|FG000|Overall Study|Baseline Tasks Expired|41|||
127826168|NCT04964063|459983596|FG000|Overall Study|Participant withdrawn in error|1|||
127826169|NCT01035606|459983597|FG000|Overall Study|change in health, job demands,family|3|||
127826170|NCT01035606|459983598|FG001|Overall Study|change in health, job demands,family|3|||
127826171|NCT01035606|459983599|FG002|Overall Study|change in health, job demands,family|4|||
127826172|NCT03350750|459983601|FG000|Overall Study|Death|1|||
127826173|NCT03350750|459983602|FG001|Overall Study|Death|1|||
127826174|NCT02433288|459983603|FG000|Overall Study|Severe non-compliance to protocol|13|||
127826175|NCT02433288|459983604|FG001|Overall Study|Severe non-compliance to protocol|7|||
127826176|NCT02433288|459983603|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
127826177|NCT02433288|459983604|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
127826178|NCT02433288|459983603|FG000|Overall Study|Withdrawal by Subject|101|||
127826179|NCT02433288|459983604|FG001|Overall Study|Withdrawal by Subject|99|||
127826180|NCT02433288|459983603|FG000|Overall Study|Lost to Follow-up|2|||
127826181|NCT02433288|459983604|FG001|Overall Study|Lost to Follow-up|14|||
127826182|NCT02433288|459983603|FG000|Overall Study|Death|0|||
127826183|NCT02433288|459983604|FG001|Overall Study|Death|3|||
127826184|NCT01849250|459983605|FG000|Overall Study|Withdrawal by Subject|1|||
127826185|NCT01849250|459983606|FG001|Overall Study|Withdrawal by Subject|0|||
127826186|NCT01849250|459983605|FG000|Overall Study|Not Evaluable|5|||
127826187|NCT01849250|459983606|FG001|Overall Study|Not Evaluable|3|||
127826188|NCT01849250|459983605|FG000|Overall Study|Screen Failure|1|||
127826189|NCT01849250|459983606|FG001|Overall Study|Screen Failure|0|||
127826190|NCT00367640|459983607|FG000|Overall Study|Adverse Event|3|||
127894881|NCT02688400|460238544|FG000|Overall Study|Lost to Follow-up|0|||
127826191|NCT00367640|459983608|FG001|Overall Study|Adverse Event|6|||
127826192|NCT00367640|459983609|FG002|Overall Study|Adverse Event|8|||
127826193|NCT00367640|459983610|FG003|Overall Study|Adverse Event|0|||
127826194|NCT00367640|459983607|FG000|Overall Study|Withdrawal by Subject|8|||
127826195|NCT00367640|459983608|FG001|Overall Study|Withdrawal by Subject|11|||
127826196|NCT00367640|459983609|FG002|Overall Study|Withdrawal by Subject|8|||
127826197|NCT00367640|459983610|FG003|Overall Study|Withdrawal by Subject|6|||
127826198|NCT00367640|459983607|FG000|Overall Study|Any other reason not above-mentioned|7|||
127826199|NCT00367640|459983608|FG001|Overall Study|Any other reason not above-mentioned|5|||
127826200|NCT00367640|459983609|FG002|Overall Study|Any other reason not above-mentioned|3|||
127826201|NCT00367640|459983610|FG003|Overall Study|Any other reason not above-mentioned|4|||
127826202|NCT01063751|459983613|FG000|Overall Study|Censored from analyses|42|||
127826203|NCT01063751|459983613|FG000|Overall Study|Withdrawal by Subject|34|||
127826204|NCT01063751|459983613|FG000|Overall Study|Lost to Follow-up|30|||
127826205|NCT01063751|459983613|FG000|Overall Study|Death|13|||
127826206|NCT01063751|459983613|FG000|Overall Study|Sponsored Terminated Study|60|||
127826207|NCT01063751|459983613|FG000|Overall Study|Cases terminated due to investigator leaving the site and site closure.|35|||
127826208|NCT01063751|459983613|FG000|Overall Study|Investigator site closed|10|||
127826209|NCT01063751|459983613|FG000|Overall Study|Revision|6|||
127826210|NCT01063751|459983613|FG000|Overall Study|Physician Decision|4|||
127826211|NCT01525849|459983616|FG000|Overall Study|Lost to Follow-up|3|||
127826212|NCT01525849|459983617|FG001|Overall Study|Lost to Follow-up|2|||
127826213|NCT01525849|459983616|FG000|Overall Study|Withdrawal by Subject|1|||
127826214|NCT01525849|459983617|FG001|Overall Study|Withdrawal by Subject|9|||
127826215|NCT01525849|459983616|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
127826216|NCT01525849|459983617|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
127826217|NCT01525849|459983616|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
127826218|NCT01525849|459983617|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
127826219|NCT00793819|459983618|FG000|Overall Study|Adverse Event|8|||
127826220|NCT00793819|459983619|FG001|Overall Study|Adverse Event|4|||
127826221|NCT00793819|459983618|FG000|Overall Study|Lack of Efficacy|1|||
127826222|NCT00793819|459983619|FG001|Overall Study|Lack of Efficacy|1|||
127826223|NCT00793819|459983618|FG000|Overall Study|Withdrawal by Subject|4|||
127826224|NCT00793819|459983619|FG001|Overall Study|Withdrawal by Subject|3|||
127826225|NCT00793819|459983618|FG000|Overall Study|Lost to Follow-up|1|||
127826226|NCT00793819|459983619|FG001|Overall Study|Lost to Follow-up|1|||
127826227|NCT00446446|459983620|FG000|Overall Study|Death|10|||
127826228|NCT00446446|459983620|FG000|Overall Study|Withdrawal by Subject|6|||
127826229|NCT00446446|459983620|FG000|Overall Study|Other|4|||
127826230|NCT00446446|459983620|FG000|Overall Study|Disease Progession|2|||
127826231|NCT00446446|459983620|FG000|Overall Study|Adverse Event|1|||
127826232|NCT00446446|459983620|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
127826233|NCT02142894|459983621|FG000|Overall Study|Protocol Violation|8|||
127826234|NCT00257192|459983625|FG000|Overall Study|Adverse Event|21|||
127826235|NCT00257192|459983626|FG001|Overall Study|Adverse Event|10|||
127826236|NCT00257192|459983625|FG000|Overall Study|Laboratory abnormality|1|||
127826237|NCT00257192|459983626|FG001|Overall Study|Laboratory abnormality|1|||
127826238|NCT00257192|459983625|FG000|Overall Study|Lost to Follow-up|3|||
127826239|NCT00257192|459983626|FG001|Overall Study|Lost to Follow-up|3|||
127826240|NCT00257192|459983625|FG000|Overall Study|Insufficient clinical response|18|||
127826241|NCT00257192|459983626|FG001|Overall Study|Insufficient clinical response|18|||
127826242|NCT00257192|459983625|FG000|Overall Study|Withdrawal by Subject|14|||
127826243|NCT00257192|459983626|FG001|Overall Study|Withdrawal by Subject|2|||
127826244|NCT00257192|459983625|FG000|Overall Study|Randomized but not treated|0|||
127826245|NCT00257192|459983626|FG001|Overall Study|Randomized but not treated|1|||
127826246|NCT00257192|459983625|FG000|Overall Study|Study terminated by sponsor|1|||
127826247|NCT00257192|459983626|FG001|Overall Study|Study terminated by sponsor|0|||
127826248|NCT00257192|459983625|FG000|Overall Study|Miscellaneous|0|||
127826249|NCT00257192|459983626|FG001|Overall Study|Miscellaneous|4|||
127826250|NCT02062151|459983627|FG000|Overall Study|screen failure|1|||
127826251|NCT00570739|459983628|FG000|Overall Study|Adverse Event|8|||
127826252|NCT00570739|459983629|FG001|Overall Study|Adverse Event|6|||
127826253|NCT00570739|459983630|FG002|Overall Study|Adverse Event|2|||
127826254|NCT00570739|459983631|FG003|Overall Study|Adverse Event|2|||
127826255|NCT00570739|459983628|FG000|Overall Study|Lost to Follow-up|4|||
127826256|NCT00570739|459983629|FG001|Overall Study|Lost to Follow-up|5|||
127826257|NCT00570739|459983630|FG002|Overall Study|Lost to Follow-up|4|||
127826258|NCT00570739|459983631|FG003|Overall Study|Lost to Follow-up|1|||
127826259|NCT00570739|459983628|FG000|Overall Study|Physician Decision|1|||
127826260|NCT00570739|459983629|FG001|Overall Study|Physician Decision|1|||
127826261|NCT00570739|459983630|FG002|Overall Study|Physician Decision|0|||
127826262|NCT00570739|459983631|FG003|Overall Study|Physician Decision|0|||
127826263|NCT00570739|459983628|FG000|Overall Study|Withdrawal by Subject|7|||
127826264|NCT00570739|459983629|FG001|Overall Study|Withdrawal by Subject|7|||
127826265|NCT00570739|459983630|FG002|Overall Study|Withdrawal by Subject|3|||
127826266|NCT00570739|459983631|FG003|Overall Study|Withdrawal by Subject|5|||
127826267|NCT00570739|459983628|FG000|Overall Study|Required restricted medication|0|||
127826268|NCT00570739|459983629|FG001|Overall Study|Required restricted medication|0|||
127826269|NCT00570739|459983630|FG002|Overall Study|Required restricted medication|1|||
127826270|NCT00570739|459983631|FG003|Overall Study|Required restricted medication|0|||
127826271|NCT00570739|459983628|FG000|Overall Study|Met discontinuation criteria|1|||
127826272|NCT00570739|459983629|FG001|Overall Study|Met discontinuation criteria|0|||
127826273|NCT00570739|459983630|FG002|Overall Study|Met discontinuation criteria|1|||
127826274|NCT00570739|459983631|FG003|Overall Study|Met discontinuation criteria|1|||
127826275|NCT00570739|459983628|FG000|Overall Study|Other|0|||
127826276|NCT00570739|459983629|FG001|Overall Study|Other|2|||
127826277|NCT00570739|459983630|FG002|Overall Study|Other|5|||
127826278|NCT00570739|459983631|FG003|Overall Study|Other|3|||
127826279|NCT01844700|459983641|FG000|Overall Study|Lack of Efficacy|1|||
127826280|NCT01844700|459983642|FG001|Overall Study|Lack of Efficacy|0|||
127826281|NCT01844700|459983641|FG000|Overall Study|refused medication switch|1|||
127826282|NCT01844700|459983642|FG001|Overall Study|refused medication switch|0|||
127826283|NCT01844700|459983641|FG000|Overall Study|Withdrawal by Subject|1|||
127826284|NCT01844700|459983642|FG001|Overall Study|Withdrawal by Subject|0|||
127826285|NCT01844700|459983641|FG000|Overall Study|stopped taking meds|0|||
127826286|NCT01844700|459983642|FG001|Overall Study|stopped taking meds|1|||
127826287|NCT02375698|459983643|FG000|Overall Study|Withdrawal by Subject|0|||
127826288|NCT02375698|459983644|FG001|Overall Study|Withdrawal by Subject|2|||
127826289|NCT02375698|459983643|FG000|Overall Study|Physician Decision|2|||
127826290|NCT02375698|459983644|FG001|Overall Study|Physician Decision|0|||
127826291|NCT02680847|459983645|FG000|Overall Study|Other|2|||
127826292|NCT02680847|459983646|FG001|Overall Study|Other|0|||
127826293|NCT02680847|459983647|FG002|Overall Study|Other|0|||
127826294|NCT02680847|459983645|FG000|Overall Study|No longer met eligibility criteria|2|||
127826295|NCT02680847|459983646|FG001|Overall Study|No longer met eligibility criteria|2|||
127826296|NCT02680847|459983647|FG002|Overall Study|No longer met eligibility criteria|0|||
127826297|NCT02680847|459983645|FG000|Overall Study|Unwilling to participate in study|1|||
127826298|NCT02680847|459983646|FG001|Overall Study|Unwilling to participate in study|1|||
127826299|NCT02680847|459983647|FG002|Overall Study|Unwilling to participate in study|0|||
127826300|NCT02680847|459983645|FG000|Overall Study|Lack of Efficacy|0|||
127826301|NCT02680847|459983646|FG001|Overall Study|Lack of Efficacy|0|||
127826302|NCT02680847|459983647|FG002|Overall Study|Lack of Efficacy|2|||
127826303|NCT02680847|459983645|FG000|Overall Study|Adverse Event|0|||
127826304|NCT02680847|459983646|FG001|Overall Study|Adverse Event|0|||
127826305|NCT02680847|459983647|FG002|Overall Study|Adverse Event|1|||
127826306|NCT00803244|459983650|FG000|Overall Study|Adverse Event|1|||
127826307|NCT00803244|459983651|FG001|Overall Study|Adverse Event|2|||
127826308|NCT00803244|459983650|FG000|Overall Study|Withdrawal by Subject|2|||
127826309|NCT00803244|459983651|FG001|Overall Study|Withdrawal by Subject|3|||
127826310|NCT00803244|459983650|FG000|Overall Study|Any other reason not above-mentioned|4|||
127826311|NCT00803244|459983651|FG001|Overall Study|Any other reason not above-mentioned|10|||
127826312|NCT02021812|459983655|FG000|Overall Study|Death|8|||
127826313|NCT02021812|459983655|FG000|Overall Study|Withdrawal by Subject|3|||
127826314|NCT02021812|459983655|FG000|Overall Study|Lost to Follow-up|2|||
127826315|NCT02021812|459983655|FG000|Overall Study|Refuse to return, COVD 19|2|||
127826316|NCT00564629|459983656|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
127826317|NCT00564629|459983657|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
127826318|NCT03241173|459983658|FG000|Overall Study|Death|3|||
127826319|NCT03241173|459983659|FG001|Overall Study|Death|2|||
127826320|NCT03241173|459983660|FG002|Overall Study|Death|4|||
127826321|NCT03241173|459983661|FG003|Overall Study|Death|4|||
127826322|NCT03241173|459983662|FG004|Overall Study|Death|2|||
127826323|NCT03241173|459983663|FG005|Overall Study|Death|2|||
127826324|NCT03241173|459983664|FG006|Overall Study|Death|3|||
127826325|NCT03241173|459983665|FG007|Overall Study|Death|1|||
127826326|NCT03241173|459983666|FG008|Overall Study|Death|0|||
127826327|NCT03241173|459983667|FG009|Overall Study|Death|5|||
127826328|NCT03241173|459983668|FG010|Overall Study|Death|4|||
127826329|NCT03241173|459983669|FG011|Overall Study|Death|3|||
127826330|NCT03241173|459983670|FG012|Overall Study|Death|0|||
127826331|NCT03241173|459983671|FG013|Overall Study|Death|0|||
127826332|NCT03241173|459983672|FG014|Overall Study|Death|0|||
127826333|NCT03241173|459983658|FG000|Overall Study|Withdrawal by Subject|0|||
127826334|NCT03241173|459983659|FG001|Overall Study|Withdrawal by Subject|0|||
127826335|NCT03241173|459983660|FG002|Overall Study|Withdrawal by Subject|1|||
127826336|NCT03241173|459983661|FG003|Overall Study|Withdrawal by Subject|0|||
127826337|NCT03241173|459983662|FG004|Overall Study|Withdrawal by Subject|0|||
127826338|NCT03241173|459983663|FG005|Overall Study|Withdrawal by Subject|1|||
127826339|NCT03241173|459983664|FG006|Overall Study|Withdrawal by Subject|0|||
127826340|NCT03241173|459983665|FG007|Overall Study|Withdrawal by Subject|0|||
127826341|NCT03241173|459983666|FG008|Overall Study|Withdrawal by Subject|0|||
127826342|NCT03241173|459983667|FG009|Overall Study|Withdrawal by Subject|0|||
127826343|NCT03241173|459983668|FG010|Overall Study|Withdrawal by Subject|0|||
127826344|NCT03241173|459983669|FG011|Overall Study|Withdrawal by Subject|0|||
127826345|NCT03241173|459983670|FG012|Overall Study|Withdrawal by Subject|0|||
127826346|NCT03241173|459983671|FG013|Overall Study|Withdrawal by Subject|0|||
127826347|NCT03241173|459983672|FG014|Overall Study|Withdrawal by Subject|0|||
127826348|NCT03241173|459983658|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
127826349|NCT03241173|459983659|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
127826350|NCT03241173|459983660|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
127826351|NCT03241173|459983661|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
127826352|NCT03241173|459983662|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
127826353|NCT03241173|459983663|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
127826354|NCT03241173|459983664|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
127826355|NCT03241173|459983665|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
127826356|NCT03241173|459983666|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
127826357|NCT03241173|459983667|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
127826358|NCT03241173|459983668|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
127826359|NCT03241173|459983669|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
127826360|NCT03241173|459983670|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
127826361|NCT03241173|459983671|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
127826362|NCT03241173|459983672|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
127826363|NCT03241173|459983658|FG000|Overall Study|Lost to Follow-up|0|||
127826364|NCT03241173|459983659|FG001|Overall Study|Lost to Follow-up|0|||
127826365|NCT03241173|459983660|FG002|Overall Study|Lost to Follow-up|0|||
127826366|NCT03241173|459983661|FG003|Overall Study|Lost to Follow-up|0|||
127826367|NCT03241173|459983662|FG004|Overall Study|Lost to Follow-up|1|||
127826368|NCT03241173|459983663|FG005|Overall Study|Lost to Follow-up|0|||
127826369|NCT03241173|459983664|FG006|Overall Study|Lost to Follow-up|0|||
127826370|NCT03241173|459983665|FG007|Overall Study|Lost to Follow-up|0|||
127826371|NCT03241173|459983666|FG008|Overall Study|Lost to Follow-up|0|||
127826372|NCT03241173|459983667|FG009|Overall Study|Lost to Follow-up|1|||
127826373|NCT03241173|459983668|FG010|Overall Study|Lost to Follow-up|0|||
127826374|NCT03241173|459983669|FG011|Overall Study|Lost to Follow-up|0|||
127826375|NCT03241173|459983670|FG012|Overall Study|Lost to Follow-up|0|||
127826376|NCT03241173|459983671|FG013|Overall Study|Lost to Follow-up|0|||
127826377|NCT03241173|459983672|FG014|Overall Study|Lost to Follow-up|0|||
127826378|NCT03634072|459983673|FG000|Overall Study|Early termination of overall study|1|||
127826379|NCT03634072|459983674|FG001|Overall Study|Early termination of overall study|0|||
127826380|NCT00590681|459983675|FG000|Overall Study|Withdrawal by Subject|7|||
127826381|NCT00590681|459983675|FG000|Overall Study|Adverse Event|8|||
127826382|NCT00590681|459983675|FG000|Overall Study|Death|3|||
127826383|NCT00590681|459983675|FG000|Overall Study|Lost to Follow-up|1|||
127826384|NCT00590681|459983675|FG000|Overall Study|disease progression|1|||
127826385|NCT00053846|459983678|FG000|Overall Study|Changed mind|8|||
127826386|NCT00053846|459983679|FG001|Overall Study|Changed mind|13|||
127826387|NCT00053846|459983678|FG000|Overall Study|Became too ill|8|||
127826388|NCT00053846|459983679|FG001|Overall Study|Became too ill|7|||
127826389|NCT00053846|459983678|FG000|Overall Study|Expired|5|||
127826390|NCT00053846|459983679|FG001|Overall Study|Expired|0|||
127826391|NCT00053846|459983678|FG000|Overall Study|Became ineligible|3|||
127826392|NCT00053846|459983679|FG001|Overall Study|Became ineligible|1|||
127826393|NCT00053846|459983678|FG000|Overall Study|Did not return data|1|||
127826394|NCT00053846|459983679|FG001|Overall Study|Did not return data|2|||
127826395|NCT00053846|459983678|FG000|Overall Study|Quit due to side effects|1|||
127826396|NCT00053846|459983679|FG001|Overall Study|Quit due to side effects|3|||
127826397|NCT00053846|459983678|FG000|Overall Study|Pills too large|0|||
127826398|NCT00053846|459983679|FG001|Overall Study|Pills too large|1|||
127826399|NCT00064662|459983680|FG000|Overall Study|Death|1|||
127826400|NCT00064662|459983681|FG001|Overall Study|Death|1|||
127826401|NCT00064662|459983680|FG000|Overall Study|Lost to Follow-up|57|||
127826402|NCT00064662|459983681|FG001|Overall Study|Lost to Follow-up|44|||
127826403|NCT00064662|459983680|FG000|Overall Study|Withdrawal by Subject|14|||
127826404|NCT00064662|459983681|FG001|Overall Study|Withdrawal by Subject|14|||
127826405|NCT00064662|459983680|FG000|Overall Study|Administratively withdrawn|2|||
127826406|NCT00064662|459983681|FG001|Overall Study|Administratively withdrawn|2|||
127826407|NCT01345786|459983693|FG000|Overall Study|Adverse Event|0|||
127826408|NCT01345786|459983694|FG001|Overall Study|Adverse Event|1|||
127826409|NCT01345786|459983695|FG002|Overall Study|Adverse Event|3|||
127826410|NCT01345786|459983696|FG003|Overall Study|Adverse Event|1|||
127826411|NCT01345786|459983693|FG000|Overall Study|Subject withdrew consent|2|||
127826412|NCT01345786|459983694|FG001|Overall Study|Subject withdrew consent|2|||
127826413|NCT01345786|459983695|FG002|Overall Study|Subject withdrew consent|1|||
127826414|NCT01345786|459983696|FG003|Overall Study|Subject withdrew consent|0|||
127826415|NCT01345786|459983693|FG000|Overall Study|Noncompliance with protocol|1|||
127826416|NCT01345786|459983694|FG001|Overall Study|Noncompliance with protocol|0|||
127826417|NCT01345786|459983695|FG002|Overall Study|Noncompliance with protocol|1|||
127826418|NCT01345786|459983696|FG003|Overall Study|Noncompliance with protocol|0|||
127826419|NCT01345786|459983693|FG000|Overall Study|Administrative|3|||
127826420|NCT01345786|459983694|FG001|Overall Study|Administrative|5|||
127826421|NCT01345786|459983695|FG002|Overall Study|Administrative|0|||
127826422|NCT01345786|459983696|FG003|Overall Study|Administrative|0|||
127826423|NCT01345786|459983693|FG000|Overall Study|Lost to Follow-up|0|||
127826424|NCT01345786|459983694|FG001|Overall Study|Lost to Follow-up|0|||
127826425|NCT01345786|459983695|FG002|Overall Study|Lost to Follow-up|0|||
127826426|NCT01345786|459983696|FG003|Overall Study|Lost to Follow-up|2|||
127826427|NCT01929044|459983697|FG000|Overall Study|Adverse Event|1|||
127826428|NCT01929044|459983698|FG001|Overall Study|Adverse Event|0|||
127826429|NCT01929044|459983697|FG000|Overall Study|Protocol Violation|9|||
127826430|NCT01929044|459983698|FG001|Overall Study|Protocol Violation|14|||
127826431|NCT01929044|459983697|FG000|Overall Study|Not Treated|1|||
127826432|NCT01929044|459983698|FG001|Overall Study|Not Treated|3|||
127826433|NCT02807454|459983701|FG000|Overall Study|Adverse Event|1|||
127826434|NCT02807454|459983702|FG001|Overall Study|Adverse Event|0|||
127826435|NCT02807454|459983701|FG000|Overall Study|Withdrawal by Subject|0|||
127826436|NCT02807454|459983702|FG001|Overall Study|Withdrawal by Subject|1|||
127826437|NCT02807454|459983701|FG000|Overall Study|Progressive Disease|30|||
127826438|NCT02807454|459983702|FG001|Overall Study|Progressive Disease|3|||
127826439|NCT02807454|459983701|FG000|Overall Study|Other Reasons|1|||
127826440|NCT02807454|459983702|FG001|Overall Study|Other Reasons|1|||
127826441|NCT01989546|459985791|FG000|Overall Study|Clinical Progression|1|||
127826442|NCT01989546|459985791|FG000|Overall Study|Disease progression on study|8|||
127826443|NCT00059215|459985793|FG000|Overall Study|Adverse Event|5|||
127826444|NCT00059215|459985794|FG001|Overall Study|Adverse Event|5|||
127826445|NCT00059215|459985795|FG002|Overall Study|Adverse Event|9|||
127826446|NCT00059215|459985796|FG003|Overall Study|Adverse Event|9|||
127826447|NCT00059215|459985793|FG000|Overall Study|Death|0|||
127826448|NCT00059215|459985794|FG001|Overall Study|Death|0|||
127826449|NCT00059215|459985795|FG002|Overall Study|Death|3|||
127826450|NCT00059215|459985796|FG003|Overall Study|Death|0|||
127826451|NCT00059215|459985793|FG000|Overall Study|Lost to Follow-up|1|||
127826452|NCT00059215|459985794|FG001|Overall Study|Lost to Follow-up|2|||
127826453|NCT00059215|459985795|FG002|Overall Study|Lost to Follow-up|0|||
127826454|NCT00059215|459985796|FG003|Overall Study|Lost to Follow-up|0|||
127826455|NCT00059215|459985793|FG000|Overall Study|Withdrawal by Subject|4|||
127826456|NCT00059215|459985794|FG001|Overall Study|Withdrawal by Subject|4|||
127826457|NCT00059215|459985795|FG002|Overall Study|Withdrawal by Subject|1|||
127826458|NCT00059215|459985796|FG003|Overall Study|Withdrawal by Subject|3|||
127826459|NCT00059215|459985793|FG000|Overall Study|Protocol Violation|1|||
127826460|NCT00059215|459985794|FG001|Overall Study|Protocol Violation|0|||
127826461|NCT00059215|459985795|FG002|Overall Study|Protocol Violation|1|||
127826462|NCT00059215|459985796|FG003|Overall Study|Protocol Violation|0|||
127826463|NCT00059215|459985793|FG000|Overall Study|Protocol entry criteria not met|1|||
127826464|NCT00059215|459985794|FG001|Overall Study|Protocol entry criteria not met|1|||
127826465|NCT00059215|459985795|FG002|Overall Study|Protocol entry criteria not met|0|||
127826466|NCT00059215|459985796|FG003|Overall Study|Protocol entry criteria not met|2|||
127826467|NCT00059215|459985793|FG000|Overall Study|Physician Decision|1|||
127826468|NCT00059215|459985794|FG001|Overall Study|Physician Decision|2|||
127826469|NCT00059215|459985795|FG002|Overall Study|Physician Decision|1|||
127826470|NCT00059215|459985796|FG003|Overall Study|Physician Decision|1|||
127826471|NCT00414310|459985799|FG000|Overall Study|Not treated|1|||
127826472|NCT00414310|459985800|FG001|Overall Study|Not treated|0|||
127826473|NCT01254604|459985801|FG000|Overall Study|Lost to Follow-up|1|||
127826474|NCT01254604|459985802|FG001|Overall Study|Lost to Follow-up|1|||
127826475|NCT01254604|459985801|FG000|Overall Study|Protocol Violation|2|||
127826476|NCT01254604|459985802|FG001|Overall Study|Protocol Violation|2|||
127826477|NCT01254604|459985801|FG000|Overall Study|Withdrawal by Subject|2|||
127826478|NCT01254604|459985802|FG001|Overall Study|Withdrawal by Subject|4|||
127826479|NCT01254604|459985801|FG000|Overall Study|Adverse Event|3|||
127826480|NCT01254604|459985802|FG001|Overall Study|Adverse Event|2|||
127826481|NCT03074162|459985803|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
127826482|NCT03074162|459985804|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
127826483|NCT03074162|459985805|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
127826484|NCT03074162|459985806|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
127826485|NCT03074162|459985807|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
127826486|NCT03074162|459985808|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
127826487|NCT03074162|459985803|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
127826488|NCT03074162|459985804|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
127826489|NCT03074162|459985805|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
127826490|NCT03074162|459985806|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
127826491|NCT03074162|459985807|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
127826492|NCT03074162|459985808|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
127826493|NCT03074162|459985803|FG000|Period 3|Withdrawal by Subject|1|||
127826494|NCT03074162|459985804|FG001|Period 3|Withdrawal by Subject|0|||
127826495|NCT03074162|459985805|FG002|Period 3|Withdrawal by Subject|0|||
127826496|NCT03074162|459985806|FG003|Period 3|Withdrawal by Subject|0|||
127826497|NCT03074162|459985807|FG004|Period 3|Withdrawal by Subject|1|||
127826498|NCT03074162|459985808|FG005|Period 3|Withdrawal by Subject|0|||
127826499|NCT01993329|459985809|FG000|Period 2|Adverse Event|0|||
127826500|NCT01993329|459985810|FG001|Period 2|Adverse Event|0|||
127826501|NCT01993329|459985811|FG002|Period 2|Adverse Event|0|||
127826502|NCT01993329|459985812|FG003|Period 2|Adverse Event|0|||
127826503|NCT01993329|459985813|FG004|Period 2|Adverse Event|0|||
127826504|NCT01993329|459985814|FG005|Period 2|Adverse Event|1|||
127826505|NCT01993329|459985809|FG000|Wash-out|Personal reasons|0|||
127826506|NCT01993329|459985810|FG001|Wash-out|Personal reasons|1|||
127826507|NCT01993329|459985811|FG002|Wash-out|Personal reasons|0|||
127826508|NCT01993329|459985812|FG003|Wash-out|Personal reasons|0|||
127826509|NCT01993329|459985813|FG004|Wash-out|Personal reasons|0|||
127826510|NCT01993329|459985814|FG005|Wash-out|Personal reasons|0|||
127826511|NCT03041116|459985815|FG000|Double-blind|Death|0|||
127826512|NCT03041116|459985816|FG001|Double-blind|Death|2|||
127826513|NCT03041116|459985815|FG000|Double-blind|Withdrawal by Subject|0|||
127826514|NCT03041116|459985816|FG001|Double-blind|Withdrawal by Subject|4|||
127826515|NCT03041116|459985815|FG000|Open-label|Death|1|||
127826516|NCT03041116|459985816|FG001|Open-label|Death|0|||
127826517|NCT03041116|459985815|FG000|Open-label|Termination of the study by Sponsor|39|||
127826518|NCT03041116|459985816|FG001|Open-label|Termination of the study by Sponsor|37|||
127826519|NCT03041116|459985815|FG000|Open-label|Withdrawal by Subject|1|||
127826520|NCT03041116|459985816|FG001|Open-label|Withdrawal by Subject|0|||
127826521|NCT01781429|459985820|FG000|Overall Study|Death|0|||
127826522|NCT01781429|459985821|FG001|Overall Study|Death|0|||
127826523|NCT01781429|459985822|FG002|Overall Study|Death|0|||
127826524|NCT01781429|459985823|FG003|Overall Study|Death|0|||
127826525|NCT01781429|459985824|FG004|Overall Study|Death|0|||
127826526|NCT01781429|459985825|FG005|Overall Study|Death|0|||
127826527|NCT01781429|459985826|FG006|Overall Study|Death|0|||
127826528|NCT01781429|459985827|FG007|Overall Study|Death|0|||
127826529|NCT01781429|459985828|FG008|Overall Study|Death|0|||
127826530|NCT01781429|459985829|FG009|Overall Study|Death|1|||
127826531|NCT01781429|459985830|FG010|Overall Study|Death|0|||
127826532|NCT01781429|459985831|FG011|Overall Study|Death|0|||
127826533|NCT01781429|459985832|FG012|Overall Study|Death|1|||
127826534|NCT01781429|459985833|FG013|Overall Study|Death|0|||
127826535|NCT01781429|459985834|FG014|Overall Study|Death|1|||
127826536|NCT01781429|459985835|FG015|Overall Study|Death|0|||
127826537|NCT01781429|459985820|FG000|Overall Study|Withdrawal by Subject|0|||
127826538|NCT01781429|459985821|FG001|Overall Study|Withdrawal by Subject|0|||
127826539|NCT01781429|459985822|FG002|Overall Study|Withdrawal by Subject|0|||
127826540|NCT01781429|459985823|FG003|Overall Study|Withdrawal by Subject|0|||
127826541|NCT01781429|459985824|FG004|Overall Study|Withdrawal by Subject|0|||
127826542|NCT01781429|459985825|FG005|Overall Study|Withdrawal by Subject|0|||
127826543|NCT01781429|459985826|FG006|Overall Study|Withdrawal by Subject|0|||
127826544|NCT01781429|459985827|FG007|Overall Study|Withdrawal by Subject|0|||
127826545|NCT01781429|459985828|FG008|Overall Study|Withdrawal by Subject|1|||
127826546|NCT01781429|459985829|FG009|Overall Study|Withdrawal by Subject|3|||
127826547|NCT01781429|459985830|FG010|Overall Study|Withdrawal by Subject|1|||
127826548|NCT01781429|459985831|FG011|Overall Study|Withdrawal by Subject|1|||
127826549|NCT01781429|459985832|FG012|Overall Study|Withdrawal by Subject|5|||
127826550|NCT01781429|459985833|FG013|Overall Study|Withdrawal by Subject|2|||
127826551|NCT01781429|459985834|FG014|Overall Study|Withdrawal by Subject|3|||
127826552|NCT01781429|459985835|FG015|Overall Study|Withdrawal by Subject|0|||
127894882|NCT02688400|460238545|FG001|Overall Study|Lost to Follow-up|3|||
127826553|NCT01781429|459985820|FG000|Overall Study|Disease Progression|1|||
127826554|NCT01781429|459985821|FG001|Overall Study|Disease Progression|0|||
127826555|NCT01781429|459985822|FG002|Overall Study|Disease Progression|1|||
127826556|NCT01781429|459985823|FG003|Overall Study|Disease Progression|1|||
127826557|NCT01781429|459985824|FG004|Overall Study|Disease Progression|1|||
127826558|NCT01781429|459985825|FG005|Overall Study|Disease Progression|4|||
127894883|NCT02295774|460238547|FG000|Overall Study|Physician Decision|1|||
127826559|NCT01781429|459985826|FG006|Overall Study|Disease Progression|7|||
127826560|NCT01781429|459985827|FG007|Overall Study|Disease Progression|4|||
127826561|NCT01781429|459985828|FG008|Overall Study|Disease Progression|6|||
127826562|NCT01781429|459985829|FG009|Overall Study|Disease Progression|15|||
127826563|NCT01781429|459985830|FG010|Overall Study|Disease Progression|15|||
127826564|NCT01781429|459985831|FG011|Overall Study|Disease Progression|15|||
127826565|NCT01781429|459985832|FG012|Overall Study|Disease Progression|15|||
127826566|NCT01781429|459985833|FG013|Overall Study|Disease Progression|4|||
127826567|NCT01781429|459985834|FG014|Overall Study|Disease Progression|11|||
127826568|NCT01781429|459985835|FG015|Overall Study|Disease Progression|0|||
127826569|NCT01781429|459985820|FG000|Overall Study|Unacceptable Toxicity|0|||
127826570|NCT01781429|459985821|FG001|Overall Study|Unacceptable Toxicity|0|||
127826571|NCT01781429|459985822|FG002|Overall Study|Unacceptable Toxicity|0|||
127826572|NCT01781429|459985823|FG003|Overall Study|Unacceptable Toxicity|0|||
127826573|NCT01781429|459985824|FG004|Overall Study|Unacceptable Toxicity|0|||
127826574|NCT01781429|459985825|FG005|Overall Study|Unacceptable Toxicity|0|||
127826575|NCT01781429|459985826|FG006|Overall Study|Unacceptable Toxicity|0|||
127826576|NCT01781429|459985827|FG007|Overall Study|Unacceptable Toxicity|0|||
127826577|NCT01781429|459985828|FG008|Overall Study|Unacceptable Toxicity|0|||
127826578|NCT01781429|459985829|FG009|Overall Study|Unacceptable Toxicity|0|||
127826579|NCT01781429|459985830|FG010|Overall Study|Unacceptable Toxicity|0|||
127826580|NCT01781429|459985831|FG011|Overall Study|Unacceptable Toxicity|2|||
127826581|NCT01781429|459985832|FG012|Overall Study|Unacceptable Toxicity|0|||
127826582|NCT01781429|459985833|FG013|Overall Study|Unacceptable Toxicity|0|||
127826583|NCT01781429|459985834|FG014|Overall Study|Unacceptable Toxicity|0|||
127826584|NCT01781429|459985835|FG015|Overall Study|Unacceptable Toxicity|0|||
127826585|NCT01781429|459985820|FG000|Overall Study|Patient Condition Changed|0|||
127826586|NCT01781429|459985821|FG001|Overall Study|Patient Condition Changed|0|||
127826587|NCT01781429|459985822|FG002|Overall Study|Patient Condition Changed|0|||
127826588|NCT01781429|459985823|FG003|Overall Study|Patient Condition Changed|0|||
127826589|NCT01781429|459985824|FG004|Overall Study|Patient Condition Changed|0|||
127826590|NCT01781429|459985825|FG005|Overall Study|Patient Condition Changed|0|||
127826591|NCT01781429|459985826|FG006|Overall Study|Patient Condition Changed|0|||
127826592|NCT01781429|459985827|FG007|Overall Study|Patient Condition Changed|0|||
127826593|NCT01781429|459985828|FG008|Overall Study|Patient Condition Changed|0|||
127826594|NCT01781429|459985829|FG009|Overall Study|Patient Condition Changed|4|||
127826595|NCT01781429|459985830|FG010|Overall Study|Patient Condition Changed|0|||
127826596|NCT01781429|459985831|FG011|Overall Study|Patient Condition Changed|1|||
127826597|NCT01781429|459985832|FG012|Overall Study|Patient Condition Changed|0|||
127826598|NCT01781429|459985833|FG013|Overall Study|Patient Condition Changed|1|||
127826599|NCT01781429|459985834|FG014|Overall Study|Patient Condition Changed|0|||
127826600|NCT01781429|459985835|FG015|Overall Study|Patient Condition Changed|0|||
127826601|NCT01781429|459985820|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
127826602|NCT01781429|459985821|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
127826603|NCT01781429|459985822|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
127826604|NCT01781429|459985823|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
127826605|NCT01781429|459985824|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
127826606|NCT01781429|459985825|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
127826607|NCT01781429|459985826|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
127826608|NCT01781429|459985827|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
127826609|NCT01781429|459985828|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
127826610|NCT01781429|459985829|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
127826611|NCT01781429|459985830|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
127826612|NCT01781429|459985831|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
127826613|NCT01781429|459985832|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
127826614|NCT01781429|459985833|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
127826615|NCT01781429|459985834|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
127826616|NCT01781429|459985835|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
127826617|NCT01781429|459985820|FG000|Overall Study|Enrolled, but not treated|0|||
127826618|NCT01781429|459985821|FG001|Overall Study|Enrolled, but not treated|0|||
127826619|NCT01781429|459985822|FG002|Overall Study|Enrolled, but not treated|0|||
127826620|NCT01781429|459985823|FG003|Overall Study|Enrolled, but not treated|0|||
127826621|NCT01781429|459985824|FG004|Overall Study|Enrolled, but not treated|0|||
127826622|NCT01781429|459985825|FG005|Overall Study|Enrolled, but not treated|0|||
127826623|NCT01781429|459985826|FG006|Overall Study|Enrolled, but not treated|0|||
127826624|NCT01781429|459985827|FG007|Overall Study|Enrolled, but not treated|0|||
127826625|NCT01781429|459985828|FG008|Overall Study|Enrolled, but not treated|0|||
127826626|NCT01781429|459985829|FG009|Overall Study|Enrolled, but not treated|0|||
127826627|NCT01781429|459985830|FG010|Overall Study|Enrolled, but not treated|1|||
127826628|NCT01781429|459985831|FG011|Overall Study|Enrolled, but not treated|0|||
127826629|NCT01781429|459985832|FG012|Overall Study|Enrolled, but not treated|0|||
127826630|NCT01781429|459985833|FG013|Overall Study|Enrolled, but not treated|0|||
127826631|NCT01781429|459985834|FG014|Overall Study|Enrolled, but not treated|0|||
127826632|NCT01781429|459985835|FG015|Overall Study|Enrolled, but not treated|0|||
127826633|NCT02678741|459985836|FG000|Overall Study|Death|4|||
127826634|NCT02678741|459985836|FG000|Overall Study|Withdrawal by Subject|1|||
127826635|NCT02678741|459985836|FG000|Overall Study|ineligible|3|||
127826636|NCT02678741|459985836|FG000|Overall Study|Not RECIST Measurable|2|||
127826637|NCT02678741|459985836|FG000|Overall Study|Lack of Efficacy|10|||
127826638|NCT00903032|459985837|FG000|Overall Study|Withdrawal by Subject|5|||
127826639|NCT00903032|459985838|FG001|Overall Study|Withdrawal by Subject|3|||
127826640|NCT00903032|459985837|FG000|Overall Study|Lost to Follow-up|2|||
127826641|NCT00903032|459985838|FG001|Overall Study|Lost to Follow-up|2|||
127826642|NCT00931892|459985852|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
127826643|NCT00931892|459985853|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
127826644|NCT01876732|459985854|FG000|Overall Study|MMA was not over 800mg/dL|75|||
127826645|NCT02531373|459985857|FG000|Overall Study|Lack of Efficacy|0|||
127826646|NCT02531373|459985858|FG001|Overall Study|Lack of Efficacy|0|||
127826647|NCT02531373|459985859|FG002|Overall Study|Lack of Efficacy|0|||
127826648|NCT02531373|459985860|FG003|Overall Study|Lack of Efficacy|0|||
127826649|NCT02531373|459985861|FG004|Overall Study|Lack of Efficacy|3|||
127826650|NCT02531373|459985862|FG005|Overall Study|Lack of Efficacy|2|||
127826651|NCT02531373|459985863|FG006|Overall Study|Lack of Efficacy|4|||
127826652|NCT02531373|459985864|FG007|Overall Study|Lack of Efficacy|8|||
127826653|NCT02531373|459985865|FG008|Overall Study|Lack of Efficacy|5|||
127826654|NCT02531373|459985857|FG000|Overall Study|Lost to Follow-up|0|||
127826655|NCT02531373|459985858|FG001|Overall Study|Lost to Follow-up|0|||
127826656|NCT02531373|459985859|FG002|Overall Study|Lost to Follow-up|0|||
127826657|NCT02531373|459985860|FG003|Overall Study|Lost to Follow-up|0|||
127826658|NCT02531373|459985861|FG004|Overall Study|Lost to Follow-up|0|||
127826659|NCT02531373|459985862|FG005|Overall Study|Lost to Follow-up|2|||
127826660|NCT02531373|459985863|FG006|Overall Study|Lost to Follow-up|2|||
127826661|NCT02531373|459985864|FG007|Overall Study|Lost to Follow-up|0|||
127826662|NCT02531373|459985865|FG008|Overall Study|Lost to Follow-up|0|||
127826663|NCT02531373|459985857|FG000|Overall Study|Physician Decision|0|||
127826664|NCT02531373|459985858|FG001|Overall Study|Physician Decision|0|||
127826665|NCT02531373|459985859|FG002|Overall Study|Physician Decision|0|||
127826666|NCT02531373|459985860|FG003|Overall Study|Physician Decision|0|||
127826667|NCT02531373|459985861|FG004|Overall Study|Physician Decision|2|||
127826668|NCT02531373|459985862|FG005|Overall Study|Physician Decision|1|||
127826669|NCT02531373|459985863|FG006|Overall Study|Physician Decision|0|||
127826670|NCT02531373|459985864|FG007|Overall Study|Physician Decision|0|||
127826671|NCT02531373|459985865|FG008|Overall Study|Physician Decision|0|||
127826672|NCT02531373|459985857|FG000|Overall Study|Protocol Violation|0|||
127826673|NCT02531373|459985858|FG001|Overall Study|Protocol Violation|0|||
127826674|NCT02531373|459985859|FG002|Overall Study|Protocol Violation|0|||
127826675|NCT02531373|459985860|FG003|Overall Study|Protocol Violation|0|||
127826676|NCT02531373|459985861|FG004|Overall Study|Protocol Violation|0|||
127826677|NCT02531373|459985862|FG005|Overall Study|Protocol Violation|1|||
127826678|NCT02531373|459985863|FG006|Overall Study|Protocol Violation|1|||
127826679|NCT02531373|459985864|FG007|Overall Study|Protocol Violation|0|||
127826680|NCT02531373|459985865|FG008|Overall Study|Protocol Violation|1|||
127826681|NCT02531373|459985857|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
127826682|NCT02531373|459985858|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
127826683|NCT02531373|459985859|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
127826684|NCT02531373|459985860|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
127826685|NCT02531373|459985861|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
127826686|NCT02531373|459985862|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
127826687|NCT02531373|459985863|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
127826688|NCT02531373|459985864|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
127826689|NCT02531373|459985865|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
127826690|NCT02531373|459985857|FG000|Overall Study|Withdrawal by Subject|0|||
127826691|NCT02531373|459985858|FG001|Overall Study|Withdrawal by Subject|0|||
127826692|NCT02531373|459985859|FG002|Overall Study|Withdrawal by Subject|0|||
127826693|NCT02531373|459985860|FG003|Overall Study|Withdrawal by Subject|0|||
127826694|NCT02531373|459985861|FG004|Overall Study|Withdrawal by Subject|3|||
127826695|NCT02531373|459985862|FG005|Overall Study|Withdrawal by Subject|0|||
127826696|NCT02531373|459985863|FG006|Overall Study|Withdrawal by Subject|0|||
127826697|NCT02531373|459985864|FG007|Overall Study|Withdrawal by Subject|0|||
127826698|NCT02531373|459985865|FG008|Overall Study|Withdrawal by Subject|0|||
127826699|NCT00536731|459985866|FG000|Overall Study|Adverse Event|3|||
127826700|NCT00536731|459985867|FG001|Overall Study|Adverse Event|2|||
127826701|NCT00536731|459985868|FG002|Overall Study|Adverse Event|3|||
127826702|NCT00536731|459985866|FG000|Overall Study|Withdrawal by Subject|0|||
127826703|NCT00536731|459985867|FG001|Overall Study|Withdrawal by Subject|2|||
127826704|NCT00536731|459985868|FG002|Overall Study|Withdrawal by Subject|0|||
127826705|NCT00536731|459985866|FG000|Overall Study|Intake of prohibited conc. medication|0|||
127826706|NCT00536731|459985867|FG001|Overall Study|Intake of prohibited conc. medication|0|||
127826707|NCT00536731|459985868|FG002|Overall Study|Intake of prohibited conc. medication|1|||
127826708|NCT00536731|459985866|FG000|Overall Study|Safety reasons|0|||
127826709|NCT00536731|459985867|FG001|Overall Study|Safety reasons|0|||
127826710|NCT00536731|459985868|FG002|Overall Study|Safety reasons|1|||
127826711|NCT00536731|459985866|FG000|Overall Study|Other|1|||
127826712|NCT00536731|459985867|FG001|Overall Study|Other|1|||
127826713|NCT00536731|459985868|FG002|Overall Study|Other|0|||
127826714|NCT01675531|459985869|FG000|Overall Study|Adverse Event|9|||
127826715|NCT01675531|459985869|FG000|Overall Study|Withdrawal by Subject|7|||
127826716|NCT01675531|459985869|FG000|Overall Study|Lack of Efficacy|1|||
127826717|NCT01675531|459985869|FG000|Overall Study|Protocol Violation|8|||
127826718|NCT00623467|459985870|FG000|Overall Study|Lost to Follow-up|1|||
127826719|NCT00623467|459985870|FG000|Overall Study|Protocol Violation|4|||
127826720|NCT00623467|459985870|FG000|Overall Study|Withdrawal by Subject|2|||
127826721|NCT02795988|459985879|FG000|Phase 1b|Withdrawal by Subject|0|||
127826722|NCT02795988|459985880|FG001|Phase 1b|Withdrawal by Subject|1|||
127826723|NCT02795988|459985881|FG002|Phase 1b|Withdrawal by Subject|0|||
127826724|NCT02795988|459985882|FG003|Phase 1b|Withdrawal by Subject|0|||
127826725|NCT02795988|459985883|FG004|Phase 1b|Withdrawal by Subject|0|||
127826726|NCT02795988|459985884|FG005|Phase 1b|Withdrawal by Subject|0|||
127826727|NCT02795988|459985885|FG006|Phase 1b|Withdrawal by Subject|0|||
127826728|NCT02795988|459985879|FG000|Phase 1b|Death|1|||
127826729|NCT02795988|459985880|FG001|Phase 1b|Death|2|||
127826730|NCT02795988|459985881|FG002|Phase 1b|Death|1|||
127826731|NCT02795988|459985882|FG003|Phase 1b|Death|0|||
127826732|NCT02795988|459985883|FG004|Phase 1b|Death|0|||
127826733|NCT02795988|459985884|FG005|Phase 1b|Death|0|||
127826734|NCT02795988|459985885|FG006|Phase 1b|Death|0|||
127826735|NCT02795988|459985879|FG000|Phase 1b|Physician Decision|0|||
127826736|NCT02795988|459985880|FG001|Phase 1b|Physician Decision|0|||
127826737|NCT02795988|459985881|FG002|Phase 1b|Physician Decision|1|||
127826738|NCT02795988|459985882|FG003|Phase 1b|Physician Decision|0|||
127826739|NCT02795988|459985883|FG004|Phase 1b|Physician Decision|0|||
127826740|NCT02795988|459985884|FG005|Phase 1b|Physician Decision|0|||
127826741|NCT02795988|459985885|FG006|Phase 1b|Physician Decision|0|||
127826742|NCT02795988|459985879|FG000|Phase 1b|Progressive Disease|2|||
127826743|NCT02795988|459985880|FG001|Phase 1b|Progressive Disease|2|||
127826744|NCT02795988|459985881|FG002|Phase 1b|Progressive Disease|0|||
127826745|NCT02795988|459985882|FG003|Phase 1b|Progressive Disease|0|||
127826746|NCT02795988|459985883|FG004|Phase 1b|Progressive Disease|0|||
127826747|NCT02795988|459985884|FG005|Phase 1b|Progressive Disease|0|||
127826748|NCT02795988|459985885|FG006|Phase 1b|Progressive Disease|0|||
127826749|NCT02795988|459985879|FG000|Phase 2|Withdrawal by Subject|0|||
127826750|NCT02795988|459985880|FG001|Phase 2|Withdrawal by Subject|0|||
127826751|NCT02795988|459985881|FG002|Phase 2|Withdrawal by Subject|0|||
127826752|NCT02795988|459985882|FG003|Phase 2|Withdrawal by Subject|1|||
127826753|NCT02795988|459985883|FG004|Phase 2|Withdrawal by Subject|0|||
127826754|NCT02795988|459985884|FG005|Phase 2|Withdrawal by Subject|0|||
127826755|NCT02795988|459985885|FG006|Phase 2|Withdrawal by Subject|0|||
127826756|NCT02795988|459985879|FG000|Phase 2|Death|0|||
127826757|NCT02795988|459985880|FG001|Phase 2|Death|0|||
127826758|NCT02795988|459985881|FG002|Phase 2|Death|0|||
127826759|NCT02795988|459985882|FG003|Phase 2|Death|17|||
127826760|NCT02795988|459985883|FG004|Phase 2|Death|17|||
127826761|NCT02795988|459985884|FG005|Phase 2|Death|0|||
127826762|NCT02795988|459985885|FG006|Phase 2|Death|0|||
127826763|NCT02795988|459985879|FG000|Phase 2|Other|0|||
127826764|NCT02795988|459985880|FG001|Phase 2|Other|0|||
127826765|NCT02795988|459985881|FG002|Phase 2|Other|0|||
127826766|NCT02795988|459985882|FG003|Phase 2|Other|1|||
127826767|NCT02795988|459985883|FG004|Phase 2|Other|0|||
127826768|NCT02795988|459985884|FG005|Phase 2|Other|0|||
127826769|NCT02795988|459985885|FG006|Phase 2|Other|0|||
127826770|NCT02795988|459985879|FG000|Phase 2 Extension|Death|0|||
127826771|NCT02795988|459985880|FG001|Phase 2 Extension|Death|0|||
127826772|NCT02795988|459985881|FG002|Phase 2 Extension|Death|0|||
127826773|NCT02795988|459985882|FG003|Phase 2 Extension|Death|0|||
127826774|NCT02795988|459985883|FG004|Phase 2 Extension|Death|0|||
127826775|NCT02795988|459985884|FG005|Phase 2 Extension|Death|5|||
127826776|NCT02795988|459985885|FG006|Phase 2 Extension|Death|6|||
127826777|NCT02795988|459985879|FG000|Phase 2 Extension|Other reasons|0|||
127826778|NCT02795988|459985880|FG001|Phase 2 Extension|Other reasons|0|||
127826779|NCT02795988|459985881|FG002|Phase 2 Extension|Other reasons|0|||
127826780|NCT02795988|459985882|FG003|Phase 2 Extension|Other reasons|0|||
127826781|NCT02795988|459985883|FG004|Phase 2 Extension|Other reasons|0|||
127826782|NCT02795988|459985884|FG005|Phase 2 Extension|Other reasons|2|||
127826783|NCT02795988|459985885|FG006|Phase 2 Extension|Other reasons|1|||
127826784|NCT02834403|459985886|FG000|Overall Study|Physician Decision|2|||
127826785|NCT02834403|459985887|FG001|Overall Study|Physician Decision|1|||
127826786|NCT02834403|459985888|FG002|Overall Study|Physician Decision|2|||
127826787|NCT02834403|459985889|FG003|Overall Study|Physician Decision|1|||
127826788|NCT02834403|459985890|FG004|Overall Study|Physician Decision|1|||
127826789|NCT02834403|459985891|FG005|Overall Study|Physician Decision|2|||
127826790|NCT02834403|459985892|FG006|Overall Study|Physician Decision|12|||
127826791|NCT02834403|459985886|FG000|Overall Study|Adverse Event|0|||
127826792|NCT02834403|459985887|FG001|Overall Study|Adverse Event|0|||
127826793|NCT02834403|459985888|FG002|Overall Study|Adverse Event|0|||
127826794|NCT02834403|459985889|FG003|Overall Study|Adverse Event|0|||
127826795|NCT02834403|459985890|FG004|Overall Study|Adverse Event|1|||
127826796|NCT02834403|459985891|FG005|Overall Study|Adverse Event|1|||
127826797|NCT02834403|459985892|FG006|Overall Study|Adverse Event|3|||
127826798|NCT02834403|459985886|FG000|Overall Study|Withdrawal by Subject|0|||
127826799|NCT02834403|459985887|FG001|Overall Study|Withdrawal by Subject|1|||
127826800|NCT02834403|459985888|FG002|Overall Study|Withdrawal by Subject|0|||
127826801|NCT02834403|459985889|FG003|Overall Study|Withdrawal by Subject|0|||
127826802|NCT02834403|459985890|FG004|Overall Study|Withdrawal by Subject|1|||
127826803|NCT02834403|459985891|FG005|Overall Study|Withdrawal by Subject|0|||
127826804|NCT02834403|459985892|FG006|Overall Study|Withdrawal by Subject|0|||
127826805|NCT02834403|459985886|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
127826806|NCT02834403|459985887|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
127826807|NCT02834403|459985888|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
127826808|NCT02834403|459985889|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
127826809|NCT02834403|459985890|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
127826810|NCT02834403|459985891|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
127826811|NCT02834403|459985892|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
127826812|NCT02341014|459985893|FG000|Overall Study|Adverse Event|0|||
127826813|NCT02341014|459985894|FG001|Overall Study|Adverse Event|1|||
127826814|NCT02341014|459985895|FG002|Overall Study|Adverse Event|0|||
127826815|NCT02341014|459985896|FG003|Overall Study|Adverse Event|0|||
127826816|NCT02341014|459985897|FG004|Overall Study|Adverse Event|2|||
127826817|NCT04705597|459985898|FG000|Overall Study|Death|16|||
127826818|NCT04705597|459985899|FG001|Overall Study|Death|9|||
127826819|NCT04705597|459985898|FG000|Overall Study|Lost to Follow-up|1|||
127826820|NCT04705597|459985899|FG001|Overall Study|Lost to Follow-up|0|||
127826821|NCT04705597|459985898|FG000|Overall Study|Withdrawal by Subject|1|||
127826822|NCT04705597|459985899|FG001|Overall Study|Withdrawal by Subject|2|||
127826823|NCT00273858|459985911|FG000|Overall Study|Not completed 24 month observation time|334|||
127826824|NCT00273858|459985911|FG000|Overall Study|Lost to Follow-up|101|||
127826825|NCT00273858|459985911|FG000|Overall Study|Withdrawal by Subject|21|||
127826826|NCT00273858|459985911|FG000|Overall Study|Adverse Event|81|||
127826827|NCT02232516|459985912|FG000|Study Treatment Period: Cycles 1-3|Adverse Event|6|||
127826828|NCT02232516|459985912|FG000|Study Treatment Period: Cycles 1-3|Withdrawal by Subject|1|||
127826829|NCT02232516|459985912|FG000|Study Treatment Period: Cycles 1-3|No Response|1|||
127826830|NCT02232516|459985912|FG000|Study Treatment Period: Cycles 1-3|Screen failure|1|||
127826831|NCT02232516|459985912|FG000|Study Treatment Period: Cycles 1-3|Disease Progression|1|||
127826832|NCT02232516|459985912|FG000|Study Treatment Period: Cycles 4-6|Disease Progression|4|||
127826833|NCT02232516|459985912|FG000|Study Treatment Period: Cycles 4-6|Adverse Event|1|||
127826834|NCT02232516|459985912|FG000|Study Treatment Period: Cycles 4-6|Withdrawal by Subject|2|||
127826835|NCT02232516|459985912|FG000|Study Treatment Period: Cycles 7-9|Adverse Event|4|||
127826836|NCT02232516|459985912|FG000|Study Treatment Period: Cycles 7-9|Disease Progression|2|||
127826837|NCT02232516|459985912|FG000|Study Treatment Period: Cycles 7-9|Withdrawal by Subject|3|||
127826838|NCT02232516|459985912|FG000|Study Treatment Period: Cycles 7-9|Physician Decision|1|||
127826839|NCT02232516|459985912|FG000|Study Treatment Period: Cycles 10-12|Adverse Event|1|||
127826840|NCT02232516|459985912|FG000|Study Treatment Period: Cycles 10-12|Disease Progression|1|||
127826841|NCT02232516|459985912|FG000|Survival Follow-up|Death|15|||
127826842|NCT02232516|459985912|FG000|Survival Follow-up|Withdrawal by Subject|3|||
127826843|NCT02232516|459985912|FG000|Survival Follow-up|Lost to Follow-up|1|||
127826844|NCT02232516|459985912|FG000|Survival Follow-up|Still in follow-up|5|||
127826845|NCT01070550|459985913|FG000|Overall Study|Adverse Event|43|||
127826846|NCT01070550|459985914|FG001|Overall Study|Adverse Event|1|||
127826847|NCT01070550|459985915|FG002|Overall Study|Adverse Event|3|||
127826848|NCT01070550|459985916|FG003|Overall Study|Adverse Event|0|||
127826849|NCT01070550|459985917|FG004|Overall Study|Adverse Event|0|||
127826850|NCT01070550|459985918|FG005|Overall Study|Adverse Event|0|||
127826851|NCT01070550|459985913|FG000|Overall Study|Death|20|||
127826852|NCT01070550|459985914|FG001|Overall Study|Death|4|||
127826853|NCT01070550|459985915|FG002|Overall Study|Death|3|||
127826854|NCT01070550|459985916|FG003|Overall Study|Death|0|||
127826855|NCT01070550|459985917|FG004|Overall Study|Death|0|||
127826856|NCT01070550|459985918|FG005|Overall Study|Death|0|||
127826857|NCT01070550|459985913|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
127826858|NCT01070550|459985914|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
127826859|NCT01070550|459985915|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
127826860|NCT01070550|459985916|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
127826861|NCT01070550|459985917|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
127826862|NCT01070550|459985918|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
127826863|NCT01070550|459985913|FG000|Overall Study|Early termination|3|||
127826864|NCT01070550|459985914|FG001|Overall Study|Early termination|0|||
127826865|NCT01070550|459985915|FG002|Overall Study|Early termination|0|||
127826866|NCT01070550|459985916|FG003|Overall Study|Early termination|0|||
127826867|NCT01070550|459985917|FG004|Overall Study|Early termination|0|||
127826868|NCT01070550|459985918|FG005|Overall Study|Early termination|0|||
127826869|NCT01070550|459985913|FG000|Overall Study|Failed to return|450|||
127826870|NCT01070550|459985914|FG001|Overall Study|Failed to return|33|||
127826871|NCT01070550|459985915|FG002|Overall Study|Failed to return|144|||
127826872|NCT01070550|459985916|FG003|Overall Study|Failed to return|40|||
127826873|NCT01070550|459985917|FG004|Overall Study|Failed to return|1|||
127826874|NCT01070550|459985918|FG005|Overall Study|Failed to return|2|||
127826875|NCT01070550|459985913|FG000|Overall Study|Incomplete treatment|2|||
127826876|NCT01070550|459985914|FG001|Overall Study|Incomplete treatment|0|||
127826877|NCT01070550|459985915|FG002|Overall Study|Incomplete treatment|0|||
127826878|NCT01070550|459985916|FG003|Overall Study|Incomplete treatment|0|||
127826879|NCT01070550|459985917|FG004|Overall Study|Incomplete treatment|0|||
127826880|NCT01070550|459985918|FG005|Overall Study|Incomplete treatment|0|||
127826881|NCT01070550|459985913|FG000|Overall Study|Lab test not done|22|||
127826882|NCT01070550|459985914|FG001|Overall Study|Lab test not done|3|||
127826883|NCT01070550|459985915|FG002|Overall Study|Lab test not done|4|||
127826884|NCT01070550|459985916|FG003|Overall Study|Lab test not done|1|||
127826885|NCT01070550|459985917|FG004|Overall Study|Lab test not done|0|||
127826886|NCT01070550|459985918|FG005|Overall Study|Lab test not done|1|||
127826887|NCT01070550|459985913|FG000|Overall Study|Lack of Efficacy|65|||
127826888|NCT01070550|459985914|FG001|Overall Study|Lack of Efficacy|1|||
127826889|NCT01070550|459985915|FG002|Overall Study|Lack of Efficacy|5|||
127826890|NCT01070550|459985916|FG003|Overall Study|Lack of Efficacy|5|||
127826891|NCT01070550|459985917|FG004|Overall Study|Lack of Efficacy|0|||
127826892|NCT01070550|459985918|FG005|Overall Study|Lack of Efficacy|1|||
127826893|NCT01070550|459985913|FG000|Overall Study|Miscellaneous|12|||
127826894|NCT01070550|459985914|FG001|Overall Study|Miscellaneous|2|||
127826895|NCT01070550|459985915|FG002|Overall Study|Miscellaneous|3|||
127826896|NCT01070550|459985916|FG003|Overall Study|Miscellaneous|1|||
127826897|NCT01070550|459985917|FG004|Overall Study|Miscellaneous|0|||
127826898|NCT01070550|459985918|FG005|Overall Study|Miscellaneous|0|||
127826899|NCT01070550|459985913|FG000|Overall Study|New treatment started|3|||
127826900|NCT01070550|459985914|FG001|Overall Study|New treatment started|1|||
127826901|NCT01070550|459985915|FG002|Overall Study|New treatment started|0|||
127826902|NCT01070550|459985916|FG003|Overall Study|New treatment started|2|||
127826903|NCT01070550|459985917|FG004|Overall Study|New treatment started|0|||
127826904|NCT01070550|459985918|FG005|Overall Study|New treatment started|0|||
127826905|NCT01070550|459985913|FG000|Overall Study|Non-responders|493|||
127826906|NCT01070550|459985914|FG001|Overall Study|Non-responders|4|||
127826907|NCT01070550|459985915|FG002|Overall Study|Non-responders|21|||
127826908|NCT01070550|459985916|FG003|Overall Study|Non-responders|20|||
127826909|NCT01070550|459985917|FG004|Overall Study|Non-responders|0|||
127826910|NCT01070550|459985918|FG005|Overall Study|Non-responders|2|||
127826911|NCT01070550|459985913|FG000|Overall Study|Not categorized|33|||
127826912|NCT01070550|459985914|FG001|Overall Study|Not categorized|2|||
127826913|NCT01070550|459985915|FG002|Overall Study|Not categorized|6|||
127826914|NCT01070550|459985916|FG003|Overall Study|Not categorized|1|||
127826915|NCT01070550|459985917|FG004|Overall Study|Not categorized|0|||
127826916|NCT01070550|459985918|FG005|Overall Study|Not categorized|1|||
127826917|NCT01070550|459985913|FG000|Overall Study|Protocol Violation|15|||
127826918|NCT01070550|459985914|FG001|Overall Study|Protocol Violation|1|||
127826919|NCT01070550|459985915|FG002|Overall Study|Protocol Violation|1|||
127826920|NCT01070550|459985916|FG003|Overall Study|Protocol Violation|1|||
127826921|NCT01070550|459985917|FG004|Overall Study|Protocol Violation|0|||
127826922|NCT01070550|459985918|FG005|Overall Study|Protocol Violation|0|||
127826923|NCT01070550|459985913|FG000|Overall Study|Relapse|44|||
127894884|NCT02295774|460238547|FG000|Overall Study|Withdrawal by Subject|2|||
127826924|NCT01070550|459985914|FG001|Overall Study|Relapse|5|||
127826925|NCT01070550|459985915|FG002|Overall Study|Relapse|14|||
127826926|NCT01070550|459985916|FG003|Overall Study|Relapse|4|||
127826927|NCT01070550|459985917|FG004|Overall Study|Relapse|0|||
127894885|NCT01075763|460238548|FG000|Overall Study|Lost to Follow-up|2|||
127826928|NCT01070550|459985918|FG005|Overall Study|Relapse|0|||
127826929|NCT01070550|459985913|FG000|Overall Study|Result not available|3|||
127826930|NCT01070550|459985914|FG001|Overall Study|Result not available|1|||
127826931|NCT01070550|459985915|FG002|Overall Study|Result not available|3|||
127826932|NCT01070550|459985916|FG003|Overall Study|Result not available|0|||
127826933|NCT01070550|459985917|FG004|Overall Study|Result not available|0|||
127826934|NCT01070550|459985918|FG005|Overall Study|Result not available|0|||
127826935|NCT01070550|459985913|FG000|Overall Study|Screen failure|1|||
127826936|NCT01070550|459985914|FG001|Overall Study|Screen failure|0|||
127826937|NCT01070550|459985915|FG002|Overall Study|Screen failure|0|||
127826938|NCT01070550|459985916|FG003|Overall Study|Screen failure|0|||
127826939|NCT01070550|459985917|FG004|Overall Study|Screen failure|0|||
127826940|NCT01070550|459985918|FG005|Overall Study|Screen failure|0|||
127826941|NCT01070550|459985913|FG000|Overall Study|Sponsor decision|1|||
127826942|NCT01070550|459985914|FG001|Overall Study|Sponsor decision|0|||
127826943|NCT01070550|459985915|FG002|Overall Study|Sponsor decision|0|||
127826944|NCT01070550|459985916|FG003|Overall Study|Sponsor decision|0|||
127826945|NCT01070550|459985917|FG004|Overall Study|Sponsor decision|0|||
127826946|NCT01070550|459985918|FG005|Overall Study|Sponsor decision|0|||
127826947|NCT01070550|459985913|FG000|Overall Study|Treatment duration shortened|1|||
127826948|NCT01070550|459985914|FG001|Overall Study|Treatment duration shortened|0|||
127826949|NCT01070550|459985915|FG002|Overall Study|Treatment duration shortened|0|||
127826950|NCT01070550|459985916|FG003|Overall Study|Treatment duration shortened|0|||
127826951|NCT01070550|459985917|FG004|Overall Study|Treatment duration shortened|0|||
127826952|NCT01070550|459985918|FG005|Overall Study|Treatment duration shortened|0|||
127826953|NCT01070550|459985913|FG000|Overall Study|Treatment interrupted|7|||
127826954|NCT01070550|459985914|FG001|Overall Study|Treatment interrupted|0|||
127826955|NCT01070550|459985915|FG002|Overall Study|Treatment interrupted|1|||
127826956|NCT01070550|459985916|FG003|Overall Study|Treatment interrupted|1|||
127826957|NCT01070550|459985917|FG004|Overall Study|Treatment interrupted|0|||
127826958|NCT01070550|459985918|FG005|Overall Study|Treatment interrupted|0|||
127826959|NCT01070550|459985913|FG000|Overall Study|Treatment not started|14|||
127826960|NCT01070550|459985914|FG001|Overall Study|Treatment not started|2|||
127826961|NCT01070550|459985915|FG002|Overall Study|Treatment not started|4|||
127826962|NCT01070550|459985916|FG003|Overall Study|Treatment not started|0|||
127826963|NCT01070550|459985917|FG004|Overall Study|Treatment not started|0|||
127826964|NCT01070550|459985918|FG005|Overall Study|Treatment not started|0|||
127826965|NCT01070550|459985913|FG000|Overall Study|Treatment restarted|0|||
127826966|NCT01070550|459985914|FG001|Overall Study|Treatment restarted|1|||
127826967|NCT01070550|459985915|FG002|Overall Study|Treatment restarted|0|||
127826968|NCT01070550|459985916|FG003|Overall Study|Treatment restarted|0|||
127826969|NCT01070550|459985917|FG004|Overall Study|Treatment restarted|0|||
127826970|NCT01070550|459985918|FG005|Overall Study|Treatment restarted|0|||
127826971|NCT01070550|459985913|FG000|Overall Study|Treatment stopped|3|||
127826972|NCT01070550|459985914|FG001|Overall Study|Treatment stopped|0|||
127826973|NCT01070550|459985915|FG002|Overall Study|Treatment stopped|0|||
127826974|NCT01070550|459985916|FG003|Overall Study|Treatment stopped|0|||
127826975|NCT01070550|459985917|FG004|Overall Study|Treatment stopped|0|||
127826976|NCT01070550|459985918|FG005|Overall Study|Treatment stopped|0|||
127826977|NCT01070550|459985913|FG000|Overall Study|Treatment unavailable|1|||
127826978|NCT01070550|459985914|FG001|Overall Study|Treatment unavailable|0|||
127826979|NCT01070550|459985915|FG002|Overall Study|Treatment unavailable|0|||
127826980|NCT01070550|459985916|FG003|Overall Study|Treatment unavailable|0|||
127826981|NCT01070550|459985917|FG004|Overall Study|Treatment unavailable|0|||
127826982|NCT01070550|459985918|FG005|Overall Study|Treatment unavailable|0|||
127826983|NCT01070550|459985913|FG000|Overall Study|Treatment was stopped early|7|||
127826984|NCT01070550|459985914|FG001|Overall Study|Treatment was stopped early|0|||
127826985|NCT01070550|459985915|FG002|Overall Study|Treatment was stopped early|0|||
127826986|NCT01070550|459985916|FG003|Overall Study|Treatment was stopped early|0|||
127826987|NCT01070550|459985917|FG004|Overall Study|Treatment was stopped early|0|||
127826988|NCT01070550|459985918|FG005|Overall Study|Treatment was stopped early|0|||
127826989|NCT01070550|459985913|FG000|Overall Study|Other|5|||
127826990|NCT01070550|459985914|FG001|Overall Study|Other|0|||
127826991|NCT01070550|459985915|FG002|Overall Study|Other|0|||
127826992|NCT01070550|459985916|FG003|Overall Study|Other|1|||
127826993|NCT01070550|459985917|FG004|Overall Study|Other|0|||
127826994|NCT01070550|459985918|FG005|Overall Study|Other|0|||
127826995|NCT01070550|459985913|FG000|Overall Study|Withdrawal by Subject|35|||
127826996|NCT01070550|459985914|FG001|Overall Study|Withdrawal by Subject|0|||
127826997|NCT01070550|459985915|FG002|Overall Study|Withdrawal by Subject|3|||
127826998|NCT01070550|459985916|FG003|Overall Study|Withdrawal by Subject|0|||
127826999|NCT01070550|459985917|FG004|Overall Study|Withdrawal by Subject|0|||
127827000|NCT01070550|459985918|FG005|Overall Study|Withdrawal by Subject|0|||
127827001|NCT01585961|459985919|FG000|Overall Study|Death|6|||
127827002|NCT01585961|459985919|FG000|Overall Study|Physician Decision|1|||
127827003|NCT01585961|459985919|FG000|Overall Study|Decision to use non-study catheter|1|||
127827004|NCT01585961|459985919|FG000|Overall Study|Withdrawal by Subject|1|||
127827005|NCT01585961|459985919|FG000|Overall Study|Lost to Follow-up|23|||
127827006|NCT01585961|459985919|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
127827007|NCT01258348|459985920|FG000|Overall Study|Adverse Event|1|||
127827008|NCT01258348|459985921|FG001|Overall Study|Adverse Event|1|||
127827009|NCT01258348|459985922|FG002|Overall Study|Adverse Event|3|||
127827010|NCT01258348|459985923|FG003|Overall Study|Adverse Event|2|||
127827011|NCT01258348|459985924|FG004|Overall Study|Adverse Event|4|||
127827012|NCT01258348|459985920|FG000|Overall Study|Progressive Disease|0|||
127827013|NCT01258348|459985921|FG001|Overall Study|Progressive Disease|3|||
127827014|NCT01258348|459985922|FG002|Overall Study|Progressive Disease|0|||
127827015|NCT01258348|459985923|FG003|Overall Study|Progressive Disease|2|||
127827016|NCT01258348|459985924|FG004|Overall Study|Progressive Disease|2|||
127827017|NCT01258348|459985920|FG000|Overall Study|Physician Decision|0|||
127827018|NCT01258348|459985921|FG001|Overall Study|Physician Decision|0|||
127827019|NCT01258348|459985922|FG002|Overall Study|Physician Decision|0|||
127827020|NCT01258348|459985923|FG003|Overall Study|Physician Decision|2|||
127827021|NCT01258348|459985924|FG004|Overall Study|Physician Decision|0|||
127827022|NCT01258348|459985920|FG000|Overall Study|Withdrawal by Subject|0|||
127827023|NCT01258348|459985921|FG001|Overall Study|Withdrawal by Subject|1|||
127827024|NCT01258348|459985922|FG002|Overall Study|Withdrawal by Subject|0|||
127827025|NCT01258348|459985923|FG003|Overall Study|Withdrawal by Subject|0|||
127827026|NCT01258348|459985924|FG004|Overall Study|Withdrawal by Subject|0|||
127827027|NCT01809262|459985925|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
127827028|NCT01809262|459985926|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
127827029|NCT01809262|459985927|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
127827030|NCT01809262|459985928|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
127827031|NCT01809262|459985929|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
127827032|NCT01809262|459985930|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
127827033|NCT01809262|459985931|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
127827034|NCT01809262|459985932|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
127827035|NCT01809262|459985933|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
127827036|NCT01809262|459985934|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
127827037|NCT01809262|459985925|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
127827038|NCT01809262|459985926|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
127827039|NCT01809262|459985927|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
127827040|NCT01809262|459985928|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
127827041|NCT01809262|459985929|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
127827042|NCT01809262|459985930|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
127827043|NCT01809262|459985931|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
127827044|NCT01809262|459985932|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
127827045|NCT01809262|459985933|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
127827046|NCT01809262|459985934|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
127827047|NCT02064439|459985936|FG000|Overall Study|Adverse Event|51|||
127827048|NCT02064439|459985937|FG001|Overall Study|Adverse Event|47|||
127827049|NCT02064439|459985938|FG002|Overall Study|Adverse Event|46|||
127827050|NCT02064439|459985936|FG000|Overall Study|Death|0|||
127827051|NCT02064439|459985937|FG001|Overall Study|Death|2|||
127827052|NCT02064439|459985938|FG002|Overall Study|Death|3|||
127827053|NCT02064439|459985936|FG000|Overall Study|Withdrawal by Subject|29|||
127827054|NCT02064439|459985937|FG001|Overall Study|Withdrawal by Subject|18|||
127827055|NCT02064439|459985938|FG002|Overall Study|Withdrawal by Subject|26|||
127827056|NCT02064439|459985936|FG000|Overall Study|Protocol Violation|3|||
127827057|NCT02064439|459985937|FG001|Overall Study|Protocol Violation|5|||
127827058|NCT02064439|459985938|FG002|Overall Study|Protocol Violation|3|||
127827059|NCT02064439|459985936|FG000|Overall Study|Lost to Follow-up|1|||
127827060|NCT02064439|459985937|FG001|Overall Study|Lost to Follow-up|3|||
127827061|NCT02064439|459985938|FG002|Overall Study|Lost to Follow-up|4|||
127827062|NCT02064439|459985936|FG000|Overall Study|Non-compliance with study medication|21|||
127827063|NCT02064439|459985937|FG001|Overall Study|Non-compliance with study medication|19|||
127827064|NCT02064439|459985938|FG002|Overall Study|Non-compliance with study medication|23|||
127827065|NCT02064439|459985936|FG000|Overall Study|Physician Decision|0|||
127827066|NCT02064439|459985937|FG001|Overall Study|Physician Decision|1|||
127827067|NCT02064439|459985938|FG002|Overall Study|Physician Decision|1|||
127827068|NCT02064439|459985936|FG000|Overall Study|Logistical difficulties|6|||
127827069|NCT02064439|459985937|FG001|Overall Study|Logistical difficulties|5|||
127827070|NCT02064439|459985938|FG002|Overall Study|Logistical difficulties|2|||
127827071|NCT02064439|459985936|FG000|Overall Study|Efficacy outcome reached|18|||
127827072|NCT02064439|459985937|FG001|Overall Study|Efficacy outcome reached|16|||
127827073|NCT02064439|459985938|FG002|Overall Study|Efficacy outcome reached|57|||
127827074|NCT02064439|459985936|FG000|Overall Study|Safety outcome reached|12|||
127827075|NCT02064439|459985937|FG001|Overall Study|Safety outcome reached|20|||
127827076|NCT02064439|459985938|FG002|Overall Study|Safety outcome reached|10|||
127827077|NCT02064439|459985936|FG000|Overall Study|Other|2|||
127827078|NCT02064439|459985937|FG001|Overall Study|Other|2|||
127827079|NCT02064439|459985938|FG002|Overall Study|Other|7|||
127827080|NCT01120093|459985943|FG000|Treatment Period 1|Adverse Event|0|||
127827081|NCT01120093|459985944|FG001|Treatment Period 1|Adverse Event|0|||
127827082|NCT01120093|459985945|FG002|Treatment Period 1|Adverse Event|1|||
127827083|NCT01120093|459985946|FG003|Treatment Period 1|Adverse Event|0|||
127827084|NCT01120093|459985947|FG004|Treatment Period 1|Adverse Event|1|||
127827085|NCT01120093|459985943|FG000|Treatment Period 1|Withdrawal by Subject|0|||
127827086|NCT01120093|459985944|FG001|Treatment Period 1|Withdrawal by Subject|1|||
127827087|NCT01120093|459985945|FG002|Treatment Period 1|Withdrawal by Subject|0|||
127827088|NCT01120093|459985946|FG003|Treatment Period 1|Withdrawal by Subject|0|||
127894886|NCT01075763|460238549|FG001|Overall Study|Lost to Follow-up|1|||
127894887|NCT01075763|460238548|FG000|Overall Study|Lack of Efficacy|0|||
127894888|NCT01075763|460238549|FG001|Overall Study|Lack of Efficacy|1|||
127827089|NCT01120093|459985947|FG004|Treatment Period 1|Withdrawal by Subject|0|||
127827090|NCT01120093|459985943|FG000|Treatment Period 2|Adverse Event|0|||
127827091|NCT01120093|459985944|FG001|Treatment Period 2|Adverse Event|0|||
127827092|NCT01120093|459985945|FG002|Treatment Period 2|Adverse Event|0|||
127827093|NCT01120093|459985946|FG003|Treatment Period 2|Adverse Event|1|||
127827094|NCT01120093|459985947|FG004|Treatment Period 2|Adverse Event|0|||
127827095|NCT01120093|459985943|FG000|Treatment Period 2|Withdrawal by Subject|0|||
127827096|NCT01120093|459985944|FG001|Treatment Period 2|Withdrawal by Subject|0|||
127827097|NCT01120093|459985945|FG002|Treatment Period 2|Withdrawal by Subject|0|||
127827098|NCT01120093|459985946|FG003|Treatment Period 2|Withdrawal by Subject|0|||
127827099|NCT01120093|459985947|FG004|Treatment Period 2|Withdrawal by Subject|1|||
127827100|NCT01120093|459985943|FG000|Treatment Period 3|Lack of Efficacy|0|||
127827101|NCT01120093|459985944|FG001|Treatment Period 3|Lack of Efficacy|0|||
127827102|NCT01120093|459985945|FG002|Treatment Period 3|Lack of Efficacy|0|||
127827103|NCT01120093|459985946|FG003|Treatment Period 3|Lack of Efficacy|1|||
127827104|NCT01120093|459985947|FG004|Treatment Period 3|Lack of Efficacy|0|||
127827105|NCT01120093|459985943|FG000|Treatment Period 3|Adverse Event|0|||
127827106|NCT01120093|459985944|FG001|Treatment Period 3|Adverse Event|0|||
127827107|NCT01120093|459985945|FG002|Treatment Period 3|Adverse Event|0|||
127827108|NCT01120093|459985946|FG003|Treatment Period 3|Adverse Event|0|||
127827109|NCT01120093|459985947|FG004|Treatment Period 3|Adverse Event|1|||
127827110|NCT01120093|459985943|FG000|Treatment Period 3|Withdrawal by Subject|0|||
127827111|NCT01120093|459985944|FG001|Treatment Period 3|Withdrawal by Subject|0|||
127827112|NCT01120093|459985945|FG002|Treatment Period 3|Withdrawal by Subject|1|||
127827113|NCT01120093|459985946|FG003|Treatment Period 3|Withdrawal by Subject|0|||
127827114|NCT01120093|459985947|FG004|Treatment Period 3|Withdrawal by Subject|0|||
127827115|NCT01120093|459985943|FG000|Treatment Period 4|Adverse Event|1|||
127827116|NCT01120093|459985944|FG001|Treatment Period 4|Adverse Event|0|||
127827117|NCT01120093|459985945|FG002|Treatment Period 4|Adverse Event|0|||
127827118|NCT01120093|459985946|FG003|Treatment Period 4|Adverse Event|0|||
127827119|NCT01120093|459985947|FG004|Treatment Period 4|Adverse Event|0|||
127827120|NCT01120093|459985943|FG000|Treatment Period 5|Adverse Event|0|||
127827121|NCT01120093|459985944|FG001|Treatment Period 5|Adverse Event|1|||
127827122|NCT01120093|459985945|FG002|Treatment Period 5|Adverse Event|0|||
127827123|NCT01120093|459985946|FG003|Treatment Period 5|Adverse Event|1|||
127827124|NCT01120093|459985947|FG004|Treatment Period 5|Adverse Event|0|||
127827125|NCT03649321|459985950|FG000|Overall Study|Withdrawal by Subject|1|||
127827126|NCT03649321|459985951|FG001|Overall Study|Withdrawal by Subject|0|||
127827127|NCT03649321|459985950|FG000|Overall Study|Death|1|||
127827128|NCT03649321|459985951|FG001|Overall Study|Death|0|||
127827129|NCT01702363|459985952|FG000|Overall Study|Adverse Event|14|||
127827130|NCT01702363|459985952|FG000|Overall Study|Lack of Efficacy|4|||
127827131|NCT01702363|459985952|FG000|Overall Study|Withdrawal by Subject|2|||
127827132|NCT02184143|459985959|FG000|Overall Study|Withdrawal by Subject|4|||
127827133|NCT02184143|459985960|FG001|Overall Study|Withdrawal by Subject|4|||
127827134|NCT02184143|459985959|FG000|Overall Study|Lost to Follow-up|5|||
127827135|NCT02184143|459985960|FG001|Overall Study|Lost to Follow-up|3|||
127827136|NCT02184143|459985959|FG000|Overall Study|Death|1|||
127827137|NCT02184143|459985960|FG001|Overall Study|Death|0|||
127827138|NCT00321984|459985961|FG000|Overall Study|Adverse Event|9|||
127827139|NCT00321984|459985962|FG001|Overall Study|Adverse Event|6|||
127827140|NCT00321984|459985963|FG002|Overall Study|Adverse Event|8|||
127827141|NCT00321984|459985961|FG000|Overall Study|Protocol Violation|0|||
127827142|NCT00321984|459985962|FG001|Overall Study|Protocol Violation|1|||
127827143|NCT00321984|459985963|FG002|Overall Study|Protocol Violation|1|||
127827144|NCT00321984|459985961|FG000|Overall Study|Lost to Follow-up|2|||
127827145|NCT00321984|459985962|FG001|Overall Study|Lost to Follow-up|4|||
127827146|NCT00321984|459985963|FG002|Overall Study|Lost to Follow-up|2|||
127827147|NCT00321984|459985961|FG000|Overall Study|Withdrawal by Subject|8|||
127827148|NCT00321984|459985962|FG001|Overall Study|Withdrawal by Subject|6|||
127827149|NCT00321984|459985963|FG002|Overall Study|Withdrawal by Subject|5|||
127827150|NCT00321984|459985961|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
127827151|NCT00321984|459985962|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
127827152|NCT00321984|459985963|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
127827153|NCT00321984|459985961|FG000|Overall Study|Lack of Efficacy|3|||
127827154|NCT00321984|459985962|FG001|Overall Study|Lack of Efficacy|1|||
127827155|NCT00321984|459985963|FG002|Overall Study|Lack of Efficacy|3|||
127827156|NCT00321984|459985961|FG000|Overall Study|Noncompliant|0|||
127827157|NCT00321984|459985962|FG001|Overall Study|Noncompliant|0|||
127827158|NCT00321984|459985963|FG002|Overall Study|Noncompliant|2|||
127827159|NCT00321984|459985961|FG000|Overall Study|Pregnancy|0|||
127827160|NCT00321984|459985962|FG001|Overall Study|Pregnancy|1|||
127827161|NCT00321984|459985963|FG002|Overall Study|Pregnancy|0|||
127894889|NCT01075763|460238548|FG000|Overall Study|Withdrawal by Subject|2|||
127827162|NCT00321984|459985961|FG000|Overall Study|Per Subject Request|1|||
127827163|NCT00321984|459985962|FG001|Overall Study|Per Subject Request|0|||
127827164|NCT00321984|459985963|FG002|Overall Study|Per Subject Request|0|||
127827165|NCT00321984|459985961|FG000|Overall Study|Per Investigator Request|1|||
127827166|NCT00321984|459985962|FG001|Overall Study|Per Investigator Request|0|||
127827167|NCT00321984|459985963|FG002|Overall Study|Per Investigator Request|0|||
127827168|NCT00321984|459985961|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
127827169|NCT00321984|459985962|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
127827170|NCT00321984|459985963|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
127827171|NCT00739297|459985964|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
127827172|NCT00739297|459985965|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
127827173|NCT00739297|459985966|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
127827174|NCT00739297|459985967|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
127827175|NCT00739297|459985968|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
127827176|NCT00739297|459985969|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
127827177|NCT00739297|459985970|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
127827178|NCT00739297|459985964|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
127827179|NCT00739297|459985965|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
127827180|NCT00739297|459985966|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
127827181|NCT00739297|459985967|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
127827182|NCT00739297|459985968|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
127827183|NCT00739297|459985969|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
127827184|NCT00739297|459985970|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
127827185|NCT01757704|459985971|FG000|Overall Study|Protocol Violation|1|||
127827186|NCT01757704|459985972|FG001|Overall Study|Protocol Violation|3|||
127827187|NCT02749721|459985976|FG000|Screening|Withdrawal by Subject|1|||
127827188|NCT02749721|459985976|FG000|Screening|Lost to Follow-up|2|||
127827189|NCT02749721|459985976|FG000|Screening|Protocol Violation|3|||
127827190|NCT02749721|459985976|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
127827191|NCT02749721|459985976|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
127827192|NCT02137772|459985977|FG000|Overall Study|Adverse Event|6|||
127827193|NCT02137772|459985978|FG001|Overall Study|Adverse Event|3|||
127827194|NCT02137772|459985977|FG000|Overall Study|Death|71|||
127827195|NCT02137772|459985978|FG001|Overall Study|Death|44|||
127827196|NCT02137772|459985977|FG000|Overall Study|Lost to Follow-up|8|||
127827197|NCT02137772|459985978|FG001|Overall Study|Lost to Follow-up|4|||
127827198|NCT02137772|459985977|FG000|Overall Study|Physician Decision|15|||
127827199|NCT02137772|459985978|FG001|Overall Study|Physician Decision|5|||
127827200|NCT02137772|459985977|FG000|Overall Study|Withdrawal by Subject|28|||
127827201|NCT02137772|459985978|FG001|Overall Study|Withdrawal by Subject|17|||
127827202|NCT02137772|459985977|FG000|Overall Study|Non-compliance with study drug|1|||
127827203|NCT02137772|459985978|FG001|Overall Study|Non-compliance with study drug|0|||
127827204|NCT02137772|459985977|FG000|Overall Study|Not treated|3|||
127827205|NCT02137772|459985978|FG001|Overall Study|Not treated|2|||
127827206|NCT00616239|459985979|FG000|Overall Study|Withdrawal by Subject|2|||
127827207|NCT02144220|459985981|FG000|Overall Study|technology incompatibility|9|||
127827208|NCT02144220|459985981|FG000|Overall Study|Lack of Efficacy|4|||
127827209|NCT02144220|459985981|FG000|Overall Study|Physician Decision|3|||
127827210|NCT02144220|459985981|FG000|Overall Study|Withdrawal by Subject|2|||
127827211|NCT02144220|459985981|FG000|Overall Study|Protocol Violation|1|||
127827212|NCT03648996|459985982|FG000|Overall Study|Withdrawal by Subject|0|||
127827213|NCT03648996|459985983|FG001|Overall Study|Withdrawal by Subject|2|||
127827214|NCT03648996|459985984|FG002|Overall Study|Withdrawal by Subject|2|||
127827215|NCT03648996|459985982|FG000|Overall Study|Physician Decision|2|||
127827216|NCT03648996|459985983|FG001|Overall Study|Physician Decision|0|||
127827217|NCT03648996|459985984|FG002|Overall Study|Physician Decision|0|||
127827218|NCT00504166|459985989|FG000|Overall Study|Adverse Event|1|||
127827219|NCT00504166|459985990|FG001|Overall Study|Adverse Event|4|||
127827220|NCT00504166|459985989|FG000|Overall Study|Withdrawal by Subject|3|||
127827221|NCT00504166|459985990|FG001|Overall Study|Withdrawal by Subject|6|||
127827222|NCT00504166|459985989|FG000|Overall Study|Physician Decision|1|||
127827223|NCT00504166|459985990|FG001|Overall Study|Physician Decision|1|||
127827224|NCT00504166|459985989|FG000|Overall Study|Lost to Follow-up|1|||
127827225|NCT00504166|459985990|FG001|Overall Study|Lost to Follow-up|3|||
127827226|NCT02650284|459985991|FG000|Overall Study|Lost to Follow-up|3|||
127827227|NCT02650284|459985992|FG001|Overall Study|Lost to Follow-up|3|||
127827228|NCT02650284|459985991|FG000|Overall Study|Consent incorrectly taken|0|||
127827229|NCT02650284|459985992|FG001|Overall Study|Consent incorrectly taken|1|||
127827230|NCT01165203|459985995|FG000|Active Phase|Serious Adverse Event|1|||
127827231|NCT01165203|459985996|FG001|Active Phase|Serious Adverse Event|0|||
127827232|NCT01165203|459985995|FG000|Active Phase|Withdrawal by Subject|2|||
127827233|NCT01165203|459985996|FG001|Active Phase|Withdrawal by Subject|1|||
127827234|NCT01165203|459985995|FG000|Active Phase|Migrated/moved from study area|0|||
127827235|NCT01165203|459985996|FG001|Active Phase|Migrated/moved from study area|1|||
127827236|NCT01165203|459985995|FG000|Active Phase|Lost to Follow-up|2|||
127827237|NCT01165203|459985996|FG001|Active Phase|Lost to Follow-up|0|||
127827238|NCT01165203|459985995|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
127827239|NCT01165203|459985996|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
127827240|NCT01165203|459985995|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
127827241|NCT01165203|459985996|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
127827242|NCT01165203|459985995|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
127827243|NCT01165203|459985996|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
127827244|NCT01165203|459985995|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
127827245|NCT01165203|459985996|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
127827246|NCT01165203|459985995|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
127827247|NCT01165203|459985996|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
127827248|NCT01780389|459985998|FG000|Overall Study|Adverse Event|1|||
127827249|NCT02566525|459986002|FG000|Overall Study|Protocol Violation|3|||
127827250|NCT02566525|459986003|FG001|Overall Study|Protocol Violation|5|||
127827251|NCT00337467|459986004|FG000|Overall Study|Adverse Event|3|||
127827252|NCT00337467|459986004|FG000|Overall Study|Subject Withdrew Consent|2|||
127827253|NCT00337467|459986004|FG000|Overall Study|Pregnancy|1|||
127827254|NCT00337467|459986004|FG000|Overall Study|Lost to Follow-up|2|||
127827255|NCT00337467|459986004|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
127827256|NCT04083222|459986005|FG000|Overall Study|Voluntary Withdrawal|0|||
127827257|NCT04083222|459986006|FG001|Overall Study|Voluntary Withdrawal|1|||
127827258|NCT04083222|459986005|FG000|Overall Study|Reason not Specified|0|||
127827259|NCT04083222|459986006|FG001|Overall Study|Reason not Specified|1|||
127827260|NCT03103750|459986007|FG000|Overall Study|Adverse Event|1|||
127827261|NCT03103750|459986008|FG001|Overall Study|Adverse Event|0|||
127827262|NCT03103750|459986007|FG000|Overall Study|Lost to Follow-up|1|||
127827263|NCT03103750|459986008|FG001|Overall Study|Lost to Follow-up|0|||
127827264|NCT03103750|459986007|FG000|Overall Study|PET Equipment Related|2|||
127827265|NCT03103750|459986008|FG001|Overall Study|PET Equipment Related|2|||
127827266|NCT02429427|459986016|FG000|Overall Study|Adverse Event|220|||
127827267|NCT02429427|459986017|FG001|Overall Study|Adverse Event|92|||
127827268|NCT02429427|459986016|FG000|Overall Study|Protocol Violation|10|||
127827269|NCT02429427|459986017|FG001|Overall Study|Protocol Violation|6|||
127827270|NCT02429427|459986016|FG000|Overall Study|Lost to Follow-up|15|||
127827271|NCT02429427|459986017|FG001|Overall Study|Lost to Follow-up|6|||
127827272|NCT02429427|459986016|FG000|Overall Study|Withdrawal by Subject|64|||
127827273|NCT02429427|459986017|FG001|Overall Study|Withdrawal by Subject|34|||
127827274|NCT02429427|459986016|FG000|Overall Study|Other|62|||
127827275|NCT02429427|459986017|FG001|Overall Study|Other|41|||
127827276|NCT00747617|459987363|FG000|Overall Study|Lost to Follow-up|3|||
127827277|NCT00747617|459987364|FG001|Overall Study|Lost to Follow-up|1|||
127827278|NCT01746732|459987365|FG000|Lead-In Period|Withdrawal by Subject|1|||
127827279|NCT01746732|459987366|FG001|Lead-In Period|Withdrawal by Subject|0|||
127827280|NCT01746732|459987367|FG002|Lead-In Period|Withdrawal by Subject|0|||
127827281|NCT01746732|459987365|FG000|Period 1|Physician Decision|0|||
127827282|NCT01746732|459987366|FG001|Period 1|Physician Decision|1|||
127827283|NCT01746732|459987367|FG002|Period 1|Physician Decision|0|||
127827284|NCT01746732|459987365|FG000|Period 2|Withdrawal by Subject|0|||
127827285|NCT01746732|459987366|FG001|Period 2|Withdrawal by Subject|0|||
127827286|NCT01746732|459987367|FG002|Period 2|Withdrawal by Subject|2|||
127827287|NCT01746732|459987365|FG000|Period 2|Adverse Event|0|||
127827288|NCT01746732|459987366|FG001|Period 2|Adverse Event|0|||
127827289|NCT01746732|459987367|FG002|Period 2|Adverse Event|1|||
127827290|NCT01746732|459987365|FG000|Period 2|Lost to Follow-up|0|||
127827291|NCT01746732|459987366|FG001|Period 2|Lost to Follow-up|0|||
127827292|NCT01746732|459987367|FG002|Period 2|Lost to Follow-up|1|||
127827293|NCT02279524|459987368|FG000|Overall Study|Withdrawal by Subject|3|||
127827294|NCT02279524|459987369|FG001|Overall Study|Withdrawal by Subject|6|||
127827295|NCT02279524|459987370|FG002|Overall Study|Withdrawal by Subject|3|||
127827296|NCT02279524|459987368|FG000|Overall Study|Adverse Event|4|||
127827297|NCT02279524|459987369|FG001|Overall Study|Adverse Event|3|||
127827298|NCT02279524|459987370|FG002|Overall Study|Adverse Event|2|||
127827299|NCT02279524|459987368|FG000|Overall Study|Lost to Follow-up|1|||
127827300|NCT02279524|459987369|FG001|Overall Study|Lost to Follow-up|1|||
127827301|NCT02279524|459987370|FG002|Overall Study|Lost to Follow-up|0|||
127827302|NCT02279524|459987368|FG000|Overall Study|Disallowed medication|1|||
127827303|NCT02279524|459987369|FG001|Overall Study|Disallowed medication|1|||
127827304|NCT02279524|459987370|FG002|Overall Study|Disallowed medication|2|||
127827305|NCT02279524|459987368|FG000|Overall Study|Bariatric surgery|1|||
127827306|NCT02279524|459987369|FG001|Overall Study|Bariatric surgery|0|||
127827307|NCT02279524|459987370|FG002|Overall Study|Bariatric surgery|0|||
127827308|NCT03509207|459987371|FG000|Overall Study|Death|2|||
127827309|NCT02817555|459987372|FG000|Overall Study|Death|1|||
127827310|NCT02817555|459987373|FG001|Overall Study|Death|3|||
127827311|NCT02817555|459987372|FG000|Overall Study|moved away|1|||
127827312|NCT02817555|459987373|FG001|Overall Study|moved away|0|||
127827313|NCT02817555|459987372|FG000|Overall Study|transplant|1|||
127827314|NCT02817555|459987373|FG001|Overall Study|transplant|1|||
127827315|NCT02817555|459987372|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
127827316|NCT02817555|459987373|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
127827317|NCT00137436|459987374|FG000|Overall Study|Adverse Event|13|||
127827318|NCT00137436|459987374|FG000|Overall Study|Death|2|||
127827319|NCT00137436|459987374|FG000|Overall Study|Lack of Efficacy|17|||
127827320|NCT00137436|459987374|FG000|Overall Study|Withdrawal by Subject|6|||
127827321|NCT00137436|459987374|FG000|Overall Study|Other|5|||
127827322|NCT00912015|459987378|FG000|Overall Study|Lack of Efficacy|1|||
127827323|NCT00912015|459987379|FG001|Overall Study|Lack of Efficacy|0|||
127827324|NCT00912015|459987380|FG002|Overall Study|Lack of Efficacy|0|||
127827325|NCT00912015|459987381|FG003|Overall Study|Lack of Efficacy|0|||
127827326|NCT00912015|459987378|FG000|Overall Study|Withdrawal by Subject|8|||
127827327|NCT00912015|459987379|FG001|Overall Study|Withdrawal by Subject|8|||
127827328|NCT00912015|459987380|FG002|Overall Study|Withdrawal by Subject|3|||
127827329|NCT00912015|459987381|FG003|Overall Study|Withdrawal by Subject|0|||
127827330|NCT00912015|459987378|FG000|Overall Study|Protocol Violation|1|||
127827331|NCT00912015|459987379|FG001|Overall Study|Protocol Violation|0|||
127827332|NCT00912015|459987380|FG002|Overall Study|Protocol Violation|0|||
127827333|NCT00912015|459987381|FG003|Overall Study|Protocol Violation|1|||
127827334|NCT00912015|459987378|FG000|Overall Study|Adverse Event|6|||
127827335|NCT00912015|459987379|FG001|Overall Study|Adverse Event|0|||
127827336|NCT00912015|459987380|FG002|Overall Study|Adverse Event|0|||
127827337|NCT00912015|459987381|FG003|Overall Study|Adverse Event|1|||
127827338|NCT01356602|459987382|FG000|Overall Study|Protocol Deviation|0|||
127827339|NCT01356602|459987383|FG001|Overall Study|Protocol Deviation|1|||
127827340|NCT01356602|459987384|FG002|Overall Study|Protocol Deviation|1|||
127827341|NCT01356602|459987382|FG000|Overall Study|Administrative Problems|1|||
127827342|NCT01356602|459987383|FG001|Overall Study|Administrative Problems|4|||
127827343|NCT01356602|459987384|FG002|Overall Study|Administrative Problems|5|||
127827344|NCT01356602|459987382|FG000|Overall Study|Lost to Follow-up|4|||
127827345|NCT01356602|459987383|FG001|Overall Study|Lost to Follow-up|5|||
127827346|NCT01356602|459987384|FG002|Overall Study|Lost to Follow-up|6|||
127827347|NCT01356602|459987382|FG000|Overall Study|Withdrawal by Subject|4|||
127827348|NCT01356602|459987383|FG001|Overall Study|Withdrawal by Subject|3|||
127827349|NCT01356602|459987384|FG002|Overall Study|Withdrawal by Subject|7|||
127827350|NCT01356602|459987382|FG000|Overall Study|Lack of Efficacy|0|||
127827351|NCT01356602|459987383|FG001|Overall Study|Lack of Efficacy|1|||
127827352|NCT01356602|459987384|FG002|Overall Study|Lack of Efficacy|4|||
127827353|NCT01356602|459987382|FG000|Overall Study|Adverse Event|0|||
127827354|NCT01356602|459987383|FG001|Overall Study|Adverse Event|1|||
127827355|NCT01356602|459987384|FG002|Overall Study|Adverse Event|1|||
127827356|NCT01115569|459987385|FG000|Conversion/Titration Phase|Adverse Event|59|||
127827357|NCT01115569|459987386|FG001|Conversion/Titration Phase|Adverse Event|0|||
127827358|NCT01115569|459987385|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
127827359|NCT01115569|459987386|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
127827360|NCT01115569|459987385|FG000|Conversion/Titration Phase|Physician Decision|5|||
127827361|NCT01115569|459987386|FG001|Conversion/Titration Phase|Physician Decision|0|||
127827362|NCT01115569|459987385|FG000|Conversion/Titration Phase|Protocol Violation|68|||
127827363|NCT01115569|459987386|FG001|Conversion/Titration Phase|Protocol Violation|0|||
127827364|NCT01115569|459987385|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
127827365|NCT01115569|459987386|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
127827366|NCT01115569|459987385|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
127827367|NCT01115569|459987386|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
127827368|NCT01115569|459987385|FG000|Maintenance Phase|Adverse Event|0|||
127827369|NCT01115569|459987386|FG001|Maintenance Phase|Adverse Event|43|||
127827370|NCT01115569|459987385|FG000|Maintenance Phase|Lost to Follow-up|0|||
127827371|NCT01115569|459987386|FG001|Maintenance Phase|Lost to Follow-up|8|||
127827372|NCT01115569|459987385|FG000|Maintenance Phase|Physician Decision|0|||
127827373|NCT01115569|459987386|FG001|Maintenance Phase|Physician Decision|3|||
127827374|NCT01115569|459987385|FG000|Maintenance Phase|Protocol Violation|0|||
127827375|NCT01115569|459987386|FG001|Maintenance Phase|Protocol Violation|9|||
127827376|NCT01115569|459987385|FG000|Maintenance Phase|Withdrawal by Subject|0|||
127827377|NCT01115569|459987386|FG001|Maintenance Phase|Withdrawal by Subject|27|||
127827378|NCT01115569|459987385|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
127827379|NCT01115569|459987386|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
127827380|NCT01115569|459987385|FG000|Maintenance Phase|Administrative|0|||
127827381|NCT01115569|459987386|FG001|Maintenance Phase|Administrative|1|||
127827382|NCT02361762|459987387|FG000|Overall Study|Withdrawal by Subject|0|||
127827383|NCT02361762|459987388|FG001|Overall Study|Withdrawal by Subject|1|||
127827384|NCT02361762|459987387|FG000|Overall Study|Lost to Follow-up|0|||
127827385|NCT02361762|459987388|FG001|Overall Study|Lost to Follow-up|1|||
127827386|NCT01931462|459987389|FG000|Overall Study|Withdrawal by Subject|1|||
127827387|NCT02819310|459987390|FG000|Overall Study|Withdrawal by Subject|37|||
127827388|NCT02819310|459987390|FG000|Overall Study|Lost to Follow-up|16|||
127827389|NCT02819310|459987390|FG000|Overall Study|Adverse Event|13|||
127827390|NCT02819310|459987390|FG000|Overall Study|Lack of Efficacy|5|||
127827391|NCT02819310|459987390|FG000|Overall Study|Physician Decision|8|||
127827392|NCT02819310|459987390|FG000|Overall Study|Protocol Violation|30|||
127827393|NCT01793051|459987395|FG000|Overall Study|Withdrawal by Subject|6|||
127827394|NCT01793051|459987396|FG001|Overall Study|Withdrawal by Subject|4|||
127827395|NCT01793051|459987395|FG000|Overall Study|Adverse Event|0|||
127827396|NCT01793051|459987396|FG001|Overall Study|Adverse Event|2|||
127827397|NCT01793051|459987395|FG000|Overall Study|Too ill to continue|1|||
127827398|NCT01793051|459987396|FG001|Overall Study|Too ill to continue|0|||
127827399|NCT01793051|459987395|FG000|Overall Study|Switched chemo|1|||
127827400|NCT01793051|459987396|FG001|Overall Study|Switched chemo|1|||
127827401|NCT01793051|459987395|FG000|Overall Study|Lack of compliance|1|||
127827402|NCT01793051|459987396|FG001|Overall Study|Lack of compliance|0|||
127827403|NCT01793051|459987395|FG000|Overall Study|Requested to be removed from the study|1|||
127827404|NCT01793051|459987396|FG001|Overall Study|Requested to be removed from the study|1|||
127827405|NCT05070429|459987398|FG000|Overall Study|Death|0|||
127827406|NCT05070429|459987399|FG001|Overall Study|Death|4|||
127827407|NCT05070429|459987398|FG000|Overall Study|Withdrawal by Subject|2|||
127827408|NCT05070429|459987399|FG001|Overall Study|Withdrawal by Subject|1|||
127827409|NCT05070429|459987398|FG000|Overall Study|Other|15|||
127827410|NCT05070429|459987399|FG001|Overall Study|Other|5|||
127827411|NCT03276936|459987400|FG000|Overall Study|Adverse Event|4|||
127827412|NCT03276936|459987401|FG001|Overall Study|Adverse Event|2|||
127827413|NCT03276936|459987400|FG000|Overall Study|Lost to Follow-up|16|||
127827414|NCT03276936|459987401|FG001|Overall Study|Lost to Follow-up|13|||
127827415|NCT03276936|459987400|FG000|Overall Study|Withdrawal by Subject|30|||
127827416|NCT03276936|459987401|FG001|Overall Study|Withdrawal by Subject|20|||
127827417|NCT03276936|459987400|FG000|Overall Study|Not mentioned|6|||
127827418|NCT03276936|459987401|FG001|Overall Study|Not mentioned|3|||
127827419|NCT00943319|459987402|FG000|Overall Study|Death|1|||
127827420|NCT02043301|459987403|FG000|Overall Study|Discontinued|0|||
127827421|NCT02043301|459987404|FG001|Overall Study|Discontinued|1|||
127827422|NCT02043301|459987405|FG002|Overall Study|Discontinued|0|||
127827423|NCT03097328|459987406|FG000|Overall Study|Still on Therapy|2|||
127827424|NCT03097328|459987406|FG000|Overall Study|Progressive Disease|29|||
127827425|NCT03097328|459987406|FG000|Overall Study|Adverse Event|4|||
127827426|NCT03097328|459987406|FG000|Overall Study|Withdrawal by Subject|1|||
127827427|NCT03097328|459987406|FG000|Overall Study|Physician Decision|1|||
127827428|NCT03097328|459987406|FG000|Overall Study|Patient Decision|1|||
127827429|NCT03097328|459987406|FG000|Overall Study|Ineligible for Study Drug|1|||
127827430|NCT01798134|459987407|FG000|Overall Study|Lost to Follow-up|1|||
127827431|NCT01798134|459987407|FG000|Overall Study|Withdrawal by Subject|3|||
127827432|NCT01798134|459987407|FG000|Overall Study|Death|2|||
127827433|NCT01798134|459987407|FG000|Overall Study|Adverse Event|3|||
127827434|NCT01798134|459987407|FG000|Overall Study|Physician Decision|3|||
127827435|NCT01798134|459987407|FG000|Overall Study|Liver transplant/surgery|4|||
127827436|NCT02653976|459987408|FG000|Overall Study|Withdrawal by Subject|5|||
127827437|NCT02653976|459987408|FG000|Overall Study|Death|4|||
127827438|NCT02023164|459987409|FG000|24-Hour Follow-Up|Lost to Follow-up|0|||
127827439|NCT02023164|459987410|FG001|24-Hour Follow-Up|Lost to Follow-up|2|||
127827440|NCT00883558|459987411|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
127827441|NCT00883558|459987412|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
127827442|NCT00883558|459987413|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
127827443|NCT00883558|459987411|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
127827444|NCT00883558|459987412|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
127827445|NCT00883558|459987413|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
127827446|NCT00883558|459987411|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
127827447|NCT00883558|459987412|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
127827448|NCT00883558|459987413|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
127827449|NCT00883558|459987411|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
127827450|NCT00883558|459987412|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
127827451|NCT00883558|459987413|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
127827452|NCT00883558|459987411|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
127827453|NCT00883558|459987412|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
127827454|NCT00883558|459987413|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
127827455|NCT02436577|459987414|FG000|Overall Study|Protocol Deviation|0|||
127827456|NCT02436577|459987415|FG001|Overall Study|Protocol Deviation|1|||
127827457|NCT02436577|459987416|FG002|Overall Study|Protocol Deviation|0|||
127827458|NCT02436577|459987417|FG003|Overall Study|Protocol Deviation|0|||
127827459|NCT02436577|459987418|FG004|Overall Study|Protocol Deviation|0|||
127827460|NCT02436577|459987419|FG005|Overall Study|Protocol Deviation|0|||
127827461|NCT03703375|459987420|FG000|Randomization Period|Withdrawal by Subject|0|||
127827462|NCT03703375|459987421|FG001|Randomization Period|Withdrawal by Subject|0|||
127827463|NCT03703375|459987422|FG002|Randomization Period|Withdrawal by Subject|0|||
127827464|NCT03703375|459987423|FG003|Randomization Period|Withdrawal by Subject|1|||
127827465|NCT03703375|459987420|FG000|Randomization Period|Completed safety run-in treatment|7|||
127827466|NCT03703375|459987421|FG001|Randomization Period|Completed safety run-in treatment|0|||
127827467|NCT03703375|459987422|FG002|Randomization Period|Completed safety run-in treatment|0|||
127827468|NCT03703375|459987423|FG003|Randomization Period|Completed safety run-in treatment|0|||
127827469|NCT03703375|459987420|FG000|Treatment Period|Other Reasons|0|||
127827470|NCT03703375|459987421|FG001|Treatment Period|Other Reasons|1|||
127827471|NCT03703375|459987422|FG002|Treatment Period|Other Reasons|0|||
127827472|NCT03703375|459987423|FG003|Treatment Period|Other Reasons|3|||
127827473|NCT03703375|459987420|FG000|Treatment Period|Consent Withdrawal|0|||
127827474|NCT03703375|459987421|FG001|Treatment Period|Consent Withdrawal|0|||
127827475|NCT03703375|459987422|FG002|Treatment Period|Consent Withdrawal|0|||
127827476|NCT03703375|459987423|FG003|Treatment Period|Consent Withdrawal|1|||
127827477|NCT03703375|459987420|FG000|Treatment Period|Death|1|||
127827478|NCT03703375|459987421|FG001|Treatment Period|Death|0|||
127827479|NCT03703375|459987422|FG002|Treatment Period|Death|1|||
127827480|NCT03703375|459987423|FG003|Treatment Period|Death|2|||
127827481|NCT03703375|459987420|FG000|Treatment Period|Toxicity of Study Treatment|2|||
127827482|NCT03703375|459987421|FG001|Treatment Period|Toxicity of Study Treatment|0|||
127827483|NCT03703375|459987422|FG002|Treatment Period|Toxicity of Study Treatment|4|||
127827484|NCT03703375|459987423|FG003|Treatment Period|Toxicity of Study Treatment|1|||
127827485|NCT03703375|459987420|FG000|Treatment Period|Progression|32|||
127827486|NCT03703375|459987421|FG001|Treatment Period|Progression|1|||
127827487|NCT03703375|459987422|FG002|Treatment Period|Progression|7|||
127827488|NCT03703375|459987423|FG003|Treatment Period|Progression|11|||
127827489|NCT03703375|459987420|FG000|Treatment Period|Completed treatment|7|||
127827490|NCT03703375|459987421|FG001|Treatment Period|Completed treatment|2|||
127827491|NCT03703375|459987422|FG002|Treatment Period|Completed treatment|0|||
127827492|NCT03703375|459987423|FG003|Treatment Period|Completed treatment|0|||
127827493|NCT01675011|459987424|FG000|Overall Study|Trial terminated by Sponsor|3|||
127827494|NCT01675011|459987425|FG001|Overall Study|Trial terminated by Sponsor|1|||
127827495|NCT00625365|459987427|FG000|Overall Study|Withdrawal by Subject|1|||
127827496|NCT00625365|459987427|FG000|Overall Study|No IV access|5|||
127827497|NCT00625365|459987427|FG000|Overall Study|VSD|1|||
127827498|NCT01234402|459987429|FG000|Overall Study|Lost to Follow-up|0|||
127827499|NCT01234402|459987430|FG001|Overall Study|Lost to Follow-up|1|||
127827500|NCT01234402|459987431|FG002|Overall Study|Lost to Follow-up|3|||
127827501|NCT01234402|459987429|FG000|Overall Study|Withdrawal by Subject|1|||
127827502|NCT01234402|459987430|FG001|Overall Study|Withdrawal by Subject|3|||
127827503|NCT01234402|459987431|FG002|Overall Study|Withdrawal by Subject|4|||
127827504|NCT01234402|459987429|FG000|Overall Study|Never treated: Death|0|||
127827505|NCT01234402|459987430|FG001|Overall Study|Never treated: Death|0|||
127827506|NCT01234402|459987431|FG002|Overall Study|Never treated: Death|1|||
127827507|NCT01234402|459987429|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
127827508|NCT01234402|459987430|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
127827509|NCT01234402|459987431|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
127827510|NCT01234402|459987429|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
127827511|NCT01234402|459987430|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
127827512|NCT01234402|459987431|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
127827513|NCT02389816|459987434|FG000|Overall Study|Randomized but Not Treated|1|||
127827514|NCT02389816|459987435|FG001|Overall Study|Randomized but Not Treated|0|||
127827515|NCT02389816|459987436|FG002|Overall Study|Randomized but Not Treated|0|||
127827516|NCT02389816|459987434|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
127827517|NCT02389816|459987435|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
127827518|NCT02389816|459987436|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
127827519|NCT02389816|459987434|FG000|Overall Study|Major Protocol Deviation|1|||
127827520|NCT02389816|459987435|FG001|Overall Study|Major Protocol Deviation|0|||
127827521|NCT02389816|459987436|FG002|Overall Study|Major Protocol Deviation|0|||
127827522|NCT02389816|459987434|FG000|Overall Study|Lost to Follow-up|1|||
127827523|NCT02389816|459987435|FG001|Overall Study|Lost to Follow-up|0|||
127827524|NCT02389816|459987436|FG002|Overall Study|Lost to Follow-up|0|||
127827525|NCT02389816|459987434|FG000|Overall Study|Withdrawal of Consent|6|||
127827526|NCT02389816|459987435|FG001|Overall Study|Withdrawal of Consent|4|||
127827527|NCT02389816|459987436|FG002|Overall Study|Withdrawal of Consent|4|||
127827528|NCT02389816|459987434|FG000|Overall Study|Lack of Efficacy|1|||
127827529|NCT02389816|459987435|FG001|Overall Study|Lack of Efficacy|0|||
127827530|NCT02389816|459987436|FG002|Overall Study|Lack of Efficacy|0|||
127827531|NCT02389816|459987434|FG000|Overall Study|Non Compliance with Study Drug|1|||
127827532|NCT02389816|459987435|FG001|Overall Study|Non Compliance with Study Drug|1|||
127827533|NCT02389816|459987436|FG002|Overall Study|Non Compliance with Study Drug|1|||
127827534|NCT02389816|459987434|FG000|Overall Study|Reason not Specified|0|||
127827535|NCT02389816|459987435|FG001|Overall Study|Reason not Specified|2|||
127827536|NCT02389816|459987436|FG002|Overall Study|Reason not Specified|0|||
127827537|NCT02417233|459987437|FG000|Overall Study|Death|4|||
127827538|NCT02417233|459987438|FG001|Overall Study|Death|10|||
127827539|NCT02417233|459987439|FG002|Overall Study|Death|14|||
127827540|NCT02417233|459987437|FG000|Overall Study|Lost to Follow-up|27|||
127827541|NCT02417233|459987438|FG001|Overall Study|Lost to Follow-up|39|||
127827542|NCT02417233|459987439|FG002|Overall Study|Lost to Follow-up|34|||
127827543|NCT02417233|459987437|FG000|Overall Study|Protocol Violation|2|||
127827544|NCT02417233|459987438|FG001|Overall Study|Protocol Violation|0|||
127827545|NCT02417233|459987439|FG002|Overall Study|Protocol Violation|2|||
127827546|NCT02417233|459987437|FG000|Overall Study|Withdrawal by Subject|2|||
127827547|NCT02417233|459987438|FG001|Overall Study|Withdrawal by Subject|1|||
127827548|NCT02417233|459987439|FG002|Overall Study|Withdrawal by Subject|8|||
127827549|NCT02417233|459987437|FG000|Overall Study|Relocation out of study area|1|||
127827550|NCT02417233|459987438|FG001|Overall Study|Relocation out of study area|0|||
127827551|NCT02417233|459987439|FG002|Overall Study|Relocation out of study area|1|||
127827552|NCT02417233|459987437|FG000|Overall Study|Mentally unstable|0|||
127827553|NCT02417233|459987438|FG001|Overall Study|Mentally unstable|1|||
127827554|NCT02417233|459987439|FG002|Overall Study|Mentally unstable|0|||
127827555|NCT02985450|459987443|FG000|Overall Study|Lost to Follow-up|7|||
127827556|NCT00431847|459987446|FG000|Overall Study|completion of less than two study visits|6|||
127827557|NCT00431847|459987447|FG001|Overall Study|completion of less than two study visits|3|||
127827558|NCT00431847|459987448|FG002|Overall Study|completion of less than two study visits|4|||
127827559|NCT00431847|459987449|FG003|Overall Study|completion of less than two study visits|14|||
127827560|NCT00431847|459987450|FG004|Overall Study|completion of less than two study visits|0|||
127827561|NCT00431847|459987446|FG000|Overall Study|Protocol Violation|0|||
127827562|NCT00431847|459987447|FG001|Overall Study|Protocol Violation|0|||
127827563|NCT00431847|459987448|FG002|Overall Study|Protocol Violation|0|||
127827564|NCT00431847|459987449|FG003|Overall Study|Protocol Violation|0|||
127827565|NCT00431847|459987450|FG004|Overall Study|Protocol Violation|1|||
127827566|NCT01469013|459987451|FG000|Part A (Treatment Period)|Adverse Event|1|||
127827567|NCT01469013|459987452|FG001|Part A (Treatment Period)|Adverse Event|0|||
127827568|NCT01469013|459987453|FG002|Part A (Treatment Period)|Adverse Event|0|||
127827569|NCT01469013|459987454|FG003|Part A (Treatment Period)|Adverse Event|0|||
127827570|NCT01469013|459987455|FG004|Part A (Treatment Period)|Adverse Event|1|||
127827571|NCT01469013|459987456|FG005|Part A (Treatment Period)|Adverse Event|0|||
127827572|NCT01469013|459987457|FG006|Part A (Treatment Period)|Adverse Event|0|||
127827573|NCT01469013|459987458|FG007|Part A (Treatment Period)|Adverse Event|0|||
127827574|NCT01469013|459987459|FG008|Part A (Treatment Period)|Adverse Event|0|||
127827575|NCT01469013|459987460|FG009|Part A (Treatment Period)|Adverse Event|0|||
127827576|NCT01469013|459987461|FG010|Part A (Treatment Period)|Adverse Event|0|||
127827577|NCT01469013|459987462|FG011|Part A (Treatment Period)|Adverse Event|0|||
127827578|NCT01469013|459987463|FG012|Part A (Treatment Period)|Adverse Event|0|||
127827579|NCT01469013|459987451|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
127827580|NCT01469013|459987452|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
127827581|NCT01469013|459987453|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
127827582|NCT01469013|459987454|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
127827583|NCT01469013|459987455|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
127827584|NCT01469013|459987456|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
127827585|NCT01469013|459987457|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
127827586|NCT01469013|459987458|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
127827587|NCT01469013|459987459|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
127827588|NCT01469013|459987460|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
127827589|NCT01469013|459987461|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
127827590|NCT01469013|459987462|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
127827591|NCT01469013|459987463|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
127827592|NCT01469013|459987451|FG000|Part B (Extension Period)|Adverse Event|0|||
127827593|NCT01469013|459987452|FG001|Part B (Extension Period)|Adverse Event|0|||
127827594|NCT01469013|459987453|FG002|Part B (Extension Period)|Adverse Event|0|||
127827595|NCT01469013|459987454|FG003|Part B (Extension Period)|Adverse Event|0|||
127827596|NCT01469013|459987455|FG004|Part B (Extension Period)|Adverse Event|0|||
127827597|NCT01469013|459987456|FG005|Part B (Extension Period)|Adverse Event|2|||
127827598|NCT01469013|459987457|FG006|Part B (Extension Period)|Adverse Event|5|||
127827599|NCT01469013|459987458|FG007|Part B (Extension Period)|Adverse Event|5|||
127827600|NCT01469013|459987459|FG008|Part B (Extension Period)|Adverse Event|3|||
127827601|NCT01469013|459987460|FG009|Part B (Extension Period)|Adverse Event|3|||
127827602|NCT01469013|459987461|FG010|Part B (Extension Period)|Adverse Event|1|||
127827603|NCT01469013|459987462|FG011|Part B (Extension Period)|Adverse Event|6|||
127827604|NCT01469013|459987463|FG012|Part B (Extension Period)|Adverse Event|3|||
127827605|NCT01469013|459987451|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
127827606|NCT01469013|459987452|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
127827607|NCT01469013|459987453|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
127827608|NCT01469013|459987454|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
127827609|NCT01469013|459987455|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
127827610|NCT01469013|459987456|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
127827611|NCT01469013|459987457|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
127827612|NCT01469013|459987458|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
127827613|NCT01469013|459987459|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
127827614|NCT01469013|459987460|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
127827615|NCT01469013|459987461|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
127827616|NCT01469013|459987462|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
127827617|NCT01469013|459987463|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
127827618|NCT00002663|459987464|FG000|Overall Study|Death|4|||
127827619|NCT00002663|459987465|FG001|Overall Study|Death|1|||
127827620|NCT00002663|459987466|FG002|Overall Study|Death|1|||
127827621|NCT00002663|459987467|FG003|Overall Study|Death|0|||
127827622|NCT00002663|459987468|FG004|Overall Study|Death|0|||
127827623|NCT00002663|459987469|FG005|Overall Study|Death|13|||
127827624|NCT00002663|459987470|FG006|Overall Study|Death|0|||
127827625|NCT00002663|459987471|FG007|Overall Study|Death|1|||
127827626|NCT00002663|459987472|FG008|Overall Study|Death|1|||
127827627|NCT00002663|459987473|FG009|Overall Study|Death|1|||
127827628|NCT00002663|459987464|FG000|Overall Study|Lost to Follow-up|3|||
127827629|NCT00002663|459987465|FG001|Overall Study|Lost to Follow-up|0|||
127827630|NCT00002663|459987466|FG002|Overall Study|Lost to Follow-up|0|||
127827631|NCT00002663|459987467|FG003|Overall Study|Lost to Follow-up|1|||
127827632|NCT00002663|459987468|FG004|Overall Study|Lost to Follow-up|0|||
127827633|NCT00002663|459987469|FG005|Overall Study|Lost to Follow-up|1|||
127827634|NCT00002663|459987470|FG006|Overall Study|Lost to Follow-up|0|||
127827635|NCT00002663|459987471|FG007|Overall Study|Lost to Follow-up|0|||
127827636|NCT00002663|459987472|FG008|Overall Study|Lost to Follow-up|0|||
127827637|NCT00002663|459987473|FG009|Overall Study|Lost to Follow-up|0|||
127827638|NCT00002663|459987464|FG000|Overall Study|Other|0|||
127827639|NCT00002663|459987465|FG001|Overall Study|Other|1|||
127827640|NCT00002663|459987466|FG002|Overall Study|Other|0|||
127827641|NCT00002663|459987467|FG003|Overall Study|Other|0|||
127827642|NCT00002663|459987468|FG004|Overall Study|Other|0|||
127827643|NCT00002663|459987469|FG005|Overall Study|Other|1|||
127827644|NCT00002663|459987470|FG006|Overall Study|Other|1|||
127827645|NCT00002663|459987471|FG007|Overall Study|Other|0|||
127827646|NCT00002663|459987472|FG008|Overall Study|Other|0|||
127827647|NCT00002663|459987473|FG009|Overall Study|Other|0|||
127827648|NCT00002663|459987464|FG000|Overall Study|Physician Decision|0|||
127827649|NCT00002663|459987465|FG001|Overall Study|Physician Decision|0|||
127827650|NCT00002663|459987466|FG002|Overall Study|Physician Decision|0|||
127827651|NCT00002663|459987467|FG003|Overall Study|Physician Decision|0|||
127827652|NCT00002663|459987468|FG004|Overall Study|Physician Decision|1|||
127827653|NCT00002663|459987469|FG005|Overall Study|Physician Decision|0|||
127827654|NCT00002663|459987470|FG006|Overall Study|Physician Decision|0|||
127827655|NCT00002663|459987471|FG007|Overall Study|Physician Decision|0|||
127827656|NCT00002663|459987472|FG008|Overall Study|Physician Decision|1|||
127827657|NCT00002663|459987473|FG009|Overall Study|Physician Decision|1|||
127827658|NCT00002663|459987464|FG000|Overall Study|Adverse Event|0|||
127827659|NCT00002663|459987465|FG001|Overall Study|Adverse Event|0|||
127827660|NCT00002663|459987466|FG002|Overall Study|Adverse Event|0|||
127827661|NCT00002663|459987467|FG003|Overall Study|Adverse Event|1|||
127827662|NCT00002663|459987468|FG004|Overall Study|Adverse Event|0|||
127827663|NCT00002663|459987469|FG005|Overall Study|Adverse Event|0|||
127827664|NCT00002663|459987470|FG006|Overall Study|Adverse Event|0|||
127827665|NCT00002663|459987471|FG007|Overall Study|Adverse Event|1|||
127827666|NCT00002663|459987472|FG008|Overall Study|Adverse Event|0|||
127827667|NCT00002663|459987473|FG009|Overall Study|Adverse Event|0|||
127827668|NCT01603641|459987477|FG000|Overall Study|Did not Receive Treatment|3|||
127827669|NCT01603641|459987477|FG000|Overall Study|Adverse Event|1|||
127827670|NCT01603641|459987477|FG000|Overall Study|Lack of Efficacy|1|||
127827671|NCT01603641|459987477|FG000|Overall Study|Lost to Follow-up|6|||
127827672|NCT01603641|459987477|FG000|Overall Study|Personal Reasons|18|||
127827673|NCT01603641|459987477|FG000|Overall Study|Other Miscellaneous Reasons|6|||
127827674|NCT03161678|459987478|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
127827675|NCT03161678|459987479|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
127827676|NCT03161678|459987480|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
127827677|NCT03161678|459987481|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
127827678|NCT03161678|459987482|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
127827679|NCT03161678|459987483|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
127827680|NCT03161678|459987478|FG000|Intervention 1 (8 Days)|Adverse Event|0|||
127827681|NCT03161678|459987479|FG001|Intervention 1 (8 Days)|Adverse Event|0|||
127827682|NCT03161678|459987480|FG002|Intervention 1 (8 Days)|Adverse Event|0|||
127827683|NCT03161678|459987481|FG003|Intervention 1 (8 Days)|Adverse Event|1|||
127827684|NCT03161678|459987482|FG004|Intervention 1 (8 Days)|Adverse Event|0|||
127827685|NCT03161678|459987483|FG005|Intervention 1 (8 Days)|Adverse Event|0|||
127827686|NCT03161678|459987478|FG000|Washout (14 Days)|Withdrawal by Subject|0|||
127827687|NCT03161678|459987479|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
127827688|NCT03161678|459987480|FG002|Washout (14 Days)|Withdrawal by Subject|1|||
127827689|NCT03161678|459987481|FG003|Washout (14 Days)|Withdrawal by Subject|0|||
127827690|NCT03161678|459987482|FG004|Washout (14 Days)|Withdrawal by Subject|2|||
127827691|NCT03161678|459987483|FG005|Washout (14 Days)|Withdrawal by Subject|1|||
127827692|NCT03161678|459987478|FG000|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
127827693|NCT03161678|459987479|FG001|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
127827694|NCT03161678|459987480|FG002|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
127827695|NCT03161678|459987481|FG003|Intervention 2 (8 Days)|Withdrawal by Subject|1|||
127827696|NCT03161678|459987482|FG004|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
127827697|NCT03161678|459987483|FG005|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
127827698|NCT02890329|459987486|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
127827699|NCT02890329|459987487|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|1|||
127827700|NCT02890329|459987488|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
127827701|NCT02890329|459987489|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
127827702|NCT02890329|459987490|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
127827703|NCT02890329|459987491|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
127827704|NCT02890329|459987486|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
127827705|NCT02890329|459987487|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
127827706|NCT02890329|459987488|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
127827707|NCT02890329|459987489|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
127827708|NCT02890329|459987490|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
127827709|NCT02890329|459987491|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
127827710|NCT02890329|459987486|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
127827711|NCT02890329|459987487|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
127827712|NCT02890329|459987488|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
127827713|NCT02890329|459987489|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|2|||
127827714|NCT02890329|459987490|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
127827715|NCT02890329|459987491|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
127827716|NCT02890329|459987486|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
127827717|NCT02890329|459987487|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
127827718|NCT02890329|459987488|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|1|||
127827719|NCT02890329|459987489|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
127827720|NCT02890329|459987490|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
127827721|NCT02890329|459987491|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
127827722|NCT00443430|459987493|FG000|Overall Study|Lack of Efficacy|3|||
127827723|NCT00443430|459987494|FG001|Overall Study|Lack of Efficacy|3|||
127827724|NCT00443430|459987493|FG000|Overall Study|Adverse Event|1|||
127827725|NCT00443430|459987494|FG001|Overall Study|Adverse Event|1|||
127827726|NCT02229864|459987495|FG000|Overall Study|Death|2|||
127827727|NCT02229864|459987495|FG000|Overall Study|Lost to Follow-up|1|||
127827728|NCT02084134|459987498|FG000|Overall Study|Protocol Violation|4|||
127827729|NCT02084134|459987499|FG001|Overall Study|Protocol Violation|2|||
127827730|NCT02084134|459987498|FG000|Overall Study|Death|0|||
127827731|NCT02084134|459987499|FG001|Overall Study|Death|1|||
127827732|NCT00374907|459987500|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
127827733|NCT00374907|459987501|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
127827734|NCT00374907|459987500|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
127827735|NCT00374907|459987501|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
127827736|NCT00374907|459987500|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
127827737|NCT00374907|459987501|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
127894890|NCT01075763|460238549|FG001|Overall Study|Withdrawal by Subject|2|||
127827738|NCT00374907|459987500|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
127827739|NCT00374907|459987501|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
127827740|NCT00374907|459987500|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
127827741|NCT00374907|459987501|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
127827742|NCT01095250|459987507|FG000|Overall Study|administrative reasons|8|||
127827743|NCT01095250|459987508|FG001|Overall Study|administrative reasons|10|||
127827744|NCT01095250|459987509|FG002|Overall Study|administrative reasons|7|||
127827745|NCT01095250|459987510|FG003|Overall Study|administrative reasons|5|||
127827746|NCT01095250|459987507|FG000|Overall Study|Withdrawal by Subject|0|||
127827747|NCT01095250|459987508|FG001|Overall Study|Withdrawal by Subject|0|||
127827748|NCT01095250|459987509|FG002|Overall Study|Withdrawal by Subject|1|||
127827749|NCT01095250|459987510|FG003|Overall Study|Withdrawal by Subject|0|||
127827750|NCT01323673|459987511|FG000|Overall Study|Adverse Event|0|||
127827751|NCT01323673|459987512|FG001|Overall Study|Adverse Event|1|||
127827752|NCT01323673|459987511|FG000|Overall Study|Lost to Follow-up|0|||
127827753|NCT01323673|459987512|FG001|Overall Study|Lost to Follow-up|1|||
127827754|NCT01323673|459987511|FG000|Overall Study|Protocol Violation|1|||
127827755|NCT01323673|459987512|FG001|Overall Study|Protocol Violation|0|||
127827756|NCT01323673|459987511|FG000|Overall Study|Withdrawal by Subject|2|||
127827757|NCT01323673|459987512|FG001|Overall Study|Withdrawal by Subject|3|||
127827758|NCT04598165|459987513|FG000|Completed 6-week Follow-up|Withdrawal by Subject|6|||
127827759|NCT04598165|459987514|FG001|Completed 6-week Follow-up|Withdrawal by Subject|3|||
127827760|NCT04598165|459987513|FG000|Completed 6-week Follow-up|Death|2|||
127827761|NCT04598165|459987514|FG001|Completed 6-week Follow-up|Death|1|||
127827762|NCT04598165|459987513|FG000|Completed 6-week Follow-up|Lost to Follow-up|26|||
127827763|NCT04598165|459987514|FG001|Completed 6-week Follow-up|Lost to Follow-up|33|||
127827764|NCT04598165|459987513|FG000|Completed 6-week Follow-up|Ineligible|4|||
127827765|NCT04598165|459987514|FG001|Completed 6-week Follow-up|Ineligible|3|||
127827766|NCT04598165|459987513|FG000|Completed 6-week Follow-up|Partner refusal|0|||
127827767|NCT04598165|459987514|FG001|Completed 6-week Follow-up|Partner refusal|1|||
127827768|NCT04598165|459987513|FG000|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|67|||
127827769|NCT04598165|459987514|FG001|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|69|||
127827770|NCT02379923|459987515|FG000|Overall Study|Death|5|||
127827771|NCT00426751|459987516|FG000|Overall Study|Adverse Event|8|||
127827772|NCT00426751|459987517|FG001|Overall Study|Adverse Event|1|||
127827773|NCT00426751|459987516|FG000|Overall Study|Lost to Follow-up|7|||
127827774|NCT00426751|459987517|FG001|Overall Study|Lost to Follow-up|6|||
127827775|NCT00426751|459987516|FG000|Overall Study|Consent Withdrawn|0|||
127827776|NCT00426751|459987517|FG001|Overall Study|Consent Withdrawn|1|||
127827777|NCT00426751|459987516|FG000|Overall Study|Other Reasons|7|||
127827778|NCT00426751|459987517|FG001|Overall Study|Other Reasons|12|||
127827779|NCT01200511|459987518|FG000|Overall Study|Lost to Follow-up|3|||
127827780|NCT01200511|459987518|FG000|Overall Study|Withdrawal by Subject|1|||
127827781|NCT01200511|459987518|FG000|Overall Study|Adverse Event|1|||
127827782|NCT02488759|459987522|FG000|Overall Study|Disease progression|73|||
127827783|NCT02488759|459987523|FG001|Overall Study|Disease progression|111|||
127827784|NCT02488759|459987524|FG002|Overall Study|Disease progression|62|||
127827785|NCT02488759|459987525|FG003|Overall Study|Disease progression|7|||
127827786|NCT02488759|459987526|FG004|Overall Study|Disease progression|4|||
127827787|NCT02488759|459987527|FG005|Overall Study|Disease progression|2|||
127827788|NCT02488759|459987522|FG000|Overall Study|Study drug toxicity|11|||
127827789|NCT02488759|459987523|FG001|Overall Study|Study drug toxicity|33|||
127827790|NCT02488759|459987524|FG002|Overall Study|Study drug toxicity|31|||
127827791|NCT02488759|459987525|FG003|Overall Study|Study drug toxicity|0|||
127827792|NCT02488759|459987526|FG004|Overall Study|Study drug toxicity|0|||
127827793|NCT02488759|459987527|FG005|Overall Study|Study drug toxicity|2|||
127827794|NCT02488759|459987522|FG000|Overall Study|Adverse event unrelated to study drug|9|||
127827795|NCT02488759|459987523|FG001|Overall Study|Adverse event unrelated to study drug|11|||
127827796|NCT02488759|459987524|FG002|Overall Study|Adverse event unrelated to study drug|7|||
127827797|NCT02488759|459987525|FG003|Overall Study|Adverse event unrelated to study drug|0|||
127827798|NCT02488759|459987526|FG004|Overall Study|Adverse event unrelated to study drug|1|||
127827799|NCT02488759|459987527|FG005|Overall Study|Adverse event unrelated to study drug|0|||
127827800|NCT02488759|459987522|FG000|Overall Study|Participant request to discontinue study treatment|6|||
127827801|NCT02488759|459987523|FG001|Overall Study|Participant request to discontinue study treatment|8|||
127827802|NCT02488759|459987524|FG002|Overall Study|Participant request to discontinue study treatment|4|||
127827803|NCT02488759|459987525|FG003|Overall Study|Participant request to discontinue study treatment|0|||
127827804|NCT02488759|459987526|FG004|Overall Study|Participant request to discontinue study treatment|0|||
127827805|NCT02488759|459987527|FG005|Overall Study|Participant request to discontinue study treatment|0|||
127827806|NCT02488759|459987522|FG000|Overall Study|Withdrawal by Subject|4|||
127827807|NCT02488759|459987523|FG001|Overall Study|Withdrawal by Subject|0|||
127827808|NCT02488759|459987524|FG002|Overall Study|Withdrawal by Subject|3|||
127827809|NCT02488759|459987525|FG003|Overall Study|Withdrawal by Subject|0|||
127827810|NCT02488759|459987526|FG004|Overall Study|Withdrawal by Subject|0|||
127827811|NCT02488759|459987527|FG005|Overall Study|Withdrawal by Subject|2|||
127827812|NCT02488759|459987522|FG000|Overall Study|Lost to Follow-up|0|||
127827813|NCT02488759|459987523|FG001|Overall Study|Lost to Follow-up|0|||
127827814|NCT02488759|459987524|FG002|Overall Study|Lost to Follow-up|2|||
127827815|NCT02488759|459987525|FG003|Overall Study|Lost to Follow-up|0|||
127827816|NCT02488759|459987526|FG004|Overall Study|Lost to Follow-up|0|||
127827817|NCT02488759|459987527|FG005|Overall Study|Lost to Follow-up|0|||
127827818|NCT02488759|459987522|FG000|Overall Study|Maximum clinical benefit|3|||
127827819|NCT02488759|459987523|FG001|Overall Study|Maximum clinical benefit|0|||
127827820|NCT02488759|459987524|FG002|Overall Study|Maximum clinical benefit|1|||
127827821|NCT02488759|459987525|FG003|Overall Study|Maximum clinical benefit|0|||
127827822|NCT02488759|459987526|FG004|Overall Study|Maximum clinical benefit|0|||
127827823|NCT02488759|459987527|FG005|Overall Study|Maximum clinical benefit|0|||
127827824|NCT02488759|459987522|FG000|Overall Study|Other reasons|7|||
127827825|NCT02488759|459987523|FG001|Overall Study|Other reasons|32|||
127827826|NCT02488759|459987524|FG002|Overall Study|Other reasons|23|||
127827827|NCT02488759|459987525|FG003|Overall Study|Other reasons|1|||
127827828|NCT02488759|459987526|FG004|Overall Study|Other reasons|1|||
127827829|NCT02488759|459987527|FG005|Overall Study|Other reasons|1|||
127827830|NCT04400318|459988480|FG000|Overall Study|Adverse Event|1|||
127827831|NCT04400318|459988481|FG001|Overall Study|Adverse Event|0|||
127827832|NCT04400318|459988480|FG000|Overall Study|Withdrawal by Subject|1|||
127827833|NCT04400318|459988481|FG001|Overall Study|Withdrawal by Subject|1|||
127827834|NCT04400318|459988480|FG000|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|0|||
127827835|NCT04400318|459988481|FG001|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|3|||
127827836|NCT01096446|459988482|FG000|Overall Study|Death|1|||
127827837|NCT01096446|459988483|FG001|Overall Study|Death|0|||
127827838|NCT01096446|459988482|FG000|Overall Study|Protocol Violation|2|||
127827839|NCT01096446|459988483|FG001|Overall Study|Protocol Violation|0|||
127827840|NCT00165646|459988484|FG000|Overall Study|Adverse Event|1|||
127827841|NCT00165646|459988485|FG001|Overall Study|Adverse Event|1|||
127827842|NCT00165646|459988486|FG002|Overall Study|Adverse Event|1|||
127827843|NCT00165646|459988484|FG000|Overall Study|Lack of Efficacy|1|||
127827844|NCT00165646|459988485|FG001|Overall Study|Lack of Efficacy|2|||
127827845|NCT00165646|459988486|FG002|Overall Study|Lack of Efficacy|0|||
127827846|NCT00165646|459988484|FG000|Overall Study|Withdrawal by Subject|0|||
127827847|NCT00165646|459988485|FG001|Overall Study|Withdrawal by Subject|2|||
127827848|NCT00165646|459988486|FG002|Overall Study|Withdrawal by Subject|1|||
127827849|NCT00165646|459988484|FG000|Overall Study|Physician Decision|2|||
127827850|NCT00165646|459988485|FG001|Overall Study|Physician Decision|0|||
127827851|NCT00165646|459988486|FG002|Overall Study|Physician Decision|2|||
127827852|NCT00165646|459988484|FG000|Overall Study|Protocol Violation|1|||
127827853|NCT00165646|459988485|FG001|Overall Study|Protocol Violation|0|||
127827854|NCT00165646|459988486|FG002|Overall Study|Protocol Violation|0|||
127827855|NCT04657016|459988487|FG000|Overall Study|Adverse Event|2|||
127827856|NCT04657016|459988488|FG001|Overall Study|Adverse Event|4|||
127827857|NCT04657016|459988487|FG000|Overall Study|Death|1|||
127827858|NCT04657016|459988488|FG001|Overall Study|Death|1|||
127827859|NCT04657016|459988487|FG000|Overall Study|Lost to Follow-up|24|||
127827860|NCT04657016|459988488|FG001|Overall Study|Lost to Follow-up|12|||
127827861|NCT04657016|459988487|FG000|Overall Study|Physician Decision|1|||
127827862|NCT04657016|459988488|FG001|Overall Study|Physician Decision|2|||
127827863|NCT04657016|459988487|FG000|Overall Study|Pregnancy|2|||
127827864|NCT04657016|459988488|FG001|Overall Study|Pregnancy|2|||
127827865|NCT04657016|459988487|FG000|Overall Study|Protocol Deviation|1|||
127827866|NCT04657016|459988488|FG001|Overall Study|Protocol Deviation|0|||
127827867|NCT04657016|459988487|FG000|Overall Study|Withdrawal by Subject|28|||
127827868|NCT04657016|459988488|FG001|Overall Study|Withdrawal by Subject|14|||
127827869|NCT04657016|459988487|FG000|Overall Study|Other - as reported by the investigator|6|||
127827870|NCT04657016|459988488|FG001|Overall Study|Other - as reported by the investigator|0|||
127827871|NCT01755195|459988489|FG000|Overall Study|Participant noncompliance|2|||
127827872|NCT01755195|459988489|FG000|Overall Study|Switched to alternative treatment|4|||
127827873|NCT01755195|459988489|FG000|Overall Study|Withdrawal by Subject|1|||
127827874|NCT01755195|459988489|FG000|Overall Study|Participant refused to start treatment|1|||
127827875|NCT01755195|459988489|FG000|Overall Study|Participant has been consented for another trial|1|||
127827876|NCT01755195|459988489|FG000|Overall Study|Refused further treatment|3|||
127827877|NCT01755195|459988489|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
127827878|NCT03470922|459988490|FG000|Overall Study|Death|107|||
127827879|NCT03470922|459988491|FG001|Overall Study|Death|118|||
127827880|NCT03470922|459988490|FG000|Overall Study|Lost to Follow-up|5|||
127827881|NCT03470922|459988491|FG001|Overall Study|Lost to Follow-up|5|||
127827882|NCT03470922|459988490|FG000|Overall Study|Participant Withdrew Consent|4|||
127827883|NCT03470922|459988491|FG001|Overall Study|Participant Withdrew Consent|9|||
127827884|NCT03470922|459988490|FG000|Overall Study|Other reasons|1|||
127827885|NCT03470922|459988491|FG001|Overall Study|Other reasons|0|||
127827886|NCT03470922|459988490|FG000|Overall Study|Not reported|1|||
127827887|NCT03470922|459988491|FG001|Overall Study|Not reported|0|||
127827888|NCT02340819|459988492|FG000|Overall Study|Adverse Event|1|||
127827889|NCT02340819|459988492|FG000|Overall Study|Withdrawal by Subject|2|||
127827890|NCT02340819|459988492|FG000|Overall Study|Discontinued with other reason|1|||
127827891|NCT04467164|459988496|FG000|Washout (1 Week)|Lost to Follow-up|2|||
127827892|NCT04467164|459988497|FG001|Washout (1 Week)|Lost to Follow-up|0|||
127827893|NCT01703286|459988501|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
127827894|NCT01703286|459988502|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
127827895|NCT01703286|459988503|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
127827896|NCT01703286|459988504|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
127827897|NCT01703286|459988505|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
127827898|NCT01703286|459988506|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
127827899|NCT01703286|459988501|FG000|Period 2 Including Washout|Adverse Event|0|||
127827900|NCT01703286|459988502|FG001|Period 2 Including Washout|Adverse Event|0|||
127827901|NCT01703286|459988503|FG002|Period 2 Including Washout|Adverse Event|0|||
127827902|NCT01703286|459988504|FG003|Period 2 Including Washout|Adverse Event|1|||
127827903|NCT01703286|459988505|FG004|Period 2 Including Washout|Adverse Event|0|||
127827904|NCT01703286|459988506|FG005|Period 2 Including Washout|Adverse Event|0|||
127827905|NCT01984346|459988507|FG000|Overall Study|Physician Decision|4|||
127827906|NCT01984346|459988508|FG001|Overall Study|Physician Decision|2|||
127827907|NCT01984346|459988507|FG000|Overall Study|Withdrawal by Subject|2|||
127827908|NCT01984346|459988508|FG001|Overall Study|Withdrawal by Subject|2|||
127827909|NCT01984346|459988507|FG000|Overall Study|Enrollment Closed|8|||
127827910|NCT01984346|459988508|FG001|Overall Study|Enrollment Closed|1|||
127827911|NCT01984346|459988507|FG000|Overall Study|Insurance Coverage|1|||
127827912|NCT01984346|459988508|FG001|Overall Study|Insurance Coverage|0|||
127827913|NCT01984346|459988507|FG000|Overall Study|Intra-operative Exclusion|2|||
127827914|NCT01984346|459988508|FG001|Overall Study|Intra-operative Exclusion|0|||
127827915|NCT05058664|459988514|FG000|Overall Study|No follow-up data provided|4|||
127827916|NCT05058664|459988515|FG001|Overall Study|No follow-up data provided|0|||
127827917|NCT05058664|459988516|FG002|Overall Study|No follow-up data provided|2|||
127827918|NCT05058664|459988514|FG000|Overall Study|Withdrawal by Subject|0|||
127827919|NCT05058664|459988515|FG001|Overall Study|Withdrawal by Subject|0|||
127827920|NCT05058664|459988516|FG002|Overall Study|Withdrawal by Subject|1|||
127827921|NCT00972244|459988517|FG000|Overall Study|Incorrect Enrolment|1|||
127827922|NCT00972244|459988518|FG001|Overall Study|Incorrect Enrolment|0|||
127827923|NCT00972244|459988519|FG002|Overall Study|Incorrect Enrolment|0|||
127827924|NCT00972244|459988520|FG003|Overall Study|Incorrect Enrolment|0|||
127827925|NCT00972244|459988521|FG004|Overall Study|Incorrect Enrolment|0|||
127827926|NCT00972244|459988517|FG000|Overall Study|Adverse Event|0|||
127827927|NCT00972244|459988518|FG001|Overall Study|Adverse Event|1|||
127827928|NCT00972244|459988519|FG002|Overall Study|Adverse Event|1|||
127827929|NCT00972244|459988520|FG003|Overall Study|Adverse Event|0|||
127827930|NCT00972244|459988521|FG004|Overall Study|Adverse Event|0|||
127827931|NCT00972244|459988517|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
127827932|NCT00972244|459988518|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
127827933|NCT00972244|459988519|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
127827934|NCT00972244|459988520|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
127827935|NCT00972244|459988521|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
127827936|NCT00972244|459988517|FG000|Overall Study|Withdrawal by Subject|1|||
127827937|NCT00972244|459988518|FG001|Overall Study|Withdrawal by Subject|2|||
127827938|NCT00972244|459988519|FG002|Overall Study|Withdrawal by Subject|1|||
127827939|NCT00972244|459988520|FG003|Overall Study|Withdrawal by Subject|0|||
127827940|NCT00972244|459988521|FG004|Overall Study|Withdrawal by Subject|1|||
127827941|NCT00972244|459988517|FG000|Overall Study|Safety|0|||
127827942|NCT00972244|459988518|FG001|Overall Study|Safety|0|||
127827943|NCT00972244|459988519|FG002|Overall Study|Safety|0|||
127827944|NCT00972244|459988520|FG003|Overall Study|Safety|0|||
127827945|NCT00972244|459988521|FG004|Overall Study|Safety|1|||
127827946|NCT00972244|459988517|FG000|Overall Study|Death|1|||
127827947|NCT00972244|459988518|FG001|Overall Study|Death|0|||
127827948|NCT00972244|459988519|FG002|Overall Study|Death|0|||
127827949|NCT00972244|459988520|FG003|Overall Study|Death|0|||
127827950|NCT00972244|459988521|FG004|Overall Study|Death|0|||
127827951|NCT00972244|459988517|FG000|Overall Study|Various|0|||
127827952|NCT00972244|459988518|FG001|Overall Study|Various|0|||
127827953|NCT00972244|459988519|FG002|Overall Study|Various|0|||
127827954|NCT00972244|459988520|FG003|Overall Study|Various|0|||
127827955|NCT00972244|459988521|FG004|Overall Study|Various|2|||
127827956|NCT01597557|459988522|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
127827957|NCT01597557|459988523|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
127827958|NCT03952468|459988527|FG000|Overall Study|Death|0|||
127827959|NCT03952468|459988528|FG001|Overall Study|Death|1|||
127827960|NCT03952468|459988527|FG000|Overall Study|Adverse Event|0|||
127827961|NCT03952468|459988528|FG001|Overall Study|Adverse Event|1|||
127827962|NCT03952468|459988527|FG000|Overall Study|Physician Decision|1|||
127827963|NCT03952468|459988528|FG001|Overall Study|Physician Decision|0|||
127827964|NCT03952468|459988527|FG000|Overall Study|Lost to Follow-up|3|||
127827965|NCT03952468|459988528|FG001|Overall Study|Lost to Follow-up|4|||
127827966|NCT03952468|459988527|FG000|Overall Study|Withdrawal by Subject|2|||
127827967|NCT03952468|459988528|FG001|Overall Study|Withdrawal by Subject|1|||
127827968|NCT05761444|459988530|FG000|Overall Study|Protocol Violation|2|||
127827969|NCT05761444|459988531|FG001|Overall Study|Protocol Violation|1|||
127827970|NCT05761444|459988530|FG000|Overall Study|Adverse Event|2|||
127827971|NCT05761444|459988531|FG001|Overall Study|Adverse Event|2|||
127827972|NCT05761444|459988530|FG000|Overall Study|Withdrawal by Subject|3|||
127827973|NCT05761444|459988531|FG001|Overall Study|Withdrawal by Subject|2|||
127827974|NCT05761444|459988530|FG000|Overall Study|Other|1|||
127827975|NCT05761444|459988531|FG001|Overall Study|Other|0|||
127827976|NCT01293032|459988532|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
127827977|NCT01293032|459988533|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
127827978|NCT01293032|459988534|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
127827979|NCT01293032|459988535|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
127827980|NCT01293032|459988532|FG000|Treatment|Adverse Event|0|||
127827981|NCT01293032|459988533|FG001|Treatment|Adverse Event|0|||
127827982|NCT01293032|459988534|FG002|Treatment|Adverse Event|1|||
127827983|NCT01293032|459988535|FG003|Treatment|Adverse Event|1|||
127827984|NCT01293032|459988532|FG000|Treatment|Withdrawal by Subject|2|||
127827985|NCT01293032|459988533|FG001|Treatment|Withdrawal by Subject|4|||
127827986|NCT01293032|459988534|FG002|Treatment|Withdrawal by Subject|0|||
127827987|NCT01293032|459988535|FG003|Treatment|Withdrawal by Subject|0|||
127827988|NCT01293032|459988532|FG000|Treatment|Disease Progression, relapse|0|||
127827989|NCT01293032|459988533|FG001|Treatment|Disease Progression, relapse|1|||
127827990|NCT01293032|459988534|FG002|Treatment|Disease Progression, relapse|0|||
127827991|NCT01293032|459988535|FG003|Treatment|Disease Progression, relapse|0|||
127827992|NCT01594476|459988536|FG000|Overall Study|Protocol Violation|1|||
127827993|NCT01594476|459988537|FG001|Overall Study|Protocol Violation|3|||
127827994|NCT02691247|459988541|FG000|Overall Study|Withdrawal by Subject|1|||
127827995|NCT02691247|459988542|FG001|Overall Study|Withdrawal by Subject|2|||
127827996|NCT02691247|459988543|FG002|Overall Study|Withdrawal by Subject|2|||
127827997|NCT02691247|459988541|FG000|Overall Study|Lost to Follow-up|2|||
127827998|NCT02691247|459988542|FG001|Overall Study|Lost to Follow-up|0|||
127827999|NCT02691247|459988543|FG002|Overall Study|Lost to Follow-up|1|||
127828000|NCT05468086|459988548|FG000|Overall Study|Withdrawal by Subject|3|||
127828001|NCT05468086|459988548|FG000|Overall Study|Subject was found ineligible after consent|1|||
127828002|NCT01108809|459988549|FG000|Overall Study|Adverse Event|3|||
127828003|NCT01108809|459988549|FG000|Overall Study|Lost to Follow-up|1|||
127828004|NCT04229446|459988552|FG000|Overall Study|Death|12|||
127828005|NCT04229446|459988553|FG001|Overall Study|Death|10|||
127828006|NCT04229446|459988552|FG000|Overall Study|Lost to Follow-up|5|||
127828007|NCT04229446|459988553|FG001|Overall Study|Lost to Follow-up|8|||
127828008|NCT00705224|459988554|FG000|Overall Study|Adverse Event|1|||
127828009|NCT00705224|459988554|FG000|Overall Study|Lack of Efficacy|2|||
127828010|NCT00705224|459988554|FG000|Overall Study|Withdrawal by Subject|3|||
127828011|NCT00705224|459988554|FG000|Overall Study|Lost to Follow-up|5|||
127828012|NCT00968253|459988555|FG000|Overall Study|Death|0|||
127828013|NCT00968253|459988556|FG001|Overall Study|Death|0|||
127828014|NCT00968253|459988557|FG002|Overall Study|Death|2|||
127828015|NCT00968253|459988555|FG000|Overall Study|Withdrawal by Subject|0|||
127828016|NCT00968253|459988556|FG001|Overall Study|Withdrawal by Subject|0|||
127828017|NCT00968253|459988557|FG002|Overall Study|Withdrawal by Subject|1|||
127828018|NCT00968253|459988555|FG000|Overall Study|Disease Progression|0|||
127828019|NCT00968253|459988556|FG001|Overall Study|Disease Progression|3|||
127828020|NCT00968253|459988557|FG002|Overall Study|Disease Progression|3|||
127828021|NCT00968253|459988555|FG000|Overall Study|Adverse Event|0|||
127828022|NCT00968253|459988556|FG001|Overall Study|Adverse Event|0|||
127828023|NCT00968253|459988557|FG002|Overall Study|Adverse Event|1|||
127828024|NCT03596177|459988558|FG000|Single Blind Period|Withdrawal by Subject|1|||
127828025|NCT03596177|459988559|FG001|Single Blind Period|Withdrawal by Subject|1|||
127828026|NCT03596177|459988558|FG000|Single Blind Period|Other|1|||
127828027|NCT03596177|459988559|FG001|Single Blind Period|Other|0|||
127828028|NCT03596177|459988558|FG000|Double Blind Period|Withdrawal by Subject|0|||
127828029|NCT03596177|459988559|FG001|Double Blind Period|Withdrawal by Subject|1|||
127828030|NCT03596177|459988558|FG000|Double Blind Period|Other|0|||
127828031|NCT03596177|459988559|FG001|Double Blind Period|Other|4|||
127828032|NCT03596177|459988558|FG000|Double Blind Period|Death during safety follow-up|0|||
127828033|NCT03596177|459988559|FG001|Double Blind Period|Death during safety follow-up|1|||
127828034|NCT03141086|459988563|FG000|Overall Study|Study Terminated By Sponsor|1|||
127828035|NCT03141086|459988564|FG001|Overall Study|Study Terminated By Sponsor|1|||
127828036|NCT03141086|459988563|FG000|Overall Study|Withdrawal by Subject|0|||
127828037|NCT03141086|459988564|FG001|Overall Study|Withdrawal by Subject|1|||
127828038|NCT03141086|459988563|FG000|Overall Study|Protocol Violation|0|||
127828039|NCT03141086|459988564|FG001|Overall Study|Protocol Violation|1|||
127828040|NCT03141086|459988563|FG000|Overall Study|Adverse Event|0|||
127828041|NCT03141086|459988564|FG001|Overall Study|Adverse Event|2|||
127828042|NCT03860844|459988567|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
127828043|NCT03860844|459988568|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
127828044|NCT03860844|459988569|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
127828045|NCT03860844|459988567|FG000|Overall Study|Progressive disease|5|||
127828046|NCT03860844|459988568|FG001|Overall Study|Progressive disease|3|||
127828047|NCT03860844|459988569|FG002|Overall Study|Progressive disease|4|||
127828048|NCT03860844|459988567|FG000|Overall Study|Other, Not related to COVID-19|0|||
127828049|NCT03860844|459988568|FG001|Overall Study|Other, Not related to COVID-19|1|||
127828050|NCT03860844|459988569|FG002|Overall Study|Other, Not related to COVID-19|0|||
127828051|NCT01678807|459988570|FG000|Overall Study|Adverse Event|4|||
127828052|NCT01678807|459988571|FG001|Overall Study|Adverse Event|4|||
127828053|NCT01678807|459988572|FG002|Overall Study|Adverse Event|0|||
127828054|NCT01678807|459988570|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
127828055|NCT01678807|459988571|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
127828056|NCT01678807|459988572|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
127828057|NCT00370149|459988573|FG000|Overall Study|Physician Decision|16|||
127828058|NCT00370149|459988574|FG001|Overall Study|Physician Decision|16|||
127828059|NCT00370149|459988573|FG000|Overall Study|Protocol Violation|1|||
127828060|NCT00370149|459988574|FG001|Overall Study|Protocol Violation|0|||
127828061|NCT00370149|459988573|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
127828062|NCT00370149|459988574|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
127828063|NCT00370149|459988573|FG000|Overall Study|Pre-existing infection|0|||
127828064|NCT00370149|459988574|FG001|Overall Study|Pre-existing infection|1|||
127828065|NCT00370149|459988573|FG000|Overall Study|Antibiotic coated dressing placed|0|||
127828066|NCT00370149|459988574|FG001|Overall Study|Antibiotic coated dressing placed|1|||
127828067|NCT00719732|459988575|FG000|Overall Study|Lost to Follow-up|20|||
127828068|NCT00719732|459988575|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
127828069|NCT00719732|459988575|FG000|Overall Study|Illness not associated with device|1|||
127828070|NCT03625986|459990147|FG000|Randomization Period|Lost to Follow-up|7|||
127828071|NCT03625986|459990148|FG001|Randomization Period|Lost to Follow-up|12|||
127828072|NCT03625986|459990147|FG000|Randomization Period|Withdrawal by Subject|10|||
127828073|NCT03625986|459990148|FG001|Randomization Period|Withdrawal by Subject|6|||
127828074|NCT04920084|459990150|FG000|Overall Study|Adverse Event|1|||
127828075|NCT04920084|459990150|FG000|Overall Study|Lost to Follow-up|2|||
127828076|NCT04920084|459990150|FG000|Overall Study|Withdrawal by Subject|2|||
127828077|NCT00620321|459990151|FG000|Overall Study|Adverse Event|1|||
127828078|NCT00620321|459990152|FG001|Overall Study|Adverse Event|1|||
127828079|NCT00620321|459990151|FG000|Overall Study|Death|1|||
127828080|NCT00620321|459990152|FG001|Overall Study|Death|1|||
127828081|NCT00620321|459990151|FG000|Overall Study|Physician Decision|0|||
127828082|NCT00620321|459990152|FG001|Overall Study|Physician Decision|7|||
127828083|NCT00620321|459990151|FG000|Overall Study|Progressive Disease|5|||
127828084|NCT00620321|459990152|FG001|Overall Study|Progressive Disease|5|||
127828085|NCT00620321|459990151|FG000|Overall Study|Sponsor Decision|0|||
127828086|NCT00620321|459990152|FG001|Overall Study|Sponsor Decision|1|||
127828087|NCT00620321|459990151|FG000|Overall Study|Withdrawal by Subject|1|||
127828088|NCT00620321|459990152|FG001|Overall Study|Withdrawal by Subject|1|||
127828089|NCT04191967|459990153|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
127828090|NCT04191967|459990153|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
127828091|NCT01431144|459990154|FG000|Overall Study|Implant mobility and removal|2|||
127828092|NCT01431144|459990155|FG001|Overall Study|Implant mobility and removal|0|||
127828093|NCT02410902|459990164|FG000|Overall Study|Adverse Event|2|||
127828094|NCT02410902|459990165|FG001|Overall Study|Adverse Event|3|||
127828095|NCT02410902|459990164|FG000|Overall Study|Lost to Follow-up|4|||
127828096|NCT02410902|459990165|FG001|Overall Study|Lost to Follow-up|1|||
127828097|NCT02410902|459990164|FG000|Overall Study|Protocol Violation|1|||
127828098|NCT02410902|459990165|FG001|Overall Study|Protocol Violation|4|||
127828099|NCT02410902|459990164|FG000|Overall Study|Withdrawal by Subject|6|||
127828100|NCT02410902|459990165|FG001|Overall Study|Withdrawal by Subject|8|||
127828101|NCT02410902|459990164|FG000|Overall Study|Non-Compliance|8|||
127828102|NCT02410902|459990165|FG001|Overall Study|Non-Compliance|2|||
127828103|NCT00953043|459990166|FG000|Overall Study|Withdrawal by Subject|4|||
127828104|NCT00953043|459990167|FG001|Overall Study|Withdrawal by Subject|0|||
127828105|NCT00953043|459990166|FG000|Overall Study|Physician Decision|0|||
127828106|NCT00953043|459990167|FG001|Overall Study|Physician Decision|2|||
127828107|NCT01043185|459990169|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
127828108|NCT01043185|459990170|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
127828109|NCT01043185|459990171|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
127828110|NCT01043185|459990172|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
127828111|NCT01043185|459990173|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
127828112|NCT01043185|459990174|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
127828113|NCT01043185|459990175|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
127828114|NCT01043185|459990176|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
127828115|NCT01043185|459990177|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
127828116|NCT01043185|459990178|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
127828117|NCT01432262|459990179|FG000|Overall Study|Withdrawal by Subject|2|||
127828118|NCT01432262|459990180|FG001|Overall Study|Withdrawal by Subject|1|||
127828119|NCT01104558|459990181|FG000|Overall Study|Protocol Violation|6|||
127828120|NCT01104558|459990181|FG000|Overall Study|Missing of primary efficacy assessment|10|||
127828121|NCT01104558|459990181|FG000|Overall Study|Missing of genetic analysis results|1|||
127828122|NCT03395197|459990184|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
127828123|NCT03395197|459990185|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
127828124|NCT03395197|459990186|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
127828125|NCT03395197|459990187|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
127828126|NCT03395197|459990188|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
127828127|NCT03395197|459990189|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
127828128|NCT03395197|459990184|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
127828129|NCT03395197|459990185|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
127828130|NCT03395197|459990186|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
127828131|NCT03395197|459990187|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
127828132|NCT03395197|459990188|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
127828133|NCT03395197|459990189|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
127828134|NCT03395197|459990184|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
127828135|NCT03395197|459990185|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
127828136|NCT03395197|459990186|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
127828137|NCT03395197|459990187|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
127828138|NCT03395197|459990188|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
127828139|NCT03395197|459990189|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
127828140|NCT03395197|459990184|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
127828141|NCT03395197|459990185|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
127828142|NCT03395197|459990186|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
127828143|NCT03395197|459990187|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
127828144|NCT03395197|459990188|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
127828145|NCT03395197|459990189|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
127828146|NCT03395197|459990184|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
127828147|NCT03395197|459990185|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
127828148|NCT03395197|459990186|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
127828149|NCT03395197|459990187|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
127828150|NCT03395197|459990188|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
127828151|NCT03395197|459990189|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
127828152|NCT03395197|459990184|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
127828153|NCT03395197|459990185|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
127828154|NCT03395197|459990186|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
127828155|NCT03395197|459990187|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
127828156|NCT03395197|459990188|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
127828157|NCT03395197|459990189|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
127828158|NCT03395197|459990184|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
127828159|NCT03395197|459990185|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
127828160|NCT03395197|459990186|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
127828161|NCT03395197|459990187|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
127828162|NCT03395197|459990188|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
127828163|NCT03395197|459990189|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
127828164|NCT03395197|459990184|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
127828165|NCT03395197|459990185|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
127828166|NCT03395197|459990186|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
127828167|NCT03395197|459990187|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
127828168|NCT03395197|459990188|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
127828169|NCT03395197|459990189|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
127828170|NCT03395197|459990184|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
127828171|NCT03395197|459990185|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
127828172|NCT03395197|459990186|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
127828173|NCT03395197|459990187|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
127828174|NCT03395197|459990188|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
127828175|NCT03395197|459990189|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
127828176|NCT03395197|459990184|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
127828177|NCT03395197|459990185|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
127828178|NCT03395197|459990186|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
127828179|NCT03395197|459990187|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
127828180|NCT03395197|459990188|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
127828181|NCT03395197|459990189|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
127828182|NCT03395197|459990184|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
127828183|NCT03395197|459990185|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
127828184|NCT03395197|459990186|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
127828185|NCT03395197|459990187|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
127828186|NCT03395197|459990188|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
127828187|NCT03395197|459990189|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
127828188|NCT03395197|459990184|FG000|Analysis for DDR-Deficient Participants|Death|0|||
127828189|NCT03395197|459990185|FG001|Analysis for DDR-Deficient Participants|Death|0|||
127828190|NCT03395197|459990186|FG002|Analysis for DDR-Deficient Participants|Death|0|||
127828191|NCT03395197|459990187|FG003|Analysis for DDR-Deficient Participants|Death|0|||
127828192|NCT03395197|459990188|FG004|Analysis for DDR-Deficient Participants|Death|1|||
127828193|NCT03395197|459990189|FG005|Analysis for DDR-Deficient Participants|Death|4|||
127828194|NCT03395197|459990184|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
127828195|NCT03395197|459990185|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
127828196|NCT03395197|459990186|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
127828197|NCT03395197|459990187|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
127828198|NCT03395197|459990188|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
127828199|NCT03395197|459990189|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
127828200|NCT03395197|459990184|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
127828201|NCT03395197|459990185|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
127828202|NCT03395197|459990186|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
127828203|NCT03395197|459990187|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
127828204|NCT03395197|459990188|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
127828205|NCT03395197|459990189|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
127828206|NCT03395197|459990184|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
127828207|NCT03395197|459990185|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
127828208|NCT03395197|459990186|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
127828209|NCT03395197|459990187|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
127828210|NCT03395197|459990188|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
127828211|NCT03395197|459990189|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
127828212|NCT03395197|459990184|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
127828213|NCT03395197|459990185|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
127828214|NCT03395197|459990186|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
127828215|NCT03395197|459990187|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
127828216|NCT03395197|459990188|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
127828217|NCT03395197|459990189|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
127828218|NCT03395197|459990184|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
127828219|NCT03395197|459990185|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
127828220|NCT03395197|459990186|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
127828221|NCT03395197|459990187|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
127828222|NCT03395197|459990188|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
127828223|NCT03395197|459990189|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
127828224|NCT03395197|459990184|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
127828225|NCT03395197|459990185|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
127828226|NCT03395197|459990186|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
127828227|NCT03395197|459990187|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
127828228|NCT03395197|459990188|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
127828229|NCT03395197|459990189|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
127828230|NCT03395197|459990184|FG000|Analysis for DDR-Deficient Participants|Other|0|||
127828231|NCT03395197|459990185|FG001|Analysis for DDR-Deficient Participants|Other|0|||
127828232|NCT03395197|459990186|FG002|Analysis for DDR-Deficient Participants|Other|0|||
127828233|NCT03395197|459990187|FG003|Analysis for DDR-Deficient Participants|Other|0|||
127828234|NCT03395197|459990188|FG004|Analysis for DDR-Deficient Participants|Other|3|||
127828235|NCT03395197|459990189|FG005|Analysis for DDR-Deficient Participants|Other|3|||
127828236|NCT03395197|459990184|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
127828237|NCT03395197|459990185|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
127828238|NCT03395197|459990186|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
127828239|NCT03395197|459990187|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
127828240|NCT03395197|459990188|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
127828241|NCT03395197|459990189|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
127828242|NCT00392171|459990190|FG000|Overall Study|Did not meet inclusion criteria|4|||
127828243|NCT00392171|459990190|FG000|Overall Study|Disease progression|101|||
127828244|NCT01605071|459990191|FG000|Overall Study|Withdrawal by Subject|3|||
127828245|NCT01605071|459990192|FG001|Overall Study|Withdrawal by Subject|2|||
127828246|NCT00028002|459990196|FG000|Overall Study|Withdrawal by Subject|3|||
127828247|NCT00028002|459990196|FG000|Overall Study|Ineligible|8|||
127828248|NCT01881620|459990200|FG000|Overall Study|Protocol Violation|4|||
127828249|NCT01808118|459990203|FG000|Period 1|Adverse Event|15|||
127828250|NCT01808118|459990204|FG001|Period 1|Adverse Event|0|||
127828251|NCT01808118|459990205|FG002|Period 1|Adverse Event|0|||
127828252|NCT01808118|459990203|FG000|Period 1|Withdrew consent|24|||
127828253|NCT01808118|459990204|FG001|Period 1|Withdrew consent|0|||
127828254|NCT01808118|459990205|FG002|Period 1|Withdrew consent|0|||
127828255|NCT01808118|459990203|FG000|Period 1|Lost to Follow-up|9|||
127828256|NCT01808118|459990204|FG001|Period 1|Lost to Follow-up|0|||
127828257|NCT01808118|459990205|FG002|Period 1|Lost to Follow-up|0|||
127828258|NCT01808118|459990203|FG000|Period 1|Did not meet criteria for remission|303|||
127828259|NCT01808118|459990204|FG001|Period 1|Did not meet criteria for remission|0|||
127828260|NCT01808118|459990205|FG002|Period 1|Did not meet criteria for remission|0|||
127828261|NCT01808118|459990203|FG000|Period 1|Enrolled in error|7|||
127828262|NCT01808118|459990204|FG001|Period 1|Enrolled in error|0|||
127828263|NCT01808118|459990205|FG002|Period 1|Enrolled in error|0|||
127828264|NCT01808118|459990203|FG000|Period 1|Did not meet inclusion criteria|3|||
127828265|NCT01808118|459990204|FG001|Period 1|Did not meet inclusion criteria|0|||
127828266|NCT01808118|459990205|FG002|Period 1|Did not meet inclusion criteria|0|||
127828267|NCT01808118|459990203|FG000|Period 1|Non-conformance with inclusion criteria|3|||
127828268|NCT01808118|459990204|FG001|Period 1|Non-conformance with inclusion criteria|0|||
127828269|NCT01808118|459990205|FG002|Period 1|Non-conformance with inclusion criteria|0|||
127828270|NCT01808118|459990203|FG000|Period 1|Investigator decision: site closure|2|||
127828271|NCT01808118|459990204|FG001|Period 1|Investigator decision: site closure|0|||
127828272|NCT01808118|459990205|FG002|Period 1|Investigator decision: site closure|0|||
127828273|NCT01808118|459990203|FG000|Period 1|Non-compliance per sponsor|1|||
127828274|NCT01808118|459990204|FG001|Period 1|Non-compliance per sponsor|0|||
127828275|NCT01808118|459990205|FG002|Period 1|Non-compliance per sponsor|0|||
127828276|NCT01808118|459990203|FG000|Period 1|Lack of Efficacy|1|||
127828277|NCT01808118|459990204|FG001|Period 1|Lack of Efficacy|0|||
127828278|NCT01808118|459990205|FG002|Period 1|Lack of Efficacy|0|||
127828279|NCT01808118|459990203|FG000|Period 2|Adverse Event|0|||
127828280|NCT01808118|459990204|FG001|Period 2|Adverse Event|4|||
127828281|NCT01808118|459990205|FG002|Period 2|Adverse Event|0|||
127828282|NCT01808118|459990203|FG000|Period 2|Withdrew consent|0|||
127828283|NCT01808118|459990204|FG001|Period 2|Withdrew consent|7|||
127828284|NCT01808118|459990205|FG002|Period 2|Withdrew consent|6|||
127828285|NCT01808118|459990203|FG000|Period 2|Lost to Follow-up|0|||
127828286|NCT01808118|459990204|FG001|Period 2|Lost to Follow-up|0|||
127828287|NCT01808118|459990205|FG002|Period 2|Lost to Follow-up|2|||
127828288|NCT01808118|459990203|FG000|Period 2|Investigator no longer conducting trials|0|||
127828289|NCT01808118|459990204|FG001|Period 2|Investigator no longer conducting trials|1|||
127828290|NCT01808118|459990205|FG002|Period 2|Investigator no longer conducting trials|0|||
127828291|NCT01808118|459990203|FG000|Period 2|Switched to other therapy|0|||
127828292|NCT01808118|459990204|FG001|Period 2|Switched to other therapy|1|||
127828293|NCT01808118|459990205|FG002|Period 2|Switched to other therapy|0|||
127828294|NCT00615290|459990211|FG000|Overall Study|Adverse Event|2|||
127828295|NCT00615290|459990211|FG000|Overall Study|Lost to Follow-up|3|||
127828296|NCT00615290|459990211|FG000|Overall Study|Withdrawal by Subject|1|||
127828297|NCT00615290|459990211|FG000|Overall Study|Other|2|||
127828298|NCT01252134|459990212|FG000|Period 1, 8 Hours|Personal Reasons|0|||
127828299|NCT01252134|459990213|FG001|Period 1, 8 Hours|Personal Reasons|1|||
127828300|NCT01252134|459990214|FG002|Period 1, 8 Hours|Personal Reasons|1|||
127828301|NCT01252134|459990215|FG003|Period 1, 8 Hours|Personal Reasons|0|||
127828302|NCT01252134|459990216|FG004|Period 1, 8 Hours|Personal Reasons|0|||
127828303|NCT01252134|459990217|FG005|Period 1, 8 Hours|Personal Reasons|0|||
127828304|NCT03650452|459990218|FG000|Overall Study|Physician Decision|1|||
127828305|NCT03650452|459990219|FG001|Overall Study|Physician Decision|0|||
127828306|NCT03650452|459990218|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
127828307|NCT03650452|459990219|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
127828308|NCT03650452|459990218|FG000|Overall Study|Adverse Event|3|||
127828309|NCT03650452|459990219|FG001|Overall Study|Adverse Event|4|||
127828310|NCT03650452|459990218|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
127828311|NCT03650452|459990219|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
127828312|NCT02273050|459990220|FG000|Overall Study|Adverse Event|4|||
127828313|NCT02273050|459990221|FG001|Overall Study|Adverse Event|3|||
127828314|NCT02273050|459990222|FG002|Overall Study|Adverse Event|3|||
127828315|NCT02273050|459990220|FG000|Overall Study|Death|0|||
127828316|NCT02273050|459990221|FG001|Overall Study|Death|0|||
127828317|NCT02273050|459990222|FG002|Overall Study|Death|1|||
127828318|NCT02273050|459990220|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
127828319|NCT02273050|459990221|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
127828320|NCT02273050|459990222|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
127828321|NCT02273050|459990220|FG000|Overall Study|Lack of Efficacy|0|||
127828322|NCT02273050|459990221|FG001|Overall Study|Lack of Efficacy|1|||
127828323|NCT02273050|459990222|FG002|Overall Study|Lack of Efficacy|1|||
127828324|NCT02273050|459990220|FG000|Overall Study|Withdrawal by Subject|17|||
127828325|NCT02273050|459990221|FG001|Overall Study|Withdrawal by Subject|14|||
127828326|NCT02273050|459990222|FG002|Overall Study|Withdrawal by Subject|16|||
127828327|NCT02273050|459990220|FG000|Overall Study|Lost to Follow-up|0|||
127828328|NCT02273050|459990221|FG001|Overall Study|Lost to Follow-up|2|||
127828329|NCT02273050|459990222|FG002|Overall Study|Lost to Follow-up|3|||
127828330|NCT02273050|459990220|FG000|Overall Study|Protocol Violation|3|||
127828331|NCT02273050|459990221|FG001|Overall Study|Protocol Violation|1|||
127828332|NCT02273050|459990222|FG002|Overall Study|Protocol Violation|4|||
127828333|NCT02042404|459990223|FG000|Overall Study|Death|1|||
127828334|NCT02042404|459990224|FG001|Overall Study|Death|0|||
127828335|NCT02042404|459990223|FG000|Overall Study|Unrelated Adverse Event|3|||
127828336|NCT02042404|459990224|FG001|Overall Study|Unrelated Adverse Event|0|||
127828337|NCT02042404|459990223|FG000|Overall Study|Inability to meet time requirements|1|||
127828338|NCT02042404|459990224|FG001|Overall Study|Inability to meet time requirements|0|||
127828339|NCT00718419|459990225|FG000|Overall Study|Adverse Event|2|||
127828340|NCT00718419|459990226|FG001|Overall Study|Adverse Event|1|||
127828341|NCT00718419|459990225|FG000|Overall Study|Physician Decision|1|||
127828342|NCT00718419|459990226|FG001|Overall Study|Physician Decision|6|||
127828343|NCT00718419|459990225|FG000|Overall Study|Sponsor decision|0|||
127828344|NCT00718419|459990226|FG001|Overall Study|Sponsor decision|1|||
127828345|NCT00718419|459990225|FG000|Overall Study|Withdrawal by Subject|0|||
127828346|NCT00718419|459990226|FG001|Overall Study|Withdrawal by Subject|5|||
127828347|NCT00718419|459990225|FG000|Overall Study|Progressive Disease|7|||
127828348|NCT00718419|459990226|FG001|Overall Study|Progressive Disease|25|||
127828349|NCT00718419|459990225|FG000|Overall Study|Death Due to Progressive Disease|2|||
127828350|NCT00718419|459990226|FG001|Overall Study|Death Due to Progressive Disease|0|||
127828351|NCT00718419|459990225|FG000|Overall Study|Death Due to Study Drug Related|0|||
127828352|NCT00718419|459990226|FG001|Overall Study|Death Due to Study Drug Related|1|||
127828353|NCT00718419|459990225|FG000|Overall Study|Death Due to Adverse Events|1|||
127828354|NCT00718419|459990226|FG001|Overall Study|Death Due to Adverse Events|0|||
127828355|NCT00726323|459990229|FG000|Overall Study|Withdrawal by Subject|3|||
127828356|NCT00726323|459990230|FG001|Overall Study|Withdrawal by Subject|1|||
127828357|NCT00726323|459990229|FG000|Overall Study|Physician Decision|1|||
127828358|NCT00726323|459990230|FG001|Overall Study|Physician Decision|0|||
127828359|NCT00726323|459990229|FG000|Overall Study|Progressive disease|23|||
127828360|NCT00726323|459990230|FG001|Overall Study|Progressive disease|16|||
127828361|NCT00726323|459990229|FG000|Overall Study|Clinical progression|0|||
127828362|NCT00726323|459990230|FG001|Overall Study|Clinical progression|3|||
127828363|NCT00726323|459990229|FG000|Overall Study|Adverse Event|9|||
127828364|NCT00726323|459990230|FG001|Overall Study|Adverse Event|9|||
127828365|NCT00726323|459990229|FG000|Overall Study|Death|1|||
127828366|NCT00726323|459990230|FG001|Overall Study|Death|0|||
127828367|NCT00726323|459990229|FG000|Overall Study|Participant wished to discontinue|0|||
127828368|NCT00726323|459990230|FG001|Overall Study|Participant wished to discontinue|1|||
127828369|NCT00726323|459990229|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
127828370|NCT00726323|459990230|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
127828371|NCT01106534|459990239|FG000|Overall Study|Withdrawal by Subject|18|||
127828372|NCT01106534|459990239|FG000|Overall Study|Lost to Follow-up|2|||
127828373|NCT01106534|459990239|FG000|Overall Study|Death|16|||
127828374|NCT01106534|459990239|FG000|Overall Study|Physician Decision|1|||
127828375|NCT04488822|459990240|FG000|Overall Study|Adverse Event|8|||
127828376|NCT04488822|459990240|FG000|Overall Study|Withdrawal by Subject|1|||
127828377|NCT03406104|459990241|FG000|Overall Study|Lost to Follow-up|2|||
127828378|NCT03406104|459990241|FG000|Overall Study|Withdrawal by Subject|2|||
127828379|NCT03406104|459990241|FG000|Overall Study|due to Covid patient did not want to travel|1|||
127828380|NCT03406104|459990241|FG000|Overall Study|Death|2|||
127828381|NCT02499146|459990250|FG000|Overall Study|Lost to Follow-up|1|||
127828382|NCT02499146|459990250|FG000|Overall Study|Withdrawal by Subject|1|||
127828383|NCT02499146|459990250|FG000|Overall Study|Other|2|||
127828384|NCT02499146|459990250|FG000|Overall Study|Ongoing at date of cut-off|9|||
127828385|NCT02499146|459990250|FG000|Overall Study|Began other treatment/therapy|13|||
127828386|NCT05692154|459990251|FG000|Overall Study|Adverse Event|0|||
127828387|NCT05692154|459990252|FG001|Overall Study|Adverse Event|1|||
127828388|NCT01879618|459990253|FG000|Overall Study|Does not meet entrance criteria|1|||
127828389|NCT01879618|459990253|FG000|Overall Study|Withdrawal by Subject|1|||
127828390|NCT01879618|459990253|FG000|Overall Study|Surgery;changed schedule; not available|8|||
127828391|NCT01879618|459990253|FG000|Overall Study|Protocol Violation|6|||
127828392|NCT01879618|459990253|FG000|Overall Study|Adverse Event|5|||
127828393|NCT01519245|459990254|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
127828394|NCT01519245|459990255|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
127828395|NCT00933335|459990256|FG000|Overall Study|Lost to Follow-up|1|||
127828396|NCT00933335|459990257|FG001|Overall Study|Lost to Follow-up|3|||
127828397|NCT00933335|459990256|FG000|Overall Study|Withdrawal by Subject|0|||
127828398|NCT00933335|459990257|FG001|Overall Study|Withdrawal by Subject|1|||
127828399|NCT00933335|459990256|FG000|Overall Study|Progressive Disease|0|||
127828400|NCT00933335|459990257|FG001|Overall Study|Progressive Disease|11|||
127828401|NCT00933335|459990256|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
127828402|NCT00933335|459990257|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
127828403|NCT00933335|459990256|FG000|Overall Study|Co-morbid Illness|1|||
127828404|NCT00933335|459990257|FG001|Overall Study|Co-morbid Illness|0|||
127828405|NCT02275026|459990258|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
127828406|NCT02275026|459990258|FG000|Overall Study|Withdrawal by Subject|4|||
127828407|NCT02275026|459990258|FG000|Overall Study|Ineligible due to medical history|13|||
127828408|NCT02275026|459990258|FG000|Overall Study|MRI malfunction precluded testing|1|||
127828409|NCT02275026|459990258|FG000|Overall Study|Ineligible after MRI findings|1|||
127828410|NCT02275026|459990258|FG000|Overall Study|Lost to Follow-up|2|||
127828411|NCT02275026|459990258|FG000|Overall Study|Scanner failure|1|||
127894891|NCT00586521|460238550|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
127894892|NCT03731182|460238558|FG000|Overall Study|Lost to Follow-up|2|||
127828412|NCT00001262|459990261|FG000|Overall Study|Death|10|||
127828413|NCT00001262|459990262|FG001|Overall Study|Death|11|||
127828414|NCT00001262|459990263|FG002|Overall Study|Death|0|||
127828415|NCT00001262|459990261|FG000|Overall Study|Withdrawal by Subject|0|||
127828416|NCT00001262|459990262|FG001|Overall Study|Withdrawal by Subject|3|||
127828417|NCT00001262|459990263|FG002|Overall Study|Withdrawal by Subject|0|||
127828418|NCT00783705|459990264|FG000|Overall Study|Adverse Event|2|||
127828419|NCT00783705|459990265|FG001|Overall Study|Adverse Event|0|||
127828420|NCT00783705|459990264|FG000|Overall Study|Withdrawal by Subject|3|||
127828421|NCT00783705|459990265|FG001|Overall Study|Withdrawal by Subject|2|||
127828422|NCT00783705|459990264|FG000|Overall Study|Lost to Follow-up|1|||
127828423|NCT00783705|459990265|FG001|Overall Study|Lost to Follow-up|3|||
127828424|NCT01954121|459990266|FG000|Overall Study|Lack of Efficacy|94|||
127828425|NCT01954121|459990267|FG001|Overall Study|Lack of Efficacy|41|||
127828426|NCT01954121|459990266|FG000|Overall Study|Protocol Violation|0|||
127828427|NCT01954121|459990267|FG001|Overall Study|Protocol Violation|2|||
127828428|NCT01954121|459990266|FG000|Overall Study|Lost to Follow-up|5|||
127828429|NCT01954121|459990267|FG001|Overall Study|Lost to Follow-up|6|||
127828430|NCT01954121|459990266|FG000|Overall Study|Withdrawal by Subject|18|||
127828431|NCT01954121|459990267|FG001|Overall Study|Withdrawal by Subject|12|||
127828432|NCT01954121|459990266|FG000|Overall Study|Pregnancy|1|||
127828433|NCT01954121|459990267|FG001|Overall Study|Pregnancy|1|||
127828434|NCT01954121|459990266|FG000|Overall Study|AE, serious fatal|1|||
127828435|NCT01954121|459990267|FG001|Overall Study|AE, serious fatal|0|||
127828436|NCT01954121|459990266|FG000|Overall Study|AE, non-serious non-fatal|5|||
127828437|NCT01954121|459990267|FG001|Overall Study|AE, non-serious non-fatal|22|||
127828438|NCT01954121|459990266|FG000|Overall Study|SAE, non-fatal|1|||
127828439|NCT01954121|459990267|FG001|Overall Study|SAE, non-fatal|4|||
127828440|NCT01954121|459990266|FG000|Overall Study|Non-compliant with study procedures|1|||
127828441|NCT01954121|459990267|FG001|Overall Study|Non-compliant with study procedures|0|||
127828442|NCT01954121|459990266|FG000|Overall Study|Non-compliant patient|1|||
127828443|NCT01954121|459990267|FG001|Overall Study|Non-compliant patient|1|||
127828444|NCT01954121|459990266|FG000|Overall Study|Subject did not follow instructions|0|||
127828445|NCT01954121|459990267|FG001|Overall Study|Subject did not follow instructions|2|||
127828446|NCT03844633|459990268|FG000|1 Week FU|Lost to Follow-up|0|||
127828447|NCT03844633|459990269|FG001|1 Week FU|Lost to Follow-up|1|||
127828448|NCT03844633|459990270|FG002|1 Week FU|Lost to Follow-up|4|||
127828449|NCT03844633|459990268|FG000|12-month Follow-up|Lost to Follow-up|7|||
127828450|NCT03844633|459990269|FG001|12-month Follow-up|Lost to Follow-up|5|||
127828451|NCT03844633|459990270|FG002|12-month Follow-up|Lost to Follow-up|8|||
127828452|NCT02504892|459990279|FG000|Overall Study|Adverse event-pneumonitis|2|||
127828453|NCT00576693|459990280|FG000|Overall Study|Lost to Follow-up|7|||
127828454|NCT00576693|459990281|FG001|Overall Study|Lost to Follow-up|11|||
127828455|NCT00576693|459990280|FG000|Overall Study|Withdrawal by Subject|3|||
127828456|NCT00576693|459990281|FG001|Overall Study|Withdrawal by Subject|13|||
127828457|NCT01413178|459990282|FG000|Overall Study|Toxicity|1|||
127828458|NCT01413178|459990283|FG001|Overall Study|Toxicity|0|||
127828459|NCT01413178|459990282|FG000|Overall Study|Ineligible|0|||
127828460|NCT01413178|459990283|FG001|Overall Study|Ineligible|2|||
127828461|NCT00804193|459990284|FG000|Overall Study|Lack of baseline fungus|32|||
127828462|NCT00804193|459990285|FG001|Overall Study|Lack of baseline fungus|31|||
127828463|NCT00804193|459990286|FG002|Overall Study|Lack of baseline fungus|19|||
127828464|NCT00804193|459990284|FG000|Overall Study|Adverse Event|0|||
127828465|NCT00804193|459990285|FG001|Overall Study|Adverse Event|0|||
127828466|NCT00804193|459990286|FG002|Overall Study|Adverse Event|2|||
127828467|NCT00804193|459990284|FG000|Overall Study|Lack of Efficacy|1|||
127828468|NCT00804193|459990285|FG001|Overall Study|Lack of Efficacy|1|||
127828469|NCT00804193|459990286|FG002|Overall Study|Lack of Efficacy|3|||
127828470|NCT00804193|459990284|FG000|Overall Study|Protocol Violation|0|||
127828471|NCT00804193|459990285|FG001|Overall Study|Protocol Violation|8|||
127828472|NCT00804193|459990286|FG002|Overall Study|Protocol Violation|2|||
127828473|NCT00804193|459990284|FG000|Overall Study|Lost to Follow-up|3|||
127828474|NCT00804193|459990285|FG001|Overall Study|Lost to Follow-up|3|||
127828475|NCT00804193|459990286|FG002|Overall Study|Lost to Follow-up|4|||
127828476|NCT00804193|459990284|FG000|Overall Study|Withdrawal by Subject|3|||
127828477|NCT00804193|459990285|FG001|Overall Study|Withdrawal by Subject|1|||
127828478|NCT00804193|459990286|FG002|Overall Study|Withdrawal by Subject|2|||
127828479|NCT04072146|459990287|FG000|Overall Study|Adverse Event|0|||
127828480|NCT04072146|459990288|FG001|Overall Study|Adverse Event|1|||
127828481|NCT01987986|459990289|FG000|Overall Study|Lost to Follow-up|1|||
127828482|NCT01987986|459990290|FG001|Overall Study|Lost to Follow-up|0|||
127828483|NCT01987986|459990291|FG002|Overall Study|Lost to Follow-up|0|||
127828484|NCT01987986|459990292|FG003|Overall Study|Lost to Follow-up|0|||
127828485|NCT01987986|459990289|FG000|Overall Study|Adverse Event|1|||
127828486|NCT01987986|459990290|FG001|Overall Study|Adverse Event|0|||
127828487|NCT01987986|459990291|FG002|Overall Study|Adverse Event|2|||
127828488|NCT01987986|459990292|FG003|Overall Study|Adverse Event|0|||
127828489|NCT01617434|459990293|FG000|Overall Study|Adverse Event|12|||
127828490|NCT01617434|459990294|FG001|Overall Study|Adverse Event|3|||
127828491|NCT01617434|459990293|FG000|Overall Study|Protocol Violation|8|||
127828492|NCT01617434|459990294|FG001|Overall Study|Protocol Violation|7|||
127828493|NCT01617434|459990293|FG000|Overall Study|Withdrawal Criteria|12|||
127828494|NCT01617434|459990294|FG001|Overall Study|Withdrawal Criteria|37|||
127828495|NCT01617434|459990293|FG000|Overall Study|Unclassified|3|||
127828496|NCT01617434|459990294|FG001|Overall Study|Unclassified|4|||
127828497|NCT03283163|459990295|FG000|Overall Study|Lost to Follow-up|1|||
127828498|NCT03283163|459990295|FG000|Overall Study|other life commitments|6|||
127828499|NCT03283163|459990295|FG000|Overall Study|COVID-19 institution wide halting|1|||
127828500|NCT03283163|459990295|FG000|Overall Study|Participants tested positive for illicit drugs on the day of the testing and/or training procedures|2|||
127828501|NCT03283163|459990295|FG000|Overall Study|Participant found to not be forthcoming with screening/baseline assessments|1|||
127828502|NCT00237796|459990296|FG000|Overall Study|Baseline and one other ILSS required|10|||
127828503|NCT00237796|459990297|FG001|Overall Study|Baseline and one other ILSS required|5|||
127828504|NCT04238663|459990301|FG000|Overall Study|Lost to Follow-up|0|||
127828505|NCT04238663|459990302|FG001|Overall Study|Lost to Follow-up|1|||
127828506|NCT04238663|459990303|FG002|Overall Study|Lost to Follow-up|0|||
127828507|NCT04070378|459990304|FG000|Overall Study|Withdrawal by Subject|2|||
127828508|NCT04070378|459990304|FG000|Overall Study|Screen Failure|6|||
127828509|NCT04070378|459990304|FG000|Overall Study|Physician Decision|1|||
127828510|NCT04070378|459990304|FG000|Overall Study|Adverse Event|1|||
127828511|NCT03259334|459990305|FG000|Overall Study|Adverse Event|3|||
127828512|NCT03259334|459990306|FG001|Overall Study|Adverse Event|8|||
127828513|NCT03259334|459990307|FG002|Overall Study|Adverse Event|5|||
127828514|NCT03259334|459990305|FG000|Overall Study|Withdrawal by Subject|4|||
127828515|NCT03259334|459990306|FG001|Overall Study|Withdrawal by Subject|2|||
127828516|NCT03259334|459990307|FG002|Overall Study|Withdrawal by Subject|4|||
127828517|NCT03259334|459990305|FG000|Overall Study|Physician Decision|1|||
127828518|NCT03259334|459990306|FG001|Overall Study|Physician Decision|0|||
127828519|NCT03259334|459990307|FG002|Overall Study|Physician Decision|0|||
127828520|NCT03259334|459990305|FG000|Overall Study|Lost to Follow-up|0|||
127828521|NCT03259334|459990306|FG001|Overall Study|Lost to Follow-up|2|||
127828522|NCT03259334|459990307|FG002|Overall Study|Lost to Follow-up|1|||
127828523|NCT03259334|459990305|FG000|Overall Study|Protocol Deviation|0|||
127828524|NCT03259334|459990306|FG001|Overall Study|Protocol Deviation|3|||
127828525|NCT03259334|459990307|FG002|Overall Study|Protocol Deviation|2|||
127828526|NCT03259334|459990305|FG000|Overall Study|Lack of Efficacy|2|||
127828527|NCT03259334|459990306|FG001|Overall Study|Lack of Efficacy|0|||
127828528|NCT03259334|459990307|FG002|Overall Study|Lack of Efficacy|1|||
127828529|NCT03259334|459990305|FG000|Overall Study|Randomized but never treated|0|||
127828530|NCT03259334|459990306|FG001|Overall Study|Randomized but never treated|2|||
127828531|NCT03259334|459990307|FG002|Overall Study|Randomized but never treated|0|||
127828532|NCT00701727|459991780|FG000|First Treatment Period|Adverse Event|0|||
127828533|NCT00701727|459991781|FG001|First Treatment Period|Adverse Event|0|||
127828534|NCT00701727|459991780|FG000|First Treatment Period|Withdrawal by Subject|1|||
127828535|NCT00701727|459991781|FG001|First Treatment Period|Withdrawal by Subject|0|||
127828536|NCT00701727|459991780|FG000|First Treatment Period|sponsor decision|0|||
127828537|NCT00701727|459991781|FG001|First Treatment Period|sponsor decision|1|||
127828538|NCT00701727|459991780|FG000|First Treatment Period|Lost to Follow-up|0|||
127828539|NCT00701727|459991781|FG001|First Treatment Period|Lost to Follow-up|1|||
127828540|NCT00701727|459991780|FG000|Second Treatment Period|Withdrawal by Subject|2|||
127828541|NCT00701727|459991781|FG001|Second Treatment Period|Withdrawal by Subject|0|||
127828542|NCT05113953|459991784|FG000|Overall Study|Adverse Event|5|||
127828543|NCT05113953|459991785|FG001|Overall Study|Adverse Event|0|||
127828544|NCT05113953|459991786|FG002|Overall Study|Adverse Event|3|||
127828545|NCT05113953|459991784|FG000|Overall Study|Lost to Follow-up|3|||
127828546|NCT05113953|459991785|FG001|Overall Study|Lost to Follow-up|4|||
127828547|NCT05113953|459991786|FG002|Overall Study|Lost to Follow-up|2|||
127828548|NCT05113953|459991784|FG000|Overall Study|Non-compliance with Study Drug|1|||
127828549|NCT05113953|459991785|FG001|Overall Study|Non-compliance with Study Drug|0|||
127828550|NCT05113953|459991786|FG002|Overall Study|Non-compliance with Study Drug|0|||
127828551|NCT05113953|459991784|FG000|Overall Study|Withdrawal by Subject|2|||
127828552|NCT05113953|459991785|FG001|Overall Study|Withdrawal by Subject|6|||
127828553|NCT05113953|459991786|FG002|Overall Study|Withdrawal by Subject|4|||
127828554|NCT05113953|459991784|FG000|Overall Study|Reason not Specified|2|||
127828555|NCT05113953|459991785|FG001|Overall Study|Reason not Specified|0|||
127828556|NCT05113953|459991786|FG002|Overall Study|Reason not Specified|0|||
127828557|NCT00523341|459991787|FG000|Overall Study|Withdrawal by Subject|399|||
127828558|NCT00523341|459991788|FG001|Overall Study|Withdrawal by Subject|427|||
127828559|NCT00523341|459991787|FG000|Overall Study|Other|181|||
127828560|NCT00523341|459991788|FG001|Overall Study|Other|198|||
127828561|NCT00523341|459991787|FG000|Overall Study|Adverse Event|122|||
127828562|NCT00523341|459991788|FG001|Overall Study|Adverse Event|155|||
127828563|NCT00523341|459991787|FG000|Overall Study|Death|101|||
127828564|NCT00523341|459991788|FG001|Overall Study|Death|110|||
127828565|NCT00523341|459991787|FG000|Overall Study|Lost to Follow-up|73|||
127828566|NCT00523341|459991788|FG001|Overall Study|Lost to Follow-up|61|||
127828567|NCT00523341|459991787|FG000|Overall Study|Non-compliance|20|||
127828568|NCT00523341|459991788|FG001|Overall Study|Non-compliance|13|||
127828569|NCT00523341|459991787|FG000|Overall Study|Physician Decision|14|||
127828570|NCT00523341|459991788|FG001|Overall Study|Physician Decision|13|||
127828571|NCT00523341|459991787|FG000|Overall Study|Requirement for Alternative Therapy|4|||
127828572|NCT00523341|459991788|FG001|Overall Study|Requirement for Alternative Therapy|14|||
127828573|NCT00523341|459991787|FG000|Overall Study|Protocol Deviation|6|||
127828574|NCT00523341|459991788|FG001|Overall Study|Protocol Deviation|5|||
127828575|NCT00523341|459991787|FG000|Overall Study|Ineligibility Determined|3|||
127828576|NCT00523341|459991788|FG001|Overall Study|Ineligibility Determined|4|||
127828577|NCT00523341|459991787|FG000|Overall Study|Disease Progression|1|||
127828578|NCT00523341|459991788|FG001|Overall Study|Disease Progression|0|||
127828579|NCT05137041|459991789|FG000|Overall Study|Lost to Follow-up|1|||
127828580|NCT05137041|459991790|FG001|Overall Study|Lost to Follow-up|1|||
127828581|NCT05137041|459991789|FG000|Overall Study|Withdrawal by Subject|0|||
127828582|NCT05137041|459991790|FG001|Overall Study|Withdrawal by Subject|2|||
127828583|NCT05137041|459991789|FG000|Overall Study|Reason not Specified|0|||
127828584|NCT05137041|459991790|FG001|Overall Study|Reason not Specified|1|||
127828585|NCT02626819|459991791|FG000|Overall Study|Lost to Follow-up|3|||
127828586|NCT02626819|459991792|FG001|Overall Study|Lost to Follow-up|2|||
127828587|NCT02626819|459991791|FG000|Overall Study|Withdrawal by Subject|1|||
127828588|NCT02626819|459991792|FG001|Overall Study|Withdrawal by Subject|0|||
127828589|NCT02626819|459991791|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
127828590|NCT02626819|459991792|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
127828591|NCT00502307|459991795|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
127828592|NCT00502307|459991796|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
127828593|NCT00502307|459991797|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
127828594|NCT00502307|459991795|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
127828595|NCT00502307|459991796|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
127828596|NCT00502307|459991797|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
127828597|NCT00502307|459991795|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
127828598|NCT00502307|459991796|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
127828599|NCT00502307|459991797|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
127828600|NCT00502307|459991795|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
127828601|NCT00502307|459991796|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
127828602|NCT00502307|459991797|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
127828603|NCT00502307|459991795|FG000|Maintenance Period|Progressive disease|80|||
127828604|NCT00502307|459991796|FG001|Maintenance Period|Progressive disease|0|||
127828605|NCT00502307|459991797|FG002|Maintenance Period|Progressive disease|0|||
127828606|NCT00502307|459991795|FG000|Maintenance Period|Discontinued due to other reasons|68|||
127828607|NCT00502307|459991796|FG001|Maintenance Period|Discontinued due to other reasons|0|||
127828608|NCT00502307|459991797|FG002|Maintenance Period|Discontinued due to other reasons|0|||
127828609|NCT04907539|459991798|FG000|Overall Study|Consent withdrawn|1|||
127828610|NCT04907539|459991799|FG001|Overall Study|Consent withdrawn|0|||
127828611|NCT04907539|459991798|FG000|Overall Study|Death|14|||
127828612|NCT04907539|459991799|FG001|Overall Study|Death|3|||
127828613|NCT00051558|459991800|FG000|Overall Study|Adverse Event|30|||
127828614|NCT00051558|459991801|FG001|Overall Study|Adverse Event|18|||
127828615|NCT00051558|459991800|FG000|Overall Study|Withdrawal by Subject|29|||
127828616|NCT00051558|459991801|FG001|Overall Study|Withdrawal by Subject|42|||
127828617|NCT00051558|459991800|FG000|Overall Study|Death|9|||
127828618|NCT00051558|459991801|FG001|Overall Study|Death|15|||
127828619|NCT00051558|459991800|FG000|Overall Study|Lost to Follow-up|4|||
127828620|NCT00051558|459991801|FG001|Overall Study|Lost to Follow-up|13|||
127828621|NCT00051558|459991800|FG000|Overall Study|Protocol Violation|3|||
127828622|NCT00051558|459991801|FG001|Overall Study|Protocol Violation|4|||
127828623|NCT00051558|459991800|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
127828624|NCT00051558|459991801|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
127828625|NCT00051558|459991800|FG000|Overall Study|Sponsor Decision|6|||
127828626|NCT00051558|459991801|FG001|Overall Study|Sponsor Decision|1|||
127828627|NCT00051558|459991800|FG000|Overall Study|Other|2|||
127828628|NCT00051558|459991801|FG001|Overall Study|Other|1|||
127828629|NCT00051558|459991800|FG000|Overall Study|Significant Lab Value|2|||
127894893|NCT03731182|460238559|FG001|Overall Study|Lost to Follow-up|0|||
127894894|NCT03731182|460238558|FG000|Overall Study|Physician Decision|1|||
127828630|NCT00051558|459991801|FG001|Overall Study|Significant Lab Value|0|||
127828631|NCT00051558|459991800|FG000|Overall Study|Physician Decision|5|||
127828632|NCT00051558|459991801|FG001|Overall Study|Physician Decision|0|||
127828633|NCT01701583|459991805|FG000|Overall Study|Withdrawal by Subject|2|||
127828634|NCT01701583|459991806|FG001|Overall Study|Withdrawal by Subject|0|||
127828635|NCT01441440|459991807|FG000|Overall Study|Death|1|||
127828636|NCT01441440|459991808|FG001|Overall Study|Death|0|||
127828637|NCT01441440|459991809|FG002|Overall Study|Death|1|||
127828638|NCT01441440|459991807|FG000|Overall Study|Adverse Event|2|||
127828639|NCT01441440|459991808|FG001|Overall Study|Adverse Event|9|||
127828640|NCT01441440|459991809|FG002|Overall Study|Adverse Event|9|||
127828641|NCT01441440|459991807|FG000|Overall Study|Lost to Follow-up|0|||
127828642|NCT01441440|459991808|FG001|Overall Study|Lost to Follow-up|2|||
127828643|NCT01441440|459991809|FG002|Overall Study|Lost to Follow-up|1|||
127828644|NCT01441440|459991807|FG000|Overall Study|Withdrawal by Subject|11|||
127828645|NCT01441440|459991808|FG001|Overall Study|Withdrawal by Subject|9|||
127828646|NCT01441440|459991809|FG002|Overall Study|Withdrawal by Subject|9|||
127828647|NCT01441440|459991807|FG000|Overall Study|Pregnancy|1|||
127828648|NCT01441440|459991808|FG001|Overall Study|Pregnancy|0|||
127828649|NCT01441440|459991809|FG002|Overall Study|Pregnancy|0|||
127828650|NCT01441440|459991807|FG000|Overall Study|Lack of Efficacy|1|||
127828651|NCT01441440|459991808|FG001|Overall Study|Lack of Efficacy|0|||
127828652|NCT01441440|459991809|FG002|Overall Study|Lack of Efficacy|1|||
127828653|NCT01441440|459991807|FG000|Overall Study|Moving|0|||
127828654|NCT01441440|459991808|FG001|Overall Study|Moving|1|||
127828655|NCT01441440|459991809|FG002|Overall Study|Moving|1|||
127828656|NCT01441440|459991807|FG000|Overall Study|Work-related matter|0|||
127828657|NCT01441440|459991808|FG001|Overall Study|Work-related matter|1|||
127828658|NCT01441440|459991809|FG002|Overall Study|Work-related matter|0|||
127828659|NCT01441440|459991807|FG000|Overall Study|Difficllty in keeping the schedule|1|||
127894895|NCT03731182|460238559|FG001|Overall Study|Physician Decision|0|||
127894896|NCT03731182|460238558|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
127828660|NCT01441440|459991808|FG001|Overall Study|Difficllty in keeping the schedule|1|||
127828661|NCT01441440|459991809|FG002|Overall Study|Difficllty in keeping the schedule|0|||
127828662|NCT02750813|459991810|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
127828663|NCT02750813|459991811|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
127828664|NCT02750813|459991810|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
127828665|NCT02750813|459991811|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
127828666|NCT00366548|459991814|FG000|Infant Series|Adverse Event|1|||
127828667|NCT00366548|459991815|FG001|Infant Series|Adverse Event|3|||
127828668|NCT00366548|459991814|FG000|Infant Series|Protocol Violation|0|||
127828669|NCT00366548|459991815|FG001|Infant Series|Protocol Violation|1|||
127828670|NCT00366548|459991814|FG000|Infant Series|Withdrawal by Subject|3|||
127828671|NCT00366548|459991815|FG001|Infant Series|Withdrawal by Subject|1|||
127828672|NCT00366548|459991814|FG000|After Infant Series|Withdrawal by Subject|3|||
127828673|NCT00366548|459991815|FG001|After Infant Series|Withdrawal by Subject|1|||
127828674|NCT00366548|459991814|FG000|After Infant Series|Adverse Event|2|||
127828675|NCT00366548|459991815|FG001|After Infant Series|Adverse Event|0|||
127828676|NCT00366548|459991814|FG000|After Infant Series|Lost to Follow-up|1|||
127828677|NCT00366548|459991815|FG001|After Infant Series|Lost to Follow-up|0|||
127828678|NCT02849990|459991816|FG000|Overall Study|Adverse Event|1|||
127828679|NCT02849990|459991816|FG000|Overall Study|Withdrawal by Subject|1|||
127828680|NCT01795898|459991818|FG000|Overall Study|Adverse Event|27|||
127828681|NCT01795898|459991818|FG000|Overall Study|Lost to Follow-up|20|||
127828682|NCT01795898|459991818|FG000|Overall Study|Withdrawal of consent|6|||
127828683|NCT01795898|459991818|FG000|Overall Study|Diagnosed with metastasis|1|||
127828684|NCT01795898|459991818|FG000|Overall Study|No pain|1|||
127828685|NCT01795898|459991818|FG000|Overall Study|Death|1|||
127828686|NCT01795898|459991818|FG000|Overall Study|Withdrew consent & had adverse events|3|||
127828687|NCT01795898|459991818|FG000|Overall Study|Physician Decision|1|||
127828688|NCT03539458|459991819|FG000|Overall Study|Death|1|||
127828689|NCT02297438|459991820|FG000|Overall Study|Death|79|||
127828690|NCT02297438|459991821|FG001|Overall Study|Death|86|||
127828691|NCT02297438|459991820|FG000|Overall Study|Lost to Follow-up|9|||
127828692|NCT02297438|459991821|FG001|Overall Study|Lost to Follow-up|7|||
127828693|NCT02297438|459991820|FG000|Overall Study|Withdrawal by Subject|7|||
127828694|NCT02297438|459991821|FG001|Overall Study|Withdrawal by Subject|0|||
127828695|NCT02297438|459991820|FG000|Overall Study|Other|9|||
127828696|NCT02297438|459991821|FG001|Overall Study|Other|5|||
127828697|NCT02297438|459991820|FG000|Overall Study|Ongoing|65|||
127828698|NCT02297438|459991821|FG001|Overall Study|Ongoing|73|||
127828699|NCT03521154|459991823|FG000|Overall Study|Ongoing study at data cut-off|111|||
127828700|NCT03521154|459991824|FG001|Overall Study|Ongoing study at data cut-off|52|||
127828701|NCT00972478|459991826|FG000|Overall Study|Adverse Event|3|||
127828702|NCT00972478|459991827|FG001|Overall Study|Adverse Event|16|||
127828703|NCT00972478|459991826|FG000|Overall Study|Withdrawal by Subject|1|||
127828704|NCT00972478|459991827|FG001|Overall Study|Withdrawal by Subject|8|||
127828705|NCT00972478|459991826|FG000|Overall Study|Progression/Relapse|0|||
127828706|NCT00972478|459991827|FG001|Overall Study|Progression/Relapse|2|||
127828707|NCT00972478|459991826|FG000|Overall Study|Death|0|||
127828708|NCT00972478|459991827|FG001|Overall Study|Death|2|||
127828709|NCT00972478|459991826|FG000|Overall Study|Not protocol specified|1|||
127828710|NCT00972478|459991827|FG001|Overall Study|Not protocol specified|1|||
127828711|NCT00972478|459991826|FG000|Overall Study|Ineligible|1|||
127828712|NCT00972478|459991827|FG001|Overall Study|Ineligible|7|||
127828713|NCT00972478|459991826|FG000|Overall Study|Not start protocol treatment|1|||
127828714|NCT00972478|459991827|FG001|Overall Study|Not start protocol treatment|2|||
127828715|NCT02561000|459991828|FG000|Overall Study|Withdrawal by Subject|2|||
127828716|NCT02561000|459991829|FG001|Overall Study|Withdrawal by Subject|3|||
127828717|NCT02561000|459991830|FG002|Overall Study|Withdrawal by Subject|0|||
127828718|NCT02561000|459991828|FG000|Overall Study|Adverse Event|0|||
127828719|NCT02561000|459991829|FG001|Overall Study|Adverse Event|1|||
127828720|NCT02561000|459991830|FG002|Overall Study|Adverse Event|0|||
127828721|NCT01522976|459991831|FG000|Overall Study|Ineligible|4|||
127828722|NCT01522976|459991832|FG001|Overall Study|Ineligible|0|||
127828723|NCT01522976|459991833|FG002|Overall Study|Ineligible|1|||
127828724|NCT01522976|459991831|FG000|Overall Study|Death|7|||
127828725|NCT01522976|459991832|FG001|Overall Study|Death|6|||
127828726|NCT01522976|459991833|FG002|Overall Study|Death|2|||
127828727|NCT01522976|459991831|FG000|Overall Study|Still on treatment|9|||
127828728|NCT01522976|459991832|FG001|Overall Study|Still on treatment|9|||
127828729|NCT01522976|459991833|FG002|Overall Study|Still on treatment|6|||
127828730|NCT01522976|459991831|FG000|Overall Study|Disease progression|28|||
127828731|NCT01522976|459991832|FG001|Overall Study|Disease progression|30|||
127828732|NCT01522976|459991833|FG002|Overall Study|Disease progression|25|||
127828733|NCT01522976|459991831|FG000|Overall Study|Adverse Event|17|||
127828734|NCT01522976|459991832|FG001|Overall Study|Adverse Event|7|||
127828735|NCT01522976|459991833|FG002|Overall Study|Adverse Event|18|||
127828736|NCT01522976|459991831|FG000|Overall Study|Refusal unrelated to adverse event|10|||
127828737|NCT01522976|459991832|FG001|Overall Study|Refusal unrelated to adverse event|13|||
127828738|NCT01522976|459991833|FG002|Overall Study|Refusal unrelated to adverse event|14|||
127828739|NCT01522976|459991831|FG000|Overall Study|Not protocol specified|22|||
127828740|NCT01522976|459991832|FG001|Overall Study|Not protocol specified|27|||
127828741|NCT01522976|459991833|FG002|Overall Study|Not protocol specified|27|||
127828742|NCT04075266|459991836|FG000|OOE Period: 264 Week|Ongoing in Study|5|||
127828743|NCT04075266|459991837|FG001|OOE Period: 264 Week|Ongoing in Study|17|||
127828744|NCT04075266|459991836|FG000|OOE Period: 264 Week|Withdrawal by Subject|1|||
127828745|NCT04075266|459991837|FG001|OOE Period: 264 Week|Withdrawal by Subject|0|||
127828746|NCT05132569|459991838|FG000|DB Period: 26 Weeks|Withdrawal by Subject|0|||
127828747|NCT05132569|459991839|FG001|DB Period: 26 Weeks|Withdrawal by Subject|1|||
127828748|NCT05132569|459991838|FG000|DB Period: 26 Weeks|Study terminated by sponsor|1|||
127828749|NCT05132569|459991839|FG001|DB Period: 26 Weeks|Study terminated by sponsor|1|||
127828750|NCT05132569|459991838|FG000|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|2|||
127828751|NCT05132569|459991839|FG001|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|1|||
127828752|NCT04102098|459991840|FG000|Main Study Period|Ongoing in study|302|||
127828753|NCT04102098|459991841|FG001|Main Study Period|Ongoing in study|291|||
127828754|NCT04102098|459991840|FG000|Main Study Period|Death|20|||
127828755|NCT04102098|459991841|FG001|Main Study Period|Death|27|||
127828756|NCT04102098|459991840|FG000|Main Study Period|Lost to Follow-up|1|||
127828757|NCT04102098|459991841|FG001|Main Study Period|Lost to Follow-up|1|||
127828758|NCT04102098|459991840|FG000|Main Study Period|Physician Decision|0|||
127828759|NCT04102098|459991841|FG001|Main Study Period|Physician Decision|1|||
127828760|NCT04102098|459991840|FG000|Main Study Period|Withdrawal by Subject|11|||
127828761|NCT04102098|459991841|FG001|Main Study Period|Withdrawal by Subject|14|||
127828762|NCT04102098|459991840|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
127828763|NCT04102098|459991841|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
127828764|NCT04102098|459991840|FG000|Crossover: AS Who Crossed Over|Death|11|||
127828765|NCT04102098|459991841|FG001|Crossover: AS Who Crossed Over|Death|0|||
127828766|NCT04102098|459991840|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
127828767|NCT04102098|459991841|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
127828768|NCT04742907|459991842|FG000|Overall Study|Adverse Event|1|||
127828769|NCT04742907|459991843|FG001|Overall Study|Adverse Event|0|||
127828770|NCT04742907|459991844|FG002|Overall Study|Adverse Event|1|||
127828771|NCT04742907|459991842|FG000|Overall Study|Lost to Follow-up|3|||
127828772|NCT04742907|459991843|FG001|Overall Study|Lost to Follow-up|3|||
127828773|NCT04742907|459991844|FG002|Overall Study|Lost to Follow-up|2|||
127828774|NCT04742907|459991842|FG000|Overall Study|Physician Decision|0|||
127828775|NCT04742907|459991843|FG001|Overall Study|Physician Decision|1|||
127828776|NCT04742907|459991844|FG002|Overall Study|Physician Decision|0|||
127828777|NCT04742907|459991842|FG000|Overall Study|Protocol Violation|1|||
127828778|NCT04742907|459991843|FG001|Overall Study|Protocol Violation|1|||
127828779|NCT04742907|459991844|FG002|Overall Study|Protocol Violation|1|||
127828780|NCT04742907|459991842|FG000|Overall Study|Withdrawal by Subject|5|||
127828781|NCT04742907|459991843|FG001|Overall Study|Withdrawal by Subject|6|||
127828782|NCT04742907|459991844|FG002|Overall Study|Withdrawal by Subject|4|||
127828783|NCT04742907|459991842|FG000|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
127828784|NCT04742907|459991843|FG001|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|5|||
127828785|NCT04742907|459991844|FG002|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
127828786|NCT04742907|459991842|FG000|Overall Study|Did Not Receive the Study Drug|2|||
127828787|NCT04742907|459991843|FG001|Overall Study|Did Not Receive the Study Drug|4|||
127828788|NCT04742907|459991844|FG002|Overall Study|Did Not Receive the Study Drug|4|||
127828789|NCT00365716|459991845|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
127828790|NCT00365716|459991846|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
127828791|NCT00365716|459991847|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
127828792|NCT00365716|459991848|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
127828793|NCT00365716|459991849|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
127894897|NCT03731182|460238559|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
127894898|NCT02006706|460238560|FG000|Overall Study|Lost to Follow-up|1|||
127894899|NCT00582036|460238561|FG000|Overall Study|Withdrawal by Subject|0|||
127894900|NCT00582036|460238562|FG001|Overall Study|Withdrawal by Subject|1|||
127894901|NCT04161144|460238564|FG000|Overall Study|Withdrawal by Subject|0|||
127828794|NCT00365716|459991850|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
127828795|NCT00365716|459991851|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
127828796|NCT00365716|459991845|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
127828797|NCT00365716|459991846|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
127894902|NCT04161144|460238565|FG001|Overall Study|Withdrawal by Subject|1|||
127894903|NCT04161144|460238564|FG000|Overall Study|Protocol Violation|1|||
127894904|NCT04161144|460238565|FG001|Overall Study|Protocol Violation|0|||
127894905|NCT00958256|460238567|FG000|Overall Study|Adverse Event|3|||
127894906|NCT03036579|460238570|FG000|2 Years|Lost to Follow-up|1|||
127894907|NCT03036579|460238571|FG001|2 Years|Lost to Follow-up|0|||
127894908|NCT03036579|460238570|FG000|3 Years|Lost to Follow-up|0|||
127894909|NCT03036579|460238571|FG001|3 Years|Lost to Follow-up|1|||
127828798|NCT00365716|459991847|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
127894910|NCT00992407|460238574|FG000|Overall Study|Protocol Violation|2|||
127894911|NCT00992407|460238575|FG001|Overall Study|Protocol Violation|1|||
127828799|NCT00365716|459991848|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
127828800|NCT00365716|459991849|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
127828801|NCT00365716|459991850|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
127828802|NCT00365716|459991851|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
127828803|NCT00365716|459991845|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
127828804|NCT00365716|459991846|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
127828805|NCT00365716|459991847|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
127828806|NCT00365716|459991848|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
127828807|NCT00365716|459991849|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
127828808|NCT00365716|459991850|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
127828809|NCT00365716|459991851|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
127828810|NCT00365716|459991845|FG000|Base Study (Day 1 to Month 7)|Other|0|||
127828811|NCT00365716|459991846|FG001|Base Study (Day 1 to Month 7)|Other|1|||
127828812|NCT00365716|459991847|FG002|Base Study (Day 1 to Month 7)|Other|0|||
127828813|NCT00365716|459991848|FG003|Base Study (Day 1 to Month 7)|Other|0|||
127828814|NCT00365716|459991849|FG004|Base Study (Day 1 to Month 7)|Other|0|||
127828815|NCT00365716|459991850|FG005|Base Study (Day 1 to Month 7)|Other|0|||
127828816|NCT00365716|459991851|FG006|Base Study (Day 1 to Month 7)|Other|0|||
127828817|NCT00365716|459991845|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
127828818|NCT00365716|459991846|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
127828819|NCT00365716|459991847|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
127828820|NCT00365716|459991848|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
127828821|NCT00365716|459991849|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
127828822|NCT00365716|459991850|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
127828823|NCT00365716|459991851|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
127828824|NCT00365716|459991845|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
127828825|NCT00365716|459991846|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
127828826|NCT00365716|459991847|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
127828827|NCT00365716|459991848|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
127828828|NCT00365716|459991849|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
127828829|NCT00365716|459991850|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
127828830|NCT00365716|459991851|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
127828831|NCT00365716|459991845|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
127828832|NCT00365716|459991846|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
127828833|NCT00365716|459991847|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
127828834|NCT00365716|459991848|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
127828835|NCT00365716|459991849|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
127828836|NCT00365716|459991850|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
127828837|NCT00365716|459991851|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
127828838|NCT00365716|459991845|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
127828839|NCT00365716|459991846|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
127828840|NCT00365716|459991847|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
127828841|NCT00365716|459991848|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
127828842|NCT00365716|459991849|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
127828843|NCT00365716|459991850|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
127828844|NCT00365716|459991851|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
127828845|NCT00365716|459991845|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
127828846|NCT00365716|459991846|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
127828847|NCT00365716|459991847|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
127828848|NCT00365716|459991848|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
127828849|NCT00365716|459991849|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
127828850|NCT00365716|459991850|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
127828851|NCT00365716|459991851|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
127828852|NCT00365716|459991845|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
127828853|NCT00365716|459991846|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
127828854|NCT00365716|459991847|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
127828855|NCT00365716|459991848|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
127828856|NCT00365716|459991849|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
127828857|NCT00365716|459991850|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
127828858|NCT00365716|459991851|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
127828859|NCT00365716|459991845|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
127828860|NCT00365716|459991846|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
127828861|NCT00365716|459991847|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
127828862|NCT00365716|459991848|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
127828863|NCT00365716|459991849|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
127828864|NCT00365716|459991850|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
127828865|NCT00365716|459991851|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
127828866|NCT00365716|459991845|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
127828867|NCT00365716|459991846|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
127828868|NCT00365716|459991847|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
127828869|NCT00365716|459991848|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
127828870|NCT00365716|459991849|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
127828871|NCT00365716|459991850|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
127828872|NCT00365716|459991851|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
127828873|NCT00365716|459991845|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
127828874|NCT00365716|459991846|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
127828875|NCT00365716|459991847|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
127828876|NCT00365716|459991848|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
127828877|NCT00365716|459991849|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
127828878|NCT00365716|459991850|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
127828879|NCT00365716|459991851|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
127828880|NCT00365716|459991845|FG000|Extension 1|Lost to Follow-up|0|||
127828881|NCT00365716|459991846|FG001|Extension 1|Lost to Follow-up|0|||
127828882|NCT00365716|459991847|FG002|Extension 1|Lost to Follow-up|0|||
127828883|NCT00365716|459991848|FG003|Extension 1|Lost to Follow-up|0|||
127828884|NCT00365716|459991849|FG004|Extension 1|Lost to Follow-up|0|||
127828885|NCT00365716|459991850|FG005|Extension 1|Lost to Follow-up|1|||
127828886|NCT00365716|459991851|FG006|Extension 1|Lost to Follow-up|0|||
127828887|NCT00365716|459991845|FG000|Extension 1|Other|0|||
127828888|NCT00365716|459991846|FG001|Extension 1|Other|0|||
127828889|NCT00365716|459991847|FG002|Extension 1|Other|0|||
127828890|NCT00365716|459991848|FG003|Extension 1|Other|0|||
127828891|NCT00365716|459991849|FG004|Extension 1|Other|0|||
127828892|NCT00365716|459991850|FG005|Extension 1|Other|9|||
127828893|NCT00365716|459991851|FG006|Extension 1|Other|0|||
127828894|NCT00365716|459991845|FG000|Extension 1|Moved|0|||
127828895|NCT00365716|459991846|FG001|Extension 1|Moved|0|||
127828896|NCT00365716|459991847|FG002|Extension 1|Moved|0|||
127828897|NCT00365716|459991848|FG003|Extension 1|Moved|0|||
127828898|NCT00365716|459991849|FG004|Extension 1|Moved|0|||
127828899|NCT00365716|459991850|FG005|Extension 1|Moved|4|||
127828900|NCT00365716|459991851|FG006|Extension 1|Moved|0|||
127828901|NCT00365716|459991845|FG000|Extension 1|Withdrawal by Subject|0|||
127828902|NCT00365716|459991846|FG001|Extension 1|Withdrawal by Subject|0|||
127828903|NCT00365716|459991847|FG002|Extension 1|Withdrawal by Subject|0|||
127828904|NCT00365716|459991848|FG003|Extension 1|Withdrawal by Subject|0|||
127828905|NCT00365716|459991849|FG004|Extension 1|Withdrawal by Subject|0|||
127828906|NCT00365716|459991850|FG005|Extension 1|Withdrawal by Subject|3|||
127828907|NCT00365716|459991851|FG006|Extension 1|Withdrawal by Subject|0|||
127828908|NCT00365716|459991845|FG000|Extension 1|Pregnancy|0|||
127828909|NCT00365716|459991846|FG001|Extension 1|Pregnancy|0|||
127828910|NCT00365716|459991847|FG002|Extension 1|Pregnancy|0|||
127828911|NCT00365716|459991848|FG003|Extension 1|Pregnancy|0|||
127828912|NCT00365716|459991849|FG004|Extension 1|Pregnancy|0|||
127828913|NCT00365716|459991850|FG005|Extension 1|Pregnancy|4|||
127828914|NCT00365716|459991851|FG006|Extension 1|Pregnancy|0|||
127828915|NCT00365716|459991845|FG000|Extension 1|Protocol Violation|0|||
127828916|NCT00365716|459991846|FG001|Extension 1|Protocol Violation|0|||
127828917|NCT00365716|459991847|FG002|Extension 1|Protocol Violation|0|||
127828918|NCT00365716|459991848|FG003|Extension 1|Protocol Violation|0|||
127828919|NCT00365716|459991849|FG004|Extension 1|Protocol Violation|0|||
127828920|NCT00365716|459991850|FG005|Extension 1|Protocol Violation|1|||
127828921|NCT00365716|459991851|FG006|Extension 1|Protocol Violation|0|||
127828922|NCT00365716|459991845|FG000|Extension 2|Lost to Follow-up|0|||
127828923|NCT00365716|459991846|FG001|Extension 2|Lost to Follow-up|0|||
127828924|NCT00365716|459991847|FG002|Extension 2|Lost to Follow-up|0|||
127828925|NCT00365716|459991848|FG003|Extension 2|Lost to Follow-up|0|||
127828926|NCT00365716|459991849|FG004|Extension 2|Lost to Follow-up|0|||
127828927|NCT00365716|459991850|FG005|Extension 2|Lost to Follow-up|0|||
127828928|NCT00365716|459991851|FG006|Extension 2|Lost to Follow-up|2|||
127828929|NCT00365716|459991845|FG000|Extension 2|Other|0|||
127828930|NCT00365716|459991846|FG001|Extension 2|Other|0|||
127828931|NCT00365716|459991847|FG002|Extension 2|Other|0|||
127828932|NCT00365716|459991848|FG003|Extension 2|Other|0|||
127828933|NCT00365716|459991849|FG004|Extension 2|Other|0|||
127828934|NCT00365716|459991850|FG005|Extension 2|Other|0|||
127828935|NCT00365716|459991851|FG006|Extension 2|Other|3|||
127828936|NCT00365716|459991845|FG000|Extension 2|Withdrawal by Subject|0|||
127828937|NCT00365716|459991846|FG001|Extension 2|Withdrawal by Subject|0|||
127828938|NCT00365716|459991847|FG002|Extension 2|Withdrawal by Subject|0|||
127828939|NCT00365716|459991848|FG003|Extension 2|Withdrawal by Subject|0|||
127828940|NCT00365716|459991849|FG004|Extension 2|Withdrawal by Subject|0|||
127828941|NCT00365716|459991850|FG005|Extension 2|Withdrawal by Subject|0|||
127828942|NCT00365716|459991851|FG006|Extension 2|Withdrawal by Subject|5|||
127828943|NCT02280291|459991852|FG000|Overall Study|Lost to Follow-up|2|||
127828944|NCT02280291|459991853|FG001|Overall Study|Lost to Follow-up|1|||
127828945|NCT02280291|459991854|FG002|Overall Study|Lost to Follow-up|3|||
127828946|NCT02280291|459991855|FG003|Overall Study|Lost to Follow-up|8|||
127828947|NCT02280291|459991852|FG000|Overall Study|Protocol Violation|1|||
127828948|NCT02280291|459991853|FG001|Overall Study|Protocol Violation|0|||
127828949|NCT02280291|459991854|FG002|Overall Study|Protocol Violation|0|||
127828950|NCT02280291|459991855|FG003|Overall Study|Protocol Violation|0|||
127828951|NCT02280291|459991852|FG000|Overall Study|Other|1|||
127828952|NCT02280291|459991853|FG001|Overall Study|Other|1|||
127828953|NCT02280291|459991854|FG002|Overall Study|Other|0|||
127894912|NCT00992407|460238574|FG000|Overall Study|Lost to Follow-up|3|||
127894913|NCT00992407|460238575|FG001|Overall Study|Lost to Follow-up|3|||
127894914|NCT00992407|460238574|FG000|Overall Study|Adverse Event|3|||
127894915|NCT00992407|460238575|FG001|Overall Study|Adverse Event|2|||
127828954|NCT02280291|459991855|FG003|Overall Study|Other|0|||
127828955|NCT06150573|459991856|FG000|Overall Study|Did not meet study criteria|1|||
127828956|NCT06150573|459991857|FG001|Overall Study|Did not meet study criteria|0|||
127828957|NCT06150573|459991856|FG000|Overall Study|Adverse Event|1|||
127828958|NCT06150573|459991857|FG001|Overall Study|Adverse Event|0|||
127828959|NCT06150573|459991856|FG000|Overall Study|Lost to Follow-up|0|||
127828960|NCT06150573|459991857|FG001|Overall Study|Lost to Follow-up|1|||
127828961|NCT06150573|459991856|FG000|Overall Study|Protocol Violation|0|||
127828962|NCT06150573|459991857|FG001|Overall Study|Protocol Violation|1|||
127828963|NCT06150573|459991856|FG000|Overall Study|Withdrawal by Subject|2|||
127828964|NCT06150573|459991857|FG001|Overall Study|Withdrawal by Subject|0|||
127828965|NCT00069095|459991858|FG000|Primary Treatment Phase|Ongoing|0|||
127828966|NCT00069095|459991859|FG001|Primary Treatment Phase|Ongoing|0|||
127828967|NCT00069095|459991860|FG002|Primary Treatment Phase|Ongoing|5|||
127828968|NCT00069095|459991861|FG003|Primary Treatment Phase|Ongoing|7|||
127828969|NCT00069095|459991862|FG004|Primary Treatment Phase|Ongoing|7|||
127828970|NCT00069095|459991863|FG005|Primary Treatment Phase|Ongoing|4|||
127828971|NCT00069095|459991858|FG000|Primary Treatment Phase|Admin/Other|29|||
127828972|NCT00069095|459991859|FG001|Primary Treatment Phase|Admin/Other|38|||
127828973|NCT00069095|459991860|FG002|Primary Treatment Phase|Admin/Other|31|||
127828974|NCT00069095|459991861|FG003|Primary Treatment Phase|Admin/Other|45|||
127828975|NCT00069095|459991862|FG004|Primary Treatment Phase|Admin/Other|48|||
127828976|NCT00069095|459991863|FG005|Primary Treatment Phase|Admin/Other|42|||
127828977|NCT00069095|459991858|FG000|Primary Treatment Phase|Adverse Event|99|||
127828978|NCT00069095|459991859|FG001|Primary Treatment Phase|Adverse Event|92|||
127828979|NCT00069095|459991860|FG002|Primary Treatment Phase|Adverse Event|71|||
127828980|NCT00069095|459991861|FG003|Primary Treatment Phase|Adverse Event|72|||
127828981|NCT00069095|459991862|FG004|Primary Treatment Phase|Adverse Event|109|||
127828982|NCT00069095|459991863|FG005|Primary Treatment Phase|Adverse Event|101|||
127828983|NCT00069095|459991858|FG000|Primary Treatment Phase|Death|14|||
127828984|NCT00069095|459991859|FG001|Primary Treatment Phase|Death|8|||
127828985|NCT00069095|459991860|FG002|Primary Treatment Phase|Death|2|||
127828986|NCT00069095|459991861|FG003|Primary Treatment Phase|Death|5|||
127828987|NCT00069095|459991862|FG004|Primary Treatment Phase|Death|8|||
127828988|NCT00069095|459991863|FG005|Primary Treatment Phase|Death|8|||
127828989|NCT00069095|459991858|FG000|Primary Treatment Phase|Failure to return|5|||
127828990|NCT00069095|459991859|FG001|Primary Treatment Phase|Failure to return|5|||
127828991|NCT00069095|459991860|FG002|Primary Treatment Phase|Failure to return|0|||
127828992|NCT00069095|459991861|FG003|Primary Treatment Phase|Failure to return|0|||
127828993|NCT00069095|459991862|FG004|Primary Treatment Phase|Failure to return|0|||
127828994|NCT00069095|459991863|FG005|Primary Treatment Phase|Failure to return|2|||
127828995|NCT00069095|459991858|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
127828996|NCT00069095|459991859|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
127828997|NCT00069095|459991860|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
127828998|NCT00069095|459991861|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
127828999|NCT00069095|459991862|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
127829000|NCT00069095|459991863|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
127829001|NCT00069095|459991858|FG000|Primary Treatment Phase|Refused treatment|15|||
127829002|NCT00069095|459991859|FG001|Primary Treatment Phase|Refused treatment|26|||
127829003|NCT00069095|459991860|FG002|Primary Treatment Phase|Refused treatment|17|||
127829004|NCT00069095|459991861|FG003|Primary Treatment Phase|Refused treatment|31|||
127829005|NCT00069095|459991862|FG004|Primary Treatment Phase|Refused treatment|24|||
127829006|NCT00069095|459991863|FG005|Primary Treatment Phase|Refused treatment|27|||
127829007|NCT00069095|459991858|FG000|Primary Treatment Phase|Withdrew|2|||
127829008|NCT00069095|459991859|FG001|Primary Treatment Phase|Withdrew|3|||
127829009|NCT00069095|459991860|FG002|Primary Treatment Phase|Withdrew|8|||
127829010|NCT00069095|459991861|FG003|Primary Treatment Phase|Withdrew|2|||
127829011|NCT00069095|459991862|FG004|Primary Treatment Phase|Withdrew|4|||
127829012|NCT00069095|459991863|FG005|Primary Treatment Phase|Withdrew|9|||
127829013|NCT00069095|459991858|FG000|Primary Treatment Phase|Other Violation|0|||
127829014|NCT00069095|459991859|FG001|Primary Treatment Phase|Other Violation|1|||
127829015|NCT00069095|459991860|FG002|Primary Treatment Phase|Other Violation|1|||
127829016|NCT00069095|459991861|FG003|Primary Treatment Phase|Other Violation|1|||
127829017|NCT00069095|459991862|FG004|Primary Treatment Phase|Other Violation|0|||
127829018|NCT00069095|459991863|FG005|Primary Treatment Phase|Other Violation|1|||
127829019|NCT00069095|459991858|FG000|Primary Treatment Phase|Violation criteria|0|||
127829020|NCT00069095|459991859|FG001|Primary Treatment Phase|Violation criteria|2|||
127829021|NCT00069095|459991860|FG002|Primary Treatment Phase|Violation criteria|4|||
127829022|NCT00069095|459991861|FG003|Primary Treatment Phase|Violation criteria|3|||
127829023|NCT00069095|459991862|FG004|Primary Treatment Phase|Violation criteria|1|||
127829024|NCT00069095|459991863|FG005|Primary Treatment Phase|Violation criteria|5|||
127829025|NCT00069095|459991858|FG000|Post-study Treatment Phase|Missing reason|1|||
127829026|NCT00069095|459991859|FG001|Post-study Treatment Phase|Missing reason|3|||
127829027|NCT00069095|459991860|FG002|Post-study Treatment Phase|Missing reason|12|||
127829028|NCT00069095|459991861|FG003|Post-study Treatment Phase|Missing reason|8|||
127829029|NCT00069095|459991862|FG004|Post-study Treatment Phase|Missing reason|18|||
127829030|NCT00069095|459991863|FG005|Post-study Treatment Phase|Missing reason|17|||
127829031|NCT00069095|459991858|FG000|Post-study Treatment Phase|Adverse Event|2|||
127829032|NCT00069095|459991859|FG001|Post-study Treatment Phase|Adverse Event|3|||
127829033|NCT00069095|459991860|FG002|Post-study Treatment Phase|Adverse Event|1|||
127829034|NCT00069095|459991861|FG003|Post-study Treatment Phase|Adverse Event|0|||
127829035|NCT00069095|459991862|FG004|Post-study Treatment Phase|Adverse Event|5|||
127829036|NCT00069095|459991863|FG005|Post-study Treatment Phase|Adverse Event|1|||
127829037|NCT00069095|459991858|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
127829038|NCT00069095|459991859|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
127829039|NCT00069095|459991860|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
127829040|NCT00069095|459991861|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
127829041|NCT00069095|459991862|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
127829042|NCT00069095|459991863|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
127829043|NCT00069095|459991858|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
127829044|NCT00069095|459991859|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
127829045|NCT00069095|459991860|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
127829046|NCT00069095|459991861|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
127829047|NCT00069095|459991862|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
127829048|NCT00069095|459991863|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
127829049|NCT00069095|459991858|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
127829050|NCT00069095|459991859|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
127829051|NCT00069095|459991860|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
127829052|NCT00069095|459991861|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
127829053|NCT00069095|459991862|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
127829054|NCT00069095|459991863|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
127829055|NCT00069095|459991858|FG000|Post-study Treatment Phase|Participant had complete response|1|||
127829056|NCT00069095|459991859|FG001|Post-study Treatment Phase|Participant had complete response|1|||
127829057|NCT00069095|459991860|FG002|Post-study Treatment Phase|Participant had complete response|0|||
127829058|NCT00069095|459991861|FG003|Post-study Treatment Phase|Participant had complete response|0|||
127829059|NCT00069095|459991862|FG004|Post-study Treatment Phase|Participant had complete response|0|||
127829060|NCT00069095|459991863|FG005|Post-study Treatment Phase|Participant had complete response|0|||
127829061|NCT00069095|459991858|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
127829062|NCT00069095|459991859|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
127829063|NCT00069095|459991860|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
127829064|NCT00069095|459991861|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
127829065|NCT00069095|459991862|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
127829066|NCT00069095|459991863|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
127829067|NCT00069095|459991858|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
127829068|NCT00069095|459991859|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
127829069|NCT00069095|459991860|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
127829070|NCT00069095|459991861|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
127829071|NCT00069095|459991862|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
127829072|NCT00069095|459991863|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
127829073|NCT00069095|459991858|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
127829074|NCT00069095|459991859|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
127829075|NCT00069095|459991860|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
127829076|NCT00069095|459991861|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
127829077|NCT00069095|459991862|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
127829078|NCT00069095|459991863|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
127829079|NCT00069095|459991858|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
127829080|NCT00069095|459991859|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
127829081|NCT00069095|459991860|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
127829082|NCT00069095|459991861|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
127829083|NCT00069095|459991862|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
127829084|NCT00069095|459991863|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
127829085|NCT00069095|459991858|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
127829086|NCT00069095|459991859|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
127829087|NCT00069095|459991860|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
127829088|NCT00069095|459991861|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
127829089|NCT00069095|459991862|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
127829090|NCT00069095|459991863|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
127829091|NCT00069095|459991858|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
127829092|NCT00069095|459991859|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
127829093|NCT00069095|459991860|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
127829094|NCT00069095|459991861|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
127829095|NCT00069095|459991862|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
127829096|NCT00069095|459991863|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
127829097|NCT00069095|459991858|FG000|Post-study Treatment Phase|Surgery|0|||
127829098|NCT00069095|459991859|FG001|Post-study Treatment Phase|Surgery|0|||
127829099|NCT00069095|459991860|FG002|Post-study Treatment Phase|Surgery|0|||
127829100|NCT00069095|459991861|FG003|Post-study Treatment Phase|Surgery|1|||
127829101|NCT00069095|459991862|FG004|Post-study Treatment Phase|Surgery|1|||
127829102|NCT00069095|459991863|FG005|Post-study Treatment Phase|Surgery|0|||
127829103|NCT00069095|459991858|FG000|Post-study Treatment Phase|Death|0|||
127829104|NCT00069095|459991859|FG001|Post-study Treatment Phase|Death|0|||
127829105|NCT00069095|459991860|FG002|Post-study Treatment Phase|Death|0|||
127829106|NCT00069095|459991861|FG003|Post-study Treatment Phase|Death|0|||
127829107|NCT00069095|459991862|FG004|Post-study Treatment Phase|Death|1|||
127829108|NCT00069095|459991863|FG005|Post-study Treatment Phase|Death|0|||
127829109|NCT00069095|459991858|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
127829110|NCT00069095|459991859|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
127829111|NCT00069095|459991860|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
127829112|NCT00069095|459991861|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
127829113|NCT00069095|459991862|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
127829114|NCT00069095|459991863|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
127829115|NCT00069095|459991858|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
127829116|NCT00069095|459991859|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
127829117|NCT00069095|459991860|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
127829118|NCT00069095|459991861|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
127829119|NCT00069095|459991862|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
127829120|NCT00069095|459991863|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
127829121|NCT00069095|459991858|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
127829122|NCT00069095|459991859|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
127829123|NCT00069095|459991860|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
127829124|NCT00069095|459991861|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
127829125|NCT00069095|459991862|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
127829126|NCT00069095|459991863|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
127829127|NCT00069095|459991858|FG000|Post-study Treatment Phase|Investigator decision|0|||
127829128|NCT00069095|459991859|FG001|Post-study Treatment Phase|Investigator decision|0|||
127829129|NCT00069095|459991860|FG002|Post-study Treatment Phase|Investigator decision|0|||
127829130|NCT00069095|459991861|FG003|Post-study Treatment Phase|Investigator decision|0|||
127829131|NCT00069095|459991862|FG004|Post-study Treatment Phase|Investigator decision|0|||
127829132|NCT00069095|459991863|FG005|Post-study Treatment Phase|Investigator decision|1|||
127829133|NCT00069095|459991858|FG000|Follow-up Phase|Death|174|||
127829134|NCT00069095|459991859|FG001|Follow-up Phase|Death|206|||
127829135|NCT00069095|459991860|FG002|Follow-up Phase|Death|120|||
127829136|NCT00069095|459991861|FG003|Follow-up Phase|Death|112|||
127829137|NCT00069095|459991862|FG004|Follow-up Phase|Death|92|||
127829138|NCT00069095|459991863|FG005|Follow-up Phase|Death|101|||
127829139|NCT03508622|459991864|FG000|Overall Study|Protocol Violation|1|||
127829140|NCT03508622|459991865|FG001|Overall Study|Protocol Violation|0|||
127829141|NCT03508622|459991864|FG000|Overall Study|Withdrawal by Subject|1|||
127829142|NCT03508622|459991865|FG001|Overall Study|Withdrawal by Subject|0|||
127829143|NCT03508622|459991864|FG000|Overall Study|Lost to Follow-up|16|||
127829144|NCT03508622|459991865|FG001|Overall Study|Lost to Follow-up|0|||
127829145|NCT03508622|459991864|FG000|Overall Study|Incomplete data|0|||
127829146|NCT03508622|459991865|FG001|Overall Study|Incomplete data|24|||
127829147|NCT00210158|459991867|FG000|Overall Study|Protocol Violation|0|||
127829148|NCT00210158|459991868|FG001|Overall Study|Protocol Violation|2|||
127829149|NCT04716933|459991869|FG000|Overall Study|Sponsor Decision|36|||
127829150|NCT04716933|459991870|FG001|Overall Study|Sponsor Decision|33|||
127829151|NCT04716933|459991869|FG000|Overall Study|Death|65|||
127829152|NCT04716933|459991870|FG001|Overall Study|Death|67|||
127829153|NCT03196505|459991874|FG000|Overall Study|Physician Decision|26|||
127829154|NCT03196505|459991875|FG001|Overall Study|Physician Decision|26|||
127829155|NCT01005719|459991876|FG000|Period 1|Adverse Event|0|||
127829156|NCT01005719|459991877|FG001|Period 1|Adverse Event|0|||
127829157|NCT01005719|459991878|FG002|Period 1|Adverse Event|0|||
127829158|NCT01005719|459991879|FG003|Period 1|Adverse Event|1|||
127829159|NCT01005719|459991880|FG004|Period 1|Adverse Event|0|||
127829160|NCT01005719|459991881|FG005|Period 1|Adverse Event|0|||
127829161|NCT01005719|459991876|FG000|Period 1|Delay in completing study procedures|0|||
127829162|NCT01005719|459991877|FG001|Period 1|Delay in completing study procedures|0|||
127829163|NCT01005719|459991878|FG002|Period 1|Delay in completing study procedures|0|||
127829164|NCT01005719|459991879|FG003|Period 1|Delay in completing study procedures|0|||
127829165|NCT01005719|459991880|FG004|Period 1|Delay in completing study procedures|0|||
127829166|NCT01005719|459991881|FG005|Period 1|Delay in completing study procedures|1|||
127829167|NCT01005719|459991876|FG000|Period 2|Adverse Event|0|||
127829168|NCT01005719|459991877|FG001|Period 2|Adverse Event|0|||
127829169|NCT01005719|459991878|FG002|Period 2|Adverse Event|0|||
127829170|NCT01005719|459991879|FG003|Period 2|Adverse Event|0|||
127829171|NCT01005719|459991880|FG004|Period 2|Adverse Event|1|||
127829172|NCT01005719|459991881|FG005|Period 2|Adverse Event|1|||
127829173|NCT04430738|459991882|FG000|Phase 1: Dose Escalation|Death|1|||
127829174|NCT04430738|459991883|FG001|Phase 1: Dose Escalation|Death|4|||
127829175|NCT04430738|459991884|FG002|Phase 1: Dose Escalation|Death|4|||
127829176|NCT04430738|459991885|FG003|Phase 1: Dose Escalation|Death|1|||
127829177|NCT04430738|459991886|FG004|Phase 1: Dose Escalation|Death|6|||
127829178|NCT04430738|459991887|FG005|Phase 1: Dose Escalation|Death|0|||
127829179|NCT04430738|459991882|FG000|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
127829180|NCT04430738|459991883|FG001|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
127829181|NCT04430738|459991884|FG002|Phase 1: Dose Escalation|Participation terminated by sponsor|3|||
127829182|NCT04430738|459991885|FG003|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
127829183|NCT04430738|459991886|FG004|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
127829184|NCT04430738|459991887|FG005|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
127829185|NCT04430738|459991882|FG000|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
127829186|NCT04430738|459991883|FG001|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
127829187|NCT04430738|459991884|FG002|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
127829188|NCT04430738|459991885|FG003|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
127829189|NCT04430738|459991886|FG004|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
127829190|NCT04430738|459991887|FG005|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
127829191|NCT04430738|459991882|FG000|Phase 1: Dose Escalation|Other|1|||
127829192|NCT04430738|459991883|FG001|Phase 1: Dose Escalation|Other|0|||
127829193|NCT04430738|459991884|FG002|Phase 1: Dose Escalation|Other|0|||
127829194|NCT04430738|459991885|FG003|Phase 1: Dose Escalation|Other|0|||
127829195|NCT04430738|459991886|FG004|Phase 1: Dose Escalation|Other|0|||
127829196|NCT04430738|459991887|FG005|Phase 1: Dose Escalation|Other|0|||
127829197|NCT04430738|459991882|FG000|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
127829198|NCT04430738|459991883|FG001|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
127829199|NCT04430738|459991884|FG002|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
127829200|NCT04430738|459991885|FG003|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
127829201|NCT04430738|459991886|FG004|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
127829202|NCT04430738|459991887|FG005|Phase 1: Dose Expansion|Participation terminated by sponsor|3|||
127829203|NCT04430738|459991882|FG000|Phase 1: Dose Expansion|Continuing to LTEP|0|||
127829204|NCT04430738|459991883|FG001|Phase 1: Dose Expansion|Continuing to LTEP|0|||
127829205|NCT04430738|459991884|FG002|Phase 1: Dose Expansion|Continuing to LTEP|0|||
127829206|NCT04430738|459991885|FG003|Phase 1: Dose Expansion|Continuing to LTEP|0|||
127829207|NCT04430738|459991886|FG004|Phase 1: Dose Expansion|Continuing to LTEP|0|||
127829208|NCT04430738|459991887|FG005|Phase 1: Dose Expansion|Continuing to LTEP|2|||
127829209|NCT05590793|459991888|FG000|Overall Study|Withdrawal by Subject|6|||
127829210|NCT05590793|459991888|FG000|Overall Study|Physician Decision|1|||
127829211|NCT05187013|459991889|FG000|Overall Study|Withdrawal by Subject|1|||
127829212|NCT05187013|459991890|FG001|Overall Study|Withdrawal by Subject|1|||
127829213|NCT05187013|459991891|FG002|Overall Study|Withdrawal by Subject|0|||
127829214|NCT05187013|459991889|FG000|Overall Study|Death|0|||
127829215|NCT05187013|459991890|FG001|Overall Study|Death|1|||
127829216|NCT05187013|459991891|FG002|Overall Study|Death|0|||
127829217|NCT05187013|459991889|FG000|Overall Study|Lost to Follow-up|20|||
127829218|NCT05187013|459991890|FG001|Overall Study|Lost to Follow-up|17|||
127829219|NCT05187013|459991891|FG002|Overall Study|Lost to Follow-up|0|||
127829220|NCT05187013|459991889|FG000|Overall Study|Ongoing Participants|3|||
127829221|NCT05187013|459991890|FG001|Overall Study|Ongoing Participants|5|||
127829222|NCT05187013|459991891|FG002|Overall Study|Ongoing Participants|0|||
127829223|NCT03838367|459991892|FG000|Overall Study|Early termination of study|3|||
127829224|NCT03838367|459991893|FG001|Overall Study|Early termination of study|4|||
127829225|NCT03838367|459991894|FG002|Overall Study|Early termination of study|3|||
127829226|NCT03838367|459991895|FG003|Overall Study|Early termination of study|0|||
127829227|NCT03015610|459991901|FG000|Overall Study|Lost to Follow-up|1|||
127829228|NCT03015610|459991902|FG001|Overall Study|Lost to Follow-up|5|||
127829229|NCT00938327|459991904|FG000|Overall Study|Adverse Event|2|||
127829230|NCT00938327|459991904|FG000|Overall Study|Protocol Violation|1|||
127829231|NCT00938327|459991904|FG000|Overall Study|Withdrawal by Subject|4|||
127829232|NCT00938327|459991904|FG000|Overall Study|Lost to Follow-up|37|||
127829233|NCT00938327|459991904|FG000|Overall Study|2nd dose received outside of the study|7|||
127829234|NCT00938327|459991904|FG000|Overall Study|Vaccine not received as out of stock|9|||
127829235|NCT02552355|459991905|FG000|Overall Study|Adverse Event|0|||
127829236|NCT02552355|459991906|FG001|Overall Study|Adverse Event|2|||
127829237|NCT02552355|459991907|FG002|Overall Study|Adverse Event|2|||
127829238|NCT02552355|459991908|FG003|Overall Study|Adverse Event|0|||
127829239|NCT02552355|459991905|FG000|Overall Study|Withdrawal by Subject|0|||
127829240|NCT02552355|459991906|FG001|Overall Study|Withdrawal by Subject|0|||
127829241|NCT02552355|459991907|FG002|Overall Study|Withdrawal by Subject|0|||
127829242|NCT02552355|459991908|FG003|Overall Study|Withdrawal by Subject|1|||
127829243|NCT00878072|459991913|FG000|Overall Study|Withdrew consent|2|||
127829244|NCT02588248|459991917|FG000|Overall Study|Physician Decision|4|||
127829245|NCT02588248|459991918|FG001|Overall Study|Physician Decision|3|||
127829246|NCT03643432|459991919|FG000|Overall Study|Lost to Follow-up|1|||
127829247|NCT03643432|459991920|FG001|Overall Study|Lost to Follow-up|0|||
127829248|NCT01193348|459991925|FG000|Screening Period|Screen Failure|5|||
127829249|NCT01193348|459991925|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
127829250|NCT01193348|459991925|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
127829251|NCT01193348|459991925|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
127829252|NCT01193348|459991925|FG000|Extension Treatment Period|Physician Decision|1|||
127829253|NCT01193348|459991925|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
127829254|NCT05306873|459993402|FG000|Stage 2|Study stopped|1|||
127829255|NCT05306873|459993403|FG001|Stage 2|Study stopped|1|||
127829256|NCT05306873|459993404|FG002|Stage 2|Study stopped|0|||
127829257|NCT05306873|459993405|FG003|Stage 2|Study stopped|0|||
127829258|NCT05306873|459993402|FG000|Stage 2|Stage 2 Treatment Failure|2|||
127829259|NCT05306873|459993403|FG001|Stage 2|Stage 2 Treatment Failure|3|||
127829260|NCT05306873|459993404|FG002|Stage 2|Stage 2 Treatment Failure|0|||
127829261|NCT05306873|459993405|FG003|Stage 2|Stage 2 Treatment Failure|0|||
127829262|NCT05306873|459993402|FG000|Stage 2|Logistical issues due to participant moving|1|||
127829263|NCT05306873|459993403|FG001|Stage 2|Logistical issues due to participant moving|0|||
127829264|NCT05306873|459993404|FG002|Stage 2|Logistical issues due to participant moving|0|||
127829265|NCT05306873|459993405|FG003|Stage 2|Logistical issues due to participant moving|0|||
127829266|NCT05306873|459993402|FG000|Stage 3|Stage 3 Treatment Failure|0|||
127829267|NCT05306873|459993403|FG001|Stage 3|Stage 3 Treatment Failure|0|||
127829268|NCT05306873|459993404|FG002|Stage 3|Stage 3 Treatment Failure|0|||
127829269|NCT05306873|459993405|FG003|Stage 3|Stage 3 Treatment Failure|1|||
127829270|NCT05306873|459993402|FG000|Stage 3|Study Stopped|0|||
127829271|NCT05306873|459993403|FG001|Stage 3|Study Stopped|0|||
127829272|NCT05306873|459993404|FG002|Stage 3|Study Stopped|1|||
127829273|NCT05306873|459993405|FG003|Stage 3|Study Stopped|0|||
127829274|NCT02245568|459993406|FG000|Overall Study|Study terminated by Sponsor|346|||
127829275|NCT02245568|459993406|FG000|Overall Study|Adverse Event|144|||
127829276|NCT02245568|459993406|FG000|Overall Study|Lack of Efficacy|98|||
127829277|NCT02245568|459993406|FG000|Overall Study|Withdrawal by Caregiver|85|||
127829278|NCT02245568|459993406|FG000|Overall Study|Withdrawal by Subject|77|||
127829279|NCT02245568|459993406|FG000|Overall Study|Withdrawal by Legal Representative|31|||
127829280|NCT02245568|459993406|FG000|Overall Study|Missing (Site closure)|16|||
127829281|NCT02245568|459993406|FG000|Overall Study|Physician Decision|14|||
127829282|NCT02245568|459993406|FG000|Overall Study|Non-compliance with study drug|11|||
127829283|NCT02245568|459993406|FG000|Overall Study|Death|9|||
127829284|NCT02245568|459993406|FG000|Overall Study|Blue staining|6|||
127829285|NCT02245568|459993406|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
127829286|NCT02245568|459993406|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
127829287|NCT02245568|459993406|FG000|Overall Study|Lost to Follow-up|5|||
127829288|NCT01051986|459993408|FG000|Overall Study|Death|1|||
127829289|NCT01051986|459993409|FG001|Overall Study|Death|0|||
127829290|NCT01051986|459993408|FG000|Overall Study|Withdrawal by Subject|2|||
127829291|NCT01051986|459993409|FG001|Overall Study|Withdrawal by Subject|1|||
127829292|NCT01051986|459993408|FG000|Overall Study|Protocol Violation|2|||
127829293|NCT01051986|459993409|FG001|Overall Study|Protocol Violation|3|||
127829294|NCT01725152|459993411|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
127829295|NCT01725152|459993412|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
127829296|NCT01725152|459993411|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
127829297|NCT01725152|459993412|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
127829298|NCT01725152|459993411|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
127829299|NCT01725152|459993412|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
127829300|NCT01725152|459993411|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
127829301|NCT01725152|459993412|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
127829302|NCT02044159|459993413|FG000|Overall Study|Consent declined (deferred consent)|2|||
127829303|NCT02044159|459993414|FG001|Overall Study|Consent declined (deferred consent)|4|||
127829304|NCT02044159|459993413|FG000|Overall Study|No longer eligible, drug not given|1|||
127829305|NCT02044159|459993414|FG001|Overall Study|No longer eligible, drug not given|0|||
127829306|NCT02044159|459993413|FG000|Overall Study|Nurse declined to give study drug|1|||
127829307|NCT02044159|459993414|FG001|Overall Study|Nurse declined to give study drug|0|||
127829308|NCT01111539|459993415|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
127829309|NCT01111539|459993416|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
127829310|NCT01111539|459993417|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
127829311|NCT01111539|459993418|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
127829312|NCT01111539|459993419|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
127829313|NCT01111539|459993415|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
127829314|NCT01111539|459993416|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
127829315|NCT01111539|459993417|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
127829316|NCT01111539|459993418|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
127829317|NCT01111539|459993419|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
127829318|NCT01111539|459993415|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
127829319|NCT01111539|459993416|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
127829320|NCT01111539|459993417|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
127829321|NCT01111539|459993418|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
127829322|NCT01111539|459993419|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
127829323|NCT01111539|459993415|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
127829324|NCT01111539|459993416|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
127829325|NCT01111539|459993417|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
127829326|NCT01111539|459993418|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
127829327|NCT01111539|459993419|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
127829328|NCT01111539|459993415|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
127829329|NCT01111539|459993416|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
127829330|NCT01111539|459993417|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
127829331|NCT01111539|459993418|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
127829332|NCT01111539|459993419|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
127829333|NCT01111539|459993415|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
127829334|NCT01111539|459993416|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
127829335|NCT01111539|459993417|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
127829336|NCT01111539|459993418|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
127829337|NCT01111539|459993419|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
127829338|NCT01111539|459993415|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
127829339|NCT01111539|459993416|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
127829340|NCT01111539|459993417|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
127829341|NCT01111539|459993418|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
127829342|NCT01111539|459993419|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
127829343|NCT01111539|459993415|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
127829344|NCT01111539|459993416|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
127829345|NCT01111539|459993417|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
127829346|NCT01111539|459993418|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
127829347|NCT01111539|459993419|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
127829348|NCT01111539|459993415|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
127829349|NCT01111539|459993416|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
127829350|NCT01111539|459993417|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
127829351|NCT01111539|459993418|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
127829352|NCT01111539|459993419|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
127829353|NCT01111539|459993415|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
127829354|NCT01111539|459993416|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
127829355|NCT01111539|459993417|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
127829356|NCT01111539|459993418|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
127829357|NCT01111539|459993419|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
127829358|NCT01111539|459993415|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
127829359|NCT01111539|459993416|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
127829360|NCT01111539|459993417|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
127829361|NCT01111539|459993418|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
127829362|NCT01111539|459993419|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
127829363|NCT01111539|459993415|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
127829364|NCT01111539|459993416|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
127829365|NCT01111539|459993417|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
127829366|NCT01111539|459993418|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
127829367|NCT01111539|459993419|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
127829368|NCT01111539|459993415|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
127829369|NCT01111539|459993416|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
127829370|NCT01111539|459993417|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
127829371|NCT01111539|459993418|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
127829372|NCT01111539|459993419|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
127829373|NCT01111539|459993415|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
127829374|NCT01111539|459993416|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
127829375|NCT01111539|459993417|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
127829376|NCT01111539|459993418|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
127829377|NCT01111539|459993419|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
127829378|NCT03628417|459993420|FG000|Overall Study|Death|1|||
127829379|NCT03628417|459993421|FG001|Overall Study|Death|1|||
127829380|NCT00372190|459993422|FG000|Overall Study|Lost to Follow-up|3|||
127829381|NCT00372190|459993423|FG001|Overall Study|Lost to Follow-up|1|||
127829382|NCT01856595|459993429|FG000|Overall Study|Withdrawal by Subject|0|||
127829383|NCT01856595|459993430|FG001|Overall Study|Withdrawal by Subject|1|||
127829384|NCT01856595|459993431|FG002|Overall Study|Withdrawal by Subject|0|||
127829385|NCT01856595|459993432|FG003|Overall Study|Withdrawal by Subject|0|||
127829386|NCT01856595|459993433|FG004|Overall Study|Withdrawal by Subject|0|||
127829387|NCT01856595|459993434|FG005|Overall Study|Withdrawal by Subject|0|||
127829388|NCT01856595|459993435|FG006|Overall Study|Withdrawal by Subject|1|||
127829389|NCT01856595|459993436|FG007|Overall Study|Withdrawal by Subject|0|||
127829390|NCT01856595|459993437|FG008|Overall Study|Withdrawal by Subject|0|||
127829391|NCT04426825|459993439|FG000|Overall Study|Death|17|||
127829392|NCT04426825|459993439|FG000|Overall Study|Lost to Follow-up|1|||
127829393|NCT04426825|459993439|FG000|Overall Study|Study terminated by sponsor|5|||
127829394|NCT03249792|459993445|FG000|Arms 1, 2, and 4|Death|1|||
127829395|NCT03249792|459993446|FG001|Arms 1, 2, and 4|Death|1|||
127829396|NCT03249792|459993447|FG002|Arms 1, 2, and 4|Death|0|||
127829397|NCT03249792|459993448|FG003|Arms 1, 2, and 4|Death|2|||
127829398|NCT03249792|459993449|FG004|Arms 1, 2, and 4|Death|3|||
127829399|NCT03249792|459993450|FG005|Arms 1, 2, and 4|Death|2|||
127829400|NCT03249792|459993451|FG006|Arms 1, 2, and 4|Death|2|||
127829401|NCT03249792|459993452|FG007|Arms 1, 2, and 4|Death|4|||
127829402|NCT03249792|459993453|FG008|Arms 1, 2, and 4|Death|2|||
127829403|NCT03249792|459993454|FG009|Arms 1, 2, and 4|Death|1|||
127829404|NCT03249792|459993455|FG010|Arms 1, 2, and 4|Death|7|||
127829405|NCT03249792|459993456|FG011|Arms 1, 2, and 4|Death|7|||
127829406|NCT03249792|459993457|FG012|Arms 1, 2, and 4|Death|12|||
127829407|NCT03249792|459993458|FG013|Arms 1, 2, and 4|Death|7|||
127829408|NCT03249792|459993459|FG014|Arms 1, 2, and 4|Death|0|||
127829409|NCT03249792|459993460|FG015|Arms 1, 2, and 4|Death|4|||
127829410|NCT03249792|459993461|FG016|Arms 1, 2, and 4|Death|4|||
127829411|NCT03249792|459993462|FG017|Arms 1, 2, and 4|Death|12|||
127829412|NCT03249792|459993463|FG018|Arms 1, 2, and 4|Death|6|||
127829413|NCT03249792|459993464|FG019|Arms 1, 2, and 4|Death|4|||
127829414|NCT03249792|459993465|FG020|Arms 1, 2, and 4|Death|2|||
127829415|NCT03249792|459993466|FG021|Arms 1, 2, and 4|Death|3|||
127829416|NCT03249792|459993467|FG022|Arms 1, 2, and 4|Death|1|||
127829417|NCT03249792|459993468|FG023|Arms 1, 2, and 4|Death|1|||
127829418|NCT03249792|459993469|FG024|Arms 1, 2, and 4|Death|4|||
127829419|NCT03249792|459993470|FG025|Arms 1, 2, and 4|Death|0|||
127829420|NCT03249792|459993471|FG026|Arms 1, 2, and 4|Death|0|||
127829421|NCT03249792|459993472|FG027|Arms 1, 2, and 4|Death|0|||
127829422|NCT03249792|459993473|FG028|Arms 1, 2, and 4|Death|0|||
127829423|NCT03249792|459993474|FG029|Arms 1, 2, and 4|Death|0|||
127829424|NCT03249792|459993475|FG030|Arms 1, 2, and 4|Death|0|||
127829425|NCT03249792|459993476|FG031|Arms 1, 2, and 4|Death|0|||
127829426|NCT03249792|459993477|FG032|Arms 1, 2, and 4|Death|0|||
127829427|NCT03249792|459993445|FG000|Arms 1, 2, and 4|Withdrawal by Subject|0|||
127829428|NCT03249792|459993446|FG001|Arms 1, 2, and 4|Withdrawal by Subject|0|||
127829429|NCT03249792|459993447|FG002|Arms 1, 2, and 4|Withdrawal by Subject|1|||
127829430|NCT03249792|459993448|FG003|Arms 1, 2, and 4|Withdrawal by Subject|0|||
127829431|NCT03249792|459993449|FG004|Arms 1, 2, and 4|Withdrawal by Subject|0|||
127829432|NCT03249792|459993450|FG005|Arms 1, 2, and 4|Withdrawal by Subject|1|||
127829433|NCT03249792|459993451|FG006|Arms 1, 2, and 4|Withdrawal by Subject|4|||
127829434|NCT03249792|459993452|FG007|Arms 1, 2, and 4|Withdrawal by Subject|0|||
127829435|NCT03249792|459993453|FG008|Arms 1, 2, and 4|Withdrawal by Subject|2|||
127829436|NCT03249792|459993454|FG009|Arms 1, 2, and 4|Withdrawal by Subject|1|||
127829437|NCT03249792|459993455|FG010|Arms 1, 2, and 4|Withdrawal by Subject|4|||
127829438|NCT03249792|459993456|FG011|Arms 1, 2, and 4|Withdrawal by Subject|3|||
127829439|NCT03249792|459993457|FG012|Arms 1, 2, and 4|Withdrawal by Subject|5|||
127829440|NCT03249792|459993458|FG013|Arms 1, 2, and 4|Withdrawal by Subject|3|||
127829441|NCT03249792|459993459|FG014|Arms 1, 2, and 4|Withdrawal by Subject|0|||
127829442|NCT03249792|459993460|FG015|Arms 1, 2, and 4|Withdrawal by Subject|0|||
127829443|NCT03249792|459993461|FG016|Arms 1, 2, and 4|Withdrawal by Subject|3|||
127829444|NCT03249792|459993462|FG017|Arms 1, 2, and 4|Withdrawal by Subject|0|||
127829445|NCT03249792|459993463|FG018|Arms 1, 2, and 4|Withdrawal by Subject|1|||
127829446|NCT03249792|459993464|FG019|Arms 1, 2, and 4|Withdrawal by Subject|0|||
127829447|NCT03249792|459993465|FG020|Arms 1, 2, and 4|Withdrawal by Subject|0|||
127829448|NCT03249792|459993466|FG021|Arms 1, 2, and 4|Withdrawal by Subject|0|||
127829449|NCT03249792|459993467|FG022|Arms 1, 2, and 4|Withdrawal by Subject|1|||
127829450|NCT03249792|459993468|FG023|Arms 1, 2, and 4|Withdrawal by Subject|1|||
127829451|NCT03249792|459993469|FG024|Arms 1, 2, and 4|Withdrawal by Subject|0|||
127829452|NCT03249792|459993470|FG025|Arms 1, 2, and 4|Withdrawal by Subject|0|||
127829453|NCT03249792|459993471|FG026|Arms 1, 2, and 4|Withdrawal by Subject|0|||
127829454|NCT03249792|459993472|FG027|Arms 1, 2, and 4|Withdrawal by Subject|0|||
127829455|NCT03249792|459993473|FG028|Arms 1, 2, and 4|Withdrawal by Subject|0|||
127829456|NCT03249792|459993474|FG029|Arms 1, 2, and 4|Withdrawal by Subject|0|||
127829457|NCT03249792|459993475|FG030|Arms 1, 2, and 4|Withdrawal by Subject|0|||
127829458|NCT03249792|459993476|FG031|Arms 1, 2, and 4|Withdrawal by Subject|0|||
127829459|NCT03249792|459993477|FG032|Arms 1, 2, and 4|Withdrawal by Subject|0|||
127829460|NCT03249792|459993445|FG000|Arms 1, 2, and 4|Sponsor Decision|0|||
127829461|NCT03249792|459993446|FG001|Arms 1, 2, and 4|Sponsor Decision|0|||
127829462|NCT03249792|459993447|FG002|Arms 1, 2, and 4|Sponsor Decision|0|||
127829463|NCT03249792|459993448|FG003|Arms 1, 2, and 4|Sponsor Decision|0|||
127829464|NCT03249792|459993449|FG004|Arms 1, 2, and 4|Sponsor Decision|0|||
127829465|NCT03249792|459993450|FG005|Arms 1, 2, and 4|Sponsor Decision|0|||
127829466|NCT03249792|459993451|FG006|Arms 1, 2, and 4|Sponsor Decision|0|||
127829467|NCT03249792|459993452|FG007|Arms 1, 2, and 4|Sponsor Decision|0|||
127829468|NCT03249792|459993453|FG008|Arms 1, 2, and 4|Sponsor Decision|1|||
127829469|NCT03249792|459993454|FG009|Arms 1, 2, and 4|Sponsor Decision|0|||
127829470|NCT03249792|459993455|FG010|Arms 1, 2, and 4|Sponsor Decision|2|||
127829471|NCT03249792|459993456|FG011|Arms 1, 2, and 4|Sponsor Decision|1|||
127829472|NCT03249792|459993457|FG012|Arms 1, 2, and 4|Sponsor Decision|1|||
127829473|NCT03249792|459993458|FG013|Arms 1, 2, and 4|Sponsor Decision|3|||
127829474|NCT03249792|459993459|FG014|Arms 1, 2, and 4|Sponsor Decision|0|||
127829475|NCT03249792|459993460|FG015|Arms 1, 2, and 4|Sponsor Decision|0|||
127829476|NCT03249792|459993461|FG016|Arms 1, 2, and 4|Sponsor Decision|0|||
127829477|NCT03249792|459993462|FG017|Arms 1, 2, and 4|Sponsor Decision|0|||
127829478|NCT03249792|459993463|FG018|Arms 1, 2, and 4|Sponsor Decision|0|||
127829479|NCT03249792|459993464|FG019|Arms 1, 2, and 4|Sponsor Decision|1|||
127829480|NCT03249792|459993465|FG020|Arms 1, 2, and 4|Sponsor Decision|1|||
127829481|NCT03249792|459993466|FG021|Arms 1, 2, and 4|Sponsor Decision|0|||
127829482|NCT03249792|459993467|FG022|Arms 1, 2, and 4|Sponsor Decision|1|||
127829483|NCT03249792|459993468|FG023|Arms 1, 2, and 4|Sponsor Decision|2|||
127829484|NCT03249792|459993469|FG024|Arms 1, 2, and 4|Sponsor Decision|0|||
127829485|NCT03249792|459993470|FG025|Arms 1, 2, and 4|Sponsor Decision|0|||
127829486|NCT03249792|459993471|FG026|Arms 1, 2, and 4|Sponsor Decision|0|||
127829487|NCT03249792|459993472|FG027|Arms 1, 2, and 4|Sponsor Decision|0|||
127829488|NCT03249792|459993473|FG028|Arms 1, 2, and 4|Sponsor Decision|0|||
127829489|NCT03249792|459993474|FG029|Arms 1, 2, and 4|Sponsor Decision|0|||
127829490|NCT03249792|459993475|FG030|Arms 1, 2, and 4|Sponsor Decision|0|||
127829491|NCT03249792|459993476|FG031|Arms 1, 2, and 4|Sponsor Decision|0|||
127829492|NCT03249792|459993477|FG032|Arms 1, 2, and 4|Sponsor Decision|0|||
127829493|NCT03249792|459993445|FG000|Arms 1, 2, and 4|Lost to Follow-up|0|||
127829494|NCT03249792|459993446|FG001|Arms 1, 2, and 4|Lost to Follow-up|0|||
127829495|NCT03249792|459993447|FG002|Arms 1, 2, and 4|Lost to Follow-up|0|||
127829496|NCT03249792|459993448|FG003|Arms 1, 2, and 4|Lost to Follow-up|0|||
127829497|NCT03249792|459993449|FG004|Arms 1, 2, and 4|Lost to Follow-up|0|||
127829498|NCT03249792|459993450|FG005|Arms 1, 2, and 4|Lost to Follow-up|0|||
127829499|NCT03249792|459993451|FG006|Arms 1, 2, and 4|Lost to Follow-up|0|||
127829500|NCT03249792|459993452|FG007|Arms 1, 2, and 4|Lost to Follow-up|0|||
127829501|NCT03249792|459993453|FG008|Arms 1, 2, and 4|Lost to Follow-up|1|||
127829502|NCT03249792|459993454|FG009|Arms 1, 2, and 4|Lost to Follow-up|0|||
127829503|NCT03249792|459993455|FG010|Arms 1, 2, and 4|Lost to Follow-up|0|||
127829504|NCT03249792|459993456|FG011|Arms 1, 2, and 4|Lost to Follow-up|0|||
127829505|NCT03249792|459993457|FG012|Arms 1, 2, and 4|Lost to Follow-up|0|||
127829506|NCT03249792|459993458|FG013|Arms 1, 2, and 4|Lost to Follow-up|0|||
127829507|NCT03249792|459993459|FG014|Arms 1, 2, and 4|Lost to Follow-up|0|||
127829508|NCT03249792|459993460|FG015|Arms 1, 2, and 4|Lost to Follow-up|0|||
127829509|NCT03249792|459993461|FG016|Arms 1, 2, and 4|Lost to Follow-up|1|||
127829510|NCT03249792|459993462|FG017|Arms 1, 2, and 4|Lost to Follow-up|2|||
127829511|NCT03249792|459993463|FG018|Arms 1, 2, and 4|Lost to Follow-up|0|||
127829512|NCT03249792|459993464|FG019|Arms 1, 2, and 4|Lost to Follow-up|1|||
127829513|NCT03249792|459993465|FG020|Arms 1, 2, and 4|Lost to Follow-up|0|||
127829514|NCT03249792|459993466|FG021|Arms 1, 2, and 4|Lost to Follow-up|0|||
127829515|NCT03249792|459993467|FG022|Arms 1, 2, and 4|Lost to Follow-up|0|||
127829516|NCT03249792|459993468|FG023|Arms 1, 2, and 4|Lost to Follow-up|0|||
127829517|NCT03249792|459993469|FG024|Arms 1, 2, and 4|Lost to Follow-up|0|||
127829518|NCT03249792|459993470|FG025|Arms 1, 2, and 4|Lost to Follow-up|0|||
127829519|NCT03249792|459993471|FG026|Arms 1, 2, and 4|Lost to Follow-up|0|||
127829520|NCT03249792|459993472|FG027|Arms 1, 2, and 4|Lost to Follow-up|0|||
127829521|NCT03249792|459993473|FG028|Arms 1, 2, and 4|Lost to Follow-up|0|||
127829522|NCT03249792|459993474|FG029|Arms 1, 2, and 4|Lost to Follow-up|0|||
127829523|NCT03249792|459993475|FG030|Arms 1, 2, and 4|Lost to Follow-up|0|||
127829524|NCT03249792|459993476|FG031|Arms 1, 2, and 4|Lost to Follow-up|0|||
127829525|NCT03249792|459993477|FG032|Arms 1, 2, and 4|Lost to Follow-up|0|||
127829526|NCT03249792|459993445|FG000|Switch Over Period|Withdrawal by Subject|0|||
127829527|NCT03249792|459993446|FG001|Switch Over Period|Withdrawal by Subject|0|||
127829528|NCT03249792|459993447|FG002|Switch Over Period|Withdrawal by Subject|0|||
127829529|NCT03249792|459993448|FG003|Switch Over Period|Withdrawal by Subject|0|||
127829530|NCT03249792|459993449|FG004|Switch Over Period|Withdrawal by Subject|0|||
127829531|NCT03249792|459993450|FG005|Switch Over Period|Withdrawal by Subject|0|||
127829532|NCT03249792|459993451|FG006|Switch Over Period|Withdrawal by Subject|0|||
127829533|NCT03249792|459993452|FG007|Switch Over Period|Withdrawal by Subject|0|||
127829534|NCT03249792|459993453|FG008|Switch Over Period|Withdrawal by Subject|0|||
127829535|NCT03249792|459993454|FG009|Switch Over Period|Withdrawal by Subject|0|||
127829536|NCT03249792|459993455|FG010|Switch Over Period|Withdrawal by Subject|0|||
127829537|NCT03249792|459993456|FG011|Switch Over Period|Withdrawal by Subject|0|||
127829538|NCT03249792|459993457|FG012|Switch Over Period|Withdrawal by Subject|0|||
127829539|NCT03249792|459993458|FG013|Switch Over Period|Withdrawal by Subject|0|||
127829540|NCT03249792|459993459|FG014|Switch Over Period|Withdrawal by Subject|0|||
127829541|NCT03249792|459993460|FG015|Switch Over Period|Withdrawal by Subject|0|||
127829542|NCT03249792|459993461|FG016|Switch Over Period|Withdrawal by Subject|0|||
127829543|NCT03249792|459993462|FG017|Switch Over Period|Withdrawal by Subject|0|||
127829544|NCT03249792|459993463|FG018|Switch Over Period|Withdrawal by Subject|0|||
127829545|NCT03249792|459993464|FG019|Switch Over Period|Withdrawal by Subject|0|||
127829546|NCT03249792|459993465|FG020|Switch Over Period|Withdrawal by Subject|0|||
127829547|NCT03249792|459993466|FG021|Switch Over Period|Withdrawal by Subject|0|||
127829548|NCT03249792|459993467|FG022|Switch Over Period|Withdrawal by Subject|0|||
127829549|NCT03249792|459993468|FG023|Switch Over Period|Withdrawal by Subject|0|||
127829550|NCT03249792|459993469|FG024|Switch Over Period|Withdrawal by Subject|0|||
127829551|NCT03249792|459993470|FG025|Switch Over Period|Withdrawal by Subject|0|||
127829552|NCT03249792|459993471|FG026|Switch Over Period|Withdrawal by Subject|0|||
127829553|NCT03249792|459993472|FG027|Switch Over Period|Withdrawal by Subject|0|||
127829554|NCT03249792|459993473|FG028|Switch Over Period|Withdrawal by Subject|0|||
127829555|NCT03249792|459993474|FG029|Switch Over Period|Withdrawal by Subject|0|||
127829556|NCT03249792|459993475|FG030|Switch Over Period|Withdrawal by Subject|0|||
127829557|NCT03249792|459993476|FG031|Switch Over Period|Withdrawal by Subject|1|||
127829558|NCT03249792|459993477|FG032|Switch Over Period|Withdrawal by Subject|0|||
127829559|NCT03249792|459993445|FG000|Switch Over Period|Progressive Disease|0|||
127829560|NCT03249792|459993446|FG001|Switch Over Period|Progressive Disease|0|||
127829561|NCT03249792|459993447|FG002|Switch Over Period|Progressive Disease|0|||
127829562|NCT03249792|459993448|FG003|Switch Over Period|Progressive Disease|0|||
127829563|NCT03249792|459993449|FG004|Switch Over Period|Progressive Disease|0|||
127829564|NCT03249792|459993450|FG005|Switch Over Period|Progressive Disease|0|||
127829565|NCT03249792|459993451|FG006|Switch Over Period|Progressive Disease|0|||
127829566|NCT03249792|459993452|FG007|Switch Over Period|Progressive Disease|0|||
127829567|NCT03249792|459993453|FG008|Switch Over Period|Progressive Disease|0|||
127829568|NCT03249792|459993454|FG009|Switch Over Period|Progressive Disease|0|||
127829569|NCT03249792|459993455|FG010|Switch Over Period|Progressive Disease|0|||
127829570|NCT03249792|459993456|FG011|Switch Over Period|Progressive Disease|0|||
127829571|NCT03249792|459993457|FG012|Switch Over Period|Progressive Disease|0|||
127829572|NCT03249792|459993458|FG013|Switch Over Period|Progressive Disease|0|||
127829573|NCT03249792|459993459|FG014|Switch Over Period|Progressive Disease|0|||
127829574|NCT03249792|459993460|FG015|Switch Over Period|Progressive Disease|0|||
127829575|NCT03249792|459993461|FG016|Switch Over Period|Progressive Disease|0|||
127829576|NCT03249792|459993462|FG017|Switch Over Period|Progressive Disease|0|||
127829577|NCT03249792|459993463|FG018|Switch Over Period|Progressive Disease|0|||
127829578|NCT03249792|459993464|FG019|Switch Over Period|Progressive Disease|0|||
127829579|NCT03249792|459993465|FG020|Switch Over Period|Progressive Disease|0|||
127829580|NCT03249792|459993466|FG021|Switch Over Period|Progressive Disease|0|||
127829581|NCT03249792|459993467|FG022|Switch Over Period|Progressive Disease|0|||
127829582|NCT03249792|459993468|FG023|Switch Over Period|Progressive Disease|0|||
127829583|NCT03249792|459993469|FG024|Switch Over Period|Progressive Disease|0|||
127829584|NCT03249792|459993470|FG025|Switch Over Period|Progressive Disease|0|||
127829585|NCT03249792|459993471|FG026|Switch Over Period|Progressive Disease|1|||
127829586|NCT03249792|459993472|FG027|Switch Over Period|Progressive Disease|0|||
127829587|NCT03249792|459993473|FG028|Switch Over Period|Progressive Disease|1|||
127829588|NCT03249792|459993474|FG029|Switch Over Period|Progressive Disease|2|||
127894916|NCT00992407|460238574|FG000|Overall Study|protocol Violation & Adverse events|2|||
127894917|NCT00992407|460238575|FG001|Overall Study|protocol Violation & Adverse events|4|||
127894918|NCT00992407|460238574|FG000|Overall Study|Other|2|||
127894919|NCT00992407|460238575|FG001|Overall Study|Other|0|||
127894920|NCT00992407|460238574|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
127894921|NCT00992407|460238575|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
127894922|NCT00992407|460238574|FG000|Overall Study|Study medication not administered|17|||
127894923|NCT00992407|460238575|FG001|Overall Study|Study medication not administered|13|||
127894924|NCT02918162|460238576|FG000|Overall Study|Withdrawal by Subject|1|||
127894925|NCT02918162|460238576|FG000|Overall Study|Omental Disease|1|||
127894926|NCT00395226|460238577|FG000|Overall Study|Adverse Event|4|||
127894927|NCT00395226|460238578|FG001|Overall Study|Adverse Event|3|||
127894928|NCT00395226|460238577|FG000|Overall Study|Withdrawal by Subject|0|||
127894929|NCT00395226|460238578|FG001|Overall Study|Withdrawal by Subject|1|||
127894930|NCT00395226|460238577|FG000|Overall Study|Lost to Follow-up|0|||
127894931|NCT00395226|460238578|FG001|Overall Study|Lost to Follow-up|1|||
127894932|NCT01000337|460238582|FG000|Overall Study|Lost to Follow-up|4|||
127894933|NCT01000337|460238583|FG001|Overall Study|Lost to Follow-up|3|||
127894934|NCT01612000|460238584|FG000|Overall Study|Lost to Follow-up|6|||
127894935|NCT01612000|460238585|FG001|Overall Study|Lost to Follow-up|4|||
127894936|NCT01612000|460238586|FG002|Overall Study|Lost to Follow-up|4|||
127894937|NCT01612000|460238587|FG003|Overall Study|Lost to Follow-up|8|||
127894938|NCT01612000|460238584|FG000|Overall Study|Physician Decision|0|||
127894939|NCT01612000|460238585|FG001|Overall Study|Physician Decision|0|||
127894940|NCT01612000|460238586|FG002|Overall Study|Physician Decision|1|||
127894941|NCT01612000|460238587|FG003|Overall Study|Physician Decision|0|||
127894942|NCT01612000|460238584|FG000|Overall Study|Withdrawal by Subject|3|||
127894943|NCT01612000|460238585|FG001|Overall Study|Withdrawal by Subject|1|||
127894944|NCT01612000|460238586|FG002|Overall Study|Withdrawal by Subject|2|||
127894945|NCT01612000|460238587|FG003|Overall Study|Withdrawal by Subject|2|||
127894946|NCT04652453|460238591|FG000|Overall Study|Death|8|||
127894947|NCT04652453|460238592|FG001|Overall Study|Death|2|||
127894948|NCT04652453|460238593|FG002|Overall Study|Death|0|||
127894949|NCT04652453|460238591|FG000|Overall Study|Hospice|5|||
127894950|NCT04652453|460238592|FG001|Overall Study|Hospice|5|||
127894951|NCT04652453|460238593|FG002|Overall Study|Hospice|0|||
127894952|NCT04652453|460238591|FG000|Overall Study|Withdrawal by Subject|2|||
127894953|NCT04652453|460238592|FG001|Overall Study|Withdrawal by Subject|0|||
127894954|NCT04652453|460238593|FG002|Overall Study|Withdrawal by Subject|0|||
127894955|NCT02978326|460238594|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
127894956|NCT02978326|460238595|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
127894957|NCT02978326|460238596|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
127894958|NCT02978326|460238594|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
127894959|NCT02978326|460238595|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
127894960|NCT02978326|460238596|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
127829589|NCT03249792|459993475|FG030|Switch Over Period|Progressive Disease|1|||
127829590|NCT03249792|459993476|FG031|Switch Over Period|Progressive Disease|0|||
127829591|NCT03249792|459993477|FG032|Switch Over Period|Progressive Disease|1|||
127829592|NCT03249792|459993445|FG000|Switch Over Period|Adverse Event|0|||
127829593|NCT03249792|459993446|FG001|Switch Over Period|Adverse Event|0|||
127829594|NCT03249792|459993447|FG002|Switch Over Period|Adverse Event|0|||
127829595|NCT03249792|459993448|FG003|Switch Over Period|Adverse Event|0|||
127829596|NCT03249792|459993449|FG004|Switch Over Period|Adverse Event|0|||
127829597|NCT03249792|459993450|FG005|Switch Over Period|Adverse Event|0|||
127829598|NCT03249792|459993451|FG006|Switch Over Period|Adverse Event|0|||
127829599|NCT03249792|459993452|FG007|Switch Over Period|Adverse Event|0|||
127829600|NCT03249792|459993453|FG008|Switch Over Period|Adverse Event|0|||
127829601|NCT03249792|459993454|FG009|Switch Over Period|Adverse Event|0|||
127829602|NCT03249792|459993455|FG010|Switch Over Period|Adverse Event|0|||
127829603|NCT03249792|459993456|FG011|Switch Over Period|Adverse Event|0|||
127829604|NCT03249792|459993457|FG012|Switch Over Period|Adverse Event|0|||
127829605|NCT03249792|459993458|FG013|Switch Over Period|Adverse Event|0|||
127829606|NCT03249792|459993459|FG014|Switch Over Period|Adverse Event|0|||
127829607|NCT03249792|459993460|FG015|Switch Over Period|Adverse Event|0|||
127829608|NCT03249792|459993461|FG016|Switch Over Period|Adverse Event|0|||
127829609|NCT03249792|459993462|FG017|Switch Over Period|Adverse Event|0|||
127829610|NCT03249792|459993463|FG018|Switch Over Period|Adverse Event|0|||
127894961|NCT02978326|460238594|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
127894962|NCT02978326|460238595|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
127894963|NCT02978326|460238596|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
127894964|NCT02978326|460238594|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
127894965|NCT02978326|460238595|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
127894966|NCT02978326|460238596|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
127829611|NCT03249792|459993464|FG019|Switch Over Period|Adverse Event|0|||
127829612|NCT03249792|459993465|FG020|Switch Over Period|Adverse Event|0|||
127829613|NCT03249792|459993466|FG021|Switch Over Period|Adverse Event|0|||
127829614|NCT03249792|459993467|FG022|Switch Over Period|Adverse Event|0|||
127829615|NCT03249792|459993468|FG023|Switch Over Period|Adverse Event|0|||
127829616|NCT03249792|459993469|FG024|Switch Over Period|Adverse Event|0|||
127829617|NCT03249792|459993470|FG025|Switch Over Period|Adverse Event|1|||
127829618|NCT03249792|459993471|FG026|Switch Over Period|Adverse Event|0|||
127829619|NCT03249792|459993472|FG027|Switch Over Period|Adverse Event|1|||
127829620|NCT03249792|459993473|FG028|Switch Over Period|Adverse Event|0|||
127829621|NCT03249792|459993474|FG029|Switch Over Period|Adverse Event|0|||
127829622|NCT03249792|459993475|FG030|Switch Over Period|Adverse Event|0|||
127829623|NCT03249792|459993476|FG031|Switch Over Period|Adverse Event|0|||
127829624|NCT03249792|459993477|FG032|Switch Over Period|Adverse Event|0|||
127829625|NCT00069576|459993481|FG000|Original Trial|Lost to Follow-up|25|||
127829626|NCT00069576|459993482|FG001|Original Trial|Lost to Follow-up|33|||
127829627|NCT00069576|459993481|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
127829628|NCT00069576|459993482|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
127829629|NCT05100199|459993488|FG000|Overall Study|Lost to Follow-up|5|||
127829630|NCT05100199|459993489|FG001|Overall Study|Lost to Follow-up|8|||
127829631|NCT05100199|459993490|FG002|Overall Study|Lost to Follow-up|3|||
127829632|NCT05100199|459993491|FG003|Overall Study|Lost to Follow-up|6|||
127829633|NCT05100199|459993488|FG000|Overall Study|Withdrawal by Subject|3|||
127829634|NCT05100199|459993489|FG001|Overall Study|Withdrawal by Subject|3|||
127829635|NCT05100199|459993490|FG002|Overall Study|Withdrawal by Subject|9|||
127829636|NCT05100199|459993491|FG003|Overall Study|Withdrawal by Subject|7|||
127829637|NCT05100199|459993488|FG000|Overall Study|Other|0|||
127829638|NCT05100199|459993489|FG001|Overall Study|Other|0|||
127829639|NCT05100199|459993490|FG002|Overall Study|Other|1|||
127829640|NCT05100199|459993491|FG003|Overall Study|Other|1|||
127829641|NCT00830037|459993492|FG000|Overall Study|Withdrawal by Subject|2|||
127829642|NCT00830037|459993493|FG001|Overall Study|Withdrawal by Subject|3|||
127829643|NCT00830037|459993492|FG000|Overall Study|Lost to Follow-up|1|||
127829644|NCT00830037|459993493|FG001|Overall Study|Lost to Follow-up|2|||
127829645|NCT00830037|459993492|FG000|Overall Study|Active when terminated by DSMB|15|||
127829646|NCT00830037|459993493|FG001|Overall Study|Active when terminated by DSMB|14|||
127829647|NCT00752609|459993494|FG000|Overall Study|Adverse Event|2|||
127829648|NCT00752609|459993495|FG001|Overall Study|Adverse Event|2|||
127829649|NCT00752609|459993494|FG000|Overall Study|Withdrawal by Subject|3|||
127829650|NCT00752609|459993495|FG001|Overall Study|Withdrawal by Subject|0|||
127829651|NCT00752609|459993494|FG000|Overall Study|Physician Decision|1|||
127829652|NCT00752609|459993495|FG001|Overall Study|Physician Decision|0|||
127829653|NCT00752609|459993494|FG000|Overall Study|Death|1|||
127829654|NCT00752609|459993495|FG001|Overall Study|Death|0|||
127829655|NCT00752609|459993494|FG000|Overall Study|Met exclusion criteria|1|||
127829656|NCT00752609|459993495|FG001|Overall Study|Met exclusion criteria|0|||
127829657|NCT00752609|459993494|FG000|Overall Study|Received Aranesp in error|1|||
127829658|NCT00752609|459993495|FG001|Overall Study|Received Aranesp in error|0|||
127829659|NCT05114590|459993496|FG000|Overall Study|Adverse Event|1|||
127829660|NCT05114590|459993496|FG000|Overall Study|Investigator decision|1|||
127829661|NCT05114590|459993496|FG000|Overall Study|Lost to Follow-up|5|||
127829662|NCT05114590|459993496|FG000|Overall Study|Withdrawal by Subject|5|||
127829663|NCT05114590|459993496|FG000|Overall Study|Other|2|||
127829664|NCT00358917|459993499|FG000|Overall Study|Adverse Event|14|||
127829665|NCT00358917|459993500|FG001|Overall Study|Adverse Event|21|||
127829666|NCT00358917|459993499|FG000|Overall Study|Withdrawal by Subject|5|||
127829667|NCT00358917|459993500|FG001|Overall Study|Withdrawal by Subject|7|||
127829668|NCT00358917|459993499|FG000|Overall Study|Lost to Follow-up|20|||
127829669|NCT00358917|459993500|FG001|Overall Study|Lost to Follow-up|17|||
127829670|NCT00358917|459993499|FG000|Overall Study|Noncompliance|12|||
127829671|NCT00358917|459993500|FG001|Overall Study|Noncompliance|11|||
127829672|NCT00358917|459993499|FG000|Overall Study|Death|2|||
127829673|NCT00358917|459993500|FG001|Overall Study|Death|3|||
127829674|NCT00358917|459993499|FG000|Overall Study|Virologic failure|11|||
127829675|NCT00358917|459993500|FG001|Overall Study|Virologic failure|8|||
127829676|NCT00358917|459993499|FG000|Overall Study|Unable to Continue Participation|2|||
127829677|NCT00358917|459993500|FG001|Overall Study|Unable to Continue Participation|2|||
127829678|NCT01379534|459993509|FG000|Treatment Phase|Withdrawal by Subject|2|||
127829679|NCT01379534|459993510|FG001|Treatment Phase|Withdrawal by Subject|2|||
127829680|NCT01379534|459993509|FG000|Treatment Phase|Progressive disease|13|||
127829681|NCT01379534|459993510|FG001|Treatment Phase|Progressive disease|22|||
127829682|NCT01379534|459993509|FG000|Treatment Phase|Adverse Event|7|||
127829683|NCT01379534|459993510|FG001|Treatment Phase|Adverse Event|7|||
127829684|NCT01379534|459993509|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
127829685|NCT01379534|459993510|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
127829686|NCT01379534|459993509|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
127829687|NCT01379534|459993510|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
127829688|NCT01379534|459993509|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
127829689|NCT01379534|459993510|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
127829690|NCT01379534|459993509|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
127829691|NCT01379534|459993510|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
127829692|NCT05372575|459993517|FG000|Overall Study|Protocol Violation|7|||
127829693|NCT05372575|459993518|FG001|Overall Study|Protocol Violation|16|||
127829694|NCT01096550|459993519|FG000|Overall Study|discontinued site|10|||
127829695|NCT01096550|459993520|FG001|Overall Study|discontinued site|11|||
127829696|NCT01096550|459993519|FG000|Overall Study|non-regular treatment track at clinic|1|||
127829697|NCT01096550|459993520|FG001|Overall Study|non-regular treatment track at clinic|1|||
127829698|NCT01096550|459993519|FG000|Overall Study|clinic readmission|1|||
127829699|NCT01096550|459993520|FG001|Overall Study|clinic readmission|1|||
127829700|NCT01096550|459993519|FG000|Overall Study|Withdrawal by Subject|0|||
127829701|NCT01096550|459993520|FG001|Overall Study|Withdrawal by Subject|1|||
127829702|NCT01096550|459993519|FG000|Overall Study|non-African American participant|13|||
127829703|NCT01096550|459993520|FG001|Overall Study|non-African American participant|6|||
127829704|NCT01096550|459993519|FG000|Overall Study|Lost to Follow-up|12|||
127829705|NCT01096550|459993520|FG001|Overall Study|Lost to Follow-up|9|||
127829706|NCT01544595|459993523|FG000|Status at Week 68|Adverse Event|3|||
127829707|NCT01544595|459993524|FG001|Status at Week 68|Adverse Event|2|||
127829708|NCT01544595|459993525|FG002|Status at Week 68|Adverse Event|1|||
127829709|NCT01544595|459993526|FG003|Status at Week 68|Adverse Event|0|||
127829710|NCT01544595|459993527|FG004|Status at Week 68|Adverse Event|0|||
127829711|NCT01544595|459993528|FG005|Status at Week 68|Adverse Event|0|||
127829712|NCT01544595|459993523|FG000|Status at Week 68|Lack of Efficacy|1|||
127829713|NCT01544595|459993524|FG001|Status at Week 68|Lack of Efficacy|0|||
127829714|NCT01544595|459993525|FG002|Status at Week 68|Lack of Efficacy|0|||
127829715|NCT01544595|459993526|FG003|Status at Week 68|Lack of Efficacy|0|||
127829716|NCT01544595|459993527|FG004|Status at Week 68|Lack of Efficacy|0|||
127829717|NCT01544595|459993528|FG005|Status at Week 68|Lack of Efficacy|0|||
127829718|NCT01544595|459993523|FG000|Status at Week 68|Lost to Follow-up|1|||
127829719|NCT01544595|459993524|FG001|Status at Week 68|Lost to Follow-up|1|||
127829720|NCT01544595|459993525|FG002|Status at Week 68|Lost to Follow-up|0|||
127829721|NCT01544595|459993526|FG003|Status at Week 68|Lost to Follow-up|0|||
127829722|NCT01544595|459993527|FG004|Status at Week 68|Lost to Follow-up|0|||
127829723|NCT01544595|459993528|FG005|Status at Week 68|Lost to Follow-up|0|||
127829724|NCT01544595|459993523|FG000|Status at Week 68|Non-compliance with study treatment|1|||
127829725|NCT01544595|459993524|FG001|Status at Week 68|Non-compliance with study treatment|0|||
127829726|NCT01544595|459993525|FG002|Status at Week 68|Non-compliance with study treatment|0|||
127829727|NCT01544595|459993526|FG003|Status at Week 68|Non-compliance with study treatment|1|||
127829728|NCT01544595|459993527|FG004|Status at Week 68|Non-compliance with study treatment|0|||
127829729|NCT01544595|459993528|FG005|Status at Week 68|Non-compliance with study treatment|0|||
127829730|NCT01544595|459993523|FG000|Status at Week 68|Protocol Violation|2|||
127829731|NCT01544595|459993524|FG001|Status at Week 68|Protocol Violation|0|||
127829732|NCT01544595|459993525|FG002|Status at Week 68|Protocol Violation|1|||
127829733|NCT01544595|459993526|FG003|Status at Week 68|Protocol Violation|1|||
127829734|NCT01544595|459993527|FG004|Status at Week 68|Protocol Violation|0|||
127829735|NCT01544595|459993528|FG005|Status at Week 68|Protocol Violation|0|||
127829736|NCT01544595|459993523|FG000|Status at Week 68|Technical problems|1|||
127829737|NCT01544595|459993524|FG001|Status at Week 68|Technical problems|0|||
127829738|NCT01544595|459993525|FG002|Status at Week 68|Technical problems|0|||
127829739|NCT01544595|459993526|FG003|Status at Week 68|Technical problems|1|||
127829740|NCT01544595|459993527|FG004|Status at Week 68|Technical problems|0|||
127829741|NCT01544595|459993528|FG005|Status at Week 68|Technical problems|0|||
127829742|NCT01544595|459993523|FG000|Status at Week 68|Withdrawal by Subject|0|||
127829743|NCT01544595|459993524|FG001|Status at Week 68|Withdrawal by Subject|1|||
127829744|NCT01544595|459993525|FG002|Status at Week 68|Withdrawal by Subject|1|||
127829745|NCT01544595|459993526|FG003|Status at Week 68|Withdrawal by Subject|2|||
127829746|NCT01544595|459993527|FG004|Status at Week 68|Withdrawal by Subject|0|||
127829747|NCT01544595|459993528|FG005|Status at Week 68|Withdrawal by Subject|0|||
127829748|NCT01544595|459993523|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
127829749|NCT01544595|459993524|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
127829750|NCT01544595|459993525|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
127829751|NCT01544595|459993526|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
127829752|NCT01544595|459993527|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
127829753|NCT01544595|459993528|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
127829754|NCT01544595|459993523|FG000|Status at Week 156|Withdrawal by Subject|9|||
127829755|NCT01544595|459993524|FG001|Status at Week 156|Withdrawal by Subject|10|||
127829756|NCT01544595|459993525|FG002|Status at Week 156|Withdrawal by Subject|4|||
127829757|NCT01544595|459993526|FG003|Status at Week 156|Withdrawal by Subject|9|||
127829758|NCT01544595|459993527|FG004|Status at Week 156|Withdrawal by Subject|20|||
127829759|NCT01544595|459993528|FG005|Status at Week 156|Withdrawal by Subject|6|||
127829760|NCT01544595|459993523|FG000|Status at Week 156|Adverse Event|9|||
127829761|NCT01544595|459993524|FG001|Status at Week 156|Adverse Event|11|||
127829762|NCT01544595|459993525|FG002|Status at Week 156|Adverse Event|1|||
127829763|NCT01544595|459993526|FG003|Status at Week 156|Adverse Event|3|||
127829764|NCT01544595|459993527|FG004|Status at Week 156|Adverse Event|4|||
127829765|NCT01544595|459993528|FG005|Status at Week 156|Adverse Event|2|||
127829766|NCT01544595|459993523|FG000|Status at Week 156|Lost to Follow-up|4|||
127829767|NCT01544595|459993524|FG001|Status at Week 156|Lost to Follow-up|4|||
127829768|NCT01544595|459993525|FG002|Status at Week 156|Lost to Follow-up|0|||
127829769|NCT01544595|459993526|FG003|Status at Week 156|Lost to Follow-up|1|||
127829770|NCT01544595|459993527|FG004|Status at Week 156|Lost to Follow-up|4|||
127829771|NCT01544595|459993528|FG005|Status at Week 156|Lost to Follow-up|1|||
127829772|NCT01544595|459993523|FG000|Status at Week 156|Non-compliance with study treatement|0|||
127829773|NCT01544595|459993524|FG001|Status at Week 156|Non-compliance with study treatement|1|||
127829774|NCT01544595|459993525|FG002|Status at Week 156|Non-compliance with study treatement|0|||
127829775|NCT01544595|459993526|FG003|Status at Week 156|Non-compliance with study treatement|1|||
127829776|NCT01544595|459993527|FG004|Status at Week 156|Non-compliance with study treatement|0|||
127829777|NCT01544595|459993528|FG005|Status at Week 156|Non-compliance with study treatement|1|||
127829778|NCT01544595|459993523|FG000|Status at Week 156|Physician Decision|0|||
127829779|NCT01544595|459993524|FG001|Status at Week 156|Physician Decision|3|||
127829780|NCT01544595|459993525|FG002|Status at Week 156|Physician Decision|1|||
127829781|NCT01544595|459993526|FG003|Status at Week 156|Physician Decision|0|||
127829782|NCT01544595|459993527|FG004|Status at Week 156|Physician Decision|0|||
127829783|NCT01544595|459993528|FG005|Status at Week 156|Physician Decision|0|||
127829784|NCT01544595|459993523|FG000|Status at Week 156|Pregnancy|2|||
127829785|NCT01544595|459993524|FG001|Status at Week 156|Pregnancy|3|||
127829786|NCT01544595|459993525|FG002|Status at Week 156|Pregnancy|0|||
127829787|NCT01544595|459993526|FG003|Status at Week 156|Pregnancy|0|||
127829788|NCT01544595|459993527|FG004|Status at Week 156|Pregnancy|0|||
127829789|NCT01544595|459993528|FG005|Status at Week 156|Pregnancy|0|||
127829790|NCT01544595|459993523|FG000|Status at Week 156|Protocol Violation|3|||
127829791|NCT01544595|459993524|FG001|Status at Week 156|Protocol Violation|1|||
127829792|NCT01544595|459993525|FG002|Status at Week 156|Protocol Violation|2|||
127829793|NCT01544595|459993526|FG003|Status at Week 156|Protocol Violation|2|||
127829794|NCT01544595|459993527|FG004|Status at Week 156|Protocol Violation|0|||
127829795|NCT01544595|459993528|FG005|Status at Week 156|Protocol Violation|0|||
127829796|NCT01544595|459993523|FG000|Status at Week 156|Technical problems|3|||
127829797|NCT01544595|459993524|FG001|Status at Week 156|Technical problems|1|||
127829798|NCT01544595|459993525|FG002|Status at Week 156|Technical problems|0|||
127829799|NCT01544595|459993526|FG003|Status at Week 156|Technical problems|1|||
127829800|NCT01544595|459993527|FG004|Status at Week 156|Technical problems|0|||
127829801|NCT01544595|459993528|FG005|Status at Week 156|Technical problems|0|||
127829802|NCT01544595|459993523|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
127829803|NCT01544595|459993524|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
127829804|NCT01544595|459993525|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
127829805|NCT01544595|459993526|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
127829806|NCT01544595|459993527|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
127829807|NCT01544595|459993528|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
127829808|NCT01544595|459993523|FG000|Status at Week 156|Lack of Efficacy|1|||
127829809|NCT01544595|459993524|FG001|Status at Week 156|Lack of Efficacy|0|||
127829810|NCT01544595|459993525|FG002|Status at Week 156|Lack of Efficacy|1|||
127829811|NCT01544595|459993526|FG003|Status at Week 156|Lack of Efficacy|4|||
127829812|NCT01544595|459993527|FG004|Status at Week 156|Lack of Efficacy|10|||
127829813|NCT01544595|459993528|FG005|Status at Week 156|Lack of Efficacy|5|||
127829814|NCT04333433|459993533|FG000|Overall Study|Withdrawal by Subject|6|||
127829815|NCT04333433|459993534|FG001|Overall Study|Withdrawal by Subject|3|||
127829816|NCT04333433|459993533|FG000|Overall Study|Death|3|||
127829817|NCT04333433|459993534|FG001|Overall Study|Death|0|||
127829818|NCT04333433|459993533|FG000|Overall Study|Lost to Follow-up|6|||
127829819|NCT04333433|459993534|FG001|Overall Study|Lost to Follow-up|1|||
127829820|NCT04333433|459993533|FG000|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|4|||
127829821|NCT04333433|459993534|FG001|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|0|||
127829822|NCT00320385|459993535|FG000|Overall Study|Lost to Follow-up|7|||
127829823|NCT00320385|459993536|FG001|Overall Study|Lost to Follow-up|10|||
127829824|NCT00320385|459993535|FG000|Overall Study|Withdrawal by Subject|6|||
127829825|NCT00320385|459993536|FG001|Overall Study|Withdrawal by Subject|7|||
127829826|NCT00320385|459993535|FG000|Overall Study|Sponsor Terminated Study|2|||
127829827|NCT00320385|459993536|FG001|Overall Study|Sponsor Terminated Study|1|||
127829828|NCT00320385|459993535|FG000|Overall Study|Investigator Decision|0|||
127829829|NCT00320385|459993536|FG001|Overall Study|Investigator Decision|1|||
127829830|NCT00320385|459993535|FG000|Overall Study|Death|1|||
127829831|NCT00320385|459993536|FG001|Overall Study|Death|2|||
127829832|NCT00320385|459993535|FG000|Overall Study|Serious Adverse Event|1|||
127829833|NCT00320385|459993536|FG001|Overall Study|Serious Adverse Event|0|||
127829834|NCT00320385|459993535|FG000|Overall Study|Withdrew Consent|1|||
127829835|NCT00320385|459993536|FG001|Overall Study|Withdrew Consent|0|||
127829836|NCT00320385|459993535|FG000|Overall Study|Adverse Event|0|||
127829837|NCT00320385|459993536|FG001|Overall Study|Adverse Event|1|||
127829838|NCT03288779|459993542|FG000|Overall Study|Withdrawal by Subject|3|||
127829839|NCT01355068|459993543|FG000|First Intervention Period|Adverse Event|0|||
127829840|NCT01355068|459993544|FG001|First Intervention Period|Adverse Event|1|||
127829841|NCT01355068|459993543|FG000|First Intervention Period|Withdrawal by Subject|0|||
127829842|NCT01355068|459993544|FG001|First Intervention Period|Withdrawal by Subject|1|||
127829843|NCT00524745|459993545|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
127829844|NCT00524745|459993546|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
127829845|NCT00524745|459993547|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
127829846|NCT00524745|459993548|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
127829847|NCT00872170|459993549|FG000|Overall Study|Adverse Event|1|||
127829848|NCT00872170|459993550|FG001|Overall Study|Adverse Event|0|||
127829849|NCT01721408|459993551|FG000|Overall Study|Adverse Event|6|||
127829850|NCT01721408|459993552|FG001|Overall Study|Adverse Event|1|||
127829851|NCT01721408|459993551|FG000|Overall Study|Death|1|||
127829852|NCT01721408|459993552|FG001|Overall Study|Death|0|||
127829853|NCT01721408|459993551|FG000|Overall Study|Insufficient clinical response|15|||
127829854|NCT01721408|459993552|FG001|Overall Study|Insufficient clinical response|6|||
127829855|NCT01721408|459993551|FG000|Overall Study|No longer willing to participate study|9|||
127829856|NCT01721408|459993552|FG001|Overall Study|No longer willing to participate study|10|||
127829857|NCT01721408|459993551|FG000|Overall Study|Protocol Violation|0|||
127829858|NCT01721408|459993552|FG001|Overall Study|Protocol Violation|2|||
127829859|NCT01721408|459993551|FG000|Overall Study|Other|3|||
127829860|NCT01721408|459993552|FG001|Overall Study|Other|3|||
127829861|NCT01721408|459993551|FG000|Overall Study|Lost to Follow-up|1|||
127829862|NCT01721408|459993552|FG001|Overall Study|Lost to Follow-up|2|||
127829863|NCT01721408|459993551|FG000|Overall Study|Does not meet entrance criteria|1|||
127829864|NCT01721408|459993552|FG001|Overall Study|Does not meet entrance criteria|0|||
127829865|NCT01064648|459993553|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
127829866|NCT01064648|459993554|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
127829867|NCT01064648|459993555|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
127829868|NCT01064648|459993556|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
127829869|NCT01064648|459993553|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
127829870|NCT01064648|459993554|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
127829871|NCT01064648|459993555|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
127829872|NCT01064648|459993556|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
127829873|NCT01064648|459993553|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
127829874|NCT01064648|459993554|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
127829875|NCT01064648|459993555|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
127829876|NCT01064648|459993556|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
127829877|NCT01064648|459993553|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
127829878|NCT01064648|459993554|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
127829879|NCT01064648|459993555|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
127829880|NCT01064648|459993556|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
127829881|NCT01064648|459993553|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
127829882|NCT01064648|459993554|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
127829883|NCT01064648|459993555|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
127829884|NCT01064648|459993556|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
127829885|NCT01064648|459993553|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
127829886|NCT01064648|459993554|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
127829887|NCT01064648|459993555|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
127829888|NCT01064648|459993556|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
127829889|NCT01064648|459993553|FG000|Phase II|Adverse Event|0|||
127829890|NCT01064648|459993554|FG001|Phase II|Adverse Event|0|||
127829891|NCT01064648|459993555|FG002|Phase II|Adverse Event|15|||
127829892|NCT01064648|459993556|FG003|Phase II|Adverse Event|8|||
127829893|NCT01064648|459993553|FG000|Phase II|Death|0|||
127829894|NCT01064648|459993554|FG001|Phase II|Death|0|||
127829895|NCT01064648|459993555|FG002|Phase II|Death|4|||
127829896|NCT01064648|459993556|FG003|Phase II|Death|5|||
127829897|NCT01064648|459993553|FG000|Phase II|Withdrawal by Subject|0|||
127829898|NCT01064648|459993554|FG001|Phase II|Withdrawal by Subject|0|||
127829899|NCT01064648|459993555|FG002|Phase II|Withdrawal by Subject|2|||
127829900|NCT01064648|459993556|FG003|Phase II|Withdrawal by Subject|5|||
127829901|NCT01064648|459993553|FG000|Phase II|Progression|0|||
127829902|NCT01064648|459993554|FG001|Phase II|Progression|0|||
127829903|NCT01064648|459993555|FG002|Phase II|Progression|21|||
127829904|NCT01064648|459993556|FG003|Phase II|Progression|27|||
127829905|NCT01064648|459993553|FG000|Phase II|Non-protocol specified|0|||
127829906|NCT01064648|459993554|FG001|Phase II|Non-protocol specified|0|||
127829907|NCT01064648|459993555|FG002|Phase II|Non-protocol specified|5|||
127829908|NCT01064648|459993556|FG003|Phase II|Non-protocol specified|3|||
127829909|NCT01064648|459993553|FG000|Phase II|Under Review|0|||
127829910|NCT01064648|459993554|FG001|Phase II|Under Review|0|||
127829911|NCT01064648|459993555|FG002|Phase II|Under Review|2|||
127829912|NCT01064648|459993556|FG003|Phase II|Under Review|0|||
127829913|NCT05128162|459993557|FG000|Overall Study|Concerns about participant ability to follow study procedures|1|||
127829914|NCT05128162|459993557|FG000|Overall Study|Physician Decision|1|||
127829915|NCT04038255|459995426|FG000|Overall Study|Lost to Follow-up|0|||
127829916|NCT04038255|459995427|FG001|Overall Study|Lost to Follow-up|9|||
127829917|NCT04038255|459995428|FG002|Overall Study|Lost to Follow-up|5|||
127829918|NCT04038255|459995426|FG000|Overall Study|Withdrawal by Subject|0|||
127829919|NCT04038255|459995427|FG001|Overall Study|Withdrawal by Subject|0|||
127829920|NCT04038255|459995428|FG002|Overall Study|Withdrawal by Subject|1|||
127829921|NCT01286272|459995429|FG000|Overall Study|Ineligible after beginning treatment|1|||
127829922|NCT01286272|459995430|FG001|Overall Study|Ineligible after beginning treatment|3|||
127829923|NCT00074412|459995431|FG000|Overall Study|Death|30|||
127829924|NCT00074412|459995432|FG001|Overall Study|Death|26|||
127829925|NCT00074412|459995431|FG000|Overall Study|Lost to Follow-up|52|||
127829926|NCT00074412|459995432|FG001|Overall Study|Lost to Follow-up|58|||
127829927|NCT00418834|459995437|FG000|Overall Study|Adverse Event|16|||
127829928|NCT00418834|459995438|FG001|Overall Study|Adverse Event|9|||
127829929|NCT00418834|459995437|FG000|Overall Study|Lost to Follow-up|0|||
127829930|NCT00418834|459995438|FG001|Overall Study|Lost to Follow-up|1|||
127829931|NCT00418834|459995437|FG000|Overall Study|Protocol Violation|4|||
127829932|NCT00418834|459995438|FG001|Overall Study|Protocol Violation|3|||
127829933|NCT00418834|459995437|FG000|Overall Study|Withdrawal by Subject|3|||
127829934|NCT00418834|459995438|FG001|Overall Study|Withdrawal by Subject|7|||
127829935|NCT01953328|459995439|FG000|Overall Study|Withdrawal by Subject|0|||
127829936|NCT01953328|459995440|FG001|Overall Study|Withdrawal by Subject|0|||
127829937|NCT01953328|459995441|FG002|Overall Study|Withdrawal by Subject|0|||
127829938|NCT01953328|459995442|FG003|Overall Study|Withdrawal by Subject|0|||
127829939|NCT01953328|459995443|FG004|Overall Study|Withdrawal by Subject|1|||
127829940|NCT01953328|459995444|FG005|Overall Study|Withdrawal by Subject|0|||
127829941|NCT01953328|459995445|FG006|Overall Study|Withdrawal by Subject|0|||
127829942|NCT01953328|459995446|FG007|Overall Study|Withdrawal by Subject|0|||
127829943|NCT01953328|459995439|FG000|Overall Study|Lost to Follow-up|0|||
127829944|NCT01953328|459995440|FG001|Overall Study|Lost to Follow-up|0|||
127829945|NCT01953328|459995441|FG002|Overall Study|Lost to Follow-up|0|||
127829946|NCT01953328|459995442|FG003|Overall Study|Lost to Follow-up|0|||
127829947|NCT01953328|459995443|FG004|Overall Study|Lost to Follow-up|1|||
127829948|NCT01953328|459995444|FG005|Overall Study|Lost to Follow-up|0|||
127829949|NCT01953328|459995445|FG006|Overall Study|Lost to Follow-up|0|||
127829950|NCT01953328|459995446|FG007|Overall Study|Lost to Follow-up|0|||
127829951|NCT02364947|459995455|FG000|Overall Study|Withdrawal by Subject|10|||
127829952|NCT02364947|459995456|FG001|Overall Study|Withdrawal by Subject|8|||
127829953|NCT02364947|459995457|FG002|Overall Study|Withdrawal by Subject|9|||
127829954|NCT02364947|459995455|FG000|Overall Study|Adverse Event|45|||
127829955|NCT02364947|459995456|FG001|Overall Study|Adverse Event|33|||
127829956|NCT02364947|459995457|FG002|Overall Study|Adverse Event|11|||
127829957|NCT02364947|459995455|FG000|Overall Study|Protocol Violation|1|||
127829958|NCT02364947|459995456|FG001|Overall Study|Protocol Violation|1|||
127829959|NCT02364947|459995457|FG002|Overall Study|Protocol Violation|1|||
127829960|NCT02364947|459995455|FG000|Overall Study|Physician Decision|3|||
127829961|NCT02364947|459995456|FG001|Overall Study|Physician Decision|2|||
127829962|NCT02364947|459995457|FG002|Overall Study|Physician Decision|5|||
127829963|NCT02364947|459995455|FG000|Overall Study|Death|0|||
127829964|NCT02364947|459995456|FG001|Overall Study|Death|1|||
127829965|NCT02364947|459995457|FG002|Overall Study|Death|0|||
127829966|NCT00423085|459995458|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
127829967|NCT00423085|459995459|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
127829968|NCT00423085|459995460|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
127829969|NCT00423085|459995461|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
127829970|NCT00423085|459995458|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
127829971|NCT00423085|459995459|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
127829972|NCT00423085|459995460|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
127829973|NCT00423085|459995461|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
127829974|NCT00423085|459995458|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
127829975|NCT00423085|459995459|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
127829976|NCT00423085|459995460|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
127829977|NCT00423085|459995461|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
127829978|NCT00423085|459995458|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
127829979|NCT00423085|459995459|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
127829980|NCT00423085|459995460|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
127829981|NCT00423085|459995461|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
127829982|NCT00423085|459995458|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
127829983|NCT00423085|459995459|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
127829984|NCT00423085|459995460|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
127829985|NCT00423085|459995461|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
127829986|NCT00423085|459995458|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
127829987|NCT00423085|459995459|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
127829988|NCT00423085|459995460|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
127829989|NCT00423085|459995461|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
127829990|NCT00423085|459995458|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
127829991|NCT00423085|459995459|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
127829992|NCT00423085|459995460|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
127829993|NCT00423085|459995461|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
127829994|NCT00423085|459995458|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
127829995|NCT00423085|459995459|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
127829996|NCT00423085|459995460|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
127829997|NCT00423085|459995461|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
127829998|NCT00423085|459995458|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
127829999|NCT00423085|459995459|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
127830000|NCT00423085|459995460|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
127830001|NCT00423085|459995461|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
127830002|NCT00423085|459995458|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
127830003|NCT00423085|459995459|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
127830004|NCT00423085|459995460|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
127830005|NCT00423085|459995461|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
127830006|NCT00423085|459995458|FG000|52-Week Open-Label Extension Phase|Death|0|||
127830007|NCT00423085|459995459|FG001|52-Week Open-Label Extension Phase|Death|0|||
127830008|NCT00423085|459995460|FG002|52-Week Open-Label Extension Phase|Death|0|||
127830009|NCT00423085|459995461|FG003|52-Week Open-Label Extension Phase|Death|2|||
127830010|NCT02163993|459995462|FG000|Treatment Period|Adverse Event|0|||
127830011|NCT02163993|459995463|FG001|Treatment Period|Adverse Event|1|||
127830012|NCT02163993|459995464|FG002|Treatment Period|Adverse Event|0|||
127830013|NCT02163993|459995465|FG003|Treatment Period|Adverse Event|0|||
127830014|NCT02163993|459995466|FG004|Treatment Period|Adverse Event|1|||
127830015|NCT02163993|459995462|FG000|Treatment Period|Lost to Follow-up|2|||
127830016|NCT02163993|459995463|FG001|Treatment Period|Lost to Follow-up|3|||
127830017|NCT02163993|459995464|FG002|Treatment Period|Lost to Follow-up|1|||
127830018|NCT02163993|459995465|FG003|Treatment Period|Lost to Follow-up|3|||
127830019|NCT02163993|459995466|FG004|Treatment Period|Lost to Follow-up|1|||
127830020|NCT02163993|459995462|FG000|Treatment Period|Physician Decision|1|||
127830021|NCT02163993|459995463|FG001|Treatment Period|Physician Decision|0|||
127830022|NCT02163993|459995464|FG002|Treatment Period|Physician Decision|0|||
127830023|NCT02163993|459995465|FG003|Treatment Period|Physician Decision|0|||
127830024|NCT02163993|459995466|FG004|Treatment Period|Physician Decision|0|||
127830025|NCT02163993|459995462|FG000|Treatment Period|Protocol Violation|2|||
127830026|NCT02163993|459995463|FG001|Treatment Period|Protocol Violation|1|||
127830027|NCT02163993|459995464|FG002|Treatment Period|Protocol Violation|0|||
127830028|NCT02163993|459995465|FG003|Treatment Period|Protocol Violation|1|||
127830029|NCT02163993|459995466|FG004|Treatment Period|Protocol Violation|2|||
127830030|NCT02163993|459995462|FG000|Treatment Period|Withdrawal by Subject|6|||
127830031|NCT02163993|459995463|FG001|Treatment Period|Withdrawal by Subject|4|||
127830032|NCT02163993|459995464|FG002|Treatment Period|Withdrawal by Subject|1|||
127830033|NCT02163993|459995465|FG003|Treatment Period|Withdrawal by Subject|4|||
127830034|NCT02163993|459995466|FG004|Treatment Period|Withdrawal by Subject|1|||
127830035|NCT02163993|459995462|FG000|Treatment Period|Not treated|1|||
127830036|NCT02163993|459995463|FG001|Treatment Period|Not treated|0|||
127830037|NCT02163993|459995464|FG002|Treatment Period|Not treated|0|||
127894967|NCT00947427|460238597|FG000|Overall Study|Withdrawal by Subject|1|||
127830038|NCT02163993|459995465|FG003|Treatment Period|Not treated|1|||
127830039|NCT02163993|459995466|FG004|Treatment Period|Not treated|2|||
127830040|NCT02163993|459995462|FG000|Post-treatment Period|Adverse Event|0|||
127830041|NCT02163993|459995463|FG001|Post-treatment Period|Adverse Event|0|||
127830042|NCT02163993|459995464|FG002|Post-treatment Period|Adverse Event|1|||
127830043|NCT02163993|459995465|FG003|Post-treatment Period|Adverse Event|0|||
127830044|NCT02163993|459995466|FG004|Post-treatment Period|Adverse Event|0|||
127830045|NCT02163993|459995462|FG000|Post-treatment Period|Lost to Follow-up|2|||
127830046|NCT02163993|459995463|FG001|Post-treatment Period|Lost to Follow-up|2|||
127830047|NCT02163993|459995464|FG002|Post-treatment Period|Lost to Follow-up|3|||
127830048|NCT02163993|459995465|FG003|Post-treatment Period|Lost to Follow-up|1|||
127830049|NCT02163993|459995466|FG004|Post-treatment Period|Lost to Follow-up|0|||
127830050|NCT02163993|459995462|FG000|Post-treatment Period|Protocol Violation|0|||
127830051|NCT02163993|459995463|FG001|Post-treatment Period|Protocol Violation|0|||
127830052|NCT02163993|459995464|FG002|Post-treatment Period|Protocol Violation|0|||
127830053|NCT02163993|459995465|FG003|Post-treatment Period|Protocol Violation|0|||
127830054|NCT02163993|459995466|FG004|Post-treatment Period|Protocol Violation|1|||
127830055|NCT02163993|459995462|FG000|Post-treatment Period|Withdrawal by Subject|2|||
127830056|NCT02163993|459995463|FG001|Post-treatment Period|Withdrawal by Subject|4|||
127830057|NCT02163993|459995464|FG002|Post-treatment Period|Withdrawal by Subject|0|||
127830058|NCT02163993|459995465|FG003|Post-treatment Period|Withdrawal by Subject|1|||
127830059|NCT02163993|459995466|FG004|Post-treatment Period|Withdrawal by Subject|2|||
127830060|NCT00853489|459995467|FG000|Overall Study|Lost to Follow-up|5|||
127830061|NCT00853489|459995468|FG001|Overall Study|Lost to Follow-up|2|||
127830062|NCT05525975|459995469|FG000|Overall Study|Surgery cancellation|4|||
127830063|NCT05525975|459995470|FG001|Overall Study|Surgery cancellation|5|||
127830064|NCT05525975|459995469|FG000|Overall Study|didn't fill prescription|1|||
127830065|NCT05525975|459995470|FG001|Overall Study|didn't fill prescription|0|||
127830066|NCT05525975|459995469|FG000|Overall Study|Withdrawal by Subject|0|||
127830067|NCT05525975|459995470|FG001|Overall Study|Withdrawal by Subject|3|||
127830068|NCT02273752|459995472|FG000|Overall Study|Trial was terminated early|2|||
127830069|NCT02808312|459995473|FG000|Overall Study|Enrolled but Never Treated|0|||
127830070|NCT02808312|459995474|FG001|Overall Study|Enrolled but Never Treated|0|||
127830071|NCT02808312|459995475|FG002|Overall Study|Enrolled but Never Treated|1|||
127830072|NCT02808312|459995476|FG003|Overall Study|Enrolled but Never Treated|0|||
127830073|NCT02808312|459995477|FG004|Overall Study|Enrolled but Never Treated|0|||
127830074|NCT01623531|459995481|FG000|Overall Study|Death|1|||
127830075|NCT01623531|459995482|FG001|Overall Study|Death|0|||
127830076|NCT01623531|459995481|FG000|Overall Study|Protocol Violation|2|||
127830077|NCT01623531|459995482|FG001|Overall Study|Protocol Violation|1|||
127830078|NCT01623531|459995481|FG000|Overall Study|Missing data at primary outcome time poi|1|||
127830079|NCT01623531|459995482|FG001|Overall Study|Missing data at primary outcome time poi|1|||
127830080|NCT01429792|459995483|FG000|Overall Study|Other Reasons|67|||
127830081|NCT01429792|459995483|FG000|Overall Study|Unknown Disposition|94|||
127830082|NCT01429792|459995483|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
127830083|NCT01429792|459995483|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
127830084|NCT01429792|459995483|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
127830085|NCT01429792|459995483|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
127830086|NCT01429792|459995483|FG000|Overall Study|Withdrawal by Subject|70|||
127830087|NCT01429792|459995483|FG000|Overall Study|Lost to Follow-up|88|||
127830088|NCT04184622|459995485|FG000|Primary Treatment Period|Adverse Event|6|||
127830089|NCT04184622|459995486|FG001|Primary Treatment Period|Adverse Event|4|||
127830090|NCT04184622|459995487|FG002|Primary Treatment Period|Adverse Event|8|||
127830091|NCT04184622|459995488|FG003|Primary Treatment Period|Adverse Event|6|||
127830092|NCT04184622|459995485|FG000|Primary Treatment Period|Death|4|||
127830093|NCT04184622|459995486|FG001|Primary Treatment Period|Death|4|||
127830094|NCT04184622|459995487|FG002|Primary Treatment Period|Death|2|||
127830095|NCT04184622|459995488|FG003|Primary Treatment Period|Death|1|||
127830096|NCT04184622|459995485|FG000|Primary Treatment Period|Lost to Follow-up|41|||
127830097|NCT04184622|459995486|FG001|Primary Treatment Period|Lost to Follow-up|17|||
127830098|NCT04184622|459995487|FG002|Primary Treatment Period|Lost to Follow-up|15|||
127830099|NCT04184622|459995488|FG003|Primary Treatment Period|Lost to Follow-up|13|||
127830100|NCT04184622|459995485|FG000|Primary Treatment Period|Other - as reported by the investigator|21|||
127830101|NCT04184622|459995486|FG001|Primary Treatment Period|Other - as reported by the investigator|7|||
127830102|NCT04184622|459995487|FG002|Primary Treatment Period|Other - as reported by the investigator|6|||
127830103|NCT04184622|459995488|FG003|Primary Treatment Period|Other - as reported by the investigator|12|||
127830104|NCT04184622|459995485|FG000|Primary Treatment Period|Physician Decision|0|||
127830105|NCT04184622|459995486|FG001|Primary Treatment Period|Physician Decision|0|||
127830106|NCT04184622|459995487|FG002|Primary Treatment Period|Physician Decision|3|||
127830107|NCT04184622|459995488|FG003|Primary Treatment Period|Physician Decision|1|||
127830108|NCT04184622|459995485|FG000|Primary Treatment Period|Pregnancy|4|||
127830109|NCT04184622|459995486|FG001|Primary Treatment Period|Pregnancy|3|||
127830110|NCT04184622|459995487|FG002|Primary Treatment Period|Pregnancy|4|||
127830111|NCT04184622|459995488|FG003|Primary Treatment Period|Pregnancy|1|||
127830112|NCT04184622|459995485|FG000|Primary Treatment Period|Withdrawal by Subject|58|||
127830113|NCT04184622|459995486|FG001|Primary Treatment Period|Withdrawal by Subject|26|||
127830114|NCT04184622|459995487|FG002|Primary Treatment Period|Withdrawal by Subject|32|||
127830115|NCT04184622|459995488|FG003|Primary Treatment Period|Withdrawal by Subject|21|||
127830116|NCT04184622|459995485|FG000|Additional Treatment Period|Adverse Event|1|||
127830117|NCT04184622|459995486|FG001|Additional Treatment Period|Adverse Event|2|||
127830118|NCT04184622|459995487|FG002|Additional Treatment Period|Adverse Event|1|||
127830119|NCT04184622|459995488|FG003|Additional Treatment Period|Adverse Event|0|||
127830120|NCT04184622|459995485|FG000|Additional Treatment Period|Death|0|||
127830121|NCT04184622|459995486|FG001|Additional Treatment Period|Death|0|||
127830122|NCT04184622|459995487|FG002|Additional Treatment Period|Death|1|||
127830123|NCT04184622|459995488|FG003|Additional Treatment Period|Death|1|||
127830124|NCT04184622|459995485|FG000|Additional Treatment Period|Lost to Follow-up|6|||
127830125|NCT04184622|459995486|FG001|Additional Treatment Period|Lost to Follow-up|4|||
127830126|NCT04184622|459995487|FG002|Additional Treatment Period|Lost to Follow-up|8|||
127830127|NCT04184622|459995488|FG003|Additional Treatment Period|Lost to Follow-up|6|||
127830128|NCT04184622|459995485|FG000|Additional Treatment Period|Other - as reported by the investigator|2|||
127830129|NCT04184622|459995486|FG001|Additional Treatment Period|Other - as reported by the investigator|5|||
127830130|NCT04184622|459995487|FG002|Additional Treatment Period|Other - as reported by the investigator|2|||
127830131|NCT04184622|459995488|FG003|Additional Treatment Period|Other - as reported by the investigator|0|||
127830132|NCT04184622|459995485|FG000|Additional Treatment Period|Physician Decision|0|||
127830133|NCT04184622|459995486|FG001|Additional Treatment Period|Physician Decision|0|||
127830134|NCT04184622|459995487|FG002|Additional Treatment Period|Physician Decision|1|||
127830135|NCT04184622|459995488|FG003|Additional Treatment Period|Physician Decision|0|||
127830136|NCT04184622|459995485|FG000|Additional Treatment Period|Pregnancy|0|||
127830137|NCT04184622|459995486|FG001|Additional Treatment Period|Pregnancy|0|||
127830138|NCT04184622|459995487|FG002|Additional Treatment Period|Pregnancy|0|||
127830139|NCT04184622|459995488|FG003|Additional Treatment Period|Pregnancy|1|||
127830140|NCT04184622|459995485|FG000|Additional Treatment Period|Protocol deviation|0|||
127830141|NCT04184622|459995486|FG001|Additional Treatment Period|Protocol deviation|0|||
127830142|NCT04184622|459995487|FG002|Additional Treatment Period|Protocol deviation|1|||
127830143|NCT04184622|459995488|FG003|Additional Treatment Period|Protocol deviation|0|||
127830144|NCT04184622|459995485|FG000|Additional Treatment Period|Site closed|1|||
127830145|NCT04184622|459995486|FG001|Additional Treatment Period|Site closed|0|||
127830146|NCT04184622|459995487|FG002|Additional Treatment Period|Site closed|1|||
127830147|NCT04184622|459995488|FG003|Additional Treatment Period|Site closed|0|||
127830148|NCT04184622|459995485|FG000|Additional Treatment Period|Withdrawal by Subject|21|||
127830149|NCT04184622|459995486|FG001|Additional Treatment Period|Withdrawal by Subject|15|||
127830150|NCT04184622|459995487|FG002|Additional Treatment Period|Withdrawal by Subject|3|||
127830151|NCT04184622|459995488|FG003|Additional Treatment Period|Withdrawal by Subject|7|||
127830152|NCT04184622|459995485|FG000|Safety Follow-up Period|Adverse Event|6|||
127830153|NCT04184622|459995486|FG001|Safety Follow-up Period|Adverse Event|8|||
127830154|NCT04184622|459995487|FG002|Safety Follow-up Period|Adverse Event|9|||
127830155|NCT04184622|459995488|FG003|Safety Follow-up Period|Adverse Event|16|||
127830156|NCT04184622|459995485|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
127830157|NCT04184622|459995486|FG001|Safety Follow-up Period|Lost to Follow-up|4|||
127830158|NCT04184622|459995487|FG002|Safety Follow-up Period|Lost to Follow-up|10|||
127830159|NCT04184622|459995488|FG003|Safety Follow-up Period|Lost to Follow-up|3|||
127830160|NCT04184622|459995485|FG000|Safety Follow-up Period|Missing Weight at Week 176|3|||
127830161|NCT04184622|459995486|FG001|Safety Follow-up Period|Missing Weight at Week 176|2|||
127830162|NCT04184622|459995487|FG002|Safety Follow-up Period|Missing Weight at Week 176|2|||
127830163|NCT04184622|459995488|FG003|Safety Follow-up Period|Missing Weight at Week 176|2|||
127830164|NCT04184622|459995485|FG000|Safety Follow-up Period|Other - as reported by the investigator|10|||
127830165|NCT04184622|459995486|FG001|Safety Follow-up Period|Other - as reported by the investigator|5|||
127830166|NCT04184622|459995487|FG002|Safety Follow-up Period|Other - as reported by the investigator|6|||
127830167|NCT04184622|459995488|FG003|Safety Follow-up Period|Other - as reported by the investigator|5|||
127830168|NCT04184622|459995485|FG000|Safety Follow-up Period|Physician Decision|1|||
127830169|NCT04184622|459995486|FG001|Safety Follow-up Period|Physician Decision|0|||
127830170|NCT04184622|459995487|FG002|Safety Follow-up Period|Physician Decision|0|||
127830171|NCT04184622|459995488|FG003|Safety Follow-up Period|Physician Decision|1|||
127830172|NCT04184622|459995485|FG000|Safety Follow-up Period|Pregnancy|1|||
127830173|NCT04184622|459995486|FG001|Safety Follow-up Period|Pregnancy|3|||
127830174|NCT04184622|459995487|FG002|Safety Follow-up Period|Pregnancy|0|||
127830175|NCT04184622|459995488|FG003|Safety Follow-up Period|Pregnancy|6|||
127830176|NCT04184622|459995485|FG000|Safety Follow-up Period|Protocol deviation|1|||
127830177|NCT04184622|459995486|FG001|Safety Follow-up Period|Protocol deviation|0|||
127830178|NCT04184622|459995487|FG002|Safety Follow-up Period|Protocol deviation|0|||
127830179|NCT04184622|459995488|FG003|Safety Follow-up Period|Protocol deviation|0|||
127830180|NCT04184622|459995485|FG000|Safety Follow-up Period|Withdrawal by Subject|31|||
127830181|NCT04184622|459995486|FG001|Safety Follow-up Period|Withdrawal by Subject|13|||
127830182|NCT04184622|459995487|FG002|Safety Follow-up Period|Withdrawal by Subject|7|||
127830183|NCT04184622|459995488|FG003|Safety Follow-up Period|Withdrawal by Subject|9|||
127830184|NCT00769704|459995489|FG000|Overall Study|Lost to Follow-up|3|||
127830185|NCT00769704|459995490|FG001|Overall Study|Lost to Follow-up|2|||
127830186|NCT00769704|459995489|FG000|Overall Study|Death|95|||
127830187|NCT00769704|459995490|FG001|Overall Study|Death|190|||
127830188|NCT00769704|459995489|FG000|Overall Study|Withdrawal by Subject|12|||
127830189|NCT00769704|459995490|FG001|Overall Study|Withdrawal by Subject|5|||
127830190|NCT00769704|459995489|FG000|Overall Study|Other|1|||
127830191|NCT00769704|459995490|FG001|Overall Study|Other|2|||
127830192|NCT01617681|459995493|FG000|Period 1 Double Blind|Adverse Event|2|||
127830193|NCT01617681|459995494|FG001|Period 1 Double Blind|Adverse Event|0|||
127830194|NCT01617681|459995495|FG002|Period 1 Double Blind|Adverse Event|0|||
127830195|NCT01617681|459995496|FG003|Period 1 Double Blind|Adverse Event|2|||
127830196|NCT01617681|459995497|FG004|Period 1 Double Blind|Adverse Event|0|||
127830197|NCT01617681|459995493|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
127830198|NCT01617681|459995494|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
127830199|NCT01617681|459995495|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
127830200|NCT01617681|459995496|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
127830201|NCT01617681|459995497|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
127830202|NCT01617681|459995493|FG000|Period 2 Open Label|Adverse Event|0|||
127830203|NCT01617681|459995494|FG001|Period 2 Open Label|Adverse Event|0|||
127830204|NCT01617681|459995495|FG002|Period 2 Open Label|Adverse Event|0|||
127830205|NCT01617681|459995496|FG003|Period 2 Open Label|Adverse Event|0|||
127830206|NCT01617681|459995497|FG004|Period 2 Open Label|Adverse Event|3|||
127830207|NCT01617681|459995493|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
127830208|NCT01617681|459995494|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
127830209|NCT01617681|459995495|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
127830210|NCT01617681|459995496|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
127830211|NCT01617681|459995497|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
127830212|NCT01763905|459995506|FG000|Overall Study|Withdrawal by Subject|1|||
127830213|NCT01763905|459995507|FG001|Overall Study|Withdrawal by Subject|1|||
127830214|NCT01763905|459995508|FG002|Overall Study|Withdrawal by Subject|0|||
127830215|NCT01763905|459995509|FG003|Overall Study|Withdrawal by Subject|1|||
127830216|NCT01763905|459995506|FG000|Overall Study|Decision by sponsor|5|||
127830217|NCT01763905|459995507|FG001|Overall Study|Decision by sponsor|0|||
127830218|NCT01763905|459995508|FG002|Overall Study|Decision by sponsor|8|||
127830219|NCT01763905|459995509|FG003|Overall Study|Decision by sponsor|0|||
127830220|NCT01763905|459995506|FG000|Overall Study|Lost to Follow-up|0|||
127830221|NCT01763905|459995507|FG001|Overall Study|Lost to Follow-up|0|||
127830222|NCT01763905|459995508|FG002|Overall Study|Lost to Follow-up|1|||
127830223|NCT01763905|459995509|FG003|Overall Study|Lost to Follow-up|0|||
127830224|NCT04346628|459995510|FG000|Overall Study|Lost to Follow-up|4|||
127830225|NCT04346628|459995511|FG001|Overall Study|Lost to Follow-up|4|||
127830226|NCT04346628|459995510|FG000|Overall Study|Withdrew (had personal reasons)|2|||
127830227|NCT04346628|459995511|FG001|Overall Study|Withdrew (had personal reasons)|5|||
127830228|NCT04346628|459995510|FG000|Overall Study|Withdrew (medication intolerant)|0|||
127830229|NCT04346628|459995511|FG001|Overall Study|Withdrew (medication intolerant)|3|||
127830230|NCT04346628|459995510|FG000|Overall Study|Withdrew (declined intervention)|0|||
127830231|NCT04346628|459995511|FG001|Overall Study|Withdrew (declined intervention)|1|||
127830232|NCT01028651|459995514|FG000|Overall Study|Death|2|||
127830233|NCT01028651|459995514|FG000|Overall Study|Adverse Event|1|||
127830234|NCT01554956|459995517|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
127830235|NCT01554956|459995518|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
127830236|NCT01554956|459995519|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
127830237|NCT01554956|459995517|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
127830238|NCT01554956|459995518|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
127830239|NCT01554956|459995519|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
127830240|NCT01554956|459995517|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
127830241|NCT01554956|459995518|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
127830242|NCT01554956|459995519|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
127830243|NCT00913978|459995520|FG000|Overall Study|Surgeon choice|1|||
127830244|NCT00913978|459995521|FG001|Overall Study|Surgeon choice|3|||
127830245|NCT01327651|459995525|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
127830246|NCT01327651|459995526|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
127830247|NCT01327651|459995527|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
127830248|NCT01327651|459995528|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
127830249|NCT01327651|459995529|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
127830250|NCT01327651|459995530|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
127830251|NCT01327651|459995531|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
127830252|NCT01327651|459995532|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
127830253|NCT01327651|459995533|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
127830254|NCT01327651|459995525|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
127830255|NCT01327651|459995526|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
127830256|NCT01327651|459995527|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
127830257|NCT01327651|459995528|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
127830258|NCT01327651|459995529|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
127830259|NCT01327651|459995530|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
127830260|NCT01327651|459995531|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
127830261|NCT01327651|459995532|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
127830262|NCT01327651|459995533|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
127830263|NCT01327651|459995525|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
127830264|NCT01327651|459995526|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
127830265|NCT01327651|459995527|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
127830266|NCT01327651|459995528|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
127830267|NCT01327651|459995529|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
127830268|NCT01327651|459995530|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
127830269|NCT01327651|459995531|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
127830270|NCT01327651|459995532|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
127830271|NCT01327651|459995533|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
127830272|NCT01327651|459995525|FG000|Post Study Follow-up|Lost to Follow-up|0|||
127830273|NCT01327651|459995526|FG001|Post Study Follow-up|Lost to Follow-up|1|||
127830274|NCT01327651|459995527|FG002|Post Study Follow-up|Lost to Follow-up|1|||
127830275|NCT01327651|459995528|FG003|Post Study Follow-up|Lost to Follow-up|0|||
127830276|NCT01327651|459995529|FG004|Post Study Follow-up|Lost to Follow-up|0|||
127830277|NCT01327651|459995530|FG005|Post Study Follow-up|Lost to Follow-up|0|||
127830278|NCT01327651|459995531|FG006|Post Study Follow-up|Lost to Follow-up|4|||
127830279|NCT01327651|459995532|FG007|Post Study Follow-up|Lost to Follow-up|1|||
127830280|NCT01327651|459995533|FG008|Post Study Follow-up|Lost to Follow-up|2|||
127830281|NCT04590937|459995537|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
127830282|NCT01635933|459995538|FG000|Overall Study|Adverse Event|1|||
127830283|NCT01635933|459995539|FG001|Overall Study|Adverse Event|0|||
127830284|NCT01635933|459995538|FG000|Overall Study|Lost to Follow-up|0|||
127830285|NCT01635933|459995539|FG001|Overall Study|Lost to Follow-up|5|||
127830286|NCT01635933|459995538|FG000|Overall Study|Subject decision|1|||
127830287|NCT01635933|459995539|FG001|Overall Study|Subject decision|1|||
127830288|NCT01635933|459995538|FG000|Overall Study|Noncompliance|0|||
127830289|NCT01635933|459995539|FG001|Overall Study|Noncompliance|1|||
127830290|NCT01635933|459995538|FG000|Overall Study|No longer had transportation|0|||
127830291|NCT01635933|459995539|FG001|Overall Study|No longer had transportation|1|||
127830292|NCT04743635|459995542|FG000|Overall Study|Lost to Follow-up|2|||
127830293|NCT04743635|459995543|FG001|Overall Study|Lost to Follow-up|0|||
127830294|NCT03382899|459995544|FG000|Overall Study|Ineligibility Determined|0|||
127830295|NCT03382899|459995545|FG001|Overall Study|Ineligibility Determined|1|||
127830296|NCT03382899|459995544|FG000|Overall Study|Lost to Follow-up|0|||
127830297|NCT03382899|459995545|FG001|Overall Study|Lost to Follow-up|1|||
127830298|NCT03382899|459995544|FG000|Overall Study|Sponsor's decision|31|||
127830299|NCT03382899|459995545|FG001|Overall Study|Sponsor's decision|28|||
127830300|NCT03382899|459995544|FG000|Overall Study|Withdrawal by Subject|0|||
127830301|NCT03382899|459995545|FG001|Overall Study|Withdrawal by Subject|5|||
127830302|NCT00540449|459995546|FG000|Overall Study|Adverse Event|12|||
127830303|NCT00540449|459995547|FG001|Overall Study|Adverse Event|32|||
127830304|NCT00540449|459995546|FG000|Overall Study|Sponsor's Decision|1|||
127830305|NCT00540449|459995547|FG001|Overall Study|Sponsor's Decision|1|||
127830306|NCT00540449|459995546|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
127830307|NCT00540449|459995547|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
127830308|NCT00540449|459995546|FG000|Overall Study|Lost to Follow-up|19|||
127830309|NCT00540449|459995547|FG001|Overall Study|Lost to Follow-up|17|||
127830310|NCT00540449|459995546|FG000|Overall Study|Subject Non-Compliant|7|||
127830311|NCT00540449|459995547|FG001|Overall Study|Subject Non-Compliant|5|||
127830312|NCT00540449|459995546|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
127830313|NCT00540449|459995547|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
127830314|NCT00540449|459995546|FG000|Overall Study|Withdrawal by Subject|10|||
127830315|NCT00540449|459995547|FG001|Overall Study|Withdrawal by Subject|10|||
127830316|NCT00540449|459995546|FG000|Overall Study|Other|1|||
127830317|NCT00540449|459995547|FG001|Overall Study|Other|4|||
127830318|NCT00601523|459995548|FG000|Overall Study|Adverse Event|42|||
127830319|NCT00601523|459995549|FG001|Overall Study|Adverse Event|14|||
127830320|NCT00601523|459995548|FG000|Overall Study|Lack of Efficacy|3|||
127830321|NCT00601523|459995549|FG001|Overall Study|Lack of Efficacy|0|||
127830322|NCT00601523|459995548|FG000|Overall Study|Protocol Violation|5|||
127830323|NCT00601523|459995549|FG001|Overall Study|Protocol Violation|1|||
127830324|NCT00601523|459995548|FG000|Overall Study|Lost to Follow-up|0|||
127830325|NCT00601523|459995549|FG001|Overall Study|Lost to Follow-up|1|||
127830326|NCT00601523|459995548|FG000|Overall Study|Withdrawal by Subject|18|||
127830327|NCT00601523|459995549|FG001|Overall Study|Withdrawal by Subject|9|||
127830328|NCT00601523|459995548|FG000|Overall Study|Other|9|||
127830329|NCT00601523|459995549|FG001|Overall Study|Other|1|||
127830330|NCT00524316|459995550|FG000|Overall Study|Withdrawal by Subject|2|||
127830331|NCT00524316|459995550|FG000|Overall Study|Adverse Event|7|||
127830332|NCT00524316|459995550|FG000|Overall Study|Disease Progression|7|||
127830333|NCT02426658|459995551|FG000|Overall Study|Withdrawal by Subject|1|||
127830334|NCT02426658|459995551|FG000|Overall Study|Patient expired before treatment|2|||
127830335|NCT01402284|459995554|FG000|Overall Study|Withdrawal consent|2|||
127830336|NCT01402284|459995554|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
127830337|NCT01402284|459995554|FG000|Overall Study|Physician Decision|1|||
127830338|NCT01402284|459995554|FG000|Overall Study|Disease progression on study|10|||
127830339|NCT01199263|459995555|FG000|Overall Study|Ineligible|0|||
127830340|NCT01199263|459995556|FG001|Overall Study|Ineligible|2|||
127830341|NCT01199263|459995555|FG000|Overall Study|Never Treated|6|||
127830342|NCT01199263|459995556|FG001|Overall Study|Never Treated|0|||
127830343|NCT02928406|459995557|FG000|Overall Study|Death|780|||
127830344|NCT02928406|459995557|FG000|Overall Study|Progressive disease|3|||
127830345|NCT02928406|459995557|FG000|Overall Study|Lost to Follow-up|49|||
127830346|NCT02928406|459995557|FG000|Overall Study|Non-compliance|2|||
127830347|NCT02928406|459995557|FG000|Overall Study|Withdrawal by Subject|40|||
127830348|NCT02928406|459995557|FG000|Overall Study|Study terminated by sponsor|57|||
127830349|NCT02928406|459995557|FG000|Overall Study|Physician Decision|1|||
127830350|NCT02928406|459995557|FG000|Overall Study|Various reasons|72|||
127830351|NCT03987620|459995558|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
127830352|NCT03987620|459995559|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
127830353|NCT03987620|459995558|FG000|Overall Study|Adverse Event|3|||
127830354|NCT03987620|459995559|FG001|Overall Study|Adverse Event|0|||
127830355|NCT03987620|459995558|FG000|Overall Study|Lost to Follow-up|1|||
127830356|NCT03987620|459995559|FG001|Overall Study|Lost to Follow-up|2|||
127830357|NCT03987620|459995558|FG000|Overall Study|Physician Decision|0|||
127830358|NCT03987620|459995559|FG001|Overall Study|Physician Decision|1|||
127830359|NCT03987620|459995558|FG000|Overall Study|Pregnancy|1|||
127830360|NCT03987620|459995559|FG001|Overall Study|Pregnancy|0|||
127830361|NCT03987620|459995558|FG000|Overall Study|Withdrawal by Subject|7|||
127830362|NCT03987620|459995559|FG001|Overall Study|Withdrawal by Subject|1|||
127830363|NCT03987620|459995558|FG000|Overall Study|Other|2|||
127830364|NCT03987620|459995559|FG001|Overall Study|Other|5|||
127830365|NCT02149836|459995560|FG000|Overall Study|Withdrawal by Subject|1|||
127830366|NCT01204658|459995564|FG000|Primary Phase|Adverse Event|0|||
127830367|NCT01204658|459995565|FG001|Primary Phase|Adverse Event|0|||
127830368|NCT01204658|459995566|FG002|Primary Phase|Adverse Event|1|||
127830369|NCT01204658|459995567|FG003|Primary Phase|Adverse Event|0|||
127830370|NCT04937816|459995568|FG000|Overall Study|Study drug stopped, reason missing|5|||
127830371|NCT04937816|459995569|FG001|Overall Study|Study drug stopped, reason missing|3|||
127830372|NCT04937816|459995570|FG002|Overall Study|Study drug stopped, reason missing|4|||
127830373|NCT04937816|459995571|FG003|Overall Study|Study drug stopped, reason missing|6|||
127830374|NCT04937816|459995572|FG004|Overall Study|Study drug stopped, reason missing|1|||
127830375|NCT04937816|459995573|FG005|Overall Study|Study drug stopped, reason missing|0|||
127830376|NCT04937816|459995574|FG006|Overall Study|Study drug stopped, reason missing|0|||
127830377|NCT04937816|459995568|FG000|Overall Study|Other than stated below|173|||
127830378|NCT04937816|459995569|FG001|Overall Study|Other than stated below|143|||
127830379|NCT04937816|459995570|FG002|Overall Study|Other than stated below|125|||
127830380|NCT04937816|459995571|FG003|Overall Study|Other than stated below|44|||
127830381|NCT04937816|459995572|FG004|Overall Study|Other than stated below|45|||
127830382|NCT04937816|459995573|FG005|Overall Study|Other than stated below|28|||
127830383|NCT04937816|459995574|FG006|Overall Study|Other than stated below|31|||
127830384|NCT04937816|459995568|FG000|Overall Study|Patient refusal to continue, not due to AE|172|||
127830385|NCT04937816|459995569|FG001|Overall Study|Patient refusal to continue, not due to AE|118|||
127830386|NCT04937816|459995570|FG002|Overall Study|Patient refusal to continue, not due to AE|122|||
127830387|NCT04937816|459995571|FG003|Overall Study|Patient refusal to continue, not due to AE|304|||
127830388|NCT04937816|459995572|FG004|Overall Study|Patient refusal to continue, not due to AE|284|||
127830389|NCT04937816|459995573|FG005|Overall Study|Patient refusal to continue, not due to AE|124|||
127830390|NCT04937816|459995574|FG006|Overall Study|Patient refusal to continue, not due to AE|92|||
127830391|NCT04937816|459995568|FG000|Overall Study|Lost to Follow-up|15|||
127830392|NCT04937816|459995569|FG001|Overall Study|Lost to Follow-up|9|||
127830393|NCT04937816|459995570|FG002|Overall Study|Lost to Follow-up|6|||
127830394|NCT04937816|459995571|FG003|Overall Study|Lost to Follow-up|6|||
127830395|NCT04937816|459995572|FG004|Overall Study|Lost to Follow-up|16|||
127830396|NCT04937816|459995573|FG005|Overall Study|Lost to Follow-up|11|||
127830397|NCT04937816|459995574|FG006|Overall Study|Lost to Follow-up|17|||
127830398|NCT04937816|459995568|FG000|Overall Study|Protocol Violation|15|||
127830399|NCT04937816|459995569|FG001|Overall Study|Protocol Violation|15|||
127830400|NCT04937816|459995570|FG002|Overall Study|Protocol Violation|12|||
127830401|NCT04937816|459995571|FG003|Overall Study|Protocol Violation|30|||
127830402|NCT04937816|459995572|FG004|Overall Study|Protocol Violation|24|||
127830403|NCT04937816|459995573|FG005|Overall Study|Protocol Violation|5|||
127830404|NCT04937816|459995574|FG006|Overall Study|Protocol Violation|5|||
127830405|NCT04937816|459995568|FG000|Overall Study|Adverse Event|303|||
127830406|NCT04937816|459995569|FG001|Overall Study|Adverse Event|267|||
127830407|NCT04937816|459995570|FG002|Overall Study|Adverse Event|273|||
127830408|NCT04937816|459995571|FG003|Overall Study|Adverse Event|553|||
127830409|NCT04937816|459995572|FG004|Overall Study|Adverse Event|575|||
127830410|NCT04937816|459995573|FG005|Overall Study|Adverse Event|343|||
127830411|NCT04937816|459995574|FG006|Overall Study|Adverse Event|337|||
127830412|NCT04937816|459995568|FG000|Overall Study|Not treated|4|||
127830413|NCT04937816|459995569|FG001|Overall Study|Not treated|2|||
127830414|NCT04937816|459995570|FG002|Overall Study|Not treated|2|||
127830415|NCT04937816|459995571|FG003|Overall Study|Not treated|2|||
127830416|NCT04937816|459995572|FG004|Overall Study|Not treated|1|||
127830417|NCT04937816|459995573|FG005|Overall Study|Not treated|4|||
127830418|NCT04937816|459995574|FG006|Overall Study|Not treated|0|||
127830419|NCT00977574|459995579|FG000|Overall Study|Never Treated|4|||
127830420|NCT00977574|459995580|FG001|Overall Study|Never Treated|2|||
127830421|NCT00977574|459995581|FG002|Overall Study|Never Treated|4|||
127830422|NCT05281523|459995582|FG000|Overall Study|Adverse Event|1|||
127830423|NCT05281523|459995583|FG001|Overall Study|Adverse Event|1|||
127830424|NCT05281523|459995582|FG000|Overall Study|Physician Decision|1|||
127830425|NCT05281523|459995583|FG001|Overall Study|Physician Decision|1|||
127830426|NCT05281523|459995582|FG000|Overall Study|Withdrawal by Subject|5|||
127830427|NCT05281523|459995583|FG001|Overall Study|Withdrawal by Subject|15|||
127830428|NCT05281523|459995582|FG000|Overall Study|GCP violations|3|||
127830429|NCT05281523|459995583|FG001|Overall Study|GCP violations|4|||
127830430|NCT05513391|459995584|FG000|Overall Study|Adverse Event|1|||
127830431|NCT05513391|459995585|FG001|Overall Study|Adverse Event|0|||
127830432|NCT05513391|459995584|FG000|Overall Study|Protocol Deviation|0|||
127830433|NCT05513391|459995585|FG001|Overall Study|Protocol Deviation|1|||
127830434|NCT05513391|459995584|FG000|Overall Study|Withdrawal by Subject|3|||
127830435|NCT05513391|459995585|FG001|Overall Study|Withdrawal by Subject|1|||
127830436|NCT05513391|459995584|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
127830437|NCT05513391|459995585|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
127830438|NCT05513391|459995584|FG000|Overall Study|Lost to Follow-up|0|||
127830439|NCT05513391|459995585|FG001|Overall Study|Lost to Follow-up|2|||
127830440|NCT05183867|459997606|FG000|Overall Study|Withdrawal by Subject|3|||
127830441|NCT05183867|459997607|FG001|Overall Study|Withdrawal by Subject|2|||
127830442|NCT05183867|459997608|FG002|Overall Study|Withdrawal by Subject|0|||
127830443|NCT04491877|459997611|FG000|Overall Study|Protocol Deviation|1|||
127830444|NCT04491877|459997612|FG001|Overall Study|Protocol Deviation|0|||
127830445|NCT04491877|459997613|FG002|Overall Study|Protocol Deviation|2|||
127830446|NCT04491877|459997614|FG003|Overall Study|Protocol Deviation|0|||
127830447|NCT04491877|459997615|FG004|Overall Study|Protocol Deviation|0|||
127830448|NCT04491877|459997616|FG005|Overall Study|Protocol Deviation|0|||
127830449|NCT04491877|459997617|FG006|Overall Study|Protocol Deviation|1|||
127830450|NCT04491877|459997618|FG007|Overall Study|Protocol Deviation|1|||
127830451|NCT04491877|459997619|FG008|Overall Study|Protocol Deviation|0|||
127830452|NCT04491877|459997611|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
127830453|NCT04491877|459997612|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
127830454|NCT04491877|459997613|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
127830455|NCT04491877|459997614|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
127830456|NCT04491877|459997615|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
127830457|NCT04491877|459997616|FG005|Overall Study|Withdrawal by Parent/Guardian|2|||
127830458|NCT04491877|459997617|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
127830459|NCT04491877|459997618|FG007|Overall Study|Withdrawal by Parent/Guardian|5|||
127830460|NCT04491877|459997619|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
127830461|NCT04491877|459997611|FG000|Overall Study|Lost to Follow-up|0|||
127830462|NCT04491877|459997612|FG001|Overall Study|Lost to Follow-up|2|||
127830463|NCT04491877|459997613|FG002|Overall Study|Lost to Follow-up|0|||
127830464|NCT04491877|459997614|FG003|Overall Study|Lost to Follow-up|0|||
127830465|NCT04491877|459997615|FG004|Overall Study|Lost to Follow-up|0|||
127830466|NCT04491877|459997616|FG005|Overall Study|Lost to Follow-up|0|||
127830467|NCT04491877|459997617|FG006|Overall Study|Lost to Follow-up|2|||
127830468|NCT04491877|459997618|FG007|Overall Study|Lost to Follow-up|1|||
127830469|NCT04491877|459997619|FG008|Overall Study|Lost to Follow-up|1|||
127830470|NCT00492856|459997624|FG000|Induction|Adverse Event|2|||
127830471|NCT00492856|459997625|FG001|Induction|Adverse Event|0|||
127830472|NCT00492856|459997626|FG002|Induction|Adverse Event|0|||
127830473|NCT00492856|459997627|FG003|Induction|Adverse Event|0|||
127830474|NCT00492856|459997624|FG000|Induction|Withdrawal by Subject|1|||
127830475|NCT00492856|459997625|FG001|Induction|Withdrawal by Subject|0|||
127830476|NCT00492856|459997626|FG002|Induction|Withdrawal by Subject|0|||
127830477|NCT00492856|459997627|FG003|Induction|Withdrawal by Subject|0|||
127830478|NCT00492856|459997624|FG000|Induction|Death|3|||
127830479|NCT00492856|459997625|FG001|Induction|Death|0|||
127830480|NCT00492856|459997626|FG002|Induction|Death|0|||
127830481|NCT00492856|459997627|FG003|Induction|Death|0|||
127830482|NCT00492856|459997624|FG000|Consolidation|Adverse Event|6|||
127830483|NCT00492856|459997625|FG001|Consolidation|Adverse Event|0|||
127830484|NCT00492856|459997626|FG002|Consolidation|Adverse Event|0|||
127830485|NCT00492856|459997627|FG003|Consolidation|Adverse Event|0|||
127830486|NCT00492856|459997624|FG000|Consolidation|Not protocol specified|2|||
127830487|NCT00492856|459997625|FG001|Consolidation|Not protocol specified|0|||
127830488|NCT00492856|459997626|FG002|Consolidation|Not protocol specified|0|||
127830489|NCT00492856|459997627|FG003|Consolidation|Not protocol specified|0|||
127830490|NCT00492856|459997624|FG000|Consolidation|Lost to Follow-up|1|||
127830491|NCT00492856|459997625|FG001|Consolidation|Lost to Follow-up|0|||
127830492|NCT00492856|459997626|FG002|Consolidation|Lost to Follow-up|0|||
127830493|NCT00492856|459997627|FG003|Consolidation|Lost to Follow-up|0|||
127830494|NCT00492856|459997624|FG000|Post-consolidation|Adverse Event|0|||
127830495|NCT00492856|459997625|FG001|Post-consolidation|Adverse Event|4|||
127830496|NCT00492856|459997626|FG002|Post-consolidation|Adverse Event|0|||
127830497|NCT00492856|459997627|FG003|Post-consolidation|Adverse Event|1|||
127830498|NCT00492856|459997624|FG000|Post-consolidation|Withdrawal by Subject|0|||
127830499|NCT00492856|459997625|FG001|Post-consolidation|Withdrawal by Subject|4|||
127830500|NCT00492856|459997626|FG002|Post-consolidation|Withdrawal by Subject|0|||
127830501|NCT00492856|459997627|FG003|Post-consolidation|Withdrawal by Subject|0|||
127830502|NCT00492856|459997624|FG000|Post-consolidation|Death|0|||
127830503|NCT00492856|459997625|FG001|Post-consolidation|Death|1|||
127830504|NCT00492856|459997626|FG002|Post-consolidation|Death|0|||
127830505|NCT00492856|459997627|FG003|Post-consolidation|Death|0|||
127830506|NCT00492856|459997624|FG000|Post-consolidation|Not protocol specified|0|||
127830507|NCT00492856|459997625|FG001|Post-consolidation|Not protocol specified|1|||
127830508|NCT00492856|459997626|FG002|Post-consolidation|Not protocol specified|0|||
127830509|NCT00492856|459997627|FG003|Post-consolidation|Not protocol specified|0|||
127830510|NCT00492856|459997624|FG000|Post-consolidation|Lost to Follow-up|0|||
127830511|NCT00492856|459997625|FG001|Post-consolidation|Lost to Follow-up|2|||
127830512|NCT00492856|459997626|FG002|Post-consolidation|Lost to Follow-up|0|||
127830513|NCT00492856|459997627|FG003|Post-consolidation|Lost to Follow-up|0|||
127830514|NCT00492856|459997624|FG000|Post-consolidation|Observation Arm|0|||
127830515|NCT00492856|459997625|FG001|Post-consolidation|Observation Arm|0|||
127830516|NCT00492856|459997626|FG002|Post-consolidation|Observation Arm|27|||
127830517|NCT00492856|459997627|FG003|Post-consolidation|Observation Arm|0|||
127830518|NCT01520324|459997628|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
127830519|NCT03488472|459997629|FG000|Overall Study|disease progression additional mets|1|||
127830520|NCT01998581|459997630|FG000|Overall Study|Refused repeat treatment|20|||
127830521|NCT01998581|459997631|FG001|Overall Study|Refused repeat treatment|4|||
127830522|NCT01998581|459997630|FG000|Overall Study|Protocol Violation|1|||
127830523|NCT01998581|459997631|FG001|Overall Study|Protocol Violation|0|||
127830524|NCT01998581|459997630|FG000|Overall Study|Withdrawal by Subject|8|||
127830525|NCT01998581|459997631|FG001|Overall Study|Withdrawal by Subject|1|||
127830526|NCT01998581|459997630|FG000|Overall Study|Lost to Follow-up|12|||
127830527|NCT01998581|459997631|FG001|Overall Study|Lost to Follow-up|4|||
127830528|NCT01998581|459997630|FG000|Overall Study|Adverse Event|1|||
127830529|NCT01998581|459997631|FG001|Overall Study|Adverse Event|1|||
127894968|NCT00947427|460238598|FG001|Overall Study|Withdrawal by Subject|3|||
127894969|NCT00947427|460238597|FG000|Overall Study|Protocol Violation|0|||
127894970|NCT00947427|460238598|FG001|Overall Study|Protocol Violation|1|||
127894971|NCT01937364|460238601|FG000|Overall Study|Adverse Event|2|||
127894972|NCT01937364|460238602|FG001|Overall Study|Adverse Event|1|||
127894973|NCT00936975|460238603|FG000|Overall Study|Withdrawal by Subject|1|||
127894974|NCT00936975|460238603|FG000|Overall Study|Disease progression|3|||
127894975|NCT00936975|460238603|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
127894976|NCT04104646|460238604|FG000|Overall Study|Withdrawal by Subject|1|||
127894977|NCT04104646|460238605|FG001|Overall Study|Withdrawal by Subject|1|||
127894978|NCT04104646|460238604|FG000|Overall Study|Lost to Follow-up|1|||
127894979|NCT04104646|460238605|FG001|Overall Study|Lost to Follow-up|0|||
127830530|NCT01998581|459997630|FG000|Overall Study|Other reasons|3|||
127830531|NCT01998581|459997631|FG001|Overall Study|Other reasons|2|||
127894980|NCT04104646|460238604|FG000|Overall Study|Physician Decision|2|||
127830532|NCT01998581|459997630|FG000|Overall Study|Randomized but withdrew before treatment|1|||
127830533|NCT01998581|459997631|FG001|Overall Study|Randomized but withdrew before treatment|0|||
127830534|NCT01251276|459997632|FG000|Overall Study|Protocol Violation|1|||
127830535|NCT01251276|459997633|FG001|Overall Study|Protocol Violation|0|||
127830536|NCT01251276|459997632|FG000|Overall Study|Lost to Follow-up|0|||
127830537|NCT01251276|459997633|FG001|Overall Study|Lost to Follow-up|1|||
127830538|NCT01345123|459997634|FG000|Overall Study|participants no longer with health plan|79|||
127830539|NCT01345123|459997635|FG001|Overall Study|participants no longer with health plan|85|||
127894981|NCT04104646|460238605|FG001|Overall Study|Physician Decision|0|||
127894982|NCT03271528|460238608|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
127894983|NCT03271528|460238609|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
127894984|NCT03271528|460238608|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
127894985|NCT03271528|460238609|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
127894986|NCT03271528|460238608|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
127894987|NCT03271528|460238609|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
127894988|NCT03271528|460238608|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
127894989|NCT03271528|460238609|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
127894990|NCT03271528|460238608|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
127894991|NCT03271528|460238609|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
127894992|NCT03271528|460238608|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
127894993|NCT03271528|460238609|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
127894994|NCT03271528|460238608|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
127894995|NCT03271528|460238609|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
127894996|NCT01873859|460238610|FG000|Overall Study|Withdrawal by Subject|0|||
127894997|NCT01873859|460238611|FG001|Overall Study|Withdrawal by Subject|4|||
127894998|NCT03977584|460238612|FG000|Overall Study|Reason not disclosed to prevent genetic unblinding|2|||
127894999|NCT03977584|460238613|FG001|Overall Study|Reason not disclosed to prevent genetic unblinding|0|||
127895000|NCT03977584|460238614|FG002|Overall Study|Reason not disclosed to prevent genetic unblinding|4|||
127895001|NCT03504852|460238618|FG000|Overall Study|Withdrawal of informed consent|2|||
127895002|NCT03504852|460238619|FG001|Overall Study|Withdrawal of informed consent|1|||
127895003|NCT03504852|460238620|FG002|Overall Study|Withdrawal of informed consent|0|||
127895004|NCT03504852|460238618|FG000|Overall Study|Withdrawal by Subject|5|||
127895005|NCT03504852|460238619|FG001|Overall Study|Withdrawal by Subject|5|||
127895006|NCT03504852|460238620|FG002|Overall Study|Withdrawal by Subject|1|||
127895007|NCT03504852|460238618|FG000|Overall Study|Lost to Follow-up|4|||
127895008|NCT03504852|460238619|FG001|Overall Study|Lost to Follow-up|1|||
127830540|NCT01345123|459997636|FG002|Overall Study|participants no longer with health plan|88|||
127830541|NCT00441441|459997640|FG000|Overall Study|Adverse Event|2|||
127830542|NCT00441441|459997641|FG001|Overall Study|Adverse Event|1|||
127830543|NCT00441441|459997640|FG000|Overall Study|Protocol Violation|4|||
127830544|NCT00441441|459997641|FG001|Overall Study|Protocol Violation|6|||
127830545|NCT00441441|459997640|FG000|Overall Study|Exacerbation of asthma|1|||
127830546|NCT00441441|459997641|FG001|Overall Study|Exacerbation of asthma|2|||
127830547|NCT00441441|459997640|FG000|Overall Study|Withdrawal by Subject|1|||
127830548|NCT00441441|459997641|FG001|Overall Study|Withdrawal by Subject|2|||
127830549|NCT00441441|459997640|FG000|Overall Study|Other|3|||
127830550|NCT00441441|459997641|FG001|Overall Study|Other|3|||
127830551|NCT00262080|459997642|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
127830552|NCT00262080|459997643|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
127830553|NCT00262080|459997644|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
127830554|NCT00262080|459997642|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
127830555|NCT00262080|459997643|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
127830556|NCT00262080|459997644|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
127830557|NCT00262080|459997642|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
127895009|NCT03504852|460238620|FG002|Overall Study|Lost to Follow-up|0|||
127830558|NCT00262080|459997643|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
127895010|NCT03504852|460238618|FG000|Overall Study|New therapy for study indication|1|||
127830559|NCT00262080|459997644|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
127830560|NCT00262080|459997642|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
127830561|NCT00262080|459997643|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
127830562|NCT00262080|459997644|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
127830563|NCT00262080|459997642|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
127830564|NCT00262080|459997643|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
127830565|NCT00262080|459997644|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
127830566|NCT00262080|459997642|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
127830567|NCT00262080|459997643|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
127830568|NCT00262080|459997644|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
127830569|NCT03100942|459997647|FG000|Randomized Treatment Period|Withdrew Consent|4|||
127830570|NCT03100942|459997648|FG001|Randomized Treatment Period|Withdrew Consent|5|||
127830571|NCT03100942|459997649|FG002|Randomized Treatment Period|Withdrew Consent|3|||
127830572|NCT03100942|459997650|FG003|Randomized Treatment Period|Withdrew Consent|3|||
127830573|NCT03100942|459997651|FG004|Randomized Treatment Period|Withdrew Consent|0|||
127830574|NCT03100942|459997652|FG005|Randomized Treatment Period|Withdrew Consent|0|||
127830575|NCT03100942|459997653|FG006|Randomized Treatment Period|Withdrew Consent|0|||
127830576|NCT03100942|459997647|FG000|Randomized Treatment Period|Adverse Event|5|||
127830577|NCT03100942|459997648|FG001|Randomized Treatment Period|Adverse Event|2|||
127830578|NCT03100942|459997649|FG002|Randomized Treatment Period|Adverse Event|1|||
127830579|NCT03100942|459997650|FG003|Randomized Treatment Period|Adverse Event|0|||
127830580|NCT03100942|459997651|FG004|Randomized Treatment Period|Adverse Event|0|||
127830581|NCT03100942|459997652|FG005|Randomized Treatment Period|Adverse Event|0|||
127830582|NCT03100942|459997653|FG006|Randomized Treatment Period|Adverse Event|0|||
127830583|NCT03100942|459997647|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
127830584|NCT03100942|459997648|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
127830585|NCT03100942|459997649|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
127830586|NCT03100942|459997650|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
127830587|NCT03100942|459997651|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
127830588|NCT03100942|459997652|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
127830589|NCT03100942|459997653|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
127830590|NCT03100942|459997647|FG000|Randomized Treatment Period|Protocol Violation|0|||
127830591|NCT03100942|459997648|FG001|Randomized Treatment Period|Protocol Violation|1|||
127830592|NCT03100942|459997649|FG002|Randomized Treatment Period|Protocol Violation|1|||
127830593|NCT03100942|459997650|FG003|Randomized Treatment Period|Protocol Violation|1|||
127830594|NCT03100942|459997651|FG004|Randomized Treatment Period|Protocol Violation|0|||
127830595|NCT03100942|459997652|FG005|Randomized Treatment Period|Protocol Violation|0|||
127830596|NCT03100942|459997653|FG006|Randomized Treatment Period|Protocol Violation|0|||
127830597|NCT03100942|459997647|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
127830598|NCT03100942|459997648|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
127830599|NCT03100942|459997649|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
127830600|NCT03100942|459997650|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
127830601|NCT03100942|459997651|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
127830602|NCT03100942|459997652|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
127830603|NCT03100942|459997653|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
127830604|NCT03100942|459997647|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
127830605|NCT03100942|459997648|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
127830606|NCT03100942|459997649|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
127830607|NCT03100942|459997650|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
127830608|NCT03100942|459997651|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
127830609|NCT03100942|459997652|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
127830610|NCT03100942|459997653|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
127830611|NCT03100942|459997647|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
127830612|NCT03100942|459997648|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
127830613|NCT03100942|459997649|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
127830614|NCT03100942|459997650|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
127830615|NCT03100942|459997651|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
127830616|NCT03100942|459997652|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
127830617|NCT03100942|459997653|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
127830618|NCT04009096|459997654|FG000|Overall Study|Withdrawal by Subject|0|||
127830619|NCT04009096|459997655|FG001|Overall Study|Withdrawal by Subject|7|||
127830620|NCT04009096|459997656|FG002|Overall Study|Withdrawal by Subject|0|||
127830621|NCT04009096|459997654|FG000|Overall Study|Physician Decision|0|||
127830622|NCT04009096|459997655|FG001|Overall Study|Physician Decision|1|||
127830623|NCT04009096|459997656|FG002|Overall Study|Physician Decision|0|||
127830624|NCT05151471|459997657|FG000|Overall Study|Adverse Event|21|||
127830625|NCT05151471|459997658|FG001|Overall Study|Adverse Event|16|||
127830626|NCT05151471|459997657|FG000|Overall Study|Death|1|||
127830627|NCT05151471|459997658|FG001|Overall Study|Death|0|||
127830628|NCT05151471|459997657|FG000|Overall Study|Lost to Follow-up|0|||
127830629|NCT05151471|459997658|FG001|Overall Study|Lost to Follow-up|1|||
127830630|NCT05151471|459997657|FG000|Overall Study|Withdrawal by Subject|7|||
127830631|NCT05151471|459997658|FG001|Overall Study|Withdrawal by Subject|9|||
127830632|NCT05151471|459997657|FG000|Overall Study|Study terminated by sponsor|49|||
127830633|NCT05151471|459997658|FG001|Overall Study|Study terminated by sponsor|47|||
127830634|NCT05151471|459997657|FG000|Overall Study|Other|2|||
127830635|NCT05151471|459997658|FG001|Overall Study|Other|1|||
127830636|NCT04263142|459997659|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
127830637|NCT04263142|459997660|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
127830638|NCT04263142|459997661|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
127830639|NCT04263142|459997662|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
127830640|NCT04263142|459997663|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
127830641|NCT04263142|459997659|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
127830642|NCT04263142|459997660|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
127830643|NCT04263142|459997661|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
127830644|NCT04263142|459997662|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
127830645|NCT04263142|459997663|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
127830646|NCT01428063|459997665|FG000|Overall Study|Lack of Efficacy|8|||
127830647|NCT01428063|459997666|FG001|Overall Study|Lack of Efficacy|4|||
127830648|NCT01428063|459997667|FG002|Overall Study|Lack of Efficacy|1|||
127830649|NCT01428063|459997665|FG000|Overall Study|Adverse Event|2|||
127830650|NCT01428063|459997666|FG001|Overall Study|Adverse Event|3|||
127830651|NCT01428063|459997667|FG002|Overall Study|Adverse Event|0|||
127830652|NCT01428063|459997665|FG000|Overall Study|Lost to Follow-up|0|||
127830653|NCT01428063|459997666|FG001|Overall Study|Lost to Follow-up|2|||
127830654|NCT01428063|459997667|FG002|Overall Study|Lost to Follow-up|0|||
127830655|NCT01428063|459997665|FG000|Overall Study|No longer meets study criteria|0|||
127830656|NCT01428063|459997666|FG001|Overall Study|No longer meets study criteria|1|||
127830657|NCT01428063|459997667|FG002|Overall Study|No longer meets study criteria|0|||
127830658|NCT02284906|459997668|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
127830659|NCT02284906|459997669|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
127830660|NCT02284906|459997670|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
127830661|NCT02284906|459997668|FG000|Overall Study|Major Protocol Deviation|0|||
127830662|NCT02284906|459997669|FG001|Overall Study|Major Protocol Deviation|1|||
127830663|NCT02284906|459997670|FG002|Overall Study|Major Protocol Deviation|0|||
127830664|NCT02284906|459997668|FG000|Overall Study|Voluntary Withdrawal|2|||
127830665|NCT02284906|459997669|FG001|Overall Study|Voluntary Withdrawal|4|||
127830666|NCT02284906|459997670|FG002|Overall Study|Voluntary Withdrawal|5|||
127830667|NCT02284906|459997668|FG000|Overall Study|Study Termination|0|||
127830668|NCT02284906|459997669|FG001|Overall Study|Study Termination|11|||
127830669|NCT02284906|459997670|FG002|Overall Study|Study Termination|14|||
127830670|NCT02284906|459997668|FG000|Overall Study|Reason not Specified|1|||
127830671|NCT02284906|459997669|FG001|Overall Study|Reason not Specified|1|||
127830672|NCT02284906|459997670|FG002|Overall Study|Reason not Specified|0|||
127830673|NCT00316303|459997671|FG000|Overall Study|Lost to Follow-up|11|||
127830674|NCT00316303|459997672|FG001|Overall Study|Lost to Follow-up|16|||
127830675|NCT00850759|459997673|FG000|Overall Study|Lost to Follow-up|7|||
127830676|NCT00850759|459997674|FG001|Overall Study|Lost to Follow-up|5|||
127830677|NCT00850759|459997675|FG002|Overall Study|Lost to Follow-up|5|||
127830678|NCT00850759|459997676|FG003|Overall Study|Lost to Follow-up|3|||
127830679|NCT00532948|459997677|FG000|Overall Study|Protocol Violation|1|||
127830680|NCT00532948|459997678|FG001|Overall Study|Protocol Violation|0|||
127830681|NCT00532948|459997679|FG002|Overall Study|Protocol Violation|0|||
127830682|NCT00532948|459997677|FG000|Overall Study|Death|3|||
127830683|NCT00532948|459997678|FG001|Overall Study|Death|3|||
127830684|NCT00532948|459997679|FG002|Overall Study|Death|4|||
127830685|NCT00532948|459997677|FG000|Overall Study|Violation of selection criteria at entry|0|||
127830686|NCT00532948|459997678|FG001|Overall Study|Violation of selection criteria at entry|1|||
127830687|NCT00532948|459997679|FG002|Overall Study|Violation of selection criteria at entry|0|||
127830688|NCT00532948|459997677|FG000|Overall Study|Failure to return|0|||
127830689|NCT00532948|459997678|FG001|Overall Study|Failure to return|1|||
127830690|NCT00532948|459997679|FG002|Overall Study|Failure to return|0|||
127830691|NCT01753076|459997680|FG000|Overall Study|Adverse Event|17|||
127830692|NCT01753076|459997681|FG001|Overall Study|Adverse Event|18|||
127830693|NCT01753076|459997680|FG000|Overall Study|Lack of Efficacy|3|||
127830694|NCT01753076|459997681|FG001|Overall Study|Lack of Efficacy|1|||
127830695|NCT01753076|459997680|FG000|Overall Study|Lost to Follow-up|2|||
127830696|NCT01753076|459997681|FG001|Overall Study|Lost to Follow-up|1|||
127830697|NCT01753076|459997680|FG000|Overall Study|Physician Decision|4|||
127830698|NCT01753076|459997681|FG001|Overall Study|Physician Decision|2|||
127830699|NCT01753076|459997680|FG000|Overall Study|Withdrawal by Subject|14|||
127830700|NCT01753076|459997681|FG001|Overall Study|Withdrawal by Subject|24|||
127830701|NCT01753076|459997680|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
127830702|NCT01753076|459997681|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
127830703|NCT02575079|459997682|FG000|Overall Study|Death|3|||
127830704|NCT02575079|459997683|FG001|Overall Study|Death|0|||
127830705|NCT02575079|459997682|FG000|Overall Study|Withdrawal by Subject|3|||
127830706|NCT02575079|459997683|FG001|Overall Study|Withdrawal by Subject|0|||
127830707|NCT02918266|459997684|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
127830708|NCT02918266|459997685|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
127830709|NCT02918266|459997686|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
127830710|NCT02918266|459997687|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
127830711|NCT02918266|459997688|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
127830712|NCT02918266|459997689|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
127830713|NCT02918266|459997690|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
127830714|NCT02918266|459997691|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
127830715|NCT02918266|459997692|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
127830716|NCT02918266|459997693|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
127830717|NCT02918266|459997694|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
127830718|NCT01259856|459997701|FG000|Overall Study|Adverse Event|12|||
127830719|NCT01259856|459997702|FG001|Overall Study|Adverse Event|9|||
127830720|NCT01259856|459997701|FG000|Overall Study|Death|0|||
127830721|NCT01259856|459997702|FG001|Overall Study|Death|1|||
127830722|NCT01259856|459997701|FG000|Overall Study|Lack of Efficacy|3|||
127830723|NCT01259856|459997702|FG001|Overall Study|Lack of Efficacy|1|||
127830724|NCT01259856|459997701|FG000|Overall Study|Lost to Follow-up|1|||
127830725|NCT01259856|459997702|FG001|Overall Study|Lost to Follow-up|1|||
127830726|NCT01259856|459997701|FG000|Overall Study|Physician Decision|2|||
127830727|NCT01259856|459997702|FG001|Overall Study|Physician Decision|1|||
127830728|NCT01259856|459997701|FG000|Overall Study|Withdrawal by Subject|9|||
127830729|NCT01259856|459997702|FG001|Overall Study|Withdrawal by Subject|10|||
127830730|NCT01259856|459997701|FG000|Overall Study|Treatment never started|0|||
127830731|NCT01259856|459997702|FG001|Overall Study|Treatment never started|6|||
127830732|NCT01259856|459997701|FG000|Overall Study|Study closure by sponsor|40|||
127830733|NCT01259856|459997702|FG001|Overall Study|Study closure by sponsor|41|||
127830734|NCT01259856|459997701|FG000|Overall Study|Patient developed other disease|0|||
127830735|NCT01259856|459997702|FG001|Overall Study|Patient developed other disease|1|||
127830736|NCT01259856|459997701|FG000|Overall Study|Transfer to another study|0|||
127830737|NCT01259856|459997702|FG001|Overall Study|Transfer to another study|1|||
127830738|NCT01259856|459997701|FG000|Overall Study|Unknown/missing|2|||
127830739|NCT01259856|459997702|FG001|Overall Study|Unknown/missing|2|||
127830740|NCT00788775|459997703|FG000|Overall Study|Progressive Disease|8|||
127830741|NCT00788775|459997704|FG001|Overall Study|Progressive Disease|6|||
127830742|NCT00788775|459997703|FG000|Overall Study|Withdrawal by Subject|0|||
127830743|NCT00788775|459997704|FG001|Overall Study|Withdrawal by Subject|2|||
127830744|NCT00788775|459997703|FG000|Overall Study|Patient Non-Compliance|1|||
127830745|NCT00788775|459997704|FG001|Overall Study|Patient Non-Compliance|0|||
127830746|NCT00788775|459997703|FG000|Overall Study|Patient's measurable disease resected.|1|||
127830747|NCT00788775|459997704|FG001|Overall Study|Patient's measurable disease resected.|0|||
127830748|NCT00578864|459997705|FG000|Overall Study|Death|1|||
127830749|NCT00578864|459997706|FG001|Overall Study|Death|0|||
127830750|NCT01253044|459997711|FG000|Overall Study|Lost to Follow-up|38|||
127830751|NCT01253044|459997712|FG001|Overall Study|Lost to Follow-up|29|||
127830752|NCT04060667|459997715|FG000|Overall Study|Lost to Follow-up|75|||
127830753|NCT04060667|459997716|FG001|Overall Study|Lost to Follow-up|10|||
127830754|NCT02702193|459997721|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
127830755|NCT02702193|459997722|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
127830756|NCT02702193|459997721|FG000|4 Month Follow up|Withdrawal by Subject|1|||
127895011|NCT03504852|460238619|FG001|Overall Study|New therapy for study indication|0|||
127895012|NCT03504852|460238620|FG002|Overall Study|New therapy for study indication|0|||
127830757|NCT02702193|459997722|FG001|4 Month Follow up|Withdrawal by Subject|0|||
127830758|NCT02702193|459997721|FG000|4 Month Follow up|Lost to Follow-up|17|||
127830759|NCT02702193|459997722|FG001|4 Month Follow up|Lost to Follow-up|18|||
127830760|NCT02702193|459997721|FG000|8 Month Follow up|Withdrawal by Subject|1|||
127830761|NCT02702193|459997722|FG001|8 Month Follow up|Withdrawal by Subject|0|||
127830762|NCT02702193|459997721|FG000|8 Month Follow up|Lost to Follow-up|14|||
127830763|NCT02702193|459997722|FG001|8 Month Follow up|Lost to Follow-up|18|||
127830764|NCT02702193|459997721|FG000|12 Month Follow up|Withdrawal by Subject|1|||
127830765|NCT02702193|459997722|FG001|12 Month Follow up|Withdrawal by Subject|0|||
127830766|NCT02702193|459997721|FG000|12 Month Follow up|Lost to Follow-up|16|||
127830767|NCT02702193|459997722|FG001|12 Month Follow up|Lost to Follow-up|18|||
127830768|NCT01201798|459997725|FG000|Overall Study|Adverse Event|2|||
127895013|NCT03504852|460238618|FG000|Overall Study|Lack of Efficacy|1|||
127830769|NCT01201798|459997726|FG001|Overall Study|Adverse Event|0|||
127830770|NCT01201798|459997725|FG000|Overall Study|Lost to Follow-up|3|||
127830771|NCT01201798|459997726|FG001|Overall Study|Lost to Follow-up|5|||
127895014|NCT03504852|460238619|FG001|Overall Study|Lack of Efficacy|2|||
127895015|NCT03504852|460238620|FG002|Overall Study|Lack of Efficacy|0|||
127895016|NCT03504852|460238618|FG000|Overall Study|Death|0|||
127895017|NCT03504852|460238619|FG001|Overall Study|Death|1|||
127895018|NCT03504852|460238620|FG002|Overall Study|Death|0|||
127895019|NCT03504852|460238618|FG000|Overall Study|Adverse Event|4|||
127895020|NCT03504852|460238619|FG001|Overall Study|Adverse Event|8|||
127895021|NCT03504852|460238620|FG002|Overall Study|Adverse Event|2|||
127895022|NCT01066052|460238621|FG000|Overall Study|Enrolled But Not Treated|3|||
127830772|NCT01201798|459997725|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
127830773|NCT01201798|459997726|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
127830774|NCT01201798|459997725|FG000|Overall Study|Noncompliance|1|||
127830775|NCT01201798|459997726|FG001|Overall Study|Noncompliance|0|||
127830776|NCT01201798|459997725|FG000|Overall Study|Protocol Violation|1|||
127830777|NCT01201798|459997726|FG001|Overall Study|Protocol Violation|1|||
127830778|NCT01201798|459997725|FG000|Overall Study|Treatment Failure|1|||
127830779|NCT01201798|459997726|FG001|Overall Study|Treatment Failure|8|||
127830780|NCT00525148|459997728|FG000|Overall Study|Other Adverse Event|3|||
127830781|NCT00525148|459997729|FG001|Overall Study|Other Adverse Event|5|||
127830782|NCT00525148|459997730|FG002|Overall Study|Other Adverse Event|1|||
127830783|NCT00525148|459997731|FG003|Overall Study|Other Adverse Event|8|||
127830784|NCT00525148|459997728|FG000|Overall Study|Progressive disease|18|||
127830785|NCT00525148|459997729|FG001|Overall Study|Progressive disease|30|||
127830786|NCT00525148|459997730|FG002|Overall Study|Progressive disease|6|||
127830787|NCT00525148|459997731|FG003|Overall Study|Progressive disease|49|||
127830788|NCT00525148|459997728|FG000|Overall Study|Refused continuation of study medication|0|||
127830789|NCT00525148|459997729|FG001|Overall Study|Refused continuation of study medication|2|||
127830790|NCT00525148|459997730|FG002|Overall Study|Refused continuation of study medication|0|||
127830791|NCT00525148|459997731|FG003|Overall Study|Refused continuation of study medication|1|||
127830792|NCT00525148|459997728|FG000|Overall Study|Other than stated|2|||
127830793|NCT00525148|459997729|FG001|Overall Study|Other than stated|1|||
127830794|NCT00525148|459997730|FG002|Overall Study|Other than stated|0|||
127830795|NCT00525148|459997731|FG003|Overall Study|Other than stated|3|||
127830796|NCT00114972|459997733|FG000|Overall Study|Withdrawal by Subject|40|||
127830797|NCT00114972|459997734|FG001|Overall Study|Withdrawal by Subject|7|||
127830798|NCT00114972|459997733|FG000|Overall Study|Lost to Follow-up|8|||
127830799|NCT00114972|459997734|FG001|Overall Study|Lost to Follow-up|5|||
127830800|NCT01425190|459997735|FG000|Overall Study|Full dose not consumed.|1|||
127830801|NCT01425190|459997736|FG001|Overall Study|Full dose not consumed.|0|||
127830802|NCT01425190|459997737|FG002|Overall Study|Full dose not consumed.|0|||
127830803|NCT01035255|459997738|FG000|Overall Study|Death|724|||
127830804|NCT01035255|459997739|FG001|Overall Study|Death|844|||
127830805|NCT01035255|459997738|FG000|Overall Study|Lost to Follow-up|2|||
127830806|NCT01035255|459997739|FG001|Overall Study|Lost to Follow-up|5|||
127830807|NCT01035255|459997738|FG000|Overall Study|patient's request|15|||
127830808|NCT01035255|459997739|FG001|Overall Study|patient's request|13|||
127830809|NCT03196297|459997740|FG000|Main Period|Withdrawal by Subject|4|||
127830810|NCT03196297|459997740|FG000|Extension Period|Withdrawal by Subject|1|||
127830811|NCT03196297|459997740|FG000|Extension Period|Lack of Efficacy|2|||
127830812|NCT02538666|459997741|FG000|Pre-Treatment|Disease progression|1|||
127830813|NCT02538666|459997742|FG001|Pre-Treatment|Disease progression|0|||
127830814|NCT02538666|459997743|FG002|Pre-Treatment|Disease progression|0|||
127830815|NCT02538666|459997741|FG000|Pre-Treatment|no longer meets study criteria|1|||
127830816|NCT02538666|459997742|FG001|Pre-Treatment|no longer meets study criteria|0|||
127830817|NCT02538666|459997743|FG002|Pre-Treatment|no longer meets study criteria|0|||
127830818|NCT02538666|459997741|FG000|Pre-Treatment|Withdrew Consent|0|||
127830819|NCT02538666|459997742|FG001|Pre-Treatment|Withdrew Consent|1|||
127830820|NCT02538666|459997743|FG002|Pre-Treatment|Withdrew Consent|1|||
127830821|NCT02538666|459997741|FG000|Treatment|Disease progression|270|||
127830822|NCT02538666|459997742|FG001|Treatment|Disease progression|227|||
127830823|NCT02538666|459997743|FG002|Treatment|Disease progression|165|||
127895023|NCT01066052|460238622|FG001|Overall Study|Enrolled But Not Treated|0|||
127895024|NCT02928848|460238623|FG000|Arm 2|Withdrawal by Subject|1|||
127895025|NCT02928848|460238624|FG001|Arm 2|Withdrawal by Subject|0|||
127830824|NCT02538666|459997741|FG000|Treatment|Study drug toxicity|1|||
127830825|NCT02538666|459997742|FG001|Treatment|Study drug toxicity|29|||
127830826|NCT02538666|459997743|FG002|Treatment|Study drug toxicity|92|||
127830827|NCT02538666|459997741|FG000|Treatment|Death|0|||
127830828|NCT02538666|459997742|FG001|Treatment|Death|2|||
127830829|NCT02538666|459997743|FG002|Treatment|Death|3|||
127830830|NCT02538666|459997741|FG000|Treatment|Adverse event unrelated to study drug|8|||
127830831|NCT02538666|459997742|FG001|Treatment|Adverse event unrelated to study drug|10|||
127830832|NCT02538666|459997743|FG002|Treatment|Adverse event unrelated to study drug|15|||
127830833|NCT02538666|459997741|FG000|Treatment|Participant request to discontinue study treatment|3|||
127830834|NCT02538666|459997742|FG001|Treatment|Participant request to discontinue study treatment|6|||
127830835|NCT02538666|459997743|FG002|Treatment|Participant request to discontinue study treatment|11|||
127830836|NCT02538666|459997741|FG000|Treatment|Participant withdrew consent|2|||
127830837|NCT02538666|459997742|FG001|Treatment|Participant withdrew consent|5|||
127830838|NCT02538666|459997743|FG002|Treatment|Participant withdrew consent|3|||
127830839|NCT02538666|459997741|FG000|Treatment|Lost to Follow-up|0|||
127830840|NCT02538666|459997742|FG001|Treatment|Lost to Follow-up|1|||
127830841|NCT02538666|459997743|FG002|Treatment|Lost to Follow-up|1|||
127830842|NCT02538666|459997741|FG000|Treatment|Maximum clinical benefit|4|||
127830843|NCT02538666|459997742|FG001|Treatment|Maximum clinical benefit|3|||
127830844|NCT02538666|459997743|FG002|Treatment|Maximum clinical benefit|4|||
127830845|NCT02538666|459997741|FG000|Treatment|Poor/non-compliance|0|||
127830846|NCT02538666|459997742|FG001|Treatment|Poor/non-compliance|1|||
127830847|NCT02538666|459997743|FG002|Treatment|Poor/non-compliance|0|||
127830848|NCT02538666|459997741|FG000|Treatment|Participant no longer meets study criteria|0|||
127830849|NCT02538666|459997742|FG001|Treatment|Participant no longer meets study criteria|2|||
127830850|NCT02538666|459997743|FG002|Treatment|Participant no longer meets study criteria|0|||
127830851|NCT02538666|459997741|FG000|Treatment|Administrative reason by sponsor|0|||
127830852|NCT02538666|459997742|FG001|Treatment|Administrative reason by sponsor|0|||
127830853|NCT02538666|459997743|FG002|Treatment|Administrative reason by sponsor|1|||
127830854|NCT02538666|459997741|FG000|Treatment|Other reasons|8|||
127830855|NCT02538666|459997742|FG001|Treatment|Other reasons|15|||
127830856|NCT02538666|459997743|FG002|Treatment|Other reasons|5|||
127830857|NCT02538666|459997741|FG000|Treatment|Not reported|2|||
127830858|NCT02538666|459997742|FG001|Treatment|Not reported|2|||
127830859|NCT02538666|459997743|FG002|Treatment|Not reported|2|||
127830860|NCT03345836|459997744|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
127830861|NCT03345836|459997745|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
127830862|NCT03345836|459997746|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
127830863|NCT03345836|459997747|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
127830864|NCT03345836|459997748|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
127830865|NCT03345836|459997749|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
127830866|NCT03345836|459997744|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
127830867|NCT03345836|459997745|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
127830868|NCT03345836|459997746|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
127830869|NCT03345836|459997747|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
127830870|NCT03345836|459997748|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
127830871|NCT03345836|459997749|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
127830872|NCT03345836|459997744|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
127830873|NCT03345836|459997745|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
127830874|NCT03345836|459997746|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
127830875|NCT03345836|459997747|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
127830876|NCT03345836|459997748|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
127830877|NCT03345836|459997749|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
127830878|NCT03345836|459997744|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
127830879|NCT03345836|459997745|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
127830880|NCT03345836|459997746|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
127830881|NCT03345836|459997747|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
127830882|NCT03345836|459997748|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
127830883|NCT03345836|459997749|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
127830884|NCT03345836|459997744|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
127830885|NCT03345836|459997745|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
127830886|NCT03345836|459997746|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
127830887|NCT03345836|459997747|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
127830888|NCT03345836|459997748|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
127830889|NCT03345836|459997749|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
127830890|NCT03345836|459997744|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
127830891|NCT03345836|459997745|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
127830892|NCT03345836|459997746|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
127830893|NCT03345836|459997747|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
127830894|NCT03345836|459997748|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
127830895|NCT03345836|459997749|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
127830896|NCT03345836|459997744|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
127830897|NCT03345836|459997745|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
127830898|NCT03345836|459997746|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
127830899|NCT03345836|459997747|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
127895026|NCT03850509|460238625|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
127895027|NCT03850509|460238626|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
127830900|NCT03345836|459997748|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
127830901|NCT03345836|459997749|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
127830902|NCT03345836|459997744|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
127830903|NCT03345836|459997745|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
127830904|NCT03345836|459997746|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
127830905|NCT03345836|459997747|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
127830906|NCT03345836|459997748|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
127830907|NCT03345836|459997749|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
127830908|NCT03345836|459997744|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
127830909|NCT03345836|459997745|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
127830910|NCT03345836|459997746|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
127830911|NCT03345836|459997747|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
127830912|NCT03345836|459997748|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
127830913|NCT03345836|459997749|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
127830914|NCT03345836|459997744|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
127830915|NCT03345836|459997745|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
127830916|NCT03345836|459997746|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
127895028|NCT00969332|460238627|FG000|Overall Study|Physician Decision|8|||
127830917|NCT03345836|459997747|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
127830918|NCT03345836|459997748|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
127830919|NCT03345836|459997749|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
127830920|NCT03345836|459997744|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
127830921|NCT03345836|459997745|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
127830922|NCT03345836|459997746|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
127830923|NCT03345836|459997747|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
127830924|NCT03345836|459997748|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
127830925|NCT03345836|459997749|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
127830926|NCT00829166|459997750|FG000|Overall Study|Death|305|||
127830927|NCT00829166|459997751|FG001|Overall Study|Death|333|||
127830928|NCT00829166|459997750|FG000|Overall Study|Lost to Follow-up|5|||
127830929|NCT00829166|459997751|FG001|Overall Study|Lost to Follow-up|4|||
127830930|NCT00829166|459997750|FG000|Overall Study|Physician's Decision|4|||
127830931|NCT00829166|459997751|FG001|Overall Study|Physician's Decision|3|||
127830932|NCT00829166|459997750|FG000|Overall Study|Subject's Decision|41|||
127830933|NCT00829166|459997751|FG001|Overall Study|Subject's Decision|55|||
127830934|NCT00829166|459997750|FG000|Overall Study|Sponsor's Decision|137|||
127830935|NCT00829166|459997751|FG001|Overall Study|Sponsor's Decision|98|||
127830936|NCT00829166|459997750|FG000|Overall Study|Reason Not Specified|3|||
127830937|NCT00829166|459997751|FG001|Overall Study|Reason Not Specified|3|||
127830938|NCT03510663|459997754|FG000|Overall Study|Withdrawal by Subject|0|||
127830939|NCT03510663|459997755|FG001|Overall Study|Withdrawal by Subject|1|||
127830940|NCT03510663|459997756|FG002|Overall Study|Withdrawal by Subject|0|||
127830941|NCT03510663|459997757|FG003|Overall Study|Withdrawal by Subject|0|||
127830942|NCT03510663|459997758|FG004|Overall Study|Withdrawal by Subject|0|||
127830943|NCT03510663|459997759|FG005|Overall Study|Withdrawal by Subject|0|||
127830944|NCT03510663|459997760|FG006|Overall Study|Withdrawal by Subject|0|||
127830945|NCT03510663|459997761|FG007|Overall Study|Withdrawal by Subject|0|||
127830946|NCT01555463|459997764|FG000|Treatment|Adverse Event|6|||
127830947|NCT01555463|459997765|FG001|Treatment|Adverse Event|12|||
127830948|NCT01555463|459997764|FG000|Treatment|Withdrawal by Subject|24|||
127830949|NCT01555463|459997765|FG001|Treatment|Withdrawal by Subject|36|||
127830950|NCT01555463|459997764|FG000|Treatment|Lost to Follow-up|28|||
127830951|NCT01555463|459997765|FG001|Treatment|Lost to Follow-up|23|||
127830952|NCT01555463|459997764|FG000|Treatment|Protocol Violation|4|||
127830953|NCT01555463|459997765|FG001|Treatment|Protocol Violation|5|||
127830954|NCT01555463|459997764|FG000|Treatment|Other reason|2|||
127830955|NCT01555463|459997765|FG001|Treatment|Other reason|3|||
127830956|NCT01555463|459997764|FG000|Follow up|Adverse Event|2|||
127830957|NCT01555463|459997765|FG001|Follow up|Adverse Event|5|||
127830958|NCT01555463|459997764|FG000|Follow up|Death|0|||
127830959|NCT01555463|459997765|FG001|Follow up|Death|1|||
127830960|NCT01555463|459997764|FG000|Follow up|Withdrawal by Subject|22|||
127830961|NCT01555463|459997765|FG001|Follow up|Withdrawal by Subject|22|||
127830962|NCT01555463|459997764|FG000|Follow up|Lost to Follow-up|9|||
127830963|NCT01555463|459997765|FG001|Follow up|Lost to Follow-up|10|||
127895029|NCT00969332|460238627|FG000|Overall Study|Withdrawal by Subject|3|||
127895030|NCT01835145|460238630|FG000|Overall Study|Ineligible prior to treatment|1|||
127895031|NCT01835145|460238631|FG001|Overall Study|Ineligible prior to treatment|0|||
127895032|NCT02729896|460238632|FG000|Overall Study|Death|0|||
127895033|NCT02729896|460238633|FG001|Overall Study|Death|2|||
127895034|NCT02729896|460238634|FG002|Overall Study|Death|13|||
127895035|NCT02729896|460238632|FG000|Overall Study|Lost to Follow-up|0|||
127830964|NCT01555463|459997764|FG000|Follow up|Protocol Violation|2|||
127830965|NCT01555463|459997765|FG001|Follow up|Protocol Violation|4|||
127830966|NCT01555463|459997764|FG000|Follow up|Other reason|3|||
127830967|NCT01555463|459997765|FG001|Follow up|Other reason|3|||
127830968|NCT02026271|459997766|FG000|Overall Study|Adverse Event|2|||
127830969|NCT02026271|459997767|FG001|Overall Study|Adverse Event|3|||
127830970|NCT02026271|459997768|FG002|Overall Study|Adverse Event|2|||
127830971|NCT02026271|459997769|FG003|Overall Study|Adverse Event|3|||
127830972|NCT02026271|459997770|FG004|Overall Study|Adverse Event|0|||
127895036|NCT02729896|460238633|FG001|Overall Study|Lost to Follow-up|2|||
127830973|NCT02026271|459997766|FG000|Overall Study|Withdrawal by Subject|0|||
127895037|NCT02729896|460238634|FG002|Overall Study|Lost to Follow-up|3|||
127895038|NCT02729896|460238632|FG000|Overall Study|Other|0|||
127895039|NCT02729896|460238633|FG001|Overall Study|Other|2|||
127830974|NCT02026271|459997767|FG001|Overall Study|Withdrawal by Subject|0|||
127830975|NCT02026271|459997768|FG002|Overall Study|Withdrawal by Subject|0|||
127830976|NCT02026271|459997769|FG003|Overall Study|Withdrawal by Subject|0|||
127830977|NCT02026271|459997770|FG004|Overall Study|Withdrawal by Subject|1|||
127830978|NCT04370028|459997771|FG000|Overall Study|Withdrawal by Subject|695|||
127830979|NCT04370028|459997771|FG000|Overall Study|Protocol Violation|9|||
127830980|NCT04370028|459997771|FG000|Overall Study|Adverse Event|3|||
127895040|NCT02729896|460238634|FG002|Overall Study|Other|0|||
127830981|NCT02213198|459997774|FG000|Baseline|No show for intake|7|||
127830982|NCT02213198|459997775|FG001|Baseline|No show for intake|9|||
127830983|NCT02213198|459997774|FG000|Baseline|Withdrawal by Subject|34|||
127830984|NCT02213198|459997775|FG001|Baseline|Withdrawal by Subject|11|||
127830985|NCT02213198|459997774|FG000|Baseline|transferred out of clinic|7|||
127830986|NCT02213198|459997775|FG001|Baseline|transferred out of clinic|9|||
127830987|NCT02213198|459997774|FG000|Baseline|Lost to Follow-up|40|||
127830988|NCT02213198|459997775|FG001|Baseline|Lost to Follow-up|21|||
127830989|NCT02213198|459997774|FG000|Baseline|incarcerated,violent|0|||
127830990|NCT02213198|459997775|FG001|Baseline|incarcerated,violent|1|||
127830991|NCT02213198|459997774|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
127830992|NCT02213198|459997775|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
127830993|NCT02213198|459997774|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
127830994|NCT02213198|459997775|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
127830995|NCT02213198|459997774|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
127830996|NCT02213198|459997775|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
127830997|NCT02213198|459997774|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
127830998|NCT02213198|459997775|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
127830999|NCT02213198|459997774|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
127831000|NCT02213198|459997775|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
127831001|NCT02213198|459997774|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
127831002|NCT02213198|459997775|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
127831003|NCT02689219|459997778|FG000|Overall Study|Death|1|||
127831004|NCT02689219|459997779|FG001|Overall Study|Death|1|||
127831005|NCT02689219|459997778|FG000|Overall Study|Disease Progression|10|||
127831006|NCT02689219|459997779|FG001|Overall Study|Disease Progression|6|||
127831007|NCT00905021|459997781|FG000|Overall Study|Adverse Event|2|||
127831008|NCT05513053|459997782|FG000|Overall Study|Lost to Follow-up|9|||
127831009|NCT05513053|459997783|FG001|Overall Study|Lost to Follow-up|11|||
127831010|NCT05513053|459997782|FG000|Overall Study|Withdrawal by parent/guardian|2|||
127831011|NCT05513053|459997783|FG001|Overall Study|Withdrawal by parent/guardian|0|||
127831012|NCT05513053|459997782|FG000|Overall Study|Withdrawal by Subject|2|||
127831013|NCT05513053|459997783|FG001|Overall Study|Withdrawal by Subject|9|||
127831014|NCT05513053|459997782|FG000|Overall Study|Protocol Violation|6|||
127831015|NCT05513053|459997783|FG001|Overall Study|Protocol Violation|3|||
127831016|NCT05513053|459997782|FG000|Overall Study|Adverse Event|0|||
127831017|NCT05513053|459997783|FG001|Overall Study|Adverse Event|2|||
127831018|NCT03484923|459999347|FG000|Overall Study|Adverse Event|3|||
127831019|NCT03484923|459999348|FG001|Overall Study|Adverse Event|3|||
127831020|NCT03484923|459999349|FG002|Overall Study|Adverse Event|5|||
127831021|NCT03484923|459999350|FG003|Overall Study|Adverse Event|11|||
127831022|NCT03484923|459999351|FG004|Overall Study|Adverse Event|1|||
127831023|NCT03484923|459999347|FG000|Overall Study|Death|2|||
127831024|NCT03484923|459999348|FG001|Overall Study|Death|2|||
127831025|NCT03484923|459999349|FG002|Overall Study|Death|3|||
127831026|NCT03484923|459999350|FG003|Overall Study|Death|0|||
127831027|NCT03484923|459999351|FG004|Overall Study|Death|1|||
127831028|NCT03484923|459999347|FG000|Overall Study|Physician Decision|6|||
127831029|NCT03484923|459999348|FG001|Overall Study|Physician Decision|7|||
127831030|NCT03484923|459999349|FG002|Overall Study|Physician Decision|6|||
127831031|NCT03484923|459999350|FG003|Overall Study|Physician Decision|3|||
127831032|NCT03484923|459999351|FG004|Overall Study|Physician Decision|2|||
127831033|NCT03484923|459999347|FG000|Overall Study|Progressive disease|33|||
127831034|NCT03484923|459999348|FG001|Overall Study|Progressive disease|28|||
127831035|NCT03484923|459999349|FG002|Overall Study|Progressive disease|26|||
127831036|NCT03484923|459999350|FG003|Overall Study|Progressive disease|30|||
127831037|NCT03484923|459999351|FG004|Overall Study|Progressive disease|16|||
127831038|NCT03484923|459999347|FG000|Overall Study|Subject Decision|1|||
127831039|NCT03484923|459999348|FG001|Overall Study|Subject Decision|3|||
127831040|NCT03484923|459999349|FG002|Overall Study|Subject Decision|3|||
127831041|NCT03484923|459999350|FG003|Overall Study|Subject Decision|0|||
127831042|NCT03484923|459999351|FG004|Overall Study|Subject Decision|1|||
127831043|NCT03165721|459999352|FG000|Overall Study|Refused further treatment|3|||
127831044|NCT03165721|459999353|FG001|Overall Study|Refused further treatment|0|||
127831045|NCT03165721|459999354|FG002|Overall Study|Refused further treatment|0|||
127831046|NCT03165721|459999352|FG000|Overall Study|Physician Decision|1|||
127831047|NCT03165721|459999353|FG001|Overall Study|Physician Decision|0|||
127831048|NCT03165721|459999354|FG002|Overall Study|Physician Decision|0|||
127831049|NCT01863849|459999356|FG000|Overall Study|Lost to Follow-up|1|||
127831050|NCT01863849|459999357|FG001|Overall Study|Lost to Follow-up|0|||
127831051|NCT01457118|459999358|FG000|Overall Study|Adverse Event|1|||
127831052|NCT01457118|459999359|FG001|Overall Study|Adverse Event|0|||
127831053|NCT01457118|459999360|FG002|Overall Study|Adverse Event|0|||
127831054|NCT01457118|459999361|FG003|Overall Study|Adverse Event|1|||
127831055|NCT01457118|459999358|FG000|Overall Study|Clinical Progression|0|||
127831056|NCT01457118|459999359|FG001|Overall Study|Clinical Progression|1|||
127831057|NCT01457118|459999360|FG002|Overall Study|Clinical Progression|0|||
127831058|NCT01457118|459999361|FG003|Overall Study|Clinical Progression|1|||
127831059|NCT01457118|459999358|FG000|Overall Study|Physician Decision|2|||
127831060|NCT01457118|459999359|FG001|Overall Study|Physician Decision|0|||
127831061|NCT01457118|459999360|FG002|Overall Study|Physician Decision|0|||
127831062|NCT01457118|459999361|FG003|Overall Study|Physician Decision|0|||
127831063|NCT01457118|459999358|FG000|Overall Study|Progressive Disease by RECIST|12|||
127831064|NCT01457118|459999359|FG001|Overall Study|Progressive Disease by RECIST|3|||
127831065|NCT01457118|459999360|FG002|Overall Study|Progressive Disease by RECIST|1|||
127831066|NCT01457118|459999361|FG003|Overall Study|Progressive Disease by RECIST|0|||
127831067|NCT01457118|459999358|FG000|Overall Study|Withdrawal by Subject|5|||
127831068|NCT01457118|459999359|FG001|Overall Study|Withdrawal by Subject|0|||
127831069|NCT01457118|459999360|FG002|Overall Study|Withdrawal by Subject|0|||
127831070|NCT01457118|459999361|FG003|Overall Study|Withdrawal by Subject|0|||
127831071|NCT03456713|459999365|FG000|Overall Study|Lost to Follow-up|1|||
127831072|NCT03456713|459999366|FG001|Overall Study|Lost to Follow-up|0|||
127831073|NCT03456713|459999367|FG002|Overall Study|Lost to Follow-up|0|||
127831074|NCT03456713|459999368|FG003|Overall Study|Lost to Follow-up|0|||
127831075|NCT01263691|459999373|FG000|Overall Study|Lost to Follow-up|1|||
127831076|NCT01263691|459999374|FG001|Overall Study|Lost to Follow-up|0|||
127831077|NCT01263691|459999375|FG002|Overall Study|Lost to Follow-up|1|||
127831078|NCT01263691|459999376|FG003|Overall Study|Lost to Follow-up|1|||
127831079|NCT01263691|459999377|FG004|Overall Study|Lost to Follow-up|0|||
127831080|NCT01263691|459999378|FG005|Overall Study|Lost to Follow-up|0|||
127831081|NCT01263691|459999373|FG000|Overall Study|Withdrawal by Subject|1|||
127831082|NCT01263691|459999374|FG001|Overall Study|Withdrawal by Subject|0|||
127831083|NCT01263691|459999375|FG002|Overall Study|Withdrawal by Subject|0|||
127831084|NCT01263691|459999376|FG003|Overall Study|Withdrawal by Subject|0|||
127831085|NCT01263691|459999377|FG004|Overall Study|Withdrawal by Subject|0|||
127831086|NCT01263691|459999378|FG005|Overall Study|Withdrawal by Subject|0|||
127831087|NCT01263691|459999373|FG000|Overall Study|Adverse Event|1|||
127831088|NCT01263691|459999374|FG001|Overall Study|Adverse Event|0|||
127831089|NCT01263691|459999375|FG002|Overall Study|Adverse Event|0|||
127831090|NCT01263691|459999376|FG003|Overall Study|Adverse Event|0|||
127831091|NCT01263691|459999377|FG004|Overall Study|Adverse Event|0|||
127831092|NCT01263691|459999378|FG005|Overall Study|Adverse Event|0|||
127831093|NCT01202227|459999381|FG000|Overall Study|Adverse Event|16|||
127831094|NCT01202227|459999381|FG000|Overall Study|Withdrawal by Subject|2|||
127831095|NCT01202227|459999381|FG000|Overall Study|Lack of Efficacy|1|||
127831096|NCT00643487|459999382|FG000|Overall Study|Technical difficulty|3|||
127831097|NCT04402008|459999385|FG000|Overall Study|Adverse Event|0|||
127831098|NCT04402008|459999386|FG001|Overall Study|Adverse Event|0|||
127831099|NCT04402008|459999387|FG002|Overall Study|Adverse Event|0|||
127831100|NCT04402008|459999388|FG003|Overall Study|Adverse Event|1|||
127831101|NCT04402008|459999389|FG004|Overall Study|Adverse Event|0|||
127831102|NCT04402008|459999390|FG005|Overall Study|Adverse Event|0|||
127831103|NCT04402008|459999391|FG006|Overall Study|Adverse Event|0|||
127831104|NCT04402008|459999385|FG000|Overall Study|Disease Progression|3|||
127831105|NCT04402008|459999386|FG001|Overall Study|Disease Progression|2|||
127831106|NCT04402008|459999387|FG002|Overall Study|Disease Progression|3|||
127831107|NCT04402008|459999388|FG003|Overall Study|Disease Progression|3|||
127831108|NCT04402008|459999389|FG004|Overall Study|Disease Progression|4|||
127831109|NCT04402008|459999390|FG005|Overall Study|Disease Progression|3|||
127831110|NCT04402008|459999391|FG006|Overall Study|Disease Progression|10|||
127831111|NCT04402008|459999385|FG000|Overall Study|Withdrawal by Subject|0|||
127831112|NCT04402008|459999386|FG001|Overall Study|Withdrawal by Subject|1|||
127831113|NCT04402008|459999387|FG002|Overall Study|Withdrawal by Subject|0|||
127831114|NCT04402008|459999388|FG003|Overall Study|Withdrawal by Subject|0|||
127831115|NCT04402008|459999389|FG004|Overall Study|Withdrawal by Subject|1|||
127831116|NCT04402008|459999390|FG005|Overall Study|Withdrawal by Subject|0|||
127831117|NCT04402008|459999391|FG006|Overall Study|Withdrawal by Subject|0|||
127831118|NCT04402008|459999385|FG000|Overall Study|Sponsor Decision|0|||
127831119|NCT04402008|459999386|FG001|Overall Study|Sponsor Decision|0|||
127831120|NCT04402008|459999387|FG002|Overall Study|Sponsor Decision|0|||
127831121|NCT04402008|459999388|FG003|Overall Study|Sponsor Decision|0|||
127831122|NCT04402008|459999389|FG004|Overall Study|Sponsor Decision|0|||
127831123|NCT04402008|459999390|FG005|Overall Study|Sponsor Decision|0|||
127831124|NCT04402008|459999391|FG006|Overall Study|Sponsor Decision|3|||
127831125|NCT04402008|459999385|FG000|Overall Study|Death|0|||
127831126|NCT04402008|459999386|FG001|Overall Study|Death|0|||
127831127|NCT04402008|459999387|FG002|Overall Study|Death|0|||
127831128|NCT04402008|459999388|FG003|Overall Study|Death|0|||
127831129|NCT04402008|459999389|FG004|Overall Study|Death|1|||
127831130|NCT04402008|459999390|FG005|Overall Study|Death|0|||
127831131|NCT04402008|459999391|FG006|Overall Study|Death|2|||
127831132|NCT04402008|459999385|FG000|Overall Study|Other|0|||
127831133|NCT04402008|459999386|FG001|Overall Study|Other|0|||
127831134|NCT04402008|459999387|FG002|Overall Study|Other|0|||
127831135|NCT04402008|459999388|FG003|Overall Study|Other|0|||
127831136|NCT04402008|459999389|FG004|Overall Study|Other|0|||
127831137|NCT04402008|459999390|FG005|Overall Study|Other|0|||
127831138|NCT04402008|459999391|FG006|Overall Study|Other|5|||
127895041|NCT02729896|460238632|FG000|Overall Study|Physician Decision|1|||
127895042|NCT02729896|460238633|FG001|Overall Study|Physician Decision|2|||
127895043|NCT02729896|460238634|FG002|Overall Study|Physician Decision|3|||
127895044|NCT02729896|460238632|FG000|Overall Study|Progressive Disease|0|||
127895045|NCT02729896|460238633|FG001|Overall Study|Progressive Disease|1|||
127895046|NCT02729896|460238634|FG002|Overall Study|Progressive Disease|0|||
127895047|NCT02729896|460238632|FG000|Overall Study|Withdrawal by Subject|1|||
127895048|NCT02729896|460238633|FG001|Overall Study|Withdrawal by Subject|0|||
127895049|NCT02729896|460238634|FG002|Overall Study|Withdrawal by Subject|3|||
127895050|NCT00582309|460238635|FG000|Overall Study|Protocol Violation|0|||
127895051|NCT00582309|460238636|FG001|Overall Study|Protocol Violation|0|||
127895052|NCT00582309|460238637|FG002|Overall Study|Protocol Violation|2|||
127895053|NCT01565083|460238638|FG000|Overall Study|Withdrawal by Subject|6|||
127831139|NCT00411788|459999393|FG000|Overall Study|Protocol Violation|1|||
127895054|NCT01565083|460238639|FG001|Overall Study|Withdrawal by Subject|4|||
127831140|NCT00411788|459999393|FG000|Overall Study|Adverse Event|1|||
127831141|NCT01533935|459999394|FG000|Overall Study|Adverse Event|5|||
127831142|NCT01533935|459999395|FG001|Overall Study|Adverse Event|7|||
127831143|NCT01533935|459999396|FG002|Overall Study|Adverse Event|1|||
127831144|NCT01533935|459999397|FG003|Overall Study|Adverse Event|5|||
127831145|NCT01533935|459999398|FG004|Overall Study|Adverse Event|3|||
127895055|NCT01565083|460238638|FG000|Overall Study|Lost to Follow-up|2|||
127895056|NCT01565083|460238639|FG001|Overall Study|Lost to Follow-up|7|||
127831146|NCT01533935|459999394|FG000|Overall Study|Protocol Violation|0|||
127831147|NCT01533935|459999395|FG001|Overall Study|Protocol Violation|2|||
127895057|NCT01565083|460238638|FG000|Overall Study|Death|22|||
127895058|NCT01565083|460238639|FG001|Overall Study|Death|23|||
127895059|NCT01565083|460238638|FG000|Overall Study|Other|3|||
127831148|NCT01533935|459999396|FG002|Overall Study|Protocol Violation|0|||
127831149|NCT01533935|459999397|FG003|Overall Study|Protocol Violation|0|||
127831150|NCT01533935|459999398|FG004|Overall Study|Protocol Violation|0|||
127831151|NCT01533935|459999394|FG000|Overall Study|Lost to Follow-up|0|||
127831152|NCT01533935|459999395|FG001|Overall Study|Lost to Follow-up|0|||
127831153|NCT01533935|459999396|FG002|Overall Study|Lost to Follow-up|1|||
127831154|NCT01533935|459999397|FG003|Overall Study|Lost to Follow-up|0|||
127831155|NCT01533935|459999398|FG004|Overall Study|Lost to Follow-up|0|||
127831156|NCT01533935|459999394|FG000|Overall Study|Withdrawal by Subject|0|||
127831157|NCT01533935|459999395|FG001|Overall Study|Withdrawal by Subject|4|||
127831158|NCT01533935|459999396|FG002|Overall Study|Withdrawal by Subject|5|||
127831159|NCT01533935|459999397|FG003|Overall Study|Withdrawal by Subject|2|||
127831160|NCT01533935|459999398|FG004|Overall Study|Withdrawal by Subject|4|||
127831161|NCT01533935|459999394|FG000|Overall Study|Other reason not defined above|1|||
127831162|NCT01533935|459999395|FG001|Overall Study|Other reason not defined above|0|||
127831163|NCT01533935|459999396|FG002|Overall Study|Other reason not defined above|1|||
127831164|NCT01533935|459999397|FG003|Overall Study|Other reason not defined above|0|||
127831165|NCT01533935|459999398|FG004|Overall Study|Other reason not defined above|1|||
127831166|NCT00879814|459999399|FG000|Overall Study|Adverse Event|0|||
127831167|NCT00879814|459999400|FG001|Overall Study|Adverse Event|1|||
127831168|NCT00879814|459999401|FG002|Overall Study|Adverse Event|0|||
127831169|NCT00879814|459999402|FG003|Overall Study|Adverse Event|0|||
127831170|NCT00879814|459999399|FG000|Overall Study|Lost to Follow-up|1|||
127831171|NCT00879814|459999400|FG001|Overall Study|Lost to Follow-up|0|||
127831172|NCT00879814|459999401|FG002|Overall Study|Lost to Follow-up|0|||
127831173|NCT00879814|459999402|FG003|Overall Study|Lost to Follow-up|2|||
127831174|NCT00879814|459999399|FG000|Overall Study|Participant Failed to Return|0|||
127831175|NCT00879814|459999400|FG001|Overall Study|Participant Failed to Return|0|||
127831176|NCT00879814|459999401|FG002|Overall Study|Participant Failed to Return|0|||
127831177|NCT00879814|459999402|FG003|Overall Study|Participant Failed to Return|1|||
127831178|NCT00879814|459999399|FG000|Overall Study|Withdrawal by Subject|3|||
127831179|NCT00879814|459999400|FG001|Overall Study|Withdrawal by Subject|1|||
127831180|NCT00879814|459999401|FG002|Overall Study|Withdrawal by Subject|1|||
127831181|NCT00879814|459999402|FG003|Overall Study|Withdrawal by Subject|2|||
127831182|NCT00879814|459999399|FG000|Overall Study|Physician Decision|0|||
127831183|NCT00879814|459999400|FG001|Overall Study|Physician Decision|0|||
127831184|NCT00879814|459999401|FG002|Overall Study|Physician Decision|1|||
127831185|NCT00879814|459999402|FG003|Overall Study|Physician Decision|0|||
127831186|NCT00879814|459999399|FG000|Overall Study|Other|0|||
127831187|NCT00879814|459999400|FG001|Overall Study|Other|0|||
127831188|NCT00879814|459999401|FG002|Overall Study|Other|1|||
127831189|NCT00879814|459999402|FG003|Overall Study|Other|0|||
127831190|NCT00630812|459999415|FG000|Randomisation to First Dose|Adverse Event|1|||
127831191|NCT00630812|459999416|FG001|Randomisation to First Dose|Adverse Event|1|||
127831192|NCT00630812|459999415|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
127831193|NCT00630812|459999416|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
127831194|NCT00630812|459999415|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
127831195|NCT00630812|459999416|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
127831196|NCT00630812|459999415|FG000|Randomisation to First Dose|Protocol Violation|4|||
127831197|NCT00630812|459999416|FG001|Randomisation to First Dose|Protocol Violation|1|||
127831198|NCT00630812|459999415|FG000|Double Blind Treatment Period|Adverse Event|13|||
127831199|NCT00630812|459999416|FG001|Double Blind Treatment Period|Adverse Event|5|||
127831200|NCT00630812|459999415|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
127831201|NCT00630812|459999416|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
127831202|NCT00630812|459999415|FG000|Double Blind Treatment Period|Physician Decision|2|||
127831203|NCT00630812|459999416|FG001|Double Blind Treatment Period|Physician Decision|1|||
127831204|NCT00630812|459999415|FG000|Double Blind Treatment Period|Protocol Violation|1|||
127831205|NCT00630812|459999416|FG001|Double Blind Treatment Period|Protocol Violation|0|||
127831206|NCT00630812|459999415|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
127831207|NCT00630812|459999416|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
127831208|NCT00630812|459999415|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
127831209|NCT00630812|459999416|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
127831210|NCT00630812|459999415|FG000|Double Blind Treatment Period|Non-compliance|0|||
127831211|NCT00630812|459999416|FG001|Double Blind Treatment Period|Non-compliance|1|||
127831212|NCT01219959|459999417|FG000|Overall Study|Adverse Event|6|||
127831213|NCT01219959|459999418|FG001|Overall Study|Adverse Event|14|||
127831214|NCT01219959|459999417|FG000|Overall Study|Physician Decision|0|||
127831215|NCT01219959|459999418|FG001|Overall Study|Physician Decision|4|||
127831216|NCT01219959|459999417|FG000|Overall Study|Withdrawal by Subject|0|||
127831217|NCT01219959|459999418|FG001|Overall Study|Withdrawal by Subject|2|||
127831218|NCT01219959|459999417|FG000|Overall Study|Renal Transplantation|0|||
127831219|NCT01219959|459999418|FG001|Overall Study|Renal Transplantation|3|||
127831220|NCT01219959|459999417|FG000|Overall Study|Other|1|||
127831221|NCT01219959|459999418|FG001|Overall Study|Other|0|||
127831222|NCT02935634|459999419|FG000|Randomization|Participant withdrew consent|0|||
127831223|NCT02935634|459999420|FG001|Randomization|Participant withdrew consent|1|||
127831224|NCT02935634|459999421|FG002|Randomization|Participant withdrew consent|0|||
127831225|NCT02935634|459999422|FG003|Randomization|Participant withdrew consent|0|||
127895060|NCT01565083|460238639|FG001|Overall Study|Other|5|||
127831226|NCT02935634|459999423|FG004|Randomization|Participant withdrew consent|0|||
127831227|NCT02935634|459999424|FG005|Randomization|Participant withdrew consent|0|||
127831228|NCT02935634|459999419|FG000|Randomization|Death|2|||
127831229|NCT02935634|459999420|FG001|Randomization|Death|1|||
127831230|NCT02935634|459999421|FG002|Randomization|Death|1|||
127831231|NCT02935634|459999422|FG003|Randomization|Death|0|||
127831232|NCT02935634|459999423|FG004|Randomization|Death|0|||
127831233|NCT02935634|459999424|FG005|Randomization|Death|0|||
127831234|NCT02935634|459999419|FG000|Randomization|Other reasons|0|||
127831235|NCT02935634|459999420|FG001|Randomization|Other reasons|2|||
127831236|NCT02935634|459999421|FG002|Randomization|Other reasons|2|||
127831237|NCT02935634|459999422|FG003|Randomization|Other reasons|0|||
127831238|NCT02935634|459999423|FG004|Randomization|Other reasons|0|||
127831239|NCT02935634|459999424|FG005|Randomization|Other reasons|0|||
127831240|NCT02935634|459999419|FG000|Treatment: Track 1|Disease progression|15|||
127831241|NCT02935634|459999420|FG001|Treatment: Track 1|Disease progression|17|||
127831242|NCT02935634|459999421|FG002|Treatment: Track 1|Disease progression|28|||
127831243|NCT02935634|459999422|FG003|Treatment: Track 1|Disease progression|4|||
127831244|NCT02935634|459999423|FG004|Treatment: Track 1|Disease progression|6|||
127831245|NCT02935634|459999424|FG005|Treatment: Track 1|Disease progression|2|||
127831246|NCT02935634|459999419|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
127831247|NCT02935634|459999420|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
127831248|NCT02935634|459999421|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
127831249|NCT02935634|459999422|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
127831250|NCT02935634|459999423|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
127831251|NCT02935634|459999424|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
127831252|NCT02935634|459999419|FG000|Treatment: Track 1|Lost to Follow-up|1|||
127831253|NCT02935634|459999420|FG001|Treatment: Track 1|Lost to Follow-up|0|||
127831254|NCT02935634|459999421|FG002|Treatment: Track 1|Lost to Follow-up|0|||
127831255|NCT02935634|459999422|FG003|Treatment: Track 1|Lost to Follow-up|0|||
127831256|NCT02935634|459999423|FG004|Treatment: Track 1|Lost to Follow-up|0|||
127831257|NCT02935634|459999424|FG005|Treatment: Track 1|Lost to Follow-up|0|||
127831258|NCT02935634|459999419|FG000|Treatment: Track 1|Study drug toxicity|2|||
127831259|NCT02935634|459999420|FG001|Treatment: Track 1|Study drug toxicity|1|||
127831260|NCT02935634|459999421|FG002|Treatment: Track 1|Study drug toxicity|3|||
127831261|NCT02935634|459999422|FG003|Treatment: Track 1|Study drug toxicity|0|||
127831262|NCT02935634|459999423|FG004|Treatment: Track 1|Study drug toxicity|0|||
127831263|NCT02935634|459999424|FG005|Treatment: Track 1|Study drug toxicity|1|||
127831264|NCT02935634|459999419|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
127831265|NCT02935634|459999420|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
127831266|NCT02935634|459999421|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
127831267|NCT02935634|459999422|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
127831268|NCT02935634|459999423|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
127831269|NCT02935634|459999424|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
127831270|NCT02935634|459999419|FG000|Treatment: Track 1|Participant withdrew consent|2|||
127831271|NCT02935634|459999420|FG001|Treatment: Track 1|Participant withdrew consent|0|||
127831272|NCT02935634|459999421|FG002|Treatment: Track 1|Participant withdrew consent|1|||
127831273|NCT02935634|459999422|FG003|Treatment: Track 1|Participant withdrew consent|0|||
127831274|NCT02935634|459999423|FG004|Treatment: Track 1|Participant withdrew consent|1|||
127831275|NCT02935634|459999424|FG005|Treatment: Track 1|Participant withdrew consent|0|||
127831276|NCT02935634|459999419|FG000|Treatment: Track 1|Other reasons|0|||
127831277|NCT02935634|459999420|FG001|Treatment: Track 1|Other reasons|0|||
127831278|NCT02935634|459999421|FG002|Treatment: Track 1|Other reasons|2|||
127831279|NCT02935634|459999422|FG003|Treatment: Track 1|Other reasons|0|||
127831280|NCT02935634|459999423|FG004|Treatment: Track 1|Other reasons|0|||
127831281|NCT02935634|459999424|FG005|Treatment: Track 1|Other reasons|0|||
127831282|NCT02935634|459999419|FG000|Treatment: Track 2|Disease progression|13|||
127831283|NCT02935634|459999420|FG001|Treatment: Track 2|Disease progression|26|||
127831284|NCT02935634|459999421|FG002|Treatment: Track 2|Disease progression|20|||
127831285|NCT02935634|459999422|FG003|Treatment: Track 2|Disease progression|5|||
127831286|NCT02935634|459999423|FG004|Treatment: Track 2|Disease progression|1|||
127831287|NCT02935634|459999424|FG005|Treatment: Track 2|Disease progression|4|||
127831288|NCT02935634|459999419|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
127831289|NCT02935634|459999420|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
127831290|NCT02935634|459999421|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
127831291|NCT02935634|459999422|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
127831292|NCT02935634|459999423|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
127831293|NCT02935634|459999424|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
127831294|NCT02935634|459999419|FG000|Treatment: Track 2|Study drug toxicity|7|||
127831295|NCT02935634|459999420|FG001|Treatment: Track 2|Study drug toxicity|3|||
127831296|NCT02935634|459999421|FG002|Treatment: Track 2|Study drug toxicity|0|||
127831297|NCT02935634|459999422|FG003|Treatment: Track 2|Study drug toxicity|0|||
127831298|NCT02935634|459999423|FG004|Treatment: Track 2|Study drug toxicity|0|||
127831299|NCT02935634|459999424|FG005|Treatment: Track 2|Study drug toxicity|0|||
127831300|NCT02935634|459999419|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
127831301|NCT02935634|459999420|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
127831302|NCT02935634|459999421|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
127831303|NCT02935634|459999422|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
127831304|NCT02935634|459999423|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
127831305|NCT02935634|459999424|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
127831306|NCT02935634|459999419|FG000|Treatment: Track 2|Participant withdrew consent|0|||
127831307|NCT02935634|459999420|FG001|Treatment: Track 2|Participant withdrew consent|1|||
127831308|NCT02935634|459999421|FG002|Treatment: Track 2|Participant withdrew consent|1|||
127831309|NCT02935634|459999422|FG003|Treatment: Track 2|Participant withdrew consent|0|||
127831310|NCT02935634|459999423|FG004|Treatment: Track 2|Participant withdrew consent|1|||
127831311|NCT02935634|459999424|FG005|Treatment: Track 2|Participant withdrew consent|0|||
127831312|NCT03430245|459999425|FG000|Overall Study|Withdrawal by Subject|6|||
127831313|NCT03430245|459999425|FG000|Overall Study|Lost to Follow-up|1|||
127831314|NCT05628181|459999426|FG000|Overall Study|Death|2|||
127831315|NCT05628181|459999427|FG001|Overall Study|Death|4|||
127831316|NCT05628181|459999428|FG002|Overall Study|Death|0|||
127831317|NCT03656926|459999435|FG000|Overall Study|Adverse Event|5|||
127831318|NCT03656926|459999436|FG001|Overall Study|Adverse Event|4|||
127831319|NCT03656926|459999435|FG000|Overall Study|Withdrawal by Subject|7|||
127831320|NCT03656926|459999436|FG001|Overall Study|Withdrawal by Subject|2|||
127831321|NCT03656926|459999435|FG000|Overall Study|Screen fail after randomization|1|||
127831322|NCT03656926|459999436|FG001|Overall Study|Screen fail after randomization|0|||
127831323|NCT03656926|459999435|FG000|Overall Study|PI decision due to patient condition|1|||
127831324|NCT03656926|459999436|FG001|Overall Study|PI decision due to patient condition|0|||
127831325|NCT03656926|459999435|FG000|Overall Study|Patient unresponsiveness|1|||
127831326|NCT03656926|459999436|FG001|Overall Study|Patient unresponsiveness|0|||
127831327|NCT05610176|459999437|FG000|Overall Study|Death|6|||
127831328|NCT01087528|459999438|FG000|Overall Study|Withdrawal by Subject|1|||
127831329|NCT01087528|459999438|FG000|Overall Study|Incomplete CE procedure|6|||
127831330|NCT00905307|459999443|FG000|Overall Study|Switched to Open Label Rescue|7|||
127831331|NCT00905307|459999444|FG001|Overall Study|Switched to Open Label Rescue|17|||
127831332|NCT00905307|459999445|FG002|Overall Study|Switched to Open Label Rescue|11|||
127831333|NCT00905307|459999446|FG003|Overall Study|Switched to Open Label Rescue|11|||
127831334|NCT00905307|459999447|FG004|Overall Study|Switched to Open Label Rescue|4|||
127831335|NCT00905307|459999448|FG005|Overall Study|Switched to Open Label Rescue|15|||
127831336|NCT00905307|459999443|FG000|Overall Study|Lost to Follow-up|0|||
127831337|NCT00905307|459999444|FG001|Overall Study|Lost to Follow-up|0|||
127831338|NCT00905307|459999445|FG002|Overall Study|Lost to Follow-up|0|||
127831339|NCT00905307|459999446|FG003|Overall Study|Lost to Follow-up|0|||
127831340|NCT00905307|459999447|FG004|Overall Study|Lost to Follow-up|1|||
127831341|NCT00905307|459999448|FG005|Overall Study|Lost to Follow-up|1|||
127831342|NCT00905307|459999443|FG000|Overall Study|Adverse Event|3|||
127831343|NCT00905307|459999444|FG001|Overall Study|Adverse Event|4|||
127831344|NCT00905307|459999445|FG002|Overall Study|Adverse Event|5|||
127831345|NCT00905307|459999446|FG003|Overall Study|Adverse Event|11|||
127831346|NCT00905307|459999447|FG004|Overall Study|Adverse Event|3|||
127831347|NCT00905307|459999448|FG005|Overall Study|Adverse Event|5|||
127831348|NCT00905307|459999443|FG000|Overall Study|Withdrawal by Subject|5|||
127831349|NCT00905307|459999444|FG001|Overall Study|Withdrawal by Subject|13|||
127831350|NCT00905307|459999445|FG002|Overall Study|Withdrawal by Subject|15|||
127831351|NCT00905307|459999446|FG003|Overall Study|Withdrawal by Subject|11|||
127831352|NCT00905307|459999447|FG004|Overall Study|Withdrawal by Subject|4|||
127831353|NCT00905307|459999448|FG005|Overall Study|Withdrawal by Subject|13|||
127831354|NCT00905307|459999443|FG000|Overall Study|Protocol Violation|1|||
127831355|NCT00905307|459999444|FG001|Overall Study|Protocol Violation|0|||
127831356|NCT00905307|459999445|FG002|Overall Study|Protocol Violation|1|||
127831357|NCT00905307|459999446|FG003|Overall Study|Protocol Violation|0|||
127831358|NCT00905307|459999447|FG004|Overall Study|Protocol Violation|0|||
127831359|NCT00905307|459999448|FG005|Overall Study|Protocol Violation|0|||
127831360|NCT00905307|459999443|FG000|Overall Study|Lack of Efficacy|6|||
127831361|NCT00905307|459999444|FG001|Overall Study|Lack of Efficacy|3|||
127831362|NCT00905307|459999445|FG002|Overall Study|Lack of Efficacy|5|||
127831363|NCT00905307|459999446|FG003|Overall Study|Lack of Efficacy|4|||
127831364|NCT00905307|459999447|FG004|Overall Study|Lack of Efficacy|4|||
127831365|NCT00905307|459999448|FG005|Overall Study|Lack of Efficacy|8|||
127831366|NCT01864018|459999449|FG000|Overall Study|Ineligible|3|||
127895061|NCT01058421|460238640|FG000|1 Month Outcomes|Death|10|||
127831367|NCT01864018|459999450|FG001|Overall Study|Ineligible|1|||
127831368|NCT03609359|459999453|FG000|Overall Study|Progression of primary disease (PD)|25|||
127831369|NCT03609359|459999453|FG000|Overall Study|Patient's refusal|1|||
127831370|NCT03609359|459999453|FG000|Overall Study|Physician Decision|1|||
127831371|NCT03609359|459999453|FG000|Overall Study|The protocol treatment was discontinued for undergoing primary tumor resection.|1|||
127831372|NCT01912729|459999455|FG000|Overall Study|Withdrawal by Subject|0|||
127831373|NCT01912729|459999456|FG001|Overall Study|Withdrawal by Subject|1|||
127831374|NCT01952834|459999457|FG000|Overall Study|Adverse Event|1|||
127831375|NCT04285346|459999458|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
127831376|NCT04285346|459999459|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
127831377|NCT04285346|459999458|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
127831378|NCT04285346|459999459|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
127831379|NCT04285346|459999458|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
127831380|NCT04285346|459999459|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
127831381|NCT00610935|459999460|FG000|Overall Study|Lost to Follow-up|0|||
127831382|NCT00610935|459999461|FG001|Overall Study|Lost to Follow-up|1|||
127831383|NCT00610935|459999460|FG000|Overall Study|Withdrawal by Subject|0|||
127831384|NCT00610935|459999461|FG001|Overall Study|Withdrawal by Subject|2|||
127831385|NCT00610935|459999460|FG000|Overall Study|Sponsor Discontinuation|1|||
127831386|NCT00610935|459999461|FG001|Overall Study|Sponsor Discontinuation|0|||
127831387|NCT00740779|459999462|FG000|Overall Study|Adverse Event|4|||
127831388|NCT00740779|459999463|FG001|Overall Study|Adverse Event|6|||
127831389|NCT00740779|459999464|FG002|Overall Study|Adverse Event|3|||
127831390|NCT00740779|459999462|FG000|Overall Study|Protocol Violation|1|||
127831391|NCT00740779|459999463|FG001|Overall Study|Protocol Violation|1|||
127831392|NCT00740779|459999464|FG002|Overall Study|Protocol Violation|1|||
127831393|NCT00740779|459999462|FG000|Overall Study|Lack of Efficacy|0|||
127831394|NCT00740779|459999463|FG001|Overall Study|Lack of Efficacy|0|||
127831395|NCT00740779|459999464|FG002|Overall Study|Lack of Efficacy|2|||
127831396|NCT00740779|459999462|FG000|Overall Study|Withdrawal by Subject|2|||
127831397|NCT00740779|459999463|FG001|Overall Study|Withdrawal by Subject|4|||
127831398|NCT00740779|459999464|FG002|Overall Study|Withdrawal by Subject|2|||
127831399|NCT00740779|459999462|FG000|Overall Study|Lost to Follow-up|2|||
127831400|NCT00740779|459999463|FG001|Overall Study|Lost to Follow-up|3|||
127831401|NCT00740779|459999464|FG002|Overall Study|Lost to Follow-up|5|||
127831402|NCT00850460|459999465|FG000|Overall Study|Lost to Follow-up|4|||
127831403|NCT00850460|459999466|FG001|Overall Study|Lost to Follow-up|4|||
127831404|NCT02399813|459999469|FG000|Overall Study|Progressive Disease-Radiographic|2|||
127831405|NCT02399813|459999469|FG000|Overall Study|Death|20|||
127831406|NCT02399813|459999469|FG000|Overall Study|Withdrawal by Subject|3|||
127831407|NCT02399813|459999469|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
127831408|NCT02399813|459999469|FG000|Overall Study|Lost to Follow-up|2|||
127831409|NCT02399813|459999469|FG000|Overall Study|Other than specified|5|||
127831410|NCT00988559|459999470|FG000|Overall Study|Withdrawal by Subject|1|||
127831411|NCT00988559|459999471|FG001|Overall Study|Withdrawal by Subject|1|||
127831412|NCT00988559|459999472|FG002|Overall Study|Withdrawal by Subject|0|||
127831413|NCT00988559|459999473|FG003|Overall Study|Withdrawal by Subject|1|||
127831414|NCT00988559|459999470|FG000|Overall Study|Pregnancy|0|||
127831415|NCT00988559|459999471|FG001|Overall Study|Pregnancy|1|||
127831416|NCT00988559|459999472|FG002|Overall Study|Pregnancy|1|||
127831417|NCT00988559|459999473|FG003|Overall Study|Pregnancy|0|||
127831418|NCT00988559|459999470|FG000|Overall Study|Lost to Follow-up|0|||
127831419|NCT00988559|459999471|FG001|Overall Study|Lost to Follow-up|0|||
127831420|NCT00988559|459999472|FG002|Overall Study|Lost to Follow-up|1|||
127831421|NCT00988559|459999473|FG003|Overall Study|Lost to Follow-up|0|||
127831422|NCT03007953|459999474|FG000|Overall Study|Withdrawal by Subject|5|||
127831423|NCT03007953|459999475|FG001|Overall Study|Withdrawal by Subject|2|||
127831424|NCT03007953|459999474|FG000|Overall Study|Death|5|||
127831425|NCT03007953|459999475|FG001|Overall Study|Death|7|||
127831426|NCT03007953|459999474|FG000|Overall Study|Lost to Follow-up|3|||
127831427|NCT03007953|459999475|FG001|Overall Study|Lost to Follow-up|2|||
127831428|NCT03007953|459999474|FG000|Overall Study|Enrolled in Hospice|3|||
127831429|NCT03007953|459999475|FG001|Overall Study|Enrolled in Hospice|2|||
127895062|NCT01058421|460238641|FG001|1 Month Outcomes|Death|6|||
127895063|NCT01058421|460238640|FG000|1 Month Outcomes|Lost to Follow-up|8|||
127895064|NCT01058421|460238641|FG001|1 Month Outcomes|Lost to Follow-up|7|||
127831430|NCT02224846|459999476|FG000|Period 1 (Month 3)|Adverse Event|2|||
127831431|NCT02224846|459999477|FG001|Period 1 (Month 3)|Adverse Event|1|||
127831432|NCT02224846|459999476|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
127831433|NCT02224846|459999477|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
127831434|NCT02224846|459999476|FG000|Period 1 (Month 3)|Protocol Violation|4|||
127831435|NCT02224846|459999477|FG001|Period 1 (Month 3)|Protocol Violation|8|||
127831436|NCT02224846|459999476|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
127831437|NCT02224846|459999477|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
127831438|NCT02224846|459999476|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
127831439|NCT02224846|459999477|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
127831440|NCT02224846|459999476|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
127831441|NCT02224846|459999477|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
127831442|NCT02224846|459999476|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
127831443|NCT02224846|459999477|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
127831444|NCT02224846|459999476|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
127831445|NCT02224846|459999477|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
127831446|NCT02224846|459999476|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
127831447|NCT02224846|459999477|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
127831448|NCT02224846|459999476|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
127831449|NCT02224846|459999477|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
127831450|NCT02224846|459999476|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
127831451|NCT02224846|459999477|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
127831452|NCT02224846|459999476|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
127831453|NCT02224846|459999477|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
127831454|NCT02224846|459999476|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
127831455|NCT02224846|459999477|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
127831456|NCT02224846|459999476|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
127831457|NCT02224846|459999477|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
127831458|NCT02224846|459999476|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
127831459|NCT02224846|459999477|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
127831460|NCT02224846|459999476|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
127831461|NCT02224846|459999477|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
127831462|NCT02224846|459999476|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
127831463|NCT02224846|459999477|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
127831464|NCT03280550|459999478|FG000|Overall Study|Withdrawal by Subject|2|||
127831465|NCT03280550|459999479|FG001|Overall Study|Withdrawal by Subject|2|||
127831466|NCT03280550|459999478|FG000|Overall Study|Physician Decision|0|||
127831467|NCT03280550|459999479|FG001|Overall Study|Physician Decision|1|||
127831468|NCT02203838|459999482|FG000|Overall Study|Lack of Efficacy|7|||
127831469|NCT02203838|459999483|FG001|Overall Study|Lack of Efficacy|0|||
127831470|NCT02203838|459999484|FG002|Overall Study|Lack of Efficacy|1|||
127831471|NCT02203838|459999485|FG003|Overall Study|Lack of Efficacy|1|||
127831472|NCT02203838|459999482|FG000|Overall Study|Adverse Event|46|||
127831473|NCT02203838|459999483|FG001|Overall Study|Adverse Event|6|||
127831474|NCT02203838|459999484|FG002|Overall Study|Adverse Event|3|||
127831475|NCT02203838|459999485|FG003|Overall Study|Adverse Event|2|||
127895065|NCT01058421|460238640|FG000|1 Month Outcomes|Remained in Hospital|5|||
127895066|NCT01058421|460238641|FG001|1 Month Outcomes|Remained in Hospital|12|||
127895067|NCT01058421|460238640|FG000|1 Month Outcomes|Remained in Other Facility|16|||
127895068|NCT01058421|460238641|FG001|1 Month Outcomes|Remained in Other Facility|17|||
127895069|NCT01058421|460238640|FG000|3 Month Outcomes|Death|3|||
127895070|NCT01058421|460238641|FG001|3 Month Outcomes|Death|5|||
127895071|NCT01058421|460238640|FG000|3 Month Outcomes|Lost to Follow-up|12|||
127895072|NCT01058421|460238641|FG001|3 Month Outcomes|Lost to Follow-up|11|||
127895073|NCT01058421|460238640|FG000|3 Month Outcomes|Remained in Hospital|0|||
127895074|NCT01058421|460238641|FG001|3 Month Outcomes|Remained in Hospital|2|||
127895075|NCT01058421|460238640|FG000|3 Month Outcomes|Remained in Other Facility|5|||
127895076|NCT01058421|460238641|FG001|3 Month Outcomes|Remained in Other Facility|8|||
127895077|NCT01058421|460238640|FG000|6 Month Outcomes|Death|2|||
127831476|NCT02203838|459999482|FG000|Overall Study|Lost to Follow-up|39|||
127831477|NCT02203838|459999483|FG001|Overall Study|Lost to Follow-up|3|||
127831478|NCT02203838|459999484|FG002|Overall Study|Lost to Follow-up|2|||
127831479|NCT02203838|459999485|FG003|Overall Study|Lost to Follow-up|1|||
127831480|NCT02203838|459999482|FG000|Overall Study|Protocol Violation|7|||
127831481|NCT02203838|459999483|FG001|Overall Study|Protocol Violation|3|||
127895078|NCT01058421|460238641|FG001|6 Month Outcomes|Death|2|||
127895079|NCT01058421|460238640|FG000|6 Month Outcomes|Lost to Follow-up|16|||
127895080|NCT01058421|460238641|FG001|6 Month Outcomes|Lost to Follow-up|21|||
127895081|NCT01058421|460238640|FG000|6 Month Outcomes|Remained in Other Facility|1|||
127831482|NCT02203838|459999484|FG002|Overall Study|Protocol Violation|0|||
127831483|NCT02203838|459999485|FG003|Overall Study|Protocol Violation|0|||
127831484|NCT02203838|459999482|FG000|Overall Study|Withdrawal by Subject|83|||
127831485|NCT02203838|459999483|FG001|Overall Study|Withdrawal by Subject|10|||
127831486|NCT02203838|459999484|FG002|Overall Study|Withdrawal by Subject|8|||
127831487|NCT02203838|459999485|FG003|Overall Study|Withdrawal by Subject|11|||
127831488|NCT02203838|459999482|FG000|Overall Study|Physician Decision|27|||
127831489|NCT02203838|459999483|FG001|Overall Study|Physician Decision|0|||
127831490|NCT02203838|459999484|FG002|Overall Study|Physician Decision|2|||
127831491|NCT02203838|459999485|FG003|Overall Study|Physician Decision|3|||
127831492|NCT02203838|459999482|FG000|Overall Study|Other|1|||
127831493|NCT02203838|459999483|FG001|Overall Study|Other|0|||
127831494|NCT02203838|459999484|FG002|Overall Study|Other|0|||
127831495|NCT02203838|459999485|FG003|Overall Study|Other|0|||
127831496|NCT01915849|459999490|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
127831497|NCT01915849|459999491|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
127831498|NCT01915849|459999492|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
127831499|NCT01915849|459999493|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
127831500|NCT01915849|459999490|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
127831501|NCT01915849|459999491|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
127831502|NCT01915849|459999492|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
127831503|NCT01915849|459999493|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
127831504|NCT01067508|459999494|FG000|Overall Study|Physician Decision|0|||
127831505|NCT01067508|459999495|FG001|Overall Study|Physician Decision|1|||
127831506|NCT01067508|459999494|FG000|Overall Study|Withdrawal by Subject|0|||
127831507|NCT01067508|459999495|FG001|Overall Study|Withdrawal by Subject|1|||
127831508|NCT00444626|459999496|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
127831509|NCT00444626|459999496|FG000|Initial Treatment Period|Adverse Event|1|||
127831510|NCT00444626|459999496|FG000|Initial Treatment Period|Lost to Follow-up|9|||
127831511|NCT00786838|459999497|FG000|Overall Study|Physician Decision|4|||
127831512|NCT00786838|459999497|FG000|Overall Study|Death|4|||
127831513|NCT00786838|459999497|FG000|Overall Study|Adverse Event|6|||
127831514|NCT00786838|459999497|FG000|Overall Study|Progressive disease|31|||
127831515|NCT00786838|459999497|FG000|Overall Study|Withdrawal by Subject|4|||
127831516|NCT04594239|459999498|FG000|Overall Study|Withdrawal by Subject|3|||
127831517|NCT04594239|459999499|FG001|Overall Study|Withdrawal by Subject|4|||
127895082|NCT01058421|460238641|FG001|6 Month Outcomes|Remained in Other Facility|3|||
127895083|NCT01309919|460238662|FG000|Overall Study|Did not receive a postpartum IUD|17|||
127895084|NCT01309919|460238663|FG001|Overall Study|Did not receive a postpartum IUD|48|||
127895085|NCT00319449|460238664|FG000|Overall Study|Subject did not wish to continue|1|||
127895086|NCT00319449|460238665|FG001|Overall Study|Subject did not wish to continue|0|||
127895087|NCT00319449|460238664|FG000|Overall Study|Noncompliance with the protocol|1|||
127895088|NCT00319449|460238665|FG001|Overall Study|Noncompliance with the protocol|0|||
127831518|NCT04594239|459999500|FG002|Overall Study|Withdrawal by Subject|2|||
127831519|NCT04594239|459999501|FG003|Overall Study|Withdrawal by Subject|4|||
127831520|NCT04594239|459999498|FG000|Overall Study|Lost to Follow-up|8|||
127831521|NCT04594239|459999499|FG001|Overall Study|Lost to Follow-up|5|||
127831522|NCT04594239|459999500|FG002|Overall Study|Lost to Follow-up|4|||
127831523|NCT04594239|459999501|FG003|Overall Study|Lost to Follow-up|6|||
127831524|NCT04594239|459999498|FG000|Overall Study|Subject relocated|0|||
127831525|NCT04594239|459999499|FG001|Overall Study|Subject relocated|0|||
127831526|NCT04594239|459999500|FG002|Overall Study|Subject relocated|0|||
127831527|NCT04594239|459999501|FG003|Overall Study|Subject relocated|1|||
127831528|NCT00091390|459999502|FG000|Overall Study|Protocol Violation|1|||
127831529|NCT00091390|459999502|FG000|Overall Study|No protocol treatment|3|||
127831530|NCT00436215|459999503|FG000|Overall Study|Refused further treatment|3|||
127831531|NCT00436215|459999503|FG000|Overall Study|Small bowel obstruction|1|||
127831532|NCT00309777|459999504|FG000|Overall Study|Adverse Event|13|||
127831533|NCT00309777|459999505|FG001|Overall Study|Adverse Event|2|||
127831534|NCT00309777|459999506|FG002|Overall Study|Adverse Event|8|||
127831535|NCT00309777|459999507|FG003|Overall Study|Adverse Event|1|||
127831536|NCT00309777|459999504|FG000|Overall Study|Protocol Violation|4|||
127831537|NCT00309777|459999505|FG001|Overall Study|Protocol Violation|1|||
127831538|NCT00309777|459999506|FG002|Overall Study|Protocol Violation|3|||
127831539|NCT00309777|459999507|FG003|Overall Study|Protocol Violation|1|||
127831540|NCT00309777|459999504|FG000|Overall Study|Withdrawal by Subject|6|||
127831541|NCT00309777|459999505|FG001|Overall Study|Withdrawal by Subject|5|||
127831542|NCT00309777|459999506|FG002|Overall Study|Withdrawal by Subject|7|||
127831543|NCT00309777|459999507|FG003|Overall Study|Withdrawal by Subject|2|||
127831544|NCT00309777|459999504|FG000|Overall Study|Lost to Follow-up|0|||
127831545|NCT00309777|459999505|FG001|Overall Study|Lost to Follow-up|0|||
127831546|NCT00309777|459999506|FG002|Overall Study|Lost to Follow-up|1|||
127831547|NCT00309777|459999507|FG003|Overall Study|Lost to Follow-up|0|||
127831548|NCT00309777|459999504|FG000|Overall Study|Death|0|||
127831549|NCT00309777|459999505|FG001|Overall Study|Death|1|||
127831550|NCT00309777|459999506|FG002|Overall Study|Death|0|||
127831551|NCT00309777|459999507|FG003|Overall Study|Death|0|||
127831552|NCT03580382|460001113|FG000|Overall Study|Early Termination of Study|0|||
127831553|NCT03580382|460001114|FG001|Overall Study|Early Termination of Study|3|||
127831554|NCT05619172|460001115|FG000|Safety Cohort 1|Death|7|||
127831555|NCT05619172|460001116|FG001|Safety Cohort 1|Death|0|||
127831556|NCT05619172|460001115|FG000|Safety Cohort 1|Study terminated by sponsor|7|||
127831557|NCT05619172|460001116|FG001|Safety Cohort 1|Study terminated by sponsor|0|||
127831558|NCT05619172|460001115|FG000|Safety Cohort 2|Death|0|||
127831559|NCT05619172|460001116|FG001|Safety Cohort 2|Death|1|||
127831560|NCT05619172|460001115|FG000|Safety Cohort 2|Study terminated by sponsor|0|||
127831561|NCT05619172|460001116|FG001|Safety Cohort 2|Study terminated by sponsor|1|||
127831562|NCT00450372|460001118|FG000|Overall Study|Physician Decision|1|||
127831563|NCT03010423|460001119|FG000|Overall Study|Study termination|8|||
127831564|NCT01718509|460001125|FG000|Overall Study|Lost to Follow-up|18|||
127831565|NCT01718509|460001126|FG001|Overall Study|Lost to Follow-up|15|||
127831566|NCT01718509|460001125|FG000|Overall Study|Withdrawal by Subject|7|||
127831567|NCT01718509|460001126|FG001|Overall Study|Withdrawal by Subject|13|||
127831568|NCT01718509|460001125|FG000|Overall Study|Adverse Event|5|||
127831569|NCT01718509|460001126|FG001|Overall Study|Adverse Event|7|||
127831570|NCT01718509|460001125|FG000|Overall Study|Other|13|||
127831571|NCT01718509|460001126|FG001|Overall Study|Other|11|||
127831572|NCT01718509|460001125|FG000|Overall Study|Protocol Violation|4|||
127831573|NCT01718509|460001126|FG001|Overall Study|Protocol Violation|2|||
127831574|NCT01718509|460001125|FG000|Overall Study|Lack of Efficacy|1|||
127831575|NCT01718509|460001126|FG001|Overall Study|Lack of Efficacy|0|||
127831576|NCT01728584|460001129|FG000|Overall Study|Adverse Event|1|||
127831577|NCT01728584|460001130|FG001|Overall Study|Adverse Event|0|||
127831578|NCT01728584|460001131|FG002|Overall Study|Adverse Event|0|||
127831579|NCT01728584|460001132|FG003|Overall Study|Adverse Event|0|||
127831580|NCT01728584|460001129|FG000|Overall Study|Physician Decision|4|||
127831581|NCT01728584|460001130|FG001|Overall Study|Physician Decision|0|||
127831582|NCT01728584|460001131|FG002|Overall Study|Physician Decision|1|||
127831583|NCT01728584|460001132|FG003|Overall Study|Physician Decision|0|||
127895089|NCT02102490|460238666|FG000|Overall Study|Death|6|||
127831584|NCT01728584|460001129|FG000|Overall Study|Withdrawal by Subject|1|||
127831585|NCT01728584|460001130|FG001|Overall Study|Withdrawal by Subject|0|||
127831586|NCT01728584|460001131|FG002|Overall Study|Withdrawal by Subject|0|||
127831587|NCT01728584|460001132|FG003|Overall Study|Withdrawal by Subject|0|||
127831588|NCT01728584|460001129|FG000|Overall Study|Screen failure|1|||
127831589|NCT01728584|460001130|FG001|Overall Study|Screen failure|0|||
127831590|NCT01728584|460001131|FG002|Overall Study|Screen failure|0|||
127831591|NCT01728584|460001132|FG003|Overall Study|Screen failure|0|||
127831592|NCT01728584|460001129|FG000|Overall Study|Other reason (not specified)|1|||
127831593|NCT01728584|460001130|FG001|Overall Study|Other reason (not specified)|0|||
127831594|NCT01728584|460001131|FG002|Overall Study|Other reason (not specified)|0|||
127831595|NCT01728584|460001132|FG003|Overall Study|Other reason (not specified)|1|||
127831596|NCT05906732|460001133|FG000|Overall Study|Withdrawal by Subject|1|||
127831597|NCT05906732|460001134|FG001|Overall Study|Withdrawal by Subject|0|||
127831598|NCT05906732|460001135|FG002|Overall Study|Withdrawal by Subject|0|||
127831599|NCT05906732|460001136|FG003|Overall Study|Withdrawal by Subject|0|||
127831600|NCT05906732|460001133|FG000|Overall Study|Physician Decision|2|||
127831601|NCT05906732|460001134|FG001|Overall Study|Physician Decision|4|||
127831602|NCT05906732|460001135|FG002|Overall Study|Physician Decision|0|||
127831603|NCT05906732|460001136|FG003|Overall Study|Physician Decision|0|||
127831604|NCT01727713|460001142|FG000|Overall Study|Lost to Follow-up|5|||
127831605|NCT01727713|460001142|FG000|Overall Study|Adverse Event|10|||
127831606|NCT01727713|460001142|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
127831607|NCT01727713|460001142|FG000|Overall Study|Withdrawal by Subject|13|||
127831608|NCT01727713|460001142|FG000|Overall Study|Protocol Deviation|2|||
127831609|NCT00471536|460001147|FG000|Overall Study|Withdrawal by Subject|1|||
127895090|NCT02102490|460238666|FG000|Overall Study|Lost to Follow-up|1|||
127895091|NCT01346410|460238667|FG000|Overall Study|Death|1|||
127831610|NCT02651194|460001148|FG000|Overall Study|Lost to Follow-up|3|||
127831611|NCT02651194|460001148|FG000|Overall Study|Other|2|||
127831612|NCT03885726|460001151|FG000|Overall Study|Staffing issues/lost interest|1|||
127831613|NCT03885726|460001151|FG000|Overall Study|Early discharge from hospital|3|||
127831614|NCT01217190|460001152|FG000|Second Dosing|Withdrawal by Subject|0|||
127831615|NCT01217190|460001153|FG001|Second Dosing|Withdrawal by Subject|2|||
127831616|NCT03116399|460001154|FG000|Overall Study|Death|8|||
127831617|NCT03116399|460001155|FG001|Overall Study|Death|3|||
127831618|NCT03116399|460001154|FG000|Overall Study|Lost to Follow-up|7|||
127831619|NCT03116399|460001155|FG001|Overall Study|Lost to Follow-up|11|||
127831620|NCT03116399|460001154|FG000|Overall Study|Investigator Decision|1|||
127831621|NCT03116399|460001155|FG001|Overall Study|Investigator Decision|1|||
127831622|NCT03116399|460001154|FG000|Overall Study|Withdrawal by Subject|24|||
127831623|NCT03116399|460001155|FG001|Overall Study|Withdrawal by Subject|9|||
127831624|NCT00195260|460001157|FG000|Part 1: Dose Escalation|Adverse Event|0|||
127831625|NCT00195260|460001158|FG001|Part 1: Dose Escalation|Adverse Event|1|||
127831626|NCT00195260|460001159|FG002|Part 1: Dose Escalation|Adverse Event|0|||
127831627|NCT00195260|460001160|FG003|Part 1: Dose Escalation|Adverse Event|1|||
127831628|NCT00195260|460001161|FG004|Part 1: Dose Escalation|Adverse Event|1|||
127831629|NCT00195260|460001162|FG005|Part 1: Dose Escalation|Adverse Event|0|||
127831630|NCT00195260|460001163|FG006|Part 1: Dose Escalation|Adverse Event|3|||
127831631|NCT00195260|460001164|FG007|Part 1: Dose Escalation|Adverse Event|0|||
127831632|NCT00195260|460001165|FG008|Part 1: Dose Escalation|Adverse Event|0|||
127831633|NCT00195260|460001166|FG009|Part 1: Dose Escalation|Adverse Event|0|||
127831634|NCT00195260|460001167|FG010|Part 1: Dose Escalation|Adverse Event|0|||
127831635|NCT00195260|460001157|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
127831636|NCT00195260|460001158|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
127831637|NCT00195260|460001159|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
127831638|NCT00195260|460001160|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
127831639|NCT00195260|460001161|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
127831640|NCT00195260|460001162|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
127831641|NCT00195260|460001163|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
127831642|NCT00195260|460001164|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
127831643|NCT00195260|460001165|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
127831644|NCT00195260|460001166|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
127831645|NCT00195260|460001167|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
127831646|NCT00195260|460001157|FG000|Part 1: Dose Escalation|Death|0|||
127831647|NCT00195260|460001158|FG001|Part 1: Dose Escalation|Death|0|||
127831648|NCT00195260|460001159|FG002|Part 1: Dose Escalation|Death|0|||
127831649|NCT00195260|460001160|FG003|Part 1: Dose Escalation|Death|0|||
127831650|NCT00195260|460001161|FG004|Part 1: Dose Escalation|Death|0|||
127831651|NCT00195260|460001162|FG005|Part 1: Dose Escalation|Death|0|||
127831652|NCT00195260|460001163|FG006|Part 1: Dose Escalation|Death|0|||
127831653|NCT00195260|460001164|FG007|Part 1: Dose Escalation|Death|1|||
127831654|NCT00195260|460001165|FG008|Part 1: Dose Escalation|Death|0|||
127831655|NCT00195260|460001166|FG009|Part 1: Dose Escalation|Death|0|||
127831656|NCT00195260|460001167|FG010|Part 1: Dose Escalation|Death|0|||
127831657|NCT00195260|460001157|FG000|Part 1: Dose Escalation|Disease Progression|3|||
127831658|NCT00195260|460001158|FG001|Part 1: Dose Escalation|Disease Progression|2|||
127831659|NCT00195260|460001159|FG002|Part 1: Dose Escalation|Disease Progression|5|||
127831660|NCT00195260|460001160|FG003|Part 1: Dose Escalation|Disease Progression|6|||
127831661|NCT00195260|460001161|FG004|Part 1: Dose Escalation|Disease Progression|4|||
127831662|NCT00195260|460001162|FG005|Part 1: Dose Escalation|Disease Progression|6|||
127831663|NCT00195260|460001163|FG006|Part 1: Dose Escalation|Disease Progression|7|||
127831664|NCT00195260|460001164|FG007|Part 1: Dose Escalation|Disease Progression|4|||
127831665|NCT00195260|460001165|FG008|Part 1: Dose Escalation|Disease Progression|0|||
127831666|NCT00195260|460001166|FG009|Part 1: Dose Escalation|Disease Progression|0|||
127831667|NCT00195260|460001167|FG010|Part 1: Dose Escalation|Disease Progression|0|||
127831668|NCT00195260|460001157|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
127831669|NCT00195260|460001158|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
127831670|NCT00195260|460001159|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
127831671|NCT00195260|460001160|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
127831672|NCT00195260|460001161|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
127831673|NCT00195260|460001162|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
127831674|NCT00195260|460001163|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
127831675|NCT00195260|460001164|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
127831676|NCT00195260|460001165|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
127831677|NCT00195260|460001166|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
127831678|NCT00195260|460001167|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
127831679|NCT00195260|460001157|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
127831680|NCT00195260|460001158|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
127831681|NCT00195260|460001159|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
127831682|NCT00195260|460001160|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
127831683|NCT00195260|460001161|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
127831684|NCT00195260|460001162|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
127831685|NCT00195260|460001163|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
127831686|NCT00195260|460001164|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
127831687|NCT00195260|460001165|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
127831688|NCT00195260|460001166|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
127831689|NCT00195260|460001167|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
127831690|NCT00195260|460001157|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
127831691|NCT00195260|460001158|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
127831692|NCT00195260|460001159|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
127831693|NCT00195260|460001160|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
127831694|NCT00195260|460001161|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
127831695|NCT00195260|460001162|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
127831696|NCT00195260|460001163|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
127831697|NCT00195260|460001164|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
127831698|NCT00195260|460001165|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
127831699|NCT00195260|460001166|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
127831700|NCT00195260|460001167|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
127831701|NCT00195260|460001157|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
127895092|NCT02154529|460238668|FG000|Overall Study|Death|1|||
127831702|NCT00195260|460001158|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
127831703|NCT00195260|460001159|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
127831704|NCT00195260|460001160|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
127831705|NCT00195260|460001161|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
127831706|NCT00195260|460001162|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
127831707|NCT00195260|460001163|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
127831708|NCT00195260|460001164|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
127831709|NCT00195260|460001165|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
127831710|NCT00195260|460001166|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
127831711|NCT00195260|460001167|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
127831712|NCT00195260|460001157|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
127831713|NCT00195260|460001158|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
127831714|NCT00195260|460001159|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
127831715|NCT00195260|460001160|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
127831716|NCT00195260|460001161|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
127831717|NCT00195260|460001162|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
127831718|NCT00195260|460001163|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
127831719|NCT00195260|460001164|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
127831720|NCT00195260|460001165|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
127831721|NCT00195260|460001166|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
127831722|NCT00195260|460001167|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
127831723|NCT01975272|460001172|FG000|Overall Study|Excluded after protocol amendment|1|||
127831724|NCT01975272|460001173|FG001|Overall Study|Excluded after protocol amendment|1|||
127831725|NCT01975272|460001174|FG002|Overall Study|Excluded after protocol amendment|2|||
127831726|NCT00515008|460001177|FG000|Overall Study|Lost to Follow-up|1|||
127831727|NCT00515008|460001178|FG001|Overall Study|Lost to Follow-up|0|||
127831728|NCT00515008|460001177|FG000|Overall Study|Declined|0|||
127831729|NCT00515008|460001178|FG001|Overall Study|Declined|3|||
127831730|NCT00515008|460001177|FG000|Overall Study|Left the Boston Area|1|||
127831731|NCT00515008|460001178|FG001|Overall Study|Left the Boston Area|1|||
127831732|NCT00515008|460001177|FG000|Overall Study|Scheduling conflict|1|||
127831733|NCT00515008|460001178|FG001|Overall Study|Scheduling conflict|0|||
127831734|NCT05091060|460001179|FG000|Overall Study|Lost to Follow-up|1|||
127831735|NCT01798706|460001180|FG000|Overall Study|Adverse Event|15|||
127831736|NCT01798706|460001181|FG001|Overall Study|Adverse Event|10|||
127831737|NCT01798706|460001180|FG000|Overall Study|Lack of Efficacy|0|||
127831738|NCT01798706|460001181|FG001|Overall Study|Lack of Efficacy|2|||
127831739|NCT01798706|460001180|FG000|Overall Study|Poor compliance to protocol|1|||
127831740|NCT01798706|460001181|FG001|Overall Study|Poor compliance to protocol|0|||
127831741|NCT01798706|460001180|FG000|Overall Study|Other than specified above|5|||
127831742|NCT01798706|460001181|FG001|Overall Study|Other than specified above|9|||
127831743|NCT00496873|460001182|FG000|Overall Study|Ineligible|2|||
127831744|NCT00496873|460001182|FG000|Overall Study|Death|2|||
127831745|NCT00496873|460001182|FG000|Overall Study|Withdrawal by Subject|3|||
127831746|NCT02775864|460001183|FG000|Overall Study|Data ended end of 2010|1764|||
127831747|NCT02775864|460001184|FG001|Overall Study|Data ended end of 2010|2880|||
127831748|NCT02775864|460001185|FG002|Overall Study|Data ended end of 2010|1140|||
127831749|NCT02775864|460001186|FG003|Overall Study|Data ended end of 2010|1194|||
127831750|NCT02775864|460001183|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
127831751|NCT02775864|460001184|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
127831752|NCT02775864|460001185|FG002|Overall Study|Medicaid eligibility discontinued|720|||
127831753|NCT02775864|460001186|FG003|Overall Study|Medicaid eligibility discontinued|890|||
127831754|NCT03238235|460001187|FG000|Overall Study|Adverse Event|2|||
127831755|NCT03238235|460001188|FG001|Overall Study|Adverse Event|0|||
127831756|NCT03238235|460001187|FG000|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|2|||
127831757|NCT03238235|460001188|FG001|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|0|||
127831758|NCT05896761|460001189|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
127831759|NCT05896761|460001190|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
127831760|NCT05896761|460001189|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
127831761|NCT05896761|460001190|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
127831762|NCT02028338|460001192|FG000|Overall Study|Withdrawal by Subject|3|||
127831763|NCT02028338|460001193|FG001|Overall Study|Withdrawal by Subject|1|||
127831764|NCT02028338|460001192|FG000|Overall Study|Unable to contact participant|1|||
127831765|NCT02028338|460001193|FG001|Overall Study|Unable to contact participant|0|||
127831766|NCT03552549|460001195|FG000|Overall Study|Disease progression|25|||
127831767|NCT03552549|460001196|FG001|Overall Study|Disease progression|17|||
127831768|NCT03552549|460001195|FG000|Overall Study|Adverse event in first 12 months|12|||
127831769|NCT03552549|460001196|FG001|Overall Study|Adverse event in first 12 months|8|||
127831770|NCT03552549|460001195|FG000|Overall Study|Withdrawal by Subject|7|||
127831771|NCT03552549|460001196|FG001|Overall Study|Withdrawal by Subject|7|||
127831772|NCT03552549|460001195|FG000|Overall Study|Unknown (no reason provided)|4|||
127831773|NCT03552549|460001196|FG001|Overall Study|Unknown (no reason provided)|2|||
127895093|NCT02154529|460238669|FG001|Overall Study|Death|1|||
127895094|NCT02154529|460238670|FG002|Overall Study|Death|5|||
127895095|NCT02154529|460238671|FG003|Overall Study|Death|1|||
127895096|NCT02154529|460238668|FG000|Overall Study|Termination of study by sponsor|2|||
127895097|NCT02154529|460238669|FG001|Overall Study|Termination of study by sponsor|2|||
127895098|NCT02154529|460238670|FG002|Overall Study|Termination of study by sponsor|3|||
127895099|NCT02154529|460238671|FG003|Overall Study|Termination of study by sponsor|1|||
127895100|NCT02154529|460238668|FG000|Overall Study|Lost to Follow-up|1|||
127895101|NCT02154529|460238669|FG001|Overall Study|Lost to Follow-up|0|||
127895102|NCT02154529|460238670|FG002|Overall Study|Lost to Follow-up|0|||
127895103|NCT02154529|460238671|FG003|Overall Study|Lost to Follow-up|0|||
127895104|NCT00458302|460240586|FG000|Overall Study|Adverse Event|4|||
127895105|NCT00458302|460240587|FG001|Overall Study|Adverse Event|14|||
127895106|NCT00458302|460240586|FG000|Overall Study|Pregnancy|2|||
127895107|NCT00458302|460240587|FG001|Overall Study|Pregnancy|1|||
127895108|NCT00458302|460240586|FG000|Overall Study|Protocol Violation|0|||
127895109|NCT00458302|460240587|FG001|Overall Study|Protocol Violation|2|||
127895110|NCT00458302|460240586|FG000|Overall Study|Withdrawal by Subject|6|||
127895111|NCT00458302|460240587|FG001|Overall Study|Withdrawal by Subject|4|||
127895112|NCT00458302|460240586|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
127895113|NCT00458302|460240587|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
127895114|NCT00458302|460240586|FG000|Overall Study|Study Termination By Sponsor|1|||
127895115|NCT00458302|460240587|FG001|Overall Study|Study Termination By Sponsor|0|||
127895116|NCT00458302|460240586|FG000|Overall Study|Lost to Follow-up|2|||
127895117|NCT00458302|460240587|FG001|Overall Study|Lost to Follow-up|0|||
127895118|NCT00458302|460240586|FG000|Overall Study|Other|4|||
127895119|NCT00458302|460240587|FG001|Overall Study|Other|2|||
127895120|NCT02178709|460240588|FG000|Overall Study|Adverse Event|5|||
127895121|NCT02178709|460240588|FG000|Overall Study|Death|2|||
127895122|NCT02178709|460240588|FG000|Overall Study|Withdrawal by Subject|2|||
127895123|NCT02178709|460240588|FG000|Overall Study|Physician Decision|2|||
127895124|NCT02178709|460240588|FG000|Overall Study|Disease Progression|5|||
127895125|NCT04849988|460240589|FG000|Overall Study|Lack of Efficacy|3|||
127895126|NCT04849988|460240590|FG001|Overall Study|Lack of Efficacy|4|||
127895127|NCT04849988|460240591|FG002|Overall Study|Lack of Efficacy|1|||
127895128|NCT04849988|460240592|FG003|Overall Study|Lack of Efficacy|4|||
127895129|NCT04849988|460240589|FG000|Overall Study|Other reasons|1|||
127895130|NCT04849988|460240590|FG001|Overall Study|Other reasons|2|||
127831774|NCT03552549|460001195|FG000|Overall Study|Not in participant's best interest|2|||
127831775|NCT03552549|460001196|FG001|Overall Study|Not in participant's best interest|1|||
127831776|NCT03552549|460001195|FG000|Overall Study|Did not complete study treatment|2|||
127831777|NCT03552549|460001196|FG001|Overall Study|Did not complete study treatment|3|||
127831778|NCT03552549|460001195|FG000|Overall Study|Did not meet eligibility criteria|1|||
127831779|NCT03552549|460001196|FG001|Overall Study|Did not meet eligibility criteria|0|||
127831780|NCT03552549|460001195|FG000|Overall Study|Administrative|0|||
127831781|NCT03552549|460001196|FG001|Overall Study|Administrative|14|||
127831782|NCT02739594|460001204|FG000|Overall Study|Undesired Event|3|||
127831783|NCT02739594|460001205|FG001|Overall Study|Undesired Event|4|||
127831784|NCT02739594|460001204|FG000|Overall Study|Violation of Eligibility Criteria|1|||
127831785|NCT02739594|460001205|FG001|Overall Study|Violation of Eligibility Criteria|2|||
127831786|NCT02739594|460001204|FG000|Overall Study|Protocol Violation|5|||
127831787|NCT02739594|460001205|FG001|Overall Study|Protocol Violation|6|||
127831788|NCT02739594|460001204|FG000|Overall Study|Death|4|||
127831789|NCT02739594|460001205|FG001|Overall Study|Death|2|||
127831790|NCT02739594|460001204|FG000|Overall Study|Renal Insufficiency|4|||
127831791|NCT02739594|460001205|FG001|Overall Study|Renal Insufficiency|6|||
127895131|NCT04849988|460240591|FG002|Overall Study|Other reasons|2|||
127895132|NCT04849988|460240592|FG003|Overall Study|Other reasons|1|||
127895133|NCT01052116|460240597|FG000|Overall Study|Lost to Follow-up|11|||
127895134|NCT01052116|460240598|FG001|Overall Study|Lost to Follow-up|17|||
127895135|NCT01052116|460240597|FG000|Overall Study|Withdrawal by Subject|3|||
127895136|NCT01052116|460240598|FG001|Overall Study|Withdrawal by Subject|6|||
127895137|NCT01052116|460240597|FG000|Overall Study|Spirometry not performed|0|||
127831792|NCT02739594|460001204|FG000|Overall Study|Administrative Reasons|1|||
127831793|NCT02739594|460001205|FG001|Overall Study|Administrative Reasons|3|||
127831794|NCT02739594|460001204|FG000|Overall Study|Withdrawal by Subject|1|||
127831795|NCT02739594|460001205|FG001|Overall Study|Withdrawal by Subject|1|||
127831796|NCT02739594|460001204|FG000|Overall Study|Lost to Follow-up|0|||
127831797|NCT02739594|460001205|FG001|Overall Study|Lost to Follow-up|1|||
127831798|NCT02739594|460001204|FG000|Overall Study|Elevated Serum Creatinine|0|||
127831799|NCT02739594|460001205|FG001|Overall Study|Elevated Serum Creatinine|1|||
127831800|NCT02739594|460001204|FG000|Overall Study|Other|6|||
127831801|NCT02739594|460001205|FG001|Overall Study|Other|2|||
127831802|NCT01465178|460001208|FG000|Overall Study|Withdrawal by Subject|1|||
127831803|NCT01465178|460001209|FG001|Overall Study|Withdrawal by Subject|0|||
127831804|NCT00527111|460001210|FG000|Overall Study|Adverse Event|14|||
127831805|NCT00527111|460001211|FG001|Overall Study|Adverse Event|13|||
127485450|NCT01240863|458741182|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
127831806|NCT00527111|460001210|FG000|Overall Study|Death|0|||
127831807|NCT00527111|460001211|FG001|Overall Study|Death|1|||
127831808|NCT00527111|460001210|FG000|Overall Study|Investigator Request|2|||
127831809|NCT00527111|460001211|FG001|Overall Study|Investigator Request|1|||
127895138|NCT01052116|460240598|FG001|Overall Study|Spirometry not performed|4|||
127895139|NCT02146430|460240599|FG000|Overall Study|Protocol Violation|5|||
127895140|NCT02146430|460240600|FG001|Overall Study|Protocol Violation|4|||
127895141|NCT02146430|460240601|FG002|Overall Study|Protocol Violation|8|||
127895142|NCT02146430|460240602|FG003|Overall Study|Protocol Violation|6|||
127895143|NCT02146430|460240599|FG000|Overall Study|Lack of Efficacy|13|||
127895144|NCT02146430|460240600|FG001|Overall Study|Lack of Efficacy|11|||
127895145|NCT02146430|460240601|FG002|Overall Study|Lack of Efficacy|8|||
127895146|NCT02146430|460240602|FG003|Overall Study|Lack of Efficacy|5|||
127895147|NCT02146430|460240599|FG000|Overall Study|Adverse Event|20|||
127895148|NCT02146430|460240600|FG001|Overall Study|Adverse Event|40|||
127895149|NCT02146430|460240601|FG002|Overall Study|Adverse Event|32|||
127895150|NCT02146430|460240602|FG003|Overall Study|Adverse Event|49|||
127895151|NCT02146430|460240599|FG000|Overall Study|Reason missing or not reported|2|||
127895152|NCT02146430|460240600|FG001|Overall Study|Reason missing or not reported|3|||
127895153|NCT02146430|460240601|FG002|Overall Study|Reason missing or not reported|4|||
127895154|NCT02146430|460240602|FG003|Overall Study|Reason missing or not reported|5|||
127895155|NCT02146430|460240599|FG000|Overall Study|Withdrawal by Subject|27|||
127895156|NCT02146430|460240600|FG001|Overall Study|Withdrawal by Subject|29|||
127895157|NCT02146430|460240601|FG002|Overall Study|Withdrawal by Subject|30|||
127895158|NCT02146430|460240602|FG003|Overall Study|Withdrawal by Subject|34|||
127895159|NCT01893905|460240603|FG000|Overall Study|Withdrawal by Subject|1|||
127895160|NCT01893905|460240604|FG001|Overall Study|Withdrawal by Subject|0|||
127895161|NCT01893905|460240603|FG000|Overall Study|Adverse Event|9|||
127895162|NCT01893905|460240604|FG001|Overall Study|Adverse Event|3|||
127895163|NCT01893905|460240603|FG000|Overall Study|Lack of Efficacy|5|||
127895164|NCT01893905|460240604|FG001|Overall Study|Lack of Efficacy|7|||
127895165|NCT01893905|460240603|FG000|Overall Study|Lost to Follow-up|1|||
127895166|NCT01893905|460240604|FG001|Overall Study|Lost to Follow-up|0|||
127895167|NCT01893905|460240603|FG000|Overall Study|Protocol Violation|6|||
127895168|NCT01893905|460240604|FG001|Overall Study|Protocol Violation|1|||
127895169|NCT01893905|460240603|FG000|Overall Study|Lack of adherence to treatment|2|||
127895170|NCT01893905|460240604|FG001|Overall Study|Lack of adherence to treatment|0|||
127895171|NCT01893905|460240603|FG000|Overall Study|Other reason|1|||
127895172|NCT01893905|460240604|FG001|Overall Study|Other reason|3|||
127895173|NCT01768858|460240605|FG000|Overall Study|Lost to Follow-up|9|||
127895174|NCT01768858|460240605|FG000|Overall Study|Lack of Efficacy|8|||
127895175|NCT01768858|460240605|FG000|Overall Study|Serious Adverse Event|1|||
127895176|NCT01768858|460240605|FG000|Overall Study|Participant moved to Germany|1|||
127895177|NCT01768858|460240605|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
127895178|NCT01768858|460240605|FG000|Overall Study|Exanthema|1|||
127895179|NCT01768858|460240605|FG000|Overall Study|Withdrawal by Subject|1|||
127895180|NCT00614055|460240609|FG000|Overall Study|Adverse Event|1|||
127895181|NCT00614055|460240610|FG001|Overall Study|Adverse Event|0|||
127895182|NCT00614055|460240611|FG002|Overall Study|Adverse Event|0|||
127895183|NCT00614055|460240609|FG000|Overall Study|Protocol Violation|2|||
127895184|NCT00614055|460240610|FG001|Overall Study|Protocol Violation|2|||
127895185|NCT00614055|460240611|FG002|Overall Study|Protocol Violation|1|||
127831810|NCT00527111|460001210|FG000|Overall Study|Patient Request|2|||
127831811|NCT00527111|460001211|FG001|Overall Study|Patient Request|5|||
127831812|NCT00527111|460001210|FG000|Overall Study|Other|2|||
127831813|NCT00527111|460001211|FG001|Overall Study|Other|2|||
127831814|NCT03827473|460001214|FG000|Overall Study|Withdrawal by Subject|1|||
127831815|NCT03827473|460001215|FG001|Overall Study|Withdrawal by Subject|0|||
127831816|NCT01477892|460001216|FG000|Overall Study|Withdrawal by Subject|0|||
127831817|NCT01477892|460001217|FG001|Overall Study|Withdrawal by Subject|2|||
127831818|NCT01921257|460001218|FG000|Overall Study|Adverse Event|1|||
127831819|NCT01921257|460001218|FG000|Overall Study|Protocol Violation|1|||
127831820|NCT01921257|460001218|FG000|Overall Study|Withdrawal by Subject|1|||
127831821|NCT05515601|460001222|FG000|Overall Study|Withdrawal by Subject|1|||
127831822|NCT05515601|460001223|FG001|Overall Study|Withdrawal by Subject|3|||
127831823|NCT05515601|460001224|FG002|Overall Study|Withdrawal by Subject|2|||
127831824|NCT05515601|460001225|FG003|Overall Study|Withdrawal by Subject|1|||
127831825|NCT05515601|460001226|FG004|Overall Study|Withdrawal by Subject|1|||
127831826|NCT05515601|460001227|FG005|Overall Study|Withdrawal by Subject|1|||
127831827|NCT05515601|460001222|FG000|Overall Study|Lost to Follow-up|0|||
127831828|NCT05515601|460001223|FG001|Overall Study|Lost to Follow-up|0|||
127831829|NCT05515601|460001224|FG002|Overall Study|Lost to Follow-up|0|||
127831830|NCT05515601|460001225|FG003|Overall Study|Lost to Follow-up|0|||
127895186|NCT00614055|460240609|FG000|Overall Study|Lack of Efficacy|0|||
127895187|NCT00614055|460240610|FG001|Overall Study|Lack of Efficacy|0|||
127831831|NCT05515601|460001226|FG004|Overall Study|Lost to Follow-up|1|||
127895188|NCT00614055|460240611|FG002|Overall Study|Lack of Efficacy|2|||
127895189|NCT00614055|460240609|FG000|Overall Study|Unclassified|1|||
127895190|NCT00614055|460240610|FG001|Overall Study|Unclassified|4|||
127831832|NCT05515601|460001227|FG005|Overall Study|Lost to Follow-up|0|||
127895191|NCT00614055|460240611|FG002|Overall Study|Unclassified|2|||
127831833|NCT00777491|460001228|FG000|Overall Study|Protocol Violation|0|||
127831834|NCT00777491|460001229|FG001|Overall Study|Protocol Violation|2|||
127831835|NCT00777491|460001228|FG000|Overall Study|Did not receive any protocol treatment|2|||
127831836|NCT00777491|460001229|FG001|Overall Study|Did not receive any protocol treatment|0|||
127831837|NCT01912768|460001230|FG000|Overall Study|Adverse Event|2|||
127831838|NCT01912768|460001231|FG001|Overall Study|Adverse Event|0|||
127831839|NCT01912768|460001230|FG000|Overall Study|Lost to Follow-up|2|||
127831840|NCT01912768|460001231|FG001|Overall Study|Lost to Follow-up|1|||
127831841|NCT01912768|460001230|FG000|Overall Study|Withdrawal by Subject|5|||
127831842|NCT01912768|460001231|FG001|Overall Study|Withdrawal by Subject|3|||
127831843|NCT01912768|460001230|FG000|Overall Study|Randomized in error|1|||
127831844|NCT01912768|460001231|FG001|Overall Study|Randomized in error|0|||
127831845|NCT04160468|460001232|FG000|Overall Study|Lost to Follow-up|19|||
127831846|NCT04160468|460001233|FG001|Overall Study|Lost to Follow-up|4|||
127831847|NCT04160468|460001232|FG000|Overall Study|Randomized but not dosed|6|||
127831848|NCT04160468|460001233|FG001|Overall Study|Randomized but not dosed|0|||
127831849|NCT04160468|460001232|FG000|Overall Study|Withdrawal by Subject|4|||
127831850|NCT04160468|460001233|FG001|Overall Study|Withdrawal by Subject|1|||
127831851|NCT04160468|460001232|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
127831852|NCT04160468|460001233|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
127831853|NCT04160468|460001232|FG000|Overall Study|Participant incarcerated|1|||
127831854|NCT04160468|460001233|FG001|Overall Study|Participant incarcerated|0|||
127831855|NCT01187901|460001234|FG000|Overall Study|Protocol Violation|1|||
127831856|NCT01187901|460001235|FG001|Overall Study|Protocol Violation|0|||
127895192|NCT04583579|460240614|FG000|Overall Study|Lost to Follow-up|4|||
127895193|NCT01691859|460240615|FG000|Overall Study|Adverse Event|19|||
127895194|NCT01691859|460240615|FG000|Overall Study|Lack of Efficacy|11|||
127895195|NCT01691859|460240615|FG000|Overall Study|Protocol Violation|4|||
127895196|NCT01691859|460240615|FG000|Overall Study|Product commercially available|221|||
127895197|NCT01691859|460240615|FG000|Overall Study|Study closed/terminated|50|||
127895198|NCT01691859|460240615|FG000|Overall Study|Lost to Follow-up|5|||
127895199|NCT01691859|460240615|FG000|Overall Study|Physician Decision|6|||
127895200|NCT01691859|460240615|FG000|Overall Study|Withdrawal by Subject|31|||
127895201|NCT04820842|460240616|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
127895202|NCT04820842|460240617|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
127895203|NCT04820842|460240618|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
127895204|NCT04820842|460240619|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
127895205|NCT04820842|460240620|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
127895206|NCT04820842|460240621|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
127895207|NCT04820842|460240622|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
127895208|NCT04820842|460240616|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
127895209|NCT04820842|460240617|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
127895210|NCT04820842|460240618|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
127895211|NCT04820842|460240619|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
127895212|NCT04820842|460240620|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
127895213|NCT04820842|460240621|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
127895214|NCT04820842|460240622|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
127895215|NCT04820842|460240616|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
127895216|NCT04820842|460240617|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
127895217|NCT04820842|460240618|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
127895218|NCT04820842|460240619|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
127895219|NCT04820842|460240620|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
127831857|NCT01187901|460001234|FG000|Overall Study|Lost to Follow-up|1|||
127831858|NCT01187901|460001235|FG001|Overall Study|Lost to Follow-up|2|||
127831859|NCT01187901|460001234|FG000|Overall Study|Unrelated Health Reasons|1|||
127831860|NCT01187901|460001235|FG001|Overall Study|Unrelated Health Reasons|2|||
127831861|NCT01187901|460001234|FG000|Overall Study|Suspected Allergic Reaction|1|||
127831862|NCT01187901|460001235|FG001|Overall Study|Suspected Allergic Reaction|1|||
127831863|NCT01187901|460001234|FG000|Overall Study|Adverse Event|3|||
127831864|NCT01187901|460001235|FG001|Overall Study|Adverse Event|0|||
127831865|NCT01187901|460001234|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
127831866|NCT01187901|460001235|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
127831867|NCT01187901|460001234|FG000|Overall Study|Pregnancy|0|||
127831868|NCT01187901|460001235|FG001|Overall Study|Pregnancy|2|||
127831869|NCT00540436|460001238|FG000|First 12-Week Treatment Period|Adverse Event|1|||
127831870|NCT00540436|460001238|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
127831871|NCT00540436|460001238|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
127831872|NCT00540436|460001238|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
127831873|NCT03255291|460001239|FG000|Overall Study|Determined to be ineligible|10|||
127831874|NCT03255291|460001240|FG001|Overall Study|Determined to be ineligible|12|||
127831875|NCT03255291|460001241|FG002|Overall Study|Determined to be ineligible|6|||
127831876|NCT03255291|460001242|FG003|Overall Study|Determined to be ineligible|6|||
127831877|NCT03255291|460001243|FG004|Overall Study|Determined to be ineligible|5|||
127831878|NCT03255291|460001244|FG005|Overall Study|Determined to be ineligible|10|||
127831879|NCT03255291|460001239|FG000|Overall Study|Baseline data collection issues|3|||
127831880|NCT03255291|460001240|FG001|Overall Study|Baseline data collection issues|0|||
127831881|NCT03255291|460001241|FG002|Overall Study|Baseline data collection issues|0|||
127831882|NCT03255291|460001242|FG003|Overall Study|Baseline data collection issues|0|||
127831883|NCT03255291|460001243|FG004|Overall Study|Baseline data collection issues|2|||
127831884|NCT03255291|460001244|FG005|Overall Study|Baseline data collection issues|0|||
127831885|NCT01745393|460001245|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
127831886|NCT01745393|460001246|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
127831887|NCT01745393|460001245|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
127831888|NCT01745393|460001246|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
127831889|NCT01745393|460001245|FG000|12-month Follow-up|Lost to Follow-up|6|||
127831890|NCT01745393|460001246|FG001|12-month Follow-up|Lost to Follow-up|5|||
127831891|NCT00471445|460001248|FG000|Overall Study|Withdrawal by Subject|1|||
127831892|NCT00471445|460001249|FG001|Overall Study|Withdrawal by Subject|1|||
127831893|NCT00471445|460001248|FG000|Overall Study|Ineligible|1|||
127831894|NCT00471445|460001249|FG001|Overall Study|Ineligible|0|||
127831895|NCT00471445|460001248|FG000|Overall Study|Protocol Violation|0|||
127831896|NCT00471445|460001249|FG001|Overall Study|Protocol Violation|1|||
127831897|NCT03591146|460001252|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
127831898|NCT03591146|460001253|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
127831899|NCT03591146|460001254|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
127831900|NCT03591146|460001255|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
127831901|NCT03591146|460001256|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
127831902|NCT03591146|460001252|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
127831903|NCT03591146|460001253|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
127831904|NCT03591146|460001254|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
127831905|NCT03591146|460001255|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
127831906|NCT03591146|460001256|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
127831907|NCT03591146|460001252|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
127831908|NCT03591146|460001253|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
127831909|NCT03591146|460001254|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
127831910|NCT03591146|460001255|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
127831911|NCT03591146|460001256|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
127831912|NCT03591146|460001252|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
127831913|NCT03591146|460001253|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
127831914|NCT03591146|460001254|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
127831915|NCT03591146|460001255|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
127831916|NCT03591146|460001256|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
127831917|NCT04737031|460001257|FG000|Overall Study|Patients who did not have a treatment visit|0|||
127831918|NCT04737031|460001258|FG001|Overall Study|Patients who did not have a treatment visit|31|||
127831919|NCT04737031|460001259|FG002|Overall Study|Patients who did not have a treatment visit|93|||
127831920|NCT04737031|460001260|FG003|Overall Study|Patients who did not have a treatment visit|227|||
127831921|NCT01511419|460001265|FG000|Dose 2|Physician Decision|1|||
127831922|NCT01511419|460001266|FG001|Dose 2|Physician Decision|0|||
127831923|NCT03229759|460001267|FG000|Overall Study|Screen Failure|30|||
127831924|NCT03050359|460002386|FG000|Overall Study|Randomized But Not Treated|2|||
127831925|NCT03050359|460002387|FG001|Overall Study|Randomized But Not Treated|0|||
127831926|NCT03050359|460002386|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
127831927|NCT03050359|460002387|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
127831928|NCT03050359|460002386|FG000|Overall Study|Significant Protocol Deviation|2|||
127831929|NCT03050359|460002387|FG001|Overall Study|Significant Protocol Deviation|3|||
127831930|NCT03050359|460002386|FG000|Overall Study|Lost to Follow-up|2|||
127831931|NCT03050359|460002387|FG001|Overall Study|Lost to Follow-up|1|||
127831932|NCT03050359|460002386|FG000|Overall Study|Voluntary Withdrawal|4|||
127831933|NCT03050359|460002387|FG001|Overall Study|Voluntary Withdrawal|6|||
127831934|NCT03050359|460002386|FG000|Overall Study|Pregnancy|1|||
127831935|NCT03050359|460002387|FG001|Overall Study|Pregnancy|0|||
127831936|NCT03050359|460002386|FG000|Overall Study|Reason Not Specified|1|||
127831937|NCT03050359|460002387|FG001|Overall Study|Reason Not Specified|0|||
127831938|NCT02614287|460002390|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
127831939|NCT02614287|460002391|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
127831940|NCT02614287|460002390|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
127831941|NCT02614287|460002391|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
127831942|NCT02614287|460002390|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
127831943|NCT02614287|460002391|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
127831944|NCT02614287|460002390|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
127831945|NCT02614287|460002391|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
127831946|NCT02614287|460002390|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
127831947|NCT02614287|460002391|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
127831948|NCT02614287|460002390|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
127831949|NCT02614287|460002391|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
127831950|NCT02614287|460002390|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
127831951|NCT02614287|460002391|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
127831952|NCT02614287|460002390|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
127831953|NCT02614287|460002391|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
127831954|NCT00833248|460002396|FG000|Overall Study|Adverse Event|3|||
127831955|NCT00833248|460002397|FG001|Overall Study|Adverse Event|0|||
127831956|NCT00833248|460002396|FG000|Overall Study|Protocol Violation|1|||
127831957|NCT00833248|460002397|FG001|Overall Study|Protocol Violation|2|||
127831958|NCT00833248|460002396|FG000|Overall Study|Withdrawal by Subject|0|||
127831959|NCT00833248|460002397|FG001|Overall Study|Withdrawal by Subject|1|||
127831960|NCT02006667|460002399|FG000|Overall Study|Adverse Event|3|||
127831961|NCT02006667|460002399|FG000|Overall Study|Death|2|||
127831962|NCT02006667|460002399|FG000|Overall Study|Withdrawal by Subject|1|||
127831963|NCT02939937|460002400|FG000|Overall Study|Adverse Event|5|||
127831964|NCT02939937|460002401|FG001|Overall Study|Adverse Event|0|||
127831965|NCT02939937|460002400|FG000|Overall Study|Lost to Follow-up|1|||
127831966|NCT02939937|460002401|FG001|Overall Study|Lost to Follow-up|3|||
127831967|NCT00520676|460002413|FG000|Overall Study|Death|84|||
127831968|NCT00520676|460002414|FG001|Overall Study|Death|81|||
127831969|NCT00520676|460002413|FG000|Overall Study|Lost to Follow-up|6|||
127831970|NCT00520676|460002414|FG001|Overall Study|Lost to Follow-up|10|||
127831971|NCT00520676|460002413|FG000|Overall Study|Physician Decision|4|||
127831972|NCT00520676|460002414|FG001|Overall Study|Physician Decision|1|||
127831973|NCT00520676|460002413|FG000|Overall Study|Withdrawal by Subject|7|||
127831974|NCT00520676|460002414|FG001|Overall Study|Withdrawal by Subject|11|||
127831975|NCT02179515|460002415|FG000|Overall Study|switched to alternative treatment|0|||
127831976|NCT02179515|460002416|FG001|Overall Study|switched to alternative treatment|1|||
127831977|NCT02179515|460002417|FG002|Overall Study|switched to alternative treatment|1|||
127831978|NCT02179515|460002415|FG000|Overall Study|Death|0|||
127831979|NCT02179515|460002416|FG001|Overall Study|Death|1|||
127831980|NCT02179515|460002417|FG002|Overall Study|Death|1|||
127831981|NCT02179515|460002415|FG000|Overall Study|refused further treatment|0|||
127831982|NCT02179515|460002416|FG001|Overall Study|refused further treatment|3|||
127831983|NCT02179515|460002417|FG002|Overall Study|refused further treatment|4|||
127831984|NCT02179515|460002415|FG000|Overall Study|Disease progression on study|2|||
127831985|NCT02179515|460002416|FG001|Overall Study|Disease progression on study|11|||
127831986|NCT02179515|460002417|FG002|Overall Study|Disease progression on study|8|||
127831987|NCT00115349|460002418|FG000|Overall Study|Study closed due to low enrollment.|11|||
127831988|NCT00115349|460002419|FG001|Overall Study|Study closed due to low enrollment.|9|||
127831989|NCT02116660|460002420|FG000|Overall Study|Deteriorating renal function|0|||
127831990|NCT02116660|460002421|FG001|Overall Study|Deteriorating renal function|1|||
127831991|NCT02116660|460002420|FG000|Overall Study|Adverse Event|1|||
127831992|NCT02116660|460002421|FG001|Overall Study|Adverse Event|1|||
127831993|NCT02116660|460002420|FG000|Overall Study|Withdrawal by Subject|0|||
127831994|NCT02116660|460002421|FG001|Overall Study|Withdrawal by Subject|2|||
127831995|NCT02116660|460002420|FG000|Overall Study|Organization reason|1|||
127831996|NCT02116660|460002421|FG001|Overall Study|Organization reason|0|||
127831997|NCT00390416|460002422|FG000|Overall Study|Withdrawal by Subject|1|||
127831998|NCT00390416|460002422|FG000|Overall Study|Not treated|3|||
127831999|NCT00506077|460002423|FG000|Treatment Period 1|Adverse Event|2|||
127832000|NCT00506077|460002424|FG001|Treatment Period 1|Adverse Event|1|||
127832001|NCT00506077|460002423|FG000|Treatment Period 1|Lost to Follow-up|0|||
127832002|NCT00506077|460002424|FG001|Treatment Period 1|Lost to Follow-up|2|||
127832003|NCT00506077|460002423|FG000|Treatment Period 1|Withdrawal by Subject|2|||
127832004|NCT00506077|460002424|FG001|Treatment Period 1|Withdrawal by Subject|0|||
127832005|NCT00506077|460002423|FG000|Treatment Period 2|Adverse Event|0|||
127832006|NCT00506077|460002424|FG001|Treatment Period 2|Adverse Event|1|||
127832007|NCT00506077|460002423|FG000|Treatment Period 2|Withdrawal by Subject|1|||
127832008|NCT00506077|460002424|FG001|Treatment Period 2|Withdrawal by Subject|0|||
127832009|NCT02868216|460002426|FG000|Overall Study|Death|0|||
127832010|NCT02868216|460002427|FG001|Overall Study|Death|1|||
127832011|NCT02868216|460002426|FG000|Overall Study|coronary artery bypass|1|||
127832012|NCT02868216|460002427|FG001|Overall Study|coronary artery bypass|0|||
127832013|NCT02868216|460002426|FG000|Overall Study|Withdrawal by Subject|7|||
127832014|NCT02868216|460002427|FG001|Overall Study|Withdrawal by Subject|5|||
127832015|NCT02496585|460002428|FG000|Overall Study|Death|3|||
127832016|NCT02496585|460002429|FG001|Overall Study|Death|0|||
127832017|NCT02496585|460002428|FG000|Overall Study|Lost to Follow-up|2|||
127832018|NCT02496585|460002429|FG001|Overall Study|Lost to Follow-up|0|||
127832019|NCT02496585|460002428|FG000|Overall Study|Withdrawal by Subject|1|||
127832020|NCT02496585|460002429|FG001|Overall Study|Withdrawal by Subject|2|||
127832021|NCT02496585|460002428|FG000|Overall Study|Progression of Malignancy|4|||
127832022|NCT02496585|460002429|FG001|Overall Study|Progression of Malignancy|1|||
127832023|NCT04891770|460002430|FG000|Overall Study|Withdrew consent|1|||
127832024|NCT04891770|460002431|FG001|Overall Study|Withdrew consent|3|||
127832025|NCT04891770|460002432|FG002|Overall Study|Withdrew consent|0|||
127832026|NCT04891770|460002430|FG000|Overall Study|Enrolled but never treated|0|||
127832027|NCT04891770|460002431|FG001|Overall Study|Enrolled but never treated|0|||
127832028|NCT04891770|460002432|FG002|Overall Study|Enrolled but never treated|1|||
127832029|NCT04891770|460002430|FG000|Overall Study|Investigator's discretion|0|||
127832030|NCT04891770|460002431|FG001|Overall Study|Investigator's discretion|1|||
127832031|NCT04891770|460002432|FG002|Overall Study|Investigator's discretion|0|||
127832032|NCT00222729|460002441|FG000|Overall Study|Adverse Event|3|||
127832033|NCT01318083|460002444|FG000|Overall Study|Adverse Event|4|||
127832034|NCT01318083|460002445|FG001|Overall Study|Adverse Event|1|||
127832035|NCT01318083|460002446|FG002|Overall Study|Adverse Event|2|||
127832036|NCT01318083|460002444|FG000|Overall Study|Withdrawal by Subject|1|||
127832037|NCT01318083|460002445|FG001|Overall Study|Withdrawal by Subject|0|||
127832038|NCT01318083|460002446|FG002|Overall Study|Withdrawal by Subject|2|||
127832039|NCT01318083|460002444|FG000|Overall Study|Lack of Efficacy|0|||
127832040|NCT01318083|460002445|FG001|Overall Study|Lack of Efficacy|0|||
127832041|NCT01318083|460002446|FG002|Overall Study|Lack of Efficacy|1|||
127832042|NCT01318083|460002444|FG000|Overall Study|Treatment Complications|1|||
127832043|NCT01318083|460002445|FG001|Overall Study|Treatment Complications|0|||
127832044|NCT01318083|460002446|FG002|Overall Study|Treatment Complications|0|||
127832045|NCT01318083|460002444|FG000|Overall Study|Lack of Study Medication Compliance|0|||
127832046|NCT01318083|460002445|FG001|Overall Study|Lack of Study Medication Compliance|1|||
127832047|NCT01318083|460002446|FG002|Overall Study|Lack of Study Medication Compliance|0|||
127832048|NCT02761993|460002451|FG000|Overall Study|Adverse Event|0|||
127832049|NCT02761993|460002452|FG001|Overall Study|Adverse Event|2|||
127832050|NCT02761993|460002453|FG002|Overall Study|Adverse Event|0|||
127832051|NCT02761993|460002451|FG000|Overall Study|Lost to Follow-up|1|||
127832052|NCT02761993|460002452|FG001|Overall Study|Lost to Follow-up|3|||
127832053|NCT02761993|460002453|FG002|Overall Study|Lost to Follow-up|2|||
127832054|NCT02761993|460002451|FG000|Overall Study|Withdrawal by Subject|1|||
127832055|NCT02761993|460002452|FG001|Overall Study|Withdrawal by Subject|1|||
127832056|NCT02761993|460002453|FG002|Overall Study|Withdrawal by Subject|2|||
127832057|NCT01842620|460002454|FG000|Period 1|Withdrawal by Subject|1|||
127832058|NCT01842620|460002455|FG001|Period 1|Withdrawal by Subject|0|||
127832059|NCT00256867|460002456|FG000|Overall Study|Adverse Event|0|||
127832060|NCT00256867|460002457|FG001|Overall Study|Adverse Event|1|||
127832061|NCT00256867|460002458|FG002|Overall Study|Adverse Event|1|||
127832062|NCT00256867|460002459|FG003|Overall Study|Adverse Event|1|||
127832063|NCT00256867|460002460|FG004|Overall Study|Adverse Event|2|||
127832064|NCT00256867|460002461|FG005|Overall Study|Adverse Event|2|||
127832065|NCT00256867|460002462|FG006|Overall Study|Adverse Event|1|||
127832066|NCT00256867|460002463|FG007|Overall Study|Adverse Event|4|||
127832067|NCT00256867|460002456|FG000|Overall Study|Lost to Follow-up|2|||
127832068|NCT00256867|460002457|FG001|Overall Study|Lost to Follow-up|2|||
127832069|NCT00256867|460002458|FG002|Overall Study|Lost to Follow-up|2|||
127832070|NCT00256867|460002459|FG003|Overall Study|Lost to Follow-up|3|||
127832071|NCT00256867|460002460|FG004|Overall Study|Lost to Follow-up|2|||
127832072|NCT00256867|460002461|FG005|Overall Study|Lost to Follow-up|0|||
127832073|NCT00256867|460002462|FG006|Overall Study|Lost to Follow-up|1|||
127832074|NCT00256867|460002463|FG007|Overall Study|Lost to Follow-up|2|||
127832075|NCT00256867|460002456|FG000|Overall Study|Protocol Violation|0|||
127832076|NCT00256867|460002457|FG001|Overall Study|Protocol Violation|0|||
127832077|NCT00256867|460002458|FG002|Overall Study|Protocol Violation|0|||
127832078|NCT00256867|460002459|FG003|Overall Study|Protocol Violation|1|||
127895220|NCT04820842|460240621|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
127832079|NCT00256867|460002460|FG004|Overall Study|Protocol Violation|0|||
127832080|NCT00256867|460002461|FG005|Overall Study|Protocol Violation|1|||
127832081|NCT00256867|460002462|FG006|Overall Study|Protocol Violation|0|||
127832082|NCT00256867|460002463|FG007|Overall Study|Protocol Violation|1|||
127832083|NCT00256867|460002456|FG000|Overall Study|Withdrawal by Subject|0|||
127832084|NCT00256867|460002457|FG001|Overall Study|Withdrawal by Subject|0|||
127832085|NCT00256867|460002458|FG002|Overall Study|Withdrawal by Subject|1|||
127832086|NCT00256867|460002459|FG003|Overall Study|Withdrawal by Subject|1|||
127832087|NCT00256867|460002460|FG004|Overall Study|Withdrawal by Subject|2|||
127832088|NCT00256867|460002461|FG005|Overall Study|Withdrawal by Subject|2|||
127832089|NCT00256867|460002462|FG006|Overall Study|Withdrawal by Subject|3|||
127832090|NCT00256867|460002463|FG007|Overall Study|Withdrawal by Subject|2|||
127832091|NCT00256867|460002456|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
127832092|NCT00256867|460002457|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
127832093|NCT00256867|460002458|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
127832094|NCT00256867|460002459|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
127832095|NCT00256867|460002460|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
127832096|NCT00256867|460002461|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
127832097|NCT00256867|460002462|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
127832098|NCT00256867|460002463|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
127832099|NCT00256867|460002456|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
127832100|NCT00256867|460002457|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
127832101|NCT00256867|460002458|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
127832102|NCT00256867|460002459|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
127832103|NCT00256867|460002460|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
127832104|NCT00256867|460002461|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
127832105|NCT00256867|460002462|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
127832106|NCT00256867|460002463|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
127832107|NCT00256867|460002456|FG000|Overall Study|Investigator's Decision|0|||
127832108|NCT00256867|460002457|FG001|Overall Study|Investigator's Decision|0|||
127832109|NCT00256867|460002458|FG002|Overall Study|Investigator's Decision|0|||
127832110|NCT00256867|460002459|FG003|Overall Study|Investigator's Decision|0|||
127832111|NCT00256867|460002460|FG004|Overall Study|Investigator's Decision|1|||
127832112|NCT00256867|460002461|FG005|Overall Study|Investigator's Decision|0|||
127832113|NCT00256867|460002462|FG006|Overall Study|Investigator's Decision|0|||
127832114|NCT00256867|460002463|FG007|Overall Study|Investigator's Decision|0|||
127832115|NCT00256867|460002456|FG000|Overall Study|Non-compliance with study medication|0|||
127832116|NCT00256867|460002457|FG001|Overall Study|Non-compliance with study medication|0|||
127832117|NCT00256867|460002458|FG002|Overall Study|Non-compliance with study medication|0|||
127832118|NCT00256867|460002459|FG003|Overall Study|Non-compliance with study medication|0|||
127832119|NCT00256867|460002460|FG004|Overall Study|Non-compliance with study medication|0|||
127832120|NCT00256867|460002461|FG005|Overall Study|Non-compliance with study medication|0|||
127832121|NCT00256867|460002462|FG006|Overall Study|Non-compliance with study medication|0|||
127832122|NCT00256867|460002463|FG007|Overall Study|Non-compliance with study medication|1|||
127832123|NCT00256867|460002456|FG000|Overall Study|Participant travelled Overseas|0|||
127832124|NCT00256867|460002457|FG001|Overall Study|Participant travelled Overseas|1|||
127832125|NCT00256867|460002458|FG002|Overall Study|Participant travelled Overseas|0|||
127832126|NCT00256867|460002459|FG003|Overall Study|Participant travelled Overseas|0|||
127832127|NCT00256867|460002460|FG004|Overall Study|Participant travelled Overseas|0|||
127832128|NCT00256867|460002461|FG005|Overall Study|Participant travelled Overseas|0|||
127832129|NCT00256867|460002462|FG006|Overall Study|Participant travelled Overseas|0|||
127832130|NCT00256867|460002463|FG007|Overall Study|Participant travelled Overseas|0|||
127832131|NCT00256867|460002456|FG000|Overall Study|Participant out of assessment window|0|||
127832132|NCT00256867|460002457|FG001|Overall Study|Participant out of assessment window|0|||
127832133|NCT00256867|460002458|FG002|Overall Study|Participant out of assessment window|1|||
127832134|NCT00256867|460002459|FG003|Overall Study|Participant out of assessment window|0|||
127832135|NCT00256867|460002460|FG004|Overall Study|Participant out of assessment window|0|||
127832136|NCT00256867|460002461|FG005|Overall Study|Participant out of assessment window|0|||
127832137|NCT00256867|460002462|FG006|Overall Study|Participant out of assessment window|0|||
127832138|NCT00256867|460002463|FG007|Overall Study|Participant out of assessment window|0|||
127832139|NCT00256867|460002456|FG000|Overall Study|Withdrawal by participant|0|||
127832140|NCT00256867|460002457|FG001|Overall Study|Withdrawal by participant|0|||
127832141|NCT00256867|460002458|FG002|Overall Study|Withdrawal by participant|0|||
127832142|NCT00256867|460002459|FG003|Overall Study|Withdrawal by participant|0|||
127832143|NCT00256867|460002460|FG004|Overall Study|Withdrawal by participant|0|||
127832144|NCT00256867|460002461|FG005|Overall Study|Withdrawal by participant|1|||
127832145|NCT00256867|460002462|FG006|Overall Study|Withdrawal by participant|0|||
127832146|NCT00256867|460002463|FG007|Overall Study|Withdrawal by participant|0|||
127832147|NCT02993224|460002464|FG000|Core Phase - Period 1|Adverse Event|4|||
127832148|NCT02993224|460002464|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
127832149|NCT02993224|460002464|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
127832150|NCT02993224|460002464|FG000|Core Phase- Period 2|Adverse Event|1|||
127832151|NCT02993224|460002464|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
127832152|NCT02993224|460002464|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
127832153|NCT02993224|460002464|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
127832154|NCT02993224|460002464|FG000|Extension Phase|Adverse Event|3|||
127832155|NCT02993224|460002464|FG000|Extension Phase|Withdrawal by Subject|3|||
127832156|NCT02993224|460002464|FG000|Extension Phase|Lost to Follow-up|2|||
127832157|NCT02993224|460002464|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
127832158|NCT01930799|460002468|FG000|Overall Study|Withdrawal by Subject|3|||
127832159|NCT01930799|460002468|FG000|Overall Study|Lost to Follow-up|5|||
127832160|NCT00952289|460002469|FG000|All Participants|Death|9|||
127832161|NCT00952289|460002470|FG001|All Participants|Death|9|||
127832162|NCT00952289|460002469|FG000|All Participants|Adverse Event|8|||
127832163|NCT00952289|460002470|FG001|All Participants|Adverse Event|8|||
127832164|NCT00952289|460002469|FG000|All Participants|Disease progression|3|||
127832165|NCT00952289|460002470|FG001|All Participants|Disease progression|12|||
127832166|NCT00952289|460002469|FG000|All Participants|Withdrawal by Subject|1|||
127832167|NCT00952289|460002470|FG001|All Participants|Withdrawal by Subject|10|||
127832168|NCT00952289|460002469|FG000|All Participants|Data lost during site relocation|0|||
127832169|NCT00952289|460002470|FG001|All Participants|Data lost during site relocation|1|||
127832170|NCT00952289|460002469|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
127832171|NCT00952289|460002470|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
127832172|NCT00952289|460002469|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
127832173|NCT00952289|460002470|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
127832174|NCT00952289|460002469|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
127832175|NCT00952289|460002470|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
127832176|NCT00952289|460002469|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
127832177|NCT00952289|460002470|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
127832178|NCT00952289|460002469|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
127832179|NCT00952289|460002470|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
127832180|NCT00875017|460002471|FG000|First Intervention|Withdrawal by Subject|1|||
127832181|NCT00875017|460002472|FG001|First Intervention|Withdrawal by Subject|0|||
127832182|NCT00875017|460002473|FG002|First Intervention|Withdrawal by Subject|1|||
127832183|NCT00875017|460002474|FG003|First Intervention|Withdrawal by Subject|0|||
127832184|NCT00875017|460002475|FG004|First Intervention|Withdrawal by Subject|0|||
127832185|NCT00875017|460002476|FG005|First Intervention|Withdrawal by Subject|0|||
127832186|NCT00875017|460002471|FG000|First Intervention|Adverse Event|0|||
127895221|NCT04820842|460240622|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
127832187|NCT00875017|460002472|FG001|First Intervention|Adverse Event|0|||
127832188|NCT00875017|460002473|FG002|First Intervention|Adverse Event|0|||
127832189|NCT00875017|460002474|FG003|First Intervention|Adverse Event|1|||
127832190|NCT00875017|460002475|FG004|First Intervention|Adverse Event|0|||
127832191|NCT00875017|460002476|FG005|First Intervention|Adverse Event|0|||
127832192|NCT00875017|460002471|FG000|First Intervention|Problems collecting rectal effluent|1|||
127832193|NCT00875017|460002472|FG001|First Intervention|Problems collecting rectal effluent|0|||
127832194|NCT00875017|460002473|FG002|First Intervention|Problems collecting rectal effluent|0|||
127832195|NCT00875017|460002474|FG003|First Intervention|Problems collecting rectal effluent|0|||
127832196|NCT00875017|460002475|FG004|First Intervention|Problems collecting rectal effluent|0|||
127832197|NCT00875017|460002476|FG005|First Intervention|Problems collecting rectal effluent|0|||
127832198|NCT00875017|460002471|FG000|First Intervention|Intolerance to nasogastric tube|0|||
127832199|NCT00875017|460002472|FG001|First Intervention|Intolerance to nasogastric tube|0|||
127832200|NCT00875017|460002473|FG002|First Intervention|Intolerance to nasogastric tube|0|||
127832201|NCT00875017|460002474|FG003|First Intervention|Intolerance to nasogastric tube|0|||
127832202|NCT00875017|460002475|FG004|First Intervention|Intolerance to nasogastric tube|1|||
127832203|NCT00875017|460002476|FG005|First Intervention|Intolerance to nasogastric tube|0|||
127832204|NCT00875017|460002471|FG000|Washout|Problem collecting rectal effluent|0|||
127832205|NCT00875017|460002472|FG001|Washout|Problem collecting rectal effluent|0|||
127832206|NCT00875017|460002473|FG002|Washout|Problem collecting rectal effluent|1|||
127832207|NCT00875017|460002474|FG003|Washout|Problem collecting rectal effluent|0|||
127832208|NCT00875017|460002475|FG004|Washout|Problem collecting rectal effluent|0|||
127832209|NCT00875017|460002476|FG005|Washout|Problem collecting rectal effluent|0|||
127832210|NCT00875017|460002471|FG000|Second Intervention|Adverse Event|0|||
127832211|NCT00875017|460002472|FG001|Second Intervention|Adverse Event|0|||
127832212|NCT00875017|460002473|FG002|Second Intervention|Adverse Event|0|||
127832213|NCT00875017|460002474|FG003|Second Intervention|Adverse Event|1|||
127832214|NCT00875017|460002475|FG004|Second Intervention|Adverse Event|0|||
127832215|NCT00875017|460002476|FG005|Second Intervention|Adverse Event|0|||
127832216|NCT00875017|460002471|FG000|Washout|Problems collecting rectal effluent|0|||
127832217|NCT00875017|460002472|FG001|Washout|Problems collecting rectal effluent|1|||
127832218|NCT00875017|460002473|FG002|Washout|Problems collecting rectal effluent|0|||
127832219|NCT00875017|460002474|FG003|Washout|Problems collecting rectal effluent|0|||
127832220|NCT00875017|460002475|FG004|Washout|Problems collecting rectal effluent|0|||
127832221|NCT00875017|460002476|FG005|Washout|Problems collecting rectal effluent|0|||
127832222|NCT00875017|460002471|FG000|Third Intervention|Adverse Event|0|||
127832223|NCT00875017|460002472|FG001|Third Intervention|Adverse Event|1|||
127832224|NCT00875017|460002473|FG002|Third Intervention|Adverse Event|1|||
127832225|NCT00875017|460002474|FG003|Third Intervention|Adverse Event|0|||
127832226|NCT00875017|460002475|FG004|Third Intervention|Adverse Event|0|||
127832227|NCT00875017|460002476|FG005|Third Intervention|Adverse Event|0|||
127832228|NCT00875017|460002471|FG000|Washout|Withdrawal by Subject|0|||
127832229|NCT00875017|460002472|FG001|Washout|Withdrawal by Subject|0|||
127832230|NCT00875017|460002473|FG002|Washout|Withdrawal by Subject|0|||
127832231|NCT00875017|460002474|FG003|Washout|Withdrawal by Subject|0|||
127832232|NCT00875017|460002475|FG004|Washout|Withdrawal by Subject|1|||
127832233|NCT00875017|460002476|FG005|Washout|Withdrawal by Subject|0|||
127832234|NCT00875017|460002471|FG000|Fourth Intervention|Inability to comply with fasting|0|||
127895222|NCT04820842|460240616|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
127895223|NCT04820842|460240617|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
127895224|NCT04820842|460240618|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
127895225|NCT04820842|460240619|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
127895226|NCT04820842|460240620|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
127895227|NCT04820842|460240621|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
127895228|NCT04820842|460240622|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
127895229|NCT01296932|460240623|FG000|Overall Study|Dose limiting toxicity|0|||
127895230|NCT01296932|460240624|FG001|Overall Study|Dose limiting toxicity|0|||
127895231|NCT01296932|460240625|FG002|Overall Study|Dose limiting toxicity|0|||
127895232|NCT01296932|460240626|FG003|Overall Study|Dose limiting toxicity|0|||
127895233|NCT01296932|460240627|FG004|Overall Study|Dose limiting toxicity|0|||
127895234|NCT01296932|460240628|FG005|Overall Study|Dose limiting toxicity|0|||
127832235|NCT00875017|460002472|FG001|Fourth Intervention|Inability to comply with fasting|0|||
127832236|NCT00875017|460002473|FG002|Fourth Intervention|Inability to comply with fasting|0|||
127832237|NCT00875017|460002474|FG003|Fourth Intervention|Inability to comply with fasting|0|||
127832238|NCT00875017|460002475|FG004|Fourth Intervention|Inability to comply with fasting|0|||
127832239|NCT00875017|460002476|FG005|Fourth Intervention|Inability to comply with fasting|1|||
127832240|NCT03342469|460002477|FG000|Overall Study|Withdrawal by Subject|0|||
127832241|NCT03342469|460002478|FG001|Overall Study|Withdrawal by Subject|1|||
127832242|NCT03342469|460002479|FG002|Overall Study|Withdrawal by Subject|0|||
127832243|NCT03342469|460002480|FG003|Overall Study|Withdrawal by Subject|0|||
127832244|NCT03136185|460002488|FG000|Overall Study|Adverse Event|0|||
127832245|NCT03136185|460002489|FG001|Overall Study|Adverse Event|1|||
127832246|NCT03136185|460002490|FG002|Overall Study|Adverse Event|3|||
127832247|NCT03136185|460002491|FG003|Overall Study|Adverse Event|1|||
127832248|NCT03136185|460002492|FG004|Overall Study|Adverse Event|2|||
127832249|NCT03136185|460002493|FG005|Overall Study|Adverse Event|2|||
127832250|NCT03136185|460002494|FG006|Overall Study|Adverse Event|5|||
127832251|NCT03136185|460002495|FG007|Overall Study|Adverse Event|1|||
127832252|NCT03136185|460002496|FG008|Overall Study|Adverse Event|1|||
127832253|NCT03136185|460002488|FG000|Overall Study|Death|0|||
127832254|NCT03136185|460002489|FG001|Overall Study|Death|0|||
127832255|NCT03136185|460002490|FG002|Overall Study|Death|0|||
127832256|NCT03136185|460002491|FG003|Overall Study|Death|1|||
127832257|NCT03136185|460002492|FG004|Overall Study|Death|1|||
127832258|NCT03136185|460002493|FG005|Overall Study|Death|0|||
127832259|NCT03136185|460002494|FG006|Overall Study|Death|1|||
127832260|NCT03136185|460002495|FG007|Overall Study|Death|0|||
127832261|NCT03136185|460002496|FG008|Overall Study|Death|0|||
127832262|NCT03136185|460002488|FG000|Overall Study|Physician Decision|3|||
127832263|NCT03136185|460002489|FG001|Overall Study|Physician Decision|1|||
127832264|NCT03136185|460002490|FG002|Overall Study|Physician Decision|1|||
127832265|NCT03136185|460002491|FG003|Overall Study|Physician Decision|2|||
127832266|NCT03136185|460002492|FG004|Overall Study|Physician Decision|1|||
127832267|NCT03136185|460002493|FG005|Overall Study|Physician Decision|2|||
127832268|NCT03136185|460002494|FG006|Overall Study|Physician Decision|1|||
127832269|NCT03136185|460002495|FG007|Overall Study|Physician Decision|0|||
127832270|NCT03136185|460002496|FG008|Overall Study|Physician Decision|1|||
127832271|NCT03136185|460002488|FG000|Overall Study|Protocol Defined Disease Progression|0|||
127832272|NCT03136185|460002489|FG001|Overall Study|Protocol Defined Disease Progression|0|||
127832273|NCT03136185|460002490|FG002|Overall Study|Protocol Defined Disease Progression|1|||
127832274|NCT03136185|460002491|FG003|Overall Study|Protocol Defined Disease Progression|0|||
127832275|NCT03136185|460002492|FG004|Overall Study|Protocol Defined Disease Progression|0|||
127832276|NCT03136185|460002493|FG005|Overall Study|Protocol Defined Disease Progression|1|||
127832277|NCT03136185|460002494|FG006|Overall Study|Protocol Defined Disease Progression|0|||
127832278|NCT03136185|460002495|FG007|Overall Study|Protocol Defined Disease Progression|1|||
127832279|NCT03136185|460002496|FG008|Overall Study|Protocol Defined Disease Progression|1|||
127832280|NCT03136185|460002488|FG000|Overall Study|Withdrawal by Subject|1|||
127832281|NCT03136185|460002489|FG001|Overall Study|Withdrawal by Subject|0|||
127832282|NCT03136185|460002490|FG002|Overall Study|Withdrawal by Subject|1|||
127832283|NCT03136185|460002491|FG003|Overall Study|Withdrawal by Subject|1|||
127832284|NCT03136185|460002492|FG004|Overall Study|Withdrawal by Subject|1|||
127832285|NCT03136185|460002493|FG005|Overall Study|Withdrawal by Subject|1|||
127832286|NCT03136185|460002494|FG006|Overall Study|Withdrawal by Subject|2|||
127832287|NCT03136185|460002495|FG007|Overall Study|Withdrawal by Subject|3|||
127832288|NCT03136185|460002496|FG008|Overall Study|Withdrawal by Subject|3|||
127832289|NCT03136185|460002488|FG000|Overall Study|Not Reported|4|||
127832290|NCT03136185|460002489|FG001|Overall Study|Not Reported|1|||
127832291|NCT03136185|460002490|FG002|Overall Study|Not Reported|0|||
127832292|NCT03136185|460002491|FG003|Overall Study|Not Reported|1|||
127832293|NCT03136185|460002492|FG004|Overall Study|Not Reported|0|||
127832294|NCT03136185|460002493|FG005|Overall Study|Not Reported|2|||
127832295|NCT03136185|460002494|FG006|Overall Study|Not Reported|1|||
127832296|NCT03136185|460002495|FG007|Overall Study|Not Reported|1|||
127832297|NCT03136185|460002496|FG008|Overall Study|Not Reported|0|||
127832298|NCT00364845|460002502|FG000|Overall Study|Adverse Event|1|||
127832299|NCT00364845|460002503|FG001|Overall Study|Adverse Event|0|||
127832300|NCT00364845|460002502|FG000|Overall Study|Withdrawal by Subject|2|||
127832301|NCT00364845|460002503|FG001|Overall Study|Withdrawal by Subject|1|||
127832302|NCT00364845|460002502|FG000|Overall Study|Physician Decision|8|||
127832303|NCT00364845|460002503|FG001|Overall Study|Physician Decision|8|||
127832304|NCT00364845|460002502|FG000|Overall Study|Lost to Follow-up|0|||
127832305|NCT00364845|460002503|FG001|Overall Study|Lost to Follow-up|1|||
127832306|NCT00364845|460002502|FG000|Overall Study|Death|0|||
127832307|NCT00364845|460002503|FG001|Overall Study|Death|1|||
127832308|NCT00488033|460002504|FG000|Overall Study|Withdrawal by Subject|1|||
127832309|NCT00488033|460002505|FG001|Overall Study|Withdrawal by Subject|0|||
127832310|NCT04715230|460002512|FG000|Overall Study|Withdrawal by Subject|1|||
127832311|NCT04715230|460002513|FG001|Overall Study|Withdrawal by Subject|0|||
127832312|NCT04715230|460002514|FG002|Overall Study|Withdrawal by Subject|0|||
127832313|NCT04715230|460002512|FG000|Overall Study|Lost to Follow-up|0|||
127832314|NCT04715230|460002513|FG001|Overall Study|Lost to Follow-up|5|||
127832315|NCT04715230|460002514|FG002|Overall Study|Lost to Follow-up|1|||
127832316|NCT03453151|460002515|FG000|Overall Study|Withdrawal by Subject|1|||
127832317|NCT03453151|460002515|FG000|Overall Study|Physician Decision|3|||
127832318|NCT01468909|460002516|FG000|Overall Study|Never Treated|2|||
127832319|NCT01468909|460002517|FG001|Overall Study|Never Treated|2|||
127832320|NCT00488618|460002522|FG000|Overall Study|Adverse Event|13|||
127832321|NCT00488618|460002523|FG001|Overall Study|Adverse Event|17|||
127832322|NCT00488618|460002522|FG000|Overall Study|Insufficient Therapeutic Response|18|||
127832323|NCT00488618|460002523|FG001|Overall Study|Insufficient Therapeutic Response|11|||
127832324|NCT00488618|460002522|FG000|Overall Study|Protocol Violation|0|||
127832325|NCT00488618|460002523|FG001|Overall Study|Protocol Violation|2|||
127832326|NCT00488618|460002522|FG000|Overall Study|Withdrawal of Consent|15|||
127832327|NCT00488618|460002523|FG001|Overall Study|Withdrawal of Consent|13|||
127832328|NCT00488618|460002522|FG000|Overall Study|Lost to Follow-up|1|||
127832329|NCT00488618|460002523|FG001|Overall Study|Lost to Follow-up|0|||
127832330|NCT02326467|460003957|FG000|Overall Study|Withdrawal by Subject|1|||
127832331|NCT00434512|460003958|FG000|Overall Study|Migrated/moved from study area|0|||
127832332|NCT00434512|460003959|FG001|Overall Study|Migrated/moved from study area|0|||
127832333|NCT00434512|460003960|FG002|Overall Study|Migrated/moved from study area|0|||
127832334|NCT00434512|460003961|FG003|Overall Study|Migrated/moved from study area|1|||
127832335|NCT00434512|460003962|FG004|Overall Study|Migrated/moved from study area|1|||
127832336|NCT00434512|460003963|FG005|Overall Study|Migrated/moved from study area|1|||
127832337|NCT00434512|460003958|FG000|Overall Study|Other|0|||
127832338|NCT00434512|460003959|FG001|Overall Study|Other|1|||
127832339|NCT00434512|460003960|FG002|Overall Study|Other|0|||
127832340|NCT00434512|460003961|FG003|Overall Study|Other|0|||
127832341|NCT00434512|460003962|FG004|Overall Study|Other|0|||
127832342|NCT00434512|460003963|FG005|Overall Study|Other|0|||
127832343|NCT01575197|460003966|FG000|Overall Study|Migration out of study area|1|||
127832344|NCT01575197|460003967|FG001|Overall Study|Migration out of study area|5|||
127832345|NCT01575197|460003968|FG002|Overall Study|Migration out of study area|4|||
127832346|NCT01575197|460003966|FG000|Overall Study|SAE|0|||
127832347|NCT01575197|460003967|FG001|Overall Study|SAE|1|||
127832348|NCT01575197|460003968|FG002|Overall Study|SAE|0|||
127832349|NCT01575197|460003966|FG000|Overall Study|Lost to Follow-up|0|||
127832350|NCT01575197|460003967|FG001|Overall Study|Lost to Follow-up|1|||
127832351|NCT01575197|460003968|FG002|Overall Study|Lost to Follow-up|0|||
127832352|NCT01575197|460003966|FG000|Overall Study|Withdrawal by Subject|0|||
127832353|NCT01575197|460003967|FG001|Overall Study|Withdrawal by Subject|1|||
127832354|NCT01575197|460003968|FG002|Overall Study|Withdrawal by Subject|1|||
127832355|NCT01575197|460003966|FG000|Overall Study|Protocol Violation|2|||
127832356|NCT01575197|460003967|FG001|Overall Study|Protocol Violation|1|||
127832357|NCT01575197|460003968|FG002|Overall Study|Protocol Violation|1|||
127832358|NCT00111475|460003972|FG000|Overall Study|Lost to Follow-up|0|||
127832359|NCT00111475|460003973|FG001|Overall Study|Lost to Follow-up|0|||
127832360|NCT00111475|460003974|FG002|Overall Study|Lost to Follow-up|0|||
127832361|NCT00111475|460003975|FG003|Overall Study|Lost to Follow-up|0|||
127832362|NCT00111475|460003976|FG004|Overall Study|Lost to Follow-up|0|||
127832363|NCT00111475|460003977|FG005|Overall Study|Lost to Follow-up|1|||
127832364|NCT00111475|460003978|FG006|Overall Study|Lost to Follow-up|0|||
127832365|NCT00111475|460003979|FG007|Overall Study|Lost to Follow-up|0|||
127832366|NCT00111475|460003980|FG008|Overall Study|Lost to Follow-up|0|||
127832367|NCT00111475|460003981|FG009|Overall Study|Lost to Follow-up|0|||
127832368|NCT03303092|460003982|FG000|Overall Study|Adverse Event|1|||
127832369|NCT03303092|460003983|FG001|Overall Study|Adverse Event|0|||
127832370|NCT03303092|460003984|FG002|Overall Study|Adverse Event|1|||
127832371|NCT03303092|460003982|FG000|Overall Study|Protocol Violation|1|||
127832372|NCT03303092|460003983|FG001|Overall Study|Protocol Violation|5|||
127832373|NCT03303092|460003984|FG002|Overall Study|Protocol Violation|1|||
127832374|NCT03303092|460003982|FG000|Overall Study|Withdrawal by Subject|1|||
127832375|NCT03303092|460003983|FG001|Overall Study|Withdrawal by Subject|1|||
127832376|NCT03303092|460003984|FG002|Overall Study|Withdrawal by Subject|3|||
127832377|NCT04281030|460003990|FG000|Overall Study|Technology issues prevented participant from receiving intervention|2|||
127832378|NCT04281030|460003991|FG001|Overall Study|Technology issues prevented participant from receiving intervention|2|||
127832379|NCT04281030|460003990|FG000|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|8|||
127832380|NCT04281030|460003991|FG001|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|6|||
127832381|NCT01361009|460003992|FG000|Overall Study|Protocol Violation|116|||
127832382|NCT01826422|460003993|FG000|Overall Study|Withdrawal by Subject|1|||
127832383|NCT01826422|460003994|FG001|Overall Study|Withdrawal by Subject|3|||
127832384|NCT03439748|460003997|FG000|Overall Study|Withdrawal by Subject|11|||
127832385|NCT03439748|460003998|FG001|Overall Study|Withdrawal by Subject|17|||
127832386|NCT05131451|460003999|FG000|Overall Study|Protocol Violation|1|||
127832387|NCT05131451|460004000|FG001|Overall Study|Protocol Violation|0|||
127832388|NCT00782418|460004001|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
127832389|NCT00782418|460004002|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
127832390|NCT00782418|460004003|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
127832391|NCT00782418|460004004|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
127832392|NCT00782418|460004005|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
127832393|NCT00782418|460004006|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
127832394|NCT00782418|460004007|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
127832395|NCT00782418|460004001|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
127832396|NCT00782418|460004002|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
127832397|NCT00782418|460004003|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
127832398|NCT00782418|460004004|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
127832399|NCT00782418|460004005|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
127832400|NCT00782418|460004006|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
127832401|NCT00782418|460004007|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
127832402|NCT02324842|460004008|FG000|Overall Study|Lost to Follow-up|1|||
127832403|NCT02324842|460004009|FG001|Overall Study|Lost to Follow-up|1|||
127832404|NCT02324842|460004010|FG002|Overall Study|Lost to Follow-up|2|||
127832405|NCT02750800|460004011|FG000|Overall Study|Adverse Event|18|||
127832406|NCT02750800|460004011|FG000|Overall Study|Lost to Follow-up|12|||
127832407|NCT02750800|460004011|FG000|Overall Study|Investigator decision|53|||
127832408|NCT02750800|460004011|FG000|Overall Study|Patient request|12|||
127832409|NCT02750800|460004011|FG000|Overall Study|Other, not specified|3|||
127832410|NCT03298412|460004012|FG000|Run-in Period|Other, Not Specified|1|||
127832411|NCT03298412|460004012|FG000|Run-in Period|Disease Progression|1|||
127832412|NCT03298412|460004012|FG000|Run-in Period|Ineligibility Determined|1|||
127832413|NCT03298412|460004012|FG000|Run-in Period|Decision by Sponsor|6|||
127832414|NCT05631548|460004014|FG000|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|0|||
127832415|NCT05631548|460004015|FG001|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|1|||
127832416|NCT00995345|460004020|FG000|Overall Study|Withdrawal by Subject|4|||
127832417|NCT00995345|460004021|FG001|Overall Study|Withdrawal by Subject|2|||
127832418|NCT00995345|460004022|FG002|Overall Study|Withdrawal by Subject|1|||
127832419|NCT00995345|460004023|FG003|Overall Study|Withdrawal by Subject|3|||
127832420|NCT00995345|460004024|FG004|Overall Study|Withdrawal by Subject|1|||
127832421|NCT00995345|460004020|FG000|Overall Study|Adverse Event|3|||
127832422|NCT00995345|460004021|FG001|Overall Study|Adverse Event|1|||
127832423|NCT00995345|460004022|FG002|Overall Study|Adverse Event|2|||
127832424|NCT00995345|460004023|FG003|Overall Study|Adverse Event|0|||
127832425|NCT00995345|460004024|FG004|Overall Study|Adverse Event|1|||
127832426|NCT00995345|460004020|FG000|Overall Study|Lost to Follow-up|2|||
127832427|NCT00995345|460004021|FG001|Overall Study|Lost to Follow-up|2|||
127832428|NCT00995345|460004022|FG002|Overall Study|Lost to Follow-up|2|||
127832429|NCT00995345|460004023|FG003|Overall Study|Lost to Follow-up|1|||
127832430|NCT00995345|460004024|FG004|Overall Study|Lost to Follow-up|0|||
127832431|NCT00995345|460004020|FG000|Overall Study|all other reasons combined|2|||
127832432|NCT00995345|460004021|FG001|Overall Study|all other reasons combined|2|||
127832433|NCT00995345|460004022|FG002|Overall Study|all other reasons combined|2|||
127832434|NCT00995345|460004023|FG003|Overall Study|all other reasons combined|1|||
127832435|NCT00995345|460004024|FG004|Overall Study|all other reasons combined|3|||
127895235|NCT01296932|460240629|FG006|Overall Study|Dose limiting toxicity|1|||
127895236|NCT01296932|460240630|FG007|Overall Study|Dose limiting toxicity|0|||
127895237|NCT01296932|460240631|FG008|Overall Study|Dose limiting toxicity|1|||
127895238|NCT01296932|460240623|FG000|Overall Study|Progressive disease|2|||
127832436|NCT01860534|460004025|FG000|ROP #1|Needed treatment for ROP|0|||
127832437|NCT01860534|460004026|FG001|ROP #1|Needed treatment for ROP|1|||
127832438|NCT01860534|460004025|FG000|ROP #2|discharged prior to ROP #2|1|||
127832439|NCT01860534|460004026|FG001|ROP #2|discharged prior to ROP #2|0|||
127832440|NCT05122650|460004030|FG000|Overall Study|Adverse Event|4|||
127832441|NCT05122650|460004031|FG001|Overall Study|Adverse Event|16|||
127832442|NCT05122650|460004032|FG002|Overall Study|Adverse Event|11|||
127832443|NCT05122650|460004033|FG003|Overall Study|Adverse Event|12|||
127832444|NCT05122650|460004030|FG000|Overall Study|Lack of Efficacy|0|||
127832445|NCT05122650|460004031|FG001|Overall Study|Lack of Efficacy|1|||
127832446|NCT05122650|460004032|FG002|Overall Study|Lack of Efficacy|1|||
127832447|NCT05122650|460004033|FG003|Overall Study|Lack of Efficacy|2|||
127832448|NCT05122650|460004030|FG000|Overall Study|Lost to Follow-up|1|||
127832449|NCT05122650|460004031|FG001|Overall Study|Lost to Follow-up|1|||
127832450|NCT05122650|460004032|FG002|Overall Study|Lost to Follow-up|3|||
127832451|NCT05122650|460004033|FG003|Overall Study|Lost to Follow-up|0|||
127832452|NCT05122650|460004030|FG000|Overall Study|Non-compliance with study intervention|0|||
127832453|NCT05122650|460004031|FG001|Overall Study|Non-compliance with study intervention|0|||
127832454|NCT05122650|460004032|FG002|Overall Study|Non-compliance with study intervention|0|||
127832455|NCT05122650|460004033|FG003|Overall Study|Non-compliance with study intervention|2|||
127832456|NCT05122650|460004030|FG000|Overall Study|Protocol Violation|0|||
127832457|NCT05122650|460004031|FG001|Overall Study|Protocol Violation|1|||
127832458|NCT05122650|460004032|FG002|Overall Study|Protocol Violation|0|||
127832459|NCT05122650|460004033|FG003|Overall Study|Protocol Violation|1|||
127832460|NCT05122650|460004030|FG000|Overall Study|Randomized by mistake|0|||
127832461|NCT05122650|460004031|FG001|Overall Study|Randomized by mistake|0|||
127832462|NCT05122650|460004032|FG002|Overall Study|Randomized by mistake|3|||
127832463|NCT05122650|460004033|FG003|Overall Study|Randomized by mistake|2|||
127832464|NCT05122650|460004030|FG000|Overall Study|Sponsor request|0|||
127832465|NCT05122650|460004031|FG001|Overall Study|Sponsor request|1|||
127832466|NCT05122650|460004032|FG002|Overall Study|Sponsor request|1|||
127832467|NCT05122650|460004033|FG003|Overall Study|Sponsor request|2|||
127832468|NCT05122650|460004030|FG000|Overall Study|Withdrawal by Subject|3|||
127832469|NCT05122650|460004031|FG001|Overall Study|Withdrawal by Subject|7|||
127832470|NCT05122650|460004032|FG002|Overall Study|Withdrawal by Subject|4|||
127832471|NCT05122650|460004033|FG003|Overall Study|Withdrawal by Subject|8|||
127832472|NCT05122650|460004030|FG000|Overall Study|Other|5|||
127832473|NCT05122650|460004031|FG001|Overall Study|Other|0|||
127832474|NCT05122650|460004032|FG002|Overall Study|Other|0|||
127832475|NCT05122650|460004033|FG003|Overall Study|Other|0|||
127832476|NCT01401010|460004034|FG000|Overall Study|Could not interpret assay results|1|||
127832477|NCT01401010|460004035|FG001|Overall Study|Could not interpret assay results|0|||
127832478|NCT04360187|460004041|FG000|Double-Blind Treatment|Adverse Event|9|||
127832479|NCT04360187|460004042|FG001|Double-Blind Treatment|Adverse Event|11|||
127832480|NCT04360187|460004041|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
127832481|NCT04360187|460004042|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
127832482|NCT04360187|460004041|FG000|Double-Blind Treatment|Physician Decision|1|||
127832483|NCT04360187|460004042|FG001|Double-Blind Treatment|Physician Decision|0|||
127832484|NCT04360187|460004041|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
127832485|NCT04360187|460004042|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
127832486|NCT04360187|460004041|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
127832487|NCT04360187|460004042|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
127832488|NCT04360187|460004041|FG000|Follow-Up|Lost to Follow-up|1|||
127832489|NCT04360187|460004042|FG001|Follow-Up|Lost to Follow-up|0|||
127832490|NCT01423617|460004053|FG000|Overall Study|Lost to Follow-up|0|||
127832491|NCT01423617|460004054|FG001|Overall Study|Lost to Follow-up|1|||
127832492|NCT01515306|460004055|FG000|Overall Study|Adverse Event|3|||
127832493|NCT01515306|460004056|FG001|Overall Study|Adverse Event|2|||
127832494|NCT01515306|460004055|FG000|Overall Study|Progressive Disease|19|||
127832495|NCT01515306|460004056|FG001|Overall Study|Progressive Disease|9|||
127832496|NCT01515306|460004055|FG000|Overall Study|Withdrawal by Subject|1|||
127832497|NCT01515306|460004056|FG001|Overall Study|Withdrawal by Subject|2|||
127832498|NCT01515306|460004055|FG000|Overall Study|Physician Decision|1|||
127832499|NCT01515306|460004056|FG001|Overall Study|Physician Decision|1|||
127895239|NCT01296932|460240624|FG001|Overall Study|Progressive disease|0|||
127832500|NCT00634244|460004060|FG000|Overall Study|Never started treatment|0|||
127832501|NCT00634244|460004061|FG001|Overall Study|Never started treatment|1|||
127832502|NCT00634244|460004062|FG002|Overall Study|Never started treatment|0|||
127832503|NCT00634244|460004060|FG000|Overall Study|Death|1|||
127832504|NCT00634244|460004061|FG001|Overall Study|Death|6|||
127832505|NCT00634244|460004062|FG002|Overall Study|Death|0|||
127832506|NCT00634244|460004060|FG000|Overall Study|Adverse Event|0|||
127832507|NCT00634244|460004061|FG001|Overall Study|Adverse Event|2|||
127832508|NCT00634244|460004062|FG002|Overall Study|Adverse Event|0|||
127832509|NCT00634244|460004060|FG000|Overall Study|Withdrawal by Subject|0|||
127895240|NCT01296932|460240625|FG002|Overall Study|Progressive disease|1|||
127832510|NCT00634244|460004061|FG001|Overall Study|Withdrawal by Subject|1|||
127832511|NCT00634244|460004062|FG002|Overall Study|Withdrawal by Subject|0|||
127832512|NCT00634244|460004060|FG000|Overall Study|Physician Decision|0|||
127832513|NCT00634244|460004061|FG001|Overall Study|Physician Decision|1|||
127832514|NCT00634244|460004062|FG002|Overall Study|Physician Decision|0|||
127832515|NCT00634244|460004060|FG000|Overall Study|Disease progression/relapse|0|||
127832516|NCT00634244|460004061|FG001|Overall Study|Disease progression/relapse|1|||
127832517|NCT00634244|460004062|FG002|Overall Study|Disease progression/relapse|0|||
127832518|NCT00634244|460004060|FG000|Overall Study|Other complicating disease|0|||
127832519|NCT00634244|460004061|FG001|Overall Study|Other complicating disease|1|||
127832520|NCT00634244|460004062|FG002|Overall Study|Other complicating disease|0|||
127832521|NCT02435277|460004068|FG000|Overall Study|Adverse Event|1|||
127832522|NCT02435277|460004069|FG001|Overall Study|Adverse Event|1|||
127832523|NCT02435277|460004070|FG002|Overall Study|Adverse Event|0|||
127832524|NCT02435277|460004071|FG003|Overall Study|Adverse Event|0|||
127832525|NCT02435277|460004068|FG000|Overall Study|Withdrawal by Subject|1|||
127832526|NCT02435277|460004069|FG001|Overall Study|Withdrawal by Subject|0|||
127832527|NCT02435277|460004070|FG002|Overall Study|Withdrawal by Subject|0|||
127832528|NCT02435277|460004071|FG003|Overall Study|Withdrawal by Subject|0|||
127832529|NCT00008138|460004072|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
127832530|NCT00008138|460004072|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
127832531|NCT00008138|460004072|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
127832532|NCT00008138|460004072|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
127832533|NCT00008138|460004072|FG000|Interval Debulking|Withdrawal by Subject|2|||
127832534|NCT00008138|460004072|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
127832535|NCT00008138|460004072|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
127832536|NCT00008138|460004072|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
127832537|NCT02635737|460004082|FG000|Overall Study|Protocol Violation|1|||
127832538|NCT00937768|460004083|FG000|Overall Study|Refused Further Treatment|3|||
127832539|NCT00937768|460004084|FG001|Overall Study|Refused Further Treatment|2|||
127832540|NCT00937768|460004083|FG000|Overall Study|Disease Progression|1|||
127832541|NCT00937768|460004084|FG001|Overall Study|Disease Progression|1|||
127832542|NCT00937768|460004083|FG000|Overall Study|Alternate Treatment|0|||
127832543|NCT00937768|460004084|FG001|Overall Study|Alternate Treatment|1|||
127832544|NCT00937768|460004083|FG000|Overall Study|No Further Funding|4|||
127832545|NCT00937768|460004084|FG001|Overall Study|No Further Funding|4|||
127832546|NCT01687413|460004085|FG000|Overall Study|Withdrawal by Subject|0|||
127832547|NCT01687413|460004086|FG001|Overall Study|Withdrawal by Subject|2|||
127832548|NCT01687413|460004085|FG000|Overall Study|Not eligible|0|||
127832549|NCT01687413|460004086|FG001|Overall Study|Not eligible|2|||
127832550|NCT01687413|460004085|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
127895241|NCT01296932|460240626|FG003|Overall Study|Progressive disease|1|||
127832551|NCT01687413|460004086|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
127832552|NCT00992446|460004106|FG000|Overall Study|Disease Progression|1|||
127832553|NCT00992446|460004106|FG000|Overall Study|Withdrawal by Subject|2|||
127832554|NCT00992446|460004106|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
127832555|NCT03675737|460004108|FG000|Overall Study|Death|593|||
127832556|NCT03675737|460004109|FG001|Overall Study|Death|660|||
127832557|NCT03675737|460004108|FG000|Overall Study|Lost to Follow-up|1|||
127832558|NCT03675737|460004109|FG001|Overall Study|Lost to Follow-up|5|||
127832559|NCT03675737|460004108|FG000|Overall Study|Physician Decision|1|||
127832560|NCT03675737|460004109|FG001|Overall Study|Physician Decision|0|||
127832561|NCT03675737|460004108|FG000|Overall Study|Withdrawal by Subject|14|||
127832562|NCT03675737|460004109|FG001|Overall Study|Withdrawal by Subject|12|||
127832563|NCT03675737|460004108|FG000|Overall Study|Ongoing in Study|181|||
127832564|NCT03675737|460004109|FG001|Overall Study|Ongoing in Study|112|||
127832565|NCT02349789|460005603|FG000|Overall Study|Withdrawal by Subject|2|||
127832566|NCT00683475|460005604|FG000|Overall Study|Withdrawal by Subject|1|||
127832567|NCT00683475|460005605|FG001|Overall Study|Withdrawal by Subject|0|||
127832568|NCT00683475|460005604|FG000|Overall Study|Never Treated: Adverse Event|2|||
127832569|NCT00683475|460005605|FG001|Overall Study|Never Treated: Adverse Event|3|||
127832570|NCT00683475|460005604|FG000|Overall Study|Never Treated: Progressive Disease|1|||
127832571|NCT00683475|460005605|FG001|Overall Study|Never Treated: Progressive Disease|0|||
127832572|NCT02922634|460005606|FG000|Overall Study|Withdrawal by Subject|5|||
127832573|NCT02922634|460005606|FG000|Overall Study|Did not have their surgery|5|||
127832574|NCT02723604|460005607|FG000|Overall Study|ineligible|1|||
127832575|NCT02723604|460005607|FG000|Overall Study|never received treatment|1|||
127832576|NCT00352755|460005608|FG000|Overall Study|Physician Decision|1|||
127832577|NCT00352755|460005608|FG000|Overall Study|Adverse Event|1|||
127832578|NCT01694420|460005610|FG000|Overall Study|Lost to Follow-up|3|||
127832579|NCT03987919|460005611|FG000|Overall Study|Adverse Event|1|||
127832580|NCT03987919|460005612|FG001|Overall Study|Adverse Event|4|||
127832581|NCT03987919|460005613|FG002|Overall Study|Adverse Event|1|||
127832582|NCT03987919|460005614|FG003|Overall Study|Adverse Event|3|||
127832583|NCT03987919|460005611|FG000|Overall Study|Death|4|||
127832584|NCT03987919|460005612|FG001|Overall Study|Death|4|||
127832585|NCT03987919|460005613|FG002|Overall Study|Death|4|||
127832586|NCT03987919|460005614|FG003|Overall Study|Death|1|||
127832587|NCT03987919|460005611|FG000|Overall Study|Lost to Follow-up|5|||
127832588|NCT03987919|460005612|FG001|Overall Study|Lost to Follow-up|6|||
127832589|NCT03987919|460005613|FG002|Overall Study|Lost to Follow-up|8|||
127832590|NCT03987919|460005614|FG003|Overall Study|Lost to Follow-up|12|||
127832591|NCT03987919|460005611|FG000|Overall Study|Physician Decision|0|||
127832592|NCT03987919|460005612|FG001|Overall Study|Physician Decision|2|||
127832593|NCT03987919|460005613|FG002|Overall Study|Physician Decision|0|||
127832594|NCT03987919|460005614|FG003|Overall Study|Physician Decision|4|||
127832595|NCT03987919|460005611|FG000|Overall Study|Pregnancy|1|||
127832596|NCT03987919|460005612|FG001|Overall Study|Pregnancy|0|||
127832597|NCT03987919|460005613|FG002|Overall Study|Pregnancy|1|||
127832598|NCT03987919|460005614|FG003|Overall Study|Pregnancy|1|||
127832599|NCT03987919|460005611|FG000|Overall Study|Protocol Violation|0|||
127832600|NCT03987919|460005612|FG001|Overall Study|Protocol Violation|1|||
127895242|NCT01296932|460240627|FG004|Overall Study|Progressive disease|2|||
127895243|NCT01296932|460240628|FG005|Overall Study|Progressive disease|3|||
127832601|NCT03987919|460005613|FG002|Overall Study|Protocol Violation|0|||
127832602|NCT03987919|460005614|FG003|Overall Study|Protocol Violation|0|||
127895244|NCT01296932|460240629|FG006|Overall Study|Progressive disease|1|||
127832603|NCT03987919|460005611|FG000|Overall Study|Site terminated by Sponsor|0|||
127832604|NCT03987919|460005612|FG001|Overall Study|Site terminated by Sponsor|0|||
127832605|NCT03987919|460005613|FG002|Overall Study|Site terminated by Sponsor|0|||
127832606|NCT03987919|460005614|FG003|Overall Study|Site terminated by Sponsor|1|||
127895245|NCT01296932|460240630|FG007|Overall Study|Progressive disease|0|||
127832607|NCT03987919|460005611|FG000|Overall Study|Withdrawal by Subject|7|||
127832608|NCT03987919|460005612|FG001|Overall Study|Withdrawal by Subject|7|||
127832609|NCT03987919|460005613|FG002|Overall Study|Withdrawal by Subject|8|||
127832610|NCT03987919|460005614|FG003|Overall Study|Withdrawal by Subject|4|||
127832611|NCT03987919|460005611|FG000|Overall Study|Other - as reported by the investigator|1|||
127832612|NCT03987919|460005612|FG001|Overall Study|Other - as reported by the investigator|3|||
127832613|NCT03987919|460005613|FG002|Overall Study|Other - as reported by the investigator|2|||
127832614|NCT03987919|460005614|FG003|Overall Study|Other - as reported by the investigator|0|||
127832615|NCT01194804|460005615|FG000|Overall Study|Withdrawal by Subject|1|||
127895246|NCT01296932|460240631|FG008|Overall Study|Progressive disease|0|||
127832616|NCT03621943|460005616|FG000|First Randomized Intervention|Lost to Follow-up|51|||
127832617|NCT03621943|460005617|FG001|First Randomized Intervention|Lost to Follow-up|54|||
127832618|NCT03621943|460005616|FG000|First Randomized Intervention|Withdrawal by Subject|3|||
127832619|NCT03621943|460005617|FG001|First Randomized Intervention|Withdrawal by Subject|3|||
127832620|NCT03621943|460005616|FG000|Crossover Randomized Intervention|Lost to Follow-up|75|||
127832621|NCT03621943|460005617|FG001|Crossover Randomized Intervention|Lost to Follow-up|45|||
127832622|NCT03621943|460005616|FG000|Crossover Randomized Intervention|Withdrawal by Subject|0|||
127832623|NCT03621943|460005617|FG001|Crossover Randomized Intervention|Withdrawal by Subject|5|||
127832624|NCT00748553|460005618|FG000|Overall Study|Adverse Event|0|||
127832625|NCT00748553|460005619|FG001|Overall Study|Adverse Event|1|||
127832626|NCT00748553|460005618|FG000|Overall Study|disease progression|2|||
127832627|NCT00748553|460005619|FG001|Overall Study|disease progression|0|||
127832628|NCT00748553|460005618|FG000|Overall Study|noncompliance|1|||
127832629|NCT00748553|460005619|FG001|Overall Study|noncompliance|0|||
127832630|NCT00315705|460005620|FG000|Phase 1|Refused further treatment|1|||
127832631|NCT00315705|460005620|FG000|Phase 1|Failure to achieve response|8|||
127832632|NCT00315705|460005620|FG000|Phase 1|Disease relapse|4|||
127832633|NCT00315705|460005620|FG000|Phase 1|Scheduled for transplant|9|||
127832634|NCT00315705|460005620|FG000|Phase 1|Death|3|||
127832635|NCT00315705|460005620|FG000|Phase 2|Physician Decision|4|||
127832636|NCT00315705|460005620|FG000|Phase 2|Adverse Event|1|||
127832637|NCT00315705|460005620|FG000|Phase 2|Failure to achieve response|3|||
127832638|NCT00315705|460005620|FG000|Phase 2|Disease relapse|1|||
127832639|NCT00315705|460005620|FG000|Phase 2|Scheduled for transplant|8|||
127832640|NCT00315705|460005620|FG000|Phase 2|Other|1|||
127832641|NCT00315705|460005620|FG000|Phase 2|Death|7|||
127832642|NCT00948818|460005622|FG000|Overall Study|Adverse Event|10|||
127832643|NCT00948818|460005623|FG001|Overall Study|Adverse Event|32|||
127832644|NCT00948818|460005622|FG000|Overall Study|Protocol Violation|9|||
127832645|NCT00948818|460005623|FG001|Overall Study|Protocol Violation|10|||
127832646|NCT00948818|460005622|FG000|Overall Study|Withdrawal by Subject|25|||
127832647|NCT00948818|460005623|FG001|Overall Study|Withdrawal by Subject|25|||
127832648|NCT00948818|460005622|FG000|Overall Study|Lost to Follow-up|10|||
127832649|NCT00948818|460005623|FG001|Overall Study|Lost to Follow-up|17|||
127832650|NCT00948818|460005622|FG000|Overall Study|Lack of Efficacy|4|||
127832651|NCT00948818|460005623|FG001|Overall Study|Lack of Efficacy|5|||
127832652|NCT00948818|460005622|FG000|Overall Study|Other Reason|4|||
127832653|NCT00948818|460005623|FG001|Overall Study|Other Reason|5|||
127832654|NCT00745368|460005624|FG000|Overall Study|Unable to provide sample|3|||
127832655|NCT03446651|460005633|FG000|Overall Study|Lost to Follow-up|4|||
127832656|NCT03446651|460005634|FG001|Overall Study|Lost to Follow-up|0|||
127832657|NCT03446651|460005633|FG000|Overall Study|Open Label Participants|5|||
127832658|NCT03446651|460005634|FG001|Overall Study|Open Label Participants|0|||
127832659|NCT01894477|460005643|FG000|Overall Study|Protocol Violation|0|||
127832660|NCT01894477|460005644|FG001|Overall Study|Protocol Violation|1|||
127832661|NCT01894477|460005643|FG000|Overall Study|protocol changed due SC changed to cord|0|||
127832662|NCT01894477|460005644|FG001|Overall Study|protocol changed due SC changed to cord|1|||
127832663|NCT01592409|460005645|FG000|Overall Study|Withdrawal by Subject|0|||
127832664|NCT01592409|460005646|FG001|Overall Study|Withdrawal by Subject|1|||
127832665|NCT01409031|460005647|FG000|Overall Study|transferred to other hosp|1|||
127832666|NCT01409031|460005648|FG001|Overall Study|transferred to other hosp|0|||
127832667|NCT00748540|460005654|FG000|Overall Study|Physician Decision|1|||
127832668|NCT01814800|460005655|FG000|Overall Study|Adverse Event|2|||
127832669|NCT01814800|460005655|FG000|Overall Study|Pregnancy|1|||
127832670|NCT01814800|460005655|FG000|Overall Study|Sponsor decision|1|||
127832671|NCT01814800|460005655|FG000|Overall Study|Subject relocation|1|||
127832672|NCT02371759|460005658|FG000|Overall Study|Protocol Violation|3|||
127832673|NCT02371759|460005659|FG001|Overall Study|Protocol Violation|1|||
127832674|NCT02371759|460005660|FG002|Overall Study|Protocol Violation|1|||
127832675|NCT02371759|460005661|FG003|Overall Study|Protocol Violation|0|||
127832676|NCT02371759|460005662|FG004|Overall Study|Protocol Violation|3|||
127832677|NCT02371759|460005663|FG005|Overall Study|Protocol Violation|1|||
127832678|NCT02371759|460005664|FG006|Overall Study|Protocol Violation|0|||
127832679|NCT02371759|460005665|FG007|Overall Study|Protocol Violation|3|||
127832680|NCT02371759|460005658|FG000|Overall Study|Withdrawal by Subject|0|||
127832681|NCT02371759|460005659|FG001|Overall Study|Withdrawal by Subject|0|||
127895247|NCT01296932|460240623|FG000|Overall Study|Withdrawal by Subject|0|||
127895248|NCT01296932|460240624|FG001|Overall Study|Withdrawal by Subject|0|||
127895249|NCT01296932|460240625|FG002|Overall Study|Withdrawal by Subject|1|||
127895250|NCT01296932|460240626|FG003|Overall Study|Withdrawal by Subject|1|||
127832682|NCT02371759|460005660|FG002|Overall Study|Withdrawal by Subject|0|||
127895251|NCT01296932|460240627|FG004|Overall Study|Withdrawal by Subject|0|||
127895252|NCT01296932|460240628|FG005|Overall Study|Withdrawal by Subject|0|||
127895253|NCT01296932|460240629|FG006|Overall Study|Withdrawal by Subject|3|||
127895254|NCT01296932|460240630|FG007|Overall Study|Withdrawal by Subject|0|||
127895255|NCT01296932|460240631|FG008|Overall Study|Withdrawal by Subject|0|||
127895256|NCT01296932|460240623|FG000|Overall Study|Adverse Event|1|||
127895257|NCT01296932|460240624|FG001|Overall Study|Adverse Event|1|||
127895258|NCT01296932|460240625|FG002|Overall Study|Adverse Event|1|||
127895259|NCT01296932|460240626|FG003|Overall Study|Adverse Event|2|||
127895260|NCT01296932|460240627|FG004|Overall Study|Adverse Event|1|||
127895261|NCT01296932|460240628|FG005|Overall Study|Adverse Event|0|||
127895262|NCT01296932|460240629|FG006|Overall Study|Adverse Event|0|||
127895263|NCT01296932|460240630|FG007|Overall Study|Adverse Event|0|||
127895264|NCT01296932|460240631|FG008|Overall Study|Adverse Event|1|||
127895265|NCT01296932|460240623|FG000|Overall Study|Investigator decision|0|||
127895266|NCT01296932|460240624|FG001|Overall Study|Investigator decision|1|||
127895267|NCT01296932|460240625|FG002|Overall Study|Investigator decision|0|||
127895268|NCT01296932|460240626|FG003|Overall Study|Investigator decision|1|||
127895269|NCT01296932|460240627|FG004|Overall Study|Investigator decision|0|||
127895270|NCT01296932|460240628|FG005|Overall Study|Investigator decision|0|||
127895271|NCT01296932|460240629|FG006|Overall Study|Investigator decision|1|||
127895272|NCT01296932|460240630|FG007|Overall Study|Investigator decision|0|||
127895273|NCT01296932|460240631|FG008|Overall Study|Investigator decision|1|||
127895274|NCT01296932|460240623|FG000|Overall Study|No clinical benefit anymore|0|||
127895275|NCT01296932|460240624|FG001|Overall Study|No clinical benefit anymore|1|||
127895276|NCT01296932|460240625|FG002|Overall Study|No clinical benefit anymore|0|||
127895277|NCT01296932|460240626|FG003|Overall Study|No clinical benefit anymore|0|||
127895278|NCT01296932|460240627|FG004|Overall Study|No clinical benefit anymore|0|||
127895279|NCT01296932|460240628|FG005|Overall Study|No clinical benefit anymore|0|||
127895280|NCT01296932|460240629|FG006|Overall Study|No clinical benefit anymore|0|||
127895281|NCT01296932|460240630|FG007|Overall Study|No clinical benefit anymore|0|||
127895282|NCT01296932|460240631|FG008|Overall Study|No clinical benefit anymore|0|||
127895283|NCT01296932|460240623|FG000|Overall Study|Physician Decision|0|||
127895284|NCT01296932|460240624|FG001|Overall Study|Physician Decision|0|||
127895285|NCT01296932|460240625|FG002|Overall Study|Physician Decision|1|||
127895286|NCT01296932|460240626|FG003|Overall Study|Physician Decision|0|||
127895287|NCT01296932|460240627|FG004|Overall Study|Physician Decision|0|||
127895288|NCT01296932|460240628|FG005|Overall Study|Physician Decision|0|||
127895289|NCT01296932|460240629|FG006|Overall Study|Physician Decision|0|||
127895290|NCT01296932|460240630|FG007|Overall Study|Physician Decision|0|||
127895291|NCT01296932|460240631|FG008|Overall Study|Physician Decision|0|||
127895292|NCT01296932|460240623|FG000|Overall Study|IV problems, administration not possible|0|||
127895293|NCT01296932|460240624|FG001|Overall Study|IV problems, administration not possible|0|||
127895294|NCT01296932|460240625|FG002|Overall Study|IV problems, administration not possible|1|||
127895295|NCT01296932|460240626|FG003|Overall Study|IV problems, administration not possible|0|||
127895296|NCT01296932|460240627|FG004|Overall Study|IV problems, administration not possible|0|||
127895297|NCT01296932|460240628|FG005|Overall Study|IV problems, administration not possible|0|||
127895298|NCT01296932|460240629|FG006|Overall Study|IV problems, administration not possible|0|||
127895299|NCT01296932|460240630|FG007|Overall Study|IV problems, administration not possible|0|||
127895300|NCT01296932|460240631|FG008|Overall Study|IV problems, administration not possible|0|||
127895301|NCT01296932|460240623|FG000|Overall Study|per protocol|0|||
127895302|NCT01296932|460240624|FG001|Overall Study|per protocol|0|||
127895303|NCT01296932|460240625|FG002|Overall Study|per protocol|1|||
127895304|NCT01296932|460240626|FG003|Overall Study|per protocol|1|||
127895305|NCT01296932|460240627|FG004|Overall Study|per protocol|0|||
127895306|NCT01296932|460240628|FG005|Overall Study|per protocol|0|||
127895307|NCT01296932|460240629|FG006|Overall Study|per protocol|0|||
127895308|NCT01296932|460240630|FG007|Overall Study|per protocol|0|||
127895309|NCT01296932|460240631|FG008|Overall Study|per protocol|0|||
127895310|NCT01296932|460240623|FG000|Overall Study|Low benefit and too many side effects|0|||
127895311|NCT01296932|460240624|FG001|Overall Study|Low benefit and too many side effects|0|||
127895312|NCT01296932|460240625|FG002|Overall Study|Low benefit and too many side effects|0|||
127832683|NCT02371759|460005661|FG003|Overall Study|Withdrawal by Subject|0|||
127832684|NCT02371759|460005662|FG004|Overall Study|Withdrawal by Subject|0|||
127832685|NCT02371759|460005663|FG005|Overall Study|Withdrawal by Subject|0|||
127832686|NCT02371759|460005664|FG006|Overall Study|Withdrawal by Subject|0|||
127832687|NCT02371759|460005665|FG007|Overall Study|Withdrawal by Subject|1|||
127832688|NCT00243230|460005668|FG000|Double-Blind Period|Adverse Event|0|||
127832689|NCT00243230|460005669|FG001|Double-Blind Period|Adverse Event|2|||
127832690|NCT00243230|460005670|FG002|Double-Blind Period|Adverse Event|2|||
127832691|NCT00243230|460005671|FG003|Double-Blind Period|Adverse Event|0|||
127832692|NCT00243230|460005668|FG000|Double-Blind Period|Withdrawal by Subject|1|||
127832693|NCT00243230|460005669|FG001|Double-Blind Period|Withdrawal by Subject|0|||
127832694|NCT00243230|460005670|FG002|Double-Blind Period|Withdrawal by Subject|0|||
127832695|NCT00243230|460005671|FG003|Double-Blind Period|Withdrawal by Subject|0|||
127832696|NCT00243230|460005668|FG000|Double-Blind Period|Protocol Violation|0|||
127832697|NCT00243230|460005669|FG001|Double-Blind Period|Protocol Violation|0|||
127832698|NCT00243230|460005670|FG002|Double-Blind Period|Protocol Violation|1|||
127832699|NCT00243230|460005671|FG003|Double-Blind Period|Protocol Violation|0|||
127832700|NCT00243230|460005668|FG000|Double-Blind Period|Randomized but Not Treated|0|||
127832701|NCT00243230|460005669|FG001|Double-Blind Period|Randomized but Not Treated|0|||
127832702|NCT00243230|460005670|FG002|Double-Blind Period|Randomized but Not Treated|2|||
127832703|NCT00243230|460005671|FG003|Double-Blind Period|Randomized but Not Treated|0|||
127832704|NCT00243230|460005668|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
127832705|NCT00243230|460005669|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
127832706|NCT00243230|460005670|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
127832707|NCT00243230|460005671|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
127832708|NCT00243230|460005668|FG000|Open Label Period|Adverse Event|0|||
127832709|NCT00243230|460005669|FG001|Open Label Period|Adverse Event|0|||
127832710|NCT00243230|460005670|FG002|Open Label Period|Adverse Event|0|||
127832711|NCT00243230|460005671|FG003|Open Label Period|Adverse Event|2|||
127832712|NCT00243230|460005668|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
127832713|NCT00243230|460005669|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
127832714|NCT00243230|460005670|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
127832715|NCT00243230|460005671|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
127832716|NCT00243230|460005668|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
127832717|NCT00243230|460005669|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
127832718|NCT00243230|460005670|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
127832719|NCT00243230|460005671|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
127832720|NCT00243230|460005668|FG000|Open Label Period|Lost to Follow-up|0|||
127832721|NCT00243230|460005669|FG001|Open Label Period|Lost to Follow-up|0|||
127832722|NCT00243230|460005670|FG002|Open Label Period|Lost to Follow-up|0|||
127832723|NCT00243230|460005671|FG003|Open Label Period|Lost to Follow-up|2|||
127832724|NCT00243230|460005668|FG000|Open Label Period|Withdrawal by Subject|0|||
127832725|NCT00243230|460005669|FG001|Open Label Period|Withdrawal by Subject|0|||
127832726|NCT00243230|460005670|FG002|Open Label Period|Withdrawal by Subject|0|||
127832727|NCT00243230|460005671|FG003|Open Label Period|Withdrawal by Subject|2|||
127832728|NCT00243230|460005668|FG000|Open Label Period|Protocol Violation|0|||
127832729|NCT00243230|460005669|FG001|Open Label Period|Protocol Violation|0|||
127832730|NCT00243230|460005670|FG002|Open Label Period|Protocol Violation|0|||
127832731|NCT00243230|460005671|FG003|Open Label Period|Protocol Violation|2|||
127832732|NCT00243230|460005668|FG000|Open Label Period|Administrative Reason|0|||
127832733|NCT00243230|460005669|FG001|Open Label Period|Administrative Reason|0|||
127832734|NCT00243230|460005670|FG002|Open Label Period|Administrative Reason|0|||
127832735|NCT00243230|460005671|FG003|Open Label Period|Administrative Reason|63|||
127832736|NCT01689207|460005672|FG000|Overall Study|Adverse Event|0|||
127832737|NCT01689207|460005673|FG001|Overall Study|Adverse Event|1|||
127832738|NCT01689207|460005674|FG002|Overall Study|Adverse Event|0|||
127832739|NCT01689207|460005675|FG003|Overall Study|Adverse Event|0|||
127832740|NCT01689207|460005676|FG004|Overall Study|Adverse Event|2|||
127832741|NCT01689207|460005677|FG005|Overall Study|Adverse Event|1|||
127832742|NCT01689207|460005678|FG006|Overall Study|Adverse Event|0|||
127832743|NCT01689207|460005679|FG007|Overall Study|Adverse Event|0|||
127832744|NCT01689207|460005680|FG008|Overall Study|Adverse Event|1|||
127832745|NCT01689207|460005681|FG009|Overall Study|Adverse Event|0|||
127832746|NCT01689207|460005682|FG010|Overall Study|Adverse Event|0|||
127832747|NCT05118386|460005683|FG000|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
127832748|NCT05118386|460005684|FG001|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
127832749|NCT05118386|460005685|FG002|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
127832750|NCT05118386|460005686|FG003|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|2|||
127832751|NCT05118386|460005687|FG004|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
127832752|NCT05118386|460005688|FG005|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
127832753|NCT05118386|460005683|FG000|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
127832754|NCT05118386|460005684|FG001|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
127832755|NCT05118386|460005685|FG002|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
127832756|NCT05118386|460005686|FG003|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
127832757|NCT05118386|460005687|FG004|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|1|||
127832758|NCT05118386|460005688|FG005|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
127832759|NCT00303108|460005689|FG000|Overall Study|Adverse Event|5|||
127832760|NCT00303108|460005690|FG001|Overall Study|Adverse Event|6|||
127832761|NCT00303108|460005691|FG002|Overall Study|Adverse Event|7|||
127832762|NCT00303108|460005689|FG000|Overall Study|Patient Request|4|||
127832763|NCT00303108|460005690|FG001|Overall Study|Patient Request|2|||
127832764|NCT00303108|460005691|FG002|Overall Study|Patient Request|8|||
127832765|NCT00303108|460005689|FG000|Overall Study|Failed Entry|1|||
127832766|NCT00303108|460005690|FG001|Overall Study|Failed Entry|0|||
127832767|NCT00303108|460005691|FG002|Overall Study|Failed Entry|1|||
127832768|NCT00303108|460005689|FG000|Overall Study|ineligible|2|||
127832769|NCT00303108|460005690|FG001|Overall Study|ineligible|1|||
127832770|NCT00303108|460005691|FG002|Overall Study|ineligible|0|||
127832771|NCT03201198|460005692|FG000|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|35|||
127832772|NCT03201198|460005693|FG001|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|37|||
127832773|NCT03201198|460005692|FG000|Overall Study|Withdrawal by Subject|2|||
127832774|NCT03201198|460005693|FG001|Overall Study|Withdrawal by Subject|3|||
127832775|NCT03855137|460005694|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
127895313|NCT01296932|460240626|FG003|Overall Study|Low benefit and too many side effects|0|||
127895314|NCT01296932|460240627|FG004|Overall Study|Low benefit and too many side effects|0|||
127895315|NCT01296932|460240628|FG005|Overall Study|Low benefit and too many side effects|0|||
127895316|NCT01296932|460240629|FG006|Overall Study|Low benefit and too many side effects|0|||
127895317|NCT01296932|460240630|FG007|Overall Study|Low benefit and too many side effects|1|||
127895318|NCT01296932|460240631|FG008|Overall Study|Low benefit and too many side effects|0|||
127895319|NCT01296932|460240623|FG000|Overall Study|No adequate treatment response|0|||
127895320|NCT01296932|460240624|FG001|Overall Study|No adequate treatment response|0|||
127895321|NCT01296932|460240625|FG002|Overall Study|No adequate treatment response|0|||
127895322|NCT01296932|460240626|FG003|Overall Study|No adequate treatment response|0|||
127895323|NCT01296932|460240627|FG004|Overall Study|No adequate treatment response|0|||
127895324|NCT01296932|460240628|FG005|Overall Study|No adequate treatment response|0|||
127895325|NCT01296932|460240629|FG006|Overall Study|No adequate treatment response|0|||
127895326|NCT01296932|460240630|FG007|Overall Study|No adequate treatment response|1|||
127895327|NCT01296932|460240631|FG008|Overall Study|No adequate treatment response|0|||
127895328|NCT01296932|460240623|FG000|Overall Study|Dosage already reduced, AE still present|0|||
127895329|NCT01296932|460240624|FG001|Overall Study|Dosage already reduced, AE still present|0|||
127895330|NCT01296932|460240625|FG002|Overall Study|Dosage already reduced, AE still present|0|||
127895331|NCT01296932|460240626|FG003|Overall Study|Dosage already reduced, AE still present|0|||
127895332|NCT01296932|460240627|FG004|Overall Study|Dosage already reduced, AE still present|0|||
127895333|NCT01296932|460240628|FG005|Overall Study|Dosage already reduced, AE still present|0|||
127895334|NCT01296932|460240629|FG006|Overall Study|Dosage already reduced, AE still present|0|||
127895335|NCT01296932|460240630|FG007|Overall Study|Dosage already reduced, AE still present|0|||
127895336|NCT01296932|460240631|FG008|Overall Study|Dosage already reduced, AE still present|1|||
127895337|NCT02848599|460240636|FG000|Overall Study|Protocol Violation|7|||
127895338|NCT02848599|460240637|FG001|Overall Study|Protocol Violation|9|||
127895339|NCT02352337|460240638|FG000|Overall Study|Patients never treated|4|||
127895340|NCT02352337|460240639|FG001|Overall Study|Patients never treated|1|||
127895341|NCT02352337|460240640|FG002|Overall Study|Patients never treated|2|||
127895342|NCT01090765|460240641|FG000|Overall Study|Patient withdrew consent|0|||
127895343|NCT01090765|460240642|FG001|Overall Study|Patient withdrew consent|0|||
127895344|NCT01090765|460240643|FG002|Overall Study|Patient withdrew consent|0|||
127895345|NCT01090765|460240644|FG003|Overall Study|Patient withdrew consent|0|||
127895346|NCT01090765|460240645|FG004|Overall Study|Patient withdrew consent|1|||
127895347|NCT01090765|460240646|FG005|Overall Study|Patient withdrew consent|1|||
127895348|NCT01090765|460240641|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
127895349|NCT01090765|460240642|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
127895350|NCT01090765|460240643|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
127895351|NCT01090765|460240644|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
127895352|NCT01090765|460240645|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
127895353|NCT01090765|460240646|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
127895354|NCT01090765|460240641|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
127895355|NCT01090765|460240642|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
127895356|NCT01090765|460240643|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
127895357|NCT01090765|460240644|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
127895358|NCT01090765|460240645|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
127895359|NCT01090765|460240646|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
127895360|NCT02623959|460240650|FG000|Overall Study|Progression|0|||
127895361|NCT02623959|460240651|FG001|Overall Study|Progression|1|||
127895362|NCT00421174|460240652|FG000|Overall Study|Withdrawal by Subject|0|||
127895363|NCT00421174|460240653|FG001|Overall Study|Withdrawal by Subject|1|||
127895364|NCT00421174|460240652|FG000|Overall Study|Ineligible due to infection|2|||
127832776|NCT03855137|460005695|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
127832777|NCT03855137|460005696|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
127832778|NCT03855137|460005694|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
127832779|NCT03855137|460005695|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
127832780|NCT03855137|460005696|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
127832781|NCT03855137|460005694|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
127832782|NCT03855137|460005695|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
127832783|NCT03855137|460005696|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
127832784|NCT03855137|460005694|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
127832785|NCT03855137|460005695|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
127832786|NCT03855137|460005696|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
127832787|NCT03855137|460005694|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
127832788|NCT03855137|460005695|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
127832789|NCT03855137|460005696|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
127832790|NCT03855137|460005694|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
127832791|NCT03855137|460005695|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
127832792|NCT03855137|460005696|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
127832793|NCT03855137|460005694|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
127832794|NCT03855137|460005695|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
127832795|NCT03855137|460005696|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
127832796|NCT03855137|460005694|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
127832797|NCT03855137|460005695|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
127832798|NCT03855137|460005696|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
127832799|NCT03855137|460005694|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
127832800|NCT03855137|460005695|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
127832801|NCT03855137|460005696|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
127832802|NCT03855137|460005694|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
127832803|NCT03855137|460005695|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
127832804|NCT03855137|460005696|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
127832805|NCT02427477|460005697|FG000|Period 1|Adverse Event|1|||
127832806|NCT02427477|460005698|FG001|Period 1|Adverse Event|0|||
127832807|NCT04369430|460005700|FG000|Overall Study|Adverse Event|2|||
127832808|NCT04369430|460005701|FG001|Overall Study|Adverse Event|3|||
127832809|NCT04369430|460005700|FG000|Overall Study|Death|1|||
127832810|NCT04369430|460005701|FG001|Overall Study|Death|0|||
127832811|NCT04369430|460005700|FG000|Overall Study|Withdrawal by Subject|4|||
127832812|NCT04369430|460005701|FG001|Overall Study|Withdrawal by Subject|3|||
127832813|NCT04369430|460005700|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
127832814|NCT04369430|460005701|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
127832815|NCT04369430|460005700|FG000|Overall Study|Lost to Follow-up|0|||
127832816|NCT04369430|460005701|FG001|Overall Study|Lost to Follow-up|1|||
127832817|NCT02065622|460005702|FG000|Induction Study|Adverse Event|13|||
127832818|NCT02065622|460005703|FG001|Induction Study|Adverse Event|19|||
127832819|NCT02065622|460005704|FG002|Induction Study|Adverse Event|0|||
127832820|NCT02065622|460005705|FG003|Induction Study|Adverse Event|0|||
127832821|NCT02065622|460005706|FG004|Induction Study|Adverse Event|0|||
127832822|NCT02065622|460005702|FG000|Induction Study|Withdrawal by Subject|3|||
127832823|NCT02065622|460005703|FG001|Induction Study|Withdrawal by Subject|5|||
127832824|NCT02065622|460005704|FG002|Induction Study|Withdrawal by Subject|0|||
127832825|NCT02065622|460005705|FG003|Induction Study|Withdrawal by Subject|0|||
127832826|NCT02065622|460005706|FG004|Induction Study|Withdrawal by Subject|0|||
127832827|NCT02065622|460005702|FG000|Induction Study|Lost to Follow-up|1|||
127832828|NCT02065622|460005703|FG001|Induction Study|Lost to Follow-up|0|||
127832829|NCT02065622|460005704|FG002|Induction Study|Lost to Follow-up|0|||
127832830|NCT02065622|460005705|FG003|Induction Study|Lost to Follow-up|0|||
127832831|NCT02065622|460005706|FG004|Induction Study|Lost to Follow-up|0|||
127832832|NCT02065622|460005702|FG000|Induction Study|Lack of Efficacy|22|||
127832833|NCT02065622|460005703|FG001|Induction Study|Lack of Efficacy|27|||
127832834|NCT02065622|460005704|FG002|Induction Study|Lack of Efficacy|0|||
127832835|NCT02065622|460005705|FG003|Induction Study|Lack of Efficacy|0|||
127832836|NCT02065622|460005706|FG004|Induction Study|Lack of Efficacy|0|||
127832837|NCT02065622|460005702|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
127832838|NCT02065622|460005703|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
127832839|NCT02065622|460005704|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
127832840|NCT02065622|460005705|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
127832841|NCT02065622|460005706|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
127832842|NCT02065622|460005702|FG000|Induction Study|Subject Noncompliance|1|||
127832843|NCT02065622|460005703|FG001|Induction Study|Subject Noncompliance|1|||
127832844|NCT02065622|460005704|FG002|Induction Study|Subject Noncompliance|0|||
127832845|NCT02065622|460005705|FG003|Induction Study|Subject Noncompliance|0|||
127832846|NCT02065622|460005706|FG004|Induction Study|Subject Noncompliance|0|||
127832847|NCT02065622|460005702|FG000|Induction Study|Other, Not Specified|3|||
127832848|NCT02065622|460005703|FG001|Induction Study|Other, Not Specified|2|||
127832849|NCT02065622|460005704|FG002|Induction Study|Other, Not Specified|0|||
127832850|NCT02065622|460005705|FG003|Induction Study|Other, Not Specified|0|||
127832851|NCT02065622|460005706|FG004|Induction Study|Other, Not Specified|0|||
127832852|NCT02065622|460005702|FG000|Maintenance Study|Adverse Event|0|||
127895365|NCT00421174|460240653|FG001|Overall Study|Ineligible due to infection|0|||
127895366|NCT01829464|460240654|FG000|Overall Study|Adverse Event|1|||
127895367|NCT01829464|460240655|FG001|Overall Study|Adverse Event|0|||
127895368|NCT01829464|460240656|FG002|Overall Study|Adverse Event|0|||
127895369|NCT01829464|460240654|FG000|Overall Study|Lost to Follow-up|0|||
127895370|NCT01829464|460240655|FG001|Overall Study|Lost to Follow-up|0|||
127895371|NCT01829464|460240656|FG002|Overall Study|Lost to Follow-up|1|||
127895372|NCT01829464|460240654|FG000|Overall Study|Withdrawal by Subject|2|||
127895373|NCT01829464|460240655|FG001|Overall Study|Withdrawal by Subject|0|||
127895374|NCT01829464|460240656|FG002|Overall Study|Withdrawal by Subject|0|||
127895375|NCT01829464|460240654|FG000|Overall Study|Study terminated by sponsor|25|||
127895376|NCT01829464|460240655|FG001|Overall Study|Study terminated by sponsor|28|||
127895377|NCT01829464|460240656|FG002|Overall Study|Study terminated by sponsor|25|||
127895378|NCT01829464|460240654|FG000|Overall Study|Lack of Efficacy|0|||
127895379|NCT01829464|460240655|FG001|Overall Study|Lack of Efficacy|1|||
127895380|NCT01829464|460240656|FG002|Overall Study|Lack of Efficacy|0|||
127895381|NCT02336737|460240663|FG000|Overall Study|Withdrawal by Subject|5|||
127895382|NCT02336737|460240663|FG000|Overall Study|Physician Decision|8|||
127895383|NCT02396381|460240664|FG000|Overall Study|Adverse Event|3|||
127895384|NCT02396381|460240665|FG001|Overall Study|Adverse Event|2|||
127895385|NCT02396381|460240664|FG000|Overall Study|Withdrawal by Subject|33|||
127895386|NCT02396381|460240665|FG001|Overall Study|Withdrawal by Subject|24|||
127895387|NCT02396381|460240664|FG000|Overall Study|Lost to Follow-up|49|||
127895388|NCT02396381|460240665|FG001|Overall Study|Lost to Follow-up|31|||
127895389|NCT02396381|460240664|FG000|Overall Study|Protocol Violation|1|||
127895390|NCT02396381|460240665|FG001|Overall Study|Protocol Violation|0|||
127895391|NCT02396381|460240664|FG000|Overall Study|Site terminated by sponsor|7|||
127895392|NCT02396381|460240665|FG001|Overall Study|Site terminated by sponsor|8|||
127895393|NCT02396381|460240664|FG000|Overall Study|Physician Decision|5|||
127895394|NCT02396381|460240665|FG001|Overall Study|Physician Decision|5|||
127895395|NCT02396381|460240664|FG000|Overall Study|Pregnancy|2|||
127895396|NCT02396381|460240665|FG001|Overall Study|Pregnancy|0|||
127895397|NCT02396381|460240664|FG000|Overall Study|Non-compliance with study procedures|1|||
127895398|NCT02396381|460240665|FG001|Overall Study|Non-compliance with study procedures|0|||
127895399|NCT02396381|460240664|FG000|Overall Study|Moved out of town/state|1|||
127895400|NCT02396381|460240665|FG001|Overall Study|Moved out of town/state|3|||
127895401|NCT02396381|460240664|FG000|Overall Study|Could not complete visit|1|||
127895402|NCT02396381|460240665|FG001|Overall Study|Could not complete visit|0|||
127895403|NCT02396381|460240664|FG000|Overall Study|Possible conflict of interest|1|||
127895404|NCT02396381|460240665|FG001|Overall Study|Possible conflict of interest|0|||
127895405|NCT02396381|460240664|FG000|Overall Study|Randomization/Screening Error|3|||
127895406|NCT02396381|460240665|FG001|Overall Study|Randomization/Screening Error|1|||
127895407|NCT00356200|460240667|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
127895408|NCT00356200|460240668|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
127895409|NCT00356200|460240667|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
127895410|NCT00356200|460240668|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
127895411|NCT00635778|460240669|FG000|Overall Study|Adverse Event|1|||
127895412|NCT00635778|460240670|FG001|Overall Study|Adverse Event|0|||
127895413|NCT00635778|460240671|FG002|Overall Study|Adverse Event|0|||
127895414|NCT00635778|460240672|FG003|Overall Study|Adverse Event|3|||
127895415|NCT00635778|460240673|FG004|Overall Study|Adverse Event|3|||
127895416|NCT00635778|460240674|FG005|Overall Study|Adverse Event|6|||
127895417|NCT00635778|460240675|FG006|Overall Study|Adverse Event|1|||
127895418|NCT00635778|460240669|FG000|Overall Study|Withdrawal by Subject|0|||
127895419|NCT00635778|460240670|FG001|Overall Study|Withdrawal by Subject|0|||
127895420|NCT00635778|460240671|FG002|Overall Study|Withdrawal by Subject|0|||
127895421|NCT00635778|460240672|FG003|Overall Study|Withdrawal by Subject|1|||
127895422|NCT00635778|460240673|FG004|Overall Study|Withdrawal by Subject|0|||
127895423|NCT00635778|460240674|FG005|Overall Study|Withdrawal by Subject|1|||
127895424|NCT00635778|460240675|FG006|Overall Study|Withdrawal by Subject|1|||
127895425|NCT00635778|460240669|FG000|Overall Study|Progressive disease|0|||
127895426|NCT00635778|460240670|FG001|Overall Study|Progressive disease|3|||
127895427|NCT00635778|460240671|FG002|Overall Study|Progressive disease|3|||
127895428|NCT00635778|460240672|FG003|Overall Study|Progressive disease|4|||
127895429|NCT00635778|460240673|FG004|Overall Study|Progressive disease|5|||
127895430|NCT00635778|460240674|FG005|Overall Study|Progressive disease|14|||
127895431|NCT00635778|460240675|FG006|Overall Study|Progressive disease|4|||
127895432|NCT00812253|460240676|FG000|Overall Study|Withdrawal by Subject|3|||
127895433|NCT00812253|460240677|FG001|Overall Study|Withdrawal by Subject|2|||
127895434|NCT00812253|460240676|FG000|Overall Study|Protocol Violation|1|||
127895435|NCT00812253|460240677|FG001|Overall Study|Protocol Violation|1|||
127895436|NCT00812253|460240676|FG000|Overall Study|Lost to Follow-up|2|||
127895437|NCT00812253|460240677|FG001|Overall Study|Lost to Follow-up|0|||
127895438|NCT01884025|460240678|FG000|Overall Study|Lost to Follow-up|3|||
127895439|NCT01884025|460240679|FG001|Overall Study|Lost to Follow-up|4|||
127895440|NCT02324465|460240680|FG000|Overall Study|device failure|0|||
127895441|NCT02324465|460240681|FG001|Overall Study|device failure|1|||
127895442|NCT02655237|460240684|FG000|Overall Study|Adverse Event|10|||
127895443|NCT02655237|460240685|FG001|Overall Study|Adverse Event|7|||
127895444|NCT02655237|460240684|FG000|Overall Study|Protocol Deviation|2|||
127895445|NCT02655237|460240685|FG001|Overall Study|Protocol Deviation|0|||
127895446|NCT02655237|460240684|FG000|Overall Study|Withdrawal by Participant|1|||
127895447|NCT02655237|460240685|FG001|Overall Study|Withdrawal by Participant|2|||
127895448|NCT02655237|460240684|FG000|Overall Study|Lack of Efficacy|0|||
127895449|NCT02655237|460240685|FG001|Overall Study|Lack of Efficacy|1|||
127895450|NCT02655237|460240684|FG000|Overall Study|Recovery Leading to Surgery|2|||
127895451|NCT02655237|460240685|FG001|Overall Study|Recovery Leading to Surgery|1|||
127895452|NCT02655237|460240684|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
127895453|NCT02655237|460240685|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
127895454|NCT02655237|460240684|FG000|Overall Study|Randomized but Not Treated|1|||
127895455|NCT02655237|460240685|FG001|Overall Study|Randomized but Not Treated|0|||
127895456|NCT03679741|460240688|FG000|Period 1|No longer meet eligibility criteria|1|||
127895457|NCT03679741|460240689|FG001|Period 1|No longer meet eligibility criteria|0|||
127895458|NCT03679741|460240688|FG000|Period 1|Lost to Follow-up|0|||
127895459|NCT03679741|460240689|FG001|Period 1|Lost to Follow-up|1|||
127895460|NCT03679741|460240688|FG000|Period 1|Adverse Event|1|||
127895461|NCT03679741|460240689|FG001|Period 1|Adverse Event|1|||
127895462|NCT03679741|460240688|FG000|Period 1|Withdrawal by Subject|0|||
127895463|NCT03679741|460240689|FG001|Period 1|Withdrawal by Subject|1|||
127832853|NCT02065622|460005703|FG001|Maintenance Study|Adverse Event|0|||
127832854|NCT02065622|460005704|FG002|Maintenance Study|Adverse Event|25|||
127832855|NCT02065622|460005705|FG003|Maintenance Study|Adverse Event|22|||
127832856|NCT02065622|460005706|FG004|Maintenance Study|Adverse Event|11|||
127832857|NCT02065622|460005702|FG000|Maintenance Study|Withdrawal by Subject|0|||
127832858|NCT02065622|460005703|FG001|Maintenance Study|Withdrawal by Subject|0|||
127832859|NCT02065622|460005704|FG002|Maintenance Study|Withdrawal by Subject|11|||
127832860|NCT02065622|460005705|FG003|Maintenance Study|Withdrawal by Subject|5|||
127832861|NCT02065622|460005706|FG004|Maintenance Study|Withdrawal by Subject|7|||
127832862|NCT02065622|460005702|FG000|Maintenance Study|Lost to Follow-up|0|||
127832863|NCT02065622|460005703|FG001|Maintenance Study|Lost to Follow-up|0|||
127832864|NCT02065622|460005704|FG002|Maintenance Study|Lost to Follow-up|4|||
127832865|NCT02065622|460005705|FG003|Maintenance Study|Lost to Follow-up|1|||
127832866|NCT02065622|460005706|FG004|Maintenance Study|Lost to Follow-up|1|||
127832867|NCT02065622|460005702|FG000|Maintenance Study|Lack of Efficacy|0|||
127832868|NCT02065622|460005703|FG001|Maintenance Study|Lack of Efficacy|0|||
127832869|NCT02065622|460005704|FG002|Maintenance Study|Lack of Efficacy|70|||
127832870|NCT02065622|460005705|FG003|Maintenance Study|Lack of Efficacy|55|||
127832871|NCT02065622|460005706|FG004|Maintenance Study|Lack of Efficacy|19|||
127832872|NCT02065622|460005702|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
127832873|NCT02065622|460005703|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
127832874|NCT02065622|460005704|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
127832875|NCT02065622|460005705|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
127895464|NCT03679741|460240688|FG000|Period 2|Adverse Event|2|||
127895465|NCT03679741|460240689|FG001|Period 2|Adverse Event|1|||
127895466|NCT03679741|460240688|FG000|Period 2|Withdrawal by Subject|1|||
127895467|NCT03679741|460240689|FG001|Period 2|Withdrawal by Subject|1|||
127895468|NCT01860976|460240691|FG000|Blinded Treatment|Adverse Event|1|||
127895469|NCT01860976|460240692|FG001|Blinded Treatment|Adverse Event|3|||
127832876|NCT02065622|460005706|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
127895470|NCT01860976|460240691|FG000|Blinded Treatment|Lack of Efficacy|5|||
127895471|NCT01860976|460240692|FG001|Blinded Treatment|Lack of Efficacy|12|||
127832877|NCT02065622|460005702|FG000|Maintenance Study|Subject Non-Compliance|0|||
127832878|NCT02065622|460005703|FG001|Maintenance Study|Subject Non-Compliance|0|||
127832879|NCT02065622|460005704|FG002|Maintenance Study|Subject Non-Compliance|1|||
127832880|NCT02065622|460005705|FG003|Maintenance Study|Subject Non-Compliance|3|||
127832881|NCT02065622|460005706|FG004|Maintenance Study|Subject Non-Compliance|2|||
127832882|NCT02065622|460005702|FG000|Maintenance Study|Other, Not Specified|0|||
127832883|NCT02065622|460005703|FG001|Maintenance Study|Other, Not Specified|0|||
127832884|NCT02065622|460005704|FG002|Maintenance Study|Other, Not Specified|6|||
127832885|NCT02065622|460005705|FG003|Maintenance Study|Other, Not Specified|14|||
127832886|NCT02065622|460005706|FG004|Maintenance Study|Other, Not Specified|2|||
127832887|NCT02065622|460005702|FG000|Maintenance Study|Unknown Reason|0|||
127832888|NCT02065622|460005703|FG001|Maintenance Study|Unknown Reason|0|||
127832889|NCT02065622|460005704|FG002|Maintenance Study|Unknown Reason|0|||
127832890|NCT02065622|460005705|FG003|Maintenance Study|Unknown Reason|1|||
127832891|NCT02065622|460005706|FG004|Maintenance Study|Unknown Reason|0|||
127832892|NCT01767194|460005707|FG000|Overall Study|Adverse Event|1|||
127832893|NCT01767194|460005708|FG001|Overall Study|Adverse Event|1|||
127832894|NCT01767194|460005707|FG000|Overall Study|Death|0|||
127832895|NCT01767194|460005708|FG001|Overall Study|Death|1|||
127832896|NCT01767194|460005707|FG000|Overall Study|Lack of Efficacy|12|||
127832897|NCT01767194|460005708|FG001|Overall Study|Lack of Efficacy|11|||
127832898|NCT01767194|460005707|FG000|Overall Study|Physician Decision|2|||
127832899|NCT01767194|460005708|FG001|Overall Study|Physician Decision|23|||
127832900|NCT01767194|460005707|FG000|Overall Study|Withdrawal by Subject|0|||
127832901|NCT01767194|460005708|FG001|Overall Study|Withdrawal by Subject|1|||
127832902|NCT01767194|460005707|FG000|Overall Study|Ineligible|1|||
127832903|NCT01767194|460005708|FG001|Overall Study|Ineligible|1|||
127832904|NCT01767194|460005707|FG000|Overall Study|Refusal by patient/parent|2|||
127832905|NCT01767194|460005708|FG001|Overall Study|Refusal by patient/parent|4|||
127832906|NCT01767194|460005707|FG000|Overall Study|Criteria not met on time for next cycle|0|||
127832907|NCT01767194|460005708|FG001|Overall Study|Criteria not met on time for next cycle|1|||
127832908|NCT04973228|460005709|FG000|Overall Study|Adverse Event|2|||
127832909|NCT04973228|460005710|FG001|Overall Study|Adverse Event|3|||
127832910|NCT04973228|460005709|FG000|Overall Study|Lack of Efficacy|1|||
127832911|NCT04973228|460005710|FG001|Overall Study|Lack of Efficacy|3|||
127832912|NCT04973228|460005709|FG000|Overall Study|Lost to Follow-up|12|||
127832913|NCT04973228|460005710|FG001|Overall Study|Lost to Follow-up|4|||
127832914|NCT04973228|460005709|FG000|Overall Study|Withdrawal by Subject|11|||
127832915|NCT04973228|460005710|FG001|Overall Study|Withdrawal by Subject|4|||
127832916|NCT04973228|460005709|FG000|Overall Study|Did not tolerate application|1|||
127832917|NCT04973228|460005710|FG001|Overall Study|Did not tolerate application|0|||
127832918|NCT04973228|460005709|FG000|Overall Study|Wanted to early terminate and use own product|0|||
127832919|NCT04973228|460005710|FG001|Overall Study|Wanted to early terminate and use own product|1|||
127832920|NCT04973228|460005709|FG000|Overall Study|Missed visits due to new work schedule|1|||
127832921|NCT04973228|460005710|FG001|Overall Study|Missed visits due to new work schedule|0|||
127832922|NCT02678780|460005713|FG000|Overall Study|Adverse Event|11|||
127832923|NCT02678780|460005714|FG001|Overall Study|Adverse Event|14|||
127832924|NCT02678780|460005713|FG000|Overall Study|Withdrawal by Subject|2|||
127832925|NCT02678780|460005714|FG001|Overall Study|Withdrawal by Subject|1|||
127832926|NCT02678780|460005713|FG000|Overall Study|Sponsor discontinuation|7|||
127832927|NCT02678780|460005714|FG001|Overall Study|Sponsor discontinuation|4|||
127832928|NCT02678780|460005713|FG000|Overall Study|Death|1|||
127832929|NCT02678780|460005714|FG001|Overall Study|Death|1|||
127832930|NCT02678780|460005713|FG000|Overall Study|Other|6|||
127832931|NCT02678780|460005714|FG001|Overall Study|Other|8|||
127832932|NCT01454401|460005715|FG000|Overall Study|Death|1|||
127832933|NCT01454401|460005715|FG000|Overall Study|hospitalised|1|||
127832934|NCT01454401|460005715|FG000|Overall Study|osteomyelitis|2|||
127832935|NCT01454401|460005715|FG000|Overall Study|non-adherence|1|||
127832936|NCT00755846|460007062|FG000|Overall Study|Adverse Event|0|||
127832937|NCT00755846|460007063|FG001|Overall Study|Adverse Event|0|||
127832938|NCT00755846|460007064|FG002|Overall Study|Adverse Event|0|||
127832939|NCT00755846|460007065|FG003|Overall Study|Adverse Event|1|||
127832940|NCT00755846|460007066|FG004|Overall Study|Adverse Event|3|||
127832941|NCT00755846|460007067|FG005|Overall Study|Adverse Event|2|||
127832942|NCT00755846|460007062|FG000|Overall Study|Protocol Violation|1|||
127832943|NCT00755846|460007063|FG001|Overall Study|Protocol Violation|1|||
127832944|NCT00755846|460007064|FG002|Overall Study|Protocol Violation|1|||
127832945|NCT00755846|460007065|FG003|Overall Study|Protocol Violation|1|||
127832946|NCT00755846|460007066|FG004|Overall Study|Protocol Violation|1|||
127832947|NCT00755846|460007067|FG005|Overall Study|Protocol Violation|1|||
127832948|NCT00755846|460007062|FG000|Overall Study|Lost to Follow-up|0|||
127832949|NCT00755846|460007063|FG001|Overall Study|Lost to Follow-up|2|||
127832950|NCT00755846|460007064|FG002|Overall Study|Lost to Follow-up|1|||
127832951|NCT00755846|460007065|FG003|Overall Study|Lost to Follow-up|0|||
127832952|NCT00755846|460007066|FG004|Overall Study|Lost to Follow-up|4|||
127832953|NCT00755846|460007067|FG005|Overall Study|Lost to Follow-up|2|||
127832954|NCT00755846|460007062|FG000|Overall Study|Withdrawal by Subject|2|||
127832955|NCT00755846|460007063|FG001|Overall Study|Withdrawal by Subject|3|||
127832956|NCT00755846|460007064|FG002|Overall Study|Withdrawal by Subject|5|||
127832957|NCT00755846|460007065|FG003|Overall Study|Withdrawal by Subject|2|||
127832958|NCT00755846|460007066|FG004|Overall Study|Withdrawal by Subject|0|||
127832959|NCT00755846|460007067|FG005|Overall Study|Withdrawal by Subject|1|||
127832960|NCT00755846|460007062|FG000|Overall Study|Hyperglycemic Rescue|21|||
127832961|NCT00755846|460007063|FG001|Overall Study|Hyperglycemic Rescue|7|||
127832962|NCT00755846|460007064|FG002|Overall Study|Hyperglycemic Rescue|5|||
127832963|NCT00755846|460007065|FG003|Overall Study|Hyperglycemic Rescue|8|||
127832964|NCT00755846|460007066|FG004|Overall Study|Hyperglycemic Rescue|8|||
127832965|NCT00755846|460007067|FG005|Overall Study|Hyperglycemic Rescue|7|||
127832966|NCT00755846|460007062|FG000|Overall Study|Physician Decision|1|||
127832967|NCT00755846|460007063|FG001|Overall Study|Physician Decision|3|||
127832968|NCT00755846|460007064|FG002|Overall Study|Physician Decision|0|||
127832969|NCT00755846|460007065|FG003|Overall Study|Physician Decision|1|||
127832970|NCT00755846|460007066|FG004|Overall Study|Physician Decision|0|||
127832971|NCT00755846|460007067|FG005|Overall Study|Physician Decision|1|||
127832972|NCT00755846|460007062|FG000|Overall Study|Administrative Error|0|||
127832973|NCT00755846|460007063|FG001|Overall Study|Administrative Error|1|||
127832974|NCT00755846|460007064|FG002|Overall Study|Administrative Error|0|||
127832975|NCT00755846|460007065|FG003|Overall Study|Administrative Error|0|||
127832976|NCT00755846|460007066|FG004|Overall Study|Administrative Error|0|||
127832977|NCT00755846|460007067|FG005|Overall Study|Administrative Error|0|||
127832978|NCT00755846|460007062|FG000|Overall Study|Participant Non-compliance|0|||
127832979|NCT00755846|460007063|FG001|Overall Study|Participant Non-compliance|0|||
127832980|NCT00755846|460007064|FG002|Overall Study|Participant Non-compliance|0|||
127832981|NCT00755846|460007065|FG003|Overall Study|Participant Non-compliance|0|||
127832982|NCT00755846|460007066|FG004|Overall Study|Participant Non-compliance|1|||
127832983|NCT00755846|460007067|FG005|Overall Study|Participant Non-compliance|0|||
127832984|NCT00786032|460007070|FG000|Overall Study|Death|4|||
127832985|NCT00786032|460007070|FG000|Overall Study|Withdrawal by Subject|14|||
127832986|NCT00786032|460007070|FG000|Overall Study|Did not complete in the timeframe|6|||
127832987|NCT00311181|460007073|FG000|Overall Study|Final DFTs were not obtained|96|||
127895472|NCT01860976|460240691|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
127895473|NCT01860976|460240692|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
127895474|NCT01860976|460240691|FG000|Blinded Treatment|Withdrawal by Subject|3|||
127895475|NCT01860976|460240692|FG001|Blinded Treatment|Withdrawal by Subject|5|||
127895476|NCT01860976|460240691|FG000|Blinded Treatment|Subject no longer met criteria|1|||
127895477|NCT01860976|460240692|FG001|Blinded Treatment|Subject no longer met criteria|0|||
127895478|NCT01860976|460240691|FG000|Blinded Treatment|Entered Open-Label in error|0|||
127895479|NCT01860976|460240692|FG001|Blinded Treatment|Entered Open-Label in error|1|||
127895480|NCT01860976|460240691|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
127895481|NCT01860976|460240692|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
127895482|NCT01860976|460240691|FG000|Open-Label|Adverse Event|2|||
127895483|NCT01860976|460240692|FG001|Open-Label|Adverse Event|4|||
127895484|NCT01860976|460240691|FG000|Open-Label|Lack of Efficacy|16|||
127895485|NCT01860976|460240692|FG001|Open-Label|Lack of Efficacy|8|||
127895486|NCT01860976|460240691|FG000|Open-Label|Lost to Follow-up|1|||
127895487|NCT01860976|460240692|FG001|Open-Label|Lost to Follow-up|2|||
127895488|NCT01860976|460240691|FG000|Open-Label|Subject request discontinue treatment|4|||
127895489|NCT01860976|460240692|FG001|Open-Label|Subject request discontinue treatment|3|||
127895490|NCT01860976|460240691|FG000|Open-Label|Withdrawal by Subject|4|||
127895491|NCT01860976|460240692|FG001|Open-Label|Withdrawal by Subject|1|||
127895492|NCT01860976|460240691|FG000|Open-Label|Other Reasons|1|||
127895493|NCT01860976|460240692|FG001|Open-Label|Other Reasons|1|||
127895494|NCT01860976|460240691|FG000|Long Term Extension|Adverse Event|4|||
127895495|NCT01860976|460240692|FG001|Long Term Extension|Adverse Event|0|||
127895496|NCT01860976|460240691|FG000|Long Term Extension|Lack of Efficacy|2|||
127895497|NCT01860976|460240692|FG001|Long Term Extension|Lack of Efficacy|0|||
127895498|NCT01860976|460240691|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
127895499|NCT01860976|460240692|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
127895500|NCT01860976|460240691|FG000|Long Term Extension|Lost to Follow-up|2|||
127895501|NCT01860976|460240692|FG001|Long Term Extension|Lost to Follow-up|0|||
127895502|NCT01860976|460240691|FG000|Long Term Extension|subject withdrew consent|7|||
127895503|NCT01860976|460240692|FG001|Long Term Extension|subject withdrew consent|0|||
127895504|NCT02227862|460240693|FG000|Overall Study|Protocol Violation|7|||
127895505|NCT02227862|460240694|FG001|Overall Study|Protocol Violation|9|||
127895506|NCT02227862|460240693|FG000|Overall Study|Other|0|||
127895507|NCT02227862|460240694|FG001|Overall Study|Other|2|||
127895508|NCT02227862|460240693|FG000|Overall Study|Adverse Event|4|||
127895509|NCT02227862|460240694|FG001|Overall Study|Adverse Event|3|||
127895510|NCT02227862|460240693|FG000|Overall Study|Withdrawal by Subject|7|||
127895511|NCT02227862|460240694|FG001|Overall Study|Withdrawal by Subject|6|||
127895512|NCT02227862|460240693|FG000|Overall Study|Lost to Follow-up|1|||
127895513|NCT02227862|460240694|FG001|Overall Study|Lost to Follow-up|2|||
127895514|NCT02204371|460240705|FG000|Overall Study|Adverse Event|1|||
127895515|NCT02419313|460240706|FG000|First Intervention|Lost to Follow-up|2|||
127895516|NCT02419313|460240707|FG001|First Intervention|Lost to Follow-up|0|||
127895517|NCT02419313|460240706|FG000|Second Intervention|Lost to Follow-up|1|||
127895518|NCT02419313|460240707|FG001|Second Intervention|Lost to Follow-up|0|||
127895519|NCT00620763|460240710|FG000|Period: First Intervention|Withdrawal by Subject|0|||
127895520|NCT00620763|460240711|FG001|Period: First Intervention|Withdrawal by Subject|2|||
127895521|NCT00620763|460240710|FG000|Period: First Intervention|Protocol Violation|0|||
127895522|NCT00620763|460240711|FG001|Period: First Intervention|Protocol Violation|3|||
127895523|NCT00620763|460240710|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
127895524|NCT00620763|460240711|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
127895525|NCT00368966|460240715|FG000|Infant Series|Withdrawal by Subject|11|||
127895526|NCT00368966|460240716|FG001|Infant Series|Withdrawal by Subject|6|||
127895527|NCT00368966|460240715|FG000|Infant Series|Protocol Violation|2|||
127895528|NCT00368966|460240716|FG001|Infant Series|Protocol Violation|1|||
127895529|NCT00368966|460240715|FG000|Infant Series|Lost to Follow-up|2|||
127895530|NCT00368966|460240716|FG001|Infant Series|Lost to Follow-up|0|||
127895531|NCT00368966|460240715|FG000|Infant Series|Randomization error|0|||
127895532|NCT00368966|460240716|FG001|Infant Series|Randomization error|1|||
127895533|NCT00368966|460240715|FG000|Infant Series|Failed to meet eligibility criteria|0|||
127895534|NCT00368966|460240716|FG001|Infant Series|Failed to meet eligibility criteria|1|||
127895535|NCT00368966|460240715|FG000|Infant Series|Adverse Event|0|||
127895536|NCT00368966|460240716|FG001|Infant Series|Adverse Event|1|||
127895537|NCT00368966|460240715|FG000|Infant Series|Failed to return|1|||
127895538|NCT00368966|460240716|FG001|Infant Series|Failed to return|0|||
127895539|NCT00368966|460240715|FG000|After Infant|Failed to return|3|||
127895540|NCT00368966|460240716|FG001|After Infant|Failed to return|1|||
127895541|NCT00368966|460240715|FG000|After Infant|Adverse Event|1|||
127895542|NCT00368966|460240716|FG001|After Infant|Adverse Event|2|||
127895543|NCT00368966|460240715|FG000|After Infant|Withdrawal by Subject|1|||
127832988|NCT02669862|460007074|FG000|Overall Study|Lost to Follow-up|0|||
127832989|NCT02669862|460007075|FG001|Overall Study|Lost to Follow-up|2|||
127832990|NCT02669862|460007076|FG002|Overall Study|Lost to Follow-up|1|||
127832991|NCT02669862|460007074|FG000|Overall Study|Withdrawal by Subject|2|||
127832992|NCT02669862|460007075|FG001|Overall Study|Withdrawal by Subject|2|||
127832993|NCT02669862|460007076|FG002|Overall Study|Withdrawal by Subject|3|||
127832994|NCT02669862|460007074|FG000|Overall Study|moved|0|||
127832995|NCT02669862|460007075|FG001|Overall Study|moved|1|||
127832996|NCT02669862|460007076|FG002|Overall Study|moved|0|||
127832997|NCT02669862|460007074|FG000|Overall Study|Protocol Violation|0|||
127832998|NCT02669862|460007075|FG001|Overall Study|Protocol Violation|0|||
127832999|NCT02669862|460007076|FG002|Overall Study|Protocol Violation|1|||
127833000|NCT02294318|460007079|FG000|Overall Study|Worsening of drinking|3|||
127833001|NCT02294318|460007080|FG001|Overall Study|Worsening of drinking|0|||
127833002|NCT02294318|460007079|FG000|Overall Study|Not exposed to intervention|0|||
127833003|NCT02294318|460007080|FG001|Overall Study|Not exposed to intervention|2|||
127833004|NCT02429258|460007081|FG000|Overall Study|Withdrawal by Subject|2|||
127833005|NCT02429258|460007082|FG001|Overall Study|Withdrawal by Subject|0|||
127833006|NCT02429258|460007081|FG000|Overall Study|Protocol Violation|0|||
127833007|NCT02429258|460007082|FG001|Overall Study|Protocol Violation|1|||
127833008|NCT02397694|460007083|FG000|Double-Blinded Phase|Adverse Event|1|||
127833009|NCT02397694|460007084|FG001|Double-Blinded Phase|Adverse Event|0|||
127833010|NCT02397694|460007083|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
127895544|NCT00368966|460240716|FG001|After Infant|Withdrawal by Subject|1|||
127895545|NCT00368966|460240715|FG000|After Infant|Death|1|||
127895546|NCT00368966|460240716|FG001|After Infant|Death|0|||
127895547|NCT00368966|460240715|FG000|After Infant|Lost to Follow-up|0|||
127833011|NCT02397694|460007084|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
127833012|NCT02397694|460007083|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
127833013|NCT02397694|460007084|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
127833014|NCT02397694|460007083|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
127833015|NCT02397694|460007084|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
127833016|NCT02397694|460007083|FG000|Open Label Extension Phase|Protocol Violation|1|||
127833017|NCT02397694|460007084|FG001|Open Label Extension Phase|Protocol Violation|0|||
127895548|NCT00368966|460240716|FG001|After Infant|Lost to Follow-up|1|||
127833018|NCT02397694|460007083|FG000|Open Label Extension Phase|Withdrew Consent|3|||
127833019|NCT02397694|460007084|FG001|Open Label Extension Phase|Withdrew Consent|1|||
127833020|NCT02397694|460007083|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
127833021|NCT02397694|460007084|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
127833022|NCT03725202|460007087|FG000|Period 1 (Baseline - Week 52)|Adverse Event|13|||
127833023|NCT03725202|460007088|FG001|Period 1 (Baseline - Week 52)|Adverse Event|11|||
127833024|NCT03725202|460007089|FG002|Period 1 (Baseline - Week 52)|Adverse Event|17|||
127833025|NCT03725202|460007090|FG003|Period 1 (Baseline - Week 52)|Adverse Event|0|||
127833026|NCT03725202|460007091|FG004|Period 1 (Baseline - Week 52)|Adverse Event|0|||
127833027|NCT03725202|460007092|FG005|Period 1 (Baseline - Week 52)|Adverse Event|0|||
127833028|NCT03725202|460007093|FG006|Period 1 (Baseline - Week 52)|Adverse Event|0|||
127833029|NCT03725202|460007094|FG007|Period 1 (Baseline - Week 52)|Adverse Event|0|||
127833030|NCT03725202|460007087|FG000|Period 1 (Baseline - Week 52)|Withdrew consent|5|||
127833031|NCT03725202|460007088|FG001|Period 1 (Baseline - Week 52)|Withdrew consent|6|||
127833032|NCT03725202|460007089|FG002|Period 1 (Baseline - Week 52)|Withdrew consent|10|||
127833033|NCT03725202|460007090|FG003|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
127833034|NCT03725202|460007091|FG004|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
127833035|NCT03725202|460007092|FG005|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
127833036|NCT03725202|460007093|FG006|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
127833037|NCT03725202|460007094|FG007|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
127833038|NCT03725202|460007087|FG000|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|1|||
127833039|NCT03725202|460007088|FG001|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
127833040|NCT03725202|460007089|FG002|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
127833041|NCT03725202|460007090|FG003|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
127833042|NCT03725202|460007091|FG004|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
127833043|NCT03725202|460007092|FG005|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
127833044|NCT03725202|460007093|FG006|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
127833045|NCT03725202|460007094|FG007|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
127833046|NCT03725202|460007087|FG000|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|2|||
127833047|NCT03725202|460007088|FG001|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
127833048|NCT03725202|460007089|FG002|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
127833049|NCT03725202|460007090|FG003|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
127833050|NCT03725202|460007091|FG004|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
127833051|NCT03725202|460007092|FG005|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
127833052|NCT03725202|460007093|FG006|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
127833053|NCT03725202|460007094|FG007|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
127833054|NCT03725202|460007087|FG000|Period 1 (Baseline - Week 52)|Other, not specified|5|||
127833055|NCT03725202|460007088|FG001|Period 1 (Baseline - Week 52)|Other, not specified|5|||
127833056|NCT03725202|460007089|FG002|Period 1 (Baseline - Week 52)|Other, not specified|5|||
127833057|NCT03725202|460007090|FG003|Period 1 (Baseline - Week 52)|Other, not specified|0|||
127833058|NCT03725202|460007091|FG004|Period 1 (Baseline - Week 52)|Other, not specified|0|||
127833059|NCT03725202|460007092|FG005|Period 1 (Baseline - Week 52)|Other, not specified|0|||
127833060|NCT03725202|460007093|FG006|Period 1 (Baseline - Week 52)|Other, not specified|0|||
127833061|NCT03725202|460007094|FG007|Period 1 (Baseline - Week 52)|Other, not specified|0|||
127833062|NCT03725202|460007087|FG000|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
127833063|NCT03725202|460007088|FG001|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
127833064|NCT03725202|460007089|FG002|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|1|||
127833065|NCT03725202|460007090|FG003|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
127833066|NCT03725202|460007091|FG004|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
127833067|NCT03725202|460007092|FG005|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
127895549|NCT00368966|460240715|FG000|Toddler Dose|Withdrawal by Subject|1|||
127895550|NCT00368966|460240716|FG001|Toddler Dose|Withdrawal by Subject|1|||
127895551|NCT00368966|460240715|FG000|Toddler Dose|Lost to Follow-up|0|||
127895552|NCT00368966|460240716|FG001|Toddler Dose|Lost to Follow-up|2|||
127895553|NCT02866175|460240717|FG000|Overall Study|Adverse Event|56|||
127895554|NCT02866175|460240718|FG001|Overall Study|Adverse Event|54|||
127895555|NCT02866175|460240717|FG000|Overall Study|Withdrawal by Subject|31|||
127895556|NCT02866175|460240718|FG001|Overall Study|Withdrawal by Subject|52|||
127895557|NCT02866175|460240717|FG000|Overall Study|Death|30|||
127895558|NCT02866175|460240718|FG001|Overall Study|Death|23|||
127895559|NCT02866175|460240717|FG000|Overall Study|Other|7|||
127895560|NCT02866175|460240718|FG001|Overall Study|Other|14|||
127895561|NCT02866175|460240717|FG000|Overall Study|Progressive disease|1|||
127895562|NCT02866175|460240718|FG001|Overall Study|Progressive disease|1|||
127895563|NCT02866175|460240717|FG000|Overall Study|Lost to Follow-up|2|||
127895564|NCT02866175|460240718|FG001|Overall Study|Lost to Follow-up|0|||
127895565|NCT02866175|460240717|FG000|Overall Study|Lack of Efficacy|0|||
127895566|NCT02866175|460240718|FG001|Overall Study|Lack of Efficacy|1|||
127895567|NCT02866175|460240717|FG000|Overall Study|Physician Decision|3|||
127895568|NCT02866175|460240718|FG001|Overall Study|Physician Decision|15|||
127895569|NCT02866175|460240717|FG000|Overall Study|Did not receive treatment|5|||
127895570|NCT02866175|460240718|FG001|Overall Study|Did not receive treatment|15|||
127895571|NCT02907203|460240719|FG000|Overall Study|Death|1|||
127895572|NCT02907203|460240719|FG000|Overall Study|Lost to Follow-up|3|||
127895573|NCT02907203|460240719|FG000|Overall Study|Withdrawal by Subject|3|||
127895574|NCT02907203|460240719|FG000|Overall Study|Surgical bypass|1|||
127895575|NCT00760383|460240720|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
127895576|NCT00760383|460240721|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
127895577|NCT01816477|460240723|FG000|Overall Study|Withdrawal by Subject|13|||
127895578|NCT01816477|460240724|FG001|Overall Study|Withdrawal by Subject|1|||
127895579|NCT01816477|460240723|FG000|Overall Study|Unable to tolerate catheter placement|3|||
127895580|NCT01816477|460240724|FG001|Overall Study|Unable to tolerate catheter placement|0|||
127895581|NCT00819247|460240725|FG000|Overall Study|Adverse Event|0|||
127895582|NCT00819247|460240726|FG001|Overall Study|Adverse Event|5|||
127895583|NCT00819247|460240727|FG002|Overall Study|Adverse Event|3|||
127895584|NCT00819247|460240725|FG000|Overall Study|Insufficient testosterone response|5|||
127895585|NCT00819247|460240726|FG001|Overall Study|Insufficient testosterone response|8|||
127895586|NCT00819247|460240727|FG002|Overall Study|Insufficient testosterone response|10|||
127895587|NCT00819247|460240725|FG000|Overall Study|Withdrawal by Subject|1|||
127895588|NCT00819247|460240726|FG001|Overall Study|Withdrawal by Subject|0|||
127895589|NCT00819247|460240727|FG002|Overall Study|Withdrawal by Subject|0|||
127895590|NCT00819247|460240725|FG000|Overall Study|Protocol Violation|1|||
127895591|NCT00819247|460240726|FG001|Overall Study|Protocol Violation|0|||
127895592|NCT00819247|460240727|FG002|Overall Study|Protocol Violation|1|||
127895593|NCT00819247|460240725|FG000|Overall Study|Mistakenly withdrawn|0|||
127895594|NCT00819247|460240726|FG001|Overall Study|Mistakenly withdrawn|1|||
127895595|NCT00819247|460240727|FG002|Overall Study|Mistakenly withdrawn|0|||
127895596|NCT00819247|460240725|FG000|Overall Study|Bad prostate-specific antigen response|3|||
127895597|NCT00819247|460240726|FG001|Overall Study|Bad prostate-specific antigen response|2|||
127895598|NCT00819247|460240727|FG002|Overall Study|Bad prostate-specific antigen response|0|||
127895599|NCT00819247|460240725|FG000|Overall Study|Other|1|||
127895600|NCT00819247|460240726|FG001|Overall Study|Other|0|||
127895601|NCT00819247|460240727|FG002|Overall Study|Other|0|||
127833068|NCT03725202|460007093|FG006|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
127833069|NCT03725202|460007094|FG007|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
127833070|NCT03725202|460007087|FG000|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
127833071|NCT03725202|460007088|FG001|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
127895602|NCT00282256|460240728|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
127895603|NCT00282256|460240728|FG000|Extension Treatment Period|Adverse Event|2|||
127895604|NCT02540356|460240729|FG000|Overall Study|Terminated due to disease progression|1|||
127895605|NCT02540356|460240730|FG001|Overall Study|Terminated due to disease progression|0|||
127895606|NCT01513148|460240731|FG000|Overall Study|Protocol Violation|2|||
127895607|NCT01513148|460240732|FG001|Overall Study|Protocol Violation|2|||
127895608|NCT01411995|460240742|FG000|Overall Study|Failed IUD insertion|0|||
127895609|NCT01411995|460240743|FG001|Overall Study|Failed IUD insertion|1|||
127895610|NCT02974153|460240744|FG000|Overall Study|Adverse Event|6|||
127895611|NCT02974153|460240745|FG001|Overall Study|Adverse Event|0|||
127895612|NCT02974153|460240746|FG002|Overall Study|Adverse Event|1|||
127895613|NCT02974153|460240744|FG000|Overall Study|Lack of Efficacy|6|||
127895614|NCT02974153|460240745|FG001|Overall Study|Lack of Efficacy|5|||
127895615|NCT02974153|460240746|FG002|Overall Study|Lack of Efficacy|10|||
127895616|NCT02974153|460240744|FG000|Overall Study|Lost to Follow-up|9|||
127895617|NCT02974153|460240745|FG001|Overall Study|Lost to Follow-up|10|||
127895618|NCT02974153|460240746|FG002|Overall Study|Lost to Follow-up|17|||
127895619|NCT02974153|460240744|FG000|Overall Study|Physician Decision|0|||
127895620|NCT02974153|460240745|FG001|Overall Study|Physician Decision|2|||
127895621|NCT02974153|460240746|FG002|Overall Study|Physician Decision|1|||
127895622|NCT02974153|460240744|FG000|Overall Study|Withdrawal by Subject|9|||
127895623|NCT02974153|460240745|FG001|Overall Study|Withdrawal by Subject|16|||
127895624|NCT02974153|460240746|FG002|Overall Study|Withdrawal by Subject|11|||
127895625|NCT02974153|460240744|FG000|Overall Study|Study Burden|8|||
127895626|NCT02974153|460240745|FG001|Overall Study|Study Burden|7|||
127895627|NCT02974153|460240746|FG002|Overall Study|Study Burden|3|||
127895628|NCT02974153|460240744|FG000|Overall Study|Other|14|||
127895629|NCT02974153|460240745|FG001|Overall Study|Other|8|||
127895630|NCT02974153|460240746|FG002|Overall Study|Other|7|||
127895631|NCT02277769|460240747|FG000|Overall Study|Protocol Violation|3|||
127895632|NCT02277769|460240748|FG001|Overall Study|Protocol Violation|3|||
127895633|NCT02277769|460240749|FG002|Overall Study|Protocol Violation|5|||
127895634|NCT02277769|460240747|FG000|Overall Study|Lack of Efficacy|17|||
127895635|NCT02277769|460240748|FG001|Overall Study|Lack of Efficacy|0|||
127895636|NCT02277769|460240749|FG002|Overall Study|Lack of Efficacy|4|||
127895637|NCT02277769|460240747|FG000|Overall Study|Adverse Event|14|||
127895638|NCT02277769|460240748|FG001|Overall Study|Adverse Event|2|||
127895639|NCT02277769|460240749|FG002|Overall Study|Adverse Event|4|||
127895640|NCT02277769|460240747|FG000|Overall Study|Other than specified above|12|||
127895641|NCT02277769|460240748|FG001|Overall Study|Other than specified above|8|||
127895642|NCT02277769|460240749|FG002|Overall Study|Other than specified above|5|||
127895643|NCT00203307|460240752|FG000|First Intervention|Adverse Event|2|||
127895644|NCT00203307|460240753|FG001|First Intervention|Adverse Event|0|||
127895645|NCT03730103|460240754|FG000|Overall Study|Did not meet inclusion criteria|0|||
127895646|NCT03730103|460240755|FG001|Overall Study|Did not meet inclusion criteria|5|||
127895647|NCT01488578|460240756|FG000|Overall Study|Protocol Violation|1836|||
127895648|NCT02308111|460240757|FG000|Overall Study|Adverse Event|31|||
127895649|NCT02308111|460240758|FG001|Overall Study|Adverse Event|19|||
127895650|NCT02308111|460240757|FG000|Overall Study|Death|9|||
127895651|NCT02308111|460240758|FG001|Overall Study|Death|6|||
127895652|NCT02308111|460240757|FG000|Overall Study|Lost to Follow-up|2|||
127895653|NCT02308111|460240758|FG001|Overall Study|Lost to Follow-up|7|||
127895654|NCT02308111|460240757|FG000|Overall Study|Physician Decision|6|||
127895655|NCT02308111|460240758|FG001|Overall Study|Physician Decision|17|||
127895656|NCT02308111|460240757|FG000|Overall Study|Protocol Violation|0|||
127895657|NCT02308111|460240758|FG001|Overall Study|Protocol Violation|1|||
127895658|NCT02308111|460240757|FG000|Overall Study|Withdrawal by Subject|28|||
127895659|NCT02308111|460240758|FG001|Overall Study|Withdrawal by Subject|38|||
127895660|NCT02308111|460240757|FG000|Overall Study|Study Terminated by Sponsor|72|||
127895661|NCT02308111|460240758|FG001|Overall Study|Study Terminated by Sponsor|61|||
127895662|NCT02308111|460240757|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
127895663|NCT02308111|460240758|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
127895664|NCT02308111|460240757|FG000|Overall Study|Site Closure|3|||
127895665|NCT02308111|460240758|FG001|Overall Study|Site Closure|3|||
127895666|NCT02308111|460240757|FG000|Overall Study|Non-compliance with Study Drug|3|||
127895667|NCT02308111|460240758|FG001|Overall Study|Non-compliance with Study Drug|1|||
127895668|NCT02308111|460240757|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
127895669|NCT02308111|460240758|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
127895670|NCT02308111|460240757|FG000|Overall Study|Liver Transplant|3|||
127895671|NCT02308111|460240758|FG001|Overall Study|Liver Transplant|3|||
127895672|NCT02308111|460240757|FG000|Overall Study|Liver Transplant Waitlist|2|||
127895673|NCT02308111|460240758|FG001|Overall Study|Liver Transplant Waitlist|2|||
127895674|NCT02308111|460240757|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
127895675|NCT02308111|460240758|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
127895676|NCT00455533|460240761|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
127895677|NCT00455533|460240762|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
127833072|NCT03725202|460007089|FG002|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
127833073|NCT03725202|460007090|FG003|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|19|||
127833074|NCT03725202|460007091|FG004|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|11|||
127833075|NCT03725202|460007092|FG005|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|2|||
127833076|NCT03725202|460007093|FG006|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|27|||
127833077|NCT03725202|460007094|FG007|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|8|||
127833078|NCT03725202|460007087|FG000|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
127833079|NCT03725202|460007088|FG001|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
127833080|NCT03725202|460007089|FG002|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
127833081|NCT03725202|460007090|FG003|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
127833082|NCT03725202|460007091|FG004|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
127833083|NCT03725202|460007092|FG005|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
127833084|NCT03725202|460007093|FG006|Period 2 (Week 52 - Week 104)|Adverse Event|4|||
127833085|NCT03725202|460007094|FG007|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
127833086|NCT03725202|460007087|FG000|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
127833087|NCT03725202|460007088|FG001|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
127833088|NCT03725202|460007089|FG002|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
127833089|NCT03725202|460007090|FG003|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
127833090|NCT03725202|460007091|FG004|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
127833091|NCT03725202|460007092|FG005|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
127833092|NCT03725202|460007093|FG006|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
127833093|NCT03725202|460007094|FG007|Period 2 (Week 52 - Week 104)|Withdrew consent|2|||
127833094|NCT03725202|460007087|FG000|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
127833095|NCT03725202|460007088|FG001|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
127833096|NCT03725202|460007089|FG002|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
127833097|NCT03725202|460007090|FG003|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
127833098|NCT03725202|460007091|FG004|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
127833099|NCT03725202|460007092|FG005|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
127833100|NCT03725202|460007093|FG006|Period 2 (Week 52 - Week 104)|Lost to Follow-up|1|||
127833101|NCT03725202|460007094|FG007|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
127833102|NCT03725202|460007087|FG000|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
127833103|NCT03725202|460007088|FG001|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
127833104|NCT03725202|460007089|FG002|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
127833105|NCT03725202|460007090|FG003|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
127833106|NCT03725202|460007091|FG004|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
127833107|NCT03725202|460007092|FG005|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|1|||
127833108|NCT03725202|460007093|FG006|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
127833109|NCT03725202|460007094|FG007|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
127833110|NCT03725202|460007087|FG000|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
127833111|NCT03725202|460007088|FG001|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
127833112|NCT03725202|460007089|FG002|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
127833113|NCT03725202|460007090|FG003|Period 2 (Week 52 - Week 104)|Other, not specified|2|||
127833114|NCT03725202|460007091|FG004|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
127833115|NCT03725202|460007092|FG005|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
127833116|NCT03725202|460007093|FG006|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
127833117|NCT03725202|460007094|FG007|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
127833118|NCT01328249|460007097|FG000|Overall Study|Adverse Event|3|||
127833119|NCT01328249|460007098|FG001|Overall Study|Adverse Event|0|||
127833120|NCT01328249|460007097|FG000|Overall Study|Disease progression|1|||
127833121|NCT01328249|460007098|FG001|Overall Study|Disease progression|0|||
127833122|NCT01328249|460007097|FG000|Overall Study|Withdrawal by Subject|1|||
127833123|NCT01328249|460007098|FG001|Overall Study|Withdrawal by Subject|1|||
127833124|NCT01328249|460007097|FG000|Overall Study|Moved before end of treatment visit|1|||
127833125|NCT01328249|460007098|FG001|Overall Study|Moved before end of treatment visit|0|||
127833126|NCT01328249|460007097|FG000|Overall Study|Subject choice|1|||
127833127|NCT01328249|460007098|FG001|Overall Study|Subject choice|1|||
127833128|NCT01328249|460007097|FG000|Overall Study|Protocol Violation|0|||
127833129|NCT01328249|460007098|FG001|Overall Study|Protocol Violation|1|||
127833130|NCT01215734|460007099|FG000|Overall Study|Death|0|||
127833131|NCT01215734|460007100|FG001|Overall Study|Death|1|||
127833132|NCT01716533|460007101|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
127833133|NCT01716533|460007102|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
127833134|NCT01716533|460007103|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
127833135|NCT01716533|460007104|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
127833136|NCT01716533|460007101|FG000|Overall Study|Withdrawal by Subject|0|||
127833137|NCT01716533|460007102|FG001|Overall Study|Withdrawal by Subject|0|||
127833138|NCT01716533|460007103|FG002|Overall Study|Withdrawal by Subject|0|||
127833139|NCT01716533|460007104|FG003|Overall Study|Withdrawal by Subject|5|||
127833140|NCT01716533|460007101|FG000|Overall Study|Death|0|||
127833141|NCT01716533|460007102|FG001|Overall Study|Death|0|||
127833142|NCT01716533|460007103|FG002|Overall Study|Death|0|||
127833143|NCT01716533|460007104|FG003|Overall Study|Death|2|||
127833144|NCT01716533|460007101|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
127833145|NCT01716533|460007102|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
127833146|NCT01716533|460007103|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
127833147|NCT01716533|460007104|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
127833148|NCT02330549|460007105|FG000|Overall Study|Adverse Event|1|||
127833149|NCT02330549|460007106|FG001|Overall Study|Adverse Event|0|||
127833150|NCT02330549|460007105|FG000|Overall Study|Subject withdrew consent|2|||
127833151|NCT02330549|460007106|FG001|Overall Study|Subject withdrew consent|1|||
127833152|NCT02330549|460007105|FG000|Overall Study|Failure to meet randomization criteria|1|||
127833153|NCT02330549|460007106|FG001|Overall Study|Failure to meet randomization criteria|0|||
127833154|NCT00495495|460007112|FG000|Overall Study|Protocol Violation|99|||
127833155|NCT03331666|460007116|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
127833156|NCT03331666|460007117|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
127833157|NCT01026389|460007120|FG000|Overall Study|Withdrawal by Subject|1|||
127833158|NCT01026389|460007121|FG001|Overall Study|Withdrawal by Subject|3|||
127833159|NCT01026389|460007120|FG000|Overall Study|change of treatment, patient moved|4|||
127976287|NCT03395184|460533177|FG004|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
127976288|NCT03395184|460533178|FG005|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
127976289|NCT03395184|460533179|FG006|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
127976290|NCT03395184|460533173|FG000|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
127976291|NCT03395184|460533174|FG001|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|2|||
127976292|NCT03395184|460533175|FG002|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|1|||
127976293|NCT03395184|460533176|FG003|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
127976294|NCT03395184|460533177|FG004|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
127976295|NCT03395184|460533178|FG005|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
127976296|NCT03395184|460533179|FG006|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
127976297|NCT03395184|460533173|FG000|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
127976298|NCT03395184|460533174|FG001|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
127976299|NCT03395184|460533175|FG002|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
127976300|NCT03395184|460533176|FG003|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
127976301|NCT03395184|460533177|FG004|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
127976302|NCT03395184|460533178|FG005|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
127976303|NCT03395184|460533179|FG006|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
127976304|NCT03395184|460533173|FG000|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
127976305|NCT03395184|460533174|FG001|Induction Period (Up to 12 Weeks)|Lost to Follow-up|1|||
127976306|NCT03395184|460533175|FG002|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
127976307|NCT03395184|460533176|FG003|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
127976308|NCT03395184|460533177|FG004|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
127976309|NCT03395184|460533178|FG005|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
127976310|NCT03395184|460533179|FG006|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
127976311|NCT03395184|460533173|FG000|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
127976312|NCT03395184|460533174|FG001|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
127976313|NCT03395184|460533175|FG002|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
127976314|NCT03395184|460533176|FG003|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
127976315|NCT03395184|460533177|FG004|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
127976316|NCT03395184|460533178|FG005|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
127976317|NCT03395184|460533179|FG006|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
127976318|NCT03395184|460533173|FG000|Induction Period (Up to 12 Weeks)|Other|1|||
127976319|NCT03395184|460533174|FG001|Induction Period (Up to 12 Weeks)|Other|0|||
127976320|NCT03395184|460533175|FG002|Induction Period (Up to 12 Weeks)|Other|0|||
127976321|NCT03395184|460533176|FG003|Induction Period (Up to 12 Weeks)|Other|0|||
127976322|NCT03395184|460533177|FG004|Induction Period (Up to 12 Weeks)|Other|0|||
127976323|NCT03395184|460533178|FG005|Induction Period (Up to 12 Weeks)|Other|0|||
127976324|NCT03395184|460533179|FG006|Induction Period (Up to 12 Weeks)|Other|0|||
127976325|NCT03395184|460533173|FG000|OLE Period (Up to 52 Weeks)|Other|0|||
127976326|NCT03395184|460533174|FG001|OLE Period (Up to 52 Weeks)|Other|0|||
127976327|NCT03395184|460533175|FG002|OLE Period (Up to 52 Weeks)|Other|0|||
127976328|NCT03395184|460533176|FG003|OLE Period (Up to 52 Weeks)|Other|0|||
127976329|NCT03395184|460533177|FG004|OLE Period (Up to 52 Weeks)|Other|2|||
127976330|NCT03395184|460533178|FG005|OLE Period (Up to 52 Weeks)|Other|0|||
127976331|NCT03395184|460533179|FG006|OLE Period (Up to 52 Weeks)|Other|2|||
127976332|NCT03395184|460533173|FG000|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
127976333|NCT03395184|460533174|FG001|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
127976334|NCT03395184|460533175|FG002|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
127976335|NCT03395184|460533176|FG003|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
127833160|NCT01026389|460007121|FG001|Overall Study|change of treatment, patient moved|2|||
127833161|NCT01995136|460007122|FG000|Overall Study|Change in residence|1|||
127833162|NCT04410198|460007123|FG000|Overall Study|Death|10|||
127833163|NCT04410198|460007123|FG000|Overall Study|Withdrawal by Subject|7|||
127833164|NCT04410198|460007123|FG000|Overall Study|Transferred/Relocation|4|||
127833165|NCT04410198|460007123|FG000|Overall Study|Kidney Transplant|9|||
127833166|NCT04410198|460007123|FG000|Overall Study|Adverse Event|4|||
127833167|NCT04410198|460007123|FG000|Overall Study|Physician Decision|2|||
127833168|NCT04410198|460007123|FG000|Overall Study|Other than specified|1|||
127833169|NCT01830543|460007129|FG000|Overall Study|Subject Decision|19|||
127833170|NCT01830543|460007130|FG001|Overall Study|Subject Decision|21|||
127833171|NCT01830543|460007131|FG002|Overall Study|Subject Decision|57|||
127833172|NCT01830543|460007129|FG000|Overall Study|Adverse Event|91|||
127833173|NCT01830543|460007130|FG001|Overall Study|Adverse Event|77|||
127833174|NCT01830543|460007131|FG002|Overall Study|Adverse Event|76|||
127833175|NCT01830543|460007129|FG000|Overall Study|Death|20|||
127833176|NCT01830543|460007130|FG001|Overall Study|Death|22|||
127833177|NCT01830543|460007131|FG002|Overall Study|Death|22|||
127833178|NCT01830543|460007129|FG000|Overall Study|Protocol Violation|3|||
127833179|NCT01830543|460007130|FG001|Overall Study|Protocol Violation|7|||
127833180|NCT01830543|460007131|FG002|Overall Study|Protocol Violation|7|||
127833181|NCT01830543|460007129|FG000|Overall Study|Physician Decision|11|||
127833182|NCT01830543|460007130|FG001|Overall Study|Physician Decision|5|||
127833183|NCT01830543|460007131|FG002|Overall Study|Physician Decision|12|||
127833184|NCT01830543|460007129|FG000|Overall Study|Withdrawal by consent|3|||
127833185|NCT01830543|460007130|FG001|Overall Study|Withdrawal by consent|3|||
127833186|NCT01830543|460007131|FG002|Overall Study|Withdrawal by consent|3|||
127833187|NCT01830543|460007129|FG000|Overall Study|Other|12|||
127833188|NCT01830543|460007130|FG001|Overall Study|Other|17|||
127833189|NCT01830543|460007131|FG002|Overall Study|Other|37|||
127833190|NCT03583372|460007134|FG000|Overall Study|Withdrawal by Subject|6|||
127833191|NCT03583372|460007135|FG001|Overall Study|Withdrawal by Subject|11|||
127833192|NCT03583372|460007136|FG002|Overall Study|Withdrawal by Subject|7|||
127833193|NCT03583372|460007137|FG003|Overall Study|Withdrawal by Subject|8|||
127833194|NCT03583372|460007134|FG000|Overall Study|Lost to Follow-up|4|||
127833195|NCT03583372|460007135|FG001|Overall Study|Lost to Follow-up|6|||
127833196|NCT03583372|460007136|FG002|Overall Study|Lost to Follow-up|3|||
127833197|NCT03583372|460007137|FG003|Overall Study|Lost to Follow-up|2|||
127833198|NCT03583372|460007134|FG000|Overall Study|Adverse Event|1|||
127833199|NCT03583372|460007135|FG001|Overall Study|Adverse Event|3|||
127833200|NCT03583372|460007136|FG002|Overall Study|Adverse Event|4|||
127833201|NCT03583372|460007137|FG003|Overall Study|Adverse Event|4|||
127833202|NCT03583372|460007134|FG000|Overall Study|Physician Decision|0|||
127833203|NCT03583372|460007135|FG001|Overall Study|Physician Decision|1|||
127833204|NCT03583372|460007136|FG002|Overall Study|Physician Decision|1|||
127833205|NCT03583372|460007137|FG003|Overall Study|Physician Decision|1|||
127833206|NCT03583372|460007134|FG000|Overall Study|Lack of Efficacy|0|||
127833207|NCT03583372|460007135|FG001|Overall Study|Lack of Efficacy|1|||
127833208|NCT03583372|460007136|FG002|Overall Study|Lack of Efficacy|0|||
127833209|NCT03583372|460007137|FG003|Overall Study|Lack of Efficacy|1|||
127833210|NCT03583372|460007134|FG000|Overall Study|Death|1|||
127833211|NCT03583372|460007135|FG001|Overall Study|Death|0|||
127833212|NCT03583372|460007136|FG002|Overall Study|Death|0|||
127833213|NCT03583372|460007137|FG003|Overall Study|Death|0|||
127833214|NCT03583372|460007134|FG000|Overall Study|Protocol Violation|0|||
127833215|NCT03583372|460007135|FG001|Overall Study|Protocol Violation|1|||
127833216|NCT03583372|460007136|FG002|Overall Study|Protocol Violation|0|||
127833217|NCT03583372|460007137|FG003|Overall Study|Protocol Violation|0|||
127833218|NCT03583372|460007134|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
127833219|NCT03583372|460007135|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
127833220|NCT03583372|460007136|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
127833221|NCT03583372|460007137|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
127833222|NCT03583372|460007134|FG000|Overall Study|Did Not Receive Study Drug|0|||
127833223|NCT03583372|460007135|FG001|Overall Study|Did Not Receive Study Drug|1|||
127833224|NCT03583372|460007136|FG002|Overall Study|Did Not Receive Study Drug|0|||
127833225|NCT03583372|460007137|FG003|Overall Study|Did Not Receive Study Drug|0|||
127833226|NCT03583372|460007134|FG000|Overall Study|Captured as Other in the Database|1|||
127833227|NCT03583372|460007135|FG001|Overall Study|Captured as Other in the Database|2|||
127833228|NCT03583372|460007136|FG002|Overall Study|Captured as Other in the Database|4|||
127833229|NCT03583372|460007137|FG003|Overall Study|Captured as Other in the Database|1|||
127833230|NCT01030458|460007143|FG000|Overall Study|Lost to Follow-up|9|||
127833231|NCT01030458|460007144|FG001|Overall Study|Lost to Follow-up|10|||
127833232|NCT01030458|460007143|FG000|Overall Study|Withdrawal by Subject|2|||
127833233|NCT01030458|460007144|FG001|Overall Study|Withdrawal by Subject|3|||
127833234|NCT01030458|460007143|FG000|Overall Study|Logistical reasons|9|||
127833235|NCT01030458|460007144|FG001|Overall Study|Logistical reasons|5|||
127833236|NCT01030458|460007143|FG000|Overall Study|Moved or changed job|6|||
127833237|NCT01030458|460007144|FG001|Overall Study|Moved or changed job|13|||
127833238|NCT01030458|460007143|FG000|Overall Study|Side effect of medication|1|||
127833239|NCT01030458|460007144|FG001|Overall Study|Side effect of medication|1|||
127833240|NCT02420223|460007145|FG000|Overall Study|Adverse Event|1|||
127833241|NCT02420223|460007146|FG001|Overall Study|Adverse Event|0|||
127833242|NCT02420223|460007145|FG000|Overall Study|Physician Decision|0|||
127833243|NCT02420223|460007146|FG001|Overall Study|Physician Decision|2|||
127833244|NCT05142332|460007153|FG000|Overall Study|Withdrawal by Subject|0|||
127833245|NCT05142332|460007154|FG001|Overall Study|Withdrawal by Subject|1|||
127833246|NCT05142332|460007155|FG002|Overall Study|Withdrawal by Subject|2|||
127833247|NCT05142332|460007156|FG003|Overall Study|Withdrawal by Subject|0|||
127833248|NCT05142332|460007157|FG004|Overall Study|Withdrawal by Subject|0|||
127833249|NCT05142332|460007158|FG005|Overall Study|Withdrawal by Subject|2|||
127833250|NCT05142332|460007159|FG006|Overall Study|Withdrawal by Subject|6|||
127833251|NCT05142332|460007153|FG000|Overall Study|Left ED|3|||
127833252|NCT05142332|460007154|FG001|Overall Study|Left ED|0|||
127833253|NCT05142332|460007155|FG002|Overall Study|Left ED|4|||
127833254|NCT05142332|460007156|FG003|Overall Study|Left ED|6|||
127833255|NCT05142332|460007157|FG004|Overall Study|Left ED|1|||
127833256|NCT05142332|460007158|FG005|Overall Study|Left ED|2|||
127833257|NCT05142332|460007159|FG006|Overall Study|Left ED|6|||
127833258|NCT05142332|460007153|FG000|Overall Study|Physician Decision|0|||
127833259|NCT05142332|460007154|FG001|Overall Study|Physician Decision|0|||
127833260|NCT05142332|460007155|FG002|Overall Study|Physician Decision|2|||
127833261|NCT05142332|460007156|FG003|Overall Study|Physician Decision|1|||
127833262|NCT05142332|460007157|FG004|Overall Study|Physician Decision|0|||
127833263|NCT05142332|460007158|FG005|Overall Study|Physician Decision|0|||
127833264|NCT05142332|460007159|FG006|Overall Study|Physician Decision|3|||
127833265|NCT05142332|460007153|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
127833266|NCT05142332|460007154|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
127833267|NCT05142332|460007155|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
127833268|NCT05142332|460007156|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
127833269|NCT05142332|460007157|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
127833270|NCT05142332|460007158|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
127833271|NCT05142332|460007159|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
127833272|NCT02052778|460007164|FG000|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
127833273|NCT02052778|460007165|FG001|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
127833274|NCT02052778|460007166|FG002|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
127833275|NCT02052778|460007167|FG003|Dose Escalation(Approximately 60 Months)|Radiographic progression|1|||
127833276|NCT02052778|460007168|FG004|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
127833277|NCT02052778|460007169|FG005|Dose Escalation(Approximately 60 Months)|Radiographic progression|3|||
127833278|NCT02052778|460007170|FG006|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
127833279|NCT02052778|460007171|FG007|Dose Escalation(Approximately 60 Months)|Radiographic progression|6|||
127833280|NCT02052778|460007172|FG008|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
127833281|NCT02052778|460007173|FG009|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
127833282|NCT02052778|460007174|FG010|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
127833283|NCT02052778|460007175|FG011|Dose Escalation(Approximately 60 Months)|Radiographic progression|11|||
127833284|NCT02052778|460007176|FG012|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
127833285|NCT02052778|460007177|FG013|Dose Escalation(Approximately 60 Months)|Radiographic progression|7|||
127833286|NCT02052778|460007178|FG014|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
127833287|NCT02052778|460007179|FG015|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
127833288|NCT02052778|460007180|FG016|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
127833289|NCT02052778|460007181|FG017|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
127833290|NCT02052778|460007182|FG018|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
127833291|NCT02052778|460007183|FG019|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
127833292|NCT02052778|460007184|FG020|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
127833293|NCT02052778|460007185|FG021|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
127833294|NCT02052778|460007186|FG022|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
127833295|NCT02052778|460007164|FG000|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
127833296|NCT02052778|460007165|FG001|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
127833297|NCT02052778|460007166|FG002|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
127833298|NCT02052778|460007167|FG003|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
127833299|NCT02052778|460007168|FG004|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
127833300|NCT02052778|460007169|FG005|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
127833301|NCT02052778|460007170|FG006|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
127833302|NCT02052778|460007171|FG007|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
127833303|NCT02052778|460007172|FG008|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
127833304|NCT02052778|460007173|FG009|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
127833305|NCT02052778|460007174|FG010|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
127833306|NCT02052778|460007175|FG011|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
127833307|NCT02052778|460007176|FG012|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
127833308|NCT02052778|460007177|FG013|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
127833309|NCT02052778|460007178|FG014|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
127833310|NCT02052778|460007179|FG015|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
127833311|NCT02052778|460007180|FG016|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
127833312|NCT02052778|460007181|FG017|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
127833313|NCT02052778|460007182|FG018|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
127833314|NCT02052778|460007183|FG019|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
127833315|NCT02052778|460007184|FG020|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
127833316|NCT02052778|460007185|FG021|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
127833317|NCT02052778|460007186|FG022|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
127833318|NCT02052778|460007164|FG000|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
127833319|NCT02052778|460007165|FG001|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
127833320|NCT02052778|460007166|FG002|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
127833321|NCT02052778|460007167|FG003|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
127833322|NCT02052778|460007168|FG004|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
127833323|NCT02052778|460007169|FG005|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
127833324|NCT02052778|460007170|FG006|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
127833325|NCT02052778|460007171|FG007|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
127833326|NCT02052778|460007172|FG008|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
127833327|NCT02052778|460007173|FG009|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
127833328|NCT02052778|460007174|FG010|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
127833329|NCT02052778|460007175|FG011|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
127833330|NCT02052778|460007176|FG012|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
127833331|NCT02052778|460007177|FG013|Dose Escalation(Approximately 60 Months)|Adverse Event|1|||
127833332|NCT02052778|460007178|FG014|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
127833333|NCT02052778|460007179|FG015|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
127833334|NCT02052778|460007180|FG016|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
127833335|NCT02052778|460007181|FG017|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
127833336|NCT02052778|460007182|FG018|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
127833337|NCT02052778|460007183|FG019|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
127833338|NCT02052778|460007184|FG020|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
127833339|NCT02052778|460007185|FG021|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
127833340|NCT02052778|460007186|FG022|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
127833341|NCT02052778|460007164|FG000|Dose Escalation(Approximately 60 Months)|Death|0|||
127833342|NCT02052778|460007165|FG001|Dose Escalation(Approximately 60 Months)|Death|0|||
127833343|NCT02052778|460007166|FG002|Dose Escalation(Approximately 60 Months)|Death|0|||
127833344|NCT02052778|460007167|FG003|Dose Escalation(Approximately 60 Months)|Death|0|||
127833345|NCT02052778|460007168|FG004|Dose Escalation(Approximately 60 Months)|Death|0|||
127833346|NCT02052778|460007169|FG005|Dose Escalation(Approximately 60 Months)|Death|0|||
127833347|NCT02052778|460007170|FG006|Dose Escalation(Approximately 60 Months)|Death|1|||
127833348|NCT02052778|460007171|FG007|Dose Escalation(Approximately 60 Months)|Death|0|||
127833349|NCT02052778|460007172|FG008|Dose Escalation(Approximately 60 Months)|Death|0|||
127833350|NCT02052778|460007173|FG009|Dose Escalation(Approximately 60 Months)|Death|0|||
127833351|NCT02052778|460007174|FG010|Dose Escalation(Approximately 60 Months)|Death|0|||
127976336|NCT03395184|460533177|FG004|OLE Period (Up to 52 Weeks)|Lack of Efficacy|11|||
127833352|NCT02052778|460007175|FG011|Dose Escalation(Approximately 60 Months)|Death|1|||
127833353|NCT02052778|460007176|FG012|Dose Escalation(Approximately 60 Months)|Death|0|||
127833354|NCT02052778|460007177|FG013|Dose Escalation(Approximately 60 Months)|Death|0|||
127976337|NCT03395184|460533178|FG005|OLE Period (Up to 52 Weeks)|Lack of Efficacy|3|||
127976338|NCT03395184|460533179|FG006|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
127976339|NCT03395184|460533173|FG000|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
127976340|NCT03395184|460533174|FG001|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
127976341|NCT03395184|460533175|FG002|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
127976342|NCT03395184|460533176|FG003|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
127976343|NCT03395184|460533177|FG004|OLE Period (Up to 52 Weeks)|Lost to Follow-up|2|||
127976344|NCT03395184|460533178|FG005|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
127976345|NCT03395184|460533179|FG006|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
127976346|NCT03395184|460533173|FG000|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
127976347|NCT03395184|460533174|FG001|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
127976348|NCT03395184|460533175|FG002|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
127976349|NCT03395184|460533176|FG003|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
127976350|NCT03395184|460533177|FG004|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|11|||
127976351|NCT03395184|460533178|FG005|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
127976352|NCT03395184|460533179|FG006|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|8|||
127976353|NCT03395184|460533173|FG000|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
127976354|NCT03395184|460533174|FG001|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
127976355|NCT03395184|460533175|FG002|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
127976356|NCT03395184|460533176|FG003|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
127976357|NCT03395184|460533177|FG004|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
127976358|NCT03395184|460533178|FG005|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
127976359|NCT03395184|460533179|FG006|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
127976360|NCT03395184|460533173|FG000|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
127976361|NCT03395184|460533174|FG001|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
127976362|NCT03395184|460533175|FG002|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
127976363|NCT03395184|460533176|FG003|OLE Period (Up to 52 Weeks)|Adverse Event|7|||
127976364|NCT03395184|460533177|FG004|OLE Period (Up to 52 Weeks)|Adverse Event|13|||
127976365|NCT03395184|460533178|FG005|OLE Period (Up to 52 Weeks)|Adverse Event|4|||
127976366|NCT03395184|460533179|FG006|OLE Period (Up to 52 Weeks)|Adverse Event|15|||
127976367|NCT03339726|460536102|FG000|Overall Study|Withdrawal by Subject|1|||
127976368|NCT03339726|460536103|FG001|Overall Study|Withdrawal by Subject|0|||
127976369|NCT03339726|460536104|FG002|Overall Study|Withdrawal by Subject|0|||
127976370|NCT03339726|460536102|FG000|Overall Study|Lost to Follow-up|0|||
127976371|NCT03339726|460536103|FG001|Overall Study|Lost to Follow-up|1|||
127976372|NCT03339726|460536104|FG002|Overall Study|Lost to Follow-up|0|||
127976373|NCT01275755|460536105|FG000|Double-blind Treatment Period|Adverse Event|0|||
127976374|NCT01275755|460536106|FG001|Double-blind Treatment Period|Adverse Event|2|||
127976375|NCT01275755|460536105|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
127976376|NCT01275755|460536106|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
127976377|NCT01275755|460536105|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
127976378|NCT01275755|460536106|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
127976379|NCT01275755|460536105|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
127976380|NCT01275755|460536106|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
127976381|NCT00636194|460536112|FG000|Overall Study|Study related symptoms and complaints|1|||
127976382|NCT00636194|460536113|FG001|Overall Study|Study related symptoms and complaints|0|||
127976383|NCT00636194|460536112|FG000|Overall Study|Protocol Violation|2|||
127976384|NCT00636194|460536113|FG001|Overall Study|Protocol Violation|0|||
127976385|NCT04934189|460536118|FG000|Overall Study|Lost to Follow-up|4|||
127976386|NCT04934189|460536118|FG000|Overall Study|Withdrawal by Subject|17|||
127976387|NCT03962790|460536119|FG000|Period 1|Adverse Event|0|||
127976388|NCT03962790|460536120|FG001|Period 1|Adverse Event|1|||
127976389|NCT03962790|460536119|FG000|Period 1|Failed to meet all eligibility criteria|1|||
127976390|NCT03962790|460536120|FG001|Period 1|Failed to meet all eligibility criteria|1|||
127833355|NCT02052778|460007178|FG014|Dose Escalation(Approximately 60 Months)|Death|0|||
127833356|NCT02052778|460007179|FG015|Dose Escalation(Approximately 60 Months)|Death|0|||
127833357|NCT02052778|460007180|FG016|Dose Escalation(Approximately 60 Months)|Death|0|||
127833358|NCT02052778|460007181|FG017|Dose Escalation(Approximately 60 Months)|Death|0|||
127833359|NCT02052778|460007182|FG018|Dose Escalation(Approximately 60 Months)|Death|0|||
127833360|NCT02052778|460007183|FG019|Dose Escalation(Approximately 60 Months)|Death|0|||
127833361|NCT02052778|460007184|FG020|Dose Escalation(Approximately 60 Months)|Death|0|||
127833362|NCT02052778|460007185|FG021|Dose Escalation(Approximately 60 Months)|Death|0|||
127833363|NCT02052778|460007186|FG022|Dose Escalation(Approximately 60 Months)|Death|0|||
127833364|NCT02052778|460007164|FG000|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
127833365|NCT02052778|460007165|FG001|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
127833366|NCT02052778|460007166|FG002|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
127833367|NCT02052778|460007167|FG003|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
127833368|NCT02052778|460007168|FG004|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
127833369|NCT02052778|460007169|FG005|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
127833370|NCT02052778|460007170|FG006|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
127833371|NCT02052778|460007171|FG007|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
127833372|NCT02052778|460007172|FG008|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|1|||
127833373|NCT02052778|460007173|FG009|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
127833374|NCT02052778|460007174|FG010|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
127833375|NCT02052778|460007175|FG011|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
127833376|NCT02052778|460007176|FG012|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
127833377|NCT02052778|460007177|FG013|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|3|||
127833378|NCT02052778|460007178|FG014|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
127833379|NCT02052778|460007179|FG015|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
127833380|NCT02052778|460007180|FG016|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
127833381|NCT02052778|460007181|FG017|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
127833382|NCT02052778|460007182|FG018|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
127833383|NCT02052778|460007183|FG019|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
127833384|NCT02052778|460007184|FG020|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
127833385|NCT02052778|460007185|FG021|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
127833386|NCT02052778|460007186|FG022|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
127833387|NCT02052778|460007164|FG000|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
127833388|NCT02052778|460007165|FG001|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
127833389|NCT02052778|460007166|FG002|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
127833390|NCT02052778|460007167|FG003|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
127833391|NCT02052778|460007168|FG004|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
127833392|NCT02052778|460007169|FG005|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
127833393|NCT02052778|460007170|FG006|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
127833394|NCT02052778|460007171|FG007|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
127833395|NCT02052778|460007172|FG008|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
127833396|NCT02052778|460007173|FG009|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
127833397|NCT02052778|460007174|FG010|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
127833398|NCT02052778|460007175|FG011|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
127833399|NCT02052778|460007176|FG012|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
127833400|NCT02052778|460007177|FG013|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
127833401|NCT02052778|460007178|FG014|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
127833402|NCT02052778|460007179|FG015|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
127833403|NCT02052778|460007180|FG016|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
127833404|NCT02052778|460007181|FG017|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
127833405|NCT02052778|460007182|FG018|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
127833406|NCT02052778|460007183|FG019|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
127833407|NCT02052778|460007184|FG020|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
127833408|NCT02052778|460007185|FG021|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
127833409|NCT02052778|460007186|FG022|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
127833410|NCT02052778|460007164|FG000|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
127833411|NCT02052778|460007165|FG001|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
127833412|NCT02052778|460007166|FG002|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
127833413|NCT02052778|460007167|FG003|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
127833414|NCT02052778|460007168|FG004|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
127833415|NCT02052778|460007169|FG005|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
127833416|NCT02052778|460007170|FG006|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
127833417|NCT02052778|460007171|FG007|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
127833418|NCT02052778|460007172|FG008|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
127833419|NCT02052778|460007173|FG009|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
127833420|NCT02052778|460007174|FG010|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
127833421|NCT02052778|460007175|FG011|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
127833422|NCT02052778|460007176|FG012|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
127833423|NCT02052778|460007177|FG013|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
127833424|NCT02052778|460007178|FG014|Dose Expansion (Approximately 59 Months)|Radiographic progression|38|||
127833425|NCT02052778|460007179|FG015|Dose Expansion (Approximately 59 Months)|Radiographic progression|23|||
127833426|NCT02052778|460007180|FG016|Dose Expansion (Approximately 59 Months)|Radiographic progression|12|||
127833427|NCT02052778|460007181|FG017|Dose Expansion (Approximately 59 Months)|Radiographic progression|11|||
127833428|NCT02052778|460007182|FG018|Dose Expansion (Approximately 59 Months)|Radiographic progression|17|||
127833429|NCT02052778|460007183|FG019|Dose Expansion (Approximately 59 Months)|Radiographic progression|21|||
127833430|NCT02052778|460007184|FG020|Dose Expansion (Approximately 59 Months)|Radiographic progression|14|||
127833431|NCT02052778|460007185|FG021|Dose Expansion (Approximately 59 Months)|Radiographic progression|6|||
127833432|NCT02052778|460007186|FG022|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
127833433|NCT02052778|460007164|FG000|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
127833434|NCT02052778|460007165|FG001|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
127833435|NCT02052778|460007166|FG002|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
127833436|NCT02052778|460007167|FG003|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
127833437|NCT02052778|460007168|FG004|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
127833438|NCT02052778|460007169|FG005|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
127833439|NCT02052778|460007170|FG006|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
127833440|NCT02052778|460007171|FG007|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
127833441|NCT02052778|460007172|FG008|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
127833442|NCT02052778|460007173|FG009|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
127833443|NCT02052778|460007174|FG010|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
127833444|NCT02052778|460007175|FG011|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
127833445|NCT02052778|460007176|FG012|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
127833446|NCT02052778|460007177|FG013|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
127833447|NCT02052778|460007178|FG014|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|6|||
127833448|NCT02052778|460007179|FG015|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
127833449|NCT02052778|460007180|FG016|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
127833450|NCT02052778|460007181|FG017|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|2|||
127833451|NCT02052778|460007182|FG018|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
127833452|NCT02052778|460007183|FG019|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|4|||
127833453|NCT02052778|460007184|FG020|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|5|||
127833454|NCT02052778|460007185|FG021|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|1|||
127833455|NCT02052778|460007186|FG022|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
127833456|NCT02052778|460007164|FG000|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
127833457|NCT02052778|460007165|FG001|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
127833458|NCT02052778|460007166|FG002|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
127833459|NCT02052778|460007167|FG003|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
127833460|NCT02052778|460007168|FG004|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
127833461|NCT02052778|460007169|FG005|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
127833462|NCT02052778|460007170|FG006|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
127833463|NCT02052778|460007171|FG007|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
127833464|NCT02052778|460007172|FG008|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
127833465|NCT02052778|460007173|FG009|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
127833466|NCT02052778|460007174|FG010|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
127833467|NCT02052778|460007175|FG011|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
127833468|NCT02052778|460007176|FG012|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
127833469|NCT02052778|460007177|FG013|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
127833470|NCT02052778|460007178|FG014|Dose Expansion (Approximately 59 Months)|Adverse Event|5|||
127833471|NCT02052778|460007179|FG015|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
127833472|NCT02052778|460007180|FG016|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
127833473|NCT02052778|460007181|FG017|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
127833474|NCT02052778|460007182|FG018|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
127833475|NCT02052778|460007183|FG019|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
127833476|NCT02052778|460007184|FG020|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
127833477|NCT02052778|460007185|FG021|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
127833478|NCT02052778|460007186|FG022|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
127833479|NCT02052778|460007164|FG000|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
127833480|NCT02052778|460007165|FG001|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
127833481|NCT02052778|460007166|FG002|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
127833482|NCT02052778|460007167|FG003|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
127833483|NCT02052778|460007168|FG004|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
127833484|NCT02052778|460007169|FG005|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
127833485|NCT02052778|460007170|FG006|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
127833486|NCT02052778|460007171|FG007|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
127833487|NCT02052778|460007172|FG008|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
127833488|NCT02052778|460007173|FG009|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
127833489|NCT02052778|460007174|FG010|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
127833490|NCT02052778|460007175|FG011|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
127833491|NCT02052778|460007176|FG012|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
127833492|NCT02052778|460007177|FG013|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
127833493|NCT02052778|460007178|FG014|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|2|||
127833494|NCT02052778|460007179|FG015|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|3|||
127833495|NCT02052778|460007180|FG016|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
127833496|NCT02052778|460007181|FG017|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
127833497|NCT02052778|460007182|FG018|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
127833498|NCT02052778|460007183|FG019|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
127833499|NCT02052778|460007184|FG020|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
127833500|NCT02052778|460007185|FG021|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
127833501|NCT02052778|460007186|FG022|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
127833502|NCT02052778|460007164|FG000|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
127833503|NCT02052778|460007165|FG001|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
127833504|NCT02052778|460007166|FG002|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
127833505|NCT02052778|460007167|FG003|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
127833506|NCT02052778|460007168|FG004|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
127833507|NCT02052778|460007169|FG005|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
127833508|NCT02052778|460007170|FG006|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
127895678|NCT00455533|460240763|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
127895679|NCT00455533|460240761|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
127895680|NCT00455533|460240762|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
127895681|NCT00455533|460240763|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
127895682|NCT00455533|460240761|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
127895683|NCT00455533|460240762|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
127895684|NCT00455533|460240763|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
127895685|NCT00455533|460240761|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
127895686|NCT00455533|460240762|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
127895687|NCT00455533|460240763|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
127895688|NCT00455533|460240761|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
127895689|NCT00455533|460240762|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
127895690|NCT00455533|460240763|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
127895691|NCT00455533|460240761|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
127895692|NCT00455533|460240762|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
127895693|NCT00455533|460240763|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
127895694|NCT00455533|460240761|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
127895695|NCT00455533|460240762|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
127895696|NCT00455533|460240763|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
127895697|NCT00455533|460240761|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
127895698|NCT00455533|460240762|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
127895699|NCT00455533|460240763|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
127895700|NCT00455533|460240761|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
127895701|NCT00455533|460240762|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
127895702|NCT00455533|460240763|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
127833509|NCT02052778|460007171|FG007|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
127833510|NCT02052778|460007172|FG008|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
127833511|NCT02052778|460007173|FG009|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
127833512|NCT02052778|460007174|FG010|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
127833513|NCT02052778|460007175|FG011|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
127833514|NCT02052778|460007176|FG012|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
127833515|NCT02052778|460007177|FG013|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
127833516|NCT02052778|460007178|FG014|Dose Expansion (Approximately 59 Months)|Investigator decision|5|||
127833517|NCT02052778|460007179|FG015|Dose Expansion (Approximately 59 Months)|Investigator decision|3|||
127833518|NCT02052778|460007180|FG016|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
127833519|NCT02052778|460007181|FG017|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
127833520|NCT02052778|460007182|FG018|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
127833521|NCT02052778|460007183|FG019|Dose Expansion (Approximately 59 Months)|Investigator decision|1|||
127833522|NCT02052778|460007184|FG020|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
127833523|NCT02052778|460007185|FG021|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
127833524|NCT02052778|460007186|FG022|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
127833525|NCT02052778|460007164|FG000|Dose Expansion (Approximately 59 Months)|Other|0|||
127833526|NCT02052778|460007165|FG001|Dose Expansion (Approximately 59 Months)|Other|0|||
127833527|NCT02052778|460007166|FG002|Dose Expansion (Approximately 59 Months)|Other|0|||
127833528|NCT02052778|460007167|FG003|Dose Expansion (Approximately 59 Months)|Other|0|||
127833529|NCT02052778|460007168|FG004|Dose Expansion (Approximately 59 Months)|Other|0|||
127833530|NCT02052778|460007169|FG005|Dose Expansion (Approximately 59 Months)|Other|0|||
127833531|NCT02052778|460007170|FG006|Dose Expansion (Approximately 59 Months)|Other|0|||
127833532|NCT02052778|460007171|FG007|Dose Expansion (Approximately 59 Months)|Other|0|||
127833533|NCT02052778|460007172|FG008|Dose Expansion (Approximately 59 Months)|Other|0|||
127833534|NCT02052778|460007173|FG009|Dose Expansion (Approximately 59 Months)|Other|0|||
127833535|NCT02052778|460007174|FG010|Dose Expansion (Approximately 59 Months)|Other|0|||
127833536|NCT02052778|460007175|FG011|Dose Expansion (Approximately 59 Months)|Other|0|||
127833537|NCT02052778|460007176|FG012|Dose Expansion (Approximately 59 Months)|Other|0|||
127833538|NCT02052778|460007177|FG013|Dose Expansion (Approximately 59 Months)|Other|0|||
127833539|NCT02052778|460007178|FG014|Dose Expansion (Approximately 59 Months)|Other|1|||
127833540|NCT02052778|460007179|FG015|Dose Expansion (Approximately 59 Months)|Other|1|||
127833541|NCT02052778|460007180|FG016|Dose Expansion (Approximately 59 Months)|Other|0|||
127833542|NCT02052778|460007181|FG017|Dose Expansion (Approximately 59 Months)|Other|0|||
127833543|NCT02052778|460007182|FG018|Dose Expansion (Approximately 59 Months)|Other|1|||
127833544|NCT02052778|460007183|FG019|Dose Expansion (Approximately 59 Months)|Other|0|||
127833545|NCT02052778|460007184|FG020|Dose Expansion (Approximately 59 Months)|Other|0|||
127833546|NCT02052778|460007185|FG021|Dose Expansion (Approximately 59 Months)|Other|1|||
127833547|NCT02052778|460007186|FG022|Dose Expansion (Approximately 59 Months)|Other|0|||
127833548|NCT02052778|460007164|FG000|Dose Expansion (Approximately 59 Months)|Untreated|0|||
127833549|NCT02052778|460007165|FG001|Dose Expansion (Approximately 59 Months)|Untreated|0|||
127833550|NCT02052778|460007166|FG002|Dose Expansion (Approximately 59 Months)|Untreated|0|||
127833551|NCT02052778|460007167|FG003|Dose Expansion (Approximately 59 Months)|Untreated|0|||
127833552|NCT02052778|460007168|FG004|Dose Expansion (Approximately 59 Months)|Untreated|0|||
127833553|NCT02052778|460007169|FG005|Dose Expansion (Approximately 59 Months)|Untreated|0|||
127833554|NCT02052778|460007170|FG006|Dose Expansion (Approximately 59 Months)|Untreated|0|||
127833555|NCT02052778|460007171|FG007|Dose Expansion (Approximately 59 Months)|Untreated|0|||
127833556|NCT02052778|460007172|FG008|Dose Expansion (Approximately 59 Months)|Untreated|0|||
127833557|NCT02052778|460007173|FG009|Dose Expansion (Approximately 59 Months)|Untreated|0|||
127833558|NCT02052778|460007174|FG010|Dose Expansion (Approximately 59 Months)|Untreated|0|||
127833559|NCT02052778|460007175|FG011|Dose Expansion (Approximately 59 Months)|Untreated|0|||
127833560|NCT02052778|460007176|FG012|Dose Expansion (Approximately 59 Months)|Untreated|0|||
127833561|NCT02052778|460007177|FG013|Dose Expansion (Approximately 59 Months)|Untreated|0|||
127833562|NCT02052778|460007178|FG014|Dose Expansion (Approximately 59 Months)|Untreated|1|||
127833563|NCT02052778|460007179|FG015|Dose Expansion (Approximately 59 Months)|Untreated|1|||
127833564|NCT02052778|460007180|FG016|Dose Expansion (Approximately 59 Months)|Untreated|1|||
127833565|NCT02052778|460007181|FG017|Dose Expansion (Approximately 59 Months)|Untreated|0|||
127833566|NCT02052778|460007182|FG018|Dose Expansion (Approximately 59 Months)|Untreated|1|||
127833567|NCT02052778|460007183|FG019|Dose Expansion (Approximately 59 Months)|Untreated|0|||
127833568|NCT02052778|460007184|FG020|Dose Expansion (Approximately 59 Months)|Untreated|0|||
127833569|NCT02052778|460007185|FG021|Dose Expansion (Approximately 59 Months)|Untreated|0|||
127833570|NCT02052778|460007186|FG022|Dose Expansion (Approximately 59 Months)|Untreated|0|||
127833571|NCT02052778|460007164|FG000|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
127833572|NCT02052778|460007165|FG001|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
127833573|NCT02052778|460007166|FG002|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
127833574|NCT02052778|460007167|FG003|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
127833575|NCT02052778|460007168|FG004|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
127833576|NCT02052778|460007169|FG005|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
127833577|NCT02052778|460007170|FG006|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
127833578|NCT02052778|460007171|FG007|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
127833579|NCT02052778|460007172|FG008|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
127833580|NCT02052778|460007173|FG009|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
127833581|NCT02052778|460007174|FG010|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
127833582|NCT02052778|460007175|FG011|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
127833583|NCT02052778|460007176|FG012|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
127833584|NCT02052778|460007177|FG013|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
127833585|NCT02052778|460007178|FG014|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
127833586|NCT02052778|460007179|FG015|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
127833587|NCT02052778|460007180|FG016|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
127833588|NCT02052778|460007181|FG017|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
127833589|NCT02052778|460007182|FG018|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
127833590|NCT02052778|460007183|FG019|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
127833591|NCT02052778|460007184|FG020|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
127833592|NCT02052778|460007185|FG021|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
127833593|NCT02052778|460007186|FG022|Phase 2 (Approximately 63 Months)|Adverse Event|7|||
127833594|NCT02052778|460007164|FG000|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
127833595|NCT02052778|460007165|FG001|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
127833596|NCT02052778|460007166|FG002|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
127833597|NCT02052778|460007167|FG003|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
127833598|NCT02052778|460007168|FG004|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
127833599|NCT02052778|460007169|FG005|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
127833600|NCT02052778|460007170|FG006|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
127833601|NCT02052778|460007171|FG007|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
127833602|NCT02052778|460007172|FG008|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
127833603|NCT02052778|460007173|FG009|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
127833604|NCT02052778|460007174|FG010|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
127833605|NCT02052778|460007175|FG011|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
127833606|NCT02052778|460007176|FG012|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
127833607|NCT02052778|460007177|FG013|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
127833608|NCT02052778|460007178|FG014|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
127833609|NCT02052778|460007179|FG015|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
127833610|NCT02052778|460007180|FG016|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
127833611|NCT02052778|460007181|FG017|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
127833612|NCT02052778|460007182|FG018|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
127833613|NCT02052778|460007183|FG019|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
127833614|NCT02052778|460007184|FG020|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
127833615|NCT02052778|460007185|FG021|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
127833616|NCT02052778|460007186|FG022|Phase 2 (Approximately 63 Months)|Radiologic Progression|78|||
127833617|NCT02052778|460007164|FG000|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
127833618|NCT02052778|460007165|FG001|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
127833619|NCT02052778|460007166|FG002|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
127833620|NCT02052778|460007167|FG003|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
127833621|NCT02052778|460007168|FG004|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
127833622|NCT02052778|460007169|FG005|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
127833623|NCT02052778|460007170|FG006|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
127833624|NCT02052778|460007171|FG007|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
127833625|NCT02052778|460007172|FG008|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
127833626|NCT02052778|460007173|FG009|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
127833627|NCT02052778|460007174|FG010|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
127833628|NCT02052778|460007175|FG011|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
127833629|NCT02052778|460007176|FG012|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
127833630|NCT02052778|460007177|FG013|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
127833631|NCT02052778|460007178|FG014|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
127833632|NCT02052778|460007179|FG015|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
127833633|NCT02052778|460007180|FG016|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
127833634|NCT02052778|460007181|FG017|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
127833635|NCT02052778|460007182|FG018|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
127833636|NCT02052778|460007183|FG019|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
127833637|NCT02052778|460007184|FG020|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
127833638|NCT02052778|460007185|FG021|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
127833639|NCT02052778|460007186|FG022|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|6|||
127833640|NCT02052778|460007164|FG000|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
127833641|NCT02052778|460007165|FG001|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
127833642|NCT02052778|460007166|FG002|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
127833643|NCT02052778|460007167|FG003|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
127833644|NCT02052778|460007168|FG004|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
127833645|NCT02052778|460007169|FG005|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
127833646|NCT02052778|460007170|FG006|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
127833647|NCT02052778|460007171|FG007|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
127833648|NCT02052778|460007172|FG008|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
127833649|NCT02052778|460007173|FG009|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
127833650|NCT02052778|460007174|FG010|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
127833651|NCT02052778|460007175|FG011|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
127833652|NCT02052778|460007176|FG012|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
127833653|NCT02052778|460007177|FG013|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
127833654|NCT02052778|460007178|FG014|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
127833655|NCT02052778|460007179|FG015|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
127833656|NCT02052778|460007180|FG016|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
127833657|NCT02052778|460007181|FG017|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
127833658|NCT02052778|460007182|FG018|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
127833659|NCT02052778|460007183|FG019|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
127833660|NCT02052778|460007184|FG020|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
127833661|NCT02052778|460007185|FG021|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
127833662|NCT02052778|460007186|FG022|Phase 2 (Approximately 63 Months)|Withdrawal by participant|2|||
127833663|NCT02052778|460007164|FG000|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
127833664|NCT02052778|460007165|FG001|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
127833665|NCT02052778|460007166|FG002|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
127833666|NCT02052778|460007167|FG003|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
127833667|NCT02052778|460007168|FG004|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
127833668|NCT02052778|460007169|FG005|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
127833669|NCT02052778|460007170|FG006|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
127833670|NCT02052778|460007171|FG007|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
127833671|NCT02052778|460007172|FG008|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
127833672|NCT02052778|460007173|FG009|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
127833673|NCT02052778|460007174|FG010|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
127833674|NCT02052778|460007175|FG011|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
127833675|NCT02052778|460007176|FG012|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
127833676|NCT02052778|460007177|FG013|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
127833677|NCT02052778|460007178|FG014|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
127833678|NCT02052778|460007179|FG015|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
127833679|NCT02052778|460007180|FG016|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
127833680|NCT02052778|460007181|FG017|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
127833681|NCT02052778|460007182|FG018|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
127833682|NCT02052778|460007183|FG019|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
127833683|NCT02052778|460007184|FG020|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
127833684|NCT02052778|460007185|FG021|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
127833685|NCT02052778|460007186|FG022|Phase 2 (Approximately 63 Months)|Investigator Decision|3|||
127833686|NCT02052778|460007164|FG000|Phase 2 (Approximately 63 Months)|Other|0|||
127833687|NCT02052778|460007165|FG001|Phase 2 (Approximately 63 Months)|Other|0|||
127833688|NCT02052778|460007166|FG002|Phase 2 (Approximately 63 Months)|Other|0|||
127833689|NCT02052778|460007167|FG003|Phase 2 (Approximately 63 Months)|Other|0|||
127833690|NCT02052778|460007168|FG004|Phase 2 (Approximately 63 Months)|Other|0|||
127833691|NCT02052778|460007169|FG005|Phase 2 (Approximately 63 Months)|Other|0|||
127833692|NCT02052778|460007170|FG006|Phase 2 (Approximately 63 Months)|Other|0|||
127833693|NCT02052778|460007171|FG007|Phase 2 (Approximately 63 Months)|Other|0|||
127833694|NCT02052778|460007172|FG008|Phase 2 (Approximately 63 Months)|Other|0|||
127833695|NCT02052778|460007173|FG009|Phase 2 (Approximately 63 Months)|Other|0|||
127833696|NCT02052778|460007174|FG010|Phase 2 (Approximately 63 Months)|Other|0|||
127833697|NCT02052778|460007175|FG011|Phase 2 (Approximately 63 Months)|Other|0|||
127833698|NCT02052778|460007176|FG012|Phase 2 (Approximately 63 Months)|Other|0|||
127833699|NCT02052778|460007177|FG013|Phase 2 (Approximately 63 Months)|Other|0|||
127833700|NCT02052778|460007178|FG014|Phase 2 (Approximately 63 Months)|Other|0|||
127833701|NCT02052778|460007179|FG015|Phase 2 (Approximately 63 Months)|Other|0|||
127833702|NCT02052778|460007180|FG016|Phase 2 (Approximately 63 Months)|Other|0|||
127833703|NCT02052778|460007181|FG017|Phase 2 (Approximately 63 Months)|Other|0|||
127833704|NCT02052778|460007182|FG018|Phase 2 (Approximately 63 Months)|Other|0|||
127833705|NCT02052778|460007183|FG019|Phase 2 (Approximately 63 Months)|Other|0|||
127833706|NCT02052778|460007184|FG020|Phase 2 (Approximately 63 Months)|Other|0|||
127833707|NCT02052778|460007185|FG021|Phase 2 (Approximately 63 Months)|Other|0|||
127833708|NCT02052778|460007186|FG022|Phase 2 (Approximately 63 Months)|Other|7|||
127833709|NCT02052778|460007164|FG000|Phase 2 (Approximately 63 Months)|Untreated|0|||
127833710|NCT02052778|460007165|FG001|Phase 2 (Approximately 63 Months)|Untreated|0|||
127833711|NCT02052778|460007166|FG002|Phase 2 (Approximately 63 Months)|Untreated|0|||
127833712|NCT02052778|460007167|FG003|Phase 2 (Approximately 63 Months)|Untreated|0|||
127833713|NCT02052778|460007168|FG004|Phase 2 (Approximately 63 Months)|Untreated|0|||
127833714|NCT02052778|460007169|FG005|Phase 2 (Approximately 63 Months)|Untreated|0|||
127833715|NCT02052778|460007170|FG006|Phase 2 (Approximately 63 Months)|Untreated|0|||
127833716|NCT02052778|460007171|FG007|Phase 2 (Approximately 63 Months)|Untreated|0|||
127833717|NCT02052778|460007172|FG008|Phase 2 (Approximately 63 Months)|Untreated|0|||
127833718|NCT02052778|460007173|FG009|Phase 2 (Approximately 63 Months)|Untreated|0|||
127833719|NCT02052778|460007174|FG010|Phase 2 (Approximately 63 Months)|Untreated|0|||
127833720|NCT02052778|460007175|FG011|Phase 2 (Approximately 63 Months)|Untreated|0|||
127833721|NCT02052778|460007176|FG012|Phase 2 (Approximately 63 Months)|Untreated|0|||
127833722|NCT02052778|460007177|FG013|Phase 2 (Approximately 63 Months)|Untreated|0|||
127833723|NCT02052778|460007178|FG014|Phase 2 (Approximately 63 Months)|Untreated|0|||
127833724|NCT02052778|460007179|FG015|Phase 2 (Approximately 63 Months)|Untreated|0|||
127833725|NCT02052778|460007180|FG016|Phase 2 (Approximately 63 Months)|Untreated|0|||
127833726|NCT02052778|460007181|FG017|Phase 2 (Approximately 63 Months)|Untreated|0|||
127833727|NCT02052778|460007182|FG018|Phase 2 (Approximately 63 Months)|Untreated|0|||
127833728|NCT02052778|460007183|FG019|Phase 2 (Approximately 63 Months)|Untreated|0|||
127833729|NCT02052778|460007184|FG020|Phase 2 (Approximately 63 Months)|Untreated|0|||
127833730|NCT02052778|460007185|FG021|Phase 2 (Approximately 63 Months)|Untreated|0|||
127833731|NCT02052778|460007186|FG022|Phase 2 (Approximately 63 Months)|Untreated|17|||
127833732|NCT01980706|460007191|FG000|Overall Study|Withdrawal by Subject|9|||
127833733|NCT01980706|460007192|FG001|Overall Study|Withdrawal by Subject|6|||
127833734|NCT01980706|460007193|FG002|Overall Study|Withdrawal by Subject|2|||
127833735|NCT01980706|460007191|FG000|Overall Study|Adverse Event|1|||
127833736|NCT01980706|460007192|FG001|Overall Study|Adverse Event|2|||
127833737|NCT01980706|460007193|FG002|Overall Study|Adverse Event|5|||
127895703|NCT00455533|460240761|FG000|Period Two: Randomized Period|Death|0|||
127895704|NCT00455533|460240762|FG001|Period Two: Randomized Period|Death|0|||
127895705|NCT00455533|460240763|FG002|Period Two: Randomized Period|Death|3|||
127895706|NCT00455533|460240761|FG000|Period Two: Randomized Period|Disease Progression|0|||
127895707|NCT00455533|460240762|FG001|Period Two: Randomized Period|Disease Progression|1|||
127895708|NCT00455533|460240763|FG002|Period Two: Randomized Period|Disease Progression|1|||
127895709|NCT00455533|460240761|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
127895710|NCT00455533|460240762|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
127895711|NCT00455533|460240763|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
127895712|NCT00455533|460240761|FG000|Period Two: Randomized Period|Other - need reasons|0|||
127895713|NCT00455533|460240762|FG001|Period Two: Randomized Period|Other - need reasons|1|||
127895714|NCT00455533|460240763|FG002|Period Two: Randomized Period|Other - need reasons|0|||
127895715|NCT00455533|460240761|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
127895716|NCT00455533|460240762|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
127833738|NCT01980706|460007191|FG000|Overall Study|Lost to Follow-up|3|||
127833739|NCT01980706|460007192|FG001|Overall Study|Lost to Follow-up|4|||
127833740|NCT01980706|460007193|FG002|Overall Study|Lost to Follow-up|3|||
127833741|NCT01980706|460007191|FG000|Overall Study|miscellaneous|4|||
127833742|NCT01980706|460007192|FG001|Overall Study|miscellaneous|5|||
127833743|NCT01980706|460007193|FG002|Overall Study|miscellaneous|3|||
127833744|NCT01094730|460007196|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
127833745|NCT01094730|460007197|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
127833746|NCT01094730|460007196|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
127833747|NCT01094730|460007197|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
127833748|NCT01094730|460007196|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
127833749|NCT01094730|460007197|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
127833750|NCT01094730|460007196|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
127833751|NCT01094730|460007197|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
127833752|NCT01094730|460007196|FG000|Period 2 (14 Days)|Protocol Violation|2|||
127833753|NCT01094730|460007197|FG001|Period 2 (14 Days)|Protocol Violation|0|||
127833754|NCT01094730|460007196|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
127833755|NCT01094730|460007197|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
127833756|NCT01094730|460007196|FG000|Period 2 (14 Days)|Adverse Event|0|||
127833757|NCT01094730|460007197|FG001|Period 2 (14 Days)|Adverse Event|1|||
127833758|NCT01094730|460007196|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
127833759|NCT01094730|460007197|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
127833760|NCT04171037|460007198|FG000|Overall Study|Lost to Follow-up|1|||
127833761|NCT04171037|460007199|FG001|Overall Study|Lost to Follow-up|0|||
127833762|NCT04171037|460007198|FG000|Overall Study|Physician Decision|3|||
127833763|NCT04171037|460007199|FG001|Overall Study|Physician Decision|3|||
127833764|NCT01934894|460007200|FG000|Overall Study|Adverse Event|1|||
127833765|NCT01934894|460007201|FG001|Overall Study|Adverse Event|2|||
127833766|NCT01934894|460007200|FG000|Overall Study|Death|2|||
127833767|NCT01934894|460007201|FG001|Overall Study|Death|0|||
127833768|NCT01934894|460007200|FG000|Overall Study|Withdrawal by Subject|0|||
127833769|NCT01934894|460007201|FG001|Overall Study|Withdrawal by Subject|1|||
127833770|NCT01934894|460007200|FG000|Overall Study|Progressive Disease|3|||
127833771|NCT01934894|460007201|FG001|Overall Study|Progressive Disease|2|||
127833772|NCT01100307|460007203|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
127833773|NCT01100307|460007204|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
127833774|NCT01100307|460007203|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
127833775|NCT01100307|460007204|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
127833776|NCT01100307|460007203|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
127833777|NCT01100307|460007204|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
127833778|NCT01100307|460007203|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
127833779|NCT01100307|460007204|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
127833780|NCT01100307|460007203|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
127833781|NCT01100307|460007204|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
127833782|NCT01100307|460007203|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
127833783|NCT01100307|460007204|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
127833784|NCT03135028|460007205|FG000|Overall Study|Death|6|||
127833785|NCT03135028|460007205|FG000|Overall Study|Study Terminated by Sponsor|2|||
127833786|NCT03135028|460007205|FG000|Overall Study|Withdrew Consent|1|||
127833787|NCT04436822|460007207|FG000|Overall Study|Physician Decision|2|||
127895717|NCT00455533|460240763|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
127833788|NCT04436822|460007208|FG001|Overall Study|Physician Decision|0|||
127833789|NCT04436822|460007207|FG000|Overall Study|Sponsor request|1|||
127833790|NCT04436822|460007208|FG001|Overall Study|Sponsor request|0|||
127833791|NCT04436822|460007207|FG000|Overall Study|Withdrawal by parent/guardian|0|||
127833792|NCT04436822|460007208|FG001|Overall Study|Withdrawal by parent/guardian|3|||
127895718|NCT00455533|460240761|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
127833793|NCT04436822|460007207|FG000|Overall Study|Unsuccessful procedure|0|||
127833794|NCT04436822|460007208|FG001|Overall Study|Unsuccessful procedure|1|||
127833795|NCT04436822|460007207|FG000|Overall Study|Withdrawal due to Covid-19|8|||
127833796|NCT04436822|460007208|FG001|Overall Study|Withdrawal due to Covid-19|1|||
127833797|NCT04436822|460007207|FG000|Overall Study|Withdrawal by Subject|1|||
127833798|NCT04436822|460007208|FG001|Overall Study|Withdrawal by Subject|0|||
127833799|NCT04436822|460007207|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
127833800|NCT04436822|460007208|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
127833801|NCT03375112|460007209|FG000|Overall Study|Withdrawal by Subject|3|||
127833802|NCT03375112|460007210|FG001|Overall Study|Withdrawal by Subject|0|||
127895719|NCT00455533|460240762|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
127833803|NCT00894413|460007214|FG000|Overall Study|Physician Decision|0|||
127833804|NCT00894413|460007215|FG001|Overall Study|Physician Decision|2|||
127833805|NCT00894413|460007214|FG000|Overall Study|Adverse Event|0|||
127833806|NCT00894413|460007215|FG001|Overall Study|Adverse Event|2|||
127895720|NCT00455533|460240763|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
127895721|NCT00979628|460240768|FG000|Overall Study|received regimen < 24 hours|7|||
127895722|NCT00979628|460240769|FG001|Overall Study|received regimen < 24 hours|6|||
127895723|NCT00979628|460240770|FG002|Overall Study|received regimen < 24 hours|5|||
127895724|NCT00979628|460240768|FG000|Overall Study|received steroids|1|||
127895725|NCT00979628|460240769|FG001|Overall Study|received steroids|1|||
127895726|NCT00979628|460240770|FG002|Overall Study|received steroids|0|||
127895727|NCT00979628|460240768|FG000|Overall Study|transferred to ICU|1|||
127895728|NCT00979628|460240769|FG001|Overall Study|transferred to ICU|2|||
127895729|NCT00979628|460240770|FG002|Overall Study|transferred to ICU|1|||
127895730|NCT01736553|460240775|FG000|Overall Study|Death|12|||
127895731|NCT01736553|460240776|FG001|Overall Study|Death|0|||
127895732|NCT01736553|460240775|FG000|Overall Study|Withdrawal by Subject|5|||
127895733|NCT01736553|460240776|FG001|Overall Study|Withdrawal by Subject|2|||
127833807|NCT00894413|460007214|FG000|Overall Study|Withdrawal by Subject|0|||
127833808|NCT00894413|460007215|FG001|Overall Study|Withdrawal by Subject|4|||
127833809|NCT03213626|460007218|FG000|Overall Study|Adverse Event|1|||
127833810|NCT03213626|460007218|FG000|Overall Study|Progressive Disease|6|||
127833811|NCT00406640|460007229|FG000|Acute Phase|Adverse Event|18|||
127833812|NCT00406640|460007230|FG001|Acute Phase|Adverse Event|13|||
127833813|NCT00406640|460007229|FG000|Acute Phase|Failed to Return|5|||
127833814|NCT00406640|460007230|FG001|Acute Phase|Failed to Return|1|||
127833815|NCT00406640|460007229|FG000|Acute Phase|Physician Decision|0|||
127833816|NCT00406640|460007230|FG001|Acute Phase|Physician Decision|1|||
127833817|NCT00406640|460007229|FG000|Acute Phase|Lost to Follow-up|7|||
127833818|NCT00406640|460007230|FG001|Acute Phase|Lost to Follow-up|4|||
127833819|NCT00406640|460007229|FG000|Acute Phase|Protocol deviation|4|||
127833820|NCT00406640|460007230|FG001|Acute Phase|Protocol deviation|10|||
127833821|NCT00406640|460007229|FG000|Acute Phase|Protocol Violation|3|||
127833822|NCT00406640|460007230|FG001|Acute Phase|Protocol Violation|2|||
127833823|NCT00406640|460007229|FG000|Acute Phase|Withdrawal by Subject|11|||
127895734|NCT01736553|460240775|FG000|Overall Study|Lost to Follow-up|2|||
127895735|NCT01736553|460240776|FG001|Overall Study|Lost to Follow-up|2|||
127895736|NCT02224456|460242763|FG000|Overall Study|Lack of Efficacy|1|||
127833824|NCT00406640|460007230|FG001|Acute Phase|Withdrawal by Subject|9|||
127833825|NCT00406640|460007229|FG000|Acute Phase|Lack of Efficacy|3|||
127833826|NCT00406640|460007230|FG001|Acute Phase|Lack of Efficacy|3|||
127895737|NCT02224456|460242763|FG000|Overall Study|Lost to Follow-up|15|||
127833827|NCT00406640|460007229|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
127833828|NCT00406640|460007230|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
127833829|NCT00406640|460007229|FG000|DB Continuation Phase for Responders|Death|1|||
127895738|NCT02224456|460242763|FG000|Overall Study|Withdrawal by Subject|9|||
127895739|NCT02224456|460242763|FG000|Overall Study|Physician Decision|3|||
127895740|NCT02224456|460242763|FG000|Overall Study|Death|2|||
127895741|NCT02224456|460242763|FG000|Overall Study|Pregnancy|4|||
127895742|NCT02224456|460242763|FG000|Overall Study|Protocol Violation|1|||
127833830|NCT00406640|460007230|FG001|DB Continuation Phase for Responders|Death|0|||
127833831|NCT00406640|460007229|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
127833832|NCT00406640|460007230|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
127833833|NCT00406640|460007229|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
127833834|NCT00406640|460007230|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
127833835|NCT00406640|460007229|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
127833836|NCT00406640|460007230|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
127833837|NCT00406640|460007229|FG000|DB Continuation Phase for Responders|non-compliance|7|||
127833838|NCT00406640|460007230|FG001|DB Continuation Phase for Responders|non-compliance|5|||
127833839|NCT00406640|460007229|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
127833840|NCT00406640|460007230|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
127833841|NCT00406640|460007229|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
127833842|NCT00406640|460007230|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
127833843|NCT00406640|460007229|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
127833844|NCT00406640|460007230|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
127833845|NCT00406640|460007229|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
127833846|NCT00406640|460007230|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
127833847|NCT00406640|460007229|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
127833848|NCT00406640|460007230|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
127833849|NCT00406640|460007229|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
127833850|NCT00406640|460007230|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
127833851|NCT00406640|460007229|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
127833852|NCT00406640|460007230|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
127833853|NCT00406640|460007229|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
127833854|NCT00406640|460007230|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
127833855|NCT00406640|460007229|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
127833856|NCT00406640|460007230|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
127833857|NCT00406640|460007229|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
127833858|NCT00406640|460007230|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
127833859|NCT02457182|460009079|FG000|Overall Study|Lost to Follow-up|1|||
127833860|NCT02457182|460009080|FG001|Overall Study|Lost to Follow-up|0|||
127833861|NCT00762372|460009082|FG000|Overall Study|Adverse Event|1|||
127833862|NCT00762372|460009083|FG001|Overall Study|Adverse Event|0|||
127833863|NCT00762372|460009084|FG002|Overall Study|Adverse Event|0|||
127833864|NCT03364335|460009085|FG000|Overall Study|Adverse Event|3|||
127833865|NCT03364335|460009086|FG001|Overall Study|Adverse Event|4|||
127833866|NCT03364335|460009087|FG002|Overall Study|Adverse Event|1|||
127833867|NCT03364335|460009088|FG003|Overall Study|Adverse Event|2|||
127833868|NCT03364335|460009089|FG004|Overall Study|Adverse Event|0|||
127833869|NCT03364335|460009085|FG000|Overall Study|Lost to Follow-up|7|||
127833870|NCT03364335|460009086|FG001|Overall Study|Lost to Follow-up|7|||
127833871|NCT03364335|460009087|FG002|Overall Study|Lost to Follow-up|10|||
127833872|NCT03364335|460009088|FG003|Overall Study|Lost to Follow-up|11|||
127833873|NCT03364335|460009089|FG004|Overall Study|Lost to Follow-up|11|||
127833874|NCT02670915|460009090|FG000|Overall Study|Withdrawal by Subject|0|||
127833875|NCT02670915|460009091|FG001|Overall Study|Withdrawal by Subject|1|||
127833876|NCT02670915|460009092|FG002|Overall Study|Withdrawal by Subject|4|||
127833877|NCT02670915|460009090|FG000|Overall Study|Withdrawal by parent/guardian|4|||
127833878|NCT02670915|460009091|FG001|Overall Study|Withdrawal by parent/guardian|4|||
127833879|NCT02670915|460009092|FG002|Overall Study|Withdrawal by parent/guardian|1|||
127833880|NCT02670915|460009090|FG000|Overall Study|Unclassified|0|||
127833881|NCT02670915|460009091|FG001|Overall Study|Unclassified|3|||
127833882|NCT02670915|460009092|FG002|Overall Study|Unclassified|0|||
127833883|NCT00818207|460009093|FG000|Overall Study|Adverse Event|6|||
127833884|NCT00818207|460009094|FG001|Overall Study|Adverse Event|0|||
127833885|NCT00818207|460009093|FG000|Overall Study|Lost to Follow-up|160|||
127833886|NCT00818207|460009094|FG001|Overall Study|Lost to Follow-up|146|||
127833887|NCT00818207|460009093|FG000|Overall Study|Multiple reasons|11|||
127833888|NCT00818207|460009094|FG001|Overall Study|Multiple reasons|12|||
127833889|NCT00818207|460009093|FG000|Overall Study|Withdrawal by Subject|42|||
127833890|NCT00818207|460009094|FG001|Overall Study|Withdrawal by Subject|104|||
127833891|NCT00818207|460009093|FG000|Overall Study|Death|3|||
127833892|NCT00818207|460009094|FG001|Overall Study|Death|5|||
127833893|NCT02494778|460009095|FG000|Overall Study|Death|3|||
127833894|NCT02494778|460009095|FG000|Overall Study|Other|173|||
127833895|NCT02494778|460009095|FG000|Overall Study|Lack of Efficacy|4|||
127895743|NCT02224456|460242763|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
127833896|NCT02494778|460009095|FG000|Overall Study|Adverse Event|18|||
127833897|NCT02494778|460009095|FG000|Overall Study|Withdrawal by Subject|20|||
127833898|NCT02494778|460009095|FG000|Overall Study|Lost to Follow-up|2|||
127833899|NCT02494778|460009095|FG000|Overall Study|Noncompliant with study drug admin.|1|||
127833900|NCT02616185|460009096|FG000|Overall Study|Death|0|||
127833901|NCT02616185|460009097|FG001|Overall Study|Death|0|||
127833902|NCT02616185|460009098|FG002|Overall Study|Death|0|||
127833903|NCT02616185|460009099|FG003|Overall Study|Death|1|||
127833904|NCT02616185|460009100|FG004|Overall Study|Death|2|||
127833905|NCT02616185|460009101|FG005|Overall Study|Death|0|||
127833906|NCT02616185|460009102|FG006|Overall Study|Death|0|||
127833907|NCT02616185|460009103|FG007|Overall Study|Death|2|||
127833908|NCT02616185|460009104|FG008|Overall Study|Death|1|||
127833909|NCT02616185|460009096|FG000|Overall Study|Study terminated by sponsor|0|||
127833910|NCT02616185|460009097|FG001|Overall Study|Study terminated by sponsor|0|||
127833911|NCT02616185|460009098|FG002|Overall Study|Study terminated by sponsor|1|||
127833912|NCT02616185|460009099|FG003|Overall Study|Study terminated by sponsor|0|||
127833913|NCT02616185|460009100|FG004|Overall Study|Study terminated by sponsor|0|||
127833914|NCT02616185|460009101|FG005|Overall Study|Study terminated by sponsor|0|||
127833915|NCT02616185|460009102|FG006|Overall Study|Study terminated by sponsor|5|||
127833916|NCT02616185|460009103|FG007|Overall Study|Study terminated by sponsor|2|||
127833917|NCT02616185|460009104|FG008|Overall Study|Study terminated by sponsor|0|||
127833918|NCT02616185|460009096|FG000|Overall Study|Participant refused further follow-up|1|||
127833919|NCT02616185|460009097|FG001|Overall Study|Participant refused further follow-up|1|||
127833920|NCT02616185|460009098|FG002|Overall Study|Participant refused further follow-up|2|||
127833921|NCT02616185|460009099|FG003|Overall Study|Participant refused further follow-up|3|||
127833922|NCT02616185|460009100|FG004|Overall Study|Participant refused further follow-up|4|||
127833923|NCT02616185|460009101|FG005|Overall Study|Participant refused further follow-up|0|||
127833924|NCT02616185|460009102|FG006|Overall Study|Participant refused further follow-up|3|||
127833925|NCT02616185|460009103|FG007|Overall Study|Participant refused further follow-up|4|||
127833926|NCT02616185|460009104|FG008|Overall Study|Participant refused further follow-up|3|||
127833927|NCT02616185|460009096|FG000|Overall Study|Not reported|0|||
127833928|NCT02616185|460009097|FG001|Overall Study|Not reported|0|||
127833929|NCT02616185|460009098|FG002|Overall Study|Not reported|0|||
127833930|NCT02616185|460009099|FG003|Overall Study|Not reported|1|||
127833931|NCT02616185|460009100|FG004|Overall Study|Not reported|3|||
127833932|NCT02616185|460009101|FG005|Overall Study|Not reported|1|||
127833933|NCT02616185|460009102|FG006|Overall Study|Not reported|0|||
127833934|NCT02616185|460009103|FG007|Overall Study|Not reported|5|||
127833935|NCT02616185|460009104|FG008|Overall Study|Not reported|2|||
127833936|NCT01303380|460009105|FG000|Overall Study|Lack of compliance to study procedures|1|||
127833937|NCT01346371|460009106|FG000|Overall Study|Lost to Follow-up|2|||
127833938|NCT01346371|460009107|FG001|Overall Study|Lost to Follow-up|0|||
127833939|NCT01670656|460009109|FG000|Overall Study|Non-compliance with study drug|0|||
127833940|NCT01670656|460009110|FG001|Overall Study|Non-compliance with study drug|0|||
127833941|NCT01670656|460009111|FG002|Overall Study|Non-compliance with study drug|3|||
127833942|NCT01670656|460009112|FG003|Overall Study|Non-compliance with study drug|0|||
127833943|NCT01670656|460009113|FG004|Overall Study|Non-compliance with study drug|1|||
127833944|NCT01670656|460009109|FG000|Overall Study|Pregnancy|0|||
127833945|NCT01670656|460009110|FG001|Overall Study|Pregnancy|0|||
127833946|NCT01670656|460009111|FG002|Overall Study|Pregnancy|0|||
127833947|NCT01670656|460009112|FG003|Overall Study|Pregnancy|0|||
127833948|NCT01670656|460009113|FG004|Overall Study|Pregnancy|1|||
127833949|NCT01670656|460009109|FG000|Overall Study|Withdrawal by Subject|1|||
127833950|NCT01670656|460009110|FG001|Overall Study|Withdrawal by Subject|1|||
127833951|NCT01670656|460009111|FG002|Overall Study|Withdrawal by Subject|0|||
127833952|NCT01670656|460009112|FG003|Overall Study|Withdrawal by Subject|0|||
127833953|NCT01670656|460009113|FG004|Overall Study|Withdrawal by Subject|0|||
127833954|NCT01670656|460009109|FG000|Overall Study|Non-compliance with protocol|0|||
127833955|NCT01670656|460009110|FG001|Overall Study|Non-compliance with protocol|3|||
127833956|NCT01670656|460009111|FG002|Overall Study|Non-compliance with protocol|1|||
127833957|NCT01670656|460009112|FG003|Overall Study|Non-compliance with protocol|1|||
127833958|NCT01670656|460009113|FG004|Overall Study|Non-compliance with protocol|2|||
127833959|NCT01670656|460009109|FG000|Overall Study|Adverse Event|2|||
127833960|NCT01670656|460009110|FG001|Overall Study|Adverse Event|2|||
127833961|NCT01670656|460009111|FG002|Overall Study|Adverse Event|2|||
127833962|NCT01670656|460009112|FG003|Overall Study|Adverse Event|3|||
127833963|NCT01670656|460009113|FG004|Overall Study|Adverse Event|3|||
127833964|NCT01670656|460009109|FG000|Overall Study|Subject withdrew consent|0|||
127833965|NCT01670656|460009110|FG001|Overall Study|Subject withdrew consent|1|||
127833966|NCT01670656|460009111|FG002|Overall Study|Subject withdrew consent|2|||
127833967|NCT01670656|460009112|FG003|Overall Study|Subject withdrew consent|1|||
127833968|NCT01670656|460009113|FG004|Overall Study|Subject withdrew consent|1|||
127833969|NCT01670656|460009109|FG000|Overall Study|Lost to Follow-up|0|||
127833970|NCT01670656|460009110|FG001|Overall Study|Lost to Follow-up|0|||
127833971|NCT01670656|460009111|FG002|Overall Study|Lost to Follow-up|0|||
127833972|NCT01670656|460009112|FG003|Overall Study|Lost to Follow-up|0|||
127833973|NCT01670656|460009113|FG004|Overall Study|Lost to Follow-up|3|||
127833974|NCT01670656|460009109|FG000|Overall Study|Subject moved|0|||
127833975|NCT01670656|460009110|FG001|Overall Study|Subject moved|0|||
127833976|NCT01670656|460009111|FG002|Overall Study|Subject moved|0|||
127833977|NCT01670656|460009112|FG003|Overall Study|Subject moved|1|||
127833978|NCT01670656|460009113|FG004|Overall Study|Subject moved|0|||
127833979|NCT00789958|460009114|FG000|Overall Study|Adverse Event|3|||
127833980|NCT00789958|460009114|FG000|Overall Study|Withdrawal by Subject|4|||
127833981|NCT00789958|460009114|FG000|Overall Study|Progression|3|||
127833982|NCT00789958|460009114|FG000|Overall Study|not protocol specified|1|||
127833983|NCT00789958|460009114|FG000|Overall Study|Not eligible/not analyzable|26|||
127833984|NCT03137121|460009117|FG000|Overall Study|Withdrawal by Subject|0|||
127833985|NCT03137121|460009118|FG001|Overall Study|Withdrawal by Subject|1|||
127833986|NCT00836277|460009119|FG000|Overall Study|Not evaluable for response|6|||
127833987|NCT01354353|460009122|FG000|Overall Study|Adverse Event|1|||
127833988|NCT01354353|460009123|FG001|Overall Study|Adverse Event|0|||
127833989|NCT01354353|460009124|FG002|Overall Study|Adverse Event|0|||
127833990|NCT01354353|460009125|FG003|Overall Study|Adverse Event|4|||
127833991|NCT01354353|460009126|FG004|Overall Study|Adverse Event|0|||
127833992|NCT01354353|460009127|FG005|Overall Study|Adverse Event|5|||
127833993|NCT01354353|460009122|FG000|Overall Study|Entry Criteria Not Met|0|||
127833994|NCT01354353|460009123|FG001|Overall Study|Entry Criteria Not Met|0|||
127833995|NCT01354353|460009124|FG002|Overall Study|Entry Criteria Not Met|0|||
127833996|NCT01354353|460009125|FG003|Overall Study|Entry Criteria Not Met|1|||
127833997|NCT01354353|460009126|FG004|Overall Study|Entry Criteria Not Met|1|||
127833998|NCT01354353|460009127|FG005|Overall Study|Entry Criteria Not Met|0|||
127833999|NCT01354353|460009122|FG000|Overall Study|Physician Decision|0|||
127834000|NCT01354353|460009123|FG001|Overall Study|Physician Decision|1|||
127834001|NCT01354353|460009124|FG002|Overall Study|Physician Decision|1|||
127834002|NCT01354353|460009125|FG003|Overall Study|Physician Decision|0|||
127834003|NCT01354353|460009126|FG004|Overall Study|Physician Decision|0|||
127834004|NCT01354353|460009127|FG005|Overall Study|Physician Decision|0|||
127834005|NCT01354353|460009122|FG000|Overall Study|Withdrawal by Subject|2|||
127834006|NCT01354353|460009123|FG001|Overall Study|Withdrawal by Subject|0|||
127834007|NCT01354353|460009124|FG002|Overall Study|Withdrawal by Subject|1|||
127834008|NCT01354353|460009125|FG003|Overall Study|Withdrawal by Subject|0|||
127834009|NCT01354353|460009126|FG004|Overall Study|Withdrawal by Subject|0|||
127834010|NCT01354353|460009127|FG005|Overall Study|Withdrawal by Subject|1|||
127834011|NCT04831515|460009130|FG000|First Intervention|Adverse Event|0|||
127834012|NCT04831515|460009131|FG001|First Intervention|Adverse Event|1|||
127834013|NCT01640925|460009134|FG000|Overall Study|Withdrawal by Subject|1|||
127834014|NCT01640925|460009135|FG001|Overall Study|Withdrawal by Subject|0|||
127834015|NCT01640925|460009134|FG000|Overall Study|Previously enrolled in this trial|13|||
127834016|NCT01640925|460009135|FG001|Overall Study|Previously enrolled in this trial|11|||
127834017|NCT01332019|460009146|FG000|Overall Study|Was Not Dosed|1|||
127834018|NCT01332019|460009147|FG001|Overall Study|Was Not Dosed|0|||
127834019|NCT01332019|460009146|FG000|Overall Study|Other|16|||
127834020|NCT01332019|460009147|FG001|Overall Study|Other|18|||
127834021|NCT01332019|460009146|FG000|Overall Study|Death|2|||
127834022|NCT01332019|460009147|FG001|Overall Study|Death|1|||
127834023|NCT01332019|460009146|FG000|Overall Study|Physician Decision|4|||
127834024|NCT01332019|460009147|FG001|Overall Study|Physician Decision|3|||
127834025|NCT01332019|460009146|FG000|Overall Study|Withdrawal by Subject|73|||
127834026|NCT01332019|460009147|FG001|Overall Study|Withdrawal by Subject|71|||
127834027|NCT01332019|460009146|FG000|Overall Study|Lost to Follow-up|4|||
127834028|NCT01332019|460009147|FG001|Overall Study|Lost to Follow-up|7|||
127834029|NCT01332019|460009146|FG000|Overall Study|Adverse Event|13|||
127834030|NCT01332019|460009147|FG001|Overall Study|Adverse Event|22|||
127834031|NCT01395368|460009148|FG000|Overall Study|Physician Decision|14|||
127834032|NCT01395368|460009148|FG000|Overall Study|Withdrawal by Subject|2|||
127834033|NCT00288860|460009149|FG000|Overall Study|Did not complete intake|4|||
127834034|NCT00288860|460009150|FG001|Overall Study|Did not complete intake|8|||
127834035|NCT00288860|460009149|FG000|Overall Study|Death|4|||
127834036|NCT00288860|460009150|FG001|Overall Study|Death|3|||
127834037|NCT00288860|460009149|FG000|Overall Study|Withdrawal by Subject|20|||
127834038|NCT00288860|460009150|FG001|Overall Study|Withdrawal by Subject|15|||
127834039|NCT00288860|460009149|FG000|Overall Study|Lost to Follow-up|74|||
127834040|NCT00288860|460009150|FG001|Overall Study|Lost to Follow-up|71|||
127834041|NCT03072719|460009155|FG000|Overall Study|Adverse Event|1|||
127834042|NCT03072719|460009156|FG001|Overall Study|Adverse Event|1|||
127834043|NCT00882999|460009158|FG000|Overall Study|Adverse Event|0|||
127834044|NCT00882999|460009159|FG001|Overall Study|Adverse Event|0|||
127834045|NCT00882999|460009160|FG002|Overall Study|Adverse Event|0|||
127834046|NCT00882999|460009161|FG003|Overall Study|Adverse Event|0|||
127834047|NCT00882999|460009162|FG004|Overall Study|Adverse Event|1|||
127834048|NCT00882999|460009163|FG005|Overall Study|Adverse Event|0|||
127834049|NCT00882999|460009164|FG006|Overall Study|Adverse Event|0|||
127834050|NCT00882999|460009158|FG000|Overall Study|Death|0|||
127834051|NCT00882999|460009159|FG001|Overall Study|Death|1|||
127834052|NCT00882999|460009160|FG002|Overall Study|Death|0|||
127834053|NCT00882999|460009161|FG003|Overall Study|Death|0|||
127834054|NCT00882999|460009162|FG004|Overall Study|Death|0|||
127834055|NCT00882999|460009163|FG005|Overall Study|Death|0|||
127834056|NCT00882999|460009164|FG006|Overall Study|Death|0|||
127834057|NCT00882999|460009158|FG000|Overall Study|Withdrawal by Subject|7|||
127834058|NCT00882999|460009159|FG001|Overall Study|Withdrawal by Subject|6|||
127834059|NCT00882999|460009160|FG002|Overall Study|Withdrawal by Subject|3|||
127834060|NCT00882999|460009161|FG003|Overall Study|Withdrawal by Subject|3|||
127834061|NCT00882999|460009162|FG004|Overall Study|Withdrawal by Subject|6|||
127834062|NCT00882999|460009163|FG005|Overall Study|Withdrawal by Subject|5|||
127834063|NCT00882999|460009164|FG006|Overall Study|Withdrawal by Subject|5|||
127834064|NCT00882999|460009158|FG000|Overall Study|Lost to Follow-up|0|||
127834065|NCT00882999|460009159|FG001|Overall Study|Lost to Follow-up|1|||
127834066|NCT00882999|460009160|FG002|Overall Study|Lost to Follow-up|1|||
127834067|NCT00882999|460009161|FG003|Overall Study|Lost to Follow-up|2|||
127834068|NCT00882999|460009162|FG004|Overall Study|Lost to Follow-up|1|||
127834069|NCT00882999|460009163|FG005|Overall Study|Lost to Follow-up|1|||
127834070|NCT00882999|460009164|FG006|Overall Study|Lost to Follow-up|2|||
127834071|NCT00882999|460009158|FG000|Overall Study|Physician Decision|1|||
127834072|NCT00882999|460009159|FG001|Overall Study|Physician Decision|0|||
127834073|NCT00882999|460009160|FG002|Overall Study|Physician Decision|0|||
127834074|NCT00882999|460009161|FG003|Overall Study|Physician Decision|0|||
127834075|NCT00882999|460009162|FG004|Overall Study|Physician Decision|0|||
127834076|NCT00882999|460009163|FG005|Overall Study|Physician Decision|1|||
127834077|NCT00882999|460009164|FG006|Overall Study|Physician Decision|1|||
127834078|NCT01104584|460009165|FG000|Overall Study|Study drug never administered|21|||
127834079|NCT01104584|460009165|FG000|Overall Study|Study prematurely discontinued|2|||
127834080|NCT04017442|460009166|FG000|Overall Study|Withdrawal by Subject|0|||
127834081|NCT04017442|460009167|FG001|Overall Study|Withdrawal by Subject|3|||
127834082|NCT04017442|460009166|FG000|Overall Study|Lost to Follow-up|21|||
127834083|NCT04017442|460009167|FG001|Overall Study|Lost to Follow-up|19|||
127834084|NCT02586233|460009168|FG000|Overall Study|Randomized but did not receive treatment|0|||
127834085|NCT02586233|460009169|FG001|Overall Study|Randomized but did not receive treatment|1|||
127834086|NCT02586233|460009170|FG002|Overall Study|Randomized but did not receive treatment|0|||
127834087|NCT02586233|460009171|FG003|Overall Study|Randomized but did not receive treatment|0|||
127834088|NCT02586233|460009172|FG004|Overall Study|Randomized but did not receive treatment|0|||
127834089|NCT02586233|460009173|FG005|Overall Study|Randomized but did not receive treatment|2|||
127834090|NCT02586233|460009174|FG006|Overall Study|Randomized but did not receive treatment|2|||
127834091|NCT02586233|460009168|FG000|Overall Study|Death|0|||
127834092|NCT02586233|460009169|FG001|Overall Study|Death|1|||
127834093|NCT02586233|460009170|FG002|Overall Study|Death|0|||
127834094|NCT02586233|460009171|FG003|Overall Study|Death|0|||
127834095|NCT02586233|460009172|FG004|Overall Study|Death|2|||
127834096|NCT02586233|460009173|FG005|Overall Study|Death|0|||
127834097|NCT02586233|460009174|FG006|Overall Study|Death|0|||
127834098|NCT01358877|460009175|FG000|Overall Study|Death|80|||
127834099|NCT01358877|460009176|FG001|Overall Study|Death|89|||
127834100|NCT01358877|460009175|FG000|Overall Study|Ongoing follow-up for post-recurrence|87|||
127834101|NCT01358877|460009176|FG001|Overall Study|Ongoing follow-up for post-recurrence|108|||
127834102|NCT01358877|460009175|FG000|Overall Study|Ongoing follow-up for IDFS event|2084|||
127834103|NCT01358877|460009176|FG001|Overall Study|Ongoing follow-up for IDFS event|2073|||
127834104|NCT01358877|460009175|FG000|Overall Study|Ongoing follow-up for overall survival|7|||
127834105|NCT01358877|460009176|FG001|Overall Study|Ongoing follow-up for overall survival|5|||
127834106|NCT01358877|460009175|FG000|Overall Study|Other|142|||
127834107|NCT01358877|460009176|FG001|Overall Study|Other|129|||
127834108|NCT01911845|460009181|FG000|Overall Study|Adverse Event|2|||
127834109|NCT01911845|460009181|FG000|Overall Study|Lost to Follow-up|1|||
127834110|NCT01911845|460009181|FG000|Overall Study|Other (not specified)|3|||
127834111|NCT01994226|460009182|FG000|Overall Study|Protocol Violation|13|||
127834112|NCT01994226|460009183|FG001|Overall Study|Protocol Violation|10|||
127895744|NCT01644890|460242764|FG000|Overall Study|Adverse Event|7|||
127834113|NCT01994226|460009182|FG000|Overall Study|Early Cessation of treatment|6|||
127834114|NCT01994226|460009183|FG001|Overall Study|Early Cessation of treatment|11|||
127834115|NCT02345252|460009193|FG000|Double-Blind Phase|Adverse Event|2|||
127834116|NCT02345252|460009194|FG001|Double-Blind Phase|Adverse Event|3|||
127834117|NCT02345252|460009193|FG000|Double-Blind Phase|Death|1|||
127834118|NCT02345252|460009194|FG001|Double-Blind Phase|Death|2|||
127834119|NCT02345252|460009193|FG000|Double-Blind Phase|Lack of Efficacy|1|||
127834120|NCT02345252|460009194|FG001|Double-Blind Phase|Lack of Efficacy|0|||
127834121|NCT02345252|460009193|FG000|Double-Blind Phase|Investigator's Discretion|4|||
127834122|NCT02345252|460009194|FG001|Double-Blind Phase|Investigator's Discretion|6|||
127834123|NCT02345252|460009193|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
127834124|NCT02345252|460009194|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
127834125|NCT02345252|460009193|FG000|Double-Blind Phase|Protocol Violation|2|||
127834126|NCT02345252|460009194|FG001|Double-Blind Phase|Protocol Violation|1|||
127834127|NCT02345252|460009193|FG000|Double-Blind Phase|Withdrew Consent|21|||
127834128|NCT02345252|460009194|FG001|Double-Blind Phase|Withdrew Consent|23|||
127834129|NCT02345252|460009193|FG000|Double-Blind Phase|Lost to Follow-up|8|||
127834130|NCT02345252|460009194|FG001|Double-Blind Phase|Lost to Follow-up|10|||
127834131|NCT02345252|460009193|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
127834132|NCT02345252|460009194|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
127834133|NCT01842308|460009197|FG000|Overall Study|Withdrawal by Subject|0|||
127895745|NCT01644890|460242765|FG001|Overall Study|Adverse Event|20|||
127895746|NCT01644890|460242764|FG000|Overall Study|Death|1|||
127895747|NCT01644890|460242765|FG001|Overall Study|Death|3|||
127895748|NCT01644890|460242764|FG000|Overall Study|Physician Decision|3|||
127895749|NCT01644890|460242765|FG001|Overall Study|Physician Decision|9|||
127895750|NCT01644890|460242764|FG000|Overall Study|Protocol Violation|6|||
127895751|NCT01644890|460242765|FG001|Overall Study|Protocol Violation|7|||
127895752|NCT01644890|460242764|FG000|Overall Study|Withdrawal by Subject|19|||
127895753|NCT01644890|460242765|FG001|Overall Study|Withdrawal by Subject|27|||
127895754|NCT01644890|460242764|FG000|Overall Study|Progression Disease|160|||
127895755|NCT01644890|460242765|FG001|Overall Study|Progression Disease|131|||
127895756|NCT01644890|460242764|FG000|Overall Study|Clinical Progression|6|||
127895757|NCT01644890|460242765|FG001|Overall Study|Clinical Progression|6|||
127895758|NCT01644890|460242764|FG000|Overall Study|> 28 days since last dose of study drug|6|||
127895759|NCT01644890|460242765|FG001|Overall Study|> 28 days since last dose of study drug|3|||
127895760|NCT01644890|460242764|FG000|Overall Study|Other|8|||
127895761|NCT01644890|460242765|FG001|Overall Study|Other|9|||
127895762|NCT02761980|460242768|FG000|Overall Study|Adverse Event|4|||
127895763|NCT02761980|460242769|FG001|Overall Study|Adverse Event|6|||
127895764|NCT02761980|460242770|FG002|Overall Study|Adverse Event|5|||
127895765|NCT02761980|460242771|FG003|Overall Study|Adverse Event|6|||
127895766|NCT02761980|460242768|FG000|Overall Study|Withdrawal by Subject|0|||
127895767|NCT02761980|460242769|FG001|Overall Study|Withdrawal by Subject|1|||
127895768|NCT02761980|460242770|FG002|Overall Study|Withdrawal by Subject|0|||
127895769|NCT02761980|460242771|FG003|Overall Study|Withdrawal by Subject|0|||
127895770|NCT02761980|460242768|FG000|Overall Study|Other|0|||
127895771|NCT02761980|460242769|FG001|Overall Study|Other|0|||
127895772|NCT02761980|460242770|FG002|Overall Study|Other|1|||
127895773|NCT02761980|460242771|FG003|Overall Study|Other|0|||
127895774|NCT00101582|460242772|FG000|Overall Study|Ineligibility determined|0|||
127895775|NCT00101582|460242773|FG001|Overall Study|Ineligibility determined|1|||
127895776|NCT00101582|460242772|FG000|Overall Study|Adverse Event|1|||
127895777|NCT00101582|460242773|FG001|Overall Study|Adverse Event|4|||
127895778|NCT00101582|460242772|FG000|Overall Study|Withdrawal by Subject|6|||
127895779|NCT00101582|460242773|FG001|Overall Study|Withdrawal by Subject|4|||
127895780|NCT00101582|460242772|FG000|Overall Study|Physician Decision|1|||
127895781|NCT00101582|460242773|FG001|Overall Study|Physician Decision|0|||
127895782|NCT00101582|460242772|FG000|Overall Study|Death|3|||
127895783|NCT00101582|460242773|FG001|Overall Study|Death|5|||
127895784|NCT00101582|460242772|FG000|Overall Study|Other|0|||
127895785|NCT00101582|460242773|FG001|Overall Study|Other|1|||
127895786|NCT00056160|460242774|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
127895787|NCT00056160|460242775|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
127895788|NCT00056160|460242774|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
127895789|NCT00056160|460242775|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
127834134|NCT01842308|460009198|FG001|Overall Study|Withdrawal by Subject|0|||
127834135|NCT01842308|460009199|FG002|Overall Study|Withdrawal by Subject|0|||
127895790|NCT00056160|460242774|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
127895791|NCT00056160|460242775|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
127895792|NCT00056160|460242774|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
127895793|NCT00056160|460242775|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
127895794|NCT00056160|460242774|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
127834136|NCT01842308|460009200|FG003|Overall Study|Withdrawal by Subject|0|||
127834137|NCT01842308|460009201|FG004|Overall Study|Withdrawal by Subject|1|||
127834138|NCT00779324|460009202|FG000|Overall Study|Lost to Follow-up|2|||
127834139|NCT00779324|460009203|FG001|Overall Study|Lost to Follow-up|1|||
127834140|NCT00779324|460009202|FG000|Overall Study|Withdrawal by Subject|4|||
127834141|NCT00779324|460009203|FG001|Overall Study|Withdrawal by Subject|2|||
127834142|NCT00779324|460009202|FG000|Overall Study|Missed visit|1|||
127834143|NCT00779324|460009203|FG001|Overall Study|Missed visit|1|||
127834144|NCT00617409|460009204|FG000|Overall Study|Withdrawal by Subject|4|||
127834145|NCT00617409|460009205|FG001|Overall Study|Withdrawal by Subject|1|||
127834146|NCT00617409|460009206|FG002|Overall Study|Withdrawal by Subject|2|||
127834147|NCT00617409|460009204|FG000|Overall Study|Adverse Event|0|||
127834148|NCT00617409|460009205|FG001|Overall Study|Adverse Event|2|||
127834149|NCT00617409|460009206|FG002|Overall Study|Adverse Event|3|||
127834150|NCT00617409|460009204|FG000|Overall Study|Disease Progression|8|||
127834151|NCT00617409|460009205|FG001|Overall Study|Disease Progression|8|||
127834152|NCT00617409|460009206|FG002|Overall Study|Disease Progression|18|||
127834153|NCT00617409|460009204|FG000|Overall Study|Death|3|||
127834154|NCT00617409|460009205|FG001|Overall Study|Death|5|||
127834155|NCT00617409|460009206|FG002|Overall Study|Death|4|||
127834156|NCT00617409|460009204|FG000|Overall Study|Alternative Therapy|1|||
127834157|NCT00617409|460009205|FG001|Overall Study|Alternative Therapy|2|||
127834158|NCT00617409|460009206|FG002|Overall Study|Alternative Therapy|0|||
127834159|NCT00987623|460009207|FG000|Overall Study|Lost to Follow-up|2|||
127834160|NCT00987623|460009208|FG001|Overall Study|Lost to Follow-up|1|||
127834161|NCT00987623|460009207|FG000|Overall Study|Time/job conflict|2|||
127834162|NCT00987623|460009208|FG001|Overall Study|Time/job conflict|0|||
127834163|NCT00987623|460009207|FG000|Overall Study|Discomfort|1|||
127834164|NCT00987623|460009208|FG001|Overall Study|Discomfort|0|||
127834165|NCT00987623|460009207|FG000|Overall Study|Biomicroscopy|0|||
127834166|NCT00987623|460009208|FG001|Overall Study|Biomicroscopy|1|||
127834167|NCT00987623|460009207|FG000|Overall Study|Influenza|0|||
127834168|NCT00987623|460009208|FG001|Overall Study|Influenza|1|||
127834169|NCT02509598|460009209|FG000|Overall Study|Withdrawal by Subject|1|||
127834170|NCT04056455|460009210|FG000|Overall Study|Adverse Event|1|||
127834171|NCT04056455|460009211|FG001|Overall Study|Adverse Event|0|||
127834172|NCT02196038|460009212|FG000|Overall Study|Death|16|||
127834173|NCT02196038|460009213|FG001|Overall Study|Death|21|||
127834174|NCT02196038|460009212|FG000|Overall Study|Withdrawal by Subject|0|||
127834175|NCT02196038|460009213|FG001|Overall Study|Withdrawal by Subject|1|||
127834176|NCT02196038|460009212|FG000|Overall Study|Lost to Follow-up|1|||
127834177|NCT02196038|460009213|FG001|Overall Study|Lost to Follow-up|0|||
127834178|NCT01276457|460009219|FG000|Core Study|Adverse Event|6|||
127834179|NCT01276457|460009220|FG001|Core Study|Adverse Event|3|||
127834180|NCT01276457|460009219|FG000|Core Study|Lost to Follow-up|1|||
127834181|NCT01276457|460009220|FG001|Core Study|Lost to Follow-up|2|||
127834182|NCT01276457|460009219|FG000|Core Study|Administrative problems|1|||
127834183|NCT01276457|460009220|FG001|Core Study|Administrative problems|1|||
127834184|NCT01276457|460009219|FG000|Core Study|Death|2|||
127834185|NCT01276457|460009220|FG001|Core Study|Death|2|||
127895795|NCT00056160|460242775|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
127895796|NCT00056160|460242774|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
127895797|NCT00056160|460242775|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
127895798|NCT00056160|460242774|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
127895799|NCT00056160|460242775|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
127895800|NCT00056160|460242774|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
127895801|NCT00056160|460242775|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
127895802|NCT00056160|460242774|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
127895803|NCT00056160|460242775|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
127895804|NCT00056160|460242774|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
127895805|NCT00056160|460242775|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
127895806|NCT00056160|460242774|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
127895807|NCT00056160|460242775|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
127895808|NCT00056160|460242774|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
127895809|NCT00056160|460242775|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
127895810|NCT00056160|460242774|FG000|Final Follow-up|Transferred into expanded access study.|3|||
127895811|NCT00056160|460242775|FG001|Final Follow-up|Transferred into expanded access study.|0|||
127895812|NCT00056160|460242774|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
127895813|NCT00056160|460242775|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
127895814|NCT00056160|460242774|FG000|Final Follow-up|Adverse Event|1|||
127895815|NCT00056160|460242775|FG001|Final Follow-up|Adverse Event|0|||
127895816|NCT03312530|460242777|FG000|Overall Study|Death|5|||
127895817|NCT03312530|460242778|FG001|Overall Study|Death|5|||
127895818|NCT03312530|460242779|FG002|Overall Study|Death|4|||
127895819|NCT03312530|460242780|FG003|Overall Study|Death|10|||
127895820|NCT03312530|460242781|FG004|Overall Study|Death|8|||
127895821|NCT03312530|460242777|FG000|Overall Study|Lost to Follow-up|0|||
127895822|NCT03312530|460242778|FG001|Overall Study|Lost to Follow-up|0|||
127895823|NCT03312530|460242779|FG002|Overall Study|Lost to Follow-up|0|||
127895824|NCT03312530|460242780|FG003|Overall Study|Lost to Follow-up|1|||
127895825|NCT03312530|460242781|FG004|Overall Study|Lost to Follow-up|0|||
127895826|NCT03312530|460242777|FG000|Overall Study|Participant in another sponsor study.|0|||
127895827|NCT03312530|460242778|FG001|Overall Study|Participant in another sponsor study.|0|||
127895828|NCT03312530|460242779|FG002|Overall Study|Participant in another sponsor study.|0|||
127895829|NCT03312530|460242780|FG003|Overall Study|Participant in another sponsor study.|1|||
127895830|NCT03312530|460242781|FG004|Overall Study|Participant in another sponsor study.|0|||
127895831|NCT03312530|460242777|FG000|Overall Study|Study terminated by sponsor|1|||
127895832|NCT03312530|460242778|FG001|Overall Study|Study terminated by sponsor|0|||
127895833|NCT03312530|460242779|FG002|Overall Study|Study terminated by sponsor|2|||
127895834|NCT03312530|460242780|FG003|Overall Study|Study terminated by sponsor|3|||
127895835|NCT03312530|460242781|FG004|Overall Study|Study terminated by sponsor|7|||
127895836|NCT03312530|460242777|FG000|Overall Study|Withdrawal by Subject|0|||
127895837|NCT03312530|460242778|FG001|Overall Study|Withdrawal by Subject|1|||
127834186|NCT01276457|460009219|FG000|Core Study|Lack of Efficacy|3|||
127834187|NCT01276457|460009220|FG001|Core Study|Lack of Efficacy|12|||
127834188|NCT01276457|460009219|FG000|Extension Study|Lost to Follow-up|3|||
127834189|NCT01276457|460009220|FG001|Extension Study|Lost to Follow-up|0|||
127834190|NCT01276457|460009219|FG000|Extension Study|Death|0|||
127834191|NCT01276457|460009220|FG001|Extension Study|Death|1|||
127834192|NCT01276457|460009219|FG000|Extension Study|Lack of Efficacy|3|||
127834193|NCT01276457|460009220|FG001|Extension Study|Lack of Efficacy|1|||
127834194|NCT02065869|460009227|FG000|Overall Study|Death|7|||
127834195|NCT02065869|460009227|FG000|Overall Study|Disease relapse|16|||
127834196|NCT02065869|460009227|FG000|Overall Study|Lost to Follow-up|4|||
127834197|NCT02065869|460009227|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
127834198|NCT02065869|460009227|FG000|Overall Study|Withdrawal by Subject|1|||
127834199|NCT02402218|460009228|FG000|Overall Study|Did not pickup study medication|12|||
127834200|NCT02402218|460009229|FG001|Overall Study|Did not pickup study medication|9|||
127834201|NCT02402218|460009230|FG002|Overall Study|Did not pickup study medication|13|||
127834202|NCT02402218|460009228|FG000|Overall Study|Lack of Efficacy|0|||
127834203|NCT02402218|460009229|FG001|Overall Study|Lack of Efficacy|1|||
127895838|NCT03312530|460242779|FG002|Overall Study|Withdrawal by Subject|0|||
127895839|NCT03312530|460242780|FG003|Overall Study|Withdrawal by Subject|0|||
127895840|NCT03312530|460242781|FG004|Overall Study|Withdrawal by Subject|0|||
127895841|NCT03312530|460242777|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
127895842|NCT03312530|460242778|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
127895843|NCT03312530|460242779|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
127895844|NCT03312530|460242780|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
127895845|NCT03312530|460242781|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
127834204|NCT02402218|460009230|FG002|Overall Study|Lack of Efficacy|1|||
127834205|NCT02402218|460009228|FG000|Overall Study|Death|1|||
127834206|NCT02402218|460009229|FG001|Overall Study|Death|0|||
127834207|NCT02402218|460009230|FG002|Overall Study|Death|0|||
127834208|NCT02402218|460009228|FG000|Overall Study|Reinfection|0|||
127895846|NCT03093324|460242782|FG000|Overall Study|Adverse Event|4|||
127895847|NCT03093324|460242783|FG001|Overall Study|Adverse Event|15|||
127895848|NCT03093324|460242782|FG000|Overall Study|Lost to Follow-up|1|||
127895849|NCT03093324|460242783|FG001|Overall Study|Lost to Follow-up|0|||
127895850|NCT03093324|460242782|FG000|Overall Study|Protocol Deviation|2|||
127895851|NCT03093324|460242783|FG001|Overall Study|Protocol Deviation|2|||
127834209|NCT02402218|460009229|FG001|Overall Study|Reinfection|0|||
127834210|NCT02402218|460009230|FG002|Overall Study|Reinfection|1|||
127834211|NCT02402218|460009228|FG000|Overall Study|Adverse Event|0|||
127834212|NCT02402218|460009229|FG001|Overall Study|Adverse Event|2|||
127834213|NCT02402218|460009230|FG002|Overall Study|Adverse Event|1|||
127834214|NCT02402218|460009228|FG000|Overall Study|Withdrawal by Subject|1|||
127834215|NCT02402218|460009229|FG001|Overall Study|Withdrawal by Subject|1|||
127834216|NCT02402218|460009230|FG002|Overall Study|Withdrawal by Subject|1|||
127834217|NCT03807739|460009231|FG000|Overall Study|Adverse Event|1|||
127834218|NCT03807739|460009232|FG001|Overall Study|Adverse Event|0|||
127834219|NCT03807739|460009233|FG002|Overall Study|Adverse Event|0|||
127834220|NCT03807739|460009234|FG003|Overall Study|Adverse Event|0|||
127834221|NCT03807739|460009231|FG000|Overall Study|Withdrawal by Subject|1|||
127834222|NCT03807739|460009232|FG001|Overall Study|Withdrawal by Subject|0|||
127834223|NCT03807739|460009233|FG002|Overall Study|Withdrawal by Subject|0|||
127834224|NCT03807739|460009234|FG003|Overall Study|Withdrawal by Subject|0|||
127834225|NCT00789191|460011210|FG000|Overall Study|Adverse Event|2|||
127834226|NCT00789191|460011211|FG001|Overall Study|Adverse Event|4|||
127834227|NCT00789191|460011210|FG000|Overall Study|Lack of Efficacy|0|||
127834228|NCT00789191|460011211|FG001|Overall Study|Lack of Efficacy|5|||
127834229|NCT00789191|460011210|FG000|Overall Study|Protocol Violation|5|||
127834230|NCT00789191|460011211|FG001|Overall Study|Protocol Violation|3|||
127834231|NCT00789191|460011210|FG000|Overall Study|Withdrawal Criteria|2|||
127834232|NCT00789191|460011211|FG001|Overall Study|Withdrawal Criteria|4|||
127834233|NCT00789191|460011210|FG000|Overall Study|Unclassified|5|||
127834234|NCT00789191|460011211|FG001|Overall Study|Unclassified|3|||
127834235|NCT01009983|460011212|FG000|Overall Study|necessary scans not completed|1|||
127834236|NCT03497429|460011213|FG000|Overall Study|Progressive disease|3|||
127834237|NCT03497429|460011214|FG001|Overall Study|Progressive disease|4|||
127834238|NCT03497429|460011213|FG000|Overall Study|Adverse Event|0|||
127834239|NCT03497429|460011214|FG001|Overall Study|Adverse Event|2|||
127834240|NCT00506948|460011215|FG000|Overall Study|Death|4|||
127834241|NCT00506948|460011215|FG000|Overall Study|Adverse Event|5|||
127834242|NCT00506948|460011215|FG000|Overall Study|Physician Decision|1|||
127834243|NCT02174861|460011216|FG000|Overall Study|Decision by sponsor|8|||
127834244|NCT02174861|460011216|FG000|Overall Study|Withdrawal by Subject|124|||
127834245|NCT02174861|460011216|FG000|Overall Study|Lost to Follow-up|26|||
127834246|NCT02702518|460011226|FG000|Overall Study|Lost to Follow-up|3|||
127834247|NCT02702518|460011227|FG001|Overall Study|Lost to Follow-up|4|||
127834248|NCT01000727|460011229|FG000|Overall Study|Lost to Follow-up|41|||
127834249|NCT01000727|460011230|FG001|Overall Study|Lost to Follow-up|43|||
127834250|NCT01000727|460011229|FG000|Overall Study|Withdrawal by Subject|111|||
127834251|NCT01000727|460011230|FG001|Overall Study|Withdrawal by Subject|109|||
127834252|NCT01000727|460011229|FG000|Overall Study|Study closed/terminated|23|||
127834253|NCT01000727|460011230|FG001|Overall Study|Study closed/terminated|24|||
127834254|NCT03544268|460011233|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
127834255|NCT03544268|460011234|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
127834256|NCT00568958|460011236|FG000|Allocation|Withdrawal by Subject|7|||
127834257|NCT00568958|460011237|FG001|Allocation|Withdrawal by Subject|3|||
127834258|NCT00568958|460011236|FG000|Allocation|Physician Decision|2|||
127834259|NCT00568958|460011237|FG001|Allocation|Physician Decision|0|||
127834260|NCT00568958|460011236|FG000|Follow-Up|Withdrawal by Subject|6|||
127834261|NCT00568958|460011237|FG001|Follow-Up|Withdrawal by Subject|6|||
127834262|NCT00568958|460011236|FG000|Follow-Up|Physician Decision|1|||
127834263|NCT00568958|460011237|FG001|Follow-Up|Physician Decision|1|||
127834264|NCT00568958|460011236|FG000|Follow-Up|Family Emergency|1|||
127834265|NCT00568958|460011237|FG001|Follow-Up|Family Emergency|0|||
127834266|NCT00568958|460011236|FG000|Follow-Up|Adverse Event|1|||
127834267|NCT00568958|460011237|FG001|Follow-Up|Adverse Event|0|||
127834268|NCT00377611|460011242|FG000|Overall Study|Adverse Event|2|||
127834269|NCT00377611|460011243|FG001|Overall Study|Adverse Event|9|||
127834270|NCT00377611|460011242|FG000|Overall Study|Protocol Violation|2|||
127834271|NCT00377611|460011243|FG001|Overall Study|Protocol Violation|0|||
127834272|NCT00377611|460011242|FG000|Overall Study|Withdrawal by Subject|0|||
127834273|NCT00377611|460011243|FG001|Overall Study|Withdrawal by Subject|5|||
127834274|NCT00377611|460011242|FG000|Overall Study|Lost to Follow-up|18|||
127834275|NCT00377611|460011243|FG001|Overall Study|Lost to Follow-up|16|||
127834276|NCT00377611|460011242|FG000|Overall Study|Other|0|||
127834277|NCT00377611|460011243|FG001|Overall Study|Other|3|||
127834278|NCT02156492|460011246|FG000|Period 1|No Reason Given|0|||
127834279|NCT02156492|460011247|FG001|Period 1|No Reason Given|1|||
127834280|NCT02156492|460011248|FG002|Period 1|No Reason Given|0|||
127834281|NCT02156492|460011246|FG000|Period 3|Adverse Event|0|||
127834282|NCT02156492|460011247|FG001|Period 3|Adverse Event|1|||
127834283|NCT02156492|460011248|FG002|Period 3|Adverse Event|0|||
127834284|NCT00871377|460011249|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
127834285|NCT00871377|460011250|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
127834286|NCT00871377|460011251|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
127834287|NCT00871377|460011252|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
127834288|NCT00871377|460011253|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
127834289|NCT00871377|460011254|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
127834290|NCT00871377|460011249|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
127834291|NCT00871377|460011250|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
127834292|NCT00871377|460011251|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
127834293|NCT00871377|460011252|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
127834294|NCT00871377|460011253|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
127834295|NCT00871377|460011254|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
127834296|NCT00871377|460011249|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
127834297|NCT00871377|460011250|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
127834298|NCT00871377|460011251|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
127834299|NCT00871377|460011252|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
127834300|NCT00871377|460011253|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
127834301|NCT00871377|460011254|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
127834302|NCT00871377|460011249|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
127834303|NCT00871377|460011250|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
127834304|NCT00871377|460011251|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
127834305|NCT00871377|460011252|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
127834306|NCT00871377|460011253|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
127834307|NCT00871377|460011254|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
127834308|NCT00871377|460011249|FG000|Third Intervention (10 Weeks)|Death|0|||
127834309|NCT00871377|460011250|FG001|Third Intervention (10 Weeks)|Death|0|||
127834310|NCT00871377|460011251|FG002|Third Intervention (10 Weeks)|Death|0|||
127834311|NCT00871377|460011252|FG003|Third Intervention (10 Weeks)|Death|1|||
127834312|NCT00871377|460011253|FG004|Third Intervention (10 Weeks)|Death|0|||
127834313|NCT00871377|460011254|FG005|Third Intervention (10 Weeks)|Death|0|||
127834314|NCT01757405|460011260|FG000|Overall Study|Lost to Follow-up|1|||
127834315|NCT01757405|460011261|FG001|Overall Study|Lost to Follow-up|1|||
127834316|NCT01757405|460011260|FG000|Overall Study|Withdrawal by Subject|0|||
127834317|NCT01757405|460011261|FG001|Overall Study|Withdrawal by Subject|1|||
127834318|NCT00082758|460011263|FG000|Overall Study|Adverse Event|0|||
127834319|NCT00082758|460011264|FG001|Overall Study|Adverse Event|2|||
127834320|NCT00082758|460011265|FG002|Overall Study|Adverse Event|0|||
127834321|NCT00082758|460011263|FG000|Overall Study|Lack of Efficacy|12|||
127834322|NCT00082758|460011264|FG001|Overall Study|Lack of Efficacy|13|||
127834323|NCT00082758|460011265|FG002|Overall Study|Lack of Efficacy|0|||
127834324|NCT00082758|460011263|FG000|Overall Study|Physician Decision|0|||
127834325|NCT00082758|460011264|FG001|Overall Study|Physician Decision|1|||
127834326|NCT00082758|460011265|FG002|Overall Study|Physician Decision|0|||
127834327|NCT00082758|460011263|FG000|Overall Study|Withdrawal by Subject|3|||
127834328|NCT00082758|460011264|FG001|Overall Study|Withdrawal by Subject|0|||
127834329|NCT00082758|460011265|FG002|Overall Study|Withdrawal by Subject|0|||
127834330|NCT00082758|460011263|FG000|Overall Study|Protocol Violation|0|||
127834331|NCT00082758|460011264|FG001|Overall Study|Protocol Violation|1|||
127834332|NCT00082758|460011265|FG002|Overall Study|Protocol Violation|0|||
127834333|NCT00238303|460011266|FG000|Overall Study|Withdrawal by Subject|11|||
127834334|NCT00238303|460011267|FG001|Overall Study|Withdrawal by Subject|1|||
127834335|NCT00238303|460011268|FG002|Overall Study|Withdrawal by Subject|2|||
127834336|NCT00238303|460011266|FG000|Overall Study|Death|1|||
127834337|NCT00238303|460011267|FG001|Overall Study|Death|0|||
127834338|NCT00238303|460011268|FG002|Overall Study|Death|1|||
127834339|NCT00238303|460011266|FG000|Overall Study|Other Medical Problems|2|||
127834340|NCT00238303|460011267|FG001|Overall Study|Other Medical Problems|0|||
127834341|NCT00238303|460011268|FG002|Overall Study|Other Medical Problems|2|||
127834342|NCT00238303|460011266|FG000|Overall Study|Poor tolerance of study treatment|1|||
127834343|NCT00238303|460011267|FG001|Overall Study|Poor tolerance of study treatment|0|||
127834344|NCT00238303|460011268|FG002|Overall Study|Poor tolerance of study treatment|1|||
127834345|NCT00238303|460011266|FG000|Overall Study|Adverse Event|0|||
127834346|NCT00238303|460011267|FG001|Overall Study|Adverse Event|1|||
127834347|NCT00238303|460011268|FG002|Overall Study|Adverse Event|3|||
127834348|NCT02561299|460011272|FG000|Overall Study|Death|2|||
127834349|NCT02561299|460011273|FG001|Overall Study|Death|4|||
127834350|NCT02561299|460011272|FG000|Overall Study|Lost to Follow-up|1|||
127834351|NCT02561299|460011273|FG001|Overall Study|Lost to Follow-up|0|||
127834352|NCT02561299|460011272|FG000|Overall Study|Withdrawal by Subject|2|||
127834353|NCT02561299|460011273|FG001|Overall Study|Withdrawal by Subject|2|||
127834354|NCT00501046|460011274|FG000|Overall Study|Adverse Event|21|||
127834355|NCT00501046|460011275|FG001|Overall Study|Adverse Event|25|||
127834356|NCT00501046|460011274|FG000|Overall Study|Death|23|||
127834357|NCT00501046|460011275|FG001|Overall Study|Death|30|||
127834358|NCT00501046|460011274|FG000|Overall Study|Lost to Follow-up|14|||
127834359|NCT00501046|460011275|FG001|Overall Study|Lost to Follow-up|13|||
127834360|NCT00501046|460011274|FG000|Overall Study|Physician Decision|7|||
127834361|NCT00501046|460011275|FG001|Overall Study|Physician Decision|2|||
127834362|NCT00501046|460011274|FG000|Overall Study|Pregnancy|0|||
127834363|NCT00501046|460011275|FG001|Overall Study|Pregnancy|3|||
127834364|NCT00501046|460011274|FG000|Overall Study|Protocol Violation|2|||
127834365|NCT00501046|460011275|FG001|Overall Study|Protocol Violation|1|||
127834366|NCT00501046|460011274|FG000|Overall Study|Withdrawal by Subject|84|||
127834367|NCT00501046|460011275|FG001|Overall Study|Withdrawal by Subject|83|||
127834368|NCT00501046|460011274|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
127834369|NCT00501046|460011275|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
127834370|NCT04507867|460011276|FG000|Overall Study|Death|7|||
127834371|NCT04507867|460011277|FG001|Overall Study|Death|1|||
127834372|NCT00781599|460011290|FG000|Overall Study|Lost to Follow-up|7|||
127834373|NCT00781599|460011291|FG001|Overall Study|Lost to Follow-up|4|||
127834374|NCT01106625|460011295|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
127834375|NCT01106625|460011296|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
127834376|NCT01106625|460011297|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
127834377|NCT01106625|460011295|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
127834378|NCT01106625|460011296|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
127834379|NCT01106625|460011297|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
127834380|NCT01106625|460011295|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
127834381|NCT01106625|460011296|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
127834382|NCT01106625|460011297|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
127834383|NCT01106625|460011295|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
127834384|NCT01106625|460011296|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
127834385|NCT01106625|460011297|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
127834386|NCT01106625|460011295|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
127834387|NCT01106625|460011296|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
127834388|NCT01106625|460011297|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
127834389|NCT01106625|460011295|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
127834390|NCT01106625|460011296|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
127834391|NCT01106625|460011297|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
127834392|NCT01106625|460011295|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
127834393|NCT01106625|460011296|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
127834394|NCT01106625|460011297|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
127834395|NCT01106625|460011295|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
127834396|NCT01106625|460011296|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
127834397|NCT01106625|460011297|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
127834398|NCT01106625|460011295|FG000|Core Period: Baseline to Week 26|Other|8|||
127834399|NCT01106625|460011296|FG001|Core Period: Baseline to Week 26|Other|7|||
127834400|NCT01106625|460011297|FG002|Core Period: Baseline to Week 26|Other|4|||
127834401|NCT01106625|460011295|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
127834402|NCT01106625|460011296|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
127834403|NCT01106625|460011297|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
127834404|NCT01106625|460011295|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
127834405|NCT01106625|460011296|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
127834406|NCT01106625|460011297|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
127834407|NCT01106625|460011295|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
127834408|NCT01106625|460011296|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
127834409|NCT01106625|460011297|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
127834410|NCT01106625|460011295|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
127834411|NCT01106625|460011296|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
127834412|NCT01106625|460011297|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
127834413|NCT01106625|460011295|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
127834414|NCT01106625|460011296|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
127834415|NCT01106625|460011297|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
127834416|NCT01106625|460011295|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
127834417|NCT01106625|460011296|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
127834418|NCT01106625|460011297|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
127834419|NCT01106625|460011295|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
127834420|NCT01106625|460011296|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
127834421|NCT01106625|460011297|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
127834422|NCT01106625|460011295|FG000|Extension Period: Week 26 to Week 52|Other|5|||
127834423|NCT01106625|460011296|FG001|Extension Period: Week 26 to Week 52|Other|5|||
127834424|NCT01106625|460011297|FG002|Extension Period: Week 26 to Week 52|Other|4|||
127834425|NCT01088438|460011306|FG000|Overall Study|Withdrawal by Subject|11|||
127834426|NCT01088438|460011307|FG001|Overall Study|Withdrawal by Subject|6|||
127834427|NCT01088438|460011306|FG000|Overall Study|Lost to Follow-up|18|||
127834428|NCT01088438|460011307|FG001|Overall Study|Lost to Follow-up|30|||
127834429|NCT00511342|460011308|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
127834430|NCT00511342|460011309|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
127834431|NCT00511342|460011308|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
127834432|NCT00511342|460011309|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
127834433|NCT00511342|460011308|FG000|Overall Study|Pregnancy|0|||
127834434|NCT00511342|460011309|FG001|Overall Study|Pregnancy|1|||
127834435|NCT00511342|460011308|FG000|Overall Study|Pregnancy wish|0|||
127834436|NCT00511342|460011309|FG001|Overall Study|Pregnancy wish|1|||
127834437|NCT00511342|460011308|FG000|Overall Study|Lost to Follow-up|1|||
127834438|NCT00511342|460011309|FG001|Overall Study|Lost to Follow-up|5|||
127834439|NCT00511342|460011308|FG000|Overall Study|Other Reason|2|||
127834440|NCT00511342|460011309|FG001|Overall Study|Other Reason|2|||
127834441|NCT01496430|460011315|FG000|Overall Study|Adverse Event|0|||
127834442|NCT01496430|460011316|FG001|Overall Study|Adverse Event|0|||
127834443|NCT01496430|460011317|FG002|Overall Study|Adverse Event|1|||
127834444|NCT01496430|460011315|FG000|Overall Study|Major Protocol Deviation|0|||
127834445|NCT01496430|460011316|FG001|Overall Study|Major Protocol Deviation|0|||
127834446|NCT01496430|460011317|FG002|Overall Study|Major Protocol Deviation|1|||
127834447|NCT01496430|460011315|FG000|Overall Study|Lost to Follow-up|2|||
127834448|NCT01496430|460011316|FG001|Overall Study|Lost to Follow-up|3|||
127834449|NCT01496430|460011317|FG002|Overall Study|Lost to Follow-up|1|||
127834450|NCT01496430|460011315|FG000|Overall Study|Voluntary Withdrawal|2|||
127834451|NCT01496430|460011316|FG001|Overall Study|Voluntary Withdrawal|1|||
127834452|NCT01496430|460011317|FG002|Overall Study|Voluntary Withdrawal|6|||
127834453|NCT01496430|460011315|FG000|Overall Study|Principal Investigator Discretion|0|||
127834454|NCT01496430|460011316|FG001|Overall Study|Principal Investigator Discretion|1|||
127834455|NCT01496430|460011317|FG002|Overall Study|Principal Investigator Discretion|1|||
127834456|NCT01496430|460011315|FG000|Overall Study|Other|2|||
127834457|NCT01496430|460011316|FG001|Overall Study|Other|0|||
127834458|NCT01496430|460011317|FG002|Overall Study|Other|0|||
127834459|NCT00997321|460011318|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
127834460|NCT00997321|460011319|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
127834461|NCT02512068|460011324|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
127834462|NCT02512068|460011325|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
127834463|NCT02512068|460011324|FG000|Overall Study|Major Protocol Deviation|1|||
127834464|NCT02512068|460011325|FG001|Overall Study|Major Protocol Deviation|0|||
127834465|NCT02512068|460011324|FG000|Overall Study|Voluntary Withdrawal|0|||
127834466|NCT02512068|460011325|FG001|Overall Study|Voluntary Withdrawal|1|||
127834467|NCT02512068|460011324|FG000|Overall Study|Lack of Efficacy|0|||
127834468|NCT02512068|460011325|FG001|Overall Study|Lack of Efficacy|1|||
127895852|NCT03093324|460242782|FG000|Overall Study|Withdrawal by Subject|2|||
127834469|NCT02512068|460011324|FG000|Overall Study|Reason Not Specified|3|||
127834470|NCT02512068|460011325|FG001|Overall Study|Reason Not Specified|5|||
127834471|NCT03521687|460011330|FG000|Overall Study|Adverse Event|4|||
127834472|NCT03521687|460011330|FG000|Overall Study|Physician Decision|1|||
127834473|NCT01151579|460011335|FG000|Overall Study|Physician Decision|3|||
127834474|NCT01151579|460011336|FG001|Overall Study|Physician Decision|1|||
127834475|NCT01151579|460011335|FG000|Overall Study|Withdrawal by Subject|3|||
127834476|NCT01151579|460011336|FG001|Overall Study|Withdrawal by Subject|2|||
127834477|NCT01151579|460011335|FG000|Overall Study|Not meet inclusion criteria|6|||
127834478|NCT01151579|460011336|FG001|Overall Study|Not meet inclusion criteria|4|||
127834479|NCT01153763|460011339|FG000|Overall Study|Study Closed|16|||
127834480|NCT01153763|460011339|FG000|Overall Study|Lost to Follow-up|1|||
127834481|NCT01153763|460011339|FG000|Overall Study|Physician Decision|2|||
127834482|NCT01153763|460011339|FG000|Overall Study|Withdrawal by Subject|2|||
127834483|NCT01474746|460011340|FG000|Overall Study|Lost to Follow-up|1|||
127834484|NCT01474746|460011341|FG001|Overall Study|Lost to Follow-up|1|||
127834485|NCT01474746|460011340|FG000|Overall Study|Withdrawal by Subject|2|||
127834486|NCT01474746|460011341|FG001|Overall Study|Withdrawal by Subject|1|||
127834487|NCT01766336|460011343|FG000|Overall Study|Adverse Event|11|||
127834488|NCT01766336|460011344|FG001|Overall Study|Adverse Event|8|||
127834489|NCT01766336|460011343|FG000|Overall Study|Death|4|||
127834490|NCT01766336|460011344|FG001|Overall Study|Death|3|||
127834491|NCT01766336|460011343|FG000|Overall Study|Lost to Follow-up|1|||
127834492|NCT01766336|460011344|FG001|Overall Study|Lost to Follow-up|3|||
127834493|NCT01766336|460011343|FG000|Overall Study|Physician Decision|4|||
127834494|NCT01766336|460011344|FG001|Overall Study|Physician Decision|2|||
127834495|NCT01766336|460011343|FG000|Overall Study|Protocol Violation|0|||
127834496|NCT01766336|460011344|FG001|Overall Study|Protocol Violation|1|||
127834497|NCT01766336|460011343|FG000|Overall Study|Sponsor Decision|52|||
127834498|NCT01766336|460011344|FG001|Overall Study|Sponsor Decision|43|||
127834499|NCT01766336|460011343|FG000|Overall Study|Withdrawal by Subject|18|||
127834500|NCT01766336|460011344|FG001|Overall Study|Withdrawal by Subject|15|||
127834501|NCT02605447|460011345|FG000|Overall Study|Death|66|||
127834502|NCT02605447|460011345|FG000|Overall Study|Physician Decision|1|||
127834503|NCT02605447|460011345|FG000|Overall Study|Lost to Follow-up|24|||
127834504|NCT02605447|460011345|FG000|Overall Study|Withdrawal by Subject|10|||
127834505|NCT02605447|460011345|FG000|Overall Study|Not disclosed|1|||
127834506|NCT04544709|460011348|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
127834507|NCT02045212|460011349|FG000|Overall Study|Adverse Event|0|||
127834508|NCT02045212|460011350|FG001|Overall Study|Adverse Event|1|||
127834509|NCT02045212|460011349|FG000|Overall Study|Withdrawal by Subject|1|||
127834510|NCT02045212|460011350|FG001|Overall Study|Withdrawal by Subject|0|||
127834511|NCT02045212|460011349|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
127834512|NCT02045212|460011350|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
127834513|NCT00369668|460011355|FG000|Overall Study|Lack of Efficacy|4|||
127834514|NCT00369668|460011356|FG001|Overall Study|Lack of Efficacy|5|||
127834515|NCT00369668|460011357|FG002|Overall Study|Lack of Efficacy|7|||
127834516|NCT03126539|460011365|FG000|Overall Study|Lost to Follow-up|1|||
127834517|NCT03126539|460011366|FG001|Overall Study|Lost to Follow-up|1|||
127834518|NCT03126539|460011367|FG002|Overall Study|Lost to Follow-up|1|||
127834519|NCT03126539|460011368|FG003|Overall Study|Lost to Follow-up|0|||
127834520|NCT03126539|460011369|FG004|Overall Study|Lost to Follow-up|0|||
127834521|NCT03352414|460011370|FG000|Overall Study|Ineligible by operative criteria|12|||
127834522|NCT03352414|460011371|FG001|Overall Study|Ineligible by operative criteria|10|||
127834523|NCT02632110|460011372|FG000|Overall Study|Withdrawal by Subject|1|||
127834524|NCT02632110|460011373|FG001|Overall Study|Withdrawal by Subject|1|||
127834525|NCT02632110|460011374|FG002|Overall Study|Withdrawal by Subject|0|||
127834526|NCT02632110|460011375|FG003|Overall Study|Withdrawal by Subject|0|||
127834527|NCT02632110|460011376|FG004|Overall Study|Withdrawal by Subject|1|||
127834528|NCT02632110|460011377|FG005|Overall Study|Withdrawal by Subject|1|||
127834529|NCT02632110|460011378|FG006|Overall Study|Withdrawal by Subject|3|||
127834530|NCT02632110|460011379|FG007|Overall Study|Withdrawal by Subject|3|||
127834531|NCT02632110|460011380|FG008|Overall Study|Withdrawal by Subject|1|||
127834532|NCT02632110|460011381|FG009|Overall Study|Withdrawal by Subject|1|||
127834533|NCT00516269|460011384|FG000|Overall Study|Adverse Event|2|||
127834534|NCT00516269|460011385|FG001|Overall Study|Adverse Event|1|||
127834535|NCT00516269|460011384|FG000|Overall Study|Lost to Follow-up|0|||
127834536|NCT00516269|460011385|FG001|Overall Study|Lost to Follow-up|1|||
127834537|NCT00516269|460011384|FG000|Overall Study|Protocol Violation|0|||
127834538|NCT00516269|460011385|FG001|Overall Study|Protocol Violation|1|||
127834539|NCT00142519|460011386|FG000|Overall Study|Not Treated|7|||
127834540|NCT00142519|460011387|FG001|Overall Study|Not Treated|9|||
127834541|NCT00142519|460011386|FG000|Overall Study|Protocol Violation|1|||
127834542|NCT00142519|460011387|FG001|Overall Study|Protocol Violation|0|||
127834543|NCT00142519|460011386|FG000|Overall Study|Withdrawal by Subject|10|||
127834544|NCT00142519|460011387|FG001|Overall Study|Withdrawal by Subject|7|||
127834545|NCT01005732|460011388|FG000|Overall Study|Lost to Follow-up|10|||
127834546|NCT01005732|460011388|FG000|Overall Study|Death|1|||
127834547|NCT02596711|460011389|FG000|Overall Study|Lost to Follow-up|1|||
127834548|NCT02596711|460011390|FG001|Overall Study|Lost to Follow-up|2|||
127834549|NCT02596711|460011391|FG002|Overall Study|Lost to Follow-up|3|||
127834550|NCT01552928|460011392|FG000|Period 3|Adverse Event|0|||
127834551|NCT01552928|460011393|FG001|Period 3|Adverse Event|0|||
127834552|NCT01552928|460011394|FG002|Period 3|Adverse Event|1|||
127834553|NCT01552928|460011395|FG003|Period 3|Adverse Event|0|||
127834554|NCT01079962|460011397|FG000|Overall Study|Adverse Event|2|||
127834555|NCT01079962|460011398|FG001|Overall Study|Adverse Event|2|||
127834556|NCT01079962|460011397|FG000|Overall Study|Withdrawal by Subject|5|||
127834557|NCT01079962|460011398|FG001|Overall Study|Withdrawal by Subject|7|||
127834558|NCT01079962|460011397|FG000|Overall Study|Protocol Violation|2|||
127834559|NCT01079962|460011398|FG001|Overall Study|Protocol Violation|2|||
127834560|NCT01079962|460011397|FG000|Overall Study|No blood pressure (BP) control|3|||
127834561|NCT01079962|460011398|FG001|Overall Study|No blood pressure (BP) control|0|||
127834562|NCT01079962|460011397|FG000|Overall Study|Inclusion/exclusion criteria|1|||
127834563|NCT01079962|460011398|FG001|Overall Study|Inclusion/exclusion criteria|3|||
127834564|NCT01079962|460011397|FG000|Overall Study|Participant not returning for next visit|1|||
127834565|NCT01079962|460011398|FG001|Overall Study|Participant not returning for next visit|0|||
127834566|NCT01079962|460011397|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
127834567|NCT01079962|460011398|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
127834568|NCT01331239|460011399|FG000|Part II: Core Study|Adverse Event|0|||
127834569|NCT01331239|460011400|FG001|Part II: Core Study|Adverse Event|3|||
127834570|NCT01331239|460011401|FG002|Part II: Core Study|Adverse Event|0|||
127834571|NCT01331239|460011399|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
127834572|NCT01331239|460011400|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
127834573|NCT01331239|460011401|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
127834574|NCT01331239|460011399|FG000|Part II: Core Study|Withdrawal by Subject|0|||
127834575|NCT01331239|460011400|FG001|Part II: Core Study|Withdrawal by Subject|2|||
127834576|NCT01331239|460011401|FG002|Part II: Core Study|Withdrawal by Subject|0|||
127834577|NCT01331239|460011399|FG000|Part II: Core Study|Administrative problems|0|||
127834578|NCT01331239|460011400|FG001|Part II: Core Study|Administrative problems|1|||
127834579|NCT01331239|460011401|FG002|Part II: Core Study|Administrative problems|0|||
127834580|NCT00946530|460011402|FG000|Overall Study|Withdrawal by Subject|0|||
127834581|NCT00946530|460011403|FG001|Overall Study|Withdrawal by Subject|3|||
127834582|NCT00946530|460011404|FG002|Overall Study|Withdrawal by Subject|0|||
127834583|NCT00946530|460011405|FG003|Overall Study|Withdrawal by Subject|3|||
127834584|NCT00946530|460011402|FG000|Overall Study|Physician Decision|1|||
127834585|NCT00946530|460011403|FG001|Overall Study|Physician Decision|1|||
127834586|NCT00946530|460011404|FG002|Overall Study|Physician Decision|1|||
127834587|NCT00946530|460011405|FG003|Overall Study|Physician Decision|1|||
127834588|NCT01008995|460011408|FG000|Controlled Period|Adverse Event|1|||
127834589|NCT01008995|460011409|FG001|Controlled Period|Adverse Event|2|||
127834590|NCT01008995|460011410|FG002|Controlled Period|Adverse Event|0|||
127834591|NCT01008995|460011411|FG003|Controlled Period|Adverse Event|0|||
127834592|NCT01008995|460011408|FG000|Controlled Period|Other|2|||
127834593|NCT01008995|460011409|FG001|Controlled Period|Other|1|||
127834594|NCT01008995|460011410|FG002|Controlled Period|Other|0|||
127834595|NCT01008995|460011411|FG003|Controlled Period|Other|0|||
127834596|NCT01008995|460011408|FG000|After Controlled Period|Adverse Event|0|||
127834597|NCT01008995|460011409|FG001|After Controlled Period|Adverse Event|0|||
127834598|NCT01008995|460011410|FG002|After Controlled Period|Adverse Event|1|||
127834599|NCT01008995|460011411|FG003|After Controlled Period|Adverse Event|1|||
127834600|NCT01008995|460011408|FG000|After Controlled Period|Other|0|||
127834601|NCT01008995|460011409|FG001|After Controlled Period|Other|0|||
127834602|NCT01008995|460011410|FG002|After Controlled Period|Other|1|||
127834603|NCT01008995|460011411|FG003|After Controlled Period|Other|0|||
127834604|NCT02625324|460012902|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
127834605|NCT02625324|460012902|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
127834606|NCT02625324|460012902|FG000|6-Month Follow-up Subject Accountability|Death|5|||
127834607|NCT02625324|460012902|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
127834608|NCT02625324|460012902|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
127834609|NCT02625324|460012902|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
127834610|NCT02625324|460012902|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
127834611|NCT02625324|460012902|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
127834612|NCT02625324|460012902|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
127834613|NCT02625324|460012902|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
127834614|NCT02625324|460012902|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
127834615|NCT02625324|460012902|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
127834616|NCT02625324|460012902|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
127834617|NCT02625324|460012902|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
127834618|NCT02625324|460012902|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
127834619|NCT02625324|460012902|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
127834620|NCT02625324|460012902|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
127834621|NCT01116687|460012907|FG000|Overall Study|Withdrawal by Subject|4|||
127834622|NCT00165841|460012908|FG000|Overall Study|Adverse Event|2|||
127834623|NCT00165841|460012909|FG001|Overall Study|Adverse Event|3|||
127834624|NCT00165841|460012908|FG000|Overall Study|Lack of Efficacy|6|||
127834625|NCT00165841|460012909|FG001|Overall Study|Lack of Efficacy|33|||
127834626|NCT00165841|460012908|FG000|Overall Study|Lost to Follow-up|4|||
127834627|NCT00165841|460012909|FG001|Overall Study|Lost to Follow-up|4|||
127834628|NCT00165841|460012908|FG000|Overall Study|Withdrawal by Subject|7|||
127834629|NCT00165841|460012909|FG001|Overall Study|Withdrawal by Subject|8|||
127834630|NCT00165841|460012908|FG000|Overall Study|Physician Decision|1|||
127834631|NCT00165841|460012909|FG001|Overall Study|Physician Decision|0|||
127834632|NCT00165841|460012908|FG000|Overall Study|Protocol Violation|6|||
127834633|NCT00165841|460012909|FG001|Overall Study|Protocol Violation|8|||
127834634|NCT00165841|460012908|FG000|Overall Study|Other|3|||
127834635|NCT00165841|460012909|FG001|Overall Study|Other|5|||
127834636|NCT00165841|460012908|FG000|Overall Study|Medication Noncompliance|1|||
127834637|NCT00165841|460012909|FG001|Overall Study|Medication Noncompliance|1|||
127834638|NCT03196193|460012916|FG000|Overall Study|Adverse Event|1|||
127834639|NCT03196193|460012917|FG001|Overall Study|Adverse Event|0|||
127834640|NCT03196193|460012916|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
127834641|NCT03196193|460012917|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
127834642|NCT02709083|460012918|FG000|Overall Study|Original PI left institution|7|||
127834643|NCT01697267|460012919|FG000|Overall Study|Death|3|||
127834644|NCT01697267|460012920|FG001|Overall Study|Death|1|||
127834645|NCT01697267|460012919|FG000|Overall Study|Withdrawal by Subject|5|||
127834646|NCT01697267|460012920|FG001|Overall Study|Withdrawal by Subject|5|||
127834647|NCT01697267|460012919|FG000|Overall Study|Adverse Event|2|||
127834648|NCT01697267|460012920|FG001|Overall Study|Adverse Event|1|||
127834649|NCT01697267|460012919|FG000|Overall Study|Lost to Follow-up|2|||
127834650|NCT01697267|460012920|FG001|Overall Study|Lost to Follow-up|4|||
127834651|NCT01697267|460012919|FG000|Overall Study|Physician Decision|2|||
127834652|NCT01697267|460012920|FG001|Overall Study|Physician Decision|4|||
127834653|NCT00333619|460012921|FG000|Overall Study|Death|12|||
127834654|NCT00333619|460012922|FG001|Overall Study|Death|6|||
127834655|NCT00333619|460012921|FG000|Overall Study|Withdrawal by Subject|6|||
127834656|NCT00333619|460012922|FG001|Overall Study|Withdrawal by Subject|1|||
127834657|NCT00333619|460012921|FG000|Overall Study|Lost to Follow-up|3|||
127834658|NCT00333619|460012922|FG001|Overall Study|Lost to Follow-up|3|||
127834659|NCT04031404|460012923|FG000|Baseline|Lost to Follow-up|0|||
127834660|NCT04031404|460012924|FG001|Baseline|Lost to Follow-up|1|||
127834661|NCT04031404|460012923|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
127834662|NCT04031404|460012924|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
127834663|NCT04031404|460012923|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
127834664|NCT04031404|460012924|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
127834665|NCT04031404|460012923|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
127834666|NCT04031404|460012924|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
127834667|NCT04031404|460012923|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
127834668|NCT04031404|460012924|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
127834669|NCT02796391|460012927|FG000|Overall Study|Lost to Follow-up|2|||
127834670|NCT02796391|460012928|FG001|Overall Study|Lost to Follow-up|2|||
127834671|NCT02796391|460012929|FG002|Overall Study|Lost to Follow-up|13|||
127834672|NCT02796391|460012930|FG003|Overall Study|Lost to Follow-up|8|||
127834673|NCT02796391|460012931|FG004|Overall Study|Lost to Follow-up|14|||
127834674|NCT02796391|460012932|FG005|Overall Study|Lost to Follow-up|13|||
127834675|NCT02796391|460012927|FG000|Overall Study|COVID|0|||
127834676|NCT02796391|460012928|FG001|Overall Study|COVID|0|||
127834677|NCT02796391|460012929|FG002|Overall Study|COVID|5|||
127834678|NCT02796391|460012930|FG003|Overall Study|COVID|5|||
127834679|NCT02796391|460012931|FG004|Overall Study|COVID|2|||
127834680|NCT02796391|460012932|FG005|Overall Study|COVID|4|||
127834681|NCT02796391|460012927|FG000|Overall Study|Participant did not like study cigarettes|0|||
127834682|NCT02796391|460012928|FG001|Overall Study|Participant did not like study cigarettes|0|||
127834683|NCT02796391|460012929|FG002|Overall Study|Participant did not like study cigarettes|3|||
127834684|NCT02796391|460012930|FG003|Overall Study|Participant did not like study cigarettes|0|||
127834685|NCT02796391|460012931|FG004|Overall Study|Participant did not like study cigarettes|0|||
127834686|NCT02796391|460012932|FG005|Overall Study|Participant did not like study cigarettes|0|||
127834687|NCT02796391|460012927|FG000|Overall Study|Withdrawal by Subject|1|||
127834688|NCT02796391|460012928|FG001|Overall Study|Withdrawal by Subject|1|||
127834689|NCT02796391|460012929|FG002|Overall Study|Withdrawal by Subject|4|||
127834690|NCT02796391|460012930|FG003|Overall Study|Withdrawal by Subject|3|||
127834691|NCT02796391|460012931|FG004|Overall Study|Withdrawal by Subject|4|||
127834692|NCT02796391|460012932|FG005|Overall Study|Withdrawal by Subject|3|||
127834693|NCT02796391|460012927|FG000|Overall Study|Adverse Event|0|||
127834694|NCT02796391|460012928|FG001|Overall Study|Adverse Event|0|||
127834695|NCT02796391|460012929|FG002|Overall Study|Adverse Event|0|||
127834696|NCT02796391|460012930|FG003|Overall Study|Adverse Event|1|||
127834697|NCT02796391|460012931|FG004|Overall Study|Adverse Event|0|||
127834698|NCT02796391|460012932|FG005|Overall Study|Adverse Event|0|||
127834699|NCT02796391|460012927|FG000|Overall Study|Protocol Violation|0|||
127834700|NCT02796391|460012928|FG001|Overall Study|Protocol Violation|0|||
127834701|NCT02796391|460012929|FG002|Overall Study|Protocol Violation|0|||
127834702|NCT02796391|460012930|FG003|Overall Study|Protocol Violation|1|||
127834703|NCT02796391|460012931|FG004|Overall Study|Protocol Violation|0|||
127834704|NCT02796391|460012932|FG005|Overall Study|Protocol Violation|0|||
127834705|NCT02681055|460012933|FG000|Weeks 5-12|Adverse Event|1|||
127834706|NCT02695524|460012934|FG000|Overall Study|Lost to Follow-up|3|||
127834707|NCT02695524|460012935|FG001|Overall Study|Lost to Follow-up|2|||
127834708|NCT02695524|460012934|FG000|Overall Study|Death|0|||
127834709|NCT02695524|460012935|FG001|Overall Study|Death|1|||
127834710|NCT00831441|460012936|FG000|Randomized|Death|82|||
127834711|NCT00831441|460012937|FG001|Randomized|Death|81|||
127834712|NCT00831441|460012936|FG000|Randomized|Adverse Event|248|||
127834713|NCT00831441|460012937|FG001|Randomized|Adverse Event|321|||
127834714|NCT00831441|460012936|FG000|Randomized|Emergency procedure|2|||
127834715|NCT00831441|460012937|FG001|Randomized|Emergency procedure|2|||
127834716|NCT00831441|460012936|FG000|Randomized|Elective procedure|26|||
127834717|NCT00831441|460012937|FG001|Randomized|Elective procedure|25|||
127834718|NCT00831441|460012936|FG000|Randomized|Physician Decision|26|||
127834719|NCT00831441|460012937|FG001|Randomized|Physician Decision|35|||
127834720|NCT00831441|460012936|FG000|Randomized|No longer met criteria|13|||
127834721|NCT00831441|460012937|FG001|Randomized|No longer met criteria|19|||
127834722|NCT00831441|460012936|FG000|Randomized|Withdrawal by Subject|178|||
127834723|NCT00831441|460012937|FG001|Randomized|Withdrawal by Subject|212|||
127834724|NCT00831441|460012936|FG000|Randomized|Lost to Follow-up|26|||
127834725|NCT00831441|460012937|FG001|Randomized|Lost to Follow-up|35|||
127834726|NCT00831441|460012936|FG000|Randomized|Administrative reason by sponsor|2780|||
127834727|NCT00831441|460012937|FG001|Randomized|Administrative reason by sponsor|2671|||
127834728|NCT00831441|460012936|FG000|Randomized|poor/non-compliance|30|||
127834729|NCT00831441|460012937|FG001|Randomized|poor/non-compliance|38|||
127834730|NCT00831441|460012936|FG000|Randomized|non-specified|276|||
127834731|NCT00831441|460012937|FG001|Randomized|non-specified|266|||
127834732|NCT00831441|460012936|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
127834733|NCT00831441|460012937|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
127834734|NCT00831441|460012936|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
127834735|NCT00831441|460012937|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
127834736|NCT00831441|460012936|FG000|Follow Up (30 Days)|Death|63|||
127834737|NCT00831441|460012937|FG001|Follow Up (30 Days)|Death|86|||
127834738|NCT00831441|460012936|FG000|Follow Up (30 Days)|non-specified|16|||
127834739|NCT00831441|460012937|FG001|Follow Up (30 Days)|non-specified|26|||
127834740|NCT00831441|460012936|FG000|Follow Up (30 Days)|missing end of study status|0|||
127834741|NCT00831441|460012937|FG001|Follow Up (30 Days)|missing end of study status|1|||
127834742|NCT05674344|460012938|FG000|Overall Study|Screen Fail|21|||
127834743|NCT05674344|460012938|FG000|Overall Study|Incomplete study procedures|3|||
127834744|NCT00111917|460012939|FG000|Overall Study|Withdrawal by Subject|1|||
127834745|NCT00111917|460012940|FG001|Overall Study|Withdrawal by Subject|1|||
127834746|NCT00798655|460012941|FG000|Overall Study|Did not receive at least one dose of pan|2|||
127834747|NCT00960934|460012942|FG000|Overall Study|Adverse Event|2|||
127834748|NCT00960934|460012943|FG001|Overall Study|Adverse Event|3|||
127834749|NCT00960934|460012944|FG002|Overall Study|Adverse Event|3|||
127834750|NCT00960934|460012945|FG003|Overall Study|Adverse Event|2|||
127834751|NCT00960934|460012946|FG004|Overall Study|Adverse Event|4|||
127834752|NCT00960934|460012947|FG005|Overall Study|Adverse Event|3|||
127834753|NCT00960934|460012942|FG000|Overall Study|Lack of Efficacy|1|||
127834754|NCT00960934|460012943|FG001|Overall Study|Lack of Efficacy|0|||
127834755|NCT00960934|460012944|FG002|Overall Study|Lack of Efficacy|0|||
127834756|NCT00960934|460012945|FG003|Overall Study|Lack of Efficacy|0|||
127834757|NCT00960934|460012946|FG004|Overall Study|Lack of Efficacy|0|||
127834758|NCT00960934|460012947|FG005|Overall Study|Lack of Efficacy|0|||
127834759|NCT00960934|460012942|FG000|Overall Study|Lost to Follow-up|0|||
127834760|NCT00960934|460012943|FG001|Overall Study|Lost to Follow-up|1|||
127834761|NCT00960934|460012944|FG002|Overall Study|Lost to Follow-up|0|||
127834762|NCT00960934|460012945|FG003|Overall Study|Lost to Follow-up|0|||
127834763|NCT00960934|460012946|FG004|Overall Study|Lost to Follow-up|0|||
127834764|NCT00960934|460012947|FG005|Overall Study|Lost to Follow-up|0|||
127834765|NCT00960934|460012942|FG000|Overall Study|Other|2|||
127834766|NCT00960934|460012943|FG001|Overall Study|Other|1|||
127834767|NCT00960934|460012944|FG002|Overall Study|Other|5|||
127834768|NCT00960934|460012945|FG003|Overall Study|Other|4|||
127834769|NCT00960934|460012946|FG004|Overall Study|Other|2|||
127834770|NCT00960934|460012947|FG005|Overall Study|Other|2|||
127834771|NCT00960934|460012942|FG000|Overall Study|Physician Decision|0|||
127834772|NCT00960934|460012943|FG001|Overall Study|Physician Decision|1|||
127834773|NCT00960934|460012944|FG002|Overall Study|Physician Decision|0|||
127834774|NCT00960934|460012945|FG003|Overall Study|Physician Decision|0|||
127834775|NCT00960934|460012946|FG004|Overall Study|Physician Decision|0|||
127834776|NCT00960934|460012947|FG005|Overall Study|Physician Decision|0|||
127834777|NCT00960934|460012942|FG000|Overall Study|Progressive Disease|1|||
127834778|NCT00960934|460012943|FG001|Overall Study|Progressive Disease|1|||
127834779|NCT00960934|460012944|FG002|Overall Study|Progressive Disease|0|||
127834780|NCT00960934|460012945|FG003|Overall Study|Progressive Disease|0|||
127834781|NCT00960934|460012946|FG004|Overall Study|Progressive Disease|1|||
127834782|NCT00960934|460012947|FG005|Overall Study|Progressive Disease|1|||
127834783|NCT00960934|460012942|FG000|Overall Study|Protocol Violation|3|||
127834784|NCT00960934|460012943|FG001|Overall Study|Protocol Violation|4|||
127834785|NCT00960934|460012944|FG002|Overall Study|Protocol Violation|0|||
127834786|NCT00960934|460012945|FG003|Overall Study|Protocol Violation|3|||
127834787|NCT00960934|460012946|FG004|Overall Study|Protocol Violation|3|||
127834788|NCT00960934|460012947|FG005|Overall Study|Protocol Violation|2|||
127834789|NCT00960934|460012942|FG000|Overall Study|Withdrawal by Subject|5|||
127834790|NCT00960934|460012943|FG001|Overall Study|Withdrawal by Subject|6|||
127834791|NCT00960934|460012944|FG002|Overall Study|Withdrawal by Subject|4|||
127834792|NCT00960934|460012945|FG003|Overall Study|Withdrawal by Subject|5|||
127834793|NCT00960934|460012946|FG004|Overall Study|Withdrawal by Subject|5|||
127834794|NCT00960934|460012947|FG005|Overall Study|Withdrawal by Subject|7|||
127834795|NCT00960934|460012942|FG000|Overall Study|Study Terminated by Sponsor|50|||
127834796|NCT00960934|460012943|FG001|Overall Study|Study Terminated by Sponsor|46|||
127834797|NCT00960934|460012944|FG002|Overall Study|Study Terminated by Sponsor|52|||
127834798|NCT00960934|460012945|FG003|Overall Study|Study Terminated by Sponsor|50|||
127834799|NCT00960934|460012946|FG004|Overall Study|Study Terminated by Sponsor|49|||
127895853|NCT03093324|460242783|FG001|Overall Study|Withdrawal by Subject|2|||
127895854|NCT00278200|460242784|FG000|Overall Study|Death|1|||
127895855|NCT00278200|460242785|FG001|Overall Study|Death|3|||
127895856|NCT00278200|460242784|FG000|Overall Study|Physician Decision|0|||
127895857|NCT00278200|460242785|FG001|Overall Study|Physician Decision|1|||
127895858|NCT03519256|460242788|FG000|Overall Study|Disease recurrence|4|||
127895859|NCT03519256|460242789|FG001|Overall Study|Disease recurrence|4|||
127895860|NCT03519256|460242790|FG002|Overall Study|Disease recurrence|5|||
127895861|NCT03519256|460242791|FG003|Overall Study|Disease recurrence|2|||
127895862|NCT03519256|460242788|FG000|Overall Study|Study drug toxicity|0|||
127834800|NCT00960934|460012947|FG005|Overall Study|Study Terminated by Sponsor|49|||
127834801|NCT05254613|460012954|FG000|Overall Study|Lost to Follow-up|0|||
127834802|NCT05254613|460012955|FG001|Overall Study|Lost to Follow-up|0|||
127834803|NCT05254613|460012956|FG002|Overall Study|Lost to Follow-up|1|||
127895863|NCT03519256|460242789|FG001|Overall Study|Study drug toxicity|2|||
127895864|NCT03519256|460242790|FG002|Overall Study|Study drug toxicity|5|||
127834804|NCT02387372|460012957|FG000|Overall Study|Not Treated|1|||
127834805|NCT02387372|460012958|FG001|Overall Study|Not Treated|0|||
127834806|NCT00848549|460012959|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
127834807|NCT00848549|460012960|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
127834808|NCT00848549|460012959|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
127834809|NCT00848549|460012960|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
127834810|NCT00848549|460012959|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
127834811|NCT00848549|460012960|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
127834812|NCT00848549|460012959|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
127834813|NCT00848549|460012960|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
127834814|NCT00848549|460012959|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
127834815|NCT00848549|460012960|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
127834816|NCT00848549|460012959|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
127834817|NCT00848549|460012960|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
127834818|NCT00848549|460012959|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
127834819|NCT00848549|460012960|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
127834820|NCT00848549|460012959|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
127834821|NCT00848549|460012960|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
127834822|NCT00848549|460012959|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
127834823|NCT00848549|460012960|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
127834824|NCT00848549|460012959|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
127834825|NCT00848549|460012960|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
127895865|NCT03519256|460242791|FG003|Overall Study|Study drug toxicity|2|||
127895866|NCT03519256|460242788|FG000|Overall Study|Adverse event unrelated to study drug|0|||
127895867|NCT03519256|460242789|FG001|Overall Study|Adverse event unrelated to study drug|1|||
127895868|NCT03519256|460242790|FG002|Overall Study|Adverse event unrelated to study drug|1|||
127895869|NCT03519256|460242791|FG003|Overall Study|Adverse event unrelated to study drug|0|||
127895870|NCT03519256|460242788|FG000|Overall Study|Participant request to discontinue study treatment|0|||
127895871|NCT03519256|460242789|FG001|Overall Study|Participant request to discontinue study treatment|0|||
127834826|NCT00848549|460012959|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
127895872|NCT03519256|460242790|FG002|Overall Study|Participant request to discontinue study treatment|0|||
127834827|NCT00848549|460012960|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
127895873|NCT03519256|460242791|FG003|Overall Study|Participant request to discontinue study treatment|2|||
127895874|NCT03519256|460242788|FG000|Overall Study|Other reasons|0|||
127834828|NCT00848549|460012959|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
127834829|NCT00848549|460012960|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
127834830|NCT00848549|460012959|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
127895875|NCT03519256|460242789|FG001|Overall Study|Other reasons|0|||
127895876|NCT03519256|460242790|FG002|Overall Study|Other reasons|2|||
127895877|NCT03519256|460242791|FG003|Overall Study|Other reasons|0|||
127834831|NCT00848549|460012960|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
127834832|NCT00848549|460012959|FG000|E2090-E044-314 (Extension Study)|Other|5|||
127834833|NCT00848549|460012960|FG001|E2090-E044-314 (Extension Study)|Other|6|||
127834834|NCT01248130|460012963|FG000|Overall Study|Protocol Violation|1|||
127834835|NCT01248130|460012964|FG001|Overall Study|Protocol Violation|0|||
127834836|NCT01248130|460012963|FG000|Overall Study|Ineligible|1|||
127834837|NCT01248130|460012964|FG001|Overall Study|Ineligible|0|||
127834838|NCT02106455|460012969|FG000|Overall Study|Case Report Form Uncollected|6|||
127834839|NCT02106455|460012969|FG000|Overall Study|Protocol Deviation|2|||
127834840|NCT02488551|460012973|FG000|Overall Study|Lost to Follow-up|4|||
127895878|NCT03519256|460242788|FG000|Overall Study|Disease progression|6|||
127895879|NCT03519256|460242789|FG001|Overall Study|Disease progression|3|||
127895880|NCT03519256|460242790|FG002|Overall Study|Disease progression|2|||
127834841|NCT02488551|460012974|FG001|Overall Study|Lost to Follow-up|7|||
127834842|NCT02488551|460012975|FG002|Overall Study|Lost to Follow-up|0|||
127834843|NCT02488551|460012976|FG003|Overall Study|Lost to Follow-up|0|||
127834844|NCT02488551|460012973|FG000|Overall Study|Military Deployment|1|||
127834845|NCT02488551|460012974|FG001|Overall Study|Military Deployment|1|||
127834846|NCT02488551|460012975|FG002|Overall Study|Military Deployment|0|||
127834847|NCT02488551|460012976|FG003|Overall Study|Military Deployment|0|||
127834848|NCT03364608|460012979|FG000|Overall Study|Withdrawal by Subject|4|||
127834849|NCT03364608|460012979|FG000|Overall Study|Protocol Violation|2|||
127834850|NCT03364608|460012979|FG000|Overall Study|Lost to Follow-up|2|||
127834851|NCT00436566|460012988|FG000|Overall Study|Withdrawal by Subject|2|||
127834852|NCT00436566|460012988|FG000|Overall Study|Protocol Violation|1|||
127834853|NCT01188564|460012989|FG000|Double-blind Phase|randomized not treated|1|||
127834854|NCT01188564|460012990|FG001|Double-blind Phase|randomized not treated|0|||
127834855|NCT02492997|460012991|FG000|Overall Study|Withdrawal by Subject|1|||
127834856|NCT02492997|460012992|FG001|Overall Study|Withdrawal by Subject|0|||
127834857|NCT02492997|460012991|FG000|Overall Study|Gained Weight|1|||
127834858|NCT02492997|460012992|FG001|Overall Study|Gained Weight|0|||
127834859|NCT02492997|460012991|FG000|Overall Study|Lost to Follow-up|0|||
127834860|NCT02492997|460012992|FG001|Overall Study|Lost to Follow-up|1|||
127834861|NCT03888391|460012999|FG000|Overall Study|Lost to Follow-up|15|||
127834862|NCT01954251|460013001|FG000|Overall Study|Adverse Event|5|||
127834863|NCT01954251|460013002|FG001|Overall Study|Adverse Event|7|||
127834864|NCT01954251|460013001|FG000|Overall Study|Lost to Follow-up|6|||
127834865|NCT01954251|460013002|FG001|Overall Study|Lost to Follow-up|6|||
127834866|NCT01954251|460013001|FG000|Overall Study|Withdrawal by Subject|2|||
127834867|NCT01954251|460013002|FG001|Overall Study|Withdrawal by Subject|6|||
127834868|NCT02175771|460013003|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
127834869|NCT02175771|460013004|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
127834870|NCT02175771|460013005|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
127834871|NCT02175771|460013006|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
127834872|NCT02175771|460013007|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
127834873|NCT02175771|460013008|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
127834874|NCT02175771|460013009|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
127834875|NCT02175771|460013010|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
127834876|NCT02175771|460013011|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
127834877|NCT02175771|460013003|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
127834878|NCT02175771|460013004|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
127834879|NCT02175771|460013005|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
127834880|NCT02175771|460013006|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
127834881|NCT02175771|460013007|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
127834882|NCT02175771|460013008|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
127834883|NCT02175771|460013009|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
127834884|NCT02175771|460013010|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
127834885|NCT02175771|460013011|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
127834886|NCT02175771|460013003|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
127834887|NCT02175771|460013004|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
127834888|NCT02175771|460013005|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
127834889|NCT02175771|460013006|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
127834890|NCT02175771|460013007|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
127834891|NCT02175771|460013008|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
127834892|NCT02175771|460013009|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
127834893|NCT02175771|460013010|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
127834894|NCT02175771|460013011|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
127834895|NCT02175771|460013003|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
127834896|NCT02175771|460013004|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
127834897|NCT02175771|460013005|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
127834898|NCT02175771|460013006|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
127834899|NCT02175771|460013007|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
127834900|NCT02175771|460013008|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
127834901|NCT02175771|460013009|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
127834902|NCT02175771|460013010|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
127834903|NCT02175771|460013011|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
127834904|NCT02175771|460013003|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
127834905|NCT02175771|460013004|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
127834906|NCT02175771|460013005|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
127834907|NCT02175771|460013006|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
127834908|NCT02175771|460013007|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
127834909|NCT02175771|460013008|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
127834910|NCT02175771|460013009|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
127834911|NCT02175771|460013010|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
127834912|NCT02175771|460013011|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
127834913|NCT02175771|460013003|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
127834914|NCT02175771|460013004|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
127834915|NCT02175771|460013005|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
127834916|NCT02175771|460013006|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
127834917|NCT02175771|460013007|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
127834918|NCT02175771|460013008|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
127834919|NCT02175771|460013009|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
127834920|NCT02175771|460013010|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
127834921|NCT02175771|460013011|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
127834922|NCT02175771|460013003|FG000|Run-In Period (Pre-assignment)|Other|8|||
127834923|NCT02175771|460013004|FG001|Run-In Period (Pre-assignment)|Other|0|||
127834924|NCT02175771|460013005|FG002|Run-In Period (Pre-assignment)|Other|0|||
127834925|NCT02175771|460013006|FG003|Run-In Period (Pre-assignment)|Other|0|||
127834926|NCT02175771|460013007|FG004|Run-In Period (Pre-assignment)|Other|0|||
127834927|NCT02175771|460013008|FG005|Run-In Period (Pre-assignment)|Other|0|||
127834928|NCT02175771|460013009|FG006|Run-In Period (Pre-assignment)|Other|0|||
127834929|NCT02175771|460013010|FG007|Run-In Period (Pre-assignment)|Other|0|||
127834930|NCT02175771|460013011|FG008|Run-In Period (Pre-assignment)|Other|0|||
127834931|NCT02175771|460013003|FG000|Treatment Period|Adverse Event|0|||
127834932|NCT02175771|460013004|FG001|Treatment Period|Adverse Event|2|||
127834933|NCT02175771|460013005|FG002|Treatment Period|Adverse Event|1|||
127834934|NCT02175771|460013006|FG003|Treatment Period|Adverse Event|1|||
127834935|NCT02175771|460013007|FG004|Treatment Period|Adverse Event|1|||
127834936|NCT02175771|460013008|FG005|Treatment Period|Adverse Event|3|||
127834937|NCT02175771|460013009|FG006|Treatment Period|Adverse Event|2|||
127834938|NCT02175771|460013010|FG007|Treatment Period|Adverse Event|0|||
127834939|NCT02175771|460013011|FG008|Treatment Period|Adverse Event|1|||
127834940|NCT02175771|460013003|FG000|Treatment Period|Withdrawal by Subject|0|||
127834941|NCT02175771|460013004|FG001|Treatment Period|Withdrawal by Subject|9|||
127834942|NCT02175771|460013005|FG002|Treatment Period|Withdrawal by Subject|3|||
127834943|NCT02175771|460013006|FG003|Treatment Period|Withdrawal by Subject|6|||
127834944|NCT02175771|460013007|FG004|Treatment Period|Withdrawal by Subject|2|||
127834945|NCT02175771|460013008|FG005|Treatment Period|Withdrawal by Subject|4|||
127834946|NCT02175771|460013009|FG006|Treatment Period|Withdrawal by Subject|2|||
127834947|NCT02175771|460013010|FG007|Treatment Period|Withdrawal by Subject|9|||
127834948|NCT02175771|460013011|FG008|Treatment Period|Withdrawal by Subject|2|||
127834949|NCT02175771|460013003|FG000|Treatment Period|Noncompliance|0|||
127834950|NCT02175771|460013004|FG001|Treatment Period|Noncompliance|1|||
127834951|NCT02175771|460013005|FG002|Treatment Period|Noncompliance|2|||
127834952|NCT02175771|460013006|FG003|Treatment Period|Noncompliance|0|||
127834953|NCT02175771|460013007|FG004|Treatment Period|Noncompliance|0|||
127834954|NCT02175771|460013008|FG005|Treatment Period|Noncompliance|0|||
127834955|NCT02175771|460013009|FG006|Treatment Period|Noncompliance|0|||
127834956|NCT02175771|460013010|FG007|Treatment Period|Noncompliance|0|||
127834957|NCT02175771|460013011|FG008|Treatment Period|Noncompliance|1|||
127895881|NCT03519256|460242791|FG003|Overall Study|Disease progression|1|||
127834958|NCT02175771|460013003|FG000|Treatment Period|Protocol Violation|0|||
127834959|NCT02175771|460013004|FG001|Treatment Period|Protocol Violation|0|||
127834960|NCT02175771|460013005|FG002|Treatment Period|Protocol Violation|0|||
127834961|NCT02175771|460013006|FG003|Treatment Period|Protocol Violation|0|||
127834962|NCT02175771|460013007|FG004|Treatment Period|Protocol Violation|0|||
127834963|NCT02175771|460013008|FG005|Treatment Period|Protocol Violation|0|||
127834964|NCT02175771|460013009|FG006|Treatment Period|Protocol Violation|0|||
127834965|NCT02175771|460013010|FG007|Treatment Period|Protocol Violation|1|||
127834966|NCT02175771|460013011|FG008|Treatment Period|Protocol Violation|0|||
127834967|NCT02175771|460013003|FG000|Treatment Period|Disease progression|0|||
127834968|NCT02175771|460013004|FG001|Treatment Period|Disease progression|0|||
127834969|NCT02175771|460013005|FG002|Treatment Period|Disease progression|0|||
127834970|NCT02175771|460013006|FG003|Treatment Period|Disease progression|0|||
127834971|NCT02175771|460013007|FG004|Treatment Period|Disease progression|0|||
127834972|NCT02175771|460013008|FG005|Treatment Period|Disease progression|0|||
127834973|NCT02175771|460013009|FG006|Treatment Period|Disease progression|0|||
127834974|NCT02175771|460013010|FG007|Treatment Period|Disease progression|2|||
127834975|NCT02175771|460013011|FG008|Treatment Period|Disease progression|0|||
127834976|NCT02175771|460013003|FG000|Treatment Period|Lost to Follow-up|0|||
127834977|NCT02175771|460013004|FG001|Treatment Period|Lost to Follow-up|3|||
127834978|NCT02175771|460013005|FG002|Treatment Period|Lost to Follow-up|1|||
127834979|NCT02175771|460013006|FG003|Treatment Period|Lost to Follow-up|3|||
127834980|NCT02175771|460013007|FG004|Treatment Period|Lost to Follow-up|1|||
127834981|NCT02175771|460013008|FG005|Treatment Period|Lost to Follow-up|2|||
127834982|NCT02175771|460013009|FG006|Treatment Period|Lost to Follow-up|1|||
127834983|NCT02175771|460013010|FG007|Treatment Period|Lost to Follow-up|2|||
127834984|NCT02175771|460013011|FG008|Treatment Period|Lost to Follow-up|2|||
127834985|NCT02175771|460013003|FG000|Treatment Period|Lack of Efficacy|0|||
127834986|NCT02175771|460013004|FG001|Treatment Period|Lack of Efficacy|0|||
127834987|NCT02175771|460013005|FG002|Treatment Period|Lack of Efficacy|0|||
127834988|NCT02175771|460013006|FG003|Treatment Period|Lack of Efficacy|0|||
127834989|NCT02175771|460013007|FG004|Treatment Period|Lack of Efficacy|0|||
127834990|NCT02175771|460013008|FG005|Treatment Period|Lack of Efficacy|1|||
127834991|NCT02175771|460013009|FG006|Treatment Period|Lack of Efficacy|0|||
127834992|NCT02175771|460013010|FG007|Treatment Period|Lack of Efficacy|1|||
127834993|NCT02175771|460013011|FG008|Treatment Period|Lack of Efficacy|0|||
127834994|NCT02175771|460013003|FG000|Treatment Period|Other|0|||
127834995|NCT02175771|460013004|FG001|Treatment Period|Other|1|||
127834996|NCT02175771|460013005|FG002|Treatment Period|Other|0|||
127834997|NCT02175771|460013006|FG003|Treatment Period|Other|3|||
127834998|NCT02175771|460013007|FG004|Treatment Period|Other|1|||
127834999|NCT02175771|460013008|FG005|Treatment Period|Other|0|||
127835000|NCT02175771|460013009|FG006|Treatment Period|Other|0|||
127835001|NCT02175771|460013010|FG007|Treatment Period|Other|2|||
127835002|NCT02175771|460013011|FG008|Treatment Period|Other|0|||
127835003|NCT02232087|460013012|FG000|Overall Study|Withdrawal by Subject|2|||
127835004|NCT02232087|460013013|FG001|Overall Study|Withdrawal by Subject|0|||
127835005|NCT02232087|460013014|FG002|Overall Study|Withdrawal by Subject|0|||
127835006|NCT02232087|460013015|FG003|Overall Study|Withdrawal by Subject|0|||
127835007|NCT02232087|460013016|FG004|Overall Study|Withdrawal by Subject|0|||
127835008|NCT02232087|460013017|FG005|Overall Study|Withdrawal by Subject|1|||
127835009|NCT02232087|460013012|FG000|Overall Study|poor inhalation technique|0|||
127835010|NCT02232087|460013013|FG001|Overall Study|poor inhalation technique|1|||
127835011|NCT02232087|460013014|FG002|Overall Study|poor inhalation technique|0|||
127835012|NCT02232087|460013015|FG003|Overall Study|poor inhalation technique|0|||
127895882|NCT03519256|460242788|FG000|Overall Study|Lost to Follow-up|0|||
127895883|NCT03519256|460242789|FG001|Overall Study|Lost to Follow-up|1|||
127895884|NCT03519256|460242790|FG002|Overall Study|Lost to Follow-up|0|||
127895885|NCT03519256|460242791|FG003|Overall Study|Lost to Follow-up|0|||
127895886|NCT05431153|460242792|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
127895887|NCT05431153|460242793|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
127895888|NCT05431153|460242794|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
127895889|NCT05431153|460242795|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
127895890|NCT05431153|460242796|FG004|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
127895891|NCT05431153|460242797|FG005|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
127895892|NCT04828161|460242798|FG000|Overall Study|Withdrawal by Subject|0|||
127895893|NCT04828161|460242799|FG001|Overall Study|Withdrawal by Subject|3|||
127895894|NCT04828161|460242800|FG002|Overall Study|Withdrawal by Subject|3|||
127895895|NCT04828161|460242801|FG003|Overall Study|Withdrawal by Subject|4|||
127895896|NCT04828161|460242798|FG000|Overall Study|Lost to Follow-up|1|||
127895897|NCT04828161|460242799|FG001|Overall Study|Lost to Follow-up|4|||
127895898|NCT04828161|460242800|FG002|Overall Study|Lost to Follow-up|2|||
127895899|NCT04828161|460242801|FG003|Overall Study|Lost to Follow-up|2|||
127895900|NCT04828161|460242798|FG000|Overall Study|Other|2|||
127895901|NCT04828161|460242799|FG001|Overall Study|Other|0|||
127895902|NCT04828161|460242800|FG002|Overall Study|Other|2|||
127895903|NCT04828161|460242801|FG003|Overall Study|Other|0|||
127895904|NCT04828161|460242798|FG000|Overall Study|Death|0|||
127895905|NCT04828161|460242799|FG001|Overall Study|Death|0|||
127895906|NCT04828161|460242800|FG002|Overall Study|Death|0|||
127895907|NCT04828161|460242801|FG003|Overall Study|Death|2|||
127895908|NCT02458638|460242804|FG000|Overall Study|Death|309|||
127895909|NCT02458638|460242804|FG000|Overall Study|End of Cohort/End of Study|67|||
127895910|NCT02458638|460242804|FG000|Overall Study|Lost to Follow-up|31|||
127895911|NCT02458638|460242804|FG000|Overall Study|Other Reasons|4|||
127895912|NCT02458638|460242804|FG000|Overall Study|Physician Decision|1|||
127895913|NCT02458638|460242804|FG000|Overall Study|Withdrawal by Subject|47|||
127895914|NCT00135707|460242813|FG000|Overall Study|Lost to Follow-up|94|||
127895915|NCT00135707|460242814|FG001|Overall Study|Lost to Follow-up|89|||
127895916|NCT00135707|460242813|FG000|Overall Study|Withdrawal by Subject|0|||
127835013|NCT02232087|460013016|FG004|Overall Study|poor inhalation technique|0|||
127835014|NCT02232087|460013017|FG005|Overall Study|poor inhalation technique|2|||
127895917|NCT00135707|460242814|FG001|Overall Study|Withdrawal by Subject|1|||
127895918|NCT00135707|460242813|FG000|Overall Study|Institutional review board request|1|||
127895919|NCT00135707|460242814|FG001|Overall Study|Institutional review board request|0|||
127895920|NCT03093454|460242815|FG000|Overall Study|Withdrawal by Subject|1|||
127895921|NCT03093454|460242816|FG001|Overall Study|Withdrawal by Subject|1|||
127895922|NCT03093454|460242815|FG000|Overall Study|Scheduling conflict|3|||
127895923|NCT03093454|460242816|FG001|Overall Study|Scheduling conflict|1|||
127895924|NCT03093454|460242815|FG000|Overall Study|Physician Decision|2|||
127835015|NCT02232087|460013012|FG000|Overall Study|protocol stop criteria|0|||
127835016|NCT02232087|460013013|FG001|Overall Study|protocol stop criteria|1|||
127835017|NCT02232087|460013014|FG002|Overall Study|protocol stop criteria|0|||
127835018|NCT02232087|460013015|FG003|Overall Study|protocol stop criteria|1|||
127835019|NCT02232087|460013016|FG004|Overall Study|protocol stop criteria|0|||
127835020|NCT02232087|460013017|FG005|Overall Study|protocol stop criteria|0|||
127835021|NCT02232087|460013012|FG000|Overall Study|Adverse Event|0|||
127835022|NCT02232087|460013013|FG001|Overall Study|Adverse Event|0|||
127835023|NCT02232087|460013014|FG002|Overall Study|Adverse Event|0|||
127835024|NCT02232087|460013015|FG003|Overall Study|Adverse Event|0|||
127835025|NCT02232087|460013016|FG004|Overall Study|Adverse Event|1|||
127835026|NCT02232087|460013017|FG005|Overall Study|Adverse Event|0|||
127835027|NCT04069156|460013018|FG000|Modified Intent-to-Treat (mITT)|Death|1|||
127835028|NCT04069156|460013019|FG001|Modified Intent-to-Treat (mITT)|Death|2|||
127835029|NCT04069156|460013018|FG000|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|9|||
127835030|NCT04069156|460013019|FG001|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|7|||
127835031|NCT04069156|460013018|FG000|Modified Intent-to-Treat (mITT)|Transitioned to open label|8|||
127835032|NCT04069156|460013019|FG001|Modified Intent-to-Treat (mITT)|Transitioned to open label|12|||
127835033|NCT04069156|460013018|FG000|Principal Analysis|Withdrawn without primary end point event|25|||
127835034|NCT04069156|460013019|FG001|Principal Analysis|Withdrawn without primary end point event|20|||
127835035|NCT02207556|460013020|FG000|Overall Study|Physician Decision|1|||
127835036|NCT02207556|460013021|FG001|Overall Study|Physician Decision|0|||
127835037|NCT02207556|460013020|FG000|Overall Study|Withdrawal by Subject|1|||
127835038|NCT02207556|460013021|FG001|Overall Study|Withdrawal by Subject|0|||
127835039|NCT02207556|460013020|FG000|Overall Study|Death|0|||
127835040|NCT02207556|460013021|FG001|Overall Study|Death|5|||
127835041|NCT03558555|460013022|FG000|Overall Study|Lost to Follow-up|2|||
127835042|NCT03558555|460013023|FG001|Overall Study|Lost to Follow-up|1|||
127835043|NCT01958125|460013024|FG000|Overall Study|Missing diary data|2|||
127835044|NCT01958125|460013025|FG001|Overall Study|Missing diary data|6|||
127835045|NCT01958125|460013024|FG000|Overall Study|No headache attacks|0|||
127835046|NCT01958125|460013025|FG001|Overall Study|No headache attacks|2|||
127835047|NCT00668200|460013027|FG000|Overall Study|Withdrawal by Subject|2|||
127835048|NCT00668200|460013027|FG000|Overall Study|Lost to Follow-up|1|||
127835049|NCT01098461|460013029|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
127835050|NCT01098461|460013030|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
127835051|NCT01098461|460013031|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
127835052|NCT01098461|460013032|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
127835053|NCT01098461|460013029|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
127835054|NCT01098461|460013030|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
127835055|NCT01098461|460013031|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
127835056|NCT01098461|460013032|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
127835057|NCT01098461|460013029|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
127835058|NCT01098461|460013030|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
127835059|NCT01098461|460013031|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
127835060|NCT01098461|460013032|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
127835061|NCT01098461|460013029|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
127835062|NCT01098461|460013030|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
127835063|NCT01098461|460013031|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
127835064|NCT01098461|460013032|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
127895925|NCT03093454|460242816|FG001|Overall Study|Physician Decision|1|||
127895926|NCT04540497|460242820|FG000|Overall Study|Adverse Event|0|||
127895927|NCT04540497|460242821|FG001|Overall Study|Adverse Event|2|||
127895928|NCT04540497|460242820|FG000|Overall Study|Lost to Follow-up|1|||
127895929|NCT04540497|460242821|FG001|Overall Study|Lost to Follow-up|0|||
127895930|NCT04540497|460242820|FG000|Overall Study|Withdrawal by Subject|1|||
127895931|NCT04540497|460242821|FG001|Overall Study|Withdrawal by Subject|1|||
127895932|NCT04540497|460242820|FG000|Overall Study|Miscellaneous|2|||
127895933|NCT04540497|460242821|FG001|Overall Study|Miscellaneous|1|||
127895934|NCT02524379|460242826|FG000|Overall Study|Death|1|||
127895935|NCT01290263|460242829|FG000|Overall Study|Adverse Event|0|||
127895936|NCT01290263|460242830|FG001|Overall Study|Adverse Event|0|||
127895937|NCT01290263|460242831|FG002|Overall Study|Adverse Event|0|||
127895938|NCT01290263|460242832|FG003|Overall Study|Adverse Event|1|||
127895939|NCT01290263|460242833|FG004|Overall Study|Adverse Event|1|||
127835065|NCT01098461|460013029|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
127895940|NCT01290263|460242829|FG000|Overall Study|Lack of Efficacy|8|||
127835066|NCT01098461|460013030|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
127835067|NCT01098461|460013031|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
127895941|NCT01290263|460242830|FG001|Overall Study|Lack of Efficacy|2|||
127895942|NCT01290263|460242831|FG002|Overall Study|Lack of Efficacy|7|||
127895943|NCT01290263|460242832|FG003|Overall Study|Lack of Efficacy|24|||
127895944|NCT01290263|460242833|FG004|Overall Study|Lack of Efficacy|33|||
127895945|NCT01290263|460242829|FG000|Overall Study|Withdrawal by Subject|3|||
127895946|NCT01290263|460242830|FG001|Overall Study|Withdrawal by Subject|1|||
127895947|NCT01290263|460242831|FG002|Overall Study|Withdrawal by Subject|0|||
127895948|NCT01290263|460242832|FG003|Overall Study|Withdrawal by Subject|1|||
127895949|NCT01290263|460242833|FG004|Overall Study|Withdrawal by Subject|2|||
127895950|NCT01290263|460242829|FG000|Overall Study|Participant Non-Compliance|0|||
127895951|NCT01290263|460242830|FG001|Overall Study|Participant Non-Compliance|0|||
127895952|NCT01290263|460242831|FG002|Overall Study|Participant Non-Compliance|0|||
127895953|NCT01290263|460242832|FG003|Overall Study|Participant Non-Compliance|1|||
127895954|NCT01290263|460242833|FG004|Overall Study|Participant Non-Compliance|1|||
127895955|NCT04700449|460242834|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
127895956|NCT04700449|460242835|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
127895957|NCT04700449|460242836|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
127895958|NCT04700449|460242837|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
127895959|NCT04700449|460242834|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
127895960|NCT04700449|460242835|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
127895961|NCT04700449|460242836|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
127895962|NCT04700449|460242837|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
127895963|NCT04700449|460242834|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
127895964|NCT04700449|460242835|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
127895965|NCT04700449|460242836|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
127835068|NCT01098461|460013032|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
127835069|NCT01098461|460013029|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
127835070|NCT01098461|460013030|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
127835071|NCT01098461|460013031|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
127835072|NCT01098461|460013032|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
127835073|NCT01098461|460013029|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
127835074|NCT01098461|460013030|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
127835075|NCT01098461|460013031|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
127835076|NCT01098461|460013032|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
127835077|NCT03628508|460013033|FG000|Overall Study|Lost to Follow-up|1|||
127835078|NCT04570657|460013035|FG000|Overall Study|Adverse Event|0|||
127835079|NCT04570657|460013036|FG001|Overall Study|Adverse Event|0|||
127835080|NCT04570657|460013037|FG002|Overall Study|Adverse Event|1|||
127835081|NCT04570657|460013035|FG000|Overall Study|Lost to Follow-up|0|||
127835082|NCT04570657|460013036|FG001|Overall Study|Lost to Follow-up|0|||
127835083|NCT04570657|460013037|FG002|Overall Study|Lost to Follow-up|1|||
127835084|NCT04570657|460013035|FG000|Overall Study|Physician Decision|0|||
127895966|NCT04700449|460242837|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
127895967|NCT04700449|460242834|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
127895968|NCT04700449|460242835|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
127895969|NCT04700449|460242836|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
127895970|NCT04700449|460242837|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
127835085|NCT04570657|460013036|FG001|Overall Study|Physician Decision|1|||
127835086|NCT04570657|460013037|FG002|Overall Study|Physician Decision|0|||
127835087|NCT04570657|460013035|FG000|Overall Study|Withdrawal by Subject|1|||
127835088|NCT04570657|460013036|FG001|Overall Study|Withdrawal by Subject|2|||
127835089|NCT04570657|460013037|FG002|Overall Study|Withdrawal by Subject|2|||
127895971|NCT04700449|460242834|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
127895972|NCT04700449|460242835|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
127895973|NCT04700449|460242836|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
127895974|NCT04700449|460242837|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
127895975|NCT04700449|460242834|FG000|Stage 1: Double-Blind Period|Other|0|||
127895976|NCT04700449|460242835|FG001|Stage 1: Double-Blind Period|Other|0|||
127895977|NCT04700449|460242836|FG002|Stage 1: Double-Blind Period|Other|1|||
127895978|NCT04700449|460242837|FG003|Stage 1: Double-Blind Period|Other|0|||
127895979|NCT04700449|460242834|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
127895980|NCT04700449|460242835|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
127895981|NCT04700449|460242836|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
127895982|NCT04700449|460242837|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
127835090|NCT01072539|460013038|FG000|Overall Study|Treated prior to the Site Initiation|1|||
127835091|NCT01072539|460013038|FG000|Overall Study|Protocol Violation|2|||
127835092|NCT00115804|460013041|FG000|Overall Study|Adverse Event|2|||
127835093|NCT01752842|460013042|FG000|Overall Study|Adverse Event|3|||
127835094|NCT01752842|460013043|FG001|Overall Study|Adverse Event|0|||
127895983|NCT04700449|460242834|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
127835095|NCT01752842|460013042|FG000|Overall Study|Withdrawal by Subject|0|||
127835096|NCT01752842|460013043|FG001|Overall Study|Withdrawal by Subject|2|||
127835097|NCT01683071|460013044|FG000|Part 1|Lack of Efficacy|1|||
127835098|NCT01683071|460013045|FG001|Part 1|Lack of Efficacy|0|||
127835099|NCT01683071|460013046|FG002|Part 1|Lack of Efficacy|0|||
127835100|NCT01683071|460013047|FG003|Part 1|Lack of Efficacy|3|||
127835101|NCT01683071|460013048|FG004|Part 1|Lack of Efficacy|0|||
127835102|NCT01683071|460013049|FG005|Part 1|Lack of Efficacy|0|||
127835103|NCT01683071|460013044|FG000|Part 1|Withdrawal by Subject|1|||
127835104|NCT01683071|460013045|FG001|Part 1|Withdrawal by Subject|2|||
127835105|NCT01683071|460013046|FG002|Part 1|Withdrawal by Subject|2|||
127835106|NCT01683071|460013047|FG003|Part 1|Withdrawal by Subject|1|||
127835107|NCT01683071|460013048|FG004|Part 1|Withdrawal by Subject|0|||
127835108|NCT01683071|460013049|FG005|Part 1|Withdrawal by Subject|0|||
127835109|NCT01683071|460013044|FG000|Part 1|Surgery Cancelled|1|||
127835110|NCT01683071|460013045|FG001|Part 1|Surgery Cancelled|0|||
127835111|NCT01683071|460013046|FG002|Part 1|Surgery Cancelled|0|||
127835112|NCT01683071|460013047|FG003|Part 1|Surgery Cancelled|0|||
127835113|NCT01683071|460013048|FG004|Part 1|Surgery Cancelled|0|||
127835114|NCT01683071|460013049|FG005|Part 1|Surgery Cancelled|0|||
127835115|NCT01683071|460013044|FG000|Part 1|Did not receive study drug|1|||
127835116|NCT01683071|460013045|FG001|Part 1|Did not receive study drug|0|||
127835117|NCT01683071|460013046|FG002|Part 1|Did not receive study drug|0|||
127835118|NCT01683071|460013047|FG003|Part 1|Did not receive study drug|1|||
127835119|NCT01683071|460013048|FG004|Part 1|Did not receive study drug|0|||
127835120|NCT01683071|460013049|FG005|Part 1|Did not receive study drug|0|||
127835121|NCT01683071|460013044|FG000|Part 1|Early termination; met exclusion criteria|0|||
127835122|NCT01683071|460013045|FG001|Part 1|Early termination; met exclusion criteria|2|||
127835123|NCT01683071|460013046|FG002|Part 1|Early termination; met exclusion criteria|1|||
127835124|NCT01683071|460013047|FG003|Part 1|Early termination; met exclusion criteria|0|||
127835125|NCT01683071|460013048|FG004|Part 1|Early termination; met exclusion criteria|0|||
127835126|NCT01683071|460013049|FG005|Part 1|Early termination; met exclusion criteria|0|||
127835127|NCT01683071|460013044|FG000|Part 2|Lack of Efficacy|0|||
127835128|NCT01683071|460013045|FG001|Part 2|Lack of Efficacy|0|||
127835129|NCT01683071|460013046|FG002|Part 2|Lack of Efficacy|0|||
127835130|NCT01683071|460013047|FG003|Part 2|Lack of Efficacy|0|||
127835131|NCT01683071|460013048|FG004|Part 2|Lack of Efficacy|3|||
127835132|NCT01683071|460013049|FG005|Part 2|Lack of Efficacy|4|||
127835133|NCT01683071|460013044|FG000|Part 2|Lost to Follow-up|0|||
127835134|NCT01683071|460013045|FG001|Part 2|Lost to Follow-up|0|||
127835135|NCT01683071|460013046|FG002|Part 2|Lost to Follow-up|0|||
127835136|NCT01683071|460013047|FG003|Part 2|Lost to Follow-up|0|||
127835137|NCT01683071|460013048|FG004|Part 2|Lost to Follow-up|2|||
127835138|NCT01683071|460013049|FG005|Part 2|Lost to Follow-up|0|||
127835139|NCT01683071|460013044|FG000|Part 2|Withdrawal by Subject|0|||
127835140|NCT01683071|460013045|FG001|Part 2|Withdrawal by Subject|0|||
127835141|NCT01683071|460013046|FG002|Part 2|Withdrawal by Subject|0|||
127835142|NCT01683071|460013047|FG003|Part 2|Withdrawal by Subject|0|||
127835143|NCT01683071|460013048|FG004|Part 2|Withdrawal by Subject|3|||
127835144|NCT01683071|460013049|FG005|Part 2|Withdrawal by Subject|3|||
127835145|NCT01683071|460013044|FG000|Part 2|Surgery cancelled|0|||
127835146|NCT01683071|460013045|FG001|Part 2|Surgery cancelled|0|||
127835147|NCT01683071|460013046|FG002|Part 2|Surgery cancelled|0|||
127835148|NCT01683071|460013047|FG003|Part 2|Surgery cancelled|0|||
127835149|NCT01683071|460013048|FG004|Part 2|Surgery cancelled|4|||
127835150|NCT01683071|460013049|FG005|Part 2|Surgery cancelled|2|||
127835151|NCT01683071|460013044|FG000|Part 2|Did not receive study drug|0|||
127835152|NCT01683071|460013045|FG001|Part 2|Did not receive study drug|0|||
127835153|NCT01683071|460013046|FG002|Part 2|Did not receive study drug|0|||
127835154|NCT01683071|460013047|FG003|Part 2|Did not receive study drug|0|||
127835155|NCT01683071|460013048|FG004|Part 2|Did not receive study drug|2|||
127835156|NCT01683071|460013049|FG005|Part 2|Did not receive study drug|1|||
127835157|NCT01683071|460013044|FG000|Part 2|Met exclusion criterion|0|||
127835158|NCT01683071|460013045|FG001|Part 2|Met exclusion criterion|0|||
127835159|NCT01683071|460013046|FG002|Part 2|Met exclusion criterion|0|||
127835160|NCT01683071|460013047|FG003|Part 2|Met exclusion criterion|0|||
127835161|NCT01683071|460013048|FG004|Part 2|Met exclusion criterion|1|||
127835162|NCT01683071|460013049|FG005|Part 2|Met exclusion criterion|1|||
127835163|NCT01683071|460013044|FG000|Part 2|Protocol deviation|0|||
127835164|NCT01683071|460013045|FG001|Part 2|Protocol deviation|0|||
127835165|NCT01683071|460013046|FG002|Part 2|Protocol deviation|0|||
127835166|NCT01683071|460013047|FG003|Part 2|Protocol deviation|0|||
127835167|NCT01683071|460013048|FG004|Part 2|Protocol deviation|1|||
127835168|NCT01683071|460013049|FG005|Part 2|Protocol deviation|2|||
127835169|NCT01683071|460013044|FG000|Part 2|Withdrawal by investigator decision|0|||
127835170|NCT01683071|460013045|FG001|Part 2|Withdrawal by investigator decision|0|||
127835171|NCT01683071|460013046|FG002|Part 2|Withdrawal by investigator decision|0|||
127835172|NCT01683071|460013047|FG003|Part 2|Withdrawal by investigator decision|0|||
127835173|NCT01683071|460013048|FG004|Part 2|Withdrawal by investigator decision|1|||
127835174|NCT01683071|460013049|FG005|Part 2|Withdrawal by investigator decision|2|||
127835175|NCT01968187|460013052|FG000|Overall Study|Adverse Event|0|||
127835176|NCT01968187|460013053|FG001|Overall Study|Adverse Event|1|||
127835177|NCT01968187|460013052|FG000|Overall Study|Randomized but not treated|1|||
127835178|NCT01968187|460013053|FG001|Overall Study|Randomized but not treated|0|||
127835179|NCT04095286|460013054|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
127835180|NCT04095286|460013055|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
127835181|NCT04095286|460013056|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
127835182|NCT04095286|460013057|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
127835183|NCT04095286|460013058|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
127835184|NCT04095286|460013059|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
127835185|NCT04095286|460013054|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
127835186|NCT04095286|460013055|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
127835187|NCT04095286|460013056|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
127835188|NCT04095286|460013057|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
127835189|NCT04095286|460013058|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
127835190|NCT04095286|460013059|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
127835191|NCT04095286|460013054|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
127835192|NCT04095286|460013055|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
127835193|NCT04095286|460013056|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
127835194|NCT04095286|460013057|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
127835195|NCT04095286|460013058|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
127835196|NCT04095286|460013059|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
127835197|NCT04095286|460013054|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
127835198|NCT04095286|460013055|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
127835199|NCT04095286|460013056|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
127835200|NCT04095286|460013057|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
127835201|NCT04095286|460013058|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
127835202|NCT04095286|460013059|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
127835203|NCT04095286|460013054|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
127835204|NCT04095286|460013055|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
127835205|NCT04095286|460013056|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
127835206|NCT04095286|460013057|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
127835207|NCT04095286|460013058|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
127835208|NCT04095286|460013059|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
127835209|NCT02020031|460015252|FG000|Overall Study|Physician Decision|1|||
127835210|NCT02020031|460015253|FG001|Overall Study|Physician Decision|1|||
127835211|NCT04092816|460015265|FG000|Overall Study|Lost to Follow-up|1|||
127835212|NCT04092816|460015266|FG001|Overall Study|Lost to Follow-up|2|||
127835213|NCT00424528|460015267|FG000|Overall Study|Adverse Event|2|||
127835214|NCT00424528|460015268|FG001|Overall Study|Adverse Event|1|||
127835215|NCT00424528|460015269|FG002|Overall Study|Adverse Event|2|||
127835216|NCT00424528|460015267|FG000|Overall Study|Protocol Violation|1|||
127835217|NCT00424528|460015268|FG001|Overall Study|Protocol Violation|1|||
127835218|NCT00424528|460015269|FG002|Overall Study|Protocol Violation|0|||
127835219|NCT00424528|460015267|FG000|Overall Study|Lost to Follow-up|0|||
127835220|NCT00424528|460015268|FG001|Overall Study|Lost to Follow-up|1|||
127835221|NCT00424528|460015269|FG002|Overall Study|Lost to Follow-up|0|||
127835222|NCT00424528|460015267|FG000|Overall Study|noncompliance with study requirements|2|||
127835223|NCT00424528|460015268|FG001|Overall Study|noncompliance with study requirements|1|||
127835224|NCT00424528|460015269|FG002|Overall Study|noncompliance with study requirements|2|||
127835225|NCT02395653|460015273|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
127835226|NCT02395653|460015273|FG000|Overall Study|Consent Withdrawn at Screening|1|||
127835227|NCT02395653|460015273|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
127835228|NCT02395653|460015273|FG000|Overall Study|Investigator Decision at Screening|1|||
127835229|NCT02395653|460015273|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
127835230|NCT02395653|460015273|FG000|Overall Study|Withdrawal by Subject|1|||
127835231|NCT02395653|460015273|FG000|Overall Study|Lost to Follow-up|1|||
127835232|NCT00967226|460015277|FG000|Overall Study|Adverse Event|0|||
127835233|NCT00967226|460015278|FG001|Overall Study|Adverse Event|5|||
127835234|NCT00967226|460015277|FG000|Overall Study|Protocol Violation|2|||
127835235|NCT00967226|460015278|FG001|Overall Study|Protocol Violation|0|||
127835236|NCT00967226|460015277|FG000|Overall Study|Physician Decision|0|||
127835237|NCT00967226|460015278|FG001|Overall Study|Physician Decision|1|||
127835238|NCT00605722|460015279|FG000|Overall Study|Adverse Event|6|||
127835239|NCT00605722|460015279|FG000|Overall Study|Insufficient therapeutic response|44|||
127835240|NCT00605722|460015279|FG000|Overall Study|Failure to return|1|||
127835241|NCT00487084|460015282|FG000|Overall Study|Did not receive intervention|4|||
127835242|NCT00487084|460015283|FG001|Overall Study|Did not receive intervention|3|||
127835243|NCT00487084|460015284|FG002|Overall Study|Did not receive intervention|5|||
127835244|NCT00254293|460015285|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
127835245|NCT00254293|460015286|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
127835246|NCT00254293|460015287|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
127835247|NCT00254293|460015288|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
127835248|NCT00254293|460015289|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
127835249|NCT00254293|460015290|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
127835250|NCT00254293|460015291|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
127835251|NCT00254293|460015285|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
127835252|NCT00254293|460015286|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
127835253|NCT00254293|460015287|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
127835254|NCT00254293|460015288|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
127835255|NCT00254293|460015289|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
127835256|NCT00254293|460015290|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
127835257|NCT00254293|460015291|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
127835258|NCT00254293|460015285|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
127835259|NCT00254293|460015286|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
127835260|NCT00254293|460015287|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
127835261|NCT00254293|460015288|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
127835262|NCT00254293|460015289|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
127835263|NCT00254293|460015290|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
127835264|NCT00254293|460015291|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
127835265|NCT00254293|460015285|FG000|LTE Open Label Variable SC Dosing|Death|0|||
127835266|NCT00254293|460015286|FG001|LTE Open Label Variable SC Dosing|Death|0|||
127835267|NCT00254293|460015287|FG002|LTE Open Label Variable SC Dosing|Death|1|||
127835268|NCT00254293|460015288|FG003|LTE Open Label Variable SC Dosing|Death|0|||
127835269|NCT00254293|460015289|FG004|LTE Open Label Variable SC Dosing|Death|0|||
127835270|NCT00254293|460015290|FG005|LTE Open Label Variable SC Dosing|Death|0|||
127835271|NCT00254293|460015291|FG006|LTE Open Label Variable SC Dosing|Death|0|||
127835272|NCT00254293|460015285|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
127835273|NCT00254293|460015286|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
127835274|NCT00254293|460015287|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
127835275|NCT00254293|460015288|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
127835276|NCT00254293|460015289|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
127835277|NCT00254293|460015290|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
127835278|NCT00254293|460015291|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
127835279|NCT00254293|460015285|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
127835280|NCT00254293|460015286|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
127835281|NCT00254293|460015287|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
127835282|NCT00254293|460015288|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
127835283|NCT00254293|460015289|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
127835284|NCT00254293|460015290|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
127835285|NCT00254293|460015291|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
127835286|NCT00254293|460015285|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
127835287|NCT00254293|460015286|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
127835288|NCT00254293|460015287|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
127835289|NCT00254293|460015288|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
127835290|NCT00254293|460015289|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
127835291|NCT00254293|460015290|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
127835292|NCT00254293|460015291|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
127835293|NCT00254293|460015285|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
127835294|NCT00254293|460015286|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
127835295|NCT00254293|460015287|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
127835296|NCT00254293|460015288|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
127835297|NCT00254293|460015289|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
127835298|NCT00254293|460015290|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
127835299|NCT00254293|460015291|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
127835300|NCT00254293|460015285|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
127835301|NCT00254293|460015286|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
127835302|NCT00254293|460015287|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
127835303|NCT00254293|460015288|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
127835304|NCT00254293|460015289|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
127835305|NCT00254293|460015290|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
127835306|NCT00254293|460015291|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
127835307|NCT00254293|460015285|FG000|LTE Open Label Variable SC Dosing|Other|0|||
127835308|NCT00254293|460015286|FG001|LTE Open Label Variable SC Dosing|Other|0|||
127835309|NCT00254293|460015287|FG002|LTE Open Label Variable SC Dosing|Other|2|||
127835310|NCT00254293|460015288|FG003|LTE Open Label Variable SC Dosing|Other|0|||
127835311|NCT00254293|460015289|FG004|LTE Open Label Variable SC Dosing|Other|0|||
127835312|NCT00254293|460015290|FG005|LTE Open Label Variable SC Dosing|Other|0|||
127835313|NCT00254293|460015291|FG006|LTE Open Label Variable SC Dosing|Other|0|||
127835314|NCT00254293|460015285|FG000|LTE Open Label Fixed Dosing|Death|0|||
127835315|NCT00254293|460015286|FG001|LTE Open Label Fixed Dosing|Death|0|||
127835316|NCT00254293|460015287|FG002|LTE Open Label Fixed Dosing|Death|0|||
127835317|NCT00254293|460015288|FG003|LTE Open Label Fixed Dosing|Death|0|||
127835318|NCT00254293|460015289|FG004|LTE Open Label Fixed Dosing|Death|0|||
127835319|NCT00254293|460015290|FG005|LTE Open Label Fixed Dosing|Death|0|||
127835320|NCT00254293|460015291|FG006|LTE Open Label Fixed Dosing|Death|3|||
127835321|NCT00254293|460015285|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
127835322|NCT00254293|460015286|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
127835323|NCT00254293|460015287|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
127835324|NCT00254293|460015288|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
127835325|NCT00254293|460015289|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
127835326|NCT00254293|460015290|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
127835327|NCT00254293|460015291|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
127835328|NCT00254293|460015285|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
127835329|NCT00254293|460015286|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
127835330|NCT00254293|460015287|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
127835331|NCT00254293|460015288|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
127835332|NCT00254293|460015289|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
127835333|NCT00254293|460015290|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
127835334|NCT00254293|460015291|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
127835335|NCT00254293|460015285|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
127835336|NCT00254293|460015286|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
127835337|NCT00254293|460015287|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
127835338|NCT00254293|460015288|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
127835339|NCT00254293|460015289|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
127835340|NCT00254293|460015290|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
127895984|NCT04700449|460242835|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
127835341|NCT00254293|460015291|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
127835342|NCT00254293|460015285|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
127835343|NCT00254293|460015286|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
127835344|NCT00254293|460015287|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
127835345|NCT00254293|460015288|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
127835346|NCT00254293|460015289|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
127835347|NCT00254293|460015290|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
127835348|NCT00254293|460015291|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
127835349|NCT00254293|460015285|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
127835350|NCT00254293|460015286|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
127835351|NCT00254293|460015287|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
127835352|NCT00254293|460015288|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
127835353|NCT00254293|460015289|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
127835354|NCT00254293|460015290|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
127835355|NCT00254293|460015291|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
127835356|NCT00254293|460015285|FG000|LTE Open Label Fixed Dosing|Other|0|||
127835357|NCT00254293|460015286|FG001|LTE Open Label Fixed Dosing|Other|0|||
127835358|NCT00254293|460015287|FG002|LTE Open Label Fixed Dosing|Other|0|||
127835359|NCT00254293|460015288|FG003|LTE Open Label Fixed Dosing|Other|0|||
127835360|NCT00254293|460015289|FG004|LTE Open Label Fixed Dosing|Other|0|||
127835361|NCT00254293|460015290|FG005|LTE Open Label Fixed Dosing|Other|0|||
127835362|NCT00254293|460015291|FG006|LTE Open Label Fixed Dosing|Other|1|||
127835363|NCT01626352|460015299|FG000|Overall Study|Disease Progression|3|||
127835364|NCT01626352|460015299|FG000|Overall Study|Intercurrent Illness|2|||
127835365|NCT01626352|460015299|FG000|Overall Study|Death|2|||
127835366|NCT01626352|460015299|FG000|Overall Study|Withdrawal by Subject|1|||
127835367|NCT01626352|460015299|FG000|Overall Study|Non-Compliance|1|||
127835368|NCT01626352|460015299|FG000|Overall Study|Never Treated|1|||
127835369|NCT02338492|460015304|FG000|Overall Study|Death|32|||
127835370|NCT02338492|460015304|FG000|Overall Study|Adverse Event|3|||
127835371|NCT02338492|460015304|FG000|Overall Study|Lost to Follow-up|4|||
127835372|NCT02338492|460015304|FG000|Overall Study|Reason not captured above|6|||
127835373|NCT00839423|460015307|FG000|Overall Study|Adverse Event|4|||
127835374|NCT00839423|460015308|FG001|Overall Study|Adverse Event|3|||
127835375|NCT00839423|460015309|FG002|Overall Study|Adverse Event|7|||
127835376|NCT00839423|460015310|FG003|Overall Study|Adverse Event|16|||
127835377|NCT00839423|460015307|FG000|Overall Study|Lack of Efficacy|6|||
127835378|NCT00839423|460015308|FG001|Overall Study|Lack of Efficacy|6|||
127835379|NCT00839423|460015309|FG002|Overall Study|Lack of Efficacy|3|||
127835380|NCT00839423|460015310|FG003|Overall Study|Lack of Efficacy|2|||
127835381|NCT00839423|460015307|FG000|Overall Study|Non-compliance|0|||
127835382|NCT00839423|460015308|FG001|Overall Study|Non-compliance|0|||
127835383|NCT00839423|460015309|FG002|Overall Study|Non-compliance|0|||
127835384|NCT00839423|460015310|FG003|Overall Study|Non-compliance|1|||
127835385|NCT00839423|460015307|FG000|Overall Study|Protocol Violation|0|||
127835386|NCT00839423|460015308|FG001|Overall Study|Protocol Violation|1|||
127835387|NCT00839423|460015309|FG002|Overall Study|Protocol Violation|2|||
127835388|NCT00839423|460015310|FG003|Overall Study|Protocol Violation|0|||
127835389|NCT00839423|460015307|FG000|Overall Study|Withdrawal of consent|4|||
127835390|NCT00839423|460015308|FG001|Overall Study|Withdrawal of consent|0|||
127835391|NCT00839423|460015309|FG002|Overall Study|Withdrawal of consent|4|||
127835392|NCT00839423|460015310|FG003|Overall Study|Withdrawal of consent|1|||
127835393|NCT00839423|460015307|FG000|Overall Study|Lost to Follow-up|1|||
127835394|NCT00839423|460015308|FG001|Overall Study|Lost to Follow-up|0|||
127835395|NCT00839423|460015309|FG002|Overall Study|Lost to Follow-up|1|||
127835396|NCT00839423|460015310|FG003|Overall Study|Lost to Follow-up|0|||
127835397|NCT00839423|460015307|FG000|Overall Study|Administrative or other reasons|3|||
127835398|NCT00839423|460015308|FG001|Overall Study|Administrative or other reasons|0|||
127835399|NCT00839423|460015309|FG002|Overall Study|Administrative or other reasons|1|||
127835400|NCT00839423|460015310|FG003|Overall Study|Administrative or other reasons|0|||
127835401|NCT04348656|460015311|FG000|Overall Study|Withdrawal by Subject|2|||
127835402|NCT04348656|460015312|FG001|Overall Study|Withdrawal by Subject|0|||
127835403|NCT04348656|460015311|FG000|Overall Study|Lost to Follow-up|11|||
127835404|NCT04348656|460015312|FG001|Overall Study|Lost to Follow-up|6|||
127835405|NCT00937560|460015316|FG000|Initial Treatment|Death|6|||
127835406|NCT00937560|460015316|FG000|Initial Treatment|Withdraw consent|3|||
127835407|NCT00937560|460015316|FG000|Initial Treatment|Adverse Event|1|||
127835408|NCT00937560|460015316|FG000|Initial Treatment|Lost to Follow-up|1|||
127835409|NCT00937560|460015316|FG000|Initial Treatment|No end of study page|10|||
127835410|NCT00937560|460015316|FG000|Maintenance Treatment|Death|12|||
127835411|NCT00937560|460015316|FG000|Maintenance Treatment|Withdraw consent|5|||
127835412|NCT00937560|460015316|FG000|Maintenance Treatment|According to protocol|1|||
127835413|NCT03421964|460015319|FG000|Overall Study|Lost to Follow-up|11|||
127835414|NCT03421964|460015320|FG001|Overall Study|Lost to Follow-up|21|||
127835415|NCT03421964|460015319|FG000|Overall Study|Withdrawal by Subject|9|||
127835416|NCT03421964|460015320|FG001|Overall Study|Withdrawal by Subject|3|||
127895985|NCT04700449|460242836|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
127835417|NCT03421964|460015319|FG000|Overall Study|Incarcerated|1|||
127835418|NCT03421964|460015320|FG001|Overall Study|Incarcerated|0|||
127835419|NCT03421964|460015319|FG000|Overall Study|Inpt Treatment Facility|1|||
127835420|NCT03421964|460015320|FG001|Overall Study|Inpt Treatment Facility|1|||
127835421|NCT03421964|460015319|FG000|Overall Study|Virtual Platform Issues|1|||
127835422|NCT03421964|460015320|FG001|Overall Study|Virtual Platform Issues|1|||
127835423|NCT00229203|460015321|FG000|Overall Study|Progressive disease|18|||
127835424|NCT00229203|460015322|FG001|Overall Study|Progressive disease|9|||
127835425|NCT00229203|460015321|FG000|Overall Study|Toxicity|6|||
127835426|NCT00229203|460015322|FG001|Overall Study|Toxicity|1|||
127835427|NCT00229203|460015321|FG000|Overall Study|Death|4|||
127835428|NCT00229203|460015322|FG001|Overall Study|Death|2|||
127835429|NCT00229203|460015321|FG000|Overall Study|Other|3|||
127835430|NCT00229203|460015322|FG001|Overall Study|Other|3|||
127835431|NCT00229203|460015321|FG000|Overall Study|Withdrawal by Subject|1|||
127835432|NCT00229203|460015322|FG001|Overall Study|Withdrawal by Subject|4|||
127895986|NCT04700449|460242837|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
127835433|NCT03607838|460015323|FG000|Overall Study|Lack of Efficacy|14|||
127835434|NCT03607838|460015324|FG001|Overall Study|Lack of Efficacy|20|||
127835435|NCT03607838|460015323|FG000|Overall Study|Withdrawal by Subject|13|||
127835436|NCT03607838|460015324|FG001|Overall Study|Withdrawal by Subject|8|||
127835437|NCT03607838|460015323|FG000|Overall Study|Lost to Follow-up|6|||
127835438|NCT03607838|460015324|FG001|Overall Study|Lost to Follow-up|11|||
127835439|NCT03607838|460015323|FG000|Overall Study|Adverse Event|2|||
127835440|NCT03607838|460015324|FG001|Overall Study|Adverse Event|2|||
127835441|NCT03607838|460015323|FG000|Overall Study|Physician Decision|2|||
127835442|NCT03607838|460015324|FG001|Overall Study|Physician Decision|0|||
127835443|NCT03607838|460015323|FG000|Overall Study|Failure to meet randomization criteria|1|||
127835444|NCT03607838|460015324|FG001|Overall Study|Failure to meet randomization criteria|2|||
127835445|NCT03607838|460015323|FG000|Overall Study|Pregnancy|1|||
127835446|NCT03607838|460015324|FG001|Overall Study|Pregnancy|0|||
127835447|NCT03607838|460015323|FG000|Overall Study|Protocol Violation|1|||
127835448|NCT03607838|460015324|FG001|Overall Study|Protocol Violation|0|||
127835449|NCT03607838|460015323|FG000|Overall Study|Due to work|1|||
127835450|NCT03607838|460015324|FG001|Overall Study|Due to work|0|||
127835451|NCT03607838|460015323|FG000|Overall Study|Litigation|0|||
127835452|NCT03607838|460015324|FG001|Overall Study|Litigation|1|||
127835453|NCT03607838|460015323|FG000|Overall Study|Temperature excursion for study drug|0|||
127835454|NCT03607838|460015324|FG001|Overall Study|Temperature excursion for study drug|1|||
127835455|NCT03607838|460015323|FG000|Overall Study|Change of mind|0|||
127835456|NCT03607838|460015324|FG001|Overall Study|Change of mind|1|||
127835457|NCT01576016|460015325|FG000|Lead Safety|Death|132|||
127835458|NCT01576016|460015326|FG001|Lead Safety|Death|0|||
127835459|NCT01576016|460015325|FG000|Lead Safety|Withdrawal by Subject|81|||
127835460|NCT01576016|460015326|FG001|Lead Safety|Withdrawal by Subject|0|||
127835461|NCT01576016|460015325|FG000|Lead Safety|System Explanted without Replacement|24|||
127835462|NCT01576016|460015326|FG001|Lead Safety|System Explanted without Replacement|0|||
127835463|NCT01576016|460015325|FG000|Lead Safety|Physician Decision|14|||
127835464|NCT01576016|460015326|FG001|Lead Safety|Physician Decision|0|||
127835465|NCT01576016|460015325|FG000|Lead Safety|Lost to Follow-up|13|||
127835466|NCT01576016|460015326|FG001|Lead Safety|Lost to Follow-up|0|||
127835467|NCT01576016|460015325|FG000|Lead Safety|Unsuccessful implant|2|||
127835468|NCT01576016|460015326|FG001|Lead Safety|Unsuccessful implant|0|||
127835469|NCT01576016|460015325|FG000|Lead Safety|Sponsor request|1|||
127835470|NCT01576016|460015326|FG001|Lead Safety|Sponsor request|0|||
127835471|NCT01576016|460015325|FG000|Lead Safety|Device replaced with CRT-D|1|||
127835472|NCT01576016|460015326|FG001|Lead Safety|Device replaced with CRT-D|0|||
127835473|NCT01576016|460015325|FG000|Lead Safety|Patient on Palliative Care|1|||
127835474|NCT01576016|460015326|FG001|Lead Safety|Patient on Palliative Care|0|||
127835475|NCT01576016|460015325|FG000|Lead Safety|Patient noncompliance|1|||
127835476|NCT01576016|460015326|FG001|Lead Safety|Patient noncompliance|0|||
127835477|NCT01576016|460015325|FG000|Lead Safety|Too far from study site|1|||
127835478|NCT01576016|460015326|FG001|Lead Safety|Too far from study site|0|||
127835479|NCT01576016|460015325|FG000|Lead Safety|System deactivated|1|||
127835480|NCT01576016|460015326|FG001|Lead Safety|System deactivated|0|||
127835481|NCT01576016|460015325|FG000|Lead Safety|Patient no longer followed by study PI|1|||
127835482|NCT01576016|460015326|FG001|Lead Safety|Patient no longer followed by study PI|0|||
127835483|NCT01576016|460015325|FG000|MRI Safety|Withdrawal by Subject|0|||
127835484|NCT01576016|460015326|FG001|MRI Safety|Withdrawal by Subject|10|||
127835485|NCT01576016|460015325|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
127835486|NCT01576016|460015326|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
127835487|NCT01576016|460015325|FG000|MRI Safety|Has not yet completed MRI scan|0|||
127835488|NCT01576016|460015326|FG001|MRI Safety|Has not yet completed MRI scan|56|||
127835489|NCT01576016|460015325|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
127895987|NCT04700449|460242834|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
127895988|NCT04700449|460242835|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
127895989|NCT04700449|460242836|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
127895990|NCT04700449|460242837|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
127895991|NCT04700449|460242834|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
127895992|NCT04700449|460242835|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
127895993|NCT04700449|460242836|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
127895994|NCT04700449|460242837|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
127895995|NCT04700449|460242834|FG000|Stage 2 Sub-study 1|Other|1|||
127835490|NCT01576016|460015326|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
127835491|NCT02546674|460015329|FG000|Overall Study|Adverse Event|19|||
127835492|NCT02546674|460015329|FG000|Overall Study|Death|1|||
127835493|NCT02546674|460015329|FG000|Overall Study|Lost to Follow-up|1|||
127835494|NCT02546674|460015329|FG000|Overall Study|Physician Decision|13|||
127835495|NCT02546674|460015329|FG000|Overall Study|Pregnancy|1|||
127835496|NCT02546674|460015329|FG000|Overall Study|Progressive Disease|2|||
127835497|NCT02546674|460015329|FG000|Overall Study|Protocol Deviation|2|||
127835498|NCT02546674|460015329|FG000|Overall Study|Subject/Guardian Decision|6|||
127835499|NCT02546674|460015329|FG000|Overall Study|Withdrawal of Informed Consent|3|||
127835500|NCT01163253|460015330|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
127835501|NCT01163253|460015331|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
127835502|NCT01163253|460015330|FG000|Overall Study|Study Terminated by Sponsor|978|||
127895996|NCT04700449|460242835|FG001|Stage 2 Sub-study 1|Other|2|||
127895997|NCT04700449|460242836|FG002|Stage 2 Sub-study 1|Other|0|||
127895998|NCT04700449|460242837|FG003|Stage 2 Sub-study 1|Other|0|||
127895999|NCT04700449|460242834|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
127896000|NCT04700449|460242835|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
127896001|NCT04700449|460242836|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
127896002|NCT04700449|460242837|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
127896003|NCT04700449|460242834|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
127896004|NCT04700449|460242835|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
127896005|NCT04700449|460242836|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
127896006|NCT04700449|460242837|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
127896007|NCT04700449|460242834|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
127896008|NCT04700449|460242835|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
127896009|NCT04700449|460242836|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
127896010|NCT04700449|460242837|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
127896011|NCT04700449|460242834|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
127896012|NCT04700449|460242835|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
127896013|NCT04700449|460242836|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
127896014|NCT04700449|460242837|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
127896015|NCT04700449|460242834|FG000|Stage 2 Sub-study 2|Other|0|||
127896016|NCT04700449|460242835|FG001|Stage 2 Sub-study 2|Other|0|||
127896017|NCT04700449|460242836|FG002|Stage 2 Sub-study 2|Other|0|||
127896018|NCT04700449|460242837|FG003|Stage 2 Sub-study 2|Other|5|||
127896019|NCT03738332|460242838|FG000|Overall Study|Withdrawal by Subject|1|||
127896020|NCT01521559|460242839|FG000|Overall Study|Adverse Event|0|||
127896021|NCT01521559|460242840|FG001|Overall Study|Adverse Event|4|||
127896022|NCT01521559|460242839|FG000|Overall Study|Death|1|||
127896023|NCT01521559|460242840|FG001|Overall Study|Death|0|||
127896024|NCT01521559|460242839|FG000|Overall Study|Withdrawal by Subject|9|||
127896025|NCT01521559|460242840|FG001|Overall Study|Withdrawal by Subject|11|||
127896026|NCT01521559|460242839|FG000|Overall Study|Lost to Follow-up|3|||
127896027|NCT01521559|460242840|FG001|Overall Study|Lost to Follow-up|1|||
127896028|NCT01521559|460242839|FG000|Overall Study|Protocol Violation|1|||
127896029|NCT01521559|460242840|FG001|Overall Study|Protocol Violation|0|||
127896030|NCT01521559|460242839|FG000|Overall Study|Other|1|||
127896031|NCT01521559|460242840|FG001|Overall Study|Other|2|||
127896032|NCT02228382|460242841|FG000|Overall Study|Death|5|||
127896033|NCT02228382|460242842|FG001|Overall Study|Death|7|||
127896034|NCT02228382|460242843|FG002|Overall Study|Death|5|||
127896035|NCT02228382|460242844|FG003|Overall Study|Death|0|||
127896036|NCT02228382|460242845|FG004|Overall Study|Death|2|||
127896037|NCT02228382|460242841|FG000|Overall Study|Participant refused further follow-up|0|||
127835503|NCT01163253|460015331|FG001|Overall Study|Study Terminated by Sponsor|349|||
127835504|NCT01163253|460015330|FG000|Overall Study|Protocol Violation|43|||
127835505|NCT01163253|460015331|FG001|Overall Study|Protocol Violation|12|||
127835506|NCT01163253|460015330|FG000|Overall Study|Withdrawal by Subject|199|||
127835507|NCT01163253|460015331|FG001|Overall Study|Withdrawal by Subject|50|||
127835508|NCT01163253|460015330|FG000|Overall Study|Medication Error|1|||
127835509|NCT01163253|460015331|FG001|Overall Study|Medication Error|0|||
127835510|NCT01163253|460015330|FG000|Overall Study|Lost to Follow-up|125|||
127835511|NCT01163253|460015331|FG001|Overall Study|Lost to Follow-up|23|||
127835512|NCT01163253|460015330|FG000|Overall Study|Insufficient Clinical Response|423|||
127835513|NCT01163253|460015331|FG001|Overall Study|Insufficient Clinical Response|29|||
127835514|NCT01163253|460015330|FG000|Overall Study|Adverse Event|300|||
127835515|NCT01163253|460015331|FG001|Overall Study|Adverse Event|78|||
127835516|NCT01163253|460015330|FG000|Overall Study|Death|17|||
127835517|NCT01163253|460015331|FG001|Overall Study|Death|5|||
127835518|NCT01163253|460015330|FG000|Overall Study|Ongoing|13|||
127835519|NCT01163253|460015331|FG001|Overall Study|Ongoing|4|||
127835520|NCT01163253|460015330|FG000|Overall Study|Other Unspecified|170|||
127835521|NCT01163253|460015331|FG001|Overall Study|Other Unspecified|34|||
127835522|NCT00423735|460015332|FG000|Overall Study|Ineligible / No protocol treatment|8|||
127835523|NCT00423735|460015333|FG001|Overall Study|Ineligible / No protocol treatment|6|||
127896038|NCT02228382|460242842|FG001|Overall Study|Participant refused further follow-up|0|||
127896039|NCT02228382|460242843|FG002|Overall Study|Participant refused further follow-up|1|||
127896040|NCT02228382|460242844|FG003|Overall Study|Participant refused further follow-up|0|||
127896041|NCT02228382|460242845|FG004|Overall Study|Participant refused further follow-up|0|||
127896042|NCT02228382|460242841|FG000|Overall Study|Study terminated by sponsor|3|||
127896043|NCT02228382|460242842|FG001|Overall Study|Study terminated by sponsor|5|||
127896044|NCT02228382|460242843|FG002|Overall Study|Study terminated by sponsor|7|||
127896045|NCT02228382|460242844|FG003|Overall Study|Study terminated by sponsor|0|||
127896046|NCT02228382|460242845|FG004|Overall Study|Study terminated by sponsor|0|||
127835524|NCT00423735|460015334|FG002|Overall Study|Ineligible / No protocol treatment|0|||
127896047|NCT02228382|460242841|FG000|Overall Study|Lost to Follow-up|0|||
127896048|NCT02228382|460242842|FG001|Overall Study|Lost to Follow-up|0|||
127835525|NCT02864940|460015335|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
127835526|NCT02864940|460015336|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
127835527|NCT00579501|460015341|FG000|Overall Study|Death|1|||
127835528|NCT00579501|460015341|FG000|Overall Study|End of neoadjuvant therapy|25|||
127835529|NCT00579501|460015341|FG000|Overall Study|toxicity|1|||
127835530|NCT00579501|460015341|FG000|Overall Study|Secondary lesion|1|||
127835531|NCT00579501|460015341|FG000|Overall Study|Radiation therapy before surgery|1|||
127835532|NCT03364673|460015342|FG000|Overall Study|Withdrawal by Subject|2|||
127835533|NCT03364673|460015342|FG000|Overall Study|Injury unrelated to study|3|||
127896049|NCT02228382|460242843|FG002|Overall Study|Lost to Follow-up|3|||
127896050|NCT02228382|460242844|FG003|Overall Study|Lost to Follow-up|1|||
127896051|NCT02228382|460242845|FG004|Overall Study|Lost to Follow-up|0|||
127896052|NCT02228382|460242841|FG000|Overall Study|Withdrawal by Subject|0|||
127896053|NCT02228382|460242842|FG001|Overall Study|Withdrawal by Subject|3|||
127896054|NCT02228382|460242843|FG002|Overall Study|Withdrawal by Subject|2|||
127896055|NCT02228382|460242844|FG003|Overall Study|Withdrawal by Subject|1|||
127896056|NCT02228382|460242845|FG004|Overall Study|Withdrawal by Subject|0|||
127896057|NCT02228382|460242841|FG000|Overall Study|Other|2|||
127896058|NCT02228382|460242842|FG001|Overall Study|Other|3|||
127896059|NCT02228382|460242843|FG002|Overall Study|Other|3|||
127896060|NCT02228382|460242844|FG003|Overall Study|Other|0|||
127896061|NCT02228382|460242845|FG004|Overall Study|Other|0|||
127896062|NCT02132247|460242847|FG000|Overall Study|Protocol Violation|1|||
127896063|NCT02132247|460242848|FG001|Overall Study|Protocol Violation|0|||
127896064|NCT00520741|460242849|FG000|Overall Study|Adverse Event|16|||
127896065|NCT00520741|460242850|FG001|Overall Study|Adverse Event|56|||
127896066|NCT00520741|460242849|FG000|Overall Study|Lack of Efficacy|11|||
127896067|NCT00520741|460242850|FG001|Overall Study|Lack of Efficacy|30|||
127896068|NCT00520741|460242849|FG000|Overall Study|Withdrawal by Subject|0|||
127896069|NCT00520741|460242850|FG001|Overall Study|Withdrawal by Subject|11|||
127896070|NCT00520741|460242849|FG000|Overall Study|Protocol Violation|2|||
127896071|NCT00520741|460242850|FG001|Overall Study|Protocol Violation|15|||
127896072|NCT00520741|460242849|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
127896073|NCT00520741|460242850|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
127896074|NCT00520741|460242849|FG000|Overall Study|Lost to Follow-up|4|||
127896075|NCT00520741|460242850|FG001|Overall Study|Lost to Follow-up|4|||
127896076|NCT00520741|460242849|FG000|Overall Study|Other reasons for premature termination|0|||
127896077|NCT00520741|460242850|FG001|Overall Study|Other reasons for premature termination|6|||
127896078|NCT02750761|460242851|FG000|Overall Study|Lost to Follow-up|0|||
127896079|NCT02750761|460242852|FG001|Overall Study|Lost to Follow-up|0|||
127896080|NCT02750761|460242853|FG002|Overall Study|Lost to Follow-up|1|||
127896081|NCT02750761|460242854|FG003|Overall Study|Lost to Follow-up|0|||
127896082|NCT02750761|460242855|FG004|Overall Study|Lost to Follow-up|0|||
127896083|NCT02750761|460242856|FG005|Overall Study|Lost to Follow-up|0|||
127896084|NCT02354586|460242859|FG000|Overall Study|Death|230|||
127896085|NCT02354586|460242859|FG000|Overall Study|Withdrawal by Subject|59|||
127896086|NCT02354586|460242859|FG000|Overall Study|Lost to Follow-up|11|||
127896087|NCT02354586|460242859|FG000|Overall Study|Sponsor decision|51|||
127896088|NCT02354586|460242859|FG000|Overall Study|Site closure|2|||
127896089|NCT02354586|460242859|FG000|Overall Study|Intercurrent illness|1|||
127896090|NCT02354586|460242859|FG000|Overall Study|Protocol Violation|3|||
127896091|NCT02354586|460242859|FG000|Overall Study|Physician Decision|13|||
127896092|NCT02354586|460242859|FG000|Overall Study|Lack of Efficacy|86|||
127896093|NCT02354586|460242859|FG000|Overall Study|Adverse Event|7|||
127896094|NCT00634907|460242862|FG000|Overall Study|Withdrawal by Subject|3|||
127896095|NCT00634907|460242863|FG001|Overall Study|Withdrawal by Subject|0|||
127896096|NCT00634907|460242862|FG000|Overall Study|Physician Decision|3|||
127896097|NCT00634907|460242863|FG001|Overall Study|Physician Decision|9|||
127896098|NCT00634907|460242862|FG000|Overall Study|Withdrawal by Subject|11|||
127896099|NCT00634907|460242863|FG001|Overall Study|Withdrawal by Subject|8|||
127896100|NCT01694485|460242865|FG000|Overall Study|Withdrawal by Subject|20|||
127896101|NCT01694485|460242866|FG001|Overall Study|Withdrawal by Subject|6|||
127896102|NCT01694485|460242867|FG002|Overall Study|Withdrawal by Subject|7|||
127896103|NCT01694485|460242868|FG003|Overall Study|Withdrawal by Subject|25|||
127896104|NCT01694485|460242869|FG004|Overall Study|Withdrawal by Subject|18|||
127896105|NCT01694485|460242865|FG000|Overall Study|Sponsor Decision|3|||
127896106|NCT01694485|460242866|FG001|Overall Study|Sponsor Decision|0|||
127835534|NCT03025217|460015343|FG000|Overall Study|Pregnancy|1|||
127896107|NCT01694485|460242867|FG002|Overall Study|Sponsor Decision|0|||
127896108|NCT01694485|460242868|FG003|Overall Study|Sponsor Decision|2|||
127896109|NCT01694485|460242869|FG004|Overall Study|Sponsor Decision|0|||
127896110|NCT01694485|460242865|FG000|Overall Study|Lost to Follow-up|9|||
127896111|NCT01694485|460242866|FG001|Overall Study|Lost to Follow-up|1|||
127835535|NCT03025217|460015343|FG000|Overall Study|Lost to Follow-up|1|||
127896112|NCT01694485|460242867|FG002|Overall Study|Lost to Follow-up|6|||
127896113|NCT01694485|460242868|FG003|Overall Study|Lost to Follow-up|10|||
127896114|NCT01694485|460242869|FG004|Overall Study|Lost to Follow-up|7|||
127896115|NCT01694485|460242865|FG000|Overall Study|Death|1|||
127896116|NCT01694485|460242866|FG001|Overall Study|Death|0|||
127896117|NCT01694485|460242867|FG002|Overall Study|Death|0|||
127896118|NCT01694485|460242868|FG003|Overall Study|Death|1|||
127896119|NCT01694485|460242869|FG004|Overall Study|Death|0|||
127835536|NCT03025217|460015343|FG000|Overall Study|Not eligible, poor English|2|||
127835537|NCT02208024|460015344|FG000|Overall Study|Withdrawal by Subject|1|||
127835538|NCT04096326|460015345|FG000|Overall Study|Withdrawal by Subject|0|||
127835539|NCT04096326|460015346|FG001|Overall Study|Withdrawal by Subject|0|||
127835540|NCT04096326|460015347|FG002|Overall Study|Withdrawal by Subject|0|||
127835541|NCT04096326|460015348|FG003|Overall Study|Withdrawal by Subject|0|||
127835542|NCT04096326|460015349|FG004|Overall Study|Withdrawal by Subject|0|||
127835543|NCT04096326|460015350|FG005|Overall Study|Withdrawal by Subject|0|||
127835544|NCT04096326|460015351|FG006|Overall Study|Withdrawal by Subject|1|||
127835545|NCT04096326|460015352|FG007|Overall Study|Withdrawal by Subject|0|||
127835546|NCT04096326|460015353|FG008|Overall Study|Withdrawal by Subject|0|||
127835547|NCT04096326|460015354|FG009|Overall Study|Withdrawal by Subject|0|||
127835548|NCT04096326|460015345|FG000|Overall Study|Lost to Follow-up|0|||
127896120|NCT01595009|460242870|FG000|Core|Patients completed per protocol|85|||
127896121|NCT01595009|460242871|FG001|Core|Patients completed per protocol|44|||
127835549|NCT04096326|460015346|FG001|Overall Study|Lost to Follow-up|1|||
127835550|NCT04096326|460015347|FG002|Overall Study|Lost to Follow-up|0|||
127896122|NCT01595009|460242872|FG002|Core|Patients completed per protocol|0|||
127896123|NCT01595009|460242873|FG003|Core|Patients completed per protocol|0|||
127896124|NCT01595009|460242870|FG000|Core|Adverse Event|19|||
127835551|NCT04096326|460015348|FG003|Overall Study|Lost to Follow-up|0|||
127835552|NCT04096326|460015349|FG004|Overall Study|Lost to Follow-up|0|||
127835553|NCT04096326|460015350|FG005|Overall Study|Lost to Follow-up|0|||
127896125|NCT01595009|460242871|FG001|Core|Adverse Event|23|||
127896126|NCT01595009|460242872|FG002|Core|Adverse Event|0|||
127896127|NCT01595009|460242873|FG003|Core|Adverse Event|0|||
127896128|NCT01595009|460242870|FG000|Core|Disease progression|14|||
127896129|NCT01595009|460242871|FG001|Core|Disease progression|26|||
127835554|NCT04096326|460015351|FG006|Overall Study|Lost to Follow-up|0|||
127835555|NCT04096326|460015352|FG007|Overall Study|Lost to Follow-up|0|||
127835556|NCT04096326|460015353|FG008|Overall Study|Lost to Follow-up|0|||
127835557|NCT04096326|460015354|FG009|Overall Study|Lost to Follow-up|0|||
127835558|NCT04096326|460015345|FG000|Overall Study|COVID-19-related reasons|0|||
127835559|NCT04096326|460015346|FG001|Overall Study|COVID-19-related reasons|0|||
127835560|NCT04096326|460015347|FG002|Overall Study|COVID-19-related reasons|0|||
127835561|NCT04096326|460015348|FG003|Overall Study|COVID-19-related reasons|0|||
127835562|NCT04096326|460015349|FG004|Overall Study|COVID-19-related reasons|1|||
127896130|NCT01595009|460242872|FG002|Core|Disease progression|0|||
127835563|NCT04096326|460015350|FG005|Overall Study|COVID-19-related reasons|5|||
127835564|NCT04096326|460015351|FG006|Overall Study|COVID-19-related reasons|0|||
127896131|NCT01595009|460242873|FG003|Core|Disease progression|0|||
127835565|NCT04096326|460015352|FG007|Overall Study|COVID-19-related reasons|0|||
127835566|NCT04096326|460015353|FG008|Overall Study|COVID-19-related reasons|0|||
127835567|NCT04096326|460015354|FG009|Overall Study|COVID-19-related reasons|0|||
127835568|NCT00194025|460015355|FG000|Overall Study|Adverse Event|1|||
127835569|NCT00194025|460015355|FG000|Overall Study|non-adherence with study medication|4|||
127835570|NCT04804033|460015359|FG000|Period 1: DBT Phase|Adverse Event|1|||
127835571|NCT04804033|460015360|FG001|Period 1: DBT Phase|Adverse Event|5|||
127835572|NCT04804033|460015361|FG002|Period 1: DBT Phase|Adverse Event|3|||
127835573|NCT04804033|460015362|FG003|Period 1: DBT Phase|Adverse Event|4|||
127835574|NCT04804033|460015359|FG000|Period 1: DBT Phase|Death|1|||
127835575|NCT04804033|460015360|FG001|Period 1: DBT Phase|Death|0|||
127835576|NCT04804033|460015361|FG002|Period 1: DBT Phase|Death|0|||
127835577|NCT04804033|460015362|FG003|Period 1: DBT Phase|Death|0|||
127835578|NCT04804033|460015359|FG000|Period 1: DBT Phase|Lost to Follow-up|3|||
127835579|NCT04804033|460015360|FG001|Period 1: DBT Phase|Lost to Follow-up|7|||
127835580|NCT04804033|460015361|FG002|Period 1: DBT Phase|Lost to Follow-up|1|||
127835581|NCT04804033|460015362|FG003|Period 1: DBT Phase|Lost to Follow-up|3|||
127835582|NCT04804033|460015359|FG000|Period 1: DBT Phase|Non-compliance|1|||
127835583|NCT04804033|460015360|FG001|Period 1: DBT Phase|Non-compliance|0|||
127835584|NCT04804033|460015361|FG002|Period 1: DBT Phase|Non-compliance|1|||
127835585|NCT04804033|460015362|FG003|Period 1: DBT Phase|Non-compliance|2|||
127835586|NCT04804033|460015359|FG000|Period 1: DBT Phase|Other|0|||
127835587|NCT04804033|460015360|FG001|Period 1: DBT Phase|Other|1|||
127835588|NCT04804033|460015361|FG002|Period 1: DBT Phase|Other|0|||
127835589|NCT04804033|460015362|FG003|Period 1: DBT Phase|Other|0|||
127835590|NCT04804033|460015359|FG000|Period 1: DBT Phase|Pregnancy|2|||
127835591|NCT04804033|460015360|FG001|Period 1: DBT Phase|Pregnancy|0|||
127835592|NCT04804033|460015361|FG002|Period 1: DBT Phase|Pregnancy|0|||
127835593|NCT04804033|460015362|FG003|Period 1: DBT Phase|Pregnancy|0|||
127835594|NCT04804033|460015359|FG000|Period 1: DBT Phase|Study terminated by sponsor|15|||
127835595|NCT04804033|460015360|FG001|Period 1: DBT Phase|Study terminated by sponsor|16|||
127835596|NCT04804033|460015361|FG002|Period 1: DBT Phase|Study terminated by sponsor|5|||
127835597|NCT04804033|460015362|FG003|Period 1: DBT Phase|Study terminated by sponsor|9|||
127835598|NCT04804033|460015359|FG000|Period 1: DBT Phase|Withdrawal by Subject|6|||
127835599|NCT04804033|460015360|FG001|Period 1: DBT Phase|Withdrawal by Subject|12|||
127835600|NCT04804033|460015361|FG002|Period 1: DBT Phase|Withdrawal by Subject|7|||
127835601|NCT04804033|460015362|FG003|Period 1: DBT Phase|Withdrawal by Subject|6|||
127835602|NCT04804033|460015359|FG000|Period 1: DBT Phase|Randomized but not treated|5|||
127835603|NCT04804033|460015360|FG001|Period 1: DBT Phase|Randomized but not treated|5|||
127835604|NCT04804033|460015361|FG002|Period 1: DBT Phase|Randomized but not treated|2|||
127835605|NCT04804033|460015362|FG003|Period 1: DBT Phase|Randomized but not treated|0|||
127835606|NCT04804033|460015359|FG000|Period 2: OLE Phase|Adverse Event|3|||
127835607|NCT04804033|460015360|FG001|Period 2: OLE Phase|Adverse Event|4|||
127835608|NCT04804033|460015361|FG002|Period 2: OLE Phase|Adverse Event|2|||
127835609|NCT04804033|460015362|FG003|Period 2: OLE Phase|Adverse Event|0|||
127835610|NCT04804033|460015359|FG000|Period 2: OLE Phase|Lost to Follow-up|8|||
127835611|NCT04804033|460015360|FG001|Period 2: OLE Phase|Lost to Follow-up|4|||
127835612|NCT04804033|460015361|FG002|Period 2: OLE Phase|Lost to Follow-up|3|||
127835613|NCT04804033|460015362|FG003|Period 2: OLE Phase|Lost to Follow-up|4|||
127835614|NCT04804033|460015359|FG000|Period 2: OLE Phase|Non-compliance|2|||
127835615|NCT04804033|460015360|FG001|Period 2: OLE Phase|Non-compliance|2|||
127835616|NCT04804033|460015361|FG002|Period 2: OLE Phase|Non-compliance|0|||
127835617|NCT04804033|460015362|FG003|Period 2: OLE Phase|Non-compliance|1|||
127835618|NCT04804033|460015359|FG000|Period 2: OLE Phase|Other|0|||
127835619|NCT04804033|460015360|FG001|Period 2: OLE Phase|Other|2|||
127835620|NCT04804033|460015361|FG002|Period 2: OLE Phase|Other|0|||
127835621|NCT04804033|460015362|FG003|Period 2: OLE Phase|Other|0|||
127835622|NCT04804033|460015359|FG000|Period 2: OLE Phase|Physician Decision|1|||
127835623|NCT04804033|460015360|FG001|Period 2: OLE Phase|Physician Decision|1|||
127835624|NCT04804033|460015361|FG002|Period 2: OLE Phase|Physician Decision|0|||
127835625|NCT04804033|460015362|FG003|Period 2: OLE Phase|Physician Decision|0|||
127835626|NCT04804033|460015359|FG000|Period 2: OLE Phase|Pregnancy|0|||
127835627|NCT04804033|460015360|FG001|Period 2: OLE Phase|Pregnancy|0|||
127835628|NCT04804033|460015361|FG002|Period 2: OLE Phase|Pregnancy|2|||
127835629|NCT04804033|460015362|FG003|Period 2: OLE Phase|Pregnancy|0|||
127835630|NCT04804033|460015359|FG000|Period 2: OLE Phase|Study terminated by sponsor|41|||
127835631|NCT04804033|460015360|FG001|Period 2: OLE Phase|Study terminated by sponsor|37|||
127835632|NCT04804033|460015361|FG002|Period 2: OLE Phase|Study terminated by sponsor|17|||
127835633|NCT04804033|460015362|FG003|Period 2: OLE Phase|Study terminated by sponsor|19|||
127835634|NCT04804033|460015359|FG000|Period 2: OLE Phase|Withdrawal by Subject|16|||
127835635|NCT04804033|460015360|FG001|Period 2: OLE Phase|Withdrawal by Subject|8|||
127835636|NCT04804033|460015361|FG002|Period 2: OLE Phase|Withdrawal by Subject|3|||
127835637|NCT04804033|460015362|FG003|Period 2: OLE Phase|Withdrawal by Subject|7|||
127835638|NCT04804033|460015359|FG000|Period 2: OLE Phase|Not reported|0|||
127835639|NCT04804033|460015360|FG001|Period 2: OLE Phase|Not reported|2|||
127835640|NCT04804033|460015361|FG002|Period 2: OLE Phase|Not reported|0|||
127835641|NCT04804033|460015362|FG003|Period 2: OLE Phase|Not reported|0|||
127835642|NCT04804033|460015359|FG000|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
127835643|NCT04804033|460015360|FG001|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
127835644|NCT04804033|460015361|FG002|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
127835645|NCT04804033|460015362|FG003|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
127835646|NCT04804033|460015359|FG000|Period 3: Follow-up Phase|Lost to Follow-up|5|||
127835647|NCT04804033|460015360|FG001|Period 3: Follow-up Phase|Lost to Follow-up|9|||
127835648|NCT04804033|460015361|FG002|Period 3: Follow-up Phase|Lost to Follow-up|0|||
127835649|NCT04804033|460015362|FG003|Period 3: Follow-up Phase|Lost to Follow-up|1|||
127835650|NCT04804033|460015359|FG000|Period 3: Follow-up Phase|Other|0|||
127835651|NCT04804033|460015360|FG001|Period 3: Follow-up Phase|Other|1|||
127835652|NCT04804033|460015361|FG002|Period 3: Follow-up Phase|Other|2|||
127835653|NCT04804033|460015362|FG003|Period 3: Follow-up Phase|Other|1|||
127835654|NCT04804033|460015359|FG000|Period 3: Follow-up Phase|Withdrawal by Subject|7|||
127835655|NCT04804033|460015360|FG001|Period 3: Follow-up Phase|Withdrawal by Subject|6|||
127835656|NCT04804033|460015361|FG002|Period 3: Follow-up Phase|Withdrawal by Subject|3|||
127835657|NCT04804033|460015362|FG003|Period 3: Follow-up Phase|Withdrawal by Subject|4|||
127835658|NCT04804033|460015359|FG000|Period 3: Follow-up Phase|Not reported|18|||
127835659|NCT04804033|460015360|FG001|Period 3: Follow-up Phase|Not reported|15|||
127835660|NCT04804033|460015361|FG002|Period 3: Follow-up Phase|Not reported|1|||
127896132|NCT01595009|460242870|FG000|Core|Withdrawal by Subject|4|||
127896133|NCT01595009|460242871|FG001|Core|Withdrawal by Subject|17|||
127896134|NCT01595009|460242872|FG002|Core|Withdrawal by Subject|0|||
127896135|NCT01595009|460242873|FG003|Core|Withdrawal by Subject|0|||
127896136|NCT01595009|460242870|FG000|Core|Death|3|||
127896137|NCT01595009|460242871|FG001|Core|Death|6|||
127896138|NCT01595009|460242872|FG002|Core|Death|0|||
127896139|NCT01595009|460242873|FG003|Core|Death|0|||
127896140|NCT01595009|460242870|FG000|Core|Lost to Follow-up|1|||
127896141|NCT01595009|460242871|FG001|Core|Lost to Follow-up|2|||
127896142|NCT01595009|460242872|FG002|Core|Lost to Follow-up|0|||
127896143|NCT01595009|460242873|FG003|Core|Lost to Follow-up|0|||
127835661|NCT04804033|460015362|FG003|Period 3: Follow-up Phase|Not reported|4|||
127835662|NCT00209170|460015363|FG000|Overall Study|Adverse Event|0|||
127835663|NCT00209170|460015364|FG001|Overall Study|Adverse Event|1|||
127835664|NCT00209170|460015363|FG000|Overall Study|Withdrawal by Subject|2|||
127835665|NCT00209170|460015364|FG001|Overall Study|Withdrawal by Subject|1|||
127835666|NCT00209170|460015363|FG000|Overall Study|Lack of Efficacy|0|||
127835667|NCT00209170|460015364|FG001|Overall Study|Lack of Efficacy|1|||
127835668|NCT00543569|460015365|FG000|Overall Study|Death|2|||
127835669|NCT00543569|460015366|FG001|Overall Study|Death|2|||
127835670|NCT00543569|460015367|FG002|Overall Study|Death|3|||
127835671|NCT00543569|460015368|FG003|Overall Study|Death|1|||
127835672|NCT00543569|460015365|FG000|Overall Study|Lost to Follow-up|0|||
127835673|NCT00543569|460015366|FG001|Overall Study|Lost to Follow-up|0|||
127835674|NCT00543569|460015367|FG002|Overall Study|Lost to Follow-up|1|||
127835675|NCT00543569|460015368|FG003|Overall Study|Lost to Follow-up|1|||
127835676|NCT00543569|460015365|FG000|Overall Study|Miscellaneous Reasons|7|||
127896144|NCT01595009|460242870|FG000|Core|Protocol deviation|0|||
127896145|NCT01595009|460242871|FG001|Core|Protocol deviation|1|||
127896146|NCT01595009|460242872|FG002|Core|Protocol deviation|0|||
127896147|NCT01595009|460242873|FG003|Core|Protocol deviation|0|||
127896148|NCT01595009|460242870|FG000|Core|Administrative problems|0|||
127896149|NCT01595009|460242871|FG001|Core|Administrative problems|1|||
127835677|NCT00543569|460015366|FG001|Overall Study|Miscellaneous Reasons|3|||
127835678|NCT00543569|460015367|FG002|Overall Study|Miscellaneous Reasons|11|||
127835679|NCT00543569|460015368|FG003|Overall Study|Miscellaneous Reasons|4|||
127835680|NCT00543569|460015365|FG000|Overall Study|Randomized but never received study drug|3|||
127835681|NCT00543569|460015366|FG001|Overall Study|Randomized but never received study drug|3|||
127835682|NCT00543569|460015367|FG002|Overall Study|Randomized but never received study drug|5|||
127835683|NCT00543569|460015368|FG003|Overall Study|Randomized but never received study drug|3|||
127835684|NCT02124707|460015369|FG000|Overall Study|Adverse Event|5|||
127835685|NCT02124707|460015369|FG000|Overall Study|Physician Decision|1|||
127835686|NCT02124707|460015369|FG000|Overall Study|Death|1|||
127835687|NCT00089479|460015378|FG000|Overall Study|Death|108|||
127835688|NCT00089479|460015379|FG001|Overall Study|Death|75|||
127835689|NCT00089479|460015378|FG000|Overall Study|Withdrawal by Subject|86|||
127835690|NCT00089479|460015379|FG001|Overall Study|Withdrawal by Subject|107|||
127835691|NCT00089479|460015378|FG000|Overall Study|Lost to Follow-up|137|||
127835692|NCT00089479|460015379|FG001|Overall Study|Lost to Follow-up|107|||
127835693|NCT01124448|460015382|FG000|Overall Study|Lost to Follow-up|0|||
127835694|NCT01124448|460015383|FG001|Overall Study|Lost to Follow-up|3|||
127835695|NCT01124448|460015382|FG000|Overall Study|Protocol Violation|2|||
127835696|NCT01124448|460015383|FG001|Overall Study|Protocol Violation|0|||
127835697|NCT03198754|460015385|FG000|Overall Study|Withdrawal by Subject|5|||
127835698|NCT03198754|460015386|FG001|Overall Study|Withdrawal by Subject|4|||
127835699|NCT03198754|460015385|FG000|Overall Study|Lost to Follow-up|4|||
127835700|NCT03198754|460015386|FG001|Overall Study|Lost to Follow-up|3|||
127835701|NCT03198754|460015385|FG000|Overall Study|Ineligible|2|||
127835702|NCT03198754|460015386|FG001|Overall Study|Ineligible|1|||
127835703|NCT00305253|460015391|FG000|Overall Study|Withdrawal by Subject|0|||
127835704|NCT00305253|460015392|FG001|Overall Study|Withdrawal by Subject|1|||
127835705|NCT05373706|460015396|FG000|Overall Study|Lost to Follow-up|2|||
127896150|NCT01595009|460242872|FG002|Core|Administrative problems|0|||
127896151|NCT01595009|460242873|FG003|Core|Administrative problems|0|||
127896152|NCT01595009|460242870|FG000|Extension|Administrative problems|0|||
127896153|NCT01595009|460242871|FG001|Extension|Administrative problems|0|||
127896154|NCT01595009|460242872|FG002|Extension|Administrative problems|0|||
127896155|NCT01595009|460242873|FG003|Extension|Administrative problems|1|||
127896156|NCT01595009|460242870|FG000|Extension|Patients completed per protocol|0|||
127896157|NCT01595009|460242871|FG001|Extension|Patients completed per protocol|0|||
127896158|NCT01595009|460242872|FG002|Extension|Patients completed per protocol|0|||
127896159|NCT01595009|460242873|FG003|Extension|Patients completed per protocol|2|||
127896160|NCT01595009|460242870|FG000|Extension|Disease progression|0|||
127896161|NCT01595009|460242871|FG001|Extension|Disease progression|0|||
127896162|NCT01595009|460242872|FG002|Extension|Disease progression|4|||
127896163|NCT01595009|460242873|FG003|Extension|Disease progression|7|||
127896164|NCT01595009|460242870|FG000|Extension|Adverse Event|0|||
127896165|NCT01595009|460242871|FG001|Extension|Adverse Event|0|||
127896166|NCT01595009|460242872|FG002|Extension|Adverse Event|0|||
127896167|NCT01595009|460242873|FG003|Extension|Adverse Event|1|||
127896168|NCT04956666|460242874|FG000|Overall Study|Adverse Event|18|||
127896169|NCT04956666|460242874|FG000|Overall Study|Physician Decision|5|||
127896170|NCT00662025|460242879|FG000|Overall Study|Objective progression or relapse|51|||
127896171|NCT00662025|460242879|FG000|Overall Study|Adverse Event|7|||
127896172|NCT00662025|460242879|FG000|Overall Study|Withdrawal by Subject|1|||
127896173|NCT00662025|460242879|FG000|Overall Study|Results of other clinical study|2|||
127896174|NCT00662025|460242879|FG000|Overall Study|Target lesion cannot be evaluated|1|||
127896175|NCT00662025|460242879|FG000|Overall Study|Domestic circumstances|1|||
127896176|NCT00626925|460242888|FG000|Overall Study|Lost to Follow-up|1|||
127896177|NCT00626925|460242889|FG001|Overall Study|Lost to Follow-up|2|||
127896178|NCT00626925|460242888|FG000|Overall Study|relapse|1|||
127896179|NCT00626925|460242889|FG001|Overall Study|relapse|0|||
127896180|NCT00626925|460242888|FG000|Overall Study|Adverse effect|6|||
127896181|NCT00626925|460242889|FG001|Overall Study|Adverse effect|2|||
127896182|NCT00626925|460242888|FG000|Overall Study|Lack of Efficacy|1|||
127896183|NCT00626925|460242889|FG001|Overall Study|Lack of Efficacy|4|||
127896184|NCT00626925|460242888|FG000|Overall Study|Time constraints|3|||
127896185|NCT00626925|460242889|FG001|Overall Study|Time constraints|1|||
127896186|NCT01215942|460242895|FG000|Treatment Period|Adverse Event|15|||
127896187|NCT01215942|460242896|FG001|Treatment Period|Adverse Event|26|||
127896188|NCT01215942|460242895|FG000|Treatment Period|Death|2|||
127896189|NCT01215942|460242896|FG001|Treatment Period|Death|4|||
127835706|NCT05373706|460015397|FG001|Overall Study|Lost to Follow-up|2|||
127835707|NCT01479374|460015402|FG000|Overall Study|Adverse Event|2|||
127835708|NCT01479374|460015403|FG001|Overall Study|Adverse Event|1|||
127835709|NCT01479374|460015404|FG002|Overall Study|Adverse Event|0|||
127835710|NCT01479374|460015402|FG000|Overall Study|Lost to Follow-up|1|||
127835711|NCT01479374|460015403|FG001|Overall Study|Lost to Follow-up|2|||
127835712|NCT01479374|460015404|FG002|Overall Study|Lost to Follow-up|0|||
127835713|NCT01479374|460015402|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
127835714|NCT01479374|460015403|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
127835715|NCT01479374|460015404|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
127835716|NCT01479374|460015402|FG000|Overall Study|Other|0|||
127835717|NCT01479374|460015403|FG001|Overall Study|Other|4|||
127835718|NCT01479374|460015404|FG002|Overall Study|Other|5|||
127835719|NCT05086289|460015405|FG000|Overall Study|Adverse Event|4|||
127835720|NCT05086289|460015406|FG001|Overall Study|Adverse Event|2|||
127835721|NCT05086289|460015405|FG000|Overall Study|Lost to Follow-up|2|||
127835722|NCT05086289|460015406|FG001|Overall Study|Lost to Follow-up|0|||
127835723|NCT05086289|460015405|FG000|Overall Study|Non-compliance with study drug|2|||
127835724|NCT05086289|460015406|FG001|Overall Study|Non-compliance with study drug|1|||
127835725|NCT05086289|460015405|FG000|Overall Study|Physician Decision|2|||
127835726|NCT05086289|460015406|FG001|Overall Study|Physician Decision|0|||
127835727|NCT05086289|460015405|FG000|Overall Study|Withdrawal by Subject|5|||
127835728|NCT05086289|460015406|FG001|Overall Study|Withdrawal by Subject|2|||
127835729|NCT03599141|460015412|FG000|Overall Study|Lost to Follow-up|3|||
127835730|NCT03599141|460015413|FG001|Overall Study|Lost to Follow-up|1|||
127835731|NCT00807846|460015414|FG000|Overall Study|Adverse Event|5|||
127835732|NCT00807846|460015415|FG001|Overall Study|Adverse Event|0|||
127835733|NCT00807846|460015414|FG000|Overall Study|Lack of Efficacy|2|||
127835734|NCT00807846|460015415|FG001|Overall Study|Lack of Efficacy|0|||
127835735|NCT00807846|460015414|FG000|Overall Study|Protocol Violation|2|||
127896190|NCT01215942|460242895|FG000|Treatment Period|Lack of Efficacy|23|||
127896191|NCT01215942|460242896|FG001|Treatment Period|Lack of Efficacy|62|||
127896192|NCT01215942|460242895|FG000|Treatment Period|Lost to Follow-up|3|||
127896193|NCT01215942|460242896|FG001|Treatment Period|Lost to Follow-up|4|||
127835736|NCT00807846|460015415|FG001|Overall Study|Protocol Violation|1|||
127835737|NCT00807846|460015414|FG000|Overall Study|Withdrawal by Subject|2|||
127896194|NCT01215942|460242895|FG000|Treatment Period|Withdrawal by Subject|17|||
127896195|NCT01215942|460242896|FG001|Treatment Period|Withdrawal by Subject|40|||
127896196|NCT01215942|460242895|FG000|Treatment Period|Physician Decision|5|||
127896197|NCT01215942|460242896|FG001|Treatment Period|Physician Decision|5|||
127835738|NCT00807846|460015415|FG001|Overall Study|Withdrawal by Subject|1|||
127835739|NCT00807846|460015414|FG000|Overall Study|Other|1|||
127835740|NCT00807846|460015415|FG001|Overall Study|Other|2|||
127835741|NCT01081873|460015416|FG000|Overall Study|Death|86|||
127835742|NCT01081873|460015416|FG000|Overall Study|Withdrawal by Subject|10|||
127835743|NCT01081873|460015416|FG000|Overall Study|Lost to Follow-up|142|||
127835744|NCT01081873|460015416|FG000|Overall Study|Progression of prostate cancer|13|||
127835745|NCT01081873|460015416|FG000|Overall Study|Other|47|||
127835746|NCT03011840|460015417|FG000|Overall Study|Not received PIL in post PIL phase|0|||
127835747|NCT03011840|460015418|FG001|Overall Study|Not received PIL in post PIL phase|21|||
127835748|NCT02491073|460015419|FG000|Overall Study|screen failure|1|||
127835749|NCT02491073|460015420|FG001|Overall Study|screen failure|0|||
127835750|NCT01165021|460015421|FG000|Overall Study|Death|1|||
127835751|NCT01419665|460015422|FG000|Combination Treatment|Adverse Event|7|||
127835752|NCT01419665|460015423|FG001|Combination Treatment|Adverse Event|10|||
127835753|NCT01419665|460015422|FG000|Combination Treatment|Physician Decision|5|||
127835754|NCT01419665|460015423|FG001|Combination Treatment|Physician Decision|8|||
127835755|NCT01419665|460015422|FG000|Combination Treatment|Protocol Violation|6|||
127835756|NCT01419665|460015423|FG001|Combination Treatment|Protocol Violation|2|||
127835757|NCT01419665|460015422|FG000|Combination Treatment|disease progression|10|||
127835758|NCT01419665|460015423|FG001|Combination Treatment|disease progression|9|||
127835759|NCT01419665|460015422|FG000|Combination Treatment|Death|5|||
127835760|NCT01419665|460015423|FG001|Combination Treatment|Death|7|||
127835761|NCT01419665|460015422|FG000|Combination Treatment|administrative problems|0|||
127835762|NCT01419665|460015423|FG001|Combination Treatment|administrative problems|1|||
127835763|NCT01419665|460015422|FG000|Combination Treatment|Withdrawal by Subject|5|||
127835764|NCT01419665|460015423|FG001|Combination Treatment|Withdrawal by Subject|4|||
127835765|NCT01419665|460015422|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
127835766|NCT01419665|460015423|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
127835767|NCT01419665|460015422|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
127835768|NCT01419665|460015423|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
127835769|NCT01419665|460015422|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
127835770|NCT01419665|460015423|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
127835771|NCT01419665|460015422|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
127835772|NCT01419665|460015423|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
127835773|NCT01419665|460015422|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
127835774|NCT01419665|460015423|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
127835775|NCT01419665|460015422|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
127835776|NCT01419665|460015423|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
127835777|NCT01419665|460015422|FG000|Maintenance Treatment and/or Follow up|Death|1|||
127835778|NCT01419665|460015423|FG001|Maintenance Treatment and/or Follow up|Death|2|||
127835779|NCT01419665|460015422|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
127835780|NCT01419665|460015423|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
127835781|NCT01419665|460015422|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
127835782|NCT01419665|460015423|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
127835783|NCT01419665|460015422|FG000|Open Label Phase|Death|1|||
127835784|NCT01419665|460015423|FG001|Open Label Phase|Death|0|||
127835785|NCT01419665|460015422|FG000|Open Label Phase|disease progression|0|||
127835786|NCT01419665|460015423|FG001|Open Label Phase|disease progression|1|||
127835787|NCT01877382|460015427|FG000|Dose Escalation|Progressive disease|2|||
127835788|NCT01877382|460015428|FG001|Dose Escalation|Progressive disease|0|||
127835789|NCT01877382|460015429|FG002|Dose Escalation|Progressive disease|1|||
127896198|NCT01215942|460242895|FG000|Treatment Period|Protocol Violation|0|||
127896199|NCT01215942|460242896|FG001|Treatment Period|Protocol Violation|1|||
127896200|NCT01215942|460242895|FG000|Treatment Period|Sponsor Decision|349|||
127896201|NCT01215942|460242896|FG001|Treatment Period|Sponsor Decision|530|||
127896202|NCT01215942|460242895|FG000|Post-Treatment Follow-Up Period|Death|0|||
127896203|NCT01215942|460242896|FG001|Post-Treatment Follow-Up Period|Death|1|||
127896204|NCT01215942|460242895|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
127896205|NCT01215942|460242896|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
127896206|NCT01215942|460242895|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
127896207|NCT01215942|460242896|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
127896208|NCT01215942|460242895|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
127896209|NCT01215942|460242896|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
127896210|NCT01215942|460242895|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
127896211|NCT01215942|460242896|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
127896212|NCT01966042|460242897|FG000|Overall Study|Death|2|||
127896213|NCT03522948|460242898|FG000|Overall Study|Lost to Follow-up|1|||
127896214|NCT03305055|460242899|FG000|Overall Study|Withdrawal by Subject|0|||
127896215|NCT03305055|460242900|FG001|Overall Study|Withdrawal by Subject|1|||
127896216|NCT03305055|460242899|FG000|Overall Study|Adverse Event|1|||
127896217|NCT03305055|460242900|FG001|Overall Study|Adverse Event|1|||
127896218|NCT01802879|460242901|FG000|Overall Study|Administrative problems|2|||
127896219|NCT01802879|460242901|FG000|Overall Study|Disease progression|6|||
127835790|NCT01877382|460015430|FG003|Dose Escalation|Progressive disease|6|||
127835791|NCT01877382|460015431|FG004|Dose Escalation|Progressive disease|1|||
127835792|NCT01877382|460015432|FG005|Dose Escalation|Progressive disease|0|||
127835793|NCT01877382|460015433|FG006|Dose Escalation|Progressive disease|3|||
127835794|NCT01877382|460015434|FG007|Dose Escalation|Progressive disease|10|||
127835795|NCT01877382|460015435|FG008|Dose Escalation|Progressive disease|4|||
127835796|NCT01877382|460015436|FG009|Dose Escalation|Progressive disease|2|||
127835797|NCT01877382|460015437|FG010|Dose Escalation|Progressive disease|3|||
127835798|NCT01877382|460015438|FG011|Dose Escalation|Progressive disease|3|||
127835799|NCT01877382|460015439|FG012|Dose Escalation|Progressive disease|13|||
127835800|NCT01877382|460015440|FG013|Dose Escalation|Progressive disease|1|||
127835801|NCT01877382|460015441|FG014|Dose Escalation|Progressive disease|0|||
127835802|NCT01877382|460015427|FG000|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
127835803|NCT01877382|460015428|FG001|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
127835804|NCT01877382|460015429|FG002|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
127835805|NCT01877382|460015430|FG003|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
127835806|NCT01877382|460015431|FG004|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
127835807|NCT01877382|460015432|FG005|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
127835808|NCT01877382|460015433|FG006|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
127835809|NCT01877382|460015434|FG007|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
127835810|NCT01877382|460015435|FG008|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
127835811|NCT01877382|460015436|FG009|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
127835812|NCT01877382|460015437|FG010|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
127835813|NCT01877382|460015438|FG011|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
127835814|NCT01877382|460015439|FG012|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
127835815|NCT01877382|460015440|FG013|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
127835816|NCT01877382|460015441|FG014|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
127835817|NCT01877382|460015427|FG000|Dose Escalation|Clinical progression|0|||
127835818|NCT01877382|460015428|FG001|Dose Escalation|Clinical progression|1|||
127835819|NCT01877382|460015429|FG002|Dose Escalation|Clinical progression|0|||
127835820|NCT01877382|460015430|FG003|Dose Escalation|Clinical progression|2|||
127835821|NCT01877382|460015431|FG004|Dose Escalation|Clinical progression|0|||
127835822|NCT01877382|460015432|FG005|Dose Escalation|Clinical progression|0|||
127835823|NCT01877382|460015433|FG006|Dose Escalation|Clinical progression|1|||
127835824|NCT01877382|460015434|FG007|Dose Escalation|Clinical progression|0|||
127835825|NCT01877382|460015435|FG008|Dose Escalation|Clinical progression|0|||
127835826|NCT01877382|460015436|FG009|Dose Escalation|Clinical progression|1|||
127835827|NCT01877382|460015437|FG010|Dose Escalation|Clinical progression|0|||
127835828|NCT01877382|460015438|FG011|Dose Escalation|Clinical progression|0|||
127835829|NCT01877382|460015439|FG012|Dose Escalation|Clinical progression|2|||
127835830|NCT01877382|460015440|FG013|Dose Escalation|Clinical progression|1|||
127835831|NCT01877382|460015441|FG014|Dose Escalation|Clinical progression|0|||
127835832|NCT01877382|460015427|FG000|Dose Escalation|Adverse Event|0|||
127835833|NCT01877382|460015428|FG001|Dose Escalation|Adverse Event|0|||
127835834|NCT01877382|460015429|FG002|Dose Escalation|Adverse Event|0|||
127835835|NCT01877382|460015430|FG003|Dose Escalation|Adverse Event|4|||
127835836|NCT01877382|460015431|FG004|Dose Escalation|Adverse Event|1|||
127896220|NCT01047345|460242906|FG000|Base Study|Adverse Event|3|||
127896221|NCT01047345|460242907|FG001|Base Study|Adverse Event|0|||
127896222|NCT01047345|460242908|FG002|Base Study|Adverse Event|0|||
127896223|NCT01047345|460242906|FG000|Base Study|Lost to Follow-up|4|||
127835837|NCT01877382|460015432|FG005|Dose Escalation|Adverse Event|2|||
127835838|NCT01877382|460015433|FG006|Dose Escalation|Adverse Event|1|||
127835839|NCT01877382|460015434|FG007|Dose Escalation|Adverse Event|2|||
127835840|NCT01877382|460015435|FG008|Dose Escalation|Adverse Event|0|||
127835841|NCT01877382|460015436|FG009|Dose Escalation|Adverse Event|0|||
127835842|NCT01877382|460015437|FG010|Dose Escalation|Adverse Event|0|||
127835843|NCT01877382|460015438|FG011|Dose Escalation|Adverse Event|0|||
127835844|NCT01877382|460015439|FG012|Dose Escalation|Adverse Event|1|||
127835845|NCT01877382|460015440|FG013|Dose Escalation|Adverse Event|0|||
127835846|NCT01877382|460015441|FG014|Dose Escalation|Adverse Event|0|||
127835847|NCT01877382|460015427|FG000|Dose Escalation|Withdrawal by Subject|0|||
127835848|NCT01877382|460015428|FG001|Dose Escalation|Withdrawal by Subject|0|||
127835849|NCT01877382|460015429|FG002|Dose Escalation|Withdrawal by Subject|0|||
127835850|NCT01877382|460015430|FG003|Dose Escalation|Withdrawal by Subject|0|||
127835851|NCT01877382|460015431|FG004|Dose Escalation|Withdrawal by Subject|0|||
127835852|NCT01877382|460015432|FG005|Dose Escalation|Withdrawal by Subject|3|||
127835853|NCT01877382|460015433|FG006|Dose Escalation|Withdrawal by Subject|2|||
127835854|NCT01877382|460015434|FG007|Dose Escalation|Withdrawal by Subject|1|||
127835855|NCT01877382|460015435|FG008|Dose Escalation|Withdrawal by Subject|1|||
127835856|NCT01877382|460015436|FG009|Dose Escalation|Withdrawal by Subject|0|||
127835857|NCT01877382|460015437|FG010|Dose Escalation|Withdrawal by Subject|0|||
127835858|NCT01877382|460015438|FG011|Dose Escalation|Withdrawal by Subject|0|||
127835859|NCT01877382|460015439|FG012|Dose Escalation|Withdrawal by Subject|0|||
127835860|NCT01877382|460015440|FG013|Dose Escalation|Withdrawal by Subject|0|||
127835861|NCT01877382|460015441|FG014|Dose Escalation|Withdrawal by Subject|0|||
127835862|NCT01877382|460015427|FG000|Dose Escalation|Protocol Violation|0|||
127835863|NCT01877382|460015428|FG001|Dose Escalation|Protocol Violation|0|||
127835864|NCT01877382|460015429|FG002|Dose Escalation|Protocol Violation|0|||
127835865|NCT01877382|460015430|FG003|Dose Escalation|Protocol Violation|0|||
127835866|NCT01877382|460015431|FG004|Dose Escalation|Protocol Violation|0|||
127835867|NCT01877382|460015432|FG005|Dose Escalation|Protocol Violation|0|||
127835868|NCT01877382|460015433|FG006|Dose Escalation|Protocol Violation|1|||
127896224|NCT01047345|460242907|FG001|Base Study|Lost to Follow-up|1|||
127896225|NCT01047345|460242908|FG002|Base Study|Lost to Follow-up|0|||
127835869|NCT01877382|460015434|FG007|Dose Escalation|Protocol Violation|0|||
127835870|NCT01877382|460015435|FG008|Dose Escalation|Protocol Violation|0|||
127835871|NCT01877382|460015436|FG009|Dose Escalation|Protocol Violation|0|||
127835872|NCT01877382|460015437|FG010|Dose Escalation|Protocol Violation|0|||
127896226|NCT01047345|460242906|FG000|Base Study|Protocol Violation|3|||
127835873|NCT01877382|460015438|FG011|Dose Escalation|Protocol Violation|0|||
127835874|NCT01877382|460015439|FG012|Dose Escalation|Protocol Violation|0|||
127835875|NCT01877382|460015440|FG013|Dose Escalation|Protocol Violation|0|||
127835876|NCT01877382|460015441|FG014|Dose Escalation|Protocol Violation|0|||
127835877|NCT01877382|460015427|FG000|Dose Escalation|Study terminated by sponsor|0|||
127835878|NCT01877382|460015428|FG001|Dose Escalation|Study terminated by sponsor|0|||
127835879|NCT01877382|460015429|FG002|Dose Escalation|Study terminated by sponsor|0|||
127835880|NCT01877382|460015430|FG003|Dose Escalation|Study terminated by sponsor|0|||
127835881|NCT01877382|460015431|FG004|Dose Escalation|Study terminated by sponsor|0|||
127835882|NCT01877382|460015432|FG005|Dose Escalation|Study terminated by sponsor|0|||
127835883|NCT01877382|460015433|FG006|Dose Escalation|Study terminated by sponsor|0|||
127835884|NCT01877382|460015434|FG007|Dose Escalation|Study terminated by sponsor|1|||
127835885|NCT01877382|460015435|FG008|Dose Escalation|Study terminated by sponsor|1|||
127835886|NCT01877382|460015436|FG009|Dose Escalation|Study terminated by sponsor|0|||
127835887|NCT01877382|460015437|FG010|Dose Escalation|Study terminated by sponsor|0|||
127835888|NCT01877382|460015438|FG011|Dose Escalation|Study terminated by sponsor|0|||
127835889|NCT01877382|460015439|FG012|Dose Escalation|Study terminated by sponsor|3|||
127835890|NCT01877382|460015440|FG013|Dose Escalation|Study terminated by sponsor|0|||
127835891|NCT01877382|460015441|FG014|Dose Escalation|Study terminated by sponsor|0|||
127835892|NCT01877382|460015427|FG000|Dose Escalation|Death|0|||
127835893|NCT01877382|460015428|FG001|Dose Escalation|Death|0|||
127835894|NCT01877382|460015429|FG002|Dose Escalation|Death|0|||
127835895|NCT01877382|460015430|FG003|Dose Escalation|Death|0|||
127835896|NCT01877382|460015431|FG004|Dose Escalation|Death|0|||
127835897|NCT01877382|460015432|FG005|Dose Escalation|Death|0|||
127835898|NCT01877382|460015433|FG006|Dose Escalation|Death|0|||
127835899|NCT01877382|460015434|FG007|Dose Escalation|Death|1|||
127835900|NCT01877382|460015435|FG008|Dose Escalation|Death|0|||
127835901|NCT01877382|460015436|FG009|Dose Escalation|Death|0|||
127835902|NCT01877382|460015437|FG010|Dose Escalation|Death|0|||
127835903|NCT01877382|460015438|FG011|Dose Escalation|Death|0|||
127835904|NCT01877382|460015439|FG012|Dose Escalation|Death|1|||
127835905|NCT01877382|460015440|FG013|Dose Escalation|Death|1|||
127896227|NCT01047345|460242907|FG001|Base Study|Protocol Violation|1|||
127896228|NCT01047345|460242908|FG002|Base Study|Protocol Violation|0|||
127896229|NCT01047345|460242906|FG000|Base Study|Withdrawal by Subject|12|||
127896230|NCT01047345|460242907|FG001|Base Study|Withdrawal by Subject|4|||
127896231|NCT01047345|460242908|FG002|Base Study|Withdrawal by Subject|0|||
127896232|NCT01047345|460242906|FG000|Extension|Withdrawal by Subject|0|||
127896233|NCT01047345|460242907|FG001|Extension|Withdrawal by Subject|0|||
127835906|NCT01877382|460015441|FG014|Dose Escalation|Death|0|||
127835907|NCT01877382|460015427|FG000|Dose Expansion|Progressive disease|0|||
127835908|NCT01877382|460015428|FG001|Dose Expansion|Progressive disease|0|||
127835909|NCT01877382|460015429|FG002|Dose Expansion|Progressive disease|0|||
127835910|NCT01877382|460015430|FG003|Dose Expansion|Progressive disease|0|||
127835911|NCT01877382|460015431|FG004|Dose Expansion|Progressive disease|0|||
127896234|NCT01047345|460242908|FG002|Extension|Withdrawal by Subject|1|||
127896235|NCT01047345|460242906|FG000|Extension|Lost to Follow-up|0|||
127835912|NCT01877382|460015432|FG005|Dose Expansion|Progressive disease|0|||
127835913|NCT01877382|460015433|FG006|Dose Expansion|Progressive disease|0|||
127835914|NCT01877382|460015434|FG007|Dose Expansion|Progressive disease|0|||
127835915|NCT01877382|460015435|FG008|Dose Expansion|Progressive disease|0|||
127835916|NCT01877382|460015436|FG009|Dose Expansion|Progressive disease|0|||
127835917|NCT01877382|460015437|FG010|Dose Expansion|Progressive disease|0|||
127835918|NCT01877382|460015438|FG011|Dose Expansion|Progressive disease|0|||
127835919|NCT01877382|460015439|FG012|Dose Expansion|Progressive disease|0|||
127835920|NCT01877382|460015440|FG013|Dose Expansion|Progressive disease|0|||
127835921|NCT01877382|460015441|FG014|Dose Expansion|Progressive disease|11|||
127835922|NCT01877382|460015427|FG000|Dose Expansion|Clinical progression|0|||
127896236|NCT01047345|460242907|FG001|Extension|Lost to Follow-up|0|||
127896237|NCT01047345|460242908|FG002|Extension|Lost to Follow-up|5|||
127896238|NCT00698685|460242911|FG000|Overall Study|Sister withdrew as donor|1|||
127835923|NCT01877382|460015428|FG001|Dose Expansion|Clinical progression|0|||
127835924|NCT01877382|460015429|FG002|Dose Expansion|Clinical progression|0|||
127835925|NCT01877382|460015430|FG003|Dose Expansion|Clinical progression|0|||
127835926|NCT01877382|460015431|FG004|Dose Expansion|Clinical progression|0|||
127835927|NCT01877382|460015432|FG005|Dose Expansion|Clinical progression|0|||
127835928|NCT01877382|460015433|FG006|Dose Expansion|Clinical progression|0|||
127835929|NCT01877382|460015434|FG007|Dose Expansion|Clinical progression|0|||
127835930|NCT01877382|460015435|FG008|Dose Expansion|Clinical progression|0|||
127835931|NCT01877382|460015436|FG009|Dose Expansion|Clinical progression|0|||
127835932|NCT01877382|460015437|FG010|Dose Expansion|Clinical progression|0|||
127835933|NCT01877382|460015438|FG011|Dose Expansion|Clinical progression|0|||
127835934|NCT01877382|460015439|FG012|Dose Expansion|Clinical progression|0|||
127835935|NCT01877382|460015440|FG013|Dose Expansion|Clinical progression|0|||
127835936|NCT01877382|460015441|FG014|Dose Expansion|Clinical progression|6|||
127835937|NCT01877382|460015427|FG000|Dose Expansion|Adverse Event|0|||
127835938|NCT01877382|460015428|FG001|Dose Expansion|Adverse Event|0|||
127835939|NCT01877382|460015429|FG002|Dose Expansion|Adverse Event|0|||
127835940|NCT01877382|460015430|FG003|Dose Expansion|Adverse Event|0|||
127835941|NCT01877382|460015431|FG004|Dose Expansion|Adverse Event|0|||
127835942|NCT01877382|460015432|FG005|Dose Expansion|Adverse Event|0|||
127835943|NCT01877382|460015433|FG006|Dose Expansion|Adverse Event|0|||
127835944|NCT01877382|460015434|FG007|Dose Expansion|Adverse Event|0|||
127835945|NCT01877382|460015435|FG008|Dose Expansion|Adverse Event|0|||
127835946|NCT01877382|460015436|FG009|Dose Expansion|Adverse Event|0|||
127835947|NCT01877382|460015437|FG010|Dose Expansion|Adverse Event|0|||
127835948|NCT01877382|460015438|FG011|Dose Expansion|Adverse Event|0|||
127835949|NCT01877382|460015439|FG012|Dose Expansion|Adverse Event|0|||
127835950|NCT01877382|460015440|FG013|Dose Expansion|Adverse Event|0|||
127835951|NCT01877382|460015441|FG014|Dose Expansion|Adverse Event|1|||
127835952|NCT01877382|460015427|FG000|Dose Expansion|Death|0|||
127835953|NCT01877382|460015428|FG001|Dose Expansion|Death|0|||
127835954|NCT01877382|460015429|FG002|Dose Expansion|Death|0|||
127835955|NCT01877382|460015430|FG003|Dose Expansion|Death|0|||
127835956|NCT01877382|460015431|FG004|Dose Expansion|Death|0|||
127835957|NCT01877382|460015432|FG005|Dose Expansion|Death|0|||
127896239|NCT00698685|460242911|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
127835958|NCT01877382|460015433|FG006|Dose Expansion|Death|0|||
127835959|NCT01877382|460015434|FG007|Dose Expansion|Death|0|||
127835960|NCT01877382|460015435|FG008|Dose Expansion|Death|0|||
127835961|NCT01877382|460015436|FG009|Dose Expansion|Death|0|||
127835962|NCT01877382|460015437|FG010|Dose Expansion|Death|0|||
127835963|NCT01877382|460015438|FG011|Dose Expansion|Death|0|||
127835964|NCT01877382|460015439|FG012|Dose Expansion|Death|0|||
127835965|NCT01877382|460015440|FG013|Dose Expansion|Death|0|||
127835966|NCT01877382|460015441|FG014|Dose Expansion|Death|1|||
127835967|NCT01877382|460015427|FG000|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
127835968|NCT01877382|460015428|FG001|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
127835969|NCT01877382|460015429|FG002|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
127835970|NCT01877382|460015430|FG003|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
127835971|NCT01877382|460015431|FG004|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
127835972|NCT01877382|460015432|FG005|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
127835973|NCT01877382|460015433|FG006|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
127835974|NCT01877382|460015434|FG007|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
127835975|NCT01877382|460015435|FG008|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
127835976|NCT01877382|460015436|FG009|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
127835977|NCT01877382|460015437|FG010|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
127835978|NCT01877382|460015438|FG011|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
127835979|NCT01877382|460015439|FG012|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
127835980|NCT01877382|460015440|FG013|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
127835981|NCT01877382|460015441|FG014|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
127835982|NCT02690207|460017237|FG000|Overall Study|Lost to Follow-up|48|||
127835983|NCT02690207|460017237|FG000|Overall Study|Withdrawal by Subject|46|||
127835984|NCT02690207|460017237|FG000|Overall Study|Protocol Violation|2|||
127835985|NCT02690207|460017237|FG000|Overall Study|Serious adverse event|110|||
127835986|NCT02690207|460017237|FG000|Overall Study|Non-serious Adverse Event|18|||
127835987|NCT02690207|460017237|FG000|Overall Study|Migrated/moved from study area|5|||
127835988|NCT02690207|460017237|FG000|Overall Study|Suspected HZ Episode|1|||
127835989|NCT02690207|460017237|FG000|Overall Study|Other reasons for withdrawal|23|||
127835990|NCT00343291|460017238|FG000|Overall Study|Adverse Event|13|||
127835991|NCT00343291|460017239|FG001|Overall Study|Adverse Event|13|||
127835992|NCT00343291|460017238|FG000|Overall Study|Death|3|||
127835993|NCT00343291|460017239|FG001|Overall Study|Death|2|||
127835994|NCT00343291|460017238|FG000|Overall Study|Progressive disease|33|||
127835995|NCT00343291|460017239|FG001|Overall Study|Progressive disease|34|||
127835996|NCT00343291|460017238|FG000|Overall Study|Withdrawal by Subject|0|||
127835997|NCT00343291|460017239|FG001|Overall Study|Withdrawal by Subject|2|||
127835998|NCT00343291|460017238|FG000|Overall Study|Other|8|||
127835999|NCT00343291|460017239|FG001|Overall Study|Other|5|||
127836000|NCT03712345|460017240|FG000|Overall Study|Failure to meet randomization criteria|0|||
127836001|NCT03712345|460017241|FG001|Overall Study|Failure to meet randomization criteria|0|||
127836002|NCT03712345|460017242|FG002|Overall Study|Failure to meet randomization criteria|1|||
127836003|NCT01071096|460017246|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
127836004|NCT01071096|460017247|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
127836005|NCT00485589|460017248|FG000|Overall Study|Death|2|||
127836006|NCT00485589|460017249|FG001|Overall Study|Death|2|||
127836007|NCT00485589|460017250|FG002|Overall Study|Death|0|||
127836008|NCT00485589|460017248|FG000|Overall Study|Failure to return|6|||
127836009|NCT00485589|460017249|FG001|Overall Study|Failure to return|5|||
127836010|NCT00485589|460017250|FG002|Overall Study|Failure to return|1|||
127836011|NCT00485589|460017248|FG000|Overall Study|Protocol Violation|1|||
127836012|NCT00485589|460017249|FG001|Overall Study|Protocol Violation|0|||
127836013|NCT00485589|460017250|FG002|Overall Study|Protocol Violation|0|||
127836014|NCT00485589|460017248|FG000|Overall Study|Violation of selection criteria at entry|0|||
127836015|NCT00485589|460017249|FG001|Overall Study|Violation of selection criteria at entry|3|||
127836016|NCT00485589|460017250|FG002|Overall Study|Violation of selection criteria at entry|1|||
127836017|NCT00485589|460017248|FG000|Overall Study|Administrative/Other|1|||
127836018|NCT00485589|460017249|FG001|Overall Study|Administrative/Other|2|||
127836019|NCT00485589|460017250|FG002|Overall Study|Administrative/Other|1|||
127836020|NCT00485589|460017248|FG000|Overall Study|Insufficient therapeutic response|10|||
127836021|NCT00485589|460017249|FG001|Overall Study|Insufficient therapeutic response|3|||
127836022|NCT00485589|460017250|FG002|Overall Study|Insufficient therapeutic response|1|||
127836023|NCT00485589|460017248|FG000|Overall Study|Refused treatment/did not cooperate|1|||
127836024|NCT00485589|460017249|FG001|Overall Study|Refused treatment/did not cooperate|0|||
127836025|NCT00485589|460017250|FG002|Overall Study|Refused treatment/did not cooperate|2|||
127836026|NCT00485589|460017248|FG000|Overall Study|Withdrawal by Subject|3|||
127836027|NCT00485589|460017249|FG001|Overall Study|Withdrawal by Subject|2|||
127836028|NCT00485589|460017250|FG002|Overall Study|Withdrawal by Subject|2|||
127836029|NCT00485589|460017248|FG000|Overall Study|Adverse Event|3|||
127836030|NCT00485589|460017249|FG001|Overall Study|Adverse Event|3|||
127836031|NCT00485589|460017250|FG002|Overall Study|Adverse Event|10|||
127836032|NCT02585999|460017251|FG000|Overall Study|Lost to Follow-up|1|||
127836033|NCT02585999|460017251|FG000|Overall Study|Protocol Violation|1|||
127836034|NCT01369849|460017252|FG000|Overall Study|Ineligible prior to treatment|0|||
127836035|NCT01369849|460017253|FG001|Overall Study|Ineligible prior to treatment|0|||
127836036|NCT01369849|460017254|FG002|Overall Study|Ineligible prior to treatment|1|||
127836037|NCT01369849|460017252|FG000|Overall Study|Ineligible after receiving treatment|0|||
127836038|NCT01369849|460017253|FG001|Overall Study|Ineligible after receiving treatment|1|||
127836039|NCT01369849|460017254|FG002|Overall Study|Ineligible after receiving treatment|0|||
127836040|NCT00756886|460017258|FG000|Overall Study|Lost to Follow-up|1|||
127836041|NCT00756886|460017259|FG001|Overall Study|Lost to Follow-up|0|||
127836042|NCT00756886|460017258|FG000|Overall Study|Adverse Event|0|||
127836043|NCT00756886|460017259|FG001|Overall Study|Adverse Event|3|||
127836044|NCT00756886|460017258|FG000|Overall Study|Lack of Efficacy|1|||
127836045|NCT00756886|460017259|FG001|Overall Study|Lack of Efficacy|0|||
127836046|NCT00756886|460017258|FG000|Overall Study|Ineligible|9|||
127836047|NCT00756886|460017259|FG001|Overall Study|Ineligible|4|||
127836048|NCT00174785|460017260|FG000|Overall Study|Adverse Event|293|||
127836049|NCT00174785|460017261|FG001|Overall Study|Adverse Event|191|||
127836050|NCT00174785|460017260|FG000|Overall Study|Protocol Violation|14|||
127836051|NCT00174785|460017261|FG001|Overall Study|Protocol Violation|14|||
127836052|NCT00174785|460017260|FG000|Overall Study|Withdrawal by Subject|173|||
127836053|NCT00174785|460017261|FG001|Overall Study|Withdrawal by Subject|175|||
127836054|NCT00174785|460017260|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
127836055|NCT00174785|460017261|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
127836056|NCT00174785|460017260|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
127836057|NCT00174785|460017261|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
127836058|NCT00174785|460017260|FG000|Overall Study|Other prohibited medication|5|||
127836059|NCT00174785|460017261|FG001|Overall Study|Other prohibited medication|3|||
127836060|NCT00174785|460017260|FG000|Overall Study|Family request|6|||
127836061|NCT00174785|460017261|FG001|Overall Study|Family request|8|||
127836062|NCT00174785|460017260|FG000|Overall Study|Not pre-specified/Not coded|56|||
127836063|NCT00174785|460017261|FG001|Overall Study|Not pre-specified/Not coded|70|||
127836064|NCT00120289|460017263|FG000|Overall Study|Death|96|||
127836065|NCT00120289|460017264|FG001|Overall Study|Death|82|||
127836066|NCT00120289|460017263|FG000|Overall Study|Lost to Follow-up|11|||
127836067|NCT00120289|460017264|FG001|Overall Study|Lost to Follow-up|14|||
127836068|NCT00120289|460017263|FG000|Overall Study|Withdrawal by Subject|14|||
127836069|NCT00120289|460017264|FG001|Overall Study|Withdrawal by Subject|13|||
127836070|NCT01944969|460017265|FG000|Overall Study|Adverse Event|1|||
127836071|NCT01944969|460017265|FG000|Overall Study|Lack of Efficacy|1|||
127836072|NCT01944969|460017265|FG000|Overall Study|Non-compliance with IMP|1|||
127836073|NCT01944969|460017265|FG000|Overall Study|Administrative or other reasons|23|||
127836074|NCT02938585|460017271|FG000|Overall Study|Withdrawal by parent or guardian|0|||
127836075|NCT02938585|460017272|FG001|Overall Study|Withdrawal by parent or guardian|1|||
127836076|NCT02938585|460017273|FG002|Overall Study|Withdrawal by parent or guardian|0|||
127836077|NCT02938585|460017274|FG003|Overall Study|Withdrawal by parent or guardian|0|||
127836078|NCT02938585|460017271|FG000|Overall Study|Withdrawal by Subject|0|||
127836079|NCT02938585|460017272|FG001|Overall Study|Withdrawal by Subject|0|||
127836080|NCT02938585|460017273|FG002|Overall Study|Withdrawal by Subject|0|||
127836081|NCT02938585|460017274|FG003|Overall Study|Withdrawal by Subject|5|||
127836082|NCT02411201|460017278|FG000|Overall Study|Adverse Event|2|||
127836083|NCT02411201|460017278|FG000|Overall Study|Withdrawal by Subject|2|||
127836084|NCT02411201|460017278|FG000|Overall Study|Age group completed|2|||
127836085|NCT01260467|460017279|FG000|Overall Study|Withdrawal by Subject|2|||
127836086|NCT02504268|460017283|FG000|Overall Study|Adverse Event|18|||
127836087|NCT02504268|460017284|FG001|Overall Study|Adverse Event|8|||
127836088|NCT02504268|460017285|FG002|Overall Study|Adverse Event|14|||
127836089|NCT02504268|460017286|FG003|Overall Study|Adverse Event|0|||
127836090|NCT02504268|460017287|FG004|Overall Study|Adverse Event|0|||
127836091|NCT02504268|460017288|FG005|Overall Study|Adverse Event|0|||
127836092|NCT02504268|460017289|FG006|Overall Study|Adverse Event|0|||
127836093|NCT02504268|460017290|FG007|Overall Study|Adverse Event|0|||
127836094|NCT02504268|460017291|FG008|Overall Study|Adverse Event|0|||
127836095|NCT02504268|460017283|FG000|Overall Study|Withdrawal of Consent|11|||
127896240|NCT02576990|460242912|FG000|Overall Study|Death|29|||
127896241|NCT02576990|460242913|FG001|Overall Study|Death|18|||
127836096|NCT02504268|460017284|FG001|Overall Study|Withdrawal of Consent|10|||
127836097|NCT02504268|460017285|FG002|Overall Study|Withdrawal of Consent|3|||
127836098|NCT02504268|460017286|FG003|Overall Study|Withdrawal of Consent|0|||
127836099|NCT02504268|460017287|FG004|Overall Study|Withdrawal of Consent|0|||
127896242|NCT02576990|460242912|FG000|Overall Study|Physician Decision|1|||
127836100|NCT02504268|460017288|FG005|Overall Study|Withdrawal of Consent|0|||
127836101|NCT02504268|460017289|FG006|Overall Study|Withdrawal of Consent|0|||
127836102|NCT02504268|460017290|FG007|Overall Study|Withdrawal of Consent|0|||
127836103|NCT02504268|460017291|FG008|Overall Study|Withdrawal of Consent|0|||
127836104|NCT02504268|460017283|FG000|Overall Study|Pregnancy|2|||
127836105|NCT02504268|460017284|FG001|Overall Study|Pregnancy|0|||
127836106|NCT02504268|460017285|FG002|Overall Study|Pregnancy|0|||
127836107|NCT02504268|460017286|FG003|Overall Study|Pregnancy|0|||
127836108|NCT02504268|460017287|FG004|Overall Study|Pregnancy|0|||
127836109|NCT02504268|460017288|FG005|Overall Study|Pregnancy|0|||
127836110|NCT02504268|460017289|FG006|Overall Study|Pregnancy|0|||
127836111|NCT02504268|460017290|FG007|Overall Study|Pregnancy|0|||
127836112|NCT02504268|460017291|FG008|Overall Study|Pregnancy|0|||
127836113|NCT02504268|460017283|FG000|Overall Study|Lost to Follow-up|3|||
127836114|NCT02504268|460017284|FG001|Overall Study|Lost to Follow-up|6|||
127836115|NCT02504268|460017285|FG002|Overall Study|Lost to Follow-up|4|||
127836116|NCT02504268|460017286|FG003|Overall Study|Lost to Follow-up|0|||
127836117|NCT02504268|460017287|FG004|Overall Study|Lost to Follow-up|0|||
127836118|NCT02504268|460017288|FG005|Overall Study|Lost to Follow-up|0|||
127836119|NCT02504268|460017289|FG006|Overall Study|Lost to Follow-up|0|||
127836120|NCT02504268|460017290|FG007|Overall Study|Lost to Follow-up|0|||
127836121|NCT02504268|460017291|FG008|Overall Study|Lost to Follow-up|0|||
127836122|NCT02504268|460017283|FG000|Overall Study|Death|1|||
127836123|NCT02504268|460017284|FG001|Overall Study|Death|1|||
127836124|NCT02504268|460017285|FG002|Overall Study|Death|0|||
127836125|NCT02504268|460017286|FG003|Overall Study|Death|0|||
127896243|NCT02576990|460242913|FG001|Overall Study|Physician Decision|0|||
127836126|NCT02504268|460017287|FG004|Overall Study|Death|0|||
127836127|NCT02504268|460017288|FG005|Overall Study|Death|0|||
127836128|NCT02504268|460017289|FG006|Overall Study|Death|0|||
127836129|NCT02504268|460017290|FG007|Overall Study|Death|0|||
127836130|NCT02504268|460017291|FG008|Overall Study|Death|0|||
127836131|NCT02504268|460017283|FG000|Overall Study|Subject Request to Discontinue|11|||
127836132|NCT02504268|460017284|FG001|Overall Study|Subject Request to Discontinue|3|||
127896244|NCT02576990|460242912|FG000|Overall Study|Screen failure|2|||
127896245|NCT02576990|460242913|FG001|Overall Study|Screen failure|0|||
127896246|NCT02576990|460242912|FG000|Overall Study|Sponsor's decision|24|||
127896247|NCT02576990|460242913|FG001|Overall Study|Sponsor's decision|4|||
127896248|NCT02576990|460242912|FG000|Overall Study|Withdrawal by Subject|0|||
127896249|NCT02576990|460242913|FG001|Overall Study|Withdrawal by Subject|2|||
127896250|NCT00911859|460242914|FG000|Treatment Period|Adverse Event|3|||
127896251|NCT00911859|460242915|FG001|Treatment Period|Adverse Event|3|||
127896252|NCT00911859|460242916|FG002|Treatment Period|Adverse Event|7|||
127896253|NCT00911859|460242914|FG000|Treatment Period|Death|1|||
127896254|NCT00911859|460242915|FG001|Treatment Period|Death|3|||
127896255|NCT00911859|460242916|FG002|Treatment Period|Death|5|||
127896256|NCT00911859|460242914|FG000|Treatment Period|Lack of Efficacy|1|||
127896257|NCT00911859|460242915|FG001|Treatment Period|Lack of Efficacy|7|||
127896258|NCT00911859|460242916|FG002|Treatment Period|Lack of Efficacy|5|||
127896259|NCT00911859|460242914|FG000|Treatment Period|Physician Decision|3|||
127896260|NCT00911859|460242915|FG001|Treatment Period|Physician Decision|3|||
127896261|NCT00911859|460242916|FG002|Treatment Period|Physician Decision|3|||
127896262|NCT00911859|460242914|FG000|Treatment Period|Withdrawal by Subject|0|||
127896263|NCT00911859|460242915|FG001|Treatment Period|Withdrawal by Subject|4|||
127896264|NCT00911859|460242916|FG002|Treatment Period|Withdrawal by Subject|5|||
127896265|NCT00911859|460242914|FG000|Treatment Period|Did not receive study treatment|0|||
127896266|NCT00911859|460242915|FG001|Treatment Period|Did not receive study treatment|1|||
127896267|NCT00911859|460242916|FG002|Treatment Period|Did not receive study treatment|0|||
127896268|NCT00911859|460242914|FG000|Maintainance Period|Lack of Efficacy|0|||
127896269|NCT00911859|460242915|FG001|Maintainance Period|Lack of Efficacy|0|||
127896270|NCT00911859|460242916|FG002|Maintainance Period|Lack of Efficacy|9|||
127896271|NCT00911859|460242914|FG000|Maintainance Period|Physician Decision|0|||
127896272|NCT00911859|460242915|FG001|Maintainance Period|Physician Decision|0|||
127896273|NCT00911859|460242916|FG002|Maintainance Period|Physician Decision|9|||
127896274|NCT00911859|460242914|FG000|Maintainance Period|Withdrawal by Subject|0|||
127896275|NCT00911859|460242915|FG001|Maintainance Period|Withdrawal by Subject|0|||
127896276|NCT00911859|460242916|FG002|Maintainance Period|Withdrawal by Subject|3|||
127896277|NCT00911859|460242914|FG000|Follow-up Period|Death|5|||
127836133|NCT02504268|460017285|FG002|Overall Study|Subject Request to Discontinue|6|||
127836134|NCT02504268|460017286|FG003|Overall Study|Subject Request to Discontinue|0|||
127836135|NCT02504268|460017287|FG004|Overall Study|Subject Request to Discontinue|0|||
127836136|NCT02504268|460017288|FG005|Overall Study|Subject Request to Discontinue|0|||
127836137|NCT02504268|460017289|FG006|Overall Study|Subject Request to Discontinue|0|||
127836138|NCT02504268|460017290|FG007|Overall Study|Subject Request to Discontinue|0|||
127836139|NCT02504268|460017291|FG008|Overall Study|Subject Request to Discontinue|0|||
127836140|NCT02504268|460017283|FG000|Overall Study|No Longer Meets Study Criteria|2|||
127896278|NCT00911859|460242915|FG001|Follow-up Period|Death|8|||
127896279|NCT00911859|460242916|FG002|Follow-up Period|Death|10|||
127896280|NCT00911859|460242914|FG000|Follow-up Period|Lost to Follow-up|1|||
127836141|NCT02504268|460017284|FG001|Overall Study|No Longer Meets Study Criteria|3|||
127836142|NCT02504268|460017285|FG002|Overall Study|No Longer Meets Study Criteria|0|||
127836143|NCT02504268|460017286|FG003|Overall Study|No Longer Meets Study Criteria|0|||
127836144|NCT02504268|460017287|FG004|Overall Study|No Longer Meets Study Criteria|0|||
127836145|NCT02504268|460017288|FG005|Overall Study|No Longer Meets Study Criteria|0|||
127836146|NCT02504268|460017289|FG006|Overall Study|No Longer Meets Study Criteria|0|||
127836147|NCT02504268|460017290|FG007|Overall Study|No Longer Meets Study Criteria|0|||
127836148|NCT02504268|460017291|FG008|Overall Study|No Longer Meets Study Criteria|0|||
127836149|NCT02504268|460017283|FG000|Overall Study|Lack of Efficacy|11|||
127836150|NCT02504268|460017284|FG001|Overall Study|Lack of Efficacy|35|||
127836151|NCT02504268|460017285|FG002|Overall Study|Lack of Efficacy|9|||
127896281|NCT00911859|460242915|FG001|Follow-up Period|Lost to Follow-up|1|||
127896282|NCT00911859|460242916|FG002|Follow-up Period|Lost to Follow-up|0|||
127896283|NCT00911859|460242914|FG000|Follow-up Period|Withdrawal by Subject|0|||
127836152|NCT02504268|460017286|FG003|Overall Study|Lack of Efficacy|0|||
127836153|NCT02504268|460017287|FG004|Overall Study|Lack of Efficacy|0|||
127896284|NCT00911859|460242915|FG001|Follow-up Period|Withdrawal by Subject|4|||
127896285|NCT00911859|460242916|FG002|Follow-up Period|Withdrawal by Subject|4|||
127896286|NCT00911859|460242914|FG000|Follow-up Period|Study terminated by sponsor|5|||
127896287|NCT00911859|460242915|FG001|Follow-up Period|Study terminated by sponsor|33|||
127896288|NCT00911859|460242916|FG002|Follow-up Period|Study terminated by sponsor|27|||
127836154|NCT02504268|460017288|FG005|Overall Study|Lack of Efficacy|0|||
127836155|NCT02504268|460017289|FG006|Overall Study|Lack of Efficacy|0|||
127836156|NCT02504268|460017290|FG007|Overall Study|Lack of Efficacy|0|||
127896289|NCT01048333|460242919|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
127896290|NCT01048333|460242920|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
127896291|NCT01048333|460242921|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
127836157|NCT02504268|460017291|FG008|Overall Study|Lack of Efficacy|0|||
127836158|NCT02504268|460017283|FG000|Overall Study|Poor/Non-Compliance|3|||
127836159|NCT02504268|460017284|FG001|Overall Study|Poor/Non-Compliance|2|||
127836160|NCT02504268|460017285|FG002|Overall Study|Poor/Non-Compliance|3|||
127836161|NCT02504268|460017286|FG003|Overall Study|Poor/Non-Compliance|0|||
127836162|NCT02504268|460017287|FG004|Overall Study|Poor/Non-Compliance|0|||
127836163|NCT02504268|460017288|FG005|Overall Study|Poor/Non-Compliance|0|||
127836164|NCT02504268|460017289|FG006|Overall Study|Poor/Non-Compliance|0|||
127836165|NCT02504268|460017290|FG007|Overall Study|Poor/Non-Compliance|0|||
127836166|NCT02504268|460017291|FG008|Overall Study|Poor/Non-Compliance|0|||
127836167|NCT02504268|460017283|FG000|Overall Study|Not Disclosed|1|||
127836168|NCT02504268|460017284|FG001|Overall Study|Not Disclosed|0|||
127836169|NCT02504268|460017285|FG002|Overall Study|Not Disclosed|2|||
127836170|NCT02504268|460017286|FG003|Overall Study|Not Disclosed|0|||
127836171|NCT02504268|460017287|FG004|Overall Study|Not Disclosed|0|||
127836172|NCT02504268|460017288|FG005|Overall Study|Not Disclosed|0|||
127836173|NCT02504268|460017289|FG006|Overall Study|Not Disclosed|0|||
127836174|NCT02504268|460017290|FG007|Overall Study|Not Disclosed|0|||
127836175|NCT02504268|460017291|FG008|Overall Study|Not Disclosed|0|||
127836176|NCT02130427|460017292|FG000|Overall Study|Imaging results not interpretable|30|||
127836177|NCT03150095|460017297|FG000|Overall Study|Death|0|||
127836178|NCT03150095|460017298|FG001|Overall Study|Death|1|||
127836179|NCT03150095|460017297|FG000|Overall Study|Lost to Follow-up|1|||
127836180|NCT03150095|460017298|FG001|Overall Study|Lost to Follow-up|1|||
127836181|NCT03150095|460017297|FG000|Overall Study|Withdrawal by Subject|4|||
127836182|NCT03150095|460017298|FG001|Overall Study|Withdrawal by Subject|0|||
127836183|NCT03150095|460017297|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
127836184|NCT03150095|460017298|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
127836185|NCT04032171|460017299|FG000|Overall Study|Study Termination|1|||
127836186|NCT04032171|460017300|FG001|Overall Study|Study Termination|0|||
127836187|NCT02108951|460017304|FG000|Overall Study|Lost to Follow-up|1|||
127836188|NCT02108951|460017304|FG000|Overall Study|Patient's/guardian's decision|1|||
127836189|NCT02108951|460017304|FG000|Overall Study|Study Terminated by Sponsor|14|||
127836190|NCT00718666|460017305|FG000|Booster Phase Year 5|No active participation request|0|||
127836191|NCT00718666|460017306|FG001|Booster Phase Year 5|No active participation request|0|||
127836192|NCT00718666|460017307|FG002|Booster Phase Year 5|No active participation request|1|||
127836193|NCT00718666|460017305|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
127836194|NCT00718666|460017306|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
127836195|NCT00718666|460017307|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
127836196|NCT00718666|460017305|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
127836197|NCT00718666|460017306|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
127836198|NCT00718666|460017307|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
127836199|NCT00718666|460017305|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
127836200|NCT00718666|460017306|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
127836201|NCT00718666|460017307|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
127836202|NCT00421343|460017310|FG000|Overall Study|Death|1|||
127836203|NCT00421343|460017310|FG000|Overall Study|Withdrawal by Subject|2|||
127836204|NCT00421343|460017310|FG000|Overall Study|Lost to Follow-up|3|||
127836205|NCT03471767|460017314|FG000|Overall Study|Withdrawal by Subject|3|||
127836206|NCT03471767|460017315|FG001|Overall Study|Withdrawal by Subject|1|||
127836207|NCT03471767|460017314|FG000|Overall Study|Adverse Event|1|||
127836208|NCT03471767|460017315|FG001|Overall Study|Adverse Event|0|||
127896292|NCT01048333|460242922|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
127896293|NCT01048333|460242923|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
127896294|NCT01048333|460242924|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
127896295|NCT00634179|460242932|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
127896296|NCT00767325|460242933|FG000|Overall Study|Lack of Efficacy|2|||
127896297|NCT00767325|460242933|FG000|Overall Study|Adverse Event|7|||
127896298|NCT00767325|460242933|FG000|Overall Study|Lost to Follow-up|3|||
127896299|NCT00767325|460242933|FG000|Overall Study|No longer met study criteria|2|||
127896300|NCT00767325|460242933|FG000|Overall Study|Missed visit due to family reasons|1|||
127896301|NCT03538756|460242934|FG000|Long-Term Follow-up|Adverse Event|0|||
127896302|NCT03538756|460242935|FG001|Long-Term Follow-up|Adverse Event|0|||
127896303|NCT03538756|460242936|FG002|Long-Term Follow-up|Adverse Event|6|||
127836209|NCT03471767|460017314|FG000|Overall Study|Lost to Follow-up|1|||
127836210|NCT03471767|460017315|FG001|Overall Study|Lost to Follow-up|0|||
127836211|NCT03471767|460017314|FG000|Overall Study|PI Withdrawal|1|||
127836212|NCT03471767|460017315|FG001|Overall Study|PI Withdrawal|3|||
127836213|NCT00678587|460017318|FG000|Overall Study|Adverse Event|3|||
127836214|NCT00678587|460017319|FG001|Overall Study|Adverse Event|3|||
127836215|NCT00678587|460017318|FG000|Overall Study|Lack of Efficacy|1|||
127836216|NCT00678587|460017319|FG001|Overall Study|Lack of Efficacy|0|||
127836217|NCT00678587|460017318|FG000|Overall Study|Protocol Violation|2|||
127836218|NCT00678587|460017319|FG001|Overall Study|Protocol Violation|1|||
127836219|NCT00678587|460017318|FG000|Overall Study|Study Closed/Terminated|1|||
127836220|NCT00678587|460017319|FG001|Overall Study|Study Closed/Terminated|0|||
127836221|NCT00678587|460017318|FG000|Overall Study|Lost to Follow-up|3|||
127836222|NCT00678587|460017319|FG001|Overall Study|Lost to Follow-up|5|||
127836223|NCT00678587|460017318|FG000|Overall Study|Investigator Discretion|2|||
127836224|NCT00678587|460017319|FG001|Overall Study|Investigator Discretion|6|||
127836225|NCT00678587|460017318|FG000|Overall Study|Withdrew Consent|8|||
127836226|NCT00678587|460017319|FG001|Overall Study|Withdrew Consent|3|||
127836227|NCT03806179|460017320|FG000|Overall Study|Progressive disease|0|||
127836228|NCT03806179|460017321|FG001|Overall Study|Progressive disease|2|||
127836229|NCT01952730|460017324|FG000|Overall Study|FDA shut down core lab used by study|1|||
127836230|NCT01606761|460017327|FG000|Prior to Week 24|Lost to Follow-up|0|||
127836231|NCT01606761|460017328|FG001|Prior to Week 24|Lost to Follow-up|3|||
127836232|NCT01606761|460017329|FG002|Prior to Week 24|Lost to Follow-up|2|||
127836233|NCT01606761|460017330|FG003|Prior to Week 24|Lost to Follow-up|0|||
127836234|NCT01606761|460017331|FG004|Prior to Week 24|Lost to Follow-up|0|||
127836235|NCT01606761|460017327|FG000|Prior to Week 24|Withdrawal by Subject|12|||
127836236|NCT01606761|460017328|FG001|Prior to Week 24|Withdrawal by Subject|10|||
127836237|NCT01606761|460017329|FG002|Prior to Week 24|Withdrawal by Subject|9|||
127836238|NCT01606761|460017330|FG003|Prior to Week 24|Withdrawal by Subject|0|||
127836239|NCT01606761|460017331|FG004|Prior to Week 24|Withdrawal by Subject|0|||
127836240|NCT01606761|460017327|FG000|Prior to Week 24|Adverse Event|11|||
127836241|NCT01606761|460017328|FG001|Prior to Week 24|Adverse Event|18|||
127836242|NCT01606761|460017329|FG002|Prior to Week 24|Adverse Event|22|||
127836243|NCT01606761|460017330|FG003|Prior to Week 24|Adverse Event|0|||
127836244|NCT01606761|460017331|FG004|Prior to Week 24|Adverse Event|0|||
127836245|NCT01606761|460017327|FG000|Prior to Week 24|Lack of Efficacy|15|||
127836246|NCT01606761|460017328|FG001|Prior to Week 24|Lack of Efficacy|14|||
127836247|NCT01606761|460017329|FG002|Prior to Week 24|Lack of Efficacy|8|||
127836248|NCT01606761|460017330|FG003|Prior to Week 24|Lack of Efficacy|0|||
127836249|NCT01606761|460017331|FG004|Prior to Week 24|Lack of Efficacy|0|||
127836250|NCT01606761|460017327|FG000|Prior to Week 24|Physician Decision|0|||
127836251|NCT01606761|460017328|FG001|Prior to Week 24|Physician Decision|3|||
127836252|NCT01606761|460017329|FG002|Prior to Week 24|Physician Decision|1|||
127836253|NCT01606761|460017330|FG003|Prior to Week 24|Physician Decision|0|||
127836254|NCT01606761|460017331|FG004|Prior to Week 24|Physician Decision|0|||
127836255|NCT01606761|460017327|FG000|Prior to Week 24|Other|4|||
127836256|NCT01606761|460017328|FG001|Prior to Week 24|Other|7|||
127836257|NCT01606761|460017329|FG002|Prior to Week 24|Other|5|||
127836258|NCT01606761|460017330|FG003|Prior to Week 24|Other|0|||
127836259|NCT01606761|460017331|FG004|Prior to Week 24|Other|0|||
127836260|NCT01606761|460017327|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
127836261|NCT01606761|460017328|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
127896304|NCT03538756|460242934|FG000|Long-Term Follow-up|Death|0|||
127836262|NCT01606761|460017329|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
127836263|NCT01606761|460017330|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
127836264|NCT01606761|460017331|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
127836265|NCT01606761|460017327|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
127836266|NCT01606761|460017328|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
127836267|NCT01606761|460017329|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
127836268|NCT01606761|460017330|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
127836269|NCT01606761|460017331|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
127836270|NCT01606761|460017327|FG000|Week 24 to Week 52|Adverse Event|0|||
127836271|NCT01606761|460017328|FG001|Week 24 to Week 52|Adverse Event|11|||
127836272|NCT01606761|460017329|FG002|Week 24 to Week 52|Adverse Event|14|||
127836273|NCT01606761|460017330|FG003|Week 24 to Week 52|Adverse Event|3|||
127836274|NCT01606761|460017331|FG004|Week 24 to Week 52|Adverse Event|15|||
127836275|NCT01606761|460017327|FG000|Week 24 to Week 52|Death|0|||
127836276|NCT01606761|460017328|FG001|Week 24 to Week 52|Death|0|||
127836277|NCT01606761|460017329|FG002|Week 24 to Week 52|Death|2|||
127836278|NCT01606761|460017330|FG003|Week 24 to Week 52|Death|1|||
127836279|NCT01606761|460017331|FG004|Week 24 to Week 52|Death|0|||
127836280|NCT01606761|460017327|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
127836281|NCT01606761|460017328|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
127836282|NCT01606761|460017329|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
127836283|NCT01606761|460017330|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
127836284|NCT01606761|460017331|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
127836285|NCT01606761|460017327|FG000|Week 24 to Week 52|Physician Decision|0|||
127836286|NCT01606761|460017328|FG001|Week 24 to Week 52|Physician Decision|1|||
127836287|NCT01606761|460017329|FG002|Week 24 to Week 52|Physician Decision|1|||
127836288|NCT01606761|460017330|FG003|Week 24 to Week 52|Physician Decision|0|||
127836289|NCT01606761|460017331|FG004|Week 24 to Week 52|Physician Decision|0|||
127836290|NCT01606761|460017327|FG000|Week 24 to Week 52|Other|0|||
127836291|NCT01606761|460017328|FG001|Week 24 to Week 52|Other|1|||
127836292|NCT01606761|460017329|FG002|Week 24 to Week 52|Other|5|||
127836293|NCT01606761|460017330|FG003|Week 24 to Week 52|Other|2|||
127836294|NCT01606761|460017331|FG004|Week 24 to Week 52|Other|2|||
127836295|NCT01606761|460017327|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
127836296|NCT01606761|460017328|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
127836297|NCT01606761|460017329|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
127836298|NCT01606761|460017330|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
127836299|NCT01606761|460017331|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
127836300|NCT01606761|460017327|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
127836301|NCT01606761|460017328|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
127836302|NCT01606761|460017329|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
127836303|NCT01606761|460017330|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
127836304|NCT01606761|460017331|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
127836305|NCT01606761|460017327|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
127836306|NCT01606761|460017328|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
127836307|NCT01606761|460017329|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
127836308|NCT01606761|460017330|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
127836309|NCT01606761|460017331|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
127836310|NCT01606761|460017327|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
127836311|NCT01606761|460017328|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
127836312|NCT01606761|460017329|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
127896305|NCT03538756|460242935|FG001|Long-Term Follow-up|Death|0|||
127836313|NCT01606761|460017330|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
127836314|NCT01606761|460017331|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
127836315|NCT02237157|460017332|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
127896306|NCT03538756|460242936|FG002|Long-Term Follow-up|Death|1|||
127896307|NCT03538756|460242934|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
127896308|NCT03538756|460242935|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
127836316|NCT02237157|460017333|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
127836317|NCT02237157|460017334|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
127836318|NCT02237157|460017335|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
127836319|NCT02237157|460017332|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
127836320|NCT02237157|460017333|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
127836321|NCT02237157|460017334|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
127836322|NCT02237157|460017335|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
127836323|NCT01996748|460017336|FG000|Overall Study|Personal reason|1|||
127836324|NCT01996748|460017337|FG001|Overall Study|Personal reason|0|||
127836325|NCT01996748|460017336|FG000|Overall Study|Physician Decision|2|||
127836326|NCT01996748|460017337|FG001|Overall Study|Physician Decision|0|||
127836327|NCT01996748|460017336|FG000|Overall Study|Adverse Event|1|||
127896309|NCT03538756|460242936|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
127896310|NCT03538756|460242934|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
127896311|NCT03538756|460242935|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
127896312|NCT03538756|460242936|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
127896313|NCT03538756|460242934|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
127896314|NCT03538756|460242935|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
127896315|NCT03538756|460242936|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
127896316|NCT00752856|460242937|FG000|Overall Study|randomized but did not do viral kinetics|0|||
127896317|NCT00752856|460242938|FG001|Overall Study|randomized but did not do viral kinetics|1|||
127896318|NCT03131999|460242939|FG000|Overall Study|Withdrawal by Subject|0|||
127896319|NCT03131999|460242940|FG001|Overall Study|Withdrawal by Subject|1|||
127896320|NCT02260492|460242941|FG000|Overall Study|Adverse Event|6|||
127896321|NCT02260492|460242942|FG001|Overall Study|Adverse Event|1|||
127836328|NCT01996748|460017337|FG001|Overall Study|Adverse Event|4|||
127836329|NCT01996748|460017336|FG000|Overall Study|Withdrawal by Subject|0|||
127836330|NCT01996748|460017337|FG001|Overall Study|Withdrawal by Subject|1|||
127836331|NCT01996748|460017336|FG000|Overall Study|Lost to Follow-up|4|||
127836332|NCT01996748|460017337|FG001|Overall Study|Lost to Follow-up|1|||
127836333|NCT03738566|460017339|FG000|Initial Study Phase|Withdrawal by Subject|1|||
127836334|NCT03738566|460017340|FG001|Initial Study Phase|Withdrawal by Subject|1|||
127836335|NCT03738566|460017341|FG002|Initial Study Phase|Withdrawal by Subject|2|||
127836336|NCT03738566|460017342|FG003|Initial Study Phase|Withdrawal by Subject|0|||
127836337|NCT03738566|460017339|FG000|Initial Study Phase|Death|0|||
127836338|NCT03738566|460017340|FG001|Initial Study Phase|Death|1|||
127836339|NCT03738566|460017341|FG002|Initial Study Phase|Death|0|||
127836340|NCT03738566|460017342|FG003|Initial Study Phase|Death|0|||
127836341|NCT03738566|460017339|FG000|Initial Study Phase|Treatment failure|5|||
127836342|NCT03738566|460017340|FG001|Initial Study Phase|Treatment failure|0|||
127836343|NCT03738566|460017341|FG002|Initial Study Phase|Treatment failure|0|||
127836344|NCT03738566|460017342|FG003|Initial Study Phase|Treatment failure|0|||
127836345|NCT03738566|460017339|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
127836346|NCT03738566|460017340|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
127836347|NCT03738566|460017341|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
127836348|NCT03738566|460017342|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
127836349|NCT01655823|460017343|FG000|Overall Study|Lost to Follow-up|0|||
127836350|NCT01655823|460017344|FG001|Overall Study|Lost to Follow-up|1|||
127836351|NCT01655823|460017345|FG002|Overall Study|Lost to Follow-up|0|||
127836352|NCT01655823|460017346|FG003|Overall Study|Lost to Follow-up|0|||
127836353|NCT01655823|460017347|FG004|Overall Study|Lost to Follow-up|1|||
127836354|NCT01655823|460017343|FG000|Overall Study|Withdrawal by Subject|0|||
127836355|NCT01655823|460017344|FG001|Overall Study|Withdrawal by Subject|1|||
127836356|NCT01655823|460017345|FG002|Overall Study|Withdrawal by Subject|0|||
127836357|NCT01655823|460017346|FG003|Overall Study|Withdrawal by Subject|1|||
127836358|NCT01655823|460017347|FG004|Overall Study|Withdrawal by Subject|0|||
127836359|NCT04799405|460017350|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
127836360|NCT02683525|460017351|FG000|Overall Study|Lost to Follow-up|1|||
127836361|NCT02683525|460017351|FG000|Overall Study|Physician Decision|1|||
127836362|NCT02683525|460017351|FG000|Overall Study|Disease Progression|6|||
127836363|NCT00926796|460017355|FG000|Overall Study|Did not receive randomized treatment|4|||
127836364|NCT00926796|460017356|FG001|Overall Study|Did not receive randomized treatment|7|||
127836365|NCT00926796|460017355|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
127836366|NCT00926796|460017356|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
127836367|NCT00926796|460017355|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
127836368|NCT00926796|460017356|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
127836369|NCT00926796|460017355|FG000|Overall Study|Adverse Event|7|||
127836370|NCT00926796|460017356|FG001|Overall Study|Adverse Event|14|||
127896322|NCT02260492|460242943|FG002|Overall Study|Adverse Event|2|||
127836371|NCT00926796|460017355|FG000|Overall Study|Lost to Follow-up|22|||
127836372|NCT00926796|460017356|FG001|Overall Study|Lost to Follow-up|13|||
127836373|NCT00926796|460017355|FG000|Overall Study|Protocol Violation|15|||
127836374|NCT00926796|460017356|FG001|Overall Study|Protocol Violation|11|||
127836375|NCT00926796|460017355|FG000|Overall Study|Withdrawal by Subject|1|||
127836376|NCT00926796|460017356|FG001|Overall Study|Withdrawal by Subject|0|||
127836377|NCT01341652|460017360|FG000|Overall Study|Incorrect Random Assignment|0|||
127836378|NCT01341652|460017361|FG001|Overall Study|Incorrect Random Assignment|1|||
127836379|NCT01341652|460017360|FG000|Overall Study|ineligible; presence metastatic disease|0|||
127836380|NCT01341652|460017361|FG001|Overall Study|ineligible; presence metastatic disease|1|||
127836381|NCT00632463|460017363|FG000|Overall Study|Adverse Event|0|||
127836382|NCT00632463|460017364|FG001|Overall Study|Adverse Event|1|||
127836383|NCT00632463|460017365|FG002|Overall Study|Adverse Event|0|||
127836384|NCT02998554|460017369|FG000|Overall Study|Adverse Event|8|||
127836385|NCT02998554|460017370|FG001|Overall Study|Adverse Event|3|||
127836386|NCT02998554|460017369|FG000|Overall Study|Protocol deviation|1|||
127836387|NCT02998554|460017370|FG001|Overall Study|Protocol deviation|0|||
127836388|NCT02998554|460017369|FG000|Overall Study|Withdrawal by Subject|2|||
127896323|NCT02260492|460242941|FG000|Overall Study|Death|0|||
127896324|NCT02260492|460242942|FG001|Overall Study|Death|1|||
127836389|NCT02998554|460017370|FG001|Overall Study|Withdrawal by Subject|6|||
127836390|NCT02998554|460017369|FG000|Overall Study|Lost to Follow-up|0|||
127836391|NCT02998554|460017370|FG001|Overall Study|Lost to Follow-up|1|||
127836392|NCT02998554|460017369|FG000|Overall Study|Lack of Efficacy|0|||
127836393|NCT02998554|460017370|FG001|Overall Study|Lack of Efficacy|1|||
127836394|NCT04167306|460017372|FG000|Overall Study|Lost to Follow-up|2|||
127836395|NCT04167306|460017373|FG001|Overall Study|Lost to Follow-up|2|||
127836396|NCT04167306|460017374|FG002|Overall Study|Lost to Follow-up|5|||
127836397|NCT04167306|460017375|FG003|Overall Study|Lost to Follow-up|5|||
127836398|NCT04167306|460017372|FG000|Overall Study|Adverse Event|13|||
127836399|NCT04167306|460017373|FG001|Overall Study|Adverse Event|14|||
127836400|NCT04167306|460017374|FG002|Overall Study|Adverse Event|5|||
127836401|NCT04167306|460017375|FG003|Overall Study|Adverse Event|4|||
127836402|NCT04167306|460017372|FG000|Overall Study|Withdrawal by Subject|4|||
127836403|NCT04167306|460017373|FG001|Overall Study|Withdrawal by Subject|6|||
127836404|NCT04167306|460017374|FG002|Overall Study|Withdrawal by Subject|8|||
127836405|NCT04167306|460017375|FG003|Overall Study|Withdrawal by Subject|3|||
127836406|NCT04167306|460017372|FG000|Overall Study|covid|1|||
127836407|NCT04167306|460017373|FG001|Overall Study|covid|1|||
127836408|NCT04167306|460017374|FG002|Overall Study|covid|2|||
127836409|NCT04167306|460017375|FG003|Overall Study|covid|1|||
127836410|NCT04167306|460017372|FG000|Overall Study|concomitant medication|0|||
127836411|NCT04167306|460017373|FG001|Overall Study|concomitant medication|0|||
127836412|NCT04167306|460017374|FG002|Overall Study|concomitant medication|0|||
127836413|NCT04167306|460017375|FG003|Overall Study|concomitant medication|1|||
127836414|NCT04167306|460017372|FG000|Overall Study|Alcohol treatment|0|||
127836415|NCT04167306|460017373|FG001|Overall Study|Alcohol treatment|4|||
127836416|NCT04167306|460017374|FG002|Overall Study|Alcohol treatment|3|||
127836417|NCT04167306|460017375|FG003|Overall Study|Alcohol treatment|2|||
127836418|NCT04167306|460017372|FG000|Overall Study|non-compliance|0|||
127836419|NCT04167306|460017373|FG001|Overall Study|non-compliance|0|||
127836420|NCT04167306|460017374|FG002|Overall Study|non-compliance|1|||
127836421|NCT04167306|460017375|FG003|Overall Study|non-compliance|0|||
127836422|NCT04167306|460017372|FG000|Overall Study|incorrectly randomized or did not commence study drug|1|||
127836423|NCT04167306|460017373|FG001|Overall Study|incorrectly randomized or did not commence study drug|1|||
127836424|NCT04167306|460017374|FG002|Overall Study|incorrectly randomized or did not commence study drug|2|||
127836425|NCT04167306|460017375|FG003|Overall Study|incorrectly randomized or did not commence study drug|0|||
127836426|NCT03731364|460017380|FG000|Overall Study|Adverse Event|0|||
127836427|NCT03731364|460017381|FG001|Overall Study|Adverse Event|0|||
127836428|NCT03731364|460017382|FG002|Overall Study|Adverse Event|1|||
127836429|NCT03731364|460017383|FG003|Overall Study|Adverse Event|2|||
127836430|NCT03731364|460017384|FG004|Overall Study|Adverse Event|1|||
127836431|NCT01934192|460017385|FG000|Overall Study|Protocol Violation|0|||
127836432|NCT01934192|460017386|FG001|Overall Study|Protocol Violation|0|||
127836433|NCT01934192|460017387|FG002|Overall Study|Protocol Violation|0|||
127836434|NCT01934192|460017388|FG003|Overall Study|Protocol Violation|1|||
127836435|NCT01934192|460017385|FG000|Overall Study|Other: reached stopping criteria|6|||
127836436|NCT01934192|460017386|FG001|Overall Study|Other: reached stopping criteria|5|||
127836437|NCT01934192|460017387|FG002|Overall Study|Other: reached stopping criteria|1|||
127836438|NCT01934192|460017388|FG003|Overall Study|Other: reached stopping criteria|0|||
127836439|NCT01934192|460017385|FG000|Overall Study|Physician Decision|3|||
127836440|NCT01934192|460017386|FG001|Overall Study|Physician Decision|2|||
127836441|NCT01934192|460017387|FG002|Overall Study|Physician Decision|0|||
127836442|NCT01934192|460017388|FG003|Overall Study|Physician Decision|0|||
127836443|NCT02357849|460017389|FG000|Overall Study|Withdrawal by Subject|2|||
127836444|NCT02357849|460017390|FG001|Overall Study|Withdrawal by Subject|3|||
127836445|NCT03095521|460017391|FG000|Overall Study|Withdrawal by Subject|0|||
127836446|NCT03095521|460017392|FG001|Overall Study|Withdrawal by Subject|1|||
127836447|NCT03095521|460017391|FG000|Overall Study|Lost to Follow-up|0|||
127836448|NCT03095521|460017392|FG001|Overall Study|Lost to Follow-up|1|||
127836449|NCT01536119|460017393|FG000|Overall Study|Lost to Follow-up|17|||
127836450|NCT01536119|460017394|FG001|Overall Study|Lost to Follow-up|14|||
127836451|NCT01810042|460017395|FG000|Overall Study|Lost to Follow-up|10|||
127836452|NCT02773238|460017397|FG000|Overall Study|Lack of Efficacy|4|||
127836453|NCT03829332|460017400|FG000|Overall Study|Death|225|||
127836454|NCT03829332|460017401|FG001|Overall Study|Death|230|||
127836455|NCT03829332|460017400|FG000|Overall Study|Lost to Follow-up|1|||
127836456|NCT03829332|460017401|FG001|Overall Study|Lost to Follow-up|3|||
127836457|NCT03829332|460017400|FG000|Overall Study|Physician Decision|1|||
127836458|NCT03829332|460017401|FG001|Overall Study|Physician Decision|0|||
127836459|NCT03829332|460017400|FG000|Overall Study|Sponsor Decision|71|||
127836460|NCT03829332|460017401|FG001|Overall Study|Sponsor Decision|72|||
127836461|NCT03829332|460017400|FG000|Overall Study|Withdrawal by Subject|11|||
127836462|NCT03829332|460017401|FG001|Overall Study|Withdrawal by Subject|9|||
127836463|NCT00430521|460017402|FG000|Overall Study|Adverse Event|0|||
127836464|NCT00430521|460017403|FG001|Overall Study|Adverse Event|0|||
127836465|NCT00430521|460017404|FG002|Overall Study|Adverse Event|0|||
127836466|NCT00430521|460017405|FG003|Overall Study|Adverse Event|0|||
127836467|NCT00430521|460017406|FG004|Overall Study|Adverse Event|0|||
127836468|NCT00430521|460017407|FG005|Overall Study|Adverse Event|2|||
127836469|NCT00430521|460017408|FG006|Overall Study|Adverse Event|1|||
127836470|NCT00430521|460017409|FG007|Overall Study|Adverse Event|0|||
127836471|NCT00430521|460017402|FG000|Overall Study|Lost to Follow-up|7|||
127836472|NCT00430521|460017403|FG001|Overall Study|Lost to Follow-up|8|||
127836473|NCT00430521|460017404|FG002|Overall Study|Lost to Follow-up|3|||
127896325|NCT02260492|460242943|FG002|Overall Study|Death|0|||
127896326|NCT02260492|460242941|FG000|Overall Study|Lost to Follow-up|12|||
127896327|NCT02260492|460242942|FG001|Overall Study|Lost to Follow-up|9|||
127896328|NCT02260492|460242943|FG002|Overall Study|Lost to Follow-up|0|||
127896329|NCT02260492|460242941|FG000|Overall Study|Physician Decision|2|||
127896330|NCT02260492|460242942|FG001|Overall Study|Physician Decision|0|||
127896331|NCT02260492|460242943|FG002|Overall Study|Physician Decision|1|||
127896332|NCT02260492|460242941|FG000|Overall Study|Withdrawal by Subject|3|||
127896333|NCT02260492|460242942|FG001|Overall Study|Withdrawal by Subject|2|||
127896334|NCT02260492|460242943|FG002|Overall Study|Withdrawal by Subject|2|||
127896335|NCT00996736|460242949|FG000|Overall Study|Death|1|||
127896336|NCT00996736|460242950|FG001|Overall Study|Death|1|||
127896337|NCT00996736|460242949|FG000|Overall Study|Lost to Follow-up|15|||
127896338|NCT00996736|460242950|FG001|Overall Study|Lost to Follow-up|14|||
127896339|NCT00996736|460242949|FG000|Overall Study|Visit not within 3-month window|5|||
127896340|NCT00996736|460242950|FG001|Overall Study|Visit not within 3-month window|3|||
127896341|NCT02688608|460242951|FG000|Overall Study|Lost to Follow-up|1|||
127896342|NCT02456909|460242952|FG000|Overall Study|Did not receive allocated intervention|24|||
127896343|NCT02456909|460242953|FG001|Overall Study|Did not receive allocated intervention|26|||
127896344|NCT02456909|460242952|FG000|Overall Study|Did not complete the primary outcome|0|||
127896345|NCT02456909|460242953|FG001|Overall Study|Did not complete the primary outcome|1|||
127896346|NCT01497938|460242956|FG000|Overall Study|Adverse Event|0|||
127896347|NCT01497938|460242957|FG001|Overall Study|Adverse Event|1|||
127896348|NCT01497938|460242956|FG000|Overall Study|Physician Decision|0|||
127896349|NCT01497938|460242957|FG001|Overall Study|Physician Decision|1|||
127896350|NCT01497938|460242956|FG000|Overall Study|Withdrawal by Subject|4|||
127896351|NCT01497938|460242957|FG001|Overall Study|Withdrawal by Subject|0|||
127896352|NCT01497938|460242956|FG000|Overall Study|Device Violation|1|||
127896353|NCT01497938|460242957|FG001|Overall Study|Device Violation|0|||
127896354|NCT00365352|460242958|FG000|Overall Study|Adverse Event|6|||
127896355|NCT00365352|460242959|FG001|Overall Study|Adverse Event|7|||
127896356|NCT00365352|460242960|FG002|Overall Study|Adverse Event|8|||
127896357|NCT00365352|460242958|FG000|Overall Study|Participant Withdrew Consent|8|||
127896358|NCT00365352|460242959|FG001|Overall Study|Participant Withdrew Consent|3|||
127896359|NCT00365352|460242960|FG002|Overall Study|Participant Withdrew Consent|4|||
127896360|NCT00365352|460242958|FG000|Overall Study|Lack of Efficacy|3|||
127896361|NCT00365352|460242959|FG001|Overall Study|Lack of Efficacy|0|||
127896362|NCT00365352|460242960|FG002|Overall Study|Lack of Efficacy|0|||
127896363|NCT00365352|460242958|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
127896364|NCT00365352|460242959|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
127896365|NCT00365352|460242960|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
127896366|NCT00365352|460242958|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
127896367|NCT00365352|460242959|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
127896368|NCT00365352|460242960|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
127896369|NCT00365352|460242958|FG000|Overall Study|Lost to Follow-up|1|||
127896370|NCT00365352|460242959|FG001|Overall Study|Lost to Follow-up|1|||
127896371|NCT00365352|460242960|FG002|Overall Study|Lost to Follow-up|0|||
127896372|NCT00365352|460242958|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
127896373|NCT00365352|460242959|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
127896374|NCT00365352|460242960|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
127896375|NCT02946385|460245243|FG000|Overall Study|Lost to Follow-up|0|||
127896376|NCT02946385|460245244|FG001|Overall Study|Lost to Follow-up|0|||
127896377|NCT02946385|460245245|FG002|Overall Study|Lost to Follow-up|3|||
127896378|NCT02946385|460245246|FG003|Overall Study|Lost to Follow-up|0|||
127896379|NCT02946385|460245247|FG004|Overall Study|Lost to Follow-up|2|||
127896380|NCT02946385|460245248|FG005|Overall Study|Lost to Follow-up|1|||
127896381|NCT01060670|460245249|FG000|Run In|screen failure|0|||
127896382|NCT01060670|460245250|FG001|Run In|screen failure|238|||
127896383|NCT00275002|460245254|FG000|Overall Study|Death|1|||
127896384|NCT00275002|460245255|FG001|Overall Study|Death|0|||
127896385|NCT00275002|460245254|FG000|Overall Study|Disease progression|21|||
127896386|NCT00275002|460245255|FG001|Overall Study|Disease progression|15|||
127896387|NCT00275002|460245254|FG000|Overall Study|Adverse Event|0|||
127896388|NCT00275002|460245255|FG001|Overall Study|Adverse Event|1|||
127896389|NCT00576381|460245262|FG000|Overall Study|Reoperation|3|||
127896390|NCT00576381|460245262|FG000|Overall Study|Adverse Event|4|||
127896391|NCT01031537|460245266|FG000|Overall Study|medical reasons not related to study|3|||
127896392|NCT01031537|460245266|FG000|Overall Study|Lack of Efficacy|1|||
127896393|NCT01031537|460245266|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
127896394|NCT01031537|460245266|FG000|Overall Study|moved, met exclusion criteria|10|||
127896395|NCT01031537|460245266|FG000|Overall Study|Withdrawal by Subject|5|||
127896396|NCT01031537|460245266|FG000|Overall Study|PI removal, no longer met eligibility|12|||
127896397|NCT00623103|460245267|FG000|Overall Study|Adverse Event|70|||
127896398|NCT00623103|460245268|FG001|Overall Study|Adverse Event|60|||
127896399|NCT00623103|460245267|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
127896400|NCT00623103|460245268|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
127896401|NCT00623103|460245267|FG000|Overall Study|Withdrawal by Subject|18|||
127896402|NCT00623103|460245268|FG001|Overall Study|Withdrawal by Subject|24|||
127896403|NCT00623103|460245267|FG000|Overall Study|Lost to Follow-up|4|||
127896404|NCT00623103|460245268|FG001|Overall Study|Lost to Follow-up|1|||
127896405|NCT00623103|460245267|FG000|Overall Study|Administrative problems|2|||
127896406|NCT00623103|460245268|FG001|Overall Study|Administrative problems|4|||
127896407|NCT00623103|460245267|FG000|Overall Study|Death|11|||
127896408|NCT00623103|460245268|FG001|Overall Study|Death|11|||
127896409|NCT00623103|460245267|FG000|Overall Study|Protocol deviation|2|||
127896410|NCT00623103|460245268|FG001|Overall Study|Protocol deviation|1|||
127896411|NCT01506947|460245272|FG000|Overall Study|Lost to Follow-up|7|||
127896412|NCT01506947|460245272|FG000|Overall Study|Adverse Event|5|||
127896413|NCT01506947|460245272|FG000|Overall Study|Death|1|||
127896414|NCT01506947|460245272|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
127896415|NCT01700621|460245273|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
127896416|NCT01700621|460245274|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
127896417|NCT01700621|460245273|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
127896418|NCT01700621|460245274|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
127896419|NCT01700621|460245273|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
127896420|NCT01700621|460245274|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
127896421|NCT02166697|460245275|FG000|Overall Study|Protocol Violation|347|||
127896422|NCT02720510|460245279|FG000|Overall Study|Study Terminated by the sponsor|2|||
127896423|NCT02720510|460245280|FG001|Overall Study|Study Terminated by the sponsor|0|||
127896424|NCT02720510|460245279|FG000|Overall Study|Adverse Event|0|||
127896425|NCT02720510|460245280|FG001|Overall Study|Adverse Event|1|||
127896426|NCT02720510|460245279|FG000|Overall Study|Physician Decision|1|||
127896427|NCT02720510|460245280|FG001|Overall Study|Physician Decision|2|||
127896428|NCT01618266|460245286|FG000|Overall Study|Lost to Follow-up|9|||
127896429|NCT01618266|460245286|FG000|Overall Study|Treatment satisfaction|10|||
127896430|NCT01618266|460245286|FG000|Overall Study|Other reasons|11|||
127896431|NCT01618266|460245286|FG000|Overall Study|Lack of Efficacy|23|||
127896432|NCT01618266|460245286|FG000|Overall Study|Protocol Violation|43|||
127896433|NCT02985151|460245287|FG000|Original Randomization|Withdrawal by Subject|0|||
127896434|NCT02985151|460245288|FG001|Original Randomization|Withdrawal by Subject|1|||
127896435|NCT00625807|460245291|FG000|Overall Study|schedule conflict|2|||
127896436|NCT00625807|460245292|FG001|Overall Study|schedule conflict|8|||
127896437|NCT02224391|460245293|FG000|Overall Study|Lost to Follow-up|26|||
127896438|NCT02224391|460245294|FG001|Overall Study|Lost to Follow-up|19|||
127896439|NCT02224391|460245293|FG000|Overall Study|Withdrawal by Subject|6|||
127896440|NCT02224391|460245294|FG001|Overall Study|Withdrawal by Subject|5|||
127896441|NCT00084084|460245296|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
127896442|NCT00084084|460245296|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
127896443|NCT00108732|460245297|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
127896444|NCT00108732|460245297|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
127896445|NCT00108732|460245297|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
127896446|NCT00108732|460245297|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
127896447|NCT00108732|460245297|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
127896448|NCT00108732|460245297|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
127896449|NCT00108732|460245297|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
127896450|NCT02187042|460245298|FG000|Overall Study|Death|1|||
127896451|NCT02187042|460245299|FG001|Overall Study|Death|1|||
127896452|NCT02187042|460245298|FG000|Overall Study|Toxicity|6|||
127836474|NCT00430521|460017405|FG003|Overall Study|Lost to Follow-up|5|||
127836475|NCT00430521|460017406|FG004|Overall Study|Lost to Follow-up|5|||
127836476|NCT00430521|460017407|FG005|Overall Study|Lost to Follow-up|2|||
127836477|NCT00430521|460017408|FG006|Overall Study|Lost to Follow-up|8|||
127836478|NCT00430521|460017409|FG007|Overall Study|Lost to Follow-up|10|||
127836479|NCT00430521|460017402|FG000|Overall Study|Pregnancy|0|||
127836480|NCT00430521|460017403|FG001|Overall Study|Pregnancy|0|||
127836481|NCT00430521|460017404|FG002|Overall Study|Pregnancy|0|||
127836482|NCT00430521|460017405|FG003|Overall Study|Pregnancy|0|||
127836483|NCT00430521|460017406|FG004|Overall Study|Pregnancy|0|||
127836484|NCT00430521|460017407|FG005|Overall Study|Pregnancy|0|||
127836485|NCT00430521|460017408|FG006|Overall Study|Pregnancy|1|||
127836486|NCT00430521|460017409|FG007|Overall Study|Pregnancy|0|||
127836487|NCT00430521|460017402|FG000|Overall Study|Vaccine Expired|0|||
127836488|NCT00430521|460017403|FG001|Overall Study|Vaccine Expired|0|||
127896453|NCT02187042|460245299|FG001|Overall Study|Toxicity|5|||
127896454|NCT02187042|460245298|FG000|Overall Study|Participant choice|1|||
127896455|NCT02187042|460245299|FG001|Overall Study|Participant choice|0|||
127836489|NCT00430521|460017404|FG002|Overall Study|Vaccine Expired|0|||
127836490|NCT00430521|460017405|FG003|Overall Study|Vaccine Expired|0|||
127896456|NCT02187042|460245298|FG000|Overall Study|Doctor choice|1|||
127896457|NCT02187042|460245299|FG001|Overall Study|Doctor choice|0|||
127896458|NCT02187042|460245298|FG000|Overall Study|Progressive disease|4|||
127896459|NCT02187042|460245299|FG001|Overall Study|Progressive disease|8|||
127896460|NCT02116803|460245301|FG000|Overall Study|Adverse Event|2|||
127896461|NCT02116803|460245302|FG001|Overall Study|Adverse Event|1|||
127896462|NCT02116803|460245301|FG000|Overall Study|Physician Decision|1|||
127836491|NCT00430521|460017406|FG004|Overall Study|Vaccine Expired|0|||
127836492|NCT00430521|460017407|FG005|Overall Study|Vaccine Expired|1|||
127836493|NCT00430521|460017408|FG006|Overall Study|Vaccine Expired|0|||
127836494|NCT00430521|460017409|FG007|Overall Study|Vaccine Expired|0|||
127836495|NCT00430521|460017402|FG000|Overall Study|Protocol Violation|1|||
127836496|NCT00430521|460017403|FG001|Overall Study|Protocol Violation|0|||
127836497|NCT00430521|460017404|FG002|Overall Study|Protocol Violation|0|||
127836498|NCT00430521|460017405|FG003|Overall Study|Protocol Violation|0|||
127836499|NCT00430521|460017406|FG004|Overall Study|Protocol Violation|0|||
127836500|NCT00430521|460017407|FG005|Overall Study|Protocol Violation|0|||
127836501|NCT00430521|460017408|FG006|Overall Study|Protocol Violation|0|||
127836502|NCT00430521|460017409|FG007|Overall Study|Protocol Violation|0|||
127836503|NCT00430521|460017402|FG000|Overall Study|Withdrawal by Subject|3|||
127836504|NCT00430521|460017403|FG001|Overall Study|Withdrawal by Subject|1|||
127836505|NCT00430521|460017404|FG002|Overall Study|Withdrawal by Subject|0|||
127836506|NCT00430521|460017405|FG003|Overall Study|Withdrawal by Subject|3|||
127836507|NCT00430521|460017406|FG004|Overall Study|Withdrawal by Subject|0|||
127836508|NCT00430521|460017407|FG005|Overall Study|Withdrawal by Subject|0|||
127836509|NCT00430521|460017408|FG006|Overall Study|Withdrawal by Subject|0|||
127836510|NCT00430521|460017409|FG007|Overall Study|Withdrawal by Subject|2|||
127836511|NCT02115113|460019642|FG000|Participants in Run-in Period|Death|0|||
127836512|NCT02115113|460019643|FG001|Participants in Run-in Period|Death|0|||
127836513|NCT02115113|460019644|FG002|Participants in Run-in Period|Death|1|||
127836514|NCT02115113|460019642|FG000|Participants in Run-in Period|Administrative problems|0|||
127836515|NCT02115113|460019643|FG001|Participants in Run-in Period|Administrative problems|0|||
127836516|NCT02115113|460019644|FG002|Participants in Run-in Period|Administrative problems|1|||
127836517|NCT02115113|460019642|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
127836518|NCT02115113|460019643|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
127836519|NCT02115113|460019644|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
127836520|NCT02115113|460019642|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
127836521|NCT02115113|460019643|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
127836522|NCT02115113|460019644|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
127836523|NCT02115113|460019642|FG000|Participants Randomized|Lost to Follow-up|1|||
127836524|NCT02115113|460019643|FG001|Participants Randomized|Lost to Follow-up|0|||
127836525|NCT02115113|460019644|FG002|Participants Randomized|Lost to Follow-up|0|||
127836526|NCT02115113|460019642|FG000|Participants Randomized|Death|1|||
127836527|NCT02115113|460019643|FG001|Participants Randomized|Death|0|||
127836528|NCT02115113|460019644|FG002|Participants Randomized|Death|0|||
127836529|NCT02622724|460019645|FG000|Overall Study|Death|51|||
127836530|NCT02622724|460019646|FG001|Overall Study|Death|53|||
127836531|NCT02622724|460019645|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
127836532|NCT02622724|460019646|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
127836533|NCT02622724|460019645|FG000|Overall Study|Early termination of study|38|||
127836534|NCT02622724|460019646|FG001|Overall Study|Early termination of study|43|||
127836535|NCT00296725|460019647|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
127836536|NCT00296725|460019647|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
127836537|NCT00296725|460019647|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
127836538|NCT00356863|460019648|FG000|Overall Study|Death|16|||
127836539|NCT00356863|460019649|FG001|Overall Study|Death|32|||
127836540|NCT00356863|460019648|FG000|Overall Study|Lost to Follow-up|76|||
127836541|NCT00356863|460019649|FG001|Overall Study|Lost to Follow-up|43|||
127836542|NCT00213980|460019655|FG000|Overall Study|Withdrawal by Subject|3|||
127836543|NCT00213980|460019656|FG001|Overall Study|Withdrawal by Subject|1|||
127836544|NCT00213980|460019655|FG000|Overall Study|Adverse Event|1|||
127836545|NCT00213980|460019656|FG001|Overall Study|Adverse Event|1|||
127836546|NCT00213980|460019655|FG000|Overall Study|Disease progression|0|||
127836547|NCT00213980|460019656|FG001|Overall Study|Disease progression|2|||
127836548|NCT00213980|460019655|FG000|Overall Study|Developed ovarian cancer|1|||
127836549|NCT00213980|460019656|FG001|Overall Study|Developed ovarian cancer|0|||
127836550|NCT00213980|460019655|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
127836551|NCT00213980|460019656|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
127836552|NCT00798694|460019657|FG000|Overall Study|Lost to Follow-up|1|||
127836553|NCT00798694|460019658|FG001|Overall Study|Lost to Follow-up|1|||
127836554|NCT00798694|460019657|FG000|Overall Study|Physician Decision|1|||
127836555|NCT00798694|460019658|FG001|Overall Study|Physician Decision|0|||
127836556|NCT01774344|460019660|FG000|Overall Study|Withdrawal by Subject|3|||
127836557|NCT01774344|460019661|FG001|Overall Study|Withdrawal by Subject|10|||
127836558|NCT01774344|460019660|FG000|Overall Study|Protocol Violation|0|||
127836559|NCT01774344|460019661|FG001|Overall Study|Protocol Violation|1|||
127836560|NCT01774344|460019660|FG000|Overall Study|Lost to Follow-up|4|||
127836561|NCT01774344|460019661|FG001|Overall Study|Lost to Follow-up|10|||
127836562|NCT01774344|460019660|FG000|Overall Study|End of survival follow-up not available|2|||
127836563|NCT01774344|460019661|FG001|Overall Study|End of survival follow-up not available|2|||
127836564|NCT01774344|460019660|FG000|Overall Study|Data collection finished|4|||
127836565|NCT01774344|460019661|FG001|Overall Study|Data collection finished|14|||
127836566|NCT01774344|460019660|FG000|Overall Study|Other|0|||
127836567|NCT01774344|460019661|FG001|Overall Study|Other|1|||
127836568|NCT01774344|460019660|FG000|Overall Study|Did not enter Survival Follow up|49|||
127836569|NCT01774344|460019661|FG001|Overall Study|Did not enter Survival Follow up|83|||
127836570|NCT01397552|460019674|FG000|Overall Study|Adverse Event|1|||
127836571|NCT01397552|460019675|FG001|Overall Study|Adverse Event|0|||
127836572|NCT01397552|460019674|FG000|Overall Study|Withdrawal by Subject|2|||
127836573|NCT01397552|460019675|FG001|Overall Study|Withdrawal by Subject|1|||
127836574|NCT01089582|460019677|FG000|Overall Study|Death|2|||
127836575|NCT01089582|460019677|FG000|Overall Study|Adverse Event|15|||
127836576|NCT01089582|460019677|FG000|Overall Study|Lost to Follow-up|8|||
127836577|NCT01089582|460019677|FG000|Overall Study|Other|4|||
127836578|NCT01089582|460019677|FG000|Overall Study|Withdrawal by Subject|1|||
127836579|NCT02108600|460019678|FG000|Overall Study|Withdrawal by Subject|2|||
127836580|NCT02108600|460019679|FG001|Overall Study|Withdrawal by Subject|0|||
127836581|NCT02108600|460019678|FG000|Overall Study|Lost to Follow-up|1|||
127836582|NCT02108600|460019679|FG001|Overall Study|Lost to Follow-up|1|||
127836583|NCT00862849|460019680|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
127836584|NCT00862849|460019681|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
127836585|NCT00862849|460019682|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
127836586|NCT00862849|460019683|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
127836587|NCT00862849|460019684|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
127836588|NCT00862849|460019685|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
127836589|NCT00862849|460019680|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
127836590|NCT00862849|460019681|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
127836591|NCT00862849|460019682|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
127836592|NCT00862849|460019683|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
127836593|NCT00862849|460019684|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
127836594|NCT00862849|460019685|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
127836595|NCT00992784|460019693|FG000|Overall Study|Adverse Event|2|||
127836596|NCT00992784|460019694|FG001|Overall Study|Adverse Event|1|||
127836597|NCT00992784|460019695|FG002|Overall Study|Adverse Event|0|||
127836598|NCT00992784|460019693|FG000|Overall Study|Withdrawal by Subject|1|||
127836599|NCT00992784|460019694|FG001|Overall Study|Withdrawal by Subject|1|||
127836600|NCT00992784|460019695|FG002|Overall Study|Withdrawal by Subject|1|||
127836601|NCT01363713|460019696|FG000|Overall Study|Adverse Event|1|||
127836602|NCT01363713|460019696|FG000|Overall Study|Protocol Violation|3|||
127836603|NCT01363713|460019696|FG000|Overall Study|Withdrawal by Subject|2|||
127836604|NCT00289185|460019701|FG000|Overall Study|Withdrawal by Subject|4|||
127836605|NCT00289185|460019702|FG001|Overall Study|Withdrawal by Subject|8|||
127836606|NCT00289185|460019701|FG000|Overall Study|Lost to Follow-up|23|||
127836607|NCT00289185|460019702|FG001|Overall Study|Lost to Follow-up|17|||
127836608|NCT00289185|460019701|FG000|Overall Study|Death|1|||
127836609|NCT00289185|460019702|FG001|Overall Study|Death|1|||
127836610|NCT01658579|460019703|FG000|Treatment Period A|Other|0|||
127836611|NCT01658579|460019704|FG001|Treatment Period A|Other|0|||
127836612|NCT01658579|460019705|FG002|Treatment Period A|Other|1|||
127836613|NCT01658579|460019706|FG003|Treatment Period A|Other|1|||
127836614|NCT01658579|460019703|FG000|Treatment Period A|Adverse Event|1|||
127836615|NCT01658579|460019704|FG001|Treatment Period A|Adverse Event|0|||
127836616|NCT01658579|460019705|FG002|Treatment Period A|Adverse Event|0|||
127836617|NCT01658579|460019706|FG003|Treatment Period A|Adverse Event|0|||
127836618|NCT01658579|460019703|FG000|Treatment Period B|Other|0|||
127836619|NCT01658579|460019704|FG001|Treatment Period B|Other|0|||
127836620|NCT01658579|460019705|FG002|Treatment Period B|Other|0|||
127836621|NCT01658579|460019706|FG003|Treatment Period B|Other|1|||
127836622|NCT02432040|460019709|FG000|Overall Study|Lack of Efficacy|3|||
127836623|NCT02432040|460019710|FG001|Overall Study|Lack of Efficacy|0|||
127836624|NCT02432040|460019709|FG000|Overall Study|Lost to Follow-up|4|||
127836625|NCT02432040|460019710|FG001|Overall Study|Lost to Follow-up|5|||
127836626|NCT02432040|460019709|FG000|Overall Study|Physician Decision|1|||
127836627|NCT02432040|460019710|FG001|Overall Study|Physician Decision|1|||
127836628|NCT00608530|460019711|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
127836629|NCT00608530|460019712|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
127836630|NCT00608530|460019713|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
127836631|NCT00608530|460019714|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
127836632|NCT00608530|460019711|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
127836633|NCT00608530|460019712|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
127836634|NCT00608530|460019713|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
127836635|NCT00608530|460019714|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
127836636|NCT00608530|460019711|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
127836637|NCT00608530|460019712|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
127836638|NCT00608530|460019713|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
127836639|NCT00608530|460019714|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
127836640|NCT00608530|460019711|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
127836641|NCT00608530|460019712|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
127836642|NCT00608530|460019713|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
127836643|NCT00608530|460019714|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
127836644|NCT00608530|460019711|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
127836645|NCT00608530|460019712|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
127836646|NCT00608530|460019713|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
127836647|NCT00608530|460019714|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
127836648|NCT00608530|460019711|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
127836649|NCT00608530|460019712|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
127836650|NCT00608530|460019713|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
127836651|NCT00608530|460019714|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
127836652|NCT01357915|460019715|FG000|Overall Study|Lost to Follow-up|3|||
127836653|NCT01357915|460019716|FG001|Overall Study|Lost to Follow-up|0|||
127836654|NCT01514188|460019717|FG000|Overall Study|Adverse Event|3|||
127836655|NCT01514188|460019718|FG001|Overall Study|Adverse Event|5|||
127836656|NCT01514188|460019717|FG000|Overall Study|Withdrawal by Subject|2|||
127836657|NCT01514188|460019718|FG001|Overall Study|Withdrawal by Subject|4|||
127836658|NCT01514188|460019717|FG000|Overall Study|Protocol Violation|2|||
127836659|NCT01514188|460019718|FG001|Overall Study|Protocol Violation|4|||
127836660|NCT01514188|460019717|FG000|Overall Study|Physician Decision|0|||
127836661|NCT01514188|460019718|FG001|Overall Study|Physician Decision|2|||
127836662|NCT01514188|460019717|FG000|Overall Study|Disease Progression|13|||
127836663|NCT01514188|460019718|FG001|Overall Study|Disease Progression|14|||
127836664|NCT01514188|460019717|FG000|Overall Study|Death|1|||
127836665|NCT01514188|460019718|FG001|Overall Study|Death|3|||
127836666|NCT01514188|460019717|FG000|Overall Study|Other|2|||
127836667|NCT01514188|460019718|FG001|Overall Study|Other|1|||
127836668|NCT01019486|460019719|FG000|Overall Study|Withdrawal by Subject|1|||
127836669|NCT01019486|460019720|FG001|Overall Study|Withdrawal by Subject|1|||
127836670|NCT01019486|460019721|FG002|Overall Study|Withdrawal by Subject|1|||
127836671|NCT02932332|460019726|FG000|Overall Study|Withdrawal by Subject|1|||
127836672|NCT02932332|460019727|FG001|Overall Study|Withdrawal by Subject|1|||
127836673|NCT02932332|460019728|FG002|Overall Study|Withdrawal by Subject|0|||
127836674|NCT02932332|460019729|FG003|Overall Study|Withdrawal by Subject|1|||
127836675|NCT02932332|460019726|FG000|Overall Study|Chest pain|0|||
127836676|NCT02932332|460019727|FG001|Overall Study|Chest pain|0|||
127836677|NCT02932332|460019728|FG002|Overall Study|Chest pain|0|||
127836678|NCT02932332|460019729|FG003|Overall Study|Chest pain|1|||
127836679|NCT02932332|460019726|FG000|Overall Study|Not Dyspneic cough|1|||
127896463|NCT02116803|460245302|FG001|Overall Study|Physician Decision|0|||
127836680|NCT02932332|460019727|FG001|Overall Study|Not Dyspneic cough|2|||
127836681|NCT02932332|460019728|FG002|Overall Study|Not Dyspneic cough|1|||
127836682|NCT02932332|460019729|FG003|Overall Study|Not Dyspneic cough|0|||
127836683|NCT02841787|460019730|FG000|Overall Study|Lost to Follow-up|1|||
127836684|NCT02841787|460019731|FG001|Overall Study|Lost to Follow-up|0|||
127836685|NCT02841787|460019732|FG002|Overall Study|Lost to Follow-up|0|||
127836686|NCT02841787|460019730|FG000|Overall Study|Symptoms dropped below threshold|1|||
127836687|NCT02841787|460019731|FG001|Overall Study|Symptoms dropped below threshold|0|||
127896464|NCT02116803|460245301|FG000|Overall Study|Progressive disease|4|||
127896465|NCT02116803|460245302|FG001|Overall Study|Progressive disease|0|||
127896466|NCT02116803|460245301|FG000|Overall Study|Study terminated by sponsor|2|||
127896467|NCT02116803|460245302|FG001|Overall Study|Study terminated by sponsor|1|||
127896468|NCT02116803|460245301|FG000|Overall Study|Death|1|||
127896469|NCT02116803|460245302|FG001|Overall Study|Death|0|||
127896470|NCT01974895|460245305|FG000|Overall Study|Protocol Violation|1|||
127896471|NCT01974895|460245306|FG001|Overall Study|Protocol Violation|0|||
127896472|NCT01974895|460245305|FG000|Overall Study|Lost to Follow-up|4|||
127896473|NCT01974895|460245306|FG001|Overall Study|Lost to Follow-up|6|||
127896474|NCT01974895|460245305|FG000|Overall Study|Withdrawal by Subject|0|||
127896475|NCT01974895|460245306|FG001|Overall Study|Withdrawal by Subject|1|||
127896476|NCT01974895|460245305|FG000|Overall Study|Other (Missed Visit)|1|||
127896477|NCT01974895|460245306|FG001|Overall Study|Other (Missed Visit)|0|||
127896478|NCT01974895|460245305|FG000|Overall Study|Other (Reason unknown)|9|||
127896479|NCT01974895|460245306|FG001|Overall Study|Other (Reason unknown)|8|||
127896480|NCT01984242|460245307|FG000|Overall Study|Death|52|||
127896481|NCT01984242|460245308|FG001|Overall Study|Death|50|||
127896482|NCT01984242|460245309|FG002|Overall Study|Death|52|||
127896483|NCT01984242|460245307|FG000|Overall Study|Withdrawal by Subject|5|||
127896484|NCT01984242|460245308|FG001|Overall Study|Withdrawal by Subject|3|||
127896485|NCT01984242|460245309|FG002|Overall Study|Withdrawal by Subject|10|||
127896486|NCT01984242|460245307|FG000|Overall Study|Physician Decision|0|||
127896487|NCT01984242|460245308|FG001|Overall Study|Physician Decision|0|||
127896488|NCT01984242|460245309|FG002|Overall Study|Physician Decision|1|||
127896489|NCT01984242|460245307|FG000|Overall Study|Lost to Follow-up|4|||
127896490|NCT01984242|460245308|FG001|Overall Study|Lost to Follow-up|0|||
127836688|NCT02841787|460019732|FG002|Overall Study|Symptoms dropped below threshold|0|||
127836689|NCT02841787|460019730|FG000|Overall Study|Withdrawal by Subject|1|||
127836690|NCT02841787|460019731|FG001|Overall Study|Withdrawal by Subject|4|||
127836691|NCT02841787|460019732|FG002|Overall Study|Withdrawal by Subject|0|||
127836692|NCT03633227|460019733|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
127836693|NCT03633227|460019734|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
127836694|NCT03633227|460019733|FG000|Double Blind (DB), up to Week 48|Death|2|||
127836695|NCT03633227|460019734|FG001|Double Blind (DB), up to Week 48|Death|1|||
127836696|NCT03633227|460019733|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
127836697|NCT03633227|460019734|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
127836698|NCT03633227|460019733|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
127836699|NCT03633227|460019734|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
127836700|NCT03633227|460019733|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
127836701|NCT03633227|460019734|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
127836702|NCT03633227|460019733|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
127836703|NCT03633227|460019734|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
127836704|NCT03633227|460019733|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
127836705|NCT03633227|460019734|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
127836706|NCT03633227|460019733|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
127836707|NCT03633227|460019734|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
127836708|NCT03633227|460019733|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
127836709|NCT03633227|460019734|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
127836710|NCT03633227|460019733|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
127836711|NCT03633227|460019734|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
127836712|NCT03633227|460019733|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
127836713|NCT03633227|460019734|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
127836714|NCT03633227|460019733|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
127836715|NCT03633227|460019734|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
127836716|NCT03029650|460019739|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
127836717|NCT03029650|460019740|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
127836718|NCT03029650|460019739|FG000|Washout (1 Week)|Physician Decision|0|||
127836719|NCT03029650|460019740|FG001|Washout (1 Week)|Physician Decision|1|||
127836720|NCT01875367|460019741|FG000|Overall Study|Not complete at least 2 questionaries|4|||
127836721|NCT01875367|460019742|FG001|Overall Study|Not complete at least 2 questionaries|2|||
127836722|NCT01875367|460019741|FG000|Overall Study|Not receive study treatment|1|||
127836723|NCT01875367|460019742|FG001|Overall Study|Not receive study treatment|0|||
127836724|NCT04533815|460019743|FG000|Overall Study|Adverse Event|2|||
127836725|NCT04533815|460019743|FG000|Overall Study|Site withdrew|5|||
127896491|NCT01984242|460245309|FG002|Overall Study|Lost to Follow-up|3|||
127896492|NCT01984242|460245307|FG000|Overall Study|Sponsor Decision|1|||
127896493|NCT01984242|460245308|FG001|Overall Study|Sponsor Decision|0|||
127896494|NCT01984242|460245309|FG002|Overall Study|Sponsor Decision|0|||
127896495|NCT01984242|460245307|FG000|Overall Study|Non-Compliance|1|||
127896496|NCT01984242|460245308|FG001|Overall Study|Non-Compliance|0|||
127896497|NCT01984242|460245309|FG002|Overall Study|Non-Compliance|0|||
127836726|NCT02951988|460019746|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
127836727|NCT02951988|460019747|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
127836728|NCT02951988|460019748|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
127836729|NCT02951988|460019749|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
127836730|NCT02951988|460019746|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
127836731|NCT02951988|460019747|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
127836732|NCT02951988|460019748|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
127836733|NCT02951988|460019749|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
127836734|NCT02951988|460019746|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
127836735|NCT02951988|460019747|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
127836736|NCT02951988|460019748|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
127836737|NCT02951988|460019749|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
127836738|NCT02951988|460019746|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
127836739|NCT02951988|460019747|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
127836740|NCT02951988|460019748|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
127836741|NCT02951988|460019749|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
127836742|NCT02951988|460019746|FG000|Open-Label Treatment Period|Protocol Violation|22|||
127836743|NCT02951988|460019747|FG001|Open-Label Treatment Period|Protocol Violation|0|||
127836744|NCT02951988|460019748|FG002|Open-Label Treatment Period|Protocol Violation|0|||
127836745|NCT02951988|460019749|FG003|Open-Label Treatment Period|Protocol Violation|0|||
127836746|NCT02951988|460019746|FG000|Open-Label Treatment Period|Pregnancy|2|||
127836747|NCT02951988|460019747|FG001|Open-Label Treatment Period|Pregnancy|0|||
127836748|NCT02951988|460019748|FG002|Open-Label Treatment Period|Pregnancy|0|||
127836749|NCT02951988|460019749|FG003|Open-Label Treatment Period|Pregnancy|0|||
127836750|NCT02951988|460019746|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
127836751|NCT02951988|460019747|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
127836752|NCT02951988|460019748|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
127836753|NCT02951988|460019749|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
127836754|NCT02951988|460019746|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
127836755|NCT02951988|460019747|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
127836756|NCT02951988|460019748|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
127836757|NCT02951988|460019749|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
127836758|NCT02951988|460019746|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
127836759|NCT02951988|460019747|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
127836760|NCT02951988|460019748|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
127836761|NCT02951988|460019749|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
127836762|NCT02951988|460019746|FG000|Open-Label Treatment Period|Adverse Event|45|||
127836763|NCT02951988|460019747|FG001|Open-Label Treatment Period|Adverse Event|0|||
127836764|NCT02951988|460019748|FG002|Open-Label Treatment Period|Adverse Event|0|||
127836765|NCT02951988|460019749|FG003|Open-Label Treatment Period|Adverse Event|0|||
127836766|NCT02951988|460019746|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
127836767|NCT02951988|460019747|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
127836768|NCT02951988|460019748|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
127836769|NCT02951988|460019749|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
127836770|NCT02951988|460019746|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
127836771|NCT02951988|460019747|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
127836772|NCT02951988|460019748|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
127836773|NCT02951988|460019749|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
127836774|NCT02951988|460019746|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
127836775|NCT02951988|460019747|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
127836776|NCT02951988|460019748|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
127836777|NCT02951988|460019749|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
127836778|NCT02951988|460019746|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
127836779|NCT02951988|460019747|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
127836780|NCT02951988|460019748|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
127836781|NCT02951988|460019749|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
127836782|NCT02951988|460019746|FG000|Double-Blind Treatment Period|Pregnancy|0|||
127836783|NCT02951988|460019747|FG001|Double-Blind Treatment Period|Pregnancy|1|||
127836784|NCT02951988|460019748|FG002|Double-Blind Treatment Period|Pregnancy|1|||
127836785|NCT02951988|460019749|FG003|Double-Blind Treatment Period|Pregnancy|0|||
127836786|NCT02951988|460019746|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
127836787|NCT02951988|460019747|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
127836788|NCT02951988|460019748|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
127836789|NCT02951988|460019749|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
127836790|NCT02951988|460019746|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
127836791|NCT02951988|460019747|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
127836792|NCT02951988|460019748|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
127836793|NCT02951988|460019749|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
127836794|NCT02951988|460019746|FG000|Double-Blind Treatment Period|Adverse Event|0|||
127836795|NCT02951988|460019747|FG001|Double-Blind Treatment Period|Adverse Event|8|||
127836796|NCT02951988|460019748|FG002|Double-Blind Treatment Period|Adverse Event|3|||
127836797|NCT02951988|460019749|FG003|Double-Blind Treatment Period|Adverse Event|6|||
127836798|NCT02951988|460019746|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
127836799|NCT02951988|460019747|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
127836800|NCT02951988|460019748|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
127836801|NCT02951988|460019749|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
127836802|NCT03977727|460019750|FG000|Second Treatment|Lost to Follow-up|0|||
127836803|NCT03977727|460019751|FG001|Second Treatment|Lost to Follow-up|3|||
127836804|NCT00603980|460019757|FG000|Study Qualification|Protocol Violation|3|||
127836805|NCT00603980|460019757|FG000|Study Qualification|Inconsistent data reporting|13|||
127836806|NCT00603980|460019757|FG000|Main Study|14th subject completed trial|1|||
127836807|NCT01627067|460019758|FG000|Overall Study|Screen Failure|1|||
127836808|NCT00586924|460019759|FG000|Overall Study|Adverse event/serious adverse event|0|||
127836809|NCT00586924|460019760|FG001|Overall Study|Adverse event/serious adverse event|0|||
127836810|NCT00586924|460019761|FG002|Overall Study|Adverse event/serious adverse event|0|||
127836811|NCT00586924|460019762|FG003|Overall Study|Adverse event/serious adverse event|1|||
127836812|NCT00586924|460019763|FG004|Overall Study|Adverse event/serious adverse event|0|||
127836813|NCT00586924|460019764|FG005|Overall Study|Adverse event/serious adverse event|2|||
127836814|NCT00586924|460019759|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
127836815|NCT00586924|460019760|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
127836816|NCT00586924|460019761|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
127836817|NCT00586924|460019762|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
127836818|NCT00586924|460019763|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
127836819|NCT00586924|460019764|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
127836820|NCT00586924|460019759|FG000|Overall Study|Disease progression|0|||
127836821|NCT00586924|460019760|FG001|Overall Study|Disease progression|0|||
127836822|NCT00586924|460019761|FG002|Overall Study|Disease progression|0|||
127836823|NCT00586924|460019762|FG003|Overall Study|Disease progression|1|||
127836824|NCT00586924|460019763|FG004|Overall Study|Disease progression|1|||
127836825|NCT00586924|460019764|FG005|Overall Study|Disease progression|0|||
127836826|NCT00586924|460019759|FG000|Overall Study|Development of neutralizing antibodies|2|||
127836827|NCT00586924|460019760|FG001|Overall Study|Development of neutralizing antibodies|2|||
127836828|NCT00586924|460019761|FG002|Overall Study|Development of neutralizing antibodies|2|||
127836829|NCT00586924|460019762|FG003|Overall Study|Development of neutralizing antibodies|0|||
127836830|NCT00586924|460019763|FG004|Overall Study|Development of neutralizing antibodies|0|||
127836831|NCT00586924|460019764|FG005|Overall Study|Development of neutralizing antibodies|22|||
127836832|NCT00586924|460019759|FG000|Overall Study|Complete response|0|||
127836833|NCT00586924|460019760|FG001|Overall Study|Complete response|1|||
127836834|NCT00586924|460019761|FG002|Overall Study|Complete response|0|||
127836835|NCT00586924|460019762|FG003|Overall Study|Complete response|0|||
127836836|NCT00586924|460019763|FG004|Overall Study|Complete response|2|||
127836837|NCT00586924|460019764|FG005|Overall Study|Complete response|2|||
127836838|NCT00586924|460019759|FG000|Overall Study|Other|1|||
127836839|NCT00586924|460019760|FG001|Overall Study|Other|0|||
127836840|NCT00586924|460019761|FG002|Overall Study|Other|1|||
127836841|NCT00586924|460019762|FG003|Overall Study|Other|1|||
127836842|NCT00586924|460019763|FG004|Overall Study|Other|1|||
127836843|NCT00586924|460019764|FG005|Overall Study|Other|6|||
127836844|NCT04146467|460019767|FG000|Overall Study|Adverse Event|0|||
127836845|NCT04146467|460019768|FG001|Overall Study|Adverse Event|1|||
127836846|NCT04146467|460019767|FG000|Overall Study|Lost to Follow-up|0|||
127836847|NCT04146467|460019768|FG001|Overall Study|Lost to Follow-up|2|||
127836848|NCT01189435|460019770|FG000|Overall Study|Withdrawal by Subject|1|||
127836849|NCT01189435|460019770|FG000|Overall Study|Physician Decision|1|||
127836850|NCT01982773|460019779|FG000|Overall Study|Withdrawal by Subject|1|||
127836851|NCT01982773|460019780|FG001|Overall Study|Withdrawal by Subject|3|||
127836852|NCT01982773|460019779|FG000|Overall Study|Lost to Follow-up|7|||
127836853|NCT01982773|460019780|FG001|Overall Study|Lost to Follow-up|1|||
127836854|NCT01029886|460019781|FG000|Overall Study|Adverse Event|12|||
127836855|NCT01029886|460019782|FG001|Overall Study|Adverse Event|25|||
127836856|NCT01029886|460019781|FG000|Overall Study|Lost to Follow-up|1|||
127836857|NCT01029886|460019782|FG001|Overall Study|Lost to Follow-up|0|||
127836858|NCT01029886|460019781|FG000|Overall Study|Physician Decision|2|||
127836859|NCT01029886|460019782|FG001|Overall Study|Physician Decision|6|||
127836860|NCT01029886|460019781|FG000|Overall Study|Protocol Violation|17|||
127836861|NCT01029886|460019782|FG001|Overall Study|Protocol Violation|5|||
127836862|NCT01029886|460019781|FG000|Overall Study|Withdrawal by Subject|8|||
127836863|NCT01029886|460019782|FG001|Overall Study|Withdrawal by Subject|18|||
127836864|NCT01029886|460019781|FG000|Overall Study|Entry Criteria Not Met|13|||
127836865|NCT01029886|460019782|FG001|Overall Study|Entry Criteria Not Met|5|||
127836866|NCT01029886|460019781|FG000|Overall Study|Sponsor Decision|1|||
127836867|NCT01029886|460019782|FG001|Overall Study|Sponsor Decision|0|||
127836868|NCT01029886|460019781|FG000|Overall Study|Loss Glucose Control|7|||
127836869|NCT01029886|460019782|FG001|Overall Study|Loss Glucose Control|1|||
127836870|NCT01778127|460019783|FG000|Overall Study|Lost to Follow-up|5|||
127836871|NCT01778127|460019784|FG001|Overall Study|Lost to Follow-up|1|||
127836872|NCT01778127|460019785|FG002|Overall Study|Lost to Follow-up|2|||
127836873|NCT01778127|460019783|FG000|Overall Study|Withdrawal by Subject|3|||
127836874|NCT01778127|460019784|FG001|Overall Study|Withdrawal by Subject|1|||
127836875|NCT01778127|460019785|FG002|Overall Study|Withdrawal by Subject|4|||
127836876|NCT03722784|460019786|FG000|Overall Study|Withdrawal by Subject|1|||
127836877|NCT03722784|460019787|FG001|Overall Study|Withdrawal by Subject|0|||
127836878|NCT03722784|460019786|FG000|Overall Study|Physician Decision|1|||
127836879|NCT03722784|460019787|FG001|Overall Study|Physician Decision|1|||
127836880|NCT03722784|460019786|FG000|Overall Study|Protocol Violation|0|||
127836881|NCT03722784|460019787|FG001|Overall Study|Protocol Violation|1|||
127836882|NCT03259490|460019789|FG000|Period 1|Withdrawal by Subject|0|||
127836883|NCT03259490|460019790|FG001|Period 1|Withdrawal by Subject|1|||
127836884|NCT03259490|460019789|FG000|Period 2|Protocol Violation|1|||
127836885|NCT03259490|460019790|FG001|Period 2|Protocol Violation|0|||
127836886|NCT01963208|460019791|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
127836887|NCT01963208|460019792|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
127836888|NCT01963208|460019793|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
127836889|NCT01963208|460019794|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
127836890|NCT01963208|460019795|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
127836891|NCT01963208|460019796|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
127836892|NCT01963208|460019791|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
127836893|NCT01963208|460019792|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
127836894|NCT01963208|460019793|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
127836895|NCT01963208|460019794|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
127836896|NCT01963208|460019795|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
127836897|NCT01963208|460019796|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
127836898|NCT01963208|460019791|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
127836899|NCT01963208|460019792|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
127836900|NCT01963208|460019793|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
127836901|NCT01963208|460019794|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
127836902|NCT01963208|460019795|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
127836903|NCT01963208|460019796|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
127836904|NCT01963208|460019791|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
127836905|NCT01963208|460019792|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
127836906|NCT01963208|460019793|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
127836907|NCT01963208|460019794|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
127836908|NCT01963208|460019795|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
127836909|NCT01963208|460019796|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
127836910|NCT01963208|460019791|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
127836911|NCT01963208|460019792|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
127836912|NCT01963208|460019793|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
127836913|NCT01963208|460019794|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
127836914|NCT01963208|460019795|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
127836915|NCT01963208|460019796|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
127836916|NCT01963208|460019791|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
127836917|NCT01963208|460019792|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
127836918|NCT01963208|460019793|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
127836919|NCT01963208|460019794|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
127836920|NCT01963208|460019795|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
127836921|NCT01963208|460019796|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
127836922|NCT01963208|460019791|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
127836923|NCT01963208|460019792|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
127836924|NCT01963208|460019793|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
127836925|NCT01963208|460019794|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
127836926|NCT01963208|460019795|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
127836927|NCT01963208|460019796|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
127836928|NCT01963208|460019791|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
127836929|NCT01963208|460019792|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
127836930|NCT01963208|460019793|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
127836931|NCT01963208|460019794|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
127836932|NCT01963208|460019795|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
127836933|NCT01963208|460019796|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
127836934|NCT01963208|460019791|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
127836935|NCT01963208|460019792|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
127836936|NCT01963208|460019793|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
127836937|NCT01963208|460019794|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
127836938|NCT01963208|460019795|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
127836939|NCT01963208|460019796|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
127836940|NCT01963208|460019791|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
127836941|NCT01963208|460019792|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
127836942|NCT01963208|460019793|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
127836943|NCT01963208|460019794|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
127836944|NCT01963208|460019795|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
127836945|NCT01963208|460019796|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
127836946|NCT01963208|460019791|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
127836947|NCT01963208|460019792|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
127836948|NCT01963208|460019793|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
127836949|NCT01963208|460019794|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
127836950|NCT01963208|460019795|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
127836951|NCT01963208|460019796|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
127836952|NCT01963208|460019791|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
127836953|NCT01963208|460019792|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
127836954|NCT01963208|460019793|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
127836955|NCT01963208|460019794|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
127896498|NCT01984242|460245307|FG000|Overall Study|Study terminated by Sponsor|38|||
127896499|NCT01984242|460245308|FG001|Overall Study|Study terminated by Sponsor|50|||
127896500|NCT01984242|460245309|FG002|Overall Study|Study terminated by Sponsor|34|||
127896501|NCT01984242|460245307|FG000|Overall Study|Disease Progression|0|||
127896502|NCT01984242|460245308|FG001|Overall Study|Disease Progression|0|||
127896503|NCT01984242|460245309|FG002|Overall Study|Disease Progression|1|||
127896504|NCT04543136|460245312|FG000|Overall Study|Withdrawal by Subject|0|||
127896505|NCT04543136|460245313|FG001|Overall Study|Withdrawal by Subject|1|||
127896506|NCT04543136|460245314|FG002|Overall Study|Withdrawal by Subject|0|||
127896507|NCT04543136|460245315|FG003|Overall Study|Withdrawal by Subject|1|||
127896508|NCT04543136|460245316|FG004|Overall Study|Withdrawal by Subject|0|||
127896509|NCT04543136|460245317|FG005|Overall Study|Withdrawal by Subject|0|||
127896510|NCT01626079|460245318|FG000|Overall Study|Death|167|||
127896511|NCT01626079|460245319|FG001|Overall Study|Death|192|||
127896512|NCT01626079|460245320|FG002|Overall Study|Death|39|||
127896513|NCT01626079|460245318|FG000|Overall Study|Withdrawal by Subject|23|||
127896514|NCT01626079|460245319|FG001|Overall Study|Withdrawal by Subject|37|||
127896515|NCT01626079|460245320|FG002|Overall Study|Withdrawal by Subject|5|||
127896516|NCT01626079|460245318|FG000|Overall Study|Lost to Follow-up|7|||
127896517|NCT01626079|460245319|FG001|Overall Study|Lost to Follow-up|4|||
127896518|NCT01626079|460245320|FG002|Overall Study|Lost to Follow-up|2|||
127896519|NCT01626079|460245318|FG000|Overall Study|Missed Visits|1|||
127896520|NCT01626079|460245319|FG001|Overall Study|Missed Visits|4|||
127896521|NCT01626079|460245320|FG002|Overall Study|Missed Visits|6|||
127896522|NCT00865709|460245321|FG000|Treatment|Adverse Event|9|||
127896523|NCT00865709|460245322|FG001|Treatment|Adverse Event|6|||
127896524|NCT00865709|460245321|FG000|Treatment|Withdrawal by Subject|10|||
127896525|NCT00865709|460245322|FG001|Treatment|Withdrawal by Subject|7|||
127896526|NCT00865709|460245321|FG000|Treatment|Physician Decision|3|||
127896527|NCT00865709|460245322|FG001|Treatment|Physician Decision|2|||
127896528|NCT00865709|460245321|FG000|Treatment|Surgery|8|||
127896529|NCT00865709|460245322|FG001|Treatment|Surgery|3|||
127896530|NCT00429923|460245323|FG000|Overall Study|Adverse Event|0|||
127896531|NCT00429923|460245324|FG001|Overall Study|Adverse Event|2|||
127896532|NCT00429923|460245325|FG002|Overall Study|Adverse Event|3|||
127896533|NCT00429923|460245323|FG000|Overall Study|Lack of Efficacy|4|||
127896534|NCT00429923|460245324|FG001|Overall Study|Lack of Efficacy|1|||
127896535|NCT00429923|460245325|FG002|Overall Study|Lack of Efficacy|33|||
127896536|NCT00429923|460245323|FG000|Overall Study|Lost to Follow-up|0|||
127896537|NCT00429923|460245324|FG001|Overall Study|Lost to Follow-up|0|||
127896538|NCT00429923|460245325|FG002|Overall Study|Lost to Follow-up|2|||
127896539|NCT00429923|460245323|FG000|Overall Study|Withdrew Consent|1|||
127896540|NCT00429923|460245324|FG001|Overall Study|Withdrew Consent|0|||
127896541|NCT00429923|460245325|FG002|Overall Study|Withdrew Consent|1|||
127896542|NCT00429923|460245323|FG000|Overall Study|Early Termination|0|||
127896543|NCT00429923|460245324|FG001|Overall Study|Early Termination|1|||
127896544|NCT00429923|460245325|FG002|Overall Study|Early Termination|0|||
127896545|NCT00662129|460245332|FG000|Overall Study|Protocol Violation|1|||
127896546|NCT00662129|460245332|FG000|Overall Study|Cancel prior to beginning treatment|1|||
127896547|NCT00662129|460245332|FG000|Overall Study|Ineligible|1|||
127896548|NCT02153736|460245333|FG000|Overall Study|Lost to Follow-up|1|||
127896549|NCT02153736|460245334|FG001|Overall Study|Lost to Follow-up|0|||
127896550|NCT02153736|460245333|FG000|Overall Study|Medical status change made ineligible|1|||
127896551|NCT02153736|460245334|FG001|Overall Study|Medical status change made ineligible|0|||
127896552|NCT02153736|460245333|FG000|Overall Study|Death|0|||
127896553|NCT02153736|460245334|FG001|Overall Study|Death|1|||
127896554|NCT02153736|460245333|FG000|Overall Study|Withdrawal by Subject|0|||
127896555|NCT02153736|460245334|FG001|Overall Study|Withdrawal by Subject|1|||
127896556|NCT02799602|460245339|FG000|Overall Study|Protocol Violation|1|||
127896557|NCT02799602|460245340|FG001|Overall Study|Protocol Violation|0|||
127896558|NCT02799602|460245339|FG000|Overall Study|Physician Decision|5|||
127896559|NCT02799602|460245340|FG001|Overall Study|Physician Decision|6|||
127896560|NCT02799602|460245339|FG000|Overall Study|Lost to Follow-up|4|||
127896561|NCT02799602|460245340|FG001|Overall Study|Lost to Follow-up|2|||
127896562|NCT02799602|460245339|FG000|Overall Study|Additional primary malignancy|11|||
127896563|NCT02799602|460245340|FG001|Overall Study|Additional primary malignancy|6|||
127896564|NCT02799602|460245339|FG000|Overall Study|Non-compliance with study drug|14|||
127896565|NCT02799602|460245340|FG001|Overall Study|Non-compliance with study drug|12|||
127896566|NCT02799602|460245339|FG000|Overall Study|Adverse event associated with clinical disease progression|24|||
127896567|NCT02799602|460245340|FG001|Overall Study|Adverse event associated with clinical disease progression|26|||
127896568|NCT02799602|460245339|FG000|Overall Study|Withdrawal by Subject|26|||
127896569|NCT02799602|460245340|FG001|Overall Study|Withdrawal by Subject|40|||
127896570|NCT02799602|460245339|FG000|Overall Study|Progressive disease - clinical progression|131|||
127896571|NCT02799602|460245340|FG001|Overall Study|Progressive disease - clinical progression|276|||
127836956|NCT01963208|460019795|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
127836957|NCT01963208|460019796|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
127836958|NCT01963208|460019791|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
127836959|NCT01963208|460019792|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
127836960|NCT01963208|460019793|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
127836961|NCT01963208|460019794|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
127836962|NCT01963208|460019795|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
127836963|NCT01963208|460019796|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
127836964|NCT01963208|460019791|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
127836965|NCT01963208|460019792|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
127836966|NCT01963208|460019793|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
127836967|NCT01963208|460019794|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
127836968|NCT01963208|460019795|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
127836969|NCT01963208|460019796|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
127836970|NCT00448916|460019797|FG000|Overall Study|Adverse Event|2|||
127836971|NCT00448916|460019798|FG001|Overall Study|Adverse Event|2|||
127836972|NCT00448916|460019799|FG002|Overall Study|Adverse Event|3|||
127836973|NCT00448916|460019800|FG003|Overall Study|Adverse Event|2|||
127836974|NCT00448916|460019797|FG000|Overall Study|Lack of Efficacy|1|||
127836975|NCT00448916|460019798|FG001|Overall Study|Lack of Efficacy|0|||
127836976|NCT00448916|460019799|FG002|Overall Study|Lack of Efficacy|2|||
127836977|NCT00448916|460019800|FG003|Overall Study|Lack of Efficacy|1|||
127836978|NCT00448916|460019797|FG000|Overall Study|Withdrawal by Subject|3|||
127836979|NCT00448916|460019798|FG001|Overall Study|Withdrawal by Subject|3|||
127836980|NCT00448916|460019799|FG002|Overall Study|Withdrawal by Subject|1|||
127836981|NCT00448916|460019800|FG003|Overall Study|Withdrawal by Subject|1|||
127836982|NCT00448916|460019797|FG000|Overall Study|Other|1|||
127836983|NCT00448916|460019798|FG001|Overall Study|Other|0|||
127836984|NCT00448916|460019799|FG002|Overall Study|Other|0|||
127836985|NCT00448916|460019800|FG003|Overall Study|Other|0|||
127836986|NCT00448916|460019797|FG000|Overall Study|Lost to Follow-up|0|||
127836987|NCT00448916|460019798|FG001|Overall Study|Lost to Follow-up|1|||
127836988|NCT00448916|460019799|FG002|Overall Study|Lost to Follow-up|0|||
127836989|NCT00448916|460019800|FG003|Overall Study|Lost to Follow-up|1|||
127836990|NCT00448916|460019797|FG000|Overall Study|Protocol Violation|0|||
127836991|NCT00448916|460019798|FG001|Overall Study|Protocol Violation|0|||
127836992|NCT00448916|460019799|FG002|Overall Study|Protocol Violation|0|||
127836993|NCT00448916|460019800|FG003|Overall Study|Protocol Violation|1|||
127836994|NCT03521193|460019801|FG000|Overall Study|Withdrawal by Subject|8|||
127836995|NCT03521193|460019802|FG001|Overall Study|Withdrawal by Subject|0|||
127836996|NCT03521193|460019801|FG000|Overall Study|non compliant to ASA treatment|8|||
127836997|NCT03521193|460019802|FG001|Overall Study|non compliant to ASA treatment|0|||
127836998|NCT03707158|460019803|FG000|Midtreatment|Lost to Follow-up|16|||
127836999|NCT03707158|460019804|FG001|Midtreatment|Lost to Follow-up|7|||
127837000|NCT03707158|460019803|FG000|Midtreatment|Withdrawal by Subject|28|||
127837001|NCT03707158|460019804|FG001|Midtreatment|Withdrawal by Subject|19|||
127837002|NCT03707158|460019803|FG000|Posttreatment|Lost to Follow-up|0|||
127837003|NCT03707158|460019804|FG001|Posttreatment|Lost to Follow-up|5|||
127837004|NCT03707158|460019803|FG000|Follow-up|Lost to Follow-up|19|||
127837005|NCT03707158|460019804|FG001|Follow-up|Lost to Follow-up|18|||
127837006|NCT03707158|460019803|FG000|Follow-up|Withdrawal by Subject|13|||
127837007|NCT03707158|460019804|FG001|Follow-up|Withdrawal by Subject|6|||
127837008|NCT05301322|460019805|FG000|Overall Study|Adverse Event|7|||
127837009|NCT05301322|460019806|FG001|Overall Study|Adverse Event|3|||
127837010|NCT05301322|460019805|FG000|Overall Study|Death|0|||
127837011|NCT05301322|460019806|FG001|Overall Study|Death|1|||
127837012|NCT05301322|460019805|FG000|Overall Study|Lost to Follow-up|2|||
127837013|NCT05301322|460019806|FG001|Overall Study|Lost to Follow-up|1|||
127837014|NCT05301322|460019805|FG000|Overall Study|Protocol Violation|3|||
127837015|NCT05301322|460019806|FG001|Overall Study|Protocol Violation|1|||
127837016|NCT05301322|460019805|FG000|Overall Study|Withdrawal by Subject|3|||
127837017|NCT05301322|460019806|FG001|Overall Study|Withdrawal by Subject|0|||
127837018|NCT05301322|460019805|FG000|Overall Study|Other|4|||
127837019|NCT05301322|460019806|FG001|Overall Study|Other|0|||
127837020|NCT05108805|460019807|FG000|Overall Study|T-cell expansion was not successful.|5|||
127837021|NCT02198651|460021628|FG000|Lead-in Period|Withdrew consent|13|||
127837022|NCT02198651|460021629|FG001|Lead-in Period|Withdrew consent|0|||
127837023|NCT02198651|460021630|FG002|Lead-in Period|Withdrew consent|0|||
127837024|NCT02198651|460021631|FG003|Lead-in Period|Withdrew consent|0|||
127837025|NCT02198651|460021632|FG004|Lead-in Period|Withdrew consent|0|||
127837026|NCT02198651|460021628|FG000|Lead-in Period|Adverse Event|2|||
127837027|NCT02198651|460021629|FG001|Lead-in Period|Adverse Event|0|||
127837028|NCT02198651|460021630|FG002|Lead-in Period|Adverse Event|0|||
127837029|NCT02198651|460021631|FG003|Lead-in Period|Adverse Event|0|||
127837030|NCT02198651|460021632|FG004|Lead-in Period|Adverse Event|0|||
127837031|NCT02198651|460021628|FG000|Lead-in Period|Other, not specified|22|||
127837032|NCT02198651|460021629|FG001|Lead-in Period|Other, not specified|0|||
127837033|NCT02198651|460021630|FG002|Lead-in Period|Other, not specified|0|||
127837034|NCT02198651|460021631|FG003|Lead-in Period|Other, not specified|0|||
127837035|NCT02198651|460021632|FG004|Lead-in Period|Other, not specified|0|||
127837036|NCT02198651|460021628|FG000|Double-blind Period|Withdrew consent|0|||
127837037|NCT02198651|460021629|FG001|Double-blind Period|Withdrew consent|4|||
127837038|NCT02198651|460021630|FG002|Double-blind Period|Withdrew consent|0|||
127837039|NCT02198651|460021631|FG003|Double-blind Period|Withdrew consent|0|||
127837040|NCT02198651|460021632|FG004|Double-blind Period|Withdrew consent|0|||
127837041|NCT02198651|460021628|FG000|Double-blind Period|Adverse Event|0|||
127837042|NCT02198651|460021629|FG001|Double-blind Period|Adverse Event|1|||
127837043|NCT02198651|460021630|FG002|Double-blind Period|Adverse Event|0|||
127837044|NCT02198651|460021631|FG003|Double-blind Period|Adverse Event|0|||
127837045|NCT02198651|460021632|FG004|Double-blind Period|Adverse Event|0|||
127837046|NCT02198651|460021628|FG000|Double-blind Period|Other, not specified|0|||
127837047|NCT02198651|460021629|FG001|Double-blind Period|Other, not specified|4|||
127837048|NCT02198651|460021630|FG002|Double-blind Period|Other, not specified|1|||
127837049|NCT02198651|460021631|FG003|Double-blind Period|Other, not specified|0|||
127837050|NCT02198651|460021632|FG004|Double-blind Period|Other, not specified|0|||
127837051|NCT02198651|460021628|FG000|Open-label Rescue Period|Withdrew consent|0|||
127837052|NCT02198651|460021629|FG001|Open-label Rescue Period|Withdrew consent|0|||
127837053|NCT02198651|460021630|FG002|Open-label Rescue Period|Withdrew consent|0|||
127837054|NCT02198651|460021631|FG003|Open-label Rescue Period|Withdrew consent|2|||
127837055|NCT02198651|460021632|FG004|Open-label Rescue Period|Withdrew consent|0|||
127837056|NCT02198651|460021628|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
127837057|NCT02198651|460021629|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
127837058|NCT02198651|460021630|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
127837059|NCT02198651|460021631|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
127837060|NCT02198651|460021632|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
127837061|NCT02924688|460021634|FG000|Overall Study|Adverse Event|9|||
127837062|NCT02924688|460021635|FG001|Overall Study|Adverse Event|3|||
127837063|NCT02924688|460021636|FG002|Overall Study|Adverse Event|2|||
127837064|NCT02924688|460021637|FG003|Overall Study|Adverse Event|2|||
127837065|NCT02924688|460021638|FG004|Overall Study|Adverse Event|3|||
127837066|NCT02924688|460021639|FG005|Overall Study|Adverse Event|2|||
127837067|NCT02924688|460021634|FG000|Overall Study|Lack of Efficacy|2|||
127837068|NCT02924688|460021635|FG001|Overall Study|Lack of Efficacy|3|||
127837069|NCT02924688|460021636|FG002|Overall Study|Lack of Efficacy|4|||
127837070|NCT02924688|460021637|FG003|Overall Study|Lack of Efficacy|2|||
127837071|NCT02924688|460021638|FG004|Overall Study|Lack of Efficacy|1|||
127837072|NCT02924688|460021639|FG005|Overall Study|Lack of Efficacy|1|||
127837073|NCT02924688|460021634|FG000|Overall Study|Protocol Violation|3|||
127837074|NCT02924688|460021635|FG001|Overall Study|Protocol Violation|7|||
127837075|NCT02924688|460021636|FG002|Overall Study|Protocol Violation|5|||
127837076|NCT02924688|460021637|FG003|Overall Study|Protocol Violation|6|||
127837077|NCT02924688|460021638|FG004|Overall Study|Protocol Violation|2|||
127837078|NCT02924688|460021639|FG005|Overall Study|Protocol Violation|2|||
127896572|NCT02799602|460245339|FG000|Overall Study|Progressive disease - radiological progression|90|||
127896573|NCT02799602|460245340|FG001|Overall Study|Progressive disease - radiological progression|133|||
127896574|NCT02799602|460245339|FG000|Overall Study|Adverse event not associated with clinical disease progression|49|||
127837079|NCT02924688|460021634|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
127837080|NCT02924688|460021635|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
127837081|NCT02924688|460021636|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
127837082|NCT02924688|460021637|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
127837083|NCT02924688|460021638|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
127837084|NCT02924688|460021639|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
127837085|NCT02924688|460021634|FG000|Overall Study|Lost to Follow-up|2|||
127837086|NCT02924688|460021635|FG001|Overall Study|Lost to Follow-up|4|||
127837087|NCT02924688|460021636|FG002|Overall Study|Lost to Follow-up|2|||
127837088|NCT02924688|460021637|FG003|Overall Study|Lost to Follow-up|4|||
127837089|NCT02924688|460021638|FG004|Overall Study|Lost to Follow-up|2|||
127837090|NCT02924688|460021639|FG005|Overall Study|Lost to Follow-up|4|||
127837091|NCT02924688|460021634|FG000|Overall Study|Physician Decision|2|||
127837092|NCT02924688|460021635|FG001|Overall Study|Physician Decision|1|||
127837093|NCT02924688|460021636|FG002|Overall Study|Physician Decision|0|||
127837094|NCT02924688|460021637|FG003|Overall Study|Physician Decision|1|||
127837095|NCT02924688|460021638|FG004|Overall Study|Physician Decision|1|||
127837096|NCT02924688|460021639|FG005|Overall Study|Physician Decision|1|||
127837097|NCT02924688|460021634|FG000|Overall Study|Withdrawal by Subject|14|||
127837098|NCT02924688|460021635|FG001|Overall Study|Withdrawal by Subject|13|||
127837099|NCT02924688|460021636|FG002|Overall Study|Withdrawal by Subject|9|||
127837100|NCT02924688|460021637|FG003|Overall Study|Withdrawal by Subject|12|||
127837101|NCT02924688|460021638|FG004|Overall Study|Withdrawal by Subject|13|||
127837102|NCT02924688|460021639|FG005|Overall Study|Withdrawal by Subject|14|||
127837103|NCT01754922|460021640|FG000|Overall Study|Adverse Event|0|||
127837104|NCT01754922|460021641|FG001|Overall Study|Adverse Event|1|||
127837105|NCT00310388|460021643|FG000|Primary Reporting Phase|Adverse Event|101|||
127837106|NCT00310388|460021644|FG001|Primary Reporting Phase|Adverse Event|0|||
127837107|NCT00310388|460021643|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
127837108|NCT00310388|460021644|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
127837109|NCT00310388|460021643|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
127837110|NCT00310388|460021644|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
127837111|NCT00310388|460021643|FG000|Primary Reporting Phase|Protocol Violation|10|||
127837112|NCT00310388|460021644|FG001|Primary Reporting Phase|Protocol Violation|0|||
127837113|NCT00310388|460021643|FG000|Primary Reporting Phase|Pregnancy|3|||
127837114|NCT00310388|460021644|FG001|Primary Reporting Phase|Pregnancy|0|||
127837115|NCT00310388|460021643|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
127837116|NCT00310388|460021644|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
127837117|NCT00310388|460021643|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
127837118|NCT00310388|460021644|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
127837119|NCT00310388|460021643|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
127837120|NCT00310388|460021644|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
127837121|NCT00310388|460021643|FG000|Primary Reporting Phase|Physician Decision|2|||
127837122|NCT00310388|460021644|FG001|Primary Reporting Phase|Physician Decision|0|||
127837123|NCT00310388|460021643|FG000|Primary Reporting Phase|Request of the sponsor|19|||
127837124|NCT00310388|460021644|FG001|Primary Reporting Phase|Request of the sponsor|0|||
127837125|NCT00310388|460021643|FG000|Primary Reporting Phase|Failed to return|8|||
127837126|NCT00310388|460021644|FG001|Primary Reporting Phase|Failed to return|0|||
127837127|NCT00310388|460021643|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
127837128|NCT00310388|460021644|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
127837129|NCT00310388|460021643|FG000|Primary Reporting Phase|Participant request|2|||
127837130|NCT00310388|460021644|FG001|Primary Reporting Phase|Participant request|0|||
127837131|NCT00310388|460021643|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
127837132|NCT00310388|460021644|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
127837133|NCT00310388|460021643|FG000|Primary Reporting Phase|Discontinuation of study|1|||
127837134|NCT00310388|460021644|FG001|Primary Reporting Phase|Discontinuation of study|0|||
127837135|NCT00310388|460021643|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
127837136|NCT00310388|460021644|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
127837137|NCT00310388|460021643|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
127837138|NCT00310388|460021644|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
127837139|NCT00310388|460021643|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
127837140|NCT00310388|460021644|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
127837141|NCT00310388|460021643|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
127837142|NCT00310388|460021644|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
127837143|NCT00310388|460021643|FG000|Primary Reporting Phase|Participant passed away|1|||
127837144|NCT00310388|460021644|FG001|Primary Reporting Phase|Participant passed away|0|||
127837145|NCT00310388|460021643|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
127837146|NCT00310388|460021644|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
127837147|NCT00310388|460021643|FG000|Primary Reporting Phase|Missing|1|||
127837148|NCT00310388|460021644|FG001|Primary Reporting Phase|Missing|0|||
127837149|NCT00310388|460021643|FG000|Primary Reporting Phase|Other|1|||
127837150|NCT00310388|460021644|FG001|Primary Reporting Phase|Other|0|||
127837151|NCT00310388|460021643|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
127837152|NCT00310388|460021644|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
127837153|NCT00310388|460021643|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
127837154|NCT00310388|460021644|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
127837155|NCT00310388|460021643|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
127837156|NCT00310388|460021644|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
127837157|NCT00310388|460021643|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
127837158|NCT00310388|460021644|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
127837159|NCT00848250|460021646|FG000|Overall Study|surgery was completed without cardiopulm|0|||
127837160|NCT00848250|460021647|FG001|Overall Study|surgery was completed without cardiopulm|1|||
127837161|NCT01069523|460021648|FG000|Overall Study|Withdrawal by Subject|4|||
127837162|NCT01069523|460021649|FG001|Overall Study|Withdrawal by Subject|7|||
127837163|NCT05836818|460021654|FG000|Overall Study|Physician Decision|1|||
127837164|NCT05836818|460021655|FG001|Overall Study|Physician Decision|1|||
127837165|NCT05836818|460021656|FG002|Overall Study|Physician Decision|0|||
127837166|NCT05836818|460021654|FG000|Overall Study|Withdrawal by Subject|0|||
127837167|NCT05836818|460021655|FG001|Overall Study|Withdrawal by Subject|0|||
127837168|NCT05836818|460021656|FG002|Overall Study|Withdrawal by Subject|1|||
127837169|NCT05836818|460021654|FG000|Overall Study|Later found to be previously vaccinated|0|||
127837170|NCT05836818|460021655|FG001|Overall Study|Later found to be previously vaccinated|1|||
127837171|NCT05836818|460021656|FG002|Overall Study|Later found to be previously vaccinated|3|||
127837172|NCT05836818|460021654|FG000|Overall Study|Pregnancy|0|||
127837173|NCT05836818|460021655|FG001|Overall Study|Pregnancy|1|||
127837174|NCT05836818|460021656|FG002|Overall Study|Pregnancy|0|||
127837175|NCT05836818|460021654|FG000|Overall Study|Allergic to vaccines|0|||
127837176|NCT05836818|460021655|FG001|Overall Study|Allergic to vaccines|1|||
127837177|NCT05836818|460021656|FG002|Overall Study|Allergic to vaccines|0|||
127837178|NCT00621855|460021665|FG000|Overall Study|Adverse Event|32|||
127837179|NCT00621855|460021666|FG001|Overall Study|Adverse Event|31|||
127837180|NCT00621855|460021667|FG002|Overall Study|Adverse Event|48|||
127837181|NCT00621855|460021668|FG003|Overall Study|Adverse Event|34|||
127837182|NCT00621855|460021669|FG004|Overall Study|Adverse Event|31|||
127837183|NCT00621855|460021665|FG000|Overall Study|Lost to Follow-up|0|||
127837184|NCT00621855|460021666|FG001|Overall Study|Lost to Follow-up|1|||
127837185|NCT00621855|460021667|FG002|Overall Study|Lost to Follow-up|3|||
127837186|NCT00621855|460021668|FG003|Overall Study|Lost to Follow-up|4|||
127837187|NCT00621855|460021669|FG004|Overall Study|Lost to Follow-up|1|||
127837188|NCT00621855|460021665|FG000|Overall Study|Protocol Violation|16|||
127837189|NCT00621855|460021666|FG001|Overall Study|Protocol Violation|8|||
127837190|NCT00621855|460021667|FG002|Overall Study|Protocol Violation|6|||
127837191|NCT00621855|460021668|FG003|Overall Study|Protocol Violation|7|||
127837192|NCT00621855|460021669|FG004|Overall Study|Protocol Violation|8|||
127837193|NCT00621855|460021665|FG000|Overall Study|Withdrawal by Subject|16|||
127837194|NCT00621855|460021666|FG001|Overall Study|Withdrawal by Subject|11|||
127837195|NCT00621855|460021667|FG002|Overall Study|Withdrawal by Subject|13|||
127837196|NCT00621855|460021668|FG003|Overall Study|Withdrawal by Subject|13|||
127837197|NCT00621855|460021669|FG004|Overall Study|Withdrawal by Subject|9|||
127837198|NCT00621855|460021665|FG000|Overall Study|Other|9|||
127837199|NCT00621855|460021666|FG001|Overall Study|Other|7|||
127837200|NCT00621855|460021667|FG002|Overall Study|Other|6|||
127837201|NCT00621855|460021668|FG003|Overall Study|Other|5|||
127837202|NCT00621855|460021669|FG004|Overall Study|Other|4|||
127837203|NCT00621855|460021665|FG000|Overall Study|Patients did not receive study drug|3|||
127837204|NCT00621855|460021666|FG001|Overall Study|Patients did not receive study drug|3|||
127837205|NCT00621855|460021667|FG002|Overall Study|Patients did not receive study drug|5|||
127837206|NCT00621855|460021668|FG003|Overall Study|Patients did not receive study drug|4|||
127837207|NCT00621855|460021669|FG004|Overall Study|Patients did not receive study drug|2|||
127837208|NCT02953782|460021670|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
127837209|NCT02953782|460021671|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
127837210|NCT02953782|460021672|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
127837211|NCT02953782|460021673|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
127837212|NCT02953782|460021674|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
127837213|NCT02953782|460021675|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
127837214|NCT02953782|460021676|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
127837215|NCT02953782|460021677|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
127837216|NCT02953782|460021670|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
127837217|NCT02953782|460021671|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
127837218|NCT02953782|460021672|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
127837219|NCT02953782|460021673|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
127837220|NCT02953782|460021674|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
127837221|NCT02953782|460021675|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
127837222|NCT02953782|460021676|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
127837223|NCT02953782|460021677|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
127837224|NCT02953782|460021670|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
127837225|NCT02953782|460021671|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
127837226|NCT02953782|460021672|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
127837227|NCT02953782|460021673|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
127837228|NCT02953782|460021674|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
127837229|NCT02953782|460021675|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
127837230|NCT02953782|460021676|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
127837231|NCT02953782|460021677|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
127837232|NCT02953782|460021670|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
127837233|NCT02953782|460021671|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
127837234|NCT02953782|460021672|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
127837235|NCT02953782|460021673|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
127837236|NCT02953782|460021674|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
127837237|NCT02953782|460021675|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
127837238|NCT02953782|460021676|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
127837239|NCT02953782|460021677|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
127837240|NCT02953782|460021670|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
127837241|NCT02953782|460021671|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
127837242|NCT02953782|460021672|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
127837243|NCT02953782|460021673|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
127837244|NCT02953782|460021674|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
127837245|NCT02953782|460021675|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
127837246|NCT02953782|460021676|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
127837247|NCT02953782|460021677|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
127837248|NCT02953782|460021670|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
127837249|NCT02953782|460021671|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
127837250|NCT02953782|460021672|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
127837251|NCT02953782|460021673|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
127837252|NCT02953782|460021674|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
127837253|NCT02953782|460021675|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
127837254|NCT02953782|460021676|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
127837255|NCT02953782|460021677|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
127837256|NCT02953782|460021670|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
127837257|NCT02953782|460021671|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
127837258|NCT02953782|460021672|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
127896575|NCT02799602|460245340|FG001|Overall Study|Adverse event not associated with clinical disease progression|27|||
127896576|NCT02799602|460245339|FG000|Overall Study|Death|9|||
127896577|NCT02799602|460245340|FG001|Overall Study|Death|5|||
127896578|NCT02799602|460245339|FG000|Overall Study|Other|287|||
127896579|NCT02799602|460245340|FG001|Overall Study|Other|118|||
127896580|NCT02799602|460245339|FG000|Overall Study|Study drug never administered|0|||
127896581|NCT02799602|460245340|FG001|Overall Study|Study drug never administered|3|||
127896582|NCT02626949|460245341|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
127896583|NCT02626949|460245342|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
127896584|NCT02626949|460245341|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
127896585|NCT02626949|460245342|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
127896586|NCT02626949|460245341|FG000|Enrolled|Lost to Follow-up|7|||
127896587|NCT02626949|460245342|FG001|Enrolled|Lost to Follow-up|6|||
127896588|NCT02626949|460245341|FG000|Enrolled|Withdrawal by Subject|3|||
127896589|NCT02626949|460245342|FG001|Enrolled|Withdrawal by Subject|2|||
127896590|NCT00720122|460245351|FG000|Overall Study|Lost to Follow-up|1|||
127896591|NCT00720122|460245351|FG000|Overall Study|Physician Decision|1|||
127896592|NCT00720122|460245351|FG000|Overall Study|Withdrawal by Subject|7|||
127896593|NCT03072459|460245352|FG000|Overall Study|Device revised/removed|1|||
127896594|NCT03072459|460245352|FG000|Overall Study|Subject not able to return|1|||
127896595|NCT00329602|460245353|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
127896596|NCT00329602|460245354|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
127896597|NCT00329602|460245355|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
127896598|NCT00329602|460245353|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
127896599|NCT00329602|460245354|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
127896600|NCT00329602|460245355|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
127896601|NCT00329602|460245353|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
127896602|NCT00329602|460245354|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
127896603|NCT00329602|460245355|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
127896604|NCT00329602|460245353|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
127896605|NCT00329602|460245354|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
127896606|NCT00329602|460245355|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
127896607|NCT00329602|460245353|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
127896608|NCT00329602|460245354|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
127896609|NCT00329602|460245355|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
127896610|NCT00329602|460245353|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
127896611|NCT00329602|460245354|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
127896612|NCT00329602|460245355|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
127896613|NCT02275364|460245356|FG000|Period 1|Withdrawal by Subject|1|||
127896614|NCT02275364|460245357|FG001|Period 1|Withdrawal by Subject|0|||
127896615|NCT02275364|460245356|FG000|Period 1|Other reason|1|||
127896616|NCT02275364|460245357|FG001|Period 1|Other reason|0|||
127896617|NCT01361126|460245362|FG000|Overall Study|Sponsor decision|0|||
127896618|NCT01361126|460245363|FG001|Overall Study|Sponsor decision|2|||
127896619|NCT00663871|460245365|FG000|Overall Study|Lost to Follow-up|5|||
127896620|NCT00663871|460245366|FG001|Overall Study|Lost to Follow-up|5|||
127896621|NCT00663871|460245365|FG000|Overall Study|Withdrawal by Subject|5|||
127896622|NCT00663871|460245366|FG001|Overall Study|Withdrawal by Subject|2|||
127896623|NCT04094870|460245367|FG000|Overall Study|Lost to Follow-up|1|||
127896624|NCT04094870|460245368|FG001|Overall Study|Lost to Follow-up|1|||
127896625|NCT02742181|460245371|FG000|Overall Study|Physician Decision|1|||
127896626|NCT02742181|460245372|FG001|Overall Study|Physician Decision|0|||
127896627|NCT02739984|460245373|FG000|Overall Study|Sponsor Decision|1|||
127896628|NCT02739984|460245374|FG001|Overall Study|Sponsor Decision|0|||
127896629|NCT02739984|460245373|FG000|Overall Study|Withdrawal by Subject|1|||
127896630|NCT02739984|460245374|FG001|Overall Study|Withdrawal by Subject|1|||
127896631|NCT02739984|460245373|FG000|Overall Study|Death|0|||
127896632|NCT02739984|460245374|FG001|Overall Study|Death|1|||
127896633|NCT02739984|460245373|FG000|Overall Study|Lost to Follow-up|3|||
127896634|NCT02739984|460245374|FG001|Overall Study|Lost to Follow-up|0|||
127896635|NCT02415959|460245375|FG000|Overall Study|Adverse Event|0|||
127896636|NCT02415959|460245376|FG001|Overall Study|Adverse Event|1|||
127896637|NCT02415959|460245377|FG002|Overall Study|Adverse Event|0|||
127896638|NCT02415959|460245378|FG003|Overall Study|Adverse Event|0|||
127896639|NCT02415959|460245379|FG004|Overall Study|Adverse Event|0|||
127896640|NCT02415959|460245375|FG000|Overall Study|Protocol Violation|0|||
127896641|NCT02415959|460245376|FG001|Overall Study|Protocol Violation|0|||
127896642|NCT02415959|460245377|FG002|Overall Study|Protocol Violation|0|||
127896643|NCT02415959|460245378|FG003|Overall Study|Protocol Violation|1|||
127896644|NCT02415959|460245379|FG004|Overall Study|Protocol Violation|0|||
127896645|NCT02109133|460245384|FG000|Overall Study|Lost to Follow-up|1|||
127896646|NCT02109133|460245385|FG001|Overall Study|Lost to Follow-up|0|||
127896647|NCT00409578|460245388|FG000|Overall Study|Adverse Event|27|||
127896648|NCT00409578|460245389|FG001|Overall Study|Adverse Event|37|||
127837259|NCT02953782|460021673|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
127837260|NCT02953782|460021674|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
127837261|NCT02953782|460021675|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
127837262|NCT02953782|460021676|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
127837263|NCT02953782|460021677|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
127837264|NCT02953782|460021670|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
127837265|NCT02953782|460021671|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
127837266|NCT02953782|460021672|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
127837267|NCT02953782|460021673|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
127837268|NCT02953782|460021674|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
127837269|NCT02953782|460021675|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
127837270|NCT02953782|460021676|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
127837271|NCT02953782|460021677|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
127837272|NCT01737840|460021678|FG000|Overall Study|Diagnosed with an other pathology|2|||
127837273|NCT01737840|460021679|FG001|Overall Study|Diagnosed with an other pathology|2|||
127837274|NCT03105700|460021680|FG000|Overall Study|screen fail|3|||
127837275|NCT03105700|460021680|FG000|Overall Study|Lost to Follow-up|4|||
127837276|NCT00403559|460021683|FG000|Overall Study|Adverse Event|0|||
127837277|NCT00403559|460021684|FG001|Overall Study|Adverse Event|1|||
127837278|NCT00403559|460021683|FG000|Overall Study|Lost to Follow-up|3|||
127837279|NCT00403559|460021684|FG001|Overall Study|Lost to Follow-up|3|||
127837280|NCT00403559|460021683|FG000|Overall Study|Withdrawal by Subject|1|||
127837281|NCT00403559|460021684|FG001|Overall Study|Withdrawal by Subject|0|||
127837282|NCT01253421|460021685|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
127837283|NCT01253421|460021686|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
127837284|NCT01253421|460021687|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
127837285|NCT01253421|460021688|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
127837286|NCT01253421|460021689|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
127837287|NCT01253421|460021685|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
127837288|NCT01253421|460021686|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
127837289|NCT01253421|460021687|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
127837290|NCT01253421|460021688|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
127837291|NCT01253421|460021689|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
127837292|NCT01253421|460021685|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
127837293|NCT01253421|460021686|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
127837294|NCT01253421|460021687|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
127837295|NCT01253421|460021688|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
127837296|NCT01253421|460021689|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
127837297|NCT01253421|460021685|FG000|Assessment and Scheduling|Physician Decision|1|||
127837298|NCT01253421|460021686|FG001|Assessment and Scheduling|Physician Decision|0|||
127837299|NCT01253421|460021687|FG002|Assessment and Scheduling|Physician Decision|0|||
127837300|NCT01253421|460021688|FG003|Assessment and Scheduling|Physician Decision|0|||
127837301|NCT01253421|460021689|FG004|Assessment and Scheduling|Physician Decision|0|||
127837302|NCT01253421|460021685|FG000|Drug+Scanning Visit|Physician Decision|0|||
127837303|NCT01253421|460021686|FG001|Drug+Scanning Visit|Physician Decision|0|||
127837304|NCT01253421|460021687|FG002|Drug+Scanning Visit|Physician Decision|0|||
127837305|NCT01253421|460021688|FG003|Drug+Scanning Visit|Physician Decision|0|||
127837306|NCT01253421|460021689|FG004|Drug+Scanning Visit|Physician Decision|1|||
127837307|NCT00929734|460021690|FG000|Overall Study|Lost to Follow-up|2|||
127837308|NCT00929734|460021691|FG001|Overall Study|Lost to Follow-up|1|||
127837309|NCT00929734|460021690|FG000|Overall Study|Withdrawal by Subject|0|||
127837310|NCT00929734|460021691|FG001|Overall Study|Withdrawal by Subject|2|||
127837311|NCT00980980|460021693|FG000|Overall Study|Withdrawal by Hospital|0|||
127837312|NCT00980980|460021694|FG001|Overall Study|Withdrawal by Hospital|1|||
127837313|NCT00980980|460021695|FG002|Overall Study|Withdrawal by Hospital|0|||
127837314|NCT00121992|460021696|FG000|Overall Study|Treatment not received|2|||
127837315|NCT00121992|460021697|FG001|Overall Study|Treatment not received|11|||
127837316|NCT00414960|460021698|FG000|Overall Study|Adverse Event|4|||
127837317|NCT00414960|460021699|FG001|Overall Study|Adverse Event|0|||
127837318|NCT00414960|460021698|FG000|Overall Study|Withdrawal by Subject|3|||
127837319|NCT00414960|460021699|FG001|Overall Study|Withdrawal by Subject|0|||
127837320|NCT00414960|460021698|FG000|Overall Study|Physician Decision|0|||
127837321|NCT00414960|460021699|FG001|Overall Study|Physician Decision|1|||
127837322|NCT01449682|460021700|FG000|Overall Study|Death|0|||
127837323|NCT01449682|460021701|FG001|Overall Study|Death|1|||
127837324|NCT01449682|460021700|FG000|Overall Study|Adverse Event|1|||
127837325|NCT01449682|460021701|FG001|Overall Study|Adverse Event|0|||
127837326|NCT04863014|460021702|FG000|Overall Study|Lost to Follow-up|3|||
127837327|NCT04863014|460021703|FG001|Overall Study|Lost to Follow-up|2|||
127896649|NCT00409578|460245390|FG002|Overall Study|Adverse Event|25|||
127837328|NCT04863014|460021702|FG000|Overall Study|Subject Decision|0|||
127837329|NCT04863014|460021703|FG001|Overall Study|Subject Decision|4|||
127837330|NCT04633473|460021704|FG000|Overall Study|Withdrawal by Subject|6|||
127837331|NCT03294681|460021705|FG000|Overall Study|Withdrawal by Subject|1|||
127837332|NCT01553916|460021706|FG000|Overall Study|Withdrawal by Subject|2|||
127837333|NCT01553916|460021706|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
127837334|NCT03089216|460021711|FG000|Overall Study|Adverse Event|0|||
127837335|NCT03089216|460021712|FG001|Overall Study|Adverse Event|0|||
127837336|NCT03089216|460021713|FG002|Overall Study|Adverse Event|0|||
127837337|NCT03089216|460021714|FG003|Overall Study|Adverse Event|1|||
127837338|NCT00417976|460021715|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
127837339|NCT00417976|460021715|FG000|Overall Study|Treatment -related toxicity|2|||
127837340|NCT04348591|460021718|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
127837341|NCT04348591|460021719|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
127837342|NCT04348591|460021718|FG000|Imaging Session (120 Min)|Physician Decision|0|||
127837343|NCT04348591|460021719|FG001|Imaging Session (120 Min)|Physician Decision|1|||
127837344|NCT04348591|460021718|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
127837345|NCT04348591|460021719|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
127837346|NCT02104804|460021722|FG000|Overall Study|Did not take study medication|0|||
127896650|NCT00409578|460245391|FG003|Overall Study|Adverse Event|33|||
127837347|NCT02104804|460021723|FG001|Overall Study|Did not take study medication|1|||
127896651|NCT00409578|460245388|FG000|Overall Study|Abnormal laboratory value(s)|2|||
127837348|NCT02104804|460021722|FG000|Overall Study|Study specific discontinuation criteria|6|||
127837349|NCT02104804|460021723|FG001|Overall Study|Study specific discontinuation criteria|1|||
127837350|NCT02104804|460021722|FG000|Overall Study|Other listed|2|||
127837351|NCT02104804|460021723|FG001|Overall Study|Other listed|1|||
127837352|NCT02104804|460021722|FG000|Overall Study|Protocol Violation|0|||
127837353|NCT02104804|460021723|FG001|Overall Study|Protocol Violation|1|||
127837354|NCT02104804|460021722|FG000|Overall Study|Adverse Event|4|||
127837355|NCT02104804|460021723|FG001|Overall Study|Adverse Event|3|||
127837356|NCT02104804|460021722|FG000|Overall Study|Withdrawal by Subject|4|||
127837357|NCT02104804|460021723|FG001|Overall Study|Withdrawal by Subject|12|||
127837358|NCT01348425|460021724|FG000|Overall Study|Imaging was not taken.|1|||
127837359|NCT01348425|460021725|FG001|Overall Study|Imaging was not taken.|1|||
127837360|NCT02720016|460021726|FG000|Overall Study|Separation of couple|6|||
127837361|NCT02720016|460021727|FG001|Overall Study|Separation of couple|8|||
127837362|NCT02720016|460021728|FG002|Overall Study|Separation of couple|2|||
127837363|NCT02720016|460021726|FG000|Overall Study|Withdrawal by Subject|6|||
127837364|NCT02720016|460021727|FG001|Overall Study|Withdrawal by Subject|6|||
127837365|NCT02720016|460021728|FG002|Overall Study|Withdrawal by Subject|4|||
127837366|NCT02720016|460021726|FG000|Overall Study|Scheduling issues|2|||
127837367|NCT02720016|460021727|FG001|Overall Study|Scheduling issues|4|||
127837368|NCT02720016|460021728|FG002|Overall Study|Scheduling issues|7|||
127837369|NCT02720016|460021726|FG000|Overall Study|Childcare|2|||
127837370|NCT02720016|460021727|FG001|Overall Study|Childcare|0|||
127837371|NCT02720016|460021728|FG002|Overall Study|Childcare|2|||
127837372|NCT02720016|460021726|FG000|Overall Study|Withdrawal by PI|2|||
127837373|NCT02720016|460021727|FG001|Overall Study|Withdrawal by PI|2|||
127837374|NCT02720016|460021728|FG002|Overall Study|Withdrawal by PI|0|||
127837375|NCT02720016|460021726|FG000|Overall Study|Moved away|2|||
127837376|NCT02720016|460021727|FG001|Overall Study|Moved away|0|||
127837377|NCT02720016|460021728|FG002|Overall Study|Moved away|0|||
127837378|NCT02720016|460021726|FG000|Overall Study|Not Primary Health Concern|0|||
127837379|NCT02720016|460021727|FG001|Overall Study|Not Primary Health Concern|0|||
127837380|NCT02720016|460021728|FG002|Overall Study|Not Primary Health Concern|2|||
127837381|NCT02720016|460021726|FG000|Overall Study|Transportation issues|0|||
127837382|NCT02720016|460021727|FG001|Overall Study|Transportation issues|0|||
127837383|NCT02720016|460021728|FG002|Overall Study|Transportation issues|1|||
127837384|NCT02720016|460021726|FG000|Overall Study|Other|0|||
127837385|NCT02720016|460021727|FG001|Overall Study|Other|0|||
127837386|NCT02720016|460021728|FG002|Overall Study|Other|2|||
127837387|NCT01968954|460021735|FG000|Overall Study|Adverse Event|6|||
127837388|NCT01968954|460021736|FG001|Overall Study|Adverse Event|3|||
127485451|NCT01240863|458741183|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
127837389|NCT01968954|460021735|FG000|Overall Study|Death|1|||
127837390|NCT01968954|460021736|FG001|Overall Study|Death|2|||
127837391|NCT01968954|460021735|FG000|Overall Study|Lost to Follow-up|6|||
127837392|NCT01968954|460021736|FG001|Overall Study|Lost to Follow-up|4|||
127837393|NCT01968954|460021735|FG000|Overall Study|Withdrawal by Subject|20|||
127837394|NCT01968954|460021736|FG001|Overall Study|Withdrawal by Subject|23|||
127837395|NCT01968954|460021735|FG000|Overall Study|Other|7|||
127837396|NCT01968954|460021736|FG001|Overall Study|Other|8|||
127837397|NCT01968954|460021735|FG000|Overall Study|Protocol Violation|0|||
127837398|NCT01968954|460021736|FG001|Overall Study|Protocol Violation|1|||
127837399|NCT01968954|460021735|FG000|Overall Study|Did not met inclusion criteria|0|||
127837400|NCT01968954|460021736|FG001|Overall Study|Did not met inclusion criteria|2|||
127837401|NCT00751114|460021737|FG000|Overall Study|Adverse Event|2|||
127837402|NCT00751114|460021738|FG001|Overall Study|Adverse Event|4|||
127837403|NCT00751114|460021737|FG000|Overall Study|Protocol Violation|8|||
127837404|NCT00751114|460021738|FG001|Overall Study|Protocol Violation|9|||
127837405|NCT00751114|460021737|FG000|Overall Study|Withdrawal by Subject|9|||
127837406|NCT00751114|460021738|FG001|Overall Study|Withdrawal by Subject|4|||
127837407|NCT00751114|460021737|FG000|Overall Study|Lost to Follow-up|4|||
127837408|NCT00751114|460021738|FG001|Overall Study|Lost to Follow-up|7|||
127837409|NCT00751114|460021737|FG000|Overall Study|Lack of Efficacy|0|||
127837410|NCT00751114|460021738|FG001|Overall Study|Lack of Efficacy|7|||
127837411|NCT00751114|460021737|FG000|Overall Study|Not Treated|13|||
127837412|NCT00751114|460021738|FG001|Overall Study|Not Treated|1|||
127837413|NCT00751114|460021737|FG000|Overall Study|Out of country for 2 months|1|||
127837414|NCT00751114|460021738|FG001|Overall Study|Out of country for 2 months|0|||
127837415|NCT00751114|460021737|FG000|Overall Study|Move to another city|1|||
127837416|NCT00751114|460021738|FG001|Overall Study|Move to another city|0|||
127837417|NCT05319080|460021739|FG000|Overall Study|Withdrawal by Subject|2|||
127837418|NCT05319080|460021739|FG000|Overall Study|Physician Decision|4|||
127837419|NCT04465396|460021742|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
127837420|NCT04465396|460021743|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
127837421|NCT04465396|460021744|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
127837422|NCT04465396|460021745|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
127837423|NCT02648724|460021746|FG000|Overall Study|Withdrawal by Subject|0|||
127837424|NCT02648724|460021747|FG001|Overall Study|Withdrawal by Subject|1|||
127837425|NCT02648724|460021748|FG002|Overall Study|Withdrawal by Subject|1|||
127837426|NCT02648724|460021749|FG003|Overall Study|Withdrawal by Subject|0|||
127837427|NCT02648724|460021750|FG004|Overall Study|Withdrawal by Subject|1|||
127837428|NCT02648724|460021751|FG005|Overall Study|Withdrawal by Subject|0|||
127837429|NCT02648724|460021752|FG006|Overall Study|Withdrawal by Subject|0|||
127837430|NCT02648724|460021746|FG000|Overall Study|Progressive disease|2|||
127837431|NCT02648724|460021747|FG001|Overall Study|Progressive disease|2|||
127837432|NCT02648724|460021748|FG002|Overall Study|Progressive disease|2|||
127837433|NCT02648724|460021749|FG003|Overall Study|Progressive disease|3|||
127837434|NCT02648724|460021750|FG004|Overall Study|Progressive disease|22|||
127837435|NCT02648724|460021751|FG005|Overall Study|Progressive disease|7|||
127837436|NCT02648724|460021752|FG006|Overall Study|Progressive disease|8|||
127837437|NCT02648724|460021746|FG000|Overall Study|Other reason (unknown)|1|||
127837438|NCT02648724|460021747|FG001|Overall Study|Other reason (unknown)|0|||
127837439|NCT02648724|460021748|FG002|Overall Study|Other reason (unknown)|0|||
127837440|NCT02648724|460021749|FG003|Overall Study|Other reason (unknown)|0|||
127837441|NCT02648724|460021750|FG004|Overall Study|Other reason (unknown)|0|||
127837442|NCT02648724|460021751|FG005|Overall Study|Other reason (unknown)|0|||
127837443|NCT02648724|460021752|FG006|Overall Study|Other reason (unknown)|0|||
127837444|NCT02648724|460021746|FG000|Overall Study|Protocol Violation|0|||
127837445|NCT02648724|460021747|FG001|Overall Study|Protocol Violation|0|||
127837446|NCT02648724|460021748|FG002|Overall Study|Protocol Violation|0|||
127837447|NCT02648724|460021749|FG003|Overall Study|Protocol Violation|0|||
127837448|NCT02648724|460021750|FG004|Overall Study|Protocol Violation|1|||
127837449|NCT02648724|460021751|FG005|Overall Study|Protocol Violation|0|||
127837450|NCT02648724|460021752|FG006|Overall Study|Protocol Violation|0|||
127837451|NCT02648724|460021746|FG000|Overall Study|Death|0|||
127837452|NCT02648724|460021747|FG001|Overall Study|Death|0|||
127837453|NCT02648724|460021748|FG002|Overall Study|Death|0|||
127837454|NCT02648724|460021749|FG003|Overall Study|Death|0|||
127837455|NCT02648724|460021750|FG004|Overall Study|Death|0|||
127837456|NCT02648724|460021751|FG005|Overall Study|Death|0|||
127837457|NCT02648724|460021752|FG006|Overall Study|Death|3|||
127837458|NCT02648724|460021746|FG000|Overall Study|Physician Decision|0|||
127837459|NCT02648724|460021747|FG001|Overall Study|Physician Decision|0|||
127837460|NCT02648724|460021748|FG002|Overall Study|Physician Decision|0|||
127837461|NCT02648724|460021749|FG003|Overall Study|Physician Decision|0|||
127837462|NCT02648724|460021750|FG004|Overall Study|Physician Decision|1|||
127896652|NCT00409578|460245389|FG001|Overall Study|Abnormal laboratory value(s)|2|||
127896653|NCT00409578|460245390|FG002|Overall Study|Abnormal laboratory value(s)|2|||
127896654|NCT00409578|460245391|FG003|Overall Study|Abnormal laboratory value(s)|4|||
127896655|NCT00409578|460245388|FG000|Overall Study|Lack of Efficacy|0|||
127837463|NCT02648724|460021751|FG005|Overall Study|Physician Decision|0|||
127837464|NCT02648724|460021752|FG006|Overall Study|Physician Decision|1|||
127837465|NCT02648724|460021746|FG000|Overall Study|Transferred to named patient program|0|||
127837466|NCT02648724|460021747|FG001|Overall Study|Transferred to named patient program|0|||
127837467|NCT02648724|460021748|FG002|Overall Study|Transferred to named patient program|0|||
127837468|NCT02648724|460021749|FG003|Overall Study|Transferred to named patient program|0|||
127837469|NCT02648724|460021750|FG004|Overall Study|Transferred to named patient program|0|||
127837470|NCT02648724|460021751|FG005|Overall Study|Transferred to named patient program|1|||
127837471|NCT02648724|460021752|FG006|Overall Study|Transferred to named patient program|0|||
127837472|NCT03076190|460021755|FG000|Overall Study|Lost to Follow-up|9|||
127837473|NCT03076190|460021756|FG001|Overall Study|Lost to Follow-up|34|||
127837474|NCT03076190|460021755|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
127837475|NCT03076190|460021756|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
127837476|NCT00434122|460021757|FG000|Overall Study|Non-compliance with protocol|0|||
127837477|NCT00434122|460021758|FG001|Overall Study|Non-compliance with protocol|1|||
127837478|NCT00434122|460021757|FG000|Overall Study|loss of subject contact|1|||
127837479|NCT00434122|460021758|FG001|Overall Study|loss of subject contact|1|||
127837480|NCT00434122|460021757|FG000|Overall Study|Personal reasons|1|||
127837481|NCT00434122|460021758|FG001|Overall Study|Personal reasons|1|||
127837482|NCT00434122|460021757|FG000|Overall Study|Large follicle size|2|||
127837483|NCT00434122|460021758|FG001|Overall Study|Large follicle size|2|||
127837484|NCT00434122|460021757|FG000|Overall Study|Low follicular response.|1|||
127837485|NCT00434122|460021758|FG001|Overall Study|Low follicular response.|2|||
127837486|NCT00434122|460021757|FG000|Overall Study|Travelling of subject.|1|||
127837487|NCT00434122|460021758|FG001|Overall Study|Travelling of subject.|0|||
127837488|NCT04191577|460021759|FG000|Overall Study|Withdrawal by Subject|2|||
127837489|NCT04191577|460021760|FG001|Overall Study|Withdrawal by Subject|2|||
127837490|NCT04191577|460021761|FG002|Overall Study|Withdrawal by Subject|1|||
127837491|NCT04191577|460021759|FG000|Overall Study|Physician Decision|1|||
127837492|NCT04191577|460021760|FG001|Overall Study|Physician Decision|1|||
127837493|NCT04191577|460021761|FG002|Overall Study|Physician Decision|0|||
127837494|NCT04191577|460021759|FG000|Overall Study|Adverse Event|0|||
127837495|NCT04191577|460021760|FG001|Overall Study|Adverse Event|0|||
127837496|NCT04191577|460021761|FG002|Overall Study|Adverse Event|1|||
127837497|NCT04191577|460021759|FG000|Overall Study|Death|0|||
127837498|NCT04191577|460021760|FG001|Overall Study|Death|0|||
127837499|NCT04191577|460021761|FG002|Overall Study|Death|1|||
127837500|NCT01185249|460021762|FG000|Overall Study|Patients discharged or change in status|42|||
127837501|NCT00406783|460021765|FG000|Overall Study|Adverse Event|4|||
127837502|NCT00406783|460021766|FG001|Overall Study|Adverse Event|4|||
127837503|NCT00406783|460021765|FG000|Overall Study|Treatment Failure|2|||
127837504|NCT00406783|460021766|FG001|Overall Study|Treatment Failure|3|||
127837505|NCT00406783|460021765|FG000|Overall Study|Lost to Follow-up|3|||
127837506|NCT00406783|460021766|FG001|Overall Study|Lost to Follow-up|0|||
127837507|NCT00406783|460021765|FG000|Overall Study|Withdrawal by Subject|1|||
127837508|NCT00406783|460021766|FG001|Overall Study|Withdrawal by Subject|4|||
127837509|NCT00406783|460021765|FG000|Overall Study|Protocol Violation|4|||
127837510|NCT00406783|460021766|FG001|Overall Study|Protocol Violation|4|||
127837511|NCT00012012|460021767|FG000|Overall Study|Protocol Violation|1|||
127837512|NCT00012012|460021768|FG001|Overall Study|Protocol Violation|1|||
127837513|NCT00012012|460021767|FG000|Overall Study|Withdrawal by Subject|0|||
127837514|NCT00012012|460021768|FG001|Overall Study|Withdrawal by Subject|2|||
127837515|NCT01391819|460021769|FG000|Overall Study|Withdrawal by Subject|56|||
127837516|NCT01391819|460021769|FG000|Overall Study|Migrated/moved from study area|82|||
127837517|NCT01391819|460021769|FG000|Overall Study|Lost to Follow-up|252|||
127837518|NCT01391819|460021769|FG000|Overall Study|Death|3|||
127837519|NCT01391819|460021769|FG000|Overall Study|Other|9|||
127837520|NCT01208038|460021772|FG000|Overall Study|Withdrawal by Subject|1|||
127837521|NCT03260205|460021776|FG000|Overall Study|Adverse Event|2|||
127837522|NCT03260205|460021777|FG001|Overall Study|Adverse Event|0|||
127837523|NCT03260205|460021778|FG002|Overall Study|Adverse Event|2|||
127837524|NCT03260205|460021779|FG003|Overall Study|Adverse Event|2|||
127837525|NCT03260205|460021780|FG004|Overall Study|Adverse Event|4|||
127896656|NCT00409578|460245389|FG001|Overall Study|Lack of Efficacy|0|||
127896657|NCT00409578|460245390|FG002|Overall Study|Lack of Efficacy|0|||
127896658|NCT00409578|460245391|FG003|Overall Study|Lack of Efficacy|2|||
127896659|NCT00409578|460245388|FG000|Overall Study|Subject no longer requires study drug|0|||
127896660|NCT00409578|460245389|FG001|Overall Study|Subject no longer requires study drug|0|||
127896661|NCT00409578|460245390|FG002|Overall Study|Subject no longer requires study drug|0|||
127896662|NCT00409578|460245391|FG003|Overall Study|Subject no longer requires study drug|1|||
127896663|NCT00409578|460245388|FG000|Overall Study|Withdrawal by Subject|8|||
127896664|NCT00409578|460245389|FG001|Overall Study|Withdrawal by Subject|15|||
127896665|NCT00409578|460245390|FG002|Overall Study|Withdrawal by Subject|16|||
127896666|NCT00409578|460245391|FG003|Overall Study|Withdrawal by Subject|17|||
127896667|NCT00409578|460245388|FG000|Overall Study|Lost to Follow-up|2|||
127896668|NCT00409578|460245389|FG001|Overall Study|Lost to Follow-up|0|||
127896669|NCT00409578|460245390|FG002|Overall Study|Lost to Follow-up|2|||
127896670|NCT00409578|460245391|FG003|Overall Study|Lost to Follow-up|2|||
127896671|NCT00409578|460245388|FG000|Overall Study|Administrative problems|8|||
127896672|NCT00409578|460245389|FG001|Overall Study|Administrative problems|9|||
127896673|NCT00409578|460245390|FG002|Overall Study|Administrative problems|2|||
127896674|NCT00409578|460245391|FG003|Overall Study|Administrative problems|4|||
127896675|NCT00409578|460245388|FG000|Overall Study|Death|2|||
127896676|NCT00409578|460245389|FG001|Overall Study|Death|4|||
127837526|NCT03260205|460021776|FG000|Overall Study|Lost to Follow-up|2|||
127837527|NCT03260205|460021777|FG001|Overall Study|Lost to Follow-up|2|||
127837528|NCT03260205|460021778|FG002|Overall Study|Lost to Follow-up|1|||
127837529|NCT03260205|460021779|FG003|Overall Study|Lost to Follow-up|1|||
127837530|NCT03260205|460021780|FG004|Overall Study|Lost to Follow-up|5|||
127837531|NCT03260205|460021776|FG000|Overall Study|Protocol Violation|0|||
127837532|NCT03260205|460021777|FG001|Overall Study|Protocol Violation|0|||
127837533|NCT03260205|460021778|FG002|Overall Study|Protocol Violation|2|||
127837534|NCT03260205|460021779|FG003|Overall Study|Protocol Violation|0|||
127837535|NCT03260205|460021780|FG004|Overall Study|Protocol Violation|1|||
127837536|NCT03260205|460021776|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
127837537|NCT03260205|460021777|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
127837538|NCT03260205|460021778|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
127837539|NCT03260205|460021779|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
127837540|NCT03260205|460021780|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
127837541|NCT03260205|460021776|FG000|Overall Study|Other: Unspecified|0|||
127837542|NCT03260205|460021777|FG001|Overall Study|Other: Unspecified|0|||
127837543|NCT03260205|460021778|FG002|Overall Study|Other: Unspecified|3|||
127837544|NCT03260205|460021779|FG003|Overall Study|Other: Unspecified|1|||
127837545|NCT03260205|460021780|FG004|Overall Study|Other: Unspecified|1|||
127837546|NCT03260205|460021776|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
127837547|NCT03260205|460021777|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
127837548|NCT03260205|460021778|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
127837549|NCT03260205|460021779|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
127837550|NCT03260205|460021780|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
127837551|NCT00808249|460021785|FG000|Overall Study|Adverse Event|4|||
127837552|NCT00808249|460021786|FG001|Overall Study|Adverse Event|7|||
127837553|NCT00808249|460021787|FG002|Overall Study|Adverse Event|10|||
127837554|NCT00808249|460021788|FG003|Overall Study|Adverse Event|6|||
127837555|NCT00808249|460021785|FG000|Overall Study|Lost to Follow-up|2|||
127837556|NCT00808249|460021786|FG001|Overall Study|Lost to Follow-up|3|||
127837557|NCT00808249|460021787|FG002|Overall Study|Lost to Follow-up|3|||
127837558|NCT00808249|460021788|FG003|Overall Study|Lost to Follow-up|5|||
127837559|NCT00808249|460021785|FG000|Overall Study|Withdrawal by Subject|4|||
127837560|NCT00808249|460021786|FG001|Overall Study|Withdrawal by Subject|0|||
127837561|NCT00808249|460021787|FG002|Overall Study|Withdrawal by Subject|2|||
127837562|NCT00808249|460021788|FG003|Overall Study|Withdrawal by Subject|4|||
127837563|NCT00808249|460021785|FG000|Overall Study|Protocol Violation|3|||
127837564|NCT00808249|460021786|FG001|Overall Study|Protocol Violation|3|||
127837565|NCT00808249|460021787|FG002|Overall Study|Protocol Violation|3|||
127896677|NCT00409578|460245390|FG002|Overall Study|Death|4|||
127896678|NCT00409578|460245391|FG003|Overall Study|Death|2|||
127896679|NCT00409578|460245388|FG000|Overall Study|Protocol Violation|3|||
127896680|NCT00409578|460245389|FG001|Overall Study|Protocol Violation|2|||
127896681|NCT00409578|460245390|FG002|Overall Study|Protocol Violation|3|||
127837566|NCT00808249|460021788|FG003|Overall Study|Protocol Violation|0|||
127837567|NCT00808249|460021785|FG000|Overall Study|Lack of Efficacy|1|||
127837568|NCT00808249|460021786|FG001|Overall Study|Lack of Efficacy|1|||
127837569|NCT00808249|460021787|FG002|Overall Study|Lack of Efficacy|0|||
127837570|NCT00808249|460021788|FG003|Overall Study|Lack of Efficacy|0|||
127837571|NCT00808249|460021785|FG000|Overall Study|study specific discontinuation criteria|1|||
127837572|NCT00808249|460021786|FG001|Overall Study|study specific discontinuation criteria|0|||
127837573|NCT00808249|460021787|FG002|Overall Study|study specific discontinuation criteria|1|||
127837574|NCT00808249|460021788|FG003|Overall Study|study specific discontinuation criteria|0|||
127896682|NCT00409578|460245391|FG003|Overall Study|Protocol Violation|1|||
127896683|NCT00409578|460245388|FG000|Overall Study|Missing|0|||
127896684|NCT00409578|460245389|FG001|Overall Study|Missing|1|||
127837575|NCT00808249|460021785|FG000|Overall Study|All other reasons|2|||
127837576|NCT00808249|460021786|FG001|Overall Study|All other reasons|1|||
127837577|NCT00808249|460021787|FG002|Overall Study|All other reasons|3|||
127837578|NCT00808249|460021788|FG003|Overall Study|All other reasons|1|||
127837579|NCT00479557|460021789|FG000|Overall Study|Death|0|||
127837580|NCT00479557|460021790|FG001|Overall Study|Death|0|||
127837581|NCT00479557|460021791|FG002|Overall Study|Death|0|||
127837582|NCT00479557|460021792|FG003|Overall Study|Death|0|||
127837583|NCT00479557|460021793|FG004|Overall Study|Death|0|||
127837584|NCT00479557|460021794|FG005|Overall Study|Death|1|||
127837585|NCT00479557|460021795|FG006|Overall Study|Death|0|||
127837586|NCT00479557|460021789|FG000|Overall Study|Lack of Efficacy|1|||
127837587|NCT00479557|460021790|FG001|Overall Study|Lack of Efficacy|0|||
127837588|NCT00479557|460021791|FG002|Overall Study|Lack of Efficacy|0|||
127837589|NCT00479557|460021792|FG003|Overall Study|Lack of Efficacy|0|||
127837590|NCT00479557|460021793|FG004|Overall Study|Lack of Efficacy|0|||
127837591|NCT00479557|460021794|FG005|Overall Study|Lack of Efficacy|0|||
127837592|NCT00479557|460021795|FG006|Overall Study|Lack of Efficacy|0|||
127837593|NCT00479557|460021789|FG000|Overall Study|Lost to Follow-up|0|||
127837594|NCT00479557|460021790|FG001|Overall Study|Lost to Follow-up|2|||
127837595|NCT00479557|460021791|FG002|Overall Study|Lost to Follow-up|0|||
127837596|NCT00479557|460021792|FG003|Overall Study|Lost to Follow-up|2|||
127837597|NCT00479557|460021793|FG004|Overall Study|Lost to Follow-up|0|||
127837598|NCT00479557|460021794|FG005|Overall Study|Lost to Follow-up|0|||
127837599|NCT00479557|460021795|FG006|Overall Study|Lost to Follow-up|0|||
127837600|NCT00479557|460021789|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
127837601|NCT00479557|460021790|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
127837602|NCT00479557|460021791|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
127837603|NCT00479557|460021792|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
127837604|NCT00479557|460021793|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
127837605|NCT00479557|460021794|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
127837606|NCT00479557|460021795|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
127837607|NCT00479557|460021789|FG000|Overall Study|AE not related to Study Drug|1|||
127837608|NCT00479557|460021790|FG001|Overall Study|AE not related to Study Drug|3|||
127837609|NCT00479557|460021791|FG002|Overall Study|AE not related to Study Drug|0|||
127837610|NCT00479557|460021792|FG003|Overall Study|AE not related to Study Drug|0|||
127837611|NCT00479557|460021793|FG004|Overall Study|AE not related to Study Drug|2|||
127837612|NCT00479557|460021794|FG005|Overall Study|AE not related to Study Drug|2|||
127837613|NCT00479557|460021795|FG006|Overall Study|AE not related to Study Drug|1|||
127837614|NCT00479557|460021789|FG000|Overall Study|Caregiver Request|2|||
127837615|NCT00479557|460021790|FG001|Overall Study|Caregiver Request|2|||
127837616|NCT00479557|460021791|FG002|Overall Study|Caregiver Request|2|||
127837617|NCT00479557|460021792|FG003|Overall Study|Caregiver Request|0|||
127837618|NCT00479557|460021793|FG004|Overall Study|Caregiver Request|1|||
127837619|NCT00479557|460021794|FG005|Overall Study|Caregiver Request|2|||
127837620|NCT00479557|460021795|FG006|Overall Study|Caregiver Request|0|||
127837621|NCT00479557|460021789|FG000|Overall Study|Investigator Request|0|||
127837622|NCT00479557|460021790|FG001|Overall Study|Investigator Request|0|||
127837623|NCT00479557|460021791|FG002|Overall Study|Investigator Request|1|||
127837624|NCT00479557|460021792|FG003|Overall Study|Investigator Request|0|||
127837625|NCT00479557|460021793|FG004|Overall Study|Investigator Request|0|||
127837626|NCT00479557|460021794|FG005|Overall Study|Investigator Request|0|||
127837627|NCT00479557|460021795|FG006|Overall Study|Investigator Request|0|||
127837628|NCT00479557|460021789|FG000|Overall Study|Subject Request|3|||
127837629|NCT00479557|460021790|FG001|Overall Study|Subject Request|0|||
127837630|NCT00479557|460021791|FG002|Overall Study|Subject Request|1|||
127837631|NCT00479557|460021792|FG003|Overall Study|Subject Request|1|||
127837632|NCT00479557|460021793|FG004|Overall Study|Subject Request|1|||
127837633|NCT00479557|460021794|FG005|Overall Study|Subject Request|4|||
127837634|NCT00479557|460021795|FG006|Overall Study|Subject Request|1|||
127896685|NCT00409578|460245390|FG002|Overall Study|Missing|0|||
127837635|NCT00479557|460021789|FG000|Overall Study|Other|2|||
127896686|NCT00409578|460245391|FG003|Overall Study|Missing|1|||
127837636|NCT00479557|460021790|FG001|Overall Study|Other|3|||
127837637|NCT00479557|460021791|FG002|Overall Study|Other|1|||
127837638|NCT00479557|460021792|FG003|Overall Study|Other|0|||
127837639|NCT00479557|460021793|FG004|Overall Study|Other|0|||
127837640|NCT00479557|460021794|FG005|Overall Study|Other|3|||
127837641|NCT00479557|460021795|FG006|Overall Study|Other|0|||
127837642|NCT04752189|460021796|FG000|Overall Study|Withdrawal by Subject|0|||
127837643|NCT04752189|460021797|FG001|Overall Study|Withdrawal by Subject|150|||
127837644|NCT04752189|460021796|FG000|Overall Study|Lost to Follow-up|261|||
127837645|NCT04752189|460021797|FG001|Overall Study|Lost to Follow-up|126|||
127837646|NCT03422133|460021798|FG000|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|14|||
127837647|NCT03422133|460021799|FG001|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|4|||
127837648|NCT03003403|460021800|FG000|Overall Study|Ineligible|8|||
127837649|NCT03003403|460021801|FG001|Overall Study|Ineligible|7|||
127837650|NCT03003403|460021800|FG000|Overall Study|Withdrawal by Subject|3|||
127837651|NCT03003403|460021801|FG001|Overall Study|Withdrawal by Subject|1|||
127837652|NCT00280150|460023694|FG000|Overall Study|Adverse Event|0|||
127837653|NCT00280150|460023695|FG001|Overall Study|Adverse Event|1|||
127837654|NCT00280150|460023696|FG002|Overall Study|Adverse Event|2|||
127837655|NCT00280150|460023697|FG003|Overall Study|Adverse Event|3|||
127837656|NCT00280150|460023694|FG000|Overall Study|Lack of Efficacy|0|||
127837657|NCT00280150|460023695|FG001|Overall Study|Lack of Efficacy|0|||
127837658|NCT00280150|460023696|FG002|Overall Study|Lack of Efficacy|0|||
127837659|NCT00280150|460023697|FG003|Overall Study|Lack of Efficacy|3|||
127837660|NCT00280150|460023694|FG000|Overall Study|Physician Decision|0|||
127837661|NCT00280150|460023695|FG001|Overall Study|Physician Decision|0|||
127837662|NCT00280150|460023696|FG002|Overall Study|Physician Decision|0|||
127837663|NCT00280150|460023697|FG003|Overall Study|Physician Decision|1|||
127837664|NCT00280150|460023694|FG000|Overall Study|Protocol Violation|0|||
127837665|NCT00280150|460023695|FG001|Overall Study|Protocol Violation|0|||
127837666|NCT00280150|460023696|FG002|Overall Study|Protocol Violation|0|||
127837667|NCT00280150|460023697|FG003|Overall Study|Protocol Violation|1|||
127837668|NCT00280150|460023694|FG000|Overall Study|Withdrawal by Subject|0|||
127837669|NCT00280150|460023695|FG001|Overall Study|Withdrawal by Subject|0|||
127837670|NCT00280150|460023696|FG002|Overall Study|Withdrawal by Subject|0|||
127837671|NCT00280150|460023697|FG003|Overall Study|Withdrawal by Subject|1|||
127837672|NCT00280150|460023694|FG000|Overall Study|Did not get consolidation therapy|3|||
127837673|NCT00280150|460023695|FG001|Overall Study|Did not get consolidation therapy|0|||
127837674|NCT00280150|460023696|FG002|Overall Study|Did not get consolidation therapy|3|||
127837675|NCT00280150|460023697|FG003|Overall Study|Did not get consolidation therapy|0|||
127837676|NCT00280150|460023694|FG000|Overall Study|Declining Performance Status|0|||
127837677|NCT00280150|460023695|FG001|Overall Study|Declining Performance Status|0|||
127837678|NCT00280150|460023696|FG002|Overall Study|Declining Performance Status|0|||
127837679|NCT00280150|460023697|FG003|Overall Study|Declining Performance Status|1|||
127837680|NCT02871401|460023701|FG000|Overall Study|Adverse Event|1|||
127837681|NCT02871401|460023702|FG001|Overall Study|Adverse Event|0|||
127837682|NCT01120379|460023703|FG000|One Year Timepoint|Withdrawal by Subject|41|||
127837683|NCT01120379|460023703|FG000|One Year Timepoint|Lost to Follow-up|115|||
127837684|NCT01120379|460023703|FG000|One Year Timepoint|Death|108|||
127837685|NCT01120379|460023703|FG000|One Year Timepoint|Physician Decision|9|||
127837686|NCT01120379|460023703|FG000|One Year Timepoint|Any other reason for early termination|5|||
127837687|NCT01120379|460023703|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
127837688|NCT01120379|460023703|FG000|Two Year Timepoint|Lost to Follow-up|87|||
127837689|NCT01120379|460023703|FG000|Two Year Timepoint|Death|123|||
127837690|NCT01120379|460023703|FG000|Two Year Timepoint|Physician Decision|12|||
127837691|NCT01120379|460023703|FG000|Two Year Timepoint|Any other reason for early termination|4|||
127837692|NCT01120379|460023703|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
127837693|NCT01120379|460023703|FG000|Three Year Timepoint|Lost to Follow-up|43|||
127837694|NCT01120379|460023703|FG000|Three Year Timepoint|Death|120|||
127837695|NCT01120379|460023703|FG000|Three Year Timepoint|Physician Decision|9|||
127837696|NCT01120379|460023703|FG000|Three Year Timepoint|Any other reason for early termination|17|||
127837697|NCT01120379|460023703|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
127837698|NCT01120379|460023703|FG000|Four Year Timepoint|Lost to Follow-up|10|||
127837699|NCT01120379|460023703|FG000|Four Year Timepoint|Death|131|||
127837700|NCT01120379|460023703|FG000|Four Year Timepoint|Physician Decision|5|||
127837701|NCT01120379|460023703|FG000|Four Year Timepoint|Any other reason for early termination|217|||
127837702|NCT03162055|460023704|FG000|Overall Study|Adverse Event|6|||
127837703|NCT03162055|460023705|FG001|Overall Study|Adverse Event|5|||
127837704|NCT03162055|460023704|FG000|Overall Study|Death|3|||
127837705|NCT03162055|460023705|FG001|Overall Study|Death|3|||
127837706|NCT03162055|460023704|FG000|Overall Study|Lost to Follow-up|0|||
127837707|NCT03162055|460023705|FG001|Overall Study|Lost to Follow-up|1|||
127837708|NCT03162055|460023704|FG000|Overall Study|Study-specific withdrawal criteria|22|||
127896687|NCT05200858|460245392|FG000|Blinded Phase (4 Weeks)|Lost to Follow-up|3|||
127896688|NCT05200858|460245393|FG001|Blinded Phase (4 Weeks)|Lost to Follow-up|2|||
127837709|NCT03162055|460023705|FG001|Overall Study|Study-specific withdrawal criteria|14|||
127837710|NCT03162055|460023704|FG000|Overall Study|Withdrawal by Subject|17|||
127837711|NCT03162055|460023705|FG001|Overall Study|Withdrawal by Subject|2|||
127837712|NCT03162055|460023704|FG000|Overall Study|Did not receive treatment|2|||
127837713|NCT03162055|460023705|FG001|Overall Study|Did not receive treatment|0|||
127837714|NCT03162055|460023704|FG000|Overall Study|Incorrect randomization|4|||
127837715|NCT03162055|460023705|FG001|Overall Study|Incorrect randomization|3|||
127837716|NCT03162055|460023704|FG000|Overall Study|Other|8|||
127837717|NCT03162055|460023705|FG001|Overall Study|Other|15|||
127837718|NCT01993615|460023709|FG000|Overall Study|Death|1|||
127837719|NCT01993615|460023710|FG001|Overall Study|Death|0|||
127837720|NCT01617655|460023711|FG000|Overall Study|Adverse Event|2|||
127837721|NCT01617655|460023712|FG001|Overall Study|Adverse Event|3|||
127837722|NCT01617655|460023711|FG000|Overall Study|Poor compliance to protocol|1|||
127837723|NCT01617655|460023712|FG001|Overall Study|Poor compliance to protocol|4|||
127837724|NCT01617655|460023711|FG000|Overall Study|Participants moved|0|||
127837725|NCT01617655|460023712|FG001|Overall Study|Participants moved|4|||
127837726|NCT01617655|460023711|FG000|Overall Study|Consent withdrawn by participant|1|||
127837727|NCT01617655|460023712|FG001|Overall Study|Consent withdrawn by participant|1|||
127837728|NCT01617655|460023711|FG000|Overall Study|Last visit outside protocol visit window|1|||
127837729|NCT01617655|460023712|FG001|Overall Study|Last visit outside protocol visit window|10|||
127837730|NCT01617655|460023711|FG000|Overall Study|Site closure|3|||
127837731|NCT01617655|460023712|FG001|Overall Study|Site closure|5|||
127837732|NCT01617655|460023711|FG000|Overall Study|Other than specified above|1|||
127837733|NCT01617655|460023712|FG001|Overall Study|Other than specified above|2|||
127837734|NCT01175213|460023715|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
127837735|NCT01175213|460023716|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
127837736|NCT01175213|460023715|FG000|IGSC, 10%/rHuPH20|Death|1|||
127837737|NCT01175213|460023716|FG001|IGSC, 10%/rHuPH20|Death|0|||
127837738|NCT01175213|460023715|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
127896689|NCT05200858|460245394|FG002|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
127837739|NCT01175213|460023716|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
127837740|NCT01175213|460023715|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
127837741|NCT01175213|460023716|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
127896690|NCT05200858|460245395|FG003|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
127896691|NCT00313703|460247032|FG000|Overall Study|Lost to Follow-up|11|||
127896692|NCT00313703|460247033|FG001|Overall Study|Lost to Follow-up|2|||
127896693|NCT00313703|460247034|FG002|Overall Study|Lost to Follow-up|5|||
127896694|NCT00313703|460247035|FG003|Overall Study|Lost to Follow-up|12|||
127896695|NCT01691508|460247039|FG000|Overall Study|Adverse Event|3|||
127896696|NCT01691508|460247040|FG001|Overall Study|Adverse Event|3|||
127896697|NCT01691508|460247039|FG000|Overall Study|Withdrawal by Subject|1|||
127896698|NCT01691508|460247040|FG001|Overall Study|Withdrawal by Subject|0|||
127896699|NCT02309099|460247046|FG000|Overall Study|Adverse Event|2|||
127896700|NCT02309099|460247047|FG001|Overall Study|Adverse Event|0|||
127896701|NCT03702621|460247060|FG000|Overall Study|Physician Decision|6|||
127896702|NCT03702621|460247061|FG001|Overall Study|Physician Decision|6|||
127896703|NCT00527423|460247062|FG000|Overall Study|Protocol Violation|1|||
127896704|NCT00527423|460247062|FG000|Overall Study|Adverse Event|5|||
127896705|NCT00527423|460247062|FG000|Overall Study|Physician Decision|4|||
127896706|NCT00527423|460247062|FG000|Overall Study|Withdrawal by Subject|10|||
127896707|NCT00527423|460247062|FG000|Overall Study|Lost to Follow-up|4|||
127896708|NCT00527423|460247062|FG000|Overall Study|OTHER|4|||
127896709|NCT00527423|460247062|FG000|Overall Study|Death|9|||
127896710|NCT00436007|460247063|FG000|Overall Study|Withdrawal by Subject|5|||
127896711|NCT00436007|460247064|FG001|Overall Study|Withdrawal by Subject|3|||
127896712|NCT00436007|460247065|FG002|Overall Study|Withdrawal by Subject|4|||
127896713|NCT00436007|460247063|FG000|Overall Study|Lost to Follow-up|14|||
127896714|NCT00436007|460247064|FG001|Overall Study|Lost to Follow-up|10|||
127896715|NCT00436007|460247065|FG002|Overall Study|Lost to Follow-up|13|||
127896716|NCT00436007|460247063|FG000|Overall Study|Physician Decision|0|||
127896717|NCT00436007|460247064|FG001|Overall Study|Physician Decision|0|||
127896718|NCT00436007|460247065|FG002|Overall Study|Physician Decision|2|||
127896719|NCT00436007|460247063|FG000|Overall Study|Death|0|||
127896720|NCT00436007|460247064|FG001|Overall Study|Death|1|||
127896721|NCT00436007|460247065|FG002|Overall Study|Death|3|||
127896722|NCT00436007|460247063|FG000|Overall Study|Other|0|||
127896723|NCT00436007|460247064|FG001|Overall Study|Other|0|||
127896724|NCT00436007|460247065|FG002|Overall Study|Other|1|||
127896725|NCT01957488|460247067|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
127896726|NCT01957488|460247068|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
127896727|NCT01957488|460247069|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
127896728|NCT01957488|460247070|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
127896729|NCT01957488|460247071|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
127896730|NCT01957488|460247072|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
127896731|NCT01957488|460247067|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
127896732|NCT01957488|460247068|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
127896733|NCT01957488|460247069|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
127896734|NCT01957488|460247070|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
127896735|NCT01957488|460247071|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
127896736|NCT01957488|460247072|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
127896737|NCT01957488|460247067|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
127896738|NCT01957488|460247068|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
127896739|NCT01957488|460247069|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
127896740|NCT01957488|460247070|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
127896741|NCT01957488|460247071|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
127896742|NCT01957488|460247072|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
127896743|NCT01957488|460247067|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
127896744|NCT01957488|460247068|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
127896745|NCT01957488|460247069|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
127896746|NCT01957488|460247070|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
127896747|NCT01957488|460247071|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
127896748|NCT01957488|460247072|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
127896749|NCT01957488|460247067|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
127896750|NCT01957488|460247068|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
127896751|NCT01957488|460247069|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
127896752|NCT01957488|460247070|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
127896753|NCT01957488|460247071|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
127896754|NCT01957488|460247072|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
127896755|NCT01957488|460247067|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
127896756|NCT01957488|460247068|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
127896757|NCT01957488|460247069|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
127896758|NCT01957488|460247070|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
127896759|NCT01957488|460247071|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
127896760|NCT01957488|460247072|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
127896761|NCT01957488|460247067|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
127896762|NCT01957488|460247068|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
127896763|NCT01957488|460247069|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
127896764|NCT01957488|460247070|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
127896765|NCT01957488|460247071|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
127896766|NCT01957488|460247072|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
127896767|NCT01957488|460247067|FG000|Test Period 2 (2 Weeks)|Other|1|||
127896768|NCT01957488|460247068|FG001|Test Period 2 (2 Weeks)|Other|0|||
127896769|NCT01957488|460247069|FG002|Test Period 2 (2 Weeks)|Other|0|||
127896770|NCT01957488|460247070|FG003|Test Period 2 (2 Weeks)|Other|0|||
127896771|NCT01957488|460247071|FG004|Test Period 2 (2 Weeks)|Other|0|||
127896772|NCT01957488|460247072|FG005|Test Period 2 (2 Weeks)|Other|0|||
127896773|NCT01957488|460247067|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
127896774|NCT01957488|460247068|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
127896775|NCT01957488|460247069|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
127896776|NCT01957488|460247070|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
127896777|NCT01957488|460247071|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
127896778|NCT01957488|460247072|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
127896779|NCT01957488|460247067|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
127896780|NCT01957488|460247068|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
127896781|NCT01957488|460247069|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
127896782|NCT01957488|460247070|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
127896783|NCT01957488|460247071|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
127896784|NCT01957488|460247072|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
127896785|NCT01957488|460247067|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
127896786|NCT01957488|460247068|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
127896787|NCT01957488|460247069|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
127896788|NCT01957488|460247070|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
127896789|NCT01957488|460247071|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
127896790|NCT01957488|460247072|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
127896791|NCT01957488|460247067|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
127896792|NCT01957488|460247068|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
127896793|NCT01957488|460247069|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
127896794|NCT01957488|460247070|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
127896795|NCT01957488|460247071|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
127896796|NCT01957488|460247072|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
127896797|NCT01957488|460247067|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
127896798|NCT01957488|460247068|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
127896799|NCT01957488|460247069|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
127896800|NCT01957488|460247070|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
127896801|NCT01957488|460247071|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
127896802|NCT01957488|460247072|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
127896803|NCT01439165|460247073|FG000|Overall Study|Protocol Violation|3|||
127896804|NCT01439165|460247074|FG001|Overall Study|Protocol Violation|0|||
127896805|NCT01439165|460247073|FG000|Overall Study|Lost to Follow-up|11|||
127896806|NCT01439165|460247074|FG001|Overall Study|Lost to Follow-up|1|||
127896807|NCT01439165|460247073|FG000|Overall Study|Withdrawal by Subject|7|||
127896808|NCT01439165|460247074|FG001|Overall Study|Withdrawal by Subject|1|||
127896809|NCT00810368|460247075|FG000|Overall Study|Lost to Follow-up|4|||
127896810|NCT00810368|460247076|FG001|Overall Study|Lost to Follow-up|2|||
127896811|NCT00810368|460247075|FG000|Overall Study|Lack of Efficacy|2|||
127896812|NCT00810368|460247076|FG001|Overall Study|Lack of Efficacy|0|||
127896813|NCT02433678|460247080|FG000|Overall Study|Lost to Follow-up|1|||
127896814|NCT02433678|460247081|FG001|Overall Study|Lost to Follow-up|2|||
127896815|NCT03365375|460247084|FG000|Overall Study|Withdrawal by Subject|0|||
127896816|NCT03365375|460247085|FG001|Overall Study|Withdrawal by Subject|1|||
127896817|NCT03365375|460247084|FG000|Overall Study|Lost to Follow-up|0|||
127896818|NCT03365375|460247085|FG001|Overall Study|Lost to Follow-up|4|||
127896819|NCT00266409|460247089|FG000|Overall Study|Lack of Efficacy|2|||
127896820|NCT00266409|460247090|FG001|Overall Study|Lack of Efficacy|6|||
127896821|NCT00266409|460247091|FG002|Overall Study|Lack of Efficacy|1|||
127896822|NCT00266409|460247092|FG003|Overall Study|Lack of Efficacy|2|||
127896823|NCT00266409|460247089|FG000|Overall Study|Adverse Event|7|||
127896824|NCT00266409|460247090|FG001|Overall Study|Adverse Event|2|||
127896825|NCT00266409|460247091|FG002|Overall Study|Adverse Event|1|||
127896826|NCT00266409|460247092|FG003|Overall Study|Adverse Event|1|||
127896827|NCT00266409|460247089|FG000|Overall Study|Lost to Follow-up|18|||
127896828|NCT00266409|460247090|FG001|Overall Study|Lost to Follow-up|21|||
127896829|NCT00266409|460247091|FG002|Overall Study|Lost to Follow-up|6|||
127896830|NCT00266409|460247092|FG003|Overall Study|Lost to Follow-up|8|||
127896831|NCT00266409|460247089|FG000|Overall Study|Withdrawal by Subject|6|||
127896832|NCT00266409|460247090|FG001|Overall Study|Withdrawal by Subject|10|||
127896833|NCT00266409|460247091|FG002|Overall Study|Withdrawal by Subject|3|||
127896834|NCT00266409|460247092|FG003|Overall Study|Withdrawal by Subject|9|||
127896835|NCT00266409|460247089|FG000|Overall Study|Protocol Violation|5|||
127896836|NCT00266409|460247090|FG001|Overall Study|Protocol Violation|3|||
127896837|NCT00266409|460247091|FG002|Overall Study|Protocol Violation|4|||
127896838|NCT00266409|460247092|FG003|Overall Study|Protocol Violation|2|||
127896839|NCT00266409|460247089|FG000|Overall Study|Other|7|||
127896840|NCT00266409|460247090|FG001|Overall Study|Other|4|||
127896841|NCT00266409|460247091|FG002|Overall Study|Other|2|||
127896842|NCT00266409|460247092|FG003|Overall Study|Other|0|||
127896843|NCT00635154|460247096|FG000|Overall Study|Alternative Treatment|8|||
127896844|NCT00635154|460247096|FG000|Overall Study|Other|4|||
127896845|NCT00635154|460247096|FG000|Overall Study|Still on treatment|21|||
127896846|NCT01399736|460247097|FG000|Overall Study|Withdrawal by Subject|4|||
127896847|NCT01399736|460247098|FG001|Overall Study|Withdrawal by Subject|2|||
127896848|NCT01399736|460247097|FG000|Overall Study|Lost to Follow-up|0|||
127896849|NCT01399736|460247098|FG001|Overall Study|Lost to Follow-up|2|||
127896850|NCT03500484|460247099|FG000|Overall Study|Adverse Event|2|||
127896851|NCT03500484|460247100|FG001|Overall Study|Adverse Event|0|||
127896852|NCT03500484|460247099|FG000|Overall Study|Physician Decision|1|||
127896853|NCT03500484|460247100|FG001|Overall Study|Physician Decision|0|||
127896854|NCT03500484|460247099|FG000|Overall Study|Could not be scanned or followed up due to COVID|1|||
127896855|NCT03500484|460247100|FG001|Overall Study|Could not be scanned or followed up due to COVID|0|||
127896856|NCT00536575|460247101|FG000|Overall Study|Withdrawal by Subject|1|||
127896857|NCT00536575|460247101|FG000|Overall Study|Death|1|||
127896858|NCT01457053|460247111|FG000|Overall Study|Unable to undergo selected treatment|1|||
127896859|NCT01457053|460247112|FG001|Overall Study|Unable to undergo selected treatment|1|||
127896860|NCT03982433|460247113|FG000|Overall Study|Lost to Follow-up|1|||
127896861|NCT04799158|460247114|FG000|Run-In Period|Adverse Event|6|||
127896862|NCT04799158|460247115|FG001|Run-In Period|Adverse Event|0|||
127896863|NCT04799158|460247116|FG002|Run-In Period|Adverse Event|0|||
127896864|NCT04799158|460247117|FG003|Run-In Period|Adverse Event|0|||
127896865|NCT04799158|460247118|FG004|Run-In Period|Adverse Event|0|||
127896866|NCT04799158|460247114|FG000|Run-In Period|Lost to Follow-up|4|||
127896867|NCT04799158|460247115|FG001|Run-In Period|Lost to Follow-up|0|||
127896868|NCT04799158|460247116|FG002|Run-In Period|Lost to Follow-up|0|||
127896869|NCT04799158|460247117|FG003|Run-In Period|Lost to Follow-up|0|||
127896870|NCT04799158|460247118|FG004|Run-In Period|Lost to Follow-up|0|||
127896871|NCT04799158|460247114|FG000|Run-In Period|Significant Protocol Deviation|1|||
127896872|NCT04799158|460247115|FG001|Run-In Period|Significant Protocol Deviation|0|||
127896873|NCT04799158|460247116|FG002|Run-In Period|Significant Protocol Deviation|0|||
127896874|NCT04799158|460247117|FG003|Run-In Period|Significant Protocol Deviation|0|||
127896875|NCT04799158|460247118|FG004|Run-In Period|Significant Protocol Deviation|0|||
127896876|NCT04799158|460247114|FG000|Run-In Period|Withdrawal by Subject|11|||
127896877|NCT04799158|460247115|FG001|Run-In Period|Withdrawal by Subject|0|||
127896878|NCT04799158|460247116|FG002|Run-In Period|Withdrawal by Subject|0|||
127896879|NCT04799158|460247117|FG003|Run-In Period|Withdrawal by Subject|0|||
127896880|NCT04799158|460247118|FG004|Run-In Period|Withdrawal by Subject|0|||
127896881|NCT04799158|460247114|FG000|Run-In Period|Miscellaneous|3|||
127896882|NCT04799158|460247115|FG001|Run-In Period|Miscellaneous|0|||
127896883|NCT04799158|460247116|FG002|Run-In Period|Miscellaneous|0|||
127896884|NCT04799158|460247117|FG003|Run-In Period|Miscellaneous|0|||
127896885|NCT04799158|460247118|FG004|Run-In Period|Miscellaneous|0|||
127896886|NCT04799158|460247114|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
127896887|NCT04799158|460247115|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
127896888|NCT04799158|460247116|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
127896889|NCT04799158|460247117|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
127896890|NCT04799158|460247118|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
127896891|NCT04799158|460247114|FG000|On-Demand Treatment Period|Adverse Event|0|||
127896892|NCT04799158|460247115|FG001|On-Demand Treatment Period|Adverse Event|1|||
127896893|NCT04799158|460247116|FG002|On-Demand Treatment Period|Adverse Event|0|||
127896894|NCT04799158|460247117|FG003|On-Demand Treatment Period|Adverse Event|0|||
127896895|NCT04799158|460247118|FG004|On-Demand Treatment Period|Adverse Event|1|||
127896896|NCT04799158|460247114|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
127896897|NCT04799158|460247115|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
127896898|NCT04799158|460247116|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
127896899|NCT04799158|460247117|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
127896900|NCT04799158|460247118|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
127896901|NCT04799158|460247114|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
127896902|NCT04799158|460247115|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
127896903|NCT04799158|460247116|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
127896904|NCT04799158|460247117|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
127896905|NCT04799158|460247118|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
127896906|NCT04799158|460247114|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
127896907|NCT04799158|460247115|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
127896908|NCT04799158|460247116|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
127896909|NCT04799158|460247117|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
127896910|NCT04799158|460247118|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
127896911|NCT04799158|460247114|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
127896912|NCT04799158|460247115|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
127896913|NCT04799158|460247116|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
127896914|NCT04799158|460247117|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
127896915|NCT04799158|460247118|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
127896916|NCT04799158|460247114|FG000|On-Demand Treatment Period|Miscellaneous|0|||
127896917|NCT04799158|460247115|FG001|On-Demand Treatment Period|Miscellaneous|0|||
127896918|NCT04799158|460247116|FG002|On-Demand Treatment Period|Miscellaneous|0|||
127896919|NCT04799158|460247117|FG003|On-Demand Treatment Period|Miscellaneous|0|||
127896920|NCT04799158|460247118|FG004|On-Demand Treatment Period|Miscellaneous|1|||
127896921|NCT03922477|460247119|FG000|Overall Study|Death|9|||
127896922|NCT03922477|460247119|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
127896923|NCT03922477|460247119|FG000|Overall Study|Physician Decision|1|||
127896924|NCT03922477|460247119|FG000|Overall Study|Withdrawal by Subject|2|||
127896925|NCT00788957|460247127|FG000|Part 1|Death|8|||
127896926|NCT00788957|460247128|FG001|Part 1|Death|0|||
127896927|NCT00788957|460247129|FG002|Part 1|Death|0|||
127896928|NCT00788957|460247130|FG003|Part 1|Death|0|||
127896929|NCT00788957|460247131|FG004|Part 1|Death|0|||
127896930|NCT00788957|460247132|FG005|Part 1|Death|0|||
127896931|NCT00788957|460247127|FG000|Part 1|Lost to Follow-up|1|||
127896932|NCT00788957|460247128|FG001|Part 1|Lost to Follow-up|0|||
127896933|NCT00788957|460247129|FG002|Part 1|Lost to Follow-up|0|||
127896934|NCT00788957|460247130|FG003|Part 1|Lost to Follow-up|0|||
127896935|NCT00788957|460247131|FG004|Part 1|Lost to Follow-up|0|||
127896936|NCT00788957|460247132|FG005|Part 1|Lost to Follow-up|0|||
127896937|NCT00788957|460247127|FG000|Part 2|Withdrawal by Subject|0|||
127896938|NCT00788957|460247128|FG001|Part 2|Withdrawal by Subject|9|||
127896939|NCT00788957|460247129|FG002|Part 2|Withdrawal by Subject|5|||
127896940|NCT00788957|460247130|FG003|Part 2|Withdrawal by Subject|3|||
127896941|NCT00788957|460247131|FG004|Part 2|Withdrawal by Subject|0|||
127896942|NCT00788957|460247132|FG005|Part 2|Withdrawal by Subject|0|||
127896943|NCT00788957|460247127|FG000|Part 2|Death|0|||
127896944|NCT00788957|460247128|FG001|Part 2|Death|32|||
127896945|NCT00788957|460247129|FG002|Part 2|Death|35|||
127896946|NCT00788957|460247130|FG003|Part 2|Death|37|||
127896947|NCT00788957|460247131|FG004|Part 2|Death|0|||
127896948|NCT00788957|460247132|FG005|Part 2|Death|0|||
127896949|NCT00788957|460247127|FG000|Part 2|Lost to Follow-up|0|||
127896950|NCT00788957|460247128|FG001|Part 2|Lost to Follow-up|0|||
127896951|NCT00788957|460247129|FG002|Part 2|Lost to Follow-up|3|||
127896952|NCT00788957|460247130|FG003|Part 2|Lost to Follow-up|0|||
127896953|NCT00788957|460247131|FG004|Part 2|Lost to Follow-up|0|||
127896954|NCT00788957|460247132|FG005|Part 2|Lost to Follow-up|0|||
127896955|NCT00788957|460247127|FG000|Part 2|On-study at time of data cut-off|0|||
127896956|NCT00788957|460247128|FG001|Part 2|On-study at time of data cut-off|1|||
127896957|NCT00788957|460247129|FG002|Part 2|On-study at time of data cut-off|1|||
127896958|NCT00788957|460247130|FG003|Part 2|On-study at time of data cut-off|1|||
127896959|NCT00788957|460247131|FG004|Part 2|On-study at time of data cut-off|0|||
127896960|NCT00788957|460247132|FG005|Part 2|On-study at time of data cut-off|0|||
127896961|NCT00788957|460247127|FG000|Part 3|Withdrawal by Subject|0|||
127896962|NCT00788957|460247128|FG001|Part 3|Withdrawal by Subject|0|||
127896963|NCT00788957|460247129|FG002|Part 3|Withdrawal by Subject|0|||
127896964|NCT00788957|460247130|FG003|Part 3|Withdrawal by Subject|0|||
127896965|NCT00788957|460247131|FG004|Part 3|Withdrawal by Subject|0|||
127896966|NCT00788957|460247132|FG005|Part 3|Withdrawal by Subject|2|||
127896967|NCT00788957|460247127|FG000|Part 3|Death|0|||
127896968|NCT00788957|460247128|FG001|Part 3|Death|0|||
127896969|NCT00788957|460247129|FG002|Part 3|Death|0|||
127896970|NCT00788957|460247130|FG003|Part 3|Death|0|||
127896971|NCT00788957|460247131|FG004|Part 3|Death|8|||
127896972|NCT00788957|460247132|FG005|Part 3|Death|8|||
127896973|NCT00788957|460247127|FG000|Part 3|On-study at time of data cut-off|0|||
127896974|NCT00788957|460247128|FG001|Part 3|On-study at time of data cut-off|0|||
127896975|NCT00788957|460247129|FG002|Part 3|On-study at time of data cut-off|0|||
127896976|NCT00788957|460247130|FG003|Part 3|On-study at time of data cut-off|0|||
127896977|NCT00788957|460247131|FG004|Part 3|On-study at time of data cut-off|1|||
127896978|NCT00788957|460247132|FG005|Part 3|On-study at time of data cut-off|0|||
127896979|NCT03387098|460247133|FG000|Overall Study|progressive disease|1|||
127896980|NCT03387098|460247133|FG000|Overall Study|Withdrawal by Subject|2|||
127896981|NCT03387098|460247133|FG000|Overall Study|study terminated by sponsor|1|||
127896982|NCT03276975|460247134|FG000|Overall Study|Withdrawal by Subject|1|||
127896983|NCT03276975|460247135|FG001|Overall Study|Withdrawal by Subject|0|||
127896984|NCT00918567|460247138|FG000|Overall Study|Lack of Efficacy|3|||
127896985|NCT00918567|460247139|FG001|Overall Study|Lack of Efficacy|1|||
127896986|NCT00918567|460247138|FG000|Overall Study|Withdrawal by Subject|1|||
127896987|NCT00918567|460247139|FG001|Overall Study|Withdrawal by Subject|1|||
127896988|NCT00918567|460247138|FG000|Overall Study|Adverse Event|1|||
127896989|NCT00918567|460247139|FG001|Overall Study|Adverse Event|0|||
127896990|NCT02568384|460247141|FG000|Overall Study|Mobile devices incompatible with App|2|||
127896991|NCT01485536|460247142|FG000|Overall Study|Withdrawal by Subject|3|||
127896992|NCT01485536|460247142|FG000|Overall Study|Adverse Event|1|||
127896993|NCT00796510|460247143|FG000|Overall Study|Death|1|||
127896994|NCT00796510|460247144|FG001|Overall Study|Death|0|||
127896995|NCT00796510|460247143|FG000|Overall Study|Study Terminated|2|||
127896996|NCT00796510|460247144|FG001|Overall Study|Study Terminated|0|||
127896997|NCT02579096|460247145|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
127896998|NCT02579096|460247146|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
127896999|NCT02579096|460247145|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
127897000|NCT02579096|460247146|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
127897001|NCT02579096|460247145|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
127897002|NCT02579096|460247146|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
127897003|NCT02579096|460247145|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
127897004|NCT02579096|460247146|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
127897005|NCT02579096|460247145|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
127897006|NCT02579096|460247146|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
127897007|NCT02579096|460247145|FG000|Phase 2, Weeks 25 - 48|Death|2|||
127897008|NCT02579096|460247146|FG001|Phase 2, Weeks 25 - 48|Death|4|||
127897009|NCT02579096|460247145|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
127897010|NCT02579096|460247146|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
127897011|NCT02579096|460247145|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
127897012|NCT02579096|460247146|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
127897013|NCT02579096|460247145|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
127897014|NCT02579096|460247146|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
127897015|NCT02579096|460247145|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
127897016|NCT02579096|460247146|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
127897017|NCT02579096|460247145|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
127897018|NCT02579096|460247146|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
127897019|NCT02579096|460247145|FG000|Phase 3, Weeks 49 - 72|Death|3|||
127897020|NCT02579096|460247146|FG001|Phase 3, Weeks 49 - 72|Death|2|||
127897021|NCT02579096|460247145|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
127897022|NCT02579096|460247146|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
127897023|NCT02579096|460247145|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
127897024|NCT02579096|460247146|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
127897025|NCT02579096|460247145|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
127897026|NCT02579096|460247146|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
127897027|NCT02579096|460247145|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
127897028|NCT02579096|460247146|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
127897029|NCT02579096|460247145|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
127897030|NCT02579096|460247146|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
127897031|NCT02579096|460247145|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
127897032|NCT02579096|460247146|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
127897033|NCT02097121|460247147|FG000|Overall Study|Other, not specified|4|||
127897034|NCT02097121|460247148|FG001|Overall Study|Other, not specified|2|||
127897035|NCT02097121|460247149|FG002|Overall Study|Other, not specified|3|||
127897036|NCT02097121|460247147|FG000|Overall Study|Lack of Efficacy|2|||
127897037|NCT02097121|460247148|FG001|Overall Study|Lack of Efficacy|1|||
127897038|NCT02097121|460247149|FG002|Overall Study|Lack of Efficacy|3|||
127897039|NCT02097121|460247147|FG000|Overall Study|Withdrawal by Subject|0|||
127897040|NCT02097121|460247148|FG001|Overall Study|Withdrawal by Subject|1|||
127897041|NCT02097121|460247149|FG002|Overall Study|Withdrawal by Subject|2|||
127897042|NCT02097121|460247147|FG000|Overall Study|Adverse Event|0|||
127897043|NCT02097121|460247148|FG001|Overall Study|Adverse Event|1|||
127897044|NCT02097121|460247149|FG002|Overall Study|Adverse Event|0|||
127897045|NCT02097121|460247147|FG000|Overall Study|Lost to Follow-up|1|||
127897046|NCT02097121|460247148|FG001|Overall Study|Lost to Follow-up|1|||
127897047|NCT02097121|460247149|FG002|Overall Study|Lost to Follow-up|2|||
127897048|NCT03066999|460247150|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
127897049|NCT03066999|460247151|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
127897050|NCT00661999|460247152|FG000|Overall Study|Adverse Event|11|||
127897051|NCT00661999|460247153|FG001|Overall Study|Adverse Event|5|||
127897052|NCT00661999|460247154|FG002|Overall Study|Adverse Event|8|||
127897053|NCT00661999|460247152|FG000|Overall Study|Death|8|||
127897054|NCT00661999|460247153|FG001|Overall Study|Death|6|||
127897055|NCT00661999|460247154|FG002|Overall Study|Death|3|||
127897056|NCT00661999|460247152|FG000|Overall Study|Other Reasons|5|||
127897057|NCT00661999|460247153|FG001|Overall Study|Other Reasons|12|||
127897058|NCT00661999|460247154|FG002|Overall Study|Other Reasons|23|||
127897059|NCT00661999|460247152|FG000|Overall Study|Withdrawal by Subject|30|||
127897060|NCT00661999|460247153|FG001|Overall Study|Withdrawal by Subject|23|||
127897061|NCT00661999|460247154|FG002|Overall Study|Withdrawal by Subject|14|||
127897062|NCT00661999|460247152|FG000|Overall Study|Alternative Treatment|1|||
127897063|NCT00661999|460247153|FG001|Overall Study|Alternative Treatment|0|||
127837742|NCT01175213|460023715|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
127837743|NCT01175213|460023716|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
127837744|NCT01175213|460023715|FG000|Safety Follow-up|Adverse Event|1|||
127837745|NCT01175213|460023716|FG001|Safety Follow-up|Adverse Event|0|||
127897064|NCT00661999|460247154|FG002|Overall Study|Alternative Treatment|0|||
127897065|NCT00661999|460247152|FG000|Overall Study|Other Medical Problems|4|||
127897066|NCT00661999|460247153|FG001|Overall Study|Other Medical Problems|4|||
127897067|NCT00661999|460247154|FG002|Overall Study|Other Medical Problems|9|||
127897068|NCT00510510|460247155|FG000|Overall Study|Adverse Event|4|||
127897069|NCT00510510|460247156|FG001|Overall Study|Adverse Event|3|||
127897070|NCT00510510|460247157|FG002|Overall Study|Adverse Event|6|||
127897071|NCT00510510|460247155|FG000|Overall Study|Lack of Efficacy|0|||
127897072|NCT00510510|460247156|FG001|Overall Study|Lack of Efficacy|1|||
127897073|NCT00510510|460247157|FG002|Overall Study|Lack of Efficacy|1|||
127897074|NCT00510510|460247155|FG000|Overall Study|Subjects no longer requires study drug|0|||
127897075|NCT00510510|460247156|FG001|Overall Study|Subjects no longer requires study drug|0|||
127897076|NCT00510510|460247157|FG002|Overall Study|Subjects no longer requires study drug|2|||
127897077|NCT00510510|460247155|FG000|Overall Study|Withdrawal by Subject|1|||
127897078|NCT00510510|460247156|FG001|Overall Study|Withdrawal by Subject|2|||
127897079|NCT00510510|460247157|FG002|Overall Study|Withdrawal by Subject|3|||
127897080|NCT00510510|460247155|FG000|Overall Study|Lost to Follow-up|0|||
127897081|NCT00510510|460247156|FG001|Overall Study|Lost to Follow-up|0|||
127897082|NCT00510510|460247157|FG002|Overall Study|Lost to Follow-up|1|||
127897083|NCT00510510|460247155|FG000|Overall Study|Protocol Violation|0|||
127897084|NCT00510510|460247156|FG001|Overall Study|Protocol Violation|3|||
127897085|NCT00510510|460247157|FG002|Overall Study|Protocol Violation|4|||
127897086|NCT03595657|460247158|FG000|Overall Study|Adverse Event|14|||
127897087|NCT03595657|460247158|FG000|Overall Study|Death|1|||
127897088|NCT03595657|460247158|FG000|Overall Study|Lack of Efficacy|40|||
127897089|NCT03595657|460247158|FG000|Overall Study|Withdrawal by Subject|10|||
127897090|NCT03595657|460247158|FG000|Overall Study|Dosing delayed over 9 weeks|1|||
127897091|NCT03595657|460247158|FG000|Overall Study|Achieved CR and completed 2 years of treatment|1|||
127897092|NCT03384745|460247159|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
127897093|NCT03384745|460247160|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
127897094|NCT03384745|460247161|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
127897095|NCT03384745|460247162|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
127897096|NCT03384745|460247163|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
127897097|NCT03384745|460247164|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
127897098|NCT03384745|460247159|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
127897099|NCT03384745|460247160|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
127897100|NCT03384745|460247161|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
127897101|NCT03384745|460247162|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
127897102|NCT03384745|460247163|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
127897103|NCT03384745|460247164|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
127897104|NCT03384745|460247159|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
127897105|NCT03384745|460247160|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
127897106|NCT03384745|460247161|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
127897107|NCT03384745|460247162|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
127897108|NCT03384745|460247163|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
127897109|NCT03384745|460247164|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
127897110|NCT03384745|460247159|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
127897111|NCT03384745|460247160|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
127897112|NCT03384745|460247161|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
127897113|NCT03384745|460247162|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
127897114|NCT03384745|460247163|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
127897115|NCT03384745|460247164|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
127897116|NCT03384745|460247159|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
127897117|NCT03384745|460247160|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
127897118|NCT03384745|460247161|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
127897119|NCT03384745|460247162|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
127897120|NCT03384745|460247163|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
127897121|NCT03384745|460247164|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
127897122|NCT03384745|460247159|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
127897123|NCT03384745|460247160|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
127897124|NCT03384745|460247161|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
127897125|NCT03384745|460247162|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
127897126|NCT03384745|460247163|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
127897127|NCT03384745|460247164|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
127897128|NCT03384745|460247159|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
127897129|NCT03384745|460247160|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
127897130|NCT03384745|460247161|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
127897131|NCT03384745|460247162|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
127897132|NCT03384745|460247163|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
127837746|NCT01245764|460023721|FG000|Study Phase A|Other|3|||
127837747|NCT01245764|460023722|FG001|Study Phase A|Other|2|||
127837748|NCT01245764|460023723|FG002|Study Phase A|Other|3|||
127837749|NCT01245764|460023724|FG003|Study Phase A|Other|1|||
127837750|NCT01245764|460023721|FG000|Study Phase A|Protocol Violation|6|||
127837751|NCT01245764|460023722|FG001|Study Phase A|Protocol Violation|3|||
127837752|NCT01245764|460023723|FG002|Study Phase A|Protocol Violation|2|||
127837753|NCT01245764|460023724|FG003|Study Phase A|Protocol Violation|2|||
127837754|NCT01245764|460023721|FG000|Study Phase A|Lost to Follow-up|0|||
127837755|NCT01245764|460023722|FG001|Study Phase A|Lost to Follow-up|0|||
127837756|NCT01245764|460023723|FG002|Study Phase A|Lost to Follow-up|5|||
127837757|NCT01245764|460023724|FG003|Study Phase A|Lost to Follow-up|0|||
127837758|NCT00003476|460023725|FG000|Overall Study|Not evaluable|1|||
127837759|NCT00781963|460023730|FG000|Overall Study|Death|3|||
127837760|NCT00781963|460023731|FG001|Overall Study|Death|0|||
127837761|NCT00781963|460023730|FG000|Overall Study|Lost to Follow-up|2|||
127837762|NCT00781963|460023731|FG001|Overall Study|Lost to Follow-up|1|||
127837763|NCT00781963|460023730|FG000|Overall Study|Withdrawal by Subject|3|||
127837764|NCT00781963|460023731|FG001|Overall Study|Withdrawal by Subject|1|||
127837765|NCT00781963|460023730|FG000|Overall Study|Refused follow-up|9|||
127837766|NCT00781963|460023731|FG001|Overall Study|Refused follow-up|0|||
127837767|NCT02064205|460023735|FG000|Overall Study|Withdrawal by Subject|1|||
127837768|NCT03057951|460023736|FG000|Overall Study|Adverse Event|553|||
127837769|NCT03057951|460023737|FG001|Overall Study|Adverse Event|575|||
127837770|NCT03057951|460023736|FG000|Overall Study|Protocol Violation|30|||
127837771|NCT03057951|460023737|FG001|Overall Study|Protocol Violation|24|||
127837772|NCT03057951|460023736|FG000|Overall Study|Lost to Follow-up|6|||
127837773|NCT03057951|460023737|FG001|Overall Study|Lost to Follow-up|16|||
127837774|NCT03057951|460023736|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
127837775|NCT03057951|460023737|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
127837776|NCT03057951|460023736|FG000|Overall Study|Study drug stopped, reason missing|6|||
127837777|NCT03057951|460023737|FG001|Overall Study|Study drug stopped, reason missing|1|||
127837778|NCT03057951|460023736|FG000|Overall Study|Medical advice|6|||
127837779|NCT03057951|460023737|FG001|Overall Study|Medical advice|2|||
127837780|NCT03057951|460023736|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
127837781|NCT03057951|460023737|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
127837782|NCT03057951|460023736|FG000|Overall Study|Investigator decision|2|||
127837783|NCT03057951|460023737|FG001|Overall Study|Investigator decision|0|||
127837784|NCT03057951|460023736|FG000|Overall Study|Patient decision|5|||
127837785|NCT03057951|460023737|FG001|Overall Study|Patient decision|2|||
127837786|NCT03057951|460023736|FG000|Overall Study|Not attending study visits|3|||
127837787|NCT03057951|460023737|FG001|Overall Study|Not attending study visits|0|||
127837788|NCT03057951|460023736|FG000|Overall Study|Patient moved away|3|||
127837789|NCT03057951|460023737|FG001|Overall Study|Patient moved away|4|||
127837790|NCT03057951|460023736|FG000|Overall Study|Other reason than stated above|23|||
127837791|NCT03057951|460023737|FG001|Overall Study|Other reason than stated above|29|||
127837792|NCT03057951|460023736|FG000|Overall Study|Not treated|2|||
127837793|NCT03057951|460023737|FG001|Overall Study|Not treated|1|||
127837794|NCT00696436|460023738|FG000|Overall Study|Adverse Event|7|||
127837795|NCT00696436|460023739|FG001|Overall Study|Adverse Event|9|||
127837796|NCT00696436|460023740|FG002|Overall Study|Adverse Event|8|||
127837797|NCT00696436|460023741|FG003|Overall Study|Adverse Event|6|||
127837798|NCT00696436|460023742|FG004|Overall Study|Adverse Event|4|||
127837799|NCT00696436|460023738|FG000|Overall Study|Protocol Violation|3|||
127837800|NCT00696436|460023739|FG001|Overall Study|Protocol Violation|2|||
127837801|NCT00696436|460023740|FG002|Overall Study|Protocol Violation|2|||
127837802|NCT00696436|460023741|FG003|Overall Study|Protocol Violation|0|||
127837803|NCT00696436|460023742|FG004|Overall Study|Protocol Violation|1|||
127837804|NCT00696436|460023738|FG000|Overall Study|Lost to Follow-up|1|||
127837805|NCT00696436|460023739|FG001|Overall Study|Lost to Follow-up|6|||
127837806|NCT00696436|460023740|FG002|Overall Study|Lost to Follow-up|2|||
127837807|NCT00696436|460023741|FG003|Overall Study|Lost to Follow-up|4|||
127837808|NCT00696436|460023742|FG004|Overall Study|Lost to Follow-up|3|||
127837809|NCT00696436|460023738|FG000|Overall Study|Withdrawal by Subject|4|||
127837810|NCT00696436|460023739|FG001|Overall Study|Withdrawal by Subject|11|||
127897133|NCT03384745|460247164|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
127837811|NCT00696436|460023740|FG002|Overall Study|Withdrawal by Subject|5|||
127837812|NCT00696436|460023741|FG003|Overall Study|Withdrawal by Subject|7|||
127837813|NCT00696436|460023742|FG004|Overall Study|Withdrawal by Subject|1|||
127837814|NCT00696436|460023738|FG000|Overall Study|Lack of Efficacy|3|||
127837815|NCT00696436|460023739|FG001|Overall Study|Lack of Efficacy|1|||
127837816|NCT00696436|460023740|FG002|Overall Study|Lack of Efficacy|5|||
127837817|NCT00696436|460023741|FG003|Overall Study|Lack of Efficacy|2|||
127837818|NCT00696436|460023742|FG004|Overall Study|Lack of Efficacy|4|||
127837819|NCT00696436|460023738|FG000|Overall Study|Participant Unavailability|2|||
127837820|NCT00696436|460023739|FG001|Overall Study|Participant Unavailability|0|||
127837821|NCT00696436|460023740|FG002|Overall Study|Participant Unavailability|2|||
127837822|NCT00696436|460023741|FG003|Overall Study|Participant Unavailability|1|||
127897134|NCT03384745|460247159|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
127897135|NCT03384745|460247160|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
127897136|NCT03384745|460247161|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
127897137|NCT03384745|460247162|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
127897138|NCT03384745|460247163|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
127897139|NCT03384745|460247164|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
127897140|NCT03384745|460247159|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
127897141|NCT03384745|460247160|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
127897142|NCT03384745|460247161|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
127897143|NCT03384745|460247162|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
127897144|NCT03384745|460247163|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
127897145|NCT03384745|460247164|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
127897146|NCT03384745|460247159|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
127897147|NCT03384745|460247160|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
127897148|NCT03384745|460247161|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
127897149|NCT03384745|460247162|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
127897150|NCT03384745|460247163|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
127897151|NCT03384745|460247164|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
127897152|NCT03384745|460247159|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
127897153|NCT03384745|460247160|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
127897154|NCT03384745|460247161|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
127897155|NCT03384745|460247162|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
127897156|NCT03384745|460247163|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
127897157|NCT03384745|460247164|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
127897158|NCT02984683|460247167|FG000|Overall Study|Adverse Event|3|||
127897159|NCT02984683|460247168|FG001|Overall Study|Adverse Event|3|||
127897160|NCT02984683|460247167|FG000|Overall Study|Withdrawal by Subject|1|||
127897161|NCT02984683|460247168|FG001|Overall Study|Withdrawal by Subject|0|||
127897162|NCT02984683|460247167|FG000|Overall Study|Disease progression|7|||
127897163|NCT02984683|460247168|FG001|Overall Study|Disease progression|9|||
127897164|NCT03008460|460247169|FG000|Overall Study|Protocol deviation|0|||
127897165|NCT03008460|460247170|FG001|Overall Study|Protocol deviation|2|||
127897166|NCT03008460|460247169|FG000|Overall Study|Study drug not dispensed|0|||
127897167|NCT03008460|460247170|FG001|Overall Study|Study drug not dispensed|1|||
127897168|NCT03008460|460247169|FG000|Overall Study|Adverse Event|0|||
127897169|NCT03008460|460247170|FG001|Overall Study|Adverse Event|1|||
127897170|NCT03008460|460247169|FG000|Overall Study|Withdrawal by Subject|5|||
127897171|NCT03008460|460247170|FG001|Overall Study|Withdrawal by Subject|6|||
127897172|NCT03008460|460247169|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
127897173|NCT03008460|460247170|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
127897174|NCT03008460|460247169|FG000|Overall Study|End of study visit outside permitted time window|0|||
127897175|NCT03008460|460247170|FG001|Overall Study|End of study visit outside permitted time window|1|||
127897176|NCT03008460|460247169|FG000|Overall Study|Lost to Follow-up|1|||
127897177|NCT03008460|460247170|FG001|Overall Study|Lost to Follow-up|3|||
127897178|NCT04947579|460247173|FG000|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
127897179|NCT04947579|460247174|FG001|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
127897180|NCT04947579|460247175|FG002|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
127897181|NCT04947579|460247176|FG003|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|1|||
127897182|NCT04947579|460247177|FG004|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
127897183|NCT04947579|460247178|FG005|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
127897184|NCT04947579|460247173|FG000|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
127897185|NCT04947579|460247174|FG001|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
127897186|NCT04947579|460247175|FG002|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|1|||
127897187|NCT04947579|460247176|FG003|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
127897188|NCT04947579|460247177|FG004|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
127897189|NCT04947579|460247178|FG005|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
127897190|NCT04947579|460247173|FG000|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
127897191|NCT04947579|460247174|FG001|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
127897192|NCT04947579|460247175|FG002|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
127897193|NCT04947579|460247176|FG003|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
127897194|NCT04947579|460247177|FG004|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
127897195|NCT04947579|460247178|FG005|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
127897196|NCT04947579|460247173|FG000|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|5|||
127897197|NCT04947579|460247174|FG001|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|6|||
127897198|NCT04947579|460247175|FG002|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|7|||
127897199|NCT04947579|460247176|FG003|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
127897200|NCT04947579|460247177|FG004|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|0|||
127897201|NCT04947579|460247178|FG005|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
127897202|NCT04947579|460247173|FG000|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|1|||
127897203|NCT04947579|460247174|FG001|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
127897204|NCT04947579|460247175|FG002|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
127897205|NCT04947579|460247176|FG003|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
127897206|NCT04947579|460247177|FG004|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
127897207|NCT04947579|460247178|FG005|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
127897208|NCT04947579|460247173|FG000|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
127897209|NCT04947579|460247174|FG001|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
127897210|NCT04947579|460247175|FG002|Week 12 - Week 64 (Long-Term Extension)|Death|1|||
127897211|NCT04947579|460247176|FG003|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
127897212|NCT04947579|460247177|FG004|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
127897213|NCT04947579|460247178|FG005|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
127897214|NCT04947579|460247173|FG000|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
127897215|NCT04947579|460247174|FG001|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
127897216|NCT04947579|460247175|FG002|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
127897217|NCT04947579|460247176|FG003|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
127897218|NCT04947579|460247177|FG004|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
127897219|NCT04947579|460247178|FG005|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
127897220|NCT04947579|460247173|FG000|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
127897221|NCT04947579|460247174|FG001|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
127897222|NCT04947579|460247175|FG002|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|1|||
127897223|NCT04947579|460247176|FG003|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
127897224|NCT04947579|460247177|FG004|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
127897225|NCT04947579|460247178|FG005|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
127897226|NCT04947579|460247173|FG000|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
127897227|NCT04947579|460247174|FG001|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|54|||
127897228|NCT04947579|460247175|FG002|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|46|||
127897229|NCT04947579|460247176|FG003|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
127897230|NCT04947579|460247177|FG004|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|5|||
127897231|NCT04947579|460247178|FG005|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|4|||
127897232|NCT04947579|460247173|FG000|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
127897233|NCT04947579|460247174|FG001|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|2|||
127897234|NCT04947579|460247175|FG002|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|4|||
127897235|NCT04947579|460247176|FG003|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
127897236|NCT04947579|460247177|FG004|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|1|||
127897237|NCT04947579|460247178|FG005|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|3|||
127897238|NCT04947579|460247173|FG000|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
127897239|NCT04947579|460247174|FG001|Week 12 - Week 64 (Long-Term Extension)|Other reasons|5|||
127897240|NCT04947579|460247175|FG002|Week 12 - Week 64 (Long-Term Extension)|Other reasons|8|||
127897241|NCT04947579|460247176|FG003|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
127897242|NCT04947579|460247177|FG004|Week 12 - Week 64 (Long-Term Extension)|Other reasons|1|||
127897243|NCT04947579|460247178|FG005|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
127897244|NCT01575054|460247179|FG000|Overall Study|Other Reasons|5|||
127897245|NCT01575054|460247180|FG001|Overall Study|Other Reasons|3|||
127897246|NCT01575054|460247179|FG000|Overall Study|Protocol Violation|2|||
127897247|NCT01575054|460247180|FG001|Overall Study|Protocol Violation|1|||
127897248|NCT01575054|460247179|FG000|Overall Study|Personal Reasons|10|||
127897249|NCT01575054|460247180|FG001|Overall Study|Personal Reasons|11|||
127897250|NCT01575054|460247179|FG000|Overall Study|Lost to Follow-up|3|||
127897251|NCT01575054|460247180|FG001|Overall Study|Lost to Follow-up|3|||
127897252|NCT01575054|460247179|FG000|Overall Study|Adverse Event|9|||
127897253|NCT01575054|460247180|FG001|Overall Study|Adverse Event|8|||
127897254|NCT00462982|460247185|FG000|Overall Study|Adverse Event|1|||
127897255|NCT00462982|460247185|FG000|Overall Study|Patient Not Treated|2|||
127897256|NCT02683187|460247186|FG000|Overall Study|Failed IV access|3|||
127897257|NCT02683187|460247186|FG000|Overall Study|Withdrawal by Subject|5|||
127897258|NCT00770315|460247187|FG000|Overall Study|Adverse Event|11|||
127897259|NCT00770315|460247188|FG001|Overall Study|Adverse Event|17|||
127897260|NCT00770315|460247189|FG002|Overall Study|Adverse Event|16|||
127897261|NCT00770315|460247190|FG003|Overall Study|Adverse Event|6|||
127897262|NCT00770315|460247187|FG000|Overall Study|Lost to Follow-up|9|||
127897263|NCT00770315|460247188|FG001|Overall Study|Lost to Follow-up|5|||
127897264|NCT00770315|460247189|FG002|Overall Study|Lost to Follow-up|10|||
127897265|NCT00770315|460247190|FG003|Overall Study|Lost to Follow-up|3|||
127897266|NCT00770315|460247187|FG000|Overall Study|Withdrawal by Subject|13|||
127897267|NCT00770315|460247188|FG001|Overall Study|Withdrawal by Subject|17|||
127897268|NCT00770315|460247189|FG002|Overall Study|Withdrawal by Subject|24|||
127897269|NCT00770315|460247190|FG003|Overall Study|Withdrawal by Subject|20|||
127897270|NCT00770315|460247187|FG000|Overall Study|Noncompliance with Protocol|7|||
127897271|NCT00770315|460247188|FG001|Overall Study|Noncompliance with Protocol|4|||
127897272|NCT00770315|460247189|FG002|Overall Study|Noncompliance with Protocol|7|||
127897273|NCT00770315|460247190|FG003|Overall Study|Noncompliance with Protocol|9|||
127897274|NCT02585258|460247191|FG000|Overall Study|Adverse Event|28|||
127897275|NCT02585258|460247192|FG001|Overall Study|Adverse Event|29|||
127897276|NCT02585258|460247191|FG000|Overall Study|Death|3|||
127897277|NCT02585258|460247192|FG001|Overall Study|Death|2|||
127897278|NCT02585258|460247191|FG000|Overall Study|Lack of Efficacy|7|||
127897279|NCT02585258|460247192|FG001|Overall Study|Lack of Efficacy|9|||
127897280|NCT02585258|460247191|FG000|Overall Study|includes covid-related access problems|42|||
127897281|NCT02585258|460247192|FG001|Overall Study|includes covid-related access problems|46|||
127897282|NCT02585258|460247191|FG000|Overall Study|Lost to Follow-up|5|||
127897283|NCT02585258|460247192|FG001|Overall Study|Lost to Follow-up|2|||
127897284|NCT01919190|460249398|FG000|Overall Study|Intra-op findings, etc.|3|||
127897285|NCT01919190|460249399|FG001|Overall Study|Intra-op findings, etc.|0|||
127897286|NCT02322047|460249400|FG000|Overall Study|Physician Decision|1|||
127897287|NCT02322047|460249401|FG001|Overall Study|Physician Decision|0|||
127897288|NCT02322047|460249402|FG002|Overall Study|Physician Decision|0|||
127897289|NCT02322047|460249403|FG003|Overall Study|Physician Decision|0|||
127897290|NCT02322047|460249400|FG000|Overall Study|Withdrawal by Subject|1|||
127897291|NCT02322047|460249401|FG001|Overall Study|Withdrawal by Subject|0|||
127897292|NCT02322047|460249402|FG002|Overall Study|Withdrawal by Subject|0|||
127897293|NCT02322047|460249403|FG003|Overall Study|Withdrawal by Subject|1|||
127897294|NCT02322047|460249400|FG000|Overall Study|Adverse Event|0|||
127897295|NCT02322047|460249401|FG001|Overall Study|Adverse Event|1|||
127897296|NCT02322047|460249402|FG002|Overall Study|Adverse Event|0|||
127897297|NCT02322047|460249403|FG003|Overall Study|Adverse Event|0|||
127897298|NCT02322047|460249400|FG000|Overall Study|Lost to Follow-up|0|||
127897299|NCT02322047|460249401|FG001|Overall Study|Lost to Follow-up|0|||
127897300|NCT02322047|460249402|FG002|Overall Study|Lost to Follow-up|1|||
127897301|NCT02322047|460249403|FG003|Overall Study|Lost to Follow-up|1|||
127897302|NCT02207231|460249404|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
127897303|NCT02207231|460249405|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
127897304|NCT02207231|460249406|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
127897305|NCT02207231|460249407|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
127897306|NCT02207231|460249404|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
127897307|NCT02207231|460249405|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
127897308|NCT02207231|460249406|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
127897309|NCT02207231|460249407|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
127897310|NCT02207231|460249404|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
127897311|NCT02207231|460249405|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
127897312|NCT02207231|460249406|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
127897313|NCT02207231|460249407|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
127897314|NCT02207231|460249404|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
127897315|NCT02207231|460249405|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
127897316|NCT02207231|460249406|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
127897317|NCT02207231|460249407|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
127897318|NCT02207231|460249404|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
127897319|NCT02207231|460249405|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
127897320|NCT02207231|460249406|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
127897321|NCT02207231|460249407|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
127897322|NCT02207231|460249404|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
127897323|NCT02207231|460249405|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
127897324|NCT02207231|460249406|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
127897325|NCT02207231|460249407|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
127897326|NCT02207231|460249404|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
127897327|NCT02207231|460249405|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
127897328|NCT02207231|460249406|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
127897329|NCT02207231|460249407|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
127897330|NCT02207231|460249404|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
127897331|NCT02207231|460249405|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
127897332|NCT02207231|460249406|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
127897333|NCT02207231|460249407|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
127897334|NCT02207231|460249404|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
127897335|NCT02207231|460249405|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
127897336|NCT02207231|460249406|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
127837823|NCT00696436|460023742|FG004|Overall Study|Participant Unavailability|0|||
127837824|NCT00696436|460023738|FG000|Overall Study|Administrative Error|2|||
127837825|NCT00696436|460023739|FG001|Overall Study|Administrative Error|0|||
127837826|NCT00696436|460023740|FG002|Overall Study|Administrative Error|2|||
127837827|NCT00696436|460023741|FG003|Overall Study|Administrative Error|0|||
127837828|NCT00696436|460023742|FG004|Overall Study|Administrative Error|0|||
127837829|NCT00696436|460023738|FG000|Overall Study|Participant Non-compliance|0|||
127837830|NCT00696436|460023739|FG001|Overall Study|Participant Non-compliance|0|||
127837831|NCT00696436|460023740|FG002|Overall Study|Participant Non-compliance|1|||
127837832|NCT00696436|460023741|FG003|Overall Study|Participant Non-compliance|2|||
127837833|NCT00696436|460023742|FG004|Overall Study|Participant Non-compliance|0|||
127837834|NCT00696436|460023738|FG000|Overall Study|Administrative Decision|1|||
127837835|NCT00696436|460023739|FG001|Overall Study|Administrative Decision|0|||
127837836|NCT00696436|460023740|FG002|Overall Study|Administrative Decision|0|||
127837837|NCT00696436|460023741|FG003|Overall Study|Administrative Decision|0|||
127837838|NCT00696436|460023742|FG004|Overall Study|Administrative Decision|0|||
127837839|NCT00696436|460023738|FG000|Overall Study|Missing|0|||
127837840|NCT00696436|460023739|FG001|Overall Study|Missing|1|||
127837841|NCT00696436|460023740|FG002|Overall Study|Missing|1|||
127837842|NCT00696436|460023741|FG003|Overall Study|Missing|0|||
127837843|NCT00696436|460023742|FG004|Overall Study|Missing|0|||
127837844|NCT02282982|460023743|FG000|Overall Study|Lost to Follow-up|15|||
127837845|NCT02282982|460023743|FG000|Overall Study|Withdrew consent|2|||
127837846|NCT02282982|460023743|FG000|Overall Study|Death|4|||
127837847|NCT02282982|460023743|FG000|Overall Study|Lack of product|156|||
127837848|NCT02282982|460023743|FG000|Overall Study|Palivizumab is ended|11|||
127837849|NCT02282982|460023743|FG000|Overall Study|Other, not specified|18|||
127837850|NCT02062463|460023744|FG000|Crossover Stage 1|Withdrawals during stage 1 were not captured|3|||
127837851|NCT02062463|460023745|FG001|Crossover Stage 1|Withdrawals during stage 1 were not captured|1|||
127837852|NCT02062463|460023746|FG002|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
127837853|NCT02062463|460023747|FG003|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
127837854|NCT02062463|460023744|FG000|Stage 2|Adverse Event|0|||
127837855|NCT02062463|460023745|FG001|Stage 2|Adverse Event|0|||
127837856|NCT02062463|460023746|FG002|Stage 2|Adverse Event|12|||
127837857|NCT02062463|460023747|FG003|Stage 2|Adverse Event|20|||
127837858|NCT02062463|460023744|FG000|Stage 2|Lack of Efficacy|0|||
127837859|NCT02062463|460023745|FG001|Stage 2|Lack of Efficacy|0|||
127837860|NCT02062463|460023746|FG002|Stage 2|Lack of Efficacy|3|||
127837861|NCT02062463|460023747|FG003|Stage 2|Lack of Efficacy|4|||
127837862|NCT02062463|460023744|FG000|Stage 2|Lost to Follow-up|0|||
127837863|NCT02062463|460023745|FG001|Stage 2|Lost to Follow-up|0|||
127837864|NCT02062463|460023746|FG002|Stage 2|Lost to Follow-up|20|||
127837865|NCT02062463|460023747|FG003|Stage 2|Lost to Follow-up|20|||
127837866|NCT02062463|460023744|FG000|Stage 2|Non-Compliance|0|||
127837867|NCT02062463|460023745|FG001|Stage 2|Non-Compliance|0|||
127837868|NCT02062463|460023746|FG002|Stage 2|Non-Compliance|0|||
127837869|NCT02062463|460023747|FG003|Stage 2|Non-Compliance|1|||
127837870|NCT02062463|460023744|FG000|Stage 2|Other than specified|0|||
127837871|NCT02062463|460023745|FG001|Stage 2|Other than specified|0|||
127837872|NCT02062463|460023746|FG002|Stage 2|Other than specified|3|||
127837873|NCT02062463|460023747|FG003|Stage 2|Other than specified|1|||
127837874|NCT02062463|460023744|FG000|Stage 2|Withdrawal by Subject|0|||
127837875|NCT02062463|460023745|FG001|Stage 2|Withdrawal by Subject|0|||
127837876|NCT02062463|460023746|FG002|Stage 2|Withdrawal by Subject|15|||
127837877|NCT02062463|460023747|FG003|Stage 2|Withdrawal by Subject|10|||
127837878|NCT04124692|460023748|FG000|Overall Study|Medical reason|0|||
127837879|NCT04124692|460023749|FG001|Overall Study|Medical reason|1|||
127837880|NCT04124692|460023748|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
127837881|NCT04124692|460023749|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
127837882|NCT04124692|460023748|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
127837883|NCT04124692|460023749|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
127837884|NCT04124692|460023748|FG000|Overall Study|Lost to Follow-up|2|||
127837885|NCT04124692|460023749|FG001|Overall Study|Lost to Follow-up|4|||
127837886|NCT04124692|460023748|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
127837887|NCT04124692|460023749|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
127837888|NCT02370498|460023750|FG000|Overall Study|Adverse Event|10|||
127837889|NCT02370498|460023751|FG001|Overall Study|Adverse Event|8|||
127837890|NCT02370498|460023750|FG000|Overall Study|Death|263|||
127837891|NCT02370498|460023751|FG001|Overall Study|Death|265|||
127837892|NCT02370498|460023750|FG000|Overall Study|Protocol Violation|1|||
127837893|NCT02370498|460023751|FG001|Overall Study|Protocol Violation|2|||
127837894|NCT02370498|460023750|FG000|Overall Study|Withdrawal by Subject|7|||
127837895|NCT02370498|460023751|FG001|Overall Study|Withdrawal by Subject|12|||
127837896|NCT02370498|460023750|FG000|Overall Study|Sponsor's decision|15|||
127837897|NCT02370498|460023751|FG001|Overall Study|Sponsor's decision|9|||
127837898|NCT03457103|460023762|FG000|Overall Study|illness/hospitalization|4|||
127837899|NCT03457103|460023763|FG001|Overall Study|illness/hospitalization|2|||
127837900|NCT03457103|460023762|FG000|Overall Study|Lost to Follow-up|2|||
127837901|NCT03457103|460023763|FG001|Overall Study|Lost to Follow-up|1|||
127837902|NCT03457103|460023762|FG000|Overall Study|Withdrawal by Subject|1|||
127837903|NCT03457103|460023763|FG001|Overall Study|Withdrawal by Subject|2|||
127837904|NCT03457103|460023762|FG000|Overall Study|financial/ insurance issues|1|||
127837905|NCT03457103|460023763|FG001|Overall Study|financial/ insurance issues|1|||
127837906|NCT03943953|460023764|FG000|Trial of ITG 1|Lost to Follow-up|19|||
127837907|NCT03943953|460023765|FG001|Trial of ITG 1|Lost to Follow-up|1|||
127837908|NCT03943953|460023764|FG000|Trial of ITG 2|Lost to Follow-up|8|||
127837909|NCT03943953|460023765|FG001|Trial of ITG 2|Lost to Follow-up|0|||
127837910|NCT03943953|460023764|FG000|Trial of ITG 3|Lost to Follow-up|2|||
127837911|NCT03943953|460023765|FG001|Trial of ITG 3|Lost to Follow-up|0|||
127837912|NCT03943953|460023764|FG000|Trial of ITG 4|Lost to Follow-up|2|||
127837913|NCT03943953|460023765|FG001|Trial of ITG 4|Lost to Follow-up|0|||
127837914|NCT01199055|460023766|FG000|Overall Study|Death|0|||
127837915|NCT01199055|460023767|FG001|Overall Study|Death|1|||
127837916|NCT01199055|460023768|FG002|Overall Study|Death|0|||
127897337|NCT02207231|460249407|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
127897338|NCT02207231|460249404|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
127897339|NCT02207231|460249405|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
127897340|NCT02207231|460249406|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
127897341|NCT02207231|460249407|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
127897342|NCT02207231|460249404|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
127897343|NCT02207231|460249405|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
127897344|NCT02207231|460249406|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
127897345|NCT02207231|460249407|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
127897346|NCT02207231|460249404|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
127897347|NCT02207231|460249405|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
127897348|NCT02207231|460249406|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
127897349|NCT02207231|460249407|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
127897350|NCT02207231|460249404|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
127897351|NCT02207231|460249405|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
127897352|NCT02207231|460249406|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
127897353|NCT02207231|460249407|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
127897354|NCT02207231|460249404|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
127897355|NCT02207231|460249405|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
127897356|NCT02207231|460249406|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
127897357|NCT02207231|460249407|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
127897358|NCT02207231|460249404|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
127897359|NCT02207231|460249405|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
127897360|NCT02207231|460249406|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
127897361|NCT02207231|460249407|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
127897362|NCT02207231|460249404|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
127897363|NCT02207231|460249405|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
127897364|NCT02207231|460249406|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
127897365|NCT02207231|460249407|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
127897366|NCT02207231|460249404|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
127897367|NCT02207231|460249405|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
127897368|NCT02207231|460249406|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
127897369|NCT02207231|460249407|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
127897370|NCT02207231|460249404|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
127897371|NCT02207231|460249405|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
127897372|NCT02207231|460249406|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
127897373|NCT02207231|460249407|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
127897374|NCT02207231|460249404|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
127897375|NCT02207231|460249405|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
127897376|NCT02207231|460249406|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
127897377|NCT02207231|460249407|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
127897378|NCT02207231|460249404|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
127897379|NCT02207231|460249405|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
127897380|NCT02207231|460249406|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
127897381|NCT02207231|460249407|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
127897382|NCT02207231|460249404|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
127897383|NCT02207231|460249405|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
127897384|NCT02207231|460249406|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
127897385|NCT02207231|460249407|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
127897386|NCT02016300|460249415|FG000|Overall Study|Lost to Follow-up|0|||
127897387|NCT02016300|460249416|FG001|Overall Study|Lost to Follow-up|3|||
127897388|NCT06165744|460249417|FG000|Overall Study|Non device-related adverse event|1|||
127897389|NCT05456529|460249418|FG000|8-week Continuous Treatment (CT) Period|Lost to Follow-up|5|||
127897390|NCT05456529|460249418|FG000|8-week Continuous Treatment (CT) Period|Lack of Efficacy|2|||
127897391|NCT05456529|460249418|FG000|8-week Continuous Treatment (CT) Period|Protocol-specified Withdrawal Criterion Met|1|||
127897392|NCT05456529|460249418|FG000|8-week Continuous Treatment (CT) Period|Withdrawal by Subject|3|||
127897393|NCT05456529|460249418|FG000|44-week Long-term Safety Period|Lost to Follow-up|12|||
127897394|NCT05456529|460249418|FG000|44-week Long-term Safety Period|Lack of Efficacy|1|||
127897395|NCT05456529|460249418|FG000|44-week Long-term Safety Period|Physician Decision|2|||
127897396|NCT05456529|460249418|FG000|44-week Long-term Safety Period|Protocol-specified Withdrawal Criterion Met|1|||
127897397|NCT05456529|460249418|FG000|44-week Long-term Safety Period|Withdrawal by Subject|12|||
127897398|NCT05456529|460249418|FG000|44-week Long-term Safety Period|Withdrawal by Sponsor|2|||
127897399|NCT05456529|460249418|FG000|44-week Long-term Safety Period|Unable to Attend the Follow-up Visit|1|||
127897400|NCT00797108|460249419|FG000|Overall Study|Adverse Event|1|||
127897401|NCT00797108|460249420|FG001|Overall Study|Adverse Event|0|||
127897402|NCT00797108|460249421|FG002|Overall Study|Adverse Event|3|||
127837917|NCT01199055|460023766|FG000|Overall Study|Physician Decision|0|||
127837918|NCT01199055|460023767|FG001|Overall Study|Physician Decision|1|||
127837919|NCT01199055|460023768|FG002|Overall Study|Physician Decision|1|||
127837920|NCT01199055|460023766|FG000|Overall Study|Progressive disease|2|||
127837921|NCT01199055|460023767|FG001|Overall Study|Progressive disease|1|||
127837922|NCT01199055|460023768|FG002|Overall Study|Progressive disease|2|||
127837923|NCT01199055|460023766|FG000|Overall Study|Withdrawal by Subject|0|||
127837924|NCT01199055|460023767|FG001|Overall Study|Withdrawal by Subject|0|||
127837925|NCT01199055|460023768|FG002|Overall Study|Withdrawal by Subject|1|||
127837926|NCT00488592|460023779|FG000|Overall Study|Withdrawal by Subject|1|||
127837927|NCT00488592|460023779|FG000|Overall Study|Disease progression|1|||
127837928|NCT00488592|460023779|FG000|Overall Study|Enrolled but not treated|1|||
127837929|NCT03670641|460023780|FG000|Overall Study|Lost to Follow-up|3|||
127837930|NCT01096849|460023781|FG000|Overall Study|Consent Withdrawn|1|||
127837931|NCT01096849|460023782|FG001|Overall Study|Consent Withdrawn|4|||
127837932|NCT01096849|460023783|FG002|Overall Study|Consent Withdrawn|2|||
127837933|NCT01096849|460023781|FG000|Overall Study|Lack of Efficacy|0|||
127837934|NCT01096849|460023782|FG001|Overall Study|Lack of Efficacy|2|||
127837935|NCT01096849|460023783|FG002|Overall Study|Lack of Efficacy|0|||
127837936|NCT01096849|460023781|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
127837937|NCT01096849|460023782|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
127837938|NCT01096849|460023783|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
127837939|NCT01096849|460023781|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
127837940|NCT01096849|460023782|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
127837941|NCT01096849|460023783|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
127837942|NCT01096849|460023781|FG000|Overall Study|Administrative Reasons|0|||
127837943|NCT01096849|460023782|FG001|Overall Study|Administrative Reasons|1|||
127837944|NCT01096849|460023783|FG002|Overall Study|Administrative Reasons|2|||
127837945|NCT01096849|460023781|FG000|Overall Study|Lost to Follow-up|1|||
127837946|NCT01096849|460023782|FG001|Overall Study|Lost to Follow-up|3|||
127837947|NCT01096849|460023783|FG002|Overall Study|Lost to Follow-up|1|||
127837948|NCT00118482|460023785|FG000|Overall Study|Lost to Follow-up|7|||
127837949|NCT00118482|460023786|FG001|Overall Study|Lost to Follow-up|7|||
127837950|NCT00118482|460023785|FG000|Overall Study|Withdrawal by Subject|23|||
127837951|NCT00118482|460023786|FG001|Overall Study|Withdrawal by Subject|22|||
127837952|NCT00242580|460023787|FG000|Overall Study|Adverse Event|3|||
127837953|NCT00242580|460023788|FG001|Overall Study|Adverse Event|0|||
127837954|NCT00242580|460023789|FG002|Overall Study|Adverse Event|2|||
127837955|NCT00242580|460023787|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
127837956|NCT00242580|460023788|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
127837957|NCT00242580|460023789|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
127837958|NCT00242580|460023787|FG000|Overall Study|Protocol Violation|0|||
127837959|NCT00242580|460023788|FG001|Overall Study|Protocol Violation|0|||
127837960|NCT00242580|460023789|FG002|Overall Study|Protocol Violation|1|||
127837961|NCT00242580|460023787|FG000|Overall Study|Subject withdrew consent|2|||
127837962|NCT00242580|460023788|FG001|Overall Study|Subject withdrew consent|2|||
127837963|NCT00242580|460023789|FG002|Overall Study|Subject withdrew consent|5|||
127837964|NCT00242580|460023787|FG000|Overall Study|Lost to Follow-up|0|||
127837965|NCT00242580|460023788|FG001|Overall Study|Lost to Follow-up|3|||
127837966|NCT00242580|460023789|FG002|Overall Study|Lost to Follow-up|0|||
127837967|NCT00242580|460023787|FG000|Overall Study|Death|1|||
127837968|NCT00242580|460023788|FG001|Overall Study|Death|2|||
127837969|NCT00242580|460023789|FG002|Overall Study|Death|1|||
127837970|NCT03970395|460023792|FG000|Overall Study|Withdrawal by Subject|3|||
127837971|NCT03970395|460023793|FG001|Overall Study|Withdrawal by Subject|4|||
127837972|NCT03970395|460023792|FG000|Overall Study|Lost to Follow-up|4|||
127837973|NCT03970395|460023793|FG001|Overall Study|Lost to Follow-up|8|||
127837974|NCT00125190|460023795|FG000|Overall Study|Subject/Parent Decision|7|||
127837975|NCT00125190|460023795|FG000|Overall Study|Non-compliance|2|||
127837976|NCT00125190|460023795|FG000|Overall Study|Adverse Event|1|||
127837977|NCT00125190|460023795|FG000|Overall Study|Other|1|||
127837978|NCT00125190|460023795|FG000|Overall Study|Lost to Follow-up|4|||
127837979|NCT03666858|460023798|FG000|Cohort 1|Adverse Event|1|||
127837980|NCT03666858|460023799|FG001|Cohort 1|Adverse Event|0|||
127837981|NCT03666858|460023798|FG000|Cohort 2|Adverse Event|0|||
127837982|NCT03666858|460023799|FG001|Cohort 2|Adverse Event|1|||
127837983|NCT02921919|460023800|FG000|Overall Study|Other|5|||
127837984|NCT02921919|460023801|FG001|Overall Study|Other|6|||
127837985|NCT02921919|460023800|FG000|Overall Study|Lost to Follow-up|0|||
127837986|NCT02921919|460023801|FG001|Overall Study|Lost to Follow-up|1|||
127837987|NCT02921919|460023800|FG000|Overall Study|Withdrawal by Subject|5|||
127837988|NCT02921919|460023801|FG001|Overall Study|Withdrawal by Subject|1|||
127837989|NCT02921919|460023800|FG000|Overall Study|Disease Progression|47|||
127837990|NCT02921919|460023801|FG001|Overall Study|Disease Progression|38|||
127837991|NCT02921919|460023800|FG000|Overall Study|Physician Decision|3|||
127837992|NCT02921919|460023801|FG001|Overall Study|Physician Decision|2|||
127837993|NCT02921919|460023800|FG000|Overall Study|Adverse Event|6|||
127837994|NCT02921919|460023801|FG001|Overall Study|Adverse Event|4|||
127837995|NCT03282357|460023802|FG000|Overall Study|Lost to Follow-up|3|||
127837996|NCT03282357|460023802|FG000|Overall Study|Withdrawal by Subject|4|||
127837997|NCT03282357|460023802|FG000|Overall Study|Adverse Event|1|||
127837998|NCT03282357|460023802|FG000|Overall Study|Other|9|||
127837999|NCT01586156|460023803|FG000|Overall Study|Pregnancy|0|||
127838000|NCT01586156|460023804|FG001|Overall Study|Pregnancy|1|||
127838001|NCT01586156|460023805|FG002|Overall Study|Pregnancy|0|||
127838002|NCT00547378|460023806|FG000|Randomized Cohort|Withdrawal by Subject|7|||
127838003|NCT00547378|460023807|FG001|Randomized Cohort|Withdrawal by Subject|5|||
127838004|NCT00547378|460023808|FG002|Randomized Cohort|Withdrawal by Subject|0|||
127838005|NCT00547378|460023806|FG000|Randomized Cohort|Death|0|||
127838006|NCT00547378|460023807|FG001|Randomized Cohort|Death|1|||
127838007|NCT00547378|460023808|FG002|Randomized Cohort|Death|0|||
127838008|NCT00547378|460023806|FG000|Randomized Cohort|Lost to Follow-up|1|||
127838009|NCT00547378|460023807|FG001|Randomized Cohort|Lost to Follow-up|0|||
127838010|NCT00547378|460023808|FG002|Randomized Cohort|Lost to Follow-up|0|||
127897403|NCT00797108|460249419|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
127897404|NCT00797108|460249420|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
127897405|NCT00797108|460249421|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
127897406|NCT00797108|460249419|FG000|Overall Study|Global Deterioration of Health Status|0|||
127897407|NCT00797108|460249420|FG001|Overall Study|Global Deterioration of Health Status|1|||
127897408|NCT00797108|460249421|FG002|Overall Study|Global Deterioration of Health Status|0|||
127897409|NCT00797108|460249419|FG000|Overall Study|Lack of Efficacy|1|||
127897410|NCT00797108|460249420|FG001|Overall Study|Lack of Efficacy|0|||
127897411|NCT00797108|460249421|FG002|Overall Study|Lack of Efficacy|1|||
127897412|NCT00797108|460249419|FG000|Overall Study|Other|0|||
127897413|NCT00797108|460249420|FG001|Overall Study|Other|0|||
127897414|NCT00797108|460249421|FG002|Overall Study|Other|2|||
127897415|NCT00797108|460249419|FG000|Overall Study|Randomized but not Treated|2|||
127897416|NCT00797108|460249420|FG001|Overall Study|Randomized but not Treated|0|||
127897417|NCT00797108|460249421|FG002|Overall Study|Randomized but not Treated|0|||
127897418|NCT02518113|460249422|FG000|Overall Study|Adverse Event|1|||
127897419|NCT02518113|460249423|FG001|Overall Study|Adverse Event|0|||
127897420|NCT02518113|460249424|FG002|Overall Study|Adverse Event|1|||
127897421|NCT02518113|460249425|FG003|Overall Study|Adverse Event|0|||
127897422|NCT02518113|460249422|FG000|Overall Study|Death|1|||
127897423|NCT02518113|460249423|FG001|Overall Study|Death|2|||
127897424|NCT02518113|460249424|FG002|Overall Study|Death|0|||
127897425|NCT02518113|460249425|FG003|Overall Study|Death|0|||
127897426|NCT02518113|460249422|FG000|Overall Study|Physician Decision|0|||
127897427|NCT02518113|460249423|FG001|Overall Study|Physician Decision|1|||
127897428|NCT02518113|460249424|FG002|Overall Study|Physician Decision|0|||
127897429|NCT02518113|460249425|FG003|Overall Study|Physician Decision|0|||
127897430|NCT02518113|460249422|FG000|Overall Study|Progressive Disease|1|||
127897431|NCT02518113|460249423|FG001|Overall Study|Progressive Disease|2|||
127897432|NCT02518113|460249424|FG002|Overall Study|Progressive Disease|3|||
127897433|NCT02518113|460249425|FG003|Overall Study|Progressive Disease|0|||
127897434|NCT02270736|460249426|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
127897435|NCT02270736|460249427|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
127897436|NCT02270736|460249428|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
127897437|NCT02270736|460249429|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
127897438|NCT02270736|460249430|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
127897439|NCT02270736|460249426|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
127897440|NCT02270736|460249427|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
127897441|NCT02270736|460249428|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
127897442|NCT02270736|460249429|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
127897443|NCT02270736|460249430|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
127897444|NCT02270736|460249426|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
127897445|NCT02270736|460249427|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
127897446|NCT02270736|460249428|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
127897447|NCT02270736|460249429|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
127897448|NCT02270736|460249430|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
127897449|NCT02270736|460249426|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
127897450|NCT02270736|460249427|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
127897451|NCT02270736|460249428|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
127897452|NCT02270736|460249429|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
127897453|NCT02270736|460249430|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
127897454|NCT02270736|460249426|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
127838011|NCT00547378|460023806|FG000|Randomized Cohort|Adverse Event|1|||
127838012|NCT00547378|460023807|FG001|Randomized Cohort|Adverse Event|0|||
127838013|NCT00547378|460023808|FG002|Randomized Cohort|Adverse Event|0|||
127838014|NCT00547378|460023806|FG000|Randomized Cohort|Other reasons|2|||
127838015|NCT00547378|460023807|FG001|Randomized Cohort|Other reasons|0|||
127838016|NCT00547378|460023808|FG002|Randomized Cohort|Other reasons|0|||
127838017|NCT00547378|460023806|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
127838018|NCT00547378|460023807|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
127838019|NCT00547378|460023808|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
127838020|NCT00547378|460023806|FG000|All Implanted Cohort|Adverse Event|4|||
127838021|NCT00547378|460023807|FG001|All Implanted Cohort|Adverse Event|10|||
127838022|NCT00547378|460023808|FG002|All Implanted Cohort|Adverse Event|17|||
127897455|NCT02270736|460249427|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
127838023|NCT00547378|460023806|FG000|All Implanted Cohort|Lost to Follow-up|0|||
127838024|NCT00547378|460023807|FG001|All Implanted Cohort|Lost to Follow-up|1|||
127838025|NCT00547378|460023808|FG002|All Implanted Cohort|Lost to Follow-up|14|||
127838026|NCT00547378|460023806|FG000|All Implanted Cohort|Death|3|||
127838027|NCT00547378|460023807|FG001|All Implanted Cohort|Death|1|||
127838028|NCT00547378|460023808|FG002|All Implanted Cohort|Death|4|||
127838029|NCT00547378|460023806|FG000|All Implanted Cohort|Physician Decision|0|||
127838030|NCT00547378|460023807|FG001|All Implanted Cohort|Physician Decision|2|||
127838031|NCT00547378|460023808|FG002|All Implanted Cohort|Physician Decision|6|||
127838032|NCT00547378|460023806|FG000|All Implanted Cohort|Site closure|2|||
127838033|NCT00547378|460023807|FG001|All Implanted Cohort|Site closure|0|||
127838034|NCT00547378|460023808|FG002|All Implanted Cohort|Site closure|1|||
127838035|NCT00547378|460023806|FG000|All Implanted Cohort|Other reasons|1|||
127838036|NCT00547378|460023807|FG001|All Implanted Cohort|Other reasons|0|||
127838037|NCT00547378|460023808|FG002|All Implanted Cohort|Other reasons|1|||
127838038|NCT04105244|460023809|FG000|Overall Study|Withdrawal by Subject|10|||
127838039|NCT04105244|460023810|FG001|Overall Study|Withdrawal by Subject|12|||
127838040|NCT04105244|460023809|FG000|Overall Study|Lost to Follow-up|20|||
127838041|NCT04105244|460023810|FG001|Overall Study|Lost to Follow-up|15|||
127838042|NCT04105244|460023809|FG000|Overall Study|Parent no longer eligible- child not living at home|0|||
127838043|NCT04105244|460023810|FG001|Overall Study|Parent no longer eligible- child not living at home|2|||
127838044|NCT04105244|460023809|FG000|Overall Study|Unable to contact to complete the intervention.|0|||
127838045|NCT04105244|460023810|FG001|Overall Study|Unable to contact to complete the intervention.|9|||
127838046|NCT02112994|460023811|FG000|Overall Study|Progressive Disease|0|||
127838047|NCT02112994|460023812|FG001|Overall Study|Progressive Disease|0|||
127838048|NCT02112994|460023813|FG002|Overall Study|Progressive Disease|1|||
127838049|NCT02112994|460023811|FG000|Overall Study|Pregnancy|0|||
127838050|NCT02112994|460023812|FG001|Overall Study|Pregnancy|1|||
127838051|NCT02112994|460023813|FG002|Overall Study|Pregnancy|1|||
127838052|NCT02112994|460023811|FG000|Overall Study|Liver Transplant|0|||
127838053|NCT02112994|460023812|FG001|Overall Study|Liver Transplant|1|||
127838054|NCT02112994|460023813|FG002|Overall Study|Liver Transplant|0|||
127838055|NCT02112994|460023811|FG000|Overall Study|Withdrawal by Subject|0|||
127838056|NCT02112994|460023812|FG001|Overall Study|Withdrawal by Subject|0|||
127838057|NCT02112994|460023813|FG002|Overall Study|Withdrawal by Subject|1|||
127838058|NCT02768194|460023815|FG000|Period 1|Adverse Event|0|||
127838059|NCT02768194|460023816|FG001|Period 1|Adverse Event|0|||
127838060|NCT02768194|460023817|FG002|Period 1|Adverse Event|0|||
127838061|NCT02768194|460023818|FG003|Period 1|Adverse Event|1|||
127838062|NCT02768194|460023819|FG004|Period 1|Adverse Event|0|||
127838063|NCT02768194|460023820|FG005|Period 1|Adverse Event|0|||
127838064|NCT02768194|460023815|FG000|Period 2|Other (Reason not specified)|1|||
127838065|NCT02768194|460023816|FG001|Period 2|Other (Reason not specified)|0|||
127838066|NCT02768194|460023817|FG002|Period 2|Other (Reason not specified)|0|||
127838067|NCT02768194|460023818|FG003|Period 2|Other (Reason not specified)|0|||
127838068|NCT02768194|460023819|FG004|Period 2|Other (Reason not specified)|0|||
127838069|NCT02768194|460023820|FG005|Period 2|Other (Reason not specified)|0|||
127838070|NCT02768194|460023815|FG000|Period 3|Other (Reason not specified)|0|||
127838071|NCT02768194|460023816|FG001|Period 3|Other (Reason not specified)|1|||
127838072|NCT02768194|460023817|FG002|Period 3|Other (Reason not specified)|0|||
127838073|NCT02768194|460023818|FG003|Period 3|Other (Reason not specified)|0|||
127838074|NCT02768194|460023819|FG004|Period 3|Other (Reason not specified)|0|||
127838075|NCT02768194|460023820|FG005|Period 3|Other (Reason not specified)|0|||
127838076|NCT00975195|460023821|FG000|Overall Study|Adverse Event|108|||
127838077|NCT00975195|460023822|FG001|Overall Study|Adverse Event|101|||
127838078|NCT00975195|460023821|FG000|Overall Study|Lack of Efficacy|6|||
127838079|NCT00975195|460023822|FG001|Overall Study|Lack of Efficacy|6|||
127838080|NCT00975195|460023821|FG000|Overall Study|Protocol Violation|27|||
127838081|NCT00975195|460023822|FG001|Overall Study|Protocol Violation|23|||
127838082|NCT00975195|460023821|FG000|Overall Study|Lost to Follow-up|9|||
127838083|NCT00975195|460023822|FG001|Overall Study|Lost to Follow-up|7|||
127838084|NCT00975195|460023821|FG000|Overall Study|Withdrawal by Subject|48|||
127838085|NCT00975195|460023822|FG001|Overall Study|Withdrawal by Subject|61|||
127838086|NCT00975195|460023821|FG000|Overall Study|Other reason not defined above|29|||
127838087|NCT00975195|460023822|FG001|Overall Study|Other reason not defined above|33|||
127838088|NCT00975195|460023821|FG000|Overall Study|Not treated|1|||
127838089|NCT00975195|460023822|FG001|Overall Study|Not treated|2|||
127838090|NCT01608724|460023827|FG000|Overall Study|Withdrawal by Subject|131|||
127838091|NCT01608724|460023827|FG000|Overall Study|Lost to Follow-up|41|||
127838092|NCT01608724|460023827|FG000|Overall Study|Study-specific discontinuation criteria|32|||
127838093|NCT01608724|460023827|FG000|Overall Study|Adverse Event|29|||
127838094|NCT01608724|460023827|FG000|Overall Study|Protocol Violation|6|||
127838095|NCT01608724|460023827|FG000|Overall Study|bood sugar too high, etc.|3|||
127838096|NCT01608724|460023827|FG000|Overall Study|Safety reasons|1|||
127838097|NCT00363246|460023828|FG000|Overall Study|Death|40|||
127838098|NCT00363246|460023828|FG000|Overall Study|Withdrawal by Subject|19|||
127838099|NCT00363246|460023828|FG000|Overall Study|Lost to Follow-up|14|||
127838100|NCT00363246|460023828|FG000|Overall Study|Bad health|6|||
127897456|NCT02270736|460249428|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
127897457|NCT02270736|460249429|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
127897458|NCT02270736|460249430|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
127897459|NCT02270736|460249426|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
127897460|NCT02270736|460249427|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
127897461|NCT02270736|460249428|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
127897462|NCT02270736|460249429|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
127897463|NCT02270736|460249430|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
127897464|NCT02270736|460249426|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
127897465|NCT02270736|460249427|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
127897466|NCT02270736|460249428|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
127897467|NCT02270736|460249429|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
127897468|NCT02270736|460249430|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
127897469|NCT02270736|460249426|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
127897470|NCT02270736|460249427|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
127897471|NCT02270736|460249428|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
127897472|NCT02270736|460249429|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
127897473|NCT02270736|460249430|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
127897474|NCT02270736|460249426|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
127897475|NCT02270736|460249427|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
127897476|NCT02270736|460249428|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
127897477|NCT02270736|460249429|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
127897478|NCT02270736|460249430|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
127897479|NCT01631864|460249431|FG000|Overall Study|Withdrawal by Subject|0|||
127897480|NCT01631864|460249432|FG001|Overall Study|Withdrawal by Subject|1|||
127897481|NCT01631864|460249431|FG000|Overall Study|Adverse Event|2|||
127897482|NCT01631864|460249432|FG001|Overall Study|Adverse Event|3|||
127897483|NCT03194464|460249452|FG000|Overall Study|data not usable|2|||
127897484|NCT03103100|460249453|FG000|Overall Study|Adverse Event|1|||
127897485|NCT03103100|460249454|FG001|Overall Study|Adverse Event|0|||
127897486|NCT03103100|460249455|FG002|Overall Study|Adverse Event|0|||
127897487|NCT03103100|460249453|FG000|Overall Study|Physician Decision|1|||
127897488|NCT03103100|460249454|FG001|Overall Study|Physician Decision|0|||
127897489|NCT03103100|460249455|FG002|Overall Study|Physician Decision|2|||
127897490|NCT02153398|460249458|FG000|Overall Study|Withdrawal by Subject|1|||
127897491|NCT02153398|460249459|FG001|Overall Study|Withdrawal by Subject|0|||
127897492|NCT02153398|460249460|FG002|Overall Study|Withdrawal by Subject|0|||
127897493|NCT02153398|460249461|FG003|Overall Study|Withdrawal by Subject|0|||
127897494|NCT02153398|460249462|FG004|Overall Study|Withdrawal by Subject|0|||
127897495|NCT02153398|460249458|FG000|Overall Study|Adverse Event|0|||
127897496|NCT02153398|460249459|FG001|Overall Study|Adverse Event|0|||
127897497|NCT02153398|460249460|FG002|Overall Study|Adverse Event|1|||
127897498|NCT02153398|460249461|FG003|Overall Study|Adverse Event|1|||
127897499|NCT02153398|460249462|FG004|Overall Study|Adverse Event|0|||
127897500|NCT02402166|460249463|FG000|Overall Study|Adverse Event|2|||
127897501|NCT02402166|460249463|FG000|Overall Study|Withdrawal by Subject|2|||
127897502|NCT02402166|460249463|FG000|Overall Study|Lost to Follow-up|1|||
127897503|NCT03331042|460249464|FG000|Overall Study|Protocol Violation|1|||
127897504|NCT03331042|460249465|FG001|Overall Study|Protocol Violation|0|||
127897505|NCT03331042|460249466|FG002|Overall Study|Protocol Violation|0|||
127897506|NCT03331042|460249467|FG003|Overall Study|Protocol Violation|0|||
127897507|NCT03331042|460249464|FG000|Overall Study|Physician Decision|0|||
127897508|NCT03331042|460249465|FG001|Overall Study|Physician Decision|0|||
127897509|NCT03331042|460249466|FG002|Overall Study|Physician Decision|1|||
127897510|NCT03331042|460249467|FG003|Overall Study|Physician Decision|0|||
127897511|NCT03331042|460249464|FG000|Overall Study|Lost to Follow-up|0|||
127897512|NCT03331042|460249465|FG001|Overall Study|Lost to Follow-up|0|||
127897513|NCT03331042|460249466|FG002|Overall Study|Lost to Follow-up|0|||
127897514|NCT03331042|460249467|FG003|Overall Study|Lost to Follow-up|1|||
127897515|NCT00688064|460249471|FG000|Overall Study|Protocol Violation|0|||
127897516|NCT00688064|460249472|FG001|Overall Study|Protocol Violation|1|||
127897517|NCT00688064|460249471|FG000|Overall Study|Adverse Event|2|||
127897518|NCT00688064|460249472|FG001|Overall Study|Adverse Event|4|||
127897519|NCT00688064|460249471|FG000|Overall Study|Withdrawal by Subject|7|||
127897520|NCT00688064|460249472|FG001|Overall Study|Withdrawal by Subject|7|||
127897521|NCT00688064|460249471|FG000|Overall Study|Lost to Follow-up|10|||
127897522|NCT00688064|460249472|FG001|Overall Study|Lost to Follow-up|10|||
127838101|NCT00363246|460023828|FG000|Overall Study|Stopped using wheelchair|11|||
127838102|NCT00363246|460023828|FG000|Overall Study|Subject expressed security concerns|2|||
127838103|NCT00363246|460023828|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
127838104|NCT04387136|460023829|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
127838105|NCT04387136|460023830|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
127838106|NCT00264849|460023831|FG000|Overall Study|Adverse Event|7|||
127838107|NCT00264849|460023832|FG001|Overall Study|Adverse Event|2|||
127838108|NCT00264849|460023831|FG000|Overall Study|Withdrawal by Subject|7|||
127838109|NCT00264849|460023832|FG001|Overall Study|Withdrawal by Subject|11|||
127838110|NCT00264849|460023831|FG000|Overall Study|Protocol Violation|5|||
127838111|NCT00264849|460023832|FG001|Overall Study|Protocol Violation|3|||
127838112|NCT00264849|460023831|FG000|Overall Study|Lack of Efficacy|1|||
127838113|NCT00264849|460023832|FG001|Overall Study|Lack of Efficacy|6|||
127838114|NCT00264849|460023831|FG000|Overall Study|Lost to Follow-up|0|||
127838115|NCT00264849|460023832|FG001|Overall Study|Lost to Follow-up|2|||
127838116|NCT00264849|460023831|FG000|Overall Study|Death|0|||
127838117|NCT00264849|460023832|FG001|Overall Study|Death|1|||
127838118|NCT00264849|460023831|FG000|Overall Study|Administrative Problems|2|||
127838119|NCT00264849|460023832|FG001|Overall Study|Administrative Problems|0|||
127838120|NCT00099359|460023833|FG000|Overall Study|Death|11|||
127838121|NCT00099359|460023834|FG001|Overall Study|Death|15|||
127838122|NCT00099359|460023835|FG002|Overall Study|Death|17|||
127838123|NCT00099359|460023833|FG000|Overall Study|Withdrawal by Subject|19|||
127838124|NCT00099359|460023834|FG001|Overall Study|Withdrawal by Subject|19|||
127838125|NCT00099359|460023835|FG002|Overall Study|Withdrawal by Subject|23|||
127838126|NCT00099359|460023833|FG000|Overall Study|Lost to Follow-up|15|||
127838127|NCT00099359|460023834|FG001|Overall Study|Lost to Follow-up|24|||
127838128|NCT00099359|460023835|FG002|Overall Study|Lost to Follow-up|24|||
127838129|NCT00099359|460023833|FG000|Overall Study|moved out of area|9|||
127897523|NCT00688064|460249471|FG000|Overall Study|Lack of Efficacy|0|||
127897524|NCT00688064|460249472|FG001|Overall Study|Lack of Efficacy|1|||
127897525|NCT00688064|460249471|FG000|Overall Study|Pregnancy|1|||
127897526|NCT00688064|460249472|FG001|Overall Study|Pregnancy|0|||
127897527|NCT00688064|460249471|FG000|Overall Study|Any other reasons|1|||
127897528|NCT00688064|460249472|FG001|Overall Study|Any other reasons|3|||
127897529|NCT00001849|460249473|FG000|Overall Study|Death|4|||
127897530|NCT00001849|460249473|FG000|Overall Study|Lost to Follow-up|2|||
127897531|NCT00001849|460249473|FG000|Overall Study|Withdrawal by Subject|2|||
127897532|NCT00001849|460249473|FG000|Overall Study|tumor remained occult|6|||
127897533|NCT02428699|460249474|FG000|Washout Period 1|Screen Failure|1|||
127897534|NCT02428699|460249475|FG001|Washout Period 1|Screen Failure|2|||
127897535|NCT01781286|460249478|FG000|Overall Study|Lost to Follow-up|0|||
127897536|NCT01781286|460249479|FG001|Overall Study|Lost to Follow-up|0|||
127897537|NCT01781286|460249480|FG002|Overall Study|Lost to Follow-up|0|||
127897538|NCT01781286|460249481|FG003|Overall Study|Lost to Follow-up|0|||
127897539|NCT01781286|460249482|FG004|Overall Study|Lost to Follow-up|0|||
127897540|NCT01781286|460249483|FG005|Overall Study|Lost to Follow-up|1|||
127897541|NCT01781286|460249478|FG000|Overall Study|Time Constraints|2|||
127897542|NCT01781286|460249479|FG001|Overall Study|Time Constraints|0|||
127897543|NCT01781286|460249480|FG002|Overall Study|Time Constraints|2|||
127897544|NCT01781286|460249481|FG003|Overall Study|Time Constraints|0|||
127897545|NCT01781286|460249482|FG004|Overall Study|Time Constraints|0|||
127838130|NCT00099359|460023834|FG001|Overall Study|moved out of area|7|||
127838131|NCT00099359|460023835|FG002|Overall Study|moved out of area|4|||
127838132|NCT02756650|460023838|FG000|Overall Study|Physician Decision|1|||
127838133|NCT02756650|460023838|FG000|Overall Study|Adverse Event|1|||
127838134|NCT01822691|460023839|FG000|Overall Study|Withdrawal by Subject|2|||
127838135|NCT04501679|460023844|FG000|Overall Study|Pregnancy|0|||
127838136|NCT04501679|460023845|FG001|Overall Study|Pregnancy|1|||
127838137|NCT04501679|460023844|FG000|Overall Study|Adverse Event|4|||
127838138|NCT04501679|460023845|FG001|Overall Study|Adverse Event|2|||
127838139|NCT04501679|460023844|FG000|Overall Study|Withdrawal by Subject|2|||
127838140|NCT04501679|460023845|FG001|Overall Study|Withdrawal by Subject|0|||
127838141|NCT04501679|460023844|FG000|Overall Study|Physician Decision|1|||
127838142|NCT04501679|460023845|FG001|Overall Study|Physician Decision|0|||
127838143|NCT04501679|460023844|FG000|Overall Study|Lost to Follow-up|2|||
127838144|NCT04501679|460023845|FG001|Overall Study|Lost to Follow-up|0|||
127838145|NCT02358369|460023851|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
127897546|NCT01781286|460249483|FG005|Overall Study|Time Constraints|0|||
127897547|NCT01781286|460249478|FG000|Overall Study|Noncompliance|0|||
127897548|NCT01781286|460249479|FG001|Overall Study|Noncompliance|0|||
127897549|NCT01781286|460249480|FG002|Overall Study|Noncompliance|0|||
127897550|NCT01781286|460249481|FG003|Overall Study|Noncompliance|1|||
127838146|NCT02358369|460023852|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
127838147|NCT02358369|460023853|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
127838148|NCT02358369|460023854|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
127838149|NCT02358369|460023855|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
127897551|NCT01781286|460249482|FG004|Overall Study|Noncompliance|0|||
127838150|NCT02358369|460023851|FG000|Treatment Period A/B|Adverse Event|0|||
127838151|NCT02358369|460023852|FG001|Treatment Period A/B|Adverse Event|0|||
127838152|NCT02358369|460023853|FG002|Treatment Period A/B|Adverse Event|1|||
127838153|NCT02358369|460023854|FG003|Treatment Period A/B|Adverse Event|2|||
127838154|NCT02358369|460023855|FG004|Treatment Period A/B|Adverse Event|0|||
127897552|NCT01781286|460249483|FG005|Overall Study|Noncompliance|0|||
127897553|NCT03594123|460249484|FG000|Overall Study|Lost to Follow-up|0|||
127897554|NCT03594123|460249485|FG001|Overall Study|Lost to Follow-up|1|||
127897555|NCT03594123|460249484|FG000|Overall Study|Adverse Event|8|||
127897556|NCT03594123|460249485|FG001|Overall Study|Adverse Event|5|||
127897557|NCT03594123|460249484|FG000|Overall Study|Site Terminated by Sponsor|4|||
127897558|NCT03594123|460249485|FG001|Overall Study|Site Terminated by Sponsor|1|||
127897559|NCT03594123|460249484|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
127897560|NCT03594123|460249485|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
127897561|NCT03594123|460249484|FG000|Overall Study|Lack of Efficacy|1|||
127897562|NCT03594123|460249485|FG001|Overall Study|Lack of Efficacy|0|||
127897563|NCT03594123|460249484|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
127897564|NCT03594123|460249485|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
127897565|NCT02483975|460249486|FG000|Overall Study|Adverse Event|0|||
127897566|NCT02483975|460249487|FG001|Overall Study|Adverse Event|1|||
127897567|NCT02483975|460249486|FG000|Overall Study|Lost to Follow-up|0|||
127897568|NCT02483975|460249487|FG001|Overall Study|Lost to Follow-up|1|||
127897569|NCT02483975|460249486|FG000|Overall Study|Physician Decision|2|||
127897570|NCT02483975|460249487|FG001|Overall Study|Physician Decision|0|||
127897571|NCT01505530|460249490|FG000|Overall Study|Progressive Disease|19|||
127897572|NCT01505530|460249491|FG001|Overall Study|Progressive Disease|17|||
127897573|NCT01505530|460249492|FG002|Overall Study|Progressive Disease|18|||
127897574|NCT01505530|460249490|FG000|Overall Study|Adverse Event|1|||
127897575|NCT01505530|460249491|FG001|Overall Study|Adverse Event|1|||
127897576|NCT01505530|460249492|FG002|Overall Study|Adverse Event|0|||
127897577|NCT01505530|460249490|FG000|Overall Study|Withdrawal by Subject|7|||
127897578|NCT01505530|460249491|FG001|Overall Study|Withdrawal by Subject|8|||
127897579|NCT01505530|460249492|FG002|Overall Study|Withdrawal by Subject|6|||
127897580|NCT01505530|460249490|FG000|Overall Study|Physician Decision|6|||
127897581|NCT01505530|460249491|FG001|Overall Study|Physician Decision|2|||
127897582|NCT01505530|460249492|FG002|Overall Study|Physician Decision|5|||
127897583|NCT01505530|460249490|FG000|Overall Study|Sponsor Decision|1|||
127897584|NCT01505530|460249491|FG001|Overall Study|Sponsor Decision|8|||
127897585|NCT01505530|460249492|FG002|Overall Study|Sponsor Decision|7|||
127897586|NCT01505530|460249490|FG000|Overall Study|Death|7|||
127897587|NCT01505530|460249491|FG001|Overall Study|Death|6|||
127897588|NCT01505530|460249492|FG002|Overall Study|Death|5|||
127838155|NCT02358369|460023851|FG000|Treatment Period A/B|Death|0|||
127838156|NCT02358369|460023852|FG001|Treatment Period A/B|Death|0|||
127838157|NCT02358369|460023853|FG002|Treatment Period A/B|Death|1|||
127838158|NCT02358369|460023854|FG003|Treatment Period A/B|Death|0|||
127838159|NCT02358369|460023855|FG004|Treatment Period A/B|Death|0|||
127838160|NCT02358369|460023851|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
127838161|NCT02358369|460023852|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
127838162|NCT02358369|460023853|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
127838163|NCT02358369|460023854|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
127838164|NCT02358369|460023855|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
127838165|NCT02358369|460023851|FG000|Treatment Period C|Adverse Event|0|||
127838166|NCT02358369|460023852|FG001|Treatment Period C|Adverse Event|0|||
127838167|NCT02358369|460023853|FG002|Treatment Period C|Adverse Event|0|||
127838168|NCT02358369|460023854|FG003|Treatment Period C|Adverse Event|0|||
127838169|NCT02358369|460023855|FG004|Treatment Period C|Adverse Event|7|||
127838170|NCT03655717|460023860|FG000|Overall Study|Withdrawal by Subject|4|||
127838171|NCT03655717|460023861|FG001|Overall Study|Withdrawal by Subject|8|||
127897589|NCT01505530|460249490|FG000|Overall Study|entry criteria not met|0|||
127897590|NCT01505530|460249491|FG001|Overall Study|entry criteria not met|1|||
127897591|NCT01505530|460249492|FG002|Overall Study|entry criteria not met|0|||
127897592|NCT00973700|460249493|FG000|Overall Study|Withdrawal by Subject|2|||
127897593|NCT00973700|460249494|FG001|Overall Study|Withdrawal by Subject|2|||
127897594|NCT00973700|460249495|FG002|Overall Study|Withdrawal by Subject|8|||
127897595|NCT00973700|460249496|FG003|Overall Study|Withdrawal by Subject|4|||
127838172|NCT03655717|460023862|FG002|Overall Study|Withdrawal by Subject|1|||
127838173|NCT03655717|460023863|FG003|Overall Study|Withdrawal by Subject|0|||
127838174|NCT03655717|460023864|FG004|Overall Study|Withdrawal by Subject|0|||
127838175|NCT03655717|460023865|FG005|Overall Study|Withdrawal by Subject|1|||
127838176|NCT03655717|460023866|FG006|Overall Study|Withdrawal by Subject|3|||
127838177|NCT03655717|460023867|FG007|Overall Study|Withdrawal by Subject|1|||
127838178|NCT03655717|460023868|FG008|Overall Study|Withdrawal by Subject|2|||
127838179|NCT03655717|460023869|FG009|Overall Study|Withdrawal by Subject|0|||
127838180|NCT03655717|460023870|FG010|Overall Study|Withdrawal by Subject|0|||
127838181|NCT03655717|460023871|FG011|Overall Study|Withdrawal by Subject|1|||
127838182|NCT03655717|460023872|FG012|Overall Study|Withdrawal by Subject|0|||
127838183|NCT03655717|460023873|FG013|Overall Study|Withdrawal by Subject|3|||
127838184|NCT03655717|460023874|FG014|Overall Study|Withdrawal by Subject|0|||
127838185|NCT03655717|460023875|FG015|Overall Study|Withdrawal by Subject|1|||
127838186|NCT03655717|460023876|FG016|Overall Study|Withdrawal by Subject|0|||
127838187|NCT03655717|460023877|FG017|Overall Study|Withdrawal by Subject|0|||
127838188|NCT03655717|460023878|FG018|Overall Study|Withdrawal by Subject|1|||
127838189|NCT03655717|460023879|FG019|Overall Study|Withdrawal by Subject|0|||
127838190|NCT03655717|460023880|FG020|Overall Study|Withdrawal by Subject|0|||
127838191|NCT03655717|460023881|FG021|Overall Study|Withdrawal by Subject|1|||
127838192|NCT03655717|460023882|FG022|Overall Study|Withdrawal by Subject|2|||
127838193|NCT03655717|460023883|FG023|Overall Study|Withdrawal by Subject|1|||
127838194|NCT03655717|460023884|FG024|Overall Study|Withdrawal by Subject|1|||
127838195|NCT03655717|460023885|FG025|Overall Study|Withdrawal by Subject|0|||
127838196|NCT03655717|460023860|FG000|Overall Study|Physician Decision|3|||
127838197|NCT03655717|460023861|FG001|Overall Study|Physician Decision|3|||
127838198|NCT03655717|460023862|FG002|Overall Study|Physician Decision|0|||
127838199|NCT03655717|460023863|FG003|Overall Study|Physician Decision|0|||
127838200|NCT03655717|460023864|FG004|Overall Study|Physician Decision|0|||
127838201|NCT03655717|460023865|FG005|Overall Study|Physician Decision|0|||
127838202|NCT03655717|460023866|FG006|Overall Study|Physician Decision|0|||
127838203|NCT03655717|460023867|FG007|Overall Study|Physician Decision|0|||
127838204|NCT03655717|460023868|FG008|Overall Study|Physician Decision|0|||
127838205|NCT03655717|460023869|FG009|Overall Study|Physician Decision|1|||
127838206|NCT03655717|460023870|FG010|Overall Study|Physician Decision|0|||
127838207|NCT03655717|460023871|FG011|Overall Study|Physician Decision|0|||
127838208|NCT03655717|460023872|FG012|Overall Study|Physician Decision|0|||
127838209|NCT03655717|460023873|FG013|Overall Study|Physician Decision|0|||
127838210|NCT03655717|460023874|FG014|Overall Study|Physician Decision|0|||
127838211|NCT03655717|460023875|FG015|Overall Study|Physician Decision|0|||
127838212|NCT03655717|460023876|FG016|Overall Study|Physician Decision|0|||
127838213|NCT03655717|460023877|FG017|Overall Study|Physician Decision|0|||
127838214|NCT03655717|460023878|FG018|Overall Study|Physician Decision|0|||
127838215|NCT03655717|460023879|FG019|Overall Study|Physician Decision|1|||
127838216|NCT03655717|460023880|FG020|Overall Study|Physician Decision|0|||
127838217|NCT03655717|460023881|FG021|Overall Study|Physician Decision|0|||
127838218|NCT03655717|460023882|FG022|Overall Study|Physician Decision|0|||
127838219|NCT03655717|460023883|FG023|Overall Study|Physician Decision|1|||
127838220|NCT03655717|460023884|FG024|Overall Study|Physician Decision|0|||
127838221|NCT03655717|460023885|FG025|Overall Study|Physician Decision|0|||
127838222|NCT03655717|460023860|FG000|Overall Study|Lost to Follow-up|3|||
127838223|NCT03655717|460023861|FG001|Overall Study|Lost to Follow-up|1|||
127838224|NCT03655717|460023862|FG002|Overall Study|Lost to Follow-up|0|||
127838225|NCT03655717|460023863|FG003|Overall Study|Lost to Follow-up|1|||
127838226|NCT03655717|460023864|FG004|Overall Study|Lost to Follow-up|0|||
127838227|NCT03655717|460023865|FG005|Overall Study|Lost to Follow-up|1|||
127838228|NCT03655717|460023866|FG006|Overall Study|Lost to Follow-up|0|||
127838229|NCT03655717|460023867|FG007|Overall Study|Lost to Follow-up|0|||
127838230|NCT03655717|460023868|FG008|Overall Study|Lost to Follow-up|0|||
127838231|NCT03655717|460023869|FG009|Overall Study|Lost to Follow-up|0|||
127838232|NCT03655717|460023870|FG010|Overall Study|Lost to Follow-up|0|||
127838233|NCT03655717|460023871|FG011|Overall Study|Lost to Follow-up|1|||
127838234|NCT03655717|460023872|FG012|Overall Study|Lost to Follow-up|0|||
127838235|NCT03655717|460023873|FG013|Overall Study|Lost to Follow-up|0|||
127838236|NCT03655717|460023874|FG014|Overall Study|Lost to Follow-up|0|||
127838237|NCT03655717|460023875|FG015|Overall Study|Lost to Follow-up|0|||
127838238|NCT03655717|460023876|FG016|Overall Study|Lost to Follow-up|0|||
127838239|NCT03655717|460023877|FG017|Overall Study|Lost to Follow-up|0|||
127838240|NCT03655717|460023878|FG018|Overall Study|Lost to Follow-up|0|||
127838241|NCT03655717|460023879|FG019|Overall Study|Lost to Follow-up|0|||
127838242|NCT03655717|460023880|FG020|Overall Study|Lost to Follow-up|0|||
127838243|NCT03655717|460023881|FG021|Overall Study|Lost to Follow-up|0|||
127838244|NCT03655717|460023882|FG022|Overall Study|Lost to Follow-up|0|||
127838245|NCT03655717|460023883|FG023|Overall Study|Lost to Follow-up|0|||
127838246|NCT03655717|460023884|FG024|Overall Study|Lost to Follow-up|0|||
127838247|NCT03655717|460023885|FG025|Overall Study|Lost to Follow-up|0|||
127838248|NCT03073213|460025313|FG000|Multiple Dose Period|Protocol Violation|0|||
127838249|NCT03073213|460025314|FG001|Multiple Dose Period|Protocol Violation|0|||
127838250|NCT03073213|460025315|FG002|Multiple Dose Period|Protocol Violation|1|||
127838251|NCT00190983|460025323|FG000|Overall Study|Inevaluable (never treated)|2|||
127838252|NCT00502320|460025324|FG000|Overall Study|Lost to Follow-up|1|||
127838253|NCT00502320|460025325|FG001|Overall Study|Lost to Follow-up|1|||
127838254|NCT00502320|460025324|FG000|Overall Study|Withdrew Consent|1|||
127838255|NCT00502320|460025325|FG001|Overall Study|Withdrew Consent|0|||
127838256|NCT00502320|460025324|FG000|Overall Study|No longer met criteria|1|||
127838257|NCT00502320|460025325|FG001|Overall Study|No longer met criteria|0|||
127838258|NCT00502320|460025324|FG000|Overall Study|Screen Failure|0|||
127838259|NCT00502320|460025325|FG001|Overall Study|Screen Failure|1|||
127838260|NCT00502320|460025324|FG000|Overall Study|Adverse Event|3|||
127838261|NCT00502320|460025325|FG001|Overall Study|Adverse Event|5|||
127838262|NCT01453998|460025326|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
127897596|NCT00973700|460249497|FG004|Overall Study|Withdrawal by Subject|4|||
127897597|NCT00973700|460249493|FG000|Overall Study|Lost to Follow-up|5|||
127897598|NCT00973700|460249494|FG001|Overall Study|Lost to Follow-up|0|||
127897599|NCT00973700|460249495|FG002|Overall Study|Lost to Follow-up|1|||
127897600|NCT00973700|460249496|FG003|Overall Study|Lost to Follow-up|8|||
127897601|NCT00973700|460249497|FG004|Overall Study|Lost to Follow-up|5|||
127897602|NCT00973700|460249493|FG000|Overall Study|Inappropriate enrolment|0|||
127897603|NCT00973700|460249494|FG001|Overall Study|Inappropriate enrolment|0|||
127897604|NCT00973700|460249495|FG002|Overall Study|Inappropriate enrolment|0|||
127897605|NCT00973700|460249496|FG003|Overall Study|Inappropriate enrolment|4|||
127897606|NCT00973700|460249497|FG004|Overall Study|Inappropriate enrolment|0|||
127897607|NCT00973700|460249493|FG000|Overall Study|Unable to Classify|0|||
127897608|NCT00973700|460249494|FG001|Overall Study|Unable to Classify|0|||
127897609|NCT00973700|460249495|FG002|Overall Study|Unable to Classify|1|||
127897610|NCT00973700|460249496|FG003|Overall Study|Unable to Classify|2|||
127897611|NCT00973700|460249497|FG004|Overall Study|Unable to Classify|1|||
127897612|NCT02492958|460249498|FG000|Overall Study|Withdrawal by Subject|0|||
127897613|NCT02492958|460249499|FG001|Overall Study|Withdrawal by Subject|0|||
127897614|NCT02492958|460249500|FG002|Overall Study|Withdrawal by Subject|1|||
127897615|NCT02492958|460249501|FG003|Overall Study|Withdrawal by Subject|0|||
127897616|NCT02492958|460249498|FG000|Overall Study|Adverse Event|1|||
127897617|NCT02492958|460249499|FG001|Overall Study|Adverse Event|0|||
127897618|NCT02492958|460249500|FG002|Overall Study|Adverse Event|1|||
127897619|NCT02492958|460249501|FG003|Overall Study|Adverse Event|0|||
127897620|NCT01193608|460249502|FG000|Overall Study|Other|0|||
127897621|NCT01193608|460249503|FG001|Overall Study|Other|1|||
127897622|NCT01193608|460249504|FG002|Overall Study|Other|0|||
127897623|NCT01193608|460249505|FG003|Overall Study|Other|0|||
127897624|NCT01193608|460249506|FG004|Overall Study|Other|0|||
127897625|NCT01193608|460249507|FG005|Overall Study|Other|0|||
127897626|NCT01193608|460249502|FG000|Overall Study|Withdrawal by Subject|0|||
127897627|NCT01193608|460249503|FG001|Overall Study|Withdrawal by Subject|1|||
127897628|NCT01193608|460249504|FG002|Overall Study|Withdrawal by Subject|2|||
127897629|NCT01193608|460249505|FG003|Overall Study|Withdrawal by Subject|3|||
127897630|NCT01193608|460249506|FG004|Overall Study|Withdrawal by Subject|3|||
127897631|NCT01193608|460249507|FG005|Overall Study|Withdrawal by Subject|0|||
127897632|NCT01193608|460249502|FG000|Overall Study|Lost to Follow-up|0|||
127897633|NCT01193608|460249503|FG001|Overall Study|Lost to Follow-up|0|||
127897634|NCT01193608|460249504|FG002|Overall Study|Lost to Follow-up|0|||
127897635|NCT01193608|460249505|FG003|Overall Study|Lost to Follow-up|0|||
127897636|NCT01193608|460249506|FG004|Overall Study|Lost to Follow-up|1|||
127897637|NCT01193608|460249507|FG005|Overall Study|Lost to Follow-up|2|||
127897638|NCT01193608|460249502|FG000|Overall Study|Adverse Event|0|||
127897639|NCT01193608|460249503|FG001|Overall Study|Adverse Event|0|||
127897640|NCT01193608|460249504|FG002|Overall Study|Adverse Event|0|||
127897641|NCT01193608|460249505|FG003|Overall Study|Adverse Event|0|||
127897642|NCT01193608|460249506|FG004|Overall Study|Adverse Event|1|||
127897643|NCT01193608|460249507|FG005|Overall Study|Adverse Event|0|||
127897644|NCT02795104|460249508|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
127897645|NCT02795104|460249509|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
127897646|NCT02795104|460249510|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
127897647|NCT02795104|460249508|FG000|Overall Study|Withdrawal by Subject|0|||
127897648|NCT02795104|460249509|FG001|Overall Study|Withdrawal by Subject|2|||
127838263|NCT01453998|460025327|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
127897649|NCT02795104|460249510|FG002|Overall Study|Withdrawal by Subject|0|||
127897650|NCT02795104|460249508|FG000|Overall Study|Lost to Follow-up|0|||
127897651|NCT02795104|460249509|FG001|Overall Study|Lost to Follow-up|0|||
127897652|NCT02795104|460249510|FG002|Overall Study|Lost to Follow-up|1|||
127897653|NCT00948675|460249511|FG000|Overall Study|Lost to Follow-up|1|||
127897654|NCT00948675|460249512|FG001|Overall Study|Lost to Follow-up|0|||
127897655|NCT00770510|460249516|FG000|Overall Study|Lost to Follow-up|2|||
127897656|NCT00770510|460249516|FG000|Overall Study|Pregnancy|1|||
127897657|NCT00770510|460249516|FG000|Overall Study|Withdrawal by Subject|2|||
127897658|NCT01089647|460249523|FG000|Overall Study|Lost to Follow-up|2|||
127897659|NCT01089647|460249524|FG001|Overall Study|Lost to Follow-up|2|||
127897660|NCT01089647|460249523|FG000|Overall Study|Withdrawal by Subject|2|||
127897661|NCT01089647|460249524|FG001|Overall Study|Withdrawal by Subject|1|||
127897662|NCT01089647|460249523|FG000|Overall Study|Adverse Event|0|||
127897663|NCT01089647|460249524|FG001|Overall Study|Adverse Event|1|||
127897664|NCT00995553|460249525|FG000|Overall Study|Withdrawal by Subject|2|||
127897665|NCT00995553|460249526|FG001|Overall Study|Withdrawal by Subject|6|||
127897666|NCT00927810|460249527|FG000|Overall Study|Withdrawal by Subject|0|||
127897667|NCT00927810|460249528|FG001|Overall Study|Withdrawal by Subject|3|||
127897668|NCT00927810|460249529|FG002|Overall Study|Withdrawal by Subject|0|||
127897669|NCT00927810|460249530|FG003|Overall Study|Withdrawal by Subject|1|||
127897670|NCT00927810|460249527|FG000|Overall Study|Lost to Follow-up|0|||
127897671|NCT00927810|460249528|FG001|Overall Study|Lost to Follow-up|2|||
127897672|NCT00927810|460249529|FG002|Overall Study|Lost to Follow-up|1|||
127897673|NCT00927810|460249530|FG003|Overall Study|Lost to Follow-up|1|||
127897674|NCT00927810|460249527|FG000|Overall Study|Death|0|||
127897675|NCT00927810|460249528|FG001|Overall Study|Death|2|||
127897676|NCT00927810|460249529|FG002|Overall Study|Death|0|||
127897677|NCT00927810|460249530|FG003|Overall Study|Death|0|||
127897678|NCT00927810|460249527|FG000|Overall Study|Abnormal laboratory value(s)|0|||
127897679|NCT00927810|460249528|FG001|Overall Study|Abnormal laboratory value(s)|1|||
127897680|NCT00927810|460249529|FG002|Overall Study|Abnormal laboratory value(s)|0|||
127897681|NCT00927810|460249530|FG003|Overall Study|Abnormal laboratory value(s)|0|||
127897682|NCT00198029|460249533|FG000|Overall Study|Withdrawal by Subject|4|||
127897683|NCT00814463|460249534|FG000|Overall Study|Lost to Follow-up|1|||
127897684|NCT00368277|460249537|FG000|Overall Study|Adverse Event|33|||
127897685|NCT00368277|460249538|FG001|Overall Study|Adverse Event|49|||
127897686|NCT00368277|460249537|FG000|Overall Study|Death|2|||
127897687|NCT00368277|460249538|FG001|Overall Study|Death|1|||
127897688|NCT00368277|460249537|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
127897689|NCT00368277|460249538|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
127897690|NCT00368277|460249537|FG000|Overall Study|Protocol deviation|7|||
127897691|NCT00368277|460249538|FG001|Overall Study|Protocol deviation|0|||
127897692|NCT00368277|460249537|FG000|Overall Study|Patient withdrew consent|32|||
127897693|NCT00368277|460249538|FG001|Overall Study|Patient withdrew consent|28|||
127897694|NCT00368277|460249537|FG000|Overall Study|Lost to Follow-up|8|||
127897695|NCT00368277|460249538|FG001|Overall Study|Lost to Follow-up|6|||
127897696|NCT00984295|460249539|FG000|Overall Study|Lost to Follow-up|31|||
127897697|NCT00984295|460249540|FG001|Overall Study|Lost to Follow-up|12|||
127897698|NCT00984295|460249541|FG002|Overall Study|Lost to Follow-up|13|||
127897699|NCT00984295|460249539|FG000|Overall Study|Protocol Violation|2|||
127897700|NCT00984295|460249540|FG001|Overall Study|Protocol Violation|1|||
127897701|NCT00984295|460249541|FG002|Overall Study|Protocol Violation|4|||
127897702|NCT00984295|460249539|FG000|Overall Study|Withdrawal by Subject|18|||
127897703|NCT00984295|460249540|FG001|Overall Study|Withdrawal by Subject|9|||
127897704|NCT00984295|460249541|FG002|Overall Study|Withdrawal by Subject|12|||
127897705|NCT00984295|460249539|FG000|Overall Study|CAE - discontinued test vaccine|0|||
127897706|NCT00984295|460249540|FG001|Overall Study|CAE - discontinued test vaccine|1|||
127897707|NCT00984295|460249541|FG002|Overall Study|CAE - discontinued test vaccine|3|||
127897708|NCT00984295|460249539|FG000|Overall Study|Missed one or more blood samplings|3|||
127897709|NCT00984295|460249540|FG001|Overall Study|Missed one or more blood samplings|7|||
127897710|NCT00984295|460249541|FG002|Overall Study|Missed one or more blood samplings|2|||
127897711|NCT00984295|460249539|FG000|Overall Study|Incomplete safety follow-up|11|||
127897712|NCT00984295|460249540|FG001|Overall Study|Incomplete safety follow-up|2|||
127897713|NCT00984295|460249541|FG002|Overall Study|Incomplete safety follow-up|3|||
127897714|NCT03283709|460249557|FG000|Overall Study|trial terminated|0|||
127897715|NCT03283709|460249558|FG001|Overall Study|trial terminated|1|||
127897716|NCT01734772|460249559|FG000|Overall Study|Adverse Event|1|||
127897717|NCT01734772|460249560|FG001|Overall Study|Adverse Event|2|||
127897718|NCT01734772|460249559|FG000|Overall Study|Withdrawal by Subject|0|||
127897719|NCT01734772|460249560|FG001|Overall Study|Withdrawal by Subject|1|||
127897720|NCT01790568|460249563|FG000|Overall Study|Progression prior to transplant|0|||
127897721|NCT01790568|460249564|FG001|Overall Study|Progression prior to transplant|1|||
127897722|NCT02994056|460249565|FG000|Overall Study|Death|8|||
127897723|NCT02994056|460249565|FG000|Overall Study|Withdrew Consent|1|||
127897724|NCT03481309|460249571|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
127897725|NCT03481309|460249572|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
127897726|NCT03481309|460249573|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
127897727|NCT03481309|460249574|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
127897728|NCT03481309|460249575|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
127838264|NCT01453998|460025328|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
127838265|NCT03654755|460025337|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
127838266|NCT03654755|460025338|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
127838267|NCT03654755|460025339|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
127838268|NCT03654755|460025337|FG000|Overall Study|Withdrawal by Subject|2|||
127838269|NCT03654755|460025338|FG001|Overall Study|Withdrawal by Subject|4|||
127838270|NCT03654755|460025339|FG002|Overall Study|Withdrawal by Subject|8|||
127838271|NCT03654755|460025337|FG000|Overall Study|Lost to Follow-up|1|||
127838272|NCT03654755|460025338|FG001|Overall Study|Lost to Follow-up|3|||
127838273|NCT03654755|460025339|FG002|Overall Study|Lost to Follow-up|7|||
127838274|NCT03654755|460025337|FG000|Overall Study|Physician Decision|0|||
127838275|NCT03654755|460025338|FG001|Overall Study|Physician Decision|1|||
127838276|NCT03654755|460025339|FG002|Overall Study|Physician Decision|0|||
127838277|NCT03654755|460025337|FG000|Overall Study|Adverse Event|0|||
127838278|NCT03654755|460025338|FG001|Overall Study|Adverse Event|0|||
127838279|NCT03654755|460025339|FG002|Overall Study|Adverse Event|4|||
127838280|NCT03654755|460025337|FG000|Overall Study|Lack of Efficacy|0|||
127838281|NCT03654755|460025338|FG001|Overall Study|Lack of Efficacy|0|||
127838282|NCT03654755|460025339|FG002|Overall Study|Lack of Efficacy|1|||
127838283|NCT02394808|460025340|FG000|Period 1|Unsatisfactory lens fitting|0|||
127838284|NCT02394808|460025341|FG001|Period 1|Unsatisfactory lens fitting|1|||
127838285|NCT02394808|460025340|FG000|Period 2|Lost to Follow-up|1|||
127838286|NCT02394808|460025341|FG001|Period 2|Lost to Follow-up|0|||
127838287|NCT03341923|460025345|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
127838288|NCT03341923|460025346|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
127838289|NCT04580394|460025347|FG000|First Intervention|Incorrectly Randomized|1|||
127838290|NCT04580394|460025347|FG000|First Intervention|Physician Decision|1|||
127838291|NCT04580394|460025347|FG000|First Intervention|Lost to Follow-up|1|||
127838292|NCT04580394|460025347|FG000|Washout (One Week)|Withdrawal by Subject|1|||
127838293|NCT04580394|460025347|FG000|Washout (One Week)|Adverse Event|1|||
127838294|NCT04580394|460025347|FG000|Washout (One Week)|Withdrawal by Subject|2|||
127838295|NCT04580394|460025347|FG000|Third Intervention|Adverse Event|1|||
127838296|NCT04580394|460025347|FG000|Third Intervention|Withdrawal by Subject|1|||
127838297|NCT04580394|460025347|FG000|Washout (One Week)|Withdrawal by Subject|2|||
127838298|NCT00642746|460025349|FG000|Overall Study|Patient unevaluable|1|||
127838299|NCT00642746|460025350|FG001|Overall Study|Patient unevaluable|0|||
127838300|NCT03337152|460025353|FG000|Overall Study|Physician Decision|1|||
127838301|NCT03337152|460025354|FG001|Overall Study|Physician Decision|0|||
127838302|NCT03337152|460025353|FG000|Overall Study|Lost to Follow-up|1|||
127838303|NCT03337152|460025354|FG001|Overall Study|Lost to Follow-up|3|||
127838304|NCT03337152|460025353|FG000|Overall Study|Adverse Event|3|||
127838305|NCT03337152|460025354|FG001|Overall Study|Adverse Event|1|||
127838306|NCT03337152|460025353|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
127838307|NCT03337152|460025354|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
127838308|NCT00077610|460025355|FG000|Overall Study|Adverse Event|9|||
127838309|NCT00077610|460025356|FG001|Overall Study|Adverse Event|7|||
127838310|NCT00077610|460025357|FG002|Overall Study|Adverse Event|1|||
127838311|NCT00077610|460025355|FG000|Overall Study|Lost to Follow-up|0|||
127838312|NCT00077610|460025356|FG001|Overall Study|Lost to Follow-up|1|||
127838313|NCT00077610|460025357|FG002|Overall Study|Lost to Follow-up|2|||
127838314|NCT00077610|460025355|FG000|Overall Study|Withdrawal by Subject|4|||
127838315|NCT00077610|460025356|FG001|Overall Study|Withdrawal by Subject|10|||
127838316|NCT00077610|460025357|FG002|Overall Study|Withdrawal by Subject|6|||
127838317|NCT00077610|460025355|FG000|Overall Study|Death|17|||
127838318|NCT00077610|460025356|FG001|Overall Study|Death|13|||
127838319|NCT00077610|460025357|FG002|Overall Study|Death|13|||
127838320|NCT00077610|460025355|FG000|Overall Study|Renal transplant|12|||
127838321|NCT00077610|460025356|FG001|Overall Study|Renal transplant|15|||
127838322|NCT00077610|460025357|FG002|Overall Study|Renal transplant|11|||
127838323|NCT00077610|460025355|FG000|Overall Study|Withdrew from dialysis care|5|||
127838324|NCT00077610|460025356|FG001|Overall Study|Withdrew from dialysis care|0|||
127838325|NCT00077610|460025357|FG002|Overall Study|Withdrew from dialysis care|3|||
127838326|NCT00077610|460025355|FG000|Overall Study|Insufficient Therapeutic Response|1|||
127838327|NCT00077610|460025356|FG001|Overall Study|Insufficient Therapeutic Response|0|||
127838328|NCT00077610|460025357|FG002|Overall Study|Insufficient Therapeutic Response|0|||
127838329|NCT00077610|460025355|FG000|Overall Study|Multiple blood transfusions|0|||
127838330|NCT00077610|460025356|FG001|Overall Study|Multiple blood transfusions|0|||
127838331|NCT00077610|460025357|FG002|Overall Study|Multiple blood transfusions|1|||
127838332|NCT00077610|460025355|FG000|Overall Study|Principal Investigator's decision|1|||
127838333|NCT00077610|460025356|FG001|Overall Study|Principal Investigator's decision|0|||
127838334|NCT00077610|460025357|FG002|Overall Study|Principal Investigator's decision|1|||
127838335|NCT00077610|460025355|FG000|Overall Study|Worsening of health condition|1|||
127838336|NCT00077610|460025356|FG001|Overall Study|Worsening of health condition|1|||
127838337|NCT00077610|460025357|FG002|Overall Study|Worsening of health condition|0|||
127897729|NCT03481309|460249576|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
127897730|NCT03495869|460249577|FG000|Overall Study|Lost to Follow-up|4|||
127897731|NCT03495869|460249578|FG001|Overall Study|Lost to Follow-up|17|||
127897732|NCT03495869|460249579|FG002|Overall Study|Lost to Follow-up|8|||
127897733|NCT03495869|460249580|FG003|Overall Study|Lost to Follow-up|14|||
127897734|NCT03495869|460249577|FG000|Overall Study|Withdrawal by Subject|0|||
127897735|NCT03495869|460249578|FG001|Overall Study|Withdrawal by Subject|3|||
127897736|NCT03495869|460249579|FG002|Overall Study|Withdrawal by Subject|0|||
127897737|NCT03495869|460249580|FG003|Overall Study|Withdrawal by Subject|3|||
127897738|NCT03495869|460249577|FG000|Overall Study|Dropped from study|0|||
127897739|NCT03495869|460249578|FG001|Overall Study|Dropped from study|7|||
127897740|NCT03495869|460249579|FG002|Overall Study|Dropped from study|2|||
127897741|NCT03495869|460249580|FG003|Overall Study|Dropped from study|4|||
127897742|NCT02346201|460249582|FG000|Overall Study|Adverse Event|3|||
127897743|NCT02346201|460249583|FG001|Overall Study|Adverse Event|2|||
127897744|NCT02346201|460249582|FG000|Overall Study|Lost to Follow-up|1|||
127897745|NCT02346201|460249583|FG001|Overall Study|Lost to Follow-up|0|||
127897746|NCT02346201|460249582|FG000|Overall Study|Withdrawal by Subject|6|||
127897747|NCT02346201|460249583|FG001|Overall Study|Withdrawal by Subject|3|||
127897748|NCT02346201|460249582|FG000|Overall Study|Unavailable for future follow-up|0|||
127897749|NCT02346201|460249583|FG001|Overall Study|Unavailable for future follow-up|1|||
127897750|NCT02346201|460249582|FG000|Overall Study|Physician Decision|0|||
127897751|NCT02346201|460249583|FG001|Overall Study|Physician Decision|1|||
127897752|NCT02346201|460249582|FG000|Overall Study|Missed final visit|0|||
127897753|NCT02346201|460249583|FG001|Overall Study|Missed final visit|2|||
127897754|NCT03708211|460249584|FG000|Overall Study|Progressive Disease|10|||
127897755|NCT03708211|460249585|FG001|Overall Study|Progressive Disease|7|||
127897756|NCT03708211|460249584|FG000|Overall Study|Withdrawal by Subject|0|||
127897757|NCT03708211|460249585|FG001|Overall Study|Withdrawal by Subject|1|||
127897758|NCT03708211|460249584|FG000|Overall Study|Other|2|||
127897759|NCT03708211|460249585|FG001|Overall Study|Other|0|||
127897760|NCT01508936|460249586|FG000|Overall Study|Adverse Event|11|||
127897761|NCT01508936|460249587|FG001|Overall Study|Adverse Event|32|||
127897762|NCT01508936|460249586|FG000|Overall Study|Lack of Efficacy|0|||
127897763|NCT01508936|460249587|FG001|Overall Study|Lack of Efficacy|1|||
127897764|NCT01508936|460249586|FG000|Overall Study|Withdrawal by Subject|4|||
127897765|NCT01508936|460249587|FG001|Overall Study|Withdrawal by Subject|18|||
127897766|NCT01508936|460249586|FG000|Overall Study|Protocol Violation|2|||
127897767|NCT01508936|460249587|FG001|Overall Study|Protocol Violation|3|||
127897768|NCT01508936|460249586|FG000|Overall Study|Lost to Follow-up|2|||
127838338|NCT00077610|460025355|FG000|Overall Study|Given Epogen in hospital|1|||
127838339|NCT00077610|460025356|FG001|Overall Study|Given Epogen in hospital|0|||
127838340|NCT00077610|460025357|FG002|Overall Study|Given Epogen in hospital|0|||
127838341|NCT00077610|460025355|FG000|Overall Study|Transferred to other unit|0|||
127838342|NCT00077610|460025356|FG001|Overall Study|Transferred to other unit|0|||
127838343|NCT00077610|460025357|FG002|Overall Study|Transferred to other unit|1|||
127838344|NCT00077610|460025355|FG000|Overall Study|Transferred to nursing home|0|||
127838345|NCT00077610|460025356|FG001|Overall Study|Transferred to nursing home|0|||
127838346|NCT00077610|460025357|FG002|Overall Study|Transferred to nursing home|1|||
127838347|NCT00077610|460025355|FG000|Overall Study|Transfer to satellite unit|1|||
127838348|NCT00077610|460025356|FG001|Overall Study|Transfer to satellite unit|0|||
127838349|NCT00077610|460025357|FG002|Overall Study|Transfer to satellite unit|0|||
127838350|NCT00077610|460025355|FG000|Overall Study|Transfer to other center for surgery|1|||
127838351|NCT00077610|460025356|FG001|Overall Study|Transfer to other center for surgery|0|||
127838352|NCT00077610|460025357|FG002|Overall Study|Transfer to other center for surgery|0|||
127838353|NCT00077610|460025355|FG000|Overall Study|Change in dialysis modality|1|||
127838354|NCT00077610|460025356|FG001|Overall Study|Change in dialysis modality|0|||
127838355|NCT00077610|460025357|FG002|Overall Study|Change in dialysis modality|0|||
127838356|NCT00077610|460025355|FG000|Overall Study|Relocation|0|||
127838357|NCT00077610|460025356|FG001|Overall Study|Relocation|8|||
127838358|NCT00077610|460025357|FG002|Overall Study|Relocation|5|||
127838359|NCT00077610|460025355|FG000|Overall Study|Financial issues|0|||
127838360|NCT00077610|460025356|FG001|Overall Study|Financial issues|1|||
127838361|NCT00077610|460025357|FG002|Overall Study|Financial issues|0|||
127838362|NCT00077610|460025355|FG000|Overall Study|Sponsors decision to withdraw|0|||
127838363|NCT00077610|460025356|FG001|Overall Study|Sponsors decision to withdraw|0|||
127838364|NCT00077610|460025357|FG002|Overall Study|Sponsors decision to withdraw|1|||
127838365|NCT00976950|460025358|FG000|Overall Study|Adverse Event|3|||
127838366|NCT00976950|460025358|FG000|Overall Study|Events with no relationship to Aptivus|3|||
127897769|NCT01508936|460249587|FG001|Overall Study|Lost to Follow-up|9|||
127897770|NCT01508936|460249586|FG000|Overall Study|Other|0|||
127897771|NCT01508936|460249587|FG001|Overall Study|Other|5|||
127897772|NCT01508936|460249586|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
127897773|NCT01508936|460249587|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
127897774|NCT00679367|460249588|FG000|Overall Study|Adverse Event|7|||
127897775|NCT00679367|460249588|FG000|Overall Study|inability to swallow oral drugs|1|||
127897776|NCT00679367|460249588|FG000|Overall Study|Lack of Efficacy|3|||
127838367|NCT00304915|460025359|FG000|Overall Study|Lost to Follow-up|11|||
127838368|NCT00304915|460025360|FG001|Overall Study|Lost to Follow-up|11|||
127838369|NCT00304915|460025359|FG000|Overall Study|Death|4|||
127838370|NCT00304915|460025360|FG001|Overall Study|Death|5|||
127838371|NCT00304915|460025359|FG000|Overall Study|Withdrawal by Subject|3|||
127838372|NCT00304915|460025360|FG001|Overall Study|Withdrawal by Subject|0|||
127838373|NCT02662985|460025369|FG000|Treatment Period 1|Adverse Event|0|||
127838374|NCT02662985|460025370|FG001|Treatment Period 1|Adverse Event|2|||
127838375|NCT02662985|460025369|FG000|Treatment Period 1|Protocol Violation|0|||
127838376|NCT02662985|460025370|FG001|Treatment Period 1|Protocol Violation|1|||
127838377|NCT02662985|460025369|FG000|Treatment Period 1|Physician Decision|1|||
127838378|NCT02662985|460025370|FG001|Treatment Period 1|Physician Decision|0|||
127838379|NCT02662985|460025369|FG000|Treatment Period 1|Withdrawal by Subject|0|||
127838380|NCT02662985|460025370|FG001|Treatment Period 1|Withdrawal by Subject|1|||
127838381|NCT02662985|460025369|FG000|Treatment Period 2|Lack of Efficacy|0|||
127838382|NCT02662985|460025370|FG001|Treatment Period 2|Lack of Efficacy|1|||
127838383|NCT02662985|460025369|FG000|Treatment Period 2|Lost to Follow-up|1|||
127838384|NCT02662985|460025370|FG001|Treatment Period 2|Lost to Follow-up|0|||
127838385|NCT02662985|460025369|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
127897777|NCT00679367|460249588|FG000|Overall Study|Withdrawal by Subject|1|||
127838386|NCT02662985|460025370|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
127838387|NCT02662985|460025369|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
127838388|NCT02662985|460025370|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
127838389|NCT02662985|460025369|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
127838390|NCT02662985|460025370|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
127897778|NCT04603937|460249591|FG000|Overall Study|Adverse Event|9|||
127897779|NCT04603937|460249592|FG001|Overall Study|Adverse Event|10|||
127897780|NCT04603937|460249591|FG000|Overall Study|Withdrawal by Subject|7|||
127838391|NCT02662985|460025369|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
127838392|NCT02662985|460025370|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
127838393|NCT02662985|460025369|FG000|Treatment Period 3 (Extension Period)|Death|0|||
127838394|NCT02662985|460025370|FG001|Treatment Period 3 (Extension Period)|Death|1|||
127838395|NCT03442829|460025371|FG000|Overall Study|Scheduling clash|3|||
127838396|NCT03442829|460025372|FG001|Overall Study|Scheduling clash|1|||
127838397|NCT03442829|460025371|FG000|Overall Study|Illness unrelated to study|1|||
127838398|NCT03442829|460025372|FG001|Overall Study|Illness unrelated to study|1|||
127838399|NCT01486784|460025373|FG000|Overall Study|Withdrawal by Subject|0|||
127838400|NCT01486784|460025374|FG001|Overall Study|Withdrawal by Subject|0|||
127838401|NCT01486784|460025375|FG002|Overall Study|Withdrawal by Subject|1|||
127838402|NCT01486784|460025376|FG003|Overall Study|Withdrawal by Subject|0|||
127897781|NCT04603937|460249592|FG001|Overall Study|Withdrawal by Subject|6|||
127897782|NCT04603937|460249591|FG000|Overall Study|Lost to Follow-up|5|||
127838403|NCT01486784|460025377|FG004|Overall Study|Withdrawal by Subject|1|||
127838404|NCT01486784|460025378|FG005|Overall Study|Withdrawal by Subject|2|||
127838405|NCT01486784|460025373|FG000|Overall Study|Subject did not meet entry criteria|0|||
127838406|NCT01486784|460025374|FG001|Overall Study|Subject did not meet entry criteria|0|||
127838407|NCT01486784|460025375|FG002|Overall Study|Subject did not meet entry criteria|0|||
127838408|NCT01486784|460025376|FG003|Overall Study|Subject did not meet entry criteria|0|||
127838409|NCT01486784|460025377|FG004|Overall Study|Subject did not meet entry criteria|1|||
127838410|NCT01486784|460025378|FG005|Overall Study|Subject did not meet entry criteria|0|||
127838411|NCT01486784|460025373|FG000|Overall Study|Death|0|||
127838412|NCT01486784|460025374|FG001|Overall Study|Death|0|||
127838413|NCT01486784|460025375|FG002|Overall Study|Death|0|||
127838414|NCT01486784|460025376|FG003|Overall Study|Death|0|||
127838415|NCT01486784|460025377|FG004|Overall Study|Death|0|||
127838416|NCT01486784|460025378|FG005|Overall Study|Death|1|||
127838417|NCT01021852|460025381|FG000|Treatment Period 1|Adverse Event|3|||
127838418|NCT01021852|460025382|FG001|Treatment Period 1|Adverse Event|1|||
127838419|NCT01021852|460025383|FG002|Treatment Period 1|Adverse Event|1|||
127838420|NCT01021852|460025384|FG003|Treatment Period 1|Adverse Event|0|||
127838421|NCT01021852|460025385|FG004|Treatment Period 1|Adverse Event|2|||
127838422|NCT01021852|460025386|FG005|Treatment Period 1|Adverse Event|2|||
127838423|NCT01021852|460025387|FG006|Treatment Period 1|Adverse Event|0|||
127838424|NCT01021852|460025388|FG007|Treatment Period 1|Adverse Event|0|||
127838425|NCT01021852|460025381|FG000|Treatment Period 1|Pregnancy|0|||
127838426|NCT01021852|460025382|FG001|Treatment Period 1|Pregnancy|0|||
127838427|NCT01021852|460025383|FG002|Treatment Period 1|Pregnancy|1|||
127838428|NCT01021852|460025384|FG003|Treatment Period 1|Pregnancy|0|||
127838429|NCT01021852|460025385|FG004|Treatment Period 1|Pregnancy|0|||
127838430|NCT01021852|460025386|FG005|Treatment Period 1|Pregnancy|0|||
127838431|NCT01021852|460025387|FG006|Treatment Period 1|Pregnancy|0|||
127838432|NCT01021852|460025388|FG007|Treatment Period 1|Pregnancy|0|||
127838433|NCT01021852|460025381|FG000|Treatment Period 1|Withdrawal by Subject|0|||
127838434|NCT01021852|460025382|FG001|Treatment Period 1|Withdrawal by Subject|0|||
127838435|NCT01021852|460025383|FG002|Treatment Period 1|Withdrawal by Subject|0|||
127838436|NCT01021852|460025384|FG003|Treatment Period 1|Withdrawal by Subject|0|||
127838437|NCT01021852|460025385|FG004|Treatment Period 1|Withdrawal by Subject|1|||
127838438|NCT01021852|460025386|FG005|Treatment Period 1|Withdrawal by Subject|0|||
127838439|NCT01021852|460025387|FG006|Treatment Period 1|Withdrawal by Subject|0|||
127838440|NCT01021852|460025388|FG007|Treatment Period 1|Withdrawal by Subject|1|||
127838441|NCT01021852|460025381|FG000|Treatment Period 1|Not Treated|0|||
127838442|NCT01021852|460025382|FG001|Treatment Period 1|Not Treated|0|||
127838443|NCT01021852|460025383|FG002|Treatment Period 1|Not Treated|0|||
127838444|NCT01021852|460025384|FG003|Treatment Period 1|Not Treated|2|||
127838445|NCT01021852|460025385|FG004|Treatment Period 1|Not Treated|0|||
127838446|NCT01021852|460025386|FG005|Treatment Period 1|Not Treated|0|||
127838447|NCT01021852|460025387|FG006|Treatment Period 1|Not Treated|0|||
127838448|NCT01021852|460025388|FG007|Treatment Period 1|Not Treated|0|||
127838449|NCT01021852|460025381|FG000|Washout Period-Placebo|Adverse Event|0|||
127838450|NCT01021852|460025382|FG001|Washout Period-Placebo|Adverse Event|0|||
127838451|NCT01021852|460025383|FG002|Washout Period-Placebo|Adverse Event|0|||
127838452|NCT01021852|460025384|FG003|Washout Period-Placebo|Adverse Event|1|||
127838453|NCT01021852|460025385|FG004|Washout Period-Placebo|Adverse Event|0|||
127838454|NCT01021852|460025386|FG005|Washout Period-Placebo|Adverse Event|1|||
127838455|NCT01021852|460025387|FG006|Washout Period-Placebo|Adverse Event|0|||
127838456|NCT01021852|460025388|FG007|Washout Period-Placebo|Adverse Event|0|||
127838457|NCT01021852|460025381|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
127838458|NCT01021852|460025382|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
127838459|NCT01021852|460025383|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
127838460|NCT01021852|460025384|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
127838461|NCT01021852|460025385|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
127838462|NCT01021852|460025386|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
127838463|NCT01021852|460025387|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
127838464|NCT01021852|460025388|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
127838465|NCT01021852|460025381|FG000|Washout Period-Placebo|Protocol Violation|0|||
127838466|NCT01021852|460025382|FG001|Washout Period-Placebo|Protocol Violation|0|||
127838467|NCT01021852|460025383|FG002|Washout Period-Placebo|Protocol Violation|0|||
127838468|NCT01021852|460025384|FG003|Washout Period-Placebo|Protocol Violation|0|||
127838469|NCT01021852|460025385|FG004|Washout Period-Placebo|Protocol Violation|0|||
127838470|NCT01021852|460025386|FG005|Washout Period-Placebo|Protocol Violation|0|||
127838471|NCT01021852|460025387|FG006|Washout Period-Placebo|Protocol Violation|1|||
127838472|NCT01021852|460025388|FG007|Washout Period-Placebo|Protocol Violation|0|||
127838473|NCT01021852|460025381|FG000|Washout Period-No Drug|Adverse Event|1|||
127838474|NCT01021852|460025382|FG001|Washout Period-No Drug|Adverse Event|0|||
127838475|NCT01021852|460025383|FG002|Washout Period-No Drug|Adverse Event|0|||
127838476|NCT01021852|460025384|FG003|Washout Period-No Drug|Adverse Event|0|||
127838477|NCT01021852|460025385|FG004|Washout Period-No Drug|Adverse Event|0|||
127838478|NCT01021852|460025386|FG005|Washout Period-No Drug|Adverse Event|1|||
127838479|NCT01021852|460025387|FG006|Washout Period-No Drug|Adverse Event|0|||
127897783|NCT04603937|460249592|FG001|Overall Study|Lost to Follow-up|6|||
127897784|NCT04603937|460249591|FG000|Overall Study|Physician Decision|0|||
127897785|NCT04603937|460249592|FG001|Overall Study|Physician Decision|1|||
127897786|NCT04603937|460249591|FG000|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|0|||
127897787|NCT04603937|460249592|FG001|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|1|||
127897788|NCT01922349|460249593|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
127897789|NCT01922349|460249594|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
127897790|NCT01922349|460249595|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
127897791|NCT01922349|460249596|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
127897792|NCT00922779|460249597|FG000|Overall Study|Adverse Event|67|||
127897793|NCT00922779|460249597|FG000|Overall Study|Pregnancy|7|||
127897794|NCT00922779|460249597|FG000|Overall Study|Withdrawal by Subject|308|||
127897795|NCT00922779|460249597|FG000|Overall Study|Lost to Follow-up|44|||
127897796|NCT00922779|460249597|FG000|Overall Study|Other|27|||
127897797|NCT00922779|460249597|FG000|Overall Study|Missing|1874|||
127897798|NCT02448771|460249598|FG000|Overall Study|Disease Progression|30|||
127897799|NCT02448771|460249598|FG000|Overall Study|Unacceptable Toxicity|1|||
127897800|NCT02448771|460249598|FG000|Overall Study|Physician Decision|3|||
127897801|NCT02448771|460249598|FG000|Overall Study|Started new therapy|2|||
127976391|NCT03962790|460536119|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
127976392|NCT03962790|460536120|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
127976393|NCT03962790|460536119|FG000|Period 1|Withdrawal by Subject|1|||
127976394|NCT03962790|460536120|FG001|Period 1|Withdrawal by Subject|0|||
127976395|NCT01286168|460536122|FG000|Overall Study|Withdrawal by Subject|1|||
127976396|NCT01286168|460536122|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
127976397|NCT04598451|460536123|FG000|Overall Study|Adverse Event|3|||
127838480|NCT01021852|460025388|FG007|Washout Period-No Drug|Adverse Event|0|||
127838481|NCT01021852|460025381|FG000|Treatment Period 2|Adverse Event|0|||
127838482|NCT01021852|460025382|FG001|Treatment Period 2|Adverse Event|1|||
127838483|NCT01021852|460025383|FG002|Treatment Period 2|Adverse Event|0|||
127838484|NCT01021852|460025384|FG003|Treatment Period 2|Adverse Event|0|||
127838485|NCT01021852|460025385|FG004|Treatment Period 2|Adverse Event|1|||
127838486|NCT01021852|460025386|FG005|Treatment Period 2|Adverse Event|0|||
127838487|NCT01021852|460025387|FG006|Treatment Period 2|Adverse Event|1|||
127838488|NCT01021852|460025388|FG007|Treatment Period 2|Adverse Event|0|||
127838489|NCT01021852|460025381|FG000|Treatment Period 2|Lack of Efficacy|0|||
127838490|NCT01021852|460025382|FG001|Treatment Period 2|Lack of Efficacy|0|||
127838491|NCT01021852|460025383|FG002|Treatment Period 2|Lack of Efficacy|0|||
127838492|NCT01021852|460025384|FG003|Treatment Period 2|Lack of Efficacy|0|||
127838493|NCT01021852|460025385|FG004|Treatment Period 2|Lack of Efficacy|0|||
127838494|NCT01021852|460025386|FG005|Treatment Period 2|Lack of Efficacy|1|||
127838495|NCT01021852|460025387|FG006|Treatment Period 2|Lack of Efficacy|0|||
127838496|NCT01021852|460025388|FG007|Treatment Period 2|Lack of Efficacy|0|||
127838497|NCT01021852|460025381|FG000|Treatment Period 2|Physician Decision|0|||
127838498|NCT01021852|460025382|FG001|Treatment Period 2|Physician Decision|0|||
127838499|NCT01021852|460025383|FG002|Treatment Period 2|Physician Decision|1|||
127838500|NCT01021852|460025384|FG003|Treatment Period 2|Physician Decision|0|||
127838501|NCT01021852|460025385|FG004|Treatment Period 2|Physician Decision|0|||
127838502|NCT01021852|460025386|FG005|Treatment Period 2|Physician Decision|0|||
127838503|NCT01021852|460025387|FG006|Treatment Period 2|Physician Decision|0|||
127838504|NCT01021852|460025388|FG007|Treatment Period 2|Physician Decision|0|||
127838505|NCT01021852|460025381|FG000|Treatment Period 2|Protocol Violation|0|||
127838506|NCT01021852|460025382|FG001|Treatment Period 2|Protocol Violation|0|||
127838507|NCT01021852|460025383|FG002|Treatment Period 2|Protocol Violation|0|||
127838508|NCT01021852|460025384|FG003|Treatment Period 2|Protocol Violation|0|||
127838509|NCT01021852|460025385|FG004|Treatment Period 2|Protocol Violation|1|||
127838510|NCT01021852|460025386|FG005|Treatment Period 2|Protocol Violation|0|||
127838511|NCT01021852|460025387|FG006|Treatment Period 2|Protocol Violation|1|||
127838512|NCT01021852|460025388|FG007|Treatment Period 2|Protocol Violation|0|||
127838513|NCT01021852|460025381|FG000|Treatment Period 2|Withdrawal by Subject|0|||
127838514|NCT01021852|460025382|FG001|Treatment Period 2|Withdrawal by Subject|0|||
127838515|NCT01021852|460025383|FG002|Treatment Period 2|Withdrawal by Subject|0|||
127838516|NCT01021852|460025384|FG003|Treatment Period 2|Withdrawal by Subject|0|||
127838517|NCT01021852|460025385|FG004|Treatment Period 2|Withdrawal by Subject|0|||
127838518|NCT01021852|460025386|FG005|Treatment Period 2|Withdrawal by Subject|0|||
127838519|NCT01021852|460025387|FG006|Treatment Period 2|Withdrawal by Subject|1|||
127838520|NCT01021852|460025388|FG007|Treatment Period 2|Withdrawal by Subject|2|||
127838521|NCT02493426|460025389|FG000|Overall Study|Withdrawal by Subject|0|||
127838522|NCT02493426|460025390|FG001|Overall Study|Withdrawal by Subject|1|||
127838523|NCT03491553|460025391|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
127838524|NCT03491553|460025392|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
127838525|NCT03491553|460025393|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
127838526|NCT03491553|460025394|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
127838527|NCT03491553|460025395|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
127838528|NCT03491553|460025396|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
127838529|NCT03491553|460025391|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
127838530|NCT03491553|460025392|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
127838531|NCT03491553|460025393|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
127838532|NCT03491553|460025394|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
127838533|NCT03491553|460025395|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
127838534|NCT03491553|460025396|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
127838535|NCT01025817|460025398|FG000|Completed Study Medication|Adverse Event|66|||
127838536|NCT01025817|460025399|FG001|Completed Study Medication|Adverse Event|39|||
127838537|NCT01025817|460025398|FG000|Completed Study Medication|Protocol Deviation|9|||
127838538|NCT01025817|460025399|FG001|Completed Study Medication|Protocol Deviation|8|||
127838539|NCT01025817|460025398|FG000|Completed Study Medication|Withdrawal by Subject|8|||
127838540|NCT01025817|460025399|FG001|Completed Study Medication|Withdrawal by Subject|9|||
127838541|NCT01025817|460025398|FG000|Completed Study Medication|Administrative problems|7|||
127838542|NCT01025817|460025399|FG001|Completed Study Medication|Administrative problems|5|||
127838543|NCT01025817|460025398|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
127838544|NCT01025817|460025399|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
127838545|NCT01025817|460025398|FG000|Completed Study Medication|Abnormal test procedure|4|||
127838546|NCT01025817|460025399|FG001|Completed Study Medication|Abnormal test procedure|0|||
127838547|NCT01025817|460025398|FG000|Completed Study Medication|Graft loss|2|||
127838548|NCT01025817|460025399|FG001|Completed Study Medication|Graft loss|5|||
127838549|NCT01025817|460025398|FG000|Completed Study Medication|Death|2|||
127838550|NCT01025817|460025399|FG001|Completed Study Medication|Death|2|||
127838551|NCT01025817|460025398|FG000|Completed Study Medication|Abnormal lab values|0|||
127838552|NCT01025817|460025399|FG001|Completed Study Medication|Abnormal lab values|2|||
127838553|NCT01025817|460025398|FG000|Completed Study Medication|Subject no longer required study drug|0|||
127838554|NCT01025817|460025399|FG001|Completed Study Medication|Subject no longer required study drug|1|||
127838555|NCT01025817|460025398|FG000|Completed Study Medication|Lost to Follow-up|0|||
127838556|NCT01025817|460025399|FG001|Completed Study Medication|Lost to Follow-up|1|||
127838557|NCT01025817|460025398|FG000|Completed Study|Withdrawal by Subject|8|||
127838558|NCT01025817|460025399|FG001|Completed Study|Withdrawal by Subject|16|||
127838559|NCT01025817|460025398|FG000|Completed Study|Death|6|||
127838560|NCT01025817|460025399|FG001|Completed Study|Death|5|||
127838561|NCT01025817|460025398|FG000|Completed Study|Missing|2|||
127838562|NCT01025817|460025399|FG001|Completed Study|Missing|0|||
127838563|NCT01025817|460025398|FG000|Completed Study|Lost to Follow-up|0|||
127838564|NCT01025817|460025399|FG001|Completed Study|Lost to Follow-up|1|||
127838565|NCT00973921|460025400|FG000|Overall Study|IVUS results were not available|9|||
127838566|NCT00101192|460025401|FG000|Overall Study|Ineligible|6|||
127838567|NCT00101192|460025401|FG000|Overall Study|Inevaluable|1|||
127838568|NCT02618928|460025402|FG000|Overall Study|Failure to Return|28|||
127838569|NCT02618928|460025402|FG000|Overall Study|Insufficient Virological Response|1|||
127838570|NCT02618928|460025402|FG000|Overall Study|Withdrawal by Subject|2|||
127838571|NCT02618928|460025402|FG000|Overall Study|Death|3|||
127838572|NCT02618928|460025402|FG000|Overall Study|Other|11|||
127838573|NCT02618928|460025402|FG000|Overall Study|Missing|6|||
127838574|NCT02618928|460025402|FG000|Overall Study|Treatment Never Started|7|||
127838575|NCT01232894|460025403|FG000|Overall Study|Lost to Follow-up|0|||
127838576|NCT01232894|460025404|FG001|Overall Study|Lost to Follow-up|1|||
127838577|NCT01232894|460025403|FG000|Overall Study|Death|1|||
127838578|NCT01232894|460025404|FG001|Overall Study|Death|0|||
127838579|NCT01232894|460025403|FG000|Overall Study|Protocol Violation|1|||
127838580|NCT01232894|460025404|FG001|Overall Study|Protocol Violation|1|||
127838581|NCT01232894|460025403|FG000|Overall Study|Withdrawal by Subject|8|||
127838582|NCT01232894|460025404|FG001|Overall Study|Withdrawal by Subject|5|||
127838583|NCT01232894|460025403|FG000|Overall Study|Physician Decision|2|||
127838584|NCT01232894|460025404|FG001|Overall Study|Physician Decision|1|||
127838585|NCT02128763|460025405|FG000|Overall Study|Death|1|||
127838586|NCT02128763|460025406|FG001|Overall Study|Death|0|||
127838587|NCT02128763|460025405|FG000|Overall Study|Lost to Follow-up|19|||
127838588|NCT02128763|460025406|FG001|Overall Study|Lost to Follow-up|16|||
127838589|NCT00717366|460025407|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
127838590|NCT00717366|460025408|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
127838591|NCT00717366|460025407|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
127838592|NCT00717366|460025408|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
127838593|NCT00717366|460025407|FG000|Core Study Period (20 Weeks)|Death|0|||
127838594|NCT00717366|460025408|FG001|Core Study Period (20 Weeks)|Death|1|||
127838595|NCT00717366|460025407|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
127838596|NCT00717366|460025408|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
127838597|NCT00717366|460025407|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
127838598|NCT00717366|460025408|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
127838599|NCT00717366|460025407|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
127838600|NCT00717366|460025408|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
127838601|NCT00717366|460025407|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
127838602|NCT00717366|460025408|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
127838603|NCT00910429|460025409|FG000|Overall Study|Death|18|||
127838604|NCT00910429|460025410|FG001|Overall Study|Death|12|||
127838605|NCT00910429|460025409|FG000|Overall Study|Withdrawal by Subject|3|||
127838606|NCT00910429|460025410|FG001|Overall Study|Withdrawal by Subject|2|||
127838607|NCT00910429|460025409|FG000|Overall Study|Protocol Violation|1|||
127838608|NCT00910429|460025410|FG001|Overall Study|Protocol Violation|0|||
127838609|NCT00910429|460025409|FG000|Overall Study|Lost to Follow-up|2|||
127838610|NCT00910429|460025410|FG001|Overall Study|Lost to Follow-up|1|||
127838611|NCT00910429|460025409|FG000|Overall Study|Adverse Event|10|||
127838612|NCT00910429|460025410|FG001|Overall Study|Adverse Event|5|||
127838613|NCT00910429|460025409|FG000|Overall Study|Drug non-compliance|1|||
127838614|NCT00910429|460025410|FG001|Overall Study|Drug non-compliance|0|||
127838615|NCT00910429|460025409|FG000|Overall Study|Lack of Efficacy|4|||
127838616|NCT00910429|460025410|FG001|Overall Study|Lack of Efficacy|1|||
127838617|NCT02121756|460025412|FG000|Overall Study|Adverse Event|3|||
127838618|NCT02121756|460025413|FG001|Overall Study|Adverse Event|0|||
127838619|NCT02121756|460025412|FG000|Overall Study|Protocol Violation|1|||
127838620|NCT02121756|460025413|FG001|Overall Study|Protocol Violation|1|||
127838621|NCT02121756|460025412|FG000|Overall Study|Physician Decision|2|||
127838622|NCT02121756|460025413|FG001|Overall Study|Physician Decision|1|||
127838623|NCT00255086|460025416|FG000|Overall Study|Adverse Event|1|||
127838624|NCT00255086|460025417|FG001|Overall Study|Adverse Event|1|||
127838625|NCT00255086|460025416|FG000|Overall Study|Protocol Violation|1|||
127838626|NCT00255086|460025417|FG001|Overall Study|Protocol Violation|1|||
127838627|NCT02365584|460025419|FG000|Overall Study|Adverse Event|2|||
127838628|NCT02365584|460025420|FG001|Overall Study|Adverse Event|2|||
127838629|NCT02365584|460025419|FG000|Overall Study|Withdrawal by Subject|1|||
127838630|NCT02365584|460025420|FG001|Overall Study|Withdrawal by Subject|0|||
127838631|NCT02365584|460025419|FG000|Overall Study|Disease Progression|9|||
127838632|NCT02365584|460025420|FG001|Overall Study|Disease Progression|12|||
127838633|NCT01973452|460025421|FG000|Overall Study|Lack of Efficacy|0|||
127838634|NCT01973452|460025422|FG001|Overall Study|Lack of Efficacy|1|||
127838635|NCT01973452|460025421|FG000|Overall Study|Lost to Follow-up|1|||
127838636|NCT01973452|460025422|FG001|Overall Study|Lost to Follow-up|0|||
127838637|NCT01973452|460025421|FG000|Overall Study|Withdrawal by Subject|10|||
127838638|NCT01973452|460025422|FG001|Overall Study|Withdrawal by Subject|9|||
127838639|NCT01973452|460025421|FG000|Overall Study|Ineligible|1|||
127838640|NCT01973452|460025422|FG001|Overall Study|Ineligible|1|||
127838641|NCT01973452|460025421|FG000|Overall Study|Surgery canceled by participant|5|||
127838642|NCT01973452|460025422|FG001|Overall Study|Surgery canceled by participant|3|||
127838643|NCT00349752|460025427|FG000|Overall Study|Adverse Event|8|||
127838644|NCT00349752|460025428|FG001|Overall Study|Adverse Event|12|||
127838645|NCT00349752|460025427|FG000|Overall Study|Lack of Efficacy|37|||
127838646|NCT00349752|460025428|FG001|Overall Study|Lack of Efficacy|42|||
127838647|NCT00349752|460025427|FG000|Overall Study|Lost to Follow-up|4|||
127838648|NCT00349752|460025428|FG001|Overall Study|Lost to Follow-up|2|||
127838649|NCT00349752|460025427|FG000|Overall Study|Personal reasons|6|||
127838650|NCT00349752|460025428|FG001|Overall Study|Personal reasons|5|||
127838651|NCT00349752|460025427|FG000|Overall Study|Other: Required exclusionary medication|0|||
127838652|NCT00349752|460025428|FG001|Overall Study|Other: Required exclusionary medication|1|||
127838653|NCT00349752|460025427|FG000|Overall Study|Other: Non compliance|0|||
127838654|NCT00349752|460025428|FG001|Overall Study|Other: Non compliance|1|||
127838655|NCT00349752|460025427|FG000|Overall Study|Other: Patient stopped steroids|0|||
127838656|NCT00349752|460025428|FG001|Overall Study|Other: Patient stopped steroids|1|||
127838657|NCT00349752|460025427|FG000|Overall Study|Other: Patient's steroid use|1|||
127838658|NCT00349752|460025428|FG001|Overall Study|Other: Patient's steroid use|0|||
127838659|NCT00349752|460025427|FG000|Overall Study|Other: Ineligible|1|||
127838660|NCT00349752|460025428|FG001|Overall Study|Other: Ineligible|0|||
127838661|NCT00349752|460025427|FG000|Overall Study|Other: Inadvertently unblinded|1|||
127838662|NCT00349752|460025428|FG001|Overall Study|Other: Inadvertently unblinded|0|||
127838663|NCT00349752|460025427|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
127838664|NCT00349752|460025428|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
127838665|NCT05294211|460025430|FG000|Overall Study|Withdrawal by Subject|3|||
127838666|NCT05294211|460025430|FG000|Overall Study|Physician Decision|2|||
127838667|NCT05294211|460025430|FG000|Overall Study|Progressed to active labor|1|||
127838668|NCT05294211|460025430|FG000|Overall Study|Did not complete 5-minute monitoring session|15|||
127838669|NCT05294211|460025430|FG000|Overall Study|Did not have ≥ 1 minute of concurrent data|19|||
127838670|NCT00064350|460025431|FG000|Induction Treatment|Disease Progression|5|||
127838671|NCT00064350|460025432|FG001|Induction Treatment|Disease Progression|1|||
127838672|NCT00064350|460025433|FG002|Induction Treatment|Disease Progression|110|||
127838673|NCT00064350|460025431|FG000|Induction Treatment|Adverse Event|0|||
127838674|NCT00064350|460025432|FG001|Induction Treatment|Adverse Event|2|||
127838675|NCT00064350|460025433|FG002|Induction Treatment|Adverse Event|49|||
127838676|NCT00064350|460025431|FG000|Induction Treatment|Death|0|||
127838677|NCT00064350|460025432|FG001|Induction Treatment|Death|0|||
127838678|NCT00064350|460025433|FG002|Induction Treatment|Death|9|||
127838679|NCT00064350|460025431|FG000|Induction Treatment|Withdrawal by Subject|0|||
127838680|NCT00064350|460025432|FG001|Induction Treatment|Withdrawal by Subject|0|||
127838681|NCT00064350|460025433|FG002|Induction Treatment|Withdrawal by Subject|21|||
127838682|NCT00064350|460025431|FG000|Induction Treatment|Ineligible or never started treatment|3|||
127838683|NCT00064350|460025432|FG001|Induction Treatment|Ineligible or never started treatment|6|||
127838684|NCT00064350|460025433|FG002|Induction Treatment|Ineligible or never started treatment|34|||
127838685|NCT00064350|460025431|FG000|Induction Treatment|Other|0|||
127838686|NCT00064350|460025432|FG001|Induction Treatment|Other|0|||
127838687|NCT00064350|460025433|FG002|Induction Treatment|Other|13|||
127838688|NCT00064350|460025431|FG000|Randomization|Adverse Event|8|||
127838689|NCT00064350|460025432|FG001|Randomization|Adverse Event|3|||
127838690|NCT00064350|460025433|FG002|Randomization|Adverse Event|0|||
127838691|NCT00064350|460025431|FG000|Randomization|Death|3|||
127838692|NCT00064350|460025432|FG001|Randomization|Death|0|||
127838693|NCT00064350|460025433|FG002|Randomization|Death|0|||
127838694|NCT00064350|460025431|FG000|Randomization|Withdrawal by Subject|1|||
127838695|NCT00064350|460025432|FG001|Randomization|Withdrawal by Subject|0|||
127838696|NCT00064350|460025433|FG002|Randomization|Withdrawal by Subject|0|||
127838697|NCT00064350|460025431|FG000|Randomization|Ineligible or never started treatment|9|||
127838698|NCT00064350|460025432|FG001|Randomization|Ineligible or never started treatment|15|||
127838699|NCT00064350|460025433|FG002|Randomization|Ineligible or never started treatment|0|||
127838700|NCT00064350|460025431|FG000|Randomization|Other|5|||
127838701|NCT00064350|460025432|FG001|Randomization|Other|0|||
127838702|NCT00064350|460025433|FG002|Randomization|Other|0|||
127897802|NCT00262600|460251454|FG000|Overall Study|Lost to Follow-up|17|||
127838703|NCT00064350|460025431|FG000|Cross-Over|Adverse Event|0|||
127838704|NCT00064350|460025432|FG001|Cross-Over|Adverse Event|1|||
127838705|NCT00064350|460025433|FG002|Cross-Over|Adverse Event|0|||
127838706|NCT00064350|460025431|FG000|Cross-Over|Death|1|||
127838707|NCT00064350|460025432|FG001|Cross-Over|Death|3|||
127838708|NCT00064350|460025433|FG002|Cross-Over|Death|0|||
127838709|NCT00064350|460025431|FG000|Cross-Over|Withdrawal by Subject|2|||
127838710|NCT00064350|460025432|FG001|Cross-Over|Withdrawal by Subject|2|||
127897803|NCT00262600|460251455|FG001|Overall Study|Lost to Follow-up|31|||
127897804|NCT00262600|460251456|FG002|Overall Study|Lost to Follow-up|41|||
127897805|NCT00262600|460251454|FG000|Overall Study|Withdrawal by Subject|128|||
127897806|NCT00262600|460251455|FG001|Overall Study|Withdrawal by Subject|145|||
127897807|NCT00262600|460251456|FG002|Overall Study|Withdrawal by Subject|139|||
127897808|NCT00262600|460251454|FG000|Overall Study|Not Treated|32|||
127897809|NCT00262600|460251455|FG001|Overall Study|Not Treated|17|||
127897810|NCT00262600|460251456|FG002|Overall Study|Not Treated|24|||
127897811|NCT00262600|460251454|FG000|Overall Study|Other|58|||
127897812|NCT00262600|460251455|FG001|Overall Study|Other|59|||
127897813|NCT00262600|460251456|FG002|Overall Study|Other|62|||
127897814|NCT00376220|460251457|FG000|Overall Study|Lost to Follow-up|7|||
127897815|NCT00376220|460251458|FG001|Overall Study|Lost to Follow-up|10|||
127897816|NCT00376220|460251457|FG000|Overall Study|Withdrawal by Subject|3|||
127897817|NCT00376220|460251458|FG001|Overall Study|Withdrawal by Subject|2|||
127897818|NCT00531206|460251463|FG000|Overall Study|Adverse Event related|5|||
127897819|NCT00531206|460251463|FG000|Overall Study|Lack of Efficacy|2|||
127897820|NCT00531206|460251463|FG000|Overall Study|Lost to Follow-up|5|||
127897821|NCT00531206|460251463|FG000|Overall Study|including non-related adverse events|8|||
127897822|NCT00721409|460251464|FG000|Overall Study|Global deterioration of health status|2|||
127897823|NCT00721409|460251465|FG001|Overall Study|Global deterioration of health status|6|||
127897824|NCT00721409|460251466|FG002|Overall Study|Global deterioration of health status|3|||
127897825|NCT00721409|460251464|FG000|Overall Study|Death|0|||
127897826|NCT00721409|460251465|FG001|Overall Study|Death|1|||
127897827|NCT00721409|460251466|FG002|Overall Study|Death|0|||
127897828|NCT00721409|460251464|FG000|Overall Study|Randomized not Treated|0|||
127897829|NCT00721409|460251465|FG001|Overall Study|Randomized not Treated|1|||
127897830|NCT00721409|460251466|FG002|Overall Study|Randomized not Treated|4|||
127897831|NCT00721409|460251464|FG000|Overall Study|Reason not specified|1|||
127897832|NCT00721409|460251465|FG001|Overall Study|Reason not specified|0|||
127897833|NCT00721409|460251466|FG002|Overall Study|Reason not specified|2|||
127897834|NCT00721409|460251464|FG000|Overall Study|Adverse Event|0|||
127897835|NCT00721409|460251465|FG001|Overall Study|Adverse Event|13|||
127897836|NCT00721409|460251466|FG002|Overall Study|Adverse Event|2|||
127897837|NCT00721409|460251464|FG000|Overall Study|Lost to Follow-up|0|||
127897838|NCT00721409|460251465|FG001|Overall Study|Lost to Follow-up|0|||
127897839|NCT00721409|460251466|FG002|Overall Study|Lost to Follow-up|1|||
127897840|NCT00721409|460251464|FG000|Overall Study|Withdrawal by Subject|1|||
127897841|NCT00721409|460251465|FG001|Overall Study|Withdrawal by Subject|6|||
127897842|NCT00721409|460251466|FG002|Overall Study|Withdrawal by Subject|5|||
127897843|NCT00721409|460251464|FG000|Overall Study|Objective progression or relapse|8|||
127897844|NCT00721409|460251465|FG001|Overall Study|Objective progression or relapse|55|||
127897845|NCT00721409|460251466|FG002|Overall Study|Objective progression or relapse|62|||
127897846|NCT00322491|460251470|FG000|Overall Study|Adverse Event|1|||
127897847|NCT00322491|460251471|FG001|Overall Study|Adverse Event|0|||
127897848|NCT00322491|460251470|FG000|Overall Study|Death|1|||
127897849|NCT00322491|460251471|FG001|Overall Study|Death|2|||
127897850|NCT00720096|460251473|FG000|Overall Study|Withdrawal by Subject|0|||
127897851|NCT00720096|460251474|FG001|Overall Study|Withdrawal by Subject|2|||
127897852|NCT00442936|460251475|FG000|Overall Study|Protocol Violation|1|||
127897853|NCT00442936|460251476|FG001|Overall Study|Protocol Violation|0|||
127897854|NCT00442936|460251477|FG002|Overall Study|Protocol Violation|1|||
127897855|NCT00442936|460251478|FG003|Overall Study|Protocol Violation|1|||
127897856|NCT00524459|460251479|FG000|Overall Study|Withdrawal by Subject|1|||
127897857|NCT00524459|460251479|FG000|Overall Study|Other|1|||
127897858|NCT01574248|460251480|FG000|Overall Study|Withdrawal by Subject|2|||
127897859|NCT01574248|460251481|FG001|Overall Study|Withdrawal by Subject|0|||
127897860|NCT01574248|460251480|FG000|Overall Study|Missing primary endpoint data|1|||
127897861|NCT01574248|460251481|FG001|Overall Study|Missing primary endpoint data|0|||
127897862|NCT01424722|460251482|FG000|Overall Study|Sponsor terminated investigation|2258|||
127897863|NCT00995410|460251483|FG000|Overall Study|Adverse Event|51|||
127897864|NCT00995410|460251483|FG000|Overall Study|Withdrawal by Subject|7|||
127897865|NCT00995410|460251483|FG000|Overall Study|Lost to Follow-up|2|||
127897866|NCT00995410|460251483|FG000|Overall Study|Misc|28|||
127897867|NCT00818883|460251484|FG000|Overall Study|Adverse Event|28|||
127897868|NCT00818883|460251485|FG001|Overall Study|Adverse Event|19|||
127897869|NCT00818883|460251484|FG000|Overall Study|Protocol Violation|2|||
127897870|NCT00818883|460251485|FG001|Overall Study|Protocol Violation|2|||
127897871|NCT00818883|460251484|FG000|Overall Study|Lost to Follow-up|3|||
127897872|NCT00818883|460251485|FG001|Overall Study|Lost to Follow-up|2|||
127897873|NCT00818883|460251484|FG000|Overall Study|Withdrawal by Subject|16|||
127897874|NCT00818883|460251485|FG001|Overall Study|Withdrawal by Subject|14|||
127897875|NCT00818883|460251484|FG000|Overall Study|Lack of Efficacy|0|||
127897876|NCT00818883|460251485|FG001|Overall Study|Lack of Efficacy|2|||
127897877|NCT00818883|460251484|FG000|Overall Study|Other|2|||
127897878|NCT00818883|460251485|FG001|Overall Study|Other|7|||
127897879|NCT03992196|460251486|FG000|Enrollment|lost to follow-up prior dosing|1|||
127897880|NCT03992196|460251487|FG001|Enrollment|lost to follow-up prior dosing|0|||
127838711|NCT00064350|460025433|FG002|Cross-Over|Withdrawal by Subject|0|||
127838712|NCT00064350|460025431|FG000|Cross-Over|Ineligible or never started treatment|3|||
127838713|NCT00064350|460025432|FG001|Cross-Over|Ineligible or never started treatment|6|||
127838714|NCT00064350|460025433|FG002|Cross-Over|Ineligible or never started treatment|0|||
127838715|NCT00064350|460025431|FG000|Cross-Over|Other|0|||
127838716|NCT00064350|460025432|FG001|Cross-Over|Other|2|||
127838717|NCT00064350|460025433|FG002|Cross-Over|Other|0|||
127838718|NCT00838916|460025434|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
127838719|NCT00838916|460025435|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
127838720|NCT00838916|460025434|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
127838721|NCT00838916|460025435|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
127838722|NCT00838916|460025434|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
127838723|NCT00838916|460025435|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
127838724|NCT00838916|460025434|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
127838725|NCT00838916|460025435|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
127838726|NCT00838916|460025434|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
127838727|NCT00838916|460025435|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
127838728|NCT00838916|460025434|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
127838729|NCT00838916|460025435|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
127838730|NCT00838916|460025434|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
127838731|NCT00838916|460025435|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
127838732|NCT00838916|460025434|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
127838733|NCT00838916|460025435|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
127838734|NCT00838916|460025434|FG000|Treatment Period (156 Weeks)|Missing|3|||
127838735|NCT00838916|460025435|FG001|Treatment Period (156 Weeks)|Missing|1|||
127838736|NCT00838916|460025434|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
127838737|NCT00838916|460025435|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
127838738|NCT00838916|460025434|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
127838739|NCT00838916|460025435|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
127838740|NCT00838916|460025434|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
127838741|NCT00838916|460025435|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
127838742|NCT00838916|460025434|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
127838743|NCT00838916|460025435|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
127838744|NCT00838916|460025434|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
127838745|NCT00838916|460025435|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
127838746|NCT00838916|460025434|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
127838747|NCT00838916|460025435|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
127838748|NCT00838916|460025434|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
127838749|NCT00838916|460025435|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
127838750|NCT00838916|460025434|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
127838751|NCT00838916|460025435|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
127838752|NCT00838916|460025434|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
127838753|NCT00838916|460025435|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
127838754|NCT00838916|460025434|FG000|Follow-up Period (8 Weeks)|Missing|3|||
127838755|NCT00838916|460025435|FG001|Follow-up Period (8 Weeks)|Missing|0|||
127838756|NCT02034474|460025436|FG000|Overall Study|Adverse Event|3|||
127838757|NCT02034474|460025437|FG001|Overall Study|Adverse Event|2|||
127838758|NCT02034474|460025436|FG000|Overall Study|Withdrawal by Subject|1|||
127838759|NCT02034474|460025437|FG001|Overall Study|Withdrawal by Subject|2|||
127838760|NCT03600714|460025438|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
127838761|NCT00675103|460025439|FG000|Overall Study|Lack of Efficacy|2|||
127838762|NCT00675103|460025439|FG000|Overall Study|Adverse Event|1|||
127838763|NCT02164513|460025440|FG000|Overall Study|Adverse Event|162|||
127838764|NCT02164513|460025441|FG001|Overall Study|Adverse Event|180|||
127838765|NCT02164513|460025442|FG002|Overall Study|Adverse Event|111|||
127838766|NCT02164513|460025440|FG000|Overall Study|Other: Study Closed or terminated|5|||
127838767|NCT02164513|460025441|FG001|Overall Study|Other: Study Closed or terminated|2|||
127838768|NCT02164513|460025442|FG002|Overall Study|Other: Study Closed or terminated|4|||
127838769|NCT02164513|460025440|FG000|Overall Study|Lost to Follow-up|30|||
127838770|NCT02164513|460025441|FG001|Overall Study|Lost to Follow-up|36|||
127838771|NCT02164513|460025442|FG002|Overall Study|Lost to Follow-up|22|||
127838772|NCT02164513|460025440|FG000|Overall Study|Physician Decision|47|||
127838773|NCT02164513|460025441|FG001|Overall Study|Physician Decision|57|||
127838774|NCT02164513|460025442|FG002|Overall Study|Physician Decision|28|||
127838775|NCT02164513|460025440|FG000|Overall Study|Withdrawal by Subject|192|||
127838776|NCT02164513|460025441|FG001|Overall Study|Withdrawal by Subject|261|||
127838777|NCT02164513|460025442|FG002|Overall Study|Withdrawal by Subject|130|||
127838778|NCT02164513|460025440|FG000|Overall Study|Other: Reason not provided by site|1|||
127838779|NCT02164513|460025441|FG001|Overall Study|Other: Reason not provided by site|0|||
127838780|NCT02164513|460025442|FG002|Overall Study|Other: Reason not provided by site|0|||
127838781|NCT02509494|460025449|FG000|Overall Study|Lost to Follow-up|8|||
127838782|NCT02509494|460025450|FG001|Overall Study|Lost to Follow-up|47|||
127838783|NCT02509494|460025451|FG002|Overall Study|Lost to Follow-up|19|||
127838784|NCT02509494|460025452|FG003|Overall Study|Lost to Follow-up|6|||
127838785|NCT02509494|460025453|FG004|Overall Study|Lost to Follow-up|3|||
127838786|NCT02509494|460025454|FG005|Overall Study|Lost to Follow-up|3|||
127838787|NCT02509494|460025455|FG006|Overall Study|Lost to Follow-up|1|||
127838788|NCT02509494|460025456|FG007|Overall Study|Lost to Follow-up|3|||
127838789|NCT02509494|460025457|FG008|Overall Study|Lost to Follow-up|1|||
127838790|NCT02509494|460025449|FG000|Overall Study|Physician Decision|2|||
127838791|NCT02509494|460025450|FG001|Overall Study|Physician Decision|1|||
127838792|NCT02509494|460025451|FG002|Overall Study|Physician Decision|0|||
127838793|NCT02509494|460025452|FG003|Overall Study|Physician Decision|0|||
127838794|NCT02509494|460025453|FG004|Overall Study|Physician Decision|0|||
127838795|NCT02509494|460025454|FG005|Overall Study|Physician Decision|0|||
127838796|NCT02509494|460025455|FG006|Overall Study|Physician Decision|0|||
127838797|NCT02509494|460025456|FG007|Overall Study|Physician Decision|0|||
127838798|NCT02509494|460025457|FG008|Overall Study|Physician Decision|0|||
127838799|NCT02509494|460025449|FG000|Overall Study|Withdrawal by Subject|4|||
127838800|NCT02509494|460025450|FG001|Overall Study|Withdrawal by Subject|17|||
127838801|NCT02509494|460025451|FG002|Overall Study|Withdrawal by Subject|7|||
127838802|NCT02509494|460025452|FG003|Overall Study|Withdrawal by Subject|5|||
127838803|NCT02509494|460025453|FG004|Overall Study|Withdrawal by Subject|0|||
127838804|NCT02509494|460025454|FG005|Overall Study|Withdrawal by Subject|6|||
127838805|NCT02509494|460025455|FG006|Overall Study|Withdrawal by Subject|1|||
127838806|NCT02509494|460025456|FG007|Overall Study|Withdrawal by Subject|2|||
127838807|NCT02509494|460025457|FG008|Overall Study|Withdrawal by Subject|1|||
127838808|NCT02509494|460025449|FG000|Overall Study|Death|0|||
127838809|NCT02509494|460025450|FG001|Overall Study|Death|1|||
127838810|NCT02509494|460025451|FG002|Overall Study|Death|0|||
127838811|NCT02509494|460025452|FG003|Overall Study|Death|0|||
127838812|NCT02509494|460025453|FG004|Overall Study|Death|1|||
127838813|NCT02509494|460025454|FG005|Overall Study|Death|0|||
127838814|NCT02509494|460025455|FG006|Overall Study|Death|0|||
127838815|NCT02509494|460025456|FG007|Overall Study|Death|1|||
127838816|NCT02509494|460025457|FG008|Overall Study|Death|0|||
127838817|NCT02509494|460025449|FG000|Overall Study|Other|0|||
127838818|NCT02509494|460025450|FG001|Overall Study|Other|4|||
127838819|NCT02509494|460025451|FG002|Overall Study|Other|5|||
127838820|NCT02509494|460025452|FG003|Overall Study|Other|0|||
127976398|NCT04598451|460536124|FG001|Overall Study|Adverse Event|2|||
127838821|NCT02509494|460025453|FG004|Overall Study|Other|0|||
127838822|NCT02509494|460025454|FG005|Overall Study|Other|0|||
127838823|NCT02509494|460025455|FG006|Overall Study|Other|0|||
127838824|NCT02509494|460025456|FG007|Overall Study|Other|0|||
127838825|NCT02509494|460025457|FG008|Overall Study|Other|0|||
127838826|NCT02509494|460025449|FG000|Overall Study|Non-Compliance With Study Drug|1|||
127838827|NCT02509494|460025450|FG001|Overall Study|Non-Compliance With Study Drug|11|||
127838828|NCT02509494|460025451|FG002|Overall Study|Non-Compliance With Study Drug|7|||
127838829|NCT02509494|460025452|FG003|Overall Study|Non-Compliance With Study Drug|0|||
127838830|NCT02509494|460025453|FG004|Overall Study|Non-Compliance With Study Drug|1|||
127838831|NCT02509494|460025454|FG005|Overall Study|Non-Compliance With Study Drug|2|||
127976399|NCT04598451|460536123|FG000|Overall Study|Withdrawal by Subject|3|||
127976400|NCT04598451|460536124|FG001|Overall Study|Withdrawal by Subject|7|||
127976401|NCT04598451|460536123|FG000|Overall Study|Lost to Follow-up|2|||
127976402|NCT04598451|460536124|FG001|Overall Study|Lost to Follow-up|0|||
127976403|NCT04598451|460536123|FG000|Overall Study|Physician Decision|4|||
127838832|NCT02509494|460025455|FG006|Overall Study|Non-Compliance With Study Drug|1|||
127838833|NCT02509494|460025456|FG007|Overall Study|Non-Compliance With Study Drug|1|||
127838834|NCT02509494|460025457|FG008|Overall Study|Non-Compliance With Study Drug|0|||
127838835|NCT01179347|460026815|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
127838836|NCT01179347|460026816|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
127838837|NCT01179347|460026815|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
127838838|NCT01179347|460026816|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
127838839|NCT01179347|460026815|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
127838840|NCT01179347|460026816|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
127838841|NCT01179347|460026815|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
127838842|NCT01179347|460026816|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
127838843|NCT01179347|460026815|FG000|Double-blind Period (12 Weeks)|Other|2|||
127838844|NCT01179347|460026816|FG001|Double-blind Period (12 Weeks)|Other|4|||
127838845|NCT01179347|460026815|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
127838846|NCT01179347|460026816|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
127838847|NCT01179347|460026815|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
127838848|NCT01179347|460026816|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
127838849|NCT01179347|460026815|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
127838850|NCT01179347|460026816|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
127838851|NCT01179347|460026815|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
127838852|NCT01179347|460026816|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
127838853|NCT01179347|460026815|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
127838854|NCT01179347|460026816|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
127838855|NCT01179347|460026815|FG000|Open-label Period (12 Weeks)|Other|7|||
127838856|NCT01179347|460026816|FG001|Open-label Period (12 Weeks)|Other|4|||
127838857|NCT00369967|460026817|FG000|Overall Study|Lost to Follow-up|23|||
127838858|NCT00369967|460026818|FG001|Overall Study|Lost to Follow-up|12|||
127838859|NCT02586077|460026819|FG000|Overall Study|Withdrawal by Subject|1|||
127838860|NCT02586077|460026819|FG000|Overall Study|Physician Decision|4|||
127838861|NCT02586077|460026819|FG000|Overall Study|Lost to Follow-up|3|||
127838862|NCT00205699|460026830|FG000|Overall Study|Lost to Follow-up|1|||
127838863|NCT00205699|460026831|FG001|Overall Study|Lost to Follow-up|3|||
127838864|NCT00205699|460026832|FG002|Overall Study|Lost to Follow-up|5|||
127838865|NCT00205699|460026830|FG000|Overall Study|Adverse Event|1|||
127838866|NCT00205699|460026831|FG001|Overall Study|Adverse Event|0|||
127838867|NCT00205699|460026832|FG002|Overall Study|Adverse Event|0|||
127838868|NCT00205699|460026830|FG000|Overall Study|Withdrawal by Subject|1|||
127838869|NCT00205699|460026831|FG001|Overall Study|Withdrawal by Subject|2|||
127838870|NCT00205699|460026832|FG002|Overall Study|Withdrawal by Subject|1|||
127838871|NCT00205699|460026830|FG000|Overall Study|Lack of Efficacy|0|||
127838872|NCT00205699|460026831|FG001|Overall Study|Lack of Efficacy|1|||
127838873|NCT00205699|460026832|FG002|Overall Study|Lack of Efficacy|0|||
127838874|NCT03225716|460026838|FG000|Overall Study|Withdrawal by Subject|2|||
127838875|NCT03225716|460026839|FG001|Overall Study|Withdrawal by Subject|2|||
127838876|NCT03225716|460026840|FG002|Overall Study|Withdrawal by Subject|0|||
127838877|NCT03225716|460026838|FG000|Overall Study|Lack of Efficacy|1|||
127838878|NCT03225716|460026839|FG001|Overall Study|Lack of Efficacy|0|||
127838879|NCT03225716|460026840|FG002|Overall Study|Lack of Efficacy|0|||
127838880|NCT03225716|460026838|FG000|Overall Study|Adverse Event|2|||
127838881|NCT03225716|460026839|FG001|Overall Study|Adverse Event|0|||
127838882|NCT03225716|460026840|FG002|Overall Study|Adverse Event|1|||
127838883|NCT03225716|460026838|FG000|Overall Study|Study early termination by Sponsor|0|||
127838884|NCT03225716|460026839|FG001|Overall Study|Study early termination by Sponsor|0|||
127838885|NCT03225716|460026840|FG002|Overall Study|Study early termination by Sponsor|2|||
127838886|NCT01170702|460026843|FG000|Overall Study|Exclusion criteria met after consent|1|||
127838887|NCT01170702|460026844|FG001|Overall Study|Exclusion criteria met after consent|2|||
127838888|NCT01170702|460026845|FG002|Overall Study|Exclusion criteria met after consent|0|||
127838889|NCT01170702|460026846|FG003|Overall Study|Exclusion criteria met after consent|2|||
127838890|NCT01677507|460026847|FG000|Initial Assignment|Adverse Event|0|||
127838891|NCT01677507|460026848|FG001|Initial Assignment|Adverse Event|1|||
127838892|NCT01677507|460026847|FG000|Initial Assignment|Protocol Violation|0|||
127838893|NCT01677507|460026848|FG001|Initial Assignment|Protocol Violation|1|||
127838894|NCT01677507|460026847|FG000|Second Assigment|Withdrawal by Subject|2|||
127838895|NCT01677507|460026848|FG001|Second Assigment|Withdrawal by Subject|2|||
127838896|NCT01677507|460026847|FG000|Second Assigment|Adverse Event|1|||
127838897|NCT01677507|460026848|FG001|Second Assigment|Adverse Event|3|||
127838898|NCT00571688|460026849|FG000|Overall Study|Lost to Follow-up|3|||
127838899|NCT00571688|460026850|FG001|Overall Study|Lost to Follow-up|6|||
127838900|NCT00571688|460026849|FG000|Overall Study|subject did not tolerate Consta|1|||
127838901|NCT00571688|460026850|FG001|Overall Study|subject did not tolerate Consta|0|||
127838902|NCT00571688|460026849|FG000|Overall Study|subject moved out of the area|1|||
127838903|NCT00571688|460026850|FG001|Overall Study|subject moved out of the area|0|||
127838904|NCT04321252|460026853|FG000|Overall Study|Withdrawal by Subject|0|||
127838905|NCT04321252|460026854|FG001|Overall Study|Withdrawal by Subject|0|||
127838906|NCT04321252|460026855|FG002|Overall Study|Withdrawal by Subject|0|||
127838907|NCT04321252|460026856|FG003|Overall Study|Withdrawal by Subject|0|||
127838908|NCT04321252|460026857|FG004|Overall Study|Withdrawal by Subject|0|||
127838909|NCT04321252|460026858|FG005|Overall Study|Withdrawal by Subject|1|||
127838910|NCT04321252|460026859|FG006|Overall Study|Withdrawal by Subject|0|||
127838911|NCT04321252|460026860|FG007|Overall Study|Withdrawal by Subject|0|||
127838912|NCT04321252|460026861|FG008|Overall Study|Withdrawal by Subject|0|||
127838913|NCT03004469|460026862|FG000|Overall Study|Adverse Event|6|||
127838914|NCT03004469|460026863|FG001|Overall Study|Adverse Event|4|||
127838915|NCT03004469|460026864|FG002|Overall Study|Adverse Event|6|||
127838916|NCT03004469|460026862|FG000|Overall Study|Lack of Efficacy|1|||
127838917|NCT03004469|460026863|FG001|Overall Study|Lack of Efficacy|0|||
127838918|NCT03004469|460026864|FG002|Overall Study|Lack of Efficacy|1|||
127838919|NCT03004469|460026862|FG000|Overall Study|Lost to Follow-up|23|||
127838920|NCT03004469|460026863|FG001|Overall Study|Lost to Follow-up|14|||
127838921|NCT03004469|460026864|FG002|Overall Study|Lost to Follow-up|6|||
127838922|NCT03004469|460026862|FG000|Overall Study|Non-Compliance with Study Drug|2|||
127838923|NCT03004469|460026863|FG001|Overall Study|Non-Compliance with Study Drug|0|||
127838924|NCT03004469|460026864|FG002|Overall Study|Non-Compliance with Study Drug|0|||
127838925|NCT03004469|460026862|FG000|Overall Study|Protocol Violation|0|||
127838926|NCT03004469|460026863|FG001|Overall Study|Protocol Violation|0|||
127838927|NCT03004469|460026864|FG002|Overall Study|Protocol Violation|1|||
127838928|NCT03004469|460026862|FG000|Overall Study|Withdrawal by Subject|29|||
127838929|NCT03004469|460026863|FG001|Overall Study|Withdrawal by Subject|27|||
127838930|NCT03004469|460026864|FG002|Overall Study|Withdrawal by Subject|10|||
127838931|NCT03004469|460026862|FG000|Overall Study|Other unspecified reason|0|||
127838932|NCT03004469|460026863|FG001|Overall Study|Other unspecified reason|4|||
127838933|NCT03004469|460026864|FG002|Overall Study|Other unspecified reason|1|||
127838934|NCT00259740|460026865|FG000|Overall Study|Physician Decision|1|||
127838935|NCT00259740|460026866|FG001|Overall Study|Physician Decision|1|||
127838936|NCT00259740|460026865|FG000|Overall Study|Adverse Event|0|||
127838937|NCT00259740|460026866|FG001|Overall Study|Adverse Event|2|||
127838938|NCT00259740|460026865|FG000|Overall Study|Withdrawal by Subject|2|||
127838939|NCT00259740|460026866|FG001|Overall Study|Withdrawal by Subject|6|||
127838940|NCT00259740|460026865|FG000|Overall Study|Death|1|||
127838941|NCT00259740|460026866|FG001|Overall Study|Death|1|||
127838942|NCT00259740|460026865|FG000|Overall Study|Disease progression|19|||
127838943|NCT00259740|460026866|FG001|Overall Study|Disease progression|36|||
127838944|NCT00259740|460026865|FG000|Overall Study|Ongoing|17|||
127838945|NCT00259740|460026866|FG001|Overall Study|Ongoing|3|||
127838946|NCT00259740|460026865|FG000|Overall Study|Other|3|||
127838947|NCT00259740|460026866|FG001|Overall Study|Other|0|||
127838948|NCT00259740|460026865|FG000|Overall Study|Requirement for alternative therapy|0|||
127838949|NCT00259740|460026866|FG001|Overall Study|Requirement for alternative therapy|4|||
127838950|NCT02287402|460026867|FG000|Treatment Period|Adverse Event|17|||
127838951|NCT02287402|460026867|FG000|Treatment Period|Voluntary Withdrawal|10|||
127838952|NCT02287402|460026867|FG000|Follow-up|Lost to Follow-up|1|||
127838953|NCT02287402|460026867|FG000|Follow-up|Voluntary Withdrawal|2|||
127838954|NCT01844830|460026868|FG000|Overall Study|Withdrawal by Subject|1|||
127838955|NCT01844830|460026869|FG001|Overall Study|Withdrawal by Subject|0|||
127838956|NCT04247815|460026870|FG000|Overall Study|Adverse Event|1|||
127838957|NCT04247815|460026871|FG001|Overall Study|Adverse Event|0|||
127838958|NCT04247815|460026870|FG000|Overall Study|Withdrawal by Subject|1|||
127838959|NCT04247815|460026871|FG001|Overall Study|Withdrawal by Subject|0|||
127838960|NCT04247815|460026870|FG000|Overall Study|Protocol Violation|0|||
127838961|NCT04247815|460026871|FG001|Overall Study|Protocol Violation|1|||
127838962|NCT03495453|460026876|FG000|Overall Study|Withdrawal by Subject|0|||
127838963|NCT03495453|460026877|FG001|Overall Study|Withdrawal by Subject|1|||
127838964|NCT00712322|460026881|FG000|Overall Study|Protocol deviation|0|||
127838965|NCT00712322|460026882|FG001|Overall Study|Protocol deviation|1|||
127838966|NCT00712322|460026883|FG002|Overall Study|Protocol deviation|0|||
127838967|NCT02802878|460026888|FG000|Overall Study|Withdrawal by Subject|3|||
127838968|NCT02802878|460026889|FG001|Overall Study|Withdrawal by Subject|3|||
127838969|NCT02802878|460026888|FG000|Overall Study|Protocol Violation|1|||
127838970|NCT02802878|460026889|FG001|Overall Study|Protocol Violation|0|||
127838971|NCT01599754|460026890|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
127838972|NCT01599754|460026891|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
127838973|NCT01599754|460026890|FG000|Overall Study|Participant noncompliance|4|||
127838974|NCT01599754|460026891|FG001|Overall Study|Participant noncompliance|4|||
127838975|NCT01599754|460026890|FG000|Overall Study|Lost to Follow-up|13|||
127838976|NCT01599754|460026891|FG001|Overall Study|Lost to Follow-up|6|||
127838977|NCT01599754|460026890|FG000|Overall Study|Death|31|||
127838978|NCT01599754|460026891|FG001|Overall Study|Death|33|||
127838979|NCT01599754|460026890|FG000|Overall Study|Adverse Event|3|||
127838980|NCT01599754|460026891|FG001|Overall Study|Adverse Event|2|||
127838981|NCT01599754|460026890|FG000|Overall Study|Investigator decision|1|||
127838982|NCT01599754|460026891|FG001|Overall Study|Investigator decision|3|||
127838983|NCT01599754|460026890|FG000|Overall Study|Withdrawal by Subject|24|||
127838984|NCT01599754|460026891|FG001|Overall Study|Withdrawal by Subject|25|||
127838985|NCT01599754|460026890|FG000|Overall Study|Study terminated by sponsor|282|||
127838986|NCT01599754|460026891|FG001|Overall Study|Study terminated by sponsor|285|||
127838987|NCT01029002|460026892|FG000|Overall Study|Lost to Follow-up|2|||
127838988|NCT01029002|460026893|FG001|Overall Study|Lost to Follow-up|4|||
127838989|NCT00702052|460026894|FG000|Overall Study|Adverse Event|23|||
127838990|NCT00702052|460026894|FG000|Overall Study|Disease Progression|30|||
127838991|NCT00702052|460026894|FG000|Overall Study|Withdrawal by Subject|5|||
127897881|NCT03992196|460251488|FG002|Enrollment|lost to follow-up prior dosing|0|||
127897882|NCT03992196|460251486|FG000|Treatment|Protocol Violation|0|||
127897883|NCT03992196|460251487|FG001|Treatment|Protocol Violation|0|||
127897884|NCT03992196|460251488|FG002|Treatment|Protocol Violation|1|||
127897885|NCT03992196|460251486|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
127897886|NCT03992196|460251487|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
127897887|NCT03992196|460251488|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
127897888|NCT03992196|460251486|FG000|Treatment|Withdrawal due to non-compliance|0|||
127897889|NCT03992196|460251487|FG001|Treatment|Withdrawal due to non-compliance|0|||
127897890|NCT03992196|460251488|FG002|Treatment|Withdrawal due to non-compliance|1|||
127897891|NCT03992196|460251486|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
127897892|NCT03992196|460251487|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
127897893|NCT03992196|460251488|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
127897894|NCT03992196|460251486|FG000|Treatment|Withdrawal by parent/guardian|0|||
127897895|NCT03992196|460251487|FG001|Treatment|Withdrawal by parent/guardian|0|||
127897896|NCT03992196|460251488|FG002|Treatment|Withdrawal by parent/guardian|2|||
127897897|NCT00048048|460251489|FG000|Core Treatment|Withdrawal by Subject|0|||
127838992|NCT01577160|460026895|FG000|Overall Study|Adverse Event|9|||
127838993|NCT01577160|460026895|FG000|Overall Study|Lack of Efficacy|15|||
127838994|NCT01577160|460026895|FG000|Overall Study|Lost to Follow-up|40|||
127838995|NCT01577160|460026895|FG000|Overall Study|Withdrawal by Subject|18|||
127838996|NCT01577160|460026895|FG000|Overall Study|Subject Uncooperative|7|||
127838997|NCT01577160|460026895|FG000|Overall Study|Other|9|||
127838998|NCT01551758|460026896|FG000|Overall Study|Adverse Event|29|||
127838999|NCT01551758|460026897|FG001|Overall Study|Adverse Event|43|||
127839000|NCT01551758|460026896|FG000|Overall Study|Lack of Efficacy|0|||
127839001|NCT01551758|460026897|FG001|Overall Study|Lack of Efficacy|1|||
127839002|NCT01551758|460026896|FG000|Overall Study|Protocol Violation|5|||
127839003|NCT01551758|460026897|FG001|Overall Study|Protocol Violation|6|||
127839004|NCT01551758|460026896|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
127839005|NCT01551758|460026897|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
127839006|NCT01551758|460026896|FG000|Overall Study|Lost to Follow-up|29|||
127839007|NCT01551758|460026897|FG001|Overall Study|Lost to Follow-up|25|||
127839008|NCT01551758|460026896|FG000|Overall Study|Physician Decision|9|||
127839009|NCT01551758|460026897|FG001|Overall Study|Physician Decision|3|||
127839010|NCT01551758|460026896|FG000|Overall Study|Withdrawal by Subject|14|||
127839011|NCT01551758|460026897|FG001|Overall Study|Withdrawal by Subject|17|||
127839012|NCT00916370|460026902|FG000|Overall Study|Death|3|||
127839013|NCT00916370|460026903|FG001|Overall Study|Death|1|||
127839014|NCT00916370|460026902|FG000|Overall Study|Withdrawal by Subject|2|||
127839015|NCT00916370|460026903|FG001|Overall Study|Withdrawal by Subject|0|||
127839016|NCT00916370|460026902|FG000|Overall Study|Physician Decision|0|||
127839017|NCT00916370|460026903|FG001|Overall Study|Physician Decision|1|||
127839018|NCT01317615|460026906|FG000|Overall Study|Disease progression|25|||
127839019|NCT01317615|460026906|FG000|Overall Study|New cancer therapy|5|||
127839020|NCT01317615|460026906|FG000|Overall Study|Death|6|||
127839021|NCT01317615|460026906|FG000|Overall Study|Withdrawal by Subject|5|||
127839022|NCT01317615|460026906|FG000|Overall Study|Abnormal laboratory value(s)|1|||
127839023|NCT01317615|460026906|FG000|Overall Study|Adverse Event|7|||
127839024|NCT00438399|460026909|FG000|Overall Study|Lost to Follow-up|2|||
127839025|NCT00438399|460026910|FG001|Overall Study|Lost to Follow-up|2|||
127839026|NCT00438399|460026911|FG002|Overall Study|Lost to Follow-up|1|||
127839027|NCT00438399|460026912|FG003|Overall Study|Lost to Follow-up|1|||
127839028|NCT00438399|460026913|FG004|Overall Study|Lost to Follow-up|1|||
127839029|NCT00438399|460026914|FG005|Overall Study|Lost to Follow-up|1|||
127839030|NCT00438399|460026909|FG000|Overall Study|Adverse Event|0|||
127839031|NCT00438399|460026910|FG001|Overall Study|Adverse Event|0|||
127839032|NCT00438399|460026911|FG002|Overall Study|Adverse Event|1|||
127839033|NCT00438399|460026912|FG003|Overall Study|Adverse Event|1|||
127839034|NCT00438399|460026913|FG004|Overall Study|Adverse Event|0|||
127839035|NCT00438399|460026914|FG005|Overall Study|Adverse Event|1|||
127839036|NCT00438399|460026909|FG000|Overall Study|Withdrawal by Subject|5|||
127839037|NCT00438399|460026910|FG001|Overall Study|Withdrawal by Subject|6|||
127839038|NCT00438399|460026911|FG002|Overall Study|Withdrawal by Subject|3|||
127839039|NCT00438399|460026912|FG003|Overall Study|Withdrawal by Subject|2|||
127839040|NCT00438399|460026913|FG004|Overall Study|Withdrawal by Subject|2|||
127839041|NCT00438399|460026914|FG005|Overall Study|Withdrawal by Subject|2|||
127897898|NCT00048048|460251490|FG001|Core Treatment|Withdrawal by Subject|0|||
127897899|NCT00048048|460251491|FG002|Core Treatment|Withdrawal by Subject|1|||
127897900|NCT00048048|460251492|FG003|Core Treatment|Withdrawal by Subject|0|||
127839042|NCT00438399|460026909|FG000|Overall Study|Protocol Violation|0|||
127839043|NCT00438399|460026910|FG001|Overall Study|Protocol Violation|0|||
127839044|NCT00438399|460026911|FG002|Overall Study|Protocol Violation|1|||
127839045|NCT00438399|460026912|FG003|Overall Study|Protocol Violation|0|||
127839046|NCT00438399|460026913|FG004|Overall Study|Protocol Violation|0|||
127839047|NCT00438399|460026914|FG005|Overall Study|Protocol Violation|1|||
127839048|NCT00438399|460026909|FG000|Overall Study|Subje stopped study|0|||
127839049|NCT00438399|460026910|FG001|Overall Study|Subje stopped study|0|||
127839050|NCT00438399|460026911|FG002|Overall Study|Subje stopped study|1|||
127839051|NCT00438399|460026912|FG003|Overall Study|Subje stopped study|0|||
127839052|NCT00438399|460026913|FG004|Overall Study|Subje stopped study|0|||
127839053|NCT00438399|460026914|FG005|Overall Study|Subje stopped study|0|||
127839054|NCT00438399|460026909|FG000|Overall Study|Pregnancy|0|||
127839055|NCT00438399|460026910|FG001|Overall Study|Pregnancy|0|||
127839056|NCT00438399|460026911|FG002|Overall Study|Pregnancy|0|||
127839057|NCT00438399|460026912|FG003|Overall Study|Pregnancy|0|||
127839058|NCT00438399|460026913|FG004|Overall Study|Pregnancy|0|||
127839059|NCT00438399|460026914|FG005|Overall Study|Pregnancy|1|||
127839060|NCT00438399|460026909|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
127839061|NCT00438399|460026910|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
127839062|NCT00438399|460026911|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
127839063|NCT00438399|460026912|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
127839064|NCT00438399|460026913|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
127839065|NCT00438399|460026914|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
127839066|NCT00632541|460026917|FG000|Overall Study|Adverse Event|7|||
127839067|NCT01842607|460026919|FG000|Overall Study|Adverse Event|11|||
127839068|NCT01842607|460026919|FG000|Overall Study|Lack of Efficacy|19|||
127839069|NCT01842607|460026919|FG000|Overall Study|Protocol Violation|8|||
127839070|NCT01842607|460026919|FG000|Overall Study|Protocol defined stopping criteria|2|||
127839071|NCT01842607|460026919|FG000|Overall Study|Lost to Follow-up|3|||
127839072|NCT01842607|460026919|FG000|Overall Study|Physician Decision|9|||
127839073|NCT01842607|460026919|FG000|Overall Study|Withdrawal by Subject|14|||
127839074|NCT01927419|460026920|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
127839075|NCT01927419|460026921|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
127839076|NCT01927419|460026920|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
127839077|NCT01927419|460026921|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
127839078|NCT01927419|460026920|FG000|Treatment Period|Disease progression|17|||
127839079|NCT01927419|460026921|FG001|Treatment Period|Disease progression|20|||
127839080|NCT01927419|460026920|FG000|Treatment Period|Study drug toxicity|48|||
127839081|NCT01927419|460026921|FG001|Treatment Period|Study drug toxicity|10|||
127839082|NCT01927419|460026920|FG000|Treatment Period|Death|0|||
127839083|NCT01927419|460026921|FG001|Treatment Period|Death|1|||
127839084|NCT01927419|460026920|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
127839085|NCT01927419|460026921|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
127839086|NCT01927419|460026920|FG000|Treatment Period|Participant request to discontinue|12|||
127839087|NCT01927419|460026921|FG001|Treatment Period|Participant request to discontinue|4|||
127839088|NCT01927419|460026920|FG000|Treatment Period|Withdrawal by Subject|1|||
127839089|NCT01927419|460026921|FG001|Treatment Period|Withdrawal by Subject|1|||
127839090|NCT01927419|460026920|FG000|Treatment Period|Maximum Clinical Benefit|6|||
127839091|NCT01927419|460026921|FG001|Treatment Period|Maximum Clinical Benefit|2|||
127839092|NCT01927419|460026920|FG000|Treatment Period|Other reasons|3|||
127839093|NCT01927419|460026921|FG001|Treatment Period|Other reasons|4|||
127839094|NCT01927419|460026920|FG000|Treatment Period|Not Reported|1|||
127839095|NCT01927419|460026921|FG001|Treatment Period|Not Reported|1|||
127839096|NCT00393913|460026922|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
127839097|NCT00393913|460026922|FG000|Initial Assessment|Withdrawal by Subject|16|||
127839098|NCT00393913|460026922|FG000|CPAP|Withdrawal by Subject|3|||
127839099|NCT00393913|460026922|FG000|CPAP|Physician Decision|1|||
127839100|NCT00393913|460026922|FG000|CPAP|TEchnical problem with CPAP|3|||
127839101|NCT03488251|460026923|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
127839102|NCT03488251|460026924|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
127839103|NCT03488251|460026925|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
127839104|NCT03488251|460026926|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
127839105|NCT03488251|460026923|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
127839106|NCT03488251|460026924|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
127839107|NCT03488251|460026925|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
127839108|NCT03488251|460026926|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
127839109|NCT03488251|460026923|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
127839110|NCT03488251|460026924|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
127839111|NCT03488251|460026925|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
127839112|NCT03488251|460026926|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
127839113|NCT03488251|460026923|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
127839114|NCT03488251|460026924|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
127839115|NCT03488251|460026925|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
127839116|NCT03488251|460026926|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
127839117|NCT03488251|460026923|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
127839118|NCT03488251|460026924|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
127897901|NCT00048048|460251493|FG004|Core Treatment|Withdrawal by Subject|0|||
127897902|NCT00048048|460251494|FG005|Core Treatment|Withdrawal by Subject|0|||
127897903|NCT00048048|460251495|FG006|Core Treatment|Withdrawal by Subject|0|||
127897904|NCT00048048|460251496|FG007|Core Treatment|Withdrawal by Subject|0|||
127897905|NCT00048048|460251497|FG008|Core Treatment|Withdrawal by Subject|0|||
127897906|NCT00048048|460251498|FG009|Core Treatment|Withdrawal by Subject|0|||
127897907|NCT00048048|460251499|FG010|Core Treatment|Withdrawal by Subject|0|||
127897908|NCT00048048|460251500|FG011|Core Treatment|Withdrawal by Subject|0|||
127897909|NCT00048048|460251489|FG000|Core Treatment|Adverse Event|0|||
127897910|NCT00048048|460251490|FG001|Core Treatment|Adverse Event|0|||
127897911|NCT00048048|460251491|FG002|Core Treatment|Adverse Event|0|||
127897912|NCT00048048|460251492|FG003|Core Treatment|Adverse Event|0|||
127897913|NCT00048048|460251493|FG004|Core Treatment|Adverse Event|0|||
127897914|NCT00048048|460251494|FG005|Core Treatment|Adverse Event|0|||
127897915|NCT00048048|460251495|FG006|Core Treatment|Adverse Event|0|||
127897916|NCT00048048|460251496|FG007|Core Treatment|Adverse Event|1|||
127897917|NCT00048048|460251497|FG008|Core Treatment|Adverse Event|0|||
127897918|NCT00048048|460251498|FG009|Core Treatment|Adverse Event|0|||
127897919|NCT00048048|460251499|FG010|Core Treatment|Adverse Event|0|||
127897920|NCT00048048|460251500|FG011|Core Treatment|Adverse Event|0|||
127897921|NCT00048048|460251489|FG000|Extension Year 1|Early withdrawals|0|||
127897922|NCT00048048|460251490|FG001|Extension Year 1|Early withdrawals|0|||
127897923|NCT00048048|460251491|FG002|Extension Year 1|Early withdrawals|0|||
127897924|NCT00048048|460251492|FG003|Extension Year 1|Early withdrawals|0|||
127897925|NCT00048048|460251493|FG004|Extension Year 1|Early withdrawals|0|||
127897926|NCT00048048|460251494|FG005|Extension Year 1|Early withdrawals|0|||
127897927|NCT00048048|460251495|FG006|Extension Year 1|Early withdrawals|0|||
127897928|NCT00048048|460251496|FG007|Extension Year 1|Early withdrawals|0|||
127897929|NCT00048048|460251497|FG008|Extension Year 1|Early withdrawals|0|||
127897930|NCT00048048|460251498|FG009|Extension Year 1|Early withdrawals|2|||
127897931|NCT00048048|460251499|FG010|Extension Year 1|Early withdrawals|2|||
127839119|NCT03488251|460026925|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
127839120|NCT03488251|460026926|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
127839121|NCT00592553|460026932|FG000|Overall Study|Protocol Noncompliance|1|||
127839122|NCT00592553|460026933|FG001|Overall Study|Protocol Noncompliance|0|||
127839123|NCT00592553|460026934|FG002|Overall Study|Protocol Noncompliance|0|||
127839124|NCT02379390|460026937|FG000|Overall Study|Adverse Event|1|||
127839125|NCT02379390|460026938|FG001|Overall Study|Adverse Event|1|||
127839126|NCT02379390|460026937|FG000|Overall Study|Investigator's decision|1|||
127839127|NCT02379390|460026938|FG001|Overall Study|Investigator's decision|0|||
127839128|NCT02379390|460026937|FG000|Overall Study|Study Termination|0|||
127839129|NCT02379390|460026938|FG001|Overall Study|Study Termination|1|||
127839130|NCT01244191|460026939|FG000|Overall Study|Progressive disease|295|||
127839131|NCT01244191|460026940|FG001|Overall Study|Progressive disease|350|||
127839132|NCT01244191|460026939|FG000|Overall Study|Clinical disease progression|54|||
127839133|NCT01244191|460026940|FG001|Overall Study|Clinical disease progression|36|||
127839134|NCT01244191|460026939|FG000|Overall Study|Adverse Event|65|||
127839135|NCT01244191|460026940|FG001|Overall Study|Adverse Event|48|||
127897932|NCT00048048|460251500|FG011|Extension Year 1|Early withdrawals|4|||
127897933|NCT00048048|460251489|FG000|Extension Year 2|Early withdrawals|0|||
127839136|NCT01244191|460026939|FG000|Overall Study|Death|22|||
127897934|NCT00048048|460251490|FG001|Extension Year 2|Early withdrawals|0|||
127897935|NCT00048048|460251491|FG002|Extension Year 2|Early withdrawals|0|||
127897936|NCT00048048|460251492|FG003|Extension Year 2|Early withdrawals|0|||
127897937|NCT00048048|460251493|FG004|Extension Year 2|Early withdrawals|0|||
127897938|NCT00048048|460251494|FG005|Extension Year 2|Early withdrawals|0|||
127897939|NCT00048048|460251495|FG006|Extension Year 2|Early withdrawals|0|||
127839137|NCT01244191|460026940|FG001|Overall Study|Death|29|||
127839138|NCT01244191|460026939|FG000|Overall Study|Lost to Follow-up|0|||
127839139|NCT01244191|460026940|FG001|Overall Study|Lost to Follow-up|2|||
127897940|NCT00048048|460251496|FG007|Extension Year 2|Early withdrawals|0|||
127897941|NCT00048048|460251497|FG008|Extension Year 2|Early withdrawals|0|||
127897942|NCT00048048|460251498|FG009|Extension Year 2|Early withdrawals|0|||
127897943|NCT00048048|460251499|FG010|Extension Year 2|Early withdrawals|4|||
127897944|NCT00048048|460251500|FG011|Extension Year 2|Early withdrawals|2|||
127897945|NCT02684578|460251501|FG000|Overall Study|Withdrawal by Subject|10|||
127897946|NCT02684578|460251502|FG001|Overall Study|Withdrawal by Subject|7|||
127897947|NCT02684578|460251501|FG000|Overall Study|Lost to Follow-up|0|||
127897948|NCT02684578|460251502|FG001|Overall Study|Lost to Follow-up|3|||
127897949|NCT02684578|460251501|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
127897950|NCT02684578|460251502|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
127897951|NCT02684578|460251501|FG000|Overall Study|Missing follow-up data|0|||
127897952|NCT02684578|460251502|FG001|Overall Study|Missing follow-up data|1|||
127897953|NCT05518487|460251503|FG000|Overall Study|Withdrawal by Subject|3|||
127897954|NCT02752776|460251505|FG000|Overall Study|Adverse Event|15|||
127897955|NCT02752776|460251506|FG001|Overall Study|Adverse Event|23|||
127897956|NCT02752776|460251507|FG002|Overall Study|Adverse Event|11|||
127897957|NCT02752776|460251505|FG000|Overall Study|Lack of Efficacy|2|||
127897958|NCT02752776|460251506|FG001|Overall Study|Lack of Efficacy|6|||
127897959|NCT02752776|460251507|FG002|Overall Study|Lack of Efficacy|14|||
127897960|NCT02752776|460251505|FG000|Overall Study|Lost to Follow-up|11|||
127897961|NCT02752776|460251506|FG001|Overall Study|Lost to Follow-up|12|||
127897962|NCT02752776|460251507|FG002|Overall Study|Lost to Follow-up|4|||
127897963|NCT02752776|460251505|FG000|Overall Study|Non-compliance with study treatment|0|||
127897964|NCT02752776|460251506|FG001|Overall Study|Non-compliance with study treatment|0|||
127897965|NCT02752776|460251507|FG002|Overall Study|Non-compliance with study treatment|1|||
127897966|NCT02752776|460251505|FG000|Overall Study|Physician Decision|2|||
127897967|NCT02752776|460251506|FG001|Overall Study|Physician Decision|6|||
127897968|NCT02752776|460251507|FG002|Overall Study|Physician Decision|2|||
127897969|NCT02752776|460251505|FG000|Overall Study|Pregnancy|1|||
127897970|NCT02752776|460251506|FG001|Overall Study|Pregnancy|6|||
127897971|NCT02752776|460251507|FG002|Overall Study|Pregnancy|3|||
127897972|NCT02752776|460251505|FG000|Overall Study|Protocol Violation|10|||
127897973|NCT02752776|460251506|FG001|Overall Study|Protocol Violation|13|||
127897974|NCT02752776|460251507|FG002|Overall Study|Protocol Violation|6|||
127897975|NCT02752776|460251505|FG000|Overall Study|Subject/guardian decision|8|||
127897976|NCT02752776|460251506|FG001|Overall Study|Subject/guardian decision|6|||
127897977|NCT02752776|460251507|FG002|Overall Study|Subject/guardian decision|4|||
127897978|NCT02752776|460251505|FG000|Overall Study|Death|0|||
127897979|NCT02752776|460251506|FG001|Overall Study|Death|0|||
127897980|NCT02752776|460251507|FG002|Overall Study|Death|1|||
127897981|NCT02752776|460251505|FG000|Overall Study|Withdrawal by Subject|3|||
127897982|NCT02752776|460251506|FG001|Overall Study|Withdrawal by Subject|4|||
127897983|NCT02752776|460251507|FG002|Overall Study|Withdrawal by Subject|2|||
127897984|NCT00712010|460251508|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
127897985|NCT01946165|460251509|FG000|Overall Study|Physician Decision|2|||
127897986|NCT01946165|460251510|FG001|Overall Study|Physician Decision|0|||
127897987|NCT01946165|460251509|FG000|Overall Study|Withdrawal by Subject|0|||
127897988|NCT01946165|460251510|FG001|Overall Study|Withdrawal by Subject|2|||
127897989|NCT01901055|460251511|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
127897990|NCT01901055|460251512|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
127897991|NCT01901055|460251511|FG000|Randomization But Not Titrated|Physician Decision|0|||
127897992|NCT01901055|460251512|FG001|Randomization But Not Titrated|Physician Decision|1|||
127897993|NCT01901055|460251511|FG000|Started Protocol to Week 6|Physician Decision|2|||
127897994|NCT01901055|460251512|FG001|Started Protocol to Week 6|Physician Decision|1|||
127897995|NCT01901055|460251511|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
127897996|NCT01901055|460251512|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
127897997|NCT01901055|460251511|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
127897998|NCT01901055|460251512|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
127897999|NCT01901055|460251511|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
127898000|NCT01901055|460251512|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
127898001|NCT01901055|460251511|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
127898002|NCT01901055|460251512|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
127898003|NCT01901055|460251511|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
127898004|NCT01901055|460251512|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
127898005|NCT01901055|460251511|FG000|Week 24|Withdrawal by Subject|13|||
127898006|NCT01901055|460251512|FG001|Week 24|Withdrawal by Subject|19|||
127898007|NCT01901055|460251511|FG000|Week 24|Physician Decision|1|||
127898008|NCT01901055|460251512|FG001|Week 24|Physician Decision|0|||
127898009|NCT01901055|460251511|FG000|Week 36|Withdrawal by Subject|0|||
127898010|NCT01901055|460251512|FG001|Week 36|Withdrawal by Subject|5|||
127898011|NCT01179919|460251515|FG000|Overall Study|Protocol Violation|1|||
127898012|NCT01179919|460251515|FG000|Overall Study|Adverse Event|1|||
127898013|NCT00806156|460251519|FG000|Overall Study|Death|35|||
127898014|NCT00806156|460251520|FG001|Overall Study|Death|95|||
127898015|NCT00806156|460251519|FG000|Overall Study|Did not meet eligibility criteria|1|||
127898016|NCT00806156|460251520|FG001|Overall Study|Did not meet eligibility criteria|0|||
127898017|NCT00806156|460251519|FG000|Overall Study|Study terminated by Sponsor|2|||
127898018|NCT00806156|460251520|FG001|Overall Study|Study terminated by Sponsor|40|||
127898019|NCT00806156|460251519|FG000|Overall Study|Consent withdrawn by subject|1|||
127898020|NCT00806156|460251520|FG001|Overall Study|Consent withdrawn by subject|3|||
127898021|NCT00806156|460251519|FG000|Overall Study|Lost to Follow-up|0|||
127898022|NCT00806156|460251520|FG001|Overall Study|Lost to Follow-up|1|||
127898023|NCT00525590|460251524|FG000|Overall Study|Adverse Event|3|||
127898024|NCT00525590|460251524|FG000|Overall Study|Physician Decision|3|||
127898025|NCT00525590|460251524|FG000|Overall Study|Withdrawal by Subject|16|||
127839140|NCT01244191|460026939|FG000|Overall Study|Protocol Violation|1|||
127839141|NCT01244191|460026940|FG001|Overall Study|Protocol Violation|2|||
127839142|NCT01244191|460026939|FG000|Overall Study|Withdrawal by Subject|31|||
127839143|NCT01244191|460026940|FG001|Overall Study|Withdrawal by Subject|23|||
127839144|NCT01244191|460026939|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
127839145|NCT01244191|460026940|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
127839146|NCT01511107|460026942|FG000|Overall Study|Ineligible|3|||
127839147|NCT01511107|460026943|FG001|Overall Study|Ineligible|2|||
127839148|NCT01511107|460026942|FG000|Overall Study|Lost to Follow-up|10|||
127839149|NCT01511107|460026943|FG001|Overall Study|Lost to Follow-up|19|||
127839150|NCT01511107|460026942|FG000|Overall Study|Withdrawal by Subject|9|||
127839151|NCT01511107|460026943|FG001|Overall Study|Withdrawal by Subject|20|||
127839152|NCT01830816|460029434|FG000|Overall Study|Progressive Disease|12|||
127839153|NCT01830816|460029435|FG001|Overall Study|Progressive Disease|7|||
127839154|NCT01830816|460029436|FG002|Overall Study|Progressive Disease|7|||
127839155|NCT01830816|460029434|FG000|Overall Study|Adverse Event|3|||
127839156|NCT01830816|460029435|FG001|Overall Study|Adverse Event|4|||
127839157|NCT01830816|460029436|FG002|Overall Study|Adverse Event|0|||
127839158|NCT01830816|460029434|FG000|Overall Study|Study Terminated by Sponsor|1|||
127839159|NCT01830816|460029435|FG001|Overall Study|Study Terminated by Sponsor|1|||
127839160|NCT01830816|460029436|FG002|Overall Study|Study Terminated by Sponsor|0|||
127839161|NCT01830816|460029434|FG000|Overall Study|Withdrawal by Subject|1|||
127839162|NCT01830816|460029435|FG001|Overall Study|Withdrawal by Subject|1|||
127839163|NCT01830816|460029436|FG002|Overall Study|Withdrawal by Subject|0|||
127839164|NCT01830816|460029434|FG000|Overall Study|Lost to Follow-up|0|||
127839165|NCT01830816|460029435|FG001|Overall Study|Lost to Follow-up|1|||
127839166|NCT01830816|460029436|FG002|Overall Study|Lost to Follow-up|0|||
127839167|NCT01830816|460029434|FG000|Overall Study|Symptomatic Deterioration|1|||
127839168|NCT01830816|460029435|FG001|Overall Study|Symptomatic Deterioration|0|||
127839169|NCT01830816|460029436|FG002|Overall Study|Symptomatic Deterioration|0|||
127839170|NCT01830816|460029434|FG000|Overall Study|Reason not Specified|2|||
127839171|NCT01830816|460029435|FG001|Overall Study|Reason not Specified|0|||
127839172|NCT01830816|460029436|FG002|Overall Study|Reason not Specified|0|||
127839173|NCT00363051|460029437|FG000|Overall Study|Adminstrative problems|1|||
127839174|NCT00363051|460029438|FG001|Overall Study|Adminstrative problems|1|||
127839175|NCT00363051|460029437|FG000|Overall Study|Adverse Event|21|||
127839176|NCT00363051|460029438|FG001|Overall Study|Adverse Event|12|||
127839177|NCT00363051|460029437|FG000|Overall Study|New Cancer Therapy|2|||
127839178|NCT00363051|460029438|FG001|Overall Study|New Cancer Therapy|1|||
127839179|NCT00363051|460029437|FG000|Overall Study|Withdrawal by Subject|11|||
127839180|NCT00363051|460029438|FG001|Overall Study|Withdrawal by Subject|3|||
127839181|NCT00363051|460029437|FG000|Overall Study|Lost to Follow-up|0|||
127839182|NCT00363051|460029438|FG001|Overall Study|Lost to Follow-up|1|||
127839183|NCT00363051|460029437|FG000|Overall Study|Protocol Violation|0|||
127839184|NCT00363051|460029438|FG001|Overall Study|Protocol Violation|2|||
127839185|NCT00363051|460029437|FG000|Overall Study|Death|3|||
127839186|NCT00363051|460029438|FG001|Overall Study|Death|2|||
127839187|NCT00830115|460029441|FG000|Overall Study|Adverse Event|2|||
127839188|NCT00830115|460029441|FG000|Overall Study|Improvement/recovery|1|||
127839189|NCT01207388|460029449|FG000|Overall Study|Death|67|||
127839190|NCT01207388|460029449|FG000|Overall Study|Withdrawal by Subject|1|||
127839191|NCT01885078|460029450|FG000|Treatment Period|Adverse Event|52|||
127839192|NCT01885078|460029451|FG001|Treatment Period|Adverse Event|136|||
127839193|NCT01885078|460029452|FG002|Treatment Period|Adverse Event|30|||
127839194|NCT01885078|460029453|FG003|Treatment Period|Adverse Event|73|||
127839195|NCT01885078|460029454|FG004|Treatment Period|Adverse Event|17|||
127839196|NCT01885078|460029455|FG005|Treatment Period|Adverse Event|72|||
127839197|NCT01885078|460029456|FG006|Treatment Period|Adverse Event|24|||
127839198|NCT01885078|460029457|FG007|Treatment Period|Adverse Event|5|||
127839199|NCT01885078|460029458|FG008|Treatment Period|Adverse Event|0|||
127839200|NCT01885078|460029459|FG009|Treatment Period|Adverse Event|0|||
127839201|NCT01885078|460029450|FG000|Treatment Period|Death|13|||
127839202|NCT01885078|460029451|FG001|Treatment Period|Death|33|||
127839203|NCT01885078|460029452|FG002|Treatment Period|Death|5|||
127839204|NCT01885078|460029453|FG003|Treatment Period|Death|9|||
127839205|NCT01885078|460029454|FG004|Treatment Period|Death|2|||
127839206|NCT01885078|460029455|FG005|Treatment Period|Death|10|||
127839207|NCT01885078|460029456|FG006|Treatment Period|Death|3|||
127839208|NCT01885078|460029457|FG007|Treatment Period|Death|2|||
127839209|NCT01885078|460029458|FG008|Treatment Period|Death|0|||
127839210|NCT01885078|460029459|FG009|Treatment Period|Death|0|||
127839211|NCT01885078|460029450|FG000|Treatment Period|Lack of Efficacy|12|||
127839212|NCT01885078|460029451|FG001|Treatment Period|Lack of Efficacy|33|||
127839213|NCT01885078|460029452|FG002|Treatment Period|Lack of Efficacy|10|||
127839214|NCT01885078|460029453|FG003|Treatment Period|Lack of Efficacy|23|||
127839215|NCT01885078|460029454|FG004|Treatment Period|Lack of Efficacy|24|||
127839216|NCT01885078|460029455|FG005|Treatment Period|Lack of Efficacy|58|||
127839217|NCT01885078|460029456|FG006|Treatment Period|Lack of Efficacy|9|||
127839218|NCT01885078|460029457|FG007|Treatment Period|Lack of Efficacy|5|||
127839219|NCT01885078|460029458|FG008|Treatment Period|Lack of Efficacy|0|||
127839220|NCT01885078|460029459|FG009|Treatment Period|Lack of Efficacy|0|||
127839221|NCT01885078|460029450|FG000|Treatment Period|Lost to Follow-up|16|||
127839222|NCT01885078|460029451|FG001|Treatment Period|Lost to Follow-up|19|||
127839223|NCT01885078|460029452|FG002|Treatment Period|Lost to Follow-up|7|||
127839224|NCT01885078|460029453|FG003|Treatment Period|Lost to Follow-up|9|||
127839225|NCT01885078|460029454|FG004|Treatment Period|Lost to Follow-up|2|||
127839226|NCT01885078|460029455|FG005|Treatment Period|Lost to Follow-up|8|||
127839227|NCT01885078|460029456|FG006|Treatment Period|Lost to Follow-up|2|||
127839228|NCT01885078|460029457|FG007|Treatment Period|Lost to Follow-up|0|||
127839229|NCT01885078|460029458|FG008|Treatment Period|Lost to Follow-up|0|||
127839230|NCT01885078|460029459|FG009|Treatment Period|Lost to Follow-up|0|||
127839231|NCT01885078|460029450|FG000|Treatment Period|Physician Decision|19|||
127839232|NCT01885078|460029451|FG001|Treatment Period|Physician Decision|21|||
127839233|NCT01885078|460029452|FG002|Treatment Period|Physician Decision|5|||
127839234|NCT01885078|460029453|FG003|Treatment Period|Physician Decision|12|||
127839235|NCT01885078|460029454|FG004|Treatment Period|Physician Decision|9|||
127839236|NCT01885078|460029455|FG005|Treatment Period|Physician Decision|24|||
127839237|NCT01885078|460029456|FG006|Treatment Period|Physician Decision|4|||
127839238|NCT01885078|460029457|FG007|Treatment Period|Physician Decision|3|||
127839239|NCT01885078|460029458|FG008|Treatment Period|Physician Decision|0|||
127839240|NCT01885078|460029459|FG009|Treatment Period|Physician Decision|0|||
127839241|NCT01885078|460029450|FG000|Treatment Period|Protocol Violation|3|||
127839242|NCT01885078|460029451|FG001|Treatment Period|Protocol Violation|5|||
127839243|NCT01885078|460029452|FG002|Treatment Period|Protocol Violation|0|||
127839244|NCT01885078|460029453|FG003|Treatment Period|Protocol Violation|3|||
127839245|NCT01885078|460029454|FG004|Treatment Period|Protocol Violation|1|||
127839246|NCT01885078|460029455|FG005|Treatment Period|Protocol Violation|6|||
127839247|NCT01885078|460029456|FG006|Treatment Period|Protocol Violation|0|||
127839248|NCT01885078|460029457|FG007|Treatment Period|Protocol Violation|0|||
127839249|NCT01885078|460029458|FG008|Treatment Period|Protocol Violation|0|||
127839250|NCT01885078|460029459|FG009|Treatment Period|Protocol Violation|0|||
127839251|NCT01885078|460029450|FG000|Treatment Period|Sponsor Decision|245|||
127839252|NCT01885078|460029451|FG001|Treatment Period|Sponsor Decision|648|||
127839253|NCT01885078|460029452|FG002|Treatment Period|Sponsor Decision|49|||
127839254|NCT01885078|460029453|FG003|Treatment Period|Sponsor Decision|90|||
127839255|NCT01885078|460029454|FG004|Treatment Period|Sponsor Decision|20|||
127839256|NCT01885078|460029455|FG005|Treatment Period|Sponsor Decision|38|||
127839257|NCT01885078|460029456|FG006|Treatment Period|Sponsor Decision|162|||
127839258|NCT01885078|460029457|FG007|Treatment Period|Sponsor Decision|3|||
127839259|NCT01885078|460029458|FG008|Treatment Period|Sponsor Decision|0|||
127839260|NCT01885078|460029459|FG009|Treatment Period|Sponsor Decision|0|||
127839261|NCT01885078|460029450|FG000|Treatment Period|Withdrawal by Subject|72|||
127839262|NCT01885078|460029451|FG001|Treatment Period|Withdrawal by Subject|132|||
127839263|NCT01885078|460029452|FG002|Treatment Period|Withdrawal by Subject|25|||
127839264|NCT01885078|460029453|FG003|Treatment Period|Withdrawal by Subject|63|||
127839265|NCT01885078|460029454|FG004|Treatment Period|Withdrawal by Subject|15|||
127839266|NCT01885078|460029455|FG005|Treatment Period|Withdrawal by Subject|34|||
127839267|NCT01885078|460029456|FG006|Treatment Period|Withdrawal by Subject|17|||
127839268|NCT01885078|460029457|FG007|Treatment Period|Withdrawal by Subject|10|||
127839269|NCT01885078|460029458|FG008|Treatment Period|Withdrawal by Subject|0|||
127839270|NCT01885078|460029459|FG009|Treatment Period|Withdrawal by Subject|0|||
127839271|NCT01885078|460029450|FG000|Treatment Period|Other|0|||
127839272|NCT01885078|460029451|FG001|Treatment Period|Other|0|||
127839273|NCT01885078|460029452|FG002|Treatment Period|Other|0|||
127839274|NCT01885078|460029453|FG003|Treatment Period|Other|1|||
127839275|NCT01885078|460029454|FG004|Treatment Period|Other|0|||
127839276|NCT01885078|460029455|FG005|Treatment Period|Other|0|||
127839277|NCT01885078|460029456|FG006|Treatment Period|Other|0|||
127839278|NCT01885078|460029457|FG007|Treatment Period|Other|0|||
127839279|NCT01885078|460029458|FG008|Treatment Period|Other|0|||
127839280|NCT01885078|460029459|FG009|Treatment Period|Other|0|||
127839281|NCT01885078|460029450|FG000|Step-down Period|Sponsor Decision|0|||
127839282|NCT01885078|460029451|FG001|Step-down Period|Sponsor Decision|0|||
127839283|NCT01885078|460029452|FG002|Step-down Period|Sponsor Decision|0|||
127839284|NCT01885078|460029453|FG003|Step-down Period|Sponsor Decision|0|||
127839285|NCT01885078|460029454|FG004|Step-down Period|Sponsor Decision|0|||
127839286|NCT01885078|460029455|FG005|Step-down Period|Sponsor Decision|0|||
127839287|NCT01885078|460029456|FG006|Step-down Period|Sponsor Decision|0|||
127839288|NCT01885078|460029457|FG007|Step-down Period|Sponsor Decision|0|||
127839289|NCT01885078|460029458|FG008|Step-down Period|Sponsor Decision|1|||
127839290|NCT01885078|460029459|FG009|Step-down Period|Sponsor Decision|1|||
127839291|NCT01885078|460029450|FG000|Step-down Period|Adverse Event|0|||
127839292|NCT01885078|460029451|FG001|Step-down Period|Adverse Event|0|||
127898026|NCT00525590|460251524|FG000|Overall Study|Lost to Follow-up|1|||
127898027|NCT00525590|460251524|FG000|Overall Study|Death|9|||
127898028|NCT00525590|460251524|FG000|Overall Study|Other|13|||
127898029|NCT00449150|460251525|FG000|Overall Study|Adverse Event|11|||
127898030|NCT00449150|460251526|FG001|Overall Study|Adverse Event|18|||
127898031|NCT00449150|460251527|FG002|Overall Study|Adverse Event|9|||
127898032|NCT00449150|460251525|FG000|Overall Study|Lack of Efficacy|1|||
127898033|NCT00449150|460251526|FG001|Overall Study|Lack of Efficacy|2|||
127898034|NCT00449150|460251527|FG002|Overall Study|Lack of Efficacy|2|||
127898035|NCT00449150|460251525|FG000|Overall Study|Other|16|||
127898036|NCT00449150|460251526|FG001|Overall Study|Other|13|||
127898037|NCT00449150|460251527|FG002|Overall Study|Other|14|||
127898038|NCT00449150|460251525|FG000|Overall Study|Withdrawal by Subject|17|||
127898039|NCT00449150|460251526|FG001|Overall Study|Withdrawal by Subject|18|||
127898040|NCT00449150|460251527|FG002|Overall Study|Withdrawal by Subject|21|||
127898041|NCT00449150|460251525|FG000|Overall Study|Protocol Violation|1|||
127898042|NCT00449150|460251526|FG001|Overall Study|Protocol Violation|2|||
127898043|NCT00449150|460251527|FG002|Overall Study|Protocol Violation|1|||
127898044|NCT03830164|460251531|FG000|Overall Study|Adverse Event|0|||
127898045|NCT03830164|460251532|FG001|Overall Study|Adverse Event|2|||
127898046|NCT03830164|460251533|FG002|Overall Study|Adverse Event|0|||
127898047|NCT03830164|460251531|FG000|Overall Study|Lack of Efficacy|1|||
127898048|NCT03830164|460251532|FG001|Overall Study|Lack of Efficacy|5|||
127898049|NCT03830164|460251533|FG002|Overall Study|Lack of Efficacy|0|||
127898050|NCT03830164|460251531|FG000|Overall Study|Lost to Follow-up|0|||
127898051|NCT03830164|460251532|FG001|Overall Study|Lost to Follow-up|1|||
127898052|NCT03830164|460251533|FG002|Overall Study|Lost to Follow-up|0|||
127898053|NCT03830164|460251531|FG000|Overall Study|Withdrawal by Subject|1|||
127898054|NCT03830164|460251532|FG001|Overall Study|Withdrawal by Subject|0|||
127898055|NCT03830164|460251533|FG002|Overall Study|Withdrawal by Subject|0|||
127898056|NCT02192099|460251534|FG000|Overall Study|Adverse Event|1|||
127898057|NCT02192099|460251534|FG000|Overall Study|Lost to Follow-up|2|||
127898058|NCT02192099|460251534|FG000|Overall Study|Physician Decision|1|||
127898059|NCT02192099|460251534|FG000|Overall Study|Pregnancy|1|||
127898060|NCT02192099|460251534|FG000|Overall Study|Protocol Violation|8|||
127898061|NCT02192099|460251534|FG000|Overall Study|Study Terminated by Sponsor|32|||
127898062|NCT02192099|460251534|FG000|Overall Study|Withdrawal by Subject|11|||
127898063|NCT02192099|460251534|FG000|Overall Study|Miscellaneous Reasons|5|||
127898064|NCT02796664|460251537|FG000|Overall Study|Withdrawal by Subject|0|||
127898065|NCT02796664|460251538|FG001|Overall Study|Withdrawal by Subject|3|||
127898066|NCT02796664|460251537|FG000|Overall Study|Noncompliance|1|||
127898067|NCT02796664|460251538|FG001|Overall Study|Noncompliance|1|||
127898068|NCT02796664|460251537|FG000|Overall Study|Death|0|||
127898069|NCT02796664|460251538|FG001|Overall Study|Death|1|||
127898070|NCT02246478|460251539|FG000|Multiple-dose Phase|Protocol Violation|1|||
127898071|NCT02246478|460251540|FG001|Multiple-dose Phase|Protocol Violation|0|||
127898072|NCT02246478|460251541|FG002|Multiple-dose Phase|Protocol Violation|0|||
127898073|NCT02246478|460251542|FG003|Multiple-dose Phase|Protocol Violation|1|||
127898074|NCT01531205|460251544|FG000|Overall Study|Did not proceed to surgery|1|||
127898075|NCT02001558|460251545|FG000|Overall Study|Lost to Follow-up|8|||
127898076|NCT02001558|460251546|FG001|Overall Study|Lost to Follow-up|14|||
127898077|NCT04128007|460251547|FG000|Overall Study|Withdrawal by Subject|9|||
127839293|NCT01885078|460029452|FG002|Step-down Period|Adverse Event|0|||
127839294|NCT01885078|460029453|FG003|Step-down Period|Adverse Event|0|||
127839295|NCT01885078|460029454|FG004|Step-down Period|Adverse Event|0|||
127839296|NCT01885078|460029455|FG005|Step-down Period|Adverse Event|0|||
127839297|NCT01885078|460029456|FG006|Step-down Period|Adverse Event|0|||
127839298|NCT01885078|460029457|FG007|Step-down Period|Adverse Event|0|||
127839299|NCT01885078|460029458|FG008|Step-down Period|Adverse Event|29|||
127839300|NCT01885078|460029459|FG009|Step-down Period|Adverse Event|38|||
127839301|NCT01885078|460029450|FG000|Step-down Period|Withdrawal by Subject|0|||
127839302|NCT01885078|460029451|FG001|Step-down Period|Withdrawal by Subject|0|||
127839303|NCT01885078|460029452|FG002|Step-down Period|Withdrawal by Subject|0|||
127898078|NCT04128007|460251548|FG001|Overall Study|Withdrawal by Subject|6|||
127898079|NCT04128007|460251547|FG000|Overall Study|Protocol Violation|1|||
127898080|NCT04128007|460251548|FG001|Overall Study|Protocol Violation|0|||
127898081|NCT04128007|460251547|FG000|Overall Study|Lost to Follow-up|8|||
127898082|NCT04128007|460251548|FG001|Overall Study|Lost to Follow-up|7|||
127898083|NCT04128007|460251547|FG000|Overall Study|Adverse Event|5|||
127839304|NCT01885078|460029453|FG003|Step-down Period|Withdrawal by Subject|0|||
127839305|NCT01885078|460029454|FG004|Step-down Period|Withdrawal by Subject|0|||
127839306|NCT01885078|460029455|FG005|Step-down Period|Withdrawal by Subject|0|||
127898084|NCT04128007|460251548|FG001|Overall Study|Adverse Event|2|||
127898085|NCT04128007|460251547|FG000|Overall Study|Not reported|0|||
127898086|NCT04128007|460251548|FG001|Overall Study|Not reported|2|||
127898087|NCT04117607|460251549|FG000|Overall Study|Early Termination|0|||
127898088|NCT04117607|460251550|FG001|Overall Study|Early Termination|1|||
127898089|NCT04117607|460251551|FG002|Overall Study|Early Termination|0|||
127898090|NCT04117607|460251552|FG003|Overall Study|Early Termination|0|||
127898091|NCT04117607|460251553|FG004|Overall Study|Early Termination|0|||
127839307|NCT01885078|460029456|FG006|Step-down Period|Withdrawal by Subject|0|||
127898092|NCT04117607|460251554|FG005|Overall Study|Early Termination|0|||
127898093|NCT04117607|460251555|FG006|Overall Study|Early Termination|1|||
127898094|NCT04117607|460251556|FG007|Overall Study|Early Termination|0|||
127898095|NCT04117607|460251557|FG008|Overall Study|Early Termination|0|||
127898096|NCT04117607|460251558|FG009|Overall Study|Early Termination|0|||
127898097|NCT04117607|460251559|FG010|Overall Study|Early Termination|0|||
127898098|NCT04117607|460251560|FG011|Overall Study|Early Termination|0|||
127898099|NCT04117607|460251561|FG012|Overall Study|Early Termination|0|||
127898100|NCT04117607|460251562|FG013|Overall Study|Early Termination|0|||
127898101|NCT00950807|460251566|FG000|Treatment Period 1|Lack of Efficacy|1|||
127898102|NCT00950807|460251567|FG001|Treatment Period 1|Lack of Efficacy|0|||
127898103|NCT00950807|460251568|FG002|Treatment Period 1|Lack of Efficacy|0|||
127898104|NCT00950807|460251569|FG003|Treatment Period 1|Lack of Efficacy|0|||
127898105|NCT00950807|460251570|FG004|Treatment Period 1|Lack of Efficacy|0|||
127898106|NCT00950807|460251571|FG005|Treatment Period 1|Lack of Efficacy|1|||
127898107|NCT00950807|460251572|FG006|Treatment Period 1|Lack of Efficacy|0|||
127898108|NCT00950807|460251573|FG007|Treatment Period 1|Lack of Efficacy|0|||
127898109|NCT00950807|460251574|FG008|Treatment Period 1|Lack of Efficacy|0|||
127898110|NCT00950807|460251575|FG009|Treatment Period 1|Lack of Efficacy|0|||
127898111|NCT00950807|460251566|FG000|Treatment Period 1|Protocol Violation|1|||
127898112|NCT00950807|460251567|FG001|Treatment Period 1|Protocol Violation|0|||
127898113|NCT00950807|460251568|FG002|Treatment Period 1|Protocol Violation|0|||
127898114|NCT00950807|460251569|FG003|Treatment Period 1|Protocol Violation|0|||
127898115|NCT00950807|460251570|FG004|Treatment Period 1|Protocol Violation|0|||
127898116|NCT00950807|460251571|FG005|Treatment Period 1|Protocol Violation|0|||
127898117|NCT00950807|460251572|FG006|Treatment Period 1|Protocol Violation|0|||
127898118|NCT00950807|460251573|FG007|Treatment Period 1|Protocol Violation|0|||
127839308|NCT01885078|460029457|FG007|Step-down Period|Withdrawal by Subject|0|||
127839309|NCT01885078|460029458|FG008|Step-down Period|Withdrawal by Subject|25|||
127839310|NCT01885078|460029459|FG009|Step-down Period|Withdrawal by Subject|15|||
127839311|NCT01885078|460029450|FG000|Step-down Period|Physician Decision|0|||
127839312|NCT01885078|460029451|FG001|Step-down Period|Physician Decision|0|||
127839313|NCT01885078|460029452|FG002|Step-down Period|Physician Decision|0|||
127839314|NCT01885078|460029453|FG003|Step-down Period|Physician Decision|0|||
127839315|NCT01885078|460029454|FG004|Step-down Period|Physician Decision|0|||
127839316|NCT01885078|460029455|FG005|Step-down Period|Physician Decision|0|||
127839317|NCT01885078|460029456|FG006|Step-down Period|Physician Decision|0|||
127839318|NCT01885078|460029457|FG007|Step-down Period|Physician Decision|0|||
127839319|NCT01885078|460029458|FG008|Step-down Period|Physician Decision|7|||
127839320|NCT01885078|460029459|FG009|Step-down Period|Physician Decision|2|||
127839321|NCT01885078|460029450|FG000|Step-down Period|Death|0|||
127839322|NCT01885078|460029451|FG001|Step-down Period|Death|0|||
127839323|NCT01885078|460029452|FG002|Step-down Period|Death|0|||
127839324|NCT01885078|460029453|FG003|Step-down Period|Death|0|||
127839325|NCT01885078|460029454|FG004|Step-down Period|Death|0|||
127839326|NCT01885078|460029455|FG005|Step-down Period|Death|0|||
127839327|NCT01885078|460029456|FG006|Step-down Period|Death|0|||
127839328|NCT01885078|460029457|FG007|Step-down Period|Death|0|||
127839329|NCT01885078|460029458|FG008|Step-down Period|Death|4|||
127839330|NCT01885078|460029459|FG009|Step-down Period|Death|3|||
127839331|NCT01885078|460029450|FG000|Step-down Period|Lost to Follow-up|0|||
127839332|NCT01885078|460029451|FG001|Step-down Period|Lost to Follow-up|0|||
127839333|NCT01885078|460029452|FG002|Step-down Period|Lost to Follow-up|0|||
127839334|NCT01885078|460029453|FG003|Step-down Period|Lost to Follow-up|0|||
127898119|NCT00950807|460251574|FG008|Treatment Period 1|Protocol Violation|0|||
127898120|NCT00950807|460251575|FG009|Treatment Period 1|Protocol Violation|0|||
127898121|NCT00950807|460251566|FG000|Treatment Period 1|Lost to Follow-up|0|||
127898122|NCT00950807|460251567|FG001|Treatment Period 1|Lost to Follow-up|0|||
127898123|NCT00950807|460251568|FG002|Treatment Period 1|Lost to Follow-up|1|||
127898124|NCT00950807|460251569|FG003|Treatment Period 1|Lost to Follow-up|0|||
127898125|NCT00950807|460251570|FG004|Treatment Period 1|Lost to Follow-up|0|||
127898126|NCT00950807|460251571|FG005|Treatment Period 1|Lost to Follow-up|0|||
127898127|NCT00950807|460251572|FG006|Treatment Period 1|Lost to Follow-up|0|||
127839335|NCT01885078|460029454|FG004|Step-down Period|Lost to Follow-up|0|||
127839336|NCT01885078|460029455|FG005|Step-down Period|Lost to Follow-up|0|||
127898128|NCT00950807|460251573|FG007|Treatment Period 1|Lost to Follow-up|0|||
127839337|NCT01885078|460029456|FG006|Step-down Period|Lost to Follow-up|0|||
127839338|NCT01885078|460029457|FG007|Step-down Period|Lost to Follow-up|0|||
127839339|NCT01885078|460029458|FG008|Step-down Period|Lost to Follow-up|1|||
127839340|NCT01885078|460029459|FG009|Step-down Period|Lost to Follow-up|1|||
127839341|NCT01885078|460029450|FG000|Step-down Period|Lack of Efficacy|0|||
127839342|NCT01885078|460029451|FG001|Step-down Period|Lack of Efficacy|0|||
127839343|NCT01885078|460029452|FG002|Step-down Period|Lack of Efficacy|0|||
127839344|NCT01885078|460029453|FG003|Step-down Period|Lack of Efficacy|0|||
127839345|NCT01885078|460029454|FG004|Step-down Period|Lack of Efficacy|0|||
127839346|NCT01885078|460029455|FG005|Step-down Period|Lack of Efficacy|0|||
127839347|NCT01885078|460029456|FG006|Step-down Period|Lack of Efficacy|0|||
127839348|NCT01885078|460029457|FG007|Step-down Period|Lack of Efficacy|0|||
127839349|NCT01885078|460029458|FG008|Step-down Period|Lack of Efficacy|1|||
127839350|NCT01885078|460029459|FG009|Step-down Period|Lack of Efficacy|0|||
127839351|NCT01885078|460029450|FG000|Step-down Period|Protocol Violation|0|||
127839352|NCT01885078|460029451|FG001|Step-down Period|Protocol Violation|0|||
127839353|NCT01885078|460029452|FG002|Step-down Period|Protocol Violation|0|||
127839354|NCT01885078|460029453|FG003|Step-down Period|Protocol Violation|0|||
127839355|NCT01885078|460029454|FG004|Step-down Period|Protocol Violation|0|||
127839356|NCT01885078|460029455|FG005|Step-down Period|Protocol Violation|0|||
127839357|NCT01885078|460029456|FG006|Step-down Period|Protocol Violation|0|||
127839358|NCT01885078|460029457|FG007|Step-down Period|Protocol Violation|0|||
127839359|NCT01885078|460029458|FG008|Step-down Period|Protocol Violation|1|||
127839360|NCT01885078|460029459|FG009|Step-down Period|Protocol Violation|1|||
127839361|NCT03115112|460029460|FG000|Overall Study|Adverse Event|5|||
127839362|NCT03115112|460029461|FG001|Overall Study|Adverse Event|1|||
127839363|NCT03115112|460029460|FG000|Overall Study|Withdrawal by Subject|4|||
127839364|NCT03115112|460029461|FG001|Overall Study|Withdrawal by Subject|2|||
127839365|NCT03115112|460029460|FG000|Overall Study|Lost to Follow-up|0|||
127839366|NCT03115112|460029461|FG001|Overall Study|Lost to Follow-up|1|||
127839367|NCT03115112|460029460|FG000|Overall Study|Death|1|||
127839368|NCT03115112|460029461|FG001|Overall Study|Death|0|||
127839369|NCT03115112|460029460|FG000|Overall Study|Pregnancy|1|||
127839370|NCT03115112|460029461|FG001|Overall Study|Pregnancy|0|||
127839371|NCT03115112|460029460|FG000|Overall Study|Site closure|1|||
127839372|NCT03115112|460029461|FG001|Overall Study|Site closure|1|||
127839373|NCT04019795|460029463|FG000|Overall Study|Withdrawal by Subject|1|||
127839374|NCT04019795|460029464|FG001|Overall Study|Withdrawal by Subject|2|||
127839375|NCT04019795|460029465|FG002|Overall Study|Withdrawal by Subject|2|||
127839376|NCT04019795|460029466|FG003|Overall Study|Withdrawal by Subject|1|||
127839377|NCT04019795|460029463|FG000|Overall Study|Lost to Follow-up|0|||
127898129|NCT00950807|460251574|FG008|Treatment Period 1|Lost to Follow-up|0|||
127898130|NCT00950807|460251575|FG009|Treatment Period 1|Lost to Follow-up|0|||
127898131|NCT00950807|460251566|FG000|Treatment Period 1|Withdrawal by Subject|1|||
127898132|NCT00950807|460251567|FG001|Treatment Period 1|Withdrawal by Subject|0|||
127898133|NCT00950807|460251568|FG002|Treatment Period 1|Withdrawal by Subject|0|||
127898134|NCT00950807|460251569|FG003|Treatment Period 1|Withdrawal by Subject|0|||
127898135|NCT00950807|460251570|FG004|Treatment Period 1|Withdrawal by Subject|1|||
127898136|NCT00950807|460251571|FG005|Treatment Period 1|Withdrawal by Subject|0|||
127898137|NCT00950807|460251572|FG006|Treatment Period 1|Withdrawal by Subject|0|||
127898138|NCT00950807|460251573|FG007|Treatment Period 1|Withdrawal by Subject|0|||
127898139|NCT00950807|460251574|FG008|Treatment Period 1|Withdrawal by Subject|1|||
127898140|NCT00950807|460251575|FG009|Treatment Period 1|Withdrawal by Subject|0|||
127898141|NCT00950807|460251566|FG000|Treatment Period 1|Adverse Event|0|||
127898142|NCT00950807|460251567|FG001|Treatment Period 1|Adverse Event|0|||
127898143|NCT00950807|460251568|FG002|Treatment Period 1|Adverse Event|0|||
127898144|NCT00950807|460251569|FG003|Treatment Period 1|Adverse Event|0|||
127898145|NCT00950807|460251570|FG004|Treatment Period 1|Adverse Event|0|||
127898146|NCT00950807|460251571|FG005|Treatment Period 1|Adverse Event|1|||
127898147|NCT00950807|460251572|FG006|Treatment Period 1|Adverse Event|0|||
127898148|NCT00950807|460251573|FG007|Treatment Period 1|Adverse Event|0|||
127898149|NCT00950807|460251574|FG008|Treatment Period 1|Adverse Event|0|||
127898150|NCT00950807|460251575|FG009|Treatment Period 1|Adverse Event|0|||
127839378|NCT04019795|460029464|FG001|Overall Study|Lost to Follow-up|1|||
127839379|NCT04019795|460029465|FG002|Overall Study|Lost to Follow-up|1|||
127839380|NCT04019795|460029466|FG003|Overall Study|Lost to Follow-up|2|||
127839381|NCT04019795|460029463|FG000|Overall Study|Treatment non-compliance|3|||
127839382|NCT04019795|460029464|FG001|Overall Study|Treatment non-compliance|1|||
127839383|NCT04019795|460029465|FG002|Overall Study|Treatment non-compliance|2|||
127839384|NCT04019795|460029466|FG003|Overall Study|Treatment non-compliance|0|||
127839385|NCT04019795|460029463|FG000|Overall Study|Physician Decision|0|||
127839386|NCT04019795|460029464|FG001|Overall Study|Physician Decision|0|||
127839387|NCT04019795|460029465|FG002|Overall Study|Physician Decision|1|||
127839388|NCT04019795|460029466|FG003|Overall Study|Physician Decision|0|||
127839389|NCT04019795|460029463|FG000|Overall Study|Adverse Event|1|||
127839390|NCT04019795|460029464|FG001|Overall Study|Adverse Event|0|||
127839391|NCT04019795|460029465|FG002|Overall Study|Adverse Event|0|||
127839392|NCT04019795|460029466|FG003|Overall Study|Adverse Event|0|||
127839393|NCT02168803|460029467|FG000|Overall Study|Lost to Follow-up|1|||
127839394|NCT02168803|460029468|FG001|Overall Study|Lost to Follow-up|0|||
127839395|NCT02168803|460029469|FG002|Overall Study|Lost to Follow-up|1|||
127839396|NCT02168803|460029467|FG000|Overall Study|Withdrawal by Subject|1|||
127839397|NCT02168803|460029468|FG001|Overall Study|Withdrawal by Subject|1|||
127839398|NCT02168803|460029469|FG002|Overall Study|Withdrawal by Subject|2|||
127839399|NCT02168803|460029467|FG000|Overall Study|Physician Decision|0|||
127839400|NCT02168803|460029468|FG001|Overall Study|Physician Decision|1|||
127839401|NCT02168803|460029469|FG002|Overall Study|Physician Decision|0|||
127898151|NCT00950807|460251566|FG000|Washout Period 1|Lack of Efficacy|0|||
127839402|NCT02168803|460029467|FG000|Overall Study|Adverse Event|0|||
127839403|NCT02168803|460029468|FG001|Overall Study|Adverse Event|1|||
127839404|NCT02168803|460029469|FG002|Overall Study|Adverse Event|1|||
127839405|NCT02168803|460029467|FG000|Overall Study|Death|0|||
127839406|NCT02168803|460029468|FG001|Overall Study|Death|0|||
127839407|NCT02168803|460029469|FG002|Overall Study|Death|1|||
127839408|NCT02168803|460029467|FG000|Overall Study|Sponsor Decision|0|||
127839409|NCT02168803|460029468|FG001|Overall Study|Sponsor Decision|0|||
127839410|NCT02168803|460029469|FG002|Overall Study|Sponsor Decision|1|||
127839411|NCT01114373|460029470|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
127839412|NCT01114373|460029471|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
127898152|NCT00950807|460251567|FG001|Washout Period 1|Lack of Efficacy|0|||
127839413|NCT01114373|460029470|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
127839414|NCT01114373|460029471|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
127898153|NCT00950807|460251568|FG002|Washout Period 1|Lack of Efficacy|0|||
127898154|NCT00950807|460251569|FG003|Washout Period 1|Lack of Efficacy|0|||
127898155|NCT00950807|460251570|FG004|Washout Period 1|Lack of Efficacy|0|||
127898156|NCT00950807|460251571|FG005|Washout Period 1|Lack of Efficacy|0|||
127839415|NCT01114373|460029470|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
127839416|NCT01114373|460029471|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
127839417|NCT01114373|460029470|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
127898157|NCT00950807|460251572|FG006|Washout Period 1|Lack of Efficacy|1|||
127839418|NCT01114373|460029471|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
127839419|NCT01107405|460029476|FG000|Overall Study|Adverse Event|1|||
127839420|NCT01107405|460029477|FG001|Overall Study|Adverse Event|1|||
127898158|NCT00950807|460251573|FG007|Washout Period 1|Lack of Efficacy|0|||
127898159|NCT00950807|460251574|FG008|Washout Period 1|Lack of Efficacy|0|||
127898160|NCT00950807|460251575|FG009|Washout Period 1|Lack of Efficacy|0|||
127839421|NCT01107405|460029478|FG002|Overall Study|Adverse Event|0|||
127839422|NCT01107405|460029479|FG003|Overall Study|Adverse Event|0|||
127839423|NCT01107405|460029480|FG004|Overall Study|Adverse Event|2|||
127839424|NCT01107405|460029476|FG000|Overall Study|Withdrawal by Subject|1|||
127839425|NCT01107405|460029477|FG001|Overall Study|Withdrawal by Subject|0|||
127898161|NCT00950807|460251566|FG000|Washout Period 1|Withdrawal by Subject|0|||
127898162|NCT00950807|460251567|FG001|Washout Period 1|Withdrawal by Subject|0|||
127898163|NCT00950807|460251568|FG002|Washout Period 1|Withdrawal by Subject|0|||
127898164|NCT00950807|460251569|FG003|Washout Period 1|Withdrawal by Subject|0|||
127839426|NCT01107405|460029478|FG002|Overall Study|Withdrawal by Subject|1|||
127839427|NCT01107405|460029479|FG003|Overall Study|Withdrawal by Subject|2|||
127839428|NCT01107405|460029480|FG004|Overall Study|Withdrawal by Subject|1|||
127839429|NCT01107405|460029476|FG000|Overall Study|Protocol Violation|0|||
127839430|NCT01107405|460029477|FG001|Overall Study|Protocol Violation|0|||
127839431|NCT01107405|460029478|FG002|Overall Study|Protocol Violation|1|||
127839432|NCT01107405|460029479|FG003|Overall Study|Protocol Violation|1|||
127898165|NCT00950807|460251570|FG004|Washout Period 1|Withdrawal by Subject|0|||
127898166|NCT00950807|460251571|FG005|Washout Period 1|Withdrawal by Subject|0|||
127898167|NCT00950807|460251572|FG006|Washout Period 1|Withdrawal by Subject|0|||
127898168|NCT00950807|460251573|FG007|Washout Period 1|Withdrawal by Subject|0|||
127898169|NCT00950807|460251574|FG008|Washout Period 1|Withdrawal by Subject|1|||
127898170|NCT00950807|460251575|FG009|Washout Period 1|Withdrawal by Subject|0|||
127898171|NCT00950807|460251566|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
127898172|NCT00950807|460251567|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
127898173|NCT00950807|460251568|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
127898174|NCT00950807|460251569|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
127898175|NCT00950807|460251570|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
127898176|NCT00950807|460251571|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
127898177|NCT00950807|460251572|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
127898178|NCT00950807|460251573|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
127898179|NCT00950807|460251574|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
127898180|NCT00950807|460251575|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
127898181|NCT00950807|460251566|FG000|Washout Period 1|Adverse Event|2|||
127898182|NCT00950807|460251567|FG001|Washout Period 1|Adverse Event|0|||
127839433|NCT01107405|460029480|FG004|Overall Study|Protocol Violation|0|||
127839434|NCT01895452|460029484|FG000|Overall Study|Adverse Event|1|||
127839435|NCT01895452|460029485|FG001|Overall Study|Adverse Event|4|||
127839436|NCT01895452|460029484|FG000|Overall Study|Lost to Follow-up|1|||
127839437|NCT01895452|460029485|FG001|Overall Study|Lost to Follow-up|5|||
127839438|NCT01895452|460029484|FG000|Overall Study|Pregnancy|0|||
127839439|NCT01895452|460029485|FG001|Overall Study|Pregnancy|1|||
127839440|NCT01895452|460029484|FG000|Overall Study|Withdrawal by Subject|2|||
127839441|NCT01895452|460029485|FG001|Overall Study|Withdrawal by Subject|14|||
127839442|NCT01895452|460029484|FG000|Overall Study|Underlying disease|0|||
127839443|NCT01895452|460029485|FG001|Overall Study|Underlying disease|3|||
127898183|NCT00950807|460251568|FG002|Washout Period 1|Adverse Event|0|||
127898184|NCT00950807|460251569|FG003|Washout Period 1|Adverse Event|1|||
127898185|NCT00950807|460251570|FG004|Washout Period 1|Adverse Event|1|||
127898186|NCT00950807|460251571|FG005|Washout Period 1|Adverse Event|0|||
127898187|NCT00950807|460251572|FG006|Washout Period 1|Adverse Event|0|||
127898188|NCT00950807|460251573|FG007|Washout Period 1|Adverse Event|0|||
127839444|NCT01895452|460029484|FG000|Overall Study|Noncompliance with study drug|0|||
127839445|NCT01895452|460029485|FG001|Overall Study|Noncompliance with study drug|1|||
127898189|NCT00950807|460251574|FG008|Washout Period 1|Adverse Event|0|||
127898190|NCT00950807|460251575|FG009|Washout Period 1|Adverse Event|0|||
127839446|NCT01653158|460029486|FG000|Overall Study|Death|0|||
127839447|NCT01653158|460029487|FG001|Overall Study|Death|0|||
127839448|NCT01653158|460029488|FG002|Overall Study|Death|0|||
127839449|NCT01653158|460029489|FG003|Overall Study|Death|1|||
127839450|NCT01653158|460029490|FG004|Overall Study|Death|0|||
127839451|NCT01653158|460029491|FG005|Overall Study|Death|0|||
127839452|NCT01653158|460029492|FG006|Overall Study|Death|0|||
127839453|NCT01653158|460029493|FG007|Overall Study|Death|2|||
127839454|NCT01653158|460029486|FG000|Overall Study|Adverse Event|0|||
127839455|NCT01653158|460029487|FG001|Overall Study|Adverse Event|0|||
127839456|NCT01653158|460029488|FG002|Overall Study|Adverse Event|0|||
127839457|NCT01653158|460029489|FG003|Overall Study|Adverse Event|1|||
127839458|NCT01653158|460029490|FG004|Overall Study|Adverse Event|0|||
127839459|NCT01653158|460029491|FG005|Overall Study|Adverse Event|0|||
127839460|NCT01653158|460029492|FG006|Overall Study|Adverse Event|0|||
127839461|NCT01653158|460029493|FG007|Overall Study|Adverse Event|3|||
127839462|NCT01653158|460029486|FG000|Overall Study|Other|0|||
127839463|NCT01653158|460029487|FG001|Overall Study|Other|0|||
127839464|NCT01653158|460029488|FG002|Overall Study|Other|0|||
127839465|NCT01653158|460029489|FG003|Overall Study|Other|0|||
127839466|NCT01653158|460029490|FG004|Overall Study|Other|0|||
127839467|NCT01653158|460029491|FG005|Overall Study|Other|0|||
127839468|NCT01653158|460029492|FG006|Overall Study|Other|0|||
127839469|NCT01653158|460029493|FG007|Overall Study|Other|1|||
127839470|NCT01653158|460029486|FG000|Overall Study|Progressive disease|0|||
127839471|NCT01653158|460029487|FG001|Overall Study|Progressive disease|0|||
127839472|NCT01653158|460029488|FG002|Overall Study|Progressive disease|0|||
127839473|NCT01653158|460029489|FG003|Overall Study|Progressive disease|0|||
127839474|NCT01653158|460029490|FG004|Overall Study|Progressive disease|1|||
127839475|NCT01653158|460029491|FG005|Overall Study|Progressive disease|1|||
127839476|NCT01653158|460029492|FG006|Overall Study|Progressive disease|2|||
127839477|NCT01653158|460029493|FG007|Overall Study|Progressive disease|9|||
127839478|NCT01653158|460029486|FG000|Overall Study|Withdrawal by Subject|1|||
127839479|NCT01653158|460029487|FG001|Overall Study|Withdrawal by Subject|0|||
127839480|NCT01653158|460029488|FG002|Overall Study|Withdrawal by Subject|0|||
127839481|NCT01653158|460029489|FG003|Overall Study|Withdrawal by Subject|0|||
127839482|NCT01653158|460029490|FG004|Overall Study|Withdrawal by Subject|0|||
127839483|NCT01653158|460029491|FG005|Overall Study|Withdrawal by Subject|0|||
127839484|NCT01653158|460029492|FG006|Overall Study|Withdrawal by Subject|0|||
127839485|NCT01653158|460029493|FG007|Overall Study|Withdrawal by Subject|0|||
127839486|NCT00980343|460029494|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
127839487|NCT00980343|460029495|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
127839488|NCT03444870|460029502|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
127839489|NCT03444870|460029503|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
127839490|NCT03444870|460029504|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
127839491|NCT03444870|460029505|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
127839492|NCT03444870|460029506|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
127839493|NCT03444870|460029507|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
127839494|NCT03444870|460029502|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
127839495|NCT03444870|460029503|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
127839496|NCT03444870|460029504|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
127839497|NCT03444870|460029505|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
127839498|NCT03444870|460029506|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
127839499|NCT03444870|460029507|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
127839500|NCT03444870|460029502|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
127839501|NCT03444870|460029503|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
127839502|NCT03444870|460029504|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
127839503|NCT03444870|460029505|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
127839504|NCT03444870|460029506|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
127839505|NCT03444870|460029507|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
127839506|NCT03444870|460029502|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
127839507|NCT03444870|460029503|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
127839508|NCT03444870|460029504|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
127839509|NCT03444870|460029505|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
127839510|NCT03444870|460029506|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
127839511|NCT03444870|460029507|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
127839512|NCT03444870|460029502|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
127839513|NCT03444870|460029503|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
127839514|NCT03444870|460029504|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
127839515|NCT03444870|460029505|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
127839516|NCT03444870|460029506|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
127839517|NCT03444870|460029507|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
127839518|NCT03444870|460029502|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
127839519|NCT03444870|460029503|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
127839520|NCT03444870|460029504|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
127839521|NCT03444870|460029505|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
127839522|NCT03444870|460029506|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
127839523|NCT03444870|460029507|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
127839524|NCT03444870|460029502|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
127839525|NCT03444870|460029503|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
127839526|NCT03444870|460029504|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
127839527|NCT03444870|460029505|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
127839528|NCT03444870|460029506|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
127839529|NCT03444870|460029507|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
127839530|NCT03444870|460029502|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
127839531|NCT03444870|460029503|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
127839532|NCT03444870|460029504|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
127839533|NCT03444870|460029505|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
127839534|NCT03444870|460029506|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
127839535|NCT03444870|460029507|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
127839536|NCT03444870|460029502|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
127839537|NCT03444870|460029503|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
127839538|NCT03444870|460029504|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
127839539|NCT03444870|460029505|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
127839540|NCT03444870|460029506|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
127839541|NCT03444870|460029507|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
127839542|NCT03444870|460029502|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
127839543|NCT03444870|460029503|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
127839544|NCT03444870|460029504|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
127839545|NCT03444870|460029505|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
127839546|NCT03444870|460029506|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
127839547|NCT03444870|460029507|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
127839548|NCT03444870|460029502|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
127839549|NCT03444870|460029503|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
127839550|NCT03444870|460029504|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
127839551|NCT03444870|460029505|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
127839552|NCT03444870|460029506|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
127839553|NCT03444870|460029507|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
127839554|NCT03444870|460029502|FG000|Open-Label Extension (OLE) Period|Death|0|||
127839555|NCT03444870|460029503|FG001|Open-Label Extension (OLE) Period|Death|0|||
127839556|NCT03444870|460029504|FG002|Open-Label Extension (OLE) Period|Death|0|||
127839557|NCT03444870|460029505|FG003|Open-Label Extension (OLE) Period|Death|0|||
127839558|NCT03444870|460029506|FG004|Open-Label Extension (OLE) Period|Death|1|||
127839559|NCT03444870|460029507|FG005|Open-Label Extension (OLE) Period|Death|0|||
127839560|NCT01205451|460029510|FG000|Overall Study|Lost to Follow-up|1|||
127839561|NCT01205451|460029511|FG001|Overall Study|Lost to Follow-up|1|||
127839562|NCT01205451|460029510|FG000|Overall Study|Withdrawal by Subject|5|||
127839563|NCT01205451|460029511|FG001|Overall Study|Withdrawal by Subject|9|||
127839564|NCT01194869|460029512|FG000|Overall Study|Disease Progression|2|||
127839565|NCT01194869|460029512|FG000|Overall Study|Toxicity|2|||
127839566|NCT03084718|460029516|FG000|Overall Study|Withdrawal by Subject|4|||
127839567|NCT03084718|460029517|FG001|Overall Study|Withdrawal by Subject|3|||
127839568|NCT03084718|460029518|FG002|Overall Study|Withdrawal by Subject|4|||
127839569|NCT03084718|460029519|FG003|Overall Study|Withdrawal by Subject|0|||
127839570|NCT03084718|460029520|FG004|Overall Study|Withdrawal by Subject|0|||
127839571|NCT03084718|460029516|FG000|Overall Study|Physician Decision|1|||
127839572|NCT03084718|460029517|FG001|Overall Study|Physician Decision|0|||
127839573|NCT03084718|460029518|FG002|Overall Study|Physician Decision|0|||
127839574|NCT03084718|460029519|FG003|Overall Study|Physician Decision|0|||
127839575|NCT03084718|460029520|FG004|Overall Study|Physician Decision|0|||
127839576|NCT03084718|460029516|FG000|Overall Study|Adverse Event|3|||
127839577|NCT03084718|460029517|FG001|Overall Study|Adverse Event|5|||
127839578|NCT03084718|460029518|FG002|Overall Study|Adverse Event|5|||
127839579|NCT03084718|460029519|FG003|Overall Study|Adverse Event|8|||
127839580|NCT03084718|460029520|FG004|Overall Study|Adverse Event|2|||
127839581|NCT03084718|460029516|FG000|Overall Study|Lack of Efficacy|2|||
127839582|NCT03084718|460029517|FG001|Overall Study|Lack of Efficacy|0|||
127839583|NCT03084718|460029518|FG002|Overall Study|Lack of Efficacy|1|||
127839584|NCT03084718|460029519|FG003|Overall Study|Lack of Efficacy|4|||
127839585|NCT03084718|460029520|FG004|Overall Study|Lack of Efficacy|0|||
127839586|NCT03084718|460029516|FG000|Overall Study|Lost to Follow-up|0|||
127839587|NCT03084718|460029517|FG001|Overall Study|Lost to Follow-up|1|||
127839588|NCT03084718|460029518|FG002|Overall Study|Lost to Follow-up|0|||
127839589|NCT03084718|460029519|FG003|Overall Study|Lost to Follow-up|0|||
127839590|NCT03084718|460029520|FG004|Overall Study|Lost to Follow-up|2|||
127839591|NCT03084718|460029516|FG000|Overall Study|Protocol Violation|0|||
127839592|NCT03084718|460029517|FG001|Overall Study|Protocol Violation|0|||
127839593|NCT03084718|460029518|FG002|Overall Study|Protocol Violation|1|||
127839594|NCT03084718|460029519|FG003|Overall Study|Protocol Violation|0|||
127839595|NCT03084718|460029520|FG004|Overall Study|Protocol Violation|0|||
127839596|NCT03084718|460029516|FG000|Overall Study|Death|0|||
127839597|NCT03084718|460029517|FG001|Overall Study|Death|1|||
127839598|NCT03084718|460029518|FG002|Overall Study|Death|0|||
127839599|NCT03084718|460029519|FG003|Overall Study|Death|0|||
127839600|NCT03084718|460029520|FG004|Overall Study|Death|0|||
127839601|NCT03084718|460029516|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
127839602|NCT03084718|460029517|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
127839603|NCT03084718|460029518|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
127839604|NCT03084718|460029519|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
127839605|NCT03084718|460029520|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
127839606|NCT01742078|460029521|FG000|Overall Study|Withdrawal by Subject|0|||
127839607|NCT01742078|460029522|FG001|Overall Study|Withdrawal by Subject|0|||
127839608|NCT01742078|460029523|FG002|Overall Study|Withdrawal by Subject|0|||
127839609|NCT01742078|460029524|FG003|Overall Study|Withdrawal by Subject|1|||
127839610|NCT01742078|460029525|FG004|Overall Study|Withdrawal by Subject|0|||
127839611|NCT01742078|460029526|FG005|Overall Study|Withdrawal by Subject|0|||
127839612|NCT01742078|460029527|FG006|Overall Study|Withdrawal by Subject|0|||
127839613|NCT01742078|460029528|FG007|Overall Study|Withdrawal by Subject|0|||
127839614|NCT01742078|460029529|FG008|Overall Study|Withdrawal by Subject|0|||
127839615|NCT00084929|460029530|FG000|Overall Study|ineligible - medical contraindication|1|||
127839616|NCT00084929|460029530|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
127839617|NCT00084929|460029530|FG000|Overall Study|Ineligible - Medical history|6|||
127839618|NCT00084929|460029530|FG000|Overall Study|Withdrawal by Subject|10|||
127839619|NCT00084929|460029530|FG000|Overall Study|Missing/incomplete CTC exam|9|||
127839620|NCT00084929|460029530|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
127839621|NCT03247413|460029532|FG000|Overall Study|Lost to Follow-up|28|||
127839622|NCT00424294|460029533|FG000|Overall Study|Adverse Event|4|||
127839623|NCT00424294|460029534|FG001|Overall Study|Adverse Event|10|||
127839624|NCT00424294|460029533|FG000|Overall Study|Lack of Efficacy|2|||
127839625|NCT00424294|460029534|FG001|Overall Study|Lack of Efficacy|1|||
127839626|NCT00424294|460029533|FG000|Overall Study|Withdrawal by Subject|1|||
127839627|NCT00424294|460029534|FG001|Overall Study|Withdrawal by Subject|2|||
127839628|NCT00424294|460029533|FG000|Overall Study|Other|0|||
127839629|NCT00424294|460029534|FG001|Overall Study|Other|2|||
127839630|NCT00424294|460029533|FG000|Overall Study|Randomized but not Treated|1|||
127839631|NCT00424294|460029534|FG001|Overall Study|Randomized but not Treated|0|||
127839632|NCT04397718|460029535|FG000|Overall Study|Death|7|||
127839633|NCT04397718|460029536|FG001|Overall Study|Death|11|||
127839634|NCT04397718|460029535|FG000|Overall Study|Lost to Follow-up|0|||
127839635|NCT04397718|460029536|FG001|Overall Study|Lost to Follow-up|4|||
127839636|NCT01797965|460029537|FG000|Overall Study|Adverse Event|104|||
127839637|NCT01797965|460029538|FG001|Overall Study|Adverse Event|129|||
127839638|NCT01797965|460029539|FG002|Overall Study|Adverse Event|4|||
127839639|NCT01797965|460029540|FG003|Overall Study|Adverse Event|21|||
127839640|NCT01797965|460029537|FG000|Overall Study|Lost to Follow-up|9|||
127839641|NCT01797965|460029538|FG001|Overall Study|Lost to Follow-up|8|||
127839642|NCT01797965|460029539|FG002|Overall Study|Lost to Follow-up|1|||
127839643|NCT01797965|460029540|FG003|Overall Study|Lost to Follow-up|2|||
127839644|NCT01797965|460029537|FG000|Overall Study|Consent withdrawn|130|||
127839645|NCT01797965|460029538|FG001|Overall Study|Consent withdrawn|117|||
127839646|NCT01797965|460029539|FG002|Overall Study|Consent withdrawn|3|||
127839647|NCT01797965|460029540|FG003|Overall Study|Consent withdrawn|35|||
127839648|NCT01797965|460029537|FG000|Overall Study|Investigator decision|21|||
127839649|NCT01797965|460029538|FG001|Overall Study|Investigator decision|15|||
127839650|NCT01797965|460029539|FG002|Overall Study|Investigator decision|0|||
127839651|NCT01797965|460029540|FG003|Overall Study|Investigator decision|0|||
127839652|NCT01797965|460029537|FG000|Overall Study|Death|2|||
127839653|NCT01797965|460029538|FG001|Overall Study|Death|4|||
127839654|NCT01797965|460029539|FG002|Overall Study|Death|0|||
127839655|NCT01797965|460029540|FG003|Overall Study|Death|0|||
127839656|NCT01797965|460029537|FG000|Overall Study|Disease progression, defined by protocol|3|||
127839657|NCT01797965|460029538|FG001|Overall Study|Disease progression, defined by protocol|1|||
127839658|NCT01797965|460029539|FG002|Overall Study|Disease progression, defined by protocol|0|||
127839659|NCT01797965|460029540|FG003|Overall Study|Disease progression, defined by protocol|0|||
127839660|NCT01797965|460029537|FG000|Overall Study|Reason Not Specified|280|||
127839661|NCT01797965|460029538|FG001|Overall Study|Reason Not Specified|295|||
127839662|NCT01797965|460029539|FG002|Overall Study|Reason Not Specified|0|||
127839663|NCT01797965|460029540|FG003|Overall Study|Reason Not Specified|15|||
127839664|NCT02670330|460029542|FG000|Overall Study|Protocol Deviation|1|||
127839665|NCT02670330|460029543|FG001|Overall Study|Protocol Deviation|0|||
127839666|NCT02670330|460029542|FG000|Overall Study|Study Terminated By Sponsor|36|||
127839667|NCT02670330|460029543|FG001|Overall Study|Study Terminated By Sponsor|43|||
127839668|NCT02670330|460029542|FG000|Overall Study|Adverse Event|1|||
127839669|NCT02670330|460029543|FG001|Overall Study|Adverse Event|3|||
127839670|NCT02670330|460029542|FG000|Overall Study|Withdrawal by Subject|34|||
127839671|NCT02670330|460029543|FG001|Overall Study|Withdrawal by Subject|29|||
127839672|NCT02670330|460029542|FG000|Overall Study|Lost to Follow-up|3|||
127839673|NCT02670330|460029543|FG001|Overall Study|Lost to Follow-up|2|||
127839674|NCT04404010|460029544|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
127839675|NCT04404010|460029545|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
127839676|NCT02120157|460029546|FG000|Overall Study|Death|8|||
127839677|NCT00441103|460029550|FG000|Overall Study|Adverse Event|2|||
127839678|NCT00441103|460029551|FG001|Overall Study|Adverse Event|1|||
127839679|NCT00441103|460029550|FG000|Overall Study|Death|1|||
127839680|NCT00441103|460029551|FG001|Overall Study|Death|0|||
127839681|NCT00441103|460029550|FG000|Overall Study|Disease Progression|2|||
127839682|NCT00441103|460029551|FG001|Overall Study|Disease Progression|0|||
127839683|NCT00441103|460029550|FG000|Overall Study|Lost to Follow-up|1|||
127839684|NCT00441103|460029551|FG001|Overall Study|Lost to Follow-up|0|||
127839685|NCT00441103|460029550|FG000|Overall Study|Protocol Violation|1|||
127839686|NCT00441103|460029551|FG001|Overall Study|Protocol Violation|0|||
127839687|NCT00441103|460029550|FG000|Overall Study|Participant unable to use Rebiject II|1|||
127839688|NCT00441103|460029551|FG001|Overall Study|Participant unable to use Rebiject II|0|||
127839689|NCT00441103|460029550|FG000|Overall Study|Participant refused MRI|1|||
127839690|NCT00441103|460029551|FG001|Overall Study|Participant refused MRI|0|||
127839691|NCT00441103|460029550|FG000|Overall Study|Inclusion criteria absent|1|||
127839692|NCT00441103|460029551|FG001|Overall Study|Inclusion criteria absent|0|||
127839693|NCT00441103|460029550|FG000|Overall Study|Non-compliant|0|||
127839694|NCT00441103|460029551|FG001|Overall Study|Non-compliant|1|||
127839695|NCT00441103|460029550|FG000|Overall Study|Participant decided to withdraw|1|||
127839696|NCT00441103|460029551|FG001|Overall Study|Participant decided to withdraw|0|||
127839697|NCT00441103|460029550|FG000|Overall Study|Participant's reason|0|||
127839698|NCT00441103|460029551|FG001|Overall Study|Participant's reason|1|||
127839699|NCT00441103|460029550|FG000|Overall Study|Participant decided to stop|0|||
127839700|NCT00441103|460029551|FG001|Overall Study|Participant decided to stop|1|||
127839701|NCT00239837|460029554|FG000|Overall Study|Lost to Follow-up|3|||
127839702|NCT00239837|460029555|FG001|Overall Study|Lost to Follow-up|7|||
127839703|NCT01153893|460029556|FG000|Overall Study|Adverse Event|1|||
127839704|NCT01153893|460029557|FG001|Overall Study|Adverse Event|0|||
127839705|NCT01838590|460029558|FG000|Overall Study|Lack of Efficacy|12|||
127839706|NCT01838590|460029559|FG001|Overall Study|Lack of Efficacy|4|||
127839707|NCT01838590|460029558|FG000|Overall Study|Lost to Follow-up|0|||
127839708|NCT01838590|460029559|FG001|Overall Study|Lost to Follow-up|1|||
127839709|NCT01354431|460029560|FG000|Pre-Treatment Period|Not reported|1|||
127839710|NCT01354431|460029561|FG001|Pre-Treatment Period|Not reported|0|||
127839711|NCT01354431|460029562|FG002|Pre-Treatment Period|Not reported|0|||
127839712|NCT01354431|460029560|FG000|Treatment Period|Disease Progression|50|||
127839713|NCT01354431|460029561|FG001|Treatment Period|Disease Progression|40|||
127839714|NCT01354431|460029562|FG002|Treatment Period|Disease Progression|44|||
127839715|NCT01354431|460029560|FG000|Treatment Period|Study Drug Toxicity|5|||
127839716|NCT01354431|460029561|FG001|Treatment Period|Study Drug Toxicity|8|||
127839717|NCT01354431|460029562|FG002|Treatment Period|Study Drug Toxicity|4|||
127839718|NCT01354431|460029560|FG000|Treatment Period|Death|0|||
127839719|NCT01354431|460029561|FG001|Treatment Period|Death|1|||
127839720|NCT01354431|460029562|FG002|Treatment Period|Death|0|||
127839721|NCT01354431|460029560|FG000|Treatment Period|AE unrelated to study drug|1|||
127839722|NCT01354431|460029561|FG001|Treatment Period|AE unrelated to study drug|2|||
127839723|NCT01354431|460029562|FG002|Treatment Period|AE unrelated to study drug|5|||
127839724|NCT01354431|460029560|FG000|Treatment Period|Participant request to discontinue|2|||
127839725|NCT01354431|460029561|FG001|Treatment Period|Participant request to discontinue|2|||
127839726|NCT01354431|460029562|FG002|Treatment Period|Participant request to discontinue|1|||
127839727|NCT01354431|460029560|FG000|Treatment Period|Participant withdrew consent|0|||
127839728|NCT01354431|460029561|FG001|Treatment Period|Participant withdrew consent|1|||
127839729|NCT01354431|460029562|FG002|Treatment Period|Participant withdrew consent|0|||
127839730|NCT01354431|460029560|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
127839731|NCT01354431|460029561|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
127839732|NCT01354431|460029562|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
127839733|NCT00536978|460029563|FG000|Overall Study|Not eligible for Adback Infusion|22|||
127839734|NCT03550131|460029565|FG000|Overall Study|Lost to Follow-up|16|||
127839735|NCT03550131|460029566|FG001|Overall Study|Lost to Follow-up|24|||
127839736|NCT03550131|460029565|FG000|Overall Study|Withdrawal by Subject|36|||
127839737|NCT03550131|460029566|FG001|Overall Study|Withdrawal by Subject|28|||
127839738|NCT03550131|460029565|FG000|Overall Study|Illness of dyad member|10|||
127839739|NCT03550131|460029566|FG001|Overall Study|Illness of dyad member|2|||
127976404|NCT04598451|460536124|FG001|Overall Study|Physician Decision|1|||
127898191|NCT00950807|460251566|FG000|Treatment Period 2|Lack of Efficacy|1|||
127898192|NCT00950807|460251567|FG001|Treatment Period 2|Lack of Efficacy|0|||
127898193|NCT00950807|460251568|FG002|Treatment Period 2|Lack of Efficacy|0|||
127898194|NCT00950807|460251569|FG003|Treatment Period 2|Lack of Efficacy|0|||
127898195|NCT00950807|460251570|FG004|Treatment Period 2|Lack of Efficacy|0|||
127898196|NCT00950807|460251571|FG005|Treatment Period 2|Lack of Efficacy|0|||
127898197|NCT00950807|460251572|FG006|Treatment Period 2|Lack of Efficacy|0|||
127898198|NCT00950807|460251573|FG007|Treatment Period 2|Lack of Efficacy|0|||
127898199|NCT00950807|460251574|FG008|Treatment Period 2|Lack of Efficacy|0|||
127898200|NCT00950807|460251575|FG009|Treatment Period 2|Lack of Efficacy|0|||
127898201|NCT00950807|460251566|FG000|Treatment Period 2|Withdrawal by Subject|0|||
127898202|NCT00950807|460251567|FG001|Treatment Period 2|Withdrawal by Subject|0|||
127898203|NCT00950807|460251568|FG002|Treatment Period 2|Withdrawal by Subject|0|||
127839740|NCT03550131|460029565|FG000|Overall Study|Death of person with dementia|4|||
127839741|NCT03550131|460029566|FG001|Overall Study|Death of person with dementia|8|||
127839742|NCT01318512|460029567|FG000|Maintenance Period (6 Months)|Death|2|||
127839743|NCT01318512|460029567|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
127839744|NCT00878215|460029569|FG000|Overall Study|Determined to be ineligible|0|||
127839745|NCT00878215|460029570|FG001|Overall Study|Determined to be ineligible|10|||
127839746|NCT00878215|460029571|FG002|Overall Study|Determined to be ineligible|0|||
127839747|NCT00878215|460029572|FG003|Overall Study|Determined to be ineligible|0|||
127839748|NCT01364233|460029573|FG000|Overall Study|Lost to Follow-up|1|||
127839749|NCT00302718|460029575|FG000|Overall Study|Participant left the hospital|1|||
127839750|NCT00302718|460029576|FG001|Overall Study|Participant left the hospital|0|||
127839751|NCT00302718|460029577|FG002|Overall Study|Participant left the hospital|0|||
127839752|NCT00302718|460029578|FG003|Overall Study|Participant left the hospital|1|||
127839753|NCT00302718|460029575|FG000|Overall Study|Withdrawal by Subject|0|||
127839754|NCT00302718|460029576|FG001|Overall Study|Withdrawal by Subject|1|||
127839755|NCT00302718|460029577|FG002|Overall Study|Withdrawal by Subject|0|||
127839756|NCT00302718|460029578|FG003|Overall Study|Withdrawal by Subject|0|||
127839757|NCT00302718|460029575|FG000|Overall Study|Participant left primary care setting|0|||
127839758|NCT00302718|460029576|FG001|Overall Study|Participant left primary care setting|0|||
127839759|NCT00302718|460029577|FG002|Overall Study|Participant left primary care setting|2|||
127839760|NCT00302718|460029578|FG003|Overall Study|Participant left primary care setting|1|||
127839761|NCT00819585|460029579|FG000|Core Study|Adverse Event|2|||
127839762|NCT00819585|460029580|FG001|Core Study|Adverse Event|1|||
127839763|NCT00819585|460029581|FG002|Core Study|Adverse Event|1|||
127839764|NCT00819585|460029582|FG003|Core Study|Adverse Event|4|||
127839765|NCT00819585|460029583|FG004|Core Study|Adverse Event|1|||
127839766|NCT00819585|460029584|FG005|Core Study|Adverse Event|0|||
127839767|NCT00819585|460029585|FG006|Core Study|Adverse Event|2|||
127839768|NCT00819585|460029586|FG007|Core Study|Adverse Event|0|||
127839769|NCT00819585|460029587|FG008|Core Study|Adverse Event|0|||
127839770|NCT00819585|460029588|FG009|Core Study|Adverse Event|0|||
127839771|NCT00819585|460029589|FG010|Core Study|Adverse Event|0|||
127839772|NCT00819585|460029579|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
127839773|NCT00819585|460029580|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
127839774|NCT00819585|460029581|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
127839775|NCT00819585|460029582|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
127839776|NCT00819585|460029583|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
127839777|NCT00819585|460029584|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
127839778|NCT00819585|460029585|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
127839779|NCT00819585|460029586|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
127839780|NCT00819585|460029587|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
127839781|NCT00819585|460029588|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
127839782|NCT00819585|460029589|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
127839783|NCT00819585|460029579|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
127839784|NCT00819585|460029580|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
127839785|NCT00819585|460029581|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
127839786|NCT00819585|460029582|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
127839787|NCT00819585|460029583|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
127839788|NCT00819585|460029584|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
127839789|NCT00819585|460029585|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
127839790|NCT00819585|460029586|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
127839791|NCT00819585|460029587|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
127839792|NCT00819585|460029588|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
127839793|NCT00819585|460029589|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
127839794|NCT00819585|460029579|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
127839795|NCT00819585|460029580|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
127839796|NCT00819585|460029581|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
127839797|NCT00819585|460029582|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
127839798|NCT00819585|460029583|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
127839799|NCT00819585|460029584|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
127839800|NCT00819585|460029585|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
127839801|NCT00819585|460029586|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
127839802|NCT00819585|460029587|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
127839803|NCT00819585|460029588|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
127839804|NCT00819585|460029589|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
127839805|NCT00819585|460029579|FG000|Core Study|Subject Withdrew Consent|0|||
127839806|NCT00819585|460029580|FG001|Core Study|Subject Withdrew Consent|3|||
127839807|NCT00819585|460029581|FG002|Core Study|Subject Withdrew Consent|2|||
127839808|NCT00819585|460029582|FG003|Core Study|Subject Withdrew Consent|1|||
127839809|NCT00819585|460029583|FG004|Core Study|Subject Withdrew Consent|0|||
127839810|NCT00819585|460029584|FG005|Core Study|Subject Withdrew Consent|0|||
127839811|NCT00819585|460029585|FG006|Core Study|Subject Withdrew Consent|3|||
127839812|NCT00819585|460029586|FG007|Core Study|Subject Withdrew Consent|0|||
127839813|NCT00819585|460029587|FG008|Core Study|Subject Withdrew Consent|0|||
127898204|NCT00950807|460251569|FG003|Treatment Period 2|Withdrawal by Subject|0|||
127898205|NCT00950807|460251570|FG004|Treatment Period 2|Withdrawal by Subject|0|||
127898206|NCT00950807|460251571|FG005|Treatment Period 2|Withdrawal by Subject|0|||
127898207|NCT00950807|460251572|FG006|Treatment Period 2|Withdrawal by Subject|1|||
127898208|NCT00950807|460251573|FG007|Treatment Period 2|Withdrawal by Subject|2|||
127898209|NCT00950807|460251574|FG008|Treatment Period 2|Withdrawal by Subject|0|||
127898210|NCT00950807|460251575|FG009|Treatment Period 2|Withdrawal by Subject|0|||
127898211|NCT00950807|460251566|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
127898212|NCT00950807|460251567|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
127898213|NCT00950807|460251568|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
127898214|NCT00950807|460251569|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
127898215|NCT00950807|460251570|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
127898216|NCT00950807|460251571|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
127898217|NCT00950807|460251572|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
127898218|NCT00950807|460251573|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
127898219|NCT00950807|460251574|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
127898220|NCT00950807|460251575|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
127898221|NCT00950807|460251566|FG000|Treatment Period 2|Adverse Event|0|||
127898222|NCT00950807|460251567|FG001|Treatment Period 2|Adverse Event|1|||
127898223|NCT00950807|460251568|FG002|Treatment Period 2|Adverse Event|0|||
127898224|NCT00950807|460251569|FG003|Treatment Period 2|Adverse Event|1|||
127898225|NCT00950807|460251570|FG004|Treatment Period 2|Adverse Event|0|||
127898226|NCT00950807|460251571|FG005|Treatment Period 2|Adverse Event|1|||
127898227|NCT00950807|460251572|FG006|Treatment Period 2|Adverse Event|0|||
127898228|NCT00950807|460251573|FG007|Treatment Period 2|Adverse Event|1|||
127898229|NCT00950807|460251574|FG008|Treatment Period 2|Adverse Event|0|||
127898230|NCT00950807|460251575|FG009|Treatment Period 2|Adverse Event|0|||
127898231|NCT00950807|460251566|FG000|Washout Period 2|Lack of Efficacy|1|||
127898232|NCT00950807|460251567|FG001|Washout Period 2|Lack of Efficacy|0|||
127898233|NCT00950807|460251568|FG002|Washout Period 2|Lack of Efficacy|0|||
127898234|NCT00950807|460251569|FG003|Washout Period 2|Lack of Efficacy|0|||
127898235|NCT00950807|460251570|FG004|Washout Period 2|Lack of Efficacy|0|||
127898236|NCT00950807|460251571|FG005|Washout Period 2|Lack of Efficacy|0|||
127898237|NCT00950807|460251572|FG006|Washout Period 2|Lack of Efficacy|0|||
127898238|NCT00950807|460251573|FG007|Washout Period 2|Lack of Efficacy|0|||
127898239|NCT00950807|460251574|FG008|Washout Period 2|Lack of Efficacy|0|||
127898240|NCT00950807|460251575|FG009|Washout Period 2|Lack of Efficacy|0|||
127898241|NCT00950807|460251566|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
127898242|NCT00950807|460251567|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
127898243|NCT00950807|460251568|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
127898244|NCT00950807|460251569|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
127898245|NCT00950807|460251570|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
127898246|NCT00950807|460251571|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
127898247|NCT00950807|460251572|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
127898248|NCT00950807|460251573|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
127898249|NCT00950807|460251574|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
127898250|NCT00950807|460251575|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
127898251|NCT00950807|460251566|FG000|Washout Period 2|Adverse Event|3|||
127898252|NCT00950807|460251567|FG001|Washout Period 2|Adverse Event|0|||
127898253|NCT00950807|460251568|FG002|Washout Period 2|Adverse Event|0|||
127898254|NCT00950807|460251569|FG003|Washout Period 2|Adverse Event|1|||
127898255|NCT00950807|460251570|FG004|Washout Period 2|Adverse Event|0|||
127898256|NCT00950807|460251571|FG005|Washout Period 2|Adverse Event|0|||
127898257|NCT00950807|460251572|FG006|Washout Period 2|Adverse Event|0|||
127898258|NCT00950807|460251573|FG007|Washout Period 2|Adverse Event|0|||
127898259|NCT00950807|460251574|FG008|Washout Period 2|Adverse Event|0|||
127898260|NCT00950807|460251575|FG009|Washout Period 2|Adverse Event|0|||
127898261|NCT00950807|460251566|FG000|Treatment Period 3|Withdrawal by Subject|0|||
127898262|NCT00950807|460251567|FG001|Treatment Period 3|Withdrawal by Subject|0|||
127898263|NCT00950807|460251568|FG002|Treatment Period 3|Withdrawal by Subject|0|||
127898264|NCT00950807|460251569|FG003|Treatment Period 3|Withdrawal by Subject|0|||
127898265|NCT00950807|460251570|FG004|Treatment Period 3|Withdrawal by Subject|0|||
127898266|NCT00950807|460251571|FG005|Treatment Period 3|Withdrawal by Subject|0|||
127898267|NCT00950807|460251572|FG006|Treatment Period 3|Withdrawal by Subject|0|||
127898268|NCT00950807|460251573|FG007|Treatment Period 3|Withdrawal by Subject|0|||
127898269|NCT00950807|460251574|FG008|Treatment Period 3|Withdrawal by Subject|0|||
127898270|NCT00950807|460251575|FG009|Treatment Period 3|Withdrawal by Subject|1|||
127898271|NCT00950807|460251566|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
127898272|NCT00950807|460251567|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
127898273|NCT00950807|460251568|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
127898274|NCT00950807|460251569|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
127898275|NCT00950807|460251570|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
127898276|NCT00950807|460251571|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
127898277|NCT00950807|460251572|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
127898278|NCT00950807|460251573|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
127898279|NCT00950807|460251574|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
127898280|NCT00950807|460251575|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
127898281|NCT00950807|460251566|FG000|Treatment Period 3|Adverse Event|0|||
127898282|NCT00950807|460251567|FG001|Treatment Period 3|Adverse Event|0|||
127898283|NCT00950807|460251568|FG002|Treatment Period 3|Adverse Event|0|||
127898284|NCT00950807|460251569|FG003|Treatment Period 3|Adverse Event|0|||
127898285|NCT00950807|460251570|FG004|Treatment Period 3|Adverse Event|0|||
127898286|NCT00950807|460251571|FG005|Treatment Period 3|Adverse Event|0|||
127898287|NCT00950807|460251572|FG006|Treatment Period 3|Adverse Event|1|||
127898288|NCT00950807|460251573|FG007|Treatment Period 3|Adverse Event|0|||
127898289|NCT00950807|460251574|FG008|Treatment Period 3|Adverse Event|0|||
127898290|NCT00950807|460251575|FG009|Treatment Period 3|Adverse Event|0|||
127898291|NCT00337077|460251576|FG000|Overall Study|Progressive disease|25|||
127898292|NCT00337077|460251577|FG001|Overall Study|Progressive disease|37|||
127898293|NCT00337077|460251578|FG002|Overall Study|Progressive disease|19|||
127898294|NCT00337077|460251576|FG000|Overall Study|Adverse Event|7|||
127898295|NCT00337077|460251577|FG001|Overall Study|Adverse Event|7|||
127898296|NCT00337077|460251578|FG002|Overall Study|Adverse Event|1|||
127898297|NCT00337077|460251576|FG000|Overall Study|Death|0|||
127898298|NCT00337077|460251577|FG001|Overall Study|Death|1|||
127898299|NCT00337077|460251578|FG002|Overall Study|Death|0|||
127898300|NCT00337077|460251576|FG000|Overall Study|Withdrawal by Subject|7|||
127898301|NCT00337077|460251577|FG001|Overall Study|Withdrawal by Subject|2|||
127898302|NCT00337077|460251578|FG002|Overall Study|Withdrawal by Subject|2|||
127898303|NCT00337077|460251576|FG000|Overall Study|Alternative therapy|1|||
127898304|NCT00337077|460251577|FG001|Overall Study|Alternative therapy|0|||
127898305|NCT00337077|460251578|FG002|Overall Study|Alternative therapy|0|||
127898306|NCT00337077|460251576|FG000|Overall Study|Physician Decision|1|||
127898307|NCT00337077|460251577|FG001|Overall Study|Physician Decision|4|||
127898308|NCT00337077|460251578|FG002|Overall Study|Physician Decision|2|||
127898309|NCT00337077|460251576|FG000|Overall Study|Never started treatment|1|||
127898310|NCT00337077|460251577|FG001|Overall Study|Never started treatment|1|||
127898311|NCT00337077|460251578|FG002|Overall Study|Never started treatment|0|||
127898312|NCT00337077|460251576|FG000|Overall Study|Ineligible|1|||
127898313|NCT00337077|460251577|FG001|Overall Study|Ineligible|1|||
127898314|NCT00337077|460251578|FG002|Overall Study|Ineligible|1|||
127898315|NCT02430870|460251591|FG000|Part 2|Voluntary Withdrawal|0|||
127898316|NCT02430870|460251592|FG001|Part 2|Voluntary Withdrawal|0|||
127898317|NCT02430870|460251593|FG002|Part 2|Voluntary Withdrawal|0|||
127898318|NCT02430870|460251594|FG003|Part 2|Voluntary Withdrawal|0|||
127898319|NCT02430870|460251595|FG004|Part 2|Voluntary Withdrawal|0|||
127898320|NCT02430870|460251596|FG005|Part 2|Voluntary Withdrawal|0|||
127898321|NCT02430870|460251597|FG006|Part 2|Voluntary Withdrawal|1|||
127898322|NCT02430870|460251598|FG007|Part 2|Voluntary Withdrawal|0|||
127898323|NCT02430870|460251591|FG000|Part 2|Other Reason Not Specified|0|||
127898324|NCT02430870|460251592|FG001|Part 2|Other Reason Not Specified|0|||
127898325|NCT02430870|460251593|FG002|Part 2|Other Reason Not Specified|0|||
127898326|NCT02430870|460251594|FG003|Part 2|Other Reason Not Specified|0|||
127898327|NCT02430870|460251595|FG004|Part 2|Other Reason Not Specified|0|||
127898328|NCT02430870|460251596|FG005|Part 2|Other Reason Not Specified|0|||
127898329|NCT02430870|460251597|FG006|Part 2|Other Reason Not Specified|0|||
127898330|NCT02430870|460251598|FG007|Part 2|Other Reason Not Specified|1|||
127898331|NCT01265784|460251599|FG000|Overall Study|Lost to Follow-up|5|||
127898332|NCT01265784|460251600|FG001|Overall Study|Lost to Follow-up|3|||
127898333|NCT01265784|460251601|FG002|Overall Study|Lost to Follow-up|2|||
127898334|NCT01265784|460251599|FG000|Overall Study|Withdrawal by Subject|0|||
127898335|NCT01265784|460251600|FG001|Overall Study|Withdrawal by Subject|5|||
127898336|NCT01265784|460251601|FG002|Overall Study|Withdrawal by Subject|0|||
127898337|NCT01265784|460251599|FG000|Overall Study|Physician Decision|1|||
127898338|NCT01265784|460251600|FG001|Overall Study|Physician Decision|0|||
127898339|NCT01265784|460251601|FG002|Overall Study|Physician Decision|1|||
127898340|NCT01265784|460251599|FG000|Overall Study|Adverse Event|1|||
127898341|NCT01265784|460251600|FG001|Overall Study|Adverse Event|0|||
127898342|NCT01265784|460251601|FG002|Overall Study|Adverse Event|0|||
127898343|NCT01265784|460251599|FG000|Overall Study|Death|3|||
127898344|NCT01265784|460251600|FG001|Overall Study|Death|0|||
127898345|NCT01265784|460251601|FG002|Overall Study|Death|0|||
127898346|NCT01265784|460251599|FG000|Overall Study|Protocol Violation|2|||
127898347|NCT01265784|460251600|FG001|Overall Study|Protocol Violation|0|||
127898348|NCT01265784|460251601|FG002|Overall Study|Protocol Violation|0|||
127898349|NCT01265784|460251599|FG000|Overall Study|Incorrectly Randomized|0|||
127898350|NCT01265784|460251600|FG001|Overall Study|Incorrectly Randomized|0|||
127839814|NCT00819585|460029588|FG009|Core Study|Subject Withdrew Consent|0|||
127839815|NCT00819585|460029589|FG010|Core Study|Subject Withdrew Consent|0|||
127839816|NCT00819585|460029579|FG000|Core Study|Lost to Follow-up|2|||
127839817|NCT00819585|460029580|FG001|Core Study|Lost to Follow-up|1|||
127839818|NCT00819585|460029581|FG002|Core Study|Lost to Follow-up|2|||
127839819|NCT00819585|460029582|FG003|Core Study|Lost to Follow-up|0|||
127839820|NCT00819585|460029583|FG004|Core Study|Lost to Follow-up|1|||
127839821|NCT00819585|460029584|FG005|Core Study|Lost to Follow-up|1|||
127839822|NCT00819585|460029585|FG006|Core Study|Lost to Follow-up|1|||
127839823|NCT00819585|460029586|FG007|Core Study|Lost to Follow-up|0|||
127839824|NCT00819585|460029587|FG008|Core Study|Lost to Follow-up|0|||
127839825|NCT00819585|460029588|FG009|Core Study|Lost to Follow-up|0|||
127839826|NCT00819585|460029589|FG010|Core Study|Lost to Follow-up|0|||
127839827|NCT00819585|460029579|FG000|Core Study|Administrative Problems|0|||
127839828|NCT00819585|460029580|FG001|Core Study|Administrative Problems|0|||
127839829|NCT00819585|460029581|FG002|Core Study|Administrative Problems|0|||
127839830|NCT00819585|460029582|FG003|Core Study|Administrative Problems|0|||
127839831|NCT00819585|460029583|FG004|Core Study|Administrative Problems|0|||
127839832|NCT00819585|460029584|FG005|Core Study|Administrative Problems|0|||
127839833|NCT00819585|460029585|FG006|Core Study|Administrative Problems|2|||
127839834|NCT00819585|460029586|FG007|Core Study|Administrative Problems|0|||
127839835|NCT00819585|460029587|FG008|Core Study|Administrative Problems|0|||
127839836|NCT00819585|460029588|FG009|Core Study|Administrative Problems|0|||
127839837|NCT00819585|460029589|FG010|Core Study|Administrative Problems|0|||
127839838|NCT00819585|460029579|FG000|Core Study|Death|0|||
127839839|NCT00819585|460029580|FG001|Core Study|Death|0|||
127839840|NCT00819585|460029581|FG002|Core Study|Death|0|||
127839841|NCT00819585|460029582|FG003|Core Study|Death|0|||
127839842|NCT00819585|460029583|FG004|Core Study|Death|0|||
127839843|NCT00819585|460029584|FG005|Core Study|Death|0|||
127839844|NCT00819585|460029585|FG006|Core Study|Death|1|||
127839845|NCT00819585|460029586|FG007|Core Study|Death|0|||
127839846|NCT00819585|460029587|FG008|Core Study|Death|0|||
127839847|NCT00819585|460029588|FG009|Core Study|Death|0|||
127839848|NCT00819585|460029589|FG010|Core Study|Death|0|||
127839849|NCT00819585|460029579|FG000|Core Study|Protocol Violation|0|||
127839850|NCT00819585|460029580|FG001|Core Study|Protocol Violation|0|||
127839851|NCT00819585|460029581|FG002|Core Study|Protocol Violation|1|||
127839852|NCT00819585|460029582|FG003|Core Study|Protocol Violation|0|||
127839853|NCT00819585|460029583|FG004|Core Study|Protocol Violation|0|||
127839854|NCT00819585|460029584|FG005|Core Study|Protocol Violation|1|||
127839855|NCT00819585|460029585|FG006|Core Study|Protocol Violation|3|||
127839856|NCT00819585|460029586|FG007|Core Study|Protocol Violation|0|||
127839857|NCT00819585|460029587|FG008|Core Study|Protocol Violation|0|||
127839858|NCT00819585|460029588|FG009|Core Study|Protocol Violation|0|||
127839859|NCT00819585|460029589|FG010|Core Study|Protocol Violation|0|||
127839860|NCT00819585|460029579|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
127839861|NCT00819585|460029580|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
127839862|NCT00819585|460029581|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
127839863|NCT00819585|460029582|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
127839864|NCT00819585|460029583|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
127839865|NCT00819585|460029584|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
127839866|NCT00819585|460029585|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
127839867|NCT00819585|460029586|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
127839868|NCT00819585|460029587|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
127839869|NCT00819585|460029588|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
127839870|NCT00819585|460029589|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
127839871|NCT00819585|460029579|FG000|Extension Study|Subject Withdrew Consent|0|||
127839872|NCT00819585|460029580|FG001|Extension Study|Subject Withdrew Consent|0|||
127839873|NCT00819585|460029581|FG002|Extension Study|Subject Withdrew Consent|0|||
127839874|NCT00819585|460029582|FG003|Extension Study|Subject Withdrew Consent|0|||
127839875|NCT00819585|460029583|FG004|Extension Study|Subject Withdrew Consent|0|||
127839876|NCT00819585|460029584|FG005|Extension Study|Subject Withdrew Consent|0|||
127839877|NCT00819585|460029585|FG006|Extension Study|Subject Withdrew Consent|0|||
127839878|NCT00819585|460029586|FG007|Extension Study|Subject Withdrew Consent|0|||
127839879|NCT00819585|460029587|FG008|Extension Study|Subject Withdrew Consent|3|||
127839880|NCT00819585|460029588|FG009|Extension Study|Subject Withdrew Consent|0|||
127839881|NCT00819585|460029589|FG010|Extension Study|Subject Withdrew Consent|1|||
127839882|NCT00819585|460029579|FG000|Extension Study|Lost to Follow-up|0|||
127898351|NCT01265784|460251601|FG002|Overall Study|Incorrectly Randomized|1|||
127839883|NCT00819585|460029580|FG001|Extension Study|Lost to Follow-up|0|||
127839884|NCT00819585|460029581|FG002|Extension Study|Lost to Follow-up|0|||
127839885|NCT00819585|460029582|FG003|Extension Study|Lost to Follow-up|0|||
127839886|NCT00819585|460029583|FG004|Extension Study|Lost to Follow-up|0|||
127839887|NCT00819585|460029584|FG005|Extension Study|Lost to Follow-up|0|||
127839888|NCT00819585|460029585|FG006|Extension Study|Lost to Follow-up|0|||
127839889|NCT00819585|460029586|FG007|Extension Study|Lost to Follow-up|0|||
127839890|NCT00819585|460029587|FG008|Extension Study|Lost to Follow-up|2|||
127839891|NCT00819585|460029588|FG009|Extension Study|Lost to Follow-up|1|||
127898352|NCT01867242|460251602|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
127898353|NCT01867242|460251603|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
127898354|NCT01867242|460251604|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
127898355|NCT00264810|460251608|FG000|Baseline|Withdrawal by Subject|10|||
127898356|NCT00264810|460251609|FG001|Baseline|Withdrawal by Subject|10|||
127898357|NCT00264810|460251608|FG000|Baseline|Physician Decision|7|||
127898358|NCT00264810|460251609|FG001|Baseline|Physician Decision|8|||
127898359|NCT00264810|460251608|FG000|Baseline|Subject Compliance Failure|3|||
127898360|NCT00264810|460251609|FG001|Baseline|Subject Compliance Failure|3|||
127898361|NCT00264810|460251608|FG000|Baseline|Insufficient Seizure Frequency|2|||
127898362|NCT00264810|460251609|FG001|Baseline|Insufficient Seizure Frequency|2|||
127898363|NCT00264810|460251608|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
127898364|NCT00264810|460251609|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
127898365|NCT00264810|460251608|FG000|Baseline|Other|0|||
127898366|NCT00264810|460251609|FG001|Baseline|Other|1|||
127898367|NCT00264810|460251608|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
127898368|NCT00264810|460251609|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
127898369|NCT00264810|460251608|FG000|Stimulation Optimization Period|Death|0|||
127898370|NCT00264810|460251609|FG001|Stimulation Optimization Period|Death|1|||
127898371|NCT00264810|460251608|FG000|Blinded Evaluation Period|Explant due to infection|1|||
127898372|NCT00264810|460251609|FG001|Blinded Evaluation Period|Explant due to infection|1|||
127898373|NCT00264810|460251608|FG000|Open Label Evaluation Period|Explant due to infection|1|||
127898374|NCT00264810|460251609|FG001|Open Label Evaluation Period|Explant due to infection|1|||
127898375|NCT00264810|460251608|FG000|Open Label Evaluation Period|Death|3|||
127898376|NCT00264810|460251609|FG001|Open Label Evaluation Period|Death|2|||
127898377|NCT00264810|460251608|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
127898378|NCT00264810|460251609|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
127898379|NCT02199509|460251610|FG000|Overall Study|Suicidal Ideation|0|||
127898380|NCT02199509|460251611|FG001|Overall Study|Suicidal Ideation|1|||
127898381|NCT02199509|460251610|FG000|Overall Study|Misunderstood titration schedule|1|||
127898382|NCT02199509|460251611|FG001|Overall Study|Misunderstood titration schedule|0|||
127898383|NCT02093689|460251612|FG000|Overall Study|Physician Decision|4|||
127898384|NCT02093689|460251613|FG001|Overall Study|Physician Decision|0|||
127898385|NCT02093689|460251614|FG002|Overall Study|Physician Decision|0|||
127898386|NCT03309956|460251615|FG000|Overall Study|Devices worn for <24 hrs or >72 hrs, device failing to record, or devices were lost|47|||
127898387|NCT02768298|460251616|FG000|Overall Study|Adverse Event|1|||
127898388|NCT02768298|460251617|FG001|Overall Study|Adverse Event|4|||
127898389|NCT02768298|460251616|FG000|Overall Study|Death|2|||
127898390|NCT02768298|460251617|FG001|Overall Study|Death|1|||
127898391|NCT02768298|460251616|FG000|Overall Study|Non-compliance with study treatment|0|||
127898392|NCT02768298|460251617|FG001|Overall Study|Non-compliance with study treatment|1|||
127898393|NCT02768298|460251616|FG000|Overall Study|Subject/guardian decision|1|||
127898394|NCT02768298|460251617|FG001|Overall Study|Subject/guardian decision|0|||
127898395|NCT02768298|460251616|FG000|Overall Study|Withdrawal of informed consent|0|||
127898396|NCT02768298|460251617|FG001|Overall Study|Withdrawal of informed consent|1|||
127898397|NCT04634409|460251618|FG000|Overall Study|Death|0|||
127898398|NCT04634409|460251619|FG001|Overall Study|Death|0|||
127898399|NCT04634409|460251620|FG002|Overall Study|Death|0|||
127898400|NCT04634409|460251621|FG003|Overall Study|Death|0|||
127898401|NCT04634409|460251622|FG004|Overall Study|Death|0|||
127898402|NCT04634409|460251623|FG005|Overall Study|Death|0|||
127898403|NCT04634409|460251624|FG006|Overall Study|Death|0|||
127898404|NCT04634409|460251625|FG007|Overall Study|Death|0|||
127898405|NCT04634409|460251626|FG008|Overall Study|Death|0|||
127898406|NCT04634409|460251627|FG009|Overall Study|Death|0|||
127898407|NCT04634409|460251628|FG010|Overall Study|Death|1|||
127898408|NCT04634409|460251629|FG011|Overall Study|Death|0|||
127898409|NCT04634409|460251630|FG012|Overall Study|Death|1|||
127839892|NCT00819585|460029589|FG010|Extension Study|Lost to Follow-up|1|||
127839893|NCT00819585|460029579|FG000|Extension Study|Death|0|||
127839894|NCT00819585|460029580|FG001|Extension Study|Death|0|||
127839895|NCT00819585|460029581|FG002|Extension Study|Death|0|||
127839896|NCT00819585|460029582|FG003|Extension Study|Death|0|||
127839897|NCT00819585|460029583|FG004|Extension Study|Death|0|||
127839898|NCT00819585|460029584|FG005|Extension Study|Death|0|||
127839899|NCT00819585|460029585|FG006|Extension Study|Death|0|||
127898410|NCT04634409|460251631|FG013|Overall Study|Death|0|||
127898411|NCT04634409|460251632|FG014|Overall Study|Death|0|||
127839900|NCT00819585|460029586|FG007|Extension Study|Death|0|||
127898412|NCT04634409|460251633|FG015|Overall Study|Death|0|||
127898413|NCT04634409|460251634|FG016|Overall Study|Death|0|||
127839901|NCT00819585|460029587|FG008|Extension Study|Death|2|||
127839902|NCT00819585|460029588|FG009|Extension Study|Death|0|||
127839903|NCT00819585|460029589|FG010|Extension Study|Death|0|||
127898414|NCT04634409|460251635|FG017|Overall Study|Death|0|||
127898415|NCT04634409|460251636|FG018|Overall Study|Death|0|||
127898416|NCT04634409|460251637|FG019|Overall Study|Death|0|||
127898417|NCT04634409|460251638|FG020|Overall Study|Death|0|||
127898418|NCT04634409|460251639|FG021|Overall Study|Death|0|||
127839904|NCT00738374|460029590|FG000|Induction Treatment Phase|Adverse Event|14|||
127839905|NCT00738374|460029591|FG001|Induction Treatment Phase|Adverse Event|0|||
127839906|NCT00738374|460029592|FG002|Induction Treatment Phase|Adverse Event|0|||
127839907|NCT00738374|460029593|FG003|Induction Treatment Phase|Adverse Event|0|||
127839908|NCT00738374|460029590|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
127839909|NCT00738374|460029591|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
127839910|NCT00738374|460029592|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
127839911|NCT00738374|460029593|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
127839912|NCT00738374|460029590|FG000|Induction Treatment Phase|Physician Decision|2|||
127839913|NCT00738374|460029591|FG001|Induction Treatment Phase|Physician Decision|0|||
127839914|NCT00738374|460029592|FG002|Induction Treatment Phase|Physician Decision|0|||
127839915|NCT00738374|460029593|FG003|Induction Treatment Phase|Physician Decision|0|||
127839916|NCT00738374|460029590|FG000|Induction Treatment Phase|Protocol Violation|2|||
127839917|NCT00738374|460029591|FG001|Induction Treatment Phase|Protocol Violation|0|||
127839918|NCT00738374|460029592|FG002|Induction Treatment Phase|Protocol Violation|0|||
127839919|NCT00738374|460029593|FG003|Induction Treatment Phase|Protocol Violation|0|||
127839920|NCT00738374|460029590|FG000|Induction Treatment Phase|Non-compliance|1|||
127839921|NCT00738374|460029591|FG001|Induction Treatment Phase|Non-compliance|0|||
127839922|NCT00738374|460029592|FG002|Induction Treatment Phase|Non-compliance|0|||
127839923|NCT00738374|460029593|FG003|Induction Treatment Phase|Non-compliance|0|||
127839924|NCT00738374|460029590|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
127839925|NCT00738374|460029591|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
127839926|NCT00738374|460029592|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
127839927|NCT00738374|460029593|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
127839928|NCT00738374|460029590|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
127839929|NCT00738374|460029591|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
127839930|NCT00738374|460029592|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
127839931|NCT00738374|460029593|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
127839932|NCT00738374|460029590|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
127839933|NCT00738374|460029591|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
127839934|NCT00738374|460029592|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
127839935|NCT00738374|460029593|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
127839936|NCT00738374|460029590|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
127839937|NCT00738374|460029591|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
127839938|NCT00738374|460029592|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
127839939|NCT00738374|460029593|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
127839940|NCT00738374|460029590|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
127839941|NCT00738374|460029591|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
127839942|NCT00738374|460029592|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
127839943|NCT00738374|460029593|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
127839944|NCT00738374|460029590|FG000|Maintenance Treatment/Observation Phase|Other|0|||
127839945|NCT00738374|460029591|FG001|Maintenance Treatment/Observation Phase|Other|1|||
127839946|NCT00738374|460029592|FG002|Maintenance Treatment/Observation Phase|Other|0|||
127839947|NCT00738374|460029593|FG003|Maintenance Treatment/Observation Phase|Other|0|||
127839948|NCT03334396|460029594|FG000|Overall Study|Adverse Event|1|||
127839949|NCT03334396|460029595|FG001|Overall Study|Adverse Event|0|||
127839950|NCT03334396|460029596|FG002|Overall Study|Adverse Event|1|||
127839951|NCT03334396|460029597|FG003|Overall Study|Adverse Event|0|||
127839952|NCT03334396|460029598|FG004|Overall Study|Adverse Event|0|||
127839953|NCT03334396|460029599|FG005|Overall Study|Adverse Event|0|||
127839954|NCT03334396|460029600|FG006|Overall Study|Adverse Event|0|||
127839955|NCT03334396|460029601|FG007|Overall Study|Adverse Event|0|||
127839956|NCT03334396|460029594|FG000|Overall Study|Lack of Efficacy|10|||
127839957|NCT03334396|460029595|FG001|Overall Study|Lack of Efficacy|4|||
127839958|NCT03334396|460029596|FG002|Overall Study|Lack of Efficacy|1|||
127839959|NCT03334396|460029597|FG003|Overall Study|Lack of Efficacy|3|||
127839960|NCT03334396|460029598|FG004|Overall Study|Lack of Efficacy|1|||
127839961|NCT03334396|460029599|FG005|Overall Study|Lack of Efficacy|0|||
127839962|NCT03334396|460029600|FG006|Overall Study|Lack of Efficacy|0|||
127839963|NCT03334396|460029601|FG007|Overall Study|Lack of Efficacy|1|||
127839964|NCT03334396|460029594|FG000|Overall Study|Lost to Follow-up|0|||
127839965|NCT03334396|460029595|FG001|Overall Study|Lost to Follow-up|0|||
127839966|NCT03334396|460029596|FG002|Overall Study|Lost to Follow-up|1|||
127839967|NCT03334396|460029597|FG003|Overall Study|Lost to Follow-up|0|||
127839968|NCT03334396|460029598|FG004|Overall Study|Lost to Follow-up|0|||
127839969|NCT03334396|460029599|FG005|Overall Study|Lost to Follow-up|0|||
127839970|NCT03334396|460029600|FG006|Overall Study|Lost to Follow-up|1|||
127839971|NCT03334396|460029601|FG007|Overall Study|Lost to Follow-up|0|||
127839972|NCT03334396|460029594|FG000|Overall Study|Physician Decision|1|||
127839973|NCT03334396|460029595|FG001|Overall Study|Physician Decision|0|||
127898419|NCT04634409|460251640|FG022|Overall Study|Death|0|||
127898420|NCT04634409|460251641|FG023|Overall Study|Death|0|||
127839974|NCT03334396|460029596|FG002|Overall Study|Physician Decision|0|||
127839975|NCT03334396|460029597|FG003|Overall Study|Physician Decision|0|||
127839976|NCT03334396|460029598|FG004|Overall Study|Physician Decision|0|||
127839977|NCT03334396|460029599|FG005|Overall Study|Physician Decision|0|||
127839978|NCT03334396|460029600|FG006|Overall Study|Physician Decision|0|||
127839979|NCT03334396|460029601|FG007|Overall Study|Physician Decision|0|||
127839980|NCT03334396|460029594|FG000|Overall Study|Withdrawal by Subject|10|||
127839981|NCT03334396|460029595|FG001|Overall Study|Withdrawal by Subject|5|||
127839982|NCT03334396|460029596|FG002|Overall Study|Withdrawal by Subject|7|||
127839983|NCT03334396|460029597|FG003|Overall Study|Withdrawal by Subject|2|||
127839984|NCT03334396|460029598|FG004|Overall Study|Withdrawal by Subject|2|||
127839985|NCT03334396|460029599|FG005|Overall Study|Withdrawal by Subject|1|||
127839986|NCT03334396|460029600|FG006|Overall Study|Withdrawal by Subject|2|||
127839987|NCT03334396|460029601|FG007|Overall Study|Withdrawal by Subject|0|||
127839988|NCT03334396|460029594|FG000|Overall Study|Pregnancy|0|||
127839989|NCT03334396|460029595|FG001|Overall Study|Pregnancy|1|||
127839990|NCT03334396|460029596|FG002|Overall Study|Pregnancy|0|||
127839991|NCT03334396|460029597|FG003|Overall Study|Pregnancy|0|||
127839992|NCT03334396|460029598|FG004|Overall Study|Pregnancy|0|||
127839993|NCT03334396|460029599|FG005|Overall Study|Pregnancy|0|||
127839994|NCT03334396|460029600|FG006|Overall Study|Pregnancy|0|||
127839995|NCT03334396|460029601|FG007|Overall Study|Pregnancy|0|||
127839996|NCT03334396|460029594|FG000|Overall Study|Ineligible|0|||
127839997|NCT03334396|460029595|FG001|Overall Study|Ineligible|1|||
127839998|NCT03334396|460029596|FG002|Overall Study|Ineligible|0|||
127839999|NCT03334396|460029597|FG003|Overall Study|Ineligible|0|||
127840000|NCT03334396|460029598|FG004|Overall Study|Ineligible|0|||
127840001|NCT03334396|460029599|FG005|Overall Study|Ineligible|0|||
127840002|NCT03334396|460029600|FG006|Overall Study|Ineligible|0|||
127840003|NCT03334396|460029601|FG007|Overall Study|Ineligible|0|||
127898421|NCT04634409|460251642|FG024|Overall Study|Death|0|||
127898422|NCT04634409|460251643|FG025|Overall Study|Death|0|||
127840004|NCT03334396|460029594|FG000|Overall Study|Started New Job|1|||
127840005|NCT03334396|460029595|FG001|Overall Study|Started New Job|0|||
127840006|NCT03334396|460029596|FG002|Overall Study|Started New Job|0|||
127840007|NCT03334396|460029597|FG003|Overall Study|Started New Job|0|||
127840008|NCT03334396|460029598|FG004|Overall Study|Started New Job|0|||
127840009|NCT03334396|460029599|FG005|Overall Study|Started New Job|0|||
127840010|NCT03334396|460029600|FG006|Overall Study|Started New Job|0|||
127840011|NCT03334396|460029601|FG007|Overall Study|Started New Job|0|||
127840012|NCT01969799|460029602|FG000|Overall Study|Adverse Event|0|||
127840013|NCT01969799|460029603|FG001|Overall Study|Adverse Event|1|||
127840014|NCT01969799|460029602|FG000|Overall Study|Death|16|||
127840015|NCT01969799|460029603|FG001|Overall Study|Death|11|||
127840016|NCT01969799|460029602|FG000|Overall Study|Lost to Follow-up|0|||
127840017|NCT01969799|460029603|FG001|Overall Study|Lost to Follow-up|2|||
127840018|NCT01969799|460029602|FG000|Overall Study|Physician Decision|1|||
127840019|NCT01969799|460029603|FG001|Overall Study|Physician Decision|0|||
127840020|NCT02159469|460029606|FG000|Overall Study|Missing Completion status|1|||
127840021|NCT02159469|460029606|FG000|Overall Study|Adverse Event|5|||
127840022|NCT02159469|460029606|FG000|Overall Study|Non-compliance|2|||
127840023|NCT02159469|460029606|FG000|Overall Study|Withdrawal by Subject|9|||
127840024|NCT02159469|460029606|FG000|Overall Study|Lost to Follow-up|1|||
127840025|NCT02159469|460029606|FG000|Overall Study|Sponsor's request|2|||
127840026|NCT02159469|460029606|FG000|Overall Study|Met Stopping Criteria|3|||
127840027|NCT02159469|460029606|FG000|Overall Study|Other|1|||
127840028|NCT02159469|460029606|FG000|Overall Study|Multiple|29|||
127840029|NCT02927873|460029607|FG000|Overall Study|Lost to Follow-up|0|||
127840030|NCT02927873|460029608|FG001|Overall Study|Lost to Follow-up|1|||
127840031|NCT02927873|460029609|FG002|Overall Study|Lost to Follow-up|0|||
127840032|NCT02927873|460029610|FG003|Overall Study|Lost to Follow-up|0|||
127840033|NCT02927873|460029611|FG004|Overall Study|Lost to Follow-up|0|||
127840034|NCT02927873|460029612|FG005|Overall Study|Lost to Follow-up|0|||
127840035|NCT02927873|460029607|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
127840036|NCT02927873|460029608|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
127840037|NCT02927873|460029609|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
127840038|NCT02927873|460029610|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
127840039|NCT02927873|460029611|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
127840040|NCT02927873|460029612|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
127840041|NCT02927873|460029607|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127840042|NCT02927873|460029608|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127840043|NCT02927873|460029609|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127840044|NCT02927873|460029610|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127840045|NCT02927873|460029611|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127840046|NCT02927873|460029612|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
127840047|NCT02927873|460029607|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
127840048|NCT02927873|460029608|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
127840049|NCT02927873|460029609|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
127840050|NCT02927873|460029610|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
127840051|NCT02927873|460029611|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
127840052|NCT02927873|460029612|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
127840053|NCT02927873|460029607|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
127840054|NCT02927873|460029608|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
127840055|NCT02927873|460029609|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
127840056|NCT02927873|460029610|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
127840057|NCT02927873|460029611|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
127840058|NCT02927873|460029612|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
127840059|NCT02927873|460029607|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
127840060|NCT02927873|460029608|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
127840061|NCT02927873|460029609|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
127840062|NCT02927873|460029610|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
127840063|NCT02927873|460029611|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
127898423|NCT04634409|460251644|FG026|Overall Study|Death|0|||
127898424|NCT04634409|460251618|FG000|Overall Study|Adverse Event|0|||
127898425|NCT04634409|460251619|FG001|Overall Study|Adverse Event|0|||
127898426|NCT04634409|460251620|FG002|Overall Study|Adverse Event|1|||
127898427|NCT04634409|460251621|FG003|Overall Study|Adverse Event|0|||
127840064|NCT02927873|460029612|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
127898428|NCT04634409|460251622|FG004|Overall Study|Adverse Event|0|||
127840065|NCT03629041|460029618|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
127840066|NCT03629041|460029619|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
127840067|NCT03629041|460029620|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
127840068|NCT03629041|460029621|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
127840069|NCT00383721|460029623|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
127840070|NCT00383721|460029624|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
127840071|NCT00383721|460029625|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
127840072|NCT00383721|460029626|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
127840073|NCT00383721|460029627|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
127840074|NCT00383721|460029623|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
127840075|NCT00383721|460029624|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
127840076|NCT00383721|460029625|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
127840077|NCT00383721|460029626|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
127840078|NCT00383721|460029627|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
127840079|NCT00383721|460029623|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
127840080|NCT00383721|460029624|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
127840081|NCT00383721|460029625|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
127840082|NCT00383721|460029626|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
127840083|NCT00383721|460029627|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
127840084|NCT00383721|460029623|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
127840085|NCT00383721|460029624|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
127840086|NCT00383721|460029625|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
127840087|NCT00383721|460029626|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
127840088|NCT00383721|460029627|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
127840089|NCT00383721|460029623|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
127840090|NCT00383721|460029624|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
127840091|NCT00383721|460029625|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
127840092|NCT00383721|460029626|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
127840093|NCT00383721|460029627|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
127840094|NCT00383721|460029623|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
127840095|NCT00383721|460029624|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
127840096|NCT00383721|460029625|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
127840097|NCT00383721|460029626|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
127840098|NCT00383721|460029627|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
127840099|NCT00383721|460029623|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
127840100|NCT00383721|460029624|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
127840101|NCT00383721|460029625|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
127840102|NCT00383721|460029626|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
127840103|NCT00383721|460029627|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
127840104|NCT00383721|460029623|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
127840105|NCT00383721|460029624|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
127840106|NCT00383721|460029625|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
127840107|NCT00383721|460029626|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
127840108|NCT00383721|460029627|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
127840109|NCT00383721|460029623|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
127840110|NCT00383721|460029624|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
127840111|NCT00383721|460029625|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
127840112|NCT00383721|460029626|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
127840113|NCT00383721|460029627|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
127840114|NCT00383721|460029623|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
127840115|NCT00383721|460029624|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
127840116|NCT00383721|460029625|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
127840117|NCT00383721|460029626|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
127840118|NCT00383721|460029627|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
127840119|NCT00383721|460029623|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
127898429|NCT04634409|460251623|FG005|Overall Study|Adverse Event|1|||
127898430|NCT04634409|460251624|FG006|Overall Study|Adverse Event|0|||
127898431|NCT04634409|460251625|FG007|Overall Study|Adverse Event|0|||
127898432|NCT04634409|460251626|FG008|Overall Study|Adverse Event|0|||
127840120|NCT00383721|460029624|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
127840121|NCT00383721|460029625|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
127840122|NCT00383721|460029626|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
127840123|NCT00383721|460029627|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
127840124|NCT00383721|460029623|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
127840125|NCT00383721|460029624|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
127840126|NCT00383721|460029625|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
127840127|NCT00383721|460029626|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
127840128|NCT00383721|460029627|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
127840129|NCT00383721|460029623|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
127840130|NCT00383721|460029624|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
127840131|NCT00383721|460029625|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
127840132|NCT00383721|460029626|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
127840133|NCT00383721|460029627|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
127840134|NCT00383721|460029623|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
127840135|NCT00383721|460029624|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
127840136|NCT00383721|460029625|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
127840137|NCT00383721|460029626|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
127840138|NCT00383721|460029627|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
127840139|NCT00383721|460029623|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
127840140|NCT00383721|460029624|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
127840141|NCT00383721|460029625|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
127840142|NCT00383721|460029626|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
127840143|NCT00383721|460029627|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
127840144|NCT00383721|460029623|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
127840145|NCT00383721|460029624|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
127840146|NCT00383721|460029625|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
127898433|NCT04634409|460251627|FG009|Overall Study|Adverse Event|0|||
127898434|NCT04634409|460251628|FG010|Overall Study|Adverse Event|0|||
127898435|NCT04634409|460251629|FG011|Overall Study|Adverse Event|0|||
127898436|NCT04634409|460251630|FG012|Overall Study|Adverse Event|0|||
127898437|NCT04634409|460251631|FG013|Overall Study|Adverse Event|0|||
127898438|NCT04634409|460251632|FG014|Overall Study|Adverse Event|0|||
127898439|NCT04634409|460251633|FG015|Overall Study|Adverse Event|0|||
127898440|NCT04634409|460251634|FG016|Overall Study|Adverse Event|0|||
127898441|NCT04634409|460251635|FG017|Overall Study|Adverse Event|0|||
127898442|NCT04634409|460251636|FG018|Overall Study|Adverse Event|0|||
127898443|NCT04634409|460251637|FG019|Overall Study|Adverse Event|0|||
127898444|NCT04634409|460251638|FG020|Overall Study|Adverse Event|0|||
127898445|NCT04634409|460251639|FG021|Overall Study|Adverse Event|0|||
127898446|NCT04634409|460251640|FG022|Overall Study|Adverse Event|0|||
127898447|NCT04634409|460251641|FG023|Overall Study|Adverse Event|0|||
127898448|NCT04634409|460251642|FG024|Overall Study|Adverse Event|0|||
127898449|NCT04634409|460251643|FG025|Overall Study|Adverse Event|0|||
127898450|NCT04634409|460251644|FG026|Overall Study|Adverse Event|0|||
127898451|NCT04634409|460251618|FG000|Overall Study|Lost to Follow-up|3|||
127898452|NCT04634409|460251619|FG001|Overall Study|Lost to Follow-up|1|||
127898453|NCT04634409|460251620|FG002|Overall Study|Lost to Follow-up|1|||
127898454|NCT04634409|460251621|FG003|Overall Study|Lost to Follow-up|3|||
127898455|NCT04634409|460251622|FG004|Overall Study|Lost to Follow-up|1|||
127898456|NCT04634409|460251623|FG005|Overall Study|Lost to Follow-up|1|||
127898457|NCT04634409|460251624|FG006|Overall Study|Lost to Follow-up|1|||
127898458|NCT04634409|460251625|FG007|Overall Study|Lost to Follow-up|3|||
127898459|NCT04634409|460251626|FG008|Overall Study|Lost to Follow-up|3|||
127898460|NCT04634409|460251627|FG009|Overall Study|Lost to Follow-up|11|||
127898461|NCT04634409|460251628|FG010|Overall Study|Lost to Follow-up|8|||
127898462|NCT04634409|460251629|FG011|Overall Study|Lost to Follow-up|15|||
127898463|NCT04634409|460251630|FG012|Overall Study|Lost to Follow-up|3|||
127898464|NCT04634409|460251631|FG013|Overall Study|Lost to Follow-up|2|||
127898465|NCT04634409|460251632|FG014|Overall Study|Lost to Follow-up|7|||
127898466|NCT04634409|460251633|FG015|Overall Study|Lost to Follow-up|0|||
127898467|NCT04634409|460251634|FG016|Overall Study|Lost to Follow-up|0|||
127898468|NCT04634409|460251635|FG017|Overall Study|Lost to Follow-up|0|||
127898469|NCT04634409|460251636|FG018|Overall Study|Lost to Follow-up|0|||
127898470|NCT04634409|460251637|FG019|Overall Study|Lost to Follow-up|0|||
127898471|NCT04634409|460251638|FG020|Overall Study|Lost to Follow-up|0|||
127898472|NCT04634409|460251639|FG021|Overall Study|Lost to Follow-up|0|||
127898473|NCT04634409|460251640|FG022|Overall Study|Lost to Follow-up|0|||
127898474|NCT04634409|460251641|FG023|Overall Study|Lost to Follow-up|0|||
127898475|NCT04634409|460251642|FG024|Overall Study|Lost to Follow-up|0|||
127898476|NCT04634409|460251643|FG025|Overall Study|Lost to Follow-up|0|||
127898477|NCT04634409|460251644|FG026|Overall Study|Lost to Follow-up|0|||
127898478|NCT04634409|460251618|FG000|Overall Study|Withdrawal by Subject|3|||
127898479|NCT04634409|460251619|FG001|Overall Study|Withdrawal by Subject|1|||
127898480|NCT04634409|460251620|FG002|Overall Study|Withdrawal by Subject|6|||
127898481|NCT04634409|460251621|FG003|Overall Study|Withdrawal by Subject|4|||
127898482|NCT04634409|460251622|FG004|Overall Study|Withdrawal by Subject|2|||
127898483|NCT04634409|460251623|FG005|Overall Study|Withdrawal by Subject|0|||
127898484|NCT04634409|460251624|FG006|Overall Study|Withdrawal by Subject|0|||
127898485|NCT04634409|460251625|FG007|Overall Study|Withdrawal by Subject|2|||
127898486|NCT04634409|460251626|FG008|Overall Study|Withdrawal by Subject|3|||
127898487|NCT04634409|460251627|FG009|Overall Study|Withdrawal by Subject|2|||
127898488|NCT04634409|460251628|FG010|Overall Study|Withdrawal by Subject|3|||
127898489|NCT04634409|460251629|FG011|Overall Study|Withdrawal by Subject|2|||
127898490|NCT04634409|460251630|FG012|Overall Study|Withdrawal by Subject|2|||
127898491|NCT04634409|460251631|FG013|Overall Study|Withdrawal by Subject|1|||
127898492|NCT04634409|460251632|FG014|Overall Study|Withdrawal by Subject|5|||
127898493|NCT04634409|460251633|FG015|Overall Study|Withdrawal by Subject|0|||
127898494|NCT04634409|460251634|FG016|Overall Study|Withdrawal by Subject|0|||
127898495|NCT04634409|460251635|FG017|Overall Study|Withdrawal by Subject|1|||
127898496|NCT04634409|460251636|FG018|Overall Study|Withdrawal by Subject|0|||
127898497|NCT04634409|460251637|FG019|Overall Study|Withdrawal by Subject|0|||
127898498|NCT04634409|460251638|FG020|Overall Study|Withdrawal by Subject|0|||
127898499|NCT04634409|460251639|FG021|Overall Study|Withdrawal by Subject|0|||
127898500|NCT04634409|460251640|FG022|Overall Study|Withdrawal by Subject|0|||
127898501|NCT04634409|460251641|FG023|Overall Study|Withdrawal by Subject|1|||
127898502|NCT04634409|460251642|FG024|Overall Study|Withdrawal by Subject|0|||
127898503|NCT04634409|460251643|FG025|Overall Study|Withdrawal by Subject|0|||
127898504|NCT04634409|460251644|FG026|Overall Study|Withdrawal by Subject|0|||
127898505|NCT04634409|460251618|FG000|Overall Study|Other - As reported by Investigator|1|||
127898506|NCT04634409|460251619|FG001|Overall Study|Other - As reported by Investigator|0|||
127898507|NCT04634409|460251620|FG002|Overall Study|Other - As reported by Investigator|0|||
127898508|NCT04634409|460251621|FG003|Overall Study|Other - As reported by Investigator|0|||
127898509|NCT04634409|460251622|FG004|Overall Study|Other - As reported by Investigator|0|||
127898510|NCT04634409|460251623|FG005|Overall Study|Other - As reported by Investigator|0|||
127898511|NCT04634409|460251624|FG006|Overall Study|Other - As reported by Investigator|0|||
127898512|NCT04634409|460251625|FG007|Overall Study|Other - As reported by Investigator|6|||
127898513|NCT04634409|460251626|FG008|Overall Study|Other - As reported by Investigator|4|||
127898514|NCT04634409|460251627|FG009|Overall Study|Other - As reported by Investigator|0|||
127898515|NCT04634409|460251628|FG010|Overall Study|Other - As reported by Investigator|1|||
127898516|NCT04634409|460251629|FG011|Overall Study|Other - As reported by Investigator|2|||
127898517|NCT04634409|460251630|FG012|Overall Study|Other - As reported by Investigator|2|||
127898518|NCT04634409|460251631|FG013|Overall Study|Other - As reported by Investigator|1|||
127898519|NCT04634409|460251632|FG014|Overall Study|Other - As reported by Investigator|0|||
127898520|NCT04634409|460251633|FG015|Overall Study|Other - As reported by Investigator|0|||
127898521|NCT04634409|460251634|FG016|Overall Study|Other - As reported by Investigator|0|||
127898522|NCT04634409|460251635|FG017|Overall Study|Other - As reported by Investigator|0|||
127898523|NCT04634409|460251636|FG018|Overall Study|Other - As reported by Investigator|0|||
127898524|NCT04634409|460251637|FG019|Overall Study|Other - As reported by Investigator|0|||
127898525|NCT04634409|460251638|FG020|Overall Study|Other - As reported by Investigator|0|||
127898526|NCT04634409|460251639|FG021|Overall Study|Other - As reported by Investigator|0|||
127898527|NCT04634409|460251640|FG022|Overall Study|Other - As reported by Investigator|0|||
127898528|NCT04634409|460251641|FG023|Overall Study|Other - As reported by Investigator|0|||
127898529|NCT04634409|460251642|FG024|Overall Study|Other - As reported by Investigator|0|||
127898530|NCT04634409|460251643|FG025|Overall Study|Other - As reported by Investigator|0|||
127898531|NCT04634409|460251644|FG026|Overall Study|Other - As reported by Investigator|0|||
127898532|NCT02518685|460251645|FG000|Overall Study|Adverse Event|29|||
127898533|NCT02518685|460251646|FG001|Overall Study|Adverse Event|1|||
127898534|NCT02518685|460251645|FG000|Overall Study|Withdrawal by Subject|10|||
127898535|NCT02518685|460251646|FG001|Overall Study|Withdrawal by Subject|3|||
127898536|NCT02518685|460251645|FG000|Overall Study|relocation, study fatigue|7|||
127898537|NCT02518685|460251646|FG001|Overall Study|relocation, study fatigue|2|||
127898538|NCT02518685|460251645|FG000|Overall Study|Pregnancy|1|||
127840147|NCT00383721|460029626|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
127840148|NCT00383721|460029627|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
127840149|NCT00383721|460029623|FG000|26-Week Treatment Safety Extension|Administrative|1|||
127840150|NCT00383721|460029624|FG001|26-Week Treatment Safety Extension|Administrative|2|||
127840151|NCT00383721|460029625|FG002|26-Week Treatment Safety Extension|Administrative|3|||
127840152|NCT00383721|460029626|FG003|26-Week Treatment Safety Extension|Administrative|1|||
127840153|NCT00383721|460029627|FG004|26-Week Treatment Safety Extension|Administrative|0|||
127840154|NCT01283997|460031096|FG000|Overall Study|Physician Decision|8|||
127840155|NCT01283997|460031097|FG001|Overall Study|Physician Decision|10|||
127840156|NCT01283997|460031096|FG000|Overall Study|Withdrawal by Subject|3|||
127840157|NCT01283997|460031097|FG001|Overall Study|Withdrawal by Subject|2|||
127840158|NCT01283997|460031096|FG000|Overall Study|Physically unable to continue|0|||
127840159|NCT01283997|460031097|FG001|Overall Study|Physically unable to continue|1|||
127840160|NCT01283997|460031096|FG000|Overall Study|Progressive disease|1|||
127840161|NCT01283997|460031097|FG001|Overall Study|Progressive disease|0|||
127840162|NCT01283997|460031096|FG000|Overall Study|Other|4|||
127840163|NCT01283997|460031097|FG001|Overall Study|Other|4|||
127840164|NCT02017899|460031098|FG000|Overall Study|Withdrawal by Subject|0|||
127840165|NCT02017899|460031099|FG001|Overall Study|Withdrawal by Subject|0|||
127840166|NCT02017899|460031100|FG002|Overall Study|Withdrawal by Subject|0|||
127840167|NCT02017899|460031101|FG003|Overall Study|Withdrawal by Subject|1|||
127840168|NCT02017899|460031102|FG004|Overall Study|Withdrawal by Subject|1|||
127840169|NCT02017899|460031103|FG005|Overall Study|Withdrawal by Subject|0|||
127898539|NCT02518685|460251646|FG001|Overall Study|Pregnancy|0|||
127898540|NCT02518685|460251645|FG000|Overall Study|Physician Decision|1|||
127898541|NCT02518685|460251646|FG001|Overall Study|Physician Decision|0|||
127898542|NCT02518685|460251645|FG000|Overall Study|Lost to Follow-up|1|||
127840170|NCT01677624|460031108|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
127840171|NCT01747811|460031109|FG000|Overall Study|Lack of Efficacy|2|||
127840172|NCT01747811|460031110|FG001|Overall Study|Lack of Efficacy|4|||
127840173|NCT01337167|460031111|FG000|Infant Series|Adverse Event|1|||
127840174|NCT01337167|460031112|FG001|Infant Series|Adverse Event|1|||
127840175|NCT01337167|460031111|FG000|Infant Series|Death|1|||
127840176|NCT01337167|460031112|FG001|Infant Series|Death|1|||
127840177|NCT01337167|460031111|FG000|Infant Series|Lost to Follow-up|13|||
127840178|NCT01337167|460031112|FG001|Infant Series|Lost to Follow-up|7|||
127840179|NCT01337167|460031111|FG000|Infant Series|Non-compliance with study drug|2|||
127840180|NCT01337167|460031112|FG001|Infant Series|Non-compliance with study drug|1|||
127840181|NCT01337167|460031111|FG000|Infant Series|Physician Decision|3|||
127840182|NCT01337167|460031112|FG001|Infant Series|Physician Decision|1|||
127840183|NCT01337167|460031111|FG000|Infant Series|Protocol Violation|22|||
127840184|NCT01337167|460031112|FG001|Infant Series|Protocol Violation|9|||
127840185|NCT01337167|460031111|FG000|Infant Series|Withdrawal by Subject|15|||
127840186|NCT01337167|460031112|FG001|Infant Series|Withdrawal by Subject|4|||
127840187|NCT01337167|460031111|FG000|Infant Series|Randomized but not vaccinated|5|||
127840188|NCT01337167|460031112|FG001|Infant Series|Randomized but not vaccinated|3|||
127840189|NCT01337167|460031111|FG000|Interim Period|Lost to Follow-up|51|||
127840190|NCT01337167|460031112|FG001|Interim Period|Lost to Follow-up|23|||
127840191|NCT01337167|460031111|FG000|Interim Period|Non-compliance with study drug|1|||
127840192|NCT01337167|460031112|FG001|Interim Period|Non-compliance with study drug|0|||
127840193|NCT01337167|460031111|FG000|Interim Period|Physician Decision|6|||
127840194|NCT01337167|460031112|FG001|Interim Period|Physician Decision|3|||
127840195|NCT01337167|460031111|FG000|Interim Period|Protocol Violation|5|||
127840196|NCT01337167|460031112|FG001|Interim Period|Protocol Violation|3|||
127840197|NCT01337167|460031111|FG000|Interim Period|Withdrawal by Subject|18|||
127840198|NCT01337167|460031112|FG001|Interim Period|Withdrawal by Subject|10|||
127840199|NCT01337167|460031111|FG000|Interim Period|Other protocol criterion not met|0|||
127840200|NCT01337167|460031112|FG001|Interim Period|Other protocol criterion not met|1|||
127840201|NCT01337167|460031111|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
127840202|NCT01337167|460031112|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
127840203|NCT01337167|460031111|FG000|Toddler Vaccinations|Protocol Violation|0|||
127840204|NCT01337167|460031112|FG001|Toddler Vaccinations|Protocol Violation|1|||
127840205|NCT01337167|460031111|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
127840206|NCT01337167|460031112|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
127840207|NCT03833817|460031113|FG000|Overall Study|Withdrawal by Subject|3|||
127840208|NCT03833817|460031114|FG001|Overall Study|Withdrawal by Subject|3|||
127840209|NCT03833817|460031113|FG000|Overall Study|Lost to Follow-up|3|||
127840210|NCT03833817|460031114|FG001|Overall Study|Lost to Follow-up|3|||
127840211|NCT00884221|460031117|FG000|Overall Study|Withdrawal by Subject|0|||
127840212|NCT00884221|460031118|FG001|Overall Study|Withdrawal by Subject|3|||
127840213|NCT00884221|460031117|FG000|Overall Study|Adverse Event|6|||
127840214|NCT00884221|460031118|FG001|Overall Study|Adverse Event|3|||
127840215|NCT00884221|460031117|FG000|Overall Study|Protocol Violation|16|||
127840216|NCT00884221|460031118|FG001|Overall Study|Protocol Violation|13|||
127840217|NCT00884221|460031117|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
127840218|NCT00884221|460031118|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
127898543|NCT02518685|460251646|FG001|Overall Study|Lost to Follow-up|4|||
127840219|NCT03363919|460031121|FG000|Overall Study|Withdrawal by subject - did not receive allocated intervention|0|||
127840220|NCT03363919|460031122|FG001|Overall Study|Withdrawal by subject - did not receive allocated intervention|1|||
127840221|NCT03363919|460031121|FG000|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|1|||
127840222|NCT03363919|460031122|FG001|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|4|||
127840223|NCT01646398|460031123|FG000|Overall Study|Withdrawal by Subject|1|||
127840224|NCT01646398|460031124|FG001|Overall Study|Withdrawal by Subject|0|||
127840225|NCT00255034|460031125|FG000|Overall Study|Withdrawal by Subject|15|||
127840226|NCT00255034|460031126|FG001|Overall Study|Withdrawal by Subject|38|||
127840227|NCT00574119|460031127|FG000|Overall Study|Adverse Event|1|||
127840228|NCT00574119|460031127|FG000|Overall Study|Protocol Violation|1|||
127840229|NCT00574119|460031127|FG000|Overall Study|Withdrawal by Subject|1|||
127840230|NCT00574119|460031127|FG000|Overall Study|Physician Decision|1|||
127840231|NCT02667457|460031130|FG000|Overall Study|Withdrawal by Subject|1|||
127840232|NCT02667457|460031131|FG001|Overall Study|Withdrawal by Subject|0|||
127840233|NCT02667457|460031130|FG000|Overall Study|Other Reason|0|||
127840234|NCT02667457|460031131|FG001|Overall Study|Other Reason|2|||
127840235|NCT02475850|460031132|FG000|Overall Study|Death|155|||
127840236|NCT02475850|460031133|FG001|Overall Study|Death|141|||
127840237|NCT02475850|460031132|FG000|Overall Study|Lost to Follow-up|217|||
127840238|NCT02475850|460031133|FG001|Overall Study|Lost to Follow-up|188|||
127840239|NCT02475850|460031132|FG000|Overall Study|Withdrawal by Subject|221|||
127840240|NCT02475850|460031133|FG001|Overall Study|Withdrawal by Subject|155|||
127840241|NCT03297216|460031138|FG000|Overall Study|Death|0|||
127840242|NCT03297216|460031139|FG001|Overall Study|Death|1|||
127840243|NCT03297216|460031138|FG000|Overall Study|Miscarriage|0|||
127840244|NCT03297216|460031139|FG001|Overall Study|Miscarriage|2|||
127840245|NCT03297216|460031138|FG000|Overall Study|Lost to Follow-up|3|||
127840246|NCT03297216|460031139|FG001|Overall Study|Lost to Follow-up|2|||
127840247|NCT02700919|460031140|FG000|Overall Study|Physician Decision|1|||
127840248|NCT02700919|460031141|FG001|Overall Study|Physician Decision|0|||
127840249|NCT02700919|460031142|FG002|Overall Study|Physician Decision|0|||
127840250|NCT02700919|460031140|FG000|Overall Study|Protocol Violation|1|||
127840251|NCT02700919|460031141|FG001|Overall Study|Protocol Violation|0|||
127840252|NCT02700919|460031142|FG002|Overall Study|Protocol Violation|0|||
127840253|NCT02700919|460031140|FG000|Overall Study|Adverse Event|1|||
127840254|NCT02700919|460031141|FG001|Overall Study|Adverse Event|3|||
127840255|NCT02700919|460031142|FG002|Overall Study|Adverse Event|1|||
127840256|NCT02700919|460031140|FG000|Overall Study|Withdrawal by Subject|5|||
127840257|NCT02700919|460031141|FG001|Overall Study|Withdrawal by Subject|8|||
127840258|NCT02700919|460031142|FG002|Overall Study|Withdrawal by Subject|2|||
127840259|NCT02700919|460031140|FG000|Overall Study|Lost to Follow-up|2|||
127840260|NCT02700919|460031141|FG001|Overall Study|Lost to Follow-up|0|||
127840261|NCT02700919|460031142|FG002|Overall Study|Lost to Follow-up|0|||
127840262|NCT02700919|460031140|FG000|Overall Study|Other|2|||
127840263|NCT02700919|460031141|FG001|Overall Study|Other|1|||
127840264|NCT02700919|460031142|FG002|Overall Study|Other|1|||
127840265|NCT03434418|460031143|FG000|Overall Study|Disease Progression|11|||
127840266|NCT03434418|460031143|FG000|Overall Study|Adverse Event|2|||
127840267|NCT03434418|460031143|FG000|Overall Study|Physician Decision|1|||
127840268|NCT03434418|460031143|FG000|Overall Study|Decline in Performance Status (PS)|1|||
127840269|NCT01517412|460031147|FG000|Overall Study|Adverse Event|10|||
127840270|NCT01517412|460031148|FG001|Overall Study|Adverse Event|11|||
127840271|NCT01517412|460031147|FG000|Overall Study|Lack of Efficacy|10|||
127840272|NCT01517412|460031148|FG001|Overall Study|Lack of Efficacy|5|||
127840273|NCT01517412|460031147|FG000|Overall Study|Poor compliance to protocol|8|||
127840274|NCT01517412|460031148|FG001|Overall Study|Poor compliance to protocol|3|||
127840275|NCT01517412|460031147|FG000|Overall Study|Other than specified above|8|||
127840276|NCT01517412|460031148|FG001|Overall Study|Other than specified above|5|||
127840277|NCT01253187|460031149|FG000|Period 2|Withdrawal by Subject|0|||
127840278|NCT01253187|460031150|FG001|Period 2|Withdrawal by Subject|0|||
127840279|NCT01253187|460031151|FG002|Period 2|Withdrawal by Subject|0|||
127840280|NCT01253187|460031152|FG003|Period 2|Withdrawal by Subject|0|||
127840281|NCT01253187|460031153|FG004|Period 2|Withdrawal by Subject|1|||
127840282|NCT01253187|460031154|FG005|Period 2|Withdrawal by Subject|0|||
127840283|NCT01253187|460031149|FG000|Period 3|Pregnancy|1|||
127840284|NCT01253187|460031150|FG001|Period 3|Pregnancy|0|||
127840285|NCT01253187|460031151|FG002|Period 3|Pregnancy|0|||
127840286|NCT01253187|460031152|FG003|Period 3|Pregnancy|0|||
127840287|NCT01253187|460031153|FG004|Period 3|Pregnancy|0|||
127840288|NCT01253187|460031154|FG005|Period 3|Pregnancy|0|||
127840289|NCT01253187|460031149|FG000|Period 3|difficulty with blood sampling|0|||
127840290|NCT01253187|460031150|FG001|Period 3|difficulty with blood sampling|1|||
127840291|NCT01253187|460031151|FG002|Period 3|difficulty with blood sampling|0|||
127840292|NCT01253187|460031152|FG003|Period 3|difficulty with blood sampling|0|||
127840293|NCT01253187|460031153|FG004|Period 3|difficulty with blood sampling|0|||
127840294|NCT01253187|460031154|FG005|Period 3|difficulty with blood sampling|0|||
127840295|NCT01253187|460031149|FG000|Period 3|non-compliance|0|||
127840296|NCT01253187|460031150|FG001|Period 3|non-compliance|0|||
127840297|NCT01253187|460031151|FG002|Period 3|non-compliance|0|||
127840298|NCT01253187|460031152|FG003|Period 3|non-compliance|0|||
127840299|NCT01253187|460031153|FG004|Period 3|non-compliance|1|||
127840300|NCT01253187|460031154|FG005|Period 3|non-compliance|0|||
127840301|NCT01956240|460031157|FG000|Overall Study|Lost to Follow-up|6|||
127840302|NCT01956240|460031158|FG001|Overall Study|Lost to Follow-up|20|||
127840303|NCT01956240|460031157|FG000|Overall Study|Adverse Event|17|||
127840304|NCT01956240|460031158|FG001|Overall Study|Adverse Event|4|||
127840305|NCT00600028|460031161|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
127840306|NCT00600028|460031162|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
127840307|NCT00600028|460031161|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
127840308|NCT00600028|460031162|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
127840309|NCT00600028|460031161|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
127840310|NCT00600028|460031162|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
127840311|NCT03172481|460031166|FG000|Double-blind|Withdrawal by Subject|1|||
127840312|NCT03172481|460031167|FG001|Double-blind|Withdrawal by Subject|0|||
127840313|NCT01957709|460031168|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
127840314|NCT02310906|460031169|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
127840315|NCT02310906|460031170|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
127840316|NCT02310906|460031171|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
127840317|NCT02310906|460031172|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
127840318|NCT02310906|460031169|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
127840319|NCT02310906|460031170|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
127840320|NCT02310906|460031171|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
127840321|NCT02310906|460031172|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
127840322|NCT02310906|460031169|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
127840323|NCT02310906|460031170|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
127840324|NCT02310906|460031171|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
127840325|NCT02310906|460031172|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
127840326|NCT02310906|460031169|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
127840327|NCT02310906|460031170|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
127840328|NCT02310906|460031171|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
127840329|NCT02310906|460031172|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
127840330|NCT01204697|460031174|FG000|Overall Study|Death|26|||
127840331|NCT01204697|460031175|FG001|Overall Study|Death|27|||
127840332|NCT01204697|460031174|FG000|Overall Study|Lost to Follow-up|3|||
127840333|NCT01204697|460031175|FG001|Overall Study|Lost to Follow-up|4|||
127898544|NCT01611090|460251647|FG000|Randomized Period|Lost to Follow-up|8|||
127898545|NCT01611090|460251648|FG001|Randomized Period|Lost to Follow-up|3|||
127898546|NCT01611090|460251649|FG002|Randomized Period|Lost to Follow-up|0|||
127898547|NCT01611090|460251647|FG000|Randomized Period|Withdrawal by Subject|22|||
127898548|NCT01611090|460251648|FG001|Randomized Period|Withdrawal by Subject|26|||
127840334|NCT01204697|460031174|FG000|Overall Study|Withdrawal by Subject|2|||
127840335|NCT01204697|460031175|FG001|Overall Study|Withdrawal by Subject|4|||
127898549|NCT01611090|460251649|FG002|Randomized Period|Withdrawal by Subject|0|||
127840336|NCT01204697|460031174|FG000|Overall Study|Randomized, but not treated|0|||
127840337|NCT01204697|460031175|FG001|Overall Study|Randomized, but not treated|1|||
127840338|NCT00098020|460031181|FG000|Overall Study|Adverse Event|2|||
127840339|NCT00098020|460031181|FG000|Overall Study|Lost to Follow-up|1|||
127840340|NCT00098020|460031181|FG000|Overall Study|elevated liver enzymes|1|||
127840341|NCT00098020|460031181|FG000|Overall Study|Low urine PCR|1|||
127840342|NCT00098020|460031181|FG000|Overall Study|Low epidermal growth factor receptor|1|||
127840343|NCT01840228|460031182|FG000|Overall Study|Lost to Follow-up|1|||
127840344|NCT01840228|460031183|FG001|Overall Study|Lost to Follow-up|1|||
127840345|NCT00712933|460031184|FG000|Overall Study|Adverse Event|69|||
127840346|NCT00712933|460031184|FG000|Overall Study|Lack of Efficacy|6|||
127840347|NCT00712933|460031184|FG000|Overall Study|Lost to Follow-up|22|||
127840348|NCT00712933|460031184|FG000|Overall Study|Non-compliance with study drug|13|||
127840349|NCT00712933|460031184|FG000|Overall Study|Other Pregnancy|37|||
127840350|NCT00712933|460031184|FG000|Overall Study|Sponsor decision|14|||
127840351|NCT00712933|460031184|FG000|Overall Study|Withdrew consent|4|||
127840352|NCT00712933|460031184|FG000|Overall Study|Hip replacement surgery|1|||
127840353|NCT00712933|460031184|FG000|Overall Study|Involved in Clinical research|3|||
127840354|NCT00712933|460031184|FG000|Overall Study|Participant hospitalized|1|||
127840355|NCT00712933|460031184|FG000|Overall Study|Participant travelled overseas|2|||
127840356|NCT00712933|460031184|FG000|Overall Study|Death of patient|1|||
127840357|NCT00712933|460031184|FG000|Overall Study|Other Physician decision|1|||
127840358|NCT00712933|460031184|FG000|Overall Study|Not committed to contraception|1|||
127840359|NCT00712933|460031184|FG000|Overall Study|Participant received medication|1|||
127840360|NCT00712933|460031184|FG000|Overall Study|Physician Decision|36|||
127840361|NCT00712933|460031184|FG000|Overall Study|Protocol Violation|4|||
127840362|NCT00712933|460031184|FG000|Overall Study|Withdrawal by Subject|151|||
127840363|NCT01295580|460031187|FG000|Overall Study|Protocol Violation|4|||
127840364|NCT01295580|460031188|FG001|Overall Study|Protocol Violation|2|||
127840365|NCT01295580|460031187|FG000|Overall Study|Withdrawal by Subject|1|||
127840366|NCT01295580|460031188|FG001|Overall Study|Withdrawal by Subject|4|||
127840367|NCT01295580|460031187|FG000|Overall Study|Adverse Event|2|||
127840368|NCT01295580|460031188|FG001|Overall Study|Adverse Event|1|||
127840369|NCT01295580|460031187|FG000|Overall Study|Lost to Follow-up|1|||
127840370|NCT01295580|460031188|FG001|Overall Study|Lost to Follow-up|0|||
127840371|NCT01295580|460031187|FG000|Overall Study|Lack of Efficacy|1|||
127840372|NCT01295580|460031188|FG001|Overall Study|Lack of Efficacy|0|||
127840373|NCT01295580|460031187|FG000|Overall Study|Other: inconvenience|1|||
127840374|NCT01295580|460031188|FG001|Overall Study|Other: inconvenience|0|||
127840375|NCT01295580|460031187|FG000|Overall Study|Other: family objection|0|||
127840376|NCT01295580|460031188|FG001|Overall Study|Other: family objection|1|||
127840377|NCT02022033|460031194|FG000|Overall Study|Physician Decision|1|||
127840378|NCT01879319|460031197|FG000|Overall Study|Withdrawal by Subject|1|||
127840379|NCT01879319|460031198|FG001|Overall Study|Withdrawal by Subject|0|||
127840380|NCT01879319|460031197|FG000|Overall Study|Lost to Follow-up|1|||
127840381|NCT01879319|460031198|FG001|Overall Study|Lost to Follow-up|5|||
127840382|NCT01360762|460031199|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
127840383|NCT01360762|460031199|FG000|Main Study Period (12-month Treatment)|Death|5|||
127840384|NCT01360762|460031199|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
127840385|NCT01360762|460031199|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
127840386|NCT01360762|460031199|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
127840387|NCT01360762|460031199|FG000|Whole Study Period|Lost to Follow-up|10|||
127840388|NCT01360762|460031199|FG000|Whole Study Period|Death|7|||
127840389|NCT01360762|460031199|FG000|Whole Study Period|Patient relapsed|18|||
127840390|NCT01360762|460031199|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
127840391|NCT01103778|460031200|FG000|Overall Study|Lost to Follow-up|1|||
127840392|NCT01103778|460031200|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
127840393|NCT01103778|460031200|FG000|Overall Study|Screen failure|1|||
127840394|NCT04724733|460031201|FG000|Overall Study|Lost to Follow-up|1|||
127840395|NCT04724733|460031202|FG001|Overall Study|Lost to Follow-up|1|||
127840396|NCT04724733|460031203|FG002|Overall Study|Lost to Follow-up|1|||
127840397|NCT03986190|460031204|FG000|Overall Study|Withdrawal by Subject|12|||
127840398|NCT03986190|460031205|FG001|Overall Study|Withdrawal by Subject|0|||
127840399|NCT04511819|460031206|FG000|Overall Study|Non-compliance with study drug|5|||
127840400|NCT04511819|460031207|FG001|Overall Study|Non-compliance with study drug|1|||
127840401|NCT04511819|460031206|FG000|Overall Study|Withdrawal by Subject|0|||
127840402|NCT04511819|460031207|FG001|Overall Study|Withdrawal by Subject|3|||
127840403|NCT04511819|460031206|FG000|Overall Study|Adverse Event|0|||
127840404|NCT04511819|460031207|FG001|Overall Study|Adverse Event|1|||
127840405|NCT04511819|460031206|FG000|Overall Study|Protocol deviation|1|||
127840406|NCT04511819|460031207|FG001|Overall Study|Protocol deviation|0|||
127840407|NCT04929613|460031208|FG000|Overall Study|Withdrawal by Subject|12|||
127840408|NCT00844649|460031210|FG000|Overall Study|Progressive Disease|196|||
127840409|NCT00844649|460031211|FG001|Overall Study|Progressive Disease|245|||
127840410|NCT00844649|460031210|FG000|Overall Study|Adverse Event|128|||
127840411|NCT00844649|460031211|FG001|Overall Study|Adverse Event|73|||
127840412|NCT00844649|460031210|FG000|Overall Study|Physician Decision|25|||
127840413|NCT00844649|460031211|FG001|Overall Study|Physician Decision|18|||
127840414|NCT00844649|460031210|FG000|Overall Study|Protocol Violation|10|||
127840415|NCT00844649|460031211|FG001|Overall Study|Protocol Violation|6|||
127840416|NCT00844649|460031210|FG000|Overall Study|Withdrawal by Subject|28|||
127898550|NCT01611090|460251647|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
127898551|NCT01611090|460251648|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
127840417|NCT00844649|460031211|FG001|Overall Study|Withdrawal by Subject|39|||
127840418|NCT00844649|460031210|FG000|Overall Study|Other|7|||
127840419|NCT00844649|460031211|FG001|Overall Study|Other|10|||
127840420|NCT00844649|460031210|FG000|Overall Study|Withdrew prior to starting treatment|11|||
127840421|NCT00844649|460031211|FG001|Overall Study|Withdrew prior to starting treatment|27|||
127840422|NCT02767856|460031212|FG000|Overall Study|Lost to Follow-up|9|||
127840423|NCT02767856|460031213|FG001|Overall Study|Lost to Follow-up|1|||
127840424|NCT02767856|460031212|FG000|Overall Study|Withdrawal by Subject|2|||
127840425|NCT02767856|460031213|FG001|Overall Study|Withdrawal by Subject|1|||
127840426|NCT01464788|460031216|FG000|Overall Study|Lost to Follow-up|0|||
127840427|NCT01464788|460031217|FG001|Overall Study|Lost to Follow-up|1|||
127840428|NCT01464788|460031218|FG002|Overall Study|Lost to Follow-up|0|||
127840429|NCT01464788|460031216|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
127840430|NCT01464788|460031217|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
127840431|NCT01464788|460031218|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
127840432|NCT00091026|460031219|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
127840433|NCT00091026|460031220|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
127840434|NCT00091026|460031219|FG000|Overall Study|Patient withdrew and never received trea|0|||
127840435|NCT00091026|460031220|FG001|Overall Study|Patient withdrew and never received trea|2|||
127840436|NCT00091026|460031219|FG000|Overall Study|Unknown-never received treatment|0|||
127840437|NCT00091026|460031220|FG001|Overall Study|Unknown-never received treatment|1|||
127840438|NCT00589979|460031221|FG000|Run-In Period|Adverse Event|5|||
127840439|NCT00589979|460031222|FG001|Run-In Period|Adverse Event|0|||
127840440|NCT00589979|460031223|FG002|Run-In Period|Adverse Event|0|||
127840441|NCT00589979|460031221|FG000|Run-In Period|Protocol Violation|3|||
127840442|NCT00589979|460031222|FG001|Run-In Period|Protocol Violation|0|||
127840443|NCT00589979|460031223|FG002|Run-In Period|Protocol Violation|0|||
127840444|NCT00589979|460031221|FG000|Run-In Period|Did not qualify for randomization|54|||
127840445|NCT00589979|460031222|FG001|Run-In Period|Did not qualify for randomization|0|||
127840446|NCT00589979|460031223|FG002|Run-In Period|Did not qualify for randomization|0|||
127840447|NCT00589979|460031221|FG000|Run-In Period|Withdrawal by Subject|10|||
127840448|NCT00589979|460031222|FG001|Run-In Period|Withdrawal by Subject|0|||
127840449|NCT00589979|460031223|FG002|Run-In Period|Withdrawal by Subject|0|||
127840450|NCT00589979|460031221|FG000|Run-In Period|Informed Consent Withdrawn|4|||
127840451|NCT00589979|460031222|FG001|Run-In Period|Informed Consent Withdrawn|0|||
127840452|NCT00589979|460031223|FG002|Run-In Period|Informed Consent Withdrawn|0|||
127840453|NCT00589979|460031221|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
127840454|NCT00589979|460031222|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
127840455|NCT00589979|460031223|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
127840456|NCT00589979|460031221|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
127840457|NCT00589979|460031222|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
127840458|NCT00589979|460031223|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
127840459|NCT00589979|460031221|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
127840460|NCT00589979|460031222|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
127840461|NCT00589979|460031223|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
127840462|NCT00589979|460031221|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
127840463|NCT00589979|460031222|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
127840464|NCT00589979|460031223|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
127840465|NCT00589979|460031221|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
127840466|NCT00589979|460031222|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
127840467|NCT00589979|460031223|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
127840468|NCT00589979|460031221|FG000|Double-Blind Treatment Period 2|Other|0|||
127840469|NCT00589979|460031222|FG001|Double-Blind Treatment Period 2|Other|0|||
127840470|NCT00589979|460031223|FG002|Double-Blind Treatment Period 2|Other|1|||
127840471|NCT00589979|460031221|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
127840472|NCT00589979|460031222|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
127840473|NCT00589979|460031223|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
127898552|NCT01611090|460251649|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
127898553|NCT01611090|460251647|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
127840474|NCT00589979|460031221|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
127840475|NCT00589979|460031222|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
127840476|NCT00589979|460031223|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
127840477|NCT01397448|460031226|FG000|Overall Study|Adverse Event|4|||
127840478|NCT01397448|460031227|FG001|Overall Study|Adverse Event|4|||
127840479|NCT01397448|460031228|FG002|Overall Study|Adverse Event|6|||
127840480|NCT01397448|460031226|FG000|Overall Study|Withdrawal by Subject|4|||
127840481|NCT01397448|460031227|FG001|Overall Study|Withdrawal by Subject|4|||
127840482|NCT01397448|460031228|FG002|Overall Study|Withdrawal by Subject|3|||
127840483|NCT01397448|460031226|FG000|Overall Study|Lack of Efficacy|2|||
127840484|NCT01397448|460031227|FG001|Overall Study|Lack of Efficacy|0|||
127840485|NCT01397448|460031228|FG002|Overall Study|Lack of Efficacy|5|||
127840486|NCT01397448|460031226|FG000|Overall Study|Other|8|||
127840487|NCT01397448|460031227|FG001|Overall Study|Other|7|||
127840488|NCT01397448|460031228|FG002|Overall Study|Other|4|||
127840489|NCT02180217|460031231|FG000|Overall Study|Adverse Event|3|||
127840490|NCT02180217|460031232|FG001|Overall Study|Adverse Event|2|||
127840491|NCT02180217|460031233|FG002|Overall Study|Adverse Event|22|||
127840492|NCT02180217|460031231|FG000|Overall Study|Death|1|||
127840493|NCT02180217|460031232|FG001|Overall Study|Death|1|||
127840494|NCT02180217|460031233|FG002|Overall Study|Death|0|||
127840495|NCT02180217|460031231|FG000|Overall Study|Withdrawal by Subject|1|||
127840496|NCT02180217|460031232|FG001|Overall Study|Withdrawal by Subject|1|||
127840497|NCT02180217|460031233|FG002|Overall Study|Withdrawal by Subject|4|||
127840498|NCT02180217|460031231|FG000|Overall Study|Subject/Guardian decision|5|||
127840499|NCT02180217|460031232|FG001|Overall Study|Subject/Guardian decision|3|||
127840500|NCT02180217|460031233|FG002|Overall Study|Subject/Guardian decision|6|||
127840501|NCT02180217|460031231|FG000|Overall Study|Physician Decision|1|||
127840502|NCT02180217|460031232|FG001|Overall Study|Physician Decision|1|||
127840503|NCT02180217|460031233|FG002|Overall Study|Physician Decision|6|||
127840504|NCT02180217|460031231|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
127840505|NCT02180217|460031232|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
127840506|NCT02180217|460031233|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
127840507|NCT00995670|460031238|FG000|Overall Study|Failed arterial cannulation|1|||
127840508|NCT00995670|460031239|FG001|Overall Study|Failed arterial cannulation|0|||
127840509|NCT00995670|460031240|FG002|Overall Study|Failed arterial cannulation|3|||
127840510|NCT03784027|460031248|FG000|Period 1|Withdrawal by Subject|0|||
127840511|NCT03784027|460031249|FG001|Period 1|Withdrawal by Subject|1|||
127840512|NCT01255306|460032785|FG000|Overall Study|Physician Decision|1|||
127840513|NCT01255306|460032786|FG001|Overall Study|Physician Decision|1|||
127840514|NCT01146951|460032787|FG000|Overall Study|Adverse Event|4|||
127840515|NCT01146951|460032788|FG001|Overall Study|Adverse Event|1|||
127840516|NCT00804843|460032792|FG000|Overall Study|Protocol Violation|1|||
127840517|NCT00804843|460032793|FG001|Overall Study|Protocol Violation|0|||
127840518|NCT00804843|460032792|FG000|Overall Study|Adverse Event|8|||
127840519|NCT00804843|460032793|FG001|Overall Study|Adverse Event|5|||
127840520|NCT00804843|460032792|FG000|Overall Study|Withdrawal by Subject|1|||
127840521|NCT00804843|460032793|FG001|Overall Study|Withdrawal by Subject|2|||
127840522|NCT02126670|460032800|FG000|Overall Study|Withdrawal by Subject|1|||
127840523|NCT02126670|460032801|FG001|Overall Study|Withdrawal by Subject|0|||
127840524|NCT02126670|460032802|FG002|Overall Study|Withdrawal by Subject|0|||
127840525|NCT02126670|460032803|FG003|Overall Study|Withdrawal by Subject|1|||
127840526|NCT01975246|460032806|FG000|Overall Study|Adverse Event|2|||
127840527|NCT01975246|460032807|FG001|Overall Study|Adverse Event|1|||
127840528|NCT01975246|460032806|FG000|Overall Study|Lack of Efficacy|1|||
127840529|NCT01975246|460032807|FG001|Overall Study|Lack of Efficacy|0|||
127840530|NCT01975246|460032806|FG000|Overall Study|Protocol Violation|1|||
127840531|NCT01975246|460032807|FG001|Overall Study|Protocol Violation|0|||
127840532|NCT01975246|460032806|FG000|Overall Study|Other than stated|0|||
127840533|NCT01975246|460032807|FG001|Overall Study|Other than stated|1|||
127840534|NCT01263093|460032808|FG000|Washout|Physician Decision|1|||
127840535|NCT01263093|460032809|FG001|Washout|Physician Decision|0|||
127840536|NCT01263093|460032808|FG000|Period 2|Adverse Event|1|||
127840537|NCT01263093|460032809|FG001|Period 2|Adverse Event|0|||
127840538|NCT00424346|460032810|FG000|Core Study|Adverse Event|5|||
127840539|NCT00424346|460032811|FG001|Core Study|Adverse Event|3|||
127840540|NCT00424346|460032812|FG002|Core Study|Adverse Event|1|||
127898554|NCT01611090|460251648|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
127840541|NCT00424346|460032813|FG003|Core Study|Adverse Event|1|||
127840542|NCT00424346|460032810|FG000|Core Study|Abnormal Laboratory Values|0|||
127840543|NCT00424346|460032811|FG001|Core Study|Abnormal Laboratory Values|1|||
127840544|NCT00424346|460032812|FG002|Core Study|Abnormal Laboratory Values|0|||
127840545|NCT00424346|460032813|FG003|Core Study|Abnormal Laboratory Values|0|||
127840546|NCT00424346|460032810|FG000|Core Study|Lack of Efficacy|1|||
127840547|NCT00424346|460032811|FG001|Core Study|Lack of Efficacy|3|||
127840548|NCT00424346|460032812|FG002|Core Study|Lack of Efficacy|0|||
127840549|NCT00424346|460032813|FG003|Core Study|Lack of Efficacy|4|||
127840550|NCT00424346|460032810|FG000|Core Study|Withdrawal by Subject|1|||
127840551|NCT00424346|460032811|FG001|Core Study|Withdrawal by Subject|0|||
127840552|NCT00424346|460032812|FG002|Core Study|Withdrawal by Subject|0|||
127840553|NCT00424346|460032813|FG003|Core Study|Withdrawal by Subject|2|||
127840554|NCT00424346|460032810|FG000|Core Study|Lost to Follow-up|1|||
127840555|NCT00424346|460032811|FG001|Core Study|Lost to Follow-up|1|||
127840556|NCT00424346|460032812|FG002|Core Study|Lost to Follow-up|0|||
127840557|NCT00424346|460032813|FG003|Core Study|Lost to Follow-up|0|||
127840558|NCT00424346|460032810|FG000|Core Study|Administrative Problems|1|||
127840559|NCT00424346|460032811|FG001|Core Study|Administrative Problems|0|||
127840560|NCT00424346|460032812|FG002|Core Study|Administrative Problems|1|||
127840561|NCT00424346|460032813|FG003|Core Study|Administrative Problems|0|||
127840562|NCT00424346|460032810|FG000|Core Study|Protocol Violation|0|||
127840563|NCT00424346|460032811|FG001|Core Study|Protocol Violation|0|||
127840564|NCT00424346|460032812|FG002|Core Study|Protocol Violation|2|||
127840565|NCT00424346|460032813|FG003|Core Study|Protocol Violation|0|||
127840566|NCT00424346|460032810|FG000|Extension Phase|Adverse Event|0|||
127840567|NCT00424346|460032811|FG001|Extension Phase|Adverse Event|9|||
127840568|NCT00424346|460032812|FG002|Extension Phase|Adverse Event|5|||
127840569|NCT00424346|460032813|FG003|Extension Phase|Adverse Event|4|||
127840570|NCT00424346|460032810|FG000|Extension Phase|Lack of Efficacy|0|||
127840571|NCT00424346|460032811|FG001|Extension Phase|Lack of Efficacy|16|||
127840572|NCT00424346|460032812|FG002|Extension Phase|Lack of Efficacy|14|||
127840573|NCT00424346|460032813|FG003|Extension Phase|Lack of Efficacy|11|||
127840574|NCT00424346|460032810|FG000|Extension Phase|Withdrawal by Subject|0|||
127840575|NCT00424346|460032811|FG001|Extension Phase|Withdrawal by Subject|5|||
127840576|NCT00424346|460032812|FG002|Extension Phase|Withdrawal by Subject|3|||
127840577|NCT00424346|460032813|FG003|Extension Phase|Withdrawal by Subject|4|||
127840578|NCT00424346|460032810|FG000|Extension Phase|Lost to Follow-up|0|||
127840579|NCT00424346|460032811|FG001|Extension Phase|Lost to Follow-up|2|||
127840580|NCT00424346|460032812|FG002|Extension Phase|Lost to Follow-up|0|||
127840581|NCT00424346|460032813|FG003|Extension Phase|Lost to Follow-up|0|||
127840582|NCT00424346|460032810|FG000|Extension Phase|Administrative Problems|0|||
127840583|NCT00424346|460032811|FG001|Extension Phase|Administrative Problems|69|||
127840584|NCT00424346|460032812|FG002|Extension Phase|Administrative Problems|32|||
127840585|NCT00424346|460032813|FG003|Extension Phase|Administrative Problems|35|||
127840586|NCT00424346|460032810|FG000|Extension Phase|Death|0|||
127840587|NCT00424346|460032811|FG001|Extension Phase|Death|0|||
127840588|NCT00424346|460032812|FG002|Extension Phase|Death|0|||
127840589|NCT00424346|460032813|FG003|Extension Phase|Death|1|||
127840590|NCT00424346|460032810|FG000|Extension Phase|Protocol Violation|0|||
127840591|NCT00424346|460032811|FG001|Extension Phase|Protocol Violation|1|||
127840592|NCT00424346|460032812|FG002|Extension Phase|Protocol Violation|1|||
127840593|NCT00424346|460032813|FG003|Extension Phase|Protocol Violation|0|||
127840594|NCT01827319|460032814|FG000|Overall Study|Lost to Follow-up|3|||
127840595|NCT00571519|460032815|FG000|Overall Study|Subject withdrew consent|0|||
127840596|NCT00571519|460032816|FG001|Overall Study|Subject withdrew consent|1|||
127840597|NCT00571519|460032817|FG002|Overall Study|Subject withdrew consent|0|||
127840598|NCT00571519|460032818|FG003|Overall Study|Subject withdrew consent|2|||
127840599|NCT00571519|460032819|FG004|Overall Study|Subject withdrew consent|1|||
127840600|NCT00571519|460032820|FG005|Overall Study|Subject withdrew consent|1|||
127840601|NCT00571519|460032821|FG006|Overall Study|Subject withdrew consent|2|||
127840602|NCT00571519|460032815|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
127840603|NCT00571519|460032816|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
127840604|NCT00571519|460032817|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
127840605|NCT00571519|460032818|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
127840606|NCT00571519|460032819|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
127840607|NCT00571519|460032820|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
127840608|NCT00571519|460032821|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
127840609|NCT00571519|460032815|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
127840610|NCT00571519|460032816|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
127840611|NCT00571519|460032817|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
127840612|NCT00571519|460032818|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
127840613|NCT00571519|460032819|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
127840614|NCT00571519|460032820|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
127840615|NCT00571519|460032821|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
127840616|NCT00571519|460032815|FG000|Overall Study|Termination of study by Sponsor|2|||
127898555|NCT01611090|460251649|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
127840617|NCT00571519|460032816|FG001|Overall Study|Termination of study by Sponsor|7|||
127840618|NCT00571519|460032817|FG002|Overall Study|Termination of study by Sponsor|10|||
127840619|NCT00571519|460032818|FG003|Overall Study|Termination of study by Sponsor|24|||
127840620|NCT00571519|460032819|FG004|Overall Study|Termination of study by Sponsor|8|||
127840621|NCT00571519|460032820|FG005|Overall Study|Termination of study by Sponsor|9|||
127840622|NCT00571519|460032821|FG006|Overall Study|Termination of study by Sponsor|22|||
127840623|NCT00571519|460032815|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
127840624|NCT00571519|460032816|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
127840625|NCT00571519|460032817|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
127840626|NCT00571519|460032818|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
127898556|NCT01298570|460253466|FG000|Overall Study|Disease progression, relapse during acti|64|||
127898557|NCT01298570|460253467|FG001|Overall Study|Disease progression, relapse during acti|40|||
127898558|NCT01298570|460253466|FG000|Overall Study|Adverse Event|20|||
127898559|NCT01298570|460253467|FG001|Overall Study|Adverse Event|2|||
127898560|NCT01298570|460253466|FG000|Overall Study|Withdrawal by Subject|21|||
127898561|NCT01298570|460253467|FG001|Overall Study|Withdrawal by Subject|6|||
127898562|NCT01298570|460253466|FG000|Overall Study|Treatment delay > 4 weeks|4|||
127898563|NCT01298570|460253467|FG001|Overall Study|Treatment delay > 4 weeks|5|||
127898564|NCT01298570|460253466|FG000|Overall Study|Physician Decision|4|||
127898565|NCT01298570|460253467|FG001|Overall Study|Physician Decision|2|||
127898566|NCT01298570|460253466|FG000|Overall Study|Other complicating disease|2|||
127898567|NCT01298570|460253467|FG001|Overall Study|Other complicating disease|1|||
127898568|NCT01298570|460253466|FG000|Overall Study|Surgery|2|||
127840627|NCT00571519|460032819|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
127840628|NCT00571519|460032820|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
127840629|NCT00571519|460032821|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
127840630|NCT00562640|460032823|FG000|Overall Study|Death|0|||
127840631|NCT00562640|460032824|FG001|Overall Study|Death|1|||
127840632|NCT00562640|460032825|FG002|Overall Study|Death|1|||
127840633|NCT00562640|460032826|FG003|Overall Study|Death|0|||
127840634|NCT05263921|460032827|FG000|Overall Study|Other: family emergency.|0|||
127840635|NCT05263921|460032828|FG001|Overall Study|Other: family emergency.|0|||
127840636|NCT05263921|460032829|FG002|Overall Study|Other: family emergency.|1|||
127840637|NCT05263921|460032830|FG003|Overall Study|Other: family emergency.|0|||
127840638|NCT02499575|460032831|FG000|Overall Study|Protocol Violation|0|||
127840639|NCT02499575|460032832|FG001|Overall Study|Protocol Violation|1|||
127840640|NCT02658968|460032833|FG000|Received Rituximab|Adverse Event|0|||
127840641|NCT02658968|460032834|FG001|Received Rituximab|Adverse Event|0|||
127840642|NCT02658968|460032835|FG002|Received Rituximab|Adverse Event|0|||
127840643|NCT02658968|460032836|FG003|Received Rituximab|Adverse Event|0|||
127840644|NCT02658968|460032837|FG004|Received Rituximab|Adverse Event|1|||
127840645|NCT02658968|460032833|FG000|Received Rituximab|Progressive disease|0|||
127840646|NCT02658968|460032834|FG001|Received Rituximab|Progressive disease|0|||
127840647|NCT02658968|460032835|FG002|Received Rituximab|Progressive disease|0|||
127840648|NCT02658968|460032836|FG003|Received Rituximab|Progressive disease|0|||
127840649|NCT02658968|460032837|FG004|Received Rituximab|Progressive disease|1|||
127840650|NCT02658968|460032833|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
127840651|NCT02658968|460032834|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
127840652|NCT02658968|460032835|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
127840653|NCT02658968|460032836|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
127840654|NCT02658968|460032837|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
127840655|NCT02658968|460032833|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
127840656|NCT02658968|460032834|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
127840657|NCT02658968|460032835|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
127840658|NCT02658968|460032836|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
127840659|NCT02658968|460032837|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
127840660|NCT02658968|460032833|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
127840661|NCT02658968|460032834|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
127840662|NCT02658968|460032835|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
127840663|NCT02658968|460032836|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
127840664|NCT02658968|460032837|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
127840665|NCT02658968|460032833|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
127840666|NCT02658968|460032834|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
127840667|NCT02658968|460032835|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
127840668|NCT02658968|460032836|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
127840669|NCT02658968|460032837|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
127840670|NCT02658968|460032833|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
127840671|NCT02658968|460032834|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
127840672|NCT02658968|460032835|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
127840673|NCT02658968|460032836|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
127840674|NCT02658968|460032837|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
127840675|NCT00912340|460032849|FG000|Overall Study|Adverse Event|2|||
127840676|NCT00912340|460032850|FG001|Overall Study|Adverse Event|4|||
127840677|NCT00912340|460032851|FG002|Overall Study|Adverse Event|0|||
127840678|NCT00912340|460032849|FG000|Overall Study|Protocol revised to remove arm|0|||
127898569|NCT01298570|460253467|FG001|Overall Study|Surgery|1|||
127898570|NCT01298570|460253466|FG000|Overall Study|Symptomatic progression/deterioration|3|||
127898571|NCT01298570|460253467|FG001|Overall Study|Symptomatic progression/deterioration|2|||
127898572|NCT01298570|460253466|FG000|Overall Study|Death|0|||
127898573|NCT01298570|460253467|FG001|Overall Study|Death|1|||
127898574|NCT01298570|460253466|FG000|Overall Study|Ineligibility|0|||
127898575|NCT01298570|460253467|FG001|Overall Study|Ineligibility|1|||
127898576|NCT01210001|460253468|FG000|Overall Study|Not treated|1|||
127898577|NCT01210001|460253469|FG001|Overall Study|Not treated|0|||
127840679|NCT00912340|460032850|FG001|Overall Study|Protocol revised to remove arm|0|||
127840680|NCT00912340|460032851|FG002|Overall Study|Protocol revised to remove arm|4|||
127840681|NCT01061736|460032856|FG000|Overall Study|Dose regimen not selected|0|||
127840682|NCT01061736|460032857|FG001|Overall Study|Dose regimen not selected|0|||
127898578|NCT01210001|460253470|FG002|Overall Study|Not treated|0|||
127898579|NCT01210001|460253468|FG000|Overall Study|Adverse Event|4|||
127898580|NCT01210001|460253469|FG001|Overall Study|Adverse Event|2|||
127898581|NCT01210001|460253470|FG002|Overall Study|Adverse Event|5|||
127898582|NCT01210001|460253468|FG000|Overall Study|Non compliant with protocol|2|||
127898583|NCT01210001|460253469|FG001|Overall Study|Non compliant with protocol|2|||
127898584|NCT01210001|460253470|FG002|Overall Study|Non compliant with protocol|3|||
127898585|NCT01210001|460253468|FG000|Overall Study|Lost to Follow-up|4|||
127898586|NCT01210001|460253469|FG001|Overall Study|Lost to Follow-up|3|||
127898587|NCT01210001|460253470|FG002|Overall Study|Lost to Follow-up|2|||
127898588|NCT01210001|460253468|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
127898589|NCT01210001|460253469|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
127898590|NCT01210001|460253470|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
127898591|NCT01210001|460253468|FG000|Overall Study|Other reason not defined above|2|||
127898592|NCT01210001|460253469|FG001|Overall Study|Other reason not defined above|2|||
127898593|NCT01210001|460253470|FG002|Overall Study|Other reason not defined above|1|||
127898594|NCT01739790|460253471|FG000|Overall Study|Early Trial Termination|2|||
127898595|NCT01739790|460253472|FG001|Overall Study|Early Trial Termination|4|||
127898596|NCT01451762|460253476|FG000|Overall Study|Lost to Follow-up|3|||
127898597|NCT01451762|460253477|FG001|Overall Study|Lost to Follow-up|6|||
127898598|NCT01451762|460253478|FG002|Overall Study|Lost to Follow-up|6|||
127898599|NCT00502775|460253484|FG000|Overall Study|Adverse Event|1|||
127898600|NCT00502775|460253485|FG001|Overall Study|Adverse Event|2|||
127898601|NCT00502775|460253486|FG002|Overall Study|Adverse Event|1|||
127898602|NCT00502775|460253484|FG000|Overall Study|Protocol Violation|1|||
127898603|NCT00502775|460253485|FG001|Overall Study|Protocol Violation|5|||
127898604|NCT00502775|460253486|FG002|Overall Study|Protocol Violation|2|||
127898605|NCT00502775|460253484|FG000|Overall Study|Withdrawal by Subject|1|||
127898606|NCT00502775|460253485|FG001|Overall Study|Withdrawal by Subject|1|||
127898607|NCT00502775|460253486|FG002|Overall Study|Withdrawal by Subject|2|||
127898608|NCT00502775|460253484|FG000|Overall Study|Sponsor Terminated Study|1|||
127898609|NCT00502775|460253485|FG001|Overall Study|Sponsor Terminated Study|0|||
127840683|NCT01061736|460032858|FG002|Overall Study|Dose regimen not selected|0|||
127840684|NCT01061736|460032859|FG003|Overall Study|Dose regimen not selected|0|||
127840685|NCT01061736|460032860|FG004|Overall Study|Dose regimen not selected|0|||
127840686|NCT01061736|460032861|FG005|Overall Study|Dose regimen not selected|0|||
127840687|NCT01061736|460032862|FG006|Overall Study|Dose regimen not selected|79|||
127840688|NCT01061736|460032863|FG007|Overall Study|Dose regimen not selected|0|||
127840689|NCT01061736|460032864|FG008|Overall Study|Dose regimen not selected|0|||
127840690|NCT01061736|460032865|FG009|Overall Study|Dose regimen not selected|0|||
127840691|NCT01061736|460032856|FG000|Overall Study|Adverse Event|13|||
127840692|NCT01061736|460032857|FG001|Overall Study|Adverse Event|1|||
127840693|NCT01061736|460032858|FG002|Overall Study|Adverse Event|3|||
127840694|NCT01061736|460032859|FG003|Overall Study|Adverse Event|2|||
127840695|NCT01061736|460032860|FG004|Overall Study|Adverse Event|4|||
127840696|NCT01061736|460032861|FG005|Overall Study|Adverse Event|1|||
127840697|NCT01061736|460032862|FG006|Overall Study|Adverse Event|4|||
127840698|NCT01061736|460032863|FG007|Overall Study|Adverse Event|63|||
127898610|NCT00502775|460253486|FG002|Overall Study|Sponsor Terminated Study|1|||
127898611|NCT00502775|460253484|FG000|Overall Study|Non-compliance with eDiary|4|||
127898612|NCT00502775|460253485|FG001|Overall Study|Non-compliance with eDiary|1|||
127898613|NCT00502775|460253486|FG002|Overall Study|Non-compliance with eDiary|1|||
127898614|NCT00502775|460253484|FG000|Overall Study|Subject unable to swallow capsule|1|||
127898615|NCT00502775|460253485|FG001|Overall Study|Subject unable to swallow capsule|0|||
127898616|NCT00502775|460253486|FG002|Overall Study|Subject unable to swallow capsule|1|||
127898617|NCT00502775|460253484|FG000|Overall Study|Logpad compliance <80%|1|||
127898618|NCT00502775|460253485|FG001|Overall Study|Logpad compliance <80%|0|||
127898619|NCT00502775|460253486|FG002|Overall Study|Logpad compliance <80%|0|||
127898620|NCT00502775|460253484|FG000|Overall Study|Randomized in error|0|||
127840699|NCT01061736|460032864|FG008|Overall Study|Adverse Event|67|||
127840700|NCT01061736|460032865|FG009|Overall Study|Adverse Event|34|||
127840701|NCT01061736|460032856|FG000|Overall Study|Lack of Efficacy|0|||
127840702|NCT01061736|460032857|FG001|Overall Study|Lack of Efficacy|2|||
127840703|NCT01061736|460032858|FG002|Overall Study|Lack of Efficacy|1|||
127898621|NCT00502775|460253485|FG001|Overall Study|Randomized in error|1|||
127898622|NCT00502775|460253486|FG002|Overall Study|Randomized in error|1|||
127898623|NCT00502775|460253484|FG000|Overall Study|Non-compliance|0|||
127898624|NCT00502775|460253485|FG001|Overall Study|Non-compliance|2|||
127898625|NCT00502775|460253486|FG002|Overall Study|Non-compliance|2|||
127898626|NCT00502775|460253484|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
127898627|NCT00502775|460253485|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
127898628|NCT00502775|460253486|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
127898629|NCT00502775|460253484|FG000|Overall Study|Declining pollen counts|0|||
127898630|NCT00502775|460253485|FG001|Overall Study|Declining pollen counts|1|||
127898631|NCT00502775|460253486|FG002|Overall Study|Declining pollen counts|1|||
127898632|NCT00502775|460253484|FG000|Overall Study|Subject in jail|0|||
127898633|NCT00502775|460253485|FG001|Overall Study|Subject in jail|1|||
127898634|NCT00502775|460253486|FG002|Overall Study|Subject in jail|0|||
127898635|NCT00502775|460253484|FG000|Overall Study|Subject took disallowed drug|0|||
127898636|NCT00502775|460253485|FG001|Overall Study|Subject took disallowed drug|0|||
127898637|NCT00502775|460253486|FG002|Overall Study|Subject took disallowed drug|1|||
127898638|NCT00287118|460253488|FG000|Overall Study|Adverse Event|30|||
127898639|NCT00287118|460253488|FG000|Overall Study|Death|1|||
127898640|NCT00287118|460253488|FG000|Overall Study|Lack of Efficacy|11|||
127840704|NCT01061736|460032859|FG003|Overall Study|Lack of Efficacy|1|||
127840705|NCT01061736|460032860|FG004|Overall Study|Lack of Efficacy|1|||
127840706|NCT01061736|460032861|FG005|Overall Study|Lack of Efficacy|2|||
127840707|NCT01061736|460032862|FG006|Overall Study|Lack of Efficacy|1|||
127840708|NCT01061736|460032863|FG007|Overall Study|Lack of Efficacy|9|||
127840709|NCT01061736|460032864|FG008|Overall Study|Lack of Efficacy|9|||
127840710|NCT01061736|460032865|FG009|Overall Study|Lack of Efficacy|10|||
127840711|NCT01061736|460032856|FG000|Overall Study|Poor compliance to protocol|0|||
127840712|NCT01061736|460032857|FG001|Overall Study|Poor compliance to protocol|0|||
127840713|NCT01061736|460032858|FG002|Overall Study|Poor compliance to protocol|0|||
127840714|NCT01061736|460032859|FG003|Overall Study|Poor compliance to protocol|0|||
127840715|NCT01061736|460032860|FG004|Overall Study|Poor compliance to protocol|0|||
127840716|NCT01061736|460032861|FG005|Overall Study|Poor compliance to protocol|0|||
127840717|NCT01061736|460032862|FG006|Overall Study|Poor compliance to protocol|0|||
127840718|NCT01061736|460032863|FG007|Overall Study|Poor compliance to protocol|2|||
127840719|NCT01061736|460032864|FG008|Overall Study|Poor compliance to protocol|5|||
127840720|NCT01061736|460032865|FG009|Overall Study|Poor compliance to protocol|9|||
127840721|NCT01061736|460032856|FG000|Overall Study|Not treated|0|||
127840722|NCT01061736|460032857|FG001|Overall Study|Not treated|0|||
127840723|NCT01061736|460032858|FG002|Overall Study|Not treated|0|||
127840724|NCT01061736|460032859|FG003|Overall Study|Not treated|0|||
127840725|NCT01061736|460032860|FG004|Overall Study|Not treated|1|||
127840726|NCT01061736|460032861|FG005|Overall Study|Not treated|0|||
127840727|NCT01061736|460032862|FG006|Overall Study|Not treated|0|||
127840728|NCT01061736|460032863|FG007|Overall Study|Not treated|2|||
127840729|NCT01061736|460032864|FG008|Overall Study|Not treated|1|||
127840730|NCT01061736|460032865|FG009|Overall Study|Not treated|0|||
127840731|NCT01061736|460032856|FG000|Overall Study|Other than specified above|0|||
127840732|NCT01061736|460032857|FG001|Overall Study|Other than specified above|1|||
127840733|NCT01061736|460032858|FG002|Overall Study|Other than specified above|2|||
127840734|NCT01061736|460032859|FG003|Overall Study|Other than specified above|0|||
127840735|NCT01061736|460032860|FG004|Overall Study|Other than specified above|1|||
127840736|NCT01061736|460032861|FG005|Overall Study|Other than specified above|0|||
127840737|NCT01061736|460032862|FG006|Overall Study|Other than specified above|0|||
127840738|NCT01061736|460032863|FG007|Overall Study|Other than specified above|18|||
127840739|NCT01061736|460032864|FG008|Overall Study|Other than specified above|15|||
127840740|NCT01061736|460032865|FG009|Overall Study|Other than specified above|21|||
127840741|NCT01610076|460032866|FG000|Overall Study|Technical issue with video|0|||
127840742|NCT01610076|460032867|FG001|Overall Study|Technical issue with video|1|||
127840743|NCT01610076|460032866|FG000|Overall Study|Lost to Follow-up|3|||
127840744|NCT01610076|460032867|FG001|Overall Study|Lost to Follow-up|4|||
127840745|NCT02680587|460032870|FG000|Overall Study|Withdrawal by Subject|1|||
127840746|NCT02680587|460032871|FG001|Overall Study|Withdrawal by Subject|0|||
127840747|NCT02899377|460032872|FG000|Overall Study|Adverse Event|1|||
127840748|NCT02899377|460032873|FG001|Overall Study|Adverse Event|0|||
127840749|NCT00469209|460032874|FG000|Overall Study|Adverse Event|1|||
127840750|NCT00469209|460032875|FG001|Overall Study|Adverse Event|0|||
127840751|NCT00469209|460032876|FG002|Overall Study|Adverse Event|1|||
127898641|NCT00287118|460253488|FG000|Overall Study|Lost to Follow-up|1|||
127840752|NCT00865189|460032882|FG000|Overall Study|Other|1|||
127840753|NCT00865189|460032883|FG001|Overall Study|Other|2|||
127840754|NCT00865189|460032882|FG000|Overall Study|Death|4|||
127840755|NCT00865189|460032883|FG001|Overall Study|Death|11|||
127840756|NCT00865189|460032882|FG000|Overall Study|Lost to Follow-up|6|||
127840757|NCT00865189|460032883|FG001|Overall Study|Lost to Follow-up|6|||
127840758|NCT00865189|460032882|FG000|Overall Study|Withdrawal by Subject|1|||
127840759|NCT00865189|460032883|FG001|Overall Study|Withdrawal by Subject|0|||
127840760|NCT00843843|460032892|FG000|Overall Study|Physician Decision|1|||
127898642|NCT00287118|460253488|FG000|Overall Study|Protocol Violation|2|||
127840761|NCT00843843|460032893|FG001|Overall Study|Physician Decision|1|||
127840762|NCT00843843|460032892|FG000|Overall Study|Protocol Violation|1|||
127898643|NCT00287118|460253488|FG000|Overall Study|Other|7|||
127898644|NCT04471207|460253489|FG000|Overall Study|Lost to Follow-up|4|||
127898645|NCT04471207|460253490|FG001|Overall Study|Lost to Follow-up|1|||
127840763|NCT00843843|460032893|FG001|Overall Study|Protocol Violation|1|||
127840764|NCT01594333|460032894|FG000|Overall Study|Death|96|||
127840765|NCT01594333|460032895|FG001|Overall Study|Death|83|||
127840766|NCT01594333|460032894|FG000|Overall Study|Lost to Follow-up|5|||
127840767|NCT01594333|460032895|FG001|Overall Study|Lost to Follow-up|5|||
127840768|NCT01594333|460032894|FG000|Overall Study|Withdrawal by Subject|60|||
127840769|NCT01594333|460032895|FG001|Overall Study|Withdrawal by Subject|63|||
127840770|NCT00565058|460032896|FG000|Overall Study|Adverse Event|1|||
127840771|NCT00565058|460032897|FG001|Overall Study|Adverse Event|0|||
127840772|NCT00830804|460032900|FG000|Overall Study|Lost to Follow-up|4|||
127840773|NCT00830804|460032900|FG000|Overall Study|Death|1|||
127840774|NCT00830804|460032900|FG000|Overall Study|Unable to get to clinic|7|||
127840775|NCT00830804|460032900|FG000|Overall Study|Consent withdrawn|2|||
127840776|NCT00830804|460032900|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
127840777|NCT03691610|460032908|FG000|Overall Study|Adverse Event|0|||
127840778|NCT03691610|460032909|FG001|Overall Study|Adverse Event|1|||
127840779|NCT03691610|460032910|FG002|Overall Study|Adverse Event|0|||
127840780|NCT03691610|460032911|FG003|Overall Study|Adverse Event|0|||
127840781|NCT03691610|460032908|FG000|Overall Study|Protocol Deviation|15|||
127840782|NCT03691610|460032909|FG001|Overall Study|Protocol Deviation|8|||
127840783|NCT03691610|460032910|FG002|Overall Study|Protocol Deviation|1|||
127840784|NCT03691610|460032911|FG003|Overall Study|Protocol Deviation|2|||
127840785|NCT03691610|460032908|FG000|Overall Study|Withdrawal by Parent/Guardian|47|||
127840786|NCT03691610|460032909|FG001|Overall Study|Withdrawal by Parent/Guardian|60|||
127840787|NCT03691610|460032910|FG002|Overall Study|Withdrawal by Parent/Guardian|7|||
127840788|NCT03691610|460032911|FG003|Overall Study|Withdrawal by Parent/Guardian|6|||
127840789|NCT03691610|460032908|FG000|Overall Study|Lost to Follow-up|20|||
127840790|NCT03691610|460032909|FG001|Overall Study|Lost to Follow-up|11|||
127840791|NCT03691610|460032910|FG002|Overall Study|Lost to Follow-up|5|||
127840792|NCT03691610|460032911|FG003|Overall Study|Lost to Follow-up|2|||
127840793|NCT02475395|460032916|FG000|Overall Study|Protocol Violation|30|||
127840794|NCT02475395|460032917|FG001|Overall Study|Protocol Violation|3|||
127840795|NCT03730194|460032918|FG000|First Stage Treatment|Withdrawal by Subject|1|||
127840796|NCT03730194|460032919|FG001|First Stage Treatment|Withdrawal by Subject|1|||
127840797|NCT03730194|460032920|FG002|First Stage Treatment|Withdrawal by Subject|0|||
127840798|NCT03730194|460032921|FG003|First Stage Treatment|Withdrawal by Subject|0|||
127840799|NCT03730194|460032922|FG004|First Stage Treatment|Withdrawal by Subject|0|||
127840800|NCT03730194|460032923|FG005|First Stage Treatment|Withdrawal by Subject|0|||
127840801|NCT03730194|460032918|FG000|First Stage Treatment|Protocol Violation|3|||
127840802|NCT03730194|460032919|FG001|First Stage Treatment|Protocol Violation|3|||
127840803|NCT03730194|460032920|FG002|First Stage Treatment|Protocol Violation|0|||
127840804|NCT03730194|460032921|FG003|First Stage Treatment|Protocol Violation|0|||
127840805|NCT03730194|460032922|FG004|First Stage Treatment|Protocol Violation|0|||
127840806|NCT03730194|460032923|FG005|First Stage Treatment|Protocol Violation|0|||
127840807|NCT00115765|460032924|FG000|Overall Study|Withdrawal by Subject|22|||
127840808|NCT00115765|460032925|FG001|Overall Study|Withdrawal by Subject|53|||
127840809|NCT00115765|460032926|FG002|Overall Study|Withdrawal by Subject|76|||
127840810|NCT00115765|460032927|FG003|Overall Study|Withdrawal by Subject|15|||
127840811|NCT00115765|460032924|FG000|Overall Study|Physician Decision|4|||
127840812|NCT00115765|460032925|FG001|Overall Study|Physician Decision|15|||
127840813|NCT00115765|460032926|FG002|Overall Study|Physician Decision|18|||
127840814|NCT00115765|460032927|FG003|Overall Study|Physician Decision|13|||
127840815|NCT00115765|460032924|FG000|Overall Study|Lost to Follow-up|3|||
127840816|NCT00115765|460032925|FG001|Overall Study|Lost to Follow-up|20|||
127840817|NCT00115765|460032926|FG002|Overall Study|Lost to Follow-up|18|||
127840818|NCT00115765|460032927|FG003|Overall Study|Lost to Follow-up|1|||
127840819|NCT00115765|460032924|FG000|Overall Study|Other|6|||
127840820|NCT00115765|460032925|FG001|Overall Study|Other|12|||
127840821|NCT00115765|460032926|FG002|Overall Study|Other|9|||
127840822|NCT00115765|460032927|FG003|Overall Study|Other|2|||
127840823|NCT00567541|460032929|FG000|Overall Study|Adverse Event|0|||
127840824|NCT00567541|460032930|FG001|Overall Study|Adverse Event|1|||
127840825|NCT01890512|460032931|FG000|Overall Study|Physician Decision|1|||
127840826|NCT01890512|460032931|FG000|Overall Study|Withdrawal by Subject|1|||
127840827|NCT01890512|460032931|FG000|Overall Study|Protocol Violation|1|||
127840828|NCT03519516|460032932|FG000|Overall Study|Adverse Event|0|||
127840829|NCT03519516|460032933|FG001|Overall Study|Adverse Event|1|||
127840830|NCT01935336|460032934|FG000|Overall Study|Adverse Event|1|||
127840831|NCT01935336|460032935|FG001|Overall Study|Adverse Event|0|||
127840832|NCT01935336|460032936|FG002|Overall Study|Adverse Event|0|||
127840833|NCT01935336|460032937|FG003|Overall Study|Adverse Event|0|||
127840834|NCT01935336|460032934|FG000|Overall Study|Progressive disease|5|||
127840835|NCT01935336|460032935|FG001|Overall Study|Progressive disease|3|||
127840836|NCT01935336|460032936|FG002|Overall Study|Progressive disease|47|||
127840837|NCT01935336|460032937|FG003|Overall Study|Progressive disease|66|||
127840838|NCT03337139|460032940|FG000|Phase I|Withdrawal by Subject|10|||
127840839|NCT03337139|460032941|FG001|Phase I|Withdrawal by Subject|0|||
127840840|NCT03288493|460032942|FG000|Overall Study|Withdrawal by Subject|4|||
127840841|NCT03288493|460032943|FG001|Overall Study|Withdrawal by Subject|0|||
127840842|NCT03288493|460032944|FG002|Overall Study|Withdrawal by Subject|0|||
127840843|NCT03288493|460032945|FG003|Overall Study|Withdrawal by Subject|0|||
127840844|NCT03288493|460032946|FG004|Overall Study|Withdrawal by Subject|0|||
127840845|NCT03288493|460032947|FG005|Overall Study|Withdrawal by Subject|2|||
127840846|NCT03288493|460032948|FG006|Overall Study|Withdrawal by Subject|0|||
127840847|NCT03288493|460032942|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
127840848|NCT03288493|460032943|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
127840849|NCT03288493|460032944|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
127840850|NCT03288493|460032945|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
127840851|NCT03288493|460032946|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
127840852|NCT03288493|460032947|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
127840853|NCT03288493|460032948|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
127840854|NCT03288493|460032942|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
127840855|NCT03288493|460032943|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
127840856|NCT03288493|460032944|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
127840857|NCT03288493|460032945|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
127840858|NCT03288493|460032946|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
127840859|NCT03288493|460032947|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
127840860|NCT03288493|460032948|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
127840861|NCT03288493|460032942|FG000|Overall Study|Death|2|||
127840862|NCT03288493|460032943|FG001|Overall Study|Death|0|||
127840863|NCT03288493|460032944|FG002|Overall Study|Death|0|||
127840864|NCT03288493|460032945|FG003|Overall Study|Death|0|||
127840865|NCT03288493|460032946|FG004|Overall Study|Death|0|||
127840866|NCT03288493|460032947|FG005|Overall Study|Death|0|||
127840867|NCT03288493|460032948|FG006|Overall Study|Death|0|||
127840868|NCT03288493|460032942|FG000|Overall Study|other reason not listed above|2|||
127840869|NCT03288493|460032943|FG001|Overall Study|other reason not listed above|0|||
127840870|NCT03288493|460032944|FG002|Overall Study|other reason not listed above|0|||
127840871|NCT03288493|460032945|FG003|Overall Study|other reason not listed above|0|||
127840872|NCT03288493|460032946|FG004|Overall Study|other reason not listed above|0|||
127840873|NCT03288493|460032947|FG005|Overall Study|other reason not listed above|0|||
127840874|NCT03288493|460032948|FG006|Overall Study|other reason not listed above|0|||
127840875|NCT04095442|460035239|FG000|Overall Study|Lost to Follow-up|0|||
127840876|NCT04095442|460035240|FG001|Overall Study|Lost to Follow-up|1|||
127840877|NCT04095442|460035239|FG000|Overall Study|Screen failure|1|||
127840878|NCT04095442|460035240|FG001|Overall Study|Screen failure|0|||
127840879|NCT03947255|460035243|FG000|Overall Study|Study Closure by Sponsor|2|||
127840880|NCT03947255|460035244|FG001|Overall Study|Study Closure by Sponsor|2|||
127840881|NCT03947255|460035243|FG000|Overall Study|Withdrawal by Subject|2|||
127840882|NCT03947255|460035244|FG001|Overall Study|Withdrawal by Subject|2|||
127840883|NCT03947255|460035243|FG000|Overall Study|Lost to Follow-up|2|||
127840884|NCT03947255|460035244|FG001|Overall Study|Lost to Follow-up|0|||
127840885|NCT03947255|460035243|FG000|Overall Study|Death|0|||
127840886|NCT03947255|460035244|FG001|Overall Study|Death|2|||
127840887|NCT04656418|460035245|FG000|Overall Study|Withdrawal by Subject|1|||
127840888|NCT04656418|460035246|FG001|Overall Study|Withdrawal by Subject|3|||
127840889|NCT00603733|460035248|FG000|Active Phase ITT|Adverse Event|8|||
127840890|NCT00603733|460035249|FG001|Active Phase ITT|Adverse Event|7|||
127840891|NCT00603733|460035248|FG000|Active Phase ITT|Withdrawal by Subject|0|||
127840892|NCT00603733|460035249|FG001|Active Phase ITT|Withdrawal by Subject|3|||
127840893|NCT00603733|460035248|FG000|Active Phase ITT|Lost to Follow-up|0|||
127840894|NCT00603733|460035249|FG001|Active Phase ITT|Lost to Follow-up|1|||
127840895|NCT00603733|460035248|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
127840896|NCT00603733|460035249|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
127840897|NCT00603733|460035248|FG000|Active Phase ITT|Lack of Efficacy|1|||
127840898|NCT00603733|460035249|FG001|Active Phase ITT|Lack of Efficacy|2|||
127840899|NCT00603733|460035248|FG000|Active Phase ITT|Subject moved, site closed|1|||
127840900|NCT00603733|460035249|FG001|Active Phase ITT|Subject moved, site closed|1|||
127840901|NCT00603733|460035248|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
127840902|NCT00603733|460035249|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
127840903|NCT00603733|460035248|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
127840904|NCT00603733|460035249|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
127840905|NCT00603733|460035248|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
127840906|NCT00603733|460035249|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
127840907|NCT00603733|460035248|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
127840908|NCT00603733|460035249|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
127840909|NCT00603733|460035248|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
127840910|NCT00603733|460035249|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
127840911|NCT00603733|460035248|FG000|Maintenance Phase ITT|Adverse Event|3|||
127840912|NCT00603733|460035249|FG001|Maintenance Phase ITT|Adverse Event|6|||
127840913|NCT00603733|460035248|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
127840914|NCT00603733|460035249|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
127840915|NCT00603733|460035248|FG000|Maintenance Phase ITT|Protocol Violation|1|||
127840916|NCT00603733|460035249|FG001|Maintenance Phase ITT|Protocol Violation|1|||
127840917|NCT00603733|460035248|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
127840918|NCT00603733|460035249|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
127840919|NCT00603733|460035248|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
127840920|NCT00603733|460035249|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
127840921|NCT00603733|460035248|FG000|Maintenance Phase ITT|Physician Decision|0|||
127840922|NCT00603733|460035249|FG001|Maintenance Phase ITT|Physician Decision|1|||
127840923|NCT00603733|460035248|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
127840924|NCT00603733|460035249|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
127840925|NCT01297309|460035256|FG000|Overall Study|Eligibility failure|2|||
127840926|NCT01297309|460035256|FG000|Overall Study|Screen failure|2|||
127840927|NCT01297309|460035256|FG000|Overall Study|Withdrawal by Subject|5|||
127840928|NCT01297309|460035256|FG000|Overall Study|Adverse Event|1|||
127840929|NCT01297309|460035256|FG000|Overall Study|Investigator Decision|2|||
127840930|NCT01297309|460035256|FG000|Overall Study|Death|1|||
127840931|NCT01297309|460035256|FG000|Overall Study|Participant not entering extensionperiod|1|||
127840932|NCT03039738|460035257|FG000|Overall Study|Incomplete data sets|54|||
127840933|NCT03039738|460035258|FG001|Overall Study|Incomplete data sets|0|||
127840934|NCT01149343|460035263|FG000|Overall Study|Withdrawal by Subject|1|||
127840935|NCT01149343|460035264|FG001|Overall Study|Withdrawal by Subject|1|||
127840936|NCT01149343|460035265|FG002|Overall Study|Withdrawal by Subject|1|||
127840937|NCT01149343|460035266|FG003|Overall Study|Withdrawal by Subject|5|||
127840938|NCT01149343|460035263|FG000|Overall Study|Death|10|||
127840939|NCT01149343|460035264|FG001|Overall Study|Death|13|||
127840940|NCT01149343|460035265|FG002|Overall Study|Death|18|||
127840941|NCT01149343|460035266|FG003|Overall Study|Death|18|||
127840942|NCT01149343|460035263|FG000|Overall Study|Lost to Follow-up|1|||
127840943|NCT01149343|460035264|FG001|Overall Study|Lost to Follow-up|0|||
127840944|NCT01149343|460035265|FG002|Overall Study|Lost to Follow-up|0|||
127840945|NCT01149343|460035266|FG003|Overall Study|Lost to Follow-up|1|||
127840946|NCT01149343|460035263|FG000|Overall Study|Other|8|||
127840947|NCT01149343|460035264|FG001|Overall Study|Other|10|||
127840948|NCT01149343|460035265|FG002|Overall Study|Other|2|||
127840949|NCT01149343|460035266|FG003|Overall Study|Other|14|||
127840950|NCT01149343|460035263|FG000|Overall Study|Sponsor study termination|0|||
127840951|NCT01149343|460035264|FG001|Overall Study|Sponsor study termination|0|||
127840952|NCT01149343|460035265|FG002|Overall Study|Sponsor study termination|0|||
127840953|NCT01149343|460035266|FG003|Overall Study|Sponsor study termination|2|||
127840954|NCT01149343|460035263|FG000|Overall Study|Recurrence / Progressive disease|0|||
127840955|NCT01149343|460035264|FG001|Overall Study|Recurrence / Progressive disease|0|||
127840956|NCT01149343|460035265|FG002|Overall Study|Recurrence / Progressive disease|1|||
127840957|NCT01149343|460035266|FG003|Overall Study|Recurrence / Progressive disease|0|||
127840958|NCT01093755|460035267|FG000|Overall Study|Withdrawal by Subject|3|||
127840959|NCT01093755|460035268|FG001|Overall Study|Withdrawal by Subject|4|||
127840960|NCT00085917|460035272|FG000|Overall Study|Adverse Event|4|||
127840961|NCT00085917|460035273|FG001|Overall Study|Adverse Event|3|||
127840962|NCT01429077|460035274|FG000|Overall Study|Lost to Follow-up|0|||
127840963|NCT01429077|460035275|FG001|Overall Study|Lost to Follow-up|3|||
127840964|NCT03067129|460035277|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
127840965|NCT03067129|460035278|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
127840966|NCT03067129|460035279|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
127840967|NCT03067129|460035280|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
127840968|NCT03067129|460035277|FG000|Overall Study|Withdrawal by Subject|0|||
127840969|NCT03067129|460035278|FG001|Overall Study|Withdrawal by Subject|0|||
127840970|NCT03067129|460035279|FG002|Overall Study|Withdrawal by Subject|1|||
127840971|NCT03067129|460035280|FG003|Overall Study|Withdrawal by Subject|2|||
127840972|NCT03067129|460035277|FG000|Overall Study|Lost to Follow-up|5|||
127840973|NCT03067129|460035278|FG001|Overall Study|Lost to Follow-up|5|||
127840974|NCT03067129|460035279|FG002|Overall Study|Lost to Follow-up|4|||
127840975|NCT03067129|460035280|FG003|Overall Study|Lost to Follow-up|3|||
127840976|NCT03372603|460035281|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
127840977|NCT03372603|460035282|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
127840978|NCT03372603|460035281|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
127840979|NCT03372603|460035282|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
127840980|NCT02806947|460035283|FG000|Overall Study|Withdrawal by Subject|5|||
127840981|NCT02806947|460035284|FG001|Overall Study|Withdrawal by Subject|1|||
127840982|NCT00664209|460035285|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
127840983|NCT00664209|460035285|FG000|Study Treatment Period|Physician Decision|4|||
127840984|NCT00664209|460035285|FG000|Study Treatment Period|Withdrawal by Subject|2|||
127840985|NCT00418379|460035296|FG000|Year 1|Adverse Event|9|||
127840986|NCT00418379|460035297|FG001|Year 1|Adverse Event|15|||
127840987|NCT00418379|460035298|FG002|Year 1|Adverse Event|3|||
127840988|NCT00418379|460035296|FG000|Year 1|Withdrawal by Subject|7|||
127840989|NCT00418379|460035297|FG001|Year 1|Withdrawal by Subject|8|||
127840990|NCT00418379|460035298|FG002|Year 1|Withdrawal by Subject|5|||
127840991|NCT00418379|460035296|FG000|Year 1|Any other reason not above-mentioned|2|||
127840992|NCT00418379|460035297|FG001|Year 1|Any other reason not above-mentioned|5|||
127840993|NCT00418379|460035298|FG002|Year 1|Any other reason not above-mentioned|7|||
127840994|NCT00418379|460035296|FG000|Year 2|Adverse Event|5|||
127840995|NCT00418379|460035297|FG001|Year 2|Adverse Event|2|||
127840996|NCT00418379|460035298|FG002|Year 2|Adverse Event|1|||
127840997|NCT00418379|460035296|FG000|Year 2|Withdrawal by Subject|1|||
127840998|NCT00418379|460035297|FG001|Year 2|Withdrawal by Subject|1|||
127840999|NCT00418379|460035298|FG002|Year 2|Withdrawal by Subject|3|||
127841000|NCT00418379|460035296|FG000|Year 2|Any other reason not above-mentioned|2|||
127841001|NCT00418379|460035297|FG001|Year 2|Any other reason not above-mentioned|1|||
127841002|NCT00418379|460035298|FG002|Year 2|Any other reason not above-mentioned|6|||
127841003|NCT00418379|460035296|FG000|Year 3|Withdrawal by Subject|1|||
127841004|NCT00418379|460035297|FG001|Year 3|Withdrawal by Subject|1|||
127841005|NCT00418379|460035298|FG002|Year 3|Withdrawal by Subject|2|||
127841006|NCT00418379|460035296|FG000|Year 3|Any other reason not above-mentioned|2|||
127841007|NCT00418379|460035297|FG001|Year 3|Any other reason not above-mentioned|1|||
127841008|NCT00418379|460035298|FG002|Year 3|Any other reason not above-mentioned|1|||
127841009|NCT00418379|460035296|FG000|Year 4|Adverse Event|0|||
127841010|NCT00418379|460035297|FG001|Year 4|Adverse Event|1|||
127841011|NCT00418379|460035298|FG002|Year 4|Adverse Event|0|||
127841012|NCT00418379|460035296|FG000|Year 4|Withdrawal by Subject|2|||
127841013|NCT00418379|460035297|FG001|Year 4|Withdrawal by Subject|3|||
127841014|NCT00418379|460035298|FG002|Year 4|Withdrawal by Subject|2|||
127841015|NCT00418379|460035296|FG000|Year 4|Any other reason not above-mentioned|1|||
127841016|NCT00418379|460035297|FG001|Year 4|Any other reason not above-mentioned|1|||
127841017|NCT00418379|460035298|FG002|Year 4|Any other reason not above-mentioned|0|||
127841018|NCT00418379|460035296|FG000|Year 5|Adverse Event|0|||
127841019|NCT00418379|460035297|FG001|Year 5|Adverse Event|1|||
127841020|NCT00418379|460035298|FG002|Year 5|Adverse Event|0|||
127841021|NCT00418379|460035296|FG000|Year 5|Any other reason not above-mentioned|2|||
127841022|NCT00418379|460035297|FG001|Year 5|Any other reason not above-mentioned|4|||
127841023|NCT00418379|460035298|FG002|Year 5|Any other reason not above-mentioned|3|||
127841024|NCT00065442|460035299|FG000|Overall Study|Lost to Follow-up|1|||
127841025|NCT00065442|460035300|FG001|Overall Study|Lost to Follow-up|1|||
127841026|NCT00065442|460035299|FG000|Overall Study|Death|121|||
127841027|NCT00065442|460035300|FG001|Overall Study|Death|210|||
127841028|NCT00065442|460035299|FG000|Overall Study|Withdrawal by Subject|3|||
127841029|NCT00065442|460035300|FG001|Overall Study|Withdrawal by Subject|9|||
127841030|NCT02029638|460035302|FG000|Overall Study|Death|0|||
127841031|NCT02029638|460035303|FG001|Overall Study|Death|0|||
127841032|NCT02029638|460035304|FG002|Overall Study|Death|1|||
127841033|NCT02029638|460035302|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
127841034|NCT02029638|460035303|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
127841035|NCT02029638|460035304|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
127841036|NCT01153841|460035305|FG000|Overall Study|Adverse Event|1|||
127841037|NCT01153841|460035306|FG001|Overall Study|Adverse Event|0|||
127841038|NCT01153841|460035305|FG000|Overall Study|Withdrawal by Subject|1|||
127841039|NCT01153841|460035306|FG001|Overall Study|Withdrawal by Subject|0|||
127841040|NCT01153841|460035305|FG000|Overall Study|Protocol Violation|2|||
127841041|NCT01153841|460035306|FG001|Overall Study|Protocol Violation|0|||
127841042|NCT01153841|460035305|FG000|Overall Study|Lost to Follow-up|2|||
127841043|NCT01153841|460035306|FG001|Overall Study|Lost to Follow-up|0|||
127841044|NCT03428997|460035307|FG000|Overall Study|Sponsor decision.|1|||
127841045|NCT03428997|460035307|FG000|Overall Study|Withdrawal by Subject|3|||
127841046|NCT03428997|460035307|FG000|Overall Study|Lost to Follow-up|4|||
127841047|NCT00510068|460035311|FG000|Double-blind Period|Disease progression|98|||
127841048|NCT00510068|460035312|FG001|Double-blind Period|Disease progression|169|||
127841049|NCT00510068|460035311|FG000|Double-blind Period|Final primary analysis|52|||
127841050|NCT00510068|460035312|FG001|Double-blind Period|Final primary analysis|18|||
127841051|NCT00510068|460035311|FG000|Double-blind Period|Adverse Event|37|||
127841052|NCT00510068|460035312|FG001|Double-blind Period|Adverse Event|7|||
127841053|NCT00510068|460035311|FG000|Double-blind Period|Withdrawal by Subject|8|||
127841054|NCT00510068|460035312|FG001|Double-blind Period|Withdrawal by Subject|6|||
127841055|NCT00510068|460035311|FG000|Double-blind Period|Death|4|||
127841056|NCT00510068|460035312|FG001|Double-blind Period|Death|3|||
127841057|NCT00510068|460035311|FG000|Double-blind Period|Abnormal test result (s)|1|||
127841058|NCT00510068|460035312|FG001|Double-blind Period|Abnormal test result (s)|0|||
127841059|NCT00510068|460035311|FG000|Double-blind Period|Lost to Follow-up|1|||
127841060|NCT00510068|460035312|FG001|Double-blind Period|Lost to Follow-up|0|||
127841061|NCT00510068|460035311|FG000|Double-blind Period|Protocol Violation|6|||
127841062|NCT00510068|460035312|FG001|Double-blind Period|Protocol Violation|0|||
127841063|NCT00510068|460035311|FG000|Open-label Period|Disease Progression|124|||
127841064|NCT00510068|460035312|FG001|Open-label Period|Disease Progression|0|||
127841065|NCT00510068|460035311|FG000|Open-label Period|Adverse Event|46|||
127841066|NCT00510068|460035312|FG001|Open-label Period|Adverse Event|0|||
127841067|NCT00510068|460035311|FG000|Open-label Period|Withdrawal by Subject|21|||
127841068|NCT00510068|460035312|FG001|Open-label Period|Withdrawal by Subject|0|||
127841069|NCT00510068|460035311|FG000|Open-label Period|Administrative problems|17|||
127841070|NCT00510068|460035312|FG001|Open-label Period|Administrative problems|0|||
127841071|NCT00510068|460035311|FG000|Open-label Period|Death|7|||
127841072|NCT00510068|460035312|FG001|Open-label Period|Death|0|||
127841073|NCT00510068|460035311|FG000|Open-label Period|New cancer therapy|7|||
127841074|NCT00510068|460035312|FG001|Open-label Period|New cancer therapy|0|||
127841075|NCT00510068|460035311|FG000|Open-label Period|Protocol Violation|2|||
127841076|NCT00510068|460035312|FG001|Open-label Period|Protocol Violation|0|||
127841077|NCT00510068|460035311|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
127841078|NCT00510068|460035312|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
127841079|NCT02563925|460035313|FG000|Overall Study|Withdrawal by Subject|2|||
127841080|NCT00400712|460035314|FG000|Overall Study|Death|1|||
127841081|NCT00400712|460035315|FG001|Overall Study|Death|0|||
127841082|NCT00400712|460035314|FG000|Overall Study|Withdrawal by Subject|11|||
127841083|NCT00400712|460035315|FG001|Overall Study|Withdrawal by Subject|12|||
127841084|NCT00400712|460035314|FG000|Overall Study|Physician Decision|5|||
127841085|NCT00400712|460035315|FG001|Overall Study|Physician Decision|4|||
127841086|NCT00622869|460035318|FG000|Overall Study|Subject Withdrew Consent|13|||
127841087|NCT00622869|460035319|FG001|Overall Study|Subject Withdrew Consent|17|||
127841088|NCT00622869|460035320|FG002|Overall Study|Subject Withdrew Consent|11|||
127841089|NCT00622869|460035318|FG000|Overall Study|Administrative Problems|11|||
127841090|NCT00622869|460035319|FG001|Overall Study|Administrative Problems|17|||
127841091|NCT00622869|460035320|FG002|Overall Study|Administrative Problems|13|||
127841092|NCT00622869|460035318|FG000|Overall Study|Death|12|||
127841093|NCT00622869|460035319|FG001|Overall Study|Death|15|||
127841094|NCT00622869|460035320|FG002|Overall Study|Death|10|||
127841095|NCT00622869|460035318|FG000|Overall Study|Lost to Follow-up|2|||
127841096|NCT00622869|460035319|FG001|Overall Study|Lost to Follow-up|4|||
127841097|NCT00622869|460035320|FG002|Overall Study|Lost to Follow-up|2|||
127841098|NCT00622869|460035318|FG000|Overall Study|Graft Loss|5|||
127841099|NCT00622869|460035319|FG001|Overall Study|Graft Loss|3|||
127841100|NCT00622869|460035320|FG002|Overall Study|Graft Loss|2|||
127841101|NCT00622869|460035318|FG000|Overall Study|Missing|0|||
127841102|NCT00622869|460035319|FG001|Overall Study|Missing|1|||
127841103|NCT00622869|460035320|FG002|Overall Study|Missing|1|||
127841104|NCT00645567|460035321|FG000|Overall Study|Adverse Event|1|||
127841105|NCT03543358|460035324|FG000|Overall Study|Death|1|||
127841106|NCT03543358|460035325|FG001|Overall Study|Death|0|||
127841107|NCT03543358|460035324|FG000|Overall Study|Disease Progression|1|||
127841108|NCT03543358|460035325|FG001|Overall Study|Disease Progression|0|||
127841109|NCT03543358|460035324|FG000|Overall Study|Parent Study Closure|1|||
127841110|NCT03543358|460035325|FG001|Overall Study|Parent Study Closure|0|||
127841111|NCT00870818|460035328|FG000|Overall Study|Lost to Follow-up|3|||
127841112|NCT00870818|460035329|FG001|Overall Study|Lost to Follow-up|2|||
127841113|NCT00870818|460035330|FG002|Overall Study|Lost to Follow-up|1|||
127841114|NCT00870818|460035331|FG003|Overall Study|Lost to Follow-up|0|||
127841115|NCT00870818|460035332|FG004|Overall Study|Lost to Follow-up|0|||
127841116|NCT00870818|460035328|FG000|Overall Study|Withdrawal by Subject|0|||
127841117|NCT00870818|460035329|FG001|Overall Study|Withdrawal by Subject|0|||
127841118|NCT00870818|460035330|FG002|Overall Study|Withdrawal by Subject|1|||
127841119|NCT00870818|460035331|FG003|Overall Study|Withdrawal by Subject|2|||
127841120|NCT00870818|460035332|FG004|Overall Study|Withdrawal by Subject|0|||
127841121|NCT00870818|460035328|FG000|Overall Study|Terminated by sponsor|29|||
127841122|NCT00870818|460035329|FG001|Overall Study|Terminated by sponsor|70|||
127841123|NCT00870818|460035330|FG002|Overall Study|Terminated by sponsor|36|||
127841124|NCT00870818|460035331|FG003|Overall Study|Terminated by sponsor|36|||
127841125|NCT00870818|460035332|FG004|Overall Study|Terminated by sponsor|38|||
127841126|NCT00870818|460035328|FG000|Overall Study|Other|0|||
127841127|NCT00870818|460035329|FG001|Overall Study|Other|1|||
127841128|NCT00870818|460035330|FG002|Overall Study|Other|0|||
127841129|NCT00870818|460035331|FG003|Overall Study|Other|0|||
127841130|NCT00870818|460035332|FG004|Overall Study|Other|0|||
127898646|NCT04471207|460253489|FG000|Overall Study|Medication Contraindication|0|||
127898647|NCT04471207|460253490|FG001|Overall Study|Medication Contraindication|1|||
127898648|NCT04471207|460253489|FG000|Overall Study|Loss of Interest|2|||
127841131|NCT00178464|460035333|FG000|Overall Study|Withdrawal by Subject|1|||
127841132|NCT00178464|460035333|FG000|Overall Study|Physician Decision|1|||
127841133|NCT02227108|460035334|FG000|Overall Study|Did not receive treatment|2|||
127841134|NCT02227108|460035334|FG000|Overall Study|Other|3|||
127841135|NCT02227108|460035334|FG000|Overall Study|Progressive disease|17|||
127841136|NCT02227108|460035334|FG000|Overall Study|Initiation of alternative therapy|2|||
127841137|NCT02227108|460035334|FG000|Overall Study|Investigator discretion|1|||
127841138|NCT02227108|460035334|FG000|Overall Study|Adverse Event|6|||
127841139|NCT02486952|460035335|FG000|Overall Study|Not Started Induction Therapy|3|||
127841140|NCT02486952|460035335|FG000|Overall Study|Adverse Event|1|||
127841141|NCT02486952|460035335|FG000|Overall Study|Death|15|||
127841142|NCT02486952|460035335|FG000|Overall Study|Lack of Efficacy|3|||
127841143|NCT02486952|460035335|FG000|Overall Study|Lost to Follow-up|26|||
127841144|NCT02486952|460035335|FG000|Overall Study|Other|2|||
127841145|NCT03814590|460035336|FG000|Overall Study|Adverse Event|0|||
127841146|NCT03814590|460035337|FG001|Overall Study|Adverse Event|0|||
127841147|NCT03814590|460035338|FG002|Overall Study|Adverse Event|0|||
127841148|NCT03814590|460035339|FG003|Overall Study|Adverse Event|0|||
127841149|NCT03814590|460035340|FG004|Overall Study|Adverse Event|0|||
127841150|NCT03814590|460035341|FG005|Overall Study|Adverse Event|1|||
127841151|NCT03814590|460035342|FG006|Overall Study|Adverse Event|1|||
127841152|NCT03814590|460035343|FG007|Overall Study|Adverse Event|1|||
127841153|NCT03814590|460035344|FG008|Overall Study|Adverse Event|0|||
127841154|NCT03814590|460035345|FG009|Overall Study|Adverse Event|0|||
127841155|NCT03814590|460035346|FG010|Overall Study|Adverse Event|1|||
127841156|NCT03814590|460035347|FG011|Overall Study|Adverse Event|0|||
127841157|NCT03814590|460035348|FG012|Overall Study|Adverse Event|3|||
127841158|NCT03814590|460035349|FG013|Overall Study|Adverse Event|0|||
127841159|NCT03814590|460035336|FG000|Overall Study|Lost to Follow-up|0|||
127841160|NCT03814590|460035337|FG001|Overall Study|Lost to Follow-up|2|||
127841161|NCT03814590|460035338|FG002|Overall Study|Lost to Follow-up|1|||
127841162|NCT03814590|460035339|FG003|Overall Study|Lost to Follow-up|0|||
127841163|NCT03814590|460035340|FG004|Overall Study|Lost to Follow-up|1|||
127841164|NCT03814590|460035341|FG005|Overall Study|Lost to Follow-up|1|||
127841165|NCT03814590|460035342|FG006|Overall Study|Lost to Follow-up|1|||
127841166|NCT03814590|460035343|FG007|Overall Study|Lost to Follow-up|1|||
127841167|NCT03814590|460035344|FG008|Overall Study|Lost to Follow-up|0|||
127841168|NCT03814590|460035345|FG009|Overall Study|Lost to Follow-up|0|||
127841169|NCT03814590|460035346|FG010|Overall Study|Lost to Follow-up|1|||
127841170|NCT03814590|460035347|FG011|Overall Study|Lost to Follow-up|0|||
127841171|NCT03814590|460035348|FG012|Overall Study|Lost to Follow-up|0|||
127841172|NCT03814590|460035349|FG013|Overall Study|Lost to Follow-up|1|||
127841173|NCT03814590|460035336|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
127841174|NCT03814590|460035337|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
127841175|NCT03814590|460035338|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
127841176|NCT03814590|460035339|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
127841177|NCT03814590|460035340|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
127841178|NCT03814590|460035341|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
127841179|NCT03814590|460035342|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
127841180|NCT03814590|460035343|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
127841181|NCT03814590|460035344|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
127841182|NCT03814590|460035345|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
127841183|NCT03814590|460035346|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
127898649|NCT04471207|460253490|FG001|Overall Study|Loss of Interest|1|||
127898650|NCT04471207|460253489|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
127898651|NCT04471207|460253490|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
127898652|NCT04471207|460253489|FG000|Overall Study|Scheduling Conflicts|3|||
127898653|NCT04471207|460253490|FG001|Overall Study|Scheduling Conflicts|1|||
127898654|NCT04471207|460253489|FG000|Overall Study|Physician Decision|1|||
127898655|NCT04471207|460253490|FG001|Overall Study|Physician Decision|0|||
127841184|NCT03814590|460035347|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
127841185|NCT03814590|460035348|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
127841186|NCT03814590|460035349|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
127841187|NCT03814590|460035336|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
127841188|NCT03814590|460035337|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
127841189|NCT03814590|460035338|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
127841190|NCT03814590|460035339|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
127841191|NCT03814590|460035340|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
127841192|NCT03814590|460035341|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
127841193|NCT03814590|460035342|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
127841194|NCT03814590|460035343|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
127841195|NCT03814590|460035344|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
127898656|NCT04471207|460253489|FG000|Overall Study|Unwilling to Use System|0|||
127898657|NCT04471207|460253490|FG001|Overall Study|Unwilling to Use System|1|||
127898658|NCT00561730|460253491|FG000|Overall Study|Adverse Event|2|||
127898659|NCT00561730|460253491|FG000|Overall Study|Handling of the drug|1|||
127898660|NCT00561730|460253491|FG000|Overall Study|Lost to Follow-up|5|||
127898661|NCT00561730|460253491|FG000|Overall Study|Not specified reasons|1|||
127898662|NCT02906709|460253498|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
127898663|NCT02906709|460253499|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
127898664|NCT02906709|460253498|FG000|Phase A (Week 0 to Week 16)|Death|0|||
127898665|NCT02906709|460253499|FG001|Phase A (Week 0 to Week 16)|Death|1|||
127898666|NCT02906709|460253498|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
127898667|NCT02906709|460253499|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
127898668|NCT02906709|460253498|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
127898669|NCT02906709|460253499|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
127898670|NCT00920140|460253501|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
127898671|NCT00920140|460253502|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
127898672|NCT00920140|460253503|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
127898673|NCT00920140|460253504|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
127898674|NCT00920140|460253505|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
127898675|NCT00920140|460253501|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
127898676|NCT00920140|460253502|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
127898677|NCT00920140|460253503|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
127898678|NCT00920140|460253504|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
127898679|NCT00920140|460253505|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
127898680|NCT00920140|460253501|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
127898681|NCT00920140|460253502|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
127898682|NCT00920140|460253503|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
127898683|NCT00920140|460253504|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
127898684|NCT00920140|460253505|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
127898685|NCT00920140|460253501|FG000|Phase 2|Adverse Event|0|||
127898686|NCT00920140|460253502|FG001|Phase 2|Adverse Event|0|||
127898687|NCT00920140|460253503|FG002|Phase 2|Adverse Event|14|||
127898688|NCT00920140|460253504|FG003|Phase 2|Adverse Event|2|||
127898689|NCT00920140|460253505|FG004|Phase 2|Adverse Event|3|||
127898690|NCT00920140|460253501|FG000|Phase 2|Lack of Efficacy|0|||
127898691|NCT00920140|460253502|FG001|Phase 2|Lack of Efficacy|0|||
127898692|NCT00920140|460253503|FG002|Phase 2|Lack of Efficacy|29|||
127898693|NCT00920140|460253504|FG003|Phase 2|Lack of Efficacy|14|||
127898694|NCT00920140|460253505|FG004|Phase 2|Lack of Efficacy|5|||
127841196|NCT03814590|460035345|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
127841197|NCT03814590|460035346|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
127841198|NCT03814590|460035347|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
127841199|NCT03814590|460035348|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
127841200|NCT03814590|460035349|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
127841201|NCT03814590|460035336|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127841202|NCT03814590|460035337|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127841203|NCT03814590|460035338|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127841204|NCT03814590|460035339|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127841205|NCT03814590|460035340|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127841206|NCT03814590|460035341|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127841207|NCT03814590|460035342|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127841208|NCT03814590|460035343|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
127841209|NCT03814590|460035344|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127841210|NCT03814590|460035345|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
127841211|NCT03814590|460035346|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127841212|NCT03814590|460035347|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127841213|NCT03814590|460035348|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127841214|NCT03814590|460035349|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127841215|NCT03814590|460035336|FG000|Overall Study|UNKNOWN REASON|0|||
127841216|NCT03814590|460035337|FG001|Overall Study|UNKNOWN REASON|0|||
127841217|NCT03814590|460035338|FG002|Overall Study|UNKNOWN REASON|0|||
127841218|NCT03814590|460035339|FG003|Overall Study|UNKNOWN REASON|0|||
127841219|NCT03814590|460035340|FG004|Overall Study|UNKNOWN REASON|0|||
127841220|NCT03814590|460035341|FG005|Overall Study|UNKNOWN REASON|0|||
127898695|NCT00920140|460253501|FG000|Phase 2|Lost to Follow-up|0|||
127898696|NCT00920140|460253502|FG001|Phase 2|Lost to Follow-up|0|||
127898697|NCT00920140|460253503|FG002|Phase 2|Lost to Follow-up|0|||
127898698|NCT00920140|460253504|FG003|Phase 2|Lost to Follow-up|1|||
127898699|NCT00920140|460253505|FG004|Phase 2|Lost to Follow-up|0|||
127898700|NCT00920140|460253501|FG000|Phase 2|Physician Decision|0|||
127898701|NCT00920140|460253502|FG001|Phase 2|Physician Decision|0|||
127898702|NCT00920140|460253503|FG002|Phase 2|Physician Decision|3|||
127841221|NCT03814590|460035342|FG006|Overall Study|UNKNOWN REASON|0|||
127841222|NCT03814590|460035343|FG007|Overall Study|UNKNOWN REASON|1|||
127841223|NCT03814590|460035344|FG008|Overall Study|UNKNOWN REASON|0|||
127841224|NCT03814590|460035345|FG009|Overall Study|UNKNOWN REASON|0|||
127841225|NCT03814590|460035346|FG010|Overall Study|UNKNOWN REASON|0|||
127841226|NCT03814590|460035347|FG011|Overall Study|UNKNOWN REASON|0|||
127841227|NCT03814590|460035348|FG012|Overall Study|UNKNOWN REASON|0|||
127841228|NCT03814590|460035349|FG013|Overall Study|UNKNOWN REASON|0|||
127841229|NCT01529385|460035354|FG000|Overall Study|Lost to Follow-up|2|||
127841230|NCT01529385|460035355|FG001|Overall Study|Lost to Follow-up|1|||
127841231|NCT00964158|460035356|FG000|Overall Study|Lost to Follow-up|0|||
127841232|NCT00964158|460035357|FG001|Overall Study|Lost to Follow-up|1|||
127841233|NCT00964158|460035358|FG002|Overall Study|Lost to Follow-up|2|||
127841234|NCT00964158|460035356|FG000|Overall Study|Withdrawal by Subject|0|||
127841235|NCT00964158|460035357|FG001|Overall Study|Withdrawal by Subject|0|||
127841236|NCT00964158|460035358|FG002|Overall Study|Withdrawal by Subject|6|||
127841237|NCT01054976|460035370|FG000|Overall Study|Adverse Event|16|||
127841238|NCT01054976|460035370|FG000|Overall Study|Uncooperative participations to study|7|||
127841239|NCT01054976|460035370|FG000|Overall Study|Withdrawal by Subject|4|||
127841240|NCT01054976|460035370|FG000|Overall Study|Other|8|||
127841241|NCT01763866|460035371|FG000|Overall Study|Withdrawal by Subject|2|||
127841242|NCT01763866|460035372|FG001|Overall Study|Withdrawal by Subject|1|||
127841243|NCT01763866|460035373|FG002|Overall Study|Withdrawal by Subject|4|||
127841244|NCT01763866|460035374|FG003|Overall Study|Withdrawal by Subject|0|||
127841245|NCT01763866|460035375|FG004|Overall Study|Withdrawal by Subject|0|||
127841246|NCT01763866|460035376|FG005|Overall Study|Withdrawal by Subject|3|||
127841247|NCT01763866|460035377|FG006|Overall Study|Withdrawal by Subject|4|||
127841248|NCT01763866|460035378|FG007|Overall Study|Withdrawal by Subject|0|||
127841249|NCT01763866|460035379|FG008|Overall Study|Withdrawal by Subject|1|||
127841250|NCT01763866|460035380|FG009|Overall Study|Withdrawal by Subject|1|||
127841251|NCT01763866|460035381|FG010|Overall Study|Withdrawal by Subject|2|||
127841252|NCT01763866|460035382|FG011|Overall Study|Withdrawal by Subject|2|||
127841253|NCT01763866|460035383|FG012|Overall Study|Withdrawal by Subject|2|||
127841254|NCT01763866|460035384|FG013|Overall Study|Withdrawal by Subject|0|||
127841255|NCT01763866|460035385|FG014|Overall Study|Withdrawal by Subject|6|||
127841256|NCT01763866|460035386|FG015|Overall Study|Withdrawal by Subject|3|||
127841257|NCT01763866|460035387|FG016|Overall Study|Withdrawal by Subject|0|||
127841258|NCT01763866|460035388|FG017|Overall Study|Withdrawal by Subject|1|||
127841259|NCT01763866|460035389|FG018|Overall Study|Withdrawal by Subject|1|||
127841260|NCT01763866|460035390|FG019|Overall Study|Withdrawal by Subject|1|||
127841261|NCT01763866|460035391|FG020|Overall Study|Withdrawal by Subject|2|||
127841262|NCT01763866|460035392|FG021|Overall Study|Withdrawal by Subject|1|||
127841263|NCT01763866|460035393|FG022|Overall Study|Withdrawal by Subject|2|||
127841264|NCT01763866|460035394|FG023|Overall Study|Withdrawal by Subject|1|||
127841265|NCT01763866|460035371|FG000|Overall Study|Decision by sponsor|0|||
127841266|NCT01763866|460035372|FG001|Overall Study|Decision by sponsor|0|||
127841267|NCT01763866|460035373|FG002|Overall Study|Decision by sponsor|1|||
127841268|NCT01763866|460035374|FG003|Overall Study|Decision by sponsor|0|||
127841269|NCT01763866|460035375|FG004|Overall Study|Decision by sponsor|2|||
127841270|NCT01763866|460035376|FG005|Overall Study|Decision by sponsor|0|||
127841271|NCT01763866|460035377|FG006|Overall Study|Decision by sponsor|2|||
127841272|NCT01763866|460035378|FG007|Overall Study|Decision by sponsor|0|||
127841273|NCT01763866|460035379|FG008|Overall Study|Decision by sponsor|2|||
127841274|NCT01763866|460035380|FG009|Overall Study|Decision by sponsor|0|||
127841275|NCT01763866|460035381|FG010|Overall Study|Decision by sponsor|6|||
127841276|NCT01763866|460035382|FG011|Overall Study|Decision by sponsor|0|||
127841277|NCT01763866|460035383|FG012|Overall Study|Decision by sponsor|1|||
127841278|NCT01763866|460035384|FG013|Overall Study|Decision by sponsor|0|||
127841279|NCT01763866|460035385|FG014|Overall Study|Decision by sponsor|5|||
127841280|NCT01763866|460035386|FG015|Overall Study|Decision by sponsor|0|||
127841281|NCT01763866|460035387|FG016|Overall Study|Decision by sponsor|0|||
127841282|NCT01763866|460035388|FG017|Overall Study|Decision by sponsor|0|||
127841283|NCT01763866|460035389|FG018|Overall Study|Decision by sponsor|4|||
127841284|NCT01763866|460035390|FG019|Overall Study|Decision by sponsor|0|||
127841285|NCT01763866|460035391|FG020|Overall Study|Decision by sponsor|2|||
127841286|NCT01763866|460035392|FG021|Overall Study|Decision by sponsor|0|||
127841287|NCT01763866|460035393|FG022|Overall Study|Decision by sponsor|1|||
127841288|NCT01763866|460035394|FG023|Overall Study|Decision by sponsor|0|||
127841289|NCT01763866|460035371|FG000|Overall Study|Lost to Follow-up|0|||
127841290|NCT01763866|460035372|FG001|Overall Study|Lost to Follow-up|0|||
127841291|NCT01763866|460035373|FG002|Overall Study|Lost to Follow-up|0|||
127841292|NCT01763866|460035374|FG003|Overall Study|Lost to Follow-up|0|||
127841293|NCT01763866|460035375|FG004|Overall Study|Lost to Follow-up|0|||
127841294|NCT01763866|460035376|FG005|Overall Study|Lost to Follow-up|0|||
127841295|NCT01763866|460035377|FG006|Overall Study|Lost to Follow-up|1|||
127841296|NCT01763866|460035378|FG007|Overall Study|Lost to Follow-up|0|||
127841297|NCT01763866|460035379|FG008|Overall Study|Lost to Follow-up|0|||
127841298|NCT01763866|460035380|FG009|Overall Study|Lost to Follow-up|0|||
127841299|NCT01763866|460035381|FG010|Overall Study|Lost to Follow-up|0|||
127898703|NCT00920140|460253504|FG003|Phase 2|Physician Decision|3|||
127898704|NCT00920140|460253505|FG004|Phase 2|Physician Decision|2|||
127898705|NCT00920140|460253501|FG000|Phase 2|Withdrawal by Subject|0|||
127898706|NCT00920140|460253502|FG001|Phase 2|Withdrawal by Subject|0|||
127898707|NCT00920140|460253503|FG002|Phase 2|Withdrawal by Subject|4|||
127898708|NCT00920140|460253504|FG003|Phase 2|Withdrawal by Subject|2|||
127898709|NCT00920140|460253505|FG004|Phase 2|Withdrawal by Subject|1|||
127898710|NCT01124149|460253506|FG000|Acute Phase|Withdrawal by Subject|22|||
127898711|NCT01124149|460253506|FG000|Acute Phase|Adverse Event|21|||
127898712|NCT01124149|460253506|FG000|Acute Phase|Lack of Efficacy|17|||
127898713|NCT01124149|460253506|FG000|Acute Phase|Protocol Violation|14|||
127898714|NCT01124149|460253506|FG000|Acute Phase|Lost to Follow-up|2|||
127898715|NCT01124149|460253506|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
127898716|NCT01124149|460253506|FG000|Acute Phase|Sponsor request|1|||
127898717|NCT01124149|460253506|FG000|Acute Phase|UC symptoms not ameliorated|1|||
127898718|NCT01124149|460253506|FG000|Acute Phase|Non-compliance|1|||
127898719|NCT01124149|460253506|FG000|Acute Phase|Low hemoglobin|1|||
127898720|NCT01124149|460253506|FG000|Acute Phase|Travelling to another country|1|||
127898721|NCT01124149|460253506|FG000|Acute Phase|Sponsor decision|1|||
127898722|NCT01124149|460253506|FG000|Maintenance Phase|Lack of Efficacy|40|||
127898723|NCT01124149|460253506|FG000|Maintenance Phase|Adverse Event|24|||
127898724|NCT01124149|460253506|FG000|Maintenance Phase|Lost to Follow-up|15|||
127898725|NCT01124149|460253506|FG000|Maintenance Phase|Withdrawal by Subject|10|||
127898726|NCT01124149|460253506|FG000|Maintenance Phase|Protocol Violation|5|||
127898727|NCT01124149|460253506|FG000|Maintenance Phase|Coordinator error|1|||
127898728|NCT01124149|460253506|FG000|Maintenance Phase|Non-compliance|1|||
127898729|NCT00977106|460253507|FG000|Overall Study|Adverse Event|5|||
127898730|NCT00977106|460253508|FG001|Overall Study|Adverse Event|6|||
127898731|NCT00977106|460253507|FG000|Overall Study|Withdrawal by Subject|2|||
127898732|NCT00977106|460253508|FG001|Overall Study|Withdrawal by Subject|2|||
127898733|NCT00977106|460253507|FG000|Overall Study|Lack of Efficacy|2|||
127898734|NCT00977106|460253508|FG001|Overall Study|Lack of Efficacy|2|||
127898735|NCT00977106|460253507|FG000|Overall Study|Protocol Violation|0|||
127898736|NCT00977106|460253508|FG001|Overall Study|Protocol Violation|1|||
127898737|NCT00977106|460253507|FG000|Overall Study|Other|1|||
127898738|NCT00977106|460253508|FG001|Overall Study|Other|0|||
127898739|NCT01644500|460253509|FG000|Overall Study|Adverse Event|6|||
127898740|NCT01644500|460253510|FG001|Overall Study|Adverse Event|1|||
127898741|NCT01644500|460253511|FG002|Overall Study|Adverse Event|2|||
127898742|NCT01644500|460253509|FG000|Overall Study|Death|0|||
127898743|NCT01644500|460253510|FG001|Overall Study|Death|1|||
127898744|NCT01644500|460253511|FG002|Overall Study|Death|0|||
127898745|NCT01644500|460253509|FG000|Overall Study|Lost to Follow-up|3|||
127898746|NCT01644500|460253510|FG001|Overall Study|Lost to Follow-up|8|||
127898747|NCT01644500|460253511|FG002|Overall Study|Lost to Follow-up|0|||
127898748|NCT01644500|460253509|FG000|Overall Study|Protocol Violation|1|||
127898749|NCT01644500|460253510|FG001|Overall Study|Protocol Violation|1|||
127898750|NCT01644500|460253511|FG002|Overall Study|Protocol Violation|0|||
127898751|NCT01644500|460253509|FG000|Overall Study|Withdrawal by Subject|11|||
127898752|NCT01644500|460253510|FG001|Overall Study|Withdrawal by Subject|12|||
127898753|NCT01644500|460253511|FG002|Overall Study|Withdrawal by Subject|12|||
127898754|NCT01644500|460253509|FG000|Overall Study|Physician Decision|1|||
127898755|NCT01644500|460253510|FG001|Overall Study|Physician Decision|1|||
127898756|NCT01644500|460253511|FG002|Overall Study|Physician Decision|1|||
127898757|NCT01400425|460253519|FG000|Overall Study|Withdrawal by Subject|10|||
127898758|NCT02388763|460253522|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
127898759|NCT02388763|460253523|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
127898760|NCT02388763|460253522|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
127898761|NCT02388763|460253523|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
127898762|NCT01458405|460253532|FG000|Phase 1 (up to 12 Months)|Other|0|||
127898763|NCT01458405|460253533|FG001|Phase 1 (up to 12 Months)|Other|1|||
127898764|NCT01458405|460253534|FG002|Phase 1 (up to 12 Months)|Other|0|||
127898765|NCT01458405|460253535|FG003|Phase 1 (up to 12 Months)|Other|0|||
127898766|NCT01458405|460253532|FG000|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
127898767|NCT01458405|460253533|FG001|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
127898768|NCT01458405|460253534|FG002|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|11|||
127898769|NCT01458405|460253535|FG003|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|20|||
127898770|NCT01458405|460253532|FG000|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
127898771|NCT01458405|460253533|FG001|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
127898772|NCT01458405|460253534|FG002|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
127898773|NCT01458405|460253535|FG003|Phase 2 (up to 12 Months)|Lost to Follow-up|2|||
127898774|NCT01458405|460253532|FG000|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
127898775|NCT01458405|460253533|FG001|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
127898776|NCT01458405|460253534|FG002|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
127898777|NCT01458405|460253535|FG003|Phase 2 (up to 12 Months)|Withdrawal by Subject|1|||
127898778|NCT02194998|460253536|FG000|On-HCV Treatment|Did not pick up study medication|0|||
127841300|NCT01763866|460035382|FG011|Overall Study|Lost to Follow-up|0|||
127841301|NCT01763866|460035383|FG012|Overall Study|Lost to Follow-up|1|||
127841302|NCT01763866|460035384|FG013|Overall Study|Lost to Follow-up|0|||
127841303|NCT01763866|460035385|FG014|Overall Study|Lost to Follow-up|1|||
127841304|NCT01763866|460035386|FG015|Overall Study|Lost to Follow-up|0|||
127841305|NCT01763866|460035387|FG016|Overall Study|Lost to Follow-up|0|||
127841306|NCT01763866|460035388|FG017|Overall Study|Lost to Follow-up|0|||
127841307|NCT01763866|460035389|FG018|Overall Study|Lost to Follow-up|1|||
127841308|NCT01763866|460035390|FG019|Overall Study|Lost to Follow-up|1|||
127841309|NCT01763866|460035391|FG020|Overall Study|Lost to Follow-up|0|||
127841310|NCT01763866|460035392|FG021|Overall Study|Lost to Follow-up|0|||
127841311|NCT01763866|460035393|FG022|Overall Study|Lost to Follow-up|0|||
127841312|NCT01763866|460035394|FG023|Overall Study|Lost to Follow-up|1|||
127841313|NCT01763866|460035371|FG000|Overall Study|Death|0|||
127841314|NCT01763866|460035372|FG001|Overall Study|Death|0|||
127841315|NCT01763866|460035373|FG002|Overall Study|Death|0|||
127841316|NCT01763866|460035374|FG003|Overall Study|Death|0|||
127841317|NCT01763866|460035375|FG004|Overall Study|Death|0|||
127898779|NCT02194998|460253537|FG001|On-HCV Treatment|Did not pick up study medication|1|||
127898780|NCT02194998|460253538|FG002|On-HCV Treatment|Did not pick up study medication|0|||
127898781|NCT02194998|460253539|FG003|On-HCV Treatment|Did not pick up study medication|0|||
127898782|NCT02194998|460253536|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
127898783|NCT02194998|460253537|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
127898784|NCT02194998|460253538|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
127898785|NCT02194998|460253539|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
127898786|NCT02497781|460253542|FG000|Overall Study|Withdrawal by Subject|2|||
127898787|NCT02497781|460253543|FG001|Overall Study|Withdrawal by Subject|0|||
127898788|NCT02497781|460253542|FG000|Overall Study|Lack of Efficacy|0|||
127898789|NCT02497781|460253543|FG001|Overall Study|Lack of Efficacy|1|||
127898790|NCT02497781|460253542|FG000|Overall Study|Randomised but not treated|1|||
127898791|NCT02497781|460253543|FG001|Overall Study|Randomised but not treated|1|||
127898792|NCT02497781|460253542|FG000|Overall Study|Lost to Follow-up|1|||
127898793|NCT02497781|460253543|FG001|Overall Study|Lost to Follow-up|1|||
127898794|NCT02236130|460253544|FG000|Overall Study|Lost to Follow-up|7|||
127898795|NCT02236130|460253545|FG001|Overall Study|Lost to Follow-up|12|||
127898796|NCT00454636|460253546|FG000|Overall Study|Adverse Event|10|||
127898797|NCT00454636|460253547|FG001|Overall Study|Adverse Event|6|||
127898798|NCT00454636|460253548|FG002|Overall Study|Adverse Event|9|||
127898799|NCT00454636|460253549|FG003|Overall Study|Adverse Event|15|||
127898800|NCT00454636|460253546|FG000|Overall Study|Disease Progression|11|||
127898801|NCT00454636|460253547|FG001|Overall Study|Disease Progression|12|||
127898802|NCT00454636|460253548|FG002|Overall Study|Disease Progression|4|||
127898803|NCT00454636|460253549|FG003|Overall Study|Disease Progression|11|||
127898804|NCT00454636|460253546|FG000|Overall Study|Protocol Violation|3|||
127898805|NCT00454636|460253547|FG001|Overall Study|Protocol Violation|2|||
127898806|NCT00454636|460253548|FG002|Overall Study|Protocol Violation|3|||
127898807|NCT00454636|460253549|FG003|Overall Study|Protocol Violation|3|||
127898808|NCT00454636|460253546|FG000|Overall Study|Death|6|||
127898809|NCT00454636|460253547|FG001|Overall Study|Death|1|||
127898810|NCT00454636|460253548|FG002|Overall Study|Death|1|||
127898811|NCT00454636|460253549|FG003|Overall Study|Death|1|||
127898812|NCT00454636|460253546|FG000|Overall Study|Patient refusal|1|||
127898813|NCT00454636|460253547|FG001|Overall Study|Patient refusal|1|||
127898814|NCT00454636|460253548|FG002|Overall Study|Patient refusal|3|||
127898815|NCT00454636|460253549|FG003|Overall Study|Patient refusal|2|||
127898816|NCT00454636|460253546|FG000|Overall Study|Lost to Follow-up|0|||
127898817|NCT00454636|460253547|FG001|Overall Study|Lost to Follow-up|1|||
127898818|NCT00454636|460253548|FG002|Overall Study|Lost to Follow-up|0|||
127898819|NCT00454636|460253549|FG003|Overall Study|Lost to Follow-up|0|||
127898820|NCT01400113|460253550|FG000|Overall Study|Withdrawal by Subject|1|||
127898821|NCT01400113|460253551|FG001|Overall Study|Withdrawal by Subject|1|||
127898822|NCT01025037|460253556|FG000|Overall Study|Adverse Event|3|||
127841318|NCT01763866|460035376|FG005|Overall Study|Death|0|||
127898823|NCT01025037|460253556|FG000|Overall Study|Lost to Follow-up|7|||
127898824|NCT01025037|460253556|FG000|Overall Study|Withdrawal by Subject|1|||
127898825|NCT00337571|460253557|FG000|Overall Study|Lack of Efficacy|3|||
127898826|NCT00337571|460253558|FG001|Overall Study|Lack of Efficacy|0|||
127898827|NCT00337571|460253559|FG002|Overall Study|Lack of Efficacy|0|||
127898828|NCT00337571|460253560|FG003|Overall Study|Lack of Efficacy|0|||
127898829|NCT00337571|460253557|FG000|Overall Study|Adverse Event|4|||
127841319|NCT01763866|460035377|FG006|Overall Study|Death|0|||
127841320|NCT01763866|460035378|FG007|Overall Study|Death|0|||
127841321|NCT01763866|460035379|FG008|Overall Study|Death|0|||
127841322|NCT01763866|460035380|FG009|Overall Study|Death|0|||
127898830|NCT00337571|460253558|FG001|Overall Study|Adverse Event|5|||
127898831|NCT00337571|460253559|FG002|Overall Study|Adverse Event|8|||
127898832|NCT00337571|460253560|FG003|Overall Study|Adverse Event|4|||
127898833|NCT00337571|460253557|FG000|Overall Study|Withdrawal by Subject|2|||
127898834|NCT00337571|460253558|FG001|Overall Study|Withdrawal by Subject|2|||
127898835|NCT00337571|460253559|FG002|Overall Study|Withdrawal by Subject|1|||
127898836|NCT00337571|460253560|FG003|Overall Study|Withdrawal by Subject|0|||
127841323|NCT01763866|460035381|FG010|Overall Study|Death|0|||
127841324|NCT01763866|460035382|FG011|Overall Study|Death|0|||
127841325|NCT01763866|460035383|FG012|Overall Study|Death|0|||
127841326|NCT01763866|460035384|FG013|Overall Study|Death|0|||
127841327|NCT01763866|460035385|FG014|Overall Study|Death|0|||
127841328|NCT01763866|460035386|FG015|Overall Study|Death|0|||
127841329|NCT01763866|460035387|FG016|Overall Study|Death|1|||
127841330|NCT01763866|460035388|FG017|Overall Study|Death|0|||
127841331|NCT01763866|460035389|FG018|Overall Study|Death|0|||
127841332|NCT01763866|460035390|FG019|Overall Study|Death|0|||
127841333|NCT01763866|460035391|FG020|Overall Study|Death|0|||
127841334|NCT01763866|460035392|FG021|Overall Study|Death|0|||
127841335|NCT01763866|460035393|FG022|Overall Study|Death|0|||
127841336|NCT01763866|460035394|FG023|Overall Study|Death|0|||
127841337|NCT01669811|460035401|FG000|Overall Study|Investigator decision|0|||
127841338|NCT01669811|460035402|FG001|Overall Study|Investigator decision|1|||
127841339|NCT01669811|460035401|FG000|Overall Study|Withdrawal by Subject|1|||
127841340|NCT01669811|460035402|FG001|Overall Study|Withdrawal by Subject|2|||
127841341|NCT01669811|460035401|FG000|Overall Study|Adverse Event|2|||
127841342|NCT01669811|460035402|FG001|Overall Study|Adverse Event|6|||
127841343|NCT01669811|460035401|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
127841344|NCT01669811|460035402|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
127841345|NCT03245723|460035403|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
127841346|NCT03245723|460035404|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
127841347|NCT03245723|460035403|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
127841348|NCT03245723|460035404|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
127841349|NCT03245723|460035403|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
127841350|NCT03245723|460035404|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
127841351|NCT03245723|460035403|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
127841352|NCT03245723|460035404|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
127841353|NCT00077376|460035405|FG000|Overall Study|Adverse Event|8|||
127841354|NCT00077376|460035405|FG000|Overall Study|Withdrawal by Subject|2|||
127841355|NCT00077376|460035405|FG000|Overall Study|Death|1|||
127841356|NCT00077376|460035405|FG000|Overall Study|Physician Decision|1|||
127841357|NCT00077376|460035405|FG000|Overall Study|Alternative therapy|5|||
127841358|NCT00077376|460035405|FG000|Overall Study|Complicating disease|1|||
127841359|NCT00077376|460035405|FG000|Overall Study|Still on treatment|1|||
127841360|NCT00077376|460035405|FG000|Overall Study|Symptomatic deterioration|1|||
127841361|NCT00077376|460035405|FG000|Overall Study|Surgery|1|||
127841362|NCT00077376|460035405|FG000|Overall Study|Insurance ran out|1|||
127841363|NCT00646113|460037134|FG000|Overall Study|Lost to Follow-up|5|||
127841364|NCT00646113|460037134|FG000|Overall Study|Adverse Event|3|||
127841365|NCT02109744|460037135|FG000|Overall Study|Death|1|||
127841366|NCT02109744|460037136|FG001|Overall Study|Death|1|||
127841367|NCT02109744|460037135|FG000|Overall Study|no marrow exam|1|||
127841368|NCT02109744|460037136|FG001|Overall Study|no marrow exam|0|||
127841369|NCT03287245|460037137|FG000|Overall Study|Study terminated by sponsor|3|||
127841370|NCT03287245|460037138|FG001|Overall Study|Study terminated by sponsor|0|||
127841371|NCT03287245|460037139|FG002|Overall Study|Study terminated by sponsor|3|||
127841372|NCT03287245|460037140|FG003|Overall Study|Study terminated by sponsor|1|||
127841373|NCT03287245|460037137|FG000|Overall Study|Adverse Event|1|||
127841374|NCT03287245|460037138|FG001|Overall Study|Adverse Event|0|||
127841375|NCT03287245|460037139|FG002|Overall Study|Adverse Event|0|||
127841376|NCT03287245|460037140|FG003|Overall Study|Adverse Event|0|||
127841377|NCT03287245|460037137|FG000|Overall Study|Withdrawal by Subject|8|||
127841378|NCT03287245|460037138|FG001|Overall Study|Withdrawal by Subject|3|||
127841379|NCT03287245|460037139|FG002|Overall Study|Withdrawal by Subject|3|||
127841380|NCT03287245|460037140|FG003|Overall Study|Withdrawal by Subject|0|||
127841381|NCT03287245|460037137|FG000|Overall Study|Physician Decision|3|||
127841382|NCT03287245|460037138|FG001|Overall Study|Physician Decision|2|||
127841383|NCT03287245|460037139|FG002|Overall Study|Physician Decision|0|||
127898837|NCT00337571|460253557|FG000|Overall Study|Lost to Follow-up|3|||
127898838|NCT00337571|460253558|FG001|Overall Study|Lost to Follow-up|1|||
127898839|NCT00337571|460253559|FG002|Overall Study|Lost to Follow-up|0|||
127898840|NCT00337571|460253560|FG003|Overall Study|Lost to Follow-up|1|||
127841384|NCT03287245|460037140|FG003|Overall Study|Physician Decision|0|||
127841385|NCT02701192|460037141|FG000|Overall Study|Protocol Violation|2|||
127841386|NCT02701192|460037141|FG000|Overall Study|Lost to Follow-up|4|||
127841387|NCT03097614|460037142|FG000|Overall Study|Adverse Event|3|||
127841388|NCT02150213|460037143|FG000|Overall Study|Lost to Follow-up|1|||
127841389|NCT02150213|460037143|FG000|Overall Study|Withdrawal by Subject|1|||
127841390|NCT02678312|460037145|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
127841391|NCT02678312|460037146|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
127841392|NCT02678312|460037147|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
127898841|NCT00337571|460253557|FG000|Overall Study|Poor/noncompliance|1|||
127841393|NCT02678312|460037148|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
127841394|NCT02678312|460037149|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
127841395|NCT02678312|460037145|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
127841396|NCT02678312|460037146|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
127841397|NCT02678312|460037147|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
127841398|NCT02678312|460037148|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
127841399|NCT02678312|460037149|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
127841400|NCT02678312|460037145|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
127841401|NCT02678312|460037146|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
127841402|NCT02678312|460037147|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
127841403|NCT02678312|460037148|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
127841404|NCT02678312|460037149|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
127841405|NCT02678312|460037145|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
127841406|NCT02678312|460037146|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
127841407|NCT02678312|460037147|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
127841408|NCT02678312|460037148|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
127841409|NCT02678312|460037149|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
127841410|NCT02678312|460037145|FG000|Part 2 Double Blind Epoch|Death|0|||
127841411|NCT02678312|460037146|FG001|Part 2 Double Blind Epoch|Death|0|||
127841412|NCT02678312|460037147|FG002|Part 2 Double Blind Epoch|Death|0|||
127841413|NCT02678312|460037148|FG003|Part 2 Double Blind Epoch|Death|8|||
127841414|NCT02678312|460037149|FG004|Part 2 Double Blind Epoch|Death|12|||
127841415|NCT02678312|460037145|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
127841416|NCT02678312|460037146|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
127841417|NCT02678312|460037147|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
127841418|NCT02678312|460037148|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
127841419|NCT02678312|460037149|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
127841420|NCT02678312|460037145|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
127841421|NCT02678312|460037146|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
127841422|NCT02678312|460037147|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
127841423|NCT02678312|460037148|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
127841424|NCT02678312|460037149|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
127841425|NCT02678312|460037145|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
127841426|NCT02678312|460037146|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
127841427|NCT02678312|460037147|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
127841428|NCT02678312|460037148|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
127841429|NCT02678312|460037149|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
127841430|NCT02254551|460037155|FG000|Dose Escalation|Physician Decision|1|||
127841431|NCT02254551|460037155|FG000|Dose Escalation|Dose-limiting toxicity|2|||
127841432|NCT02716194|460037158|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
127841433|NCT02716194|460037159|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
127841434|NCT02716194|460037160|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
127841435|NCT00971425|460037164|FG000|Overall Study|Adverse Event|1|||
127841436|NCT00971425|460037165|FG001|Overall Study|Adverse Event|1|||
127841437|NCT00971425|460037164|FG000|Overall Study|Withdrawal by Subject|0|||
127841438|NCT00971425|460037165|FG001|Overall Study|Withdrawal by Subject|1|||
127841439|NCT03587584|460037173|FG000|Overall Study|SOC deviations|4|||
127841440|NCT03587584|460037174|FG001|Overall Study|SOC deviations|6|||
127841441|NCT03587584|460037173|FG000|Overall Study|Incomplete data|0|||
127841442|NCT03587584|460037174|FG001|Overall Study|Incomplete data|3|||
127841443|NCT00387348|460037175|FG000|Overall Study|Death|1|||
127841444|NCT00387348|460037176|FG001|Overall Study|Death|1|||
127841445|NCT00387348|460037177|FG002|Overall Study|Death|0|||
127841446|NCT00387348|460037175|FG000|Overall Study|Physician Decision|1|||
127841447|NCT00387348|460037176|FG001|Overall Study|Physician Decision|0|||
127841448|NCT00387348|460037177|FG002|Overall Study|Physician Decision|1|||
127841449|NCT00387348|460037175|FG000|Overall Study|Withdrawal by Subject|0|||
127841450|NCT00387348|460037176|FG001|Overall Study|Withdrawal by Subject|2|||
127841451|NCT00387348|460037177|FG002|Overall Study|Withdrawal by Subject|2|||
127841452|NCT00387348|460037175|FG000|Overall Study|Adverse Event|1|||
127841453|NCT00387348|460037176|FG001|Overall Study|Adverse Event|0|||
127841454|NCT00387348|460037177|FG002|Overall Study|Adverse Event|1|||
127841455|NCT00505752|460037180|FG000|Overall Study|Adverse Event|1|||
127841456|NCT00505752|460037181|FG001|Overall Study|Adverse Event|0|||
127841457|NCT00505752|460037182|FG002|Overall Study|Adverse Event|1|||
127841458|NCT00505752|460037183|FG003|Overall Study|Adverse Event|0|||
127841459|NCT00505752|460037180|FG000|Overall Study|Lost to Follow-up|1|||
127841460|NCT00505752|460037181|FG001|Overall Study|Lost to Follow-up|0|||
127841461|NCT00505752|460037182|FG002|Overall Study|Lost to Follow-up|0|||
127841462|NCT00505752|460037183|FG003|Overall Study|Lost to Follow-up|0|||
127841463|NCT00505752|460037180|FG000|Overall Study|Lack of ovarian response|1|||
127841464|NCT00505752|460037181|FG001|Overall Study|Lack of ovarian response|3|||
127841465|NCT00505752|460037182|FG002|Overall Study|Lack of ovarian response|0|||
127841466|NCT00505752|460037183|FG003|Overall Study|Lack of ovarian response|0|||
127841467|NCT00505752|460037180|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
127841468|NCT00505752|460037181|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
127898842|NCT00337571|460253558|FG001|Overall Study|Poor/noncompliance|1|||
127898843|NCT00337571|460253559|FG002|Overall Study|Poor/noncompliance|1|||
127898844|NCT00337571|460253560|FG003|Overall Study|Poor/noncompliance|1|||
127898845|NCT00337571|460253557|FG000|Overall Study|No longer met study criteria|1|||
127898846|NCT00337571|460253558|FG001|Overall Study|No longer met study criteria|0|||
127898847|NCT00337571|460253559|FG002|Overall Study|No longer met study criteria|0|||
127898848|NCT00337571|460253560|FG003|Overall Study|No longer met study criteria|0|||
127898849|NCT00337571|460253557|FG000|Overall Study|High Potassium level|0|||
127898850|NCT00337571|460253558|FG001|Overall Study|High Potassium level|0|||
127898851|NCT00337571|460253559|FG002|Overall Study|High Potassium level|0|||
127898852|NCT00337571|460253560|FG003|Overall Study|High Potassium level|1|||
127898853|NCT01890915|460253562|FG000|Overall Study|Adverse Event|1|||
127898854|NCT01890915|460253563|FG001|Overall Study|Adverse Event|0|||
127898855|NCT01890915|460253562|FG000|Overall Study|Protocol Violation|2|||
127898856|NCT01890915|460253563|FG001|Overall Study|Protocol Violation|0|||
127898857|NCT01890915|460253562|FG000|Overall Study|Equipment Malfunction|0|||
127898858|NCT01890915|460253563|FG001|Overall Study|Equipment Malfunction|1|||
127898859|NCT02114697|460253564|FG000|Overall Study|Study terminated|5|||
127898860|NCT02114697|460253565|FG001|Overall Study|Study terminated|4|||
127898861|NCT00424489|460253566|FG000|Overall Study|Death|3|||
127898862|NCT03552757|460253573|FG000|Overall Study|Withdrawal by Subject|10|||
127898863|NCT03552757|460253574|FG001|Overall Study|Withdrawal by Subject|5|||
127898864|NCT03552757|460253575|FG002|Overall Study|Withdrawal by Subject|12|||
127898865|NCT03552757|460253573|FG000|Overall Study|Lost to Follow-up|2|||
127898866|NCT03552757|460253574|FG001|Overall Study|Lost to Follow-up|7|||
127898867|NCT03552757|460253575|FG002|Overall Study|Lost to Follow-up|7|||
127898868|NCT03552757|460253573|FG000|Overall Study|Death|1|||
127898869|NCT03552757|460253574|FG001|Overall Study|Death|1|||
127898870|NCT03552757|460253575|FG002|Overall Study|Death|1|||
127898871|NCT02674334|460253576|FG000|Overall Study|Lost to Follow-up|5|||
127898872|NCT02674334|460253577|FG001|Overall Study|Lost to Follow-up|3|||
127898873|NCT02674334|460253576|FG000|Overall Study|participant difficulty breathing|1|||
127898874|NCT02674334|460253577|FG001|Overall Study|participant difficulty breathing|0|||
127898875|NCT02674334|460253576|FG000|Overall Study|NIRS not recording|1|||
127898876|NCT02674334|460253577|FG001|Overall Study|NIRS not recording|0|||
127898877|NCT02660242|460253584|FG000|Glucose Tabs|Lost to Follow-up|1|||
127898878|NCT02660242|460253584|FG000|Glucagon Injection|Lost to Follow-up|1|||
127898879|NCT01345019|460253587|FG000|Blinded Treatment Phase|Death|147|||
127898880|NCT01345019|460253588|FG001|Blinded Treatment Phase|Death|137|||
127898881|NCT01345019|460253587|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
127898882|NCT01345019|460253588|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
127898883|NCT01345019|460253587|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
127898884|NCT01345019|460253588|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
127898885|NCT01345019|460253587|FG000|Blinded Treatment Phase|Disease Progression|12|||
127898886|NCT01345019|460253588|FG001|Blinded Treatment Phase|Disease Progression|10|||
127898887|NCT01345019|460253587|FG000|Blinded Treatment Phase|Adverse Event|6|||
127898888|NCT01345019|460253588|FG001|Blinded Treatment Phase|Adverse Event|13|||
127898889|NCT01345019|460253587|FG000|Blinded Treatment Phase|Administrative Decision|10|||
127898890|NCT01345019|460253588|FG001|Blinded Treatment Phase|Administrative Decision|8|||
127898891|NCT01345019|460253587|FG000|Blinded Treatment Phase|Noncompliance|5|||
127898892|NCT01345019|460253588|FG001|Blinded Treatment Phase|Noncompliance|3|||
127898893|NCT01345019|460253587|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
127898894|NCT01345019|460253588|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
127898895|NCT01345019|460253587|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
127898896|NCT01345019|460253588|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
127898897|NCT01345019|460253587|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
127898898|NCT01345019|460253588|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
127898899|NCT01345019|460253587|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
127898900|NCT01345019|460253588|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
127898901|NCT01345019|460253587|FG000|Open Label Treatment Phase|Death|49|||
127898902|NCT01345019|460253588|FG001|Open Label Treatment Phase|Death|48|||
127898903|NCT01345019|460253587|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
127898904|NCT01345019|460253588|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
127898905|NCT01345019|460253587|FG000|Open Label Treatment Phase|Adverse Event|30|||
127898906|NCT01345019|460253588|FG001|Open Label Treatment Phase|Adverse Event|51|||
127898907|NCT01345019|460253587|FG000|Open Label Treatment Phase|Administrative Decision|30|||
127898908|NCT01345019|460253588|FG001|Open Label Treatment Phase|Administrative Decision|15|||
127898909|NCT01345019|460253587|FG000|Open Label Treatment Phase|Disease Progression|17|||
127898910|NCT01345019|460253588|FG001|Open Label Treatment Phase|Disease Progression|18|||
127898911|NCT01345019|460253587|FG000|Open Label Treatment Phase|Noncompliance|5|||
127898912|NCT01345019|460253588|FG001|Open Label Treatment Phase|Noncompliance|4|||
127898913|NCT01345019|460253587|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
127898914|NCT01345019|460253588|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
127898915|NCT01345019|460253587|FG000|Open Label Treatment Phase|Pregnancy|1|||
127898916|NCT01345019|460253588|FG001|Open Label Treatment Phase|Pregnancy|0|||
127841469|NCT00505752|460037182|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
127841470|NCT00505752|460037183|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
127841471|NCT00505752|460037180|FG000|Overall Study|No oocytes retrieved|0|||
127841472|NCT00505752|460037181|FG001|Overall Study|No oocytes retrieved|2|||
127841473|NCT00505752|460037182|FG002|Overall Study|No oocytes retrieved|0|||
127841474|NCT00505752|460037183|FG003|Overall Study|No oocytes retrieved|1|||
127841475|NCT00505752|460037180|FG000|Overall Study|No Fertilization|1|||
127841476|NCT00505752|460037181|FG001|Overall Study|No Fertilization|1|||
127841477|NCT00505752|460037182|FG002|Overall Study|No Fertilization|2|||
127841478|NCT00505752|460037183|FG003|Overall Study|No Fertilization|1|||
127841479|NCT00505752|460037180|FG000|Overall Study|All embryos/blastocysts discarded|0|||
127841480|NCT00505752|460037181|FG001|Overall Study|All embryos/blastocysts discarded|0|||
127841481|NCT00505752|460037182|FG002|Overall Study|All embryos/blastocysts discarded|1|||
127841482|NCT00505752|460037183|FG003|Overall Study|All embryos/blastocysts discarded|1|||
127841483|NCT00505752|460037180|FG000|Overall Study|Other|1|||
127841484|NCT00505752|460037181|FG001|Overall Study|Other|2|||
127841485|NCT00505752|460037182|FG002|Overall Study|Other|1|||
127841486|NCT00505752|460037183|FG003|Overall Study|Other|2|||
127841487|NCT01925612|460037184|FG000|Overall Study|Progressive Disease|1|||
127898917|NCT01345019|460253587|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
127841488|NCT01925612|460037185|FG001|Overall Study|Progressive Disease|1|||
127841489|NCT01925612|460037186|FG002|Overall Study|Progressive Disease|1|||
127841490|NCT01925612|460037187|FG003|Overall Study|Progressive Disease|0|||
127841491|NCT01925612|460037188|FG004|Overall Study|Progressive Disease|0|||
127841492|NCT01925612|460037184|FG000|Overall Study|Adverse Event|3|||
127841493|NCT01925612|460037185|FG001|Overall Study|Adverse Event|3|||
127841494|NCT01925612|460037186|FG002|Overall Study|Adverse Event|0|||
127841495|NCT01925612|460037187|FG003|Overall Study|Adverse Event|1|||
127841496|NCT01925612|460037188|FG004|Overall Study|Adverse Event|2|||
127841497|NCT04624672|460037192|FG000|Overall Study|Early Study Closure|2|||
127841498|NCT04624672|460037193|FG001|Overall Study|Early Study Closure|1|||
127841499|NCT03472040|460037194|FG000|Overall Study|Physician Decision|0|||
127841500|NCT03472040|460037195|FG001|Overall Study|Physician Decision|3|||
127841501|NCT03472040|460037194|FG000|Overall Study|Withdrawal by Subject|10|||
127841502|NCT03472040|460037195|FG001|Overall Study|Withdrawal by Subject|23|||
127898918|NCT01345019|460253588|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
127898919|NCT01345019|460253587|FG000|Open Label Treatment Phase|Protocol Violation|0|||
127898920|NCT01345019|460253588|FG001|Open Label Treatment Phase|Protocol Violation|1|||
127898921|NCT00386009|460253591|FG000|Overall Study|Adverse Event|0|||
127898922|NCT00386009|460253592|FG001|Overall Study|Adverse Event|2|||
127898923|NCT00386009|460253591|FG000|Overall Study|Death|1|||
127898924|NCT00386009|460253592|FG001|Overall Study|Death|0|||
127898925|NCT00386009|460253591|FG000|Overall Study|Entry Criteria Not Met|0|||
127898926|NCT00386009|460253592|FG001|Overall Study|Entry Criteria Not Met|2|||
127841503|NCT03472040|460037194|FG000|Overall Study|Perceived Lack of Efficacy|29|||
127841504|NCT03472040|460037195|FG001|Overall Study|Perceived Lack of Efficacy|30|||
127841505|NCT03472040|460037194|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
127841506|NCT03472040|460037195|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
127841507|NCT03472040|460037194|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
127841508|NCT03472040|460037195|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
127841509|NCT03472040|460037194|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
127841510|NCT03472040|460037195|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
127841511|NCT03472040|460037194|FG000|Overall Study|Subject Non-compliance|2|||
127841512|NCT03472040|460037195|FG001|Overall Study|Subject Non-compliance|5|||
127841513|NCT03472040|460037194|FG000|Overall Study|Discontinuation due to Rash|0|||
127841514|NCT03472040|460037195|FG001|Overall Study|Discontinuation due to Rash|1|||
127841515|NCT03472040|460037194|FG000|Overall Study|Subsequent Ineligibility|0|||
127841516|NCT03472040|460037195|FG001|Overall Study|Subsequent Ineligibility|2|||
127841517|NCT03472040|460037194|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
127841518|NCT03472040|460037195|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
127841519|NCT00225147|460037200|FG000|Open-label Phase|Lost to Follow-up|0|||
127841520|NCT00225147|460037201|FG001|Open-label Phase|Lost to Follow-up|0|||
127841521|NCT00225147|460037202|FG002|Open-label Phase|Lost to Follow-up|0|||
127841522|NCT00225147|460037203|FG003|Open-label Phase|Lost to Follow-up|4|||
127841523|NCT00225147|460037200|FG000|Open-label Phase|Withdrawal by Subject|0|||
127898927|NCT00386009|460253591|FG000|Overall Study|Lost to Follow-up|1|||
127898928|NCT00386009|460253592|FG001|Overall Study|Lost to Follow-up|1|||
127898929|NCT00386009|460253591|FG000|Overall Study|Protocol Violation|1|||
127841524|NCT00225147|460037201|FG001|Open-label Phase|Withdrawal by Subject|0|||
127841525|NCT00225147|460037202|FG002|Open-label Phase|Withdrawal by Subject|0|||
127841526|NCT00225147|460037203|FG003|Open-label Phase|Withdrawal by Subject|6|||
127841527|NCT02685995|460037206|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
127898930|NCT00386009|460253592|FG001|Overall Study|Protocol Violation|0|||
127841528|NCT02685995|460037207|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
127841529|NCT03625141|460037208|FG000|Overall Study|Adverse Event|0|||
127841530|NCT03625141|460037209|FG001|Overall Study|Adverse Event|2|||
127841531|NCT03625141|460037208|FG000|Overall Study|Study Terminated By Sponsor|1|||
127841532|NCT03625141|460037209|FG001|Overall Study|Study Terminated By Sponsor|13|||
127841533|NCT03625141|460037208|FG000|Overall Study|Withdrawal by Subject|3|||
127841534|NCT03625141|460037209|FG001|Overall Study|Withdrawal by Subject|0|||
127841535|NCT03625141|460037208|FG000|Overall Study|Withdrawal Of Consent|0|||
127841536|NCT03625141|460037209|FG001|Overall Study|Withdrawal Of Consent|1|||
127841537|NCT03625141|460037208|FG000|Overall Study|Death|11|||
127841538|NCT03625141|460037209|FG001|Overall Study|Death|47|||
127841539|NCT03625141|460037208|FG000|Overall Study|Progressive Disease|0|||
127841540|NCT03625141|460037209|FG001|Overall Study|Progressive Disease|2|||
127841541|NCT00868166|460037211|FG000|Overall Study|Death|58|||
127841542|NCT00868166|460037212|FG001|Overall Study|Death|65|||
127841543|NCT00868166|460037211|FG000|Overall Study|Withdrawal by Subject|33|||
127841544|NCT00868166|460037212|FG001|Overall Study|Withdrawal by Subject|25|||
127841545|NCT00868166|460037211|FG000|Overall Study|Protocol Violation|1|||
127841546|NCT00868166|460037212|FG001|Overall Study|Protocol Violation|0|||
127841547|NCT00868166|460037211|FG000|Overall Study|Lost to Follow-up|1|||
127841548|NCT00868166|460037212|FG001|Overall Study|Lost to Follow-up|3|||
127841549|NCT00868166|460037211|FG000|Overall Study|Adverse Event|9|||
127841550|NCT00868166|460037212|FG001|Overall Study|Adverse Event|10|||
127841551|NCT00868166|460037211|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
127841552|NCT00868166|460037212|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
127841553|NCT00868166|460037211|FG000|Overall Study|Non-compliance with IMP|1|||
127841554|NCT00868166|460037212|FG001|Overall Study|Non-compliance with IMP|1|||
127841555|NCT00433446|460037219|FG000|Overall Study|Adverse Event|4|||
127841556|NCT00433446|460037219|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
127841557|NCT00433446|460037219|FG000|Overall Study|Progression|44|||
127841558|NCT00433446|460037219|FG000|Overall Study|Other - Not Protocol specified|3|||
127841559|NCT00433446|460037219|FG000|Overall Study|Ineligible|9|||
127841560|NCT03819218|460037220|FG000|Overall Study|Protocol Violation|1|||
127841561|NCT02267278|460037221|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
127841562|NCT02267278|460037221|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
127841563|NCT02267278|460037221|FG000|Overall Study|Developed new cancer diagnoses|2|||
127841564|NCT02267278|460037221|FG000|Overall Study|prescribed prohibited medication|1|||
127841565|NCT00650091|460037222|FG000|Amended Study Design|Withdrawal by Subject|12|||
127841566|NCT00650091|460037223|FG001|Amended Study Design|Withdrawal by Subject|11|||
127841567|NCT00650091|460037224|FG002|Amended Study Design|Withdrawal by Subject|0|||
127841568|NCT00650091|460037222|FG000|Amended Study Design|Physician Decision|5|||
127841569|NCT00650091|460037223|FG001|Amended Study Design|Physician Decision|0|||
127841570|NCT00650091|460037224|FG002|Amended Study Design|Physician Decision|0|||
127841571|NCT00650091|460037222|FG000|Amended Study Design|Adverse Event|1|||
127841572|NCT00650091|460037223|FG001|Amended Study Design|Adverse Event|4|||
127841573|NCT00650091|460037224|FG002|Amended Study Design|Adverse Event|0|||
127841574|NCT00650091|460037222|FG000|Amended Study Design|Lung transplantation|4|||
127841575|NCT00650091|460037223|FG001|Amended Study Design|Lung transplantation|2|||
127841576|NCT00650091|460037224|FG002|Amended Study Design|Lung transplantation|0|||
127841577|NCT00650091|460037222|FG000|Amended Study Design|Other|1|||
127841578|NCT00650091|460037223|FG001|Amended Study Design|Other|3|||
127841579|NCT00650091|460037224|FG002|Amended Study Design|Other|0|||
127841580|NCT02553317|460037229|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
127841581|NCT02553317|460037230|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
127841582|NCT02553317|460037229|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
127841583|NCT02553317|460037230|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
127841584|NCT02553317|460037229|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
127841585|NCT02553317|460037230|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
127841586|NCT02553317|460037229|FG000|Overall Treatment Period + Follow-up|Death|1|||
127841587|NCT02553317|460037230|FG001|Overall Treatment Period + Follow-up|Death|3|||
127841588|NCT02553317|460037229|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
127841589|NCT02553317|460037230|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
127841590|NCT02553317|460037229|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
127841591|NCT02553317|460037230|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
127841592|NCT02553317|460037229|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
127841593|NCT02553317|460037230|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
127841594|NCT02553317|460037229|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
127841595|NCT02553317|460037230|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
127841596|NCT02553317|460037229|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
127841597|NCT02553317|460037230|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
127841598|NCT02553317|460037229|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
127841599|NCT02553317|460037230|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
127841600|NCT04664855|460037232|FG000|Overall Study|Withdrawal by Subject|0|||
127841601|NCT04664855|460037233|FG001|Overall Study|Withdrawal by Subject|2|||
127841602|NCT02219087|460037234|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
127841603|NCT02219087|460037235|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
127841604|NCT03454412|460037238|FG000|Baseline Assesment|Physician Decision|12|||
127841605|NCT01518244|460037239|FG000|Overall Study|Adverse Event|3|||
127841606|NCT01766817|460037241|FG000|Overall Study|Drug-related adverse event|1|||
127841607|NCT01766817|460037242|FG001|Overall Study|Drug-related adverse event|2|||
127841608|NCT01766817|460037243|FG002|Overall Study|Drug-related adverse event|1|||
127841609|NCT01766817|460037241|FG000|Overall Study|Drug-unrelated adverse event|3|||
127841610|NCT01766817|460037242|FG001|Overall Study|Drug-unrelated adverse event|3|||
127841611|NCT01766817|460037243|FG002|Overall Study|Drug-unrelated adverse event|3|||
127841612|NCT01766817|460037241|FG000|Overall Study|Death|1|||
127841613|NCT01766817|460037242|FG001|Overall Study|Death|1|||
127841614|NCT01766817|460037243|FG002|Overall Study|Death|0|||
127841615|NCT01766817|460037241|FG000|Overall Study|Unable to take study drug|0|||
127841616|NCT01766817|460037242|FG001|Overall Study|Unable to take study drug|1|||
127841617|NCT01766817|460037243|FG002|Overall Study|Unable to take study drug|0|||
127841618|NCT01766817|460037241|FG000|Overall Study|Withdrawal by Subject|2|||
127841619|NCT01766817|460037242|FG001|Overall Study|Withdrawal by Subject|0|||
127841620|NCT01766817|460037243|FG002|Overall Study|Withdrawal by Subject|3|||
127841621|NCT01766817|460037241|FG000|Overall Study|Subject non-compliance|0|||
127841622|NCT01766817|460037242|FG001|Overall Study|Subject non-compliance|1|||
127841623|NCT01766817|460037243|FG002|Overall Study|Subject non-compliance|2|||
127841624|NCT01766817|460037241|FG000|Overall Study|Physician Decision|3|||
127841625|NCT01766817|460037242|FG001|Overall Study|Physician Decision|3|||
127841626|NCT01766817|460037243|FG002|Overall Study|Physician Decision|4|||
127841627|NCT01766817|460037241|FG000|Overall Study|Other|1|||
127841628|NCT01766817|460037242|FG001|Overall Study|Other|0|||
127841629|NCT01766817|460037243|FG002|Overall Study|Other|0|||
127841630|NCT04900038|460037244|FG000|Overall Study|Adverse Event|1|||
127841631|NCT04900038|460037245|FG001|Overall Study|Adverse Event|0|||
127841632|NCT04900038|460037246|FG002|Overall Study|Adverse Event|1|||
127841633|NCT04900038|460037247|FG003|Overall Study|Adverse Event|1|||
127841634|NCT04900038|460037244|FG000|Overall Study|Withdrawal by Subject|0|||
127841635|NCT04900038|460037245|FG001|Overall Study|Withdrawal by Subject|1|||
127841636|NCT04900038|460037246|FG002|Overall Study|Withdrawal by Subject|0|||
127841637|NCT04900038|460037247|FG003|Overall Study|Withdrawal by Subject|0|||
127841638|NCT04900038|460037244|FG000|Overall Study|Study terminated by sponsor|18|||
127841639|NCT04900038|460037245|FG001|Overall Study|Study terminated by sponsor|15|||
127841640|NCT04900038|460037246|FG002|Overall Study|Study terminated by sponsor|17|||
127841641|NCT04900038|460037247|FG003|Overall Study|Study terminated by sponsor|14|||
127841642|NCT04900038|460037244|FG000|Overall Study|Protocol Deviation|1|||
127841643|NCT04900038|460037245|FG001|Overall Study|Protocol Deviation|1|||
127841644|NCT04900038|460037246|FG002|Overall Study|Protocol Deviation|0|||
127841645|NCT04900038|460037247|FG003|Overall Study|Protocol Deviation|0|||
127841646|NCT04900038|460037244|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
127841647|NCT04900038|460037245|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
127841648|NCT04900038|460037246|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
127841649|NCT04900038|460037247|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
127841650|NCT04900038|460037244|FG000|Overall Study|Lost to Follow-up|0|||
127841651|NCT04900038|460037245|FG001|Overall Study|Lost to Follow-up|0|||
127841652|NCT04900038|460037246|FG002|Overall Study|Lost to Follow-up|0|||
127841653|NCT04900038|460037247|FG003|Overall Study|Lost to Follow-up|1|||
127841654|NCT01928485|460037251|FG000|Overall Study|Physician Decision|0|||
127841655|NCT01928485|460037252|FG001|Overall Study|Physician Decision|1|||
127841656|NCT04111107|460037253|FG000|Overall Study|Withdrawal by Subject|6|||
127841657|NCT04111107|460037253|FG000|Overall Study|Declining Health|5|||
127841658|NCT02260648|460037254|FG000|Overall Study|Adverse Event|3|||
127841659|NCT02260648|460037255|FG001|Overall Study|Adverse Event|0|||
127841660|NCT02260648|460037256|FG002|Overall Study|Adverse Event|1|||
127841661|NCT02260648|460037254|FG000|Overall Study|Withdrawal by Subject|1|||
127841662|NCT02260648|460037255|FG001|Overall Study|Withdrawal by Subject|1|||
127841663|NCT02260648|460037256|FG002|Overall Study|Withdrawal by Subject|0|||
127841664|NCT02260648|460037254|FG000|Overall Study|Protocol Violation|1|||
127841665|NCT02260648|460037255|FG001|Overall Study|Protocol Violation|0|||
127841666|NCT02260648|460037256|FG002|Overall Study|Protocol Violation|0|||
127841667|NCT02260648|460037254|FG000|Overall Study|Discontinue Due to Study Termination|13|||
127841668|NCT02260648|460037255|FG001|Overall Study|Discontinue Due to Study Termination|12|||
127841669|NCT02260648|460037256|FG002|Overall Study|Discontinue Due to Study Termination|7|||
127841670|NCT03956225|460037257|FG000|Overall Study|Lack of Efficacy|1|||
127841671|NCT03956225|460037258|FG001|Overall Study|Lack of Efficacy|1|||
127841672|NCT03956225|460037257|FG000|Overall Study|Lost to Follow-up|0|||
127841673|NCT03956225|460037258|FG001|Overall Study|Lost to Follow-up|1|||
127841674|NCT03956225|460037257|FG000|Overall Study|Withdrawal by Subject|2|||
127841675|NCT03956225|460037258|FG001|Overall Study|Withdrawal by Subject|1|||
127841676|NCT03956225|460037257|FG000|Overall Study|Other Reasons|2|||
127841677|NCT03956225|460037258|FG001|Overall Study|Other Reasons|1|||
127841678|NCT04093258|460037259|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
127841679|NCT04093258|460037260|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
127841680|NCT00594204|460037261|FG000|Overall Study|Adverse Event|15|||
127841681|NCT00594204|460037262|FG001|Overall Study|Adverse Event|3|||
127841682|NCT00594204|460037261|FG000|Overall Study|Lost to Follow-up|9|||
127898931|NCT00386009|460253591|FG000|Overall Study|Sponsor Decision|1|||
127898932|NCT00386009|460253592|FG001|Overall Study|Sponsor Decision|1|||
127898933|NCT00386009|460253591|FG000|Overall Study|Withdrawal by Subject|5|||
127898934|NCT00386009|460253592|FG001|Overall Study|Withdrawal by Subject|4|||
127841683|NCT00594204|460037262|FG001|Overall Study|Lost to Follow-up|5|||
127841684|NCT00594204|460037261|FG000|Overall Study|Withdrawal by Subject|23|||
127841685|NCT00594204|460037262|FG001|Overall Study|Withdrawal by Subject|29|||
127841686|NCT00594204|460037261|FG000|Overall Study|Other|4|||
127841687|NCT00594204|460037262|FG001|Overall Study|Other|3|||
127841688|NCT00594204|460037261|FG000|Overall Study|Lack of Efficacy|3|||
127841689|NCT00594204|460037262|FG001|Overall Study|Lack of Efficacy|4|||
127841690|NCT00594204|460037261|FG000|Overall Study|Randomized but not treated|4|||
127841691|NCT00594204|460037262|FG001|Overall Study|Randomized but not treated|1|||
127841692|NCT01401465|460037263|FG000|Treatment Period 1|Adverse Event|4|||
127841693|NCT01401465|460037264|FG001|Treatment Period 1|Adverse Event|1|||
127841694|NCT01401465|460037263|FG000|Treatment Period 1|Pregnancy|0|||
127841695|NCT01401465|460037264|FG001|Treatment Period 1|Pregnancy|1|||
127841696|NCT01401465|460037263|FG000|Treatment Period 1|Protocol Violation|5|||
127841697|NCT01401465|460037264|FG001|Treatment Period 1|Protocol Violation|0|||
127841698|NCT01401465|460037263|FG000|Treatment Period 1|Withdrawal by Subject|1|||
127841699|NCT01401465|460037264|FG001|Treatment Period 1|Withdrawal by Subject|4|||
127841700|NCT01401465|460037263|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
127841701|NCT01401465|460037264|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
127841702|NCT01401465|460037263|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
127841703|NCT01401465|460037264|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
127841704|NCT01401465|460037263|FG000|Treatment Period 1|Scheduling Difficulties|1|||
127841705|NCT01401465|460037264|FG001|Treatment Period 1|Scheduling Difficulties|1|||
127841706|NCT01401465|460037263|FG000|Treatment Period 2|Lost to Follow-up|0|||
127841707|NCT01401465|460037264|FG001|Treatment Period 2|Lost to Follow-up|1|||
127841708|NCT01401465|460037263|FG000|Treatment Period 2|Withdrawal by Subject|0|||
127841709|NCT01401465|460037264|FG001|Treatment Period 2|Withdrawal by Subject|1|||
127841710|NCT00986427|460037265|FG000|Overall Study|Lost to Follow-up|2|||
127841711|NCT00986427|460037266|FG001|Overall Study|Lost to Follow-up|0|||
127841712|NCT00986427|460037265|FG000|Overall Study|Lack of Efficacy|1|||
127841713|NCT00986427|460037266|FG001|Overall Study|Lack of Efficacy|0|||
127841714|NCT00986427|460037265|FG000|Overall Study|Withdrawal by Subject|1|||
127841715|NCT00986427|460037266|FG001|Overall Study|Withdrawal by Subject|0|||
127841716|NCT01115738|460037267|FG000|Overall Study|Death|1|||
127841717|NCT01115738|460037268|FG001|Overall Study|Death|0|||
127841718|NCT01115738|460037269|FG002|Overall Study|Death|0|||
127841719|NCT01115738|460037267|FG000|Overall Study|Lost to Follow-up|0|||
127841720|NCT01115738|460037268|FG001|Overall Study|Lost to Follow-up|0|||
127898935|NCT02780687|460253594|FG000|Overall Study|Adverse Event|1|||
127898936|NCT02780687|460253595|FG001|Overall Study|Adverse Event|1|||
127898937|NCT02780687|460253594|FG000|Overall Study|Withdrawal by Subject|2|||
127898938|NCT02780687|460253595|FG001|Overall Study|Withdrawal by Subject|1|||
127898939|NCT02780687|460253594|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
127898940|NCT02780687|460253595|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
127898941|NCT02780687|460253594|FG000|Overall Study|progressive disease|29|||
127898942|NCT02780687|460253595|FG001|Overall Study|progressive disease|6|||
127898943|NCT02603952|460253598|FG000|Overall Study|Withdrawal by Subject|1|||
127898944|NCT02603952|460253599|FG001|Overall Study|Withdrawal by Subject|0|||
127841721|NCT01115738|460037269|FG002|Overall Study|Lost to Follow-up|1|||
127841722|NCT01115738|460037267|FG000|Overall Study|Physician Decision|18|||
127841723|NCT01115738|460037268|FG001|Overall Study|Physician Decision|15|||
127841724|NCT01115738|460037269|FG002|Overall Study|Physician Decision|17|||
127898945|NCT02603952|460253600|FG002|Overall Study|Withdrawal by Subject|0|||
127898946|NCT02603952|460253601|FG003|Overall Study|Withdrawal by Subject|0|||
127841725|NCT01115738|460037267|FG000|Overall Study|Withdrawal by Subject|6|||
127841726|NCT01115738|460037268|FG001|Overall Study|Withdrawal by Subject|6|||
127841727|NCT01115738|460037269|FG002|Overall Study|Withdrawal by Subject|9|||
127841728|NCT02721251|460037270|FG000|Overall Study|Withdrawal by Subject|8|||
127841729|NCT02721251|460037271|FG001|Overall Study|Withdrawal by Subject|7|||
127841730|NCT02721251|460037272|FG002|Overall Study|Withdrawal by Subject|9|||
127841731|NCT02721251|460037270|FG000|Overall Study|poor adherence|2|||
127841732|NCT02721251|460037271|FG001|Overall Study|poor adherence|2|||
127841733|NCT02721251|460037272|FG002|Overall Study|poor adherence|2|||
127841734|NCT01714817|460037273|FG000|Year 1 Period|Lack of Efficacy|11|||
127898947|NCT02603952|460253598|FG000|Overall Study|Received oseltamivir by error|0|||
127841735|NCT01714817|460037274|FG001|Year 1 Period|Lack of Efficacy|9|||
127841736|NCT01714817|460037273|FG000|Year 1 Period|Adverse Event|20|||
127841737|NCT01714817|460037274|FG001|Year 1 Period|Adverse Event|17|||
127841738|NCT01714817|460037273|FG000|Year 1 Period|Withdrawal by Subject|6|||
127841739|NCT01714817|460037274|FG001|Year 1 Period|Withdrawal by Subject|7|||
127841740|NCT01714817|460037273|FG000|Year 1 Period|Death|1|||
127841741|NCT01714817|460037274|FG001|Year 1 Period|Death|1|||
127841742|NCT01714817|460037273|FG000|Year 1 Period|Lost to Follow-up|0|||
127841743|NCT01714817|460037274|FG001|Year 1 Period|Lost to Follow-up|2|||
127841744|NCT01714817|460037273|FG000|Year 1 Period|Poor / non-compliance|0|||
127841745|NCT01714817|460037274|FG001|Year 1 Period|Poor / non-compliance|1|||
127841746|NCT01714817|460037273|FG000|Year 1 Period|Pregnancy|2|||
127841747|NCT01714817|460037274|FG001|Year 1 Period|Pregnancy|0|||
127841748|NCT01714817|460037273|FG000|Year 1 Period|Participant no longer meets criteria|6|||
127841749|NCT01714817|460037274|FG001|Year 1 Period|Participant no longer meets criteria|2|||
127841750|NCT01714817|460037273|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
127841751|NCT01714817|460037274|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
127841752|NCT01714817|460037273|FG000|Year 1 Period|Change in Concomitant Medication|0|||
127841753|NCT01714817|460037274|FG001|Year 1 Period|Change in Concomitant Medication|1|||
127841754|NCT01714817|460037273|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
127841755|NCT01714817|460037274|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
127841756|NCT01714817|460037273|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
127841757|NCT01714817|460037274|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
127841758|NCT01714817|460037273|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
127841759|NCT01714817|460037274|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
127841760|NCT01714817|460037273|FG000|Year 2 Period|Lack of Efficacy|4|||
127841761|NCT01714817|460037274|FG001|Year 2 Period|Lack of Efficacy|12|||
127841762|NCT01714817|460037273|FG000|Year 2 Period|Adverse Event|7|||
127841763|NCT01714817|460037274|FG001|Year 2 Period|Adverse Event|6|||
127841764|NCT01714817|460037273|FG000|Year 2 Period|Participant request to stop treatment|4|||
127841765|NCT01714817|460037274|FG001|Year 2 Period|Participant request to stop treatment|4|||
127841766|NCT01714817|460037273|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
127841767|NCT01714817|460037274|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
127841768|NCT01714817|460037273|FG000|Year 2 Period|Participant withdrew consent|1|||
127841769|NCT01714817|460037274|FG001|Year 2 Period|Participant withdrew consent|5|||
127841770|NCT01714817|460037273|FG000|Year 2 Period|Participant no longer meets criteria|1|||
127841771|NCT01714817|460037274|FG001|Year 2 Period|Participant no longer meets criteria|4|||
127841772|NCT01714817|460037273|FG000|Year 2 Period|Lost to Follow-up|2|||
127841773|NCT01714817|460037274|FG001|Year 2 Period|Lost to Follow-up|0|||
127841774|NCT01714817|460037273|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
127841775|NCT01714817|460037274|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
127841776|NCT01714817|460037273|FG000|Year 2 Period|Pregnancy|1|||
127841777|NCT01714817|460037274|FG001|Year 2 Period|Pregnancy|1|||
127841778|NCT01714817|460037273|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
127841779|NCT01714817|460037274|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
127841780|NCT01714817|460037273|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
127841781|NCT01714817|460037274|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
127841782|NCT01714817|460037273|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
127841783|NCT01714817|460037274|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
127841784|NCT01714817|460037273|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
127841785|NCT01714817|460037274|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
127841786|NCT01714817|460037273|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
127841787|NCT01714817|460037274|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
127841788|NCT01714817|460037273|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
127841789|NCT01714817|460037274|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
127841790|NCT01714817|460037273|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
127841791|NCT01714817|460037274|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
127841792|NCT01714817|460037273|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
127841793|NCT01714817|460037274|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
127841794|NCT01714817|460037273|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
127841795|NCT01714817|460037274|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
127841796|NCT01714817|460037273|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
127841797|NCT01714817|460037274|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
127841798|NCT01714817|460037273|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
127841799|NCT01714817|460037274|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
127841800|NCT01714817|460037273|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
127841801|NCT01714817|460037274|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
127841802|NCT01714817|460037273|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
127841803|NCT01714817|460037274|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
127898948|NCT02603952|460253599|FG001|Overall Study|Received oseltamivir by error|0|||
127898949|NCT02603952|460253600|FG002|Overall Study|Received oseltamivir by error|0|||
127898950|NCT02603952|460253601|FG003|Overall Study|Received oseltamivir by error|1|||
127898951|NCT04646109|460253604|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
127898952|NCT04646109|460253605|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
127898953|NCT00577460|460253606|FG000|Overall Study|Adverse Event|11|||
127898954|NCT00577460|460253607|FG001|Overall Study|Adverse Event|7|||
127898955|NCT00577460|460253608|FG002|Overall Study|Adverse Event|14|||
127898956|NCT00577460|460253606|FG000|Overall Study|Protocol Violation|0|||
127898957|NCT00577460|460253607|FG001|Overall Study|Protocol Violation|1|||
127898958|NCT00577460|460253608|FG002|Overall Study|Protocol Violation|1|||
127898959|NCT00577460|460253606|FG000|Overall Study|Lost to Follow-up|0|||
127898960|NCT00577460|460253607|FG001|Overall Study|Lost to Follow-up|3|||
127898961|NCT00577460|460253608|FG002|Overall Study|Lost to Follow-up|4|||
127898962|NCT00577460|460253606|FG000|Overall Study|Withdrawal by Subject|5|||
127898963|NCT00577460|460253607|FG001|Overall Study|Withdrawal by Subject|5|||
127898964|NCT00577460|460253608|FG002|Overall Study|Withdrawal by Subject|6|||
127898965|NCT00577460|460253606|FG000|Overall Study|Other|0|||
127898966|NCT00577460|460253607|FG001|Overall Study|Other|3|||
127898967|NCT00577460|460253608|FG002|Overall Study|Other|2|||
127898968|NCT03184441|460253617|FG000|Overall Study|Withdrawal by Subject|1|||
127898969|NCT00182091|460253618|FG000|Overall Study|Withdrawal by Subject|1|||
127898970|NCT00182091|460253619|FG001|Overall Study|Withdrawal by Subject|0|||
127898971|NCT00182091|460253620|FG002|Overall Study|Withdrawal by Subject|0|||
127898972|NCT00182091|460253621|FG003|Overall Study|Withdrawal by Subject|0|||
127898973|NCT00993616|460253625|FG000|Overall Study|No tumor at entry|1|||
127898974|NCT00993616|460253625|FG000|Overall Study|Never treated|1|||
127898975|NCT03815942|460254836|FG000|Overall Study|Withdrawal by Subject|0|||
127898976|NCT03815942|460254837|FG001|Overall Study|Withdrawal by Subject|17|||
127898977|NCT02785913|460254838|FG000|Overall Study|Adverse Event|5|||
127898978|NCT02785913|460254838|FG000|Overall Study|Death|2|||
127898979|NCT02785913|460254838|FG000|Overall Study|Progression|18|||
127898980|NCT02785913|460254838|FG000|Overall Study|Not protocol specified|1|||
127898981|NCT03717064|460254839|FG000|Period 2|Adverse Event|1|||
127898982|NCT02841709|460254840|FG000|5th Intervention|Adverse Event|2|||
127898983|NCT02841709|460254841|FG001|5th Intervention|Adverse Event|0|||
127898984|NCT02841709|460254842|FG002|5th Intervention|Adverse Event|0|||
127898985|NCT02841709|460254843|FG003|5th Intervention|Adverse Event|0|||
127898986|NCT02841709|460254844|FG004|5th Intervention|Adverse Event|2|||
127898987|NCT01929109|460254845|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
127898988|NCT01929109|460254846|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
127898989|NCT01929109|460254847|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
127898990|NCT01929109|460254848|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
127898991|NCT01929109|460254849|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
127898992|NCT00076102|460254850|FG000|Overall Study|Clinical progression|1|||
127898993|NCT00076102|460254850|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
127898994|NCT00076102|460254850|FG000|Overall Study|plexiform neurofibroma surgery|1|||
127898995|NCT00076102|460254850|FG000|Overall Study|refusal of further therapy|2|||
127898996|NCT01402908|460254852|FG000|Overall Study|Withdrawal by Subject|30|||
127898997|NCT01402908|460254853|FG001|Overall Study|Withdrawal by Subject|17|||
127898998|NCT01402908|460254852|FG000|Overall Study|Lost to Follow-up|3|||
127898999|NCT01402908|460254853|FG001|Overall Study|Lost to Follow-up|1|||
127899000|NCT01402908|460254852|FG000|Overall Study|Physician Decision|1|||
127899001|NCT01402908|460254853|FG001|Overall Study|Physician Decision|0|||
127899002|NCT02581345|460254855|FG000|Part 1: up to Week 16|Adverse Event|3|||
127899003|NCT02581345|460254856|FG001|Part 1: up to Week 16|Adverse Event|8|||
127899004|NCT02581345|460254857|FG002|Part 1: up to Week 16|Adverse Event|0|||
127899005|NCT02581345|460254858|FG003|Part 1: up to Week 16|Adverse Event|0|||
127899006|NCT02581345|460254855|FG000|Part 1: up to Week 16|Physician Decision|2|||
127899007|NCT02581345|460254856|FG001|Part 1: up to Week 16|Physician Decision|4|||
127899008|NCT02581345|460254857|FG002|Part 1: up to Week 16|Physician Decision|0|||
127899009|NCT02581345|460254858|FG003|Part 1: up to Week 16|Physician Decision|0|||
127899010|NCT02581345|460254855|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
127899011|NCT02581345|460254856|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
127899012|NCT02581345|460254857|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
127899013|NCT02581345|460254858|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
127899014|NCT02581345|460254855|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
127899015|NCT02581345|460254856|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
127899016|NCT02581345|460254857|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
127899017|NCT02581345|460254858|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
127899018|NCT02581345|460254855|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
127899019|NCT02581345|460254856|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
127899020|NCT02581345|460254857|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
127899021|NCT02581345|460254858|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
127899022|NCT02581345|460254855|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
127899023|NCT02581345|460254856|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
127899024|NCT02581345|460254857|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
127899025|NCT02581345|460254858|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
127899026|NCT02581345|460254855|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
127899027|NCT02581345|460254856|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
127899028|NCT02581345|460254857|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
127899029|NCT02581345|460254858|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
127899030|NCT02581345|460254855|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
127899031|NCT02581345|460254856|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
127899032|NCT02581345|460254857|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
127899033|NCT02581345|460254858|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
127899034|NCT02581345|460254855|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
127899035|NCT02581345|460254856|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
127899036|NCT02581345|460254857|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
127899037|NCT02581345|460254858|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
127899038|NCT02581345|460254855|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
127899039|NCT02581345|460254856|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
127899040|NCT02581345|460254857|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
127899041|NCT02581345|460254858|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
127899042|NCT02581345|460254855|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
127899043|NCT02581345|460254856|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
127899044|NCT02581345|460254857|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
127899045|NCT02581345|460254858|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
127899046|NCT02581345|460254855|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
127899047|NCT02581345|460254856|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
127899048|NCT02581345|460254857|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
127899049|NCT02581345|460254858|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
127899050|NCT01244126|460254861|FG000|Overall Study|Protocol Violation|3|||
127899051|NCT01244126|460254862|FG001|Overall Study|Protocol Violation|3|||
127899052|NCT01244126|460254863|FG002|Overall Study|Protocol Violation|9|||
127899053|NCT00863746|460254868|FG000|Treatment|Not treated|4|||
127899054|NCT00863746|460254869|FG001|Treatment|Not treated|2|||
127899055|NCT00863746|460254868|FG000|Treatment|Adverse Event|41|||
127899056|NCT00863746|460254869|FG001|Treatment|Adverse Event|16|||
127899057|NCT00863746|460254868|FG000|Treatment|non-compliant with study medication|4|||
127899058|NCT00863746|460254869|FG001|Treatment|non-compliant with study medication|0|||
127899059|NCT00863746|460254868|FG000|Treatment|Consent withdrawn|15|||
127899060|NCT00863746|460254869|FG001|Treatment|Consent withdrawn|14|||
127899061|NCT00863746|460254868|FG000|Treatment|Lost to Follow-up|1|||
127899062|NCT00863746|460254869|FG001|Treatment|Lost to Follow-up|0|||
127899063|NCT00863746|460254868|FG000|Treatment|Protocol Violation|5|||
127899064|NCT00863746|460254869|FG001|Treatment|Protocol Violation|3|||
127899065|NCT00863746|460254868|FG000|Treatment|Other|1|||
127899066|NCT00863746|460254869|FG001|Treatment|Other|0|||
127899067|NCT00863746|460254868|FG000|Survival Follow up|Death|244|||
127899068|NCT00863746|460254869|FG001|Survival Follow up|Death|271|||
127899069|NCT00863746|460254868|FG000|Survival Follow up|Lost to Follow-up|2|||
127899070|NCT00863746|460254869|FG001|Survival Follow up|Lost to Follow-up|1|||
127899071|NCT00863746|460254868|FG000|Survival Follow up|Consent Withdrawn|7|||
127899072|NCT00863746|460254869|FG001|Survival Follow up|Consent Withdrawn|8|||
127899073|NCT00453362|460254870|FG000|Overall Study|Adverse Event|5|||
127899074|NCT00453362|460254870|FG000|Overall Study|Death|7|||
127899075|NCT00453362|460254870|FG000|Overall Study|Physician Decision|2|||
127899076|NCT00453362|460254870|FG000|Overall Study|Withdrawal by Subject|3|||
127899077|NCT00453362|460254870|FG000|Overall Study|Progression of disease|56|||
127899078|NCT00453362|460254870|FG000|Overall Study|Screening Failure|14|||
127899079|NCT04885296|460254871|FG000|Period 1|Covid-19 Related|1|||
127899080|NCT04885296|460254872|FG001|Period 1|Covid-19 Related|0|||
127899081|NCT04885296|460254871|FG000|Period 1|Adverse Event|0|||
127899082|NCT04885296|460254872|FG001|Period 1|Adverse Event|1|||
127899083|NCT04885296|460254871|FG000|Period 1|Withdrawal by Subject|1|||
127899084|NCT04885296|460254872|FG001|Period 1|Withdrawal by Subject|1|||
127899085|NCT04885296|460254871|FG000|Period 1|Test Article No Longer Available|1|||
127899086|NCT04885296|460254872|FG001|Period 1|Test Article No Longer Available|0|||
127899087|NCT04885296|460254871|FG000|Period 1|Dispensed Study lens in Error|1|||
127899088|NCT04885296|460254872|FG001|Period 1|Dispensed Study lens in Error|0|||
127899089|NCT04885296|460254871|FG000|Period 1|Lost to Follow-up|1|||
127899090|NCT04885296|460254872|FG001|Period 1|Lost to Follow-up|0|||
127899091|NCT04885296|460254871|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
127899092|NCT04885296|460254872|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
127899093|NCT00862979|460254873|FG000|Overall Study|Adverse Event|6|||
127899094|NCT00862979|460254874|FG001|Overall Study|Adverse Event|3|||
127899095|NCT00862979|460254873|FG000|Overall Study|Protocol Violation|0|||
127899096|NCT00862979|460254874|FG001|Overall Study|Protocol Violation|1|||
127899097|NCT00862979|460254873|FG000|Overall Study|Patient withdrew consent|2|||
127899098|NCT00862979|460254874|FG001|Overall Study|Patient withdrew consent|1|||
127899099|NCT00862979|460254873|FG000|Overall Study|Administrative problems|0|||
127899100|NCT00862979|460254874|FG001|Overall Study|Administrative problems|1|||
127899101|NCT00862979|460254873|FG000|Overall Study|Death|0|||
127899102|NCT00862979|460254874|FG001|Overall Study|Death|1|||
127899103|NCT01367275|460254878|FG000|Overall Study|Ineligible|1|||
127899104|NCT01367275|460254878|FG000|Overall Study|Disease Progression|2|||
127899105|NCT05346055|460254879|FG000|Overall Study|Withdrawal by Subject|1|||
127899106|NCT05346055|460254879|FG000|Overall Study|Protocol Violation|1|||
127899107|NCT05346055|460254879|FG000|Overall Study|Therapist decision|1|||
127899108|NCT01545076|460254882|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
127899109|NCT01545076|460254883|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
127899110|NCT01545076|460254884|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
127899111|NCT01545076|460254885|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
127899112|NCT01545076|460254886|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
127899113|NCT01545076|460254882|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
127899114|NCT01545076|460254883|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
127899115|NCT01545076|460254884|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
127899116|NCT01545076|460254885|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
127899117|NCT01545076|460254886|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
127899118|NCT01545076|460254882|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
127899119|NCT01545076|460254883|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
127899120|NCT01545076|460254884|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
127899121|NCT01545076|460254885|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
127899122|NCT01545076|460254886|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
127899123|NCT01545076|460254882|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
127899124|NCT01545076|460254883|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
127899125|NCT01545076|460254884|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
127899126|NCT01545076|460254885|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
127899127|NCT01545076|460254886|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
127899128|NCT01545076|460254882|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
127899129|NCT01545076|460254883|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
127899130|NCT01545076|460254884|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
127899131|NCT01545076|460254885|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
127899132|NCT01545076|460254886|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
127899133|NCT01545076|460254882|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
127899134|NCT01545076|460254883|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
127899135|NCT01545076|460254884|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
127899136|NCT01545076|460254885|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
127899137|NCT01545076|460254886|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
127899138|NCT01545076|460254882|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
127899139|NCT01545076|460254883|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
127899140|NCT01545076|460254884|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
127899141|NCT01545076|460254885|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
127899142|NCT01545076|460254886|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
127899143|NCT01545076|460254882|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
127899144|NCT01545076|460254883|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
127899145|NCT01545076|460254884|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
127899146|NCT01545076|460254885|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
127899147|NCT01545076|460254886|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
127899148|NCT01545076|460254882|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
127899149|NCT01545076|460254883|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
127899150|NCT01545076|460254884|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
127899151|NCT01545076|460254885|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
127899152|NCT01545076|460254886|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
127899153|NCT00264797|460254894|FG000|Overall Study|Withdrawal by Subject|11|||
127899154|NCT00264797|460254895|FG001|Overall Study|Withdrawal by Subject|11|||
127899155|NCT00264797|460254894|FG000|Overall Study|Lost to Follow-up|9|||
127899156|NCT00264797|460254895|FG001|Overall Study|Lost to Follow-up|17|||
127899157|NCT00264797|460254894|FG000|Overall Study|Moved from area|3|||
127899158|NCT00264797|460254895|FG001|Overall Study|Moved from area|1|||
127899159|NCT00264797|460254894|FG000|Overall Study|Practical Problems|2|||
127899160|NCT00264797|460254895|FG001|Overall Study|Practical Problems|3|||
127899161|NCT00264797|460254894|FG000|Overall Study|Incarceration|4|||
127899162|NCT00264797|460254895|FG001|Overall Study|Incarceration|5|||
127899163|NCT00264797|460254894|FG000|Overall Study|Pressure/advice from Outsiders|1|||
127899164|NCT00264797|460254895|FG001|Overall Study|Pressure/advice from Outsiders|1|||
127899165|NCT00264797|460254894|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
127899166|NCT00264797|460254895|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
127899167|NCT00264797|460254894|FG000|Overall Study|Other|3|||
127899168|NCT00264797|460254895|FG001|Overall Study|Other|4|||
127841804|NCT01714817|460037273|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
127841805|NCT01714817|460037274|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
127841806|NCT01714817|460037273|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
127841807|NCT01714817|460037274|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
127841808|NCT01714817|460037273|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
127841809|NCT01714817|460037274|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
127841810|NCT02921763|460037275|FG000|Overall Study|Adverse Event|4|||
127841811|NCT02921763|460037275|FG000|Overall Study|Lost to Follow-up|4|||
127841812|NCT02921763|460037275|FG000|Overall Study|Lack of Efficacy|3|||
127841813|NCT02921763|460037275|FG000|Overall Study|Protocol Violation|2|||
127841814|NCT02921763|460037275|FG000|Overall Study|Withdrawal by Subject|2|||
127841815|NCT02921763|460037275|FG000|Overall Study|Physician Decision|1|||
127841816|NCT02921763|460037275|FG000|Overall Study|No data obtained|2|||
127841817|NCT01582971|460037276|FG000|Overall Study|Death|2|||
127841818|NCT01582971|460037277|FG001|Overall Study|Death|1|||
127841819|NCT01582971|460037276|FG000|Overall Study|Lost to Follow-up|18|||
127841820|NCT01582971|460037277|FG001|Overall Study|Lost to Follow-up|21|||
127841821|NCT01582971|460037276|FG000|Overall Study|Withdrawal by Subject|4|||
127841822|NCT01582971|460037277|FG001|Overall Study|Withdrawal by Subject|2|||
127841823|NCT01582971|460037276|FG000|Overall Study|Other|15|||
127841824|NCT01582971|460037277|FG001|Overall Study|Other|13|||
127841825|NCT02554253|460037282|FG000|Overall Study|ineligible after enrollment|1|||
127841826|NCT02554253|460037283|FG001|Overall Study|ineligible after enrollment|0|||
127841827|NCT02554253|460037282|FG000|Overall Study|converted to transcatheter procedure|0|||
127841828|NCT02554253|460037283|FG001|Overall Study|converted to transcatheter procedure|1|||
127841829|NCT02554253|460037282|FG000|Overall Study|received both drugs|0|||
127841830|NCT02554253|460037283|FG001|Overall Study|received both drugs|1|||
127899169|NCT01153984|460254896|FG000|Overall Study|Withdrawal by Subject|1|||
127899170|NCT01153984|460254896|FG000|Overall Study|Adverse Event|1|||
127899171|NCT02460159|460254897|FG000|Overall Study|Adverse Event|4|||
127899172|NCT02460159|460254898|FG001|Overall Study|Adverse Event|1|||
127899173|NCT02460159|460254897|FG000|Overall Study|Withdrawal by Subject|2|||
127899174|NCT02460159|460254898|FG001|Overall Study|Withdrawal by Subject|0|||
127899175|NCT02636907|460254901|FG000|Autoinjector Assessment Period|Adverse Event|2|||
127899176|NCT02636907|460254901|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
127899177|NCT02636907|460254901|FG000|Extension Phase|Adverse Event|2|||
127899178|NCT02636907|460254901|FG000|Extension Phase|Withdrawal by Subject|4|||
127899179|NCT02636907|460254901|FG000|Extension Phase|Physician Decision|1|||
127899180|NCT02636907|460254901|FG000|Extension Phase|Lost to Follow-up|2|||
127899181|NCT02636907|460254901|FG000|Extension Phase|Lack of Efficacy|1|||
127899182|NCT00860405|460254908|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
127899183|NCT00860405|460254909|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
127899184|NCT02465567|460254910|FG000|Overall Study|Adverse Event|118|||
127899185|NCT02465567|460254911|FG001|Overall Study|Adverse Event|113|||
127899186|NCT02465567|460254912|FG002|Overall Study|Adverse Event|147|||
127899187|NCT02465567|460254913|FG003|Overall Study|Adverse Event|138|||
127899188|NCT02465567|460254910|FG000|Overall Study|Lack of Efficacy|103|||
127899189|NCT02465567|460254911|FG001|Overall Study|Lack of Efficacy|102|||
127899190|NCT02465567|460254912|FG002|Overall Study|Lack of Efficacy|171|||
127899191|NCT02465567|460254913|FG003|Overall Study|Lack of Efficacy|135|||
127899192|NCT02465567|460254910|FG000|Overall Study|Withdrawal by Subject|104|||
127899193|NCT02465567|460254911|FG001|Overall Study|Withdrawal by Subject|94|||
127899194|NCT02465567|460254912|FG002|Overall Study|Withdrawal by Subject|123|||
127899195|NCT02465567|460254913|FG003|Overall Study|Withdrawal by Subject|130|||
127899196|NCT02465567|460254910|FG000|Overall Study|Physician Decision|23|||
127899197|NCT02465567|460254911|FG001|Overall Study|Physician Decision|33|||
127899198|NCT02465567|460254912|FG002|Overall Study|Physician Decision|38|||
127899199|NCT02465567|460254913|FG003|Overall Study|Physician Decision|28|||
127899200|NCT02465567|460254910|FG000|Overall Study|Major Protocol Deviation|24|||
127899201|NCT02465567|460254911|FG001|Overall Study|Major Protocol Deviation|26|||
127899202|NCT02465567|460254912|FG002|Overall Study|Major Protocol Deviation|22|||
127899203|NCT02465567|460254913|FG003|Overall Study|Major Protocol Deviation|25|||
127899204|NCT02465567|460254910|FG000|Overall Study|Lost to Follow-up|25|||
127899205|NCT02465567|460254911|FG001|Overall Study|Lost to Follow-up|21|||
127899206|NCT02465567|460254912|FG002|Overall Study|Lost to Follow-up|19|||
127899207|NCT02465567|460254913|FG003|Overall Study|Lost to Follow-up|15|||
127899208|NCT02465567|460254910|FG000|Overall Study|Protocol Specified Criteria|20|||
127899209|NCT02465567|460254911|FG001|Overall Study|Protocol Specified Criteria|10|||
127899210|NCT02465567|460254912|FG002|Overall Study|Protocol Specified Criteria|9|||
127899211|NCT02465567|460254913|FG003|Overall Study|Protocol Specified Criteria|12|||
127899212|NCT02465567|460254910|FG000|Overall Study|Administrative Reasons|12|||
127899213|NCT02465567|460254911|FG001|Overall Study|Administrative Reasons|9|||
127899214|NCT02465567|460254912|FG002|Overall Study|Administrative Reasons|11|||
127899215|NCT02465567|460254913|FG003|Overall Study|Administrative Reasons|5|||
127899216|NCT02465567|460254910|FG000|Overall Study|Randomized but not treated|1|||
127899217|NCT02465567|460254911|FG001|Overall Study|Randomized but not treated|5|||
127899218|NCT02465567|460254912|FG002|Overall Study|Randomized but not treated|4|||
127899219|NCT02465567|460254913|FG003|Overall Study|Randomized but not treated|5|||
127899220|NCT02465567|460254910|FG000|Overall Study|enrolled in >1 studies|18|||
127899221|NCT02465567|460254911|FG001|Overall Study|enrolled in >1 studies|11|||
127899222|NCT02465567|460254912|FG002|Overall Study|enrolled in >1 studies|19|||
127899223|NCT02465567|460254913|FG003|Overall Study|enrolled in >1 studies|15|||
127899224|NCT02465567|460254910|FG000|Overall Study|missing PI Signature|1|||
127899225|NCT02465567|460254911|FG001|Overall Study|missing PI Signature|0|||
127899226|NCT02465567|460254912|FG002|Overall Study|missing PI Signature|0|||
127899227|NCT02465567|460254913|FG003|Overall Study|missing PI Signature|0|||
127899228|NCT00497796|460254916|FG000|Overall Study|Adverse event (not related)|9|||
127899229|NCT00497796|460254917|FG001|Overall Study|Adverse event (not related)|9|||
127899230|NCT00497796|460254916|FG000|Overall Study|Adverse event (related)|5|||
127899231|NCT00497796|460254917|FG001|Overall Study|Adverse event (related)|4|||
127899232|NCT00497796|460254916|FG000|Overall Study|CMV infection or disease treatment|30|||
127899233|NCT00497796|460254917|FG001|Overall Study|CMV infection or disease treatment|4|||
127899234|NCT00497796|460254916|FG000|Overall Study|Consent withdrawn|10|||
127899235|NCT00497796|460254917|FG001|Overall Study|Consent withdrawn|3|||
127899236|NCT00497796|460254916|FG000|Overall Study|Investigator/sponsor discretion|31|||
127899237|NCT00497796|460254917|FG001|Overall Study|Investigator/sponsor discretion|34|||
127899238|NCT00497796|460254916|FG000|Overall Study|Lost to Follow-up|0|||
127899239|NCT00497796|460254917|FG001|Overall Study|Lost to Follow-up|1|||
127899240|NCT00497796|460254916|FG000|Overall Study|Not applicable (randomized not treated)|0|||
127899241|NCT00497796|460254917|FG001|Overall Study|Not applicable (randomized not treated)|4|||
127899242|NCT01492400|460254920|FG000|Overall Study|Miscellaneous Reasons|2|||
127899243|NCT01492400|460254921|FG001|Overall Study|Miscellaneous Reasons|3|||
127899244|NCT01492400|460254920|FG000|Overall Study|Personal Reasons|0|||
127899245|NCT01492400|460254921|FG001|Overall Study|Personal Reasons|5|||
127899246|NCT01492400|460254920|FG000|Overall Study|Lost to Follow-up|3|||
127899247|NCT01492400|460254921|FG001|Overall Study|Lost to Follow-up|1|||
127899248|NCT01492400|460254920|FG000|Overall Study|Pregnancy|0|||
127899249|NCT01492400|460254921|FG001|Overall Study|Pregnancy|1|||
127899250|NCT01492400|460254920|FG000|Overall Study|Lack of Efficacy|1|||
127899251|NCT01492400|460254921|FG001|Overall Study|Lack of Efficacy|1|||
127899252|NCT01492400|460254920|FG000|Overall Study|Adverse Event|10|||
127899253|NCT01492400|460254921|FG001|Overall Study|Adverse Event|5|||
127899254|NCT00604500|460254922|FG000|Overall Study|Adverse Event|2|||
127899255|NCT00604500|460254922|FG000|Overall Study|Protocol Violation|2|||
127899256|NCT00604500|460254922|FG000|Overall Study|Treatment Failure|1|||
127899257|NCT00604500|460254922|FG000|Overall Study|Withdrawal by Subject|4|||
127899258|NCT00604500|460254922|FG000|Overall Study|Administrative|1|||
127899259|NCT00604500|460254922|FG000|Overall Study|Did not meet protocol eligibility|1|||
127899260|NCT00320112|460254923|FG000|Overall Study|Lost to Follow-up|3|||
127899261|NCT00320112|460254924|FG001|Overall Study|Lost to Follow-up|4|||
127899262|NCT00320112|460254923|FG000|Overall Study|Withdrawal by Subject|3|||
127899263|NCT00320112|460254924|FG001|Overall Study|Withdrawal by Subject|0|||
127899264|NCT00320112|460254923|FG000|Overall Study|Death|2|||
127899265|NCT00320112|460254924|FG001|Overall Study|Death|1|||
127899266|NCT02899338|460254925|FG000|Overall Study|Adverse Event|1|||
127899267|NCT02899338|460254926|FG001|Overall Study|Adverse Event|2|||
127899268|NCT02899338|460254925|FG000|Overall Study|Withdrawal by Subject|2|||
127899269|NCT02899338|460254926|FG001|Overall Study|Withdrawal by Subject|0|||
127899270|NCT02353169|460254928|FG000|Overall Study|QTc > 450 msec|1|||
127899271|NCT02353169|460254929|FG001|Overall Study|QTc > 450 msec|1|||
127899272|NCT02353169|460254930|FG002|Overall Study|QTc > 450 msec|1|||
127899273|NCT02353169|460254931|FG003|Overall Study|QTc > 450 msec|1|||
127899274|NCT02353169|460254928|FG000|Overall Study|OR team declined|2|||
127899275|NCT02353169|460254929|FG001|Overall Study|OR team declined|0|||
127899276|NCT02353169|460254930|FG002|Overall Study|OR team declined|0|||
127899277|NCT02353169|460254931|FG003|Overall Study|OR team declined|0|||
127899278|NCT02353169|460254928|FG000|Overall Study|Inhalational induction|0|||
127899279|NCT02353169|460254929|FG001|Overall Study|Inhalational induction|2|||
127899280|NCT02353169|460254930|FG002|Overall Study|Inhalational induction|0|||
127899281|NCT02353169|460254931|FG003|Overall Study|Inhalational induction|0|||
127899282|NCT02353169|460254928|FG000|Overall Study|ECG data error|0|||
127899283|NCT02353169|460254929|FG001|Overall Study|ECG data error|3|||
127899284|NCT02353169|460254930|FG002|Overall Study|ECG data error|2|||
127899285|NCT02353169|460254931|FG003|Overall Study|ECG data error|2|||
127899286|NCT02353169|460254928|FG000|Overall Study|Pre-op medication|0|||
127899287|NCT02353169|460254929|FG001|Overall Study|Pre-op medication|0|||
127899288|NCT02353169|460254930|FG002|Overall Study|Pre-op medication|1|||
127899289|NCT02353169|460254931|FG003|Overall Study|Pre-op medication|0|||
127899290|NCT00796822|460254932|FG000|Overall Study|Lost to Follow-up|2|||
127899291|NCT00796822|460254933|FG001|Overall Study|Lost to Follow-up|0|||
127899292|NCT00796822|460254932|FG000|Overall Study|Adverse Event|1|||
127899293|NCT00796822|460254933|FG001|Overall Study|Adverse Event|0|||
127899294|NCT00117949|460254936|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
127899295|NCT00117949|460254937|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
127899296|NCT00117949|460254938|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
127899297|NCT00117949|460254939|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
127899298|NCT00117949|460254936|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
127899299|NCT00117949|460254937|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
127899300|NCT00117949|460254938|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
127899301|NCT00117949|460254939|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
127899302|NCT00117949|460254936|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
127899303|NCT00117949|460254937|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
127899304|NCT00117949|460254938|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
127899305|NCT00117949|460254939|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
127899306|NCT00117949|460254936|FG000|Overall Study|PSA increase >=10ng/mL|0|||
127899307|NCT00117949|460254937|FG001|Overall Study|PSA increase >=10ng/mL|1|||
127899308|NCT00117949|460254938|FG002|Overall Study|PSA increase >=10ng/mL|1|||
127899309|NCT00117949|460254939|FG003|Overall Study|PSA increase >=10ng/mL|0|||
127899310|NCT00117949|460254936|FG000|Overall Study|PSA reduction <=50%|0|||
127899311|NCT00117949|460254937|FG001|Overall Study|PSA reduction <=50%|2|||
127899312|NCT00117949|460254938|FG002|Overall Study|PSA reduction <=50%|2|||
127899313|NCT00117949|460254939|FG003|Overall Study|PSA reduction <=50%|4|||
127899314|NCT00117949|460254936|FG000|Overall Study|Hepatic abnormalities|0|||
127899315|NCT00117949|460254937|FG001|Overall Study|Hepatic abnormalities|1|||
127899316|NCT00117949|460254938|FG002|Overall Study|Hepatic abnormalities|0|||
127899317|NCT00117949|460254939|FG003|Overall Study|Hepatic abnormalities|1|||
127899318|NCT04591626|460254940|FG000|Overall Study|Adverse Event|4|||
127899319|NCT04591626|460254941|FG001|Overall Study|Adverse Event|0|||
127899320|NCT04591626|460254940|FG000|Overall Study|Withdrawal by Subject|5|||
127899321|NCT04591626|460254941|FG001|Overall Study|Withdrawal by Subject|3|||
127841831|NCT01736254|460037286|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
127841832|NCT01736254|460037286|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
127841833|NCT02559206|460037287|FG000|Overall Study|Adverse Event|0|||
127841834|NCT02559206|460037288|FG001|Overall Study|Adverse Event|4|||
127841835|NCT02559206|460037289|FG002|Overall Study|Adverse Event|1|||
127841836|NCT02559206|460037290|FG003|Overall Study|Adverse Event|5|||
127841837|NCT02559206|460037291|FG004|Overall Study|Adverse Event|3|||
127841838|NCT02559206|460037292|FG005|Overall Study|Adverse Event|0|||
127841839|NCT02559206|460037293|FG006|Overall Study|Adverse Event|1|||
127841840|NCT02559206|460037294|FG007|Overall Study|Adverse Event|0|||
127841841|NCT02559206|460037287|FG000|Overall Study|Protocol Violation|1|||
127841842|NCT02559206|460037288|FG001|Overall Study|Protocol Violation|0|||
127841843|NCT02559206|460037289|FG002|Overall Study|Protocol Violation|1|||
127841844|NCT02559206|460037290|FG003|Overall Study|Protocol Violation|0|||
127841845|NCT02559206|460037291|FG004|Overall Study|Protocol Violation|0|||
127841846|NCT02559206|460037292|FG005|Overall Study|Protocol Violation|2|||
127841847|NCT02559206|460037293|FG006|Overall Study|Protocol Violation|0|||
127841848|NCT02559206|460037294|FG007|Overall Study|Protocol Violation|0|||
127841849|NCT02559206|460037287|FG000|Overall Study|Withdrawal by Subject|3|||
127841850|NCT02559206|460037288|FG001|Overall Study|Withdrawal by Subject|3|||
127841851|NCT02559206|460037289|FG002|Overall Study|Withdrawal by Subject|1|||
127841852|NCT02559206|460037290|FG003|Overall Study|Withdrawal by Subject|3|||
127841853|NCT02559206|460037291|FG004|Overall Study|Withdrawal by Subject|5|||
127841854|NCT02559206|460037292|FG005|Overall Study|Withdrawal by Subject|4|||
127841855|NCT02559206|460037293|FG006|Overall Study|Withdrawal by Subject|1|||
127841856|NCT02559206|460037294|FG007|Overall Study|Withdrawal by Subject|2|||
127841857|NCT02559206|460037287|FG000|Overall Study|Lost to Follow-up|3|||
127841858|NCT02559206|460037288|FG001|Overall Study|Lost to Follow-up|5|||
127841859|NCT02559206|460037289|FG002|Overall Study|Lost to Follow-up|3|||
127841860|NCT02559206|460037290|FG003|Overall Study|Lost to Follow-up|3|||
127841861|NCT02559206|460037291|FG004|Overall Study|Lost to Follow-up|2|||
127841862|NCT02559206|460037292|FG005|Overall Study|Lost to Follow-up|5|||
127841863|NCT02559206|460037293|FG006|Overall Study|Lost to Follow-up|1|||
127841864|NCT02559206|460037294|FG007|Overall Study|Lost to Follow-up|4|||
127841865|NCT02559206|460037287|FG000|Overall Study|Lack of Efficacy|1|||
127841866|NCT02559206|460037288|FG001|Overall Study|Lack of Efficacy|0|||
127841867|NCT02559206|460037289|FG002|Overall Study|Lack of Efficacy|3|||
127899322|NCT04591626|460254940|FG000|Overall Study|Physician Decision|0|||
127899323|NCT04591626|460254941|FG001|Overall Study|Physician Decision|1|||
127841868|NCT02559206|460037290|FG003|Overall Study|Lack of Efficacy|2|||
127841869|NCT02559206|460037291|FG004|Overall Study|Lack of Efficacy|2|||
127841870|NCT02559206|460037292|FG005|Overall Study|Lack of Efficacy|3|||
127841871|NCT02559206|460037293|FG006|Overall Study|Lack of Efficacy|3|||
127841872|NCT02559206|460037294|FG007|Overall Study|Lack of Efficacy|3|||
127841873|NCT02559206|460037287|FG000|Overall Study|Other Not Specified|0|||
127841874|NCT02559206|460037288|FG001|Overall Study|Other Not Specified|0|||
127841875|NCT02559206|460037289|FG002|Overall Study|Other Not Specified|0|||
127841876|NCT02559206|460037290|FG003|Overall Study|Other Not Specified|1|||
127841877|NCT02559206|460037291|FG004|Overall Study|Other Not Specified|0|||
127841878|NCT02559206|460037292|FG005|Overall Study|Other Not Specified|0|||
127841879|NCT02559206|460037293|FG006|Overall Study|Other Not Specified|0|||
127899324|NCT04591626|460254940|FG000|Overall Study|Death|0|||
127899325|NCT04591626|460254941|FG001|Overall Study|Death|1|||
127899326|NCT04591626|460254940|FG000|Overall Study|Non-Compliance with Study Drug|1|||
127899327|NCT04591626|460254941|FG001|Overall Study|Non-Compliance with Study Drug|0|||
127899328|NCT02672553|460254942|FG000|Overall Study|Death|3|||
127899329|NCT02672553|460254943|FG001|Overall Study|Death|5|||
127899330|NCT02672553|460254942|FG000|Overall Study|Valve Explant|1|||
127899331|NCT02672553|460254943|FG001|Overall Study|Valve Explant|0|||
127899332|NCT02672553|460254942|FG000|Overall Study|Conversion to Commercial Valve|3|||
127899333|NCT02672553|460254943|FG001|Overall Study|Conversion to Commercial Valve|0|||
127899334|NCT02672553|460254942|FG000|Overall Study|Withdrawal by Subject|3|||
127899335|NCT02672553|460254943|FG001|Overall Study|Withdrawal by Subject|3|||
127899336|NCT02672553|460254942|FG000|Overall Study|Intraoperative screen failure|2|||
127899337|NCT02672553|460254943|FG001|Overall Study|Intraoperative screen failure|0|||
127841880|NCT02559206|460037294|FG007|Overall Study|Other Not Specified|0|||
127841881|NCT01561560|460037295|FG000|First Two Weeks of Wear|Time/job conflict|0|||
127841882|NCT01561560|460037296|FG001|First Two Weeks of Wear|Time/job conflict|1|||
127841883|NCT01561560|460037295|FG000|First Two Weeks of Wear|Adverse Event|0|||
127841884|NCT01561560|460037296|FG001|First Two Weeks of Wear|Adverse Event|1|||
127841885|NCT01561560|460037295|FG000|Second Two Weeks of Wear|Adverse Event|0|||
127841886|NCT01561560|460037296|FG001|Second Two Weeks of Wear|Adverse Event|1|||
127841887|NCT06025396|460038979|FG000|Overall Study|Protocol-Specified Withdrawal|5|||
127841888|NCT06025396|460038980|FG001|Overall Study|Protocol-Specified Withdrawal|0|||
127841889|NCT06025396|460038981|FG002|Overall Study|Protocol-Specified Withdrawal|0|||
127841890|NCT06025396|460038982|FG003|Overall Study|Protocol-Specified Withdrawal|1|||
127841891|NCT06025396|460038983|FG004|Overall Study|Protocol-Specified Withdrawal|1|||
127841892|NCT06025396|460038979|FG000|Overall Study|Withdrawal by Subject|0|||
127841893|NCT06025396|460038980|FG001|Overall Study|Withdrawal by Subject|1|||
127841894|NCT06025396|460038981|FG002|Overall Study|Withdrawal by Subject|1|||
127841895|NCT06025396|460038982|FG003|Overall Study|Withdrawal by Subject|0|||
127841896|NCT06025396|460038983|FG004|Overall Study|Withdrawal by Subject|0|||
127841897|NCT05691829|460038984|FG000|Overall Study|Physician Decision|2|||
127841898|NCT05691829|460038984|FG000|Overall Study|Eligibility criteria not met|3|||
127841899|NCT00949910|460038985|FG000|Overall Study|Progressive Disease|3750|||
127841900|NCT00949910|460038985|FG000|Overall Study|Symptomatic Deterioration|1088|||
127841901|NCT00949910|460038985|FG000|Overall Study|Lost to Follow-up|100|||
127841902|NCT00949910|460038985|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
127899338|NCT00841100|460254946|FG000|Phase 1 (28 Days)|Adverse Event|1|||
127899339|NCT00841100|460254946|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
127899340|NCT01355081|460254947|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
127899341|NCT01355081|460254948|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
127899342|NCT01355081|460254949|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
127899343|NCT01355081|460254947|FG000|Overall Study|Major Protocol Deviation|0|||
127899344|NCT01355081|460254948|FG001|Overall Study|Major Protocol Deviation|1|||
127899345|NCT01355081|460254949|FG002|Overall Study|Major Protocol Deviation|0|||
127899346|NCT01355081|460254947|FG000|Overall Study|Lost to Follow-up|0|||
127899347|NCT01355081|460254948|FG001|Overall Study|Lost to Follow-up|0|||
127899348|NCT01355081|460254949|FG002|Overall Study|Lost to Follow-up|1|||
127899349|NCT01355081|460254947|FG000|Overall Study|Withdrawal of Consent|2|||
127899350|NCT01355081|460254948|FG001|Overall Study|Withdrawal of Consent|3|||
127899351|NCT01355081|460254949|FG002|Overall Study|Withdrawal of Consent|3|||
127899352|NCT01355081|460254947|FG000|Overall Study|Lack of Efficacy|2|||
127899353|NCT01355081|460254948|FG001|Overall Study|Lack of Efficacy|1|||
127899354|NCT01355081|460254949|FG002|Overall Study|Lack of Efficacy|1|||
127899355|NCT01355081|460254947|FG000|Overall Study|Non Compliance with Study Medication|0|||
127899356|NCT01355081|460254948|FG001|Overall Study|Non Compliance with Study Medication|1|||
127899357|NCT01355081|460254949|FG002|Overall Study|Non Compliance with Study Medication|0|||
127899358|NCT01475474|460254950|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
127899359|NCT01475474|460254950|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
127899360|NCT01868009|460254953|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
127899361|NCT01868009|460254954|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
127899362|NCT01868009|460254953|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
127899363|NCT01868009|460254954|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
127899364|NCT01868009|460254953|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
127899365|NCT01868009|460254954|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
127899366|NCT04803357|460254957|FG000|Overall Study|Withdrawal by Subject|31|||
127899367|NCT04803357|460254958|FG001|Overall Study|Withdrawal by Subject|5|||
127899368|NCT01046253|460254961|FG000|Second Intervention|Adverse Event|0|||
127899369|NCT01046253|460254962|FG001|Second Intervention|Adverse Event|1|||
127899370|NCT01046253|460254961|FG000|Second Intervention|Protocol Violation|0|||
127899371|NCT01046253|460254962|FG001|Second Intervention|Protocol Violation|1|||
127899372|NCT02339909|460254963|FG000|Overall Study|Became ineligible after randomisation|89|||
127899373|NCT02339909|460254964|FG001|Overall Study|Became ineligible after randomisation|63|||
127899374|NCT02339909|460254965|FG002|Overall Study|Became ineligible after randomisation|71|||
127899375|NCT00860028|460254970|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
127899376|NCT00860028|460254971|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
127899377|NCT01658943|460254973|FG000|Overall Study|Adverse Event|6|||
127899378|NCT01658943|460254974|FG001|Overall Study|Adverse Event|13|||
127899379|NCT01658943|460254973|FG000|Overall Study|Withdrawal by Subject|9|||
127899380|NCT01658943|460254974|FG001|Overall Study|Withdrawal by Subject|2|||
127899381|NCT01658943|460254973|FG000|Overall Study|Progression/Relapse|39|||
127899382|NCT01658943|460254974|FG001|Overall Study|Progression/Relapse|40|||
127899383|NCT01658943|460254973|FG000|Overall Study|Death|4|||
127899384|NCT01658943|460254974|FG001|Overall Study|Death|2|||
127899385|NCT01658943|460254973|FG000|Overall Study|not protocol specified|4|||
127899386|NCT01658943|460254974|FG001|Overall Study|not protocol specified|1|||
127899387|NCT01658943|460254973|FG000|Overall Study|Not eligible|7|||
127899388|NCT01658943|460254974|FG001|Overall Study|Not eligible|9|||
127899389|NCT01658943|460254973|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
127899390|NCT01658943|460254974|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
127899391|NCT01027143|460256424|FG000|Overall Study|Lost to Follow-up|9|||
127899392|NCT01027143|460256425|FG001|Overall Study|Lost to Follow-up|4|||
127899393|NCT02564263|460256426|FG000|Overall Study|Adverse Event|31|||
127899394|NCT02564263|460256427|FG001|Overall Study|Adverse Event|29|||
127899395|NCT02564263|460256426|FG000|Overall Study|Death|270|||
127899396|NCT02564263|460256427|FG001|Overall Study|Death|262|||
127899397|NCT02564263|460256426|FG000|Overall Study|Withdrawal by Subject|4|||
127899398|NCT02564263|460256427|FG001|Overall Study|Withdrawal by Subject|19|||
127899399|NCT02564263|460256426|FG000|Overall Study|Sponsor's decision|9|||
127899400|NCT02564263|460256427|FG001|Overall Study|Sponsor's decision|4|||
127899401|NCT02319148|460256428|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
127899402|NCT02319148|460256429|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
127899403|NCT02319148|460256430|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
127899404|NCT02319148|460256431|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
127899405|NCT02319148|460256428|FG000|Second Intervention Period|No longer willing to participate|0|||
127899406|NCT02319148|460256429|FG001|Second Intervention Period|No longer willing to participate|1|||
127899407|NCT02319148|460256430|FG002|Second Intervention Period|No longer willing to participate|0|||
127899408|NCT02319148|460256431|FG003|Second Intervention Period|No longer willing to participate|0|||
127899409|NCT02319148|460256428|FG000|Second Intervention Period|Other|0|||
127899410|NCT02319148|460256429|FG001|Second Intervention Period|Other|0|||
127899411|NCT02319148|460256430|FG002|Second Intervention Period|Other|0|||
127899412|NCT02319148|460256431|FG003|Second Intervention Period|Other|1|||
127899413|NCT01087970|460256433|FG000|Overall Study|Protocol Violation|2|||
127899414|NCT00762086|460256434|FG000|Overall Study|Adverse Event|2|||
127899415|NCT00762086|460256435|FG001|Overall Study|Adverse Event|0|||
127899416|NCT00762086|460256434|FG000|Overall Study|Lost to Follow-up|0|||
127899417|NCT00762086|460256435|FG001|Overall Study|Lost to Follow-up|2|||
127899418|NCT00762086|460256434|FG000|Overall Study|Non compliance|1|||
127899419|NCT00762086|460256435|FG001|Overall Study|Non compliance|0|||
127899420|NCT00762086|460256434|FG000|Overall Study|Withdrawal by Subject|2|||
127899421|NCT00762086|460256435|FG001|Overall Study|Withdrawal by Subject|2|||
127899422|NCT00762086|460256434|FG000|Overall Study|Ineligible to participate in the study|1|||
127899423|NCT00762086|460256435|FG001|Overall Study|Ineligible to participate in the study|0|||
127899424|NCT01074554|460256436|FG000|Overall Study|Adverse Event|3|||
127899425|NCT01074554|460256437|FG001|Overall Study|Adverse Event|3|||
127899426|NCT01074554|460256436|FG000|Overall Study|Lost to Follow-up|0|||
127899427|NCT01074554|460256437|FG001|Overall Study|Lost to Follow-up|1|||
127899428|NCT04276883|460256438|FG000|Overall Study|Withdrawal by Subject|2|||
127899429|NCT04276883|460256439|FG001|Overall Study|Withdrawal by Subject|3|||
127899430|NCT04276883|460256440|FG002|Overall Study|Withdrawal by Subject|6|||
127899431|NCT04276883|460256438|FG000|Overall Study|Lost to Follow-up|1|||
127899432|NCT04276883|460256439|FG001|Overall Study|Lost to Follow-up|3|||
127899433|NCT04276883|460256440|FG002|Overall Study|Lost to Follow-up|0|||
127899434|NCT04276883|460256438|FG000|Overall Study|Adverse Event|0|||
127899435|NCT04276883|460256439|FG001|Overall Study|Adverse Event|1|||
127899436|NCT04276883|460256440|FG002|Overall Study|Adverse Event|0|||
127899437|NCT04276883|460256438|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
127899438|NCT04276883|460256439|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
127899439|NCT04276883|460256440|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
127899440|NCT01876706|460256441|FG000|Overall Study|BPH Intervention|9|||
127899441|NCT01876706|460256441|FG000|Overall Study|Lost to Follow-up|7|||
127899442|NCT01876706|460256441|FG000|Overall Study|Withdrawals|6|||
127899443|NCT01876706|460256441|FG000|Overall Study|Death|3|||
127899444|NCT01370408|460256446|FG000|Overall Study|treatment failure|9|||
127899445|NCT02073643|460256448|FG000|Overall Study|Lost to Follow-up|24|||
127899446|NCT01062256|460256449|FG000|Overall Study|Adverse Event|1|||
127899447|NCT01062256|460256450|FG001|Overall Study|Adverse Event|0|||
127899448|NCT01062256|460256451|FG002|Overall Study|Adverse Event|0|||
127899449|NCT01062256|460256449|FG000|Overall Study|Withdrawal by Subject|1|||
127899450|NCT01062256|460256450|FG001|Overall Study|Withdrawal by Subject|1|||
127899451|NCT01062256|460256451|FG002|Overall Study|Withdrawal by Subject|1|||
127899452|NCT01062256|460256449|FG000|Overall Study|Ineligible|1|||
127899453|NCT01062256|460256450|FG001|Overall Study|Ineligible|4|||
127899454|NCT01062256|460256451|FG002|Overall Study|Ineligible|3|||
127899455|NCT01062256|460256449|FG000|Overall Study|Administrative|0|||
127841903|NCT00949910|460038985|FG000|Overall Study|Participant Refusal|390|||
127841904|NCT00949910|460038985|FG000|Overall Study|Death Due to Malignant Disease|456|||
127841905|NCT00949910|460038985|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
127841906|NCT00949910|460038985|FG000|Overall Study|Death Due to Adverse Event|115|||
127841907|NCT00949910|460038985|FG000|Overall Study|Death Due to Toxicity|3|||
127841908|NCT00949910|460038985|FG000|Overall Study|Death from Unknown Cause|5|||
127841909|NCT00949910|460038985|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
127841910|NCT00949910|460038985|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
127841911|NCT00949910|460038985|FG000|Overall Study|Switched to Commercial Treatment|4|||
127841912|NCT00949910|460038985|FG000|Overall Study|Violation of Eligibility|23|||
127841913|NCT00949910|460038985|FG000|Overall Study|Logistical Reasons|13|||
127841914|NCT00949910|460038985|FG000|Overall Study|Non-Compliance|10|||
127841915|NCT00949910|460038985|FG000|Overall Study|Prolonged Dosing Interruption|4|||
127841916|NCT00949910|460038985|FG000|Overall Study|Adverse Event|83|||
127841917|NCT00949910|460038985|FG000|Overall Study|Serious Adverse Event|6|||
127841918|NCT00949910|460038985|FG000|Overall Study|Physician/Participant Decision|7|||
127841919|NCT00949910|460038985|FG000|Overall Study|Other|4|||
127841920|NCT00949910|460038985|FG000|Overall Study|No Data|9|||
127841921|NCT02759562|460038986|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
127841922|NCT02759562|460038987|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
127841923|NCT02759562|460038986|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
127841924|NCT02759562|460038987|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
127841925|NCT02769832|460038990|FG000|Overall Study|Death|30|||
127841926|NCT01188538|460038998|FG000|Overall Study|Lost to Follow-up|0|||
127841927|NCT01188538|460038999|FG001|Overall Study|Lost to Follow-up|1|||
127841928|NCT01231607|460039003|FG000|Overall Study|Adverse Event|0|||
127841929|NCT01231607|460039004|FG001|Overall Study|Adverse Event|8|||
127841930|NCT01231607|460039005|FG002|Overall Study|Adverse Event|4|||
127841931|NCT01231607|460039006|FG003|Overall Study|Adverse Event|4|||
127841932|NCT01231607|460039007|FG004|Overall Study|Adverse Event|5|||
127841933|NCT01231607|460039003|FG000|Overall Study|Lost to Follow-up|13|||
127841934|NCT01231607|460039004|FG001|Overall Study|Lost to Follow-up|11|||
127841935|NCT01231607|460039005|FG002|Overall Study|Lost to Follow-up|10|||
127841936|NCT01231607|460039006|FG003|Overall Study|Lost to Follow-up|10|||
127841937|NCT01231607|460039007|FG004|Overall Study|Lost to Follow-up|4|||
127841938|NCT01231607|460039003|FG000|Overall Study|Physician Decision|4|||
127841939|NCT01231607|460039004|FG001|Overall Study|Physician Decision|4|||
127841940|NCT01231607|460039005|FG002|Overall Study|Physician Decision|3|||
127841941|NCT01231607|460039006|FG003|Overall Study|Physician Decision|5|||
127841942|NCT01231607|460039007|FG004|Overall Study|Physician Decision|4|||
127841943|NCT01231607|460039003|FG000|Overall Study|Protocol Violation|3|||
127841944|NCT01231607|460039004|FG001|Overall Study|Protocol Violation|2|||
127841945|NCT01231607|460039005|FG002|Overall Study|Protocol Violation|0|||
127841946|NCT01231607|460039006|FG003|Overall Study|Protocol Violation|2|||
127841947|NCT01231607|460039007|FG004|Overall Study|Protocol Violation|2|||
127841948|NCT01231607|460039003|FG000|Overall Study|Withdrawal by Subject|9|||
127841949|NCT01231607|460039004|FG001|Overall Study|Withdrawal by Subject|9|||
127841950|NCT01231607|460039005|FG002|Overall Study|Withdrawal by Subject|14|||
127841951|NCT01231607|460039006|FG003|Overall Study|Withdrawal by Subject|17|||
127841952|NCT01231607|460039007|FG004|Overall Study|Withdrawal by Subject|9|||
127841953|NCT02501902|460039008|FG000|Overall Study|Subject Refused Further Follow-up|0|||
127841954|NCT02501902|460039009|FG001|Overall Study|Subject Refused Further Follow-up|0|||
127841955|NCT02501902|460039010|FG002|Overall Study|Subject Refused Further Follow-up|0|||
127841956|NCT02501902|460039011|FG003|Overall Study|Subject Refused Further Follow-up|0|||
127841957|NCT02501902|460039012|FG004|Overall Study|Subject Refused Further Follow-up|0|||
127841958|NCT02501902|460039013|FG005|Overall Study|Subject Refused Further Follow-up|0|||
127841959|NCT02501902|460039014|FG006|Overall Study|Subject Refused Further Follow-up|0|||
127841960|NCT02501902|460039015|FG007|Overall Study|Subject Refused Further Follow-up|1|||
127899456|NCT01062256|460256450|FG001|Overall Study|Administrative|2|||
127899457|NCT01062256|460256451|FG002|Overall Study|Administrative|0|||
127899458|NCT03049488|460256454|FG000|Overall Study|Lost to Follow-up|1|||
127899459|NCT03049488|460256455|FG001|Overall Study|Lost to Follow-up|1|||
127899460|NCT03049488|460256456|FG002|Overall Study|Lost to Follow-up|0|||
127841961|NCT02501902|460039008|FG000|Overall Study|Study Terminated by Sponsor|0|||
127841962|NCT02501902|460039009|FG001|Overall Study|Study Terminated by Sponsor|3|||
127841963|NCT02501902|460039010|FG002|Overall Study|Study Terminated by Sponsor|0|||
127841964|NCT02501902|460039011|FG003|Overall Study|Study Terminated by Sponsor|1|||
127841965|NCT02501902|460039012|FG004|Overall Study|Study Terminated by Sponsor|1|||
127899461|NCT03049488|460256457|FG003|Overall Study|Lost to Follow-up|0|||
127899462|NCT03049488|460256458|FG004|Overall Study|Lost to Follow-up|0|||
127899463|NCT03049488|460256459|FG005|Overall Study|Lost to Follow-up|0|||
127899464|NCT03049488|460256454|FG000|Overall Study|Moved from Area|1|||
127841966|NCT02501902|460039013|FG005|Overall Study|Study Terminated by Sponsor|0|||
127841967|NCT02501902|460039014|FG006|Overall Study|Study Terminated by Sponsor|2|||
127841968|NCT02501902|460039015|FG007|Overall Study|Study Terminated by Sponsor|4|||
127841969|NCT02501902|460039008|FG000|Overall Study|Death|3|||
127841970|NCT02501902|460039009|FG001|Overall Study|Death|4|||
127841971|NCT02501902|460039010|FG002|Overall Study|Death|4|||
127841972|NCT02501902|460039011|FG003|Overall Study|Death|10|||
127841973|NCT02501902|460039012|FG004|Overall Study|Death|10|||
127841974|NCT02501902|460039013|FG005|Overall Study|Death|11|||
127841975|NCT02501902|460039014|FG006|Overall Study|Death|7|||
127841976|NCT02501902|460039015|FG007|Overall Study|Death|15|||
127841977|NCT02513771|460039016|FG000|Overall Study|Lost to Follow-up|1|||
127841978|NCT02513771|460039017|FG001|Overall Study|Lost to Follow-up|1|||
127841979|NCT02513771|460039016|FG000|Overall Study|Not being able to get to clinic|1|||
127841980|NCT02513771|460039017|FG001|Overall Study|Not being able to get to clinic|0|||
127841981|NCT01797445|460039020|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
127841982|NCT01797445|460039021|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
127841983|NCT01797445|460039020|FG000|Double-Blind Phase|Adverse Event|3|||
127841984|NCT01797445|460039021|FG001|Double-Blind Phase|Adverse Event|0|||
127841985|NCT01797445|460039020|FG000|Double-Blind Phase|Death|5|||
127841986|NCT01797445|460039021|FG001|Double-Blind Phase|Death|4|||
127841987|NCT01797445|460039020|FG000|Double-Blind Phase|Pregnancy|0|||
127841988|NCT01797445|460039021|FG001|Double-Blind Phase|Pregnancy|1|||
127841989|NCT01797445|460039020|FG000|Double-Blind Phase|Lack of Efficacy|1|||
127841990|NCT01797445|460039021|FG001|Double-Blind Phase|Lack of Efficacy|2|||
127841991|NCT01797445|460039020|FG000|Double-Blind Phase|Investigator's Discretion|15|||
127841992|NCT01797445|460039021|FG001|Double-Blind Phase|Investigator's Discretion|17|||
127841993|NCT01797445|460039020|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
127841994|NCT01797445|460039021|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
127841995|NCT01797445|460039020|FG000|Double-Blind Phase|Protocol Violation|0|||
127841996|NCT01797445|460039021|FG001|Double-Blind Phase|Protocol Violation|1|||
127841997|NCT01797445|460039020|FG000|Double-Blind Phase|Withdrew Consent|20|||
127841998|NCT01797445|460039021|FG001|Double-Blind Phase|Withdrew Consent|35|||
127841999|NCT01797445|460039020|FG000|Double-Blind Phase|Lost to Follow-up|34|||
127842000|NCT01797445|460039021|FG001|Double-Blind Phase|Lost to Follow-up|26|||
127842001|NCT01797445|460039020|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
127842002|NCT01797445|460039021|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
127842003|NCT01595438|460039024|FG000|Overall Study|Lost to Follow-up|20|||
127842004|NCT01595438|460039025|FG001|Overall Study|Lost to Follow-up|20|||
127842005|NCT01595438|460039024|FG000|Overall Study|Withdrawal by Subject|12|||
127842006|NCT01595438|460039025|FG001|Overall Study|Withdrawal by Subject|12|||
127842007|NCT01595438|460039024|FG000|Overall Study|Other Eligibility criteria|11|||
127842008|NCT01595438|460039025|FG001|Overall Study|Other Eligibility criteria|9|||
127842009|NCT01280266|460039032|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
127842010|NCT01280266|460039033|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
127842011|NCT01280266|460039032|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
127842012|NCT01280266|460039033|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
127842013|NCT04116073|460039040|FG000|Overall Study|Withdrawal by Subject|2|||
127842014|NCT04116073|460039040|FG000|Overall Study|failed to maintained eligibility|1|||
127842015|NCT00881361|460039045|FG000|Overall Study|Terminated prior to surgery|27|||
127842016|NCT00881361|460039046|FG001|Overall Study|Terminated prior to surgery|7|||
127842017|NCT00881361|460039047|FG002|Overall Study|Terminated prior to surgery|0|||
127842018|NCT00881361|460039045|FG000|Overall Study|Ineligible|17|||
127842019|NCT00881361|460039046|FG001|Overall Study|Ineligible|2|||
127842020|NCT00881361|460039047|FG002|Overall Study|Ineligible|2|||
127842021|NCT01413542|460039050|FG000|Overall Study|Physician Decision|1|||
127842022|NCT01413542|460039051|FG001|Overall Study|Physician Decision|0|||
127842023|NCT01413542|460039052|FG002|Overall Study|Physician Decision|3|||
127842024|NCT01413542|460039053|FG003|Overall Study|Physician Decision|0|||
127842025|NCT01413542|460039050|FG000|Overall Study|Adverse Event|0|||
127842026|NCT01413542|460039051|FG001|Overall Study|Adverse Event|0|||
127899465|NCT03049488|460256455|FG001|Overall Study|Moved from Area|0|||
127899466|NCT03049488|460256456|FG002|Overall Study|Moved from Area|0|||
127842027|NCT01413542|460039052|FG002|Overall Study|Adverse Event|0|||
127842028|NCT01413542|460039053|FG003|Overall Study|Adverse Event|1|||
127842029|NCT02505542|460039054|FG000|Part A: Open-Label Period|Adverse Event|31|||
127842030|NCT02505542|460039055|FG001|Part A: Open-Label Period|Adverse Event|0|||
127842031|NCT02505542|460039056|FG002|Part A: Open-Label Period|Adverse Event|0|||
127842032|NCT02505542|460039057|FG003|Part A: Open-Label Period|Adverse Event|0|||
127842033|NCT02505542|460039054|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
127842034|NCT02505542|460039055|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
127842035|NCT02505542|460039056|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
127842036|NCT02505542|460039057|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
127842037|NCT02505542|460039054|FG000|Part A: Open-Label Period|Protocol Violation|1|||
127842038|NCT02505542|460039055|FG001|Part A: Open-Label Period|Protocol Violation|0|||
127842039|NCT02505542|460039056|FG002|Part A: Open-Label Period|Protocol Violation|0|||
127899467|NCT03049488|460256457|FG003|Overall Study|Moved from Area|1|||
127842040|NCT02505542|460039057|FG003|Part A: Open-Label Period|Protocol Violation|0|||
127842041|NCT02505542|460039054|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
127842042|NCT02505542|460039055|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
127842043|NCT02505542|460039056|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
127842044|NCT02505542|460039057|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
127842045|NCT02505542|460039054|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
127842046|NCT02505542|460039055|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
127842047|NCT02505542|460039056|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
127842048|NCT02505542|460039057|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
127842049|NCT02505542|460039054|FG000|Part A: Open-Label Period|New medical history available|1|||
127842050|NCT02505542|460039055|FG001|Part A: Open-Label Period|New medical history available|0|||
127842051|NCT02505542|460039056|FG002|Part A: Open-Label Period|New medical history available|0|||
127842052|NCT02505542|460039057|FG003|Part A: Open-Label Period|New medical history available|0|||
127842053|NCT02505542|460039054|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
127842054|NCT02505542|460039055|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
127842055|NCT02505542|460039056|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
127842056|NCT02505542|460039057|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
127842057|NCT02505542|460039054|FG000|Part A: Open-Label Period|Pregnancy|2|||
127842058|NCT02505542|460039055|FG001|Part A: Open-Label Period|Pregnancy|0|||
127842059|NCT02505542|460039056|FG002|Part A: Open-Label Period|Pregnancy|0|||
127842060|NCT02505542|460039057|FG003|Part A: Open-Label Period|Pregnancy|0|||
127842061|NCT02505542|460039054|FG000|Part A: Open-Label Period|Sponsor directive|1|||
127842062|NCT02505542|460039055|FG001|Part A: Open-Label Period|Sponsor directive|0|||
127842063|NCT02505542|460039056|FG002|Part A: Open-Label Period|Sponsor directive|0|||
127842064|NCT02505542|460039057|FG003|Part A: Open-Label Period|Sponsor directive|0|||
127842065|NCT02505542|460039054|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
127842066|NCT02505542|460039055|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
127842067|NCT02505542|460039056|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
127842068|NCT02505542|460039057|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
127842069|NCT02505542|460039054|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
127842070|NCT02505542|460039055|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
127842071|NCT02505542|460039056|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
127842072|NCT02505542|460039057|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
127842073|NCT02505542|460039054|FG000|Part A: Open-Label Period|Non-compliance|1|||
127842074|NCT02505542|460039055|FG001|Part A: Open-Label Period|Non-compliance|0|||
127842075|NCT02505542|460039056|FG002|Part A: Open-Label Period|Non-compliance|0|||
127842076|NCT02505542|460039057|FG003|Part A: Open-Label Period|Non-compliance|0|||
127842077|NCT02505542|460039054|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
127842078|NCT02505542|460039055|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
127842079|NCT02505542|460039056|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
127842080|NCT02505542|460039057|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
127842081|NCT02505542|460039054|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
127842082|NCT02505542|460039055|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
127842083|NCT02505542|460039056|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
127842084|NCT02505542|460039057|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
127842085|NCT02505542|460039054|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
127842086|NCT02505542|460039055|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
127842087|NCT02505542|460039056|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
127842088|NCT02505542|460039057|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
127842089|NCT02505542|460039054|FG000|Part B: Double-Blind Period|Adverse Event|0|||
127842090|NCT02505542|460039055|FG001|Part B: Double-Blind Period|Adverse Event|0|||
127842091|NCT02505542|460039056|FG002|Part B: Double-Blind Period|Adverse Event|1|||
127842092|NCT02505542|460039057|FG003|Part B: Double-Blind Period|Adverse Event|3|||
127842093|NCT02505542|460039054|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
127842094|NCT02505542|460039055|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
127842095|NCT02505542|460039056|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
127842096|NCT02505542|460039057|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
127842097|NCT02505542|460039054|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
127842098|NCT02505542|460039055|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
127842099|NCT02505542|460039056|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
127842100|NCT02505542|460039057|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
127842101|NCT02505542|460039054|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
127842102|NCT02505542|460039055|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
127842103|NCT02505542|460039056|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
127842104|NCT02505542|460039057|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
127842105|NCT02505542|460039054|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
127842106|NCT02505542|460039055|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
127899468|NCT03049488|460256458|FG004|Overall Study|Moved from Area|1|||
127899469|NCT03049488|460256459|FG005|Overall Study|Moved from Area|0|||
127899470|NCT03049488|460256454|FG000|Overall Study|Physician Decision|0|||
127899471|NCT03049488|460256455|FG001|Overall Study|Physician Decision|1|||
127899472|NCT03049488|460256456|FG002|Overall Study|Physician Decision|0|||
127899473|NCT03049488|460256457|FG003|Overall Study|Physician Decision|0|||
127899474|NCT03049488|460256458|FG004|Overall Study|Physician Decision|0|||
127899475|NCT03049488|460256459|FG005|Overall Study|Physician Decision|0|||
127899476|NCT03049488|460256454|FG000|Overall Study|Withdrawal by Subject|0|||
127899477|NCT03049488|460256455|FG001|Overall Study|Withdrawal by Subject|0|||
127899478|NCT03049488|460256456|FG002|Overall Study|Withdrawal by Subject|0|||
127899479|NCT03049488|460256457|FG003|Overall Study|Withdrawal by Subject|1|||
127899480|NCT03049488|460256458|FG004|Overall Study|Withdrawal by Subject|1|||
127899481|NCT03049488|460256459|FG005|Overall Study|Withdrawal by Subject|0|||
127899482|NCT00891293|460256462|FG000|Overall Study|Adverse Event|2|||
127899483|NCT00891293|460256462|FG000|Overall Study|Protocol Violation|2|||
127899484|NCT00891293|460256462|FG000|Overall Study|Laboratory abnormality|4|||
127899485|NCT00891293|460256462|FG000|Overall Study|Lost to Follow-up|7|||
127899486|NCT00891293|460256462|FG000|Overall Study|Subject withdrew consent|7|||
127899487|NCT00891293|460256462|FG000|Overall Study|Sponsor termination|62|||
127899488|NCT01448057|460256463|FG000|Overall Study|Protocol Violation|3|||
127899489|NCT01448057|460256464|FG001|Overall Study|Protocol Violation|2|||
127899490|NCT01448057|460256463|FG000|Overall Study|Lost to Follow-up|3|||
127899491|NCT01448057|460256464|FG001|Overall Study|Lost to Follow-up|0|||
127899492|NCT01448057|460256463|FG000|Overall Study|Adverse Event|0|||
127899493|NCT01448057|460256464|FG001|Overall Study|Adverse Event|2|||
127842107|NCT02505542|460039056|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
127842108|NCT02505542|460039057|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
127842109|NCT02505542|460039054|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
127842110|NCT02505542|460039055|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
127842111|NCT02505542|460039056|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
127842112|NCT02505542|460039057|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
127842113|NCT02505542|460039054|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
127842114|NCT02505542|460039055|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
127842115|NCT02505542|460039056|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
127842116|NCT02505542|460039057|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
127842117|NCT02505542|460039054|FG000|Part B: Double-Blind Period|Miscalculation|0|||
127842118|NCT02505542|460039055|FG001|Part B: Double-Blind Period|Miscalculation|1|||
127842119|NCT02505542|460039056|FG002|Part B: Double-Blind Period|Miscalculation|0|||
127842120|NCT02505542|460039057|FG003|Part B: Double-Blind Period|Miscalculation|0|||
127842121|NCT02505542|460039054|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
127842122|NCT02505542|460039055|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
127842123|NCT02505542|460039056|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
127842124|NCT02505542|460039057|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
127842125|NCT00618995|460039060|FG000|Period 1|Adverse Event|0|||
127842126|NCT00618995|460039061|FG001|Period 1|Adverse Event|0|||
127842127|NCT00618995|460039062|FG002|Period 1|Adverse Event|1|||
127842128|NCT00618995|460039063|FG003|Period 1|Adverse Event|0|||
127842129|NCT00618995|460039060|FG000|Period 1|Protocol Violation|0|||
127842130|NCT00618995|460039061|FG001|Period 1|Protocol Violation|1|||
127842131|NCT00618995|460039062|FG002|Period 1|Protocol Violation|1|||
127842132|NCT00618995|460039063|FG003|Period 1|Protocol Violation|0|||
127842133|NCT00618995|460039060|FG000|Period 2|Protocol Violation|0|||
127842134|NCT00618995|460039061|FG001|Period 2|Protocol Violation|0|||
127842135|NCT00618995|460039062|FG002|Period 2|Protocol Violation|1|||
127842136|NCT00618995|460039063|FG003|Period 2|Protocol Violation|0|||
127842137|NCT00618995|460039060|FG000|Period 4|Adverse Event|1|||
127842138|NCT00618995|460039061|FG001|Period 4|Adverse Event|0|||
127842139|NCT00618995|460039062|FG002|Period 4|Adverse Event|0|||
127842140|NCT00618995|460039063|FG003|Period 4|Adverse Event|0|||
127842141|NCT02988219|460039064|FG000|Overall Study|Lack of Efficacy|1|||
127842142|NCT02988219|460039065|FG001|Overall Study|Lack of Efficacy|1|||
127842143|NCT02988219|460039064|FG000|Overall Study|Withdrawal by Subject|0|||
127842144|NCT02988219|460039065|FG001|Overall Study|Withdrawal by Subject|2|||
127842145|NCT01522443|460039066|FG000|Overall Study|No longer receiving clinical benefit|36|||
127842146|NCT01522443|460039067|FG001|Overall Study|No longer receiving clinical benefit|28|||
127842147|NCT01522443|460039066|FG000|Overall Study|Adverse Event|10|||
127842148|NCT01522443|460039067|FG001|Overall Study|Adverse Event|15|||
127899494|NCT01448057|460256463|FG000|Overall Study|Withdrawal by Subject|2|||
127899495|NCT01448057|460256464|FG001|Overall Study|Withdrawal by Subject|0|||
127899496|NCT03883906|460256469|FG000|Overall Study|Withdrawal by Subject|2|||
127899497|NCT03883906|460256469|FG000|Overall Study|Physician Decision|5|||
127899498|NCT00906347|460256472|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
127899499|NCT00906347|460256473|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
127899500|NCT00906347|460256472|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
127842149|NCT01522443|460039066|FG000|Overall Study|Withdrawal by Subject|5|||
127842150|NCT01522443|460039067|FG001|Overall Study|Withdrawal by Subject|8|||
127842151|NCT01522443|460039066|FG000|Overall Study|No study treatment given|1|||
127842152|NCT01522443|460039067|FG001|Overall Study|No study treatment given|1|||
127842153|NCT01522443|460039066|FG000|Overall Study|Other|1|||
127842154|NCT01522443|460039067|FG001|Overall Study|Other|3|||
127842155|NCT05590767|460039070|FG000|Overall Study|Protocol Violation|1|||
127842156|NCT05590767|460039070|FG000|Overall Study|surgery canceled|1|||
127842157|NCT05590767|460039070|FG000|Overall Study|interscalene brachial block not performed|1|||
127842158|NCT01764256|460039071|FG000|Received All Vaccinations|Adverse Event|1|||
127842159|NCT01764256|460039072|FG001|Received All Vaccinations|Adverse Event|1|||
127842160|NCT01764256|460039073|FG002|Received All Vaccinations|Adverse Event|0|||
127842161|NCT01764256|460039074|FG003|Received All Vaccinations|Adverse Event|0|||
127842162|NCT01764256|460039071|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
127842163|NCT01764256|460039072|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
127842164|NCT01764256|460039073|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
127842165|NCT01764256|460039074|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
127842166|NCT01764256|460039071|FG000|Received All Vaccinations|Lost to Follow-up|1|||
127842167|NCT01764256|460039072|FG001|Received All Vaccinations|Lost to Follow-up|0|||
127842168|NCT01764256|460039073|FG002|Received All Vaccinations|Lost to Follow-up|0|||
127842169|NCT01764256|460039074|FG003|Received All Vaccinations|Lost to Follow-up|0|||
127842170|NCT01764256|460039071|FG000|Completed Study|Lost to Follow-up|0|||
127842171|NCT01764256|460039072|FG001|Completed Study|Lost to Follow-up|0|||
127842172|NCT01764256|460039073|FG002|Completed Study|Lost to Follow-up|0|||
127842173|NCT01764256|460039074|FG003|Completed Study|Lost to Follow-up|1|||
127842174|NCT00776555|460039086|FG000|Overall Study|Study terminated|3|||
127842175|NCT00776555|460039087|FG001|Overall Study|Study terminated|0|||
127842176|NCT03483116|460039088|FG000|Overall Study|Adverse Event|0|||
127842177|NCT03483116|460039089|FG001|Overall Study|Adverse Event|1|||
127842178|NCT03483116|460039090|FG002|Overall Study|Adverse Event|0|||
127842179|NCT03483116|460039091|FG003|Overall Study|Adverse Event|1|||
127842180|NCT03483116|460039088|FG000|Overall Study|Protocol Violation|1|||
127842181|NCT03483116|460039089|FG001|Overall Study|Protocol Violation|0|||
127842182|NCT03483116|460039090|FG002|Overall Study|Protocol Violation|0|||
127842183|NCT03483116|460039091|FG003|Overall Study|Protocol Violation|7|||
127842184|NCT03483116|460039088|FG000|Overall Study|Lost to Follow-up|9|||
127842185|NCT03483116|460039089|FG001|Overall Study|Lost to Follow-up|4|||
127842186|NCT03483116|460039090|FG002|Overall Study|Lost to Follow-up|9|||
127842187|NCT03483116|460039091|FG003|Overall Study|Lost to Follow-up|5|||
127842188|NCT03483116|460039088|FG000|Overall Study|Death|1|||
127842189|NCT03483116|460039089|FG001|Overall Study|Death|0|||
127842190|NCT03483116|460039090|FG002|Overall Study|Death|2|||
127842191|NCT03483116|460039091|FG003|Overall Study|Death|1|||
127842192|NCT03483116|460039088|FG000|Overall Study|Withdrawal by Subject|14|||
127842193|NCT03483116|460039089|FG001|Overall Study|Withdrawal by Subject|16|||
127842194|NCT03483116|460039090|FG002|Overall Study|Withdrawal by Subject|14|||
127842195|NCT03483116|460039091|FG003|Overall Study|Withdrawal by Subject|16|||
127842196|NCT03483116|460039088|FG000|Overall Study|Unknown other reason|3|||
127842197|NCT03483116|460039089|FG001|Overall Study|Unknown other reason|2|||
127842198|NCT03483116|460039090|FG002|Overall Study|Unknown other reason|1|||
127842199|NCT03483116|460039091|FG003|Overall Study|Unknown other reason|1|||
127842200|NCT01181102|460039092|FG000|Overall Study|Adverse Event|28|||
127842201|NCT01181102|460039093|FG001|Overall Study|Adverse Event|26|||
127842202|NCT01181102|460039092|FG000|Overall Study|Lack of Efficacy|3|||
127842203|NCT01181102|460039093|FG001|Overall Study|Lack of Efficacy|1|||
127842204|NCT01181102|460039092|FG000|Overall Study|Lost to Follow-up|2|||
127842205|NCT01181102|460039093|FG001|Overall Study|Lost to Follow-up|0|||
127842206|NCT01181102|460039092|FG000|Overall Study|Physician Decision|3|||
127842207|NCT01181102|460039093|FG001|Overall Study|Physician Decision|1|||
127842208|NCT01181102|460039092|FG000|Overall Study|Protocol Violation|5|||
127842209|NCT01181102|460039093|FG001|Overall Study|Protocol Violation|6|||
127842210|NCT01181102|460039092|FG000|Overall Study|Withdrawal by Subject|10|||
127842211|NCT01181102|460039093|FG001|Overall Study|Withdrawal by Subject|12|||
127842212|NCT04685499|460039096|FG000|Overall Study|Study Terminated Early|1|||
127842213|NCT03176277|460039097|FG000|Part A Dose Escalation Study|Adverse Event|1|||
127842214|NCT03176277|460039098|FG001|Part A Dose Escalation Study|Adverse Event|0|||
127842215|NCT03176277|460039099|FG002|Part A Dose Escalation Study|Adverse Event|1|||
127842216|NCT03176277|460039100|FG003|Part A Dose Escalation Study|Adverse Event|0|||
127842217|NCT03176277|460039097|FG000|Part A Dose Escalation Study|Physician Decision|1|||
127842218|NCT03176277|460039098|FG001|Part A Dose Escalation Study|Physician Decision|1|||
127842219|NCT03176277|460039099|FG002|Part A Dose Escalation Study|Physician Decision|2|||
127842220|NCT03176277|460039100|FG003|Part A Dose Escalation Study|Physician Decision|0|||
127842221|NCT03176277|460039097|FG000|Part A Dose Escalation Study|Withdrawal by Subject|5|||
127842222|NCT03176277|460039098|FG001|Part A Dose Escalation Study|Withdrawal by Subject|1|||
127842223|NCT03176277|460039099|FG002|Part A Dose Escalation Study|Withdrawal by Subject|1|||
127842224|NCT03176277|460039100|FG003|Part A Dose Escalation Study|Withdrawal by Subject|0|||
127842225|NCT03176277|460039097|FG000|Part A Dose Escalation Study|Progressive disease|3|||
127842226|NCT03176277|460039098|FG001|Part A Dose Escalation Study|Progressive disease|1|||
127842227|NCT03176277|460039099|FG002|Part A Dose Escalation Study|Progressive disease|3|||
127842228|NCT03176277|460039100|FG003|Part A Dose Escalation Study|Progressive disease|0|||
127842229|NCT00634114|460039101|FG000|Overall Study|Adverse Event|6|||
127842230|NCT00634114|460039102|FG001|Overall Study|Adverse Event|8|||
127842231|NCT00634114|460039103|FG002|Overall Study|Adverse Event|3|||
127842232|NCT00634114|460039101|FG000|Overall Study|Withdrawal by Subject|9|||
127842233|NCT00634114|460039102|FG001|Overall Study|Withdrawal by Subject|6|||
127842234|NCT00634114|460039103|FG002|Overall Study|Withdrawal by Subject|11|||
127842235|NCT00634114|460039101|FG000|Overall Study|Lost to Follow-up|0|||
127842236|NCT00634114|460039102|FG001|Overall Study|Lost to Follow-up|0|||
127842237|NCT00634114|460039103|FG002|Overall Study|Lost to Follow-up|1|||
127842238|NCT00634114|460039101|FG000|Overall Study|Protocol Violation|3|||
127842239|NCT00634114|460039102|FG001|Overall Study|Protocol Violation|3|||
127842240|NCT00634114|460039103|FG002|Overall Study|Protocol Violation|1|||
127842241|NCT00634114|460039101|FG000|Overall Study|Pregnancy|1|||
127842242|NCT00634114|460039102|FG001|Overall Study|Pregnancy|0|||
127842243|NCT00634114|460039103|FG002|Overall Study|Pregnancy|0|||
127842244|NCT00634114|460039101|FG000|Overall Study|Incorrect enrolment|0|||
127842245|NCT00634114|460039102|FG001|Overall Study|Incorrect enrolment|1|||
127842246|NCT00634114|460039103|FG002|Overall Study|Incorrect enrolment|0|||
127842247|NCT00634114|460039101|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
127842248|NCT00634114|460039102|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
127842249|NCT00634114|460039103|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
127842250|NCT00634114|460039101|FG000|Overall Study|Difficult to continue|3|||
127842251|NCT00634114|460039102|FG001|Overall Study|Difficult to continue|1|||
127842252|NCT00634114|460039103|FG002|Overall Study|Difficult to continue|1|||
127842253|NCT00634114|460039101|FG000|Overall Study|Other reason|1|||
127842254|NCT00634114|460039102|FG001|Overall Study|Other reason|1|||
127842255|NCT00634114|460039103|FG002|Overall Study|Other reason|1|||
127842256|NCT02940626|460039104|FG000|Overall Study|Death|40|||
127842257|NCT02940626|460039105|FG001|Overall Study|Death|32|||
127842258|NCT02940626|460039104|FG000|Overall Study|Lost to Follow-up|5|||
127842259|NCT02940626|460039105|FG001|Overall Study|Lost to Follow-up|2|||
127842260|NCT02940626|460039104|FG000|Overall Study|Withdrawal by Subject|1|||
127842261|NCT02940626|460039105|FG001|Overall Study|Withdrawal by Subject|0|||
127842262|NCT02940626|460039104|FG000|Overall Study|Transfer to Hospice Care|1|||
127842263|NCT02940626|460039105|FG001|Overall Study|Transfer to Hospice Care|0|||
127842264|NCT02940626|460039104|FG000|Overall Study|Prohibited Concomitant Medication|0|||
127842265|NCT02940626|460039105|FG001|Overall Study|Prohibited Concomitant Medication|1|||
127842266|NCT01996904|460039106|FG000|Overall Study|Lost to Follow-up|38|||
127842267|NCT01996904|460039107|FG001|Overall Study|Lost to Follow-up|27|||
127842268|NCT00585923|460039108|FG000|Overall Study|Physician decided not to continue|31|||
127842269|NCT00585923|460039109|FG001|Overall Study|Physician decided not to continue|33|||
127842270|NCT00618449|460039110|FG000|Overall Study|Lost to Follow-up|98|||
127842271|NCT00618449|460039111|FG001|Overall Study|Lost to Follow-up|110|||
127842272|NCT05127421|460039112|FG000|4-Week Double-Blind Period|Lost to Follow-up|1|||
127842273|NCT05127421|460039113|FG001|4-Week Double-Blind Period|Lost to Follow-up|0|||
127842274|NCT05127421|460039114|FG002|4-Week Double-Blind Period|Lost to Follow-up|0|||
127842275|NCT05127421|460039115|FG003|4-Week Double-Blind Period|Lost to Follow-up|0|||
127842276|NCT05127421|460039112|FG000|4-Week Double-Blind Period|Physician Decision|1|||
127842277|NCT05127421|460039113|FG001|4-Week Double-Blind Period|Physician Decision|0|||
127842278|NCT05127421|460039114|FG002|4-Week Double-Blind Period|Physician Decision|0|||
127842279|NCT05127421|460039115|FG003|4-Week Double-Blind Period|Physician Decision|0|||
127842280|NCT05127421|460039112|FG000|4-Week Double-Blind Period|Withdrawal by Subject|3|||
127842281|NCT05127421|460039113|FG001|4-Week Double-Blind Period|Withdrawal by Subject|1|||
127899501|NCT00906347|460256473|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
127899502|NCT00906347|460256472|FG000|Received Study Drug|Refused study drug|1|||
127899503|NCT00906347|460256473|FG001|Received Study Drug|Refused study drug|0|||
127899504|NCT00906347|460256472|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
127842282|NCT05127421|460039114|FG002|4-Week Double-Blind Period|Withdrawal by Subject|0|||
127842283|NCT05127421|460039115|FG003|4-Week Double-Blind Period|Withdrawal by Subject|0|||
127842284|NCT05127421|460039112|FG000|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
127842285|NCT05127421|460039113|FG001|4-Week Double-Blind Period|Withdrawn by Sponsor|4|||
127842286|NCT05127421|460039114|FG002|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
127842287|NCT05127421|460039115|FG003|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
127842288|NCT05127421|460039112|FG000|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
127842289|NCT05127421|460039113|FG001|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|1|||
127842290|NCT05127421|460039114|FG002|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
127842291|NCT05127421|460039115|FG003|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
127842292|NCT05127421|460039112|FG000|4-Week Open-Label Period|Lost to Follow-up|0|||
127842293|NCT05127421|460039113|FG001|4-Week Open-Label Period|Lost to Follow-up|0|||
127899505|NCT00906347|460256473|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
127842294|NCT05127421|460039114|FG002|4-Week Open-Label Period|Lost to Follow-up|0|||
127842295|NCT05127421|460039115|FG003|4-Week Open-Label Period|Lost to Follow-up|1|||
127842296|NCT05127421|460039112|FG000|4-Week Open-Label Period|Withdrawal by Subject|0|||
127842297|NCT05127421|460039113|FG001|4-Week Open-Label Period|Withdrawal by Subject|0|||
127842298|NCT05127421|460039114|FG002|4-Week Open-Label Period|Withdrawal by Subject|1|||
127842299|NCT05127421|460039115|FG003|4-Week Open-Label Period|Withdrawal by Subject|1|||
127842300|NCT05127421|460039112|FG000|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
127842301|NCT05127421|460039113|FG001|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
127842302|NCT05127421|460039114|FG002|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
127842303|NCT05127421|460039115|FG003|4-Week Open-Label Period|Withdrawn by Sponsor|1|||
127842304|NCT01441115|460039116|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
127842305|NCT00574496|460039121|FG000|Overall Study|Withdrawal by Subject|1|||
127842306|NCT01681576|460039124|FG000|Period 1|Adverse Event|1|||
127842307|NCT01681576|460039125|FG001|Period 1|Adverse Event|0|||
127842308|NCT01681576|460039124|FG000|Period 1|Protocol Deviation|1|||
127842309|NCT01681576|460039125|FG001|Period 1|Protocol Deviation|0|||
127842310|NCT01681576|460039124|FG000|Period 2|subject/guardian decision|3|||
127842311|NCT01681576|460039125|FG001|Period 2|subject/guardian decision|1|||
127842312|NCT01681576|460039124|FG000|Period 2|Non-compliance with study treatment|1|||
127842313|NCT01681576|460039125|FG001|Period 2|Non-compliance with study treatment|0|||
127842314|NCT01195363|460039131|FG000|Overall Study|Lost to Follow-up|7|||
127842315|NCT01195363|460039132|FG001|Overall Study|Lost to Follow-up|4|||
127842316|NCT01195363|460039131|FG000|Overall Study|Adverse Event|3|||
127842317|NCT01195363|460039132|FG001|Overall Study|Adverse Event|1|||
127842318|NCT01195363|460039131|FG000|Overall Study|Lack of Efficacy|0|||
127842319|NCT01195363|460039132|FG001|Overall Study|Lack of Efficacy|4|||
127842320|NCT01195363|460039131|FG000|Overall Study|incarceration|1|||
127842321|NCT01195363|460039132|FG001|Overall Study|incarceration|0|||
127842322|NCT01871896|460039139|FG000|Overall Study|Lost to Follow-up|1|||
127868866|NCT02546193|460137412|FG003|Overall Study|Not eligible at time of induction|0|||
127868867|NCT00310440|460137413|FG000|Overall Study|Lost to Follow-up|17|||
127868868|NCT00310440|460137414|FG001|Overall Study|Lost to Follow-up|8|||
127868869|NCT00310440|460137413|FG000|Overall Study|Withdrawal by Subject|2|||
127868870|NCT00310440|460137414|FG001|Overall Study|Withdrawal by Subject|1|||
127868871|NCT00310440|460137413|FG000|Overall Study|Missed 12 Month Visit|7|||
127868872|NCT00310440|460137414|FG001|Overall Study|Missed 12 Month Visit|4|||
127899506|NCT00680121|460256477|FG000|Overall Study|Lost to Follow-up|27|||
127899507|NCT00680121|460256478|FG001|Overall Study|Lost to Follow-up|23|||
127868873|NCT01474291|460137415|FG000|Overall Study|Not Evaluable for Efficacy|26|||
127868874|NCT01474291|460137415|FG000|Overall Study|Lack of Treatment Efficacy|88|||
127868875|NCT01474291|460137415|FG000|Overall Study|Adverse Event|53|||
127899508|NCT01226797|460256497|FG000|Overall Study|Adverse Event|1|||
127899509|NCT01226797|460256498|FG001|Overall Study|Adverse Event|0|||
127899510|NCT01226797|460256497|FG000|Overall Study|No longer willing to participate|1|||
127899511|NCT01226797|460256498|FG001|Overall Study|No longer willing to participate|0|||
127899512|NCT01226797|460256497|FG000|Overall Study|Protocol Violation|0|||
127899513|NCT01226797|460256498|FG001|Overall Study|Protocol Violation|1|||
127899514|NCT01318499|460256499|FG000|Overall Study|Adverse Event|16|||
127899515|NCT01318499|460256500|FG001|Overall Study|Adverse Event|11|||
127899516|NCT01318499|460256501|FG002|Overall Study|Adverse Event|6|||
127899517|NCT01318499|460256499|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
127868876|NCT01474291|460137415|FG000|Overall Study|Lost to Follow-up|29|||
127868877|NCT01474291|460137415|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
127868878|NCT01474291|460137415|FG000|Overall Study|No Reason Reported|10|||
127868879|NCT01474291|460137415|FG000|Overall Study|Death|2|||
127868880|NCT01287403|460137416|FG000|1st Intervention (1 Day)|Adverse Event|1|||
127868881|NCT00148109|460137417|FG000|Overall Study|Lack of Efficacy|10|||
127868882|NCT00148109|460137418|FG001|Overall Study|Lack of Efficacy|18|||
127868883|NCT00148109|460137417|FG000|Overall Study|Adverse Event|0|||
127868884|NCT00148109|460137418|FG001|Overall Study|Adverse Event|2|||
127868885|NCT00148109|460137417|FG000|Overall Study|Withdrawal by Subject|2|||
127868886|NCT00148109|460137418|FG001|Overall Study|Withdrawal by Subject|0|||
127868887|NCT01098266|460137419|FG000|Overall Study|Physician Decision|1|||
127868888|NCT01098266|460137420|FG001|Overall Study|Physician Decision|0|||
127899518|NCT01318499|460256500|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
127868889|NCT01098266|460137419|FG000|Overall Study|Death|3|||
127868890|NCT01098266|460137420|FG001|Overall Study|Death|2|||
127868891|NCT01098266|460137419|FG000|Overall Study|Withdrawal by Subject|3|||
127868892|NCT01098266|460137420|FG001|Overall Study|Withdrawal by Subject|5|||
127868893|NCT00525499|460137424|FG000|Overall Study|Lost to Follow-up|2|||
127868894|NCT00525499|460137425|FG001|Overall Study|Lost to Follow-up|4|||
127899519|NCT01318499|460256501|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
127868895|NCT00525499|460137426|FG002|Overall Study|Lost to Follow-up|1|||
127868896|NCT00525499|460137427|FG003|Overall Study|Lost to Follow-up|4|||
127868897|NCT00525499|460137424|FG000|Overall Study|Adverse Event|0|||
127899520|NCT01318499|460256499|FG000|Overall Study|Noncompliance|2|||
127899521|NCT01318499|460256500|FG001|Overall Study|Noncompliance|3|||
127757763|NCT01803282|459738658|FG010|Overall Study|Enrolled but Never Treated|0|||
127757764|NCT01803282|459738659|FG011|Overall Study|Enrolled but Never Treated|0|||
127757765|NCT01743989|459738660|FG000|Treatment Phase|Unstable MR4.0|0|||
127757766|NCT01743989|459738661|FG001|Treatment Phase|Unstable MR4.0|6|||
127757767|NCT01743989|459738662|FG002|Treatment Phase|Unstable MR4.0|263|||
127757768|NCT01743989|459738660|FG000|Treatment Phase|Adverse Event|0|||
127757769|NCT01743989|459738661|FG001|Treatment Phase|Adverse Event|4|||
127757770|NCT01743989|459738662|FG002|Treatment Phase|Adverse Event|67|||
127757771|NCT01743989|459738660|FG000|Treatment Phase|Withdrawal by Subject|1|||
127757772|NCT01743989|459738661|FG001|Treatment Phase|Withdrawal by Subject|3|||
127757773|NCT01743989|459738662|FG002|Treatment Phase|Withdrawal by Subject|28|||
127757774|NCT01743989|459738660|FG000|Treatment Phase|Death|0|||
127757775|NCT01743989|459738661|FG001|Treatment Phase|Death|1|||
127757776|NCT01743989|459738662|FG002|Treatment Phase|Death|3|||
127757777|NCT01743989|459738660|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
127757778|NCT01743989|459738661|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
127757779|NCT01743989|459738662|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
127757780|NCT01743989|459738660|FG000|Treatment Phase|Protocol deviation|0|||
127757781|NCT01743989|459738661|FG001|Treatment Phase|Protocol deviation|0|||
127757782|NCT01743989|459738662|FG002|Treatment Phase|Protocol deviation|3|||
127757783|NCT01743989|459738660|FG000|Treatment Phase|Pregnancy|0|||
127757784|NCT01743989|459738661|FG001|Treatment Phase|Pregnancy|0|||
127757785|NCT01743989|459738662|FG002|Treatment Phase|Pregnancy|2|||
127757786|NCT01743989|459738660|FG000|Treatment Phase|Lost to Follow-up|0|||
127757787|NCT01743989|459738661|FG001|Treatment Phase|Lost to Follow-up|0|||
127757788|NCT01743989|459738662|FG002|Treatment Phase|Lost to Follow-up|2|||
127757789|NCT01743989|459738660|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
127757790|NCT01743989|459738661|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
127757791|NCT01743989|459738662|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
127757792|NCT01743989|459738660|FG000|Treatment Phase|Administrative problems|0|||
127757793|NCT01743989|459738661|FG001|Treatment Phase|Administrative problems|0|||
127757794|NCT01743989|459738662|FG002|Treatment Phase|Administrative problems|1|||
127757795|NCT01743989|459738660|FG000|Treatment Phase|New cancer (CML) therapy|0|||
127757796|NCT01743989|459738661|FG001|Treatment Phase|New cancer (CML) therapy|1|||
127757797|NCT01743989|459738662|FG002|Treatment Phase|New cancer (CML) therapy|0|||
127757798|NCT01743989|459738660|FG000|Treatment Phase|Physician Decision|0|||
127757799|NCT01743989|459738661|FG001|Treatment Phase|Physician Decision|0|||
127757800|NCT01743989|459738662|FG002|Treatment Phase|Physician Decision|3|||
127757801|NCT01743989|459738660|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
127757802|NCT01743989|459738661|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
127757803|NCT01743989|459738662|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
127757804|NCT01743989|459738660|FG000|Treatment Phase|Not randomized by mistake|0|||
127757805|NCT01743989|459738661|FG001|Treatment Phase|Not randomized by mistake|0|||
127757806|NCT01743989|459738662|FG002|Treatment Phase|Not randomized by mistake|1|||
127757807|NCT01743989|459738660|FG000|Treatment Phase|Included by mistake|0|||
127757808|NCT01743989|459738661|FG001|Treatment Phase|Included by mistake|0|||
127757809|NCT01743989|459738662|FG002|Treatment Phase|Included by mistake|1|||
127757810|NCT01743989|459738660|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
127757811|NCT01743989|459738661|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
127757812|NCT01743989|459738662|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
127757813|NCT01743989|459738660|FG000|TFR Phase|Adverse Event|0|||
127842323|NCT01512108|460040654|FG000|Overall Study|Adverse Event|9|||
127842324|NCT01512108|460040655|FG001|Overall Study|Adverse Event|4|||
127842325|NCT01512108|460040654|FG000|Overall Study|Protocol Violation|1|||
127842326|NCT01512108|460040655|FG001|Overall Study|Protocol Violation|2|||
127842327|NCT01512108|460040654|FG000|Overall Study|Withdrawal Criteria|1|||
127842328|NCT01512108|460040655|FG001|Overall Study|Withdrawal Criteria|0|||
127842329|NCT01512108|460040654|FG000|Overall Study|Unclassified|11|||
127842330|NCT01512108|460040655|FG001|Overall Study|Unclassified|3|||
127842331|NCT06422377|460040661|FG000|Overall Study|Study Terminated by Sponsor|1|||
127842332|NCT02843178|460040662|FG000|Overall Study|Lost to Follow-up|8|||
127842333|NCT02843178|460040663|FG001|Overall Study|Lost to Follow-up|8|||
127842334|NCT02843178|460040664|FG002|Overall Study|Lost to Follow-up|6|||
127842335|NCT02843178|460040665|FG003|Overall Study|Lost to Follow-up|3|||
127842336|NCT02843178|460040662|FG000|Overall Study|Withdrawal by Subject|0|||
127757814|NCT01743989|459738661|FG001|TFR Phase|Adverse Event|1|||
127842337|NCT02843178|460040663|FG001|Overall Study|Withdrawal by Subject|0|||
127757815|NCT01743989|459738662|FG002|TFR Phase|Adverse Event|0|||
127757816|NCT01743989|459738660|FG000|TFR Phase|Lost to Follow-up|0|||
127757817|NCT01743989|459738661|FG001|TFR Phase|Lost to Follow-up|2|||
127757818|NCT01743989|459738662|FG002|TFR Phase|Lost to Follow-up|0|||
127757819|NCT01743989|459738660|FG000|TFR Phase|Physician Decision|0|||
127757820|NCT01743989|459738661|FG001|TFR Phase|Physician Decision|1|||
127757821|NCT01743989|459738662|FG002|TFR Phase|Physician Decision|0|||
127757822|NCT01743989|459738660|FG000|TFR Phase|Logistical problems|0|||
127757823|NCT01743989|459738661|FG001|TFR Phase|Logistical problems|2|||
127757824|NCT01743989|459738662|FG002|TFR Phase|Logistical problems|0|||
127757825|NCT01743989|459738660|FG000|TFR Phase|Protocol deviation|0|||
127899522|NCT01318499|460256501|FG002|Overall Study|Noncompliance|0|||
127899523|NCT01318499|460256499|FG000|Overall Study|Treatment Failure|19|||
127899524|NCT01318499|460256500|FG001|Overall Study|Treatment Failure|19|||
127899525|NCT01318499|460256501|FG002|Overall Study|Treatment Failure|101|||
127899526|NCT01318499|460256499|FG000|Overall Study|Protocol Violation|2|||
127899527|NCT01318499|460256500|FG001|Overall Study|Protocol Violation|4|||
127899528|NCT01318499|460256501|FG002|Overall Study|Protocol Violation|2|||
127899529|NCT01318499|460256499|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
127899530|NCT01318499|460256500|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
127899531|NCT01318499|460256501|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
127899532|NCT01318499|460256499|FG000|Overall Study|Other|7|||
127899533|NCT01318499|460256500|FG001|Overall Study|Other|10|||
127899534|NCT01318499|460256501|FG002|Overall Study|Other|22|||
127899535|NCT04977336|460256505|FG000|Overall Study|Withdrawal of Consent (not due to AE)|1|||
127899536|NCT04977336|460256506|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
127899537|NCT04977336|460256507|FG002|Overall Study|Withdrawal of Consent (not due to AE)|0|||
127899538|NCT04977336|460256508|FG003|Overall Study|Withdrawal of Consent (not due to AE)|1|||
127899539|NCT04977336|460256509|FG004|Overall Study|Withdrawal of Consent (not due to AE)|2|||
127899540|NCT04977336|460256505|FG000|Overall Study|Lost to Follow-up|0|||
127899541|NCT04977336|460256506|FG001|Overall Study|Lost to Follow-up|0|||
127757826|NCT01743989|459738661|FG001|TFR Phase|Protocol deviation|1|||
127757827|NCT01743989|459738662|FG002|TFR Phase|Protocol deviation|0|||
127899542|NCT04977336|460256507|FG002|Overall Study|Lost to Follow-up|1|||
127899543|NCT04977336|460256508|FG003|Overall Study|Lost to Follow-up|0|||
127899544|NCT04977336|460256509|FG004|Overall Study|Lost to Follow-up|0|||
127899545|NCT01347710|460256510|FG000|Overall Study|Withdrawal by Subject|2|||
127899546|NCT01347710|460256510|FG000|Overall Study|Adverse Event|4|||
127899547|NCT01347710|460256510|FG000|Overall Study|Angio or SPECT not completed|18|||
127899548|NCT01347710|460256510|FG000|Overall Study|issue with vitals prior to dosing|1|||
127899549|NCT01347710|460256510|FG000|Overall Study|Lost to Follow-up|1|||
127899550|NCT01347710|460256510|FG000|Overall Study|Physician Decision|2|||
127899551|NCT01347710|460256510|FG000|Overall Study|Other|3|||
127757828|NCT01743989|459738660|FG000|TFR Phase|Withdrawal by Subject|0|||
127842338|NCT02843178|460040664|FG002|Overall Study|Withdrawal by Subject|1|||
127842339|NCT02843178|460040665|FG003|Overall Study|Withdrawal by Subject|1|||
127842340|NCT00453180|460040673|FG000|Overall Study|Lost to Follow-up|2|||
127842341|NCT00453180|460040674|FG001|Overall Study|Lost to Follow-up|1|||
127842342|NCT00453180|460040673|FG000|Overall Study|Adverse Event|1|||
127842343|NCT00453180|460040674|FG001|Overall Study|Adverse Event|2|||
127842344|NCT02420795|460040679|FG000|Overall Study|Withdrawal by Subject|1|||
127842345|NCT02420795|460040680|FG001|Overall Study|Withdrawal by Subject|0|||
127842346|NCT02420795|460040681|FG002|Overall Study|Withdrawal by Subject|0|||
127842347|NCT02420795|460040679|FG000|Overall Study|Adverse Event|1|||
127842348|NCT02420795|460040680|FG001|Overall Study|Adverse Event|0|||
127842349|NCT02420795|460040681|FG002|Overall Study|Adverse Event|0|||
127842350|NCT02420795|460040679|FG000|Overall Study|Progressive disease|2|||
127842351|NCT02420795|460040680|FG001|Overall Study|Progressive disease|2|||
127842352|NCT02420795|460040681|FG002|Overall Study|Progressive disease|4|||
127842353|NCT02420795|460040679|FG000|Overall Study|Death|0|||
127842354|NCT02420795|460040680|FG001|Overall Study|Death|0|||
127842355|NCT02420795|460040681|FG002|Overall Study|Death|1|||
127842356|NCT01002742|460040684|FG000|Overall Study|Determined to be ineligible|0|||
127842357|NCT01002742|460040685|FG001|Overall Study|Determined to be ineligible|1|||
127757829|NCT01743989|459738661|FG001|TFR Phase|Withdrawal by Subject|2|||
127757830|NCT01743989|459738662|FG002|TFR Phase|Withdrawal by Subject|0|||
127757831|NCT01743989|459738660|FG000|Re-treatment Phase|Adverse Event|8|||
127899552|NCT01004172|460256512|FG000|Overall Study|Progressive Disease in CNS Only|16|||
127899553|NCT01004172|460256512|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
127899554|NCT01004172|460256512|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
127899555|NCT01004172|460256512|FG000|Overall Study|Adverse Event|1|||
127899556|NCT01004172|460256512|FG000|Overall Study|Physician Decision|1|||
127899557|NCT01004172|460256512|FG000|Overall Study|Symptomatic Deterioration|2|||
127757832|NCT01743989|459738661|FG001|Re-treatment Phase|Adverse Event|4|||
127899558|NCT01606306|460256513|FG000|Overall Study|Lack of Efficacy|2|||
127899559|NCT01606306|460256514|FG001|Overall Study|Lack of Efficacy|1|||
127899560|NCT01606306|460256515|FG002|Overall Study|Lack of Efficacy|4|||
127899561|NCT01606306|460256516|FG003|Overall Study|Lack of Efficacy|4|||
127899562|NCT01606306|460256517|FG004|Overall Study|Lack of Efficacy|1|||
127757833|NCT01743989|459738662|FG002|Re-treatment Phase|Adverse Event|0|||
127842358|NCT02862548|460040697|FG000|Randomized Phase (Up to Week 48)|Death|0|||
127842359|NCT02862548|460040698|FG001|Randomized Phase (Up to Week 48)|Death|1|||
127757834|NCT01743989|459738660|FG000|Re-treatment Phase|Death|1|||
127842360|NCT02862548|460040697|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
127842361|NCT02862548|460040698|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
127842362|NCT02862548|460040697|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
127842363|NCT02862548|460040698|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
127757835|NCT01743989|459738661|FG001|Re-treatment Phase|Death|1|||
127757836|NCT01743989|459738662|FG002|Re-treatment Phase|Death|0|||
127757837|NCT01743989|459738660|FG000|Re-treatment Phase|Administrative problems|1|||
127757838|NCT01743989|459738661|FG001|Re-treatment Phase|Administrative problems|1|||
127757839|NCT01743989|459738662|FG002|Re-treatment Phase|Administrative problems|0|||
127757840|NCT01743989|459738660|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
127757841|NCT01743989|459738661|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
127757842|NCT01743989|459738662|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
127757843|NCT01743989|459738660|FG000|Re-treatment Phase|Unstable MR|1|||
127757844|NCT01743989|459738661|FG001|Re-treatment Phase|Unstable MR|0|||
127757845|NCT01743989|459738662|FG002|Re-treatment Phase|Unstable MR|0|||
127842364|NCT02862548|460040697|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
127842365|NCT02862548|460040698|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
127842366|NCT00880763|460040699|FG000|Extension Period (Part 2)|Adverse Event|0|||
127842367|NCT00880763|460040700|FG001|Extension Period (Part 2)|Adverse Event|0|||
127842368|NCT00880763|460040701|FG002|Extension Period (Part 2)|Adverse Event|1|||
127842369|NCT00880763|460040702|FG003|Extension Period (Part 2)|Adverse Event|1|||
127842370|NCT00880763|460040699|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
127842371|NCT00880763|460040700|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
127842372|NCT00880763|460040701|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
127842373|NCT00880763|460040702|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
127842374|NCT00880763|460040699|FG000|Extension Period (Part 2)|Physician Decision|0|||
127842375|NCT00880763|460040700|FG001|Extension Period (Part 2)|Physician Decision|1|||
127842376|NCT00880763|460040701|FG002|Extension Period (Part 2)|Physician Decision|1|||
127842377|NCT00880763|460040702|FG003|Extension Period (Part 2)|Physician Decision|0|||
127842378|NCT00880763|460040699|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
127842379|NCT00880763|460040700|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
127842380|NCT00880763|460040701|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
127842381|NCT00880763|460040702|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
127842382|NCT03287869|460040706|FG000|Overall Study|Adverse Event|14|||
127842383|NCT03287869|460040707|FG001|Overall Study|Adverse Event|12|||
127842384|NCT03287869|460040706|FG000|Overall Study|Lack of Efficacy|1|||
127842385|NCT03287869|460040707|FG001|Overall Study|Lack of Efficacy|0|||
127842386|NCT03287869|460040706|FG000|Overall Study|Lost to Follow-up|13|||
127757846|NCT01743989|459738660|FG000|Re-treatment Phase|Physician Decision|0|||
127757847|NCT01743989|459738661|FG001|Re-treatment Phase|Physician Decision|1|||
127757848|NCT01743989|459738662|FG002|Re-treatment Phase|Physician Decision|0|||
127757849|NCT01743989|459738660|FG000|Re-treatment Phase|Lost to Follow-up|0|||
127757850|NCT01743989|459738661|FG001|Re-treatment Phase|Lost to Follow-up|1|||
127757851|NCT01743989|459738662|FG002|Re-treatment Phase|Lost to Follow-up|0|||
127757852|NCT02235311|459738667|FG000|Overall Study|Lost to Follow-up|0|||
127757853|NCT02235311|459738668|FG001|Overall Study|Lost to Follow-up|1|||
127842387|NCT03287869|460040707|FG001|Overall Study|Lost to Follow-up|19|||
127842388|NCT03287869|460040706|FG000|Overall Study|Non-Compliance With Study Drug|5|||
127842389|NCT03287869|460040707|FG001|Overall Study|Non-Compliance With Study Drug|9|||
127842390|NCT03287869|460040706|FG000|Overall Study|Progressive Disease|1|||
127757854|NCT02235311|459738667|FG000|Overall Study|Protocol Violation|0|||
127757855|NCT02235311|459738668|FG001|Overall Study|Protocol Violation|1|||
127757856|NCT02626455|459738669|FG000|Overall Study|Other|1|||
127757857|NCT02626455|459738670|FG001|Overall Study|Other|1|||
127757858|NCT02626455|459738671|FG002|Overall Study|Other|0|||
127757859|NCT02626455|459738672|FG003|Overall Study|Other|0|||
127757860|NCT02626455|459738673|FG004|Overall Study|Other|0|||
127757861|NCT02626455|459738674|FG005|Overall Study|Other|17|||
127757862|NCT02626455|459738675|FG006|Overall Study|Other|23|||
127757863|NCT02626455|459738669|FG000|Overall Study|Withdrawal by Subject|1|||
127757864|NCT02626455|459738670|FG001|Overall Study|Withdrawal by Subject|0|||
127757865|NCT02626455|459738671|FG002|Overall Study|Withdrawal by Subject|0|||
127757866|NCT02626455|459738672|FG003|Overall Study|Withdrawal by Subject|0|||
127757867|NCT02626455|459738673|FG004|Overall Study|Withdrawal by Subject|0|||
127757868|NCT02626455|459738674|FG005|Overall Study|Withdrawal by Subject|10|||
127757869|NCT02626455|459738675|FG006|Overall Study|Withdrawal by Subject|6|||
127757870|NCT02626455|459738669|FG000|Overall Study|Physician Decision|0|||
127757871|NCT02626455|459738670|FG001|Overall Study|Physician Decision|2|||
127757872|NCT02626455|459738671|FG002|Overall Study|Physician Decision|2|||
127757873|NCT02626455|459738672|FG003|Overall Study|Physician Decision|2|||
127757874|NCT02626455|459738673|FG004|Overall Study|Physician Decision|1|||
127757875|NCT02626455|459738674|FG005|Overall Study|Physician Decision|10|||
127757876|NCT02626455|459738675|FG006|Overall Study|Physician Decision|3|||
127757877|NCT02626455|459738669|FG000|Overall Study|Patient decision: COVID-19 pandemic related|0|||
127757878|NCT02626455|459738670|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
127757879|NCT02626455|459738671|FG002|Overall Study|Patient decision: COVID-19 pandemic related|0|||
127757880|NCT02626455|459738672|FG003|Overall Study|Patient decision: COVID-19 pandemic related|0|||
127757881|NCT02626455|459738673|FG004|Overall Study|Patient decision: COVID-19 pandemic related|0|||
127757882|NCT02626455|459738674|FG005|Overall Study|Patient decision: COVID-19 pandemic related|0|||
127757883|NCT02626455|459738675|FG006|Overall Study|Patient decision: COVID-19 pandemic related|1|||
127757884|NCT02626455|459738669|FG000|Overall Study|Physician decision: COVID-19 pandemic related|0|||
127757885|NCT02626455|459738670|FG001|Overall Study|Physician decision: COVID-19 pandemic related|0|||
127757886|NCT02626455|459738671|FG002|Overall Study|Physician decision: COVID-19 pandemic related|0|||
127757887|NCT02626455|459738672|FG003|Overall Study|Physician decision: COVID-19 pandemic related|0|||
127757888|NCT02626455|459738673|FG004|Overall Study|Physician decision: COVID-19 pandemic related|0|||
127757889|NCT02626455|459738674|FG005|Overall Study|Physician decision: COVID-19 pandemic related|0|||
127757890|NCT02626455|459738675|FG006|Overall Study|Physician decision: COVID-19 pandemic related|2|||
127757891|NCT02626455|459738669|FG000|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
127757892|NCT02626455|459738670|FG001|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
127757893|NCT02626455|459738671|FG002|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
127842391|NCT03287869|460040707|FG001|Overall Study|Progressive Disease|0|||
127842392|NCT03287869|460040706|FG000|Overall Study|Protocol Deviation|2|||
127842393|NCT03287869|460040707|FG001|Overall Study|Protocol Deviation|1|||
127842394|NCT03287869|460040706|FG000|Overall Study|Withdrawal by Subject|36|||
127842395|NCT03287869|460040707|FG001|Overall Study|Withdrawal by Subject|43|||
127842396|NCT03287869|460040706|FG000|Overall Study|Early Closure of the Site|0|||
127842397|NCT03287869|460040707|FG001|Overall Study|Early Closure of the Site|1|||
127899563|NCT01606306|460256518|FG005|Overall Study|Lack of Efficacy|2|||
127842398|NCT03287869|460040706|FG000|Overall Study|Physician Decision|5|||
127842399|NCT03287869|460040707|FG001|Overall Study|Physician Decision|5|||
127842400|NCT03287869|460040706|FG000|Overall Study|Reason not Specified|6|||
127842401|NCT03287869|460040707|FG001|Overall Study|Reason not Specified|3|||
127842402|NCT03488238|460040708|FG000|Overall Study|Equipment malfunction|1|||
127842403|NCT03488238|460040708|FG000|Overall Study|Adverse Event|1|||
127842404|NCT02670928|460040709|FG000|Overall Study|Adverse Event|3|||
127842405|NCT02670928|460040710|FG001|Overall Study|Adverse Event|1|||
127842406|NCT02670928|460040709|FG000|Overall Study|Withdrawal by Subject|4|||
127842407|NCT02670928|460040710|FG001|Overall Study|Withdrawal by Subject|0|||
127842408|NCT02670928|460040709|FG000|Overall Study|Lost to Follow-up|1|||
127842409|NCT02670928|460040710|FG001|Overall Study|Lost to Follow-up|0|||
127842410|NCT02670928|460040709|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
127842411|NCT02670928|460040710|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
127842412|NCT02591238|460040711|FG000|Overall Study|Pregnancy|1|||
127842413|NCT02591238|460040712|FG001|Overall Study|Pregnancy|0|||
127842414|NCT02591238|460040713|FG002|Overall Study|Pregnancy|0|||
127842415|NCT02591238|460040714|FG003|Overall Study|Pregnancy|0|||
127842416|NCT02591238|460040711|FG000|Overall Study|Withdrawal by Subject|0|||
127842417|NCT02591238|460040712|FG001|Overall Study|Withdrawal by Subject|0|||
127842418|NCT02591238|460040713|FG002|Overall Study|Withdrawal by Subject|0|||
127899564|NCT01606306|460256513|FG000|Overall Study|Adverse Event|1|||
127899565|NCT01606306|460256514|FG001|Overall Study|Adverse Event|0|||
127899566|NCT01606306|460256515|FG002|Overall Study|Adverse Event|1|||
127899567|NCT01606306|460256516|FG003|Overall Study|Adverse Event|1|||
127899568|NCT01606306|460256517|FG004|Overall Study|Adverse Event|2|||
127899569|NCT01606306|460256518|FG005|Overall Study|Adverse Event|0|||
127899570|NCT01606306|460256513|FG000|Overall Study|Lost to Follow-up|7|||
127899571|NCT01606306|460256514|FG001|Overall Study|Lost to Follow-up|4|||
127899572|NCT01606306|460256515|FG002|Overall Study|Lost to Follow-up|5|||
127899573|NCT01606306|460256516|FG003|Overall Study|Lost to Follow-up|4|||
127899574|NCT01606306|460256517|FG004|Overall Study|Lost to Follow-up|3|||
127899575|NCT01606306|460256518|FG005|Overall Study|Lost to Follow-up|5|||
127842419|NCT02591238|460040714|FG003|Overall Study|Withdrawal by Subject|1|||
127842420|NCT02591238|460040711|FG000|Overall Study|influenza|0|||
127842421|NCT02591238|460040712|FG001|Overall Study|influenza|0|||
127842422|NCT02591238|460040713|FG002|Overall Study|influenza|0|||
127842423|NCT02591238|460040714|FG003|Overall Study|influenza|1|||
127842424|NCT02591238|460040711|FG000|Overall Study|personal circumstances|0|||
127842425|NCT02591238|460040712|FG001|Overall Study|personal circumstances|0|||
127899576|NCT01606306|460256513|FG000|Overall Study|Withdrawal by Subject|4|||
127899577|NCT01606306|460256514|FG001|Overall Study|Withdrawal by Subject|3|||
127899578|NCT01606306|460256515|FG002|Overall Study|Withdrawal by Subject|4|||
127899579|NCT01606306|460256516|FG003|Overall Study|Withdrawal by Subject|4|||
127899580|NCT01606306|460256517|FG004|Overall Study|Withdrawal by Subject|5|||
127899581|NCT01606306|460256518|FG005|Overall Study|Withdrawal by Subject|4|||
127842426|NCT02591238|460040713|FG002|Overall Study|personal circumstances|0|||
127842427|NCT02591238|460040714|FG003|Overall Study|personal circumstances|1|||
127899582|NCT01606306|460256513|FG000|Overall Study|Physician Decision|1|||
127899583|NCT01606306|460256514|FG001|Overall Study|Physician Decision|2|||
127899584|NCT01606306|460256515|FG002|Overall Study|Physician Decision|0|||
127899585|NCT01606306|460256516|FG003|Overall Study|Physician Decision|0|||
127899586|NCT01606306|460256517|FG004|Overall Study|Physician Decision|0|||
127899587|NCT01606306|460256518|FG005|Overall Study|Physician Decision|0|||
127899588|NCT00408902|460256521|FG000|Overall Study|Lack of Efficacy|7|||
127899589|NCT00408902|460256521|FG000|Overall Study|Adverse Event|3|||
127899590|NCT00970281|460256522|FG000|Overall Study|Lack of Efficacy|1|||
127899591|NCT00970281|460256523|FG001|Overall Study|Lack of Efficacy|14|||
127757894|NCT02626455|459738672|FG003|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
127757895|NCT02626455|459738673|FG004|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
127757896|NCT02626455|459738674|FG005|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
127757897|NCT02626455|459738675|FG006|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
127757898|NCT02626455|459738669|FG000|Overall Study|Patient decision|0|||
127757899|NCT02626455|459738670|FG001|Overall Study|Patient decision|1|||
127757900|NCT02626455|459738671|FG002|Overall Study|Patient decision|0|||
127757901|NCT02626455|459738672|FG003|Overall Study|Patient decision|0|||
127757902|NCT02626455|459738673|FG004|Overall Study|Patient decision|1|||
127757903|NCT02626455|459738674|FG005|Overall Study|Patient decision|36|||
127757904|NCT02626455|459738675|FG006|Overall Study|Patient decision|22|||
127757905|NCT02626455|459738669|FG000|Overall Study|Protocol Violation|0|||
127757906|NCT02626455|459738670|FG001|Overall Study|Protocol Violation|0|||
127757907|NCT02626455|459738671|FG002|Overall Study|Protocol Violation|0|||
127757908|NCT02626455|459738672|FG003|Overall Study|Protocol Violation|0|||
127757909|NCT02626455|459738673|FG004|Overall Study|Protocol Violation|0|||
127757910|NCT02626455|459738674|FG005|Overall Study|Protocol Violation|0|||
127757911|NCT02626455|459738675|FG006|Overall Study|Protocol Violation|1|||
127757912|NCT02626455|459738669|FG000|Overall Study|Progressive disease - radiological progression|0|||
127757913|NCT02626455|459738670|FG001|Overall Study|Progressive disease - radiological progression|0|||
127757914|NCT02626455|459738671|FG002|Overall Study|Progressive disease - radiological progression|0|||
127757915|NCT02626455|459738672|FG003|Overall Study|Progressive disease - radiological progression|0|||
127757916|NCT02626455|459738673|FG004|Overall Study|Progressive disease - radiological progression|0|||
127757917|NCT02626455|459738674|FG005|Overall Study|Progressive disease - radiological progression|11|||
127757918|NCT02626455|459738675|FG006|Overall Study|Progressive disease - radiological progression|22|||
127757919|NCT02626455|459738669|FG000|Overall Study|Progressive disease - clinical progression|0|||
127757920|NCT02626455|459738670|FG001|Overall Study|Progressive disease - clinical progression|0|||
127757921|NCT02626455|459738671|FG002|Overall Study|Progressive disease - clinical progression|0|||
127757922|NCT02626455|459738672|FG003|Overall Study|Progressive disease - clinical progression|0|||
127899592|NCT00970281|460256522|FG000|Overall Study|Withdrawal by Subject|0|||
127899593|NCT00970281|460256523|FG001|Overall Study|Withdrawal by Subject|1|||
127899594|NCT00970281|460256522|FG000|Overall Study|Physician Decision|1|||
127899595|NCT00970281|460256523|FG001|Overall Study|Physician Decision|1|||
127899596|NCT02003183|460256524|FG000|Overall Study|Lost to Follow-up|0|||
127899597|NCT02003183|460256525|FG001|Overall Study|Lost to Follow-up|2|||
127899598|NCT00878995|460256526|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
127899599|NCT00878995|460256527|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
127899600|NCT03338972|460256528|FG000|Overall Study|Death|1|||
127899601|NCT03338972|460256529|FG001|Overall Study|Death|1|||
127899602|NCT03338972|460256530|FG002|Overall Study|Death|0|||
127899603|NCT03338972|460256531|FG003|Overall Study|Death|0|||
127899604|NCT03338972|460256528|FG000|Overall Study|Withdrawal by Subject|1|||
127899605|NCT03338972|460256529|FG001|Overall Study|Withdrawal by Subject|0|||
127899606|NCT03338972|460256530|FG002|Overall Study|Withdrawal by Subject|0|||
127899607|NCT03338972|460256531|FG003|Overall Study|Withdrawal by Subject|0|||
127899608|NCT02480764|460256532|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
127899609|NCT02480764|460256533|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
127899610|NCT02480764|460256534|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
127899611|NCT02480764|460256532|FG000|Overall Study|Major Protocol Deviation|1|||
127899612|NCT02480764|460256533|FG001|Overall Study|Major Protocol Deviation|4|||
127899613|NCT02480764|460256534|FG002|Overall Study|Major Protocol Deviation|3|||
127899614|NCT02480764|460256532|FG000|Overall Study|Lost to Follow-up|0|||
127899615|NCT02480764|460256533|FG001|Overall Study|Lost to Follow-up|1|||
127899616|NCT02480764|460256534|FG002|Overall Study|Lost to Follow-up|2|||
127899617|NCT02480764|460256532|FG000|Overall Study|Voluntary Withdrawal|6|||
127757923|NCT02626455|459738673|FG004|Overall Study|Progressive disease - clinical progression|0|||
127757924|NCT02626455|459738674|FG005|Overall Study|Progressive disease - clinical progression|1|||
127757925|NCT02626455|459738675|FG006|Overall Study|Progressive disease - clinical progression|2|||
127757926|NCT02626455|459738669|FG000|Overall Study|Lost to Follow-up|0|||
127757927|NCT02626455|459738670|FG001|Overall Study|Lost to Follow-up|0|||
127899618|NCT02480764|460256533|FG001|Overall Study|Voluntary Withdrawal|5|||
127899619|NCT02480764|460256534|FG002|Overall Study|Voluntary Withdrawal|10|||
127899620|NCT02480764|460256532|FG000|Overall Study|Lack of Efficacy|0|||
127899621|NCT02480764|460256533|FG001|Overall Study|Lack of Efficacy|3|||
127899622|NCT02480764|460256534|FG002|Overall Study|Lack of Efficacy|3|||
127899623|NCT02480764|460256532|FG000|Overall Study|Reason not Specified|0|||
127899624|NCT02480764|460256533|FG001|Overall Study|Reason not Specified|1|||
127899625|NCT02480764|460256534|FG002|Overall Study|Reason not Specified|0|||
127899626|NCT03629249|460256535|FG000|Overall Study|Study terminated by sponsor|197|||
127899627|NCT03629249|460256536|FG001|Overall Study|Study terminated by sponsor|197|||
127899628|NCT03629249|460256537|FG002|Overall Study|Study terminated by sponsor|194|||
127899629|NCT03629249|460256535|FG000|Overall Study|Protocol deviation|0|||
127757928|NCT02626455|459738671|FG002|Overall Study|Lost to Follow-up|0|||
127757929|NCT02626455|459738672|FG003|Overall Study|Lost to Follow-up|0|||
127757930|NCT02626455|459738673|FG004|Overall Study|Lost to Follow-up|0|||
127757931|NCT02626455|459738674|FG005|Overall Study|Lost to Follow-up|1|||
127757932|NCT02626455|459738675|FG006|Overall Study|Lost to Follow-up|0|||
127757933|NCT02626455|459738669|FG000|Overall Study|AE not associated with clinical disease progression|1|||
127757934|NCT02626455|459738670|FG001|Overall Study|AE not associated with clinical disease progression|1|||
127757935|NCT02626455|459738671|FG002|Overall Study|AE not associated with clinical disease progression|0|||
127757936|NCT02626455|459738672|FG003|Overall Study|AE not associated with clinical disease progression|2|||
127757937|NCT02626455|459738673|FG004|Overall Study|AE not associated with clinical disease progression|1|||
127757938|NCT02626455|459738674|FG005|Overall Study|AE not associated with clinical disease progression|65|||
127757939|NCT02626455|459738675|FG006|Overall Study|AE not associated with clinical disease progression|21|||
127757940|NCT02626455|459738669|FG000|Overall Study|AE associated with clinical disease progression|0|||
127757941|NCT02626455|459738670|FG001|Overall Study|AE associated with clinical disease progression|0|||
127757942|NCT02626455|459738671|FG002|Overall Study|AE associated with clinical disease progression|0|||
127757943|NCT02626455|459738672|FG003|Overall Study|AE associated with clinical disease progression|0|||
127757944|NCT02626455|459738673|FG004|Overall Study|AE associated with clinical disease progression|0|||
127757945|NCT02626455|459738674|FG005|Overall Study|AE associated with clinical disease progression|1|||
127757946|NCT02626455|459738675|FG006|Overall Study|AE associated with clinical disease progression|2|||
127757947|NCT02626455|459738669|FG000|Overall Study|Study intervention never administered|0|||
127757948|NCT02626455|459738670|FG001|Overall Study|Study intervention never administered|0|||
127757949|NCT02626455|459738671|FG002|Overall Study|Study intervention never administered|0|||
127757950|NCT02626455|459738672|FG003|Overall Study|Study intervention never administered|0|||
127757951|NCT02626455|459738673|FG004|Overall Study|Study intervention never administered|0|||
127757952|NCT02626455|459738674|FG005|Overall Study|Study intervention never administered|1|||
127757953|NCT02626455|459738675|FG006|Overall Study|Study intervention never administered|3|||
127757954|NCT00384397|459738678|FG000|Overall Study|Adverse Event|0|||
127757955|NCT00384397|459738679|FG001|Overall Study|Adverse Event|1|||
127899630|NCT03629249|460256536|FG001|Overall Study|Protocol deviation|2|||
127899631|NCT03629249|460256537|FG002|Overall Study|Protocol deviation|5|||
127899632|NCT03629249|460256535|FG000|Overall Study|Subject decision|1|||
127899633|NCT03629249|460256536|FG001|Overall Study|Subject decision|1|||
127899634|NCT03629249|460256537|FG002|Overall Study|Subject decision|3|||
127899635|NCT03629249|460256535|FG000|Overall Study|Adverse Event|1|||
127899636|NCT03629249|460256536|FG001|Overall Study|Adverse Event|1|||
127899637|NCT03629249|460256537|FG002|Overall Study|Adverse Event|0|||
127899638|NCT03629249|460256535|FG000|Overall Study|Death|1|||
127899639|NCT03629249|460256536|FG001|Overall Study|Death|0|||
127899640|NCT03629249|460256537|FG002|Overall Study|Death|0|||
127899641|NCT03629249|460256535|FG000|Overall Study|Physician Decision|1|||
127899642|NCT03629249|460256536|FG001|Overall Study|Physician Decision|0|||
127899643|NCT03629249|460256537|FG002|Overall Study|Physician Decision|0|||
127899644|NCT01030965|460256540|FG000|Overall Study|Lack of Efficacy|3|||
127899645|NCT01030965|460256541|FG001|Overall Study|Lack of Efficacy|2|||
127899646|NCT01030965|460256542|FG002|Overall Study|Lack of Efficacy|0|||
127899647|NCT01030965|460256543|FG003|Overall Study|Lack of Efficacy|3|||
127899648|NCT01030965|460256540|FG000|Overall Study|Protocol Violation|1|||
127899649|NCT01030965|460256541|FG001|Overall Study|Protocol Violation|1|||
127899650|NCT01030965|460256542|FG002|Overall Study|Protocol Violation|1|||
127899651|NCT01030965|460256543|FG003|Overall Study|Protocol Violation|1|||
127899652|NCT01030965|460256540|FG000|Overall Study|Adverse Event|0|||
127899653|NCT01030965|460256541|FG001|Overall Study|Adverse Event|1|||
127899654|NCT01030965|460256542|FG002|Overall Study|Adverse Event|2|||
127899655|NCT01030965|460256543|FG003|Overall Study|Adverse Event|1|||
127899656|NCT01030965|460256540|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
127899657|NCT01030965|460256541|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
127899658|NCT01030965|460256542|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
127899659|NCT01030965|460256543|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
127899660|NCT01030965|460256540|FG000|Overall Study|Withdrawal by Subject|0|||
127899661|NCT01030965|460256541|FG001|Overall Study|Withdrawal by Subject|1|||
127899662|NCT01030965|460256542|FG002|Overall Study|Withdrawal by Subject|0|||
127899663|NCT01030965|460256543|FG003|Overall Study|Withdrawal by Subject|2|||
127899664|NCT02097290|460256544|FG000|Overall Study|Death|6|||
127899665|NCT02097290|460256544|FG000|Overall Study|Total Withdrawals|3|||
127899666|NCT02097290|460256544|FG000|Overall Study|Attempt|8|||
127899667|NCT03144687|460256547|FG000|Overall Study|Death|0|||
127899668|NCT03144687|460256548|FG001|Overall Study|Death|2|||
127899669|NCT03144687|460256547|FG000|Overall Study|Lost to Follow-up|0|||
127899670|NCT03144687|460256548|FG001|Overall Study|Lost to Follow-up|1|||
127899671|NCT03144687|460256547|FG000|Overall Study|Physician Decision|0|||
127899672|NCT03144687|460256548|FG001|Overall Study|Physician Decision|1|||
127899673|NCT03144687|460256547|FG000|Overall Study|Withdrawal by Subject|1|||
127899674|NCT03144687|460256548|FG001|Overall Study|Withdrawal by Subject|3|||
127899675|NCT03144687|460256547|FG000|Overall Study|Not Reported|2|||
127899676|NCT03144687|460256548|FG001|Overall Study|Not Reported|0|||
127899677|NCT00743197|460256549|FG000|Overall Study|Study terminated due to departure of PI.|1|||
127899678|NCT00743197|460256550|FG001|Overall Study|Study terminated due to departure of PI.|2|||
127899679|NCT00475020|460256551|FG000|Overall Study|Physician Decision|3|||
127899680|NCT00475020|460256551|FG000|Overall Study|Insurance Denial|1|||
127899681|NCT00475020|460256551|FG000|Overall Study|Donor not able to donate the last minute|1|||
127899682|NCT02514174|460256555|FG000|Overall Study|Patient refused to continue medication|1|||
127899683|NCT02514174|460256555|FG000|Overall Study|Adverse Event|2|||
127899684|NCT02514174|460256555|FG000|Overall Study|Study closed by sponsor|9|||
127899685|NCT02514174|460256555|FG000|Overall Study|Progressive disease|11|||
127899686|NCT02514174|460256555|FG000|Overall Study|Treatment change|1|||
127899687|NCT02514174|460256555|FG000|Overall Study|Treated off study with Afatinib.|1|||
127899688|NCT02130466|460256556|FG000|Overall Study|Death|4|||
127899689|NCT02130466|460256557|FG001|Overall Study|Death|1|||
127899690|NCT02130466|460256558|FG002|Overall Study|Death|1|||
127899691|NCT02130466|460256559|FG003|Overall Study|Death|3|||
127899692|NCT02130466|460256560|FG004|Overall Study|Death|2|||
127899693|NCT02130466|460256561|FG005|Overall Study|Death|30|||
127899694|NCT02130466|460256562|FG006|Overall Study|Death|45|||
127899695|NCT02130466|460256563|FG007|Overall Study|Death|2|||
127899696|NCT02130466|460256564|FG008|Overall Study|Death|3|||
127899697|NCT02130466|460256565|FG009|Overall Study|Death|4|||
127899698|NCT02130466|460256566|FG010|Overall Study|Death|5|||
127899699|NCT02130466|460256567|FG011|Overall Study|Death|3|||
127899700|NCT02130466|460256568|FG012|Overall Study|Death|11|||
127899701|NCT02130466|460256569|FG013|Overall Study|Death|7|||
127899702|NCT02130466|460256556|FG000|Overall Study|Lost to Follow-up|1|||
127899703|NCT02130466|460256557|FG001|Overall Study|Lost to Follow-up|0|||
127899704|NCT02130466|460256558|FG002|Overall Study|Lost to Follow-up|0|||
127899705|NCT02130466|460256559|FG003|Overall Study|Lost to Follow-up|0|||
127899706|NCT02130466|460256560|FG004|Overall Study|Lost to Follow-up|0|||
127899707|NCT02130466|460256561|FG005|Overall Study|Lost to Follow-up|1|||
127899708|NCT02130466|460256562|FG006|Overall Study|Lost to Follow-up|0|||
127899709|NCT02130466|460256563|FG007|Overall Study|Lost to Follow-up|0|||
127899710|NCT02130466|460256564|FG008|Overall Study|Lost to Follow-up|0|||
127899711|NCT02130466|460256565|FG009|Overall Study|Lost to Follow-up|0|||
127899712|NCT02130466|460256566|FG010|Overall Study|Lost to Follow-up|0|||
127899713|NCT02130466|460256567|FG011|Overall Study|Lost to Follow-up|0|||
127899714|NCT02130466|460256568|FG012|Overall Study|Lost to Follow-up|1|||
127899715|NCT02130466|460256569|FG013|Overall Study|Lost to Follow-up|0|||
127899716|NCT02130466|460256556|FG000|Overall Study|Physician Decision|0|||
127899717|NCT02130466|460256557|FG001|Overall Study|Physician Decision|0|||
127899718|NCT02130466|460256558|FG002|Overall Study|Physician Decision|0|||
127899719|NCT02130466|460256559|FG003|Overall Study|Physician Decision|0|||
127899720|NCT02130466|460256560|FG004|Overall Study|Physician Decision|0|||
127899721|NCT02130466|460256561|FG005|Overall Study|Physician Decision|1|||
127899722|NCT02130466|460256562|FG006|Overall Study|Physician Decision|1|||
127899723|NCT02130466|460256563|FG007|Overall Study|Physician Decision|0|||
127899724|NCT02130466|460256564|FG008|Overall Study|Physician Decision|0|||
127899725|NCT02130466|460256565|FG009|Overall Study|Physician Decision|0|||
127899726|NCT02130466|460256566|FG010|Overall Study|Physician Decision|0|||
127899727|NCT02130466|460256567|FG011|Overall Study|Physician Decision|0|||
127899728|NCT02130466|460256568|FG012|Overall Study|Physician Decision|0|||
127899729|NCT02130466|460256569|FG013|Overall Study|Physician Decision|0|||
127899730|NCT02130466|460256556|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
127899731|NCT02130466|460256557|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
127899732|NCT02130466|460256558|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
127899733|NCT02130466|460256559|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
127899734|NCT02130466|460256560|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
127899735|NCT02130466|460256561|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
127899736|NCT02130466|460256562|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
127899737|NCT02130466|460256563|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
127899738|NCT02130466|460256564|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
127899739|NCT02130466|460256565|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
127899740|NCT02130466|460256566|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
127899741|NCT02130466|460256567|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
127899742|NCT02130466|460256568|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
127899743|NCT02130466|460256569|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
127899744|NCT02130466|460256556|FG000|Overall Study|Withdrawal by Subject|1|||
127899745|NCT02130466|460256557|FG001|Overall Study|Withdrawal by Subject|0|||
127899746|NCT02130466|460256558|FG002|Overall Study|Withdrawal by Subject|0|||
127757956|NCT00384397|459738680|FG002|Overall Study|Adverse Event|2|||
127757957|NCT00384397|459738678|FG000|Overall Study|Protocol Violation|7|||
127757958|NCT00384397|459738679|FG001|Overall Study|Protocol Violation|15|||
127757959|NCT00384397|459738680|FG002|Overall Study|Protocol Violation|13|||
127757960|NCT00384397|459738678|FG000|Overall Study|Lost to Follow-up|11|||
127757961|NCT00384397|459738679|FG001|Overall Study|Lost to Follow-up|13|||
127757962|NCT00384397|459738680|FG002|Overall Study|Lost to Follow-up|3|||
127757963|NCT00384397|459738678|FG000|Overall Study|Withdrawal by Subject|14|||
127757964|NCT00384397|459738679|FG001|Overall Study|Withdrawal by Subject|17|||
127757965|NCT00384397|459738680|FG002|Overall Study|Withdrawal by Subject|15|||
127757966|NCT04372121|459738681|FG000|Overall Study|Lost to Follow-up|0|||
127757967|NCT04372121|459738682|FG001|Overall Study|Lost to Follow-up|0|||
127757968|NCT04372121|459738683|FG002|Overall Study|Lost to Follow-up|0|||
127757969|NCT04372121|459738684|FG003|Overall Study|Lost to Follow-up|1|||
127757970|NCT04372121|459738681|FG000|Overall Study|Protocol Violation|0|||
127757971|NCT04372121|459738682|FG001|Overall Study|Protocol Violation|0|||
127757972|NCT04372121|459738683|FG002|Overall Study|Protocol Violation|1|||
127757973|NCT04372121|459738684|FG003|Overall Study|Protocol Violation|0|||
127757974|NCT04372121|459738681|FG000|Overall Study|Withdrawal by Subject|3|||
127757975|NCT04372121|459738682|FG001|Overall Study|Withdrawal by Subject|1|||
127757976|NCT04372121|459738683|FG002|Overall Study|Withdrawal by Subject|0|||
127757977|NCT04372121|459738684|FG003|Overall Study|Withdrawal by Subject|0|||
127757978|NCT04372121|459738681|FG000|Overall Study|Study termination|6|||
127757979|NCT04372121|459738682|FG001|Overall Study|Study termination|5|||
127757980|NCT04372121|459738683|FG002|Overall Study|Study termination|1|||
127757981|NCT04372121|459738684|FG003|Overall Study|Study termination|1|||
127757982|NCT04372121|459738681|FG000|Overall Study|Hysterectomy planned|1|||
127757983|NCT04372121|459738682|FG001|Overall Study|Hysterectomy planned|0|||
127757984|NCT04372121|459738683|FG002|Overall Study|Hysterectomy planned|0|||
127757985|NCT04372121|459738684|FG003|Overall Study|Hysterectomy planned|0|||
127757986|NCT03345576|459738685|FG000|Overall Study|Withdrawal by Subject|2|||
127757987|NCT03345576|459738686|FG001|Overall Study|Withdrawal by Subject|2|||
127757988|NCT03345576|459738685|FG000|Overall Study|Adverse Event|1|||
127757989|NCT03345576|459738686|FG001|Overall Study|Adverse Event|0|||
127757990|NCT03002220|459740374|FG000|Overall Study|Lack of Efficacy|2|||
127757991|NCT03002220|459740374|FG000|Overall Study|Withdrawal by Subject|3|||
127757992|NCT03002220|459740374|FG000|Overall Study|Adverse Event|2|||
127757993|NCT03002220|459740374|FG000|Overall Study|Disease progression|13|||
127757994|NCT03002220|459740374|FG000|Overall Study|Physician Decision|1|||
127757995|NCT01302080|459740378|FG000|Overall Study|Withdrew Consent|92|||
127899747|NCT02130466|460256559|FG003|Overall Study|Withdrawal by Subject|0|||
127899748|NCT02130466|460256560|FG004|Overall Study|Withdrawal by Subject|0|||
127899749|NCT02130466|460256561|FG005|Overall Study|Withdrawal by Subject|1|||
127899750|NCT02130466|460256562|FG006|Overall Study|Withdrawal by Subject|0|||
127899751|NCT02130466|460256563|FG007|Overall Study|Withdrawal by Subject|0|||
127899752|NCT02130466|460256564|FG008|Overall Study|Withdrawal by Subject|1|||
127899753|NCT02130466|460256565|FG009|Overall Study|Withdrawal by Subject|0|||
127899754|NCT02130466|460256566|FG010|Overall Study|Withdrawal by Subject|0|||
127899755|NCT02130466|460256567|FG011|Overall Study|Withdrawal by Subject|0|||
127899756|NCT02130466|460256568|FG012|Overall Study|Withdrawal by Subject|0|||
127899757|NCT02130466|460256569|FG013|Overall Study|Withdrawal by Subject|0|||
127899758|NCT04529109|460256570|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
127899759|NCT04529109|460256571|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
127899760|NCT02170688|460256572|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
127899761|NCT02170688|460256573|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
127899762|NCT02170688|460256574|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
127899763|NCT02170688|460256575|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
127899764|NCT02170688|460256576|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
127899765|NCT02170688|460256572|FG000|Overall Study|Full dose not received|0|||
127899766|NCT02170688|460256573|FG001|Overall Study|Full dose not received|1|||
127899767|NCT02170688|460256574|FG002|Overall Study|Full dose not received|0|||
127899768|NCT02170688|460256575|FG003|Overall Study|Full dose not received|0|||
127899769|NCT02170688|460256576|FG004|Overall Study|Full dose not received|0|||
127899770|NCT02170688|460256572|FG000|Overall Study|Physician Decision|0|||
127899771|NCT02170688|460256573|FG001|Overall Study|Physician Decision|0|||
127899772|NCT02170688|460256574|FG002|Overall Study|Physician Decision|1|||
127899773|NCT02170688|460256575|FG003|Overall Study|Physician Decision|0|||
127757996|NCT01302080|459740379|FG001|Overall Study|Withdrew Consent|39|||
127757997|NCT01302080|459740378|FG000|Overall Study|Patient/Family Moved|28|||
127757998|NCT01302080|459740379|FG001|Overall Study|Patient/Family Moved|3|||
127757999|NCT01302080|459740378|FG000|Overall Study|Lost to Follow-up|192|||
127758000|NCT01302080|459740379|FG001|Overall Study|Lost to Follow-up|93|||
127758001|NCT01302080|459740378|FG000|Overall Study|Death|1|||
127758002|NCT01302080|459740379|FG001|Overall Study|Death|0|||
127758003|NCT01302080|459740378|FG000|Overall Study|Other|52|||
127899774|NCT02170688|460256576|FG004|Overall Study|Physician Decision|0|||
127758004|NCT01302080|459740379|FG001|Overall Study|Other|8|||
127899775|NCT02507375|460256580|FG000|Overall Study|Progressive Disease|4|||
127899776|NCT02507375|460256581|FG001|Overall Study|Progressive Disease|5|||
127899777|NCT02507375|460256580|FG000|Overall Study|Death|0|||
127899778|NCT02507375|460256581|FG001|Overall Study|Death|1|||
127899779|NCT02507375|460256580|FG000|Overall Study|Refused treatment|0|||
127899780|NCT02507375|460256581|FG001|Overall Study|Refused treatment|1|||
127899781|NCT02507375|460256580|FG000|Overall Study|Adverse Event|0|||
127899782|NCT02507375|460256581|FG001|Overall Study|Adverse Event|1|||
127899783|NCT00522457|460256582|FG000|Overall Study|Due to disease progression|16|||
127899784|NCT00522457|460256582|FG000|Overall Study|Adverse Event|2|||
127899785|NCT01691248|460256583|FG000|Overall Study|Protocol Violation|43|||
127899786|NCT01691248|460256584|FG001|Overall Study|Protocol Violation|27|||
127899787|NCT01691248|460256583|FG000|Overall Study|Adverse Event|24|||
127899788|NCT01691248|460256584|FG001|Overall Study|Adverse Event|22|||
127899789|NCT01691248|460256583|FG000|Overall Study|Withdrawal by Subject|20|||
127899790|NCT01691248|460256584|FG001|Overall Study|Withdrawal by Subject|18|||
127899791|NCT01691248|460256583|FG000|Overall Study|Confirmed CDAD|14|||
127899792|NCT01691248|460256584|FG001|Overall Study|Confirmed CDAD|31|||
127899793|NCT01691248|460256583|FG000|Overall Study|Lost to Follow-up|2|||
127899794|NCT01691248|460256584|FG001|Overall Study|Lost to Follow-up|5|||
127899795|NCT01691248|460256583|FG000|Overall Study|Reason not provided|4|||
127899796|NCT01691248|460256584|FG001|Overall Study|Reason not provided|4|||
127899797|NCT01691248|460256583|FG000|Overall Study|Not Treated|4|||
127899798|NCT01691248|460256584|FG001|Overall Study|Not Treated|7|||
127899799|NCT02863575|460256585|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
127899800|NCT02863575|460256586|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
127899801|NCT02863575|460256587|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
127899802|NCT02863575|460256585|FG000|Overall Study|Withdrawal by Subject|0|||
127899803|NCT02863575|460256586|FG001|Overall Study|Withdrawal by Subject|1|||
127899804|NCT02863575|460256587|FG002|Overall Study|Withdrawal by Subject|1|||
127899805|NCT02863575|460256585|FG000|Overall Study|Adverse Event|0|||
127899806|NCT02863575|460256586|FG001|Overall Study|Adverse Event|1|||
127899807|NCT02863575|460256587|FG002|Overall Study|Adverse Event|0|||
127899808|NCT00788125|460258410|FG000|Overall Study|Death|6|||
127899809|NCT00444145|460258418|FG000|Overall Study|Withdrawal by Subject|2|||
127899810|NCT00444145|460258418|FG000|Overall Study|Lost to Follow-up|1|||
127899811|NCT00444145|460258418|FG000|Overall Study|non-compliant|11|||
127899812|NCT00444145|460258418|FG000|Overall Study|Screen Failures|5|||
127899813|NCT01374919|460258419|FG000|Overall Study|Withdrawal by Subject|2|||
127899814|NCT01494506|460258420|FG000|Overall Study|Lack of Efficacy|77|||
127899815|NCT01494506|460258421|FG001|Overall Study|Lack of Efficacy|83|||
127899816|NCT01494506|460258422|FG002|Overall Study|Lack of Efficacy|57|||
127899817|NCT01494506|460258420|FG000|Overall Study|Adverse Event|17|||
127899818|NCT01494506|460258421|FG001|Overall Study|Adverse Event|10|||
127899819|NCT01494506|460258422|FG002|Overall Study|Adverse Event|11|||
127899820|NCT01494506|460258420|FG000|Overall Study|Death|9|||
127899821|NCT01494506|460258421|FG001|Overall Study|Death|5|||
127899822|NCT01494506|460258422|FG002|Overall Study|Death|2|||
127899823|NCT01494506|460258420|FG000|Overall Study|Physician Decision|7|||
127899824|NCT01494506|460258421|FG001|Overall Study|Physician Decision|5|||
127899825|NCT01494506|460258422|FG002|Overall Study|Physician Decision|4|||
127899826|NCT01494506|460258420|FG000|Overall Study|Withdrawal by Subject|17|||
127899827|NCT01494506|460258421|FG001|Overall Study|Withdrawal by Subject|20|||
127899828|NCT01494506|460258422|FG002|Overall Study|Withdrawal by Subject|14|||
127899829|NCT01494506|460258420|FG000|Overall Study|Clinical Deterioration|21|||
127899830|NCT01494506|460258421|FG001|Overall Study|Clinical Deterioration|17|||
127899831|NCT01494506|460258422|FG002|Overall Study|Clinical Deterioration|13|||
127899832|NCT01494506|460258420|FG000|Overall Study|Sponsor Decision|0|||
127899833|NCT01494506|460258421|FG001|Overall Study|Sponsor Decision|0|||
127899834|NCT01494506|460258422|FG002|Overall Study|Sponsor Decision|1|||
127899835|NCT01494506|460258420|FG000|Overall Study|Other|0|||
127899836|NCT01494506|460258421|FG001|Overall Study|Other|3|||
127899837|NCT01494506|460258422|FG002|Overall Study|Other|1|||
127899838|NCT02777528|460258428|FG000|Overall Study|Still in study|24|||
127899839|NCT02777528|460258429|FG001|Overall Study|Still in study|10|||
127899840|NCT02777528|460258430|FG002|Overall Study|Still in study|1|||
127899841|NCT02777528|460258428|FG000|Overall Study|Study Device Explanted|1|||
127899842|NCT02777528|460258429|FG001|Overall Study|Study Device Explanted|0|||
127899843|NCT02777528|460258430|FG002|Overall Study|Study Device Explanted|0|||
127899844|NCT02777528|460258428|FG000|Overall Study|Death|14|||
127899845|NCT02777528|460258429|FG001|Overall Study|Death|7|||
127899846|NCT02777528|460258430|FG002|Overall Study|Death|1|||
127899847|NCT02777528|460258428|FG000|Overall Study|Withdrawal by Subject|2|||
127899848|NCT02777528|460258429|FG001|Overall Study|Withdrawal by Subject|2|||
127899849|NCT02777528|460258430|FG002|Overall Study|Withdrawal by Subject|1|||
127899850|NCT02777528|460258428|FG000|Overall Study|Physician Decision|2|||
127899851|NCT02777528|460258429|FG001|Overall Study|Physician Decision|1|||
127899852|NCT02777528|460258430|FG002|Overall Study|Physician Decision|0|||
127899853|NCT02777528|460258428|FG000|Overall Study|Lost to Follow-up|2|||
127899854|NCT02777528|460258429|FG001|Overall Study|Lost to Follow-up|0|||
127899855|NCT02777528|460258430|FG002|Overall Study|Lost to Follow-up|0|||
127758005|NCT01302080|459740378|FG000|Overall Study|Reason Missing For Discontinuation|1|||
127758006|NCT01302080|459740379|FG001|Overall Study|Reason Missing For Discontinuation|0|||
127758007|NCT02040584|459740383|FG000|Overall Study|Adverse Event|13|||
127758008|NCT02040584|459740384|FG001|Overall Study|Adverse Event|6|||
127758009|NCT02040584|459740383|FG000|Overall Study|Protocol Violation|9|||
127758010|NCT02040584|459740384|FG001|Overall Study|Protocol Violation|11|||
127758011|NCT02040584|459740383|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
127758012|NCT02040584|459740384|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
127758013|NCT02040584|459740383|FG000|Overall Study|Death|6|||
127758014|NCT02040584|459740384|FG001|Overall Study|Death|3|||
127758015|NCT02040584|459740383|FG000|Overall Study|Transplant rejection/retransplant|0|||
127758016|NCT02040584|459740384|FG001|Overall Study|Transplant rejection/retransplant|1|||
127758017|NCT02040584|459740383|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
127758018|NCT02040584|459740384|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
127758019|NCT01802567|459740385|FG000|Overall Study|Withdrawal by Subject|2|||
127758020|NCT01802567|459740385|FG000|Overall Study|Physician Decision|1|||
127758021|NCT01802567|459740385|FG000|Overall Study|Lack of Efficacy|7|||
127758022|NCT01802567|459740385|FG000|Overall Study|Consented but did not start therapy|7|||
127758023|NCT01802567|459740385|FG000|Overall Study|Protocol Violation|1|||
127758024|NCT02591953|459740388|FG000|Overall Study|Lost to Follow-up|6|||
127758025|NCT02591953|459740389|FG001|Overall Study|Lost to Follow-up|6|||
127758026|NCT03167359|459740392|FG000|Overall Study|Physician Decision|1|||
127758027|NCT03167359|459740392|FG000|Overall Study|Lost to Follow-up|1|||
127758028|NCT01896557|459740393|FG000|Clopidogrel Alone|Adverse Event|1|||
127758029|NCT01896557|459740394|FG001|Clopidogrel Alone|Adverse Event|0|||
127758030|NCT01896557|459740393|FG000|Clopidogrel + GI Protector|low adherence|1|||
127758031|NCT01896557|459740394|FG001|Clopidogrel + GI Protector|low adherence|1|||
127758032|NCT01896557|459740393|FG000|Clopidogrel + GI Protector|Reading error|1|||
127758033|NCT01896557|459740394|FG001|Clopidogrel + GI Protector|Reading error|3|||
127758034|NCT01517295|459740395|FG000|Overall Study|Physician Decision|1|||
127758035|NCT01517295|459740396|FG001|Overall Study|Physician Decision|0|||
127758036|NCT02236988|459740397|FG000|Overall Study|Lost to Follow-up|0|||
127758037|NCT02236988|459740398|FG001|Overall Study|Lost to Follow-up|0|||
127758038|NCT02236988|459740399|FG002|Overall Study|Lost to Follow-up|0|||
127758039|NCT02236988|459740400|FG003|Overall Study|Lost to Follow-up|1|||
127758040|NCT02236988|459740397|FG000|Overall Study|Unable to Comply with Study Visits|0|||
127758041|NCT02236988|459740398|FG001|Overall Study|Unable to Comply with Study Visits|0|||
127758042|NCT02236988|459740399|FG002|Overall Study|Unable to Comply with Study Visits|0|||
127758043|NCT02236988|459740400|FG003|Overall Study|Unable to Comply with Study Visits|2|||
127758044|NCT04032613|459740401|FG000|Overall Study|Did not complete post-program assessment|5|||
127758045|NCT04032613|459740402|FG001|Overall Study|Did not complete post-program assessment|2|||
127758046|NCT01659853|459740403|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
127758047|NCT01659853|459740404|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
127758048|NCT01659853|459740403|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
127842428|NCT02591238|460040711|FG000|Overall Study|personal circumstances|0|||
127842429|NCT02591238|460040712|FG001|Overall Study|personal circumstances|1|||
127842430|NCT02591238|460040713|FG002|Overall Study|personal circumstances|0|||
127842431|NCT02591238|460040714|FG003|Overall Study|personal circumstances|0|||
127842432|NCT01293006|460040715|FG000|Period 2|Lost to Follow-up|1|||
127842433|NCT01293006|460040716|FG001|Period 2|Lost to Follow-up|0|||
127842434|NCT01293006|460040717|FG002|Period 2|Lost to Follow-up|0|||
127842435|NCT01293006|460040718|FG003|Period 2|Lost to Follow-up|0|||
127842436|NCT00436982|460040719|FG000|Overall Study|Withdrawal by Subject|3|||
127842437|NCT00436982|460040720|FG001|Overall Study|Withdrawal by Subject|1|||
127842438|NCT00436982|460040719|FG000|Overall Study|Did not receive allocated intervention|0|||
127842439|NCT00436982|460040720|FG001|Overall Study|Did not receive allocated intervention|1|||
127842440|NCT00436982|460040719|FG000|Overall Study|no RSA data|1|||
127842441|NCT00436982|460040720|FG001|Overall Study|no RSA data|2|||
127842442|NCT00953225|460040721|FG000|Overall Study|Withdrawal by Subject|2|||
127842443|NCT00953225|460040722|FG001|Overall Study|Withdrawal by Subject|0|||
127842444|NCT02215616|460040726|FG000|Overall Study|Sponsor requested to stop study drug|0|||
127842445|NCT02215616|460040727|FG001|Overall Study|Sponsor requested to stop study drug|0|||
127842446|NCT02215616|460040728|FG002|Overall Study|Sponsor requested to stop study drug|1|||
127842447|NCT02215616|460040729|FG003|Overall Study|Sponsor requested to stop study drug|4|||
127842448|NCT02215616|460040726|FG000|Overall Study|Death|1|||
127899856|NCT02777528|460258428|FG000|Overall Study|Discontinued due to Other|1|||
127758049|NCT01659853|459740404|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
127758050|NCT03053518|459740405|FG000|Overall Study|Withdrawal by Subject|3|||
127758051|NCT03053518|459740405|FG000|Overall Study|Lost to Follow-up|2|||
127758052|NCT03053518|459740405|FG000|Overall Study|Ineligible|5|||
127758053|NCT02071290|459740406|FG000|Overall Study|Death|1|||
127758054|NCT02071290|459740407|FG001|Overall Study|Death|0|||
127758055|NCT02071290|459740406|FG000|Overall Study|Withdrawal by Subject|0|||
127758056|NCT02071290|459740407|FG001|Overall Study|Withdrawal by Subject|1|||
127758057|NCT02071290|459740406|FG000|Overall Study|Protocol Violation|3|||
127758058|NCT02071290|459740407|FG001|Overall Study|Protocol Violation|5|||
127842449|NCT02215616|460040727|FG001|Overall Study|Death|0|||
127842450|NCT02215616|460040728|FG002|Overall Study|Death|0|||
127842451|NCT02215616|460040729|FG003|Overall Study|Death|0|||
127842452|NCT02215616|460040726|FG000|Overall Study|Adverse Event|7|||
127842453|NCT02215616|460040727|FG001|Overall Study|Adverse Event|4|||
127842454|NCT02215616|460040728|FG002|Overall Study|Adverse Event|9|||
127842455|NCT02215616|460040729|FG003|Overall Study|Adverse Event|2|||
127842456|NCT02215616|460040726|FG000|Overall Study|Withdrawal by Subject|1|||
127842457|NCT02215616|460040727|FG001|Overall Study|Withdrawal by Subject|8|||
127842458|NCT02215616|460040728|FG002|Overall Study|Withdrawal by Subject|2|||
127842459|NCT02215616|460040729|FG003|Overall Study|Withdrawal by Subject|5|||
127842460|NCT02215616|460040726|FG000|Overall Study|Non-compliance|0|||
127842461|NCT02215616|460040727|FG001|Overall Study|Non-compliance|2|||
127842462|NCT02215616|460040728|FG002|Overall Study|Non-compliance|1|||
127842463|NCT02215616|460040729|FG003|Overall Study|Non-compliance|0|||
127842464|NCT02215616|460040726|FG000|Overall Study|Protocol Violation|0|||
127842465|NCT02215616|460040727|FG001|Overall Study|Protocol Violation|2|||
127842466|NCT02215616|460040728|FG002|Overall Study|Protocol Violation|0|||
127842467|NCT02215616|460040729|FG003|Overall Study|Protocol Violation|0|||
127842468|NCT02215616|460040726|FG000|Overall Study|Lost to Follow-up|1|||
127842469|NCT02215616|460040727|FG001|Overall Study|Lost to Follow-up|1|||
127842470|NCT02215616|460040728|FG002|Overall Study|Lost to Follow-up|0|||
127842471|NCT02215616|460040729|FG003|Overall Study|Lost to Follow-up|1|||
127842472|NCT02215616|460040726|FG000|Overall Study|Other than specified|1|||
127842473|NCT02215616|460040727|FG001|Overall Study|Other than specified|0|||
127842474|NCT02215616|460040728|FG002|Overall Study|Other than specified|1|||
127842475|NCT02215616|460040729|FG003|Overall Study|Other than specified|1|||
127842476|NCT03728140|460040731|FG000|Overall Study|Abnormal embryo transfer operation|10|||
127842477|NCT03728140|460040732|FG001|Overall Study|Abnormal embryo transfer operation|7|||
127842478|NCT01381718|460040733|FG000|Overall Study|Withdrawal by Subject|2|||
127842479|NCT01381718|460040734|FG001|Overall Study|Withdrawal by Subject|5|||
127842480|NCT01381718|460040733|FG000|Overall Study|Lost to Follow-up|3|||
127842481|NCT01381718|460040734|FG001|Overall Study|Lost to Follow-up|5|||
127842482|NCT01381718|460040733|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
127842483|NCT01381718|460040734|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
127842484|NCT02759861|460040737|FG000|Overall Study|Death|1|||
127842485|NCT01504971|460040738|FG000|Overall Study|Physician Decision|13|||
127758059|NCT02071290|459740406|FG000|Overall Study|Physician Decision|0|||
127758060|NCT02071290|459740407|FG001|Overall Study|Physician Decision|1|||
127758061|NCT05560243|459740409|FG000|Overall Study|11 did not start the intervention, and 14 were lost to follow-up|25|||
127758062|NCT00939822|459740412|FG000|Overall Study|Lost to Follow-up|1|||
127758063|NCT00939822|459740413|FG001|Overall Study|Lost to Follow-up|0|||
127758064|NCT00939822|459740412|FG000|Overall Study|withdrew from study due to busy schedule|1|||
127758065|NCT00939822|459740413|FG001|Overall Study|withdrew from study due to busy schedule|1|||
127758066|NCT00939822|459740412|FG000|Overall Study|Mental health issues|0|||
127758067|NCT00939822|459740413|FG001|Overall Study|Mental health issues|2|||
127758068|NCT01072630|459740418|FG000|Overall Study|Adverse Event|11|||
127758069|NCT01072630|459740419|FG001|Overall Study|Adverse Event|19|||
127758070|NCT01072630|459740420|FG002|Overall Study|Adverse Event|2|||
127758071|NCT01072630|459740418|FG000|Overall Study|Lack of Efficacy|10|||
127758072|NCT01072630|459740419|FG001|Overall Study|Lack of Efficacy|10|||
127758073|NCT01072630|459740420|FG002|Overall Study|Lack of Efficacy|1|||
127758074|NCT01072630|459740418|FG000|Overall Study|Withdrawal by Subject|8|||
127758075|NCT01072630|459740419|FG001|Overall Study|Withdrawal by Subject|7|||
127758076|NCT01072630|459740420|FG002|Overall Study|Withdrawal by Subject|2|||
127758077|NCT01072630|459740418|FG000|Overall Study|Protocol Violation|10|||
127758078|NCT01072630|459740419|FG001|Overall Study|Protocol Violation|8|||
127758079|NCT01072630|459740420|FG002|Overall Study|Protocol Violation|4|||
127758080|NCT01072630|459740418|FG000|Overall Study|Lost to Follow-up|11|||
127758081|NCT01072630|459740419|FG001|Overall Study|Lost to Follow-up|11|||
127758082|NCT01072630|459740420|FG002|Overall Study|Lost to Follow-up|1|||
127758083|NCT01072630|459740418|FG000|Overall Study|Noncompliance with study medication|1|||
127758084|NCT01072630|459740419|FG001|Overall Study|Noncompliance with study medication|1|||
127758085|NCT01072630|459740420|FG002|Overall Study|Noncompliance with study medication|1|||
127758086|NCT01072630|459740418|FG000|Overall Study|Noncompliance with study procedures|1|||
127758087|NCT01072630|459740419|FG001|Overall Study|Noncompliance with study procedures|2|||
127758088|NCT01072630|459740420|FG002|Overall Study|Noncompliance with study procedures|1|||
127842486|NCT00936117|460040739|FG000|Overall Study|Adverse Event|7|||
127842487|NCT00936117|460040739|FG000|Overall Study|Unable to continue oral medication|3|||
127842488|NCT00225212|460040749|FG000|Overall Study|Disease progression|2|||
127842489|NCT00225212|460040749|FG000|Overall Study|Death|1|||
127842490|NCT00225212|460040749|FG000|Overall Study|Adverse Event|2|||
127842491|NCT00225212|460040749|FG000|Overall Study|Intercurrent illness|1|||
127842492|NCT01309841|460040752|FG000|Overall Study|Other|0|||
127842493|NCT01309841|460040753|FG001|Overall Study|Other|1|||
127758089|NCT01072630|459740418|FG000|Overall Study|Other|3|||
127758090|NCT01072630|459740419|FG001|Overall Study|Other|2|||
127899857|NCT02777528|460258429|FG001|Overall Study|Discontinued due to Other|0|||
127899858|NCT02777528|460258430|FG002|Overall Study|Discontinued due to Other|0|||
127899859|NCT03100903|460258431|FG000|Overall Study|Withdrawal by Subject|0|||
127899860|NCT03100903|460258432|FG001|Overall Study|Withdrawal by Subject|0|||
127899861|NCT03100903|460258433|FG002|Overall Study|Withdrawal by Subject|1|||
127899862|NCT00433147|460258434|FG000|Overall Study|Adverse Event|0|||
127899863|NCT00433147|460258435|FG001|Overall Study|Adverse Event|1|||
127899864|NCT00433147|460258436|FG002|Overall Study|Adverse Event|0|||
127899865|NCT00433147|460258437|FG003|Overall Study|Adverse Event|0|||
127899866|NCT01492361|460258440|FG000|Overall Study|Withdrawal by Subject|281|||
127899867|NCT01492361|460258441|FG001|Overall Study|Withdrawal by Subject|297|||
127899868|NCT01492361|460258440|FG000|Overall Study|Physician Decision|12|||
127899869|NCT01492361|460258441|FG001|Overall Study|Physician Decision|12|||
127899870|NCT01492361|460258440|FG000|Overall Study|Lost to Follow-up|6|||
127899871|NCT01492361|460258441|FG001|Overall Study|Lost to Follow-up|13|||
127899872|NCT01492361|460258440|FG000|Overall Study|Other than specified above|106|||
127899873|NCT01492361|460258441|FG001|Overall Study|Other than specified above|138|||
127899874|NCT03444038|460258442|FG000|Overall Study|Adverse Event|12|||
127899875|NCT03444038|460258442|FG000|Overall Study|Withdrawal by Subject|7|||
127899876|NCT03444038|460258442|FG000|Overall Study|Lost to Follow-up|1|||
127899877|NCT03444038|460258442|FG000|Overall Study|Physician Decision|2|||
127899878|NCT03444038|460258442|FG000|Overall Study|Lack of Efficacy|7|||
127899879|NCT00728949|460258443|FG000|Overall Study|Adverse Event|8|||
127899880|NCT00728949|460258444|FG001|Overall Study|Adverse Event|0|||
127899881|NCT00728949|460258443|FG000|Overall Study|Withdrawal by Subject|2|||
127899882|NCT00728949|460258444|FG001|Overall Study|Withdrawal by Subject|2|||
127899883|NCT00728949|460258443|FG000|Overall Study|Abnormal Lab Results|0|||
127899884|NCT00728949|460258444|FG001|Overall Study|Abnormal Lab Results|2|||
127899885|NCT00728949|460258443|FG000|Overall Study|On treatment at cutoff date|1|||
127899886|NCT00728949|460258444|FG001|Overall Study|On treatment at cutoff date|0|||
127899887|NCT00543309|460258446|FG000|Overall Study|Physician Decision|0|||
127899888|NCT00543309|460258447|FG001|Overall Study|Physician Decision|1|||
127899889|NCT00543309|460258448|FG002|Overall Study|Physician Decision|0|||
127899890|NCT01249664|460258449|FG000|Overall Study|Withdrawal by Subject|5|||
127899891|NCT01249664|460258450|FG001|Overall Study|Withdrawal by Subject|0|||
127899892|NCT01249664|460258449|FG000|Overall Study|Adverse Event|1|||
127899893|NCT01249664|460258450|FG001|Overall Study|Adverse Event|0|||
127899894|NCT02143102|460258453|FG000|Overall Study|Lost to Follow-up|11|||
127899895|NCT02143102|460258454|FG001|Overall Study|Lost to Follow-up|0|||
127899896|NCT03247556|460258459|FG000|Overall Study|Adverse Event|1|||
127899897|NCT03247556|460258460|FG001|Overall Study|Adverse Event|4|||
127899898|NCT03247556|460258461|FG002|Overall Study|Adverse Event|5|||
127899899|NCT03247556|460258459|FG000|Overall Study|Lost to Follow-up|5|||
127899900|NCT03247556|460258460|FG001|Overall Study|Lost to Follow-up|5|||
127899901|NCT03247556|460258461|FG002|Overall Study|Lost to Follow-up|4|||
127899902|NCT03247556|460258459|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
127899903|NCT03247556|460258460|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
127899904|NCT03247556|460258461|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
127899905|NCT03247556|460258459|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
127899906|NCT03247556|460258460|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
127899907|NCT03247556|460258461|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
127899908|NCT03247556|460258459|FG000|Overall Study|Protocol Violation|2|||
127899909|NCT03247556|460258460|FG001|Overall Study|Protocol Violation|0|||
127899910|NCT03247556|460258461|FG002|Overall Study|Protocol Violation|1|||
127899911|NCT03247556|460258459|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
127899912|NCT03247556|460258460|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
127899913|NCT03247556|460258461|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
127899914|NCT01203878|460258462|FG000|Overall Study|Withdrawal by Subject|0|||
127899915|NCT01203878|460258463|FG001|Overall Study|Withdrawal by Subject|0|||
127899916|NCT01203878|460258464|FG002|Overall Study|Withdrawal by Subject|1|||
127899917|NCT01203878|460258462|FG000|Overall Study|Adverse Event|0|||
127899918|NCT01203878|460258463|FG001|Overall Study|Adverse Event|0|||
127899919|NCT01203878|460258464|FG002|Overall Study|Adverse Event|2|||
127899920|NCT01682083|460258467|FG000|Overall Study|Lost to Follow-up|11|||
127899921|NCT01682083|460258468|FG001|Overall Study|Lost to Follow-up|18|||
127899922|NCT01682083|460258467|FG000|Overall Study|Withdrawal by Subject|31|||
127899923|NCT01682083|460258468|FG001|Overall Study|Withdrawal by Subject|40|||
127899924|NCT01682083|460258467|FG000|Overall Study|Death|60|||
127899925|NCT01682083|460258468|FG001|Overall Study|Death|93|||
127899926|NCT01682083|460258467|FG000|Overall Study|Physician Decision|5|||
127899927|NCT01682083|460258468|FG001|Overall Study|Physician Decision|4|||
127899928|NCT03952143|460258469|FG000|Lead-In Period|Adverse Event|2|||
127899929|NCT03952143|460258470|FG001|Lead-In Period|Adverse Event|0|||
127899930|NCT03952143|460258471|FG002|Lead-In Period|Adverse Event|0|||
127899931|NCT03952143|460258469|FG000|Lead-In Period|Lack of Efficacy|2|||
127899932|NCT03952143|460258470|FG001|Lead-In Period|Lack of Efficacy|0|||
127899933|NCT03952143|460258471|FG002|Lead-In Period|Lack of Efficacy|0|||
127758091|NCT01072630|459740420|FG002|Overall Study|Other|1|||
127899934|NCT03952143|460258469|FG000|Lead-In Period|Physician Decision|5|||
127899935|NCT03952143|460258470|FG001|Lead-In Period|Physician Decision|0|||
127899936|NCT03952143|460258471|FG002|Lead-In Period|Physician Decision|0|||
127899937|NCT03952143|460258469|FG000|Lead-In Period|Protocol Violation|5|||
127899938|NCT03952143|460258470|FG001|Lead-In Period|Protocol Violation|0|||
127899939|NCT03952143|460258471|FG002|Lead-In Period|Protocol Violation|0|||
127899940|NCT03952143|460258469|FG000|Lead-In Period|Withdrawal by Subject|19|||
127899941|NCT03952143|460258470|FG001|Lead-In Period|Withdrawal by Subject|0|||
127899942|NCT03952143|460258471|FG002|Lead-In Period|Withdrawal by Subject|0|||
127899943|NCT03952143|460258469|FG000|Treatment Period|Adverse Event|0|||
127899944|NCT03952143|460258470|FG001|Treatment Period|Adverse Event|0|||
127899945|NCT03952143|460258471|FG002|Treatment Period|Adverse Event|1|||
127899946|NCT03952143|460258469|FG000|Treatment Period|Lost to Follow-up|0|||
127899947|NCT03952143|460258470|FG001|Treatment Period|Lost to Follow-up|2|||
127899948|NCT03952143|460258471|FG002|Treatment Period|Lost to Follow-up|0|||
127899949|NCT03952143|460258469|FG000|Treatment Period|Physician Decision|0|||
127899950|NCT03952143|460258470|FG001|Treatment Period|Physician Decision|0|||
127899951|NCT03952143|460258471|FG002|Treatment Period|Physician Decision|2|||
127899952|NCT03952143|460258469|FG000|Treatment Period|Protocol Violation|0|||
127899953|NCT03952143|460258470|FG001|Treatment Period|Protocol Violation|0|||
127899954|NCT03952143|460258471|FG002|Treatment Period|Protocol Violation|1|||
127899955|NCT03952143|460258469|FG000|Treatment Period|Withdrawal by Subject|0|||
127899956|NCT03952143|460258470|FG001|Treatment Period|Withdrawal by Subject|5|||
127899957|NCT03952143|460258471|FG002|Treatment Period|Withdrawal by Subject|26|||
127899958|NCT03952143|460258469|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
127899959|NCT03952143|460258470|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
127899960|NCT03952143|460258471|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
127899961|NCT03952143|460258469|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
127899962|NCT03952143|460258470|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
127899963|NCT03952143|460258471|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
127899964|NCT01866319|460258472|FG000|Overall Study|Adverse Event|12|||
127899965|NCT01866319|460258473|FG001|Overall Study|Adverse Event|5|||
127899966|NCT01866319|460258474|FG002|Overall Study|Adverse Event|9|||
127899967|NCT01866319|460258472|FG000|Overall Study|Clinical progression|3|||
127899968|NCT01866319|460258473|FG001|Overall Study|Clinical progression|2|||
127899969|NCT01866319|460258474|FG002|Overall Study|Clinical progression|2|||
127899970|NCT01866319|460258472|FG000|Overall Study|Death|153|||
127899971|NCT01866319|460258473|FG001|Overall Study|Death|154|||
127899972|NCT01866319|460258474|FG002|Overall Study|Death|147|||
127899973|NCT01866319|460258472|FG000|Overall Study|Lost to Follow-up|6|||
127899974|NCT01866319|460258473|FG001|Overall Study|Lost to Follow-up|3|||
127899975|NCT01866319|460258474|FG002|Overall Study|Lost to Follow-up|8|||
127899976|NCT01866319|460258472|FG000|Overall Study|Physician Decision|1|||
127899977|NCT01866319|460258473|FG001|Overall Study|Physician Decision|0|||
127899978|NCT01866319|460258474|FG002|Overall Study|Physician Decision|1|||
127899979|NCT01866319|460258472|FG000|Overall Study|Protocol Violation|0|||
127899980|NCT01866319|460258473|FG001|Overall Study|Protocol Violation|0|||
127899981|NCT01866319|460258474|FG002|Overall Study|Protocol Violation|1|||
127899982|NCT01866319|460258472|FG000|Overall Study|Withdrawal by Subject|32|||
127899983|NCT01866319|460258473|FG001|Overall Study|Withdrawal by Subject|14|||
127899984|NCT01866319|460258474|FG002|Overall Study|Withdrawal by Subject|12|||
127899985|NCT03980483|460258479|FG000|Overall Study|Adverse Event|13|||
127899986|NCT03980483|460258480|FG001|Overall Study|Adverse Event|29|||
127899987|NCT03980483|460258481|FG002|Overall Study|Adverse Event|11|||
127899988|NCT03980483|460258482|FG003|Overall Study|Adverse Event|2|||
127899989|NCT03980483|460258483|FG004|Overall Study|Adverse Event|2|||
127899990|NCT03980483|460258484|FG005|Overall Study|Adverse Event|2|||
127899991|NCT03980483|460258479|FG000|Overall Study|Lack of Efficacy|7|||
127899992|NCT03980483|460258480|FG001|Overall Study|Lack of Efficacy|6|||
127758092|NCT01232738|459740421|FG000|Overall Study|Death|3|||
127758093|NCT01232738|459740421|FG000|Overall Study|Physician Decision|2|||
127758094|NCT01232738|459740421|FG000|Overall Study|Lost to Follow-up|1|||
127758095|NCT01232738|459740421|FG000|Overall Study|Withdrawal by Subject|2|||
127758096|NCT01232738|459740421|FG000|Overall Study|Adverse Event|5|||
127758097|NCT00910039|459740422|FG000|Overall Study|Physician Decision|1|||
127758098|NCT03547739|459740430|FG000|Overall Study|Death|0|||
127758099|NCT03547739|459740431|FG001|Overall Study|Death|1|||
127758100|NCT03547739|459740432|FG002|Overall Study|Death|5|||
127758101|NCT03547739|459740430|FG000|Overall Study|Adverse Event|24|||
127758102|NCT03547739|459740431|FG001|Overall Study|Adverse Event|11|||
127758103|NCT03547739|459740432|FG002|Overall Study|Adverse Event|13|||
127758104|NCT03547739|459740430|FG000|Overall Study|Partner discontinued due to the death of the female participant or adverse event|24|||
127758105|NCT03547739|459740431|FG001|Overall Study|Partner discontinued due to the death of the female participant or adverse event|12|||
127758106|NCT03547739|459740432|FG002|Overall Study|Partner discontinued due to the death of the female participant or adverse event|18|||
127758107|NCT03547739|459740430|FG000|Overall Study|Lost to Follow-up|80|||
127758108|NCT03547739|459740431|FG001|Overall Study|Lost to Follow-up|84|||
127899993|NCT03980483|460258481|FG002|Overall Study|Lack of Efficacy|0|||
127899994|NCT03980483|460258482|FG003|Overall Study|Lack of Efficacy|3|||
127899995|NCT03980483|460258483|FG004|Overall Study|Lack of Efficacy|1|||
127899996|NCT03980483|460258484|FG005|Overall Study|Lack of Efficacy|1|||
127899997|NCT03980483|460258479|FG000|Overall Study|Lost to Follow-up|2|||
127899998|NCT03980483|460258480|FG001|Overall Study|Lost to Follow-up|4|||
127899999|NCT03980483|460258481|FG002|Overall Study|Lost to Follow-up|2|||
127900000|NCT03980483|460258482|FG003|Overall Study|Lost to Follow-up|1|||
127900001|NCT03980483|460258483|FG004|Overall Study|Lost to Follow-up|2|||
127900002|NCT03980483|460258484|FG005|Overall Study|Lost to Follow-up|0|||
127900003|NCT03980483|460258479|FG000|Overall Study|Protocol Violation|4|||
127900004|NCT03980483|460258480|FG001|Overall Study|Protocol Violation|2|||
127900005|NCT03980483|460258481|FG002|Overall Study|Protocol Violation|1|||
127900006|NCT03980483|460258482|FG003|Overall Study|Protocol Violation|1|||
127900007|NCT03980483|460258483|FG004|Overall Study|Protocol Violation|0|||
127900008|NCT03980483|460258484|FG005|Overall Study|Protocol Violation|0|||
127900009|NCT03980483|460258479|FG000|Overall Study|Physician Decision|14|||
127900010|NCT03980483|460258480|FG001|Overall Study|Physician Decision|10|||
127900011|NCT03980483|460258481|FG002|Overall Study|Physician Decision|7|||
127900012|NCT03980483|460258482|FG003|Overall Study|Physician Decision|4|||
127900013|NCT03980483|460258483|FG004|Overall Study|Physician Decision|4|||
127900014|NCT03980483|460258484|FG005|Overall Study|Physician Decision|2|||
127900015|NCT03980483|460258479|FG000|Overall Study|Withdrawal by Subject|38|||
127900016|NCT03980483|460258480|FG001|Overall Study|Withdrawal by Subject|21|||
127900017|NCT03980483|460258481|FG002|Overall Study|Withdrawal by Subject|15|||
127900018|NCT03980483|460258482|FG003|Overall Study|Withdrawal by Subject|5|||
127900019|NCT03980483|460258483|FG004|Overall Study|Withdrawal by Subject|3|||
127900020|NCT03980483|460258484|FG005|Overall Study|Withdrawal by Subject|4|||
127900021|NCT03980483|460258479|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
127900022|NCT03980483|460258480|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
127900023|NCT03980483|460258481|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
127900024|NCT03980483|460258482|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
127900025|NCT03980483|460258483|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
127900026|NCT03980483|460258484|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
127900027|NCT03980483|460258479|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
127900028|NCT03980483|460258480|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
127900029|NCT03980483|460258481|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
127900030|NCT03980483|460258482|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
127900031|NCT03980483|460258483|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
127900032|NCT03980483|460258484|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
127900033|NCT03980483|460258479|FG000|Overall Study|Other|0|||
127900034|NCT03980483|460258480|FG001|Overall Study|Other|1|||
127900035|NCT03980483|460258481|FG002|Overall Study|Other|0|||
127758109|NCT03547739|459740432|FG002|Overall Study|Lost to Follow-up|116|||
127758110|NCT04035499|459740435|FG000|Overall Study|Death|2|||
127758111|NCT04035499|459740435|FG000|Overall Study|Withdrawal by Subject|1|||
127758112|NCT02530970|459740436|FG000|Overall Study|Adverse Event|8|||
127758113|NCT02530970|459740436|FG000|Overall Study|Lost to Follow-up|88|||
127758114|NCT02530970|459740436|FG000|Overall Study|Physician Decision|5|||
127758115|NCT02530970|459740436|FG000|Overall Study|Withdrawal by Subject|14|||
127758116|NCT02530970|459740436|FG000|Overall Study|Death|6|||
127758117|NCT02530970|459740436|FG000|Overall Study|Hospitalization|1|||
127758118|NCT02530970|459740436|FG000|Overall Study|Insurance|2|||
127758119|NCT02530970|459740436|FG000|Overall Study|Explant|2|||
127758120|NCT02530970|459740436|FG000|Overall Study|Change in Provider|5|||
127758121|NCT02530970|459740436|FG000|Overall Study|Relocation|3|||
127758122|NCT02770612|459740438|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
127758123|NCT02003222|459740439|FG000|Induction|Never started treatment|0|||
127758124|NCT02003222|459740440|FG001|Induction|Never started treatment|0|||
127758125|NCT02003222|459740441|FG002|Induction|Never started treatment|0|||
127758126|NCT02003222|459740442|FG003|Induction|Never started treatment|0|||
127758127|NCT02003222|459740443|FG004|Induction|Never started treatment|8|||
127758128|NCT02003222|459740439|FG000|Induction|Complete remission or complete remission incomplete not achieved|0|||
127758129|NCT02003222|459740440|FG001|Induction|Complete remission or complete remission incomplete not achieved|0|||
127758130|NCT02003222|459740441|FG002|Induction|Complete remission or complete remission incomplete not achieved|0|||
127758131|NCT02003222|459740442|FG003|Induction|Complete remission or complete remission incomplete not achieved|0|||
127758132|NCT02003222|459740443|FG004|Induction|Complete remission or complete remission incomplete not achieved|67|||
127900036|NCT03980483|460258482|FG003|Overall Study|Other|0|||
127900037|NCT03980483|460258483|FG004|Overall Study|Other|0|||
127900038|NCT03980483|460258484|FG005|Overall Study|Other|0|||
127900039|NCT00760266|460258487|FG000|Overall Study|Adverse Event|13|||
127900040|NCT00760266|460258488|FG001|Overall Study|Adverse Event|7|||
127900041|NCT00760266|460258487|FG000|Overall Study|Abnormal laboratory value(s)|1|||
127758133|NCT02003222|459740439|FG000|Induction|Adverse Event|0|||
127758134|NCT02003222|459740440|FG001|Induction|Adverse Event|0|||
127758135|NCT02003222|459740441|FG002|Induction|Adverse Event|0|||
127758136|NCT02003222|459740442|FG003|Induction|Adverse Event|0|||
127900042|NCT00760266|460258488|FG001|Overall Study|Abnormal laboratory value(s)|0|||
127900043|NCT00760266|460258487|FG000|Overall Study|Abnormal test procedure result(s)|1|||
127900044|NCT00760266|460258488|FG001|Overall Study|Abnormal test procedure result(s)|0|||
127900045|NCT00760266|460258487|FG000|Overall Study|Lack of Efficacy|2|||
127900046|NCT00760266|460258488|FG001|Overall Study|Lack of Efficacy|2|||
127900047|NCT00760266|460258487|FG000|Overall Study|Protocol deviation|2|||
127900048|NCT00760266|460258488|FG001|Overall Study|Protocol deviation|4|||
127758137|NCT02003222|459740443|FG004|Induction|Adverse Event|13|||
127758138|NCT02003222|459740439|FG000|Induction|Alternative therapy|0|||
127900049|NCT00760266|460258487|FG000|Overall Study|Patient withdrew consent|3|||
127900050|NCT00760266|460258488|FG001|Overall Study|Patient withdrew consent|3|||
127900051|NCT00760266|460258487|FG000|Overall Study|Lost to Follow-up|2|||
127900052|NCT00760266|460258488|FG001|Overall Study|Lost to Follow-up|1|||
127900053|NCT00760266|460258487|FG000|Overall Study|Administrative Problems|0|||
127900054|NCT00760266|460258488|FG001|Overall Study|Administrative Problems|1|||
127900055|NCT00220337|460258491|FG000|Overall Study|Adverse Event|70|||
127900056|NCT00220337|460258491|FG000|Overall Study|Lack of Efficacy|17|||
127900057|NCT00220337|460258491|FG000|Overall Study|Withdrawal by Subject|68|||
127900058|NCT00220337|460258491|FG000|Overall Study|Protocol Violation|2|||
127900059|NCT00220337|460258491|FG000|Overall Study|Lost to Follow-up|5|||
127900060|NCT00220337|460258491|FG000|Overall Study|Other|12|||
127900061|NCT00220337|460258491|FG000|Overall Study|Unsatisfactory compliance|5|||
127900062|NCT00659607|460258494|FG000|Overall Study|No blood pressure recorded|147|||
127900063|NCT00659607|460258494|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
127900064|NCT00659607|460258494|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
127900065|NCT00659607|460258494|FG000|Overall Study|No recorded efficacy data|15|||
127900066|NCT00659607|460258494|FG000|Overall Study|Inconsistent BP measuring date|2|||
127900067|NCT02191891|460258495|FG000|Overall Study|Withdrawal by Subject|0|||
127900068|NCT02191891|460258496|FG001|Overall Study|Withdrawal by Subject|1|||
127900069|NCT02191891|460258497|FG002|Overall Study|Withdrawal by Subject|0|||
127900070|NCT02191891|460258498|FG003|Overall Study|Withdrawal by Subject|0|||
127900071|NCT02191891|460258499|FG004|Overall Study|Withdrawal by Subject|1|||
127900072|NCT02191891|460258495|FG000|Overall Study|Adverse Event|0|||
127900073|NCT02191891|460258496|FG001|Overall Study|Adverse Event|1|||
127900074|NCT02191891|460258497|FG002|Overall Study|Adverse Event|0|||
127900075|NCT02191891|460258498|FG003|Overall Study|Adverse Event|0|||
127900076|NCT02191891|460258499|FG004|Overall Study|Adverse Event|2|||
127900077|NCT02191891|460258495|FG000|Overall Study|Disease Progression|4|||
127900078|NCT02191891|460258496|FG001|Overall Study|Disease Progression|10|||
127900079|NCT02191891|460258497|FG002|Overall Study|Disease Progression|4|||
127900080|NCT02191891|460258498|FG003|Overall Study|Disease Progression|2|||
127900081|NCT02191891|460258499|FG004|Overall Study|Disease Progression|7|||
127900082|NCT00486837|460258500|FG000|Overall Study|Withdrawal by Subject|1|||
127900083|NCT00486837|460258501|FG001|Overall Study|Withdrawal by Subject|0|||
127900084|NCT00486837|460258500|FG000|Overall Study|Adverse Event|1|||
127900085|NCT00486837|460258501|FG001|Overall Study|Adverse Event|1|||
127900086|NCT00486837|460258500|FG000|Overall Study|Protocol Violation|4|||
127900087|NCT00486837|460258501|FG001|Overall Study|Protocol Violation|2|||
127900088|NCT00486837|460258500|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
127900089|NCT00486837|460258501|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
127900090|NCT02468778|460258504|FG000|Overall Study|Death|2|||
127758139|NCT02003222|459740440|FG001|Induction|Alternative therapy|0|||
127758140|NCT02003222|459740441|FG002|Induction|Alternative therapy|0|||
127758141|NCT02003222|459740442|FG003|Induction|Alternative therapy|0|||
127758142|NCT02003222|459740443|FG004|Induction|Alternative therapy|12|||
127758143|NCT02003222|459740439|FG000|Induction|Disease progression|0|||
127758144|NCT02003222|459740440|FG001|Induction|Disease progression|0|||
127900091|NCT02468778|460258505|FG001|Overall Study|Death|1|||
127900092|NCT02468778|460258506|FG002|Overall Study|Death|0|||
127900093|NCT02468778|460258504|FG000|Overall Study|Lost to Follow-up|1|||
127900094|NCT02468778|460258505|FG001|Overall Study|Lost to Follow-up|2|||
127900095|NCT02468778|460258506|FG002|Overall Study|Lost to Follow-up|2|||
127900096|NCT02468778|460258504|FG000|Overall Study|Withdrawal by Subject|0|||
127900097|NCT02468778|460258505|FG001|Overall Study|Withdrawal by Subject|1|||
127900098|NCT02468778|460258506|FG002|Overall Study|Withdrawal by Subject|1|||
127900099|NCT03130699|460258514|FG000|Overall Study|Lost to Follow-up|34|||
127900100|NCT03130699|460258515|FG001|Overall Study|Lost to Follow-up|37|||
127900101|NCT03130699|460258516|FG002|Overall Study|Lost to Follow-up|26|||
127900102|NCT03130699|460258514|FG000|Overall Study|Withdrawal by Subject|5|||
127900103|NCT03130699|460258515|FG001|Overall Study|Withdrawal by Subject|1|||
127900104|NCT03130699|460258516|FG002|Overall Study|Withdrawal by Subject|0|||
127758145|NCT02003222|459740441|FG002|Induction|Disease progression|0|||
127758146|NCT02003222|459740442|FG003|Induction|Disease progression|0|||
127758147|NCT02003222|459740443|FG004|Induction|Disease progression|22|||
127758148|NCT02003222|459740439|FG000|Induction|Death|0|||
127758149|NCT02003222|459740440|FG001|Induction|Death|0|||
127758150|NCT02003222|459740441|FG002|Induction|Death|0|||
127758151|NCT02003222|459740442|FG003|Induction|Death|0|||
127758152|NCT02003222|459740443|FG004|Induction|Death|3|||
127758153|NCT02003222|459740439|FG000|Induction|Withdrawal by Subject|0|||
127758154|NCT02003222|459740440|FG001|Induction|Withdrawal by Subject|0|||
127758155|NCT02003222|459740441|FG002|Induction|Withdrawal by Subject|0|||
127758156|NCT02003222|459740442|FG003|Induction|Withdrawal by Subject|0|||
127900105|NCT03130699|460258514|FG000|Overall Study|Withdrawal by PI|1|||
127900106|NCT03130699|460258515|FG001|Overall Study|Withdrawal by PI|2|||
127900107|NCT03130699|460258516|FG002|Overall Study|Withdrawal by PI|5|||
127900108|NCT03130699|460258514|FG000|Overall Study|Death|0|||
127900109|NCT03130699|460258515|FG001|Overall Study|Death|0|||
127900110|NCT03130699|460258516|FG002|Overall Study|Death|1|||
127900111|NCT01199861|460258517|FG000|Overall Study|Administrative problems|1|||
127900112|NCT01199861|460258518|FG001|Overall Study|Administrative problems|0|||
127900113|NCT01199861|460258517|FG000|Overall Study|Adverse Event|1|||
127900114|NCT01199861|460258518|FG001|Overall Study|Adverse Event|0|||
127900115|NCT00669864|460258519|FG000|Overall Study|Lost to Follow-up|2|||
127900116|NCT00669864|460258519|FG000|Overall Study|Protocol Violation|2|||
127900117|NCT00669864|460258519|FG000|Overall Study|Withdrawal by Subject|3|||
127900118|NCT00669864|460258519|FG000|Overall Study|Other|2|||
127900119|NCT02545998|460258524|FG000|Overall Study|Lost to Follow-up|12|||
127900120|NCT02545998|460258525|FG001|Overall Study|Lost to Follow-up|3|||
127900121|NCT02545998|460258524|FG000|Overall Study|Withdrawal by Subject|3|||
127900122|NCT02545998|460258525|FG001|Overall Study|Withdrawal by Subject|2|||
127900123|NCT01054599|460258534|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
127900124|NCT01054599|460258535|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
127900125|NCT01054599|460258534|FG000|Overall Study|Protocol Violation|1|||
127900126|NCT01054599|460258535|FG001|Overall Study|Protocol Violation|0|||
127900127|NCT01054599|460258534|FG000|Overall Study|Spells/seizure-like episodes|1|||
127900128|NCT01054599|460258535|FG001|Overall Study|Spells/seizure-like episodes|1|||
127900129|NCT01054599|460258534|FG000|Overall Study|Timing/scheduling difficulties|1|||
127900130|NCT01054599|460258535|FG001|Overall Study|Timing/scheduling difficulties|1|||
127900131|NCT01054599|460258534|FG000|Overall Study|Visual impairment, WTAR <80|0|||
127900132|NCT01054599|460258535|FG001|Overall Study|Visual impairment, WTAR <80|1|||
127900133|NCT01054599|460258534|FG000|Overall Study|Lost to Follow-up|0|||
127900134|NCT01054599|460258535|FG001|Overall Study|Lost to Follow-up|2|||
127900135|NCT01054599|460258534|FG000|Overall Study|Adverse Event|0|||
127900136|NCT01054599|460258535|FG001|Overall Study|Adverse Event|1|||
127900137|NCT01054599|460258534|FG000|Overall Study|Withdrawal by Subject|0|||
127900138|NCT01054599|460258535|FG001|Overall Study|Withdrawal by Subject|1|||
127900139|NCT01478620|460258536|FG000|Overall Study|Lost to Follow-up|6|||
127900140|NCT04025879|460258539|FG000|Randomization|Participant withdrew consent|0|||
127900141|NCT04025879|460258540|FG001|Randomization|Participant withdrew consent|1|||
127900142|NCT04025879|460258539|FG000|Randomization|Participant no longer met study criteria|1|||
127900143|NCT04025879|460258540|FG001|Randomization|Participant no longer met study criteria|1|||
127900144|NCT04025879|460258539|FG000|Treatment|Ongoing treatment|10|||
127900145|NCT04025879|460258540|FG001|Treatment|Ongoing treatment|8|||
127900146|NCT04025879|460258539|FG000|Treatment|Disease progression/recurrence|36|||
127900147|NCT04025879|460258540|FG001|Treatment|Disease progression/recurrence|72|||
127900148|NCT04025879|460258539|FG000|Treatment|Study drug toxicity|36|||
127900149|NCT04025879|460258540|FG001|Treatment|Study drug toxicity|13|||
127900150|NCT04025879|460258539|FG000|Treatment|Death|2|||
127900151|NCT04025879|460258540|FG001|Treatment|Death|0|||
127900152|NCT04025879|460258539|FG000|Treatment|Adverse event unrelated to study drug|21|||
127900153|NCT04025879|460258540|FG001|Treatment|Adverse event unrelated to study drug|14|||
127900154|NCT04025879|460258539|FG000|Treatment|Participant request to discontinue study treatment|16|||
127900155|NCT04025879|460258540|FG001|Treatment|Participant request to discontinue study treatment|8|||
127900156|NCT04025879|460258539|FG000|Treatment|Participant withdrew consent|1|||
127900157|NCT04025879|460258540|FG001|Treatment|Participant withdrew consent|3|||
127900158|NCT04025879|460258539|FG000|Treatment|Participant no longer meets study criteria|3|||
127900159|NCT04025879|460258540|FG001|Treatment|Participant no longer meets study criteria|2|||
127900160|NCT04025879|460258539|FG000|Treatment|Lost to Follow-up|1|||
127900161|NCT04025879|460258540|FG001|Treatment|Lost to Follow-up|0|||
127900162|NCT04025879|460258539|FG000|Treatment|Other reasons|15|||
127900163|NCT04025879|460258540|FG001|Treatment|Other reasons|17|||
127900164|NCT04025879|460258539|FG000|Treatment|Administrative reason by sponsor|0|||
127900165|NCT04025879|460258540|FG001|Treatment|Administrative reason by sponsor|1|||
127900166|NCT04025879|460258539|FG000|Treatment|Not reported|2|||
127900167|NCT04025879|460258540|FG001|Treatment|Not reported|0|||
127900168|NCT02888171|460258543|FG000|Overall Study|Lost to Follow-up|2|||
127758157|NCT02003222|459740443|FG004|Induction|Withdrawal by Subject|8|||
127758158|NCT02003222|459740439|FG000|Induction|Other reasons|0|||
127758159|NCT02003222|459740440|FG001|Induction|Other reasons|0|||
127758160|NCT02003222|459740441|FG002|Induction|Other reasons|0|||
127758161|NCT02003222|459740442|FG003|Induction|Other reasons|0|||
127900169|NCT02888171|460258544|FG001|Overall Study|Lost to Follow-up|1|||
127758162|NCT02003222|459740443|FG004|Induction|Other reasons|22|||
127758163|NCT02003222|459740439|FG000|Intensification|Never started treatment|0|||
127758164|NCT02003222|459740440|FG001|Intensification|Never started treatment|0|||
127758165|NCT02003222|459740441|FG002|Intensification|Never started treatment|0|||
127758166|NCT02003222|459740442|FG003|Intensification|Never started treatment|0|||
127758167|NCT02003222|459740443|FG004|Intensification|Never started treatment|2|||
127758168|NCT02003222|459740439|FG000|Intensification|Adverse Event|0|||
127758169|NCT02003222|459740440|FG001|Intensification|Adverse Event|0|||
127758170|NCT02003222|459740441|FG002|Intensification|Adverse Event|0|||
127758171|NCT02003222|459740442|FG003|Intensification|Adverse Event|0|||
127758172|NCT02003222|459740443|FG004|Intensification|Adverse Event|6|||
127758173|NCT02003222|459740439|FG000|Intensification|Alternative therapy|0|||
127758174|NCT02003222|459740440|FG001|Intensification|Alternative therapy|0|||
127758175|NCT02003222|459740441|FG002|Intensification|Alternative therapy|0|||
127758176|NCT02003222|459740442|FG003|Intensification|Alternative therapy|0|||
127758177|NCT02003222|459740443|FG004|Intensification|Alternative therapy|8|||
127758178|NCT02003222|459740439|FG000|Intensification|Disease progression|0|||
127758179|NCT02003222|459740440|FG001|Intensification|Disease progression|0|||
127758180|NCT02003222|459740441|FG002|Intensification|Disease progression|0|||
127758181|NCT02003222|459740442|FG003|Intensification|Disease progression|0|||
127758182|NCT02003222|459740443|FG004|Intensification|Disease progression|18|||
127758183|NCT02003222|459740439|FG000|Intensification|Withdrawal by Subject|0|||
127758184|NCT02003222|459740440|FG001|Intensification|Withdrawal by Subject|0|||
127758185|NCT02003222|459740441|FG002|Intensification|Withdrawal by Subject|0|||
127758186|NCT02003222|459740442|FG003|Intensification|Withdrawal by Subject|0|||
127758187|NCT02003222|459740443|FG004|Intensification|Withdrawal by Subject|5|||
127758188|NCT02003222|459740439|FG000|Intensification|Other reasons|0|||
127758189|NCT02003222|459740440|FG001|Intensification|Other reasons|0|||
127758190|NCT02003222|459740441|FG002|Intensification|Other reasons|0|||
127758191|NCT02003222|459740442|FG003|Intensification|Other reasons|0|||
127758192|NCT02003222|459740443|FG004|Intensification|Other reasons|8|||
127758193|NCT01365481|459740444|FG000|Overall Study|Adverse Event|6|||
127758194|NCT01365481|459740445|FG001|Overall Study|Adverse Event|9|||
127758195|NCT01365481|459740446|FG002|Overall Study|Adverse Event|0|||
127758196|NCT01365481|459740447|FG003|Overall Study|Adverse Event|2|||
127758197|NCT01365481|459740444|FG000|Overall Study|Withdrawal by Subject|0|||
127758198|NCT01365481|459740445|FG001|Overall Study|Withdrawal by Subject|2|||
127758199|NCT01365481|459740446|FG002|Overall Study|Withdrawal by Subject|1|||
127758200|NCT01365481|459740447|FG003|Overall Study|Withdrawal by Subject|1|||
127758201|NCT01365481|459740444|FG000|Overall Study|Lost to Follow-up|1|||
127758202|NCT01365481|459740445|FG001|Overall Study|Lost to Follow-up|1|||
127758203|NCT01365481|459740446|FG002|Overall Study|Lost to Follow-up|2|||
127758204|NCT01365481|459740447|FG003|Overall Study|Lost to Follow-up|3|||
127758205|NCT01365481|459740444|FG000|Overall Study|Abnormal laboratory value(s)|0|||
127758206|NCT01365481|459740445|FG001|Overall Study|Abnormal laboratory value(s)|1|||
127758207|NCT01365481|459740446|FG002|Overall Study|Abnormal laboratory value(s)|0|||
127758208|NCT01365481|459740447|FG003|Overall Study|Abnormal laboratory value(s)|0|||
127758209|NCT01365481|459740444|FG000|Overall Study|Administrative problems|0|||
127758210|NCT01365481|459740445|FG001|Overall Study|Administrative problems|1|||
127758211|NCT01365481|459740446|FG002|Overall Study|Administrative problems|0|||
127758212|NCT01365481|459740447|FG003|Overall Study|Administrative problems|0|||
127758213|NCT01365481|459740444|FG000|Overall Study|Protocol deviation|0|||
127758214|NCT01365481|459740445|FG001|Overall Study|Protocol deviation|1|||
127758215|NCT01365481|459740446|FG002|Overall Study|Protocol deviation|0|||
127758216|NCT01365481|459740447|FG003|Overall Study|Protocol deviation|1|||
127758217|NCT01365481|459740444|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
127758218|NCT01365481|459740445|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
127758219|NCT01365481|459740446|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
127758220|NCT01365481|459740447|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
127758221|NCT00958841|459740452|FG000|Overall Study|Abnormal laboratory value(s)|1|||
127758222|NCT00958841|459740452|FG000|Overall Study|Abnormal test procedure result(s)|3|||
127758223|NCT00958841|459740452|FG000|Overall Study|Administrative problems|1|||
127758224|NCT00958841|459740452|FG000|Overall Study|Adverse Event|8|||
127758225|NCT00958841|459740452|FG000|Overall Study|New cancer therapy|5|||
127758226|NCT00958841|459740452|FG000|Overall Study|Withdrawal by Subject|1|||
127758227|NCT00958841|459740452|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
127758228|NCT00958841|459740452|FG000|Overall Study|Completed M6/did not enter extension|27|||
127758229|NCT00958841|459740452|FG000|Overall Study|Discontinued prior to M*|28|||
127758230|NCT03014011|459740456|FG000|First Intervention|Withdrawal by Subject|1|||
127758231|NCT03014011|459740457|FG001|First Intervention|Withdrawal by Subject|0|||
127758232|NCT03014011|459740456|FG000|Washout|Withdrawal by Subject|1|||
127758233|NCT03014011|459740457|FG001|Washout|Withdrawal by Subject|0|||
127758234|NCT02416453|459740458|FG000|Overall Study|Adverse Event|0|||
127758235|NCT02416453|459740459|FG001|Overall Study|Adverse Event|0|||
127758236|NCT02416453|459740460|FG002|Overall Study|Adverse Event|0|||
127758237|NCT02416453|459740461|FG003|Overall Study|Adverse Event|2|||
127758238|NCT02416453|459740462|FG004|Overall Study|Adverse Event|0|||
127758239|NCT02416453|459740463|FG005|Overall Study|Adverse Event|1|||
127758240|NCT02416453|459740464|FG006|Overall Study|Adverse Event|0|||
127758241|NCT02416453|459740465|FG007|Overall Study|Adverse Event|0|||
127758242|NCT02416453|459740466|FG008|Overall Study|Adverse Event|0|||
127758243|NCT02416453|459740467|FG009|Overall Study|Adverse Event|0|||
127758244|NCT02416453|459740468|FG010|Overall Study|Adverse Event|0|||
127758245|NCT02416453|459740458|FG000|Overall Study|Lost to Follow-up|1|||
127758246|NCT02416453|459740459|FG001|Overall Study|Lost to Follow-up|3|||
127758247|NCT02416453|459740460|FG002|Overall Study|Lost to Follow-up|0|||
127758248|NCT02416453|459740461|FG003|Overall Study|Lost to Follow-up|8|||
127758249|NCT02416453|459740462|FG004|Overall Study|Lost to Follow-up|0|||
127758250|NCT02416453|459740463|FG005|Overall Study|Lost to Follow-up|5|||
127758251|NCT02416453|459740464|FG006|Overall Study|Lost to Follow-up|1|||
127758252|NCT02416453|459740465|FG007|Overall Study|Lost to Follow-up|3|||
127758253|NCT02416453|459740466|FG008|Overall Study|Lost to Follow-up|1|||
127758254|NCT02416453|459740467|FG009|Overall Study|Lost to Follow-up|0|||
127758255|NCT02416453|459740468|FG010|Overall Study|Lost to Follow-up|0|||
127758256|NCT02416453|459740458|FG000|Overall Study|Physician Decision|0|||
127758257|NCT02416453|459740459|FG001|Overall Study|Physician Decision|0|||
127758258|NCT02416453|459740460|FG002|Overall Study|Physician Decision|0|||
127758259|NCT02416453|459740461|FG003|Overall Study|Physician Decision|0|||
127758260|NCT02416453|459740462|FG004|Overall Study|Physician Decision|0|||
127758261|NCT02416453|459740463|FG005|Overall Study|Physician Decision|1|||
127758262|NCT02416453|459740464|FG006|Overall Study|Physician Decision|1|||
127758263|NCT02416453|459740465|FG007|Overall Study|Physician Decision|1|||
127758264|NCT02416453|459740466|FG008|Overall Study|Physician Decision|0|||
127758265|NCT02416453|459740467|FG009|Overall Study|Physician Decision|0|||
127758266|NCT02416453|459740468|FG010|Overall Study|Physician Decision|0|||
127758267|NCT02416453|459740458|FG000|Overall Study|Withdrawal by Subject|2|||
127842494|NCT01309841|460040754|FG002|Overall Study|Other|1|||
127842495|NCT01309841|460040752|FG000|Overall Study|Lost to Follow-up|7|||
127842496|NCT01309841|460040753|FG001|Overall Study|Lost to Follow-up|6|||
127842497|NCT01309841|460040754|FG002|Overall Study|Lost to Follow-up|4|||
127842498|NCT01309841|460040752|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
127842499|NCT01309841|460040753|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
127842500|NCT01309841|460040754|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
127842501|NCT01309841|460040752|FG000|Overall Study|Lack of Efficacy|0|||
127842502|NCT01309841|460040753|FG001|Overall Study|Lack of Efficacy|0|||
127842503|NCT01309841|460040754|FG002|Overall Study|Lack of Efficacy|2|||
127842504|NCT01309841|460040752|FG000|Overall Study|Adverse Event|9|||
127842505|NCT01309841|460040753|FG001|Overall Study|Adverse Event|22|||
127842506|NCT01309841|460040754|FG002|Overall Study|Adverse Event|11|||
127842507|NCT01309841|460040752|FG000|Overall Study|Death|1|||
127842508|NCT01309841|460040753|FG001|Overall Study|Death|0|||
127842509|NCT01309841|460040754|FG002|Overall Study|Death|0|||
127842510|NCT01309841|460040752|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
127842511|NCT01309841|460040753|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
127842512|NCT01309841|460040754|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
127842513|NCT01309841|460040752|FG000|Overall Study|Withdrawal by Subject|17|||
127842514|NCT01309841|460040753|FG001|Overall Study|Withdrawal by Subject|6|||
127842515|NCT01309841|460040754|FG002|Overall Study|Withdrawal by Subject|13|||
127842516|NCT01309841|460040752|FG000|Overall Study|Did Not Receive Treatment|2|||
127842517|NCT01309841|460040753|FG001|Overall Study|Did Not Receive Treatment|0|||
127842518|NCT01309841|460040754|FG002|Overall Study|Did Not Receive Treatment|1|||
127842519|NCT01309841|460040752|FG000|Overall Study|Severe non-compliance with protocol|0|||
127842520|NCT01309841|460040753|FG001|Overall Study|Severe non-compliance with protocol|5|||
127842521|NCT01309841|460040754|FG002|Overall Study|Severe non-compliance with protocol|2|||
127842522|NCT03699631|460040755|FG000|Overall Study|Adverse Event|3|||
127842523|NCT01324622|460040756|FG000|Overall Study|Lost to Follow-up|7|||
127842524|NCT01324622|460040757|FG001|Overall Study|Lost to Follow-up|7|||
127842525|NCT01324622|460040756|FG000|Overall Study|Death|1|||
127842526|NCT01324622|460040757|FG001|Overall Study|Death|0|||
127842527|NCT01324622|460040756|FG000|Overall Study|Lack of Efficacy|1|||
127842528|NCT01324622|460040757|FG001|Overall Study|Lack of Efficacy|0|||
127842529|NCT00138424|460040758|FG000|Overall Study|Physician Decision|0|||
127842530|NCT00138424|460040759|FG001|Overall Study|Physician Decision|1|||
127842531|NCT00138424|460040760|FG002|Overall Study|Physician Decision|0|||
127842532|NCT00138424|460040761|FG003|Overall Study|Physician Decision|0|||
127842533|NCT04311177|460040762|FG000|Overall Study|Adverse Event|3|||
127842534|NCT04311177|460040763|FG001|Overall Study|Adverse Event|1|||
127842535|NCT04311177|460040762|FG000|Overall Study|Physician Decision|4|||
127842536|NCT04311177|460040763|FG001|Overall Study|Physician Decision|3|||
127842537|NCT04311177|460040762|FG000|Overall Study|Withdrawal by Subject|1|||
127842538|NCT04311177|460040763|FG001|Overall Study|Withdrawal by Subject|0|||
127842539|NCT00413062|460040766|FG000|Overall Study|Adverse event/serious adverse event|289|||
127842540|NCT00413062|460040767|FG001|Overall Study|Adverse event/serious adverse event|56|||
127758268|NCT02416453|459740459|FG001|Overall Study|Withdrawal by Subject|0|||
127758269|NCT02416453|459740460|FG002|Overall Study|Withdrawal by Subject|0|||
127900170|NCT02888171|460258543|FG000|Overall Study|Withdrawal by Subject|3|||
127900171|NCT02888171|460258544|FG001|Overall Study|Withdrawal by Subject|2|||
127900172|NCT02888171|460258543|FG000|Overall Study|Adverse Event|0|||
127900173|NCT02888171|460258544|FG001|Overall Study|Adverse Event|1|||
127900174|NCT01411332|460258545|FG000|Enrollment|Protocol Violation|0|||
127842541|NCT00413062|460040766|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
127842542|NCT00413062|460040767|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
127842543|NCT00413062|460040766|FG000|Overall Study|Withdrawal of informed consent|111|||
127842544|NCT00413062|460040767|FG001|Overall Study|Withdrawal of informed consent|36|||
127842545|NCT00413062|460040766|FG000|Overall Study|Pregnancy|15|||
127842546|NCT00413062|460040767|FG001|Overall Study|Pregnancy|5|||
127842547|NCT00413062|460040766|FG000|Overall Study|Pregnancy wish|17|||
127842548|NCT00413062|460040767|FG001|Overall Study|Pregnancy wish|6|||
127758270|NCT02416453|459740461|FG003|Overall Study|Withdrawal by Subject|5|||
127758271|NCT02416453|459740462|FG004|Overall Study|Withdrawal by Subject|1|||
127842549|NCT00413062|460040766|FG000|Overall Study|Lost to Follow-up|175|||
127842550|NCT00413062|460040767|FG001|Overall Study|Lost to Follow-up|73|||
127842551|NCT00413062|460040766|FG000|Overall Study|Other reason|70|||
127842552|NCT00413062|460040767|FG001|Overall Study|Other reason|34|||
127842553|NCT02176291|460040768|FG000|Overall Study|Death|1|||
127842554|NCT02176291|460040769|FG001|Overall Study|Death|0|||
127842555|NCT02176291|460040768|FG000|Overall Study|non compliance with protocol|2|||
127842556|NCT02176291|460040769|FG001|Overall Study|non compliance with protocol|0|||
127842557|NCT02176291|460040768|FG000|Overall Study|Withdrawal by Subject|2|||
127842558|NCT02176291|460040769|FG001|Overall Study|Withdrawal by Subject|0|||
127842559|NCT02815293|460040772|FG000|Overall Study|Study termination by sponsor|10|||
127842560|NCT02815293|460040773|FG001|Overall Study|Study termination by sponsor|7|||
127842561|NCT02815293|460040774|FG002|Overall Study|Study termination by sponsor|0|||
127842562|NCT02815293|460040772|FG000|Overall Study|Participants not randomized|0|||
127842563|NCT02815293|460040773|FG001|Overall Study|Participants not randomized|0|||
127842564|NCT02815293|460040774|FG002|Overall Study|Participants not randomized|18|||
127842565|NCT02815293|460040772|FG000|Overall Study|Adverse Event|0|||
127842566|NCT02815293|460040773|FG001|Overall Study|Adverse Event|1|||
127842567|NCT02815293|460040774|FG002|Overall Study|Adverse Event|0|||
127842568|NCT00006604|460040775|FG000|Overall Study|Met study objective - no further FU|1|||
127758272|NCT02416453|459740463|FG005|Overall Study|Withdrawal by Subject|8|||
127758273|NCT02416453|459740464|FG006|Overall Study|Withdrawal by Subject|0|||
127842569|NCT00006604|460040776|FG001|Overall Study|Met study objective - no further FU|0|||
127842570|NCT00006604|460040777|FG002|Overall Study|Met study objective - no further FU|0|||
127842571|NCT00006604|460040778|FG003|Overall Study|Met study objective - no further FU|0|||
127842572|NCT00006604|460040779|FG004|Overall Study|Met study objective - no further FU|0|||
127842573|NCT00006604|460040780|FG005|Overall Study|Met study objective - no further FU|0|||
127842574|NCT00006604|460040781|FG006|Overall Study|Met study objective - no further FU|0|||
127842575|NCT00006604|460040782|FG007|Overall Study|Met study objective - no further FU|0|||
127842576|NCT00006604|460040783|FG008|Overall Study|Met study objective - no further FU|0|||
127842577|NCT00006604|460040784|FG009|Overall Study|Met study objective - no further FU|0|||
127842578|NCT00006604|460040785|FG010|Overall Study|Met study objective - no further FU|0|||
127842579|NCT00006604|460040786|FG011|Overall Study|Met study objective - no further FU|0|||
127900175|NCT01411332|460258546|FG001|Enrollment|Protocol Violation|1|||
127758274|NCT02416453|459740465|FG007|Overall Study|Withdrawal by Subject|8|||
127900176|NCT01411332|460258545|FG000|Enrollment|Withdrawal by Subject|0|||
127900177|NCT01411332|460258546|FG001|Enrollment|Withdrawal by Subject|1|||
127900178|NCT01411332|460258545|FG000|Treatment|Lost to Follow-up|1|||
127900179|NCT01411332|460258546|FG001|Treatment|Lost to Follow-up|0|||
127900180|NCT01471522|460258548|FG000|Overall Study|Withdrawal by Subject|28|||
127900181|NCT01471522|460258549|FG001|Overall Study|Withdrawal by Subject|22|||
127900182|NCT01471522|460258548|FG000|Overall Study|Lost to Follow-up|36|||
127900183|NCT01471522|460258549|FG001|Overall Study|Lost to Follow-up|26|||
127900184|NCT02637232|460260135|FG000|Overall Study|Lost to Follow-up|42|||
127900185|NCT02637232|460260135|FG000|Overall Study|Adverse Event|11|||
127900186|NCT02637232|460260135|FG000|Overall Study|patient 's decision|2|||
127900187|NCT02999178|460260136|FG000|Overall Study|Adverse Event|85|||
127900188|NCT02999178|460260137|FG001|Overall Study|Adverse Event|62|||
127900189|NCT02999178|460260136|FG000|Overall Study|Protocol Violation|1|||
127900190|NCT02999178|460260137|FG001|Overall Study|Protocol Violation|2|||
127758275|NCT02416453|459740466|FG008|Overall Study|Withdrawal by Subject|4|||
127758276|NCT02416453|459740467|FG009|Overall Study|Withdrawal by Subject|0|||
127758277|NCT02416453|459740468|FG010|Overall Study|Withdrawal by Subject|0|||
127758278|NCT02416453|459740458|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
127758279|NCT02416453|459740459|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
127758280|NCT02416453|459740460|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
127900191|NCT02999178|460260136|FG000|Overall Study|Lost to Follow-up|0|||
127900192|NCT02999178|460260137|FG001|Overall Study|Lost to Follow-up|2|||
127758281|NCT02416453|459740461|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
127758282|NCT02416453|459740462|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
127900193|NCT02999178|460260136|FG000|Overall Study|Withdrawal by Subject|21|||
127900194|NCT02999178|460260137|FG001|Overall Study|Withdrawal by Subject|21|||
127900195|NCT02999178|460260136|FG000|Overall Study|Other reason not defined above|7|||
127900196|NCT02999178|460260137|FG001|Overall Study|Other reason not defined above|13|||
127900197|NCT00090857|460260138|FG000|Overall Study|Lost to Follow-up|0|||
127900198|NCT00090857|460260139|FG001|Overall Study|Lost to Follow-up|1|||
127900199|NCT00090857|460260138|FG000|Overall Study|Withdrawal by Subject|2|||
127900200|NCT00090857|460260139|FG001|Overall Study|Withdrawal by Subject|0|||
127900201|NCT00090857|460260138|FG000|Overall Study|Adverse Event|2|||
127900202|NCT00090857|460260139|FG001|Overall Study|Adverse Event|2|||
127900203|NCT05097326|460260140|FG000|Overall Study|Spontaneous labor prior to medication administration|1|||
127900204|NCT05097326|460260141|FG001|Overall Study|Spontaneous labor prior to medication administration|0|||
127900205|NCT02684344|460260142|FG000|Overall Study|Withdrawal by Subject|0|||
127900206|NCT02684344|460260143|FG001|Overall Study|Withdrawal by Subject|1|||
127900207|NCT03480425|460260144|FG000|Overall Study|Force transducer technical failure|1|||
127900208|NCT02424188|460260146|FG000|Overall Study|Death|2|||
127900209|NCT02424188|460260147|FG001|Overall Study|Death|2|||
127900210|NCT02424188|460260146|FG000|Overall Study|Lost to Follow-up|1|||
127900211|NCT02424188|460260147|FG001|Overall Study|Lost to Follow-up|3|||
127900212|NCT02424188|460260146|FG000|Overall Study|Incarceration|1|||
127900213|NCT02424188|460260147|FG001|Overall Study|Incarceration|0|||
127900214|NCT00630305|460260148|FG000|Overall Study|Withdrawal by Subject|1|||
127900215|NCT00630305|460260148|FG000|Overall Study|Inability to insert contact lens|1|||
127900216|NCT03471078|460260159|FG000|Overall Study|Withdrawal by Subject|9|||
127900217|NCT03471078|460260160|FG001|Overall Study|Withdrawal by Subject|1|||
127900218|NCT03471078|460260159|FG000|Overall Study|Adverse Event|4|||
127900219|NCT03471078|460260160|FG001|Overall Study|Adverse Event|1|||
127900220|NCT03471078|460260159|FG000|Overall Study|Physician Decision|3|||
127900221|NCT03471078|460260160|FG001|Overall Study|Physician Decision|2|||
127900222|NCT03471078|460260159|FG000|Overall Study|Death|2|||
127900223|NCT03471078|460260160|FG001|Overall Study|Death|0|||
127900224|NCT03471078|460260159|FG000|Overall Study|Other|3|||
127900225|NCT03471078|460260160|FG001|Overall Study|Other|2|||
127900226|NCT02473640|460260164|FG000|Treatment Period 1|Adverse Event|1|||
127900227|NCT02395822|460260165|FG000|Overall Study|Withdrawal by Subject|1|||
127900228|NCT02395822|460260165|FG000|Overall Study|Death|1|||
127900229|NCT01882647|460260168|FG000|Overall Study|Lost to Follow-up|2|||
127758283|NCT02416453|459740463|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
127758284|NCT02416453|459740464|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
127758285|NCT02416453|459740465|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
127758286|NCT02416453|459740466|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
127758287|NCT02416453|459740467|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
127758288|NCT02416453|459740468|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
127758289|NCT02416453|459740458|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
127758290|NCT02416453|459740459|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
127758291|NCT02416453|459740460|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
127900230|NCT01882647|460260169|FG001|Overall Study|Lost to Follow-up|2|||
127900231|NCT01882647|460260168|FG000|Overall Study|Withdrawal by Subject|0|||
127900232|NCT01882647|460260169|FG001|Overall Study|Withdrawal by Subject|4|||
127900233|NCT03292653|460260171|FG000|Overall Study|Adverse Event|0|||
127900234|NCT03292653|460260172|FG001|Overall Study|Adverse Event|0|||
127900235|NCT03292653|460260173|FG002|Overall Study|Adverse Event|1|||
127900236|NCT03292653|460260171|FG000|Overall Study|Did not Receive Treatment|1|||
127900237|NCT03292653|460260172|FG001|Overall Study|Did not Receive Treatment|0|||
127900238|NCT03292653|460260173|FG002|Overall Study|Did not Receive Treatment|0|||
127900239|NCT04720664|460260174|FG000|Overall Study|Adverse Event|2|||
127900240|NCT04720664|460260174|FG000|Overall Study|Lack of Efficacy|9|||
127900241|NCT03311646|460260175|FG000|Overall Study|Physician Decision|1|||
127900242|NCT03311646|460260175|FG000|Overall Study|Withdrawal by Subject|5|||
127900243|NCT03311646|460260175|FG000|Overall Study|Lost to Follow-up|5|||
127900244|NCT03311646|460260175|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
127900245|NCT03127137|460260186|FG000|Overall Study|Requested sedation after consent|1|||
127900246|NCT03127137|460260187|FG001|Overall Study|Requested sedation after consent|0|||
127900247|NCT03127137|460260186|FG000|Overall Study|Malfunction in electronic data collection|1|||
127900248|NCT03127137|460260187|FG001|Overall Study|Malfunction in electronic data collection|0|||
127900249|NCT03127137|460260186|FG000|Overall Study|Post procedure testing could not be obtained|0|||
127900250|NCT03127137|460260187|FG001|Overall Study|Post procedure testing could not be obtained|1|||
127900251|NCT01996033|460260188|FG000|Overall Study|Death|1|||
127900252|NCT01996033|460260188|FG000|Overall Study|Physician Decision|1|||
127900253|NCT01996033|460260188|FG000|Overall Study|Withdrawal by Subject|4|||
127900254|NCT01996033|460260188|FG000|Overall Study|Lost to Follow-up|3|||
127900255|NCT01225146|460260189|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
127900256|NCT01225146|460260190|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
127900257|NCT01239121|460260191|FG000|Overall Study|Withdrawal by Subject|2|||
127900258|NCT01239121|460260192|FG001|Overall Study|Withdrawal by Subject|4|||
127758292|NCT02416453|459740461|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
127758293|NCT02416453|459740462|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
127758294|NCT02416453|459740463|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
127758295|NCT02416453|459740464|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
127758296|NCT02416453|459740465|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
127758297|NCT02416453|459740466|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
127758298|NCT02416453|459740467|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
127900259|NCT01239121|460260193|FG002|Overall Study|Withdrawal by Subject|0|||
127900260|NCT00944697|460260194|FG000|Overall Study|Withdrawal by Subject|1|||
127900261|NCT00944697|460260195|FG001|Overall Study|Withdrawal by Subject|1|||
127900262|NCT00944697|460260194|FG000|Overall Study|Adverse Event|0|||
127900263|NCT00944697|460260195|FG001|Overall Study|Adverse Event|3|||
127900264|NCT00944697|460260194|FG000|Overall Study|Administrative|1|||
127900265|NCT00944697|460260195|FG001|Overall Study|Administrative|1|||
127900266|NCT01273181|460260196|FG000|Phase I, Dose 1|Study termination|1|||
127900267|NCT01273181|460260197|FG001|Phase I, Dose 1|Study termination|0|||
127900268|NCT01273181|460260198|FG002|Phase I, Dose 1|Study termination|0|||
127900269|NCT01273181|460260199|FG003|Phase I, Dose 1|Study termination|0|||
127900270|NCT01273181|460260196|FG000|Phase I, Dose 2|Death during treatment|0|||
127900271|NCT01273181|460260197|FG001|Phase I, Dose 2|Death during treatment|1|||
127900272|NCT01273181|460260198|FG002|Phase I, Dose 2|Death during treatment|0|||
127900273|NCT01273181|460260199|FG003|Phase I, Dose 2|Death during treatment|0|||
127900274|NCT01273181|460260196|FG000|Phase 2, Dose 1|Study termination|0|||
127900275|NCT01273181|460260197|FG001|Phase 2, Dose 1|Study termination|0|||
127900276|NCT01273181|460260198|FG002|Phase 2, Dose 1|Study termination|1|||
127900277|NCT01273181|460260199|FG003|Phase 2, Dose 1|Study termination|0|||
127900278|NCT01273181|460260196|FG000|Phase 2, Dose 2|Death during treatment|0|||
127900279|NCT01273181|460260197|FG001|Phase 2, Dose 2|Death during treatment|0|||
127900280|NCT01273181|460260198|FG002|Phase 2, Dose 2|Death during treatment|0|||
127900281|NCT01273181|460260199|FG003|Phase 2, Dose 2|Death during treatment|1|||
127900282|NCT03657160|460260200|FG000|Overall Study|Adverse Event|5|||
127900283|NCT03657160|460260201|FG001|Overall Study|Adverse Event|6|||
127900284|NCT03657160|460260200|FG000|Overall Study|Protocol Deviation|3|||
127900285|NCT03657160|460260201|FG001|Overall Study|Protocol Deviation|0|||
127900286|NCT03657160|460260200|FG000|Overall Study|Withdrawal by Subject|18|||
127900287|NCT03657160|460260201|FG001|Overall Study|Withdrawal by Subject|16|||
127900288|NCT03657160|460260200|FG000|Overall Study|Site Termination|1|||
127900289|NCT03657160|460260201|FG001|Overall Study|Site Termination|0|||
127900290|NCT03657160|460260200|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
127900291|NCT03657160|460260201|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
127900292|NCT03657160|460260200|FG000|Overall Study|Death|33|||
127900293|NCT03657160|460260201|FG001|Overall Study|Death|26|||
127900294|NCT03657160|460260200|FG000|Overall Study|Death (COVID-19-Related)|1|||
127900295|NCT03657160|460260201|FG001|Overall Study|Death (COVID-19-Related)|0|||
127900296|NCT03657160|460260200|FG000|Overall Study|Reason Not Specified|5|||
127900297|NCT03657160|460260201|FG001|Overall Study|Reason Not Specified|5|||
127900298|NCT03657160|460260200|FG000|Overall Study|Other (COVID-19-Related)|0|||
127900299|NCT03657160|460260201|FG001|Overall Study|Other (COVID-19-Related)|1|||
127900300|NCT02732210|460260202|FG000|Overall Study|Site Closed|0|||
127900301|NCT02732210|460260203|FG001|Overall Study|Site Closed|11|||
127900302|NCT02732210|460260202|FG000|Overall Study|Study Ended|13|||
127900303|NCT02732210|460260203|FG001|Overall Study|Study Ended|13|||
127900304|NCT02732210|460260202|FG000|Overall Study|Withdrawal by Subject|28|||
127900305|NCT02732210|460260203|FG001|Overall Study|Withdrawal by Subject|87|||
127900306|NCT02732210|460260202|FG000|Overall Study|Lost to Follow-up|5|||
127900307|NCT02732210|460260203|FG001|Overall Study|Lost to Follow-up|57|||
127900308|NCT02732210|460260202|FG000|Overall Study|Death|4|||
127900309|NCT02732210|460260203|FG001|Overall Study|Death|15|||
127900310|NCT02732210|460260202|FG000|Overall Study|Other|35|||
127900311|NCT02732210|460260203|FG001|Overall Study|Other|103|||
127900312|NCT02732210|460260202|FG000|Overall Study|Missing|0|||
127900313|NCT02732210|460260203|FG001|Overall Study|Missing|8|||
127900314|NCT04638153|460260204|FG000|Overall Study|Withdrawal by parent/guardian|0|||
127900315|NCT04638153|460260205|FG001|Overall Study|Withdrawal by parent/guardian|0|||
127900316|NCT04638153|460260206|FG002|Overall Study|Withdrawal by parent/guardian|1|||
127900317|NCT04638153|460260204|FG000|Overall Study|Study terminated by sponsor|4|||
127900318|NCT04638153|460260205|FG001|Overall Study|Study terminated by sponsor|2|||
127900319|NCT04638153|460260206|FG002|Overall Study|Study terminated by sponsor|14|||
127900320|NCT04006171|460260209|FG000|Overall Study|Withdrawal by Subject|8|||
127900321|NCT04006171|460260210|FG001|Overall Study|Withdrawal by Subject|7|||
127900322|NCT04006171|460260209|FG000|Overall Study|missing serum samples|2|||
127758299|NCT02416453|459740468|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
127758300|NCT00743431|459740473|FG000|Overall Study|Toxicity|6|||
127758301|NCT00743431|459740473|FG000|Overall Study|Tumor progression|56|||
127758302|NCT00743431|459740473|FG000|Overall Study|Withdrawal by Subject|13|||
127758303|NCT00743431|459740473|FG000|Overall Study|Death|9|||
127758304|NCT00743431|459740473|FG000|Overall Study|Reason for discontinuation not specified|29|||
127900323|NCT04006171|460260210|FG001|Overall Study|missing serum samples|2|||
127900324|NCT04006171|460260209|FG000|Overall Study|insufficient sample volume|2|||
127900325|NCT04006171|460260210|FG001|Overall Study|insufficient sample volume|3|||
127900326|NCT00440557|460260212|FG000|Overall Study|Withdrawal by Subject|10|||
127900327|NCT00440557|460260213|FG001|Overall Study|Withdrawal by Subject|5|||
127900328|NCT00440557|460260214|FG002|Overall Study|Withdrawal by Subject|11|||
127900329|NCT00440557|460260212|FG000|Overall Study|Lost to Follow-up|1|||
127900330|NCT00440557|460260213|FG001|Overall Study|Lost to Follow-up|2|||
127900331|NCT00440557|460260214|FG002|Overall Study|Lost to Follow-up|6|||
127900332|NCT00440557|460260212|FG000|Overall Study|Adverse Event|3|||
127842580|NCT00006604|460040787|FG012|Overall Study|Met study objective - no further FU|0|||
127842581|NCT00006604|460040788|FG013|Overall Study|Met study objective - no further FU|0|||
127842582|NCT00006604|460040789|FG014|Overall Study|Met study objective - no further FU|1|||
127842583|NCT00006604|460040790|FG015|Overall Study|Met study objective - no further FU|1|||
127842584|NCT00006604|460040791|FG016|Overall Study|Met study objective - no further FU|0|||
127842585|NCT00006604|460040775|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
127758305|NCT00743431|459740473|FG000|Overall Study|No documentation available|13|||
127758306|NCT03291288|459740474|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
127758307|NCT03291288|459740475|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
127758308|NCT03291288|459740474|FG000|Drug-drug Interaction Phase|Disease progression|1|||
127758309|NCT03291288|459740475|FG001|Drug-drug Interaction Phase|Disease progression|0|||
127758310|NCT03291288|459740474|FG000|Drug-drug Interaction Phase|Other|3|||
127758311|NCT03291288|459740475|FG001|Drug-drug Interaction Phase|Other|0|||
127758312|NCT03291288|459740474|FG000|Pexidartinib Only|Ongoing|0|||
127758313|NCT03291288|459740475|FG001|Pexidartinib Only|Ongoing|2|||
127758314|NCT04276415|459740476|FG000|Overall Study|Adverse Event|0|||
127758315|NCT04276415|459740477|FG001|Overall Study|Adverse Event|0|||
127758316|NCT04276415|459740478|FG002|Overall Study|Adverse Event|0|||
127758317|NCT04276415|459740479|FG003|Overall Study|Adverse Event|3|||
127758318|NCT04276415|459740480|FG004|Overall Study|Adverse Event|0|||
127758319|NCT04276415|459740481|FG005|Overall Study|Adverse Event|0|||
127758320|NCT04276415|459740476|FG000|Overall Study|Clinical progression|1|||
127758321|NCT04276415|459740477|FG001|Overall Study|Clinical progression|1|||
127758322|NCT04276415|459740478|FG002|Overall Study|Clinical progression|0|||
127758323|NCT04276415|459740479|FG003|Overall Study|Clinical progression|0|||
127758324|NCT04276415|459740480|FG004|Overall Study|Clinical progression|1|||
127758325|NCT04276415|459740481|FG005|Overall Study|Clinical progression|0|||
127758326|NCT04276415|459740476|FG000|Overall Study|Other|0|||
127758327|NCT04276415|459740477|FG001|Overall Study|Other|0|||
127758328|NCT04276415|459740478|FG002|Overall Study|Other|0|||
127758329|NCT04276415|459740479|FG003|Overall Study|Other|1|||
127758330|NCT04276415|459740480|FG004|Overall Study|Other|0|||
127758331|NCT04276415|459740481|FG005|Overall Study|Other|0|||
127758332|NCT04276415|459740476|FG000|Overall Study|Physician Decision|0|||
127758333|NCT04276415|459740477|FG001|Overall Study|Physician Decision|0|||
127758334|NCT04276415|459740478|FG002|Overall Study|Physician Decision|1|||
127758335|NCT04276415|459740479|FG003|Overall Study|Physician Decision|3|||
127758336|NCT04276415|459740480|FG004|Overall Study|Physician Decision|2|||
127758337|NCT04276415|459740481|FG005|Overall Study|Physician Decision|0|||
127842586|NCT00006604|460040776|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
127842587|NCT00006604|460040777|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
127758338|NCT04276415|459740476|FG000|Overall Study|Progressive disease|3|||
127758339|NCT04276415|459740477|FG001|Overall Study|Progressive disease|3|||
127758340|NCT04276415|459740478|FG002|Overall Study|Progressive disease|4|||
127758341|NCT04276415|459740479|FG003|Overall Study|Progressive disease|5|||
127758342|NCT04276415|459740480|FG004|Overall Study|Progressive disease|1|||
127758343|NCT04276415|459740481|FG005|Overall Study|Progressive disease|2|||
127758344|NCT04276415|459740476|FG000|Overall Study|Withdrawal by patient|0|||
127758345|NCT04276415|459740477|FG001|Overall Study|Withdrawal by patient|0|||
127758346|NCT04276415|459740478|FG002|Overall Study|Withdrawal by patient|0|||
127758347|NCT04276415|459740479|FG003|Overall Study|Withdrawal by patient|1|||
127758348|NCT04276415|459740480|FG004|Overall Study|Withdrawal by patient|2|||
127758349|NCT04276415|459740481|FG005|Overall Study|Withdrawal by patient|0|||
127758350|NCT03309813|459740482|FG000|Main Randomized Study|Withdrawal by Subject|1|||
127758351|NCT03309813|459740483|FG001|Main Randomized Study|Withdrawal by Subject|0|||
127758352|NCT01989169|459740486|FG000|Period 2|Adverse Event|0|||
127758353|NCT01989169|459740487|FG001|Period 2|Adverse Event|1|||
127900333|NCT00440557|460260213|FG001|Overall Study|Adverse Event|3|||
127758354|NCT02406677|459740488|FG000|Overall Study|Death|16|||
127758355|NCT02406677|459740489|FG001|Overall Study|Death|8|||
127758356|NCT02406677|459740488|FG000|Overall Study|Discharged without P2Y12|1|||
127900334|NCT00440557|460260214|FG002|Overall Study|Adverse Event|5|||
127900335|NCT00440557|460260212|FG000|Overall Study|Death|2|||
127758357|NCT02406677|459740489|FG001|Overall Study|Discharged without P2Y12|3|||
127758358|NCT02406677|459740488|FG000|Overall Study|Discharged on prasugrel|283|||
127758359|NCT02406677|459740489|FG001|Overall Study|Discharged on prasugrel|587|||
127842588|NCT00006604|460040778|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
127842589|NCT00006604|460040779|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
127900336|NCT00440557|460260213|FG001|Overall Study|Death|6|||
127900337|NCT00440557|460260214|FG002|Overall Study|Death|3|||
127900338|NCT00440557|460260212|FG000|Overall Study|Began Dialysis|4|||
127900339|NCT00440557|460260213|FG001|Overall Study|Began Dialysis|1|||
127900340|NCT00440557|460260214|FG002|Overall Study|Began Dialysis|4|||
127900341|NCT00440557|460260212|FG000|Overall Study|Principal Investigator decision|0|||
127900342|NCT00440557|460260213|FG001|Overall Study|Principal Investigator decision|3|||
127900343|NCT00440557|460260214|FG002|Overall Study|Principal Investigator decision|1|||
127900344|NCT00440557|460260212|FG000|Overall Study|Patient moved|1|||
127900345|NCT00440557|460260213|FG001|Overall Study|Patient moved|2|||
127900346|NCT00440557|460260214|FG002|Overall Study|Patient moved|1|||
127900347|NCT00440557|460260212|FG000|Overall Study|Principal Investigator's office closed|3|||
127900348|NCT00440557|460260213|FG001|Overall Study|Principal Investigator's office closed|6|||
127900349|NCT00440557|460260214|FG002|Overall Study|Principal Investigator's office closed|4|||
127900350|NCT00440557|460260212|FG000|Overall Study|Patient transferred to nursing home|0|||
127900351|NCT00440557|460260213|FG001|Overall Study|Patient transferred to nursing home|1|||
127900352|NCT00440557|460260214|FG002|Overall Study|Patient transferred to nursing home|0|||
127900353|NCT00440557|460260212|FG000|Overall Study|Patient had surgery|1|||
127900354|NCT00440557|460260213|FG001|Overall Study|Patient had surgery|0|||
127900355|NCT00440557|460260214|FG002|Overall Study|Patient had surgery|0|||
127900356|NCT00874237|460260220|FG000|Overall Study|Physician Decision|0|||
127900357|NCT00874237|460260221|FG001|Overall Study|Physician Decision|1|||
127900358|NCT00874237|460260222|FG002|Overall Study|Physician Decision|0|||
127900359|NCT00874237|460260223|FG003|Overall Study|Physician Decision|0|||
127900360|NCT00874237|460260224|FG004|Overall Study|Physician Decision|0|||
127900361|NCT00874237|460260225|FG005|Overall Study|Physician Decision|0|||
127900362|NCT00874237|460260220|FG000|Overall Study|Withdrawal by Subject|0|||
127900363|NCT00874237|460260221|FG001|Overall Study|Withdrawal by Subject|0|||
127900364|NCT00874237|460260222|FG002|Overall Study|Withdrawal by Subject|1|||
127900365|NCT00874237|460260223|FG003|Overall Study|Withdrawal by Subject|0|||
127900366|NCT00874237|460260224|FG004|Overall Study|Withdrawal by Subject|0|||
127900367|NCT00874237|460260225|FG005|Overall Study|Withdrawal by Subject|0|||
127900368|NCT03912337|460260226|FG000|Overall Study|Withdrawal of Consent From Study|1|||
127900369|NCT03912337|460260227|FG001|Overall Study|Withdrawal of Consent From Study|0|||
127900370|NCT03912337|460260226|FG000|Overall Study|Lost to Follow-up|1|||
127900371|NCT03912337|460260227|FG001|Overall Study|Lost to Follow-up|1|||
127900372|NCT03752528|460260228|FG000|Part A|Lost to Follow-up|1|||
127900373|NCT03752528|460260228|FG000|Part A|Protocol Violation|1|||
127900374|NCT03752528|460260228|FG000|Part B|Protocol Violation|1|||
127900375|NCT03752528|460260228|FG000|Part B|Study terminated by sponsor|3|||
127900376|NCT00537030|460260229|FG000|Overall Study|Physician Decision|2|||
127900377|NCT00537030|460260229|FG000|Overall Study|Withdrawal by Subject|2|||
127900378|NCT00537030|460260229|FG000|Overall Study|≥ Grade 2 allergy|7|||
127900379|NCT00537030|460260229|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
127900380|NCT00537030|460260229|FG000|Overall Study|Ineligible|2|||
127900381|NCT00537030|460260229|FG000|Overall Study|Inevaluable|2|||
127900382|NCT00414765|460260230|FG000|Overall Study|Adverse Event|5|||
127900383|NCT00414765|460260231|FG001|Overall Study|Adverse Event|9|||
127900384|NCT00414765|460260230|FG000|Overall Study|Withdrawal by Subject|1|||
127900385|NCT00414765|460260231|FG001|Overall Study|Withdrawal by Subject|1|||
127900386|NCT00414765|460260230|FG000|Overall Study|Disease Progression|0|||
127900387|NCT00414765|460260231|FG001|Overall Study|Disease Progression|1|||
127900388|NCT02458469|460260232|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
127900389|NCT02458469|460260233|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
127758360|NCT02406677|459740488|FG000|Overall Study|Withdrawal by Subject|1|||
127758361|NCT02406677|459740489|FG001|Overall Study|Withdrawal by Subject|0|||
127758362|NCT04531904|459740490|FG000|Overall Study|Lost to Follow-up|1|||
127758363|NCT04531904|459740490|FG000|Overall Study|Death|14|||
127758364|NCT00283244|459740491|FG000|Overall Study|Adverse Event|0|||
127758365|NCT00283244|459740492|FG001|Overall Study|Adverse Event|8|||
127758366|NCT00283244|459740493|FG002|Overall Study|Adverse Event|11|||
127758367|NCT00283244|459740491|FG000|Overall Study|Death|4|||
127758368|NCT00283244|459740492|FG001|Overall Study|Death|3|||
127758369|NCT00283244|459740493|FG002|Overall Study|Death|2|||
127758370|NCT00283244|459740491|FG000|Overall Study|Lack of Efficacy|8|||
127758371|NCT00283244|459740492|FG001|Overall Study|Lack of Efficacy|32|||
127758372|NCT00283244|459740493|FG002|Overall Study|Lack of Efficacy|26|||
127900390|NCT02458469|460260234|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
127758373|NCT00283244|459740491|FG000|Overall Study|Withdrawal by Subject|1|||
127758374|NCT00283244|459740492|FG001|Overall Study|Withdrawal by Subject|2|||
127758375|NCT00283244|459740493|FG002|Overall Study|Withdrawal by Subject|2|||
127758376|NCT00283244|459740491|FG000|Overall Study|Physician Decision|0|||
127900391|NCT02458469|460260235|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
127900392|NCT02458469|460260236|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
127758377|NCT00283244|459740492|FG001|Overall Study|Physician Decision|0|||
127758378|NCT00283244|459740493|FG002|Overall Study|Physician Decision|1|||
127900393|NCT02458469|460260237|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
127900394|NCT02458469|460260232|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
127758379|NCT00283244|459740491|FG000|Overall Study|Medical illness (other complicating dz)|4|||
127758380|NCT00283244|459740492|FG001|Overall Study|Medical illness (other complicating dz)|3|||
127758381|NCT00283244|459740493|FG002|Overall Study|Medical illness (other complicating dz)|6|||
127758382|NCT00283244|459740491|FG000|Overall Study|Clinical deterioration|1|||
127758383|NCT00283244|459740492|FG001|Overall Study|Clinical deterioration|3|||
127758384|NCT00283244|459740493|FG002|Overall Study|Clinical deterioration|3|||
127758385|NCT00658788|459740494|FG000|Overall Study|Adverse Event|11|||
127758386|NCT00658788|459740494|FG000|Overall Study|Withdrawal by Subject|13|||
127758387|NCT00658788|459740494|FG000|Overall Study|Lost to Follow-up|18|||
127758388|NCT00658788|459740494|FG000|Overall Study|Treatment Discontinuation|32|||
127758389|NCT00653523|459740495|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
127758390|NCT00653523|459740495|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
127758391|NCT00653523|459740495|FG000|Overall Study|Adverse Event|7|||
127758392|NCT00653523|459740495|FG000|Overall Study|Withdrawal by Subject|6|||
127758393|NCT00653523|459740495|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
127758394|NCT00653523|459740495|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
127758395|NCT05384938|459740496|FG000|Overall Study|Withdrawal by Subject|8|||
127758396|NCT05384938|459740496|FG000|Overall Study|Lost to Follow-up|6|||
127842590|NCT00006604|460040780|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
127842591|NCT00006604|460040781|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
127842592|NCT00006604|460040782|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
127842593|NCT00006604|460040783|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
127842594|NCT00006604|460040784|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
127842595|NCT00006604|460040785|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
127868898|NCT00525499|460137425|FG001|Overall Study|Adverse Event|1|||
127868899|NCT00525499|460137426|FG002|Overall Study|Adverse Event|0|||
127868900|NCT00525499|460137427|FG003|Overall Study|Adverse Event|1|||
127868901|NCT00525499|460137424|FG000|Overall Study|Withdrawal by Subject|5|||
127868902|NCT00525499|460137425|FG001|Overall Study|Withdrawal by Subject|1|||
127868903|NCT00525499|460137426|FG002|Overall Study|Withdrawal by Subject|5|||
127868904|NCT00525499|460137427|FG003|Overall Study|Withdrawal by Subject|2|||
127868905|NCT00525499|460137424|FG000|Overall Study|Protocol Violation|0|||
127868906|NCT00525499|460137425|FG001|Overall Study|Protocol Violation|1|||
127868907|NCT00525499|460137426|FG002|Overall Study|Protocol Violation|1|||
127868908|NCT00525499|460137427|FG003|Overall Study|Protocol Violation|0|||
127868909|NCT00438815|460137428|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
127868910|NCT00438815|460137428|FG000|Overall Study|3-month follow-up no longer required|12|||
127868911|NCT00438815|460137428|FG000|Overall Study|Noncompliance with protocol requirements|9|||
127868912|NCT00438815|460137428|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
127868913|NCT00438815|460137428|FG000|Overall Study|Lost to Follow-up|6|||
127868914|NCT00438815|460137428|FG000|Overall Study|Withdrawal by Subject|6|||
127868915|NCT00438815|460137428|FG000|Overall Study|Death|1|||
127868916|NCT01733758|460137429|FG000|Overall Study|Adverse Event|5|||
127868917|NCT01733758|460137430|FG001|Overall Study|Adverse Event|7|||
127868918|NCT01733758|460137431|FG002|Overall Study|Adverse Event|8|||
127868919|NCT01733758|460137432|FG003|Overall Study|Adverse Event|1|||
127868920|NCT01733758|460137429|FG000|Overall Study|Withdrawal by Subject|1|||
127868921|NCT01733758|460137430|FG001|Overall Study|Withdrawal by Subject|1|||
127868922|NCT01733758|460137431|FG002|Overall Study|Withdrawal by Subject|5|||
127868923|NCT01733758|460137432|FG003|Overall Study|Withdrawal by Subject|3|||
127868924|NCT01733758|460137429|FG000|Overall Study|Persistent Hyperglycemia|3|||
127868925|NCT01733758|460137430|FG001|Overall Study|Persistent Hyperglycemia|2|||
127868926|NCT01733758|460137431|FG002|Overall Study|Persistent Hyperglycemia|0|||
127868927|NCT01733758|460137432|FG003|Overall Study|Persistent Hyperglycemia|0|||
127868928|NCT01733758|460137429|FG000|Overall Study|Protocol Violation|0|||
127868929|NCT01733758|460137430|FG001|Overall Study|Protocol Violation|1|||
127868930|NCT01733758|460137431|FG002|Overall Study|Protocol Violation|2|||
127868931|NCT01733758|460137432|FG003|Overall Study|Protocol Violation|2|||
127868932|NCT01733758|460137429|FG000|Overall Study|Non-compliance|1|||
127868933|NCT01733758|460137430|FG001|Overall Study|Non-compliance|0|||
127868934|NCT01733758|460137431|FG002|Overall Study|Non-compliance|0|||
127868935|NCT01733758|460137432|FG003|Overall Study|Non-compliance|0|||
127868936|NCT01733758|460137429|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
127868937|NCT01733758|460137430|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
127868938|NCT01733758|460137431|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
127868939|NCT01733758|460137432|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
127868940|NCT01733758|460137429|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
127868941|NCT01733758|460137430|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
127868942|NCT01733758|460137431|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
127868943|NCT01733758|460137432|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
127868944|NCT03380091|460137440|FG000|Overall Study|Withdrawal by Subject|2|||
127868945|NCT03380091|460137441|FG001|Overall Study|Withdrawal by Subject|1|||
127842596|NCT00006604|460040786|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
127842597|NCT00006604|460040787|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
127842598|NCT00006604|460040788|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
127842599|NCT00006604|460040789|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
127842600|NCT00006604|460040790|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
127842601|NCT00006604|460040791|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
127842602|NCT00006604|460040775|FG000|Overall Study|Death|0|||
127842603|NCT00006604|460040776|FG001|Overall Study|Death|0|||
127842604|NCT00006604|460040777|FG002|Overall Study|Death|0|||
127842605|NCT00006604|460040778|FG003|Overall Study|Death|0|||
127842606|NCT00006604|460040779|FG004|Overall Study|Death|0|||
127842607|NCT00006604|460040780|FG005|Overall Study|Death|0|||
127842608|NCT00006604|460040781|FG006|Overall Study|Death|0|||
127842609|NCT00006604|460040782|FG007|Overall Study|Death|0|||
127842610|NCT00006604|460040783|FG008|Overall Study|Death|0|||
127842611|NCT00006604|460040784|FG009|Overall Study|Death|1|||
127842612|NCT00006604|460040785|FG010|Overall Study|Death|1|||
127842613|NCT00006604|460040786|FG011|Overall Study|Death|1|||
127842614|NCT00006604|460040787|FG012|Overall Study|Death|0|||
127842615|NCT00006604|460040788|FG013|Overall Study|Death|0|||
127842616|NCT00006604|460040789|FG014|Overall Study|Death|0|||
127842617|NCT00006604|460040790|FG015|Overall Study|Death|0|||
127842618|NCT00006604|460040791|FG016|Overall Study|Death|0|||
127842619|NCT00006604|460040775|FG000|Overall Study|Severe debilitation, unable to continue|0|||
127842620|NCT00006604|460040776|FG001|Overall Study|Severe debilitation, unable to continue|0|||
127842621|NCT00006604|460040777|FG002|Overall Study|Severe debilitation, unable to continue|0|||
127842622|NCT00006604|460040778|FG003|Overall Study|Severe debilitation, unable to continue|0|||
127842623|NCT00006604|460040779|FG004|Overall Study|Severe debilitation, unable to continue|0|||
127842624|NCT00006604|460040780|FG005|Overall Study|Severe debilitation, unable to continue|0|||
127842625|NCT00006604|460040781|FG006|Overall Study|Severe debilitation, unable to continue|3|||
127842626|NCT00006604|460040782|FG007|Overall Study|Severe debilitation, unable to continue|0|||
127842627|NCT00006604|460040783|FG008|Overall Study|Severe debilitation, unable to continue|0|||
127842628|NCT00006604|460040784|FG009|Overall Study|Severe debilitation, unable to continue|5|||
127842629|NCT00006604|460040785|FG010|Overall Study|Severe debilitation, unable to continue|0|||
127842630|NCT00006604|460040786|FG011|Overall Study|Severe debilitation, unable to continue|2|||
127842631|NCT00006604|460040787|FG012|Overall Study|Severe debilitation, unable to continue|1|||
127842632|NCT00006604|460040788|FG013|Overall Study|Severe debilitation, unable to continue|0|||
127842633|NCT00006604|460040789|FG014|Overall Study|Severe debilitation, unable to continue|2|||
127842634|NCT00006604|460040790|FG015|Overall Study|Severe debilitation, unable to continue|0|||
127842635|NCT00006604|460040791|FG016|Overall Study|Severe debilitation, unable to continue|0|||
127842636|NCT00006604|460040775|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
127842637|NCT00006604|460040776|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
127842638|NCT00006604|460040777|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
127842639|NCT00006604|460040778|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
127842640|NCT00006604|460040779|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
127842641|NCT00006604|460040780|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
127842642|NCT00006604|460040781|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
127842643|NCT00006604|460040782|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
127842644|NCT00006604|460040783|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
127842645|NCT00006604|460040784|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
127842646|NCT00006604|460040785|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
127842647|NCT00006604|460040786|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
127842648|NCT00006604|460040787|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
127842649|NCT00006604|460040788|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
127842650|NCT00006604|460040789|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
127842651|NCT00006604|460040790|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
127842652|NCT00006604|460040791|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
127842653|NCT00006604|460040775|FG000|Overall Study|Site closing|0|||
127842654|NCT00006604|460040776|FG001|Overall Study|Site closing|0|||
127842655|NCT00006604|460040777|FG002|Overall Study|Site closing|1|||
127842656|NCT00006604|460040778|FG003|Overall Study|Site closing|1|||
127842657|NCT00006604|460040779|FG004|Overall Study|Site closing|0|||
127842658|NCT00006604|460040780|FG005|Overall Study|Site closing|0|||
127842659|NCT00006604|460040781|FG006|Overall Study|Site closing|0|||
127842660|NCT00006604|460040782|FG007|Overall Study|Site closing|1|||
127842661|NCT00006604|460040783|FG008|Overall Study|Site closing|0|||
127842662|NCT00006604|460040784|FG009|Overall Study|Site closing|0|||
127842663|NCT00006604|460040785|FG010|Overall Study|Site closing|0|||
127842664|NCT00006604|460040786|FG011|Overall Study|Site closing|1|||
127900395|NCT02458469|460260233|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
127842665|NCT00006604|460040787|FG012|Overall Study|Site closing|1|||
127900396|NCT02458469|460260234|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
127842666|NCT00006604|460040788|FG013|Overall Study|Site closing|1|||
127842667|NCT00006604|460040789|FG014|Overall Study|Site closing|0|||
127842668|NCT00006604|460040790|FG015|Overall Study|Site closing|0|||
127842669|NCT00006604|460040791|FG016|Overall Study|Site closing|1|||
127842670|NCT00006604|460040775|FG000|Overall Study|Withdrawal by Subject|1|||
127842671|NCT00006604|460040776|FG001|Overall Study|Withdrawal by Subject|0|||
127842672|NCT00006604|460040777|FG002|Overall Study|Withdrawal by Subject|2|||
127842673|NCT00006604|460040778|FG003|Overall Study|Withdrawal by Subject|0|||
127842674|NCT00006604|460040779|FG004|Overall Study|Withdrawal by Subject|1|||
127842675|NCT00006604|460040780|FG005|Overall Study|Withdrawal by Subject|2|||
127842676|NCT00006604|460040781|FG006|Overall Study|Withdrawal by Subject|2|||
127842677|NCT00006604|460040782|FG007|Overall Study|Withdrawal by Subject|0|||
127842678|NCT00006604|460040783|FG008|Overall Study|Withdrawal by Subject|1|||
127842679|NCT00006604|460040784|FG009|Overall Study|Withdrawal by Subject|3|||
127900397|NCT02458469|460260235|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
127900398|NCT02458469|460260236|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
127900399|NCT02458469|460260237|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
127900400|NCT02458469|460260232|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
127900401|NCT02458469|460260233|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
127900402|NCT02458469|460260234|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
127900403|NCT02458469|460260235|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
127900404|NCT02458469|460260236|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
127900405|NCT02458469|460260237|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
127900406|NCT04534283|460260238|FG000|Overall Study|Physician Decision|2|||
127900407|NCT04534283|460260238|FG000|Overall Study|Withdrawal by Subject|1|||
127900408|NCT04534283|460260238|FG000|Overall Study|Disease Progression|12|||
127900409|NCT04534283|460260238|FG000|Overall Study|Adverse Event|1|||
127900410|NCT00661505|460260239|FG000|Overall Study|Adverse Event|3|||
127900411|NCT00661505|460260239|FG000|Overall Study|Protocol Violation|14|||
127900412|NCT00661505|460260239|FG000|Overall Study|Withdrawal by Subject|8|||
127900413|NCT00661505|460260239|FG000|Overall Study|Lost to Follow-up|3|||
127900414|NCT00661505|460260239|FG000|Overall Study|Other|2|||
127900415|NCT03561883|460260240|FG000|Overall Study|Adverse Event|10|||
127900416|NCT03561883|460260241|FG001|Overall Study|Adverse Event|13|||
127900417|NCT03561883|460260240|FG000|Overall Study|Non-Compliance With Study Drug|1|||
127900418|NCT03561883|460260241|FG001|Overall Study|Non-Compliance With Study Drug|2|||
127900419|NCT03561883|460260240|FG000|Overall Study|Protocol Violation|2|||
127900420|NCT03561883|460260241|FG001|Overall Study|Protocol Violation|3|||
127900421|NCT03561883|460260240|FG000|Overall Study|Withdrawal by Subject|14|||
127900422|NCT03561883|460260241|FG001|Overall Study|Withdrawal by Subject|6|||
127900423|NCT03561883|460260240|FG000|Overall Study|Lost to Follow-up|2|||
127900424|NCT03561883|460260241|FG001|Overall Study|Lost to Follow-up|6|||
127900425|NCT03561883|460260240|FG000|Overall Study|Study Terminated by Sponsor|12|||
127900426|NCT03561883|460260241|FG001|Overall Study|Study Terminated by Sponsor|11|||
127900427|NCT03561883|460260240|FG000|Overall Study|Physician Decision|1|||
127900428|NCT03561883|460260241|FG001|Overall Study|Physician Decision|0|||
127900429|NCT03561883|460260240|FG000|Overall Study|Randomized by Mistake|1|||
127900430|NCT03561883|460260241|FG001|Overall Study|Randomized by Mistake|0|||
127900431|NCT03561883|460260240|FG000|Overall Study|Other, Not Specified|3|||
127900432|NCT03561883|460260241|FG001|Overall Study|Other, Not Specified|2|||
127900433|NCT06354270|460260242|FG000|Overall Study|Withdrawal by Subject|1|||
127900434|NCT06354270|460260243|FG001|Overall Study|Withdrawal by Subject|0|||
127900435|NCT01939197|460260244|FG000|Overall Study|Withdrawal by Subject|1|||
127900436|NCT01939197|460260245|FG001|Overall Study|Withdrawal by Subject|0|||
127900437|NCT01939197|460260246|FG002|Overall Study|Withdrawal by Subject|0|||
127900438|NCT01939197|460260247|FG003|Overall Study|Withdrawal by Subject|0|||
127900439|NCT01939197|460260248|FG004|Overall Study|Withdrawal by Subject|1|||
127900440|NCT01939197|460260249|FG005|Overall Study|Withdrawal by Subject|0|||
127900441|NCT01939197|460260250|FG006|Overall Study|Withdrawal by Subject|0|||
127900442|NCT01939197|460260244|FG000|Overall Study|Lost to Follow-up|0|||
127900443|NCT01939197|460260245|FG001|Overall Study|Lost to Follow-up|1|||
127900444|NCT01939197|460260246|FG002|Overall Study|Lost to Follow-up|0|||
127900445|NCT01939197|460260247|FG003|Overall Study|Lost to Follow-up|1|||
127900446|NCT01939197|460260248|FG004|Overall Study|Lost to Follow-up|3|||
127900447|NCT01939197|460260249|FG005|Overall Study|Lost to Follow-up|1|||
127900448|NCT01939197|460260250|FG006|Overall Study|Lost to Follow-up|2|||
127900449|NCT00745095|460260251|FG000|Overall Study|Declined to participate|1|||
127900450|NCT00745095|460260252|FG001|Overall Study|Declined to participate|0|||
127900451|NCT00745095|460260253|FG002|Overall Study|Declined to participate|0|||
127842680|NCT00006604|460040785|FG010|Overall Study|Withdrawal by Subject|2|||
127842681|NCT00006604|460040786|FG011|Overall Study|Withdrawal by Subject|0|||
127842682|NCT00006604|460040787|FG012|Overall Study|Withdrawal by Subject|1|||
127900452|NCT00745095|460260254|FG003|Overall Study|Declined to participate|0|||
127900453|NCT00745095|460260255|FG004|Overall Study|Declined to participate|92|||
127900454|NCT00745095|460260256|FG005|Overall Study|Declined to participate|95|||
127842683|NCT00006604|460040788|FG013|Overall Study|Withdrawal by Subject|2|||
127842684|NCT00006604|460040789|FG014|Overall Study|Withdrawal by Subject|1|||
127842685|NCT00006604|460040790|FG015|Overall Study|Withdrawal by Subject|0|||
127842686|NCT00006604|460040791|FG016|Overall Study|Withdrawal by Subject|1|||
127842687|NCT00006604|460040775|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
127842688|NCT00006604|460040776|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
127842689|NCT00006604|460040777|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
127842690|NCT00006604|460040778|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
127842691|NCT00006604|460040779|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
127842692|NCT00006604|460040780|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
127842693|NCT00006604|460040781|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
127842694|NCT00006604|460040782|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
127842695|NCT00006604|460040783|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
127842696|NCT00006604|460040784|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
127842697|NCT00006604|460040785|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
127842698|NCT00006604|460040786|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
127842699|NCT00006604|460040787|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
127842700|NCT00006604|460040788|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
127842701|NCT00006604|460040789|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
127842702|NCT00006604|460040790|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
127842703|NCT00006604|460040791|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
127842704|NCT00006604|460040775|FG000|Overall Study|Lost to Follow-up|0|||
127842705|NCT00006604|460040776|FG001|Overall Study|Lost to Follow-up|0|||
127842706|NCT00006604|460040777|FG002|Overall Study|Lost to Follow-up|0|||
127842707|NCT00006604|460040778|FG003|Overall Study|Lost to Follow-up|0|||
127842708|NCT00006604|460040779|FG004|Overall Study|Lost to Follow-up|0|||
127842709|NCT00006604|460040780|FG005|Overall Study|Lost to Follow-up|0|||
127842710|NCT00006604|460040781|FG006|Overall Study|Lost to Follow-up|0|||
127842711|NCT00006604|460040782|FG007|Overall Study|Lost to Follow-up|1|||
127842712|NCT00006604|460040783|FG008|Overall Study|Lost to Follow-up|0|||
127842713|NCT00006604|460040784|FG009|Overall Study|Lost to Follow-up|2|||
127842714|NCT00006604|460040785|FG010|Overall Study|Lost to Follow-up|0|||
127842715|NCT00006604|460040786|FG011|Overall Study|Lost to Follow-up|0|||
127842716|NCT00006604|460040787|FG012|Overall Study|Lost to Follow-up|0|||
127842717|NCT00006604|460040788|FG013|Overall Study|Lost to Follow-up|0|||
127842718|NCT00006604|460040789|FG014|Overall Study|Lost to Follow-up|0|||
127842719|NCT00006604|460040790|FG015|Overall Study|Lost to Follow-up|1|||
127842720|NCT00006604|460040791|FG016|Overall Study|Lost to Follow-up|3|||
127842721|NCT00006604|460040775|FG000|Overall Study|Other Reason|0|||
127842722|NCT00006604|460040776|FG001|Overall Study|Other Reason|0|||
127842723|NCT00006604|460040777|FG002|Overall Study|Other Reason|0|||
127842724|NCT00006604|460040778|FG003|Overall Study|Other Reason|0|||
127842725|NCT00006604|460040779|FG004|Overall Study|Other Reason|0|||
127842726|NCT00006604|460040780|FG005|Overall Study|Other Reason|1|||
127842727|NCT00006604|460040781|FG006|Overall Study|Other Reason|0|||
127842728|NCT00006604|460040782|FG007|Overall Study|Other Reason|0|||
127900455|NCT00745095|460260251|FG000|Overall Study|Ineligible due to GFR criteria|0|||
127900456|NCT00745095|460260252|FG001|Overall Study|Ineligible due to GFR criteria|2|||
127900457|NCT00745095|460260253|FG002|Overall Study|Ineligible due to GFR criteria|3|||
127900458|NCT00745095|460260254|FG003|Overall Study|Ineligible due to GFR criteria|3|||
127900459|NCT00745095|460260255|FG004|Overall Study|Ineligible due to GFR criteria|30|||
127900460|NCT00745095|460260256|FG005|Overall Study|Ineligible due to GFR criteria|28|||
127900461|NCT00958243|460260257|FG000|Overall Study|Withdrawal by Subject|0|||
127900462|NCT00958243|460260258|FG001|Overall Study|Withdrawal by Subject|1|||
127900463|NCT00958243|460260259|FG002|Overall Study|Withdrawal by Subject|3|||
127900464|NCT00958243|460260260|FG003|Overall Study|Withdrawal by Subject|1|||
127900465|NCT00958243|460260261|FG004|Overall Study|Withdrawal by Subject|1|||
127900466|NCT00958243|460260262|FG005|Overall Study|Withdrawal by Subject|5|||
127900467|NCT00958243|460260257|FG000|Overall Study|Lost to Follow-up|2|||
127900468|NCT00958243|460260258|FG001|Overall Study|Lost to Follow-up|5|||
127900469|NCT00958243|460260259|FG002|Overall Study|Lost to Follow-up|11|||
127900470|NCT00958243|460260260|FG003|Overall Study|Lost to Follow-up|2|||
127900471|NCT00958243|460260261|FG004|Overall Study|Lost to Follow-up|8|||
127900472|NCT00958243|460260262|FG005|Overall Study|Lost to Follow-up|5|||
127900473|NCT01974141|460260267|FG000|Overall Study|Other Reasons|28|||
127900474|NCT01974141|460260268|FG001|Overall Study|Other Reasons|18|||
127900475|NCT01974141|460260267|FG000|Overall Study|Protocol Violation|2|||
127900476|NCT01974141|460260268|FG001|Overall Study|Protocol Violation|6|||
127900477|NCT01974141|460260267|FG000|Overall Study|Personal Reasons|21|||
127900478|NCT01974141|460260268|FG001|Overall Study|Personal Reasons|20|||
127842729|NCT00006604|460040783|FG008|Overall Study|Other Reason|0|||
127842730|NCT00006604|460040784|FG009|Overall Study|Other Reason|1|||
127842731|NCT00006604|460040785|FG010|Overall Study|Other Reason|0|||
127842732|NCT00006604|460040786|FG011|Overall Study|Other Reason|0|||
127900479|NCT01974141|460260267|FG000|Overall Study|Lost to Follow-up|38|||
127842733|NCT00006604|460040787|FG012|Overall Study|Other Reason|0|||
127842734|NCT00006604|460040788|FG013|Overall Study|Other Reason|0|||
127842735|NCT00006604|460040789|FG014|Overall Study|Other Reason|0|||
127842736|NCT00006604|460040790|FG015|Overall Study|Other Reason|0|||
127842737|NCT00006604|460040791|FG016|Overall Study|Other Reason|0|||
127842738|NCT01056341|460040794|FG000|Overall Study|Treatment Intolerance|0|||
127842739|NCT01056341|460040795|FG001|Overall Study|Treatment Intolerance|2|||
127842740|NCT01056341|460040796|FG002|Overall Study|Treatment Intolerance|0|||
127842741|NCT01056341|460040797|FG003|Overall Study|Treatment Intolerance|2|||
127842742|NCT01056341|460040798|FG004|Overall Study|Treatment Intolerance|0|||
127842743|NCT01056341|460040794|FG000|Overall Study|Lack of Efficacy|32|||
127842744|NCT01056341|460040795|FG001|Overall Study|Lack of Efficacy|30|||
127842745|NCT01056341|460040796|FG002|Overall Study|Lack of Efficacy|7|||
127842746|NCT01056341|460040797|FG003|Overall Study|Lack of Efficacy|25|||
127842747|NCT01056341|460040798|FG004|Overall Study|Lack of Efficacy|9|||
127842748|NCT01056341|460040794|FG000|Overall Study|Other reasons|4|||
127842749|NCT01056341|460040795|FG001|Overall Study|Other reasons|4|||
127842750|NCT01056341|460040796|FG002|Overall Study|Other reasons|8|||
127842751|NCT01056341|460040797|FG003|Overall Study|Other reasons|9|||
127842752|NCT01056341|460040798|FG004|Overall Study|Other reasons|5|||
127842753|NCT01086150|460040799|FG000|Overall Study|Withdrawal by Subject|0|||
127842754|NCT01086150|460040800|FG001|Overall Study|Withdrawal by Subject|4|||
127842755|NCT01086150|460040801|FG002|Overall Study|Withdrawal by Subject|1|||
127842756|NCT01086150|460040799|FG000|Overall Study|Lost to Follow-up|0|||
127842757|NCT01086150|460040800|FG001|Overall Study|Lost to Follow-up|1|||
127842758|NCT01086150|460040801|FG002|Overall Study|Lost to Follow-up|0|||
127842759|NCT01086150|460040799|FG000|Overall Study|Screen Failure|0|||
127842760|NCT01086150|460040800|FG001|Overall Study|Screen Failure|1|||
127842761|NCT01086150|460040801|FG002|Overall Study|Screen Failure|0|||
127842762|NCT01167582|460040802|FG000|Overall Study|Lost to Follow-up|0|||
127842763|NCT01167582|460040803|FG001|Overall Study|Lost to Follow-up|1|||
127842764|NCT01182337|460040806|FG000|Overall Study|Withdrawal by Subject|3|||
127842765|NCT01182337|460040807|FG001|Overall Study|Withdrawal by Subject|1|||
127842766|NCT01182337|460040806|FG000|Overall Study|Lost to Follow-up|0|||
127842767|NCT01182337|460040807|FG001|Overall Study|Lost to Follow-up|1|||
127842768|NCT03448224|460040808|FG000|Overall Study|Provided same answer to every question|1|||
127842769|NCT03448224|460040809|FG001|Overall Study|Provided same answer to every question|0|||
127842770|NCT03103906|460040810|FG000|Overall Study|Adverse Event|2|||
127842771|NCT03103906|460040811|FG001|Overall Study|Adverse Event|3|||
127842772|NCT03103906|460040810|FG000|Overall Study|Other|2|||
127842773|NCT03103906|460040811|FG001|Overall Study|Other|0|||
127842774|NCT03571256|460040812|FG000|Overall Study|Adverse Event|3|||
127842775|NCT03571256|460040813|FG001|Overall Study|Adverse Event|0|||
127842776|NCT03571256|460040814|FG002|Overall Study|Adverse Event|1|||
127842777|NCT03571256|460040812|FG000|Overall Study|Withdrawal by Subject|3|||
127842778|NCT03571256|460040813|FG001|Overall Study|Withdrawal by Subject|1|||
127842779|NCT03571256|460040814|FG002|Overall Study|Withdrawal by Subject|1|||
127842780|NCT03571256|460040812|FG000|Overall Study|Other than specified|0|||
127842781|NCT03571256|460040813|FG001|Overall Study|Other than specified|1|||
127842782|NCT03571256|460040814|FG002|Overall Study|Other than specified|1|||
127842783|NCT03571256|460040812|FG000|Overall Study|Protocol Violation|0|||
127842784|NCT03571256|460040813|FG001|Overall Study|Protocol Violation|1|||
127842785|NCT03571256|460040814|FG002|Overall Study|Protocol Violation|1|||
127842786|NCT00575094|460040815|FG000|Overall Study|Adverse Event|2|||
127842787|NCT00575094|460040815|FG000|Overall Study|Withdrawal by Subject|1|||
127842788|NCT00772382|460040821|FG000|Overall Study|Adverse Event|19|||
127842789|NCT00772382|460040821|FG000|Overall Study|Death|6|||
127842790|NCT00772382|460040821|FG000|Overall Study|Lack of Efficacy|4|||
127842791|NCT00772382|460040821|FG000|Overall Study|Physician Decision|5|||
127842792|NCT00772382|460040821|FG000|Overall Study|Protocol Violation|1|||
127842793|NCT00772382|460040821|FG000|Overall Study|Withdrawal by Subject|10|||
127842794|NCT00772382|460040821|FG000|Overall Study|Other Reasons|10|||
127842795|NCT00643604|460040822|FG000|Overall Study|Death|1|||
127842796|NCT02702011|460040825|FG000|Overall Study|Withdrawal by Subject|0|||
127842797|NCT02702011|460040826|FG001|Overall Study|Withdrawal by Subject|1|||
127842798|NCT02702011|460040827|FG002|Overall Study|Withdrawal by Subject|0|||
127842799|NCT02702011|460040828|FG003|Overall Study|Withdrawal by Subject|0|||
127842800|NCT04142216|460040830|FG000|Overall Study|Hospitalization|0|||
127842801|NCT04142216|460040831|FG001|Overall Study|Hospitalization|2|||
127842802|NCT04142216|460040830|FG000|Overall Study|Death|3|||
127842803|NCT04142216|460040831|FG001|Overall Study|Death|1|||
127842804|NCT04142216|460040830|FG000|Overall Study|Referral to another hemodialysis unit|3|||
127842805|NCT04142216|460040831|FG001|Overall Study|Referral to another hemodialysis unit|2|||
127842806|NCT04142216|460040830|FG000|Overall Study|Use of clove|0|||
127842807|NCT04142216|460040831|FG001|Overall Study|Use of clove|1|||
127842808|NCT02007954|460040832|FG000|Overall Study|Received liver transplant|3|||
127842809|NCT02007954|460040832|FG000|Overall Study|Switch in treatment modality|2|||
127842810|NCT02007954|460040832|FG000|Overall Study|Disease progression and unrelated AE|1|||
127842811|NCT02007954|460040832|FG000|Overall Study|Death|1|||
127842812|NCT00475540|460040833|FG000|36 Months|Lost to Follow-up|4|||
127842813|NCT00475540|460040834|FG001|36 Months|Lost to Follow-up|4|||
127842814|NCT00475540|460040833|FG000|36 Months|Death|1|||
127842815|NCT00475540|460040834|FG001|36 Months|Death|2|||
127842816|NCT00475540|460040833|FG000|36 Months|Censored due to reoperation|3|||
127842817|NCT00475540|460040834|FG001|36 Months|Censored due to reoperation|0|||
127842818|NCT00377429|460040835|FG000|Overall Study|Withdrawal by Subject|5|||
127842819|NCT00377429|460040835|FG000|Overall Study|Adverse Event|8|||
127842820|NCT00377429|460040835|FG000|Overall Study|Physician Decision|1|||
127842821|NCT00377429|460040835|FG000|Overall Study|Patient non-compliance|1|||
127842822|NCT01033487|460040838|FG000|Fourth Intervention Period|Adverse Event|0|||
127842823|NCT01033487|460040839|FG001|Fourth Intervention Period|Adverse Event|0|||
127842824|NCT01033487|460040840|FG002|Fourth Intervention Period|Adverse Event|0|||
127842825|NCT01033487|460040841|FG003|Fourth Intervention Period|Adverse Event|0|||
127842826|NCT01033487|460040842|FG004|Fourth Intervention Period|Adverse Event|0|||
127842827|NCT01033487|460040843|FG005|Fourth Intervention Period|Adverse Event|0|||
127842828|NCT01033487|460040844|FG006|Fourth Intervention Period|Adverse Event|0|||
127842829|NCT01033487|460040845|FG007|Fourth Intervention Period|Adverse Event|0|||
127842830|NCT01033487|460040846|FG008|Fourth Intervention Period|Adverse Event|1|||
127900480|NCT01974141|460260268|FG001|Overall Study|Lost to Follow-up|29|||
127842831|NCT01033487|460040847|FG009|Fourth Intervention Period|Adverse Event|0|||
127842832|NCT02939599|460040851|FG000|Overall Study|Adverse Event|1|||
127842833|NCT02939599|460040852|FG001|Overall Study|Adverse Event|0|||
127842834|NCT02939599|460040851|FG000|Overall Study|Study Terminated By Sponsor|2|||
127842835|NCT02939599|460040852|FG001|Overall Study|Study Terminated By Sponsor|2|||
127900481|NCT01974141|460260267|FG000|Overall Study|Pregnancy|3|||
127900482|NCT01974141|460260268|FG001|Overall Study|Pregnancy|3|||
127900483|NCT01974141|460260267|FG000|Overall Study|Lack of Efficacy|0|||
127900484|NCT01974141|460260268|FG001|Overall Study|Lack of Efficacy|1|||
127900485|NCT01974141|460260267|FG000|Overall Study|Adverse Event|4|||
127900486|NCT01974141|460260268|FG001|Overall Study|Adverse Event|5|||
127900487|NCT00950872|460260272|FG000|Overall Study|Withdrawal by Subject|1|||
127842836|NCT02148211|460040853|FG000|Overall Study|Lost to Follow-up|352|||
127842837|NCT02726113|460040854|FG000|Total Enrollment|Physician Decision|0|||
127842838|NCT02726113|460040855|FG001|Total Enrollment|Physician Decision|1|||
127842839|NCT02726113|460040854|FG000|Total Enrollment|Protocol Violation|1|||
127842840|NCT02726113|460040855|FG001|Total Enrollment|Protocol Violation|0|||
127842841|NCT02726113|460040854|FG000|Total Enrollment|Withdrawal by Subject|2|||
127842842|NCT02726113|460040855|FG001|Total Enrollment|Withdrawal by Subject|1|||
127842843|NCT02726113|460040854|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
127842844|NCT02726113|460040855|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
127842845|NCT02726113|460040854|FG000|Genomic Analysis|Protocol Violation|1|||
127842846|NCT02726113|460040855|FG001|Genomic Analysis|Protocol Violation|0|||
127842847|NCT02726113|460040854|FG000|Genomic Analysis|Withdrawal by Subject|2|||
127842848|NCT02726113|460040855|FG001|Genomic Analysis|Withdrawal by Subject|1|||
127842849|NCT02726113|460040854|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
127842850|NCT02726113|460040855|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
127842851|NCT00656084|460043006|FG000|Overall Study|Adverse Event|4|||
127842852|NCT00656084|460043006|FG000|Overall Study|Withdrawal by Subject|1|||
127842853|NCT00656084|460043006|FG000|Overall Study|Patient Request|1|||
127842854|NCT00656084|460043006|FG000|Overall Study|Investigator Request|1|||
127842855|NCT01494987|460043007|FG000|Overall Study|Adverse Event|6|||
127842856|NCT01494987|460043008|FG001|Overall Study|Adverse Event|5|||
127842857|NCT01494987|460043007|FG000|Overall Study|Hyperglycemia|6|||
127842858|NCT01494987|460043008|FG001|Overall Study|Hyperglycemia|4|||
127842859|NCT01494987|460043007|FG000|Overall Study|Investigator's Discretion|1|||
127842860|NCT01494987|460043008|FG001|Overall Study|Investigator's Discretion|2|||
127842861|NCT01494987|460043007|FG000|Overall Study|Lost to Follow-up|1|||
127900488|NCT00950872|460260272|FG000|Overall Study|Did not have surgery|2|||
127842862|NCT01494987|460043008|FG001|Overall Study|Lost to Follow-up|1|||
127842863|NCT01494987|460043007|FG000|Overall Study|Protocol Violation|3|||
127842864|NCT01494987|460043008|FG001|Overall Study|Protocol Violation|3|||
127900489|NCT01139164|460260274|FG000|Overall Study|Withdrawn prior to study start|0|||
127900490|NCT01139164|460260275|FG001|Overall Study|Withdrawn prior to study start|2|||
127842865|NCT01494987|460043007|FG000|Overall Study|Subject Non-Compliance|9|||
127842866|NCT01494987|460043008|FG001|Overall Study|Subject Non-Compliance|10|||
127842867|NCT01494987|460043007|FG000|Overall Study|Subject Withdrew Consent|2|||
127842868|NCT01494987|460043008|FG001|Overall Study|Subject Withdrew Consent|3|||
127842869|NCT00640146|460043014|FG000|Overall Study|Adverse Event|2|||
127842870|NCT00640146|460043015|FG001|Overall Study|Adverse Event|0|||
127842871|NCT00640146|460043014|FG000|Overall Study|Lost to Follow-up|0|||
127842872|NCT00640146|460043015|FG001|Overall Study|Lost to Follow-up|1|||
127900491|NCT01139164|460260276|FG002|Overall Study|Withdrawn prior to study start|0|||
127900492|NCT01759290|460260279|FG000|Overall Study|Subjects withdrawn consent|5|||
127900493|NCT01759290|460260279|FG000|Overall Study|Physician Decision|2|||
127842873|NCT00640146|460043014|FG000|Overall Study|Lack of Efficacy|0|||
127842874|NCT00640146|460043015|FG001|Overall Study|Lack of Efficacy|1|||
127842875|NCT00640146|460043014|FG000|Overall Study|Withdrawal by Subject|1|||
127842876|NCT00640146|460043015|FG001|Overall Study|Withdrawal by Subject|1|||
127842877|NCT00640146|460043014|FG000|Overall Study|Randomized but not treated|1|||
127842878|NCT00640146|460043015|FG001|Overall Study|Randomized but not treated|3|||
127842879|NCT04058158|460043016|FG000|Period 1|Death|1|||
127842880|NCT04058158|460043017|FG001|Period 1|Death|0|||
127842881|NCT04058158|460043016|FG000|Period 1|Adverse Event|1|||
127842882|NCT04058158|460043017|FG001|Period 1|Adverse Event|1|||
127900494|NCT01759290|460260279|FG000|Overall Study|Death|17|||
127900495|NCT01759290|460260279|FG000|Overall Study|Lost to Follow-up|53|||
127900496|NCT01759290|460260279|FG000|Overall Study|Unknown reason|4|||
127900497|NCT00406848|460260282|FG000|Overall Study|Withdrawal by Subject|27|||
127900498|NCT00406848|460260283|FG001|Overall Study|Withdrawal by Subject|22|||
127900499|NCT00406848|460260282|FG000|Overall Study|Adverse Event|38|||
127900500|NCT00406848|460260283|FG001|Overall Study|Adverse Event|7|||
127900501|NCT00406848|460260282|FG000|Overall Study|Lack of Efficacy|9|||
127900502|NCT00406848|460260283|FG001|Overall Study|Lack of Efficacy|14|||
127900503|NCT00406848|460260282|FG000|Overall Study|Protocol Violation|10|||
127900504|NCT00406848|460260283|FG001|Overall Study|Protocol Violation|6|||
127900505|NCT00406848|460260282|FG000|Overall Study|Lost to Follow-up|6|||
127900506|NCT00406848|460260283|FG001|Overall Study|Lost to Follow-up|2|||
127900507|NCT00406848|460260282|FG000|Overall Study|Physician Decision|2|||
127900508|NCT00406848|460260283|FG001|Overall Study|Physician Decision|2|||
127900509|NCT00406848|460260282|FG000|Overall Study|Sponsor Decision|1|||
127900510|NCT00406848|460260283|FG001|Overall Study|Sponsor Decision|1|||
127900511|NCT00352690|460260284|FG000|Overall Study|Determined to be ineligible|2|||
127900512|NCT00352690|460260285|FG001|Overall Study|Determined to be ineligible|0|||
127900513|NCT02719522|460260290|FG000|Overall Study|Implant Failure|4|||
127900514|NCT02719522|460260290|FG000|Overall Study|Death|2|||
127900515|NCT02719522|460260290|FG000|Overall Study|Lost to Follow-up|5|||
127900516|NCT05277389|460260292|FG000|Overall Study|Lost to Follow-up|1|||
127900517|NCT05277389|460260293|FG001|Overall Study|Lost to Follow-up|4|||
127900518|NCT06096168|460260294|FG000|Overall Study|Death|30|||
127900519|NCT06096168|460260294|FG000|Overall Study|Revision|2|||
127900520|NCT01706926|460260297|FG000|Overall Study|Lost to Follow-up|0|||
127900521|NCT01706926|460260298|FG001|Overall Study|Lost to Follow-up|0|||
127900522|NCT01706926|460260299|FG002|Overall Study|Lost to Follow-up|1|||
127900523|NCT01706926|460260300|FG003|Overall Study|Lost to Follow-up|0|||
127900524|NCT01706926|460260297|FG000|Overall Study|Withdrawal by Subject|2|||
127900525|NCT01706926|460260298|FG001|Overall Study|Withdrawal by Subject|0|||
127900526|NCT01706926|460260299|FG002|Overall Study|Withdrawal by Subject|1|||
127900527|NCT01706926|460260300|FG003|Overall Study|Withdrawal by Subject|2|||
127900528|NCT01706926|460260297|FG000|Overall Study|Other|4|||
127900529|NCT01706926|460260298|FG001|Overall Study|Other|4|||
127900530|NCT01706926|460260299|FG002|Overall Study|Other|4|||
127900531|NCT01706926|460260300|FG003|Overall Study|Other|3|||
127900532|NCT00419770|460261235|FG000|Overall Study|Withdrawal by Subject|5|||
127900533|NCT00419770|460261236|FG001|Overall Study|Withdrawal by Subject|1|||
127900534|NCT02848326|460261237|FG000|Treatment Period|Adverse Event|5|||
127900535|NCT02848326|460261238|FG001|Treatment Period|Adverse Event|4|||
127900536|NCT02848326|460261239|FG002|Treatment Period|Adverse Event|11|||
127900537|NCT02848326|460261240|FG003|Treatment Period|Adverse Event|6|||
127900538|NCT02848326|460261241|FG004|Treatment Period|Adverse Event|5|||
127900539|NCT02848326|460261242|FG005|Treatment Period|Adverse Event|7|||
127900540|NCT02848326|460261237|FG000|Treatment Period|Withdrawal of Consent|20|||
127900541|NCT02848326|460261238|FG001|Treatment Period|Withdrawal of Consent|6|||
127900542|NCT02848326|460261239|FG002|Treatment Period|Withdrawal of Consent|9|||
127900543|NCT02848326|460261240|FG003|Treatment Period|Withdrawal of Consent|6|||
127900544|NCT02848326|460261241|FG004|Treatment Period|Withdrawal of Consent|9|||
127900545|NCT02848326|460261242|FG005|Treatment Period|Withdrawal of Consent|6|||
127900546|NCT02848326|460261237|FG000|Treatment Period|Lost to Follow-up|5|||
127900547|NCT02848326|460261238|FG001|Treatment Period|Lost to Follow-up|1|||
127900548|NCT02848326|460261239|FG002|Treatment Period|Lost to Follow-up|11|||
127900549|NCT02848326|460261240|FG003|Treatment Period|Lost to Follow-up|7|||
127900550|NCT02848326|460261241|FG004|Treatment Period|Lost to Follow-up|2|||
127842883|NCT04058158|460043016|FG000|Period 1|Pregnancy|0|||
127842884|NCT04058158|460043017|FG001|Period 1|Pregnancy|1|||
127900551|NCT02848326|460261242|FG005|Treatment Period|Lost to Follow-up|3|||
127900552|NCT02848326|460261237|FG000|Treatment Period|Pregnancy|0|||
127900553|NCT02848326|460261238|FG001|Treatment Period|Pregnancy|0|||
127900554|NCT02848326|460261239|FG002|Treatment Period|Pregnancy|1|||
127900555|NCT02848326|460261240|FG003|Treatment Period|Pregnancy|1|||
127900556|NCT02848326|460261241|FG004|Treatment Period|Pregnancy|0|||
127900557|NCT02848326|460261242|FG005|Treatment Period|Pregnancy|1|||
127900558|NCT02848326|460261237|FG000|Treatment Period|Protocol Violation|4|||
127900559|NCT02848326|460261238|FG001|Treatment Period|Protocol Violation|3|||
127900560|NCT02848326|460261239|FG002|Treatment Period|Protocol Violation|4|||
127900561|NCT02848326|460261240|FG003|Treatment Period|Protocol Violation|2|||
127900562|NCT02848326|460261241|FG004|Treatment Period|Protocol Violation|3|||
127900563|NCT02848326|460261242|FG005|Treatment Period|Protocol Violation|3|||
127842885|NCT04847141|460043018|FG000|Overall Study|Adverse Event|1|||
127842886|NCT04847141|460043019|FG001|Overall Study|Adverse Event|0|||
127842887|NCT04847141|460043020|FG002|Overall Study|Adverse Event|1|||
127842888|NCT04847141|460043018|FG000|Overall Study|Withdrawal by Subject|2|||
127842889|NCT04847141|460043019|FG001|Overall Study|Withdrawal by Subject|4|||
127842890|NCT04847141|460043020|FG002|Overall Study|Withdrawal by Subject|3|||
127842891|NCT04847141|460043018|FG000|Overall Study|Lost to Follow-up|7|||
127842892|NCT04847141|460043019|FG001|Overall Study|Lost to Follow-up|5|||
127842893|NCT04847141|460043020|FG002|Overall Study|Lost to Follow-up|7|||
127842894|NCT04847141|460043018|FG000|Overall Study|Reason not Specified|0|||
127842895|NCT04847141|460043019|FG001|Overall Study|Reason not Specified|1|||
127842896|NCT04847141|460043020|FG002|Overall Study|Reason not Specified|0|||
127842897|NCT01634113|460043021|FG000|Overall Study|Not treated|0|||
127842898|NCT01634113|460043022|FG001|Overall Study|Not treated|0|||
127842899|NCT01634113|460043023|FG002|Overall Study|Not treated|1|||
127842900|NCT00324740|460043024|FG000|Overall Study|Withdrawal by Subject|1|||
127842901|NCT00324740|460043025|FG001|Overall Study|Withdrawal by Subject|0|||
127842902|NCT00324740|460043026|FG002|Overall Study|Withdrawal by Subject|1|||
127842903|NCT00520299|460043029|FG000|Overall Study|Withdrawal by Subject|0|||
127842904|NCT00520299|460043030|FG001|Overall Study|Withdrawal by Subject|0|||
127842905|NCT00520299|460043031|FG002|Overall Study|Withdrawal by Subject|2|||
127842906|NCT00520299|460043029|FG000|Overall Study|Progressive disease|0|||
127842907|NCT00520299|460043030|FG001|Overall Study|Progressive disease|3|||
127842908|NCT00520299|460043031|FG002|Overall Study|Progressive disease|4|||
127842909|NCT01352845|460043032|FG000|Overall Study|Lost to Follow-up|313|||
127842910|NCT01352845|460043033|FG001|Overall Study|Lost to Follow-up|92|||
127842911|NCT01352845|460043032|FG000|Overall Study|No Longer Willing to Participate|205|||
127842912|NCT01352845|460043033|FG001|Overall Study|No Longer Willing to Participate|58|||
127842913|NCT01352845|460043032|FG000|Overall Study|Withdrawal by Subject|48|||
127842914|NCT01352845|460043033|FG001|Overall Study|Withdrawal by Subject|16|||
127842915|NCT01352845|460043032|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
127842916|NCT01352845|460043033|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
127842917|NCT01352845|460043032|FG000|Overall Study|Pregnancy|27|||
127842918|NCT01352845|460043033|FG001|Overall Study|Pregnancy|7|||
127842919|NCT01352845|460043032|FG000|Overall Study|Adverse Event|22|||
127842920|NCT01352845|460043033|FG001|Overall Study|Adverse Event|6|||
127842921|NCT01352845|460043032|FG000|Overall Study|Other|17|||
127842922|NCT01352845|460043033|FG001|Overall Study|Other|7|||
127842923|NCT01352845|460043032|FG000|Overall Study|Protocol Violation|12|||
127842924|NCT01352845|460043033|FG001|Overall Study|Protocol Violation|6|||
127842925|NCT01352845|460043032|FG000|Overall Study|Death|3|||
127842926|NCT01352845|460043033|FG001|Overall Study|Death|0|||
127842927|NCT02528253|460043039|FG000|Overall Study|Adverse Event|3|||
127842928|NCT02528253|460043040|FG001|Overall Study|Adverse Event|4|||
127842929|NCT02528253|460043041|FG002|Overall Study|Adverse Event|4|||
127842930|NCT02528253|460043042|FG003|Overall Study|Adverse Event|8|||
127842931|NCT02528253|460043043|FG004|Overall Study|Adverse Event|18|||
127842932|NCT02528253|460043039|FG000|Overall Study|Death|2|||
127842933|NCT02528253|460043040|FG001|Overall Study|Death|2|||
127842934|NCT02528253|460043041|FG002|Overall Study|Death|1|||
127842935|NCT02528253|460043042|FG003|Overall Study|Death|0|||
127842936|NCT02528253|460043043|FG004|Overall Study|Death|1|||
127842937|NCT02528253|460043039|FG000|Overall Study|Insufficient clinical response|7|||
127842938|NCT02528253|460043040|FG001|Overall Study|Insufficient clinical response|10|||
127842939|NCT02528253|460043041|FG002|Overall Study|Insufficient clinical response|13|||
127842940|NCT02528253|460043042|FG003|Overall Study|Insufficient clinical response|12|||
127842941|NCT02528253|460043043|FG004|Overall Study|Insufficient clinical response|16|||
127842942|NCT02528253|460043039|FG000|Overall Study|Lost to Follow-up|16|||
127842943|NCT02528253|460043040|FG001|Overall Study|Lost to Follow-up|9|||
127842944|NCT02528253|460043041|FG002|Overall Study|Lost to Follow-up|31|||
127842945|NCT02528253|460043042|FG003|Overall Study|Lost to Follow-up|16|||
127842946|NCT02528253|460043043|FG004|Overall Study|Lost to Follow-up|34|||
127842947|NCT02528253|460043039|FG000|Overall Study|Other|21|||
127842948|NCT02528253|460043040|FG001|Overall Study|Other|22|||
127842949|NCT02528253|460043041|FG002|Overall Study|Other|58|||
127842950|NCT02528253|460043042|FG003|Overall Study|Other|52|||
127842951|NCT02528253|460043043|FG004|Overall Study|Other|76|||
127842952|NCT02528253|460043039|FG000|Overall Study|Withdrawal by Subject|25|||
127842953|NCT02528253|460043040|FG001|Overall Study|Withdrawal by Subject|20|||
127842954|NCT02528253|460043041|FG002|Overall Study|Withdrawal by Subject|29|||
127900564|NCT02848326|460261237|FG000|Treatment Period|Non-compliance with Study Drug|4|||
127842955|NCT02528253|460043042|FG003|Overall Study|Withdrawal by Subject|48|||
127842956|NCT02528253|460043043|FG004|Overall Study|Withdrawal by Subject|73|||
127842957|NCT02528253|460043039|FG000|Overall Study|Protocol Violation|1|||
127842958|NCT02528253|460043040|FG001|Overall Study|Protocol Violation|2|||
127900565|NCT02848326|460261238|FG001|Treatment Period|Non-compliance with Study Drug|0|||
127900566|NCT02848326|460261239|FG002|Treatment Period|Non-compliance with Study Drug|0|||
127900567|NCT02848326|460261240|FG003|Treatment Period|Non-compliance with Study Drug|1|||
127900568|NCT02848326|460261241|FG004|Treatment Period|Non-compliance with Study Drug|0|||
127900569|NCT02848326|460261242|FG005|Treatment Period|Non-compliance with Study Drug|0|||
127900570|NCT02848326|460261237|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
127900571|NCT02848326|460261238|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
127900572|NCT02848326|460261239|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
127900573|NCT02848326|460261240|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
127900574|NCT02848326|460261241|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
127900575|NCT02848326|460261242|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
127900576|NCT02848326|460261237|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
127900577|NCT02848326|460261238|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
127900578|NCT02848326|460261239|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
127900579|NCT02848326|460261240|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
127900580|NCT02848326|460261241|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
127900581|NCT02848326|460261242|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
127900582|NCT04526210|460261244|FG000|Overall Study|Sponsor decision|7|||
127900583|NCT04526210|460261245|FG001|Overall Study|Sponsor decision|5|||
127900584|NCT04526210|460261244|FG000|Overall Study|Withdrawal by Subject|3|||
127900585|NCT04526210|460261245|FG001|Overall Study|Withdrawal by Subject|2|||
127900586|NCT02937701|460261246|FG000|Day 1 to Week 22|Adverse Event|11|||
127900587|NCT02937701|460261247|FG001|Day 1 to Week 22|Adverse Event|14|||
127900588|NCT02937701|460261248|FG002|Day 1 to Week 22|Adverse Event|0|||
127842959|NCT02528253|460043041|FG002|Overall Study|Protocol Violation|4|||
127842960|NCT02528253|460043042|FG003|Overall Study|Protocol Violation|0|||
127900589|NCT02937701|460261249|FG003|Day 1 to Week 22|Adverse Event|0|||
127900590|NCT02937701|460261250|FG004|Day 1 to Week 22|Adverse Event|0|||
127900591|NCT02937701|460261246|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
127900592|NCT02937701|460261247|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
127900593|NCT02937701|460261248|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
127900594|NCT02937701|460261249|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
127900595|NCT02937701|460261250|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
127900596|NCT02937701|460261246|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
127900597|NCT02937701|460261247|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
127900598|NCT02937701|460261248|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
127900599|NCT02937701|460261249|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
127900600|NCT02937701|460261250|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
127900601|NCT02937701|460261246|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
127900602|NCT02937701|460261247|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
127900603|NCT02937701|460261248|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
127900604|NCT02937701|460261249|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
127900605|NCT02937701|460261250|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
127900606|NCT02937701|460261246|FG000|Day 1 to Week 22|Death|1|||
127900607|NCT02937701|460261247|FG001|Day 1 to Week 22|Death|1|||
127842961|NCT02528253|460043043|FG004|Overall Study|Protocol Violation|4|||
127842962|NCT02528253|460043039|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
127842963|NCT02528253|460043040|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
127842964|NCT02528253|460043041|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
127842965|NCT02528253|460043042|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
127842966|NCT02528253|460043043|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
127842967|NCT01357980|460043044|FG000|Overall Study|Lack of Efficacy|0|||
127842968|NCT01357980|460043045|FG001|Overall Study|Lack of Efficacy|1|||
127842969|NCT01357980|460043046|FG002|Overall Study|Lack of Efficacy|0|||
127842970|NCT01357980|460043047|FG003|Overall Study|Lack of Efficacy|0|||
127842971|NCT01357980|460043044|FG000|Overall Study|Consent withdrawn|0|||
127900608|NCT02937701|460261248|FG002|Day 1 to Week 22|Death|0|||
127900609|NCT02937701|460261249|FG003|Day 1 to Week 22|Death|0|||
127900610|NCT02937701|460261250|FG004|Day 1 to Week 22|Death|0|||
127900611|NCT02937701|460261246|FG000|Day 1 to Week 22|Protocol Violation|1|||
127900612|NCT02937701|460261247|FG001|Day 1 to Week 22|Protocol Violation|1|||
127900613|NCT02937701|460261248|FG002|Day 1 to Week 22|Protocol Violation|0|||
127900614|NCT02937701|460261249|FG003|Day 1 to Week 22|Protocol Violation|0|||
127900615|NCT02937701|460261250|FG004|Day 1 to Week 22|Protocol Violation|0|||
127900616|NCT02937701|460261246|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
127900617|NCT02937701|460261247|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
127900618|NCT02937701|460261248|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
127842972|NCT01357980|460043045|FG001|Overall Study|Consent withdrawn|0|||
127900619|NCT02937701|460261249|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
127900620|NCT02937701|460261250|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
127842973|NCT01357980|460043046|FG002|Overall Study|Consent withdrawn|1|||
127900621|NCT02937701|460261246|FG000|Day 1 to Week 22|Physician Decision|2|||
127842974|NCT01357980|460043047|FG003|Overall Study|Consent withdrawn|0|||
127842975|NCT04507776|460043048|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
127842976|NCT02293993|460043050|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
127842977|NCT02293993|460043051|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
127842978|NCT02293993|460043052|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
127842979|NCT02293993|460043053|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
127842980|NCT02293993|460043050|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
127842981|NCT02293993|460043051|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
127842982|NCT02293993|460043052|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
127842983|NCT02293993|460043053|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
127842984|NCT02293993|460043050|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
127842985|NCT02293993|460043051|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
127842986|NCT02293993|460043052|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
127842987|NCT02293993|460043053|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
127842988|NCT02293993|460043050|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
127842989|NCT02293993|460043051|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
127842990|NCT02293993|460043052|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
127842991|NCT02293993|460043053|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
127842992|NCT02293993|460043050|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
127842993|NCT02293993|460043051|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
127842994|NCT02293993|460043052|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
127842995|NCT02293993|460043053|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
127842996|NCT00094835|460043054|FG000|Overall Study|Physician Decision|1|||
127842997|NCT00094835|460043055|FG001|Overall Study|Physician Decision|0|||
127842998|NCT00094835|460043056|FG002|Overall Study|Physician Decision|0|||
127842999|NCT00094835|460043057|FG003|Overall Study|Physician Decision|0|||
127843000|NCT00094835|460043058|FG004|Overall Study|Physician Decision|0|||
127843001|NCT00094835|460043059|FG005|Overall Study|Physician Decision|1|||
127843002|NCT00094835|460043060|FG006|Overall Study|Physician Decision|0|||
127843003|NCT00094835|460043054|FG000|Overall Study|Withdrawal by Subject|0|||
127843004|NCT00094835|460043055|FG001|Overall Study|Withdrawal by Subject|0|||
127843005|NCT00094835|460043056|FG002|Overall Study|Withdrawal by Subject|0|||
127843006|NCT00094835|460043057|FG003|Overall Study|Withdrawal by Subject|0|||
127843007|NCT00094835|460043058|FG004|Overall Study|Withdrawal by Subject|0|||
127843008|NCT00094835|460043059|FG005|Overall Study|Withdrawal by Subject|0|||
127843009|NCT00094835|460043060|FG006|Overall Study|Withdrawal by Subject|1|||
127843010|NCT00094835|460043054|FG000|Overall Study|Lost to Follow-up|0|||
127843011|NCT00094835|460043055|FG001|Overall Study|Lost to Follow-up|0|||
127843012|NCT00094835|460043056|FG002|Overall Study|Lost to Follow-up|0|||
127843013|NCT00094835|460043057|FG003|Overall Study|Lost to Follow-up|0|||
127843014|NCT00094835|460043058|FG004|Overall Study|Lost to Follow-up|1|||
127843015|NCT00094835|460043059|FG005|Overall Study|Lost to Follow-up|0|||
127843016|NCT00094835|460043060|FG006|Overall Study|Lost to Follow-up|0|||
127843017|NCT00094835|460043054|FG000|Overall Study|Death|1|||
127843018|NCT00094835|460043055|FG001|Overall Study|Death|0|||
127843019|NCT00094835|460043056|FG002|Overall Study|Death|0|||
127843020|NCT00094835|460043057|FG003|Overall Study|Death|0|||
127843021|NCT00094835|460043058|FG004|Overall Study|Death|1|||
127900622|NCT02937701|460261247|FG001|Day 1 to Week 22|Physician Decision|0|||
127900623|NCT02937701|460261248|FG002|Day 1 to Week 22|Physician Decision|0|||
127900624|NCT02937701|460261249|FG003|Day 1 to Week 22|Physician Decision|0|||
127900625|NCT02937701|460261250|FG004|Day 1 to Week 22|Physician Decision|0|||
127900626|NCT02937701|460261246|FG000|Day 1 to Week 22|Other|1|||
127900627|NCT02937701|460261247|FG001|Day 1 to Week 22|Other|0|||
127900628|NCT02937701|460261248|FG002|Day 1 to Week 22|Other|0|||
127900629|NCT02937701|460261249|FG003|Day 1 to Week 22|Other|0|||
127900630|NCT02937701|460261250|FG004|Day 1 to Week 22|Other|0|||
127900631|NCT02937701|460261246|FG000|Week 22 to Week 50|Adverse Event|0|||
127900632|NCT02937701|460261247|FG001|Week 22 to Week 50|Adverse Event|0|||
127900633|NCT02937701|460261248|FG002|Week 22 to Week 50|Adverse Event|10|||
127900634|NCT02937701|460261249|FG003|Week 22 to Week 50|Adverse Event|3|||
127900635|NCT02937701|460261250|FG004|Week 22 to Week 50|Adverse Event|3|||
127900636|NCT02937701|460261246|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
127900637|NCT02937701|460261247|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
127900638|NCT02937701|460261248|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
127900639|NCT02937701|460261249|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
127900640|NCT02937701|460261250|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
127900641|NCT02937701|460261246|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
127900642|NCT02937701|460261247|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
127843022|NCT00094835|460043059|FG005|Overall Study|Death|0|||
127843023|NCT00094835|460043060|FG006|Overall Study|Death|0|||
127843024|NCT00094835|460043054|FG000|Overall Study|Non-compliance|1|||
127843025|NCT00094835|460043055|FG001|Overall Study|Non-compliance|2|||
127843026|NCT00094835|460043056|FG002|Overall Study|Non-compliance|2|||
127843027|NCT00094835|460043057|FG003|Overall Study|Non-compliance|0|||
127843028|NCT00094835|460043058|FG004|Overall Study|Non-compliance|2|||
127843029|NCT00094835|460043059|FG005|Overall Study|Non-compliance|2|||
127843030|NCT00094835|460043060|FG006|Overall Study|Non-compliance|1|||
127900643|NCT02937701|460261248|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
127900644|NCT02937701|460261249|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
127900645|NCT02937701|460261250|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
127900646|NCT02937701|460261246|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
127900647|NCT02937701|460261247|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
127900648|NCT02937701|460261248|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
127900649|NCT02937701|460261249|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
127900650|NCT02937701|460261250|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
127900651|NCT02937701|460261246|FG000|Week 22 to Week 50|Physician Decision|0|||
127900652|NCT02937701|460261247|FG001|Week 22 to Week 50|Physician Decision|0|||
127900653|NCT02937701|460261248|FG002|Week 22 to Week 50|Physician Decision|2|||
127900654|NCT02937701|460261249|FG003|Week 22 to Week 50|Physician Decision|0|||
127900655|NCT02937701|460261250|FG004|Week 22 to Week 50|Physician Decision|1|||
127900656|NCT02937701|460261246|FG000|Week 22 to Week 50|Other|0|||
127900657|NCT02937701|460261247|FG001|Week 22 to Week 50|Other|0|||
127900658|NCT02937701|460261248|FG002|Week 22 to Week 50|Other|0|||
127900659|NCT02937701|460261249|FG003|Week 22 to Week 50|Other|0|||
127900660|NCT02937701|460261250|FG004|Week 22 to Week 50|Other|1|||
127900661|NCT03227445|460261253|FG000|Period 1 (28 Days)|Adverse Event|1|||
127900662|NCT03227445|460261254|FG001|Period 1 (28 Days)|Adverse Event|2|||
127900663|NCT03227445|460261255|FG002|Period 1 (28 Days)|Adverse Event|0|||
127900664|NCT03227445|460261256|FG003|Period 1 (28 Days)|Adverse Event|1|||
127900665|NCT03227445|460261253|FG000|Period 1 (28 Days)|Protocol Violation|1|||
127900666|NCT03227445|460261254|FG001|Period 1 (28 Days)|Protocol Violation|0|||
127900667|NCT03227445|460261255|FG002|Period 1 (28 Days)|Protocol Violation|0|||
127900668|NCT03227445|460261256|FG003|Period 1 (28 Days)|Protocol Violation|0|||
127900669|NCT03227445|460261253|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
127900670|NCT03227445|460261254|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
127900671|NCT03227445|460261255|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
127900672|NCT03227445|460261256|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
127900673|NCT03227445|460261253|FG000|Period 2 (28 Days)|Adverse Event|1|||
127900674|NCT03227445|460261254|FG001|Period 2 (28 Days)|Adverse Event|0|||
127900675|NCT03227445|460261255|FG002|Period 2 (28 Days)|Adverse Event|2|||
127900676|NCT03227445|460261256|FG003|Period 2 (28 Days)|Adverse Event|1|||
127900677|NCT03227445|460261253|FG000|Period 2 (28 Days)|Protocol Violation|0|||
127900678|NCT03227445|460261254|FG001|Period 2 (28 Days)|Protocol Violation|0|||
127843031|NCT00094835|460043054|FG000|Overall Study|Other|1|||
127843032|NCT00094835|460043055|FG001|Overall Study|Other|1|||
127843033|NCT00094835|460043056|FG002|Overall Study|Other|1|||
127843034|NCT00094835|460043057|FG003|Overall Study|Other|1|||
127843035|NCT00094835|460043058|FG004|Overall Study|Other|0|||
127843036|NCT00094835|460043059|FG005|Overall Study|Other|0|||
127843037|NCT00094835|460043060|FG006|Overall Study|Other|0|||
127843038|NCT03024255|460043065|FG000|Overall Study|Adverse Event|1|||
127843039|NCT03024255|460043066|FG001|Overall Study|Adverse Event|4|||
127843040|NCT03024255|460043067|FG002|Overall Study|Adverse Event|8|||
127843041|NCT03024255|460043068|FG003|Overall Study|Adverse Event|0|||
127843042|NCT03024255|460043065|FG000|Overall Study|Withdrawal by Subject|3|||
127843043|NCT03024255|460043066|FG001|Overall Study|Withdrawal by Subject|1|||
127843044|NCT03024255|460043067|FG002|Overall Study|Withdrawal by Subject|0|||
127843045|NCT03024255|460043068|FG003|Overall Study|Withdrawal by Subject|3|||
127843046|NCT03024255|460043065|FG000|Overall Study|Protocol Violation|0|||
127843047|NCT03024255|460043066|FG001|Overall Study|Protocol Violation|0|||
127843048|NCT03024255|460043067|FG002|Overall Study|Protocol Violation|2|||
127843049|NCT03024255|460043068|FG003|Overall Study|Protocol Violation|0|||
127843050|NCT03024255|460043065|FG000|Overall Study|Lost to Follow-up|1|||
127843051|NCT03024255|460043066|FG001|Overall Study|Lost to Follow-up|2|||
127843052|NCT03024255|460043067|FG002|Overall Study|Lost to Follow-up|1|||
127843053|NCT03024255|460043068|FG003|Overall Study|Lost to Follow-up|1|||
127843054|NCT03024255|460043065|FG000|Overall Study|Lack of Efficacy|1|||
127843055|NCT03024255|460043066|FG001|Overall Study|Lack of Efficacy|0|||
127843056|NCT03024255|460043067|FG002|Overall Study|Lack of Efficacy|0|||
127900679|NCT03227445|460261255|FG002|Period 2 (28 Days)|Protocol Violation|0|||
127900680|NCT03227445|460261256|FG003|Period 2 (28 Days)|Protocol Violation|1|||
127900681|NCT03227445|460261253|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
127900682|NCT03227445|460261254|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
127900683|NCT03227445|460261255|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
127843057|NCT03024255|460043068|FG003|Overall Study|Lack of Efficacy|0|||
127843058|NCT03024255|460043065|FG000|Overall Study|Protocol Noncompliance|1|||
127843059|NCT03024255|460043066|FG001|Overall Study|Protocol Noncompliance|1|||
127900684|NCT03227445|460261256|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
127843060|NCT03024255|460043067|FG002|Overall Study|Protocol Noncompliance|0|||
127843061|NCT03024255|460043068|FG003|Overall Study|Protocol Noncompliance|1|||
127843062|NCT03583606|460043069|FG000|Overall Study|Lost to Follow-up|0|||
127843063|NCT03583606|460043070|FG001|Overall Study|Lost to Follow-up|1|||
127843064|NCT03583606|460043071|FG002|Overall Study|Lost to Follow-up|0|||
127843065|NCT03583606|460043069|FG000|Overall Study|Ineligible at baseline|1|||
127843066|NCT03583606|460043070|FG001|Overall Study|Ineligible at baseline|0|||
127843067|NCT03583606|460043071|FG002|Overall Study|Ineligible at baseline|0|||
127843068|NCT00126581|460043076|FG000|Overall Study|Adverse Event|3|||
127843069|NCT00126581|460043077|FG001|Overall Study|Adverse Event|7|||
127843070|NCT00126581|460043076|FG000|Overall Study|Death|3|||
127843071|NCT00126581|460043077|FG001|Overall Study|Death|2|||
127843072|NCT00126581|460043076|FG000|Overall Study|Withdrawal by Subject|1|||
127843073|NCT00126581|460043077|FG001|Overall Study|Withdrawal by Subject|4|||
127843074|NCT00126581|460043076|FG000|Overall Study|Alternative therapy|3|||
127843075|NCT00126581|460043077|FG001|Overall Study|Alternative therapy|3|||
127843076|NCT00126581|460043076|FG000|Overall Study|Other illness/MD discretion|3|||
127843077|NCT00126581|460043077|FG001|Overall Study|Other illness/MD discretion|4|||
127843078|NCT00793182|460043078|FG000|Overall Study|Adverse Event|0|||
127843079|NCT00793182|460043079|FG001|Overall Study|Adverse Event|1|||
127843080|NCT02197897|460043080|FG000|Overall Study|not eligible|1|||
127843081|NCT02384395|460043081|FG000|Overall Study|Physician Decision|4|||
127843082|NCT02384395|460043081|FG000|Overall Study|Withdrawal by Subject|3|||
127843083|NCT02384395|460043081|FG000|Overall Study|Lost to Follow-up|3|||
127843084|NCT04295356|460043083|FG000|Overall Study|Physician Decision|1|||
127843085|NCT04295356|460043084|FG001|Overall Study|Physician Decision|0|||
127843086|NCT04295356|460043083|FG000|Overall Study|Lost to Follow-up|0|||
127843087|NCT04295356|460043084|FG001|Overall Study|Lost to Follow-up|3|||
127843088|NCT04295356|460043083|FG000|Overall Study|Protocol Violation|0|||
127843089|NCT04295356|460043084|FG001|Overall Study|Protocol Violation|1|||
127843090|NCT01106391|460043085|FG000|Overall Study|Death|12|||
127843091|NCT01106391|460043085|FG000|Overall Study|Withdrawal by Subject|7|||
127843092|NCT03939637|460043095|FG000|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|2|||
127843093|NCT03939637|460043096|FG001|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|0|||
127843094|NCT03939637|460043095|FG000|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
127843095|NCT03939637|460043096|FG001|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
127843096|NCT05224076|460043097|FG000|Overall Study|Lost to Follow-up|24|||
127843097|NCT04268004|460043098|FG000|Overall Study|Excluded from analyses|0|||
127843098|NCT04268004|460043099|FG001|Overall Study|Excluded from analyses|1|||
127843099|NCT03783442|460043100|FG000|Overall Study|Death|252|||
127843100|NCT03783442|460043101|FG001|Overall Study|Death|268|||
127843101|NCT03783442|460043100|FG000|Overall Study|Withdrawal by Subject|19|||
127843102|NCT03783442|460043101|FG001|Overall Study|Withdrawal by Subject|21|||
127843103|NCT03783442|460043100|FG000|Overall Study|Lost to Follow-up|7|||
127843104|NCT03783442|460043101|FG001|Overall Study|Lost to Follow-up|6|||
127843105|NCT03783442|460043100|FG000|Overall Study|Sponsor Ended Study|48|||
127843106|NCT03783442|460043101|FG001|Overall Study|Sponsor Ended Study|28|||
127843107|NCT04190186|460043102|FG000|Overall Study|ILR is no longer functioning|0|||
127843108|NCT04190186|460043103|FG001|Overall Study|ILR is no longer functioning|1|||
127843109|NCT04190186|460043102|FG000|Overall Study|Lost to Follow-up|0|||
127843110|NCT04190186|460043103|FG001|Overall Study|Lost to Follow-up|1|||
127843111|NCT04190186|460043102|FG000|Overall Study|Withdrawal by Subject|2|||
127843112|NCT04190186|460043103|FG001|Overall Study|Withdrawal by Subject|0|||
127843113|NCT04190186|460043102|FG000|Overall Study|Subject choice to explant|1|||
127843114|NCT04190186|460043103|FG001|Overall Study|Subject choice to explant|0|||
127843115|NCT04190186|460043102|FG000|Overall Study|Physician Decision|0|||
127843116|NCT04190186|460043103|FG001|Overall Study|Physician Decision|1|||
127843117|NCT04190186|460043102|FG000|Overall Study|Study was stopped|4|||
127843118|NCT04190186|460043103|FG001|Overall Study|Study was stopped|5|||
127843119|NCT00992186|460043106|FG000|Overall Study|Withdrawal by Subject|2|||
127843120|NCT00992186|460043106|FG000|Overall Study|Protocol Violation|1|||
127843121|NCT00992186|460043106|FG000|Overall Study|Physician Decision|1|||
127843122|NCT00992186|460043106|FG000|Overall Study|Adverse Event|9|||
127843123|NCT00992186|460043106|FG000|Overall Study|Progressive Disease|30|||
127843124|NCT00992186|460043106|FG000|Overall Study|Refusal To Receive Study Agent|3|||
127843125|NCT02677220|460043107|FG000|Overall Study|Adverse Event|1|||
127843126|NCT00965146|460043108|FG000|Overall Study|Death|7|||
127843127|NCT00965146|460043108|FG000|Overall Study|Lost to Follow-up|22|||
127843128|NCT00965146|460043108|FG000|Overall Study|Withdrawal by Subject|17|||
127843129|NCT00965146|460043108|FG000|Overall Study|Unable to return|1|||
127843130|NCT00965146|460043108|FG000|Overall Study|Unwilling to return|11|||
127843131|NCT00965146|460043108|FG000|Overall Study|Intercurrent illness|1|||
127843132|NCT00965146|460043108|FG000|Overall Study|Revision / Removal of Study Implant|6|||
127843133|NCT00965146|460043108|FG000|Overall Study|Overall Study Termination|145|||
127843134|NCT00830960|460043109|FG000|Overall Study|Death|5|||
127843135|NCT00830960|460043110|FG001|Overall Study|Death|4|||
127843136|NCT00830960|460043111|FG002|Overall Study|Death|3|||
127843137|NCT00830960|460043112|FG003|Overall Study|Death|2|||
127843138|NCT00830960|460043113|FG004|Overall Study|Death|6|||
127843139|NCT00830960|460043114|FG005|Overall Study|Death|1|||
127843140|NCT00830960|460043109|FG000|Overall Study|Lost to Follow-up|1|||
127843141|NCT00830960|460043110|FG001|Overall Study|Lost to Follow-up|1|||
127843142|NCT00830960|460043111|FG002|Overall Study|Lost to Follow-up|1|||
127843143|NCT00830960|460043112|FG003|Overall Study|Lost to Follow-up|0|||
127843144|NCT00830960|460043113|FG004|Overall Study|Lost to Follow-up|0|||
127843145|NCT00830960|460043114|FG005|Overall Study|Lost to Follow-up|1|||
127843146|NCT00830960|460043109|FG000|Overall Study|Withdrawal by Subject|19|||
127843147|NCT00830960|460043110|FG001|Overall Study|Withdrawal by Subject|19|||
127843148|NCT00830960|460043111|FG002|Overall Study|Withdrawal by Subject|18|||
127843149|NCT00830960|460043112|FG003|Overall Study|Withdrawal by Subject|23|||
127843150|NCT00830960|460043113|FG004|Overall Study|Withdrawal by Subject|16|||
127843151|NCT00830960|460043114|FG005|Overall Study|Withdrawal by Subject|21|||
127843152|NCT00830960|460043109|FG000|Overall Study|Sponsor Decision|1|||
127843153|NCT00830960|460043110|FG001|Overall Study|Sponsor Decision|2|||
127843154|NCT00830960|460043111|FG002|Overall Study|Sponsor Decision|3|||
127843155|NCT00830960|460043112|FG003|Overall Study|Sponsor Decision|4|||
127843156|NCT00830960|460043113|FG004|Overall Study|Sponsor Decision|5|||
127843157|NCT00830960|460043114|FG005|Overall Study|Sponsor Decision|7|||
127843158|NCT00830960|460043109|FG000|Overall Study|No study drug received|7|||
127843159|NCT00830960|460043110|FG001|Overall Study|No study drug received|2|||
127843160|NCT00830960|460043111|FG002|Overall Study|No study drug received|4|||
127843161|NCT00830960|460043112|FG003|Overall Study|No study drug received|3|||
127843162|NCT00830960|460043113|FG004|Overall Study|No study drug received|5|||
127843163|NCT00830960|460043114|FG005|Overall Study|No study drug received|7|||
127843164|NCT02855450|460043115|FG000|Overall Study|Adverse Event|1|||
127843165|NCT02855450|460043116|FG001|Overall Study|Adverse Event|0|||
127843166|NCT02855450|460043115|FG000|Overall Study|Lost to Follow-up|4|||
127843167|NCT02855450|460043116|FG001|Overall Study|Lost to Follow-up|0|||
127843168|NCT00426556|460043117|FG000|Phase I - Core Phase|Disease Progression|0|||
127843169|NCT00426556|460043118|FG001|Phase I - Core Phase|Disease Progression|6|||
127843170|NCT00426556|460043119|FG002|Phase I - Core Phase|Disease Progression|2|||
127843171|NCT00426556|460043120|FG003|Phase I - Core Phase|Disease Progression|0|||
127843172|NCT00426556|460043117|FG000|Phase I - Core Phase|Adverse Event|1|||
127843173|NCT00426556|460043118|FG001|Phase I - Core Phase|Adverse Event|3|||
127843174|NCT00426556|460043119|FG002|Phase I - Core Phase|Adverse Event|1|||
127843175|NCT00426556|460043120|FG003|Phase I - Core Phase|Adverse Event|0|||
127843176|NCT00426556|460043117|FG000|Phase I - Core Phase|Death|0|||
127843177|NCT00426556|460043118|FG001|Phase I - Core Phase|Death|1|||
127843178|NCT00426556|460043119|FG002|Phase I - Core Phase|Death|0|||
127843179|NCT00426556|460043120|FG003|Phase I - Core Phase|Death|0|||
127843180|NCT00426556|460043117|FG000|Phase I - Extension Phase|Adverse Event|0|||
127843181|NCT00426556|460043118|FG001|Phase I - Extension Phase|Adverse Event|1|||
127843182|NCT00426556|460043119|FG002|Phase I - Extension Phase|Adverse Event|1|||
127843183|NCT00426556|460043120|FG003|Phase I - Extension Phase|Adverse Event|0|||
127843184|NCT00426556|460043117|FG000|Phase I - Extension Phase|Disease Progression|5|||
127843185|NCT00426556|460043118|FG001|Phase I - Extension Phase|Disease Progression|5|||
127843186|NCT00426556|460043119|FG002|Phase I - Extension Phase|Disease Progression|6|||
127843187|NCT00426556|460043120|FG003|Phase I - Extension Phase|Disease Progression|0|||
127843188|NCT00426556|460043117|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
127843189|NCT00426556|460043118|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
127843190|NCT00426556|460043119|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
127843191|NCT00426556|460043120|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
127843192|NCT00426556|460043117|FG000|Phase II - Core Phase|Disease Progression|0|||
127843193|NCT00426556|460043118|FG001|Phase II - Core Phase|Disease Progression|0|||
127843194|NCT00426556|460043119|FG002|Phase II - Core Phase|Disease Progression|0|||
127843195|NCT00426556|460043120|FG003|Phase II - Core Phase|Disease Progression|16|||
127843196|NCT00426556|460043117|FG000|Phase II - Core Phase|Adverse Event|0|||
127843197|NCT00426556|460043118|FG001|Phase II - Core Phase|Adverse Event|0|||
127843198|NCT00426556|460043119|FG002|Phase II - Core Phase|Adverse Event|0|||
127843199|NCT00426556|460043120|FG003|Phase II - Core Phase|Adverse Event|8|||
127843200|NCT00426556|460043117|FG000|Phase II - Extension Phase|Disease Progression|0|||
127843201|NCT00426556|460043118|FG001|Phase II - Extension Phase|Disease Progression|0|||
127843202|NCT00426556|460043119|FG002|Phase II - Extension Phase|Disease Progression|0|||
127843203|NCT00426556|460043120|FG003|Phase II - Extension Phase|Disease Progression|21|||
127843204|NCT00426556|460043117|FG000|Phase II - Extension Phase|Adverse Event|0|||
127843205|NCT00426556|460043118|FG001|Phase II - Extension Phase|Adverse Event|0|||
127843206|NCT00426556|460043119|FG002|Phase II - Extension Phase|Adverse Event|0|||
127843207|NCT00426556|460043120|FG003|Phase II - Extension Phase|Adverse Event|2|||
127843208|NCT00805545|460043121|FG000|Overall Study|Protocol Violation|3|||
127843209|NCT00805545|460043122|FG001|Overall Study|Protocol Violation|2|||
127843210|NCT00805545|460043121|FG000|Overall Study|Protocol Violation|3|||
127843211|NCT00805545|460043122|FG001|Overall Study|Protocol Violation|1|||
127843212|NCT00507416|460043123|FG000|Overall Study|Adverse Event|58|||
127843213|NCT00507416|460043124|FG001|Overall Study|Adverse Event|67|||
127843214|NCT00507416|460043125|FG002|Overall Study|Adverse Event|65|||
127843215|NCT00507416|460043123|FG000|Overall Study|Protocol Violation|1|||
127843216|NCT00507416|460043124|FG001|Overall Study|Protocol Violation|2|||
127843217|NCT00507416|460043125|FG002|Overall Study|Protocol Violation|0|||
127843218|NCT00507416|460043123|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
127843219|NCT00507416|460043124|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
127843220|NCT00507416|460043125|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
127843221|NCT00507416|460043123|FG000|Overall Study|Progressive Disease|20|||
127843222|NCT00507416|460043124|FG001|Overall Study|Progressive Disease|10|||
127843223|NCT00507416|460043125|FG002|Overall Study|Progressive Disease|13|||
127843224|NCT00507416|460043123|FG000|Overall Study|Patient declined further treatment|18|||
127843225|NCT00507416|460043124|FG001|Overall Study|Patient declined further treatment|14|||
127843226|NCT00507416|460043125|FG002|Overall Study|Patient declined further treatment|11|||
127843227|NCT00507416|460043123|FG000|Overall Study|Other|11|||
127843228|NCT00507416|460043124|FG001|Overall Study|Other|16|||
127843229|NCT00507416|460043125|FG002|Overall Study|Other|13|||
127843230|NCT00507416|460043123|FG000|Overall Study|Did not Receive Study Treatment|3|||
127843231|NCT00507416|460043124|FG001|Overall Study|Did not Receive Study Treatment|9|||
127843232|NCT00507416|460043125|FG002|Overall Study|Did not Receive Study Treatment|4|||
127843233|NCT02157506|460043128|FG000|Overall Study|Adverse Event|0|||
127900685|NCT00755196|460261258|FG000|Overall Study|Lost to Follow-up|1|||
127900686|NCT00755196|460261258|FG000|Overall Study|Lack of Efficiency|1|||
127900687|NCT01703832|460261259|FG000|Overall Study|Withdrawal by Subject|1|||
127900688|NCT01703832|460261260|FG001|Overall Study|Withdrawal by Subject|0|||
127900689|NCT01991470|460261261|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
127900690|NCT01991470|460261261|FG000|Enlite 1 Period|Adverse Event|1|||
127900691|NCT01991470|460261261|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
127900692|NCT01991470|460261261|FG000|Enlite 3 Period|Lost to Follow-up|1|||
127900693|NCT01991470|460261261|FG000|Enlite 3 Period|Physician Decision|2|||
127900694|NCT01991470|460261261|FG000|Enlite 3 Period|Physician Decision|8|||
127900695|NCT01991470|460261261|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
127900696|NCT00243932|460261262|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
127900697|NCT00243932|460261263|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
127900698|NCT00243932|460261264|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
127900699|NCT00880568|460261265|FG000|Overall Study|Disease progression|3|||
127900700|NCT00880568|460261266|FG001|Overall Study|Disease progression|3|||
127900701|NCT00880568|460261267|FG002|Overall Study|Disease progression|3|||
127900702|NCT00880568|460261268|FG003|Overall Study|Disease progression|1|||
127900703|NCT00880568|460261269|FG004|Overall Study|Disease progression|3|||
127900704|NCT00880568|460261270|FG005|Overall Study|Disease progression|3|||
127900705|NCT00880568|460261271|FG006|Overall Study|Disease progression|5|||
127900706|NCT00880568|460261272|FG007|Overall Study|Disease progression|0|||
127900707|NCT00880568|460261273|FG008|Overall Study|Disease progression|3|||
127900708|NCT00880568|460261265|FG000|Overall Study|Adverse Event|0|||
127900709|NCT00880568|460261266|FG001|Overall Study|Adverse Event|0|||
127900710|NCT00880568|460261267|FG002|Overall Study|Adverse Event|0|||
127900711|NCT00880568|460261268|FG003|Overall Study|Adverse Event|0|||
127900712|NCT00880568|460261269|FG004|Overall Study|Adverse Event|0|||
127900713|NCT00880568|460261270|FG005|Overall Study|Adverse Event|0|||
127900714|NCT00880568|460261271|FG006|Overall Study|Adverse Event|1|||
127900715|NCT00880568|460261272|FG007|Overall Study|Adverse Event|1|||
127900716|NCT00880568|460261273|FG008|Overall Study|Adverse Event|0|||
127900717|NCT00880568|460261265|FG000|Overall Study|Withdrawal by Subject|0|||
127900718|NCT00880568|460261266|FG001|Overall Study|Withdrawal by Subject|0|||
127900719|NCT00880568|460261267|FG002|Overall Study|Withdrawal by Subject|0|||
127900720|NCT00880568|460261268|FG003|Overall Study|Withdrawal by Subject|0|||
127900721|NCT00880568|460261269|FG004|Overall Study|Withdrawal by Subject|0|||
127843234|NCT02157506|460043129|FG001|Overall Study|Adverse Event|1|||
127900722|NCT00880568|460261270|FG005|Overall Study|Withdrawal by Subject|0|||
127900723|NCT00880568|460261271|FG006|Overall Study|Withdrawal by Subject|0|||
127900724|NCT00880568|460261272|FG007|Overall Study|Withdrawal by Subject|1|||
127900725|NCT00880568|460261273|FG008|Overall Study|Withdrawal by Subject|0|||
127900726|NCT00437658|460261274|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
127900727|NCT00437658|460261275|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
127843235|NCT02157506|460043130|FG002|Overall Study|Adverse Event|0|||
127843236|NCT02157506|460043131|FG003|Overall Study|Adverse Event|0|||
127843237|NCT02157506|460043132|FG004|Overall Study|Adverse Event|0|||
127843238|NCT02157506|460043128|FG000|Overall Study|Lost to Follow-up|0|||
127843239|NCT02157506|460043129|FG001|Overall Study|Lost to Follow-up|0|||
127843240|NCT02157506|460043130|FG002|Overall Study|Lost to Follow-up|1|||
127900728|NCT00437658|460261276|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
127900729|NCT00437658|460261274|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
127900730|NCT00437658|460261275|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
127900731|NCT00437658|460261276|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
127900732|NCT00437658|460261274|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
127900733|NCT00437658|460261275|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
127900734|NCT00437658|460261276|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
127900735|NCT00437658|460261274|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
127900736|NCT00437658|460261275|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
127900737|NCT00437658|460261276|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
127900738|NCT00437658|460261274|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
127900739|NCT00437658|460261275|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
127843241|NCT02157506|460043131|FG003|Overall Study|Lost to Follow-up|0|||
127843242|NCT02157506|460043132|FG004|Overall Study|Lost to Follow-up|0|||
127843243|NCT03101514|460043133|FG000|Overall Study|Withdrawal by Subject|4|||
127843244|NCT03101514|460043133|FG000|Overall Study|Protocol Violation|2|||
127843245|NCT03101514|460043133|FG000|Overall Study|patient's information was incomplete|1|||
127843246|NCT01021813|460043134|FG000|DB Treatment Phase|Adverse Event|60|||
127843247|NCT01021813|460043135|FG001|DB Treatment Phase|Adverse Event|22|||
127843248|NCT01021813|460043136|FG002|DB Treatment Phase|Adverse Event|0|||
127843249|NCT01021813|460043137|FG003|DB Treatment Phase|Adverse Event|0|||
127843250|NCT01021813|460043138|FG004|DB Treatment Phase|Adverse Event|0|||
127843251|NCT01021813|460043134|FG000|DB Treatment Phase|Lack of Efficacy|44|||
127843252|NCT01021813|460043135|FG001|DB Treatment Phase|Lack of Efficacy|28|||
127843253|NCT01021813|460043136|FG002|DB Treatment Phase|Lack of Efficacy|0|||
127843254|NCT01021813|460043137|FG003|DB Treatment Phase|Lack of Efficacy|0|||
127843255|NCT01021813|460043138|FG004|DB Treatment Phase|Lack of Efficacy|0|||
127843256|NCT01021813|460043134|FG000|DB Treatment Phase|Lost to Follow-up|14|||
127843257|NCT01021813|460043135|FG001|DB Treatment Phase|Lost to Follow-up|12|||
127843258|NCT01021813|460043136|FG002|DB Treatment Phase|Lost to Follow-up|0|||
127843259|NCT01021813|460043137|FG003|DB Treatment Phase|Lost to Follow-up|0|||
127843260|NCT01021813|460043138|FG004|DB Treatment Phase|Lost to Follow-up|0|||
127843261|NCT01021813|460043134|FG000|DB Treatment Phase|Physician Decision|17|||
127843262|NCT01021813|460043135|FG001|DB Treatment Phase|Physician Decision|8|||
127843263|NCT01021813|460043136|FG002|DB Treatment Phase|Physician Decision|0|||
127843264|NCT01021813|460043137|FG003|DB Treatment Phase|Physician Decision|0|||
127843265|NCT01021813|460043138|FG004|DB Treatment Phase|Physician Decision|0|||
127843266|NCT01021813|460043134|FG000|DB Treatment Phase|Pregnancy|1|||
127843267|NCT01021813|460043135|FG001|DB Treatment Phase|Pregnancy|0|||
127843268|NCT01021813|460043136|FG002|DB Treatment Phase|Pregnancy|0|||
127843269|NCT01021813|460043137|FG003|DB Treatment Phase|Pregnancy|0|||
127843270|NCT01021813|460043138|FG004|DB Treatment Phase|Pregnancy|0|||
127843271|NCT01021813|460043134|FG000|DB Treatment Phase|Protocol Violation|4|||
127843272|NCT01021813|460043135|FG001|DB Treatment Phase|Protocol Violation|3|||
127843273|NCT01021813|460043136|FG002|DB Treatment Phase|Protocol Violation|0|||
127843274|NCT01021813|460043137|FG003|DB Treatment Phase|Protocol Violation|0|||
127843275|NCT01021813|460043138|FG004|DB Treatment Phase|Protocol Violation|0|||
127843276|NCT01021813|460043134|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
127843277|NCT01021813|460043135|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
127843278|NCT01021813|460043136|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
127843279|NCT01021813|460043137|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
127843280|NCT01021813|460043138|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
127843281|NCT01021813|460043134|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
127843282|NCT01021813|460043135|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
127843283|NCT01021813|460043136|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
127843284|NCT01021813|460043137|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
127843285|NCT01021813|460043138|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
127843286|NCT01021813|460043134|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
127843287|NCT01021813|460043135|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
127843288|NCT01021813|460043136|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
127900740|NCT00437658|460261276|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
127900741|NCT00437658|460261274|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
127900742|NCT00437658|460261275|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
127900743|NCT00437658|460261276|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
127900744|NCT00437658|460261274|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
127900745|NCT00437658|460261275|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
127900746|NCT00437658|460261276|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
127900747|NCT00437658|460261274|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
127900748|NCT00437658|460261275|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
127843289|NCT01021813|460043137|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
127843290|NCT01021813|460043138|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
127843291|NCT01021813|460043134|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
127843292|NCT01021813|460043135|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
127843293|NCT01021813|460043136|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
127843294|NCT01021813|460043137|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
127843295|NCT01021813|460043138|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
127843296|NCT01021813|460043134|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
127900749|NCT00437658|460261276|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
127843297|NCT01021813|460043135|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
127843298|NCT01021813|460043136|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
127843299|NCT01021813|460043137|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
127843300|NCT01021813|460043138|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
127843301|NCT01021813|460043134|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
127843302|NCT01021813|460043135|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
127843303|NCT01021813|460043136|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
127843304|NCT01021813|460043137|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
127843305|NCT01021813|460043138|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
127843306|NCT00764478|460043139|FG000|Overall Study|Adverse Event|1|||
127843307|NCT00764478|460043140|FG001|Overall Study|Adverse Event|1|||
127843308|NCT00764478|460043141|FG002|Overall Study|Adverse Event|1|||
127843309|NCT00764478|460043139|FG000|Overall Study|Withdrawal by Subject|7|||
127843310|NCT00764478|460043140|FG001|Overall Study|Withdrawal by Subject|12|||
127843311|NCT00764478|460043141|FG002|Overall Study|Withdrawal by Subject|1|||
127843312|NCT00764478|460043139|FG000|Overall Study|Lost to Follow-up|7|||
127843313|NCT00764478|460043140|FG001|Overall Study|Lost to Follow-up|8|||
127843314|NCT00764478|460043141|FG002|Overall Study|Lost to Follow-up|5|||
127843315|NCT00764478|460043139|FG000|Overall Study|Protocol Violation|0|||
127843316|NCT00764478|460043140|FG001|Overall Study|Protocol Violation|1|||
127843317|NCT00764478|460043141|FG002|Overall Study|Protocol Violation|1|||
127843318|NCT01740388|460043142|FG000|Overall Study|Withdrawal by Subject|1|||
127843319|NCT01740388|460043143|FG001|Overall Study|Withdrawal by Subject|2|||
127843320|NCT01740388|460043142|FG000|Overall Study|Lost to Follow-up|2|||
127843321|NCT01740388|460043143|FG001|Overall Study|Lost to Follow-up|0|||
127843322|NCT01740388|460043142|FG000|Overall Study|Physician Decision|2|||
127843323|NCT01740388|460043143|FG001|Overall Study|Physician Decision|6|||
127843324|NCT01740388|460043142|FG000|Overall Study|Subjects missing data, completed|41|||
127843325|NCT01740388|460043143|FG001|Overall Study|Subjects missing data, completed|36|||
127843326|NCT00862121|460043146|FG000|Overall Study|Adverse Event|1|||
127843327|NCT00862121|460043147|FG001|Overall Study|Adverse Event|2|||
127843328|NCT00862121|460043146|FG000|Overall Study|Lack of Efficacy|0|||
127843329|NCT00862121|460043147|FG001|Overall Study|Lack of Efficacy|3|||
127843330|NCT00862121|460043146|FG000|Overall Study|Protocol Violation|0|||
127843331|NCT00862121|460043147|FG001|Overall Study|Protocol Violation|1|||
127843332|NCT00862121|460043146|FG000|Overall Study|Exclusion criterion violation|0|||
127843333|NCT00862121|460043147|FG001|Overall Study|Exclusion criterion violation|1|||
127843334|NCT00862121|460043146|FG000|Overall Study|Incorrect randomisation|0|||
127843335|NCT00862121|460043147|FG001|Overall Study|Incorrect randomisation|1|||
127843336|NCT00171314|460043152|FG000|Overall Study|Adverse Event|44|||
127843337|NCT00171314|460043153|FG001|Overall Study|Adverse Event|41|||
127843338|NCT00171314|460043152|FG000|Overall Study|Lack of Efficacy|19|||
127843339|NCT00171314|460043153|FG001|Overall Study|Lack of Efficacy|14|||
127843340|NCT00171314|460043152|FG000|Overall Study|Withdrawal by Subject|9|||
127843341|NCT00171314|460043153|FG001|Overall Study|Withdrawal by Subject|6|||
127843342|NCT00171314|460043152|FG000|Overall Study|Abnormal Test Procedure Results|9|||
127843343|NCT00171314|460043153|FG001|Overall Study|Abnormal Test Procedure Results|3|||
127843344|NCT00171314|460043152|FG000|Overall Study|Protocol Violation|3|||
127843345|NCT00171314|460043153|FG001|Overall Study|Protocol Violation|7|||
127843346|NCT00171314|460043152|FG000|Overall Study|Administrative Problems|4|||
127843347|NCT00171314|460043153|FG001|Overall Study|Administrative Problems|3|||
127843348|NCT00171314|460043152|FG000|Overall Study|Lost to Follow-up|1|||
127843349|NCT00171314|460043153|FG001|Overall Study|Lost to Follow-up|3|||
127843350|NCT00171314|460043152|FG000|Overall Study|Death|2|||
127843351|NCT00171314|460043153|FG001|Overall Study|Death|1|||
127843352|NCT03326869|460044655|FG000|Overall Study|Study data has been lost to natural disa|1|||
127843353|NCT03326869|460044656|FG001|Overall Study|Study data has been lost to natural disa|1|||
127843354|NCT03788967|460044657|FG000|Overall Study|Lost to Follow-up|14|||
127843355|NCT03788967|460044658|FG001|Overall Study|Lost to Follow-up|10|||
127843356|NCT03788967|460044657|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
127843357|NCT03788967|460044658|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
127843358|NCT03788967|460044657|FG000|Overall Study|Participant Withdrawal of Consent|13|||
127843359|NCT03788967|460044658|FG001|Overall Study|Participant Withdrawal of Consent|5|||
127843360|NCT03788967|460044657|FG000|Overall Study|Adverse Event|1|||
127843361|NCT03788967|460044658|FG001|Overall Study|Adverse Event|1|||
127843362|NCT03788967|460044657|FG000|Overall Study|COVID-19|1|||
127843363|NCT03788967|460044658|FG001|Overall Study|COVID-19|2|||
127843364|NCT03927911|460044659|FG000|Overall Study|problems with eDiary|0|||
127843365|NCT03927911|460044660|FG001|Overall Study|problems with eDiary|1|||
127843366|NCT03927911|460044661|FG002|Overall Study|problems with eDiary|0|||
127843367|NCT03927911|460044662|FG003|Overall Study|problems with eDiary|1|||
127843368|NCT03927911|460044663|FG004|Overall Study|problems with eDiary|0|||
127843369|NCT03927911|460044664|FG005|Overall Study|problems with eDiary|4|||
127843370|NCT03927911|460044659|FG000|Overall Study|Adverse Event|0|||
127843371|NCT03927911|460044660|FG001|Overall Study|Adverse Event|0|||
127843372|NCT03927911|460044661|FG002|Overall Study|Adverse Event|0|||
127843373|NCT03927911|460044662|FG003|Overall Study|Adverse Event|0|||
127843374|NCT03927911|460044663|FG004|Overall Study|Adverse Event|0|||
127843375|NCT03927911|460044664|FG005|Overall Study|Adverse Event|1|||
127843376|NCT03927911|460044659|FG000|Overall Study|not treated -study terminated by sponsor|0|||
127843377|NCT03927911|460044660|FG001|Overall Study|not treated -study terminated by sponsor|1|||
127843378|NCT03927911|460044661|FG002|Overall Study|not treated -study terminated by sponsor|0|||
127843379|NCT03927911|460044662|FG003|Overall Study|not treated -study terminated by sponsor|0|||
127843380|NCT03927911|460044663|FG004|Overall Study|not treated -study terminated by sponsor|0|||
127843381|NCT03927911|460044664|FG005|Overall Study|not treated -study terminated by sponsor|0|||
127843382|NCT03927911|460044659|FG000|Overall Study|Surgery cancelled|0|||
127843383|NCT03927911|460044660|FG001|Overall Study|Surgery cancelled|0|||
127843384|NCT03927911|460044661|FG002|Overall Study|Surgery cancelled|0|||
127843385|NCT03927911|460044662|FG003|Overall Study|Surgery cancelled|1|||
127843386|NCT03927911|460044663|FG004|Overall Study|Surgery cancelled|0|||
127843387|NCT03927911|460044664|FG005|Overall Study|Surgery cancelled|1|||
127843388|NCT03927911|460044659|FG000|Overall Study|Protocol Violation|0|||
127843389|NCT03927911|460044660|FG001|Overall Study|Protocol Violation|0|||
127843390|NCT03927911|460044661|FG002|Overall Study|Protocol Violation|0|||
127843391|NCT03927911|460044662|FG003|Overall Study|Protocol Violation|0|||
127843392|NCT03927911|460044663|FG004|Overall Study|Protocol Violation|0|||
127843393|NCT03927911|460044664|FG005|Overall Study|Protocol Violation|1|||
127843394|NCT04432376|460044665|FG000|Double-blind Treatment Period|Adverse Event|2|||
127843395|NCT04432376|460044666|FG001|Double-blind Treatment Period|Adverse Event|6|||
127843396|NCT04432376|460044667|FG002|Double-blind Treatment Period|Adverse Event|0|||
127843397|NCT04432376|460044665|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
127843398|NCT04432376|460044666|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
127843399|NCT04432376|460044667|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
127843400|NCT04432376|460044665|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
127843401|NCT04432376|460044666|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
127843402|NCT04432376|460044667|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
127843403|NCT04432376|460044665|FG000|Double-blind Treatment Period|Protocol Violation|0|||
127843404|NCT04432376|460044666|FG001|Double-blind Treatment Period|Protocol Violation|1|||
127843405|NCT04432376|460044667|FG002|Double-blind Treatment Period|Protocol Violation|0|||
127843406|NCT04432376|460044665|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
127843407|NCT04432376|460044666|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
127843408|NCT04432376|460044667|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
127843409|NCT01824693|460044668|FG000|Overall Study|Death|0|||
127843410|NCT01824693|460044669|FG001|Overall Study|Death|1|||
127843411|NCT01824693|460044670|FG002|Overall Study|Death|0|||
127843412|NCT01824693|460044668|FG000|Overall Study|Physician Decision|1|||
127843413|NCT01824693|460044669|FG001|Overall Study|Physician Decision|1|||
127843414|NCT01824693|460044670|FG002|Overall Study|Physician Decision|1|||
127843415|NCT01824693|460044668|FG000|Overall Study|Withdrawal by Subject|0|||
127843416|NCT01824693|460044669|FG001|Overall Study|Withdrawal by Subject|0|||
127843417|NCT01824693|460044670|FG002|Overall Study|Withdrawal by Subject|1|||
127843418|NCT01824693|460044668|FG000|Overall Study|Progressive Disease|0|||
127843419|NCT01824693|460044669|FG001|Overall Study|Progressive Disease|5|||
127843420|NCT01824693|460044670|FG002|Overall Study|Progressive Disease|0|||
127843421|NCT01824693|460044668|FG000|Overall Study|Ineligible|0|||
127843422|NCT01824693|460044669|FG001|Overall Study|Ineligible|0|||
127843423|NCT01824693|460044670|FG002|Overall Study|Ineligible|3|||
127843424|NCT01824693|460044668|FG000|Overall Study|No Transplant Planned|0|||
127843425|NCT01824693|460044669|FG001|Overall Study|No Transplant Planned|0|||
127843426|NCT01824693|460044670|FG002|Overall Study|No Transplant Planned|10|||
127843427|NCT03628599|460044671|FG000|Overall Study|Adverse Event|0|||
127843428|NCT03628599|460044672|FG001|Overall Study|Adverse Event|1|||
127843429|NCT01624506|460044673|FG000|Overall Study|Lost to Follow-up|29|||
127843430|NCT01624506|460044674|FG001|Overall Study|Lost to Follow-up|15|||
127843431|NCT01624506|460044673|FG000|Overall Study|Withdrawal by Subject|9|||
127843432|NCT01624506|460044674|FG001|Overall Study|Withdrawal by Subject|2|||
127843433|NCT01624506|460044673|FG000|Overall Study|Death|1|||
127843434|NCT01624506|460044674|FG001|Overall Study|Death|0|||
127843435|NCT01624506|460044673|FG000|Overall Study|LINX explants|23|||
127843436|NCT01624506|460044674|FG001|Overall Study|LINX explants|0|||
127843437|NCT01624506|460044673|FG000|Overall Study|Adverse Event|3|||
127843438|NCT01624506|460044674|FG001|Overall Study|Adverse Event|0|||
127843439|NCT00132314|460044677|FG000|Overall Study|Lost to Follow-up|70|||
127843440|NCT00132314|460044678|FG001|Overall Study|Lost to Follow-up|62|||
127843441|NCT00132314|460044677|FG000|Overall Study|Lacked SSN|1|||
127843442|NCT00132314|460044678|FG001|Overall Study|Lacked SSN|3|||
127843443|NCT00132314|460044677|FG000|Overall Study|Refused intervention at baseline|2|||
127843444|NCT00132314|460044678|FG001|Overall Study|Refused intervention at baseline|7|||
127843445|NCT02966353|460044679|FG000|Overall Study|Withdrawal by Subject|7|||
127843446|NCT02966353|460044679|FG000|Overall Study|Adverse Event|4|||
127843447|NCT02966353|460044679|FG000|Overall Study|Death|4|||
127843448|NCT02966353|460044679|FG000|Overall Study|Physician Decision|3|||
127843449|NCT02966353|460044679|FG000|Overall Study|Progressive disease|2|||
127843450|NCT02966353|460044679|FG000|Overall Study|Protocol deviation|2|||
127843451|NCT00093470|460044680|FG000|Overall Study|Disease progression|39|||
127843452|NCT00093470|460044681|FG001|Overall Study|Disease progression|0|||
127843453|NCT00093470|460044680|FG000|Overall Study|Adverse Event|15|||
127843454|NCT00093470|460044681|FG001|Overall Study|Adverse Event|0|||
127843455|NCT00093470|460044680|FG000|Overall Study|Death|2|||
127843456|NCT00093470|460044681|FG001|Overall Study|Death|0|||
127843457|NCT00093470|460044680|FG000|Overall Study|Withdrawal by Subject|8|||
127843458|NCT00093470|460044681|FG001|Overall Study|Withdrawal by Subject|0|||
127843459|NCT00093470|460044680|FG000|Overall Study|Alternative therapy|2|||
127843460|NCT00093470|460044681|FG001|Overall Study|Alternative therapy|0|||
127843461|NCT00093470|460044680|FG000|Overall Study|Other complicating disease|3|||
127843462|NCT00093470|460044681|FG001|Overall Study|Other complicating disease|0|||
127843463|NCT00093470|460044680|FG000|Overall Study|Physician Decision|2|||
127843464|NCT00093470|460044681|FG001|Overall Study|Physician Decision|0|||
127900750|NCT00437658|460261274|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
127900751|NCT00437658|460261275|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
127900752|NCT00437658|460261276|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
127900753|NCT00437658|460261274|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
127900754|NCT00437658|460261275|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
127900755|NCT00437658|460261276|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
127900756|NCT00437658|460261274|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
127900757|NCT00437658|460261275|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
127900758|NCT00437658|460261276|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
127900759|NCT00437658|460261274|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
127900760|NCT00437658|460261275|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
127900761|NCT00437658|460261276|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
127900762|NCT04407806|460261277|FG000|Overall Study|Withdrawal by Subject|1|||
127900763|NCT04407806|460261278|FG001|Overall Study|Withdrawal by Subject|2|||
127900764|NCT02731157|460261279|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
127900765|NCT00623779|460261281|FG000|Overall Study|Adverse Event|1|||
127900766|NCT00623779|460261282|FG001|Overall Study|Adverse Event|3|||
127900767|NCT00623779|460261283|FG002|Overall Study|Adverse Event|0|||
127900768|NCT00623779|460261281|FG000|Overall Study|Criteria from CSR|2|||
127900769|NCT00623779|460261282|FG001|Overall Study|Criteria from CSR|0|||
127900770|NCT00623779|460261283|FG002|Overall Study|Criteria from CSR|1|||
127900771|NCT01434693|460261286|FG000|Overall Study|Adverse Event|1|||
127900772|NCT01434693|460261287|FG001|Overall Study|Adverse Event|0|||
127900773|NCT01434693|460261288|FG002|Overall Study|Adverse Event|0|||
127900774|NCT01434693|460261289|FG003|Overall Study|Adverse Event|0|||
127900775|NCT01434693|460261286|FG000|Overall Study|Withdrawal by Subject|1|||
127900776|NCT01434693|460261287|FG001|Overall Study|Withdrawal by Subject|0|||
127900777|NCT01434693|460261288|FG002|Overall Study|Withdrawal by Subject|1|||
127900778|NCT01434693|460261289|FG003|Overall Study|Withdrawal by Subject|1|||
127900779|NCT01434693|460261286|FG000|Overall Study|Lost to Follow-up|1|||
127900780|NCT01434693|460261287|FG001|Overall Study|Lost to Follow-up|0|||
127900781|NCT01434693|460261288|FG002|Overall Study|Lost to Follow-up|0|||
127900782|NCT01434693|460261289|FG003|Overall Study|Lost to Follow-up|0|||
127900783|NCT01440283|460261290|FG000|Overall Study|Death|3|||
127900784|NCT01440283|460261290|FG000|Overall Study|Withdrawal by Subject|4|||
127900785|NCT01440283|460261290|FG000|Overall Study|Physician Decision|3|||
127900786|NCT01936948|460261294|FG000|Overall Study|no 30-day follow-up data|0|||
127900787|NCT01936948|460261295|FG001|Overall Study|no 30-day follow-up data|3|||
127900788|NCT01936948|460261296|FG002|Overall Study|no 30-day follow-up data|3|||
127900789|NCT01936948|460261297|FG003|Overall Study|no 30-day follow-up data|3|||
127900790|NCT02781727|460261298|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
127900791|NCT02781727|460261299|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
127900792|NCT02781727|460261298|FG000|Treatment Period|Withdrawal by Subject|1|||
127900793|NCT02781727|460261299|FG001|Treatment Period|Withdrawal by Subject|0|||
127900794|NCT02781727|460261298|FG000|Treatment Period|Lost to Follow-up|0|||
127900795|NCT02781727|460261299|FG001|Treatment Period|Lost to Follow-up|1|||
127900796|NCT02327130|460261300|FG000|Overall Study|Discharged in less than 5 days|5|||
127843465|NCT00093470|460044680|FG000|Overall Study|Never started treatment|1|||
127843466|NCT00093470|460044681|FG001|Overall Study|Never started treatment|0|||
127843467|NCT00093470|460044680|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
127843468|NCT00093470|460044681|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
127843469|NCT05905601|460044682|FG000|Overall Study|Lost to Follow-up|1|||
127843470|NCT05905601|460044683|FG001|Overall Study|Lost to Follow-up|3|||
127900797|NCT02327130|460261300|FG000|Overall Study|Physician Decision|2|||
127900798|NCT02327130|460261300|FG000|Overall Study|Unable to provide breath sample|1|||
127900799|NCT02327130|460261300|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
127900800|NCT02327130|460261300|FG000|Overall Study|Met exclusion criteria|3|||
127900801|NCT01378975|460261303|FG000|Overall Study|Death|77|||
127843471|NCT02514772|460044684|FG000|Overall Study|Adverse Event|1|||
127843472|NCT02514772|460044685|FG001|Overall Study|Adverse Event|0|||
127843473|NCT02514772|460044684|FG000|Overall Study|Death|0|||
127843474|NCT02514772|460044685|FG001|Overall Study|Death|1|||
127843475|NCT02514772|460044684|FG000|Overall Study|Withdrawal by Subject|2|||
127843476|NCT02514772|460044685|FG001|Overall Study|Withdrawal by Subject|1|||
127843477|NCT01415908|460044686|FG000|Overall Study|Withdrawal by Subject|1|||
127843478|NCT01415908|460044687|FG001|Overall Study|Withdrawal by Subject|0|||
127843479|NCT03250377|460044688|FG000|Overall Study|Adverse Event|2|||
127843480|NCT03250377|460044689|FG001|Overall Study|Adverse Event|4|||
127843481|NCT03250377|460044690|FG002|Overall Study|Adverse Event|0|||
127843482|NCT03250377|460044691|FG003|Overall Study|Adverse Event|4|||
127843483|NCT03250377|460044688|FG000|Overall Study|Lack of Efficacy|5|||
127843484|NCT03250377|460044689|FG001|Overall Study|Lack of Efficacy|14|||
127843485|NCT03250377|460044690|FG002|Overall Study|Lack of Efficacy|1|||
127843486|NCT03250377|460044691|FG003|Overall Study|Lack of Efficacy|3|||
127843487|NCT03250377|460044688|FG000|Overall Study|Protocol Violation|0|||
127843488|NCT03250377|460044689|FG001|Overall Study|Protocol Violation|2|||
127843489|NCT03250377|460044690|FG002|Overall Study|Protocol Violation|0|||
127843490|NCT03250377|460044691|FG003|Overall Study|Protocol Violation|1|||
127843491|NCT03250377|460044688|FG000|Overall Study|Lost to Follow-up|0|||
127843492|NCT03250377|460044689|FG001|Overall Study|Lost to Follow-up|1|||
127843493|NCT03250377|460044690|FG002|Overall Study|Lost to Follow-up|0|||
127843494|NCT03250377|460044691|FG003|Overall Study|Lost to Follow-up|0|||
127843495|NCT03250377|460044688|FG000|Overall Study|Withdrawal by Subject|7|||
127843496|NCT03250377|460044689|FG001|Overall Study|Withdrawal by Subject|7|||
127843497|NCT03250377|460044690|FG002|Overall Study|Withdrawal by Subject|0|||
127843498|NCT03250377|460044691|FG003|Overall Study|Withdrawal by Subject|4|||
127843499|NCT03250377|460044688|FG000|Overall Study|Investigator's Judgment|1|||
127843500|NCT03250377|460044689|FG001|Overall Study|Investigator's Judgment|0|||
127843501|NCT03250377|460044690|FG002|Overall Study|Investigator's Judgment|0|||
127843502|NCT03250377|460044691|FG003|Overall Study|Investigator's Judgment|0|||
127843503|NCT03250377|460044688|FG000|Overall Study|She wanted to change other therapeutic medication|1|||
127843504|NCT03250377|460044689|FG001|Overall Study|She wanted to change other therapeutic medication|0|||
127843505|NCT03250377|460044690|FG002|Overall Study|She wanted to change other therapeutic medication|0|||
127843506|NCT03250377|460044691|FG003|Overall Study|She wanted to change other therapeutic medication|0|||
127843507|NCT03250377|460044688|FG000|Overall Study|The Subject Go Abroad and Not Return|1|||
127843508|NCT03250377|460044689|FG001|Overall Study|The Subject Go Abroad and Not Return|0|||
127843509|NCT03250377|460044690|FG002|Overall Study|The Subject Go Abroad and Not Return|0|||
127843510|NCT03250377|460044691|FG003|Overall Study|The Subject Go Abroad and Not Return|0|||
127843511|NCT03250377|460044688|FG000|Overall Study|Epilepsy Surgery|0|||
127843512|NCT03250377|460044689|FG001|Overall Study|Epilepsy Surgery|1|||
127843513|NCT03250377|460044690|FG002|Overall Study|Epilepsy Surgery|2|||
127843514|NCT03250377|460044691|FG003|Overall Study|Epilepsy Surgery|0|||
127843515|NCT03250377|460044688|FG000|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
127843516|NCT03250377|460044689|FG001|Overall Study|Subject moved to kanagawa (faraway from clinic)|1|||
127843517|NCT03250377|460044690|FG002|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
127843518|NCT03250377|460044691|FG003|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
127900802|NCT01378975|460261304|FG001|Overall Study|Death|46|||
127900803|NCT01378975|460261303|FG000|Overall Study|Investigator Request|1|||
127900804|NCT01378975|460261304|FG001|Overall Study|Investigator Request|0|||
127900805|NCT01378975|460261303|FG000|Overall Study|Lost to Follow-up|4|||
127900806|NCT01378975|460261304|FG001|Overall Study|Lost to Follow-up|1|||
127900807|NCT01378975|460261303|FG000|Overall Study|Withdrew Consent|4|||
127900808|NCT01378975|460261304|FG001|Overall Study|Withdrew Consent|3|||
127900809|NCT02343120|460261308|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
127900810|NCT02343120|460261309|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
127900811|NCT02343120|460261310|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
127900812|NCT02343120|460261311|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
127900813|NCT02343120|460261312|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
127900814|NCT02343120|460261308|FG000|Part 1: Dose Escalation|Death|1|||
127900815|NCT02343120|460261309|FG001|Part 1: Dose Escalation|Death|2|||
127900816|NCT02343120|460261310|FG002|Part 1: Dose Escalation|Death|2|||
127900817|NCT02343120|460261311|FG003|Part 1: Dose Escalation|Death|2|||
127843519|NCT03250377|460044688|FG000|Overall Study|Request From The Sponsor|0|||
127843520|NCT03250377|460044689|FG001|Overall Study|Request From The Sponsor|1|||
127900818|NCT02343120|460261312|FG004|Part 1: Dose Escalation|Death|1|||
127900819|NCT02343120|460261308|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
127900820|NCT02343120|460261309|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
127843521|NCT03250377|460044690|FG002|Overall Study|Request From The Sponsor|0|||
127843522|NCT03250377|460044691|FG003|Overall Study|Request From The Sponsor|0|||
127843523|NCT03250377|460044688|FG000|Overall Study|Subject did not follow procedure or study drug|0|||
127843524|NCT03250377|460044689|FG001|Overall Study|Subject did not follow procedure or study drug|1|||
127900821|NCT02343120|460261310|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
127900822|NCT02343120|460261311|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
127900823|NCT02343120|460261312|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
127843525|NCT03250377|460044690|FG002|Overall Study|Subject did not follow procedure or study drug|0|||
127843526|NCT03250377|460044691|FG003|Overall Study|Subject did not follow procedure or study drug|0|||
127843527|NCT03250377|460044688|FG000|Overall Study|Subject stopped drug; did not wish to continue|0|||
127843528|NCT03250377|460044689|FG001|Overall Study|Subject stopped drug; did not wish to continue|1|||
127843529|NCT03250377|460044690|FG002|Overall Study|Subject stopped drug; did not wish to continue|0|||
127843530|NCT03250377|460044691|FG003|Overall Study|Subject stopped drug; did not wish to continue|0|||
127843531|NCT03250377|460044688|FG000|Overall Study|Subjects did not follow procedures or medication|0|||
127843532|NCT03250377|460044689|FG001|Overall Study|Subjects did not follow procedures or medication|1|||
127843533|NCT03250377|460044690|FG002|Overall Study|Subjects did not follow procedures or medication|0|||
127843534|NCT03250377|460044691|FG003|Overall Study|Subjects did not follow procedures or medication|0|||
127843535|NCT03250377|460044688|FG000|Overall Study|Pregnancy Event|0|||
127843536|NCT03250377|460044689|FG001|Overall Study|Pregnancy Event|1|||
127843537|NCT03250377|460044690|FG002|Overall Study|Pregnancy Event|0|||
127843538|NCT03250377|460044691|FG003|Overall Study|Pregnancy Event|0|||
127843539|NCT03250377|460044688|FG000|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
127843540|NCT03250377|460044689|FG001|Overall Study|PI's opinion:Subject noncompliant with medication|1|||
127843541|NCT03250377|460044690|FG002|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
127843542|NCT03250377|460044691|FG003|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
127843543|NCT03250377|460044688|FG000|Overall Study|Subjects felt no effect;want to discontinue study|0|||
127843544|NCT03250377|460044689|FG001|Overall Study|Subjects felt no effect;want to discontinue study|1|||
127843545|NCT03250377|460044690|FG002|Overall Study|Subjects felt no effect;want to discontinue study|0|||
127843546|NCT03250377|460044691|FG003|Overall Study|Subjects felt no effect;want to discontinue study|0|||
127843547|NCT03250377|460044688|FG000|Overall Study|Subjects underweight; intolerant to study drugs|0|||
127843548|NCT03250377|460044689|FG001|Overall Study|Subjects underweight; intolerant to study drugs|1|||
127843549|NCT03250377|460044690|FG002|Overall Study|Subjects underweight; intolerant to study drugs|0|||
127843550|NCT03250377|460044691|FG003|Overall Study|Subjects underweight; intolerant to study drugs|0|||
127843551|NCT03250377|460044688|FG000|Overall Study|Patient requested to change hospital|0|||
127843552|NCT03250377|460044689|FG001|Overall Study|Patient requested to change hospital|0|||
127843553|NCT03250377|460044690|FG002|Overall Study|Patient requested to change hospital|0|||
127843554|NCT03250377|460044691|FG003|Overall Study|Patient requested to change hospital|1|||
127843555|NCT03250377|460044688|FG000|Overall Study|Admission To Geriatric Health Facility|0|||
127843556|NCT03250377|460044689|FG001|Overall Study|Admission To Geriatric Health Facility|0|||
127843557|NCT03250377|460044690|FG002|Overall Study|Admission To Geriatric Health Facility|0|||
127843558|NCT03250377|460044691|FG003|Overall Study|Admission To Geriatric Health Facility|1|||
127843559|NCT00817206|460044692|FG000|Overall Study|Adverse Event|10|||
127843560|NCT00817206|460044693|FG001|Overall Study|Adverse Event|3|||
127843561|NCT00817206|460044692|FG000|Overall Study|Protocol Violation|0|||
127843562|NCT00817206|460044693|FG001|Overall Study|Protocol Violation|2|||
127843563|NCT00817206|460044692|FG000|Overall Study|Lost to Follow-up|0|||
127843564|NCT00817206|460044693|FG001|Overall Study|Lost to Follow-up|1|||
127843565|NCT00817206|460044692|FG000|Overall Study|Death|2|||
127843566|NCT00817206|460044693|FG001|Overall Study|Death|0|||
127843567|NCT00817206|460044692|FG000|Overall Study|Withdrawal by Subject|7|||
127843568|NCT00817206|460044693|FG001|Overall Study|Withdrawal by Subject|3|||
127843569|NCT00817206|460044692|FG000|Overall Study|Physician Decision|2|||
127843570|NCT00817206|460044693|FG001|Overall Study|Physician Decision|0|||
127843571|NCT02034552|460044694|FG000|Overall Study|Never treated|3|||
127843572|NCT02034552|460044695|FG001|Overall Study|Never treated|2|||
127843573|NCT02034552|460044696|FG002|Overall Study|Never treated|0|||
127843574|NCT02034552|460044694|FG000|Overall Study|Radiological progression|3|||
127843575|NCT02034552|460044695|FG001|Overall Study|Radiological progression|5|||
127843576|NCT02034552|460044696|FG002|Overall Study|Radiological progression|4|||
127843577|NCT02034552|460044694|FG000|Overall Study|AE not assoc. with disease progression|1|||
127843578|NCT02034552|460044695|FG001|Overall Study|AE not assoc. with disease progression|4|||
127843579|NCT02034552|460044696|FG002|Overall Study|AE not assoc. with disease progression|2|||
127843580|NCT02034552|460044694|FG000|Overall Study|AE associated with disease progression|0|||
127843581|NCT02034552|460044695|FG001|Overall Study|AE associated with disease progression|1|||
127843582|NCT02034552|460044696|FG002|Overall Study|AE associated with disease progression|0|||
127843583|NCT02034552|460044694|FG000|Overall Study|Withdrawal by Subject|2|||
127843584|NCT02034552|460044695|FG001|Overall Study|Withdrawal by Subject|1|||
127843585|NCT02034552|460044696|FG002|Overall Study|Withdrawal by Subject|1|||
127843586|NCT02034552|460044694|FG000|Overall Study|Non-compliance with study drug|0|||
127843587|NCT02034552|460044695|FG001|Overall Study|Non-compliance with study drug|0|||
127843588|NCT02034552|460044696|FG002|Overall Study|Non-compliance with study drug|1|||
127843589|NCT02034552|460044694|FG000|Overall Study|Clinical progression|5|||
127843590|NCT02034552|460044695|FG001|Overall Study|Clinical progression|7|||
127843591|NCT02034552|460044696|FG002|Overall Study|Clinical progression|9|||
127843592|NCT00291499|460044702|FG000|Overall Study|Adverse Event|3|||
127843593|NCT00291499|460044703|FG001|Overall Study|Adverse Event|8|||
127843594|NCT00291499|460044702|FG000|Overall Study|Change to other therapy|2|||
127843595|NCT00291499|460044703|FG001|Overall Study|Change to other therapy|1|||
127843596|NCT00291499|460044702|FG000|Overall Study|Intercurrent illness|1|||
127843597|NCT00291499|460044703|FG001|Overall Study|Intercurrent illness|0|||
127843598|NCT00291499|460044702|FG000|Overall Study|Protocol Violation|2|||
127843599|NCT00291499|460044703|FG001|Overall Study|Protocol Violation|2|||
127843600|NCT00291499|460044702|FG000|Overall Study|Other reasons|1|||
127843601|NCT00291499|460044703|FG001|Overall Study|Other reasons|4|||
127843602|NCT01532570|460044704|FG000|Overall Study|Lack of Efficacy|1|||
127843603|NCT01532570|460044705|FG001|Overall Study|Lack of Efficacy|0|||
127843604|NCT01532570|460044706|FG002|Overall Study|Lack of Efficacy|0|||
127843605|NCT01532570|460044707|FG003|Overall Study|Lack of Efficacy|0|||
127843606|NCT01532570|460044704|FG000|Overall Study|Withdrawal by Subject|0|||
127843607|NCT01532570|460044705|FG001|Overall Study|Withdrawal by Subject|1|||
127843608|NCT01532570|460044706|FG002|Overall Study|Withdrawal by Subject|0|||
127843609|NCT01532570|460044707|FG003|Overall Study|Withdrawal by Subject|0|||
127843610|NCT01082367|460044708|FG000|Double-blind Period|Administrative problems|0|||
127843611|NCT01082367|460044709|FG001|Double-blind Period|Administrative problems|1|||
127843612|NCT01082367|460044708|FG000|Double-blind Period|Lack of Efficacy|5|||
127843613|NCT01082367|460044709|FG001|Double-blind Period|Lack of Efficacy|11|||
127843614|NCT01082367|460044708|FG000|Double-blind Period|Adverse Event|0|||
127843615|NCT01082367|460044709|FG001|Double-blind Period|Adverse Event|1|||
127843616|NCT01082367|460044708|FG000|Follow-up (F-U) Period|Administrative problems|1|||
127843617|NCT01082367|460044709|FG001|Follow-up (F-U) Period|Administrative problems|0|||
127843618|NCT01082367|460044708|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
127843619|NCT01082367|460044709|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
127843620|NCT01082367|460044708|FG000|Follow-up (F-U) Period|Adverse Event|0|||
127843621|NCT01082367|460044709|FG001|Follow-up (F-U) Period|Adverse Event|1|||
127843622|NCT02016898|460044710|FG000|Overall Study|Death|1|||
127843623|NCT02016898|460044711|FG001|Overall Study|Death|1|||
127843624|NCT02016898|460044710|FG000|Overall Study|Lost to Follow-up|4|||
127843625|NCT02016898|460044711|FG001|Overall Study|Lost to Follow-up|4|||
127843626|NCT01665768|460044712|FG000|Overall Study|Adverse Event|3|||
127843627|NCT01665768|460044712|FG000|Overall Study|Lack of Efficacy|19|||
127843628|NCT01665768|460044712|FG000|Overall Study|Withdrawal by Subject|1|||
127843629|NCT01329341|460044713|FG000|Overall Study|Withdrawal by Subject|44|||
127843630|NCT03017846|460044714|FG000|Overall Study|Lost to Follow-up|3|||
127843631|NCT03017846|460044714|FG000|Overall Study|Adverse Event|2|||
127843632|NCT04603391|460044715|FG000|First Intervention (4 Days)|Adverse Event|1|||
127843633|NCT04603391|460044716|FG001|First Intervention (4 Days)|Adverse Event|0|||
127843634|NCT04603391|460044715|FG000|First Intervention (4 Days)|Lost to Follow-up|1|||
127843635|NCT04603391|460044716|FG001|First Intervention (4 Days)|Lost to Follow-up|0|||
127843636|NCT02151682|460044717|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
127843637|NCT02151682|460044718|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
127843638|NCT02151682|460044719|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
127843639|NCT02151682|460044720|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
127843640|NCT02151682|460044721|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
127843641|NCT02151682|460044722|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
127843642|NCT02151682|460044717|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
127843643|NCT02151682|460044718|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
127843644|NCT02151682|460044719|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
127900824|NCT02343120|460261308|FG000|Part 2: Expansion|Sponsor decision|0|||
127900825|NCT02343120|460261309|FG001|Part 2: Expansion|Sponsor decision|0|||
127900826|NCT02343120|460261310|FG002|Part 2: Expansion|Sponsor decision|0|||
127843645|NCT02151682|460044720|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
127843646|NCT02151682|460044721|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
127843647|NCT02151682|460044722|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
127900827|NCT02343120|460261311|FG003|Part 2: Expansion|Sponsor decision|165|||
127900828|NCT02343120|460261312|FG004|Part 2: Expansion|Sponsor decision|67|||
127900829|NCT02343120|460261308|FG000|Part 2: Expansion|Death|0|||
127900830|NCT02343120|460261309|FG001|Part 2: Expansion|Death|0|||
127900831|NCT02343120|460261310|FG002|Part 2: Expansion|Death|0|||
127900832|NCT02343120|460261311|FG003|Part 2: Expansion|Death|74|||
127900833|NCT02343120|460261312|FG004|Part 2: Expansion|Death|17|||
127843648|NCT02151682|460044717|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
127843649|NCT02151682|460044718|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
127843650|NCT02151682|460044719|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
127843651|NCT02151682|460044720|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
127843652|NCT02151682|460044721|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
127843653|NCT02151682|460044722|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
127843654|NCT02151682|460044717|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
127843655|NCT02151682|460044718|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
127843656|NCT02151682|460044719|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
127843657|NCT02151682|460044720|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
127843658|NCT02151682|460044721|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
127843659|NCT02151682|460044722|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
127843660|NCT02151682|460044717|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
127843661|NCT02151682|460044718|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
127843662|NCT02151682|460044719|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
127843663|NCT02151682|460044720|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
127843664|NCT02151682|460044721|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
127843665|NCT02151682|460044722|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
127843666|NCT02151682|460044717|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
127843667|NCT02151682|460044718|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
127843668|NCT02151682|460044719|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
127843669|NCT02151682|460044720|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
127843670|NCT02151682|460044721|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
127843671|NCT02151682|460044722|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
127843672|NCT02151682|460044717|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
127843673|NCT02151682|460044718|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
127843674|NCT02151682|460044719|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
127843675|NCT02151682|460044720|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
127843676|NCT02151682|460044721|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
127843677|NCT02151682|460044722|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
127843678|NCT02151682|460044717|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
127843679|NCT02151682|460044718|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
127843680|NCT02151682|460044719|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
127843681|NCT02151682|460044720|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
127843682|NCT02151682|460044721|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
127843683|NCT02151682|460044722|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
127843684|NCT02151682|460044717|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
127843685|NCT02151682|460044718|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
127843686|NCT02151682|460044719|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
127843687|NCT02151682|460044720|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
127843688|NCT02151682|460044721|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
127843689|NCT02151682|460044722|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
127843690|NCT02151682|460044717|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
127843691|NCT02151682|460044718|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
127843692|NCT02151682|460044719|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
127843693|NCT02151682|460044720|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
127843694|NCT02151682|460044721|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
127843695|NCT02151682|460044722|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
127843696|NCT02151682|460044717|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
127843697|NCT02151682|460044718|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
127843698|NCT02151682|460044719|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
127843699|NCT02151682|460044720|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
127843700|NCT02151682|460044721|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
127843701|NCT02151682|460044722|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
127843702|NCT02151682|460044717|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
127843703|NCT02151682|460044718|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
127843704|NCT02151682|460044719|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
127843705|NCT02151682|460044720|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
127843706|NCT02151682|460044721|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
127843707|NCT02151682|460044722|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
127843708|NCT02151682|460044717|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
127843709|NCT02151682|460044718|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
127843710|NCT02151682|460044719|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
127843711|NCT02151682|460044720|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
127843712|NCT02151682|460044721|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
127843713|NCT02151682|460044722|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
127843714|NCT02151682|460044717|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
127843715|NCT02151682|460044718|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
127843716|NCT02151682|460044719|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
127843717|NCT02151682|460044720|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
127843718|NCT02151682|460044721|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
127843719|NCT02151682|460044722|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
127843720|NCT02151682|460044717|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
127843721|NCT02151682|460044718|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
127843722|NCT02151682|460044719|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
127843723|NCT02151682|460044720|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
127900834|NCT02343120|460261308|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
127900835|NCT02343120|460261309|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
127900836|NCT02343120|460261310|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
127900837|NCT02343120|460261311|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
127900838|NCT02343120|460261312|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
127843724|NCT02151682|460044721|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
127843725|NCT02151682|460044722|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
127843726|NCT02151682|460044717|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
127843727|NCT02151682|460044718|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
127843728|NCT02151682|460044719|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
127843729|NCT02151682|460044720|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
127843730|NCT02151682|460044721|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
127843731|NCT02151682|460044722|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
127843732|NCT02151682|460044717|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
127843733|NCT02151682|460044718|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
127843734|NCT02151682|460044719|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
127843735|NCT02151682|460044720|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
127843736|NCT02151682|460044721|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
127843737|NCT02151682|460044722|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
127843738|NCT02151682|460044717|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
127843739|NCT02151682|460044718|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
127843740|NCT02151682|460044719|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
127843741|NCT02151682|460044720|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
127843742|NCT02151682|460044721|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
127843743|NCT02151682|460044722|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
127843744|NCT01306032|460044723|FG000|First Intervention|Adverse Event|1|||
127843745|NCT01306032|460044724|FG001|First Intervention|Adverse Event|0|||
127843746|NCT01306032|460044725|FG002|First Intervention|Adverse Event|1|||
127843747|NCT01306032|460044726|FG003|First Intervention|Adverse Event|0|||
127843748|NCT01306032|460044727|FG004|First Intervention|Adverse Event|0|||
127843749|NCT01306032|460044728|FG005|First Intervention|Adverse Event|1|||
127843750|NCT01306032|460044723|FG000|First Intervention|Withdrawal by Subject|0|||
127843751|NCT01306032|460044724|FG001|First Intervention|Withdrawal by Subject|2|||
127843752|NCT01306032|460044725|FG002|First Intervention|Withdrawal by Subject|0|||
127843753|NCT01306032|460044726|FG003|First Intervention|Withdrawal by Subject|1|||
127843754|NCT01306032|460044727|FG004|First Intervention|Withdrawal by Subject|0|||
127843755|NCT01306032|460044728|FG005|First Intervention|Withdrawal by Subject|0|||
127843756|NCT01306032|460044723|FG000|First Intervention|Death|0|||
127843757|NCT01306032|460044724|FG001|First Intervention|Death|0|||
127843758|NCT01306032|460044725|FG002|First Intervention|Death|1|||
127843759|NCT01306032|460044726|FG003|First Intervention|Death|0|||
127843760|NCT01306032|460044727|FG004|First Intervention|Death|0|||
127843761|NCT01306032|460044728|FG005|First Intervention|Death|0|||
127843762|NCT01306032|460044723|FG000|First Intervention|Ineligible|0|||
127843763|NCT01306032|460044724|FG001|First Intervention|Ineligible|0|||
127843764|NCT01306032|460044725|FG002|First Intervention|Ineligible|0|||
127843765|NCT01306032|460044726|FG003|First Intervention|Ineligible|0|||
127843766|NCT01306032|460044727|FG004|First Intervention|Ineligible|0|||
127843767|NCT01306032|460044728|FG005|First Intervention|Ineligible|1|||
127900839|NCT02343120|460261308|FG000|Part 2: Expansion|Lost to Follow-up|0|||
127900840|NCT02343120|460261309|FG001|Part 2: Expansion|Lost to Follow-up|0|||
127900841|NCT02343120|460261310|FG002|Part 2: Expansion|Lost to Follow-up|0|||
127900842|NCT02343120|460261311|FG003|Part 2: Expansion|Lost to Follow-up|5|||
127900843|NCT02343120|460261312|FG004|Part 2: Expansion|Lost to Follow-up|2|||
127900844|NCT02343120|460261308|FG000|Part 2: Expansion|Other|0|||
127900845|NCT02343120|460261309|FG001|Part 2: Expansion|Other|0|||
127900846|NCT02343120|460261310|FG002|Part 2: Expansion|Other|0|||
127900847|NCT02343120|460261311|FG003|Part 2: Expansion|Other|1|||
127900848|NCT02343120|460261312|FG004|Part 2: Expansion|Other|5|||
127900849|NCT02343120|460261308|FG000|Part 2: Expansion|Adverse Event|0|||
127843768|NCT01306032|460044723|FG000|First Intervention|Progressive disease|0|||
127843769|NCT01306032|460044724|FG001|First Intervention|Progressive disease|0|||
127843770|NCT01306032|460044725|FG002|First Intervention|Progressive disease|0|||
127843771|NCT01306032|460044726|FG003|First Intervention|Progressive disease|0|||
127843772|NCT01306032|460044727|FG004|First Intervention|Progressive disease|2|||
127843773|NCT01306032|460044728|FG005|First Intervention|Progressive disease|0|||
127843774|NCT01306032|460044723|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
127843775|NCT01306032|460044724|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
127843776|NCT01306032|460044725|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
127843777|NCT01306032|460044726|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
127843778|NCT01306032|460044727|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
127843779|NCT01306032|460044728|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
127843780|NCT01306032|460044723|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
127843781|NCT01306032|460044724|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
127843782|NCT01306032|460044725|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
127843783|NCT01306032|460044726|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
127843784|NCT01306032|460044727|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
127843785|NCT01306032|460044728|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
127843786|NCT03260894|460044730|FG000|Overall Study|Death|6|||
127843787|NCT03260894|460044731|FG001|Overall Study|Death|8|||
127843788|NCT03260894|460044730|FG000|Overall Study|Withdrawal by Subject|4|||
127843789|NCT03260894|460044731|FG001|Overall Study|Withdrawal by Subject|11|||
127843790|NCT03260894|460044730|FG000|Overall Study|On-going at clinical cut off date|36|||
127843791|NCT03260894|460044731|FG001|Overall Study|On-going at clinical cut off date|31|||
127843792|NCT00168064|460044732|FG000|Overall Study|Adverse Event|26|||
127843793|NCT00168064|460044733|FG001|Overall Study|Adverse Event|22|||
127843794|NCT00168064|460044732|FG000|Overall Study|Withdrawal by Subject|3|||
127843795|NCT00168064|460044733|FG001|Overall Study|Withdrawal by Subject|4|||
127843796|NCT00168064|460044732|FG000|Overall Study|Lack of Efficacy|4|||
127843797|NCT00168064|460044733|FG001|Overall Study|Lack of Efficacy|4|||
127843798|NCT00168064|460044732|FG000|Overall Study|Lost to Follow-up|4|||
127843799|NCT00168064|460044733|FG001|Overall Study|Lost to Follow-up|3|||
127843800|NCT00168064|460044732|FG000|Overall Study|Non-compliance|2|||
127843801|NCT00168064|460044733|FG001|Overall Study|Non-compliance|3|||
127843802|NCT00168064|460044732|FG000|Overall Study|Concurrent Illness|4|||
127843803|NCT00168064|460044733|FG001|Overall Study|Concurrent Illness|3|||
127843804|NCT00168064|460044732|FG000|Overall Study|Subject's Best interest|2|||
127843805|NCT00168064|460044733|FG001|Overall Study|Subject's Best interest|2|||
127843806|NCT00168064|460044732|FG000|Overall Study|Various|4|||
127843807|NCT00168064|460044733|FG001|Overall Study|Various|3|||
127843808|NCT00318565|460044734|FG000|Overall Study|Excluded per protocol|24|||
127843809|NCT01896856|460044736|FG000|Overall Study|Transportation issues / Non-compliance|0|||
127843810|NCT01896856|460044737|FG001|Overall Study|Transportation issues / Non-compliance|0|||
127843811|NCT01896856|460044738|FG002|Overall Study|Transportation issues / Non-compliance|1|||
127843812|NCT01896856|460044739|FG003|Overall Study|Transportation issues / Non-compliance|0|||
127843813|NCT01896856|460044740|FG004|Overall Study|Transportation issues / Non-compliance|0|||
127843814|NCT01896856|460044741|FG005|Overall Study|Transportation issues / Non-compliance|0|||
127843815|NCT00282867|460044742|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
127843816|NCT00282867|460044743|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
127843817|NCT00282867|460044744|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
127843818|NCT01376245|460044748|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
127843819|NCT01376245|460044749|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
127843820|NCT01376245|460044750|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
127843821|NCT01376245|460044751|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
127843822|NCT01376245|460044752|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
127843823|NCT01376245|460044748|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
127843824|NCT01376245|460044749|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
127843825|NCT01376245|460044750|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
127843826|NCT01376245|460044751|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
127843827|NCT01376245|460044752|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
127843828|NCT01376245|460044748|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
127843829|NCT01376245|460044749|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
127843830|NCT01376245|460044750|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
127843831|NCT01376245|460044751|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
127843832|NCT01376245|460044752|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
127843833|NCT01376245|460044748|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
127843834|NCT01376245|460044749|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
127843835|NCT01376245|460044750|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
127843836|NCT01376245|460044751|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
127843837|NCT01376245|460044752|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
127843838|NCT01376245|460044748|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
127843839|NCT01376245|460044749|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
127843840|NCT01376245|460044750|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
127843841|NCT01376245|460044751|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
127843842|NCT01376245|460044752|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
127843843|NCT01376245|460044748|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
127843844|NCT01376245|460044749|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
127843845|NCT01376245|460044750|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
127843846|NCT01376245|460044751|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
127843847|NCT01376245|460044752|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
127843848|NCT01376245|460044748|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
127843849|NCT01376245|460044749|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
127843850|NCT01376245|460044750|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
127843851|NCT01376245|460044751|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
127843852|NCT01376245|460044752|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
127843853|NCT01376245|460044748|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
127843854|NCT01376245|460044749|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
127843855|NCT01376245|460044750|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
127843856|NCT01376245|460044751|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
127843857|NCT01376245|460044752|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
127843858|NCT01376245|460044748|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
127843859|NCT01376245|460044749|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
127843860|NCT01376245|460044750|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
127843861|NCT01376245|460044751|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
127843862|NCT01376245|460044752|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
127843863|NCT01376245|460044748|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
127843864|NCT01376245|460044749|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
127843865|NCT01376245|460044750|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
127843866|NCT01376245|460044751|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
127843867|NCT01376245|460044752|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
127843868|NCT01376245|460044748|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
127843869|NCT01376245|460044749|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
127843870|NCT01376245|460044750|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
127843871|NCT01376245|460044751|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
127843872|NCT01376245|460044752|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
127843873|NCT01376245|460044748|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
127843874|NCT01376245|460044749|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
127843875|NCT01376245|460044750|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
127843876|NCT01376245|460044751|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
127843877|NCT01376245|460044752|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
127843878|NCT05159362|460044753|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
127843879|NCT05159362|460044754|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
127843880|NCT05159362|460044755|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
127843881|NCT01357889|460044756|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
127843882|NCT01357889|460044757|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
127843883|NCT01357889|460044756|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
127843884|NCT01357889|460044757|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
127843885|NCT01357889|460044756|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
127843886|NCT01357889|460044757|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
127843887|NCT01357889|460044756|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
127843888|NCT01357889|460044757|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
127843889|NCT01357889|460044756|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
127843890|NCT01357889|460044757|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
127843891|NCT01357889|460044756|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
127843892|NCT01357889|460044757|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
127843893|NCT01357889|460044756|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
127843894|NCT01357889|460044757|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
127843895|NCT01357889|460044756|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
127843896|NCT01357889|460044757|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
127843897|NCT01357889|460044756|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
127843898|NCT01357889|460044757|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
127843899|NCT01357889|460044756|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
127843900|NCT01357889|460044757|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
127843901|NCT01357889|460044756|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
127843902|NCT01357889|460044757|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
127843903|NCT01357889|460044756|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
127843904|NCT01357889|460044757|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
127843905|NCT01357889|460044756|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
127843906|NCT01357889|460044757|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
127843907|NCT01335698|460044758|FG000|Treatment Stage 1|Lack of Efficacy|3|||
127843908|NCT01335698|460044759|FG001|Treatment Stage 1|Lack of Efficacy|1|||
127843909|NCT01335698|460044760|FG002|Treatment Stage 1|Lack of Efficacy|3|||
127843910|NCT01335698|460044761|FG003|Treatment Stage 1|Lack of Efficacy|3|||
127843911|NCT01335698|460044762|FG004|Treatment Stage 1|Lack of Efficacy|1|||
127843912|NCT01335698|460044758|FG000|Treatment Stage 1|Adverse Event|1|||
127843913|NCT01335698|460044759|FG001|Treatment Stage 1|Adverse Event|2|||
127843914|NCT01335698|460044760|FG002|Treatment Stage 1|Adverse Event|2|||
127843915|NCT01335698|460044761|FG003|Treatment Stage 1|Adverse Event|1|||
127843916|NCT01335698|460044762|FG004|Treatment Stage 1|Adverse Event|1|||
127843917|NCT01335698|460044758|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
127843918|NCT01335698|460044759|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
127843919|NCT01335698|460044760|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
127843920|NCT01335698|460044761|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
127843921|NCT01335698|460044762|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
127843922|NCT01335698|460044758|FG000|Treatment Stage 1|Lost to Follow-up|1|||
127843923|NCT01335698|460044759|FG001|Treatment Stage 1|Lost to Follow-up|1|||
127843924|NCT01335698|460044760|FG002|Treatment Stage 1|Lost to Follow-up|0|||
127843925|NCT01335698|460044761|FG003|Treatment Stage 1|Lost to Follow-up|0|||
127843926|NCT01335698|460044762|FG004|Treatment Stage 1|Lost to Follow-up|0|||
127843927|NCT01335698|460044758|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
127843928|NCT01335698|460044759|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
127843929|NCT01335698|460044760|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
127843930|NCT01335698|460044761|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
127843931|NCT01335698|460044762|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
127843932|NCT01335698|460044758|FG000|Treatment Stage 1|No longer meets study criteria|1|||
127843933|NCT01335698|460044759|FG001|Treatment Stage 1|No longer meets study criteria|1|||
127843934|NCT01335698|460044760|FG002|Treatment Stage 1|No longer meets study criteria|0|||
127843935|NCT01335698|460044761|FG003|Treatment Stage 1|No longer meets study criteria|1|||
127843936|NCT01335698|460044762|FG004|Treatment Stage 1|No longer meets study criteria|0|||
127843937|NCT01335698|460044758|FG000|Treatment Stage 1|Other|1|||
127843938|NCT01335698|460044759|FG001|Treatment Stage 1|Other|0|||
127843939|NCT01335698|460044760|FG002|Treatment Stage 1|Other|0|||
127843940|NCT01335698|460044761|FG003|Treatment Stage 1|Other|1|||
127843941|NCT01335698|460044762|FG004|Treatment Stage 1|Other|0|||
127843942|NCT01335698|460044758|FG000|Treatment Stage 2|Lack of Efficacy|2|||
127843943|NCT01335698|460044759|FG001|Treatment Stage 2|Lack of Efficacy|1|||
127843944|NCT01335698|460044760|FG002|Treatment Stage 2|Lack of Efficacy|3|||
127843945|NCT01335698|460044761|FG003|Treatment Stage 2|Lack of Efficacy|1|||
127843946|NCT01335698|460044762|FG004|Treatment Stage 2|Lack of Efficacy|0|||
127843947|NCT01335698|460044758|FG000|Treatment Stage 2|Adverse Event|2|||
127843948|NCT01335698|460044759|FG001|Treatment Stage 2|Adverse Event|0|||
127900850|NCT02343120|460261309|FG001|Part 2: Expansion|Adverse Event|0|||
127900851|NCT02343120|460261310|FG002|Part 2: Expansion|Adverse Event|0|||
127900852|NCT02343120|460261311|FG003|Part 2: Expansion|Adverse Event|1|||
127900853|NCT02343120|460261312|FG004|Part 2: Expansion|Adverse Event|1|||
127900854|NCT03544138|460261313|FG000|Overall Study|Lost to Follow-up|29|||
127900855|NCT01766778|460261314|FG000|Overall Study|Adverse Event|4|||
127900856|NCT01766778|460261315|FG001|Overall Study|Adverse Event|4|||
127843949|NCT01335698|460044760|FG002|Treatment Stage 2|Adverse Event|0|||
127843950|NCT01335698|460044761|FG003|Treatment Stage 2|Adverse Event|3|||
127843951|NCT01335698|460044762|FG004|Treatment Stage 2|Adverse Event|0|||
127843952|NCT01335698|460044758|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
127843953|NCT01335698|460044759|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
127900857|NCT01766778|460261314|FG000|Overall Study|Withdrawal by Subject|1|||
127900858|NCT01766778|460261315|FG001|Overall Study|Withdrawal by Subject|0|||
127843954|NCT01335698|460044760|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
127843955|NCT01335698|460044761|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
127843956|NCT01335698|460044762|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
127843957|NCT01335698|460044758|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
127843958|NCT01335698|460044759|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
127843959|NCT01335698|460044760|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
127843960|NCT01335698|460044761|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
127843961|NCT01335698|460044762|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
127843962|NCT01335698|460044758|FG000|Treatment Stage 2|Lost to Follow-up|1|||
127843963|NCT01335698|460044759|FG001|Treatment Stage 2|Lost to Follow-up|0|||
127843964|NCT01335698|460044760|FG002|Treatment Stage 2|Lost to Follow-up|0|||
127843965|NCT01335698|460044761|FG003|Treatment Stage 2|Lost to Follow-up|0|||
127843966|NCT01335698|460044762|FG004|Treatment Stage 2|Lost to Follow-up|0|||
127843967|NCT01335698|460044758|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
127843968|NCT01335698|460044759|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
127843969|NCT01335698|460044760|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
127843970|NCT01335698|460044761|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
127843971|NCT01335698|460044762|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
127843972|NCT01335698|460044758|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
127843973|NCT01335698|460044759|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
127843974|NCT01335698|460044760|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
127843975|NCT01335698|460044761|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
127843976|NCT01335698|460044762|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
127843977|NCT01335698|460044758|FG000|Treatment Stage 2|Switched to another formulation|1|||
127843978|NCT01335698|460044759|FG001|Treatment Stage 2|Switched to another formulation|1|||
127843979|NCT01335698|460044760|FG002|Treatment Stage 2|Switched to another formulation|0|||
127843980|NCT01335698|460044761|FG003|Treatment Stage 2|Switched to another formulation|0|||
127843981|NCT01335698|460044762|FG004|Treatment Stage 2|Switched to another formulation|0|||
127843982|NCT03970824|460044763|FG000|Overall Study|Withdrawal by Subject|1|||
127843983|NCT03970824|460044764|FG001|Overall Study|Withdrawal by Subject|1|||
127843984|NCT03970824|460044765|FG002|Overall Study|Withdrawal by Subject|3|||
127843985|NCT03970824|460044763|FG000|Overall Study|Lost to Follow-up|0|||
127843986|NCT03970824|460044764|FG001|Overall Study|Lost to Follow-up|2|||
127843987|NCT03970824|460044765|FG002|Overall Study|Lost to Follow-up|1|||
127843988|NCT03970824|460044763|FG000|Overall Study|Adverse Event|1|||
127843989|NCT03970824|460044764|FG001|Overall Study|Adverse Event|0|||
127843990|NCT03970824|460044765|FG002|Overall Study|Adverse Event|0|||
127843991|NCT00416312|460044766|FG000|Overall Study|tumors not visible on imaging|2|||
127843992|NCT02727660|460044769|FG000|Overall Study|Lack of Efficacy|40|||
127843993|NCT02727660|460044770|FG001|Overall Study|Lack of Efficacy|40|||
127843994|NCT02727660|460044771|FG002|Overall Study|Lack of Efficacy|70|||
127843995|NCT02727660|460044769|FG000|Overall Study|Adverse Event|28|||
127843996|NCT02727660|460044770|FG001|Overall Study|Adverse Event|21|||
127843997|NCT02727660|460044771|FG002|Overall Study|Adverse Event|32|||
127843998|NCT02727660|460044769|FG000|Overall Study|Withdrawal by Subject|26|||
127843999|NCT02727660|460044770|FG001|Overall Study|Withdrawal by Subject|25|||
127844000|NCT02727660|460044771|FG002|Overall Study|Withdrawal by Subject|30|||
127844001|NCT02727660|460044769|FG000|Overall Study|Physician Decision|3|||
127844002|NCT02727660|460044770|FG001|Overall Study|Physician Decision|8|||
127844003|NCT02727660|460044771|FG002|Overall Study|Physician Decision|14|||
127844004|NCT02727660|460044769|FG000|Overall Study|Lost to Follow-up|5|||
127844005|NCT02727660|460044770|FG001|Overall Study|Lost to Follow-up|9|||
127844006|NCT02727660|460044771|FG002|Overall Study|Lost to Follow-up|8|||
127844007|NCT02727660|460044769|FG000|Overall Study|Protocol Violation|7|||
127844008|NCT02727660|460044770|FG001|Overall Study|Protocol Violation|5|||
127844009|NCT02727660|460044771|FG002|Overall Study|Protocol Violation|5|||
127844010|NCT02727660|460044769|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
127844011|NCT02727660|460044770|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
127844012|NCT02727660|460044771|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
127844013|NCT02727660|460044769|FG000|Overall Study|Administrative Reasons|2|||
127844014|NCT02727660|460044770|FG001|Overall Study|Administrative Reasons|3|||
127844015|NCT02727660|460044771|FG002|Overall Study|Administrative Reasons|4|||
127844016|NCT00050960|460044772|FG000|Overall Study|Progressive Disease|137|||
127844017|NCT00050960|460044773|FG001|Overall Study|Progressive Disease|93|||
127844018|NCT00050960|460044772|FG000|Overall Study|Stable Disease|19|||
127844019|NCT00050960|460044773|FG001|Overall Study|Stable Disease|48|||
127844020|NCT00050960|460044772|FG000|Overall Study|Partial Response|14|||
127844021|NCT00050960|460044773|FG001|Overall Study|Partial Response|19|||
127844022|NCT00050960|460044772|FG000|Overall Study|Complete Response|0|||
127844023|NCT00050960|460044773|FG001|Overall Study|Complete Response|2|||
127844024|NCT00050960|460044772|FG000|Overall Study|Adverse Event|62|||
127844025|NCT00050960|460044773|FG001|Overall Study|Adverse Event|61|||
127844026|NCT00050960|460044772|FG000|Overall Study|Lost to Follow-up|0|||
127844027|NCT00050960|460044773|FG001|Overall Study|Lost to Follow-up|1|||
127844028|NCT00050960|460044772|FG000|Overall Study|Withdrawal by Subject|23|||
127844029|NCT00050960|460044773|FG001|Overall Study|Withdrawal by Subject|18|||
127844030|NCT00050960|460044772|FG000|Overall Study|Administrative|31|||
127844031|NCT00050960|460044773|FG001|Overall Study|Administrative|46|||
127844032|NCT00050960|460044772|FG000|Overall Study|Non-compliance|3|||
127844033|NCT00050960|460044773|FG001|Overall Study|Non-compliance|1|||
127844034|NCT00050960|460044772|FG000|Overall Study|Death|13|||
127844035|NCT00050960|460044773|FG001|Overall Study|Death|15|||
127844036|NCT00105560|460044774|FG000|Overall Study|Lost to Follow-up|1|||
127844037|NCT00305604|460044775|FG000|Overall Study|Adverse Event|6|||
127844038|NCT00305604|460044776|FG001|Overall Study|Adverse Event|3|||
127844039|NCT00305604|460044775|FG000|Overall Study|Lack of Efficacy|11|||
127844040|NCT00305604|460044776|FG001|Overall Study|Lack of Efficacy|18|||
127844041|NCT00305604|460044775|FG000|Overall Study|Lost to Follow-up|0|||
127844042|NCT00305604|460044776|FG001|Overall Study|Lost to Follow-up|4|||
127844043|NCT00305604|460044775|FG000|Overall Study|Protocol Violation|2|||
127844044|NCT00305604|460044776|FG001|Overall Study|Protocol Violation|1|||
127844045|NCT00305604|460044775|FG000|Overall Study|Withdrawal by Subject|12|||
127844046|NCT00305604|460044776|FG001|Overall Study|Withdrawal by Subject|21|||
127844047|NCT00305604|460044775|FG000|Overall Study|Patient moved|1|||
127844048|NCT00305604|460044776|FG001|Overall Study|Patient moved|0|||
127844049|NCT01248364|460044780|FG000|Overall Study|Adverse Event|0|||
127844050|NCT01248364|460044781|FG001|Overall Study|Adverse Event|1|||
127844051|NCT01248364|460044782|FG002|Overall Study|Adverse Event|0|||
127844052|NCT01248364|460044783|FG003|Overall Study|Adverse Event|0|||
127844053|NCT00764946|460044786|FG000|Overall Study|Lack of Efficacy|1|||
127844054|NCT00764946|460044787|FG001|Overall Study|Lack of Efficacy|0|||
127844055|NCT00764946|460044788|FG002|Overall Study|Lack of Efficacy|0|||
127844056|NCT00764946|460044786|FG000|Overall Study|Lost to Follow-up|3|||
127844057|NCT00764946|460044787|FG001|Overall Study|Lost to Follow-up|4|||
127844058|NCT00764946|460044788|FG002|Overall Study|Lost to Follow-up|0|||
127844059|NCT00764946|460044786|FG000|Overall Study|Physician Decision|2|||
127844060|NCT00764946|460044787|FG001|Overall Study|Physician Decision|4|||
127844061|NCT00764946|460044788|FG002|Overall Study|Physician Decision|0|||
127844062|NCT00764946|460044786|FG000|Overall Study|Adverse Event|3|||
127844063|NCT00764946|460044787|FG001|Overall Study|Adverse Event|2|||
127844064|NCT00764946|460044788|FG002|Overall Study|Adverse Event|1|||
127844065|NCT00764946|460044786|FG000|Overall Study|Withdrawal by Subject|3|||
127844066|NCT00764946|460044787|FG001|Overall Study|Withdrawal by Subject|6|||
127844067|NCT00764946|460044788|FG002|Overall Study|Withdrawal by Subject|2|||
127844068|NCT00764946|460044786|FG000|Overall Study|Never Treated|1|||
127844069|NCT00764946|460044787|FG001|Overall Study|Never Treated|1|||
127844070|NCT00764946|460044788|FG002|Overall Study|Never Treated|1|||
127844071|NCT01361919|460044793|FG000|Overall Study|technical issues|10|||
127844072|NCT01361919|460044794|FG001|Overall Study|technical issues|12|||
127844073|NCT01361919|460044795|FG002|Overall Study|technical issues|10|||
127844074|NCT00039741|460044799|FG000|Overall Study|Death|0|||
127844075|NCT00039741|460044800|FG001|Overall Study|Death|1|||
127844076|NCT00039741|460044801|FG002|Overall Study|Death|0|||
127844077|NCT00039741|460044802|FG003|Overall Study|Death|0|||
127844078|NCT00039741|460044799|FG000|Overall Study|Lost to Follow-up|3|||
127844079|NCT00039741|460044800|FG001|Overall Study|Lost to Follow-up|1|||
127844080|NCT00039741|460044801|FG002|Overall Study|Lost to Follow-up|5|||
127844081|NCT00039741|460044802|FG003|Overall Study|Lost to Follow-up|2|||
127844082|NCT00039741|460044799|FG000|Overall Study|Confounding medical condition|1|||
127844083|NCT00039741|460044800|FG001|Overall Study|Confounding medical condition|0|||
127844084|NCT00039741|460044801|FG002|Overall Study|Confounding medical condition|0|||
127844085|NCT00039741|460044802|FG003|Overall Study|Confounding medical condition|0|||
127844086|NCT00039741|460044799|FG000|Overall Study|Not able to get to clinic|5|||
127844087|NCT00039741|460044800|FG001|Overall Study|Not able to get to clinic|2|||
127844088|NCT00039741|460044801|FG002|Overall Study|Not able to get to clinic|0|||
127844089|NCT00039741|460044802|FG003|Overall Study|Not able to get to clinic|3|||
127844090|NCT00039741|460044799|FG000|Overall Study|Moved|3|||
127844091|NCT00039741|460044800|FG001|Overall Study|Moved|2|||
127844092|NCT00039741|460044801|FG002|Overall Study|Moved|3|||
127844093|NCT00039741|460044802|FG003|Overall Study|Moved|6|||
127844094|NCT00039741|460044799|FG000|Overall Study|Non-compliance with protocol|1|||
127844095|NCT00039741|460044800|FG001|Overall Study|Non-compliance with protocol|0|||
127844096|NCT00039741|460044801|FG002|Overall Study|Non-compliance with protocol|1|||
127844097|NCT00039741|460044802|FG003|Overall Study|Non-compliance with protocol|0|||
127844098|NCT00039741|460044799|FG000|Overall Study|Withdrew consent|0|||
127844099|NCT00039741|460044800|FG001|Overall Study|Withdrew consent|5|||
127844100|NCT00039741|460044801|FG002|Overall Study|Withdrew consent|0|||
127844101|NCT00039741|460044802|FG003|Overall Study|Withdrew consent|1|||
127844102|NCT00039741|460044799|FG000|Overall Study|Missed final visit|2|||
127844103|NCT00039741|460044800|FG001|Overall Study|Missed final visit|1|||
127844104|NCT00039741|460044801|FG002|Overall Study|Missed final visit|2|||
127844105|NCT00039741|460044802|FG003|Overall Study|Missed final visit|2|||
127844106|NCT01767519|460044803|FG000|Overall Study|Other Reasons|4|||
127844107|NCT01767519|460044804|FG001|Overall Study|Other Reasons|4|||
127844108|NCT01767519|460044805|FG002|Overall Study|Other Reasons|2|||
127844109|NCT01767519|460044803|FG000|Overall Study|Protocol Violation|0|||
127844110|NCT01767519|460044804|FG001|Overall Study|Protocol Violation|3|||
127844111|NCT01767519|460044805|FG002|Overall Study|Protocol Violation|0|||
127844112|NCT01767519|460044803|FG000|Overall Study|Personal Reasons|1|||
127844113|NCT01767519|460044804|FG001|Overall Study|Personal Reasons|0|||
127844114|NCT01767519|460044805|FG002|Overall Study|Personal Reasons|0|||
127844115|NCT01767519|460044803|FG000|Overall Study|Lost to Follow-up|3|||
127844116|NCT01767519|460044804|FG001|Overall Study|Lost to Follow-up|1|||
127844117|NCT01767519|460044805|FG002|Overall Study|Lost to Follow-up|2|||
127844118|NCT01767519|460044803|FG000|Overall Study|Lack of Efficacy|1|||
127844119|NCT01767519|460044804|FG001|Overall Study|Lack of Efficacy|0|||
127844120|NCT01767519|460044805|FG002|Overall Study|Lack of Efficacy|0|||
127844121|NCT01767519|460044803|FG000|Overall Study|Adverse Event|5|||
127844122|NCT01767519|460044804|FG001|Overall Study|Adverse Event|5|||
127844123|NCT01767519|460044805|FG002|Overall Study|Adverse Event|1|||
127844124|NCT00946881|460044806|FG000|First Treatment|Withdrawal by Subject|1|||
127844125|NCT00946881|460044806|FG000|First Treatment|Patient relocated to another state|1|||
127844126|NCT00946881|460044806|FG000|Retreatment|Withdrawal by Subject|1|||
127844127|NCT00293423|460044807|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
127844128|NCT00293423|460044808|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
127844129|NCT00293423|460044807|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
127844130|NCT00293423|460044808|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
127844131|NCT00293423|460044807|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
127844132|NCT00293423|460044808|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
127844133|NCT00293423|460044807|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
127844134|NCT00293423|460044808|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
127844135|NCT00293423|460044807|FG000|Surgical Resection|processing error during surgical resection|1|||
127844136|NCT00293423|460044808|FG001|Surgical Resection|processing error during surgical resection|0|||
127844137|NCT00293423|460044807|FG000|Surgical Resection|Withdrawal by Subject|4|||
127844138|NCT00293423|460044808|FG001|Surgical Resection|Withdrawal by Subject|0|||
127844139|NCT00293423|460044807|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
127844140|NCT00293423|460044808|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
127844141|NCT02270684|460044809|FG000|Overall Study|Lost to Follow-up|0|||
127844142|NCT02270684|460044810|FG001|Overall Study|Lost to Follow-up|3|||
127844143|NCT02270684|460044809|FG000|Overall Study|Study terminated|1|||
127844144|NCT02270684|460044810|FG001|Overall Study|Study terminated|0|||
127844145|NCT03498287|460044820|FG000|Overall Study|Withdrawal by Subject|3|||
127844146|NCT03498287|460044821|FG001|Overall Study|Withdrawal by Subject|0|||
127844147|NCT03498287|460044820|FG000|Overall Study|Protocol Violation|0|||
127844148|NCT03498287|460044821|FG001|Overall Study|Protocol Violation|4|||
127844149|NCT03498287|460044820|FG000|Overall Study|Adverse Event|0|||
127844150|NCT03498287|460044821|FG001|Overall Study|Adverse Event|1|||
127844151|NCT01374217|460044822|FG000|Overall Study|Lack of Efficacy|13|||
127844152|NCT01641991|460044823|FG000|Overall Study|Physician Decision|0|||
127844153|NCT01641991|460044824|FG001|Overall Study|Physician Decision|1|||
127844154|NCT01641991|460044825|FG002|Overall Study|Physician Decision|7|||
127844155|NCT01641991|460044826|FG003|Overall Study|Physician Decision|5|||
127844156|NCT01641991|460044823|FG000|Overall Study|Withdrawal by Subject|4|||
127844157|NCT01641991|460044824|FG001|Overall Study|Withdrawal by Subject|2|||
127844158|NCT01641991|460044825|FG002|Overall Study|Withdrawal by Subject|1|||
127844159|NCT01641991|460044826|FG003|Overall Study|Withdrawal by Subject|5|||
127844160|NCT01641991|460044823|FG000|Overall Study|Adverse Event|2|||
127844161|NCT01641991|460044824|FG001|Overall Study|Adverse Event|1|||
127844162|NCT01641991|460044825|FG002|Overall Study|Adverse Event|2|||
127844163|NCT01641991|460044826|FG003|Overall Study|Adverse Event|1|||
127844164|NCT01641991|460044823|FG000|Overall Study|Lost to Follow-up|0|||
127844165|NCT01641991|460044824|FG001|Overall Study|Lost to Follow-up|2|||
127844166|NCT01641991|460044825|FG002|Overall Study|Lost to Follow-up|3|||
127844167|NCT01641991|460044826|FG003|Overall Study|Lost to Follow-up|1|||
127844168|NCT01641991|460044823|FG000|Overall Study|Protocol Violation|1|||
127844169|NCT01641991|460044824|FG001|Overall Study|Protocol Violation|1|||
127844170|NCT01641991|460044825|FG002|Overall Study|Protocol Violation|3|||
127844171|NCT01641991|460044826|FG003|Overall Study|Protocol Violation|0|||
127844172|NCT01641991|460044823|FG000|Overall Study|Pregnancy|0|||
127844173|NCT01641991|460044824|FG001|Overall Study|Pregnancy|0|||
127844174|NCT01641991|460044825|FG002|Overall Study|Pregnancy|1|||
127844175|NCT01641991|460044826|FG003|Overall Study|Pregnancy|0|||
127844176|NCT01641991|460044823|FG000|Overall Study|no longer eligible|2|||
127844177|NCT01641991|460044824|FG001|Overall Study|no longer eligible|1|||
127844178|NCT01641991|460044825|FG002|Overall Study|no longer eligible|0|||
127844179|NCT01641991|460044826|FG003|Overall Study|no longer eligible|4|||
127844180|NCT01578785|460044827|FG000|Overall Study|Withdrawal by Subject|0|||
127844181|NCT01578785|460044828|FG001|Overall Study|Withdrawal by Subject|1|||
127844182|NCT01578785|460044827|FG000|Overall Study|Study terminated by sponsor|59|||
127844183|NCT01578785|460044828|FG001|Overall Study|Study terminated by sponsor|118|||
127844184|NCT03371732|460044829|FG000|Overall Study|Withdrawal by Subject|9|||
127844185|NCT03371732|460044830|FG001|Overall Study|Withdrawal by Subject|3|||
127844186|NCT03371732|460044829|FG000|Overall Study|Refusal to continue|3|||
127844187|NCT03371732|460044830|FG001|Overall Study|Refusal to continue|4|||
127844188|NCT02581982|460044831|FG000|Overall Study|Lack of Efficacy|12|||
127844189|NCT02581982|460044831|FG000|Overall Study|Adverse Event|3|||
127844190|NCT02581982|460044831|FG000|Overall Study|Physician Decision|1|||
127844191|NCT03479216|460044833|FG000|Overall Study|Withdrawal by Subject|3|||
127844192|NCT03479216|460044834|FG001|Overall Study|Withdrawal by Subject|2|||
127844193|NCT03479216|460044833|FG000|Overall Study|Physician Decision|2|||
127844194|NCT03479216|460044834|FG001|Overall Study|Physician Decision|3|||
127844195|NCT01181778|460044837|FG000|Overall Study|Physician Decision|48|||
127844196|NCT02332798|460046476|FG000|Overall Study|Unwilling to Participate in Study|0|||
127844197|NCT02332798|460046477|FG001|Overall Study|Unwilling to Participate in Study|1|||
127900859|NCT01104662|460261316|FG000|Overall Study|Adverse Event|2|||
127844198|NCT02332798|460046478|FG002|Overall Study|Unwilling to Participate in Study|1|||
127844199|NCT02332798|460046476|FG000|Overall Study|Positive Urine Drug Test|0|||
127844200|NCT02332798|460046477|FG001|Overall Study|Positive Urine Drug Test|1|||
127844201|NCT02332798|460046478|FG002|Overall Study|Positive Urine Drug Test|0|||
127844202|NCT02332798|460046476|FG000|Overall Study|Abnormal Laboratory Findings|1|||
127844203|NCT02332798|460046477|FG001|Overall Study|Abnormal Laboratory Findings|0|||
127844204|NCT02332798|460046478|FG002|Overall Study|Abnormal Laboratory Findings|0|||
127844205|NCT05406440|460046479|FG000|Overall Study|Lost to Follow-up|0|||
127844206|NCT05406440|460046480|FG001|Overall Study|Lost to Follow-up|0|||
127844207|NCT05406440|460046481|FG002|Overall Study|Lost to Follow-up|0|||
127844208|NCT05406440|460046482|FG003|Overall Study|Lost to Follow-up|0|||
127844209|NCT05406440|460046483|FG004|Overall Study|Lost to Follow-up|2|||
127844210|NCT05406440|460046484|FG005|Overall Study|Lost to Follow-up|0|||
127844211|NCT05406440|460046485|FG006|Overall Study|Lost to Follow-up|0|||
127844212|NCT05406440|460046479|FG000|Overall Study|Physician Decision|0|||
127844213|NCT05406440|460046480|FG001|Overall Study|Physician Decision|0|||
127844214|NCT05406440|460046481|FG002|Overall Study|Physician Decision|0|||
127844215|NCT05406440|460046482|FG003|Overall Study|Physician Decision|0|||
127844216|NCT05406440|460046483|FG004|Overall Study|Physician Decision|1|||
127844217|NCT05406440|460046484|FG005|Overall Study|Physician Decision|0|||
127844218|NCT05406440|460046485|FG006|Overall Study|Physician Decision|0|||
127844219|NCT05406440|460046479|FG000|Overall Study|Withdrawal by Subject|0|||
127844220|NCT05406440|460046480|FG001|Overall Study|Withdrawal by Subject|0|||
127844221|NCT05406440|460046481|FG002|Overall Study|Withdrawal by Subject|0|||
127844222|NCT05406440|460046482|FG003|Overall Study|Withdrawal by Subject|0|||
127844223|NCT05406440|460046483|FG004|Overall Study|Withdrawal by Subject|0|||
127844224|NCT05406440|460046484|FG005|Overall Study|Withdrawal by Subject|2|||
127844225|NCT05406440|460046485|FG006|Overall Study|Withdrawal by Subject|0|||
127844226|NCT00525785|460046487|FG000|Overall Study|Withdrawal by Subject|1|||
127844227|NCT00525785|460046487|FG000|Overall Study|Lack of Efficacy|1|||
127844228|NCT00525785|460046487|FG000|Overall Study|Physician Decision|1|||
127844229|NCT02455388|460046488|FG000|Overall Study|Protocol Violation|1|||
127844230|NCT02455388|460046489|FG001|Overall Study|Protocol Violation|0|||
127844231|NCT02455388|460046490|FG002|Overall Study|Protocol Violation|4|||
127844232|NCT02455388|460046488|FG000|Overall Study|Withdrawal by Subject|0|||
127844233|NCT02455388|460046489|FG001|Overall Study|Withdrawal by Subject|0|||
127844234|NCT02455388|460046490|FG002|Overall Study|Withdrawal by Subject|7|||
127844235|NCT01316939|460046491|FG000|Overall Study|Study closed/terminated|26|||
127844236|NCT01316939|460046492|FG001|Overall Study|Study closed/terminated|25|||
127844237|NCT01316939|460046493|FG002|Overall Study|Study closed/terminated|23|||
127844238|NCT01316939|460046491|FG000|Overall Study|Lack of Efficacy|24|||
127844239|NCT01316939|460046492|FG001|Overall Study|Lack of Efficacy|25|||
127844240|NCT01316939|460046493|FG002|Overall Study|Lack of Efficacy|25|||
127844241|NCT01316939|460046491|FG000|Overall Study|Adverse Event|9|||
127844242|NCT01316939|460046492|FG001|Overall Study|Adverse Event|12|||
127844243|NCT01316939|460046493|FG002|Overall Study|Adverse Event|11|||
127844244|NCT01316939|460046491|FG000|Overall Study|Withdrawal by Subject|1|||
127844245|NCT01316939|460046492|FG001|Overall Study|Withdrawal by Subject|3|||
127844246|NCT01316939|460046493|FG002|Overall Study|Withdrawal by Subject|6|||
127844247|NCT01316939|460046491|FG000|Overall Study|Physician Decision|2|||
127844248|NCT01316939|460046492|FG001|Overall Study|Physician Decision|2|||
127844249|NCT01316939|460046493|FG002|Overall Study|Physician Decision|1|||
127844250|NCT01316939|460046491|FG000|Overall Study|Lost to Follow-up|0|||
127844251|NCT01316939|460046492|FG001|Overall Study|Lost to Follow-up|0|||
127844252|NCT01316939|460046493|FG002|Overall Study|Lost to Follow-up|2|||
127844253|NCT01316939|460046491|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
127844254|NCT01316939|460046492|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
127844255|NCT01316939|460046493|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
127844256|NCT01316939|460046491|FG000|Overall Study|Protocol Violation|0|||
127844257|NCT01316939|460046492|FG001|Overall Study|Protocol Violation|1|||
127844258|NCT01316939|460046493|FG002|Overall Study|Protocol Violation|0|||
127844259|NCT00801892|460046494|FG000|Main Study Period|Withdrawal by Subject|0|||
127844260|NCT00801892|460046495|FG001|Main Study Period|Withdrawal by Subject|1|||
127844261|NCT00801892|460046494|FG000|Sham Crossover Period|Lost to Follow-up|0|||
127844262|NCT00801892|460046495|FG001|Sham Crossover Period|Lost to Follow-up|2|||
127844263|NCT01188096|460046513|FG000|Overall Study|progression of disease|4|||
127844264|NCT01188096|460046513|FG000|Overall Study|Withdrawal by Subject|2|||
127844265|NCT00851253|460046517|FG000|Overall Study|Disease Progression|1|||
127844266|NCT00851253|460046518|FG001|Overall Study|Disease Progression|0|||
127844267|NCT02062398|460046519|FG000|Overall Study|Implant removal|1|||
127844268|NCT01779648|460046520|FG000|Overall Study|Protocol Violation|1|||
127844269|NCT01779648|460046521|FG001|Overall Study|Protocol Violation|0|||
127844270|NCT00415519|460046522|FG000|Overall Study|Adverse Event|1|||
127844271|NCT00415519|460046523|FG001|Overall Study|Adverse Event|0|||
127900860|NCT01104662|460261317|FG001|Overall Study|Adverse Event|2|||
127900861|NCT01104662|460261318|FG002|Overall Study|Adverse Event|0|||
127844272|NCT00415519|460046522|FG000|Overall Study|Withdrawal by Subject|2|||
127900862|NCT01104662|460261319|FG003|Overall Study|Adverse Event|1|||
127844273|NCT00415519|460046523|FG001|Overall Study|Withdrawal by Subject|0|||
127844274|NCT00415519|460046522|FG000|Overall Study|Patient's convenience|1|||
127844275|NCT00415519|460046523|FG001|Overall Study|Patient's convenience|0|||
127844276|NCT03485222|460046528|FG000|Overall Study|Death|0|||
127844277|NCT03485222|460046529|FG001|Overall Study|Death|1|||
127844278|NCT03485222|460046528|FG000|Overall Study|Lost to Follow-up|2|||
127844279|NCT03485222|460046529|FG001|Overall Study|Lost to Follow-up|1|||
127844280|NCT03657810|460046532|FG000|Overall Study|Adverse Event|0|||
127844281|NCT03657810|460046533|FG001|Overall Study|Adverse Event|1|||
127844282|NCT03657810|460046534|FG002|Overall Study|Adverse Event|0|||
127844283|NCT03657810|460046532|FG000|Overall Study|Lack of Efficacy|4|||
127844284|NCT03657810|460046533|FG001|Overall Study|Lack of Efficacy|1|||
127844285|NCT03657810|460046534|FG002|Overall Study|Lack of Efficacy|3|||
127844286|NCT03657810|460046532|FG000|Overall Study|Protocol Violation|1|||
127844287|NCT03657810|460046533|FG001|Overall Study|Protocol Violation|0|||
127844288|NCT03657810|460046534|FG002|Overall Study|Protocol Violation|0|||
127844289|NCT03657810|460046532|FG000|Overall Study|Lost to Follow-up|0|||
127844290|NCT03657810|460046533|FG001|Overall Study|Lost to Follow-up|1|||
127844291|NCT03657810|460046534|FG002|Overall Study|Lost to Follow-up|0|||
127844292|NCT03657810|460046532|FG000|Overall Study|Not provided|0|||
127844293|NCT03657810|460046533|FG001|Overall Study|Not provided|1|||
127844294|NCT03657810|460046534|FG002|Overall Study|Not provided|0|||
127844295|NCT00688545|460046535|FG000|Overall Study|Lost to Follow-up|1|||
127844296|NCT00688545|460046536|FG001|Overall Study|Lost to Follow-up|4|||
127844297|NCT00688545|460046535|FG000|Overall Study|Insurance/cost of drug|0|||
127844298|NCT00688545|460046536|FG001|Overall Study|Insurance/cost of drug|1|||
127844299|NCT00688545|460046535|FG000|Overall Study|Withdrawal by Subject|2|||
127844300|NCT00688545|460046536|FG001|Overall Study|Withdrawal by Subject|3|||
127844301|NCT00688545|460046535|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
127844302|NCT00688545|460046536|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
127844303|NCT01705587|460046538|FG000|Overall Study|Withdrawal by Subject|0|||
127844304|NCT01705587|460046539|FG001|Overall Study|Withdrawal by Subject|1|||
127844305|NCT01373918|460046542|FG000|Overall Study|Physician Decision|0|||
127844306|NCT01373918|460046543|FG001|Overall Study|Physician Decision|1|||
127844307|NCT03004976|460046545|FG000|Overall Study|Lost to Follow-up|7|||
127844308|NCT03004976|460046546|FG001|Overall Study|Lost to Follow-up|5|||
127844309|NCT03004976|460046545|FG000|Overall Study|Physician Decision|1|||
127844310|NCT03004976|460046546|FG001|Overall Study|Physician Decision|0|||
127844311|NCT03004976|460046545|FG000|Overall Study|Withdrawal by Subject|1|||
127844312|NCT03004976|460046546|FG001|Overall Study|Withdrawal by Subject|0|||
127844313|NCT03004976|460046545|FG000|Overall Study|Death|4|||
127844314|NCT03004976|460046546|FG001|Overall Study|Death|1|||
127844315|NCT03892707|460046550|FG000|Overall Study|Screen failure|6|||
127844316|NCT03892707|460046551|FG001|Overall Study|Screen failure|0|||
127844317|NCT03892707|460046550|FG000|Overall Study|Pain resolution|0|||
127844318|NCT03892707|460046551|FG001|Overall Study|Pain resolution|4|||
127844319|NCT03892707|460046550|FG000|Overall Study|Withdrawal by Subject|0|||
127844320|NCT03892707|460046551|FG001|Overall Study|Withdrawal by Subject|1|||
127844321|NCT03892707|460046550|FG000|Overall Study|Other (long business trip)|0|||
127844322|NCT03892707|460046551|FG001|Overall Study|Other (long business trip)|1|||
127844323|NCT01807949|460046553|FG000|Overall Study|Adverse Event|1|||
127844324|NCT01807949|460046554|FG001|Overall Study|Adverse Event|2|||
127844325|NCT01807949|460046555|FG002|Overall Study|Adverse Event|2|||
127844326|NCT01807949|460046553|FG000|Overall Study|Withdrawal by Subject|1|||
127844327|NCT01807949|460046554|FG001|Overall Study|Withdrawal by Subject|2|||
127844328|NCT01807949|460046555|FG002|Overall Study|Withdrawal by Subject|2|||
127844329|NCT01807949|460046553|FG000|Overall Study|Non-Compliance|0|||
127844330|NCT01807949|460046554|FG001|Overall Study|Non-Compliance|0|||
127844331|NCT01807949|460046555|FG002|Overall Study|Non-Compliance|1|||
127844332|NCT01807949|460046553|FG000|Overall Study|Undefined|0|||
127844333|NCT01807949|460046554|FG001|Overall Study|Undefined|1|||
127844334|NCT01807949|460046555|FG002|Overall Study|Undefined|2|||
127844335|NCT01807949|460046553|FG000|Overall Study|Randomized But Not Treated|0|||
127844336|NCT01807949|460046554|FG001|Overall Study|Randomized But Not Treated|2|||
127844337|NCT01807949|460046555|FG002|Overall Study|Randomized But Not Treated|2|||
127844338|NCT04325906|460046558|FG000|Overall Study|Withdrawal by Subject|2|||
127844339|NCT04325906|460046559|FG001|Overall Study|Withdrawal by Subject|0|||
127844340|NCT02137837|460046560|FG000|Overall Study|Adverse Event|0|||
127844341|NCT02137837|460046561|FG001|Overall Study|Adverse Event|2|||
127844342|NCT02137837|460046562|FG002|Overall Study|Adverse Event|1|||
127844343|NCT02137837|460046560|FG000|Overall Study|Refusal unrelated to adverse event|2|||
127844344|NCT02137837|460046561|FG001|Overall Study|Refusal unrelated to adverse event|2|||
127844345|NCT02137837|460046562|FG002|Overall Study|Refusal unrelated to adverse event|1|||
127844346|NCT02137837|460046560|FG000|Overall Study|Progression/relapse|9|||
127844347|NCT02137837|460046561|FG001|Overall Study|Progression/relapse|7|||
127844348|NCT02137837|460046562|FG002|Overall Study|Progression/relapse|7|||
127844349|NCT02137837|460046560|FG000|Overall Study|Not protocol specified|2|||
127844350|NCT02137837|460046561|FG001|Overall Study|Not protocol specified|1|||
127844351|NCT02137837|460046562|FG002|Overall Study|Not protocol specified|3|||
127844352|NCT02141217|460046563|FG000|Overall Study|Adverse Event|1|||
127844353|NCT02141217|460046564|FG001|Overall Study|Adverse Event|2|||
127844354|NCT02141217|460046563|FG000|Overall Study|Protocol Violation|1|||
127844355|NCT02141217|460046564|FG001|Overall Study|Protocol Violation|4|||
127844356|NCT02141217|460046563|FG000|Overall Study|Withdrawal by Subject|6|||
127844357|NCT02141217|460046564|FG001|Overall Study|Withdrawal by Subject|0|||
127844358|NCT02141217|460046563|FG000|Overall Study|Lost to Follow-up|1|||
127844359|NCT02141217|460046564|FG001|Overall Study|Lost to Follow-up|1|||
127844360|NCT02141217|460046563|FG000|Overall Study|Physician Decision|1|||
127844361|NCT02141217|460046564|FG001|Overall Study|Physician Decision|0|||
127844362|NCT02141217|460046563|FG000|Overall Study|Surgical Intervention|1|||
127844363|NCT02141217|460046564|FG001|Overall Study|Surgical Intervention|1|||
127844364|NCT01181141|460046569|FG000|Overall Study|Adverse Event|2|||
127844365|NCT01181141|460046570|FG001|Overall Study|Adverse Event|1|||
127844366|NCT01181141|460046569|FG000|Overall Study|Lack of Efficacy|1|||
127844367|NCT01181141|460046570|FG001|Overall Study|Lack of Efficacy|0|||
127844368|NCT01181141|460046569|FG000|Overall Study|Lost to Follow-up|1|||
127844369|NCT01181141|460046570|FG001|Overall Study|Lost to Follow-up|1|||
127844370|NCT01181141|460046569|FG000|Overall Study|Physician Decision|2|||
127844371|NCT01181141|460046570|FG001|Overall Study|Physician Decision|0|||
127844372|NCT01181141|460046569|FG000|Overall Study|Protocol Violation|3|||
127844373|NCT01181141|460046570|FG001|Overall Study|Protocol Violation|1|||
127844374|NCT01181141|460046569|FG000|Overall Study|Withdrawal by Subject|3|||
127844375|NCT01181141|460046570|FG001|Overall Study|Withdrawal by Subject|1|||
127844376|NCT00290589|460046572|FG000|Overall Study|Lost to Follow-up|2|||
127844377|NCT00290589|460046573|FG001|Overall Study|Lost to Follow-up|2|||
127844378|NCT05014542|460046574|FG000|Week 1-24, Between Group Analysis|Withdrawal by Subject|6|||
127844379|NCT05014542|460046575|FG001|Week 1-24, Between Group Analysis|Withdrawal by Subject|3|||
127844380|NCT05014542|460046574|FG000|Week 1-24, Between Group Analysis|Lost to Follow-up|1|||
127844381|NCT05014542|460046575|FG001|Week 1-24, Between Group Analysis|Lost to Follow-up|0|||
127844382|NCT05014542|460046574|FG000|Week 25-39, Within Group Analysis|Withdrawal by Subject|0|||
127844383|NCT05014542|460046575|FG001|Week 25-39, Within Group Analysis|Withdrawal by Subject|5|||
127844384|NCT05014542|460046574|FG000|Week 25-39, Within Group Analysis|Lost to Follow-up|2|||
127844385|NCT05014542|460046575|FG001|Week 25-39, Within Group Analysis|Lost to Follow-up|1|||
127844386|NCT06000501|460046576|FG000|Overall Study|Screen failure|3|||
127844387|NCT06000501|460046576|FG000|Overall Study|Severe past drug dependence determined by the MINI|2|||
127844388|NCT06000501|460046576|FG000|Overall Study|Physician Decision|4|||
127844389|NCT06000501|460046576|FG000|Overall Study|Positive Urine Drug Test (UDT)|1|||
127844390|NCT06000501|460046576|FG000|Overall Study|Scheduling issues|2|||
127844391|NCT02146248|460046577|FG000|Overall Study|Withdrawal by Subject|2|||
127844392|NCT01315847|460046578|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
127844393|NCT01315847|460046579|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
127844394|NCT01315847|460046578|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
127844395|NCT01315847|460046579|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
127844396|NCT02431468|460046580|FG000|Overall Study|Adverse Event|2|||
127844397|NCT02431468|460046581|FG001|Overall Study|Adverse Event|4|||
127844398|NCT02431468|460046582|FG002|Overall Study|Adverse Event|5|||
127844399|NCT02431468|460046580|FG000|Overall Study|Withdrawal by Subject|4|||
127844400|NCT02431468|460046581|FG001|Overall Study|Withdrawal by Subject|12|||
127844401|NCT02431468|460046582|FG002|Overall Study|Withdrawal by Subject|2|||
127844402|NCT02431468|460046580|FG000|Overall Study|noncompliance, investigator termination,|2|||
127844403|NCT02431468|460046581|FG001|Overall Study|noncompliance, investigator termination,|2|||
127844404|NCT02431468|460046582|FG002|Overall Study|noncompliance, investigator termination,|2|||
127844405|NCT03589885|460046583|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
127844406|NCT03589885|460046584|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
127844407|NCT03589885|460046585|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
127844408|NCT03589885|460046586|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
127844409|NCT03589885|460046587|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
127844410|NCT03589885|460046583|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
127844411|NCT03589885|460046584|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
127844412|NCT03589885|460046585|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
127844413|NCT03589885|460046586|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
127844414|NCT03589885|460046587|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
127844415|NCT03589885|460046583|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
127844416|NCT03589885|460046584|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
127844417|NCT03589885|460046585|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
127844418|NCT03589885|460046586|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
127844419|NCT03589885|460046587|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
127844420|NCT03589885|460046583|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
127844421|NCT03589885|460046584|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
127844422|NCT03589885|460046585|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
127844423|NCT03589885|460046586|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
127844424|NCT03589885|460046587|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
127844425|NCT03589885|460046583|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
127844426|NCT03589885|460046584|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
127844427|NCT03589885|460046585|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
127844428|NCT03589885|460046586|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
127844429|NCT03589885|460046587|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
127844430|NCT03589885|460046583|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
127844431|NCT03589885|460046584|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
127844432|NCT03589885|460046585|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
127844433|NCT03589885|460046586|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
127844434|NCT03589885|460046587|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
127844435|NCT03589885|460046583|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
127844436|NCT03589885|460046584|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
127844437|NCT03589885|460046585|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
127844438|NCT03589885|460046586|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
127844439|NCT03589885|460046587|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
127844440|NCT03589885|460046583|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
127844441|NCT03589885|460046584|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
127844442|NCT03589885|460046585|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
127844443|NCT03589885|460046586|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
127844444|NCT03589885|460046587|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
127844445|NCT01117012|460046591|FG000|Overall Study|Adverse Event|0|||
127844446|NCT01117012|460046592|FG001|Overall Study|Adverse Event|1|||
127844447|NCT01117012|460046591|FG000|Overall Study|Death|1|||
127844448|NCT01117012|460046592|FG001|Overall Study|Death|1|||
127844449|NCT01117012|460046591|FG000|Overall Study|Withdrawal by Subject|3|||
127844450|NCT01117012|460046592|FG001|Overall Study|Withdrawal by Subject|0|||
127844451|NCT01117012|460046591|FG000|Overall Study|Undefined|4|||
127844452|NCT01117012|460046592|FG001|Overall Study|Undefined|3|||
127844453|NCT03695393|460046595|FG000|Overall Study|Death|3|||
127844454|NCT03695393|460046596|FG001|Overall Study|Death|1|||
127844455|NCT03695393|460046595|FG000|Overall Study|Lost to Follow-up|0|||
127844456|NCT03695393|460046596|FG001|Overall Study|Lost to Follow-up|1|||
127844457|NCT00673894|460046597|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
127844458|NCT00673894|460046598|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
127844459|NCT00673894|460046597|FG000|First Intervention 4 Weeks|Adverse Event|1|||
127844460|NCT00673894|460046598|FG001|First Intervention 4 Weeks|Adverse Event|0|||
127844461|NCT02555657|460046599|FG000|Overall Study|Death|274|||
127900863|NCT01104662|460261320|FG004|Overall Study|Adverse Event|1|||
127900864|NCT01104662|460261321|FG005|Overall Study|Adverse Event|1|||
127900865|NCT01104662|460261322|FG006|Overall Study|Adverse Event|0|||
127900866|NCT01104662|460261323|FG007|Overall Study|Adverse Event|0|||
127900867|NCT01104662|460261316|FG000|Overall Study|Clinical Failure|1|||
127900868|NCT01104662|460261317|FG001|Overall Study|Clinical Failure|0|||
127900869|NCT01104662|460261318|FG002|Overall Study|Clinical Failure|0|||
127900870|NCT01104662|460261319|FG003|Overall Study|Clinical Failure|0|||
127900871|NCT01104662|460261320|FG004|Overall Study|Clinical Failure|0|||
127900872|NCT01104662|460261321|FG005|Overall Study|Clinical Failure|1|||
127900873|NCT01104662|460261322|FG006|Overall Study|Clinical Failure|0|||
127900874|NCT01104662|460261323|FG007|Overall Study|Clinical Failure|0|||
127844462|NCT02555657|460046600|FG001|Overall Study|Death|262|||
127844463|NCT02555657|460046599|FG000|Overall Study|Physician Decision|0|||
127844464|NCT02555657|460046600|FG001|Overall Study|Physician Decision|1|||
127844465|NCT02555657|460046599|FG000|Overall Study|Sponsor Decision|27|||
127844466|NCT02555657|460046600|FG001|Overall Study|Sponsor Decision|15|||
127844467|NCT02555657|460046599|FG000|Overall Study|Withdrawal by Subject|11|||
127844468|NCT02555657|460046600|FG001|Overall Study|Withdrawal by Subject|32|||
127844469|NCT00493974|460046601|FG000|Overall Study|Death|1|||
127844470|NCT00493974|460046602|FG001|Overall Study|Death|2|||
127844471|NCT00493974|460046601|FG000|Overall Study|Withdrawal by Subject|8|||
127844472|NCT00493974|460046602|FG001|Overall Study|Withdrawal by Subject|6|||
127844473|NCT00493974|460046601|FG000|Overall Study|Lost to Follow-up|4|||
127844474|NCT00493974|460046602|FG001|Overall Study|Lost to Follow-up|6|||
127844475|NCT02807363|460046603|FG000|Dosing Period|Adverse Event|0|||
127844476|NCT02807363|460046604|FG001|Dosing Period|Adverse Event|1|||
127844477|NCT02807363|460046605|FG002|Dosing Period|Adverse Event|0|||
127844478|NCT02807363|460046606|FG003|Dosing Period|Adverse Event|0|||
127844479|NCT02188719|460046607|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
127844480|NCT02188719|460046608|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
127844481|NCT02188719|460046609|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
127900875|NCT01104662|460261316|FG000|Overall Study|Participant left investigator's care|1|||
127900876|NCT01104662|460261317|FG001|Overall Study|Participant left investigator's care|1|||
127900877|NCT01104662|460261318|FG002|Overall Study|Participant left investigator's care|0|||
127844482|NCT02188719|460046610|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
127844483|NCT00966693|460046611|FG000|Overall Study|Adverse Event|0|||
127844484|NCT00966693|460046612|FG001|Overall Study|Adverse Event|0|||
127844485|NCT00966693|460046613|FG002|Overall Study|Adverse Event|1|||
127844486|NCT00966693|460046614|FG003|Overall Study|Adverse Event|2|||
127844487|NCT00966693|460046611|FG000|Overall Study|Death|0|||
127844488|NCT00966693|460046612|FG001|Overall Study|Death|0|||
127844489|NCT00966693|460046613|FG002|Overall Study|Death|1|||
127844490|NCT00966693|460046614|FG003|Overall Study|Death|0|||
127844491|NCT00966693|460046611|FG000|Overall Study|Withdrawal by Subject|1|||
127844492|NCT00966693|460046612|FG001|Overall Study|Withdrawal by Subject|0|||
127844493|NCT00966693|460046613|FG002|Overall Study|Withdrawal by Subject|0|||
127844494|NCT00966693|460046614|FG003|Overall Study|Withdrawal by Subject|5|||
127844495|NCT00966693|460046611|FG000|Overall Study|Disease Progression|0|||
127844496|NCT00966693|460046612|FG001|Overall Study|Disease Progression|0|||
127844497|NCT00966693|460046613|FG002|Overall Study|Disease Progression|1|||
127844498|NCT00966693|460046614|FG003|Overall Study|Disease Progression|16|||
127844499|NCT01164865|460046615|FG000|Overall Study|Lost to Follow-up|2|||
127844500|NCT01164865|460046616|FG001|Overall Study|Lost to Follow-up|1|||
127844501|NCT00599027|460046619|FG000|Overall Study|Withdrawal by Subject|1|||
127844502|NCT00599027|460046620|FG001|Overall Study|Withdrawal by Subject|1|||
127844503|NCT00599027|460046619|FG000|Overall Study|Adverse Event|0|||
127844504|NCT00599027|460046620|FG001|Overall Study|Adverse Event|1|||
127844505|NCT00599027|460046619|FG000|Overall Study|Treatment Failure|0|||
127844506|NCT00599027|460046620|FG001|Overall Study|Treatment Failure|1|||
127844507|NCT00405821|460046621|FG000|Overall Study|Death|5|||
127844508|NCT00405821|460046622|FG001|Overall Study|Death|7|||
127844509|NCT00405821|460046621|FG000|Overall Study|Lost to Follow-up|7|||
127844510|NCT00405821|460046622|FG001|Overall Study|Lost to Follow-up|7|||
127844511|NCT00405821|460046621|FG000|Overall Study|Protocol Violation|1|||
127844512|NCT00405821|460046622|FG001|Overall Study|Protocol Violation|0|||
127844513|NCT00405821|460046621|FG000|Overall Study|initiated ART|9|||
127844514|NCT00405821|460046622|FG001|Overall Study|initiated ART|8|||
127844515|NCT00476996|460046623|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
127844516|NCT00476996|460046624|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
127844517|NCT00476996|460046625|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
127844518|NCT00476996|460046626|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
127844519|NCT00476996|460046623|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
127844520|NCT00476996|460046624|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
127844521|NCT00476996|460046625|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
127844522|NCT00476996|460046626|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
127844523|NCT00476996|460046623|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
127844524|NCT00476996|460046624|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
127844525|NCT00476996|460046625|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
127844526|NCT00476996|460046626|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
127844527|NCT00476996|460046623|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
127844528|NCT00476996|460046624|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
127844529|NCT00476996|460046625|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
127844530|NCT00476996|460046626|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
127844531|NCT00476996|460046623|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
127844532|NCT00476996|460046624|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
127844533|NCT00476996|460046625|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
127844534|NCT00476996|460046626|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
127844535|NCT00476996|460046623|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
127844536|NCT00476996|460046624|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
127844537|NCT00476996|460046625|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
127844538|NCT00476996|460046626|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
127844539|NCT00476996|460046623|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
127844540|NCT00476996|460046624|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
127844541|NCT00476996|460046625|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
127844542|NCT00476996|460046626|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
127844543|NCT00476996|460046623|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
127844544|NCT00476996|460046624|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
127844545|NCT00476996|460046625|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
127844546|NCT00476996|460046626|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
127900878|NCT01104662|460261319|FG003|Overall Study|Participant left investigator's care|0|||
127900879|NCT01104662|460261320|FG004|Overall Study|Participant left investigator's care|0|||
127844547|NCT00476996|460046623|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
127844548|NCT00476996|460046624|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
127844549|NCT00476996|460046625|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
127844550|NCT00476996|460046626|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
127844551|NCT00476996|460046623|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
127900880|NCT01104662|460261321|FG005|Overall Study|Participant left investigator's care|0|||
127900881|NCT01104662|460261322|FG006|Overall Study|Participant left investigator's care|0|||
127900882|NCT01104662|460261323|FG007|Overall Study|Participant left investigator's care|0|||
127900883|NCT01104662|460261316|FG000|Overall Study|Reason not specified|3|||
127900884|NCT01104662|460261317|FG001|Overall Study|Reason not specified|3|||
127900885|NCT01104662|460261318|FG002|Overall Study|Reason not specified|0|||
127900886|NCT01104662|460261319|FG003|Overall Study|Reason not specified|0|||
127900887|NCT01104662|460261320|FG004|Overall Study|Reason not specified|0|||
127900888|NCT01104662|460261321|FG005|Overall Study|Reason not specified|1|||
127900889|NCT01104662|460261322|FG006|Overall Study|Reason not specified|0|||
127900890|NCT01104662|460261323|FG007|Overall Study|Reason not specified|0|||
127900891|NCT01104662|460261316|FG000|Overall Study|Randomized but not treated|3|||
127900892|NCT01104662|460261317|FG001|Overall Study|Randomized but not treated|4|||
127900893|NCT01104662|460261318|FG002|Overall Study|Randomized but not treated|1|||
127900894|NCT01104662|460261319|FG003|Overall Study|Randomized but not treated|0|||
127900895|NCT01104662|460261320|FG004|Overall Study|Randomized but not treated|0|||
127900896|NCT01104662|460261321|FG005|Overall Study|Randomized but not treated|1|||
127900897|NCT01104662|460261322|FG006|Overall Study|Randomized but not treated|0|||
127900898|NCT01104662|460261323|FG007|Overall Study|Randomized but not treated|0|||
127900899|NCT02079532|460261324|FG000|Overall Study|Adverse Event|7|||
127900900|NCT02079532|460261324|FG000|Overall Study|Additional or changed therapy|2|||
127900901|NCT02079532|460261324|FG000|Overall Study|Lack of Efficacy|9|||
127900902|NCT02079532|460261324|FG000|Overall Study|Protocol Violation|3|||
127900903|NCT02079532|460261324|FG000|Overall Study|Withdrawal by Subject|1|||
127900904|NCT02079532|460261324|FG000|Overall Study|Administrative problems|1|||
127900905|NCT02079532|460261324|FG000|Overall Study|Inclusion into ReFIRST|3|||
127900906|NCT02079532|460261324|FG000|Overall Study|Other|3|||
127900907|NCT02158936|460261327|FG000|Overall Study|Study closed/ terminated|57|||
127900908|NCT02158936|460261328|FG001|Overall Study|Study closed/ terminated|77|||
127900909|NCT02158936|460261327|FG000|Overall Study|Azacitidine tx discontinued|53|||
127900910|NCT02158936|460261328|FG001|Overall Study|Azacitidine tx discontinued|46|||
127900911|NCT02158936|460261327|FG000|Overall Study|Adverse Event|39|||
127900912|NCT02158936|460261328|FG001|Overall Study|Adverse Event|24|||
127900913|NCT02158936|460261327|FG000|Overall Study|Withdrawal by Subject|15|||
127900914|NCT02158936|460261328|FG001|Overall Study|Withdrawal by Subject|16|||
127900915|NCT02158936|460261327|FG000|Overall Study|Physician Decision|15|||
127900916|NCT02158936|460261328|FG001|Overall Study|Physician Decision|13|||
127900917|NCT02158936|460261327|FG000|Overall Study|Lost to Follow-up|0|||
127900918|NCT02158936|460261328|FG001|Overall Study|Lost to Follow-up|1|||
127900919|NCT01432171|460261329|FG000|Overall Study|Death|1|||
127900920|NCT01432171|460261330|FG001|Overall Study|Death|2|||
127900921|NCT01432171|460261329|FG000|Overall Study|Lost to Follow-up|6|||
127900922|NCT01432171|460261330|FG001|Overall Study|Lost to Follow-up|5|||
127900923|NCT01432171|460261329|FG000|Overall Study|Withdrawal by Subject|3|||
127900924|NCT01432171|460261330|FG001|Overall Study|Withdrawal by Subject|1|||
127900925|NCT01432171|460261329|FG000|Overall Study|Noncompliance|2|||
127900926|NCT01432171|460261330|FG001|Overall Study|Noncompliance|3|||
127900927|NCT01432171|460261329|FG000|Overall Study|Insurance denial trial coverage|1|||
127900928|NCT01432171|460261330|FG001|Overall Study|Insurance denial trial coverage|0|||
127900929|NCT01432171|460261329|FG000|Overall Study|Patient moved to palliative care|1|||
127900930|NCT01432171|460261330|FG001|Overall Study|Patient moved to palliative care|0|||
127900931|NCT03805438|460262851|FG000|Overall Study|Lack of Efficacy|1|||
127900932|NCT03805438|460262851|FG000|Overall Study|Protocol Violation|1|||
127900933|NCT00366899|460262852|FG000|Infant Series|Withdrawal by Subject|4|||
127900934|NCT00366899|460262853|FG001|Infant Series|Withdrawal by Subject|7|||
127900935|NCT00366899|460262852|FG000|Infant Series|Protocol Violation|2|||
127900936|NCT00366899|460262853|FG001|Infant Series|Protocol Violation|1|||
127900937|NCT00366899|460262852|FG000|Infant Series|Failed to return|1|||
127900938|NCT00366899|460262853|FG001|Infant Series|Failed to return|1|||
127900939|NCT00366899|460262852|FG000|Infant Series|Lost to Follow-up|0|||
127900940|NCT00366899|460262853|FG001|Infant Series|Lost to Follow-up|2|||
127900941|NCT00366899|460262852|FG000|Infant Series|Adverse Event|0|||
127900942|NCT00366899|460262853|FG001|Infant Series|Adverse Event|1|||
127900943|NCT00366899|460262852|FG000|Infant Series|Physician Decision|1|||
127900944|NCT00366899|460262853|FG001|Infant Series|Physician Decision|0|||
127900945|NCT00366899|460262852|FG000|Infant Series|Randomized but not consented|1|||
127900946|NCT00366899|460262853|FG001|Infant Series|Randomized but not consented|0|||
127900947|NCT00366899|460262852|FG000|After Infant Series|Lost to Follow-up|4|||
127900948|NCT00366899|460262853|FG001|After Infant Series|Lost to Follow-up|3|||
127900949|NCT00366899|460262852|FG000|After Infant Series|Withdrawal by Subject|1|||
127900950|NCT00366899|460262853|FG001|After Infant Series|Withdrawal by Subject|4|||
127900951|NCT00366899|460262852|FG000|After Infant Series|Adverse Event|1|||
127900952|NCT00366899|460262853|FG001|After Infant Series|Adverse Event|2|||
127900953|NCT00366899|460262852|FG000|After Infant Series|Protocol Violation|1|||
127900954|NCT00366899|460262853|FG001|After Infant Series|Protocol Violation|0|||
127900955|NCT00366899|460262852|FG000|Toddler Dose|Withdrawal by Subject|1|||
127900956|NCT00366899|460262853|FG001|Toddler Dose|Withdrawal by Subject|1|||
127900957|NCT00366899|460262852|FG000|Toddler Dose|Protocol Violation|1|||
127900958|NCT00366899|460262853|FG001|Toddler Dose|Protocol Violation|0|||
127900959|NCT01619800|460262854|FG000|Overall Study|study terminated|2|||
127900960|NCT01619800|460262855|FG001|Overall Study|study terminated|0|||
127900961|NCT00414466|460262857|FG000|Overall Study|Adverse Event|0|||
127900962|NCT00414466|460262858|FG001|Overall Study|Adverse Event|0|||
127900963|NCT00414466|460262859|FG002|Overall Study|Adverse Event|1|||
127900964|NCT00414466|460262860|FG003|Overall Study|Adverse Event|1|||
127900965|NCT00414466|460262857|FG000|Overall Study|Lack of Efficacy|1|||
127900966|NCT00414466|460262858|FG001|Overall Study|Lack of Efficacy|0|||
127900967|NCT00414466|460262859|FG002|Overall Study|Lack of Efficacy|0|||
127900968|NCT00414466|460262860|FG003|Overall Study|Lack of Efficacy|0|||
127900969|NCT00414466|460262857|FG000|Overall Study|Withdrawn by Sponsor|1|||
127900970|NCT00414466|460262858|FG001|Overall Study|Withdrawn by Sponsor|0|||
127900971|NCT00414466|460262859|FG002|Overall Study|Withdrawn by Sponsor|0|||
127900972|NCT00414466|460262860|FG003|Overall Study|Withdrawn by Sponsor|0|||
127900973|NCT01781637|460262866|FG000|Overall Study|Adverse Event|1|||
127900974|NCT01781637|460262867|FG001|Overall Study|Adverse Event|0|||
127900975|NCT01781637|460262866|FG000|Overall Study|Lack of Efficacy|2|||
127900976|NCT01781637|460262867|FG001|Overall Study|Lack of Efficacy|6|||
127900977|NCT01781637|460262866|FG000|Overall Study|Withdrawal by Subject|1|||
127900978|NCT01781637|460262867|FG001|Overall Study|Withdrawal by Subject|0|||
127900979|NCT01085045|460262870|FG000|Part A|Withdrawal by Subject|4|||
127900980|NCT01085045|460262870|FG000|Part A|Adverse Event|6|||
127900981|NCT01085045|460262870|FG000|Part A|Protocol Violation|1|||
127900982|NCT01085045|460262870|FG000|Part A|Protocol Specified Criteria|7|||
127900983|NCT01085045|460262870|FG000|Part B|Withdrawal by Subject|2|||
127900984|NCT01085045|460262870|FG000|Part B|Protocol Specified Criteria|6|||
127844552|NCT00476996|460046624|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
127844553|NCT00476996|460046625|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
127844554|NCT00476996|460046626|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
127844555|NCT00476996|460046623|FG000|OLE Phase (From Week 48)|Death|0|||
127844556|NCT00476996|460046624|FG001|OLE Phase (From Week 48)|Death|0|||
127844557|NCT00476996|460046625|FG002|OLE Phase (From Week 48)|Death|0|||
127844558|NCT00476996|460046626|FG003|OLE Phase (From Week 48)|Death|7|||
127844559|NCT00476996|460046623|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
127844560|NCT00476996|460046624|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
127844561|NCT00476996|460046625|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
127844562|NCT00476996|460046626|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
127844563|NCT00476996|460046623|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
127844564|NCT00476996|460046624|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
127844565|NCT00476996|460046625|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
127844566|NCT00476996|460046626|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
127844567|NCT00476996|460046623|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
127844568|NCT00476996|460046624|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
127844569|NCT00476996|460046625|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
127844570|NCT00476996|460046626|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
127844571|NCT00476996|460046623|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
127844572|NCT00476996|460046624|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
127844573|NCT00476996|460046625|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
127844574|NCT00476996|460046626|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
127844575|NCT01265420|460046634|FG000|Overall Study|Lost to Follow-up|1|||
127844576|NCT01770145|460048434|FG000|Baseline|Adverse Event|20|||
127844577|NCT01770145|460048434|FG000|Baseline|Withdrawal by Subject|1|||
127844578|NCT01770145|460048434|FG000|Baseline|Lost to Follow-up|1|||
127844579|NCT01770145|460048434|FG000|Baseline|Unable to define optimal dose|4|||
127844580|NCT01770145|460048434|FG000|Treatment|Adverse Event|3|||
127844581|NCT01770145|460048434|FG000|Treatment|Withdrawal by Subject|1|||
127844582|NCT00595868|460048435|FG000|Overall Study|Lost to Follow-up|45|||
127844583|NCT00595868|460048436|FG001|Overall Study|Lost to Follow-up|50|||
127844584|NCT04268303|460048438|FG000|Overall Study|Lost to Follow-up|1|||
127844585|NCT04268303|460048439|FG001|Overall Study|Lost to Follow-up|1|||
127844586|NCT04268303|460048440|FG002|Overall Study|Lost to Follow-up|2|||
127844587|NCT04268303|460048438|FG000|Overall Study|Withdrawal by Subject|0|||
127844588|NCT04268303|460048439|FG001|Overall Study|Withdrawal by Subject|1|||
127844589|NCT04268303|460048440|FG002|Overall Study|Withdrawal by Subject|1|||
127900985|NCT01085045|460262870|FG000|Part B|Lost to Follow-up|1|||
127900986|NCT01085045|460262870|FG000|Part B|Adverse Event|6|||
127900987|NCT02127281|460262875|FG000|Overall Study|Lost to Follow-up|1|||
127900988|NCT02127281|460262876|FG001|Overall Study|Lost to Follow-up|0|||
127900989|NCT00416520|460262878|FG000|Open-label Period|Adverse Event|28|||
127900990|NCT00416520|460262879|FG001|Open-label Period|Adverse Event|10|||
127900991|NCT00416520|460262880|FG002|Open-label Period|Adverse Event|0|||
127900992|NCT00416520|460262881|FG003|Open-label Period|Adverse Event|0|||
127900993|NCT00416520|460262878|FG000|Open-label Period|Death|2|||
127900994|NCT00416520|460262879|FG001|Open-label Period|Death|1|||
127900995|NCT00416520|460262880|FG002|Open-label Period|Death|0|||
127900996|NCT00416520|460262881|FG003|Open-label Period|Death|0|||
127844590|NCT04268303|460048438|FG000|Overall Study|Adverse Event|2|||
127844591|NCT04268303|460048439|FG001|Overall Study|Adverse Event|0|||
127844592|NCT04268303|460048440|FG002|Overall Study|Adverse Event|0|||
127844593|NCT01711541|460048441|FG000|Overall Study|Cancel prior to treatment|0|||
127844594|NCT01711541|460048442|FG001|Overall Study|Cancel prior to treatment|0|||
127844595|NCT01711541|460048443|FG002|Overall Study|Cancel prior to treatment|0|||
127844596|NCT01711541|460048444|FG003|Overall Study|Cancel prior to treatment|1|||
127844597|NCT01711541|460048445|FG004|Overall Study|Cancel prior to treatment|0|||
127844598|NCT01711541|460048441|FG000|Overall Study|Ineligible|0|||
127844599|NCT01711541|460048442|FG001|Overall Study|Ineligible|1|||
127844600|NCT01711541|460048443|FG002|Overall Study|Ineligible|0|||
127844601|NCT01711541|460048444|FG003|Overall Study|Ineligible|0|||
127844602|NCT01711541|460048445|FG004|Overall Study|Ineligible|0|||
127844603|NCT00728936|460048446|FG000|Overall Study|Withdrawal by Subject|0|||
127844604|NCT00728936|460048447|FG001|Overall Study|Withdrawal by Subject|0|||
127844605|NCT00728936|460048448|FG002|Overall Study|Withdrawal by Subject|0|||
127844606|NCT00728936|460048449|FG003|Overall Study|Withdrawal by Subject|0|||
127844607|NCT00728936|460048450|FG004|Overall Study|Withdrawal by Subject|0|||
127844608|NCT00728936|460048451|FG005|Overall Study|Withdrawal by Subject|1|||
127844609|NCT00728936|460048452|FG006|Overall Study|Withdrawal by Subject|0|||
127844610|NCT01175590|460048458|FG000|Overall Study|Lost to Follow-up|1|||
127844611|NCT01175590|460048459|FG001|Overall Study|Lost to Follow-up|0|||
127844612|NCT01175590|460048458|FG000|Overall Study|Withdrawal by Subject|0|||
127844613|NCT01175590|460048459|FG001|Overall Study|Withdrawal by Subject|2|||
127844614|NCT01175590|460048458|FG000|Overall Study|Adverse Event|4|||
127844615|NCT01175590|460048459|FG001|Overall Study|Adverse Event|0|||
127844616|NCT01175590|460048458|FG000|Overall Study|Physician Decision|1|||
127844617|NCT01175590|460048459|FG001|Overall Study|Physician Decision|4|||
127844618|NCT01175590|460048458|FG000|Overall Study|Lack of Efficacy|1|||
127844619|NCT01175590|460048459|FG001|Overall Study|Lack of Efficacy|1|||
127844620|NCT01175590|460048458|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
127844621|NCT01175590|460048459|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
127844622|NCT01175590|460048458|FG000|Overall Study|Treated not as randomized|3|||
127844623|NCT01175590|460048459|FG001|Overall Study|Treated not as randomized|2|||
127844624|NCT01175590|460048458|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
127844625|NCT01175590|460048459|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
127844626|NCT01175590|460048458|FG000|Overall Study|Protocol Violation|0|||
127844627|NCT01175590|460048459|FG001|Overall Study|Protocol Violation|1|||
127844628|NCT00877006|460048464|FG000|Treatment Period|Death|2|||
127844629|NCT00877006|460048465|FG001|Treatment Period|Death|1|||
127844630|NCT00877006|460048464|FG000|Treatment Period|Adverse Event|10|||
127844631|NCT00877006|460048465|FG001|Treatment Period|Adverse Event|3|||
127844632|NCT00877006|460048464|FG000|Treatment Period|Withdrawal by Subject|2|||
127844633|NCT00877006|460048465|FG001|Treatment Period|Withdrawal by Subject|3|||
127844634|NCT00877006|460048464|FG000|Treatment Period|Protocol Violation|1|||
127844635|NCT00877006|460048465|FG001|Treatment Period|Protocol Violation|0|||
127844636|NCT00877006|460048464|FG000|Treatment Period|Lost to Follow-up|0|||
127844637|NCT00877006|460048465|FG001|Treatment Period|Lost to Follow-up|1|||
127844638|NCT00877006|460048464|FG000|Treatment Period|Disease Progression|1|||
127844639|NCT00877006|460048465|FG001|Treatment Period|Disease Progression|2|||
127844640|NCT00877006|460048464|FG000|Treatment Period|Started New Treatment Regimen|2|||
127844641|NCT00877006|460048465|FG001|Treatment Period|Started New Treatment Regimen|5|||
127844642|NCT00877006|460048464|FG000|Treatment Period|Other|4|||
127844643|NCT00877006|460048465|FG001|Treatment Period|Other|4|||
127844644|NCT00877006|460048464|FG000|Treatment Period|Randomized but Not Treated|3|||
127844645|NCT00877006|460048465|FG001|Treatment Period|Randomized but Not Treated|8|||
127844646|NCT00877006|460048464|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
127844647|NCT00877006|460048465|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
127844648|NCT00877006|460048464|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
127844649|NCT00877006|460048465|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
127844650|NCT00877006|460048464|FG000|Long-Term Follow-up Period|Death|26|||
127844651|NCT00877006|460048465|FG001|Long-Term Follow-up Period|Death|18|||
127844652|NCT00877006|460048464|FG000|Long-Term Follow-up Period|Other|7|||
127844653|NCT00877006|460048465|FG001|Long-Term Follow-up Period|Other|9|||
127844654|NCT03911869|460048466|FG000|Safety Lead-in Phase|Death|7|||
127844655|NCT03911869|460048467|FG001|Safety Lead-in Phase|Death|0|||
127844656|NCT03911869|460048468|FG002|Safety Lead-in Phase|Death|0|||
127844657|NCT03911869|460048466|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
127844658|NCT03911869|460048467|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
127844659|NCT03911869|460048468|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
127844660|NCT03911869|460048466|FG000|Safety Lead-in Phase|Other|1|||
127844661|NCT03911869|460048467|FG001|Safety Lead-in Phase|Other|0|||
127844662|NCT03911869|460048468|FG002|Safety Lead-in Phase|Other|0|||
127844663|NCT03911869|460048466|FG000|Phase 2|Death|0|||
127844664|NCT03911869|460048467|FG001|Phase 2|Death|3|||
127844665|NCT03911869|460048468|FG002|Phase 2|Death|0|||
127844666|NCT01878097|460048469|FG000|Baseline|Surveys not fully completed|2497|||
127844667|NCT01878097|460048470|FG001|Baseline|Surveys not fully completed|1800|||
127844668|NCT01878097|460048469|FG000|Implementation Year 1|Surveys not fully completed|3202|||
127844669|NCT01878097|460048470|FG001|Implementation Year 1|Surveys not fully completed|2549|||
127844670|NCT01878097|460048469|FG000|Implementation Year 2|Surveys not fully completed|3281|||
127844671|NCT01878097|460048470|FG001|Implementation Year 2|Surveys not fully completed|2841|||
127844672|NCT01878097|460048469|FG000|Implementation Year 3|Surveys not fully completed|3494|||
127844673|NCT01878097|460048470|FG001|Implementation Year 3|Surveys not fully completed|2980|||
127844674|NCT01878097|460048469|FG000|Implementation Year 4|Surveys not fully completed|3604|||
127844675|NCT01878097|460048470|FG001|Implementation Year 4|Surveys not fully completed|3007|||
127844676|NCT00367341|460048471|FG000|Overall Study|Physician Decision|1|||
127844677|NCT00367341|460048472|FG001|Overall Study|Physician Decision|0|||
127844678|NCT00367341|460048471|FG000|Overall Study|Protocol Violation|1|||
127844679|NCT00367341|460048472|FG001|Overall Study|Protocol Violation|0|||
127844680|NCT03325556|460048473|FG000|Open-label Period|Lack of Response in OL period|70|||
127844681|NCT03325556|460048474|FG001|Open-label Period|Lack of Response in OL period|0|||
127844682|NCT03325556|460048475|FG002|Open-label Period|Lack of Response in OL period|0|||
127844683|NCT03325556|460048473|FG000|Open-label Period|Adverse Event|27|||
127844684|NCT03325556|460048474|FG001|Open-label Period|Adverse Event|0|||
127844685|NCT03325556|460048475|FG002|Open-label Period|Adverse Event|0|||
127844686|NCT03325556|460048473|FG000|Open-label Period|Death|1|||
127844687|NCT03325556|460048474|FG001|Open-label Period|Death|0|||
127844688|NCT03325556|460048475|FG002|Open-label Period|Death|0|||
127844689|NCT03325556|460048473|FG000|Open-label Period|Lost to Follow-up|1|||
127844690|NCT03325556|460048474|FG001|Open-label Period|Lost to Follow-up|0|||
127844691|NCT03325556|460048475|FG002|Open-label Period|Lost to Follow-up|0|||
127844692|NCT03325556|460048473|FG000|Open-label Period|Non-compliance with study drug|5|||
127844693|NCT03325556|460048474|FG001|Open-label Period|Non-compliance with study drug|0|||
127844694|NCT03325556|460048475|FG002|Open-label Period|Non-compliance with study drug|0|||
127844695|NCT03325556|460048473|FG000|Open-label Period|Use of prohibited medication|1|||
127844696|NCT03325556|460048474|FG001|Open-label Period|Use of prohibited medication|0|||
127844697|NCT03325556|460048475|FG002|Open-label Period|Use of prohibited medication|0|||
127844698|NCT03325556|460048473|FG000|Open-label Period|Protocol Violation|4|||
127844699|NCT03325556|460048474|FG001|Open-label Period|Protocol Violation|0|||
127844700|NCT03325556|460048475|FG002|Open-label Period|Protocol Violation|0|||
127844701|NCT03325556|460048473|FG000|Open-label Period|Withdrawal by Subject|17|||
127844702|NCT03325556|460048474|FG001|Open-label Period|Withdrawal by Subject|0|||
127844703|NCT03325556|460048475|FG002|Open-label Period|Withdrawal by Subject|0|||
127844704|NCT03325556|460048473|FG000|Open-label Period|Not otherwise specified|8|||
127844705|NCT03325556|460048474|FG001|Open-label Period|Not otherwise specified|0|||
127844706|NCT03325556|460048475|FG002|Open-label Period|Not otherwise specified|0|||
127844707|NCT03325556|460048473|FG000|Open-label Period|Administrative discont. at study termination|41|||
127844708|NCT03325556|460048474|FG001|Open-label Period|Administrative discont. at study termination|0|||
127844709|NCT03325556|460048475|FG002|Open-label Period|Administrative discont. at study termination|0|||
127844710|NCT03325556|460048473|FG000|Double-blind Period|Relapse|0|||
127844711|NCT03325556|460048474|FG001|Double-blind Period|Relapse|15|||
127844712|NCT03325556|460048475|FG002|Double-blind Period|Relapse|34|||
127844713|NCT03325556|460048473|FG000|Double-blind Period|Adverse Event|0|||
127844714|NCT03325556|460048474|FG001|Double-blind Period|Adverse Event|3|||
127844715|NCT03325556|460048475|FG002|Double-blind Period|Adverse Event|1|||
127844716|NCT03325556|460048473|FG000|Double-blind Period|Noncompliance with study drug|0|||
127844717|NCT03325556|460048474|FG001|Double-blind Period|Noncompliance with study drug|0|||
127844718|NCT03325556|460048475|FG002|Double-blind Period|Noncompliance with study drug|1|||
127844719|NCT03325556|460048473|FG000|Double-blind Period|Use of prohibited medication|0|||
127844720|NCT03325556|460048474|FG001|Double-blind Period|Use of prohibited medication|1|||
127844721|NCT03325556|460048475|FG002|Double-blind Period|Use of prohibited medication|0|||
127844722|NCT03325556|460048473|FG000|Double-blind Period|Physician Decision|0|||
127844723|NCT03325556|460048474|FG001|Double-blind Period|Physician Decision|0|||
127844724|NCT03325556|460048475|FG002|Double-blind Period|Physician Decision|1|||
127844725|NCT03325556|460048473|FG000|Double-blind Period|Withdrawal by Subject|0|||
127844726|NCT03325556|460048474|FG001|Double-blind Period|Withdrawal by Subject|6|||
127844727|NCT03325556|460048475|FG002|Double-blind Period|Withdrawal by Subject|4|||
127844728|NCT03325556|460048473|FG000|Double-blind Period|Not otherwise specified|0|||
127844729|NCT03325556|460048474|FG001|Double-blind Period|Not otherwise specified|1|||
127844730|NCT03325556|460048475|FG002|Double-blind Period|Not otherwise specified|5|||
127844731|NCT03325556|460048473|FG000|Double-blind Period|Administrative discont. at study termination|0|||
127844732|NCT03325556|460048474|FG001|Double-blind Period|Administrative discont. at study termination|35|||
127844733|NCT03325556|460048475|FG002|Double-blind Period|Administrative discont. at study termination|31|||
127844734|NCT02119026|460048476|FG000|1st-line Treatment|Adverse Event|9|||
127844735|NCT02119026|460048477|FG001|1st-line Treatment|Adverse Event|14|||
127844736|NCT02119026|460048476|FG000|1st-line Treatment|Physician Decision|3|||
127844737|NCT02119026|460048477|FG001|1st-line Treatment|Physician Decision|8|||
127844738|NCT02119026|460048476|FG000|1st-line Treatment|Withdrawal by Subject|4|||
127844739|NCT02119026|460048477|FG001|1st-line Treatment|Withdrawal by Subject|10|||
127900997|NCT00416520|460262878|FG000|Open-label Period|Lack of Efficacy|8|||
127844740|NCT02119026|460048476|FG000|1st-line Treatment|Patient condition or compliance|6|||
127844741|NCT02119026|460048477|FG001|1st-line Treatment|Patient condition or compliance|4|||
127844742|NCT02119026|460048476|FG000|1st-line Treatment|Surgery of metastases|2|||
127844743|NCT02119026|460048477|FG001|1st-line Treatment|Surgery of metastases|1|||
127844744|NCT02119026|460048476|FG000|1st-line Treatment|Death|2|||
127844745|NCT02119026|460048477|FG001|1st-line Treatment|Death|1|||
127844746|NCT02119026|460048476|FG000|2nd-line Treatment|Lost to Follow-up|2|||
127844747|NCT02119026|460048477|FG001|2nd-line Treatment|Lost to Follow-up|0|||
127844748|NCT02119026|460048476|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
127844749|NCT02119026|460048477|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
127844750|NCT02119026|460048476|FG000|2nd-line Treatment|Adverse Event|4|||
127844751|NCT02119026|460048477|FG001|2nd-line Treatment|Adverse Event|1|||
127844752|NCT00340834|460048478|FG000|Core Phase of Study|Adverse Event|26|||
127844753|NCT00340834|460048479|FG001|Core Phase of Study|Adverse Event|9|||
127844754|NCT00340834|460048480|FG002|Core Phase of Study|Adverse Event|9|||
127844755|NCT00340834|460048481|FG003|Core Phase of Study|Adverse Event|0|||
127844756|NCT00340834|460048482|FG004|Core Phase of Study|Adverse Event|0|||
127844757|NCT00340834|460048478|FG000|Core Phase of Study|Withdrawal by Subject|11|||
127844758|NCT00340834|460048479|FG001|Core Phase of Study|Withdrawal by Subject|9|||
127844759|NCT00340834|460048480|FG002|Core Phase of Study|Withdrawal by Subject|16|||
127844760|NCT00340834|460048481|FG003|Core Phase of Study|Withdrawal by Subject|0|||
127844761|NCT00340834|460048482|FG004|Core Phase of Study|Withdrawal by Subject|0|||
127844762|NCT00340834|460048478|FG000|Core Phase of Study|Administrative Problems|6|||
127844763|NCT00340834|460048479|FG001|Core Phase of Study|Administrative Problems|2|||
127844764|NCT00340834|460048480|FG002|Core Phase of Study|Administrative Problems|7|||
127844765|NCT00340834|460048481|FG003|Core Phase of Study|Administrative Problems|0|||
127844766|NCT00340834|460048482|FG004|Core Phase of Study|Administrative Problems|0|||
127844767|NCT00340834|460048478|FG000|Core Phase of Study|Lack of Efficacy|3|||
127844768|NCT00340834|460048479|FG001|Core Phase of Study|Lack of Efficacy|3|||
127844769|NCT00340834|460048480|FG002|Core Phase of Study|Lack of Efficacy|7|||
127844770|NCT00340834|460048481|FG003|Core Phase of Study|Lack of Efficacy|0|||
127844771|NCT00340834|460048482|FG004|Core Phase of Study|Lack of Efficacy|0|||
127844772|NCT00340834|460048478|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
127844773|NCT00340834|460048479|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
127844774|NCT00340834|460048480|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
127844775|NCT00340834|460048481|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
127844776|NCT00340834|460048482|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
127844777|NCT00340834|460048478|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
127844778|NCT00340834|460048479|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
127844779|NCT00340834|460048480|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
127844780|NCT00340834|460048481|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
127844781|NCT00340834|460048482|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
127844782|NCT00340834|460048478|FG000|Core Phase of Study|Lost to Follow-up|1|||
127844783|NCT00340834|460048479|FG001|Core Phase of Study|Lost to Follow-up|1|||
127844784|NCT00340834|460048480|FG002|Core Phase of Study|Lost to Follow-up|4|||
127844785|NCT00340834|460048481|FG003|Core Phase of Study|Lost to Follow-up|0|||
127844786|NCT00340834|460048482|FG004|Core Phase of Study|Lost to Follow-up|0|||
127844787|NCT00340834|460048478|FG000|Core Phase of Study|Death|2|||
127844788|NCT00340834|460048479|FG001|Core Phase of Study|Death|0|||
127844789|NCT00340834|460048480|FG002|Core Phase of Study|Death|0|||
127844790|NCT00340834|460048481|FG003|Core Phase of Study|Death|0|||
127844791|NCT00340834|460048482|FG004|Core Phase of Study|Death|0|||
127844792|NCT00340834|460048478|FG000|Core Phase of Study|Protocol Violation|0|||
127844793|NCT00340834|460048479|FG001|Core Phase of Study|Protocol Violation|0|||
127844794|NCT00340834|460048480|FG002|Core Phase of Study|Protocol Violation|2|||
127844795|NCT00340834|460048481|FG003|Core Phase of Study|Protocol Violation|0|||
127844796|NCT00340834|460048482|FG004|Core Phase of Study|Protocol Violation|0|||
127844797|NCT00340834|460048478|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
127844798|NCT00340834|460048479|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
127844799|NCT00340834|460048480|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
127900998|NCT00416520|460262879|FG001|Open-label Period|Lack of Efficacy|1|||
127844800|NCT00340834|460048481|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
127844801|NCT00340834|460048482|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
127844802|NCT00340834|460048478|FG000|Extension Phase of Study|Subject withdrew consent|26|||
127900999|NCT00416520|460262880|FG002|Open-label Period|Lack of Efficacy|0|||
127901000|NCT00416520|460262881|FG003|Open-label Period|Lack of Efficacy|0|||
127844803|NCT00340834|460048479|FG001|Extension Phase of Study|Subject withdrew consent|31|||
127844804|NCT00340834|460048480|FG002|Extension Phase of Study|Subject withdrew consent|0|||
127844805|NCT00340834|460048481|FG003|Extension Phase of Study|Subject withdrew consent|12|||
127844806|NCT00340834|460048482|FG004|Extension Phase of Study|Subject withdrew consent|15|||
127901001|NCT00416520|460262878|FG000|Open-label Period|Protocol Violation|3|||
127901002|NCT00416520|460262879|FG001|Open-label Period|Protocol Violation|3|||
127844807|NCT00340834|460048478|FG000|Extension Phase of Study|Adverse Event|21|||
127901003|NCT00416520|460262880|FG002|Open-label Period|Protocol Violation|0|||
127901004|NCT00416520|460262881|FG003|Open-label Period|Protocol Violation|0|||
127901005|NCT00416520|460262878|FG000|Open-label Period|Withdrawal by Subject|16|||
127901006|NCT00416520|460262879|FG001|Open-label Period|Withdrawal by Subject|5|||
127901007|NCT00416520|460262880|FG002|Open-label Period|Withdrawal by Subject|0|||
127901008|NCT00416520|460262881|FG003|Open-label Period|Withdrawal by Subject|0|||
127901009|NCT00416520|460262878|FG000|Open-label Period|Other Reasons|3|||
127901010|NCT00416520|460262879|FG001|Open-label Period|Other Reasons|12|||
127901011|NCT00416520|460262880|FG002|Open-label Period|Other Reasons|0|||
127901012|NCT00416520|460262881|FG003|Open-label Period|Other Reasons|0|||
127901013|NCT00416520|460262878|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
127901014|NCT00416520|460262879|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
127901015|NCT00416520|460262880|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
127901016|NCT00416520|460262881|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
127901017|NCT00416520|460262878|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
127901018|NCT00416520|460262879|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
127901019|NCT00416520|460262880|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
127901020|NCT00416520|460262881|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
127901021|NCT00416520|460262878|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
127901022|NCT00416520|460262879|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
127901023|NCT00416520|460262880|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
127901024|NCT00416520|460262881|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
127901025|NCT05628675|460262885|FG000|Overall Study|Lost to Follow-up|2|||
127901026|NCT05628675|460262885|FG000|Overall Study|Withdrawal by Subject|1|||
127901027|NCT01648166|460262889|FG000|Overall Study|inadequate toenail samples|53|||
127901028|NCT01648166|460262890|FG001|Overall Study|inadequate toenail samples|100|||
127901029|NCT00883090|460262891|FG000|Overall Study|Sponsor's decision|1|||
127901030|NCT00883090|460262891|FG000|Overall Study|Withdrawal by Subject|1|||
127901031|NCT01475838|460262894|FG000|Randomized Phase|Randomized but Not Treated|0|||
127901032|NCT01475838|460262895|FG001|Randomized Phase|Randomized but Not Treated|5|||
127901033|NCT01475838|460262894|FG000|Randomized Phase|Adverse Event|6|||
127901034|NCT01475838|460262895|FG001|Randomized Phase|Adverse Event|1|||
127901035|NCT01475838|460262894|FG000|Randomized Phase|Pregnancy|0|||
127901036|NCT01475838|460262895|FG001|Randomized Phase|Pregnancy|1|||
127844808|NCT00340834|460048479|FG001|Extension Phase of Study|Adverse Event|22|||
127844809|NCT00340834|460048480|FG002|Extension Phase of Study|Adverse Event|0|||
127844810|NCT00340834|460048481|FG003|Extension Phase of Study|Adverse Event|19|||
127844811|NCT00340834|460048482|FG004|Extension Phase of Study|Adverse Event|7|||
127844812|NCT00340834|460048478|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
127844813|NCT00340834|460048479|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
127844814|NCT00340834|460048480|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
127844815|NCT00340834|460048481|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
127844816|NCT00340834|460048482|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
127844817|NCT00340834|460048478|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
127844818|NCT00340834|460048479|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
127844819|NCT00340834|460048480|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
127844820|NCT00340834|460048481|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
127844821|NCT00340834|460048482|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
127844822|NCT00340834|460048478|FG000|Extension Phase of Study|Lost to Follow-up|1|||
127844823|NCT00340834|460048479|FG001|Extension Phase of Study|Lost to Follow-up|1|||
127844824|NCT00340834|460048480|FG002|Extension Phase of Study|Lost to Follow-up|0|||
127844825|NCT00340834|460048481|FG003|Extension Phase of Study|Lost to Follow-up|2|||
127844826|NCT00340834|460048482|FG004|Extension Phase of Study|Lost to Follow-up|3|||
127844827|NCT00340834|460048478|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
127844828|NCT00340834|460048479|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
127844829|NCT00340834|460048480|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
127844830|NCT00340834|460048481|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
127844831|NCT00340834|460048482|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
127844832|NCT00340834|460048478|FG000|Extension Phase of Study|Administrative problems|3|||
127844833|NCT00340834|460048479|FG001|Extension Phase of Study|Administrative problems|0|||
127844834|NCT00340834|460048480|FG002|Extension Phase of Study|Administrative problems|0|||
127901037|NCT01475838|460262894|FG000|Randomized Phase|Investigators Discretion|1|||
127901038|NCT01475838|460262895|FG001|Randomized Phase|Investigators Discretion|2|||
127901039|NCT01475838|460262894|FG000|Randomized Phase|Withdrew Consent|10|||
127901040|NCT01475838|460262895|FG001|Randomized Phase|Withdrew Consent|14|||
127901041|NCT01475838|460262894|FG000|Randomized Phase|Lost to Follow-up|3|||
127901042|NCT01475838|460262895|FG001|Randomized Phase|Lost to Follow-up|4|||
127844835|NCT00340834|460048481|FG003|Extension Phase of Study|Administrative problems|1|||
127844836|NCT00340834|460048482|FG004|Extension Phase of Study|Administrative problems|1|||
127901043|NCT01475838|460262894|FG000|Randomized Phase|Participant Noncompliance|1|||
127901044|NCT01475838|460262895|FG001|Randomized Phase|Participant Noncompliance|5|||
127901045|NCT01475838|460262894|FG000|Randomized Phase|Protocol Violation|9|||
127901046|NCT01475838|460262895|FG001|Randomized Phase|Protocol Violation|4|||
127901047|NCT01475838|460262894|FG000|Extension Phase|Participant Noncompliance|1|||
127901048|NCT01475838|460262895|FG001|Extension Phase|Participant Noncompliance|0|||
127901049|NCT00048568|460262896|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
127901050|NCT00048568|460262897|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
127901051|NCT00048568|460262898|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
127901052|NCT00048568|460262896|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
127901053|NCT00048568|460262897|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
127901054|NCT00048568|460262898|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
127901055|NCT00048568|460262896|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
127901056|NCT00048568|460262897|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
127901057|NCT00048568|460262898|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
127901058|NCT00048568|460262896|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
127901059|NCT00048568|460262897|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
127901060|NCT00048568|460262898|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
127901061|NCT00048568|460262896|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
127901062|NCT00048568|460262897|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
127901063|NCT00048568|460262898|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
127901064|NCT00048568|460262896|FG000|Double-Blind Period Days 170 to 365|Death|1|||
127901065|NCT00048568|460262897|FG001|Double-Blind Period Days 170 to 365|Death|1|||
127901066|NCT00048568|460262898|FG002|Double-Blind Period Days 170 to 365|Death|0|||
127901067|NCT00048568|460262896|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
127901068|NCT00048568|460262897|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
127901069|NCT00048568|460262898|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
127901070|NCT00048568|460262896|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
127901071|NCT00048568|460262897|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
127901072|NCT00048568|460262898|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
127901073|NCT00048568|460262896|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
127901074|NCT00048568|460262897|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
127901075|NCT00048568|460262898|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
127901076|NCT00048568|460262896|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
127901077|NCT00048568|460262897|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
127901078|NCT00048568|460262898|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
127901079|NCT00048568|460262896|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
127901080|NCT00048568|460262897|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
127901081|NCT00048568|460262898|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
127901082|NCT00048568|460262896|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
127901083|NCT00048568|460262897|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
127901084|NCT00048568|460262898|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
127901085|NCT00048568|460262896|FG000|Open-Label Period|Death|0|||
127901086|NCT00048568|460262897|FG001|Open-Label Period|Death|0|||
127901087|NCT00048568|460262898|FG002|Open-Label Period|Death|13|||
127901088|NCT00048568|460262896|FG000|Open-Label Period|Adverse Event|0|||
127901089|NCT00048568|460262897|FG001|Open-Label Period|Adverse Event|0|||
127901090|NCT00048568|460262898|FG002|Open-Label Period|Adverse Event|49|||
127901091|NCT00048568|460262896|FG000|Open-Label Period|Lack of Efficacy|0|||
127901092|NCT00048568|460262897|FG001|Open-Label Period|Lack of Efficacy|0|||
127901093|NCT00048568|460262898|FG002|Open-Label Period|Lack of Efficacy|32|||
127901094|NCT00048568|460262896|FG000|Open-Label Period|Withdrawal by Subject|0|||
127901095|NCT00048568|460262897|FG001|Open-Label Period|Withdrawal by Subject|0|||
127901096|NCT00048568|460262898|FG002|Open-Label Period|Withdrawal by Subject|26|||
127901097|NCT00048568|460262896|FG000|Open-Label Period|Pregnancy|0|||
127901098|NCT00048568|460262897|FG001|Open-Label Period|Pregnancy|0|||
127901099|NCT00048568|460262898|FG002|Open-Label Period|Pregnancy|5|||
127901100|NCT00048568|460262896|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
127901101|NCT00048568|460262897|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
127901102|NCT00048568|460262898|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
127901103|NCT00048568|460262896|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
127901104|NCT00048568|460262897|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
127901105|NCT00048568|460262898|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
127901106|NCT00048568|460262896|FG000|Open-Label Period|Unknown Reasons|0|||
127901107|NCT00048568|460262897|FG001|Open-Label Period|Unknown Reasons|0|||
127901108|NCT00048568|460262898|FG002|Open-Label Period|Unknown Reasons|25|||
127901109|NCT00048568|460262896|FG000|Open-Label Period|Lost to Follow-up|0|||
127901110|NCT00048568|460262897|FG001|Open-Label Period|Lost to Follow-up|0|||
127901111|NCT00048568|460262898|FG002|Open-Label Period|Lost to Follow-up|7|||
127901112|NCT03831048|460262899|FG000|Overall Study|Protocol Violation|9|||
127901113|NCT03831048|460262900|FG001|Overall Study|Protocol Violation|3|||
127901114|NCT03831048|460262899|FG000|Overall Study|Death|4|||
127844837|NCT00340834|460048478|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
127844838|NCT00340834|460048479|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
127844839|NCT00340834|460048480|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
127844840|NCT00340834|460048481|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
127844841|NCT00340834|460048482|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
127844842|NCT00340834|460048478|FG000|Extension Phase of Study|Protocol Violation|3|||
127844843|NCT00340834|460048479|FG001|Extension Phase of Study|Protocol Violation|0|||
127844844|NCT00340834|460048480|FG002|Extension Phase of Study|Protocol Violation|0|||
127844845|NCT00340834|460048481|FG003|Extension Phase of Study|Protocol Violation|0|||
127844846|NCT00340834|460048482|FG004|Extension Phase of Study|Protocol Violation|0|||
127844847|NCT00340834|460048478|FG000|Extension Phase of Study|Death|0|||
127844848|NCT00340834|460048479|FG001|Extension Phase of Study|Death|0|||
127844849|NCT00340834|460048480|FG002|Extension Phase of Study|Death|0|||
127844850|NCT00340834|460048481|FG003|Extension Phase of Study|Death|0|||
127844851|NCT00340834|460048482|FG004|Extension Phase of Study|Death|1|||
127844852|NCT02786836|460048485|FG000|Overall Study|Death|1|||
127844853|NCT02786836|460048485|FG000|Overall Study|Lack of Efficacy|2|||
127844854|NCT02786836|460048485|FG000|Overall Study|Protocol Violation|3|||
127844855|NCT02786836|460048485|FG000|Overall Study|Withdrawal by Subject|3|||
127844856|NCT02786836|460048485|FG000|Overall Study|Liver Transplantation|2|||
127844857|NCT02786836|460048485|FG000|Overall Study|Device or Pharmacy Issues|3|||
127844858|NCT01143714|460048487|FG000|Overall Study|Adverse Event|4|||
127844859|NCT01143714|460048488|FG001|Overall Study|Adverse Event|2|||
127844860|NCT01143714|460048487|FG000|Overall Study|Withdrawal by Subject|1|||
127844861|NCT01143714|460048488|FG001|Overall Study|Withdrawal by Subject|0|||
127844862|NCT01143714|460048487|FG000|Overall Study|Subject non-compliance|0|||
127844863|NCT01143714|460048488|FG001|Overall Study|Subject non-compliance|1|||
127844864|NCT01143714|460048487|FG000|Overall Study|wound closed = deemed healed|1|||
127844865|NCT01143714|460048488|FG001|Overall Study|wound closed = deemed healed|0|||
127844866|NCT01143714|460048487|FG000|Overall Study|wound size increased|1|||
127844867|NCT01143714|460048488|FG001|Overall Study|wound size increased|0|||
127844868|NCT01387074|460048489|FG000|Overall Study|Lost to Follow-up|7|||
127844869|NCT01387074|460048489|FG000|Overall Study|Lack of Efficacy|1|||
127844870|NCT00448760|460048493|FG000|Overall Study|Death|3|||
127844871|NCT01213264|460048499|FG000|Overall Study|Adverse Event|1|||
127844872|NCT01213264|460048500|FG001|Overall Study|Adverse Event|0|||
127844873|NCT01213264|460048501|FG002|Overall Study|Adverse Event|0|||
127844874|NCT01213264|460048499|FG000|Overall Study|Lost to Follow-up|1|||
127844875|NCT01213264|460048500|FG001|Overall Study|Lost to Follow-up|2|||
127844876|NCT01213264|460048501|FG002|Overall Study|Lost to Follow-up|6|||
127844877|NCT00118911|460048502|FG000|Overall Study|Withdrawal by Subject|2|||
127844878|NCT00118911|460048503|FG001|Overall Study|Withdrawal by Subject|5|||
127844879|NCT05507580|460048504|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
127844880|NCT05507580|460048505|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
127844881|NCT05507580|460048506|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
127844882|NCT05507580|460048507|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
127844883|NCT05507580|460048508|FG004|Double-Blind Treatment Period|Lost to Follow-up|0|||
127844884|NCT05507580|460048509|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
127844885|NCT05507580|460048504|FG000|Double-Blind Treatment Period|Withdrawal by Subject|7|||
127844886|NCT05507580|460048505|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
127844887|NCT05507580|460048506|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
127844888|NCT05507580|460048507|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
127844889|NCT05507580|460048508|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
127844890|NCT05507580|460048509|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
127844891|NCT05507580|460048504|FG000|Double-Blind Treatment Period|Other, not specified|5|||
127844892|NCT05507580|460048505|FG001|Double-Blind Treatment Period|Other, not specified|4|||
127844893|NCT05507580|460048506|FG002|Double-Blind Treatment Period|Other, not specified|0|||
127844894|NCT05507580|460048507|FG003|Double-Blind Treatment Period|Other, not specified|0|||
127844895|NCT05507580|460048508|FG004|Double-Blind Treatment Period|Other, not specified|0|||
127844896|NCT05507580|460048509|FG005|Double-Blind Treatment Period|Other, not specified|0|||
127844897|NCT05507580|460048504|FG000|Single-Blind Treatment Period|Lost to Follow-up|0|||
127844898|NCT05507580|460048505|FG001|Single-Blind Treatment Period|Lost to Follow-up|0|||
127844899|NCT05507580|460048506|FG002|Single-Blind Treatment Period|Lost to Follow-up|0|||
127844900|NCT05507580|460048507|FG003|Single-Blind Treatment Period|Lost to Follow-up|0|||
127844901|NCT05507580|460048508|FG004|Single-Blind Treatment Period|Lost to Follow-up|2|||
127844902|NCT05507580|460048509|FG005|Single-Blind Treatment Period|Lost to Follow-up|1|||
127844903|NCT05507580|460048504|FG000|Single-Blind Treatment Period|Withdrawal by Subject|0|||
127844904|NCT05507580|460048505|FG001|Single-Blind Treatment Period|Withdrawal by Subject|0|||
127844905|NCT05507580|460048506|FG002|Single-Blind Treatment Period|Withdrawal by Subject|0|||
127844906|NCT05507580|460048507|FG003|Single-Blind Treatment Period|Withdrawal by Subject|5|||
127844907|NCT05507580|460048508|FG004|Single-Blind Treatment Period|Withdrawal by Subject|2|||
127844908|NCT05507580|460048509|FG005|Single-Blind Treatment Period|Withdrawal by Subject|6|||
127844909|NCT05507580|460048504|FG000|Single-Blind Treatment Period|Other, not specified|0|||
127844910|NCT05507580|460048505|FG001|Single-Blind Treatment Period|Other, not specified|0|||
127844911|NCT05507580|460048506|FG002|Single-Blind Treatment Period|Other, not specified|2|||
127844912|NCT05507580|460048507|FG003|Single-Blind Treatment Period|Other, not specified|7|||
127844913|NCT05507580|460048508|FG004|Single-Blind Treatment Period|Other, not specified|3|||
127844914|NCT05507580|460048509|FG005|Single-Blind Treatment Period|Other, not specified|5|||
127844915|NCT00555568|460048510|FG000|Overall Study|Lost to Follow-up|26|||
127844916|NCT00555568|460048511|FG001|Overall Study|Lost to Follow-up|16|||
127844917|NCT00555568|460048512|FG002|Overall Study|Lost to Follow-up|16|||
127844918|NCT04702984|460048513|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
127844919|NCT03496662|460048516|FG000|Overall Study|Adverse Event|0|||
127844920|NCT03496662|460048517|FG001|Overall Study|Adverse Event|0|||
127844921|NCT03496662|460048518|FG002|Overall Study|Adverse Event|4|||
127844922|NCT03496662|460048516|FG000|Overall Study|Withdrawal by Subject|1|||
127844923|NCT03496662|460048517|FG001|Overall Study|Withdrawal by Subject|0|||
127844924|NCT03496662|460048518|FG002|Overall Study|Withdrawal by Subject|2|||
127844925|NCT03496662|460048516|FG000|Overall Study|Death|0|||
127844926|NCT03496662|460048517|FG001|Overall Study|Death|0|||
127844927|NCT03496662|460048518|FG002|Overall Study|Death|2|||
127844928|NCT03496662|460048516|FG000|Overall Study|Noncompliance|0|||
127844929|NCT03496662|460048517|FG001|Overall Study|Noncompliance|0|||
127844930|NCT03496662|460048518|FG002|Overall Study|Noncompliance|1|||
127844931|NCT02378883|460048519|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
127844932|NCT02378883|460048519|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
127844933|NCT02378883|460048519|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
127844934|NCT02378883|460048519|FG000|30 Day Follow-Up|Physician Decision|2|||
127844935|NCT02378883|460048519|FG000|30 Day Follow-Up|Missed Visit|2|||
127844936|NCT02378883|460048519|FG000|30 Day Follow-Up|Death|1|||
127844937|NCT02378883|460048519|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
127844938|NCT02378883|460048519|FG000|12 Months Follow-Up|Death|2|||
127844939|NCT03037307|460048520|FG000|Period 1|Did Not Meet Study Criteria|0|||
127844940|NCT03037307|460048521|FG001|Period 1|Did Not Meet Study Criteria|0|||
127844941|NCT03037307|460048522|FG002|Period 1|Did Not Meet Study Criteria|0|||
127844942|NCT03037307|460048523|FG003|Period 1|Did Not Meet Study Criteria|1|||
127844943|NCT03037307|460048524|FG004|Period 1|Did Not Meet Study Criteria|0|||
127844944|NCT03037307|460048525|FG005|Period 1|Did Not Meet Study Criteria|0|||
127844945|NCT00691093|460048526|FG000|Overall Study|Adverse Event|1|||
127844946|NCT00691093|460048526|FG000|Overall Study|Lost to Follow-up|1|||
127844947|NCT00691093|460048526|FG000|Overall Study|Lack of Efficacy|1|||
127844948|NCT00691093|460048526|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
127844949|NCT01588353|460048527|FG000|Step2|Withdrawal by Subject|0|||
127844950|NCT01588353|460048528|FG001|Step2|Withdrawal by Subject|1|||
127844951|NCT01588353|460048529|FG002|Step2|Withdrawal by Subject|0|||
127844952|NCT01588353|460048527|FG000|Step3|Adverse Event|0|||
127844953|NCT01588353|460048528|FG001|Step3|Adverse Event|0|||
127844954|NCT01588353|460048529|FG002|Step3|Adverse Event|2|||
127844955|NCT00493467|460048530|FG000|Overall Study|Death|1|||
127844956|NCT05489081|460048532|FG000|Overall Study|student left classroom|0|||
127844957|NCT05489081|460048533|FG001|Overall Study|student left classroom|1|||
127844958|NCT05489081|460048532|FG000|Overall Study|teacher left school|0|||
127844959|NCT05489081|460048533|FG001|Overall Study|teacher left school|2|||
127844960|NCT00810810|460048534|FG000|Overall Study|Withdrawal by Subject|0|||
127844961|NCT00810810|460048535|FG001|Overall Study|Withdrawal by Subject|8|||
127844962|NCT00810810|460048536|FG002|Overall Study|Withdrawal by Subject|10|||
127844963|NCT00810810|460048537|FG003|Overall Study|Withdrawal by Subject|8|||
127844964|NCT00810810|460048534|FG000|Overall Study|Physician Decision|0|||
127844965|NCT00810810|460048535|FG001|Overall Study|Physician Decision|3|||
127844966|NCT00810810|460048536|FG002|Overall Study|Physician Decision|1|||
127844967|NCT00810810|460048537|FG003|Overall Study|Physician Decision|5|||
127844968|NCT01700985|460048538|FG000|Overall Study|Incarcerated|0|||
127844969|NCT01700985|460048539|FG001|Overall Study|Incarcerated|1|||
127844970|NCT01409993|460048540|FG000|Overall Study|Adverse Event|4|||
127844971|NCT01409993|460048541|FG001|Overall Study|Adverse Event|4|||
127844972|NCT01409993|460048542|FG002|Overall Study|Adverse Event|3|||
127844973|NCT01409993|460048543|FG003|Overall Study|Adverse Event|1|||
127844974|NCT01409993|460048540|FG000|Overall Study|Withdrawal by Subject|0|||
127844975|NCT01409993|460048541|FG001|Overall Study|Withdrawal by Subject|0|||
127844976|NCT01409993|460048542|FG002|Overall Study|Withdrawal by Subject|0|||
127844977|NCT01409993|460048543|FG003|Overall Study|Withdrawal by Subject|4|||
127844978|NCT01409993|460048540|FG000|Overall Study|Lost to Follow-up|0|||
127844979|NCT01409993|460048541|FG001|Overall Study|Lost to Follow-up|1|||
127844980|NCT01409993|460048542|FG002|Overall Study|Lost to Follow-up|0|||
127844981|NCT01409993|460048543|FG003|Overall Study|Lost to Follow-up|0|||
127844982|NCT05067452|460048544|FG000|Overall Study|Lost to Follow-up|0|||
127844983|NCT05067452|460048545|FG001|Overall Study|Lost to Follow-up|4|||
127844984|NCT03074149|460048548|FG000|Overall Study|Reason unknown|22|||
127844985|NCT03074149|460048549|FG001|Overall Study|Reason unknown|35|||
127901115|NCT03831048|460262900|FG001|Overall Study|Death|9|||
127901116|NCT03831048|460262899|FG000|Overall Study|Re-transplant|0|||
127901117|NCT03831048|460262900|FG001|Overall Study|Re-transplant|2|||
127901118|NCT03831048|460262899|FG000|Overall Study|Protocol violation and death|1|||
127901119|NCT03831048|460262900|FG001|Overall Study|Protocol violation and death|1|||
127901120|NCT00560235|460262904|FG000|Phase 1|Discontinued|8|||
127901121|NCT00560235|460262905|FG001|Phase 1|Discontinued|0|||
127901122|NCT00560235|460262906|FG002|Phase 1|Discontinued|0|||
127901123|NCT00560235|460262904|FG000|Phase 1B|Discontinued|0|||
127901124|NCT00560235|460262905|FG001|Phase 1B|Discontinued|19|||
127901125|NCT00560235|460262906|FG002|Phase 1B|Discontinued|0|||
127901126|NCT00560235|460262904|FG000|Phase 2|Discontinued|0|||
127901127|NCT00560235|460262905|FG001|Phase 2|Discontinued|0|||
127901128|NCT00560235|460262906|FG002|Phase 2|Discontinued|96|||
127901129|NCT00560235|460262904|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
127901130|NCT00560235|460262905|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
127901131|NCT00560235|460262906|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
127901132|NCT01315249|460262909|FG000|Overall Study|Adverse Event|22|||
127901133|NCT01315249|460262910|FG001|Overall Study|Adverse Event|26|||
127901134|NCT01315249|460262909|FG000|Overall Study|Withdrawal by Subject|11|||
127901135|NCT01315249|460262910|FG001|Overall Study|Withdrawal by Subject|10|||
127901136|NCT01315249|460262909|FG000|Overall Study|Protocol Violation|8|||
127901137|NCT01315249|460262910|FG001|Overall Study|Protocol Violation|5|||
127901138|NCT01315249|460262909|FG000|Overall Study|Abnormal test results|1|||
127901139|NCT01315249|460262910|FG001|Overall Study|Abnormal test results|2|||
127901140|NCT01315249|460262909|FG000|Overall Study|Administrative problems|1|||
127901141|NCT01315249|460262910|FG001|Overall Study|Administrative problems|0|||
127901142|NCT01315249|460262909|FG000|Overall Study|inability to use device|1|||
127901143|NCT01315249|460262910|FG001|Overall Study|inability to use device|0|||
127901144|NCT01315249|460262909|FG000|Overall Study|Lack of Efficacy|0|||
127901145|NCT01315249|460262910|FG001|Overall Study|Lack of Efficacy|1|||
127901146|NCT01315249|460262909|FG000|Overall Study|Lost to Follow-up|0|||
127901147|NCT01315249|460262910|FG001|Overall Study|Lost to Follow-up|2|||
127901148|NCT01315249|460262909|FG000|Overall Study|Death|0|||
127901149|NCT01315249|460262910|FG001|Overall Study|Death|1|||
127901150|NCT00849901|460262913|FG000|Acute Treatment Phase|Adverse Event|9|||
127901151|NCT00849901|460262914|FG001|Acute Treatment Phase|Adverse Event|1|||
127901152|NCT00849901|460262915|FG002|Acute Treatment Phase|Adverse Event|3|||
127901153|NCT00849901|460262913|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
127901154|NCT00849901|460262914|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
127901155|NCT00849901|460262915|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
127901156|NCT00849901|460262913|FG000|Acute Treatment Phase|Protocol Violation|0|||
127901157|NCT00849901|460262914|FG001|Acute Treatment Phase|Protocol Violation|2|||
127901158|NCT00849901|460262915|FG002|Acute Treatment Phase|Protocol Violation|1|||
127901159|NCT00849901|460262913|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
127901160|NCT00849901|460262914|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
127901161|NCT00849901|460262915|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
127901162|NCT00849901|460262913|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
127901163|NCT00849901|460262914|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
127901164|NCT00849901|460262915|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
127901165|NCT00849901|460262913|FG000|Acute Treatment Phase|Physician Decision|1|||
127901166|NCT00849901|460262914|FG001|Acute Treatment Phase|Physician Decision|1|||
127901167|NCT00849901|460262915|FG002|Acute Treatment Phase|Physician Decision|1|||
127901168|NCT00849901|460262913|FG000|Acute Treatment Phase|Sponsor Decision|1|||
127901169|NCT00849901|460262914|FG001|Acute Treatment Phase|Sponsor Decision|0|||
127901170|NCT00849901|460262915|FG002|Acute Treatment Phase|Sponsor Decision|0|||
127901171|NCT00849901|460262913|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
127901172|NCT00849901|460262914|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
127901173|NCT00849901|460262915|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
127901174|NCT00849901|460262913|FG000|Extension Phase|Adverse Event|2|||
127901175|NCT00849901|460262914|FG001|Extension Phase|Adverse Event|8|||
127901176|NCT00849901|460262915|FG002|Extension Phase|Adverse Event|4|||
127901177|NCT00849901|460262913|FG000|Extension Phase|Lost to Follow-up|3|||
127901178|NCT00849901|460262914|FG001|Extension Phase|Lost to Follow-up|0|||
127901179|NCT00849901|460262915|FG002|Extension Phase|Lost to Follow-up|1|||
127901180|NCT00849901|460262913|FG000|Extension Phase|Protocol Violation|2|||
127901181|NCT00849901|460262914|FG001|Extension Phase|Protocol Violation|2|||
127901182|NCT00849901|460262915|FG002|Extension Phase|Protocol Violation|4|||
127901183|NCT00849901|460262913|FG000|Extension Phase|Withdrawal by Subject|7|||
127901184|NCT00849901|460262914|FG001|Extension Phase|Withdrawal by Subject|6|||
127901185|NCT00849901|460262915|FG002|Extension Phase|Withdrawal by Subject|3|||
127901186|NCT00849901|460262913|FG000|Extension Phase|Parent or Caregiver Decision|10|||
127901187|NCT00849901|460262914|FG001|Extension Phase|Parent or Caregiver Decision|4|||
127901188|NCT00849901|460262915|FG002|Extension Phase|Parent or Caregiver Decision|4|||
127901189|NCT00849901|460262913|FG000|Extension Phase|Physician Decision|1|||
127901190|NCT00849901|460262914|FG001|Extension Phase|Physician Decision|2|||
127901191|NCT00849901|460262915|FG002|Extension Phase|Physician Decision|0|||
127901192|NCT00849901|460262913|FG000|Extension Phase|Lack of Efficacy|2|||
127901193|NCT00849901|460262914|FG001|Extension Phase|Lack of Efficacy|4|||
127901194|NCT00849901|460262915|FG002|Extension Phase|Lack of Efficacy|1|||
127901195|NCT00262223|460262916|FG000|Treatment Phase|Withdrawal by Subject|3|||
127901196|NCT00262223|460262917|FG001|Treatment Phase|Withdrawal by Subject|6|||
127901197|NCT00262223|460262916|FG000|Treatment Phase|Adverse Event|1|||
127901198|NCT00262223|460262917|FG001|Treatment Phase|Adverse Event|2|||
127901199|NCT00262223|460262916|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
127901200|NCT00262223|460262917|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
127901201|NCT00262223|460262916|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
127901202|NCT00262223|460262917|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
127901203|NCT00262223|460262916|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
127901204|NCT00262223|460262917|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
127901205|NCT01804270|460262920|FG000|Overall Study|Withdrawal by Subject|1|||
127901206|NCT01804270|460262921|FG001|Overall Study|Withdrawal by Subject|1|||
127901207|NCT01328093|460262926|FG000|Double-Blind Phase|Adverse Event|78|||
127901208|NCT01328093|460262927|FG001|Double-Blind Phase|Adverse Event|15|||
127901209|NCT01328093|460262926|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
127901210|NCT01328093|460262927|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
127901211|NCT01328093|460262926|FG000|Double-Blind Phase|Lost to Follow-up|39|||
127901212|NCT01328093|460262927|FG001|Double-Blind Phase|Lost to Follow-up|14|||
127901213|NCT01328093|460262926|FG000|Double-Blind Phase|Protocol Violation|30|||
127901214|NCT01328093|460262927|FG001|Double-Blind Phase|Protocol Violation|10|||
127901215|NCT01328093|460262926|FG000|Double-Blind Phase|Lack of Efficacy|55|||
127901216|NCT01328093|460262927|FG001|Double-Blind Phase|Lack of Efficacy|13|||
127901217|NCT01328093|460262926|FG000|Double-Blind Phase|Sponsor Decision|17|||
127901218|NCT01328093|460262927|FG001|Double-Blind Phase|Sponsor Decision|3|||
127901219|NCT01328093|460262926|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
127901220|NCT01328093|460262927|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
127901221|NCT01328093|460262926|FG000|Double-Blind Phase|Scheduling conflict|8|||
127901222|NCT01328093|460262927|FG001|Double-Blind Phase|Scheduling conflict|3|||
127901223|NCT01328093|460262926|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
127901224|NCT01328093|460262927|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
127901225|NCT01328093|460262926|FG000|Double-Blind Phase|Death|1|||
127901226|NCT01328093|460262927|FG001|Double-Blind Phase|Death|0|||
127901227|NCT01328093|460262926|FG000|Open-Label Phase|Sponsor Decision|98|||
127901228|NCT01328093|460262927|FG001|Open-Label Phase|Sponsor Decision|34|||
127901229|NCT01328093|460262926|FG000|Open-Label Phase|Protocol Violation|8|||
127901230|NCT01328093|460262927|FG001|Open-Label Phase|Protocol Violation|3|||
127901231|NCT01328093|460262926|FG000|Open-Label Phase|Lost to Follow-up|10|||
127901232|NCT01328093|460262927|FG001|Open-Label Phase|Lost to Follow-up|1|||
127901233|NCT01328093|460262926|FG000|Open-Label Phase|Adverse Event|10|||
127901234|NCT01328093|460262927|FG001|Open-Label Phase|Adverse Event|4|||
127901235|NCT01328093|460262926|FG000|Open-Label Phase|Lack of Efficacy|5|||
127901236|NCT01328093|460262927|FG001|Open-Label Phase|Lack of Efficacy|6|||
127901237|NCT01328093|460262926|FG000|Open-Label Phase|Withdrawal by Subject|4|||
127901238|NCT01328093|460262927|FG001|Open-Label Phase|Withdrawal by Subject|1|||
127901239|NCT01328093|460262926|FG000|Open-Label Phase|Scheduling conflict|2|||
127901240|NCT01328093|460262927|FG001|Open-Label Phase|Scheduling conflict|1|||
127901241|NCT01328093|460262926|FG000|Open-Label Phase|Subject is moving or has moved|2|||
127901242|NCT01328093|460262927|FG001|Open-Label Phase|Subject is moving or has moved|0|||
127901243|NCT01328093|460262926|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
127901244|NCT01328093|460262927|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
127901245|NCT05150964|460262930|FG000|Overall Study|Lost to Follow-up|2|||
127901246|NCT01856309|460262931|FG000|Overall Study|Death|4|||
127901247|NCT01856309|460262932|FG001|Overall Study|Death|6|||
127901248|NCT01856309|460262933|FG002|Overall Study|Death|11|||
127901249|NCT01856309|460262934|FG003|Overall Study|Death|6|||
127844986|NCT03074149|460048548|FG000|Overall Study|Death|10|||
127844987|NCT03074149|460048549|FG001|Overall Study|Death|45|||
127844988|NCT00067470|460048550|FG000|Overall Study|Withdrawal by Subject|0|||
127844989|NCT00067470|460048551|FG001|Overall Study|Withdrawal by Subject|1|||
127844990|NCT00050622|460048552|FG000|Overall Study|Adverse Event|1|||
127844991|NCT01192204|460048553|FG000|Overall Study|could not keep recall appointments|1|||
127844992|NCT01192204|460048554|FG001|Overall Study|could not keep recall appointments|0|||
127844993|NCT00192036|460048558|FG000|Overall Study|Protocol Violation|3|||
127844994|NCT00192036|460048558|FG000|Overall Study|Adverse Event|6|||
127844995|NCT00192036|460048558|FG000|Overall Study|Patient/Physician Perception|1|||
127844996|NCT00192036|460048558|FG000|Overall Study|Objective Tumor Progression|4|||
127844997|NCT00192036|460048558|FG000|Overall Study|Clinical Disease Progression|1|||
127901250|NCT01856309|460262931|FG000|Overall Study|Lost to Follow-up|6|||
127901251|NCT01856309|460262932|FG001|Overall Study|Lost to Follow-up|2|||
127901252|NCT01856309|460262933|FG002|Overall Study|Lost to Follow-up|4|||
127901253|NCT01856309|460262934|FG003|Overall Study|Lost to Follow-up|8|||
127901254|NCT01856309|460262931|FG000|Overall Study|Withdrawal by Subject|11|||
127901255|NCT01856309|460262932|FG001|Overall Study|Withdrawal by Subject|13|||
127901256|NCT01856309|460262933|FG002|Overall Study|Withdrawal by Subject|28|||
127844998|NCT00192036|460048558|FG000|Overall Study|Death|1|||
127844999|NCT00192036|460048558|FG000|Overall Study|Unknown or Not Specified|5|||
127845000|NCT05425719|460048559|FG000|Overall Study|Lost to Follow-up|4|||
127845001|NCT05425719|460048560|FG001|Overall Study|Lost to Follow-up|0|||
127845002|NCT05425719|460048559|FG000|Overall Study|Withdrew consent|1|||
127845003|NCT05425719|460048560|FG001|Overall Study|Withdrew consent|1|||
127845004|NCT04682353|460048563|FG000|Overall Study|Lost to Follow-up|0|||
127845005|NCT04682353|460048564|FG001|Overall Study|Lost to Follow-up|1|||
127845006|NCT04682353|460048565|FG002|Overall Study|Lost to Follow-up|0|||
127845007|NCT04682353|460048566|FG003|Overall Study|Lost to Follow-up|1|||
127845008|NCT04682353|460048563|FG000|Overall Study|Personal reasons|0|||
127845009|NCT04682353|460048564|FG001|Overall Study|Personal reasons|1|||
127845010|NCT04682353|460048565|FG002|Overall Study|Personal reasons|0|||
127845011|NCT04682353|460048566|FG003|Overall Study|Personal reasons|0|||
127845012|NCT01586806|460048568|FG000|Overall Study|Protocol Violation|0|||
127845013|NCT01586806|460048569|FG001|Overall Study|Protocol Violation|1|||
127845014|NCT01586806|460048570|FG002|Overall Study|Protocol Violation|0|||
127845015|NCT01586806|460048568|FG000|Overall Study|Withdrawal by Subject|1|||
127845016|NCT01586806|460048569|FG001|Overall Study|Withdrawal by Subject|0|||
127845017|NCT01586806|460048570|FG002|Overall Study|Withdrawal by Subject|0|||
127845018|NCT01586806|460048568|FG000|Overall Study|Lost to Follow-up|2|||
127845019|NCT01586806|460048569|FG001|Overall Study|Lost to Follow-up|3|||
127845020|NCT01586806|460048570|FG002|Overall Study|Lost to Follow-up|2|||
127845021|NCT01769469|460048571|FG000|Overall Study|Consent Withdrawn|5|||
127901257|NCT01856309|460262934|FG003|Overall Study|Withdrawal by Subject|26|||
127901258|NCT01856309|460262931|FG000|Overall Study|Other|227|||
127901259|NCT01856309|460262932|FG001|Overall Study|Other|225|||
127901260|NCT01856309|460262933|FG002|Overall Study|Other|447|||
127901261|NCT01856309|460262934|FG003|Overall Study|Other|469|||
127901262|NCT01856309|460262931|FG000|Overall Study|Lack of Efficacy|14|||
127901263|NCT01856309|460262932|FG001|Overall Study|Lack of Efficacy|9|||
127901264|NCT01856309|460262933|FG002|Overall Study|Lack of Efficacy|40|||
127901265|NCT01856309|460262934|FG003|Overall Study|Lack of Efficacy|25|||
127901266|NCT01856309|460262931|FG000|Overall Study|Adverse Event|31|||
127901267|NCT01856309|460262932|FG001|Overall Study|Adverse Event|31|||
127901268|NCT01856309|460262933|FG002|Overall Study|Adverse Event|55|||
127901269|NCT01856309|460262934|FG003|Overall Study|Adverse Event|65|||
127901270|NCT01856309|460262931|FG000|Overall Study|Pregnancy|0|||
127845022|NCT01769469|460048571|FG000|Overall Study|Moved Out Of Area|3|||
127845023|NCT01769469|460048571|FG000|Overall Study|Lost to Follow-up|17|||
127845024|NCT01769469|460048571|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
127845025|NCT01769469|460048571|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
127845026|NCT00862654|460048572|FG000|Overall Study|Lack of Efficacy|1|||
127845027|NCT00862654|460048573|FG001|Overall Study|Lack of Efficacy|0|||
127845028|NCT00862654|460048574|FG002|Overall Study|Lack of Efficacy|1|||
127845029|NCT00862654|460048575|FG003|Overall Study|Lack of Efficacy|0|||
127901271|NCT01856309|460262932|FG001|Overall Study|Pregnancy|0|||
127901272|NCT01856309|460262933|FG002|Overall Study|Pregnancy|0|||
127845030|NCT00862654|460048572|FG000|Overall Study|Lost to Follow-up|1|||
127845031|NCT00862654|460048573|FG001|Overall Study|Lost to Follow-up|2|||
127845032|NCT00862654|460048574|FG002|Overall Study|Lost to Follow-up|1|||
127845033|NCT00862654|460048575|FG003|Overall Study|Lost to Follow-up|3|||
127845034|NCT00862654|460048572|FG000|Overall Study|Adverse Event|0|||
127845035|NCT00862654|460048573|FG001|Overall Study|Adverse Event|1|||
127845036|NCT00862654|460048574|FG002|Overall Study|Adverse Event|1|||
127845037|NCT00862654|460048575|FG003|Overall Study|Adverse Event|0|||
127845038|NCT00862654|460048572|FG000|Overall Study|Pregnancy|1|||
127845039|NCT00862654|460048573|FG001|Overall Study|Pregnancy|1|||
127845040|NCT00862654|460048574|FG002|Overall Study|Pregnancy|0|||
127845041|NCT00862654|460048575|FG003|Overall Study|Pregnancy|0|||
127845042|NCT00862654|460048572|FG000|Overall Study|Withdrawal by Subject|2|||
127845043|NCT00862654|460048573|FG001|Overall Study|Withdrawal by Subject|2|||
127901273|NCT01856309|460262934|FG003|Overall Study|Pregnancy|1|||
127901274|NCT01856309|460262931|FG000|Overall Study|Physician Decision|6|||
127901275|NCT01856309|460262932|FG001|Overall Study|Physician Decision|1|||
127845044|NCT00862654|460048574|FG002|Overall Study|Withdrawal by Subject|2|||
127845045|NCT00862654|460048575|FG003|Overall Study|Withdrawal by Subject|3|||
127845046|NCT00862654|460048572|FG000|Overall Study|Subject mistake|0|||
127845047|NCT00862654|460048573|FG001|Overall Study|Subject mistake|1|||
127845048|NCT00862654|460048574|FG002|Overall Study|Subject mistake|0|||
127845049|NCT00862654|460048575|FG003|Overall Study|Subject mistake|0|||
127845050|NCT00862654|460048572|FG000|Overall Study|Familly constraint|0|||
127901276|NCT01856309|460262933|FG002|Overall Study|Physician Decision|6|||
127845051|NCT00862654|460048573|FG001|Overall Study|Familly constraint|1|||
127845052|NCT00862654|460048574|FG002|Overall Study|Familly constraint|0|||
127845053|NCT00862654|460048575|FG003|Overall Study|Familly constraint|0|||
127845054|NCT00862654|460048572|FG000|Overall Study|Never used study drugs|1|||
127845055|NCT00862654|460048573|FG001|Overall Study|Never used study drugs|0|||
127845056|NCT00862654|460048574|FG002|Overall Study|Never used study drugs|0|||
127901277|NCT01856309|460262934|FG003|Overall Study|Physician Decision|8|||
127901278|NCT01856309|460262931|FG000|Overall Study|Noncompliance With Study Drug|0|||
127845057|NCT00862654|460048575|FG003|Overall Study|Never used study drugs|0|||
127845058|NCT00862654|460048572|FG000|Overall Study|Included after end of inclusions|0|||
127845059|NCT00862654|460048573|FG001|Overall Study|Included after end of inclusions|0|||
127845060|NCT00862654|460048574|FG002|Overall Study|Included after end of inclusions|1|||
127845061|NCT00862654|460048575|FG003|Overall Study|Included after end of inclusions|0|||
127845062|NCT02394795|460048581|FG000|Overall Study|Adverse Event|92|||
127901279|NCT01856309|460262932|FG001|Overall Study|Noncompliance With Study Drug|1|||
127901280|NCT01856309|460262933|FG002|Overall Study|Noncompliance With Study Drug|4|||
127901281|NCT01856309|460262934|FG003|Overall Study|Noncompliance With Study Drug|1|||
127901282|NCT00832377|460262935|FG000|Overall Study|Protocol Violation|1|||
127901283|NCT01449630|460262937|FG000|Period 1|Physician Decision|1|||
127901284|NCT01449630|460262938|FG001|Period 1|Physician Decision|0|||
127901285|NCT01449630|460262939|FG002|Period 1|Physician Decision|0|||
127901286|NCT01449630|460262940|FG003|Period 1|Physician Decision|1|||
127901287|NCT01449630|460262941|FG004|Period 1|Physician Decision|0|||
127901288|NCT01449630|460262942|FG005|Period 1|Physician Decision|0|||
127901289|NCT01449630|460262943|FG006|Period 1|Physician Decision|0|||
127901290|NCT01449630|460262944|FG007|Period 1|Physician Decision|0|||
127901291|NCT01449630|460262945|FG008|Period 1|Physician Decision|0|||
127901292|NCT01449630|460262937|FG000|Period 1|Sponsor Decision|0|||
127901293|NCT01449630|460262938|FG001|Period 1|Sponsor Decision|0|||
127901294|NCT01449630|460262939|FG002|Period 1|Sponsor Decision|0|||
127901295|NCT01449630|460262940|FG003|Period 1|Sponsor Decision|0|||
127901296|NCT01449630|460262941|FG004|Period 1|Sponsor Decision|0|||
127901297|NCT01449630|460262942|FG005|Period 1|Sponsor Decision|1|||
127901298|NCT01449630|460262943|FG006|Period 1|Sponsor Decision|0|||
127901299|NCT01449630|460262944|FG007|Period 1|Sponsor Decision|0|||
127901300|NCT01449630|460262945|FG008|Period 1|Sponsor Decision|0|||
127901301|NCT01449630|460262937|FG000|Period 2|Sponsor Decision|0|||
127901302|NCT01449630|460262938|FG001|Period 2|Sponsor Decision|0|||
127901303|NCT01449630|460262939|FG002|Period 2|Sponsor Decision|0|||
127901304|NCT01449630|460262940|FG003|Period 2|Sponsor Decision|0|||
127901305|NCT01449630|460262941|FG004|Period 2|Sponsor Decision|0|||
127901306|NCT01449630|460262942|FG005|Period 2|Sponsor Decision|0|||
127901307|NCT01449630|460262943|FG006|Period 2|Sponsor Decision|1|||
127901308|NCT01449630|460262944|FG007|Period 2|Sponsor Decision|0|||
127901309|NCT01449630|460262945|FG008|Period 2|Sponsor Decision|0|||
127901310|NCT01735630|460262950|FG000|Overall Study|Adverse Event|8|||
127901311|NCT01735630|460262951|FG001|Overall Study|Adverse Event|7|||
127901312|NCT01735630|460262950|FG000|Overall Study|Lost to Follow-up|1|||
127901313|NCT01735630|460262951|FG001|Overall Study|Lost to Follow-up|0|||
127901314|NCT01735630|460262950|FG000|Overall Study|Physician Decision|0|||
127901315|NCT01735630|460262951|FG001|Overall Study|Physician Decision|1|||
127901316|NCT01735630|460262950|FG000|Overall Study|Sponsor Decision|2|||
127845063|NCT02394795|460048582|FG001|Overall Study|Adverse Event|70|||
127845064|NCT02394795|460048581|FG000|Overall Study|Lost to Follow-up|0|||
127845065|NCT02394795|460048582|FG001|Overall Study|Lost to Follow-up|1|||
127845066|NCT02394795|460048581|FG000|Overall Study|Withdrawal by Subject|17|||
127845067|NCT02394795|460048582|FG001|Overall Study|Withdrawal by Subject|26|||
127845068|NCT02394795|460048581|FG000|Overall Study|Lack of Efficacy|181|||
127845069|NCT02394795|460048582|FG001|Overall Study|Lack of Efficacy|211|||
127845070|NCT02394795|460048581|FG000|Overall Study|Death|4|||
127845071|NCT02394795|460048582|FG001|Overall Study|Death|5|||
127845072|NCT02394795|460048581|FG000|Overall Study|Physician Decision|109|||
127845073|NCT02394795|460048582|FG001|Overall Study|Physician Decision|93|||
127845074|NCT02031432|460048593|FG000|Overall Study|Protocol Violation|1|||
127845075|NCT02031432|460048593|FG000|Overall Study|Lack of Efficacy|5|||
127845076|NCT02031432|460048593|FG000|Overall Study|Cancer Progression|2|||
127845077|NCT02031432|460048593|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
127845078|NCT02031432|460048593|FG000|Overall Study|Adverse Event|8|||
127845079|NCT02031432|460048593|FG000|Overall Study|Withdrawal by Subject|5|||
127845080|NCT02031432|460048593|FG000|Overall Study|Lost to Follow-up|1|||
127901317|NCT01735630|460262951|FG001|Overall Study|Sponsor Decision|1|||
127901318|NCT01735630|460262950|FG000|Overall Study|Withdrawal by Subject|7|||
127901319|NCT01735630|460262951|FG001|Overall Study|Withdrawal by Subject|9|||
127901320|NCT03099538|460262952|FG000|Overall Study|Lack of Efficacy|3|||
127901321|NCT01941030|460262965|FG000|Overall Study|Death|3|||
127901322|NCT01941030|460262966|FG001|Overall Study|Death|2|||
127901323|NCT01941030|460262965|FG000|Overall Study|Lost to Follow-up|6|||
127845081|NCT02031432|460048593|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
127845082|NCT02031432|460048593|FG000|Overall Study|Death|10|||
127845083|NCT01617187|460048594|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
127845084|NCT01617187|460048595|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
127845085|NCT01617187|460048596|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
127845086|NCT01617187|460048597|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
127901324|NCT01941030|460262966|FG001|Overall Study|Lost to Follow-up|5|||
127901325|NCT01941030|460262965|FG000|Overall Study|Withdrawal by Subject|4|||
127901326|NCT01941030|460262966|FG001|Overall Study|Withdrawal by Subject|6|||
127901327|NCT00162123|460262967|FG000|Overall Study|Disease progression|27|||
127901328|NCT00162123|460262968|FG001|Overall Study|Disease progression|19|||
127901329|NCT00162123|460262969|FG002|Overall Study|Disease progression|10|||
127901330|NCT00162123|460262970|FG003|Overall Study|Disease progression|4|||
127901331|NCT00162123|460262971|FG004|Overall Study|Disease progression|8|||
127901332|NCT00162123|460262972|FG005|Overall Study|Disease progression|3|||
127901333|NCT00162123|460262973|FG006|Overall Study|Disease progression|1|||
127901334|NCT00162123|460262974|FG007|Overall Study|Disease progression|0|||
127901335|NCT00162123|460262967|FG000|Overall Study|Study drug toxicity|6|||
127901336|NCT00162123|460262968|FG001|Overall Study|Study drug toxicity|1|||
127901337|NCT00162123|460262969|FG002|Overall Study|Study drug toxicity|5|||
127901338|NCT00162123|460262970|FG003|Overall Study|Study drug toxicity|0|||
127901339|NCT00162123|460262971|FG004|Overall Study|Study drug toxicity|4|||
127901340|NCT00162123|460262972|FG005|Overall Study|Study drug toxicity|1|||
127901341|NCT00162123|460262973|FG006|Overall Study|Study drug toxicity|1|||
127901342|NCT00162123|460262974|FG007|Overall Study|Study drug toxicity|0|||
127901343|NCT00162123|460262967|FG000|Overall Study|Death|3|||
127901344|NCT00162123|460262968|FG001|Overall Study|Death|3|||
127901345|NCT00162123|460262969|FG002|Overall Study|Death|1|||
127901346|NCT00162123|460262970|FG003|Overall Study|Death|1|||
127901347|NCT00162123|460262971|FG004|Overall Study|Death|1|||
127901348|NCT00162123|460262972|FG005|Overall Study|Death|1|||
127901349|NCT00162123|460262973|FG006|Overall Study|Death|0|||
127901350|NCT00162123|460262974|FG007|Overall Study|Death|0|||
127901351|NCT00162123|460262967|FG000|Overall Study|Withdrawal by Subject|2|||
127901352|NCT00162123|460262968|FG001|Overall Study|Withdrawal by Subject|0|||
127901353|NCT00162123|460262969|FG002|Overall Study|Withdrawal by Subject|2|||
127901354|NCT00162123|460262970|FG003|Overall Study|Withdrawal by Subject|1|||
127901355|NCT00162123|460262971|FG004|Overall Study|Withdrawal by Subject|1|||
127901356|NCT00162123|460262972|FG005|Overall Study|Withdrawal by Subject|2|||
127901357|NCT00162123|460262973|FG006|Overall Study|Withdrawal by Subject|1|||
127901358|NCT00162123|460262974|FG007|Overall Study|Withdrawal by Subject|0|||
127901359|NCT00162123|460262967|FG000|Overall Study|Deterioration without progression|2|||
127901360|NCT00162123|460262968|FG001|Overall Study|Deterioration without progression|2|||
127901361|NCT00162123|460262969|FG002|Overall Study|Deterioration without progression|3|||
127901362|NCT00162123|460262970|FG003|Overall Study|Deterioration without progression|0|||
127901363|NCT00162123|460262971|FG004|Overall Study|Deterioration without progression|1|||
127901364|NCT00162123|460262972|FG005|Overall Study|Deterioration without progression|0|||
127901365|NCT00162123|460262973|FG006|Overall Study|Deterioration without progression|0|||
127901366|NCT00162123|460262974|FG007|Overall Study|Deterioration without progression|0|||
127901367|NCT00162123|460262967|FG000|Overall Study|Adverse Event|1|||
127901368|NCT00162123|460262968|FG001|Overall Study|Adverse Event|2|||
127901369|NCT00162123|460262969|FG002|Overall Study|Adverse Event|0|||
127901370|NCT00162123|460262970|FG003|Overall Study|Adverse Event|2|||
127901371|NCT00162123|460262971|FG004|Overall Study|Adverse Event|1|||
127901372|NCT00162123|460262972|FG005|Overall Study|Adverse Event|0|||
127901373|NCT00162123|460262973|FG006|Overall Study|Adverse Event|0|||
127901374|NCT00162123|460262974|FG007|Overall Study|Adverse Event|0|||
127901375|NCT00162123|460262967|FG000|Overall Study|Not specified (before treatment)|2|||
127901376|NCT00162123|460262968|FG001|Overall Study|Not specified (before treatment)|0|||
127901377|NCT00162123|460262969|FG002|Overall Study|Not specified (before treatment)|0|||
127901378|NCT00162123|460262970|FG003|Overall Study|Not specified (before treatment)|0|||
127901379|NCT00162123|460262971|FG004|Overall Study|Not specified (before treatment)|12|||
127901380|NCT00162123|460262972|FG005|Overall Study|Not specified (before treatment)|1|||
127901381|NCT00162123|460262973|FG006|Overall Study|Not specified (before treatment)|0|||
127901382|NCT00162123|460262974|FG007|Overall Study|Not specified (before treatment)|0|||
127901383|NCT00162123|460262967|FG000|Overall Study|Not specified (after start of treatment)|0|||
127901384|NCT00162123|460262968|FG001|Overall Study|Not specified (after start of treatment)|0|||
127901385|NCT00162123|460262969|FG002|Overall Study|Not specified (after start of treatment)|0|||
127901386|NCT00162123|460262970|FG003|Overall Study|Not specified (after start of treatment)|0|||
127901387|NCT00162123|460262971|FG004|Overall Study|Not specified (after start of treatment)|3|||
127901388|NCT00162123|460262972|FG005|Overall Study|Not specified (after start of treatment)|0|||
127901389|NCT00162123|460262973|FG006|Overall Study|Not specified (after start of treatment)|0|||
127901390|NCT00162123|460262974|FG007|Overall Study|Not specified (after start of treatment)|0|||
127901391|NCT00162123|460262967|FG000|Overall Study|Physician Decision|1|||
127901392|NCT00162123|460262968|FG001|Overall Study|Physician Decision|2|||
127901393|NCT00162123|460262969|FG002|Overall Study|Physician Decision|0|||
127901394|NCT00162123|460262970|FG003|Overall Study|Physician Decision|0|||
127901395|NCT00162123|460262971|FG004|Overall Study|Physician Decision|0|||
127901396|NCT00162123|460262972|FG005|Overall Study|Physician Decision|1|||
127901397|NCT00162123|460262973|FG006|Overall Study|Physician Decision|1|||
127901398|NCT00162123|460262974|FG007|Overall Study|Physician Decision|0|||
127901399|NCT00162123|460262967|FG000|Overall Study|Tumor assessment only (not treated)|0|||
127901400|NCT00162123|460262968|FG001|Overall Study|Tumor assessment only (not treated)|0|||
127901401|NCT00162123|460262969|FG002|Overall Study|Tumor assessment only (not treated)|0|||
127901402|NCT00162123|460262970|FG003|Overall Study|Tumor assessment only (not treated)|0|||
127901403|NCT00162123|460262971|FG004|Overall Study|Tumor assessment only (not treated)|0|||
127845087|NCT01617187|460048594|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
127845088|NCT01617187|460048595|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
127845089|NCT01617187|460048596|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
127845090|NCT01617187|460048597|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
127901404|NCT00162123|460262972|FG005|Overall Study|Tumor assessment only (not treated)|0|||
127901405|NCT00162123|460262973|FG006|Overall Study|Tumor assessment only (not treated)|0|||
127901406|NCT00162123|460262974|FG007|Overall Study|Tumor assessment only (not treated)|1|||
127901407|NCT00162123|460262967|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
127901408|NCT00162123|460262968|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
127901409|NCT00162123|460262969|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
127901410|NCT00162123|460262970|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
127901411|NCT00162123|460262971|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
127901412|NCT00162123|460262972|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
127901413|NCT00162123|460262973|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
127901414|NCT00162123|460262974|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
127901415|NCT02930005|460262975|FG000|Overall Study|Lost to Follow-up|1|||
127901416|NCT02930005|460262976|FG001|Overall Study|Lost to Follow-up|5|||
127901417|NCT00822926|460262981|FG000|Second Injection Visit|Lost to Follow-up|1|||
127901418|NCT00822926|460262982|FG001|Second Injection Visit|Lost to Follow-up|0|||
127901419|NCT00822926|460262981|FG000|Second Injection Visit|Withdrawal by Subject|0|||
127901420|NCT00822926|460262982|FG001|Second Injection Visit|Withdrawal by Subject|1|||
127901421|NCT03991494|460262989|FG000|Overall Study|Progressive Disease|4|||
127901422|NCT02534493|460262995|FG000|Overall Study|Lost to Follow-up|1|||
127901423|NCT02534493|460262995|FG000|Overall Study|Withdrawal by Subject|1|||
127901424|NCT01469546|460263000|FG000|Received 5 mg Dose|Adverse Event|13|||
127901425|NCT01469546|460263000|FG000|Received 5 mg Dose|Death|2|||
127901426|NCT01469546|460263000|FG000|Received 5 mg Dose|Protocol Violation|2|||
127901427|NCT01469546|460263000|FG000|Received 5 mg Dose|Progressive Disease|3|||
127901428|NCT01469546|460263000|FG000|Received 5 mg Dose|Physician Decision|3|||
127901429|NCT01101022|460265028|FG000|Overall Study|Adverse Event|6|||
127901430|NCT01101022|460265029|FG001|Overall Study|Adverse Event|2|||
127901431|NCT01101022|460265028|FG000|Overall Study|Protocol Violation|4|||
127901432|NCT01101022|460265029|FG001|Overall Study|Protocol Violation|3|||
127845091|NCT01617187|460048594|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
127845092|NCT01617187|460048595|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
127845093|NCT01617187|460048596|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
127845094|NCT01617187|460048597|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
127845095|NCT01617187|460048594|FG000|Treatment Through Study Completion|Adverse Event|1|||
127845096|NCT01617187|460048595|FG001|Treatment Through Study Completion|Adverse Event|1|||
127845097|NCT01617187|460048596|FG002|Treatment Through Study Completion|Adverse Event|0|||
127845098|NCT01617187|460048597|FG003|Treatment Through Study Completion|Adverse Event|1|||
127845099|NCT01617187|460048594|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
127845100|NCT01617187|460048595|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
127845101|NCT01617187|460048596|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
127845102|NCT01617187|460048597|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
127845103|NCT01617187|460048594|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
127845104|NCT01617187|460048595|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
127845105|NCT01617187|460048596|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
127845106|NCT01617187|460048597|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
127845107|NCT01617187|460048594|FG000|Treatment Through Study Completion|Protocol Violation|1|||
127845108|NCT01617187|460048595|FG001|Treatment Through Study Completion|Protocol Violation|0|||
127845109|NCT01617187|460048596|FG002|Treatment Through Study Completion|Protocol Violation|0|||
127845110|NCT01617187|460048597|FG003|Treatment Through Study Completion|Protocol Violation|1|||
127845111|NCT03862131|460048601|FG000|Overall Study|Lost to Follow-up|1|||
127845112|NCT03862131|460048602|FG001|Overall Study|Lost to Follow-up|0|||
127845113|NCT03862131|460048603|FG002|Overall Study|Lost to Follow-up|1|||
127845114|NCT03862131|460048601|FG000|Overall Study|Determined to be ineligible|0|||
127845115|NCT03862131|460048602|FG001|Overall Study|Determined to be ineligible|0|||
127845116|NCT03862131|460048603|FG002|Overall Study|Determined to be ineligible|5|||
127845117|NCT03862131|460048601|FG000|Overall Study|Death|4|||
127901433|NCT01101022|460265028|FG000|Overall Study|Withdrawal by Subject|3|||
127901434|NCT01101022|460265029|FG001|Overall Study|Withdrawal by Subject|8|||
127901435|NCT01101022|460265028|FG000|Overall Study|Lost to Follow-up|1|||
127901436|NCT01101022|460265029|FG001|Overall Study|Lost to Follow-up|4|||
127901437|NCT01101022|460265028|FG000|Overall Study|Lack of Efficacy|0|||
127901438|NCT01101022|460265029|FG001|Overall Study|Lack of Efficacy|7|||
127901439|NCT01101022|460265028|FG000|Overall Study|Sponsor decision|1|||
127845118|NCT03862131|460048602|FG001|Overall Study|Death|4|||
127845119|NCT03862131|460048603|FG002|Overall Study|Death|0|||
127845120|NCT03862131|460048601|FG000|Overall Study|Withdrawal by Subject|5|||
127845121|NCT03862131|460048602|FG001|Overall Study|Withdrawal by Subject|3|||
127845122|NCT03862131|460048603|FG002|Overall Study|Withdrawal by Subject|0|||
127845123|NCT03862131|460048601|FG000|Overall Study|Physician Decision|0|||
127845124|NCT03862131|460048602|FG001|Overall Study|Physician Decision|1|||
127845125|NCT03862131|460048603|FG002|Overall Study|Physician Decision|0|||
127845126|NCT02293902|460048604|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
127845127|NCT02293902|460048605|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
127845128|NCT02293902|460048606|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
127845129|NCT02293902|460048607|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
127845130|NCT02293902|460048608|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
127845131|NCT02293902|460048604|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
127845132|NCT02293902|460048605|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
127845133|NCT02293902|460048606|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
127845134|NCT02293902|460048607|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
127845135|NCT02293902|460048608|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
127845136|NCT02293902|460048604|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
127845137|NCT02293902|460048605|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
127845138|NCT02293902|460048606|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
127845139|NCT02293902|460048607|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
127845140|NCT02293902|460048608|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
127845141|NCT02293902|460048604|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
127845142|NCT02293902|460048605|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
127845143|NCT02293902|460048606|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
127845144|NCT02293902|460048607|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
127845145|NCT02293902|460048608|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
127845146|NCT02293902|460048604|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
127845147|NCT02293902|460048605|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
127845148|NCT02293902|460048606|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
127845149|NCT02293902|460048607|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
127845150|NCT02293902|460048608|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
127845151|NCT02947022|460048609|FG000|Overall Study|Study Stopped|1|||
127845152|NCT05742841|460050343|FG000|Overall Study|Withdrawal by Subject|1|||
127845153|NCT05742841|460050343|FG000|Overall Study|Lost to Follow-up|1|||
127845154|NCT04671342|460050349|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
127845155|NCT04671342|460050349|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
127845156|NCT04671342|460050349|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
127845157|NCT04671342|460050349|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
127845158|NCT04671342|460050349|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
127845159|NCT04671342|460050349|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
127845160|NCT02273037|460050350|FG000|Overall Study|Lost to Follow-up|1|||
127845161|NCT02273037|460050351|FG001|Overall Study|Lost to Follow-up|0|||
127901440|NCT01101022|460265029|FG001|Overall Study|Sponsor decision|1|||
127901441|NCT01101022|460265028|FG000|Overall Study|Non-compliance|1|||
127901442|NCT01101022|460265029|FG001|Overall Study|Non-compliance|0|||
127901443|NCT01101022|460265028|FG000|Overall Study|Work schedule|1|||
127901444|NCT01101022|460265029|FG001|Overall Study|Work schedule|1|||
127901445|NCT01101022|460265028|FG000|Overall Study|Vacation|0|||
127901446|NCT01101022|460265029|FG001|Overall Study|Vacation|1|||
127901447|NCT01519661|460265030|FG000|Overall Study|Protocol deviation|6|||
127901448|NCT01519661|460265030|FG000|Overall Study|Lost to Follow-up|3|||
127901449|NCT01519661|460265030|FG000|Overall Study|Withdrawal by Subject|17|||
127901450|NCT01519661|460265030|FG000|Overall Study|Lack of Efficacy|6|||
127901451|NCT01519661|460265030|FG000|Overall Study|Adverse Event|29|||
127901452|NCT01139047|460265031|FG000|Overall Study|Withdrawal by Subject|1|||
127901453|NCT01941095|460265032|FG000|Overall Study|Insufficient therapeutic response|13|||
127901454|NCT01941095|460265032|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
127901455|NCT01941095|460265032|FG000|Overall Study|Adverse Event|11|||
127901456|NCT01941095|460265032|FG000|Overall Study|Physician Decision|3|||
127845162|NCT02273037|460050350|FG000|Overall Study|Delivered before monitoring initiated|1|||
127845163|NCT02273037|460050351|FG001|Overall Study|Delivered before monitoring initiated|3|||
127845164|NCT02273037|460050350|FG000|Overall Study|Breech delivery|2|||
127901457|NCT01941095|460265032|FG000|Overall Study|Withdrawal by Subject|17|||
127901458|NCT01941095|460265032|FG000|Overall Study|Lost to Follow-up|10|||
127901459|NCT02918877|460265035|FG000|Overall Study|Withdrawal by Subject|2|||
127901460|NCT02918877|460265036|FG001|Overall Study|Withdrawal by Subject|2|||
127901461|NCT02918877|460265035|FG000|Overall Study|Surgery cancelled|1|||
127901462|NCT02918877|460265036|FG001|Overall Study|Surgery cancelled|0|||
127845165|NCT02273037|460050351|FG001|Overall Study|Breech delivery|3|||
127845166|NCT02273037|460050350|FG000|Overall Study|Multiple delivery|2|||
127845167|NCT02273037|460050351|FG001|Overall Study|Multiple delivery|2|||
127845168|NCT02273037|460050350|FG000|Overall Study|Other complication|2|||
127845169|NCT02273037|460050351|FG001|Overall Study|Other complication|0|||
127901463|NCT02918877|460265035|FG000|Overall Study|Physician Decision|1|||
127845170|NCT03351478|460050354|FG000|Overall Study|At the subject's own request|11|||
127845171|NCT03351478|460050355|FG001|Overall Study|At the subject's own request|12|||
127845172|NCT03351478|460050356|FG002|Overall Study|At the subject's own request|5|||
127845173|NCT03351478|460050354|FG000|Overall Study|Adverse Event|1|||
127845174|NCT03351478|460050355|FG001|Overall Study|Adverse Event|2|||
127845175|NCT03351478|460050356|FG002|Overall Study|Adverse Event|1|||
127845176|NCT03351478|460050354|FG000|Overall Study|Poor compliance to protocol|1|||
127845177|NCT03351478|460050355|FG001|Overall Study|Poor compliance to protocol|0|||
127845178|NCT03351478|460050356|FG002|Overall Study|Poor compliance to protocol|0|||
127845179|NCT03351478|460050354|FG000|Overall Study|Reason not Specified|1|||
127845180|NCT03351478|460050355|FG001|Overall Study|Reason not Specified|3|||
127845181|NCT03351478|460050356|FG002|Overall Study|Reason not Specified|0|||
127845182|NCT03351478|460050354|FG000|Overall Study|Lost to Follow-up|0|||
127845183|NCT03351478|460050355|FG001|Overall Study|Lost to Follow-up|0|||
127845184|NCT03351478|460050356|FG002|Overall Study|Lost to Follow-up|1|||
127845185|NCT00510484|460050358|FG000|Wash-out Period|Adverse Event|0|||
127845186|NCT00510484|460050359|FG001|Wash-out Period|Adverse Event|1|||
127845187|NCT00762268|460050362|FG000|Overall Study|Withdrawal by Subject|3|||
127845188|NCT00762268|460050363|FG001|Overall Study|Withdrawal by Subject|3|||
127845189|NCT02533401|460050366|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
127845190|NCT02533401|460050366|FG000|Overall Study|Death|5|||
127845191|NCT02533401|460050366|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
127845192|NCT02533401|460050366|FG000|Overall Study|Lost to Follow-up|1|||
127845193|NCT02533401|460050366|FG000|Overall Study|Violation of Selection Criteria|1|||
127845194|NCT01438307|460050375|FG000|Overall Study|Death|1|||
127845195|NCT01438307|460050376|FG001|Overall Study|Death|1|||
127845196|NCT00973622|460050378|FG000|Overall Study|did not attend MRI|14|||
127845197|NCT00973622|460050379|FG001|Overall Study|did not attend MRI|3|||
127845198|NCT00973622|460050378|FG000|Overall Study|did not pass MRI screen|6|||
127845199|NCT00973622|460050379|FG001|Overall Study|did not pass MRI screen|0|||
127845200|NCT00973622|460050378|FG000|Overall Study|did not complete rTMS sessions|11|||
127845201|NCT00973622|460050379|FG001|Overall Study|did not complete rTMS sessions|2|||
127845202|NCT03814005|460050385|FG000|Part B: Day 8 to Day 343|Adverse Event|2|||
127845203|NCT03814005|460050386|FG001|Part B: Day 8 to Day 343|Adverse Event|0|||
127845204|NCT03814005|460050387|FG002|Part B: Day 8 to Day 343|Adverse Event|0|||
127845205|NCT03814005|460050385|FG000|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
127845206|NCT03814005|460050386|FG001|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
127845207|NCT03814005|460050387|FG002|Part B: Day 8 to Day 343|Withdrawal by Subject|3|||
127845208|NCT03814005|460050385|FG000|Part B: Day 8 to Day 343|Progressive Disease|4|||
127845209|NCT03814005|460050386|FG001|Part B: Day 8 to Day 343|Progressive Disease|2|||
127845210|NCT03814005|460050387|FG002|Part B: Day 8 to Day 343|Progressive Disease|0|||
127845211|NCT03814005|460050385|FG000|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|2|||
127845212|NCT03814005|460050386|FG001|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
127845213|NCT03814005|460050387|FG002|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
127845214|NCT03814005|460050385|FG000|Part B: Day 8 to Day 343|Symptomatic Deterioration|1|||
127845215|NCT03814005|460050386|FG001|Part B: Day 8 to Day 343|Symptomatic Deterioration|2|||
127845216|NCT03814005|460050387|FG002|Part B: Day 8 to Day 343|Symptomatic Deterioration|0|||
127845217|NCT03814005|460050385|FG000|Part B: Day 8 to Day 343|Reason not Specified|1|||
127845218|NCT03814005|460050386|FG001|Part B: Day 8 to Day 343|Reason not Specified|0|||
127845219|NCT03814005|460050387|FG002|Part B: Day 8 to Day 343|Reason not Specified|0|||
127845220|NCT03395223|460050388|FG000|Overall Study|Lost to Follow-up|3|||
127845221|NCT03395223|460050388|FG000|Overall Study|Other|1|||
127845222|NCT01855945|460050394|FG000|Overall Study|Adverse Event|0|||
127845223|NCT01855945|460050395|FG001|Overall Study|Adverse Event|0|||
127845224|NCT01855945|460050396|FG002|Overall Study|Adverse Event|0|||
127845225|NCT01855945|460050397|FG003|Overall Study|Adverse Event|0|||
127845226|NCT01855945|460050398|FG004|Overall Study|Adverse Event|0|||
127845227|NCT01855945|460050399|FG005|Overall Study|Adverse Event|0|||
127845228|NCT01855945|460050400|FG006|Overall Study|Adverse Event|1|||
127845229|NCT01855945|460050401|FG007|Overall Study|Adverse Event|0|||
127845230|NCT01855945|460050402|FG008|Overall Study|Adverse Event|0|||
127845231|NCT01855945|460050403|FG009|Overall Study|Adverse Event|0|||
127845232|NCT01855945|460050404|FG010|Overall Study|Adverse Event|0|||
127845233|NCT01855945|460050405|FG011|Overall Study|Adverse Event|0|||
127845234|NCT01855945|460050394|FG000|Overall Study|Death|0|||
127845235|NCT01855945|460050395|FG001|Overall Study|Death|0|||
127845236|NCT01855945|460050396|FG002|Overall Study|Death|0|||
127845237|NCT01855945|460050397|FG003|Overall Study|Death|0|||
127845238|NCT01855945|460050398|FG004|Overall Study|Death|0|||
127845239|NCT01855945|460050399|FG005|Overall Study|Death|0|||
127845240|NCT01855945|460050400|FG006|Overall Study|Death|2|||
127845241|NCT01855945|460050401|FG007|Overall Study|Death|0|||
127845242|NCT01855945|460050402|FG008|Overall Study|Death|0|||
127845243|NCT01855945|460050403|FG009|Overall Study|Death|0|||
127845244|NCT01855945|460050404|FG010|Overall Study|Death|0|||
127845245|NCT01855945|460050405|FG011|Overall Study|Death|0|||
127901464|NCT02918877|460265036|FG001|Overall Study|Physician Decision|0|||
127845246|NCT01855945|460050394|FG000|Overall Study|Lost to Follow-up|11|||
127845247|NCT01855945|460050395|FG001|Overall Study|Lost to Follow-up|10|||
127845248|NCT01855945|460050396|FG002|Overall Study|Lost to Follow-up|7|||
127845249|NCT01855945|460050397|FG003|Overall Study|Lost to Follow-up|3|||
127845250|NCT01855945|460050398|FG004|Overall Study|Lost to Follow-up|0|||
127845251|NCT01855945|460050399|FG005|Overall Study|Lost to Follow-up|3|||
127845252|NCT01855945|460050400|FG006|Overall Study|Lost to Follow-up|4|||
127845253|NCT01855945|460050401|FG007|Overall Study|Lost to Follow-up|7|||
127845254|NCT01855945|460050402|FG008|Overall Study|Lost to Follow-up|2|||
127845255|NCT01855945|460050403|FG009|Overall Study|Lost to Follow-up|0|||
127845256|NCT01855945|460050404|FG010|Overall Study|Lost to Follow-up|0|||
127845257|NCT01855945|460050405|FG011|Overall Study|Lost to Follow-up|2|||
127845258|NCT01855945|460050394|FG000|Overall Study|Other - Unclassified|1|||
127845259|NCT01855945|460050395|FG001|Overall Study|Other - Unclassified|1|||
127845260|NCT01855945|460050396|FG002|Overall Study|Other - Unclassified|1|||
127845261|NCT01855945|460050397|FG003|Overall Study|Other - Unclassified|0|||
127845262|NCT01855945|460050398|FG004|Overall Study|Other - Unclassified|0|||
127845263|NCT01855945|460050399|FG005|Overall Study|Other - Unclassified|0|||
127845264|NCT01855945|460050400|FG006|Overall Study|Other - Unclassified|2|||
127845265|NCT01855945|460050401|FG007|Overall Study|Other - Unclassified|1|||
127845266|NCT01855945|460050402|FG008|Overall Study|Other - Unclassified|0|||
127845267|NCT01855945|460050403|FG009|Overall Study|Other - Unclassified|0|||
127845268|NCT01855945|460050404|FG010|Overall Study|Other - Unclassified|1|||
127845269|NCT01855945|460050405|FG011|Overall Study|Other - Unclassified|0|||
127845270|NCT01855945|460050394|FG000|Overall Study|Withdrawal by Subject|4|||
127845271|NCT01855945|460050395|FG001|Overall Study|Withdrawal by Subject|0|||
127845272|NCT01855945|460050396|FG002|Overall Study|Withdrawal by Subject|4|||
127845273|NCT01855945|460050397|FG003|Overall Study|Withdrawal by Subject|1|||
127845274|NCT01855945|460050398|FG004|Overall Study|Withdrawal by Subject|1|||
127845275|NCT01855945|460050399|FG005|Overall Study|Withdrawal by Subject|0|||
127845276|NCT01855945|460050400|FG006|Overall Study|Withdrawal by Subject|1|||
127845277|NCT01855945|460050401|FG007|Overall Study|Withdrawal by Subject|0|||
127845278|NCT01855945|460050402|FG008|Overall Study|Withdrawal by Subject|0|||
127845279|NCT01855945|460050403|FG009|Overall Study|Withdrawal by Subject|2|||
127845280|NCT01855945|460050404|FG010|Overall Study|Withdrawal by Subject|4|||
127845281|NCT01855945|460050405|FG011|Overall Study|Withdrawal by Subject|1|||
127845282|NCT01135017|460050406|FG000|Overall Study|Adverse Event|3|||
127845283|NCT01135017|460050407|FG001|Overall Study|Adverse Event|8|||
127845284|NCT01135017|460050406|FG000|Overall Study|Other than above|3|||
127845285|NCT01135017|460050407|FG001|Overall Study|Other than above|4|||
127845286|NCT01148693|460050408|FG000|Overall Study|Attempts for cannulation were failed|13|||
127845287|NCT01148693|460050409|FG001|Overall Study|Attempts for cannulation were failed|10|||
127845288|NCT01074658|460050411|FG000|Overall Study|No implant attempted|19|||
127845289|NCT01342952|460050412|FG000|Overall Study|Adverse Event|0|||
127845290|NCT01342952|460050413|FG001|Overall Study|Adverse Event|5|||
127845291|NCT01342952|460050414|FG002|Overall Study|Adverse Event|1|||
127845292|NCT01342952|460050415|FG003|Overall Study|Adverse Event|0|||
127845293|NCT01342952|460050412|FG000|Overall Study|Lost to Follow-up|0|||
127845294|NCT01342952|460050413|FG001|Overall Study|Lost to Follow-up|2|||
127845295|NCT01342952|460050414|FG002|Overall Study|Lost to Follow-up|0|||
127845296|NCT01342952|460050415|FG003|Overall Study|Lost to Follow-up|0|||
127845297|NCT01342952|460050412|FG000|Overall Study|Withdrawal by Subject|1|||
127845298|NCT01342952|460050413|FG001|Overall Study|Withdrawal by Subject|1|||
127845299|NCT01342952|460050414|FG002|Overall Study|Withdrawal by Subject|0|||
127845300|NCT01342952|460050415|FG003|Overall Study|Withdrawal by Subject|0|||
127845301|NCT01342952|460050412|FG000|Overall Study|Physician Decision|3|||
127845302|NCT01342952|460050413|FG001|Overall Study|Physician Decision|3|||
127845303|NCT01342952|460050414|FG002|Overall Study|Physician Decision|1|||
127845304|NCT01342952|460050415|FG003|Overall Study|Physician Decision|0|||
127845305|NCT02156804|460050416|FG000|Overall Study|Withdrawal by Subject|1|||
127845306|NCT03228394|460050417|FG000|Overall Study|Lost to Follow-up|0|||
127845307|NCT03228394|460050418|FG001|Overall Study|Lost to Follow-up|0|||
127845308|NCT03228394|460050419|FG002|Overall Study|Lost to Follow-up|1|||
127845309|NCT03228394|460050420|FG003|Overall Study|Lost to Follow-up|1|||
127845310|NCT03228394|460050421|FG004|Overall Study|Lost to Follow-up|0|||
127845311|NCT03228394|460050422|FG005|Overall Study|Lost to Follow-up|0|||
127845312|NCT03228394|460050423|FG006|Overall Study|Lost to Follow-up|2|||
127845313|NCT03228394|460050424|FG007|Overall Study|Lost to Follow-up|0|||
127845314|NCT03228394|460050417|FG000|Overall Study|Withdrawal by Subject|0|||
127845315|NCT03228394|460050418|FG001|Overall Study|Withdrawal by Subject|0|||
127845316|NCT03228394|460050419|FG002|Overall Study|Withdrawal by Subject|1|||
127845317|NCT03228394|460050420|FG003|Overall Study|Withdrawal by Subject|0|||
127845318|NCT03228394|460050421|FG004|Overall Study|Withdrawal by Subject|0|||
127845319|NCT03228394|460050422|FG005|Overall Study|Withdrawal by Subject|0|||
127845320|NCT03228394|460050423|FG006|Overall Study|Withdrawal by Subject|1|||
127845321|NCT03228394|460050424|FG007|Overall Study|Withdrawal by Subject|3|||
127845322|NCT03228394|460050417|FG000|Overall Study|Protocol Violation|0|||
127845323|NCT03228394|460050418|FG001|Overall Study|Protocol Violation|0|||
127845324|NCT03228394|460050419|FG002|Overall Study|Protocol Violation|0|||
127845325|NCT03228394|460050420|FG003|Overall Study|Protocol Violation|1|||
127845326|NCT03228394|460050421|FG004|Overall Study|Protocol Violation|0|||
127845327|NCT03228394|460050422|FG005|Overall Study|Protocol Violation|0|||
127845328|NCT03228394|460050423|FG006|Overall Study|Protocol Violation|0|||
127845329|NCT03228394|460050424|FG007|Overall Study|Protocol Violation|0|||
127845330|NCT03228394|460050417|FG000|Overall Study|Physician Decision|0|||
127845331|NCT03228394|460050418|FG001|Overall Study|Physician Decision|0|||
127845332|NCT03228394|460050419|FG002|Overall Study|Physician Decision|0|||
127845333|NCT03228394|460050420|FG003|Overall Study|Physician Decision|0|||
127845334|NCT03228394|460050421|FG004|Overall Study|Physician Decision|0|||
127845335|NCT03228394|460050422|FG005|Overall Study|Physician Decision|0|||
127845336|NCT03228394|460050423|FG006|Overall Study|Physician Decision|1|||
127845337|NCT03228394|460050424|FG007|Overall Study|Physician Decision|0|||
127845338|NCT03228394|460050417|FG000|Overall Study|Noncompliance|0|||
127845339|NCT03228394|460050418|FG001|Overall Study|Noncompliance|0|||
127845340|NCT03228394|460050419|FG002|Overall Study|Noncompliance|0|||
127845341|NCT03228394|460050420|FG003|Overall Study|Noncompliance|0|||
127845342|NCT03228394|460050421|FG004|Overall Study|Noncompliance|0|||
127845343|NCT03228394|460050422|FG005|Overall Study|Noncompliance|0|||
127845344|NCT03228394|460050423|FG006|Overall Study|Noncompliance|1|||
127845345|NCT03228394|460050424|FG007|Overall Study|Noncompliance|0|||
127845346|NCT04581863|460050425|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
127845347|NCT04581863|460050426|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
127845348|NCT01803711|460050431|FG000|Overall Study|Adverse Event|1|||
127845349|NCT01803711|460050432|FG001|Overall Study|Adverse Event|1|||
127845350|NCT01170221|460050436|FG000|Overall Study|Lost to Follow-up|22|||
127845351|NCT01170221|460050437|FG001|Overall Study|Lost to Follow-up|21|||
127845352|NCT01170221|460050436|FG000|Overall Study|Withdrawal by Subject|9|||
127845353|NCT01170221|460050437|FG001|Overall Study|Withdrawal by Subject|7|||
127845354|NCT01170221|460050436|FG000|Overall Study|Subject completed only screening and LFU|1|||
127845355|NCT01170221|460050437|FG001|Overall Study|Subject completed only screening and LFU|0|||
127845356|NCT01170221|460050436|FG000|Overall Study|Randomized but not treated|1|||
127845357|NCT01170221|460050437|FG001|Overall Study|Randomized but not treated|0|||
127845358|NCT00432562|460050438|FG000|Overall Study|Death|3|||
127845359|NCT00432562|460050439|FG001|Overall Study|Death|0|||
127845360|NCT02693691|460050440|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
127845361|NCT02693691|460050440|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
127845362|NCT02693691|460050440|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
127845363|NCT02693691|460050440|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
127845364|NCT02693691|460050440|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
127845365|NCT02693691|460050440|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
127845366|NCT02693691|460050440|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
127845367|NCT01162304|460050443|FG000|Overall Study|Beck scale to high|11|||
127845368|NCT02247401|460050444|FG000|Overall Study|Adverse Event|1|||
127845369|NCT02247401|460050445|FG001|Overall Study|Adverse Event|0|||
127845370|NCT02247401|460050446|FG002|Overall Study|Adverse Event|0|||
127845371|NCT02247401|460050444|FG000|Overall Study|Withdrawal by Subject|4|||
127845372|NCT02247401|460050445|FG001|Overall Study|Withdrawal by Subject|1|||
127845373|NCT02247401|460050446|FG002|Overall Study|Withdrawal by Subject|1|||
127845374|NCT02247401|460050444|FG000|Overall Study|Lost to Follow-up|1|||
127845375|NCT02247401|460050445|FG001|Overall Study|Lost to Follow-up|1|||
127845376|NCT02247401|460050446|FG002|Overall Study|Lost to Follow-up|1|||
127901465|NCT02918877|460265035|FG000|Overall Study|Received intraoperative steroids|1|||
127901466|NCT02918877|460265036|FG001|Overall Study|Received intraoperative steroids|0|||
127901467|NCT02918877|460265035|FG000|Overall Study|Unable to obtain lab samples|1|||
127901468|NCT02918877|460265036|FG001|Overall Study|Unable to obtain lab samples|0|||
127845377|NCT04377672|460050447|FG000|Overall Study|Participants was withdrawn from study due to false positive COVID-19 test|1|||
127845378|NCT03954444|460050448|FG000|Overall Study|Withdrawal by Subject|5|||
127845379|NCT03954444|460050449|FG001|Overall Study|Withdrawal by Subject|5|||
127845380|NCT03954444|460050450|FG002|Overall Study|Withdrawal by Subject|5|||
127845381|NCT03954444|460050448|FG000|Overall Study|Adverse Event|1|||
127845382|NCT03954444|460050449|FG001|Overall Study|Adverse Event|3|||
127845383|NCT03954444|460050450|FG002|Overall Study|Adverse Event|2|||
127845384|NCT03954444|460050448|FG000|Overall Study|Protocol Violation|0|||
127845385|NCT03954444|460050449|FG001|Overall Study|Protocol Violation|3|||
127845386|NCT03954444|460050450|FG002|Overall Study|Protocol Violation|5|||
127845387|NCT03954444|460050448|FG000|Overall Study|Use of prohibited therapy|1|||
127845388|NCT03954444|460050449|FG001|Overall Study|Use of prohibited therapy|1|||
127845389|NCT03954444|460050450|FG002|Overall Study|Use of prohibited therapy|2|||
127845390|NCT03954444|460050448|FG000|Overall Study|Lost to Follow-up|1|||
127845391|NCT03954444|460050449|FG001|Overall Study|Lost to Follow-up|0|||
127845392|NCT03954444|460050450|FG002|Overall Study|Lost to Follow-up|1|||
127845393|NCT03954444|460050448|FG000|Overall Study|Non-compliant with study drug application|2|||
127845394|NCT03954444|460050449|FG001|Overall Study|Non-compliant with study drug application|2|||
127845395|NCT03954444|460050450|FG002|Overall Study|Non-compliant with study drug application|0|||
127845396|NCT03954444|460050448|FG000|Overall Study|Administrative reasons|0|||
127845397|NCT03954444|460050449|FG001|Overall Study|Administrative reasons|0|||
127845398|NCT03954444|460050450|FG002|Overall Study|Administrative reasons|1|||
127845399|NCT03954444|460050448|FG000|Overall Study|Miscellaneous|3|||
127845400|NCT03954444|460050449|FG001|Overall Study|Miscellaneous|2|||
127845401|NCT03954444|460050450|FG002|Overall Study|Miscellaneous|1|||
127845402|NCT02447458|460050451|FG000|Overall Study|Other|0|||
127845403|NCT02447458|460050452|FG001|Overall Study|Other|0|||
127845404|NCT02447458|460050453|FG002|Overall Study|Other|1|||
127845405|NCT02447458|460050454|FG003|Overall Study|Other|0|||
127845406|NCT02447458|460050455|FG004|Overall Study|Other|0|||
127845407|NCT02447458|460050456|FG005|Overall Study|Other|0|||
127845408|NCT02133742|460050457|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
127845409|NCT02133742|460050457|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
127845410|NCT02133742|460050457|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
127845411|NCT02133742|460050457|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
127845412|NCT02133742|460050457|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
127845413|NCT03505749|460050459|FG000|Overall Study|Lost to Follow-up|7|||
127845414|NCT03505749|460050460|FG001|Overall Study|Lost to Follow-up|11|||
127845415|NCT03505749|460050459|FG000|Overall Study|Withdrawal by Subject|6|||
127845416|NCT03505749|460050460|FG001|Overall Study|Withdrawal by Subject|0|||
127845417|NCT03505749|460050459|FG000|Overall Study|Discharged from treatment|3|||
127845418|NCT03505749|460050460|FG001|Overall Study|Discharged from treatment|6|||
127845419|NCT01688635|460050461|FG000|Washout 1|Withdrawal by Subject|1|||
127845420|NCT01688635|460050462|FG001|Washout 1|Withdrawal by Subject|0|||
127845421|NCT01688635|460050461|FG000|Washout 1|Adverse Event|0|||
127845422|NCT01688635|460050462|FG001|Washout 1|Adverse Event|1|||
127845423|NCT01688635|460050461|FG000|Washout 1|Physician Decision|0|||
127845424|NCT01688635|460050462|FG001|Washout 1|Physician Decision|1|||
127845425|NCT01688635|460050461|FG000|Washout 2|Physician Decision|1|||
127845426|NCT01688635|460050462|FG001|Washout 2|Physician Decision|0|||
127845427|NCT01688635|460050461|FG000|Washout 2|Withdrawal by Subject|1|||
127845428|NCT01688635|460050462|FG001|Washout 2|Withdrawal by Subject|0|||
127845429|NCT01688635|460050461|FG000|Washout 2|Sponsor Decision|1|||
127845430|NCT01688635|460050462|FG001|Washout 2|Sponsor Decision|2|||
127845431|NCT01688635|460050461|FG000|Washout 3|Withdrawal by Subject|1|||
127845432|NCT01688635|460050462|FG001|Washout 3|Withdrawal by Subject|0|||
127845433|NCT03549117|460050466|FG000|Overall Study|Withdrawal by Subject|1|||
127845434|NCT03549117|460050467|FG001|Overall Study|Withdrawal by Subject|0|||
127845435|NCT00888615|460050469|FG000|Overall Study|No treatment|2|||
127845436|NCT02091921|460050472|FG000|Overall Study|Adverse Event|3|||
127845437|NCT03307629|460050473|FG000|Overall Study|Withdrawal by Subject|0|||
127845438|NCT03307629|460050474|FG001|Overall Study|Withdrawal by Subject|0|||
127845439|NCT03307629|460050475|FG002|Overall Study|Withdrawal by Subject|0|||
127845440|NCT03307629|460050476|FG003|Overall Study|Withdrawal by Subject|2|||
127845441|NCT03307629|460050473|FG000|Overall Study|Disease Progression|0|||
127845442|NCT03307629|460050474|FG001|Overall Study|Disease Progression|0|||
127845443|NCT03307629|460050475|FG002|Overall Study|Disease Progression|0|||
127845444|NCT03307629|460050476|FG003|Overall Study|Disease Progression|3|||
127845445|NCT03307629|460050473|FG000|Overall Study|Death|0|||
127845446|NCT03307629|460050474|FG001|Overall Study|Death|3|||
127845447|NCT03307629|460050475|FG002|Overall Study|Death|0|||
127845448|NCT03307629|460050476|FG003|Overall Study|Death|1|||
127845449|NCT00719953|460050481|FG000|Overall Study|Adverse Event|4|||
127845450|NCT01626989|460050482|FG000|Screening Period|Screen Failure|15|||
127845451|NCT01626989|460050483|FG001|Screening Period|Screen Failure|0|||
127845452|NCT01626989|460050484|FG002|Screening Period|Screen Failure|0|||
127845453|NCT01626989|460050482|FG000|Screening Period|Withdrawal by Subject|2|||
127845454|NCT01626989|460050483|FG001|Screening Period|Withdrawal by Subject|0|||
127845455|NCT01626989|460050484|FG002|Screening Period|Withdrawal by Subject|0|||
127845456|NCT01432457|460052648|FG000|Overall Study|Adverse Event|7|||
127845457|NCT01432457|460052649|FG001|Overall Study|Adverse Event|10|||
127845458|NCT01432457|460052650|FG002|Overall Study|Adverse Event|16|||
127845459|NCT01432457|460052648|FG000|Overall Study|Lack of Efficacy|2|||
127845460|NCT01432457|460052649|FG001|Overall Study|Lack of Efficacy|1|||
127845461|NCT01432457|460052650|FG002|Overall Study|Lack of Efficacy|1|||
127845462|NCT01432457|460052648|FG000|Overall Study|Lost to Follow-up|11|||
127845463|NCT01432457|460052649|FG001|Overall Study|Lost to Follow-up|15|||
127845464|NCT01432457|460052650|FG002|Overall Study|Lost to Follow-up|20|||
127845465|NCT01432457|460052648|FG000|Overall Study|Protocol Violation|3|||
127845466|NCT01432457|460052649|FG001|Overall Study|Protocol Violation|2|||
127845467|NCT01432457|460052650|FG002|Overall Study|Protocol Violation|6|||
127845468|NCT01432457|460052648|FG000|Overall Study|Withdrawal by Subject|6|||
127845469|NCT01432457|460052649|FG001|Overall Study|Withdrawal by Subject|11|||
127845470|NCT01432457|460052650|FG002|Overall Study|Withdrawal by Subject|9|||
127845471|NCT01432457|460052648|FG000|Overall Study|Reasons not defined|2|||
127845472|NCT01432457|460052649|FG001|Overall Study|Reasons not defined|3|||
127845473|NCT01432457|460052650|FG002|Overall Study|Reasons not defined|4|||
127845474|NCT01432457|460052648|FG000|Overall Study|Did not take study drug|6|||
127845475|NCT01432457|460052649|FG001|Overall Study|Did not take study drug|6|||
127845476|NCT01432457|460052650|FG002|Overall Study|Did not take study drug|3|||
127845477|NCT02574481|460052651|FG000|Overall Study|Withdrawal by Subject|29|||
127845478|NCT02574481|460052652|FG001|Overall Study|Withdrawal by Subject|15|||
127845479|NCT02574481|460052653|FG002|Overall Study|Withdrawal by Subject|4|||
127845480|NCT02574481|460052654|FG003|Overall Study|Withdrawal by Subject|1|||
127845481|NCT02574481|460052651|FG000|Overall Study|Adverse Event|5|||
127845482|NCT02574481|460052652|FG001|Overall Study|Adverse Event|1|||
127845483|NCT02574481|460052653|FG002|Overall Study|Adverse Event|1|||
127845484|NCT02574481|460052654|FG003|Overall Study|Adverse Event|0|||
127845485|NCT02574481|460052651|FG000|Overall Study|Visit Missed|15|||
127845486|NCT02574481|460052652|FG001|Overall Study|Visit Missed|7|||
127845487|NCT02574481|460052653|FG002|Overall Study|Visit Missed|5|||
127845488|NCT02574481|460052654|FG003|Overall Study|Visit Missed|0|||
127845489|NCT02574481|460052651|FG000|Overall Study|Other|7|||
127845490|NCT02574481|460052652|FG001|Overall Study|Other|2|||
127845491|NCT02574481|460052653|FG002|Overall Study|Other|0|||
127845492|NCT02574481|460052654|FG003|Overall Study|Other|0|||
127845493|NCT02574481|460052651|FG000|Overall Study|Death|48|||
127845494|NCT02574481|460052652|FG001|Overall Study|Death|26|||
127845495|NCT02574481|460052653|FG002|Overall Study|Death|12|||
127845496|NCT02574481|460052654|FG003|Overall Study|Death|4|||
127845497|NCT02574481|460052651|FG000|Overall Study|Physician Decision|5|||
127845498|NCT02574481|460052652|FG001|Overall Study|Physician Decision|2|||
127845499|NCT02574481|460052653|FG002|Overall Study|Physician Decision|0|||
127845500|NCT02574481|460052654|FG003|Overall Study|Physician Decision|0|||
127845501|NCT02574481|460052651|FG000|Overall Study|Lost to Follow-up|5|||
127845502|NCT02574481|460052652|FG001|Overall Study|Lost to Follow-up|1|||
127845503|NCT02574481|460052653|FG002|Overall Study|Lost to Follow-up|3|||
127845504|NCT02574481|460052654|FG003|Overall Study|Lost to Follow-up|0|||
127845505|NCT04134728|460052655|FG000|Overall Study|Adverse Event|3|||
127845506|NCT04134728|460052656|FG001|Overall Study|Adverse Event|2|||
127845507|NCT04134728|460052657|FG002|Overall Study|Adverse Event|9|||
127845508|NCT04134728|460052658|FG003|Overall Study|Adverse Event|0|||
127845509|NCT04134728|460052659|FG004|Overall Study|Adverse Event|0|||
127845510|NCT04134728|460052660|FG005|Overall Study|Adverse Event|0|||
127845511|NCT04134728|460052655|FG000|Overall Study|Lack of Efficacy|3|||
127845512|NCT04134728|460052656|FG001|Overall Study|Lack of Efficacy|3|||
127845513|NCT04134728|460052657|FG002|Overall Study|Lack of Efficacy|1|||
127845514|NCT04134728|460052658|FG003|Overall Study|Lack of Efficacy|2|||
127845515|NCT04134728|460052659|FG004|Overall Study|Lack of Efficacy|0|||
127845516|NCT04134728|460052660|FG005|Overall Study|Lack of Efficacy|0|||
127845517|NCT04134728|460052655|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
127845518|NCT04134728|460052656|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
127845519|NCT04134728|460052657|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
127845520|NCT04134728|460052658|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
127845521|NCT04134728|460052659|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
127845522|NCT04134728|460052660|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
127845523|NCT04134728|460052655|FG000|Overall Study|Protocol Deviation|0|||
127845524|NCT04134728|460052656|FG001|Overall Study|Protocol Deviation|0|||
127845525|NCT04134728|460052657|FG002|Overall Study|Protocol Deviation|1|||
127845526|NCT04134728|460052658|FG003|Overall Study|Protocol Deviation|0|||
127845527|NCT04134728|460052659|FG004|Overall Study|Protocol Deviation|0|||
127845528|NCT04134728|460052660|FG005|Overall Study|Protocol Deviation|0|||
127845529|NCT04134728|460052655|FG000|Overall Study|Informed Consent Withdrawn|3|||
127845530|NCT04134728|460052656|FG001|Overall Study|Informed Consent Withdrawn|6|||
127845531|NCT04134728|460052657|FG002|Overall Study|Informed Consent Withdrawn|8|||
127845532|NCT04134728|460052658|FG003|Overall Study|Informed Consent Withdrawn|1|||
127845533|NCT04134728|460052659|FG004|Overall Study|Informed Consent Withdrawn|1|||
127845534|NCT04134728|460052660|FG005|Overall Study|Informed Consent Withdrawn|0|||
127845535|NCT04134728|460052655|FG000|Overall Study|Physician Decision|2|||
127845536|NCT04134728|460052656|FG001|Overall Study|Physician Decision|0|||
127845537|NCT04134728|460052657|FG002|Overall Study|Physician Decision|0|||
127845538|NCT04134728|460052658|FG003|Overall Study|Physician Decision|0|||
127845539|NCT04134728|460052659|FG004|Overall Study|Physician Decision|0|||
127845540|NCT04134728|460052660|FG005|Overall Study|Physician Decision|0|||
127845541|NCT04134728|460052655|FG000|Overall Study|Lost to Follow-up|1|||
127845542|NCT04134728|460052656|FG001|Overall Study|Lost to Follow-up|2|||
127845543|NCT04134728|460052657|FG002|Overall Study|Lost to Follow-up|1|||
127845544|NCT04134728|460052658|FG003|Overall Study|Lost to Follow-up|0|||
127845545|NCT04134728|460052659|FG004|Overall Study|Lost to Follow-up|0|||
127845546|NCT04134728|460052660|FG005|Overall Study|Lost to Follow-up|1|||
127845547|NCT04134728|460052655|FG000|Overall Study|Investigator Site Closed|0|||
127845548|NCT04134728|460052656|FG001|Overall Study|Investigator Site Closed|1|||
127845549|NCT04134728|460052657|FG002|Overall Study|Investigator Site Closed|1|||
127845550|NCT04134728|460052658|FG003|Overall Study|Investigator Site Closed|0|||
127845551|NCT04134728|460052659|FG004|Overall Study|Investigator Site Closed|0|||
127845552|NCT04134728|460052660|FG005|Overall Study|Investigator Site Closed|0|||
127845553|NCT02905825|460052669|FG000|Overall Study|Protocol Violation|11|||
127845554|NCT02905825|460052669|FG000|Overall Study|Device Malfunction|1|||
127845555|NCT01281189|460052670|FG000|Overall Study|Adverse Event|7|||
127845556|NCT01281189|460052671|FG001|Overall Study|Adverse Event|9|||
127845557|NCT01281189|460052670|FG000|Overall Study|Lost to Follow-up|6|||
127845558|NCT01281189|460052671|FG001|Overall Study|Lost to Follow-up|4|||
127845559|NCT01281189|460052670|FG000|Overall Study|Withdrawal by Subject|21|||
127845560|NCT01281189|460052671|FG001|Overall Study|Withdrawal by Subject|24|||
127845561|NCT01281189|460052670|FG000|Overall Study|Physician Decision|2|||
127845562|NCT01281189|460052671|FG001|Overall Study|Physician Decision|3|||
127845563|NCT01281189|460052670|FG000|Overall Study|Death|103|||
127845564|NCT01281189|460052671|FG001|Overall Study|Death|91|||
127845565|NCT01281189|460052670|FG000|Overall Study|Other|8|||
127845566|NCT01281189|460052671|FG001|Overall Study|Other|12|||
127845567|NCT05355818|460052672|FG000|Overall Study|Adverse Event|1|||
127845568|NCT05355818|460052673|FG001|Overall Study|Adverse Event|1|||
127845569|NCT05355818|460052672|FG000|Overall Study|Lack of Efficacy|2|||
127845570|NCT05355818|460052673|FG001|Overall Study|Lack of Efficacy|1|||
127845571|NCT05355818|460052672|FG000|Overall Study|Lost to Follow-up|0|||
127845572|NCT05355818|460052673|FG001|Overall Study|Lost to Follow-up|1|||
127845573|NCT01136746|460052676|FG000|Overall Study|Lost to Follow-up|0|||
127845574|NCT01136746|460052677|FG001|Overall Study|Lost to Follow-up|2|||
127845575|NCT01136746|460052676|FG000|Overall Study|Protocol Violation|2|||
127845576|NCT01136746|460052677|FG001|Overall Study|Protocol Violation|1|||
127845577|NCT01136746|460052676|FG000|Overall Study|Death|1|||
127845578|NCT01136746|460052677|FG001|Overall Study|Death|0|||
127845579|NCT00092677|460052687|FG000|Overall Study|Lost to Follow-up|0|||
127845580|NCT00092677|460052688|FG001|Overall Study|Lost to Follow-up|2|||
127845581|NCT00092677|460052687|FG000|Overall Study|Adminstrative|5|||
127845582|NCT00092677|460052688|FG001|Overall Study|Adminstrative|9|||
127845583|NCT01601704|460052689|FG000|Overall Study|Randomized but not dispensed study med|1|||
127845584|NCT01601704|460052690|FG001|Overall Study|Randomized but not dispensed study med|4|||
127845585|NCT01090102|460052691|FG000|First 12 Weeks|Withdrawal by Subject|1|||
127845586|NCT01090102|460052692|FG001|First 12 Weeks|Withdrawal by Subject|1|||
127845587|NCT01090102|460052691|FG000|First 12 Weeks|Adverse Event|2|||
127845588|NCT01090102|460052692|FG001|First 12 Weeks|Adverse Event|0|||
127845589|NCT01090102|460052691|FG000|First 12 Weeks|Death|1|||
127845590|NCT01090102|460052692|FG001|First 12 Weeks|Death|1|||
127845591|NCT01090102|460052691|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
127845592|NCT01090102|460052692|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
127845593|NCT03518034|460052693|FG000|Overall Study|Not Treated|5|||
127845594|NCT03518034|460052694|FG001|Overall Study|Not Treated|1|||
127845595|NCT03518034|460052693|FG000|Overall Study|Withdrawal by Subject|309|||
127845596|NCT03518034|460052694|FG001|Overall Study|Withdrawal by Subject|351|||
127845597|NCT03518034|460052693|FG000|Overall Study|Lost to Follow-up|446|||
127845598|NCT03518034|460052694|FG001|Overall Study|Lost to Follow-up|458|||
127845599|NCT03518034|460052693|FG000|Overall Study|Adverse Event|138|||
127845600|NCT03518034|460052694|FG001|Overall Study|Adverse Event|130|||
127845601|NCT03518034|460052693|FG000|Overall Study|Lack of Efficacy|11|||
127845602|NCT03518034|460052694|FG001|Overall Study|Lack of Efficacy|23|||
127845603|NCT03518034|460052693|FG000|Overall Study|COVID-19 Logistical Restriction|7|||
127845604|NCT03518034|460052694|FG001|Overall Study|COVID-19 Logistical Restriction|3|||
127845605|NCT03518034|460052693|FG000|Overall Study|Serum Testosterone Level >750 ng/dL|5|||
127845606|NCT03518034|460052694|FG001|Overall Study|Serum Testosterone Level >750 ng/dL|0|||
127845607|NCT03518034|460052693|FG000|Overall Study|Other, Not Specified|84|||
127845608|NCT03518034|460052694|FG001|Overall Study|Other, Not Specified|53|||
127845609|NCT03518034|460052693|FG000|Overall Study|Reason Missing|2|||
127845610|NCT03518034|460052694|FG001|Overall Study|Reason Missing|3|||
127845611|NCT00010803|460052700|FG000|Overall Study|Withdrawal by Subject|97|||
127845612|NCT00010803|460052701|FG001|Overall Study|Withdrawal by Subject|98|||
127845613|NCT01019252|460052702|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
127845614|NCT01019252|460052703|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
127845615|NCT01019252|460052702|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
127845616|NCT01019252|460052703|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
127845617|NCT01019252|460052702|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
127845618|NCT01019252|460052703|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
127845619|NCT01019252|460052702|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
127845620|NCT01019252|460052703|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
127845621|NCT00985738|460052706|FG000|Overall Study|Study closed prematurely|8|||
127845622|NCT00985738|460052707|FG001|Overall Study|Study closed prematurely|8|||
127845623|NCT02227849|460052709|FG000|Overall Study|Adverse Event|4|||
127845624|NCT02227849|460052709|FG000|Overall Study|Physician Decision|1|||
127845625|NCT02227849|460052709|FG000|Overall Study|Withdrawal by Subject|3|||
127845626|NCT01590212|460052712|FG000|Overall Study|Withdrawal by Subject|2|||
127845627|NCT01590212|460052713|FG001|Overall Study|Withdrawal by Subject|2|||
127845628|NCT01590212|460052714|FG002|Overall Study|Withdrawal by Subject|2|||
127901469|NCT02918877|460265035|FG000|Overall Study|Unsafe to perform BAL|0|||
127901470|NCT02918877|460265036|FG001|Overall Study|Unsafe to perform BAL|1|||
127901471|NCT05818137|460265037|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
127901472|NCT05818137|460265037|FG000|Extension Treatment Period|Ongoing participants|44|||
127845629|NCT01590212|460052712|FG000|Overall Study|Lost to Follow-up|1|||
127845630|NCT01590212|460052713|FG001|Overall Study|Lost to Follow-up|2|||
127845631|NCT01590212|460052714|FG002|Overall Study|Lost to Follow-up|3|||
127845632|NCT04897594|460052716|FG000|Overall Study|Lost to Follow-up|0|||
127845633|NCT04897594|460052717|FG001|Overall Study|Lost to Follow-up|1|||
127845634|NCT04897594|460052718|FG002|Overall Study|Lost to Follow-up|1|||
127845635|NCT04897594|460052716|FG000|Overall Study|Sponsor Decision|0|||
127845636|NCT04897594|460052717|FG001|Overall Study|Sponsor Decision|0|||
127845637|NCT04897594|460052718|FG002|Overall Study|Sponsor Decision|1|||
127845638|NCT04897594|460052716|FG000|Overall Study|Withdrawal by Subject|1|||
127845639|NCT04897594|460052717|FG001|Overall Study|Withdrawal by Subject|0|||
127845640|NCT04897594|460052718|FG002|Overall Study|Withdrawal by Subject|1|||
127845641|NCT00150345|460052721|FG000|Overall Study|Death|5|||
127845642|NCT00150345|460052722|FG001|Overall Study|Death|2|||
127845643|NCT00150345|460052721|FG000|Overall Study|Adverse Event|8|||
127845644|NCT00150345|460052722|FG001|Overall Study|Adverse Event|6|||
127845645|NCT00150345|460052721|FG000|Overall Study|Lack of Efficacy|5|||
127845646|NCT00150345|460052722|FG001|Overall Study|Lack of Efficacy|4|||
127845647|NCT00150345|460052721|FG000|Overall Study|Withdrawal by Subject|3|||
127845648|NCT00150345|460052722|FG001|Overall Study|Withdrawal by Subject|4|||
127845649|NCT00150345|460052721|FG000|Overall Study|Laboratory abnormality|1|||
127845650|NCT00150345|460052722|FG001|Overall Study|Laboratory abnormality|2|||
127845651|NCT00150345|460052721|FG000|Overall Study|Other|12|||
127845652|NCT00150345|460052722|FG001|Overall Study|Other|14|||
127845653|NCT01457924|460052725|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
127845654|NCT01457924|460052726|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
127845655|NCT01457924|460052727|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
127845656|NCT01457924|460052728|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
127845657|NCT01457924|460052729|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
127845658|NCT01457924|460052725|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
127845659|NCT01457924|460052726|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
127845660|NCT01457924|460052727|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
127845661|NCT01457924|460052728|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
127845662|NCT01457924|460052729|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
127845663|NCT01457924|460052725|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
127845664|NCT01457924|460052726|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
127845665|NCT01457924|460052727|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
127845666|NCT01457924|460052728|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
127845667|NCT01457924|460052729|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
127845668|NCT01457924|460052725|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
127845669|NCT01457924|460052726|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
127845670|NCT01457924|460052727|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
127845671|NCT01457924|460052728|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
127845672|NCT01457924|460052729|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
127845673|NCT01457924|460052725|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
127845674|NCT01457924|460052726|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
127845675|NCT01457924|460052727|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
127845676|NCT01457924|460052728|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
127845677|NCT01457924|460052729|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
127901473|NCT02532764|460265040|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
127901474|NCT02532764|460265041|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
127845678|NCT01457924|460052725|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
127845679|NCT01457924|460052726|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
127845680|NCT01457924|460052727|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
127845681|NCT01457924|460052728|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
127845682|NCT01457924|460052729|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
127845683|NCT01457924|460052725|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
127845684|NCT01457924|460052726|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
127845685|NCT01457924|460052727|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
127901475|NCT02532764|460265042|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
127845686|NCT01457924|460052728|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
127845687|NCT01457924|460052729|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
127845688|NCT01457924|460052725|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
127845689|NCT01457924|460052726|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
127845690|NCT01457924|460052727|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
127845691|NCT01457924|460052728|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
127845692|NCT01457924|460052729|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
127845693|NCT01457924|460052725|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
127901476|NCT02532764|460265043|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
127901477|NCT02532764|460265044|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
127901478|NCT02532764|460265045|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
127901479|NCT02532764|460265046|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
127901480|NCT02532764|460265047|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
127901481|NCT02532764|460265048|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
127901482|NCT02532764|460265049|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
127901483|NCT03527745|460265050|FG000|Overall Study|Lost to Follow-up|3|||
127901484|NCT03527745|460265051|FG001|Overall Study|Lost to Follow-up|6|||
127901485|NCT03527745|460265052|FG002|Overall Study|Lost to Follow-up|7|||
127901486|NCT03527745|460265053|FG003|Overall Study|Lost to Follow-up|9|||
127901487|NCT03527745|460265054|FG004|Overall Study|Lost to Follow-up|0|||
127901488|NCT03527745|460265055|FG005|Overall Study|Lost to Follow-up|2|||
127901489|NCT03527745|460265056|FG006|Overall Study|Lost to Follow-up|3|||
127901490|NCT03527745|460265057|FG007|Overall Study|Lost to Follow-up|2|||
127901491|NCT03527745|460265058|FG008|Overall Study|Lost to Follow-up|3|||
127901492|NCT03527745|460265059|FG009|Overall Study|Lost to Follow-up|2|||
127901493|NCT03527745|460265060|FG010|Overall Study|Lost to Follow-up|1|||
127901494|NCT03527745|460265061|FG011|Overall Study|Lost to Follow-up|1|||
127901495|NCT03527745|460265062|FG012|Overall Study|Lost to Follow-up|0|||
127901496|NCT03527745|460265063|FG013|Overall Study|Lost to Follow-up|0|||
127901497|NCT03527745|460265064|FG014|Overall Study|Lost to Follow-up|0|||
127901498|NCT03527745|460265065|FG015|Overall Study|Lost to Follow-up|0|||
127901499|NCT03527745|460265066|FG016|Overall Study|Lost to Follow-up|1|||
127901500|NCT03527745|460265067|FG017|Overall Study|Lost to Follow-up|0|||
127901501|NCT03527745|460265068|FG018|Overall Study|Lost to Follow-up|0|||
127901502|NCT03527745|460265069|FG019|Overall Study|Lost to Follow-up|1|||
127901503|NCT03527745|460265070|FG020|Overall Study|Lost to Follow-up|1|||
127901504|NCT03527745|460265071|FG021|Overall Study|Lost to Follow-up|5|||
127901505|NCT03527745|460265072|FG022|Overall Study|Lost to Follow-up|6|||
127901506|NCT03527745|460265073|FG023|Overall Study|Lost to Follow-up|8|||
127901507|NCT03527745|460265074|FG024|Overall Study|Lost to Follow-up|1|||
127901508|NCT03527745|460265075|FG025|Overall Study|Lost to Follow-up|3|||
127901509|NCT01717976|460265076|FG000|Overall Study|Protocol Violation|0|||
127901510|NCT01717976|460265077|FG001|Overall Study|Protocol Violation|1|||
127901511|NCT01604850|460265078|FG000|Overall Study|Enrolled but never treated|0|||
127901512|NCT01604850|460265079|FG001|Overall Study|Enrolled but never treated|1|||
127901513|NCT01604850|460265078|FG000|Overall Study|Efficacy Failure|50|||
127901514|NCT01604850|460265079|FG001|Overall Study|Efficacy Failure|29|||
127901515|NCT01604850|460265078|FG000|Overall Study|Lost to Follow-up|1|||
127901516|NCT01604850|460265079|FG001|Overall Study|Lost to Follow-up|0|||
127901517|NCT01604850|460265078|FG000|Overall Study|Subject withdrew consent|1|||
127901518|NCT01604850|460265079|FG001|Overall Study|Subject withdrew consent|0|||
127901519|NCT04099888|460265100|FG000|Overall Study|Study terminated by sponsor|9|||
127901520|NCT04099888|460265101|FG001|Overall Study|Study terminated by sponsor|11|||
127901521|NCT04099888|460265100|FG000|Overall Study|Lost to Follow-up|1|||
127901522|NCT04099888|460265101|FG001|Overall Study|Lost to Follow-up|1|||
127901523|NCT04099888|460265100|FG000|Overall Study|Withdrawal by Subject|5|||
127901524|NCT04099888|460265101|FG001|Overall Study|Withdrawal by Subject|6|||
127901525|NCT04099888|460265100|FG000|Overall Study|Death|5|||
127901526|NCT04099888|460265101|FG001|Overall Study|Death|2|||
127901527|NCT04099888|460265100|FG000|Overall Study|Other|1|||
127901528|NCT04099888|460265101|FG001|Overall Study|Other|0|||
127901529|NCT04538170|460265102|FG000|Overall Study|Withdrawal by Subject|104|||
127901530|NCT04538170|460265103|FG001|Overall Study|Withdrawal by Subject|210|||
127901531|NCT00051025|460265107|FG000|Overall Study|Progressive Disease|1|||
127901532|NCT00051025|460265108|FG001|Overall Study|Progressive Disease|1|||
127901533|NCT00051025|460265107|FG000|Overall Study|Adverse Event|1|||
127901534|NCT00051025|460265108|FG001|Overall Study|Adverse Event|1|||
127901535|NCT00051025|460265107|FG000|Overall Study|Withdrawal by Subject|0|||
127901536|NCT00051025|460265108|FG001|Overall Study|Withdrawal by Subject|1|||
127901537|NCT00051025|460265107|FG000|Overall Study|Death|0|||
127901538|NCT00051025|460265108|FG001|Overall Study|Death|1|||
127901539|NCT00274937|460265109|FG000|Overall Study|Physician Decision|10|||
127901540|NCT00274937|460265109|FG000|Overall Study|Withdrawal by Subject|6|||
127901541|NCT00274937|460265109|FG000|Overall Study|Progressive Disease|4|||
127901542|NCT02189941|460265110|FG000|Overall Study|Non-compliance|0|||
127901543|NCT02189941|460265111|FG001|Overall Study|Non-compliance|0|||
127901544|NCT02189941|460265112|FG002|Overall Study|Non-compliance|1|||
127901545|NCT00445003|460265114|FG000|Overall Study|Death|1|||
127901546|NCT00445003|460265115|FG001|Overall Study|Death|2|||
127901547|NCT00445003|460265116|FG002|Overall Study|Death|1|||
127901548|NCT00445003|460265114|FG000|Overall Study|Missed Visit|3|||
127901549|NCT00445003|460265115|FG001|Overall Study|Missed Visit|5|||
127901550|NCT00445003|460265116|FG002|Overall Study|Missed Visit|1|||
127901551|NCT00445003|460265114|FG000|Overall Study|Dropped|1|||
127901552|NCT00445003|460265115|FG001|Overall Study|Dropped|3|||
127901553|NCT00445003|460265116|FG002|Overall Study|Dropped|2|||
127901554|NCT01471093|460265117|FG000|Overall Study|Adverse Event|1|||
127845694|NCT01457924|460052726|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
127845695|NCT01457924|460052727|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
127845696|NCT01457924|460052728|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
127845697|NCT01457924|460052729|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
127845698|NCT01457924|460052725|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
127845699|NCT01457924|460052726|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
127845700|NCT01457924|460052727|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
127845701|NCT01457924|460052728|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
127845702|NCT01457924|460052729|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
127845703|NCT01457924|460052725|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
127845704|NCT01457924|460052726|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
127845705|NCT01457924|460052727|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
127845706|NCT01457924|460052728|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
127845707|NCT01457924|460052729|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
127845708|NCT01457924|460052725|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
127845709|NCT01457924|460052726|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
127845710|NCT01457924|460052727|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
127845711|NCT01457924|460052728|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
127845712|NCT01457924|460052729|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
127845713|NCT01457924|460052725|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
127845714|NCT01457924|460052726|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
127845715|NCT01457924|460052727|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
127845716|NCT01457924|460052728|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
127845717|NCT01457924|460052729|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
127845718|NCT00636441|460052730|FG000|Overall Study|Adverse Event|0|||
127845719|NCT00636441|460052731|FG001|Overall Study|Adverse Event|1|||
127845720|NCT00636441|460052732|FG002|Overall Study|Adverse Event|1|||
127845721|NCT00636441|460052733|FG003|Overall Study|Adverse Event|0|||
127845722|NCT00636441|460052734|FG004|Overall Study|Adverse Event|0|||
127845723|NCT00636441|460052735|FG005|Overall Study|Adverse Event|1|||
127845724|NCT00636441|460052736|FG006|Overall Study|Adverse Event|0|||
127845725|NCT00636441|460052730|FG000|Overall Study|Late, ineligible|0|||
127845726|NCT00636441|460052731|FG001|Overall Study|Late, ineligible|0|||
127845727|NCT00636441|460052732|FG002|Overall Study|Late, ineligible|0|||
127845728|NCT00636441|460052733|FG003|Overall Study|Late, ineligible|0|||
127845729|NCT00636441|460052734|FG004|Overall Study|Late, ineligible|0|||
127845730|NCT00636441|460052735|FG005|Overall Study|Late, ineligible|0|||
127845731|NCT00636441|460052736|FG006|Overall Study|Late, ineligible|1|||
127845732|NCT00636441|460052730|FG000|Overall Study|Screen Failure|0|||
127845733|NCT00636441|460052731|FG001|Overall Study|Screen Failure|0|||
127845734|NCT00636441|460052732|FG002|Overall Study|Screen Failure|0|||
127845735|NCT00636441|460052733|FG003|Overall Study|Screen Failure|0|||
127845736|NCT00636441|460052734|FG004|Overall Study|Screen Failure|0|||
127845737|NCT00636441|460052735|FG005|Overall Study|Screen Failure|0|||
127845738|NCT00636441|460052736|FG006|Overall Study|Screen Failure|17|||
127845739|NCT03495817|460052737|FG000|26 Week Open Label|Adverse Event|3|||
127845740|NCT03495817|460052737|FG000|26 Week Open Label|Withdrawal by Subject|4|||
127845741|NCT03495817|460052737|FG000|26 Week Open Label|Lost to Follow-up|1|||
127845742|NCT03495817|460052737|FG000|26 Week Extension|Lost to Follow-up|2|||
127845743|NCT04169061|460052739|FG000|Overall Study|Adverse Event|2|||
127845744|NCT04169061|460052739|FG000|Overall Study|Death|1|||
127845745|NCT04169061|460052739|FG000|Overall Study|Withdrawal by Subject|1|||
127845746|NCT04169061|460052739|FG000|Overall Study|Protocol Violation|1|||
127845747|NCT04585451|460052743|FG000|Overall Study|Withdrawal by Subject|26|||
127845748|NCT04585451|460052744|FG001|Overall Study|Withdrawal by Subject|0|||
127845749|NCT00326417|460052745|FG000|Overall Study|Withdrawal by Subject|0|||
127845750|NCT00326417|460052746|FG001|Overall Study|Withdrawal by Subject|0|||
127845751|NCT00326417|460052747|FG002|Overall Study|Withdrawal by Subject|1|||
127845752|NCT00326417|460052748|FG003|Overall Study|Withdrawal by Subject|0|||
127845753|NCT00326417|460052745|FG000|Overall Study|Arm Closed|7|||
127845754|NCT00326417|460052746|FG001|Overall Study|Arm Closed|0|||
127845755|NCT00326417|460052747|FG002|Overall Study|Arm Closed|0|||
127845756|NCT00326417|460052748|FG003|Overall Study|Arm Closed|3|||
127845757|NCT00326417|460052745|FG000|Overall Study|Death|7|||
127845758|NCT00326417|460052746|FG001|Overall Study|Death|0|||
127845759|NCT00326417|460052747|FG002|Overall Study|Death|0|||
127845760|NCT00326417|460052748|FG003|Overall Study|Death|0|||
127845761|NCT00844285|460052749|FG000|Overall Study|Other|0|||
127845762|NCT00844285|460052750|FG001|Overall Study|Other|1|||
127901555|NCT01471093|460265118|FG001|Overall Study|Adverse Event|0|||
127845763|NCT00844285|460052751|FG002|Overall Study|Other|0|||
127845764|NCT00844285|460052749|FG000|Overall Study|Other than specified|95|||
127845765|NCT00844285|460052750|FG001|Overall Study|Other than specified|129|||
127845766|NCT00844285|460052751|FG002|Overall Study|Other than specified|12|||
127845767|NCT00844285|460052749|FG000|Overall Study|Site closure|256|||
127845768|NCT00844285|460052750|FG001|Overall Study|Site closure|450|||
127901556|NCT01471093|460265119|FG002|Overall Study|Adverse Event|0|||
127901557|NCT01471093|460265120|FG003|Overall Study|Adverse Event|0|||
127901558|NCT02475954|460265121|FG000|Overall Study|Withdrawal by Subject|2|||
127901559|NCT02475954|460265122|FG001|Overall Study|Withdrawal by Subject|2|||
127901560|NCT02475954|460265121|FG000|Overall Study|Lost to Follow-up|11|||
127901561|NCT02475954|460265122|FG001|Overall Study|Lost to Follow-up|9|||
127901562|NCT02475954|460265121|FG000|Overall Study|Death|1|||
127901563|NCT02475954|460265122|FG001|Overall Study|Death|1|||
127901564|NCT02932878|460265123|FG000|Overall Study|Due to Lab Results|2|||
127901565|NCT02932878|460265124|FG001|Overall Study|Due to Lab Results|1|||
127901566|NCT01918397|460265127|FG000|Overall Study|Never started treatment|2|||
127901567|NCT01918397|460265128|FG001|Overall Study|Never started treatment|1|||
127901568|NCT01918397|460265129|FG002|Overall Study|Never started treatment|0|||
127901569|NCT01918397|460265130|FG003|Overall Study|Never started treatment|0|||
127901570|NCT01918397|460265127|FG000|Overall Study|Adverse Event|1|||
127901571|NCT01918397|460265128|FG001|Overall Study|Adverse Event|1|||
127901572|NCT01918397|460265129|FG002|Overall Study|Adverse Event|1|||
127901573|NCT01918397|460265130|FG003|Overall Study|Adverse Event|0|||
127901574|NCT01918397|460265127|FG000|Overall Study|Lack of compliance|2|||
127901575|NCT01918397|460265128|FG001|Overall Study|Lack of compliance|2|||
127901576|NCT01918397|460265129|FG002|Overall Study|Lack of compliance|3|||
127901577|NCT01918397|460265130|FG003|Overall Study|Lack of compliance|0|||
127901578|NCT01918397|460265127|FG000|Overall Study|Pregnancy|0|||
127901579|NCT01918397|460265128|FG001|Overall Study|Pregnancy|1|||
127901580|NCT01918397|460265129|FG002|Overall Study|Pregnancy|0|||
127901581|NCT01918397|460265130|FG003|Overall Study|Pregnancy|0|||
127901582|NCT01918397|460265127|FG000|Overall Study|Rifampin susceptible|0|||
127901583|NCT01918397|460265128|FG001|Overall Study|Rifampin susceptible|0|||
127901584|NCT01918397|460265129|FG002|Overall Study|Rifampin susceptible|0|||
127901585|NCT01918397|460265130|FG003|Overall Study|Rifampin susceptible|2|||
127901586|NCT01918397|460265127|FG000|Overall Study|Treatment failure|0|||
127901587|NCT01918397|460265128|FG001|Overall Study|Treatment failure|0|||
127901588|NCT01918397|460265129|FG002|Overall Study|Treatment failure|0|||
127901589|NCT01918397|460265130|FG003|Overall Study|Treatment failure|1|||
127901590|NCT01918397|460265127|FG000|Overall Study|Withdrawal by Subject|3|||
127901591|NCT01918397|460265128|FG001|Overall Study|Withdrawal by Subject|2|||
127901592|NCT01918397|460265129|FG002|Overall Study|Withdrawal by Subject|1|||
127901593|NCT01918397|460265130|FG003|Overall Study|Withdrawal by Subject|1|||
127901594|NCT01918397|460265127|FG000|Overall Study|XDR at baseline|0|||
127901595|NCT01918397|460265128|FG001|Overall Study|XDR at baseline|0|||
127901596|NCT01918397|460265129|FG002|Overall Study|XDR at baseline|1|||
127901597|NCT01918397|460265130|FG003|Overall Study|XDR at baseline|0|||
127901598|NCT01918397|460265127|FG000|Overall Study|Lost to Follow-up|2|||
127901599|NCT01918397|460265128|FG001|Overall Study|Lost to Follow-up|1|||
127901600|NCT01918397|460265129|FG002|Overall Study|Lost to Follow-up|1|||
127901601|NCT01918397|460265130|FG003|Overall Study|Lost to Follow-up|1|||
127901602|NCT01918397|460265127|FG000|Overall Study|Increased QTc|1|||
127901603|NCT01918397|460265128|FG001|Overall Study|Increased QTc|0|||
127901604|NCT01918397|460265129|FG002|Overall Study|Increased QTc|0|||
127901605|NCT01918397|460265130|FG003|Overall Study|Increased QTc|1|||
127901606|NCT01918397|460265127|FG000|Overall Study|Death|0|||
127901607|NCT01918397|460265128|FG001|Overall Study|Death|0|||
127901608|NCT01918397|460265129|FG002|Overall Study|Death|1|||
127901609|NCT01918397|460265130|FG003|Overall Study|Death|0|||
127901610|NCT01918397|460265127|FG000|Overall Study|Involved in another investigative trial|0|||
127901611|NCT01918397|460265128|FG001|Overall Study|Involved in another investigative trial|0|||
127901612|NCT01918397|460265129|FG002|Overall Study|Involved in another investigative trial|0|||
127901613|NCT01918397|460265130|FG003|Overall Study|Involved in another investigative trial|1|||
127901614|NCT00864097|460265131|FG000|Overall Study|Death|0|||
127901615|NCT00864097|460265132|FG001|Overall Study|Death|1|||
127901616|NCT00864097|460265133|FG002|Overall Study|Death|0|||
127901617|NCT00864097|460265134|FG003|Overall Study|Death|0|||
127901618|NCT00864097|460265131|FG000|Overall Study|Adverse Event|6|||
127901619|NCT00864097|460265132|FG001|Overall Study|Adverse Event|8|||
127901620|NCT00864097|460265133|FG002|Overall Study|Adverse Event|11|||
127901621|NCT00864097|460265134|FG003|Overall Study|Adverse Event|9|||
127901622|NCT00864097|460265131|FG000|Overall Study|Lack of Efficacy|9|||
127901623|NCT00864097|460265132|FG001|Overall Study|Lack of Efficacy|3|||
127901624|NCT00864097|460265133|FG002|Overall Study|Lack of Efficacy|7|||
127901625|NCT00864097|460265134|FG003|Overall Study|Lack of Efficacy|2|||
127901626|NCT00864097|460265131|FG000|Overall Study|Lost to Follow-up|0|||
127901627|NCT00864097|460265132|FG001|Overall Study|Lost to Follow-up|1|||
127901628|NCT00864097|460265133|FG002|Overall Study|Lost to Follow-up|0|||
127901629|NCT00864097|460265134|FG003|Overall Study|Lost to Follow-up|1|||
127901630|NCT00864097|460265131|FG000|Overall Study|Withdrawal by Subject|15|||
127901631|NCT00864097|460265132|FG001|Overall Study|Withdrawal by Subject|11|||
127901632|NCT00864097|460265133|FG002|Overall Study|Withdrawal by Subject|11|||
127901633|NCT00864097|460265134|FG003|Overall Study|Withdrawal by Subject|12|||
127901634|NCT00864097|460265131|FG000|Overall Study|Protocol Violation|2|||
127901635|NCT00864097|460265132|FG001|Overall Study|Protocol Violation|1|||
127901636|NCT00864097|460265133|FG002|Overall Study|Protocol Violation|0|||
127901637|NCT00864097|460265134|FG003|Overall Study|Protocol Violation|1|||
127901638|NCT00864097|460265131|FG000|Overall Study|Terminated by sponsor|105|||
127901639|NCT00864097|460265132|FG001|Overall Study|Terminated by sponsor|112|||
127901640|NCT00864097|460265133|FG002|Overall Study|Terminated by sponsor|102|||
127901641|NCT00864097|460265134|FG003|Overall Study|Terminated by sponsor|99|||
127901642|NCT00864097|460265131|FG000|Overall Study|Randomized but not treated|2|||
127901643|NCT00864097|460265132|FG001|Overall Study|Randomized but not treated|0|||
127901644|NCT00864097|460265133|FG002|Overall Study|Randomized but not treated|1|||
127901645|NCT00864097|460265134|FG003|Overall Study|Randomized but not treated|0|||
127901646|NCT00864097|460265131|FG000|Overall Study|Other|0|||
127845769|NCT00844285|460052751|FG002|Overall Study|Site closure|50|||
127845770|NCT00844285|460052749|FG000|Overall Study|Follow-up < 8 years|16|||
127845771|NCT00844285|460052750|FG001|Overall Study|Follow-up < 8 years|23|||
127845772|NCT00844285|460052751|FG002|Overall Study|Follow-up < 8 years|4|||
127845773|NCT00844285|460052749|FG000|Overall Study|Protocol Violation|26|||
127845774|NCT00844285|460052750|FG001|Overall Study|Protocol Violation|28|||
127901647|NCT00864097|460265132|FG001|Overall Study|Other|0|||
127901648|NCT00864097|460265133|FG002|Overall Study|Other|0|||
127901649|NCT00864097|460265134|FG003|Overall Study|Other|1|||
127901650|NCT00620022|460265138|FG000|Treatment Period 1|Adverse Event|4|||
127901651|NCT00620022|460265139|FG001|Treatment Period 1|Adverse Event|6|||
127901652|NCT00620022|460265138|FG000|Treatment Period 1|Subject withdrew consent|1|||
127901653|NCT00620022|460265139|FG001|Treatment Period 1|Subject withdrew consent|0|||
127901654|NCT00620022|460265138|FG000|Treatment Period 2|Adverse Event|2|||
127901655|NCT00620022|460265139|FG001|Treatment Period 2|Adverse Event|2|||
127901656|NCT02334722|460265140|FG000|Overall Study|Lost to Follow-up|4|||
127901657|NCT02334722|460265141|FG001|Overall Study|Lost to Follow-up|0|||
127901658|NCT02334722|460265140|FG000|Overall Study|6 week questionnaire not completed|2|||
127901659|NCT02334722|460265141|FG001|Overall Study|6 week questionnaire not completed|0|||
127901660|NCT02334722|460265140|FG000|Overall Study|Unable to obtain medication|1|||
127901661|NCT02334722|460265141|FG001|Overall Study|Unable to obtain medication|1|||
127901662|NCT02334722|460265140|FG000|Overall Study|Withdrawal by Subject|0|||
127901663|NCT02334722|460265141|FG001|Overall Study|Withdrawal by Subject|3|||
127901664|NCT02334722|460265140|FG000|Overall Study|Adverse Event|0|||
127901665|NCT02334722|460265141|FG001|Overall Study|Adverse Event|2|||
127901666|NCT02334722|460265140|FG000|Overall Study|Physician Decision|0|||
127845775|NCT00844285|460052751|FG002|Overall Study|Protocol Violation|54|||
127845776|NCT00844285|460052749|FG000|Overall Study|Death|22|||
127845777|NCT00844285|460052750|FG001|Overall Study|Death|21|||
127845778|NCT00844285|460052751|FG002|Overall Study|Death|8|||
127845779|NCT00844285|460052749|FG000|Overall Study|Withdrew Consent|344|||
127845780|NCT00844285|460052750|FG001|Overall Study|Withdrew Consent|466|||
127845781|NCT00844285|460052751|FG002|Overall Study|Withdrew Consent|70|||
127845782|NCT00844285|460052749|FG000|Overall Study|Lost to Follow-up|330|||
127845783|NCT00844285|460052750|FG001|Overall Study|Lost to Follow-up|486|||
127845784|NCT00844285|460052751|FG002|Overall Study|Lost to Follow-up|74|||
127845785|NCT03219567|460052758|FG000|Overall Study|Withdrawal by Subject|0|||
127845786|NCT03219567|460052759|FG001|Overall Study|Withdrawal by Subject|1|||
127845787|NCT02849626|460052762|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
127845788|NCT02849626|460052763|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
127845789|NCT02849626|460052764|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
127845790|NCT02849626|460052765|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
127845791|NCT02849626|460052762|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
127845792|NCT02849626|460052763|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
127845793|NCT02849626|460052764|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
127845794|NCT02849626|460052765|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
127845795|NCT02849626|460052762|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
127845796|NCT02849626|460052763|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
127901667|NCT02334722|460265141|FG001|Overall Study|Physician Decision|1|||
127901668|NCT00856388|460265142|FG000|Overall Study|Other|1|||
127901669|NCT03661528|460265143|FG000|Overall Study|Death|1|||
127845797|NCT02849626|460052764|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
127901670|NCT03661528|460265144|FG001|Overall Study|Death|0|||
127901671|NCT03661528|460265143|FG000|Overall Study|Physician Decision|3|||
127901672|NCT03661528|460265144|FG001|Overall Study|Physician Decision|1|||
127845798|NCT02849626|460052765|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
127901673|NCT03661528|460265143|FG000|Overall Study|Other than Specified|5|||
127845799|NCT02849626|460052762|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
127845800|NCT02849626|460052763|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
127845801|NCT02849626|460052764|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
127845802|NCT02849626|460052765|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
127901674|NCT03661528|460265144|FG001|Overall Study|Other than Specified|2|||
127901675|NCT03661528|460265143|FG000|Overall Study|Withdrawal by Subject|5|||
127845803|NCT02849626|460052762|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
127901676|NCT03661528|460265144|FG001|Overall Study|Withdrawal by Subject|3|||
127901677|NCT03661528|460265143|FG000|Overall Study|Disease Progression|8|||
127845804|NCT02849626|460052763|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
127845805|NCT02849626|460052764|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
127845806|NCT02849626|460052765|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
127845807|NCT02849626|460052762|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
127845808|NCT02849626|460052763|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
127845809|NCT02849626|460052764|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
127845810|NCT02849626|460052765|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
127845811|NCT02849626|460052762|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
127845812|NCT02849626|460052763|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
127845813|NCT02849626|460052764|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
127845814|NCT02849626|460052765|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
127845815|NCT02849626|460052762|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
127845816|NCT02849626|460052763|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
127845817|NCT02849626|460052764|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
127845818|NCT02849626|460052765|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
127845819|NCT02849626|460052762|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
127845820|NCT02849626|460052763|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
127845821|NCT02849626|460052764|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
127845822|NCT02849626|460052765|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
127845823|NCT02849626|460052762|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
127845824|NCT02849626|460052763|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
127845825|NCT02849626|460052764|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
127845826|NCT02849626|460052765|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
127845827|NCT02849626|460052762|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
127845828|NCT02849626|460052763|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
127845829|NCT02849626|460052764|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
127845830|NCT02849626|460052765|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
127845831|NCT01654523|460052766|FG000|Overall Study|Withdrawal by Subject|1|||
127845832|NCT01313208|460052767|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
127845833|NCT01313208|460052768|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
127845834|NCT01313208|460052767|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
127845835|NCT01313208|460052768|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
127845836|NCT01313208|460052767|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
127845837|NCT01313208|460052768|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
127845838|NCT01313208|460052767|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
127845839|NCT01313208|460052768|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
127845840|NCT01313208|460052767|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
127845841|NCT01313208|460052768|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
127845842|NCT01313208|460052767|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
127845843|NCT01313208|460052768|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
127845844|NCT01313208|460052767|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
127845845|NCT01313208|460052768|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
127845846|NCT01313208|460052767|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
127845847|NCT01313208|460052768|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
127845848|NCT01313208|460052767|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
127845849|NCT01313208|460052768|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
127845850|NCT01957787|460052771|FG000|Overall Study|Death|18|||
127845851|NCT01957787|460052771|FG000|Overall Study|Lost to Follow-up|3|||
127845852|NCT01957787|460052771|FG000|Overall Study|Withdrawal by Subject|3|||
127845853|NCT01957787|460052771|FG000|Overall Study|Entered Hospice or Similar Program|2|||
127845854|NCT01957787|460052771|FG000|Overall Study|Index Tumor(s) Resected|2|||
127845855|NCT01957787|460052771|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
127845856|NCT01957787|460052771|FG000|Overall Study|Local therapy, not cryoablation|6|||
127845857|NCT04176445|460052772|FG000|Overall Study|Adverse Event|0|||
127845858|NCT04176445|460052773|FG001|Overall Study|Adverse Event|1|||
127845859|NCT04176445|460052772|FG000|Overall Study|change plans weaning after first intervention|0|||
127845860|NCT04176445|460052773|FG001|Overall Study|change plans weaning after first intervention|1|||
127845861|NCT04046341|460052775|FG000|Overall Study|Lost to Follow-up|2|||
127845862|NCT04046341|460052775|FG000|Overall Study|Withdrawal by Subject|1|||
127845863|NCT00405652|460052778|FG000|Overall Study|Adverse Event|4|||
127845864|NCT00435994|460052780|FG000|Overall Study|Lost to Follow-up|7|||
127845865|NCT00435994|460052781|FG001|Overall Study|Lost to Follow-up|0|||
127845866|NCT00435994|460052782|FG002|Overall Study|Lost to Follow-up|0|||
127845867|NCT03846219|460052786|FG000|Overall Study|Withdrawal by Subject|3|||
127845868|NCT03846219|460052787|FG001|Overall Study|Withdrawal by Subject|2|||
127845869|NCT03846219|460052788|FG002|Overall Study|Withdrawal by Subject|2|||
127845870|NCT03846219|460052786|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
127845871|NCT03846219|460052787|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
127901678|NCT03661528|460265144|FG001|Overall Study|Disease Progression|13|||
127901679|NCT03661528|460265143|FG000|Overall Study|Adverse Event|61|||
127901680|NCT03661528|460265144|FG001|Overall Study|Adverse Event|55|||
127901681|NCT01617668|460265147|FG000|Overall Study|Adverse Event|7|||
127901682|NCT01617668|460265148|FG001|Overall Study|Adverse Event|0|||
127901683|NCT01617668|460265149|FG002|Overall Study|Adverse Event|12|||
127901684|NCT01617668|460265150|FG003|Overall Study|Adverse Event|5|||
127901685|NCT01617668|460265147|FG000|Overall Study|Physician Decision|1|||
127901686|NCT01617668|460265148|FG001|Overall Study|Physician Decision|2|||
127901687|NCT01617668|460265149|FG002|Overall Study|Physician Decision|3|||
127901688|NCT01617668|460265150|FG003|Overall Study|Physician Decision|0|||
127901689|NCT01617668|460265147|FG000|Overall Study|Progressive Disease|4|||
127901690|NCT01617668|460265148|FG001|Overall Study|Progressive Disease|4|||
127901691|NCT01617668|460265149|FG002|Overall Study|Progressive Disease|6|||
127901692|NCT01617668|460265150|FG003|Overall Study|Progressive Disease|9|||
127901693|NCT01617668|460265147|FG000|Overall Study|Subject/guardian decision|1|||
127901694|NCT01617668|460265148|FG001|Overall Study|Subject/guardian decision|3|||
127901695|NCT01617668|460265149|FG002|Overall Study|Subject/guardian decision|2|||
127901696|NCT01617668|460265150|FG003|Overall Study|Subject/guardian decision|1|||
127901697|NCT02017964|460265151|FG000|Overall Study|Patient deemed ineligible|1|||
127901698|NCT00925769|460265152|FG000|Overall Study|Major toxicity|1|||
127901699|NCT00925769|460265153|FG001|Overall Study|Major toxicity|0|||
127901700|NCT00925769|460265154|FG002|Overall Study|Major toxicity|1|||
127901701|NCT00925769|460265155|FG003|Overall Study|Major toxicity|1|||
127901702|NCT00925769|460265156|FG004|Overall Study|Major toxicity|0|||
127901703|NCT00925769|460265157|FG005|Overall Study|Major toxicity|0|||
127901704|NCT00925769|460265152|FG000|Overall Study|Disease progression|4|||
127901705|NCT00925769|460265153|FG001|Overall Study|Disease progression|5|||
127901706|NCT00925769|460265154|FG002|Overall Study|Disease progression|3|||
127901707|NCT00925769|460265155|FG003|Overall Study|Disease progression|4|||
127901708|NCT00925769|460265156|FG004|Overall Study|Disease progression|2|||
127901709|NCT00925769|460265157|FG005|Overall Study|Disease progression|3|||
127901710|NCT00925769|460265152|FG000|Overall Study|Death|0|||
127901711|NCT00925769|460265153|FG001|Overall Study|Death|0|||
127901712|NCT00925769|460265154|FG002|Overall Study|Death|1|||
127901713|NCT00925769|460265155|FG003|Overall Study|Death|0|||
127901714|NCT00925769|460265156|FG004|Overall Study|Death|0|||
127901715|NCT00925769|460265157|FG005|Overall Study|Death|0|||
127901716|NCT00925769|460265152|FG000|Overall Study|Physician Decision|1|||
127901717|NCT00925769|460265153|FG001|Overall Study|Physician Decision|0|||
127901718|NCT00925769|460265154|FG002|Overall Study|Physician Decision|0|||
127901719|NCT00925769|460265155|FG003|Overall Study|Physician Decision|0|||
127901720|NCT00925769|460265156|FG004|Overall Study|Physician Decision|0|||
127901721|NCT00925769|460265157|FG005|Overall Study|Physician Decision|0|||
127901722|NCT00925769|460265152|FG000|Overall Study|Missing documentation|0|||
127901723|NCT00925769|460265153|FG001|Overall Study|Missing documentation|1|||
127901724|NCT00925769|460265154|FG002|Overall Study|Missing documentation|0|||
127901725|NCT00925769|460265155|FG003|Overall Study|Missing documentation|0|||
127901726|NCT00925769|460265156|FG004|Overall Study|Missing documentation|0|||
127901727|NCT00925769|460265157|FG005|Overall Study|Missing documentation|0|||
127901728|NCT00925769|460265152|FG000|Overall Study|End of study visit not done|0|||
127901729|NCT00925769|460265153|FG001|Overall Study|End of study visit not done|0|||
127901730|NCT00925769|460265154|FG002|Overall Study|End of study visit not done|1|||
127901731|NCT00925769|460265155|FG003|Overall Study|End of study visit not done|0|||
127901732|NCT00925769|460265156|FG004|Overall Study|End of study visit not done|0|||
127901733|NCT00925769|460265157|FG005|Overall Study|End of study visit not done|0|||
127901734|NCT00925769|460265152|FG000|Overall Study|Participant is unable to swallow drug|0|||
127901735|NCT00925769|460265153|FG001|Overall Study|Participant is unable to swallow drug|0|||
127901736|NCT00925769|460265154|FG002|Overall Study|Participant is unable to swallow drug|0|||
127901737|NCT00925769|460265155|FG003|Overall Study|Participant is unable to swallow drug|1|||
127901738|NCT00925769|460265156|FG004|Overall Study|Participant is unable to swallow drug|0|||
127901739|NCT00925769|460265157|FG005|Overall Study|Participant is unable to swallow drug|0|||
127901740|NCT00925769|460265152|FG000|Overall Study|Adverse Event|0|||
127901741|NCT00925769|460265153|FG001|Overall Study|Adverse Event|0|||
127901742|NCT00925769|460265154|FG002|Overall Study|Adverse Event|0|||
127901743|NCT00925769|460265155|FG003|Overall Study|Adverse Event|0|||
127901744|NCT00925769|460265156|FG004|Overall Study|Adverse Event|1|||
127901745|NCT00925769|460265157|FG005|Overall Study|Adverse Event|0|||
127901746|NCT00686959|460265159|FG000|Overall Study|Participants censored (no death events)|124|||
127901747|NCT00686959|460265160|FG001|Overall Study|Participants censored (no death events)|117|||
127901748|NCT00150462|460265161|FG000|Overall Study|Disease Progression or Relapse|3|||
127901749|NCT00150462|460265162|FG001|Overall Study|Disease Progression or Relapse|1|||
127901750|NCT00150462|460265163|FG002|Overall Study|Disease Progression or Relapse|2|||
127901751|NCT00150462|460265164|FG003|Overall Study|Disease Progression or Relapse|1|||
127901752|NCT00150462|460265165|FG004|Overall Study|Disease Progression or Relapse|2|||
127901753|NCT00150462|460265166|FG005|Overall Study|Disease Progression or Relapse|2|||
127901754|NCT00150462|460265167|FG006|Overall Study|Disease Progression or Relapse|3|||
127901755|NCT00150462|460265168|FG007|Overall Study|Disease Progression or Relapse|5|||
127901756|NCT00150462|460265169|FG008|Overall Study|Disease Progression or Relapse|5|||
127845872|NCT03846219|460052788|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
127845873|NCT03846219|460052786|FG000|Overall Study|Physician Decision|0|||
127845874|NCT03846219|460052787|FG001|Overall Study|Physician Decision|0|||
127845875|NCT03846219|460052788|FG002|Overall Study|Physician Decision|2|||
127845876|NCT05109702|460052789|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
127845877|NCT05109702|460052790|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
127845878|NCT05109702|460052791|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
127845879|NCT05109702|460052789|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
127845880|NCT05109702|460052790|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
127845881|NCT05109702|460052791|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
127845882|NCT05109702|460052789|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
127845883|NCT05109702|460052790|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
127845884|NCT05109702|460052791|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
127845885|NCT05109702|460052789|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
127845886|NCT05109702|460052790|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
127845887|NCT05109702|460052791|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
127845888|NCT05109702|460052789|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
127845889|NCT05109702|460052790|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
127845890|NCT05109702|460052791|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
127845891|NCT01392378|460052796|FG000|Infant Series|Adverse Event|0|||
127845892|NCT01392378|460052797|FG001|Infant Series|Adverse Event|0|||
127845893|NCT01392378|460052798|FG002|Infant Series|Adverse Event|0|||
127845894|NCT01392378|460052799|FG003|Infant Series|Adverse Event|1|||
127845895|NCT01392378|460052800|FG004|Infant Series|Adverse Event|0|||
127845896|NCT01392378|460052796|FG000|Infant Series|Lost to Follow-up|0|||
127845897|NCT01392378|460052797|FG001|Infant Series|Lost to Follow-up|0|||
127845898|NCT01392378|460052798|FG002|Infant Series|Lost to Follow-up|0|||
127845899|NCT01392378|460052799|FG003|Infant Series|Lost to Follow-up|1|||
127845900|NCT01392378|460052800|FG004|Infant Series|Lost to Follow-up|0|||
127845901|NCT01392378|460052796|FG000|Infant Series|Protocol Violation|0|||
127845902|NCT01392378|460052797|FG001|Infant Series|Protocol Violation|1|||
127845903|NCT01392378|460052798|FG002|Infant Series|Protocol Violation|0|||
127845904|NCT01392378|460052799|FG003|Infant Series|Protocol Violation|0|||
127845905|NCT01392378|460052800|FG004|Infant Series|Protocol Violation|0|||
127845906|NCT01392378|460052796|FG000|Infant Series|Withdrawal by Parent|4|||
127845907|NCT01392378|460052797|FG001|Infant Series|Withdrawal by Parent|1|||
127845908|NCT01392378|460052798|FG002|Infant Series|Withdrawal by Parent|0|||
127845909|NCT01392378|460052799|FG003|Infant Series|Withdrawal by Parent|0|||
127845910|NCT01392378|460052800|FG004|Infant Series|Withdrawal by Parent|0|||
127845911|NCT01392378|460052796|FG000|After Infant Series|Lost to Follow-up|0|||
127845912|NCT01392378|460052797|FG001|After Infant Series|Lost to Follow-up|0|||
127845913|NCT01392378|460052798|FG002|After Infant Series|Lost to Follow-up|1|||
127845914|NCT01392378|460052799|FG003|After Infant Series|Lost to Follow-up|0|||
127845915|NCT01392378|460052800|FG004|After Infant Series|Lost to Follow-up|0|||
127845916|NCT01392378|460052796|FG000|After Infant Series|Withdrawal by Parent|0|||
127845917|NCT01392378|460052797|FG001|After Infant Series|Withdrawal by Parent|1|||
127845918|NCT01392378|460052798|FG002|After Infant Series|Withdrawal by Parent|1|||
127845919|NCT01392378|460052799|FG003|After Infant Series|Withdrawal by Parent|0|||
127845920|NCT01392378|460052800|FG004|After Infant Series|Withdrawal by Parent|1|||
127845921|NCT01392378|460052796|FG000|Toddler Dose|Lost to Follow-up|0|||
127845922|NCT01392378|460052797|FG001|Toddler Dose|Lost to Follow-up|0|||
127845923|NCT01392378|460052798|FG002|Toddler Dose|Lost to Follow-up|0|||
127845924|NCT01392378|460052799|FG003|Toddler Dose|Lost to Follow-up|1|||
127845925|NCT01392378|460052800|FG004|Toddler Dose|Lost to Follow-up|0|||
127845926|NCT01392378|460052796|FG000|Toddler Dose|Withdrawal by Parent|0|||
127845927|NCT01392378|460052797|FG001|Toddler Dose|Withdrawal by Parent|1|||
127845928|NCT01392378|460052798|FG002|Toddler Dose|Withdrawal by Parent|0|||
127845929|NCT01392378|460052799|FG003|Toddler Dose|Withdrawal by Parent|1|||
127845930|NCT01392378|460052800|FG004|Toddler Dose|Withdrawal by Parent|1|||
127845931|NCT02322411|460052801|FG000|Overall Study|Lost to Follow-up|4|||
127845932|NCT02322411|460052802|FG001|Overall Study|Lost to Follow-up|7|||
127845933|NCT02322411|460052801|FG000|Overall Study|Withdrawal by Subject|1|||
127845934|NCT02322411|460052802|FG001|Overall Study|Withdrawal by Subject|0|||
127845935|NCT02713789|460052808|FG000|Overall Study|Lost to Follow-up|0|||
127845936|NCT02713789|460052809|FG001|Overall Study|Lost to Follow-up|1|||
127845937|NCT02713789|460052810|FG002|Overall Study|Lost to Follow-up|1|||
127845938|NCT00367432|460052811|FG000|First Period (16 Weeks)|Adverse Event|6|||
127845939|NCT00367432|460052812|FG001|First Period (16 Weeks)|Adverse Event|0|||
127845940|NCT00367432|460052811|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
127845941|NCT00367432|460052812|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
127845942|NCT00367432|460052811|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
127845943|NCT00367432|460052812|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
127845944|NCT00367432|460052811|FG000|First Period (16 Weeks)|Other Reason|2|||
127845945|NCT00367432|460052812|FG001|First Period (16 Weeks)|Other Reason|0|||
127845946|NCT00367432|460052811|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
127845947|NCT00367432|460052812|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
127901757|NCT00150462|460265170|FG009|Overall Study|Disease Progression or Relapse|3|||
127901758|NCT00150462|460265171|FG010|Overall Study|Disease Progression or Relapse|2|||
127901759|NCT00150462|460265161|FG000|Overall Study|Withdrawal by Subject|0|||
127901760|NCT00150462|460265162|FG001|Overall Study|Withdrawal by Subject|1|||
127901761|NCT00150462|460265163|FG002|Overall Study|Withdrawal by Subject|1|||
127901762|NCT00150462|460265164|FG003|Overall Study|Withdrawal by Subject|0|||
127901763|NCT00150462|460265165|FG004|Overall Study|Withdrawal by Subject|1|||
127901764|NCT00150462|460265166|FG005|Overall Study|Withdrawal by Subject|2|||
127901765|NCT00150462|460265167|FG006|Overall Study|Withdrawal by Subject|0|||
127901766|NCT00150462|460265168|FG007|Overall Study|Withdrawal by Subject|1|||
127901767|NCT00150462|460265169|FG008|Overall Study|Withdrawal by Subject|0|||
127901768|NCT00150462|460265170|FG009|Overall Study|Withdrawal by Subject|1|||
127901769|NCT00150462|460265171|FG010|Overall Study|Withdrawal by Subject|0|||
127901770|NCT00150462|460265161|FG000|Overall Study|Death|0|||
127901771|NCT00150462|460265162|FG001|Overall Study|Death|1|||
127901772|NCT00150462|460265163|FG002|Overall Study|Death|0|||
127901773|NCT00150462|460265164|FG003|Overall Study|Death|0|||
127901774|NCT00150462|460265165|FG004|Overall Study|Death|0|||
127901775|NCT00150462|460265166|FG005|Overall Study|Death|0|||
127901776|NCT00150462|460265167|FG006|Overall Study|Death|0|||
127901777|NCT00150462|460265168|FG007|Overall Study|Death|0|||
127901778|NCT00150462|460265169|FG008|Overall Study|Death|1|||
127901779|NCT00150462|460265170|FG009|Overall Study|Death|0|||
127901780|NCT00150462|460265171|FG010|Overall Study|Death|0|||
127901781|NCT00150462|460265161|FG000|Overall Study|Adverse Event|0|||
127901782|NCT00150462|460265162|FG001|Overall Study|Adverse Event|0|||
127901783|NCT00150462|460265163|FG002|Overall Study|Adverse Event|0|||
127901784|NCT00150462|460265164|FG003|Overall Study|Adverse Event|1|||
127901785|NCT00150462|460265165|FG004|Overall Study|Adverse Event|0|||
127901786|NCT00150462|460265166|FG005|Overall Study|Adverse Event|0|||
127901787|NCT00150462|460265167|FG006|Overall Study|Adverse Event|0|||
127901788|NCT00150462|460265168|FG007|Overall Study|Adverse Event|2|||
127901789|NCT00150462|460265169|FG008|Overall Study|Adverse Event|0|||
127901790|NCT00150462|460265170|FG009|Overall Study|Adverse Event|1|||
127901791|NCT00150462|460265171|FG010|Overall Study|Adverse Event|0|||
127901792|NCT00150462|460265161|FG000|Overall Study|Physician Decision|0|||
127901793|NCT00150462|460265162|FG001|Overall Study|Physician Decision|0|||
127901794|NCT00150462|460265163|FG002|Overall Study|Physician Decision|1|||
127901795|NCT00150462|460265164|FG003|Overall Study|Physician Decision|1|||
127901796|NCT00150462|460265165|FG004|Overall Study|Physician Decision|0|||
127901797|NCT00150462|460265166|FG005|Overall Study|Physician Decision|0|||
127901798|NCT00150462|460265167|FG006|Overall Study|Physician Decision|0|||
127901799|NCT00150462|460265168|FG007|Overall Study|Physician Decision|0|||
127901800|NCT00150462|460265169|FG008|Overall Study|Physician Decision|0|||
127901801|NCT00150462|460265170|FG009|Overall Study|Physician Decision|0|||
127901802|NCT00150462|460265171|FG010|Overall Study|Physician Decision|0|||
127901803|NCT00150462|460265161|FG000|Overall Study|Other|0|||
127901804|NCT00150462|460265162|FG001|Overall Study|Other|0|||
127901805|NCT00150462|460265163|FG002|Overall Study|Other|0|||
127901806|NCT00150462|460265164|FG003|Overall Study|Other|0|||
127901807|NCT00150462|460265165|FG004|Overall Study|Other|0|||
127901808|NCT00150462|460265166|FG005|Overall Study|Other|0|||
127901809|NCT00150462|460265167|FG006|Overall Study|Other|0|||
127901810|NCT00150462|460265168|FG007|Overall Study|Other|0|||
127901811|NCT00150462|460265169|FG008|Overall Study|Other|0|||
127901812|NCT00150462|460265170|FG009|Overall Study|Other|1|||
127901813|NCT00150462|460265171|FG010|Overall Study|Other|1|||
127901814|NCT01196052|460265174|FG000|Overall Study|Adverse Event|9|||
127901815|NCT01196052|460265174|FG000|Overall Study|Lost to Follow-up|1|||
127901816|NCT01196052|460265174|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
127901817|NCT01196052|460265174|FG000|Overall Study|Reason not Specified|5|||
127901818|NCT01196052|460265174|FG000|Overall Study|Withdrawal by Subject|6|||
127901819|NCT02178722|460265175|FG000|Overall Study|Withdrawal by Subject|0|||
127901820|NCT02178722|460265176|FG001|Overall Study|Withdrawal by Subject|0|||
127901821|NCT02178722|460265177|FG002|Overall Study|Withdrawal by Subject|0|||
127901822|NCT02178722|460265178|FG003|Overall Study|Withdrawal by Subject|2|||
127901823|NCT02178722|460265179|FG004|Overall Study|Withdrawal by Subject|33|||
127901824|NCT02178722|460265175|FG000|Overall Study|Death|2|||
127901825|NCT02178722|460265176|FG001|Overall Study|Death|13|||
127901826|NCT02178722|460265177|FG002|Overall Study|Death|12|||
127901827|NCT02178722|460265178|FG003|Overall Study|Death|12|||
127901828|NCT02178722|460265179|FG004|Overall Study|Death|205|||
127901829|NCT02178722|460265175|FG000|Overall Study|Lost to Follow-up|0|||
127901830|NCT02178722|460265176|FG001|Overall Study|Lost to Follow-up|0|||
127901831|NCT02178722|460265177|FG002|Overall Study|Lost to Follow-up|0|||
127901832|NCT02178722|460265178|FG003|Overall Study|Lost to Follow-up|2|||
127901833|NCT02178722|460265179|FG004|Overall Study|Lost to Follow-up|11|||
127901834|NCT02178722|460265175|FG000|Overall Study|Study terminated by Sponsor|2|||
127901835|NCT02178722|460265176|FG001|Overall Study|Study terminated by Sponsor|7|||
127901836|NCT02178722|460265177|FG002|Overall Study|Study terminated by Sponsor|6|||
127901837|NCT02178722|460265178|FG003|Overall Study|Study terminated by Sponsor|4|||
127901838|NCT02178722|460265179|FG004|Overall Study|Study terminated by Sponsor|128|||
127901839|NCT02178722|460265175|FG000|Overall Study|Physician Decision|0|||
127901840|NCT02178722|460265176|FG001|Overall Study|Physician Decision|0|||
127901841|NCT02178722|460265177|FG002|Overall Study|Physician Decision|0|||
127901842|NCT02178722|460265178|FG003|Overall Study|Physician Decision|0|||
127901843|NCT02178722|460265179|FG004|Overall Study|Physician Decision|3|||
127901844|NCT02178722|460265175|FG000|Overall Study|Other|0|||
127901845|NCT02178722|460265176|FG001|Overall Study|Other|0|||
127901846|NCT02178722|460265177|FG002|Overall Study|Other|0|||
127901847|NCT02178722|460265178|FG003|Overall Study|Other|0|||
127901848|NCT02178722|460265179|FG004|Overall Study|Other|2|||
127901849|NCT03553823|460265180|FG000|Overall Study|Physician Decision|0|||
127901850|NCT03553823|460265181|FG001|Overall Study|Physician Decision|1|||
127901851|NCT01572948|460265182|FG000|Overall Study|Lost to Follow-up|1|||
127901852|NCT01572948|460265183|FG001|Overall Study|Lost to Follow-up|0|||
127901853|NCT01572948|460265182|FG000|Overall Study|unable to contact|0|||
127901854|NCT01572948|460265183|FG001|Overall Study|unable to contact|1|||
127901855|NCT03340727|460265184|FG000|Overall Study|Death|1|||
127901856|NCT03340727|460265185|FG001|Overall Study|Death|0|||
127901857|NCT03340727|460265184|FG000|Overall Study|Lost to Follow-up|31|||
127901858|NCT03340727|460265185|FG001|Overall Study|Lost to Follow-up|35|||
127901859|NCT03340727|460265184|FG000|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
127901860|NCT03340727|460265185|FG001|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
127901861|NCT03340727|460265184|FG000|Overall Study|Transferred to another facility|10|||
127901862|NCT03340727|460265185|FG001|Overall Study|Transferred to another facility|7|||
127901863|NCT03340727|460265184|FG000|Overall Study|Withdrawal by Subject|28|||
127901864|NCT03340727|460265185|FG001|Overall Study|Withdrawal by Subject|17|||
127901865|NCT01720264|460265186|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
127901866|NCT01720264|460265186|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
127901867|NCT01720264|460265186|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
127901868|NCT00877032|460265187|FG000|Overall Study|Did not meet entrance criteria|0|||
127901869|NCT00877032|460265188|FG001|Overall Study|Did not meet entrance criteria|0|||
127901870|NCT00877032|460265189|FG002|Overall Study|Did not meet entrance criteria|0|||
127901871|NCT00877032|460265190|FG003|Overall Study|Did not meet entrance criteria|1|||
127901872|NCT00877032|460265191|FG004|Overall Study|Did not meet entrance criteria|0|||
127901873|NCT00877032|460265192|FG005|Overall Study|Did not meet entrance criteria|0|||
127901874|NCT00877032|460265193|FG006|Overall Study|Did not meet entrance criteria|2|||
127901875|NCT00615069|460265203|FG000|Overall Study|Death|10|||
127901876|NCT00615069|460265203|FG000|Overall Study|Physician Decision|2|||
127901877|NCT00615069|460265203|FG000|Overall Study|Withdrawal by Subject|4|||
127901878|NCT00669942|460265205|FG000|Parts 2 and 3|Adverse Event|0|||
127901879|NCT00669942|460265206|FG001|Parts 2 and 3|Adverse Event|0|||
127901880|NCT00669942|460265207|FG002|Parts 2 and 3|Adverse Event|0|||
127901881|NCT00669942|460265208|FG003|Parts 2 and 3|Adverse Event|0|||
127901882|NCT00669942|460265209|FG004|Parts 2 and 3|Adverse Event|0|||
127901883|NCT00669942|460265210|FG005|Parts 2 and 3|Adverse Event|0|||
127901884|NCT00669942|460265211|FG006|Parts 2 and 3|Adverse Event|0|||
127901885|NCT00669942|460265212|FG007|Parts 2 and 3|Adverse Event|2|||
127901886|NCT00669942|460265213|FG008|Parts 2 and 3|Adverse Event|1|||
127901887|NCT00669942|460265214|FG009|Parts 2 and 3|Adverse Event|0|||
127901888|NCT00669942|460265215|FG010|Parts 2 and 3|Adverse Event|0|||
127901889|NCT00669942|460265216|FG011|Parts 2 and 3|Adverse Event|0|||
127901890|NCT00669942|460265205|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
127901891|NCT00669942|460265206|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
127901892|NCT00669942|460265207|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
127901893|NCT00669942|460265208|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
127901894|NCT00669942|460265209|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
127901895|NCT00669942|460265210|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
127901896|NCT00669942|460265211|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
127901897|NCT00669942|460265212|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
127901898|NCT00669942|460265213|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
127901899|NCT00669942|460265214|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
127901900|NCT00669942|460265215|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
127901901|NCT00669942|460265216|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
127901902|NCT00669942|460265205|FG000|Parts 2 and 3|Protocol Violation|0|||
127901903|NCT00669942|460265206|FG001|Parts 2 and 3|Protocol Violation|0|||
127901904|NCT00669942|460265207|FG002|Parts 2 and 3|Protocol Violation|0|||
127901905|NCT00669942|460265208|FG003|Parts 2 and 3|Protocol Violation|0|||
127901906|NCT00669942|460265209|FG004|Parts 2 and 3|Protocol Violation|0|||
127901907|NCT00669942|460265210|FG005|Parts 2 and 3|Protocol Violation|1|||
127901908|NCT00669942|460265211|FG006|Parts 2 and 3|Protocol Violation|0|||
127901909|NCT00669942|460265212|FG007|Parts 2 and 3|Protocol Violation|0|||
127901910|NCT00669942|460265213|FG008|Parts 2 and 3|Protocol Violation|0|||
127901911|NCT00669942|460265214|FG009|Parts 2 and 3|Protocol Violation|0|||
127901912|NCT00669942|460265215|FG010|Parts 2 and 3|Protocol Violation|0|||
127901913|NCT00669942|460265216|FG011|Parts 2 and 3|Protocol Violation|0|||
127901914|NCT00259012|460265218|FG000|Overall Study|Adverse Event|0|||
127901915|NCT00259012|460265219|FG001|Overall Study|Adverse Event|1|||
127901916|NCT00259012|460265218|FG000|Overall Study|Withdrawal by Subject|1|||
127901917|NCT00259012|460265219|FG001|Overall Study|Withdrawal by Subject|0|||
127901918|NCT00259012|460265218|FG000|Overall Study|Physician Decision|0|||
127901919|NCT00259012|460265219|FG001|Overall Study|Physician Decision|1|||
127901920|NCT00259012|460265218|FG000|Overall Study|Lost to Follow-up|0|||
127901921|NCT00259012|460265219|FG001|Overall Study|Lost to Follow-up|1|||
127901922|NCT00259012|460265218|FG000|Overall Study|Protocol Violation|1|||
127901923|NCT00259012|460265219|FG001|Overall Study|Protocol Violation|1|||
127901924|NCT00870870|460265223|FG000|Overall Study|Withdrawal by Subject|0|||
127901925|NCT00870870|460265224|FG001|Overall Study|Withdrawal by Subject|1|||
127901926|NCT00870870|460265225|FG002|Overall Study|Withdrawal by Subject|1|||
127901927|NCT00870870|460265226|FG003|Overall Study|Withdrawal by Subject|3|||
127901928|NCT00870870|460265223|FG000|Overall Study|Adverse Event|0|||
127901929|NCT00870870|460265224|FG001|Overall Study|Adverse Event|0|||
127901930|NCT00870870|460265225|FG002|Overall Study|Adverse Event|2|||
127901931|NCT00870870|460265226|FG003|Overall Study|Adverse Event|2|||
127901932|NCT03125200|460265229|FG000|Overall Study|Study Termination|0|||
127901933|NCT03125200|460265230|FG001|Overall Study|Study Termination|0|||
127901934|NCT03125200|460265231|FG002|Overall Study|Study Termination|0|||
127901935|NCT03125200|460265232|FG003|Overall Study|Study Termination|1|||
127901936|NCT03125200|460265233|FG004|Overall Study|Study Termination|1|||
127901937|NCT03125200|460265234|FG005|Overall Study|Study Termination|2|||
127901938|NCT03125200|460265235|FG006|Overall Study|Study Termination|1|||
127901939|NCT03125200|460265229|FG000|Overall Study|Clinical Progression|0|||
127901940|NCT03125200|460265230|FG001|Overall Study|Clinical Progression|0|||
127901941|NCT03125200|460265231|FG002|Overall Study|Clinical Progression|0|||
127901942|NCT03125200|460265232|FG003|Overall Study|Clinical Progression|1|||
127901943|NCT03125200|460265233|FG004|Overall Study|Clinical Progression|0|||
127901944|NCT03125200|460265234|FG005|Overall Study|Clinical Progression|1|||
127901945|NCT03125200|460265235|FG006|Overall Study|Clinical Progression|0|||
127901946|NCT03125200|460265229|FG000|Overall Study|Progressive Disease|2|||
127901947|NCT03125200|460265230|FG001|Overall Study|Progressive Disease|1|||
127901948|NCT03125200|460265231|FG002|Overall Study|Progressive Disease|2|||
127901949|NCT03125200|460265232|FG003|Overall Study|Progressive Disease|1|||
127901950|NCT03125200|460265233|FG004|Overall Study|Progressive Disease|2|||
127901951|NCT03125200|460265234|FG005|Overall Study|Progressive Disease|0|||
127901952|NCT03125200|460265235|FG006|Overall Study|Progressive Disease|1|||
127901953|NCT03125200|460265229|FG000|Overall Study|Lack of Efficacy|0|||
127901954|NCT03125200|460265230|FG001|Overall Study|Lack of Efficacy|0|||
127901955|NCT03125200|460265231|FG002|Overall Study|Lack of Efficacy|0|||
127901956|NCT03125200|460265232|FG003|Overall Study|Lack of Efficacy|1|||
127901957|NCT03125200|460265233|FG004|Overall Study|Lack of Efficacy|0|||
127901958|NCT03125200|460265234|FG005|Overall Study|Lack of Efficacy|0|||
127901959|NCT03125200|460265235|FG006|Overall Study|Lack of Efficacy|0|||
127901960|NCT03125200|460265229|FG000|Overall Study|Toxicity|0|||
127901961|NCT03125200|460265230|FG001|Overall Study|Toxicity|0|||
127901962|NCT03125200|460265231|FG002|Overall Study|Toxicity|0|||
127901963|NCT03125200|460265232|FG003|Overall Study|Toxicity|1|||
127901964|NCT03125200|460265233|FG004|Overall Study|Toxicity|0|||
127901965|NCT03125200|460265234|FG005|Overall Study|Toxicity|0|||
127901966|NCT03125200|460265235|FG006|Overall Study|Toxicity|0|||
127901967|NCT03125200|460265229|FG000|Overall Study|Consent Withdrawn by Subject|0|||
127845948|NCT00367432|460052811|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
127845949|NCT00367432|460052812|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
127845950|NCT00367432|460052811|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
127845951|NCT00367432|460052812|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
127845952|NCT00367432|460052811|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
127845953|NCT00367432|460052812|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
127845954|NCT00367432|460052811|FG000|Second Period (up to 54 Months)|Other Reason|6|||
127845955|NCT00367432|460052812|FG001|Second Period (up to 54 Months)|Other Reason|2|||
127845956|NCT00903370|460052813|FG000|Overall Study|Death|13|||
127845957|NCT00903370|460052814|FG001|Overall Study|Death|10|||
127845958|NCT00903370|460052813|FG000|Overall Study|Withdrawal by Subject|9|||
127845959|NCT00903370|460052814|FG001|Overall Study|Withdrawal by Subject|6|||
127845960|NCT00903370|460052813|FG000|Overall Study|Lost to Follow-up|6|||
127845961|NCT00903370|460052814|FG001|Overall Study|Lost to Follow-up|8|||
127845962|NCT00014911|460052815|FG000|Overall Study|Adverse Event|1|||
127901968|NCT03125200|460265230|FG001|Overall Study|Consent Withdrawn by Subject|1|||
127901969|NCT03125200|460265231|FG002|Overall Study|Consent Withdrawn by Subject|0|||
127901970|NCT03125200|460265232|FG003|Overall Study|Consent Withdrawn by Subject|0|||
127901971|NCT03125200|460265233|FG004|Overall Study|Consent Withdrawn by Subject|1|||
127901972|NCT03125200|460265234|FG005|Overall Study|Consent Withdrawn by Subject|0|||
127901973|NCT03125200|460265235|FG006|Overall Study|Consent Withdrawn by Subject|1|||
127845963|NCT00014911|460052815|FG000|Overall Study|Lost to Follow-up|1|||
127845964|NCT00014911|460052815|FG000|Overall Study|Withdrawal by Subject|6|||
127845965|NCT00014911|460052815|FG000|Overall Study|Unknown Reasons|2|||
127901974|NCT00119379|460265239|FG000|Overall Study|Adverse Event|4|||
127901975|NCT00119379|460265240|FG001|Overall Study|Adverse Event|1|||
127901976|NCT01937390|460265246|FG000|Overall Study|Death|2|||
127901977|NCT01937390|460265246|FG000|Overall Study|Lost to Follow-up|7|||
127901978|NCT01937390|460265246|FG000|Overall Study|Withdrawal by Subject|5|||
127901979|NCT01937390|460265246|FG000|Overall Study|Fail to return|21|||
127901980|NCT01706536|460265249|FG000|Overall Study|Withdrawal by Subject|1|||
127845966|NCT00014911|460052815|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
127845967|NCT01924299|460052816|FG000|Period 2|Withdrawal by Subject|1|||
127845968|NCT01924299|460052817|FG001|Period 2|Withdrawal by Subject|0|||
127845969|NCT01924299|460052816|FG000|Period 2|Adverse Event|0|||
127845970|NCT01924299|460052817|FG001|Period 2|Adverse Event|1|||
127845971|NCT01999946|460052821|FG000|Overall Study|Participant not released from jail|2|||
127845972|NCT01999946|460052822|FG001|Overall Study|Participant not released from jail|2|||
127845973|NCT01999946|460052823|FG002|Overall Study|Participant not released from jail|0|||
127845974|NCT01999946|460052821|FG000|Overall Study|Not included in primary outcome analysis|0|||
127845975|NCT01999946|460052822|FG001|Overall Study|Not included in primary outcome analysis|0|||
127845976|NCT01999946|460052823|FG002|Overall Study|Not included in primary outcome analysis|79|||
127845977|NCT01230749|460052829|FG000|Overall Study|Adverse Event|0|||
127845978|NCT01230749|460052830|FG001|Overall Study|Adverse Event|0|||
127845979|NCT01230749|460052831|FG002|Overall Study|Adverse Event|0|||
127845980|NCT01230749|460052832|FG003|Overall Study|Adverse Event|1|||
127845981|NCT01230749|460052829|FG000|Overall Study|Physician Decision|0|||
127845982|NCT01230749|460052830|FG001|Overall Study|Physician Decision|0|||
127845983|NCT01230749|460052831|FG002|Overall Study|Physician Decision|1|||
127845984|NCT01230749|460052832|FG003|Overall Study|Physician Decision|0|||
127845985|NCT01230749|460052829|FG000|Overall Study|Withdrawal by Subject|0|||
127845986|NCT01230749|460052830|FG001|Overall Study|Withdrawal by Subject|1|||
127845987|NCT01230749|460052831|FG002|Overall Study|Withdrawal by Subject|0|||
127845988|NCT01230749|460052832|FG003|Overall Study|Withdrawal by Subject|0|||
127845989|NCT01230749|460052829|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
127845990|NCT01230749|460052830|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
127845991|NCT01230749|460052831|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
127845992|NCT01230749|460052832|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
127845993|NCT04021706|460054092|FG000|Overall Study|Adverse Event|2|||
127845994|NCT04021706|460054093|FG001|Overall Study|Adverse Event|0|||
127845995|NCT04021706|460054092|FG000|Overall Study|Withdrawal by Subject|1|||
127845996|NCT04021706|460054093|FG001|Overall Study|Withdrawal by Subject|2|||
127845997|NCT04021706|460054092|FG000|Overall Study|Physician Decision|1|||
127845998|NCT04021706|460054093|FG001|Overall Study|Physician Decision|0|||
127845999|NCT00355134|460054096|FG000|Core Phase|Withdrawal by Subject|35|||
127846000|NCT00355134|460054097|FG001|Core Phase|Withdrawal by Subject|24|||
127846001|NCT00355134|460054098|FG002|Core Phase|Withdrawal by Subject|35|||
127846002|NCT00355134|460054099|FG003|Core Phase|Withdrawal by Subject|0|||
127846003|NCT00355134|460054100|FG004|Core Phase|Withdrawal by Subject|0|||
127846004|NCT00355134|460054096|FG000|Core Phase|Adverse Event|28|||
127846005|NCT00355134|460054097|FG001|Core Phase|Adverse Event|22|||
127846006|NCT00355134|460054098|FG002|Core Phase|Adverse Event|16|||
127846007|NCT00355134|460054099|FG003|Core Phase|Adverse Event|0|||
127846008|NCT00355134|460054100|FG004|Core Phase|Adverse Event|0|||
127846009|NCT00355134|460054096|FG000|Core Phase|Lost to Follow-up|17|||
127846010|NCT00355134|460054097|FG001|Core Phase|Lost to Follow-up|13|||
127846011|NCT00355134|460054098|FG002|Core Phase|Lost to Follow-up|21|||
127846012|NCT00355134|460054099|FG003|Core Phase|Lost to Follow-up|0|||
127846013|NCT00355134|460054100|FG004|Core Phase|Lost to Follow-up|0|||
127846014|NCT00355134|460054096|FG000|Core Phase|Abnormal laboratory value(s)|19|||
127846015|NCT00355134|460054097|FG001|Core Phase|Abnormal laboratory value(s)|14|||
127846016|NCT00355134|460054098|FG002|Core Phase|Abnormal laboratory value(s)|2|||
127846017|NCT00355134|460054099|FG003|Core Phase|Abnormal laboratory value(s)|0|||
127846018|NCT00355134|460054100|FG004|Core Phase|Abnormal laboratory value(s)|0|||
127846019|NCT00355134|460054096|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
127846020|NCT00355134|460054097|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
127901981|NCT01706536|460265250|FG001|Overall Study|Withdrawal by Subject|0|||
127901982|NCT01706536|460265251|FG002|Overall Study|Withdrawal by Subject|1|||
127901983|NCT01706536|460265252|FG003|Overall Study|Withdrawal by Subject|0|||
127846021|NCT00355134|460054098|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
127901984|NCT01706536|460265253|FG004|Overall Study|Withdrawal by Subject|0|||
127846022|NCT00355134|460054099|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
127846023|NCT00355134|460054100|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
127846024|NCT00355134|460054096|FG000|Core Phase|Administrative problems|5|||
127846025|NCT00355134|460054097|FG001|Core Phase|Administrative problems|3|||
127846026|NCT00355134|460054098|FG002|Core Phase|Administrative problems|5|||
127846027|NCT00355134|460054099|FG003|Core Phase|Administrative problems|0|||
127846028|NCT00355134|460054100|FG004|Core Phase|Administrative problems|0|||
127846029|NCT00355134|460054096|FG000|Core Phase|Protocol Violation|3|||
127846030|NCT00355134|460054097|FG001|Core Phase|Protocol Violation|2|||
127846031|NCT00355134|460054098|FG002|Core Phase|Protocol Violation|2|||
127846032|NCT00355134|460054099|FG003|Core Phase|Protocol Violation|0|||
127901985|NCT01706536|460265249|FG000|Overall Study|Adverse Event|2|||
127901986|NCT01706536|460265250|FG001|Overall Study|Adverse Event|3|||
127901987|NCT01706536|460265251|FG002|Overall Study|Adverse Event|4|||
127901988|NCT01706536|460265252|FG003|Overall Study|Adverse Event|3|||
127901989|NCT01706536|460265253|FG004|Overall Study|Adverse Event|2|||
127901990|NCT01706536|460265249|FG000|Overall Study|Lack of Efficacy|1|||
127846033|NCT00355134|460054100|FG004|Core Phase|Protocol Violation|0|||
127846034|NCT00355134|460054096|FG000|Core Phase|Abnormal test procedure result(s)|1|||
127846035|NCT00355134|460054097|FG001|Core Phase|Abnormal test procedure result(s)|2|||
127846036|NCT00355134|460054098|FG002|Core Phase|Abnormal test procedure result(s)|1|||
127846037|NCT00355134|460054099|FG003|Core Phase|Abnormal test procedure result(s)|0|||
127846038|NCT00355134|460054100|FG004|Core Phase|Abnormal test procedure result(s)|0|||
127846039|NCT00355134|460054096|FG000|Core Phase|Condition no longer requires study drug|1|||
127846040|NCT00355134|460054097|FG001|Core Phase|Condition no longer requires study drug|0|||
127846041|NCT00355134|460054098|FG002|Core Phase|Condition no longer requires study drug|1|||
127846042|NCT00355134|460054099|FG003|Core Phase|Condition no longer requires study drug|0|||
127846043|NCT00355134|460054100|FG004|Core Phase|Condition no longer requires study drug|0|||
127846044|NCT00355134|460054096|FG000|Extension Phase|Withdrawal by Subject|7|||
127846045|NCT00355134|460054097|FG001|Extension Phase|Withdrawal by Subject|11|||
127846046|NCT00355134|460054098|FG002|Extension Phase|Withdrawal by Subject|0|||
127846047|NCT00355134|460054099|FG003|Extension Phase|Withdrawal by Subject|7|||
127846048|NCT00355134|460054100|FG004|Extension Phase|Withdrawal by Subject|5|||
127846049|NCT00355134|460054096|FG000|Extension Phase|Adverse Event|13|||
127846050|NCT00355134|460054097|FG001|Extension Phase|Adverse Event|9|||
127846051|NCT00355134|460054098|FG002|Extension Phase|Adverse Event|0|||
127846052|NCT00355134|460054099|FG003|Extension Phase|Adverse Event|3|||
127846053|NCT00355134|460054100|FG004|Extension Phase|Adverse Event|5|||
127846054|NCT00355134|460054096|FG000|Extension Phase|Lost to Follow-up|2|||
127846055|NCT00355134|460054097|FG001|Extension Phase|Lost to Follow-up|6|||
127846056|NCT00355134|460054098|FG002|Extension Phase|Lost to Follow-up|0|||
127846057|NCT00355134|460054099|FG003|Extension Phase|Lost to Follow-up|2|||
127846058|NCT00355134|460054100|FG004|Extension Phase|Lost to Follow-up|4|||
127846059|NCT00355134|460054096|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
127846060|NCT00355134|460054097|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
127846061|NCT00355134|460054098|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
127846062|NCT00355134|460054099|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
127846063|NCT00355134|460054100|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
127846064|NCT00355134|460054096|FG000|Extension Phase|Administrative problems|2|||
127846065|NCT00355134|460054097|FG001|Extension Phase|Administrative problems|4|||
127846066|NCT00355134|460054098|FG002|Extension Phase|Administrative problems|0|||
127846067|NCT00355134|460054099|FG003|Extension Phase|Administrative problems|1|||
127846068|NCT00355134|460054100|FG004|Extension Phase|Administrative problems|1|||
127846069|NCT00355134|460054096|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
127846070|NCT00355134|460054097|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
127846071|NCT00355134|460054098|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
127846072|NCT00355134|460054099|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
127846073|NCT00355134|460054100|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
127846074|NCT00355134|460054096|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
127846075|NCT00355134|460054097|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
127846076|NCT00355134|460054098|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
127846077|NCT00355134|460054099|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
127846078|NCT00355134|460054100|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
127846079|NCT00355134|460054096|FG000|Extension Phase|Protocol Violation|0|||
127846080|NCT00355134|460054097|FG001|Extension Phase|Protocol Violation|0|||
127846081|NCT00355134|460054098|FG002|Extension Phase|Protocol Violation|0|||
127846082|NCT00355134|460054099|FG003|Extension Phase|Protocol Violation|1|||
127846083|NCT00355134|460054100|FG004|Extension Phase|Protocol Violation|0|||
127846084|NCT01412151|460054101|FG000|Week 0 - 306 - Treatment Period|Death|1|||
127846085|NCT01412151|460054101|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
127846086|NCT01412151|460054101|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
127846087|NCT01412151|460054101|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
127901991|NCT01706536|460265250|FG001|Overall Study|Lack of Efficacy|0|||
127901992|NCT01706536|460265251|FG002|Overall Study|Lack of Efficacy|0|||
127901993|NCT01706536|460265252|FG003|Overall Study|Lack of Efficacy|1|||
127846088|NCT03127852|460054103|FG000|Overall Study|Withdrawal by Subject|4|||
127846089|NCT03127852|460054104|FG001|Overall Study|Withdrawal by Subject|1|||
127846090|NCT03127852|460054103|FG000|Overall Study|Death|1|||
127846091|NCT03127852|460054104|FG001|Overall Study|Death|1|||
127846092|NCT00859573|460054106|FG000|Overall Study|Withdrawal by Subject|4|||
127846093|NCT00859573|460054107|FG001|Overall Study|Withdrawal by Subject|1|||
127846094|NCT00859573|460054106|FG000|Overall Study|Physician Decision|1|||
127846095|NCT00859573|460054107|FG001|Overall Study|Physician Decision|1|||
127846096|NCT03077243|460054108|FG000|Overall Study|Death|1|||
127901994|NCT01706536|460265253|FG004|Overall Study|Lack of Efficacy|0|||
127901995|NCT01706536|460265249|FG000|Overall Study|non compliance|0|||
127901996|NCT01706536|460265250|FG001|Overall Study|non compliance|1|||
127901997|NCT01706536|460265251|FG002|Overall Study|non compliance|0|||
127901998|NCT01706536|460265252|FG003|Overall Study|non compliance|0|||
127901999|NCT01706536|460265253|FG004|Overall Study|non compliance|0|||
127902000|NCT00683293|460265265|FG000|Overall Study|Withdrawal by Subject|2|||
127902001|NCT00683293|460265266|FG001|Overall Study|Withdrawal by Subject|3|||
127902002|NCT03262012|460265267|FG000|Overall Study|Withdrawal by Subject|15|||
127902003|NCT03262012|460265268|FG001|Overall Study|Withdrawal by Subject|13|||
127902004|NCT03262012|460265269|FG002|Overall Study|Withdrawal by Subject|8|||
127902005|NCT03262012|460265270|FG003|Overall Study|Withdrawal by Subject|7|||
127902006|NCT03262012|460265267|FG000|Overall Study|Adverse Event|10|||
127902007|NCT03262012|460265268|FG001|Overall Study|Adverse Event|12|||
127902008|NCT03262012|460265269|FG002|Overall Study|Adverse Event|4|||
127902009|NCT03262012|460265270|FG003|Overall Study|Adverse Event|6|||
127902010|NCT03262012|460265267|FG000|Overall Study|Physician Decision|2|||
127902011|NCT03262012|460265268|FG001|Overall Study|Physician Decision|5|||
127902012|NCT03262012|460265269|FG002|Overall Study|Physician Decision|1|||
127902013|NCT03262012|460265270|FG003|Overall Study|Physician Decision|0|||
127902014|NCT03262012|460265267|FG000|Overall Study|Lack of Efficacy|0|||
127902015|NCT03262012|460265268|FG001|Overall Study|Lack of Efficacy|5|||
127902016|NCT03262012|460265269|FG002|Overall Study|Lack of Efficacy|1|||
127902017|NCT03262012|460265270|FG003|Overall Study|Lack of Efficacy|2|||
127902018|NCT03262012|460265267|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
127902019|NCT03262012|460265268|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
127902020|NCT03262012|460265269|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
127902021|NCT03262012|460265270|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
127902022|NCT02924038|460266468|FG000|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
127902023|NCT02924038|460266469|FG001|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
127902024|NCT03601637|460266470|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
127902025|NCT03601637|460266471|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
127902026|NCT03601637|460266470|FG000|Overall Study|Adverse Event|1|||
127902027|NCT03601637|460266471|FG001|Overall Study|Adverse Event|1|||
127902028|NCT03601637|460266470|FG000|Overall Study|Other|0|||
127902029|NCT03601637|460266471|FG001|Overall Study|Other|1|||
127902030|NCT01248247|460266472|FG000|Overall Study|Adverse Event|2|||
127902031|NCT01248247|460266473|FG001|Overall Study|Adverse Event|4|||
127902032|NCT01248247|460266474|FG002|Overall Study|Adverse Event|4|||
127902033|NCT01248247|460266475|FG003|Overall Study|Adverse Event|2|||
127902034|NCT01248247|460266472|FG000|Overall Study|Death|0|||
127902035|NCT01248247|460266473|FG001|Overall Study|Death|1|||
127902036|NCT01248247|460266474|FG002|Overall Study|Death|4|||
127902037|NCT01248247|460266475|FG003|Overall Study|Death|7|||
127902038|NCT01248247|460266472|FG000|Overall Study|Lost to Follow-up|0|||
127902039|NCT01248247|460266473|FG001|Overall Study|Lost to Follow-up|1|||
127902040|NCT01248247|460266474|FG002|Overall Study|Lost to Follow-up|1|||
127902041|NCT01248247|460266475|FG003|Overall Study|Lost to Follow-up|0|||
127846097|NCT03077243|460054109|FG001|Overall Study|Death|2|||
127846098|NCT03077243|460054110|FG002|Overall Study|Death|0|||
127846099|NCT03077243|460054111|FG003|Overall Study|Death|0|||
127846100|NCT03077243|460054108|FG000|Overall Study|Withdrawal by Subject|1|||
127846101|NCT03077243|460054109|FG001|Overall Study|Withdrawal by Subject|3|||
127846102|NCT03077243|460054110|FG002|Overall Study|Withdrawal by Subject|0|||
127846103|NCT03077243|460054111|FG003|Overall Study|Withdrawal by Subject|0|||
127846104|NCT03077243|460054108|FG000|Overall Study|Physician Decision|1|||
127846105|NCT03077243|460054109|FG001|Overall Study|Physician Decision|0|||
127846106|NCT03077243|460054110|FG002|Overall Study|Physician Decision|0|||
127846107|NCT03077243|460054111|FG003|Overall Study|Physician Decision|0|||
127846108|NCT03077243|460054108|FG000|Overall Study|Research at two study sites terminated early|0|||
127846109|NCT03077243|460054109|FG001|Overall Study|Research at two study sites terminated early|0|||
127846110|NCT03077243|460054110|FG002|Overall Study|Research at two study sites terminated early|0|||
127846111|NCT03077243|460054111|FG003|Overall Study|Research at two study sites terminated early|69|||
127846112|NCT02848313|460054112|FG000|Overall Study|Adverse Event|1|||
127846113|NCT02848313|460054113|FG001|Overall Study|Adverse Event|2|||
127846114|NCT02848313|460054112|FG000|Overall Study|Lack of Efficacy|0|||
127902042|NCT01248247|460266472|FG000|Overall Study|Alternative treatment|0|||
127902043|NCT01248247|460266473|FG001|Overall Study|Alternative treatment|1|||
127902044|NCT01248247|460266474|FG002|Overall Study|Alternative treatment|0|||
127902045|NCT01248247|460266475|FG003|Overall Study|Alternative treatment|0|||
127902046|NCT01248247|460266472|FG000|Overall Study|Other|2|||
127902047|NCT01248247|460266473|FG001|Overall Study|Other|8|||
127902048|NCT01248247|460266474|FG002|Overall Study|Other|8|||
127902049|NCT01248247|460266475|FG003|Overall Study|Other|5|||
127902050|NCT01248247|460266472|FG000|Overall Study|Progression|18|||
127846115|NCT02848313|460054113|FG001|Overall Study|Lack of Efficacy|1|||
127846116|NCT02848313|460054112|FG000|Overall Study|Withdrawal by Subject|1|||
127846117|NCT02848313|460054113|FG001|Overall Study|Withdrawal by Subject|1|||
127846118|NCT02848313|460054112|FG000|Overall Study|Lost to follow up|1|||
127846119|NCT02848313|460054113|FG001|Overall Study|Lost to follow up|0|||
127846120|NCT03382262|460054114|FG000|Overall Study|Physician Decision|0|||
127846121|NCT03382262|460054115|FG001|Overall Study|Physician Decision|0|||
127846122|NCT03382262|460054116|FG002|Overall Study|Physician Decision|1|||
127846123|NCT03382262|460054117|FG003|Overall Study|Physician Decision|0|||
127846124|NCT03382262|460054114|FG000|Overall Study|Withdrawal by Subject|0|||
127846125|NCT03382262|460054115|FG001|Overall Study|Withdrawal by Subject|0|||
127846126|NCT03382262|460054116|FG002|Overall Study|Withdrawal by Subject|0|||
127846127|NCT03382262|460054117|FG003|Overall Study|Withdrawal by Subject|1|||
127846128|NCT02038790|460054118|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
127846129|NCT02038790|460054119|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
127846130|NCT00438464|460054122|FG000|Overall Study|Terminated Early|14|||
127846131|NCT00438464|460054123|FG001|Overall Study|Terminated Early|5|||
127846132|NCT00438464|460054122|FG000|Overall Study|Incomplete data submission|0|||
127846133|NCT00438464|460054123|FG001|Overall Study|Incomplete data submission|2|||
127846134|NCT03943446|460054125|FG000|Overall Study|Lost to Follow-up|0|||
127846135|NCT03943446|460054126|FG001|Overall Study|Lost to Follow-up|0|||
127846136|NCT03943446|460054127|FG002|Overall Study|Lost to Follow-up|1|||
127846137|NCT03943446|460054125|FG000|Overall Study|Withdrawal by Subject|1|||
127846138|NCT03943446|460054126|FG001|Overall Study|Withdrawal by Subject|1|||
127846139|NCT03943446|460054127|FG002|Overall Study|Withdrawal by Subject|2|||
127846140|NCT03943446|460054125|FG000|Overall Study|Study Terminated by Sponsor|1|||
127846141|NCT03943446|460054126|FG001|Overall Study|Study Terminated by Sponsor|2|||
127846142|NCT03943446|460054127|FG002|Overall Study|Study Terminated by Sponsor|1|||
127846143|NCT03943446|460054125|FG000|Overall Study|Reason not Specified|5|||
127846144|NCT03943446|460054126|FG001|Overall Study|Reason not Specified|1|||
127846145|NCT03943446|460054127|FG002|Overall Study|Reason not Specified|3|||
127846146|NCT03862495|460054131|FG000|Overall Study|Lost to Follow-up|37|||
127846147|NCT03862495|460054132|FG001|Overall Study|Lost to Follow-up|35|||
127846148|NCT00615914|460054133|FG000|Overall Study|Adverse Event|274|||
127846149|NCT00615914|460054133|FG000|Overall Study|Death|20|||
127846150|NCT00615914|460054133|FG000|Overall Study|Lack of Efficacy|59|||
127846151|NCT00615914|460054133|FG000|Overall Study|Lost to Follow-up|187|||
127846152|NCT00615914|460054133|FG000|Overall Study|Withdrawal by Subject|16|||
127846153|NCT00615914|460054133|FG000|Overall Study|Physician Decision|4|||
127846154|NCT00615914|460054133|FG000|Overall Study|No data was collected.|65|||
127846155|NCT00615914|460054133|FG000|Overall Study|No treatment|2|||
127846156|NCT00615914|460054133|FG000|Overall Study|Irregularly enrolled patients|10|||
127846157|NCT03673956|460054134|FG000|Overall Study|Lost to Follow-up|1|||
127846158|NCT03673956|460054135|FG001|Overall Study|Lost to Follow-up|0|||
127846159|NCT03673956|460054136|FG002|Overall Study|Lost to Follow-up|0|||
127846160|NCT03673956|460054137|FG003|Overall Study|Lost to Follow-up|0|||
127846161|NCT03673956|460054134|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
127846162|NCT03673956|460054135|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
127846163|NCT03673956|460054136|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
127846164|NCT03673956|460054137|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
127846165|NCT00270998|460054138|FG000|3 Month Follow-up|Adverse Event|1|||
127846166|NCT00270998|460054139|FG001|3 Month Follow-up|Adverse Event|0|||
127846167|NCT00270998|460054140|FG002|3 Month Follow-up|Adverse Event|0|||
127846168|NCT00270998|460054138|FG000|3 Month Follow-up|Lack of Efficacy|1|||
127846169|NCT00270998|460054139|FG001|3 Month Follow-up|Lack of Efficacy|2|||
127846170|NCT00270998|460054140|FG002|3 Month Follow-up|Lack of Efficacy|1|||
127846171|NCT00270998|460054138|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
127846172|NCT00270998|460054139|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
127846173|NCT00270998|460054140|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
127846174|NCT00270998|460054138|FG000|3 Month Follow-up|Pessary did not fit|12|||
127846175|NCT00270998|460054139|FG001|3 Month Follow-up|Pessary did not fit|0|||
127846176|NCT00270998|460054140|FG002|3 Month Follow-up|Pessary did not fit|0|||
127846177|NCT00270998|460054138|FG000|3 Month Follow-up|Personal/family health|1|||
127846178|NCT00270998|460054139|FG001|3 Month Follow-up|Personal/family health|1|||
127846179|NCT00270998|460054140|FG002|3 Month Follow-up|Personal/family health|0|||
127846180|NCT00270998|460054138|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
127846181|NCT00270998|460054139|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
127846182|NCT00270998|460054140|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
127846183|NCT00270998|460054138|FG000|12 Month Follow-up|Lack of Efficacy|5|||
127846184|NCT00270998|460054139|FG001|12 Month Follow-up|Lack of Efficacy|4|||
127846185|NCT00270998|460054140|FG002|12 Month Follow-up|Lack of Efficacy|3|||
127846186|NCT00270998|460054138|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
127846187|NCT00270998|460054139|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
127846188|NCT00270998|460054140|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
127846189|NCT00270998|460054138|FG000|12 Month Follow-up|Pessary did not fit|1|||
127846190|NCT00270998|460054139|FG001|12 Month Follow-up|Pessary did not fit|0|||
127846191|NCT00270998|460054140|FG002|12 Month Follow-up|Pessary did not fit|0|||
127846192|NCT00270998|460054138|FG000|12 Month Follow-up|Personal/family health|0|||
127846193|NCT00270998|460054139|FG001|12 Month Follow-up|Personal/family health|5|||
127846194|NCT00270998|460054140|FG002|12 Month Follow-up|Personal/family health|1|||
127846195|NCT00270998|460054138|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
127846196|NCT00270998|460054139|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
127846197|NCT00270998|460054140|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
127846198|NCT00425113|460054141|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
127846199|NCT00425113|460054142|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
127846200|NCT00425113|460054141|FG000|Overall Study|diagnosis of abdominal TB|0|||
127846201|NCT00425113|460054142|FG001|Overall Study|diagnosis of abdominal TB|1|||
127846202|NCT00425113|460054141|FG000|Overall Study|missing study drug more than 14 days|0|||
127846203|NCT00425113|460054142|FG001|Overall Study|missing study drug more than 14 days|1|||
127846204|NCT00425113|460054141|FG000|Overall Study|Withdrawal by Subject|1|||
127846205|NCT00425113|460054142|FG001|Overall Study|Withdrawal by Subject|0|||
127846206|NCT00425100|460054153|FG000|Overall Study|Adverse Event|36|||
127846207|NCT00425100|460054153|FG000|Overall Study|Lack of Efficacy|4|||
127846208|NCT00425100|460054153|FG000|Overall Study|Lost to Follow-up|2|||
127846209|NCT00425100|460054153|FG000|Overall Study|Protocol Violation|4|||
127846210|NCT00425100|460054153|FG000|Overall Study|Withdrawal by Subject|7|||
127846211|NCT00555906|460054155|FG000|Phase 1|Objective Progression or Relapse|3|||
127846212|NCT00555906|460054156|FG001|Phase 1|Objective Progression or Relapse|5|||
127846213|NCT00555906|460054157|FG002|Phase 1|Objective Progression or Relapse|3|||
127846214|NCT00555906|460054158|FG003|Phase 1|Objective Progression or Relapse|1|||
127846215|NCT00555906|460054159|FG004|Phase 1|Objective Progression or Relapse|0|||
127846216|NCT00555906|460054155|FG000|Phase 1|Global Deterioration of Health Status|0|||
127846217|NCT00555906|460054156|FG001|Phase 1|Global Deterioration of Health Status|1|||
127846218|NCT00555906|460054157|FG002|Phase 1|Global Deterioration of Health Status|1|||
127846219|NCT00555906|460054158|FG003|Phase 1|Global Deterioration of Health Status|1|||
127846220|NCT00555906|460054159|FG004|Phase 1|Global Deterioration of Health Status|0|||
127846221|NCT00555906|460054155|FG000|Phase 1|Adverse Event|0|||
127846222|NCT00555906|460054156|FG001|Phase 1|Adverse Event|0|||
127846223|NCT00555906|460054157|FG002|Phase 1|Adverse Event|3|||
127846224|NCT00555906|460054158|FG003|Phase 1|Adverse Event|2|||
127846225|NCT00555906|460054159|FG004|Phase 1|Adverse Event|0|||
127846226|NCT00555906|460054155|FG000|Phase 1|Withdrawal by Subject|0|||
127846227|NCT00555906|460054156|FG001|Phase 1|Withdrawal by Subject|0|||
127846228|NCT00555906|460054157|FG002|Phase 1|Withdrawal by Subject|0|||
127846229|NCT00555906|460054158|FG003|Phase 1|Withdrawal by Subject|1|||
127846230|NCT00555906|460054159|FG004|Phase 1|Withdrawal by Subject|0|||
127846231|NCT00555906|460054155|FG000|Phase 2|Adverse Event|0|||
127846232|NCT00555906|460054156|FG001|Phase 2|Adverse Event|0|||
127846233|NCT00555906|460054157|FG002|Phase 2|Adverse Event|0|||
127846234|NCT00555906|460054158|FG003|Phase 2|Adverse Event|0|||
127846235|NCT00555906|460054159|FG004|Phase 2|Adverse Event|4|||
127846236|NCT00555906|460054155|FG000|Phase 2|Global Deterioration of Health Status|0|||
127846237|NCT00555906|460054156|FG001|Phase 2|Global Deterioration of Health Status|0|||
127846238|NCT00555906|460054157|FG002|Phase 2|Global Deterioration of Health Status|0|||
127846239|NCT00555906|460054158|FG003|Phase 2|Global Deterioration of Health Status|0|||
127846240|NCT00555906|460054159|FG004|Phase 2|Global Deterioration of Health Status|2|||
127846241|NCT00555906|460054155|FG000|Phase 2|Objective Progression or Relapse|0|||
127846242|NCT00555906|460054156|FG001|Phase 2|Objective Progression or Relapse|0|||
127846243|NCT00555906|460054157|FG002|Phase 2|Objective Progression or Relapse|0|||
127846244|NCT00555906|460054158|FG003|Phase 2|Objective Progression or Relapse|0|||
127846245|NCT00555906|460054159|FG004|Phase 2|Objective Progression or Relapse|16|||
127846246|NCT00555906|460054155|FG000|Phase 2|Withdrawal by Subject|0|||
127846247|NCT00555906|460054156|FG001|Phase 2|Withdrawal by Subject|0|||
127846248|NCT00555906|460054157|FG002|Phase 2|Withdrawal by Subject|0|||
127902051|NCT01248247|460266473|FG001|Overall Study|Progression|27|||
127846249|NCT00555906|460054158|FG003|Phase 2|Withdrawal by Subject|0|||
127846250|NCT00555906|460054159|FG004|Phase 2|Withdrawal by Subject|2|||
127846251|NCT00555906|460054155|FG000|Phase 2|Other|0|||
127846252|NCT00555906|460054156|FG001|Phase 2|Other|0|||
127846253|NCT00555906|460054157|FG002|Phase 2|Other|0|||
127846254|NCT00555906|460054158|FG003|Phase 2|Other|0|||
127846255|NCT00555906|460054159|FG004|Phase 2|Other|6|||
127846256|NCT00555906|460054155|FG000|Phase 2|Randomized but not Treated|0|||
127846257|NCT00555906|460054156|FG001|Phase 2|Randomized but not Treated|0|||
127846258|NCT00555906|460054157|FG002|Phase 2|Randomized but not Treated|0|||
127846259|NCT00555906|460054158|FG003|Phase 2|Randomized but not Treated|0|||
127846260|NCT00555906|460054159|FG004|Phase 2|Randomized but not Treated|2|||
127846261|NCT00889681|460054160|FG000|Overall Study|Not meeting qualification Criteria|2|||
127846262|NCT00889681|460054160|FG000|Overall Study|Insurance disapproval|1|||
127846263|NCT00788697|460054166|FG000|Overall Study|No study drug administered|12|||
127846264|NCT00788697|460054166|FG000|Overall Study|Training Patients|74|||
127846265|NCT00788697|460054166|FG000|Overall Study|no truth standard procedure available|5|||
127846266|NCT00788697|460054166|FG000|Overall Study|Technically inadequate truth standard|1|||
127846267|NCT00788697|460054166|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
127846268|NCT02248857|460054167|FG000|3 Month|Withdrawal by Subject|9|||
127846269|NCT02248857|460054168|FG001|3 Month|Withdrawal by Subject|3|||
127846270|NCT02248857|460054169|FG002|3 Month|Withdrawal by Subject|4|||
127846271|NCT02248857|460054167|FG000|3 Month|Unable to reach for 3 month|35|||
127846272|NCT02248857|460054168|FG001|3 Month|Unable to reach for 3 month|29|||
127846273|NCT02248857|460054169|FG002|3 Month|Unable to reach for 3 month|26|||
127846274|NCT02248857|460054167|FG000|3 Month|Partially completed, unable to finish|2|||
127846275|NCT02248857|460054168|FG001|3 Month|Partially completed, unable to finish|2|||
127846276|NCT02248857|460054169|FG002|3 Month|Partially completed, unable to finish|1|||
127846277|NCT02248857|460054167|FG000|6 Month|Lost to Follow-up|27|||
127846278|NCT02248857|460054168|FG001|6 Month|Lost to Follow-up|26|||
127846279|NCT02248857|460054169|FG002|6 Month|Lost to Follow-up|15|||
127846280|NCT02248857|460054167|FG000|6 Month|Partially completed, unable to finish|0|||
127846281|NCT02248857|460054168|FG001|6 Month|Partially completed, unable to finish|1|||
127846282|NCT02248857|460054169|FG002|6 Month|Partially completed, unable to finish|0|||
127846283|NCT02248857|460054167|FG000|6 Month|Withdrawal by Subject|0|||
127846284|NCT02248857|460054168|FG001|6 Month|Withdrawal by Subject|2|||
127846285|NCT02248857|460054169|FG002|6 Month|Withdrawal by Subject|2|||
127846286|NCT02248857|460054167|FG000|6 Month|Death|1|||
127846287|NCT02248857|460054168|FG001|6 Month|Death|0|||
127846288|NCT02248857|460054169|FG002|6 Month|Death|0|||
127846289|NCT02261883|460054170|FG000|Overall Study|Death|3|||
127846290|NCT02261883|460054171|FG001|Overall Study|Death|2|||
127846291|NCT02261883|460054170|FG000|Overall Study|Physician Decision|1|||
127846292|NCT02261883|460054171|FG001|Overall Study|Physician Decision|0|||
127846293|NCT02261883|460054170|FG000|Overall Study|Protocol Violation|1|||
127846294|NCT02261883|460054171|FG001|Overall Study|Protocol Violation|0|||
127846295|NCT02261883|460054170|FG000|Overall Study|Withdrawal by Subject|0|||
127846296|NCT02261883|460054171|FG001|Overall Study|Withdrawal by Subject|1|||
127846297|NCT02261883|460054170|FG000|Overall Study|Required ECMO Prior to Study Drug Administration|1|||
127846298|NCT02261883|460054171|FG001|Overall Study|Required ECMO Prior to Study Drug Administration|0|||
127846299|NCT02671461|460054172|FG000|Treatment|Adverse Event|0|||
127846300|NCT02671461|460054173|FG001|Treatment|Adverse Event|0|||
127846301|NCT02671461|460054174|FG002|Treatment|Adverse Event|1|||
127846302|NCT02671461|460054172|FG000|Treatment|Administrative Reason by Sponsor|1|||
127846303|NCT02671461|460054173|FG001|Treatment|Administrative Reason by Sponsor|3|||
127846304|NCT02671461|460054174|FG002|Treatment|Administrative Reason by Sponsor|4|||
127846305|NCT02671461|460054172|FG000|Treatment|Randomized, not treated|1|||
127846306|NCT02671461|460054173|FG001|Treatment|Randomized, not treated|0|||
127846307|NCT02671461|460054174|FG002|Treatment|Randomized, not treated|0|||
127846308|NCT02671461|460054172|FG000|Follow-up|Withdrawal by Subject|1|||
127846309|NCT02671461|460054173|FG001|Follow-up|Withdrawal by Subject|0|||
127846310|NCT02671461|460054174|FG002|Follow-up|Withdrawal by Subject|0|||
127846311|NCT02671461|460054172|FG000|Follow-up|Lost to Follow-up|0|||
127846312|NCT02671461|460054173|FG001|Follow-up|Lost to Follow-up|0|||
127846313|NCT02671461|460054174|FG002|Follow-up|Lost to Follow-up|1|||
127846314|NCT02671461|460054172|FG000|Follow-up|Administrative Reason by Sponsor|0|||
127846315|NCT02671461|460054173|FG001|Follow-up|Administrative Reason by Sponsor|1|||
127846316|NCT02671461|460054174|FG002|Follow-up|Administrative Reason by Sponsor|0|||
127846317|NCT01412060|460054175|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
127846318|NCT01412060|460054176|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
127846319|NCT01412060|460054177|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
127846320|NCT01412060|460054175|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
127846321|NCT01412060|460054176|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
127846322|NCT01412060|460054177|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
127846323|NCT01412060|460054175|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
127846324|NCT01412060|460054176|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
127902052|NCT01248247|460266474|FG002|Overall Study|Progression|56|||
127846325|NCT01412060|460054177|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
127846326|NCT01412060|460054175|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
127846327|NCT01412060|460054176|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
127846328|NCT01412060|460054177|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
127846329|NCT01412060|460054175|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
127846330|NCT01412060|460054176|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
127846331|NCT01412060|460054177|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
127846332|NCT01412060|460054175|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
127846333|NCT01412060|460054176|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
127846334|NCT01412060|460054177|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
127846335|NCT01412060|460054175|FG000|Period Between RIP and SP|Adverse Event|4|||
127846336|NCT01412060|460054176|FG001|Period Between RIP and SP|Adverse Event|0|||
127846337|NCT01412060|460054177|FG002|Period Between RIP and SP|Adverse Event|0|||
127846338|NCT01412060|460054175|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
127846339|NCT01412060|460054176|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
127846340|NCT01412060|460054177|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
127846341|NCT01412060|460054175|FG000|Period Between RIP and SP|Protocol Violation|2|||
127846342|NCT01412060|460054176|FG001|Period Between RIP and SP|Protocol Violation|0|||
127846343|NCT01412060|460054177|FG002|Period Between RIP and SP|Protocol Violation|0|||
127846344|NCT01412060|460054175|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
127846345|NCT01412060|460054176|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
127846346|NCT01412060|460054177|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
127846347|NCT01412060|460054175|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
127846348|NCT01412060|460054176|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
127846349|NCT01412060|460054177|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
127846350|NCT01412060|460054175|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
127846351|NCT01412060|460054176|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
127846352|NCT01412060|460054177|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
127846353|NCT01412060|460054175|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
127846354|NCT01412060|460054176|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
127846355|NCT01412060|460054177|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
127846356|NCT01412060|460054175|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
127846357|NCT01412060|460054176|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
127846358|NCT01412060|460054177|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
127846359|NCT01412060|460054175|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
127846360|NCT01412060|460054176|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
127846361|NCT01412060|460054177|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
127846362|NCT01412060|460054175|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
127846363|NCT01412060|460054176|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
127846364|NCT01412060|460054177|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
127846365|NCT01412060|460054175|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
127846366|NCT01412060|460054176|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
127846367|NCT01412060|460054177|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
127846368|NCT01412060|460054175|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
127846369|NCT01412060|460054176|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
127846370|NCT01412060|460054177|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
127846371|NCT01412060|460054175|FG000|Period Between SP and DBP|Protocol Violation|2|||
127846372|NCT01412060|460054176|FG001|Period Between SP and DBP|Protocol Violation|0|||
127846373|NCT01412060|460054177|FG002|Period Between SP and DBP|Protocol Violation|0|||
127846374|NCT01412060|460054175|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
127846375|NCT01412060|460054176|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
127846376|NCT01412060|460054177|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
127846377|NCT01412060|460054175|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
127846378|NCT01412060|460054176|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
127846379|NCT01412060|460054177|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
127846380|NCT01412060|460054175|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
127846381|NCT01412060|460054176|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
127846382|NCT01412060|460054177|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
127846383|NCT01412060|460054175|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
127846384|NCT01412060|460054176|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
127846385|NCT01412060|460054177|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
127846386|NCT01412060|460054175|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
127846387|NCT01412060|460054176|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
127846388|NCT01412060|460054177|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
127846389|NCT01412060|460054175|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
127846390|NCT01412060|460054176|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
127846391|NCT01412060|460054177|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
127846392|NCT01412060|460054175|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
127846393|NCT01412060|460054176|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
127846394|NCT01412060|460054177|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
127846395|NCT01412060|460054175|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
127846396|NCT01412060|460054176|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
127846397|NCT01412060|460054177|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
127846398|NCT01412060|460054175|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
127846399|NCT01412060|460054176|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
127846400|NCT01412060|460054177|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
127846401|NCT01412060|460054175|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
127846402|NCT01412060|460054176|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
127846403|NCT01412060|460054177|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
127846404|NCT00004732|460054179|FG000|Overall Study|Withdrawal by Subject|36|||
127846405|NCT00004732|460054180|FG001|Overall Study|Withdrawal by Subject|64|||
127846406|NCT00004732|460054179|FG000|Overall Study|Lost to Follow-up|33|||
127846407|NCT00004732|460054180|FG001|Overall Study|Lost to Follow-up|47|||
127846408|NCT02674685|460054184|FG000|Overall Study|Withdrawal by Subject|4|||
127846409|NCT05567393|460054189|FG000|Overall Study|Voluntary Withdrawal|0|||
127846410|NCT05567393|460054190|FG001|Overall Study|Voluntary Withdrawal|0|||
127846411|NCT05567393|460054191|FG002|Overall Study|Voluntary Withdrawal|0|||
127846412|NCT05567393|460054192|FG003|Overall Study|Voluntary Withdrawal|0|||
127846413|NCT05567393|460054193|FG004|Overall Study|Voluntary Withdrawal|0|||
127846414|NCT05567393|460054194|FG005|Overall Study|Voluntary Withdrawal|0|||
127846415|NCT05567393|460054195|FG006|Overall Study|Voluntary Withdrawal|0|||
127846416|NCT05567393|460054196|FG007|Overall Study|Voluntary Withdrawal|0|||
127846417|NCT05567393|460054197|FG008|Overall Study|Voluntary Withdrawal|0|||
127846418|NCT05567393|460054198|FG009|Overall Study|Voluntary Withdrawal|0|||
127846419|NCT05567393|460054199|FG010|Overall Study|Voluntary Withdrawal|0|||
127846420|NCT05567393|460054200|FG011|Overall Study|Voluntary Withdrawal|0|||
127846421|NCT05567393|460054201|FG012|Overall Study|Voluntary Withdrawal|0|||
127846422|NCT05567393|460054202|FG013|Overall Study|Voluntary Withdrawal|1|||
127846423|NCT05567393|460054203|FG014|Overall Study|Voluntary Withdrawal|0|||
127846424|NCT05567393|460054204|FG015|Overall Study|Voluntary Withdrawal|0|||
127846425|NCT05567393|460054205|FG016|Overall Study|Voluntary Withdrawal|0|||
127846426|NCT05567393|460054206|FG017|Overall Study|Voluntary Withdrawal|0|||
127846427|NCT04199793|460054207|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
127846428|NCT04199793|460054208|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
127846429|NCT04199793|460054207|FG000|Overall Study|Withdrawal by Subject|1|||
127846430|NCT04199793|460054208|FG001|Overall Study|Withdrawal by Subject|1|||
127846431|NCT04179786|460054209|FG000|Overall Study|Withdrawal by Subject|8|||
127846432|NCT03310580|460054210|FG000|Overall Study|Adverse Event|0|||
127846433|NCT03310580|460054211|FG001|Overall Study|Adverse Event|1|||
127846434|NCT03310580|460054212|FG002|Overall Study|Adverse Event|0|||
127846435|NCT04186663|460054219|FG000|Overall Study|Lost to Follow-up|1|||
127846436|NCT04186663|460054219|FG000|Overall Study|Unable to complete blood draw|3|||
127846437|NCT00642018|460054227|FG000|Overall Study|Adverse Event|11|||
127846438|NCT00642018|460054228|FG001|Overall Study|Adverse Event|36|||
127846439|NCT00642018|460054227|FG000|Overall Study|Withdrawal by Subject|4|||
127846440|NCT00642018|460054228|FG001|Overall Study|Withdrawal by Subject|10|||
127846441|NCT00642018|460054227|FG000|Overall Study|Progressive Disease|13|||
127846442|NCT00642018|460054228|FG001|Overall Study|Progressive Disease|18|||
127846443|NCT00642018|460054227|FG000|Overall Study|Physician Decision|0|||
127846444|NCT00642018|460054228|FG001|Overall Study|Physician Decision|10|||
127846445|NCT00642018|460054227|FG000|Overall Study|Protocol Violation|0|||
127846446|NCT00642018|460054228|FG001|Overall Study|Protocol Violation|1|||
127846447|NCT00642018|460054227|FG000|Overall Study|Death|0|||
127846448|NCT00642018|460054228|FG001|Overall Study|Death|3|||
127846449|NCT00642018|460054227|FG000|Overall Study|Entry Criteria Not Met|0|||
127846450|NCT00642018|460054228|FG001|Overall Study|Entry Criteria Not Met|1|||
127846451|NCT02687711|460056390|FG000|Overall Study|Adverse Event|89|||
127846452|NCT02687711|460056390|FG000|Overall Study|Lack of Efficacy|70|||
127846453|NCT02687711|460056390|FG000|Overall Study|Lost to Follow-up|20|||
127846454|NCT02687711|460056390|FG000|Overall Study|Consent withdrawn|15|||
127846455|NCT02687711|460056390|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
127846456|NCT02687711|460056390|FG000|Overall Study|Too expensive|4|||
127846457|NCT02687711|460056390|FG000|Overall Study|Participant moved abroad|1|||
127846458|NCT02687711|460056390|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
127846459|NCT02687711|460056390|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
127846460|NCT02687711|460056390|FG000|Overall Study|Disliked taste|1|||
127846461|NCT02687711|460056390|FG000|Overall Study|Low mood|1|||
127846462|NCT02687711|460056390|FG000|Overall Study|Side effects|1|||
127846463|NCT02687711|460056390|FG000|Overall Study|Change of Hospital|1|||
127846464|NCT02687711|460056390|FG000|Overall Study|Liver Encephalopathy|1|||
127846465|NCT02687711|460056390|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
127846466|NCT02687711|460056390|FG000|Overall Study|Withdrawn due to intake interruption|1|||
127846467|NCT02687711|460056390|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
127846468|NCT02687711|460056390|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
127846469|NCT02687711|460056390|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
127846470|NCT03621189|460056391|FG000|Overall Study|Withdrawal by Subject|0|||
127846471|NCT03621189|460056392|FG001|Overall Study|Withdrawal by Subject|3|||
127846472|NCT03621189|460056391|FG000|Overall Study|Physician Decision|0|||
127846473|NCT03621189|460056392|FG001|Overall Study|Physician Decision|2|||
127846474|NCT01544478|460056393|FG000|Overall Study|Adverse Event|1|||
127846475|NCT01544478|460056393|FG000|Overall Study|Death|1|||
127846476|NCT01544478|460056393|FG000|Overall Study|Lost to Follow-up|48|||
127846477|NCT01544478|460056393|FG000|Overall Study|Physician Decision|15|||
127846478|NCT01544478|460056393|FG000|Overall Study|Pregnancy|1|||
127846479|NCT01544478|460056393|FG000|Overall Study|Withdrawal by Subject|52|||
127868946|NCT05602818|460137442|FG000|Qualification Phase (3 Days)|Adverse Event|1|||
127846480|NCT04209530|460056399|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
127846481|NCT04209530|460056400|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
127846482|NCT04209530|460056399|FG000|Overall Study|Withdrawal by Subject|0|||
127846483|NCT04209530|460056400|FG001|Overall Study|Withdrawal by Subject|1|||
127846484|NCT00607919|460056401|FG000|Acute Phase|Adverse Event|9|||
127846485|NCT00607919|460056402|FG001|Acute Phase|Adverse Event|2|||
127846486|NCT00607919|460056401|FG000|Acute Phase|Entry Criteria Not Met|1|||
127846487|NCT00607919|460056402|FG001|Acute Phase|Entry Criteria Not Met|1|||
127846488|NCT00607919|460056401|FG000|Acute Phase|Lack of Efficacy|1|||
127846489|NCT00607919|460056402|FG001|Acute Phase|Lack of Efficacy|2|||
127846490|NCT00607919|460056401|FG000|Acute Phase|Lost to Follow-up|9|||
127846491|NCT00607919|460056402|FG001|Acute Phase|Lost to Follow-up|3|||
127846492|NCT00607919|460056401|FG000|Acute Phase|Parent/Caregiver Decision|6|||
127846493|NCT00607919|460056402|FG001|Acute Phase|Parent/Caregiver Decision|4|||
127846494|NCT00607919|460056401|FG000|Acute Phase|Protocol Violation|5|||
127846495|NCT00607919|460056402|FG001|Acute Phase|Protocol Violation|1|||
127846496|NCT00607919|460056401|FG000|Acute Phase|Withdrawal by Subject|3|||
127846497|NCT00607919|460056402|FG001|Acute Phase|Withdrawal by Subject|3|||
127846498|NCT00607919|460056401|FG000|Open-Label Phase|Adverse Event|1|||
127846499|NCT00607919|460056402|FG001|Open-Label Phase|Adverse Event|5|||
127846500|NCT00607919|460056401|FG000|Open-Label Phase|Lost to Follow-up|4|||
127846501|NCT00607919|460056402|FG001|Open-Label Phase|Lost to Follow-up|1|||
127846502|NCT00607919|460056401|FG000|Open-Label Phase|Protocol Violation|2|||
127846503|NCT00607919|460056402|FG001|Open-Label Phase|Protocol Violation|2|||
127846504|NCT00607919|460056401|FG000|Open-Label Phase|Withdrawal by Subject|2|||
127846505|NCT00607919|460056402|FG001|Open-Label Phase|Withdrawal by Subject|2|||
127846506|NCT00607919|460056401|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
127846507|NCT00607919|460056402|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
127846508|NCT02580240|460056415|FG000|Overall Study|Physician Decision|2|||
127846509|NCT02580240|460056416|FG001|Overall Study|Physician Decision|0|||
127846510|NCT01709708|460056417|FG000|Overall Study|Protocol Violation|1|||
127846511|NCT01709708|460056418|FG001|Overall Study|Protocol Violation|2|||
127846512|NCT01527110|460056421|FG000|Overall Study|Adverse Event|1|||
127846513|NCT00527072|460056422|FG000|Overall Study|Adverse Event|13|||
127846514|NCT00527072|460056422|FG000|Overall Study|Lack of Efficacy|11|||
127846515|NCT00527072|460056422|FG000|Overall Study|Lost to Follow-up|3|||
127846516|NCT00527072|460056422|FG000|Overall Study|Protocol Violation|2|||
127846517|NCT00527072|460056422|FG000|Overall Study|Withdrawal by Subject|7|||
127846518|NCT02007252|460056423|FG000|Overall Study|Administrative problems|3|||
127846519|NCT02007252|460056424|FG001|Overall Study|Administrative problems|7|||
127846520|NCT02007252|460056423|FG000|Overall Study|Abnormal laboratory value(s)|1|||
127846521|NCT02007252|460056424|FG001|Overall Study|Abnormal laboratory value(s)|0|||
127846522|NCT02007252|460056423|FG000|Overall Study|Adverse Event|7|||
127846523|NCT02007252|460056424|FG001|Overall Study|Adverse Event|4|||
127846524|NCT02001688|460056425|FG000|Overall Study|Withdrawal by Subject|0|||
127846525|NCT02001688|460056426|FG001|Overall Study|Withdrawal by Subject|0|||
127846526|NCT02001688|460056427|FG002|Overall Study|Withdrawal by Subject|1|||
127846527|NCT02001688|460056425|FG000|Overall Study|Adverse Event|0|||
127846528|NCT02001688|460056426|FG001|Overall Study|Adverse Event|1|||
127846529|NCT02001688|460056427|FG002|Overall Study|Adverse Event|0|||
127846530|NCT00813917|460056428|FG000|Overall Study|Adverse Event|0|||
127846531|NCT00813917|460056429|FG001|Overall Study|Adverse Event|1|||
127846532|NCT00813917|460056428|FG000|Overall Study|Withdrawal by Subject|3|||
127846533|NCT00813917|460056429|FG001|Overall Study|Withdrawal by Subject|4|||
127846534|NCT00813917|460056428|FG000|Overall Study|Lost to Follow-up|3|||
127846535|NCT00813917|460056429|FG001|Overall Study|Lost to Follow-up|1|||
127846536|NCT05441540|460056430|FG000|Overall Study|Withdrawal by Subject|2|||
127846537|NCT00792701|460056434|FG000|Overall Study|Adverse Event|0|||
127846538|NCT00792701|460056435|FG001|Overall Study|Adverse Event|22|||
127846539|NCT00792701|460056434|FG000|Overall Study|Ineligible|1|||
127902053|NCT01248247|460266475|FG003|Overall Study|Progression|44|||
127846540|NCT00792701|460056435|FG001|Overall Study|Ineligible|3|||
127846541|NCT00792701|460056434|FG000|Overall Study|Withdrawal by Subject|1|||
127846542|NCT00792701|460056435|FG001|Overall Study|Withdrawal by Subject|19|||
127846543|NCT00792701|460056434|FG000|Overall Study|Not protocol specified|17|||
127846544|NCT00792701|460056435|FG001|Overall Study|Not protocol specified|0|||
127846545|NCT02143141|460056446|FG000|Overall Study|pain scores at 24 hours not collected|1|||
127846546|NCT02143141|460056447|FG001|Overall Study|pain scores at 24 hours not collected|0|||
127846547|NCT00064077|460056448|FG000|Overall Study|Improper prior treatment|1|||
127846548|NCT00064077|460056449|FG001|Overall Study|Improper prior treatment|0|||
127846549|NCT00064077|460056450|FG002|Overall Study|Improper prior treatment|0|||
127846550|NCT00064077|460056451|FG003|Overall Study|Improper prior treatment|0|||
127846551|NCT00064077|460056448|FG000|Overall Study|Poor risk|2|||
127846552|NCT00064077|460056449|FG001|Overall Study|Poor risk|0|||
127846553|NCT00064077|460056450|FG002|Overall Study|Poor risk|1|||
127846554|NCT00064077|460056451|FG003|Overall Study|Poor risk|1|||
127846555|NCT00064077|460056448|FG000|Overall Study|Pathology|10|||
127846556|NCT00064077|460056449|FG001|Overall Study|Pathology|7|||
127846557|NCT00064077|460056450|FG002|Overall Study|Pathology|3|||
127846558|NCT00064077|460056451|FG003|Overall Study|Pathology|4|||
127846559|NCT00064077|460056448|FG000|Overall Study|No surgery|0|||
127846560|NCT00064077|460056449|FG001|Overall Study|No surgery|0|||
127846561|NCT00064077|460056450|FG002|Overall Study|No surgery|1|||
127846562|NCT00064077|460056451|FG003|Overall Study|No surgery|0|||
127846563|NCT00064077|460056448|FG000|Overall Study|No tumor|0|||
127846564|NCT00064077|460056449|FG001|Overall Study|No tumor|0|||
127846565|NCT00064077|460056450|FG002|Overall Study|No tumor|1|||
127846566|NCT00064077|460056451|FG003|Overall Study|No tumor|0|||
127846567|NCT00064077|460056448|FG000|Overall Study|Other reasons|2|||
127846568|NCT00064077|460056449|FG001|Overall Study|Other reasons|2|||
127846569|NCT00064077|460056450|FG002|Overall Study|Other reasons|1|||
127846570|NCT00064077|460056451|FG003|Overall Study|Other reasons|2|||
127846571|NCT01467661|460056452|FG000|Overall Study|Adverse Event|16|||
127846572|NCT01467661|460056452|FG000|Overall Study|Withdrawal by Subject|1|||
127846573|NCT01467661|460056452|FG000|Overall Study|Lack of Efficacy|3|||
127846574|NCT01467661|460056452|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
127846575|NCT00563368|460056453|FG000|Overall Study|Lost to Follow-up|14|||
127846576|NCT00563368|460056454|FG001|Overall Study|Lost to Follow-up|14|||
127846577|NCT00563368|460056455|FG002|Overall Study|Lost to Follow-up|12|||
127846578|NCT00563368|460056456|FG003|Overall Study|Lost to Follow-up|6|||
127846579|NCT00563368|460056457|FG004|Overall Study|Lost to Follow-up|9|||
127846580|NCT00563368|460056458|FG005|Overall Study|Lost to Follow-up|8|||
127846581|NCT00563368|460056459|FG006|Overall Study|Lost to Follow-up|9|||
127846582|NCT00563368|460056453|FG000|Overall Study|Adverse Event|3|||
127846583|NCT00563368|460056454|FG001|Overall Study|Adverse Event|4|||
127846584|NCT00563368|460056455|FG002|Overall Study|Adverse Event|5|||
127846585|NCT00563368|460056456|FG003|Overall Study|Adverse Event|9|||
127846586|NCT00563368|460056457|FG004|Overall Study|Adverse Event|6|||
127846587|NCT00563368|460056458|FG005|Overall Study|Adverse Event|10|||
127846588|NCT00563368|460056459|FG006|Overall Study|Adverse Event|17|||
127846589|NCT00563368|460056453|FG000|Overall Study|Withdrawal by Subject|11|||
127846590|NCT00563368|460056454|FG001|Overall Study|Withdrawal by Subject|6|||
127846591|NCT00563368|460056455|FG002|Overall Study|Withdrawal by Subject|5|||
127846592|NCT00563368|460056456|FG003|Overall Study|Withdrawal by Subject|7|||
127846593|NCT00563368|460056457|FG004|Overall Study|Withdrawal by Subject|8|||
127846594|NCT00563368|460056458|FG005|Overall Study|Withdrawal by Subject|5|||
127846595|NCT00563368|460056459|FG006|Overall Study|Withdrawal by Subject|4|||
127846596|NCT00563368|460056453|FG000|Overall Study|protocol non-compliance|1|||
127846597|NCT00563368|460056454|FG001|Overall Study|protocol non-compliance|1|||
127846598|NCT00563368|460056455|FG002|Overall Study|protocol non-compliance|2|||
127846599|NCT00563368|460056456|FG003|Overall Study|protocol non-compliance|1|||
127846600|NCT00563368|460056457|FG004|Overall Study|protocol non-compliance|0|||
127846601|NCT00563368|460056458|FG005|Overall Study|protocol non-compliance|1|||
127846602|NCT00563368|460056459|FG006|Overall Study|protocol non-compliance|3|||
127846603|NCT00563368|460056453|FG000|Overall Study|Pregnancy|1|||
127846604|NCT00563368|460056454|FG001|Overall Study|Pregnancy|0|||
127846605|NCT00563368|460056455|FG002|Overall Study|Pregnancy|1|||
127846606|NCT00563368|460056456|FG003|Overall Study|Pregnancy|2|||
127846607|NCT00563368|460056457|FG004|Overall Study|Pregnancy|1|||
127846608|NCT00563368|460056458|FG005|Overall Study|Pregnancy|2|||
127846609|NCT00563368|460056459|FG006|Overall Study|Pregnancy|0|||
127846610|NCT00563368|460056453|FG000|Overall Study|requirement for restricted medication|0|||
127846611|NCT00563368|460056454|FG001|Overall Study|requirement for restricted medication|0|||
127846612|NCT00563368|460056455|FG002|Overall Study|requirement for restricted medication|2|||
127846613|NCT00563368|460056456|FG003|Overall Study|requirement for restricted medication|0|||
127846614|NCT00563368|460056457|FG004|Overall Study|requirement for restricted medication|0|||
127846615|NCT00563368|460056458|FG005|Overall Study|requirement for restricted medication|0|||
127846616|NCT00563368|460056459|FG006|Overall Study|requirement for restricted medication|0|||
127846617|NCT00563368|460056453|FG000|Overall Study|Other|5|||
127846618|NCT00563368|460056454|FG001|Overall Study|Other|5|||
127846619|NCT00563368|460056455|FG002|Overall Study|Other|3|||
127846620|NCT00563368|460056456|FG003|Overall Study|Other|4|||
127846621|NCT00563368|460056457|FG004|Overall Study|Other|4|||
127846622|NCT00563368|460056458|FG005|Overall Study|Other|4|||
127846623|NCT00563368|460056459|FG006|Overall Study|Other|0|||
127846624|NCT01819506|460056460|FG000|Overall Study|Physician Decision|5|||
127846625|NCT01819506|460056461|FG001|Overall Study|Physician Decision|2|||
127846626|NCT01819506|460056460|FG000|Overall Study|Withdrawal by Subject|3|||
127846627|NCT01819506|460056461|FG001|Overall Study|Withdrawal by Subject|3|||
127846628|NCT00879437|460056462|FG000|Overall Study|Protocol Violation|0|||
127846629|NCT00879437|460056463|FG001|Overall Study|Protocol Violation|1|||
127846630|NCT00879437|460056462|FG000|Overall Study|Death|1|||
127846631|NCT00879437|460056463|FG001|Overall Study|Death|0|||
127846632|NCT03000686|460056464|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
127846633|NCT03000686|460056465|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
127846634|NCT03000686|460056466|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
127902054|NCT01248247|460266472|FG000|Overall Study|Refuse further treatment|0|||
127902055|NCT01248247|460266473|FG001|Overall Study|Refuse further treatment|0|||
127902056|NCT01248247|460266474|FG002|Overall Study|Refuse further treatment|1|||
127902057|NCT01248247|460266475|FG003|Overall Study|Refuse further treatment|2|||
127902058|NCT01248247|460266472|FG000|Overall Study|Complicating disease|0|||
127902059|NCT01248247|460266473|FG001|Overall Study|Complicating disease|0|||
127902060|NCT01248247|460266474|FG002|Overall Study|Complicating disease|1|||
127902061|NCT01248247|460266475|FG003|Overall Study|Complicating disease|1|||
127902062|NCT01108094|460266480|FG000|Overall Study|Adverse Event|2|||
127902063|NCT01108094|460266481|FG001|Overall Study|Adverse Event|0|||
127902064|NCT01108094|460266482|FG002|Overall Study|Adverse Event|0|||
127902065|NCT01108094|460266483|FG003|Overall Study|Adverse Event|0|||
127902066|NCT01108094|460266480|FG000|Overall Study|Withdrawal by Subject|1|||
127902067|NCT01108094|460266481|FG001|Overall Study|Withdrawal by Subject|0|||
127902068|NCT01108094|460266482|FG002|Overall Study|Withdrawal by Subject|0|||
127902069|NCT01108094|460266483|FG003|Overall Study|Withdrawal by Subject|0|||
127902070|NCT00420303|460266486|FG000|Overall Study|Serious Adverse Event|1|||
127902071|NCT00420303|460266487|FG001|Overall Study|Serious Adverse Event|0|||
127902072|NCT00420303|460266486|FG000|Overall Study|Lack of Efficacy|0|||
127902073|NCT00420303|460266487|FG001|Overall Study|Lack of Efficacy|3|||
127902074|NCT00420303|460266486|FG000|Overall Study|Physician Decision|0|||
127902075|NCT00420303|460266487|FG001|Overall Study|Physician Decision|1|||
127902076|NCT04455633|460266491|FG000|Double-Blind Period (Up to Week 6)|Adverse Event|4|||
127902077|NCT04455633|460266492|FG001|Double-Blind Period (Up to Week 6)|Adverse Event|17|||
127902078|NCT04455633|460266493|FG002|Double-Blind Period (Up to Week 6)|Adverse Event|28|||
127902079|NCT04455633|460266491|FG000|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
127902080|NCT04455633|460266492|FG001|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
127902081|NCT04455633|460266493|FG002|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|6|||
127902082|NCT04455633|460266491|FG000|Double-Blind Period (Up to Week 6)|Other, not specified|0|||
127902083|NCT04455633|460266492|FG001|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
127902084|NCT04455633|460266493|FG002|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
127902085|NCT04455633|460266491|FG000|Follow up Period (Weeks 7 to 11)|Other, not specified|1|||
127902086|NCT04455633|460266492|FG001|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
127902087|NCT04455633|460266493|FG002|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
127902088|NCT04015232|460266495|FG000|Overall Study|Withdrawal by Subject|7|||
127902089|NCT04015232|460266496|FG001|Overall Study|Withdrawal by Subject|4|||
127902090|NCT04015232|460266495|FG000|Overall Study|Protocol Violation|1|||
127902091|NCT04015232|460266496|FG001|Overall Study|Protocol Violation|0|||
127902092|NCT04015232|460266495|FG000|Overall Study|Medical Grounds|3|||
127902093|NCT04015232|460266496|FG001|Overall Study|Medical Grounds|3|||
127902094|NCT00727571|460266499|FG000|Overall Study|Ineligibility determined|1|||
127902095|NCT00727571|460266500|FG001|Overall Study|Ineligibility determined|1|||
127902096|NCT00727571|460266501|FG002|Overall Study|Ineligibility determined|1|||
127902097|NCT00727571|460266502|FG003|Overall Study|Ineligibility determined|0|||
127902098|NCT00727571|460266499|FG000|Overall Study|Death|0|||
127902099|NCT00727571|460266500|FG001|Overall Study|Death|19|||
127902100|NCT00727571|460266501|FG002|Overall Study|Death|5|||
127902101|NCT00727571|460266502|FG003|Overall Study|Death|1|||
127902102|NCT00727571|460266499|FG000|Overall Study|Physician Decision|0|||
127902103|NCT00727571|460266500|FG001|Overall Study|Physician Decision|5|||
127902104|NCT00727571|460266501|FG002|Overall Study|Physician Decision|0|||
127902105|NCT00727571|460266502|FG003|Overall Study|Physician Decision|0|||
127902106|NCT00727571|460266499|FG000|Overall Study|Withdrawal by Subject|0|||
127902107|NCT00727571|460266500|FG001|Overall Study|Withdrawal by Subject|10|||
127902108|NCT00727571|460266501|FG002|Overall Study|Withdrawal by Subject|11|||
127902109|NCT00727571|460266502|FG003|Overall Study|Withdrawal by Subject|0|||
127902110|NCT00727571|460266499|FG000|Overall Study|Subject Non Compliance|0|||
127902111|NCT00727571|460266500|FG001|Overall Study|Subject Non Compliance|6|||
127902112|NCT00727571|460266501|FG002|Overall Study|Subject Non Compliance|0|||
127902113|NCT00727571|460266502|FG003|Overall Study|Subject Non Compliance|4|||
127902114|NCT00727571|460266499|FG000|Overall Study|Dismissed from nursing home|0|||
127902115|NCT00727571|460266500|FG001|Overall Study|Dismissed from nursing home|9|||
127902116|NCT00727571|460266501|FG002|Overall Study|Dismissed from nursing home|5|||
127902117|NCT00727571|460266502|FG003|Overall Study|Dismissed from nursing home|0|||
127902118|NCT00727571|460266499|FG000|Overall Study|Hospitalization|0|||
127902119|NCT00727571|460266500|FG001|Overall Study|Hospitalization|1|||
127902120|NCT00727571|460266501|FG002|Overall Study|Hospitalization|0|||
127902121|NCT00727571|460266502|FG003|Overall Study|Hospitalization|1|||
127902122|NCT00727571|460266499|FG000|Overall Study|AE not leading to hospitalization|0|||
127902123|NCT00727571|460266500|FG001|Overall Study|AE not leading to hospitalization|0|||
127902124|NCT00727571|460266501|FG002|Overall Study|AE not leading to hospitalization|2|||
127902125|NCT00727571|460266502|FG003|Overall Study|AE not leading to hospitalization|0|||
127902126|NCT00727571|460266499|FG000|Overall Study|Other|0|||
127902127|NCT00727571|460266500|FG001|Overall Study|Other|4|||
127846635|NCT03000686|460056467|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
127846636|NCT01112982|460056471|FG000|Overall Study|Withdrawal by Subject|1|||
127846637|NCT01112982|460056471|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
127846638|NCT01001234|460056476|FG000|Overall Study|Withdrawal by Subject|2|||
127846639|NCT01001234|460056477|FG001|Overall Study|Withdrawal by Subject|0|||
127846640|NCT01001234|460056478|FG002|Overall Study|Withdrawal by Subject|3|||
127846641|NCT01001234|460056479|FG003|Overall Study|Withdrawal by Subject|0|||
127846642|NCT01001234|460056480|FG004|Overall Study|Withdrawal by Subject|0|||
127846643|NCT01001234|460056476|FG000|Overall Study|Protocol Violation|34|||
127846644|NCT01001234|460056477|FG001|Overall Study|Protocol Violation|3|||
127846645|NCT01001234|460056478|FG002|Overall Study|Protocol Violation|19|||
127846646|NCT01001234|460056479|FG003|Overall Study|Protocol Violation|18|||
127846647|NCT01001234|460056480|FG004|Overall Study|Protocol Violation|0|||
127846648|NCT01001234|460056476|FG000|Overall Study|Lost to Follow-up|0|||
127846649|NCT01001234|460056477|FG001|Overall Study|Lost to Follow-up|0|||
127846650|NCT01001234|460056478|FG002|Overall Study|Lost to Follow-up|1|||
127846651|NCT01001234|460056479|FG003|Overall Study|Lost to Follow-up|2|||
127846652|NCT01001234|460056480|FG004|Overall Study|Lost to Follow-up|0|||
127846653|NCT01001234|460056476|FG000|Overall Study|Physician Decision|1|||
127846654|NCT01001234|460056477|FG001|Overall Study|Physician Decision|0|||
127846655|NCT01001234|460056478|FG002|Overall Study|Physician Decision|0|||
127846656|NCT01001234|460056479|FG003|Overall Study|Physician Decision|0|||
127846657|NCT01001234|460056480|FG004|Overall Study|Physician Decision|0|||
127846658|NCT01001234|460056476|FG000|Overall Study|Not Treated: Adverse Event|1|||
127846659|NCT01001234|460056477|FG001|Overall Study|Not Treated: Adverse Event|0|||
127846660|NCT01001234|460056478|FG002|Overall Study|Not Treated: Adverse Event|0|||
127846661|NCT01001234|460056479|FG003|Overall Study|Not Treated: Adverse Event|0|||
127846662|NCT01001234|460056480|FG004|Overall Study|Not Treated: Adverse Event|0|||
127846663|NCT01001234|460056476|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
127846664|NCT01001234|460056477|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
127846665|NCT01001234|460056478|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
127846666|NCT01001234|460056479|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
127846667|NCT01001234|460056480|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
127846668|NCT01001234|460056476|FG000|Overall Study|Not Treated: Protocol Violation|3|||
127846669|NCT01001234|460056477|FG001|Overall Study|Not Treated: Protocol Violation|0|||
127846670|NCT01001234|460056478|FG002|Overall Study|Not Treated: Protocol Violation|0|||
127846671|NCT01001234|460056479|FG003|Overall Study|Not Treated: Protocol Violation|0|||
127846672|NCT01001234|460056480|FG004|Overall Study|Not Treated: Protocol Violation|0|||
127846673|NCT01001234|460056476|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
127846674|NCT01001234|460056477|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
127846675|NCT01001234|460056478|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
127846676|NCT01001234|460056479|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
127846677|NCT01001234|460056480|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
127846678|NCT01001234|460056476|FG000|Overall Study|Not Treated: Pregnancy|3|||
127846679|NCT01001234|460056477|FG001|Overall Study|Not Treated: Pregnancy|0|||
127846680|NCT01001234|460056478|FG002|Overall Study|Not Treated: Pregnancy|0|||
127846681|NCT01001234|460056479|FG003|Overall Study|Not Treated: Pregnancy|0|||
127846682|NCT01001234|460056480|FG004|Overall Study|Not Treated: Pregnancy|0|||
127846683|NCT01001234|460056476|FG000|Overall Study|Not Treated: Physician Decision|37|||
127846684|NCT01001234|460056477|FG001|Overall Study|Not Treated: Physician Decision|4|||
127846685|NCT01001234|460056478|FG002|Overall Study|Not Treated: Physician Decision|0|||
127846686|NCT01001234|460056479|FG003|Overall Study|Not Treated: Physician Decision|0|||
127846687|NCT01001234|460056480|FG004|Overall Study|Not Treated: Physician Decision|0|||
127846688|NCT01001234|460056476|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
127846689|NCT01001234|460056477|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
127846690|NCT01001234|460056478|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
127846691|NCT01001234|460056479|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
127846692|NCT01001234|460056480|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
127846693|NCT03379376|460056481|FG000|Overall Study|Lost to Follow-up|2|||
127846694|NCT03379376|460056481|FG000|Overall Study|Did not wish to complete follow up|1|||
127846695|NCT03379376|460056481|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
127846696|NCT03379376|460056481|FG000|Overall Study|Death|1|||
127846697|NCT01611298|460056482|FG000|Overall Study|Relapsed|2|||
127846698|NCT00753623|460056483|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
127846699|NCT00753623|460056484|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
127846700|NCT00753623|460056483|FG000|Phase I (14 Days)|Physician Decision|1|||
127846701|NCT00753623|460056484|FG001|Phase I (14 Days)|Physician Decision|2|||
127846702|NCT00753623|460056483|FG000|Phase I (14 Days)|Adverse Event|0|||
127846703|NCT00753623|460056484|FG001|Phase I (14 Days)|Adverse Event|1|||
127846704|NCT00753623|460056483|FG000|Washout (7 Days)|Physician Decision|1|||
127846705|NCT00753623|460056484|FG001|Washout (7 Days)|Physician Decision|0|||
127846706|NCT00753623|460056483|FG000|Phase II (14 Days)|Physician Decision|0|||
127846707|NCT00753623|460056484|FG001|Phase II (14 Days)|Physician Decision|1|||
127846708|NCT03332303|460056485|FG000|Overall Study|Participant did not dose|1|||
127846709|NCT03332303|460056486|FG001|Overall Study|Participant did not dose|2|||
127846710|NCT03332303|460056487|FG002|Overall Study|Participant did not dose|0|||
127846711|NCT03332303|460056485|FG000|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
127846712|NCT03332303|460056486|FG001|Overall Study|Participant did not have at least one post-randomization evaluation|1|||
127846713|NCT03332303|460056487|FG002|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
127846714|NCT03332303|460056485|FG000|Overall Study|Participant developed concurrent vaginal infection/illness|4|||
127846715|NCT03332303|460056486|FG001|Overall Study|Participant developed concurrent vaginal infection/illness|1|||
127846716|NCT03332303|460056487|FG002|Overall Study|Participant developed concurrent vaginal infection/illness|0|||
127846717|NCT03332303|460056485|FG000|Overall Study|Participant did not administer 75-125% of intended dose|0|||
127846718|NCT03332303|460056486|FG001|Overall Study|Participant did not administer 75-125% of intended dose|3|||
127846719|NCT03332303|460056487|FG002|Overall Study|Participant did not administer 75-125% of intended dose|0|||
127846720|NCT03332303|460056485|FG000|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
127846721|NCT03332303|460056486|FG001|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
127846722|NCT03332303|460056487|FG002|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|3|||
127846723|NCT03332303|460056485|FG000|Overall Study|Participant did not meet all inclusion/exclusion criteria|4|||
127846724|NCT03332303|460056486|FG001|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
127846725|NCT03332303|460056487|FG002|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
127846726|NCT03332303|460056485|FG000|Overall Study|Participant had a significant protocol deviation|0|||
127846727|NCT03332303|460056486|FG001|Overall Study|Participant had a significant protocol deviation|1|||
127846728|NCT03332303|460056487|FG002|Overall Study|Participant had a significant protocol deviation|0|||
127846729|NCT03639987|460056488|FG000|Overall Study|Study terminated by sponsor|26|||
127846730|NCT03639987|460056489|FG001|Overall Study|Study terminated by sponsor|25|||
127846731|NCT03639987|460056488|FG000|Overall Study|Lost to Follow-up|0|||
127846732|NCT03639987|460056489|FG001|Overall Study|Lost to Follow-up|1|||
127846733|NCT03820726|460056494|FG000|Overall Study|Other than listed|23|||
127846734|NCT03820726|460056494|FG000|Overall Study|Withdrawal by Subject|37|||
127846735|NCT03820726|460056494|FG000|Overall Study|Lost to Follow-up|3|||
127846736|NCT03820726|460056494|FG000|Overall Study|Protocol deviation|1|||
127846737|NCT03820726|460056494|FG000|Overall Study|Adverse Event|146|||
127846738|NCT03820726|460056494|FG000|Overall Study|Not treated|1|||
127846739|NCT00345540|460056495|FG000|Overall Study|Withdrawal by Subject|1|||
127846740|NCT01406652|460056496|FG000|Overall Study|Lost-to-follow-up|3|||
127846741|NCT01406652|460056497|FG001|Overall Study|Lost-to-follow-up|4|||
127846742|NCT01406652|460056496|FG000|Overall Study|Withdrawal by Subject|2|||
127846743|NCT01406652|460056497|FG001|Overall Study|Withdrawal by Subject|2|||
127846744|NCT01406652|460056496|FG000|Overall Study|Insufficient follow-up|5|||
127846745|NCT01406652|460056497|FG001|Overall Study|Insufficient follow-up|4|||
127846746|NCT01406652|460056496|FG000|Overall Study|Infection not sure|10|||
127846747|NCT01406652|460056497|FG001|Overall Study|Infection not sure|10|||
127846748|NCT00141037|460056498|FG000|Overall Study|Physician Decision|1|||
127846749|NCT00141037|460056499|FG001|Overall Study|Physician Decision|2|||
127846750|NCT00141037|460056498|FG000|Overall Study|Lost to Follow-up|3|||
127846751|NCT00141037|460056499|FG001|Overall Study|Lost to Follow-up|1|||
127846752|NCT00141037|460056498|FG000|Overall Study|Protocol Violation|0|||
127846753|NCT00141037|460056499|FG001|Overall Study|Protocol Violation|2|||
127846754|NCT00141037|460056498|FG000|Overall Study|Withdrawal by Subject|2|||
127846755|NCT00141037|460056499|FG001|Overall Study|Withdrawal by Subject|1|||
127846756|NCT00141037|460056498|FG000|Overall Study|Other|0|||
127846757|NCT00141037|460056499|FG001|Overall Study|Other|1|||
127846758|NCT00141037|460056498|FG000|Overall Study|Moved from area|1|||
127846759|NCT00141037|460056499|FG001|Overall Study|Moved from area|7|||
127846760|NCT00141037|460056498|FG000|Overall Study|Graft Failure|3|||
127846761|NCT00141037|460056499|FG001|Overall Study|Graft Failure|4|||
127846762|NCT00861380|460056500|FG000|Overall Study|Withdrawal Information not recorded|8427|||
127846763|NCT00861380|460056501|FG001|Overall Study|Withdrawal Information not recorded|9112|||
127846764|NCT00861380|460056502|FG002|Overall Study|Withdrawal Information not recorded|8872|||
127846765|NCT00861380|460056503|FG003|Overall Study|Withdrawal Information not recorded|3689|||
127846766|NCT00861380|460056504|FG004|Overall Study|Withdrawal Information not recorded|1812|||
127846767|NCT00861380|460056505|FG005|Overall Study|Withdrawal Information not recorded|6249|||
127846768|NCT00861380|460056506|FG006|Overall Study|Withdrawal Information not recorded|3020|||
127846769|NCT00260429|460056507|FG000|Overall Study|failure to follow appointments|1|||
127846770|NCT00260429|460056508|FG001|Overall Study|failure to follow appointments|0|||
127846771|NCT00260429|460056507|FG000|Overall Study|scheduled hand surgery|1|||
127846772|NCT00260429|460056508|FG001|Overall Study|scheduled hand surgery|0|||
127846773|NCT00628758|460056509|FG000|Overall Study|Adverse Event|2|||
127846774|NCT00628758|460056510|FG001|Overall Study|Adverse Event|3|||
127846775|NCT00628758|460056509|FG000|Overall Study|Withdrawal by Subject|6|||
127846776|NCT00628758|460056510|FG001|Overall Study|Withdrawal by Subject|3|||
127846777|NCT00628758|460056509|FG000|Overall Study|Death|1|||
127846778|NCT00628758|460056510|FG001|Overall Study|Death|0|||
127846779|NCT00628758|460056509|FG000|Overall Study|Protocol Violation|5|||
127846780|NCT00628758|460056510|FG001|Overall Study|Protocol Violation|1|||
127846781|NCT00628758|460056509|FG000|Overall Study|Lost to Follow-up|25|||
127846782|NCT00628758|460056510|FG001|Overall Study|Lost to Follow-up|31|||
127846783|NCT00628758|460056509|FG000|Overall Study|Pregnancy|2|||
127846784|NCT00628758|460056510|FG001|Overall Study|Pregnancy|2|||
127846785|NCT00628758|460056509|FG000|Overall Study|Investigator Moved|3|||
127846786|NCT00628758|460056510|FG001|Overall Study|Investigator Moved|0|||
127846787|NCT00628758|460056509|FG000|Overall Study|Treatment Failure|0|||
127846788|NCT00628758|460056510|FG001|Overall Study|Treatment Failure|2|||
127846789|NCT00637377|460056511|FG000|Overall Study|Adverse Event|2|||
127846790|NCT00637377|460056512|FG001|Overall Study|Adverse Event|6|||
127846791|NCT00637377|460056513|FG002|Overall Study|Adverse Event|8|||
127846792|NCT00637377|460056514|FG003|Overall Study|Adverse Event|9|||
127846793|NCT00637377|460056511|FG000|Overall Study|Death|1|||
127846794|NCT00637377|460056512|FG001|Overall Study|Death|3|||
127846795|NCT00637377|460056513|FG002|Overall Study|Death|2|||
127846796|NCT00637377|460056514|FG003|Overall Study|Death|1|||
127846797|NCT00637377|460056511|FG000|Overall Study|Lack of Efficacy|0|||
127846798|NCT00637377|460056512|FG001|Overall Study|Lack of Efficacy|0|||
127846799|NCT00637377|460056513|FG002|Overall Study|Lack of Efficacy|1|||
127846800|NCT00637377|460056514|FG003|Overall Study|Lack of Efficacy|1|||
127846801|NCT00637377|460056511|FG000|Overall Study|Lost to Follow-up|4|||
127846802|NCT00637377|460056512|FG001|Overall Study|Lost to Follow-up|1|||
127846803|NCT00637377|460056513|FG002|Overall Study|Lost to Follow-up|2|||
127846804|NCT00637377|460056514|FG003|Overall Study|Lost to Follow-up|2|||
127846805|NCT00637377|460056511|FG000|Overall Study|Protocol Violation|2|||
127846806|NCT00637377|460056512|FG001|Overall Study|Protocol Violation|1|||
127846807|NCT00637377|460056513|FG002|Overall Study|Protocol Violation|1|||
127846808|NCT00637377|460056514|FG003|Overall Study|Protocol Violation|0|||
127846809|NCT00637377|460056511|FG000|Overall Study|Withdrawal by Subject|11|||
127846810|NCT00637377|460056512|FG001|Overall Study|Withdrawal by Subject|15|||
127846811|NCT00637377|460056513|FG002|Overall Study|Withdrawal by Subject|13|||
127846812|NCT00637377|460056514|FG003|Overall Study|Withdrawal by Subject|11|||
127846813|NCT00637377|460056511|FG000|Overall Study|Other (no further information available)|7|||
127846814|NCT00637377|460056512|FG001|Overall Study|Other (no further information available)|6|||
127846815|NCT00637377|460056513|FG002|Overall Study|Other (no further information available)|10|||
127846816|NCT00637377|460056514|FG003|Overall Study|Other (no further information available)|5|||
127846817|NCT01938001|460056515|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
127846818|NCT01938001|460056516|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
127846819|NCT01938001|460056515|FG000|Pre-Treatment|Death|1|||
127846820|NCT01938001|460056516|FG001|Pre-Treatment|Death|0|||
127846821|NCT01938001|460056515|FG000|Treatment|Death|2|||
127846822|NCT01938001|460056516|FG001|Treatment|Death|0|||
127846823|NCT01938001|460056515|FG000|Treatment|Adverse Event|14|||
127846824|NCT01938001|460056516|FG001|Treatment|Adverse Event|8|||
127846825|NCT01938001|460056515|FG000|Treatment|Progressive Disease|21|||
127846826|NCT01938001|460056516|FG001|Treatment|Progressive Disease|54|||
127846827|NCT01938001|460056515|FG000|Treatment|Withdrawal by Subject|13|||
127846828|NCT01938001|460056516|FG001|Treatment|Withdrawal by Subject|7|||
127846829|NCT01938001|460056515|FG000|Treatment|Other reasons|2|||
127846830|NCT01938001|460056516|FG001|Treatment|Other reasons|1|||
127846831|NCT02762708|460056519|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
127846832|NCT02762708|460056520|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
127846833|NCT02762708|460056521|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
127846834|NCT02762708|460056522|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
127846835|NCT01468701|460056527|FG000|Overall Study|Not eligible|91|||
127846836|NCT01468701|460056528|FG001|Overall Study|Not eligible|140|||
127846837|NCT01468701|460056529|FG002|Overall Study|Not eligible|29|||
127846838|NCT01468701|460056530|FG003|Overall Study|Not eligible|12|||
127846839|NCT01468701|460056531|FG004|Overall Study|Not eligible|22|||
127846840|NCT01468701|460056532|FG005|Overall Study|Not eligible|2|||
127846841|NCT01468701|460056533|FG006|Overall Study|Not eligible|39|||
127846842|NCT01468701|460056534|FG007|Overall Study|Not eligible|1|||
127846843|NCT01468701|460056535|FG008|Overall Study|Not eligible|40|||
127846844|NCT01468701|460056536|FG009|Overall Study|Not eligible|126|||
127846845|NCT01468701|460056537|FG010|Overall Study|Not eligible|39|||
127846846|NCT01468701|460056538|FG011|Overall Study|Not eligible|33|||
127846847|NCT01468701|460056539|FG012|Overall Study|Not eligible|1|||
127846848|NCT01468701|460056540|FG013|Overall Study|Not eligible|19|||
127846849|NCT01468701|460056541|FG014|Overall Study|Not eligible|1|||
127846850|NCT01468701|460056542|FG015|Overall Study|Not eligible|32|||
127846851|NCT01468701|460056543|FG016|Overall Study|Not eligible|0|||
127846852|NCT01468701|460056527|FG000|Overall Study|Lost to Follow-up|306|||
127846853|NCT01468701|460056528|FG001|Overall Study|Lost to Follow-up|0|||
127846854|NCT01468701|460056529|FG002|Overall Study|Lost to Follow-up|0|||
127846855|NCT01468701|460056530|FG003|Overall Study|Lost to Follow-up|0|||
127846856|NCT01468701|460056531|FG004|Overall Study|Lost to Follow-up|0|||
127846857|NCT01468701|460056532|FG005|Overall Study|Lost to Follow-up|0|||
127846858|NCT01468701|460056533|FG006|Overall Study|Lost to Follow-up|0|||
127846859|NCT01468701|460056534|FG007|Overall Study|Lost to Follow-up|0|||
127846860|NCT01468701|460056535|FG008|Overall Study|Lost to Follow-up|215|||
127846861|NCT01468701|460056536|FG009|Overall Study|Lost to Follow-up|309|||
127846862|NCT01468701|460056537|FG010|Overall Study|Lost to Follow-up|224|||
127846863|NCT01468701|460056538|FG011|Overall Study|Lost to Follow-up|212|||
127846864|NCT01468701|460056539|FG012|Overall Study|Lost to Follow-up|11|||
127846865|NCT01468701|460056540|FG013|Overall Study|Lost to Follow-up|164|||
127846866|NCT01468701|460056541|FG014|Overall Study|Lost to Follow-up|17|||
127846867|NCT01468701|460056542|FG015|Overall Study|Lost to Follow-up|127|||
127846868|NCT01468701|460056543|FG016|Overall Study|Lost to Follow-up|1|||
127846869|NCT01468701|460056527|FG000|Overall Study|Withdrawal by Subject|165|||
127846870|NCT01468701|460056528|FG001|Overall Study|Withdrawal by Subject|0|||
127846871|NCT01468701|460056529|FG002|Overall Study|Withdrawal by Subject|0|||
127846872|NCT01468701|460056530|FG003|Overall Study|Withdrawal by Subject|0|||
127846873|NCT01468701|460056531|FG004|Overall Study|Withdrawal by Subject|0|||
127846874|NCT01468701|460056532|FG005|Overall Study|Withdrawal by Subject|0|||
127846875|NCT01468701|460056533|FG006|Overall Study|Withdrawal by Subject|0|||
127846876|NCT01468701|460056534|FG007|Overall Study|Withdrawal by Subject|0|||
127846877|NCT01468701|460056535|FG008|Overall Study|Withdrawal by Subject|83|||
127846878|NCT01468701|460056536|FG009|Overall Study|Withdrawal by Subject|88|||
127846879|NCT01468701|460056537|FG010|Overall Study|Withdrawal by Subject|100|||
127846880|NCT01468701|460056538|FG011|Overall Study|Withdrawal by Subject|114|||
127846881|NCT01468701|460056539|FG012|Overall Study|Withdrawal by Subject|9|||
127846882|NCT01468701|460056540|FG013|Overall Study|Withdrawal by Subject|47|||
127846883|NCT01468701|460056541|FG014|Overall Study|Withdrawal by Subject|6|||
127846884|NCT01468701|460056542|FG015|Overall Study|Withdrawal by Subject|31|||
127846885|NCT01468701|460056543|FG016|Overall Study|Withdrawal by Subject|0|||
127846886|NCT01468701|460056527|FG000|Overall Study|Other reasons than listed|437|||
127846887|NCT01468701|460056528|FG001|Overall Study|Other reasons than listed|0|||
127846888|NCT01468701|460056529|FG002|Overall Study|Other reasons than listed|0|||
127846889|NCT01468701|460056530|FG003|Overall Study|Other reasons than listed|0|||
127846890|NCT01468701|460056531|FG004|Overall Study|Other reasons than listed|0|||
127846891|NCT01468701|460056532|FG005|Overall Study|Other reasons than listed|0|||
127846892|NCT01468701|460056533|FG006|Overall Study|Other reasons than listed|0|||
127846893|NCT01468701|460056534|FG007|Overall Study|Other reasons than listed|0|||
127846894|NCT01468701|460056535|FG008|Overall Study|Other reasons than listed|318|||
127846895|NCT01468701|460056536|FG009|Overall Study|Other reasons than listed|658|||
127846896|NCT01468701|460056537|FG010|Overall Study|Other reasons than listed|433|||
127846897|NCT01468701|460056538|FG011|Overall Study|Other reasons than listed|504|||
127846898|NCT01468701|460056539|FG012|Overall Study|Other reasons than listed|28|||
127846899|NCT01468701|460056540|FG013|Overall Study|Other reasons than listed|239|||
127846900|NCT01468701|460056541|FG014|Overall Study|Other reasons than listed|39|||
127846901|NCT01468701|460056542|FG015|Overall Study|Other reasons than listed|172|||
127846902|NCT01468701|460056543|FG016|Overall Study|Other reasons than listed|0|||
127846903|NCT01468701|460056527|FG000|Overall Study|No end of study case report form|0|||
127846904|NCT01468701|460056528|FG001|Overall Study|No end of study case report form|0|||
127846905|NCT01468701|460056529|FG002|Overall Study|No end of study case report form|0|||
127846906|NCT01468701|460056530|FG003|Overall Study|No end of study case report form|0|||
127846907|NCT01468701|460056531|FG004|Overall Study|No end of study case report form|0|||
127846908|NCT01468701|460056532|FG005|Overall Study|No end of study case report form|0|||
127846909|NCT01468701|460056533|FG006|Overall Study|No end of study case report form|0|||
127846910|NCT01468701|460056534|FG007|Overall Study|No end of study case report form|0|||
127846911|NCT01468701|460056535|FG008|Overall Study|No end of study case report form|4|||
127846912|NCT01468701|460056536|FG009|Overall Study|No end of study case report form|1|||
127846913|NCT01468701|460056537|FG010|Overall Study|No end of study case report form|2|||
127846914|NCT01468701|460056538|FG011|Overall Study|No end of study case report form|3|||
127846915|NCT01468701|460056539|FG012|Overall Study|No end of study case report form|0|||
127846916|NCT01468701|460056540|FG013|Overall Study|No end of study case report form|1|||
127846917|NCT01468701|460056541|FG014|Overall Study|No end of study case report form|0|||
127846918|NCT01468701|460056542|FG015|Overall Study|No end of study case report form|0|||
127846919|NCT01468701|460056543|FG016|Overall Study|No end of study case report form|0|||
127846920|NCT01468701|460056527|FG000|Overall Study|Not being followed up|0|||
127846921|NCT01468701|460056528|FG001|Overall Study|Not being followed up|4963|||
127846922|NCT01468701|460056529|FG002|Overall Study|Not being followed up|1755|||
127846923|NCT01468701|460056530|FG003|Overall Study|Not being followed up|703|||
127846924|NCT01468701|460056531|FG004|Overall Study|Not being followed up|1714|||
127846925|NCT01468701|460056532|FG005|Overall Study|Not being followed up|126|||
127846926|NCT01468701|460056533|FG006|Overall Study|Not being followed up|1170|||
127846927|NCT01468701|460056534|FG007|Overall Study|Not being followed up|4|||
127846928|NCT01468701|460056535|FG008|Overall Study|Not being followed up|0|||
127846929|NCT01468701|460056536|FG009|Overall Study|Not being followed up|0|||
127846930|NCT01468701|460056537|FG010|Overall Study|Not being followed up|0|||
127846931|NCT01468701|460056538|FG011|Overall Study|Not being followed up|0|||
127846932|NCT01468701|460056539|FG012|Overall Study|Not being followed up|0|||
127902128|NCT00727571|460266501|FG002|Overall Study|Other|6|||
127902129|NCT00727571|460266502|FG003|Overall Study|Other|0|||
127902130|NCT03164772|460266504|FG000|Overall Study|Death|4|||
127902131|NCT03164772|460266505|FG001|Overall Study|Death|2|||
127902132|NCT03164772|460266504|FG000|Overall Study|Adverse Event|1|||
127902133|NCT03164772|460266505|FG001|Overall Study|Adverse Event|4|||
127902134|NCT03164772|460266504|FG000|Overall Study|Progressive Disease|11|||
127902135|NCT03164772|460266505|FG001|Overall Study|Progressive Disease|21|||
127902136|NCT03164772|460266504|FG000|Overall Study|Physician Decision|2|||
127902137|NCT03164772|460266505|FG001|Overall Study|Physician Decision|0|||
127902138|NCT03164772|460266504|FG000|Overall Study|Withdrawal by Subject|0|||
127902139|NCT03164772|460266505|FG001|Overall Study|Withdrawal by Subject|4|||
127902140|NCT01029353|460266506|FG000|Overall Study|Lost to Follow-up|4|||
127902141|NCT01029353|460266507|FG001|Overall Study|Lost to Follow-up|5|||
127902142|NCT01029353|460266508|FG002|Overall Study|Lost to Follow-up|5|||
127902143|NCT01029353|460266509|FG003|Overall Study|Lost to Follow-up|4|||
127902144|NCT01029353|460266506|FG000|Overall Study|Consent Withdrawn|2|||
127902145|NCT01029353|460266507|FG001|Overall Study|Consent Withdrawn|0|||
127902146|NCT01029353|460266508|FG002|Overall Study|Consent Withdrawn|0|||
127902147|NCT01029353|460266509|FG003|Overall Study|Consent Withdrawn|0|||
127902148|NCT01029353|460266506|FG000|Overall Study|Primary Outcome Indeterminate|1|||
127902149|NCT01029353|460266507|FG001|Overall Study|Primary Outcome Indeterminate|3|||
127902150|NCT01029353|460266508|FG002|Overall Study|Primary Outcome Indeterminate|2|||
127902151|NCT01029353|460266509|FG003|Overall Study|Primary Outcome Indeterminate|0|||
127902152|NCT01900730|460266510|FG000|Overall Study|Withdrawal by Subject|1|||
127902153|NCT01900730|460266511|FG001|Overall Study|Withdrawal by Subject|0|||
127902154|NCT01900730|460266510|FG000|Overall Study|Screen Failure|1|||
127902155|NCT01900730|460266511|FG001|Overall Study|Screen Failure|0|||
127902156|NCT02152566|460266512|FG000|Overall Study|Lost to Follow-up|1|||
127902157|NCT02152566|460266512|FG000|Overall Study|Withdrawal by Subject|2|||
127902158|NCT03603314|460266513|FG000|Overall Study|Lost to Follow-up|0|||
127902159|NCT03603314|460266514|FG001|Overall Study|Lost to Follow-up|3|||
127902160|NCT03603314|460266515|FG002|Overall Study|Lost to Follow-up|0|||
127902161|NCT03603314|460266513|FG000|Overall Study|Protocol Violation|0|||
127902162|NCT03603314|460266514|FG001|Overall Study|Protocol Violation|1|||
127902163|NCT03603314|460266515|FG002|Overall Study|Protocol Violation|0|||
127902164|NCT03603314|460266513|FG000|Overall Study|Adverse Event|2|||
127902165|NCT03603314|460266514|FG001|Overall Study|Adverse Event|0|||
127902166|NCT03603314|460266515|FG002|Overall Study|Adverse Event|0|||
127902167|NCT03603314|460266513|FG000|Overall Study|Physician Decision|1|||
127902168|NCT03603314|460266514|FG001|Overall Study|Physician Decision|1|||
127902169|NCT03603314|460266515|FG002|Overall Study|Physician Decision|0|||
127902170|NCT03603314|460266513|FG000|Overall Study|Withdrawal by Subject|4|||
127902171|NCT03603314|460266514|FG001|Overall Study|Withdrawal by Subject|5|||
127902172|NCT03603314|460266515|FG002|Overall Study|Withdrawal by Subject|3|||
127846933|NCT01468701|460056540|FG013|Overall Study|Not being followed up|0|||
127846934|NCT01468701|460056541|FG014|Overall Study|Not being followed up|0|||
127846935|NCT01468701|460056542|FG015|Overall Study|Not being followed up|0|||
127846936|NCT01468701|460056543|FG016|Overall Study|Not being followed up|0|||
127846937|NCT01068717|460056544|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
127846938|NCT01068717|460056545|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
127846939|NCT01068717|460056546|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
127846940|NCT01068717|460056547|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
127846941|NCT01822223|460056550|FG000|Overall Study|Death|0|||
127846942|NCT01822223|460056551|FG001|Overall Study|Death|1|||
127846943|NCT05200455|460056553|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
127902173|NCT03603314|460266513|FG000|Overall Study|Other|0|||
127902174|NCT03603314|460266514|FG001|Overall Study|Other|1|||
127902175|NCT03603314|460266515|FG002|Overall Study|Other|0|||
127902176|NCT03450070|460266516|FG000|Overall Study|Withdrawal by Subject|8|||
127902177|NCT01496183|460266522|FG000|Overall Study|Physician Decision|3|||
127902178|NCT01496183|460266523|FG001|Overall Study|Physician Decision|1|||
127902179|NCT01496183|460266522|FG000|Overall Study|Withdrawal by Subject|0|||
127902180|NCT01496183|460266523|FG001|Overall Study|Withdrawal by Subject|1|||
127902181|NCT03002077|460266524|FG000|Overall Study|Non-compliance with Study Drug|4|||
127902182|NCT03002077|460266524|FG000|Overall Study|Non-compliance w/Background ADT|1|||
127902183|NCT03002077|460266524|FG000|Overall Study|Study Terminated by Sponsor|257|||
127902184|NCT03002077|460266524|FG000|Overall Study|Site Terminated by Sponsor|5|||
127902185|NCT03002077|460266524|FG000|Overall Study|Miscellaneous Reasons|10|||
127902186|NCT03002077|460266524|FG000|Overall Study|Adverse Event|23|||
127902187|NCT03002077|460266524|FG000|Overall Study|Lack of Efficacy|20|||
127902188|NCT03002077|460266524|FG000|Overall Study|Withdrawal by Subject|72|||
127902189|NCT03002077|460266524|FG000|Overall Study|Lost to Follow-up|21|||
127902190|NCT03002077|460266524|FG000|Overall Study|Pregnancy|4|||
127902191|NCT03002077|460266524|FG000|Overall Study|Protocol Violation|21|||
127902192|NCT04625114|460266525|FG000|Overall Study|Adverse Event|3|||
127902193|NCT04625114|460266526|FG001|Overall Study|Adverse Event|1|||
127902194|NCT04625114|460266525|FG000|Overall Study|Withdrawal by Subject|2|||
127902195|NCT04625114|460266526|FG001|Overall Study|Withdrawal by Subject|0|||
127902196|NCT00472290|460266527|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
127902197|NCT00472290|460266527|FG000|Overall Study|Protocol Specified Criteria|7|||
127902198|NCT00472290|460266527|FG000|Overall Study|Administrative Decision|37|||
127902199|NCT00472290|460266527|FG000|Overall Study|Death|3|||
127902200|NCT00472290|460266527|FG000|Overall Study|Lost to Follow-up|1|||
127902201|NCT00472290|460266527|FG000|Overall Study|Lack of Efficacy|1|||
127902202|NCT00472290|460266527|FG000|Overall Study|Disease Progression|4|||
127902203|NCT00472290|460266527|FG000|Overall Study|Withdrawal by Subject|5|||
127902204|NCT00472290|460266527|FG000|Overall Study|Adverse Event|6|||
127902205|NCT00472290|460266527|FG000|Overall Study|Requirement for alternative therapy|7|||
127902206|NCT00777829|460266528|FG000|Overall Study|Withdrawal by Subject|0|||
127902207|NCT00777829|460266529|FG001|Overall Study|Withdrawal by Subject|2|||
127902208|NCT02016170|460266546|FG000|Overall Study|Adverse Event|1|||
127902209|NCT02016170|460266547|FG001|Overall Study|Adverse Event|1|||
127902210|NCT02016170|460266548|FG002|Overall Study|Adverse Event|0|||
127902211|NCT02016170|460266546|FG000|Overall Study|Protocol Violation|1|||
127902212|NCT02016170|460266547|FG001|Overall Study|Protocol Violation|0|||
127902213|NCT02016170|460266548|FG002|Overall Study|Protocol Violation|0|||
127902214|NCT00336479|460266549|FG000|Overall Study|Adverse Event|8|||
127902215|NCT00336479|460266550|FG001|Overall Study|Adverse Event|11|||
127902216|NCT00336479|460266551|FG002|Overall Study|Adverse Event|18|||
127902217|NCT00336479|460266552|FG003|Overall Study|Adverse Event|4|||
127902218|NCT00336479|460266549|FG000|Overall Study|Noncompliant|1|||
127902219|NCT00336479|460266550|FG001|Overall Study|Noncompliant|7|||
127902220|NCT00336479|460266551|FG002|Overall Study|Noncompliant|3|||
127902221|NCT00336479|460266552|FG003|Overall Study|Noncompliant|0|||
127902222|NCT00336479|460266549|FG000|Overall Study|Physician Decision|2|||
127902223|NCT00336479|460266550|FG001|Overall Study|Physician Decision|3|||
127902224|NCT00336479|460266551|FG002|Overall Study|Physician Decision|1|||
127902225|NCT00336479|460266552|FG003|Overall Study|Physician Decision|0|||
127902226|NCT00336479|460266549|FG000|Overall Study|Lost to Follow-up|3|||
127902227|NCT00336479|460266550|FG001|Overall Study|Lost to Follow-up|2|||
127902228|NCT00336479|460266551|FG002|Overall Study|Lost to Follow-up|0|||
127902229|NCT00336479|460266552|FG003|Overall Study|Lost to Follow-up|0|||
127902230|NCT00336479|460266549|FG000|Overall Study|Withdrawal by Subject|3|||
127902231|NCT00336479|460266550|FG001|Overall Study|Withdrawal by Subject|2|||
127902232|NCT00336479|460266551|FG002|Overall Study|Withdrawal by Subject|3|||
127902233|NCT00336479|460266552|FG003|Overall Study|Withdrawal by Subject|0|||
127902234|NCT00336479|460266549|FG000|Overall Study|Other|0|||
127902235|NCT00336479|460266550|FG001|Overall Study|Other|0|||
127902236|NCT00336479|460266551|FG002|Overall Study|Other|1|||
127902237|NCT00336479|460266552|FG003|Overall Study|Other|0|||
127902238|NCT00336479|460266549|FG000|Overall Study|Virologic Stopping Rule|20|||
127902239|NCT00336479|460266550|FG001|Overall Study|Virologic Stopping Rule|0|||
127902240|NCT00336479|460266551|FG002|Overall Study|Virologic Stopping Rule|0|||
127902241|NCT00336479|460266552|FG003|Overall Study|Virologic Stopping Rule|0|||
127902242|NCT01479439|460266553|FG000|Overall Study|Adverse Event|1|||
127902243|NCT01479439|460266554|FG001|Overall Study|Adverse Event|0|||
127902244|NCT01479439|460266555|FG002|Overall Study|Adverse Event|0|||
127902245|NCT01479439|460266553|FG000|Overall Study|Lost to Follow-up|0|||
127902246|NCT01479439|460266554|FG001|Overall Study|Lost to Follow-up|1|||
127902247|NCT01479439|460266555|FG002|Overall Study|Lost to Follow-up|0|||
127902248|NCT01479439|460266553|FG000|Overall Study|Protocol Violation|0|||
127902249|NCT01479439|460266554|FG001|Overall Study|Protocol Violation|0|||
127902250|NCT01479439|460266555|FG002|Overall Study|Protocol Violation|2|||
127902251|NCT02365207|460266556|FG000|Overall Study|Withdrawal by Subject|1|||
127902252|NCT02365207|460266556|FG000|Overall Study|Physician Decision|1|||
127902253|NCT01722877|460266557|FG000|Overall Study|Death|1|||
127902254|NCT01722877|460266557|FG000|Overall Study|Lost to Follow-up|1|||
127902255|NCT01395030|460266560|FG000|Overall Study|Did not complete FCH PET/CT|7|||
127902256|NCT02079766|460266561|FG000|Overall Study|Physician Decision|1|||
127902257|NCT02079766|460266562|FG001|Overall Study|Physician Decision|0|||
127902258|NCT02079766|460266561|FG000|Overall Study|Withdrawal by Subject|1|||
127902259|NCT02079766|460266562|FG001|Overall Study|Withdrawal by Subject|0|||
127902260|NCT05067647|460266566|FG000|Overall Study|Lost to Follow-up|1|||
127902261|NCT00857623|460266569|FG000|Overall Study|Adverse Event|5|||
127902262|NCT00857623|460266570|FG001|Overall Study|Adverse Event|2|||
127902263|NCT00857623|460266569|FG000|Overall Study|Study-specific discontinuation criteria|5|||
127902264|NCT00857623|460266570|FG001|Overall Study|Study-specific discontinuation criteria|3|||
127902265|NCT00857623|460266569|FG000|Overall Study|Withdrawal by Subject|2|||
127902266|NCT00857623|460266570|FG001|Overall Study|Withdrawal by Subject|1|||
127902267|NCT00857623|460266569|FG000|Overall Study|Lack of Efficacy|1|||
127902268|NCT00857623|460266570|FG001|Overall Study|Lack of Efficacy|1|||
127902269|NCT00857623|460266569|FG000|Overall Study|Severe non-compliance to protocol|1|||
127902270|NCT00857623|460266570|FG001|Overall Study|Severe non-compliance to protocol|1|||
127902271|NCT00857623|460266569|FG000|Overall Study|Intake of prohibited medication|0|||
127902272|NCT00857623|460266570|FG001|Overall Study|Intake of prohibited medication|1|||
127902273|NCT00857623|460266569|FG000|Overall Study|Positive for HEP C|0|||
127902274|NCT00857623|460266570|FG001|Overall Study|Positive for HEP C|1|||
127902275|NCT00694551|460266571|FG000|Overall Study|Disease Progression|1|||
127902276|NCT00694551|460266572|FG001|Overall Study|Disease Progression|0|||
127902277|NCT00694551|460266573|FG002|Overall Study|Disease Progression|1|||
127902278|NCT01569152|460266574|FG000|Phase IIa, Period 1|Early Escape|5|||
127902279|NCT01569152|460266575|FG001|Phase IIa, Period 1|Early Escape|22|||
127902280|NCT01569152|460266576|FG002|Phase IIa, Period 1|Early Escape|0|||
127902281|NCT01569152|460266574|FG000|Phase IIa, Period 1|Adverse Event|4|||
127902282|NCT01569152|460266575|FG001|Phase IIa, Period 1|Adverse Event|0|||
127902283|NCT01569152|460266576|FG002|Phase IIa, Period 1|Adverse Event|0|||
127902284|NCT01569152|460266574|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
127902285|NCT01569152|460266575|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
127902286|NCT01569152|460266576|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
127902287|NCT01569152|460266574|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
127902288|NCT01569152|460266575|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
127902289|NCT01569152|460266576|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
127902290|NCT01569152|460266574|FG000|Phase IIa, Period 1|Protocol Violation|0|||
127902291|NCT01569152|460266575|FG001|Phase IIa, Period 1|Protocol Violation|1|||
127902292|NCT01569152|460266576|FG002|Phase IIa, Period 1|Protocol Violation|0|||
127902293|NCT01569152|460266574|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
127902294|NCT01569152|460266575|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
127902295|NCT01569152|460266576|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
127902296|NCT01569152|460266574|FG000|Safety Extension, Period 3|Adverse Event|0|||
127902297|NCT01569152|460266575|FG001|Safety Extension, Period 3|Adverse Event|0|||
127902298|NCT01569152|460266576|FG002|Safety Extension, Period 3|Adverse Event|4|||
127902299|NCT01569152|460266574|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
127902300|NCT01569152|460266575|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
127902301|NCT01569152|460266576|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
127902302|NCT01569152|460266574|FG000|Safety Extension, Period 3|Physician Decision|0|||
127902303|NCT01569152|460266575|FG001|Safety Extension, Period 3|Physician Decision|0|||
127902304|NCT01569152|460266576|FG002|Safety Extension, Period 3|Physician Decision|2|||
127902305|NCT01569152|460266574|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
127902306|NCT01569152|460266575|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
127902307|NCT01569152|460266576|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
127902308|NCT02920996|460266583|FG000|Overall Study|Adverse Event|8|||
127902309|NCT02920996|460266584|FG001|Overall Study|Adverse Event|0|||
127902310|NCT02920996|460266583|FG000|Overall Study|Physician Decision|1|||
127902311|NCT02920996|460266584|FG001|Overall Study|Physician Decision|0|||
127902312|NCT02920996|460266583|FG000|Overall Study|Death|1|||
127902313|NCT02920996|460266584|FG001|Overall Study|Death|0|||
127902314|NCT02920996|460266583|FG000|Overall Study|Missing|1|||
127902315|NCT02920996|460266584|FG001|Overall Study|Missing|0|||
127902316|NCT02920996|460266583|FG000|Overall Study|Subject Non-Compliance|1|||
127902317|NCT02920996|460266584|FG001|Overall Study|Subject Non-Compliance|0|||
127902318|NCT00154102|460266585|FG000|Overall Study|investigational study phase ongoing|7|||
127902319|NCT00154102|460266586|FG001|Overall Study|investigational study phase ongoing|2|||
127902320|NCT00463606|460266587|FG000|Overall Study|Adverse Event|21|||
127902321|NCT00463606|460266588|FG001|Overall Study|Adverse Event|18|||
127902322|NCT00463606|460266589|FG002|Overall Study|Adverse Event|11|||
127902323|NCT00463606|460266587|FG000|Overall Study|Withdrawal by Subject|11|||
127902324|NCT00463606|460266588|FG001|Overall Study|Withdrawal by Subject|11|||
127902325|NCT00463606|460266589|FG002|Overall Study|Withdrawal by Subject|5|||
127902326|NCT00463606|460266587|FG000|Overall Study|Lost to Follow-up|2|||
127902327|NCT00463606|460266588|FG001|Overall Study|Lost to Follow-up|2|||
127902328|NCT00463606|460266589|FG002|Overall Study|Lost to Follow-up|3|||
127902329|NCT00463606|460266587|FG000|Overall Study|Subject noncompliance|1|||
127902330|NCT00463606|460266588|FG001|Overall Study|Subject noncompliance|1|||
127902331|NCT00463606|460266589|FG002|Overall Study|Subject noncompliance|0|||
127902332|NCT00463606|460266587|FG000|Overall Study|Subject moved out of town|1|||
127902333|NCT00463606|460266588|FG001|Overall Study|Subject moved out of town|0|||
127902334|NCT00463606|460266589|FG002|Overall Study|Subject moved out of town|0|||
127902335|NCT00463606|460266587|FG000|Overall Study|Physician Decision|0|||
127902336|NCT00463606|460266588|FG001|Overall Study|Physician Decision|1|||
127902337|NCT00463606|460266589|FG002|Overall Study|Physician Decision|0|||
127902338|NCT00463606|460266587|FG000|Overall Study|Sponsor request|0|||
127902339|NCT00463606|460266588|FG001|Overall Study|Sponsor request|1|||
127902340|NCT00463606|460266589|FG002|Overall Study|Sponsor request|0|||
127902341|NCT00463606|460266587|FG000|Overall Study|Exclusion criteria violation|2|||
127902342|NCT00463606|460266588|FG001|Overall Study|Exclusion criteria violation|0|||
127902343|NCT00463606|460266589|FG002|Overall Study|Exclusion criteria violation|0|||
127902344|NCT00463606|460266587|FG000|Overall Study|Coordinator error|1|||
127902345|NCT00463606|460266588|FG001|Overall Study|Coordinator error|0|||
127902346|NCT00463606|460266589|FG002|Overall Study|Coordinator error|0|||
127902347|NCT00463606|460266587|FG000|Overall Study|Patient randomized in error|1|||
127902348|NCT00463606|460266588|FG001|Overall Study|Patient randomized in error|0|||
127902349|NCT00463606|460266589|FG002|Overall Study|Patient randomized in error|0|||
127902350|NCT00463606|460266587|FG000|Overall Study|Participation in another ABT-335 trial|1|||
127902351|NCT00463606|460266588|FG001|Overall Study|Participation in another ABT-335 trial|0|||
127902352|NCT00463606|460266589|FG002|Overall Study|Participation in another ABT-335 trial|0|||
127902353|NCT00463606|460266587|FG000|Overall Study|Protocol Violation|0|||
127902354|NCT00463606|460266588|FG001|Overall Study|Protocol Violation|0|||
127902355|NCT00463606|460266589|FG002|Overall Study|Protocol Violation|1|||
127902356|NCT02682602|460266591|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
127902357|NCT02682602|460266592|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
127902358|NCT02682602|460266591|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
127902359|NCT02682602|460266592|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
127902360|NCT04349917|460267789|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
127902361|NCT04349917|460267790|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
127902362|NCT04349917|460267789|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
127902363|NCT04349917|460267790|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
127902364|NCT00745420|460267793|FG000|Overall Study|Ineligible|1|||
127902365|NCT00088829|460267795|FG000|Overall Study|PI left institution and study was close|22|||
127902366|NCT01287013|460267798|FG000|Overall Study|Non-evaluable|3|||
127902367|NCT01287013|460267799|FG001|Overall Study|Non-evaluable|5|||
127902368|NCT01287013|460267800|FG002|Overall Study|Non-evaluable|21|||
127902369|NCT02109042|460267801|FG000|Overall Study|Sponsor Decision|15|||
127902370|NCT03203447|460267802|FG000|Overall Study|Withdrawal by Subject|2|||
127846944|NCT01602549|460056556|FG000|Overall Study|Protocol Violation|0|||
127846945|NCT01602549|460056557|FG001|Overall Study|Protocol Violation|1|||
127846946|NCT01602549|460056556|FG000|Overall Study|Withdrawal by Subject|1|||
127846947|NCT01602549|460056557|FG001|Overall Study|Withdrawal by Subject|0|||
127846948|NCT00719862|460056558|FG000|Overall Study|Adverse Event|1|||
127846949|NCT00719862|460056559|FG001|Overall Study|Adverse Event|2|||
127846950|NCT00719862|460056558|FG000|Overall Study|Lack of Efficacy|3|||
127846951|NCT00719862|460056559|FG001|Overall Study|Lack of Efficacy|0|||
127846952|NCT00719862|460056558|FG000|Overall Study|Non-Compliance|1|||
127846953|NCT00719862|460056559|FG001|Overall Study|Non-Compliance|0|||
127846954|NCT00719862|460056558|FG000|Overall Study|Withdrawal by Subject|1|||
127846955|NCT00719862|460056559|FG001|Overall Study|Withdrawal by Subject|0|||
127846956|NCT00719862|460056558|FG000|Overall Study|Lost to Follow-up|0|||
127846957|NCT00719862|460056559|FG001|Overall Study|Lost to Follow-up|1|||
127846958|NCT00719862|460056558|FG000|Overall Study|Other|2|||
127846959|NCT00719862|460056559|FG001|Overall Study|Other|3|||
127846960|NCT00892957|460056561|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
127846961|NCT00892957|460056562|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
127846962|NCT00892957|460056561|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
127846963|NCT00892957|460056562|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
127846964|NCT01184846|460056563|FG000|Overall Study|Adverse Event|2|||
127846965|NCT01184846|460056563|FG000|Overall Study|Insufficient response|1|||
127846966|NCT02483078|460056569|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
127846967|NCT02483078|460056570|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
127846968|NCT02483078|460056569|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
127846969|NCT02483078|460056570|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
127846970|NCT02483078|460056569|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
127846971|NCT02483078|460056570|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
127846972|NCT02483078|460056569|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
127846973|NCT02483078|460056570|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
127846974|NCT02483078|460056569|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
127846975|NCT02483078|460056570|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
127846976|NCT02483078|460056569|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
127846977|NCT02483078|460056570|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
127846978|NCT02853032|460056571|FG000|Overall Study|Adverse Event|4|||
127846979|NCT02853032|460056572|FG001|Overall Study|Adverse Event|0|||
127846980|NCT02853032|460056571|FG000|Overall Study|Withdrawal by Subject|3|||
127846981|NCT02853032|460056572|FG001|Overall Study|Withdrawal by Subject|1|||
127846982|NCT02853032|460056571|FG000|Overall Study|Requested to withdraw from all treatment|2|||
127846983|NCT02853032|460056572|FG001|Overall Study|Requested to withdraw from all treatment|2|||
127846984|NCT04876599|460056573|FG000|Overall Study|Missed|2|||
127846985|NCT04876599|460056574|FG001|Overall Study|Missed|0|||
127846986|NCT04876599|460056573|FG000|Overall Study|Declined|2|||
127846987|NCT04876599|460056574|FG001|Overall Study|Declined|3|||
127846988|NCT03175562|460056575|FG000|Overall Study|Adverse Event|1|||
127846989|NCT03175562|460056575|FG000|Overall Study|Lost to Follow-up|3|||
127846990|NCT03175562|460056575|FG000|Overall Study|Withdrawal by Subject|7|||
127902371|NCT03203447|460267803|FG001|Overall Study|Withdrawal by Subject|1|||
127902372|NCT03203447|460267802|FG000|Overall Study|Lost to Follow-up|1|||
127902373|NCT03203447|460267803|FG001|Overall Study|Lost to Follow-up|10|||
127846991|NCT03175562|460056575|FG000|Overall Study|Other (Not Specified)|5|||
127846992|NCT02146833|460056576|FG000|Overall Study|Death|10|||
127846993|NCT02146833|460056576|FG000|Overall Study|No longer consented to study treatment|1|||
127846994|NCT03700736|460056577|FG000|Overall Study|Pregnancy|1|||
127846995|NCT03700736|460056578|FG001|Overall Study|Pregnancy|1|||
127846996|NCT03700736|460056577|FG000|Overall Study|Withdrawal by Subject|2|||
127846997|NCT03700736|460056578|FG001|Overall Study|Withdrawal by Subject|6|||
127846998|NCT01410799|460056580|FG000|Overall Study|PI decision|13|||
127846999|NCT04126031|460056582|FG000|Part A|Withdrawal by Subject|0|||
127847000|NCT04126031|460056583|FG001|Part A|Withdrawal by Subject|0|||
127847001|NCT04126031|460056584|FG002|Part A|Withdrawal by Subject|1|||
127847002|NCT04126031|460056585|FG003|Part A|Withdrawal by Subject|0|||
127847003|NCT04126031|460056586|FG004|Part A|Withdrawal by Subject|0|||
127847004|NCT04126031|460056587|FG005|Part A|Withdrawal by Subject|0|||
127847005|NCT04126031|460056582|FG000|Part A|Other|1|||
127847006|NCT04126031|460056583|FG001|Part A|Other|0|||
127847007|NCT04126031|460056584|FG002|Part A|Other|0|||
127847008|NCT04126031|460056585|FG003|Part A|Other|0|||
127847009|NCT04126031|460056586|FG004|Part A|Other|0|||
127847010|NCT04126031|460056587|FG005|Part A|Other|0|||
127847011|NCT04126031|460056582|FG000|Part B|Adverse Event|0|||
127847012|NCT04126031|460056583|FG001|Part B|Adverse Event|0|||
127847013|NCT04126031|460056584|FG002|Part B|Adverse Event|0|||
127847014|NCT04126031|460056585|FG003|Part B|Adverse Event|0|||
127847015|NCT04126031|460056586|FG004|Part B|Adverse Event|0|||
127847016|NCT04126031|460056587|FG005|Part B|Adverse Event|2|||
127847017|NCT04126031|460056582|FG000|Part B|Pre-existing hypertransaminasemia|0|||
127847018|NCT04126031|460056583|FG001|Part B|Pre-existing hypertransaminasemia|0|||
127847019|NCT04126031|460056584|FG002|Part B|Pre-existing hypertransaminasemia|0|||
127847020|NCT04126031|460056585|FG003|Part B|Pre-existing hypertransaminasemia|0|||
127847021|NCT04126031|460056586|FG004|Part B|Pre-existing hypertransaminasemia|1|||
127847022|NCT04126031|460056587|FG005|Part B|Pre-existing hypertransaminasemia|0|||
127847023|NCT00617656|460056588|FG000|Overall Study|Inclusion error|4|||
127847024|NCT00617656|460056589|FG001|Overall Study|Inclusion error|4|||
127847025|NCT00617656|460056590|FG002|Overall Study|Inclusion error|0|||
127847026|NCT00617656|460056591|FG003|Overall Study|Inclusion error|0|||
127847027|NCT00617656|460056588|FG000|Overall Study|Missing data|44|||
127847028|NCT00617656|460056589|FG001|Overall Study|Missing data|30|||
127847029|NCT00617656|460056590|FG002|Overall Study|Missing data|13|||
127847030|NCT00617656|460056591|FG003|Overall Study|Missing data|6|||
127847031|NCT00617656|460056588|FG000|Overall Study|Withdrawal by Subject|0|||
127847032|NCT00617656|460056589|FG001|Overall Study|Withdrawal by Subject|2|||
127902374|NCT03203447|460267802|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
127902375|NCT03203447|460267803|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
127902376|NCT03478397|460267806|FG000|Overall Study|Refused to participate|31|||
127847033|NCT00617656|460056590|FG002|Overall Study|Withdrawal by Subject|0|||
127847034|NCT00617656|460056591|FG003|Overall Study|Withdrawal by Subject|0|||
127847035|NCT00131664|460056592|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
127847036|NCT00131664|460056593|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
127847037|NCT00131664|460056594|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
127847038|NCT00131664|460056595|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
127847039|NCT00131664|460056596|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
127847040|NCT00131664|460056597|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
127847041|NCT00131664|460056592|FG000|First Period (First 6 Months)|Death|0|||
127847042|NCT00131664|460056593|FG001|First Period (First 6 Months)|Death|1|||
127847043|NCT00131664|460056594|FG002|First Period (First 6 Months)|Death|0|||
127847044|NCT00131664|460056595|FG003|First Period (First 6 Months)|Death|0|||
127847045|NCT00131664|460056596|FG004|First Period (First 6 Months)|Death|0|||
127847046|NCT00131664|460056597|FG005|First Period (First 6 Months)|Death|0|||
127847047|NCT00131664|460056592|FG000|First Period (First 6 Months)|Protocol Violation|2|||
127847048|NCT00131664|460056593|FG001|First Period (First 6 Months)|Protocol Violation|2|||
127847049|NCT00131664|460056594|FG002|First Period (First 6 Months)|Protocol Violation|1|||
127847050|NCT00131664|460056595|FG003|First Period (First 6 Months)|Protocol Violation|0|||
127847051|NCT00131664|460056596|FG004|First Period (First 6 Months)|Protocol Violation|0|||
127847052|NCT00131664|460056597|FG005|First Period (First 6 Months)|Protocol Violation|0|||
127847053|NCT00131664|460056592|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
127847054|NCT00131664|460056593|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
127847055|NCT00131664|460056594|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
127847056|NCT00131664|460056595|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
127847057|NCT00131664|460056596|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
127847058|NCT00131664|460056597|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
127847059|NCT00131664|460056592|FG000|First Period (First 6 Months)|Adverse Event|9|||
127847060|NCT00131664|460056593|FG001|First Period (First 6 Months)|Adverse Event|4|||
127847061|NCT00131664|460056594|FG002|First Period (First 6 Months)|Adverse Event|5|||
127847062|NCT00131664|460056595|FG003|First Period (First 6 Months)|Adverse Event|0|||
127847063|NCT00131664|460056596|FG004|First Period (First 6 Months)|Adverse Event|0|||
127847064|NCT00131664|460056597|FG005|First Period (First 6 Months)|Adverse Event|0|||
127847065|NCT00131664|460056592|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
127847066|NCT00131664|460056593|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
127847067|NCT00131664|460056594|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
127847068|NCT00131664|460056595|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
127847069|NCT00131664|460056596|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
127847070|NCT00131664|460056597|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
127847071|NCT00131664|460056592|FG000|First Period (First 6 Months)|Administrative reasons|2|||
127847072|NCT00131664|460056593|FG001|First Period (First 6 Months)|Administrative reasons|0|||
127847073|NCT00131664|460056594|FG002|First Period (First 6 Months)|Administrative reasons|5|||
127847074|NCT00131664|460056595|FG003|First Period (First 6 Months)|Administrative reasons|0|||
127847075|NCT00131664|460056596|FG004|First Period (First 6 Months)|Administrative reasons|0|||
127847076|NCT00131664|460056597|FG005|First Period (First 6 Months)|Administrative reasons|0|||
127847077|NCT00131664|460056592|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
127847078|NCT00131664|460056593|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
127847079|NCT00131664|460056594|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
127847080|NCT00131664|460056595|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
127847081|NCT00131664|460056596|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
127847082|NCT00131664|460056597|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
127847083|NCT00131664|460056592|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
127847084|NCT00131664|460056593|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
127847085|NCT00131664|460056594|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
127847086|NCT00131664|460056595|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
127847087|NCT00131664|460056596|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
127847088|NCT00131664|460056597|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
127847089|NCT00131664|460056592|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
127847090|NCT00131664|460056593|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
127847091|NCT00131664|460056594|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
127847092|NCT00131664|460056595|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
127847093|NCT00131664|460056596|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
127847094|NCT00131664|460056597|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
127847095|NCT00131664|460056592|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
127847096|NCT00131664|460056593|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
127847097|NCT00131664|460056594|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
127847098|NCT00131664|460056595|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
127847099|NCT00131664|460056596|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
127847100|NCT00131664|460056597|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
127847101|NCT00131664|460056592|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
127847102|NCT00131664|460056593|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
127847103|NCT00131664|460056594|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
127847104|NCT00131664|460056595|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
127847105|NCT00131664|460056596|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
127847106|NCT00131664|460056597|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
127847107|NCT00131664|460056592|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
127847108|NCT00131664|460056593|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
127847109|NCT00131664|460056594|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
127847110|NCT00131664|460056595|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
127847111|NCT00131664|460056596|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
127847112|NCT00131664|460056597|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
127847113|NCT02688153|460059178|FG000|Overall Study|Death|7|||
127847114|NCT02688153|460059179|FG001|Overall Study|Death|5|||
127847115|NCT02688153|460059178|FG000|Overall Study|Withdrawal by Subject|4|||
127847116|NCT02688153|460059179|FG001|Overall Study|Withdrawal by Subject|2|||
127847117|NCT02688153|460059178|FG000|Overall Study|Valve Explant|1|||
127847118|NCT02688153|460059179|FG001|Overall Study|Valve Explant|0|||
127847119|NCT02688153|460059178|FG000|Overall Study|Conversion to Commercial Valve|3|||
127847120|NCT02688153|460059179|FG001|Overall Study|Conversion to Commercial Valve|0|||
127847121|NCT00107172|460059180|FG000|Overall Study|Withdrawal by Subject|1|||
127902377|NCT03478397|460267807|FG001|Overall Study|Refused to participate|7|||
127902378|NCT02942264|460267808|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
127902379|NCT02942264|460267809|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
127902380|NCT02942264|460267810|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
127902381|NCT02942264|460267811|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
127902382|NCT02942264|460267812|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
127902383|NCT02942264|460267813|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
127847122|NCT00107172|460059181|FG001|Overall Study|Withdrawal by Subject|0|||
127847123|NCT00107172|460059180|FG000|Overall Study|Death|0|||
127847124|NCT00107172|460059181|FG001|Overall Study|Death|2|||
127847125|NCT00107172|460059180|FG000|Overall Study|Other Reason|4|||
127847126|NCT00107172|460059181|FG001|Overall Study|Other Reason|3|||
127847127|NCT01102140|460059182|FG000|Overall Study|Lost to Follow-up|1|||
127847128|NCT01102140|460059183|FG001|Overall Study|Lost to Follow-up|0|||
127847129|NCT01102140|460059182|FG000|Overall Study|Investigator terminated study|2|||
127847130|NCT01102140|460059183|FG001|Overall Study|Investigator terminated study|2|||
127847131|NCT01742091|460059188|FG000|Overall Study|Adverse Event|0|||
127847132|NCT01742091|460059189|FG001|Overall Study|Adverse Event|0|||
127847133|NCT01742091|460059190|FG002|Overall Study|Adverse Event|0|||
127847134|NCT01742091|460059191|FG003|Overall Study|Adverse Event|0|||
127847135|NCT01742091|460059192|FG004|Overall Study|Adverse Event|1|||
127847136|NCT01742091|460059193|FG005|Overall Study|Adverse Event|0|||
127847137|NCT01742091|460059188|FG000|Overall Study|Physician Decision|0|||
127847138|NCT01742091|460059189|FG001|Overall Study|Physician Decision|0|||
127847139|NCT01742091|460059190|FG002|Overall Study|Physician Decision|0|||
127847140|NCT01742091|460059191|FG003|Overall Study|Physician Decision|0|||
127847141|NCT01742091|460059192|FG004|Overall Study|Physician Decision|0|||
127847142|NCT01742091|460059193|FG005|Overall Study|Physician Decision|1|||
127847143|NCT01742091|460059188|FG000|Overall Study|Withdrawal by Subject|0|||
127847144|NCT01742091|460059189|FG001|Overall Study|Withdrawal by Subject|0|||
127847145|NCT01742091|460059190|FG002|Overall Study|Withdrawal by Subject|0|||
127847146|NCT01742091|460059191|FG003|Overall Study|Withdrawal by Subject|1|||
127847147|NCT01742091|460059192|FG004|Overall Study|Withdrawal by Subject|0|||
127847148|NCT01742091|460059193|FG005|Overall Study|Withdrawal by Subject|0|||
127847149|NCT01742091|460059188|FG000|Overall Study|Lost to Follow-up|0|||
127847150|NCT01742091|460059189|FG001|Overall Study|Lost to Follow-up|0|||
127847151|NCT01742091|460059190|FG002|Overall Study|Lost to Follow-up|0|||
127847152|NCT01742091|460059191|FG003|Overall Study|Lost to Follow-up|0|||
127847153|NCT01742091|460059192|FG004|Overall Study|Lost to Follow-up|0|||
127847154|NCT01742091|460059193|FG005|Overall Study|Lost to Follow-up|1|||
127847155|NCT03706040|460059194|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
127847156|NCT03706040|460059195|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
127847157|NCT03706040|460059196|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
127847158|NCT03706040|460059197|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
127847159|NCT03706040|460059198|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
127847160|NCT03706040|460059199|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
127847161|NCT03706040|460059200|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
127847162|NCT03706040|460059194|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
127847163|NCT03706040|460059195|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
127847164|NCT03706040|460059196|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
127847165|NCT03706040|460059197|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
127847166|NCT03706040|460059198|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
127847167|NCT03706040|460059199|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
127847168|NCT03706040|460059200|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
127847169|NCT03706040|460059194|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
127847170|NCT03706040|460059195|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
127847171|NCT03706040|460059196|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
127847172|NCT03706040|460059197|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
127847173|NCT03706040|460059198|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
127847174|NCT03706040|460059199|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
127847175|NCT03706040|460059200|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
127847176|NCT03706040|460059194|FG000|Period A (Week 0 to Week 16)|Other|2|||
127847177|NCT03706040|460059195|FG001|Period A (Week 0 to Week 16)|Other|0|||
127847178|NCT03706040|460059196|FG002|Period A (Week 0 to Week 16)|Other|2|||
127847179|NCT03706040|460059197|FG003|Period A (Week 0 to Week 16)|Other|0|||
127847180|NCT03706040|460059198|FG004|Period A (Week 0 to Week 16)|Other|0|||
127847181|NCT03706040|460059199|FG005|Period A (Week 0 to Week 16)|Other|0|||
127847182|NCT03706040|460059200|FG006|Period A (Week 0 to Week 16)|Other|0|||
127847183|NCT03706040|460059194|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
127847184|NCT03706040|460059195|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
127847185|NCT03706040|460059196|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
127847186|NCT03706040|460059197|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
127847187|NCT03706040|460059198|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
127847188|NCT03706040|460059199|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
127902384|NCT02942264|460267814|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
127902385|NCT02942264|460267815|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
127902386|NCT02942264|460267816|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
127902387|NCT02942264|460267808|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
127902388|NCT02942264|460267809|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
127902389|NCT02942264|460267810|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
127902390|NCT02942264|460267811|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
127902391|NCT02942264|460267812|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
127902392|NCT02942264|460267813|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
127902393|NCT02942264|460267814|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
127902394|NCT02942264|460267815|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
127902395|NCT02942264|460267816|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
127902396|NCT02188303|460267817|FG000|Overall Study|Adverse Event|0|||
127902397|NCT02188303|460267818|FG001|Overall Study|Adverse Event|0|||
127902398|NCT02188303|460267819|FG002|Overall Study|Adverse Event|0|||
127902399|NCT02188303|460267820|FG003|Overall Study|Adverse Event|0|||
127902400|NCT02188303|460267821|FG004|Overall Study|Adverse Event|0|||
127902401|NCT02188303|460267822|FG005|Overall Study|Adverse Event|2|||
127902402|NCT02188303|460267823|FG006|Overall Study|Adverse Event|0|||
127902403|NCT02188303|460267824|FG007|Overall Study|Adverse Event|2|||
127902404|NCT02188303|460267817|FG000|Overall Study|Dose Termination Criteria Met|0|||
127902405|NCT02188303|460267818|FG001|Overall Study|Dose Termination Criteria Met|0|||
127902406|NCT02188303|460267819|FG002|Overall Study|Dose Termination Criteria Met|0|||
127902407|NCT02188303|460267820|FG003|Overall Study|Dose Termination Criteria Met|0|||
127902408|NCT02188303|460267821|FG004|Overall Study|Dose Termination Criteria Met|0|||
127902409|NCT02188303|460267822|FG005|Overall Study|Dose Termination Criteria Met|0|||
127902410|NCT02188303|460267823|FG006|Overall Study|Dose Termination Criteria Met|2|||
127902411|NCT02188303|460267824|FG007|Overall Study|Dose Termination Criteria Met|4|||
127902412|NCT04206332|460267825|FG000|Part A|Lost to Follow-up|0|||
127902413|NCT04206332|460267826|FG001|Part A|Lost to Follow-up|1|||
127902414|NCT04206332|460267827|FG002|Part A|Lost to Follow-up|0|||
127902415|NCT04206332|460267828|FG003|Part A|Lost to Follow-up|0|||
127902416|NCT04206332|460267829|FG004|Part A|Lost to Follow-up|0|||
127902417|NCT04206332|460267830|FG005|Part A|Lost to Follow-up|0|||
127902418|NCT04206332|460267831|FG006|Part A|Lost to Follow-up|0|||
127902419|NCT04206332|460267832|FG007|Part A|Lost to Follow-up|0|||
127902420|NCT04206332|460267833|FG008|Part A|Lost to Follow-up|0|||
127902421|NCT04206332|460267834|FG009|Part A|Lost to Follow-up|0|||
127902422|NCT04206332|460267835|FG010|Part A|Lost to Follow-up|0|||
127902423|NCT04206332|460267836|FG011|Part A|Lost to Follow-up|0|||
127902424|NCT04206332|460267837|FG012|Part A|Lost to Follow-up|0|||
127902425|NCT04206332|460267838|FG013|Part A|Lost to Follow-up|0|||
127902426|NCT04206332|460267839|FG014|Part A|Lost to Follow-up|0|||
127902427|NCT04206332|460267840|FG015|Part A|Lost to Follow-up|0|||
127902428|NCT04206332|460267841|FG016|Part A|Lost to Follow-up|0|||
127902429|NCT04206332|460267825|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
127902430|NCT04206332|460267826|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
127902431|NCT04206332|460267827|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
127902432|NCT04206332|460267828|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
127902433|NCT04206332|460267829|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
127902434|NCT04206332|460267830|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
127902435|NCT04206332|460267831|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
127902436|NCT04206332|460267832|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
127902437|NCT04206332|460267833|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
127902438|NCT04206332|460267834|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
127902439|NCT04206332|460267835|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
127902440|NCT04206332|460267836|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
127902441|NCT04206332|460267837|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
127902442|NCT04206332|460267838|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
127902443|NCT04206332|460267839|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
127902444|NCT04206332|460267840|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
127902445|NCT04206332|460267841|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
127902446|NCT04206332|460267825|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
127902447|NCT04206332|460267826|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
127902448|NCT04206332|460267827|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
127976405|NCT04598451|460536123|FG000|Overall Study|Requires Prohibited Medication|1|||
127902449|NCT04206332|460267828|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
127902450|NCT04206332|460267829|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
127902451|NCT04206332|460267830|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
127902452|NCT04206332|460267831|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
127902453|NCT04206332|460267832|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
127902454|NCT04206332|460267833|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
127902455|NCT04206332|460267834|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
127902456|NCT04206332|460267835|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
127902457|NCT04206332|460267836|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
127902458|NCT04206332|460267837|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
127902459|NCT04206332|460267838|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
127902460|NCT04206332|460267839|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
127902461|NCT04206332|460267840|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
127902462|NCT04206332|460267841|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
127902463|NCT04206332|460267825|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
127902464|NCT04206332|460267826|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
127902465|NCT04206332|460267827|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
127902466|NCT04206332|460267828|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
127902467|NCT04206332|460267829|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
127902468|NCT04206332|460267830|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
127902469|NCT04206332|460267831|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
127902470|NCT04206332|460267832|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
127902471|NCT04206332|460267833|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
127902472|NCT04206332|460267834|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
127902473|NCT04206332|460267835|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
127902474|NCT04206332|460267836|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
127902475|NCT04206332|460267837|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
127902476|NCT04206332|460267838|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
127902477|NCT04206332|460267839|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
127902478|NCT04206332|460267840|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
127902479|NCT04206332|460267841|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
127902480|NCT04206332|460267825|FG000|Part C|Withdrawal by Subject|0|||
127902481|NCT04206332|460267826|FG001|Part C|Withdrawal by Subject|0|||
127902482|NCT04206332|460267827|FG002|Part C|Withdrawal by Subject|0|||
127902483|NCT04206332|460267828|FG003|Part C|Withdrawal by Subject|0|||
127902484|NCT04206332|460267829|FG004|Part C|Withdrawal by Subject|0|||
127902485|NCT04206332|460267830|FG005|Part C|Withdrawal by Subject|0|||
127902486|NCT04206332|460267831|FG006|Part C|Withdrawal by Subject|0|||
127902487|NCT04206332|460267832|FG007|Part C|Withdrawal by Subject|0|||
127902488|NCT04206332|460267833|FG008|Part C|Withdrawal by Subject|0|||
127902489|NCT04206332|460267834|FG009|Part C|Withdrawal by Subject|0|||
127902490|NCT04206332|460267835|FG010|Part C|Withdrawal by Subject|0|||
127902491|NCT04206332|460267836|FG011|Part C|Withdrawal by Subject|0|||
127902492|NCT04206332|460267837|FG012|Part C|Withdrawal by Subject|0|||
127902493|NCT04206332|460267838|FG013|Part C|Withdrawal by Subject|0|||
127902494|NCT04206332|460267839|FG014|Part C|Withdrawal by Subject|2|||
127902495|NCT04206332|460267840|FG015|Part C|Withdrawal by Subject|0|||
127902496|NCT04206332|460267841|FG016|Part C|Withdrawal by Subject|0|||
127902497|NCT00569374|460267846|FG000|Overall Study|Withdrawal by Subject|4|||
127902498|NCT00050778|460267849|FG000|Overall Study|Adverse Event|13|||
127902499|NCT00050778|460267850|FG001|Overall Study|Adverse Event|3|||
127902500|NCT00050778|460267851|FG002|Overall Study|Adverse Event|2|||
127902501|NCT00050778|460267849|FG000|Overall Study|Death|0|||
127902502|NCT00050778|460267850|FG001|Overall Study|Death|1|||
127902503|NCT00050778|460267851|FG002|Overall Study|Death|1|||
127902504|NCT00050778|460267849|FG000|Overall Study|Lack of Efficacy|16|||
127902505|NCT00050778|460267850|FG001|Overall Study|Lack of Efficacy|2|||
127902506|NCT00050778|460267851|FG002|Overall Study|Lack of Efficacy|2|||
127902507|NCT00050778|460267849|FG000|Overall Study|Lost to Follow-up|0|||
127902508|NCT00050778|460267850|FG001|Overall Study|Lost to Follow-up|2|||
127902509|NCT00050778|460267851|FG002|Overall Study|Lost to Follow-up|4|||
127902510|NCT00050778|460267849|FG000|Overall Study|Physician Decision|3|||
127847189|NCT03706040|460059200|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
127847190|NCT03706040|460059194|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
127847191|NCT03706040|460059195|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
127847192|NCT03706040|460059196|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
127847193|NCT03706040|460059197|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
127847194|NCT03706040|460059198|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
127847195|NCT03706040|460059199|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
127847196|NCT03706040|460059200|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
127847197|NCT03706040|460059194|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
127847198|NCT03706040|460059195|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
127847199|NCT03706040|460059196|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
127847200|NCT03706040|460059197|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
127847201|NCT03706040|460059198|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
127847202|NCT03706040|460059199|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
127847203|NCT03706040|460059200|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
127847204|NCT03706040|460059194|FG000|Period B (Week 16 to Week 52)|Other|0|||
127847205|NCT03706040|460059195|FG001|Period B (Week 16 to Week 52)|Other|0|||
127847206|NCT03706040|460059196|FG002|Period B (Week 16 to Week 52)|Other|0|||
127847207|NCT03706040|460059197|FG003|Period B (Week 16 to Week 52)|Other|4|||
127847208|NCT03706040|460059198|FG004|Period B (Week 16 to Week 52)|Other|5|||
127847209|NCT03706040|460059199|FG005|Period B (Week 16 to Week 52)|Other|23|||
127847210|NCT03706040|460059200|FG006|Period B (Week 16 to Week 52)|Other|17|||
127847211|NCT00212758|460059204|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
127847212|NCT00212758|460059205|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
127847213|NCT00212758|460059204|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
127847214|NCT00212758|460059205|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
127847215|NCT00247273|460059211|FG000|Overall Study|Adverse Event|85|||
127847216|NCT00247273|460059212|FG001|Overall Study|Adverse Event|80|||
127847217|NCT00247273|460059211|FG000|Overall Study|Physician Decision|6|||
127847218|NCT00247273|460059212|FG001|Overall Study|Physician Decision|3|||
127847219|NCT00247273|460059211|FG000|Overall Study|Lost to Follow-up|7|||
127847220|NCT00247273|460059212|FG001|Overall Study|Lost to Follow-up|7|||
127847221|NCT00247273|460059211|FG000|Overall Study|Withdrawal by Subject|46|||
127847222|NCT00247273|460059212|FG001|Overall Study|Withdrawal by Subject|47|||
127847223|NCT00247273|460059211|FG000|Overall Study|Did not take any study drug|2|||
127847224|NCT00247273|460059212|FG001|Overall Study|Did not take any study drug|0|||
127847225|NCT01419015|460059214|FG000|Overall Study|Death|2|||
127847226|NCT03276572|460059215|FG000|Overall Study|In follow-up|0|||
127847227|NCT03276572|460059216|FG001|Overall Study|In follow-up|0|||
127847228|NCT03276572|460059217|FG002|Overall Study|In follow-up|0|||
127847229|NCT03276572|460059218|FG003|Overall Study|In follow-up|0|||
127847230|NCT03276572|460059219|FG004|Overall Study|In follow-up|0|||
127847231|NCT03276572|460059220|FG005|Overall Study|In follow-up|1|||
127847232|NCT03276572|460059221|FG006|Overall Study|In follow-up|1|||
127847233|NCT03276572|460059215|FG000|Overall Study|Lost to Follow-up|0|||
127847234|NCT03276572|460059216|FG001|Overall Study|Lost to Follow-up|0|||
127847235|NCT03276572|460059217|FG002|Overall Study|Lost to Follow-up|0|||
127847236|NCT03276572|460059218|FG003|Overall Study|Lost to Follow-up|0|||
127847237|NCT03276572|460059219|FG004|Overall Study|Lost to Follow-up|0|||
127847238|NCT03276572|460059220|FG005|Overall Study|Lost to Follow-up|0|||
127847239|NCT03276572|460059221|FG006|Overall Study|Lost to Follow-up|1|||
127847240|NCT02657434|460059222|FG000|Overall Study|Study Terminated By Sponsor|64|||
127847241|NCT02657434|460059223|FG001|Overall Study|Study Terminated By Sponsor|82|||
127847242|NCT02657434|460059222|FG000|Overall Study|Death|189|||
127902511|NCT00050778|460267850|FG001|Overall Study|Physician Decision|0|||
127902512|NCT00050778|460267851|FG002|Overall Study|Physician Decision|2|||
127847243|NCT02657434|460059223|FG001|Overall Study|Death|190|||
127847244|NCT02657434|460059222|FG000|Overall Study|Lost to Follow-up|2|||
127847245|NCT02657434|460059223|FG001|Overall Study|Lost to Follow-up|2|||
127847246|NCT02657434|460059222|FG000|Overall Study|Randomization by Error|2|||
127847247|NCT02657434|460059223|FG001|Overall Study|Randomization by Error|0|||
127847248|NCT02657434|460059222|FG000|Overall Study|Withdrawal by Subject|28|||
127847249|NCT02657434|460059223|FG001|Overall Study|Withdrawal by Subject|17|||
127847250|NCT02657434|460059222|FG000|Overall Study|Protocol Violation|1|||
127847251|NCT02657434|460059223|FG001|Overall Study|Protocol Violation|0|||
127847252|NCT02657434|460059222|FG000|Overall Study|Physician Decision|0|||
127847253|NCT02657434|460059223|FG001|Overall Study|Physician Decision|1|||
127847254|NCT01628393|460059224|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
127847255|NCT01628393|460059225|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
127847256|NCT01628393|460059226|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
127847257|NCT01628393|460059227|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
127847258|NCT01628393|460059228|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
127847259|NCT01628393|460059224|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
127847260|NCT01628393|460059225|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
127902513|NCT00050778|460267849|FG000|Overall Study|Protocol Violation|2|||
127902514|NCT00050778|460267850|FG001|Overall Study|Protocol Violation|0|||
127902515|NCT00050778|460267851|FG002|Overall Study|Protocol Violation|1|||
127902516|NCT00050778|460267849|FG000|Overall Study|Withdrawal by Subject|6|||
127902517|NCT00050778|460267850|FG001|Overall Study|Withdrawal by Subject|8|||
127902518|NCT00050778|460267851|FG002|Overall Study|Withdrawal by Subject|4|||
127902519|NCT00050778|460267849|FG000|Overall Study|Randomized but not treated|4|||
127902520|NCT00050778|460267850|FG001|Overall Study|Randomized but not treated|5|||
127902521|NCT00050778|460267851|FG002|Overall Study|Randomized but not treated|2|||
127902522|NCT00050778|460267849|FG000|Overall Study|Familial and personal reasons|1|||
127902523|NCT00050778|460267850|FG001|Overall Study|Familial and personal reasons|0|||
127902524|NCT00050778|460267851|FG002|Overall Study|Familial and personal reasons|0|||
127902525|NCT01126736|460267854|FG000|Overall Study|Death|2|||
127902526|NCT01126736|460267855|FG001|Overall Study|Death|2|||
127902527|NCT01126736|460267856|FG002|Overall Study|Death|1|||
127902528|NCT01126736|460267857|FG003|Overall Study|Death|19|||
127902529|NCT01126736|460267858|FG004|Overall Study|Death|19|||
127902530|NCT01126736|460267854|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
127902531|NCT01126736|460267855|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
127902532|NCT01126736|460267856|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
127902533|NCT01126736|460267857|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
127902534|NCT01126736|460267858|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
127902535|NCT01126736|460267854|FG000|Overall Study|Lost to Follow-up|0|||
127902536|NCT01126736|460267855|FG001|Overall Study|Lost to Follow-up|0|||
127902537|NCT01126736|460267856|FG002|Overall Study|Lost to Follow-up|0|||
127902538|NCT01126736|460267857|FG003|Overall Study|Lost to Follow-up|1|||
127902539|NCT01126736|460267858|FG004|Overall Study|Lost to Follow-up|1|||
127902540|NCT01126736|460267854|FG000|Overall Study|Administrative reasons|0|||
127902541|NCT01126736|460267855|FG001|Overall Study|Administrative reasons|0|||
127902542|NCT01126736|460267856|FG002|Overall Study|Administrative reasons|0|||
127902543|NCT01126736|460267857|FG003|Overall Study|Administrative reasons|0|||
127902544|NCT01126736|460267858|FG004|Overall Study|Administrative reasons|1|||
127902545|NCT01126736|460267854|FG000|Overall Study|Progressive disease|0|||
127902546|NCT01126736|460267855|FG001|Overall Study|Progressive disease|0|||
127902547|NCT01126736|460267856|FG002|Overall Study|Progressive disease|0|||
127902548|NCT01126736|460267857|FG003|Overall Study|Progressive disease|2|||
127902549|NCT01126736|460267858|FG004|Overall Study|Progressive disease|1|||
127902550|NCT01126736|460267854|FG000|Overall Study|Withdrawal by Subject|0|||
127902551|NCT01126736|460267855|FG001|Overall Study|Withdrawal by Subject|0|||
127902552|NCT01126736|460267856|FG002|Overall Study|Withdrawal by Subject|0|||
127902553|NCT01126736|460267857|FG003|Overall Study|Withdrawal by Subject|1|||
127902554|NCT01126736|460267858|FG004|Overall Study|Withdrawal by Subject|1|||
127902555|NCT01126736|460267854|FG000|Overall Study|Other|2|||
127902556|NCT01126736|460267855|FG001|Overall Study|Other|4|||
127902557|NCT01126736|460267856|FG002|Overall Study|Other|4|||
127902558|NCT01126736|460267857|FG003|Overall Study|Other|16|||
127902559|NCT01126736|460267858|FG004|Overall Study|Other|15|||
127902560|NCT00064753|460267861|FG000|Overall Study|Death|251|||
127902561|NCT00064753|460267862|FG001|Overall Study|Death|242|||
127902562|NCT00064753|460267861|FG000|Overall Study|Withdrawal by Subject|198|||
127902563|NCT00064753|460267862|FG001|Overall Study|Withdrawal by Subject|171|||
127902564|NCT00064753|460267861|FG000|Overall Study|Lost to Follow-up|225|||
127902565|NCT00064753|460267862|FG001|Overall Study|Lost to Follow-up|235|||
127902566|NCT00813293|460267868|FG000|Overall Study|Intercurrent illness|1|||
127902567|NCT00813293|460267869|FG001|Overall Study|Intercurrent illness|0|||
127902568|NCT00813293|460267868|FG000|Overall Study|Adverse Event|0|||
127902569|NCT00813293|460267869|FG001|Overall Study|Adverse Event|1|||
127902570|NCT02107092|460267870|FG000|Overall Study|Miscellaneous|3|||
127902571|NCT02107092|460267870|FG000|Overall Study|Subject compliance|3|||
127902572|NCT02107092|460267870|FG000|Overall Study|Hypo-or hyperkalemia|2|||
127902573|NCT02107092|460267870|FG000|Overall Study|Met ECG withdrawal criteria|3|||
127902574|NCT02107092|460267870|FG000|Overall Study|Physician Decision|3|||
127902575|NCT02107092|460267870|FG000|Overall Study|Lost to Follow-up|2|||
127902576|NCT02107092|460267870|FG000|Overall Study|Withdrawal by Subject|9|||
127902577|NCT02107092|460267870|FG000|Overall Study|Adverse Event|7|||
127902578|NCT02107092|460267870|FG000|Overall Study|Expected progression of CKD|12|||
127902579|NCT00707161|460267871|FG000|Overall Study|Physician Decision|6|||
127902580|NCT02661295|460267874|FG000|Overall Study|Death|1|||
127902581|NCT02661295|460267874|FG000|Overall Study|Transferred Out|1|||
127902582|NCT02661295|460267874|FG000|Overall Study|Kidney Transplant|1|||
127902583|NCT02661295|460267874|FG000|Overall Study|Withdrawn due to side effects|8|||
127902584|NCT02661295|460267874|FG000|Overall Study|Withdrawn due to access type|1|||
127902585|NCT02661295|460267874|FG000|Overall Study|Withdrawn due to allergies|1|||
127902586|NCT02661295|460267874|FG000|Overall Study|Withdrawn due to non-compliance|1|||
127902587|NCT02661295|460267874|FG000|Overall Study|Withdrawal by Subject|3|||
127902588|NCT02661295|460267874|FG000|Overall Study|Failed screening|2|||
127902589|NCT00565448|460267880|FG000|Overall Study|Adverse Event|1|||
127902590|NCT00565448|460267881|FG001|Overall Study|Adverse Event|2|||
127902591|NCT00565448|460267880|FG000|Overall Study|Disease progression|1|||
127902592|NCT00565448|460267881|FG001|Overall Study|Disease progression|0|||
127902593|NCT00565448|460267880|FG000|Overall Study|Withdrawal by Subject|1|||
127902594|NCT00565448|460267881|FG001|Overall Study|Withdrawal by Subject|0|||
127902595|NCT00302952|460267882|FG000|Overall Study|Physician Decision|1|||
127902596|NCT00302952|460267883|FG001|Overall Study|Physician Decision|1|||
127902597|NCT00302952|460267882|FG000|Overall Study|Withdrawal by Subject|2|||
127902598|NCT00302952|460267883|FG001|Overall Study|Withdrawal by Subject|3|||
127902599|NCT00302952|460267882|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
127902600|NCT00302952|460267883|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
127902601|NCT02373098|460267884|FG000|Overall Study|Lost to Follow-up|1|||
127902602|NCT02373098|460267885|FG001|Overall Study|Lost to Follow-up|0|||
127902603|NCT02373098|460267884|FG000|Overall Study|Protocol Violation|3|||
127902604|NCT02373098|460267885|FG001|Overall Study|Protocol Violation|0|||
127902605|NCT02373098|460267884|FG000|Overall Study|Withdrawal by Subject|5|||
127902606|NCT02373098|460267885|FG001|Overall Study|Withdrawal by Subject|0|||
127902607|NCT02373098|460267884|FG000|Overall Study|Adverse Event|3|||
127902608|NCT02373098|460267885|FG001|Overall Study|Adverse Event|0|||
127902609|NCT00420238|460267886|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
127902610|NCT00420238|460267887|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
127902611|NCT00420238|460267886|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
127902612|NCT00420238|460267887|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
127902613|NCT00420238|460267886|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
127902614|NCT00420238|460267887|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
127902615|NCT00420238|460267886|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
127902616|NCT00420238|460267887|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
127902617|NCT00420238|460267886|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
127902618|NCT00420238|460267887|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
127902619|NCT00420238|460267886|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
127902620|NCT00420238|460267887|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
127902621|NCT05214560|460267888|FG000|Overall Study|Screening Failure|1|||
127902622|NCT05214560|460267888|FG000|Overall Study|Physician Decision|4|||
127902623|NCT05214560|460267888|FG000|Overall Study|Withdrawal by Subject|1|||
127902624|NCT05214560|460267888|FG000|Overall Study|Lost to Follow-up|2|||
127902625|NCT05214560|460267888|FG000|Overall Study|General anesthesia at the request of the surgeon|2|||
127902626|NCT05214560|460267888|FG000|Overall Study|Study physician not available for the anesthesia|3|||
127902627|NCT05214560|460267888|FG000|Overall Study|Anesthesia rejected by the patient on the day of surgery|1|||
127902628|NCT05214560|460267888|FG000|Overall Study|Device not listed in the study was used for the procedure|1|||
127902629|NCT05214560|460267888|FG000|Overall Study|Surgery not performed|3|||
127902630|NCT03639311|460267889|FG000|Maintenance Phase|Lost to Follow-up|1|||
127902631|NCT03639311|460267890|FG001|Maintenance Phase|Lost to Follow-up|0|||
127902632|NCT03639311|460267891|FG002|Maintenance Phase|Lost to Follow-up|0|||
127902633|NCT03639311|460267889|FG000|Maintenance Phase|Adverse Event|1|||
127902634|NCT03639311|460267890|FG001|Maintenance Phase|Adverse Event|0|||
127902635|NCT03639311|460267891|FG002|Maintenance Phase|Adverse Event|0|||
127902636|NCT03639311|460267889|FG000|Maintenance Phase|DECISION BY SUBJECT OR PROXY|7|||
127902637|NCT03639311|460267890|FG001|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
127902638|NCT03639311|460267891|FG002|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
127902639|NCT03639311|460267889|FG000|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|3|||
127902640|NCT03639311|460267890|FG001|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
127902641|NCT03639311|460267891|FG002|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
127902642|NCT03639311|460267889|FG000|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
127902643|NCT03639311|460267890|FG001|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
127902644|NCT03639311|460267891|FG002|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
127902645|NCT03639311|460267889|FG000|Maintenance Phase|Lack of Efficacy|1|||
127902646|NCT03639311|460267890|FG001|Maintenance Phase|Lack of Efficacy|0|||
127902647|NCT03639311|460267891|FG002|Maintenance Phase|Lack of Efficacy|0|||
127902648|NCT03018249|460267892|FG000|Overall Study|Withdrawal by Subject|2|||
127902649|NCT03018249|460267893|FG001|Overall Study|Withdrawal by Subject|2|||
127902650|NCT00304083|460267901|FG000|Overall Study|Withdrawal by Subject|4|||
127902651|NCT00304083|460267902|FG001|Overall Study|Withdrawal by Subject|2|||
127902652|NCT00304083|460267901|FG000|Overall Study|Physician Decision|8|||
127902653|NCT00304083|460267902|FG001|Overall Study|Physician Decision|3|||
127902654|NCT00304083|460267901|FG000|Overall Study|Disease Progression|5|||
127902655|NCT00304083|460267902|FG001|Overall Study|Disease Progression|1|||
127902656|NCT00304083|460267901|FG000|Overall Study|Other|5|||
127902657|NCT00304083|460267902|FG001|Overall Study|Other|2|||
127902658|NCT03966365|460267905|FG000|Overall Study|Protocol Violation|1|||
127902659|NCT03966365|460267906|FG001|Overall Study|Protocol Violation|0|||
127902660|NCT01044732|460267907|FG000|Overall Study|Lost to Follow-up|2|||
127902661|NCT01044732|460267908|FG001|Overall Study|Lost to Follow-up|1|||
127902662|NCT01044732|460267907|FG000|Overall Study|Physician Decision|5|||
127902663|NCT01044732|460267908|FG001|Overall Study|Physician Decision|3|||
127902664|NCT01044732|460267907|FG000|Overall Study|Protocol Violation|11|||
127902665|NCT01044732|460267908|FG001|Overall Study|Protocol Violation|12|||
127902666|NCT01044732|460267907|FG000|Overall Study|Withdrawal by Subject|0|||
127902667|NCT01044732|460267908|FG001|Overall Study|Withdrawal by Subject|1|||
127902668|NCT01044732|460267907|FG000|Overall Study|Inadequate bowel preparation|11|||
127902669|NCT01044732|460267908|FG001|Overall Study|Inadequate bowel preparation|17|||
127902670|NCT01044732|460267907|FG000|Overall Study|Inability to reach cecum|5|||
127902671|NCT01044732|460267908|FG001|Overall Study|Inability to reach cecum|2|||
127902672|NCT01044732|460267907|FG000|Overall Study|Technical error or malfunction|15|||
127902673|NCT01044732|460267908|FG001|Overall Study|Technical error or malfunction|14|||
127902674|NCT00824265|460267911|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
127902675|NCT00824265|460267912|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
127902676|NCT00824265|460267911|FG000|Treatment Phase|Protocol Violation|1|||
127902677|NCT00824265|460267912|FG001|Treatment Phase|Protocol Violation|0|||
127902678|NCT00824265|460267911|FG000|Treatment Phase|Lost to Follow-up|1|||
127902679|NCT00824265|460267912|FG001|Treatment Phase|Lost to Follow-up|1|||
127902680|NCT00824265|460267911|FG000|Treatment Phase|Physician Decision|6|||
127902681|NCT00824265|460267912|FG001|Treatment Phase|Physician Decision|12|||
127902682|NCT00824265|460267911|FG000|Treatment Phase|Withdrawal by Subject|6|||
127902683|NCT00824265|460267912|FG001|Treatment Phase|Withdrawal by Subject|15|||
127902684|NCT00824265|460267911|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
127902685|NCT00824265|460267912|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
127902686|NCT00824265|460267911|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
127902687|NCT00824265|460267912|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
127902688|NCT01402947|460267915|FG000|First Intervention|Adverse Event|0|||
127902689|NCT01402947|460267916|FG001|First Intervention|Adverse Event|1|||
127902690|NCT00385684|460267917|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
127902691|NCT00385684|460267918|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
127902692|NCT00385684|460267917|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
127902693|NCT00385684|460267918|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
127902694|NCT00385684|460267917|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
127902695|NCT00385684|460267918|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
127902696|NCT02801877|460267919|FG000|Overall Study|Lost to Follow-up|1|||
127902697|NCT02801877|460267920|FG001|Overall Study|Lost to Follow-up|1|||
127902698|NCT02801877|460267921|FG002|Overall Study|Lost to Follow-up|2|||
127902699|NCT02801877|460267922|FG003|Overall Study|Lost to Follow-up|0|||
127902700|NCT02801877|460267919|FG000|Overall Study|Never Started Treatment|2|||
127902701|NCT02801877|460267920|FG001|Overall Study|Never Started Treatment|0|||
127902702|NCT02801877|460267921|FG002|Overall Study|Never Started Treatment|4|||
127902703|NCT02801877|460267922|FG003|Overall Study|Never Started Treatment|0|||
127902704|NCT00591630|460267923|FG000|Overall Study|Death|0|||
127902705|NCT00591630|460267924|FG001|Overall Study|Death|0|||
127902706|NCT00591630|460267925|FG002|Overall Study|Death|1|||
127902707|NCT00591630|460267926|FG003|Overall Study|Death|0|||
127902708|NCT04188106|460270007|FG000|Overall Study|Lost to Follow-up|5|||
127902709|NCT04188106|460270007|FG000|Overall Study|Non-Compliance|1|||
127902710|NCT00705536|460270008|FG000|Start Period 1|Withdrawal by Subject|0|||
127902711|NCT00705536|460270009|FG001|Start Period 1|Withdrawal by Subject|0|||
127902712|NCT00705536|460270010|FG002|Start Period 1|Withdrawal by Subject|0|||
127902713|NCT00705536|460270011|FG003|Start Period 1|Withdrawal by Subject|1|||
127902714|NCT00441467|460270012|FG000|Overall Study|Adverse Event|6|||
127902715|NCT00441467|460270012|FG000|Overall Study|Withdrawal by Subject|3|||
127902716|NCT00441467|460270012|FG000|Overall Study|Progressive disease|9|||
127902717|NCT02289963|460270013|FG000|Overall Study|Adverse Event|1|||
127902718|NCT02289963|460270014|FG001|Overall Study|Adverse Event|2|||
127902719|NCT02289963|460270013|FG000|Overall Study|Poor compliance to protocol|1|||
127902720|NCT02289963|460270014|FG001|Overall Study|Poor compliance to protocol|0|||
127902721|NCT02289963|460270013|FG000|Overall Study|Withdrawal by Subject|1|||
127902722|NCT02289963|460270014|FG001|Overall Study|Withdrawal by Subject|0|||
127902723|NCT02289963|460270013|FG000|Overall Study|Last injection missed|2|||
127902724|NCT02289963|460270014|FG001|Overall Study|Last injection missed|2|||
127902725|NCT02289963|460270013|FG000|Overall Study|End treatment visit outside visit window|0|||
127902726|NCT02289963|460270014|FG001|Overall Study|End treatment visit outside visit window|4|||
127902727|NCT02289963|460270013|FG000|Overall Study|Other than specified above|0|||
127902728|NCT02289963|460270014|FG001|Overall Study|Other than specified above|2|||
127902729|NCT01042522|460270015|FG000|Overall Study|Adverse Event|1|||
127902730|NCT01042522|460270016|FG001|Overall Study|Adverse Event|2|||
127902731|NCT01042522|460270015|FG000|Overall Study|Disease Progression|5|||
127902732|NCT01042522|460270016|FG001|Overall Study|Disease Progression|0|||
127902733|NCT01042522|460270015|FG000|Overall Study|Death|1|||
127902734|NCT01042522|460270016|FG001|Overall Study|Death|0|||
127902735|NCT01042522|460270015|FG000|Overall Study|Patient Refused|0|||
127902736|NCT01042522|460270016|FG001|Overall Study|Patient Refused|3|||
127902737|NCT01042522|460270015|FG000|Overall Study|Withdrawal by Subject|1|||
127902738|NCT01042522|460270016|FG001|Overall Study|Withdrawal by Subject|1|||
127902739|NCT00549718|460270019|FG000|Overall Study|Insufficient clinical response|20|||
127902740|NCT00549718|460270020|FG001|Overall Study|Insufficient clinical response|7|||
127902741|NCT00549718|460270021|FG002|Overall Study|Insufficient clinical response|18|||
127902742|NCT00549718|460270022|FG003|Overall Study|Insufficient clinical response|32|||
127902743|NCT00549718|460270019|FG000|Overall Study|Adverse Event|6|||
127902744|NCT00549718|460270020|FG001|Overall Study|Adverse Event|8|||
127902745|NCT00549718|460270021|FG002|Overall Study|Adverse Event|7|||
127902746|NCT00549718|460270022|FG003|Overall Study|Adverse Event|3|||
127902747|NCT00549718|460270019|FG000|Overall Study|Lost to Follow-up|4|||
127902748|NCT00549718|460270020|FG001|Overall Study|Lost to Follow-up|2|||
127902749|NCT00549718|460270021|FG002|Overall Study|Lost to Follow-up|0|||
127902750|NCT00549718|460270022|FG003|Overall Study|Lost to Follow-up|6|||
127902751|NCT00549718|460270019|FG000|Overall Study|Withdrawal by Subject|9|||
127902752|NCT00549718|460270020|FG001|Overall Study|Withdrawal by Subject|18|||
127902753|NCT00549718|460270021|FG002|Overall Study|Withdrawal by Subject|12|||
127902754|NCT00549718|460270022|FG003|Overall Study|Withdrawal by Subject|13|||
127902755|NCT00549718|460270019|FG000|Overall Study|Administrative|2|||
127902756|NCT00549718|460270020|FG001|Overall Study|Administrative|2|||
127902757|NCT00549718|460270021|FG002|Overall Study|Administrative|2|||
127902758|NCT00549718|460270022|FG003|Overall Study|Administrative|1|||
127902759|NCT01507051|460270023|FG000|Overall Study|Withdrawal by Subject|1|||
127902760|NCT01507051|460270024|FG001|Overall Study|Withdrawal by Subject|3|||
127902761|NCT01507051|460270025|FG002|Overall Study|Withdrawal by Subject|1|||
127902762|NCT01507051|460270026|FG003|Overall Study|Withdrawal by Subject|6|||
127902763|NCT01507051|460270023|FG000|Overall Study|Physician Decision|0|||
127902764|NCT01507051|460270024|FG001|Overall Study|Physician Decision|0|||
127902765|NCT01507051|460270025|FG002|Overall Study|Physician Decision|0|||
127902766|NCT01507051|460270026|FG003|Overall Study|Physician Decision|1|||
127902767|NCT01507051|460270023|FG000|Overall Study|Adverse Event|1|||
127902768|NCT01507051|460270024|FG001|Overall Study|Adverse Event|0|||
127902769|NCT01507051|460270025|FG002|Overall Study|Adverse Event|0|||
127902770|NCT01507051|460270026|FG003|Overall Study|Adverse Event|0|||
127902771|NCT02311361|460270027|FG000|Overall Study|Did not receive treatment|0|||
127902772|NCT02311361|460270028|FG001|Overall Study|Did not receive treatment|1|||
127902773|NCT02311361|460270029|FG002|Overall Study|Did not receive treatment|0|||
127902774|NCT02311361|460270030|FG003|Overall Study|Did not receive treatment|1|||
127902775|NCT02653664|460270031|FG000|Post-Treatment|Withdrawal by Subject|6|||
127902776|NCT02653664|460270032|FG001|Post-Treatment|Withdrawal by Subject|5|||
127902777|NCT02653664|460270033|FG002|Post-Treatment|Withdrawal by Subject|7|||
127902778|NCT02653664|460270031|FG000|Post-Treatment|Lost to Follow-up|8|||
127902779|NCT02653664|460270032|FG001|Post-Treatment|Lost to Follow-up|1|||
127902780|NCT02653664|460270033|FG002|Post-Treatment|Lost to Follow-up|7|||
127902781|NCT02653664|460270031|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
127902782|NCT02653664|460270032|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
127902783|NCT02653664|460270033|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
127902784|NCT02653664|460270031|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
127902785|NCT02653664|460270032|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
127902786|NCT02653664|460270033|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
127902787|NCT02653664|460270031|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
127902788|NCT02653664|460270032|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
127902789|NCT02653664|460270033|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
127902790|NCT02653664|460270031|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
127902791|NCT02653664|460270032|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
127902792|NCT02653664|460270033|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
127902793|NCT02653664|460270031|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
127902794|NCT02653664|460270032|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
127902795|NCT02653664|460270033|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
127902796|NCT02653664|460270031|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
127902797|NCT02653664|460270032|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
127902798|NCT02653664|460270033|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
127902799|NCT02653664|460270031|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
127902800|NCT02653664|460270032|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
127902801|NCT02653664|460270033|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
127902802|NCT02653664|460270031|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
127902803|NCT02653664|460270032|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
127902804|NCT02653664|460270033|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
127902805|NCT00485472|460270034|FG000|Overall Study|Adverse Event|8|||
127902806|NCT00485472|460270035|FG001|Overall Study|Adverse Event|5|||
127902807|NCT00485472|460270034|FG000|Overall Study|Lack of Efficacy|5|||
127902808|NCT00485472|460270035|FG001|Overall Study|Lack of Efficacy|4|||
127902809|NCT00485472|460270034|FG000|Overall Study|Withdrawal by Subject|1|||
127902810|NCT00485472|460270035|FG001|Overall Study|Withdrawal by Subject|0|||
127847261|NCT01628393|460059226|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
127847262|NCT01628393|460059227|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
127847263|NCT01628393|460059228|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
127847264|NCT01628393|460059224|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
127847265|NCT01628393|460059225|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
127847266|NCT01628393|460059226|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
127847267|NCT01628393|460059227|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
127847268|NCT01628393|460059228|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
127847269|NCT01628393|460059224|FG000|Blinded Active Extension Period|Adverse Event|0|||
127847270|NCT01628393|460059225|FG001|Blinded Active Extension Period|Adverse Event|1|||
127847271|NCT01628393|460059226|FG002|Blinded Active Extension Period|Adverse Event|0|||
127847272|NCT01628393|460059227|FG003|Blinded Active Extension Period|Adverse Event|2|||
127847273|NCT01628393|460059228|FG004|Blinded Active Extension Period|Adverse Event|2|||
127847274|NCT01628393|460059224|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
127847275|NCT01628393|460059225|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
127847276|NCT01628393|460059226|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
127847277|NCT01628393|460059227|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
127847278|NCT01628393|460059228|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
127847279|NCT01628393|460059224|FG000|Blinded Active Extension Period|Physician Decision|0|||
127847280|NCT01628393|460059225|FG001|Blinded Active Extension Period|Physician Decision|3|||
127847281|NCT01628393|460059226|FG002|Blinded Active Extension Period|Physician Decision|0|||
127847282|NCT01628393|460059227|FG003|Blinded Active Extension Period|Physician Decision|1|||
127847283|NCT01628393|460059228|FG004|Blinded Active Extension Period|Physician Decision|0|||
127847284|NCT01628393|460059224|FG000|Blinded Active Extension Period|Protocol Violation|0|||
127847285|NCT01628393|460059225|FG001|Blinded Active Extension Period|Protocol Violation|0|||
127847286|NCT01628393|460059226|FG002|Blinded Active Extension Period|Protocol Violation|2|||
127847287|NCT01628393|460059227|FG003|Blinded Active Extension Period|Protocol Violation|1|||
127847288|NCT01628393|460059228|FG004|Blinded Active Extension Period|Protocol Violation|0|||
127847289|NCT01628393|460059224|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
127847290|NCT01628393|460059225|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
127847291|NCT01628393|460059226|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
127847292|NCT01628393|460059227|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
127847293|NCT01628393|460059228|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
127847294|NCT01989754|460059232|FG000|Overall Study|Withdrawal by Subject|10|||
127847295|NCT01989754|460059233|FG001|Overall Study|Withdrawal by Subject|14|||
127847296|NCT01989754|460059232|FG000|Overall Study|Lost to Follow-up|28|||
127847297|NCT01989754|460059233|FG001|Overall Study|Lost to Follow-up|20|||
127847298|NCT01989754|460059232|FG000|Overall Study|Closed Site|1|||
127847299|NCT01989754|460059233|FG001|Overall Study|Closed Site|1|||
127847300|NCT01369225|460059237|FG000|Overall Study|Withdrawal by Subject|1|||
127847301|NCT01369225|460059238|FG001|Overall Study|Withdrawal by Subject|0|||
127847302|NCT01369225|460059239|FG002|Overall Study|Withdrawal by Subject|2|||
127847303|NCT01369225|460059240|FG003|Overall Study|Withdrawal by Subject|1|||
127847304|NCT01369225|460059241|FG004|Overall Study|Withdrawal by Subject|0|||
127847305|NCT01369225|460059242|FG005|Overall Study|Withdrawal by Subject|0|||
127847306|NCT01369225|460059237|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
127847307|NCT01369225|460059238|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
127847308|NCT01369225|460059239|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
127847309|NCT01369225|460059240|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
127847310|NCT01369225|460059241|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
127847311|NCT01369225|460059242|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
127847312|NCT01369225|460059237|FG000|Overall Study|Other|1|||
127847313|NCT01369225|460059238|FG001|Overall Study|Other|0|||
127847314|NCT01369225|460059239|FG002|Overall Study|Other|0|||
127902811|NCT00485472|460270034|FG000|Overall Study|Protocol Violation|0|||
127902812|NCT00485472|460270035|FG001|Overall Study|Protocol Violation|1|||
127847315|NCT01369225|460059240|FG003|Overall Study|Other|0|||
127847316|NCT01369225|460059241|FG004|Overall Study|Other|1|||
127847317|NCT01369225|460059242|FG005|Overall Study|Other|0|||
127847318|NCT01369225|460059237|FG000|Overall Study|Adverse Event|0|||
127847319|NCT01369225|460059238|FG001|Overall Study|Adverse Event|0|||
127847320|NCT01369225|460059239|FG002|Overall Study|Adverse Event|0|||
127847321|NCT01369225|460059240|FG003|Overall Study|Adverse Event|1|||
127847322|NCT01369225|460059241|FG004|Overall Study|Adverse Event|1|||
127847323|NCT01369225|460059242|FG005|Overall Study|Adverse Event|0|||
127847324|NCT00105183|460059243|FG000|Overall Study|Death|19|||
127847325|NCT00105183|460059244|FG001|Overall Study|Death|13|||
127847326|NCT00105183|460059245|FG002|Overall Study|Death|15|||
127847327|NCT00105183|460059243|FG000|Overall Study|Withdrawal by Subject|1|||
127847328|NCT00105183|460059244|FG001|Overall Study|Withdrawal by Subject|1|||
127847329|NCT00105183|460059245|FG002|Overall Study|Withdrawal by Subject|4|||
127847330|NCT00105183|460059243|FG000|Overall Study|Physician Decision|1|||
127847331|NCT00105183|460059244|FG001|Overall Study|Physician Decision|2|||
127902813|NCT00485472|460270034|FG000|Overall Study|Other|2|||
127902814|NCT00485472|460270035|FG001|Overall Study|Other|1|||
127847332|NCT00105183|460059245|FG002|Overall Study|Physician Decision|3|||
127847333|NCT00105183|460059243|FG000|Overall Study|Lost to Follow-up|0|||
127847334|NCT00105183|460059244|FG001|Overall Study|Lost to Follow-up|1|||
127847335|NCT00105183|460059245|FG002|Overall Study|Lost to Follow-up|1|||
127847336|NCT00105183|460059243|FG000|Overall Study|Other reason|1|||
127847337|NCT00105183|460059244|FG001|Overall Study|Other reason|2|||
127847338|NCT00105183|460059245|FG002|Overall Study|Other reason|0|||
127847339|NCT02980692|460059246|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
127847340|NCT02980692|460059247|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
127847341|NCT02980692|460059248|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
127847342|NCT02980692|460059249|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
127847343|NCT02980692|460059250|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
127847344|NCT02980692|460059246|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
127847345|NCT02980692|460059247|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
127847346|NCT02980692|460059248|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
127847347|NCT02980692|460059249|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
127847348|NCT02980692|460059250|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
127847349|NCT02980692|460059246|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
127847350|NCT02980692|460059247|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
127847351|NCT02980692|460059248|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
127847352|NCT02980692|460059249|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
127847353|NCT02980692|460059250|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
127847354|NCT02980692|460059246|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
127847355|NCT02980692|460059247|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
127847356|NCT02980692|460059248|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
127847357|NCT02980692|460059249|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
127847358|NCT02980692|460059250|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
127847359|NCT02980692|460059246|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
127847360|NCT02980692|460059247|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
127847361|NCT02980692|460059248|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
127847362|NCT02980692|460059249|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
127847363|NCT02980692|460059250|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
127847364|NCT02980692|460059246|FG000|Double Blind Placebo Controlled Period|Other|1|||
127847365|NCT02980692|460059247|FG001|Double Blind Placebo Controlled Period|Other|0|||
127847366|NCT02980692|460059248|FG002|Double Blind Placebo Controlled Period|Other|0|||
127847367|NCT02980692|460059249|FG003|Double Blind Placebo Controlled Period|Other|0|||
127847368|NCT02980692|460059250|FG004|Double Blind Placebo Controlled Period|Other|1|||
127847369|NCT02980692|460059246|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
127847370|NCT02980692|460059247|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
127847371|NCT02980692|460059248|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
127847372|NCT02980692|460059249|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
127847373|NCT02980692|460059250|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
127847374|NCT02980692|460059246|FG000|Double-blind Follow-up Period|Adverse Event|0|||
127847375|NCT02980692|460059247|FG001|Double-blind Follow-up Period|Adverse Event|0|||
127847376|NCT02980692|460059248|FG002|Double-blind Follow-up Period|Adverse Event|0|||
127847377|NCT02980692|460059249|FG003|Double-blind Follow-up Period|Adverse Event|1|||
127847378|NCT02980692|460059250|FG004|Double-blind Follow-up Period|Adverse Event|1|||
127847379|NCT02980692|460059246|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
127902815|NCT00485472|460270034|FG000|Overall Study|Lost to Follow-up|0|||
127902816|NCT00485472|460270035|FG001|Overall Study|Lost to Follow-up|1|||
127902817|NCT00633594|460270036|FG000|Overall Study|Adverse Event|0|||
127902818|NCT00633594|460270037|FG001|Overall Study|Adverse Event|4|||
127902819|NCT00633594|460270038|FG002|Overall Study|Adverse Event|7|||
127902820|NCT00633594|460270036|FG000|Overall Study|Death|0|||
127902821|NCT00633594|460270037|FG001|Overall Study|Death|1|||
127902822|NCT00633594|460270038|FG002|Overall Study|Death|2|||
127902823|NCT00633594|460270036|FG000|Overall Study|Disease Progression|0|||
127902824|NCT00633594|460270037|FG001|Overall Study|Disease Progression|0|||
127902825|NCT00633594|460270038|FG002|Overall Study|Disease Progression|1|||
127902826|NCT00365300|460270042|FG000|Open-label Phase|Adverse Event|4|||
127902827|NCT00365300|460270043|FG001|Open-label Phase|Adverse Event|0|||
127902828|NCT00365300|460270042|FG000|Open-label Phase|Failed to Return|1|||
127902829|NCT00365300|460270043|FG001|Open-label Phase|Failed to Return|0|||
127902830|NCT00365300|460270042|FG000|Open-label Phase|Physician Decision|1|||
127902831|NCT00365300|460270043|FG001|Open-label Phase|Physician Decision|0|||
127847380|NCT02980692|460059247|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
127847381|NCT02980692|460059248|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
127847382|NCT02980692|460059249|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
127847383|NCT02980692|460059250|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
127847384|NCT02980692|460059246|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
127847385|NCT02980692|460059247|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
127847386|NCT02980692|460059248|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
127847387|NCT02980692|460059249|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
127847388|NCT02980692|460059250|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
127847389|NCT02980692|460059246|FG000|Double-blind Follow-up Period|Pregnancy|0|||
127847390|NCT02980692|460059247|FG001|Double-blind Follow-up Period|Pregnancy|0|||
127847391|NCT02980692|460059248|FG002|Double-blind Follow-up Period|Pregnancy|1|||
127847392|NCT02980692|460059249|FG003|Double-blind Follow-up Period|Pregnancy|1|||
127847393|NCT02980692|460059250|FG004|Double-blind Follow-up Period|Pregnancy|0|||
127847394|NCT02980692|460059246|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
127847395|NCT02980692|460059247|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
127847396|NCT02980692|460059248|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
127847397|NCT02980692|460059249|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
127847398|NCT02980692|460059250|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
127847399|NCT02980692|460059246|FG000|Double-blind Follow-up Period|Other|0|||
127847400|NCT02980692|460059247|FG001|Double-blind Follow-up Period|Other|0|||
127847401|NCT02980692|460059248|FG002|Double-blind Follow-up Period|Other|1|||
127847402|NCT02980692|460059249|FG003|Double-blind Follow-up Period|Other|1|||
127847403|NCT02980692|460059250|FG004|Double-blind Follow-up Period|Other|3|||
127847404|NCT00294684|460059251|FG000|Overall Study|Lost to Follow-up|5|||
127847405|NCT00294684|460059252|FG001|Overall Study|Lost to Follow-up|8|||
127847406|NCT00389441|460059253|FG000|Overall Study|Adverse Event|7|||
127847407|NCT00389441|460059253|FG000|Overall Study|Death|4|||
127847408|NCT00389441|460059253|FG000|Overall Study|Lost to Follow-up|2|||
127847409|NCT00389441|460059253|FG000|Overall Study|Withdrawal by Subject|4|||
127847410|NCT00389441|460059253|FG000|Overall Study|Physician Decision|1|||
127902832|NCT00365300|460270042|FG000|Open-label Phase|Noncompliance|9|||
127902833|NCT00365300|460270043|FG001|Open-label Phase|Noncompliance|0|||
127902834|NCT00365300|460270042|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
127902835|NCT00365300|460270043|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
127902836|NCT00365300|460270042|FG000|Open-label Phase|Protocol Violation|1|||
127902837|NCT00365300|460270043|FG001|Open-label Phase|Protocol Violation|0|||
127902838|NCT00365300|460270042|FG000|Open-label Phase|Lack of Efficacy|1|||
127902839|NCT00365300|460270043|FG001|Open-label Phase|Lack of Efficacy|0|||
127902840|NCT00365300|460270042|FG000|Open-label Phase|Patient skipped open label phase|1|||
127902841|NCT00365300|460270043|FG001|Open-label Phase|Patient skipped open label phase|0|||
127902842|NCT00365300|460270042|FG000|Double-blind Phase|Failed to return|1|||
127902843|NCT00365300|460270043|FG001|Double-blind Phase|Failed to return|0|||
127902844|NCT00365300|460270042|FG000|Double-blind Phase|Noncompliance|1|||
127902845|NCT00365300|460270043|FG001|Double-blind Phase|Noncompliance|1|||
127902846|NCT00365300|460270042|FG000|Double-blind Phase|Withdrawal by Subject|0|||
127902847|NCT00365300|460270043|FG001|Double-blind Phase|Withdrawal by Subject|1|||
127902848|NCT00365300|460270042|FG000|Double-blind Phase|Protocol Violation|3|||
127902849|NCT00365300|460270043|FG001|Double-blind Phase|Protocol Violation|1|||
127902850|NCT00365300|460270042|FG000|Double-blind Phase|Lack of Efficacy|6|||
127902851|NCT00365300|460270043|FG001|Double-blind Phase|Lack of Efficacy|6|||
127902852|NCT01179048|460270044|FG000|Overall Study|Withdrawn - does not allow contact|4|||
127902853|NCT01179048|460270045|FG001|Overall Study|Withdrawn - does not allow contact|8|||
127902854|NCT01179048|460270044|FG000|Overall Study|Lost to Follow-up|8|||
127902855|NCT01179048|460270045|FG001|Overall Study|Lost to Follow-up|9|||
127902856|NCT01179048|460270044|FG000|Overall Study|Alive|127|||
127847411|NCT00389441|460059253|FG000|Overall Study|Protocol Violation|1|||
127847412|NCT00389441|460059253|FG000|Overall Study|Global deterioration of health status|4|||
127847413|NCT00389441|460059253|FG000|Overall Study|Objective progression or relapse|26|||
127902857|NCT01179048|460270045|FG001|Overall Study|Alive|142|||
127902858|NCT00528606|460270047|FG000|Overall Study|Withdrew consent|4|||
127902859|NCT00528606|460270048|FG001|Overall Study|Withdrew consent|3|||
127902860|NCT00528606|460270047|FG000|Overall Study|Lost to Follow-up|4|||
127902861|NCT00528606|460270048|FG001|Overall Study|Lost to Follow-up|1|||
127902862|NCT00528606|460270047|FG000|Overall Study|Adverse Event|3|||
127902863|NCT00528606|460270048|FG001|Overall Study|Adverse Event|0|||
127902864|NCT00528606|460270047|FG000|Overall Study|Other|2|||
127902865|NCT00528606|460270048|FG001|Overall Study|Other|0|||
127902866|NCT01520909|460270057|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
127847414|NCT00389441|460059253|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
127902867|NCT01520909|460270058|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
127902868|NCT01520909|460270059|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
127902869|NCT01520909|460270057|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
127902870|NCT01520909|460270058|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
127902871|NCT01520909|460270059|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
127902872|NCT01520909|460270057|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
127902873|NCT01520909|460270058|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
127902874|NCT01520909|460270059|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
127902875|NCT01520909|460270057|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
127902876|NCT01520909|460270058|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
127902877|NCT01520909|460270059|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
127902878|NCT00912288|460270060|FG000|Overall Study|Death|0|||
127902879|NCT00912288|460270061|FG001|Overall Study|Death|1|||
127902880|NCT00912288|460270060|FG000|Overall Study|Adverse Event|1|||
127902881|NCT00912288|460270061|FG001|Overall Study|Adverse Event|1|||
127902882|NCT00912288|460270060|FG000|Overall Study|Lost to Follow-up|1|||
127902883|NCT00912288|460270061|FG001|Overall Study|Lost to Follow-up|0|||
127902884|NCT00912288|460270060|FG000|Overall Study|Protocol Violation|1|||
127902885|NCT00912288|460270061|FG001|Overall Study|Protocol Violation|0|||
127902886|NCT00912288|460270060|FG000|Overall Study|Withdrawal by Subject|3|||
127902887|NCT00912288|460270061|FG001|Overall Study|Withdrawal by Subject|3|||
127902888|NCT00912288|460270060|FG000|Overall Study|Study terminated by sponsor|34|||
127902889|NCT00912288|460270061|FG001|Overall Study|Study terminated by sponsor|35|||
127902890|NCT00912288|460270060|FG000|Overall Study|Other|1|||
127902891|NCT00912288|460270061|FG001|Overall Study|Other|0|||
127902892|NCT04869787|460270062|FG000|Screening|Physician Decision|1|||
127902893|NCT04869787|460270062|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
127902894|NCT01544127|460270063|FG000|Overall Study|Lost to Follow-up|4|||
127902895|NCT01544127|460270064|FG001|Overall Study|Lost to Follow-up|2|||
127902896|NCT01544127|460270065|FG002|Overall Study|Lost to Follow-up|9|||
127902897|NCT01544127|460270063|FG000|Overall Study|Withdrawal by Subject|2|||
127902898|NCT01544127|460270064|FG001|Overall Study|Withdrawal by Subject|2|||
127902899|NCT01544127|460270065|FG002|Overall Study|Withdrawal by Subject|1|||
127902900|NCT01544127|460270063|FG000|Overall Study|Discharged out of catchment area|1|||
127902901|NCT01544127|460270064|FG001|Overall Study|Discharged out of catchment area|1|||
127902902|NCT01544127|460270065|FG002|Overall Study|Discharged out of catchment area|1|||
127902903|NCT01544127|460270063|FG000|Overall Study|Death|1|||
127902904|NCT01544127|460270064|FG001|Overall Study|Death|0|||
127902905|NCT01544127|460270065|FG002|Overall Study|Death|0|||
127902906|NCT01544127|460270063|FG000|Overall Study|Jail or Prison|1|||
127902907|NCT01544127|460270064|FG001|Overall Study|Jail or Prison|1|||
127902908|NCT01544127|460270065|FG002|Overall Study|Jail or Prison|2|||
127902909|NCT01544127|460270063|FG000|Overall Study|Became Psychotic|1|||
127902910|NCT01544127|460270064|FG001|Overall Study|Became Psychotic|0|||
127902911|NCT01544127|460270065|FG002|Overall Study|Became Psychotic|0|||
127902912|NCT01544127|460270063|FG000|Overall Study|Researcher withdrew|1|||
127902913|NCT01544127|460270064|FG001|Overall Study|Researcher withdrew|0|||
127902914|NCT01544127|460270065|FG002|Overall Study|Researcher withdrew|0|||
127902915|NCT01544127|460270063|FG000|Overall Study|Went active duty|0|||
127902916|NCT01544127|460270064|FG001|Overall Study|Went active duty|0|||
127902917|NCT01544127|460270065|FG002|Overall Study|Went active duty|1|||
127902918|NCT00533273|460270066|FG000|Double-blind|Withdrew consent|0|||
127902919|NCT00533273|460270067|FG001|Double-blind|Withdrew consent|2|||
127902920|NCT00533273|460270066|FG000|Open-label|Withdrawal by Subject|6|||
127902921|NCT00533273|460270067|FG001|Open-label|Withdrawal by Subject|0|||
127902922|NCT02914600|460270071|FG000|Overall Study|Adverse Event|298|||
127902923|NCT02914600|460270072|FG001|Overall Study|Adverse Event|35|||
127902924|NCT02914600|460270073|FG002|Overall Study|Adverse Event|25|||
127902925|NCT02914600|460270071|FG000|Overall Study|Sponsors decision|287|||
127902926|NCT02914600|460270072|FG001|Overall Study|Sponsors decision|41|||
127902927|NCT02914600|460270073|FG002|Overall Study|Sponsors decision|12|||
127902928|NCT02914600|460270071|FG000|Overall Study|Withdrawal by Subject|158|||
127902929|NCT02914600|460270072|FG001|Overall Study|Withdrawal by Subject|20|||
127902930|NCT02914600|460270073|FG002|Overall Study|Withdrawal by Subject|18|||
127902931|NCT02914600|460270071|FG000|Overall Study|Investigators discretion|169|||
127902932|NCT02914600|460270072|FG001|Overall Study|Investigators discretion|14|||
127902933|NCT02914600|460270073|FG002|Overall Study|Investigators discretion|13|||
127902934|NCT02914600|460270071|FG000|Overall Study|Lost to Follow-up|10|||
127902935|NCT02914600|460270072|FG001|Overall Study|Lost to Follow-up|4|||
127902936|NCT02914600|460270073|FG002|Overall Study|Lost to Follow-up|0|||
127902937|NCT02914600|460270071|FG000|Overall Study|Pregnancy|8|||
127902938|NCT02914600|460270072|FG001|Overall Study|Pregnancy|0|||
127902939|NCT02914600|460270073|FG002|Overall Study|Pregnancy|0|||
127902940|NCT02914600|460270071|FG000|Overall Study|Protocol Violation|5|||
127902941|NCT02914600|460270072|FG001|Overall Study|Protocol Violation|3|||
127902942|NCT02914600|460270073|FG002|Overall Study|Protocol Violation|0|||
127902943|NCT02914600|460270071|FG000|Overall Study|Non-compliance with study drug|6|||
127902944|NCT02914600|460270072|FG001|Overall Study|Non-compliance with study drug|1|||
127902945|NCT02914600|460270073|FG002|Overall Study|Non-compliance with study drug|0|||
127902946|NCT02914600|460270071|FG000|Overall Study|Death|3|||
127902947|NCT02914600|460270072|FG001|Overall Study|Death|1|||
127902948|NCT02914600|460270073|FG002|Overall Study|Death|1|||
127902949|NCT02914600|460270071|FG000|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
127902950|NCT02914600|460270072|FG001|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
127902951|NCT02914600|460270073|FG002|Overall Study|Current Study Unblinded and participant confirmed on Placebo|55|||
127902952|NCT02914600|460270071|FG000|Overall Study|Enrolled but not treated|1|||
127902953|NCT02914600|460270072|FG001|Overall Study|Enrolled but not treated|0|||
127902954|NCT02914600|460270073|FG002|Overall Study|Enrolled but not treated|0|||
127902955|NCT00454909|460270074|FG000|Overall Study|Withdrawal by Subject|1|||
127902956|NCT00454909|460270075|FG001|Overall Study|Withdrawal by Subject|0|||
127902957|NCT00454909|460270076|FG002|Overall Study|Withdrawal by Subject|0|||
127902958|NCT00454909|460270074|FG000|Overall Study|Migrated/moved from study area|0|||
127902959|NCT00454909|460270075|FG001|Overall Study|Migrated/moved from study area|0|||
127902960|NCT00454909|460270076|FG002|Overall Study|Migrated/moved from study area|1|||
127902961|NCT00454909|460270074|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
127902962|NCT00454909|460270075|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
127902963|NCT00454909|460270076|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
127902964|NCT00454909|460270074|FG000|Overall Study|Others|1|||
127902965|NCT00454909|460270075|FG001|Overall Study|Others|0|||
127902966|NCT00454909|460270076|FG002|Overall Study|Others|0|||
127902967|NCT02457520|460270077|FG000|Active Treatment Phase|Adverse Event|10|||
127902968|NCT02457520|460270077|FG000|Active Treatment Phase|Lost to Follow-up|8|||
127902969|NCT02457520|460270077|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
127902970|NCT02457520|460270077|FG000|Active Treatment Phase|other|4|||
127902971|NCT02457520|460270077|FG000|Active Treatment Phase|Physician Decision|1|||
127902972|NCT02457520|460270077|FG000|Active Treatment Phase|Protocol Violation|1|||
127902973|NCT02457520|460270077|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
127902974|NCT02457520|460270077|FG000|Post-treatment Period|Other: Retreatment Required|7|||
127902975|NCT02457520|460270077|FG000|Post-treatment Period|Lost to Follow-up|23|||
127902976|NCT02457520|460270077|FG000|Post-treatment Period|Other|3|||
127902977|NCT02457520|460270077|FG000|Post-treatment Period|Physician Decision|1|||
127902978|NCT02457520|460270077|FG000|Post-treatment Period|Withdrawal by Subject|14|||
127902979|NCT00282048|460270078|FG000|Overall Study|Lack of Efficacy|30|||
127902980|NCT00282048|460270078|FG000|Overall Study|Adverse Event|22|||
127902981|NCT00282048|460270078|FG000|Overall Study|Withdrawal by Subject|1|||
127902982|NCT00282048|460270078|FG000|Overall Study|Other|8|||
127902983|NCT00282048|460270078|FG000|Overall Study|Ongoing|1|||
127902984|NCT03522675|460270080|FG000|Overall Study|Screen fail|1|||
127902985|NCT03522675|460270080|FG000|Overall Study|Non-reactive to histamine|1|||
127902986|NCT00696020|460270083|FG000|Overall Study|Adverse Event|3|||
127902987|NCT00696020|460270084|FG001|Overall Study|Adverse Event|1|||
127902988|NCT00696020|460270085|FG002|Overall Study|Adverse Event|2|||
127902989|NCT00696020|460270086|FG003|Overall Study|Adverse Event|1|||
127902990|NCT00696020|460270083|FG000|Overall Study|Lack of Efficacy|1|||
127902991|NCT00696020|460270084|FG001|Overall Study|Lack of Efficacy|0|||
127902992|NCT00696020|460270085|FG002|Overall Study|Lack of Efficacy|0|||
127902993|NCT00696020|460270086|FG003|Overall Study|Lack of Efficacy|0|||
127902994|NCT00696020|460270083|FG000|Overall Study|Protocol Violation|0|||
127902995|NCT00696020|460270084|FG001|Overall Study|Protocol Violation|0|||
127902996|NCT00696020|460270085|FG002|Overall Study|Protocol Violation|0|||
127902997|NCT00696020|460270086|FG003|Overall Study|Protocol Violation|1|||
127902998|NCT00696020|460270083|FG000|Overall Study|Withdrawal by Subject|0|||
127902999|NCT00696020|460270084|FG001|Overall Study|Withdrawal by Subject|1|||
127903000|NCT00696020|460270085|FG002|Overall Study|Withdrawal by Subject|0|||
127903001|NCT00696020|460270086|FG003|Overall Study|Withdrawal by Subject|1|||
127903002|NCT00696020|460270083|FG000|Overall Study|Other not stated above|0|||
127903003|NCT00696020|460270084|FG001|Overall Study|Other not stated above|0|||
127903004|NCT00696020|460270085|FG002|Overall Study|Other not stated above|1|||
127903005|NCT00696020|460270086|FG003|Overall Study|Other not stated above|1|||
127903006|NCT01387022|460270087|FG000|Overall Study|Death|1|||
127903007|NCT01387022|460270088|FG001|Overall Study|Death|1|||
127903008|NCT01387022|460270087|FG000|Overall Study|Lost to Follow-up|0|||
127903009|NCT01387022|460270088|FG001|Overall Study|Lost to Follow-up|3|||
127903010|NCT02076022|460270089|FG000|Overall Study|Withdrawal by Subject|2|||
127903011|NCT02076022|460270090|FG001|Overall Study|Withdrawal by Subject|0|||
127903012|NCT00312663|460270091|FG000|Immunization Phase|Adverse Event|0|||
127903013|NCT00312663|460270092|FG001|Immunization Phase|Adverse Event|1|||
127903014|NCT00312663|460270093|FG002|Immunization Phase|Adverse Event|0|||
127903015|NCT00301366|460270096|FG000|Overall Study|Adverse Event|1|||
127903016|NCT04213326|460270097|FG000|Overall Study|Consent withdrawn|51|||
127903017|NCT04213326|460270098|FG001|Overall Study|Consent withdrawn|241|||
127903018|NCT04213326|460270097|FG000|Overall Study|Lost to Follow-up|50|||
127903019|NCT04213326|460270098|FG001|Overall Study|Lost to Follow-up|902|||
127903020|NCT04213326|460270097|FG000|Overall Study|Protocol Violation|3|||
127903021|NCT04213326|460270098|FG001|Overall Study|Protocol Violation|25|||
127903022|NCT04213326|460270097|FG000|Overall Study|Participant eligibility changed|106|||
127903023|NCT04213326|460270098|FG001|Overall Study|Participant eligibility changed|19|||
127903024|NCT04213326|460270097|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
127903025|NCT04213326|460270098|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
127903026|NCT04213326|460270097|FG000|Overall Study|Incomplete study visit|0|||
127903027|NCT04213326|460270098|FG001|Overall Study|Incomplete study visit|367|||
127903028|NCT02549092|460270101|FG000|Treatment Period|Adverse Event|2|||
127903029|NCT02549092|460270102|FG001|Treatment Period|Adverse Event|2|||
127903030|NCT02549092|460270101|FG000|Treatment Period|Withdrawal by Subject|1|||
127903031|NCT02549092|460270102|FG001|Treatment Period|Withdrawal by Subject|3|||
127903032|NCT02549092|460270101|FG000|Treatment Period|Lack of Efficacy|0|||
127903033|NCT02549092|460270102|FG001|Treatment Period|Lack of Efficacy|2|||
127903034|NCT02549092|460270101|FG000|Extension/Transition Period|Adverse Event|1|||
127903035|NCT02549092|460270102|FG001|Extension/Transition Period|Adverse Event|1|||
127903036|NCT02549092|460270101|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
127903037|NCT02549092|460270102|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
127903038|NCT02549092|460270101|FG000|Extension/Transition Period|Other, Not Specified|4|||
127903039|NCT02549092|460270102|FG001|Extension/Transition Period|Other, Not Specified|2|||
127903040|NCT02511782|460270109|FG000|Overall Study|Withdrawal by Subject|1|||
127903041|NCT02511782|460270110|FG001|Overall Study|Withdrawal by Subject|0|||
127903042|NCT02511782|460270111|FG002|Overall Study|Withdrawal by Subject|0|||
127903043|NCT03627091|460270112|FG000|Overall Study|Adverse Event|0|||
127903044|NCT03627091|460270113|FG001|Overall Study|Adverse Event|0|||
127903045|NCT03627091|460270114|FG002|Overall Study|Adverse Event|2|||
127903046|NCT03627091|460270112|FG000|Overall Study|Withdrawal by Subject|2|||
127903047|NCT03627091|460270113|FG001|Overall Study|Withdrawal by Subject|0|||
127903048|NCT03627091|460270114|FG002|Overall Study|Withdrawal by Subject|2|||
127903049|NCT03627091|460270112|FG000|Overall Study|Physician Decision|2|||
127903050|NCT03627091|460270113|FG001|Overall Study|Physician Decision|0|||
127903051|NCT03627091|460270114|FG002|Overall Study|Physician Decision|0|||
127903052|NCT03627091|460270112|FG000|Overall Study|Site terminated by sponsor|0|||
127903053|NCT03627091|460270113|FG001|Overall Study|Site terminated by sponsor|1|||
127903054|NCT03627091|460270114|FG002|Overall Study|Site terminated by sponsor|0|||
127903055|NCT03627091|460270112|FG000|Overall Study|Disease relapse|7|||
127903056|NCT03627091|460270113|FG001|Overall Study|Disease relapse|5|||
127903057|NCT03627091|460270114|FG002|Overall Study|Disease relapse|1|||
127903058|NCT03627091|460270112|FG000|Overall Study|Other|1|||
127903059|NCT03627091|460270113|FG001|Overall Study|Other|0|||
127903060|NCT03627091|460270114|FG002|Overall Study|Other|0|||
127903061|NCT01376167|460270119|FG000|Overall Study|Lost to Follow-up|2|||
127903062|NCT01376167|460270120|FG001|Overall Study|Lost to Follow-up|4|||
127903063|NCT01376167|460270121|FG002|Overall Study|Lost to Follow-up|2|||
127903064|NCT01376167|460270119|FG000|Overall Study|Physician Decision|1|||
127903065|NCT01376167|460270120|FG001|Overall Study|Physician Decision|1|||
127903066|NCT01376167|460270121|FG002|Overall Study|Physician Decision|0|||
127903067|NCT01376167|460270119|FG000|Overall Study|Withdrawal by Subject|1|||
127903068|NCT01376167|460270120|FG001|Overall Study|Withdrawal by Subject|5|||
127903069|NCT01376167|460270121|FG002|Overall Study|Withdrawal by Subject|4|||
127903070|NCT01173692|460270127|FG000|Overall Study|Adverse Event|1|||
127903071|NCT01173692|460270128|FG001|Overall Study|Adverse Event|2|||
127903072|NCT01173692|460270127|FG000|Overall Study|Withdrawal by Subject|1|||
127903073|NCT01173692|460270128|FG001|Overall Study|Withdrawal by Subject|3|||
127903074|NCT00678639|460270129|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
127903075|NCT00678639|460270130|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
127903076|NCT00986245|460270133|FG000|First Intervention|Poor compliance|8|||
127903077|NCT00986245|460270134|FG001|First Intervention|Poor compliance|4|||
127903078|NCT00986245|460270133|FG000|First Intervention|Lack of Efficacy|1|||
127903079|NCT00986245|460270134|FG001|First Intervention|Lack of Efficacy|2|||
127903080|NCT00986245|460270133|FG000|First Intervention|Withdrawal by Subject|0|||
127903081|NCT00986245|460270134|FG001|First Intervention|Withdrawal by Subject|1|||
127903082|NCT00986245|460270133|FG000|First Intervention|Protocol Violation|0|||
127903083|NCT00986245|460270134|FG001|First Intervention|Protocol Violation|1|||
127903084|NCT00986245|460270133|FG000|First Intervention|Out of indication|1|||
127903085|NCT00986245|460270134|FG001|First Intervention|Out of indication|0|||
127903086|NCT00986245|460270133|FG000|Second Intervention|Poor compliance|1|||
127903087|NCT00986245|460270134|FG001|Second Intervention|Poor compliance|0|||
127903088|NCT00986245|460270133|FG000|Second Intervention|Lost to Follow-up|1|||
127903089|NCT00986245|460270134|FG001|Second Intervention|Lost to Follow-up|0|||
127903090|NCT00986245|460270133|FG000|Second Intervention|Protocol Violation|0|||
127903091|NCT00986245|460270134|FG001|Second Intervention|Protocol Violation|1|||
127903092|NCT01214850|460270137|FG000|Overall Study|Withdrawal by Subject|38|||
127903093|NCT01214850|460270138|FG001|Overall Study|Withdrawal by Subject|31|||
127903094|NCT01214850|460270139|FG002|Overall Study|Withdrawal by Subject|28|||
127903095|NCT01214850|460270137|FG000|Overall Study|Lost to Follow-up|124|||
127903096|NCT01214850|460270138|FG001|Overall Study|Lost to Follow-up|98|||
127903097|NCT01214850|460270139|FG002|Overall Study|Lost to Follow-up|123|||
127903098|NCT01214850|460270137|FG000|Overall Study|Protocol Violation|5|||
127903099|NCT01214850|460270138|FG001|Overall Study|Protocol Violation|5|||
127847415|NCT00389441|460059253|FG000|Overall Study|Clinical progression|1|||
127847416|NCT01981109|460059254|FG000|Overall Study|Death|36|||
127847417|NCT01981109|460059254|FG000|Overall Study|Withdrawal by Subject|40|||
127847418|NCT01981109|460059254|FG000|Overall Study|Lost to Follow-up|9|||
127847419|NCT01981109|460059254|FG000|Overall Study|No Discontinuation Documentation|37|||
127847420|NCT01981109|460059254|FG000|Overall Study|Study Termination|100|||
127847421|NCT01981109|460059254|FG000|Overall Study|No data available|2|||
127847422|NCT03407170|460059255|FG000|Overall Study|Adverse Event|1|||
127847423|NCT00126672|460059256|FG000|Overall Study|Adverse Event|4|||
127847424|NCT00126672|460059256|FG000|Overall Study|Lost to Follow-up|4|||
127847425|NCT01851863|460059258|FG000|Overall Study|Did not receive study medication|2|||
127847426|NCT01851863|460059259|FG001|Overall Study|Did not receive study medication|5|||
127847427|NCT01851863|460059260|FG002|Overall Study|Did not receive study medication|3|||
127847428|NCT01851863|460059261|FG003|Overall Study|Did not receive study medication|0|||
127847429|NCT01851863|460059258|FG000|Overall Study|Lost to Follow-up|3|||
127847430|NCT01851863|460059259|FG001|Overall Study|Lost to Follow-up|4|||
127847431|NCT01851863|460059260|FG002|Overall Study|Lost to Follow-up|2|||
127847432|NCT01851863|460059261|FG003|Overall Study|Lost to Follow-up|3|||
127847433|NCT02076334|460059262|FG000|Overall Study|Protocol Violation|1|||
127847434|NCT02076334|460059263|FG001|Overall Study|Protocol Violation|0|||
127847435|NCT02076334|460059264|FG002|Overall Study|Protocol Violation|0|||
127847436|NCT02076334|460059265|FG003|Overall Study|Protocol Violation|0|||
127847437|NCT02076334|460059262|FG000|Overall Study|Lost to Follow-up|0|||
127847438|NCT02076334|460059263|FG001|Overall Study|Lost to Follow-up|1|||
127847439|NCT02076334|460059264|FG002|Overall Study|Lost to Follow-up|1|||
127847440|NCT02076334|460059265|FG003|Overall Study|Lost to Follow-up|0|||
127847441|NCT02076334|460059262|FG000|Overall Study|muscle soreness|0|||
127847442|NCT02076334|460059263|FG001|Overall Study|muscle soreness|0|||
127847443|NCT02076334|460059264|FG002|Overall Study|muscle soreness|0|||
127847444|NCT02076334|460059265|FG003|Overall Study|muscle soreness|1|||
127847445|NCT03238352|460059266|FG000|Overall Study|Lost to Follow-up|0|||
127847446|NCT03238352|460059267|FG001|Overall Study|Lost to Follow-up|2|||
127847447|NCT03238352|460059268|FG002|Overall Study|Lost to Follow-up|1|||
127847448|NCT03238352|460059266|FG000|Overall Study|Withdrawal by Subject|0|||
127847449|NCT03238352|460059267|FG001|Overall Study|Withdrawal by Subject|1|||
127847450|NCT03238352|460059268|FG002|Overall Study|Withdrawal by Subject|0|||
127847451|NCT00928512|460059269|FG000|Overall Study|Adverse Event|4|||
127847452|NCT00928512|460059270|FG001|Overall Study|Adverse Event|3|||
127847453|NCT00928512|460059271|FG002|Overall Study|Adverse Event|2|||
127847454|NCT00928512|460059272|FG003|Overall Study|Adverse Event|8|||
127847455|NCT00928512|460059273|FG004|Overall Study|Adverse Event|6|||
127847456|NCT00928512|460059269|FG000|Overall Study|Lack of Efficacy|2|||
127847457|NCT00928512|460059270|FG001|Overall Study|Lack of Efficacy|0|||
127847458|NCT00928512|460059271|FG002|Overall Study|Lack of Efficacy|4|||
127847459|NCT00928512|460059272|FG003|Overall Study|Lack of Efficacy|7|||
127847460|NCT00928512|460059273|FG004|Overall Study|Lack of Efficacy|3|||
127847461|NCT00928512|460059269|FG000|Overall Study|Protocol Violation|0|||
127847462|NCT00928512|460059270|FG001|Overall Study|Protocol Violation|1|||
127847463|NCT00928512|460059271|FG002|Overall Study|Protocol Violation|0|||
127847464|NCT00928512|460059272|FG003|Overall Study|Protocol Violation|1|||
127847465|NCT00928512|460059273|FG004|Overall Study|Protocol Violation|3|||
127847466|NCT00928512|460059269|FG000|Overall Study|Withdrawal by Subject|3|||
127847467|NCT00928512|460059270|FG001|Overall Study|Withdrawal by Subject|0|||
127847468|NCT00928512|460059271|FG002|Overall Study|Withdrawal by Subject|3|||
127847469|NCT00928512|460059272|FG003|Overall Study|Withdrawal by Subject|4|||
127847470|NCT00928512|460059273|FG004|Overall Study|Withdrawal by Subject|0|||
127847471|NCT00928512|460059269|FG000|Overall Study|Lost to Follow-up|1|||
127847472|NCT00928512|460059270|FG001|Overall Study|Lost to Follow-up|1|||
127847473|NCT00928512|460059271|FG002|Overall Study|Lost to Follow-up|2|||
127847474|NCT00928512|460059272|FG003|Overall Study|Lost to Follow-up|1|||
127847475|NCT00928512|460059273|FG004|Overall Study|Lost to Follow-up|3|||
127847476|NCT00928512|460059269|FG000|Overall Study|Administrative Problems|0|||
127847477|NCT00928512|460059270|FG001|Overall Study|Administrative Problems|1|||
127847478|NCT00928512|460059271|FG002|Overall Study|Administrative Problems|0|||
127847479|NCT00928512|460059272|FG003|Overall Study|Administrative Problems|0|||
127847480|NCT00928512|460059273|FG004|Overall Study|Administrative Problems|0|||
127847481|NCT04153929|460059274|FG000|Overall Study|Other than listed|2|||
127847482|NCT04153929|460059275|FG001|Overall Study|Other than listed|2|||
127847483|NCT04153929|460059276|FG002|Overall Study|Other than listed|0|||
127847484|NCT04153929|460059277|FG003|Overall Study|Other than listed|1|||
127903100|NCT01214850|460270139|FG002|Overall Study|Protocol Violation|6|||
127847485|NCT04153929|460059278|FG004|Overall Study|Other than listed|0|||
127847486|NCT04153929|460059279|FG005|Overall Study|Other than listed|2|||
127847487|NCT04153929|460059280|FG006|Overall Study|Other than listed|2|||
127847488|NCT04153929|460059281|FG007|Overall Study|Other than listed|1|||
127847489|NCT04153929|460059274|FG000|Overall Study|Lost to Follow-up|2|||
127847490|NCT04153929|460059275|FG001|Overall Study|Lost to Follow-up|1|||
127847491|NCT04153929|460059276|FG002|Overall Study|Lost to Follow-up|0|||
127847492|NCT04153929|460059277|FG003|Overall Study|Lost to Follow-up|1|||
127847493|NCT04153929|460059278|FG004|Overall Study|Lost to Follow-up|1|||
127847494|NCT04153929|460059279|FG005|Overall Study|Lost to Follow-up|0|||
127847495|NCT04153929|460059280|FG006|Overall Study|Lost to Follow-up|0|||
127847496|NCT04153929|460059281|FG007|Overall Study|Lost to Follow-up|0|||
127847497|NCT04153929|460059274|FG000|Overall Study|Withdrawal by Subject|3|||
127847498|NCT04153929|460059275|FG001|Overall Study|Withdrawal by Subject|1|||
127847499|NCT04153929|460059276|FG002|Overall Study|Withdrawal by Subject|0|||
127847500|NCT04153929|460059277|FG003|Overall Study|Withdrawal by Subject|3|||
127847501|NCT04153929|460059278|FG004|Overall Study|Withdrawal by Subject|1|||
127847502|NCT04153929|460059279|FG005|Overall Study|Withdrawal by Subject|0|||
127847503|NCT04153929|460059280|FG006|Overall Study|Withdrawal by Subject|1|||
127847504|NCT04153929|460059281|FG007|Overall Study|Withdrawal by Subject|0|||
127847505|NCT04153929|460059274|FG000|Overall Study|Protocol Violation|0|||
127847506|NCT04153929|460059275|FG001|Overall Study|Protocol Violation|0|||
127847507|NCT04153929|460059276|FG002|Overall Study|Protocol Violation|0|||
127847508|NCT04153929|460059277|FG003|Overall Study|Protocol Violation|0|||
127847509|NCT04153929|460059278|FG004|Overall Study|Protocol Violation|0|||
127847510|NCT04153929|460059279|FG005|Overall Study|Protocol Violation|0|||
127847511|NCT04153929|460059280|FG006|Overall Study|Protocol Violation|1|||
127847512|NCT04153929|460059281|FG007|Overall Study|Protocol Violation|2|||
127847513|NCT04153929|460059274|FG000|Overall Study|Adverse Event|3|||
127847514|NCT04153929|460059275|FG001|Overall Study|Adverse Event|5|||
127847515|NCT04153929|460059276|FG002|Overall Study|Adverse Event|5|||
127847516|NCT04153929|460059277|FG003|Overall Study|Adverse Event|11|||
127847517|NCT04153929|460059278|FG004|Overall Study|Adverse Event|15|||
127847518|NCT04153929|460059279|FG005|Overall Study|Adverse Event|4|||
127847519|NCT04153929|460059280|FG006|Overall Study|Adverse Event|8|||
127847520|NCT04153929|460059281|FG007|Overall Study|Adverse Event|2|||
127847521|NCT04153929|460059274|FG000|Overall Study|Not treated|1|||
127847522|NCT04153929|460059275|FG001|Overall Study|Not treated|0|||
127847523|NCT04153929|460059276|FG002|Overall Study|Not treated|0|||
127847524|NCT04153929|460059277|FG003|Overall Study|Not treated|0|||
127847525|NCT04153929|460059278|FG004|Overall Study|Not treated|0|||
127847526|NCT04153929|460059279|FG005|Overall Study|Not treated|0|||
127847527|NCT04153929|460059280|FG006|Overall Study|Not treated|1|||
127847528|NCT04153929|460059281|FG007|Overall Study|Not treated|0|||
127847529|NCT01963780|460059282|FG000|Overall Study|Death|7|||
127847530|NCT04083794|460059283|FG000|Overall Study|Lost to Follow-up|9|||
127847531|NCT03383614|460059284|FG000|Overall Study|Withdrawal by Subject|0|||
127847532|NCT03383614|460059285|FG001|Overall Study|Withdrawal by Subject|1|||
127847533|NCT03383614|460059286|FG002|Overall Study|Withdrawal by Subject|0|||
127847534|NCT03383614|460059287|FG003|Overall Study|Withdrawal by Subject|0|||
127847535|NCT01296698|460059290|FG000|Overall Study|Adverse Event|1|||
127847536|NCT01296698|460059291|FG001|Overall Study|Adverse Event|0|||
127847537|NCT01296698|460059290|FG000|Overall Study|Death|1|||
127847538|NCT01296698|460059291|FG001|Overall Study|Death|0|||
127847539|NCT01296698|460059290|FG000|Overall Study|Lost to Follow-up|19|||
127847540|NCT01296698|460059291|FG001|Overall Study|Lost to Follow-up|1|||
127847541|NCT01296698|460059290|FG000|Overall Study|Withdrawal by Subject|12|||
127847542|NCT01296698|460059291|FG001|Overall Study|Withdrawal by Subject|0|||
127847543|NCT01296698|460059290|FG000|Overall Study|Difficulty Contacting Subject|2|||
127847544|NCT01296698|460059291|FG001|Overall Study|Difficulty Contacting Subject|0|||
127847545|NCT01296698|460059290|FG000|Overall Study|Study Terminated by Sponsor|209|||
127847546|NCT01296698|460059291|FG001|Overall Study|Study Terminated by Sponsor|12|||
127847547|NCT00729326|460059296|FG000|Overall Study|Lost to Follow-up|2|||
127847548|NCT00729326|460059297|FG001|Overall Study|Lost to Follow-up|0|||
127847549|NCT00729326|460059296|FG000|Overall Study|Physician Decision|0|||
127847550|NCT00729326|460059297|FG001|Overall Study|Physician Decision|1|||
127847551|NCT00729326|460059296|FG000|Overall Study|Protocol Violation|3|||
127847552|NCT00729326|460059297|FG001|Overall Study|Protocol Violation|2|||
127847553|NCT00729326|460059296|FG000|Overall Study|Subject Decision|4|||
127847554|NCT00729326|460059297|FG001|Overall Study|Subject Decision|4|||
127847555|NCT00729326|460059296|FG000|Overall Study|Sponsor Decision|1|||
127847556|NCT00729326|460059297|FG001|Overall Study|Sponsor Decision|2|||
127847557|NCT01235728|460059298|FG000|Overall Study|Protocol Violation|0|||
127847558|NCT01235728|460059299|FG001|Overall Study|Protocol Violation|0|||
127847559|NCT01235728|460059300|FG002|Overall Study|Protocol Violation|0|||
127847560|NCT01235728|460059301|FG003|Overall Study|Protocol Violation|1|||
127847561|NCT01235728|460059302|FG004|Overall Study|Protocol Violation|0|||
127847562|NCT01235728|460059303|FG005|Overall Study|Protocol Violation|0|||
127847563|NCT01235728|460059304|FG006|Overall Study|Protocol Violation|0|||
127847564|NCT01235728|460059305|FG007|Overall Study|Protocol Violation|0|||
127847565|NCT02559713|460059306|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
127847566|NCT02193828|460059310|FG000|Overall Study|Withdrawal by Subject|0|||
127903101|NCT01214850|460270137|FG000|Overall Study|Adverse event or death|11|||
127903102|NCT01214850|460270138|FG001|Overall Study|Adverse event or death|8|||
127903103|NCT01214850|460270139|FG002|Overall Study|Adverse event or death|3|||
127903104|NCT01214850|460270137|FG000|Overall Study|Inappropriate enrollment|2|||
127903105|NCT01214850|460270138|FG001|Overall Study|Inappropriate enrollment|1|||
127903106|NCT01214850|460270139|FG002|Overall Study|Inappropriate enrollment|0|||
127903107|NCT01214850|460270137|FG000|Overall Study|Administrative reason|1|||
127903108|NCT01214850|460270138|FG001|Overall Study|Administrative reason|0|||
127903109|NCT01214850|460270139|FG002|Overall Study|Administrative reason|0|||
127903110|NCT01214850|460270137|FG000|Overall Study|Unable to classify|2|||
127903111|NCT01214850|460270138|FG001|Overall Study|Unable to classify|1|||
127903112|NCT01214850|460270139|FG002|Overall Study|Unable to classify|1|||
127903113|NCT02849652|460270140|FG000|Overall Study|Lost to Follow-up|104|||
127903114|NCT02849652|460270141|FG001|Overall Study|Lost to Follow-up|35|||
127903115|NCT02849652|460270142|FG002|Overall Study|Lost to Follow-up|116|||
127903116|NCT02849652|460270143|FG003|Overall Study|Lost to Follow-up|22|||
127903117|NCT02849652|460270140|FG000|Overall Study|Withdrawal by Subject|10|||
127903118|NCT02849652|460270141|FG001|Overall Study|Withdrawal by Subject|2|||
127903119|NCT02849652|460270142|FG002|Overall Study|Withdrawal by Subject|8|||
127903120|NCT02849652|460270143|FG003|Overall Study|Withdrawal by Subject|4|||
127903121|NCT01863745|460270144|FG000|Overall Study|Disease Progression|9|||
127903122|NCT01863745|460270144|FG000|Overall Study|Adverse Event|2|||
127903123|NCT01863745|460270144|FG000|Overall Study|Death|1|||
127903124|NCT01863745|460270144|FG000|Overall Study|Withdrawal by Subject|1|||
127903125|NCT00193609|460270145|FG000|Overall Study|Lack of Efficacy|2|||
127903126|NCT00193609|460270145|FG000|Overall Study|Adverse Event|2|||
127903127|NCT00854308|460270148|FG000|Overall Study|Disease progression|42|||
127903128|NCT00854308|460270149|FG001|Overall Study|Disease progression|50|||
127903129|NCT00854308|460270148|FG000|Overall Study|Adverse Event|8|||
127903130|NCT00854308|460270149|FG001|Overall Study|Adverse Event|3|||
127903131|NCT00854308|460270148|FG000|Overall Study|Death|2|||
127903132|NCT00854308|460270149|FG001|Overall Study|Death|5|||
127903133|NCT00854308|460270148|FG000|Overall Study|Physician Decision|6|||
127903134|NCT00854308|460270149|FG001|Overall Study|Physician Decision|6|||
127903135|NCT00854308|460270148|FG000|Overall Study|Withdrawal by Subject|4|||
127903136|NCT00854308|460270149|FG001|Overall Study|Withdrawal by Subject|2|||
127903137|NCT00854308|460270148|FG000|Overall Study|Sponsor's decision to terminate study|0|||
127903138|NCT00854308|460270149|FG001|Overall Study|Sponsor's decision to terminate study|1|||
127903139|NCT00610363|460270150|FG000|Overall Study|Non-compliance with protocol|0|||
127903140|NCT00610363|460270151|FG001|Overall Study|Non-compliance with protocol|1|||
127903141|NCT00610363|460270150|FG000|Overall Study|Adverse Event|3|||
127903142|NCT00610363|460270151|FG001|Overall Study|Adverse Event|1|||
127903143|NCT00610363|460270150|FG000|Overall Study|Lack of Efficacy|2|||
127903144|NCT00610363|460270151|FG001|Overall Study|Lack of Efficacy|0|||
127903145|NCT00610363|460270150|FG000|Overall Study|Lost to Follow-up|4|||
127903146|NCT00610363|460270151|FG001|Overall Study|Lost to Follow-up|0|||
127903147|NCT00610363|460270150|FG000|Overall Study|Withdrawal by Subject|1|||
127903148|NCT00610363|460270151|FG001|Overall Study|Withdrawal by Subject|0|||
127903149|NCT00610363|460270150|FG000|Overall Study|Other than specified above|1|||
127903150|NCT00610363|460270151|FG001|Overall Study|Other than specified above|1|||
127903151|NCT03048500|460270152|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
127903152|NCT03048500|460270152|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
127903153|NCT03048500|460270152|FG000|Reached 1st Response/Continued Treatment|Death|1|||
127903154|NCT03048500|460270152|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
127903155|NCT03048500|460270152|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
127903156|NCT03048500|460270152|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
127903157|NCT03048500|460270152|FG000|Follow up for 3 Years|Death|12|||
127903158|NCT02008565|460270166|FG000|Overall Study|Protocol Violation|1|||
127903159|NCT02008565|460270167|FG001|Overall Study|Protocol Violation|1|||
127903160|NCT02008565|460270168|FG002|Overall Study|Protocol Violation|2|||
127903161|NCT02008565|460270169|FG003|Overall Study|Protocol Violation|0|||
127903162|NCT02193178|460270170|FG000|Overall Study|Lost to Follow-up|1|||
127903163|NCT02193178|460270170|FG000|Overall Study|Dry eyes|1|||
127903164|NCT03435081|460270171|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
127903165|NCT03435081|460270172|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
127903166|NCT03435081|460270173|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
127903167|NCT03435081|460270171|FG000|Week 0 to Week 16|Adverse Event|2|||
127903168|NCT03435081|460270172|FG001|Week 0 to Week 16|Adverse Event|2|||
127903169|NCT03435081|460270173|FG002|Week 0 to Week 16|Adverse Event|2|||
127903170|NCT03435081|460270171|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
127903171|NCT03435081|460270172|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
127903172|NCT03435081|460270173|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
127903173|NCT03435081|460270171|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
127903174|NCT03435081|460270172|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
127903175|NCT03435081|460270173|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
127903176|NCT03435081|460270171|FG000|Week 0 to Week 16|Pregnancy|1|||
127903177|NCT03435081|460270172|FG001|Week 0 to Week 16|Pregnancy|0|||
127903178|NCT03435081|460270173|FG002|Week 0 to Week 16|Pregnancy|0|||
127903179|NCT03435081|460270171|FG000|Week 0 to Week 16|Non-compliance|1|||
127903180|NCT03435081|460270172|FG001|Week 0 to Week 16|Non-compliance|0|||
127903181|NCT03435081|460270173|FG002|Week 0 to Week 16|Non-compliance|2|||
127903182|NCT03435081|460270171|FG000|Week 0 to Week 16|Inadequate Response|0|||
127903183|NCT03435081|460270172|FG001|Week 0 to Week 16|Inadequate Response|1|||
127903184|NCT03435081|460270173|FG002|Week 0 to Week 16|Inadequate Response|0|||
127903185|NCT03435081|460270171|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
127903186|NCT03435081|460270172|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
127903187|NCT03435081|460270173|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
127903188|NCT03435081|460270171|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
127903189|NCT03435081|460270172|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
127903190|NCT03435081|460270173|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
127903191|NCT03435081|460270171|FG000|Week 16 to Week 104|Adverse Event|1|||
127903192|NCT03435081|460270172|FG001|Week 16 to Week 104|Adverse Event|0|||
127903193|NCT03435081|460270173|FG002|Week 16 to Week 104|Adverse Event|2|||
127903194|NCT03435081|460270171|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
127903195|NCT03435081|460270172|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
127903196|NCT03435081|460270173|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
127903197|NCT03435081|460270171|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
127903198|NCT03435081|460270172|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
127903199|NCT03435081|460270173|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
127903200|NCT03435081|460270171|FG000|Week 16 to Week 104|Non--Compliance|0|||
127903201|NCT03435081|460270172|FG001|Week 16 to Week 104|Non--Compliance|0|||
127903202|NCT03435081|460270173|FG002|Week 16 to Week 104|Non--Compliance|1|||
127903203|NCT04320849|460270176|FG000|Overall Study|Withdrawal by Subject|4|||
127903204|NCT04320849|460270176|FG000|Overall Study|Imaging data unavailable|2|||
127903205|NCT04320849|460270176|FG000|Overall Study|Incomplete imaging|2|||
127903206|NCT00214422|460270177|FG000|Overall Study|Physician Decision|2|||
127903207|NCT00214422|460270178|FG001|Overall Study|Physician Decision|0|||
127903208|NCT00214422|460270179|FG002|Overall Study|Physician Decision|0|||
127903209|NCT00214422|460270177|FG000|Overall Study|Developed esophageal ca|1|||
127903210|NCT00214422|460270178|FG001|Overall Study|Developed esophageal ca|0|||
127847567|NCT02193828|460059311|FG001|Overall Study|Withdrawal by Subject|0|||
127847568|NCT02193828|460059312|FG002|Overall Study|Withdrawal by Subject|1|||
127847569|NCT02193828|460059313|FG003|Overall Study|Withdrawal by Subject|1|||
127847570|NCT01185704|460059314|FG000|Overall Study|Randomized but not treated|3|||
127847571|NCT01185704|460059315|FG001|Overall Study|Randomized but not treated|3|||
127847572|NCT01185704|460059314|FG000|Overall Study|Lack of ovarian response|5|||
127847573|NCT01185704|460059315|FG001|Overall Study|Lack of ovarian response|1|||
127847574|NCT01185704|460059314|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
127847575|NCT01185704|460059315|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
127847576|NCT01185704|460059314|FG000|Overall Study|Ectopic pregnancy|0|||
127847577|NCT01185704|460059315|FG001|Overall Study|Ectopic pregnancy|1|||
127847578|NCT01686958|460059318|FG000|Overall Study|Withdrawal by Subject|1|||
127847579|NCT01151540|460059319|FG000|Overall Study|Other|2|||
127847580|NCT01151540|460059319|FG000|Overall Study|Adverse event, non-fatal|4|||
127847581|NCT01151540|460059319|FG000|Overall Study|Withdrawal by Subject|7|||
127847582|NCT03094832|460059320|FG000|Overall Study|Lost to Follow-up|0|||
127847583|NCT03094832|460059321|FG001|Overall Study|Lost to Follow-up|0|||
127847584|NCT03094832|460059322|FG002|Overall Study|Lost to Follow-up|0|||
127847585|NCT03094832|460059323|FG003|Overall Study|Lost to Follow-up|1|||
127847586|NCT03094832|460059324|FG004|Overall Study|Lost to Follow-up|1|||
127847587|NCT03094832|460059320|FG000|Overall Study|Death|1|||
127847588|NCT03094832|460059321|FG001|Overall Study|Death|0|||
127847589|NCT03094832|460059322|FG002|Overall Study|Death|0|||
127847590|NCT03094832|460059323|FG003|Overall Study|Death|0|||
127847591|NCT03094832|460059324|FG004|Overall Study|Death|0|||
127847592|NCT03094832|460059320|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
127847593|NCT03094832|460059321|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
127847594|NCT03094832|460059322|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
127847595|NCT03094832|460059323|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
127847596|NCT03094832|460059324|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
127847597|NCT03094832|460059320|FG000|Overall Study|Other|13|||
127847598|NCT03094832|460059321|FG001|Overall Study|Other|20|||
127847599|NCT03094832|460059322|FG002|Overall Study|Other|1|||
127847600|NCT03094832|460059323|FG003|Overall Study|Other|7|||
127847601|NCT03094832|460059324|FG004|Overall Study|Other|1|||
127847602|NCT01998880|460059325|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
127847603|NCT01998880|460059326|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
127847604|NCT01998880|460059325|FG000|Overall Study|Disease Progression|1|||
127903211|NCT00214422|460270179|FG002|Overall Study|Developed esophageal ca|0|||
127903212|NCT00214422|460270177|FG000|Overall Study|Pt taken off study|1|||
127847605|NCT01998880|460059326|FG001|Overall Study|Disease Progression|8|||
127903213|NCT00214422|460270178|FG001|Overall Study|Pt taken off study|1|||
127903214|NCT00214422|460270179|FG002|Overall Study|Pt taken off study|0|||
127903215|NCT00214422|460270177|FG000|Overall Study|Disease progression on study|1|||
127903216|NCT00214422|460270178|FG001|Overall Study|Disease progression on study|0|||
127903217|NCT00214422|460270179|FG002|Overall Study|Disease progression on study|0|||
127903218|NCT00214422|460270177|FG000|Overall Study|Unable to make a radiation treatment|0|||
127903219|NCT00214422|460270178|FG001|Overall Study|Unable to make a radiation treatment|0|||
127903220|NCT00214422|460270179|FG002|Overall Study|Unable to make a radiation treatment|1|||
127903221|NCT03929393|460270180|FG000|Overall Study|Death|1|||
127903222|NCT03929393|460270181|FG001|Overall Study|Death|0|||
127903223|NCT03929393|460270180|FG000|Overall Study|Time Commitment|2|||
127903224|NCT03929393|460270181|FG001|Overall Study|Time Commitment|5|||
127903225|NCT03929393|460270180|FG000|Overall Study|Motor Vehicle Accident|0|||
127903226|NCT03929393|460270181|FG001|Overall Study|Motor Vehicle Accident|1|||
127903227|NCT03929393|460270180|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
127903228|NCT03929393|460270181|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
127903229|NCT03929393|460270180|FG000|Overall Study|Other|1|||
127903230|NCT03929393|460270181|FG001|Overall Study|Other|3|||
127903231|NCT04149964|460270184|FG000|Overall Study|Lost to Follow-up|19|||
127903232|NCT04149964|460270185|FG001|Overall Study|Lost to Follow-up|18|||
127903233|NCT04753437|460270186|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
127903234|NCT04753437|460270187|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
127903235|NCT04753437|460270186|FG000|Overall Study|Liver Function Test Abnormalities|2|||
127903236|NCT04753437|460270187|FG001|Overall Study|Liver Function Test Abnormalities|4|||
127903237|NCT02424097|460271885|FG000|Overall Study|Lost to Follow-up|1|||
127903238|NCT02424097|460271886|FG001|Overall Study|Lost to Follow-up|2|||
127903239|NCT01675622|460271887|FG000|Overall Study|Withdrawal by Subject|2|||
127903240|NCT01675622|460271888|FG001|Overall Study|Withdrawal by Subject|2|||
127903241|NCT01675622|460271887|FG000|Overall Study|Adverse Event|12|||
127903242|NCT01675622|460271888|FG001|Overall Study|Adverse Event|10|||
127903243|NCT01675622|460271887|FG000|Overall Study|Protocol Violation|4|||
127903244|NCT01675622|460271888|FG001|Overall Study|Protocol Violation|1|||
127903245|NCT01675622|460271887|FG000|Overall Study|Lack of Efficacy|2|||
127903246|NCT01675622|460271888|FG001|Overall Study|Lack of Efficacy|4|||
127903247|NCT01675622|460271887|FG000|Overall Study|Lost to Follow-up|1|||
127903248|NCT01675622|460271888|FG001|Overall Study|Lost to Follow-up|3|||
127903249|NCT01675622|460271887|FG000|Overall Study|Other|5|||
127903250|NCT01675622|460271888|FG001|Overall Study|Other|4|||
127903251|NCT04032977|460271889|FG000|Overall Study|Withdrawal by Subject|6|||
127903252|NCT04032977|460271890|FG001|Overall Study|Withdrawal by Subject|1|||
127903253|NCT04032977|460271889|FG000|Overall Study|Lost to Follow-up|2|||
127903254|NCT04032977|460271890|FG001|Overall Study|Lost to Follow-up|7|||
127903255|NCT04032977|460271889|FG000|Overall Study|Pregnancy|1|||
127903256|NCT04032977|460271890|FG001|Overall Study|Pregnancy|0|||
127903257|NCT02880761|460271891|FG000|Overall Study|Death|6|||
127903258|NCT02880761|460271892|FG001|Overall Study|Death|8|||
127903259|NCT02880761|460271891|FG000|Overall Study|Withdrawal by Subject|3|||
127903260|NCT02880761|460271892|FG001|Overall Study|Withdrawal by Subject|6|||
127903261|NCT02880761|460271891|FG000|Overall Study|Protocol Violation|4|||
127903262|NCT02880761|460271892|FG001|Overall Study|Protocol Violation|3|||
127903263|NCT02880761|460271891|FG000|Overall Study|Lost to Follow-up|3|||
127903264|NCT02880761|460271892|FG001|Overall Study|Lost to Follow-up|4|||
127903265|NCT02106156|460271893|FG000|Overall Study|Patient Died|19|||
127903266|NCT02106156|460271894|FG001|Overall Study|Patient Died|0|||
127847606|NCT01998880|460059325|FG000|Overall Study|Withdrew Consent|2|||
127847607|NCT01998880|460059326|FG001|Overall Study|Withdrew Consent|1|||
127847608|NCT01998880|460059325|FG000|Overall Study|Death|3|||
127847609|NCT01998880|460059326|FG001|Overall Study|Death|6|||
127847610|NCT01998880|460059325|FG000|Overall Study|Insufficient Therapeutic Response|1|||
127847611|NCT01998880|460059326|FG001|Overall Study|Insufficient Therapeutic Response|5|||
127847612|NCT01998880|460059325|FG000|Overall Study|Administrative/Other|1|||
127847613|NCT01998880|460059326|FG001|Overall Study|Administrative/Other|1|||
127847614|NCT01998880|460059325|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
127847615|NCT01998880|460059326|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
127847616|NCT01998880|460059325|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
127903267|NCT02106156|460271895|FG002|Overall Study|Patient Died|0|||
127903268|NCT02106156|460271893|FG000|Overall Study|Lack of Tolerability|305|||
127903269|NCT02106156|460271894|FG001|Overall Study|Lack of Tolerability|3|||
127903270|NCT02106156|460271895|FG002|Overall Study|Lack of Tolerability|0|||
127903271|NCT02106156|460271893|FG000|Overall Study|Lack of Virological Response|1044|||
127847617|NCT01998880|460059326|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
127847618|NCT01998880|460059325|FG000|Overall Study|Did Not Receive Treatment|3|||
127903272|NCT02106156|460271894|FG001|Overall Study|Lack of Virological Response|8|||
127903273|NCT02106156|460271895|FG002|Overall Study|Lack of Virological Response|0|||
127903274|NCT02106156|460271893|FG000|Overall Study|Concomitant Disease|74|||
127903275|NCT02106156|460271894|FG001|Overall Study|Concomitant Disease|2|||
127903276|NCT02106156|460271895|FG002|Overall Study|Concomitant Disease|0|||
127847619|NCT01998880|460059326|FG001|Overall Study|Did Not Receive Treatment|2|||
127847620|NCT01419080|460059327|FG000|Overall Study|Withdrawal by Subject|75|||
127847621|NCT01419080|460059327|FG000|Overall Study|Death|30|||
127847622|NCT01419080|460059327|FG000|Overall Study|Lost to Follow-up|23|||
127847623|NCT01419080|460059327|FG000|Overall Study|Too Ill|3|||
127847624|NCT03199638|460059331|FG000|Overall Study|inability to drink glutamine during regularly|0|||
127847625|NCT03199638|460059332|FG001|Overall Study|inability to drink glutamine during regularly|2|||
127847626|NCT01575899|460059333|FG000|Overall Study|Lost to Follow-up|3|||
127847627|NCT01575899|460059334|FG001|Overall Study|Lost to Follow-up|4|||
127847628|NCT01575899|460059335|FG002|Overall Study|Lost to Follow-up|2|||
127847629|NCT01575899|460059333|FG000|Overall Study|Protocol Violation|2|||
127847630|NCT01575899|460059334|FG001|Overall Study|Protocol Violation|1|||
127847631|NCT01575899|460059335|FG002|Overall Study|Protocol Violation|0|||
127847632|NCT02807844|460059336|FG000|Overall Study|Physician Decision|0|||
127847633|NCT02807844|460059337|FG001|Overall Study|Physician Decision|0|||
127847634|NCT02807844|460059338|FG002|Overall Study|Physician Decision|0|||
127847635|NCT02807844|460059339|FG003|Overall Study|Physician Decision|0|||
127847636|NCT02807844|460059340|FG004|Overall Study|Physician Decision|0|||
127847637|NCT02807844|460059341|FG005|Overall Study|Physician Decision|0|||
127847638|NCT02807844|460059342|FG006|Overall Study|Physician Decision|3|||
127847639|NCT02807844|460059343|FG007|Overall Study|Physician Decision|0|||
127847640|NCT02807844|460059344|FG008|Overall Study|Physician Decision|1|||
127847641|NCT02807844|460059345|FG009|Overall Study|Physician Decision|2|||
127847642|NCT02807844|460059336|FG000|Overall Study|Death|0|||
127847643|NCT02807844|460059337|FG001|Overall Study|Death|0|||
127847644|NCT02807844|460059338|FG002|Overall Study|Death|2|||
127847645|NCT02807844|460059339|FG003|Overall Study|Death|4|||
127847646|NCT02807844|460059340|FG004|Overall Study|Death|1|||
127847647|NCT02807844|460059341|FG005|Overall Study|Death|2|||
127847648|NCT02807844|460059342|FG006|Overall Study|Death|1|||
127847649|NCT02807844|460059343|FG007|Overall Study|Death|2|||
127847650|NCT02807844|460059344|FG008|Overall Study|Death|0|||
127847651|NCT02807844|460059345|FG009|Overall Study|Death|1|||
127847652|NCT02807844|460059336|FG000|Overall Study|Withdrawal by Subject|0|||
127847653|NCT02807844|460059337|FG001|Overall Study|Withdrawal by Subject|0|||
127847654|NCT02807844|460059338|FG002|Overall Study|Withdrawal by Subject|2|||
127847655|NCT02807844|460059339|FG003|Overall Study|Withdrawal by Subject|1|||
127847656|NCT02807844|460059340|FG004|Overall Study|Withdrawal by Subject|1|||
127847657|NCT02807844|460059341|FG005|Overall Study|Withdrawal by Subject|0|||
127847658|NCT02807844|460059342|FG006|Overall Study|Withdrawal by Subject|1|||
127847659|NCT02807844|460059343|FG007|Overall Study|Withdrawal by Subject|0|||
127847660|NCT02807844|460059344|FG008|Overall Study|Withdrawal by Subject|0|||
127847661|NCT02807844|460059345|FG009|Overall Study|Withdrawal by Subject|0|||
127847662|NCT02807844|460059336|FG000|Overall Study|Progressive disease|5|||
127847663|NCT02807844|460059337|FG001|Overall Study|Progressive disease|12|||
127847664|NCT02807844|460059338|FG002|Overall Study|Progressive disease|8|||
127847665|NCT02807844|460059339|FG003|Overall Study|Progressive disease|8|||
127847666|NCT02807844|460059340|FG004|Overall Study|Progressive disease|3|||
127847667|NCT02807844|460059341|FG005|Overall Study|Progressive disease|8|||
127847668|NCT02807844|460059342|FG006|Overall Study|Progressive disease|14|||
127847669|NCT02807844|460059343|FG007|Overall Study|Progressive disease|17|||
127847670|NCT02807844|460059344|FG008|Overall Study|Progressive disease|19|||
127847671|NCT02807844|460059345|FG009|Overall Study|Progressive disease|15|||
127847672|NCT02807844|460059336|FG000|Overall Study|Adverse Event|1|||
127847673|NCT02807844|460059337|FG001|Overall Study|Adverse Event|0|||
127847674|NCT02807844|460059338|FG002|Overall Study|Adverse Event|0|||
127847675|NCT02807844|460059339|FG003|Overall Study|Adverse Event|0|||
127847676|NCT02807844|460059340|FG004|Overall Study|Adverse Event|1|||
127847677|NCT02807844|460059341|FG005|Overall Study|Adverse Event|1|||
127847678|NCT02807844|460059342|FG006|Overall Study|Adverse Event|1|||
127847679|NCT02807844|460059343|FG007|Overall Study|Adverse Event|1|||
127847680|NCT02807844|460059344|FG008|Overall Study|Adverse Event|1|||
127847681|NCT02807844|460059345|FG009|Overall Study|Adverse Event|2|||
127847682|NCT04294095|460059346|FG000|Overall Study|Adverse Event|1|||
127847683|NCT04294095|460059347|FG001|Overall Study|Adverse Event|0|||
127847684|NCT02661464|460059348|FG000|Overall Study|Lost to Follow-up|28|||
127847685|NCT02661464|460059349|FG001|Overall Study|Lost to Follow-up|0|||
127847686|NCT02661464|460059350|FG002|Overall Study|Lost to Follow-up|0|||
127847687|NCT02661464|460059351|FG003|Overall Study|Lost to Follow-up|0|||
127847688|NCT02661464|460059348|FG000|Overall Study|Withdrawal by Subject|3|||
127847689|NCT02661464|460059349|FG001|Overall Study|Withdrawal by Subject|1|||
127847690|NCT02661464|460059350|FG002|Overall Study|Withdrawal by Subject|0|||
127847691|NCT02661464|460059351|FG003|Overall Study|Withdrawal by Subject|0|||
127847692|NCT02661464|460059348|FG000|Overall Study|Participants terminated prematurely|288|||
127847693|NCT02661464|460059349|FG001|Overall Study|Participants terminated prematurely|52|||
127847694|NCT02661464|460059350|FG002|Overall Study|Participants terminated prematurely|1|||
127847695|NCT02661464|460059351|FG003|Overall Study|Participants terminated prematurely|1|||
127847696|NCT02661464|460059348|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
127847697|NCT02661464|460059349|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
127847698|NCT02661464|460059350|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
127847699|NCT02661464|460059351|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
127847700|NCT03148756|460059352|FG000|Overall Study|Study Terminated|0|||
127847701|NCT03148756|460059353|FG001|Overall Study|Study Terminated|1|||
127847702|NCT02177175|460059356|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
127847703|NCT02177175|460059357|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
127847704|NCT03205982|460059367|FG000|Overall Study|Lost to Follow-up|20|||
127847705|NCT03205982|460059368|FG001|Overall Study|Lost to Follow-up|19|||
127847706|NCT03205982|460059367|FG000|Overall Study|Withdrawal by Subject|4|||
127847707|NCT03205982|460059368|FG001|Overall Study|Withdrawal by Subject|3|||
127847708|NCT03205982|460059367|FG000|Overall Study|Withdrawal by PI|0|||
127847709|NCT03205982|460059368|FG001|Overall Study|Withdrawal by PI|1|||
127847710|NCT00994162|460059369|FG000|Overall Study|Withdrawal by Subject|1|||
127847711|NCT00994162|460059369|FG000|Overall Study|Lost to Follow-up|2|||
127847712|NCT00994162|460059369|FG000|Overall Study|Product Complaint|1|||
127847713|NCT00994162|460059369|FG000|Overall Study|Poor Compliance|5|||
127847714|NCT00994162|460059369|FG000|Overall Study|Lack of Response|3|||
127847715|NCT00994162|460059369|FG000|Overall Study|Discharged from Hospital|4|||
127847716|NCT00994162|460059369|FG000|Overall Study|Death|2|||
127847717|NCT00994162|460059369|FG000|Overall Study|Care Transferred to Another Physician|2|||
127847718|NCT00994162|460059369|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
127847719|NCT00994162|460059369|FG000|Overall Study|Physician Decision|2|||
127847720|NCT00994162|460059369|FG000|Overall Study|Surrounding Wound Erythematous|1|||
127847721|NCT00994162|460059369|FG000|Overall Study|Machine Losing Vaccum|1|||
127847722|NCT00994162|460059369|FG000|Overall Study|Patient Lived Too Far Away|1|||
127847723|NCT00994162|460059369|FG000|Overall Study|Above Knee Amputation|1|||
127847724|NCT00994162|460059369|FG000|Overall Study|Reason Not Reported By Site|1|||
127847725|NCT00631540|460059374|FG000|Overall Study|Withdrawal by Subject|5|||
127847726|NCT00631540|460059374|FG000|Overall Study|Death|4|||
127847727|NCT00631540|460059374|FG000|Overall Study|Lost to Follow-up|2|||
127847728|NCT00631540|460059374|FG000|Overall Study|Core Lab Data Unavailable|3|||
127847729|NCT01946412|460059376|FG000|Overall Study|Adverse Event|1|||
127847730|NCT01946412|460059376|FG000|Overall Study|Non-Compliance|1|||
127847731|NCT01946412|460059376|FG000|Overall Study|Continued with commercial Kalydeco|2|||
127847732|NCT01946412|460059376|FG000|Overall Study|Difficulty in swallowing|1|||
127847733|NCT03682055|460061308|FG000|Overall Study|Lack of Efficacy|1|||
127847734|NCT03682055|460061309|FG001|Overall Study|Lack of Efficacy|2|||
127847735|NCT03682055|460061310|FG002|Overall Study|Lack of Efficacy|1|||
127847736|NCT03682055|460061311|FG003|Overall Study|Lack of Efficacy|2|||
127847737|NCT03682055|460061312|FG004|Overall Study|Lack of Efficacy|1|||
127847738|NCT03682055|460061313|FG005|Overall Study|Lack of Efficacy|3|||
127847739|NCT03682055|460061308|FG000|Overall Study|Withdrawal by Subject|0|||
127847740|NCT03682055|460061309|FG001|Overall Study|Withdrawal by Subject|0|||
127847741|NCT03682055|460061310|FG002|Overall Study|Withdrawal by Subject|0|||
127847742|NCT03682055|460061311|FG003|Overall Study|Withdrawal by Subject|0|||
127847743|NCT03682055|460061312|FG004|Overall Study|Withdrawal by Subject|0|||
127847744|NCT03682055|460061313|FG005|Overall Study|Withdrawal by Subject|1|||
127847745|NCT03682055|460061308|FG000|Overall Study|Termination of Study by Sponsor|0|||
127847746|NCT03682055|460061309|FG001|Overall Study|Termination of Study by Sponsor|0|||
127847747|NCT03682055|460061310|FG002|Overall Study|Termination of Study by Sponsor|0|||
127847748|NCT03682055|460061311|FG003|Overall Study|Termination of Study by Sponsor|0|||
127847749|NCT03682055|460061312|FG004|Overall Study|Termination of Study by Sponsor|0|||
127847750|NCT03682055|460061313|FG005|Overall Study|Termination of Study by Sponsor|3|||
127847751|NCT01135394|460061314|FG000|Screening|Lost to Follow-up|2|||
127847752|NCT01135394|460061314|FG000|Screening|Withdrawal by Subject|10|||
127847753|NCT01135394|460061314|FG000|Screening|Screening failure|16|||
127847754|NCT01135394|460061314|FG000|Screening|Physician Decision|5|||
127847755|NCT01135394|460061314|FG000|Baseline Assessment|Withdrawal by Subject|9|||
127847756|NCT01135394|460061314|FG000|Baseline Assessment|Physician Decision|3|||
127847757|NCT01135394|460061314|FG000|Baseline Assessment|Lost to Follow-up|2|||
127847758|NCT01135394|460061314|FG000|Baseline Assessment|Adverse Event|1|||
127847759|NCT01135394|460061314|FG000|Study Treatment|Withdrawal by Subject|1|||
127847760|NCT01135394|460061314|FG000|Study Treatment|Physician Decision|1|||
127847761|NCT01135394|460061314|FG000|Study Treatment|Adverse Event|2|||
127847762|NCT00191386|460061315|FG000|Overall Study|Adverse Event|16|||
127847763|NCT00191386|460061315|FG000|Overall Study|Lost to Follow-up|1|||
127847764|NCT00191386|460061315|FG000|Overall Study|Entry Criteria Exclusion|3|||
127847765|NCT00191386|460061315|FG000|Overall Study|Protocol Violation|18|||
127847766|NCT00191386|460061315|FG000|Overall Study|Withdrawal by Subject|96|||
127847767|NCT00191386|460061315|FG000|Overall Study|Physician Decision|11|||
127847768|NCT00191386|460061315|FG000|Overall Study|Lack of Efficacy|15|||
127847769|NCT00462488|460061316|FG000|Overall Study|Protocol Violation|1|||
127847770|NCT00462488|460061317|FG001|Overall Study|Protocol Violation|0|||
127847771|NCT00462488|460061316|FG000|Overall Study|Lack of Efficacy|19|||
127847772|NCT00462488|460061317|FG001|Overall Study|Lack of Efficacy|17|||
127847773|NCT03750240|460061318|FG000|Overall Study|Technical Difficulties|2|||
127847774|NCT00927758|460061319|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
127847775|NCT00927758|460061320|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
127847776|NCT00927758|460061321|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
127847777|NCT00927758|460061322|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
127847778|NCT00927758|460061323|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
127847779|NCT00927758|460061324|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
127847780|NCT00927758|460061319|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
127847781|NCT00927758|460061320|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
127847782|NCT00927758|460061321|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
127847783|NCT00927758|460061322|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
127847784|NCT00927758|460061323|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
127847785|NCT00927758|460061324|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
127847786|NCT00439725|460061326|FG000|Treatment Period|Withdrawal by Subject|22|||
127847787|NCT00439725|460061327|FG001|Treatment Period|Withdrawal by Subject|19|||
127847788|NCT00439725|460061326|FG000|Treatment Period|Study terminated by sponsor|156|||
127847789|NCT00439725|460061327|FG001|Treatment Period|Study terminated by sponsor|148|||
127847790|NCT00439725|460061326|FG000|Treatment Period|Site closed by investigator|1|||
127847791|NCT00439725|460061327|FG001|Treatment Period|Site closed by investigator|2|||
127847792|NCT00439725|460061326|FG000|Treatment Period|Adverse Event|39|||
127847793|NCT00439725|460061327|FG001|Treatment Period|Adverse Event|18|||
127847794|NCT00439725|460061326|FG000|Treatment Period|Physician Decision|1|||
127847795|NCT00439725|460061327|FG001|Treatment Period|Physician Decision|1|||
127847796|NCT00439725|460061326|FG000|Treatment Period|Protocol Violation|2|||
127847797|NCT00439725|460061327|FG001|Treatment Period|Protocol Violation|1|||
127847798|NCT00439725|460061326|FG000|Treatment Period|Clinical endpoint reached|6|||
127847799|NCT00439725|460061327|FG001|Treatment Period|Clinical endpoint reached|50|||
127847800|NCT00439725|460061326|FG000|Treatment Period|Technical problems|1|||
127847801|NCT00439725|460061327|FG001|Treatment Period|Technical problems|0|||
127847802|NCT00439725|460061326|FG000|Treatment Period|Lost to Follow-up|1|||
127847803|NCT00439725|460061327|FG001|Treatment Period|Lost to Follow-up|1|||
127847804|NCT00439725|460061326|FG000|Treatment Period|Participant convenience|1|||
127847805|NCT00439725|460061327|FG001|Treatment Period|Participant convenience|0|||
127847806|NCT00439725|460061326|FG000|Treatment Period|Protocol driven decision point|1|||
127847807|NCT00439725|460061327|FG001|Treatment Period|Protocol driven decision point|1|||
127847808|NCT00439725|460061326|FG000|Treatment Period|Death|1|||
127847809|NCT00439725|460061327|FG001|Treatment Period|Death|1|||
127847810|NCT00439725|460061326|FG000|Treatment Period|Participant did not receive treatment|4|||
127847811|NCT00439725|460061327|FG001|Treatment Period|Participant did not receive treatment|4|||
127847812|NCT00439725|460061326|FG000|Observational Period|Withdrawal by Subject|2|||
127847813|NCT00439725|460061327|FG001|Observational Period|Withdrawal by Subject|2|||
127847814|NCT00439725|460061326|FG000|Observational Period|Lost to Follow-up|0|||
127847815|NCT00439725|460061327|FG001|Observational Period|Lost to Follow-up|1|||
127847816|NCT00439725|460061326|FG000|Observational Period|Death|0|||
127847817|NCT00439725|460061327|FG001|Observational Period|Death|2|||
127847818|NCT00439725|460061326|FG000|Observational Period|Study termination by sponsor|1|||
127847819|NCT00439725|460061327|FG001|Observational Period|Study termination by sponsor|1|||
127847820|NCT00439725|460061326|FG000|Observational Period|Clinical endpoint reached|3|||
127847821|NCT00439725|460061327|FG001|Observational Period|Clinical endpoint reached|1|||
127847822|NCT00439725|460061326|FG000|Observational Period|Technical problems|1|||
127847823|NCT00439725|460061327|FG001|Observational Period|Technical problems|0|||
127847824|NCT00439725|460061326|FG000|Observational Period|Participant convenience|1|||
127847825|NCT00439725|460061327|FG001|Observational Period|Participant convenience|0|||
127847826|NCT03510910|460061328|FG000|Overall Study|Incomplete Survey|2|||
127847827|NCT03510910|460061329|FG001|Overall Study|Incomplete Survey|3|||
127847828|NCT01105936|460061330|FG000|Period 1|Adverse Event|0|||
127847829|NCT01105936|460061331|FG001|Period 1|Adverse Event|0|||
127847830|NCT01105936|460061332|FG002|Period 1|Adverse Event|0|||
127847831|NCT01105936|460061333|FG003|Period 1|Adverse Event|1|||
127847832|NCT01105936|460061330|FG000|Period 2|Adverse Event|1|||
127847833|NCT01105936|460061331|FG001|Period 2|Adverse Event|0|||
127847834|NCT01105936|460061332|FG002|Period 2|Adverse Event|0|||
127847835|NCT01105936|460061333|FG003|Period 2|Adverse Event|0|||
127847836|NCT01105936|460061330|FG000|Period 3|Protocol Violation|0|||
127847837|NCT01105936|460061331|FG001|Period 3|Protocol Violation|2|||
127847838|NCT01105936|460061332|FG002|Period 3|Protocol Violation|0|||
127847839|NCT01105936|460061333|FG003|Period 3|Protocol Violation|0|||
127847840|NCT01673490|460061334|FG000|Overall Study|Lost to Follow-up|1|||
127847841|NCT01673490|460061334|FG000|Overall Study|Adverse Event|3|||
127847842|NCT01673490|460061334|FG000|Overall Study|Withdrawal by Subject|3|||
127847843|NCT00379236|460061335|FG000|Double-blind|Adverse Event|11|||
127847844|NCT00379236|460061336|FG001|Double-blind|Adverse Event|6|||
127847845|NCT00379236|460061337|FG002|Double-blind|Adverse Event|0|||
127847846|NCT00379236|460061335|FG000|Double-blind|Protocol Violation|3|||
127847847|NCT00379236|460061336|FG001|Double-blind|Protocol Violation|3|||
127903277|NCT02106156|460271893|FG000|Overall Study|Lack of Compliance|211|||
127903278|NCT02106156|460271894|FG001|Overall Study|Lack of Compliance|7|||
127903279|NCT02106156|460271895|FG002|Overall Study|Lack of Compliance|0|||
127903280|NCT02106156|460271893|FG000|Overall Study|Patients Request|307|||
127903281|NCT02106156|460271894|FG001|Overall Study|Patients Request|9|||
127903282|NCT02106156|460271895|FG002|Overall Study|Patients Request|0|||
127903283|NCT02106156|460271893|FG000|Overall Study|Lost to Follow-up|451|||
127903284|NCT02106156|460271894|FG001|Overall Study|Lost to Follow-up|8|||
127903285|NCT02106156|460271895|FG002|Overall Study|Lost to Follow-up|0|||
127903286|NCT02106156|460271893|FG000|Overall Study|Unplanned Event|82|||
127903287|NCT02106156|460271894|FG001|Overall Study|Unplanned Event|2|||
127903288|NCT02106156|460271895|FG002|Overall Study|Unplanned Event|0|||
127903289|NCT02106156|460271893|FG000|Overall Study|Change of Laboratory Parameter|10|||
127903290|NCT02106156|460271894|FG001|Overall Study|Change of Laboratory Parameter|0|||
127903291|NCT02106156|460271895|FG002|Overall Study|Change of Laboratory Parameter|0|||
127903292|NCT02106156|460271893|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
127903293|NCT02106156|460271894|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
127903294|NCT02106156|460271895|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
127903295|NCT02106156|460271893|FG000|Overall Study|Relocation/Change of Physician|40|||
127847848|NCT00379236|460061337|FG002|Double-blind|Protocol Violation|0|||
127847849|NCT00379236|460061335|FG000|Double-blind|Withdrawal by Subject|12|||
127847850|NCT00379236|460061336|FG001|Double-blind|Withdrawal by Subject|13|||
127847851|NCT00379236|460061337|FG002|Double-blind|Withdrawal by Subject|0|||
127847852|NCT00379236|460061335|FG000|Double-blind|Lost to Follow-up|4|||
127847853|NCT00379236|460061336|FG001|Double-blind|Lost to Follow-up|3|||
127847854|NCT00379236|460061337|FG002|Double-blind|Lost to Follow-up|0|||
127847855|NCT00379236|460061335|FG000|Double-blind|Use of exclusionary medication|1|||
127847856|NCT00379236|460061336|FG001|Double-blind|Use of exclusionary medication|2|||
127847857|NCT00379236|460061337|FG002|Double-blind|Use of exclusionary medication|0|||
127847858|NCT00379236|460061335|FG000|Double-blind|Other|3|||
127847859|NCT00379236|460061336|FG001|Double-blind|Other|7|||
127847860|NCT00379236|460061337|FG002|Double-blind|Other|0|||
127847861|NCT00379236|460061335|FG000|Double-blind|Data could not be retrieved|2|||
127847862|NCT00379236|460061336|FG001|Double-blind|Data could not be retrieved|2|||
127847863|NCT00379236|460061337|FG002|Double-blind|Data could not be retrieved|0|||
127847864|NCT00379236|460061335|FG000|Open-label Extension|Adverse Event|0|||
127847865|NCT00379236|460061336|FG001|Open-label Extension|Adverse Event|0|||
127847866|NCT00379236|460061337|FG002|Open-label Extension|Adverse Event|13|||
127847867|NCT00379236|460061335|FG000|Open-label Extension|Protocol Violation|0|||
127847868|NCT00379236|460061336|FG001|Open-label Extension|Protocol Violation|0|||
127847869|NCT00379236|460061337|FG002|Open-label Extension|Protocol Violation|7|||
127847870|NCT00379236|460061335|FG000|Open-label Extension|Withdrawal by Subject|0|||
127847871|NCT00379236|460061336|FG001|Open-label Extension|Withdrawal by Subject|0|||
127847872|NCT00379236|460061337|FG002|Open-label Extension|Withdrawal by Subject|13|||
127847873|NCT00379236|460061335|FG000|Open-label Extension|Lost to Follow-up|0|||
127847874|NCT00379236|460061336|FG001|Open-label Extension|Lost to Follow-up|0|||
127847875|NCT00379236|460061337|FG002|Open-label Extension|Lost to Follow-up|12|||
127847876|NCT00379236|460061335|FG000|Open-label Extension|Use of exclusionary medication|0|||
127847877|NCT00379236|460061336|FG001|Open-label Extension|Use of exclusionary medication|0|||
127847878|NCT00379236|460061337|FG002|Open-label Extension|Use of exclusionary medication|3|||
127847879|NCT00379236|460061335|FG000|Open-label Extension|Other|0|||
127847880|NCT00379236|460061336|FG001|Open-label Extension|Other|0|||
127847881|NCT00379236|460061337|FG002|Open-label Extension|Other|7|||
127847882|NCT02940860|460061345|FG000|Overall Study|Non-serious AE|1|||
127847883|NCT02940860|460061346|FG001|Overall Study|Non-serious AE|2|||
127903296|NCT02106156|460271894|FG001|Overall Study|Relocation/Change of Physician|1|||
127903297|NCT02106156|460271895|FG002|Overall Study|Relocation/Change of Physician|0|||
127903298|NCT05017480|460271900|FG000|Stage 1 Study|Withdrawal by Subject|8|||
127903299|NCT05017480|460271901|FG001|Stage 1 Study|Withdrawal by Subject|6|||
127903300|NCT05017480|460271902|FG002|Stage 1 Study|Withdrawal by Subject|0|||
127903301|NCT05017480|460271903|FG003|Stage 1 Study|Withdrawal by Subject|0|||
127903302|NCT05017480|460271904|FG004|Stage 1 Study|Withdrawal by Subject|0|||
127903303|NCT05017480|460271900|FG000|Stage 1 Study|Adverse Event|1|||
127847884|NCT02940860|460061345|FG000|Overall Study|Serious AE|7|||
127903304|NCT05017480|460271901|FG001|Stage 1 Study|Adverse Event|1|||
127903305|NCT05017480|460271902|FG002|Stage 1 Study|Adverse Event|0|||
127903306|NCT05017480|460271903|FG003|Stage 1 Study|Adverse Event|0|||
127903307|NCT05017480|460271904|FG004|Stage 1 Study|Adverse Event|0|||
127903308|NCT05017480|460271900|FG000|Stage 1 Study|Poor Compliance|1|||
127903309|NCT05017480|460271901|FG001|Stage 1 Study|Poor Compliance|1|||
127903310|NCT05017480|460271902|FG002|Stage 1 Study|Poor Compliance|0|||
127847885|NCT02940860|460061346|FG001|Overall Study|Serious AE|3|||
127847886|NCT02940860|460061345|FG000|Overall Study|Withdrawal by Subject|19|||
127847887|NCT02940860|460061346|FG001|Overall Study|Withdrawal by Subject|9|||
127847888|NCT02940860|460061345|FG000|Overall Study|Lost to Follow-up|13|||
127847889|NCT02940860|460061346|FG001|Overall Study|Lost to Follow-up|7|||
127847890|NCT02940860|460061345|FG000|Overall Study|Physician Decision|5|||
127847891|NCT02940860|460061346|FG001|Overall Study|Physician Decision|3|||
127847892|NCT02940860|460061345|FG000|Overall Study|Sponsor Decision|0|||
127847893|NCT02940860|460061346|FG001|Overall Study|Sponsor Decision|1|||
127847894|NCT02940860|460061345|FG000|Overall Study|Protocol Violation|0|||
127847895|NCT02940860|460061346|FG001|Overall Study|Protocol Violation|2|||
127847896|NCT02940860|460061345|FG000|Overall Study|Death|3|||
127847897|NCT02940860|460061346|FG001|Overall Study|Death|2|||
127847898|NCT02940860|460061345|FG000|Overall Study|Moved, poor venous access, transport|6|||
127847899|NCT02940860|460061346|FG001|Overall Study|Moved, poor venous access, transport|4|||
127847900|NCT02940860|460061345|FG000|Overall Study|Not treated|2|||
127847901|NCT02940860|460061346|FG001|Overall Study|Not treated|2|||
127847902|NCT04914819|460061347|FG000|Overall Study|Pregnancy|3|||
127847903|NCT04914819|460061348|FG001|Overall Study|Pregnancy|1|||
127847904|NCT04914819|460061347|FG000|Overall Study|Discontinued study|4|||
127847905|NCT04914819|460061348|FG001|Overall Study|Discontinued study|1|||
127847906|NCT04914819|460061347|FG000|Overall Study|Lost to Follow-up|7|||
127847907|NCT04914819|460061348|FG001|Overall Study|Lost to Follow-up|0|||
127847908|NCT02715804|460061349|FG000|Overall Study|Death|222|||
127847909|NCT02715804|460061350|FG001|Overall Study|Death|106|||
127847910|NCT02715804|460061349|FG000|Overall Study|Withdrawal by Subject|5|||
127847911|NCT02715804|460061350|FG001|Overall Study|Withdrawal by Subject|4|||
127847912|NCT02715804|460061349|FG000|Overall Study|Other than specified|2|||
127847913|NCT02715804|460061350|FG001|Overall Study|Other than specified|3|||
127847914|NCT04038385|460061351|FG000|Overall Study|Completed baseline assessment only|7|||
127847915|NCT04038385|460061352|FG001|Overall Study|Completed baseline assessment only|4|||
127847916|NCT04038385|460061351|FG000|Overall Study|Moved out of area|4|||
127847917|NCT04038385|460061352|FG001|Overall Study|Moved out of area|2|||
127847918|NCT04038385|460061351|FG000|Overall Study|Discontinued study involvement|6|||
127847919|NCT04038385|460061352|FG001|Overall Study|Discontinued study involvement|1|||
127847920|NCT01625611|460061355|FG000|Overall Study|No adlib drinks Lab 1|3|||
127847921|NCT01625611|460061356|FG001|Overall Study|No adlib drinks Lab 1|0|||
127847922|NCT01625611|460061355|FG000|Overall Study|Technical issues with PET|1|||
127847923|NCT01625611|460061356|FG001|Overall Study|Technical issues with PET|0|||
127847924|NCT01625611|460061355|FG000|Overall Study|Unable to complete study procedures|1|||
127847925|NCT01625611|460061356|FG001|Overall Study|Unable to complete study procedures|0|||
127847926|NCT01625611|460061355|FG000|Overall Study|Withdrawal by Subject|3|||
127847927|NCT01625611|460061356|FG001|Overall Study|Withdrawal by Subject|0|||
127847928|NCT00948194|460061357|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
127847929|NCT00948194|460061358|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
127847930|NCT02431793|460061359|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
127847931|NCT02431793|460061360|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
127847932|NCT02431793|460061361|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
127847933|NCT02431793|460061359|FG000|Overall Study|Withdrawal by Subject|7|||
127847934|NCT02431793|460061360|FG001|Overall Study|Withdrawal by Subject|5|||
127847935|NCT02431793|460061361|FG002|Overall Study|Withdrawal by Subject|5|||
127847936|NCT02431793|460061359|FG000|Overall Study|Lost to Follow-up|101|||
127847937|NCT02431793|460061360|FG001|Overall Study|Lost to Follow-up|122|||
127847938|NCT02431793|460061361|FG002|Overall Study|Lost to Follow-up|104|||
127847939|NCT00233324|460061362|FG000|Main Study|Death|68|||
127847940|NCT00233324|460061363|FG001|Main Study|Death|60|||
127847941|NCT00233324|460061364|FG002|Main Study|Death|62|||
127847942|NCT00233324|460061365|FG003|Main Study|Death|47|||
127847943|NCT00233324|460061362|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
127847944|NCT00233324|460061363|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
127847945|NCT00233324|460061364|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
127847946|NCT00233324|460061365|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
127847947|NCT00233324|460061362|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
127847948|NCT00233324|460061363|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
127847949|NCT00233324|460061364|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
127847950|NCT00233324|460061365|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
127847951|NCT03170258|460061369|FG000|Overall Study|Physician Decision|4|||
127847952|NCT03170258|460061370|FG001|Overall Study|Physician Decision|0|||
127847953|NCT03170258|460061369|FG000|Overall Study|Equipment issues|1|||
127847954|NCT03170258|460061370|FG001|Overall Study|Equipment issues|0|||
127847955|NCT03170258|460061369|FG000|Overall Study|Medication|1|||
127847956|NCT03170258|460061370|FG001|Overall Study|Medication|0|||
127847957|NCT03170258|460061369|FG000|Overall Study|Sleep issues|1|||
127847958|NCT03170258|460061370|FG001|Overall Study|Sleep issues|0|||
127847959|NCT01563107|460061371|FG000|Overall Study|Physician Decision|0|||
127847960|NCT01563107|460061372|FG001|Overall Study|Physician Decision|1|||
127847961|NCT01563107|460061373|FG002|Overall Study|Physician Decision|1|||
127847962|NCT01563107|460061374|FG003|Overall Study|Physician Decision|3|||
127847963|NCT01563107|460061371|FG000|Overall Study|Withdrawal by Subject|1|||
127847964|NCT01563107|460061372|FG001|Overall Study|Withdrawal by Subject|2|||
127847965|NCT01563107|460061373|FG002|Overall Study|Withdrawal by Subject|1|||
127847966|NCT01563107|460061374|FG003|Overall Study|Withdrawal by Subject|2|||
127847967|NCT01998958|460061379|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
127847968|NCT01998958|460061380|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
127847969|NCT01998958|460061381|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
127847970|NCT01998958|460061382|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
127847971|NCT01998958|460061383|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
127847972|NCT01998958|460061384|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
127847973|NCT01998958|460061385|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
127847974|NCT01998958|460061386|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
127847975|NCT01998958|460061387|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
127847976|NCT01998958|460061388|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
127847977|NCT01998958|460061389|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
127847978|NCT01998958|460061390|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
127847979|NCT01998958|460061391|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
127847980|NCT01998958|460061392|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
127847981|NCT01998958|460061393|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
127847982|NCT01998958|460061394|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
127847983|NCT01998958|460061395|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
127847984|NCT01998958|460061396|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
127847985|NCT01998958|460061397|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
127847986|NCT01998958|460061398|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
127847987|NCT01998958|460061399|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
127847988|NCT01998958|460061400|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
127847989|NCT01998958|460061401|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
127847990|NCT01998958|460061402|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
127847991|NCT01998958|460061403|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
127847992|NCT01998958|460061404|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
127847993|NCT01998958|460061405|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
127847994|NCT01998958|460061406|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
127847995|NCT01998958|460061407|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
127847996|NCT01998958|460061408|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
127847997|NCT01998958|460061409|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
127847998|NCT01998958|460061410|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
127847999|NCT01998958|460061379|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
127848000|NCT01998958|460061380|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
127848001|NCT01998958|460061381|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
127848002|NCT01998958|460061382|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
127848003|NCT01998958|460061383|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
127848004|NCT01998958|460061384|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
127848005|NCT01998958|460061385|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
127848006|NCT01998958|460061386|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
127848007|NCT01998958|460061387|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
127848008|NCT01998958|460061388|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
127848009|NCT01998958|460061389|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
127848010|NCT01998958|460061390|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
127848011|NCT01998958|460061391|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
127848012|NCT01998958|460061392|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
127848013|NCT01998958|460061393|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
127848014|NCT01998958|460061394|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
127848015|NCT01998958|460061395|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
127848016|NCT01998958|460061396|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
127848017|NCT01998958|460061397|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
127848018|NCT01998958|460061398|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
127848019|NCT01998958|460061399|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
127848020|NCT01998958|460061400|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
127848021|NCT01998958|460061401|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
127848022|NCT01998958|460061402|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
127903311|NCT05017480|460271903|FG003|Stage 1 Study|Poor Compliance|0|||
127903312|NCT05017480|460271904|FG004|Stage 1 Study|Poor Compliance|0|||
127903313|NCT05017480|460271900|FG000|Stage 1 Study|Physician Decision|0|||
127903314|NCT05017480|460271901|FG001|Stage 1 Study|Physician Decision|1|||
127848023|NCT01998958|460061403|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
127848024|NCT01998958|460061404|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
127848025|NCT01998958|460061405|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
127848026|NCT01998958|460061406|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
127848027|NCT01998958|460061407|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
127848028|NCT01998958|460061408|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
127848029|NCT01998958|460061409|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
127848030|NCT01998958|460061410|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
127848031|NCT01998958|460061379|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
127848032|NCT01998958|460061380|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
127848033|NCT01998958|460061381|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
127903315|NCT05017480|460271902|FG002|Stage 1 Study|Physician Decision|0|||
127848034|NCT01998958|460061382|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
127848035|NCT01998958|460061383|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
127848036|NCT01998958|460061384|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
127848037|NCT01998958|460061385|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
127848038|NCT01998958|460061386|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
127848039|NCT01998958|460061387|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
127848040|NCT01998958|460061388|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
127848041|NCT01998958|460061389|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
127848042|NCT01998958|460061390|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
127848043|NCT01998958|460061391|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
127848044|NCT01998958|460061392|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
127848045|NCT01998958|460061393|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
127848046|NCT01998958|460061394|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
127848047|NCT01998958|460061395|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
127848048|NCT01998958|460061396|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
127848049|NCT01998958|460061397|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
127848050|NCT01998958|460061398|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
127848051|NCT01998958|460061399|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
127848052|NCT01998958|460061400|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
127848053|NCT01998958|460061401|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
127848054|NCT01998958|460061402|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
127848055|NCT01998958|460061403|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
127848056|NCT01998958|460061404|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
127848057|NCT01998958|460061405|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
127848058|NCT01998958|460061406|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
127848059|NCT01998958|460061407|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
127848060|NCT01998958|460061408|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
127848061|NCT01998958|460061409|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
127848062|NCT01998958|460061410|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
127848063|NCT01998958|460061379|FG000|Period 1 (Panel A and B)|Other|1|||
127848064|NCT01998958|460061380|FG001|Period 1 (Panel A and B)|Other|0|||
127848065|NCT01998958|460061381|FG002|Period 1 (Panel A and B)|Other|0|||
127848066|NCT01998958|460061382|FG003|Period 1 (Panel A and B)|Other|0|||
127848067|NCT01998958|460061383|FG004|Period 1 (Panel A and B)|Other|0|||
127848068|NCT01998958|460061384|FG005|Period 1 (Panel A and B)|Other|0|||
127848069|NCT01998958|460061385|FG006|Period 1 (Panel A and B)|Other|0|||
127848070|NCT01998958|460061386|FG007|Period 1 (Panel A and B)|Other|0|||
127848071|NCT01998958|460061387|FG008|Period 1 (Panel A and B)|Other|0|||
127848072|NCT01998958|460061388|FG009|Period 1 (Panel A and B)|Other|0|||
127848073|NCT01998958|460061389|FG010|Period 1 (Panel A and B)|Other|0|||
127848074|NCT01998958|460061390|FG011|Period 1 (Panel A and B)|Other|0|||
127848075|NCT01998958|460061391|FG012|Period 1 (Panel A and B)|Other|0|||
127848076|NCT01998958|460061392|FG013|Period 1 (Panel A and B)|Other|0|||
127848077|NCT01998958|460061393|FG014|Period 1 (Panel A and B)|Other|0|||
127848078|NCT01998958|460061394|FG015|Period 1 (Panel A and B)|Other|0|||
127848079|NCT01998958|460061395|FG016|Period 1 (Panel A and B)|Other|0|||
127848080|NCT01998958|460061396|FG017|Period 1 (Panel A and B)|Other|0|||
127848081|NCT01998958|460061397|FG018|Period 1 (Panel A and B)|Other|0|||
127848082|NCT01998958|460061398|FG019|Period 1 (Panel A and B)|Other|0|||
127848083|NCT01998958|460061399|FG020|Period 1 (Panel A and B)|Other|0|||
127848084|NCT01998958|460061400|FG021|Period 1 (Panel A and B)|Other|0|||
127848085|NCT01998958|460061401|FG022|Period 1 (Panel A and B)|Other|0|||
127848086|NCT01998958|460061402|FG023|Period 1 (Panel A and B)|Other|0|||
127848087|NCT01998958|460061403|FG024|Period 1 (Panel A and B)|Other|0|||
127848088|NCT01998958|460061404|FG025|Period 1 (Panel A and B)|Other|0|||
127848089|NCT01998958|460061405|FG026|Period 1 (Panel A and B)|Other|0|||
127848090|NCT01998958|460061406|FG027|Period 1 (Panel A and B)|Other|0|||
127848091|NCT01998958|460061407|FG028|Period 1 (Panel A and B)|Other|0|||
127848092|NCT01998958|460061408|FG029|Period 1 (Panel A and B)|Other|0|||
127848093|NCT01998958|460061409|FG030|Period 1 (Panel A and B)|Other|0|||
127848094|NCT01998958|460061410|FG031|Period 1 (Panel A and B)|Other|0|||
127848095|NCT01998958|460061379|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
127848096|NCT01998958|460061380|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
127848097|NCT01998958|460061381|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
127848098|NCT01998958|460061382|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
127848099|NCT01998958|460061383|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
127848100|NCT01998958|460061384|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
127848101|NCT01998958|460061385|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
127848102|NCT01998958|460061386|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
127848103|NCT01998958|460061387|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
127848104|NCT01998958|460061388|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
127848105|NCT01998958|460061389|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
127848106|NCT01998958|460061390|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
127848107|NCT01998958|460061391|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
127848108|NCT01998958|460061392|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
127903316|NCT05017480|460271903|FG003|Stage 1 Study|Physician Decision|0|||
127848109|NCT01998958|460061393|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
127848110|NCT01998958|460061394|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
127848111|NCT01998958|460061395|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
127848112|NCT01998958|460061396|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
127848113|NCT01998958|460061397|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
127848114|NCT01998958|460061398|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
127848115|NCT01998958|460061399|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
127848116|NCT01998958|460061400|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
127848117|NCT01998958|460061401|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
127848118|NCT01998958|460061402|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
127848119|NCT01998958|460061403|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
127848120|NCT01998958|460061404|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
127848121|NCT01998958|460061405|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
127848122|NCT01998958|460061406|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
127848123|NCT01998958|460061407|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
127848124|NCT01998958|460061408|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
127848125|NCT01998958|460061409|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
127848126|NCT01998958|460061410|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
127848127|NCT01998958|460061379|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
127848128|NCT01998958|460061380|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
127848129|NCT01998958|460061381|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
127848130|NCT01998958|460061382|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
127848131|NCT01998958|460061383|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
127848132|NCT01998958|460061384|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
127848133|NCT01998958|460061385|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
127848134|NCT01998958|460061386|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
127848135|NCT01998958|460061387|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
127848136|NCT01998958|460061388|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
127848137|NCT01998958|460061389|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
127848138|NCT01998958|460061390|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
127848139|NCT01998958|460061391|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
127848140|NCT01998958|460061392|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
127848141|NCT01998958|460061393|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
127848142|NCT01998958|460061394|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
127848143|NCT01998958|460061395|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
127848144|NCT01998958|460061396|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
127848145|NCT01998958|460061397|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
127848146|NCT01998958|460061398|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
127848147|NCT01998958|460061399|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
127848148|NCT01998958|460061400|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
127848149|NCT01998958|460061401|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
127848150|NCT01998958|460061402|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
127848151|NCT01998958|460061403|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
127848152|NCT01998958|460061404|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
127848153|NCT01998958|460061405|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
127848154|NCT01998958|460061406|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
127848155|NCT01998958|460061407|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
127848156|NCT01998958|460061408|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
127848157|NCT01998958|460061409|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
127848158|NCT01998958|460061410|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
127848159|NCT01998958|460061379|FG000|Open Label Phase (Optional)|Adverse Event|0|||
127848160|NCT01998958|460061380|FG001|Open Label Phase (Optional)|Adverse Event|0|||
127848161|NCT01998958|460061381|FG002|Open Label Phase (Optional)|Adverse Event|0|||
127848162|NCT01998958|460061382|FG003|Open Label Phase (Optional)|Adverse Event|0|||
127848163|NCT01998958|460061383|FG004|Open Label Phase (Optional)|Adverse Event|0|||
127848164|NCT01998958|460061384|FG005|Open Label Phase (Optional)|Adverse Event|0|||
127848165|NCT01998958|460061385|FG006|Open Label Phase (Optional)|Adverse Event|0|||
127848166|NCT01998958|460061386|FG007|Open Label Phase (Optional)|Adverse Event|0|||
127848167|NCT01998958|460061387|FG008|Open Label Phase (Optional)|Adverse Event|0|||
127848168|NCT01998958|460061388|FG009|Open Label Phase (Optional)|Adverse Event|0|||
127848169|NCT01998958|460061389|FG010|Open Label Phase (Optional)|Adverse Event|0|||
127848170|NCT01998958|460061390|FG011|Open Label Phase (Optional)|Adverse Event|0|||
127848171|NCT01998958|460061391|FG012|Open Label Phase (Optional)|Adverse Event|0|||
127848172|NCT01998958|460061392|FG013|Open Label Phase (Optional)|Adverse Event|0|||
127848173|NCT01998958|460061393|FG014|Open Label Phase (Optional)|Adverse Event|0|||
127848174|NCT01998958|460061394|FG015|Open Label Phase (Optional)|Adverse Event|0|||
127848175|NCT01998958|460061395|FG016|Open Label Phase (Optional)|Adverse Event|0|||
127848176|NCT01998958|460061396|FG017|Open Label Phase (Optional)|Adverse Event|0|||
127903317|NCT05017480|460271904|FG004|Stage 1 Study|Physician Decision|0|||
127903318|NCT05017480|460271900|FG000|Stage 2 Study|Withdrawal by Subject|0|||
127903319|NCT05017480|460271901|FG001|Stage 2 Study|Withdrawal by Subject|0|||
127903320|NCT05017480|460271902|FG002|Stage 2 Study|Withdrawal by Subject|6|||
127903321|NCT05017480|460271903|FG003|Stage 2 Study|Withdrawal by Subject|9|||
127903322|NCT05017480|460271904|FG004|Stage 2 Study|Withdrawal by Subject|11|||
127903323|NCT05017480|460271900|FG000|Stage 2 Study|Lost to Follow-up|0|||
127903324|NCT05017480|460271901|FG001|Stage 2 Study|Lost to Follow-up|0|||
127903325|NCT05017480|460271902|FG002|Stage 2 Study|Lost to Follow-up|0|||
127903326|NCT05017480|460271903|FG003|Stage 2 Study|Lost to Follow-up|2|||
127903327|NCT05017480|460271904|FG004|Stage 2 Study|Lost to Follow-up|1|||
127903328|NCT05017480|460271900|FG000|Stage 2 Study|Adverse Event|0|||
127903329|NCT05017480|460271901|FG001|Stage 2 Study|Adverse Event|0|||
127903330|NCT05017480|460271902|FG002|Stage 2 Study|Adverse Event|0|||
127903331|NCT05017480|460271903|FG003|Stage 2 Study|Adverse Event|1|||
127903332|NCT05017480|460271904|FG004|Stage 2 Study|Adverse Event|0|||
127903333|NCT05017480|460271900|FG000|Stage 2 Study|COVID-19|0|||
127903334|NCT05017480|460271901|FG001|Stage 2 Study|COVID-19|0|||
127903335|NCT05017480|460271902|FG002|Stage 2 Study|COVID-19|0|||
127903336|NCT05017480|460271903|FG003|Stage 2 Study|COVID-19|1|||
127903337|NCT05017480|460271904|FG004|Stage 2 Study|COVID-19|0|||
127903338|NCT05017480|460271900|FG000|Stage 2 Study|Pregnancy|0|||
127903339|NCT05017480|460271901|FG001|Stage 2 Study|Pregnancy|0|||
127903340|NCT05017480|460271902|FG002|Stage 2 Study|Pregnancy|0|||
127903341|NCT05017480|460271903|FG003|Stage 2 Study|Pregnancy|0|||
127903342|NCT05017480|460271904|FG004|Stage 2 Study|Pregnancy|1|||
127903343|NCT01136382|460271907|FG000|Overall Study|Other|8|||
127903344|NCT01136382|460271908|FG001|Overall Study|Other|3|||
127903345|NCT01136382|460271907|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
127903346|NCT01136382|460271908|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
127903347|NCT01136382|460271907|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
127903348|NCT01136382|460271908|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
127903349|NCT01136382|460271907|FG000|Overall Study|Withdrawal by Subject|4|||
127903350|NCT01136382|460271908|FG001|Overall Study|Withdrawal by Subject|1|||
127903351|NCT00746798|460271911|FG000|Overall Study|Protocol Violation|0|||
127903352|NCT00746798|460271912|FG001|Overall Study|Protocol Violation|1|||
127903353|NCT00746798|460271913|FG002|Overall Study|Protocol Violation|0|||
127903354|NCT00746798|460271914|FG003|Overall Study|Protocol Violation|0|||
127903355|NCT00746798|460271911|FG000|Overall Study|Withdrawal by Subject|0|||
127903356|NCT00746798|460271912|FG001|Overall Study|Withdrawal by Subject|1|||
127903357|NCT00746798|460271913|FG002|Overall Study|Withdrawal by Subject|1|||
127903358|NCT00746798|460271914|FG003|Overall Study|Withdrawal by Subject|0|||
127903359|NCT00746798|460271911|FG000|Overall Study|Death|0|||
127848177|NCT01998958|460061397|FG018|Open Label Phase (Optional)|Adverse Event|0|||
127848178|NCT01998958|460061398|FG019|Open Label Phase (Optional)|Adverse Event|0|||
127848179|NCT01998958|460061399|FG020|Open Label Phase (Optional)|Adverse Event|0|||
127848180|NCT01998958|460061400|FG021|Open Label Phase (Optional)|Adverse Event|0|||
127848181|NCT01998958|460061401|FG022|Open Label Phase (Optional)|Adverse Event|0|||
127848182|NCT01998958|460061402|FG023|Open Label Phase (Optional)|Adverse Event|1|||
127848183|NCT01998958|460061403|FG024|Open Label Phase (Optional)|Adverse Event|0|||
127848184|NCT01998958|460061404|FG025|Open Label Phase (Optional)|Adverse Event|0|||
127848185|NCT01998958|460061405|FG026|Open Label Phase (Optional)|Adverse Event|0|||
127848186|NCT01998958|460061406|FG027|Open Label Phase (Optional)|Adverse Event|0|||
127848187|NCT01998958|460061407|FG028|Open Label Phase (Optional)|Adverse Event|0|||
127848188|NCT01998958|460061408|FG029|Open Label Phase (Optional)|Adverse Event|0|||
127848189|NCT01998958|460061409|FG030|Open Label Phase (Optional)|Adverse Event|0|||
127848190|NCT01998958|460061410|FG031|Open Label Phase (Optional)|Adverse Event|0|||
127848191|NCT01998958|460061379|FG000|Open Label Phase (Optional)|Other|0|||
127848192|NCT01998958|460061380|FG001|Open Label Phase (Optional)|Other|0|||
127848193|NCT01998958|460061381|FG002|Open Label Phase (Optional)|Other|0|||
127903360|NCT00746798|460271912|FG001|Overall Study|Death|0|||
127903361|NCT00746798|460271913|FG002|Overall Study|Death|2|||
127903362|NCT00746798|460271914|FG003|Overall Study|Death|0|||
127903363|NCT00746798|460271911|FG000|Overall Study|Participant unable to return for visit|1|||
127903364|NCT00746798|460271912|FG001|Overall Study|Participant unable to return for visit|0|||
127903365|NCT00746798|460271913|FG002|Overall Study|Participant unable to return for visit|0|||
127903366|NCT00746798|460271914|FG003|Overall Study|Participant unable to return for visit|0|||
127848194|NCT01998958|460061382|FG003|Open Label Phase (Optional)|Other|0|||
127848195|NCT01998958|460061383|FG004|Open Label Phase (Optional)|Other|0|||
127903367|NCT02896361|460271915|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
127903368|NCT02896361|460271916|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
127848196|NCT01998958|460061384|FG005|Open Label Phase (Optional)|Other|0|||
127848197|NCT01998958|460061385|FG006|Open Label Phase (Optional)|Other|0|||
127848198|NCT01998958|460061386|FG007|Open Label Phase (Optional)|Other|0|||
127848199|NCT01998958|460061387|FG008|Open Label Phase (Optional)|Other|0|||
127848200|NCT01998958|460061388|FG009|Open Label Phase (Optional)|Other|0|||
127848201|NCT01998958|460061389|FG010|Open Label Phase (Optional)|Other|0|||
127848202|NCT01998958|460061390|FG011|Open Label Phase (Optional)|Other|0|||
127848203|NCT01998958|460061391|FG012|Open Label Phase (Optional)|Other|0|||
127848204|NCT01998958|460061392|FG013|Open Label Phase (Optional)|Other|0|||
127848205|NCT01998958|460061393|FG014|Open Label Phase (Optional)|Other|0|||
127848206|NCT01998958|460061394|FG015|Open Label Phase (Optional)|Other|0|||
127848207|NCT01998958|460061395|FG016|Open Label Phase (Optional)|Other|0|||
127848208|NCT01998958|460061396|FG017|Open Label Phase (Optional)|Other|0|||
127848209|NCT01998958|460061397|FG018|Open Label Phase (Optional)|Other|0|||
127848210|NCT01998958|460061398|FG019|Open Label Phase (Optional)|Other|0|||
127848211|NCT01998958|460061399|FG020|Open Label Phase (Optional)|Other|0|||
127848212|NCT01998958|460061400|FG021|Open Label Phase (Optional)|Other|0|||
127848213|NCT01998958|460061401|FG022|Open Label Phase (Optional)|Other|5|||
127848214|NCT01998958|460061402|FG023|Open Label Phase (Optional)|Other|1|||
127848215|NCT01998958|460061403|FG024|Open Label Phase (Optional)|Other|0|||
127848216|NCT01998958|460061404|FG025|Open Label Phase (Optional)|Other|0|||
127848217|NCT01998958|460061405|FG026|Open Label Phase (Optional)|Other|0|||
127848218|NCT01998958|460061406|FG027|Open Label Phase (Optional)|Other|0|||
127848219|NCT01998958|460061407|FG028|Open Label Phase (Optional)|Other|0|||
127848220|NCT01998958|460061408|FG029|Open Label Phase (Optional)|Other|0|||
127848221|NCT01998958|460061409|FG030|Open Label Phase (Optional)|Other|0|||
127848222|NCT01998958|460061410|FG031|Open Label Phase (Optional)|Other|0|||
127848223|NCT01998958|460061379|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
127848224|NCT01998958|460061380|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
127848225|NCT01998958|460061381|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
127848226|NCT01998958|460061382|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
127848227|NCT01998958|460061383|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
127848228|NCT01998958|460061384|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
127848229|NCT01998958|460061385|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
127848230|NCT01998958|460061386|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
127848231|NCT01998958|460061387|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
127848232|NCT01998958|460061388|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
127848233|NCT01998958|460061389|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
127848234|NCT01998958|460061390|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
127848235|NCT01998958|460061391|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
127848236|NCT01998958|460061392|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
127848237|NCT01998958|460061393|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
127848238|NCT01998958|460061394|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
127848239|NCT01998958|460061395|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
127848240|NCT01998958|460061396|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
127848241|NCT01998958|460061397|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
127848242|NCT01998958|460061398|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
127848243|NCT01998958|460061399|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
127848244|NCT01998958|460061400|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
127848245|NCT01998958|460061401|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
127848246|NCT01998958|460061402|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
127848247|NCT01998958|460061403|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
127848248|NCT01998958|460061404|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
127848249|NCT01998958|460061405|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
127848250|NCT01998958|460061406|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
127848251|NCT01998958|460061407|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
127848252|NCT01998958|460061408|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
127848253|NCT01998958|460061409|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
127848254|NCT01998958|460061410|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
127848255|NCT01998958|460061379|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
127848256|NCT01998958|460061380|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
127848257|NCT01998958|460061381|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
127848258|NCT01998958|460061382|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
127848259|NCT01998958|460061383|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
127848260|NCT01998958|460061384|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
127848261|NCT01998958|460061385|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
127848262|NCT01998958|460061386|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
127848263|NCT01998958|460061387|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
127848264|NCT01998958|460061388|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
127848265|NCT01998958|460061389|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
127848266|NCT01998958|460061390|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
127848267|NCT01998958|460061391|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
127848268|NCT01998958|460061392|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
127848269|NCT01998958|460061393|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
127848270|NCT01998958|460061394|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
127848271|NCT01998958|460061395|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
127848272|NCT01998958|460061396|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
127848273|NCT01998958|460061397|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
127848274|NCT01998958|460061398|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
127848275|NCT01998958|460061399|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
127848276|NCT01998958|460061400|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
127848277|NCT01998958|460061401|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
127848278|NCT01998958|460061402|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
127848279|NCT01998958|460061403|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
127848280|NCT01998958|460061404|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
127848281|NCT01998958|460061405|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
127848282|NCT01998958|460061406|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
127848283|NCT01998958|460061407|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
127848284|NCT01998958|460061408|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
127848285|NCT01998958|460061409|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
127848286|NCT01998958|460061410|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
127848287|NCT01998958|460061379|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
127848288|NCT01998958|460061380|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
127848289|NCT01998958|460061381|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
127848290|NCT01998958|460061382|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
127848291|NCT01998958|460061383|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
127848292|NCT01998958|460061384|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
127848293|NCT01998958|460061385|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
127848294|NCT01998958|460061386|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
127848295|NCT01998958|460061387|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
127848296|NCT01998958|460061388|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
127848297|NCT01998958|460061389|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
127848298|NCT01998958|460061390|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
127848299|NCT01998958|460061391|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
127848300|NCT01998958|460061392|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
127848301|NCT01998958|460061393|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
127848302|NCT01998958|460061394|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
127848303|NCT01998958|460061395|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
127848304|NCT01998958|460061396|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
127848305|NCT01998958|460061397|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
127848306|NCT01998958|460061398|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
127848307|NCT01998958|460061399|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
127848308|NCT01998958|460061400|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
127848309|NCT01998958|460061401|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
127848310|NCT01998958|460061402|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
127848311|NCT01998958|460061403|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
127848312|NCT01998958|460061404|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
127848313|NCT01998958|460061405|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
127848314|NCT01998958|460061406|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
127848315|NCT01998958|460061407|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
127848316|NCT01998958|460061408|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
127848317|NCT01998958|460061409|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
127848318|NCT01998958|460061410|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
127848319|NCT00724815|460061411|FG000|Overall Study|Randomized, not treated|31|||
127848320|NCT00724815|460061412|FG001|Overall Study|Randomized, not treated|30|||
127848321|NCT00724815|460061411|FG000|Overall Study|Adverse Event|5|||
127848322|NCT00724815|460061412|FG001|Overall Study|Adverse Event|3|||
127848323|NCT00724815|460061411|FG000|Overall Study|Lost to Follow-up|4|||
127848324|NCT00724815|460061412|FG001|Overall Study|Lost to Follow-up|1|||
127848325|NCT00724815|460061411|FG000|Overall Study|Other Various|3|||
127848326|NCT00724815|460061412|FG001|Overall Study|Other Various|5|||
127848327|NCT00810043|460061413|FG000|Overall Study|Withdrawal by Subject|1|||
127848328|NCT00810043|460061414|FG001|Overall Study|Withdrawal by Subject|0|||
127848329|NCT00810043|460061415|FG002|Overall Study|Withdrawal by Subject|2|||
127848330|NCT00810043|460061413|FG000|Overall Study|Lost to Follow-up|1|||
127848331|NCT00810043|460061414|FG001|Overall Study|Lost to Follow-up|0|||
127848332|NCT00810043|460061415|FG002|Overall Study|Lost to Follow-up|0|||
127848333|NCT00810043|460061413|FG000|Overall Study|Physician Decision|0|||
127848334|NCT00810043|460061414|FG001|Overall Study|Physician Decision|0|||
127848335|NCT00810043|460061415|FG002|Overall Study|Physician Decision|2|||
127848336|NCT00810043|460061413|FG000|Overall Study|Death|2|||
127848337|NCT00810043|460061414|FG001|Overall Study|Death|0|||
127848338|NCT00810043|460061415|FG002|Overall Study|Death|0|||
127848339|NCT00810043|460061413|FG000|Overall Study|Unrelated medical problem|0|||
127848340|NCT00810043|460061414|FG001|Overall Study|Unrelated medical problem|1|||
127848341|NCT00810043|460061415|FG002|Overall Study|Unrelated medical problem|0|||
127903369|NCT02896361|460271917|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
127903370|NCT02896361|460271915|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
127903371|NCT02896361|460271916|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
127903372|NCT02896361|460271917|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
127903373|NCT01045096|460271919|FG000|Overall Study|Withdrawal by Subject|2|||
127903374|NCT01045096|460271920|FG001|Overall Study|Withdrawal by Subject|0|||
127903375|NCT01045096|460271921|FG002|Overall Study|Withdrawal by Subject|0|||
127903376|NCT01045096|460271919|FG000|Overall Study|Other|1|||
127903377|NCT01045096|460271920|FG001|Overall Study|Other|0|||
127903378|NCT01045096|460271921|FG002|Overall Study|Other|0|||
127903379|NCT01511939|460271923|FG000|Overall Study|Withdrawal by Subject|2|||
127903380|NCT01511939|460271924|FG001|Overall Study|Withdrawal by Subject|1|||
127903381|NCT01511939|460271925|FG002|Overall Study|Withdrawal by Subject|0|||
127903382|NCT00324168|460271930|FG000|Overall Study|Lost to Follow-up|19|||
127903383|NCT00324168|460271931|FG001|Overall Study|Lost to Follow-up|18|||
127903384|NCT00324168|460271930|FG000|Overall Study|Death|3|||
127903385|NCT00324168|460271931|FG001|Overall Study|Death|3|||
127903386|NCT00324168|460271930|FG000|Overall Study|Patient did not visit in f/u window|6|||
127903387|NCT00324168|460271931|FG001|Overall Study|Patient did not visit in f/u window|9|||
127903388|NCT03497897|460271934|FG000|Overall Study|Adverse Event|1|||
127903389|NCT03497897|460271935|FG001|Overall Study|Adverse Event|1|||
127903390|NCT03497897|460271936|FG002|Overall Study|Adverse Event|1|||
127903391|NCT03497897|460271934|FG000|Overall Study|Lost to Follow-up|2|||
127903392|NCT03497897|460271935|FG001|Overall Study|Lost to Follow-up|0|||
127903393|NCT03497897|460271936|FG002|Overall Study|Lost to Follow-up|2|||
127903394|NCT03497897|460271934|FG000|Overall Study|Physician Decision|1|||
127903395|NCT03497897|460271935|FG001|Overall Study|Physician Decision|0|||
127903396|NCT03497897|460271936|FG002|Overall Study|Physician Decision|0|||
127903397|NCT03497897|460271934|FG000|Overall Study|Subject/Guardian Decision|2|||
127903398|NCT03497897|460271935|FG001|Overall Study|Subject/Guardian Decision|1|||
127903399|NCT03497897|460271936|FG002|Overall Study|Subject/Guardian Decision|3|||
127903400|NCT00358449|460271944|FG000|Overall Study|Adverse Event|1|||
127903401|NCT00358449|460271945|FG001|Overall Study|Adverse Event|0|||
127903402|NCT00358449|460271946|FG002|Overall Study|Adverse Event|1|||
127903403|NCT00358449|460271944|FG000|Overall Study|Lost to Follow-up|1|||
127848342|NCT00810043|460061413|FG000|Overall Study|Non-medical problem|0|||
127848343|NCT00810043|460061414|FG001|Overall Study|Non-medical problem|0|||
127848344|NCT00810043|460061415|FG002|Overall Study|Non-medical problem|1|||
127848345|NCT00810043|460061413|FG000|Overall Study|No longer met enrollment criteria|0|||
127848346|NCT00810043|460061414|FG001|Overall Study|No longer met enrollment criteria|0|||
127848347|NCT00810043|460061415|FG002|Overall Study|No longer met enrollment criteria|3|||
127848348|NCT01831804|460061423|FG000|Overall Study|Adverse Event|0|||
127848349|NCT01831804|460061424|FG001|Overall Study|Adverse Event|0|||
127848350|NCT01831804|460061425|FG002|Overall Study|Adverse Event|0|||
127848351|NCT01831804|460061426|FG003|Overall Study|Adverse Event|0|||
127848352|NCT01831804|460061427|FG004|Overall Study|Adverse Event|0|||
127848353|NCT01831804|460061428|FG005|Overall Study|Adverse Event|0|||
127848354|NCT01831804|460061429|FG006|Overall Study|Adverse Event|1|||
127848355|NCT01831804|460061430|FG007|Overall Study|Adverse Event|0|||
127848356|NCT01831804|460061431|FG008|Overall Study|Adverse Event|1|||
127848357|NCT01831804|460061423|FG000|Overall Study|Protocol Violation|0|||
127848358|NCT01831804|460061424|FG001|Overall Study|Protocol Violation|0|||
127848359|NCT01831804|460061425|FG002|Overall Study|Protocol Violation|2|||
127848360|NCT01831804|460061426|FG003|Overall Study|Protocol Violation|0|||
127848361|NCT01831804|460061427|FG004|Overall Study|Protocol Violation|0|||
127848362|NCT01831804|460061428|FG005|Overall Study|Protocol Violation|0|||
127848363|NCT01831804|460061429|FG006|Overall Study|Protocol Violation|0|||
127848364|NCT01831804|460061430|FG007|Overall Study|Protocol Violation|0|||
127848365|NCT01831804|460061431|FG008|Overall Study|Protocol Violation|0|||
127848366|NCT01831804|460061423|FG000|Overall Study|Protocol defined stopping criteria|1|||
127848367|NCT01831804|460061424|FG001|Overall Study|Protocol defined stopping criteria|1|||
127848368|NCT01831804|460061425|FG002|Overall Study|Protocol defined stopping criteria|3|||
127848369|NCT01831804|460061426|FG003|Overall Study|Protocol defined stopping criteria|0|||
127903404|NCT00358449|460271945|FG001|Overall Study|Lost to Follow-up|0|||
127903405|NCT00358449|460271946|FG002|Overall Study|Lost to Follow-up|0|||
127848370|NCT01831804|460061427|FG004|Overall Study|Protocol defined stopping criteria|1|||
127848371|NCT01831804|460061428|FG005|Overall Study|Protocol defined stopping criteria|0|||
127903406|NCT00358449|460271944|FG000|Overall Study|Withdrawal by Subject|2|||
127903407|NCT00358449|460271945|FG001|Overall Study|Withdrawal by Subject|0|||
127903408|NCT00358449|460271946|FG002|Overall Study|Withdrawal by Subject|0|||
127848372|NCT01831804|460061429|FG006|Overall Study|Protocol defined stopping criteria|0|||
127848373|NCT01831804|460061430|FG007|Overall Study|Protocol defined stopping criteria|0|||
127848374|NCT01831804|460061431|FG008|Overall Study|Protocol defined stopping criteria|0|||
127903409|NCT00358449|460271944|FG000|Overall Study|Lack of Efficacy|0|||
127903410|NCT00358449|460271945|FG001|Overall Study|Lack of Efficacy|1|||
127903411|NCT00358449|460271946|FG002|Overall Study|Lack of Efficacy|0|||
127903412|NCT00358449|460271944|FG000|Overall Study|Steriod Inhaler was Increased|0|||
127848375|NCT01831804|460061423|FG000|Overall Study|Lost to Follow-up|0|||
127848376|NCT01831804|460061424|FG001|Overall Study|Lost to Follow-up|0|||
127848377|NCT01831804|460061425|FG002|Overall Study|Lost to Follow-up|1|||
127848378|NCT01831804|460061426|FG003|Overall Study|Lost to Follow-up|0|||
127848379|NCT01831804|460061427|FG004|Overall Study|Lost to Follow-up|0|||
127848380|NCT01831804|460061428|FG005|Overall Study|Lost to Follow-up|0|||
127848381|NCT01831804|460061429|FG006|Overall Study|Lost to Follow-up|0|||
127848382|NCT01831804|460061430|FG007|Overall Study|Lost to Follow-up|0|||
127848383|NCT01831804|460061431|FG008|Overall Study|Lost to Follow-up|1|||
127848384|NCT01831804|460061423|FG000|Overall Study|Investigator discretion|0|||
127848385|NCT01831804|460061424|FG001|Overall Study|Investigator discretion|0|||
127848386|NCT01831804|460061425|FG002|Overall Study|Investigator discretion|0|||
127848387|NCT01831804|460061426|FG003|Overall Study|Investigator discretion|0|||
127848388|NCT01831804|460061427|FG004|Overall Study|Investigator discretion|1|||
127848389|NCT01831804|460061428|FG005|Overall Study|Investigator discretion|0|||
127848390|NCT01831804|460061429|FG006|Overall Study|Investigator discretion|0|||
127848391|NCT01831804|460061430|FG007|Overall Study|Investigator discretion|1|||
127848392|NCT01831804|460061431|FG008|Overall Study|Investigator discretion|0|||
127848393|NCT01831804|460061423|FG000|Overall Study|Withdrew Consent|0|||
127848394|NCT01831804|460061424|FG001|Overall Study|Withdrew Consent|1|||
127848395|NCT01831804|460061425|FG002|Overall Study|Withdrew Consent|0|||
127848396|NCT01831804|460061426|FG003|Overall Study|Withdrew Consent|0|||
127848397|NCT01831804|460061427|FG004|Overall Study|Withdrew Consent|0|||
127848398|NCT01831804|460061428|FG005|Overall Study|Withdrew Consent|0|||
127848399|NCT01831804|460061429|FG006|Overall Study|Withdrew Consent|0|||
127848400|NCT01831804|460061430|FG007|Overall Study|Withdrew Consent|2|||
127848401|NCT01831804|460061431|FG008|Overall Study|Withdrew Consent|0|||
127848402|NCT02920450|460061434|FG000|Overall Study|Death|1|||
127848403|NCT02920450|460061435|FG001|Overall Study|Death|0|||
127848404|NCT02920450|460061436|FG002|Overall Study|Death|0|||
127848405|NCT02920450|460061437|FG003|Overall Study|Death|0|||
127848406|NCT02920450|460061434|FG000|Overall Study|Withdrawal by Subject|1|||
127848407|NCT02920450|460061435|FG001|Overall Study|Withdrawal by Subject|0|||
127848408|NCT02920450|460061436|FG002|Overall Study|Withdrawal by Subject|0|||
127848409|NCT02920450|460061437|FG003|Overall Study|Withdrawal by Subject|0|||
127848410|NCT00968708|460061438|FG000|Overall Study|Adverse Event|169|||
127848411|NCT00968708|460061439|FG001|Overall Study|Adverse Event|150|||
127848412|NCT00968708|460061438|FG000|Overall Study|Major Protocol Deviation|0|||
127848413|NCT00968708|460061439|FG001|Overall Study|Major Protocol Deviation|1|||
127848414|NCT00968708|460061438|FG000|Overall Study|Lost to Follow-up|19|||
127848415|NCT00968708|460061439|FG001|Overall Study|Lost to Follow-up|11|||
127848416|NCT00968708|460061438|FG000|Overall Study|Voluntary Withdrawal|104|||
127848417|NCT00968708|460061439|FG001|Overall Study|Voluntary Withdrawal|101|||
127848418|NCT00968708|460061438|FG000|Overall Study|Investigator Discretion|0|||
127848419|NCT00968708|460061439|FG001|Overall Study|Investigator Discretion|1|||
127848420|NCT00968708|460061438|FG000|Overall Study|Other|26|||
127848421|NCT00968708|460061439|FG001|Overall Study|Other|34|||
127848422|NCT01732107|460061440|FG000|Overall Study|Adverse Event|2|||
127848423|NCT01732107|460061440|FG000|Overall Study|Disease Progression|8|||
127848424|NCT01732107|460061440|FG000|Overall Study|Physician Decision|1|||
127848425|NCT01732107|460061440|FG000|Overall Study|Withdrawal by Subject|2|||
127848426|NCT00615459|460061442|FG000|Period I|Adverse Event|2|||
127848427|NCT00615459|460061443|FG001|Period I|Adverse Event|0|||
127848428|NCT00615459|460061444|FG002|Period I|Adverse Event|1|||
127848429|NCT00615459|460061445|FG003|Period I|Adverse Event|0|||
127848430|NCT00615459|460061442|FG000|Period I|Subject withdrew consent|1|||
127848431|NCT00615459|460061443|FG001|Period I|Subject withdrew consent|0|||
127848432|NCT00615459|460061444|FG002|Period I|Subject withdrew consent|0|||
127848433|NCT00615459|460061445|FG003|Period I|Subject withdrew consent|1|||
127848434|NCT00615459|460061442|FG000|Period I|Abnormal test procedure results|1|||
127848435|NCT00615459|460061443|FG001|Period I|Abnormal test procedure results|1|||
127848436|NCT00615459|460061444|FG002|Period I|Abnormal test procedure results|1|||
127848437|NCT00615459|460061445|FG003|Period I|Abnormal test procedure results|0|||
127848438|NCT00615459|460061442|FG000|Period II|Adverse Event|1|||
127848439|NCT00615459|460061443|FG001|Period II|Adverse Event|0|||
127848440|NCT00615459|460061444|FG002|Period II|Adverse Event|0|||
127848441|NCT00615459|460061445|FG003|Period II|Adverse Event|0|||
127848442|NCT00615459|460061442|FG000|Period II|Lost to Follow-up|0|||
127848443|NCT00615459|460061443|FG001|Period II|Lost to Follow-up|0|||
127848444|NCT00615459|460061444|FG002|Period II|Lost to Follow-up|0|||
127848445|NCT00615459|460061445|FG003|Period II|Lost to Follow-up|1|||
127848446|NCT00615459|460061442|FG000|Period III|Adverse Event|0|||
127848447|NCT00615459|460061443|FG001|Period III|Adverse Event|1|||
127848448|NCT00615459|460061444|FG002|Period III|Adverse Event|0|||
127848449|NCT00615459|460061445|FG003|Period III|Adverse Event|0|||
127848450|NCT00615459|460061442|FG000|Period III|Administrative problems|0|||
127848451|NCT00615459|460061443|FG001|Period III|Administrative problems|1|||
127848452|NCT00615459|460061444|FG002|Period III|Administrative problems|1|||
127848453|NCT00615459|460061445|FG003|Period III|Administrative problems|0|||
127848454|NCT00615459|460061442|FG000|Period III|Unsatisfactory therapeutic effect|0|||
127848455|NCT00615459|460061443|FG001|Period III|Unsatisfactory therapeutic effect|1|||
127848456|NCT00615459|460061444|FG002|Period III|Unsatisfactory therapeutic effect|0|||
127848457|NCT00615459|460061445|FG003|Period III|Unsatisfactory therapeutic effect|0|||
127848458|NCT01975675|460061450|FG000|Overall Study|Death|0|||
127848459|NCT01975675|460061451|FG001|Overall Study|Death|1|||
127848460|NCT01975675|460061452|FG002|Overall Study|Death|0|||
127848461|NCT01975675|460061453|FG003|Overall Study|Death|0|||
127848462|NCT00224003|460061454|FG000|Overall Study|Adverse Event|1|||
127848463|NCT00224003|460061454|FG000|Overall Study|Protocol Violation|2|||
127848464|NCT00224003|460061454|FG000|Overall Study|Withdrawal by Subject|1|||
127848465|NCT00224003|460061454|FG000|Overall Study|unk|3|||
127848466|NCT01202760|460061457|FG000|Overall Study|Entry Criteria Not Met|0|||
127848467|NCT01202760|460061458|FG001|Overall Study|Entry Criteria Not Met|3|||
127848468|NCT01202760|460061459|FG002|Overall Study|Entry Criteria Not Met|1|||
127848469|NCT01202760|460061457|FG000|Overall Study|Adverse Event|11|||
127848470|NCT01202760|460061458|FG001|Overall Study|Adverse Event|9|||
127848471|NCT01202760|460061459|FG002|Overall Study|Adverse Event|10|||
127848472|NCT01202760|460061457|FG000|Overall Study|Death|2|||
127848473|NCT01202760|460061458|FG001|Overall Study|Death|1|||
127848474|NCT01202760|460061459|FG002|Overall Study|Death|0|||
127848475|NCT01202760|460061457|FG000|Overall Study|Lack of Efficacy|6|||
127848476|NCT01202760|460061458|FG001|Overall Study|Lack of Efficacy|8|||
127848477|NCT01202760|460061459|FG002|Overall Study|Lack of Efficacy|7|||
127848478|NCT01202760|460061457|FG000|Overall Study|Lost to Follow-up|0|||
127848479|NCT01202760|460061458|FG001|Overall Study|Lost to Follow-up|2|||
127848480|NCT01202760|460061459|FG002|Overall Study|Lost to Follow-up|1|||
127848481|NCT01202760|460061457|FG000|Overall Study|Parent / Caregiver Decision|0|||
127848482|NCT01202760|460061458|FG001|Overall Study|Parent / Caregiver Decision|1|||
127848483|NCT01202760|460061459|FG002|Overall Study|Parent / Caregiver Decision|0|||
127848484|NCT01202760|460061457|FG000|Overall Study|Withdrawal by Subject|17|||
127848485|NCT01202760|460061458|FG001|Overall Study|Withdrawal by Subject|18|||
127848486|NCT01202760|460061459|FG002|Overall Study|Withdrawal by Subject|14|||
127848487|NCT01202760|460061457|FG000|Overall Study|Physician Decision|0|||
127848488|NCT01202760|460061458|FG001|Overall Study|Physician Decision|1|||
127848489|NCT01202760|460061459|FG002|Overall Study|Physician Decision|0|||
127848490|NCT01202760|460061457|FG000|Overall Study|Protocol Violation|7|||
127848491|NCT01202760|460061458|FG001|Overall Study|Protocol Violation|5|||
127848492|NCT01202760|460061459|FG002|Overall Study|Protocol Violation|2|||
127848493|NCT01202760|460061457|FG000|Overall Study|Sponsor Decision|4|||
127848494|NCT01202760|460061458|FG001|Overall Study|Sponsor Decision|4|||
127848495|NCT01202760|460061459|FG002|Overall Study|Sponsor Decision|0|||
127848496|NCT00871572|460061460|FG000|Overall Study|Adverse Event|0|||
127848497|NCT00871572|460061461|FG001|Overall Study|Adverse Event|2|||
127848498|NCT00871572|460061462|FG002|Overall Study|Adverse Event|0|||
127848499|NCT00871572|460061463|FG003|Overall Study|Adverse Event|3|||
127848500|NCT00871572|460061460|FG000|Overall Study|Investigator Decision|0|||
127848501|NCT00871572|460061461|FG001|Overall Study|Investigator Decision|1|||
127848502|NCT00871572|460061462|FG002|Overall Study|Investigator Decision|0|||
127848503|NCT00871572|460061463|FG003|Overall Study|Investigator Decision|1|||
127848504|NCT00871572|460061460|FG000|Overall Study|Lost to Follow-up|0|||
127848505|NCT00871572|460061461|FG001|Overall Study|Lost to Follow-up|1|||
127848506|NCT00871572|460061462|FG002|Overall Study|Lost to Follow-up|0|||
127848507|NCT00871572|460061463|FG003|Overall Study|Lost to Follow-up|1|||
127848508|NCT00871572|460061460|FG000|Overall Study|Protocol Violation|0|||
127848509|NCT00871572|460061461|FG001|Overall Study|Protocol Violation|0|||
127848510|NCT00871572|460061462|FG002|Overall Study|Protocol Violation|1|||
127848511|NCT00871572|460061463|FG003|Overall Study|Protocol Violation|1|||
127848512|NCT00871572|460061460|FG000|Overall Study|Sponsor Decision|1|||
127848513|NCT00871572|460061461|FG001|Overall Study|Sponsor Decision|0|||
127848514|NCT00871572|460061462|FG002|Overall Study|Sponsor Decision|0|||
127848515|NCT00871572|460061463|FG003|Overall Study|Sponsor Decision|0|||
127848516|NCT00871572|460061460|FG000|Overall Study|Withdrawal by Subject|1|||
127848517|NCT00871572|460061461|FG001|Overall Study|Withdrawal by Subject|2|||
127848518|NCT00871572|460061462|FG002|Overall Study|Withdrawal by Subject|3|||
127848519|NCT00871572|460061463|FG003|Overall Study|Withdrawal by Subject|1|||
127848520|NCT04354155|460061466|FG000|Overall Study|Withdrawal by Subject|1|||
127848521|NCT04354155|460061466|FG000|Overall Study|Did not meet criteria for study intervention|1|||
127848522|NCT00187889|460061467|FG000|Overall Study|Withdrawal by Subject|6|||
127848523|NCT00187889|460061468|FG001|Overall Study|Withdrawal by Subject|4|||
127848524|NCT03097029|460061473|FG000|Overall Study|Withdrawal by Subject|1|||
127848525|NCT00709124|460061475|FG000|Overall Study|Death|3|||
127848526|NCT00709124|460061476|FG001|Overall Study|Death|1|||
127848527|NCT00709124|460061475|FG000|Overall Study|encephalopathy; can't do assessment|1|||
127848528|NCT00709124|460061476|FG001|Overall Study|encephalopathy; can't do assessment|0|||
127848529|NCT00373490|460061477|FG000|Overall Study|Adverse Event|0|||
127848530|NCT00373490|460061478|FG001|Overall Study|Adverse Event|1|||
127848531|NCT00373490|460061477|FG000|Overall Study|Lack of Efficacy|9|||
127848532|NCT00373490|460061478|FG001|Overall Study|Lack of Efficacy|4|||
127848533|NCT00373490|460061477|FG000|Overall Study|Withdrawal by Subject|0|||
127903413|NCT00358449|460271945|FG001|Overall Study|Steriod Inhaler was Increased|0|||
127903414|NCT00358449|460271946|FG002|Overall Study|Steriod Inhaler was Increased|1|||
127903415|NCT01367457|460271947|FG000|Overall Study|Death|2|||
127903416|NCT01367457|460271948|FG001|Overall Study|Death|0|||
127903417|NCT01367457|460271949|FG002|Overall Study|Death|0|||
127903418|NCT01367457|460271947|FG000|Overall Study|Investigator's decision|2|||
127903419|NCT01367457|460271948|FG001|Overall Study|Investigator's decision|0|||
127903420|NCT01367457|460271949|FG002|Overall Study|Investigator's decision|0|||
127903421|NCT01367457|460271947|FG000|Overall Study|Clinical decline (CD)|2|||
127903422|NCT01367457|460271948|FG001|Overall Study|Clinical decline (CD)|0|||
127903423|NCT01367457|460271949|FG002|Overall Study|Clinical decline (CD)|0|||
127903424|NCT01367457|460271947|FG000|Overall Study|Progression and death|8|||
127903425|NCT01367457|460271948|FG001|Overall Study|Progression and death|0|||
127903426|NCT01367457|460271949|FG002|Overall Study|Progression and death|0|||
127903427|NCT01367457|460271947|FG000|Overall Study|Toxicity|16|||
127903428|NCT01367457|460271948|FG001|Overall Study|Toxicity|0|||
127903429|NCT01367457|460271949|FG002|Overall Study|Toxicity|0|||
127903430|NCT01367457|460271947|FG000|Overall Study|Progression|137|||
127903431|NCT01367457|460271948|FG001|Overall Study|Progression|0|||
127903432|NCT01367457|460271949|FG002|Overall Study|Progression|0|||
127903433|NCT01367457|460271947|FG000|Overall Study|Patient asks for rest + slow progression|1|||
127903434|NCT01367457|460271948|FG001|Overall Study|Patient asks for rest + slow progression|0|||
127903435|NCT01367457|460271949|FG002|Overall Study|Patient asks for rest + slow progression|0|||
127903436|NCT01367457|460271947|FG000|Overall Study|Investigator's opinion, stable disease|1|||
127903437|NCT01367457|460271948|FG001|Overall Study|Investigator's opinion, stable disease|0|||
127903438|NCT01367457|460271949|FG002|Overall Study|Investigator's opinion, stable disease|0|||
127903439|NCT01367457|460271947|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
127903440|NCT01367457|460271948|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
127903441|NCT01367457|460271949|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
127903442|NCT01367457|460271947|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
127903443|NCT01367457|460271948|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
127903444|NCT01367457|460271949|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
127903445|NCT01367457|460271947|FG000|Overall Study|low grade toxicities + stable disease|1|||
127903446|NCT01367457|460271948|FG001|Overall Study|low grade toxicities + stable disease|0|||
127903447|NCT01367457|460271949|FG002|Overall Study|low grade toxicities + stable disease|0|||
127903448|NCT01367457|460271947|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
127903449|NCT01367457|460271948|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
127903450|NCT01367457|460271949|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
127903451|NCT01367457|460271947|FG000|Overall Study|Withdrawal by Subject|1|||
127903452|NCT01367457|460271948|FG001|Overall Study|Withdrawal by Subject|0|||
127903453|NCT01367457|460271949|FG002|Overall Study|Withdrawal by Subject|0|||
127903454|NCT01367457|460271947|FG000|Overall Study|CD, associated leukaemia|1|||
127903455|NCT01367457|460271948|FG001|Overall Study|CD, associated leukaemia|0|||
127903456|NCT01367457|460271949|FG002|Overall Study|CD, associated leukaemia|0|||
127903457|NCT01367457|460271947|FG000|Overall Study|Uncontrolled pain|1|||
127903458|NCT01367457|460271948|FG001|Overall Study|Uncontrolled pain|0|||
127903459|NCT01367457|460271949|FG002|Overall Study|Uncontrolled pain|0|||
127903460|NCT01367457|460271947|FG000|Overall Study|Overall status worsens to grade 4|1|||
127903461|NCT01367457|460271948|FG001|Overall Study|Overall status worsens to grade 4|0|||
127903462|NCT01367457|460271949|FG002|Overall Study|Overall status worsens to grade 4|0|||
127903463|NCT01367457|460271947|FG000|Overall Study|Stabilisation + frequent infections|1|||
127903464|NCT01367457|460271948|FG001|Overall Study|Stabilisation + frequent infections|0|||
127903465|NCT01367457|460271949|FG002|Overall Study|Stabilisation + frequent infections|0|||
127903466|NCT01367457|460271947|FG000|Overall Study|No clinical benefit|1|||
127903467|NCT01367457|460271948|FG001|Overall Study|No clinical benefit|0|||
127903468|NCT01367457|460271949|FG002|Overall Study|No clinical benefit|0|||
127903469|NCT01367457|460271947|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
127903470|NCT01367457|460271948|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
127903471|NCT01367457|460271949|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
127903472|NCT01367457|460271947|FG000|Overall Study|Overall decline|1|||
127903473|NCT01367457|460271948|FG001|Overall Study|Overall decline|0|||
127903474|NCT01367457|460271949|FG002|Overall Study|Overall decline|0|||
127903475|NCT01367457|460271947|FG000|Overall Study|Rejection of treatment|1|||
127903476|NCT01367457|460271948|FG001|Overall Study|Rejection of treatment|0|||
127903477|NCT01367457|460271949|FG002|Overall Study|Rejection of treatment|0|||
127903478|NCT01367457|460271947|FG000|Overall Study|Lost to Follow-up|1|||
127903479|NCT01367457|460271948|FG001|Overall Study|Lost to Follow-up|0|||
127903480|NCT01367457|460271949|FG002|Overall Study|Lost to Follow-up|0|||
127903481|NCT01367457|460271947|FG000|Overall Study|Death from septic shock|1|||
127903482|NCT01367457|460271948|FG001|Overall Study|Death from septic shock|0|||
127903483|NCT01367457|460271949|FG002|Overall Study|Death from septic shock|0|||
127903484|NCT01367457|460271947|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
127903485|NCT01367457|460271948|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
127903486|NCT01367457|460271949|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
127903487|NCT01367457|460271947|FG000|Overall Study|Patient's Wish|1|||
127903488|NCT01367457|460271948|FG001|Overall Study|Patient's Wish|0|||
127903489|NCT01367457|460271949|FG002|Overall Study|Patient's Wish|0|||
127903490|NCT01367457|460271947|FG000|Overall Study|Palliative. Overall decline|1|||
127903491|NCT01367457|460271948|FG001|Overall Study|Palliative. Overall decline|0|||
127903492|NCT01367457|460271949|FG002|Overall Study|Palliative. Overall decline|0|||
127903493|NCT01367457|460271947|FG000|Overall Study|Suspected DP/suspected active infection|1|||
127903494|NCT01367457|460271948|FG001|Overall Study|Suspected DP/suspected active infection|0|||
127903495|NCT01367457|460271949|FG002|Overall Study|Suspected DP/suspected active infection|0|||
127903496|NCT01038856|460271957|FG000|Overall Study|Adverse Event|2|||
127903497|NCT01391793|460271960|FG000|Overall Study|Ineligible|3|||
127903498|NCT01391793|460271961|FG001|Overall Study|Ineligible|0|||
127903499|NCT01391793|460271960|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
127903500|NCT01391793|460271961|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
127903501|NCT01391793|460271960|FG000|Overall Study|No DMSA|73|||
127903502|NCT01391793|460271961|FG001|Overall Study|No DMSA|57|||
127903503|NCT01666730|460271963|FG000|Overall Study|Adverse Event|16|||
127903504|NCT01666730|460271963|FG000|Overall Study|Death|2|||
127903505|NCT01666730|460271963|FG000|Overall Study|Physician Decision|5|||
127903506|NCT01666730|460271963|FG000|Overall Study|Withdrawal by Subject|9|||
127903507|NCT01666730|460271963|FG000|Overall Study|Disease progression/relapse|18|||
127903508|NCT02087904|460271966|FG000|Overall Study|Did Not Receive Study Drug|0|||
127903509|NCT02087904|460271967|FG001|Overall Study|Did Not Receive Study Drug|0|||
127903510|NCT02087904|460271968|FG002|Overall Study|Did Not Receive Study Drug|2|||
127903511|NCT02087904|460271969|FG003|Overall Study|Did Not Receive Study Drug|1|||
127903512|NCT02087904|460271966|FG000|Overall Study|Adverse Event|8|||
127903513|NCT02087904|460271967|FG001|Overall Study|Adverse Event|4|||
127903514|NCT02087904|460271968|FG002|Overall Study|Adverse Event|4|||
127903515|NCT02087904|460271969|FG003|Overall Study|Adverse Event|12|||
127903516|NCT02087904|460271966|FG000|Overall Study|Lack of Efficacy|3|||
127903517|NCT02087904|460271967|FG001|Overall Study|Lack of Efficacy|6|||
127903518|NCT02087904|460271968|FG002|Overall Study|Lack of Efficacy|3|||
127903519|NCT02087904|460271969|FG003|Overall Study|Lack of Efficacy|2|||
127903520|NCT02087904|460271966|FG000|Overall Study|Other|6|||
127903521|NCT02087904|460271967|FG001|Overall Study|Other|2|||
127903522|NCT02087904|460271968|FG002|Overall Study|Other|4|||
127903523|NCT02087904|460271969|FG003|Overall Study|Other|4|||
127903524|NCT02087904|460271966|FG000|Overall Study|Withdrawal by Subject|8|||
127903525|NCT02087904|460271967|FG001|Overall Study|Withdrawal by Subject|3|||
127903526|NCT02087904|460271968|FG002|Overall Study|Withdrawal by Subject|7|||
127903527|NCT02087904|460271969|FG003|Overall Study|Withdrawal by Subject|4|||
127903528|NCT02087904|460271966|FG000|Overall Study|Lost to Follow-up|0|||
127903529|NCT02087904|460271967|FG001|Overall Study|Lost to Follow-up|4|||
127903530|NCT02087904|460271968|FG002|Overall Study|Lost to Follow-up|2|||
127903531|NCT02087904|460271969|FG003|Overall Study|Lost to Follow-up|2|||
127903532|NCT03025880|460271971|FG000|Overall Study|Adverse Event|1|||
127903533|NCT03025880|460271972|FG001|Overall Study|Adverse Event|0|||
127903534|NCT03025880|460271971|FG000|Overall Study|Death|1|||
127903535|NCT03025880|460271972|FG001|Overall Study|Death|1|||
127903536|NCT03025880|460271971|FG000|Overall Study|Withdrawal by Subject|0|||
127903537|NCT03025880|460271972|FG001|Overall Study|Withdrawal by Subject|1|||
127903538|NCT03025880|460271971|FG000|Overall Study|Physician Decision|0|||
127903539|NCT03025880|460271972|FG001|Overall Study|Physician Decision|1|||
127903540|NCT03025880|460271971|FG000|Overall Study|Progressive Disease|12|||
127903541|NCT03025880|460271972|FG001|Overall Study|Progressive Disease|19|||
127903542|NCT00893464|460271973|FG000|Overall Study|Did not complete therapy/experience PD|0|||
127903543|NCT00893464|460271974|FG001|Overall Study|Did not complete therapy/experience PD|0|||
127903544|NCT00893464|460271975|FG002|Overall Study|Did not complete therapy/experience PD|0|||
127903545|NCT00893464|460271976|FG003|Overall Study|Did not complete therapy/experience PD|0|||
127903546|NCT00893464|460271977|FG004|Overall Study|Did not complete therapy/experience PD|0|||
127903547|NCT00893464|460271978|FG005|Overall Study|Did not complete therapy/experience PD|0|||
127903548|NCT00893464|460271979|FG006|Overall Study|Did not complete therapy/experience PD|2|||
127903549|NCT00893464|460271980|FG007|Overall Study|Did not complete therapy/experience PD|2|||
127903550|NCT01389102|460271981|FG000|Overall Study|Adverse Event|1|||
127903551|NCT01389102|460271982|FG001|Overall Study|Adverse Event|3|||
127903552|NCT01389102|460271983|FG002|Overall Study|Adverse Event|2|||
127903553|NCT01389102|460271984|FG003|Overall Study|Adverse Event|2|||
127903554|NCT01389102|460271985|FG004|Overall Study|Adverse Event|2|||
127903555|NCT01389102|460271986|FG005|Overall Study|Adverse Event|2|||
127903556|NCT01389102|460271981|FG000|Overall Study|Hurricane Katrina|4|||
127903557|NCT01389102|460271982|FG001|Overall Study|Hurricane Katrina|2|||
127903558|NCT01389102|460271983|FG002|Overall Study|Hurricane Katrina|3|||
127903559|NCT01389102|460271984|FG003|Overall Study|Hurricane Katrina|0|||
127903560|NCT01389102|460271985|FG004|Overall Study|Hurricane Katrina|3|||
127903561|NCT01389102|460271986|FG005|Overall Study|Hurricane Katrina|1|||
127903562|NCT01389102|460271981|FG000|Overall Study|Lost to Follow-up|4|||
127903563|NCT01389102|460271982|FG001|Overall Study|Lost to Follow-up|1|||
127903564|NCT01389102|460271983|FG002|Overall Study|Lost to Follow-up|1|||
127903565|NCT01389102|460271984|FG003|Overall Study|Lost to Follow-up|2|||
127903566|NCT01389102|460271985|FG004|Overall Study|Lost to Follow-up|4|||
127903567|NCT01389102|460271986|FG005|Overall Study|Lost to Follow-up|1|||
127903568|NCT01389102|460271981|FG000|Overall Study|Protocol Violation|0|||
127903569|NCT01389102|460271982|FG001|Overall Study|Protocol Violation|0|||
127903570|NCT01389102|460271983|FG002|Overall Study|Protocol Violation|3|||
127903571|NCT01389102|460271984|FG003|Overall Study|Protocol Violation|0|||
127903572|NCT01389102|460271985|FG004|Overall Study|Protocol Violation|1|||
127903573|NCT01389102|460271986|FG005|Overall Study|Protocol Violation|1|||
127903574|NCT01389102|460271981|FG000|Overall Study|Withdrawal by Subject|7|||
127903575|NCT01389102|460271982|FG001|Overall Study|Withdrawal by Subject|4|||
127903576|NCT01389102|460271983|FG002|Overall Study|Withdrawal by Subject|9|||
127903577|NCT01389102|460271984|FG003|Overall Study|Withdrawal by Subject|2|||
127903578|NCT01389102|460271985|FG004|Overall Study|Withdrawal by Subject|3|||
127903579|NCT01389102|460271986|FG005|Overall Study|Withdrawal by Subject|3|||
127903580|NCT01389102|460271981|FG000|Overall Study|Subject Traveling Out of Country|0|||
127903581|NCT01389102|460271982|FG001|Overall Study|Subject Traveling Out of Country|0|||
127903582|NCT01389102|460271983|FG002|Overall Study|Subject Traveling Out of Country|0|||
127903583|NCT01389102|460271984|FG003|Overall Study|Subject Traveling Out of Country|1|||
127903584|NCT01389102|460271985|FG004|Overall Study|Subject Traveling Out of Country|0|||
127903585|NCT01389102|460271986|FG005|Overall Study|Subject Traveling Out of Country|0|||
127903586|NCT01389102|460271981|FG000|Overall Study|Subject Moved|2|||
127903587|NCT01389102|460271982|FG001|Overall Study|Subject Moved|0|||
127903588|NCT01389102|460271983|FG002|Overall Study|Subject Moved|1|||
127903589|NCT01389102|460271984|FG003|Overall Study|Subject Moved|0|||
127903590|NCT01389102|460271985|FG004|Overall Study|Subject Moved|0|||
127903591|NCT01389102|460271986|FG005|Overall Study|Subject Moved|0|||
127903592|NCT01389102|460271981|FG000|Overall Study|Unavailable due to husband's illness|0|||
127903593|NCT01389102|460271982|FG001|Overall Study|Unavailable due to husband's illness|1|||
127903594|NCT01389102|460271983|FG002|Overall Study|Unavailable due to husband's illness|0|||
127903595|NCT01389102|460271984|FG003|Overall Study|Unavailable due to husband's illness|0|||
127903596|NCT01389102|460271985|FG004|Overall Study|Unavailable due to husband's illness|0|||
127903597|NCT01389102|460271986|FG005|Overall Study|Unavailable due to husband's illness|0|||
127903598|NCT01389102|460271981|FG000|Overall Study|Investigator Judgement|0|||
127903599|NCT01389102|460271982|FG001|Overall Study|Investigator Judgement|1|||
127903600|NCT01389102|460271983|FG002|Overall Study|Investigator Judgement|0|||
127903601|NCT01389102|460271984|FG003|Overall Study|Investigator Judgement|0|||
127903602|NCT01389102|460271985|FG004|Overall Study|Investigator Judgement|0|||
127903603|NCT01389102|460271986|FG005|Overall Study|Investigator Judgement|0|||
127848534|NCT00373490|460061478|FG001|Overall Study|Withdrawal by Subject|1|||
127848535|NCT00108953|460061485|FG000|Follow-up|Death|18|||
127848536|NCT00108953|460061486|FG001|Follow-up|Death|26|||
127848537|NCT00108953|460061485|FG000|Follow-up|Lost to Follow-up|1|||
127848538|NCT00108953|460061486|FG001|Follow-up|Lost to Follow-up|1|||
127848539|NCT00108953|460061485|FG000|Follow-up|Study terminated by sponsor|10|||
127848540|NCT00108953|460061486|FG001|Follow-up|Study terminated by sponsor|6|||
127848541|NCT02999100|460061492|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
127848542|NCT02999100|460061493|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
127848543|NCT02999100|460061494|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
127848544|NCT02999100|460061495|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
127848545|NCT02999100|460061496|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
127848546|NCT02999100|460061497|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
127848547|NCT02999100|460061492|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
127848548|NCT02999100|460061493|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
127848549|NCT02999100|460061494|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
127848550|NCT02999100|460061495|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
127848551|NCT02999100|460061496|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
127848552|NCT02999100|460061497|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
127848553|NCT02999100|460061492|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
127848554|NCT02999100|460061493|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
127848555|NCT02999100|460061494|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
127848556|NCT02999100|460061495|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
127848557|NCT02999100|460061496|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
127848558|NCT02999100|460061497|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
127848559|NCT01125293|460061501|FG000|Overall Study|Disease Progression|1|||
127848560|NCT01125293|460061502|FG001|Overall Study|Disease Progression|3|||
127848561|NCT01125293|460061503|FG002|Overall Study|Disease Progression|4|||
127848562|NCT01125293|460061504|FG003|Overall Study|Disease Progression|3|||
127848563|NCT01125293|460061505|FG004|Overall Study|Disease Progression|5|||
127848564|NCT01125293|460061506|FG005|Overall Study|Disease Progression|12|||
127903604|NCT02910037|460271987|FG000|Overall Study|Withdrawal by Subject|4|||
127903605|NCT02910037|460271987|FG000|Overall Study|Lost to Follow-up|6|||
127903606|NCT00436553|460271988|FG000|Overall Study|Adverse Event|4|||
127903607|NCT00436553|460271989|FG001|Overall Study|Adverse Event|3|||
127903608|NCT00436553|460271990|FG002|Overall Study|Adverse Event|4|||
127903609|NCT00436553|460271988|FG000|Overall Study|Death|3|||
127903610|NCT00436553|460271989|FG001|Overall Study|Death|1|||
127903611|NCT00436553|460271990|FG002|Overall Study|Death|3|||
127903612|NCT00436553|460271988|FG000|Overall Study|Lost to Follow-up|0|||
127903613|NCT00436553|460271989|FG001|Overall Study|Lost to Follow-up|2|||
127903614|NCT00436553|460271990|FG002|Overall Study|Lost to Follow-up|0|||
127903615|NCT00436553|460271988|FG000|Overall Study|Protocol Violation|1|||
127903616|NCT00436553|460271989|FG001|Overall Study|Protocol Violation|0|||
127903617|NCT00436553|460271990|FG002|Overall Study|Protocol Violation|0|||
127903618|NCT00436553|460271988|FG000|Overall Study|Withdrawal by Subject|5|||
127903619|NCT00436553|460271989|FG001|Overall Study|Withdrawal by Subject|6|||
127903620|NCT00436553|460271990|FG002|Overall Study|Withdrawal by Subject|3|||
127903621|NCT01035060|460271995|FG000|Overall Study|Lost to Follow-up|0|||
127903622|NCT01035060|460271996|FG001|Overall Study|Lost to Follow-up|7|||
127903623|NCT01035060|460271995|FG000|Overall Study|Did not quality after 2nd screening|14|||
127903624|NCT01035060|460271996|FG001|Overall Study|Did not quality after 2nd screening|1|||
127903625|NCT01035060|460271995|FG000|Overall Study|Withdrawal by Subject|8|||
127903626|NCT01035060|460271996|FG001|Overall Study|Withdrawal by Subject|6|||
127903627|NCT01035060|460271995|FG000|Overall Study|Physician Decision|2|||
127903628|NCT01035060|460271996|FG001|Overall Study|Physician Decision|0|||
127903629|NCT02193880|460272000|FG000|Overall Study|patients did not collect enough HPC|3|||
127903630|NCT03136380|460272001|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
127903631|NCT03136380|460272002|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
127903632|NCT03136380|460272003|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
127903633|NCT03136380|460272004|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
127903634|NCT03136380|460272005|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
127903635|NCT01661686|460272009|FG000|Overall Study|Lost to Follow-up|2|||
127903636|NCT01661686|460272010|FG001|Overall Study|Lost to Follow-up|1|||
127903637|NCT01661686|460272009|FG000|Overall Study|did not receive allocated intervention|0|||
127903638|NCT01661686|460272010|FG001|Overall Study|did not receive allocated intervention|1|||
127903639|NCT00553280|460272014|FG000|Overall Study|Adverse Event|19|||
127903640|NCT00553280|460272014|FG000|Overall Study|Lack of Efficacy|3|||
127903641|NCT00553280|460272014|FG000|Overall Study|Withdrawal by Subject|3|||
127903642|NCT00553280|460272014|FG000|Overall Study|Physician Decision|1|||
127903643|NCT02794974|460272015|FG000|Overall Study|Physician Decision|0|||
127903644|NCT02794974|460272016|FG001|Overall Study|Physician Decision|1|||
127903645|NCT02202850|460272017|FG000|Overall Study|Other|2|||
127903646|NCT02202850|460272018|FG001|Overall Study|Other|2|||
127903647|NCT02202850|460272017|FG000|Overall Study|Enbrel treatment discontinued|15|||
127903648|NCT02202850|460272018|FG001|Overall Study|Enbrel treatment discontinued|3|||
127903649|NCT02202850|460272017|FG000|Overall Study|Lost to Follow-up|7|||
127903650|NCT02202850|460272018|FG001|Overall Study|Lost to Follow-up|1|||
127903651|NCT01873586|460272019|FG000|Overall Study|Lost to Follow-up|3|||
127903652|NCT02996682|460272020|FG000|Overall Study|Death|0|||
127903653|NCT02996682|460272021|FG001|Overall Study|Death|3|||
127903654|NCT01536405|460272026|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
127903655|NCT01536405|460272027|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
127903656|NCT01536405|460272026|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
127903657|NCT01536405|460272027|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
127903658|NCT01536405|460272026|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
127903659|NCT01536405|460272027|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
127903660|NCT01536405|460272026|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
127903661|NCT01536405|460272027|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
127903662|NCT01536405|460272026|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
127903663|NCT01536405|460272027|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
127903664|NCT01536405|460272026|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
127903665|NCT01536405|460272027|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
127903666|NCT01536405|460272026|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
127903667|NCT01536405|460272027|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
127903668|NCT01536405|460272026|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
127903669|NCT01536405|460272027|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
127903670|NCT01536405|460272026|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
127903671|NCT01536405|460272027|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
127903672|NCT01536405|460272026|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
127903673|NCT01536405|460272027|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
127903674|NCT01536405|460272026|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
127903675|NCT01536405|460272027|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
127903676|NCT01536405|460272026|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
127903677|NCT01536405|460272027|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
127903678|NCT01536405|460272026|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
127903679|NCT01536405|460272027|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
127903680|NCT00450190|460272028|FG000|Overall Study|Withdrawal by Subject|2|||
127903681|NCT01536574|460272029|FG000|Overall Study|Adverse Event|4|||
127903682|NCT01536574|460272030|FG001|Overall Study|Adverse Event|5|||
127903683|NCT01536574|460272029|FG000|Overall Study|Withdrawal by Subject|1|||
127903684|NCT01536574|460272030|FG001|Overall Study|Withdrawal by Subject|2|||
127903685|NCT01536574|460272029|FG000|Overall Study|Lack of Efficacy|1|||
127903686|NCT01536574|460272030|FG001|Overall Study|Lack of Efficacy|0|||
127903687|NCT02193165|460272033|FG000|4 Week Product Use|Lost to Follow-up|1|||
127903688|NCT02193165|460272034|FG001|4 Week Product Use|Lost to Follow-up|1|||
127903689|NCT02193165|460272035|FG002|4 Week Product Use|Lost to Follow-up|1|||
127903690|NCT02193165|460272033|FG000|6 Week Product Use|Lost to Follow-up|0|||
127903691|NCT02193165|460272034|FG001|6 Week Product Use|Lost to Follow-up|1|||
127903692|NCT02193165|460272035|FG002|6 Week Product Use|Lost to Follow-up|0|||
127903693|NCT01498120|460272036|FG000|Overall Study|Lost to Follow-up|1|||
127903694|NCT01498120|460272036|FG000|Overall Study|Withdrawal by Subject|5|||
127903695|NCT01498120|460272036|FG000|Overall Study|AE, non-serious non-fatal|3|||
127903696|NCT01498120|460272036|FG000|Overall Study|Other|4|||
127903697|NCT01171963|460272037|FG000|Overall Study|Adverse Event|10|||
127903698|NCT01171963|460272038|FG001|Overall Study|Adverse Event|15|||
127903699|NCT01171963|460272037|FG000|Overall Study|Lost to Follow-up|23|||
127903700|NCT01171963|460272038|FG001|Overall Study|Lost to Follow-up|24|||
127903701|NCT01171963|460272037|FG000|Overall Study|Other - diarrhoea|1|||
127903702|NCT01171963|460272038|FG001|Overall Study|Other - diarrhoea|0|||
127903703|NCT01171963|460272037|FG000|Overall Study|Withdrawal by Subject|114|||
127903704|NCT01171963|460272038|FG001|Overall Study|Withdrawal by Subject|129|||
127903705|NCT01223365|460272039|FG000|Open-label Titration Period|Enrolled but not treated|1|||
127903706|NCT01223365|460272039|FG000|Open-label Titration Period|Adverse Event|23|||
127903707|NCT01223365|460272039|FG000|Open-label Titration Period|Lack of Efficacy|3|||
127903708|NCT01223365|460272039|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
127903709|NCT01223365|460272039|FG000|Open-label Titration Period|Protocol Violation|1|||
127903710|NCT01223365|460272039|FG000|Open-label Titration Period|Lost to Follow-up|2|||
127903711|NCT01223365|460272039|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
127903712|NCT01223365|460272039|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
127903713|NCT01223365|460272039|FG000|Open-label Titration Period|Starting physical therapy|1|||
127903714|NCT01223365|460272039|FG000|Open-label Treatment Period|Adverse Event|39|||
127903715|NCT01223365|460272039|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
127903716|NCT01223365|460272039|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
127903717|NCT01223365|460272039|FG000|Open-label Treatment Period|Protocol Violation|15|||
127903718|NCT01223365|460272039|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
127903719|NCT01223365|460272039|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
127903720|NCT01223365|460272039|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
127903721|NCT01223365|460272039|FG000|Open-label Treatment Period|Moved out of area|2|||
127903722|NCT01223365|460272039|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
127903723|NCT01223365|460272039|FG000|Open-label Treatment Period|"Out of window"|1|||
127903724|NCT01223365|460272039|FG000|Open-label Treatment Period|Starting physical therapy|1|||
127903725|NCT01223365|460272039|FG000|Open-label Treatment Period|Physician Decision|2|||
127903726|NCT03567174|460272040|FG000|Overall Study|Death|24|||
127903727|NCT03567174|460272041|FG001|Overall Study|Death|31|||
127903728|NCT03567174|460272040|FG000|Overall Study|Lost to Follow-up|165|||
127848565|NCT01125293|460061501|FG000|Overall Study|Adverse Event|1|||
127848566|NCT01125293|460061502|FG001|Overall Study|Adverse Event|0|||
127848567|NCT01125293|460061503|FG002|Overall Study|Adverse Event|0|||
127848568|NCT01125293|460061504|FG003|Overall Study|Adverse Event|0|||
127848569|NCT01125293|460061505|FG004|Overall Study|Adverse Event|2|||
127848570|NCT01125293|460061506|FG005|Overall Study|Adverse Event|8|||
127848571|NCT01125293|460061501|FG000|Overall Study|Symptomatic Deterioration|1|||
127848572|NCT01125293|460061502|FG001|Overall Study|Symptomatic Deterioration|0|||
127848573|NCT01125293|460061503|FG002|Overall Study|Symptomatic Deterioration|0|||
127848574|NCT01125293|460061504|FG003|Overall Study|Symptomatic Deterioration|0|||
127848575|NCT01125293|460061505|FG004|Overall Study|Symptomatic Deterioration|0|||
127848576|NCT01125293|460061506|FG005|Overall Study|Symptomatic Deterioration|0|||
127848577|NCT01125293|460061501|FG000|Overall Study|Death|0|||
127848578|NCT01125293|460061502|FG001|Overall Study|Death|0|||
127848579|NCT01125293|460061503|FG002|Overall Study|Death|0|||
127848580|NCT01125293|460061504|FG003|Overall Study|Death|0|||
127848581|NCT01125293|460061505|FG004|Overall Study|Death|1|||
127848582|NCT01125293|460061506|FG005|Overall Study|Death|0|||
127848583|NCT01125293|460061501|FG000|Overall Study|Withdrawal by Subject|0|||
127848584|NCT01125293|460061502|FG001|Overall Study|Withdrawal by Subject|0|||
127848585|NCT01125293|460061503|FG002|Overall Study|Withdrawal by Subject|0|||
127848586|NCT01125293|460061504|FG003|Overall Study|Withdrawal by Subject|0|||
127848587|NCT01125293|460061505|FG004|Overall Study|Withdrawal by Subject|2|||
127903729|NCT03567174|460272041|FG001|Overall Study|Lost to Follow-up|174|||
127903730|NCT03243630|460272042|FG000|Overall Study|Protocol Violation|1|||
127903731|NCT03243630|460272042|FG000|Overall Study|Physician Decision|1|||
127903732|NCT02140060|460272043|FG000|Overall Study|Adverse Event|0|||
127903733|NCT02140060|460272044|FG001|Overall Study|Adverse Event|0|||
127848588|NCT01125293|460061506|FG005|Overall Study|Withdrawal by Subject|1|||
127848589|NCT01125293|460061501|FG000|Overall Study|Physician Decision|0|||
127848590|NCT01125293|460061502|FG001|Overall Study|Physician Decision|0|||
127848591|NCT01125293|460061503|FG002|Overall Study|Physician Decision|0|||
127848592|NCT01125293|460061504|FG003|Overall Study|Physician Decision|0|||
127848593|NCT01125293|460061505|FG004|Overall Study|Physician Decision|0|||
127848594|NCT01125293|460061506|FG005|Overall Study|Physician Decision|2|||
127848595|NCT02224638|460061507|FG000|Overall Study|Adverse Event|1|||
127848596|NCT02224638|460061508|FG001|Overall Study|Adverse Event|1|||
127848597|NCT01270958|460061513|FG000|Overall Study|Lost to Follow-up|2|||
127848598|NCT01270958|460061513|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
127848599|NCT03136367|460061515|FG000|T1 Consultation|discontinued mistakenly included|2|||
127848600|NCT03136367|460061516|FG001|T1 Consultation|discontinued mistakenly included|6|||
127848601|NCT03136367|460061517|FG002|T1 Consultation|discontinued mistakenly included|1|||
127848602|NCT03136367|460061515|FG000|T1 Consultation|Discontinued other|0|||
127848603|NCT03136367|460061516|FG001|T1 Consultation|Discontinued other|1|||
127848604|NCT03136367|460061517|FG002|T1 Consultation|Discontinued other|0|||
127848605|NCT03136367|460061515|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
127848606|NCT03136367|460061516|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
127848607|NCT03136367|460061517|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
127848608|NCT03136367|460061515|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
127848609|NCT03136367|460061516|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
127848610|NCT03136367|460061517|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
127848611|NCT03136367|460061515|FG000|T2 Post-consultation|Discontinued other|0|||
127848612|NCT03136367|460061516|FG001|T2 Post-consultation|Discontinued other|2|||
127848613|NCT03136367|460061517|FG002|T2 Post-consultation|Discontinued other|6|||
127848614|NCT03136367|460061515|FG000|T2 Post-consultation|Discontinued transferred care|0|||
127848615|NCT03136367|460061516|FG001|T2 Post-consultation|Discontinued transferred care|0|||
127848616|NCT03136367|460061517|FG002|T2 Post-consultation|Discontinued transferred care|3|||
127848617|NCT03136367|460061515|FG000|T2 Post-consultation|Discontinued lost contact|0|||
127848618|NCT03136367|460061516|FG001|T2 Post-consultation|Discontinued lost contact|1|||
127848619|NCT03136367|460061517|FG002|T2 Post-consultation|Discontinued lost contact|0|||
127848620|NCT03136367|460061515|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
127848621|NCT03136367|460061516|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
127848622|NCT03136367|460061517|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
127848623|NCT03136367|460061515|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
127848624|NCT03136367|460061516|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
127848625|NCT03136367|460061517|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
127848626|NCT03136367|460061515|FG000|T3 1 Week After Surgery|other discontinued|2|||
127848627|NCT03136367|460061516|FG001|T3 1 Week After Surgery|other discontinued|4|||
127848628|NCT03136367|460061517|FG002|T3 1 Week After Surgery|other discontinued|3|||
127848629|NCT03136367|460061515|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
127848630|NCT03136367|460061516|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
127848631|NCT03136367|460061517|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
127848632|NCT03136367|460061515|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
127848633|NCT03136367|460061516|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
127848634|NCT03136367|460061517|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
127848635|NCT03136367|460061515|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
127848636|NCT03136367|460061516|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
127848637|NCT03136367|460061517|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
127848638|NCT03136367|460061515|FG000|T4 12 Weeks After Surgery|Death|0|||
127848639|NCT03136367|460061516|FG001|T4 12 Weeks After Surgery|Death|1|||
127848640|NCT03136367|460061517|FG002|T4 12 Weeks After Surgery|Death|3|||
127848641|NCT03136367|460061515|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
127848642|NCT03136367|460061516|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
127848643|NCT03136367|460061517|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
127848644|NCT03136367|460061515|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
127848645|NCT03136367|460061516|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
127848646|NCT03136367|460061517|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
127848647|NCT03136367|460061515|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
127848648|NCT03136367|460061516|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
127848649|NCT03136367|460061517|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
127848650|NCT03136367|460061515|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
127848651|NCT03136367|460061516|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
127848652|NCT03136367|460061517|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
127848653|NCT03136367|460061515|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
127848654|NCT03136367|460061516|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
127848655|NCT03136367|460061517|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
127848656|NCT03136367|460061515|FG000|T5 1 Year After Surgery|Death|0|||
127848657|NCT03136367|460061516|FG001|T5 1 Year After Surgery|Death|0|||
127848658|NCT03136367|460061517|FG002|T5 1 Year After Surgery|Death|1|||
127848659|NCT03136367|460061515|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
127848660|NCT03136367|460061516|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
127848661|NCT03136367|460061517|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
127848662|NCT03136367|460061515|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
127848663|NCT03136367|460061516|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
127848664|NCT03136367|460061517|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
127848665|NCT03136367|460061515|FG000|T5 1 Year After Surgery|study ended before due|31|||
127848666|NCT03136367|460061516|FG001|T5 1 Year After Surgery|study ended before due|103|||
127848667|NCT03136367|460061517|FG002|T5 1 Year After Surgery|study ended before due|110|||
127848668|NCT03136367|460061515|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
127848669|NCT03136367|460061516|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
127848670|NCT03136367|460061517|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
127848671|NCT00676208|460061518|FG000|Overall Study|Lost to Follow-up|0|||
127848672|NCT00676208|460061519|FG001|Overall Study|Lost to Follow-up|2|||
127848673|NCT00676208|460061518|FG000|Overall Study|Incomplete data|2|||
127848674|NCT00676208|460061519|FG001|Overall Study|Incomplete data|4|||
127848675|NCT03726333|460061520|FG000|Overall Study|Progressive Disease|0|||
127848676|NCT03726333|460061521|FG001|Overall Study|Progressive Disease|0|||
127848677|NCT03726333|460061522|FG002|Overall Study|Progressive Disease|1|||
127848678|NCT03726333|460061523|FG003|Overall Study|Progressive Disease|0|||
127848679|NCT03726333|460061524|FG004|Overall Study|Progressive Disease|0|||
127848680|NCT01375647|460063282|FG000|Overall Study|Lost to Follow-up|3|||
127848681|NCT01375647|460063283|FG001|Overall Study|Lost to Follow-up|3|||
127848682|NCT01375647|460063284|FG002|Overall Study|Lost to Follow-up|7|||
127848683|NCT01375647|460063285|FG003|Overall Study|Lost to Follow-up|10|||
127848684|NCT01375647|460063282|FG000|Overall Study|Death|1|||
127848685|NCT01375647|460063283|FG001|Overall Study|Death|2|||
127848686|NCT01375647|460063284|FG002|Overall Study|Death|1|||
127848687|NCT01375647|460063285|FG003|Overall Study|Death|0|||
127848688|NCT01375647|460063282|FG000|Overall Study|Withdrawal by Subject|17|||
127848689|NCT01375647|460063283|FG001|Overall Study|Withdrawal by Subject|20|||
127848690|NCT01375647|460063284|FG002|Overall Study|Withdrawal by Subject|26|||
127848691|NCT01375647|460063285|FG003|Overall Study|Withdrawal by Subject|14|||
127848692|NCT01375647|460063282|FG000|Overall Study|Physician Decision|1|||
127848693|NCT01375647|460063283|FG001|Overall Study|Physician Decision|0|||
127848694|NCT01375647|460063284|FG002|Overall Study|Physician Decision|0|||
127848695|NCT01375647|460063285|FG003|Overall Study|Physician Decision|0|||
127848696|NCT03366844|460063286|FG000|Overall Study|Physician Decision|1|||
127848697|NCT03366844|460063286|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
127848698|NCT02088541|460063289|FG000|Overall Study|Adverse Event|3|||
127848699|NCT02088541|460063290|FG001|Overall Study|Adverse Event|0|||
127848700|NCT02088541|460063291|FG002|Overall Study|Adverse Event|3|||
127848701|NCT02088541|460063292|FG003|Overall Study|Adverse Event|3|||
127848702|NCT02088541|460063293|FG004|Overall Study|Adverse Event|0|||
127848703|NCT02088541|460063289|FG000|Overall Study|Death|51|||
127848704|NCT02088541|460063290|FG001|Overall Study|Death|21|||
127848705|NCT02088541|460063291|FG002|Overall Study|Death|85|||
127848706|NCT02088541|460063292|FG003|Overall Study|Death|28|||
127848707|NCT02088541|460063293|FG004|Overall Study|Death|38|||
127848708|NCT02088541|460063289|FG000|Overall Study|Lost to Follow-up|2|||
127848709|NCT02088541|460063290|FG001|Overall Study|Lost to Follow-up|0|||
127848710|NCT02088541|460063291|FG002|Overall Study|Lost to Follow-up|1|||
127848711|NCT02088541|460063292|FG003|Overall Study|Lost to Follow-up|0|||
127848712|NCT02088541|460063293|FG004|Overall Study|Lost to Follow-up|0|||
127848713|NCT02088541|460063289|FG000|Overall Study|Physician Decision|2|||
127848714|NCT02088541|460063290|FG001|Overall Study|Physician Decision|1|||
127848715|NCT02088541|460063291|FG002|Overall Study|Physician Decision|2|||
127848716|NCT02088541|460063292|FG003|Overall Study|Physician Decision|0|||
127848717|NCT02088541|460063293|FG004|Overall Study|Physician Decision|2|||
127848718|NCT02088541|460063289|FG000|Overall Study|Disease progression|7|||
127848719|NCT02088541|460063290|FG001|Overall Study|Disease progression|1|||
127848720|NCT02088541|460063291|FG002|Overall Study|Disease progression|2|||
127848721|NCT02088541|460063292|FG003|Overall Study|Disease progression|3|||
127848722|NCT02088541|460063293|FG004|Overall Study|Disease progression|1|||
127848723|NCT02088541|460063289|FG000|Overall Study|Study terminated by sponsor|1|||
127848724|NCT02088541|460063290|FG001|Overall Study|Study terminated by sponsor|1|||
127848725|NCT02088541|460063291|FG002|Overall Study|Study terminated by sponsor|12|||
127848726|NCT02088541|460063292|FG003|Overall Study|Study terminated by sponsor|2|||
127848727|NCT02088541|460063293|FG004|Overall Study|Study terminated by sponsor|6|||
127848728|NCT02088541|460063289|FG000|Overall Study|Withdrawal by Subject|3|||
127848729|NCT02088541|460063290|FG001|Overall Study|Withdrawal by Subject|2|||
127848730|NCT02088541|460063291|FG002|Overall Study|Withdrawal by Subject|9|||
127848731|NCT02088541|460063292|FG003|Overall Study|Withdrawal by Subject|7|||
127848732|NCT02088541|460063293|FG004|Overall Study|Withdrawal by Subject|10|||
127848733|NCT02088541|460063289|FG000|Overall Study|Other|2|||
127848734|NCT02088541|460063290|FG001|Overall Study|Other|1|||
127848735|NCT02088541|460063291|FG002|Overall Study|Other|3|||
127848736|NCT02088541|460063292|FG003|Overall Study|Other|1|||
127903734|NCT02140060|460272045|FG002|Overall Study|Adverse Event|0|||
127903735|NCT02140060|460272046|FG003|Overall Study|Adverse Event|1|||
127903736|NCT02140060|460272047|FG004|Overall Study|Adverse Event|1|||
127903737|NCT02140060|460272048|FG005|Overall Study|Adverse Event|1|||
127903738|NCT02140060|460272043|FG000|Overall Study|Lack of Efficacy|0|||
127903739|NCT02140060|460272044|FG001|Overall Study|Lack of Efficacy|0|||
127903740|NCT02140060|460272045|FG002|Overall Study|Lack of Efficacy|0|||
127903741|NCT02140060|460272046|FG003|Overall Study|Lack of Efficacy|1|||
127903742|NCT02140060|460272047|FG004|Overall Study|Lack of Efficacy|0|||
127903743|NCT02140060|460272048|FG005|Overall Study|Lack of Efficacy|0|||
127903744|NCT02817841|460273492|FG000|Overall Study|Lost to Follow-up|287|||
127903745|NCT02817841|460273492|FG000|Overall Study|Withdrawal by Subject|183|||
127903746|NCT02817841|460273492|FG000|Overall Study|Adverse event not related to bleeding|131|||
127903747|NCT02817841|460273492|FG000|Overall Study|Adverse event related to bleeding|51|||
127903748|NCT02817841|460273492|FG000|Overall Study|Pregnancy|32|||
127903749|NCT02817841|460273492|FG000|Overall Study|Pregnancy wish|17|||
127903750|NCT02817841|460273492|FG000|Overall Study|Other reasons|53|||
127903751|NCT02817841|460273492|FG000|Overall Study|Protocol Violation|94|||
127903752|NCT01746017|460273501|FG000|Period 1|Withdrawal by Subject|0|||
127903753|NCT01746017|460273502|FG001|Period 1|Withdrawal by Subject|0|||
127903754|NCT01746017|460273503|FG002|Period 1|Withdrawal by Subject|0|||
127903755|NCT01746017|460273504|FG003|Period 1|Withdrawal by Subject|0|||
127903756|NCT01746017|460273505|FG004|Period 1|Withdrawal by Subject|0|||
127903757|NCT01746017|460273506|FG005|Period 1|Withdrawal by Subject|0|||
127903758|NCT01746017|460273507|FG006|Period 1|Withdrawal by Subject|1|||
127903759|NCT01746017|460273508|FG007|Period 1|Withdrawal by Subject|0|||
127903760|NCT01746017|460273509|FG008|Period 1|Withdrawal by Subject|0|||
127903761|NCT01746017|460273510|FG009|Period 1|Withdrawal by Subject|0|||
127903762|NCT01746017|460273511|FG010|Period 1|Withdrawal by Subject|0|||
127903763|NCT01746017|460273501|FG000|Period 3|Withdrawal by Subject|0|||
127903764|NCT01746017|460273502|FG001|Period 3|Withdrawal by Subject|0|||
127903765|NCT01746017|460273503|FG002|Period 3|Withdrawal by Subject|0|||
127903766|NCT01746017|460273504|FG003|Period 3|Withdrawal by Subject|0|||
127903767|NCT01746017|460273505|FG004|Period 3|Withdrawal by Subject|0|||
127903768|NCT01746017|460273506|FG005|Period 3|Withdrawal by Subject|1|||
127903769|NCT01746017|460273507|FG006|Period 3|Withdrawal by Subject|0|||
127903770|NCT01746017|460273508|FG007|Period 3|Withdrawal by Subject|0|||
127903771|NCT01746017|460273509|FG008|Period 3|Withdrawal by Subject|0|||
127903772|NCT01746017|460273510|FG009|Period 3|Withdrawal by Subject|0|||
127903773|NCT01746017|460273511|FG010|Period 3|Withdrawal by Subject|0|||
127903774|NCT00397488|460273512|FG000|Overall Study|Withdrawal by Subject|3|||
127903775|NCT00397488|460273512|FG000|Overall Study|Adverse Event|3|||
127903776|NCT00397488|460273512|FG000|Overall Study|Death|1|||
127903777|NCT03075761|460273514|FG000|Overall Study|Lost to Follow-up|1|||
127903778|NCT03075761|460273515|FG001|Overall Study|Lost to Follow-up|6|||
127903779|NCT03597256|460273516|FG000|Overall Study|Lost to Follow-up|3|||
127903780|NCT03597256|460273517|FG001|Overall Study|Lost to Follow-up|1|||
127903781|NCT03597256|460273516|FG000|Overall Study|Withdrawal by Subject|0|||
127903782|NCT03597256|460273517|FG001|Overall Study|Withdrawal by Subject|1|||
127903783|NCT03597256|460273516|FG000|Overall Study|Could not return for treatment|0|||
127903784|NCT03597256|460273517|FG001|Overall Study|Could not return for treatment|1|||
127903785|NCT03597256|460273516|FG000|Overall Study|Moved from location|0|||
127903786|NCT03597256|460273517|FG001|Overall Study|Moved from location|1|||
127903787|NCT03597256|460273516|FG000|Overall Study|Not accepted the treatment|0|||
127903788|NCT03597256|460273517|FG001|Overall Study|Not accepted the treatment|1|||
127903789|NCT02943447|460273518|FG000|Blinded Study Phase|Withdrew Consent|1|||
127903790|NCT02943447|460273519|FG001|Blinded Study Phase|Withdrew Consent|2|||
127903791|NCT02943447|460273520|FG002|Blinded Study Phase|Withdrew Consent|1|||
127903792|NCT02943447|460273518|FG000|Blinded Study Phase|Adverse Event|3|||
127903793|NCT02943447|460273519|FG001|Blinded Study Phase|Adverse Event|0|||
127903794|NCT02943447|460273520|FG002|Blinded Study Phase|Adverse Event|0|||
127903795|NCT02943447|460273518|FG000|Blinded Study Phase|Investigator's discretion|1|||
127903796|NCT02943447|460273519|FG001|Blinded Study Phase|Investigator's discretion|0|||
127903797|NCT02943447|460273520|FG002|Blinded Study Phase|Investigator's discretion|0|||
127903798|NCT02943447|460273518|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
127903799|NCT02943447|460273519|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
127903800|NCT02943447|460273520|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
127903801|NCT02943447|460273518|FG000|Open-Label Extension Phase|Adverse Event|4|||
127903802|NCT02943447|460273519|FG001|Open-Label Extension Phase|Adverse Event|7|||
127903803|NCT02943447|460273520|FG002|Open-Label Extension Phase|Adverse Event|3|||
127903804|NCT02943447|460273518|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
127903805|NCT02943447|460273519|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
127903806|NCT02943447|460273520|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
127903807|NCT02943447|460273518|FG000|Open-Label Extension Phase|Withdrew consent|1|||
127903808|NCT02943447|460273519|FG001|Open-Label Extension Phase|Withdrew consent|1|||
127903809|NCT02943447|460273520|FG002|Open-Label Extension Phase|Withdrew consent|1|||
127903810|NCT02943447|460273518|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
127848737|NCT02088541|460063293|FG004|Overall Study|Other|1|||
127848738|NCT03907969|460063295|FG000|Monotherapy Part A|Withdrawal by Subject|0|||
127848739|NCT03907969|460063296|FG001|Monotherapy Part A|Withdrawal by Subject|0|||
127848740|NCT03907969|460063297|FG002|Monotherapy Part A|Withdrawal by Subject|0|||
127848741|NCT03907969|460063298|FG003|Monotherapy Part A|Withdrawal by Subject|0|||
127848742|NCT03907969|460063299|FG004|Monotherapy Part A|Withdrawal by Subject|1|||
127848743|NCT03907969|460063300|FG005|Monotherapy Part A|Withdrawal by Subject|1|||
127848744|NCT03907969|460063301|FG006|Monotherapy Part A|Withdrawal by Subject|0|||
127848745|NCT03907969|460063302|FG007|Monotherapy Part A|Withdrawal by Subject|0|||
127848746|NCT03907969|460063303|FG008|Monotherapy Part A|Withdrawal by Subject|0|||
127848747|NCT03907969|460063304|FG009|Monotherapy Part A|Withdrawal by Subject|0|||
127848748|NCT03907969|460063305|FG010|Monotherapy Part A|Withdrawal by Subject|0|||
127848749|NCT03907969|460063295|FG000|Monotherapy Part A|Progressive Disease|0|||
127848750|NCT03907969|460063296|FG001|Monotherapy Part A|Progressive Disease|1|||
127848751|NCT03907969|460063297|FG002|Monotherapy Part A|Progressive Disease|0|||
127848752|NCT03907969|460063298|FG003|Monotherapy Part A|Progressive Disease|0|||
127848753|NCT03907969|460063299|FG004|Monotherapy Part A|Progressive Disease|0|||
127848754|NCT03907969|460063300|FG005|Monotherapy Part A|Progressive Disease|1|||
127848755|NCT03907969|460063301|FG006|Monotherapy Part A|Progressive Disease|2|||
127848756|NCT03907969|460063302|FG007|Monotherapy Part A|Progressive Disease|0|||
127848757|NCT03907969|460063303|FG008|Monotherapy Part A|Progressive Disease|0|||
127848758|NCT03907969|460063304|FG009|Monotherapy Part A|Progressive Disease|0|||
127848759|NCT03907969|460063305|FG010|Monotherapy Part A|Progressive Disease|0|||
127848760|NCT03907969|460063295|FG000|Monotherapy Part A|Death|0|||
127848761|NCT03907969|460063296|FG001|Monotherapy Part A|Death|0|||
127848762|NCT03907969|460063297|FG002|Monotherapy Part A|Death|1|||
127848763|NCT03907969|460063298|FG003|Monotherapy Part A|Death|1|||
127848764|NCT03907969|460063299|FG004|Monotherapy Part A|Death|0|||
127848765|NCT03907969|460063300|FG005|Monotherapy Part A|Death|1|||
127848766|NCT03907969|460063301|FG006|Monotherapy Part A|Death|0|||
127848767|NCT03907969|460063302|FG007|Monotherapy Part A|Death|0|||
127848768|NCT03907969|460063303|FG008|Monotherapy Part A|Death|0|||
127848769|NCT03907969|460063304|FG009|Monotherapy Part A|Death|0|||
127848770|NCT03907969|460063305|FG010|Monotherapy Part A|Death|0|||
127848771|NCT03907969|460063295|FG000|Combination Therapy Part A|Adverse Event|0|||
127848772|NCT03907969|460063296|FG001|Combination Therapy Part A|Adverse Event|0|||
127848773|NCT03907969|460063297|FG002|Combination Therapy Part A|Adverse Event|0|||
127848774|NCT03907969|460063298|FG003|Combination Therapy Part A|Adverse Event|0|||
127848775|NCT03907969|460063299|FG004|Combination Therapy Part A|Adverse Event|0|||
127848776|NCT03907969|460063300|FG005|Combination Therapy Part A|Adverse Event|0|||
127848777|NCT03907969|460063301|FG006|Combination Therapy Part A|Adverse Event|0|||
127848778|NCT03907969|460063302|FG007|Combination Therapy Part A|Adverse Event|0|||
127848779|NCT03907969|460063303|FG008|Combination Therapy Part A|Adverse Event|0|||
127848780|NCT03907969|460063304|FG009|Combination Therapy Part A|Adverse Event|1|||
127848781|NCT03907969|460063305|FG010|Combination Therapy Part A|Adverse Event|1|||
127848782|NCT03907969|460063295|FG000|Combination Therapy Part A|Progressive disease|0|||
127848783|NCT03907969|460063296|FG001|Combination Therapy Part A|Progressive disease|0|||
127848784|NCT03907969|460063297|FG002|Combination Therapy Part A|Progressive disease|0|||
127848785|NCT03907969|460063298|FG003|Combination Therapy Part A|Progressive disease|0|||
127848786|NCT03907969|460063299|FG004|Combination Therapy Part A|Progressive disease|0|||
127848787|NCT03907969|460063300|FG005|Combination Therapy Part A|Progressive disease|0|||
127848788|NCT03907969|460063301|FG006|Combination Therapy Part A|Progressive disease|0|||
127848789|NCT03907969|460063302|FG007|Combination Therapy Part A|Progressive disease|1|||
127848790|NCT03907969|460063303|FG008|Combination Therapy Part A|Progressive disease|0|||
127848791|NCT03907969|460063304|FG009|Combination Therapy Part A|Progressive disease|2|||
127848792|NCT03907969|460063305|FG010|Combination Therapy Part A|Progressive disease|3|||
127848793|NCT03907969|460063295|FG000|Combination Therapy Part A|Death|0|||
127848794|NCT03907969|460063296|FG001|Combination Therapy Part A|Death|0|||
127848795|NCT03907969|460063297|FG002|Combination Therapy Part A|Death|0|||
127848796|NCT03907969|460063298|FG003|Combination Therapy Part A|Death|0|||
127848797|NCT03907969|460063299|FG004|Combination Therapy Part A|Death|0|||
127848798|NCT03907969|460063300|FG005|Combination Therapy Part A|Death|0|||
127848799|NCT03907969|460063301|FG006|Combination Therapy Part A|Death|0|||
127848800|NCT03907969|460063302|FG007|Combination Therapy Part A|Death|0|||
127903811|NCT02943447|460273519|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
127903812|NCT02943447|460273520|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
127903813|NCT01294787|460273526|FG000|Period 1|Adverse Event|0|||
127903814|NCT01294787|460273527|FG001|Period 1|Adverse Event|0|||
127903815|NCT01294787|460273528|FG002|Period 1|Adverse Event|0|||
127903816|NCT01294787|460273529|FG003|Period 1|Adverse Event|0|||
127903817|NCT01294787|460273530|FG004|Period 1|Adverse Event|1|||
127903818|NCT01294787|460273531|FG005|Period 1|Adverse Event|0|||
127903819|NCT01294787|460273526|FG000|Period 1|Withdrawal by Subject|0|||
127903820|NCT01294787|460273527|FG001|Period 1|Withdrawal by Subject|0|||
127903821|NCT01294787|460273528|FG002|Period 1|Withdrawal by Subject|0|||
127903822|NCT01294787|460273529|FG003|Period 1|Withdrawal by Subject|1|||
127903823|NCT01294787|460273530|FG004|Period 1|Withdrawal by Subject|1|||
127903824|NCT01294787|460273531|FG005|Period 1|Withdrawal by Subject|1|||
127903825|NCT01294787|460273526|FG000|Period 1|Administrative problem|0|||
127903826|NCT01294787|460273527|FG001|Period 1|Administrative problem|0|||
127903827|NCT01294787|460273528|FG002|Period 1|Administrative problem|1|||
127903828|NCT01294787|460273529|FG003|Period 1|Administrative problem|0|||
127903829|NCT01294787|460273530|FG004|Period 1|Administrative problem|0|||
127903830|NCT01294787|460273531|FG005|Period 1|Administrative problem|1|||
127903831|NCT01294787|460273526|FG000|Period 2|Adverse Event|0|||
127903832|NCT01294787|460273527|FG001|Period 2|Adverse Event|3|||
127903833|NCT01294787|460273528|FG002|Period 2|Adverse Event|0|||
127903834|NCT01294787|460273529|FG003|Period 2|Adverse Event|1|||
127903835|NCT01294787|460273530|FG004|Period 2|Adverse Event|0|||
127903836|NCT01294787|460273531|FG005|Period 2|Adverse Event|0|||
127903837|NCT01294787|460273526|FG000|Period 2|No longer needs study drug|0|||
127903838|NCT01294787|460273527|FG001|Period 2|No longer needs study drug|0|||
127903839|NCT01294787|460273528|FG002|Period 2|No longer needs study drug|0|||
127903840|NCT01294787|460273529|FG003|Period 2|No longer needs study drug|1|||
127903841|NCT01294787|460273530|FG004|Period 2|No longer needs study drug|0|||
127903842|NCT01294787|460273531|FG005|Period 2|No longer needs study drug|0|||
127903843|NCT01294787|460273526|FG000|Period 3|Adverse Event|0|||
127903844|NCT01294787|460273527|FG001|Period 3|Adverse Event|0|||
127903845|NCT01294787|460273528|FG002|Period 3|Adverse Event|0|||
127903846|NCT01294787|460273529|FG003|Period 3|Adverse Event|0|||
127903847|NCT01294787|460273530|FG004|Period 3|Adverse Event|1|||
127903848|NCT01294787|460273531|FG005|Period 3|Adverse Event|0|||
127903849|NCT04657770|460273534|FG000|Overall Study|Withdrawal by Subject|3|||
127903850|NCT04657770|460273534|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
127903851|NCT03655106|460273535|FG000|Overall Study|Withdrawal by Subject|3|||
127903852|NCT03655106|460273536|FG001|Overall Study|Withdrawal by Subject|2|||
127903853|NCT03655106|460273535|FG000|Overall Study|Lost to Follow-up|2|||
127903854|NCT03655106|460273536|FG001|Overall Study|Lost to Follow-up|1|||
127903855|NCT03655106|460273535|FG000|Overall Study|Duplicate Enrollment|1|||
127903856|NCT03655106|460273536|FG001|Overall Study|Duplicate Enrollment|1|||
127848801|NCT03907969|460063303|FG008|Combination Therapy Part A|Death|1|||
127848802|NCT03907969|460063304|FG009|Combination Therapy Part A|Death|0|||
127848803|NCT03907969|460063305|FG010|Combination Therapy Part A|Death|1|||
127848804|NCT03907969|460063295|FG000|Combination Therapy Part A|Withdrawal by Subject|0|||
127848805|NCT03907969|460063296|FG001|Combination Therapy Part A|Withdrawal by Subject|0|||
127848806|NCT03907969|460063297|FG002|Combination Therapy Part A|Withdrawal by Subject|0|||
127848807|NCT03907969|460063298|FG003|Combination Therapy Part A|Withdrawal by Subject|0|||
127848808|NCT03907969|460063299|FG004|Combination Therapy Part A|Withdrawal by Subject|0|||
127848809|NCT03907969|460063300|FG005|Combination Therapy Part A|Withdrawal by Subject|0|||
127848810|NCT03907969|460063301|FG006|Combination Therapy Part A|Withdrawal by Subject|0|||
127848811|NCT03907969|460063302|FG007|Combination Therapy Part A|Withdrawal by Subject|0|||
127848812|NCT03907969|460063303|FG008|Combination Therapy Part A|Withdrawal by Subject|0|||
127848813|NCT03907969|460063304|FG009|Combination Therapy Part A|Withdrawal by Subject|1|||
127848814|NCT03907969|460063305|FG010|Combination Therapy Part A|Withdrawal by Subject|0|||
127848815|NCT03907969|460063295|FG000|Combination Therapy Part A|Other than specified main reasons|0|||
127848816|NCT03907969|460063296|FG001|Combination Therapy Part A|Other than specified main reasons|0|||
127848817|NCT03907969|460063297|FG002|Combination Therapy Part A|Other than specified main reasons|0|||
127848818|NCT03907969|460063298|FG003|Combination Therapy Part A|Other than specified main reasons|0|||
127848819|NCT03907969|460063299|FG004|Combination Therapy Part A|Other than specified main reasons|0|||
127848820|NCT03907969|460063300|FG005|Combination Therapy Part A|Other than specified main reasons|0|||
127848821|NCT03907969|460063301|FG006|Combination Therapy Part A|Other than specified main reasons|0|||
127848822|NCT03907969|460063302|FG007|Combination Therapy Part A|Other than specified main reasons|0|||
127848823|NCT03907969|460063303|FG008|Combination Therapy Part A|Other than specified main reasons|1|||
127903857|NCT03655106|460273535|FG000|Overall Study|Protocol Violation|3|||
127903858|NCT03655106|460273536|FG001|Overall Study|Protocol Violation|0|||
127903859|NCT03785548|460273537|FG000|Overall Study|age > 80|1|||
127903860|NCT03785548|460273538|FG001|Overall Study|age > 80|0|||
127903861|NCT03785548|460273537|FG000|Overall Study|no Postop queries|1|||
127903862|NCT03785548|460273538|FG001|Overall Study|no Postop queries|0|||
127903863|NCT05327491|460273541|FG000|Periods 1 & 2|Miscellaneous|0|||
127903864|NCT05327491|460273542|FG001|Periods 1 & 2|Miscellaneous|1|||
127903865|NCT05327491|460273543|FG002|Periods 1 & 2|Miscellaneous|0|||
127903866|NCT05327491|460273544|FG003|Periods 1 & 2|Miscellaneous|0|||
127903867|NCT05327491|460273541|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
127903868|NCT05327491|460273542|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
127903869|NCT05327491|460273543|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
127903870|NCT05327491|460273544|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
127903871|NCT05038293|460273545|FG000|Overall Study|device was not operating properly for one subject.|1|||
127903872|NCT05038293|460273546|FG001|Overall Study|device was not operating properly for one subject.|0|||
127903873|NCT05038293|460273545|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
127903874|NCT05038293|460273546|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
127903875|NCT01171989|460273547|FG000|Overall Study|Lost to Follow-up|0|||
127903876|NCT01171989|460273548|FG001|Overall Study|Lost to Follow-up|0|||
127903877|NCT01171989|460273549|FG002|Overall Study|Lost to Follow-up|1|||
127903878|NCT01247701|460273552|FG000|Overall Study|Death|2|||
127903879|NCT01247701|460273552|FG000|Overall Study|Relapsed|8|||
127903880|NCT04166630|460273553|FG000|Overall Study|Withdrawal by Subject|0|||
127903881|NCT04166630|460273554|FG001|Overall Study|Withdrawal by Subject|1|||
127903882|NCT00096447|460273555|FG000|Overall Study|Never treated|1|||
127903883|NCT04088760|460273556|FG000|Overall Study|Physician Decision|1|||
127903884|NCT02300103|460273557|FG000|Overall Study|Lack of Efficacy|3|||
127903885|NCT02300103|460273557|FG000|Overall Study|Protocol Violation|1|||
127903886|NCT02300103|460273557|FG000|Overall Study|Withdrew Consent|2|||
127903887|NCT04091971|460273558|FG000|Overall Study|Withdrawal by Subject|1|||
127903888|NCT04091971|460273558|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
127903889|NCT04091971|460273558|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
127903890|NCT04466111|460273560|FG000|Prior to Trial Phase|Physician Decision|1|||
127903891|NCT00105196|460273561|FG000|Overall Study|Lack of Efficacy|2|||
127903892|NCT00105196|460273562|FG001|Overall Study|Lack of Efficacy|3|||
127903893|NCT00105196|460273561|FG000|Overall Study|Adverse Event|11|||
127903894|NCT00105196|460273562|FG001|Overall Study|Adverse Event|3|||
127903895|NCT00105196|460273561|FG000|Overall Study|Withdrawal by Subject|6|||
127903896|NCT00105196|460273562|FG001|Overall Study|Withdrawal by Subject|6|||
127903897|NCT00105196|460273561|FG000|Overall Study|Lost to Follow-up|3|||
127903898|NCT00105196|460273562|FG001|Overall Study|Lost to Follow-up|2|||
127903899|NCT00105196|460273561|FG000|Overall Study|Poor/noncompliance|3|||
127903900|NCT00105196|460273562|FG001|Overall Study|Poor/noncompliance|4|||
127903901|NCT00105196|460273561|FG000|Overall Study|Protocol Violation|5|||
127903902|NCT00105196|460273562|FG001|Overall Study|Protocol Violation|2|||
127903903|NCT00105196|460273561|FG000|Overall Study|pending surgery|0|||
127903904|NCT00105196|460273562|FG001|Overall Study|pending surgery|1|||
127903905|NCT00105196|460273561|FG000|Overall Study|marijuana use|0|||
127903906|NCT00105196|460273562|FG001|Overall Study|marijuana use|1|||
127903907|NCT00105196|460273561|FG000|Overall Study|Subject became unblinded|0|||
127903908|NCT00105196|460273562|FG001|Overall Study|Subject became unblinded|1|||
127903909|NCT02015390|460273567|FG000|Overall Study|Lost to Follow-up|1|||
127903910|NCT02015390|460273568|FG001|Overall Study|Lost to Follow-up|0|||
127903911|NCT02015390|460273567|FG000|Overall Study|Adverse Event|0|||
127903912|NCT02015390|460273568|FG001|Overall Study|Adverse Event|3|||
127903913|NCT02015390|460273567|FG000|Overall Study|Physician Decision|0|||
127903914|NCT02015390|460273568|FG001|Overall Study|Physician Decision|1|||
127903915|NCT02419937|460273573|FG000|Overall Study|Lost to Follow-up|1|||
127903916|NCT02419937|460273574|FG001|Overall Study|Lost to Follow-up|0|||
127903917|NCT01981720|460273575|FG000|Overall Study|Adverse Event|1|||
127903918|NCT01981720|460273575|FG000|Overall Study|Withdrawal by Subject|3|||
127903919|NCT01981720|460273575|FG000|Overall Study|Pregnancy|1|||
127903920|NCT00184600|460273576|FG000|Overall Study|Adverse Event|9|||
127903921|NCT00184600|460273577|FG001|Overall Study|Adverse Event|0|||
127903922|NCT00184600|460273578|FG002|Overall Study|Adverse Event|5|||
127903923|NCT00184600|460273576|FG000|Overall Study|Death|3|||
127903924|NCT00184600|460273577|FG001|Overall Study|Death|9|||
127903925|NCT00184600|460273578|FG002|Overall Study|Death|7|||
127903926|NCT00184600|460273576|FG000|Overall Study|Lack of Efficacy|3|||
127903927|NCT00184600|460273577|FG001|Overall Study|Lack of Efficacy|1|||
127903928|NCT00184600|460273578|FG002|Overall Study|Lack of Efficacy|3|||
127903929|NCT00184600|460273576|FG000|Overall Study|Lost to Follow-up|4|||
127903930|NCT00184600|460273577|FG001|Overall Study|Lost to Follow-up|6|||
127903931|NCT00184600|460273578|FG002|Overall Study|Lost to Follow-up|1|||
127903932|NCT00184600|460273576|FG000|Overall Study|Protocol Violation|2|||
127903933|NCT00184600|460273577|FG001|Overall Study|Protocol Violation|2|||
127903934|NCT00184600|460273578|FG002|Overall Study|Protocol Violation|3|||
127903935|NCT00184600|460273576|FG000|Overall Study|Withdrawal by Subject|20|||
127903936|NCT00184600|460273577|FG001|Overall Study|Withdrawal by Subject|28|||
127903937|NCT00184600|460273578|FG002|Overall Study|Withdrawal by Subject|12|||
127903938|NCT00184600|460273576|FG000|Overall Study|Unclassified|4|||
127903939|NCT00184600|460273577|FG001|Overall Study|Unclassified|5|||
127903940|NCT00184600|460273578|FG002|Overall Study|Unclassified|3|||
127903941|NCT02674477|460273579|FG000|Overall Study|Protocol Violation|8|||
127848824|NCT03907969|460063304|FG009|Combination Therapy Part A|Other than specified main reasons|0|||
127848825|NCT03907969|460063305|FG010|Combination Therapy Part A|Other than specified main reasons|0|||
127848826|NCT03907969|460063295|FG000|Combination Therapy Part A|Physician Decision|0|||
127848827|NCT03907969|460063296|FG001|Combination Therapy Part A|Physician Decision|0|||
127848828|NCT03907969|460063297|FG002|Combination Therapy Part A|Physician Decision|0|||
127848829|NCT03907969|460063298|FG003|Combination Therapy Part A|Physician Decision|0|||
127848830|NCT03907969|460063299|FG004|Combination Therapy Part A|Physician Decision|0|||
127848831|NCT03907969|460063300|FG005|Combination Therapy Part A|Physician Decision|0|||
127848832|NCT03907969|460063301|FG006|Combination Therapy Part A|Physician Decision|0|||
127848833|NCT03907969|460063302|FG007|Combination Therapy Part A|Physician Decision|1|||
127848834|NCT03907969|460063303|FG008|Combination Therapy Part A|Physician Decision|0|||
127848835|NCT03907969|460063304|FG009|Combination Therapy Part A|Physician Decision|0|||
127848836|NCT03907969|460063305|FG010|Combination Therapy Part A|Physician Decision|1|||
127848837|NCT00666536|460063306|FG000|Overall Study|Adverse Event|9|||
127848838|NCT00666536|460063307|FG001|Overall Study|Adverse Event|19|||
127848839|NCT00666536|460063306|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
127848840|NCT00666536|460063307|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
127848841|NCT00666536|460063306|FG000|Overall Study|Protocol deviation(s)|8|||
127848842|NCT00666536|460063307|FG001|Overall Study|Protocol deviation(s)|6|||
127848843|NCT00666536|460063306|FG000|Overall Study|Withdrawal by Subject|10|||
127848844|NCT00666536|460063307|FG001|Overall Study|Withdrawal by Subject|9|||
127848845|NCT00666536|460063306|FG000|Overall Study|Lost to Follow-up|4|||
127848846|NCT00666536|460063307|FG001|Overall Study|Lost to Follow-up|3|||
127848847|NCT00608881|460063314|FG000|Overall Study|Death|22|||
127848848|NCT00608881|460063315|FG001|Overall Study|Death|13|||
127848849|NCT00608881|460063314|FG000|Overall Study|Adverse Event|5|||
127848850|NCT00608881|460063315|FG001|Overall Study|Adverse Event|3|||
127848851|NCT00608881|460063314|FG000|Overall Study|Lost to Follow-up|28|||
127848852|NCT00608881|460063315|FG001|Overall Study|Lost to Follow-up|14|||
127848853|NCT00608881|460063314|FG000|Overall Study|Withdrawal by Subject|18|||
127848854|NCT00608881|460063315|FG001|Overall Study|Withdrawal by Subject|29|||
127848855|NCT00608881|460063314|FG000|Overall Study|Physician Decision|5|||
127848856|NCT00608881|460063315|FG001|Overall Study|Physician Decision|5|||
127848857|NCT00608881|460063314|FG000|Overall Study|Institutionalized|1|||
127848858|NCT00608881|460063315|FG001|Overall Study|Institutionalized|2|||
127848859|NCT00511108|460063317|FG000|Overall Study|Adverse Event|2|||
127848860|NCT00511108|460063318|FG001|Overall Study|Adverse Event|0|||
127848861|NCT00511108|460063319|FG002|Overall Study|Adverse Event|1|||
127848862|NCT00511108|460063320|FG003|Overall Study|Adverse Event|2|||
127848863|NCT00511108|460063317|FG000|Overall Study|Lost to Follow-up|0|||
127848864|NCT00511108|460063318|FG001|Overall Study|Lost to Follow-up|2|||
127848865|NCT00511108|460063319|FG002|Overall Study|Lost to Follow-up|1|||
127848866|NCT00511108|460063320|FG003|Overall Study|Lost to Follow-up|0|||
127848867|NCT00511108|460063317|FG000|Overall Study|Physician Decision|0|||
127848868|NCT00511108|460063318|FG001|Overall Study|Physician Decision|0|||
127848869|NCT00511108|460063319|FG002|Overall Study|Physician Decision|0|||
127848870|NCT00511108|460063320|FG003|Overall Study|Physician Decision|1|||
127848871|NCT00511108|460063317|FG000|Overall Study|Withdrawal by Subject|4|||
127848872|NCT00511108|460063318|FG001|Overall Study|Withdrawal by Subject|0|||
127848873|NCT00511108|460063319|FG002|Overall Study|Withdrawal by Subject|3|||
127848874|NCT00511108|460063320|FG003|Overall Study|Withdrawal by Subject|2|||
127848875|NCT02954952|460063323|FG000|Overall Study|Withdrawal by Subject|1|||
127848876|NCT02954952|460063324|FG001|Overall Study|Withdrawal by Subject|0|||
127848877|NCT02954952|460063325|FG002|Overall Study|Withdrawal by Subject|0|||
127848878|NCT02954952|460063323|FG000|Overall Study|No data collected|0|||
127848879|NCT02954952|460063324|FG001|Overall Study|No data collected|1|||
127848880|NCT02954952|460063325|FG002|Overall Study|No data collected|0|||
127848881|NCT04179032|460063328|FG000|Part B (Up to Week 52)|Adverse Event|1|||
127848882|NCT04179032|460063328|FG000|Part B (Up to Week 52)|INVESTIGATOR DISCRETION|1|||
127848883|NCT04179032|460063328|FG000|Access Extension Phase|Ongoing|11|||
127848884|NCT04539262|460063330|FG000|Overall Study|Adverse Event|0|||
127848885|NCT04539262|460063331|FG001|Overall Study|Adverse Event|0|||
127848886|NCT04539262|460063332|FG002|Overall Study|Adverse Event|1|||
127848887|NCT04539262|460063333|FG003|Overall Study|Adverse Event|0|||
127848888|NCT04539262|460063334|FG004|Overall Study|Adverse Event|0|||
127848889|NCT04539262|460063335|FG005|Overall Study|Adverse Event|0|||
127848890|NCT04539262|460063336|FG006|Overall Study|Adverse Event|0|||
127848891|NCT04539262|460063337|FG007|Overall Study|Adverse Event|0|||
127848892|NCT04539262|460063330|FG000|Overall Study|Withdrew Consent|0|||
127848893|NCT04539262|460063331|FG001|Overall Study|Withdrew Consent|0|||
127848894|NCT04539262|460063332|FG002|Overall Study|Withdrew Consent|0|||
127848895|NCT04539262|460063333|FG003|Overall Study|Withdrew Consent|1|||
127848896|NCT04539262|460063334|FG004|Overall Study|Withdrew Consent|0|||
127848897|NCT04539262|460063335|FG005|Overall Study|Withdrew Consent|0|||
127848898|NCT04539262|460063336|FG006|Overall Study|Withdrew Consent|0|||
127848899|NCT04539262|460063337|FG007|Overall Study|Withdrew Consent|0|||
127848900|NCT04539262|460063330|FG000|Overall Study|Randomized, Not treated|0|||
127903942|NCT02674477|460273580|FG001|Overall Study|Protocol Violation|2|||
127903943|NCT00624065|460273581|FG000|Overall Study|Adverse Event|5|||
127903944|NCT00624065|460273582|FG001|Overall Study|Adverse Event|6|||
127903945|NCT00624065|460273581|FG000|Overall Study|Lost to Follow-up|4|||
127903946|NCT00624065|460273582|FG001|Overall Study|Lost to Follow-up|1|||
127903947|NCT00624065|460273581|FG000|Overall Study|Consent withdrawn|6|||
127903948|NCT00624065|460273582|FG001|Overall Study|Consent withdrawn|5|||
127903949|NCT00624065|460273581|FG000|Overall Study|Lack of Efficacy|0|||
127903950|NCT00624065|460273582|FG001|Overall Study|Lack of Efficacy|3|||
127903951|NCT00624065|460273581|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
127903952|NCT00624065|460273582|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
127903953|NCT00296647|460273584|FG000|Overall Study|Death|4|||
127903954|NCT00296647|460273585|FG001|Overall Study|Death|1|||
127903955|NCT00296647|460273586|FG002|Overall Study|Death|2|||
127903956|NCT00296647|460273587|FG003|Overall Study|Death|1|||
127903957|NCT00296647|460273588|FG004|Overall Study|Death|1|||
127903958|NCT00296647|460273584|FG000|Overall Study|Withdrawal by Subject|28|||
127903959|NCT00296647|460273585|FG001|Overall Study|Withdrawal by Subject|27|||
127903960|NCT00296647|460273586|FG002|Overall Study|Withdrawal by Subject|32|||
127903961|NCT00296647|460273587|FG003|Overall Study|Withdrawal by Subject|16|||
127903962|NCT00296647|460273588|FG004|Overall Study|Withdrawal by Subject|19|||
127903963|NCT01629381|460273589|FG000|Overall Study|Withdrawal by Subject|2|||
127903964|NCT01629381|460273590|FG001|Overall Study|Withdrawal by Subject|5|||
127903965|NCT00735904|460273591|FG000|Overall Study|Adverse Event|3|||
127903966|NCT00735904|460273591|FG000|Overall Study|Death|20|||
127903967|NCT00735904|460273591|FG000|Overall Study|Protocol Violation|1|||
127903968|NCT00735904|460273591|FG000|Overall Study|Withdrawal by Subject|1|||
127903969|NCT00735904|460273591|FG000|Overall Study|Study Terminated by Sponsor|5|||
127903970|NCT00735904|460273591|FG000|Overall Study|Other|8|||
127903971|NCT01390844|460273594|FG000|Treatment Phase|Adverse Event|12|||
127903972|NCT01390844|460273595|FG001|Treatment Phase|Adverse Event|2|||
127903973|NCT01390844|460273596|FG002|Treatment Phase|Adverse Event|3|||
127903974|NCT01390844|460273597|FG003|Treatment Phase|Adverse Event|2|||
127903975|NCT01390844|460273594|FG000|Treatment Phase|Treatment Failure|23|||
127903976|NCT01390844|460273595|FG001|Treatment Phase|Treatment Failure|25|||
127903977|NCT01390844|460273596|FG002|Treatment Phase|Treatment Failure|10|||
127903978|NCT01390844|460273597|FG003|Treatment Phase|Treatment Failure|13|||
127903979|NCT01390844|460273594|FG000|Treatment Phase|Non-Medical Reasons|5|||
127903980|NCT01390844|460273595|FG001|Treatment Phase|Non-Medical Reasons|1|||
127903981|NCT01390844|460273596|FG002|Treatment Phase|Non-Medical Reasons|8|||
127903982|NCT01390844|460273597|FG003|Treatment Phase|Non-Medical Reasons|1|||
127903983|NCT01390844|460273594|FG000|Treatment Phase|Non-GCP Compliant|0|||
127903984|NCT01390844|460273595|FG001|Treatment Phase|Non-GCP Compliant|0|||
127903985|NCT01390844|460273596|FG002|Treatment Phase|Non-GCP Compliant|10|||
127903986|NCT01390844|460273597|FG003|Treatment Phase|Non-GCP Compliant|3|||
127903987|NCT01390844|460273594|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
127903988|NCT01390844|460273595|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
127903989|NCT01390844|460273596|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
127903990|NCT01390844|460273597|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
127903991|NCT03204539|460273600|FG000|Overall Study|Loss of funding|0|||
127903992|NCT03204539|460273601|FG001|Overall Study|Loss of funding|1|||
127903993|NCT05093205|460273602|FG000|Part A Period 2 - Treatment|Physician Decision|0|||
127903994|NCT05093205|460273603|FG001|Part A Period 2 - Treatment|Physician Decision|1|||
127903995|NCT05093205|460273604|FG002|Part A Period 2 - Treatment|Physician Decision|0|||
127903996|NCT05093205|460273605|FG003|Part A Period 2 - Treatment|Physician Decision|0|||
127903997|NCT05093205|460273606|FG004|Part A Period 2 - Treatment|Physician Decision|0|||
127903998|NCT05093205|460273607|FG005|Part A Period 2 - Treatment|Physician Decision|0|||
127903999|NCT05093205|460273608|FG006|Part A Period 2 - Treatment|Physician Decision|0|||
127904000|NCT05093205|460273609|FG007|Part A Period 2 - Treatment|Physician Decision|0|||
127904001|NCT05093205|460273610|FG008|Part A Period 2 - Treatment|Physician Decision|0|||
127904002|NCT05093205|460273611|FG009|Part A Period 2 - Treatment|Physician Decision|0|||
127904003|NCT05093205|460273612|FG010|Part A Period 2 - Treatment|Physician Decision|0|||
127904004|NCT05093205|460273613|FG011|Part A Period 2 - Treatment|Physician Decision|0|||
127904005|NCT05093205|460273614|FG012|Part A Period 2 - Treatment|Physician Decision|0|||
127904006|NCT05093205|460273602|FG000|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
127904007|NCT05093205|460273603|FG001|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
127904008|NCT05093205|460273604|FG002|Part A Period 3 - Treatment|Withdrawal by Subject|1|||
127904009|NCT05093205|460273605|FG003|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
127904010|NCT05093205|460273606|FG004|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
127904011|NCT05093205|460273607|FG005|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
127904012|NCT05093205|460273608|FG006|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
127904013|NCT05093205|460273609|FG007|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
127904014|NCT05093205|460273610|FG008|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
127904015|NCT05093205|460273611|FG009|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
127904016|NCT05093205|460273612|FG010|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
127904017|NCT05093205|460273613|FG011|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
127904018|NCT05093205|460273614|FG012|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
127904019|NCT05093205|460273602|FG000|Part A Period 3 - Treatment|Physician Decision|0|||
127904020|NCT05093205|460273603|FG001|Part A Period 3 - Treatment|Physician Decision|0|||
127904021|NCT05093205|460273604|FG002|Part A Period 3 - Treatment|Physician Decision|1|||
127904022|NCT05093205|460273605|FG003|Part A Period 3 - Treatment|Physician Decision|0|||
127904023|NCT05093205|460273606|FG004|Part A Period 3 - Treatment|Physician Decision|0|||
127904024|NCT05093205|460273607|FG005|Part A Period 3 - Treatment|Physician Decision|0|||
127904025|NCT05093205|460273608|FG006|Part A Period 3 - Treatment|Physician Decision|0|||
127904026|NCT05093205|460273609|FG007|Part A Period 3 - Treatment|Physician Decision|0|||
127904027|NCT05093205|460273610|FG008|Part A Period 3 - Treatment|Physician Decision|0|||
127904028|NCT05093205|460273611|FG009|Part A Period 3 - Treatment|Physician Decision|0|||
127904029|NCT05093205|460273612|FG010|Part A Period 3 - Treatment|Physician Decision|0|||
127904030|NCT05093205|460273613|FG011|Part A Period 3 - Treatment|Physician Decision|0|||
127904031|NCT05093205|460273614|FG012|Part A Period 3 - Treatment|Physician Decision|0|||
127904032|NCT05093205|460273602|FG000|Part A Period 3 - Treatment|Adverse Event|0|||
127904033|NCT05093205|460273603|FG001|Part A Period 3 - Treatment|Adverse Event|0|||
127904034|NCT05093205|460273604|FG002|Part A Period 3 - Treatment|Adverse Event|2|||
127904035|NCT05093205|460273605|FG003|Part A Period 3 - Treatment|Adverse Event|0|||
127904036|NCT05093205|460273606|FG004|Part A Period 3 - Treatment|Adverse Event|0|||
127904037|NCT05093205|460273607|FG005|Part A Period 3 - Treatment|Adverse Event|0|||
127848901|NCT04539262|460063331|FG001|Overall Study|Randomized, Not treated|1|||
127848902|NCT04539262|460063332|FG002|Overall Study|Randomized, Not treated|0|||
127848903|NCT04539262|460063333|FG003|Overall Study|Randomized, Not treated|0|||
127848904|NCT04539262|460063334|FG004|Overall Study|Randomized, Not treated|0|||
127848905|NCT04539262|460063335|FG005|Overall Study|Randomized, Not treated|0|||
127848906|NCT04539262|460063336|FG006|Overall Study|Randomized, Not treated|1|||
127848907|NCT04539262|460063337|FG007|Overall Study|Randomized, Not treated|0|||
127848908|NCT01061567|460063344|FG000|Overall Study|Adverse Event|32|||
127848909|NCT01061567|460063344|FG000|Overall Study|Death|2|||
127848910|NCT01061567|460063344|FG000|Overall Study|Lack of Efficacy|3|||
127848911|NCT01061567|460063344|FG000|Overall Study|Lost to Follow-up|24|||
127848912|NCT01061567|460063344|FG000|Overall Study|Protocol Violation|1|||
127848913|NCT01061567|460063344|FG000|Overall Study|Withdrawal by Subject|11|||
127848914|NCT01061567|460063344|FG000|Overall Study|Other reason than stated above|3|||
127848915|NCT01156532|460063345|FG000|Overall Study|Family Reasons|1|||
127848916|NCT01156532|460063345|FG000|Overall Study|Lost to Follow-up|1|||
127848917|NCT00268463|460063346|FG000|Overall Study|study terminated due to low accrual|10|||
127848918|NCT00268463|460063347|FG001|Overall Study|study terminated due to low accrual|12|||
127848919|NCT02443805|460063352|FG000|Overall Study|Adverse Event|100|||
127848920|NCT02443805|460063353|FG001|Overall Study|Adverse Event|18|||
127848921|NCT02443805|460063352|FG000|Overall Study|Withdrawal by Subject|73|||
127848922|NCT02443805|460063353|FG001|Overall Study|Withdrawal by Subject|74|||
127848923|NCT02443805|460063352|FG000|Overall Study|Lost to Follow-up|19|||
127848924|NCT02443805|460063353|FG001|Overall Study|Lost to Follow-up|14|||
127848925|NCT02443805|460063352|FG000|Overall Study|Pregnancy|6|||
127848926|NCT02443805|460063353|FG001|Overall Study|Pregnancy|5|||
127848927|NCT02443805|460063352|FG000|Overall Study|Protocol Violation|2|||
127848928|NCT02443805|460063353|FG001|Overall Study|Protocol Violation|4|||
127848929|NCT02443805|460063352|FG000|Overall Study|Lack of Efficacy|1|||
127848930|NCT02443805|460063353|FG001|Overall Study|Lack of Efficacy|1|||
127848931|NCT02443805|460063352|FG000|Overall Study|Non-compliance with study drug|6|||
127848932|NCT02443805|460063353|FG001|Overall Study|Non-compliance with study drug|4|||
127848933|NCT02443805|460063352|FG000|Overall Study|Withdrawal by parent/guardian|3|||
127848934|NCT02443805|460063353|FG001|Overall Study|Withdrawal by parent/guardian|5|||
127848935|NCT02443805|460063352|FG000|Overall Study|Any other reason not above-mentioned|3|||
127848936|NCT02443805|460063353|FG001|Overall Study|Any other reason not above-mentioned|2|||
127848937|NCT04362813|460063354|FG000|Overall Study|Death|12|||
127848938|NCT04362813|460063355|FG001|Overall Study|Death|16|||
127848939|NCT04362813|460063354|FG000|Overall Study|Withdrawal by Subject|3|||
127848940|NCT04362813|460063355|FG001|Overall Study|Withdrawal by Subject|1|||
127848941|NCT04362813|460063354|FG000|Overall Study|Protocol Violation|0|||
127848942|NCT04362813|460063355|FG001|Overall Study|Protocol Violation|3|||
127848943|NCT04362813|460063354|FG000|Overall Study|Lost to Follow-up|1|||
127904038|NCT05093205|460273608|FG006|Part A Period 3 - Treatment|Adverse Event|0|||
127904039|NCT05093205|460273609|FG007|Part A Period 3 - Treatment|Adverse Event|0|||
127848944|NCT04362813|460063355|FG001|Overall Study|Lost to Follow-up|1|||
127848945|NCT04362813|460063354|FG000|Overall Study|Enrolled but did not receive treatment|2|||
127848946|NCT04362813|460063355|FG001|Overall Study|Enrolled but did not receive treatment|4|||
127848947|NCT00961116|460063356|FG000|Washout Period of 7 Days|Adverse Event|1|||
127848948|NCT00961116|460063357|FG001|Washout Period of 7 Days|Adverse Event|1|||
127848949|NCT00961116|460063356|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
127848950|NCT00961116|460063357|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
127904040|NCT05093205|460273610|FG008|Part A Period 3 - Treatment|Adverse Event|0|||
127904041|NCT05093205|460273611|FG009|Part A Period 3 - Treatment|Adverse Event|0|||
127904042|NCT05093205|460273612|FG010|Part A Period 3 - Treatment|Adverse Event|0|||
127904043|NCT05093205|460273613|FG011|Part A Period 3 - Treatment|Adverse Event|0|||
127848951|NCT00961116|460063356|FG000|Washout Period of 7 Days|Protocol Violation|0|||
127848952|NCT00961116|460063357|FG001|Washout Period of 7 Days|Protocol Violation|1|||
127848953|NCT00753688|460063358|FG000|Overall Study|Death|102|||
127848954|NCT00753688|460063359|FG001|Overall Study|Death|203|||
127848955|NCT00753688|460063358|FG000|Overall Study|Missing|4|||
127848956|NCT00753688|460063359|FG001|Overall Study|Missing|9|||
127848957|NCT00753688|460063358|FG000|Overall Study|Participant Withdrew Consent|2|||
127848958|NCT00753688|460063359|FG001|Overall Study|Participant Withdrew Consent|2|||
127848959|NCT00753688|460063358|FG000|Overall Study|Ongoing - in Follow-up|15|||
127904044|NCT05093205|460273614|FG012|Part A Period 3 - Treatment|Adverse Event|0|||
127904045|NCT05093205|460273602|FG000|Part A Period 6 - Treatment|Adverse Event|0|||
127904046|NCT05093205|460273603|FG001|Part A Period 6 - Treatment|Adverse Event|0|||
127904047|NCT05093205|460273604|FG002|Part A Period 6 - Treatment|Adverse Event|0|||
127904048|NCT05093205|460273605|FG003|Part A Period 6 - Treatment|Adverse Event|0|||
127904049|NCT05093205|460273606|FG004|Part A Period 6 - Treatment|Adverse Event|0|||
127904050|NCT05093205|460273607|FG005|Part A Period 6 - Treatment|Adverse Event|7|||
127904051|NCT05093205|460273608|FG006|Part A Period 6 - Treatment|Adverse Event|0|||
127904052|NCT05093205|460273609|FG007|Part A Period 6 - Treatment|Adverse Event|0|||
127904053|NCT05093205|460273610|FG008|Part A Period 6 - Treatment|Adverse Event|0|||
127904054|NCT05093205|460273611|FG009|Part A Period 6 - Treatment|Adverse Event|0|||
127904055|NCT05093205|460273612|FG010|Part A Period 6 - Treatment|Adverse Event|0|||
127904056|NCT05093205|460273613|FG011|Part A Period 6 - Treatment|Adverse Event|0|||
127904057|NCT05093205|460273614|FG012|Part A Period 6 - Treatment|Adverse Event|0|||
127904058|NCT05093205|460273602|FG000|Part A Period 8 - Treatment|Adverse Event|0|||
127904059|NCT05093205|460273603|FG001|Part A Period 8 - Treatment|Adverse Event|0|||
127904060|NCT05093205|460273604|FG002|Part A Period 8 - Treatment|Adverse Event|0|||
127904061|NCT05093205|460273605|FG003|Part A Period 8 - Treatment|Adverse Event|0|||
127904062|NCT05093205|460273606|FG004|Part A Period 8 - Treatment|Adverse Event|0|||
127904063|NCT05093205|460273607|FG005|Part A Period 8 - Treatment|Adverse Event|0|||
127904064|NCT05093205|460273608|FG006|Part A Period 8 - Treatment|Adverse Event|0|||
127904065|NCT05093205|460273609|FG007|Part A Period 8 - Treatment|Adverse Event|1|||
127904066|NCT05093205|460273610|FG008|Part A Period 8 - Treatment|Adverse Event|0|||
127904067|NCT05093205|460273611|FG009|Part A Period 8 - Treatment|Adverse Event|0|||
127904068|NCT05093205|460273612|FG010|Part A Period 8 - Treatment|Adverse Event|0|||
127904069|NCT05093205|460273613|FG011|Part A Period 8 - Treatment|Adverse Event|0|||
127904070|NCT05093205|460273614|FG012|Part A Period 8 - Treatment|Adverse Event|0|||
127904071|NCT05093205|460273602|FG000|Part B Period 1 - Treatment|Protocol Violation|0|||
127904072|NCT05093205|460273603|FG001|Part B Period 1 - Treatment|Protocol Violation|0|||
127904073|NCT05093205|460273604|FG002|Part B Period 1 - Treatment|Protocol Violation|0|||
127904074|NCT05093205|460273605|FG003|Part B Period 1 - Treatment|Protocol Violation|0|||
127904075|NCT05093205|460273606|FG004|Part B Period 1 - Treatment|Protocol Violation|0|||
127904076|NCT05093205|460273607|FG005|Part B Period 1 - Treatment|Protocol Violation|0|||
127904077|NCT05093205|460273608|FG006|Part B Period 1 - Treatment|Protocol Violation|0|||
127904078|NCT05093205|460273609|FG007|Part B Period 1 - Treatment|Protocol Violation|0|||
127904079|NCT05093205|460273610|FG008|Part B Period 1 - Treatment|Protocol Violation|1|||
127904080|NCT05093205|460273611|FG009|Part B Period 1 - Treatment|Protocol Violation|0|||
127904081|NCT05093205|460273612|FG010|Part B Period 1 - Treatment|Protocol Violation|0|||
127904082|NCT05093205|460273613|FG011|Part B Period 1 - Treatment|Protocol Violation|0|||
127904083|NCT05093205|460273614|FG012|Part B Period 1 - Treatment|Protocol Violation|0|||
127904084|NCT05093205|460273602|FG000|Part B Period 2 - Treatment|Adverse Event|0|||
127904085|NCT05093205|460273603|FG001|Part B Period 2 - Treatment|Adverse Event|0|||
127904086|NCT05093205|460273604|FG002|Part B Period 2 - Treatment|Adverse Event|0|||
127904087|NCT05093205|460273605|FG003|Part B Period 2 - Treatment|Adverse Event|0|||
127904088|NCT05093205|460273606|FG004|Part B Period 2 - Treatment|Adverse Event|0|||
127904089|NCT05093205|460273607|FG005|Part B Period 2 - Treatment|Adverse Event|0|||
127904090|NCT05093205|460273608|FG006|Part B Period 2 - Treatment|Adverse Event|0|||
127904091|NCT05093205|460273609|FG007|Part B Period 2 - Treatment|Adverse Event|0|||
127904092|NCT05093205|460273610|FG008|Part B Period 2 - Treatment|Adverse Event|0|||
127848960|NCT00753688|460063359|FG001|Overall Study|Ongoing - in Follow-up|31|||
127848961|NCT00753688|460063358|FG000|Overall Study|Adverse Event|0|||
127848962|NCT00753688|460063359|FG001|Overall Study|Adverse Event|1|||
127904093|NCT05093205|460273611|FG009|Part B Period 2 - Treatment|Adverse Event|2|||
127848963|NCT03595384|460063360|FG000|Overall Study|Other time commitments|8|||
127848964|NCT03595384|460063360|FG000|Overall Study|Changes to session time|7|||
127848965|NCT03595384|460063360|FG000|Overall Study|Relocation out of country|1|||
127848966|NCT03803202|460063361|FG000|Overall Study|Other|0|||
127904094|NCT05093205|460273612|FG010|Part B Period 2 - Treatment|Adverse Event|0|||
127904095|NCT05093205|460273613|FG011|Part B Period 2 - Treatment|Adverse Event|0|||
127904096|NCT05093205|460273614|FG012|Part B Period 2 - Treatment|Adverse Event|0|||
127904097|NCT05093205|460273602|FG000|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
127904098|NCT05093205|460273603|FG001|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
127904099|NCT05093205|460273604|FG002|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
127848967|NCT03803202|460063362|FG001|Overall Study|Other|1|||
127848968|NCT03803202|460063363|FG002|Overall Study|Other|0|||
127848969|NCT03803202|460063364|FG003|Overall Study|Other|0|||
127848970|NCT03803202|460063365|FG004|Overall Study|Other|0|||
127848971|NCT03803202|460063366|FG005|Overall Study|Other|0|||
127848972|NCT03803202|460063367|FG006|Overall Study|Other|0|||
127848973|NCT03803202|460063368|FG007|Overall Study|Other|0|||
127848974|NCT03803202|460063369|FG008|Overall Study|Other|0|||
127848975|NCT03803202|460063361|FG000|Overall Study|Death|0|||
127848976|NCT03803202|460063362|FG001|Overall Study|Death|0|||
127848977|NCT03803202|460063363|FG002|Overall Study|Death|0|||
127848978|NCT03803202|460063364|FG003|Overall Study|Death|0|||
127848979|NCT03803202|460063365|FG004|Overall Study|Death|0|||
127848980|NCT03803202|460063366|FG005|Overall Study|Death|1|||
127848981|NCT03803202|460063367|FG006|Overall Study|Death|0|||
127848982|NCT03803202|460063368|FG007|Overall Study|Death|0|||
127848983|NCT03803202|460063369|FG008|Overall Study|Death|0|||
127848984|NCT03803202|460063361|FG000|Overall Study|Withdrawal by Subject|0|||
127848985|NCT03803202|460063362|FG001|Overall Study|Withdrawal by Subject|0|||
127848986|NCT03803202|460063363|FG002|Overall Study|Withdrawal by Subject|1|||
127848987|NCT03803202|460063364|FG003|Overall Study|Withdrawal by Subject|0|||
127848988|NCT03803202|460063365|FG004|Overall Study|Withdrawal by Subject|0|||
127848989|NCT03803202|460063366|FG005|Overall Study|Withdrawal by Subject|0|||
127848990|NCT03803202|460063367|FG006|Overall Study|Withdrawal by Subject|0|||
127848991|NCT03803202|460063368|FG007|Overall Study|Withdrawal by Subject|1|||
127848992|NCT03803202|460063369|FG008|Overall Study|Withdrawal by Subject|0|||
127848993|NCT03803202|460063361|FG000|Overall Study|Lost to Follow-up|0|||
127848994|NCT03803202|460063362|FG001|Overall Study|Lost to Follow-up|0|||
127848995|NCT03803202|460063363|FG002|Overall Study|Lost to Follow-up|0|||
127848996|NCT03803202|460063364|FG003|Overall Study|Lost to Follow-up|1|||
127848997|NCT03803202|460063365|FG004|Overall Study|Lost to Follow-up|1|||
127848998|NCT03803202|460063366|FG005|Overall Study|Lost to Follow-up|0|||
127848999|NCT03803202|460063367|FG006|Overall Study|Lost to Follow-up|1|||
127849000|NCT03803202|460063368|FG007|Overall Study|Lost to Follow-up|0|||
127849001|NCT03803202|460063369|FG008|Overall Study|Lost to Follow-up|0|||
127849002|NCT00293241|460063370|FG000|Overall Study|Lost to Follow-up|9|||
127849003|NCT00293241|460063371|FG001|Overall Study|Lost to Follow-up|16|||
127849004|NCT00293241|460063370|FG000|Overall Study|Physician Decision|23|||
127849005|NCT00293241|460063371|FG001|Overall Study|Physician Decision|17|||
127849006|NCT00293241|460063370|FG000|Overall Study|Withdrawal by Subject|4|||
127849007|NCT00293241|460063371|FG001|Overall Study|Withdrawal by Subject|8|||
127849008|NCT00659126|460063376|FG000|Overall Study|Adverse Event|2|||
127849009|NCT00659126|460063377|FG001|Overall Study|Adverse Event|2|||
127849010|NCT00659126|460063376|FG000|Overall Study|Screen failure|1|||
127849011|NCT00659126|460063377|FG001|Overall Study|Screen failure|1|||
127849012|NCT00659126|460063376|FG000|Overall Study|Technical problems with MRI|0|||
127849013|NCT00659126|460063377|FG001|Overall Study|Technical problems with MRI|1|||
127849014|NCT02633046|460063380|FG000|Overall Study|Adverse Event|8|||
127849015|NCT02633046|460063380|FG000|Overall Study|Physician Decision|7|||
127849016|NCT02633046|460063380|FG000|Overall Study|Withdrawal by Subject|8|||
127849017|NCT02633046|460063380|FG000|Overall Study|Increased proteinuria|2|||
127849018|NCT02633046|460063380|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
127849019|NCT02633046|460063380|FG000|Overall Study|Mutual decision patient and physician|1|||
127849020|NCT02925312|460063381|FG000|Overall Study|Lost to Follow-up|25|||
127849021|NCT02925312|460063382|FG001|Overall Study|Lost to Follow-up|0|||
127849022|NCT02925312|460063381|FG000|Overall Study|Adverse Event|2|||
127849023|NCT02925312|460063382|FG001|Overall Study|Adverse Event|0|||
127904100|NCT05093205|460273605|FG003|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
127904101|NCT05093205|460273606|FG004|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
127904102|NCT05093205|460273607|FG005|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
127904103|NCT05093205|460273608|FG006|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
127904104|NCT05093205|460273609|FG007|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
127849024|NCT01455415|460063393|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
127904105|NCT05093205|460273610|FG008|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
127904106|NCT05093205|460273611|FG009|Part B Period 2 - Follow-Up|Withdrawal by Subject|1|||
127904107|NCT05093205|460273612|FG010|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
127849025|NCT01455415|460063394|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
127849026|NCT01455415|460063393|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
127849027|NCT01455415|460063394|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
127849028|NCT01455415|460063393|FG000|Period 1|Drug Error not Associated to AE|0|||
127849029|NCT01455415|460063394|FG001|Period 1|Drug Error not Associated to AE|1|||
127849030|NCT01455415|460063393|FG000|Period 1|AE Not Related to Study Drug|2|||
127849031|NCT01455415|460063394|FG001|Period 1|AE Not Related to Study Drug|6|||
127849032|NCT01455415|460063393|FG000|Period 1|Withdrawal by Subject|4|||
127849033|NCT01455415|460063394|FG001|Period 1|Withdrawal by Subject|5|||
127849034|NCT01455415|460063393|FG000|Period 1|Unspecified Reason|1|||
127849035|NCT01455415|460063394|FG001|Period 1|Unspecified Reason|1|||
127849036|NCT01455415|460063393|FG000|Period 1|Protocol Violation|0|||
127904108|NCT05093205|460273613|FG011|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
127904109|NCT05093205|460273614|FG012|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
127904110|NCT05093205|460273602|FG000|Part B Period 3 - Treatment|Adverse Event|0|||
127904111|NCT05093205|460273603|FG001|Part B Period 3 - Treatment|Adverse Event|0|||
127904112|NCT05093205|460273604|FG002|Part B Period 3 - Treatment|Adverse Event|0|||
127904113|NCT05093205|460273605|FG003|Part B Period 3 - Treatment|Adverse Event|0|||
127904114|NCT05093205|460273606|FG004|Part B Period 3 - Treatment|Adverse Event|0|||
127904115|NCT05093205|460273607|FG005|Part B Period 3 - Treatment|Adverse Event|0|||
127904116|NCT05093205|460273608|FG006|Part B Period 3 - Treatment|Adverse Event|0|||
127904117|NCT05093205|460273609|FG007|Part B Period 3 - Treatment|Adverse Event|0|||
127904118|NCT05093205|460273610|FG008|Part B Period 3 - Treatment|Adverse Event|0|||
127904119|NCT05093205|460273611|FG009|Part B Period 3 - Treatment|Adverse Event|0|||
127904120|NCT05093205|460273612|FG010|Part B Period 3 - Treatment|Adverse Event|2|||
127904121|NCT05093205|460273613|FG011|Part B Period 3 - Treatment|Adverse Event|0|||
127904122|NCT05093205|460273614|FG012|Part B Period 3 - Treatment|Adverse Event|0|||
127904123|NCT05093205|460273602|FG000|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
127904124|NCT05093205|460273603|FG001|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
127904125|NCT05093205|460273604|FG002|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
127904126|NCT05093205|460273605|FG003|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
127904127|NCT05093205|460273606|FG004|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
127904128|NCT05093205|460273607|FG005|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
127904129|NCT05093205|460273608|FG006|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
127904130|NCT05093205|460273609|FG007|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
127904131|NCT05093205|460273610|FG008|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
127904132|NCT05093205|460273611|FG009|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
127904133|NCT05093205|460273612|FG010|Part B Period 3 - Follow-Up|Withdrawal by Subject|2|||
127904134|NCT05093205|460273613|FG011|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
127904135|NCT05093205|460273614|FG012|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
127904136|NCT05093205|460273602|FG000|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
127904137|NCT05093205|460273603|FG001|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
127904138|NCT05093205|460273604|FG002|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
127904139|NCT05093205|460273605|FG003|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
127904140|NCT05093205|460273606|FG004|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
127904141|NCT05093205|460273607|FG005|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
127904142|NCT05093205|460273608|FG006|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
127904143|NCT05093205|460273609|FG007|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
127904144|NCT05093205|460273610|FG008|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
127904145|NCT05093205|460273611|FG009|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
127904146|NCT05093205|460273612|FG010|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
127904147|NCT05093205|460273613|FG011|Part B Period 4 - Treatment|Withdrawal by Subject|1|||
127904148|NCT05093205|460273614|FG012|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
127904149|NCT05093205|460273602|FG000|Part B Period 4 - Treatment|Adverse Event|0|||
127904150|NCT05093205|460273603|FG001|Part B Period 4 - Treatment|Adverse Event|0|||
127904151|NCT05093205|460273604|FG002|Part B Period 4 - Treatment|Adverse Event|0|||
127904152|NCT05093205|460273605|FG003|Part B Period 4 - Treatment|Adverse Event|0|||
127904153|NCT05093205|460273606|FG004|Part B Period 4 - Treatment|Adverse Event|0|||
127904154|NCT05093205|460273607|FG005|Part B Period 4 - Treatment|Adverse Event|0|||
127904155|NCT05093205|460273608|FG006|Part B Period 4 - Treatment|Adverse Event|0|||
127904156|NCT05093205|460273609|FG007|Part B Period 4 - Treatment|Adverse Event|0|||
127904157|NCT05093205|460273610|FG008|Part B Period 4 - Treatment|Adverse Event|0|||
127904158|NCT05093205|460273611|FG009|Part B Period 4 - Treatment|Adverse Event|0|||
127904159|NCT05093205|460273612|FG010|Part B Period 4 - Treatment|Adverse Event|0|||
127904160|NCT05093205|460273613|FG011|Part B Period 4 - Treatment|Adverse Event|2|||
127904161|NCT05093205|460273614|FG012|Part B Period 4 - Treatment|Adverse Event|0|||
127904162|NCT05093205|460273602|FG000|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
127904163|NCT05093205|460273603|FG001|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
127904164|NCT05093205|460273604|FG002|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
127904165|NCT05093205|460273605|FG003|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
127904166|NCT05093205|460273606|FG004|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
127904167|NCT05093205|460273607|FG005|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
127904168|NCT05093205|460273608|FG006|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
127904169|NCT05093205|460273609|FG007|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
127904170|NCT05093205|460273610|FG008|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
127904171|NCT05093205|460273611|FG009|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
127904172|NCT05093205|460273612|FG010|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
127904173|NCT05093205|460273613|FG011|Part B Period 4 - Follow-Up|Withdrawal by Subject|1|||
127904174|NCT05093205|460273614|FG012|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
127904175|NCT03361228|460273616|FG000|Overall Study|Other|1|||
127904176|NCT03361228|460273617|FG001|Overall Study|Other|1|||
127904177|NCT03361228|460273616|FG000|Overall Study|Death|3|||
127904178|NCT03361228|460273617|FG001|Overall Study|Death|0|||
127904179|NCT03693430|460273619|FG000|Overall Study|Lost to Follow-up|3|||
127904180|NCT03693430|460273620|FG001|Overall Study|Lost to Follow-up|14|||
127904181|NCT03693430|460273619|FG000|Overall Study|Death|1|||
127904182|NCT03693430|460273620|FG001|Overall Study|Death|0|||
127904183|NCT03693430|460273619|FG000|Overall Study|Withdrawal by Subject|0|||
127904184|NCT03693430|460273620|FG001|Overall Study|Withdrawal by Subject|4|||
127904185|NCT04185909|460273621|FG000|Overall Study|Lost to Follow-up|1|||
127904186|NCT01417078|460273622|FG000|Overall Study|Withdrawal by Subject|1|||
127904187|NCT00626548|460273623|FG000|Overall Study|Adverse Event|164|||
127904188|NCT00626548|460273624|FG001|Overall Study|Adverse Event|44|||
127904189|NCT00626548|460273623|FG000|Overall Study|Withdrawal by Subject|42|||
127904190|NCT00626548|460273624|FG001|Overall Study|Withdrawal by Subject|46|||
127904191|NCT00626548|460273623|FG000|Overall Study|Protocol Violation|4|||
127904192|NCT00626548|460273624|FG001|Overall Study|Protocol Violation|11|||
127904193|NCT00626548|460273623|FG000|Overall Study|Lost to Follow-up|2|||
127904194|NCT00626548|460273624|FG001|Overall Study|Lost to Follow-up|2|||
127904195|NCT00626548|460273623|FG000|Overall Study|Other termination reason|493|||
127904196|NCT00626548|460273624|FG001|Overall Study|Other termination reason|613|||
127904197|NCT00048581|460273625|FG000|Double-Blind Period|Adverse Event|9|||
127904198|NCT00048581|460273626|FG001|Double-Blind Period|Adverse Event|5|||
127904199|NCT00048581|460273627|FG002|Double-Blind Period|Adverse Event|0|||
127904200|NCT00048581|460273625|FG000|Double-Blind Period|Lack of Efficacy|14|||
127904201|NCT00048581|460273626|FG001|Double-Blind Period|Lack of Efficacy|27|||
127849037|NCT01455415|460063394|FG001|Period 1|Protocol Violation|2|||
127849038|NCT01455415|460063393|FG000|Washout|AE Related to Study Drug|2|||
127849039|NCT01455415|460063394|FG001|Washout|AE Related to Study Drug|0|||
127849040|NCT01455415|460063393|FG000|Washout|Lost to Follow-up|1|||
127849041|NCT01455415|460063394|FG001|Washout|Lost to Follow-up|0|||
127849042|NCT01455415|460063393|FG000|Washout|Drug Error not Associated to AE|2|||
127849043|NCT01455415|460063394|FG001|Washout|Drug Error not Associated to AE|1|||
127849044|NCT01455415|460063393|FG000|Washout|AE Not Related to Study Drug|2|||
127849045|NCT01455415|460063394|FG001|Washout|AE Not Related to Study Drug|3|||
127849046|NCT01455415|460063393|FG000|Washout|Unspecified Reason|1|||
127849047|NCT01455415|460063394|FG001|Washout|Unspecified Reason|2|||
127849048|NCT01455415|460063393|FG000|Washout|Protocol Violation|0|||
127849049|NCT01455415|460063394|FG001|Washout|Protocol Violation|1|||
127849050|NCT01455415|460063393|FG000|Period 2|AE Related to Study Drug|1|||
127849051|NCT01455415|460063394|FG001|Period 2|AE Related to Study Drug|2|||
127849052|NCT01455415|460063393|FG000|Period 2|Lost to Follow-up|2|||
127849053|NCT01455415|460063394|FG001|Period 2|Lost to Follow-up|1|||
127849054|NCT01455415|460063393|FG000|Period 2|AE Not Related to Study Drug|2|||
127849055|NCT01455415|460063394|FG001|Period 2|AE Not Related to Study Drug|1|||
127849056|NCT01455415|460063393|FG000|Period 2|Lack of Efficacy|2|||
127849057|NCT01455415|460063394|FG001|Period 2|Lack of Efficacy|0|||
127849058|NCT01455415|460063393|FG000|Period 2|Withdrawal by Subject|2|||
127849059|NCT01455415|460063394|FG001|Period 2|Withdrawal by Subject|3|||
127849060|NCT01455415|460063393|FG000|Period 2|Unspecified Reason|2|||
127849061|NCT01455415|460063394|FG001|Period 2|Unspecified Reason|3|||
127849062|NCT01455415|460063393|FG000|Period 2|Protocol Violation|2|||
127849063|NCT01455415|460063394|FG001|Period 2|Protocol Violation|0|||
127849064|NCT01455415|460063393|FG000|Follow-up|AE Related to Study Drug|0|||
127849065|NCT01455415|460063394|FG001|Follow-up|AE Related to Study Drug|1|||
127849066|NCT01455415|460063393|FG000|Follow-up|Lack of Efficacy|0|||
127849067|NCT01455415|460063394|FG001|Follow-up|Lack of Efficacy|1|||
127849068|NCT01455415|460063393|FG000|Follow-up|Withdrawal by Subject|2|||
127849069|NCT01455415|460063394|FG001|Follow-up|Withdrawal by Subject|0|||
127849070|NCT01455415|460063393|FG000|Follow-up|Unspecified Reason|1|||
127849071|NCT01455415|460063394|FG001|Follow-up|Unspecified Reason|0|||
127849072|NCT00587301|460063395|FG000|Overall Study|Screen Failure|9|||
127849073|NCT00587301|460063395|FG000|Overall Study|Lost to Follow-up|22|||
127849074|NCT00587301|460063395|FG000|Overall Study|Withdrawal by Subject|7|||
127849075|NCT00587301|460063395|FG000|Overall Study|Protocol Violation|7|||
127849076|NCT02758613|460063396|FG000|Treatment|Physician and Sponsor Decision|1|||
127849077|NCT02758613|460063397|FG001|Treatment|Physician and Sponsor Decision|0|||
127849078|NCT02758613|460063398|FG002|Treatment|Physician and Sponsor Decision|0|||
127849079|NCT02758613|460063399|FG003|Treatment|Physician and Sponsor Decision|0|||
127849080|NCT02758613|460063396|FG000|Treatment|Withdrawal by Subject|1|||
127849081|NCT02758613|460063397|FG001|Treatment|Withdrawal by Subject|0|||
127904202|NCT00048581|460273627|FG002|Double-Blind Period|Lack of Efficacy|0|||
127904203|NCT00048581|460273625|FG000|Double-Blind Period|Lost to Follow-up|5|||
127904204|NCT00048581|460273626|FG001|Double-Blind Period|Lost to Follow-up|0|||
127849082|NCT02758613|460063398|FG002|Treatment|Withdrawal by Subject|1|||
127849083|NCT02758613|460063399|FG003|Treatment|Withdrawal by Subject|0|||
127849084|NCT01496274|460063400|FG000|Overall Study|Protocol Violation|0|||
127849085|NCT01496274|460063401|FG001|Overall Study|Protocol Violation|1|||
127849086|NCT01496274|460063400|FG000|Overall Study|Adverse Event|1|||
127849087|NCT01496274|460063401|FG001|Overall Study|Adverse Event|1|||
127849088|NCT01496274|460063400|FG000|Overall Study|Withdrawal by Subject|2|||
127849089|NCT01496274|460063401|FG001|Overall Study|Withdrawal by Subject|0|||
127849090|NCT01496274|460063400|FG000|Overall Study|Lost to Follow-up|0|||
127849091|NCT01496274|460063401|FG001|Overall Study|Lost to Follow-up|3|||
127849092|NCT00351819|460063403|FG000|Overall Study|Lost to Follow-up|4|||
127849093|NCT00351819|460063404|FG001|Overall Study|Lost to Follow-up|4|||
127849094|NCT00351819|460063403|FG000|Overall Study|Withdrawal by Subject|0|||
127849095|NCT00351819|460063404|FG001|Overall Study|Withdrawal by Subject|4|||
127849096|NCT00351819|460063403|FG000|Overall Study|Elevated PSA|1|||
127849097|NCT00351819|460063404|FG001|Overall Study|Elevated PSA|1|||
127849098|NCT00351819|460063403|FG000|Overall Study|Traumatic ankle fracture|1|||
127849099|NCT00351819|460063404|FG001|Overall Study|Traumatic ankle fracture|0|||
127849100|NCT00351819|460063403|FG000|Overall Study|Unprofessional behavior|1|||
127849101|NCT00351819|460063404|FG001|Overall Study|Unprofessional behavior|0|||
127849102|NCT00351819|460063403|FG000|Overall Study|Non-compliance|0|||
127849103|NCT00351819|460063404|FG001|Overall Study|Non-compliance|1|||
127849104|NCT00351819|460063403|FG000|Overall Study|Incarcerated|0|||
127849105|NCT00351819|460063404|FG001|Overall Study|Incarcerated|1|||
127849106|NCT00351819|460063403|FG000|Overall Study|Enrolled in another trial|0|||
127849107|NCT00351819|460063404|FG001|Overall Study|Enrolled in another trial|1|||
127849108|NCT01425749|460063405|FG000|Overall Study|progression of melanoma|0|||
127849109|NCT01425749|460063406|FG001|Overall Study|progression of melanoma|1|||
127849110|NCT01293084|460063407|FG000|Overall Study|Physician Decision|3|||
127849111|NCT01293084|460063407|FG000|Overall Study|Withdrawal by Subject|2|||
127849112|NCT02096042|460063408|FG000|Overall Study|Disease Progression|1|||
127849113|NCT02096042|460063409|FG001|Overall Study|Disease Progression|0|||
127849114|NCT02096042|460063410|FG002|Overall Study|Disease Progression|0|||
127849115|NCT02983799|460063411|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
127849116|NCT02983799|460063412|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
127849117|NCT02983799|460063413|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
127849118|NCT02983799|460063414|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
127849119|NCT02983799|460063415|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
127849120|NCT02983799|460063411|FG000|Overall Study|Death|20|||
127849121|NCT02983799|460063412|FG001|Overall Study|Death|5|||
127849122|NCT02983799|460063413|FG002|Overall Study|Death|23|||
127849123|NCT02983799|460063414|FG003|Overall Study|Death|47|||
127849124|NCT02983799|460063415|FG004|Overall Study|Death|7|||
127849125|NCT02983799|460063411|FG000|Overall Study|Withdrawal by Subject|1|||
127849126|NCT02983799|460063412|FG001|Overall Study|Withdrawal by Subject|0|||
127849127|NCT02983799|460063413|FG002|Overall Study|Withdrawal by Subject|3|||
127849128|NCT02983799|460063414|FG003|Overall Study|Withdrawal by Subject|4|||
127849129|NCT02983799|460063415|FG004|Overall Study|Withdrawal by Subject|1|||
127849130|NCT02983799|460063411|FG000|Overall Study|Protocol Violation|0|||
127849131|NCT02983799|460063412|FG001|Overall Study|Protocol Violation|1|||
127849132|NCT02983799|460063413|FG002|Overall Study|Protocol Violation|0|||
127849133|NCT02983799|460063414|FG003|Overall Study|Protocol Violation|0|||
127849134|NCT02983799|460063415|FG004|Overall Study|Protocol Violation|1|||
127849135|NCT02983799|460063411|FG000|Overall Study|Lost to Follow-up|1|||
127849136|NCT02983799|460063412|FG001|Overall Study|Lost to Follow-up|0|||
127849137|NCT02983799|460063413|FG002|Overall Study|Lost to Follow-up|1|||
127849138|NCT02983799|460063414|FG003|Overall Study|Lost to Follow-up|0|||
127849139|NCT02983799|460063415|FG004|Overall Study|Lost to Follow-up|0|||
127849140|NCT01313078|460063424|FG000|Overall Study|Death|1|||
127849141|NCT01313078|460063424|FG000|Overall Study|Discontinued study drug|1|||
127849142|NCT01313078|460063424|FG000|Overall Study|Withdrawal by Subject|1|||
127849143|NCT01225172|460063429|FG000|Overall Study|Subject decision to stop|1|||
127849144|NCT01225172|460063430|FG001|Overall Study|Subject decision to stop|0|||
127849145|NCT01225172|460063429|FG000|Overall Study|Subject request to discontinue treatment|3|||
127849146|NCT01225172|460063430|FG001|Overall Study|Subject request to discontinue treatment|1|||
127849147|NCT01225172|460063429|FG000|Overall Study|Subject no longer meets study criteria|1|||
127849148|NCT01225172|460063430|FG001|Overall Study|Subject no longer meets study criteria|0|||
127849149|NCT01225172|460063429|FG000|Overall Study|Withdrawal by Subject|1|||
127849150|NCT01225172|460063430|FG001|Overall Study|Withdrawal by Subject|0|||
127849151|NCT02679781|460063431|FG000|Overall Study|Lost to Follow-up|1|||
127849152|NCT02679781|460063432|FG001|Overall Study|Lost to Follow-up|2|||
127849153|NCT02679781|460063431|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
127849154|NCT02679781|460063432|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
127849155|NCT04209400|460063433|FG000|Overall Study|Withdrawal by Subject|0|||
127849156|NCT04209400|460063434|FG001|Overall Study|Withdrawal by Subject|1|||
127849157|NCT00795509|460063443|FG000|Overall Study|Protocol Violation|31|||
127849158|NCT01601470|460063444|FG000|Period 2 - LCZ696|Physician Decision|1|||
127849159|NCT01203787|460063445|FG000|Overall Study|Death|12|||
127849160|NCT01203787|460063446|FG001|Overall Study|Death|10|||
127849161|NCT01203787|460063445|FG000|Overall Study|Withdrawal by Subject|6|||
127849162|NCT01203787|460063446|FG001|Overall Study|Withdrawal by Subject|2|||
127849163|NCT01203787|460063445|FG000|Overall Study|Lost to Follow-up|2|||
127849164|NCT01203787|460063446|FG001|Overall Study|Lost to Follow-up|0|||
127849165|NCT01203787|460063445|FG000|Overall Study|Adverse Event|11|||
127849166|NCT01203787|460063446|FG001|Overall Study|Adverse Event|15|||
127849167|NCT00970268|460063447|FG000|Overall Study|Withdrawal by Subject|12|||
127904205|NCT00048581|460273627|FG002|Double-Blind Period|Lost to Follow-up|0|||
127904206|NCT00048581|460273625|FG000|Double-Blind Period|Withdrawal by Subject|5|||
127904207|NCT00048581|460273626|FG001|Double-Blind Period|Withdrawal by Subject|2|||
127904208|NCT00048581|460273627|FG002|Double-Blind Period|Withdrawal by Subject|0|||
127904209|NCT00048581|460273625|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
127904210|NCT00048581|460273626|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
127904211|NCT00048581|460273627|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
127904212|NCT00048581|460273625|FG000|Double-Blind Period|Investigator Decision|1|||
127904213|NCT00048581|460273626|FG001|Double-Blind Period|Investigator Decision|0|||
127904214|NCT00048581|460273627|FG002|Double-Blind Period|Investigator Decision|0|||
127904215|NCT00048581|460273625|FG000|Open-Label Period|Death|0|||
127904216|NCT00048581|460273626|FG001|Open-Label Period|Death|0|||
127904217|NCT00048581|460273627|FG002|Open-Label Period|Death|4|||
127904218|NCT00048581|460273625|FG000|Open-Label Period|Adverse Event|0|||
127904219|NCT00048581|460273626|FG001|Open-Label Period|Adverse Event|0|||
127904220|NCT00048581|460273627|FG002|Open-Label Period|Adverse Event|37|||
127904221|NCT00048581|460273625|FG000|Open-Label Period|Lack of Efficacy|0|||
127904222|NCT00048581|460273626|FG001|Open-Label Period|Lack of Efficacy|0|||
127904223|NCT00048581|460273627|FG002|Open-Label Period|Lack of Efficacy|69|||
127904224|NCT00048581|460273625|FG000|Open-Label Period|Lost to Follow-up|0|||
127904225|NCT00048581|460273626|FG001|Open-Label Period|Lost to Follow-up|0|||
127904226|NCT00048581|460273627|FG002|Open-Label Period|Lost to Follow-up|14|||
127904227|NCT00048581|460273625|FG000|Open-Label Period|Withdrawal by Subject|0|||
127904228|NCT00048581|460273626|FG001|Open-Label Period|Withdrawal by Subject|0|||
127904229|NCT00048581|460273627|FG002|Open-Label Period|Withdrawal by Subject|20|||
127904230|NCT00048581|460273625|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
127904231|NCT00048581|460273626|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
127904232|NCT00048581|460273627|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
127904233|NCT00048581|460273625|FG000|Open-Label Period|Poor/Non-compliance|0|||
127904234|NCT00048581|460273626|FG001|Open-Label Period|Poor/Non-compliance|0|||
127904235|NCT00048581|460273627|FG002|Open-Label Period|Poor/Non-compliance|5|||
127904236|NCT00048581|460273625|FG000|Open-Label Period|Pregnancy|0|||
127904237|NCT00048581|460273626|FG001|Open-Label Period|Pregnancy|0|||
127904238|NCT00048581|460273627|FG002|Open-Label Period|Pregnancy|7|||
127904239|NCT00048581|460273625|FG000|Open-Label Period|Study Site Closure|0|||
127904240|NCT00048581|460273626|FG001|Open-Label Period|Study Site Closure|0|||
127904241|NCT00048581|460273627|FG002|Open-Label Period|Study Site Closure|2|||
127904242|NCT00048581|460273625|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
127904243|NCT00048581|460273626|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
127904244|NCT00048581|460273627|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
127904245|NCT00048581|460273625|FG000|Open-Label Period|Problem With Transportation To Site|0|||
127904246|NCT00048581|460273626|FG001|Open-Label Period|Problem With Transportation To Site|0|||
127904247|NCT00048581|460273627|FG002|Open-Label Period|Problem With Transportation To Site|1|||
127904248|NCT00048581|460273625|FG000|Open-Label Period|Primary Investigator Retired|0|||
127904249|NCT00048581|460273626|FG001|Open-Label Period|Primary Investigator Retired|0|||
127904250|NCT00048581|460273627|FG002|Open-Label Period|Primary Investigator Retired|2|||
127904251|NCT00048581|460273625|FG000|Open-Label Period|Study Ended By Sponsor|0|||
127904252|NCT00048581|460273626|FG001|Open-Label Period|Study Ended By Sponsor|0|||
127904253|NCT00048581|460273627|FG002|Open-Label Period|Study Ended By Sponsor|1|||
127904254|NCT01059903|460273629|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
127904255|NCT01059903|460273630|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
127904256|NCT00385593|460273637|FG000|Overall Study|Adverse Event|3|||
127904257|NCT00385593|460273638|FG001|Overall Study|Adverse Event|2|||
127904258|NCT00385593|460273637|FG000|Overall Study|Withdrawal by Subject|17|||
127904259|NCT00385593|460273638|FG001|Overall Study|Withdrawal by Subject|7|||
127904260|NCT00385593|460273637|FG000|Overall Study|Lost to Follow-up|12|||
127904261|NCT00385593|460273638|FG001|Overall Study|Lost to Follow-up|8|||
127904262|NCT00385593|460273637|FG000|Overall Study|Protocol Violation|7|||
127904263|NCT00385593|460273638|FG001|Overall Study|Protocol Violation|4|||
127904264|NCT00385593|460273637|FG000|Overall Study|Several reasons|17|||
127904265|NCT00385593|460273638|FG001|Overall Study|Several reasons|15|||
127904266|NCT00385593|460273637|FG000|Overall Study|Incorrect inclusion|2|||
127904267|NCT00385593|460273638|FG001|Overall Study|Incorrect inclusion|0|||
127904268|NCT00385593|460273637|FG000|Overall Study|Incorrect randomization|0|||
127904269|NCT00385593|460273638|FG001|Overall Study|Incorrect randomization|1|||
127904270|NCT00319735|460273639|FG000|Overall Study|Death|2|||
127904271|NCT03420300|460273641|FG000|Overall Study|Death|2|||
127904272|NCT02421952|460273642|FG000|Overall Study|Diary Not Returned|93|||
127904273|NCT02421952|460273642|FG000|Overall Study|Failed seriation task|13|||
127904274|NCT02421952|460273642|FG000|Overall Study|Subject uncooperative for baseline test|2|||
127904275|NCT02421952|460273642|FG000|Overall Study|Surgery cancelled|1|||
127904276|NCT01882257|460275404|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
127904277|NCT01882257|460275405|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
127904278|NCT01882257|460275406|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
127849168|NCT00970268|460063448|FG001|Overall Study|Withdrawal by Subject|19|||
127849169|NCT00970268|460063447|FG000|Overall Study|Adverse Event|15|||
127849170|NCT00970268|460063448|FG001|Overall Study|Adverse Event|12|||
127849171|NCT00970268|460063447|FG000|Overall Study|Lack of Efficacy|3|||
127849172|NCT00970268|460063448|FG001|Overall Study|Lack of Efficacy|6|||
127849173|NCT00970268|460063447|FG000|Overall Study|Protocol Violation|4|||
127849174|NCT00970268|460063448|FG001|Overall Study|Protocol Violation|7|||
127849175|NCT00970268|460063447|FG000|Overall Study|Other Reason|3|||
127849176|NCT00970268|460063448|FG001|Overall Study|Other Reason|1|||
127849177|NCT00970268|460063447|FG000|Overall Study|COPD Exacerbation|4|||
127849178|NCT00970268|460063448|FG001|Overall Study|COPD Exacerbation|2|||
127849179|NCT00970268|460063447|FG000|Overall Study|Lost to Follow-up|1|||
127849180|NCT00970268|460063448|FG001|Overall Study|Lost to Follow-up|2|||
127849181|NCT00970268|460063447|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
127849182|NCT00970268|460063448|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
127849183|NCT03404518|460063449|FG000|Overall Study|Lost to Follow-up|28|||
127849184|NCT03404518|460063450|FG001|Overall Study|Lost to Follow-up|30|||
127849185|NCT03404518|460063449|FG000|Overall Study|Protocol Violation|13|||
127849186|NCT03404518|460063450|FG001|Overall Study|Protocol Violation|6|||
127849187|NCT01079195|460063451|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
127849188|NCT01079195|460063451|FG000|Overall Study|No Documentation Available|437|||
127849189|NCT01079195|460063451|FG000|Overall Study|Adverse Event|157|||
127849190|NCT01079195|460063451|FG000|Overall Study|Reason Unknown|39|||
127849191|NCT01079195|460063451|FG000|Overall Study|Withdrawal by Subject|18|||
127849192|NCT01079195|460063451|FG000|Overall Study|Financial Reasons|15|||
127849193|NCT01079195|460063451|FG000|Overall Study|Lack of Effectiveness|12|||
127849194|NCT01079195|460063451|FG000|Overall Study|Physician Decision|4|||
127849195|NCT01079195|460063451|FG000|Overall Study|Improved Status of Participant|4|||
127849196|NCT01079195|460063451|FG000|Overall Study|No Follow-up Documentation Available|4|||
127849197|NCT01079195|460063451|FG000|Overall Study|Non-compliance|2|||
127849198|NCT00323310|460065563|FG000|Overall Study|Withdrawal by Subject|1|||
127849199|NCT00323310|460065563|FG000|Overall Study|a parent refused blood draw|1|||
127849200|NCT00323310|460065563|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
127849201|NCT03984812|460065564|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
127849202|NCT03984812|460065565|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
127849203|NCT03984812|460065566|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
127849204|NCT03984812|460065567|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
127849205|NCT03984812|460065568|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
127849206|NCT03984812|460065569|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
127849207|NCT03984812|460065570|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
127849208|NCT03984812|460065571|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
127849209|NCT03984812|460065572|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
127849210|NCT03984812|460065573|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
127849211|NCT03984812|460065574|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
127849212|NCT02707601|460065575|FG000|Overall Study|Death|0|||
127849213|NCT02707601|460065576|FG001|Overall Study|Death|1|||
127849214|NCT02707601|460065575|FG000|Overall Study|Lack of Efficacy|0|||
127849215|NCT02707601|460065576|FG001|Overall Study|Lack of Efficacy|1|||
127849216|NCT02707601|460065575|FG000|Overall Study|Investigator's Discretion|1|||
127849217|NCT02707601|460065576|FG001|Overall Study|Investigator's Discretion|0|||
127849218|NCT02707601|460065575|FG000|Overall Study|Withdrew Consent|0|||
127849219|NCT02707601|460065576|FG001|Overall Study|Withdrew Consent|1|||
127849220|NCT02707601|460065575|FG000|Overall Study|Lost to Follow-up|1|||
127849221|NCT02707601|460065576|FG001|Overall Study|Lost to Follow-up|1|||
127849222|NCT02707601|460065575|FG000|Overall Study|Participants Randomized but Not Treated|2|||
127849223|NCT02707601|460065576|FG001|Overall Study|Participants Randomized but Not Treated|0|||
127849224|NCT02147691|460065578|FG000|Overall Study|Withdrawal by Subject|2|||
127849225|NCT02147691|460065579|FG001|Overall Study|Withdrawal by Subject|0|||
127849226|NCT02147691|460065578|FG000|Overall Study|Adverse Event|2|||
127849227|NCT02147691|460065579|FG001|Overall Study|Adverse Event|0|||
127849228|NCT02147691|460065578|FG000|Overall Study|Lost to Follow-up|0|||
127849229|NCT02147691|460065579|FG001|Overall Study|Lost to Follow-up|1|||
127849230|NCT01392742|460065580|FG000|Overall Study|Premature study termination|42|||
127849231|NCT01392742|460065580|FG000|Overall Study|Failure to return|35|||
127849232|NCT01392742|460065580|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
127849233|NCT01392742|460065580|FG000|Overall Study|Lost to Follow-up|34|||
127849234|NCT01392742|460065580|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
127849235|NCT01392742|460065580|FG000|Overall Study|ITR and Protocol deviation|1|||
127849236|NCT01392742|460065580|FG000|Overall Study|Adverse event/intercurrent illness|17|||
127849237|NCT01392742|460065580|FG000|Overall Study|Protocol Violation|14|||
127849238|NCT01392742|460065580|FG000|Overall Study|Other|3|||
127849239|NCT01392742|460065580|FG000|Overall Study|Missing information|13|||
127849240|NCT02432703|460065581|FG000|Overall Study|Adverse Event|1|||
127849241|NCT02432703|460065582|FG001|Overall Study|Adverse Event|4|||
127849242|NCT02432703|460065581|FG000|Overall Study|Lack of Efficacy|1|||
127849243|NCT02432703|460065582|FG001|Overall Study|Lack of Efficacy|0|||
127849244|NCT02432703|460065581|FG000|Overall Study|Lost to Follow-up|5|||
127849245|NCT02432703|460065582|FG001|Overall Study|Lost to Follow-up|3|||
127849246|NCT02432703|460065581|FG000|Overall Study|Withdrawal by Subject|9|||
127849247|NCT02432703|460065582|FG001|Overall Study|Withdrawal by Subject|6|||
127849248|NCT02432703|460065581|FG000|Overall Study|Other|6|||
127849249|NCT02432703|460065582|FG001|Overall Study|Other|5|||
127849250|NCT03210220|460065583|FG000|Overall Study|Physician Decision|1|||
127849251|NCT03210220|460065584|FG001|Overall Study|Physician Decision|0|||
127849252|NCT02911519|460065585|FG000|Overall Study|Lost to Follow-up|2|||
127849253|NCT02911519|460065586|FG001|Overall Study|Lost to Follow-up|2|||
127849254|NCT02911519|460065585|FG000|Overall Study|Death|0|||
127849255|NCT02911519|460065586|FG001|Overall Study|Death|2|||
127849256|NCT00653328|460065587|FG000|Overall Study|Withdrawal by Subject|1|||
127849257|NCT00653328|460065587|FG000|Overall Study|Adverse Event|2|||
127849258|NCT00653328|460065587|FG000|Overall Study|Disease progression|10|||
127849259|NCT00653328|460065587|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
127849260|NCT00839436|460065590|FG000|Overall Study|Developed exclusionary condition|1|||
127849261|NCT00839436|460065591|FG001|Overall Study|Developed exclusionary condition|0|||
127849262|NCT00839436|460065592|FG002|Overall Study|Developed exclusionary condition|0|||
127849263|NCT00839436|460065590|FG000|Overall Study|Withdrawal by Subject|0|||
127849264|NCT00839436|460065591|FG001|Overall Study|Withdrawal by Subject|1|||
127849265|NCT00839436|460065592|FG002|Overall Study|Withdrawal by Subject|0|||
127849266|NCT00839436|460065590|FG000|Overall Study|Study drug no longer available|0|||
127849267|NCT00839436|460065591|FG001|Overall Study|Study drug no longer available|0|||
127849268|NCT00839436|460065592|FG002|Overall Study|Study drug no longer available|1|||
127849269|NCT01444898|460065594|FG000|Overall Study|Withdrawal by Subject|1|||
127849270|NCT02580591|460065596|FG000|Overall Study|Adverse Event|0|||
127849271|NCT02580591|460065597|FG001|Overall Study|Adverse Event|1|||
127849272|NCT02580591|460065598|FG002|Overall Study|Adverse Event|2|||
127849273|NCT02580591|460065599|FG003|Overall Study|Adverse Event|5|||
127849274|NCT02580591|460065596|FG000|Overall Study|Protocol Violation|3|||
127849275|NCT02580591|460065597|FG001|Overall Study|Protocol Violation|2|||
127849276|NCT02580591|460065598|FG002|Overall Study|Protocol Violation|1|||
127849277|NCT02580591|460065599|FG003|Overall Study|Protocol Violation|1|||
127849278|NCT02580591|460065596|FG000|Overall Study|Lost to Follow-up|5|||
127849279|NCT02580591|460065597|FG001|Overall Study|Lost to Follow-up|3|||
127849280|NCT02580591|460065598|FG002|Overall Study|Lost to Follow-up|3|||
127849281|NCT02580591|460065599|FG003|Overall Study|Lost to Follow-up|1|||
127849282|NCT02580591|460065596|FG000|Overall Study|Withdrawal by Subject|6|||
127849283|NCT02580591|460065597|FG001|Overall Study|Withdrawal by Subject|1|||
127849284|NCT02580591|460065598|FG002|Overall Study|Withdrawal by Subject|2|||
127849285|NCT02580591|460065599|FG003|Overall Study|Withdrawal by Subject|3|||
127849286|NCT02580591|460065596|FG000|Overall Study|Not treated|1|||
127849287|NCT02580591|460065597|FG001|Overall Study|Not treated|1|||
127849288|NCT02580591|460065598|FG002|Overall Study|Not treated|0|||
127849289|NCT02580591|460065599|FG003|Overall Study|Not treated|0|||
127849290|NCT02580591|460065596|FG000|Overall Study|Other than specified|3|||
127849291|NCT02580591|460065597|FG001|Overall Study|Other than specified|2|||
127849292|NCT02580591|460065598|FG002|Overall Study|Other than specified|5|||
127849293|NCT02580591|460065599|FG003|Overall Study|Other than specified|2|||
127849294|NCT00561340|460065603|FG000|Overall Study|refused to drink pediasure|6|||
127849295|NCT00561340|460065604|FG001|Overall Study|refused to drink pediasure|0|||
127849296|NCT00445341|460065605|FG000|Overall Study|refused further treatment|1|||
127849297|NCT00445341|460065605|FG000|Overall Study|taken off treatment too early|1|||
127849298|NCT03051217|460065606|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
127849299|NCT03051217|460065607|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
127849300|NCT03051217|460065608|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
127849301|NCT03051217|460065609|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
127849302|NCT03051217|460065610|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
127849303|NCT03051217|460065611|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
127849304|NCT03051217|460065612|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
127849305|NCT03051217|460065606|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
127849306|NCT03051217|460065607|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
127849307|NCT03051217|460065608|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
127849308|NCT03051217|460065609|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
127849309|NCT03051217|460065610|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
127849310|NCT03051217|460065611|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
127849311|NCT03051217|460065612|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
127849312|NCT03051217|460065606|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
127849313|NCT03051217|460065607|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
127849314|NCT03051217|460065608|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
127849315|NCT03051217|460065609|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
127849316|NCT03051217|460065610|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
127849317|NCT03051217|460065611|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
127904279|NCT01882257|460275404|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
127904280|NCT01882257|460275405|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
127904281|NCT01882257|460275406|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
127904282|NCT02058498|460275409|FG000|Overall Study|Withdrawal by Subject|4|||
127904283|NCT00834743|460275413|FG000|Second Intervention|Withdrawal by Subject|1|||
127904284|NCT00834743|460275414|FG001|Second Intervention|Withdrawal by Subject|0|||
127904285|NCT00086996|460275416|FG000|Overall Study|Adverse Event|29|||
127904286|NCT00086996|460275416|FG000|Overall Study|Death|4|||
127904287|NCT00086996|460275416|FG000|Overall Study|progression/relapse|7|||
127904288|NCT00086996|460275416|FG000|Overall Study|Withdrawal by Subject|13|||
127904289|NCT00086996|460275416|FG000|Overall Study|Other|6|||
127904290|NCT00086996|460275416|FG000|Overall Study|not eligible|5|||
127904291|NCT00004562|460275417|FG000|Overall Study|Lost to Follow-up|102|||
127904292|NCT00004562|460275418|FG001|Overall Study|Lost to Follow-up|91|||
127904293|NCT04274686|460275420|FG000|Overall Study|Physician Decision|1|||
127904294|NCT04274686|460275421|FG001|Overall Study|Physician Decision|0|||
127904295|NCT00376623|460275422|FG000|Overall Study|Progressive disease|35|||
127904296|NCT00376623|460275423|FG001|Overall Study|Progressive disease|22|||
127904297|NCT00376623|460275424|FG002|Overall Study|Progressive disease|17|||
127904298|NCT00376623|460275422|FG000|Overall Study|Lost to Follow-up|0|||
127904299|NCT00376623|460275423|FG001|Overall Study|Lost to Follow-up|1|||
127904300|NCT00376623|460275424|FG002|Overall Study|Lost to Follow-up|0|||
127904301|NCT00376623|460275422|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
127904302|NCT00376623|460275423|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
127904303|NCT00376623|460275424|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
127904304|NCT00376623|460275422|FG000|Overall Study|Not treated with BI 2536|1|||
127904305|NCT00376623|460275423|FG001|Overall Study|Not treated with BI 2536|0|||
127904306|NCT00376623|460275424|FG002|Overall Study|Not treated with BI 2536|0|||
127904307|NCT00376623|460275422|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
127904308|NCT00376623|460275423|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
127904309|NCT00376623|460275424|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
127904310|NCT00376623|460275422|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
127904311|NCT00376623|460275423|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
127904312|NCT00376623|460275424|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
127904313|NCT00376623|460275422|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
127904314|NCT00376623|460275423|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
127904315|NCT00376623|460275424|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
127904316|NCT00376623|460275422|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
127904317|NCT00376623|460275423|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
127904318|NCT00376623|460275424|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
127904319|NCT00376623|460275422|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
127904320|NCT00376623|460275423|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
127904321|NCT00376623|460275424|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
127904322|NCT00376623|460275422|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
127904323|NCT00376623|460275423|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
127904324|NCT00376623|460275424|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
127904325|NCT00376623|460275422|FG000|Overall Study|Increase of tumour markers|0|||
127904326|NCT00376623|460275423|FG001|Overall Study|Increase of tumour markers|1|||
127904327|NCT00376623|460275424|FG002|Overall Study|Increase of tumour markers|0|||
127904328|NCT00376623|460275422|FG000|Overall Study|Bone metastasis|1|||
127904329|NCT00376623|460275423|FG001|Overall Study|Bone metastasis|0|||
127904330|NCT00376623|460275424|FG002|Overall Study|Bone metastasis|0|||
127904331|NCT00286754|460275425|FG000|Overall Study|Adverse Event|2|||
127904332|NCT00286754|460275426|FG001|Overall Study|Adverse Event|2|||
127904333|NCT00286754|460275427|FG002|Overall Study|Adverse Event|3|||
127904334|NCT00286754|460275425|FG000|Overall Study|Withdrawal by Subject|6|||
127904335|NCT00286754|460275426|FG001|Overall Study|Withdrawal by Subject|2|||
127904336|NCT00286754|460275427|FG002|Overall Study|Withdrawal by Subject|0|||
127904337|NCT00286754|460275425|FG000|Overall Study|Lost to Follow-up|12|||
127904338|NCT00286754|460275426|FG001|Overall Study|Lost to Follow-up|14|||
127904339|NCT00286754|460275427|FG002|Overall Study|Lost to Follow-up|6|||
127904340|NCT00286754|460275425|FG000|Overall Study|Moved out of state|0|||
127904341|NCT00286754|460275426|FG001|Overall Study|Moved out of state|0|||
127904342|NCT00286754|460275427|FG002|Overall Study|Moved out of state|1|||
127904343|NCT02336165|460275428|FG000|Overall Study|Death|3|||
127904344|NCT02336165|460275429|FG001|Overall Study|Death|0|||
127904345|NCT02336165|460275430|FG002|Overall Study|Death|0|||
127904346|NCT02336165|460275431|FG003|Overall Study|Death|0|||
127904347|NCT02336165|460275432|FG004|Overall Study|Death|1|||
127904348|NCT02336165|460275428|FG000|Overall Study|Physician Decision|2|||
127904349|NCT02336165|460275429|FG001|Overall Study|Physician Decision|2|||
127904350|NCT02336165|460275430|FG002|Overall Study|Physician Decision|1|||
127904351|NCT02336165|460275431|FG003|Overall Study|Physician Decision|1|||
127904352|NCT02336165|460275432|FG004|Overall Study|Physician Decision|0|||
127904353|NCT02336165|460275428|FG000|Overall Study|Withdrawal by Subject|0|||
127904354|NCT02336165|460275429|FG001|Overall Study|Withdrawal by Subject|0|||
127904355|NCT02336165|460275430|FG002|Overall Study|Withdrawal by Subject|1|||
127904356|NCT02336165|460275431|FG003|Overall Study|Withdrawal by Subject|0|||
127904357|NCT02336165|460275432|FG004|Overall Study|Withdrawal by Subject|1|||
127904358|NCT02336165|460275428|FG000|Overall Study|Adverse Event|4|||
127904359|NCT02336165|460275429|FG001|Overall Study|Adverse Event|1|||
127904360|NCT02336165|460275430|FG002|Overall Study|Adverse Event|2|||
127904361|NCT02336165|460275431|FG003|Overall Study|Adverse Event|4|||
127904362|NCT02336165|460275432|FG004|Overall Study|Adverse Event|1|||
127904363|NCT02336165|460275428|FG000|Overall Study|Progressive disease|23|||
127904364|NCT02336165|460275429|FG001|Overall Study|Progressive disease|22|||
127904365|NCT02336165|460275430|FG002|Overall Study|Progressive disease|27|||
127904366|NCT02336165|460275431|FG003|Overall Study|Progressive disease|24|||
127904367|NCT02336165|460275432|FG004|Overall Study|Progressive disease|19|||
127904368|NCT02336165|460275428|FG000|Overall Study|Non-compliance|1|||
127904369|NCT02336165|460275429|FG001|Overall Study|Non-compliance|0|||
127904370|NCT02336165|460275430|FG002|Overall Study|Non-compliance|0|||
127904371|NCT02336165|460275431|FG003|Overall Study|Non-compliance|1|||
127904372|NCT02336165|460275432|FG004|Overall Study|Non-compliance|0|||
127904373|NCT02336165|460275428|FG000|Overall Study|Other|1|||
127904374|NCT02336165|460275429|FG001|Overall Study|Other|0|||
127904375|NCT02336165|460275430|FG002|Overall Study|Other|0|||
127904376|NCT02336165|460275431|FG003|Overall Study|Other|1|||
127904377|NCT02336165|460275432|FG004|Overall Study|Other|0|||
127904378|NCT00910663|460275439|FG000|Period 1|Withdrawal by Subject|0|||
127904379|NCT00910663|460275440|FG001|Period 1|Withdrawal by Subject|1|||
127849318|NCT03051217|460065612|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
127849319|NCT03051217|460065606|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
127849320|NCT03051217|460065607|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
127849321|NCT03051217|460065608|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
127849322|NCT03051217|460065609|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
127849323|NCT03051217|460065610|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
127849324|NCT03051217|460065611|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
127849325|NCT03051217|460065612|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
127849326|NCT03051217|460065606|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
127849327|NCT03051217|460065607|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
127849328|NCT03051217|460065608|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
127849329|NCT03051217|460065609|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
127849330|NCT03051217|460065610|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
127849331|NCT03051217|460065611|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
127849332|NCT03051217|460065612|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
127849333|NCT03051217|460065606|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
127849334|NCT03051217|460065607|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
127849335|NCT03051217|460065608|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
127849336|NCT03051217|460065609|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
127849337|NCT03051217|460065610|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
127849338|NCT03051217|460065611|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
127849339|NCT03051217|460065612|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
127849340|NCT03051217|460065606|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
127849341|NCT03051217|460065607|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
127849342|NCT03051217|460065608|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
127904380|NCT02865850|460275441|FG000|Overall Study|Death|15|||
127904381|NCT02865850|460275442|FG001|Overall Study|Death|19|||
127904382|NCT02865850|460275441|FG000|Overall Study|Withdrawal by Subject|3|||
127904383|NCT02865850|460275442|FG001|Overall Study|Withdrawal by Subject|2|||
127904384|NCT02865850|460275441|FG000|Overall Study|Lost to Follow-up|3|||
127904385|NCT02865850|460275442|FG001|Overall Study|Lost to Follow-up|2|||
127904386|NCT02726581|460275443|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
127904387|NCT02726581|460275444|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
127904388|NCT02726581|460275445|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
127904389|NCT02726581|460275443|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
127904390|NCT02726581|460275444|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
127904391|NCT02726581|460275445|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
127904392|NCT02726581|460275443|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
127904393|NCT02726581|460275444|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
127904394|NCT02726581|460275445|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
127904395|NCT02726581|460275443|FG000|Treatment Period|Disease progression|47|||
127904396|NCT02726581|460275444|FG001|Treatment Period|Disease progression|50|||
127904397|NCT02726581|460275445|FG002|Treatment Period|Disease progression|16|||
127904398|NCT02726581|460275443|FG000|Treatment Period|Other reasons|9|||
127904399|NCT02726581|460275444|FG001|Treatment Period|Other reasons|8|||
127904400|NCT02726581|460275445|FG002|Treatment Period|Other reasons|2|||
127904401|NCT02726581|460275443|FG000|Treatment Period|Study drug toxicity|6|||
127904402|NCT02726581|460275444|FG001|Treatment Period|Study drug toxicity|3|||
127904403|NCT02726581|460275445|FG002|Treatment Period|Study drug toxicity|2|||
127904404|NCT02726581|460275443|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
127904405|NCT02726581|460275444|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
127904406|NCT02726581|460275445|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
127904407|NCT02726581|460275443|FG000|Treatment Period|Participant withdrew consent|3|||
127904408|NCT02726581|460275444|FG001|Treatment Period|Participant withdrew consent|1|||
127904409|NCT02726581|460275445|FG002|Treatment Period|Participant withdrew consent|1|||
127904410|NCT02726581|460275443|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
127904411|NCT02726581|460275444|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
127904412|NCT02726581|460275445|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
127904413|NCT02726581|460275443|FG000|Treatment Period|Maximum clinical benefit|0|||
127904414|NCT02726581|460275444|FG001|Treatment Period|Maximum clinical benefit|2|||
127904415|NCT02726581|460275445|FG002|Treatment Period|Maximum clinical benefit|0|||
127904416|NCT02726581|460275443|FG000|Treatment Period|Death|1|||
127904417|NCT02726581|460275444|FG001|Treatment Period|Death|0|||
127904418|NCT02726581|460275445|FG002|Treatment Period|Death|0|||
127904419|NCT02726581|460275443|FG000|Treatment Period|Poor/non-compliance|1|||
127904420|NCT02726581|460275444|FG001|Treatment Period|Poor/non-compliance|0|||
127904421|NCT02726581|460275445|FG002|Treatment Period|Poor/non-compliance|0|||
127904422|NCT02726581|460275443|FG000|Treatment Period|Participant no longer meets study criteria|0|||
127904423|NCT02726581|460275444|FG001|Treatment Period|Participant no longer meets study criteria|1|||
127904424|NCT02726581|460275445|FG002|Treatment Period|Participant no longer meets study criteria|0|||
127904425|NCT00552669|460275446|FG000|Overall Study|Death|3|||
127904426|NCT00552669|460275447|FG001|Overall Study|Death|7|||
127904427|NCT01844375|460275451|FG000|Overall Study|Protocol Violation|1|||
127904428|NCT01844375|460275452|FG001|Overall Study|Protocol Violation|1|||
127904429|NCT01772537|460275454|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
127904430|NCT01772537|460275455|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
127904431|NCT01772537|460275456|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
127904432|NCT03195491|460275457|FG000|Overall Study|Study drug toxicity|25|||
127904433|NCT03195491|460275458|FG001|Overall Study|Study drug toxicity|3|||
127904434|NCT03195491|460275457|FG000|Overall Study|Maximum clinical benefit|5|||
127904435|NCT03195491|460275458|FG001|Overall Study|Maximum clinical benefit|0|||
127904436|NCT03195491|460275457|FG000|Overall Study|Lost to Follow-up|1|||
127904437|NCT03195491|460275458|FG001|Overall Study|Lost to Follow-up|0|||
127904438|NCT03195491|460275457|FG000|Overall Study|Death|3|||
127904439|NCT03195491|460275458|FG001|Overall Study|Death|0|||
127904440|NCT03195491|460275457|FG000|Overall Study|Adverse event unrelated to study drug|19|||
127904441|NCT03195491|460275458|FG001|Overall Study|Adverse event unrelated to study drug|2|||
127904442|NCT03195491|460275457|FG000|Overall Study|Disease progression|266|||
127904443|NCT03195491|460275458|FG001|Overall Study|Disease progression|8|||
127904444|NCT03195491|460275457|FG000|Overall Study|Other reasons|10|||
127904445|NCT03195491|460275458|FG001|Overall Study|Other reasons|0|||
127904446|NCT03195491|460275457|FG000|Overall Study|Participant withdrew consent|8|||
127904447|NCT03195491|460275458|FG001|Overall Study|Participant withdrew consent|1|||
127904448|NCT03195491|460275457|FG000|Overall Study|Participant no longer meets study criteria|0|||
127904449|NCT03195491|460275458|FG001|Overall Study|Participant no longer meets study criteria|1|||
127904450|NCT03195491|460275457|FG000|Overall Study|Participant request to discontinue study treatment|10|||
127904451|NCT03195491|460275458|FG001|Overall Study|Participant request to discontinue study treatment|0|||
127904452|NCT01263704|460275459|FG000|Overall Study|Progressive disease|18|||
127904453|NCT01263704|460275459|FG000|Overall Study|Adverse Event|3|||
127904454|NCT01263704|460275459|FG000|Overall Study|Death|2|||
127904455|NCT01263704|460275459|FG000|Overall Study|Patient withdrew consent|2|||
127904456|NCT01263704|460275459|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
127904457|NCT01263704|460275459|FG000|Overall Study|Lost to Follow-up|1|||
127904458|NCT01263704|460275459|FG000|Overall Study|Colon metastases|1|||
127904459|NCT01263704|460275459|FG000|Overall Study|Principal Investigator (PI) decision|1|||
127904460|NCT03020615|460275460|FG000|Overall Study|Physician Decision|3|||
127904461|NCT03020615|460275461|FG001|Overall Study|Physician Decision|1|||
127904462|NCT03020615|460275462|FG002|Overall Study|Physician Decision|2|||
127904463|NCT03020615|460275460|FG000|Overall Study|Parent/guardian/patient choice|3|||
127904464|NCT03020615|460275461|FG001|Overall Study|Parent/guardian/patient choice|0|||
127904465|NCT03020615|460275462|FG002|Overall Study|Parent/guardian/patient choice|4|||
127904466|NCT03020615|460275460|FG000|Overall Study|Screen failure|0|||
127904467|NCT03020615|460275461|FG001|Overall Study|Screen failure|0|||
127904468|NCT03020615|460275462|FG002|Overall Study|Screen failure|1|||
127904469|NCT03020615|460275460|FG000|Overall Study|Death|1|||
127904470|NCT03020615|460275461|FG001|Overall Study|Death|0|||
127904471|NCT03020615|460275462|FG002|Overall Study|Death|0|||
127904472|NCT03020615|460275460|FG000|Overall Study|Lost to Follow-up|0|||
127904473|NCT03020615|460275461|FG001|Overall Study|Lost to Follow-up|1|||
127904474|NCT03020615|460275462|FG002|Overall Study|Lost to Follow-up|0|||
127904475|NCT00252720|460275464|FG000|Overall Study|Withdrawal by Subject|95|||
127904476|NCT00252720|460275465|FG001|Overall Study|Withdrawal by Subject|97|||
127904477|NCT00252720|460275464|FG000|Overall Study|Death|7|||
127904478|NCT00252720|460275465|FG001|Overall Study|Death|8|||
127904479|NCT00252720|460275464|FG000|Overall Study|Moving|23|||
127904480|NCT00252720|460275465|FG001|Overall Study|Moving|42|||
127904481|NCT00252720|460275464|FG000|Overall Study|Mainly patients lost to follow-up|7|||
127904482|NCT00252720|460275465|FG001|Overall Study|Mainly patients lost to follow-up|18|||
127904483|NCT02514122|460275471|FG000|Overall Study|Withdrawal by Subject|2|||
127904484|NCT02514122|460275472|FG001|Overall Study|Withdrawal by Subject|0|||
127904485|NCT04239872|460275473|FG000|Overall Study|Lost to Follow-up|0|||
127904486|NCT04239872|460275474|FG001|Overall Study|Lost to Follow-up|1|||
127904487|NCT01472341|460275475|FG000|Overall Study|Started insulin therapy|55|||
127904488|NCT01472341|460275475|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
127904489|NCT01472341|460275475|FG000|Overall Study|Withdrawal by Subject|39|||
127904490|NCT01472341|460275475|FG000|Overall Study|Lost to Follow-up|52|||
127904491|NCT01472341|460275475|FG000|Overall Study|Laboratory parameters unavailable|25|||
127904492|NCT01472341|460275475|FG000|Overall Study|Death|9|||
127904493|NCT00112463|460275478|FG000|Overall Study|Physician Decision|1|||
127904494|NCT00112463|460275478|FG000|Overall Study|Progression|30|||
127904495|NCT00112463|460275478|FG000|Overall Study|Second Primary|1|||
127904496|NCT00112463|460275478|FG000|Overall Study|Toxicity|3|||
127904497|NCT00112463|460275478|FG000|Overall Study|Withdrawal by Subject|2|||
127904498|NCT00112463|460275478|FG000|Overall Study|Never started treatment|2|||
127904499|NCT01118312|460275485|FG000|Overall Study|Lost to Follow-up|33|||
127904500|NCT01118312|460275486|FG001|Overall Study|Lost to Follow-up|32|||
127904501|NCT01118312|460275485|FG000|Overall Study|Withdrawal by Subject|1|||
127904502|NCT01118312|460275486|FG001|Overall Study|Withdrawal by Subject|3|||
127904503|NCT01185821|460275492|FG000|Overall Study|Abnormal laboratory value(s)|1|||
127904504|NCT01185821|460275493|FG001|Overall Study|Abnormal laboratory value(s)|2|||
127904505|NCT01185821|460275494|FG002|Overall Study|Abnormal laboratory value(s)|1|||
127904506|NCT01185821|460275495|FG003|Overall Study|Abnormal laboratory value(s)|0|||
127904507|NCT01185821|460275496|FG004|Overall Study|Abnormal laboratory value(s)|0|||
127904508|NCT01185821|460275492|FG000|Overall Study|Protocol Violation|0|||
127904509|NCT01185821|460275493|FG001|Overall Study|Protocol Violation|0|||
127904510|NCT01185821|460275494|FG002|Overall Study|Protocol Violation|0|||
127904511|NCT01185821|460275495|FG003|Overall Study|Protocol Violation|1|||
127904512|NCT01185821|460275496|FG004|Overall Study|Protocol Violation|1|||
127904513|NCT01185821|460275492|FG000|Overall Study|Abnormal test procedure result|0|||
127904514|NCT01185821|460275493|FG001|Overall Study|Abnormal test procedure result|0|||
127904515|NCT01185821|460275494|FG002|Overall Study|Abnormal test procedure result|0|||
127904516|NCT01185821|460275495|FG003|Overall Study|Abnormal test procedure result|0|||
127904517|NCT01185821|460275496|FG004|Overall Study|Abnormal test procedure result|1|||
127904518|NCT01185821|460275492|FG000|Overall Study|Death|0|||
127904519|NCT01185821|460275493|FG001|Overall Study|Death|1|||
127904520|NCT01185821|460275494|FG002|Overall Study|Death|0|||
127904521|NCT01185821|460275495|FG003|Overall Study|Death|0|||
127904522|NCT01185821|460275496|FG004|Overall Study|Death|0|||
127904523|NCT01185821|460275492|FG000|Overall Study|Condition no longer required study drug|0|||
127904524|NCT01185821|460275493|FG001|Overall Study|Condition no longer required study drug|0|||
127904525|NCT01185821|460275494|FG002|Overall Study|Condition no longer required study drug|0|||
127904526|NCT01185821|460275495|FG003|Overall Study|Condition no longer required study drug|0|||
127904527|NCT01185821|460275496|FG004|Overall Study|Condition no longer required study drug|1|||
127904528|NCT01185821|460275492|FG000|Overall Study|Adverse Event|2|||
127904529|NCT01185821|460275493|FG001|Overall Study|Adverse Event|3|||
127904530|NCT01185821|460275494|FG002|Overall Study|Adverse Event|1|||
127904531|NCT01185821|460275495|FG003|Overall Study|Adverse Event|2|||
127904532|NCT01185821|460275496|FG004|Overall Study|Adverse Event|5|||
127904533|NCT01185821|460275492|FG000|Overall Study|Lack of Efficacy|0|||
127904534|NCT01185821|460275493|FG001|Overall Study|Lack of Efficacy|0|||
127904535|NCT01185821|460275494|FG002|Overall Study|Lack of Efficacy|3|||
127904536|NCT01185821|460275495|FG003|Overall Study|Lack of Efficacy|0|||
127904537|NCT01185821|460275496|FG004|Overall Study|Lack of Efficacy|9|||
127904538|NCT01185821|460275492|FG000|Overall Study|Withdrawal by Subject|3|||
127904539|NCT01185821|460275493|FG001|Overall Study|Withdrawal by Subject|2|||
127904540|NCT01185821|460275494|FG002|Overall Study|Withdrawal by Subject|2|||
127904541|NCT01185821|460275495|FG003|Overall Study|Withdrawal by Subject|1|||
127904542|NCT01185821|460275496|FG004|Overall Study|Withdrawal by Subject|3|||
127904543|NCT01185821|460275492|FG000|Overall Study|Lost to Follow-up|1|||
127904544|NCT01185821|460275493|FG001|Overall Study|Lost to Follow-up|1|||
127904545|NCT01185821|460275494|FG002|Overall Study|Lost to Follow-up|2|||
127904546|NCT01185821|460275495|FG003|Overall Study|Lost to Follow-up|1|||
127904547|NCT01185821|460275496|FG004|Overall Study|Lost to Follow-up|2|||
127904548|NCT01185821|460275492|FG000|Overall Study|Administrative problems|0|||
127904549|NCT01185821|460275493|FG001|Overall Study|Administrative problems|0|||
127904550|NCT01185821|460275494|FG002|Overall Study|Administrative problems|1|||
127904551|NCT01185821|460275495|FG003|Overall Study|Administrative problems|1|||
127904552|NCT01185821|460275496|FG004|Overall Study|Administrative problems|2|||
127904553|NCT01546545|460275497|FG000|Overall Study|Withdrawal by Subject|1|||
127904554|NCT04060147|460275498|FG000|Overall Study|Withdrew consent|1|||
127904555|NCT02057458|460275502|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
127904556|NCT02057458|460275503|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
127904557|NCT02057458|460275504|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
127904558|NCT02057458|460275502|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
127904559|NCT02057458|460275503|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
127904560|NCT02057458|460275504|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
127849343|NCT03051217|460065609|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
127849344|NCT03051217|460065610|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
127849345|NCT03051217|460065611|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
127849346|NCT03051217|460065612|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
127849347|NCT03051217|460065606|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
127849348|NCT03051217|460065607|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
127849349|NCT03051217|460065608|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
127849350|NCT03051217|460065609|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
127849351|NCT03051217|460065610|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
127849352|NCT03051217|460065611|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
127849353|NCT03051217|460065612|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
127849354|NCT00109772|460065613|FG000|Double-blind Treatment|Adverse Event|14|||
127849355|NCT00109772|460065614|FG001|Double-blind Treatment|Adverse Event|5|||
127849356|NCT00109772|460065613|FG000|Double-blind Treatment|Lack of Efficacy|1|||
127849357|NCT00109772|460065614|FG001|Double-blind Treatment|Lack of Efficacy|0|||
127849358|NCT00109772|460065613|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
127849359|NCT00109772|460065614|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
127849360|NCT00109772|460065613|FG000|Double-blind Treatment|Lost to Follow-up|2|||
127849361|NCT00109772|460065614|FG001|Double-blind Treatment|Lost to Follow-up|3|||
127849362|NCT00109772|460065613|FG000|Double-blind Treatment|Protocol Violation|0|||
127849363|NCT00109772|460065614|FG001|Double-blind Treatment|Protocol Violation|1|||
127849364|NCT00109772|460065613|FG000|Double-blind Treatment|Other|0|||
127849365|NCT00109772|460065614|FG001|Double-blind Treatment|Other|4|||
127849366|NCT00109772|460065613|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
127849367|NCT00109772|460065614|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
127849368|NCT00109772|460065613|FG000|Open-label Extension|Adverse Event|10|||
127849369|NCT00109772|460065614|FG001|Open-label Extension|Adverse Event|19|||
127849370|NCT00109772|460065613|FG000|Open-label Extension|Lack of Efficacy|19|||
127849371|NCT00109772|460065614|FG001|Open-label Extension|Lack of Efficacy|11|||
127849372|NCT00109772|460065613|FG000|Open-label Extension|Withdrawal by Subject|9|||
127849373|NCT00109772|460065614|FG001|Open-label Extension|Withdrawal by Subject|6|||
127849374|NCT00109772|460065613|FG000|Open-label Extension|Lost to Follow-up|1|||
127849375|NCT00109772|460065614|FG001|Open-label Extension|Lost to Follow-up|0|||
127849376|NCT00109772|460065613|FG000|Open-label Extension|Death|0|||
127849377|NCT00109772|460065614|FG001|Open-label Extension|Death|1|||
127849378|NCT00109772|460065613|FG000|Open-label Extension|Protocol Violation|2|||
127849379|NCT00109772|460065614|FG001|Open-label Extension|Protocol Violation|2|||
127849380|NCT00109772|460065613|FG000|Open-label Extension|Other|4|||
127849381|NCT00109772|460065614|FG001|Open-label Extension|Other|10|||
127849382|NCT01359046|460065617|FG000|Overall Study|Did not receive allocated intervention|6|||
127849383|NCT01359046|460065618|FG001|Overall Study|Did not receive allocated intervention|6|||
127849384|NCT01359046|460065617|FG000|Overall Study|Physician Decision|1|||
127849385|NCT01359046|460065618|FG001|Overall Study|Physician Decision|11|||
127849386|NCT01057862|460065619|FG000|Overall Study|Withdrawal by Subject|1|||
127849387|NCT01057862|460065620|FG001|Overall Study|Withdrawal by Subject|2|||
127849388|NCT00415584|460065621|FG000|Overall Study|Withdrawal by Subject|1|||
127849389|NCT00802867|460065622|FG000|Overall Study|Lost to Follow-up|6|||
127849390|NCT00802867|460065622|FG000|Overall Study|Protocol Violation|6|||
127849391|NCT00802867|460065622|FG000|Overall Study|Withdrawal by Subject|1|||
127849392|NCT03434041|460065623|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
127849393|NCT03434041|460065624|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
127849394|NCT03434041|460065623|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
127849395|NCT03434041|460065624|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
127849396|NCT03434041|460065623|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
127849397|NCT03434041|460065624|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
127904561|NCT02057458|460275502|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
127849398|NCT03434041|460065623|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
127849399|NCT03434041|460065624|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
127849400|NCT03434041|460065623|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
127849401|NCT03434041|460065624|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
127849402|NCT03434041|460065623|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
127849403|NCT03434041|460065624|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
127849404|NCT03434041|460065623|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
127849405|NCT03434041|460065624|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
127849406|NCT03434041|460065623|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
127849407|NCT03434041|460065624|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
127849408|NCT03434041|460065623|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
127849409|NCT03434041|460065624|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
127849410|NCT03434041|460065623|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
127849411|NCT03434041|460065624|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
127849412|NCT03434041|460065623|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
127849413|NCT03434041|460065624|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
127849414|NCT04075396|460065625|FG000|Overall Study|Death|11|||
127849415|NCT04075396|460065626|FG001|Overall Study|Death|9|||
127849416|NCT04075396|460065625|FG000|Overall Study|Withdrawal by Subject|1|||
127849417|NCT04075396|460065626|FG001|Overall Study|Withdrawal by Subject|2|||
127849418|NCT04075396|460065625|FG000|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|3|||
127849419|NCT04075396|460065626|FG001|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|2|||
127849420|NCT04075396|460065625|FG000|Overall Study|Enrolled but not-treated|0|||
127849421|NCT04075396|460065626|FG001|Overall Study|Enrolled but not-treated|1|||
127849422|NCT03363165|460065633|FG000|3-month Follow-up|Death|0|||
127849423|NCT03363165|460065634|FG001|3-month Follow-up|Death|1|||
127849424|NCT03363165|460065633|FG000|6-month Follow-up|Death|0|||
127849425|NCT03363165|460065634|FG001|6-month Follow-up|Death|1|||
127849426|NCT03363165|460065633|FG000|6-month Follow-up|Withdrawal by Subject|1|||
127849427|NCT03363165|460065634|FG001|6-month Follow-up|Withdrawal by Subject|1|||
127849428|NCT03363165|460065633|FG000|12-month Follow-up|Death|1|||
127849429|NCT03363165|460065634|FG001|12-month Follow-up|Death|1|||
127849430|NCT03363165|460065633|FG000|12-month Follow-up|Withdrawal by Subject|1|||
127849431|NCT03363165|460065634|FG001|12-month Follow-up|Withdrawal by Subject|1|||
127849432|NCT02255760|460065635|FG000|Overall Study|Lost to Follow-up|0|||
127849433|NCT02255760|460065636|FG001|Overall Study|Lost to Follow-up|1|||
127849434|NCT02255760|460065637|FG002|Overall Study|Lost to Follow-up|0|||
127849435|NCT02255760|460065638|FG003|Overall Study|Lost to Follow-up|0|||
127849436|NCT02255760|460065639|FG004|Overall Study|Lost to Follow-up|0|||
127849437|NCT00003838|460065640|FG000|Overall Study|Death|0|||
127849438|NCT00003838|460065641|FG001|Overall Study|Death|12|||
127849439|NCT00003838|460065642|FG002|Overall Study|Death|7|||
127849440|NCT00003838|460065640|FG000|Overall Study|Lost to Follow-up|0|||
127849441|NCT00003838|460065641|FG001|Overall Study|Lost to Follow-up|1|||
127849442|NCT00003838|460065642|FG002|Overall Study|Lost to Follow-up|1|||
127849443|NCT00003838|460065640|FG000|Overall Study|Disease Progression|0|||
127849444|NCT00003838|460065641|FG001|Overall Study|Disease Progression|12|||
127849445|NCT00003838|460065642|FG002|Overall Study|Disease Progression|0|||
127849446|NCT00618813|460065643|FG000|Overall Study|Lack of Efficacy|1|||
127849447|NCT00618813|460065643|FG000|Overall Study|Physician Decision|2|||
127849448|NCT00618813|460065643|FG000|Overall Study|Withdrawal by Subject|1|||
127849449|NCT01809197|460065644|FG000|Overall Study|Lost to Follow-up|4|||
127849450|NCT01809197|460065645|FG001|Overall Study|Lost to Follow-up|2|||
127849451|NCT01809197|460065644|FG000|Overall Study|Adverse Event|2|||
127849452|NCT01809197|460065645|FG001|Overall Study|Adverse Event|3|||
127849453|NCT01809197|460065644|FG000|Overall Study|Failed slit lamp exam|1|||
127849454|NCT01809197|460065645|FG001|Overall Study|Failed slit lamp exam|0|||
127849455|NCT01809197|460065644|FG000|Overall Study|Non-Compliance|1|||
127849456|NCT01809197|460065645|FG001|Overall Study|Non-Compliance|1|||
127849457|NCT01809197|460065644|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
127849458|NCT01809197|460065645|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
127849459|NCT01809197|460065644|FG000|Overall Study|Withdrawal by Subject|1|||
127849460|NCT01809197|460065645|FG001|Overall Study|Withdrawal by Subject|1|||
127849461|NCT01809197|460065644|FG000|Overall Study|Product not available|0|||
127849462|NCT01809197|460065645|FG001|Overall Study|Product not available|1|||
127849463|NCT00291187|460065648|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
127849464|NCT00291187|460065649|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
127849465|NCT00291187|460065650|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
127849466|NCT00291187|460065651|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
127904562|NCT02057458|460275503|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
127849467|NCT00114218|460065652|FG000|Overall Study|Wrong Cell Type|2|||
127849468|NCT00114218|460065652|FG000|Overall Study|Wrong Primary|1|||
127904563|NCT02057458|460275504|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
127904564|NCT00585689|460275505|FG000|Overall Study|Received different ABI-007 schedule|3|||
127904565|NCT00585689|460275505|FG000|Overall Study|Adverse Event|1|||
127904566|NCT00585689|460275505|FG000|Overall Study|Patient Declined Surgery|1|||
127904567|NCT00585689|460275505|FG000|Overall Study|Patient had unresectable disease|1|||
127904568|NCT00585689|460275505|FG000|Overall Study|Death|1|||
127904569|NCT00550537|460275506|FG000|Overall Study|Death|18|||
127904570|NCT00550537|460275506|FG000|Overall Study|Adverse Event|20|||
127904571|NCT00550537|460275506|FG000|Overall Study|Disease progression before|46|||
127904572|NCT00550537|460275506|FG000|Overall Study|Withdrawal by Subject|7|||
127904573|NCT00550537|460275506|FG000|Overall Study|Change in treatment plan|4|||
127904574|NCT00550537|460275506|FG000|Overall Study|Other complicating ilness|3|||
127904575|NCT00550537|460275506|FG000|Overall Study|Declining performance status|2|||
127904576|NCT00550537|460275506|FG000|Overall Study|Treated closer to home|4|||
127904577|NCT00617305|460275507|FG000|Overall Study|Adverse Event|4|||
127904578|NCT00617305|460275508|FG001|Overall Study|Adverse Event|0|||
127904579|NCT00617305|460275509|FG002|Overall Study|Adverse Event|0|||
127904580|NCT00617305|460275507|FG000|Overall Study|Death|1|||
127904581|NCT00617305|460275508|FG001|Overall Study|Death|0|||
127904582|NCT00617305|460275509|FG002|Overall Study|Death|0|||
127904583|NCT00617305|460275507|FG000|Overall Study|Physician Decision|1|||
127904584|NCT00617305|460275508|FG001|Overall Study|Physician Decision|0|||
127904585|NCT00617305|460275509|FG002|Overall Study|Physician Decision|0|||
127904586|NCT00617305|460275507|FG000|Overall Study|Protocol Violation|1|||
127904587|NCT00617305|460275508|FG001|Overall Study|Protocol Violation|0|||
127904588|NCT00617305|460275509|FG002|Overall Study|Protocol Violation|1|||
127904589|NCT00617305|460275507|FG000|Overall Study|Withdrawal by Subject|1|||
127904590|NCT00617305|460275508|FG001|Overall Study|Withdrawal by Subject|0|||
127904591|NCT00617305|460275509|FG002|Overall Study|Withdrawal by Subject|0|||
127904592|NCT04510285|460275510|FG000|Overall Study|Death|1|||
127904593|NCT04384978|460275513|FG000|Overall Study|Withdrawal by Subject|4|||
127904594|NCT04384978|460275514|FG001|Overall Study|Withdrawal by Subject|0|||
127904595|NCT03555305|460275515|FG000|Period 1|Physician Decision|0|||
127904596|NCT03555305|460275516|FG001|Period 1|Physician Decision|1|||
127904597|NCT03555305|460275515|FG000|Period 1|Adverse Event|0|||
127904598|NCT03555305|460275516|FG001|Period 1|Adverse Event|1|||
127904599|NCT03586726|460275517|FG000|Overall Study|Withdrawal by Subject|1|||
127904600|NCT02100228|460275520|FG000|Overall Study|Other|19|||
127904601|NCT02100228|460275521|FG001|Overall Study|Other|19|||
127904602|NCT02100228|460275520|FG000|Overall Study|Administrative reason|0|||
127904603|NCT02100228|460275521|FG001|Overall Study|Administrative reason|1|||
127904604|NCT02100228|460275520|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
127904605|NCT02100228|460275521|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
127904606|NCT02100228|460275520|FG000|Overall Study|Non-compliance|0|||
127904607|NCT02100228|460275521|FG001|Overall Study|Non-compliance|3|||
127904608|NCT02100228|460275520|FG000|Overall Study|Lost to Follow-up|0|||
127904609|NCT02100228|460275521|FG001|Overall Study|Lost to Follow-up|1|||
127904610|NCT02100228|460275520|FG000|Overall Study|Withdrawal by Subject|27|||
127904611|NCT02100228|460275521|FG001|Overall Study|Withdrawal by Subject|37|||
127904612|NCT02100228|460275520|FG000|Overall Study|Adverse Event|16|||
127904613|NCT02100228|460275521|FG001|Overall Study|Adverse Event|12|||
127904614|NCT02100228|460275520|FG000|Overall Study|Death|1|||
127904615|NCT02100228|460275521|FG001|Overall Study|Death|1|||
127904616|NCT00854100|460275529|FG000|Overall Study|Inability to complete the study visits|0|||
127904617|NCT00854100|460275530|FG001|Overall Study|Inability to complete the study visits|0|||
127904618|NCT00854100|460275531|FG002|Overall Study|Inability to complete the study visits|1|||
127904619|NCT00854100|460275529|FG000|Overall Study|Lost to Follow-up|2|||
127904620|NCT00854100|460275530|FG001|Overall Study|Lost to Follow-up|0|||
127904621|NCT00854100|460275531|FG002|Overall Study|Lost to Follow-up|3|||
127904622|NCT00854100|460275529|FG000|Overall Study|Withdrawal by Subject|3|||
127904623|NCT00854100|460275530|FG001|Overall Study|Withdrawal by Subject|1|||
127904624|NCT00854100|460275531|FG002|Overall Study|Withdrawal by Subject|2|||
127904625|NCT00854100|460275529|FG000|Overall Study|Protocol Violation|2|||
127904626|NCT00854100|460275530|FG001|Overall Study|Protocol Violation|4|||
127904627|NCT00854100|460275531|FG002|Overall Study|Protocol Violation|3|||
127904628|NCT00854100|460275529|FG000|Overall Study|Adverse Event|2|||
127904629|NCT00854100|460275530|FG001|Overall Study|Adverse Event|1|||
127904630|NCT00854100|460275531|FG002|Overall Study|Adverse Event|2|||
127904631|NCT02216071|460275542|FG000|Overall Study|Withdrawal by Subject|7|||
127904632|NCT02216071|460275543|FG001|Overall Study|Withdrawal by Subject|2|||
127904633|NCT02216071|460275542|FG000|Overall Study|Lost to Follow-up|3|||
127904634|NCT02216071|460275543|FG001|Overall Study|Lost to Follow-up|3|||
127904635|NCT02216071|460275542|FG000|Overall Study|Protocol Violation|3|||
127904636|NCT02216071|460275543|FG001|Overall Study|Protocol Violation|5|||
127904637|NCT02216071|460275542|FG000|Overall Study|Other|2|||
127904638|NCT02216071|460275543|FG001|Overall Study|Other|2|||
127904639|NCT00389064|460275544|FG000|Overall Study|Adverse Event|11|||
127904640|NCT00389064|460275545|FG001|Overall Study|Adverse Event|3|||
127904641|NCT00389064|460275544|FG000|Overall Study|Lack of Efficacy|3|||
127849469|NCT00114218|460065652|FG000|Overall Study|Never Treated|1|||
127849470|NCT03168555|460065654|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
127849471|NCT03168555|460065654|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
127849472|NCT03168555|460065654|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
127849473|NCT03168555|460065654|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
127849474|NCT01040845|460065655|FG000|Overall Study|Withdrawal by Subject|1|||
127849475|NCT01040845|460065656|FG001|Overall Study|Withdrawal by Subject|1|||
127849476|NCT01040845|460065655|FG000|Overall Study|Physician Decision|1|||
127849477|NCT01040845|460065656|FG001|Overall Study|Physician Decision|0|||
127849478|NCT02708966|460065660|FG000|Overall Study|Lost to Follow-up|2|||
127849479|NCT02708966|460065661|FG001|Overall Study|Lost to Follow-up|2|||
127849480|NCT02959190|460065665|FG000|Open Label|Adverse Event|5|||
127849481|NCT02959190|460065666|FG001|Open Label|Adverse Event|7|||
127849482|NCT02959190|460065667|FG002|Open Label|Adverse Event|3|||
127849483|NCT02959190|460065668|FG003|Open Label|Adverse Event|4|||
127849484|NCT02959190|460065665|FG000|Open Label|Pregnancy|0|||
127849485|NCT02959190|460065666|FG001|Open Label|Pregnancy|1|||
127849486|NCT02959190|460065667|FG002|Open Label|Pregnancy|0|||
127849487|NCT02959190|460065668|FG003|Open Label|Pregnancy|0|||
127849488|NCT02959190|460065665|FG000|Open Label|Withdrawal by Subject|2|||
127849489|NCT02959190|460065666|FG001|Open Label|Withdrawal by Subject|8|||
127849490|NCT02959190|460065667|FG002|Open Label|Withdrawal by Subject|0|||
127849491|NCT02959190|460065668|FG003|Open Label|Withdrawal by Subject|0|||
127849492|NCT02959190|460065665|FG000|Open Label|Physician Decision|0|||
127849493|NCT02959190|460065666|FG001|Open Label|Physician Decision|0|||
127849494|NCT02959190|460065667|FG002|Open Label|Physician Decision|1|||
127849495|NCT02959190|460065668|FG003|Open Label|Physician Decision|0|||
127849496|NCT02959190|460065665|FG000|Open Label|Protocol Violation|0|||
127849497|NCT02959190|460065666|FG001|Open Label|Protocol Violation|0|||
127849498|NCT02959190|460065667|FG002|Open Label|Protocol Violation|0|||
127849499|NCT02959190|460065668|FG003|Open Label|Protocol Violation|2|||
127849500|NCT02959190|460065665|FG000|Post Treatment Follow Up|Adverse Event|1|||
127849501|NCT02959190|460065666|FG001|Post Treatment Follow Up|Adverse Event|1|||
127849502|NCT02959190|460065667|FG002|Post Treatment Follow Up|Adverse Event|0|||
127849503|NCT02959190|460065668|FG003|Post Treatment Follow Up|Adverse Event|0|||
127849504|NCT02959190|460065665|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
127849505|NCT02959190|460065666|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
127849506|NCT02959190|460065667|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
127849507|NCT02959190|460065668|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
127849508|NCT02023268|460065669|FG000|Overall Study|Lack of Efficacy|0|||
127849509|NCT02023268|460065670|FG001|Overall Study|Lack of Efficacy|1|||
127849510|NCT02023268|460065669|FG000|Overall Study|Adverse Event|0|||
127849511|NCT02023268|460065670|FG001|Overall Study|Adverse Event|2|||
127849512|NCT02023268|460065669|FG000|Overall Study|Withdrawal by Subject|0|||
127849513|NCT02023268|460065670|FG001|Overall Study|Withdrawal by Subject|1|||
127849514|NCT02565615|460065674|FG000|Overall Study|Death|0|||
127849515|NCT02565615|460065675|FG001|Overall Study|Death|1|||
127849516|NCT02565615|460065676|FG002|Overall Study|Death|0|||
127849517|NCT02565615|460065677|FG003|Overall Study|Death|0|||
127849518|NCT02565615|460065678|FG004|Overall Study|Death|4|||
127849519|NCT02565615|460065674|FG000|Overall Study|Not willing to participate in study|2|||
127849520|NCT02565615|460065675|FG001|Overall Study|Not willing to participate in study|21|||
127849521|NCT02565615|460065676|FG002|Overall Study|Not willing to participate in study|0|||
127849522|NCT02565615|460065677|FG003|Overall Study|Not willing to participate in study|1|||
127849523|NCT02565615|460065678|FG004|Overall Study|Not willing to participate in study|169|||
127849524|NCT02565615|460065674|FG000|Overall Study|Lost to Follow-up|0|||
127849525|NCT02565615|460065675|FG001|Overall Study|Lost to Follow-up|4|||
127849526|NCT02565615|460065676|FG002|Overall Study|Lost to Follow-up|0|||
127849527|NCT02565615|460065677|FG003|Overall Study|Lost to Follow-up|1|||
127849528|NCT02565615|460065678|FG004|Overall Study|Lost to Follow-up|765|||
127849529|NCT02565615|460065674|FG000|Overall Study|Not meeting eligibility criteria|0|||
127849530|NCT02565615|460065675|FG001|Overall Study|Not meeting eligibility criteria|7|||
127849531|NCT02565615|460065676|FG002|Overall Study|Not meeting eligibility criteria|0|||
127849532|NCT02565615|460065677|FG003|Overall Study|Not meeting eligibility criteria|0|||
127849533|NCT02565615|460065678|FG004|Overall Study|Not meeting eligibility criteria|25|||
127849534|NCT02565615|460065674|FG000|Overall Study|Reason not defined|0|||
127849535|NCT02565615|460065675|FG001|Overall Study|Reason not defined|2|||
127849536|NCT02565615|460065676|FG002|Overall Study|Reason not defined|0|||
127849537|NCT02565615|460065677|FG003|Overall Study|Reason not defined|1|||
127849538|NCT02565615|460065678|FG004|Overall Study|Reason not defined|62|||
127849539|NCT02565615|460065674|FG000|Overall Study|Adverse Event|1|||
127849540|NCT02565615|460065675|FG001|Overall Study|Adverse Event|1|||
127849541|NCT02565615|460065676|FG002|Overall Study|Adverse Event|0|||
127849542|NCT02565615|460065677|FG003|Overall Study|Adverse Event|0|||
127849543|NCT02565615|460065678|FG004|Overall Study|Adverse Event|9|||
127849544|NCT02565615|460065674|FG000|Overall Study|Untreated|0|||
127849545|NCT02565615|460065675|FG001|Overall Study|Untreated|0|||
127849546|NCT02565615|460065676|FG002|Overall Study|Untreated|0|||
127849547|NCT02565615|460065677|FG003|Overall Study|Untreated|0|||
127904642|NCT00389064|460275545|FG001|Overall Study|Lack of Efficacy|14|||
127904643|NCT00389064|460275544|FG000|Overall Study|Withdrawal by Subject|17|||
127904644|NCT00389064|460275545|FG001|Overall Study|Withdrawal by Subject|27|||
127904645|NCT00389064|460275544|FG000|Overall Study|Physician Decision|2|||
127904646|NCT00389064|460275545|FG001|Overall Study|Physician Decision|2|||
127904647|NCT00389064|460275544|FG000|Overall Study|Lost to Follow-up|1|||
127904648|NCT00389064|460275545|FG001|Overall Study|Lost to Follow-up|2|||
127904649|NCT00389064|460275544|FG000|Overall Study|Protocol Violation|2|||
127904650|NCT00389064|460275545|FG001|Overall Study|Protocol Violation|0|||
127904651|NCT00389064|460275544|FG000|Overall Study|Multiple Reasons|9|||
127904652|NCT00389064|460275545|FG001|Overall Study|Multiple Reasons|11|||
127904653|NCT01387737|460277003|FG000|Overall Study|Adverse Event|20|||
127904654|NCT01387737|460277004|FG001|Overall Study|Adverse Event|30|||
127904655|NCT01387737|460277003|FG000|Overall Study|Lack of Efficacy|1|||
127904656|NCT01387737|460277004|FG001|Overall Study|Lack of Efficacy|0|||
127904657|NCT01387737|460277003|FG000|Overall Study|Physician Decision|3|||
127904658|NCT01387737|460277004|FG001|Overall Study|Physician Decision|10|||
127904659|NCT01387737|460277003|FG000|Overall Study|Withdrawal by Subject|27|||
127904660|NCT01387737|460277004|FG001|Overall Study|Withdrawal by Subject|31|||
127904661|NCT01387737|460277003|FG000|Overall Study|Clearly not eligible for the study|1|||
127904662|NCT01387737|460277004|FG001|Overall Study|Clearly not eligible for the study|3|||
127904663|NCT01215981|460277005|FG000|Overall Study|Physician Decision|0|||
127904664|NCT01215981|460277006|FG001|Overall Study|Physician Decision|1|||
127904665|NCT01215981|460277005|FG000|Overall Study|Protocol Violation|1|||
127904666|NCT01215981|460277006|FG001|Overall Study|Protocol Violation|0|||
127904667|NCT01215981|460277005|FG000|Overall Study|Withdrawal by Subject|1|||
127904668|NCT01215981|460277006|FG001|Overall Study|Withdrawal by Subject|0|||
127904669|NCT00840632|460277012|FG000|First Intervention|Withdrawal by Subject|0|||
127904670|NCT00840632|460277013|FG001|First Intervention|Withdrawal by Subject|1|||
127904671|NCT00840632|460277012|FG000|Washout|Withdrawal by Subject|1|||
127904672|NCT00840632|460277013|FG001|Washout|Withdrawal by Subject|1|||
127904673|NCT01725529|460277017|FG000|Overall Study|Adverse Event|1|||
127904674|NCT01725529|460277018|FG001|Overall Study|Adverse Event|0|||
127904675|NCT01725529|460277019|FG002|Overall Study|Adverse Event|0|||
127904676|NCT01725529|460277017|FG000|Overall Study|Lost to Follow-up|2|||
127904677|NCT01725529|460277018|FG001|Overall Study|Lost to Follow-up|1|||
127904678|NCT01725529|460277019|FG002|Overall Study|Lost to Follow-up|1|||
127904679|NCT01725529|460277017|FG000|Overall Study|Protocol Violation|0|||
127904680|NCT01725529|460277018|FG001|Overall Study|Protocol Violation|1|||
127904681|NCT01725529|460277019|FG002|Overall Study|Protocol Violation|1|||
127904682|NCT01725529|460277017|FG000|Overall Study|Withdrawal by Subject|12|||
127904683|NCT01725529|460277018|FG001|Overall Study|Withdrawal by Subject|14|||
127904684|NCT01725529|460277019|FG002|Overall Study|Withdrawal by Subject|8|||
127904685|NCT01948258|460277025|FG000|Overall Study|Pregnancy|41|||
127904686|NCT01948258|460277025|FG000|Overall Study|Did not complete by cut-off date|35|||
127904687|NCT01948258|460277025|FG000|Overall Study|Lost to Follow-up|27|||
127904688|NCT01948258|460277025|FG000|Overall Study|Withdrawal by SPD|8|||
127904689|NCT01948258|460277025|FG000|Overall Study|Withdrawal by Subject|6|||
127904690|NCT01948258|460277025|FG000|Overall Study|Health Care Professional|43|||
127904691|NCT01948258|460277025|FG000|Overall Study|Removed from statistical analysis|2|||
127904692|NCT01811953|460277026|FG000|Overall Study|Adverse Event|0|||
127904693|NCT01811953|460277027|FG001|Overall Study|Adverse Event|0|||
127904694|NCT01811953|460277028|FG002|Overall Study|Adverse Event|0|||
127904695|NCT01811953|460277029|FG003|Overall Study|Adverse Event|1|||
127904696|NCT01811953|460277030|FG004|Overall Study|Adverse Event|0|||
127904697|NCT01811953|460277031|FG005|Overall Study|Adverse Event|1|||
127904698|NCT01811953|460277026|FG000|Overall Study|Protocol Violation|0|||
127904699|NCT01811953|460277027|FG001|Overall Study|Protocol Violation|0|||
127904700|NCT01811953|460277028|FG002|Overall Study|Protocol Violation|0|||
127904701|NCT01811953|460277029|FG003|Overall Study|Protocol Violation|0|||
127904702|NCT01811953|460277030|FG004|Overall Study|Protocol Violation|1|||
127904703|NCT01811953|460277031|FG005|Overall Study|Protocol Violation|0|||
127904704|NCT02262377|460277033|FG000|Overall Study|Lost to Follow-up|5|||
127904705|NCT02262377|460277034|FG001|Overall Study|Lost to Follow-up|6|||
127904706|NCT02262377|460277033|FG000|Overall Study|Found ineligible after enrollment|3|||
127904707|NCT02262377|460277034|FG001|Overall Study|Found ineligible after enrollment|0|||
127904708|NCT02262377|460277033|FG000|Overall Study|Withdrawal by Subject|4|||
127904709|NCT02262377|460277034|FG001|Overall Study|Withdrawal by Subject|0|||
127904710|NCT00371839|460277036|FG000|Overall Study|Death|4|||
127904711|NCT00371839|460277037|FG001|Overall Study|Death|0|||
127904712|NCT00371839|460277038|FG002|Overall Study|Death|0|||
127904713|NCT00371839|460277036|FG000|Overall Study|Withdrawal by Subject|7|||
127904714|NCT00371839|460277037|FG001|Overall Study|Withdrawal by Subject|4|||
127904715|NCT00371839|460277038|FG002|Overall Study|Withdrawal by Subject|0|||
127849548|NCT02565615|460065678|FG004|Overall Study|Untreated|567|||
127849549|NCT00719537|460065689|FG000|Overall Study|Withdrawal by Subject|1|||
127849550|NCT00719537|460065690|FG001|Overall Study|Withdrawal by Subject|0|||
127849551|NCT00719537|460065689|FG000|Overall Study|Lost to Follow-up|0|||
127849552|NCT00719537|460065690|FG001|Overall Study|Lost to Follow-up|1|||
127849553|NCT01142193|460065691|FG000|Overall Study|Adverse Event|12|||
127849554|NCT01142193|460065692|FG001|Overall Study|Adverse Event|4|||
127849555|NCT01142193|460065691|FG000|Overall Study|Lack of Efficacy|2|||
127849556|NCT01142193|460065692|FG001|Overall Study|Lack of Efficacy|1|||
127849557|NCT01142193|460065691|FG000|Overall Study|Physician Decision|1|||
127849558|NCT01142193|460065692|FG001|Overall Study|Physician Decision|1|||
127849559|NCT01142193|460065691|FG000|Overall Study|Withdrawal by Subject|4|||
127849560|NCT01142193|460065692|FG001|Overall Study|Withdrawal by Subject|3|||
127849561|NCT01142193|460065691|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
127849562|NCT01142193|460065692|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
127849563|NCT01142193|460065691|FG000|Overall Study|Other|1|||
127849564|NCT01142193|460065692|FG001|Overall Study|Other|2|||
127849565|NCT01459068|460065693|FG000|Overall Study|Withdrawal by Subject|8|||
127849566|NCT01459068|460065694|FG001|Overall Study|Withdrawal by Subject|18|||
127849567|NCT01459068|460065693|FG000|Overall Study|Lost to Follow-up|31|||
127849568|NCT01459068|460065694|FG001|Overall Study|Lost to Follow-up|15|||
127849569|NCT01459068|460065693|FG000|Overall Study|Death|0|||
127849570|NCT01459068|460065694|FG001|Overall Study|Death|1|||
127849571|NCT00196196|460065697|FG000|Overall Study|Withdrawal by Subject|2|||
127849572|NCT00196196|460065697|FG000|Overall Study|Did not have required condition (hydroce|5|||
127849573|NCT02910219|460065698|FG000|Overall Study|Withdrawal by Subject|1|||
127849574|NCT02910219|460065699|FG001|Overall Study|Withdrawal by Subject|1|||
127849575|NCT00701441|460065700|FG000|Overall Study|failure in cpap compliance|0|||
127849576|NCT00701441|460065701|FG001|Overall Study|failure in cpap compliance|4|||
127849577|NCT01015820|460065702|FG000|Overall Study|Suboptimal measurements|1|||
127849578|NCT01015820|460065703|FG001|Overall Study|Suboptimal measurements|0|||
127849579|NCT03693404|460065708|FG000|Overall Study|Withdrawal by Subject|1|||
127849580|NCT03693404|460065709|FG001|Overall Study|Withdrawal by Subject|0|||
127849581|NCT03693404|460065708|FG000|Overall Study|Lost to Follow-up|0|||
127849582|NCT03693404|460065709|FG001|Overall Study|Lost to Follow-up|5|||
127849583|NCT03693404|460065708|FG000|Overall Study|Excluded from Analysis|0|||
127849584|NCT03693404|460065709|FG001|Overall Study|Excluded from Analysis|1|||
127849585|NCT02079519|460065710|FG000|Overall Study|Disease Progression|9|||
127849586|NCT02079519|460065710|FG000|Overall Study|Adverse Event|1|||
127849587|NCT01041404|460065714|FG000|Overall Study|Adverse Event|45|||
127849588|NCT01041404|460065715|FG001|Overall Study|Adverse Event|35|||
127849589|NCT01041404|460065714|FG000|Overall Study|Lack of Efficacy|200|||
127849590|NCT01041404|460065715|FG001|Overall Study|Lack of Efficacy|210|||
127849591|NCT01041404|460065714|FG000|Overall Study|Violation of Selection Criteria|0|||
127849592|NCT01041404|460065715|FG001|Overall Study|Violation of Selection Criteria|1|||
127849593|NCT01041404|460065714|FG000|Overall Study|Protocol Violation|4|||
127849594|NCT01041404|460065715|FG001|Overall Study|Protocol Violation|0|||
127849595|NCT01041404|460065714|FG000|Overall Study|Withdrawal by Subject|29|||
127849596|NCT01041404|460065715|FG001|Overall Study|Withdrawal by Subject|23|||
127849597|NCT01041404|460065714|FG000|Overall Study|Failure to Return|1|||
127849598|NCT01041404|460065715|FG001|Overall Study|Failure to Return|2|||
127849599|NCT01041404|460065714|FG000|Overall Study|Other|11|||
127849600|NCT01041404|460065715|FG001|Overall Study|Other|23|||
127849601|NCT01685203|460065717|FG000|Overall Study|Lost to Follow-up|3|||
127849602|NCT01685203|460065718|FG001|Overall Study|Lost to Follow-up|3|||
127849603|NCT01685203|460065719|FG002|Overall Study|Lost to Follow-up|0|||
127849604|NCT01685203|460065720|FG003|Overall Study|Lost to Follow-up|1|||
127849605|NCT01685203|460065721|FG004|Overall Study|Lost to Follow-up|0|||
127849606|NCT01685203|460065722|FG005|Overall Study|Lost to Follow-up|0|||
127849607|NCT01685203|460065723|FG006|Overall Study|Lost to Follow-up|0|||
127849608|NCT01685203|460065717|FG000|Overall Study|Adverse Event|0|||
127849609|NCT01685203|460065718|FG001|Overall Study|Adverse Event|0|||
127849610|NCT01685203|460065719|FG002|Overall Study|Adverse Event|0|||
127849611|NCT01685203|460065720|FG003|Overall Study|Adverse Event|0|||
127849612|NCT01685203|460065721|FG004|Overall Study|Adverse Event|0|||
127849613|NCT01685203|460065722|FG005|Overall Study|Adverse Event|2|||
127849614|NCT01685203|460065723|FG006|Overall Study|Adverse Event|0|||
127904716|NCT00371839|460277036|FG000|Overall Study|Lost to Follow-up|6|||
127849615|NCT01685203|460065717|FG000|Overall Study|Adverse event and withdrew consent|1|||
127849616|NCT01685203|460065718|FG001|Overall Study|Adverse event and withdrew consent|0|||
127849617|NCT01685203|460065719|FG002|Overall Study|Adverse event and withdrew consent|0|||
127849618|NCT01685203|460065720|FG003|Overall Study|Adverse event and withdrew consent|0|||
127849619|NCT01685203|460065721|FG004|Overall Study|Adverse event and withdrew consent|0|||
127849620|NCT01685203|460065722|FG005|Overall Study|Adverse event and withdrew consent|0|||
127849621|NCT01685203|460065723|FG006|Overall Study|Adverse event and withdrew consent|0|||
127849622|NCT01685203|460065717|FG000|Overall Study|Patient's decision|0|||
127849623|NCT01685203|460065718|FG001|Overall Study|Patient's decision|0|||
127849624|NCT01685203|460065719|FG002|Overall Study|Patient's decision|0|||
127904717|NCT00371839|460277037|FG001|Overall Study|Lost to Follow-up|3|||
127904718|NCT00371839|460277038|FG002|Overall Study|Lost to Follow-up|2|||
127904719|NCT00723528|460277039|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
127904720|NCT00723528|460277040|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
127904721|NCT00723528|460277041|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
127904722|NCT00723528|460277042|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
127904723|NCT00723528|460277043|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
127904724|NCT00723528|460277044|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
127904725|NCT00723528|460277045|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
127904726|NCT00723528|460277039|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
127904727|NCT00723528|460277040|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
127904728|NCT00723528|460277041|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
127904729|NCT00723528|460277042|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
127904730|NCT00723528|460277043|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
127904731|NCT00723528|460277044|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
127904732|NCT00723528|460277045|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
127904733|NCT00723528|460277039|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
127904734|NCT00723528|460277040|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
127904735|NCT00723528|460277041|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
127904736|NCT00723528|460277042|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
127904737|NCT00723528|460277043|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
127904738|NCT00723528|460277044|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
127904739|NCT00723528|460277045|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
127904740|NCT00723528|460277039|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
127904741|NCT00723528|460277040|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
127904742|NCT00723528|460277041|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
127904743|NCT00723528|460277042|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
127904744|NCT00723528|460277043|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
127904745|NCT00723528|460277044|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
127849625|NCT01685203|460065720|FG003|Overall Study|Patient's decision|0|||
127849626|NCT01685203|460065721|FG004|Overall Study|Patient's decision|0|||
127849627|NCT01685203|460065722|FG005|Overall Study|Patient's decision|1|||
127849628|NCT01685203|460065723|FG006|Overall Study|Patient's decision|0|||
127849629|NCT00383708|460065724|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
127849630|NCT00383708|460065724|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
127849631|NCT00383708|460065724|FG000|Run-in Period|Protocol Violation|4|||
127849632|NCT00383708|460065724|FG000|Run-in Period|Adverse Event|2|||
127849633|NCT00383708|460065724|FG000|Run-in Period|Claustrophobia|1|||
127849634|NCT00383708|460065724|FG000|Co-administration Period|Adverse Event|5|||
127849635|NCT00318370|460065725|FG000|Period 1|Lack of Efficacy|5|||
127849636|NCT00318370|460065726|FG001|Period 1|Lack of Efficacy|0|||
127849637|NCT00318370|460065727|FG002|Period 1|Lack of Efficacy|0|||
127849638|NCT00318370|460065725|FG000|Period 1|Physician Decision|1|||
127849639|NCT00318370|460065726|FG001|Period 1|Physician Decision|0|||
127849640|NCT00318370|460065727|FG002|Period 1|Physician Decision|0|||
127849641|NCT00318370|460065725|FG000|Period 1|Withdrawal by Subject|1|||
127849642|NCT00318370|460065726|FG001|Period 1|Withdrawal by Subject|0|||
127849643|NCT00318370|460065727|FG002|Period 1|Withdrawal by Subject|0|||
127849644|NCT00318370|460065725|FG000|Period 2|Adverse Event|0|||
127849645|NCT00318370|460065726|FG001|Period 2|Adverse Event|3|||
127849646|NCT00318370|460065727|FG002|Period 2|Adverse Event|0|||
127849647|NCT00318370|460065725|FG000|Period 2|Lack of Efficacy|0|||
127849648|NCT00318370|460065726|FG001|Period 2|Lack of Efficacy|5|||
127849649|NCT00318370|460065727|FG002|Period 2|Lack of Efficacy|0|||
127849650|NCT00318370|460065725|FG000|Period 2|Physician Decision|0|||
127849651|NCT00318370|460065726|FG001|Period 2|Physician Decision|1|||
127849652|NCT00318370|460065727|FG002|Period 2|Physician Decision|0|||
127849653|NCT00318370|460065725|FG000|Period 2|Withdrawal by Subject|0|||
127849654|NCT00318370|460065726|FG001|Period 2|Withdrawal by Subject|1|||
127849655|NCT00318370|460065727|FG002|Period 2|Withdrawal by Subject|0|||
127849656|NCT00318370|460065725|FG000|Period 2|Other|0|||
127849657|NCT00318370|460065726|FG001|Period 2|Other|1|||
127849658|NCT00318370|460065727|FG002|Period 2|Other|0|||
127849659|NCT00318370|460065725|FG000|Period 3|Adverse Event|0|||
127849660|NCT00318370|460065726|FG001|Period 3|Adverse Event|0|||
127849661|NCT00318370|460065727|FG002|Period 3|Adverse Event|1|||
127849662|NCT00318370|460065725|FG000|Period 3|Lack of Efficacy|0|||
127849663|NCT00318370|460065726|FG001|Period 3|Lack of Efficacy|0|||
127849664|NCT00318370|460065727|FG002|Period 3|Lack of Efficacy|24|||
127849665|NCT00318370|460065725|FG000|Period 3|Death|0|||
127849666|NCT00318370|460065726|FG001|Period 3|Death|0|||
127849667|NCT00318370|460065727|FG002|Period 3|Death|1|||
127849668|NCT00318370|460065725|FG000|Period 3|Physician Decision|0|||
127849669|NCT00318370|460065726|FG001|Period 3|Physician Decision|0|||
127849670|NCT00318370|460065727|FG002|Period 3|Physician Decision|1|||
127849671|NCT00318370|460065725|FG000|Period 3|Withdrawal by Subject|0|||
127849672|NCT00318370|460065726|FG001|Period 3|Withdrawal by Subject|0|||
127849673|NCT00318370|460065727|FG002|Period 3|Withdrawal by Subject|3|||
127849674|NCT00318370|460065725|FG000|Period 3|Other|0|||
127849675|NCT00318370|460065726|FG001|Period 3|Other|0|||
127849676|NCT00318370|460065727|FG002|Period 3|Other|3|||
127849677|NCT01750840|460065728|FG000|Overall Study|Lost to Follow-up|4|||
127849678|NCT01576406|460065730|FG000|Overall Study|Lost to Follow-up|1|||
127849679|NCT01576406|460065731|FG001|Overall Study|Lost to Follow-up|2|||
127849680|NCT01576406|460065732|FG002|Overall Study|Lost to Follow-up|0|||
127849681|NCT01576406|460065733|FG003|Overall Study|Lost to Follow-up|0|||
127849682|NCT01576406|460065734|FG004|Overall Study|Lost to Follow-up|0|||
127849683|NCT01576406|460065735|FG005|Overall Study|Lost to Follow-up|0|||
127849684|NCT01576406|460065730|FG000|Overall Study|Death|3|||
127849685|NCT01576406|460065731|FG001|Overall Study|Death|4|||
127849686|NCT01576406|460065732|FG002|Overall Study|Death|8|||
127849687|NCT01576406|460065733|FG003|Overall Study|Death|5|||
127849688|NCT01576406|460065734|FG004|Overall Study|Death|7|||
127849689|NCT01576406|460065735|FG005|Overall Study|Death|9|||
127849690|NCT01576406|460065730|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
127849691|NCT01576406|460065731|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
127849692|NCT01576406|460065732|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
127849693|NCT01576406|460065733|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
127849694|NCT01576406|460065734|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
127849695|NCT01576406|460065735|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
127849696|NCT01576406|460065730|FG000|Overall Study|Withdrawal the consent|2|||
127849697|NCT01576406|460065731|FG001|Overall Study|Withdrawal the consent|2|||
127849698|NCT01576406|460065732|FG002|Overall Study|Withdrawal the consent|5|||
127849699|NCT01576406|460065733|FG003|Overall Study|Withdrawal the consent|1|||
127849700|NCT01576406|460065734|FG004|Overall Study|Withdrawal the consent|1|||
127849701|NCT01576406|460065735|FG005|Overall Study|Withdrawal the consent|3|||
127849702|NCT01576406|460065730|FG000|Overall Study|Other|0|||
127849703|NCT01576406|460065731|FG001|Overall Study|Other|0|||
127849704|NCT01576406|460065732|FG002|Overall Study|Other|2|||
127849705|NCT01576406|460065733|FG003|Overall Study|Other|2|||
127849706|NCT01576406|460065734|FG004|Overall Study|Other|0|||
127849707|NCT01576406|460065735|FG005|Overall Study|Other|0|||
127849708|NCT03906136|460067628|FG000|Overall Study|Adverse Event|1|||
127849709|NCT03906136|460067629|FG001|Overall Study|Adverse Event|0|||
127849710|NCT03906136|460067628|FG000|Overall Study|Lost to Follow-up|7|||
127849711|NCT03906136|460067629|FG001|Overall Study|Lost to Follow-up|4|||
127849712|NCT03906136|460067628|FG000|Overall Study|Physician Decision|1|||
127849713|NCT03906136|460067629|FG001|Overall Study|Physician Decision|0|||
127849714|NCT03906136|460067628|FG000|Overall Study|Withdrawal by Subject|3|||
127849715|NCT03906136|460067629|FG001|Overall Study|Withdrawal by Subject|7|||
127849716|NCT00446641|460067630|FG000|Overall Study|Withdrawal by Subject|8|||
127849717|NCT00446641|460067631|FG001|Overall Study|Withdrawal by Subject|3|||
127849718|NCT00446641|460067630|FG000|Overall Study|poor compliance|8|||
127849719|NCT00446641|460067631|FG001|Overall Study|poor compliance|6|||
127849720|NCT00446641|460067630|FG000|Overall Study|Lost to Follow-up|1|||
127849721|NCT00446641|460067631|FG001|Overall Study|Lost to Follow-up|1|||
127849722|NCT03565991|460067633|FG000|Overall Study|Other|11|||
127849723|NCT03565991|460067634|FG001|Overall Study|Other|0|||
127849724|NCT03565991|460067633|FG000|Overall Study|Global deterioration of health status|14|||
127849725|NCT03565991|460067634|FG001|Overall Study|Global deterioration of health status|4|||
127849726|NCT03565991|460067633|FG000|Overall Study|Withdrawal by Subject|2|||
127849727|NCT03565991|460067634|FG001|Overall Study|Withdrawal by Subject|6|||
127849728|NCT03565991|460067633|FG000|Overall Study|Progressive disease|121|||
127849729|NCT03565991|460067634|FG001|Overall Study|Progressive disease|29|||
127849730|NCT03565991|460067633|FG000|Overall Study|Death|3|||
127849731|NCT03565991|460067634|FG001|Overall Study|Death|0|||
127849732|NCT03565991|460067633|FG000|Overall Study|Adverse Event|7|||
127849733|NCT03565991|460067634|FG001|Overall Study|Adverse Event|2|||
127849734|NCT03424044|460067635|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
127849735|NCT03424044|460067636|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
127849736|NCT03424044|460067637|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
127849737|NCT03424044|460067638|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
127849738|NCT03424044|460067639|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
127849739|NCT03424044|460067640|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
127849740|NCT03424044|460067641|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
127849741|NCT03424044|460067642|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
127849742|NCT03424044|460067643|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
127849743|NCT03424044|460067635|FG000|First Intervention (76 Hours)|Adverse Event|0|||
127849744|NCT03424044|460067636|FG001|First Intervention (76 Hours)|Adverse Event|0|||
127849745|NCT03424044|460067637|FG002|First Intervention (76 Hours)|Adverse Event|0|||
127849746|NCT03424044|460067638|FG003|First Intervention (76 Hours)|Adverse Event|0|||
127849747|NCT03424044|460067639|FG004|First Intervention (76 Hours)|Adverse Event|1|||
127849748|NCT03424044|460067640|FG005|First Intervention (76 Hours)|Adverse Event|0|||
127849749|NCT03424044|460067641|FG006|First Intervention (76 Hours)|Adverse Event|0|||
127849750|NCT03424044|460067642|FG007|First Intervention (76 Hours)|Adverse Event|0|||
127849751|NCT03424044|460067643|FG008|First Intervention (76 Hours)|Adverse Event|0|||
127849752|NCT03424044|460067635|FG000|First Intervention (76 Hours)|device issues|0|||
127849753|NCT03424044|460067636|FG001|First Intervention (76 Hours)|device issues|0|||
127849754|NCT03424044|460067637|FG002|First Intervention (76 Hours)|device issues|0|||
127849755|NCT03424044|460067638|FG003|First Intervention (76 Hours)|device issues|0|||
127849756|NCT03424044|460067639|FG004|First Intervention (76 Hours)|device issues|0|||
127849757|NCT03424044|460067640|FG005|First Intervention (76 Hours)|device issues|0|||
127849758|NCT03424044|460067641|FG006|First Intervention (76 Hours)|device issues|1|||
127849759|NCT03424044|460067642|FG007|First Intervention (76 Hours)|device issues|1|||
127849760|NCT03424044|460067643|FG008|First Intervention (76 Hours)|device issues|1|||
127849761|NCT03424044|460067635|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
127849762|NCT03424044|460067636|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
127849763|NCT03424044|460067637|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
127849764|NCT03424044|460067638|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
127849765|NCT03424044|460067639|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
127849766|NCT03424044|460067640|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
127849767|NCT03424044|460067641|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
127849768|NCT03424044|460067642|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
127849769|NCT03424044|460067643|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
127849770|NCT03424044|460067635|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
127849771|NCT03424044|460067636|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
127849772|NCT03424044|460067637|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
127849773|NCT03424044|460067638|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
127849774|NCT03424044|460067639|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
127849775|NCT03424044|460067640|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
127849776|NCT03424044|460067641|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
127849777|NCT03424044|460067642|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
127849778|NCT03424044|460067643|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
127849779|NCT02971007|460067644|FG000|Overall Study|Adverse Event|1|||
127849780|NCT02971007|460067645|FG001|Overall Study|Adverse Event|0|||
127849781|NCT02971007|460067646|FG002|Overall Study|Adverse Event|0|||
127849782|NCT02971007|460067644|FG000|Overall Study|Lost to Follow-up|0|||
127849783|NCT02971007|460067645|FG001|Overall Study|Lost to Follow-up|1|||
127849784|NCT02971007|460067646|FG002|Overall Study|Lost to Follow-up|1|||
127849785|NCT02971007|460067644|FG000|Overall Study|Withdrawal by Subject|0|||
127849786|NCT02971007|460067645|FG001|Overall Study|Withdrawal by Subject|1|||
127849787|NCT02971007|460067646|FG002|Overall Study|Withdrawal by Subject|0|||
127849788|NCT02971007|460067644|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
127849789|NCT02971007|460067645|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
127849790|NCT02971007|460067646|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
127849791|NCT02971007|460067644|FG000|Overall Study|Patient discontinued study drug|0|||
127849792|NCT02971007|460067645|FG001|Overall Study|Patient discontinued study drug|1|||
127849793|NCT02971007|460067646|FG002|Overall Study|Patient discontinued study drug|0|||
127849794|NCT00402285|460067649|FG000|Overall Study|insufficient RNA quality|7|||
127849795|NCT00402285|460067650|FG001|Overall Study|insufficient RNA quality|6|||
127849796|NCT00402285|460067651|FG002|Overall Study|insufficient RNA quality|2|||
127849797|NCT00784459|460067652|FG000|Overall Study|Adverse Event|0|||
127849798|NCT00784459|460067653|FG001|Overall Study|Adverse Event|2|||
127849799|NCT02009930|460067654|FG000|Overall Study|withdrawn|5|||
127849800|NCT00063986|460067658|FG000|Overall Study|Withdrawal by Subject|1|||
127849801|NCT00063986|460067658|FG000|Overall Study|Ineligible|1|||
127849802|NCT00063986|460067658|FG000|Overall Study|Intra-operatively ineligible|4|||
127849803|NCT04839393|460067667|FG000|Overall Study|Adverse Event|0|||
127849804|NCT04839393|460067668|FG001|Overall Study|Adverse Event|0|||
127849805|NCT04839393|460067669|FG002|Overall Study|Adverse Event|2|||
127849806|NCT04839393|460067667|FG000|Overall Study|Withdrawal by participant|0|||
127849807|NCT04839393|460067668|FG001|Overall Study|Withdrawal by participant|0|||
127904746|NCT00723528|460277045|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
127904747|NCT00723528|460277039|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
127849808|NCT04839393|460067669|FG002|Overall Study|Withdrawal by participant|1|||
127904748|NCT00723528|460277040|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
127849809|NCT00633893|460067674|FG000|Overall Study|Death|1|||
127849810|NCT00633893|460067675|FG001|Overall Study|Death|3|||
127849811|NCT00633893|460067676|FG002|Overall Study|Death|9|||
127849812|NCT00633893|460067674|FG000|Overall Study|Adverse Event|65|||
127849813|NCT00633893|460067675|FG001|Overall Study|Adverse Event|58|||
127849814|NCT00633893|460067676|FG002|Overall Study|Adverse Event|126|||
127849815|NCT00633893|460067674|FG000|Overall Study|Withdrawal by Subject|7|||
127849816|NCT00633893|460067675|FG001|Overall Study|Withdrawal by Subject|12|||
127904749|NCT00723528|460277041|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
127904750|NCT00723528|460277042|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
127904751|NCT00723528|460277043|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
127904752|NCT00723528|460277044|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
127904753|NCT00723528|460277045|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
127904754|NCT00723528|460277039|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
127904755|NCT00723528|460277040|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
127904756|NCT00723528|460277041|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
127904757|NCT00723528|460277042|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
127904758|NCT00723528|460277043|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
127904759|NCT00723528|460277044|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
127904760|NCT00723528|460277045|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
127904761|NCT00723528|460277039|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
127904762|NCT00723528|460277040|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
127904763|NCT00723528|460277041|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
127904764|NCT00723528|460277042|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
127904765|NCT00723528|460277043|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
127904766|NCT00723528|460277044|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
127904767|NCT00723528|460277045|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
127904768|NCT00723528|460277039|FG000|Period 2: After Controlled Period|Other|0|||
127904769|NCT00723528|460277040|FG001|Period 2: After Controlled Period|Other|0|||
127904770|NCT00723528|460277041|FG002|Period 2: After Controlled Period|Other|0|||
127904771|NCT00723528|460277042|FG003|Period 2: After Controlled Period|Other|0|||
127904772|NCT00723528|460277043|FG004|Period 2: After Controlled Period|Other|1|||
127904773|NCT00723528|460277044|FG005|Period 2: After Controlled Period|Other|4|||
127904774|NCT00723528|460277045|FG006|Period 2: After Controlled Period|Other|0|||
127904775|NCT00723528|460277039|FG000|Period 2: After Controlled Period|Adverse Event|0|||
127904776|NCT00723528|460277040|FG001|Period 2: After Controlled Period|Adverse Event|0|||
127904777|NCT00723528|460277041|FG002|Period 2: After Controlled Period|Adverse Event|0|||
127904778|NCT00723528|460277042|FG003|Period 2: After Controlled Period|Adverse Event|0|||
127904779|NCT00723528|460277043|FG004|Period 2: After Controlled Period|Adverse Event|1|||
127904780|NCT00723528|460277044|FG005|Period 2: After Controlled Period|Adverse Event|0|||
127904781|NCT00723528|460277045|FG006|Period 2: After Controlled Period|Adverse Event|1|||
127904782|NCT00723528|460277039|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
127904783|NCT00723528|460277040|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
127904784|NCT00723528|460277041|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
127904785|NCT00723528|460277042|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
127904786|NCT00723528|460277043|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
127904787|NCT00723528|460277044|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
127904788|NCT00723528|460277045|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
127904789|NCT00723528|460277039|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
127904790|NCT00723528|460277040|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
127904791|NCT00723528|460277041|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
127904792|NCT00723528|460277042|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
127904793|NCT00723528|460277043|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
127904794|NCT00723528|460277044|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
127904795|NCT00723528|460277045|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
127904796|NCT01993030|460277046|FG000|Overall Study|Adverse Event|0|||
127904797|NCT01993030|460277047|FG001|Overall Study|Adverse Event|4|||
127904798|NCT01710657|460277048|FG000|Overall Study|Lost to Follow-up|2|||
127904799|NCT01710657|460277049|FG001|Overall Study|Lost to Follow-up|0|||
127904800|NCT01710657|460277050|FG002|Overall Study|Lost to Follow-up|1|||
127904801|NCT01710657|460277048|FG000|Overall Study|Protocol Violation|2|||
127904802|NCT01710657|460277049|FG001|Overall Study|Protocol Violation|2|||
127904803|NCT01710657|460277050|FG002|Overall Study|Protocol Violation|0|||
127904804|NCT01710657|460277048|FG000|Overall Study|Adverse Event|14|||
127904805|NCT01710657|460277049|FG001|Overall Study|Adverse Event|8|||
127904806|NCT01710657|460277050|FG002|Overall Study|Adverse Event|28|||
127904807|NCT01710657|460277048|FG000|Overall Study|Withdrawal by Subject|0|||
127904808|NCT01710657|460277049|FG001|Overall Study|Withdrawal by Subject|1|||
127904809|NCT01710657|460277050|FG002|Overall Study|Withdrawal by Subject|2|||
127904810|NCT01710657|460277048|FG000|Overall Study|Lack of Efficacy|0|||
127904811|NCT01710657|460277049|FG001|Overall Study|Lack of Efficacy|1|||
127904812|NCT01710657|460277050|FG002|Overall Study|Lack of Efficacy|1|||
127904813|NCT01591785|460277053|FG000|Overall Study|worsening condition|1|||
127904814|NCT01591785|460277054|FG001|Overall Study|worsening condition|2|||
127904815|NCT01591785|460277053|FG000|Overall Study|Protocol Violation|2|||
127849817|NCT00633893|460067676|FG002|Overall Study|Withdrawal by Subject|6|||
127849818|NCT00633893|460067674|FG000|Overall Study|Lost to Follow-up|2|||
127849819|NCT00633893|460067675|FG001|Overall Study|Lost to Follow-up|4|||
127849820|NCT00633893|460067676|FG002|Overall Study|Lost to Follow-up|8|||
127849821|NCT00633893|460067674|FG000|Overall Study|Poor/non-compliance|5|||
127849822|NCT00633893|460067675|FG001|Overall Study|Poor/non-compliance|12|||
127849823|NCT00633893|460067676|FG002|Overall Study|Poor/non-compliance|3|||
127849824|NCT00633893|460067674|FG000|Overall Study|Pregnancy|2|||
127849825|NCT00633893|460067675|FG001|Overall Study|Pregnancy|1|||
127849826|NCT00633893|460067676|FG002|Overall Study|Pregnancy|1|||
127849827|NCT00633893|460067674|FG000|Overall Study|Not meet/no longer meets criteria|4|||
127849828|NCT00633893|460067675|FG001|Overall Study|Not meet/no longer meets criteria|6|||
127849829|NCT00633893|460067676|FG002|Overall Study|Not meet/no longer meets criteria|4|||
127849830|NCT00633893|460067674|FG000|Overall Study|Other|28|||
127849831|NCT00633893|460067675|FG001|Overall Study|Other|33|||
127849832|NCT00633893|460067676|FG002|Overall Study|Other|31|||
127849833|NCT02741310|460067677|FG000|Overall Study|Sponsor Decision|2|||
127849834|NCT02741310|460067678|FG001|Overall Study|Sponsor Decision|2|||
127849835|NCT05091918|460067679|FG000|Overall Study|Adverse Event|1|||
127849836|NCT05091918|460067679|FG000|Overall Study|Withdrawal by Subject|81|||
127849837|NCT00239356|460067680|FG000|Overall Study|Lack of Efficacy|1|||
127849838|NCT00239356|460067681|FG001|Overall Study|Lack of Efficacy|0|||
127849839|NCT00239356|460067680|FG000|Overall Study|Adverse Event|6|||
127849840|NCT00239356|460067681|FG001|Overall Study|Adverse Event|0|||
127849841|NCT00239356|460067680|FG000|Overall Study|Withdrawal by Subject|15|||
127849842|NCT00239356|460067681|FG001|Overall Study|Withdrawal by Subject|6|||
127849843|NCT00239356|460067680|FG000|Overall Study|Lost to Follow-up|3|||
127849844|NCT00239356|460067681|FG001|Overall Study|Lost to Follow-up|0|||
127849845|NCT00239356|460067680|FG000|Overall Study|poor/non-compliance|2|||
127849846|NCT00239356|460067681|FG001|Overall Study|poor/non-compliance|0|||
127849847|NCT00239356|460067680|FG000|Overall Study|Pregnancy|1|||
127849848|NCT00239356|460067681|FG001|Overall Study|Pregnancy|0|||
127849849|NCT00239356|460067680|FG000|Overall Study|Administrative reason|0|||
127849850|NCT00239356|460067681|FG001|Overall Study|Administrative reason|1|||
127849851|NCT00239356|460067680|FG000|Overall Study|Drug available on market|11|||
127849852|NCT00239356|460067681|FG001|Overall Study|Drug available on market|2|||
127849853|NCT02044822|460067682|FG000|Overall Study|Study Terminated by Sponsor|77|||
127849854|NCT02044822|460067682|FG000|Overall Study|Investigator's Discretion|10|||
127849855|NCT02044822|460067682|FG000|Overall Study|Withdrew Consent|3|||
127849856|NCT02044822|460067682|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
127849857|NCT02044822|460067682|FG000|Overall Study|Lost to Follow-up|1|||
127849858|NCT03417505|460067685|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
127849859|NCT03417505|460067686|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
127849860|NCT01237223|460067693|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
127849861|NCT01237223|460067694|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
127849862|NCT01237223|460067695|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
127849863|NCT01237223|460067696|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
127849864|NCT01237223|460067697|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
127849865|NCT01237223|460067698|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
127849866|NCT01237223|460067693|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
127849867|NCT01237223|460067694|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
127849868|NCT01237223|460067695|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
127849869|NCT01237223|460067696|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
127849870|NCT01237223|460067697|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
127849871|NCT01237223|460067698|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
127849872|NCT01237223|460067693|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
127849873|NCT01237223|460067694|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
127849874|NCT01237223|460067695|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
127849875|NCT01237223|460067696|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
127849876|NCT01237223|460067697|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
127849877|NCT01237223|460067698|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
127849878|NCT01237223|460067693|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
127849879|NCT01237223|460067694|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
127849880|NCT01237223|460067695|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
127849881|NCT01237223|460067696|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
127849882|NCT01237223|460067697|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
127849883|NCT01237223|460067698|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
127849884|NCT01237223|460067693|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
127849885|NCT01237223|460067694|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
127849886|NCT01237223|460067695|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
127849887|NCT01237223|460067696|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
127849888|NCT01237223|460067697|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
127849889|NCT01237223|460067698|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
127849890|NCT01237223|460067693|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
127849891|NCT01237223|460067694|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
127849892|NCT01237223|460067695|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
127849893|NCT01237223|460067696|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
127849894|NCT01237223|460067697|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
127849895|NCT01237223|460067698|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
127849896|NCT01237223|460067693|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
127849897|NCT01237223|460067694|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
127849898|NCT01237223|460067695|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
127849899|NCT01237223|460067696|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
127849900|NCT01237223|460067697|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
127849901|NCT01237223|460067698|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
127849902|NCT01237223|460067693|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
127849903|NCT01237223|460067694|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
127849904|NCT01237223|460067695|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
127849905|NCT01237223|460067696|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
127849906|NCT01237223|460067697|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
127849907|NCT01237223|460067698|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
127849908|NCT01237223|460067693|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
127849909|NCT01237223|460067694|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
127849910|NCT01237223|460067695|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
127849911|NCT01237223|460067696|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
127849912|NCT01237223|460067697|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
127849913|NCT01237223|460067698|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
127849914|NCT01237223|460067693|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
127849915|NCT01237223|460067694|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
127849916|NCT01237223|460067695|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
127849917|NCT01237223|460067696|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
127849918|NCT01237223|460067697|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
127849919|NCT01237223|460067698|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
127849920|NCT00407550|460067703|FG000|Overall Study|Adverse Event|0|||
127849921|NCT00407550|460067704|FG001|Overall Study|Adverse Event|1|||
127849922|NCT00407550|460067703|FG000|Overall Study|Withdrawal by Subject|0|||
127849923|NCT00407550|460067704|FG001|Overall Study|Withdrawal by Subject|2|||
127849924|NCT00407550|460067703|FG000|Overall Study|Death|1|||
127849925|NCT00407550|460067704|FG001|Overall Study|Death|0|||
127849926|NCT00407550|460067703|FG000|Overall Study|Insurance or Other medical condition|2|||
127849927|NCT00407550|460067704|FG001|Overall Study|Insurance or Other medical condition|1|||
127849928|NCT00443846|460067705|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
127849929|NCT00443846|460067706|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
127849930|NCT00443846|460067705|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
127849931|NCT00443846|460067706|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
127849932|NCT00443846|460067705|FG000|Overall Study|Adverse Event|0|||
127849933|NCT00443846|460067706|FG001|Overall Study|Adverse Event|1|||
127849934|NCT00443846|460067705|FG000|Overall Study|Personal reason|8|||
127849935|NCT00443846|460067706|FG001|Overall Study|Personal reason|3|||
127849936|NCT00443846|460067705|FG000|Overall Study|Lost to Follow-up|1|||
127849937|NCT00443846|460067706|FG001|Overall Study|Lost to Follow-up|2|||
127849938|NCT00641706|460067707|FG000|Overall Study|Adverse Event|2|||
127849939|NCT00641706|460067708|FG001|Overall Study|Adverse Event|1|||
127849940|NCT00641706|460067707|FG000|Overall Study|Withdrawal by Subject|6|||
127849941|NCT00641706|460067708|FG001|Overall Study|Withdrawal by Subject|1|||
127849942|NCT00641706|460067707|FG000|Overall Study|Clinical Decline|1|||
127849943|NCT00641706|460067708|FG001|Overall Study|Clinical Decline|0|||
127849944|NCT00641706|460067707|FG000|Overall Study|Lead Investigator Decision|0|||
127849945|NCT00641706|460067708|FG001|Overall Study|Lead Investigator Decision|1|||
127849946|NCT03006926|460067711|FG000|Overall Study|Adverse Event|0|||
127849947|NCT03006926|460067712|FG001|Overall Study|Adverse Event|27|||
127849948|NCT03006926|460067711|FG000|Overall Study|Withdrawal by Subject|0|||
127849949|NCT03006926|460067712|FG001|Overall Study|Withdrawal by Subject|1|||
127849950|NCT03006926|460067711|FG000|Overall Study|Radiological Disease Progression|0|||
127849951|NCT03006926|460067712|FG001|Overall Study|Radiological Disease Progression|52|||
127849952|NCT03006926|460067711|FG000|Overall Study|Clinical Disease Progression|0|||
127849953|NCT03006926|460067712|FG001|Overall Study|Clinical Disease Progression|10|||
127849954|NCT03006926|460067711|FG000|Overall Study|Other|0|||
127904816|NCT01591785|460277054|FG001|Overall Study|Protocol Violation|0|||
127904817|NCT01591785|460277053|FG000|Overall Study|Lost to Follow-up|1|||
127904818|NCT01591785|460277054|FG001|Overall Study|Lost to Follow-up|0|||
127904819|NCT01049334|460277056|FG000|Overall Study|Withdrawal by Subject|5|||
127904820|NCT01049334|460277057|FG001|Overall Study|Withdrawal by Subject|3|||
127904821|NCT01049334|460277056|FG000|Overall Study|Adverse Event|2|||
127904822|NCT01049334|460277057|FG001|Overall Study|Adverse Event|3|||
127904823|NCT01049334|460277056|FG000|Overall Study|Physician Decision|2|||
127904824|NCT01049334|460277057|FG001|Overall Study|Physician Decision|0|||
127904825|NCT01049334|460277056|FG000|Overall Study|Protocol Violation|0|||
127904826|NCT01049334|460277057|FG001|Overall Study|Protocol Violation|1|||
127904827|NCT00667095|460277070|FG000|Overall Study|Withdrawal by Subject|0|||
127904828|NCT00667095|460277071|FG001|Overall Study|Withdrawal by Subject|1|||
127904829|NCT03447262|460277073|FG000|Overall Study|Adverse Event|7|||
127904830|NCT03447262|460277073|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
127904831|NCT03447262|460277073|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
127904832|NCT03447262|460277073|FG000|Overall Study|Death|2|||
127904833|NCT03447262|460277073|FG000|Overall Study|Study Termination by Sponsor|455|||
127904834|NCT03447262|460277073|FG000|Overall Study|Other|4|||
127904835|NCT00496964|460277077|FG000|Overall Study|Withdrawal by Subject|0|||
127904836|NCT00496964|460277078|FG001|Overall Study|Withdrawal by Subject|1|||
127904837|NCT03351335|460277079|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
127904838|NCT03351335|460277080|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
127904839|NCT03351335|460277081|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
127904840|NCT00469417|460277082|FG000|Overall Study|Treatment failure all lesions|18|||
127904841|NCT00469417|460277083|FG001|Overall Study|Treatment failure all lesions|11|||
127904842|NCT00469417|460277082|FG000|Overall Study|Consent withdrawn|1|||
127904843|NCT00469417|460277083|FG001|Overall Study|Consent withdrawn|1|||
127904844|NCT00469417|460277082|FG000|Overall Study|Adverse Event|8|||
127904845|NCT00469417|460277083|FG001|Overall Study|Adverse Event|2|||
127904846|NCT00469417|460277082|FG000|Overall Study|Lost to Follow-up|1|||
127904847|NCT00469417|460277083|FG001|Overall Study|Lost to Follow-up|2|||
127904848|NCT00469417|460277082|FG000|Overall Study|Intercurrent disease|0|||
127904849|NCT00469417|460277083|FG001|Overall Study|Intercurrent disease|1|||
127904850|NCT00469417|460277082|FG000|Overall Study|Randomized but not treated|2|||
127904851|NCT00469417|460277083|FG001|Overall Study|Randomized but not treated|0|||
127904852|NCT00909610|460277084|FG000|Period: First Intervention|Adverse Event|0|||
127904853|NCT00909610|460277085|FG001|Period: First Intervention|Adverse Event|1|||
127904854|NCT00909610|460277084|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
127904855|NCT00909610|460277085|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
127904856|NCT00909610|460277084|FG000|Period: Second Intervention|Adverse Event|1|||
127904857|NCT00909610|460277085|FG001|Period: Second Intervention|Adverse Event|0|||
127904858|NCT03988803|460277091|FG000|Period 2|Prematurely discontinued from medication|2|||
127904859|NCT03988803|460277091|FG000|Period 2|Adverse Event|1|||
127904860|NCT04123548|460277098|FG000|Overall Study|Withdrawal by Subject|1|||
127904861|NCT04123548|460277098|FG000|Overall Study|Lost to Follow-up|8|||
127904862|NCT04123548|460277098|FG000|Overall Study|Death|4|||
127904863|NCT04123548|460277098|FG000|Overall Study|Reason Not Specified|1|||
127904864|NCT00418184|460277099|FG000|Double-blind Phase|Withdrawal by Subject|22|||
127904865|NCT00418184|460277100|FG001|Double-blind Phase|Withdrawal by Subject|9|||
127904866|NCT00418184|460277099|FG000|Double-blind Phase|Adverse Event|2|||
127904867|NCT00418184|460277100|FG001|Double-blind Phase|Adverse Event|1|||
127904868|NCT00418184|460277099|FG000|Double-blind Phase|Poor compliance|3|||
127904869|NCT00418184|460277100|FG001|Double-blind Phase|Poor compliance|1|||
127904870|NCT01015625|460277101|FG000|Overall Study|Lost to Follow-up|3|||
127904871|NCT01015625|460277102|FG001|Overall Study|Lost to Follow-up|1|||
127904872|NCT01015625|460277101|FG000|Overall Study|Withdrawal by Subject|2|||
127904873|NCT01015625|460277102|FG001|Overall Study|Withdrawal by Subject|3|||
127904874|NCT01015625|460277101|FG000|Overall Study|Physician Decision|2|||
127904875|NCT01015625|460277102|FG001|Overall Study|Physician Decision|0|||
127904876|NCT01015625|460277101|FG000|Overall Study|Death|30|||
127904877|NCT01015625|460277102|FG001|Overall Study|Death|22|||
127904878|NCT02728102|460277103|FG000|Overall Study|Death|3|||
127904879|NCT02728102|460277104|FG001|Overall Study|Death|0|||
127904880|NCT02728102|460277105|FG002|Overall Study|Death|1|||
127904881|NCT02728102|460277103|FG000|Overall Study|Withdrawal by Subject|0|||
127904882|NCT02728102|460277104|FG001|Overall Study|Withdrawal by Subject|2|||
127904883|NCT02728102|460277105|FG002|Overall Study|Withdrawal by Subject|3|||
127904884|NCT02728102|460277103|FG000|Overall Study|Physician Decision|1|||
127904885|NCT02728102|460277104|FG001|Overall Study|Physician Decision|1|||
127904886|NCT02728102|460277105|FG002|Overall Study|Physician Decision|0|||
127904887|NCT02728102|460277103|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
127904888|NCT02728102|460277104|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
127904889|NCT02728102|460277105|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
127904890|NCT02728102|460277103|FG000|Overall Study|Covid|0|||
127904891|NCT02728102|460277104|FG001|Overall Study|Covid|0|||
127904892|NCT02728102|460277105|FG002|Overall Study|Covid|1|||
127904893|NCT02472366|460277106|FG000|Overall Study|Lost to Follow-up|1|||
127904894|NCT02472366|460277107|FG001|Overall Study|Lost to Follow-up|0|||
127904895|NCT01182415|460277108|FG000|Overall Study|Lost to Follow-up|1|||
127904896|NCT02587962|460277109|FG000|Overall Study|Adverse Event|0|||
127904897|NCT02587962|460277110|FG001|Overall Study|Adverse Event|0|||
127904898|NCT02587962|460277111|FG002|Overall Study|Adverse Event|1|||
127904899|NCT02587962|460277112|FG003|Overall Study|Adverse Event|0|||
127904900|NCT02587962|460277113|FG004|Overall Study|Adverse Event|0|||
127904901|NCT02587962|460277109|FG000|Overall Study|Withdrawal by Subject|0|||
127904902|NCT02587962|460277110|FG001|Overall Study|Withdrawal by Subject|0|||
127904903|NCT02587962|460277111|FG002|Overall Study|Withdrawal by Subject|1|||
127904904|NCT02587962|460277112|FG003|Overall Study|Withdrawal by Subject|1|||
127904905|NCT02587962|460277113|FG004|Overall Study|Withdrawal by Subject|4|||
127904906|NCT02587962|460277109|FG000|Overall Study|Radiological progression|2|||
127904907|NCT02587962|460277110|FG001|Overall Study|Radiological progression|2|||
127904908|NCT02587962|460277111|FG002|Overall Study|Radiological progression|2|||
127904909|NCT02587962|460277112|FG003|Overall Study|Radiological progression|5|||
127904910|NCT02587962|460277113|FG004|Overall Study|Radiological progression|10|||
127904911|NCT02587962|460277109|FG000|Overall Study|Clinical progression|0|||
127904912|NCT02587962|460277110|FG001|Overall Study|Clinical progression|1|||
127904913|NCT02587962|460277111|FG002|Overall Study|Clinical progression|2|||
127904914|NCT02587962|460277112|FG003|Overall Study|Clinical progression|0|||
127904915|NCT02587962|460277113|FG004|Overall Study|Clinical progression|1|||
127904916|NCT01422538|460277117|FG000|Overall Study|Lost to Follow-up|0|||
127904917|NCT01422538|460277118|FG001|Overall Study|Lost to Follow-up|1|||
127904918|NCT01422538|460277119|FG002|Overall Study|Lost to Follow-up|1|||
127904919|NCT01422538|460277117|FG000|Overall Study|Missed visit|0|||
127904920|NCT01422538|460277118|FG001|Overall Study|Missed visit|1|||
127904921|NCT01422538|460277119|FG002|Overall Study|Missed visit|1|||
127904922|NCT02770820|460277120|FG000|Overall Study|Death|1|||
127904923|NCT02770820|460277120|FG000|Overall Study|Physician Decision|2|||
127904924|NCT02098876|460277123|FG000|Overall Study|Withdrawal by Subject|5|||
127904925|NCT02098876|460277124|FG001|Overall Study|Withdrawal by Subject|5|||
127904926|NCT01061866|460277125|FG000|Overall Study|Adverse Event|2|||
127904927|NCT00834756|460277126|FG000|First Intervention|Adverse Event|1|||
127904928|NCT00834756|460277127|FG001|First Intervention|Adverse Event|0|||
127904929|NCT00834756|460277126|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
127904930|NCT00834756|460277127|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
127904931|NCT02979353|460277133|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
127904932|NCT02979353|460277134|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
127904933|NCT02979353|460277133|FG000|Overall Study|Withdrawal by Subject|16|||
127904934|NCT02979353|460277134|FG001|Overall Study|Withdrawal by Subject|12|||
127904935|NCT02979353|460277133|FG000|Overall Study|Death|10|||
127904936|NCT02979353|460277134|FG001|Overall Study|Death|11|||
127904937|NCT02979353|460277133|FG000|Overall Study|Transfer to Hospice Care|19|||
127904938|NCT02979353|460277134|FG001|Overall Study|Transfer to Hospice Care|14|||
127904939|NCT02979353|460277133|FG000|Overall Study|Lost to Follow-up|1|||
127904940|NCT02979353|460277134|FG001|Overall Study|Lost to Follow-up|5|||
127904941|NCT01079988|460277135|FG000|Overall Study|Lost to Follow-up|0|||
127904942|NCT01079988|460277136|FG001|Overall Study|Lost to Follow-up|0|||
127904943|NCT01079988|460277137|FG002|Overall Study|Lost to Follow-up|0|||
127904944|NCT01079988|460277138|FG003|Overall Study|Lost to Follow-up|1|||
127904945|NCT01079988|460277139|FG004|Overall Study|Lost to Follow-up|0|||
127904946|NCT01079988|460277135|FG000|Overall Study|Lack of Efficacy|1|||
127904947|NCT01079988|460277136|FG001|Overall Study|Lack of Efficacy|0|||
127904948|NCT01079988|460277137|FG002|Overall Study|Lack of Efficacy|0|||
127904949|NCT01079988|460277138|FG003|Overall Study|Lack of Efficacy|0|||
127904950|NCT01079988|460277139|FG004|Overall Study|Lack of Efficacy|0|||
127904951|NCT01079988|460277135|FG000|Overall Study|Other|0|||
127904952|NCT01079988|460277136|FG001|Overall Study|Other|0|||
127904953|NCT01079988|460277137|FG002|Overall Study|Other|0|||
127904954|NCT01079988|460277138|FG003|Overall Study|Other|2|||
127904955|NCT01079988|460277139|FG004|Overall Study|Other|1|||
127904956|NCT00268905|460277140|FG000|Overall Study|Adverse Event|3|||
127904957|NCT00268905|460277141|FG001|Overall Study|Adverse Event|0|||
127904958|NCT00268905|460277142|FG002|Overall Study|Adverse Event|4|||
127904959|NCT00268905|460277140|FG000|Overall Study|Lost to Follow-up|0|||
127904960|NCT00268905|460277141|FG001|Overall Study|Lost to Follow-up|1|||
127904961|NCT00268905|460277142|FG002|Overall Study|Lost to Follow-up|0|||
127904962|NCT00268905|460277140|FG000|Overall Study|Withdrawal by Subject|0|||
127904963|NCT00268905|460277141|FG001|Overall Study|Withdrawal by Subject|0|||
127904964|NCT00268905|460277142|FG002|Overall Study|Withdrawal by Subject|3|||
127904965|NCT00268905|460277140|FG000|Overall Study|Progressive Disease|28|||
127904966|NCT00268905|460277141|FG001|Overall Study|Progressive Disease|4|||
127904967|NCT00268905|460277142|FG002|Overall Study|Progressive Disease|3|||
127904968|NCT00268905|460277140|FG000|Overall Study|Physician Decision|3|||
127904969|NCT00268905|460277141|FG001|Overall Study|Physician Decision|0|||
127904970|NCT00268905|460277142|FG002|Overall Study|Physician Decision|1|||
127904971|NCT00268905|460277140|FG000|Overall Study|Clinical Progression|9|||
127904972|NCT00268905|460277141|FG001|Overall Study|Clinical Progression|4|||
127904973|NCT00268905|460277142|FG002|Overall Study|Clinical Progression|1|||
127904974|NCT03897088|460277145|FG000|Overall Study|Withdrawal by Subject|12|||
127904975|NCT03897088|460277146|FG001|Overall Study|Withdrawal by Subject|12|||
127904976|NCT03897088|460277145|FG000|Overall Study|Lost to Follow-up|7|||
127904977|NCT03897088|460277146|FG001|Overall Study|Lost to Follow-up|15|||
127904978|NCT03897088|460277145|FG000|Overall Study|Sponsor Decision|1|||
127904979|NCT03897088|460277146|FG001|Overall Study|Sponsor Decision|2|||
127904980|NCT03897088|460277145|FG000|Overall Study|COVID-19|2|||
127904981|NCT03897088|460277146|FG001|Overall Study|COVID-19|0|||
127904982|NCT03897088|460277145|FG000|Overall Study|Other|3|||
127904983|NCT03897088|460277146|FG001|Overall Study|Other|0|||
127904984|NCT03897088|460277145|FG000|Overall Study|Non-compliance with Study Drug|1|||
127904985|NCT03897088|460277146|FG001|Overall Study|Non-compliance with Study Drug|1|||
127904986|NCT03897088|460277145|FG000|Overall Study|Pregnancy|0|||
127904987|NCT03897088|460277146|FG001|Overall Study|Pregnancy|1|||
127904988|NCT02392000|460277147|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
127904989|NCT02392000|460277147|FG000|Overall Study|Withdrawal by Subject|1|||
127904990|NCT02392000|460277147|FG000|Overall Study|Lost to Follow-up|8|||
127904991|NCT01066143|460278505|FG000|Overall Study|ineligible for the study|8|||
127904992|NCT00942968|460278506|FG000|Overall Study|Adverse Event|60|||
127904993|NCT00942968|460278506|FG000|Overall Study|Death|76|||
127904994|NCT00942968|460278506|FG000|Overall Study|Protocol Violation|9|||
127904995|NCT00942968|460278506|FG000|Overall Study|Lost to Follow-up|4|||
127904996|NCT00942968|460278506|FG000|Overall Study|Withdrawal by Subject|44|||
127904997|NCT00942968|460278506|FG000|Overall Study|Sponsor request|5|||
127904998|NCT00942968|460278506|FG000|Overall Study|Physician Decision|11|||
127904999|NCT00942968|460278506|FG000|Overall Study|Progression of disease|12|||
127905000|NCT00942968|460278506|FG000|Overall Study|Inferior vena cava filter placement|4|||
127905001|NCT00942968|460278506|FG000|Overall Study|Pulmonary embolism (PE)|1|||
127905002|NCT00942968|460278506|FG000|Overall Study|Participant required pancreatic biopsy|1|||
127905003|NCT00942968|460278506|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
127905004|NCT01466166|460278509|FG000|Overall Study|Death|1|||
127905005|NCT01466166|460278509|FG000|Overall Study|Lost to Follow-up|7|||
127905006|NCT01466166|460278509|FG000|Overall Study|Infusion Reaction (IR)|27|||
127905007|NCT01466166|460278509|FG000|Overall Study|Adverse Event (Other than IR)|11|||
127905008|NCT01466166|460278509|FG000|Overall Study|Elevated Serum Uric Acid|78|||
127905009|NCT01466166|460278509|FG000|Overall Study|Withdrawal by Subject|13|||
127905010|NCT01466166|460278509|FG000|Overall Study|Sponsor Decision|4|||
127905011|NCT01466166|460278509|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
127905012|NCT01466166|460278509|FG000|Overall Study|Other|20|||
127905013|NCT01340495|460278512|FG000|Overall Study|Withdrawal by Subject|1|||
127905014|NCT00667862|460278515|FG000|Overall Study|Adverse Event|9|||
127905015|NCT00667862|460278515|FG000|Overall Study|Death|1|||
127905016|NCT00667862|460278515|FG000|Overall Study|Disease Progression|22|||
127905017|NCT00667862|460278515|FG000|Overall Study|Withdrawal by Subject|3|||
127905018|NCT02495857|460278517|FG000|Overall Study|Adverse Event|5|||
127905019|NCT02495857|460278518|FG001|Overall Study|Adverse Event|0|||
127849955|NCT03006926|460067712|FG001|Overall Study|Other|8|||
127849956|NCT03689972|460067713|FG000|Part 1 (Day 1 up to Week 72)|Adverse Event|1|||
127849957|NCT03689972|460067714|FG001|Part 1 (Day 1 up to Week 72)|Adverse Event|3|||
127849958|NCT03689972|460067715|FG002|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
127849959|NCT03689972|460067716|FG003|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
127849960|NCT03689972|460067717|FG004|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
127849961|NCT03689972|460067713|FG000|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
127849962|NCT03689972|460067714|FG001|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|2|||
127849963|NCT03689972|460067715|FG002|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
127849964|NCT03689972|460067716|FG003|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
127849965|NCT03689972|460067717|FG004|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
127849966|NCT03689972|460067713|FG000|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
127849967|NCT03689972|460067714|FG001|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|6|||
127849968|NCT03689972|460067715|FG002|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
127849969|NCT03689972|460067716|FG003|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
127905020|NCT02495857|460278519|FG002|Overall Study|Adverse Event|1|||
127905021|NCT02495857|460278517|FG000|Overall Study|Withdrawal by Subject|9|||
127905022|NCT02495857|460278518|FG001|Overall Study|Withdrawal by Subject|6|||
127905023|NCT02495857|460278519|FG002|Overall Study|Withdrawal by Subject|10|||
127905024|NCT02495857|460278517|FG000|Overall Study|Physician Decision|0|||
127905025|NCT02495857|460278518|FG001|Overall Study|Physician Decision|1|||
127905026|NCT02495857|460278519|FG002|Overall Study|Physician Decision|0|||
127905027|NCT02495857|460278517|FG000|Overall Study|Protocol Violation|1|||
127905028|NCT02495857|460278518|FG001|Overall Study|Protocol Violation|1|||
127905029|NCT02495857|460278519|FG002|Overall Study|Protocol Violation|2|||
127849970|NCT03689972|460067717|FG004|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
127849971|NCT03689972|460067713|FG000|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|1|||
127849972|NCT03689972|460067714|FG001|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|3|||
127849973|NCT03689972|460067715|FG002|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
127849974|NCT03689972|460067716|FG003|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
127849975|NCT03689972|460067717|FG004|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
127849976|NCT03689972|460067713|FG000|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|14|||
127849977|NCT03689972|460067714|FG001|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|9|||
127849978|NCT03689972|460067715|FG002|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
127849979|NCT03689972|460067716|FG003|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
127849980|NCT03689972|460067717|FG004|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
127849981|NCT03689972|460067713|FG000|Part 1 (Day 1 up to Week 72)|Investigator Decision|9|||
127905030|NCT02495857|460278517|FG000|Overall Study|Lost to Follow-up|4|||
127905031|NCT02495857|460278518|FG001|Overall Study|Lost to Follow-up|5|||
127905032|NCT02495857|460278519|FG002|Overall Study|Lost to Follow-up|3|||
127905033|NCT02495857|460278517|FG000|Overall Study|Other|3|||
127905034|NCT02495857|460278518|FG001|Overall Study|Other|3|||
127905035|NCT02495857|460278519|FG002|Overall Study|Other|2|||
127905036|NCT00396279|460278520|FG000|Overall Study|Ongoing in study|26|||
127905037|NCT00396279|460278520|FG000|Overall Study|Disease progression|2|||
127905038|NCT00396279|460278520|FG000|Overall Study|Withdrawal by Subject|1|||
127905039|NCT00396279|460278520|FG000|Overall Study|Physician Decision|1|||
127905040|NCT00905346|460278522|FG000|Period 1|Withdrawal by Subject|1|||
127905041|NCT00905346|460278523|FG001|Period 1|Withdrawal by Subject|0|||
127905042|NCT01435265|460278524|FG000|Overall Study|Lost to Follow-up|0|||
127905043|NCT01435265|460278525|FG001|Overall Study|Lost to Follow-up|1|||
127905044|NCT05612724|460278528|FG000|Overall Study|Lost to Follow-up|4|||
127905045|NCT02128997|460278530|FG000|Overall Study|Lost to Follow-up|6|||
127905046|NCT02128997|460278531|FG001|Overall Study|Lost to Follow-up|11|||
127905047|NCT04000815|460278534|FG000|Overall Study|Lost to Follow-up|9|||
127905048|NCT04000815|460278535|FG001|Overall Study|Lost to Follow-up|2|||
127905049|NCT04000815|460278536|FG002|Overall Study|Lost to Follow-up|3|||
127905050|NCT04000815|460278534|FG000|Overall Study|Withdrawal by Subject|4|||
127905051|NCT04000815|460278535|FG001|Overall Study|Withdrawal by Subject|3|||
127905052|NCT04000815|460278536|FG002|Overall Study|Withdrawal by Subject|2|||
127905053|NCT04000815|460278534|FG000|Overall Study|Right ovarian cyst occured|1|||
127905054|NCT04000815|460278535|FG001|Overall Study|Right ovarian cyst occured|0|||
127905055|NCT04000815|460278536|FG002|Overall Study|Right ovarian cyst occured|0|||
127905056|NCT04000815|460278534|FG000|Overall Study|Hypertension occured on follow up|0|||
127905057|NCT04000815|460278535|FG001|Overall Study|Hypertension occured on follow up|0|||
127905058|NCT04000815|460278536|FG002|Overall Study|Hypertension occured on follow up|2|||
127905059|NCT00239577|460278537|FG000|Primary Phase|Adverse Event|0|||
127905060|NCT00239577|460278538|FG001|Primary Phase|Adverse Event|0|||
127905061|NCT00239577|460278539|FG002|Primary Phase|Adverse Event|1|||
127905062|NCT00239577|460278540|FG003|Primary Phase|Adverse Event|0|||
127905063|NCT00239577|460278537|FG000|Primary Phase|Other|5|||
127905064|NCT00239577|460278538|FG001|Primary Phase|Other|3|||
127905065|NCT00239577|460278539|FG002|Primary Phase|Other|2|||
127905066|NCT00239577|460278540|FG003|Primary Phase|Other|0|||
127905067|NCT02736721|460278543|FG000|Overall Study|Adverse Event|8|||
127905068|NCT02736721|460278543|FG000|Overall Study|Lost to Follow-up|3|||
127905069|NCT02736721|460278543|FG000|Overall Study|Other|5|||
127905070|NCT03021018|460278545|FG000|Overall Study|Adverse Event|1|||
127905071|NCT03021018|460278546|FG001|Overall Study|Adverse Event|0|||
127905072|NCT03021018|460278547|FG002|Overall Study|Adverse Event|0|||
127905073|NCT03021018|460278545|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
127905074|NCT03021018|460278546|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
127905075|NCT03021018|460278547|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
127905076|NCT00328926|460278552|FG000|Overall Study|Pregnancy|2|||
127905077|NCT00328926|460278553|FG001|Overall Study|Pregnancy|1|||
127849982|NCT03689972|460067714|FG001|Part 1 (Day 1 up to Week 72)|Investigator Decision|6|||
127849983|NCT03689972|460067715|FG002|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
127849984|NCT03689972|460067716|FG003|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
127849985|NCT03689972|460067717|FG004|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
127905078|NCT00328926|460278554|FG002|Overall Study|Pregnancy|0|||
127905079|NCT00328926|460278552|FG000|Overall Study|Lost to Follow-up|0|||
127905080|NCT00328926|460278553|FG001|Overall Study|Lost to Follow-up|1|||
127905081|NCT00328926|460278554|FG002|Overall Study|Lost to Follow-up|0|||
127905082|NCT00328926|460278552|FG000|Overall Study|Death|0|||
127905083|NCT00328926|460278553|FG001|Overall Study|Death|0|||
127905084|NCT00328926|460278554|FG002|Overall Study|Death|1|||
127905085|NCT00328926|460278552|FG000|Overall Study|In vitro fertilization treatment|0|||
127905086|NCT00328926|460278553|FG001|Overall Study|In vitro fertilization treatment|0|||
127905087|NCT00328926|460278554|FG002|Overall Study|In vitro fertilization treatment|1|||
127905088|NCT00328926|460278552|FG000|Overall Study|Lack of ovarian response|0|||
127905089|NCT00328926|460278553|FG001|Overall Study|Lack of ovarian response|1|||
127905090|NCT00328926|460278554|FG002|Overall Study|Lack of ovarian response|0|||
127905091|NCT00620074|460278557|FG000|Overall Study|Adverse Event|1|||
127905092|NCT00573066|460278558|FG000|Overall Study|Exclusion criteria|18|||
127905093|NCT00573066|460278558|FG000|Overall Study|IV malfunction|1|||
127905094|NCT00573066|460278558|FG000|Overall Study|Postoperative bleeding|1|||
127905095|NCT01838941|460278559|FG000|Overall Study|Adverse Event|1|||
127905096|NCT01838941|460278559|FG000|Overall Study|Withdrawal by Subject|1|||
127905097|NCT02822235|460278560|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
127905098|NCT02822235|460278561|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
127905099|NCT02822235|460278560|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
127905100|NCT02822235|460278561|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
127905101|NCT02822235|460278560|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
127905102|NCT02822235|460278561|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
127905103|NCT02822235|460278560|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
127905104|NCT02822235|460278561|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
127905105|NCT02822235|460278560|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
127905106|NCT02822235|460278561|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
127905107|NCT02822235|460278560|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
127905108|NCT02822235|460278561|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
127905109|NCT03214952|460278562|FG000|Overall Study|Protocol Deviation|45|||
127905110|NCT03214952|460278562|FG000|Overall Study|Case Report Forms Uncollected|13|||
127905111|NCT03769896|460278565|FG000|Open-label Phase|Lack of Efficacy|5|||
127905112|NCT03769896|460278566|FG001|Open-label Phase|Lack of Efficacy|0|||
127905113|NCT03769896|460278565|FG000|Open-label Phase|Adverse Event|3|||
127905114|NCT03769896|460278566|FG001|Open-label Phase|Adverse Event|0|||
127905115|NCT03769896|460278565|FG000|Open-label Phase|Withdrawal by Subject|1|||
127905116|NCT03769896|460278566|FG001|Open-label Phase|Withdrawal by Subject|0|||
127905117|NCT00377260|460278567|FG000|Overall Study|Lost to Follow-up|0|||
127905118|NCT00377260|460278568|FG001|Overall Study|Lost to Follow-up|1|||
127905119|NCT00377260|460278567|FG000|Overall Study|Withdrawal by Subject|2|||
127905120|NCT00377260|460278568|FG001|Overall Study|Withdrawal by Subject|4|||
127905121|NCT00829530|460278569|FG000|First Intervention|Adverse Event|0|||
127905122|NCT00829530|460278570|FG001|First Intervention|Adverse Event|1|||
127905123|NCT00829530|460278569|FG000|First Intervention|Intolerance to Venopuncture|0|||
127905124|NCT00829530|460278570|FG001|First Intervention|Intolerance to Venopuncture|1|||
127905125|NCT00829530|460278569|FG000|Second Intervention|Intolerance to Venopuncture|1|||
127905126|NCT00829530|460278570|FG001|Second Intervention|Intolerance to Venopuncture|0|||
127905127|NCT04112823|460278573|FG000|Overall Study|Lost to Follow-up|2|||
127905128|NCT04112823|460278574|FG001|Overall Study|Lost to Follow-up|3|||
127905129|NCT00625443|460278575|FG000|Overall Study|Adverse Event|1|||
127905130|NCT00625443|460278576|FG001|Overall Study|Adverse Event|4|||
127905131|NCT00625443|460278577|FG002|Overall Study|Adverse Event|0|||
127905132|NCT00625443|460278575|FG000|Overall Study|Non-compliance with protocol|0|||
127905133|NCT00625443|460278576|FG001|Overall Study|Non-compliance with protocol|1|||
127905134|NCT00625443|460278577|FG002|Overall Study|Non-compliance with protocol|0|||
127905135|NCT00625443|460278575|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
127905136|NCT00625443|460278576|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
127905137|NCT00625443|460278577|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
127905138|NCT00625443|460278575|FG000|Overall Study|Withdrawal by Subject|0|||
127905139|NCT00625443|460278576|FG001|Overall Study|Withdrawal by Subject|1|||
127905140|NCT00625443|460278577|FG002|Overall Study|Withdrawal by Subject|2|||
127905141|NCT00625443|460278575|FG000|Overall Study|Physician Decision|0|||
127905142|NCT00625443|460278576|FG001|Overall Study|Physician Decision|4|||
127905143|NCT00625443|460278577|FG002|Overall Study|Physician Decision|2|||
127905144|NCT00625443|460278575|FG000|Overall Study|Other|0|||
127905145|NCT00625443|460278576|FG001|Overall Study|Other|1|||
127905146|NCT00625443|460278577|FG002|Overall Study|Other|1|||
127905147|NCT02924883|460278578|FG000|Overall Study|Death|39|||
127905148|NCT02924883|460278579|FG001|Overall Study|Death|20|||
127905149|NCT02924883|460278578|FG000|Overall Study|Lost to Follow-up|1|||
127905150|NCT02924883|460278579|FG001|Overall Study|Lost to Follow-up|0|||
127905151|NCT02924883|460278578|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
127905152|NCT02924883|460278579|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
127905153|NCT02924883|460278578|FG000|Overall Study|Protocol Violation|1|||
127905154|NCT02924883|460278579|FG001|Overall Study|Protocol Violation|0|||
127905155|NCT02924883|460278578|FG000|Overall Study|Withdrawal by Subject|22|||
127905156|NCT02924883|460278579|FG001|Overall Study|Withdrawal by Subject|16|||
127905157|NCT02924883|460278578|FG000|Overall Study|Progressive Disease|1|||
127905158|NCT02924883|460278579|FG001|Overall Study|Progressive Disease|0|||
127905159|NCT02924883|460278578|FG000|Overall Study|Study Terminated by Sponsor|69|||
127905160|NCT02924883|460278579|FG001|Overall Study|Study Terminated by Sponsor|32|||
127905161|NCT00772941|460278583|FG000|Overall Study|CRFs not available|195|||
127905162|NCT00772941|460278583|FG000|Overall Study|Study not completed|16|||
127905163|NCT00772941|460278583|FG000|Overall Study|Missed Visits|374|||
127905164|NCT00772941|460278583|FG000|Overall Study|Poor Compliance|7|||
127905165|NCT00772941|460278583|FG000|Overall Study|GPSP Violation|90|||
127905166|NCT04786184|460278584|FG000|Overall Study|Adverse Event|4|||
127905167|NCT04786184|460278585|FG001|Overall Study|Adverse Event|0|||
127905168|NCT04786184|460278584|FG000|Overall Study|Withdrawal by Subject|3|||
127905169|NCT04786184|460278585|FG001|Overall Study|Withdrawal by Subject|1|||
127905170|NCT04786184|460278584|FG000|Overall Study|Lost to Follow-up|4|||
127905171|NCT04786184|460278585|FG001|Overall Study|Lost to Follow-up|2|||
127905172|NCT01702987|460278595|FG000|Overall Study|Withdrawal by Subject|1|||
127849986|NCT03689972|460067713|FG000|Part 1 (Day 1 up to Week 72)|Pregnancy|5|||
127849987|NCT03689972|460067714|FG001|Part 1 (Day 1 up to Week 72)|Pregnancy|1|||
127849988|NCT03689972|460067715|FG002|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
127849989|NCT03689972|460067716|FG003|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
127849990|NCT03689972|460067717|FG004|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
127849991|NCT03689972|460067713|FG000|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|3|||
127849992|NCT03689972|460067714|FG001|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|2|||
127849993|NCT03689972|460067715|FG002|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
127849994|NCT03689972|460067716|FG003|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
127849995|NCT03689972|460067717|FG004|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
127849996|NCT03689972|460067713|FG000|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
127849997|NCT03689972|460067714|FG001|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
127849998|NCT03689972|460067715|FG002|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
127849999|NCT03689972|460067716|FG003|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
127850000|NCT03689972|460067717|FG004|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
127850001|NCT03689972|460067713|FG000|Part 1 (Day 1 up to Week 72)|Reason not Specified|20|||
127850002|NCT03689972|460067714|FG001|Part 1 (Day 1 up to Week 72)|Reason not Specified|16|||
127850003|NCT03689972|460067715|FG002|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
127850004|NCT03689972|460067716|FG003|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
127850005|NCT03689972|460067717|FG004|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
127850006|NCT03689972|460067713|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
127850007|NCT03689972|460067714|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
127850008|NCT03689972|460067715|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|2|||
127850009|NCT03689972|460067716|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
127850010|NCT03689972|460067717|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
127850011|NCT03689972|460067713|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
127850012|NCT03689972|460067714|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
127850013|NCT03689972|460067715|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|1|||
127850014|NCT03689972|460067716|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
127850015|NCT03689972|460067717|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
127850016|NCT03689972|460067713|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
127850017|NCT03689972|460067714|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
127850018|NCT03689972|460067715|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|2|||
127850019|NCT03689972|460067716|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
127850020|NCT03689972|460067717|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
127850021|NCT03689972|460067713|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
127850022|NCT03689972|460067714|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
127850023|NCT03689972|460067715|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
127850024|NCT03689972|460067716|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
127850025|NCT03689972|460067717|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
127850026|NCT03689972|460067713|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
127850027|NCT03689972|460067714|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
127850028|NCT03689972|460067715|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
127850029|NCT03689972|460067716|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|7|||
127850030|NCT03689972|460067717|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|1|||
127850031|NCT03689972|460067713|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
127850032|NCT03689972|460067714|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
127850033|NCT03689972|460067715|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
127850034|NCT03689972|460067716|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
127850035|NCT03689972|460067717|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
127850036|NCT03689972|460067713|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
127905173|NCT01702987|460278596|FG001|Overall Study|Withdrawal by Subject|0|||
127905174|NCT02017223|460278597|FG000|Overall Study|Algorithm problems|2|||
127905175|NCT04263649|460278599|FG000|Overall Study|Adverse Event|53|||
127905176|NCT04263649|460278599|FG000|Overall Study|Lost to Follow-up|3|||
127905177|NCT04263649|460278599|FG000|Overall Study|Death|29|||
127850037|NCT03689972|460067714|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
127850038|NCT03689972|460067715|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
127850039|NCT03689972|460067716|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
127850040|NCT03689972|460067717|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|1|||
127850041|NCT03689972|460067713|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
127850042|NCT03689972|460067714|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
127850043|NCT03689972|460067715|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
127850044|NCT03689972|460067716|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|2|||
127850045|NCT03689972|460067717|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|1|||
127850046|NCT03689972|460067713|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
127850047|NCT03689972|460067714|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
127850048|NCT03689972|460067715|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
127850049|NCT03689972|460067716|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
127850050|NCT03689972|460067717|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|12|||
127850051|NCT01838213|460067718|FG000|Overall Study|Ineligible|166|||
127850052|NCT01838213|460067719|FG001|Overall Study|Ineligible|191|||
127850053|NCT00990249|460067724|FG000|Overall Study|Disease Progression|8|||
127850054|NCT00990249|460067724|FG000|Overall Study|Non-Compliance|1|||
127850055|NCT00990249|460067724|FG000|Overall Study|Death|2|||
127850056|NCT00990249|460067724|FG000|Overall Study|Not treated|2|||
127850057|NCT01548417|460067727|FG000|Overall Study|Withdrawal by Subject|0|||
127850058|NCT01548417|460067728|FG001|Overall Study|Withdrawal by Subject|2|||
127850059|NCT03725293|460067729|FG000|Overall Study|Physician Decision|9|||
127850060|NCT03725293|460067730|FG001|Overall Study|Physician Decision|6|||
127850061|NCT03725293|460067729|FG000|Overall Study|alternative vascular access needs|1|||
127850062|NCT03725293|460067730|FG001|Overall Study|alternative vascular access needs|2|||
127850063|NCT03725293|460067729|FG000|Overall Study|venous anatomy screen failures|2|||
127850064|NCT03725293|460067730|FG001|Overall Study|venous anatomy screen failures|1|||
127850065|NCT04583969|460067733|FG000|Overall Study|Death|31|||
127850066|NCT04583969|460067734|FG001|Overall Study|Death|38|||
127850067|NCT04583969|460067733|FG000|Overall Study|Lost to Follow-up|16|||
127850068|NCT04583969|460067734|FG001|Overall Study|Lost to Follow-up|13|||
127850069|NCT04583969|460067733|FG000|Overall Study|Protocol Violation|1|||
127850070|NCT04583969|460067734|FG001|Overall Study|Protocol Violation|0|||
127850071|NCT04583969|460067733|FG000|Overall Study|Withdrawal by Subject|3|||
127850072|NCT04583969|460067734|FG001|Overall Study|Withdrawal by Subject|3|||
127850073|NCT04583969|460067733|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
127850074|NCT04583969|460067734|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
127850075|NCT04583969|460067733|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
127850076|NCT04583969|460067734|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
127850077|NCT04583969|460067733|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
127850078|NCT04583969|460067734|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
127850079|NCT04583969|460067733|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
127850080|NCT04583969|460067734|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
127850081|NCT04583969|460067733|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
127850082|NCT04583969|460067734|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
127850083|NCT04397796|460067735|FG000|Overall Study|Death|3|||
127850084|NCT04397796|460067736|FG001|Overall Study|Death|1|||
127850085|NCT02640755|460067737|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
127850086|NCT02640755|460067738|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
127850087|NCT02640755|460067737|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
127850088|NCT02640755|460067738|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
127850089|NCT02640755|460067737|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
127850090|NCT02640755|460067738|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
127850091|NCT00770224|460067748|FG000|Step 1: Induction|Adverse Event|3|||
127850092|NCT00770224|460067749|FG001|Step 1: Induction|Adverse Event|0|||
127850093|NCT00770224|460067748|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
127850094|NCT00770224|460067749|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
127850095|NCT00770224|460067748|FG000|Step 1: Induction|Other reason not protocol specified|2|||
127850096|NCT00770224|460067749|FG001|Step 1: Induction|Other reason not protocol specified|0|||
127850097|NCT00770224|460067748|FG000|Step 1: Induction|Ineligible|2|||
127850098|NCT00770224|460067749|FG001|Step 1: Induction|Ineligible|0|||
127850099|NCT00770224|460067748|FG000|Step 1: Induction|No protocol treatment given|1|||
127850100|NCT00770224|460067749|FG001|Step 1: Induction|No protocol treatment given|0|||
127850101|NCT00770224|460067748|FG000|Step 2: Maintenance|Adverse Event|0|||
127850102|NCT00770224|460067749|FG001|Step 2: Maintenance|Adverse Event|10|||
127850103|NCT00770224|460067748|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
127850104|NCT00770224|460067749|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
127850105|NCT00770224|460067748|FG000|Step 2: Maintenance|Progression/relapse|0|||
127850106|NCT00770224|460067749|FG001|Step 2: Maintenance|Progression/relapse|1|||
127905178|NCT04263649|460278599|FG000|Overall Study|Device deficiency|19|||
127905179|NCT04263649|460278599|FG000|Overall Study|other reasons|11|||
127905180|NCT01534520|460278600|FG000|Overall Study|Adverse Event|0|||
127905181|NCT01534520|460278601|FG001|Overall Study|Adverse Event|1|||
127905182|NCT05169710|460278604|FG000|Overall Study|Adverse Event|1|||
127905183|NCT05169710|460278605|FG001|Overall Study|Adverse Event|2|||
127905184|NCT05169710|460278606|FG002|Overall Study|Adverse Event|2|||
127905185|NCT05169710|460278604|FG000|Overall Study|Lost to Follow-up|0|||
127905186|NCT05169710|460278605|FG001|Overall Study|Lost to Follow-up|0|||
127905187|NCT05169710|460278606|FG002|Overall Study|Lost to Follow-up|1|||
127905188|NCT05169710|460278604|FG000|Overall Study|Withdrawal by Subject|2|||
127905189|NCT05169710|460278605|FG001|Overall Study|Withdrawal by Subject|1|||
127905190|NCT05169710|460278606|FG002|Overall Study|Withdrawal by Subject|0|||
127905191|NCT05169710|460278604|FG000|Overall Study|Other Study Discontinuation Reason|0|||
127905192|NCT05169710|460278605|FG001|Overall Study|Other Study Discontinuation Reason|2|||
127905193|NCT05169710|460278606|FG002|Overall Study|Other Study Discontinuation Reason|0|||
127905194|NCT01686438|460278611|FG000|Overall Study|Lost to Follow-up|8|||
127905195|NCT01686438|460278612|FG001|Overall Study|Lost to Follow-up|9|||
127905196|NCT01686438|460278613|FG002|Overall Study|Lost to Follow-up|10|||
127905197|NCT01686438|460278611|FG000|Overall Study|Adverse Event|0|||
127905198|NCT01686438|460278612|FG001|Overall Study|Adverse Event|0|||
127905199|NCT01686438|460278613|FG002|Overall Study|Adverse Event|1|||
127905200|NCT01686438|460278611|FG000|Overall Study|Protocol Violation|0|||
127905201|NCT01686438|460278612|FG001|Overall Study|Protocol Violation|0|||
127905202|NCT01686438|460278613|FG002|Overall Study|Protocol Violation|1|||
127905203|NCT01686438|460278611|FG000|Overall Study|Withdrawal by Subject|0|||
127905204|NCT01686438|460278612|FG001|Overall Study|Withdrawal by Subject|0|||
127905205|NCT01686438|460278613|FG002|Overall Study|Withdrawal by Subject|1|||
127905206|NCT02601560|460278617|FG000|Overall Study|Other|0|||
127905207|NCT02601560|460278618|FG001|Overall Study|Other|0|||
127905208|NCT02601560|460278619|FG002|Overall Study|Other|0|||
127905209|NCT02601560|460278620|FG003|Overall Study|Other|0|||
127905210|NCT02601560|460278621|FG004|Overall Study|Other|0|||
127905211|NCT02601560|460278622|FG005|Overall Study|Other|0|||
127905212|NCT02601560|460278623|FG006|Overall Study|Other|1|||
127905213|NCT02601560|460278624|FG007|Overall Study|Other|0|||
127905214|NCT03459807|460278625|FG000|Overall Study|Withdrawal due to transplant|0|||
127905215|NCT03459807|460278626|FG001|Overall Study|Withdrawal due to transplant|1|||
127905216|NCT01406795|460278627|FG000|Overall Study|Withdrawal by Subject|1|||
127905217|NCT00855738|460278630|FG000|Overall Study|Lost to Follow-up|2|||
127905218|NCT00855738|460278630|FG000|Overall Study|Adverse Event|1|||
127905219|NCT00855738|460278630|FG000|Overall Study|Subject Defaulted|1|||
127905220|NCT00855738|460278630|FG000|Overall Study|Death|1|||
127905221|NCT03500692|460278634|FG000|Overall Study|Death|163|||
127905222|NCT03500692|460278634|FG000|Overall Study|Lost to Follow-up|75|||
127905223|NCT03500692|460278634|FG000|Overall Study|Termination Reasons|3|||
127905224|NCT03707912|460278637|FG000|Overall Study|Violation of inclusion criteria|1|||
127905225|NCT03707912|460278638|FG001|Overall Study|Violation of inclusion criteria|0|||
127905226|NCT01802320|460278639|FG000|Overall Study|Death|1|||
127905227|NCT01802320|460278639|FG000|Overall Study|Withdrawal by Subject|1|||
127905228|NCT06358820|460280137|FG000|Overall Study|Adverse Event|11|||
127905229|NCT06358820|460280137|FG000|Overall Study|kidney transplantation|3|||
127905230|NCT06358820|460280137|FG000|Overall Study|patient voluntary withdrawal|6|||
127905231|NCT06358820|460280137|FG000|Overall Study|Physician Decision|1|||
127905232|NCT05376319|460280138|FG000|Overall Study|Funding termination|2|||
127905233|NCT05376319|460280139|FG001|Overall Study|Funding termination|4|||
127905234|NCT01124175|460280140|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
127905235|NCT01124175|460280141|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
127905236|NCT00218257|460280147|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
127905237|NCT00218257|460280148|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
127905238|NCT00070291|460280153|FG000|Step 1|Withdrawal by Subject|1|||
127905239|NCT00070291|460280153|FG000|Step 1|Adverse Event|1|||
127905240|NCT00070291|460280153|FG000|Step 2|Adverse Event|1|||
127905241|NCT00520130|460280154|FG000|Overall Study|Disease progression on study|4|||
127905242|NCT00520130|460280155|FG001|Overall Study|Disease progression on study|0|||
127905243|NCT00520130|460280154|FG000|Overall Study|Physician Decision|1|||
127905244|NCT00520130|460280155|FG001|Overall Study|Physician Decision|1|||
127905245|NCT02028715|460280156|FG000|Overall Study|Adverse Event|2|||
127905246|NCT02028715|460280157|FG001|Overall Study|Adverse Event|2|||
127905247|NCT02028715|460280156|FG000|Overall Study|Physician Decision|1|||
127905248|NCT02028715|460280157|FG001|Overall Study|Physician Decision|0|||
127905249|NCT02028715|460280156|FG000|Overall Study|Did not complete satisfaction surveys|2|||
127905250|NCT02028715|460280157|FG001|Overall Study|Did not complete satisfaction surveys|2|||
127905251|NCT02883452|460280158|FG000|Overall Study|Withdrawal by Subject|1|||
127905252|NCT02883452|460280159|FG001|Overall Study|Withdrawal by Subject|1|||
127905253|NCT02883452|460280160|FG002|Overall Study|Withdrawal by Subject|3|||
127905254|NCT02883452|460280161|FG003|Overall Study|Withdrawal by Subject|0|||
127905255|NCT02883452|460280162|FG004|Overall Study|Withdrawal by Subject|2|||
127905256|NCT02883452|460280163|FG005|Overall Study|Withdrawal by Subject|5|||
127905257|NCT02883452|460280158|FG000|Overall Study|Disease progression|1|||
127905258|NCT02883452|460280159|FG001|Overall Study|Disease progression|0|||
127905259|NCT02883452|460280160|FG002|Overall Study|Disease progression|0|||
127905260|NCT02883452|460280161|FG003|Overall Study|Disease progression|1|||
127905261|NCT02883452|460280162|FG004|Overall Study|Disease progression|4|||
127905262|NCT02883452|460280163|FG005|Overall Study|Disease progression|5|||
127905263|NCT02883452|460280158|FG000|Overall Study|Adverse Event|2|||
127905264|NCT02883452|460280159|FG001|Overall Study|Adverse Event|1|||
127905265|NCT02883452|460280160|FG002|Overall Study|Adverse Event|1|||
127905266|NCT02883452|460280161|FG003|Overall Study|Adverse Event|1|||
127905267|NCT02883452|460280162|FG004|Overall Study|Adverse Event|1|||
127905268|NCT02883452|460280163|FG005|Overall Study|Adverse Event|3|||
127905269|NCT02883452|460280158|FG000|Overall Study|Physician Decision|0|||
127905270|NCT02883452|460280159|FG001|Overall Study|Physician Decision|0|||
127905271|NCT02883452|460280160|FG002|Overall Study|Physician Decision|0|||
127905272|NCT02883452|460280161|FG003|Overall Study|Physician Decision|0|||
127905273|NCT02883452|460280162|FG004|Overall Study|Physician Decision|4|||
127905274|NCT02883452|460280163|FG005|Overall Study|Physician Decision|1|||
127905275|NCT02883452|460280158|FG000|Overall Study|Death|1|||
127905276|NCT02883452|460280159|FG001|Overall Study|Death|0|||
127905277|NCT02883452|460280160|FG002|Overall Study|Death|1|||
127905278|NCT02883452|460280161|FG003|Overall Study|Death|0|||
127905279|NCT02883452|460280162|FG004|Overall Study|Death|0|||
127905280|NCT02883452|460280163|FG005|Overall Study|Death|0|||
127905281|NCT02883452|460280158|FG000|Overall Study|Other|0|||
127905282|NCT02883452|460280159|FG001|Overall Study|Other|0|||
127905283|NCT02883452|460280160|FG002|Overall Study|Other|0|||
127905284|NCT02883452|460280161|FG003|Overall Study|Other|0|||
127905285|NCT02883452|460280162|FG004|Overall Study|Other|0|||
127905286|NCT02883452|460280163|FG005|Overall Study|Other|1|||
127905287|NCT00830206|460280164|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
127905288|NCT00830206|460280165|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
127905289|NCT04605094|460280166|FG000|Overall Study|Adverse Event|2|||
127905290|NCT04605094|460280167|FG001|Overall Study|Adverse Event|2|||
127905291|NCT04605094|460280166|FG000|Overall Study|Lost to Follow-up|1|||
127905292|NCT04605094|460280167|FG001|Overall Study|Lost to Follow-up|4|||
127905293|NCT04605094|460280166|FG000|Overall Study|Physician Decision|2|||
127905294|NCT04605094|460280167|FG001|Overall Study|Physician Decision|2|||
127905295|NCT04605094|460280166|FG000|Overall Study|Study terminated by Sponsor|31|||
127905296|NCT04605094|460280167|FG001|Overall Study|Study terminated by Sponsor|33|||
127905297|NCT04605094|460280166|FG000|Overall Study|Withdrawal by Subject|22|||
127905298|NCT04605094|460280167|FG001|Overall Study|Withdrawal by Subject|19|||
127905299|NCT04605094|460280166|FG000|Overall Study|Other|1|||
127905300|NCT04605094|460280167|FG001|Overall Study|Other|1|||
127905301|NCT02724462|460280168|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
127905302|NCT02724462|460280169|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
127905303|NCT02724462|460280168|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
127905304|NCT02724462|460280169|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
127905305|NCT02724462|460280168|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
127905306|NCT02724462|460280169|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
127905307|NCT02724462|460280168|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
127905308|NCT02724462|460280169|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
127905309|NCT02724462|460280168|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
127905310|NCT02724462|460280169|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
127905311|NCT02724462|460280168|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
127905312|NCT02724462|460280169|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
127905313|NCT01900691|460280170|FG000|Overall Study|Death|7|||
127905314|NCT01900691|460280170|FG000|Overall Study|Lost to Follow-up|4|||
127905315|NCT01900691|460280170|FG000|Overall Study|Study Device Not Placed|3|||
127905316|NCT01900691|460280170|FG000|Overall Study|Non study stent placed|2|||
127905317|NCT01900691|460280170|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
127905318|NCT01900691|460280170|FG000|Overall Study|Complete stent migration through digestive tract|1|||
127905319|NCT01954394|460280175|FG000|Overall Study|Enrolled but not treated|1|||
127905320|NCT01954394|460280176|FG001|Overall Study|Enrolled but not treated|0|||
127905321|NCT01954394|460280175|FG000|Overall Study|Adverse Event|10|||
127905322|NCT01954394|460280176|FG001|Overall Study|Adverse Event|23|||
127905323|NCT01954394|460280175|FG000|Overall Study|Poor compliance to protocol|7|||
127905324|NCT01954394|460280176|FG001|Overall Study|Poor compliance to protocol|7|||
127905325|NCT01954394|460280175|FG000|Overall Study|Participant Moved|0|||
127905326|NCT01954394|460280176|FG001|Overall Study|Participant Moved|4|||
127905327|NCT01954394|460280175|FG000|Overall Study|Related to Study Drug administration|2|||
127905328|NCT01954394|460280176|FG001|Overall Study|Related to Study Drug administration|2|||
127905329|NCT01954394|460280175|FG000|Overall Study|Other than specified above|10|||
127905330|NCT01954394|460280176|FG001|Overall Study|Other than specified above|21|||
127905331|NCT02422264|460280188|FG000|Overall Study|Serious Adverse Event|1|||
127850107|NCT00770224|460067748|FG000|Step 2: Maintenance|Death|0|||
127850108|NCT00770224|460067749|FG001|Step 2: Maintenance|Death|2|||
127850109|NCT00770224|460067748|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
127850110|NCT00770224|460067749|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
127850111|NCT00770224|460067748|FG000|Step 2: Maintenance|Ineligible|0|||
127850112|NCT00770224|460067749|FG001|Step 2: Maintenance|Ineligible|2|||
127850113|NCT01484561|460067758|FG000|Overall Study|Lack of Efficacy|3|||
127850114|NCT01484561|460067759|FG001|Overall Study|Lack of Efficacy|1|||
127850115|NCT01484561|460067758|FG000|Overall Study|Lost to Follow-up|1|||
127850116|NCT01484561|460067759|FG001|Overall Study|Lost to Follow-up|0|||
127850117|NCT01484561|460067758|FG000|Overall Study|Withdrawal by Subject|3|||
127850118|NCT01484561|460067759|FG001|Overall Study|Withdrawal by Subject|0|||
127850119|NCT01484561|460067758|FG000|Overall Study|Other|1|||
127850120|NCT01484561|460067759|FG001|Overall Study|Other|1|||
127850121|NCT01484561|460067758|FG000|Overall Study|Adverse Event|1|||
127850122|NCT01484561|460067759|FG001|Overall Study|Adverse Event|4|||
127850123|NCT03371251|460067760|FG000|Overall Study|Withdrawal by Subject|1|||
127850124|NCT03371251|460067761|FG001|Overall Study|Withdrawal by Subject|0|||
127850125|NCT03371251|460067762|FG002|Overall Study|Withdrawal by Subject|1|||
127850126|NCT03371251|460067763|FG003|Overall Study|Withdrawal by Subject|0|||
127850127|NCT03371251|460067764|FG004|Overall Study|Withdrawal by Subject|2|||
127850128|NCT03371251|460067765|FG005|Overall Study|Withdrawal by Subject|2|||
127850129|NCT03371251|460067760|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
127850130|NCT03371251|460067761|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
127850131|NCT03371251|460067762|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
127850132|NCT03371251|460067763|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
127850133|NCT03371251|460067764|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
127850134|NCT03371251|460067765|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
127850135|NCT03371251|460067760|FG000|Overall Study|Adverse Event|0|||
127850136|NCT03371251|460067761|FG001|Overall Study|Adverse Event|0|||
127850137|NCT03371251|460067762|FG002|Overall Study|Adverse Event|0|||
127850138|NCT03371251|460067763|FG003|Overall Study|Adverse Event|0|||
127850139|NCT03371251|460067764|FG004|Overall Study|Adverse Event|1|||
127850140|NCT03371251|460067765|FG005|Overall Study|Adverse Event|0|||
127850141|NCT03371251|460067760|FG000|Overall Study|Decision by Sponsor|0|||
127850142|NCT03371251|460067761|FG001|Overall Study|Decision by Sponsor|0|||
127850143|NCT03371251|460067762|FG002|Overall Study|Decision by Sponsor|0|||
127850144|NCT03371251|460067763|FG003|Overall Study|Decision by Sponsor|0|||
127850145|NCT03371251|460067764|FG004|Overall Study|Decision by Sponsor|2|||
127850146|NCT03371251|460067765|FG005|Overall Study|Decision by Sponsor|0|||
127850147|NCT01505114|460067766|FG000|Overall Study|Withdrawal by Subject|5|||
127850148|NCT01505114|460067767|FG001|Overall Study|Withdrawal by Subject|4|||
127850149|NCT01505114|460067768|FG002|Overall Study|Withdrawal by Subject|4|||
127850150|NCT01505114|460067769|FG003|Overall Study|Withdrawal by Subject|7|||
127850151|NCT01505114|460067766|FG000|Overall Study|Death|1|||
127850152|NCT01505114|460067767|FG001|Overall Study|Death|0|||
127850153|NCT01505114|460067768|FG002|Overall Study|Death|0|||
127850154|NCT01505114|460067769|FG003|Overall Study|Death|1|||
127850155|NCT01505114|460067766|FG000|Overall Study|unable to adhere to visit schedule|3|||
127850156|NCT01505114|460067767|FG001|Overall Study|unable to adhere to visit schedule|2|||
127850157|NCT01505114|460067768|FG002|Overall Study|unable to adhere to visit schedule|3|||
127850158|NCT01505114|460067769|FG003|Overall Study|unable to adhere to visit schedule|3|||
127850159|NCT01505114|460067766|FG000|Overall Study|Lost to Follow-up|11|||
127850160|NCT01505114|460067767|FG001|Overall Study|Lost to Follow-up|5|||
127850161|NCT01505114|460067768|FG002|Overall Study|Lost to Follow-up|8|||
127850162|NCT01505114|460067769|FG003|Overall Study|Lost to Follow-up|7|||
127850163|NCT01505114|460067766|FG000|Overall Study|relocated|4|||
127850164|NCT01505114|460067767|FG001|Overall Study|relocated|2|||
127850165|NCT01505114|460067768|FG002|Overall Study|relocated|2|||
127850166|NCT01505114|460067769|FG003|Overall Study|relocated|3|||
127850167|NCT01505114|460067766|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
127850168|NCT01505114|460067767|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
127850169|NCT01505114|460067768|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
127850170|NCT01505114|460067769|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
127850171|NCT01505114|460067766|FG000|Overall Study|staff safety concerns|0|||
127850172|NCT01505114|460067767|FG001|Overall Study|staff safety concerns|0|||
127850173|NCT01505114|460067768|FG002|Overall Study|staff safety concerns|0|||
127850174|NCT01505114|460067769|FG003|Overall Study|staff safety concerns|1|||
127850175|NCT01505114|460067766|FG000|Overall Study|investigator decision|1|||
127850176|NCT01505114|460067767|FG001|Overall Study|investigator decision|0|||
127850177|NCT01505114|460067768|FG002|Overall Study|investigator decision|1|||
127850178|NCT01505114|460067769|FG003|Overall Study|investigator decision|0|||
127850179|NCT04445688|460067770|FG000|Washout (One Week)|Adverse Event|2|||
127850180|NCT04445688|460067770|FG000|Washout (One Week)|Withdrawal by Subject|1|||
127850181|NCT01998399|460067773|FG000|Overall Study|Lost to Follow-up|1|||
127905332|NCT02422264|460280189|FG001|Overall Study|Serious Adverse Event|0|||
127905333|NCT02422264|460280188|FG000|Overall Study|Withdrawal by Subject|1|||
127905334|NCT02422264|460280189|FG001|Overall Study|Withdrawal by Subject|2|||
127905335|NCT02422264|460280188|FG000|Overall Study|Migrated/moved from study area|3|||
127905336|NCT02422264|460280189|FG001|Overall Study|Migrated/moved from study area|1|||
127905337|NCT02422264|460280188|FG000|Overall Study|Subject vaccinated outside of the study|0|||
127905338|NCT02422264|460280189|FG001|Overall Study|Subject vaccinated outside of the study|1|||
127905339|NCT02269657|460280190|FG000|Overall Study|Protocol Violation|3|||
127905340|NCT00851877|460280193|FG000|Phase I-1|Death|1|||
127905341|NCT00851877|460280194|FG001|Phase I-1|Death|0|||
127905342|NCT00851877|460280195|FG002|Phase I-1|Death|0|||
127905343|NCT00851877|460280193|FG000|Phase II|Withdrawal by Subject|0|||
127905344|NCT00851877|460280194|FG001|Phase II|Withdrawal by Subject|0|||
127905345|NCT00851877|460280195|FG002|Phase II|Withdrawal by Subject|3|||
127905346|NCT00829673|460280196|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
127905347|NCT00829673|460280197|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
127905348|NCT03450057|460280198|FG000|Overall Study|Death|17|||
127905349|NCT03450057|460280198|FG000|Overall Study|ICF withdrawal|4|||
127905350|NCT03450057|460280198|FG000|Overall Study|Lost to Follow-up|2|||
127905351|NCT01034358|460280199|FG000|Overall Study|Withdrawal by Subject|1|||
127905352|NCT01034358|460280199|FG000|Overall Study|Protocol Violation|1|||
127905353|NCT00829790|460280202|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
127905354|NCT00829790|460280203|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
127905355|NCT02246166|460280204|FG000|Overall Study|Protocol Violation|1|||
127905356|NCT02246166|460280205|FG001|Overall Study|Protocol Violation|0|||
127905357|NCT00627016|460280206|FG000|Overall Study|Adverse Event|1|||
127905358|NCT00627016|460280207|FG001|Overall Study|Adverse Event|1|||
127905359|NCT00627016|460280206|FG000|Overall Study|Protocol Violation|0|||
127905360|NCT00627016|460280207|FG001|Overall Study|Protocol Violation|2|||
127905361|NCT00627016|460280206|FG000|Overall Study|Lost to Follow-up|0|||
127905362|NCT00627016|460280207|FG001|Overall Study|Lost to Follow-up|1|||
127905363|NCT00627016|460280206|FG000|Overall Study|Withdrawal by Subject|2|||
127905364|NCT00627016|460280207|FG001|Overall Study|Withdrawal by Subject|1|||
127905365|NCT00627016|460280206|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
127905366|NCT00627016|460280207|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
127905367|NCT00627016|460280206|FG000|Overall Study|Lack of Efficacy|1|||
127905368|NCT00627016|460280207|FG001|Overall Study|Lack of Efficacy|0|||
127905369|NCT00627016|460280206|FG000|Overall Study|Placed on Excluded Drugs|1|||
127905370|NCT00627016|460280207|FG001|Overall Study|Placed on Excluded Drugs|0|||
127905371|NCT00627016|460280206|FG000|Overall Study|Pregnancy|1|||
127905372|NCT00627016|460280207|FG001|Overall Study|Pregnancy|0|||
127905373|NCT01256684|460280210|FG000|Overall Study|Adverse Event|1|||
127905374|NCT01256684|460280211|FG001|Overall Study|Adverse Event|4|||
127905375|NCT01256684|460280212|FG002|Overall Study|Adverse Event|2|||
127905376|NCT01256684|460280210|FG000|Overall Study|Withdrawal by Subject|4|||
127905377|NCT01256684|460280211|FG001|Overall Study|Withdrawal by Subject|0|||
127905378|NCT01256684|460280212|FG002|Overall Study|Withdrawal by Subject|2|||
127905379|NCT01256684|460280210|FG000|Overall Study|Physician Decision|0|||
127905380|NCT01256684|460280211|FG001|Overall Study|Physician Decision|1|||
127905381|NCT01256684|460280212|FG002|Overall Study|Physician Decision|0|||
127905382|NCT01256684|460280210|FG000|Overall Study|Lack of Efficacy|0|||
127905383|NCT01256684|460280211|FG001|Overall Study|Lack of Efficacy|1|||
127905384|NCT01256684|460280212|FG002|Overall Study|Lack of Efficacy|1|||
127905385|NCT01256684|460280210|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
127905386|NCT01256684|460280211|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
127905387|NCT01256684|460280212|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
127905388|NCT02678286|460280214|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
127905389|NCT02678286|460280215|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
127905390|NCT02678286|460280214|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
127905391|NCT02678286|460280215|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
127905392|NCT02678286|460280214|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
127905393|NCT02678286|460280215|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
127905394|NCT02678286|460280214|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
127905395|NCT02678286|460280215|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
127905396|NCT02678286|460280214|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
127905397|NCT02678286|460280215|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
127905398|NCT02331394|460280216|FG000|Overall Study|Disease progression|1|||
127905399|NCT01313273|460280217|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
127905400|NCT01313273|460280218|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
127905401|NCT01313273|460280217|FG000|Overall Study|Withdrawal by Subject|1|||
127905402|NCT01313273|460280218|FG001|Overall Study|Withdrawal by Subject|0|||
127905403|NCT01313273|460280217|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
127905404|NCT01313273|460280218|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
127905405|NCT03687736|460280219|FG000|Overall Study|Lost to Follow-up|7|||
127905406|NCT03687736|460280219|FG000|Overall Study|Withdrawal by Subject|3|||
127905407|NCT01270503|460280220|FG000|Overall Study|Lost to Follow-up|1|||
127850182|NCT01998399|460067774|FG001|Overall Study|Lost to Follow-up|3|||
127850183|NCT01998399|460067773|FG000|Overall Study|Death|4|||
127850184|NCT01998399|460067774|FG001|Overall Study|Death|2|||
127850185|NCT01998399|460067773|FG000|Overall Study|Study stopped before dosing completed|3|||
127850186|NCT01998399|460067774|FG001|Overall Study|Study stopped before dosing completed|3|||
127850187|NCT01998399|460067773|FG000|Overall Study|Withdrawal by Subject|0|||
127850188|NCT01998399|460067774|FG001|Overall Study|Withdrawal by Subject|1|||
127850189|NCT04114539|460067778|FG000|Overall Study|Adverse Event|14|||
127850190|NCT04114539|460067778|FG000|Overall Study|Lost to Follow-up|2|||
127850191|NCT04114539|460067778|FG000|Overall Study|Non-compliance with Protocol|2|||
127850192|NCT04114539|460067778|FG000|Overall Study|Non-compliance with Study Drug|1|||
127850193|NCT04114539|460067778|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
127850194|NCT04114539|460067778|FG000|Overall Study|Withdrew consent|10|||
127850195|NCT04114539|460067778|FG000|Overall Study|Others not specified|5|||
127850196|NCT04114539|460067778|FG000|Overall Study|Investigator Decision|2|||
127850197|NCT01072448|460067783|FG000|Overall Study|Adverse Event|9|||
127850198|NCT01072448|460067784|FG001|Overall Study|Adverse Event|10|||
127850199|NCT01072448|460067783|FG000|Overall Study|Subject withdrew consent|4|||
127850200|NCT01072448|460067784|FG001|Overall Study|Subject withdrew consent|9|||
127850201|NCT01072448|460067783|FG000|Overall Study|Protocol deviation|3|||
127850202|NCT01072448|460067784|FG001|Overall Study|Protocol deviation|4|||
127850203|NCT01072448|460067783|FG000|Overall Study|Abnormal test procedure result(s)|1|||
127850204|NCT01072448|460067784|FG001|Overall Study|Abnormal test procedure result(s)|0|||
127850205|NCT01072448|460067783|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
127850206|NCT01072448|460067784|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
127850207|NCT01072448|460067783|FG000|Overall Study|Lost to Follow-up|1|||
127850208|NCT01072448|460067784|FG001|Overall Study|Lost to Follow-up|1|||
127850209|NCT01072448|460067783|FG000|Overall Study|Abnormal laboratory value(s)|0|||
127850210|NCT01072448|460067784|FG001|Overall Study|Abnormal laboratory value(s)|1|||
127850211|NCT01072448|460067783|FG000|Overall Study|Death|0|||
127850212|NCT01072448|460067784|FG001|Overall Study|Death|2|||
127850213|NCT01400139|460067787|FG000|HYD Core Study|Adverse Event|210|||
127850214|NCT01400139|460067787|FG000|HYD Core Study|Lack of Efficacy|59|||
127850215|NCT01400139|460067787|FG000|HYD Core Study|Withdrawal by Subject|114|||
127850216|NCT01400139|460067787|FG000|HYD Core Study|Lost to Follow-up|39|||
127850217|NCT01400139|460067787|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
127850218|NCT01400139|460067787|FG000|HYD Core Study|Administrative|56|||
127850219|NCT01400139|460067787|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
127850220|NCT01400139|460067787|FG000|HYD Extension Period|Adverse Event|8|||
127850221|NCT01400139|460067787|FG000|HYD Extension Period|Withdrawal by Subject|5|||
127850222|NCT01400139|460067787|FG000|HYD Extension Period|Administrative|10|||
127850223|NCT00418717|460067788|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
127850224|NCT00418717|460067788|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
127850225|NCT00249795|460067789|FG000|Overall Study|Not treated|16|||
127850226|NCT00249795|460067790|FG001|Overall Study|Not treated|14|||
127850227|NCT00249795|460067789|FG000|Overall Study|Symptomatic hypotension|127|||
127850228|NCT00249795|460067790|FG001|Overall Study|Symptomatic hypotension|64|||
127850229|NCT00249795|460067789|FG000|Overall Study|Other Serious Adverse Event|84|||
127850230|NCT00249795|460067790|FG001|Overall Study|Other Serious Adverse Event|93|||
127850231|NCT00249795|460067789|FG000|Overall Study|Qualifying condition not present|26|||
127850232|NCT00249795|460067790|FG001|Overall Study|Qualifying condition not present|29|||
127850233|NCT00249795|460067789|FG000|Overall Study|Withdrawal by Subject|678|||
127850234|NCT00249795|460067790|FG001|Overall Study|Withdrawal by Subject|742|||
127850235|NCT00249795|460067789|FG000|Overall Study|Thromboembolic / outcome event|39|||
127850236|NCT00249795|460067790|FG001|Overall Study|Thromboembolic / outcome event|45|||
127850237|NCT00249795|460067789|FG000|Overall Study|Oral anticoagulant required|2|||
127850238|NCT00249795|460067790|FG001|Overall Study|Oral anticoagulant required|0|||
127850239|NCT00249795|460067789|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
127850240|NCT00249795|460067790|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
127850241|NCT00249795|460067789|FG000|Overall Study|Non-compliance|71|||
127850242|NCT00249795|460067790|FG001|Overall Study|Non-compliance|69|||
127850243|NCT00249795|460067789|FG000|Overall Study|Study drug intolerance|3|||
127850244|NCT00249795|460067790|FG001|Overall Study|Study drug intolerance|3|||
127850245|NCT00249795|460067789|FG000|Overall Study|Other adverse events (non-serious)|188|||
127850246|NCT00249795|460067790|FG001|Overall Study|Other adverse events (non-serious)|159|||
127850247|NCT00249795|460067789|FG000|Overall Study|Physician withdrew consent|71|||
127850248|NCT00249795|460067790|FG001|Overall Study|Physician withdrew consent|63|||
127850249|NCT00249795|460067789|FG000|Overall Study|Surgery / procedure|4|||
127850250|NCT00249795|460067790|FG001|Overall Study|Surgery / procedure|5|||
127850251|NCT00249795|460067789|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
127905408|NCT02459951|460280221|FG000|Overall Study|Unable to meet holding requirement|1|||
127905409|NCT02481830|460280225|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
127905410|NCT02481830|460280226|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
127905411|NCT02481830|460280225|FG000|Pre-treatment|Withdrawal by Subject|0|||
127905412|NCT02481830|460280226|FG001|Pre-treatment|Withdrawal by Subject|10|||
127905413|NCT02481830|460280225|FG000|Pre-treatment|Disease Progression|1|||
127905414|NCT02481830|460280226|FG001|Pre-treatment|Disease Progression|1|||
127905415|NCT02481830|460280225|FG000|Pre-treatment|Other reasons|0|||
127905416|NCT02481830|460280226|FG001|Pre-treatment|Other reasons|1|||
127905417|NCT02481830|460280225|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
127905418|NCT02481830|460280226|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
127905419|NCT02481830|460280225|FG000|Treatment|Disease Progression|233|||
127905420|NCT02481830|460280226|FG001|Treatment|Disease Progression|171|||
127905421|NCT02481830|460280225|FG000|Treatment|Study drug toxicity|18|||
127905422|NCT02481830|460280226|FG001|Treatment|Study drug toxicity|38|||
127905423|NCT02481830|460280225|FG000|Treatment|Death|1|||
127905424|NCT02481830|460280226|FG001|Treatment|Death|1|||
127905425|NCT02481830|460280225|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
127905426|NCT02481830|460280226|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
127905427|NCT02481830|460280225|FG000|Treatment|Participants request to discontinue Study treatment|6|||
127905428|NCT02481830|460280226|FG001|Treatment|Participants request to discontinue Study treatment|34|||
127905429|NCT02481830|460280225|FG000|Treatment|Withdrawal by Subject|2|||
127905430|NCT02481830|460280226|FG001|Treatment|Withdrawal by Subject|3|||
127905431|NCT02481830|460280225|FG000|Treatment|Lost to Follow-up|1|||
127905432|NCT02481830|460280226|FG001|Treatment|Lost to Follow-up|0|||
127905433|NCT02481830|460280225|FG000|Treatment|Maximum Clinical Benefit|0|||
127905434|NCT02481830|460280226|FG001|Treatment|Maximum Clinical Benefit|5|||
127905435|NCT02481830|460280225|FG000|Treatment|Administrative reason by sponsor|1|||
127905436|NCT02481830|460280226|FG001|Treatment|Administrative reason by sponsor|1|||
127905437|NCT02481830|460280225|FG000|Treatment|Other reasons|6|||
127905438|NCT02481830|460280226|FG001|Treatment|Other reasons|1|||
127905439|NCT04627038|460280227|FG000|Overall Study|Adverse Event|36|||
127905440|NCT04627038|460280228|FG001|Overall Study|Adverse Event|8|||
127905441|NCT04627038|460280227|FG000|Overall Study|Lost to Follow-up|1|||
127905442|NCT04627038|460280228|FG001|Overall Study|Lost to Follow-up|0|||
127905443|NCT04627038|460280227|FG000|Overall Study|Physician Decision|0|||
127905444|NCT04627038|460280228|FG001|Overall Study|Physician Decision|1|||
127905445|NCT04627038|460280227|FG000|Overall Study|Protocol Violation|3|||
127905446|NCT04627038|460280228|FG001|Overall Study|Protocol Violation|1|||
127905447|NCT04627038|460280227|FG000|Overall Study|Withdrawal by Subject|13|||
127905448|NCT04627038|460280228|FG001|Overall Study|Withdrawal by Subject|3|||
127905449|NCT04627038|460280227|FG000|Overall Study|Non-compliance with study drug|0|||
127905450|NCT04627038|460280228|FG001|Overall Study|Non-compliance with study drug|1|||
127905451|NCT04627038|460280227|FG000|Overall Study|Prohibited Concomitant Medication|1|||
127905452|NCT04627038|460280228|FG001|Overall Study|Prohibited Concomitant Medication|0|||
127905453|NCT02255097|460280229|FG000|Overall Study|Death|151|||
127905454|NCT02255097|460280229|FG000|Overall Study|Lost to Follow-up|5|||
127905455|NCT02255097|460280229|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
127905456|NCT02255097|460280229|FG000|Overall Study|Withdrawal by Subject|7|||
127905457|NCT02255097|460280229|FG000|Overall Study|Allocated but not treated|1|||
127905458|NCT01010542|460280231|FG000|Overall Study|Adverse Event|0|||
127905459|NCT01010542|460280232|FG001|Overall Study|Adverse Event|1|||
127905460|NCT01010542|460280233|FG002|Overall Study|Adverse Event|0|||
127905461|NCT01010542|460280231|FG000|Overall Study|Lost to Follow-up|0|||
127905462|NCT01010542|460280232|FG001|Overall Study|Lost to Follow-up|1|||
127905463|NCT01010542|460280233|FG002|Overall Study|Lost to Follow-up|0|||
127905464|NCT01010542|460280231|FG000|Overall Study|Withdrawal by Subject|0|||
127905465|NCT01010542|460280232|FG001|Overall Study|Withdrawal by Subject|3|||
127905466|NCT01010542|460280233|FG002|Overall Study|Withdrawal by Subject|2|||
127905467|NCT01745120|460280236|FG000|Overall Study|Investigator decision|1|||
127905468|NCT01745120|460280237|FG001|Overall Study|Investigator decision|0|||
127905469|NCT03956862|460280238|FG000|Overall Study|Lost to Follow-up|1|||
127905470|NCT03956862|460280239|FG001|Overall Study|Lost to Follow-up|1|||
127905471|NCT03956862|460280238|FG000|Overall Study|Withdrawal by Subject|1|||
127905472|NCT03956862|460280239|FG001|Overall Study|Withdrawal by Subject|1|||
127905473|NCT00579670|460280242|FG000|Overall Study|Death|1|||
127905474|NCT00579670|460280243|FG001|Overall Study|Death|0|||
127905475|NCT00579670|460280244|FG002|Overall Study|Death|0|||
127905476|NCT00579670|460280245|FG003|Overall Study|Death|0|||
127905477|NCT00579670|460280246|FG004|Overall Study|Death|0|||
127905478|NCT00579670|460280242|FG000|Overall Study|Adverse Event|1|||
127905479|NCT00579670|460280243|FG001|Overall Study|Adverse Event|0|||
127905480|NCT00579670|460280244|FG002|Overall Study|Adverse Event|1|||
127905481|NCT00579670|460280245|FG003|Overall Study|Adverse Event|2|||
127905482|NCT00579670|460280246|FG004|Overall Study|Adverse Event|0|||
127905483|NCT00579670|460280242|FG000|Overall Study|Lack of Efficacy|0|||
127905484|NCT00579670|460280243|FG001|Overall Study|Lack of Efficacy|0|||
127905485|NCT00579670|460280244|FG002|Overall Study|Lack of Efficacy|1|||
127905486|NCT00579670|460280245|FG003|Overall Study|Lack of Efficacy|14|||
127905487|NCT00579670|460280246|FG004|Overall Study|Lack of Efficacy|0|||
127905488|NCT00579670|460280242|FG000|Overall Study|Lost to Follow-up|0|||
127905489|NCT00579670|460280243|FG001|Overall Study|Lost to Follow-up|1|||
127905490|NCT00579670|460280244|FG002|Overall Study|Lost to Follow-up|0|||
127905491|NCT00579670|460280245|FG003|Overall Study|Lost to Follow-up|4|||
127905492|NCT00579670|460280246|FG004|Overall Study|Lost to Follow-up|0|||
127905493|NCT00579670|460280242|FG000|Overall Study|Other|0|||
127905494|NCT00579670|460280243|FG001|Overall Study|Other|0|||
127905495|NCT00579670|460280244|FG002|Overall Study|Other|1|||
127905496|NCT00579670|460280245|FG003|Overall Study|Other|2|||
127905497|NCT00579670|460280246|FG004|Overall Study|Other|0|||
127905498|NCT00579670|460280242|FG000|Overall Study|Withdrawal by Subject|0|||
127905499|NCT00579670|460280243|FG001|Overall Study|Withdrawal by Subject|0|||
127905500|NCT00579670|460280244|FG002|Overall Study|Withdrawal by Subject|1|||
127905501|NCT00579670|460280245|FG003|Overall Study|Withdrawal by Subject|0|||
127905502|NCT00579670|460280246|FG004|Overall Study|Withdrawal by Subject|0|||
127905503|NCT00850174|460280250|FG000|Washout: One Week|Withdrawal by Subject|0|||
127905504|NCT00850174|460280251|FG001|Washout: One Week|Withdrawal by Subject|2|||
127905505|NCT00850174|460280250|FG000|Second Intervention|Withdrawal by Subject|1|||
127905506|NCT00850174|460280251|FG001|Second Intervention|Withdrawal by Subject|0|||
127905507|NCT01363765|460280252|FG000|Overall Study|non-diagnostic|2621|||
127905508|NCT01363765|460280253|FG001|Overall Study|non-diagnostic|1124|||
127905509|NCT01363765|460280252|FG000|Overall Study|duplicate records|736|||
127905510|NCT01363765|460280253|FG001|Overall Study|duplicate records|3177|||
127905511|NCT01363765|460280252|FG000|Overall Study|non-resident|156|||
127905512|NCT01363765|460280253|FG001|Overall Study|non-resident|76|||
127905513|NCT01363765|460280252|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
127905514|NCT01363765|460280253|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
127905515|NCT01363765|460280252|FG000|Overall Study|smear during intervention|2170|||
127905516|NCT01363765|460280253|FG001|Overall Study|smear during intervention|0|||
127905517|NCT00635492|460280254|FG000|Overall Study|Death|12|||
127905518|NCT00635492|460280255|FG001|Overall Study|Death|40|||
127905519|NCT00635492|460280254|FG000|Overall Study|Lost to Follow-up|151|||
127905520|NCT00635492|460280255|FG001|Overall Study|Lost to Follow-up|172|||
127905521|NCT00635492|460280254|FG000|Overall Study|Physician Decision|32|||
127905522|NCT00635492|460280255|FG001|Overall Study|Physician Decision|22|||
127905523|NCT00635492|460280254|FG000|Overall Study|Sponsor decision|2|||
127905524|NCT00635492|460280255|FG001|Overall Study|Sponsor decision|3|||
127905525|NCT00635492|460280254|FG000|Overall Study|Withdrawal by Subject|82|||
127905526|NCT00635492|460280255|FG001|Overall Study|Withdrawal by Subject|45|||
127905527|NCT01900626|460280256|FG000|Overall Study|study was closed due to low enrollment|1|||
127905528|NCT01900626|460280257|FG001|Overall Study|study was closed due to low enrollment|1|||
127905529|NCT00846495|460280262|FG000|Overall Study|Lost to Follow-up|1|||
127905530|NCT00846495|460280263|FG001|Overall Study|Lost to Follow-up|0|||
127905531|NCT00846495|460280262|FG000|Overall Study|Adverse Event|5|||
127905532|NCT00846495|460280263|FG001|Overall Study|Adverse Event|1|||
127905533|NCT00846495|460280262|FG000|Overall Study|Lack of Efficacy|1|||
127905534|NCT00846495|460280263|FG001|Overall Study|Lack of Efficacy|2|||
127905535|NCT00846495|460280262|FG000|Overall Study|Physician Decision|1|||
127905536|NCT00846495|460280263|FG001|Overall Study|Physician Decision|0|||
127905537|NCT01265056|460280264|FG000|Initial Study Period|Withdrawal by Subject|1|||
127905538|NCT01265056|460280265|FG001|Initial Study Period|Withdrawal by Subject|1|||
127905539|NCT01265056|460280264|FG000|Initial Study Period|Withdrawal by Subject|1|||
127905540|NCT01265056|460280265|FG001|Initial Study Period|Withdrawal by Subject|1|||
127905541|NCT01265056|460280264|FG000|Follow up|Lost to Follow-up|7|||
127905542|NCT01265056|460280265|FG001|Follow up|Lost to Follow-up|3|||
127905543|NCT03725605|460280269|FG000|Overall Study|Unsuccessful TIL expansion|2|||
127905544|NCT00965185|460280270|FG000|Overall Study|Lost to Follow-up|2|||
127905545|NCT00965185|460280271|FG001|Overall Study|Lost to Follow-up|0|||
127905546|NCT00965185|460280270|FG000|Overall Study|Withdrawal by Subject|0|||
127905547|NCT00965185|460280271|FG001|Overall Study|Withdrawal by Subject|1|||
127905548|NCT02272777|460280273|FG000|Overall Study|Adverse Event|0|||
127905549|NCT02272777|460280274|FG001|Overall Study|Adverse Event|1|||
127905550|NCT02272777|460280273|FG000|Overall Study|Withdrawal by Subject|0|||
127905551|NCT02272777|460280274|FG001|Overall Study|Withdrawal by Subject|3|||
127905552|NCT02272777|460280273|FG000|Overall Study|Lost to Follow-up|2|||
127905553|NCT02272777|460280274|FG001|Overall Study|Lost to Follow-up|0|||
127905554|NCT02272777|460280273|FG000|Overall Study|Other|2|||
127905555|NCT02272777|460280274|FG001|Overall Study|Other|0|||
127905556|NCT05275205|460280275|FG000|Overall Study|Adverse Event|1|||
127905557|NCT05275205|460280276|FG001|Overall Study|Adverse Event|2|||
127905558|NCT05275205|460280275|FG000|Overall Study|Physician Decision|1|||
127905559|NCT05275205|460280276|FG001|Overall Study|Physician Decision|1|||
127905560|NCT05275205|460280275|FG000|Overall Study|Withdrawal by Subject|2|||
127905561|NCT05275205|460280276|FG001|Overall Study|Withdrawal by Subject|3|||
127905562|NCT05275205|460280275|FG000|Overall Study|Death|1|||
127905563|NCT05275205|460280276|FG001|Overall Study|Death|0|||
127905564|NCT05275205|460280275|FG000|Overall Study|Patient unable to attend visits|1|||
127905565|NCT05275205|460280276|FG001|Overall Study|Patient unable to attend visits|0|||
127905566|NCT02066922|460280277|FG000|Overall Study|Adverse Event|1|||
127850252|NCT00249795|460067790|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
127850253|NCT00249795|460067789|FG000|Overall Study|Lightheadedness / dizziness|15|||
127905567|NCT00440297|460280278|FG000|Overall Study|Adverse Event|8|||
127905568|NCT00440297|460280279|FG001|Overall Study|Adverse Event|5|||
127905569|NCT00440297|460280278|FG000|Overall Study|Lost to Follow-up|1|||
127905570|NCT00440297|460280279|FG001|Overall Study|Lost to Follow-up|0|||
127905571|NCT00440297|460280278|FG000|Overall Study|Physician Decision|1|||
127905572|NCT00440297|460280279|FG001|Overall Study|Physician Decision|0|||
127905573|NCT00440297|460280278|FG000|Overall Study|Protocol Violation|11|||
127905574|NCT00440297|460280279|FG001|Overall Study|Protocol Violation|7|||
127905575|NCT00440297|460280278|FG000|Overall Study|Withdrawal by Subject|1|||
127905576|NCT00440297|460280279|FG001|Overall Study|Withdrawal by Subject|6|||
127905577|NCT00440297|460280278|FG000|Overall Study|Randomized by mistake|1|||
127905578|NCT00440297|460280279|FG001|Overall Study|Randomized by mistake|0|||
127905579|NCT03020641|460280280|FG000|Overall Study|Lost to Follow-up|0|||
127905580|NCT03020641|460280281|FG001|Overall Study|Lost to Follow-up|1|||
127905581|NCT03020641|460280280|FG000|Overall Study|Converted to open surgery|2|||
127905582|NCT03020641|460280281|FG001|Overall Study|Converted to open surgery|1|||
127905583|NCT03020641|460280280|FG000|Overall Study|for surgery not performed|0|||
127905584|NCT03020641|460280281|FG001|Overall Study|for surgery not performed|1|||
127905585|NCT02039908|460280285|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
127905586|NCT02039908|460280286|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
127905587|NCT02039908|460280287|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
127905588|NCT02039908|460280288|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
127905589|NCT02039908|460280285|FG000|Phase 1-Summer|Protocol Violation|6|||
127905590|NCT02039908|460280286|FG001|Phase 1-Summer|Protocol Violation|0|||
127905591|NCT02039908|460280287|FG002|Phase 1-Summer|Protocol Violation|0|||
127905592|NCT02039908|460280288|FG003|Phase 1-Summer|Protocol Violation|0|||
127905593|NCT02039908|460280285|FG000|Phase 2-School Year|Lost to Follow-up|0|||
127905594|NCT02039908|460280286|FG001|Phase 2-School Year|Lost to Follow-up|0|||
127905595|NCT02039908|460280287|FG002|Phase 2-School Year|Lost to Follow-up|1|||
127905596|NCT02039908|460280288|FG003|Phase 2-School Year|Lost to Follow-up|3|||
127905597|NCT02039908|460280285|FG000|Phase 2-School Year|Protocol Violation|0|||
127905598|NCT02039908|460280286|FG001|Phase 2-School Year|Protocol Violation|0|||
127905599|NCT02039908|460280287|FG002|Phase 2-School Year|Protocol Violation|3|||
127905600|NCT02039908|460280288|FG003|Phase 2-School Year|Protocol Violation|0|||
127905601|NCT02039908|460280285|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
127905602|NCT02039908|460280286|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
127905603|NCT02039908|460280287|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
127905604|NCT02039908|460280288|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
127905605|NCT01534663|460282094|FG000|Overall Study|Lost to Follow-up|0|||
127905606|NCT01534663|460282095|FG001|Overall Study|Lost to Follow-up|2|||
127905607|NCT01534663|460282094|FG000|Overall Study|Adverse Event|2|||
127850254|NCT00249795|460067790|FG001|Overall Study|Lightheadedness / dizziness|11|||
127850255|NCT00249795|460067789|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
127850256|NCT00249795|460067790|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
127850257|NCT00249795|460067789|FG000|Overall Study|Other contraindicated medication|1|||
127850258|NCT00249795|460067790|FG001|Overall Study|Other contraindicated medication|1|||
127850259|NCT00249795|460067789|FG000|Overall Study|Event related to cardiac condition|17|||
127850260|NCT00249795|460067790|FG001|Overall Study|Event related to cardiac condition|16|||
127850261|NCT00249795|460067789|FG000|Overall Study|Patient not wish to continue after May08|4|||
127850262|NCT00249795|460067790|FG001|Overall Study|Patient not wish to continue after May08|6|||
127850263|NCT00249795|460067789|FG000|Overall Study|Site not agree to continue after May08|1|||
127850264|NCT00249795|460067790|FG001|Overall Study|Site not agree to continue after May08|1|||
127850265|NCT00249795|460067789|FG000|Overall Study|Lost to Follow-up|0|||
127850266|NCT00249795|460067790|FG001|Overall Study|Lost to Follow-up|2|||
127850267|NCT00249795|460067789|FG000|Overall Study|Missing|0|||
127850268|NCT00249795|460067790|FG001|Overall Study|Missing|1|||
127905608|NCT01534663|460282095|FG001|Overall Study|Adverse Event|1|||
127905609|NCT03107091|460282096|FG000|Overall Study|Physician Decision|1|||
127905610|NCT04567186|460282101|FG000|Period 1|COVID-19 related|1|||
127850269|NCT02460978|460067792|FG000|Overall Study|Adverse Event|17|||
127850270|NCT02460978|460067793|FG001|Overall Study|Adverse Event|11|||
127850271|NCT02460978|460067794|FG002|Overall Study|Adverse Event|11|||
127850272|NCT02460978|460067792|FG000|Overall Study|Withdrawal by Subject|5|||
127850273|NCT02460978|460067793|FG001|Overall Study|Withdrawal by Subject|5|||
127905611|NCT04567186|460282102|FG001|Period 1|COVID-19 related|0|||
127850274|NCT02460978|460067794|FG002|Overall Study|Withdrawal by Subject|14|||
127905612|NCT04567186|460282101|FG000|Period 1|Protocol Violation|0|||
127905613|NCT04567186|460282102|FG001|Period 1|Protocol Violation|1|||
127905614|NCT04567186|460282101|FG000|Period 1|Adverse Event|0|||
127905615|NCT04567186|460282102|FG001|Period 1|Adverse Event|2|||
127905616|NCT04567186|460282101|FG000|Period 2|COVID-19 Related|0|||
127905617|NCT04567186|460282102|FG001|Period 2|COVID-19 Related|1|||
127905618|NCT04567186|460282101|FG000|Period 2|Protocol Violation|0|||
127905619|NCT04567186|460282102|FG001|Period 2|Protocol Violation|1|||
127905620|NCT04567186|460282101|FG000|Period 2|Lost to Follow-up|0|||
127905621|NCT04567186|460282102|FG001|Period 2|Lost to Follow-up|1|||
127905622|NCT04567186|460282101|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
127905623|NCT04567186|460282102|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
127905624|NCT01185548|460282105|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
127905625|NCT00102440|460282106|FG000|Overall Study|Lost to Follow-up|25|||
127905626|NCT00102440|460282107|FG001|Overall Study|Lost to Follow-up|18|||
127905627|NCT00102440|460282108|FG002|Overall Study|Lost to Follow-up|21|||
127905628|NCT00102440|460282106|FG000|Overall Study|Adverse Event|16|||
127905629|NCT00102440|460282107|FG001|Overall Study|Adverse Event|23|||
127905630|NCT00102440|460282108|FG002|Overall Study|Adverse Event|8|||
127905631|NCT00102440|460282106|FG000|Overall Study|Gout Flare|10|||
127905632|NCT00102440|460282107|FG001|Overall Study|Gout Flare|28|||
127905633|NCT00102440|460282108|FG002|Overall Study|Gout Flare|9|||
127905634|NCT00102440|460282106|FG000|Overall Study|Personal Reason(s)|19|||
127905635|NCT00102440|460282107|FG001|Overall Study|Personal Reason(s)|13|||
127905636|NCT00102440|460282108|FG002|Overall Study|Personal Reason(s)|13|||
127905637|NCT00102440|460282106|FG000|Overall Study|Other|11|||
127905638|NCT00102440|460282107|FG001|Overall Study|Other|14|||
127905639|NCT00102440|460282108|FG002|Overall Study|Other|14|||
127905640|NCT00102440|460282106|FG000|Overall Study|Protocol Violation|7|||
127905641|NCT00102440|460282107|FG001|Overall Study|Protocol Violation|2|||
127905642|NCT00102440|460282108|FG002|Overall Study|Protocol Violation|1|||
127905643|NCT03375463|460282109|FG000|Period 1|Lost to Follow-up|0|||
127905644|NCT03375463|460282110|FG001|Period 1|Lost to Follow-up|0|||
127905645|NCT03375463|460282111|FG002|Period 1|Lost to Follow-up|1|||
127905646|NCT03375463|460282112|FG003|Period 1|Lost to Follow-up|0|||
127905647|NCT03375463|460282113|FG004|Period 1|Lost to Follow-up|0|||
127905648|NCT03375463|460282114|FG005|Period 1|Lost to Follow-up|0|||
127905649|NCT03375463|460282109|FG000|Period 1|Adverse Event|0|||
127905650|NCT03375463|460282110|FG001|Period 1|Adverse Event|0|||
127905651|NCT03375463|460282111|FG002|Period 1|Adverse Event|0|||
127905652|NCT03375463|460282112|FG003|Period 1|Adverse Event|0|||
127905653|NCT03375463|460282113|FG004|Period 1|Adverse Event|1|||
127905654|NCT03375463|460282114|FG005|Period 1|Adverse Event|0|||
127905655|NCT03375463|460282109|FG000|Period 2|Lost to Follow-up|1|||
127905656|NCT03375463|460282110|FG001|Period 2|Lost to Follow-up|1|||
127905657|NCT03375463|460282111|FG002|Period 2|Lost to Follow-up|0|||
127905658|NCT03375463|460282112|FG003|Period 2|Lost to Follow-up|0|||
127905659|NCT03375463|460282113|FG004|Period 2|Lost to Follow-up|0|||
127905660|NCT03375463|460282114|FG005|Period 2|Lost to Follow-up|0|||
127905661|NCT01602419|460282115|FG000|Overall Study|Not treated with Wilate|9|||
127905662|NCT01602419|460282115|FG000|Overall Study|Adverse Drug Reaction|4|||
127905663|NCT01602419|460282115|FG000|Overall Study|Insurance issues|3|||
127905664|NCT01602419|460282115|FG000|Overall Study|Changed treatment centre|1|||
127905665|NCT01602419|460282115|FG000|Overall Study|Treatment centre closed|1|||
127905666|NCT01602419|460282115|FG000|Overall Study|Withdrawal by Subject|5|||
127905667|NCT01602419|460282115|FG000|Overall Study|Lost to Follow-up|6|||
127905668|NCT01792635|460282116|FG000|Part B|Adverse Event|0|||
127905669|NCT01792635|460282117|FG001|Part B|Adverse Event|0|||
127905670|NCT01792635|460282118|FG002|Part B|Adverse Event|1|||
127905671|NCT01792635|460282116|FG000|Part B|Study terminated|0|||
127905672|NCT01792635|460282117|FG001|Part B|Study terminated|4|||
127905673|NCT01792635|460282118|FG002|Part B|Study terminated|3|||
127905674|NCT01513174|460282124|FG000|Overall Study|Inclusion Error|1|||
127905675|NCT01513174|460282125|FG001|Overall Study|Inclusion Error|7|||
127905676|NCT01513174|460282124|FG000|Overall Study|Not receive study treatment|3|||
127905677|NCT01513174|460282125|FG001|Overall Study|Not receive study treatment|1|||
127905678|NCT02682784|460282128|FG000|Overall Study|Withdrawal by Subject|0|||
127905679|NCT02682784|460282129|FG001|Overall Study|Withdrawal by Subject|2|||
127905680|NCT02682784|460282130|FG002|Overall Study|Withdrawal by Subject|1|||
127905681|NCT02682784|460282131|FG003|Overall Study|Withdrawal by Subject|2|||
127905682|NCT02682784|460282128|FG000|Overall Study|Physician Decision|1|||
127905683|NCT02682784|460282129|FG001|Overall Study|Physician Decision|0|||
127905684|NCT02682784|460282130|FG002|Overall Study|Physician Decision|1|||
127905685|NCT02682784|460282131|FG003|Overall Study|Physician Decision|1|||
127905686|NCT00467363|460282132|FG000|Overall Study|Lost to Follow-up|80|||
127905687|NCT00467363|460282133|FG001|Overall Study|Lost to Follow-up|70|||
127905688|NCT04533594|460282134|FG000|Overall Study|Death|26|||
127905689|NCT03138967|460282139|FG000|Overall Study|Death|0|||
127905690|NCT03138967|460282140|FG001|Overall Study|Death|1|||
127905691|NCT03138967|460282139|FG000|Overall Study|Physician Decision|1|||
127905692|NCT03138967|460282140|FG001|Overall Study|Physician Decision|3|||
127905693|NCT00836056|460282145|FG000|First Intervention|Adverse Event|1|||
127905694|NCT00836056|460282146|FG001|First Intervention|Adverse Event|0|||
127905695|NCT01029340|460282148|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
127905696|NCT01029340|460282149|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
127905697|NCT01029340|460282150|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
127905698|NCT01029340|460282151|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
127905699|NCT01029340|460282152|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
127905700|NCT01029340|460282153|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
127905701|NCT01029340|460282148|FG000|Part B Treatment Period|Protocol Violation|0|||
127905702|NCT01029340|460282149|FG001|Part B Treatment Period|Protocol Violation|0|||
127905703|NCT01029340|460282150|FG002|Part B Treatment Period|Protocol Violation|1|||
127905704|NCT01029340|460282151|FG003|Part B Treatment Period|Protocol Violation|0|||
127905705|NCT01029340|460282152|FG004|Part B Treatment Period|Protocol Violation|0|||
127905706|NCT01029340|460282153|FG005|Part B Treatment Period|Protocol Violation|0|||
127905707|NCT01029340|460282148|FG000|Extension Period|Adverse Event|0|||
127905708|NCT01029340|460282149|FG001|Extension Period|Adverse Event|0|||
127905709|NCT01029340|460282150|FG002|Extension Period|Adverse Event|0|||
127905710|NCT01029340|460282151|FG003|Extension Period|Adverse Event|0|||
127905711|NCT01029340|460282152|FG004|Extension Period|Adverse Event|0|||
127905712|NCT01029340|460282153|FG005|Extension Period|Adverse Event|1|||
127905713|NCT01029340|460282148|FG000|Extension Period|starting another study|0|||
127905714|NCT01029340|460282149|FG001|Extension Period|starting another study|0|||
127905715|NCT01029340|460282150|FG002|Extension Period|starting another study|0|||
127905716|NCT01029340|460282151|FG003|Extension Period|starting another study|0|||
127905717|NCT01029340|460282152|FG004|Extension Period|starting another study|0|||
127905718|NCT01029340|460282153|FG005|Extension Period|starting another study|8|||
127905719|NCT01029340|460282148|FG000|Extension Period|non-compliance|0|||
127905720|NCT01029340|460282149|FG001|Extension Period|non-compliance|0|||
127905721|NCT01029340|460282150|FG002|Extension Period|non-compliance|0|||
127905722|NCT01029340|460282151|FG003|Extension Period|non-compliance|0|||
127905723|NCT01029340|460282152|FG004|Extension Period|non-compliance|0|||
127905724|NCT01029340|460282153|FG005|Extension Period|non-compliance|1|||
127905725|NCT01029340|460282148|FG000|Extension Period|Withdrawal by Subject|0|||
127905726|NCT01029340|460282149|FG001|Extension Period|Withdrawal by Subject|0|||
127905727|NCT01029340|460282150|FG002|Extension Period|Withdrawal by Subject|0|||
127905728|NCT01029340|460282151|FG003|Extension Period|Withdrawal by Subject|0|||
127905729|NCT01029340|460282152|FG004|Extension Period|Withdrawal by Subject|0|||
127905730|NCT01029340|460282153|FG005|Extension Period|Withdrawal by Subject|1|||
127905731|NCT01029340|460282148|FG000|Extension Period|Physician Decision|0|||
127905732|NCT01029340|460282149|FG001|Extension Period|Physician Decision|0|||
127905733|NCT01029340|460282150|FG002|Extension Period|Physician Decision|0|||
127905734|NCT01029340|460282151|FG003|Extension Period|Physician Decision|0|||
127905735|NCT01029340|460282152|FG004|Extension Period|Physician Decision|0|||
127905736|NCT01029340|460282153|FG005|Extension Period|Physician Decision|1|||
127905737|NCT02648347|460282154|FG000|Overall Study|Death|174|||
127905738|NCT02648347|460282155|FG001|Overall Study|Death|167|||
127905739|NCT02648347|460282154|FG000|Overall Study|Withdrawal by Subject|16|||
127905740|NCT02648347|460282155|FG001|Overall Study|Withdrawal by Subject|9|||
127905741|NCT02648347|460282154|FG000|Overall Study|Lost to Follow-up|18|||
127905742|NCT02648347|460282155|FG001|Overall Study|Lost to Follow-up|21|||
127905743|NCT02648347|460282154|FG000|Overall Study|Missing|1|||
127905744|NCT02648347|460282155|FG001|Overall Study|Missing|0|||
127905745|NCT03546842|460282157|FG000|Overall Study|Protocol Violation|1|||
127905746|NCT03546842|460282157|FG000|Overall Study|Withdrawal by Subject|2|||
127905747|NCT02711852|460282170|FG000|Overall Study|Death|5|||
127905748|NCT02711852|460282170|FG000|Overall Study|Lost to Follow-up|1|||
127905749|NCT02711852|460282170|FG000|Overall Study|Completed follow-up|3|||
127905750|NCT02711852|460282170|FG000|Overall Study|Withdrawal by Subject|1|||
127905751|NCT02453386|460282175|FG000|Overall Study|Adverse Event|22|||
127905752|NCT02453386|460282176|FG001|Overall Study|Adverse Event|30|||
127905753|NCT02453386|460282177|FG002|Overall Study|Adverse Event|15|||
127905754|NCT02453386|460282175|FG000|Overall Study|Protocol Violation|1|||
127905755|NCT02453386|460282176|FG001|Overall Study|Protocol Violation|0|||
127905756|NCT02453386|460282177|FG002|Overall Study|Protocol Violation|1|||
127905757|NCT02453386|460282175|FG000|Overall Study|Withdrawal by Subject|10|||
127905758|NCT02453386|460282176|FG001|Overall Study|Withdrawal by Subject|9|||
127905759|NCT02453386|460282177|FG002|Overall Study|Withdrawal by Subject|9|||
127905760|NCT02453386|460282175|FG000|Overall Study|Sponsor Terminated Study|14|||
127905761|NCT02453386|460282176|FG001|Overall Study|Sponsor Terminated Study|8|||
127905762|NCT02453386|460282177|FG002|Overall Study|Sponsor Terminated Study|11|||
127905763|NCT02453386|460282175|FG000|Overall Study|Subject Terminated by Sponsor|1|||
127905764|NCT02453386|460282176|FG001|Overall Study|Subject Terminated by Sponsor|1|||
127905765|NCT02453386|460282177|FG002|Overall Study|Subject Terminated by Sponsor|1|||
127905766|NCT02453386|460282175|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
127905767|NCT02453386|460282176|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
127905768|NCT02453386|460282177|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
127905769|NCT02453386|460282175|FG000|Overall Study|Lost to Follow-up|0|||
127905770|NCT02453386|460282176|FG001|Overall Study|Lost to Follow-up|0|||
127905771|NCT02453386|460282177|FG002|Overall Study|Lost to Follow-up|1|||
127905772|NCT02453386|460282175|FG000|Overall Study|Other|1|||
127905773|NCT02453386|460282176|FG001|Overall Study|Other|0|||
127905774|NCT02453386|460282177|FG002|Overall Study|Other|1|||
127905775|NCT00833937|460282181|FG000|Washout|Withdrawal by Subject|1|||
127905776|NCT00833937|460282182|FG001|Washout|Withdrawal by Subject|0|||
127905777|NCT04419311|460282184|FG000|Overall Study|Lost to Follow-up|1|||
127905778|NCT04419311|460282185|FG001|Overall Study|Lost to Follow-up|0|||
127905779|NCT00465270|460282195|FG000|Overall Study|Death|7|||
127905780|NCT00465270|460282196|FG001|Overall Study|Death|11|||
127905781|NCT00465270|460282195|FG000|Overall Study|Withdrawal by Subject|34|||
127905782|NCT00465270|460282196|FG001|Overall Study|Withdrawal by Subject|78|||
127905783|NCT00465270|460282195|FG000|Overall Study|Lost to Follow-up|60|||
127905784|NCT00465270|460282196|FG001|Overall Study|Lost to Follow-up|67|||
127905785|NCT00465270|460282195|FG000|Overall Study|Investigator request|3|||
127905786|NCT00465270|460282196|FG001|Overall Study|Investigator request|4|||
127905787|NCT03233724|460282208|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
127905788|NCT03233724|460282209|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
127905789|NCT03233724|460282210|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
127905790|NCT03233724|460282211|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
127905791|NCT03233724|460282212|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
127905792|NCT03233724|460282208|FG000|Phase I Dose Escalation|Best interest of participant|1|||
127905793|NCT03233724|460282209|FG001|Phase I Dose Escalation|Best interest of participant|1|||
127905794|NCT03233724|460282210|FG002|Phase I Dose Escalation|Best interest of participant|1|||
127905795|NCT03233724|460282211|FG003|Phase I Dose Escalation|Best interest of participant|0|||
127905796|NCT03233724|460282212|FG004|Phase I Dose Escalation|Best interest of participant|0|||
127905797|NCT03233724|460282208|FG000|Phase I Dose Escalation|Physician Decision|0|||
127905798|NCT03233724|460282209|FG001|Phase I Dose Escalation|Physician Decision|0|||
127905799|NCT03233724|460282210|FG002|Phase I Dose Escalation|Physician Decision|1|||
127905800|NCT03233724|460282211|FG003|Phase I Dose Escalation|Physician Decision|0|||
127905801|NCT03233724|460282212|FG004|Phase I Dose Escalation|Physician Decision|0|||
127905802|NCT03233724|460282208|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
127905803|NCT03233724|460282209|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
127905804|NCT03233724|460282210|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
127905805|NCT03233724|460282211|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
127905806|NCT03233724|460282212|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
127905807|NCT02388191|460282214|FG000|Overall Study|Patient did not receive IUD|1|||
127905808|NCT02388191|460282215|FG001|Overall Study|Patient did not receive IUD|0|||
127905809|NCT03135834|460282216|FG000|Stage 1|Adverse Event|1|||
127905810|NCT03135834|460282217|FG001|Stage 1|Adverse Event|2|||
127905811|NCT03135834|460282218|FG002|Stage 1|Adverse Event|2|||
127905812|NCT03135834|460282219|FG003|Stage 1|Adverse Event|1|||
127905813|NCT03135834|460282216|FG000|Stage 1|Death|1|||
127905814|NCT03135834|460282217|FG001|Stage 1|Death|0|||
127905815|NCT03135834|460282218|FG002|Stage 1|Death|0|||
127905816|NCT03135834|460282219|FG003|Stage 1|Death|0|||
127905817|NCT03135834|460282216|FG000|Stage 1|Lost to Follow-up|17|||
127905818|NCT03135834|460282217|FG001|Stage 1|Lost to Follow-up|24|||
127905819|NCT03135834|460282218|FG002|Stage 1|Lost to Follow-up|21|||
127905820|NCT03135834|460282219|FG003|Stage 1|Lost to Follow-up|38|||
127905821|NCT03135834|460282216|FG000|Stage 1|No longer met eligibility criteria|1|||
127905822|NCT03135834|460282217|FG001|Stage 1|No longer met eligibility criteria|6|||
127905823|NCT03135834|460282218|FG002|Stage 1|No longer met eligibility criteria|2|||
127905824|NCT03135834|460282219|FG003|Stage 1|No longer met eligibility criteria|5|||
127905825|NCT03135834|460282216|FG000|Stage 1|Other|0|||
127905826|NCT03135834|460282217|FG001|Stage 1|Other|2|||
127905827|NCT03135834|460282218|FG002|Stage 1|Other|1|||
127905828|NCT03135834|460282219|FG003|Stage 1|Other|0|||
127905829|NCT03135834|460282216|FG000|Stage 1|Physician Decision|0|||
127905830|NCT03135834|460282217|FG001|Stage 1|Physician Decision|1|||
127905831|NCT03135834|460282218|FG002|Stage 1|Physician Decision|0|||
127905832|NCT03135834|460282219|FG003|Stage 1|Physician Decision|0|||
127905833|NCT03135834|460282216|FG000|Stage 1|Pregnancy|0|||
127905834|NCT03135834|460282217|FG001|Stage 1|Pregnancy|4|||
127905835|NCT03135834|460282218|FG002|Stage 1|Pregnancy|2|||
127905836|NCT03135834|460282219|FG003|Stage 1|Pregnancy|4|||
127905837|NCT03135834|460282216|FG000|Stage 1|Protocol Violation|1|||
127905838|NCT03135834|460282217|FG001|Stage 1|Protocol Violation|1|||
127905839|NCT03135834|460282218|FG002|Stage 1|Protocol Violation|2|||
127905840|NCT03135834|460282219|FG003|Stage 1|Protocol Violation|1|||
127905841|NCT03135834|460282216|FG000|Stage 1|Withdrawal by parent/guardian|2|||
127905842|NCT03135834|460282217|FG001|Stage 1|Withdrawal by parent/guardian|10|||
127905843|NCT03135834|460282218|FG002|Stage 1|Withdrawal by parent/guardian|2|||
127905844|NCT03135834|460282219|FG003|Stage 1|Withdrawal by parent/guardian|1|||
127905845|NCT03135834|460282216|FG000|Stage 1|Withdrawal by Subject|16|||
127905846|NCT03135834|460282217|FG001|Stage 1|Withdrawal by Subject|22|||
127905847|NCT03135834|460282218|FG002|Stage 1|Withdrawal by Subject|7|||
127905848|NCT03135834|460282219|FG003|Stage 1|Withdrawal by Subject|10|||
127905849|NCT03135834|460282216|FG000|Stage 1|Randomized but not Vaccinated|0|||
127905850|NCT03135834|460282217|FG001|Stage 1|Randomized but not Vaccinated|3|||
127905851|NCT03135834|460282218|FG002|Stage 1|Randomized but not Vaccinated|1|||
127905852|NCT03135834|460282219|FG003|Stage 1|Randomized but not Vaccinated|6|||
127905853|NCT03135834|460282216|FG000|Stage 2|Lost to Follow-up|0|||
127905854|NCT03135834|460282217|FG001|Stage 2|Lost to Follow-up|1|||
127905855|NCT03135834|460282218|FG002|Stage 2|Lost to Follow-up|0|||
127905856|NCT03135834|460282219|FG003|Stage 2|Lost to Follow-up|0|||
127905857|NCT03135834|460282216|FG000|Stage 2|Withdrawal by Subject|0|||
127905858|NCT03135834|460282217|FG001|Stage 2|Withdrawal by Subject|1|||
127905859|NCT03135834|460282218|FG002|Stage 2|Withdrawal by Subject|0|||
127905860|NCT03135834|460282219|FG003|Stage 2|Withdrawal by Subject|0|||
127905861|NCT03135834|460282216|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
127905862|NCT03135834|460282217|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
127905863|NCT03135834|460282218|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
127905864|NCT03135834|460282219|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
127905865|NCT03135834|460282216|FG000|Stage 2|Did not receive Booster Vaccination|1|||
127905866|NCT03135834|460282217|FG001|Stage 2|Did not receive Booster Vaccination|1|||
127905867|NCT03135834|460282218|FG002|Stage 2|Did not receive Booster Vaccination|0|||
127905868|NCT03135834|460282219|FG003|Stage 2|Did not receive Booster Vaccination|0|||
127905869|NCT03686033|460282220|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
127905870|NCT03686033|460282221|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
127905871|NCT03686033|460282222|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
127905872|NCT03686033|460282223|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
127905873|NCT03686033|460282224|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
127905874|NCT03686033|460282225|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
127905875|NCT01045161|460282226|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
127905876|NCT01045161|460282227|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
127905877|NCT01045161|460282228|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
127905878|NCT01045161|460282226|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
127905879|NCT01045161|460282227|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
127905880|NCT01045161|460282228|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
127905881|NCT01045161|460282226|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
127905882|NCT01045161|460282227|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
127850275|NCT02460978|460067792|FG000|Overall Study|Lost to Follow-up|2|||
127850276|NCT02460978|460067793|FG001|Overall Study|Lost to Follow-up|3|||
127850277|NCT02460978|460067794|FG002|Overall Study|Lost to Follow-up|1|||
127850278|NCT02460978|460067792|FG000|Overall Study|Protocol Violation|1|||
127850279|NCT02460978|460067793|FG001|Overall Study|Protocol Violation|1|||
127850280|NCT02460978|460067794|FG002|Overall Study|Protocol Violation|1|||
127850281|NCT02460978|460067792|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
127850282|NCT02460978|460067793|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
127850283|NCT02460978|460067794|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
127850284|NCT02460978|460067792|FG000|Overall Study|Pregnancy|0|||
127850285|NCT02460978|460067793|FG001|Overall Study|Pregnancy|0|||
127850286|NCT02460978|460067794|FG002|Overall Study|Pregnancy|2|||
127850287|NCT03549429|460067797|FG000|Overall Study|Protocol Violation|5|||
127850288|NCT03549429|460067798|FG001|Overall Study|Protocol Violation|3|||
127850289|NCT00669032|460067803|FG000|Overall Study|Lost to Follow-up|6|||
127850290|NCT00669032|460067804|FG001|Overall Study|Lost to Follow-up|5|||
127850291|NCT00669032|460067803|FG000|Overall Study|Lack of Efficacy|8|||
127850292|NCT00669032|460067804|FG001|Overall Study|Lack of Efficacy|19|||
127850293|NCT00669032|460067803|FG000|Overall Study|Withdrawal by Subject|12|||
127850294|NCT00669032|460067804|FG001|Overall Study|Withdrawal by Subject|13|||
127850295|NCT00669032|460067803|FG000|Overall Study|Adverse Event|12|||
127850296|NCT00669032|460067804|FG001|Overall Study|Adverse Event|16|||
127850297|NCT00669032|460067803|FG000|Overall Study|Physician Decision|1|||
127850298|NCT00669032|460067804|FG001|Overall Study|Physician Decision|1|||
127850299|NCT00669032|460067803|FG000|Overall Study|No fulfilment of the selection criteria|5|||
127850300|NCT00669032|460067804|FG001|Overall Study|No fulfilment of the selection criteria|5|||
127850301|NCT01607073|460067805|FG000|Overall Study|Adverse Event|1|||
127850302|NCT03627494|460067806|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
127905883|NCT01045161|460282228|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
127905884|NCT01045161|460282226|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
127905885|NCT01045161|460282227|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
127905886|NCT01045161|460282228|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
127850303|NCT03627494|460067807|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
127850304|NCT03627494|460067808|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
127850305|NCT03627494|460067809|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
127850306|NCT03627494|460067810|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
127850307|NCT03627494|460067811|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
127850308|NCT03627494|460067812|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
127850309|NCT03627494|460067813|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
127850310|NCT03627494|460067814|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
127850311|NCT03627494|460067815|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
127850312|NCT03627494|460067816|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
127850313|NCT03627494|460067817|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
127850314|NCT03627494|460067806|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
127850315|NCT03627494|460067807|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
127850316|NCT03627494|460067808|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
127850317|NCT03627494|460067809|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
127850318|NCT03627494|460067810|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
127850319|NCT03627494|460067811|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
127850320|NCT03627494|460067812|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
127850321|NCT03627494|460067813|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
127850322|NCT03627494|460067814|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
127850323|NCT03627494|460067815|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
127850324|NCT03627494|460067816|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
127850325|NCT03627494|460067817|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
127850326|NCT03627494|460067806|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
127850327|NCT03627494|460067807|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
127850328|NCT03627494|460067808|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
127850329|NCT03627494|460067809|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
127850330|NCT03627494|460067810|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
127850331|NCT03627494|460067811|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
127850332|NCT03627494|460067812|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
127850333|NCT03627494|460067813|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
127850334|NCT03627494|460067814|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
127850335|NCT03627494|460067815|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
127850336|NCT03627494|460067816|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
127850337|NCT03627494|460067817|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
127850338|NCT02371980|460069677|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
127850339|NCT02371980|460069678|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
127850340|NCT02371980|460069679|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
127850341|NCT02371980|460069680|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
127850342|NCT02371980|460069681|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
127850343|NCT02371980|460069677|FG000|Open-label Period|Significant Protocol Deviation|19|||
127850344|NCT02371980|460069678|FG001|Open-label Period|Significant Protocol Deviation|0|||
127850345|NCT02371980|460069679|FG002|Open-label Period|Significant Protocol Deviation|0|||
127850346|NCT02371980|460069680|FG003|Open-label Period|Significant Protocol Deviation|0|||
127850347|NCT02371980|460069681|FG004|Open-label Period|Significant Protocol Deviation|0|||
127850348|NCT02371980|460069677|FG000|Open-label Period|Noncompliance with Study Drug|10|||
127850349|NCT02371980|460069678|FG001|Open-label Period|Noncompliance with Study Drug|0|||
127850350|NCT02371980|460069679|FG002|Open-label Period|Noncompliance with Study Drug|0|||
127850351|NCT02371980|460069680|FG003|Open-label Period|Noncompliance with Study Drug|0|||
127850352|NCT02371980|460069681|FG004|Open-label Period|Noncompliance with Study Drug|0|||
127850353|NCT02371980|460069677|FG000|Open-label Period|Lost to Follow-up|55|||
127850354|NCT02371980|460069678|FG001|Open-label Period|Lost to Follow-up|0|||
127850355|NCT02371980|460069679|FG002|Open-label Period|Lost to Follow-up|0|||
127850356|NCT02371980|460069680|FG003|Open-label Period|Lost to Follow-up|0|||
127850357|NCT02371980|460069681|FG004|Open-label Period|Lost to Follow-up|0|||
127850358|NCT02371980|460069677|FG000|Open-label Period|Voluntary Withdrawal|91|||
127850359|NCT02371980|460069678|FG001|Open-label Period|Voluntary Withdrawal|0|||
127850360|NCT02371980|460069679|FG002|Open-label Period|Voluntary Withdrawal|0|||
127850361|NCT02371980|460069680|FG003|Open-label Period|Voluntary Withdrawal|0|||
127850362|NCT02371980|460069681|FG004|Open-label Period|Voluntary Withdrawal|0|||
127850363|NCT02371980|460069677|FG000|Open-label Period|Pregnancy|1|||
127850364|NCT02371980|460069678|FG001|Open-label Period|Pregnancy|0|||
127850365|NCT02371980|460069679|FG002|Open-label Period|Pregnancy|0|||
127850366|NCT02371980|460069680|FG003|Open-label Period|Pregnancy|0|||
127850367|NCT02371980|460069681|FG004|Open-label Period|Pregnancy|0|||
127850368|NCT02371980|460069677|FG000|Open-label Period|Lack of Efficacy|116|||
127850369|NCT02371980|460069678|FG001|Open-label Period|Lack of Efficacy|0|||
127850370|NCT02371980|460069679|FG002|Open-label Period|Lack of Efficacy|0|||
127850371|NCT02371980|460069680|FG003|Open-label Period|Lack of Efficacy|0|||
127850372|NCT02371980|460069681|FG004|Open-label Period|Lack of Efficacy|0|||
127850373|NCT02371980|460069677|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
127850374|NCT02371980|460069678|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
127850375|NCT02371980|460069679|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
127905887|NCT01045161|460282226|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
127905888|NCT01045161|460282227|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
127905889|NCT01045161|460282228|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
127905890|NCT01045161|460282226|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
127905891|NCT01045161|460282227|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
127905892|NCT01045161|460282228|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
127905893|NCT01045161|460282226|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
127905894|NCT01045161|460282227|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
127905895|NCT01045161|460282228|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
127905896|NCT01045161|460282226|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
127905897|NCT01045161|460282227|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
127905898|NCT01045161|460282228|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
127905899|NCT01045161|460282226|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
127905900|NCT01045161|460282227|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
127905901|NCT01045161|460282228|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
127905902|NCT01045161|460282226|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
127905903|NCT01045161|460282227|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
127905904|NCT01045161|460282228|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
127905905|NCT01045161|460282226|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
127905906|NCT01045161|460282227|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
127905907|NCT01045161|460282228|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
127905908|NCT01045161|460282226|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
127905909|NCT01045161|460282227|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
127905910|NCT01045161|460282228|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
127905911|NCT01045161|460282226|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
127905912|NCT01045161|460282227|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
127905913|NCT01045161|460282228|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
127905914|NCT01045161|460282226|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
127905915|NCT01045161|460282227|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
127905916|NCT01045161|460282228|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
127905917|NCT03197883|460282229|FG000|Overall Study|Adverse Event|1|||
127905918|NCT03197883|460282230|FG001|Overall Study|Adverse Event|1|||
127905919|NCT03197883|460282229|FG000|Overall Study|Lost to Follow-up|1|||
127905920|NCT03197883|460282230|FG001|Overall Study|Lost to Follow-up|0|||
127905921|NCT03197883|460282229|FG000|Overall Study|Protocol Violation|1|||
127905922|NCT03197883|460282230|FG001|Overall Study|Protocol Violation|0|||
127905923|NCT03197883|460282229|FG000|Overall Study|Other (Not Specified)|0|||
127905924|NCT03197883|460282230|FG001|Overall Study|Other (Not Specified)|5|||
127905925|NCT03031847|460282231|FG000|Overall Study|Death|1|||
127905926|NCT03031847|460282232|FG001|Overall Study|Death|1|||
127905927|NCT03031847|460282233|FG002|Overall Study|Death|2|||
127905928|NCT03031847|460282234|FG003|Overall Study|Death|3|||
127850376|NCT02371980|460069680|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
127850377|NCT02371980|460069681|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
127850378|NCT02371980|460069677|FG000|Open-label Period|Reason not Specified|9|||
127850379|NCT02371980|460069678|FG001|Open-label Period|Reason not Specified|0|||
127850380|NCT02371980|460069679|FG002|Open-label Period|Reason not Specified|0|||
127850381|NCT02371980|460069680|FG003|Open-label Period|Reason not Specified|0|||
127850382|NCT02371980|460069681|FG004|Open-label Period|Reason not Specified|0|||
127850383|NCT02371980|460069677|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
127850384|NCT02371980|460069678|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
127850385|NCT02371980|460069679|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
127850386|NCT02371980|460069680|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
127850387|NCT02371980|460069681|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
127850388|NCT02371980|460069677|FG000|Double-blind Period|Significant Protocol Deviation|0|||
127850389|NCT02371980|460069678|FG001|Double-blind Period|Significant Protocol Deviation|2|||
127850390|NCT02371980|460069679|FG002|Double-blind Period|Significant Protocol Deviation|7|||
127850391|NCT02371980|460069680|FG003|Double-blind Period|Significant Protocol Deviation|3|||
127850392|NCT02371980|460069681|FG004|Double-blind Period|Significant Protocol Deviation|3|||
127850393|NCT02371980|460069677|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
127850394|NCT02371980|460069678|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
127850395|NCT02371980|460069679|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
127850396|NCT02371980|460069680|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
127850397|NCT02371980|460069681|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
127850398|NCT02371980|460069677|FG000|Double-blind Period|Lost to Follow-up|0|||
127905929|NCT03031847|460282231|FG000|Overall Study|Lost to Follow-up|1|||
127850399|NCT02371980|460069678|FG001|Double-blind Period|Lost to Follow-up|8|||
127850400|NCT02371980|460069679|FG002|Double-blind Period|Lost to Follow-up|8|||
127850401|NCT02371980|460069680|FG003|Double-blind Period|Lost to Follow-up|6|||
127850402|NCT02371980|460069681|FG004|Double-blind Period|Lost to Follow-up|5|||
127850403|NCT02371980|460069677|FG000|Double-blind Period|Voluntary Withdrawal|0|||
127850404|NCT02371980|460069678|FG001|Double-blind Period|Voluntary Withdrawal|12|||
127850405|NCT02371980|460069679|FG002|Double-blind Period|Voluntary Withdrawal|8|||
127850406|NCT02371980|460069680|FG003|Double-blind Period|Voluntary Withdrawal|9|||
127850407|NCT02371980|460069681|FG004|Double-blind Period|Voluntary Withdrawal|11|||
127850408|NCT02371980|460069677|FG000|Double-blind Period|Relapse|0|||
127850409|NCT02371980|460069678|FG001|Double-blind Period|Relapse|50|||
127850410|NCT02371980|460069679|FG002|Double-blind Period|Relapse|25|||
127850411|NCT02371980|460069680|FG003|Double-blind Period|Relapse|25|||
127850412|NCT02371980|460069681|FG004|Double-blind Period|Relapse|26|||
127850413|NCT02371980|460069677|FG000|Double-blind Period|Reason not Specified|0|||
127850414|NCT02371980|460069678|FG001|Double-blind Period|Reason not Specified|3|||
127850415|NCT02371980|460069679|FG002|Double-blind Period|Reason not Specified|3|||
127850416|NCT02371980|460069680|FG003|Double-blind Period|Reason not Specified|2|||
127850417|NCT02371980|460069681|FG004|Double-blind Period|Reason not Specified|1|||
127850418|NCT02371980|460069677|FG000|Double-blind Period|Missing|0|||
127850419|NCT02371980|460069678|FG001|Double-blind Period|Missing|1|||
127850420|NCT02371980|460069679|FG002|Double-blind Period|Missing|0|||
127850421|NCT02371980|460069680|FG003|Double-blind Period|Missing|0|||
127850422|NCT02371980|460069681|FG004|Double-blind Period|Missing|0|||
127850423|NCT01826448|460069682|FG000|Overall Study|Adverse Event|1|||
127850424|NCT01826448|460069683|FG001|Overall Study|Adverse Event|3|||
127850425|NCT01826448|460069682|FG000|Overall Study|Disease progression|2|||
127850426|NCT01826448|460069683|FG001|Overall Study|Disease progression|4|||
127850427|NCT01826448|460069682|FG000|Overall Study|Withdrawal by Subject|1|||
127850428|NCT01826448|460069683|FG001|Overall Study|Withdrawal by Subject|0|||
127850429|NCT01826448|460069682|FG000|Overall Study|Physician Decision|0|||
127850430|NCT01826448|460069683|FG001|Overall Study|Physician Decision|1|||
127850431|NCT01826448|460069682|FG000|Overall Study|2 active cancers|0|||
127850432|NCT01826448|460069683|FG001|Overall Study|2 active cancers|1|||
127850433|NCT02431702|460069689|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
127850434|NCT02431702|460069690|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
127850435|NCT02431702|460069691|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
127850436|NCT02431702|460069692|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
127850437|NCT02431702|460069693|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
127850438|NCT02431702|460069694|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
127850439|NCT02431702|460069695|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
127850440|NCT02431702|460069689|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
127850441|NCT02431702|460069690|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
127850442|NCT02431702|460069691|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
127850443|NCT02431702|460069692|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
127850444|NCT02431702|460069693|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
127850445|NCT02431702|460069694|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
127850446|NCT02431702|460069695|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
127850447|NCT02431702|460069689|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
127850448|NCT02431702|460069690|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
127850449|NCT02431702|460069691|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
127850450|NCT02431702|460069692|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
127850451|NCT02431702|460069693|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
127850452|NCT02431702|460069694|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
127850453|NCT02431702|460069695|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
127850454|NCT02431702|460069689|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
127850455|NCT02431702|460069690|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
127850456|NCT02431702|460069691|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
127850457|NCT02431702|460069692|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
127850458|NCT02431702|460069693|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
127850459|NCT02431702|460069694|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
127850460|NCT02431702|460069695|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
127850461|NCT02431702|460069689|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
127850462|NCT02431702|460069690|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
127850463|NCT02431702|460069691|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
127850464|NCT02431702|460069692|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
127905930|NCT03031847|460282232|FG001|Overall Study|Lost to Follow-up|1|||
127850465|NCT02431702|460069693|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
127850466|NCT02431702|460069694|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
127905931|NCT03031847|460282233|FG002|Overall Study|Lost to Follow-up|2|||
127905932|NCT03031847|460282234|FG003|Overall Study|Lost to Follow-up|3|||
127905933|NCT00858845|460282235|FG000|Overall Study|Patient underwent heart transplant.|0|||
127905934|NCT00858845|460282236|FG001|Overall Study|Patient underwent heart transplant.|1|||
127905935|NCT01353664|460282239|FG000|Overall Study|Other|3|||
127905936|NCT01353664|460282239|FG000|Overall Study|Disease Progression|16|||
127905937|NCT02605928|460282242|FG000|Overall Study|Model tuning phase|28|||
127905938|NCT02605928|460282242|FG000|Overall Study|Lack of Efficacy|5|||
127905939|NCT02612337|460282250|FG000|Overall Study|Lack of Efficacy|1|||
127905940|NCT02612337|460282251|FG001|Overall Study|Lack of Efficacy|0|||
127905941|NCT02612337|460282250|FG000|Overall Study|Withdrawal by Subject|2|||
127905942|NCT02612337|460282251|FG001|Overall Study|Withdrawal by Subject|2|||
127905943|NCT02612337|460282250|FG000|Overall Study|Did not receive study drug|0|||
127905944|NCT02612337|460282251|FG001|Overall Study|Did not receive study drug|1|||
127905945|NCT02242201|460282252|FG000|Overall Study|preoperative identified neuropathy|2|||
127905946|NCT02242201|460282253|FG001|Overall Study|preoperative identified neuropathy|0|||
127905947|NCT02242201|460282254|FG002|Overall Study|preoperative identified neuropathy|0|||
127905948|NCT02242201|460282252|FG000|Overall Study|planned post-op anticoagulation|1|||
127905949|NCT02242201|460282253|FG001|Overall Study|planned post-op anticoagulation|0|||
127905950|NCT02242201|460282254|FG002|Overall Study|planned post-op anticoagulation|0|||
127905951|NCT02242201|460282252|FG000|Overall Study|changed surgical procedure|1|||
127905952|NCT02242201|460282253|FG001|Overall Study|changed surgical procedure|0|||
127905953|NCT02242201|460282254|FG002|Overall Study|changed surgical procedure|0|||
127905954|NCT02242201|460282252|FG000|Overall Study|postponed surgery|0|||
127905955|NCT02242201|460282253|FG001|Overall Study|postponed surgery|0|||
127905956|NCT02242201|460282254|FG002|Overall Study|postponed surgery|1|||
127905957|NCT02242201|460282252|FG000|Overall Study|preoperative opioid consumption|0|||
127905958|NCT02242201|460282253|FG001|Overall Study|preoperative opioid consumption|1|||
127905959|NCT02242201|460282254|FG002|Overall Study|preoperative opioid consumption|0|||
127905960|NCT02374853|460282258|FG000|Overall Study|Surgery Cancelled|5|||
127905961|NCT02374853|460282259|FG001|Overall Study|Surgery Cancelled|11|||
127905962|NCT02281084|460282260|FG000|Overall Study|Death|21|||
127905963|NCT02281084|460282261|FG001|Overall Study|Death|18|||
127905964|NCT02281084|460282262|FG002|Overall Study|Death|3|||
127905965|NCT02281084|460282263|FG003|Overall Study|Death|5|||
127905966|NCT02281084|460282260|FG000|Overall Study|Adverse Event|1|||
127905967|NCT02281084|460282261|FG001|Overall Study|Adverse Event|0|||
127905968|NCT02281084|460282262|FG002|Overall Study|Adverse Event|0|||
127905969|NCT02281084|460282263|FG003|Overall Study|Adverse Event|0|||
127905970|NCT02281084|460282260|FG000|Overall Study|Withdrawal by Subject|2|||
127905971|NCT02281084|460282261|FG001|Overall Study|Withdrawal by Subject|2|||
127905972|NCT02281084|460282262|FG002|Overall Study|Withdrawal by Subject|0|||
127905973|NCT02281084|460282263|FG003|Overall Study|Withdrawal by Subject|0|||
127905974|NCT02281084|460282260|FG000|Overall Study|Site Closure by Sponsor|5|||
127905975|NCT02281084|460282261|FG001|Overall Study|Site Closure by Sponsor|1|||
127905976|NCT02281084|460282262|FG002|Overall Study|Site Closure by Sponsor|2|||
127905977|NCT02281084|460282263|FG003|Overall Study|Site Closure by Sponsor|0|||
127905978|NCT01697696|460282264|FG000|Overall Study|Study terminated by sponsor|0|||
127905979|NCT01697696|460282265|FG001|Overall Study|Study terminated by sponsor|3|||
127905980|NCT01697696|460282264|FG000|Overall Study|Protocol deviation|1|||
127905981|NCT01697696|460282265|FG001|Overall Study|Protocol deviation|0|||
127905982|NCT01697696|460282264|FG000|Overall Study|Physician Decision|1|||
127905983|NCT01697696|460282265|FG001|Overall Study|Physician Decision|0|||
127905984|NCT01697696|460282264|FG000|Overall Study|Death|4|||
127905985|NCT01697696|460282265|FG001|Overall Study|Death|2|||
127905986|NCT01697696|460282264|FG000|Overall Study|Lost to Follow-up|10|||
127905987|NCT01697696|460282265|FG001|Overall Study|Lost to Follow-up|7|||
127905988|NCT01697696|460282264|FG000|Overall Study|Subject/guardian decision|31|||
127905989|NCT01697696|460282265|FG001|Overall Study|Subject/guardian decision|35|||
127905990|NCT01424644|460282266|FG000|Overall Study|Adverse Event|2|||
127905991|NCT01424644|460282267|FG001|Overall Study|Adverse Event|0|||
127905992|NCT01424644|460282266|FG000|Overall Study|Withdrawal by Subject|9|||
127905993|NCT01424644|460282267|FG001|Overall Study|Withdrawal by Subject|12|||
127905994|NCT01424644|460282266|FG000|Overall Study|Lost to Follow-up|16|||
127905995|NCT01424644|460282267|FG001|Overall Study|Lost to Follow-up|12|||
127905996|NCT01424644|460282266|FG000|Overall Study|Protocol Violation|4|||
127905997|NCT01424644|460282267|FG001|Overall Study|Protocol Violation|3|||
127905998|NCT01424644|460282266|FG000|Overall Study|Administrative Reason|1|||
127905999|NCT01424644|460282267|FG001|Overall Study|Administrative Reason|0|||
127906000|NCT01424644|460282266|FG000|Overall Study|Unable to Classify|1|||
127906001|NCT01424644|460282267|FG001|Overall Study|Unable to Classify|0|||
127906002|NCT05593965|460282268|FG000|1st Intervention (1 Day)|Technical error|1|||
127906003|NCT05593965|460282269|FG001|1st Intervention (1 Day)|Technical error|0|||
127906004|NCT01880593|460282282|FG000|Overall Study|Adverse Event|1|||
127906005|NCT01880593|460282283|FG001|Overall Study|Adverse Event|0|||
127906006|NCT01880593|460282282|FG000|Overall Study|Lack of Efficacy|1|||
127906007|NCT01880593|460282283|FG001|Overall Study|Lack of Efficacy|5|||
127906008|NCT01880593|460282282|FG000|Overall Study|Withdrawal by Subject|6|||
127906009|NCT01880593|460282283|FG001|Overall Study|Withdrawal by Subject|1|||
127906010|NCT02024932|460282290|FG000|Overall Study|Adverse Event|2|||
127850467|NCT02431702|460069695|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
127850468|NCT02431702|460069689|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
127850469|NCT02431702|460069690|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
127850470|NCT02431702|460069691|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
127850471|NCT02431702|460069692|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
127850472|NCT02431702|460069693|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
127850473|NCT02431702|460069694|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
127850474|NCT02431702|460069695|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
127850475|NCT02431702|460069689|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
127850476|NCT02431702|460069690|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
127850477|NCT02431702|460069691|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
127850478|NCT02431702|460069692|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
127850479|NCT02431702|460069693|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
127850480|NCT02431702|460069694|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
127850481|NCT02431702|460069695|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
127850482|NCT02431702|460069689|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
127850483|NCT02431702|460069690|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
127850484|NCT02431702|460069691|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
127850485|NCT02431702|460069692|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
127850486|NCT02431702|460069693|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
127850487|NCT02431702|460069694|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
127850488|NCT02431702|460069695|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
127850489|NCT02431702|460069689|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
127850490|NCT02431702|460069690|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
127850491|NCT02431702|460069691|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
127850492|NCT02431702|460069692|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
127850493|NCT02431702|460069693|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
127850494|NCT02431702|460069694|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
127850495|NCT02431702|460069695|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
127850496|NCT02431702|460069689|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
127850497|NCT02431702|460069690|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
127850498|NCT02431702|460069691|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
127850499|NCT02431702|460069692|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
127850500|NCT02431702|460069693|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
127850501|NCT02431702|460069694|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
127850502|NCT02431702|460069695|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
127850503|NCT02431702|460069689|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
127850504|NCT02431702|460069690|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
127850505|NCT02431702|460069691|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
127850506|NCT02431702|460069692|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
127850507|NCT02431702|460069693|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
127850508|NCT02431702|460069694|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
127850509|NCT02431702|460069695|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
127850510|NCT02431702|460069689|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
127850511|NCT02431702|460069690|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
127850512|NCT02431702|460069691|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
127850513|NCT02431702|460069692|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
127850514|NCT02431702|460069693|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
127850515|NCT02431702|460069694|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
127850516|NCT02431702|460069695|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
127850517|NCT02431702|460069689|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
127850518|NCT02431702|460069690|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
127850519|NCT02431702|460069691|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
127850520|NCT02431702|460069692|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
127850521|NCT02431702|460069693|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
127850522|NCT02431702|460069694|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
127850523|NCT02431702|460069695|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
127850524|NCT02431702|460069689|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
127850525|NCT02431702|460069690|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
127850526|NCT02431702|460069691|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
127850527|NCT02431702|460069692|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
127850528|NCT02431702|460069693|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
127850529|NCT02431702|460069694|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
127850530|NCT02431702|460069695|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
127850531|NCT02431702|460069689|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
127850532|NCT02431702|460069690|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
127850533|NCT02431702|460069691|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
127850534|NCT02431702|460069692|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
127850535|NCT02431702|460069693|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
127850536|NCT02431702|460069694|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
127850537|NCT02431702|460069695|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
127850538|NCT02959970|460069699|FG000|Overall Study|Adverse Event|1|||
127850539|NCT02959970|460069700|FG001|Overall Study|Adverse Event|0|||
127850540|NCT02959970|460069699|FG000|Overall Study|Withdrawal by Subject|0|||
127850541|NCT02959970|460069700|FG001|Overall Study|Withdrawal by Subject|2|||
127850542|NCT02959970|460069699|FG000|Overall Study|Lost to Follow-up|1|||
127850543|NCT02959970|460069700|FG001|Overall Study|Lost to Follow-up|5|||
127850544|NCT00693420|460069701|FG000|Overall Study|Adverse Event|4|||
127850545|NCT00693420|460069702|FG001|Overall Study|Adverse Event|4|||
127850546|NCT00693420|460069701|FG000|Overall Study|Lost to Follow-up|0|||
127850547|NCT00693420|460069702|FG001|Overall Study|Lost to Follow-up|3|||
127850548|NCT00693420|460069701|FG000|Overall Study|Withdrawal by Subject|1|||
127850549|NCT00693420|460069702|FG001|Overall Study|Withdrawal by Subject|0|||
127850550|NCT00693420|460069701|FG000|Overall Study|Protocol Violation|0|||
127850551|NCT00693420|460069702|FG001|Overall Study|Protocol Violation|2|||
127850552|NCT00693420|460069701|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
127850553|NCT00693420|460069702|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
127850554|NCT00693420|460069701|FG000|Overall Study|Personal Reasons|1|||
127850555|NCT00693420|460069702|FG001|Overall Study|Personal Reasons|4|||
127850556|NCT03250624|460069708|FG000|Overall Study|Lack of Efficacy|1|||
127850557|NCT03250624|460069709|FG001|Overall Study|Lack of Efficacy|4|||
127850558|NCT03250624|460069708|FG000|Overall Study|Adverse Event|0|||
127850559|NCT03250624|460069709|FG001|Overall Study|Adverse Event|1|||
127850560|NCT03250624|460069708|FG000|Overall Study|Other|1|||
127850561|NCT03250624|460069709|FG001|Overall Study|Other|2|||
127850562|NCT01235338|460069712|FG000|Overall Study|Adverse Event|3|||
127850563|NCT01235338|460069713|FG001|Overall Study|Adverse Event|2|||
127850564|NCT01235338|460069712|FG000|Overall Study|Protocol Violation|1|||
127850565|NCT01235338|460069713|FG001|Overall Study|Protocol Violation|1|||
127850566|NCT01235338|460069712|FG000|Overall Study|Withdrawal by Subject|5|||
127850567|NCT01235338|460069713|FG001|Overall Study|Withdrawal by Subject|0|||
127850568|NCT01235338|460069712|FG000|Overall Study|Exclusion criteria violations|1|||
127850569|NCT01235338|460069713|FG001|Overall Study|Exclusion criteria violations|1|||
127850570|NCT01235338|460069712|FG000|Overall Study|Positive drug screen|0|||
127850571|NCT01235338|460069713|FG001|Overall Study|Positive drug screen|1|||
127850572|NCT01235338|460069712|FG000|Overall Study|Prohibited meds|1|||
127850573|NCT01235338|460069713|FG001|Overall Study|Prohibited meds|0|||
127850574|NCT02809118|460069716|FG000|Overall Study|Withdrawal by Subject|0|||
127850575|NCT02809118|460069717|FG001|Overall Study|Withdrawal by Subject|1|||
127850576|NCT02809118|460069718|FG002|Overall Study|Withdrawal by Subject|1|||
127850577|NCT00509028|460069719|FG000|Overall Study|Adverse Event|2|||
127850578|NCT00509028|460069720|FG001|Overall Study|Adverse Event|0|||
127850579|NCT00509028|460069719|FG000|Overall Study|Withdrawal by Subject|4|||
127850580|NCT00509028|460069720|FG001|Overall Study|Withdrawal by Subject|3|||
127850581|NCT00509028|460069719|FG000|Overall Study|Lost to Follow-up|0|||
127850582|NCT00509028|460069720|FG001|Overall Study|Lost to Follow-up|1|||
127850583|NCT00509028|460069719|FG000|Overall Study|Protocol Violation|4|||
127850584|NCT00509028|460069720|FG001|Overall Study|Protocol Violation|2|||
127850585|NCT00509028|460069719|FG000|Overall Study|Non-compliance|2|||
127850586|NCT00509028|460069720|FG001|Overall Study|Non-compliance|1|||
127850587|NCT00948428|460069721|FG000|Overall Study|Withdrawal by Subject|6|||
127850588|NCT00948428|460069722|FG001|Overall Study|Withdrawal by Subject|12|||
127850589|NCT00948428|460069723|FG002|Overall Study|Withdrawal by Subject|7|||
127850590|NCT00948428|460069721|FG000|Overall Study|Adverse Event|6|||
127850591|NCT00948428|460069722|FG001|Overall Study|Adverse Event|3|||
127850592|NCT00948428|460069723|FG002|Overall Study|Adverse Event|0|||
127850593|NCT00948428|460069721|FG000|Overall Study|Lost to Follow-up|2|||
127850594|NCT00948428|460069722|FG001|Overall Study|Lost to Follow-up|1|||
127850595|NCT00948428|460069723|FG002|Overall Study|Lost to Follow-up|1|||
127850596|NCT00948428|460069721|FG000|Overall Study|Death|2|||
127850597|NCT00948428|460069722|FG001|Overall Study|Death|0|||
127850598|NCT00948428|460069723|FG002|Overall Study|Death|0|||
127850599|NCT00948428|460069721|FG000|Overall Study|Intercurrent Illness|1|||
127850600|NCT00948428|460069722|FG001|Overall Study|Intercurrent Illness|0|||
127850601|NCT00948428|460069723|FG002|Overall Study|Intercurrent Illness|0|||
127850602|NCT00948428|460069721|FG000|Overall Study|Non-compliance|1|||
127850603|NCT00948428|460069722|FG001|Overall Study|Non-compliance|2|||
127850604|NCT00948428|460069723|FG002|Overall Study|Non-compliance|0|||
127850605|NCT02408484|460069725|FG000|Overall Study|Withdrawal by Subject|3|||
127850606|NCT02408484|460069725|FG000|Overall Study|Not treated during study period|1|||
127850607|NCT00441727|460069728|FG000|Overall Study|Protocol Violation|19|||
127906011|NCT02024932|460282291|FG001|Overall Study|Adverse Event|3|||
127906012|NCT02024932|460282292|FG002|Overall Study|Adverse Event|0|||
127906013|NCT02024932|460282293|FG003|Overall Study|Adverse Event|0|||
127906014|NCT02024932|460282294|FG004|Overall Study|Adverse Event|2|||
127906015|NCT02024932|460282295|FG005|Overall Study|Adverse Event|0|||
127906016|NCT02024932|460282290|FG000|Overall Study|Abnormal laboratory value|0|||
127906017|NCT02024932|460282291|FG001|Overall Study|Abnormal laboratory value|0|||
127906018|NCT02024932|460282292|FG002|Overall Study|Abnormal laboratory value|0|||
127906019|NCT02024932|460282293|FG003|Overall Study|Abnormal laboratory value|2|||
127906020|NCT02024932|460282294|FG004|Overall Study|Abnormal laboratory value|0|||
127906021|NCT02024932|460282295|FG005|Overall Study|Abnormal laboratory value|0|||
127906022|NCT00462345|460283835|FG000|Overall Study|Withdrawal by Subject|2|||
127906023|NCT00462345|460283835|FG000|Overall Study|Did not complete second course|1|||
127906024|NCT04915755|460283838|FG000|Overall Study|Physician Decision|3|||
127906025|NCT04915755|460283839|FG001|Overall Study|Physician Decision|2|||
127906026|NCT04915755|460283838|FG000|Overall Study|Withdrawal by Subject|1|||
127906027|NCT04915755|460283839|FG001|Overall Study|Withdrawal by Subject|1|||
127906028|NCT04915755|460283838|FG000|Overall Study|Ongoing for PACT|3|||
127906029|NCT04915755|460283839|FG001|Overall Study|Ongoing for PACT|2|||
127906030|NCT04915755|460283838|FG000|Overall Study|Other|7|||
127906031|NCT04915755|460283839|FG001|Overall Study|Other|11|||
127906032|NCT02533258|460283840|FG000|Overall Study|Adverse Event|1|||
127906033|NCT02533258|460283840|FG000|Overall Study|Death|2|||
127906034|NCT02533258|460283840|FG000|Overall Study|Other|1|||
127906035|NCT02533258|460283840|FG000|Overall Study|Economic factor|1|||
127906036|NCT02533258|460283840|FG000|Overall Study|Progression of pleural effusion|1|||
127906037|NCT02533258|460283840|FG000|Overall Study|Lack of Efficacy|2|||
127906038|NCT01149473|460283841|FG000|First Intervention|Adverse Event|1|||
127906039|NCT01149473|460283842|FG001|First Intervention|Adverse Event|1|||
127906040|NCT01149473|460283841|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
127906041|NCT01149473|460283842|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
127906042|NCT04089735|460283843|FG000|Overall Study|Adverse Event|1|||
127906043|NCT04089735|460283844|FG001|Overall Study|Adverse Event|0|||
127906044|NCT04089735|460283845|FG002|Overall Study|Adverse Event|1|||
127906045|NCT04089735|460283846|FG003|Overall Study|Adverse Event|1|||
127906046|NCT04089735|460283847|FG004|Overall Study|Adverse Event|0|||
127906047|NCT04089735|460283848|FG005|Overall Study|Adverse Event|0|||
127906048|NCT04089735|460283843|FG000|Overall Study|Physician Decision|0|||
127906049|NCT04089735|460283844|FG001|Overall Study|Physician Decision|3|||
127906050|NCT04089735|460283845|FG002|Overall Study|Physician Decision|0|||
127906051|NCT04089735|460283846|FG003|Overall Study|Physician Decision|0|||
127906052|NCT04089735|460283847|FG004|Overall Study|Physician Decision|0|||
127906053|NCT04089735|460283848|FG005|Overall Study|Physician Decision|0|||
127906054|NCT04089735|460283843|FG000|Overall Study|Withdrawal by Subject|0|||
127906055|NCT04089735|460283844|FG001|Overall Study|Withdrawal by Subject|0|||
127906056|NCT04089735|460283845|FG002|Overall Study|Withdrawal by Subject|1|||
127906057|NCT04089735|460283846|FG003|Overall Study|Withdrawal by Subject|0|||
127906058|NCT04089735|460283847|FG004|Overall Study|Withdrawal by Subject|0|||
127906059|NCT04089735|460283848|FG005|Overall Study|Withdrawal by Subject|0|||
127906060|NCT04089735|460283843|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
127906061|NCT04089735|460283844|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
127906062|NCT04089735|460283845|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
127906063|NCT04089735|460283846|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
127906064|NCT04089735|460283847|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
127906065|NCT04089735|460283848|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
127906066|NCT01439880|460283849|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
127906067|NCT01439880|460283850|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
127906068|NCT01439880|460283849|FG000|SOC-controlled Period (Year 1)|Death|2|||
127906069|NCT01439880|460283850|FG001|SOC-controlled Period (Year 1)|Death|1|||
127906070|NCT01439880|460283849|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
127906071|NCT01439880|460283850|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
127906072|NCT01439880|460283849|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
127906073|NCT01439880|460283850|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
127906074|NCT01439880|460283849|FG000|SOC-controlled Period (Year 1)|Other|8|||
127906075|NCT01439880|460283850|FG001|SOC-controlled Period (Year 1)|Other|13|||
127906076|NCT01439880|460283849|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
127906077|NCT01439880|460283850|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
127906078|NCT01439880|460283849|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
127906079|NCT01439880|460283850|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
127906080|NCT01439880|460283849|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
127906081|NCT01439880|460283850|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
127906082|NCT01439880|460283849|FG000|All-IP Period (Years 2 to 5)|Death|3|||
127850608|NCT00441727|460069729|FG001|Overall Study|Protocol Violation|28|||
127850609|NCT00441727|460069730|FG002|Overall Study|Protocol Violation|32|||
127850610|NCT00441727|460069728|FG000|Overall Study|Adverse Event|26|||
127850611|NCT00441727|460069729|FG001|Overall Study|Adverse Event|33|||
127850612|NCT00441727|460069730|FG002|Overall Study|Adverse Event|28|||
127850613|NCT00441727|460069728|FG000|Overall Study|Lack of Efficacy|7|||
127850614|NCT00441727|460069729|FG001|Overall Study|Lack of Efficacy|8|||
127850615|NCT00441727|460069730|FG002|Overall Study|Lack of Efficacy|48|||
127850616|NCT00441727|460069728|FG000|Overall Study|Withdrawal by Subject|40|||
127850617|NCT00441727|460069729|FG001|Overall Study|Withdrawal by Subject|34|||
127850618|NCT00441727|460069730|FG002|Overall Study|Withdrawal by Subject|47|||
127850619|NCT00441727|460069728|FG000|Overall Study|Lost to Follow-up|5|||
127850620|NCT00441727|460069729|FG001|Overall Study|Lost to Follow-up|6|||
127850621|NCT00441727|460069730|FG002|Overall Study|Lost to Follow-up|5|||
127850622|NCT00441727|460069728|FG000|Overall Study|Safety Reasons|3|||
127850623|NCT00441727|460069729|FG001|Overall Study|Safety Reasons|1|||
127850624|NCT00441727|460069730|FG002|Overall Study|Safety Reasons|3|||
127850625|NCT00441727|460069728|FG000|Overall Study|Various reason specified|6|||
127850626|NCT00441727|460069729|FG001|Overall Study|Various reason specified|8|||
127850627|NCT00441727|460069730|FG002|Overall Study|Various reason specified|5|||
127850628|NCT03235726|460069733|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
127850629|NCT03235726|460069734|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
127850630|NCT03235726|460069735|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
127850631|NCT03235726|460069736|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
127850632|NCT03235726|460069737|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
127850633|NCT03235726|460069738|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
127850634|NCT03235726|460069739|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
127850635|NCT03235726|460069740|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
127850636|NCT03235726|460069741|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
127850637|NCT03235726|460069742|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
127850638|NCT03235726|460069733|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
127850639|NCT03235726|460069734|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
127850640|NCT03235726|460069735|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
127850641|NCT03235726|460069736|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
127850642|NCT03235726|460069737|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
127850643|NCT03235726|460069738|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
127850644|NCT03235726|460069739|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
127850645|NCT03235726|460069740|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
127850646|NCT03235726|460069741|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
127850647|NCT03235726|460069742|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
127850648|NCT03135262|460069746|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
127850649|NCT03135262|460069747|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
127850650|NCT03135262|460069748|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
127850651|NCT03135262|460069749|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
127850652|NCT03135262|460069750|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
127850653|NCT03135262|460069746|FG000|Overall Study|Progression of disease|0|||
127850654|NCT03135262|460069747|FG001|Overall Study|Progression of disease|0|||
127850655|NCT03135262|460069748|FG002|Overall Study|Progression of disease|0|||
127850656|NCT03135262|460069749|FG003|Overall Study|Progression of disease|1|||
127850657|NCT03135262|460069750|FG004|Overall Study|Progression of disease|0|||
127850658|NCT03135262|460069746|FG000|Overall Study|Death|6|||
127850659|NCT03135262|460069747|FG001|Overall Study|Death|2|||
127850660|NCT03135262|460069748|FG002|Overall Study|Death|2|||
127850661|NCT03135262|460069749|FG003|Overall Study|Death|2|||
127850662|NCT03135262|460069750|FG004|Overall Study|Death|0|||
127850663|NCT03135262|460069746|FG000|Overall Study|Withdrawal by Subject|0|||
127850664|NCT03135262|460069747|FG001|Overall Study|Withdrawal by Subject|0|||
127850665|NCT03135262|460069748|FG002|Overall Study|Withdrawal by Subject|1|||
127850666|NCT03135262|460069749|FG003|Overall Study|Withdrawal by Subject|0|||
127906083|NCT01439880|460283850|FG001|All-IP Period (Years 2 to 5)|Death|13|||
127906084|NCT01439880|460283849|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
127850667|NCT03135262|460069750|FG004|Overall Study|Withdrawal by Subject|1|||
127906085|NCT01439880|460283850|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
127850668|NCT03135262|460069746|FG000|Overall Study|Study terminated by sponsor|2|||
127850669|NCT03135262|460069747|FG001|Overall Study|Study terminated by sponsor|4|||
127850670|NCT03135262|460069748|FG002|Overall Study|Study terminated by sponsor|4|||
127850671|NCT03135262|460069749|FG003|Overall Study|Study terminated by sponsor|3|||
127850672|NCT03135262|460069750|FG004|Overall Study|Study terminated by sponsor|0|||
127850673|NCT01675141|460069751|FG000|Overall Study|Lenalidomide outside NIH|3|||
127906086|NCT01439880|460283849|FG000|All-IP Period (Years 2 to 5)|Other|14|||
127850674|NCT01675141|460069751|FG000|Overall Study|Withdrawal by Subject|3|||
127850675|NCT01675141|460069751|FG000|Overall Study|Physician Decision|4|||
127850676|NCT01675141|460069751|FG000|Overall Study|No treatment, per protocol|1|||
127850677|NCT01599806|460069756|FG000|Overall Study|Lost to Follow-up|20|||
127850678|NCT01599806|460069757|FG001|Overall Study|Lost to Follow-up|20|||
127850679|NCT01599806|460069756|FG000|Overall Study|Withdrawal by Subject|12|||
127850680|NCT01599806|460069757|FG001|Overall Study|Withdrawal by Subject|12|||
127850681|NCT01599806|460069756|FG000|Overall Study|Other Eligibility criteria|11|||
127850682|NCT01599806|460069757|FG001|Overall Study|Other Eligibility criteria|9|||
127850683|NCT00391807|460069759|FG000|Overall Study|Did not receive study medication|23|||
127850684|NCT00391807|460069759|FG000|Overall Study|Adverse Event|177|||
127850685|NCT00391807|460069759|FG000|Overall Study|Pregnancy|25|||
127850686|NCT00391807|460069759|FG000|Overall Study|Lost to Follow-up|227|||
127850687|NCT00391807|460069759|FG000|Overall Study|Withdrawal by Subject|147|||
127850688|NCT00391807|460069759|FG000|Overall Study|Protocol Violation|20|||
127850689|NCT00391807|460069759|FG000|Overall Study|Various|96|||
127850690|NCT00282568|460069769|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
127850691|NCT00282568|460069769|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
127850692|NCT00282568|460069769|FG000|Extended Treatment Period|Adverse Event|17|||
127850693|NCT00282568|460069769|FG000|Extended Treatment Period|Non-compliance|4|||
127850694|NCT00282568|460069769|FG000|Extended Treatment Period|Physician Decision|1|||
127850695|NCT00282568|460069769|FG000|Extended Treatment Period|Lost to Follow-up|2|||
127850696|NCT01266070|460069770|FG000|Overall Study|Adverse Event|3|||
127850697|NCT01266070|460069770|FG000|Overall Study|Protocol Violation|1|||
127850698|NCT02417064|460069771|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
127850699|NCT02417064|460069772|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
127850700|NCT02417064|460069773|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
127850701|NCT02417064|460069771|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
127850702|NCT02417064|460069772|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
127850703|NCT02417064|460069773|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
127850704|NCT02417064|460069771|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
127850705|NCT02417064|460069772|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
127850706|NCT02417064|460069773|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
127850707|NCT02417064|460069771|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
127850708|NCT02417064|460069772|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
127850709|NCT02417064|460069773|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
127850710|NCT02417064|460069771|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
127850711|NCT02417064|460069772|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
127850712|NCT02417064|460069773|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
127850713|NCT02417064|460069771|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
127850714|NCT02417064|460069772|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
127850715|NCT02417064|460069773|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
127850716|NCT02417064|460069771|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
127850717|NCT02417064|460069772|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
127850718|NCT02417064|460069773|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
127850719|NCT02417064|460069771|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
127906087|NCT01439880|460283850|FG001|All-IP Period (Years 2 to 5)|Other|31|||
127906088|NCT01439880|460283849|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
127906089|NCT01439880|460283850|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
127850720|NCT02417064|460069772|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
127906090|NCT03874715|460283853|FG000|Overall Study|Adverse Event|2|||
127906091|NCT03874715|460283854|FG001|Overall Study|Adverse Event|0|||
127906092|NCT03874715|460283853|FG000|Overall Study|Poor compliance to protocol|5|||
127906093|NCT03874715|460283854|FG001|Overall Study|Poor compliance to protocol|1|||
127906094|NCT03874715|460283853|FG000|Overall Study|Withdrawal by Subject|1|||
127906095|NCT03874715|460283854|FG001|Overall Study|Withdrawal by Subject|0|||
127906096|NCT03874715|460283853|FG000|Overall Study|Other-unspecified|1|||
127906097|NCT03874715|460283854|FG001|Overall Study|Other-unspecified|0|||
127906098|NCT02956460|460283857|FG000|Lens 1|Lost to Follow-up|1|||
127906099|NCT02956460|460283858|FG001|Lens 1|Lost to Follow-up|0|||
127906100|NCT00834067|460283861|FG000|Washout of 21 Days|Protocol Violation|0|||
127906101|NCT00834067|460283862|FG001|Washout of 21 Days|Protocol Violation|1|||
127906102|NCT04129346|460283863|FG000|Overall Study|Death|1|||
127906103|NCT04129346|460283864|FG001|Overall Study|Death|0|||
127906104|NCT01083693|460283865|FG000|Overall Study|Adverse Event|1|||
127906105|NCT01083693|460283866|FG001|Overall Study|Adverse Event|1|||
127906106|NCT01083693|460283867|FG002|Overall Study|Adverse Event|0|||
127906107|NCT01083693|460283865|FG000|Overall Study|Lost to Follow-up|2|||
127906108|NCT01083693|460283866|FG001|Overall Study|Lost to Follow-up|0|||
127906109|NCT01083693|460283867|FG002|Overall Study|Lost to Follow-up|2|||
127906110|NCT01083693|460283865|FG000|Overall Study|Lack of effectiveness|13|||
127906111|NCT01083693|460283866|FG001|Overall Study|Lack of effectiveness|2|||
127906112|NCT01083693|460283867|FG002|Overall Study|Lack of effectiveness|2|||
127906113|NCT01083693|460283865|FG000|Overall Study|Patient Moved|0|||
127906114|NCT01083693|460283866|FG001|Overall Study|Patient Moved|1|||
127906115|NCT01083693|460283867|FG002|Overall Study|Patient Moved|0|||
127906116|NCT01083693|460283865|FG000|Overall Study|Complete remission|0|||
127906117|NCT01083693|460283866|FG001|Overall Study|Complete remission|1|||
127906118|NCT01083693|460283867|FG002|Overall Study|Complete remission|0|||
127906119|NCT01083693|460283865|FG000|Overall Study|Other medical condition/surgery|1|||
127906120|NCT01083693|460283866|FG001|Overall Study|Other medical condition/surgery|1|||
127906121|NCT01083693|460283867|FG002|Overall Study|Other medical condition/surgery|0|||
127906122|NCT01083693|460283865|FG000|Overall Study|Withdrawal by Subject|3|||
127906123|NCT01083693|460283866|FG001|Overall Study|Withdrawal by Subject|0|||
127906124|NCT01083693|460283867|FG002|Overall Study|Withdrawal by Subject|2|||
127906125|NCT01083693|460283865|FG000|Overall Study|Reason unknown|0|||
127906126|NCT01083693|460283866|FG001|Overall Study|Reason unknown|0|||
127906127|NCT01083693|460283867|FG002|Overall Study|Reason unknown|1|||
127906128|NCT01705574|460283868|FG000|Double-Blind Phase|Lost to Follow-up|12|||
127906129|NCT01705574|460283869|FG001|Double-Blind Phase|Lost to Follow-up|16|||
127906130|NCT01705574|460283870|FG002|Double-Blind Phase|Lost to Follow-up|0|||
127906131|NCT01705574|460283871|FG003|Double-Blind Phase|Lost to Follow-up|0|||
127906132|NCT01705574|460283868|FG000|Double-Blind Phase|Adverse Event|3|||
127906133|NCT01705574|460283869|FG001|Double-Blind Phase|Adverse Event|10|||
127906134|NCT01705574|460283870|FG002|Double-Blind Phase|Adverse Event|0|||
127906135|NCT01705574|460283871|FG003|Double-Blind Phase|Adverse Event|0|||
127906136|NCT01705574|460283868|FG000|Double-Blind Phase|Withdrew Consent|8|||
127906137|NCT01705574|460283869|FG001|Double-Blind Phase|Withdrew Consent|5|||
127906138|NCT01705574|460283870|FG002|Double-Blind Phase|Withdrew Consent|0|||
127906139|NCT01705574|460283871|FG003|Double-Blind Phase|Withdrew Consent|0|||
127906140|NCT01705574|460283868|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
127906141|NCT01705574|460283869|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
127906142|NCT01705574|460283870|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
127906143|NCT01705574|460283871|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
127906144|NCT01705574|460283868|FG000|Double-Blind Phase|Pregnancy|1|||
127906145|NCT01705574|460283869|FG001|Double-Blind Phase|Pregnancy|1|||
127906146|NCT01705574|460283870|FG002|Double-Blind Phase|Pregnancy|0|||
127906147|NCT01705574|460283871|FG003|Double-Blind Phase|Pregnancy|0|||
127906148|NCT01705574|460283868|FG000|Double-Blind Phase|Protocol Violation|1|||
127906149|NCT01705574|460283869|FG001|Double-Blind Phase|Protocol Violation|0|||
127906150|NCT01705574|460283870|FG002|Double-Blind Phase|Protocol Violation|0|||
127906151|NCT01705574|460283871|FG003|Double-Blind Phase|Protocol Violation|0|||
127906152|NCT01705574|460283868|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
127906153|NCT01705574|460283869|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
127906154|NCT01705574|460283870|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
127906155|NCT01705574|460283871|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
127906156|NCT01705574|460283868|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
127906157|NCT01705574|460283869|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
127906158|NCT01705574|460283870|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
127906159|NCT01705574|460283871|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
127906160|NCT01705574|460283868|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
127906161|NCT01705574|460283869|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
127906162|NCT01705574|460283870|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
127906163|NCT01705574|460283871|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
127850721|NCT02417064|460069773|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
127850722|NCT02417064|460069771|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
127850723|NCT02417064|460069772|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
127850724|NCT02417064|460069773|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
127850725|NCT02417064|460069771|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
127850726|NCT02417064|460069772|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
127850727|NCT02417064|460069773|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
127850728|NCT02417064|460069771|FG000|Follow-up Phase (24 Weeks)|Other|2|||
127850729|NCT02417064|460069772|FG001|Follow-up Phase (24 Weeks)|Other|2|||
127850730|NCT02417064|460069773|FG002|Follow-up Phase (24 Weeks)|Other|3|||
127850731|NCT01585168|460069774|FG000|Overall Study|Lost to Follow-up|3|||
127850732|NCT01585168|460069775|FG001|Overall Study|Lost to Follow-up|1|||
127850733|NCT01585168|460069776|FG002|Overall Study|Lost to Follow-up|1|||
127850734|NCT01585168|460069777|FG003|Overall Study|Lost to Follow-up|1|||
127850735|NCT01194414|460069778|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
127850736|NCT01194414|460069779|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
127850737|NCT01194414|460069780|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
127850738|NCT01194414|460069781|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
127850739|NCT01194414|460069778|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
127850740|NCT01194414|460069779|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
127850741|NCT01194414|460069780|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
127850742|NCT01194414|460069781|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
127850743|NCT01194414|460069778|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
127850744|NCT01194414|460069779|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
127850745|NCT01194414|460069780|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
127850746|NCT01194414|460069781|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
127850747|NCT01194414|460069778|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
127850748|NCT01194414|460069779|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
127850749|NCT01194414|460069780|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
127850750|NCT01194414|460069781|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
127850751|NCT01194414|460069778|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
127850752|NCT01194414|460069779|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
127850753|NCT01194414|460069780|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
127850754|NCT01194414|460069781|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
127850755|NCT01194414|460069778|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
127850756|NCT01194414|460069779|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
127850757|NCT01194414|460069780|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
127850758|NCT01194414|460069781|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
127850759|NCT01194414|460069778|FG000|24 Weeks Double Blind Period|Other|0|||
127850760|NCT01194414|460069779|FG001|24 Weeks Double Blind Period|Other|1|||
127850761|NCT01194414|460069780|FG002|24 Weeks Double Blind Period|Other|0|||
127850762|NCT01194414|460069781|FG003|24 Weeks Double Blind Period|Other|0|||
127850763|NCT01194414|460069778|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
127850764|NCT01194414|460069779|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
127850765|NCT01194414|460069780|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
127850766|NCT01194414|460069781|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
127850767|NCT01194414|460069778|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
127850768|NCT01194414|460069779|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
127850769|NCT01194414|460069780|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
127850770|NCT01194414|460069781|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
127850771|NCT01194414|460069778|FG000|24 Weeks Double Blind Period|Death|0|||
127850772|NCT01194414|460069779|FG001|24 Weeks Double Blind Period|Death|1|||
127850773|NCT01194414|460069780|FG002|24 Weeks Double Blind Period|Death|0|||
127850774|NCT01194414|460069781|FG003|24 Weeks Double Blind Period|Death|0|||
127850775|NCT01194414|460069778|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
127850776|NCT01194414|460069779|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
127850777|NCT01194414|460069780|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
127850778|NCT01194414|460069781|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
127850779|NCT01194414|460069778|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
127850780|NCT01194414|460069779|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
127850781|NCT01194414|460069780|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
127850782|NCT01194414|460069781|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
127850783|NCT01194414|460069778|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
127906164|NCT01705574|460283868|FG000|Open-Label Extension Phase|Adverse Event|3|||
127906165|NCT01705574|460283869|FG001|Open-Label Extension Phase|Adverse Event|0|||
127906166|NCT01705574|460283870|FG002|Open-Label Extension Phase|Adverse Event|0|||
127906167|NCT01705574|460283871|FG003|Open-Label Extension Phase|Adverse Event|1|||
127906168|NCT01705574|460283868|FG000|Open-Label Extension Phase|Death|2|||
127906169|NCT01705574|460283869|FG001|Open-Label Extension Phase|Death|0|||
127906170|NCT01705574|460283870|FG002|Open-Label Extension Phase|Death|1|||
127906171|NCT01705574|460283871|FG003|Open-Label Extension Phase|Death|0|||
127906172|NCT01705574|460283868|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
127906173|NCT01705574|460283869|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
127906174|NCT01705574|460283870|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
127906175|NCT01705574|460283871|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
127906176|NCT01705574|460283868|FG000|Open-Label Extension Phase|Physician Decision|0|||
127906177|NCT01705574|460283869|FG001|Open-Label Extension Phase|Physician Decision|0|||
127906178|NCT01705574|460283870|FG002|Open-Label Extension Phase|Physician Decision|2|||
127906179|NCT01705574|460283871|FG003|Open-Label Extension Phase|Physician Decision|0|||
127906180|NCT01705574|460283868|FG000|Open-Label Extension Phase|Pregnancy|0|||
127906181|NCT01705574|460283869|FG001|Open-Label Extension Phase|Pregnancy|0|||
127906182|NCT01705574|460283870|FG002|Open-Label Extension Phase|Pregnancy|1|||
127906183|NCT01705574|460283871|FG003|Open-Label Extension Phase|Pregnancy|1|||
127906184|NCT02543203|460283874|FG000|Overall Study|Unpalatable Fragrance|2|||
127906185|NCT02543203|460283875|FG001|Overall Study|Unpalatable Fragrance|2|||
127906186|NCT02543203|460283874|FG000|Overall Study|Lost to Follow-up|1|||
127906187|NCT02543203|460283875|FG001|Overall Study|Lost to Follow-up|0|||
127906188|NCT02543203|460283874|FG000|Overall Study|Increased Irritability|1|||
127906189|NCT02543203|460283875|FG001|Overall Study|Increased Irritability|0|||
127906190|NCT02543203|460283874|FG000|Overall Study|Family|1|||
127906191|NCT02543203|460283875|FG001|Overall Study|Family|2|||
127906192|NCT02543203|460283874|FG000|Overall Study|Negative Behavior|1|||
127906193|NCT02543203|460283875|FG001|Overall Study|Negative Behavior|0|||
127906194|NCT02543203|460283874|FG000|Overall Study|Withdrawal by Subject|0|||
127906195|NCT02543203|460283875|FG001|Overall Study|Withdrawal by Subject|1|||
127906196|NCT00089661|460283876|FG000|Overall Study|Adverse Event|0|||
127906197|NCT00089661|460283877|FG001|Overall Study|Adverse Event|2|||
127906198|NCT00089661|460283876|FG000|Overall Study|Death|1|||
127906199|NCT00089661|460283877|FG001|Overall Study|Death|0|||
127906200|NCT00089661|460283876|FG000|Overall Study|Lost to Follow-up|0|||
127906201|NCT00089661|460283877|FG001|Overall Study|Lost to Follow-up|3|||
127906202|NCT00089661|460283876|FG000|Overall Study|Withdrawal by Subject|11|||
127906203|NCT00089661|460283877|FG001|Overall Study|Withdrawal by Subject|9|||
127906204|NCT00089661|460283876|FG000|Overall Study|Disease progression|1|||
127906205|NCT00089661|460283877|FG001|Overall Study|Disease progression|3|||
127906206|NCT00089661|460283876|FG000|Overall Study|Ineligibility determined|4|||
127906207|NCT00089661|460283877|FG001|Overall Study|Ineligibility determined|4|||
127906208|NCT00089661|460283876|FG000|Overall Study|Noncompliance|2|||
127906209|NCT00089661|460283877|FG001|Overall Study|Noncompliance|4|||
127906210|NCT00089661|460283876|FG000|Overall Study|Other|2|||
127906211|NCT00089661|460283877|FG001|Overall Study|Other|1|||
127906212|NCT01273805|460283878|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
127906213|NCT01273805|460283879|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
127906214|NCT02647944|460283880|FG000|Overall Study|Withdrawal by Subject|0|||
127906215|NCT02647944|460283881|FG001|Overall Study|Withdrawal by Subject|3|||
127906216|NCT02647944|460283880|FG000|Overall Study|Adverse Event|2|||
127906217|NCT02647944|460283881|FG001|Overall Study|Adverse Event|0|||
127906218|NCT02077465|460283882|FG000|Overall Study|Withdrew Consent|0|||
127906219|NCT02077465|460283883|FG001|Overall Study|Withdrew Consent|1|||
127906220|NCT02077465|460283882|FG000|Overall Study|Lost to Follow-up|1|||
127906221|NCT02077465|460283883|FG001|Overall Study|Lost to Follow-up|0|||
127906222|NCT02760368|460283885|FG000|Overall Study|Withdrawal by Subject|8|||
127906223|NCT02760368|460283886|FG001|Overall Study|Withdrawal by Subject|12|||
127906224|NCT02760368|460283887|FG002|Overall Study|Withdrawal by Subject|9|||
127906225|NCT02760368|460283885|FG000|Overall Study|Screen Failure|0|||
127906226|NCT02760368|460283886|FG001|Overall Study|Screen Failure|0|||
127906227|NCT02760368|460283887|FG002|Overall Study|Screen Failure|1|||
127906228|NCT02760368|460283885|FG000|Overall Study|Death|0|||
127906229|NCT02760368|460283886|FG001|Overall Study|Death|1|||
127906230|NCT02760368|460283887|FG002|Overall Study|Death|0|||
127906231|NCT02760368|460283885|FG000|Overall Study|Withdrawal by Sponsor|0|||
127906232|NCT02760368|460283886|FG001|Overall Study|Withdrawal by Sponsor|0|||
127906233|NCT02760368|460283887|FG002|Overall Study|Withdrawal by Sponsor|1|||
127906234|NCT01827163|460283888|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
127906235|NCT01827163|460283888|FG000|Overall Study|Adverse Event|9|||
127906236|NCT02294604|460283889|FG000|Overall Study|Did not provide samples for culture|0|||
127906237|NCT02294604|460283890|FG001|Overall Study|Did not provide samples for culture|1|||
127906238|NCT02294604|460283891|FG002|Overall Study|Did not provide samples for culture|0|||
127906239|NCT02294604|460283889|FG000|Overall Study|Culture contamination|1|||
127906240|NCT02294604|460283890|FG001|Overall Study|Culture contamination|2|||
127850784|NCT01194414|460069779|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
127850785|NCT01194414|460069780|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
127850786|NCT01194414|460069781|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
127850787|NCT01194414|460069778|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
127850788|NCT01194414|460069779|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
127850789|NCT01194414|460069780|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
127850790|NCT01194414|460069781|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
127850791|NCT01194414|460069778|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
127850792|NCT01194414|460069779|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
127850793|NCT01194414|460069780|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
127850794|NCT01194414|460069781|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
127850795|NCT01194414|460069778|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
127850796|NCT01194414|460069779|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
127850797|NCT01194414|460069780|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
127850798|NCT01194414|460069781|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
127850799|NCT01194414|460069778|FG000|72 Weeks Open Label Extension|Other|2|||
127850800|NCT01194414|460069779|FG001|72 Weeks Open Label Extension|Other|1|||
127850801|NCT01194414|460069780|FG002|72 Weeks Open Label Extension|Other|0|||
127850802|NCT01194414|460069781|FG003|72 Weeks Open Label Extension|Other|0|||
127850803|NCT01194414|460069778|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
127850804|NCT01194414|460069779|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
127850805|NCT01194414|460069780|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
127850806|NCT01194414|460069781|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
127850807|NCT01194414|460069778|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
127850808|NCT01194414|460069779|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
127850809|NCT01194414|460069780|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
127850810|NCT01194414|460069781|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
127850811|NCT01194414|460069778|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
127850812|NCT01194414|460069779|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
127850813|NCT01194414|460069780|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
127850814|NCT01194414|460069781|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
127850815|NCT01194414|460069778|FG000|72 Weeks Open Label Extension|Death|1|||
127850816|NCT01194414|460069779|FG001|72 Weeks Open Label Extension|Death|2|||
127850817|NCT01194414|460069780|FG002|72 Weeks Open Label Extension|Death|0|||
127850818|NCT01194414|460069781|FG003|72 Weeks Open Label Extension|Death|2|||
127850819|NCT02260388|460069784|FG000|Overall Study|Lost to Follow-up|2|||
127850820|NCT02260388|460069785|FG001|Overall Study|Lost to Follow-up|8|||
127850821|NCT02260388|460069786|FG002|Overall Study|Lost to Follow-up|3|||
127850822|NCT02260388|460069787|FG003|Overall Study|Lost to Follow-up|4|||
127850823|NCT01235507|460069788|FG000|Overall Study|Adverse Event|1|||
127850824|NCT01235507|460069788|FG000|Overall Study|Withdrawal by Subject|1|||
127850825|NCT02017704|460069794|FG000|Overall Study|Withdrawal by Subject|2|||
127850826|NCT02017704|460069795|FG001|Overall Study|Withdrawal by Subject|0|||
127850827|NCT01587274|460069796|FG000|Overall Study|Lost to Follow-up|4|||
127850828|NCT01587274|460069797|FG001|Overall Study|Lost to Follow-up|5|||
127850829|NCT01587274|460069798|FG002|Overall Study|Lost to Follow-up|3|||
127850830|NCT00918346|460069799|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
127850831|NCT00918346|460069800|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
127850832|NCT02475629|460069801|FG000|Overall Study|Adverse Event|1|||
127850833|NCT02475629|460069801|FG000|Overall Study|Death|4|||
127850834|NCT02475629|460069801|FG000|Overall Study|Physician Decision|1|||
127850835|NCT02475629|460069801|FG000|Overall Study|Withdrawal by Subject|1|||
127850836|NCT02475629|460069801|FG000|Overall Study|Lost to Follow-up|1|||
127850837|NCT02475629|460069801|FG000|Overall Study|Subject non-compliance|1|||
127850838|NCT04423757|460069812|FG000|Overall Study|Adverse Event|2|||
127850839|NCT04423757|460069813|FG001|Overall Study|Adverse Event|0|||
127850840|NCT04423757|460069812|FG000|Overall Study|Not treated|1|||
127850841|NCT04423757|460069813|FG001|Overall Study|Not treated|1|||
127850842|NCT02709109|460069814|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
127850843|NCT02709109|460069815|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
127850844|NCT02709109|460069816|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
127850845|NCT02709109|460069817|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
127850846|NCT02709109|460069814|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
127850847|NCT02709109|460069815|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
127850848|NCT02709109|460069816|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
127850849|NCT02709109|460069817|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
127850850|NCT02709109|460069814|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
127850851|NCT02709109|460069815|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
127850852|NCT02709109|460069816|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
127850853|NCT02709109|460069817|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
127850854|NCT02709109|460069814|FG000|Washout Period (28 Days)|Other|2|||
127850855|NCT02709109|460069815|FG001|Washout Period (28 Days)|Other|2|||
127850856|NCT02709109|460069816|FG002|Washout Period (28 Days)|Other|3|||
127850857|NCT02709109|460069817|FG003|Washout Period (28 Days)|Other|0|||
127850858|NCT02709109|460069814|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
127850859|NCT02709109|460069815|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
127850860|NCT02709109|460069816|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
127850861|NCT02709109|460069817|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
127850862|NCT02709109|460069814|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
127850863|NCT02709109|460069815|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
127850864|NCT02709109|460069816|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
127850865|NCT02709109|460069817|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
127850866|NCT02709109|460069814|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
127850867|NCT02709109|460069815|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
127850868|NCT02709109|460069816|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
127850869|NCT02709109|460069817|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
127850870|NCT02709109|460069814|FG000|Treatment Period 2 (28 Days)|Other|0|||
127850871|NCT02709109|460069815|FG001|Treatment Period 2 (28 Days)|Other|0|||
127850872|NCT02709109|460069816|FG002|Treatment Period 2 (28 Days)|Other|1|||
127850873|NCT02709109|460069817|FG003|Treatment Period 2 (28 Days)|Other|0|||
127850874|NCT00996593|460069818|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
127850875|NCT00996593|460069818|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
127850876|NCT00996593|460069818|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
127850877|NCT00996593|460069818|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
127850878|NCT00996593|460069818|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
127850879|NCT00996593|460069818|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
127850880|NCT00996593|460069818|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
127850881|NCT00996593|460069818|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
127850882|NCT00996593|460069818|FG000|Long-Term Follow-Up|Site Closed|1|||
127850883|NCT02810951|460069819|FG000|Overall Study|Adverse Event|1|||
127850884|NCT01928082|460069820|FG000|Overall Study|Study terminated.|1|||
127850885|NCT05563714|460069823|FG000|Overall Study|Death|2|||
127850886|NCT05563714|460069824|FG001|Overall Study|Death|2|||
127850887|NCT05563714|460069825|FG002|Overall Study|Death|0|||
127850888|NCT05563714|460069826|FG003|Overall Study|Death|0|||
127850889|NCT05563714|460069823|FG000|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|4|||
127850890|NCT05563714|460069824|FG001|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|3|||
127850891|NCT05563714|460069825|FG002|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
127850892|NCT05563714|460069826|FG003|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
127850893|NCT05563714|460069823|FG000|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|1|||
127850894|NCT05563714|460069824|FG001|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|2|||
127850895|NCT05563714|460069825|FG002|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
127850896|NCT05563714|460069826|FG003|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
127850897|NCT05563714|460069823|FG000|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
127850898|NCT05563714|460069824|FG001|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|1|||
127850899|NCT05563714|460069825|FG002|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
127850900|NCT05563714|460069826|FG003|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
127850901|NCT05563714|460069823|FG000|Overall Study|Lost to Follow-up|22|||
127850902|NCT05563714|460069824|FG001|Overall Study|Lost to Follow-up|19|||
127850903|NCT05563714|460069825|FG002|Overall Study|Lost to Follow-up|0|||
127850904|NCT05563714|460069826|FG003|Overall Study|Lost to Follow-up|0|||
127850905|NCT01815580|460069827|FG000|Overall Study|Lost to Follow-up|4|||
127850906|NCT01815580|460069828|FG001|Overall Study|Lost to Follow-up|7|||
127850907|NCT01815580|460069827|FG000|Overall Study|Withdrawal by Subject|3|||
127850908|NCT01815580|460069828|FG001|Overall Study|Withdrawal by Subject|4|||
127850909|NCT01815580|460069827|FG000|Overall Study|Excluded from analysis|5|||
127850910|NCT01815580|460069828|FG001|Overall Study|Excluded from analysis|4|||
127850911|NCT02228564|460069829|FG000|Overall Study|Withdrawal by Subject|10|||
127850912|NCT02228564|460069829|FG000|Overall Study|Death|11|||
127850913|NCT02228564|460069829|FG000|Overall Study|Physician Decision|5|||
127850914|NCT02228564|460069829|FG000|Overall Study|Lost to Follow-up|17|||
127850915|NCT02228564|460069829|FG000|Overall Study|Other|6|||
127850916|NCT00617591|460069830|FG000|Overall Study|Withdrew consent during Induction|4|||
127850917|NCT00617591|460069830|FG000|Overall Study|Withdrew consent during Maintenance|6|||
127850918|NCT00376246|460069831|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
127850919|NCT00376246|460069832|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
127850920|NCT00376246|460069831|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
127850921|NCT00376246|460069832|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
127850922|NCT00376246|460069831|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
127850923|NCT00376246|460069832|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
127850924|NCT00588523|460069840|FG000|Overall Study|Not treated|3|||
127850925|NCT03032510|460069841|FG000|Overall Study|Adverse Event|5|||
127850926|NCT03032510|460069842|FG001|Overall Study|Adverse Event|2|||
127850927|NCT03032510|460069841|FG000|Overall Study|Lost to Follow-up|8|||
127850928|NCT03032510|460069842|FG001|Overall Study|Lost to Follow-up|7|||
127850929|NCT03032510|460069841|FG000|Overall Study|Withdrawal by Subject|8|||
127850930|NCT03032510|460069842|FG001|Overall Study|Withdrawal by Subject|7|||
127850931|NCT03032510|460069841|FG000|Overall Study|Subject noncompliance|4|||
127850932|NCT03032510|460069842|FG001|Overall Study|Subject noncompliance|2|||
127850933|NCT03032510|460069841|FG000|Overall Study|Physician Decision|2|||
127850934|NCT03032510|460069842|FG001|Overall Study|Physician Decision|0|||
127850935|NCT01731990|460072002|FG000|Overall Study|Adverse Event|1|||
127850936|NCT01731990|460072003|FG001|Overall Study|Adverse Event|5|||
127850937|NCT01731990|460072002|FG000|Overall Study|Withdrawal by Subject|1|||
127850938|NCT01731990|460072003|FG001|Overall Study|Withdrawal by Subject|1|||
127850939|NCT01731990|460072002|FG000|Overall Study|Protocol deviation|1|||
127850940|NCT01731990|460072003|FG001|Overall Study|Protocol deviation|2|||
127850941|NCT01731990|460072002|FG000|Overall Study|Death|1|||
127850942|NCT01731990|460072003|FG001|Overall Study|Death|0|||
127850943|NCT01280812|460072004|FG000|Overall Study|Withdrawal by Subject|2|||
127850944|NCT01280812|460072005|FG001|Overall Study|Withdrawal by Subject|1|||
127850945|NCT01280812|460072006|FG002|Overall Study|Withdrawal by Subject|0|||
127850946|NCT01280812|460072004|FG000|Overall Study|Lost to Follow-up|1|||
127850947|NCT01280812|460072005|FG001|Overall Study|Lost to Follow-up|1|||
127850948|NCT01280812|460072006|FG002|Overall Study|Lost to Follow-up|1|||
127850949|NCT04483544|460072007|FG000|Treatment (Completed 1 or More Cycles)|Death|1|||
127850950|NCT04483544|460072007|FG000|Post-Treatment|Admitted to hospice|2|||
127850951|NCT04483544|460072007|FG000|Post-Treatment|Study terminated|3|||
127850952|NCT01131078|460072014|FG000|Overall Study|Adverse Event|22|||
127850953|NCT01131078|460072015|FG001|Overall Study|Adverse Event|12|||
127850954|NCT01131078|460072016|FG002|Overall Study|Adverse Event|17|||
127850955|NCT01131078|460072014|FG000|Overall Study|Progressive Disease|58|||
127850956|NCT01131078|460072015|FG001|Overall Study|Progressive Disease|77|||
127850957|NCT01131078|460072016|FG002|Overall Study|Progressive Disease|71|||
127850958|NCT01131078|460072014|FG000|Overall Study|Protocol Violation|1|||
127850959|NCT01131078|460072015|FG001|Overall Study|Protocol Violation|0|||
127850960|NCT01131078|460072016|FG002|Overall Study|Protocol Violation|0|||
127850961|NCT01131078|460072014|FG000|Overall Study|Lost to Follow-up|1|||
127850962|NCT01131078|460072015|FG001|Overall Study|Lost to Follow-up|1|||
127850963|NCT01131078|460072016|FG002|Overall Study|Lost to Follow-up|1|||
127850964|NCT01131078|460072014|FG000|Overall Study|Withdrawal by Subject|2|||
127850965|NCT01131078|460072015|FG001|Overall Study|Withdrawal by Subject|4|||
127850966|NCT01131078|460072016|FG002|Overall Study|Withdrawal by Subject|3|||
127850967|NCT01131078|460072014|FG000|Overall Study|Non-compliance|3|||
127850968|NCT01131078|460072015|FG001|Overall Study|Non-compliance|0|||
127850969|NCT01131078|460072016|FG002|Overall Study|Non-compliance|0|||
127850970|NCT01131078|460072014|FG000|Overall Study|Physician Decision|10|||
127850971|NCT01131078|460072015|FG001|Overall Study|Physician Decision|6|||
127850972|NCT01131078|460072016|FG002|Overall Study|Physician Decision|8|||
127850973|NCT01131078|460072014|FG000|Overall Study|Death|4|||
127850974|NCT01131078|460072015|FG001|Overall Study|Death|0|||
127850975|NCT01131078|460072016|FG002|Overall Study|Death|2|||
127850976|NCT01131078|460072014|FG000|Overall Study|Other|0|||
127850977|NCT01131078|460072015|FG001|Overall Study|Other|1|||
127850978|NCT01131078|460072016|FG002|Overall Study|Other|0|||
127850979|NCT01685060|460072022|FG000|Overall Study|Rollover patients|16|||
127850980|NCT01685060|460072022|FG000|Overall Study|Adverse Event|12|||
127850981|NCT01685060|460072022|FG000|Overall Study|Progressive disease|69|||
127850982|NCT01685060|460072022|FG000|Overall Study|Physician Decision|14|||
127850983|NCT01685060|460072022|FG000|Overall Study|Subject/guardian decision|20|||
127850984|NCT01685060|460072022|FG000|Overall Study|Lost to Follow-up|1|||
127850985|NCT01685060|460072022|FG000|Overall Study|Death|8|||
127850986|NCT03597503|460072023|FG000|Overall Study|Withdrawal by Subject|0|||
127850987|NCT03597503|460072024|FG001|Overall Study|Withdrawal by Subject|2|||
127850988|NCT03597503|460072023|FG000|Overall Study|Lost to Follow-up|1|||
127850989|NCT03597503|460072024|FG001|Overall Study|Lost to Follow-up|2|||
127850990|NCT03597503|460072023|FG000|Overall Study|Protocol Violation|1|||
127850991|NCT03597503|460072024|FG001|Overall Study|Protocol Violation|0|||
127906241|NCT02294604|460283891|FG002|Overall Study|Culture contamination|0|||
127906242|NCT02902211|460283894|FG000|First Three Months|Withdrawal by Subject|7|||
127906243|NCT02902211|460283895|FG001|First Three Months|Withdrawal by Subject|3|||
127906244|NCT01401647|460283903|FG000|Overall Study|Withdrawal by Subject|1|||
127906245|NCT01401647|460283904|FG001|Overall Study|Withdrawal by Subject|5|||
127906246|NCT01401647|460283905|FG002|Overall Study|Withdrawal by Subject|2|||
127906247|NCT01401647|460283903|FG000|Overall Study|Lost to Follow-up|3|||
127906248|NCT01401647|460283904|FG001|Overall Study|Lost to Follow-up|3|||
127906249|NCT01401647|460283905|FG002|Overall Study|Lost to Follow-up|1|||
127906250|NCT00473330|460283909|FG000|Core Study|Adverse Event|4|||
127906251|NCT00473330|460283910|FG001|Core Study|Adverse Event|4|||
127906252|NCT00473330|460283911|FG002|Core Study|Adverse Event|1|||
127906253|NCT00473330|460283909|FG000|Core Study|Death|6|||
127906254|NCT00473330|460283910|FG001|Core Study|Death|4|||
127906255|NCT00473330|460283911|FG002|Core Study|Death|4|||
127906256|NCT00473330|460283909|FG000|Core Study|Lost to Follow-up|5|||
127906257|NCT00473330|460283910|FG001|Core Study|Lost to Follow-up|5|||
127906258|NCT00473330|460283911|FG002|Core Study|Lost to Follow-up|10|||
127906259|NCT00473330|460283909|FG000|Core Study|Physician Decision|2|||
127906260|NCT00473330|460283910|FG001|Core Study|Physician Decision|1|||
127906261|NCT00473330|460283911|FG002|Core Study|Physician Decision|3|||
127906262|NCT00473330|460283909|FG000|Core Study|Subject Non-compliance|1|||
127906263|NCT00473330|460283910|FG001|Core Study|Subject Non-compliance|2|||
127906264|NCT00473330|460283911|FG002|Core Study|Subject Non-compliance|1|||
127906265|NCT00473330|460283909|FG000|Core Study|Subject Required Other Therapy|0|||
127906266|NCT00473330|460283910|FG001|Core Study|Subject Required Other Therapy|1|||
127906267|NCT00473330|460283911|FG002|Core Study|Subject Required Other Therapy|3|||
127906268|NCT00473330|460283909|FG000|Core Study|Subject's Decision|9|||
127906269|NCT00473330|460283910|FG001|Core Study|Subject's Decision|8|||
127906270|NCT00473330|460283911|FG002|Core Study|Subject's Decision|19|||
127906271|NCT00473330|460283909|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
127906272|NCT00473330|460283910|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
127906273|NCT00473330|460283911|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
127906274|NCT00473330|460283909|FG000|Open-label Extension Through Month 48|Death|2|||
127906275|NCT00473330|460283910|FG001|Open-label Extension Through Month 48|Death|0|||
127906276|NCT00473330|460283911|FG002|Open-label Extension Through Month 48|Death|0|||
127906277|NCT00473330|460283909|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
127906278|NCT00473330|460283910|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
127906279|NCT00473330|460283911|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
127906280|NCT00473330|460283909|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
127906281|NCT00473330|460283910|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
127906282|NCT00473330|460283911|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
127906283|NCT00473330|460283909|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
127906284|NCT00473330|460283910|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
127906285|NCT00473330|460283911|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
127906286|NCT00473330|460283909|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
127906287|NCT00473330|460283910|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
127906288|NCT00473330|460283911|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
127906289|NCT00473330|460283909|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
127906290|NCT00473330|460283910|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
127906291|NCT00473330|460283911|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
127906292|NCT00473330|460283909|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
127906293|NCT00473330|460283910|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
127906294|NCT00473330|460283911|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
127906295|NCT00473330|460283909|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
127906296|NCT00473330|460283910|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
127906297|NCT00473330|460283911|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
127906298|NCT00473330|460283909|FG000|Open-label Extension Through Month 60|Death|2|||
127906299|NCT00473330|460283910|FG001|Open-label Extension Through Month 60|Death|2|||
127906300|NCT00473330|460283911|FG002|Open-label Extension Through Month 60|Death|1|||
127906301|NCT00473330|460283909|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
127850992|NCT00790218|460072025|FG000|Overall Study|Death|1|||
127850993|NCT00790218|460072026|FG001|Overall Study|Death|0|||
127850994|NCT00790218|460072027|FG002|Overall Study|Death|0|||
127850995|NCT00405275|460072030|FG000|Overall Study|Death|1|||
127850996|NCT00405275|460072031|FG001|Overall Study|Death|0|||
127850997|NCT00405275|460072030|FG000|Overall Study|Lost to Follow-up|5|||
127850998|NCT00405275|460072031|FG001|Overall Study|Lost to Follow-up|1|||
127850999|NCT00405275|460072030|FG000|Overall Study|Withdrawal by Subject|7|||
127851000|NCT00405275|460072031|FG001|Overall Study|Withdrawal by Subject|9|||
127851001|NCT00405275|460072030|FG000|Overall Study|Unwilling to continue|10|||
127851002|NCT00405275|460072031|FG001|Overall Study|Unwilling to continue|9|||
127851003|NCT02471586|460072036|FG000|Overall Study|Lost to Follow-up|3|||
127851004|NCT02471586|460072037|FG001|Overall Study|Lost to Follow-up|8|||
127851005|NCT02471586|460072038|FG002|Overall Study|Lost to Follow-up|4|||
127851006|NCT02471586|460072036|FG000|Overall Study|Death|2|||
127851007|NCT02471586|460072037|FG001|Overall Study|Death|2|||
127851008|NCT02471586|460072038|FG002|Overall Study|Death|0|||
127851009|NCT03805971|460072046|FG000|Overall Study|Withdrawal by Subject|1|||
127851010|NCT03805971|460072046|FG000|Overall Study|Protocol Violation|2|||
127851011|NCT00517413|460072050|FG000|Overall Study|Adverse Event|7|||
127851012|NCT00517413|460072050|FG000|Overall Study|Death|13|||
127851013|NCT00517413|460072050|FG000|Overall Study|Protocol Violation|15|||
127851014|NCT00517413|460072050|FG000|Overall Study|Withdrawal by Subject|2|||
127851015|NCT00517413|460072050|FG000|Overall Study|Failure to return|1|||
127851016|NCT00517413|460072050|FG000|Overall Study|Other-Reasons|23|||
127851017|NCT01510028|460072051|FG000|Overall Study|Lack of Efficacy|1|||
127851018|NCT01510028|460072052|FG001|Overall Study|Lack of Efficacy|0|||
127851019|NCT01510028|460072053|FG002|Overall Study|Lack of Efficacy|0|||
127851020|NCT01510028|460072054|FG003|Overall Study|Lack of Efficacy|0|||
127851021|NCT01355497|460072055|FG000|Overall Study|Death|19|||
127851022|NCT01355497|460072056|FG001|Overall Study|Death|18|||
127851023|NCT01355497|460072055|FG000|Overall Study|Lost to Follow-up|3|||
127851024|NCT01355497|460072056|FG001|Overall Study|Lost to Follow-up|0|||
127851025|NCT01355497|460072055|FG000|Overall Study|Protocol Violation|0|||
127851026|NCT01355497|460072056|FG001|Overall Study|Protocol Violation|1|||
127851027|NCT01355497|460072055|FG000|Overall Study|other-not provided|9|||
127851028|NCT01355497|460072056|FG001|Overall Study|other-not provided|4|||
127851029|NCT01355497|460072055|FG000|Overall Study|Withdrawal by Subject|12|||
127851030|NCT01355497|460072056|FG001|Overall Study|Withdrawal by Subject|20|||
127851031|NCT01355497|460072055|FG000|Overall Study|noncompliance|1|||
127851032|NCT01355497|460072056|FG001|Overall Study|noncompliance|2|||
127851033|NCT01355497|460072055|FG000|Overall Study|progressive disease|11|||
127851034|NCT01355497|460072056|FG001|Overall Study|progressive disease|8|||
127851035|NCT01355497|460072055|FG000|Overall Study|Adverse Event|11|||
127851036|NCT01355497|460072056|FG001|Overall Study|Adverse Event|10|||
127851037|NCT01224106|460072061|FG000|Double-Blind Treatment Phase|Death|3|||
127851038|NCT01224106|460072062|FG001|Double-Blind Treatment Phase|Death|0|||
127851039|NCT01224106|460072063|FG002|Double-Blind Treatment Phase|Death|0|||
127851040|NCT01224106|460072064|FG003|Double-Blind Treatment Phase|Death|0|||
127851041|NCT01224106|460072065|FG004|Double-Blind Treatment Phase|Death|0|||
127851042|NCT01224106|460072061|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
127851043|NCT01224106|460072062|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
127851044|NCT01224106|460072063|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
127851045|NCT01224106|460072064|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
127851046|NCT01224106|460072065|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
127851047|NCT01224106|460072061|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
127851048|NCT01224106|460072062|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
127851049|NCT01224106|460072063|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
127851050|NCT01224106|460072064|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
127851051|NCT01224106|460072065|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
127851052|NCT01224106|460072061|FG000|Double-Blind Treatment Phase|Other|0|||
127851053|NCT01224106|460072062|FG001|Double-Blind Treatment Phase|Other|0|||
127851054|NCT01224106|460072063|FG002|Double-Blind Treatment Phase|Other|1|||
127851055|NCT01224106|460072064|FG003|Double-Blind Treatment Phase|Other|0|||
127851056|NCT01224106|460072065|FG004|Double-Blind Treatment Phase|Other|0|||
127851057|NCT01224106|460072061|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
127851058|NCT01224106|460072062|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
127851059|NCT01224106|460072063|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
127851060|NCT01224106|460072064|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
127851061|NCT01224106|460072065|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
127851062|NCT01224106|460072061|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
127851063|NCT01224106|460072062|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
127851064|NCT01224106|460072063|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
127851065|NCT01224106|460072064|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
127851066|NCT01224106|460072065|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
127851067|NCT01224106|460072061|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
127906302|NCT00473330|460283910|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
127906303|NCT00473330|460283911|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
127906304|NCT00473330|460283909|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
127906305|NCT00473330|460283910|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
127906306|NCT00473330|460283911|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
127906307|NCT00473330|460283909|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
127906308|NCT00473330|460283910|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
127906309|NCT00473330|460283911|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
127906310|NCT00473330|460283909|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
127906311|NCT00473330|460283910|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
127906312|NCT00473330|460283911|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
127906313|NCT00473330|460283909|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
127906314|NCT00473330|460283910|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
127906315|NCT00473330|460283911|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
127906316|NCT00473330|460283909|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
127906317|NCT00473330|460283910|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
127906318|NCT00473330|460283911|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
127906319|NCT01975948|460283912|FG000|Overall Study|Withdrawal by Subject|17|||
127906320|NCT01975948|460283913|FG001|Overall Study|Withdrawal by Subject|21|||
127906321|NCT01975948|460283914|FG002|Overall Study|Withdrawal by Subject|7|||
127906322|NCT01975948|460283915|FG003|Overall Study|Withdrawal by Subject|6|||
127906323|NCT01675765|460283916|FG000|Overall Study|Progressive disease|4|||
127906324|NCT01675765|460283917|FG001|Overall Study|Progressive disease|4|||
127906325|NCT01675765|460283916|FG000|Overall Study|Adverse Event|1|||
127906326|NCT01675765|460283917|FG001|Overall Study|Adverse Event|2|||
127906327|NCT01675765|460283916|FG000|Overall Study|Withdrawal by Subject|2|||
127906328|NCT01675765|460283917|FG001|Overall Study|Withdrawal by Subject|0|||
127906329|NCT01675765|460283916|FG000|Overall Study|Death|1|||
127906330|NCT01675765|460283917|FG001|Overall Study|Death|0|||
127906331|NCT01675765|460283916|FG000|Overall Study|Clinical progression|3|||
127906332|NCT01675765|460283917|FG001|Overall Study|Clinical progression|2|||
127851068|NCT01224106|460072062|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
127851069|NCT01224106|460072063|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
127851070|NCT01224106|460072064|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
127851071|NCT01224106|460072065|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
127851072|NCT01224106|460072061|FG000|Open-Label Extension (OLE) Phase|Death|0|||
127851073|NCT01224106|460072062|FG001|Open-Label Extension (OLE) Phase|Death|0|||
127851074|NCT01224106|460072063|FG002|Open-Label Extension (OLE) Phase|Death|0|||
127851075|NCT01224106|460072064|FG003|Open-Label Extension (OLE) Phase|Death|1|||
127851076|NCT01224106|460072065|FG004|Open-Label Extension (OLE) Phase|Death|3|||
127851077|NCT01224106|460072061|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
127851078|NCT01224106|460072062|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
127851079|NCT01224106|460072063|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
127851080|NCT01224106|460072064|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
127851081|NCT01224106|460072065|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
127851082|NCT01224106|460072061|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
127851083|NCT01224106|460072062|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
127851084|NCT01224106|460072063|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
127851085|NCT01224106|460072064|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
127851086|NCT01224106|460072065|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
127851087|NCT01224106|460072061|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
127906333|NCT00365846|460283919|FG000|Overall Study|Lost to Follow-up|1|||
127906334|NCT04405570|460283920|FG000|Overall Study|Adverse Event|0|||
127906335|NCT04405570|460283921|FG001|Overall Study|Adverse Event|1|||
127851088|NCT01224106|460072062|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
127851089|NCT01224106|460072063|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
127906336|NCT04405570|460283922|FG002|Overall Study|Adverse Event|1|||
127906337|NCT04405570|460283923|FG003|Overall Study|Adverse Event|1|||
127851090|NCT01224106|460072064|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
127906338|NCT04405570|460283920|FG000|Overall Study|Lost to Follow-up|0|||
127906339|NCT04405570|460283921|FG001|Overall Study|Lost to Follow-up|1|||
127906340|NCT04405570|460283922|FG002|Overall Study|Lost to Follow-up|0|||
127906341|NCT04405570|460283923|FG003|Overall Study|Lost to Follow-up|0|||
127906342|NCT04405570|460283920|FG000|Overall Study|Physician Decision|0|||
127906343|NCT04405570|460283921|FG001|Overall Study|Physician Decision|0|||
127906344|NCT04405570|460283922|FG002|Overall Study|Physician Decision|1|||
127906345|NCT04405570|460283923|FG003|Overall Study|Physician Decision|0|||
127906346|NCT04405570|460283920|FG000|Overall Study|Withdrawal by Subject|0|||
127906347|NCT04405570|460283921|FG001|Overall Study|Withdrawal by Subject|1|||
127906348|NCT04405570|460283922|FG002|Overall Study|Withdrawal by Subject|1|||
127906349|NCT04405570|460283923|FG003|Overall Study|Withdrawal by Subject|0|||
127906350|NCT04405570|460283920|FG000|Overall Study|Randomized not dosed|0|||
127906351|NCT04405570|460283921|FG001|Overall Study|Randomized not dosed|2|||
127906352|NCT04405570|460283922|FG002|Overall Study|Randomized not dosed|0|||
127851091|NCT01224106|460072065|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
127851092|NCT01224106|460072061|FG000|Open-Label Extension (OLE) Phase|Other|0|||
127851093|NCT01224106|460072062|FG001|Open-Label Extension (OLE) Phase|Other|0|||
127851094|NCT01224106|460072063|FG002|Open-Label Extension (OLE) Phase|Other|0|||
127851095|NCT01224106|460072064|FG003|Open-Label Extension (OLE) Phase|Other|5|||
127851096|NCT01224106|460072065|FG004|Open-Label Extension (OLE) Phase|Other|3|||
127851097|NCT00446797|460072066|FG000|Overall Study|Lack of Efficacy|0|||
127851098|NCT00446797|460072067|FG001|Overall Study|Lack of Efficacy|2|||
127851099|NCT00446797|460072066|FG000|Overall Study|Lost to Follow-up|5|||
127851100|NCT00446797|460072067|FG001|Overall Study|Lost to Follow-up|3|||
127851101|NCT00446797|460072066|FG000|Overall Study|Withdrawal by Subject|2|||
127851102|NCT00446797|460072067|FG001|Overall Study|Withdrawal by Subject|2|||
127851103|NCT00446797|460072066|FG000|Overall Study|Protocol Violation|1|||
127851104|NCT00446797|460072067|FG001|Overall Study|Protocol Violation|3|||
127851105|NCT00446797|460072066|FG000|Overall Study|subject entered at another site|0|||
127851106|NCT00446797|460072067|FG001|Overall Study|subject entered at another site|1|||
127851107|NCT00446797|460072066|FG000|Overall Study|did not meet entrance criteria|0|||
127851108|NCT00446797|460072067|FG001|Overall Study|did not meet entrance criteria|1|||
127851109|NCT02498392|460072072|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
127851110|NCT02498392|460072073|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
127851111|NCT02498392|460072072|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
127851112|NCT02498392|460072073|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
127851113|NCT02498392|460072072|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
127851114|NCT02498392|460072073|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
127851115|NCT02498392|460072072|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
127851116|NCT02498392|460072073|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
127851117|NCT02498392|460072072|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
127851118|NCT02498392|460072073|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
127851119|NCT02498392|460072072|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
127851120|NCT02498392|460072073|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
127851121|NCT03097133|460072074|FG000|Overall Study|Lost to Follow-up|3|||
127851122|NCT03097133|460072075|FG001|Overall Study|Lost to Follow-up|2|||
127851123|NCT03097133|460072074|FG000|Overall Study|Withdrawal by Subject|2|||
127851124|NCT03097133|460072075|FG001|Overall Study|Withdrawal by Subject|5|||
127851125|NCT03097133|460072074|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
127851126|NCT03097133|460072075|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
127851127|NCT03097133|460072074|FG000|Overall Study|Other|3|||
127851128|NCT03097133|460072075|FG001|Overall Study|Other|2|||
127851129|NCT03097133|460072074|FG000|Overall Study|Adverse Event|1|||
127851130|NCT03097133|460072075|FG001|Overall Study|Adverse Event|0|||
127851131|NCT02873208|460072076|FG000|Overall Study|Withdrawal by Subject|36|||
127851132|NCT02873208|460072076|FG000|Overall Study|Lost to Follow-up|22|||
127851133|NCT02873208|460072076|FG000|Overall Study|Adverse Event|15|||
127851134|NCT02873208|460072076|FG000|Overall Study|Non-compliance with study drug|12|||
127851135|NCT02873208|460072076|FG000|Overall Study|Protocol Violation|8|||
127851136|NCT02873208|460072076|FG000|Overall Study|Pregnancy|2|||
127851137|NCT02873208|460072076|FG000|Overall Study|Incarceration|1|||
127851138|NCT02873208|460072076|FG000|Overall Study|Lack of Efficacy|1|||
127851139|NCT02873208|460072076|FG000|Overall Study|Physician Decision|1|||
127851140|NCT04080752|460072077|FG000|Overall Study|Adverse Event|2|||
127851141|NCT04080752|460072078|FG001|Overall Study|Adverse Event|3|||
127851142|NCT04080752|460072077|FG000|Overall Study|Lack of Efficacy|1|||
127851143|NCT04080752|460072078|FG001|Overall Study|Lack of Efficacy|0|||
127851144|NCT04080752|460072077|FG000|Overall Study|Lost to Follow-up|1|||
127851145|NCT04080752|460072078|FG001|Overall Study|Lost to Follow-up|0|||
127851146|NCT04080752|460072077|FG000|Overall Study|Pregnancy|0|||
127851147|NCT04080752|460072078|FG001|Overall Study|Pregnancy|1|||
127906353|NCT04405570|460283923|FG003|Overall Study|Randomized not dosed|0|||
127906354|NCT04499963|460283924|FG000|Overall Study|Adverse Event|3|||
127906355|NCT04499963|460283925|FG001|Overall Study|Adverse Event|0|||
127851148|NCT04080752|460072077|FG000|Overall Study|Withdrawal by Subject|7|||
127851149|NCT04080752|460072078|FG001|Overall Study|Withdrawal by Subject|0|||
127851150|NCT04080752|460072077|FG000|Overall Study|Non-Compliance with Study Drug|0|||
127851151|NCT04080752|460072078|FG001|Overall Study|Non-Compliance with Study Drug|1|||
127851152|NCT04080752|460072077|FG000|Overall Study|Other|2|||
127851153|NCT04080752|460072078|FG001|Overall Study|Other|1|||
127851154|NCT01192100|460072079|FG000|Overall Study|Withdrawal by Subject|0|||
127851155|NCT01192100|460072080|FG001|Overall Study|Withdrawal by Subject|0|||
127851156|NCT01192100|460072081|FG002|Overall Study|Withdrawal by Subject|0|||
127851157|NCT01192100|460072082|FG003|Overall Study|Withdrawal by Subject|0|||
127851158|NCT01192100|460072083|FG004|Overall Study|Withdrawal by Subject|1|||
127851159|NCT01192100|460072084|FG005|Overall Study|Withdrawal by Subject|0|||
127851160|NCT01192100|460072079|FG000|Overall Study|Protocol Violation|0|||
127851161|NCT01192100|460072080|FG001|Overall Study|Protocol Violation|0|||
127851162|NCT01192100|460072081|FG002|Overall Study|Protocol Violation|0|||
127851163|NCT01192100|460072082|FG003|Overall Study|Protocol Violation|1|||
127851164|NCT01192100|460072083|FG004|Overall Study|Protocol Violation|0|||
127851165|NCT01192100|460072084|FG005|Overall Study|Protocol Violation|0|||
127851166|NCT04685538|460072086|FG000|Overall Study|Adverse Event|0|||
127851167|NCT04685538|460072087|FG001|Overall Study|Adverse Event|1|||
127851168|NCT04685538|460072086|FG000|Overall Study|Lost to Follow-up|0|||
127851169|NCT04685538|460072087|FG001|Overall Study|Lost to Follow-up|2|||
127851170|NCT04737759|460072088|FG000|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|12|||
127851171|NCT04737759|460072089|FG001|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|4|||
127851172|NCT04737759|460072088|FG000|Overall Study|Death|2|||
127851173|NCT04737759|460072089|FG001|Overall Study|Death|0|||
127851174|NCT04737759|460072088|FG000|Overall Study|spouse dropped when adult with heart failure died|2|||
127851175|NCT04737759|460072089|FG001|Overall Study|spouse dropped when adult with heart failure died|0|||
127851176|NCT04737759|460072088|FG000|Overall Study|Lost to Follow-up|4|||
127851177|NCT04737759|460072089|FG001|Overall Study|Lost to Follow-up|12|||
127851178|NCT01421069|460072091|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
127851179|NCT01421069|460072091|FG000|Parent Study|Failed to return|3|||
127851180|NCT01421069|460072091|FG000|Parent Study|Withdrawal by Subject|1|||
127851181|NCT01421069|460072091|FG000|Parent Study|Lost to Follow-up|2|||
127851182|NCT01421069|460072091|FG000|Parent Study|Lack of Efficacy|1|||
127851183|NCT01421069|460072091|FG000|Overall Period for Extension Study|Other|2|||
127851184|NCT01421069|460072091|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
127851185|NCT01421069|460072091|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
127851186|NCT01421069|460072091|FG000|Overall Period for Extension Study|Pregnancy|1|||
127851187|NCT01421069|460072091|FG000|Overall Period for Extension Study|Adverse Event|1|||
127851188|NCT01421069|460072091|FG000|Overall Period for Extension Study|Protocol Violation|1|||
127851189|NCT01421069|460072091|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
127851190|NCT01421069|460072091|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
127851191|NCT01421069|460072091|FG000|Active Treatment Period|Other|1|||
127851192|NCT01421069|460072091|FG000|Active Treatment Period|No longer willing to participate in study|8|||
127851193|NCT01421069|460072091|FG000|Active Treatment Period|Insufficient clinical response|1|||
127851194|NCT01421069|460072091|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
127851195|NCT01421069|460072091|FG000|Active Treatment Period|Pregnancy|1|||
127851196|NCT01421069|460072091|FG000|Active Treatment Period|Adverse Event|1|||
127851197|NCT01421069|460072091|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
127851198|NCT01421069|460072091|FG000|Active Treatment Period|Enrolled in observational period|29|||
127851199|NCT01421069|460072091|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
127851200|NCT01421069|460072091|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
127851201|NCT01421069|460072091|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
127851202|NCT01421069|460072091|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
127851203|NCT01421069|460072091|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
127851204|NCT01421069|460072091|FG000|2b. Retreatment Period|Protocol Violation|1|||
127851205|NCT01421069|460072091|FG000|Observational Period|Other|1|||
127851206|NCT01421069|460072091|FG000|Observational Period|No longer willing to participate in study|4|||
127851207|NCT01421069|460072091|FG000|Observational Period|Lost to Follow-up|3|||
127851208|NCT01641081|460072092|FG000|Period 1|Sponsor request (potential unblinding)|0|||
127851209|NCT01641081|460072093|FG001|Period 1|Sponsor request (potential unblinding)|0|||
127851210|NCT01641081|460072094|FG002|Period 1|Sponsor request (potential unblinding)|0|||
127851211|NCT01641081|460072095|FG003|Period 1|Sponsor request (potential unblinding)|0|||
127851212|NCT01641081|460072096|FG004|Period 1|Sponsor request (potential unblinding)|0|||
127851213|NCT01641081|460072097|FG005|Period 1|Sponsor request (potential unblinding)|0|||
127851214|NCT01641081|460072098|FG006|Period 1|Sponsor request (potential unblinding)|1|||
127851215|NCT01641081|460072099|FG007|Period 1|Sponsor request (potential unblinding)|0|||
127851216|NCT01641081|460072100|FG008|Period 1|Sponsor request (potential unblinding)|0|||
127851217|NCT01641081|460072101|FG009|Period 1|Sponsor request (potential unblinding)|0|||
127851218|NCT01641081|460072092|FG000|Period 1|Protocol Violation|0|||
127851219|NCT01641081|460072093|FG001|Period 1|Protocol Violation|0|||
127851220|NCT01641081|460072094|FG002|Period 1|Protocol Violation|0|||
127851221|NCT01641081|460072095|FG003|Period 1|Protocol Violation|0|||
127851222|NCT01641081|460072096|FG004|Period 1|Protocol Violation|1|||
127851223|NCT01641081|460072097|FG005|Period 1|Protocol Violation|0|||
127851224|NCT01641081|460072098|FG006|Period 1|Protocol Violation|0|||
127851225|NCT01641081|460072099|FG007|Period 1|Protocol Violation|1|||
127851226|NCT01641081|460072100|FG008|Period 1|Protocol Violation|0|||
127851227|NCT01641081|460072101|FG009|Period 1|Protocol Violation|0|||
127851228|NCT01641081|460072092|FG000|Period 1|Adverse Event|1|||
127851229|NCT01641081|460072093|FG001|Period 1|Adverse Event|0|||
127851230|NCT01641081|460072094|FG002|Period 1|Adverse Event|0|||
127851231|NCT01641081|460072095|FG003|Period 1|Adverse Event|0|||
127851232|NCT01641081|460072096|FG004|Period 1|Adverse Event|0|||
127851233|NCT01641081|460072097|FG005|Period 1|Adverse Event|0|||
127851234|NCT01641081|460072098|FG006|Period 1|Adverse Event|0|||
127851235|NCT01641081|460072099|FG007|Period 1|Adverse Event|2|||
127851236|NCT01641081|460072100|FG008|Period 1|Adverse Event|0|||
127851237|NCT01641081|460072101|FG009|Period 1|Adverse Event|0|||
127851238|NCT01641081|460072092|FG000|Period 2|Adverse Event|0|||
127851239|NCT01641081|460072093|FG001|Period 2|Adverse Event|0|||
127851240|NCT01641081|460072094|FG002|Period 2|Adverse Event|0|||
127851241|NCT01641081|460072095|FG003|Period 2|Adverse Event|0|||
127851242|NCT01641081|460072096|FG004|Period 2|Adverse Event|0|||
127851243|NCT01641081|460072097|FG005|Period 2|Adverse Event|1|||
127851244|NCT01641081|460072098|FG006|Period 2|Adverse Event|0|||
127851245|NCT01641081|460072099|FG007|Period 2|Adverse Event|0|||
127851246|NCT01641081|460072100|FG008|Period 2|Adverse Event|0|||
127851247|NCT01641081|460072101|FG009|Period 2|Adverse Event|0|||
127851248|NCT01641081|460072092|FG000|Period 2|Withdrawal by Subject|0|||
127851249|NCT01641081|460072093|FG001|Period 2|Withdrawal by Subject|0|||
127851250|NCT01641081|460072094|FG002|Period 2|Withdrawal by Subject|0|||
127851251|NCT01641081|460072095|FG003|Period 2|Withdrawal by Subject|1|||
127851252|NCT01641081|460072096|FG004|Period 2|Withdrawal by Subject|0|||
127851253|NCT01641081|460072097|FG005|Period 2|Withdrawal by Subject|0|||
127851254|NCT01641081|460072098|FG006|Period 2|Withdrawal by Subject|2|||
127851255|NCT01641081|460072099|FG007|Period 2|Withdrawal by Subject|0|||
127851256|NCT01641081|460072100|FG008|Period 2|Withdrawal by Subject|0|||
127851257|NCT01641081|460072101|FG009|Period 2|Withdrawal by Subject|0|||
127851258|NCT01641081|460072092|FG000|Period 2|Protocol Violation|1|||
127851259|NCT01641081|460072093|FG001|Period 2|Protocol Violation|0|||
127851260|NCT01641081|460072094|FG002|Period 2|Protocol Violation|0|||
127851261|NCT01641081|460072095|FG003|Period 2|Protocol Violation|0|||
127851262|NCT01641081|460072096|FG004|Period 2|Protocol Violation|0|||
127851263|NCT01641081|460072097|FG005|Period 2|Protocol Violation|0|||
127851264|NCT01641081|460072098|FG006|Period 2|Protocol Violation|0|||
127851265|NCT01641081|460072099|FG007|Period 2|Protocol Violation|0|||
127851266|NCT01641081|460072100|FG008|Period 2|Protocol Violation|0|||
127851267|NCT01641081|460072101|FG009|Period 2|Protocol Violation|0|||
127851268|NCT01641081|460072092|FG000|Period 3|Adverse Event|0|||
127851269|NCT01641081|460072093|FG001|Period 3|Adverse Event|0|||
127851270|NCT01641081|460072094|FG002|Period 3|Adverse Event|1|||
127851271|NCT01641081|460072095|FG003|Period 3|Adverse Event|0|||
127851272|NCT01641081|460072096|FG004|Period 3|Adverse Event|0|||
127851273|NCT01641081|460072097|FG005|Period 3|Adverse Event|0|||
127851274|NCT01641081|460072098|FG006|Period 3|Adverse Event|0|||
127851275|NCT01641081|460072099|FG007|Period 3|Adverse Event|0|||
127851276|NCT01641081|460072100|FG008|Period 3|Adverse Event|0|||
127851277|NCT01641081|460072101|FG009|Period 3|Adverse Event|0|||
127851278|NCT01641081|460072092|FG000|Period 3|Withdrawal by Subject|0|||
127851279|NCT01641081|460072093|FG001|Period 3|Withdrawal by Subject|0|||
127851280|NCT01641081|460072094|FG002|Period 3|Withdrawal by Subject|0|||
127851281|NCT01641081|460072095|FG003|Period 3|Withdrawal by Subject|0|||
127851282|NCT01641081|460072096|FG004|Period 3|Withdrawal by Subject|0|||
127851283|NCT01641081|460072097|FG005|Period 3|Withdrawal by Subject|0|||
127851284|NCT01641081|460072098|FG006|Period 3|Withdrawal by Subject|0|||
127851285|NCT01641081|460072099|FG007|Period 3|Withdrawal by Subject|0|||
127851286|NCT01641081|460072100|FG008|Period 3|Withdrawal by Subject|1|||
127851287|NCT01641081|460072101|FG009|Period 3|Withdrawal by Subject|0|||
127851288|NCT01641081|460072092|FG000|Period 4|Adverse Event|0|||
127851289|NCT01641081|460072093|FG001|Period 4|Adverse Event|1|||
127851290|NCT01641081|460072094|FG002|Period 4|Adverse Event|0|||
127851291|NCT01641081|460072095|FG003|Period 4|Adverse Event|1|||
127851292|NCT01641081|460072096|FG004|Period 4|Adverse Event|0|||
127851293|NCT01641081|460072097|FG005|Period 4|Adverse Event|0|||
127851294|NCT01641081|460072098|FG006|Period 4|Adverse Event|0|||
127851295|NCT01641081|460072099|FG007|Period 4|Adverse Event|0|||
127851296|NCT01641081|460072100|FG008|Period 4|Adverse Event|0|||
127851297|NCT01641081|460072101|FG009|Period 4|Adverse Event|0|||
127851298|NCT01641081|460072092|FG000|Period 5|Adverse Event|0|||
127851299|NCT01641081|460072093|FG001|Period 5|Adverse Event|0|||
127851300|NCT01641081|460072094|FG002|Period 5|Adverse Event|2|||
127851301|NCT01641081|460072095|FG003|Period 5|Adverse Event|0|||
127851302|NCT01641081|460072096|FG004|Period 5|Adverse Event|0|||
127851303|NCT01641081|460072097|FG005|Period 5|Adverse Event|0|||
127851304|NCT01641081|460072098|FG006|Period 5|Adverse Event|0|||
127906356|NCT04499963|460283924|FG000|Overall Study|Death|3|||
127906357|NCT04499963|460283925|FG001|Overall Study|Death|0|||
127906358|NCT04499963|460283924|FG000|Overall Study|Lack of Efficacy|7|||
127906359|NCT04499963|460283925|FG001|Overall Study|Lack of Efficacy|0|||
127906360|NCT04499963|460283924|FG000|Overall Study|Lost to Follow-up|2|||
127851305|NCT01641081|460072099|FG007|Period 5|Adverse Event|0|||
127851306|NCT01641081|460072100|FG008|Period 5|Adverse Event|0|||
127851307|NCT01641081|460072101|FG009|Period 5|Adverse Event|0|||
127906361|NCT04499963|460283925|FG001|Overall Study|Lost to Follow-up|0|||
127906362|NCT01208337|460283931|FG000|Overall Study|Death|3|||
127906363|NCT03663179|460283934|FG000|Overall Study|Withdrawal by Subject|2|||
127906364|NCT03663179|460283935|FG001|Overall Study|Withdrawal by Subject|0|||
127906365|NCT03663179|460283934|FG000|Overall Study|Lost to Follow-up|1|||
127906366|NCT03663179|460283935|FG001|Overall Study|Lost to Follow-up|1|||
127906367|NCT03663179|460283934|FG000|Overall Study|Revealed exclusionary condition|1|||
127906368|NCT03663179|460283935|FG001|Overall Study|Revealed exclusionary condition|0|||
127906369|NCT00984126|460283939|FG000|Overall Study|Protocol Violation|0|||
127906370|NCT00984126|460283940|FG001|Overall Study|Protocol Violation|0|||
127906371|NCT00984126|460283941|FG002|Overall Study|Protocol Violation|1|||
127906372|NCT00984126|460283942|FG003|Overall Study|Protocol Violation|2|||
127906373|NCT00984126|460283939|FG000|Overall Study|Adverse Event|0|||
127906374|NCT00984126|460283940|FG001|Overall Study|Adverse Event|0|||
127906375|NCT00984126|460283941|FG002|Overall Study|Adverse Event|0|||
127906376|NCT00984126|460283942|FG003|Overall Study|Adverse Event|2|||
127906377|NCT00984126|460283939|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
127906378|NCT00984126|460283940|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
127906379|NCT00984126|460283941|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
127906380|NCT00984126|460283942|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
127906381|NCT00984126|460283939|FG000|Overall Study|Withdrawal criteria|0|||
127906382|NCT00984126|460283940|FG001|Overall Study|Withdrawal criteria|1|||
127906383|NCT00984126|460283941|FG002|Overall Study|Withdrawal criteria|3|||
127906384|NCT00984126|460283942|FG003|Overall Study|Withdrawal criteria|9|||
127906385|NCT01001208|460283943|FG000|Overall Study|Adverse Event|10|||
127906386|NCT01001208|460283944|FG001|Overall Study|Adverse Event|5|||
127906387|NCT01001208|460283943|FG000|Overall Study|Lost to Follow-up|5|||
127906388|NCT01001208|460283944|FG001|Overall Study|Lost to Follow-up|9|||
127906389|NCT01001208|460283943|FG000|Overall Study|Physician Decision|1|||
127906390|NCT01001208|460283944|FG001|Overall Study|Physician Decision|0|||
127906391|NCT01001208|460283943|FG000|Overall Study|Withdrawal by Subject|4|||
127906392|NCT01001208|460283944|FG001|Overall Study|Withdrawal by Subject|5|||
127906393|NCT01001208|460283943|FG000|Overall Study|Ineligibility Determined|4|||
127906394|NCT01001208|460283944|FG001|Overall Study|Ineligibility Determined|2|||
127906395|NCT01001208|460283943|FG000|Overall Study|Noncompliance|4|||
127906396|NCT01001208|460283944|FG001|Overall Study|Noncompliance|7|||
127906397|NCT01001208|460283943|FG000|Overall Study|Disease Progression|0|||
127906398|NCT01001208|460283944|FG001|Overall Study|Disease Progression|3|||
127906399|NCT01001208|460283943|FG000|Overall Study|Other|0|||
127906400|NCT01001208|460283944|FG001|Overall Study|Other|2|||
127906401|NCT01864174|460283945|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
127906402|NCT01864174|460283946|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
127906403|NCT01864174|460283945|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
127906404|NCT01864174|460283946|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
127906405|NCT01864174|460283945|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
127906406|NCT01864174|460283946|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
127851308|NCT01095666|460072102|FG000|Overall Study|Lack of Efficacy|0|||
127851309|NCT01095666|460072103|FG001|Overall Study|Lack of Efficacy|0|||
127851310|NCT01095666|460072104|FG002|Overall Study|Lack of Efficacy|1|||
127851311|NCT01095666|460072102|FG000|Overall Study|Adverse Event|2|||
127851312|NCT01095666|460072103|FG001|Overall Study|Adverse Event|1|||
127851313|NCT01095666|460072104|FG002|Overall Study|Adverse Event|3|||
127851314|NCT01095666|460072102|FG000|Overall Study|Lost to Follow-up|2|||
127851315|NCT01095666|460072103|FG001|Overall Study|Lost to Follow-up|2|||
127851316|NCT01095666|460072104|FG002|Overall Study|Lost to Follow-up|0|||
127851317|NCT01095666|460072102|FG000|Overall Study|Withdrawal by Subject|6|||
127851318|NCT01095666|460072103|FG001|Overall Study|Withdrawal by Subject|6|||
127906407|NCT01864174|460283945|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
127906408|NCT01864174|460283946|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
127906409|NCT01864174|460283945|FG000|Double Blind - Compliant Randomized|Death|1|||
127906410|NCT01864174|460283946|FG001|Double Blind - Compliant Randomized|Death|0|||
127906411|NCT01864174|460283945|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
127906412|NCT01864174|460283946|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
127906413|NCT01864174|460283945|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
127851319|NCT01095666|460072104|FG002|Overall Study|Withdrawal by Subject|1|||
127851320|NCT01095666|460072102|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
127906414|NCT01864174|460283946|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
127906415|NCT01864174|460283945|FG000|Double Blind - Compliant Randomized|Other|6|||
127851321|NCT01095666|460072103|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
127851322|NCT01095666|460072104|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
127851323|NCT01749800|460072108|FG000|Overall Study|not meeting inclusion criteria|3|||
127851324|NCT01749800|460072109|FG001|Overall Study|not meeting inclusion criteria|0|||
127851325|NCT01749800|460072110|FG002|Overall Study|not meeting inclusion criteria|0|||
127851326|NCT01749800|460072108|FG000|Overall Study|Withdrawal by Subject|0|||
127851327|NCT01749800|460072109|FG001|Overall Study|Withdrawal by Subject|1|||
127851328|NCT01749800|460072110|FG002|Overall Study|Withdrawal by Subject|0|||
127851329|NCT01451398|460072116|FG000|Overall Study|Adverse Event|7|||
127851330|NCT01451398|460072117|FG001|Overall Study|Adverse Event|9|||
127851331|NCT01451398|460072116|FG000|Overall Study|Protocol Violation|1|||
127851332|NCT01451398|460072117|FG001|Overall Study|Protocol Violation|2|||
127851333|NCT01451398|460072116|FG000|Overall Study|Physician Decision|1|||
127851334|NCT01451398|460072117|FG001|Overall Study|Physician Decision|1|||
127851335|NCT01451398|460072116|FG000|Overall Study|Withdrawal by Subject|10|||
127851336|NCT01451398|460072117|FG001|Overall Study|Withdrawal by Subject|14|||
127851337|NCT01451398|460072116|FG000|Overall Study|Lost to Follow-up|6|||
127851338|NCT01451398|460072117|FG001|Overall Study|Lost to Follow-up|4|||
127851339|NCT01451398|460072116|FG000|Overall Study|Non-compliance with study drug|1|||
127851340|NCT01451398|460072117|FG001|Overall Study|Non-compliance with study drug|3|||
127851341|NCT01451398|460072116|FG000|Overall Study|Non-compliance with protocol|1|||
127851342|NCT01451398|460072117|FG001|Overall Study|Non-compliance with protocol|1|||
127851343|NCT01451398|460072116|FG000|Overall Study|Moved out of country|0|||
127851344|NCT01451398|460072117|FG001|Overall Study|Moved out of country|1|||
127851345|NCT01451398|460072116|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
127851346|NCT01451398|460072117|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
127851347|NCT01451398|460072116|FG000|Overall Study|Lack of Efficacy|0|||
127851348|NCT01451398|460072117|FG001|Overall Study|Lack of Efficacy|1|||
127851349|NCT01000025|460072119|FG000|Overall Study|Adverse Event|43|||
127851350|NCT01000025|460072120|FG001|Overall Study|Adverse Event|2|||
127851351|NCT01000025|460072119|FG000|Overall Study|Withdrawal by Subject|13|||
127851352|NCT01000025|460072120|FG001|Overall Study|Withdrawal by Subject|8|||
127851353|NCT01000025|460072119|FG000|Overall Study|Death|23|||
127851354|NCT01000025|460072120|FG001|Overall Study|Death|13|||
127851355|NCT01000025|460072119|FG000|Overall Study|Lack of Efficacy|363|||
127851356|NCT01000025|460072120|FG001|Overall Study|Lack of Efficacy|208|||
127851357|NCT01000025|460072119|FG000|Overall Study|Intercurrent Illness|26|||
127851358|NCT01000025|460072120|FG001|Overall Study|Intercurrent Illness|7|||
127851359|NCT00422669|460072121|FG000|Overall Study|The study was terminated early.|98|||
127851360|NCT00422669|460072122|FG001|Overall Study|The study was terminated early.|100|||
127851361|NCT00422669|460072123|FG002|Overall Study|The study was terminated early.|7|||
127851362|NCT02738580|460072124|FG000|Overall Study|Adverse Event|1|||
127851363|NCT02738580|460072125|FG001|Overall Study|Adverse Event|0|||
127851364|NCT02738580|460072124|FG000|Overall Study|Lack of Efficacy|3|||
127851365|NCT02738580|460072125|FG001|Overall Study|Lack of Efficacy|2|||
127851366|NCT02738580|460072124|FG000|Overall Study|Withdrawal by Subject|0|||
127851367|NCT02738580|460072125|FG001|Overall Study|Withdrawal by Subject|1|||
127851368|NCT02738580|460072124|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
127851369|NCT02738580|460072125|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
127851370|NCT01250756|460072126|FG000|Infant Series|Withdrawal by Subject|4|||
127851371|NCT01250756|460072127|FG001|Infant Series|Withdrawal by Subject|5|||
127851372|NCT01250756|460072126|FG000|Infant Series|Randomized, Not Vaccinated|2|||
127851373|NCT01250756|460072127|FG001|Infant Series|Randomized, Not Vaccinated|2|||
127851374|NCT01250756|460072126|FG000|Infant Series|Other|22|||
127851375|NCT01250756|460072127|FG001|Infant Series|Other|0|||
127851376|NCT01250756|460072126|FG000|After Infant Series|Adverse Event|5|||
127851377|NCT01250756|460072127|FG001|After Infant Series|Adverse Event|2|||
127851378|NCT01250756|460072126|FG000|After Infant Series|Withdrawal by Subject|4|||
127851379|NCT01250756|460072127|FG001|After Infant Series|Withdrawal by Subject|1|||
127851380|NCT01250756|460072126|FG000|After Infant Series|Other|2|||
127851381|NCT01250756|460072127|FG001|After Infant Series|Other|1|||
127851382|NCT01250756|460072126|FG000|Toddler Dose|Adverse Event|0|||
127851383|NCT01250756|460072127|FG001|Toddler Dose|Adverse Event|1|||
127851384|NCT01250756|460072126|FG000|After Toddler Dose|Adverse Event|0|||
127851385|NCT01250756|460072127|FG001|After Toddler Dose|Adverse Event|1|||
127851386|NCT02142504|460072134|FG000|Overall Study|Protocol Violation|2|||
127851387|NCT02142504|460072135|FG001|Overall Study|Protocol Violation|1|||
127851388|NCT02142504|460072136|FG002|Overall Study|Protocol Violation|2|||
127851389|NCT02142504|460072134|FG000|Overall Study|Adverse Event|2|||
127851390|NCT02142504|460072135|FG001|Overall Study|Adverse Event|3|||
127851391|NCT02142504|460072136|FG002|Overall Study|Adverse Event|4|||
127851392|NCT02142504|460072134|FG000|Overall Study|Lost to Follow-up|12|||
127851393|NCT02142504|460072135|FG001|Overall Study|Lost to Follow-up|19|||
127906416|NCT01864174|460283946|FG001|Double Blind - Compliant Randomized|Other|10|||
127906417|NCT01864174|460283945|FG000|Off Treatment Follow-Up|Other|2|||
127851394|NCT02142504|460072136|FG002|Overall Study|Lost to Follow-up|17|||
127851395|NCT02142504|460072134|FG000|Overall Study|Withdrawal by Subject|7|||
127851396|NCT02142504|460072135|FG001|Overall Study|Withdrawal by Subject|9|||
127851397|NCT02142504|460072136|FG002|Overall Study|Withdrawal by Subject|11|||
127851398|NCT02142504|460072134|FG000|Overall Study|Pregnancy|4|||
127851399|NCT02142504|460072135|FG001|Overall Study|Pregnancy|4|||
127851400|NCT02142504|460072136|FG002|Overall Study|Pregnancy|2|||
127851401|NCT02142504|460072134|FG000|Overall Study|Physician Decision|0|||
127851402|NCT02142504|460072135|FG001|Overall Study|Physician Decision|1|||
127851403|NCT02142504|460072136|FG002|Overall Study|Physician Decision|3|||
127851404|NCT02142504|460072134|FG000|Overall Study|Reason Not Specified|4|||
127851405|NCT02142504|460072135|FG001|Overall Study|Reason Not Specified|5|||
127851406|NCT02142504|460072136|FG002|Overall Study|Reason Not Specified|4|||
127851407|NCT01610206|460072139|FG000|Overall Study|Adverse Event|10|||
127851408|NCT01610206|460072140|FG001|Overall Study|Adverse Event|30|||
127851409|NCT00166517|460072141|FG000|Overall Study|Lost to Follow-up|1|||
127851410|NCT00166517|460072142|FG001|Overall Study|Lost to Follow-up|0|||
127851411|NCT00166517|460072141|FG000|Overall Study|Protocol Violation|4|||
127851412|NCT00166517|460072142|FG001|Overall Study|Protocol Violation|1|||
127851413|NCT00166517|460072141|FG000|Overall Study|Withdrawal by Subject|0|||
127851414|NCT00166517|460072142|FG001|Overall Study|Withdrawal by Subject|1|||
127851415|NCT02186561|460072143|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
127851416|NCT02186561|460072143|FG000|Enrollment|Enrollment Cap Reached|5|||
127851417|NCT02186561|460072143|FG000|Enrollment|Insurance Denial|2|||
127851418|NCT02186561|460072143|FG000|Enrollment|Withdrawal by Subject|2|||
127851419|NCT02186561|460072143|FG000|Enrollment|Investigator Withdrew Consent|1|||
127851420|NCT02186561|460072143|FG000|30-Day Post Index Procedure Visit|Death|1|||
127851421|NCT02186561|460072143|FG000|1- Year Post Index Procedure Visit|Death|1|||
127851422|NCT02186561|460072143|FG000|1- Year Post Index Procedure Visit|Missed|1|||
127851423|NCT04285853|460072144|FG000|Overall Study|Withdrawal by Subject|1|||
127851424|NCT04285853|460072145|FG001|Overall Study|Withdrawal by Subject|0|||
127851425|NCT04285853|460072144|FG000|Overall Study|Lost to Follow-up|9|||
127851426|NCT04285853|460072145|FG001|Overall Study|Lost to Follow-up|5|||
127851427|NCT01814826|460072146|FG000|Overall Study|Other|3|||
127851428|NCT01814826|460072147|FG001|Overall Study|Other|5|||
127851429|NCT01814826|460072148|FG002|Overall Study|Other|0|||
127851430|NCT01814826|460072146|FG000|Overall Study|Death|29|||
127851431|NCT01814826|460072147|FG001|Overall Study|Death|24|||
127851432|NCT01814826|460072148|FG002|Overall Study|Death|3|||
127851433|NCT02917629|460072149|FG000|Overall Study|Withdrawal by Subject|0|||
127851434|NCT02917629|460072150|FG001|Overall Study|Withdrawal by Subject|1|||
127851435|NCT00718523|460072151|FG000|Overall Study|Withdrawal by Subject|5|||
127851436|NCT00718523|460072152|FG001|Overall Study|Withdrawal by Subject|7|||
127851437|NCT00718523|460072151|FG000|Overall Study|Death|13|||
127851438|NCT00718523|460072152|FG001|Overall Study|Death|17|||
127851439|NCT01042938|460072153|FG000|Overall Study|Withdrawal by Subject|1|||
127851440|NCT01042938|460072154|FG001|Overall Study|Withdrawal by Subject|1|||
127851441|NCT01042938|460072153|FG000|Overall Study|Protocol Violation|1|||
127851442|NCT01042938|460072154|FG001|Overall Study|Protocol Violation|1|||
127851443|NCT01042938|460072153|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
127851444|NCT01042938|460072154|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
127851445|NCT03136484|460072155|FG000|Overall Study|Withdrawal by Subject|19|||
127851446|NCT03136484|460072156|FG001|Overall Study|Withdrawal by Subject|14|||
127851447|NCT03136484|460072155|FG000|Overall Study|Lost to Follow-up|7|||
127851448|NCT03136484|460072156|FG001|Overall Study|Lost to Follow-up|8|||
127851449|NCT03136484|460072155|FG000|Overall Study|Death|1|||
127851450|NCT03136484|460072156|FG001|Overall Study|Death|0|||
127851451|NCT03997760|460072161|FG000|Overall Study|Protocol Deviation|0|||
127851452|NCT03997760|460072162|FG001|Overall Study|Protocol Deviation|1|||
127851453|NCT03997760|460072163|FG002|Overall Study|Protocol Deviation|0|||
127851454|NCT03997760|460072164|FG003|Overall Study|Protocol Deviation|0|||
127851455|NCT00856986|460072165|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
127851456|NCT00856986|460072166|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
127851457|NCT00856986|460072167|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
127851458|NCT00856986|460072168|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
127851459|NCT00856986|460072169|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
127851460|NCT00856986|460072165|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
127851461|NCT00856986|460072166|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
127851462|NCT00856986|460072167|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
127851463|NCT00856986|460072168|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
127851464|NCT00856986|460072169|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
127851465|NCT00856986|460072165|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
127851466|NCT00856986|460072166|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
127851467|NCT00856986|460072167|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
127851468|NCT00856986|460072168|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
127851469|NCT00856986|460072169|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
127851470|NCT00856986|460072165|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
127851471|NCT00856986|460072166|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
127851472|NCT00856986|460072167|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
127906418|NCT01864174|460283946|FG001|Off Treatment Follow-Up|Other|0|||
127906419|NCT01864174|460283945|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
127906420|NCT01864174|460283946|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
127906421|NCT01723397|460283950|FG000|Study Period 1|Protocol Violation|0|||
127906422|NCT01723397|460283951|FG001|Study Period 1|Protocol Violation|1|||
127906423|NCT01723397|460283950|FG000|Study Period 2|Protocol Violation|0|||
127906424|NCT01723397|460283951|FG001|Study Period 2|Protocol Violation|1|||
127851473|NCT00856986|460072168|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
127851474|NCT00856986|460072169|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
127851475|NCT00856986|460072165|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
127851476|NCT00856986|460072166|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
127851477|NCT00856986|460072167|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
127851478|NCT00856986|460072168|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
127851479|NCT00856986|460072169|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
127851480|NCT00856986|460072165|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
127851481|NCT00856986|460072166|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
127851482|NCT00856986|460072167|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
127851483|NCT00856986|460072168|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
127851484|NCT00856986|460072169|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
127851485|NCT00856986|460072165|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
127851486|NCT00856986|460072166|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
127851487|NCT00856986|460072167|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
127851488|NCT00856986|460072168|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
127851489|NCT00856986|460072169|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
127851490|NCT00856986|460072165|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
127851491|NCT00856986|460072166|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
127851492|NCT00856986|460072167|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
127851493|NCT00856986|460072168|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
127851494|NCT00856986|460072169|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
127851495|NCT00856986|460072165|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
127851496|NCT00856986|460072166|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
127851497|NCT00856986|460072167|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
127851498|NCT00856986|460072168|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
127851499|NCT00856986|460072169|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
127851500|NCT00856986|460072165|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
127851501|NCT00856986|460072166|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
127851502|NCT00856986|460072167|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
127851503|NCT00856986|460072168|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
127851504|NCT00856986|460072169|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
127851505|NCT00856986|460072165|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
127851506|NCT00856986|460072166|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
127851507|NCT00856986|460072167|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
127851508|NCT00856986|460072168|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
127851509|NCT00856986|460072169|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
127851510|NCT00856986|460072165|FG000|Main Period, Weeks 0-26|Unclassified|7|||
127851511|NCT00856986|460072166|FG001|Main Period, Weeks 0-26|Unclassified|6|||
127851512|NCT00856986|460072167|FG002|Main Period, Weeks 0-26|Unclassified|7|||
127851513|NCT00856986|460072168|FG003|Main Period, Weeks 0-26|Unclassified|0|||
127851514|NCT00856986|460072169|FG004|Main Period, Weeks 0-26|Unclassified|0|||
127851515|NCT00856986|460072165|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
127851516|NCT00856986|460072166|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
127851517|NCT00856986|460072167|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
127851518|NCT00856986|460072168|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
127851519|NCT00856986|460072169|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
127851520|NCT00856986|460072165|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
127851521|NCT00856986|460072166|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
127851522|NCT00856986|460072167|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
127851523|NCT00856986|460072168|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
127851524|NCT00856986|460072169|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
127851525|NCT00856986|460072165|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
127851526|NCT00856986|460072166|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
127851527|NCT00856986|460072167|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
127851528|NCT00856986|460072168|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
127851529|NCT00856986|460072169|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
127851530|NCT00856986|460072165|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
127851531|NCT00856986|460072166|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
127851532|NCT00856986|460072167|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
127851533|NCT00856986|460072168|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
127851534|NCT00856986|460072169|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
127851535|NCT00856986|460072165|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
127851536|NCT00856986|460072166|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
127851537|NCT00856986|460072167|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
127906425|NCT00468286|460283952|FG000|Overall Study|Adverse Event|1|||
127851538|NCT00856986|460072168|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
127851539|NCT00856986|460072169|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
127851540|NCT00856986|460072165|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
127851541|NCT00856986|460072166|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
127851542|NCT00856986|460072167|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
127851543|NCT00856986|460072168|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
127851544|NCT00856986|460072169|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
127851545|NCT05041062|460072170|FG000|Overall Study|Adverse Event|2|||
127851546|NCT01802515|460072176|FG000|Overall Study|Withdrawal by Subject|3|||
127851547|NCT01802515|460072177|FG001|Overall Study|Withdrawal by Subject|0|||
127851548|NCT01802515|460072178|FG002|Overall Study|Withdrawal by Subject|0|||
127851549|NCT01176240|460072179|FG000|Study 306A|Lack of Efficacy|2|||
127851550|NCT01176240|460072180|FG001|Study 306A|Lack of Efficacy|1|||
127851551|NCT01176240|460072179|FG000|Study 306A|Protocol Violation|0|||
127851552|NCT01176240|460072180|FG001|Study 306A|Protocol Violation|1|||
127851553|NCT01176240|460072179|FG000|Study 306A|Withdrawal by Subject|0|||
127851554|NCT01176240|460072180|FG001|Study 306A|Withdrawal by Subject|1|||
127851555|NCT01176240|460072179|FG000|Study 306A|Stop due to diverse problems|1|||
127851556|NCT01176240|460072180|FG001|Study 306A|Stop due to diverse problems|0|||
127851557|NCT01176240|460072179|FG000|Study 306B|Lack of Efficacy|5|||
127851558|NCT01176240|460072180|FG001|Study 306B|Lack of Efficacy|3|||
127851559|NCT01176240|460072179|FG000|Study 306B|Adverse Event|10|||
127851560|NCT01176240|460072180|FG001|Study 306B|Adverse Event|5|||
127851561|NCT01176240|460072179|FG000|Study 306B|Protocol Violation|2|||
127851562|NCT01176240|460072180|FG001|Study 306B|Protocol Violation|3|||
127851563|NCT01176240|460072179|FG000|Study 306B|Withdrawal by Subject|4|||
127851564|NCT01176240|460072180|FG001|Study 306B|Withdrawal by Subject|1|||
127851565|NCT01176240|460072179|FG000|Study 306B|Physician Decision|2|||
127851566|NCT01176240|460072180|FG001|Study 306B|Physician Decision|1|||
127851567|NCT01176240|460072179|FG000|Study 306B|Supine Hypertension|1|||
127851568|NCT01176240|460072180|FG001|Study 306B|Supine Hypertension|2|||
127851569|NCT01176240|460072179|FG000|Study 306B|Lost to Follow-up|0|||
127851570|NCT01176240|460072180|FG001|Study 306B|Lost to Follow-up|1|||
127851571|NCT01176240|460072179|FG000|Study 306B|withdrew prior to dosing|2|||
127851572|NCT01176240|460072180|FG001|Study 306B|withdrew prior to dosing|1|||
127851573|NCT03038672|460074006|FG000|Initial Treatment|Unacceptable chemistry|0|||
127851574|NCT03038672|460074007|FG001|Initial Treatment|Unacceptable chemistry|1|||
127851575|NCT03038672|460074006|FG000|Initial Treatment|Progression prior to treatment|1|||
127851576|NCT03038672|460074007|FG001|Initial Treatment|Progression prior to treatment|0|||
127851577|NCT03038672|460074006|FG000|Initial Treatment|No treatment per protocol|1|||
127851578|NCT03038672|460074007|FG001|Initial Treatment|No treatment per protocol|0|||
127851579|NCT00959894|460074008|FG000|Overall Study|Lost to Follow-up|10|||
127851580|NCT00959894|460074008|FG000|Overall Study|Adverse Event|3|||
127851581|NCT00959894|460074008|FG000|Overall Study|Withdrawal by Subject|1|||
127851582|NCT00959894|460074008|FG000|Overall Study|Need for contraindicated medication|1|||
127851583|NCT00959894|460074008|FG000|Overall Study|Subject moved out of town|1|||
127851584|NCT00653068|460074009|FG000|Overall Study|Death|9|||
127851585|NCT00653068|460074009|FG000|Overall Study|Lack of Efficacy|34|||
127851586|NCT00653068|460074009|FG000|Overall Study|Physician Decision|4|||
127851587|NCT00653068|460074009|FG000|Overall Study|Withdrawal by Subject|1|||
127851588|NCT00653068|460074009|FG000|Overall Study|Ineligible|2|||
127851589|NCT01305941|460074010|FG000|Overall Study|Adverse Event|6|||
127851590|NCT01305941|460074010|FG000|Overall Study|Clinical decline|2|||
127851591|NCT01305941|460074010|FG000|Overall Study|Withdrawal by Subject|1|||
127851592|NCT01305941|460074010|FG000|Overall Study|Death|1|||
127851593|NCT02944513|460074011|FG000|Overall Study|Withdrawal by Subject|4|||
127851594|NCT02944513|460074012|FG001|Overall Study|Withdrawal by Subject|1|||
127851595|NCT00937326|460074016|FG000|Overall Study|Adverse Event|0|||
127851596|NCT00937326|460074017|FG001|Overall Study|Adverse Event|3|||
127851597|NCT00937326|460074018|FG002|Overall Study|Adverse Event|1|||
127851598|NCT00937326|460074019|FG003|Overall Study|Adverse Event|1|||
127851599|NCT00937326|460074020|FG004|Overall Study|Adverse Event|2|||
127851600|NCT00937326|460074016|FG000|Overall Study|Death|0|||
127851601|NCT00937326|460074017|FG001|Overall Study|Death|0|||
127851602|NCT00937326|460074018|FG002|Overall Study|Death|1|||
127851603|NCT00937326|460074019|FG003|Overall Study|Death|0|||
127851604|NCT00937326|460074020|FG004|Overall Study|Death|0|||
127851605|NCT00937326|460074016|FG000|Overall Study|Withdrawal by Subject|3|||
127851606|NCT00937326|460074017|FG001|Overall Study|Withdrawal by Subject|4|||
127851607|NCT00937326|460074018|FG002|Overall Study|Withdrawal by Subject|1|||
127851608|NCT00937326|460074019|FG003|Overall Study|Withdrawal by Subject|4|||
127851609|NCT00937326|460074020|FG004|Overall Study|Withdrawal by Subject|3|||
127851610|NCT00937326|460074016|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
127851611|NCT00937326|460074017|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
127851612|NCT00937326|460074018|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
127851613|NCT00937326|460074019|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
127851614|NCT00937326|460074020|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
127851615|NCT02578992|460074021|FG000|Overall Study|equipment not available or malfunction|3|||
127851616|NCT02578992|460074022|FG001|Overall Study|equipment not available or malfunction|3|||
127851617|NCT00086385|460074025|FG000|Overall Study|Death|2|||
127851618|NCT00086385|460074026|FG001|Overall Study|Death|2|||
127851619|NCT00086385|460074027|FG002|Overall Study|Death|1|||
127851620|NCT00086385|460074028|FG003|Overall Study|Death|1|||
127851621|NCT00880100|460074031|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
127851622|NCT00880100|460074031|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
127851623|NCT00880100|460074031|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
127851624|NCT00731666|460074033|FG000|Overall Study|Adverse Event|2|||
127851625|NCT00731666|460074033|FG000|Overall Study|Lost to Follow-up|8|||
127851626|NCT00731666|460074033|FG000|Overall Study|Withdrawal by Subject|2|||
127851627|NCT02853123|460074034|FG000|Treatment Period 1|Adverse Event|0|||
127851628|NCT02853123|460074035|FG001|Treatment Period 1|Adverse Event|3|||
127851629|NCT02853123|460074034|FG000|Washout Period|Worsening of COPD|0|||
127851630|NCT02853123|460074035|FG001|Washout Period|Worsening of COPD|3|||
127851631|NCT02853123|460074034|FG000|Washout Period|Adverse Event|1|||
127851632|NCT02853123|460074035|FG001|Washout Period|Adverse Event|0|||
127851633|NCT05283499|460074036|FG000|Overall Study|Did not receive intervention|1|||
127851634|NCT05283499|460074037|FG001|Overall Study|Did not receive intervention|2|||
127851635|NCT05516134|460074038|FG000|Overall Study|Lost to Follow-up|1|||
127851636|NCT05516134|460074039|FG001|Overall Study|Lost to Follow-up|0|||
127851637|NCT05516134|460074040|FG002|Overall Study|Lost to Follow-up|0|||
127851638|NCT00254163|460074041|FG000|Overall Study|Adverse Event|29|||
127851639|NCT00254163|460074042|FG001|Overall Study|Adverse Event|26|||
127851640|NCT00254163|460074041|FG000|Overall Study|Patient request/withdrew consent|6|||
127851641|NCT00254163|460074042|FG001|Overall Study|Patient request/withdrew consent|4|||
127851642|NCT00254163|460074041|FG000|Overall Study|Investigator request|1|||
127851643|NCT00254163|460074042|FG001|Overall Study|Investigator request|3|||
127851644|NCT00254163|460074041|FG000|Overall Study|Failed entry|1|||
127851645|NCT00254163|460074042|FG001|Overall Study|Failed entry|3|||
127851646|NCT00254163|460074041|FG000|Overall Study|Progressive disease|0|||
127851647|NCT00254163|460074042|FG001|Overall Study|Progressive disease|1|||
127851648|NCT00254163|460074041|FG000|Overall Study|Death|0|||
127851649|NCT00254163|460074042|FG001|Overall Study|Death|1|||
127851650|NCT00254163|460074041|FG000|Overall Study|Other|8|||
127851651|NCT00254163|460074042|FG001|Overall Study|Other|8|||
127851652|NCT01784211|460074046|FG000|Part A (Days 1-15)|Adverse Event|1|||
127851653|NCT01784211|460074047|FG001|Part A (Days 1-15)|Adverse Event|1|||
127851654|NCT01784211|460074048|FG002|Part A (Days 1-15)|Adverse Event|0|||
127851655|NCT01784211|460074049|FG003|Part A (Days 1-15)|Adverse Event|0|||
127851656|NCT01784211|460074050|FG004|Part A (Days 1-15)|Adverse Event|0|||
127851657|NCT01784211|460074051|FG005|Part A (Days 1-15)|Adverse Event|0|||
127851658|NCT01784211|460074046|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
127851659|NCT01784211|460074047|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
127851660|NCT01784211|460074048|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
127851661|NCT01784211|460074049|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
127851662|NCT01784211|460074050|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
127851663|NCT01784211|460074051|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
127851664|NCT01001572|460074052|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
127851665|NCT01001572|460074053|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
127851666|NCT01001572|460074054|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
127851667|NCT01001572|460074052|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
127851668|NCT01001572|460074053|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
127906426|NCT00468286|460283953|FG001|Overall Study|Adverse Event|6|||
127851669|NCT01001572|460074054|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
127851670|NCT01001572|460074052|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
127851671|NCT01001572|460074053|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
127851672|NCT01001572|460074054|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
127906427|NCT00468286|460283952|FG000|Overall Study|Protocol Violation|2|||
127906428|NCT00468286|460283953|FG001|Overall Study|Protocol Violation|2|||
127906429|NCT00468286|460283952|FG000|Overall Study|Withdrawal by Subject|4|||
127906430|NCT00468286|460283953|FG001|Overall Study|Withdrawal by Subject|3|||
127906431|NCT00468286|460283952|FG000|Overall Study|Physician Decision|0|||
127906432|NCT00468286|460283953|FG001|Overall Study|Physician Decision|1|||
127906433|NCT02196675|460283954|FG000|Overall Study|Withdrawal by Subject|1|||
127906434|NCT02196675|460283955|FG001|Overall Study|Withdrawal by Subject|0|||
127851673|NCT01001572|460074052|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
127851674|NCT01001572|460074053|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
127851675|NCT01001572|460074054|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
127851676|NCT01001572|460074052|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
127851677|NCT01001572|460074053|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
127851678|NCT01001572|460074054|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
127851679|NCT01001572|460074052|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
127851680|NCT01001572|460074053|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
127851681|NCT01001572|460074054|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
127851682|NCT01001572|460074052|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
127851683|NCT01001572|460074053|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
127851684|NCT01001572|460074054|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
127851685|NCT01001572|460074052|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
127851686|NCT01001572|460074053|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
127851687|NCT01001572|460074054|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
127851688|NCT01001572|460074052|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
127851689|NCT01001572|460074053|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
127851690|NCT01001572|460074054|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
127851691|NCT01001572|460074052|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
127851692|NCT01001572|460074053|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
127851693|NCT01001572|460074054|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
127851694|NCT01001572|460074052|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
127851695|NCT01001572|460074053|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
127851696|NCT01001572|460074054|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
127851697|NCT01001572|460074052|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
127851698|NCT01001572|460074053|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
127851699|NCT01001572|460074054|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
127851700|NCT01001572|460074052|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
127851701|NCT01001572|460074053|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
127851702|NCT01001572|460074054|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
127851703|NCT01001572|460074052|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
127851704|NCT01001572|460074053|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
127851705|NCT01001572|460074054|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
127851706|NCT01094808|460074055|FG000|Overall Study|Withdrawal by Subject|1|||
127851707|NCT01094808|460074056|FG001|Overall Study|Withdrawal by Subject|1|||
127851708|NCT01094808|460074057|FG002|Overall Study|Withdrawal by Subject|0|||
127851709|NCT00369278|460074058|FG000|Overall Study|Adverse Event|14|||
127851710|NCT00369278|460074059|FG001|Overall Study|Adverse Event|11|||
127851711|NCT00369278|460074058|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
127851712|NCT00369278|460074059|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
127851713|NCT00369278|460074058|FG000|Overall Study|Protocol Violation|2|||
127851714|NCT00369278|460074059|FG001|Overall Study|Protocol Violation|1|||
127851715|NCT00369278|460074058|FG000|Overall Study|Withdrawal by Subject|2|||
127851716|NCT00369278|460074059|FG001|Overall Study|Withdrawal by Subject|2|||
127851717|NCT00369278|460074058|FG000|Overall Study|Lost to Follow-up|1|||
127851718|NCT00369278|460074059|FG001|Overall Study|Lost to Follow-up|0|||
127851719|NCT00369278|460074058|FG000|Overall Study|Graft loss|1|||
127851720|NCT00369278|460074059|FG001|Overall Study|Graft loss|2|||
127851721|NCT02133001|460074066|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
127851722|NCT02133001|460074067|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
127851723|NCT02133001|460074066|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
127851724|NCT02133001|460074067|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
127851725|NCT02133001|460074066|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
127851726|NCT02133001|460074067|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
127851727|NCT02133001|460074066|FG000|Double Blind (Day 1-25)|Other|2|||
127851728|NCT02133001|460074067|FG001|Double Blind (Day 1-25)|Other|2|||
127851729|NCT02133001|460074066|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
127851730|NCT02133001|460074067|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
127851731|NCT02133001|460074066|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
127906435|NCT02196675|460283956|FG002|Overall Study|Withdrawal by Subject|0|||
127906436|NCT02196675|460283954|FG000|Overall Study|Intra-operative surgical exclusion|1|||
127851732|NCT02133001|460074067|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
127851733|NCT02133001|460074066|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
127851734|NCT02133001|460074067|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
127851735|NCT02133001|460074066|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
127851736|NCT02133001|460074067|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
127851737|NCT01156363|460074068|FG000|Overall Study|Adverse Event|6|||
127851738|NCT01156363|460074068|FG000|Overall Study|Insufficient Therapeutic Response|5|||
127851739|NCT01156363|460074068|FG000|Overall Study|Failure to Return|1|||
127851740|NCT01156363|460074068|FG000|Overall Study|Refused Treatment|4|||
127851741|NCT01156363|460074068|FG000|Overall Study|Other|6|||
127851742|NCT04882072|460074069|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|1|||
127851743|NCT04882072|460074070|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|0|||
127851744|NCT04882072|460074069|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|1|||
127851745|NCT04882072|460074070|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|0|||
127851746|NCT04882072|460074069|FG000|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|0|||
127851747|NCT04882072|460074070|FG001|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|1|||
127851748|NCT02918318|460074071|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
127851749|NCT02918318|460074072|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
127851750|NCT02918318|460074073|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
127851751|NCT02918318|460074074|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
127851752|NCT02918318|460074075|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
127851753|NCT02918318|460074071|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
127851754|NCT02918318|460074072|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
127851755|NCT02918318|460074073|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
127851756|NCT02918318|460074074|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
127851757|NCT02918318|460074075|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
127851758|NCT02918318|460074071|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
127851759|NCT02918318|460074072|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
127851760|NCT02918318|460074073|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
127851761|NCT02918318|460074074|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
127851762|NCT02918318|460074075|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
127851763|NCT02918318|460074071|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
127851764|NCT02918318|460074072|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
127851765|NCT02918318|460074073|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
127851766|NCT02918318|460074074|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
127851767|NCT02918318|460074075|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
127851768|NCT02918318|460074071|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
127851769|NCT02918318|460074072|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
127851770|NCT02918318|460074073|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
127851771|NCT02918318|460074074|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
127851772|NCT02918318|460074075|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
127851773|NCT02918318|460074071|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
127851774|NCT02918318|460074072|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
127851775|NCT02918318|460074073|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
127851776|NCT02918318|460074074|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
127851777|NCT02918318|460074075|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
127851778|NCT02918318|460074071|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
127851779|NCT02918318|460074072|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
127851780|NCT02918318|460074073|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
127851781|NCT02918318|460074074|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
127851782|NCT02918318|460074075|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
127851783|NCT02918318|460074071|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
127851784|NCT02918318|460074072|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
127851785|NCT02918318|460074073|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
127851786|NCT02918318|460074074|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
127851787|NCT02918318|460074075|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
127851788|NCT02918318|460074071|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
127851789|NCT02918318|460074072|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
127851790|NCT02918318|460074073|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
127851791|NCT02918318|460074074|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
127851792|NCT02918318|460074075|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
127851793|NCT02918318|460074071|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
127851794|NCT02918318|460074072|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
127851795|NCT02918318|460074073|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
127851796|NCT02918318|460074074|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
127851797|NCT02918318|460074075|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
127851798|NCT02918318|460074071|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
127851799|NCT02918318|460074072|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
127851800|NCT02918318|460074073|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
127851801|NCT02918318|460074074|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
127851802|NCT02918318|460074075|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
127851803|NCT02918318|460074071|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
127851804|NCT02918318|460074072|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
127851805|NCT02918318|460074073|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
127851806|NCT02918318|460074074|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
127851807|NCT02918318|460074075|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
127851808|NCT00841672|460074081|FG000|Overall Study|Adverse Event|7|||
127851809|NCT00841672|460074082|FG001|Overall Study|Adverse Event|16|||
127851810|NCT00841672|460074081|FG000|Overall Study|Abnormal test procedure result(s)|0|||
127851811|NCT00841672|460074082|FG001|Overall Study|Abnormal test procedure result(s)|1|||
127851812|NCT00841672|460074081|FG000|Overall Study|Subject withdrew consent|2|||
127851813|NCT00841672|460074082|FG001|Overall Study|Subject withdrew consent|4|||
127851814|NCT00841672|460074081|FG000|Overall Study|Lost to Follow-up|1|||
127851815|NCT00841672|460074082|FG001|Overall Study|Lost to Follow-up|1|||
127851816|NCT00841672|460074081|FG000|Overall Study|Administrative problems|9|||
127851817|NCT00841672|460074082|FG001|Overall Study|Administrative problems|9|||
127851818|NCT00841672|460074081|FG000|Overall Study|Misrandomized|1|||
127851819|NCT00841672|460074082|FG001|Overall Study|Misrandomized|0|||
127851820|NCT00841672|460074081|FG000|Overall Study|Protocol Deviation|0|||
127851821|NCT00841672|460074082|FG001|Overall Study|Protocol Deviation|1|||
127851822|NCT00741260|460074087|FG000|Overall Study|Disease Progression|3|||
127851823|NCT00741260|460074088|FG001|Overall Study|Disease Progression|5|||
127851824|NCT00741260|460074089|FG002|Overall Study|Disease Progression|3|||
127851825|NCT00741260|460074090|FG003|Overall Study|Disease Progression|3|||
127851826|NCT00741260|460074091|FG004|Overall Study|Disease Progression|5|||
127851827|NCT00741260|460074092|FG005|Overall Study|Disease Progression|37|||
127851828|NCT00741260|460074093|FG006|Overall Study|Disease Progression|4|||
127851829|NCT00741260|460074087|FG000|Overall Study|Death|0|||
127851830|NCT00741260|460074088|FG001|Overall Study|Death|1|||
127851831|NCT00741260|460074089|FG002|Overall Study|Death|0|||
127851832|NCT00741260|460074090|FG003|Overall Study|Death|1|||
127851833|NCT00741260|460074091|FG004|Overall Study|Death|2|||
127851834|NCT00741260|460074092|FG005|Overall Study|Death|2|||
127851835|NCT00741260|460074093|FG006|Overall Study|Death|1|||
127851836|NCT00741260|460074087|FG000|Overall Study|Withdrawal by Subject|0|||
127851837|NCT00741260|460074088|FG001|Overall Study|Withdrawal by Subject|0|||
127851838|NCT00741260|460074089|FG002|Overall Study|Withdrawal by Subject|0|||
127851839|NCT00741260|460074090|FG003|Overall Study|Withdrawal by Subject|0|||
127851840|NCT00741260|460074091|FG004|Overall Study|Withdrawal by Subject|1|||
127851841|NCT00741260|460074092|FG005|Overall Study|Withdrawal by Subject|3|||
127851842|NCT00741260|460074093|FG006|Overall Study|Withdrawal by Subject|1|||
127851843|NCT00741260|460074087|FG000|Overall Study|Physician Decision|1|||
127851844|NCT00741260|460074088|FG001|Overall Study|Physician Decision|1|||
127851845|NCT00741260|460074089|FG002|Overall Study|Physician Decision|0|||
127851846|NCT00741260|460074090|FG003|Overall Study|Physician Decision|0|||
127851847|NCT00741260|460074091|FG004|Overall Study|Physician Decision|0|||
127851848|NCT00741260|460074092|FG005|Overall Study|Physician Decision|0|||
127851849|NCT00741260|460074093|FG006|Overall Study|Physician Decision|0|||
127851850|NCT00741260|460074087|FG000|Overall Study|Other|2|||
127851851|NCT00741260|460074088|FG001|Overall Study|Other|1|||
127851852|NCT00741260|460074089|FG002|Overall Study|Other|1|||
127851853|NCT00741260|460074090|FG003|Overall Study|Other|2|||
127851854|NCT00741260|460074091|FG004|Overall Study|Other|1|||
127851855|NCT00741260|460074092|FG005|Overall Study|Other|3|||
127851856|NCT00741260|460074093|FG006|Overall Study|Other|1|||
127851857|NCT02120352|460074094|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
127851858|NCT02120352|460074095|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
127851859|NCT02120352|460074096|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
127851860|NCT02120352|460074097|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
127851861|NCT02120352|460074098|FG004|Induction Period (20 Weeks)|Adverse Event|0|||
127851862|NCT02120352|460074099|FG005|Induction Period (20 Weeks)|Adverse Event|0|||
127851863|NCT02120352|460074100|FG006|Induction Period (20 Weeks)|Adverse Event|0|||
127851864|NCT02120352|460074094|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
127851865|NCT02120352|460074095|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
127851866|NCT02120352|460074096|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
127851867|NCT02120352|460074097|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
127851868|NCT02120352|460074098|FG004|Induction Period (20 Weeks)|Lack of Efficacy|0|||
127851869|NCT02120352|460074099|FG005|Induction Period (20 Weeks)|Lack of Efficacy|0|||
127851870|NCT02120352|460074100|FG006|Induction Period (20 Weeks)|Lack of Efficacy|0|||
127851871|NCT02120352|460074094|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
127851872|NCT02120352|460074095|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
127851873|NCT02120352|460074096|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
127906437|NCT02196675|460283955|FG001|Overall Study|Intra-operative surgical exclusion|1|||
127906438|NCT02196675|460283956|FG002|Overall Study|Intra-operative surgical exclusion|0|||
127906439|NCT02196675|460283954|FG000|Overall Study|Protocol Violation|0|||
127906440|NCT02196675|460283955|FG001|Overall Study|Protocol Violation|1|||
127906441|NCT02196675|460283956|FG002|Overall Study|Protocol Violation|0|||
127906442|NCT02196675|460283954|FG000|Overall Study|Death|0|||
127906443|NCT02196675|460283955|FG001|Overall Study|Death|0|||
127906444|NCT02196675|460283956|FG002|Overall Study|Death|1|||
127851874|NCT02120352|460074097|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
127851875|NCT02120352|460074098|FG004|Induction Period (20 Weeks)|Protocol Violation|0|||
127851876|NCT02120352|460074099|FG005|Induction Period (20 Weeks)|Protocol Violation|0|||
127851877|NCT02120352|460074100|FG006|Induction Period (20 Weeks)|Protocol Violation|0|||
127851878|NCT02120352|460074094|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
127851879|NCT02120352|460074095|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
127851880|NCT02120352|460074096|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
127851881|NCT02120352|460074097|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
127851882|NCT02120352|460074098|FG004|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
127851883|NCT02120352|460074099|FG005|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
127851884|NCT02120352|460074100|FG006|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
127851885|NCT02120352|460074094|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
127851886|NCT02120352|460074095|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
127851887|NCT02120352|460074096|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
127851888|NCT02120352|460074097|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
127851889|NCT02120352|460074098|FG004|Induction Period (20 Weeks)|Lost to Follow-up|0|||
127851890|NCT02120352|460074099|FG005|Induction Period (20 Weeks)|Lost to Follow-up|0|||
127851891|NCT02120352|460074100|FG006|Induction Period (20 Weeks)|Lost to Follow-up|0|||
127851892|NCT02120352|460074094|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
127851893|NCT02120352|460074095|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
127851894|NCT02120352|460074096|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
127851895|NCT02120352|460074097|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
127851896|NCT02120352|460074098|FG004|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
127851897|NCT02120352|460074099|FG005|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
127851898|NCT02120352|460074100|FG006|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
127851899|NCT02120352|460074094|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
127851900|NCT02120352|460074095|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
127851901|NCT02120352|460074096|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
127851902|NCT02120352|460074097|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
127851903|NCT02120352|460074098|FG004|Induction Period (20 Weeks)|Physician Decision|0|||
127851904|NCT02120352|460074099|FG005|Induction Period (20 Weeks)|Physician Decision|0|||
127851905|NCT02120352|460074100|FG006|Induction Period (20 Weeks)|Physician Decision|0|||
127851906|NCT02120352|460074094|FG000|Maintenance Period (Up to Week 96)|Adverse Event|0|||
127851907|NCT02120352|460074095|FG001|Maintenance Period (Up to Week 96)|Adverse Event|1|||
127851908|NCT02120352|460074096|FG002|Maintenance Period (Up to Week 96)|Adverse Event|8|||
127851909|NCT02120352|460074097|FG003|Maintenance Period (Up to Week 96)|Adverse Event|1|||
127851910|NCT02120352|460074098|FG004|Maintenance Period (Up to Week 96)|Adverse Event|0|||
127851911|NCT02120352|460074099|FG005|Maintenance Period (Up to Week 96)|Adverse Event|0|||
127851912|NCT02120352|460074100|FG006|Maintenance Period (Up to Week 96)|Adverse Event|0|||
127851913|NCT02120352|460074094|FG000|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
127851914|NCT02120352|460074095|FG001|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
127851915|NCT02120352|460074096|FG002|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
127851916|NCT02120352|460074097|FG003|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
127851917|NCT02120352|460074098|FG004|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
127851918|NCT02120352|460074099|FG005|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
127851919|NCT02120352|460074100|FG006|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
127851920|NCT02120352|460074094|FG000|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
127851921|NCT02120352|460074095|FG001|Maintenance Period (Up to Week 96)|Protocol Violation|1|||
127851922|NCT02120352|460074096|FG002|Maintenance Period (Up to Week 96)|Protocol Violation|2|||
127851923|NCT02120352|460074097|FG003|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
127851924|NCT02120352|460074098|FG004|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
127851925|NCT02120352|460074099|FG005|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
127851926|NCT02120352|460074100|FG006|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
127851927|NCT02120352|460074094|FG000|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
127851928|NCT02120352|460074095|FG001|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
127851929|NCT02120352|460074096|FG002|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
127851930|NCT02120352|460074097|FG003|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
127906445|NCT02158663|460283957|FG000|Overall Study|Withdrawal by Subject|5|||
127906446|NCT02158663|460283958|FG001|Overall Study|Withdrawal by Subject|4|||
127906447|NCT00537979|460283959|FG000|Overall Study|Adverse Event|2|||
127906448|NCT00537979|460283960|FG001|Overall Study|Adverse Event|2|||
127906449|NCT00537979|460283959|FG000|Overall Study|Withdrawal by Subject|1|||
127906450|NCT00537979|460283960|FG001|Overall Study|Withdrawal by Subject|4|||
127906451|NCT00537979|460283959|FG000|Overall Study|Lost to Follow-up|1|||
127906452|NCT00537979|460283960|FG001|Overall Study|Lost to Follow-up|4|||
127906453|NCT00537979|460283959|FG000|Overall Study|Lack of Efficacy|0|||
127906454|NCT00537979|460283960|FG001|Overall Study|Lack of Efficacy|1|||
127906455|NCT00537979|460283959|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
127906456|NCT00537979|460283960|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
127906457|NCT00537979|460283959|FG000|Overall Study|Death|0|||
127906458|NCT00537979|460283960|FG001|Overall Study|Death|3|||
127906459|NCT00537979|460283959|FG000|Overall Study|Kidney transplant|0|||
127906460|NCT00537979|460283960|FG001|Overall Study|Kidney transplant|3|||
127906461|NCT00537979|460283959|FG000|Overall Study|Heart failure|0|||
127906462|NCT00537979|460283960|FG001|Overall Study|Heart failure|1|||
127906463|NCT02009163|460283961|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
127906464|NCT02009163|460283962|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
127906465|NCT02009163|460283963|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
127906466|NCT02009163|460283961|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
127906467|NCT02009163|460283962|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
127906468|NCT02009163|460283963|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
127906469|NCT02009163|460283961|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
127906470|NCT02009163|460283962|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
127906471|NCT02009163|460283963|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
127906472|NCT02009163|460283961|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
127906473|NCT02009163|460283962|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
127906474|NCT02009163|460283963|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
127906475|NCT02009163|460283961|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
127906476|NCT02009163|460283962|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
127906477|NCT02009163|460283963|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
127906478|NCT02009163|460283961|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
127906479|NCT02009163|460283962|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
127906480|NCT02009163|460283963|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
127906481|NCT02009163|460283961|FG000|Open-label Period (Non-randomized)|Other|13|||
127906482|NCT02009163|460283962|FG001|Open-label Period (Non-randomized)|Other|0|||
127906483|NCT02009163|460283963|FG002|Open-label Period (Non-randomized)|Other|0|||
127906484|NCT02009163|460283961|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
127906485|NCT02009163|460283962|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
127906486|NCT02009163|460283963|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
127906487|NCT02009163|460283961|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
127906488|NCT02009163|460283962|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
127906489|NCT02009163|460283963|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
127906490|NCT02009163|460283961|FG000|Randomized-withdrawal Period|Adverse Event|0|||
127906491|NCT02009163|460283962|FG001|Randomized-withdrawal Period|Adverse Event|0|||
127906492|NCT02009163|460283963|FG002|Randomized-withdrawal Period|Adverse Event|6|||
127906493|NCT02009163|460283961|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
127906494|NCT02009163|460283962|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
127906495|NCT02009163|460283963|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
127906496|NCT02009163|460283961|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
127906497|NCT02009163|460283962|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
127906498|NCT02009163|460283963|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
127906499|NCT02009163|460283961|FG000|Randomized-withdrawal Period|Pregnancy|0|||
127906500|NCT02009163|460283962|FG001|Randomized-withdrawal Period|Pregnancy|0|||
127906501|NCT02009163|460283963|FG002|Randomized-withdrawal Period|Pregnancy|2|||
127906502|NCT02009163|460283961|FG000|Randomized-withdrawal Period|Other|0|||
127906503|NCT02009163|460283962|FG001|Randomized-withdrawal Period|Other|9|||
127906504|NCT02009163|460283963|FG002|Randomized-withdrawal Period|Other|5|||
127906505|NCT02089997|460283970|FG000|Overall Study|Case report forms uncollected|99|||
127906506|NCT02089997|460283970|FG000|Overall Study|Protocol Violation|147|||
127906507|NCT02441309|460283971|FG000|Overall Study|Disease progression|2|||
127906508|NCT02441309|460283972|FG001|Overall Study|Disease progression|1|||
127906509|NCT02441309|460283973|FG002|Overall Study|Disease progression|2|||
127906510|NCT02441309|460283971|FG000|Overall Study|Adverse Event|0|||
127906511|NCT02441309|460283972|FG001|Overall Study|Adverse Event|1|||
127906512|NCT02441309|460283973|FG002|Overall Study|Adverse Event|0|||
127906513|NCT02441309|460283971|FG000|Overall Study|Withdrawal by Subject|1|||
127906514|NCT02441309|460283972|FG001|Overall Study|Withdrawal by Subject|0|||
127906515|NCT02441309|460283973|FG002|Overall Study|Withdrawal by Subject|1|||
127906516|NCT02335658|460283978|FG000|Overall Study|Adverse Event|18|||
127906517|NCT02335658|460283979|FG001|Overall Study|Adverse Event|12|||
127906518|NCT02335658|460283978|FG000|Overall Study|Lack of Efficacy|4|||
127906519|NCT02335658|460283979|FG001|Overall Study|Lack of Efficacy|5|||
127906520|NCT02335658|460283978|FG000|Overall Study|Pregnancy|1|||
127906521|NCT02335658|460283979|FG001|Overall Study|Pregnancy|0|||
127906522|NCT02335658|460283978|FG000|Overall Study|Withdrawal by Subject|13|||
127906523|NCT02335658|460283979|FG001|Overall Study|Withdrawal by Subject|21|||
127906524|NCT02335658|460283978|FG000|Overall Study|non-compliance|2|||
127906525|NCT02335658|460283979|FG001|Overall Study|non-compliance|3|||
127906526|NCT02335658|460283978|FG000|Overall Study|other reason|2|||
127906527|NCT02335658|460283979|FG001|Overall Study|other reason|3|||
127906528|NCT02305758|460283980|FG000|Overall Study|Death|27|||
127906529|NCT02305758|460283981|FG001|Overall Study|Death|27|||
127906530|NCT02305758|460283980|FG000|Overall Study|Withdrew consent|9|||
127906531|NCT02305758|460283981|FG001|Overall Study|Withdrew consent|2|||
127906532|NCT02305758|460283980|FG000|Overall Study|Lost to Follow-up|6|||
127906533|NCT02305758|460283981|FG001|Overall Study|Lost to Follow-up|1|||
127906534|NCT02305758|460283980|FG000|Overall Study|Study Terminated by Sponsor|21|||
127906535|NCT02305758|460283981|FG001|Overall Study|Study Terminated by Sponsor|34|||
127906536|NCT02305758|460283980|FG000|Overall Study|Other, not specified|2|||
127906537|NCT02305758|460283981|FG001|Overall Study|Other, not specified|1|||
127906538|NCT02032888|460283982|FG000|Treatment Period|Poor compliance/noncompliance|1|||
127906539|NCT02032888|460283983|FG001|Treatment Period|Poor compliance/noncompliance|1|||
127906540|NCT02032888|460283984|FG002|Treatment Period|Poor compliance/noncompliance|0|||
127906541|NCT02032888|460283982|FG000|Treatment Period|Other|1|||
127906542|NCT02032888|460283983|FG001|Treatment Period|Other|1|||
127906543|NCT02032888|460283984|FG002|Treatment Period|Other|0|||
127906544|NCT02032888|460283982|FG000|Follow-up Period|Lost to Follow-up|1|||
127906545|NCT02032888|460283983|FG001|Follow-up Period|Lost to Follow-up|1|||
127906546|NCT02032888|460283984|FG002|Follow-up Period|Lost to Follow-up|0|||
127906547|NCT02032888|460283982|FG000|Follow-up Period|Death|1|||
127906548|NCT02032888|460283983|FG001|Follow-up Period|Death|1|||
127906549|NCT02032888|460283984|FG002|Follow-up Period|Death|0|||
127906550|NCT02032888|460283982|FG000|Follow-up Period|Other|1|||
127906551|NCT02032888|460283983|FG001|Follow-up Period|Other|0|||
127906552|NCT02032888|460283984|FG002|Follow-up Period|Other|0|||
127906553|NCT03616106|460283987|FG000|Overall Study|Removed by PI|6|||
127906554|NCT03616106|460283988|FG001|Overall Study|Removed by PI|0|||
127906555|NCT03616106|460283987|FG000|Overall Study|Withdrawal by Subject|1|||
127906556|NCT03616106|460283988|FG001|Overall Study|Withdrawal by Subject|1|||
127906557|NCT03616106|460283987|FG000|Overall Study|Lost to Follow-up|7|||
127906558|NCT03616106|460283988|FG001|Overall Study|Lost to Follow-up|0|||
127906559|NCT03206177|460283990|FG000|Overall Study|Withdrawal by Subject|1|||
127906560|NCT02445339|460283991|FG000|Overall Study|Physician Decision|1|||
127906561|NCT02445339|460283992|FG001|Overall Study|Physician Decision|0|||
127906562|NCT02445339|460283991|FG000|Overall Study|Lost to Follow-up|11|||
127906563|NCT02445339|460283992|FG001|Overall Study|Lost to Follow-up|15|||
127906564|NCT00939003|460283994|FG000|Double-blind Treatment Period|Adverse Event|1|||
127906565|NCT00939003|460283995|FG001|Double-blind Treatment Period|Adverse Event|1|||
127906566|NCT00939003|460283994|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
127906567|NCT00939003|460283995|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
127906568|NCT00939003|460283994|FG000|Double-blind Treatment Period|Pregnancy|0|||
127906569|NCT00939003|460283995|FG001|Double-blind Treatment Period|Pregnancy|1|||
127906570|NCT00939003|460283994|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
127906571|NCT00939003|460283995|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
127906572|NCT00939003|460283994|FG000|Open-label Treatment Period|Adverse Event|4|||
127906573|NCT00939003|460283995|FG001|Open-label Treatment Period|Adverse Event|8|||
127906574|NCT00939003|460283994|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
127906575|NCT00939003|460283995|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
127906576|NCT00939003|460283994|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
127906577|NCT00939003|460283995|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
127906578|NCT00939003|460283994|FG000|Open-label Treatment Period|Pregnancy|1|||
127906579|NCT00939003|460283995|FG001|Open-label Treatment Period|Pregnancy|1|||
127906580|NCT00939003|460283994|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
127906581|NCT00939003|460283995|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
127906582|NCT00939003|460283994|FG000|Open-label Treatment Period|Site Closure|3|||
127906583|NCT00939003|460283995|FG001|Open-label Treatment Period|Site Closure|4|||
127906584|NCT00727961|460283996|FG000|Overall Study|Lost to Follow-up|1|||
127906585|NCT00727961|460283996|FG000|Overall Study|Adverse Event|4|||
127906586|NCT00727961|460283996|FG000|Overall Study|Patient's refusal|2|||
127906587|NCT00727961|460283996|FG000|Overall Study|Progression|30|||
127906588|NCT02131129|460283997|FG000|Overall Study|Withdrawal by Subject|1|||
127906589|NCT02131129|460283998|FG001|Overall Study|Withdrawal by Subject|0|||
127906590|NCT02865122|460283999|FG000|Overall Study|Adverse Event|1|||
127906591|NCT02865122|460284000|FG001|Overall Study|Adverse Event|0|||
127906592|NCT02865122|460284001|FG002|Overall Study|Adverse Event|0|||
127906593|NCT03880266|460284002|FG000|Overall Study|Withdrawal by Subject|0|||
127906594|NCT03880266|460284003|FG001|Overall Study|Withdrawal by Subject|1|||
127906595|NCT03880266|460284004|FG002|Overall Study|Withdrawal by Subject|1|||
127906596|NCT03880266|460284005|FG003|Overall Study|Withdrawal by Subject|0|||
127906597|NCT03880266|460284006|FG004|Overall Study|Withdrawal by Subject|0|||
127906598|NCT03880266|460284007|FG005|Overall Study|Withdrawal by Subject|0|||
127906599|NCT03880266|460284008|FG006|Overall Study|Withdrawal by Subject|0|||
127906600|NCT03880266|460284009|FG007|Overall Study|Withdrawal by Subject|0|||
127906601|NCT03161405|460284010|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
127906602|NCT00837486|460284011|FG000|Blinded-treatment Phase|Physician Decision|1|||
127906603|NCT00837486|460284012|FG001|Blinded-treatment Phase|Physician Decision|0|||
127906604|NCT00837486|460284011|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
127906605|NCT00837486|460284012|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
127906606|NCT00837486|460284011|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
127906607|NCT00837486|460284012|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
127906608|NCT00837486|460284011|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
127906609|NCT00837486|460284012|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
127906610|NCT03235739|460285737|FG000|Overall Study|Withdrawal by Subject|2|||
127906611|NCT03235739|460285738|FG001|Overall Study|Withdrawal by Subject|2|||
127906612|NCT03235739|460285737|FG000|Overall Study|Physician Decision|0|||
127906613|NCT03235739|460285738|FG001|Overall Study|Physician Decision|1|||
127906614|NCT02847650|460285739|FG000|Overall Study|Adverse Event|2|||
127906615|NCT02847650|460285740|FG001|Overall Study|Adverse Event|4|||
127906616|NCT02847650|460285739|FG000|Overall Study|Lost to Follow-up|1|||
127906617|NCT02847650|460285740|FG001|Overall Study|Lost to Follow-up|0|||
127906618|NCT02847650|460285739|FG000|Overall Study|Protocol Violation|0|||
127906619|NCT02847650|460285740|FG001|Overall Study|Protocol Violation|1|||
127906620|NCT02847650|460285739|FG000|Overall Study|Withdrawal by Subject|1|||
127906621|NCT02847650|460285740|FG001|Overall Study|Withdrawal by Subject|1|||
127906622|NCT03818581|460285743|FG000|Overall Study|Adverse Event|1|||
127906623|NCT03818581|460285744|FG001|Overall Study|Adverse Event|0|||
127906624|NCT03818581|460285745|FG002|Overall Study|Adverse Event|0|||
127906625|NCT03818581|460285746|FG003|Overall Study|Adverse Event|0|||
127906626|NCT03818581|460285747|FG004|Overall Study|Adverse Event|0|||
127906627|NCT03818581|460285743|FG000|Overall Study|Covid-19|2|||
127906628|NCT03818581|460285744|FG001|Overall Study|Covid-19|0|||
127906629|NCT03818581|460285745|FG002|Overall Study|Covid-19|0|||
127906630|NCT03818581|460285746|FG003|Overall Study|Covid-19|0|||
127906631|NCT03818581|460285747|FG004|Overall Study|Covid-19|1|||
127906632|NCT03818581|460285743|FG000|Overall Study|Withdrawal by Subject|0|||
127906633|NCT03818581|460285744|FG001|Overall Study|Withdrawal by Subject|0|||
127906634|NCT03818581|460285745|FG002|Overall Study|Withdrawal by Subject|0|||
127906635|NCT03818581|460285746|FG003|Overall Study|Withdrawal by Subject|0|||
127906636|NCT03818581|460285747|FG004|Overall Study|Withdrawal by Subject|1|||
127906637|NCT03818581|460285743|FG000|Overall Study|No longer met study criteria|0|||
127906638|NCT03818581|460285744|FG001|Overall Study|No longer met study criteria|0|||
127906639|NCT03818581|460285745|FG002|Overall Study|No longer met study criteria|0|||
127906640|NCT03818581|460285746|FG003|Overall Study|No longer met study criteria|0|||
127906641|NCT03818581|460285747|FG004|Overall Study|No longer met study criteria|1|||
127906642|NCT00834249|460285750|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
127906643|NCT00834249|460285751|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
127906644|NCT00834249|460285750|FG000|Second Intervention|Adverse Event|1|||
127906645|NCT00834249|460285751|FG001|Second Intervention|Adverse Event|0|||
127906646|NCT01015703|460285754|FG000|Overall Study|Withdrawal by Subject|0|||
127906647|NCT01015703|460285755|FG001|Overall Study|Withdrawal by Subject|1|||
127906648|NCT01015703|460285756|FG002|Overall Study|Withdrawal by Subject|0|||
127906649|NCT01015703|460285757|FG003|Overall Study|Withdrawal by Subject|0|||
127906650|NCT01015703|460285758|FG004|Overall Study|Withdrawal by Subject|0|||
127906651|NCT01015703|460285754|FG000|Overall Study|Adverse Event|1|||
127906652|NCT01015703|460285755|FG001|Overall Study|Adverse Event|0|||
127906653|NCT01015703|460285756|FG002|Overall Study|Adverse Event|0|||
127906654|NCT01015703|460285757|FG003|Overall Study|Adverse Event|0|||
127906655|NCT01015703|460285758|FG004|Overall Study|Adverse Event|0|||
127906656|NCT01015703|460285754|FG000|Overall Study|Protocol Violation|1|||
127906657|NCT01015703|460285755|FG001|Overall Study|Protocol Violation|0|||
127906658|NCT01015703|460285756|FG002|Overall Study|Protocol Violation|0|||
127906659|NCT01015703|460285757|FG003|Overall Study|Protocol Violation|0|||
127906660|NCT01015703|460285758|FG004|Overall Study|Protocol Violation|0|||
127906661|NCT02718326|460285759|FG000|Overall Study|Adverse Event|4|||
127906662|NCT02718326|460285760|FG001|Overall Study|Adverse Event|9|||
127906663|NCT02718326|460285761|FG002|Overall Study|Adverse Event|0|||
127906664|NCT02718326|460285759|FG000|Overall Study|Death|8|||
127906665|NCT02718326|460285760|FG001|Overall Study|Death|1|||
127906666|NCT02718326|460285761|FG002|Overall Study|Death|2|||
127906667|NCT02718326|460285759|FG000|Overall Study|Withdrawal by Subject|4|||
127906668|NCT02718326|460285760|FG001|Overall Study|Withdrawal by Subject|9|||
127906669|NCT02718326|460285761|FG002|Overall Study|Withdrawal by Subject|6|||
127906670|NCT02718326|460285759|FG000|Overall Study|Lost to Follow-up|18|||
127906671|NCT02718326|460285760|FG001|Overall Study|Lost to Follow-up|5|||
127906672|NCT02718326|460285761|FG002|Overall Study|Lost to Follow-up|14|||
127906673|NCT02718326|460285759|FG000|Overall Study|Protocol Deviation|1|||
127851931|NCT02120352|460074098|FG004|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
127851932|NCT02120352|460074099|FG005|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
127851933|NCT02120352|460074100|FG006|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
127851934|NCT02120352|460074094|FG000|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
127851935|NCT02120352|460074095|FG001|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
127851936|NCT02120352|460074096|FG002|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
127851937|NCT02120352|460074097|FG003|Maintenance Period (Up to Week 96)|Lost to Follow-up|1|||
127851938|NCT02120352|460074098|FG004|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
127851939|NCT02120352|460074099|FG005|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
127851940|NCT02120352|460074100|FG006|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
127851941|NCT02120352|460074094|FG000|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
127851942|NCT02120352|460074095|FG001|Maintenance Period (Up to Week 96)|Withdrawal by Subject|1|||
127851943|NCT02120352|460074096|FG002|Maintenance Period (Up to Week 96)|Withdrawal by Subject|3|||
127851944|NCT02120352|460074097|FG003|Maintenance Period (Up to Week 96)|Withdrawal by Subject|5|||
127851945|NCT02120352|460074098|FG004|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
127851946|NCT02120352|460074099|FG005|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
127851947|NCT02120352|460074100|FG006|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
127851948|NCT02120352|460074094|FG000|Maintenance Period (Up to Week 96)|Physician Decision|0|||
127851949|NCT02120352|460074095|FG001|Maintenance Period (Up to Week 96)|Physician Decision|1|||
127851950|NCT02120352|460074096|FG002|Maintenance Period (Up to Week 96)|Physician Decision|0|||
127851951|NCT02120352|460074097|FG003|Maintenance Period (Up to Week 96)|Physician Decision|0|||
127851952|NCT02120352|460074098|FG004|Maintenance Period (Up to Week 96)|Physician Decision|0|||
127851953|NCT02120352|460074099|FG005|Maintenance Period (Up to Week 96)|Physician Decision|0|||
127851954|NCT02120352|460074100|FG006|Maintenance Period (Up to Week 96)|Physician Decision|0|||
127851955|NCT02120352|460074094|FG000|Extension Period (Week 97 to Study End)|Adverse Event|0|||
127851956|NCT02120352|460074095|FG001|Extension Period (Week 97 to Study End)|Adverse Event|3|||
127851957|NCT02120352|460074096|FG002|Extension Period (Week 97 to Study End)|Adverse Event|11|||
127851958|NCT02120352|460074097|FG003|Extension Period (Week 97 to Study End)|Adverse Event|0|||
127851959|NCT02120352|460074098|FG004|Extension Period (Week 97 to Study End)|Adverse Event|2|||
127851960|NCT02120352|460074099|FG005|Extension Period (Week 97 to Study End)|Adverse Event|1|||
127851961|NCT02120352|460074100|FG006|Extension Period (Week 97 to Study End)|Adverse Event|0|||
127851962|NCT02120352|460074094|FG000|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
127851963|NCT02120352|460074095|FG001|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
127851964|NCT02120352|460074096|FG002|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
127851965|NCT02120352|460074097|FG003|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
127851966|NCT02120352|460074098|FG004|Extension Period (Week 97 to Study End)|Lack of Efficacy|1|||
127851967|NCT02120352|460074099|FG005|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
127851968|NCT02120352|460074100|FG006|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
127851969|NCT02120352|460074094|FG000|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
127851970|NCT02120352|460074095|FG001|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
127851971|NCT02120352|460074096|FG002|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
127851972|NCT02120352|460074097|FG003|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
127851973|NCT02120352|460074098|FG004|Extension Period (Week 97 to Study End)|Protocol Violation|2|||
127851974|NCT02120352|460074099|FG005|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
127851975|NCT02120352|460074100|FG006|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
127851976|NCT02120352|460074094|FG000|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
127851977|NCT02120352|460074095|FG001|Extension Period (Week 97 to Study End)|Withdrawal by Subject|7|||
127851978|NCT02120352|460074096|FG002|Extension Period (Week 97 to Study End)|Withdrawal by Subject|9|||
127851979|NCT02120352|460074097|FG003|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
127851980|NCT02120352|460074098|FG004|Extension Period (Week 97 to Study End)|Withdrawal by Subject|2|||
127851981|NCT02120352|460074099|FG005|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
127851982|NCT02120352|460074100|FG006|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
127851983|NCT02120352|460074094|FG000|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
127851984|NCT02120352|460074095|FG001|Extension Period (Week 97 to Study End)|Lost to Follow-up|2|||
127851985|NCT02120352|460074096|FG002|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
127851986|NCT02120352|460074097|FG003|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
127851987|NCT02120352|460074098|FG004|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
127851988|NCT02120352|460074099|FG005|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
127851989|NCT02120352|460074100|FG006|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
127851990|NCT02120352|460074094|FG000|Extension Period (Week 97 to Study End)|Physician Decision|0|||
127851991|NCT02120352|460074095|FG001|Extension Period (Week 97 to Study End)|Physician Decision|2|||
127851992|NCT02120352|460074096|FG002|Extension Period (Week 97 to Study End)|Physician Decision|2|||
127851993|NCT02120352|460074097|FG003|Extension Period (Week 97 to Study End)|Physician Decision|0|||
127851994|NCT02120352|460074098|FG004|Extension Period (Week 97 to Study End)|Physician Decision|0|||
127906674|NCT02718326|460285760|FG001|Overall Study|Protocol Deviation|0|||
127906675|NCT02718326|460285761|FG002|Overall Study|Protocol Deviation|0|||
127906676|NCT02718326|460285759|FG000|Overall Study|Pregnancy|1|||
127906677|NCT02718326|460285760|FG001|Overall Study|Pregnancy|0|||
127906678|NCT02718326|460285761|FG002|Overall Study|Pregnancy|0|||
127906679|NCT03122535|460285762|FG000|Overall Study|Lost to Follow-up|68|||
127906680|NCT03122535|460285763|FG001|Overall Study|Lost to Follow-up|68|||
127906681|NCT03122535|460285762|FG000|Overall Study|Physician Decision|3|||
127906682|NCT03122535|460285763|FG001|Overall Study|Physician Decision|3|||
127906683|NCT03122535|460285762|FG000|Overall Study|Withdrawal by Subject|2|||
127906684|NCT03122535|460285763|FG001|Overall Study|Withdrawal by Subject|2|||
127906685|NCT01558635|460285767|FG000|Overall Study|Death|1|||
127906686|NCT01558635|460285767|FG000|Overall Study|Withdrawal by Subject|2|||
127906687|NCT01558635|460285767|FG000|Overall Study|Physician Decision|1|||
127906688|NCT01558635|460285767|FG000|Overall Study|Subject received other treatment|1|||
127906689|NCT01558635|460285767|FG000|Overall Study|Reveal XT was explanted|1|||
127906690|NCT00834418|460285770|FG000|Overall Study|Adverse Event|0|||
127906691|NCT00834418|460285771|FG001|Overall Study|Adverse Event|2|||
127906692|NCT01200810|460285774|FG000|Overall Study|Physician Decision|1|||
127906693|NCT01200810|460285775|FG001|Overall Study|Physician Decision|0|||
127906694|NCT01200810|460285774|FG000|Overall Study|Withdrawal by Subject|1|||
127906695|NCT01200810|460285775|FG001|Overall Study|Withdrawal by Subject|2|||
127906696|NCT01200810|460285774|FG000|Overall Study|Sponsor stopped making study drug|3|||
127906697|NCT01200810|460285775|FG001|Overall Study|Sponsor stopped making study drug|3|||
127906698|NCT00960297|460285777|FG000|Overall Study|Physician Decision|1|||
127906699|NCT00960297|460285777|FG000|Overall Study|Venous port infection|1|||
127906700|NCT00960297|460285777|FG000|Overall Study|Disease progression|1|||
127906701|NCT03965091|460285785|FG000|Overall Study|Adverse Event|0|||
127906702|NCT03965091|460285786|FG001|Overall Study|Adverse Event|2|||
127906703|NCT03965091|460285787|FG002|Overall Study|Adverse Event|3|||
127906704|NCT03965091|460285785|FG000|Overall Study|Withdrawal by Subject|11|||
127906705|NCT03965091|460285786|FG001|Overall Study|Withdrawal by Subject|3|||
127906706|NCT03965091|460285787|FG002|Overall Study|Withdrawal by Subject|5|||
127906707|NCT03965091|460285785|FG000|Overall Study|Non-compliance with study drug|0|||
127906708|NCT03965091|460285786|FG001|Overall Study|Non-compliance with study drug|0|||
127906709|NCT03965091|460285787|FG002|Overall Study|Non-compliance with study drug|1|||
127906710|NCT03965091|460285785|FG000|Overall Study|Lost to Follow-up|1|||
127906711|NCT03965091|460285786|FG001|Overall Study|Lost to Follow-up|1|||
127906712|NCT03965091|460285787|FG002|Overall Study|Lost to Follow-up|1|||
127906713|NCT03965091|460285785|FG000|Overall Study|Lack of Efficacy|2|||
127906714|NCT03965091|460285786|FG001|Overall Study|Lack of Efficacy|0|||
127906715|NCT03965091|460285787|FG002|Overall Study|Lack of Efficacy|0|||
127906716|NCT03965091|460285785|FG000|Overall Study|Other than specified|9|||
127906717|NCT03965091|460285786|FG001|Overall Study|Other than specified|11|||
127906718|NCT03965091|460285787|FG002|Overall Study|Other than specified|8|||
127906719|NCT02576938|460285789|FG000|Overall Study|Adverse Event|5|||
127906720|NCT02576938|460285790|FG001|Overall Study|Adverse Event|3|||
127906721|NCT02576938|460285791|FG002|Overall Study|Adverse Event|6|||
127906722|NCT02576938|460285789|FG000|Overall Study|Protocol Violation|1|||
127906723|NCT02576938|460285790|FG001|Overall Study|Protocol Violation|1|||
127906724|NCT02576938|460285791|FG002|Overall Study|Protocol Violation|1|||
127906725|NCT02576938|460285789|FG000|Overall Study|Withdrawal by Subject|3|||
127906726|NCT02576938|460285790|FG001|Overall Study|Withdrawal by Subject|2|||
127906727|NCT02576938|460285791|FG002|Overall Study|Withdrawal by Subject|4|||
127906728|NCT02576938|460285789|FG000|Overall Study|Lack of Efficacy|9|||
127906729|NCT02576938|460285790|FG001|Overall Study|Lack of Efficacy|4|||
127906730|NCT02576938|460285791|FG002|Overall Study|Lack of Efficacy|0|||
127906731|NCT02576938|460285789|FG000|Overall Study|Lost to Follow-up|2|||
127906732|NCT02576938|460285790|FG001|Overall Study|Lost to Follow-up|0|||
127906733|NCT02576938|460285791|FG002|Overall Study|Lost to Follow-up|1|||
127906734|NCT02576938|460285789|FG000|Overall Study|Physician Decision|0|||
127906735|NCT02576938|460285790|FG001|Overall Study|Physician Decision|1|||
127906736|NCT02576938|460285791|FG002|Overall Study|Physician Decision|0|||
127906737|NCT02576938|460285789|FG000|Overall Study|Met Exclusion Criteria|0|||
127906738|NCT02576938|460285790|FG001|Overall Study|Met Exclusion Criteria|1|||
127906739|NCT02576938|460285791|FG002|Overall Study|Met Exclusion Criteria|0|||
127906740|NCT03500341|460285792|FG000|Overall Study|Withdrawn prior to Completion|2|||
127906741|NCT00838630|460285796|FG000|First Intervention|Adverse Event|1|||
127906742|NCT00838630|460285797|FG001|First Intervention|Adverse Event|0|||
127906743|NCT00838630|460285796|FG000|Washout: 7 Days|Protocol Violation|1|||
127906744|NCT00838630|460285797|FG001|Washout: 7 Days|Protocol Violation|0|||
127906745|NCT02159950|460285802|FG000|Overall Study|Adverse Event|0|||
127906746|NCT02159950|460285803|FG001|Overall Study|Adverse Event|1|||
127906747|NCT02159950|460285802|FG000|Overall Study|Progression|0|||
127906748|NCT02159950|460285803|FG001|Overall Study|Progression|1|||
127906749|NCT00003659|460285804|FG000|Overall Study|Withdrawal by Subject|3|||
127906750|NCT04400890|460285805|FG000|Overall Study|Withdrawal by Subject|3|||
127906751|NCT04400890|460285806|FG001|Overall Study|Withdrawal by Subject|2|||
127906752|NCT03925532|460285807|FG000|Overall Study|Lost to Follow-up|1|||
127851995|NCT02120352|460074099|FG005|Extension Period (Week 97 to Study End)|Physician Decision|0|||
127851996|NCT02120352|460074100|FG006|Extension Period (Week 97 to Study End)|Physician Decision|0|||
127851997|NCT02120352|460074094|FG000|Extension Period (Week 97 to Study End)|Site closed|0|||
127851998|NCT02120352|460074095|FG001|Extension Period (Week 97 to Study End)|Site closed|0|||
127851999|NCT02120352|460074096|FG002|Extension Period (Week 97 to Study End)|Site closed|1|||
127852000|NCT02120352|460074097|FG003|Extension Period (Week 97 to Study End)|Site closed|0|||
127852001|NCT02120352|460074098|FG004|Extension Period (Week 97 to Study End)|Site closed|0|||
127852002|NCT02120352|460074099|FG005|Extension Period (Week 97 to Study End)|Site closed|1|||
127852003|NCT02120352|460074100|FG006|Extension Period (Week 97 to Study End)|Site closed|0|||
127852004|NCT02120352|460074094|FG000|Long-Term Follow-up Period (52 Weeks)|Other|0|||
127852005|NCT02120352|460074095|FG001|Long-Term Follow-up Period (52 Weeks)|Other|0|||
127852006|NCT02120352|460074096|FG002|Long-Term Follow-up Period (52 Weeks)|Other|0|||
127852007|NCT02120352|460074097|FG003|Long-Term Follow-up Period (52 Weeks)|Other|0|||
127852008|NCT02120352|460074098|FG004|Long-Term Follow-up Period (52 Weeks)|Other|0|||
127852009|NCT02120352|460074099|FG005|Long-Term Follow-up Period (52 Weeks)|Other|0|||
127852010|NCT02120352|460074100|FG006|Long-Term Follow-up Period (52 Weeks)|Other|6|||
127852011|NCT02427100|460074101|FG000|Overall Study|Lost to Follow-up|0|||
127852012|NCT02427100|460074102|FG001|Overall Study|Lost to Follow-up|2|||
127852013|NCT03094611|460074104|FG000|Overall Study|Lack of Efficacy|1|||
127852014|NCT03094611|460074104|FG000|Overall Study|Stem Cell Transplant|1|||
127852015|NCT00842361|460074105|FG000|Overall Study|Protocol Violation|1|||
127852016|NCT00842361|460074106|FG001|Overall Study|Protocol Violation|0|||
127852017|NCT00842361|460074105|FG000|Overall Study|Unclassified|0|||
127852018|NCT00842361|460074106|FG001|Overall Study|Unclassified|2|||
127852019|NCT00924729|460074114|FG000|Overall Study|insufficient volume for analysis|1|||
127852020|NCT00924729|460074115|FG001|Overall Study|insufficient volume for analysis|0|||
127852021|NCT00924729|460074114|FG000|Overall Study|Protocol Violation|1|||
127852022|NCT00924729|460074115|FG001|Overall Study|Protocol Violation|0|||
127852023|NCT02023112|460074120|FG000|Overall Study|Withdrawal by Subject|2|||
127852024|NCT02023112|460074121|FG001|Overall Study|Withdrawal by Subject|1|||
127852025|NCT00981747|460074125|FG000|Losartan|Withdrawal by Subject|1|||
127852026|NCT00981747|460074125|FG000|Losartan|Death|1|||
127852027|NCT00981747|460074125|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
127852028|NCT03339401|460074128|FG000|Overall Study|Death|2|||
127852029|NCT03339401|460074129|FG001|Overall Study|Death|1|||
127852030|NCT03339401|460074128|FG000|Overall Study|Withdrawal by Subject|2|||
127852031|NCT03339401|460074129|FG001|Overall Study|Withdrawal by Subject|0|||
127852032|NCT03339401|460074128|FG000|Overall Study|Study terminated|4|||
127852033|NCT03339401|460074129|FG001|Overall Study|Study terminated|3|||
127852034|NCT03339401|460074128|FG000|Overall Study|Investigator Decision|1|||
127852035|NCT03339401|460074129|FG001|Overall Study|Investigator Decision|0|||
127852036|NCT03271307|460074130|FG000|Overall Study|Lost to Follow-up|0|||
127852037|NCT03271307|460074131|FG001|Overall Study|Lost to Follow-up|0|||
127852038|NCT03271307|460074132|FG002|Overall Study|Lost to Follow-up|0|||
127852039|NCT03271307|460074133|FG003|Overall Study|Lost to Follow-up|28|||
127852040|NCT03271307|460074134|FG004|Overall Study|Lost to Follow-up|91|||
127852041|NCT03365947|460074135|FG000|Overall Study|Lost to Follow-up|0|||
127852042|NCT03365947|460074136|FG001|Overall Study|Lost to Follow-up|0|||
127852043|NCT03365947|460074137|FG002|Overall Study|Lost to Follow-up|0|||
127852044|NCT03365947|460074138|FG003|Overall Study|Lost to Follow-up|0|||
127852045|NCT03365947|460074139|FG004|Overall Study|Lost to Follow-up|0|||
127852046|NCT03365947|460074140|FG005|Overall Study|Lost to Follow-up|1|||
127852047|NCT03365947|460074141|FG006|Overall Study|Lost to Follow-up|0|||
127852048|NCT03365947|460074142|FG007|Overall Study|Lost to Follow-up|0|||
127852049|NCT03365947|460074143|FG008|Overall Study|Lost to Follow-up|0|||
127852050|NCT03365947|460074144|FG009|Overall Study|Lost to Follow-up|0|||
127852051|NCT03365947|460074145|FG010|Overall Study|Lost to Follow-up|0|||
127852052|NCT03365947|460074146|FG011|Overall Study|Lost to Follow-up|0|||
127852053|NCT03365947|460074147|FG012|Overall Study|Lost to Follow-up|0|||
127852054|NCT03365947|460074148|FG013|Overall Study|Lost to Follow-up|0|||
127852055|NCT03365947|460074149|FG014|Overall Study|Lost to Follow-up|0|||
127852056|NCT03365947|460074150|FG015|Overall Study|Lost to Follow-up|0|||
127852057|NCT03365947|460074151|FG016|Overall Study|Lost to Follow-up|0|||
127852058|NCT03365947|460074152|FG017|Overall Study|Lost to Follow-up|0|||
127852059|NCT03365947|460074153|FG018|Overall Study|Lost to Follow-up|0|||
127852060|NCT04018612|460074154|FG000|Overall Study|Withdrawal by Subject|1|||
127852061|NCT04018612|460074155|FG001|Overall Study|Withdrawal by Subject|0|||
127852062|NCT04018612|460074156|FG002|Overall Study|Withdrawal by Subject|1|||
127852063|NCT01915095|460074157|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
127852064|NCT01915095|460074158|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
127852065|NCT01915095|460074159|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
127852066|NCT01915095|460074160|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
127906753|NCT00723710|460285808|FG000|Overall Study|Disease progression|48|||
127906754|NCT00723710|460285808|FG000|Overall Study|Adverse Event|88|||
127906755|NCT00723710|460285808|FG000|Overall Study|Withdrawal by Subject|36|||
127906756|NCT00723710|460285808|FG000|Overall Study|Physician Decision|2|||
127906757|NCT01615198|460285809|FG000|Overall Study|Withdrawal by Subject|5|||
127906758|NCT01615198|460285810|FG001|Overall Study|Withdrawal by Subject|5|||
127906759|NCT01615198|460285809|FG000|Overall Study|Protocol deviation|1|||
127906760|NCT01615198|460285810|FG001|Overall Study|Protocol deviation|1|||
127906761|NCT01615198|460285809|FG000|Overall Study|Physician Decision|5|||
127906762|NCT01615198|460285810|FG001|Overall Study|Physician Decision|1|||
127906763|NCT01615198|460285809|FG000|Overall Study|Lost to Follow-up|1|||
127906764|NCT01615198|460285810|FG001|Overall Study|Lost to Follow-up|1|||
127906765|NCT01615198|460285809|FG000|Overall Study|Lack of Efficacy|1|||
127906766|NCT01615198|460285810|FG001|Overall Study|Lack of Efficacy|6|||
127906767|NCT01615198|460285809|FG000|Overall Study|Adverse Event|11|||
127906768|NCT01615198|460285810|FG001|Overall Study|Adverse Event|5|||
127906769|NCT02414152|460285811|FG000|Overall Study|Withdrawal by Subject|1|||
127906770|NCT02414152|460285811|FG000|Overall Study|Lack of Efficacy|1|||
127906771|NCT01289262|460285812|FG000|Overall Study|Lost to Follow-up|29|||
127906772|NCT01289262|460285813|FG001|Overall Study|Lost to Follow-up|16|||
127906773|NCT01289262|460285812|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
127906774|NCT01289262|460285813|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
127906775|NCT00838279|460285814|FG000|Washout|Protocol Violation|1|||
127906776|NCT00838279|460285815|FG001|Washout|Protocol Violation|0|||
127906777|NCT00838279|460285814|FG000|Washout|Withdrawal by Subject|0|||
127906778|NCT00838279|460285815|FG001|Washout|Withdrawal by Subject|1|||
127906779|NCT01218867|460285816|FG000|Overall Study|Death during treatment|0|||
127906780|NCT01218867|460285817|FG001|Overall Study|Death during treatment|0|||
127906781|NCT01218867|460285818|FG002|Overall Study|Death during treatment|0|||
127906782|NCT01218867|460285819|FG003|Overall Study|Death during treatment|0|||
127906783|NCT01218867|460285820|FG004|Overall Study|Death during treatment|0|||
127906784|NCT01218867|460285821|FG005|Overall Study|Death during treatment|0|||
127906785|NCT01218867|460285822|FG006|Overall Study|Death during treatment|1|||
127906786|NCT01218867|460285823|FG007|Overall Study|Death during treatment|0|||
127906787|NCT01218867|460285824|FG008|Overall Study|Death during treatment|0|||
127906788|NCT01218867|460285825|FG009|Overall Study|Death during treatment|0|||
127906789|NCT01218867|460285826|FG010|Overall Study|Death during treatment|0|||
127906790|NCT03792477|460285827|FG000|Overall Study|Adverse Event|0|||
127906791|NCT03792477|460285828|FG001|Overall Study|Adverse Event|0|||
127906792|NCT03792477|460285829|FG002|Overall Study|Adverse Event|0|||
127906793|NCT03792477|460285830|FG003|Overall Study|Adverse Event|1|||
127906794|NCT03792477|460285831|FG004|Overall Study|Adverse Event|0|||
127906795|NCT03792477|460285827|FG000|Overall Study|Lost to Follow-up|0|||
127906796|NCT03792477|460285828|FG001|Overall Study|Lost to Follow-up|0|||
127906797|NCT03792477|460285829|FG002|Overall Study|Lost to Follow-up|2|||
127906798|NCT03792477|460285830|FG003|Overall Study|Lost to Follow-up|0|||
127852067|NCT01915095|460074161|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
127852068|NCT02067533|460074164|FG000|Overall Study|Lost to Follow-up|4|||
127852069|NCT02067533|460074165|FG001|Overall Study|Lost to Follow-up|2|||
127852070|NCT02671760|460074167|FG000|Overall Study|Lost to Follow-up|0|||
127852071|NCT02671760|460074168|FG001|Overall Study|Lost to Follow-up|1|||
127852072|NCT02671760|460074169|FG002|Overall Study|Lost to Follow-up|0|||
127852073|NCT02999191|460074170|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
127852074|NCT02999191|460074171|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
127852075|NCT02999191|460074172|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
127852076|NCT00807014|460074179|FG000|Overall Study|Participant Considered Disease Cured|13|||
127852077|NCT00807014|460074180|FG001|Overall Study|Participant Considered Disease Cured|2|||
127852078|NCT00807014|460074179|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
127852079|NCT00807014|460074180|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
127852080|NCT00807014|460074179|FG000|Overall Study|Protocol Violation|2|||
127852081|NCT00807014|460074180|FG001|Overall Study|Protocol Violation|8|||
127852082|NCT00807014|460074179|FG000|Overall Study|Adverse Event|0|||
127852083|NCT00807014|460074180|FG001|Overall Study|Adverse Event|2|||
127852084|NCT00807014|460074179|FG000|Overall Study|Lost to Follow-up|9|||
127852085|NCT00807014|460074180|FG001|Overall Study|Lost to Follow-up|7|||
127852086|NCT00807014|460074179|FG000|Overall Study|Recovery|1|||
127852087|NCT00807014|460074180|FG001|Overall Study|Recovery|0|||
127852088|NCT00807014|460074179|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
127852089|NCT00807014|460074180|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
127852090|NCT00651313|460074181|FG000|Overall Study|Adverse Event|0|||
127852091|NCT00651313|460074182|FG001|Overall Study|Adverse Event|1|||
127852092|NCT00651313|460074181|FG000|Overall Study|Withdrawal by Subject|3|||
127852093|NCT00651313|460074182|FG001|Overall Study|Withdrawal by Subject|1|||
127906799|NCT03792477|460285831|FG004|Overall Study|Lost to Follow-up|0|||
127852094|NCT00651313|460074181|FG000|Overall Study|Lost to Follow-up|1|||
127906800|NCT03792477|460285827|FG000|Overall Study|Other|0|||
127906801|NCT03792477|460285828|FG001|Overall Study|Other|0|||
127906802|NCT03792477|460285829|FG002|Overall Study|Other|0|||
127852095|NCT00651313|460074182|FG001|Overall Study|Lost to Follow-up|1|||
127852096|NCT00651313|460074181|FG000|Overall Study|Adminstrative Discontinuation|2|||
127852097|NCT00651313|460074182|FG001|Overall Study|Adminstrative Discontinuation|3|||
127852098|NCT02650895|460074183|FG000|Overall Study|Withdrawal by Subject|0|||
127852099|NCT02650895|460074184|FG001|Overall Study|Withdrawal by Subject|1|||
127852100|NCT02650895|460074185|FG002|Overall Study|Withdrawal by Subject|0|||
127852101|NCT02650895|460074186|FG003|Overall Study|Withdrawal by Subject|0|||
127852102|NCT02650895|460074187|FG004|Overall Study|Withdrawal by Subject|0|||
127852103|NCT02650895|460074188|FG005|Overall Study|Withdrawal by Subject|0|||
127852104|NCT00981682|460074193|FG000|Overall Study|Adverse Event|48|||
127852105|NCT00981682|460074193|FG000|Overall Study|Withdrawal by Subject|52|||
127852106|NCT00981682|460074193|FG000|Overall Study|Lost to Follow-up|14|||
127852107|NCT00981682|460074193|FG000|Overall Study|Lack of Efficacy|13|||
127852108|NCT00981682|460074193|FG000|Overall Study|Protocol Violation|6|||
127852109|NCT00981682|460074193|FG000|Overall Study|administrative|9|||
127852110|NCT01696396|460076424|FG000|Overall Study|Withdrawal by Subject|19|||
127852111|NCT01696396|460076425|FG001|Overall Study|Withdrawal by Subject|5|||
127852112|NCT01696396|460076426|FG002|Overall Study|Withdrawal by Subject|19|||
127852113|NCT01696396|460076427|FG003|Overall Study|Withdrawal by Subject|11|||
127852114|NCT01696396|460076424|FG000|Overall Study|Decision by Sponsor|3|||
127852115|NCT01696396|460076425|FG001|Overall Study|Decision by Sponsor|1|||
127852116|NCT01696396|460076426|FG002|Overall Study|Decision by Sponsor|2|||
127852117|NCT01696396|460076427|FG003|Overall Study|Decision by Sponsor|2|||
127852118|NCT01696396|460076424|FG000|Overall Study|Lost to Follow-up|9|||
127852119|NCT01696396|460076425|FG001|Overall Study|Lost to Follow-up|1|||
127852120|NCT01696396|460076426|FG002|Overall Study|Lost to Follow-up|4|||
127852121|NCT01696396|460076427|FG003|Overall Study|Lost to Follow-up|1|||
127852122|NCT01696396|460076424|FG000|Overall Study|Death|0|||
127852123|NCT01696396|460076425|FG001|Overall Study|Death|0|||
127852124|NCT01696396|460076426|FG002|Overall Study|Death|1|||
127852125|NCT01696396|460076427|FG003|Overall Study|Death|0|||
127852126|NCT02712008|460076434|FG000|Baseline (Day 1) up to Week 12|Death|3|||
127852127|NCT02712008|460076435|FG001|Baseline (Day 1) up to Week 12|Death|0|||
127852128|NCT02712008|460076436|FG002|Baseline (Day 1) up to Week 12|Death|0|||
127852129|NCT02712008|460076437|FG003|Baseline (Day 1) up to Week 12|Death|0|||
127852130|NCT02712008|460076438|FG004|Baseline (Day 1) up to Week 12|Death|0|||
127852131|NCT02712008|460076439|FG005|Baseline (Day 1) up to Week 12|Death|0|||
127852132|NCT02712008|460076440|FG006|Baseline (Day 1) up to Week 12|Death|0|||
127852133|NCT02712008|460076441|FG007|Baseline (Day 1) up to Week 12|Death|0|||
127852134|NCT02712008|460076434|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
127852135|NCT02712008|460076435|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
127852136|NCT02712008|460076436|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
127852137|NCT02712008|460076437|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
127852138|NCT02712008|460076438|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
127852139|NCT02712008|460076439|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
127852140|NCT02712008|460076440|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
127852141|NCT02712008|460076441|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
127852142|NCT02712008|460076434|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
127852143|NCT02712008|460076435|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
127852144|NCT02712008|460076436|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
127852145|NCT02712008|460076437|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
127852146|NCT02712008|460076438|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
127852147|NCT02712008|460076439|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
127852148|NCT02712008|460076440|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
127852149|NCT02712008|460076441|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
127852150|NCT02712008|460076434|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
127852151|NCT02712008|460076435|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
127852152|NCT02712008|460076436|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
127852153|NCT02712008|460076437|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
127852154|NCT02712008|460076438|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
127852155|NCT02712008|460076439|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
127852156|NCT02712008|460076440|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
127852157|NCT02712008|460076441|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
127852158|NCT02712008|460076434|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
127852159|NCT02712008|460076435|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
127852160|NCT02712008|460076436|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
127852161|NCT02712008|460076437|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
127852162|NCT02712008|460076438|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
127852163|NCT02712008|460076439|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
127852164|NCT02712008|460076440|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
127852165|NCT02712008|460076441|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
127852166|NCT02712008|460076434|FG000|From Week 12 up to Week 36|Adverse Event|0|||
127852167|NCT02712008|460076435|FG001|From Week 12 up to Week 36|Adverse Event|0|||
127906803|NCT03792477|460285830|FG003|Overall Study|Other|0|||
127906804|NCT03792477|460285831|FG004|Overall Study|Other|1|||
127852168|NCT02712008|460076436|FG002|From Week 12 up to Week 36|Adverse Event|0|||
127852169|NCT02712008|460076437|FG003|From Week 12 up to Week 36|Adverse Event|0|||
127852170|NCT02712008|460076438|FG004|From Week 12 up to Week 36|Adverse Event|1|||
127852171|NCT02712008|460076439|FG005|From Week 12 up to Week 36|Adverse Event|0|||
127852172|NCT02712008|460076440|FG006|From Week 12 up to Week 36|Adverse Event|0|||
127852173|NCT02712008|460076441|FG007|From Week 12 up to Week 36|Adverse Event|2|||
127852174|NCT02712008|460076434|FG000|From Week 12 up to Week 36|Death|1|||
127852175|NCT02712008|460076435|FG001|From Week 12 up to Week 36|Death|0|||
127852176|NCT02712008|460076436|FG002|From Week 12 up to Week 36|Death|0|||
127852177|NCT02712008|460076437|FG003|From Week 12 up to Week 36|Death|0|||
127852178|NCT02712008|460076438|FG004|From Week 12 up to Week 36|Death|0|||
127852179|NCT02712008|460076439|FG005|From Week 12 up to Week 36|Death|0|||
127852180|NCT02712008|460076440|FG006|From Week 12 up to Week 36|Death|1|||
127852181|NCT02712008|460076441|FG007|From Week 12 up to Week 36|Death|0|||
127852182|NCT02712008|460076434|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
127852183|NCT02712008|460076435|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
127852184|NCT02712008|460076436|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
127852185|NCT02712008|460076437|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
127852186|NCT02712008|460076438|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
127852187|NCT02712008|460076439|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
127852188|NCT02712008|460076440|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
127852189|NCT02712008|460076441|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
127852190|NCT02712008|460076434|FG000|From Week 12 up to Week 36|Physician Decision|0|||
127852191|NCT02712008|460076435|FG001|From Week 12 up to Week 36|Physician Decision|0|||
127852192|NCT02712008|460076436|FG002|From Week 12 up to Week 36|Physician Decision|0|||
127852193|NCT02712008|460076437|FG003|From Week 12 up to Week 36|Physician Decision|1|||
127852194|NCT02712008|460076438|FG004|From Week 12 up to Week 36|Physician Decision|1|||
127852195|NCT02712008|460076439|FG005|From Week 12 up to Week 36|Physician Decision|0|||
127852196|NCT02712008|460076440|FG006|From Week 12 up to Week 36|Physician Decision|0|||
127852197|NCT02712008|460076441|FG007|From Week 12 up to Week 36|Physician Decision|0|||
127852198|NCT02712008|460076434|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
127852199|NCT02712008|460076435|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
127852200|NCT02712008|460076436|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
127852201|NCT02712008|460076437|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
127852202|NCT02712008|460076438|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
127852203|NCT02712008|460076439|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
127852204|NCT02712008|460076440|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
127852205|NCT02712008|460076441|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
127852206|NCT02892734|460076442|FG000|Treatment on Study|Progressive Disease|2|||
127852207|NCT02892734|460076442|FG000|Follow up for 2 Years|Death|2|||
127852208|NCT02892734|460076442|FG000|Follow up for 2 Years|Study closed early|1|||
127852209|NCT02043509|460076443|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
127852210|NCT02043509|460076444|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
127852211|NCT02043509|460076443|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
127852212|NCT02043509|460076444|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
127852213|NCT02043509|460076443|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
127852214|NCT02043509|460076444|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
127852215|NCT02043509|460076443|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
127852216|NCT02043509|460076444|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
127852217|NCT00608244|460076449|FG000|Overall Study|Adverse Event|1|||
127852218|NCT00608244|460076449|FG000|Overall Study|Low trough levels|1|||
127852219|NCT02443155|460076459|FG000|Overall Study|Adverse Event|3|||
127852220|NCT02443155|460076460|FG001|Overall Study|Adverse Event|4|||
127852221|NCT02443155|460076461|FG002|Overall Study|Adverse Event|1|||
127852222|NCT02443155|460076462|FG003|Overall Study|Adverse Event|2|||
127852223|NCT02443155|460076459|FG000|Overall Study|Unclassified|0|||
127852224|NCT02443155|460076460|FG001|Overall Study|Unclassified|0|||
127852225|NCT02443155|460076461|FG002|Overall Study|Unclassified|2|||
127852226|NCT02443155|460076462|FG003|Overall Study|Unclassified|1|||
127852227|NCT02443155|460076459|FG000|Overall Study|Withdrawal by Subject|4|||
127852228|NCT02443155|460076460|FG001|Overall Study|Withdrawal by Subject|7|||
127852229|NCT02443155|460076461|FG002|Overall Study|Withdrawal by Subject|3|||
127852230|NCT02443155|460076462|FG003|Overall Study|Withdrawal by Subject|9|||
127906805|NCT01474551|460285832|FG000|Overall Study|Death|1|||
127852231|NCT02443155|460076459|FG000|Overall Study|Pregnancy|3|||
127852232|NCT02443155|460076460|FG001|Overall Study|Pregnancy|1|||
127852233|NCT02443155|460076461|FG002|Overall Study|Pregnancy|1|||
127852234|NCT02443155|460076462|FG003|Overall Study|Pregnancy|2|||
127852235|NCT02443155|460076459|FG000|Overall Study|Lost to Follow-up|1|||
127852236|NCT02443155|460076460|FG001|Overall Study|Lost to Follow-up|2|||
127852237|NCT02443155|460076461|FG002|Overall Study|Lost to Follow-up|0|||
127852238|NCT02443155|460076462|FG003|Overall Study|Lost to Follow-up|1|||
127852239|NCT02443155|460076459|FG000|Overall Study|Protocol Violation|1|||
127906806|NCT01921062|460285833|FG000|Overall Study|Withdrawal by Subject|0|||
127852240|NCT02443155|460076460|FG001|Overall Study|Protocol Violation|0|||
127852241|NCT02443155|460076461|FG002|Overall Study|Protocol Violation|1|||
127852242|NCT02443155|460076462|FG003|Overall Study|Protocol Violation|1|||
127852243|NCT02443155|460076459|FG000|Overall Study|Death|0|||
127852244|NCT02443155|460076460|FG001|Overall Study|Death|0|||
127852245|NCT02443155|460076461|FG002|Overall Study|Death|1|||
127852246|NCT02443155|460076462|FG003|Overall Study|Death|0|||
127852247|NCT02000219|460076463|FG000|14-Week Study Period|Physician Decision|1|||
127852248|NCT02000219|460076463|FG000|14-Week Study Period|Adverse Event|1|||
127852249|NCT02000219|460076463|FG000|14-Week Study Period|Underwent transplantation|1|||
127852250|NCT02000219|460076463|FG000|Continuation Period|Withdrawal by Subject|1|||
127852251|NCT02000219|460076463|FG000|Continuation Period|Had liver transplant|2|||
127852252|NCT02000219|460076463|FG000|Continuation Period|Non-compliance with study drug|2|||
127852253|NCT00106249|460076466|FG000|Overall Study|Lost to Follow-up|3|||
127852254|NCT00106249|460076467|FG001|Overall Study|Lost to Follow-up|2|||
127852255|NCT01495689|460076475|FG000|Overall Study|Death|0|||
127852256|NCT01495689|460076476|FG001|Overall Study|Death|1|||
127852257|NCT01495689|460076475|FG000|Overall Study|Withdrawal by Subject|3|||
127852258|NCT01495689|460076476|FG001|Overall Study|Withdrawal by Subject|0|||
127852259|NCT01495689|460076475|FG000|Overall Study|Lost to Follow-up|7|||
127852260|NCT01495689|460076476|FG001|Overall Study|Lost to Follow-up|6|||
127852261|NCT00524043|460076481|FG000|Overall Study|Lack of Efficacy|15|||
127852262|NCT00524043|460076482|FG001|Overall Study|Lack of Efficacy|13|||
127852263|NCT00524043|460076483|FG002|Overall Study|Lack of Efficacy|14|||
127852264|NCT00524043|460076481|FG000|Overall Study|Withdrawal by Subject|5|||
127852265|NCT00524043|460076482|FG001|Overall Study|Withdrawal by Subject|7|||
127852266|NCT00524043|460076483|FG002|Overall Study|Withdrawal by Subject|7|||
127852267|NCT00524043|460076481|FG000|Overall Study|Adverse Event|5|||
127852268|NCT00524043|460076482|FG001|Overall Study|Adverse Event|2|||
127852269|NCT00524043|460076483|FG002|Overall Study|Adverse Event|7|||
127852270|NCT00524043|460076481|FG000|Overall Study|Lost to Follow-up|3|||
127852271|NCT00524043|460076482|FG001|Overall Study|Lost to Follow-up|5|||
127852272|NCT00524043|460076483|FG002|Overall Study|Lost to Follow-up|3|||
127852273|NCT00524043|460076481|FG000|Overall Study|Various (eg, incarceration)|2|||
127852274|NCT00524043|460076482|FG001|Overall Study|Various (eg, incarceration)|1|||
127852275|NCT00524043|460076483|FG002|Overall Study|Various (eg, incarceration)|0|||
127852276|NCT01843205|460076484|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
127852277|NCT01843205|460076485|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
127852278|NCT00606177|460076486|FG000|Overall Study|Adverse Event|9|||
127852279|NCT00606177|460076487|FG001|Overall Study|Adverse Event|5|||
127852280|NCT00606177|460076486|FG000|Overall Study|Lack of Efficacy|3|||
127852281|NCT00606177|460076487|FG001|Overall Study|Lack of Efficacy|7|||
127852282|NCT00606177|460076486|FG000|Overall Study|Physician Decision|1|||
127852283|NCT00606177|460076487|FG001|Overall Study|Physician Decision|0|||
127852284|NCT00606177|460076486|FG000|Overall Study|Protocol Violation|1|||
127852285|NCT00606177|460076487|FG001|Overall Study|Protocol Violation|4|||
127852286|NCT00606177|460076486|FG000|Overall Study|Withdrawal by Subject|5|||
127852287|NCT00606177|460076487|FG001|Overall Study|Withdrawal by Subject|6|||
127852288|NCT00606177|460076486|FG000|Overall Study|Progression to depressive phase|6|||
127852289|NCT00606177|460076487|FG001|Overall Study|Progression to depressive phase|1|||
127852290|NCT00606177|460076486|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
127852291|NCT00606177|460076487|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
127852292|NCT00606177|460076486|FG000|Overall Study|Change of residence or other commitments|1|||
127852293|NCT00606177|460076487|FG001|Overall Study|Change of residence or other commitments|1|||
127852294|NCT00136357|460076488|FG000|Overall Study|Withdrawal by Subject|3|||
127852295|NCT00136357|460076489|FG001|Overall Study|Withdrawal by Subject|2|||
127852296|NCT00216086|460076497|FG000|Overall Study|Protocol Violation|1|||
127852297|NCT00216086|460076497|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
127852298|NCT00216086|460076497|FG000|Overall Study|Social Reasons|2|||
127852299|NCT02025530|460076498|FG000|Overall Study|No longer met elligibility criteria|5|||
127852300|NCT02025530|460076499|FG001|Overall Study|No longer met elligibility criteria|1|||
127852301|NCT03551626|460076502|FG000|Overall Study|Adverse Event|88|||
127852302|NCT03551626|460076502|FG000|Overall Study|Disease relapse|18|||
127852303|NCT03551626|460076502|FG000|Overall Study|Withdrawal of informed consent|6|||
127852304|NCT03551626|460076502|FG000|Overall Study|Patient decision|5|||
127852305|NCT03551626|460076502|FG000|Overall Study|Physician Decision|4|||
127852306|NCT03551626|460076502|FG000|Overall Study|Lost to Follow-up|3|||
127852307|NCT03551626|460076502|FG000|Overall Study|Pregnancy|1|||
127852308|NCT03551626|460076502|FG000|Overall Study|Protocol deviation|1|||
127852309|NCT03551626|460076502|FG000|Overall Study|Technical problems|1|||
127852310|NCT04211961|460076503|FG000|Overall Study|Death|0|||
127852311|NCT04211961|460076504|FG001|Overall Study|Death|1|||
127852312|NCT04211961|460076503|FG000|Overall Study|Lost to Follow-up|0|||
127852313|NCT04211961|460076504|FG001|Overall Study|Lost to Follow-up|1|||
127852314|NCT04211961|460076503|FG000|Overall Study|Withdrawal by Subject|0|||
127852315|NCT04211961|460076504|FG001|Overall Study|Withdrawal by Subject|1|||
127906807|NCT01921062|460285834|FG001|Overall Study|Withdrawal by Subject|7|||
127906808|NCT01921062|460285833|FG000|Overall Study|Adverse Event|5|||
127906809|NCT01921062|460285834|FG001|Overall Study|Adverse Event|6|||
127906810|NCT01921062|460285833|FG000|Overall Study|Protocol Violation|0|||
127906811|NCT01921062|460285834|FG001|Overall Study|Protocol Violation|1|||
127906812|NCT01921062|460285833|FG000|Overall Study|VMIQ score > 72|4|||
127906813|NCT01921062|460285834|FG001|Overall Study|VMIQ score > 72|1|||
127906814|NCT01921062|460285833|FG000|Overall Study|Logistic error|0|||
127906815|NCT01921062|460285834|FG001|Overall Study|Logistic error|1|||
127906816|NCT01854047|460285835|FG000|Overall Study|Lack of Efficacy|1|||
127906817|NCT01854047|460285836|FG001|Overall Study|Lack of Efficacy|0|||
127906818|NCT01854047|460285837|FG002|Overall Study|Lack of Efficacy|0|||
127906819|NCT01854047|460285838|FG003|Overall Study|Lack of Efficacy|0|||
127906820|NCT01854047|460285839|FG004|Overall Study|Lack of Efficacy|0|||
127906821|NCT01854047|460285835|FG000|Overall Study|Poor compliance to protocol|3|||
127906822|NCT01854047|460285836|FG001|Overall Study|Poor compliance to protocol|0|||
127906823|NCT01854047|460285837|FG002|Overall Study|Poor compliance to protocol|2|||
127906824|NCT01854047|460285838|FG003|Overall Study|Poor compliance to protocol|0|||
127906825|NCT01854047|460285839|FG004|Overall Study|Poor compliance to protocol|0|||
127906826|NCT01854047|460285835|FG000|Overall Study|Adverse Event|5|||
127906827|NCT01854047|460285836|FG001|Overall Study|Adverse Event|4|||
127906828|NCT01854047|460285837|FG002|Overall Study|Adverse Event|6|||
127906829|NCT01854047|460285838|FG003|Overall Study|Adverse Event|10|||
127906830|NCT01854047|460285839|FG004|Overall Study|Adverse Event|7|||
127906831|NCT01854047|460285835|FG000|Overall Study|Randomized but not treated|0|||
127906832|NCT01854047|460285836|FG001|Overall Study|Randomized but not treated|1|||
127906833|NCT01854047|460285837|FG002|Overall Study|Randomized but not treated|2|||
127906834|NCT01854047|460285838|FG003|Overall Study|Randomized but not treated|0|||
127906835|NCT01854047|460285839|FG004|Overall Study|Randomized but not treated|4|||
127906836|NCT01854047|460285835|FG000|Overall Study|Other than specified above|3|||
127906837|NCT01854047|460285836|FG001|Overall Study|Other than specified above|3|||
127906838|NCT01854047|460285837|FG002|Overall Study|Other than specified above|3|||
127906839|NCT01854047|460285838|FG003|Overall Study|Other than specified above|5|||
127906840|NCT01854047|460285839|FG004|Overall Study|Other than specified above|8|||
127906841|NCT00576056|460285840|FG000|Overall Study|Adverse Event|1|||
127906842|NCT00576056|460285840|FG000|Overall Study|Death|1|||
127906843|NCT00576056|460285840|FG000|Overall Study|Lack of Efficacy|1|||
127906844|NCT00576056|460285840|FG000|Overall Study|Withdrawal by Subject|2|||
127906845|NCT00576056|460285840|FG000|Overall Study|did not meet eligibility criteria|8|||
127906846|NCT00576056|460285840|FG000|Overall Study|Physician Decision|1|||
127906847|NCT03273153|460285841|FG000|Overall Study|Adverse Event|1|||
127906848|NCT03273153|460285842|FG001|Overall Study|Adverse Event|2|||
127906849|NCT03273153|460285841|FG000|Overall Study|Missing|0|||
127906850|NCT03273153|460285842|FG001|Overall Study|Missing|2|||
127906851|NCT03273153|460285841|FG000|Overall Study|Other|3|||
127906852|NCT03273153|460285842|FG001|Overall Study|Other|2|||
127906853|NCT03273153|460285841|FG000|Overall Study|Symptomatic Deterioration|0|||
127906854|NCT03273153|460285842|FG001|Overall Study|Symptomatic Deterioration|1|||
127852316|NCT05784129|460076505|FG000|Overall Study|Study terminated by sponsor|2|||
127852317|NCT05784129|460076506|FG001|Overall Study|Study terminated by sponsor|2|||
127852318|NCT02728206|460076508|FG000|Overall Study|Death|1|||
127852319|NCT02773368|460076514|FG000|Overall Study|Lost to Follow-up|4|||
127852320|NCT02773368|460076515|FG001|Overall Study|Lost to Follow-up|1|||
127852321|NCT02773368|460076514|FG000|Overall Study|Withdrawal by Subject|5|||
127852322|NCT02773368|460076515|FG001|Overall Study|Withdrawal by Subject|1|||
127852323|NCT02773368|460076514|FG000|Overall Study|Unclassified|1|||
127906855|NCT03273153|460285841|FG000|Overall Study|Progressive Disease|6|||
127906856|NCT03273153|460285842|FG001|Overall Study|Progressive Disease|5|||
127906857|NCT03273153|460285841|FG000|Overall Study|Physician Decision|1|||
127906858|NCT03273153|460285842|FG001|Overall Study|Physician Decision|3|||
127906859|NCT03273153|460285841|FG000|Overall Study|Study Terminated by Sponsor|112|||
127906860|NCT03273153|460285842|FG001|Overall Study|Study Terminated by Sponsor|102|||
127906861|NCT03273153|460285841|FG000|Overall Study|Withdrawal by Subject|26|||
127906862|NCT03273153|460285842|FG001|Overall Study|Withdrawal by Subject|25|||
127852324|NCT02773368|460076515|FG001|Overall Study|Unclassified|1|||
127852325|NCT02773368|460076514|FG000|Overall Study|Missing|0|||
127852326|NCT02773368|460076515|FG001|Overall Study|Missing|1|||
127852327|NCT01929018|460076516|FG000|Overall Study|Lost to Follow-up|1|||
127852328|NCT01929018|460076517|FG001|Overall Study|Lost to Follow-up|0|||
127852329|NCT01929018|460076516|FG000|Overall Study|Hospitalization|0|||
127906863|NCT03273153|460285841|FG000|Overall Study|Protocol Deviation|3|||
127906864|NCT03273153|460285842|FG001|Overall Study|Protocol Deviation|0|||
127906865|NCT03273153|460285841|FG000|Overall Study|Lost to Follow-up|6|||
127906866|NCT03273153|460285842|FG001|Overall Study|Lost to Follow-up|11|||
127906867|NCT03273153|460285841|FG000|Overall Study|Death|66|||
127906868|NCT03273153|460285842|FG001|Overall Study|Death|69|||
127906869|NCT05323396|460285843|FG000|Overall Study|Lost to Follow-up|1|||
127906870|NCT05323396|460285844|FG001|Overall Study|Lost to Follow-up|35|||
127906871|NCT05323396|460285843|FG000|Overall Study|Pregnancy|1|||
127906872|NCT05323396|460285844|FG001|Overall Study|Pregnancy|0|||
127906873|NCT04646213|460285845|FG000|Overall Study|Physician Decision|3|||
127906874|NCT04646213|460285845|FG000|Overall Study|Withdrawal by Subject|2|||
127906875|NCT00415363|460285850|FG000|Overall Study|Withdrawal by Subject|4|||
127906876|NCT00415363|460285851|FG001|Overall Study|Withdrawal by Subject|4|||
127906877|NCT00415363|460285850|FG000|Overall Study|Adverse Event|4|||
127906878|NCT00415363|460285851|FG001|Overall Study|Adverse Event|4|||
127906879|NCT00415363|460285850|FG000|Overall Study|Lost to Follow-up|2|||
127906880|NCT00415363|460285851|FG001|Overall Study|Lost to Follow-up|1|||
127906881|NCT00415363|460285850|FG000|Overall Study|Physician Decision|3|||
127906882|NCT00415363|460285851|FG001|Overall Study|Physician Decision|1|||
127906883|NCT00415363|460285850|FG000|Overall Study|Death|16|||
127906884|NCT00415363|460285851|FG001|Overall Study|Death|12|||
127906885|NCT00415363|460285850|FG000|Overall Study|Progressive disease|26|||
127906886|NCT00415363|460285851|FG001|Overall Study|Progressive disease|32|||
127906887|NCT00095212|460285852|FG000|Overall Study|Withdrawal by Subject|1|||
127906888|NCT00095212|460285853|FG001|Overall Study|Withdrawal by Subject|3|||
127906889|NCT05341622|460285854|FG000|Overall Study|Death|0|||
127906890|NCT05341622|460285855|FG001|Overall Study|Death|0|||
127906891|NCT05341622|460285856|FG002|Overall Study|Death|0|||
127906892|NCT05341622|460285857|FG003|Overall Study|Death|0|||
127906893|NCT05341622|460285858|FG004|Overall Study|Death|1|||
127906894|NCT05341622|460285859|FG005|Overall Study|Death|0|||
127906895|NCT05341622|460285860|FG006|Overall Study|Death|0|||
127906896|NCT05341622|460285861|FG007|Overall Study|Death|1|||
127906897|NCT05341622|460285854|FG000|Overall Study|Invalid Address|0|||
127906898|NCT05341622|460285855|FG001|Overall Study|Invalid Address|1|||
127906899|NCT05341622|460285856|FG002|Overall Study|Invalid Address|0|||
127906900|NCT05341622|460285857|FG003|Overall Study|Invalid Address|0|||
127906901|NCT05341622|460285858|FG004|Overall Study|Invalid Address|0|||
127906902|NCT05341622|460285859|FG005|Overall Study|Invalid Address|0|||
127906903|NCT05341622|460285860|FG006|Overall Study|Invalid Address|0|||
127906904|NCT05341622|460285861|FG007|Overall Study|Invalid Address|0|||
127906905|NCT05341622|460285854|FG000|Overall Study|Ineligible|26|||
127906906|NCT05341622|460285855|FG001|Overall Study|Ineligible|21|||
127906907|NCT05341622|460285856|FG002|Overall Study|Ineligible|28|||
127906908|NCT05341622|460285857|FG003|Overall Study|Ineligible|24|||
127906909|NCT05341622|460285858|FG004|Overall Study|Ineligible|29|||
127906910|NCT05341622|460285859|FG005|Overall Study|Ineligible|31|||
127906911|NCT05341622|460285860|FG006|Overall Study|Ineligible|28|||
127906912|NCT05341622|460285861|FG007|Overall Study|Ineligible|26|||
127906913|NCT02658084|460285862|FG000|Overall Study|Withdrawal by Subject|1|||
127906914|NCT02658084|460285863|FG001|Overall Study|Withdrawal by Subject|0|||
127906915|NCT02658084|460285862|FG000|Overall Study|Study Termination|1|||
127906916|NCT02658084|460285863|FG001|Overall Study|Study Termination|0|||
127906917|NCT03041025|460285867|FG000|Overall Study|Adverse Event|0|||
127906918|NCT03041025|460285868|FG001|Overall Study|Adverse Event|0|||
127906919|NCT03041025|460285869|FG002|Overall Study|Adverse Event|1|||
127906920|NCT03041025|460285867|FG000|Overall Study|Lost to Follow-up|1|||
127906921|NCT03041025|460285868|FG001|Overall Study|Lost to Follow-up|0|||
127906922|NCT03041025|460285869|FG002|Overall Study|Lost to Follow-up|0|||
127906923|NCT03041025|460285867|FG000|Overall Study|Withdrawal by Subject|0|||
127906924|NCT03041025|460285868|FG001|Overall Study|Withdrawal by Subject|0|||
127906925|NCT03041025|460285869|FG002|Overall Study|Withdrawal by Subject|1|||
127906926|NCT02963259|460285870|FG000|Overall Study|IPG Replacement not Done with Abbott Device|2|||
127906927|NCT02963259|460285870|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
127906928|NCT02963259|460285870|FG000|Overall Study|Death|1|||
127906929|NCT02963259|460285870|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
127906930|NCT04611789|460285871|FG000|Overall Study|Lost to Follow-up|1|||
127906931|NCT04611789|460285872|FG001|Overall Study|Lost to Follow-up|0|||
127906932|NCT04611789|460285873|FG002|Overall Study|Lost to Follow-up|0|||
127906933|NCT02655679|460285877|FG000|Overall Study|Adverse Event|0|||
127906934|NCT02655679|460285878|FG001|Overall Study|Adverse Event|1|||
127906935|NCT02655679|460285879|FG002|Overall Study|Adverse Event|0|||
127906936|NCT02655679|460285880|FG003|Overall Study|Adverse Event|0|||
127906937|NCT02655679|460285881|FG004|Overall Study|Adverse Event|0|||
127906938|NCT02655679|460285877|FG000|Overall Study|Withdrawal by Subject|1|||
127906939|NCT02655679|460285878|FG001|Overall Study|Withdrawal by Subject|1|||
127906940|NCT02655679|460285879|FG002|Overall Study|Withdrawal by Subject|0|||
127906941|NCT02655679|460285880|FG003|Overall Study|Withdrawal by Subject|3|||
127906942|NCT02655679|460285881|FG004|Overall Study|Withdrawal by Subject|1|||
127906943|NCT02655679|460285877|FG000|Overall Study|Inability to Comply with the Protocol|1|||
127906944|NCT02655679|460285878|FG001|Overall Study|Inability to Comply with the Protocol|0|||
127906945|NCT02655679|460285879|FG002|Overall Study|Inability to Comply with the Protocol|0|||
127906946|NCT02655679|460285880|FG003|Overall Study|Inability to Comply with the Protocol|0|||
127906947|NCT02655679|460285881|FG004|Overall Study|Inability to Comply with the Protocol|0|||
127906948|NCT02655679|460285877|FG000|Overall Study|Lost to Follow-up|0|||
127852330|NCT01929018|460076517|FG001|Overall Study|Hospitalization|1|||
127852331|NCT02635867|460076520|FG000|Overall Study|Lost to Follow-up|4|||
127852332|NCT02635867|460076521|FG001|Overall Study|Lost to Follow-up|3|||
127852333|NCT02635867|460076522|FG002|Overall Study|Lost to Follow-up|3|||
127852334|NCT02635867|460076523|FG003|Overall Study|Lost to Follow-up|4|||
127852335|NCT02635867|460076524|FG004|Overall Study|Lost to Follow-up|1|||
127852336|NCT02782104|460076525|FG000|Overall Study|Other|215|||
127852337|NCT02782104|460076525|FG000|Overall Study|Induction Day 28 Non Responder|9|||
127852338|NCT02782104|460076525|FG000|Overall Study|Non-Compliance with Study Drug|2|||
127852339|NCT02782104|460076525|FG000|Overall Study|Death|8|||
127852340|NCT02782104|460076525|FG000|Overall Study|Pregnancy|6|||
127852341|NCT02782104|460076525|FG000|Overall Study|Withdrawal by Subject|63|||
127852342|NCT02782104|460076525|FG000|Overall Study|Protocol Violation|7|||
127852343|NCT02782104|460076525|FG000|Overall Study|Lack of Efficacy|61|||
127852344|NCT02782104|460076525|FG000|Overall Study|Lost to Follow-up|23|||
127852345|NCT02782104|460076525|FG000|Overall Study|Adverse Event|74|||
127852346|NCT03447821|460076526|FG000|Overall Study|Withdrawal by Subject|1|||
127852347|NCT03447821|460076527|FG001|Overall Study|Withdrawal by Subject|1|||
127852348|NCT03447821|460076528|FG002|Overall Study|Withdrawal by Subject|0|||
127852349|NCT03447821|460076526|FG000|Overall Study|Lost to Follow-up|0|||
127852350|NCT03447821|460076527|FG001|Overall Study|Lost to Follow-up|0|||
127852351|NCT03447821|460076528|FG002|Overall Study|Lost to Follow-up|1|||
127852352|NCT00329784|460076531|FG000|Overall Study|Lost to Follow-up|0|||
127852353|NCT00329784|460076532|FG001|Overall Study|Lost to Follow-up|1|||
127852354|NCT00329784|460076533|FG002|Overall Study|Lost to Follow-up|0|||
127852355|NCT00329784|460076534|FG003|Overall Study|Lost to Follow-up|0|||
127852356|NCT00329784|460076531|FG000|Overall Study|Withdrawal by Subject|4|||
127852357|NCT00329784|460076532|FG001|Overall Study|Withdrawal by Subject|2|||
127852358|NCT00329784|460076533|FG002|Overall Study|Withdrawal by Subject|0|||
127852359|NCT00329784|460076534|FG003|Overall Study|Withdrawal by Subject|0|||
127852360|NCT00329784|460076531|FG000|Overall Study|Other|1|||
127852361|NCT00329784|460076532|FG001|Overall Study|Other|2|||
127852362|NCT00329784|460076533|FG002|Overall Study|Other|0|||
127852363|NCT00329784|460076534|FG003|Overall Study|Other|0|||
127852364|NCT00045630|460076540|FG000|Overall Study|Adverse Event|1|||
127852365|NCT00045630|460076540|FG000|Overall Study|Refusal unrelated to adverse event|1|||
127852366|NCT00045630|460076540|FG000|Overall Study|Progression/relapse|1|||
127852367|NCT00045630|460076540|FG000|Overall Study|Death|1|||
127852368|NCT00045630|460076540|FG000|Overall Study|Ineligible|2|||
127852369|NCT03034057|460076541|FG000|Overall Study|Withdrawal by Subject|10|||
127852370|NCT03034057|460076541|FG000|Overall Study|Protocol Violation|1|||
127852371|NCT03034057|460076541|FG000|Overall Study|Not defined|2|||
127852372|NCT03034057|460076541|FG000|Overall Study|Lost to Follow-up|19|||
127852373|NCT03034057|460076541|FG000|Overall Study|Adverse Event|22|||
127852374|NCT03034057|460076541|FG000|Overall Study|Medication error without associated AE|1|||
127852375|NCT01929707|460076542|FG000|Intervention Period 1|Lost to Follow-up|0|||
127852376|NCT01929707|460076543|FG001|Intervention Period 1|Lost to Follow-up|0|||
127852377|NCT01929707|460076544|FG002|Intervention Period 1|Lost to Follow-up|0|||
127852378|NCT01929707|460076545|FG003|Intervention Period 1|Lost to Follow-up|1|||
127852379|NCT01929707|460076546|FG004|Intervention Period 1|Lost to Follow-up|0|||
127852380|NCT01929707|460076547|FG005|Intervention Period 1|Lost to Follow-up|0|||
127852381|NCT01929707|460076548|FG006|Intervention Period 1|Lost to Follow-up|0|||
127852382|NCT01929707|460076549|FG007|Intervention Period 1|Lost to Follow-up|0|||
127852383|NCT01929707|460076542|FG000|Intervention Period 1|Withdrawal by Subject|0|||
127852384|NCT01929707|460076543|FG001|Intervention Period 1|Withdrawal by Subject|0|||
127852385|NCT01929707|460076544|FG002|Intervention Period 1|Withdrawal by Subject|0|||
127852386|NCT01929707|460076545|FG003|Intervention Period 1|Withdrawal by Subject|2|||
127852387|NCT01929707|460076546|FG004|Intervention Period 1|Withdrawal by Subject|0|||
127852388|NCT01929707|460076547|FG005|Intervention Period 1|Withdrawal by Subject|0|||
127852389|NCT01929707|460076548|FG006|Intervention Period 1|Withdrawal by Subject|0|||
127852390|NCT01929707|460076549|FG007|Intervention Period 1|Withdrawal by Subject|0|||
127852391|NCT01929707|460076542|FG000|Intervention Period 2|Withdrawal by Subject|0|||
127852392|NCT01929707|460076543|FG001|Intervention Period 2|Withdrawal by Subject|0|||
127852393|NCT01929707|460076544|FG002|Intervention Period 2|Withdrawal by Subject|0|||
127852394|NCT01929707|460076545|FG003|Intervention Period 2|Withdrawal by Subject|0|||
127852395|NCT01929707|460076546|FG004|Intervention Period 2|Withdrawal by Subject|0|||
127852396|NCT01929707|460076547|FG005|Intervention Period 2|Withdrawal by Subject|2|||
127852397|NCT01929707|460076548|FG006|Intervention Period 2|Withdrawal by Subject|0|||
127852398|NCT01929707|460076549|FG007|Intervention Period 2|Withdrawal by Subject|0|||
127852399|NCT00437203|460076550|FG000|Overall Study|Death|0|||
127852400|NCT00437203|460076551|FG001|Overall Study|Death|0|||
127852401|NCT00437203|460076552|FG002|Overall Study|Death|1|||
127852402|NCT00437203|460076553|FG003|Overall Study|Death|0|||
127852403|NCT00437203|460076554|FG004|Overall Study|Death|0|||
127852404|NCT00437203|460076555|FG005|Overall Study|Death|0|||
127852405|NCT00437203|460076556|FG006|Overall Study|Death|0|||
127852406|NCT00437203|460076557|FG007|Overall Study|Death|1|||
127906949|NCT02655679|460285878|FG001|Overall Study|Lost to Follow-up|1|||
127906950|NCT02655679|460285879|FG002|Overall Study|Lost to Follow-up|1|||
127906951|NCT02655679|460285880|FG003|Overall Study|Lost to Follow-up|1|||
127906952|NCT02655679|460285881|FG004|Overall Study|Lost to Follow-up|0|||
127906953|NCT02655679|460285877|FG000|Overall Study|Other Miscellaneous Reasons|1|||
127906954|NCT02655679|460285878|FG001|Overall Study|Other Miscellaneous Reasons|0|||
127906955|NCT02655679|460285879|FG002|Overall Study|Other Miscellaneous Reasons|0|||
127906956|NCT02655679|460285880|FG003|Overall Study|Other Miscellaneous Reasons|0|||
127906957|NCT02655679|460285881|FG004|Overall Study|Other Miscellaneous Reasons|0|||
127906958|NCT01577381|460285882|FG000|Overall Study|Discontinued|2|||
127906959|NCT01577381|460285883|FG001|Overall Study|Discontinued|1|||
127906960|NCT01577381|460285884|FG002|Overall Study|Discontinued|2|||
127906961|NCT01577381|460285885|FG003|Overall Study|Discontinued|2|||
127906962|NCT01577381|460285882|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
127906963|NCT01577381|460285883|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
127906964|NCT01577381|460285884|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
127906965|NCT01577381|460285885|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
127906966|NCT01421277|460285886|FG000|Overall Study|Lack of qualifying event|0|||
127906967|NCT01421277|460285887|FG001|Overall Study|Lack of qualifying event|61|||
127906968|NCT01421277|460285886|FG000|Overall Study|Incomplete baseline data|0|||
127906969|NCT01421277|460285887|FG001|Overall Study|Incomplete baseline data|31|||
127906970|NCT02186821|460285888|FG000|Overall Study|Adverse Event|9|||
127906971|NCT02186821|460285888|FG000|Overall Study|Death|2|||
127906972|NCT02186821|460285888|FG000|Overall Study|Disease progression|32|||
127906973|NCT02186821|460285888|FG000|Overall Study|Protocol Violation|1|||
127906974|NCT02186821|460285888|FG000|Overall Study|Physician Decision|1|||
127906975|NCT02186821|460285888|FG000|Overall Study|Study terminated by sponsor|2|||
127906976|NCT00819741|460285895|FG000|Overall Study|Adverse Event|5|||
127906977|NCT00819741|460285896|FG001|Overall Study|Adverse Event|2|||
127906978|NCT00819741|460285895|FG000|Overall Study|Lack of Efficacy|0|||
127906979|NCT00819741|460285896|FG001|Overall Study|Lack of Efficacy|2|||
127906980|NCT00819741|460285895|FG000|Overall Study|Lost to Follow-up|3|||
127906981|NCT00819741|460285896|FG001|Overall Study|Lost to Follow-up|1|||
127906982|NCT00819741|460285895|FG000|Overall Study|Protocol Violation|3|||
127906983|NCT00819741|460285896|FG001|Overall Study|Protocol Violation|4|||
127906984|NCT00819741|460285895|FG000|Overall Study|Withdrawal by Subject|2|||
127906985|NCT00819741|460285896|FG001|Overall Study|Withdrawal by Subject|2|||
127906986|NCT00819741|460285895|FG000|Overall Study|Unclassified|6|||
127906987|NCT00819741|460285896|FG001|Overall Study|Unclassified|0|||
127906988|NCT00819741|460285895|FG000|Overall Study|Reasons unknown|3|||
127906989|NCT00819741|460285896|FG001|Overall Study|Reasons unknown|3|||
127906990|NCT00119015|460285897|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
127906991|NCT00119015|460285898|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
127906992|NCT00119015|460285899|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
127906993|NCT01597245|460285900|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
127906994|NCT01597245|460285901|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
127906995|NCT01597245|460285902|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
127906996|NCT01597245|460285903|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
127906997|NCT01597245|460285904|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
127906998|NCT01597245|460285905|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
127906999|NCT01597245|460285906|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
127907000|NCT01597245|460285907|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
127852407|NCT00437203|460076558|FG008|Overall Study|Death|0|||
127852408|NCT00437203|460076559|FG009|Overall Study|Death|1|||
127852409|NCT00437203|460076550|FG000|Overall Study|Adverse Event|1|||
127852410|NCT00437203|460076551|FG001|Overall Study|Adverse Event|1|||
127852411|NCT00437203|460076552|FG002|Overall Study|Adverse Event|0|||
127852412|NCT00437203|460076553|FG003|Overall Study|Adverse Event|0|||
127852413|NCT00437203|460076554|FG004|Overall Study|Adverse Event|0|||
127907001|NCT01597245|460285908|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
127907002|NCT01597245|460285909|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
127907003|NCT01597245|460285910|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
127907004|NCT01597245|460285911|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
127907005|NCT01597245|460285912|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
127852414|NCT00437203|460076555|FG005|Overall Study|Adverse Event|0|||
127852415|NCT00437203|460076556|FG006|Overall Study|Adverse Event|0|||
127907006|NCT01597245|460285913|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
127907007|NCT01597245|460285914|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
127907008|NCT01597245|460285915|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
127907009|NCT01597245|460285916|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
127907010|NCT01597245|460285917|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
127907011|NCT01597245|460285918|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
127907012|NCT01597245|460285919|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
127907013|NCT01597245|460285920|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
127907014|NCT01597245|460285900|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
127907015|NCT01597245|460285901|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
127907016|NCT01597245|460285902|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
127907017|NCT01597245|460285903|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
127907018|NCT01597245|460285904|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
127907019|NCT01597245|460285905|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
127907020|NCT01597245|460285906|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
127907021|NCT01597245|460285907|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
127907022|NCT01597245|460285908|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
127907023|NCT01597245|460285909|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
127907024|NCT01597245|460285910|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
127907025|NCT01597245|460285911|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
127907026|NCT01597245|460285912|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
127907027|NCT01597245|460285913|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
127907028|NCT01597245|460285914|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
127907029|NCT01597245|460285915|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
127907030|NCT01597245|460285916|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
127907031|NCT01597245|460285917|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
127907032|NCT01597245|460285918|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
127907033|NCT01597245|460285919|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
127907034|NCT01597245|460285920|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
127907035|NCT01597245|460285900|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
127907036|NCT01597245|460285901|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
127907037|NCT01597245|460285902|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
127907038|NCT01597245|460285903|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
127907039|NCT01597245|460285904|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
127907040|NCT01597245|460285905|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
127907041|NCT01597245|460285906|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
127907042|NCT01597245|460285907|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
127907043|NCT01597245|460285908|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
127907044|NCT01597245|460285909|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
127907045|NCT01597245|460285910|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
127907046|NCT01597245|460285911|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
127907047|NCT01597245|460285912|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
127907048|NCT01597245|460285913|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
127907049|NCT01597245|460285914|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
127907050|NCT01597245|460285915|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
127907051|NCT01597245|460285916|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
127907052|NCT01597245|460285917|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
127907053|NCT01597245|460285918|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
127907054|NCT01597245|460285919|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
127907055|NCT01597245|460285920|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
127907056|NCT01597245|460285900|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
127907057|NCT01597245|460285901|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
127907058|NCT01597245|460285902|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
127907059|NCT01597245|460285903|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
127907060|NCT01597245|460285904|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
127907061|NCT01597245|460285905|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
127907062|NCT01597245|460285906|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
127907063|NCT01597245|460285907|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
127907064|NCT01597245|460285908|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
127907065|NCT01597245|460285909|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
127907066|NCT01597245|460285910|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
127907067|NCT01597245|460285911|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
127907068|NCT01597245|460285912|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
127907069|NCT01597245|460285913|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
127907070|NCT01597245|460285914|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
127907071|NCT01597245|460285915|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
127907072|NCT01597245|460285916|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
127907073|NCT01597245|460285917|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
127907074|NCT01597245|460285918|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
127907075|NCT01597245|460285919|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
127907076|NCT01597245|460285920|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
127907077|NCT01597245|460285900|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
127907078|NCT01597245|460285901|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
127907079|NCT01597245|460285902|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
127907080|NCT01597245|460285903|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
127907081|NCT01597245|460285904|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
127907082|NCT01597245|460285905|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
127907083|NCT01597245|460285906|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
127907084|NCT01597245|460285907|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
127907085|NCT01597245|460285908|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
127907086|NCT01597245|460285909|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
127907087|NCT01597245|460285910|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
127907088|NCT01597245|460285911|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
127907089|NCT01597245|460285912|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
127907090|NCT01597245|460285913|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
127907091|NCT01597245|460285914|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
127907092|NCT01597245|460285915|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
127907093|NCT01597245|460285916|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
127852416|NCT00437203|460076557|FG007|Overall Study|Adverse Event|1|||
127907094|NCT01597245|460285917|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
127907095|NCT01597245|460285918|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
127907096|NCT01597245|460285919|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
127907097|NCT01597245|460285920|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
127907098|NCT01597245|460285900|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
127907099|NCT01597245|460285901|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
127907100|NCT01597245|460285902|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
127907101|NCT01597245|460285903|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
127907102|NCT01597245|460285904|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
127907103|NCT01597245|460285905|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
127907104|NCT01597245|460285906|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
127852417|NCT00437203|460076558|FG008|Overall Study|Adverse Event|0|||
127852418|NCT00437203|460076559|FG009|Overall Study|Adverse Event|1|||
127852419|NCT00437203|460076550|FG000|Overall Study|Study terminated by sponsor|0|||
127852420|NCT00437203|460076551|FG001|Overall Study|Study terminated by sponsor|0|||
127852421|NCT00437203|460076552|FG002|Overall Study|Study terminated by sponsor|0|||
127852422|NCT00437203|460076553|FG003|Overall Study|Study terminated by sponsor|0|||
127852423|NCT00437203|460076554|FG004|Overall Study|Study terminated by sponsor|0|||
127852424|NCT00437203|460076555|FG005|Overall Study|Study terminated by sponsor|0|||
127852425|NCT00437203|460076556|FG006|Overall Study|Study terminated by sponsor|0|||
127852426|NCT00437203|460076557|FG007|Overall Study|Study terminated by sponsor|0|||
127852427|NCT00437203|460076558|FG008|Overall Study|Study terminated by sponsor|1|||
127852428|NCT00437203|460076559|FG009|Overall Study|Study terminated by sponsor|0|||
127852429|NCT00437203|460076550|FG000|Overall Study|Objective progression or relapse|5|||
127852430|NCT00437203|460076551|FG001|Overall Study|Objective progression or relapse|6|||
127852431|NCT00437203|460076552|FG002|Overall Study|Objective progression or relapse|2|||
127852432|NCT00437203|460076553|FG003|Overall Study|Objective progression or relapse|3|||
127852433|NCT00437203|460076554|FG004|Overall Study|Objective progression or relapse|3|||
127852434|NCT00437203|460076555|FG005|Overall Study|Objective progression or relapse|3|||
127852435|NCT00437203|460076556|FG006|Overall Study|Objective progression or relapse|6|||
127852436|NCT00437203|460076557|FG007|Overall Study|Objective progression or relapse|1|||
127852437|NCT00437203|460076558|FG008|Overall Study|Objective progression or relapse|2|||
127852438|NCT00437203|460076559|FG009|Overall Study|Objective progression or relapse|2|||
127852439|NCT00437203|460076550|FG000|Overall Study|Other|0|||
127852440|NCT00437203|460076551|FG001|Overall Study|Other|1|||
127852441|NCT00437203|460076552|FG002|Overall Study|Other|0|||
127852442|NCT00437203|460076553|FG003|Overall Study|Other|0|||
127852443|NCT00437203|460076554|FG004|Overall Study|Other|0|||
127852444|NCT00437203|460076555|FG005|Overall Study|Other|0|||
127852445|NCT00437203|460076556|FG006|Overall Study|Other|1|||
127907105|NCT01597245|460285907|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
127907106|NCT01597245|460285908|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
127907107|NCT01597245|460285909|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
127852446|NCT00437203|460076557|FG007|Overall Study|Other|0|||
127852447|NCT00437203|460076558|FG008|Overall Study|Other|0|||
127852448|NCT00437203|460076559|FG009|Overall Study|Other|0|||
127852449|NCT01449955|460076560|FG000|Overall Study|Withdrawal by Subject|1|||
127852450|NCT01449955|460076561|FG001|Overall Study|Withdrawal by Subject|2|||
127852451|NCT00431496|460076562|FG000|Overall Study|Adverse Event|3|||
127852452|NCT00431496|460076562|FG000|Overall Study|Lost to Follow-up|1|||
127852453|NCT00431496|460076562|FG000|Overall Study|Withdrawal by Subject|2|||
127852454|NCT00431496|460076562|FG000|Overall Study|Protocol-specified criteria|5|||
127852455|NCT02566109|460076563|FG000|Overall Study|Withdrawal by Subject|1|||
127852456|NCT01906476|460076564|FG000|Overall Study|Lost to Follow-up|17|||
127852457|NCT01906476|460076565|FG001|Overall Study|Lost to Follow-up|16|||
127852458|NCT01993667|460076566|FG000|Overall Study|Insufficient data to analyze|16|||
127852459|NCT01993667|460076567|FG001|Overall Study|Insufficient data to analyze|16|||
127852460|NCT01993667|460076566|FG000|Overall Study|Insufficient altitude reached|3|||
127852461|NCT01993667|460076567|FG001|Overall Study|Insufficient altitude reached|1|||
127852462|NCT01993667|460076566|FG000|Overall Study|Lost to Follow-up|2|||
127852463|NCT01993667|460076567|FG001|Overall Study|Lost to Follow-up|2|||
127852464|NCT01931150|460076568|FG000|Overall Study|Withdrawal by Subject|1|||
127852465|NCT01931150|460076569|FG001|Overall Study|Withdrawal by Subject|2|||
127852466|NCT02896192|460076570|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
127852467|NCT02896192|460076570|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
127852468|NCT02896192|460076570|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
127852469|NCT00479167|460076575|FG000|Overall Study|Withdrawal by Subject|1|||
127852470|NCT01997281|460076580|FG000|Overall Study|Withdrawal by Subject|1|||
127852471|NCT01997281|460076581|FG001|Overall Study|Withdrawal by Subject|0|||
127852472|NCT00560794|460076582|FG000|Overall Study|Adverse Event|2|||
127852473|NCT00560794|460076582|FG000|Overall Study|Patient was not Compliant|1|||
127852474|NCT00560794|460076582|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
127852475|NCT00560794|460076582|FG000|Overall Study|Hematological Relapse|1|||
127852476|NCT00560794|460076582|FG000|Overall Study|Received Bone Marrow Transplant|6|||
127852477|NCT04857892|460076583|FG000|Part 1: Period 1 (Day 1)|Adverse Event|1|||
127852478|NCT04857892|460076584|FG001|Part 1: Period 1 (Day 1)|Adverse Event|0|||
127852479|NCT04857892|460076585|FG002|Part 1: Period 1 (Day 1)|Adverse Event|0|||
127852480|NCT04857892|460076586|FG003|Part 1: Period 1 (Day 1)|Adverse Event|0|||
127852481|NCT04857892|460076587|FG004|Part 1: Period 1 (Day 1)|Adverse Event|0|||
127852482|NCT04857892|460076583|FG000|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|2|||
127852483|NCT04857892|460076584|FG001|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
127852484|NCT04857892|460076585|FG002|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
127852485|NCT04857892|460076586|FG003|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
127852486|NCT04857892|460076587|FG004|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
127852487|NCT04857892|460076583|FG000|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
127852488|NCT04857892|460076584|FG001|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
127852489|NCT04857892|460076585|FG002|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
127852490|NCT04857892|460076586|FG003|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
127852491|NCT04857892|460076587|FG004|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|1|||
127852492|NCT02384993|460076594|FG000|Overall Study|Adverse Event|0|||
127852493|NCT02384993|460076595|FG001|Overall Study|Adverse Event|1|||
127852494|NCT01199198|460078419|FG000|Overall Study|Adverse Event|3|||
127852495|NCT01199198|460078420|FG001|Overall Study|Adverse Event|0|||
127852496|NCT01199198|460078419|FG000|Overall Study|Lost to Follow-up|1|||
127852497|NCT01199198|460078420|FG001|Overall Study|Lost to Follow-up|5|||
127852498|NCT01199198|460078419|FG000|Overall Study|Withdrawal by Subject|1|||
127852499|NCT01199198|460078420|FG001|Overall Study|Withdrawal by Subject|2|||
127852500|NCT01199198|460078419|FG000|Overall Study|ICU Transfer|1|||
127852501|NCT01199198|460078420|FG001|Overall Study|ICU Transfer|2|||
127852502|NCT01199198|460078419|FG000|Overall Study|Hospice-care transfer|1|||
127852503|NCT01199198|460078420|FG001|Overall Study|Hospice-care transfer|2|||
127852504|NCT00922974|460078421|FG000|Phase II Component|Protocol Violation|2|||
127852505|NCT00922974|460078422|FG001|Phase II Component|Protocol Violation|0|||
127852506|NCT00922974|460078421|FG000|Phase II Component|Not evaluable for treatment review|5|||
127852507|NCT00922974|460078422|FG001|Phase II Component|Not evaluable for treatment review|0|||
127852508|NCT00922974|460078421|FG000|Phase III Component|Protocol Violation|8|||
127852509|NCT00922974|460078422|FG001|Phase III Component|Protocol Violation|6|||
127852510|NCT03950440|460078423|FG000|Overall Study|Death|8|||
127852511|NCT03950440|460078424|FG001|Overall Study|Death|2|||
127852512|NCT03950440|460078425|FG002|Overall Study|Death|1|||
127852513|NCT00430027|460078426|FG000|Overall Study|Study terminated|8|||
127852514|NCT01957215|460078427|FG000|Overall Study|Adverse Event|2|||
127852515|NCT01957215|460078428|FG001|Overall Study|Adverse Event|2|||
127852516|NCT01957215|460078427|FG000|Overall Study|Lost to Follow-up|3|||
127852517|NCT01957215|460078428|FG001|Overall Study|Lost to Follow-up|3|||
127852518|NCT01957215|460078427|FG000|Overall Study|Protocol Violation|1|||
127852519|NCT01957215|460078428|FG001|Overall Study|Protocol Violation|2|||
127852520|NCT01957215|460078427|FG000|Overall Study|Withdrawal by Subject|7|||
127852521|NCT01957215|460078428|FG001|Overall Study|Withdrawal by Subject|5|||
127852522|NCT00088595|460078430|FG000|Overall Study|Adverse Event|11|||
127852523|NCT00088595|460078430|FG000|Overall Study|Withdrawal by Subject|8|||
127852524|NCT00088595|460078430|FG000|Overall Study|Ongoing (After Core)|7|||
127852525|NCT00088595|460078430|FG000|Overall Study|New Cancer Therapy|2|||
127852526|NCT00608894|460078434|FG000|Overall Study|Withdrawal by Subject|0|||
127852527|NCT00608894|460078435|FG001|Overall Study|Withdrawal by Subject|2|||
127852528|NCT01376388|460078440|FG000|Overall Study|Adverse Event|13|||
127852529|NCT01376388|460078440|FG000|Overall Study|Lack of Efficacy|2|||
127852530|NCT01376388|460078440|FG000|Overall Study|Withdrawal by Subject|3|||
127852531|NCT03938636|460078448|FG000|Overall Study|Protocol Violation|0|||
127852532|NCT03938636|460078449|FG001|Overall Study|Protocol Violation|1|||
127852533|NCT03938636|460078450|FG002|Overall Study|Protocol Violation|1|||
127852534|NCT03938636|460078448|FG000|Overall Study|Subject withdrew due to death in family|0|||
127852535|NCT03938636|460078449|FG001|Overall Study|Subject withdrew due to death in family|1|||
127852536|NCT03938636|460078450|FG002|Overall Study|Subject withdrew due to death in family|0|||
127852537|NCT03938636|460078448|FG000|Overall Study|Missed visit|0|||
127852538|NCT03938636|460078449|FG001|Overall Study|Missed visit|1|||
127852539|NCT03938636|460078450|FG002|Overall Study|Missed visit|0|||
127852540|NCT03938636|460078448|FG000|Overall Study|Adverse Event|0|||
127852541|NCT03938636|460078449|FG001|Overall Study|Adverse Event|0|||
127852542|NCT03938636|460078450|FG002|Overall Study|Adverse Event|1|||
127852543|NCT03938636|460078448|FG000|Overall Study|Lost to Follow-up|0|||
127852544|NCT03938636|460078449|FG001|Overall Study|Lost to Follow-up|0|||
127852545|NCT03938636|460078450|FG002|Overall Study|Lost to Follow-up|1|||
127852546|NCT01100658|460078451|FG000|Overall Study|Withdrawal by Subject|1|||
127852547|NCT00711412|460078452|FG000|Induction Treatment|Death|2|||
127852548|NCT00711412|460078452|FG000|Induction Treatment|Adverse Event|1|||
127852549|NCT00711412|460078452|FG000|Induction Treatment|Other|1|||
127852550|NCT00711412|460078452|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
127852551|NCT00711412|460078452|FG000|Evaluated for Combination Treatment|Death|1|||
127852552|NCT00711412|460078452|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
127852553|NCT00711412|460078452|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
127852554|NCT00711412|460078452|FG000|Combination Treatment|Progressive Disease|1|||
127852555|NCT00711412|460078452|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
127852556|NCT00711412|460078452|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
127852557|NCT00711412|460078452|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
127852558|NCT00711412|460078452|FG000|Evaluation for Response and Surgery|Death|1|||
127852559|NCT00711412|460078452|FG000|Survival Follow up Until Death|Other|12|||
127852560|NCT00420342|460078456|FG000|Overall Study|Lost to Follow-up|1|||
127852561|NCT00420342|460078457|FG001|Overall Study|Lost to Follow-up|0|||
127852562|NCT00420342|460078458|FG002|Overall Study|Lost to Follow-up|1|||
127852563|NCT00420342|460078456|FG000|Overall Study|Withdrawal by Subject|0|||
127852564|NCT00420342|460078457|FG001|Overall Study|Withdrawal by Subject|2|||
127852565|NCT00420342|460078458|FG002|Overall Study|Withdrawal by Subject|0|||
127852566|NCT01017549|460078459|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
127852567|NCT01017549|460078459|FG000|One-year Follow-up|Lost to Follow-up|2|||
127852568|NCT01017549|460078459|FG000|One-year Follow-up|Withdrawal by Subject|5|||
127852569|NCT01017549|460078459|FG000|5 Year Follow-up|Lost to Follow-up|9|||
127852570|NCT01017549|460078459|FG000|5 Year Follow-up|Mastectomy|3|||
127852571|NCT00429572|460078460|FG000|Overall Study|Disease progression|1|||
127852572|NCT01366534|460078463|FG000|Overall Study|Lost to Follow-up|1|||
127852573|NCT01366534|460078464|FG001|Overall Study|Lost to Follow-up|0|||
127852574|NCT01366534|460078465|FG002|Overall Study|Lost to Follow-up|0|||
127852575|NCT01366534|460078463|FG000|Overall Study|Migrated|1|||
127852576|NCT01366534|460078464|FG001|Overall Study|Migrated|1|||
127852577|NCT01366534|460078465|FG002|Overall Study|Migrated|0|||
127852578|NCT01366534|460078463|FG000|Overall Study|Declined challenged|0|||
127852579|NCT01366534|460078464|FG001|Overall Study|Declined challenged|1|||
127852580|NCT01366534|460078465|FG002|Overall Study|Declined challenged|0|||
127852581|NCT02565576|460078466|FG000|Overall Study|abnormal lab value|2|||
127852582|NCT02565576|460078467|FG001|Overall Study|abnormal lab value|0|||
127852583|NCT02565576|460078466|FG000|Overall Study|subject / guardian decision|1|||
127852584|NCT02565576|460078467|FG001|Overall Study|subject / guardian decision|3|||
127852585|NCT02565576|460078466|FG000|Overall Study|Lost to Follow-up|1|||
127852586|NCT02565576|460078467|FG001|Overall Study|Lost to Follow-up|0|||
127852587|NCT02565576|460078466|FG000|Overall Study|Death|0|||
127852588|NCT02565576|460078467|FG001|Overall Study|Death|2|||
127852589|NCT02565576|460078466|FG000|Overall Study|Adverse Event|1|||
127852590|NCT02565576|460078467|FG001|Overall Study|Adverse Event|0|||
127852591|NCT03345342|460078468|FG000|Open-Label Phase|Adverse Event|30|||
127852592|NCT03345342|460078469|FG001|Open-Label Phase|Adverse Event|0|||
127852593|NCT03345342|460078470|FG002|Open-Label Phase|Adverse Event|0|||
127852594|NCT03345342|460078471|FG003|Open-Label Phase|Adverse Event|0|||
127852595|NCT03345342|460078472|FG004|Open-Label Phase|Adverse Event|0|||
127852596|NCT03345342|460078468|FG000|Open-Label Phase|Death|1|||
127852597|NCT03345342|460078469|FG001|Open-Label Phase|Death|0|||
127852598|NCT03345342|460078470|FG002|Open-Label Phase|Death|0|||
127852599|NCT03345342|460078471|FG003|Open-Label Phase|Death|0|||
127852600|NCT03345342|460078472|FG004|Open-Label Phase|Death|0|||
127852601|NCT03345342|460078468|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
127852602|NCT03345342|460078469|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
127852603|NCT03345342|460078470|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
127852604|NCT03345342|460078471|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
127907108|NCT01597245|460285910|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
127907109|NCT01597245|460285911|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
127907110|NCT01597245|460285912|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
127907111|NCT01597245|460285913|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
127907112|NCT01597245|460285914|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
127907113|NCT01597245|460285915|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
127907114|NCT01597245|460285916|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
127907115|NCT01597245|460285917|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
127907116|NCT01597245|460285918|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
127907117|NCT01597245|460285919|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
127907118|NCT01597245|460285920|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
127907119|NCT01597245|460285900|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
127907120|NCT01597245|460285901|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
127907121|NCT01597245|460285902|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
127907122|NCT01597245|460285903|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
127907123|NCT01597245|460285904|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
127907124|NCT01597245|460285905|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
127907125|NCT01597245|460285906|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
127907126|NCT01597245|460285907|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
127907127|NCT01597245|460285908|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
127907128|NCT01597245|460285909|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
127907129|NCT01597245|460285910|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
127907130|NCT01597245|460285911|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
127907131|NCT01597245|460285912|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
127907132|NCT01597245|460285913|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
127907133|NCT01597245|460285914|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
127852605|NCT03345342|460078472|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
127852606|NCT03345342|460078468|FG000|Open-Label Phase|Lack of Efficacy|6|||
127852607|NCT03345342|460078469|FG001|Open-Label Phase|Lack of Efficacy|0|||
127852608|NCT03345342|460078470|FG002|Open-Label Phase|Lack of Efficacy|0|||
127852609|NCT03345342|460078471|FG003|Open-Label Phase|Lack of Efficacy|0|||
127852610|NCT03345342|460078472|FG004|Open-Label Phase|Lack of Efficacy|0|||
127852611|NCT03345342|460078468|FG000|Open-Label Phase|Lost to Follow-up|9|||
127852612|NCT03345342|460078469|FG001|Open-Label Phase|Lost to Follow-up|0|||
127852613|NCT03345342|460078470|FG002|Open-Label Phase|Lost to Follow-up|0|||
127852614|NCT03345342|460078471|FG003|Open-Label Phase|Lost to Follow-up|0|||
127852615|NCT03345342|460078472|FG004|Open-Label Phase|Lost to Follow-up|0|||
127852616|NCT03345342|460078468|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
127852617|NCT03345342|460078469|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
127852618|NCT03345342|460078470|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
127852619|NCT03345342|460078471|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
127852620|NCT03345342|460078472|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
127852621|NCT03345342|460078468|FG000|Open-Label Phase|Physician Decision|4|||
127852622|NCT03345342|460078469|FG001|Open-Label Phase|Physician Decision|0|||
127852623|NCT03345342|460078470|FG002|Open-Label Phase|Physician Decision|0|||
127852624|NCT03345342|460078471|FG003|Open-Label Phase|Physician Decision|0|||
127852625|NCT03345342|460078472|FG004|Open-Label Phase|Physician Decision|0|||
127852626|NCT03345342|460078468|FG000|Open-Label Phase|Protocol Violation|8|||
127852627|NCT03345342|460078469|FG001|Open-Label Phase|Protocol Violation|0|||
127852628|NCT03345342|460078470|FG002|Open-Label Phase|Protocol Violation|0|||
127852629|NCT03345342|460078471|FG003|Open-Label Phase|Protocol Violation|0|||
127852630|NCT03345342|460078472|FG004|Open-Label Phase|Protocol Violation|0|||
127852631|NCT03345342|460078468|FG000|Open-Label Phase|Withdrawal by Subject|57|||
127852632|NCT03345342|460078469|FG001|Open-Label Phase|Withdrawal by Subject|0|||
127852633|NCT03345342|460078470|FG002|Open-Label Phase|Withdrawal by Subject|0|||
127852634|NCT03345342|460078471|FG003|Open-Label Phase|Withdrawal by Subject|0|||
127907134|NCT01597245|460285915|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
127907135|NCT01597245|460285916|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
127907136|NCT01597245|460285917|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
127907137|NCT01597245|460285918|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
127907138|NCT01597245|460285919|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
127852635|NCT03345342|460078472|FG004|Open-Label Phase|Withdrawal by Subject|0|||
127852636|NCT03345342|460078468|FG000|Open-Label Phase|Other|15|||
127852637|NCT03345342|460078469|FG001|Open-Label Phase|Other|0|||
127852638|NCT03345342|460078470|FG002|Open-Label Phase|Other|0|||
127852639|NCT03345342|460078471|FG003|Open-Label Phase|Other|0|||
127852640|NCT03345342|460078472|FG004|Open-Label Phase|Other|0|||
127852641|NCT03345342|460078468|FG000|Double-Blind Phase|Adverse Event|0|||
127852642|NCT03345342|460078469|FG001|Double-Blind Phase|Adverse Event|1|||
127852643|NCT03345342|460078470|FG002|Double-Blind Phase|Adverse Event|6|||
127852644|NCT03345342|460078471|FG003|Double-Blind Phase|Adverse Event|0|||
127852645|NCT03345342|460078472|FG004|Double-Blind Phase|Adverse Event|0|||
127852646|NCT03345342|460078468|FG000|Double-Blind Phase|Death|0|||
127852647|NCT03345342|460078469|FG001|Double-Blind Phase|Death|2|||
127852648|NCT03345342|460078470|FG002|Double-Blind Phase|Death|1|||
127852649|NCT03345342|460078471|FG003|Double-Blind Phase|Death|0|||
127852650|NCT03345342|460078472|FG004|Double-Blind Phase|Death|0|||
127852651|NCT03345342|460078468|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
127852652|NCT03345342|460078469|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
127852653|NCT03345342|460078470|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
127852654|NCT03345342|460078471|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
127852655|NCT03345342|460078472|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
127852656|NCT03345342|460078468|FG000|Double-Blind Phase|Lost to Follow-up|0|||
127852657|NCT03345342|460078469|FG001|Double-Blind Phase|Lost to Follow-up|1|||
127852658|NCT03345342|460078470|FG002|Double-Blind Phase|Lost to Follow-up|7|||
127852659|NCT03345342|460078471|FG003|Double-Blind Phase|Lost to Follow-up|0|||
127852660|NCT03345342|460078472|FG004|Double-Blind Phase|Lost to Follow-up|0|||
127852661|NCT03345342|460078468|FG000|Double-Blind Phase|Physician Decision|0|||
127852662|NCT03345342|460078469|FG001|Double-Blind Phase|Physician Decision|1|||
127852663|NCT03345342|460078470|FG002|Double-Blind Phase|Physician Decision|4|||
127852664|NCT03345342|460078471|FG003|Double-Blind Phase|Physician Decision|0|||
127852665|NCT03345342|460078472|FG004|Double-Blind Phase|Physician Decision|0|||
127852666|NCT03345342|460078468|FG000|Double-Blind Phase|Protocol Violation|0|||
127852667|NCT03345342|460078469|FG001|Double-Blind Phase|Protocol Violation|0|||
127852668|NCT03345342|460078470|FG002|Double-Blind Phase|Protocol Violation|1|||
127852669|NCT03345342|460078471|FG003|Double-Blind Phase|Protocol Violation|0|||
127852670|NCT03345342|460078472|FG004|Double-Blind Phase|Protocol Violation|0|||
127852671|NCT03345342|460078468|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
127852672|NCT03345342|460078469|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
127852673|NCT03345342|460078470|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
127852674|NCT03345342|460078471|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
127852675|NCT03345342|460078472|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
127852676|NCT03345342|460078468|FG000|Double-Blind Phase|Other|0|||
127852677|NCT03345342|460078469|FG001|Double-Blind Phase|Other|1|||
127852678|NCT03345342|460078470|FG002|Double-Blind Phase|Other|3|||
127852679|NCT03345342|460078471|FG003|Double-Blind Phase|Other|0|||
127852680|NCT03345342|460078472|FG004|Double-Blind Phase|Other|0|||
127852681|NCT03345342|460078468|FG000|Follow-Up Phase|Adverse Event|0|||
127852682|NCT03345342|460078469|FG001|Follow-Up Phase|Adverse Event|0|||
127852683|NCT03345342|460078470|FG002|Follow-Up Phase|Adverse Event|0|||
127852684|NCT03345342|460078471|FG003|Follow-Up Phase|Adverse Event|0|||
127852685|NCT03345342|460078472|FG004|Follow-Up Phase|Adverse Event|4|||
127852686|NCT03345342|460078468|FG000|Follow-Up Phase|Lost to Follow-up|0|||
127852687|NCT03345342|460078469|FG001|Follow-Up Phase|Lost to Follow-up|0|||
127852688|NCT03345342|460078470|FG002|Follow-Up Phase|Lost to Follow-up|0|||
127852689|NCT03345342|460078471|FG003|Follow-Up Phase|Lost to Follow-up|0|||
127852690|NCT03345342|460078472|FG004|Follow-Up Phase|Lost to Follow-up|6|||
127852691|NCT03345342|460078468|FG000|Follow-Up Phase|Physician Decision|0|||
127852692|NCT03345342|460078469|FG001|Follow-Up Phase|Physician Decision|0|||
127852693|NCT03345342|460078470|FG002|Follow-Up Phase|Physician Decision|0|||
127852694|NCT03345342|460078471|FG003|Follow-Up Phase|Physician Decision|0|||
127852695|NCT03345342|460078472|FG004|Follow-Up Phase|Physician Decision|5|||
127852696|NCT03345342|460078468|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
127852697|NCT03345342|460078469|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
127852698|NCT03345342|460078470|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
127852699|NCT03345342|460078471|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
127852700|NCT03345342|460078472|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
127852701|NCT03345342|460078468|FG000|Follow-Up Phase|Other|0|||
127852702|NCT03345342|460078469|FG001|Follow-Up Phase|Other|0|||
127852703|NCT03345342|460078470|FG002|Follow-Up Phase|Other|0|||
127852704|NCT03345342|460078471|FG003|Follow-Up Phase|Other|3|||
127852705|NCT03345342|460078472|FG004|Follow-Up Phase|Other|1|||
127852706|NCT03185819|460078477|FG000|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
127852707|NCT03185819|460078478|FG001|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
127852708|NCT03185819|460078479|FG002|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
127852709|NCT03185819|460078480|FG003|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|1|||
127852710|NCT03185819|460078477|FG000|Double-Blind Phase: Day 1 to Day 25|Other|1|||
127852711|NCT03185819|460078478|FG001|Double-Blind Phase: Day 1 to Day 25|Other|0|||
127852712|NCT03185819|460078479|FG002|Double-Blind Phase: Day 1 to Day 25|Other|1|||
127852713|NCT03185819|460078480|FG003|Double-Blind Phase: Day 1 to Day 25|Other|0|||
127852714|NCT03185819|460078477|FG000|Double-Blind Phase: Day 1 to Day 25|Adverse Event|1|||
127852715|NCT03185819|460078478|FG001|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
127852716|NCT03185819|460078479|FG002|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
127907139|NCT01597245|460285920|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
127852717|NCT03185819|460078480|FG003|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
127852718|NCT03185819|460078477|FG000|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|2|||
127852719|NCT03185819|460078478|FG001|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
127852720|NCT03185819|460078479|FG002|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|1|||
127852721|NCT03185819|460078480|FG003|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
127852722|NCT03185819|460078477|FG000|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
127852723|NCT03185819|460078478|FG001|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
127852724|NCT03185819|460078479|FG002|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
127852725|NCT03185819|460078480|FG003|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|1|||
127852726|NCT03185819|460078477|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
127852727|NCT03185819|460078478|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
127852728|NCT03185819|460078479|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
127852729|NCT03185819|460078480|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
127852730|NCT03185819|460078477|FG000|Post-treatment Follow-up: Days 26 to 200|Other|1|||
127852731|NCT03185819|460078478|FG001|Post-treatment Follow-up: Days 26 to 200|Other|0|||
127852732|NCT03185819|460078479|FG002|Post-treatment Follow-up: Days 26 to 200|Other|3|||
127852733|NCT03185819|460078480|FG003|Post-treatment Follow-up: Days 26 to 200|Other|1|||
127852734|NCT03185819|460078477|FG000|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
127852735|NCT03185819|460078478|FG001|Post-treatment Follow-up: Days 26 to 200|Adverse Event|1|||
127852736|NCT03185819|460078479|FG002|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
127852737|NCT03185819|460078480|FG003|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
127852738|NCT03185819|460078477|FG000|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|1|||
127852739|NCT03185819|460078478|FG001|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
127852740|NCT03185819|460078479|FG002|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
127852741|NCT03185819|460078480|FG003|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
127852742|NCT03185819|460078477|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
127852743|NCT03185819|460078478|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
127852744|NCT03185819|460078479|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|2|||
127852745|NCT03185819|460078480|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|0|||
127852746|NCT03185819|460078477|FG000|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
127852747|NCT03185819|460078478|FG001|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
127852748|NCT03185819|460078479|FG002|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
127852749|NCT03185819|460078480|FG003|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
127852750|NCT03185819|460078477|FG000|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
127852751|NCT03185819|460078478|FG001|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|1|||
127852752|NCT03185819|460078479|FG002|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|0|||
127852753|NCT03185819|460078480|FG003|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
127852754|NCT03185819|460078477|FG000|Post-treatment Follow-up: Days 26 to 200|Death|1|||
127852755|NCT03185819|460078478|FG001|Post-treatment Follow-up: Days 26 to 200|Death|0|||
127852756|NCT03185819|460078479|FG002|Post-treatment Follow-up: Days 26 to 200|Death|0|||
127852757|NCT03185819|460078480|FG003|Post-treatment Follow-up: Days 26 to 200|Death|0|||
127852758|NCT02438787|460078481|FG000|Overall Study|Adverse Event|1|||
127852759|NCT02438787|460078482|FG001|Overall Study|Adverse Event|0|||
127852760|NCT02438787|460078483|FG002|Overall Study|Adverse Event|2|||
127852761|NCT02438787|460078481|FG000|Overall Study|Lack of Efficacy|1|||
127852762|NCT02438787|460078482|FG001|Overall Study|Lack of Efficacy|2|||
127852763|NCT02438787|460078483|FG002|Overall Study|Lack of Efficacy|0|||
127852764|NCT02438787|460078481|FG000|Overall Study|Lost to Follow-up|0|||
127852765|NCT02438787|460078482|FG001|Overall Study|Lost to Follow-up|1|||
127852766|NCT02438787|460078483|FG002|Overall Study|Lost to Follow-up|0|||
127852767|NCT02438787|460078481|FG000|Overall Study|Protocol Violation|0|||
127852768|NCT02438787|460078482|FG001|Overall Study|Protocol Violation|0|||
127852769|NCT02438787|460078483|FG002|Overall Study|Protocol Violation|1|||
127852770|NCT02438787|460078481|FG000|Overall Study|Withdrawal by Subject|15|||
127852771|NCT02438787|460078482|FG001|Overall Study|Withdrawal by Subject|7|||
127852772|NCT02438787|460078483|FG002|Overall Study|Withdrawal by Subject|10|||
127852773|NCT02438787|460078481|FG000|Overall Study|Study discontinued by sponsor|64|||
127852774|NCT02438787|460078482|FG001|Overall Study|Study discontinued by sponsor|72|||
127852775|NCT02438787|460078483|FG002|Overall Study|Study discontinued by sponsor|69|||
127852776|NCT02438787|460078481|FG000|Overall Study|Other|0|||
127852777|NCT02438787|460078482|FG001|Overall Study|Other|1|||
127852778|NCT02438787|460078483|FG002|Overall Study|Other|0|||
127852779|NCT02438787|460078481|FG000|Overall Study|Site terminated by sponsor|0|||
127852780|NCT02438787|460078482|FG001|Overall Study|Site terminated by sponsor|0|||
127852781|NCT02438787|460078483|FG002|Overall Study|Site terminated by sponsor|1|||
127852782|NCT03375203|460078484|FG000|Overall Study|Protocol Violation|0|||
127852783|NCT03375203|460078485|FG001|Overall Study|Protocol Violation|0|||
127852784|NCT03375203|460078486|FG002|Overall Study|Protocol Violation|1|||
127907140|NCT01597245|460285900|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
127907141|NCT01597245|460285901|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
127907142|NCT01597245|460285902|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
127907143|NCT01597245|460285903|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
127907144|NCT01597245|460285904|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
127907145|NCT01597245|460285905|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
127907146|NCT01597245|460285906|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
127907147|NCT01597245|460285907|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
127852785|NCT03375203|460078487|FG003|Overall Study|Protocol Violation|0|||
127852786|NCT03375203|460078488|FG004|Overall Study|Protocol Violation|0|||
127852787|NCT03375203|460078484|FG000|Overall Study|Adverse Event|2|||
127852788|NCT03375203|460078485|FG001|Overall Study|Adverse Event|3|||
127852789|NCT03375203|460078486|FG002|Overall Study|Adverse Event|0|||
127852790|NCT03375203|460078487|FG003|Overall Study|Adverse Event|2|||
127852791|NCT03375203|460078488|FG004|Overall Study|Adverse Event|2|||
127852792|NCT03375203|460078484|FG000|Overall Study|Withdrawal by Subject|3|||
127852793|NCT03375203|460078485|FG001|Overall Study|Withdrawal by Subject|0|||
127852794|NCT03375203|460078486|FG002|Overall Study|Withdrawal by Subject|1|||
127852795|NCT03375203|460078487|FG003|Overall Study|Withdrawal by Subject|0|||
127852796|NCT03375203|460078488|FG004|Overall Study|Withdrawal by Subject|2|||
127852797|NCT03375203|460078484|FG000|Overall Study|Non-compliance with study drug|1|||
127852798|NCT03375203|460078485|FG001|Overall Study|Non-compliance with study drug|0|||
127852799|NCT03375203|460078486|FG002|Overall Study|Non-compliance with study drug|0|||
127852800|NCT03375203|460078487|FG003|Overall Study|Non-compliance with study drug|0|||
127852801|NCT03375203|460078488|FG004|Overall Study|Non-compliance with study drug|0|||
127852802|NCT03375203|460078484|FG000|Overall Study|Randomized, not treated.|0|||
127852803|NCT03375203|460078485|FG001|Overall Study|Randomized, not treated.|1|||
127852804|NCT03375203|460078486|FG002|Overall Study|Randomized, not treated.|0|||
127852805|NCT03375203|460078487|FG003|Overall Study|Randomized, not treated.|0|||
127852806|NCT03375203|460078488|FG004|Overall Study|Randomized, not treated.|0|||
127852807|NCT03321526|460078489|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
127852808|NCT03321526|460078490|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
127852809|NCT03321526|460078489|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
127852810|NCT03321526|460078490|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
127852811|NCT03321526|460078489|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
127852812|NCT03321526|460078490|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
127852813|NCT03321526|460078489|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
127852814|NCT03321526|460078490|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
127852815|NCT03321526|460078489|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
127852816|NCT03321526|460078490|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
127852817|NCT03321526|460078489|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
127852818|NCT03321526|460078490|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
127852819|NCT03321526|460078489|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
127852820|NCT03321526|460078490|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
127852821|NCT03321526|460078489|FG000|Follow-up Phase (2 Weeks)|Other|24|||
127852822|NCT03321526|460078490|FG001|Follow-up Phase (2 Weeks)|Other|24|||
127852823|NCT00732641|460078491|FG000|Overall Study|Relapse or Progressive Disease|65|||
127852824|NCT00732641|460078492|FG001|Overall Study|Relapse or Progressive Disease|101|||
127852825|NCT00732641|460078491|FG000|Overall Study|Serious Adverse Events|12|||
127852826|NCT00732641|460078492|FG001|Overall Study|Serious Adverse Events|3|||
127852827|NCT00732641|460078491|FG000|Overall Study|Physician Decision|6|||
127852828|NCT00732641|460078492|FG001|Overall Study|Physician Decision|0|||
127852829|NCT00732641|460078491|FG000|Overall Study|Withdrawal by Subject|4|||
127852830|NCT00732641|460078492|FG001|Overall Study|Withdrawal by Subject|2|||
127852831|NCT00732641|460078491|FG000|Overall Study|Unable to Complete|1|||
127852832|NCT00732641|460078492|FG001|Overall Study|Unable to Complete|1|||
127852833|NCT00732641|460078491|FG000|Overall Study|Other|18|||
127852834|NCT00732641|460078492|FG001|Overall Study|Other|5|||
127907148|NCT01597245|460285908|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
127852835|NCT02939976|460078493|FG000|Overall Study|Lost to Follow-up|7|||
127852836|NCT02939976|460078494|FG001|Overall Study|Lost to Follow-up|1|||
127852837|NCT02939976|460078495|FG002|Overall Study|Lost to Follow-up|1|||
127852838|NCT02939976|460078496|FG003|Overall Study|Lost to Follow-up|2|||
127907149|NCT01597245|460285909|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
127907150|NCT01597245|460285910|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
127852839|NCT02939976|460078493|FG000|Overall Study|Withdrawal by Subject|4|||
127852840|NCT02939976|460078494|FG001|Overall Study|Withdrawal by Subject|0|||
127852841|NCT02939976|460078495|FG002|Overall Study|Withdrawal by Subject|2|||
127852842|NCT02939976|460078496|FG003|Overall Study|Withdrawal by Subject|4|||
127852843|NCT02939976|460078493|FG000|Overall Study|Due to early study closure|4|||
127852844|NCT02939976|460078494|FG001|Overall Study|Due to early study closure|3|||
127852845|NCT02939976|460078495|FG002|Overall Study|Due to early study closure|2|||
127852846|NCT02939976|460078496|FG003|Overall Study|Due to early study closure|3|||
127852847|NCT01872897|460078497|FG000|Overall Study|Withdrawal by Subject|1|||
127852848|NCT01872897|460078498|FG001|Overall Study|Withdrawal by Subject|0|||
127852849|NCT02418585|460078501|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
127852850|NCT02418585|460078502|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
127852851|NCT02418585|460078501|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
127852852|NCT02418585|460078502|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
127852853|NCT02418585|460078501|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
127852854|NCT02418585|460078502|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
127852855|NCT02418585|460078501|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
127852856|NCT02418585|460078502|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
127852857|NCT02418585|460078501|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
127852858|NCT02418585|460078502|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
127852859|NCT02418585|460078501|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
127852860|NCT02418585|460078502|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
127852861|NCT02418585|460078501|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
127852862|NCT02418585|460078502|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
127852863|NCT02418585|460078501|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
127852864|NCT02418585|460078502|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
127852865|NCT02418585|460078501|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
127852866|NCT02418585|460078502|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
127852867|NCT02418585|460078501|FG000|Follow-up Phase (24 Weeks)|Other|3|||
127852868|NCT02418585|460078502|FG001|Follow-up Phase (24 Weeks)|Other|2|||
127852869|NCT02040857|460078503|FG000|Overall Study|Adverse Event|14|||
127852870|NCT02040857|460078503|FG000|Overall Study|Physician Decision|5|||
127852871|NCT02040857|460078503|FG000|Overall Study|Withdrawal by Subject|31|||
127852872|NCT02040857|460078503|FG000|Overall Study|patient non-compliance|3|||
127852873|NCT02040857|460078503|FG000|Overall Study|Lost to Follow-up|2|||
127852874|NCT02040857|460078503|FG000|Overall Study|recurrence|4|||
127852875|NCT02040857|460078503|FG000|Overall Study|ineligible|1|||
127852876|NCT04159701|460078504|FG000|Period 1: Treatment Period|Pregnancy|1|||
127852877|NCT04159701|460078505|FG001|Period 1: Treatment Period|Pregnancy|0|||
127852878|NCT04159701|460078504|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
127852879|NCT04159701|460078505|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
127852880|NCT04159701|460078504|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
127852881|NCT04159701|460078505|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
127852882|NCT04159701|460078504|FG000|Washout Period|site terminated by sponsor|0|||
127852883|NCT04159701|460078505|FG001|Washout Period|site terminated by sponsor|1|||
127852884|NCT04159701|460078504|FG000|Washout Period|study terminated by sponsor|10|||
127852885|NCT04159701|460078505|FG001|Washout Period|study terminated by sponsor|3|||
127852886|NCT04159701|460078504|FG000|Washout Period|Withdrawal by Subject|1|||
127852887|NCT04159701|460078505|FG001|Washout Period|Withdrawal by Subject|0|||
127852888|NCT04159701|460078504|FG000|Washout Period|Inadvertent Enrollment|1|||
127852889|NCT04159701|460078505|FG001|Washout Period|Inadvertent Enrollment|0|||
127852890|NCT04159701|460078504|FG000|Washout Period|Miscellaneous|1|||
127852891|NCT04159701|460078505|FG001|Washout Period|Miscellaneous|0|||
127852892|NCT04159701|460078504|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
127852893|NCT04159701|460078505|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
127852894|NCT04159701|460078504|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
127852895|NCT04159701|460078505|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
127852896|NCT04159701|460078504|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
127852897|NCT04159701|460078505|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
127852898|NCT04159701|460078504|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
127852899|NCT04159701|460078505|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
127852900|NCT04159701|460078504|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
127852901|NCT04159701|460078505|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
127852902|NCT01782885|460078507|FG000|Overall Study|Lost to Follow-up|4|||
127852903|NCT01782885|460078508|FG001|Overall Study|Lost to Follow-up|6|||
127852904|NCT00481988|460078509|FG000|Overall Study|Withdrawal by Subject|1|||
127852905|NCT00481988|460078510|FG001|Overall Study|Withdrawal by Subject|1|||
127852906|NCT00654420|460078511|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
127852907|NCT00654420|460078512|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
127852908|NCT00654420|460078513|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
127852909|NCT00654420|460078514|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
127852910|NCT00654420|460078511|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
127852911|NCT00654420|460078512|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
127852912|NCT00654420|460078513|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
127852913|NCT00654420|460078514|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
127852914|NCT00654420|460078511|FG000|Phase II|Adverse Event|0|||
127852915|NCT00654420|460078512|FG001|Phase II|Adverse Event|0|||
127852916|NCT00654420|460078513|FG002|Phase II|Adverse Event|3|||
127852917|NCT00654420|460078514|FG003|Phase II|Adverse Event|3|||
127852918|NCT00654420|460078511|FG000|Phase II|Lost to Follow-up|0|||
127852919|NCT00654420|460078512|FG001|Phase II|Lost to Follow-up|0|||
127907151|NCT01597245|460285911|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
127907152|NCT01597245|460285912|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
127907153|NCT01597245|460285913|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
127907154|NCT01597245|460285914|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
127907155|NCT01597245|460285915|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
127907156|NCT01597245|460285916|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
127907157|NCT01597245|460285917|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
127907158|NCT01597245|460285918|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
127907159|NCT01597245|460285919|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
127907160|NCT01597245|460285920|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
127907161|NCT01597245|460285900|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
127907162|NCT01597245|460285901|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
127907163|NCT01597245|460285902|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
127907164|NCT01597245|460285903|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
127907165|NCT01597245|460285904|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
127907166|NCT01597245|460285905|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
127907167|NCT01597245|460285906|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
127907168|NCT01597245|460285907|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
127907169|NCT01597245|460285908|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
127907170|NCT01597245|460285909|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
127907171|NCT01597245|460285910|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
127907172|NCT01597245|460285911|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
127907173|NCT01597245|460285912|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
127907174|NCT01597245|460285913|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
127907175|NCT01597245|460285914|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
127907176|NCT01597245|460285915|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
127907177|NCT01597245|460285916|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
127907178|NCT01597245|460285917|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
127907179|NCT01597245|460285918|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
127907180|NCT01597245|460285919|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
127907181|NCT01597245|460285920|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
127907182|NCT01597245|460285900|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
127852920|NCT00654420|460078513|FG002|Phase II|Lost to Follow-up|0|||
127852921|NCT00654420|460078514|FG003|Phase II|Lost to Follow-up|1|||
127852922|NCT00654420|460078511|FG000|Phase II|Physician Decision|0|||
127852923|NCT00654420|460078512|FG001|Phase II|Physician Decision|0|||
127852924|NCT00654420|460078513|FG002|Phase II|Physician Decision|0|||
127852925|NCT00654420|460078514|FG003|Phase II|Physician Decision|4|||
127852926|NCT00654420|460078511|FG000|Phase II|Progressive Disease|0|||
127852927|NCT00654420|460078512|FG001|Phase II|Progressive Disease|0|||
127852928|NCT00654420|460078513|FG002|Phase II|Progressive Disease|29|||
127852929|NCT00654420|460078514|FG003|Phase II|Progressive Disease|29|||
127852930|NCT00654420|460078511|FG000|Phase II|Withdrawal by Subject|0|||
127852931|NCT00654420|460078512|FG001|Phase II|Withdrawal by Subject|0|||
127852932|NCT00654420|460078513|FG002|Phase II|Withdrawal by Subject|4|||
127852933|NCT00654420|460078514|FG003|Phase II|Withdrawal by Subject|1|||
127852934|NCT00654420|460078511|FG000|Phase II|Missing Disposition Record|0|||
127852935|NCT00654420|460078512|FG001|Phase II|Missing Disposition Record|0|||
127852936|NCT00654420|460078513|FG002|Phase II|Missing Disposition Record|1|||
127852937|NCT00654420|460078514|FG003|Phase II|Missing Disposition Record|0|||
127852938|NCT00471276|460078516|FG000|Overall Study|Death|2|||
127852939|NCT00471276|460078516|FG000|Overall Study|Adverse Event|16|||
127852940|NCT00471276|460078516|FG000|Overall Study|Protocol Violation|1|||
127852941|NCT00471276|460078516|FG000|Overall Study|Objective progression or relapse|54|||
127852942|NCT00471276|460078516|FG000|Overall Study|Global deterioration of health status|1|||
127852943|NCT00471276|460078516|FG000|Overall Study|Other|3|||
127852944|NCT00471276|460078516|FG000|Overall Study|Refused treatment|6|||
127852945|NCT00701103|460078517|FG000|Overall Study|Adverse Event|0|||
127852946|NCT00701103|460078518|FG001|Overall Study|Adverse Event|0|||
127852947|NCT00701103|460078519|FG002|Overall Study|Adverse Event|1|||
127852948|NCT00701103|460078520|FG003|Overall Study|Adverse Event|1|||
127852949|NCT00701103|460078521|FG004|Overall Study|Adverse Event|0|||
127852950|NCT00701103|460078522|FG005|Overall Study|Adverse Event|1|||
127852951|NCT00701103|460078523|FG006|Overall Study|Adverse Event|1|||
127852952|NCT00701103|460078524|FG007|Overall Study|Adverse Event|0|||
127852953|NCT00701103|460078525|FG008|Overall Study|Adverse Event|0|||
127852954|NCT00701103|460078526|FG009|Overall Study|Adverse Event|2|||
127852955|NCT00701103|460078527|FG010|Overall Study|Adverse Event|0|||
127852956|NCT00701103|460078517|FG000|Overall Study|Progressive Disease|5|||
127852957|NCT00701103|460078518|FG001|Overall Study|Progressive Disease|2|||
127852958|NCT00701103|460078519|FG002|Overall Study|Progressive Disease|6|||
127852959|NCT00701103|460078520|FG003|Overall Study|Progressive Disease|5|||
127852960|NCT00701103|460078521|FG004|Overall Study|Progressive Disease|6|||
127907183|NCT01597245|460285901|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
127907184|NCT01597245|460285902|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
127852961|NCT00701103|460078522|FG005|Overall Study|Progressive Disease|5|||
127852962|NCT00701103|460078523|FG006|Overall Study|Progressive Disease|7|||
127907185|NCT01597245|460285903|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
127907186|NCT01597245|460285904|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
127907187|NCT01597245|460285905|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
127907188|NCT01597245|460285906|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
127907189|NCT01597245|460285907|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
127907190|NCT01597245|460285908|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
127907191|NCT01597245|460285909|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
127907192|NCT01597245|460285910|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
127907193|NCT01597245|460285911|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
127907194|NCT01597245|460285912|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
127907195|NCT01597245|460285913|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
127907196|NCT01597245|460285914|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
127907197|NCT01597245|460285915|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
127907198|NCT01597245|460285916|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
127907199|NCT01597245|460285917|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
127907200|NCT01597245|460285918|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
127907201|NCT01597245|460285919|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
127907202|NCT01597245|460285920|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
127907203|NCT01597245|460285900|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
127907204|NCT01597245|460285901|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
127907205|NCT01597245|460285902|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
127852963|NCT00701103|460078524|FG007|Overall Study|Progressive Disease|7|||
127852964|NCT00701103|460078525|FG008|Overall Study|Progressive Disease|8|||
127852965|NCT00701103|460078526|FG009|Overall Study|Progressive Disease|8|||
127852966|NCT00701103|460078527|FG010|Overall Study|Progressive Disease|11|||
127852967|NCT00701103|460078517|FG000|Overall Study|Withdrawal by Subject|0|||
127852968|NCT00701103|460078518|FG001|Overall Study|Withdrawal by Subject|1|||
127852969|NCT00701103|460078519|FG002|Overall Study|Withdrawal by Subject|1|||
127852970|NCT00701103|460078520|FG003|Overall Study|Withdrawal by Subject|0|||
127852971|NCT00701103|460078521|FG004|Overall Study|Withdrawal by Subject|0|||
127852972|NCT00701103|460078522|FG005|Overall Study|Withdrawal by Subject|0|||
127852973|NCT00701103|460078523|FG006|Overall Study|Withdrawal by Subject|0|||
127852974|NCT00701103|460078524|FG007|Overall Study|Withdrawal by Subject|0|||
127852975|NCT00701103|460078525|FG008|Overall Study|Withdrawal by Subject|0|||
127852976|NCT00701103|460078526|FG009|Overall Study|Withdrawal by Subject|0|||
127852977|NCT00701103|460078527|FG010|Overall Study|Withdrawal by Subject|0|||
127852978|NCT00701103|460078517|FG000|Overall Study|Other|0|||
127852979|NCT00701103|460078518|FG001|Overall Study|Other|0|||
127852980|NCT00701103|460078519|FG002|Overall Study|Other|0|||
127852981|NCT00701103|460078520|FG003|Overall Study|Other|0|||
127852982|NCT00701103|460078521|FG004|Overall Study|Other|0|||
127852983|NCT00701103|460078522|FG005|Overall Study|Other|0|||
127852984|NCT00701103|460078523|FG006|Overall Study|Other|0|||
127852985|NCT00701103|460078524|FG007|Overall Study|Other|0|||
127852986|NCT00701103|460078525|FG008|Overall Study|Other|1|||
127852987|NCT00701103|460078526|FG009|Overall Study|Other|1|||
127852988|NCT00701103|460078527|FG010|Overall Study|Other|0|||
127852989|NCT00179517|460078528|FG000|Overall Study|Withdrawal by Subject|2|||
127852990|NCT00179517|460078529|FG001|Overall Study|Withdrawal by Subject|1|||
127907206|NCT01597245|460285903|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
127907207|NCT01597245|460285904|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
127907208|NCT01597245|460285905|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
127852991|NCT00361218|460078536|FG000|Overall Study|Lost to Follow-up|11|||
127852992|NCT00361218|460078536|FG000|Overall Study|Personal Reasons|7|||
127852993|NCT00361218|460078536|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
127852994|NCT01570309|460078539|FG000|Overall Study|Withdrawal by Subject|3|||
127852995|NCT01570309|460078540|FG001|Overall Study|Withdrawal by Subject|3|||
127852996|NCT01390038|460078541|FG000|Overall Study|Death|1|||
127852997|NCT01390038|460078541|FG000|Overall Study|Lost to Follow-up|1|||
127852998|NCT01390038|460078541|FG000|Overall Study|Withdrawal by Subject|4|||
127852999|NCT01390038|460078541|FG000|Overall Study|Simpliciti System Removal|2|||
127853000|NCT00368472|460078542|FG000|Overall Study|Adverse Event|22|||
127853001|NCT00368472|460078542|FG000|Overall Study|Medication non-compliance|4|||
127853002|NCT00368472|460078542|FG000|Overall Study|Protocol Violation|2|||
127853003|NCT00368472|460078542|FG000|Overall Study|Request of Investigator or Sponsor|3|||
127853004|NCT00368472|460078542|FG000|Overall Study|Withdrawal by Subject|40|||
127853005|NCT00368472|460078542|FG000|Overall Study|Diary non-compliance|1|||
127907209|NCT01597245|460285906|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
127907210|NCT01597245|460285907|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
127907211|NCT01597245|460285908|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
127907212|NCT01597245|460285909|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
127907213|NCT01597245|460285910|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
127907214|NCT01597245|460285911|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
127907215|NCT01597245|460285912|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
127907216|NCT01597245|460285913|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
127907217|NCT01597245|460285914|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
127907218|NCT01597245|460285915|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
127907219|NCT01597245|460285916|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
127907220|NCT01597245|460285917|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
127907221|NCT01597245|460285918|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
127853006|NCT00368472|460078542|FG000|Overall Study|Other|32|||
127853007|NCT00368472|460078542|FG000|Overall Study|Missing Final Disposition Date|1|||
127853008|NCT04095793|460078546|FG000|Overall Study|Adverse Event|3|||
127853009|NCT04095793|460078546|FG000|Overall Study|Study Terminated by Sponsor|103|||
127853010|NCT04095793|460078546|FG000|Overall Study|Withdrawal by Subject|4|||
127853011|NCT03619837|460078547|FG000|Screening|received organs from HCV-negative donors|47|||
127853012|NCT03619837|460078547|FG000|Screening|died on the wait-list|2|||
127853013|NCT03619837|460078547|FG000|Screening|remained on the wait list|40|||
127853014|NCT03619837|460078547|FG000|Screening|didn't meet eligibility criteria|3|||
127853015|NCT03619837|460078547|FG000|Screening|withdrew consent|2|||
127853016|NCT03619837|460078547|FG000|Screening|never listed for HCV-viremic donor|1|||
127853017|NCT03619837|460078547|FG000|Screening|developed exclusion criteria|2|||
127853018|NCT03619837|460078547|FG000|Screening|excluded by the investigator due to non-compliance|1|||
127853019|NCT00044213|460078548|FG000|Overall Study|Withdrawal by Subject|50|||
127853020|NCT00044213|460078549|FG001|Overall Study|Withdrawal by Subject|65|||
127853021|NCT00044213|460078550|FG002|Overall Study|Withdrawal by Subject|91|||
127853022|NCT00044213|460078551|FG003|Overall Study|Withdrawal by Subject|83|||
127853023|NCT00044213|460078548|FG000|Overall Study|Death|42|||
127853024|NCT00044213|460078549|FG001|Overall Study|Death|42|||
127853025|NCT00044213|460078550|FG002|Overall Study|Death|42|||
127853026|NCT00044213|460078551|FG003|Overall Study|Death|49|||
127853027|NCT00044213|460078548|FG000|Overall Study|Lost to Follow-up|8|||
127853028|NCT00044213|460078549|FG001|Overall Study|Lost to Follow-up|5|||
127853029|NCT00044213|460078550|FG002|Overall Study|Lost to Follow-up|5|||
127853030|NCT00044213|460078551|FG003|Overall Study|Lost to Follow-up|4|||
127853031|NCT01927068|460078553|FG000|Overall Study|Death|37|||
127853032|NCT01927068|460078554|FG001|Overall Study|Death|3|||
127853033|NCT01927068|460078553|FG000|Overall Study|Withdrawal by Subject|50|||
127853034|NCT01927068|460078554|FG001|Overall Study|Withdrawal by Subject|3|||
127853035|NCT01927068|460078553|FG000|Overall Study|Lost to Follow-up|10|||
127853036|NCT01927068|460078554|FG001|Overall Study|Lost to Follow-up|2|||
127853037|NCT01927068|460078553|FG000|Overall Study|Physician Decision|9|||
127853038|NCT01927068|460078554|FG001|Overall Study|Physician Decision|0|||
127853039|NCT01927068|460078553|FG000|Overall Study|Missed last follow-up visit|2|||
127853040|NCT01927068|460078554|FG001|Overall Study|Missed last follow-up visit|0|||
127853041|NCT00880607|460078555|FG000|Overall Study|Physician Decision|2|||
127853042|NCT00880607|460078556|FG001|Overall Study|Physician Decision|2|||
127853043|NCT00880607|460078555|FG000|Overall Study|Protocol Violation|2|||
127853044|NCT00880607|460078556|FG001|Overall Study|Protocol Violation|1|||
127853045|NCT00880607|460078555|FG000|Overall Study|surgery did not extend past L1 level|3|||
127853046|NCT00880607|460078556|FG001|Overall Study|surgery did not extend past L1 level|0|||
127853047|NCT02963766|460078558|FG000|Double-Blind Period|Adverse Event|1|||
127907222|NCT01597245|460285919|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
127853048|NCT02963766|460078559|FG001|Double-Blind Period|Adverse Event|0|||
127853049|NCT02963766|460078560|FG002|Double-Blind Period|Adverse Event|1|||
127853050|NCT02963766|460078558|FG000|Double-Blind Period|Physician Decision|1|||
127853051|NCT02963766|460078559|FG001|Double-Blind Period|Physician Decision|0|||
127853052|NCT02963766|460078560|FG002|Double-Blind Period|Physician Decision|0|||
127853053|NCT02963766|460078558|FG000|Double-Blind Period|Withdrawal by Subject|1|||
127853054|NCT02963766|460078559|FG001|Double-Blind Period|Withdrawal by Subject|1|||
127853055|NCT02963766|460078560|FG002|Double-Blind Period|Withdrawal by Subject|0|||
127853056|NCT02963766|460078558|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
127853057|NCT02963766|460078559|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
127853058|NCT02963766|460078560|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
127853059|NCT02963766|460078558|FG000|Double-Blind Period|Protocol Violation|1|||
127853060|NCT02963766|460078559|FG001|Double-Blind Period|Protocol Violation|0|||
127853061|NCT02963766|460078560|FG002|Double-Blind Period|Protocol Violation|0|||
127853062|NCT02963766|460078558|FG000|Double-Blind Period|Lost to Follow-up|0|||
127853063|NCT02963766|460078559|FG001|Double-Blind Period|Lost to Follow-up|1|||
127853064|NCT02963766|460078560|FG002|Double-Blind Period|Lost to Follow-up|0|||
127907223|NCT01597245|460285920|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
127907224|NCT01597245|460285900|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
127907225|NCT01597245|460285901|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
127907226|NCT01597245|460285902|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
127907227|NCT01597245|460285903|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
127907228|NCT01597245|460285904|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
127907229|NCT01597245|460285905|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
127907230|NCT01597245|460285906|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
127907231|NCT01597245|460285907|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
127907232|NCT01597245|460285908|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
127907233|NCT01597245|460285909|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
127907234|NCT01597245|460285910|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
127907235|NCT01597245|460285911|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
127907236|NCT01597245|460285912|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
127907237|NCT01597245|460285913|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
127907238|NCT01597245|460285914|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
127907239|NCT01597245|460285915|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
127907240|NCT01597245|460285916|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
127907241|NCT01597245|460285917|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
127907242|NCT01597245|460285918|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
127907243|NCT01597245|460285919|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
127907244|NCT01597245|460285920|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
127907245|NCT01597245|460285900|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
127907246|NCT01597245|460285901|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
127907247|NCT01597245|460285902|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
127907248|NCT01597245|460285903|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
127907249|NCT01597245|460285904|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
127907250|NCT01597245|460285905|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
127907251|NCT01597245|460285906|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
127907252|NCT01597245|460285907|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
127907253|NCT01597245|460285908|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
127907254|NCT01597245|460285909|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
127907255|NCT01597245|460285910|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
127907256|NCT01597245|460285911|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
127907257|NCT01597245|460285912|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
127907258|NCT01597245|460285913|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
127907259|NCT01597245|460285914|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
127907260|NCT01597245|460285915|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
127907261|NCT01597245|460285916|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
127907262|NCT01597245|460285917|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
127907263|NCT01597245|460285918|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
127907264|NCT01597245|460285919|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
127907265|NCT01597245|460285920|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
127907266|NCT01597245|460285900|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
127907267|NCT01597245|460285901|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
127907268|NCT01597245|460285902|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
127907269|NCT01597245|460285903|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
127907270|NCT01597245|460285904|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
127907271|NCT01597245|460285905|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
127907272|NCT01597245|460285906|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
127907273|NCT01597245|460285907|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
127907274|NCT01597245|460285908|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
127907275|NCT01597245|460285909|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
127907276|NCT01597245|460285910|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
127907277|NCT01597245|460285911|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
127907278|NCT01597245|460285912|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
127907279|NCT01597245|460285913|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
127907280|NCT01597245|460285914|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
127907281|NCT01597245|460285915|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
127907282|NCT01597245|460285916|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
127907283|NCT01597245|460285917|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
127907284|NCT01597245|460285918|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
127907285|NCT01597245|460285919|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
127907286|NCT01597245|460285920|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
127907287|NCT01597245|460285900|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
127907288|NCT01597245|460285901|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
127907289|NCT01597245|460285902|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
127907290|NCT01597245|460285903|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
127907291|NCT01597245|460285904|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
127907292|NCT01597245|460285905|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
127907293|NCT01597245|460285906|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
127907294|NCT01597245|460285907|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
127907295|NCT01597245|460285908|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
127907296|NCT01597245|460285909|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
127907297|NCT01597245|460285910|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
127907298|NCT01597245|460285911|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
127907299|NCT01597245|460285912|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
127907300|NCT01597245|460285913|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
127907301|NCT01597245|460285914|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
127907302|NCT01597245|460285915|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
127907303|NCT01597245|460285916|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
127907304|NCT01597245|460285917|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
127907305|NCT01597245|460285918|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
127907306|NCT01597245|460285919|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
127907307|NCT01597245|460285920|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
127907308|NCT01597245|460285900|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
127907309|NCT01597245|460285901|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
127907310|NCT01597245|460285902|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
127907311|NCT01597245|460285903|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
127907312|NCT01597245|460285904|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
127907313|NCT01597245|460285905|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
127907314|NCT01597245|460285906|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
127853065|NCT02963766|460078558|FG000|Open Label Extension (OLE)|Physician Decision|1|||
127853066|NCT02963766|460078559|FG001|Open Label Extension (OLE)|Physician Decision|2|||
127853067|NCT02963766|460078560|FG002|Open Label Extension (OLE)|Physician Decision|2|||
127853068|NCT02963766|460078558|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
127853069|NCT02963766|460078559|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
127853070|NCT02963766|460078560|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
127853071|NCT00499460|460078561|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
127853072|NCT00499460|460078562|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
127853073|NCT00499460|460078561|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
127853074|NCT00499460|460078562|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
127853075|NCT00499460|460078561|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
127853076|NCT00499460|460078562|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
127853077|NCT00814307|460078563|FG000|Overall Study|Randomized but not treated|1|||
127853078|NCT00814307|460078564|FG001|Overall Study|Randomized but not treated|0|||
127853079|NCT00814307|460078565|FG002|Overall Study|Randomized but not treated|0|||
127853080|NCT00814307|460078566|FG003|Overall Study|Randomized but not treated|0|||
127853081|NCT00814307|460078563|FG000|Overall Study|Adverse Event|3|||
127853082|NCT00814307|460078564|FG001|Overall Study|Adverse Event|9|||
127853083|NCT00814307|460078565|FG002|Overall Study|Adverse Event|3|||
127853084|NCT00814307|460078566|FG003|Overall Study|Adverse Event|2|||
127853085|NCT00814307|460078563|FG000|Overall Study|Lack of Efficacy|1|||
127853086|NCT00814307|460078564|FG001|Overall Study|Lack of Efficacy|1|||
127853087|NCT00814307|460078565|FG002|Overall Study|Lack of Efficacy|3|||
127853088|NCT00814307|460078566|FG003|Overall Study|Lack of Efficacy|4|||
127853089|NCT00814307|460078563|FG000|Overall Study|Other|1|||
127853090|NCT00814307|460078564|FG001|Overall Study|Other|2|||
127853091|NCT00814307|460078565|FG002|Overall Study|Other|0|||
127853092|NCT00814307|460078566|FG003|Overall Study|Other|1|||
127853093|NCT00814307|460078563|FG000|Overall Study|Protocol Violation|2|||
127853094|NCT00814307|460078564|FG001|Overall Study|Protocol Violation|8|||
127853095|NCT00814307|460078565|FG002|Overall Study|Protocol Violation|1|||
127853096|NCT00814307|460078566|FG003|Overall Study|Protocol Violation|1|||
127853097|NCT00814307|460078563|FG000|Overall Study|Withdrawal by Subject|4|||
127853098|NCT00814307|460078564|FG001|Overall Study|Withdrawal by Subject|6|||
127853099|NCT00814307|460078565|FG002|Overall Study|Withdrawal by Subject|0|||
127853100|NCT00814307|460078566|FG003|Overall Study|Withdrawal by Subject|2|||
127853101|NCT00814307|460078563|FG000|Overall Study|Death|0|||
127853102|NCT00814307|460078564|FG001|Overall Study|Death|1|||
127853103|NCT00814307|460078565|FG002|Overall Study|Death|0|||
127853104|NCT00814307|460078566|FG003|Overall Study|Death|0|||
127853105|NCT02290340|460078568|FG000|Overall Study|Lost to Follow-up|0|||
127853106|NCT02290340|460078569|FG001|Overall Study|Lost to Follow-up|0|||
127907315|NCT01597245|460285907|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
127853107|NCT02290340|460078570|FG002|Overall Study|Lost to Follow-up|0|||
127853108|NCT02290340|460078571|FG003|Overall Study|Lost to Follow-up|1|||
127853109|NCT02290340|460078568|FG000|Overall Study|Withdrawal by Subject|1|||
127853110|NCT02290340|460078569|FG001|Overall Study|Withdrawal by Subject|0|||
127853111|NCT02290340|460078570|FG002|Overall Study|Withdrawal by Subject|0|||
127853112|NCT02290340|460078571|FG003|Overall Study|Withdrawal by Subject|0|||
127853113|NCT02290340|460078568|FG000|Overall Study|Other|1|||
127853114|NCT02290340|460078569|FG001|Overall Study|Other|0|||
127853115|NCT02290340|460078570|FG002|Overall Study|Other|0|||
127853116|NCT02290340|460078571|FG003|Overall Study|Other|1|||
127853117|NCT01594749|460080645|FG000|Overall Study|Adverse Event|2|||
127853118|NCT01594749|460080646|FG001|Overall Study|Adverse Event|1|||
127853119|NCT01594749|460080645|FG000|Overall Study|Withdrawal by Subject|2|||
127853120|NCT01594749|460080646|FG001|Overall Study|Withdrawal by Subject|2|||
127853121|NCT01594749|460080645|FG000|Overall Study|Protocol Violation|2|||
127853122|NCT01594749|460080646|FG001|Overall Study|Protocol Violation|0|||
127853123|NCT01594749|460080645|FG000|Overall Study|Physician Decision|1|||
127853124|NCT01594749|460080646|FG001|Overall Study|Physician Decision|1|||
127853125|NCT01594749|460080645|FG000|Overall Study|Non-compliance with Protocol|0|||
127853126|NCT01594749|460080646|FG001|Overall Study|Non-compliance with Protocol|1|||
127853127|NCT01594749|460080645|FG000|Overall Study|Lost to Follow-up|1|||
127853128|NCT01594749|460080646|FG001|Overall Study|Lost to Follow-up|0|||
127853129|NCT01594749|460080645|FG000|Overall Study|Death|9|||
127853130|NCT01594749|460080646|FG001|Overall Study|Death|3|||
127853131|NCT01594749|460080645|FG000|Overall Study|Not Treated|4|||
127853132|NCT01594749|460080646|FG001|Overall Study|Not Treated|10|||
127853133|NCT01594749|460080645|FG000|Overall Study|Lost Source Documentation|1|||
127853134|NCT01594749|460080646|FG001|Overall Study|Lost Source Documentation|0|||
127853135|NCT02177786|460080647|FG000|Overall Study|Withdrew Consent|2|||
127853136|NCT02177786|460080648|FG001|Overall Study|Withdrew Consent|6|||
127853137|NCT02177786|460080649|FG002|Overall Study|Withdrew Consent|9|||
127853138|NCT02177786|460080650|FG003|Overall Study|Withdrew Consent|5|||
127853139|NCT02177786|460080647|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
127853140|NCT02177786|460080648|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
127853141|NCT02177786|460080649|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
127853142|NCT02177786|460080650|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
127853143|NCT02177786|460080647|FG000|Overall Study|Adverse Event|1|||
127853144|NCT02177786|460080648|FG001|Overall Study|Adverse Event|1|||
127853145|NCT02177786|460080649|FG002|Overall Study|Adverse Event|2|||
127853146|NCT02177786|460080650|FG003|Overall Study|Adverse Event|3|||
127853147|NCT02177786|460080647|FG000|Overall Study|Death|1|||
127853148|NCT02177786|460080648|FG001|Overall Study|Death|1|||
127853149|NCT02177786|460080649|FG002|Overall Study|Death|1|||
127853150|NCT02177786|460080650|FG003|Overall Study|Death|1|||
127853151|NCT02177786|460080647|FG000|Overall Study|Lost to Follow-up|0|||
127853152|NCT02177786|460080648|FG001|Overall Study|Lost to Follow-up|0|||
127853153|NCT02177786|460080649|FG002|Overall Study|Lost to Follow-up|2|||
127853154|NCT02177786|460080650|FG003|Overall Study|Lost to Follow-up|2|||
127853155|NCT02177786|460080647|FG000|Overall Study|Non-Compliance with Study Drug|0|||
127853156|NCT02177786|460080648|FG001|Overall Study|Non-Compliance with Study Drug|1|||
127853157|NCT02177786|460080649|FG002|Overall Study|Non-Compliance with Study Drug|0|||
127853158|NCT02177786|460080650|FG003|Overall Study|Non-Compliance with Study Drug|1|||
127853159|NCT02177786|460080647|FG000|Overall Study|Protocol Violation|0|||
127853160|NCT02177786|460080648|FG001|Overall Study|Protocol Violation|0|||
127853161|NCT02177786|460080649|FG002|Overall Study|Protocol Violation|2|||
127853162|NCT02177786|460080650|FG003|Overall Study|Protocol Violation|0|||
127853163|NCT02177786|460080647|FG000|Overall Study|Progressive Disease|0|||
127853164|NCT02177786|460080648|FG001|Overall Study|Progressive Disease|1|||
127853165|NCT02177786|460080649|FG002|Overall Study|Progressive Disease|0|||
127853166|NCT02177786|460080650|FG003|Overall Study|Progressive Disease|0|||
127853167|NCT02177786|460080647|FG000|Overall Study|Missing study completion status|0|||
127853168|NCT02177786|460080648|FG001|Overall Study|Missing study completion status|1|||
127853169|NCT02177786|460080649|FG002|Overall Study|Missing study completion status|0|||
127853170|NCT02177786|460080650|FG003|Overall Study|Missing study completion status|0|||
127853171|NCT00439309|460080651|FG000|Follow-Up|Death|1|||
127853172|NCT00439309|460080652|FG001|Follow-Up|Death|0|||
127853173|NCT00439309|460080651|FG000|Follow-Up|Lost to Follow-up|2|||
127853174|NCT00439309|460080652|FG001|Follow-Up|Lost to Follow-up|0|||
127853175|NCT00439309|460080651|FG000|Follow-Up|Withdrawal by Subject|0|||
127853176|NCT00439309|460080652|FG001|Follow-Up|Withdrawal by Subject|1|||
127853177|NCT00439309|460080651|FG000|Follow-Up|Late response by subject|0|||
127853178|NCT00439309|460080652|FG001|Follow-Up|Late response by subject|1|||
127853179|NCT01977040|460080653|FG000|Overall Study|Vasa previa not confirmed|2|||
127853180|NCT00634751|460080659|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
127853181|NCT00634751|460080660|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
127853182|NCT00634751|460080661|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
127853183|NCT00634751|460080662|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
127907316|NCT01597245|460285908|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
127907317|NCT01597245|460285909|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
127907318|NCT01597245|460285910|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
127907319|NCT01597245|460285911|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
127907320|NCT01597245|460285912|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
127907321|NCT01597245|460285913|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
127907322|NCT01597245|460285914|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
127907323|NCT01597245|460285915|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
127907324|NCT01597245|460285916|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
127907325|NCT01597245|460285917|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
127907326|NCT01597245|460285918|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
127907327|NCT01597245|460285919|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
127907328|NCT01597245|460285920|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
127907329|NCT01597245|460285900|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
127907330|NCT01597245|460285901|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
127907331|NCT01597245|460285902|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
127907332|NCT01597245|460285903|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
127907333|NCT01597245|460285904|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
127907334|NCT01597245|460285905|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
127907335|NCT01597245|460285906|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
127907336|NCT01597245|460285907|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
127907337|NCT01597245|460285908|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
127907338|NCT01597245|460285909|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
127907339|NCT01597245|460285910|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
127907340|NCT01597245|460285911|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
127907341|NCT01597245|460285912|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
127907342|NCT01597245|460285913|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
127907343|NCT01597245|460285914|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
127907344|NCT01597245|460285915|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
127907345|NCT01597245|460285916|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
127907346|NCT01597245|460285917|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
127907347|NCT01597245|460285918|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
127907348|NCT01597245|460285919|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
127907349|NCT01597245|460285920|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
127907350|NCT01597245|460285900|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
127907351|NCT01597245|460285901|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
127907352|NCT01597245|460285902|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
127907353|NCT01597245|460285903|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
127907354|NCT01597245|460285904|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
127907355|NCT01597245|460285905|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
127907356|NCT01597245|460285906|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
127907357|NCT01597245|460285907|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
127907358|NCT01597245|460285908|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
127907359|NCT01597245|460285909|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
127907360|NCT01597245|460285910|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
127907361|NCT01597245|460285911|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
127907362|NCT01597245|460285912|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
127907363|NCT01597245|460285913|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
127907364|NCT01597245|460285914|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
127907365|NCT01597245|460285915|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
127907366|NCT01597245|460285916|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
127907367|NCT01597245|460285917|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
127907368|NCT01597245|460285918|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
127907369|NCT01597245|460285919|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
127907370|NCT01597245|460285920|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
127907371|NCT01597245|460285900|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
127907372|NCT01597245|460285901|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
127907373|NCT01597245|460285902|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
127907374|NCT01597245|460285903|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
127907375|NCT01597245|460285904|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
127907376|NCT01597245|460285905|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
127853184|NCT00634751|460080659|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
127853185|NCT00634751|460080660|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
127853186|NCT00634751|460080661|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
127853187|NCT00634751|460080662|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
127853188|NCT00634751|460080659|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
127853189|NCT00634751|460080660|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
127853190|NCT00634751|460080661|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
127853191|NCT00634751|460080662|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
127853192|NCT01308853|460080670|FG000|Overall Study|Adverse Event|1|||
127853193|NCT01308853|460080670|FG000|Overall Study|Lost to Follow-up|2|||
127853194|NCT01308853|460080670|FG000|Overall Study|Insertion of permanent implants|1|||
127853195|NCT01119963|460080672|FG000|Overall Study|Lost to Follow-up|1|||
127853196|NCT01119963|460080673|FG001|Overall Study|Lost to Follow-up|1|||
127853197|NCT02603172|460080674|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
127853198|NCT02603172|460080675|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
127853199|NCT02603172|460080676|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
127853200|NCT02603172|460080677|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
127853201|NCT02603172|460080678|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
127853202|NCT02603172|460080679|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
127853203|NCT02603172|460080680|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
127853204|NCT02603172|460080681|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
127853205|NCT04072575|460080682|FG000|Overall Study|Physician Decision|1|||
127853206|NCT04072575|460080682|FG000|Overall Study|Adverse Event|7|||
127853207|NCT04072575|460080682|FG000|Overall Study|Withdrawal by Subject|14|||
127853208|NCT04072575|460080682|FG000|Overall Study|Other|2|||
127853209|NCT02473289|460080683|FG000|Overall Study|Adverse Event|2|||
127853210|NCT02473289|460080684|FG001|Overall Study|Adverse Event|3|||
127853211|NCT02473289|460080683|FG000|Overall Study|Lost to Follow-up|1|||
127853212|NCT02473289|460080684|FG001|Overall Study|Lost to Follow-up|1|||
127853213|NCT02473289|460080683|FG000|Overall Study|Protocol Violation|0|||
127853214|NCT02473289|460080684|FG001|Overall Study|Protocol Violation|1|||
127853215|NCT02473289|460080683|FG000|Overall Study|Withdrawal of consent|6|||
127853216|NCT02473289|460080684|FG001|Overall Study|Withdrawal of consent|7|||
127853217|NCT02473289|460080683|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
127853218|NCT02473289|460080684|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
127853219|NCT02473289|460080683|FG000|Overall Study|Other|2|||
127853220|NCT02473289|460080684|FG001|Overall Study|Other|0|||
127853221|NCT02244619|460080685|FG000|Overall Study|Did not receive study intervention|8|||
127853222|NCT02244619|460080686|FG001|Overall Study|Did not receive study intervention|21|||
127853223|NCT03285490|460080688|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
127853224|NCT03285490|460080689|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
127853225|NCT03285490|460080688|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
127853226|NCT03285490|460080689|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
127853227|NCT03745989|460080690|FG000|Overall Study|Death|3|||
127853228|NCT03745989|460080691|FG001|Overall Study|Death|7|||
127853229|NCT03745989|460080692|FG002|Overall Study|Death|4|||
127853230|NCT03745989|460080690|FG000|Overall Study|Lost to Follow-up|0|||
127853231|NCT03745989|460080691|FG001|Overall Study|Lost to Follow-up|2|||
127853232|NCT03745989|460080692|FG002|Overall Study|Lost to Follow-up|0|||
127853233|NCT03745989|460080690|FG000|Overall Study|Sponsor Decision|0|||
127853234|NCT03745989|460080691|FG001|Overall Study|Sponsor Decision|2|||
127853235|NCT03745989|460080692|FG002|Overall Study|Sponsor Decision|8|||
127853236|NCT03745989|460080690|FG000|Overall Study|Withdrawal by Subject|0|||
127853237|NCT03745989|460080691|FG001|Overall Study|Withdrawal by Subject|1|||
127853238|NCT03745989|460080692|FG002|Overall Study|Withdrawal by Subject|3|||
127853239|NCT01291511|460080693|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
127853240|NCT01291511|460080694|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
127853241|NCT01291511|460080693|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
127853242|NCT01291511|460080694|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
127853243|NCT01291511|460080693|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
127853244|NCT01291511|460080694|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
127853245|NCT01291511|460080693|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
127853246|NCT01291511|460080694|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
127853247|NCT01291511|460080693|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
127853248|NCT01291511|460080694|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
127853249|NCT01291511|460080693|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
127853250|NCT01291511|460080694|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
127853251|NCT01291511|460080693|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
127853252|NCT01291511|460080694|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
127853253|NCT01291511|460080693|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
127853254|NCT01291511|460080694|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
127853255|NCT01291511|460080693|FG000|Cross-Titration and Stabilization Phase|Death|1|||
127853256|NCT01291511|460080694|FG001|Cross-Titration and Stabilization Phase|Death|0|||
127853257|NCT01291511|460080693|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
127853258|NCT01291511|460080694|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
127853259|NCT01291511|460080693|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
127853260|NCT01291511|460080694|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
127853261|NCT01291511|460080693|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
127853262|NCT01291511|460080694|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
127853263|NCT01291511|460080693|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
127853264|NCT01291511|460080694|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
127853265|NCT01291511|460080693|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
127853266|NCT01291511|460080694|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
127853267|NCT01291511|460080693|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
127853268|NCT01291511|460080694|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
127853269|NCT01291511|460080693|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
127853270|NCT01291511|460080694|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
127853271|NCT01291511|460080693|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
127853272|NCT01291511|460080694|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
127853273|NCT01291511|460080693|FG000|Double-blind Relapse Prevention Phase|Death|1|||
127853274|NCT01291511|460080694|FG001|Double-blind Relapse Prevention Phase|Death|0|||
127853275|NCT00047008|460080696|FG000|Overall Study|Withdrawn consent|2|||
127853276|NCT00047008|460080697|FG001|Overall Study|Withdrawn consent|3|||
127853277|NCT00047008|460080696|FG000|Overall Study|Ineligible|9|||
127853278|NCT00047008|460080697|FG001|Overall Study|Ineligible|8|||
127853279|NCT01047436|460080700|FG000|Overall Study|Protocol Violation|1|||
127853280|NCT01047436|460080701|FG001|Overall Study|Protocol Violation|0|||
127853281|NCT01408732|460080702|FG000|Overall Study|Withdrawal by Subject|2|||
127853282|NCT01408732|460080703|FG001|Overall Study|Withdrawal by Subject|2|||
127853283|NCT00424099|460080704|FG000|Overall Study|Adverse Event|0|||
127853284|NCT00424099|460080705|FG001|Overall Study|Adverse Event|1|||
127853285|NCT00424099|460080706|FG002|Overall Study|Adverse Event|1|||
127853286|NCT00424099|460080707|FG003|Overall Study|Adverse Event|0|||
127853287|NCT00424099|460080704|FG000|Overall Study|Death|0|||
127853288|NCT00424099|460080705|FG001|Overall Study|Death|1|||
127853289|NCT00424099|460080706|FG002|Overall Study|Death|0|||
127853290|NCT00424099|460080707|FG003|Overall Study|Death|0|||
127853291|NCT00424099|460080704|FG000|Overall Study|Illness|2|||
127853292|NCT00424099|460080705|FG001|Overall Study|Illness|0|||
127853293|NCT00424099|460080706|FG002|Overall Study|Illness|1|||
127853294|NCT00424099|460080707|FG003|Overall Study|Illness|4|||
127853295|NCT00424099|460080704|FG000|Overall Study|Lost to Follow-up|0|||
127853296|NCT00424099|460080705|FG001|Overall Study|Lost to Follow-up|0|||
127853297|NCT00424099|460080706|FG002|Overall Study|Lost to Follow-up|3|||
127853298|NCT00424099|460080707|FG003|Overall Study|Lost to Follow-up|0|||
127853299|NCT00424099|460080704|FG000|Overall Study|Hospitalized|1|||
127853300|NCT00424099|460080705|FG001|Overall Study|Hospitalized|2|||
127853301|NCT00424099|460080706|FG002|Overall Study|Hospitalized|1|||
127853302|NCT00424099|460080707|FG003|Overall Study|Hospitalized|3|||
127853303|NCT00424099|460080704|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
127853304|NCT00424099|460080705|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
127853305|NCT00424099|460080706|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
127853306|NCT00424099|460080707|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
127853307|NCT00424099|460080704|FG000|Overall Study|Withdrawal by Subject|1|||
127853308|NCT00424099|460080705|FG001|Overall Study|Withdrawal by Subject|9|||
127853309|NCT00424099|460080706|FG002|Overall Study|Withdrawal by Subject|4|||
127853310|NCT00424099|460080707|FG003|Overall Study|Withdrawal by Subject|6|||
127853311|NCT00424099|460080704|FG000|Overall Study|Physician Decision|0|||
127853312|NCT00424099|460080705|FG001|Overall Study|Physician Decision|0|||
127853313|NCT00424099|460080706|FG002|Overall Study|Physician Decision|1|||
127853314|NCT00424099|460080707|FG003|Overall Study|Physician Decision|0|||
127853315|NCT00424099|460080704|FG000|Overall Study|Missing|0|||
127853316|NCT00424099|460080705|FG001|Overall Study|Missing|0|||
127853317|NCT00424099|460080706|FG002|Overall Study|Missing|1|||
127853318|NCT00424099|460080707|FG003|Overall Study|Missing|0|||
127853319|NCT00796003|460080708|FG000|Overall Study|Disease Progression|2|||
127853320|NCT00796003|460080709|FG001|Overall Study|Disease Progression|13|||
127853321|NCT00796003|460080708|FG000|Overall Study|Adverse Event|1|||
127853322|NCT00796003|460080709|FG001|Overall Study|Adverse Event|7|||
127853323|NCT00796003|460080708|FG000|Overall Study|Specified organ function not met|0|||
127853324|NCT00796003|460080709|FG001|Overall Study|Specified organ function not met|1|||
127853325|NCT00796003|460080708|FG000|Overall Study|Physician Decision|0|||
127853326|NCT00796003|460080709|FG001|Overall Study|Physician Decision|4|||
127853327|NCT00796003|460080708|FG000|Overall Study|Withdrawal by Subject|0|||
127853328|NCT00796003|460080709|FG001|Overall Study|Withdrawal by Subject|1|||
127853329|NCT00796003|460080708|FG000|Overall Study|Other|0|||
127853330|NCT00796003|460080709|FG001|Overall Study|Other|1|||
127853331|NCT00796003|460080708|FG000|Overall Study|Participants Not treated|0|||
127853332|NCT00796003|460080709|FG001|Overall Study|Participants Not treated|2|||
127853333|NCT02437162|460080710|FG000|Overall Study|Protocol Violation|0|||
127853334|NCT02437162|460080711|FG001|Overall Study|Protocol Violation|1|||
127853335|NCT02437162|460080712|FG002|Overall Study|Protocol Violation|0|||
127853336|NCT02437162|460080710|FG000|Overall Study|Randomized but not treated|0|||
127853337|NCT02437162|460080711|FG001|Overall Study|Randomized but not treated|0|||
127853338|NCT02437162|460080712|FG002|Overall Study|Randomized but not treated|1|||
127853339|NCT02437162|460080710|FG000|Overall Study|Study discontinued by Sponsor|93|||
127853340|NCT02437162|460080711|FG001|Overall Study|Study discontinued by Sponsor|98|||
127853341|NCT02437162|460080712|FG002|Overall Study|Study discontinued by Sponsor|97|||
127853342|NCT02437162|460080710|FG000|Overall Study|Withdrawal by Subject|13|||
127853343|NCT02437162|460080711|FG001|Overall Study|Withdrawal by Subject|7|||
127853344|NCT02437162|460080712|FG002|Overall Study|Withdrawal by Subject|9|||
127853345|NCT02437162|460080710|FG000|Overall Study|Adverse Event|0|||
127853346|NCT02437162|460080711|FG001|Overall Study|Adverse Event|1|||
127853347|NCT02437162|460080712|FG002|Overall Study|Adverse Event|0|||
127853348|NCT02437162|460080710|FG000|Overall Study|Lost to Follow-up|1|||
127853349|NCT02437162|460080711|FG001|Overall Study|Lost to Follow-up|0|||
127853350|NCT02437162|460080712|FG002|Overall Study|Lost to Follow-up|1|||
127853351|NCT02437162|460080710|FG000|Overall Study|Death|0|||
127853352|NCT02437162|460080711|FG001|Overall Study|Death|1|||
127853353|NCT02437162|460080712|FG002|Overall Study|Death|0|||
127853354|NCT02437162|460080710|FG000|Overall Study|Other|0|||
127853355|NCT02437162|460080711|FG001|Overall Study|Other|0|||
127853356|NCT02437162|460080712|FG002|Overall Study|Other|1|||
127853357|NCT03981744|460080713|FG000|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
127853358|NCT03981744|460080714|FG001|First Intervention (Prior to Week 24)|Withdrawal by Subject|2|||
127853359|NCT03981744|460080715|FG002|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
127853360|NCT03981744|460080716|FG003|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
127853361|NCT03981744|460080713|FG000|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
127853362|NCT03981744|460080714|FG001|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
127853363|NCT03981744|460080715|FG002|Second Intervention (Week 24 to Week 72)|Adverse Event|1|||
127853364|NCT03981744|460080716|FG003|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
127853365|NCT03981744|460080713|FG000|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
127853366|NCT03981744|460080714|FG001|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
127853367|NCT03981744|460080715|FG002|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|1|||
127853368|NCT03981744|460080716|FG003|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
127853369|NCT04338321|460080717|FG000|Overall Study|Adverse Event|4|||
127853370|NCT04338321|460080718|FG001|Overall Study|Adverse Event|10|||
127853371|NCT04338321|460080717|FG000|Overall Study|Death|1|||
127853372|NCT04338321|460080718|FG001|Overall Study|Death|1|||
127853373|NCT04338321|460080717|FG000|Overall Study|Lost to Follow-up|4|||
127853374|NCT04338321|460080718|FG001|Overall Study|Lost to Follow-up|9|||
127853375|NCT04338321|460080717|FG000|Overall Study|Withdrawal by Subject|45|||
127853376|NCT04338321|460080718|FG001|Overall Study|Withdrawal by Subject|69|||
127853377|NCT04338321|460080717|FG000|Overall Study|Physician Decision|5|||
127853378|NCT04338321|460080718|FG001|Overall Study|Physician Decision|9|||
127853379|NCT04338321|460080717|FG000|Overall Study|Other|3|||
127853380|NCT04338321|460080718|FG001|Overall Study|Other|10|||
127853381|NCT03107793|460080719|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
127853382|NCT03107793|460080720|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
127853383|NCT03107793|460080721|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
127853384|NCT03107793|460080722|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
127853385|NCT03107793|460080723|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
127853386|NCT03107793|460080719|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
127853387|NCT03107793|460080720|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
127853388|NCT03107793|460080721|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
127853389|NCT03107793|460080722|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
127853390|NCT03107793|460080723|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
127853391|NCT03107793|460080719|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
127853392|NCT03107793|460080720|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
127853393|NCT03107793|460080721|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
127853394|NCT03107793|460080722|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
127853395|NCT03107793|460080723|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
127853396|NCT03107793|460080719|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
127853397|NCT03107793|460080720|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
127853398|NCT03107793|460080721|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
127853399|NCT03107793|460080722|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
127853400|NCT03107793|460080723|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
127853401|NCT03107793|460080719|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
127853402|NCT03107793|460080720|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
127853403|NCT03107793|460080721|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
127853404|NCT03107793|460080722|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
127853405|NCT03107793|460080723|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
127853406|NCT03107793|460080719|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
127853407|NCT03107793|460080720|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
127853408|NCT03107793|460080721|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
127853409|NCT03107793|460080722|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
127853410|NCT03107793|460080723|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
127853411|NCT03107793|460080719|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
127853412|NCT03107793|460080720|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
127853413|NCT03107793|460080721|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
127853414|NCT03107793|460080722|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
127853415|NCT03107793|460080723|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
127853416|NCT03107793|460080719|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
127853417|NCT03107793|460080720|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
127853418|NCT03107793|460080721|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
127853419|NCT03107793|460080722|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
127853420|NCT03107793|460080723|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
127853421|NCT03107793|460080719|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
127853422|NCT03107793|460080720|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
127853423|NCT03107793|460080721|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
127853424|NCT03107793|460080722|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
127853425|NCT03107793|460080723|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
127853426|NCT03107793|460080719|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
127853427|NCT03107793|460080720|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
127853428|NCT03107793|460080721|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
127853429|NCT03107793|460080722|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
127853430|NCT03107793|460080723|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
127853431|NCT03107793|460080719|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
127853432|NCT03107793|460080720|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
127853433|NCT03107793|460080721|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
127853434|NCT03107793|460080722|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
127853435|NCT03107793|460080723|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
127853436|NCT03107793|460080719|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
127853437|NCT03107793|460080720|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
127853438|NCT03107793|460080721|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
127853439|NCT03107793|460080722|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
127853440|NCT03107793|460080723|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
127853441|NCT03107793|460080719|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
127853442|NCT03107793|460080720|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
127853443|NCT03107793|460080721|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
127853444|NCT03107793|460080722|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
127853445|NCT03107793|460080723|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
127853446|NCT03107793|460080719|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
127853447|NCT03107793|460080720|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
127853448|NCT03107793|460080721|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
127853449|NCT03107793|460080722|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
127853450|NCT03107793|460080723|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
127853451|NCT03107793|460080719|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
127853452|NCT03107793|460080720|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
127853453|NCT03107793|460080721|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
127853454|NCT03107793|460080722|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
127907377|NCT01597245|460285906|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
127907378|NCT01597245|460285907|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
127907379|NCT01597245|460285908|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
127907380|NCT01597245|460285909|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
127907381|NCT01597245|460285910|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
127853455|NCT03107793|460080723|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
127853456|NCT03107793|460080719|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
127907382|NCT01597245|460285911|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
127853457|NCT03107793|460080720|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
127907383|NCT01597245|460285912|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
127907384|NCT01597245|460285913|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
127907385|NCT01597245|460285914|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
127907386|NCT01597245|460285915|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
127907387|NCT01597245|460285916|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
127907388|NCT01597245|460285917|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
127907389|NCT01597245|460285918|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
127907390|NCT01597245|460285919|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
127907391|NCT01597245|460285920|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
127907392|NCT01597245|460285900|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
127907393|NCT01597245|460285901|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
127907394|NCT01597245|460285902|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
127907395|NCT01597245|460285903|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
127907396|NCT01597245|460285904|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
127907397|NCT01597245|460285905|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
127907398|NCT01597245|460285906|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
127907399|NCT01597245|460285907|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
127907400|NCT01597245|460285908|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
127907401|NCT01597245|460285909|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
127907402|NCT01597245|460285910|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
127907403|NCT01597245|460285911|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
127907404|NCT01597245|460285912|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
127907405|NCT01597245|460285913|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
127907406|NCT01597245|460285914|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
127907407|NCT01597245|460285915|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
127907408|NCT01597245|460285916|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
127907409|NCT01597245|460285917|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
127907410|NCT01597245|460285918|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
127907411|NCT01597245|460285919|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
127907412|NCT01597245|460285920|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
127907413|NCT01597245|460285900|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
127907414|NCT01597245|460285901|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
127907415|NCT01597245|460285902|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
127907416|NCT01597245|460285903|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
127907417|NCT01597245|460285904|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
127907418|NCT01597245|460285905|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
127907419|NCT01597245|460285906|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
127907420|NCT01597245|460285907|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
127907421|NCT01597245|460285908|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
127907422|NCT01597245|460285909|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
127907423|NCT01597245|460285910|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
127907424|NCT01597245|460285911|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
127907425|NCT01597245|460285912|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
127907426|NCT01597245|460285913|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
127907427|NCT01597245|460285914|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
127907428|NCT01597245|460285915|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
127907429|NCT01597245|460285916|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
127907430|NCT01597245|460285917|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
127907431|NCT01597245|460285918|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
127907432|NCT01597245|460285919|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
127907433|NCT01597245|460285920|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
127907434|NCT01597245|460285900|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
127907435|NCT01597245|460285901|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
127907436|NCT01597245|460285902|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
127907437|NCT01597245|460285903|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
127907438|NCT01597245|460285904|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
127907439|NCT01597245|460285905|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
127907440|NCT01597245|460285906|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
127907441|NCT01597245|460285907|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
127907442|NCT01597245|460285908|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
127907443|NCT01597245|460285909|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
127907444|NCT01597245|460285910|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
127907445|NCT01597245|460285911|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
127907446|NCT01597245|460285912|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
127907447|NCT01597245|460285913|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
127907448|NCT01597245|460285914|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
127907449|NCT01597245|460285915|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
127907450|NCT01597245|460285916|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
127907451|NCT01597245|460285917|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
127907452|NCT01597245|460285918|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
127907453|NCT01597245|460285919|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
127907454|NCT01597245|460285920|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
127907455|NCT01597245|460285900|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
127907456|NCT01597245|460285901|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
127907457|NCT01597245|460285902|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
127907458|NCT01597245|460285903|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
127907459|NCT01597245|460285904|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
127907460|NCT01597245|460285905|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
127907461|NCT01597245|460285906|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
127907462|NCT01597245|460285907|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
127907463|NCT01597245|460285908|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
127907464|NCT01597245|460285909|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
127907465|NCT01597245|460285910|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
127907466|NCT01597245|460285911|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
127907467|NCT01597245|460285912|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
127907468|NCT01597245|460285913|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
127907469|NCT01597245|460285914|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
127907470|NCT01597245|460285915|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
127907471|NCT01597245|460285916|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
127907472|NCT01597245|460285917|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
127907473|NCT01597245|460285918|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
127907474|NCT01597245|460285919|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
127907475|NCT01597245|460285920|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
127907476|NCT01597245|460285900|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
127907477|NCT01597245|460285901|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
127907478|NCT01597245|460285902|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
127907479|NCT01597245|460285903|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
127907480|NCT01597245|460285904|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
127907481|NCT01597245|460285905|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
127907482|NCT01597245|460285906|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
127907483|NCT01597245|460285907|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
127907484|NCT01597245|460285908|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
127907485|NCT01597245|460285909|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
127907486|NCT01597245|460285910|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
127907487|NCT01597245|460285911|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
127907488|NCT01597245|460285912|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
127907489|NCT01597245|460285913|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
127907490|NCT01597245|460285914|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
127907491|NCT01597245|460285915|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
127907492|NCT01597245|460285916|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
127907493|NCT01597245|460285917|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
127907494|NCT01597245|460285918|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
127907495|NCT01597245|460285919|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
127907496|NCT01597245|460285920|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
127907497|NCT01597245|460285900|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
127907498|NCT01597245|460285901|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
127907499|NCT01597245|460285902|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
127907500|NCT01597245|460285903|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
127907501|NCT01597245|460285904|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
127907502|NCT01597245|460285905|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
127907503|NCT01597245|460285906|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
127907504|NCT01597245|460285907|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
127907505|NCT01597245|460285908|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
127907506|NCT01597245|460285909|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
127907507|NCT01597245|460285910|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
127907508|NCT01597245|460285911|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
127907509|NCT01597245|460285912|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
127853458|NCT03107793|460080721|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
127853459|NCT03107793|460080722|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
127853460|NCT03107793|460080723|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
127853461|NCT03107793|460080719|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
127853462|NCT03107793|460080720|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
127853463|NCT03107793|460080721|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
127853464|NCT03107793|460080722|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
127853465|NCT03107793|460080723|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
127853466|NCT03107793|460080719|FG000|Extension Period (Week 48- Week 104)|Death|0|||
127853467|NCT03107793|460080720|FG001|Extension Period (Week 48- Week 104)|Death|0|||
127853468|NCT03107793|460080721|FG002|Extension Period (Week 48- Week 104)|Death|0|||
127853469|NCT03107793|460080722|FG003|Extension Period (Week 48- Week 104)|Death|0|||
127853470|NCT03107793|460080723|FG004|Extension Period (Week 48- Week 104)|Death|1|||
127853471|NCT03107793|460080719|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
127853472|NCT03107793|460080720|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
127853473|NCT03107793|460080721|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
127853474|NCT03107793|460080722|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
127853475|NCT03107793|460080723|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
127853476|NCT03107793|460080719|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
127853477|NCT03107793|460080720|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
127853478|NCT03107793|460080721|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
127853479|NCT03107793|460080722|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
127853480|NCT03107793|460080723|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
127853481|NCT03107793|460080719|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
127853482|NCT03107793|460080720|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
127853483|NCT03107793|460080721|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
127853484|NCT03107793|460080722|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
127853485|NCT03107793|460080723|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
127853486|NCT03107793|460080719|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
127853487|NCT03107793|460080720|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
127853488|NCT03107793|460080721|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
127853489|NCT03107793|460080722|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
127853490|NCT03107793|460080723|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
127853491|NCT03107793|460080719|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
127853492|NCT03107793|460080720|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
127853493|NCT03107793|460080721|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
127853494|NCT03107793|460080722|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
127853495|NCT03107793|460080723|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
127853496|NCT03107793|460080719|FG000|Extension Period (Week 48- Week 104)|Other|0|||
127853497|NCT03107793|460080720|FG001|Extension Period (Week 48- Week 104)|Other|0|||
127853498|NCT03107793|460080721|FG002|Extension Period (Week 48- Week 104)|Other|0|||
127853499|NCT03107793|460080722|FG003|Extension Period (Week 48- Week 104)|Other|1|||
127853500|NCT03107793|460080723|FG004|Extension Period (Week 48- Week 104)|Other|3|||
127853501|NCT03107793|460080719|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
127853502|NCT03107793|460080720|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
127853503|NCT03107793|460080721|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
127853504|NCT03107793|460080722|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
127853505|NCT03107793|460080723|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
127853506|NCT01989572|460080727|FG000|Overall Study|Lack of Efficacy|35|||
127853507|NCT01989572|460080728|FG001|Overall Study|Lack of Efficacy|48|||
127853508|NCT01989572|460080729|FG002|Overall Study|Lack of Efficacy|48|||
127853509|NCT01989572|460080730|FG003|Overall Study|Lack of Efficacy|43|||
127853510|NCT01989572|460080731|FG004|Overall Study|Lack of Efficacy|71|||
127853511|NCT01989572|460080732|FG005|Overall Study|Lack of Efficacy|79|||
127853512|NCT01989572|460080727|FG000|Overall Study|Adverse Event|2|||
127853513|NCT01989572|460080728|FG001|Overall Study|Adverse Event|1|||
127853514|NCT01989572|460080729|FG002|Overall Study|Adverse Event|3|||
127853515|NCT01989572|460080730|FG003|Overall Study|Adverse Event|0|||
127853516|NCT01989572|460080731|FG004|Overall Study|Adverse Event|3|||
127853517|NCT01989572|460080732|FG005|Overall Study|Adverse Event|0|||
127853518|NCT01989572|460080727|FG000|Overall Study|Death|0|||
127853519|NCT01989572|460080728|FG001|Overall Study|Death|0|||
127853520|NCT01989572|460080729|FG002|Overall Study|Death|0|||
127853521|NCT01989572|460080730|FG003|Overall Study|Death|0|||
127853522|NCT01989572|460080731|FG004|Overall Study|Death|1|||
127853523|NCT01989572|460080732|FG005|Overall Study|Death|0|||
127853524|NCT01989572|460080727|FG000|Overall Study|Withdrawal by Subject|4|||
127853525|NCT01989572|460080728|FG001|Overall Study|Withdrawal by Subject|1|||
127853526|NCT01989572|460080729|FG002|Overall Study|Withdrawal by Subject|5|||
127907510|NCT01597245|460285913|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
127907511|NCT01597245|460285914|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
127907512|NCT01597245|460285915|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
127907513|NCT01597245|460285916|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
127907514|NCT01597245|460285917|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
127907515|NCT01597245|460285918|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
127907516|NCT01597245|460285919|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
127907517|NCT01597245|460285920|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
127907518|NCT01597245|460285900|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
127907519|NCT01597245|460285901|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
127907520|NCT01597245|460285902|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
127907521|NCT01597245|460285903|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
127907522|NCT01597245|460285904|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
127907523|NCT01597245|460285905|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
127907524|NCT01597245|460285906|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
127907525|NCT01597245|460285907|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
127907526|NCT01597245|460285908|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
127907527|NCT01597245|460285909|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
127907528|NCT01597245|460285910|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
127907529|NCT01597245|460285911|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
127907530|NCT01597245|460285912|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
127907531|NCT01597245|460285913|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
127907532|NCT01597245|460285914|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
127907533|NCT01597245|460285915|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
127907534|NCT01597245|460285916|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
127907535|NCT01597245|460285917|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
127907536|NCT01597245|460285918|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
127907537|NCT01597245|460285919|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
127907538|NCT01597245|460285920|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
127907539|NCT01597245|460285900|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
127907540|NCT01597245|460285901|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
127907541|NCT01597245|460285902|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
127907542|NCT01597245|460285903|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
127907543|NCT01597245|460285904|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
127907544|NCT01597245|460285905|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
127907545|NCT01597245|460285906|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
127907546|NCT01597245|460285907|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
127907547|NCT01597245|460285908|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
127907548|NCT01597245|460285909|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
127907549|NCT01597245|460285910|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
127907550|NCT01597245|460285911|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
127907551|NCT01597245|460285912|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
127907552|NCT01597245|460285913|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
127907553|NCT01597245|460285914|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
127907554|NCT01597245|460285915|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
127907555|NCT01597245|460285916|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
127907556|NCT01597245|460285917|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
127907557|NCT01597245|460285918|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
127907558|NCT01597245|460285919|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
127907559|NCT01597245|460285920|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
127907560|NCT01597245|460285900|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
127907561|NCT01597245|460285901|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
127853527|NCT01989572|460080730|FG003|Overall Study|Withdrawal by Subject|1|||
127853528|NCT01989572|460080731|FG004|Overall Study|Withdrawal by Subject|12|||
127853529|NCT01989572|460080732|FG005|Overall Study|Withdrawal by Subject|4|||
127853530|NCT01989572|460080727|FG000|Overall Study|complicating disease|1|||
127853531|NCT01989572|460080728|FG001|Overall Study|complicating disease|1|||
127853532|NCT01989572|460080729|FG002|Overall Study|complicating disease|2|||
127853533|NCT01989572|460080730|FG003|Overall Study|complicating disease|0|||
127853534|NCT01989572|460080731|FG004|Overall Study|complicating disease|1|||
127853535|NCT01989572|460080732|FG005|Overall Study|complicating disease|0|||
127853536|NCT01989572|460080727|FG000|Overall Study|error|2|||
127853537|NCT01989572|460080728|FG001|Overall Study|error|1|||
127853538|NCT01989572|460080729|FG002|Overall Study|error|1|||
127853539|NCT01989572|460080730|FG003|Overall Study|error|1|||
127853540|NCT01989572|460080731|FG004|Overall Study|error|1|||
127853541|NCT01989572|460080732|FG005|Overall Study|error|1|||
127853542|NCT01989572|460080727|FG000|Overall Study|maximum dose reached|0|||
127853543|NCT01989572|460080728|FG001|Overall Study|maximum dose reached|1|||
127853544|NCT01989572|460080729|FG002|Overall Study|maximum dose reached|0|||
127853545|NCT01989572|460080730|FG003|Overall Study|maximum dose reached|0|||
127853546|NCT01989572|460080731|FG004|Overall Study|maximum dose reached|1|||
127853547|NCT01989572|460080732|FG005|Overall Study|maximum dose reached|0|||
127853548|NCT01989572|460080727|FG000|Overall Study|unknown/not specify|3|||
127853549|NCT01989572|460080728|FG001|Overall Study|unknown/not specify|4|||
127853550|NCT01989572|460080729|FG002|Overall Study|unknown/not specify|1|||
127853551|NCT01989572|460080730|FG003|Overall Study|unknown/not specify|3|||
127853552|NCT01989572|460080731|FG004|Overall Study|unknown/not specify|3|||
127853553|NCT01989572|460080732|FG005|Overall Study|unknown/not specify|5|||
127853554|NCT01989572|460080727|FG000|Overall Study|not start protocol therapy|5|||
127853555|NCT01989572|460080728|FG001|Overall Study|not start protocol therapy|1|||
127853556|NCT01989572|460080729|FG002|Overall Study|not start protocol therapy|2|||
127853557|NCT01989572|460080730|FG003|Overall Study|not start protocol therapy|3|||
127853558|NCT01989572|460080731|FG004|Overall Study|not start protocol therapy|4|||
127853559|NCT01989572|460080732|FG005|Overall Study|not start protocol therapy|18|||
127853560|NCT01989572|460080727|FG000|Overall Study|alternative therapy|3|||
127853561|NCT01989572|460080728|FG001|Overall Study|alternative therapy|0|||
127853562|NCT01989572|460080729|FG002|Overall Study|alternative therapy|0|||
127853563|NCT01989572|460080730|FG003|Overall Study|alternative therapy|0|||
127853564|NCT01989572|460080731|FG004|Overall Study|alternative therapy|1|||
127853565|NCT01989572|460080732|FG005|Overall Study|alternative therapy|3|||
127853566|NCT02910089|460080733|FG000|Overall Study|Lost insurance eligibility|22|||
127853567|NCT02910089|460080734|FG001|Overall Study|Lost insurance eligibility|16|||
127853568|NCT00732238|460080735|FG000|Overall Study|Bacteremia|4|||
127853569|NCT00732238|460080736|FG001|Overall Study|Bacteremia|1|||
127853570|NCT00732238|460080735|FG000|Overall Study|Asymptomatic bacteriuria|1|||
127853571|NCT00732238|460080736|FG001|Overall Study|Asymptomatic bacteriuria|0|||
127853572|NCT02280096|460080737|FG000|Overall Study|Pregnancy|1|||
127853573|NCT02280096|460080738|FG001|Overall Study|Pregnancy|0|||
127853574|NCT02280096|460080737|FG000|Overall Study|Functional neurological disorder|1|||
127853575|NCT02280096|460080738|FG001|Overall Study|Functional neurological disorder|0|||
127853576|NCT02280096|460080737|FG000|Overall Study|Lack of attachment|0|||
127853577|NCT02280096|460080738|FG001|Overall Study|Lack of attachment|1|||
127853578|NCT00246376|460080741|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
127853579|NCT00246376|460080742|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
127853580|NCT00246376|460080743|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
127853581|NCT00246376|460080744|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
127853582|NCT00246376|460080745|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
127853583|NCT00246376|460080741|FG000|Overall Study|Adverse Event|2|||
127853584|NCT00246376|460080742|FG001|Overall Study|Adverse Event|3|||
127853585|NCT00246376|460080743|FG002|Overall Study|Adverse Event|1|||
127853586|NCT00246376|460080744|FG003|Overall Study|Adverse Event|3|||
127853587|NCT00246376|460080745|FG004|Overall Study|Adverse Event|1|||
127853588|NCT00246376|460080741|FG000|Overall Study|Lost to Follow-up|2|||
127853589|NCT00246376|460080742|FG001|Overall Study|Lost to Follow-up|11|||
127853590|NCT00246376|460080743|FG002|Overall Study|Lost to Follow-up|11|||
127853591|NCT00246376|460080744|FG003|Overall Study|Lost to Follow-up|16|||
127853592|NCT00246376|460080745|FG004|Overall Study|Lost to Follow-up|13|||
127853593|NCT03605836|460080746|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
127853594|NCT03605836|460080747|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
127853595|NCT03605836|460080748|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
127853596|NCT03605836|460080749|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
127853597|NCT03605836|460080746|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
127853598|NCT03605836|460080747|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
127853599|NCT03605836|460080748|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
127853600|NCT03605836|460080749|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
127853601|NCT03605836|460080746|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
127853602|NCT03605836|460080747|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
127853603|NCT03605836|460080748|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
127853604|NCT03605836|460080749|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
127853605|NCT03605836|460080746|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
127853606|NCT03605836|460080747|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
127853607|NCT03605836|460080748|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
127853608|NCT03605836|460080749|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
127853609|NCT03605836|460080746|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
127853610|NCT03605836|460080747|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
127907562|NCT01597245|460285902|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
127907563|NCT01597245|460285903|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
127907564|NCT01597245|460285904|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
127907565|NCT01597245|460285905|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
127907566|NCT01597245|460285906|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
127907567|NCT01597245|460285907|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
127907568|NCT01597245|460285908|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
127907569|NCT01597245|460285909|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
127907570|NCT01597245|460285910|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
127907571|NCT01597245|460285911|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
127907572|NCT01597245|460285912|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
127907573|NCT01597245|460285913|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
127907574|NCT01597245|460285914|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
127907575|NCT01597245|460285915|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
127907576|NCT01597245|460285916|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
127907577|NCT01597245|460285917|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
127907578|NCT01597245|460285918|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
127907579|NCT01597245|460285919|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
127907580|NCT01597245|460285920|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
127907581|NCT01597245|460285900|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
127907582|NCT01597245|460285901|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
127907583|NCT01597245|460285902|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
127907584|NCT01597245|460285903|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
127853611|NCT03605836|460080748|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
127853612|NCT03605836|460080749|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
127853613|NCT03605836|460080746|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
127853614|NCT03605836|460080747|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
127853615|NCT03605836|460080748|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
127853616|NCT03605836|460080749|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
127853617|NCT03605836|460080746|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
127853618|NCT03605836|460080747|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
127853619|NCT03605836|460080748|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
127853620|NCT03605836|460080749|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
127853621|NCT03605836|460080746|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
127853622|NCT03605836|460080747|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
127853623|NCT03605836|460080748|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
127853624|NCT03605836|460080749|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
127853625|NCT03605836|460080746|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
127853626|NCT03605836|460080747|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
127853627|NCT03605836|460080748|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
127853628|NCT03605836|460080749|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
127853629|NCT03605836|460080746|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
127853630|NCT03605836|460080747|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
127853631|NCT03605836|460080748|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
127853632|NCT03605836|460080749|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
127853633|NCT03605836|460080746|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
127853634|NCT03605836|460080747|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
127853635|NCT03605836|460080748|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
127853636|NCT03605836|460080749|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
127853637|NCT03605836|460080746|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
127853638|NCT03605836|460080747|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
127853639|NCT03605836|460080748|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
127853640|NCT03605836|460080749|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
127853641|NCT03605836|460080746|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
127853642|NCT03605836|460080747|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
127853643|NCT03605836|460080748|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
127853644|NCT03605836|460080749|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
127853645|NCT03605836|460080746|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
127853646|NCT03605836|460080747|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
127853647|NCT03605836|460080748|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
127853648|NCT03605836|460080749|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
127907585|NCT01597245|460285904|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
127907586|NCT01597245|460285905|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
127907587|NCT01597245|460285906|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
127907588|NCT01597245|460285907|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
127907589|NCT01597245|460285908|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
127907590|NCT01597245|460285909|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
127907591|NCT01597245|460285910|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
127907592|NCT01597245|460285911|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
127907593|NCT01597245|460285912|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
127907594|NCT01597245|460285913|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
127907595|NCT01597245|460285914|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
127907596|NCT01597245|460285915|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
127907597|NCT01597245|460285916|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
127907598|NCT01597245|460285917|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
127907599|NCT01597245|460285918|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
127907600|NCT01597245|460285919|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
127907601|NCT01597245|460285920|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
127907602|NCT01597245|460285900|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
127907603|NCT01597245|460285901|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
127907604|NCT01597245|460285902|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
127907605|NCT01597245|460285903|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
127907606|NCT01597245|460285904|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
127907607|NCT01597245|460285905|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
127907608|NCT01597245|460285906|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
127907609|NCT01597245|460285907|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
127907610|NCT01597245|460285908|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
127907611|NCT01597245|460285909|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
127907612|NCT01597245|460285910|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
127907613|NCT01597245|460285911|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
127907614|NCT01597245|460285912|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
127907615|NCT01597245|460285913|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
127907616|NCT01597245|460285914|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
127907617|NCT01597245|460285915|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
127907618|NCT01597245|460285916|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
127907619|NCT01597245|460285917|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
127907620|NCT01597245|460285918|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
127907621|NCT01597245|460285919|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
127907622|NCT01597245|460285920|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
127907623|NCT01597245|460285900|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
127907624|NCT01597245|460285901|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
127907625|NCT01597245|460285902|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
127907626|NCT01597245|460285903|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
127907627|NCT01597245|460285904|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
127907628|NCT01597245|460285905|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
127907629|NCT01597245|460285906|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
127907630|NCT01597245|460285907|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
127907631|NCT01597245|460285908|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
127907632|NCT01597245|460285909|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
127907633|NCT01597245|460285910|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
127907634|NCT01597245|460285911|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
127907635|NCT01597245|460285912|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
127907636|NCT01597245|460285913|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
127907637|NCT01597245|460285914|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
127907638|NCT01597245|460285915|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
127907639|NCT01597245|460285916|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
127907640|NCT01597245|460285917|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
127907641|NCT01597245|460285918|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
127907642|NCT01597245|460285919|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
127907643|NCT01597245|460285920|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
127907644|NCT01597245|460285900|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
127907645|NCT01597245|460285901|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
127853649|NCT03605836|460080746|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
127853650|NCT03605836|460080747|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
127853651|NCT03605836|460080748|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
127853652|NCT03605836|460080749|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
127853653|NCT03605836|460080746|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
127853654|NCT03605836|460080747|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
127853655|NCT03605836|460080748|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
127853656|NCT03605836|460080749|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
127853657|NCT03605836|460080746|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
127853658|NCT03605836|460080747|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
127853659|NCT03605836|460080748|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
127853660|NCT03605836|460080749|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
127853661|NCT03605836|460080746|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
127853662|NCT03605836|460080747|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
127853663|NCT03605836|460080748|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
127853664|NCT03605836|460080749|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
127853665|NCT03605836|460080746|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
127853666|NCT03605836|460080747|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
127853667|NCT03605836|460080748|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
127853668|NCT03605836|460080749|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
127853669|NCT03605836|460080746|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
127853670|NCT03605836|460080747|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
127853671|NCT03605836|460080748|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
127853672|NCT03605836|460080749|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
127853673|NCT03605836|460080746|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
127853674|NCT03605836|460080747|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
127853675|NCT03605836|460080748|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
127853676|NCT03605836|460080749|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
127853677|NCT03605836|460080746|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
127853678|NCT03605836|460080747|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
127853679|NCT03605836|460080748|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
127853680|NCT03605836|460080749|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
127853681|NCT02057068|460080756|FG000|Overall Study|Withdrawal by Subject|2|||
127853682|NCT02057068|460080757|FG001|Overall Study|Withdrawal by Subject|2|||
127853683|NCT02057068|460080756|FG000|Overall Study|Caregiver (CG) Health|0|||
127853684|NCT02057068|460080757|FG001|Overall Study|Caregiver (CG) Health|2|||
127853685|NCT02057068|460080756|FG000|Overall Study|Carepartner (CP) Health|4|||
127853686|NCT02057068|460080757|FG001|Overall Study|Carepartner (CP) Health|2|||
127853687|NCT02057068|460080756|FG000|Overall Study|Lost to Follow-up|2|||
127853688|NCT02057068|460080757|FG001|Overall Study|Lost to Follow-up|2|||
127853689|NCT00865046|460080758|FG000|Overall Study|Lost to Follow-up|1|||
127853690|NCT00865046|460080759|FG001|Overall Study|Lost to Follow-up|4|||
127853691|NCT00865046|460080760|FG002|Overall Study|Lost to Follow-up|0|||
127853692|NCT00865046|460080758|FG000|Overall Study|Death|0|||
127853693|NCT00865046|460080759|FG001|Overall Study|Death|1|||
127853694|NCT00865046|460080760|FG002|Overall Study|Death|1|||
127853695|NCT00865046|460080758|FG000|Overall Study|Withdrawal by Subject|5|||
127853696|NCT00865046|460080759|FG001|Overall Study|Withdrawal by Subject|0|||
127853697|NCT00865046|460080760|FG002|Overall Study|Withdrawal by Subject|0|||
127853698|NCT01024920|460080762|FG000|Overall Study|Progressive disease|47|||
127853699|NCT01024920|460080763|FG001|Overall Study|Progressive disease|25|||
127853700|NCT01024920|460080762|FG000|Overall Study|Adverse Event|8|||
127853701|NCT01024920|460080763|FG001|Overall Study|Adverse Event|4|||
127853702|NCT01024920|460080762|FG000|Overall Study|Lost to Follow-up|0|||
127853703|NCT01024920|460080763|FG001|Overall Study|Lost to Follow-up|1|||
127853704|NCT01024920|460080762|FG000|Overall Study|Patient refusal to continue|4|||
127853705|NCT01024920|460080763|FG001|Overall Study|Patient refusal to continue|0|||
127853706|NCT01024920|460080762|FG000|Overall Study|Other than listed|5|||
127853707|NCT01024920|460080763|FG001|Overall Study|Other than listed|1|||
127907646|NCT01597245|460285902|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
127853708|NCT01024920|460080762|FG000|Overall Study|Not treated|3|||
127853709|NCT01024920|460080763|FG001|Overall Study|Not treated|0|||
127853710|NCT01024920|460080762|FG000|Overall Study|Protocol Violation|0|||
127853711|NCT01024920|460080763|FG001|Overall Study|Protocol Violation|1|||
127853712|NCT02977507|460080764|FG000|Overall Study|Protocol Deviation|1|||
127853713|NCT02977507|460080765|FG001|Overall Study|Protocol Deviation|0|||
127853714|NCT02977507|460080764|FG000|Overall Study|Lost to Follow-up|1|||
127853715|NCT02977507|460080765|FG001|Overall Study|Lost to Follow-up|0|||
127853716|NCT00633360|460080768|FG000|Overall Study|Lost to Follow-up|1|||
127907647|NCT01597245|460285903|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
127907648|NCT01597245|460285904|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
127907649|NCT01597245|460285905|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
127907650|NCT01597245|460285906|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
127907651|NCT01597245|460285907|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
127907652|NCT01597245|460285908|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
127907653|NCT01597245|460285909|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
127907654|NCT01597245|460285910|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
127907655|NCT01597245|460285911|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
127907656|NCT01597245|460285912|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
127907657|NCT01597245|460285913|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
127907658|NCT01597245|460285914|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
127907659|NCT01597245|460285915|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
127907660|NCT01597245|460285916|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
127907661|NCT01597245|460285917|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
127907662|NCT01597245|460285918|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
127907663|NCT01597245|460285919|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
127907664|NCT01597245|460285920|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
127907665|NCT01597245|460285900|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
127907666|NCT01597245|460285901|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
127907667|NCT01597245|460285902|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
127907668|NCT01597245|460285903|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
127907669|NCT01597245|460285904|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
127907670|NCT01597245|460285905|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
127907671|NCT01597245|460285906|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
127907672|NCT01597245|460285907|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
127907673|NCT01597245|460285908|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
127907674|NCT01597245|460285909|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
127907675|NCT01597245|460285910|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
127907676|NCT01597245|460285911|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
127907677|NCT01597245|460285912|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
127907678|NCT01597245|460285913|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
127907679|NCT01597245|460285914|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
127907680|NCT01597245|460285915|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
127907681|NCT01597245|460285916|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
127907682|NCT01597245|460285917|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
127907683|NCT01597245|460285918|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
127907684|NCT01597245|460285919|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
127907685|NCT01597245|460285920|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
127907686|NCT01597245|460285900|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
127907687|NCT01597245|460285901|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
127907688|NCT01597245|460285902|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
127907689|NCT01597245|460285903|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
127907690|NCT01597245|460285904|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
127907691|NCT01597245|460285905|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
127907692|NCT01597245|460285906|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
127907693|NCT01597245|460285907|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
127907694|NCT01597245|460285908|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
127907695|NCT01597245|460285909|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
127907696|NCT01597245|460285910|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
127907697|NCT01597245|460285911|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
127907698|NCT01597245|460285912|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
127907699|NCT01597245|460285913|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
127907700|NCT01597245|460285914|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
127907701|NCT01597245|460285915|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
127907702|NCT01597245|460285916|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
127907703|NCT01597245|460285917|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
127907704|NCT01597245|460285918|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
127907705|NCT01597245|460285919|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
127907706|NCT01597245|460285920|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
127907707|NCT01313780|460285921|FG000|Overall Study|Lack of Efficacy|4|||
127907708|NCT01313780|460285922|FG001|Overall Study|Lack of Efficacy|2|||
127907709|NCT01313780|460285921|FG000|Overall Study|Adverse Event|6|||
127907710|NCT01313780|460285922|FG001|Overall Study|Adverse Event|11|||
127907711|NCT01313780|460285921|FG000|Overall Study|Withdrawal by Subject|2|||
127907712|NCT01313780|460285922|FG001|Overall Study|Withdrawal by Subject|8|||
127907713|NCT01313780|460285921|FG000|Overall Study|Protocol Violation|10|||
127907714|NCT01313780|460285922|FG001|Overall Study|Protocol Violation|4|||
127907715|NCT01313780|460285921|FG000|Overall Study|missing data|3|||
127907716|NCT01313780|460285922|FG001|Overall Study|missing data|3|||
127907717|NCT00731783|460285923|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
127907718|NCT00731783|460285924|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
127907719|NCT00731783|460285923|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
127907720|NCT00731783|460285924|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
127907721|NCT00731783|460285923|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
127907722|NCT00731783|460285924|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
127907723|NCT00731783|460285923|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
127907724|NCT00731783|460285924|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
127907725|NCT02096211|460287454|FG000|Overall Study|Death|2|||
127907726|NCT02096211|460287454|FG000|Overall Study|Withdrawal by Subject|8|||
127907727|NCT02096211|460287454|FG000|Overall Study|Revision of implant|7|||
127907728|NCT02096211|460287454|FG000|Overall Study|Lost to Follow-up|43|||
127907729|NCT00519194|460287457|FG000|Overall Study|Withdrawal by Subject|9|||
127907730|NCT00519194|460287457|FG000|Overall Study|Death|9|||
127907731|NCT00519194|460287457|FG000|Overall Study|Lost to Follow-up|3|||
127907732|NCT03165994|460287458|FG000|Overall Study|Confirmed Radiographic Disease Progression|4|||
127907733|NCT03165994|460287458|FG000|Overall Study|Death|2|||
127907734|NCT03165994|460287458|FG000|Overall Study|Non-Compliance With Study Treatment or Procedure Requirements|3|||
127907735|NCT03165994|460287458|FG000|Overall Study|Physician Decision, other than adverse event (AE)|9|||
127907736|NCT03165994|460287458|FG000|Overall Study|Participant or Legal Representative Withdraws Consent|1|||
127907737|NCT03165994|460287458|FG000|Overall Study|Miscellaneous|1|||
127907738|NCT00934050|460287465|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
127907739|NCT00934050|460287466|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
127907740|NCT00934050|460287467|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
127907741|NCT00934050|460287468|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
127907742|NCT00934050|460287469|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
127907743|NCT00934050|460287470|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
127907744|NCT00934050|460287465|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
127907745|NCT00934050|460287466|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
127907746|NCT00934050|460287467|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
127907747|NCT00934050|460287468|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
127907748|NCT00934050|460287469|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
127907749|NCT00934050|460287470|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
127907750|NCT00934050|460287465|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
127907751|NCT00934050|460287466|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
127907752|NCT00934050|460287467|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
127907753|NCT00934050|460287468|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
127907754|NCT00934050|460287469|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
127907755|NCT00934050|460287470|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
127907756|NCT00934050|460287465|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
127907757|NCT00934050|460287466|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
127907758|NCT00934050|460287467|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
127907759|NCT00934050|460287468|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
127907760|NCT00934050|460287469|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
127907761|NCT00934050|460287470|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
127907762|NCT00934050|460287465|FG000|Enrolled After 15 Dec 2009|Death|0|||
127907763|NCT00934050|460287466|FG001|Enrolled After 15 Dec 2009|Death|0|||
127907764|NCT00934050|460287467|FG002|Enrolled After 15 Dec 2009|Death|0|||
127907765|NCT00934050|460287468|FG003|Enrolled After 15 Dec 2009|Death|0|||
127907766|NCT00934050|460287469|FG004|Enrolled After 15 Dec 2009|Death|0|||
127907767|NCT00934050|460287470|FG005|Enrolled After 15 Dec 2009|Death|1|||
127907768|NCT00934050|460287465|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
127907769|NCT00934050|460287466|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
127907770|NCT00934050|460287467|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
127907771|NCT00934050|460287468|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
127907772|NCT00934050|460287469|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
127907773|NCT00934050|460287470|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
127907774|NCT00934050|460287465|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
127907775|NCT00934050|460287466|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
127907776|NCT00934050|460287467|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
127907777|NCT00934050|460287468|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
127907778|NCT00934050|460287469|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
127907779|NCT00934050|460287470|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
127907780|NCT00461786|460287471|FG000|Overall Study|Entry Criteria Not Met|2|||
127907781|NCT00461786|460287471|FG000|Overall Study|Inevaluable (Never Treated)|1|||
127907782|NCT00835991|460287472|FG000|First Intervention|Adverse Event|0|||
127907783|NCT00835991|460287473|FG001|First Intervention|Adverse Event|1|||
127907784|NCT00835991|460287472|FG000|Washout|Protocol Violation|0|||
127907785|NCT00835991|460287473|FG001|Washout|Protocol Violation|2|||
127907786|NCT00835991|460287472|FG000|Washout|Withdrawal by Subject|3|||
127853717|NCT00633360|460080769|FG001|Overall Study|Lost to Follow-up|1|||
127853718|NCT00633360|460080768|FG000|Overall Study|Adverse Event|3|||
127853719|NCT00633360|460080769|FG001|Overall Study|Adverse Event|1|||
127853720|NCT00633360|460080768|FG000|Overall Study|Protocol Violation|0|||
127853721|NCT00633360|460080769|FG001|Overall Study|Protocol Violation|1|||
127853722|NCT01098032|460080770|FG000|Overall Study|Withdrawal by Subject|1|||
127853723|NCT01098032|460080771|FG001|Overall Study|Withdrawal by Subject|1|||
127853724|NCT00610207|460080772|FG000|Overall Study|Lost to Follow-up|3|||
127853725|NCT02465489|460080773|FG000|Overall Study|Adverse Event|5|||
127853726|NCT02972593|460080774|FG000|Overall Study|Lost to Follow-up|19|||
127853727|NCT02972593|460080775|FG001|Overall Study|Lost to Follow-up|15|||
127853728|NCT02972593|460080774|FG000|Overall Study|Protocol Violation|1|||
127853729|NCT02972593|460080775|FG001|Overall Study|Protocol Violation|0|||
127853730|NCT00693693|460080778|FG000|Overall Study|Lost to Follow-up|1|||
127853731|NCT00693693|460080779|FG001|Overall Study|Lost to Follow-up|1|||
127853732|NCT00693693|460080780|FG002|Overall Study|Lost to Follow-up|2|||
127853733|NCT04599972|460080781|FG000|Overall Study|Withdrawal by Subject|6|||
127853734|NCT04599972|460080782|FG001|Overall Study|Withdrawal by Subject|1|||
127853735|NCT04599972|460080781|FG000|Overall Study|Adverse Event|1|||
127853736|NCT04599972|460080782|FG001|Overall Study|Adverse Event|1|||
127853737|NCT04599972|460080781|FG000|Overall Study|Lost to Follow-up|1|||
127853738|NCT04599972|460080782|FG001|Overall Study|Lost to Follow-up|6|||
127853739|NCT04599972|460080781|FG000|Overall Study|Protocol Violation|1|||
127853740|NCT04599972|460080782|FG001|Overall Study|Protocol Violation|0|||
127853741|NCT04599972|460080781|FG000|Overall Study|Other reason|1|||
127853742|NCT04599972|460080782|FG001|Overall Study|Other reason|0|||
127853743|NCT01594411|460080784|FG000|Overall Study|Lost to Follow-up|2|||
127853744|NCT04449276|460080792|FG000|Overall Study|Adverse Event|1|||
127853745|NCT04449276|460080793|FG001|Overall Study|Adverse Event|2|||
127853746|NCT04449276|460080794|FG002|Overall Study|Adverse Event|0|||
127853747|NCT04449276|460080795|FG003|Overall Study|Adverse Event|0|||
127853748|NCT04449276|460080796|FG004|Overall Study|Adverse Event|2|||
127853749|NCT04449276|460080797|FG005|Overall Study|Adverse Event|0|||
127853750|NCT04449276|460080798|FG006|Overall Study|Adverse Event|0|||
127853751|NCT04449276|460080799|FG007|Overall Study|Adverse Event|1|||
127853752|NCT04449276|460080792|FG000|Overall Study|Withdrawal by Subject|2|||
127853753|NCT04449276|460080793|FG001|Overall Study|Withdrawal by Subject|0|||
127853754|NCT04449276|460080794|FG002|Overall Study|Withdrawal by Subject|0|||
127853755|NCT04449276|460080795|FG003|Overall Study|Withdrawal by Subject|1|||
127853756|NCT04449276|460080796|FG004|Overall Study|Withdrawal by Subject|0|||
127853757|NCT04449276|460080797|FG005|Overall Study|Withdrawal by Subject|0|||
127853758|NCT04449276|460080798|FG006|Overall Study|Withdrawal by Subject|0|||
127853759|NCT04449276|460080799|FG007|Overall Study|Withdrawal by Subject|0|||
127853760|NCT04449276|460080792|FG000|Overall Study|Other|0|||
127853761|NCT04449276|460080793|FG001|Overall Study|Other|2|||
127853762|NCT04449276|460080794|FG002|Overall Study|Other|3|||
127853763|NCT04449276|460080795|FG003|Overall Study|Other|2|||
127853764|NCT04449276|460080796|FG004|Overall Study|Other|0|||
127853765|NCT04449276|460080797|FG005|Overall Study|Other|0|||
127853766|NCT04449276|460080798|FG006|Overall Study|Other|0|||
127853767|NCT04449276|460080799|FG007|Overall Study|Other|1|||
127853768|NCT01614795|460080800|FG000|Overall Study|Adverse Event|0|||
127853769|NCT01614795|460080801|FG001|Overall Study|Adverse Event|0|||
127853770|NCT01614795|460080802|FG002|Overall Study|Adverse Event|1|||
127853771|NCT01614795|460080803|FG003|Overall Study|Adverse Event|1|||
127853772|NCT01614795|460080800|FG000|Overall Study|Lack of Efficacy|10|||
127853773|NCT01614795|460080801|FG001|Overall Study|Lack of Efficacy|10|||
127853774|NCT01614795|460080802|FG002|Overall Study|Lack of Efficacy|9|||
127853775|NCT01614795|460080803|FG003|Overall Study|Lack of Efficacy|8|||
127853776|NCT01614795|460080800|FG000|Overall Study|Physician Decision|1|||
127853777|NCT01614795|460080801|FG001|Overall Study|Physician Decision|0|||
127853778|NCT01614795|460080802|FG002|Overall Study|Physician Decision|1|||
127853779|NCT01614795|460080803|FG003|Overall Study|Physician Decision|1|||
127853780|NCT01614795|460080800|FG000|Overall Study|Withdrawal by Subject|0|||
127853781|NCT01614795|460080801|FG001|Overall Study|Withdrawal by Subject|1|||
127853782|NCT01614795|460080802|FG002|Overall Study|Withdrawal by Subject|0|||
127853783|NCT01614795|460080803|FG003|Overall Study|Withdrawal by Subject|2|||
127853784|NCT01614795|460080800|FG000|Overall Study|Ineligible|0|||
127853785|NCT01614795|460080801|FG001|Overall Study|Ineligible|1|||
127853786|NCT01614795|460080802|FG002|Overall Study|Ineligible|0|||
127853787|NCT01614795|460080803|FG003|Overall Study|Ineligible|0|||
127853788|NCT00910728|460080807|FG000|Overall Study|Lack of Efficacy|2|||
127853789|NCT00910728|460080808|FG001|Overall Study|Lack of Efficacy|3|||
127853790|NCT00910728|460080809|FG002|Overall Study|Lack of Efficacy|1|||
127853791|NCT00910728|460080810|FG003|Overall Study|Lack of Efficacy|2|||
127853792|NCT00910728|460080811|FG004|Overall Study|Lack of Efficacy|1|||
127853793|NCT00910728|460080812|FG005|Overall Study|Lack of Efficacy|0|||
127853794|NCT00910728|460080813|FG006|Overall Study|Lack of Efficacy|2|||
127853795|NCT00910728|460080814|FG007|Overall Study|Lack of Efficacy|2|||
127853796|NCT00910728|460080815|FG008|Overall Study|Lack of Efficacy|2|||
127907787|NCT00835991|460287473|FG001|Washout|Withdrawal by Subject|1|||
127907788|NCT02149420|460287474|FG000|Core Study|Administrative problems|0|||
127907789|NCT02149420|460287475|FG001|Core Study|Administrative problems|1|||
127907790|NCT02149420|460287476|FG002|Core Study|Administrative problems|2|||
127907791|NCT02149420|460287474|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
127907792|NCT02149420|460287475|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
127907793|NCT02149420|460287476|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
127907794|NCT02378935|460287477|FG000|Overall Study|Lack of Efficacy|10|||
127907795|NCT02378935|460287478|FG001|Overall Study|Lack of Efficacy|0|||
127907796|NCT02378935|460287479|FG002|Overall Study|Lack of Efficacy|2|||
127907797|NCT02378935|460287480|FG003|Overall Study|Lack of Efficacy|6|||
127907798|NCT02378935|460287481|FG004|Overall Study|Lack of Efficacy|0|||
127907799|NCT02378935|460287482|FG005|Overall Study|Lack of Efficacy|0|||
127907800|NCT02378935|460287483|FG006|Overall Study|Lack of Efficacy|0|||
127907801|NCT02378935|460287477|FG000|Overall Study|Death|0|||
127907802|NCT02378935|460287478|FG001|Overall Study|Death|0|||
127907803|NCT02378935|460287479|FG002|Overall Study|Death|1|||
127907804|NCT02378935|460287480|FG003|Overall Study|Death|0|||
127907805|NCT02378935|460287481|FG004|Overall Study|Death|0|||
127907806|NCT02378935|460287482|FG005|Overall Study|Death|0|||
127907807|NCT02378935|460287483|FG006|Overall Study|Death|0|||
127907808|NCT03616535|460287484|FG000|Overall Study|Death|2|||
127907809|NCT03616535|460287485|FG001|Overall Study|Death|0|||
127907810|NCT03616535|460287486|FG002|Overall Study|Death|0|||
127907811|NCT03616535|460287487|FG003|Overall Study|Death|1|||
127907812|NCT03616535|460287484|FG000|Overall Study|Lost to Follow-up|2|||
127907813|NCT03616535|460287485|FG001|Overall Study|Lost to Follow-up|1|||
127907814|NCT03616535|460287486|FG002|Overall Study|Lost to Follow-up|0|||
127907815|NCT03616535|460287487|FG003|Overall Study|Lost to Follow-up|2|||
127907816|NCT03616535|460287484|FG000|Overall Study|Withdrawal by Subject|1|||
127907817|NCT03616535|460287485|FG001|Overall Study|Withdrawal by Subject|2|||
127907818|NCT03616535|460287486|FG002|Overall Study|Withdrawal by Subject|5|||
127907819|NCT03616535|460287487|FG003|Overall Study|Withdrawal by Subject|1|||
127907820|NCT03616535|460287484|FG000|Overall Study|Not specified or change in eligibility|2|||
127907821|NCT03616535|460287485|FG001|Overall Study|Not specified or change in eligibility|3|||
127907822|NCT03616535|460287486|FG002|Overall Study|Not specified or change in eligibility|3|||
127907823|NCT03616535|460287487|FG003|Overall Study|Not specified or change in eligibility|1|||
127907824|NCT02146105|460287490|FG000|Overall Study|Adverse Event|1|||
127907825|NCT02146105|460287490|FG000|Overall Study|Withdrawal by Subject|5|||
127907826|NCT05755282|460287491|FG000|Overall Study|Protocol Violation|0|||
127907827|NCT05755282|460287492|FG001|Overall Study|Protocol Violation|1|||
127907828|NCT03935880|460287494|FG000|Overall Study|Lost to Follow-up|0|||
127907829|NCT03935880|460287495|FG001|Overall Study|Lost to Follow-up|1|||
127907830|NCT02476994|460287496|FG000|Overall Study|Based on feedback from FDA|1|||
127907831|NCT02476994|460287497|FG001|Overall Study|Based on feedback from FDA|0|||
127907832|NCT02563561|460287498|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
127907833|NCT02563561|460287499|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
127907834|NCT02563561|460287500|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
127907835|NCT02563561|460287498|FG000|Overall Study|Withdrew of Consent|1|||
127907836|NCT02563561|460287499|FG001|Overall Study|Withdrew of Consent|1|||
127853797|NCT00910728|460080807|FG000|Overall Study|Withdrawal by Subject|0|||
127853798|NCT00910728|460080808|FG001|Overall Study|Withdrawal by Subject|0|||
127853799|NCT00910728|460080809|FG002|Overall Study|Withdrawal by Subject|0|||
127853800|NCT00910728|460080810|FG003|Overall Study|Withdrawal by Subject|0|||
127853801|NCT00910728|460080811|FG004|Overall Study|Withdrawal by Subject|3|||
127853802|NCT00910728|460080812|FG005|Overall Study|Withdrawal by Subject|1|||
127853803|NCT00910728|460080813|FG006|Overall Study|Withdrawal by Subject|2|||
127853804|NCT00910728|460080814|FG007|Overall Study|Withdrawal by Subject|0|||
127853805|NCT00910728|460080815|FG008|Overall Study|Withdrawal by Subject|0|||
127907837|NCT02563561|460287500|FG002|Overall Study|Withdrew of Consent|2|||
127907838|NCT02563561|460287498|FG000|Overall Study|Lost to Follow-up|1|||
127907839|NCT02563561|460287499|FG001|Overall Study|Lost to Follow-up|1|||
127907840|NCT02563561|460287500|FG002|Overall Study|Lost to Follow-up|0|||
127907841|NCT02563561|460287498|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
127907842|NCT02563561|460287499|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
127907843|NCT02563561|460287500|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
127853806|NCT00910728|460080807|FG000|Overall Study|(not specified)|2|||
127853807|NCT00910728|460080808|FG001|Overall Study|(not specified)|0|||
127853808|NCT00910728|460080809|FG002|Overall Study|(not specified)|1|||
127907844|NCT02563561|460287498|FG000|Overall Study|Investigator Decision|3|||
127907845|NCT02563561|460287499|FG001|Overall Study|Investigator Decision|4|||
127907846|NCT02563561|460287500|FG002|Overall Study|Investigator Decision|2|||
127853809|NCT00910728|460080810|FG003|Overall Study|(not specified)|0|||
127907847|NCT02563561|460287498|FG000|Overall Study|Sponsor Decision|5|||
127907848|NCT02563561|460287499|FG001|Overall Study|Sponsor Decision|2|||
127907849|NCT02563561|460287500|FG002|Overall Study|Sponsor Decision|4|||
127907850|NCT02563561|460287498|FG000|Overall Study|Other|1|||
127907851|NCT02563561|460287499|FG001|Overall Study|Other|5|||
127907852|NCT02563561|460287500|FG002|Overall Study|Other|2|||
127907853|NCT02646124|460287503|FG000|Overall Study|Lost to Follow-up|0|||
127907854|NCT02646124|460287504|FG001|Overall Study|Lost to Follow-up|2|||
127907855|NCT00857454|460287505|FG000|Overall Study|Withdrawal by Subject|2|||
127907856|NCT00857454|460287505|FG000|Overall Study|Lost to Follow-up|1|||
127907857|NCT00857454|460287505|FG000|Overall Study|Adverse Event|2|||
127907858|NCT00857454|460287505|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
127907859|NCT00857454|460287505|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
127907860|NCT00857454|460287505|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
127907861|NCT03154047|460287506|FG000|Overall Study|Death|1|||
127907862|NCT03154047|460287506|FG000|Overall Study|Study terminated by sponsor|76|||
127907863|NCT03154047|460287506|FG000|Overall Study|Withdrawal by Subject|3|||
127907864|NCT00365365|460287507|FG000|Overall Study|Randomized but not treated|0|||
127907865|NCT00365365|460287508|FG001|Overall Study|Randomized but not treated|2|||
127907866|NCT00365365|460287509|FG002|Overall Study|Randomized but not treated|0|||
127907867|NCT00365365|460287507|FG000|Overall Study|Poor compliance to protocol|0|||
127907868|NCT00365365|460287508|FG001|Overall Study|Poor compliance to protocol|1|||
127907869|NCT00365365|460287509|FG002|Overall Study|Poor compliance to protocol|0|||
127907870|NCT00365365|460287507|FG000|Overall Study|Lost to Follow-up|3|||
127907871|NCT00365365|460287508|FG001|Overall Study|Lost to Follow-up|3|||
127907872|NCT00365365|460287509|FG002|Overall Study|Lost to Follow-up|3|||
127907873|NCT00365365|460287507|FG000|Overall Study|Death|1|||
127907874|NCT00365365|460287508|FG001|Overall Study|Death|3|||
127907875|NCT00365365|460287509|FG002|Overall Study|Death|0|||
127907876|NCT00365365|460287507|FG000|Overall Study|Subject's request|11|||
127853810|NCT00910728|460080811|FG004|Overall Study|(not specified)|1|||
127853811|NCT00910728|460080812|FG005|Overall Study|(not specified)|0|||
127853812|NCT00910728|460080813|FG006|Overall Study|(not specified)|0|||
127853813|NCT00910728|460080814|FG007|Overall Study|(not specified)|0|||
127853814|NCT00910728|460080815|FG008|Overall Study|(not specified)|0|||
127853815|NCT00910728|460080807|FG000|Overall Study|Adverse Event|2|||
127853816|NCT00910728|460080808|FG001|Overall Study|Adverse Event|0|||
127853817|NCT00910728|460080809|FG002|Overall Study|Adverse Event|1|||
127853818|NCT00910728|460080810|FG003|Overall Study|Adverse Event|1|||
127853819|NCT00910728|460080811|FG004|Overall Study|Adverse Event|0|||
127853820|NCT00910728|460080812|FG005|Overall Study|Adverse Event|0|||
127853821|NCT00910728|460080813|FG006|Overall Study|Adverse Event|2|||
127853822|NCT00910728|460080814|FG007|Overall Study|Adverse Event|1|||
127853823|NCT00910728|460080815|FG008|Overall Study|Adverse Event|1|||
127853824|NCT00023712|460080816|FG000|Overall Study|Not platinum sensitive|1|||
127853825|NCT00023712|460080817|FG001|Overall Study|Not platinum sensitive|0|||
127853826|NCT00023712|460080816|FG000|Overall Study|Never treated|1|||
127853827|NCT00023712|460080817|FG001|Overall Study|Never treated|1|||
127853828|NCT02571972|460080820|FG000|Overall Study|Protocol Violation|2|||
127853829|NCT02571972|460080820|FG000|Overall Study|Withdrawal by Subject|2|||
127853830|NCT03039192|460080821|FG000|Overall Study|Lost to Follow-up|4|||
127853831|NCT03039192|460080822|FG001|Overall Study|Lost to Follow-up|4|||
127853832|NCT03039192|460080821|FG000|Overall Study|Adverse event, serious fatal|0|||
127853833|NCT03039192|460080822|FG001|Overall Study|Adverse event, serious fatal|1|||
127853834|NCT03039192|460080821|FG000|Overall Study|Adverse event, non-fatal|0|||
127853835|NCT03039192|460080822|FG001|Overall Study|Adverse event, non-fatal|2|||
127853836|NCT03039192|460080821|FG000|Overall Study|Withdrawal by Subject|6|||
127853837|NCT03039192|460080822|FG001|Overall Study|Withdrawal by Subject|9|||
127853838|NCT03039192|460080821|FG000|Overall Study|Discontinued from treatment phase|19|||
127853839|NCT03039192|460080822|FG001|Overall Study|Discontinued from treatment phase|12|||
127853840|NCT03039192|460080821|FG000|Overall Study|Other|3|||
127907877|NCT00365365|460287508|FG001|Overall Study|Subject's request|13|||
127907878|NCT00365365|460287509|FG002|Overall Study|Subject's request|1|||
127853841|NCT03039192|460080822|FG001|Overall Study|Other|2|||
127853842|NCT02493868|460080823|FG000|Induction Phase: DE Participants|Adverse Event|22|||
127907879|NCT00365365|460287507|FG000|Overall Study|Disease progression/relapse|9|||
127907880|NCT00365365|460287508|FG001|Overall Study|Disease progression/relapse|6|||
127907881|NCT00365365|460287509|FG002|Overall Study|Disease progression/relapse|7|||
127907882|NCT00365365|460287507|FG000|Overall Study|Adverse Event|6|||
127907883|NCT00365365|460287508|FG001|Overall Study|Adverse Event|6|||
127907884|NCT00365365|460287509|FG002|Overall Study|Adverse Event|3|||
127907885|NCT00365365|460287507|FG000|Overall Study|Moved|2|||
127853843|NCT02493868|460080824|FG001|Induction Phase: DE Participants|Adverse Event|0|||
127907886|NCT00365365|460287508|FG001|Overall Study|Moved|0|||
127853844|NCT02493868|460080823|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
127853845|NCT02493868|460080824|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
127853846|NCT02493868|460080823|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
127853847|NCT02493868|460080824|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
127853848|NCT02493868|460080823|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
127907887|NCT00365365|460287509|FG002|Overall Study|Moved|0|||
127907888|NCT00365365|460287507|FG000|Overall Study|New cancer|1|||
127907889|NCT00365365|460287508|FG001|Overall Study|New cancer|0|||
127907890|NCT00365365|460287509|FG002|Overall Study|New cancer|0|||
127907891|NCT00365365|460287507|FG000|Overall Study|Withdrew consent|1|||
127907892|NCT00365365|460287508|FG001|Overall Study|Withdrew consent|1|||
127907893|NCT00365365|460287509|FG002|Overall Study|Withdrew consent|0|||
127907894|NCT00365365|460287507|FG000|Overall Study|Second malignancy|0|||
127907895|NCT00365365|460287508|FG001|Overall Study|Second malignancy|1|||
127907896|NCT00365365|460287509|FG002|Overall Study|Second malignancy|0|||
127907897|NCT00365365|460287507|FG000|Overall Study|Patient/physician decision|0|||
127907898|NCT00365365|460287508|FG001|Overall Study|Patient/physician decision|0|||
127907899|NCT00365365|460287509|FG002|Overall Study|Patient/physician decision|1|||
127907900|NCT00984022|460287510|FG000|Overall Study|Lost to Follow-up|10|||
127853849|NCT02493868|460080824|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
127853850|NCT02493868|460080823|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
127853851|NCT02493868|460080824|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
127853852|NCT02493868|460080823|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
127853853|NCT02493868|460080824|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
127853854|NCT02493868|460080823|FG000|Induction Phase: DE Participants|Other|8|||
127853855|NCT02493868|460080824|FG001|Induction Phase: DE Participants|Other|0|||
127853856|NCT02493868|460080823|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
127853857|NCT02493868|460080824|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
127853858|NCT02493868|460080823|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
127853859|NCT02493868|460080824|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
127853860|NCT02493868|460080823|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
127853861|NCT02493868|460080824|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
127853862|NCT02493868|460080823|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
127853863|NCT02493868|460080824|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
127853864|NCT02493868|460080823|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
127853865|NCT02493868|460080824|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
127853866|NCT02493868|460080823|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
127853867|NCT02493868|460080824|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
127853868|NCT02493868|460080823|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
127853869|NCT02493868|460080824|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
127853870|NCT02493868|460080823|FG000|Optimization Phase: DE+TE Participants|Other|10|||
127853871|NCT02493868|460080824|FG001|Optimization Phase: DE+TE Participants|Other|2|||
127853872|NCT02493868|460080823|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
127853873|NCT02493868|460080824|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
127853874|NCT02493868|460080823|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
127853875|NCT02493868|460080824|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
127853876|NCT02493868|460080823|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
127853877|NCT02493868|460080824|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
127853878|NCT02493868|460080823|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
127853879|NCT02493868|460080824|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
127853880|NCT02493868|460080823|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
127853881|NCT02493868|460080824|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
127853882|NCT02493868|460080823|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
127853883|NCT02493868|460080824|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
127853884|NCT02493868|460080823|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
127853885|NCT02493868|460080824|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
127853886|NCT02493868|460080823|FG000|Follow-up Phase|Lost to Follow-up|1|||
127853887|NCT02493868|460080824|FG001|Follow-up Phase|Lost to Follow-up|0|||
127853888|NCT02493868|460080823|FG000|Follow-up Phase|Withdrawal by Subject|3|||
127853889|NCT02493868|460080824|FG001|Follow-up Phase|Withdrawal by Subject|0|||
127853890|NCT02493868|460080823|FG000|Follow-up Phase|Investigator Decision|5|||
127907901|NCT00984022|460287511|FG001|Overall Study|Lost to Follow-up|14|||
127907902|NCT00573443|460287515|FG000|Double-Blind Phase|Lost to Follow-up|1|||
127853891|NCT02493868|460080824|FG001|Follow-up Phase|Investigator Decision|1|||
127853892|NCT02493868|460080823|FG000|Follow-up Phase|Other|2|||
127853893|NCT02493868|460080824|FG001|Follow-up Phase|Other|1|||
127853894|NCT02407236|460080825|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
127853895|NCT02407236|460080826|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
127907903|NCT00573443|460287516|FG001|Double-Blind Phase|Lost to Follow-up|3|||
127907904|NCT00573443|460287517|FG002|Double-Blind Phase|Lost to Follow-up|2|||
127853896|NCT02407236|460080827|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
127853897|NCT02407236|460080828|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
127853898|NCT02407236|460080829|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
127853899|NCT02407236|460080830|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
127853900|NCT02407236|460080831|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
127907905|NCT00573443|460287515|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
127907906|NCT00573443|460287516|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
127907907|NCT00573443|460287517|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
127907908|NCT00573443|460287515|FG000|Double-Blind Phase|Adverse Event|1|||
127907909|NCT00573443|460287516|FG001|Double-Blind Phase|Adverse Event|5|||
127907910|NCT00573443|460287517|FG002|Double-Blind Phase|Adverse Event|0|||
127907911|NCT00573443|460287515|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
127907912|NCT00573443|460287516|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
127907913|NCT00573443|460287517|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
127907914|NCT00573443|460287515|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
127907915|NCT00573443|460287516|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
127907916|NCT00573443|460287517|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
127907917|NCT00573443|460287515|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
127907918|NCT00573443|460287516|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
127907919|NCT00573443|460287517|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
127907920|NCT00573443|460287515|FG000|Double-Blind Phase|Protocol Violation|0|||
127907921|NCT00573443|460287516|FG001|Double-Blind Phase|Protocol Violation|2|||
127907922|NCT00573443|460287517|FG002|Double-Blind Phase|Protocol Violation|1|||
127907923|NCT00573443|460287515|FG000|Double-Blind Phase|Other|0|||
127907924|NCT00573443|460287516|FG001|Double-Blind Phase|Other|2|||
127907925|NCT00573443|460287517|FG002|Double-Blind Phase|Other|3|||
127907926|NCT00573443|460287515|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
127907927|NCT00573443|460287516|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
127907928|NCT00573443|460287517|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
127907929|NCT00573443|460287515|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
127907930|NCT00573443|460287516|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
127907931|NCT00573443|460287517|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
127907932|NCT00573443|460287515|FG000|Open-Label Extension Phase|Adverse Event|3|||
127907933|NCT00573443|460287516|FG001|Open-Label Extension Phase|Adverse Event|0|||
127907934|NCT00573443|460287517|FG002|Open-Label Extension Phase|Adverse Event|0|||
127907935|NCT00573443|460287515|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
127907936|NCT00573443|460287516|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
127907937|NCT00573443|460287517|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
127907938|NCT00573443|460287515|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
127907939|NCT00573443|460287516|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
127907940|NCT00573443|460287517|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
127907941|NCT00573443|460287515|FG000|Open-Label Extension Phase|Protocol Violation|2|||
127907942|NCT00573443|460287516|FG001|Open-Label Extension Phase|Protocol Violation|0|||
127907943|NCT00573443|460287517|FG002|Open-Label Extension Phase|Protocol Violation|0|||
127907944|NCT00573443|460287515|FG000|Open-Label Extension Phase|Other|2|||
127907945|NCT00573443|460287516|FG001|Open-Label Extension Phase|Other|0|||
127907946|NCT00573443|460287517|FG002|Open-Label Extension Phase|Other|0|||
127907947|NCT00905606|460287518|FG000|Period 1|Adverse Event|0|||
127907948|NCT00905606|460287519|FG001|Period 1|Adverse Event|1|||
127853901|NCT02407236|460080832|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
127853902|NCT02407236|460080833|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
127853903|NCT02407236|460080834|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
127853904|NCT02407236|460080835|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
127853905|NCT02407236|460080836|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
127853906|NCT02407236|460080837|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
127853907|NCT02407236|460080825|FG000|Induction Study (8 Weeks)|Death|0|||
127853908|NCT02407236|460080826|FG001|Induction Study (8 Weeks)|Death|0|||
127853909|NCT02407236|460080827|FG002|Induction Study (8 Weeks)|Death|1|||
127853910|NCT02407236|460080828|FG003|Induction Study (8 Weeks)|Death|0|||
127853911|NCT02407236|460080829|FG004|Induction Study (8 Weeks)|Death|0|||
127853912|NCT02407236|460080830|FG005|Induction Study (8 Weeks)|Death|0|||
127853913|NCT02407236|460080831|FG006|Induction Study (8 Weeks)|Death|0|||
127907949|NCT00905606|460287518|FG000|Washout|Withdrawal by Subject|1|||
127907950|NCT00905606|460287519|FG001|Washout|Withdrawal by Subject|0|||
127907951|NCT00804856|460287522|FG000|Overall Study|Progressive Disease|3|||
127907952|NCT00804856|460287523|FG001|Overall Study|Progressive Disease|2|||
127907953|NCT00804856|460287524|FG002|Overall Study|Progressive Disease|4|||
127907954|NCT00804856|460287525|FG003|Overall Study|Progressive Disease|6|||
127907955|NCT00804856|460287526|FG004|Overall Study|Progressive Disease|4|||
127907956|NCT00804856|460287527|FG005|Overall Study|Progressive Disease|1|||
127907957|NCT00804856|460287528|FG006|Overall Study|Progressive Disease|8|||
127907958|NCT00804856|460287529|FG007|Overall Study|Progressive Disease|2|||
127907959|NCT00804856|460287530|FG008|Overall Study|Progressive Disease|4|||
127907960|NCT00804856|460287531|FG009|Overall Study|Progressive Disease|5|||
127907961|NCT00804856|460287532|FG010|Overall Study|Progressive Disease|12|||
127907962|NCT00804856|460287533|FG011|Overall Study|Progressive Disease|2|||
127907963|NCT00804856|460287534|FG012|Overall Study|Progressive Disease|2|||
127853914|NCT02407236|460080832|FG007|Induction Study (8 Weeks)|Death|0|||
127853915|NCT02407236|460080833|FG008|Induction Study (8 Weeks)|Death|0|||
127853916|NCT02407236|460080834|FG009|Induction Study (8 Weeks)|Death|0|||
127853917|NCT02407236|460080835|FG010|Induction Study (8 Weeks)|Death|0|||
127853918|NCT02407236|460080836|FG011|Induction Study (8 Weeks)|Death|0|||
127853919|NCT02407236|460080837|FG012|Induction Study (8 Weeks)|Death|0|||
127853920|NCT02407236|460080825|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
127853921|NCT02407236|460080826|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
127853922|NCT02407236|460080827|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
127853923|NCT02407236|460080828|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
127853924|NCT02407236|460080829|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
127853925|NCT02407236|460080830|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
127853926|NCT02407236|460080831|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
127853927|NCT02407236|460080832|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
127853928|NCT02407236|460080833|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
127853929|NCT02407236|460080834|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
127853930|NCT02407236|460080835|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
127853931|NCT02407236|460080836|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
127853932|NCT02407236|460080837|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
127853933|NCT02407236|460080825|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
127853934|NCT02407236|460080826|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
127853935|NCT02407236|460080827|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
127853936|NCT02407236|460080828|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
127853937|NCT02407236|460080829|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
127853938|NCT02407236|460080830|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
127853939|NCT02407236|460080831|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
127853940|NCT02407236|460080832|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
127853941|NCT02407236|460080833|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
127853942|NCT02407236|460080834|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
127853943|NCT02407236|460080835|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
127853944|NCT02407236|460080836|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
127853945|NCT02407236|460080837|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
127853946|NCT02407236|460080825|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
127853947|NCT02407236|460080826|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
127853948|NCT02407236|460080827|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
127853949|NCT02407236|460080828|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
127853950|NCT02407236|460080829|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
127853951|NCT02407236|460080830|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
127853952|NCT02407236|460080831|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
127853953|NCT02407236|460080832|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
127853954|NCT02407236|460080833|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
127853955|NCT02407236|460080834|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
127853956|NCT02407236|460080835|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
127853957|NCT02407236|460080836|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
127853958|NCT02407236|460080837|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
127853959|NCT02407236|460080825|FG000|Induction Study (8 Weeks)|Other|2|||
127853960|NCT02407236|460080826|FG001|Induction Study (8 Weeks)|Other|1|||
127853961|NCT02407236|460080827|FG002|Induction Study (8 Weeks)|Other|5|||
127853962|NCT02407236|460080828|FG003|Induction Study (8 Weeks)|Other|0|||
127853963|NCT02407236|460080829|FG004|Induction Study (8 Weeks)|Other|0|||
127853964|NCT02407236|460080830|FG005|Induction Study (8 Weeks)|Other|0|||
127853965|NCT02407236|460080831|FG006|Induction Study (8 Weeks)|Other|0|||
127853966|NCT02407236|460080832|FG007|Induction Study (8 Weeks)|Other|0|||
127853967|NCT02407236|460080833|FG008|Induction Study (8 Weeks)|Other|0|||
127853968|NCT02407236|460080834|FG009|Induction Study (8 Weeks)|Other|0|||
127853969|NCT02407236|460080835|FG010|Induction Study (8 Weeks)|Other|0|||
127853970|NCT02407236|460080836|FG011|Induction Study (8 Weeks)|Other|0|||
127853971|NCT02407236|460080837|FG012|Induction Study (8 Weeks)|Other|0|||
127853972|NCT02407236|460080825|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
127853973|NCT02407236|460080826|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
127853974|NCT02407236|460080827|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
127853975|NCT02407236|460080828|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
127853976|NCT02407236|460080829|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
127853977|NCT02407236|460080830|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
127853978|NCT02407236|460080831|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
127853979|NCT02407236|460080832|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
127853980|NCT02407236|460080833|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
127853981|NCT02407236|460080834|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
127853982|NCT02407236|460080835|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
127853983|NCT02407236|460080836|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
127853984|NCT02407236|460080837|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
127853985|NCT02407236|460080825|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
127907964|NCT00804856|460287535|FG013|Overall Study|Progressive Disease|26|||
127853986|NCT02407236|460080826|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
127907965|NCT00804856|460287536|FG014|Overall Study|Progressive Disease|20|||
127853987|NCT02407236|460080827|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
127853988|NCT02407236|460080828|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
127853989|NCT02407236|460080829|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
127853990|NCT02407236|460080830|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
127853991|NCT02407236|460080831|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
127853992|NCT02407236|460080832|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
127853993|NCT02407236|460080833|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
127853994|NCT02407236|460080834|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
127853995|NCT02407236|460080835|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
127853996|NCT02407236|460080836|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
127853997|NCT02407236|460080837|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
127853998|NCT02407236|460080825|FG000|Maintenance Study (44 Weeks)|Other|0|||
127853999|NCT02407236|460080826|FG001|Maintenance Study (44 Weeks)|Other|0|||
127854000|NCT02407236|460080827|FG002|Maintenance Study (44 Weeks)|Other|0|||
127854001|NCT02407236|460080828|FG003|Maintenance Study (44 Weeks)|Other|5|||
127854002|NCT02407236|460080829|FG004|Maintenance Study (44 Weeks)|Other|7|||
127854003|NCT02407236|460080830|FG005|Maintenance Study (44 Weeks)|Other|8|||
127854004|NCT02407236|460080831|FG006|Maintenance Study (44 Weeks)|Other|4|||
127854005|NCT02407236|460080832|FG007|Maintenance Study (44 Weeks)|Other|6|||
127854006|NCT02407236|460080833|FG008|Maintenance Study (44 Weeks)|Other|0|||
127854007|NCT02407236|460080834|FG009|Maintenance Study (44 Weeks)|Other|0|||
127854008|NCT02407236|460080835|FG010|Maintenance Study (44 Weeks)|Other|0|||
127854009|NCT02407236|460080836|FG011|Maintenance Study (44 Weeks)|Other|0|||
127854010|NCT02407236|460080837|FG012|Maintenance Study (44 Weeks)|Other|0|||
127854011|NCT02407236|460080825|FG000|Maintenance Study (44 Weeks)|Death|0|||
127854012|NCT02407236|460080826|FG001|Maintenance Study (44 Weeks)|Death|0|||
127854013|NCT02407236|460080827|FG002|Maintenance Study (44 Weeks)|Death|0|||
127854014|NCT02407236|460080828|FG003|Maintenance Study (44 Weeks)|Death|0|||
127854015|NCT02407236|460080829|FG004|Maintenance Study (44 Weeks)|Death|0|||
127854016|NCT02407236|460080830|FG005|Maintenance Study (44 Weeks)|Death|0|||
127854017|NCT02407236|460080831|FG006|Maintenance Study (44 Weeks)|Death|0|||
127854018|NCT02407236|460080832|FG007|Maintenance Study (44 Weeks)|Death|1|||
127854019|NCT02407236|460080833|FG008|Maintenance Study (44 Weeks)|Death|0|||
127854020|NCT02407236|460080834|FG009|Maintenance Study (44 Weeks)|Death|0|||
127854021|NCT02407236|460080835|FG010|Maintenance Study (44 Weeks)|Death|0|||
127854022|NCT02407236|460080836|FG011|Maintenance Study (44 Weeks)|Death|0|||
127854023|NCT02407236|460080837|FG012|Maintenance Study (44 Weeks)|Death|0|||
127854024|NCT02407236|460080825|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
127854025|NCT02407236|460080826|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
127854026|NCT02407236|460080827|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
127907966|NCT00804856|460287522|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
127907967|NCT00804856|460287523|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
127907968|NCT00804856|460287524|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
127907969|NCT00804856|460287525|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
127907970|NCT00804856|460287526|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
127907971|NCT00804856|460287527|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
127907972|NCT00804856|460287528|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
127907973|NCT00804856|460287529|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
127907974|NCT00804856|460287530|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
127907975|NCT00804856|460287531|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
127907976|NCT00804856|460287532|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
127907977|NCT00804856|460287533|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
127907978|NCT00804856|460287534|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
127907979|NCT00804856|460287535|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
127907980|NCT00804856|460287536|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
127907981|NCT00804856|460287522|FG000|Overall Study|Other Adverse Event|1|||
127907982|NCT00804856|460287523|FG001|Overall Study|Other Adverse Event|1|||
127907983|NCT00804856|460287524|FG002|Overall Study|Other Adverse Event|1|||
127907984|NCT00804856|460287525|FG003|Overall Study|Other Adverse Event|2|||
127907985|NCT00804856|460287526|FG004|Overall Study|Other Adverse Event|2|||
127907986|NCT00804856|460287527|FG005|Overall Study|Other Adverse Event|1|||
127907987|NCT00804856|460287528|FG006|Overall Study|Other Adverse Event|3|||
127907988|NCT00804856|460287529|FG007|Overall Study|Other Adverse Event|0|||
127907989|NCT00804856|460287530|FG008|Overall Study|Other Adverse Event|0|||
127854027|NCT02407236|460080828|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
127854028|NCT02407236|460080829|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
127854029|NCT02407236|460080830|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
127854030|NCT02407236|460080831|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
127854031|NCT02407236|460080832|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
127907990|NCT00804856|460287531|FG009|Overall Study|Other Adverse Event|1|||
127854032|NCT02407236|460080833|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
127854033|NCT02407236|460080834|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
127854034|NCT02407236|460080835|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
127854035|NCT02407236|460080836|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
127907991|NCT00804856|460287532|FG010|Overall Study|Other Adverse Event|5|||
127907992|NCT00804856|460287533|FG011|Overall Study|Other Adverse Event|2|||
127907993|NCT00804856|460287534|FG012|Overall Study|Other Adverse Event|0|||
127907994|NCT00804856|460287535|FG013|Overall Study|Other Adverse Event|6|||
127907995|NCT00804856|460287536|FG014|Overall Study|Other Adverse Event|13|||
127907996|NCT00804856|460287522|FG000|Overall Study|Non compliance with protocol|0|||
127907997|NCT00804856|460287523|FG001|Overall Study|Non compliance with protocol|0|||
127907998|NCT00804856|460287524|FG002|Overall Study|Non compliance with protocol|0|||
127907999|NCT00804856|460287525|FG003|Overall Study|Non compliance with protocol|0|||
127908000|NCT00804856|460287526|FG004|Overall Study|Non compliance with protocol|0|||
127908001|NCT00804856|460287527|FG005|Overall Study|Non compliance with protocol|0|||
127908002|NCT00804856|460287528|FG006|Overall Study|Non compliance with protocol|0|||
127908003|NCT00804856|460287529|FG007|Overall Study|Non compliance with protocol|0|||
127908004|NCT00804856|460287530|FG008|Overall Study|Non compliance with protocol|0|||
127908005|NCT00804856|460287531|FG009|Overall Study|Non compliance with protocol|0|||
127908006|NCT00804856|460287532|FG010|Overall Study|Non compliance with protocol|0|||
127908007|NCT00804856|460287533|FG011|Overall Study|Non compliance with protocol|0|||
127908008|NCT00804856|460287534|FG012|Overall Study|Non compliance with protocol|0|||
127908009|NCT00804856|460287535|FG013|Overall Study|Non compliance with protocol|2|||
127908010|NCT00804856|460287536|FG014|Overall Study|Non compliance with protocol|0|||
127908011|NCT00804856|460287522|FG000|Overall Study|Refused to continue medication|0|||
127908012|NCT00804856|460287523|FG001|Overall Study|Refused to continue medication|0|||
127908013|NCT00804856|460287524|FG002|Overall Study|Refused to continue medication|0|||
127908014|NCT00804856|460287525|FG003|Overall Study|Refused to continue medication|1|||
127908015|NCT00804856|460287526|FG004|Overall Study|Refused to continue medication|1|||
127908016|NCT00804856|460287527|FG005|Overall Study|Refused to continue medication|0|||
127908017|NCT00804856|460287528|FG006|Overall Study|Refused to continue medication|0|||
127908018|NCT00804856|460287529|FG007|Overall Study|Refused to continue medication|0|||
127908019|NCT00804856|460287530|FG008|Overall Study|Refused to continue medication|0|||
127908020|NCT00804856|460287531|FG009|Overall Study|Refused to continue medication|0|||
127908021|NCT00804856|460287532|FG010|Overall Study|Refused to continue medication|3|||
127908022|NCT00804856|460287533|FG011|Overall Study|Refused to continue medication|0|||
127908023|NCT00804856|460287534|FG012|Overall Study|Refused to continue medication|1|||
127908024|NCT00804856|460287535|FG013|Overall Study|Refused to continue medication|1|||
127908025|NCT00804856|460287536|FG014|Overall Study|Refused to continue medication|5|||
127908026|NCT00804856|460287522|FG000|Overall Study|Other reason than listed above|0|||
127908027|NCT00804856|460287523|FG001|Overall Study|Other reason than listed above|0|||
127908028|NCT00804856|460287524|FG002|Overall Study|Other reason than listed above|0|||
127908029|NCT00804856|460287525|FG003|Overall Study|Other reason than listed above|0|||
127908030|NCT00804856|460287526|FG004|Overall Study|Other reason than listed above|0|||
127908031|NCT00804856|460287527|FG005|Overall Study|Other reason than listed above|1|||
127908032|NCT00804856|460287528|FG006|Overall Study|Other reason than listed above|0|||
127908033|NCT00804856|460287529|FG007|Overall Study|Other reason than listed above|0|||
127908034|NCT00804856|460287530|FG008|Overall Study|Other reason than listed above|1|||
127908035|NCT00804856|460287531|FG009|Overall Study|Other reason than listed above|0|||
127908036|NCT00804856|460287532|FG010|Overall Study|Other reason than listed above|3|||
127908037|NCT00804856|460287533|FG011|Overall Study|Other reason than listed above|1|||
127908038|NCT00804856|460287534|FG012|Overall Study|Other reason than listed above|1|||
127908039|NCT00804856|460287535|FG013|Overall Study|Other reason than listed above|10|||
127908040|NCT00804856|460287536|FG014|Overall Study|Other reason than listed above|3|||
127908041|NCT00418561|460287537|FG000|Overall Study|Participant's (guardian's) decision|0|||
127908042|NCT00418561|460287538|FG001|Overall Study|Participant's (guardian's) decision|1|||
127908043|NCT00418561|460287539|FG002|Overall Study|Participant's (guardian's) decision|0|||
127908044|NCT01796171|460287540|FG000|Enrolled|Death|0|||
127908045|NCT01796171|460287541|FG001|Enrolled|Death|0|||
127908046|NCT01796171|460287542|FG002|Enrolled|Death|0|||
127908047|NCT01796171|460287543|FG003|Enrolled|Death|0|||
127908048|NCT01796171|460287544|FG004|Enrolled|Death|0|||
127908049|NCT01796171|460287545|FG005|Enrolled|Death|0|||
127908050|NCT01796171|460287546|FG006|Enrolled|Death|0|||
127908051|NCT01796171|460287547|FG007|Enrolled|Death|0|||
127908052|NCT01796171|460287548|FG008|Enrolled|Death|0|||
127908053|NCT01796171|460287549|FG009|Enrolled|Death|0|||
127908054|NCT01796171|460287550|FG010|Enrolled|Death|0|||
127908055|NCT01796171|460287551|FG011|Enrolled|Death|0|||
127908056|NCT01796171|460287552|FG012|Enrolled|Death|0|||
127908057|NCT01796171|460287553|FG013|Enrolled|Death|0|||
127908058|NCT01796171|460287554|FG014|Enrolled|Death|1|||
127908059|NCT01796171|460287540|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
127908060|NCT01796171|460287541|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
127908061|NCT01796171|460287542|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
127908062|NCT01796171|460287543|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
127908063|NCT01796171|460287544|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
127908064|NCT01796171|460287545|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
127908065|NCT01796171|460287546|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
127908066|NCT01796171|460287547|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
127908067|NCT01796171|460287548|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
127908068|NCT01796171|460287549|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
127908069|NCT01796171|460287550|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
127908070|NCT01796171|460287551|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
127908071|NCT01796171|460287552|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
127908072|NCT01796171|460287553|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
127908073|NCT01796171|460287554|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
127908074|NCT01796171|460287540|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
127908075|NCT01796171|460287541|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
127908076|NCT01796171|460287542|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
127908077|NCT01796171|460287543|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
127908078|NCT01796171|460287544|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
127908079|NCT01796171|460287545|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
127908080|NCT01796171|460287546|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
127908081|NCT01796171|460287547|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
127908082|NCT01796171|460287548|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
127908083|NCT01796171|460287549|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
127908084|NCT01796171|460287550|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
127908085|NCT01796171|460287551|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
127908086|NCT01796171|460287552|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
127908087|NCT01796171|460287553|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
127908088|NCT01796171|460287554|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
127908089|NCT01796171|460287540|FG000|Treatment Period With Betalutin|Progressive disease|0|||
127908090|NCT01796171|460287541|FG001|Treatment Period With Betalutin|Progressive disease|1|||
127908091|NCT01796171|460287542|FG002|Treatment Period With Betalutin|Progressive disease|0|||
127908092|NCT01796171|460287543|FG003|Treatment Period With Betalutin|Progressive disease|0|||
127908093|NCT01796171|460287544|FG004|Treatment Period With Betalutin|Progressive disease|0|||
127908094|NCT01796171|460287545|FG005|Treatment Period With Betalutin|Progressive disease|0|||
127854036|NCT02407236|460080837|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
127854037|NCT02407236|460080825|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
127854038|NCT02407236|460080826|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
127854039|NCT02407236|460080827|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
127854040|NCT02407236|460080828|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
127854041|NCT02407236|460080829|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
127854042|NCT02407236|460080830|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
127854043|NCT02407236|460080831|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
127854044|NCT02407236|460080832|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
127854045|NCT02407236|460080833|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
127854046|NCT02407236|460080834|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
127908095|NCT01796171|460287546|FG006|Treatment Period With Betalutin|Progressive disease|0|||
127908096|NCT01796171|460287547|FG007|Treatment Period With Betalutin|Progressive disease|0|||
127908097|NCT01796171|460287548|FG008|Treatment Period With Betalutin|Progressive disease|0|||
127908098|NCT01796171|460287549|FG009|Treatment Period With Betalutin|Progressive disease|0|||
127908099|NCT01796171|460287550|FG010|Treatment Period With Betalutin|Progressive disease|0|||
127908100|NCT01796171|460287551|FG011|Treatment Period With Betalutin|Progressive disease|0|||
127908101|NCT01796171|460287552|FG012|Treatment Period With Betalutin|Progressive disease|0|||
127908102|NCT01796171|460287553|FG013|Treatment Period With Betalutin|Progressive disease|0|||
127908103|NCT01796171|460287554|FG014|Treatment Period With Betalutin|Progressive disease|0|||
127908104|NCT01796171|460287540|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
127908105|NCT01796171|460287541|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
127908106|NCT01796171|460287542|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
127908107|NCT01796171|460287543|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
127908108|NCT01796171|460287544|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
127908109|NCT01796171|460287545|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
127908110|NCT01796171|460287546|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
127908111|NCT01796171|460287547|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
127908112|NCT01796171|460287548|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
127908113|NCT01796171|460287549|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
127854047|NCT02407236|460080835|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
127854048|NCT02407236|460080836|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
127854049|NCT02407236|460080837|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
127854050|NCT02407236|460080825|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
127908114|NCT01796171|460287550|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
127908115|NCT01796171|460287551|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
127854051|NCT02407236|460080826|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
127908116|NCT01796171|460287552|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
127908117|NCT01796171|460287553|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
127908118|NCT01796171|460287554|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
127908119|NCT01796171|460287540|FG000|Treatment Period With Betalutin|Physician Decision|0|||
127908120|NCT01796171|460287541|FG001|Treatment Period With Betalutin|Physician Decision|0|||
127908121|NCT01796171|460287542|FG002|Treatment Period With Betalutin|Physician Decision|0|||
127908122|NCT01796171|460287543|FG003|Treatment Period With Betalutin|Physician Decision|0|||
127908123|NCT01796171|460287544|FG004|Treatment Period With Betalutin|Physician Decision|0|||
127908124|NCT01796171|460287545|FG005|Treatment Period With Betalutin|Physician Decision|0|||
127908125|NCT01796171|460287546|FG006|Treatment Period With Betalutin|Physician Decision|0|||
127908126|NCT01796171|460287547|FG007|Treatment Period With Betalutin|Physician Decision|0|||
127908127|NCT01796171|460287548|FG008|Treatment Period With Betalutin|Physician Decision|0|||
127908128|NCT01796171|460287549|FG009|Treatment Period With Betalutin|Physician Decision|0|||
127854052|NCT02407236|460080827|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
127854053|NCT02407236|460080828|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
127854054|NCT02407236|460080829|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
127854055|NCT02407236|460080830|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
127854056|NCT02407236|460080831|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
127854057|NCT02407236|460080832|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
127854058|NCT02407236|460080833|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
127854059|NCT02407236|460080834|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
127854060|NCT02407236|460080835|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
127854061|NCT02407236|460080836|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
127854062|NCT02407236|460080837|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
127854063|NCT02407236|460080825|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
127854064|NCT02407236|460080826|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
127854065|NCT02407236|460080827|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
127854066|NCT02407236|460080828|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
127854067|NCT02407236|460080829|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
127854068|NCT02407236|460080830|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
127854069|NCT02407236|460080831|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
127854070|NCT02407236|460080832|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
127854071|NCT02407236|460080833|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
127854072|NCT02407236|460080834|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
127854073|NCT02407236|460080835|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
127854074|NCT02407236|460080836|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
127854075|NCT02407236|460080837|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
127854076|NCT00464620|460082325|FG000|Overall Study|Physician Decision|1|||
127854077|NCT00464620|460082326|FG001|Overall Study|Physician Decision|0|||
127854078|NCT00464620|460082327|FG002|Overall Study|Physician Decision|0|||
127854079|NCT00464620|460082325|FG000|Overall Study|Withdrawal by Subject|1|||
127854080|NCT00464620|460082326|FG001|Overall Study|Withdrawal by Subject|0|||
127854081|NCT00464620|460082327|FG002|Overall Study|Withdrawal by Subject|3|||
127854082|NCT00464620|460082325|FG000|Overall Study|Ineligible sarcoma subtype|0|||
127854083|NCT00464620|460082326|FG001|Overall Study|Ineligible sarcoma subtype|2|||
127854084|NCT00464620|460082327|FG002|Overall Study|Ineligible sarcoma subtype|2|||
127854085|NCT00464620|460082325|FG000|Overall Study|Use of prohibited concomitant medication|0|||
127854086|NCT00464620|460082326|FG001|Overall Study|Use of prohibited concomitant medication|0|||
127854087|NCT00464620|460082327|FG002|Overall Study|Use of prohibited concomitant medication|2|||
127854088|NCT04402385|460082328|FG000|Overall Study|Withdrawal by Subject|4|||
127854089|NCT04402385|460082329|FG001|Overall Study|Withdrawal by Subject|4|||
127854090|NCT04402385|460082328|FG000|Overall Study|Lost to Follow-up|1|||
127854091|NCT04402385|460082329|FG001|Overall Study|Lost to Follow-up|1|||
127854092|NCT04402385|460082328|FG000|Overall Study|Physician Decision|0|||
127854093|NCT04402385|460082329|FG001|Overall Study|Physician Decision|1|||
127854094|NCT02204410|460082332|FG000|Overall Study|Lost to Follow-up|5|||
127854095|NCT02204410|460082332|FG000|Overall Study|Physician Decision|2|||
127854096|NCT02204410|460082332|FG000|Overall Study|Protocol Violation|1|||
127854097|NCT02204410|460082332|FG000|Overall Study|Withdrawal by Subject|3|||
127854098|NCT03654560|460082333|FG000|Overall Study|Death|3|||
127854099|NCT03654560|460082334|FG001|Overall Study|Death|1|||
127854100|NCT03654560|460082333|FG000|Overall Study|Lost to Follow-up|1|||
127854101|NCT03654560|460082334|FG001|Overall Study|Lost to Follow-up|0|||
127854102|NCT01473355|460082335|FG000|Overall Study|Protocol Violation|2|||
127854103|NCT01473355|460082335|FG000|Overall Study|Adverse Event|2|||
127854104|NCT01473355|460082335|FG000|Overall Study|Lost to Follow-up|2|||
127854105|NCT00863317|460082338|FG000|Overall Study|Lost to Follow-up|8|||
127854106|NCT00863317|460082339|FG001|Overall Study|Lost to Follow-up|9|||
127854107|NCT00038142|460082342|FG000|Overall Study|Ineligible|1|||
127854108|NCT00038142|460082343|FG001|Overall Study|Ineligible|0|||
127854109|NCT00038142|460082342|FG000|Overall Study|Progressive Disease|11|||
127908129|NCT01796171|460287550|FG010|Treatment Period With Betalutin|Physician Decision|5|||
127908130|NCT01796171|460287551|FG011|Treatment Period With Betalutin|Physician Decision|1|||
127908131|NCT01796171|460287552|FG012|Treatment Period With Betalutin|Physician Decision|1|||
127908132|NCT01796171|460287553|FG013|Treatment Period With Betalutin|Physician Decision|0|||
127908133|NCT01796171|460287554|FG014|Treatment Period With Betalutin|Physician Decision|0|||
127908134|NCT01796171|460287540|FG000|Treatment Period With Betalutin|Death|0|||
127908135|NCT01796171|460287541|FG001|Treatment Period With Betalutin|Death|0|||
127908136|NCT01796171|460287542|FG002|Treatment Period With Betalutin|Death|0|||
127908137|NCT01796171|460287543|FG003|Treatment Period With Betalutin|Death|0|||
127908138|NCT01796171|460287544|FG004|Treatment Period With Betalutin|Death|0|||
127908139|NCT01796171|460287545|FG005|Treatment Period With Betalutin|Death|0|||
127908140|NCT01796171|460287546|FG006|Treatment Period With Betalutin|Death|0|||
127908141|NCT01796171|460287547|FG007|Treatment Period With Betalutin|Death|0|||
127908142|NCT01796171|460287548|FG008|Treatment Period With Betalutin|Death|0|||
127908143|NCT01796171|460287549|FG009|Treatment Period With Betalutin|Death|0|||
127908144|NCT01796171|460287550|FG010|Treatment Period With Betalutin|Death|2|||
127908145|NCT01796171|460287551|FG011|Treatment Period With Betalutin|Death|0|||
127908146|NCT01796171|460287552|FG012|Treatment Period With Betalutin|Death|0|||
127908147|NCT01796171|460287553|FG013|Treatment Period With Betalutin|Death|0|||
127908148|NCT01796171|460287554|FG014|Treatment Period With Betalutin|Death|0|||
127908149|NCT01796171|460287540|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
127908150|NCT01796171|460287541|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
127908151|NCT01796171|460287542|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
127908152|NCT01796171|460287543|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
127908153|NCT01796171|460287544|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
127908154|NCT01796171|460287545|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
127908155|NCT01796171|460287546|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
127908156|NCT01796171|460287547|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
127908157|NCT01796171|460287548|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
127908158|NCT01796171|460287549|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
127908159|NCT01796171|460287550|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
127908160|NCT01796171|460287551|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
127908161|NCT01796171|460287552|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
127908162|NCT01796171|460287553|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
127908163|NCT01796171|460287554|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
127908164|NCT01796171|460287540|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
127908165|NCT01796171|460287541|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
127908166|NCT01796171|460287542|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
127908167|NCT01796171|460287543|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
127908168|NCT01796171|460287544|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
127908169|NCT01796171|460287545|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
127908170|NCT01796171|460287546|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
127908171|NCT01796171|460287547|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
127908172|NCT01796171|460287548|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
127908173|NCT01796171|460287549|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
127908174|NCT01796171|460287550|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
127908175|NCT01796171|460287551|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
127908176|NCT01796171|460287552|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
127908177|NCT01796171|460287553|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
127908178|NCT01796171|460287554|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
127908179|NCT01796171|460287540|FG000|Follow-up Period|Start of further anticancer therapy|4|||
127908180|NCT01796171|460287541|FG001|Follow-up Period|Start of further anticancer therapy|25|||
127908181|NCT01796171|460287542|FG002|Follow-up Period|Start of further anticancer therapy|2|||
127908182|NCT01796171|460287543|FG003|Follow-up Period|Start of further anticancer therapy|1|||
127908183|NCT01796171|460287544|FG004|Follow-up Period|Start of further anticancer therapy|2|||
127908184|NCT01796171|460287545|FG005|Follow-up Period|Start of further anticancer therapy|2|||
127908185|NCT01796171|460287546|FG006|Follow-up Period|Start of further anticancer therapy|1|||
127908186|NCT01796171|460287547|FG007|Follow-up Period|Start of further anticancer therapy|15|||
127908187|NCT01796171|460287548|FG008|Follow-up Period|Start of further anticancer therapy|2|||
127908188|NCT01796171|460287549|FG009|Follow-up Period|Start of further anticancer therapy|0|||
127908189|NCT01796171|460287550|FG010|Follow-up Period|Start of further anticancer therapy|0|||
127908190|NCT01796171|460287551|FG011|Follow-up Period|Start of further anticancer therapy|0|||
127908191|NCT01796171|460287552|FG012|Follow-up Period|Start of further anticancer therapy|0|||
127908192|NCT01796171|460287553|FG013|Follow-up Period|Start of further anticancer therapy|0|||
127908193|NCT01796171|460287554|FG014|Follow-up Period|Start of further anticancer therapy|0|||
127908194|NCT01796171|460287540|FG000|Follow-up Period|Progressive disease|0|||
127908195|NCT01796171|460287541|FG001|Follow-up Period|Progressive disease|1|||
127908196|NCT01796171|460287542|FG002|Follow-up Period|Progressive disease|0|||
127908197|NCT01796171|460287543|FG003|Follow-up Period|Progressive disease|0|||
127908198|NCT01796171|460287544|FG004|Follow-up Period|Progressive disease|0|||
127854110|NCT00038142|460082343|FG001|Overall Study|Progressive Disease|7|||
127854111|NCT00038142|460082342|FG000|Overall Study|Death|1|||
127854112|NCT00038142|460082343|FG001|Overall Study|Death|0|||
127854113|NCT00038142|460082342|FG000|Overall Study|Adverse Event|1|||
127854114|NCT00038142|460082343|FG001|Overall Study|Adverse Event|0|||
127854115|NCT00038142|460082342|FG000|Overall Study|Unknown Reason|8|||
127854116|NCT00038142|460082343|FG001|Overall Study|Unknown Reason|0|||
127854117|NCT00809614|460082350|FG000|Overall Study|Lack of Efficacy|2|||
127854118|NCT00809614|460082351|FG001|Overall Study|Lack of Efficacy|3|||
127854119|NCT00809614|460082350|FG000|Overall Study|Withdrawal by Subject|1|||
127854120|NCT00809614|460082351|FG001|Overall Study|Withdrawal by Subject|1|||
127854121|NCT01080625|460082352|FG000|Overall Study|Physician Decision|0|||
127854122|NCT01080625|460082353|FG001|Overall Study|Physician Decision|2|||
127854123|NCT01080625|460082354|FG002|Overall Study|Physician Decision|1|||
127854124|NCT00364832|460082358|FG000|Core Period|Early Withdrawals|2|||
127854125|NCT00364832|460082359|FG001|Core Period|Early Withdrawals|2|||
127854126|NCT00364832|460082360|FG002|Core Period|Early Withdrawals|1|||
127854127|NCT00364832|460082361|FG003|Core Period|Early Withdrawals|1|||
127854128|NCT00364832|460082362|FG004|Core Period|Early Withdrawals|0|||
127854129|NCT00364832|460082363|FG005|Core Period|Early Withdrawals|0|||
127854130|NCT00364832|460082364|FG006|Core Period|Early Withdrawals|4|||
127854131|NCT00364832|460082365|FG007|Core Period|Early Withdrawals|1|||
127854132|NCT00364832|460082366|FG008|Core Period|Early Withdrawals|0|||
127854133|NCT00364832|460082367|FG009|Core Period|Early Withdrawals|0|||
127854134|NCT00364832|460082368|FG010|Core Period|Early Withdrawals|0|||
127854135|NCT00364832|460082369|FG011|Core Period|Early Withdrawals|0|||
127854136|NCT00364832|460082358|FG000|Extension Year 1|Early Withdrawals|0|||
127854137|NCT00364832|460082359|FG001|Extension Year 1|Early Withdrawals|0|||
127854138|NCT00364832|460082360|FG002|Extension Year 1|Early Withdrawals|0|||
127854139|NCT00364832|460082361|FG003|Extension Year 1|Early Withdrawals|0|||
127854140|NCT00364832|460082362|FG004|Extension Year 1|Early Withdrawals|0|||
127854141|NCT00364832|460082363|FG005|Extension Year 1|Early Withdrawals|0|||
127854142|NCT00364832|460082364|FG006|Extension Year 1|Early Withdrawals|0|||
127854143|NCT00364832|460082365|FG007|Extension Year 1|Early Withdrawals|0|||
127854144|NCT00364832|460082366|FG008|Extension Year 1|Early Withdrawals|0|||
127854145|NCT00364832|460082367|FG009|Extension Year 1|Early Withdrawals|4|||
127854146|NCT00364832|460082368|FG010|Extension Year 1|Early Withdrawals|2|||
127854147|NCT00364832|460082369|FG011|Extension Year 1|Early Withdrawals|10|||
127854148|NCT00364832|460082358|FG000|Extension Year 2|Early Withdrawals|0|||
127854149|NCT00364832|460082359|FG001|Extension Year 2|Early Withdrawals|0|||
127854150|NCT00364832|460082360|FG002|Extension Year 2|Early Withdrawals|0|||
127854151|NCT00364832|460082361|FG003|Extension Year 2|Early Withdrawals|0|||
127854152|NCT00364832|460082362|FG004|Extension Year 2|Early Withdrawals|0|||
127854153|NCT00364832|460082363|FG005|Extension Year 2|Early Withdrawals|0|||
127854154|NCT00364832|460082364|FG006|Extension Year 2|Early Withdrawals|0|||
127854155|NCT00364832|460082365|FG007|Extension Year 2|Early Withdrawals|0|||
127854156|NCT00364832|460082366|FG008|Extension Year 2|Early Withdrawals|0|||
127854157|NCT00364832|460082367|FG009|Extension Year 2|Early Withdrawals|5|||
127854158|NCT00364832|460082368|FG010|Extension Year 2|Early Withdrawals|5|||
127854159|NCT00364832|460082369|FG011|Extension Year 2|Early Withdrawals|3|||
127854160|NCT00068822|460082370|FG000|First Randomized Intervention|Lost to Follow-up|1|||
127854161|NCT00068822|460082371|FG001|First Randomized Intervention|Lost to Follow-up|2|||
127854162|NCT00735072|460082375|FG000|Overall Study|interrupted study med during ARV change|1|||
127854163|NCT00735072|460082376|FG001|Overall Study|interrupted study med during ARV change|0|||
127854164|NCT00735072|460082375|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
127854165|NCT00735072|460082376|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
127854166|NCT00911144|460082377|FG000|Overall Study|Withdrawal by Subject|16|||
127854167|NCT00911144|460082378|FG001|Overall Study|Withdrawal by Subject|5|||
127854168|NCT00939341|460082383|FG000|Overall Study|Adverse Event|15|||
127854169|NCT00939341|460082383|FG000|Overall Study|Pregnancy|1|||
127854170|NCT00939341|460082383|FG000|Overall Study|Lost to Follow-up|23|||
127854171|NCT00939341|460082383|FG000|Overall Study|Withdrawal by Subject|13|||
127854172|NCT00939341|460082383|FG000|Overall Study|Protocol Violation|6|||
127854173|NCT00939341|460082383|FG000|Overall Study|Incorrect enrolment|8|||
127854174|NCT03377452|460082384|FG000|Overall Study|Refused assessment|0|||
127854175|NCT03377452|460082385|FG001|Overall Study|Refused assessment|2|||
127854176|NCT03377452|460082384|FG000|Overall Study|Lost to Follow-up|5|||
127854177|NCT03377452|460082385|FG001|Overall Study|Lost to Follow-up|4|||
127854178|NCT05179057|460082387|FG000|Overall Study|Adverse Event|3|||
127854179|NCT05179057|460082388|FG001|Overall Study|Adverse Event|2|||
127854180|NCT05179057|460082387|FG000|Overall Study|Non-compliance with protocol requirements or study-related procedures|1|||
127854181|NCT05179057|460082388|FG001|Overall Study|Non-compliance with protocol requirements or study-related procedures|0|||
127854182|NCT05179057|460082387|FG000|Overall Study|Study terminated|13|||
127854183|NCT05179057|460082388|FG001|Overall Study|Study terminated|7|||
127854184|NCT05179057|460082387|FG000|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
127854185|NCT05179057|460082388|FG001|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
127854186|NCT05179057|460082387|FG000|Overall Study|Never received primary or cross-over study treatment|1|||
127854187|NCT05179057|460082388|FG001|Overall Study|Never received primary or cross-over study treatment|3|||
127854188|NCT03146403|460082389|FG000|Overall Study|Withdrawal by Subject|0|||
127854189|NCT03146403|460082390|FG001|Overall Study|Withdrawal by Subject|3|||
127854190|NCT03146403|460082389|FG000|Overall Study|Lost to Follow-up|2|||
127854191|NCT03146403|460082390|FG001|Overall Study|Lost to Follow-up|0|||
127854192|NCT00638690|460082406|FG000|Overall Study|Death|655|||
127854193|NCT00638690|460082407|FG001|Overall Study|Death|335|||
127854194|NCT00638690|460082406|FG000|Overall Study|Withdrawal by Subject|22|||
127854195|NCT00638690|460082407|FG001|Overall Study|Withdrawal by Subject|5|||
127854196|NCT00638690|460082406|FG000|Overall Study|Lost to Follow-up|4|||
127854197|NCT00638690|460082407|FG001|Overall Study|Lost to Follow-up|2|||
127854198|NCT00621244|460082412|FG000|Overall Study|Withdrawal by Subject|7|||
127854199|NCT00621244|460082413|FG001|Overall Study|Withdrawal by Subject|3|||
127854200|NCT00621244|460082414|FG002|Overall Study|Withdrawal by Subject|3|||
127854201|NCT00621244|460082415|FG003|Overall Study|Withdrawal by Subject|3|||
127854202|NCT00621244|460082412|FG000|Overall Study|Disease progression|44|||
127854203|NCT00621244|460082413|FG001|Overall Study|Disease progression|20|||
127854204|NCT00621244|460082414|FG002|Overall Study|Disease progression|20|||
127854205|NCT00621244|460082415|FG003|Overall Study|Disease progression|15|||
127854206|NCT00621244|460082412|FG000|Overall Study|Death|3|||
127854207|NCT00621244|460082413|FG001|Overall Study|Death|3|||
127854208|NCT00621244|460082414|FG002|Overall Study|Death|1|||
127854209|NCT00621244|460082415|FG003|Overall Study|Death|1|||
127854210|NCT00621244|460082412|FG000|Overall Study|Adverse Event|27|||
127854211|NCT00621244|460082413|FG001|Overall Study|Adverse Event|7|||
127854212|NCT00621244|460082414|FG002|Overall Study|Adverse Event|9|||
127854213|NCT00621244|460082415|FG003|Overall Study|Adverse Event|2|||
127854214|NCT00621244|460082412|FG000|Overall Study|Administrative problems|5|||
127854215|NCT00621244|460082413|FG001|Overall Study|Administrative problems|1|||
127854216|NCT00621244|460082414|FG002|Overall Study|Administrative problems|0|||
127854217|NCT00621244|460082415|FG003|Overall Study|Administrative problems|2|||
127854218|NCT00565812|460082418|FG000|Overall Study|Death|2|||
127854219|NCT00565812|460082419|FG001|Overall Study|Death|1|||
127854220|NCT00565812|460082420|FG002|Overall Study|Death|3|||
127854221|NCT00565812|460082418|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
127854222|NCT00565812|460082419|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
127854223|NCT00565812|460082420|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
127854224|NCT00565812|460082418|FG000|Overall Study|Lost to Follow-up|10|||
127854225|NCT00565812|460082419|FG001|Overall Study|Lost to Follow-up|8|||
127854226|NCT00565812|460082420|FG002|Overall Study|Lost to Follow-up|8|||
127854227|NCT00565812|460082418|FG000|Overall Study|Withdrawal by Subject|58|||
127854228|NCT00565812|460082419|FG001|Overall Study|Withdrawal by Subject|47|||
127854229|NCT00565812|460082420|FG002|Overall Study|Withdrawal by Subject|48|||
127854230|NCT00565812|460082418|FG000|Overall Study|Work Schedule|5|||
127854231|NCT00565812|460082419|FG001|Overall Study|Work Schedule|3|||
127854232|NCT00565812|460082420|FG002|Overall Study|Work Schedule|1|||
127854233|NCT00565812|460082418|FG000|Overall Study|Protocol Violation|2|||
127854234|NCT00565812|460082419|FG001|Overall Study|Protocol Violation|6|||
127854235|NCT00565812|460082420|FG002|Overall Study|Protocol Violation|4|||
127854236|NCT00565812|460082418|FG000|Overall Study|Adverse Event|41|||
127854237|NCT00565812|460082419|FG001|Overall Study|Adverse Event|54|||
127854238|NCT00565812|460082420|FG002|Overall Study|Adverse Event|40|||
127854239|NCT00565812|460082418|FG000|Overall Study|Jury Duty|1|||
127854240|NCT00565812|460082419|FG001|Overall Study|Jury Duty|0|||
127854241|NCT00565812|460082420|FG002|Overall Study|Jury Duty|0|||
127854242|NCT00565812|460082418|FG000|Overall Study|Relocated Out of Area|5|||
127854243|NCT00565812|460082419|FG001|Overall Study|Relocated Out of Area|8|||
127854244|NCT00565812|460082420|FG002|Overall Study|Relocated Out of Area|9|||
127854245|NCT00565812|460082418|FG000|Overall Study|Sponsor Decision|1|||
127854246|NCT00565812|460082419|FG001|Overall Study|Sponsor Decision|5|||
127854247|NCT00565812|460082420|FG002|Overall Study|Sponsor Decision|1|||
127854248|NCT00565812|460082418|FG000|Overall Study|Domestic Reasons|7|||
127854249|NCT00565812|460082419|FG001|Overall Study|Domestic Reasons|1|||
127854250|NCT00565812|460082420|FG002|Overall Study|Domestic Reasons|3|||
127854251|NCT00565812|460082418|FG000|Overall Study|Research Site Closure|6|||
127854252|NCT00565812|460082419|FG001|Overall Study|Research Site Closure|1|||
127854253|NCT00565812|460082420|FG002|Overall Study|Research Site Closure|8|||
127854254|NCT00565812|460082418|FG000|Overall Study|Surgical Intervention|0|||
127854255|NCT00565812|460082419|FG001|Overall Study|Surgical Intervention|1|||
127854256|NCT00565812|460082420|FG002|Overall Study|Surgical Intervention|2|||
127854257|NCT00565812|460082418|FG000|Overall Study|Low Compliance|1|||
127854258|NCT00565812|460082419|FG001|Overall Study|Low Compliance|0|||
127854259|NCT00565812|460082420|FG002|Overall Study|Low Compliance|1|||
127854260|NCT00565812|460082418|FG000|Overall Study|Follow-up Visit Not Completed|2|||
127854261|NCT00565812|460082419|FG001|Overall Study|Follow-up Visit Not Completed|0|||
127854262|NCT00565812|460082420|FG002|Overall Study|Follow-up Visit Not Completed|1|||
127854263|NCT00565812|460082418|FG000|Overall Study|Physician Decision|2|||
127854264|NCT00565812|460082419|FG001|Overall Study|Physician Decision|0|||
127854265|NCT00565812|460082420|FG002|Overall Study|Physician Decision|0|||
127854266|NCT04968353|460082421|FG000|Overall Study|Non-compliance|1|||
127854267|NCT04968353|460082422|FG001|Overall Study|Non-compliance|0|||
127854268|NCT04968353|460082423|FG002|Overall Study|Non-compliance|2|||
127854269|NCT04968353|460082424|FG003|Overall Study|Non-compliance|0|||
127854270|NCT02033850|460082429|FG000|Overall Study|Death|1|||
127854271|NCT02033850|460082430|FG001|Overall Study|Death|0|||
127854272|NCT02033850|460082429|FG000|Overall Study|unrelated medical reason|1|||
127854273|NCT02033850|460082430|FG001|Overall Study|unrelated medical reason|1|||
127854274|NCT03215667|460082431|FG000|Overall Study|Physician Decision|4|||
127854275|NCT01810380|460082434|FG000|Overall Study|Randomised not treated|2|||
127854276|NCT01810380|460082435|FG001|Overall Study|Randomised not treated|1|||
127854277|NCT01810380|460082436|FG002|Overall Study|Randomised not treated|1|||
127854278|NCT01810380|460082434|FG000|Overall Study|Adverse Event|11|||
127854279|NCT01810380|460082435|FG001|Overall Study|Adverse Event|14|||
127854280|NCT01810380|460082436|FG002|Overall Study|Adverse Event|4|||
127854281|NCT01810380|460082434|FG000|Overall Study|Lack of Efficacy|24|||
127854282|NCT01810380|460082435|FG001|Overall Study|Lack of Efficacy|10|||
127854283|NCT01810380|460082436|FG002|Overall Study|Lack of Efficacy|11|||
127854284|NCT01810380|460082434|FG000|Overall Study|Protocol Violation|1|||
127854285|NCT01810380|460082435|FG001|Overall Study|Protocol Violation|0|||
127854286|NCT01810380|460082436|FG002|Overall Study|Protocol Violation|1|||
127854287|NCT01810380|460082434|FG000|Overall Study|Withdrawal by Subject|6|||
127854288|NCT01810380|460082435|FG001|Overall Study|Withdrawal by Subject|0|||
127854289|NCT01810380|460082436|FG002|Overall Study|Withdrawal by Subject|6|||
127854290|NCT01810380|460082434|FG000|Overall Study|Administrative or other reasons|11|||
127854291|NCT01810380|460082435|FG001|Overall Study|Administrative or other reasons|13|||
127854292|NCT01810380|460082436|FG002|Overall Study|Administrative or other reasons|9|||
127854293|NCT00614991|460082437|FG000|Overall Study|Adverse Event|3|||
127854294|NCT00614991|460082438|FG001|Overall Study|Adverse Event|3|||
127854295|NCT00614991|460082439|FG002|Overall Study|Adverse Event|0|||
127854296|NCT00614991|460082440|FG003|Overall Study|Adverse Event|0|||
127854297|NCT00614991|460082441|FG004|Overall Study|Adverse Event|1|||
127854298|NCT00614991|460082442|FG005|Overall Study|Adverse Event|0|||
127854299|NCT03148795|460082443|FG000|Overall Study|Progressive Disease|1|||
127854300|NCT03209362|460082448|FG000|Overall Study|Adverse Event|0|||
127854301|NCT03209362|460082449|FG001|Overall Study|Adverse Event|1|||
127854302|NCT03209362|460082448|FG000|Overall Study|Lost to Follow-up|0|||
127854303|NCT03209362|460082449|FG001|Overall Study|Lost to Follow-up|1|||
127854304|NCT03209362|460082448|FG000|Overall Study|Withdrawal by Subject|2|||
127854305|NCT03209362|460082449|FG001|Overall Study|Withdrawal by Subject|0|||
127854306|NCT03209362|460082448|FG000|Overall Study|Other|0|||
127854307|NCT03209362|460082449|FG001|Overall Study|Other|1|||
127854308|NCT00251589|460082454|FG000|Overall Study|Adverse Event|5|||
127854309|NCT00251589|460082455|FG001|Overall Study|Adverse Event|1|||
127854310|NCT00251589|460082456|FG002|Overall Study|Adverse Event|2|||
127854311|NCT00251589|460082457|FG003|Overall Study|Adverse Event|1|||
127854312|NCT00251589|460082454|FG000|Overall Study|Withdrawal by Subject|1|||
127854313|NCT00251589|460082455|FG001|Overall Study|Withdrawal by Subject|1|||
127854314|NCT00251589|460082456|FG002|Overall Study|Withdrawal by Subject|0|||
127854315|NCT00251589|460082457|FG003|Overall Study|Withdrawal by Subject|0|||
127854316|NCT00251589|460082454|FG000|Overall Study|Discontinued due to progressive disease|9|||
127854317|NCT00251589|460082455|FG001|Overall Study|Discontinued due to progressive disease|1|||
127854318|NCT00251589|460082456|FG002|Overall Study|Discontinued due to progressive disease|0|||
127854319|NCT00251589|460082457|FG003|Overall Study|Discontinued due to progressive disease|1|||
127854320|NCT03074318|460082460|FG000|Overall Study|Adverse Event|0|||
127854321|NCT03074318|460082461|FG001|Overall Study|Adverse Event|1|||
127854322|NCT03074318|460082462|FG002|Overall Study|Adverse Event|1|||
127854323|NCT03074318|460082463|FG003|Overall Study|Adverse Event|1|||
127854324|NCT03074318|460082460|FG000|Overall Study|Death|1|||
127854325|NCT03074318|460082461|FG001|Overall Study|Death|0|||
127854326|NCT03074318|460082462|FG002|Overall Study|Death|0|||
127854327|NCT03074318|460082463|FG003|Overall Study|Death|0|||
127854328|NCT03074318|460082460|FG000|Overall Study|Withdrawal by Subject|1|||
127854329|NCT03074318|460082461|FG001|Overall Study|Withdrawal by Subject|2|||
127854330|NCT03074318|460082462|FG002|Overall Study|Withdrawal by Subject|2|||
127854331|NCT03074318|460082463|FG003|Overall Study|Withdrawal by Subject|4|||
127854332|NCT03074318|460082460|FG000|Overall Study|Trial Closure|2|||
127854333|NCT03074318|460082461|FG001|Overall Study|Trial Closure|2|||
127854334|NCT03074318|460082462|FG002|Overall Study|Trial Closure|3|||
127854335|NCT03074318|460082463|FG003|Overall Study|Trial Closure|11|||
127854336|NCT01627782|460082466|FG000|Overall Study|Adverse Event|1|||
127854337|NCT01627782|460082467|FG001|Overall Study|Adverse Event|2|||
127854338|NCT01627782|460082468|FG002|Overall Study|Adverse Event|0|||
127854339|NCT01627782|460082469|FG003|Overall Study|Adverse Event|1|||
127854340|NCT01627782|460082466|FG000|Overall Study|Lack of Efficacy|11|||
127854341|NCT01627782|460082467|FG001|Overall Study|Lack of Efficacy|1|||
127854342|NCT01627782|460082468|FG002|Overall Study|Lack of Efficacy|15|||
127854343|NCT01627782|460082469|FG003|Overall Study|Lack of Efficacy|2|||
127854344|NCT01627782|460082466|FG000|Overall Study|Protocol Violation|1|||
127854345|NCT01627782|460082467|FG001|Overall Study|Protocol Violation|0|||
127854346|NCT01627782|460082468|FG002|Overall Study|Protocol Violation|0|||
127854347|NCT01627782|460082469|FG003|Overall Study|Protocol Violation|0|||
127854348|NCT01627782|460082466|FG000|Overall Study|Withdrawal by Subject|2|||
127854349|NCT01627782|460082467|FG001|Overall Study|Withdrawal by Subject|1|||
127854350|NCT01627782|460082468|FG002|Overall Study|Withdrawal by Subject|0|||
127854351|NCT01627782|460082469|FG003|Overall Study|Withdrawal by Subject|0|||
127854352|NCT01627782|460082466|FG000|Overall Study|Other|0|||
127854353|NCT01627782|460082467|FG001|Overall Study|Other|2|||
127854354|NCT01627782|460082468|FG002|Overall Study|Other|0|||
127854355|NCT01627782|460082469|FG003|Overall Study|Other|3|||
127854356|NCT01627782|460082466|FG000|Overall Study|Randomized But Not Treated|1|||
127854357|NCT01627782|460082467|FG001|Overall Study|Randomized But Not Treated|0|||
127854358|NCT01627782|460082468|FG002|Overall Study|Randomized But Not Treated|0|||
127854359|NCT01627782|460082469|FG003|Overall Study|Randomized But Not Treated|0|||
127854360|NCT03573401|460082470|FG000|Overall Study|Withdrawal by Subject|2|||
127854361|NCT03573401|460082471|FG001|Overall Study|Withdrawal by Subject|0|||
127854362|NCT03573401|460082470|FG000|Overall Study|Subject non-compliance with study schedule|1|||
127854363|NCT03573401|460082471|FG001|Overall Study|Subject non-compliance with study schedule|0|||
127854364|NCT03573401|460082470|FG000|Overall Study|Discontinuation of study treatment due to subject decision|1|||
127854365|NCT03573401|460082471|FG001|Overall Study|Discontinuation of study treatment due to subject decision|0|||
127854366|NCT03573401|460082470|FG000|Overall Study|Subject required prohibited medication for concomitant medical condition|0|||
127854367|NCT03573401|460082471|FG001|Overall Study|Subject required prohibited medication for concomitant medical condition|1|||
127854368|NCT00643448|460082473|FG000|Overall Study|Lack of Efficacy|2|||
127854369|NCT00643448|460082474|FG001|Overall Study|Lack of Efficacy|0|||
127854370|NCT00643448|460082475|FG002|Overall Study|Lack of Efficacy|4|||
127854371|NCT00643448|460082473|FG000|Overall Study|Adverse Event|2|||
127854372|NCT00643448|460082474|FG001|Overall Study|Adverse Event|2|||
127854373|NCT00643448|460082475|FG002|Overall Study|Adverse Event|2|||
127854374|NCT00643448|460082473|FG000|Overall Study|QTcF>550 ms|0|||
127854375|NCT00643448|460082474|FG001|Overall Study|QTcF>550 ms|3|||
127854376|NCT00643448|460082475|FG002|Overall Study|QTcF>550 ms|0|||
127854377|NCT05166603|460082476|FG000|Overall Study|Withdrawal by Subject|68|||
127854378|NCT05166603|460082477|FG001|Overall Study|Withdrawal by Subject|0|||
127854379|NCT00777257|460084708|FG000|Overall Study|Adverse Event|3|||
127854380|NCT00777257|460084709|FG001|Overall Study|Adverse Event|1|||
127854381|NCT00777257|460084710|FG002|Overall Study|Adverse Event|0|||
127854382|NCT00777257|460084708|FG000|Overall Study|Lost to Follow-up|3|||
127854383|NCT00777257|460084709|FG001|Overall Study|Lost to Follow-up|3|||
127854384|NCT00777257|460084710|FG002|Overall Study|Lost to Follow-up|2|||
127854385|NCT00777257|460084708|FG000|Overall Study|Protocol Violation|2|||
127854386|NCT00777257|460084709|FG001|Overall Study|Protocol Violation|2|||
127854387|NCT00777257|460084710|FG002|Overall Study|Protocol Violation|2|||
127854388|NCT00777257|460084708|FG000|Overall Study|Withdrawal by Subject|3|||
127854389|NCT00777257|460084709|FG001|Overall Study|Withdrawal by Subject|6|||
127854390|NCT00777257|460084710|FG002|Overall Study|Withdrawal by Subject|5|||
127854391|NCT04315298|460084711|FG000|Overall Study|Withdrawal by Subject|0|||
127854392|NCT04315298|460084712|FG001|Overall Study|Withdrawal by Subject|0|||
127854393|NCT04315298|460084713|FG002|Overall Study|Withdrawal by Subject|0|||
127854394|NCT04315298|460084714|FG003|Overall Study|Withdrawal by Subject|2|||
127854395|NCT04315298|460084715|FG004|Overall Study|Withdrawal by Subject|2|||
127854396|NCT04315298|460084716|FG005|Overall Study|Withdrawal by Subject|2|||
127854397|NCT04315298|460084717|FG006|Overall Study|Withdrawal by Subject|0|||
127854398|NCT04315298|460084718|FG007|Overall Study|Withdrawal by Subject|1|||
127854399|NCT04315298|460084719|FG008|Overall Study|Withdrawal by Subject|1|||
127854400|NCT04315298|460084720|FG009|Overall Study|Withdrawal by Subject|1|||
127854401|NCT04315298|460084721|FG010|Overall Study|Withdrawal by Subject|0|||
127854402|NCT04315298|460084722|FG011|Overall Study|Withdrawal by Subject|0|||
127854403|NCT04315298|460084723|FG012|Overall Study|Withdrawal by Subject|0|||
127854404|NCT04315298|460084724|FG013|Overall Study|Withdrawal by Subject|0|||
127854405|NCT04315298|460084725|FG014|Overall Study|Withdrawal by Subject|0|||
127854406|NCT04315298|460084726|FG015|Overall Study|Withdrawal by Subject|0|||
127854407|NCT04315298|460084727|FG016|Overall Study|Withdrawal by Subject|0|||
127854408|NCT04315298|460084728|FG017|Overall Study|Withdrawal by Subject|0|||
127854409|NCT04315298|460084729|FG018|Overall Study|Withdrawal by Subject|0|||
127854410|NCT04315298|460084711|FG000|Overall Study|Physician Decision|0|||
127854411|NCT04315298|460084712|FG001|Overall Study|Physician Decision|0|||
127854412|NCT04315298|460084713|FG002|Overall Study|Physician Decision|0|||
127854413|NCT04315298|460084714|FG003|Overall Study|Physician Decision|0|||
127854414|NCT04315298|460084715|FG004|Overall Study|Physician Decision|1|||
127854415|NCT04315298|460084716|FG005|Overall Study|Physician Decision|0|||
127854416|NCT04315298|460084717|FG006|Overall Study|Physician Decision|0|||
127854417|NCT04315298|460084718|FG007|Overall Study|Physician Decision|0|||
127854418|NCT04315298|460084719|FG008|Overall Study|Physician Decision|0|||
127854419|NCT04315298|460084720|FG009|Overall Study|Physician Decision|0|||
127854420|NCT04315298|460084721|FG010|Overall Study|Physician Decision|0|||
127854421|NCT04315298|460084722|FG011|Overall Study|Physician Decision|0|||
127854422|NCT04315298|460084723|FG012|Overall Study|Physician Decision|0|||
127854423|NCT04315298|460084724|FG013|Overall Study|Physician Decision|0|||
127854424|NCT04315298|460084725|FG014|Overall Study|Physician Decision|0|||
127854425|NCT04315298|460084726|FG015|Overall Study|Physician Decision|0|||
127854426|NCT04315298|460084727|FG016|Overall Study|Physician Decision|0|||
127854427|NCT04315298|460084728|FG017|Overall Study|Physician Decision|0|||
127854428|NCT04315298|460084729|FG018|Overall Study|Physician Decision|0|||
127854429|NCT04315298|460084711|FG000|Overall Study|Lost to Follow-up|5|||
127854430|NCT04315298|460084712|FG001|Overall Study|Lost to Follow-up|10|||
127854431|NCT04315298|460084713|FG002|Overall Study|Lost to Follow-up|6|||
127854432|NCT04315298|460084714|FG003|Overall Study|Lost to Follow-up|8|||
127854433|NCT04315298|460084715|FG004|Overall Study|Lost to Follow-up|12|||
127854434|NCT04315298|460084716|FG005|Overall Study|Lost to Follow-up|13|||
127854435|NCT04315298|460084717|FG006|Overall Study|Lost to Follow-up|9|||
127854436|NCT04315298|460084718|FG007|Overall Study|Lost to Follow-up|16|||
127854437|NCT04315298|460084719|FG008|Overall Study|Lost to Follow-up|14|||
127854438|NCT04315298|460084720|FG009|Overall Study|Lost to Follow-up|0|||
127854439|NCT04315298|460084721|FG010|Overall Study|Lost to Follow-up|2|||
127854440|NCT04315298|460084722|FG011|Overall Study|Lost to Follow-up|1|||
127854441|NCT04315298|460084723|FG012|Overall Study|Lost to Follow-up|0|||
127854442|NCT04315298|460084724|FG013|Overall Study|Lost to Follow-up|0|||
127854443|NCT04315298|460084725|FG014|Overall Study|Lost to Follow-up|0|||
127854444|NCT04315298|460084726|FG015|Overall Study|Lost to Follow-up|2|||
127854445|NCT04315298|460084727|FG016|Overall Study|Lost to Follow-up|0|||
127854446|NCT04315298|460084728|FG017|Overall Study|Lost to Follow-up|0|||
127854447|NCT04315298|460084729|FG018|Overall Study|Lost to Follow-up|0|||
127854448|NCT04315298|460084711|FG000|Overall Study|Death|24|||
127854449|NCT04315298|460084712|FG001|Overall Study|Death|60|||
127854450|NCT04315298|460084713|FG002|Overall Study|Death|49|||
127854451|NCT04315298|460084714|FG003|Overall Study|Death|59|||
127854452|NCT04315298|460084715|FG004|Overall Study|Death|70|||
127854453|NCT04315298|460084716|FG005|Overall Study|Death|114|||
127854454|NCT04315298|460084717|FG006|Overall Study|Death|9|||
127854455|NCT04315298|460084718|FG007|Overall Study|Death|12|||
127854456|NCT04315298|460084719|FG008|Overall Study|Death|21|||
127854457|NCT04315298|460084720|FG009|Overall Study|Death|16|||
127854458|NCT04315298|460084721|FG010|Overall Study|Death|40|||
127854459|NCT04315298|460084722|FG011|Overall Study|Death|40|||
127854460|NCT04315298|460084723|FG012|Overall Study|Death|3|||
127854461|NCT04315298|460084724|FG013|Overall Study|Death|4|||
127854462|NCT04315298|460084725|FG014|Overall Study|Death|6|||
127854463|NCT04315298|460084726|FG015|Overall Study|Death|4|||
127854464|NCT04315298|460084727|FG016|Overall Study|Death|3|||
127854465|NCT04315298|460084728|FG017|Overall Study|Death|1|||
127854466|NCT04315298|460084729|FG018|Overall Study|Death|0|||
127854467|NCT00736385|460084730|FG000|Overall Study|Withdrawal by Subject|2|||
127854468|NCT00736385|460084731|FG001|Overall Study|Withdrawal by Subject|2|||
127854469|NCT00736385|460084730|FG000|Overall Study|Adverse Event|0|||
127854470|NCT00736385|460084731|FG001|Overall Study|Adverse Event|1|||
127854471|NCT00098865|460084732|FG000|Overall Study|Progressive Disease|6|||
127854472|NCT00098865|460084732|FG000|Overall Study|Adverse Event|2|||
127854473|NCT00098865|460084732|FG000|Overall Study|Alternative Therapy|1|||
127854474|NCT01183104|460084733|FG000|Overall Study|Adverse Event|8|||
127854475|NCT01183104|460084734|FG001|Overall Study|Adverse Event|6|||
127854476|NCT01183104|460084733|FG000|Overall Study|Death|0|||
127854477|NCT01183104|460084734|FG001|Overall Study|Death|1|||
127854478|NCT01183104|460084733|FG000|Overall Study|Lost to Follow-up|14|||
127854479|NCT01183104|460084734|FG001|Overall Study|Lost to Follow-up|7|||
127854480|NCT01183104|460084733|FG000|Overall Study|Physician Decision|5|||
127854481|NCT01183104|460084734|FG001|Overall Study|Physician Decision|8|||
127854482|NCT01183104|460084733|FG000|Overall Study|Withdrawal by Subject|6|||
127854483|NCT01183104|460084734|FG001|Overall Study|Withdrawal by Subject|11|||
127854484|NCT01183104|460084733|FG000|Overall Study|Nonparticipation in Extension Study|39|||
127854485|NCT01183104|460084734|FG001|Overall Study|Nonparticipation in Extension Study|50|||
127854486|NCT01183104|460084733|FG000|Overall Study|Did not receive study drug|5|||
127854487|NCT01183104|460084734|FG001|Overall Study|Did not receive study drug|9|||
127854488|NCT03267511|460084735|FG000|Overall Study|Lost to Follow-up|0|||
127854489|NCT03267511|460084736|FG001|Overall Study|Lost to Follow-up|0|||
127854490|NCT03267511|460084737|FG002|Overall Study|Lost to Follow-up|0|||
127854491|NCT03267511|460084738|FG003|Overall Study|Lost to Follow-up|1|||
127854492|NCT00364351|460084739|FG000|Overall Study|Adverse Event|90|||
127854493|NCT00364351|460084740|FG001|Overall Study|Adverse Event|44|||
127854494|NCT00364351|460084739|FG000|Overall Study|Condition under investigation worsened|469|||
127854495|NCT00364351|460084740|FG001|Overall Study|Condition under investigation worsened|497|||
127854496|NCT00364351|460084739|FG000|Overall Study|Prohibited concomitant medication|0|||
127854497|NCT00364351|460084740|FG001|Overall Study|Prohibited concomitant medication|2|||
127854498|NCT00364351|460084739|FG000|Overall Study|Lost to Follow-up|1|||
127854499|NCT00364351|460084740|FG001|Overall Study|Lost to Follow-up|1|||
127854500|NCT00364351|460084739|FG000|Overall Study|Withdrawal by Subject|30|||
127854501|NCT00364351|460084740|FG001|Overall Study|Withdrawal by Subject|29|||
127854502|NCT00364351|460084739|FG000|Overall Study|Incorrect enrollment|1|||
127854503|NCT00364351|460084740|FG001|Overall Study|Incorrect enrollment|1|||
127854504|NCT00364351|460084739|FG000|Overall Study|Sponsor decision|1|||
127854505|NCT00364351|460084740|FG001|Overall Study|Sponsor decision|0|||
127854506|NCT00364351|460084739|FG000|Overall Study|Poor treatment compliance|0|||
127854507|NCT00364351|460084740|FG001|Overall Study|Poor treatment compliance|3|||
127854508|NCT00364351|460084739|FG000|Overall Study|Investigator error|0|||
127854509|NCT00364351|460084740|FG001|Overall Study|Investigator error|2|||
127854510|NCT00364351|460084739|FG000|Overall Study|Patient could not travel to site|0|||
127854511|NCT00364351|460084740|FG001|Overall Study|Patient could not travel to site|1|||
127854512|NCT00364351|460084739|FG000|Overall Study|Randomised treatment not started|0|||
127854513|NCT00364351|460084740|FG001|Overall Study|Randomised treatment not started|3|||
127854514|NCT00688623|460084742|FG000|Overall Study|Adverse Event|22|||
127854515|NCT00688623|460084742|FG000|Overall Study|abnormal lab value|1|||
127854516|NCT00688623|460084742|FG000|Overall Study|Withdrawal by Subject|4|||
127854517|NCT00688623|460084742|FG000|Overall Study|Death|3|||
127854518|NCT00688623|460084742|FG000|Overall Study|disease progression|23|||
127854519|NCT00688623|460084742|FG000|Overall Study|Protocol Violation|2|||
127854520|NCT02667236|460084743|FG000|Overall Study|Adverse Event|1|||
127854521|NCT02667236|460084744|FG001|Overall Study|Adverse Event|1|||
127854522|NCT02667236|460084743|FG000|Overall Study|Withdrawal by Subject|2|||
127854523|NCT02667236|460084744|FG001|Overall Study|Withdrawal by Subject|0|||
127854524|NCT04984876|460084745|FG000|Overall Study|Subject decision|2|||
127854525|NCT04984876|460084746|FG001|Overall Study|Subject decision|10|||
127854526|NCT04984876|460084747|FG002|Overall Study|Subject decision|3|||
127854527|NCT04984876|460084748|FG003|Overall Study|Subject decision|3|||
127854528|NCT04984876|460084749|FG004|Overall Study|Subject decision|3|||
127854529|NCT04984876|460084750|FG005|Overall Study|Subject decision|0|||
127854530|NCT04984876|460084745|FG000|Overall Study|Guardian decision|0|||
127854531|NCT04984876|460084746|FG001|Overall Study|Guardian decision|1|||
127854532|NCT04984876|460084747|FG002|Overall Study|Guardian decision|0|||
127854533|NCT04984876|460084748|FG003|Overall Study|Guardian decision|2|||
127854534|NCT04984876|460084749|FG004|Overall Study|Guardian decision|0|||
127854535|NCT04984876|460084750|FG005|Overall Study|Guardian decision|1|||
127854536|NCT04984876|460084745|FG000|Overall Study|Lost to Follow-up|0|||
127854537|NCT04984876|460084746|FG001|Overall Study|Lost to Follow-up|0|||
127854538|NCT04984876|460084747|FG002|Overall Study|Lost to Follow-up|1|||
127854539|NCT04984876|460084748|FG003|Overall Study|Lost to Follow-up|1|||
127854540|NCT04984876|460084749|FG004|Overall Study|Lost to Follow-up|0|||
127854541|NCT04984876|460084750|FG005|Overall Study|Lost to Follow-up|0|||
127854542|NCT04984876|460084745|FG000|Overall Study|Physician Decision|1|||
127854543|NCT04984876|460084746|FG001|Overall Study|Physician Decision|0|||
127854544|NCT04984876|460084747|FG002|Overall Study|Physician Decision|0|||
127854545|NCT04984876|460084748|FG003|Overall Study|Physician Decision|1|||
127854546|NCT04984876|460084749|FG004|Overall Study|Physician Decision|0|||
127854547|NCT04984876|460084750|FG005|Overall Study|Physician Decision|0|||
127854548|NCT04984876|460084745|FG000|Overall Study|Adverse Event|0|||
127854549|NCT04984876|460084746|FG001|Overall Study|Adverse Event|0|||
127854550|NCT04984876|460084747|FG002|Overall Study|Adverse Event|1|||
127854551|NCT04984876|460084748|FG003|Overall Study|Adverse Event|0|||
127854552|NCT04984876|460084749|FG004|Overall Study|Adverse Event|0|||
127854553|NCT04984876|460084750|FG005|Overall Study|Adverse Event|0|||
127854554|NCT00209092|460084753|FG000|Overall Study|Progression of disease|7|||
127854555|NCT00209092|460084754|FG001|Overall Study|Progression of disease|1|||
127854556|NCT00209092|460084753|FG000|Overall Study|Adverse Event|0|||
127854557|NCT00209092|460084754|FG001|Overall Study|Adverse Event|1|||
127854558|NCT00209092|460084753|FG000|Overall Study|Withdrawal by Subject|1|||
127854559|NCT00209092|460084754|FG001|Overall Study|Withdrawal by Subject|0|||
127854560|NCT01462045|460084755|FG000|Overall Study|Family matter|0|||
127854561|NCT01462045|460084756|FG001|Overall Study|Family matter|1|||
127854562|NCT01462045|460084757|FG002|Overall Study|Family matter|0|||
127854563|NCT02828644|460084762|FG000|Overall Study|Lost to Follow-up|23|||
127908199|NCT01796171|460287545|FG005|Follow-up Period|Progressive disease|0|||
127854564|NCT02828644|460084763|FG001|Overall Study|Lost to Follow-up|22|||
127854565|NCT02436915|460084764|FG000|Overall Study|Withdrawal by Subject|0|||
127854566|NCT02436915|460084765|FG001|Overall Study|Withdrawal by Subject|1|||
127854567|NCT01117181|460084772|FG000|Overall Study|Lost to Follow-up|1|||
127854568|NCT01117181|460084773|FG001|Overall Study|Lost to Follow-up|0|||
127854569|NCT01117181|460084772|FG000|Overall Study|Withdrawal by Subject|0|||
127854570|NCT01117181|460084773|FG001|Overall Study|Withdrawal by Subject|2|||
127854571|NCT02158728|460084774|FG000|Overall Study|no procedure according to CIP done|3|||
127854572|NCT02158728|460084774|FG000|Overall Study|no qualified dataset|24|||
127854573|NCT01518309|460084775|FG000|Overall Study|Adverse Event|6|||
127854574|NCT01518309|460084775|FG000|Overall Study|Death|6|||
127854575|NCT01518309|460084775|FG000|Overall Study|Lack of Efficacy|7|||
127854576|NCT01518309|460084775|FG000|Overall Study|Withdrawal by Subject|6|||
127854577|NCT01518309|460084775|FG000|Overall Study|Physician Decision|3|||
127854578|NCT01518309|460084775|FG000|Overall Study|Sponsor Decision|2|||
127854579|NCT01518309|460084775|FG000|Overall Study|Not in Predefined Categories|9|||
127854580|NCT02579863|460084778|FG000|Overall Study|Final Disposition Unknown|2|||
127854581|NCT02579863|460084779|FG001|Overall Study|Final Disposition Unknown|1|||
127854582|NCT02579863|460084778|FG000|Overall Study|Adverse Event|18|||
127854583|NCT02579863|460084779|FG001|Overall Study|Adverse Event|11|||
127854584|NCT02579863|460084778|FG000|Overall Study|Death|31|||
127854585|NCT02579863|460084779|FG001|Overall Study|Death|29|||
127854586|NCT02579863|460084778|FG000|Overall Study|Lost to Follow-up|2|||
127854587|NCT02579863|460084779|FG001|Overall Study|Lost to Follow-up|1|||
127854588|NCT02579863|460084778|FG000|Overall Study|Physician Decision|1|||
127854589|NCT02579863|460084779|FG001|Overall Study|Physician Decision|2|||
127854590|NCT02579863|460084778|FG000|Overall Study|Screen Failure|0|||
127854591|NCT02579863|460084779|FG001|Overall Study|Screen Failure|2|||
127854592|NCT02579863|460084778|FG000|Overall Study|Study Terminated at Selected Sites|82|||
127854593|NCT02579863|460084779|FG001|Overall Study|Study Terminated at Selected Sites|88|||
127854594|NCT02579863|460084778|FG000|Overall Study|Withdrawal by Subject|20|||
127854595|NCT02579863|460084779|FG001|Overall Study|Withdrawal by Subject|20|||
127854596|NCT03878160|460084783|FG000|Overall Study|Lost to Follow-up|1|||
127854597|NCT03878160|460084784|FG001|Overall Study|Lost to Follow-up|1|||
127854598|NCT03878160|460084785|FG002|Overall Study|Lost to Follow-up|1|||
127854599|NCT03878160|460084783|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
127854600|NCT03878160|460084784|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
127854601|NCT03878160|460084785|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
127854602|NCT00589602|460084787|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
127854603|NCT02658149|460084791|FG000|Overall Study|Physician Decision|1|||
127854604|NCT02658149|460084792|FG001|Overall Study|Physician Decision|0|||
127854605|NCT01804842|460084803|FG000|Overall Study|Adverse Event|1|||
127854606|NCT01804842|460084804|FG001|Overall Study|Adverse Event|1|||
127854607|NCT01804842|460084805|FG002|Overall Study|Adverse Event|0|||
127854608|NCT01804842|460084803|FG000|Overall Study|Lost to Follow-up|1|||
127854609|NCT01804842|460084804|FG001|Overall Study|Lost to Follow-up|0|||
127854610|NCT01804842|460084805|FG002|Overall Study|Lost to Follow-up|0|||
127854611|NCT01804842|460084803|FG000|Overall Study|Non-Compliance|1|||
127854612|NCT01804842|460084804|FG001|Overall Study|Non-Compliance|1|||
127854613|NCT01804842|460084805|FG002|Overall Study|Non-Compliance|0|||
127854614|NCT01804842|460084803|FG000|Overall Study|Personal Reason|0|||
127854615|NCT01804842|460084804|FG001|Overall Study|Personal Reason|0|||
127854616|NCT01804842|460084805|FG002|Overall Study|Personal Reason|1|||
127854617|NCT03887052|460084806|FG000|Overall Study|Adverse Event|2|||
127854618|NCT03887052|460084806|FG000|Overall Study|Physician Decision|2|||
127854619|NCT03887052|460084806|FG000|Overall Study|Withdrawal by Subject|3|||
127854620|NCT03887052|460084806|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
127854621|NCT03887052|460084806|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
127854622|NCT01440972|460084807|FG000|Overall Study|Withdrawal by Subject|3|||
127854623|NCT01440972|460084808|FG001|Overall Study|Withdrawal by Subject|2|||
127854624|NCT03933215|460084809|FG000|Overall Study|Other|6|||
127854625|NCT03933215|460084809|FG000|Overall Study|Sponsor decision|5|||
127854626|NCT03933215|460084809|FG000|Overall Study|Protocol Violation|5|||
127854627|NCT03933215|460084809|FG000|Overall Study|Withdrawal by Subject|6|||
127854628|NCT03933215|460084809|FG000|Overall Study|Lost to Follow-up|6|||
127854629|NCT03933215|460084809|FG000|Overall Study|Enrolled but not treated|38|||
127854630|NCT04222673|460084810|FG000|Overall Study|Lost to Follow-up|5|||
127854631|NCT02352090|460084812|FG000|Overall Study|general malaise|1|||
127854632|NCT02352090|460084813|FG001|Overall Study|general malaise|0|||
127854633|NCT02352090|460084814|FG002|Overall Study|general malaise|0|||
127854634|NCT02352090|460084812|FG000|Overall Study|non-specified mild side-effects|0|||
127854635|NCT02352090|460084813|FG001|Overall Study|non-specified mild side-effects|0|||
127854636|NCT02352090|460084814|FG002|Overall Study|non-specified mild side-effects|2|||
127854637|NCT01849562|460084815|FG000|Overall Study|Lost to Follow-up|1|||
127854638|NCT01849562|460084816|FG001|Overall Study|Lost to Follow-up|0|||
127854639|NCT01849562|460084817|FG002|Overall Study|Lost to Follow-up|0|||
127854640|NCT01849562|460084815|FG000|Overall Study|Non-compliance with Study Drug|1|||
127854641|NCT01849562|460084816|FG001|Overall Study|Non-compliance with Study Drug|0|||
127908200|NCT01796171|460287546|FG006|Follow-up Period|Progressive disease|0|||
127854642|NCT01849562|460084817|FG002|Overall Study|Non-compliance with Study Drug|0|||
127854643|NCT02182999|460084821|FG000|Overall Study|Adverse Event|4|||
127854644|NCT02182999|460084822|FG001|Overall Study|Adverse Event|3|||
127854645|NCT02182999|460084821|FG000|Overall Study|Physician Decision|1|||
127854646|NCT02182999|460084822|FG001|Overall Study|Physician Decision|0|||
127854647|NCT02252588|460084823|FG000|Overall Study|Withdrawal by Subject|4|||
127854648|NCT02252588|460084824|FG001|Overall Study|Withdrawal by Subject|0|||
127854649|NCT03039790|460084825|FG000|Overall Study|Lost to Follow-up|2|||
127854650|NCT03039790|460084826|FG001|Overall Study|Lost to Follow-up|0|||
127854651|NCT03039790|460084827|FG002|Overall Study|Lost to Follow-up|1|||
127854652|NCT03039790|460084828|FG003|Overall Study|Lost to Follow-up|1|||
127854653|NCT03039790|460084829|FG004|Overall Study|Lost to Follow-up|0|||
127854654|NCT03039790|460084830|FG005|Overall Study|Lost to Follow-up|1|||
127854655|NCT03039790|460084831|FG006|Overall Study|Lost to Follow-up|1|||
127854656|NCT03039790|460084832|FG007|Overall Study|Lost to Follow-up|1|||
127854657|NCT03039790|460084833|FG008|Overall Study|Lost to Follow-up|0|||
127854658|NCT03039790|460084834|FG009|Overall Study|Lost to Follow-up|1|||
127854659|NCT03039790|460084835|FG010|Overall Study|Lost to Follow-up|1|||
127854660|NCT03039790|460084836|FG011|Overall Study|Lost to Follow-up|0|||
127854661|NCT03039790|460084837|FG012|Overall Study|Lost to Follow-up|1|||
127854662|NCT03039790|460084838|FG013|Overall Study|Lost to Follow-up|0|||
127854663|NCT03039790|460084839|FG014|Overall Study|Lost to Follow-up|3|||
127854664|NCT03039790|460084840|FG015|Overall Study|Lost to Follow-up|1|||
127854665|NCT03039790|460084841|FG016|Overall Study|Lost to Follow-up|2|||
127854666|NCT03039790|460084842|FG017|Overall Study|Lost to Follow-up|2|||
127854667|NCT03039790|460084843|FG018|Overall Study|Lost to Follow-up|1|||
127854668|NCT03039790|460084844|FG019|Overall Study|Lost to Follow-up|3|||
127854669|NCT03039790|460084825|FG000|Overall Study|Withdrawal of Consent|1|||
127854670|NCT03039790|460084826|FG001|Overall Study|Withdrawal of Consent|0|||
127854671|NCT03039790|460084827|FG002|Overall Study|Withdrawal of Consent|0|||
127854672|NCT03039790|460084828|FG003|Overall Study|Withdrawal of Consent|1|||
127854673|NCT03039790|460084829|FG004|Overall Study|Withdrawal of Consent|0|||
127854674|NCT03039790|460084830|FG005|Overall Study|Withdrawal of Consent|0|||
127854675|NCT03039790|460084831|FG006|Overall Study|Withdrawal of Consent|0|||
127854676|NCT03039790|460084832|FG007|Overall Study|Withdrawal of Consent|0|||
127854677|NCT03039790|460084833|FG008|Overall Study|Withdrawal of Consent|0|||
127854678|NCT03039790|460084834|FG009|Overall Study|Withdrawal of Consent|1|||
127854679|NCT03039790|460084835|FG010|Overall Study|Withdrawal of Consent|0|||
127854680|NCT03039790|460084836|FG011|Overall Study|Withdrawal of Consent|0|||
127854681|NCT03039790|460084837|FG012|Overall Study|Withdrawal of Consent|2|||
127854682|NCT03039790|460084838|FG013|Overall Study|Withdrawal of Consent|0|||
127854683|NCT03039790|460084839|FG014|Overall Study|Withdrawal of Consent|1|||
127854684|NCT03039790|460084840|FG015|Overall Study|Withdrawal of Consent|5|||
127854685|NCT03039790|460084841|FG016|Overall Study|Withdrawal of Consent|3|||
127854686|NCT03039790|460084842|FG017|Overall Study|Withdrawal of Consent|0|||
127854687|NCT03039790|460084843|FG018|Overall Study|Withdrawal of Consent|2|||
127854688|NCT03039790|460084844|FG019|Overall Study|Withdrawal of Consent|5|||
127854689|NCT03039790|460084825|FG000|Overall Study|Death|0|||
127854690|NCT03039790|460084826|FG001|Overall Study|Death|0|||
127854691|NCT03039790|460084827|FG002|Overall Study|Death|0|||
127854692|NCT03039790|460084828|FG003|Overall Study|Death|0|||
127854693|NCT03039790|460084829|FG004|Overall Study|Death|0|||
127854694|NCT03039790|460084830|FG005|Overall Study|Death|0|||
127854695|NCT03039790|460084831|FG006|Overall Study|Death|0|||
127854696|NCT03039790|460084832|FG007|Overall Study|Death|0|||
127854697|NCT03039790|460084833|FG008|Overall Study|Death|0|||
127854698|NCT03039790|460084834|FG009|Overall Study|Death|0|||
127854699|NCT03039790|460084835|FG010|Overall Study|Death|0|||
127854700|NCT03039790|460084836|FG011|Overall Study|Death|0|||
127854701|NCT03039790|460084837|FG012|Overall Study|Death|0|||
127854702|NCT03039790|460084838|FG013|Overall Study|Death|0|||
127854703|NCT03039790|460084839|FG014|Overall Study|Death|0|||
127854704|NCT03039790|460084840|FG015|Overall Study|Death|1|||
127854705|NCT03039790|460084841|FG016|Overall Study|Death|3|||
127854706|NCT03039790|460084842|FG017|Overall Study|Death|0|||
127854707|NCT03039790|460084843|FG018|Overall Study|Death|2|||
127854708|NCT03039790|460084844|FG019|Overall Study|Death|0|||
127854709|NCT03039790|460084825|FG000|Overall Study|Reason, not Specified|1|||
127854710|NCT03039790|460084826|FG001|Overall Study|Reason, not Specified|0|||
127854711|NCT03039790|460084827|FG002|Overall Study|Reason, not Specified|0|||
127854712|NCT03039790|460084828|FG003|Overall Study|Reason, not Specified|0|||
127854713|NCT03039790|460084829|FG004|Overall Study|Reason, not Specified|0|||
127854714|NCT03039790|460084830|FG005|Overall Study|Reason, not Specified|0|||
127854715|NCT03039790|460084831|FG006|Overall Study|Reason, not Specified|0|||
127854716|NCT03039790|460084832|FG007|Overall Study|Reason, not Specified|0|||
127854717|NCT03039790|460084833|FG008|Overall Study|Reason, not Specified|0|||
127854718|NCT03039790|460084834|FG009|Overall Study|Reason, not Specified|0|||
127854719|NCT03039790|460084835|FG010|Overall Study|Reason, not Specified|0|||
127854720|NCT03039790|460084836|FG011|Overall Study|Reason, not Specified|0|||
127854721|NCT03039790|460084837|FG012|Overall Study|Reason, not Specified|0|||
127854722|NCT03039790|460084838|FG013|Overall Study|Reason, not Specified|0|||
127854723|NCT03039790|460084839|FG014|Overall Study|Reason, not Specified|0|||
127854724|NCT03039790|460084840|FG015|Overall Study|Reason, not Specified|0|||
127854725|NCT03039790|460084841|FG016|Overall Study|Reason, not Specified|2|||
127854726|NCT03039790|460084842|FG017|Overall Study|Reason, not Specified|0|||
127854727|NCT03039790|460084843|FG018|Overall Study|Reason, not Specified|1|||
127854728|NCT03039790|460084844|FG019|Overall Study|Reason, not Specified|0|||
127854729|NCT00498368|460084854|FG000|Overall Study|Withdrawal by Subject|3|||
127854730|NCT00498368|460084855|FG001|Overall Study|Withdrawal by Subject|2|||
127854731|NCT02266004|460084856|FG000|Overall Study|unrelated adverse event|1|||
127854732|NCT02266004|460084856|FG000|Overall Study|Physician Decision|1|||
127854733|NCT01347073|460084866|FG000|Overall Study|Adverse Event|1|||
127854734|NCT01347073|460084866|FG000|Overall Study|Liver Transplant|1|||
127854735|NCT00372489|460084873|FG000|Overall Study|Adverse Event|18|||
127854736|NCT00372489|460084873|FG000|Overall Study|Lack of Efficacy|1|||
127854737|NCT00372489|460084873|FG000|Overall Study|Lost to Follow-up|3|||
127854738|NCT00372489|460084873|FG000|Overall Study|Physician Decision|3|||
127854739|NCT00372489|460084873|FG000|Overall Study|Withdrawal by Subject|5|||
127854740|NCT00372489|460084873|FG000|Overall Study|Patient Relocation|2|||
127854741|NCT00372489|460084873|FG000|Overall Study|Renal transplant|6|||
127854742|NCT00372489|460084873|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
127854743|NCT00552344|460084878|FG000|Overall Study|Lack of Efficacy|55|||
127854744|NCT00552344|460084878|FG000|Overall Study|Loss of efficacy|75|||
127854745|NCT00552344|460084878|FG000|Overall Study|Lost to Follow-up|8|||
127854746|NCT00552344|460084878|FG000|Overall Study|Withdrawal by Subject|48|||
127854747|NCT00552344|460084878|FG000|Overall Study|SAE, non-fatal|6|||
127854748|NCT00552344|460084878|FG000|Overall Study|AE, non-serious non-fatal|38|||
127854749|NCT00552344|460084878|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
127854750|NCT00552344|460084878|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
127854751|NCT00552344|460084878|FG000|Overall Study|Other Reason|22|||
127854752|NCT01662986|460084879|FG000|Overall Study|Adverse Event|5|||
127854753|NCT01662986|460084880|FG001|Overall Study|Adverse Event|4|||
127854754|NCT01662986|460084879|FG000|Overall Study|Protocol Violation|2|||
127854755|NCT01662986|460084880|FG001|Overall Study|Protocol Violation|3|||
127854756|NCT01662986|460084879|FG000|Overall Study|Lost to Follow-up|5|||
127854757|NCT01662986|460084880|FG001|Overall Study|Lost to Follow-up|4|||
127854758|NCT01662986|460084879|FG000|Overall Study|Withdrawal by Subject|2|||
127854759|NCT01662986|460084880|FG001|Overall Study|Withdrawal by Subject|2|||
127854760|NCT01662986|460084879|FG000|Overall Study|Not Treated|1|||
127854761|NCT01662986|460084880|FG001|Overall Study|Not Treated|0|||
127854762|NCT01662986|460084879|FG000|Overall Study|Other than stated above|3|||
127854763|NCT01662986|460084880|FG001|Overall Study|Other than stated above|0|||
127854764|NCT01512693|460084883|FG000|Overall Study|Withdrawal by Subject|0|||
127854765|NCT01512693|460084884|FG001|Overall Study|Withdrawal by Subject|1|||
127854766|NCT04731922|460084885|FG000|Overall Study|Adverse Event|0|||
127854767|NCT04731922|460084886|FG001|Overall Study|Adverse Event|0|||
127854768|NCT04731922|460084887|FG002|Overall Study|Adverse Event|0|||
127854769|NCT04731922|460084888|FG003|Overall Study|Adverse Event|0|||
127854770|NCT04731922|460084889|FG004|Overall Study|Adverse Event|0|||
127854771|NCT04731922|460084890|FG005|Overall Study|Adverse Event|0|||
127854772|NCT04731922|460084891|FG006|Overall Study|Adverse Event|0|||
127854773|NCT04731922|460084892|FG007|Overall Study|Adverse Event|0|||
127854774|NCT04731922|460084893|FG008|Overall Study|Adverse Event|0|||
127854775|NCT04731922|460084894|FG009|Overall Study|Adverse Event|0|||
127854776|NCT04731922|460084895|FG010|Overall Study|Adverse Event|1|||
127854777|NCT04731922|460084896|FG011|Overall Study|Adverse Event|0|||
127854778|NCT04731922|460084897|FG012|Overall Study|Adverse Event|0|||
127854779|NCT04731922|460084898|FG013|Overall Study|Adverse Event|0|||
127854780|NCT04731922|460084899|FG014|Overall Study|Adverse Event|0|||
127854781|NCT04731922|460084900|FG015|Overall Study|Adverse Event|0|||
127854782|NCT04731922|460084901|FG016|Overall Study|Adverse Event|0|||
127854783|NCT04731922|460084885|FG000|Overall Study|Lost to Follow-up|0|||
127854784|NCT04731922|460084886|FG001|Overall Study|Lost to Follow-up|0|||
127854785|NCT04731922|460084887|FG002|Overall Study|Lost to Follow-up|0|||
127854786|NCT04731922|460084888|FG003|Overall Study|Lost to Follow-up|1|||
127854787|NCT04731922|460084889|FG004|Overall Study|Lost to Follow-up|0|||
127854788|NCT04731922|460084890|FG005|Overall Study|Lost to Follow-up|1|||
127854789|NCT04731922|460084891|FG006|Overall Study|Lost to Follow-up|0|||
127854790|NCT04731922|460084892|FG007|Overall Study|Lost to Follow-up|0|||
127854791|NCT04731922|460084893|FG008|Overall Study|Lost to Follow-up|0|||
127854792|NCT04731922|460084894|FG009|Overall Study|Lost to Follow-up|0|||
127854793|NCT04731922|460084895|FG010|Overall Study|Lost to Follow-up|0|||
127854794|NCT04731922|460084896|FG011|Overall Study|Lost to Follow-up|0|||
127854795|NCT04731922|460084897|FG012|Overall Study|Lost to Follow-up|0|||
127854796|NCT04731922|460084898|FG013|Overall Study|Lost to Follow-up|0|||
127854797|NCT04731922|460084899|FG014|Overall Study|Lost to Follow-up|0|||
127854798|NCT04731922|460084900|FG015|Overall Study|Lost to Follow-up|0|||
127854799|NCT04731922|460084901|FG016|Overall Study|Lost to Follow-up|0|||
127854800|NCT04731922|460084885|FG000|Overall Study|Withdrawal by Subject|1|||
127854801|NCT04731922|460084886|FG001|Overall Study|Withdrawal by Subject|0|||
127854802|NCT04731922|460084887|FG002|Overall Study|Withdrawal by Subject|0|||
127854803|NCT04731922|460084888|FG003|Overall Study|Withdrawal by Subject|0|||
127854804|NCT04731922|460084889|FG004|Overall Study|Withdrawal by Subject|1|||
127854805|NCT04731922|460084890|FG005|Overall Study|Withdrawal by Subject|0|||
127854806|NCT04731922|460084891|FG006|Overall Study|Withdrawal by Subject|1|||
127854807|NCT04731922|460084892|FG007|Overall Study|Withdrawal by Subject|0|||
127854808|NCT04731922|460084893|FG008|Overall Study|Withdrawal by Subject|0|||
127854809|NCT04731922|460084894|FG009|Overall Study|Withdrawal by Subject|0|||
127854810|NCT04731922|460084895|FG010|Overall Study|Withdrawal by Subject|0|||
127854811|NCT04731922|460084896|FG011|Overall Study|Withdrawal by Subject|0|||
127854812|NCT04731922|460084897|FG012|Overall Study|Withdrawal by Subject|0|||
127854813|NCT04731922|460084898|FG013|Overall Study|Withdrawal by Subject|1|||
127854814|NCT04731922|460084899|FG014|Overall Study|Withdrawal by Subject|0|||
127854815|NCT04731922|460084900|FG015|Overall Study|Withdrawal by Subject|0|||
127854816|NCT04731922|460084901|FG016|Overall Study|Withdrawal by Subject|0|||
127854817|NCT04731922|460084885|FG000|Overall Study|Other|0|||
127854818|NCT04731922|460084886|FG001|Overall Study|Other|0|||
127854819|NCT04731922|460084887|FG002|Overall Study|Other|0|||
127854820|NCT04731922|460084888|FG003|Overall Study|Other|0|||
127854821|NCT04731922|460084889|FG004|Overall Study|Other|0|||
127854822|NCT04731922|460084890|FG005|Overall Study|Other|0|||
127854823|NCT04731922|460084891|FG006|Overall Study|Other|1|||
127854824|NCT04731922|460084892|FG007|Overall Study|Other|0|||
127854825|NCT04731922|460084893|FG008|Overall Study|Other|0|||
127854826|NCT04731922|460084894|FG009|Overall Study|Other|0|||
127854827|NCT04731922|460084895|FG010|Overall Study|Other|0|||
127854828|NCT04731922|460084896|FG011|Overall Study|Other|0|||
127854829|NCT04731922|460084897|FG012|Overall Study|Other|0|||
127854830|NCT04731922|460084898|FG013|Overall Study|Other|0|||
127854831|NCT04731922|460084899|FG014|Overall Study|Other|0|||
127854832|NCT04731922|460084900|FG015|Overall Study|Other|0|||
127854833|NCT04731922|460084901|FG016|Overall Study|Other|0|||
127854834|NCT00845845|460084902|FG000|Overall Study|Lost to Follow-up|0|||
127854835|NCT00845845|460084903|FG001|Overall Study|Lost to Follow-up|4|||
127854836|NCT02820038|460084905|FG000|Overall Study|Lost to Follow-up|7|||
127854837|NCT02820038|460084906|FG001|Overall Study|Lost to Follow-up|11|||
127854838|NCT02820038|460084907|FG002|Overall Study|Lost to Follow-up|2|||
127854839|NCT02820038|460084908|FG003|Overall Study|Lost to Follow-up|9|||
127854840|NCT02820038|460084905|FG000|Overall Study|Withdrawal by Subject|3|||
127854841|NCT02820038|460084906|FG001|Overall Study|Withdrawal by Subject|14|||
127854842|NCT02820038|460084907|FG002|Overall Study|Withdrawal by Subject|3|||
127854843|NCT02820038|460084908|FG003|Overall Study|Withdrawal by Subject|13|||
127854844|NCT02623699|460084909|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
127854845|NCT02623699|460084910|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
127854846|NCT02623699|460084911|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
127854847|NCT02623699|460084912|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
127854848|NCT02623699|460084913|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
127854849|NCT02623699|460084914|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
127854850|NCT02623699|460084915|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
127854851|NCT02623699|460084916|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
127854852|NCT02623699|460084917|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
127854853|NCT02623699|460084918|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
127854854|NCT02623699|460084919|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
127854855|NCT02623699|460084920|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
127854856|NCT02623699|460084909|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
127854857|NCT02623699|460084910|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
127854858|NCT02623699|460084911|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
127854859|NCT02623699|460084912|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
127854860|NCT02623699|460084913|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
127854861|NCT02623699|460084914|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
127854862|NCT02623699|460084915|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
127854863|NCT02623699|460084916|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
127854864|NCT02623699|460084917|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
127854865|NCT02623699|460084918|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
127854866|NCT02623699|460084919|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
127854867|NCT02623699|460084920|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
127854868|NCT02623699|460084909|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
127854869|NCT02623699|460084910|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
127854870|NCT02623699|460084911|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
127854871|NCT02623699|460084912|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
127854872|NCT02623699|460084913|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
127854873|NCT02623699|460084914|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
127854874|NCT02623699|460084915|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
127854875|NCT02623699|460084916|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
127908201|NCT01796171|460287547|FG007|Follow-up Period|Progressive disease|3|||
127854876|NCT02623699|460084917|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
127854877|NCT02623699|460084918|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
127854878|NCT02623699|460084919|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
127854879|NCT02623699|460084920|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
127854880|NCT02623699|460084909|FG000|Part B (Up to 289 Days)|Death|0|||
127854881|NCT02623699|460084910|FG001|Part B (Up to 289 Days)|Death|0|||
127854882|NCT02623699|460084911|FG002|Part B (Up to 289 Days)|Death|0|||
127854883|NCT02623699|460084912|FG003|Part B (Up to 289 Days)|Death|0|||
127854884|NCT02623699|460084913|FG004|Part B (Up to 289 Days)|Death|0|||
127854885|NCT02623699|460084914|FG005|Part B (Up to 289 Days)|Death|1|||
127854886|NCT02623699|460084915|FG006|Part B (Up to 289 Days)|Death|1|||
127854887|NCT02623699|460084916|FG007|Part B (Up to 289 Days)|Death|0|||
127854888|NCT02623699|460084917|FG008|Part B (Up to 289 Days)|Death|1|||
127854889|NCT02623699|460084918|FG009|Part B (Up to 289 Days)|Death|0|||
127854890|NCT02623699|460084919|FG010|Part B (Up to 289 Days)|Death|0|||
127854891|NCT02623699|460084920|FG011|Part B (Up to 289 Days)|Death|0|||
127854892|NCT02623699|460084909|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
127854893|NCT02623699|460084910|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
127854894|NCT02623699|460084911|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
127854895|NCT02623699|460084912|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
127854896|NCT02623699|460084913|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
127854897|NCT02623699|460084914|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
127854898|NCT02623699|460084915|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
127854899|NCT02623699|460084916|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
127854900|NCT02623699|460084917|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
127854901|NCT02623699|460084918|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
127854902|NCT02623699|460084919|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
127854903|NCT02623699|460084920|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
127854904|NCT02623699|460084909|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
127854905|NCT02623699|460084910|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
127854906|NCT02623699|460084911|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
127854907|NCT02623699|460084912|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
127854908|NCT02623699|460084913|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
127854909|NCT02623699|460084914|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
127854910|NCT02623699|460084915|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
127854911|NCT02623699|460084916|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
127854912|NCT02623699|460084917|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
127854913|NCT02623699|460084918|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
127854914|NCT02623699|460084919|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
127854915|NCT02623699|460084920|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
127854916|NCT02623699|460084909|FG000|Part C (Up to 236 Days)|Death|0|||
127854917|NCT02623699|460084910|FG001|Part C (Up to 236 Days)|Death|0|||
127854918|NCT02623699|460084911|FG002|Part C (Up to 236 Days)|Death|0|||
127854919|NCT02623699|460084912|FG003|Part C (Up to 236 Days)|Death|0|||
127854920|NCT02623699|460084913|FG004|Part C (Up to 236 Days)|Death|0|||
127854921|NCT02623699|460084914|FG005|Part C (Up to 236 Days)|Death|0|||
127854922|NCT02623699|460084915|FG006|Part C (Up to 236 Days)|Death|0|||
127854923|NCT02623699|460084916|FG007|Part C (Up to 236 Days)|Death|0|||
127854924|NCT02623699|460084917|FG008|Part C (Up to 236 Days)|Death|0|||
127854925|NCT02623699|460084918|FG009|Part C (Up to 236 Days)|Death|0|||
127854926|NCT02623699|460084919|FG010|Part C (Up to 236 Days)|Death|0|||
127854927|NCT02623699|460084920|FG011|Part C (Up to 236 Days)|Death|1|||
127854928|NCT02623699|460084909|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
127854929|NCT02623699|460084910|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
127854930|NCT02623699|460084911|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
127854931|NCT02623699|460084912|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
127854932|NCT02623699|460084913|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
127854933|NCT02623699|460084914|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
127854934|NCT02623699|460084915|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
127854935|NCT02623699|460084916|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
127854936|NCT02623699|460084917|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
127854937|NCT02623699|460084918|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
127854938|NCT02623699|460084919|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
127854939|NCT02623699|460084920|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
127854940|NCT02177812|460084921|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
127854941|NCT02177812|460084922|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
127854942|NCT02177812|460084923|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
127854943|NCT02177812|460084924|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
127854944|NCT02177812|460084925|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
127854945|NCT02177812|460084926|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
127854946|NCT02177812|460084927|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
127854947|NCT02177812|460084928|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
127854948|NCT02177812|460084929|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
127854949|NCT02177812|460084921|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
127854950|NCT02177812|460084922|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
127908202|NCT01796171|460287548|FG008|Follow-up Period|Progressive disease|0|||
127854951|NCT02177812|460084923|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
127908203|NCT01796171|460287549|FG009|Follow-up Period|Progressive disease|0|||
127854952|NCT02177812|460084924|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
127854953|NCT02177812|460084925|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
127854954|NCT02177812|460084926|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
127854955|NCT02177812|460084927|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
127854956|NCT02177812|460084928|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
127854957|NCT02177812|460084929|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
127854958|NCT02177812|460084921|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
127854959|NCT02177812|460084922|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
127854960|NCT02177812|460084923|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
127854961|NCT02177812|460084924|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
127854962|NCT02177812|460084925|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
127854963|NCT02177812|460084926|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
127854964|NCT02177812|460084927|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
127854965|NCT02177812|460084928|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
127854966|NCT02177812|460084929|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
127854967|NCT00089999|460084930|FG000|Overall Study|Adverse Event|4|||
127854968|NCT00089999|460084931|FG001|Overall Study|Adverse Event|7|||
127854969|NCT00089999|460084930|FG000|Overall Study|Withdrawal by Subject|0|||
127854970|NCT00089999|460084931|FG001|Overall Study|Withdrawal by Subject|4|||
127854971|NCT00089999|460084930|FG000|Overall Study|Lost to Follow-up|2|||
127854972|NCT00089999|460084931|FG001|Overall Study|Lost to Follow-up|1|||
127854973|NCT00089999|460084930|FG000|Overall Study|Radiological Progression of Cancer|52|||
127854974|NCT00089999|460084931|FG001|Overall Study|Radiological Progression of Cancer|44|||
127854975|NCT00089999|460084930|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
127854976|NCT00089999|460084931|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
127854977|NCT00089999|460084930|FG000|Overall Study|Death|3|||
127854978|NCT00089999|460084931|FG001|Overall Study|Death|3|||
127854979|NCT00089999|460084930|FG000|Overall Study|Poor General Condition|1|||
127854980|NCT00089999|460084931|FG001|Overall Study|Poor General Condition|0|||
127854981|NCT00089999|460084930|FG000|Overall Study|Clinical Progression|1|||
127854982|NCT00089999|460084931|FG001|Overall Study|Clinical Progression|2|||
127854983|NCT00089999|460084930|FG000|Overall Study|Physician Decision|2|||
127854984|NCT00089999|460084931|FG001|Overall Study|Physician Decision|2|||
127854985|NCT00089999|460084930|FG000|Overall Study|Patient Underwent Surgery|2|||
127854986|NCT00089999|460084931|FG001|Overall Study|Patient Underwent Surgery|0|||
127854987|NCT00089999|460084930|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
127854988|NCT00089999|460084931|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
127854989|NCT01167153|460084934|FG000|Overall Study|Non-effective therapy|1|||
127854990|NCT01167153|460084935|FG001|Overall Study|Non-effective therapy|4|||
127854991|NCT01167153|460084934|FG000|Overall Study|AE including clinical laboratory AE|2|||
127854992|NCT01167153|460084935|FG001|Overall Study|AE including clinical laboratory AE|8|||
127854993|NCT01167153|460084934|FG000|Overall Study|Hypotension|1|||
127854994|NCT01167153|460084935|FG001|Overall Study|Hypotension|0|||
127854995|NCT01167153|460084934|FG000|Overall Study|Lost to Follow-up|7|||
127854996|NCT01167153|460084935|FG001|Overall Study|Lost to Follow-up|9|||
127854997|NCT01167153|460084934|FG000|Overall Study|Non-compliance to concomitant medication|0|||
127854998|NCT01167153|460084935|FG001|Overall Study|Non-compliance to concomitant medication|2|||
127854999|NCT01167153|460084934|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
127855000|NCT01167153|460084935|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
127855001|NCT01167153|460084934|FG000|Overall Study|Withdrawal consent|1|||
127855002|NCT01167153|460084935|FG001|Overall Study|Withdrawal consent|1|||
127855003|NCT01167153|460084934|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
127855004|NCT01167153|460084935|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
127855005|NCT04097028|460086514|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
127855006|NCT04097028|460086514|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
127855007|NCT04097028|460086514|FG000|Overall Study|Disease Progression prior to Surgery|2|||
127855008|NCT04097028|460086514|FG000|Overall Study|Adverse Event prior to Surgery|1|||
127855009|NCT01678313|460086515|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
127855010|NCT01678313|460086516|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
127855011|NCT01678313|460086515|FG000|Completed the 3-month Therapy|Physician Decision|3|||
127855012|NCT01678313|460086516|FG001|Completed the 3-month Therapy|Physician Decision|4|||
127855013|NCT01678313|460086515|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
127855014|NCT01678313|460086516|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
127855015|NCT01678313|460086515|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
127855016|NCT01678313|460086516|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
127855017|NCT00981292|460086519|FG000|Day 1|Protocol Violation|1|||
127855018|NCT00981292|460086520|FG001|Day 1|Protocol Violation|0|||
127855019|NCT00981292|460086521|FG002|Day 1|Protocol Violation|0|||
127855020|NCT00981292|460086522|FG003|Day 1|Protocol Violation|0|||
127855021|NCT00981292|460086523|FG004|Day 1|Protocol Violation|0|||
127855022|NCT00981292|460086524|FG005|Day 1|Protocol Violation|2|||
127855023|NCT00981292|460086519|FG000|Day 2|Protocol Violation|2|||
127855024|NCT00981292|460086520|FG001|Day 2|Protocol Violation|0|||
127855025|NCT00981292|460086521|FG002|Day 2|Protocol Violation|0|||
127855026|NCT00981292|460086522|FG003|Day 2|Protocol Violation|0|||
127855027|NCT00981292|460086523|FG004|Day 2|Protocol Violation|0|||
127855028|NCT00981292|460086524|FG005|Day 2|Protocol Violation|0|||
127855029|NCT00981292|460086519|FG000|Day 3|Protocol Violation|0|||
127855030|NCT00981292|460086520|FG001|Day 3|Protocol Violation|0|||
127855031|NCT00981292|460086521|FG002|Day 3|Protocol Violation|0|||
127855032|NCT00981292|460086522|FG003|Day 3|Protocol Violation|0|||
127855033|NCT00981292|460086523|FG004|Day 3|Protocol Violation|0|||
127855034|NCT00981292|460086524|FG005|Day 3|Protocol Violation|1|||
127855035|NCT01131130|460086525|FG000|Period 1 - Baseline|Pregnancy|1|||
127855036|NCT01131130|460086525|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
127855037|NCT03464136|460086526|FG000|Overall Study|Lost to Follow-up|5|||
127855038|NCT03464136|460086527|FG001|Overall Study|Lost to Follow-up|8|||
127855039|NCT03464136|460086526|FG000|Overall Study|Withdrawal by Subject|16|||
127855040|NCT03464136|460086527|FG001|Overall Study|Withdrawal by Subject|13|||
127855041|NCT03464136|460086526|FG000|Overall Study|Death|1|||
127855042|NCT03464136|460086527|FG001|Overall Study|Death|0|||
127855043|NCT03464136|460086526|FG000|Overall Study|Other|8|||
127855044|NCT03464136|460086527|FG001|Overall Study|Other|4|||
127855045|NCT03412565|460086528|FG000|Overall Study|Lost to Follow-up|0|||
127855046|NCT03412565|460086529|FG001|Overall Study|Lost to Follow-up|0|||
127855047|NCT03412565|460086530|FG002|Overall Study|Lost to Follow-up|1|||
127855048|NCT03412565|460086531|FG003|Overall Study|Lost to Follow-up|0|||
127855049|NCT03412565|460086528|FG000|Overall Study|Physician Decision|0|||
127855050|NCT03412565|460086529|FG001|Overall Study|Physician Decision|0|||
127855051|NCT03412565|460086530|FG002|Overall Study|Physician Decision|0|||
127855052|NCT03412565|460086531|FG003|Overall Study|Physician Decision|1|||
127855053|NCT03412565|460086528|FG000|Overall Study|Withdrawal by Subject|0|||
127855054|NCT03412565|460086529|FG001|Overall Study|Withdrawal by Subject|4|||
127855055|NCT03412565|460086530|FG002|Overall Study|Withdrawal by Subject|5|||
127855056|NCT03412565|460086531|FG003|Overall Study|Withdrawal by Subject|5|||
127855057|NCT03412565|460086528|FG000|Overall Study|Death|1|||
127855058|NCT03412565|460086529|FG001|Overall Study|Death|3|||
127855059|NCT03412565|460086530|FG002|Overall Study|Death|4|||
127855060|NCT03412565|460086531|FG003|Overall Study|Death|5|||
127855061|NCT03412565|460086528|FG000|Overall Study|Data collection ended|0|||
127855062|NCT03412565|460086529|FG001|Overall Study|Data collection ended|41|||
127855063|NCT03412565|460086530|FG002|Overall Study|Data collection ended|41|||
127855064|NCT03412565|460086531|FG003|Overall Study|Data collection ended|40|||
127855065|NCT03277105|460086532|FG000|Overall Study|Death|129|||
127855066|NCT03277105|460086533|FG001|Overall Study|Death|124|||
127855067|NCT03277105|460086532|FG000|Overall Study|Lost to Follow-up|2|||
127855068|NCT03277105|460086533|FG001|Overall Study|Lost to Follow-up|4|||
127855069|NCT03277105|460086532|FG000|Overall Study|Withdrawal by Subject|10|||
127855070|NCT03277105|460086533|FG001|Overall Study|Withdrawal by Subject|10|||
127855071|NCT03277105|460086532|FG000|Overall Study|Other|118|||
127855072|NCT03277105|460086533|FG001|Overall Study|Other|125|||
127855073|NCT00537771|460086540|FG000|Overall Study|Withdrawal by Subject|6|||
127855074|NCT00537771|460086541|FG001|Overall Study|Withdrawal by Subject|23|||
127855075|NCT00537771|460086540|FG000|Overall Study|Adverse Event|8|||
127855076|NCT00537771|460086541|FG001|Overall Study|Adverse Event|15|||
127855077|NCT00537771|460086540|FG000|Overall Study|Lost to Follow-up|9|||
127855078|NCT00537771|460086541|FG001|Overall Study|Lost to Follow-up|15|||
127855079|NCT00537771|460086540|FG000|Overall Study|Protocol Violation|2|||
127855080|NCT00537771|460086541|FG001|Overall Study|Protocol Violation|6|||
127855081|NCT00537771|460086540|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
127855082|NCT00537771|460086541|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
127855083|NCT02736929|460086543|FG000|Main Study|Lost to Follow-up|7|||
127855084|NCT02736929|460086544|FG001|Main Study|Lost to Follow-up|1|||
127855085|NCT02736929|460086545|FG002|Main Study|Lost to Follow-up|0|||
127855086|NCT02736929|460086543|FG000|Main Study|Withdrawal by Subject|1|||
127855087|NCT02736929|460086544|FG001|Main Study|Withdrawal by Subject|1|||
127855088|NCT02736929|460086545|FG002|Main Study|Withdrawal by Subject|0|||
127855089|NCT02736929|460086543|FG000|Optional Cross-Over|Withdrawal by Subject|0|||
127855090|NCT02736929|460086544|FG001|Optional Cross-Over|Withdrawal by Subject|0|||
127855091|NCT02736929|460086545|FG002|Optional Cross-Over|Withdrawal by Subject|6|||
127855092|NCT00285649|460086548|FG000|Overall Study|Lost to Follow-up|6|||
127855093|NCT00285649|460086549|FG001|Overall Study|Lost to Follow-up|4|||
127855094|NCT00285649|460086550|FG002|Overall Study|Lost to Follow-up|4|||
127855095|NCT00285649|460086548|FG000|Overall Study|Withdrawal by Subject|3|||
127855096|NCT00285649|460086549|FG001|Overall Study|Withdrawal by Subject|2|||
127855097|NCT00285649|460086550|FG002|Overall Study|Withdrawal by Subject|2|||
127855098|NCT03342404|460086551|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
127855099|NCT03342404|460086552|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
127855100|NCT03342404|460086551|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
127855101|NCT03342404|460086552|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
127855102|NCT03342404|460086551|FG000|Blinded Treatment Phase|Adverse Event|5|||
127855103|NCT03342404|460086552|FG001|Blinded Treatment Phase|Adverse Event|4|||
127855104|NCT03342404|460086551|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
127855105|NCT03342404|460086552|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
127855106|NCT03342404|460086551|FG000|Blinded Treatment Phase|Other reasons|1|||
127855107|NCT03342404|460086552|FG001|Blinded Treatment Phase|Other reasons|0|||
127855108|NCT03342404|460086551|FG000|Blinded Treatment Phase|Physician Decision|1|||
127855109|NCT03342404|460086552|FG001|Blinded Treatment Phase|Physician Decision|0|||
127855110|NCT03342404|460086551|FG000|Blinded Treatment Phase|Death|1|||
127855111|NCT03342404|460086552|FG001|Blinded Treatment Phase|Death|0|||
127855112|NCT03342404|460086551|FG000|Open-Label Phase|Lost to Follow-up|0|||
127855113|NCT03342404|460086552|FG001|Open-Label Phase|Lost to Follow-up|1|||
127855114|NCT03342404|460086551|FG000|Open-Label Phase|Other reasons|0|||
127855115|NCT03342404|460086552|FG001|Open-Label Phase|Other reasons|1|||
127855116|NCT03342404|460086551|FG000|Open-Label Phase|Adverse Event|0|||
127855117|NCT03342404|460086552|FG001|Open-Label Phase|Adverse Event|3|||
127855118|NCT03342404|460086551|FG000|Open-Label Phase|Withdrawal by Subject|0|||
127855119|NCT03342404|460086552|FG001|Open-Label Phase|Withdrawal by Subject|6|||
127855120|NCT01855425|460086553|FG000|Overall Study|Physician Decision|20|||
127855121|NCT01690988|460086554|FG000|Overall Study|Withdrawal by Subject|2|||
127855122|NCT01690988|460086555|FG001|Overall Study|Withdrawal by Subject|2|||
127855123|NCT01690988|460086556|FG002|Overall Study|Withdrawal by Subject|3|||
127855124|NCT01690988|460086554|FG000|Overall Study|Physician Decision|0|||
127855125|NCT01690988|460086555|FG001|Overall Study|Physician Decision|0|||
127855126|NCT01690988|460086556|FG002|Overall Study|Physician Decision|1|||
127855127|NCT01690988|460086554|FG000|Overall Study|Operation Cancelled|1|||
127855128|NCT01690988|460086555|FG001|Overall Study|Operation Cancelled|1|||
127855129|NCT01690988|460086556|FG002|Overall Study|Operation Cancelled|0|||
127855130|NCT01690988|460086554|FG000|Overall Study|Determined ineligible|1|||
127855131|NCT01690988|460086555|FG001|Overall Study|Determined ineligible|0|||
127855132|NCT01690988|460086556|FG002|Overall Study|Determined ineligible|0|||
127855133|NCT01690988|460086554|FG000|Overall Study|Death|1|||
127855134|NCT01690988|460086555|FG001|Overall Study|Death|1|||
127855135|NCT01690988|460086556|FG002|Overall Study|Death|1|||
127855136|NCT01690988|460086554|FG000|Overall Study|Sedated|1|||
127855137|NCT01690988|460086555|FG001|Overall Study|Sedated|1|||
127855138|NCT01690988|460086556|FG002|Overall Study|Sedated|2|||
127855139|NCT01634100|460086559|FG000|Overall Study|Withdrawal by Subject|1|||
127855140|NCT01634100|460086560|FG001|Overall Study|Withdrawal by Subject|0|||
127855141|NCT01634100|460086561|FG002|Overall Study|Withdrawal by Subject|1|||
127855142|NCT01634100|460086562|FG003|Overall Study|Withdrawal by Subject|0|||
127855143|NCT01634100|460086563|FG004|Overall Study|Withdrawal by Subject|0|||
127855144|NCT01634100|460086564|FG005|Overall Study|Withdrawal by Subject|0|||
127855145|NCT01975376|460086568|FG000|Overall Study|Adverse Event|5|||
127855146|NCT01975376|460086569|FG001|Overall Study|Adverse Event|5|||
127855147|NCT01975376|460086568|FG000|Overall Study|Death|65|||
127855148|NCT01975376|460086569|FG001|Overall Study|Death|72|||
127855149|NCT01975376|460086568|FG000|Overall Study|Lost to Follow-up|70|||
127855150|NCT01975376|460086569|FG001|Overall Study|Lost to Follow-up|66|||
127855151|NCT01975376|460086568|FG000|Overall Study|Withdrew consent|68|||
127855152|NCT01975376|460086569|FG001|Overall Study|Withdrew consent|62|||
127855153|NCT01975376|460086568|FG000|Overall Study|Other|2|||
127855154|NCT01975376|460086569|FG001|Overall Study|Other|4|||
127855155|NCT01975376|460086568|FG000|Overall Study|Randomized, Not Treated|16|||
127855156|NCT01975376|460086569|FG001|Overall Study|Randomized, Not Treated|8|||
127855157|NCT01819194|460086571|FG000|Overall Study|Loss of study articles|2|||
127855158|NCT02343952|460086574|FG000|Study Treatment|Disease Progression|23|||
127855159|NCT02343952|460086574|FG000|Study Treatment|Death|3|||
127855160|NCT02343952|460086574|FG000|Study Treatment|Adverse Event|19|||
127855161|NCT02343952|460086574|FG000|Study Treatment|Withdrawal by Subject|7|||
127855162|NCT02343952|460086574|FG000|Study Treatment|other complicating Diseases|1|||
127855163|NCT02343952|460086574|FG000|Follow up|Withdrawal by Subject|3|||
127855164|NCT02343952|460086574|FG000|Follow up|Death|33|||
127855165|NCT02343952|460086574|FG000|Follow up|Patient does not meet eligibility for study.|1|||
127855166|NCT02343952|460086574|FG000|Follow up|Research department closed by the practice.|5|||
127855167|NCT02343952|460086574|FG000|Follow up|Patient went home to Russia|1|||
127855168|NCT02343952|460086574|FG000|Follow up|Disease Progression|1|||
127855169|NCT02343952|460086574|FG000|Follow up|study terminated|1|||
127855170|NCT01448707|460086578|FG000|Overall Study|Adverse Event|3|||
127855171|NCT01448707|460086579|FG001|Overall Study|Adverse Event|1|||
127855172|NCT01448707|460086578|FG000|Overall Study|Lost to Follow-up|2|||
127855173|NCT01448707|460086579|FG001|Overall Study|Lost to Follow-up|6|||
127855174|NCT01448707|460086578|FG000|Overall Study|Withdrawal by Subject|6|||
127855175|NCT01448707|460086579|FG001|Overall Study|Withdrawal by Subject|7|||
127855176|NCT01448707|460086578|FG000|Overall Study|Other|7|||
127855177|NCT01448707|460086579|FG001|Overall Study|Other|4|||
127855178|NCT00899678|460086580|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
127855179|NCT00899678|460086581|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
127855180|NCT00899678|460086582|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
127855181|NCT00899678|460086580|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
127855182|NCT00899678|460086581|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
127855183|NCT00899678|460086582|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
127855184|NCT00899678|460086580|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
127855185|NCT00899678|460086581|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
127855186|NCT00899678|460086582|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
127855187|NCT00899678|460086580|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
127855188|NCT00899678|460086581|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
127855189|NCT00899678|460086582|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
127855190|NCT00899678|460086580|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
127855191|NCT00899678|460086581|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
127855192|NCT00899678|460086582|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
127855193|NCT00899678|460086580|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
127855194|NCT00899678|460086581|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
127855195|NCT00899678|460086582|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
127855196|NCT00899678|460086580|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
127855197|NCT00899678|460086581|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
127855198|NCT00899678|460086582|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
127855199|NCT00899678|460086580|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
127855200|NCT00899678|460086581|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
127855201|NCT00899678|460086582|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
127855202|NCT00899678|460086580|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
127855203|NCT00899678|460086581|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
127855204|NCT00899678|460086582|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
127855205|NCT00033371|460086583|FG000|Overall Study|Adverse Event|1|||
127855206|NCT00033371|460086584|FG001|Overall Study|Adverse Event|5|||
127855207|NCT00033371|460086583|FG000|Overall Study|Lost to Follow-up|2|||
127855208|NCT00033371|460086584|FG001|Overall Study|Lost to Follow-up|1|||
127855209|NCT00033371|460086583|FG000|Overall Study|Withdrawal by Subject|3|||
127855210|NCT00033371|460086584|FG001|Overall Study|Withdrawal by Subject|3|||
127855211|NCT00033371|460086583|FG000|Overall Study|Disease Progression|0|||
127855212|NCT00033371|460086584|FG001|Overall Study|Disease Progression|1|||
127855213|NCT03796195|460086587|FG000|Overall Study|Study closed early|1|||
127855214|NCT03799627|460086588|FG000|Overall Study|Adverse Event|1|||
127855215|NCT03799627|460086589|FG001|Overall Study|Adverse Event|2|||
127855216|NCT03799627|460086590|FG002|Overall Study|Adverse Event|0|||
127855217|NCT03799627|460086591|FG003|Overall Study|Adverse Event|0|||
127855218|NCT03799627|460086592|FG004|Overall Study|Adverse Event|2|||
127855219|NCT03799627|460086593|FG005|Overall Study|Adverse Event|5|||
127855220|NCT03799627|460086594|FG006|Overall Study|Adverse Event|0|||
127855221|NCT03799627|460086595|FG007|Overall Study|Adverse Event|2|||
127855222|NCT03799627|460086596|FG008|Overall Study|Adverse Event|0|||
127855223|NCT03799627|460086588|FG000|Overall Study|Physician Decision|2|||
127855224|NCT03799627|460086589|FG001|Overall Study|Physician Decision|2|||
127855225|NCT03799627|460086590|FG002|Overall Study|Physician Decision|0|||
127855226|NCT03799627|460086591|FG003|Overall Study|Physician Decision|0|||
127855227|NCT03799627|460086592|FG004|Overall Study|Physician Decision|2|||
127855228|NCT03799627|460086593|FG005|Overall Study|Physician Decision|2|||
127855229|NCT03799627|460086594|FG006|Overall Study|Physician Decision|0|||
127855230|NCT03799627|460086595|FG007|Overall Study|Physician Decision|0|||
127855231|NCT03799627|460086596|FG008|Overall Study|Physician Decision|0|||
127855232|NCT03799627|460086588|FG000|Overall Study|Withdrawal by Subject|1|||
127855233|NCT03799627|460086589|FG001|Overall Study|Withdrawal by Subject|1|||
127855234|NCT03799627|460086590|FG002|Overall Study|Withdrawal by Subject|0|||
127855235|NCT03799627|460086591|FG003|Overall Study|Withdrawal by Subject|2|||
127855236|NCT03799627|460086592|FG004|Overall Study|Withdrawal by Subject|0|||
127855237|NCT03799627|460086593|FG005|Overall Study|Withdrawal by Subject|3|||
127855238|NCT03799627|460086594|FG006|Overall Study|Withdrawal by Subject|0|||
127855239|NCT03799627|460086595|FG007|Overall Study|Withdrawal by Subject|0|||
127855240|NCT03799627|460086596|FG008|Overall Study|Withdrawal by Subject|0|||
127855241|NCT03799627|460086588|FG000|Overall Study|Lack of Efficacy|0|||
127855242|NCT03799627|460086589|FG001|Overall Study|Lack of Efficacy|0|||
127855243|NCT03799627|460086590|FG002|Overall Study|Lack of Efficacy|0|||
127855244|NCT03799627|460086591|FG003|Overall Study|Lack of Efficacy|1|||
127855245|NCT03799627|460086592|FG004|Overall Study|Lack of Efficacy|0|||
127855246|NCT03799627|460086593|FG005|Overall Study|Lack of Efficacy|0|||
127855247|NCT03799627|460086594|FG006|Overall Study|Lack of Efficacy|0|||
127908204|NCT01796171|460287550|FG010|Follow-up Period|Progressive disease|0|||
127855248|NCT03799627|460086595|FG007|Overall Study|Lack of Efficacy|0|||
127855249|NCT03799627|460086596|FG008|Overall Study|Lack of Efficacy|0|||
127855250|NCT03799627|460086588|FG000|Overall Study|Lost to Follow-up|0|||
127855251|NCT03799627|460086589|FG001|Overall Study|Lost to Follow-up|0|||
127855252|NCT03799627|460086590|FG002|Overall Study|Lost to Follow-up|0|||
127855253|NCT03799627|460086591|FG003|Overall Study|Lost to Follow-up|0|||
127855254|NCT03799627|460086592|FG004|Overall Study|Lost to Follow-up|0|||
127855255|NCT03799627|460086593|FG005|Overall Study|Lost to Follow-up|0|||
127855256|NCT03799627|460086594|FG006|Overall Study|Lost to Follow-up|1|||
127855257|NCT03799627|460086595|FG007|Overall Study|Lost to Follow-up|0|||
127855258|NCT03799627|460086596|FG008|Overall Study|Lost to Follow-up|1|||
127855259|NCT03799627|460086588|FG000|Overall Study|Death|0|||
127855260|NCT03799627|460086589|FG001|Overall Study|Death|0|||
127855261|NCT03799627|460086590|FG002|Overall Study|Death|0|||
127855262|NCT03799627|460086591|FG003|Overall Study|Death|1|||
127855263|NCT03799627|460086592|FG004|Overall Study|Death|0|||
127855264|NCT03799627|460086593|FG005|Overall Study|Death|0|||
127855265|NCT03799627|460086594|FG006|Overall Study|Death|0|||
127855266|NCT03799627|460086595|FG007|Overall Study|Death|0|||
127855267|NCT03799627|460086596|FG008|Overall Study|Death|0|||
127855268|NCT03799627|460086588|FG000|Overall Study|Study Drug Put on Hold|1|||
127855269|NCT03799627|460086589|FG001|Overall Study|Study Drug Put on Hold|0|||
127855270|NCT03799627|460086590|FG002|Overall Study|Study Drug Put on Hold|0|||
127855271|NCT03799627|460086591|FG003|Overall Study|Study Drug Put on Hold|0|||
127855272|NCT03799627|460086592|FG004|Overall Study|Study Drug Put on Hold|0|||
127855273|NCT03799627|460086593|FG005|Overall Study|Study Drug Put on Hold|0|||
127855274|NCT03799627|460086594|FG006|Overall Study|Study Drug Put on Hold|0|||
127855275|NCT03799627|460086595|FG007|Overall Study|Study Drug Put on Hold|0|||
127855276|NCT03799627|460086596|FG008|Overall Study|Study Drug Put on Hold|0|||
127855277|NCT03799627|460086588|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
127855278|NCT03799627|460086589|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
127855279|NCT03799627|460086590|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
127855280|NCT03799627|460086591|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
127855281|NCT03799627|460086592|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
127855282|NCT03799627|460086593|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
127855283|NCT03799627|460086594|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
127855284|NCT03799627|460086595|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
127855285|NCT03799627|460086596|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
127855286|NCT03799627|460086588|FG000|Overall Study|Kidney Transplantation|1|||
127855287|NCT03799627|460086589|FG001|Overall Study|Kidney Transplantation|0|||
127855288|NCT03799627|460086590|FG002|Overall Study|Kidney Transplantation|0|||
127855289|NCT03799627|460086591|FG003|Overall Study|Kidney Transplantation|1|||
127855290|NCT03799627|460086592|FG004|Overall Study|Kidney Transplantation|1|||
127855291|NCT03799627|460086593|FG005|Overall Study|Kidney Transplantation|0|||
127855292|NCT03799627|460086594|FG006|Overall Study|Kidney Transplantation|0|||
127855293|NCT03799627|460086595|FG007|Overall Study|Kidney Transplantation|0|||
127855294|NCT03799627|460086596|FG008|Overall Study|Kidney Transplantation|0|||
127855295|NCT03799627|460086588|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
127855296|NCT03799627|460086589|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
127855297|NCT03799627|460086590|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
127855298|NCT03799627|460086591|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
127855299|NCT03799627|460086592|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
127855300|NCT03799627|460086593|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
127855301|NCT03799627|460086594|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
127855302|NCT03799627|460086595|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
127855303|NCT03799627|460086596|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
127855304|NCT03799627|460086588|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
127855305|NCT03799627|460086589|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
127855306|NCT03799627|460086590|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
127855307|NCT03799627|460086591|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
127855308|NCT03799627|460086592|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
127855309|NCT03799627|460086593|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
127855310|NCT03799627|460086594|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
127855311|NCT03799627|460086595|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
127855312|NCT03799627|460086596|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
127855313|NCT03799627|460086588|FG000|Overall Study|Met Exclusion Criteria|0|||
127855314|NCT03799627|460086589|FG001|Overall Study|Met Exclusion Criteria|0|||
127855315|NCT03799627|460086590|FG002|Overall Study|Met Exclusion Criteria|0|||
127855316|NCT03799627|460086591|FG003|Overall Study|Met Exclusion Criteria|1|||
127855317|NCT03799627|460086592|FG004|Overall Study|Met Exclusion Criteria|0|||
127855318|NCT03799627|460086593|FG005|Overall Study|Met Exclusion Criteria|0|||
127855319|NCT03799627|460086594|FG006|Overall Study|Met Exclusion Criteria|0|||
127855320|NCT03799627|460086595|FG007|Overall Study|Met Exclusion Criteria|0|||
127855321|NCT03799627|460086596|FG008|Overall Study|Met Exclusion Criteria|0|||
127855322|NCT03799627|460086588|FG000|Overall Study|Investigational Product Noncompliance|0|||
127855323|NCT03799627|460086589|FG001|Overall Study|Investigational Product Noncompliance|0|||
127855324|NCT03799627|460086590|FG002|Overall Study|Investigational Product Noncompliance|0|||
127855325|NCT03799627|460086591|FG003|Overall Study|Investigational Product Noncompliance|1|||
127855326|NCT03799627|460086592|FG004|Overall Study|Investigational Product Noncompliance|0|||
127855327|NCT03799627|460086593|FG005|Overall Study|Investigational Product Noncompliance|0|||
127855328|NCT03799627|460086594|FG006|Overall Study|Investigational Product Noncompliance|0|||
127855329|NCT03799627|460086595|FG007|Overall Study|Investigational Product Noncompliance|0|||
127855330|NCT03799627|460086596|FG008|Overall Study|Investigational Product Noncompliance|0|||
127855331|NCT03799627|460086588|FG000|Overall Study|Participant Relocation|0|||
127855332|NCT03799627|460086589|FG001|Overall Study|Participant Relocation|0|||
127855333|NCT03799627|460086590|FG002|Overall Study|Participant Relocation|0|||
127855334|NCT03799627|460086591|FG003|Overall Study|Participant Relocation|1|||
127855335|NCT03799627|460086592|FG004|Overall Study|Participant Relocation|0|||
127855336|NCT03799627|460086593|FG005|Overall Study|Participant Relocation|1|||
127855337|NCT03799627|460086594|FG006|Overall Study|Participant Relocation|0|||
127855338|NCT03799627|460086595|FG007|Overall Study|Participant Relocation|0|||
127855339|NCT03799627|460086596|FG008|Overall Study|Participant Relocation|0|||
127855340|NCT03799627|460086588|FG000|Overall Study|Eurofin Issue|0|||
127855341|NCT03799627|460086589|FG001|Overall Study|Eurofin Issue|0|||
127855342|NCT03799627|460086590|FG002|Overall Study|Eurofin Issue|0|||
127855343|NCT03799627|460086591|FG003|Overall Study|Eurofin Issue|0|||
127855344|NCT03799627|460086592|FG004|Overall Study|Eurofin Issue|1|||
127855345|NCT03799627|460086593|FG005|Overall Study|Eurofin Issue|0|||
127855346|NCT03799627|460086594|FG006|Overall Study|Eurofin Issue|0|||
127855347|NCT03799627|460086595|FG007|Overall Study|Eurofin Issue|0|||
127855348|NCT03799627|460086596|FG008|Overall Study|Eurofin Issue|0|||
127855349|NCT03799627|460086588|FG000|Overall Study|Noncompliance with Site Instructions|0|||
127855350|NCT03799627|460086589|FG001|Overall Study|Noncompliance with Site Instructions|0|||
127855351|NCT03799627|460086590|FG002|Overall Study|Noncompliance with Site Instructions|0|||
127855352|NCT03799627|460086591|FG003|Overall Study|Noncompliance with Site Instructions|0|||
127855353|NCT03799627|460086592|FG004|Overall Study|Noncompliance with Site Instructions|1|||
127855354|NCT03799627|460086593|FG005|Overall Study|Noncompliance with Site Instructions|0|||
127855355|NCT03799627|460086594|FG006|Overall Study|Noncompliance with Site Instructions|0|||
127855356|NCT03799627|460086595|FG007|Overall Study|Noncompliance with Site Instructions|0|||
127855357|NCT03799627|460086596|FG008|Overall Study|Noncompliance with Site Instructions|0|||
127855358|NCT03799627|460086588|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
127855359|NCT03799627|460086589|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
127855360|NCT03799627|460086590|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
127855361|NCT03799627|460086591|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
127855362|NCT03799627|460086592|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
127855363|NCT03799627|460086593|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
127855364|NCT03799627|460086594|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
127855365|NCT03799627|460086595|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
127855366|NCT03799627|460086596|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
127855367|NCT03799627|460086588|FG000|Overall Study|Changes In Hemoglobin Values|1|||
127855368|NCT03799627|460086589|FG001|Overall Study|Changes In Hemoglobin Values|2|||
127855369|NCT03799627|460086590|FG002|Overall Study|Changes In Hemoglobin Values|1|||
127855370|NCT03799627|460086591|FG003|Overall Study|Changes In Hemoglobin Values|0|||
127855371|NCT03799627|460086592|FG004|Overall Study|Changes In Hemoglobin Values|0|||
127855372|NCT03799627|460086593|FG005|Overall Study|Changes In Hemoglobin Values|2|||
127855373|NCT03799627|460086594|FG006|Overall Study|Changes In Hemoglobin Values|1|||
127855374|NCT03799627|460086595|FG007|Overall Study|Changes In Hemoglobin Values|0|||
127855375|NCT03799627|460086596|FG008|Overall Study|Changes In Hemoglobin Values|1|||
127855376|NCT01922739|460086603|FG000|Titration/Adjustment Period|Adverse Event|3|||
127855377|NCT01922739|460086603|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
127855378|NCT01922739|460086603|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
127855379|NCT01922739|460086603|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
127855380|NCT01922739|460086603|FG000|Open-label Treatment Period|Adverse Event|6|||
127855381|NCT01922739|460086603|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
127855382|NCT01922739|460086603|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
127855383|NCT01922739|460086603|FG000|Open-label Treatment Period|Protocol Violation|5|||
127855384|NCT01922739|460086603|FG000|Open-label Treatment Period|Pregnancy|1|||
127855385|NCT01922739|460086603|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
127855386|NCT01922739|460086603|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
127855387|NCT01922739|460086603|FG000|Open-label Treatment Period|Physician Decision|1|||
127855388|NCT01922739|460086603|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
127855389|NCT04489940|460086606|FG000|Overall Study|Other|2|||
127908205|NCT01796171|460287551|FG011|Follow-up Period|Progressive disease|0|||
127855390|NCT04489940|460086606|FG000|Overall Study|Withdrawal by Subject|2|||
127855391|NCT04489940|460086606|FG000|Overall Study|Death|5|||
127855392|NCT04489940|460086606|FG000|Overall Study|Lost to Follow-up|1|||
127855393|NCT04498468|460086607|FG000|Overall Study|Lost to Follow-up|3|||
127855394|NCT02725268|460086608|FG000|Overall Study|Death|58|||
127855395|NCT02725268|460086609|FG001|Overall Study|Death|59|||
127855396|NCT02725268|460086610|FG002|Overall Study|Death|30|||
127855397|NCT02725268|460086611|FG003|Overall Study|Death|16|||
127855398|NCT02725268|460086608|FG000|Overall Study|Lost to Follow-up|4|||
127855399|NCT02725268|460086609|FG001|Overall Study|Lost to Follow-up|3|||
127855400|NCT02725268|460086610|FG002|Overall Study|Lost to Follow-up|0|||
127855401|NCT02725268|460086611|FG003|Overall Study|Lost to Follow-up|1|||
127855402|NCT02725268|460086608|FG000|Overall Study|Site Terminated by Sponsor|0|||
127855403|NCT02725268|460086609|FG001|Overall Study|Site Terminated by Sponsor|1|||
127855404|NCT02725268|460086610|FG002|Overall Study|Site Terminated by Sponsor|0|||
127855405|NCT02725268|460086611|FG003|Overall Study|Site Terminated by Sponsor|0|||
127855406|NCT02725268|460086608|FG000|Overall Study|Withdrawal by Subject|8|||
127855407|NCT02725268|460086609|FG001|Overall Study|Withdrawal by Subject|6|||
127855408|NCT02725268|460086610|FG002|Overall Study|Withdrawal by Subject|8|||
127855409|NCT02725268|460086611|FG003|Overall Study|Withdrawal by Subject|1|||
127855410|NCT02725268|460086608|FG000|Overall Study|Reason not Specified|2|||
127855411|NCT02725268|460086609|FG001|Overall Study|Reason not Specified|1|||
127855412|NCT02725268|460086610|FG002|Overall Study|Reason not Specified|0|||
127855413|NCT02725268|460086611|FG003|Overall Study|Reason not Specified|0|||
127855414|NCT00262314|460086616|FG000|Overall Study|Changing physicians|38|||
127855415|NCT00262314|460086616|FG000|Overall Study|Death|12|||
127855416|NCT00262314|460086616|FG000|Overall Study|Patient's decision|92|||
127855417|NCT00262314|460086616|FG000|Overall Study|Other|95|||
127855418|NCT00262314|460086616|FG000|Overall Study|Lost to Follow-up|70|||
127855419|NCT00262314|460086616|FG000|Overall Study|Administrative withdrawal|30|||
127855420|NCT05104749|460086617|FG000|Overall Study|Lost to Follow-up|2|||
127855421|NCT05104749|460086618|FG001|Overall Study|Lost to Follow-up|3|||
127855422|NCT03964493|460086619|FG000|Overall Study|Withdrawal by Subject|4|||
127855423|NCT03964493|460086620|FG001|Overall Study|Withdrawal by Subject|1|||
127855424|NCT03964493|460086619|FG000|Overall Study|Lost to Follow-up|13|||
127855425|NCT03964493|460086620|FG001|Overall Study|Lost to Follow-up|4|||
127855426|NCT02470429|460086621|FG000|Overall Study|Adverse Event|1|||
127855427|NCT02470429|460086622|FG001|Overall Study|Adverse Event|0|||
127855428|NCT02470429|460086621|FG000|Overall Study|Withdrawal by Subject|1|||
127855429|NCT02470429|460086622|FG001|Overall Study|Withdrawal by Subject|0|||
127855430|NCT01300767|460086623|FG000|Overall Study|Discomfort|2|||
127855431|NCT01300767|460086623|FG000|Overall Study|Biomicroscopy|1|||
127855432|NCT01300767|460086623|FG000|Overall Study|Unacceptable fit|1|||
127855433|NCT00398138|460086624|FG000|Overall Study|Adverse Event|2|||
127855434|NCT00117572|460086628|FG000|Overall Study|Site withdrew before starting treatment|2|||
127855435|NCT00117572|460086629|FG001|Overall Study|Site withdrew before starting treatment|3|||
127855436|NCT00117572|460086628|FG000|Overall Study|Withdrawal by Subject|3|||
127855437|NCT00117572|460086629|FG001|Overall Study|Withdrawal by Subject|3|||
127855438|NCT00117572|460086628|FG000|Overall Study|Protocol Violation|1|||
127855439|NCT00117572|460086629|FG001|Overall Study|Protocol Violation|0|||
127855440|NCT04973085|460086634|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
127855441|NCT04973085|460086635|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
127855442|NCT02224274|460086636|FG000|Overall Study|Death|1|||
127855443|NCT02224274|460086637|FG001|Overall Study|Death|0|||
127855444|NCT01976624|460086638|FG000|Overall Study|Participants contraindicated|2|||
127855445|NCT01976624|460086638|FG000|Overall Study|Participants age less than 19 years|12|||
127855446|NCT00412113|460086639|FG000|Overall Study|Adverse Event|11|||
127855447|NCT00412113|460086640|FG001|Overall Study|Adverse Event|15|||
127855448|NCT00412113|460086639|FG000|Overall Study|did not receive treatment|1|||
127855449|NCT00412113|460086640|FG001|Overall Study|did not receive treatment|0|||
127855450|NCT01190020|460086641|FG000|Overall Study|Adverse Event|2|||
127855451|NCT01190020|460086642|FG001|Overall Study|Adverse Event|0|||
127855452|NCT01190020|460086641|FG000|Overall Study|Lost to Follow-up|2|||
127855453|NCT01190020|460086642|FG001|Overall Study|Lost to Follow-up|0|||
127855454|NCT01190020|460086641|FG000|Overall Study|Withdrawal by Subject|3|||
127855455|NCT01190020|460086642|FG001|Overall Study|Withdrawal by Subject|0|||
127855456|NCT03573804|460086644|FG000|Overall Study|claustrophobia or MRI table problems|10|||
127855457|NCT04507360|460087988|FG000|Week 1|Lost to Follow-up|0|||
127855458|NCT04507360|460087989|FG001|Week 1|Lost to Follow-up|0|||
127855459|NCT04507360|460087990|FG002|Week 1|Lost to Follow-up|0|||
127855460|NCT04507360|460087991|FG003|Week 1|Lost to Follow-up|0|||
127855461|NCT04507360|460087992|FG004|Week 1|Lost to Follow-up|0|||
127855462|NCT04507360|460087993|FG005|Week 1|Lost to Follow-up|0|||
127855463|NCT04507360|460087994|FG006|Week 1|Lost to Follow-up|0|||
127855464|NCT04507360|460087995|FG007|Week 1|Lost to Follow-up|0|||
127855465|NCT04507360|460087996|FG008|Week 1|Lost to Follow-up|72|||
127855466|NCT04507360|460087997|FG009|Week 1|Lost to Follow-up|22|||
127855467|NCT04507360|460087998|FG010|Week 1|Lost to Follow-up|10|||
127855468|NCT04507360|460087988|FG000|Week 2|Lost to Follow-up|0|||
127855469|NCT04507360|460087989|FG001|Week 2|Lost to Follow-up|0|||
127855470|NCT04507360|460087990|FG002|Week 2|Lost to Follow-up|0|||
127855471|NCT04507360|460087991|FG003|Week 2|Lost to Follow-up|0|||
127855472|NCT04507360|460087992|FG004|Week 2|Lost to Follow-up|0|||
127855473|NCT04507360|460087993|FG005|Week 2|Lost to Follow-up|0|||
127855474|NCT04507360|460087994|FG006|Week 2|Lost to Follow-up|0|||
127855475|NCT04507360|460087995|FG007|Week 2|Lost to Follow-up|0|||
127855476|NCT04507360|460087996|FG008|Week 2|Lost to Follow-up|121|||
127855477|NCT04507360|460087997|FG009|Week 2|Lost to Follow-up|85|||
127855478|NCT04507360|460087998|FG010|Week 2|Lost to Follow-up|82|||
127855479|NCT04507360|460087988|FG000|Week 3|Lost to Follow-up|0|||
127855480|NCT04507360|460087989|FG001|Week 3|Lost to Follow-up|0|||
127855481|NCT04507360|460087990|FG002|Week 3|Lost to Follow-up|0|||
127855482|NCT04507360|460087991|FG003|Week 3|Lost to Follow-up|0|||
127855483|NCT04507360|460087992|FG004|Week 3|Lost to Follow-up|0|||
127855484|NCT04507360|460087993|FG005|Week 3|Lost to Follow-up|0|||
127855485|NCT04507360|460087994|FG006|Week 3|Lost to Follow-up|0|||
127855486|NCT04507360|460087995|FG007|Week 3|Lost to Follow-up|0|||
127855487|NCT04507360|460087996|FG008|Week 3|Lost to Follow-up|123|||
127855488|NCT04507360|460087997|FG009|Week 3|Lost to Follow-up|92|||
127855489|NCT04507360|460087998|FG010|Week 3|Lost to Follow-up|84|||
127855490|NCT04507360|460087988|FG000|Week 4|Lost to Follow-up|0|||
127855491|NCT04507360|460087989|FG001|Week 4|Lost to Follow-up|0|||
127855492|NCT04507360|460087990|FG002|Week 4|Lost to Follow-up|0|||
127855493|NCT04507360|460087991|FG003|Week 4|Lost to Follow-up|0|||
127855494|NCT04507360|460087992|FG004|Week 4|Lost to Follow-up|0|||
127855495|NCT04507360|460087993|FG005|Week 4|Lost to Follow-up|0|||
127855496|NCT04507360|460087994|FG006|Week 4|Lost to Follow-up|0|||
127855497|NCT04507360|460087995|FG007|Week 4|Lost to Follow-up|0|||
127855498|NCT04507360|460087996|FG008|Week 4|Lost to Follow-up|131|||
127855499|NCT04507360|460087997|FG009|Week 4|Lost to Follow-up|115|||
127855500|NCT04507360|460087998|FG010|Week 4|Lost to Follow-up|102|||
127855501|NCT04507360|460087988|FG000|Week 5|Lost to Follow-up|0|||
127855502|NCT04507360|460087989|FG001|Week 5|Lost to Follow-up|0|||
127855503|NCT04507360|460087990|FG002|Week 5|Lost to Follow-up|0|||
127855504|NCT04507360|460087991|FG003|Week 5|Lost to Follow-up|0|||
127855505|NCT04507360|460087992|FG004|Week 5|Lost to Follow-up|0|||
127855506|NCT04507360|460087993|FG005|Week 5|Lost to Follow-up|0|||
127855507|NCT04507360|460087994|FG006|Week 5|Lost to Follow-up|0|||
127855508|NCT04507360|460087995|FG007|Week 5|Lost to Follow-up|0|||
127855509|NCT04507360|460087996|FG008|Week 5|Lost to Follow-up|103|||
127855510|NCT04507360|460087997|FG009|Week 5|Lost to Follow-up|135|||
127855511|NCT04507360|460087998|FG010|Week 5|Lost to Follow-up|143|||
127855512|NCT04507360|460087988|FG000|Week 8|Lost to Follow-up|0|||
127855513|NCT04507360|460087989|FG001|Week 8|Lost to Follow-up|0|||
127855514|NCT04507360|460087990|FG002|Week 8|Lost to Follow-up|0|||
127855515|NCT04507360|460087991|FG003|Week 8|Lost to Follow-up|0|||
127855516|NCT04507360|460087992|FG004|Week 8|Lost to Follow-up|0|||
127855517|NCT04507360|460087993|FG005|Week 8|Lost to Follow-up|0|||
127855518|NCT04507360|460087994|FG006|Week 8|Lost to Follow-up|0|||
127855519|NCT04507360|460087995|FG007|Week 8|Lost to Follow-up|0|||
127855520|NCT04507360|460087996|FG008|Week 8|Lost to Follow-up|139|||
127855521|NCT04507360|460087997|FG009|Week 8|Lost to Follow-up|145|||
127855522|NCT04507360|460087998|FG010|Week 8|Lost to Follow-up|152|||
127855523|NCT01004159|460087999|FG000|Overall Study|Adverse Event|2|||
127855524|NCT01004159|460087999|FG000|Overall Study|Disease Progression|18|||
127855525|NCT03050307|460088003|FG000|Overall Study|Adverse Event|4|||
127855526|NCT03050307|460088004|FG001|Overall Study|Adverse Event|2|||
127855527|NCT03050307|460088003|FG000|Overall Study|Significant Protocol Deviation|0|||
127855528|NCT03050307|460088004|FG001|Overall Study|Significant Protocol Deviation|1|||
127855529|NCT03050307|460088003|FG000|Overall Study|Lost to Follow-up|0|||
127855530|NCT03050307|460088004|FG001|Overall Study|Lost to Follow-up|1|||
127855531|NCT03050307|460088003|FG000|Overall Study|Voluntary Withdrawal|3|||
127855532|NCT03050307|460088004|FG001|Overall Study|Voluntary Withdrawal|4|||
127855533|NCT03050307|460088003|FG000|Overall Study|Reason not Specified|1|||
127855534|NCT03050307|460088004|FG001|Overall Study|Reason not Specified|1|||
127855535|NCT02973997|460088005|FG000|Overall Study|Withdrawal by Subject|4|||
127855536|NCT02973997|460088006|FG001|Overall Study|Withdrawal by Subject|0|||
127855537|NCT02973997|460088005|FG000|Overall Study|Adverse Event|4|||
127855538|NCT02973997|460088006|FG001|Overall Study|Adverse Event|1|||
127855539|NCT02973997|460088005|FG000|Overall Study|Disease Progression|11|||
127855540|NCT02973997|460088006|FG001|Overall Study|Disease Progression|20|||
127908206|NCT01796171|460287552|FG012|Follow-up Period|Progressive disease|0|||
127855541|NCT02973997|460088005|FG000|Overall Study|Alternative Therapy|3|||
127855542|NCT02973997|460088006|FG001|Overall Study|Alternative Therapy|0|||
127855543|NCT02973997|460088005|FG000|Overall Study|Other complicating disease|0|||
127855544|NCT02973997|460088006|FG001|Overall Study|Other complicating disease|1|||
127855545|NCT02973997|460088005|FG000|Overall Study|Death|0|||
127855546|NCT02973997|460088006|FG001|Overall Study|Death|1|||
127855547|NCT00444951|460088007|FG000|Overall Study|Lost to Follow-up|1|||
127855548|NCT00444951|460088008|FG001|Overall Study|Lost to Follow-up|1|||
127855549|NCT00444951|460088009|FG002|Overall Study|Lost to Follow-up|0|||
127855550|NCT00444951|460088007|FG000|Overall Study|Withdrawal by Subject|4|||
127855551|NCT00444951|460088008|FG001|Overall Study|Withdrawal by Subject|5|||
127855552|NCT00444951|460088009|FG002|Overall Study|Withdrawal by Subject|3|||
127855553|NCT01998906|460088010|FG000|Overall Study|Participants ongoing in follow-up|77|||
127855554|NCT01998906|460088011|FG001|Overall Study|Participants ongoing in follow-up|60|||
127855555|NCT01998906|460088012|FG002|Overall Study|Participants ongoing in follow-up|58|||
127855556|NCT01998906|460088010|FG000|Overall Study|Death|21|||
127855557|NCT01998906|460088011|FG001|Overall Study|Death|30|||
127855558|NCT01998906|460088012|FG002|Overall Study|Death|17|||
127855559|NCT01998906|460088010|FG000|Overall Study|Lack of Efficacy|10|||
127855560|NCT01998906|460088011|FG001|Overall Study|Lack of Efficacy|9|||
127855561|NCT01998906|460088012|FG002|Overall Study|Lack of Efficacy|8|||
127855562|NCT01998906|460088010|FG000|Overall Study|Failure to return|0|||
127855563|NCT01998906|460088011|FG001|Overall Study|Failure to return|2|||
127855564|NCT01998906|460088012|FG002|Overall Study|Failure to return|4|||
127855565|NCT01998906|460088010|FG000|Overall Study|Violation of Selection Criteria|0|||
127855566|NCT01998906|460088011|FG001|Overall Study|Violation of Selection Criteria|0|||
127855567|NCT01998906|460088012|FG002|Overall Study|Violation of Selection Criteria|1|||
127855568|NCT01998906|460088010|FG000|Overall Study|Withdrawal by Subject|1|||
127855569|NCT01998906|460088011|FG001|Overall Study|Withdrawal by Subject|4|||
127855570|NCT01998906|460088012|FG002|Overall Study|Withdrawal by Subject|3|||
127855571|NCT01998906|460088010|FG000|Overall Study|Administrative/Other|2|||
127855572|NCT01998906|460088011|FG001|Overall Study|Administrative/Other|1|||
127855573|NCT01998906|460088012|FG002|Overall Study|Administrative/Other|3|||
127855574|NCT01998906|460088010|FG000|Overall Study|Other|3|||
127855575|NCT01998906|460088011|FG001|Overall Study|Other|8|||
127855576|NCT01998906|460088012|FG002|Overall Study|Other|4|||
127855577|NCT02996110|460088019|FG000|Pre-Treatment|Other Reasons|0|||
127855578|NCT02996110|460088020|FG001|Pre-Treatment|Other Reasons|1|||
127855579|NCT02996110|460088021|FG002|Pre-Treatment|Other Reasons|0|||
127855580|NCT02996110|460088022|FG003|Pre-Treatment|Other Reasons|0|||
127855581|NCT02996110|460088023|FG004|Pre-Treatment|Other Reasons|1|||
127855582|NCT02996110|460088019|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
127855583|NCT02996110|460088020|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
127855584|NCT02996110|460088021|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
127855585|NCT02996110|460088022|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
127855586|NCT02996110|460088023|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
127855587|NCT02996110|460088019|FG000|Track 1|Disease Progression|15|||
127855588|NCT02996110|460088020|FG001|Track 1|Disease Progression|17|||
127855589|NCT02996110|460088021|FG002|Track 1|Disease Progression|0|||
127855590|NCT02996110|460088022|FG003|Track 1|Disease Progression|0|||
127855591|NCT02996110|460088023|FG004|Track 1|Disease Progression|0|||
127855592|NCT02996110|460088019|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
127855593|NCT02996110|460088020|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
127855594|NCT02996110|460088021|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
127855595|NCT02996110|460088022|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
127855596|NCT02996110|460088023|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
127855597|NCT02996110|460088019|FG000|Track 1|Study Drug Toxicity|5|||
127855598|NCT02996110|460088020|FG001|Track 1|Study Drug Toxicity|3|||
127855599|NCT02996110|460088021|FG002|Track 1|Study Drug Toxicity|0|||
127855600|NCT02996110|460088022|FG003|Track 1|Study Drug Toxicity|0|||
127855601|NCT02996110|460088023|FG004|Track 1|Study Drug Toxicity|0|||
127855602|NCT02996110|460088019|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
127855603|NCT02996110|460088020|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
127855604|NCT02996110|460088021|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
127855605|NCT02996110|460088022|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
127855606|NCT02996110|460088023|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
127855607|NCT02996110|460088019|FG000|Track 1|Administrative Reason by Sponsor|0|||
127855608|NCT02996110|460088020|FG001|Track 1|Administrative Reason by Sponsor|1|||
127855609|NCT02996110|460088021|FG002|Track 1|Administrative Reason by Sponsor|0|||
127855610|NCT02996110|460088022|FG003|Track 1|Administrative Reason by Sponsor|0|||
127855611|NCT02996110|460088023|FG004|Track 1|Administrative Reason by Sponsor|0|||
127855612|NCT02996110|460088019|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
127855613|NCT02996110|460088020|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
127855614|NCT02996110|460088021|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
127855615|NCT02996110|460088022|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
127855616|NCT02996110|460088023|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
127855617|NCT02996110|460088019|FG000|Track 2|Disease Progression|33|||
127855618|NCT02996110|460088020|FG001|Track 2|Disease Progression|26|||
127855619|NCT02996110|460088021|FG002|Track 2|Disease Progression|19|||
127855620|NCT02996110|460088022|FG003|Track 2|Disease Progression|16|||
127855621|NCT02996110|460088023|FG004|Track 2|Disease Progression|15|||
127855622|NCT02996110|460088019|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
127855623|NCT02996110|460088020|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
127855624|NCT02996110|460088021|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
127855625|NCT02996110|460088022|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
127855626|NCT02996110|460088023|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
127855627|NCT02996110|460088019|FG000|Track 2|Death|0|||
127855628|NCT02996110|460088020|FG001|Track 2|Death|0|||
127855629|NCT02996110|460088021|FG002|Track 2|Death|1|||
127855630|NCT02996110|460088022|FG003|Track 2|Death|0|||
127855631|NCT02996110|460088023|FG004|Track 2|Death|1|||
127855632|NCT02996110|460088019|FG000|Track 2|Study Drug Toxicity|4|||
127855633|NCT02996110|460088020|FG001|Track 2|Study Drug Toxicity|1|||
127855634|NCT02996110|460088021|FG002|Track 2|Study Drug Toxicity|4|||
127855635|NCT02996110|460088022|FG003|Track 2|Study Drug Toxicity|1|||
127855636|NCT02996110|460088023|FG004|Track 2|Study Drug Toxicity|0|||
127855637|NCT02996110|460088019|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
127855638|NCT02996110|460088020|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
127855639|NCT02996110|460088021|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
127855640|NCT02996110|460088022|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
127855641|NCT02996110|460088023|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
127855642|NCT02996110|460088019|FG000|Track 2|Participant Withdrew Consent|1|||
127855643|NCT02996110|460088020|FG001|Track 2|Participant Withdrew Consent|2|||
127855644|NCT02996110|460088021|FG002|Track 2|Participant Withdrew Consent|3|||
127855645|NCT02996110|460088022|FG003|Track 2|Participant Withdrew Consent|1|||
127855646|NCT02996110|460088023|FG004|Track 2|Participant Withdrew Consent|1|||
127855647|NCT02996110|460088019|FG000|Track 2|Other Reasons|0|||
127855648|NCT02996110|460088020|FG001|Track 2|Other Reasons|0|||
127855649|NCT02996110|460088021|FG002|Track 2|Other Reasons|1|||
127855650|NCT02996110|460088022|FG003|Track 2|Other Reasons|0|||
127855651|NCT02996110|460088023|FG004|Track 2|Other Reasons|1|||
127855652|NCT01938391|460088024|FG000|6 Month Follow up|Withdrawal by Subject|1|||
127855653|NCT01938391|460088024|FG000|12 Month Follow up|Physician Decision|1|||
127855654|NCT01938391|460088024|FG000|12 Month Follow up|Withdrawal by Subject|1|||
127855655|NCT01077193|460088025|FG000|Overall Study|Lost to Follow-up|1|||
127855656|NCT01077193|460088025|FG000|Overall Study|Withdrawal by Subject|2|||
127855657|NCT01077193|460088025|FG000|Overall Study|Lack of Efficacy|1|||
127855658|NCT01077193|460088025|FG000|Overall Study|Study Terminated by Sponsor|40|||
127855659|NCT06048809|460088026|FG000|Overall Study|Adverse Event|2|||
127855660|NCT06048809|460088027|FG001|Overall Study|Adverse Event|0|||
127855661|NCT06048809|460088026|FG000|Overall Study|Withdrawal by Subject|1|||
127855662|NCT06048809|460088027|FG001|Overall Study|Withdrawal by Subject|1|||
127855663|NCT01536418|460088038|FG000|Overall Study|Protocol Violation|2|||
127855664|NCT01536418|460088039|FG001|Overall Study|Protocol Violation|3|||
127855665|NCT01536418|460088038|FG000|Overall Study|Physician Decision|1|||
127855666|NCT01536418|460088039|FG001|Overall Study|Physician Decision|3|||
127855667|NCT01536418|460088038|FG000|Overall Study|Study closed/terminated|41|||
127855668|NCT01536418|460088039|FG001|Overall Study|Study closed/terminated|37|||
127855669|NCT01536418|460088038|FG000|Overall Study|Lack of Efficacy|10|||
127855670|NCT01536418|460088039|FG001|Overall Study|Lack of Efficacy|16|||
127855671|NCT01536418|460088038|FG000|Overall Study|Adverse Event|9|||
127855672|NCT01536418|460088039|FG001|Overall Study|Adverse Event|4|||
127855673|NCT01536418|460088038|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
127855674|NCT01536418|460088039|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
127855675|NCT01536418|460088038|FG000|Overall Study|Withdrawal by Subject|5|||
127855676|NCT01536418|460088039|FG001|Overall Study|Withdrawal by Subject|3|||
127855677|NCT03687827|460088042|FG000|Treatment Period 1|Death|0|||
127855678|NCT03687827|460088043|FG001|Treatment Period 1|Death|1|||
127855679|NCT03687827|460088042|FG000|Treatment Period 1|Lost to Follow-up|2|||
127855680|NCT03687827|460088043|FG001|Treatment Period 1|Lost to Follow-up|2|||
127855681|NCT03687827|460088042|FG000|Treatment Period 1|Physician Decision|5|||
127855682|NCT03687827|460088043|FG001|Treatment Period 1|Physician Decision|2|||
127855683|NCT03687827|460088042|FG000|Treatment Period 1|Withdrawal by Subject|7|||
127855684|NCT03687827|460088043|FG001|Treatment Period 1|Withdrawal by Subject|3|||
127855685|NCT03687827|460088042|FG000|Treatment Period 2|Physician Decision|4|||
127855686|NCT03687827|460088043|FG001|Treatment Period 2|Physician Decision|1|||
127855687|NCT03687827|460088042|FG000|Treatment Period 2|Withdrawal by Subject|1|||
127855688|NCT03687827|460088043|FG001|Treatment Period 2|Withdrawal by Subject|2|||
127855689|NCT03748420|460088045|FG000|Overall Study|No 12 month medication adherence data available|0|||
127855690|NCT03748420|460088046|FG001|Overall Study|No 12 month medication adherence data available|1|||
127855691|NCT03748420|460088045|FG000|Overall Study|Death|24|||
127855692|NCT03748420|460088046|FG001|Overall Study|Death|28|||
127855693|NCT03748420|460088045|FG000|Overall Study|Lost to Follow-up|231|||
127855694|NCT03748420|460088046|FG001|Overall Study|Lost to Follow-up|230|||
127855695|NCT00373880|460088047|FG000|Overall Study|Physician Decision|3|||
127855696|NCT00373880|460088047|FG000|Overall Study|Arrested|1|||
127855697|NCT00373880|460088047|FG000|Overall Study|Protocol Violation|14|||
127855698|NCT01925014|460088048|FG000|Overall Study|Inappropriate enrollment|4|||
127855699|NCT01925014|460088049|FG001|Overall Study|Inappropriate enrollment|6|||
127855700|NCT01925014|460088048|FG000|Overall Study|Withdrawal by Subject|5|||
127855701|NCT01925014|460088049|FG001|Overall Study|Withdrawal by Subject|13|||
127855702|NCT04259346|460088052|FG000|Overall Study|Lost to Follow-up|1|||
127855703|NCT04259346|460088053|FG001|Overall Study|Lost to Follow-up|3|||
127855704|NCT04259346|460088052|FG000|Overall Study|Protocol Violation|1|||
127855705|NCT04259346|460088053|FG001|Overall Study|Protocol Violation|0|||
127855706|NCT04259346|460088052|FG000|Overall Study|Withdrawal by Subject|1|||
127855707|NCT04259346|460088053|FG001|Overall Study|Withdrawal by Subject|0|||
127855708|NCT04259346|460088052|FG000|Overall Study|Adverse Event|1|||
127855709|NCT04259346|460088053|FG001|Overall Study|Adverse Event|1|||
127855710|NCT01487863|460088054|FG000|Overall Study|Death|19|||
127855711|NCT01487863|460088055|FG001|Overall Study|Death|19|||
127855712|NCT00623766|460088059|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
127855713|NCT00623766|460088060|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
127855714|NCT00623766|460088059|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
127855715|NCT00623766|460088060|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
127855716|NCT00623766|460088059|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
127855717|NCT00623766|460088060|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
127855718|NCT00623766|460088059|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
127855719|NCT00623766|460088060|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
127855720|NCT00623766|460088059|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
127855721|NCT00623766|460088060|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
127855722|NCT00486889|460088061|FG000|Overall Study|Death|3|||
127855723|NCT00486889|460088061|FG000|Overall Study|Non-compliant|2|||
127855724|NCT00486889|460088061|FG000|Overall Study|Withdrawal by Subject|6|||
127855725|NCT00893763|460088062|FG000|Overall Study|extubated|110|||
127855726|NCT00893763|460088063|FG001|Overall Study|extubated|110|||
127855727|NCT00422903|460088075|FG000|Overall Study|Disease Progression|3|||
127855728|NCT00422903|460088076|FG001|Overall Study|Disease Progression|1|||
127855729|NCT00422903|460088075|FG000|Overall Study|Adverse Event|0|||
127855730|NCT00422903|460088076|FG001|Overall Study|Adverse Event|2|||
127855731|NCT00422903|460088075|FG000|Overall Study|Informed Consent Withdrawn|1|||
127855732|NCT00422903|460088076|FG001|Overall Study|Informed Consent Withdrawn|2|||
127855733|NCT00441480|460088080|FG000|Overall Study|Protocol Violation|1|||
127855734|NCT00441480|460088081|FG001|Overall Study|Protocol Violation|1|||
127855735|NCT00441480|460088080|FG000|Overall Study|Withdrawal by Subject|2|||
127855736|NCT00441480|460088081|FG001|Overall Study|Withdrawal by Subject|3|||
127855737|NCT02699125|460088082|FG000|Placebo|Lost to Follow-up|2|||
127855738|NCT02699125|460088083|FG001|Placebo|Lost to Follow-up|0|||
127855739|NCT02699125|460088082|FG000|Placebo|Protocol Violation|1|||
127855740|NCT02699125|460088083|FG001|Placebo|Protocol Violation|0|||
127855741|NCT02699125|460088082|FG000|Placebo|Withdrawal by Subject|0|||
127855742|NCT02699125|460088083|FG001|Placebo|Withdrawal by Subject|4|||
127855743|NCT02699125|460088082|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
127855744|NCT02699125|460088083|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
127855745|NCT02092324|460088088|FG000|Overall Study|Adverse Event|1|||
127855746|NCT02092324|460088088|FG000|Overall Study|Lack of Efficacy|6|||
127855747|NCT02092324|460088088|FG000|Overall Study|Proceed to Transplant|3|||
127855748|NCT02092324|460088088|FG000|Overall Study|Physician Decision|7|||
127855749|NCT02092324|460088088|FG000|Overall Study|Misdiagnosis|2|||
127855750|NCT01039428|460088089|FG000|Overall Study|Protocol Violation|1|||
127855751|NCT01039428|460088090|FG001|Overall Study|Protocol Violation|0|||
127855752|NCT01039428|460088089|FG000|Overall Study|Withdrawal by Subject|1|||
127855753|NCT01039428|460088090|FG001|Overall Study|Withdrawal by Subject|0|||
127855754|NCT00422240|460088097|FG000|Overall Study|Lack of Efficacy|1|||
127855755|NCT00422240|460088098|FG001|Overall Study|Lack of Efficacy|2|||
127855756|NCT00422240|460088099|FG002|Overall Study|Lack of Efficacy|0|||
127855757|NCT00422240|460088100|FG003|Overall Study|Lack of Efficacy|1|||
127855758|NCT00422240|460088097|FG000|Overall Study|Adverse Event|11|||
127855759|NCT00422240|460088098|FG001|Overall Study|Adverse Event|4|||
127855760|NCT00422240|460088099|FG002|Overall Study|Adverse Event|5|||
127855761|NCT00422240|460088100|FG003|Overall Study|Adverse Event|2|||
127855762|NCT00422240|460088097|FG000|Overall Study|Subject request|21|||
127855763|NCT00422240|460088098|FG001|Overall Study|Subject request|17|||
127855764|NCT00422240|460088099|FG002|Overall Study|Subject request|18|||
127855765|NCT00422240|460088100|FG003|Overall Study|Subject request|30|||
127855766|NCT00422240|460088097|FG000|Overall Study|Protocol Violation|0|||
127855767|NCT00422240|460088098|FG001|Overall Study|Protocol Violation|1|||
127855768|NCT00422240|460088099|FG002|Overall Study|Protocol Violation|0|||
127855769|NCT00422240|460088100|FG003|Overall Study|Protocol Violation|1|||
127855770|NCT00422240|460088097|FG000|Overall Study|Lost to Follow-up|31|||
127855771|NCT00422240|460088098|FG001|Overall Study|Lost to Follow-up|32|||
127855772|NCT00422240|460088099|FG002|Overall Study|Lost to Follow-up|19|||
127855773|NCT00422240|460088100|FG003|Overall Study|Lost to Follow-up|34|||
127855774|NCT00422240|460088097|FG000|Overall Study|Other|1|||
127855775|NCT00422240|460088098|FG001|Overall Study|Other|0|||
127855776|NCT00422240|460088099|FG002|Overall Study|Other|0|||
127855777|NCT00422240|460088100|FG003|Overall Study|Other|1|||
127855778|NCT00422240|460088097|FG000|Overall Study|Pregnancy|3|||
127855779|NCT00422240|460088098|FG001|Overall Study|Pregnancy|1|||
127855780|NCT00422240|460088099|FG002|Overall Study|Pregnancy|1|||
127855781|NCT00422240|460088100|FG003|Overall Study|Pregnancy|2|||
127855782|NCT00441012|460088101|FG000|Overall Study|Adverse Event|0|||
127855783|NCT00441012|460088102|FG001|Overall Study|Adverse Event|1|||
127855784|NCT00441012|460088101|FG000|Overall Study|Lost to Follow-up|3|||
127855785|NCT00441012|460088102|FG001|Overall Study|Lost to Follow-up|3|||
127855786|NCT00441012|460088101|FG000|Overall Study|Protocol Violation|10|||
127855787|NCT00441012|460088102|FG001|Overall Study|Protocol Violation|9|||
127855788|NCT00441012|460088101|FG000|Overall Study|Withdrawal by Subject|4|||
127855789|NCT00441012|460088102|FG001|Overall Study|Withdrawal by Subject|0|||
127855790|NCT00441012|460088101|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
127855791|NCT00441012|460088102|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
127855792|NCT00887068|460088103|FG000|Overall Study|Withdrawal by Subject|2|||
127855793|NCT00887068|460088104|FG001|Overall Study|Withdrawal by Subject|0|||
127855794|NCT00887068|460088103|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
127855795|NCT00887068|460088104|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
127855796|NCT01188811|460088112|FG000|Overall Study|Withdrawal by Subject|0|||
127855797|NCT01188811|460088113|FG001|Overall Study|Withdrawal by Subject|2|||
127855798|NCT01188811|460088112|FG000|Overall Study|Adverse Event|6|||
127855799|NCT01188811|460088113|FG001|Overall Study|Adverse Event|0|||
127855800|NCT01602744|460088114|FG000|Overall Study|Death|17|||
127855801|NCT01602744|460088115|FG001|Overall Study|Death|15|||
127855802|NCT01602744|460088114|FG000|Overall Study|Lost to Follow-up|13|||
127855803|NCT01602744|460088115|FG001|Overall Study|Lost to Follow-up|8|||
127855804|NCT03418376|460088116|FG000|Overall Study|Musculoskeletal injury|1|||
127855805|NCT03418376|460088117|FG001|Overall Study|Musculoskeletal injury|2|||
127855806|NCT03418376|460088118|FG002|Overall Study|Musculoskeletal injury|1|||
127855807|NCT03418376|460088119|FG003|Overall Study|Musculoskeletal injury|0|||
127855808|NCT03418376|460088116|FG000|Overall Study|Personal reasons|0|||
127855809|NCT03418376|460088117|FG001|Overall Study|Personal reasons|2|||
127855810|NCT03418376|460088118|FG002|Overall Study|Personal reasons|2|||
127855811|NCT03418376|460088119|FG003|Overall Study|Personal reasons|1|||
127855812|NCT03418376|460088116|FG000|Overall Study|Exacerbation|0|||
127855813|NCT03418376|460088117|FG001|Overall Study|Exacerbation|1|||
127855814|NCT03418376|460088118|FG002|Overall Study|Exacerbation|0|||
127855815|NCT03418376|460088119|FG003|Overall Study|Exacerbation|0|||
127855816|NCT01387594|460088124|FG000|Overall Study|Withdrawal by Subject|0|||
127855817|NCT01387594|460088125|FG001|Overall Study|Withdrawal by Subject|2|||
127855818|NCT01387594|460088124|FG000|Overall Study|Lost to Follow-up|0|||
127855819|NCT01387594|460088125|FG001|Overall Study|Lost to Follow-up|1|||
127855820|NCT04350372|460088126|FG000|Overall Study|Death|1|||
127855821|NCT00796224|460088140|FG000|Overall Study|Adverse Event|1|||
127855822|NCT00796224|460088141|FG001|Overall Study|Adverse Event|0|||
127855823|NCT00796224|460088140|FG000|Overall Study|Protocol Violation|0|||
127855824|NCT00796224|460088141|FG001|Overall Study|Protocol Violation|1|||
127855825|NCT03039569|460088142|FG000|Overall Study|Lost to Follow-up|5|||
127855826|NCT03039569|460088143|FG001|Overall Study|Lost to Follow-up|4|||
127855827|NCT02254304|460088144|FG000|Overall Study|Adverse Event|2|||
127855828|NCT02254304|460088145|FG001|Overall Study|Adverse Event|1|||
127855829|NCT02254304|460088144|FG000|Overall Study|Lost to Follow-up|2|||
127855830|NCT02254304|460088145|FG001|Overall Study|Lost to Follow-up|2|||
127855831|NCT02254304|460088144|FG000|Overall Study|Protocol Violation|1|||
127855832|NCT02254304|460088145|FG001|Overall Study|Protocol Violation|0|||
127855833|NCT02254304|460088144|FG000|Overall Study|Withdrawal by Subject|3|||
127855834|NCT02254304|460088145|FG001|Overall Study|Withdrawal by Subject|0|||
127855835|NCT02254304|460088144|FG000|Overall Study|Injection site pain and Injection fear|1|||
127855836|NCT02254304|460088145|FG001|Overall Study|Injection site pain and Injection fear|0|||
127855837|NCT02254304|460088144|FG000|Overall Study|Personal causes|4|||
127855838|NCT02254304|460088145|FG001|Overall Study|Personal causes|1|||
127855839|NCT02254304|460088144|FG000|Overall Study|Personal decision|1|||
127855840|NCT02254304|460088145|FG001|Overall Study|Personal decision|0|||
127855841|NCT01226472|460088146|FG000|Overall Study|Progressive Disease|1|||
127855842|NCT00952419|460088147|FG000|Overall Study|Adverse Event|2|||
127855843|NCT00952419|460088148|FG001|Overall Study|Adverse Event|0|||
127855844|NCT00952419|460088149|FG002|Overall Study|Adverse Event|0|||
127855845|NCT00952419|460088147|FG000|Overall Study|Protocol Violation|3|||
127855846|NCT00952419|460088148|FG001|Overall Study|Protocol Violation|7|||
127855847|NCT00952419|460088149|FG002|Overall Study|Protocol Violation|0|||
127855848|NCT00952419|460088147|FG000|Overall Study|Withdrawal by Subject|1|||
127855849|NCT00952419|460088148|FG001|Overall Study|Withdrawal by Subject|3|||
127855850|NCT00952419|460088149|FG002|Overall Study|Withdrawal by Subject|0|||
127855851|NCT01673373|460090522|FG000|Overall Study|Death|2|||
127855852|NCT05171816|460090523|FG000|Overall Study|Death|18|||
127855853|NCT05171816|460090524|FG001|Overall Study|Death|16|||
127855854|NCT04667949|460090525|FG000|Overall Study|Adverse Event|0|||
127855855|NCT04667949|460090526|FG001|Overall Study|Adverse Event|2|||
127855856|NCT04667949|460090525|FG000|Overall Study|Lost to Follow-up|0|||
127855857|NCT04667949|460090526|FG001|Overall Study|Lost to Follow-up|1|||
127855858|NCT04667949|460090525|FG000|Overall Study|Physician Decision|0|||
127855859|NCT04667949|460090526|FG001|Overall Study|Physician Decision|2|||
127855860|NCT04667949|460090525|FG000|Overall Study|Subject decision|1|||
127855861|NCT04667949|460090526|FG001|Overall Study|Subject decision|7|||
127855862|NCT02000622|460090529|FG000|Overall Study|Withdrawal by Subject|5|||
127855863|NCT02000622|460090530|FG001|Overall Study|Withdrawal by Subject|7|||
127855864|NCT02000622|460090529|FG000|Overall Study|Lost to Follow-up|4|||
127855865|NCT02000622|460090530|FG001|Overall Study|Lost to Follow-up|0|||
127855866|NCT02000622|460090529|FG000|Overall Study|Death|159|||
127855867|NCT02000622|460090530|FG001|Overall Study|Death|73|||
127855868|NCT02000622|460090529|FG000|Overall Study|Withdrawn due to site closure|1|||
127855869|NCT02000622|460090530|FG001|Overall Study|Withdrawn due to site closure|0|||
127855870|NCT01405027|460090534|FG000|Overall Study|Withdrawn consent|3|||
127855871|NCT01405027|460090535|FG001|Overall Study|Withdrawn consent|0|||
127855872|NCT01405027|460090534|FG000|Overall Study|Lost to Follow-up|16|||
127855873|NCT01405027|460090535|FG001|Overall Study|Lost to Follow-up|24|||
127855874|NCT01405027|460090534|FG000|Overall Study|Investigator judgement|0|||
127855875|NCT01405027|460090535|FG001|Overall Study|Investigator judgement|2|||
127855876|NCT01405027|460090534|FG000|Overall Study|Death|1|||
127855877|NCT01405027|460090535|FG001|Overall Study|Death|0|||
127855878|NCT01405027|460090534|FG000|Overall Study|Other or Unknown|12|||
127855879|NCT01405027|460090535|FG001|Overall Study|Other or Unknown|25|||
127855880|NCT01680991|460090537|FG000|Overall Study|Adverse Event|1|||
127855881|NCT01680991|460090538|FG001|Overall Study|Adverse Event|0|||
127855882|NCT01680991|460090539|FG002|Overall Study|Adverse Event|0|||
127855883|NCT01680991|460090537|FG000|Overall Study|Death|1|||
127855884|NCT01680991|460090538|FG001|Overall Study|Death|0|||
127855885|NCT01680991|460090539|FG002|Overall Study|Death|1|||
127855886|NCT01680991|460090537|FG000|Overall Study|Protocol Violation|0|||
127855887|NCT01680991|460090538|FG001|Overall Study|Protocol Violation|1|||
127855888|NCT01680991|460090539|FG002|Overall Study|Protocol Violation|0|||
127855889|NCT01680991|460090537|FG000|Overall Study|Withdrawal by Subject|5|||
127855890|NCT01680991|460090538|FG001|Overall Study|Withdrawal by Subject|1|||
127855891|NCT01680991|460090539|FG002|Overall Study|Withdrawal by Subject|0|||
127855892|NCT01680991|460090537|FG000|Overall Study|Progressive disease (PD)|0|||
127855893|NCT01680991|460090538|FG001|Overall Study|Progressive disease (PD)|10|||
127855894|NCT01680991|460090539|FG002|Overall Study|Progressive disease (PD)|0|||
127855895|NCT01680991|460090537|FG000|Overall Study|Physician Decision|0|||
127855896|NCT01680991|460090538|FG001|Overall Study|Physician Decision|7|||
127855897|NCT01680991|460090539|FG002|Overall Study|Physician Decision|2|||
127855898|NCT01680991|460090537|FG000|Overall Study|Bad physical condition|0|||
127855899|NCT01680991|460090538|FG001|Overall Study|Bad physical condition|0|||
127855900|NCT01680991|460090539|FG002|Overall Study|Bad physical condition|1|||
127855901|NCT01680991|460090537|FG000|Overall Study|PD confirmed in other hospital|1|||
127855902|NCT01680991|460090538|FG001|Overall Study|PD confirmed in other hospital|0|||
127855903|NCT01680991|460090539|FG002|Overall Study|PD confirmed in other hospital|0|||
127855904|NCT03728881|460090540|FG000|Enrolled and Received 1st Vaccination|Adverse Event|0|||
127855905|NCT03728881|460090541|FG001|Enrolled and Received 1st Vaccination|Adverse Event|1|||
127855906|NCT03728881|460090540|FG000|Enrolled and Received 1st Vaccination|Death|1|||
127855907|NCT03728881|460090541|FG001|Enrolled and Received 1st Vaccination|Death|1|||
127855908|NCT03728881|460090540|FG000|Enrolled and Received 1st Vaccination|Withdrawal by Subject|5|||
127855909|NCT03728881|460090541|FG001|Enrolled and Received 1st Vaccination|Withdrawal by Subject|8|||
127855910|NCT03728881|460090540|FG000|Enrolled and Received 1st Vaccination|Out of Country|1|||
127855911|NCT03728881|460090541|FG001|Enrolled and Received 1st Vaccination|Out of Country|3|||
127855912|NCT03728881|460090540|FG000|Enrolled and Received 1st Vaccination|No Show|0|||
127855913|NCT03728881|460090541|FG001|Enrolled and Received 1st Vaccination|No Show|1|||
127855914|NCT03728881|460090540|FG000|Enrolled and Received 1st Vaccination|Unable to appoint|3|||
127855915|NCT03728881|460090541|FG001|Enrolled and Received 1st Vaccination|Unable to appoint|12|||
127855916|NCT03728881|460090540|FG000|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|0|||
127855917|NCT03728881|460090541|FG001|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|49|||
127855918|NCT03728881|460090540|FG000|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|25|||
127855919|NCT03728881|460090541|FG001|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|0|||
127855920|NCT03728881|460090540|FG000|Enrolled and Received 1st Vaccination|HPV6/11 positive|10|||
127855921|NCT03728881|460090541|FG001|Enrolled and Received 1st Vaccination|HPV6/11 positive|0|||
127855922|NCT03728881|460090540|FG000|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|36|||
127855923|NCT03728881|460090541|FG001|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|179|||
127855924|NCT03728881|460090540|FG000|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|52|||
127855925|NCT03728881|460090541|FG001|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|172|||
127855926|NCT06073054|460090542|FG000|Overall Study|Withdrawal by Subject|2|||
127855927|NCT00413777|460090546|FG000|Fixed-dose Period|Lost to Follow-up|1|||
127855928|NCT00413777|460090547|FG001|Fixed-dose Period|Lost to Follow-up|1|||
127855929|NCT00413777|460090546|FG000|Fixed-dose Period|Adverse Event|2|||
127855930|NCT00413777|460090547|FG001|Fixed-dose Period|Adverse Event|1|||
127855931|NCT00413777|460090546|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
127855932|NCT00413777|460090547|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
127855933|NCT00413777|460090546|FG000|Fixed-dose Period|Withdrew Consent|0|||
127855934|NCT00413777|460090547|FG001|Fixed-dose Period|Withdrew Consent|1|||
127855935|NCT05505734|460090548|FG000|Overall Study|Withdrawal by Subject|51|||
127855936|NCT05505734|460090549|FG001|Overall Study|Withdrawal by Subject|64|||
127855937|NCT05505734|460090548|FG000|Overall Study|Adverse Event|6|||
127855938|NCT05505734|460090549|FG001|Overall Study|Adverse Event|20|||
127855939|NCT05505734|460090548|FG000|Overall Study|Protocol Violation|8|||
127855940|NCT05505734|460090549|FG001|Overall Study|Protocol Violation|15|||
127855941|NCT05505734|460090548|FG000|Overall Study|Lack of therapeutic response|0|||
127855942|NCT05505734|460090549|FG001|Overall Study|Lack of therapeutic response|1|||
127855943|NCT05505734|460090548|FG000|Overall Study|Lost to Follow-up|247|||
127855944|NCT05505734|460090549|FG001|Overall Study|Lost to Follow-up|237|||
127855945|NCT05505734|460090548|FG000|Overall Study|Physician Decision|22|||
127855946|NCT05505734|460090549|FG001|Overall Study|Physician Decision|13|||
127855947|NCT05505734|460090548|FG000|Overall Study|Death|2|||
127855948|NCT05505734|460090549|FG001|Overall Study|Death|1|||
127855949|NCT05505734|460090548|FG000|Overall Study|Withdrawal by parent/guardian|0|||
127855950|NCT05505734|460090549|FG001|Overall Study|Withdrawal by parent/guardian|1|||
127855951|NCT05505734|460090548|FG000|Overall Study|Pregnancy|1|||
127855952|NCT05505734|460090549|FG001|Overall Study|Pregnancy|0|||
127855953|NCT05505734|460090548|FG000|Overall Study|Other|17|||
127855954|NCT05505734|460090549|FG001|Overall Study|Other|13|||
127855955|NCT00764322|460090550|FG000|Overall Study|Withdrawal by Subject|11|||
127855956|NCT00764322|460090550|FG000|Overall Study|No CYP2D6 genotyping|9|||
127855957|NCT01600105|460090554|FG000|Total Participants|Withdrawal by Subject|1|||
127855958|NCT01600105|460090555|FG001|Total Participants|Withdrawal by Subject|0|||
127855959|NCT01600105|460090554|FG000|Total Participants|No images in PACS|10|||
127855960|NCT01600105|460090555|FG001|Total Participants|No images in PACS|0|||
127855961|NCT01600105|460090554|FG000|Total Participants|Insufficient image quality|30|||
127855962|NCT01600105|460090555|FG001|Total Participants|Insufficient image quality|10|||
127855963|NCT01600105|460090554|FG000|Sub Study I|Insufficient image quality|0|||
127855964|NCT01600105|460090555|FG001|Sub Study I|Insufficient image quality|10|||
127855965|NCT01600105|460090554|FG000|Sub Study II|Withdrawal by Subject|1|||
127855966|NCT01600105|460090555|FG001|Sub Study II|Withdrawal by Subject|0|||
127855967|NCT01600105|460090554|FG000|Sub Study II|No images in PACS|1|||
127855968|NCT01600105|460090555|FG001|Sub Study II|No images in PACS|0|||
127855969|NCT01600105|460090554|FG000|Sub Study II|Insufficient image quality|3|||
127855970|NCT01600105|460090555|FG001|Sub Study II|Insufficient image quality|0|||
127855971|NCT01600105|460090554|FG000|Sub Study III|Insufficient image quality|5|||
127855972|NCT01600105|460090555|FG001|Sub Study III|Insufficient image quality|0|||
127855973|NCT01600105|460090554|FG000|Sub Study V|Poor Image Quality|2|||
127855974|NCT01600105|460090555|FG001|Sub Study V|Poor Image Quality|0|||
127855975|NCT04007367|460090556|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
127855976|NCT04007367|460090557|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
127855977|NCT04007367|460090558|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
127855978|NCT04007367|460090556|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
127855979|NCT04007367|460090557|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
127855980|NCT04007367|460090558|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
127855981|NCT04007367|460090556|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
127855982|NCT04007367|460090557|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
127855983|NCT04007367|460090558|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
127855984|NCT04007367|460090556|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
127855985|NCT04007367|460090557|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
127855986|NCT04007367|460090558|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
127855987|NCT04007367|460090556|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
127855988|NCT04007367|460090557|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
127855989|NCT04007367|460090558|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
127855990|NCT01764022|460090560|FG000|Overall Study|Death|3|||
127855991|NCT01764022|460090561|FG001|Overall Study|Death|5|||
127855992|NCT01764022|460090560|FG000|Overall Study|Withdrawal by Subject|2|||
127855993|NCT01764022|460090561|FG001|Overall Study|Withdrawal by Subject|6|||
127855994|NCT01764022|460090560|FG000|Overall Study|Lack of Efficacy|0|||
127908207|NCT01796171|460287553|FG013|Follow-up Period|Progressive disease|0|||
127908208|NCT01796171|460287554|FG014|Follow-up Period|Progressive disease|0|||
127908209|NCT01796171|460287540|FG000|Follow-up Period|Physician Decision|0|||
127855995|NCT01764022|460090561|FG001|Overall Study|Lack of Efficacy|1|||
127855996|NCT01764022|460090560|FG000|Overall Study|Physician Decision|0|||
127855997|NCT01764022|460090561|FG001|Overall Study|Physician Decision|2|||
127855998|NCT01764022|460090560|FG000|Overall Study|Lost to Follow-up|2|||
127855999|NCT01764022|460090561|FG001|Overall Study|Lost to Follow-up|0|||
127856000|NCT01764022|460090560|FG000|Overall Study|Protocol Violation|1|||
127856001|NCT01764022|460090561|FG001|Overall Study|Protocol Violation|0|||
127856002|NCT01899768|460090563|FG000|Part A|Adverse Event|2|||
127856003|NCT01899768|460090563|FG000|Part A|Withdrawal by Subject|1|||
127856004|NCT01899768|460090563|FG000|Part B|Adverse Event|1|||
127856005|NCT01899768|460090563|FG000|Part B|Withdrawal by Subject|1|||
127856006|NCT02203916|460090564|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
127856007|NCT02203916|460090565|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
127856008|NCT02203916|460090566|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
127856009|NCT02203916|460090564|FG000|Overall Study|Major Protocol Deviation|1|||
127856010|NCT02203916|460090565|FG001|Overall Study|Major Protocol Deviation|1|||
127856011|NCT02203916|460090566|FG002|Overall Study|Major Protocol Deviation|0|||
127856012|NCT02203916|460090564|FG000|Overall Study|Lost to Follow-up|0|||
127856013|NCT02203916|460090565|FG001|Overall Study|Lost to Follow-up|1|||
127856014|NCT02203916|460090566|FG002|Overall Study|Lost to Follow-up|0|||
127856015|NCT02203916|460090564|FG000|Overall Study|Voluntary Withdrawal|3|||
127856016|NCT02203916|460090565|FG001|Overall Study|Voluntary Withdrawal|3|||
127856017|NCT02203916|460090566|FG002|Overall Study|Voluntary Withdrawal|8|||
127856018|NCT02203916|460090564|FG000|Overall Study|Lack of Efficacy|3|||
127856019|NCT02203916|460090565|FG001|Overall Study|Lack of Efficacy|0|||
127856020|NCT02203916|460090566|FG002|Overall Study|Lack of Efficacy|0|||
127856021|NCT02203916|460090564|FG000|Overall Study|Reason Not Specified|0|||
127856022|NCT02203916|460090565|FG001|Overall Study|Reason Not Specified|2|||
127856023|NCT02203916|460090566|FG002|Overall Study|Reason Not Specified|1|||
127856024|NCT04043416|460090567|FG000|Washout|Change in health condition|0|||
127856025|NCT04043416|460090568|FG001|Washout|Change in health condition|1|||
127856026|NCT00414973|460090570|FG000|Overall Study|Withdrawal by Subject|14|||
127856027|NCT00414973|460090571|FG001|Overall Study|Withdrawal by Subject|4|||
127856028|NCT00414973|460090572|FG002|Overall Study|Withdrawal by Subject|1|||
127856029|NCT00414973|460090573|FG003|Overall Study|Withdrawal by Subject|0|||
127856030|NCT00414973|460090570|FG000|Overall Study|Adverse Event|10|||
127856031|NCT00414973|460090571|FG001|Overall Study|Adverse Event|0|||
127856032|NCT00414973|460090572|FG002|Overall Study|Adverse Event|1|||
127856033|NCT00414973|460090573|FG003|Overall Study|Adverse Event|0|||
127856034|NCT00414973|460090570|FG000|Overall Study|Protocol Violation|3|||
127856035|NCT00414973|460090571|FG001|Overall Study|Protocol Violation|4|||
127856036|NCT00414973|460090572|FG002|Overall Study|Protocol Violation|0|||
127856037|NCT00414973|460090573|FG003|Overall Study|Protocol Violation|0|||
127856038|NCT00414973|460090570|FG000|Overall Study|Lost to Follow-up|0|||
127856039|NCT00414973|460090571|FG001|Overall Study|Lost to Follow-up|2|||
127856040|NCT00414973|460090572|FG002|Overall Study|Lost to Follow-up|0|||
127856041|NCT00414973|460090573|FG003|Overall Study|Lost to Follow-up|0|||
127856042|NCT00414973|460090570|FG000|Overall Study|Sponsor Decision|1|||
127856043|NCT00414973|460090571|FG001|Overall Study|Sponsor Decision|0|||
127856044|NCT00414973|460090572|FG002|Overall Study|Sponsor Decision|0|||
127856045|NCT00414973|460090573|FG003|Overall Study|Sponsor Decision|0|||
127856046|NCT00414973|460090570|FG000|Overall Study|Death|0|||
127856047|NCT00414973|460090571|FG001|Overall Study|Death|0|||
127856048|NCT00414973|460090572|FG002|Overall Study|Death|1|||
127856049|NCT00414973|460090573|FG003|Overall Study|Death|0|||
127856050|NCT03236506|460090574|FG000|Overall Study|Death|1|||
127856051|NCT03236506|460090575|FG001|Overall Study|Death|1|||
127856052|NCT03236506|460090576|FG002|Overall Study|Death|1|||
127856053|NCT03236506|460090574|FG000|Overall Study|Withdrawal by Subject|3|||
127856054|NCT03236506|460090575|FG001|Overall Study|Withdrawal by Subject|3|||
127856055|NCT03236506|460090576|FG002|Overall Study|Withdrawal by Subject|4|||
127856056|NCT03236506|460090574|FG000|Overall Study|Did not initiate treatment|2|||
127856057|NCT03236506|460090575|FG001|Overall Study|Did not initiate treatment|1|||
127856058|NCT03236506|460090576|FG002|Overall Study|Did not initiate treatment|2|||
127856059|NCT01466062|460090577|FG000|Overall Study|Adverse Event|1|||
127856060|NCT01466062|460090577|FG000|Overall Study|Withdrawal by Subject|1|||
127856061|NCT02865928|460090580|FG000|Overall Study|Withdrawal by Subject|1|||
127856062|NCT02865928|460090581|FG001|Overall Study|Withdrawal by Subject|0|||
127856063|NCT02865928|460090580|FG000|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|1|||
127856064|NCT02865928|460090581|FG001|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|0|||
127856065|NCT02865928|460090580|FG000|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
127856066|NCT02865928|460090581|FG001|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
127856067|NCT03152110|460090588|FG000|Overall Study|Withdrawal by Subject|3|||
127856068|NCT00312728|460090592|FG000|Overall Study|Progressive disease|53|||
127856069|NCT00312728|460090592|FG000|Overall Study|Adverse Event|32|||
127856070|NCT00312728|460090592|FG000|Overall Study|Withdrawal by Subject|10|||
127856071|NCT00312728|460090592|FG000|Overall Study|Required non-protocol cancer treatment|2|||
127856072|NCT00312728|460090592|FG000|Overall Study|Protocol Violation|2|||
127856073|NCT00312728|460090592|FG000|Overall Study|Other|10|||
127856074|NCT00312728|460090592|FG000|Overall Study|Other|1|||
127856075|NCT03696576|460090593|FG000|Overall Study|Soreness of throat after therapy|1|||
127856076|NCT03696576|460090594|FG001|Overall Study|Soreness of throat after therapy|1|||
127856077|NCT03696576|460090593|FG000|Overall Study|Lost to Follow-up|2|||
127856078|NCT03696576|460090594|FG001|Overall Study|Lost to Follow-up|4|||
127856079|NCT00850135|460090602|FG000|Overall Study|Physician Decision|1|||
127856080|NCT00338806|460090606|FG000|Acute Phase|Withdrawal by Subject|0|||
127856081|NCT00338806|460090607|FG001|Acute Phase|Withdrawal by Subject|1|||
127856082|NCT00338806|460090606|FG000|Follow-up|Lost to Follow-up|1|||
127856083|NCT00338806|460090607|FG001|Follow-up|Lost to Follow-up|3|||
127856084|NCT00744991|460090610|FG000|Overall Study|Progressive Disease|11|||
127856085|NCT00744991|460090610|FG000|Overall Study|Withdrawal by Subject|8|||
127856086|NCT00744991|460090610|FG000|Overall Study|Physician Decision|3|||
127856087|NCT00744991|460090610|FG000|Overall Study|Adverse Event|2|||
127856088|NCT00744991|460090610|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
127856089|NCT02139280|460090616|FG000|Overall Study|No longer eligible|2|||
127856090|NCT02139280|460090617|FG001|Overall Study|No longer eligible|0|||
127856091|NCT04157751|460090618|FG000|Overall Study|Withdrawal by Subject|12|||
127856092|NCT04157751|460090619|FG001|Overall Study|Withdrawal by Subject|17|||
127856093|NCT04157751|460090618|FG000|Overall Study|Lost to Follow-up|6|||
127856094|NCT04157751|460090619|FG001|Overall Study|Lost to Follow-up|2|||
127856095|NCT04157751|460090618|FG000|Overall Study|Adverse Event|34|||
127856096|NCT04157751|460090619|FG001|Overall Study|Adverse Event|23|||
127856097|NCT04157751|460090618|FG000|Overall Study|Not treated|1|||
127856098|NCT04157751|460090619|FG001|Overall Study|Not treated|5|||
127856099|NCT04157751|460090618|FG000|Overall Study|Other reason not stated above|10|||
127856100|NCT04157751|460090619|FG001|Overall Study|Other reason not stated above|10|||
127856101|NCT01302691|460090625|FG000|Overall Study|Adverse Event|2|||
127856102|NCT01302691|460090626|FG001|Overall Study|Adverse Event|0|||
127856103|NCT01302691|460090625|FG000|Overall Study|Death|0|||
127856104|NCT01302691|460090626|FG001|Overall Study|Death|1|||
127856105|NCT01302691|460090625|FG000|Overall Study|Lost to Follow-up|1|||
127856106|NCT01302691|460090626|FG001|Overall Study|Lost to Follow-up|0|||
127856107|NCT01302691|460090625|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
127856108|NCT01302691|460090626|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
127856109|NCT01302691|460090625|FG000|Overall Study|Physician Decision|0|||
127856110|NCT01302691|460090626|FG001|Overall Study|Physician Decision|1|||
127856111|NCT01302691|460090625|FG000|Overall Study|Protocol Violation|1|||
127856112|NCT01302691|460090626|FG001|Overall Study|Protocol Violation|0|||
127856113|NCT00423592|460090627|FG000|Overall Study|Adverse Event (through Week 12)|2|||
127856114|NCT00423592|460090627|FG000|Overall Study|Adverse Event (post Week 12)|5|||
127856115|NCT03446612|460090628|FG000|Overall Study|Protocol defined stopping criteria|0|||
127856116|NCT03446612|460090629|FG001|Overall Study|Protocol defined stopping criteria|1|||
127856117|NCT01437267|460090630|FG000|Overall Study|Withdrawal by Subject|0|||
127856118|NCT01437267|460090631|FG001|Overall Study|Withdrawal by Subject|0|||
127856119|NCT01437267|460090632|FG002|Overall Study|Withdrawal by Subject|0|||
127856120|NCT01437267|460090633|FG003|Overall Study|Withdrawal by Subject|1|||
127856121|NCT01437267|460090634|FG004|Overall Study|Withdrawal by Subject|0|||
127856122|NCT01437267|460090635|FG005|Overall Study|Withdrawal by Subject|0|||
127856123|NCT01437267|460090630|FG000|Overall Study|Protocol Violation|0|||
127856124|NCT01437267|460090631|FG001|Overall Study|Protocol Violation|1|||
127856125|NCT01437267|460090632|FG002|Overall Study|Protocol Violation|0|||
127856126|NCT01437267|460090633|FG003|Overall Study|Protocol Violation|0|||
127856127|NCT01437267|460090634|FG004|Overall Study|Protocol Violation|0|||
127856128|NCT01437267|460090635|FG005|Overall Study|Protocol Violation|0|||
127856129|NCT03934203|460090638|FG000|Overall Study|Adverse Event|0|||
127856130|NCT03934203|460090639|FG001|Overall Study|Adverse Event|0|||
127856131|NCT03934203|460090640|FG002|Overall Study|Adverse Event|1|||
127856132|NCT03934203|460090641|FG003|Overall Study|Adverse Event|0|||
127856133|NCT03934203|460090642|FG004|Overall Study|Adverse Event|1|||
127856134|NCT03934203|460090643|FG005|Overall Study|Adverse Event|0|||
127856135|NCT03934203|460090644|FG006|Overall Study|Adverse Event|2|||
127856136|NCT03934203|460090645|FG007|Overall Study|Adverse Event|0|||
127856137|NCT03934203|460090646|FG008|Overall Study|Adverse Event|0|||
127856138|NCT03934203|460090647|FG009|Overall Study|Adverse Event|0|||
127856139|NCT03934203|460090648|FG010|Overall Study|Adverse Event|0|||
127856140|NCT03934203|460090649|FG011|Overall Study|Adverse Event|0|||
127856141|NCT03934203|460090650|FG012|Overall Study|Adverse Event|0|||
127856142|NCT03934203|460090651|FG013|Overall Study|Adverse Event|1|||
127856143|NCT03934203|460090652|FG014|Overall Study|Adverse Event|0|||
127856144|NCT00608842|460090653|FG000|Overall Study|Participant's Request|0|||
127856145|NCT00608842|460090654|FG001|Overall Study|Participant's Request|1|||
127856146|NCT00608842|460090655|FG002|Overall Study|Participant's Request|2|||
127856147|NCT00608842|460090656|FG003|Overall Study|Participant's Request|1|||
127856148|NCT00608842|460090653|FG000|Overall Study|Lost to Follow-up|1|||
127856149|NCT00608842|460090654|FG001|Overall Study|Lost to Follow-up|0|||
127856150|NCT00608842|460090655|FG002|Overall Study|Lost to Follow-up|0|||
127856151|NCT00608842|460090656|FG003|Overall Study|Lost to Follow-up|0|||
127856152|NCT04445051|460090657|FG000|Overall Study|Adverse Event|0|||
127856153|NCT04445051|460090658|FG001|Overall Study|Adverse Event|0|||
127856154|NCT04445051|460090659|FG002|Overall Study|Adverse Event|1|||
127856155|NCT04445051|460090660|FG003|Overall Study|Adverse Event|0|||
127856156|NCT04445051|460090661|FG004|Overall Study|Adverse Event|0|||
127856157|NCT04445051|460090662|FG005|Overall Study|Adverse Event|0|||
127856158|NCT01624467|460090664|FG000|Overall Study|Withdrawal by Subject|2|||
127856159|NCT01624467|460090664|FG000|Overall Study|Lost to Follow-up|1|||
127856160|NCT01624467|460090664|FG000|Overall Study|Adverse Event|7|||
127856161|NCT01624467|460090664|FG000|Overall Study|Progressive Disease|19|||
127856162|NCT01624467|460090664|FG000|Overall Study|Per Sponsor Requirement|1|||
127856163|NCT01624467|460090664|FG000|Overall Study|Subject Withdrew from Treatment|1|||
127856164|NCT02201472|460090665|FG000|Overall Study|Lack of Efficacy|2|||
127856165|NCT00901394|460090670|FG000|Overall Study|Physician Decision|1|||
127856166|NCT00901394|460090671|FG001|Overall Study|Physician Decision|1|||
127856167|NCT00901394|460090672|FG002|Overall Study|Physician Decision|2|||
127856168|NCT03864627|460090673|FG000|Overall Study|Adverse Event|0|||
127856169|NCT03864627|460090674|FG001|Overall Study|Adverse Event|1|||
127856170|NCT03864627|460090673|FG000|Overall Study|Lack of Efficacy|0|||
127856171|NCT03864627|460090674|FG001|Overall Study|Lack of Efficacy|1|||
127856172|NCT03864627|460090673|FG000|Overall Study|Lost to Follow-up|0|||
127856173|NCT03864627|460090674|FG001|Overall Study|Lost to Follow-up|1|||
127856174|NCT03864627|460090673|FG000|Overall Study|Withdrawal by Subject|4|||
127856175|NCT03864627|460090674|FG001|Overall Study|Withdrawal by Subject|8|||
127856176|NCT03864627|460090673|FG000|Overall Study|Study terminated by sponsor|0|||
127856177|NCT03864627|460090674|FG001|Overall Study|Study terminated by sponsor|1|||
127856178|NCT01388491|460090675|FG000|Overall Study|Adverse Event|10|||
127856179|NCT01388491|460090676|FG001|Overall Study|Adverse Event|9|||
127856180|NCT01388491|460090675|FG000|Overall Study|Sponsor Request|9|||
127856181|NCT01388491|460090676|FG001|Overall Study|Sponsor Request|7|||
127856182|NCT01388491|460090675|FG000|Overall Study|Withdrawal by Subject|6|||
127856183|NCT01388491|460090676|FG001|Overall Study|Withdrawal by Subject|10|||
127856184|NCT01388491|460090675|FG000|Overall Study|Lost to Follow-up|4|||
127856185|NCT01388491|460090676|FG001|Overall Study|Lost to Follow-up|3|||
127856186|NCT01388491|460090675|FG000|Overall Study|Protocol Violation|2|||
127856187|NCT01388491|460090676|FG001|Overall Study|Protocol Violation|0|||
127856188|NCT01388491|460090675|FG000|Overall Study|Noncompliance|2|||
127856189|NCT01388491|460090676|FG001|Overall Study|Noncompliance|0|||
127856190|NCT01388491|460090675|FG000|Overall Study|Pregnancy|1|||
127856191|NCT01388491|460090676|FG001|Overall Study|Pregnancy|0|||
127856192|NCT02569398|460090679|FG000|Overall Study|Adverse Event|0|||
127856193|NCT02569398|460090680|FG001|Overall Study|Adverse Event|1|||
127856194|NCT02569398|460090681|FG002|Overall Study|Adverse Event|6|||
127856195|NCT02569398|460090679|FG000|Overall Study|Withdrawal by Subject|43|||
127856196|NCT02569398|460090680|FG001|Overall Study|Withdrawal by Subject|43|||
127856197|NCT02569398|460090681|FG002|Overall Study|Withdrawal by Subject|30|||
127856198|NCT02569398|460090679|FG000|Overall Study|Study terminated by sponsor|130|||
127856199|NCT02569398|460090680|FG001|Overall Study|Study terminated by sponsor|131|||
127856200|NCT02569398|460090681|FG002|Overall Study|Study terminated by sponsor|134|||
127856201|NCT02569398|460090679|FG000|Overall Study|Other|12|||
127856202|NCT02569398|460090680|FG001|Overall Study|Other|14|||
127856203|NCT02569398|460090681|FG002|Overall Study|Other|13|||
127856204|NCT02116361|460090684|FG000|Overall Study|Pregnancy|0|||
127856205|NCT02116361|460090685|FG001|Overall Study|Pregnancy|0|||
127856206|NCT02116361|460090686|FG002|Overall Study|Pregnancy|0|||
127856207|NCT02116361|460090687|FG003|Overall Study|Pregnancy|1|||
127856208|NCT02116361|460090684|FG000|Overall Study|Protocol Violation|1|||
127856209|NCT02116361|460090685|FG001|Overall Study|Protocol Violation|0|||
127856210|NCT02116361|460090686|FG002|Overall Study|Protocol Violation|0|||
127856211|NCT02116361|460090687|FG003|Overall Study|Protocol Violation|2|||
127856212|NCT02116361|460090684|FG000|Overall Study|Physician Decision|2|||
127856213|NCT02116361|460090685|FG001|Overall Study|Physician Decision|3|||
127856214|NCT02116361|460090686|FG002|Overall Study|Physician Decision|0|||
127856215|NCT02116361|460090687|FG003|Overall Study|Physician Decision|0|||
127856216|NCT02116361|460090684|FG000|Overall Study|Adverse Event|1|||
127856217|NCT02116361|460090685|FG001|Overall Study|Adverse Event|0|||
127856218|NCT02116361|460090686|FG002|Overall Study|Adverse Event|0|||
127856219|NCT02116361|460090687|FG003|Overall Study|Adverse Event|3|||
127856220|NCT02116361|460090684|FG000|Overall Study|Other Reasons|3|||
127856221|NCT02116361|460090685|FG001|Overall Study|Other Reasons|3|||
127856222|NCT02116361|460090686|FG002|Overall Study|Other Reasons|3|||
127856223|NCT02116361|460090687|FG003|Overall Study|Other Reasons|3|||
127856224|NCT02116361|460090684|FG000|Overall Study|Lack of Efficacy|5|||
127856225|NCT02116361|460090685|FG001|Overall Study|Lack of Efficacy|7|||
127856226|NCT02116361|460090686|FG002|Overall Study|Lack of Efficacy|4|||
127856227|NCT02116361|460090687|FG003|Overall Study|Lack of Efficacy|3|||
127856228|NCT02116361|460090684|FG000|Overall Study|Lost to Follow-up|4|||
127856229|NCT02116361|460090685|FG001|Overall Study|Lost to Follow-up|5|||
127856230|NCT02116361|460090686|FG002|Overall Study|Lost to Follow-up|7|||
127856231|NCT02116361|460090687|FG003|Overall Study|Lost to Follow-up|5|||
127856232|NCT02116361|460090684|FG000|Overall Study|Personal Reasons|6|||
127856233|NCT02116361|460090685|FG001|Overall Study|Personal Reasons|6|||
127856234|NCT02116361|460090686|FG002|Overall Study|Personal Reasons|4|||
127856235|NCT02116361|460090687|FG003|Overall Study|Personal Reasons|9|||
127856236|NCT02116361|460090684|FG000|Overall Study|Investigator Decision - Relapse|9|||
127856237|NCT02116361|460090685|FG001|Overall Study|Investigator Decision - Relapse|7|||
127856238|NCT02116361|460090686|FG002|Overall Study|Investigator Decision - Relapse|8|||
127856239|NCT02116361|460090687|FG003|Overall Study|Investigator Decision - Relapse|5|||
127856240|NCT03227224|460090688|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
127856241|NCT03227224|460090689|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
127856242|NCT03227224|460090690|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
127856243|NCT03227224|460090691|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
127856244|NCT03227224|460090688|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
127856245|NCT03227224|460090689|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
127856246|NCT03227224|460090690|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
127856247|NCT03227224|460090691|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
127856248|NCT03227224|460090688|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
127856249|NCT03227224|460090689|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
127856250|NCT03227224|460090690|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
127856251|NCT03227224|460090691|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
127856252|NCT03227224|460090688|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
127856253|NCT03227224|460090689|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
127856254|NCT03227224|460090690|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
127856255|NCT03227224|460090691|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
127856256|NCT03227224|460090688|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
127856257|NCT03227224|460090689|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
127856258|NCT03227224|460090690|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
127856259|NCT03227224|460090691|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
127856260|NCT03227224|460090688|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
127856261|NCT03227224|460090689|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
127856262|NCT03227224|460090690|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
127856263|NCT03227224|460090691|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
127856264|NCT03227224|460090688|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
127856265|NCT03227224|460090689|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
127856266|NCT03227224|460090690|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
127856267|NCT03227224|460090691|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
127856268|NCT03227224|460090688|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
127856269|NCT03227224|460090689|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
127856270|NCT03227224|460090690|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
127856271|NCT03227224|460090691|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
127856272|NCT03227224|460090688|FG000|Follow-up Phase (2 Weeks)|Other|4|||
127856273|NCT03227224|460090689|FG001|Follow-up Phase (2 Weeks)|Other|4|||
127856274|NCT03227224|460090690|FG002|Follow-up Phase (2 Weeks)|Other|6|||
127856275|NCT03227224|460090691|FG003|Follow-up Phase (2 Weeks)|Other|3|||
127856276|NCT04195750|460090692|FG000|Overall Study|Death|245|||
127856277|NCT04195750|460090693|FG001|Overall Study|Death|253|||
127856278|NCT04195750|460090694|FG002|Overall Study|Death|5|||
127856279|NCT04195750|460090692|FG000|Overall Study|Physician Decision|0|||
127856280|NCT04195750|460090693|FG001|Overall Study|Physician Decision|1|||
127856281|NCT04195750|460090694|FG002|Overall Study|Physician Decision|0|||
127856282|NCT04195750|460090692|FG000|Overall Study|Withdrawal by Subject|9|||
127856283|NCT04195750|460090693|FG001|Overall Study|Withdrawal by Subject|8|||
127856284|NCT04195750|460090694|FG002|Overall Study|Withdrawal by Subject|0|||
127856285|NCT04195750|460090692|FG000|Overall Study|Ongoing|120|||
127856286|NCT04195750|460090693|FG001|Overall Study|Ongoing|110|||
127856287|NCT04195750|460090694|FG002|Overall Study|Ongoing|4|||
127856288|NCT02406027|460090695|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
127856289|NCT02406027|460090696|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
127856290|NCT02406027|460090697|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
127856291|NCT02406027|460090698|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
127856292|NCT02406027|460090699|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
127856293|NCT02406027|460090700|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
127856294|NCT02406027|460090701|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
127856295|NCT02406027|460090695|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
127856296|NCT02406027|460090696|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
127856297|NCT02406027|460090697|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
127856298|NCT02406027|460090698|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
127856299|NCT02406027|460090699|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
127856300|NCT02406027|460090700|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
127856301|NCT02406027|460090701|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
127856302|NCT02406027|460090695|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
127856303|NCT02406027|460090696|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
127856304|NCT02406027|460090697|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
127856305|NCT02406027|460090698|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
127856306|NCT02406027|460090699|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
127856307|NCT02406027|460090700|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
127856308|NCT02406027|460090701|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
127856309|NCT02406027|460090695|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
127856310|NCT02406027|460090696|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
127856311|NCT02406027|460090697|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
127856312|NCT02406027|460090698|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
127856313|NCT02406027|460090699|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
127856314|NCT02406027|460090700|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
127856315|NCT02406027|460090701|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
127856316|NCT02406027|460090695|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
127856317|NCT02406027|460090696|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
127856318|NCT02406027|460090697|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
127856319|NCT02406027|460090698|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
127856320|NCT02406027|460090699|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
127856321|NCT02406027|460090700|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
127856322|NCT02406027|460090701|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
127856323|NCT02406027|460090695|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
127856324|NCT02406027|460090696|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
127856325|NCT02406027|460090697|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
127856326|NCT02406027|460090698|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
127856327|NCT02406027|460090699|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
127856328|NCT02406027|460090700|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
127856329|NCT02406027|460090701|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
127856330|NCT02406027|460090695|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
127856331|NCT02406027|460090696|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
127856332|NCT02406027|460090697|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
127856333|NCT02406027|460090698|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
127856334|NCT02406027|460090699|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
127856335|NCT02406027|460090700|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
127856336|NCT02406027|460090701|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
127856337|NCT02406027|460090695|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
127856338|NCT02406027|460090696|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
127856339|NCT02406027|460090697|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
127856340|NCT02406027|460090698|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
127856341|NCT02406027|460090699|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
127856342|NCT02406027|460090700|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
127856343|NCT02406027|460090701|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
127856344|NCT02406027|460090695|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
127856345|NCT02406027|460090696|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
127856346|NCT02406027|460090697|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
127856347|NCT02406027|460090698|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
127908210|NCT01796171|460287541|FG001|Follow-up Period|Physician Decision|2|||
127856348|NCT02406027|460090699|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
127856349|NCT02406027|460090700|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
127856350|NCT02406027|460090701|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
127856351|NCT02406027|460090695|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
127856352|NCT02406027|460090696|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
127856353|NCT02406027|460090697|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
127856354|NCT02406027|460090698|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
127856355|NCT02406027|460090699|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
127856356|NCT02406027|460090700|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
127856357|NCT02406027|460090701|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
127856358|NCT02497287|460090702|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
127856359|NCT02497287|460090702|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
127856360|NCT02497287|460090702|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
127856361|NCT02497287|460090702|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
127856362|NCT02497287|460090702|FG000|Induction Phase (4 Weeks)|Other|13|||
127856363|NCT02497287|460090702|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
127856364|NCT02497287|460090702|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
127856365|NCT02497287|460090702|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
127856366|NCT02497287|460090702|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
127856367|NCT02497287|460090702|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
127856368|NCT02497287|460090702|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
127856369|NCT02497287|460090702|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
127856370|NCT02497287|460090702|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
127856371|NCT02497287|460090702|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
127856372|NCT02497287|460090702|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
127856373|NCT02497287|460090702|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
127856374|NCT02497287|460090702|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
127856375|NCT02497287|460090702|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
127856376|NCT02497287|460090702|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
127856377|NCT02497287|460090702|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
127856378|NCT02497287|460090702|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
127856379|NCT02497287|460090702|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
127856380|NCT02497287|460090702|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
127856381|NCT02497287|460090702|FG000|Follow-up Phase (4 Week)|Other|1|||
127856382|NCT03782376|460090703|FG000|Overall Study|Lost to Follow-up|2|||
127856383|NCT03782376|460090704|FG001|Overall Study|Lost to Follow-up|2|||
127856384|NCT03782376|460090703|FG000|Overall Study|Withdrawal by Subject|7|||
127856385|NCT03782376|460090704|FG001|Overall Study|Withdrawal by Subject|11|||
127856386|NCT03782376|460090703|FG000|Overall Study|Death|1|||
127856387|NCT03782376|460090704|FG001|Overall Study|Death|0|||
127856388|NCT03782376|460090703|FG000|Overall Study|Other|16|||
127856389|NCT03782376|460090704|FG001|Overall Study|Other|17|||
127856390|NCT03559192|460090705|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
127856391|NCT03559192|460090706|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
127856392|NCT03559192|460090707|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
127856393|NCT03559192|460090705|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
127856394|NCT03559192|460090706|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
127856395|NCT03559192|460090707|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
127856396|NCT03559192|460090705|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
127856397|NCT03559192|460090706|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
127856398|NCT03559192|460090707|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
127856399|NCT03559192|460090705|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
127856400|NCT03559192|460090706|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
127856401|NCT03559192|460090707|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
127856402|NCT03559192|460090705|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
127856403|NCT03559192|460090706|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
127856404|NCT03559192|460090707|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
127856405|NCT03559192|460090705|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
127856406|NCT03559192|460090706|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
127856407|NCT03559192|460090707|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
127856408|NCT03559192|460090705|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
127856409|NCT03559192|460090706|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
127856410|NCT03559192|460090707|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
127856411|NCT03559192|460090705|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
127856412|NCT03559192|460090706|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
127856413|NCT03559192|460090707|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
127856414|NCT03559192|460090705|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
127856415|NCT03559192|460090706|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
127856416|NCT03559192|460090707|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
127856417|NCT03517722|460090708|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
127856418|NCT03517722|460090709|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
127856419|NCT03517722|460090708|FG000|Double Blind Period: Week 0-52|Death|0|||
127856420|NCT03517722|460090709|FG001|Double Blind Period: Week 0-52|Death|4|||
127856421|NCT03517722|460090708|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
127856422|NCT03517722|460090709|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
127856423|NCT03517722|460090708|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
127856424|NCT03517722|460090709|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
127856425|NCT03517722|460090708|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
127856426|NCT03517722|460090709|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
127856427|NCT03517722|460090708|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
127856428|NCT03517722|460090709|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
127856429|NCT03517722|460090708|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
127856430|NCT03517722|460090709|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
127856431|NCT03517722|460090708|FG000|Double Blind Period: Week 0-52|Other|4|||
127856432|NCT03517722|460090709|FG001|Double Blind Period: Week 0-52|Other|3|||
127856433|NCT03517722|460090708|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
127856434|NCT03517722|460090709|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
127856435|NCT03517722|460090708|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
127856436|NCT03517722|460090709|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
127856437|NCT03517722|460090708|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
127856438|NCT03517722|460090709|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
127856439|NCT03517722|460090708|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
127856440|NCT03517722|460090709|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
127856441|NCT03517722|460090708|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
127856442|NCT03517722|460090709|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
127856443|NCT02422186|460090710|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
127856444|NCT02422186|460090711|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
127856445|NCT02422186|460090710|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
127856446|NCT02422186|460090711|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
127856447|NCT02422186|460090710|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
127856448|NCT02422186|460090711|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
127856449|NCT02422186|460090710|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
127856450|NCT02422186|460090711|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
127856451|NCT02422186|460090710|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
127856452|NCT02422186|460090711|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
127856453|NCT02422186|460090710|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
127856454|NCT02422186|460090711|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
127856455|NCT02422186|460090710|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
127856456|NCT02422186|460090711|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
127856457|NCT02422186|460090710|FG000|Follow-up Phase (2 Weeks)|Other|3|||
127856458|NCT02422186|460090711|FG001|Follow-up Phase (2 Weeks)|Other|0|||
127856459|NCT03277794|460090716|FG000|Overall Study|Lost to Follow-up|2|||
127856460|NCT03277794|460090717|FG001|Overall Study|Lost to Follow-up|4|||
127856461|NCT03277794|460090716|FG000|Overall Study|Withdrew due to high acuity|1|||
127856462|NCT03277794|460090717|FG001|Overall Study|Withdrew due to high acuity|0|||
127856463|NCT03399786|460090721|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
127856464|NCT03399786|460090722|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
127856465|NCT03399786|460090723|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
127856466|NCT03399786|460090724|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
127856467|NCT03399786|460090721|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
127856468|NCT03399786|460090722|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
127856469|NCT03399786|460090723|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
127856470|NCT03399786|460090724|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
127856471|NCT03399786|460090721|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
127856472|NCT03399786|460090722|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
127856473|NCT03399786|460090723|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
127856474|NCT03399786|460090724|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
127856475|NCT00636155|460092261|FG000|Overall Study|Adverse Event|8|||
127856476|NCT00636155|460092261|FG000|Overall Study|Lack of Efficacy|1|||
127856477|NCT00636155|460092261|FG000|Overall Study|Withdrawal by Subject|3|||
127856478|NCT00636155|460092261|FG000|Overall Study|Stem cell transplant|1|||
127856479|NCT00636155|460092261|FG000|Overall Study|Physician Decision|5|||
127856480|NCT00400946|460092262|FG000|Overall Study|Ineligible|0|||
127856481|NCT00400946|460092263|FG001|Overall Study|Ineligible|0|||
127856482|NCT00400946|460092264|FG002|Overall Study|Ineligible|0|||
127856483|NCT00400946|460092265|FG003|Overall Study|Ineligible|5|||
127856484|NCT00400946|460092266|FG004|Overall Study|Ineligible|1|||
127856485|NCT00400946|460092262|FG000|Overall Study|Induction Failure|0|||
127856486|NCT00400946|460092263|FG001|Overall Study|Induction Failure|0|||
127856487|NCT00400946|460092264|FG002|Overall Study|Induction Failure|0|||
127856488|NCT00400946|460092265|FG003|Overall Study|Induction Failure|11|||
127856489|NCT00400946|460092266|FG004|Overall Study|Induction Failure|8|||
127856490|NCT00400946|460092262|FG000|Overall Study|Induction Death|0|||
127856491|NCT00400946|460092263|FG001|Overall Study|Induction Death|0|||
127856492|NCT00400946|460092264|FG002|Overall Study|Induction Death|0|||
127856493|NCT00400946|460092265|FG003|Overall Study|Induction Death|13|||
127856494|NCT00400946|460092266|FG004|Overall Study|Induction Death|3|||
127856495|NCT00400946|460092262|FG000|Overall Study|Lost to Follow-up|1|||
127856496|NCT00400946|460092263|FG001|Overall Study|Lost to Follow-up|1|||
127856497|NCT00400946|460092264|FG002|Overall Study|Lost to Follow-up|0|||
127856498|NCT00400946|460092265|FG003|Overall Study|Lost to Follow-up|0|||
127856499|NCT00400946|460092266|FG004|Overall Study|Lost to Follow-up|1|||
127856500|NCT00400946|460092262|FG000|Overall Study|Remission Death|1|||
127856501|NCT00400946|460092263|FG001|Overall Study|Remission Death|1|||
127856502|NCT00400946|460092264|FG002|Overall Study|Remission Death|0|||
127856503|NCT00400946|460092265|FG003|Overall Study|Remission Death|0|||
127856504|NCT00400946|460092266|FG004|Overall Study|Remission Death|1|||
127856505|NCT00400946|460092262|FG000|Overall Study|Relapse|9|||
127856506|NCT00400946|460092263|FG001|Overall Study|Relapse|2|||
127856507|NCT00400946|460092264|FG002|Overall Study|Relapse|1|||
127856508|NCT00400946|460092265|FG003|Overall Study|Relapse|1|||
127856509|NCT00400946|460092266|FG004|Overall Study|Relapse|5|||
127856510|NCT00400946|460092262|FG000|Overall Study|Transplant in CR1|0|||
127856511|NCT00400946|460092263|FG001|Overall Study|Transplant in CR1|0|||
127856512|NCT00400946|460092264|FG002|Overall Study|Transplant in CR1|0|||
127856513|NCT00400946|460092265|FG003|Overall Study|Transplant in CR1|10|||
127856514|NCT00400946|460092266|FG004|Overall Study|Transplant in CR1|1|||
127856515|NCT00400946|460092262|FG000|Overall Study|Withdrawal by Subject|2|||
127856516|NCT00400946|460092263|FG001|Overall Study|Withdrawal by Subject|5|||
127856517|NCT00400946|460092264|FG002|Overall Study|Withdrawal by Subject|1|||
127856518|NCT00400946|460092265|FG003|Overall Study|Withdrawal by Subject|5|||
127856519|NCT00400946|460092266|FG004|Overall Study|Withdrawal by Subject|8|||
127856520|NCT00400946|460092262|FG000|Overall Study|Clinical|1|||
127856521|NCT00400946|460092263|FG001|Overall Study|Clinical|2|||
127856522|NCT00400946|460092264|FG002|Overall Study|Clinical|0|||
127856523|NCT00400946|460092265|FG003|Overall Study|Clinical|2|||
127856524|NCT00400946|460092266|FG004|Overall Study|Clinical|9|||
127856525|NCT00400946|460092262|FG000|Overall Study|Other|0|||
127856526|NCT00400946|460092263|FG001|Overall Study|Other|0|||
127856527|NCT00400946|460092264|FG002|Overall Study|Other|0|||
127856528|NCT00400946|460092265|FG003|Overall Study|Other|0|||
127856529|NCT00400946|460092266|FG004|Overall Study|Other|1|||
127856530|NCT05643170|460092267|FG000|Overall Study|Withdrew from study treatment due to study termination|3|||
127856531|NCT05643170|460092267|FG000|Overall Study|Adverse event (AE) that lead to treatment discontinuation|1|||
127856532|NCT01432756|460092268|FG000|Overall Study|Lost to Follow-up|1|||
127856533|NCT01432756|460092269|FG001|Overall Study|Lost to Follow-up|0|||
127856534|NCT01432756|460092270|FG002|Overall Study|Lost to Follow-up|2|||
127856535|NCT01432756|460092271|FG003|Overall Study|Lost to Follow-up|1|||
127856536|NCT05426460|460092281|FG000|Overall Study|Protocol Violation|1|||
127856537|NCT05426460|460092282|FG001|Overall Study|Protocol Violation|1|||
127856538|NCT05426460|460092283|FG002|Overall Study|Protocol Violation|1|||
127856539|NCT05426460|460092284|FG003|Overall Study|Protocol Violation|0|||
127856540|NCT01431521|460092288|FG000|Overall Study|Withdrawal by Subject|0|||
127856541|NCT01431521|460092289|FG001|Overall Study|Withdrawal by Subject|0|||
127856542|NCT01431521|460092290|FG002|Overall Study|Withdrawal by Subject|1|||
127856543|NCT01431521|460092291|FG003|Overall Study|Withdrawal by Subject|0|||
127856544|NCT01572844|460092292|FG000|Overall Study|Physician Decision|1|||
127856545|NCT01572844|460092293|FG001|Overall Study|Physician Decision|1|||
127856546|NCT00366444|460092295|FG000|Overall Study|Withdrawal by Subject|1|||
127856547|NCT00366444|460092296|FG001|Overall Study|Withdrawal by Subject|1|||
127908211|NCT01796171|460287542|FG002|Follow-up Period|Physician Decision|0|||
127908212|NCT01796171|460287543|FG003|Follow-up Period|Physician Decision|0|||
127856548|NCT00366444|460092295|FG000|Overall Study|Lack of Efficacy|0|||
127856549|NCT00366444|460092296|FG001|Overall Study|Lack of Efficacy|1|||
127856550|NCT01320033|460092297|FG000|Overall Study|Lack of Efficacy|0|||
127856551|NCT01320033|460092298|FG001|Overall Study|Lack of Efficacy|0|||
127856552|NCT01320033|460092299|FG002|Overall Study|Lack of Efficacy|1|||
127856553|NCT01320033|460092297|FG000|Overall Study|Adverse Event|9|||
127856554|NCT01320033|460092298|FG001|Overall Study|Adverse Event|7|||
127856555|NCT01320033|460092299|FG002|Overall Study|Adverse Event|8|||
127856556|NCT01320033|460092297|FG000|Overall Study|Withdrawal by Subject|22|||
127856557|NCT01320033|460092298|FG001|Overall Study|Withdrawal by Subject|23|||
127856558|NCT01320033|460092299|FG002|Overall Study|Withdrawal by Subject|23|||
127856559|NCT01320033|460092297|FG000|Overall Study|Protocol Violation|3|||
127856560|NCT01320033|460092298|FG001|Overall Study|Protocol Violation|5|||
127856561|NCT01320033|460092299|FG002|Overall Study|Protocol Violation|3|||
127856562|NCT01320033|460092297|FG000|Overall Study|Lost to Follow-up|22|||
127856563|NCT01320033|460092298|FG001|Overall Study|Lost to Follow-up|26|||
127856564|NCT01320033|460092299|FG002|Overall Study|Lost to Follow-up|17|||
127856565|NCT01320033|460092297|FG000|Overall Study|Other|2|||
127856566|NCT01320033|460092298|FG001|Overall Study|Other|3|||
127856567|NCT01320033|460092299|FG002|Overall Study|Other|1|||
127856568|NCT00963469|460092300|FG000|Overall Study|Adverse Event|15|||
127856569|NCT00963469|460092301|FG001|Overall Study|Adverse Event|11|||
127856570|NCT00963469|460092302|FG002|Overall Study|Adverse Event|1|||
127856571|NCT00963469|460092300|FG000|Overall Study|Lack of Efficacy|10|||
127856572|NCT00963469|460092301|FG001|Overall Study|Lack of Efficacy|7|||
127856573|NCT00963469|460092302|FG002|Overall Study|Lack of Efficacy|2|||
127856574|NCT00963469|460092300|FG000|Overall Study|Lost to Follow-up|1|||
127856575|NCT00963469|460092301|FG001|Overall Study|Lost to Follow-up|1|||
127856576|NCT00963469|460092302|FG002|Overall Study|Lost to Follow-up|0|||
127856577|NCT00963469|460092300|FG000|Overall Study|Protocol Violation|5|||
127856578|NCT00963469|460092301|FG001|Overall Study|Protocol Violation|5|||
127856579|NCT00963469|460092302|FG002|Overall Study|Protocol Violation|3|||
127856580|NCT00963469|460092300|FG000|Overall Study|Withdrawal by Subject|4|||
127856581|NCT00963469|460092301|FG001|Overall Study|Withdrawal by Subject|1|||
127856582|NCT00963469|460092302|FG002|Overall Study|Withdrawal by Subject|1|||
127856583|NCT00963469|460092300|FG000|Overall Study|Pre-randomization Adverse Event|1|||
127856584|NCT00963469|460092301|FG001|Overall Study|Pre-randomization Adverse Event|2|||
127856585|NCT00963469|460092302|FG002|Overall Study|Pre-randomization Adverse Event|0|||
127856586|NCT00963469|460092300|FG000|Overall Study|Moved|1|||
127856587|NCT00963469|460092301|FG001|Overall Study|Moved|0|||
127856588|NCT00963469|460092302|FG002|Overall Study|Moved|0|||
127856589|NCT00963469|460092300|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
127856590|NCT00963469|460092301|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
127856591|NCT00963469|460092302|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
127856592|NCT03558828|460092323|FG000|Overall Study|Lost to Follow-up|4|||
127856593|NCT03558828|460092324|FG001|Overall Study|Lost to Follow-up|3|||
127856594|NCT03558828|460092325|FG002|Overall Study|Lost to Follow-up|3|||
127856595|NCT03558828|460092326|FG003|Overall Study|Lost to Follow-up|5|||
127856596|NCT03558828|460092327|FG004|Overall Study|Lost to Follow-up|2|||
127856597|NCT03558828|460092328|FG005|Overall Study|Lost to Follow-up|3|||
127856598|NCT03558828|460092323|FG000|Overall Study|dropped before the intervention|1|||
127856599|NCT03558828|460092324|FG001|Overall Study|dropped before the intervention|1|||
127856600|NCT03558828|460092325|FG002|Overall Study|dropped before the intervention|0|||
127856601|NCT03558828|460092326|FG003|Overall Study|dropped before the intervention|0|||
127856602|NCT03558828|460092327|FG004|Overall Study|dropped before the intervention|0|||
127856603|NCT03558828|460092328|FG005|Overall Study|dropped before the intervention|0|||
127856604|NCT03671148|460092334|FG000|Overall Study|Adverse Event|3|||
127856605|NCT03671148|460092335|FG001|Overall Study|Adverse Event|2|||
127856606|NCT03671148|460092334|FG000|Overall Study|Withdrawal by Subject|8|||
127856607|NCT03671148|460092335|FG001|Overall Study|Withdrawal by Subject|2|||
127856608|NCT03671148|460092334|FG000|Overall Study|Lost to Follow-up|1|||
127856609|NCT03671148|460092335|FG001|Overall Study|Lost to Follow-up|2|||
127908213|NCT01796171|460287544|FG004|Follow-up Period|Physician Decision|0|||
127856610|NCT03671148|460092334|FG000|Overall Study|Lack of Efficacy|7|||
127856611|NCT03671148|460092335|FG001|Overall Study|Lack of Efficacy|2|||
127856612|NCT03671148|460092334|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
127856613|NCT03671148|460092335|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
127856614|NCT03671148|460092334|FG000|Overall Study|Other|1|||
127856615|NCT03671148|460092335|FG001|Overall Study|Other|0|||
127908214|NCT01796171|460287545|FG005|Follow-up Period|Physician Decision|0|||
127908215|NCT01796171|460287546|FG006|Follow-up Period|Physician Decision|0|||
127908216|NCT01796171|460287547|FG007|Follow-up Period|Physician Decision|0|||
127908217|NCT01796171|460287548|FG008|Follow-up Period|Physician Decision|0|||
127908218|NCT01796171|460287549|FG009|Follow-up Period|Physician Decision|0|||
127856616|NCT03671148|460092334|FG000|Overall Study|Incomplete Randomization Visit|1|||
127856617|NCT03671148|460092335|FG001|Overall Study|Incomplete Randomization Visit|0|||
127856618|NCT00673816|460092338|FG000|Overall Study|Adverse Event|1|||
127856619|NCT00673816|460092338|FG000|Overall Study|Withdrawal by Subject|1|||
127856620|NCT02234050|460092340|FG000|Overall Study|Lack of Efficacy|38|||
127856621|NCT02234050|460092341|FG001|Overall Study|Lack of Efficacy|22|||
127856622|NCT02234050|460092340|FG000|Overall Study|Adverse Event|13|||
127856623|NCT02234050|460092341|FG001|Overall Study|Adverse Event|1|||
127856624|NCT02234050|460092340|FG000|Overall Study|Withdrawal by Subject|4|||
127856625|NCT02234050|460092341|FG001|Overall Study|Withdrawal by Subject|2|||
127856626|NCT02234050|460092340|FG000|Overall Study|Sponsor's decision|6|||
127856627|NCT02234050|460092341|FG001|Overall Study|Sponsor's decision|0|||
127856628|NCT02365506|460092342|FG000|Overall Study|Investigator's Discretion|0|||
127856629|NCT02365506|460092343|FG001|Overall Study|Investigator's Discretion|0|||
127856630|NCT02365506|460092344|FG002|Overall Study|Investigator's Discretion|1|||
127856631|NCT01852591|460092346|FG000|Overall Study|Withdrawal by Subject|2|||
127908219|NCT01796171|460287550|FG010|Follow-up Period|Physician Decision|5|||
127908220|NCT01796171|460287551|FG011|Follow-up Period|Physician Decision|0|||
127908221|NCT01796171|460287552|FG012|Follow-up Period|Physician Decision|0|||
127908222|NCT01796171|460287553|FG013|Follow-up Period|Physician Decision|0|||
127908223|NCT01796171|460287554|FG014|Follow-up Period|Physician Decision|0|||
127908224|NCT01796171|460287540|FG000|Follow-up Period|Withdrawal by Subject|0|||
127908225|NCT01796171|460287541|FG001|Follow-up Period|Withdrawal by Subject|1|||
127908226|NCT01796171|460287542|FG002|Follow-up Period|Withdrawal by Subject|0|||
127908227|NCT01796171|460287543|FG003|Follow-up Period|Withdrawal by Subject|0|||
127908228|NCT01796171|460287544|FG004|Follow-up Period|Withdrawal by Subject|0|||
127908229|NCT01796171|460287545|FG005|Follow-up Period|Withdrawal by Subject|1|||
127908230|NCT01796171|460287546|FG006|Follow-up Period|Withdrawal by Subject|0|||
127908231|NCT01796171|460287547|FG007|Follow-up Period|Withdrawal by Subject|0|||
127908232|NCT01796171|460287548|FG008|Follow-up Period|Withdrawal by Subject|0|||
127908233|NCT01796171|460287549|FG009|Follow-up Period|Withdrawal by Subject|0|||
127908234|NCT01796171|460287550|FG010|Follow-up Period|Withdrawal by Subject|3|||
127908235|NCT01796171|460287551|FG011|Follow-up Period|Withdrawal by Subject|1|||
127908236|NCT01796171|460287552|FG012|Follow-up Period|Withdrawal by Subject|0|||
127908237|NCT01796171|460287553|FG013|Follow-up Period|Withdrawal by Subject|0|||
127908238|NCT01796171|460287554|FG014|Follow-up Period|Withdrawal by Subject|0|||
127908239|NCT01796171|460287540|FG000|Follow-up Period|Death|0|||
127908240|NCT01796171|460287541|FG001|Follow-up Period|Death|0|||
127908241|NCT01796171|460287542|FG002|Follow-up Period|Death|0|||
127908242|NCT01796171|460287543|FG003|Follow-up Period|Death|0|||
127908243|NCT01796171|460287544|FG004|Follow-up Period|Death|0|||
127908244|NCT01796171|460287545|FG005|Follow-up Period|Death|0|||
127908245|NCT01796171|460287546|FG006|Follow-up Period|Death|1|||
127908246|NCT01796171|460287547|FG007|Follow-up Period|Death|0|||
127908247|NCT01796171|460287548|FG008|Follow-up Period|Death|0|||
127908248|NCT01796171|460287549|FG009|Follow-up Period|Death|0|||
127908249|NCT01796171|460287550|FG010|Follow-up Period|Death|17|||
127908250|NCT01796171|460287551|FG011|Follow-up Period|Death|9|||
127908251|NCT01796171|460287552|FG012|Follow-up Period|Death|1|||
127908252|NCT01796171|460287553|FG013|Follow-up Period|Death|0|||
127908253|NCT01796171|460287554|FG014|Follow-up Period|Death|0|||
127908254|NCT01796171|460287540|FG000|Follow-up Period|Patient transferred to other hospital|0|||
127908255|NCT01796171|460287541|FG001|Follow-up Period|Patient transferred to other hospital|1|||
127908256|NCT01796171|460287542|FG002|Follow-up Period|Patient transferred to other hospital|0|||
127908257|NCT01796171|460287543|FG003|Follow-up Period|Patient transferred to other hospital|0|||
127908258|NCT01796171|460287544|FG004|Follow-up Period|Patient transferred to other hospital|0|||
127908259|NCT01796171|460287545|FG005|Follow-up Period|Patient transferred to other hospital|0|||
127908260|NCT01796171|460287546|FG006|Follow-up Period|Patient transferred to other hospital|0|||
127908261|NCT01796171|460287547|FG007|Follow-up Period|Patient transferred to other hospital|0|||
127908262|NCT01796171|460287548|FG008|Follow-up Period|Patient transferred to other hospital|0|||
127908263|NCT01796171|460287549|FG009|Follow-up Period|Patient transferred to other hospital|0|||
127908264|NCT01796171|460287550|FG010|Follow-up Period|Patient transferred to other hospital|0|||
127908265|NCT01796171|460287551|FG011|Follow-up Period|Patient transferred to other hospital|0|||
127908266|NCT01796171|460287552|FG012|Follow-up Period|Patient transferred to other hospital|0|||
127908267|NCT01796171|460287553|FG013|Follow-up Period|Patient transferred to other hospital|0|||
127908268|NCT01796171|460287554|FG014|Follow-up Period|Patient transferred to other hospital|0|||
127908269|NCT01796171|460287540|FG000|Follow-up Period|Sponsor Decision|0|||
127908270|NCT01796171|460287541|FG001|Follow-up Period|Sponsor Decision|0|||
127908271|NCT01796171|460287542|FG002|Follow-up Period|Sponsor Decision|0|||
127908272|NCT01796171|460287543|FG003|Follow-up Period|Sponsor Decision|0|||
127908273|NCT01796171|460287544|FG004|Follow-up Period|Sponsor Decision|0|||
127908274|NCT01796171|460287545|FG005|Follow-up Period|Sponsor Decision|0|||
127908275|NCT01796171|460287546|FG006|Follow-up Period|Sponsor Decision|0|||
127908276|NCT01796171|460287547|FG007|Follow-up Period|Sponsor Decision|0|||
127908277|NCT01796171|460287548|FG008|Follow-up Period|Sponsor Decision|0|||
127908278|NCT01796171|460287549|FG009|Follow-up Period|Sponsor Decision|0|||
127908279|NCT01796171|460287550|FG010|Follow-up Period|Sponsor Decision|40|||
127908280|NCT01796171|460287551|FG011|Follow-up Period|Sponsor Decision|15|||
127908281|NCT01796171|460287552|FG012|Follow-up Period|Sponsor Decision|7|||
127908282|NCT01796171|460287553|FG013|Follow-up Period|Sponsor Decision|0|||
127908283|NCT01796171|460287554|FG014|Follow-up Period|Sponsor Decision|0|||
127908284|NCT00829309|460287555|FG000|Washout: 7 Days|Protocol Violation|1|||
127908285|NCT00829309|460287556|FG001|Washout: 7 Days|Protocol Violation|0|||
127908286|NCT00455312|460287559|FG000|Overall Study|Death|0|||
127908287|NCT00455312|460287560|FG001|Overall Study|Death|1|||
127908288|NCT01693523|460287561|FG000|Overall Study|Adverse Event|2|||
127908289|NCT01693523|460287562|FG001|Overall Study|Adverse Event|1|||
127908290|NCT01693523|460287563|FG002|Overall Study|Adverse Event|0|||
127908291|NCT01693523|460287561|FG000|Overall Study|Death|0|||
127908292|NCT01693523|460287562|FG001|Overall Study|Death|1|||
127908293|NCT01693523|460287563|FG002|Overall Study|Death|1|||
127908294|NCT01693523|460287561|FG000|Overall Study|Lost to Follow-up|0|||
127908295|NCT01693523|460287562|FG001|Overall Study|Lost to Follow-up|0|||
127908296|NCT01693523|460287563|FG002|Overall Study|Lost to Follow-up|4|||
127908297|NCT01693523|460287561|FG000|Overall Study|Physician Decision|0|||
127908298|NCT01693523|460287562|FG001|Overall Study|Physician Decision|0|||
127908299|NCT01693523|460287563|FG002|Overall Study|Physician Decision|1|||
127908300|NCT01693523|460287561|FG000|Overall Study|Withdrawal by Subject|1|||
127908301|NCT01693523|460287562|FG001|Overall Study|Withdrawal by Subject|2|||
127908302|NCT01693523|460287563|FG002|Overall Study|Withdrawal by Subject|2|||
127908303|NCT01693523|460287561|FG000|Overall Study|Lack of compliance study medication|1|||
127908304|NCT01693523|460287562|FG001|Overall Study|Lack of compliance study medication|2|||
127908305|NCT01693523|460287563|FG002|Overall Study|Lack of compliance study medication|0|||
127908306|NCT01693523|460287561|FG000|Overall Study|Chemotherapy was held|1|||
127908307|NCT01693523|460287562|FG001|Overall Study|Chemotherapy was held|2|||
127908308|NCT01693523|460287563|FG002|Overall Study|Chemotherapy was held|0|||
127908309|NCT03343535|460287564|FG000|Overall Study|Lost to Follow-up|1|||
127908310|NCT03343535|460287564|FG000|Overall Study|Subject Discontinued Due to Re-transplant|1|||
127908311|NCT03343535|460287564|FG000|Overall Study|Death|12|||
127908312|NCT00777023|460287566|FG000|Overall Study|Adverse Event|15|||
127908313|NCT00777023|460287567|FG001|Overall Study|Adverse Event|21|||
127908314|NCT00777023|460287568|FG002|Overall Study|Adverse Event|8|||
127908315|NCT00777023|460287566|FG000|Overall Study|Lack of Efficacy|1|||
127908316|NCT00777023|460287567|FG001|Overall Study|Lack of Efficacy|0|||
127908317|NCT00777023|460287568|FG002|Overall Study|Lack of Efficacy|14|||
127908318|NCT00777023|460287566|FG000|Overall Study|Protocol Violation|2|||
127908319|NCT00777023|460287567|FG001|Overall Study|Protocol Violation|1|||
127908320|NCT00777023|460287568|FG002|Overall Study|Protocol Violation|1|||
127908321|NCT00777023|460287566|FG000|Overall Study|Lost to Follow-up|2|||
127908322|NCT00777023|460287567|FG001|Overall Study|Lost to Follow-up|3|||
127908323|NCT00777023|460287568|FG002|Overall Study|Lost to Follow-up|3|||
127908324|NCT00777023|460287566|FG000|Overall Study|Death|0|||
127908325|NCT00777023|460287567|FG001|Overall Study|Death|1|||
127908326|NCT00777023|460287568|FG002|Overall Study|Death|0|||
127908327|NCT00777023|460287566|FG000|Overall Study|Withdrawal by Subject|7|||
127908328|NCT00777023|460287567|FG001|Overall Study|Withdrawal by Subject|7|||
127908329|NCT00777023|460287568|FG002|Overall Study|Withdrawal by Subject|8|||
127908330|NCT00777023|460287566|FG000|Overall Study|Missing data|1|||
127908331|NCT00777023|460287567|FG001|Overall Study|Missing data|1|||
127908332|NCT00777023|460287568|FG002|Overall Study|Missing data|0|||
127908333|NCT00777023|460287566|FG000|Overall Study|Reasons not specified|4|||
127908334|NCT00777023|460287567|FG001|Overall Study|Reasons not specified|4|||
127908335|NCT00777023|460287568|FG002|Overall Study|Reasons not specified|2|||
127908336|NCT00777023|460287566|FG000|Overall Study|Last dose date unknown|3|||
127908337|NCT00777023|460287567|FG001|Overall Study|Last dose date unknown|3|||
127908338|NCT00777023|460287568|FG002|Overall Study|Last dose date unknown|1|||
127908339|NCT02659150|460287569|FG000|Subject Enrollment|Physician Decision|3|||
127908340|NCT02659150|460287569|FG000|Subject Enrollment|Withdrawal by Subject|2|||
127908341|NCT02659150|460287569|FG000|Baseline Imaging|Withdrawal by Subject|1|||
127908342|NCT02659150|460287569|FG000|Baseline Imaging|Physician Decision|1|||
127908343|NCT02659150|460287569|FG000|Study Drug Dosing|Adverse Event|1|||
127908344|NCT03699020|460287570|FG000|Overall Study|Withdrawal by Subject|3|||
127908345|NCT03699020|460287571|FG001|Overall Study|Withdrawal by Subject|2|||
127908346|NCT02246920|460287572|FG000|Overall Study|Adverse Event|3|||
127908347|NCT02246920|460287573|FG001|Overall Study|Adverse Event|1|||
127908348|NCT02246920|460287574|FG002|Overall Study|Adverse Event|1|||
127908349|NCT02246920|460287572|FG000|Overall Study|Lost to Follow-up|2|||
127908350|NCT02246920|460287573|FG001|Overall Study|Lost to Follow-up|1|||
127908351|NCT02246920|460287574|FG002|Overall Study|Lost to Follow-up|0|||
127908352|NCT02246920|460287572|FG000|Overall Study|Protocol Violation|2|||
127908353|NCT02246920|460287573|FG001|Overall Study|Protocol Violation|5|||
127908354|NCT02246920|460287574|FG002|Overall Study|Protocol Violation|1|||
127908355|NCT02246920|460287572|FG000|Overall Study|Withdrawal by Subject|0|||
127908356|NCT02246920|460287573|FG001|Overall Study|Withdrawal by Subject|0|||
127908357|NCT02246920|460287574|FG002|Overall Study|Withdrawal by Subject|1|||
127908358|NCT00448019|460287577|FG000|Overall Study|Withdrawal by Subject|3|||
127908359|NCT00448019|460287577|FG000|Overall Study|Disease progression|1|||
127908360|NCT00448019|460287577|FG000|Overall Study|Death|2|||
127908361|NCT00448019|460287577|FG000|Overall Study|Insurance Issues|1|||
127908362|NCT03620747|460287579|FG000|Overall Study|Participant decision|7|||
127908363|NCT03620747|460287579|FG000|Overall Study|Adverse Event|6|||
127908364|NCT03620747|460287579|FG000|Overall Study|Lack of Efficacy|1|||
127908365|NCT03620747|460287579|FG000|Overall Study|Poor compliance to protocol|2|||
127908366|NCT03620747|460287579|FG000|Overall Study|Other-unspecified|3|||
127908367|NCT02714062|460287580|FG000|Overall Study|Adverse Event|0|||
127908368|NCT02714062|460287581|FG001|Overall Study|Adverse Event|0|||
127908369|NCT02714062|460287582|FG002|Overall Study|Adverse Event|2|||
127908370|NCT02714062|460287580|FG000|Overall Study|Withdrawal by Subject|1|||
127908371|NCT02714062|460287581|FG001|Overall Study|Withdrawal by Subject|0|||
127908372|NCT02714062|460287582|FG002|Overall Study|Withdrawal by Subject|1|||
127908373|NCT02714062|460287580|FG000|Overall Study|Protocol Violation|0|||
127908374|NCT02714062|460287581|FG001|Overall Study|Protocol Violation|1|||
127908375|NCT02714062|460287582|FG002|Overall Study|Protocol Violation|0|||
127908376|NCT00904215|460287586|FG000|Overall Study|Adverse Event|25|||
127908377|NCT00904215|460287586|FG000|Overall Study|Protocol Violation|10|||
127908378|NCT00904215|460287586|FG000|Overall Study|Lost to Follow-up|63|||
127908379|NCT00904215|460287586|FG000|Overall Study|Withdrawal by Subject|9|||
127908380|NCT00904215|460287586|FG000|Overall Study|Other|28|||
127908381|NCT00244764|460287587|FG000|Overall Study|Adverse Event|37|||
127908382|NCT00244764|460287587|FG000|Overall Study|Lost to Follow-up|23|||
127908383|NCT00244764|460287587|FG000|Overall Study|Withdrawal by Subject|12|||
127908384|NCT00244764|460287587|FG000|Overall Study|Disease Progression|13|||
127908385|NCT00244764|460287587|FG000|Overall Study|Protocol Violation|2|||
127908386|NCT00244764|460287587|FG000|Overall Study|Death|1|||
127908387|NCT00244764|460287587|FG000|Overall Study|Off Study Medication for >21 Days|1|||
127908388|NCT00244764|460287587|FG000|Overall Study|Declining Performance Status|1|||
127908389|NCT00244764|460287587|FG000|Overall Study|Participant was Hospitalized until Death|1|||
127908390|NCT00244764|460287587|FG000|Overall Study|Primary Investigator Discretion|2|||
127908391|NCT00244764|460287587|FG000|Overall Study|Sponsor Terminated Study|2|||
127908392|NCT00244764|460287587|FG000|Overall Study|Developed Secondary Malignancy|1|||
127908393|NCT04022954|460287597|FG000|Consented to Completed Procedure|Consented Screen Failure|1|||
127908394|NCT04022954|460287597|FG000|Completed 12-month Follow-up|Lost to Follow-up|5|||
127908395|NCT04022954|460287597|FG000|Completed 12-month Follow-up|Withdrawal by Subject|3|||
127908396|NCT03017885|460287598|FG000|Overall Study|Adverse Event|2|||
127908397|NCT03017885|460287599|FG001|Overall Study|Adverse Event|0|||
127908398|NCT03017885|460287600|FG002|Overall Study|Adverse Event|0|||
127908399|NCT03017885|460287601|FG003|Overall Study|Adverse Event|0|||
127908400|NCT03017885|460287602|FG004|Overall Study|Adverse Event|0|||
127908401|NCT03017885|460287603|FG005|Overall Study|Adverse Event|0|||
127908402|NCT03017885|460287598|FG000|Overall Study|Progression of disease|4|||
127908403|NCT03017885|460287599|FG001|Overall Study|Progression of disease|3|||
127908404|NCT03017885|460287600|FG002|Overall Study|Progression of disease|4|||
127908405|NCT03017885|460287601|FG003|Overall Study|Progression of disease|0|||
127908406|NCT03017885|460287602|FG004|Overall Study|Progression of disease|0|||
127908407|NCT03017885|460287603|FG005|Overall Study|Progression of disease|0|||
127908408|NCT03017885|460287598|FG000|Overall Study|Other than listed|1|||
127908409|NCT03017885|460287599|FG001|Overall Study|Other than listed|2|||
127908410|NCT03017885|460287600|FG002|Overall Study|Other than listed|1|||
127908411|NCT03017885|460287601|FG003|Overall Study|Other than listed|0|||
127908412|NCT03017885|460287602|FG004|Overall Study|Other than listed|0|||
127908413|NCT03017885|460287603|FG005|Overall Study|Other than listed|0|||
127908414|NCT03017885|460287598|FG000|Overall Study|Lost to Follow-up|2|||
127908415|NCT03017885|460287599|FG001|Overall Study|Lost to Follow-up|0|||
127908416|NCT03017885|460287600|FG002|Overall Study|Lost to Follow-up|3|||
127908417|NCT03017885|460287601|FG003|Overall Study|Lost to Follow-up|0|||
127908418|NCT03017885|460287602|FG004|Overall Study|Lost to Follow-up|0|||
127908419|NCT03017885|460287603|FG005|Overall Study|Lost to Follow-up|0|||
127908420|NCT03017885|460287598|FG000|Overall Study|Change to other anti-cancer therapy|0|||
127908421|NCT03017885|460287599|FG001|Overall Study|Change to other anti-cancer therapy|0|||
127908422|NCT03017885|460287600|FG002|Overall Study|Change to other anti-cancer therapy|1|||
127908423|NCT03017885|460287601|FG003|Overall Study|Change to other anti-cancer therapy|0|||
127908424|NCT03017885|460287602|FG004|Overall Study|Change to other anti-cancer therapy|0|||
127908425|NCT03017885|460287603|FG005|Overall Study|Change to other anti-cancer therapy|0|||
127908426|NCT03872128|460287606|FG000|Overall Study|Dropped out before treatment|1|||
127908427|NCT03872128|460287607|FG001|Overall Study|Dropped out before treatment|0|||
127908428|NCT03872128|460287608|FG002|Overall Study|Dropped out before treatment|4|||
127908429|NCT03872128|460287606|FG000|Overall Study|Lost to Follow-up|2|||
127908430|NCT03872128|460287607|FG001|Overall Study|Lost to Follow-up|5|||
127908431|NCT03872128|460287608|FG002|Overall Study|Lost to Follow-up|8|||
127908432|NCT03285594|460287610|FG000|Overall Study|At the Participant's Own Request|10|||
127908433|NCT03285594|460287611|FG001|Overall Study|At the Participant's Own Request|5|||
127908434|NCT03285594|460287612|FG002|Overall Study|At the Participant's Own Request|21|||
127908435|NCT03285594|460287610|FG000|Overall Study|Adverse Event|2|||
127908436|NCT03285594|460287611|FG001|Overall Study|Adverse Event|2|||
127908437|NCT03285594|460287612|FG002|Overall Study|Adverse Event|6|||
127908438|NCT03285594|460287610|FG000|Overall Study|Poor Compliance to Protocol|0|||
127908439|NCT03285594|460287611|FG001|Overall Study|Poor Compliance to Protocol|0|||
127908440|NCT03285594|460287612|FG002|Overall Study|Poor Compliance to Protocol|1|||
127908441|NCT03285594|460287610|FG000|Overall Study|Lost to Follow-up|0|||
127908442|NCT03285594|460287611|FG001|Overall Study|Lost to Follow-up|0|||
127908443|NCT03285594|460287612|FG002|Overall Study|Lost to Follow-up|1|||
127908444|NCT03285594|460287610|FG000|Overall Study|Reason Not Specified|3|||
127908445|NCT03285594|460287611|FG001|Overall Study|Reason Not Specified|4|||
127908446|NCT03285594|460287612|FG002|Overall Study|Reason Not Specified|8|||
127908447|NCT02648438|460287616|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
127908448|NCT02648438|460287617|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
127908449|NCT02648438|460287618|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
127908450|NCT02648438|460287616|FG000|Overall Study|Protocol Violation|2|||
127856632|NCT01852591|460092346|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
127856633|NCT04088331|460092348|FG000|Overall Study|Lost to Follow-up|3|||
127856634|NCT04088331|460092348|FG000|Overall Study|Withdrawal by Subject|7|||
127856635|NCT04088331|460092348|FG000|Overall Study|Adverse Event|4|||
127856636|NCT00976963|460092359|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
127856637|NCT00976963|460092360|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
127856638|NCT00976963|460092359|FG000|Overall Study|administrative error|1|||
127856639|NCT00976963|460092360|FG001|Overall Study|administrative error|0|||
127856640|NCT00976963|460092359|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
127856641|NCT00976963|460092360|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
127856642|NCT02756845|460092363|FG000|Overall Study|Death|12|||
127856643|NCT02756845|460092364|FG001|Overall Study|Death|2|||
127856644|NCT02756845|460092363|FG000|Overall Study|Withdrawal by Subject|1|||
127856645|NCT02756845|460092364|FG001|Overall Study|Withdrawal by Subject|0|||
127856646|NCT01688999|460092367|FG000|Overall Study|Withdrawal by Subject|5|||
127856647|NCT01688999|460092368|FG001|Overall Study|Withdrawal by Subject|1|||
127856648|NCT01688999|460092369|FG002|Overall Study|Withdrawal by Subject|1|||
127856649|NCT01688999|460092367|FG000|Overall Study|Adverse Event|2|||
127856650|NCT01688999|460092368|FG001|Overall Study|Adverse Event|0|||
127856651|NCT01688999|460092369|FG002|Overall Study|Adverse Event|2|||
127856652|NCT01688999|460092367|FG000|Overall Study|Ineligible/Not treated|1|||
127856653|NCT01688999|460092368|FG001|Overall Study|Ineligible/Not treated|0|||
127856654|NCT01688999|460092369|FG002|Overall Study|Ineligible/Not treated|0|||
127856655|NCT02768103|460092370|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
127856656|NCT03369704|460092392|FG000|Treatment Epoch|technical problems|1|||
127856657|NCT03369704|460092393|FG001|Treatment Epoch|technical problems|0|||
127856658|NCT03369704|460092392|FG000|Treatment Epoch|Protocol Violation|1|||
127856659|NCT03369704|460092393|FG001|Treatment Epoch|Protocol Violation|0|||
127856660|NCT03369704|460092392|FG000|Treatment Epoch|Lost to Follow-up|0|||
127856661|NCT03369704|460092393|FG001|Treatment Epoch|Lost to Follow-up|1|||
127856662|NCT03369704|460092392|FG000|Treatment Epoch|Lack of Efficacy|0|||
127856663|NCT03369704|460092393|FG001|Treatment Epoch|Lack of Efficacy|2|||
127856664|NCT03369704|460092392|FG000|Treatment Epoch|Adverse Event|2|||
127856665|NCT03369704|460092393|FG001|Treatment Epoch|Adverse Event|0|||
127856666|NCT03369704|460092392|FG000|Follow-up Epoch|Lost to Follow-up|1|||
127856667|NCT03369704|460092393|FG001|Follow-up Epoch|Lost to Follow-up|0|||
127856668|NCT02348840|460092394|FG000|Overall Study|Withdrawal by Subject|2|||
127856669|NCT02348840|460092395|FG001|Overall Study|Withdrawal by Subject|1|||
127856670|NCT02348840|460092396|FG002|Overall Study|Withdrawal by Subject|0|||
127856671|NCT02348840|460092397|FG003|Overall Study|Withdrawal by Subject|0|||
127856672|NCT02148952|460092398|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
127856673|NCT02148952|460092399|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
127856674|NCT02148952|460092398|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
127856675|NCT02148952|460092399|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
127856676|NCT02148952|460092398|FG000|Follow-Up|Lost to Follow-up|219|||
127856677|NCT02148952|460092399|FG001|Follow-Up|Lost to Follow-up|231|||
127856678|NCT02148952|460092398|FG000|Follow-Up|Withdrawal by Subject|46|||
127856679|NCT02148952|460092399|FG001|Follow-Up|Withdrawal by Subject|48|||
127856680|NCT01025232|460092400|FG000|Overall Study|Study drug no longer available|3|||
127856681|NCT01025232|460092401|FG001|Overall Study|Study drug no longer available|6|||
127856682|NCT01263444|460092402|FG000|Overall Study|Adverse Event|8|||
127856683|NCT01263444|460092402|FG000|Overall Study|Withdrawal by Subject|1|||
127856684|NCT01263444|460092402|FG000|Overall Study|Protocol Violation|1|||
127856685|NCT00085644|460092403|FG000|Double-Blind Period|Adverse Event|5|||
127856686|NCT00085644|460092404|FG001|Double-Blind Period|Adverse Event|2|||
127856687|NCT00085644|460092405|FG002|Double-Blind Period|Adverse Event|0|||
127856688|NCT00085644|460092403|FG000|Double-Blind Period|Withdrawal by Subject|3|||
127856689|NCT00085644|460092404|FG001|Double-Blind Period|Withdrawal by Subject|0|||
127856690|NCT00085644|460092405|FG002|Double-Blind Period|Withdrawal by Subject|0|||
127856691|NCT00085644|460092403|FG000|Double-Blind Period|Lost to Follow-up|2|||
127856692|NCT00085644|460092404|FG001|Double-Blind Period|Lost to Follow-up|1|||
127856693|NCT00085644|460092405|FG002|Double-Blind Period|Lost to Follow-up|0|||
127856694|NCT00085644|460092403|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
127856695|NCT00085644|460092404|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
127856696|NCT00085644|460092405|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
127908451|NCT02648438|460287617|FG001|Overall Study|Protocol Violation|0|||
127908452|NCT02648438|460287618|FG002|Overall Study|Protocol Violation|0|||
127856697|NCT00085644|460092403|FG000|Double-Blind Period|Contemplating pregnancy|1|||
127856698|NCT00085644|460092404|FG001|Double-Blind Period|Contemplating pregnancy|0|||
127856699|NCT00085644|460092405|FG002|Double-Blind Period|Contemplating pregnancy|0|||
127856700|NCT00085644|460092403|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
127856701|NCT00085644|460092404|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
127856702|NCT00085644|460092405|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
127856703|NCT00085644|460092403|FG000|Open-Label Period|Adverse Event|0|||
127856704|NCT00085644|460092404|FG001|Open-Label Period|Adverse Event|0|||
127856705|NCT00085644|460092405|FG002|Open-Label Period|Adverse Event|38|||
127856706|NCT00085644|460092403|FG000|Open-Label Period|Withdrawal by Subject|0|||
127856707|NCT00085644|460092404|FG001|Open-Label Period|Withdrawal by Subject|0|||
127856708|NCT00085644|460092405|FG002|Open-Label Period|Withdrawal by Subject|29|||
127856709|NCT00085644|460092403|FG000|Open-Label Period|Lost to Follow-up|0|||
127856710|NCT00085644|460092404|FG001|Open-Label Period|Lost to Follow-up|0|||
127856711|NCT00085644|460092405|FG002|Open-Label Period|Lost to Follow-up|13|||
127856712|NCT00085644|460092403|FG000|Open-Label Period|Lack of Efficacy|0|||
127856713|NCT00085644|460092404|FG001|Open-Label Period|Lack of Efficacy|0|||
127856714|NCT00085644|460092405|FG002|Open-Label Period|Lack of Efficacy|15|||
127856715|NCT00085644|460092403|FG000|Open-Label Period|Pregnancy|0|||
127856716|NCT00085644|460092404|FG001|Open-Label Period|Pregnancy|0|||
127856717|NCT00085644|460092405|FG002|Open-Label Period|Pregnancy|3|||
127856718|NCT00085644|460092403|FG000|Open-Label Period|Contemplating pregnancy|0|||
127856719|NCT00085644|460092404|FG001|Open-Label Period|Contemplating pregnancy|0|||
127856720|NCT00085644|460092405|FG002|Open-Label Period|Contemplating pregnancy|3|||
127856721|NCT00085644|460092403|FG000|Open-Label Period|Protocol Violation|0|||
127856722|NCT00085644|460092404|FG001|Open-Label Period|Protocol Violation|0|||
127856723|NCT00085644|460092405|FG002|Open-Label Period|Protocol Violation|4|||
127856724|NCT00085644|460092403|FG000|Open-Label Period|Personal reason|0|||
127856725|NCT00085644|460092404|FG001|Open-Label Period|Personal reason|0|||
127856726|NCT00085644|460092405|FG002|Open-Label Period|Personal reason|4|||
127856727|NCT03330106|460092406|FG000|Part A|Withdrawal by Subject|1|||
127856728|NCT03330106|460092407|FG001|Part A|Withdrawal by Subject|1|||
127856729|NCT03330106|460092408|FG002|Part A|Withdrawal by Subject|0|||
127856730|NCT03330106|460092409|FG003|Part A|Withdrawal by Subject|0|||
127856731|NCT03330106|460092406|FG000|Part A|Death|2|||
127856732|NCT03330106|460092407|FG001|Part A|Death|1|||
127856733|NCT03330106|460092408|FG002|Part A|Death|0|||
127856734|NCT03330106|460092409|FG003|Part A|Death|0|||
127856735|NCT03330106|460092406|FG000|Part A|Adverse Event|0|||
127856736|NCT03330106|460092407|FG001|Part A|Adverse Event|1|||
127856737|NCT03330106|460092408|FG002|Part A|Adverse Event|0|||
127856738|NCT03330106|460092409|FG003|Part A|Adverse Event|0|||
127856739|NCT03330106|460092406|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
127856740|NCT03330106|460092407|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
127856741|NCT03330106|460092408|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
127856742|NCT03330106|460092409|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
127856743|NCT03330106|460092406|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
127856744|NCT03330106|460092407|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
127856745|NCT03330106|460092408|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
127856746|NCT03330106|460092409|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
127856747|NCT03330106|460092406|FG000|Part A|Progressive Disease|0|||
127856748|NCT03330106|460092407|FG001|Part A|Progressive Disease|1|||
127856749|NCT03330106|460092408|FG002|Part A|Progressive Disease|0|||
127856750|NCT03330106|460092409|FG003|Part A|Progressive Disease|0|||
127856751|NCT03330106|460092406|FG000|Part B|Lost to Follow-up|0|||
127856752|NCT03330106|460092407|FG001|Part B|Lost to Follow-up|0|||
127856753|NCT03330106|460092408|FG002|Part B|Lost to Follow-up|0|||
127856754|NCT03330106|460092409|FG003|Part B|Lost to Follow-up|1|||
127856755|NCT03330106|460092406|FG000|Part B|Withdrawal by Subject|0|||
127856756|NCT03330106|460092407|FG001|Part B|Withdrawal by Subject|0|||
127856757|NCT03330106|460092408|FG002|Part B|Withdrawal by Subject|4|||
127856758|NCT03330106|460092409|FG003|Part B|Withdrawal by Subject|0|||
127856759|NCT03330106|460092406|FG000|Part B|Death|0|||
127856760|NCT03330106|460092407|FG001|Part B|Death|0|||
127856761|NCT03330106|460092408|FG002|Part B|Death|2|||
127856762|NCT03330106|460092409|FG003|Part B|Death|0|||
127856763|NCT03330106|460092406|FG000|Part B|Clinical Progression|0|||
127856764|NCT03330106|460092407|FG001|Part B|Clinical Progression|0|||
127856765|NCT03330106|460092408|FG002|Part B|Clinical Progression|1|||
127856766|NCT03330106|460092409|FG003|Part B|Clinical Progression|1|||
127856767|NCT03330106|460092406|FG000|Part B|Symptomatic Deterioration|0|||
127856768|NCT03330106|460092407|FG001|Part B|Symptomatic Deterioration|0|||
127856769|NCT03330106|460092408|FG002|Part B|Symptomatic Deterioration|0|||
127856770|NCT03330106|460092409|FG003|Part B|Symptomatic Deterioration|1|||
127856771|NCT03330106|460092406|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
127856772|NCT03330106|460092407|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
127908453|NCT02648438|460287616|FG000|Overall Study|Withdrawal by Subject|1|||
127908454|NCT02648438|460287617|FG001|Overall Study|Withdrawal by Subject|1|||
127908455|NCT02648438|460287618|FG002|Overall Study|Withdrawal by Subject|0|||
127908456|NCT02258074|460287619|FG000|Overall Study|Withdrawal by Subject|1|||
127908457|NCT02258074|460287620|FG001|Overall Study|Withdrawal by Subject|0|||
127908458|NCT02258074|460287621|FG002|Overall Study|Withdrawal by Subject|0|||
127856773|NCT03330106|460092408|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
127856774|NCT03330106|460092409|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
127856775|NCT03330106|460092406|FG000|Part B|Progressive Disease|0|||
127856776|NCT03330106|460092407|FG001|Part B|Progressive Disease|0|||
127856777|NCT03330106|460092408|FG002|Part B|Progressive Disease|11|||
127856778|NCT03330106|460092409|FG003|Part B|Progressive Disease|4|||
127856779|NCT02324049|460092411|FG000|Part C|Study terminated|11|||
127856780|NCT03198728|460092413|FG000|Overall Study|Adverse Event|10|||
127856781|NCT03198728|460092414|FG001|Overall Study|Adverse Event|5|||
127856782|NCT03198728|460092413|FG000|Overall Study|Lost to Follow-up|21|||
127856783|NCT03198728|460092414|FG001|Overall Study|Lost to Follow-up|7|||
127856784|NCT03198728|460092413|FG000|Overall Study|Physician Decision|7|||
127856785|NCT03198728|460092414|FG001|Overall Study|Physician Decision|2|||
127856786|NCT03198728|460092413|FG000|Overall Study|Withdrawal by Subject|14|||
127856787|NCT03198728|460092414|FG001|Overall Study|Withdrawal by Subject|10|||
127856788|NCT04051944|460092418|FG000|Overall Study|Study ending|1|||
127856789|NCT04051944|460092419|FG001|Overall Study|Study ending|1|||
127856790|NCT04051944|460092418|FG000|Overall Study|Early study termination by participant|1|||
127856791|NCT04051944|460092419|FG001|Overall Study|Early study termination by participant|0|||
127856792|NCT04051944|460092418|FG000|Overall Study|Withdrawal by Subject|2|||
127856793|NCT04051944|460092419|FG001|Overall Study|Withdrawal by Subject|2|||
127856794|NCT04051944|460092418|FG000|Overall Study|Lack of Efficacy|3|||
127856795|NCT04051944|460092419|FG001|Overall Study|Lack of Efficacy|0|||
127856796|NCT04051944|460092418|FG000|Overall Study|Adverse event, non- fatal|1|||
127856797|NCT04051944|460092419|FG001|Overall Study|Adverse event, non- fatal|1|||
127856798|NCT00736450|460092420|FG000|Overall Study|Not ABC gene eligible|19|||
127856799|NCT00736450|460092420|FG000|Overall Study|Withdrawal by Subject|5|||
127856800|NCT00736450|460092420|FG000|Overall Study|Physician Decision|1|||
127856801|NCT01947894|460092428|FG000|Overall Study|Other|3|||
127856802|NCT01947894|460092429|FG001|Overall Study|Other|4|||
127856803|NCT01947894|460092430|FG002|Overall Study|Other|3|||
127856804|NCT01947894|460092428|FG000|Overall Study|Withdrawal by Subject|12|||
127856805|NCT01947894|460092429|FG001|Overall Study|Withdrawal by Subject|4|||
127856806|NCT01947894|460092430|FG002|Overall Study|Withdrawal by Subject|1|||
127856807|NCT01947894|460092428|FG000|Overall Study|Death|12|||
127856808|NCT01947894|460092429|FG001|Overall Study|Death|1|||
127856809|NCT01947894|460092430|FG002|Overall Study|Death|0|||
127856810|NCT01947894|460092428|FG000|Overall Study|Physician Decision|2|||
127856811|NCT01947894|460092429|FG001|Overall Study|Physician Decision|0|||
127856812|NCT01947894|460092430|FG002|Overall Study|Physician Decision|0|||
127856813|NCT01947894|460092428|FG000|Overall Study|Adverse Event|5|||
127856814|NCT01947894|460092429|FG001|Overall Study|Adverse Event|1|||
127856815|NCT01947894|460092430|FG002|Overall Study|Adverse Event|0|||
127856816|NCT01947894|460092428|FG000|Overall Study|Switched to other growth hormone brand|53|||
127856817|NCT01947894|460092429|FG001|Overall Study|Switched to other growth hormone brand|8|||
127856818|NCT01947894|460092430|FG002|Overall Study|Switched to other growth hormone brand|23|||
127856819|NCT00333970|460092432|FG000|Overall Study|Withdrawal by Subject|13|||
127856820|NCT00333970|460092433|FG001|Overall Study|Withdrawal by Subject|7|||
127856821|NCT02829775|460092434|FG000|Overall Study|Death|1|||
127856822|NCT02829775|460092434|FG000|Overall Study|Withdrawal by Subject|3|||
127856823|NCT02829775|460092434|FG000|Overall Study|Disease remission|1|||
127856824|NCT01313039|460092441|FG000|Overall Study|Physician Decision|1|||
127856825|NCT01313039|460092441|FG000|Overall Study|Adverse Event|1|||
127856826|NCT00609167|460092442|FG000|Overall Study|Withdrawal by Subject|1|||
127856827|NCT00609167|460092443|FG001|Overall Study|Withdrawal by Subject|0|||
127856828|NCT00609167|460092442|FG000|Overall Study|Lack of Efficacy|1|||
127856829|NCT00609167|460092443|FG001|Overall Study|Lack of Efficacy|0|||
127856830|NCT00609167|460092442|FG000|Overall Study|Adverse Event|5|||
127856831|NCT00609167|460092443|FG001|Overall Study|Adverse Event|1|||
127856832|NCT00609167|460092442|FG000|Overall Study|Disease Progression|1|||
127856833|NCT00609167|460092443|FG001|Overall Study|Disease Progression|0|||
127856834|NCT00609167|460092442|FG000|Overall Study|Stem Cell Transplant|0|||
127856835|NCT00609167|460092443|FG001|Overall Study|Stem Cell Transplant|6|||
127908459|NCT02258074|460287622|FG003|Overall Study|Withdrawal by Subject|0|||
127908460|NCT02739997|460287623|FG000|Overall Study|Death|1|||
127908461|NCT02739997|460287623|FG000|Overall Study|Withdrawal by Subject|1|||
127856836|NCT01307046|460092444|FG000|Overall Study|Adverse Event|3|||
127856837|NCT01307046|460092445|FG001|Overall Study|Adverse Event|3|||
127856838|NCT01307046|460092444|FG000|Overall Study|Lack of Efficacy|0|||
127856839|NCT01307046|460092445|FG001|Overall Study|Lack of Efficacy|2|||
127856840|NCT01307046|460092444|FG000|Overall Study|Physician Decision|2|||
127908462|NCT03552393|460287627|FG000|Core Period|Kidney Transplant|1|||
127856841|NCT01307046|460092445|FG001|Overall Study|Physician Decision|0|||
127856842|NCT01307046|460092444|FG000|Overall Study|Withdrawal by Subject|1|||
127856843|NCT01307046|460092445|FG001|Overall Study|Withdrawal by Subject|1|||
127856844|NCT01307046|460092444|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
127856845|NCT01307046|460092445|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
127856846|NCT01307046|460092444|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
127856847|NCT01307046|460092445|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
127856848|NCT02574520|460092446|FG000|Overall Study|Not dosed|2|||
127856849|NCT02574520|460092447|FG001|Overall Study|Not dosed|0|||
127856850|NCT02574520|460092448|FG002|Overall Study|Not dosed|5|||
127856851|NCT02574520|460092449|FG003|Overall Study|Not dosed|4|||
127856852|NCT02574520|460092446|FG000|Overall Study|Adverse Event|0|||
127856853|NCT02574520|460092447|FG001|Overall Study|Adverse Event|0|||
127856854|NCT02574520|460092448|FG002|Overall Study|Adverse Event|0|||
127856855|NCT02574520|460092449|FG003|Overall Study|Adverse Event|1|||
127856856|NCT02574520|460092446|FG000|Overall Study|Withdrawal by Subject|0|||
127856857|NCT02574520|460092447|FG001|Overall Study|Withdrawal by Subject|0|||
127856858|NCT02574520|460092448|FG002|Overall Study|Withdrawal by Subject|0|||
127856859|NCT02574520|460092449|FG003|Overall Study|Withdrawal by Subject|1|||
127856860|NCT02574520|460092446|FG000|Overall Study|Other|0|||
127856861|NCT02574520|460092447|FG001|Overall Study|Other|0|||
127856862|NCT02574520|460092448|FG002|Overall Study|Other|0|||
127856863|NCT02574520|460092449|FG003|Overall Study|Other|2|||
127856864|NCT03935594|460092450|FG000|Overall Study|Physician Decision|3|||
127856865|NCT01435122|460092451|FG000|Overall Study|Early withdrawal due to toxicity|8|||
127856866|NCT04888507|460094563|FG000|Open-Label Treatment (OLTP) (32 Weeks)|Adverse Event|1|||
127856867|NCT02358863|460094564|FG000|Overall Study|Physician Decision|3|||
127856868|NCT02531633|460094567|FG000|Part A (52 Weeks)|Sponsor request|24|||
127856869|NCT02531633|460094568|FG001|Part A (52 Weeks)|Sponsor request|24|||
127856870|NCT02531633|460094569|FG002|Part A (52 Weeks)|Sponsor request|18|||
127856871|NCT02531633|460094570|FG003|Part A (52 Weeks)|Sponsor request|18|||
127856872|NCT02531633|460094571|FG004|Part A (52 Weeks)|Sponsor request|19|||
127856873|NCT02531633|460094572|FG005|Part A (52 Weeks)|Sponsor request|0|||
127856874|NCT02531633|460094573|FG006|Part A (52 Weeks)|Sponsor request|0|||
127856875|NCT02531633|460094574|FG007|Part A (52 Weeks)|Sponsor request|0|||
127856876|NCT02531633|460094575|FG008|Part A (52 Weeks)|Sponsor request|0|||
127856877|NCT02531633|460094576|FG009|Part A (52 Weeks)|Sponsor request|0|||
127908463|NCT03552393|460287627|FG000|Core Period|Prohibited Medication|1|||
127908464|NCT03552393|460287627|FG000|Safety Extension Period|Kidney Transplant|4|||
127908465|NCT02601625|460287628|FG000|Overall Study|Lost to Follow-up|0|||
127908466|NCT02601625|460287629|FG001|Overall Study|Lost to Follow-up|0|||
127908467|NCT02601625|460287630|FG002|Overall Study|Lost to Follow-up|1|||
127908468|NCT02601625|460287631|FG003|Overall Study|Lost to Follow-up|1|||
127908469|NCT00359281|460287633|FG000|Overall Study|Adverse Event|1|||
127908470|NCT00359281|460287634|FG001|Overall Study|Adverse Event|0|||
127908471|NCT00359281|460287635|FG002|Overall Study|Adverse Event|0|||
127908472|NCT00359281|460287636|FG003|Overall Study|Adverse Event|0|||
127908473|NCT00359281|460287637|FG004|Overall Study|Adverse Event|0|||
127908474|NCT00359281|460287638|FG005|Overall Study|Adverse Event|0|||
127908475|NCT00359281|460287639|FG006|Overall Study|Adverse Event|1|||
127908476|NCT00359281|460287640|FG007|Overall Study|Adverse Event|0|||
127908477|NCT00359281|460287641|FG008|Overall Study|Adverse Event|0|||
127908478|NCT00359281|460287633|FG000|Overall Study|Withdrawal by Subject|0|||
127908479|NCT00359281|460287634|FG001|Overall Study|Withdrawal by Subject|0|||
127908480|NCT00359281|460287635|FG002|Overall Study|Withdrawal by Subject|0|||
127908481|NCT00359281|460287636|FG003|Overall Study|Withdrawal by Subject|0|||
127908482|NCT00359281|460287637|FG004|Overall Study|Withdrawal by Subject|0|||
127908483|NCT00359281|460287638|FG005|Overall Study|Withdrawal by Subject|0|||
127856878|NCT02531633|460094567|FG000|Part A (52 Weeks)|Protocol Violation|1|||
127856879|NCT02531633|460094568|FG001|Part A (52 Weeks)|Protocol Violation|0|||
127856880|NCT02531633|460094569|FG002|Part A (52 Weeks)|Protocol Violation|0|||
127856881|NCT02531633|460094570|FG003|Part A (52 Weeks)|Protocol Violation|0|||
127856882|NCT02531633|460094571|FG004|Part A (52 Weeks)|Protocol Violation|0|||
127908484|NCT00359281|460287639|FG006|Overall Study|Withdrawal by Subject|1|||
127908485|NCT00359281|460287640|FG007|Overall Study|Withdrawal by Subject|0|||
127908486|NCT00359281|460287641|FG008|Overall Study|Withdrawal by Subject|0|||
127856883|NCT02531633|460094572|FG005|Part A (52 Weeks)|Protocol Violation|0|||
127856884|NCT02531633|460094573|FG006|Part A (52 Weeks)|Protocol Violation|0|||
127908487|NCT04887415|460287642|FG000|Overall Study|Lost to Follow-up|2|||
127908488|NCT00840411|460287646|FG000|First Intervention|Adverse Event|1|||
127908489|NCT00840411|460287647|FG001|First Intervention|Adverse Event|0|||
127908490|NCT00840411|460287646|FG000|Washout|Withdrawal by Subject|1|||
127908491|NCT00840411|460287647|FG001|Washout|Withdrawal by Subject|0|||
127908492|NCT05472038|460289125|FG000|Overall Study|Adverse Event|0|||
127908493|NCT05472038|460289126|FG001|Overall Study|Adverse Event|0|||
127908494|NCT05472038|460289127|FG002|Overall Study|Adverse Event|1|||
127908495|NCT05472038|460289128|FG003|Overall Study|Adverse Event|0|||
127908496|NCT05472038|460289129|FG004|Overall Study|Adverse Event|0|||
127908497|NCT05472038|460289130|FG005|Overall Study|Adverse Event|0|||
127908498|NCT05472038|460289131|FG006|Overall Study|Adverse Event|0|||
127908499|NCT05472038|460289132|FG007|Overall Study|Adverse Event|0|||
127908500|NCT05472038|460289133|FG008|Overall Study|Adverse Event|0|||
127908501|NCT05472038|460289134|FG009|Overall Study|Adverse Event|0|||
127908502|NCT05472038|460289135|FG010|Overall Study|Adverse Event|0|||
127908503|NCT05472038|460289136|FG011|Overall Study|Adverse Event|0|||
127908504|NCT05472038|460289125|FG000|Overall Study|Death|0|||
127908505|NCT05472038|460289126|FG001|Overall Study|Death|0|||
127908506|NCT05472038|460289127|FG002|Overall Study|Death|0|||
127908507|NCT05472038|460289128|FG003|Overall Study|Death|0|||
127908508|NCT05472038|460289129|FG004|Overall Study|Death|0|||
127908509|NCT05472038|460289130|FG005|Overall Study|Death|1|||
127908510|NCT05472038|460289131|FG006|Overall Study|Death|0|||
127908511|NCT05472038|460289132|FG007|Overall Study|Death|0|||
127908512|NCT05472038|460289133|FG008|Overall Study|Death|0|||
127908513|NCT05472038|460289134|FG009|Overall Study|Death|0|||
127908514|NCT05472038|460289135|FG010|Overall Study|Death|0|||
127908515|NCT05472038|460289136|FG011|Overall Study|Death|0|||
127908516|NCT05472038|460289125|FG000|Overall Study|Lost to Follow-up|1|||
127908517|NCT05472038|460289126|FG001|Overall Study|Lost to Follow-up|3|||
127908518|NCT05472038|460289127|FG002|Overall Study|Lost to Follow-up|3|||
127908519|NCT05472038|460289128|FG003|Overall Study|Lost to Follow-up|9|||
127908520|NCT05472038|460289129|FG004|Overall Study|Lost to Follow-up|2|||
127908521|NCT05472038|460289130|FG005|Overall Study|Lost to Follow-up|2|||
127908522|NCT05472038|460289131|FG006|Overall Study|Lost to Follow-up|1|||
127908523|NCT05472038|460289132|FG007|Overall Study|Lost to Follow-up|0|||
127908524|NCT05472038|460289133|FG008|Overall Study|Lost to Follow-up|1|||
127908525|NCT05472038|460289134|FG009|Overall Study|Lost to Follow-up|0|||
127908526|NCT05472038|460289135|FG010|Overall Study|Lost to Follow-up|2|||
127908527|NCT05472038|460289136|FG011|Overall Study|Lost to Follow-up|1|||
127908528|NCT05472038|460289125|FG000|Overall Study|Physician Decision|0|||
127908529|NCT05472038|460289126|FG001|Overall Study|Physician Decision|0|||
127908530|NCT05472038|460289127|FG002|Overall Study|Physician Decision|0|||
127908531|NCT05472038|460289128|FG003|Overall Study|Physician Decision|0|||
127908532|NCT05472038|460289129|FG004|Overall Study|Physician Decision|1|||
127908533|NCT05472038|460289130|FG005|Overall Study|Physician Decision|0|||
127908534|NCT05472038|460289131|FG006|Overall Study|Physician Decision|0|||
127908535|NCT05472038|460289132|FG007|Overall Study|Physician Decision|0|||
127908536|NCT05472038|460289133|FG008|Overall Study|Physician Decision|0|||
127908537|NCT05472038|460289134|FG009|Overall Study|Physician Decision|0|||
127908538|NCT05472038|460289135|FG010|Overall Study|Physician Decision|0|||
127908539|NCT05472038|460289136|FG011|Overall Study|Physician Decision|0|||
127908540|NCT05472038|460289125|FG000|Overall Study|Withdrawal by Subject|1|||
127908541|NCT05472038|460289126|FG001|Overall Study|Withdrawal by Subject|3|||
127908542|NCT05472038|460289127|FG002|Overall Study|Withdrawal by Subject|1|||
127908543|NCT05472038|460289128|FG003|Overall Study|Withdrawal by Subject|6|||
127908544|NCT05472038|460289129|FG004|Overall Study|Withdrawal by Subject|1|||
127908545|NCT05472038|460289130|FG005|Overall Study|Withdrawal by Subject|3|||
127908546|NCT05472038|460289131|FG006|Overall Study|Withdrawal by Subject|0|||
127908547|NCT05472038|460289132|FG007|Overall Study|Withdrawal by Subject|2|||
127908548|NCT05472038|460289133|FG008|Overall Study|Withdrawal by Subject|3|||
127908549|NCT05472038|460289134|FG009|Overall Study|Withdrawal by Subject|1|||
127908550|NCT05472038|460289135|FG010|Overall Study|Withdrawal by Subject|2|||
127908551|NCT05472038|460289136|FG011|Overall Study|Withdrawal by Subject|2|||
127908552|NCT05472038|460289125|FG000|Overall Study|Protocol Violation|0|||
127908553|NCT05472038|460289126|FG001|Overall Study|Protocol Violation|0|||
127908554|NCT05472038|460289127|FG002|Overall Study|Protocol Violation|0|||
127908555|NCT05472038|460289128|FG003|Overall Study|Protocol Violation|0|||
127908556|NCT05472038|460289129|FG004|Overall Study|Protocol Violation|0|||
127908557|NCT05472038|460289130|FG005|Overall Study|Protocol Violation|0|||
127908558|NCT05472038|460289131|FG006|Overall Study|Protocol Violation|0|||
127908559|NCT05472038|460289132|FG007|Overall Study|Protocol Violation|1|||
127908560|NCT05472038|460289133|FG008|Overall Study|Protocol Violation|1|||
127908561|NCT05472038|460289134|FG009|Overall Study|Protocol Violation|1|||
127908562|NCT05472038|460289135|FG010|Overall Study|Protocol Violation|1|||
127908563|NCT05472038|460289136|FG011|Overall Study|Protocol Violation|1|||
127908564|NCT05472038|460289125|FG000|Overall Study|Not vaccinated|0|||
127908565|NCT05472038|460289126|FG001|Overall Study|Not vaccinated|0|||
127856885|NCT02531633|460094574|FG007|Part A (52 Weeks)|Protocol Violation|0|||
127856886|NCT02531633|460094575|FG008|Part A (52 Weeks)|Protocol Violation|0|||
127856887|NCT02531633|460094576|FG009|Part A (52 Weeks)|Protocol Violation|0|||
127856888|NCT02531633|460094567|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
127856889|NCT02531633|460094568|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
127856890|NCT02531633|460094569|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
127856891|NCT02531633|460094570|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
127856892|NCT02531633|460094571|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
127856893|NCT02531633|460094572|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
127856894|NCT02531633|460094573|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
127856895|NCT02531633|460094574|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
127856896|NCT02531633|460094575|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
127856897|NCT02531633|460094576|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
127856898|NCT02531633|460094567|FG000|Part A (52 Weeks)|Physician Decision|1|||
127856899|NCT02531633|460094568|FG001|Part A (52 Weeks)|Physician Decision|4|||
127856900|NCT02531633|460094569|FG002|Part A (52 Weeks)|Physician Decision|3|||
127856901|NCT02531633|460094570|FG003|Part A (52 Weeks)|Physician Decision|1|||
127856902|NCT02531633|460094571|FG004|Part A (52 Weeks)|Physician Decision|0|||
127856903|NCT02531633|460094572|FG005|Part A (52 Weeks)|Physician Decision|0|||
127856904|NCT02531633|460094573|FG006|Part A (52 Weeks)|Physician Decision|0|||
127856905|NCT02531633|460094574|FG007|Part A (52 Weeks)|Physician Decision|0|||
127856906|NCT02531633|460094575|FG008|Part A (52 Weeks)|Physician Decision|0|||
127856907|NCT02531633|460094576|FG009|Part A (52 Weeks)|Physician Decision|0|||
127856908|NCT02531633|460094567|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
127856909|NCT02531633|460094568|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
127856910|NCT02531633|460094569|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
127856911|NCT02531633|460094570|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
127856912|NCT02531633|460094571|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
127856913|NCT02531633|460094572|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
127856914|NCT02531633|460094573|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
127856915|NCT02531633|460094574|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
127856916|NCT02531633|460094575|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
127856917|NCT02531633|460094576|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
127856918|NCT02531633|460094567|FG000|Part A (52 Weeks)|Other|2|||
127856919|NCT02531633|460094568|FG001|Part A (52 Weeks)|Other|0|||
127856920|NCT02531633|460094569|FG002|Part A (52 Weeks)|Other|0|||
127856921|NCT02531633|460094570|FG003|Part A (52 Weeks)|Other|0|||
127856922|NCT02531633|460094571|FG004|Part A (52 Weeks)|Other|0|||
127856923|NCT02531633|460094572|FG005|Part A (52 Weeks)|Other|0|||
127856924|NCT02531633|460094573|FG006|Part A (52 Weeks)|Other|0|||
127856925|NCT02531633|460094574|FG007|Part A (52 Weeks)|Other|0|||
127856926|NCT02531633|460094575|FG008|Part A (52 Weeks)|Other|0|||
127856927|NCT02531633|460094576|FG009|Part A (52 Weeks)|Other|0|||
127856928|NCT02531633|460094567|FG000|Part B (104 Weeks)|Sponsor request|0|||
127856929|NCT02531633|460094568|FG001|Part B (104 Weeks)|Sponsor request|0|||
127856930|NCT02531633|460094569|FG002|Part B (104 Weeks)|Sponsor request|0|||
127856931|NCT02531633|460094570|FG003|Part B (104 Weeks)|Sponsor request|0|||
127856932|NCT02531633|460094571|FG004|Part B (104 Weeks)|Sponsor request|0|||
127856933|NCT02531633|460094572|FG005|Part B (104 Weeks)|Sponsor request|8|||
127856934|NCT02531633|460094573|FG006|Part B (104 Weeks)|Sponsor request|5|||
127856935|NCT02531633|460094574|FG007|Part B (104 Weeks)|Sponsor request|3|||
127856936|NCT02531633|460094575|FG008|Part B (104 Weeks)|Sponsor request|5|||
127856937|NCT02531633|460094576|FG009|Part B (104 Weeks)|Sponsor request|4|||
127856938|NCT02531633|460094567|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
127856939|NCT02531633|460094568|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
127856940|NCT02531633|460094569|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
127856941|NCT02531633|460094570|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
127856942|NCT02531633|460094571|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
127856943|NCT02531633|460094572|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
127856944|NCT02531633|460094573|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
127856945|NCT02531633|460094574|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
127856946|NCT02531633|460094575|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
127856947|NCT02531633|460094576|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
127856948|NCT04960202|460094578|FG000|Overall Study|Other|5|||
127856949|NCT04960202|460094579|FG001|Overall Study|Other|0|||
127856950|NCT04960202|460094578|FG000|Overall Study|Withdrawal by Subject|37|||
127856951|NCT04960202|460094579|FG001|Overall Study|Withdrawal by Subject|43|||
127908566|NCT05472038|460289127|FG002|Overall Study|Not vaccinated|0|||
127908567|NCT05472038|460289128|FG003|Overall Study|Not vaccinated|1|||
127856952|NCT04960202|460094578|FG000|Overall Study|Lost to Follow-up|20|||
127856953|NCT04960202|460094579|FG001|Overall Study|Lost to Follow-up|16|||
127856954|NCT04960202|460094578|FG000|Overall Study|Death|0|||
127856955|NCT04960202|460094579|FG001|Overall Study|Death|15|||
127908568|NCT05472038|460289129|FG004|Overall Study|Not vaccinated|0|||
127908569|NCT05472038|460289130|FG005|Overall Study|Not vaccinated|0|||
127908570|NCT05472038|460289131|FG006|Overall Study|Not vaccinated|0|||
127908571|NCT05472038|460289132|FG007|Overall Study|Not vaccinated|0|||
127908572|NCT05472038|460289133|FG008|Overall Study|Not vaccinated|0|||
127908573|NCT05472038|460289134|FG009|Overall Study|Not vaccinated|0|||
127908574|NCT05472038|460289135|FG010|Overall Study|Not vaccinated|0|||
127908575|NCT05472038|460289136|FG011|Overall Study|Not vaccinated|0|||
127908576|NCT05369208|460289139|FG000|Core Phase|Prohibited Medication Required|2|||
127908577|NCT05369208|460289139|FG000|Core Phase|Adverse Event|1|||
127908578|NCT05369208|460289139|FG000|Core Phase|Lack of Efficacy|1|||
127908579|NCT02674152|460289140|FG000|Overall Study|Personal Reasons|1|||
127908580|NCT02674152|460289141|FG001|Overall Study|Personal Reasons|0|||
127908581|NCT02674152|460289142|FG002|Overall Study|Personal Reasons|0|||
127908582|NCT02674152|460289143|FG003|Overall Study|Personal Reasons|1|||
127908583|NCT02674152|460289144|FG004|Overall Study|Personal Reasons|1|||
127908584|NCT02674152|460289140|FG000|Overall Study|Other adverse event or clinical progression|0|||
127908585|NCT02674152|460289141|FG001|Overall Study|Other adverse event or clinical progression|1|||
127908586|NCT02674152|460289142|FG002|Overall Study|Other adverse event or clinical progression|0|||
127908587|NCT02674152|460289143|FG003|Overall Study|Other adverse event or clinical progression|3|||
127908588|NCT02674152|460289144|FG004|Overall Study|Other adverse event or clinical progression|0|||
127908589|NCT02674152|460289140|FG000|Overall Study|Dose-limiting toxicity|0|||
127908590|NCT02674152|460289141|FG001|Overall Study|Dose-limiting toxicity|0|||
127908591|NCT02674152|460289142|FG002|Overall Study|Dose-limiting toxicity|0|||
127908592|NCT02674152|460289143|FG003|Overall Study|Dose-limiting toxicity|0|||
127908593|NCT02674152|460289144|FG004|Overall Study|Dose-limiting toxicity|1|||
127908594|NCT02674152|460289140|FG000|Overall Study|Progressive Disease|2|||
127908595|NCT02674152|460289141|FG001|Overall Study|Progressive Disease|1|||
127908596|NCT02674152|460289142|FG002|Overall Study|Progressive Disease|1|||
127908597|NCT02674152|460289143|FG003|Overall Study|Progressive Disease|13|||
127908598|NCT02674152|460289144|FG004|Overall Study|Progressive Disease|2|||
127908599|NCT02674152|460289140|FG000|Overall Study|Adverse Event|0|||
127908600|NCT02674152|460289141|FG001|Overall Study|Adverse Event|0|||
127908601|NCT02674152|460289142|FG002|Overall Study|Adverse Event|1|||
127908602|NCT02674152|460289143|FG003|Overall Study|Adverse Event|0|||
127908603|NCT02674152|460289144|FG004|Overall Study|Adverse Event|1|||
127908604|NCT04934722|460289145|FG000|Overall Study|Death|4|||
127908605|NCT04934722|460289146|FG001|Overall Study|Death|3|||
127908606|NCT04934722|460289145|FG000|Overall Study|Participants Ongoing|88|||
127908607|NCT04934722|460289146|FG001|Overall Study|Participants Ongoing|91|||
127908608|NCT05265624|460289147|FG000|Overall Study|Lost to Follow-up|3|||
127908609|NCT05265624|460289148|FG001|Overall Study|Lost to Follow-up|0|||
127908610|NCT05265624|460289147|FG000|Overall Study|Withdrawal by Subject|1|||
127908611|NCT05265624|460289148|FG001|Overall Study|Withdrawal by Subject|0|||
127908612|NCT00467896|460289151|FG000|Overall Study|Consent Withdrawal|18|||
127908613|NCT00467896|460289151|FG000|Overall Study|Adverse Event|7|||
127908614|NCT00467896|460289151|FG000|Overall Study|Serious Adverse Event|13|||
127908615|NCT00467896|460289151|FG000|Overall Study|Non-compliance|3|||
127908616|NCT00467896|460289151|FG000|Overall Study|Changed therapy|2|||
127908617|NCT00467896|460289151|FG000|Overall Study|Patient received transplant|2|||
127908618|NCT00467896|460289151|FG000|Overall Study|Patient had atrial septostomy|1|||
127908619|NCT00467896|460289151|FG000|Overall Study|Patient weaned off iloprost|1|||
127908620|NCT00467896|460289151|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
127908621|NCT00467896|460289151|FG000|Overall Study|Started intravenous prostacyclin|1|||
127908622|NCT00467896|460289151|FG000|Overall Study|Started inhaled Remodulin|1|||
127908623|NCT00467896|460289151|FG000|Overall Study|Patient had no improvement|1|||
127908624|NCT03772522|460289152|FG000|Pre-intervention|Withdrawal by Subject|3|||
127908625|NCT03772522|460289153|FG001|Pre-intervention|Withdrawal by Subject|4|||
127908626|NCT03772522|460289152|FG000|Intervention|Withdrawal by Subject|1|||
127908627|NCT03772522|460289153|FG001|Intervention|Withdrawal by Subject|0|||
127908628|NCT03772522|460289152|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
127908629|NCT03772522|460289153|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
127908630|NCT02175095|460289154|FG000|Overall Study|Withdrawal by Subject|3|||
127908631|NCT03697109|460289155|FG000|Open-label (OL) Phase|Adverse Event|24|||
127908632|NCT03697109|460289156|FG001|Open-label (OL) Phase|Adverse Event|0|||
127908633|NCT03697109|460289157|FG002|Open-label (OL) Phase|Adverse Event|0|||
127908634|NCT03697109|460289155|FG000|Open-label (OL) Phase|Lost to Follow-up|2|||
127908635|NCT03697109|460289156|FG001|Open-label (OL) Phase|Lost to Follow-up|0|||
127908636|NCT03697109|460289157|FG002|Open-label (OL) Phase|Lost to Follow-up|0|||
127908637|NCT03697109|460289155|FG000|Open-label (OL) Phase|Lack of Efficacy|6|||
127908638|NCT03697109|460289156|FG001|Open-label (OL) Phase|Lack of Efficacy|0|||
127908639|NCT03697109|460289157|FG002|Open-label (OL) Phase|Lack of Efficacy|0|||
127908640|NCT03697109|460289155|FG000|Open-label (OL) Phase|Withdrawal by Subject|21|||
127908641|NCT03697109|460289156|FG001|Open-label (OL) Phase|Withdrawal by Subject|0|||
127908642|NCT03697109|460289157|FG002|Open-label (OL) Phase|Withdrawal by Subject|0|||
127908643|NCT03697109|460289155|FG000|Open-label (OL) Phase|Physician Decision|2|||
127908644|NCT03697109|460289156|FG001|Open-label (OL) Phase|Physician Decision|0|||
127908645|NCT03697109|460289157|FG002|Open-label (OL) Phase|Physician Decision|0|||
127908646|NCT03697109|460289155|FG000|Open-label (OL) Phase|Death|2|||
127908647|NCT03697109|460289156|FG001|Open-label (OL) Phase|Death|0|||
127908648|NCT03697109|460289157|FG002|Open-label (OL) Phase|Death|0|||
127908649|NCT03697109|460289155|FG000|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
127908650|NCT03697109|460289156|FG001|Randomized-withdrawal (RW) Phase|Adverse Event|1|||
127908651|NCT03697109|460289157|FG002|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
127908652|NCT03697109|460289155|FG000|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
127908653|NCT03697109|460289156|FG001|Randomized-withdrawal (RW) Phase|Lack of Efficacy|1|||
127908654|NCT03697109|460289157|FG002|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
127908655|NCT03697109|460289155|FG000|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|0|||
127908656|NCT03697109|460289156|FG001|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
127908657|NCT03697109|460289157|FG002|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
127908658|NCT00834522|460289158|FG000|Washout|Adverse Event|1|||
127908659|NCT00834522|460289159|FG001|Washout|Adverse Event|0|||
127908660|NCT00834522|460289158|FG000|Washout|Withdrawal by Subject|2|||
127908661|NCT00834522|460289159|FG001|Washout|Withdrawal by Subject|1|||
127908662|NCT01111461|460289162|FG000|Overall Study|Adverse Event|32|||
127908663|NCT01111461|460289162|FG000|Overall Study|Participant choice|11|||
127908664|NCT01111461|460289162|FG000|Overall Study|Lost to Follow-up|1|||
127908665|NCT01111461|460289162|FG000|Overall Study|Withdrawal by Subject|1|||
127908666|NCT01111461|460289162|FG000|Overall Study|Other|6|||
127908667|NCT00440518|460289164|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
127908668|NCT00440518|460289165|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
127908669|NCT00440518|460289166|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
127908670|NCT00440518|460289164|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
127908671|NCT00440518|460289165|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
127908672|NCT00440518|460289166|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
127908673|NCT00440518|460289164|FG000|Randomized /Titration Period|Protocol Deviation|1|||
127908674|NCT00440518|460289165|FG001|Randomized /Titration Period|Protocol Deviation|0|||
127908675|NCT00440518|460289166|FG002|Randomized /Titration Period|Protocol Deviation|0|||
127908676|NCT00440518|460289164|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
127908677|NCT00440518|460289165|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
127908678|NCT00440518|460289166|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
127908679|NCT00440518|460289164|FG000|Randomized /Titration Period|Other|1|||
127908680|NCT00440518|460289165|FG001|Randomized /Titration Period|Other|0|||
127908681|NCT00440518|460289166|FG002|Randomized /Titration Period|Other|0|||
127908682|NCT00440518|460289164|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
127908683|NCT00440518|460289165|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
127908684|NCT00440518|460289166|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
127908685|NCT00440518|460289164|FG000|Randomized /Titration Period|Adverse Event|2|||
127908686|NCT00440518|460289165|FG001|Randomized /Titration Period|Adverse Event|3|||
127908687|NCT00440518|460289166|FG002|Randomized /Titration Period|Adverse Event|0|||
127908688|NCT00440518|460289164|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
127908689|NCT00440518|460289165|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
127908690|NCT00440518|460289166|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
127908691|NCT00440518|460289164|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
127908692|NCT00440518|460289165|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
127908693|NCT00440518|460289166|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
127908694|NCT00440518|460289164|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
127908695|NCT00440518|460289165|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
127908696|NCT00440518|460289166|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
127908697|NCT00440518|460289164|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
127908698|NCT00440518|460289165|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
127908699|NCT00440518|460289166|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
127908700|NCT00440518|460289164|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
127908701|NCT00440518|460289165|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
127908702|NCT00440518|460289166|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
127908703|NCT00440518|460289164|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
127908704|NCT00440518|460289165|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
127908705|NCT00440518|460289166|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
127908706|NCT00272779|460289167|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
127908707|NCT00272779|460289168|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
127908708|NCT00272779|460289167|FG000|Baseline Through Week 48|Death before Week 48|4|||
127908709|NCT00272779|460289168|FG001|Baseline Through Week 48|Death before Week 48|4|||
127908710|NCT00272779|460289167|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
127908711|NCT00272779|460289168|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
127908712|NCT00272779|460289167|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
127856956|NCT00378534|460094580|FG000|Overall Study|Participants did not receive transplant|3|||
127856957|NCT00378534|460094581|FG001|Overall Study|Participants did not receive transplant|0|||
127856958|NCT04969900|460094582|FG000|Overall Study|Physician Decision|1|||
127856959|NCT04969900|460094583|FG001|Overall Study|Physician Decision|1|||
127856960|NCT04969900|460094582|FG000|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
127856961|NCT04969900|460094583|FG001|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
127856962|NCT03774875|460094584|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
127856963|NCT03774875|460094585|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
127856964|NCT03774875|460094584|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
127856965|NCT03774875|460094585|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
127856966|NCT03774875|460094584|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
127856967|NCT03774875|460094585|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
127856968|NCT03774875|460094584|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
127856969|NCT03774875|460094585|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
127856970|NCT03774875|460094584|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
127856971|NCT03774875|460094585|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
127856972|NCT03774875|460094584|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
127856973|NCT03774875|460094585|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
127856974|NCT03774875|460094584|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
127856975|NCT03774875|460094585|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
127856976|NCT03774875|460094584|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
127856977|NCT03774875|460094585|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
127856978|NCT03774875|460094584|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
127856979|NCT03774875|460094585|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
127856980|NCT03774875|460094584|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
127856981|NCT03774875|460094585|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
127856982|NCT03774875|460094584|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
127856983|NCT03774875|460094585|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
127856984|NCT03774875|460094584|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
127856985|NCT03774875|460094585|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
127856986|NCT03774875|460094584|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
127856987|NCT03774875|460094585|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
127856988|NCT03149029|460094588|FG000|Overall Study|Adverse Event|2|||
127856989|NCT03149029|460094589|FG001|Overall Study|Adverse Event|0|||
127856990|NCT03233308|460094590|FG000|Overall Study|Adverse Event|1|||
127856991|NCT03233308|460094590|FG000|Overall Study|Protocol Violation|1|||
127856992|NCT02155712|460094592|FG000|Overall Study|Death|12|||
127856993|NCT02155712|460094593|FG001|Overall Study|Death|0|||
127856994|NCT02155712|460094592|FG000|Overall Study|Lost to Follow-up|37|||
127856995|NCT02155712|460094593|FG001|Overall Study|Lost to Follow-up|22|||
127856996|NCT02155712|460094592|FG000|Overall Study|Revision of device|4|||
127856997|NCT02155712|460094593|FG001|Overall Study|Revision of device|3|||
127856998|NCT02155712|460094592|FG000|Overall Study|Withdrawal by Subject|39|||
127856999|NCT02155712|460094593|FG001|Overall Study|Withdrawal by Subject|21|||
127857000|NCT02155712|460094592|FG000|Overall Study|Site termination|77|||
127857001|NCT02155712|460094593|FG001|Overall Study|Site termination|19|||
127857002|NCT02155712|460094592|FG000|Overall Study|Sponsor terminated study early|150|||
127857003|NCT02155712|460094593|FG001|Overall Study|Sponsor terminated study early|0|||
127857004|NCT02155712|460094592|FG000|Overall Study|Missed final 5-year protocol visit|0|||
127857005|NCT02155712|460094593|FG001|Overall Study|Missed final 5-year protocol visit|32|||
127857006|NCT02155712|460094592|FG000|Overall Study|Censored because surgery cancelled|6|||
127857007|NCT02155712|460094593|FG001|Overall Study|Censored because surgery cancelled|10|||
127857008|NCT02155712|460094592|FG000|Overall Study|Censored because study device was not implanted|61|||
127857009|NCT02155712|460094593|FG001|Overall Study|Censored because study device was not implanted|66|||
127857010|NCT02155712|460094592|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
127857011|NCT02155712|460094593|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
127857012|NCT05016037|460094594|FG000|Overall Study|Lost to Follow-up|2|||
127857013|NCT01249157|460094602|FG000|Overall Study|Withdrawal by Subject|1|||
127857014|NCT00062647|460094603|FG000|Overall Study|Death|2|||
127857015|NCT00062647|460094604|FG001|Overall Study|Death|2|||
127857016|NCT00062647|460094603|FG000|Overall Study|Adverse Event|1|||
127857017|NCT00062647|460094604|FG001|Overall Study|Adverse Event|1|||
127857018|NCT00062647|460094603|FG000|Overall Study|Withdrawal by Subject|2|||
127857019|NCT00062647|460094604|FG001|Overall Study|Withdrawal by Subject|1|||
127857020|NCT00062647|460094603|FG000|Overall Study|Protocol Violation|1|||
127857021|NCT00062647|460094604|FG001|Overall Study|Protocol Violation|0|||
127857022|NCT00062647|460094603|FG000|Overall Study|Lost to Follow-up|1|||
127908713|NCT00272779|460289168|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
127908714|NCT00272779|460289167|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
127908715|NCT00272779|460289168|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
127908716|NCT00272779|460289167|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
127908717|NCT00272779|460289168|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
127908718|NCT00272779|460289167|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
127908719|NCT00272779|460289168|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
127908720|NCT00272779|460289167|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
127908721|NCT00272779|460289168|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
127908722|NCT00272779|460289167|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
127908723|NCT00272779|460289168|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
127908724|NCT00272779|460289167|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
127908725|NCT00272779|460289168|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
127908726|NCT00272779|460289167|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
127908727|NCT00272779|460289168|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
127908728|NCT00272779|460289167|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
127908729|NCT00272779|460289168|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
127908730|NCT00272779|460289167|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
127908731|NCT00272779|460289168|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
127908732|NCT00272779|460289167|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
127908733|NCT00272779|460289168|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
127908734|NCT00272779|460289167|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
127908735|NCT00272779|460289168|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
127908736|NCT00272779|460289167|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
127908737|NCT00272779|460289168|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
127908738|NCT00272779|460289167|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
127908739|NCT00272779|460289168|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
127908740|NCT00272779|460289167|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
127908741|NCT00272779|460289168|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
127908742|NCT00272779|460289167|FG000|Baseline Through Week 48|Continuing treatment|385|||
127908743|NCT00272779|460289168|FG001|Baseline Through Week 48|Continuing treatment|368|||
127908744|NCT00272779|460289167|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
127908745|NCT00272779|460289168|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
127908746|NCT00272779|460289167|FG000|Baseline Through Week 48|Never treated|2|||
127908747|NCT00272779|460289168|FG001|Baseline Through Week 48|Never treated|3|||
127908748|NCT00272779|460289167|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
127908749|NCT00272779|460289168|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
127908750|NCT00272779|460289167|FG000|Baseline Through Week 96|Death before Week 96|6|||
127908751|NCT00272779|460289168|FG001|Baseline Through Week 96|Death before Week 96|5|||
127908752|NCT00272779|460289167|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
127908753|NCT00272779|460289168|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
127908754|NCT00272779|460289167|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
127908755|NCT00272779|460289168|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
127908756|NCT00272779|460289167|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
127908757|NCT00272779|460289168|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
127908758|NCT00272779|460289167|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
127908759|NCT00272779|460289168|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
127908760|NCT00272779|460289167|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
127908761|NCT00272779|460289168|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
127908762|NCT00272779|460289167|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
127908763|NCT00272779|460289168|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
127908764|NCT00272779|460289167|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
127908765|NCT00272779|460289168|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
127908766|NCT00272779|460289167|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
127908767|NCT00272779|460289168|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
127908768|NCT00272779|460289167|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
127908769|NCT00272779|460289168|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
127908770|NCT00272779|460289167|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
127908771|NCT00272779|460289168|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
127908772|NCT00272779|460289167|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
127908773|NCT00272779|460289168|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
127908774|NCT00272779|460289167|FG000|Baseline Through Week 96|Never treated|2|||
127908775|NCT00272779|460289168|FG001|Baseline Through Week 96|Never treated|3|||
127908776|NCT00272779|460289167|FG000|Baseline Through Week 96|Continuing on treatment|61|||
127908777|NCT00272779|460289168|FG001|Baseline Through Week 96|Continuing on treatment|38|||
127908778|NCT00561015|460289169|FG000|Overall Study|Adverse Event|0|||
127908779|NCT00561015|460289170|FG001|Overall Study|Adverse Event|0|||
127908780|NCT00561015|460289171|FG002|Overall Study|Adverse Event|0|||
127908781|NCT00561015|460289172|FG003|Overall Study|Adverse Event|0|||
127908782|NCT00561015|460289173|FG004|Overall Study|Adverse Event|1|||
127908783|NCT00561015|460289174|FG005|Overall Study|Adverse Event|0|||
127908784|NCT00561015|460289169|FG000|Overall Study|Lost to Follow-up|2|||
127908785|NCT00561015|460289170|FG001|Overall Study|Lost to Follow-up|0|||
127908786|NCT00561015|460289171|FG002|Overall Study|Lost to Follow-up|0|||
127908787|NCT00561015|460289172|FG003|Overall Study|Lost to Follow-up|1|||
127908788|NCT00561015|460289173|FG004|Overall Study|Lost to Follow-up|0|||
127908789|NCT00561015|460289174|FG005|Overall Study|Lost to Follow-up|3|||
127908790|NCT00561015|460289169|FG000|Overall Study|Participant non-compliance|2|||
127908791|NCT00561015|460289170|FG001|Overall Study|Participant non-compliance|0|||
127908792|NCT00561015|460289171|FG002|Overall Study|Participant non-compliance|0|||
127908793|NCT00561015|460289172|FG003|Overall Study|Participant non-compliance|0|||
127908794|NCT00561015|460289173|FG004|Overall Study|Participant non-compliance|0|||
127908795|NCT00561015|460289174|FG005|Overall Study|Participant non-compliance|0|||
127908796|NCT02440711|460289175|FG000|Second Intervention|Lost to Follow-up|1|||
127908797|NCT02440711|460289176|FG001|Second Intervention|Lost to Follow-up|0|||
127908798|NCT00163657|460289179|FG000|Overall Study|Death|12|||
127908799|NCT00163657|460289180|FG001|Overall Study|Death|14|||
127908800|NCT00163657|460289181|FG002|Overall Study|Death|19|||
127908801|NCT00163657|460289179|FG000|Overall Study|graft loss|4|||
127908802|NCT00163657|460289180|FG001|Overall Study|graft loss|1|||
127908803|NCT00163657|460289181|FG002|Overall Study|graft loss|2|||
127908804|NCT00163657|460289179|FG000|Overall Study|Withdrawal by Subject|2|||
127908805|NCT00163657|460289180|FG001|Overall Study|Withdrawal by Subject|3|||
127908806|NCT00163657|460289181|FG002|Overall Study|Withdrawal by Subject|2|||
127908807|NCT00163657|460289179|FG000|Overall Study|Physician Decision|0|||
127908808|NCT00163657|460289180|FG001|Overall Study|Physician Decision|1|||
127908809|NCT00163657|460289181|FG002|Overall Study|Physician Decision|1|||
127908810|NCT00163657|460289179|FG000|Overall Study|Non Compliance|1|||
127908811|NCT00163657|460289180|FG001|Overall Study|Non Compliance|0|||
127908812|NCT00163657|460289181|FG002|Overall Study|Non Compliance|0|||
127908813|NCT00163657|460289179|FG000|Overall Study|Lost to Follow-up|1|||
127908814|NCT00163657|460289180|FG001|Overall Study|Lost to Follow-up|3|||
127908815|NCT00163657|460289181|FG002|Overall Study|Lost to Follow-up|10|||
127908816|NCT00163657|460289179|FG000|Overall Study|Other reason|0|||
127908817|NCT00163657|460289180|FG001|Overall Study|Other reason|1|||
127908818|NCT00163657|460289181|FG002|Overall Study|Other reason|3|||
127908819|NCT04247282|460289185|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
127908820|NCT04247282|460289186|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
127908821|NCT04247282|460289187|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
127908822|NCT04247282|460289188|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
127908823|NCT04247282|460289185|FG000|Overall Study|Refused further treatment|0|||
127908824|NCT04247282|460289186|FG001|Overall Study|Refused further treatment|1|||
127908825|NCT04247282|460289187|FG002|Overall Study|Refused further treatment|0|||
127908826|NCT04247282|460289188|FG003|Overall Study|Refused further treatment|0|||
127908827|NCT01037114|460289195|FG000|Year 20|Others|1|||
127908828|NCT00968812|460289203|FG000|Overall Study|Adverse Event|30|||
127908829|NCT00968812|460289204|FG001|Overall Study|Adverse Event|46|||
127908830|NCT00968812|460289205|FG002|Overall Study|Adverse Event|33|||
127908831|NCT00968812|460289203|FG000|Overall Study|Death|2|||
127908832|NCT00968812|460289204|FG001|Overall Study|Death|2|||
127908833|NCT00968812|460289205|FG002|Overall Study|Death|1|||
127908834|NCT00968812|460289203|FG000|Overall Study|Lack of Efficacy|9|||
127908835|NCT00968812|460289204|FG001|Overall Study|Lack of Efficacy|7|||
127908836|NCT00968812|460289205|FG002|Overall Study|Lack of Efficacy|16|||
127908837|NCT00968812|460289203|FG000|Overall Study|Lost to Follow-up|17|||
127908838|NCT00968812|460289204|FG001|Overall Study|Lost to Follow-up|12|||
127908839|NCT00968812|460289205|FG002|Overall Study|Lost to Follow-up|11|||
127908840|NCT00968812|460289203|FG000|Overall Study|Physician Decision|8|||
127908841|NCT00968812|460289204|FG001|Overall Study|Physician Decision|5|||
127908842|NCT00968812|460289205|FG002|Overall Study|Physician Decision|9|||
127908843|NCT00968812|460289203|FG000|Overall Study|Protocol Violation|7|||
127908844|NCT00968812|460289204|FG001|Overall Study|Protocol Violation|4|||
127908845|NCT00968812|460289205|FG002|Overall Study|Protocol Violation|3|||
127908846|NCT00968812|460289203|FG000|Overall Study|Withdrawal by Subject|17|||
127908847|NCT00968812|460289204|FG001|Overall Study|Withdrawal by Subject|23|||
127908848|NCT00968812|460289205|FG002|Overall Study|Withdrawal by Subject|25|||
127908849|NCT00968812|460289203|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
127908850|NCT00968812|460289204|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
127908851|NCT00968812|460289205|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
127908852|NCT00968812|460289203|FG000|Overall Study|Noncompliance with study drug|4|||
127908853|NCT00968812|460289204|FG001|Overall Study|Noncompliance with study drug|1|||
127908854|NCT00968812|460289205|FG002|Overall Study|Noncompliance with study drug|6|||
127908855|NCT00968812|460289203|FG000|Overall Study|Unable to take rescue therapy|12|||
127908856|NCT00968812|460289204|FG001|Overall Study|Unable to take rescue therapy|12|||
127857023|NCT00062647|460094604|FG001|Overall Study|Lost to Follow-up|2|||
127857024|NCT00062647|460094603|FG000|Overall Study|Failed continuation criteria|4|||
127857025|NCT00062647|460094604|FG001|Overall Study|Failed continuation criteria|2|||
127857026|NCT00062647|460094603|FG000|Overall Study|Other|4|||
127857027|NCT00062647|460094604|FG001|Overall Study|Other|4|||
127908857|NCT00968812|460289205|FG002|Overall Study|Unable to take rescue therapy|17|||
127908858|NCT00968812|460289203|FG000|Overall Study|Other|25|||
127857028|NCT00062647|460094603|FG000|Overall Study|Never received study treatment|1|||
127857029|NCT00062647|460094604|FG001|Overall Study|Never received study treatment|1|||
127857030|NCT02392468|460094606|FG000|Overall Study|Adverse Event|0|||
127857031|NCT02392468|460094607|FG001|Overall Study|Adverse Event|1|||
127857032|NCT02392468|460094608|FG002|Overall Study|Adverse Event|0|||
127857033|NCT02392468|460094609|FG003|Overall Study|Adverse Event|0|||
127857034|NCT02392468|460094610|FG004|Overall Study|Adverse Event|0|||
127857035|NCT02392468|460094611|FG005|Overall Study|Adverse Event|1|||
127857036|NCT05083949|460094617|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
127857037|NCT05083949|460094618|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
127857038|NCT05083949|460094617|FG000|Period 1|Adverse Event|1|||
127857039|NCT05083949|460094618|FG001|Period 1|Adverse Event|1|||
127857040|NCT05083949|460094617|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
127908859|NCT00968812|460289204|FG001|Overall Study|Other|37|||
127908860|NCT00968812|460289205|FG002|Overall Study|Other|40|||
127908861|NCT00640562|460289208|FG000|Overall Study|Adverse Event|8|||
127908862|NCT00640562|460289209|FG001|Overall Study|Adverse Event|5|||
127908863|NCT00640562|460289208|FG000|Overall Study|Lack of Efficacy|1|||
127908864|NCT00640562|460289209|FG001|Overall Study|Lack of Efficacy|4|||
127908865|NCT00640562|460289208|FG000|Overall Study|Protocol Violation|2|||
127908866|NCT00640562|460289209|FG001|Overall Study|Protocol Violation|4|||
127908867|NCT00640562|460289208|FG000|Overall Study|Withdrawal by Subject|6|||
127908868|NCT00640562|460289209|FG001|Overall Study|Withdrawal by Subject|10|||
127908869|NCT00640562|460289208|FG000|Overall Study|Known risperidone intolerance|0|||
127908870|NCT00640562|460289209|FG001|Overall Study|Known risperidone intolerance|1|||
127908871|NCT00640562|460289208|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
127908872|NCT00640562|460289209|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
127908873|NCT00640562|460289208|FG000|Overall Study|Low study drug dose|0|||
127908874|NCT00640562|460289209|FG001|Overall Study|Low study drug dose|1|||
127908875|NCT00640562|460289208|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
127908876|NCT00640562|460289209|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
127908877|NCT00448591|460289210|FG000|Overall Study|Withdrawal by Subject|178|||
127908878|NCT00448591|460289210|FG000|Overall Study|Progressive Disease|1382|||
127857041|NCT05083949|460094618|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
127857042|NCT05083949|460094617|FG000|Period 2|Adverse Event|0|||
127857043|NCT05083949|460094618|FG001|Period 2|Adverse Event|2|||
127857044|NCT01678560|460094619|FG000|Overall Study|Physician Decision|4|||
127857045|NCT01678560|460094620|FG001|Overall Study|Physician Decision|4|||
127857046|NCT01678560|460094619|FG000|Overall Study|Death|0|||
127857047|NCT01678560|460094620|FG001|Overall Study|Death|1|||
127857048|NCT01678560|460094619|FG000|Overall Study|Withdrawal by Subject|0|||
127857049|NCT01678560|460094620|FG001|Overall Study|Withdrawal by Subject|1|||
127857050|NCT00322387|460094624|FG000|Treatment Period|Adverse Event|0|||
127857051|NCT00322387|460094625|FG001|Treatment Period|Adverse Event|1|||
127857052|NCT00322387|460094624|FG000|Follow-up Period|Final assessment not done|1|||
127857053|NCT00322387|460094625|FG001|Follow-up Period|Final assessment not done|3|||
127857054|NCT00322387|460094624|FG000|Follow-up Period|Death|1|||
127857055|NCT00322387|460094625|FG001|Follow-up Period|Death|0|||
127857056|NCT00090766|460094630|FG000|Overall Study|Nephrectomy Planned|0|||
127857057|NCT00090766|460094631|FG001|Overall Study|Nephrectomy Planned|0|||
127857058|NCT00090766|460094632|FG002|Overall Study|Nephrectomy Planned|1|||
127857059|NCT00090766|460094630|FG000|Overall Study|Death|1|||
127857060|NCT00090766|460094631|FG001|Overall Study|Death|0|||
127857061|NCT00090766|460094632|FG002|Overall Study|Death|0|||
127857062|NCT00090766|460094630|FG000|Overall Study|Admin|0|||
127857063|NCT00090766|460094631|FG001|Overall Study|Admin|2|||
127857064|NCT00090766|460094632|FG002|Overall Study|Admin|0|||
127908879|NCT00448591|460289210|FG000|Overall Study|Adverse Event|382|||
127908880|NCT00448591|460289210|FG000|Overall Study|Protocol Violation|41|||
127908881|NCT00448591|460289210|FG000|Overall Study|Lost to Follow-up|19|||
127857065|NCT00090766|460094630|FG000|Overall Study|Lost to Follow-up|2|||
127857066|NCT00090766|460094631|FG001|Overall Study|Lost to Follow-up|0|||
127857067|NCT00090766|460094632|FG002|Overall Study|Lost to Follow-up|2|||
127857068|NCT00804986|460094633|FG000|Overall Study|Adverse Event|0|||
127857069|NCT00804986|460094634|FG001|Overall Study|Adverse Event|1|||
127857070|NCT00804986|460094635|FG002|Overall Study|Adverse Event|2|||
127857071|NCT00804986|460094636|FG003|Overall Study|Adverse Event|1|||
127857072|NCT00804986|460094637|FG004|Overall Study|Adverse Event|3|||
127857073|NCT00804986|460094638|FG005|Overall Study|Adverse Event|0|||
127857074|NCT00804986|460094633|FG000|Overall Study|Lack of Efficacy|0|||
127857075|NCT00804986|460094634|FG001|Overall Study|Lack of Efficacy|0|||
127857076|NCT00804986|460094635|FG002|Overall Study|Lack of Efficacy|0|||
127857077|NCT00804986|460094636|FG003|Overall Study|Lack of Efficacy|1|||
127857078|NCT00804986|460094637|FG004|Overall Study|Lack of Efficacy|0|||
127857079|NCT00804986|460094638|FG005|Overall Study|Lack of Efficacy|3|||
127857080|NCT00804986|460094633|FG000|Overall Study|Lost to Follow-up|0|||
127857081|NCT00804986|460094634|FG001|Overall Study|Lost to Follow-up|0|||
127857082|NCT00804986|460094635|FG002|Overall Study|Lost to Follow-up|0|||
127857083|NCT00804986|460094636|FG003|Overall Study|Lost to Follow-up|1|||
127857084|NCT00804986|460094637|FG004|Overall Study|Lost to Follow-up|1|||
127857085|NCT00804986|460094638|FG005|Overall Study|Lost to Follow-up|3|||
127857086|NCT00804986|460094633|FG000|Overall Study|Protocol Violation|0|||
127857087|NCT00804986|460094634|FG001|Overall Study|Protocol Violation|1|||
127857088|NCT00804986|460094635|FG002|Overall Study|Protocol Violation|0|||
127857089|NCT00804986|460094636|FG003|Overall Study|Protocol Violation|1|||
127857090|NCT00804986|460094637|FG004|Overall Study|Protocol Violation|0|||
127857091|NCT00804986|460094638|FG005|Overall Study|Protocol Violation|0|||
127857092|NCT00804986|460094633|FG000|Overall Study|Withdrawal by Subject|0|||
127857093|NCT00804986|460094634|FG001|Overall Study|Withdrawal by Subject|3|||
127857094|NCT00804986|460094635|FG002|Overall Study|Withdrawal by Subject|0|||
127857095|NCT00804986|460094636|FG003|Overall Study|Withdrawal by Subject|3|||
127857096|NCT00804986|460094637|FG004|Overall Study|Withdrawal by Subject|5|||
127857097|NCT00804986|460094638|FG005|Overall Study|Withdrawal by Subject|3|||
127857098|NCT00804986|460094633|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
127857099|NCT00804986|460094634|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
127857100|NCT00804986|460094635|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
127857101|NCT00804986|460094636|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
127857102|NCT00804986|460094637|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
127857103|NCT00804986|460094638|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
127857104|NCT00804986|460094633|FG000|Overall Study|Sponsor Decision|0|||
127857105|NCT00804986|460094634|FG001|Overall Study|Sponsor Decision|1|||
127857106|NCT00804986|460094635|FG002|Overall Study|Sponsor Decision|0|||
127857107|NCT00804986|460094636|FG003|Overall Study|Sponsor Decision|0|||
127857108|NCT00804986|460094637|FG004|Overall Study|Sponsor Decision|0|||
127857109|NCT00804986|460094638|FG005|Overall Study|Sponsor Decision|0|||
127857110|NCT00804986|460094633|FG000|Overall Study|Physician Decision|1|||
127857111|NCT00804986|460094634|FG001|Overall Study|Physician Decision|0|||
127857112|NCT00804986|460094635|FG002|Overall Study|Physician Decision|0|||
127857113|NCT00804986|460094636|FG003|Overall Study|Physician Decision|0|||
127857114|NCT00804986|460094637|FG004|Overall Study|Physician Decision|0|||
127857115|NCT00804986|460094638|FG005|Overall Study|Physician Decision|0|||
127857116|NCT00654368|460094645|FG000|Overall Study|Ineligibility determined|6|||
127857117|NCT00654368|460094646|FG001|Overall Study|Ineligibility determined|0|||
127857118|NCT00654368|460094647|FG002|Overall Study|Ineligibility determined|0|||
127857119|NCT00654368|460094645|FG000|Overall Study|Protocol deviation|3|||
127857120|NCT00654368|460094646|FG001|Overall Study|Protocol deviation|2|||
127857121|NCT00654368|460094647|FG002|Overall Study|Protocol deviation|1|||
127857122|NCT00654368|460094645|FG000|Overall Study|Non-compliance|2|||
127857123|NCT00654368|460094646|FG001|Overall Study|Non-compliance|1|||
127857124|NCT00654368|460094647|FG002|Overall Study|Non-compliance|2|||
127857125|NCT00654368|460094645|FG000|Overall Study|Withdrawal by Subject|5|||
127857126|NCT00654368|460094646|FG001|Overall Study|Withdrawal by Subject|2|||
127908882|NCT00448591|460289210|FG000|Overall Study|Treatment Regimen Completed|70|||
127908883|NCT00448591|460289210|FG000|Overall Study|Other|154|||
127857127|NCT00654368|460094647|FG002|Overall Study|Withdrawal by Subject|2|||
127857128|NCT00654368|460094645|FG000|Overall Study|Disease progression|21|||
127857129|NCT00654368|460094646|FG001|Overall Study|Disease progression|31|||
127857130|NCT00654368|460094647|FG002|Overall Study|Disease progression|13|||
127857131|NCT00654368|460094645|FG000|Overall Study|Requirement for alternative therapy|1|||
127857132|NCT00654368|460094646|FG001|Overall Study|Requirement for alternative therapy|1|||
127857133|NCT00654368|460094647|FG002|Overall Study|Requirement for alternative therapy|1|||
127857134|NCT00654368|460094645|FG000|Overall Study|Physician Decision|0|||
127857135|NCT00654368|460094646|FG001|Overall Study|Physician Decision|0|||
127857136|NCT00654368|460094647|FG002|Overall Study|Physician Decision|2|||
127857137|NCT00654368|460094645|FG000|Overall Study|Death|1|||
127857138|NCT00654368|460094646|FG001|Overall Study|Death|0|||
127857139|NCT00654368|460094647|FG002|Overall Study|Death|0|||
127908884|NCT00448591|460289210|FG000|Overall Study|Termination of Study|70|||
127908885|NCT02937870|460289211|FG000|Overall Study|Adverse Event|1|||
127908886|NCT02937870|460289211|FG000|Overall Study|Protocol Deviation|2|||
127908887|NCT00609674|460289215|FG000|Overall Study|Adverse Event|1|||
127908888|NCT00609674|460289216|FG001|Overall Study|Adverse Event|1|||
127908889|NCT00609674|460289215|FG000|Overall Study|Protocol Violation|3|||
127908890|NCT00609674|460289216|FG001|Overall Study|Protocol Violation|5|||
127908891|NCT00609674|460289215|FG000|Overall Study|Lost to Follow-up|1|||
127908892|NCT00609674|460289216|FG001|Overall Study|Lost to Follow-up|0|||
127908893|NCT00609674|460289215|FG000|Overall Study|Withdrew consent|2|||
127908894|NCT00609674|460289216|FG001|Overall Study|Withdrew consent|1|||
127908895|NCT03098394|460289217|FG000|Overall Study|Pregnancy|0|||
127908896|NCT03098394|460289218|FG001|Overall Study|Pregnancy|1|||
127908897|NCT00571064|460289220|FG000|Overall Study|Adverse Event|13|||
127908898|NCT00571064|460289220|FG000|Overall Study|Protocol Violation|4|||
127908899|NCT00571064|460289220|FG000|Overall Study|Withdrawal by Subject|2|||
127908900|NCT00571064|460289220|FG000|Overall Study|Other|2|||
127908901|NCT04604275|460289221|FG000|Washout-1 Week|Withdrawal by Subject|1|||
127908902|NCT04604275|460289222|FG001|Washout-1 Week|Withdrawal by Subject|0|||
127908903|NCT05615935|460289223|FG000|Overall Study|Lost to Follow-up|1|||
127908904|NCT05615935|460289224|FG001|Overall Study|Lost to Follow-up|1|||
127908905|NCT05446870|460289225|FG000|Overall Study|Death|6|||
127908906|NCT05446870|460289226|FG001|Overall Study|Death|5|||
127908907|NCT05446870|460289225|FG000|Overall Study|Lost to Follow-up|0|||
127908908|NCT05446870|460289226|FG001|Overall Study|Lost to Follow-up|1|||
127908909|NCT05446870|460289225|FG000|Overall Study|Physician Decision|52|||
127908910|NCT05446870|460289226|FG001|Overall Study|Physician Decision|53|||
127908911|NCT05446870|460289225|FG000|Overall Study|Withdrawal by Subject|3|||
127908912|NCT05446870|460289226|FG001|Overall Study|Withdrawal by Subject|3|||
127908913|NCT02689505|460289228|FG000|Overall Study|Progressive disease|2|||
127908914|NCT02689505|460289229|FG001|Overall Study|Progressive disease|2|||
127908915|NCT02689505|460289230|FG002|Overall Study|Progressive disease|3|||
127908916|NCT02689505|460289231|FG003|Overall Study|Progressive disease|9|||
127908917|NCT02689505|460289232|FG004|Overall Study|Progressive disease|1|||
127908918|NCT02689505|460289228|FG000|Overall Study|Dose Limiting Toxicity|0|||
127908919|NCT02689505|460289229|FG001|Overall Study|Dose Limiting Toxicity|1|||
127908920|NCT02689505|460289230|FG002|Overall Study|Dose Limiting Toxicity|0|||
127908921|NCT02689505|460289231|FG003|Overall Study|Dose Limiting Toxicity|0|||
127908922|NCT02689505|460289232|FG004|Overall Study|Dose Limiting Toxicity|2|||
127908923|NCT02689505|460289228|FG000|Overall Study|Other AE or clinical progression|0|||
127908924|NCT02689505|460289229|FG001|Overall Study|Other AE or clinical progression|2|||
127908925|NCT02689505|460289230|FG002|Overall Study|Other AE or clinical progression|0|||
127908926|NCT02689505|460289231|FG003|Overall Study|Other AE or clinical progression|2|||
127908927|NCT02689505|460289232|FG004|Overall Study|Other AE or clinical progression|0|||
127908928|NCT02446600|460289233|FG000|Overall Study|Never treated|20|||
127908929|NCT02446600|460289234|FG001|Overall Study|Never treated|2|||
127908930|NCT02446600|460289235|FG002|Overall Study|Never treated|6|||
127908931|NCT02446600|460289236|FG003|Overall Study|Never treated|0|||
127908932|NCT02446600|460289233|FG000|Overall Study|Withdrawal by Subject|19|||
127908933|NCT02446600|460289234|FG001|Overall Study|Withdrawal by Subject|5|||
127908934|NCT02446600|460289235|FG002|Overall Study|Withdrawal by Subject|17|||
127908935|NCT02446600|460289236|FG003|Overall Study|Withdrawal by Subject|0|||
127908936|NCT02446600|460289233|FG000|Overall Study|Ineligible|1|||
127908937|NCT02446600|460289234|FG001|Overall Study|Ineligible|4|||
127908938|NCT02446600|460289235|FG002|Overall Study|Ineligible|4|||
127908939|NCT02446600|460289236|FG003|Overall Study|Ineligible|1|||
127908940|NCT02446600|460289233|FG000|Overall Study|Duplicate Enrollment|0|||
127908941|NCT02446600|460289234|FG001|Overall Study|Duplicate Enrollment|1|||
127908942|NCT02446600|460289235|FG002|Overall Study|Duplicate Enrollment|0|||
127908943|NCT02446600|460289236|FG003|Overall Study|Duplicate Enrollment|0|||
127908944|NCT04108858|460289237|FG000|Overall Study|Adverse Event|1|||
127908945|NCT04608188|460289238|FG000|Overall Study|Withdrawal by Subject|4|||
127908946|NCT04608188|460289239|FG001|Overall Study|Withdrawal by Subject|8|||
127908947|NCT01415986|460289242|FG000|Overall Study|Lost to Follow-up|1|||
127908948|NCT01250912|460289243|FG000|Overall Study|Lost to Follow-up|1|||
127908949|NCT03122457|460289244|FG000|Overall Study|Withdrawal by Subject|6|||
127908950|NCT03653507|460289875|FG000|Overall Study|Miscellaneous|28|||
127908951|NCT03653507|460289876|FG001|Overall Study|Miscellaneous|19|||
127908952|NCT03653507|460289875|FG000|Overall Study|Withdrawal by Subject|37|||
127908953|NCT03653507|460289876|FG001|Overall Study|Withdrawal by Subject|22|||
127908954|NCT03653507|460289875|FG000|Overall Study|Protocol Deviation|2|||
127908955|NCT03653507|460289876|FG001|Overall Study|Protocol Deviation|1|||
127908956|NCT03653507|460289875|FG000|Overall Study|Progressive disease|117|||
127908957|NCT03653507|460289876|FG001|Overall Study|Progressive disease|168|||
127908958|NCT03653507|460289875|FG000|Overall Study|Lost to Follow-up|1|||
127908959|NCT03653507|460289876|FG001|Overall Study|Lost to Follow-up|1|||
127908960|NCT03653507|460289875|FG000|Overall Study|Death|25|||
127908961|NCT03653507|460289876|FG001|Overall Study|Death|22|||
127908962|NCT03653507|460289875|FG000|Overall Study|Adverse Event|35|||
127908963|NCT03653507|460289876|FG001|Overall Study|Adverse Event|14|||
127857140|NCT00654368|460094645|FG000|Overall Study|Pregnancy|0|||
127857141|NCT00654368|460094646|FG001|Overall Study|Pregnancy|0|||
127857142|NCT00654368|460094647|FG002|Overall Study|Pregnancy|2|||
127857143|NCT00654368|460094645|FG000|Overall Study|Other|0|||
127857144|NCT00654368|460094646|FG001|Overall Study|Other|2|||
127857145|NCT00654368|460094647|FG002|Overall Study|Other|3|||
127857146|NCT00654368|460094645|FG000|Overall Study|Adverse Event|14|||
127857147|NCT00654368|460094646|FG001|Overall Study|Adverse Event|9|||
127857148|NCT00654368|460094647|FG002|Overall Study|Adverse Event|6|||
127857149|NCT00959699|460094652|FG000|Treatment Period|Adverse Event|3|||
127857150|NCT00959699|460094653|FG001|Treatment Period|Adverse Event|13|||
127857151|NCT00959699|460094652|FG000|Treatment Period|Lack of Efficacy|15|||
127857152|NCT00959699|460094653|FG001|Treatment Period|Lack of Efficacy|6|||
127857153|NCT00959699|460094652|FG000|Treatment Period|Lost to Follow-up|0|||
127857154|NCT00959699|460094653|FG001|Treatment Period|Lost to Follow-up|1|||
127857155|NCT00959699|460094652|FG000|Treatment Period|Withdrawal by Subject|1|||
127857156|NCT00959699|460094653|FG001|Treatment Period|Withdrawal by Subject|3|||
127857157|NCT00959699|460094652|FG000|Treatment Period|Non-Compliance with Protocol|0|||
127857158|NCT00959699|460094653|FG001|Treatment Period|Non-Compliance with Protocol|1|||
127857159|NCT00959699|460094652|FG000|Treatment Period|Did not receive treatment|0|||
127857160|NCT00959699|460094653|FG001|Treatment Period|Did not receive treatment|1|||
127857161|NCT00959699|460094652|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
127857162|NCT00959699|460094653|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
127857163|NCT00959699|460094652|FG000|Follow-up Period|Lost to Follow-up|3|||
127857164|NCT00959699|460094653|FG001|Follow-up Period|Lost to Follow-up|2|||
127857165|NCT00959699|460094652|FG000|Follow-up Period|Withdrawal by Subject|3|||
127857166|NCT00959699|460094653|FG001|Follow-up Period|Withdrawal by Subject|4|||
127857167|NCT04228445|460094656|FG000|Overall Study|Lost to Follow-up|1|||
127857168|NCT04228445|460094657|FG001|Overall Study|Lost to Follow-up|1|||
127857169|NCT04228445|460094656|FG000|Overall Study|Physician Decision|1|||
127857170|NCT04228445|460094657|FG001|Overall Study|Physician Decision|2|||
127857171|NCT04228445|460094656|FG000|Overall Study|Withdrawal by Subject|0|||
127857172|NCT04228445|460094657|FG001|Overall Study|Withdrawal by Subject|1|||
127857173|NCT04228445|460094656|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
127857174|NCT04228445|460094657|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
127857175|NCT00606294|460094658|FG000|Overall Study|Withdrawal by Subject|36|||
127857176|NCT00606294|460094659|FG001|Overall Study|Withdrawal by Subject|0|||
127857177|NCT03924427|460094664|FG000|Overall Study|Adverse Event|4|||
127857178|NCT03924427|460094664|FG000|Overall Study|Lack of Efficacy|1|||
127857179|NCT03924427|460094664|FG000|Overall Study|Withdrawal by Subject|1|||
127857180|NCT01316380|460094665|FG000|Overall Study|Adverse Event|0|||
127857181|NCT01316380|460094666|FG001|Overall Study|Adverse Event|2|||
127857182|NCT01316380|460094667|FG002|Overall Study|Adverse Event|1|||
127857183|NCT01316380|460094665|FG000|Overall Study|Protocol Violation|0|||
127857184|NCT01316380|460094666|FG001|Overall Study|Protocol Violation|0|||
127857185|NCT01316380|460094667|FG002|Overall Study|Protocol Violation|1|||
127857186|NCT01316380|460094665|FG000|Overall Study|Withdrawal by Subject|1|||
127857187|NCT01316380|460094666|FG001|Overall Study|Withdrawal by Subject|2|||
127857188|NCT01316380|460094667|FG002|Overall Study|Withdrawal by Subject|0|||
127857189|NCT01316380|460094665|FG000|Overall Study|Other|0|||
127857190|NCT01316380|460094666|FG001|Overall Study|Other|1|||
127857191|NCT01316380|460094667|FG002|Overall Study|Other|1|||
127857192|NCT01316380|460094665|FG000|Overall Study|Not treated|1|||
127857193|NCT01316380|460094666|FG001|Overall Study|Not treated|0|||
127857194|NCT01316380|460094667|FG002|Overall Study|Not treated|0|||
127857195|NCT00149890|460094671|FG000|Overall Study|Adverse Event|1|||
127857196|NCT00149890|460094672|FG001|Overall Study|Adverse Event|8|||
127857197|NCT00149890|460094671|FG000|Overall Study|Lack of Efficacy|8|||
127857198|NCT00149890|460094672|FG001|Overall Study|Lack of Efficacy|9|||
127857199|NCT00149890|460094671|FG000|Overall Study|Protocol Violation|1|||
127857200|NCT00149890|460094672|FG001|Overall Study|Protocol Violation|0|||
127857201|NCT00149890|460094671|FG000|Overall Study|Lost to Follow-up|1|||
127857202|NCT00149890|460094672|FG001|Overall Study|Lost to Follow-up|0|||
127857203|NCT00149890|460094671|FG000|Overall Study|Graft Loss|2|||
127857204|NCT00149890|460094672|FG001|Overall Study|Graft Loss|1|||
127857205|NCT01894776|460094673|FG000|Overall Study|Withdrawal by Subject|1|||
127857206|NCT02485860|460094674|FG000|Overall Study|Lost to Follow-up|4|||
127857207|NCT02485860|460094675|FG001|Overall Study|Lost to Follow-up|1|||
127857208|NCT02485860|460094674|FG000|Overall Study|Physician Decision|1|||
127857209|NCT02485860|460094675|FG001|Overall Study|Physician Decision|2|||
127857210|NCT02485860|460094674|FG000|Overall Study|Health context (COVID-19)|1|||
127857211|NCT02485860|460094675|FG001|Overall Study|Health context (COVID-19)|0|||
127857212|NCT02332876|460094676|FG000|Overall Study|Lost to Follow-up|1|||
127857213|NCT02332876|460094677|FG001|Overall Study|Lost to Follow-up|1|||
127857214|NCT02415595|460094679|FG000|Overall Study|Administrative reason by sponsor|39|||
127857215|NCT02415595|460094680|FG001|Overall Study|Administrative reason by sponsor|40|||
127857216|NCT02415595|460094681|FG002|Overall Study|Administrative reason by sponsor|41|||
127857217|NCT02415595|460094682|FG003|Overall Study|Administrative reason by sponsor|39|||
127908964|NCT01701674|460289877|FG000|Overall Study|Unable to safely complete treatment|1|||
127908965|NCT05604170|460289878|FG000|Overall Study|Lack of Efficacy|5|||
127908966|NCT05604170|460289878|FG000|Overall Study|Adverse Event|6|||
127857218|NCT02415595|460094679|FG000|Overall Study|Adverse Event|1|||
127857219|NCT02415595|460094680|FG001|Overall Study|Adverse Event|3|||
127857220|NCT02415595|460094681|FG002|Overall Study|Adverse Event|5|||
127857221|NCT02415595|460094682|FG003|Overall Study|Adverse Event|10|||
127857222|NCT02415595|460094679|FG000|Overall Study|Lack of Efficacy|4|||
127857223|NCT02415595|460094680|FG001|Overall Study|Lack of Efficacy|4|||
127857224|NCT02415595|460094681|FG002|Overall Study|Lack of Efficacy|0|||
127857225|NCT02415595|460094682|FG003|Overall Study|Lack of Efficacy|0|||
127857226|NCT02415595|460094679|FG000|Overall Study|Lost to Follow-up|1|||
127857227|NCT02415595|460094680|FG001|Overall Study|Lost to Follow-up|3|||
127857228|NCT02415595|460094681|FG002|Overall Study|Lost to Follow-up|1|||
127857229|NCT02415595|460094682|FG003|Overall Study|Lost to Follow-up|1|||
127857230|NCT02415595|460094679|FG000|Overall Study|Poor/Non-compliance|1|||
127857231|NCT02415595|460094680|FG001|Overall Study|Poor/Non-compliance|0|||
127857232|NCT02415595|460094681|FG002|Overall Study|Poor/Non-compliance|1|||
127857233|NCT02415595|460094682|FG003|Overall Study|Poor/Non-compliance|0|||
127857234|NCT02415595|460094679|FG000|Overall Study|Reached stopping criteria|0|||
127857235|NCT02415595|460094680|FG001|Overall Study|Reached stopping criteria|1|||
127857236|NCT02415595|460094681|FG002|Overall Study|Reached stopping criteria|1|||
127857237|NCT02415595|460094682|FG003|Overall Study|Reached stopping criteria|0|||
127857238|NCT02415595|460094679|FG000|Overall Study|Withdrawal by Subject|4|||
127857239|NCT02415595|460094680|FG001|Overall Study|Withdrawal by Subject|0|||
127857240|NCT02415595|460094681|FG002|Overall Study|Withdrawal by Subject|1|||
127857241|NCT02415595|460094682|FG003|Overall Study|Withdrawal by Subject|3|||
127857242|NCT02415595|460094679|FG000|Overall Study|Other|0|||
127857243|NCT02415595|460094680|FG001|Overall Study|Other|1|||
127857244|NCT02415595|460094681|FG002|Overall Study|Other|1|||
127857245|NCT02415595|460094682|FG003|Overall Study|Other|0|||
127857246|NCT03325010|460094685|FG000|Overall Study|Adverse Event|3|||
127857247|NCT03325010|460094686|FG001|Overall Study|Adverse Event|8|||
127857248|NCT03325010|460094685|FG000|Overall Study|Protocol Violation|1|||
127857249|NCT03325010|460094686|FG001|Overall Study|Protocol Violation|8|||
127857250|NCT03325010|460094685|FG000|Overall Study|Withdrawal by Subject|1|||
127857251|NCT03325010|460094686|FG001|Overall Study|Withdrawal by Subject|3|||
127857252|NCT03325010|460094685|FG000|Overall Study|Lost to Follow-up|1|||
127857253|NCT03325010|460094686|FG001|Overall Study|Lost to Follow-up|0|||
127857254|NCT03325010|460094685|FG000|Overall Study|Physician Decision|1|||
127857255|NCT03325010|460094686|FG001|Overall Study|Physician Decision|1|||
127857256|NCT03325010|460094685|FG000|Overall Study|Lack of Efficacy|2|||
127857257|NCT03325010|460094686|FG001|Overall Study|Lack of Efficacy|0|||
127857258|NCT02614261|460094687|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
127857259|NCT02614261|460094688|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
127857260|NCT02614261|460094689|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
127857261|NCT02614261|460094690|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
127857262|NCT02614261|460094687|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
127857263|NCT02614261|460094688|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
127857264|NCT02614261|460094689|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
127857265|NCT02614261|460094690|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
127857266|NCT02614261|460094687|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
127857267|NCT02614261|460094688|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
127857268|NCT02614261|460094689|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
127857269|NCT02614261|460094690|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
127857270|NCT02614261|460094687|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
127857271|NCT02614261|460094688|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
127857272|NCT02614261|460094689|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
127857273|NCT02614261|460094690|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
127908967|NCT05604170|460289878|FG000|Overall Study|Physician Decision|6|||
127908968|NCT05604170|460289878|FG000|Overall Study|Lost to Follow-up|6|||
127908969|NCT05604170|460289878|FG000|Overall Study|Withdrawal by Subject|11|||
127908970|NCT05604170|460289878|FG000|Overall Study|Early study termination by sponsor|77|||
127857274|NCT02614261|460094687|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
127857275|NCT02614261|460094688|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
127857276|NCT02614261|460094689|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
127857277|NCT02614261|460094690|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
127857278|NCT02614261|460094687|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
127857279|NCT02614261|460094688|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
127857280|NCT02614261|460094689|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
127857281|NCT02614261|460094690|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
127908971|NCT05604170|460289878|FG000|Overall Study|Other|6|||
127857282|NCT02614261|460094687|FG000|Double-Blind Treatment Phase|Screen failure|0|||
127857283|NCT02614261|460094688|FG001|Double-Blind Treatment Phase|Screen failure|1|||
127857284|NCT02614261|460094689|FG002|Double-Blind Treatment Phase|Screen failure|2|||
127857285|NCT02614261|460094690|FG003|Double-Blind Treatment Phase|Screen failure|0|||
127857286|NCT02614261|460094687|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
127857287|NCT02614261|460094688|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
127857288|NCT02614261|460094689|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
127857289|NCT02614261|460094690|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
127857290|NCT02614261|460094687|FG000|Open-Label Extension Phase|Adverse Event|23|||
127857291|NCT02614261|460094688|FG001|Open-Label Extension Phase|Adverse Event|12|||
127857292|NCT02614261|460094689|FG002|Open-Label Extension Phase|Adverse Event|11|||
127857293|NCT02614261|460094690|FG003|Open-Label Extension Phase|Adverse Event|0|||
127857294|NCT02614261|460094687|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
127857295|NCT02614261|460094688|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
127857296|NCT02614261|460094689|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
127857297|NCT02614261|460094690|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
127857298|NCT02614261|460094687|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
127857299|NCT02614261|460094688|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
127857300|NCT02614261|460094689|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
127857301|NCT02614261|460094690|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
127857302|NCT02614261|460094687|FG000|Open-Label Extension Phase|Physician Decision|2|||
127857303|NCT02614261|460094688|FG001|Open-Label Extension Phase|Physician Decision|0|||
127857304|NCT02614261|460094689|FG002|Open-Label Extension Phase|Physician Decision|0|||
127857305|NCT02614261|460094690|FG003|Open-Label Extension Phase|Physician Decision|0|||
127857306|NCT02614261|460094687|FG000|Open-Label Extension Phase|Pregnancy|1|||
127857307|NCT02614261|460094688|FG001|Open-Label Extension Phase|Pregnancy|2|||
127857308|NCT02614261|460094689|FG002|Open-Label Extension Phase|Pregnancy|1|||
127857309|NCT02614261|460094690|FG003|Open-Label Extension Phase|Pregnancy|0|||
127857310|NCT02614261|460094687|FG000|Open-Label Extension Phase|Protocol Violation|3|||
127857311|NCT02614261|460094688|FG001|Open-Label Extension Phase|Protocol Violation|4|||
127857312|NCT02614261|460094689|FG002|Open-Label Extension Phase|Protocol Violation|1|||
127857313|NCT02614261|460094690|FG003|Open-Label Extension Phase|Protocol Violation|0|||
127857314|NCT02614261|460094687|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
127857315|NCT02614261|460094688|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
127857316|NCT02614261|460094689|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
127857317|NCT02614261|460094690|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
127857318|NCT02614261|460094687|FG000|Follow-up Phase|Adverse Event|2|||
127857319|NCT02614261|460094688|FG001|Follow-up Phase|Adverse Event|0|||
127857320|NCT02614261|460094689|FG002|Follow-up Phase|Adverse Event|1|||
127857321|NCT02614261|460094690|FG003|Follow-up Phase|Adverse Event|0|||
127857322|NCT02614261|460094687|FG000|Follow-up Phase|Lost to Follow-up|12|||
127857323|NCT02614261|460094688|FG001|Follow-up Phase|Lost to Follow-up|5|||
127857324|NCT02614261|460094689|FG002|Follow-up Phase|Lost to Follow-up|2|||
127857325|NCT02614261|460094690|FG003|Follow-up Phase|Lost to Follow-up|0|||
127857326|NCT02614261|460094687|FG000|Follow-up Phase|Physician Decision|5|||
127857327|NCT02614261|460094688|FG001|Follow-up Phase|Physician Decision|1|||
127857328|NCT02614261|460094689|FG002|Follow-up Phase|Physician Decision|0|||
127857329|NCT02614261|460094690|FG003|Follow-up Phase|Physician Decision|0|||
127857330|NCT02614261|460094687|FG000|Follow-up Phase|Pregnancy|0|||
127857331|NCT02614261|460094688|FG001|Follow-up Phase|Pregnancy|1|||
127857332|NCT02614261|460094689|FG002|Follow-up Phase|Pregnancy|0|||
127857333|NCT02614261|460094690|FG003|Follow-up Phase|Pregnancy|0|||
127857334|NCT02614261|460094687|FG000|Follow-up Phase|Protocol Violation|1|||
127857335|NCT02614261|460094688|FG001|Follow-up Phase|Protocol Violation|0|||
127857336|NCT02614261|460094689|FG002|Follow-up Phase|Protocol Violation|0|||
127857337|NCT02614261|460094690|FG003|Follow-up Phase|Protocol Violation|0|||
127857338|NCT02614261|460094687|FG000|Follow-up Phase|Withdrawal by Subject|12|||
127857339|NCT02614261|460094688|FG001|Follow-up Phase|Withdrawal by Subject|4|||
127857340|NCT02614261|460094689|FG002|Follow-up Phase|Withdrawal by Subject|11|||
127857341|NCT02614261|460094690|FG003|Follow-up Phase|Withdrawal by Subject|0|||
127857342|NCT02614261|460094687|FG000|Israel Addendum|Withdrawal by Subject|0|||
127857343|NCT02614261|460094688|FG001|Israel Addendum|Withdrawal by Subject|0|||
127857344|NCT02614261|460094689|FG002|Israel Addendum|Withdrawal by Subject|0|||
127857345|NCT02614261|460094690|FG003|Israel Addendum|Withdrawal by Subject|4|||
127857346|NCT03073200|460094699|FG000|Double Blind Treatment Period|Protocol Violation|1|||
127857347|NCT03073200|460094700|FG001|Double Blind Treatment Period|Protocol Violation|0|||
127857348|NCT03073200|460094701|FG002|Double Blind Treatment Period|Protocol Violation|0|||
127857349|NCT03073200|460094702|FG003|Double Blind Treatment Period|Protocol Violation|0|||
127857350|NCT03073200|460094703|FG004|Double Blind Treatment Period|Protocol Violation|0|||
127857351|NCT03073200|460094704|FG005|Double Blind Treatment Period|Protocol Violation|0|||
127857352|NCT03073200|460094705|FG006|Double Blind Treatment Period|Protocol Violation|0|||
127857353|NCT03073200|460094706|FG007|Double Blind Treatment Period|Protocol Violation|0|||
127857354|NCT03073200|460094707|FG008|Double Blind Treatment Period|Protocol Violation|0|||
127857355|NCT03073200|460094708|FG009|Double Blind Treatment Period|Protocol Violation|0|||
127908972|NCT03032172|460289879|FG000|Treatment Period|Adverse Event|0|||
127908973|NCT03032172|460289880|FG001|Treatment Period|Adverse Event|1|||
127908974|NCT03032172|460289881|FG002|Treatment Period|Adverse Event|0|||
127908975|NCT03032172|460289882|FG003|Treatment Period|Adverse Event|0|||
127908976|NCT03032172|460289883|FG004|Treatment Period|Adverse Event|0|||
127908977|NCT03032172|460289884|FG005|Treatment Period|Adverse Event|0|||
127908978|NCT03032172|460289885|FG006|Treatment Period|Adverse Event|0|||
127908979|NCT03032172|460289886|FG007|Treatment Period|Adverse Event|0|||
127908980|NCT03032172|460289879|FG000|Treatment Period|Lack of Efficacy|0|||
127908981|NCT03032172|460289880|FG001|Treatment Period|Lack of Efficacy|1|||
127908982|NCT03032172|460289881|FG002|Treatment Period|Lack of Efficacy|0|||
127908983|NCT03032172|460289882|FG003|Treatment Period|Lack of Efficacy|0|||
127908984|NCT03032172|460289883|FG004|Treatment Period|Lack of Efficacy|0|||
127908985|NCT03032172|460289884|FG005|Treatment Period|Lack of Efficacy|0|||
127908986|NCT03032172|460289885|FG006|Treatment Period|Lack of Efficacy|0|||
127908987|NCT03032172|460289886|FG007|Treatment Period|Lack of Efficacy|0|||
127908988|NCT03032172|460289879|FG000|Treatment Period|Non-compliance With Study Drug|0|||
127908989|NCT03032172|460289880|FG001|Treatment Period|Non-compliance With Study Drug|1|||
127908990|NCT03032172|460289881|FG002|Treatment Period|Non-compliance With Study Drug|0|||
127908991|NCT03032172|460289882|FG003|Treatment Period|Non-compliance With Study Drug|0|||
127908992|NCT03032172|460289883|FG004|Treatment Period|Non-compliance With Study Drug|0|||
127908993|NCT03032172|460289884|FG005|Treatment Period|Non-compliance With Study Drug|0|||
127908994|NCT03032172|460289885|FG006|Treatment Period|Non-compliance With Study Drug|0|||
127908995|NCT03032172|460289886|FG007|Treatment Period|Non-compliance With Study Drug|0|||
127908996|NCT03032172|460289879|FG000|Treatment Period|Reason Not Specified|0|||
127908997|NCT03032172|460289880|FG001|Treatment Period|Reason Not Specified|4|||
127908998|NCT03032172|460289881|FG002|Treatment Period|Reason Not Specified|1|||
127908999|NCT03032172|460289882|FG003|Treatment Period|Reason Not Specified|0|||
127909000|NCT03032172|460289883|FG004|Treatment Period|Reason Not Specified|0|||
127909001|NCT03032172|460289884|FG005|Treatment Period|Reason Not Specified|0|||
127909002|NCT03032172|460289885|FG006|Treatment Period|Reason Not Specified|0|||
127909003|NCT03032172|460289886|FG007|Treatment Period|Reason Not Specified|0|||
127909004|NCT03032172|460289879|FG000|Treatment Period|Physician Decision|0|||
127909005|NCT03032172|460289880|FG001|Treatment Period|Physician Decision|2|||
127909006|NCT03032172|460289881|FG002|Treatment Period|Physician Decision|1|||
127909007|NCT03032172|460289882|FG003|Treatment Period|Physician Decision|0|||
127909008|NCT03032172|460289883|FG004|Treatment Period|Physician Decision|0|||
127909009|NCT03032172|460289884|FG005|Treatment Period|Physician Decision|0|||
127909010|NCT03032172|460289885|FG006|Treatment Period|Physician Decision|0|||
127909011|NCT03032172|460289886|FG007|Treatment Period|Physician Decision|0|||
127909012|NCT03032172|460289879|FG000|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
127909013|NCT03032172|460289880|FG001|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
127909014|NCT03032172|460289881|FG002|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|2|||
127909015|NCT03032172|460289882|FG003|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
127909016|NCT03032172|460289883|FG004|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
127909017|NCT03032172|460289884|FG005|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
127909018|NCT03032172|460289885|FG006|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
127909019|NCT03032172|460289886|FG007|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
127909020|NCT03032172|460289879|FG000|Treatment Period|Withdrawal by Subject|2|||
127909021|NCT03032172|460289880|FG001|Treatment Period|Withdrawal by Subject|0|||
127909022|NCT03032172|460289881|FG002|Treatment Period|Withdrawal by Subject|3|||
127909023|NCT03032172|460289882|FG003|Treatment Period|Withdrawal by Subject|0|||
127909024|NCT03032172|460289883|FG004|Treatment Period|Withdrawal by Subject|0|||
127909025|NCT03032172|460289884|FG005|Treatment Period|Withdrawal by Subject|0|||
127909026|NCT03032172|460289885|FG006|Treatment Period|Withdrawal by Subject|0|||
127909027|NCT03032172|460289886|FG007|Treatment Period|Withdrawal by Subject|0|||
127909028|NCT03032172|460289879|FG000|Open-label Extension Period|Death|0|||
127909029|NCT03032172|460289880|FG001|Open-label Extension Period|Death|0|||
127909030|NCT03032172|460289881|FG002|Open-label Extension Period|Death|0|||
127909031|NCT03032172|460289882|FG003|Open-label Extension Period|Death|0|||
127909032|NCT03032172|460289883|FG004|Open-label Extension Period|Death|0|||
127909033|NCT03032172|460289884|FG005|Open-label Extension Period|Death|0|||
127909034|NCT03032172|460289885|FG006|Open-label Extension Period|Death|0|||
127909035|NCT03032172|460289886|FG007|Open-label Extension Period|Death|2|||
127909036|NCT03032172|460289879|FG000|Open-label Extension Period|Reason Not Specified|0|||
127909037|NCT03032172|460289880|FG001|Open-label Extension Period|Reason Not Specified|0|||
127909038|NCT03032172|460289881|FG002|Open-label Extension Period|Reason Not Specified|0|||
127909039|NCT03032172|460289882|FG003|Open-label Extension Period|Reason Not Specified|0|||
127909040|NCT03032172|460289883|FG004|Open-label Extension Period|Reason Not Specified|0|||
127909041|NCT03032172|460289884|FG005|Open-label Extension Period|Reason Not Specified|5|||
127909042|NCT03032172|460289885|FG006|Open-label Extension Period|Reason Not Specified|3|||
127909043|NCT03032172|460289886|FG007|Open-label Extension Period|Reason Not Specified|0|||
127909044|NCT03032172|460289879|FG000|Open-label Extension Period|Pregnancy|0|||
127857356|NCT03073200|460094709|FG010|Double Blind Treatment Period|Protocol Violation|0|||
127857357|NCT03073200|460094710|FG011|Double Blind Treatment Period|Protocol Violation|0|||
127857358|NCT03073200|460094711|FG012|Double Blind Treatment Period|Protocol Violation|0|||
127857359|NCT03073200|460094712|FG013|Double Blind Treatment Period|Protocol Violation|0|||
127857360|NCT03073200|460094713|FG014|Double Blind Treatment Period|Protocol Violation|0|||
127857361|NCT03073200|460094699|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
127857362|NCT03073200|460094700|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
127857363|NCT03073200|460094701|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
127857364|NCT03073200|460094702|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
127857365|NCT03073200|460094703|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
127857366|NCT03073200|460094704|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
127857367|NCT03073200|460094705|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
127857368|NCT03073200|460094706|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
127857369|NCT03073200|460094707|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
127857370|NCT03073200|460094708|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
127857371|NCT03073200|460094709|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
127857372|NCT03073200|460094710|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
127857373|NCT03073200|460094711|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
127857374|NCT03073200|460094712|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
127857375|NCT03073200|460094713|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
127857376|NCT03073200|460094699|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
127857377|NCT03073200|460094700|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
127857378|NCT03073200|460094701|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
127857379|NCT03073200|460094702|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
127857380|NCT03073200|460094703|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
127857381|NCT03073200|460094704|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
127857382|NCT03073200|460094705|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
127857383|NCT03073200|460094706|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
127857384|NCT03073200|460094707|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
127857385|NCT03073200|460094708|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
127857386|NCT03073200|460094709|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
127857387|NCT03073200|460094710|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
127857388|NCT03073200|460094711|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
127857389|NCT03073200|460094712|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
127857390|NCT03073200|460094713|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
127857391|NCT03073200|460094699|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
127857392|NCT03073200|460094700|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
127857393|NCT03073200|460094701|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
127857394|NCT03073200|460094702|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
127857395|NCT03073200|460094703|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
127857396|NCT03073200|460094704|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
127857397|NCT03073200|460094705|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
127857398|NCT03073200|460094706|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
127857399|NCT03073200|460094707|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
127857400|NCT03073200|460094708|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
127857401|NCT03073200|460094709|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
127857402|NCT03073200|460094710|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
127857403|NCT03073200|460094711|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
127857404|NCT03073200|460094712|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
127857405|NCT03073200|460094713|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
127857406|NCT03073200|460094699|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
127857407|NCT03073200|460094700|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
127857408|NCT03073200|460094701|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
127857409|NCT03073200|460094702|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
127857410|NCT03073200|460094703|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
127857411|NCT03073200|460094704|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
127857412|NCT03073200|460094705|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
127857413|NCT03073200|460094706|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
127857414|NCT03073200|460094707|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
127857415|NCT03073200|460094708|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
127857416|NCT03073200|460094709|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
127857417|NCT03073200|460094710|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
127857418|NCT03073200|460094711|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
127857419|NCT03073200|460094712|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
127857420|NCT03073200|460094713|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
127909045|NCT03032172|460289880|FG001|Open-label Extension Period|Pregnancy|0|||
127909046|NCT03032172|460289881|FG002|Open-label Extension Period|Pregnancy|0|||
127909047|NCT03032172|460289882|FG003|Open-label Extension Period|Pregnancy|0|||
127909048|NCT03032172|460289883|FG004|Open-label Extension Period|Pregnancy|0|||
127909049|NCT03032172|460289884|FG005|Open-label Extension Period|Pregnancy|0|||
127909050|NCT03032172|460289885|FG006|Open-label Extension Period|Pregnancy|1|||
127909051|NCT03032172|460289886|FG007|Open-label Extension Period|Pregnancy|0|||
127909052|NCT03032172|460289879|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
127909053|NCT03032172|460289880|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
127909054|NCT03032172|460289881|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
127909055|NCT03032172|460289882|FG003|Open-label Extension Period|Withdrawal by Subject|0|||
127909056|NCT03032172|460289883|FG004|Open-label Extension Period|Withdrawal by Subject|1|||
127909057|NCT03032172|460289884|FG005|Open-label Extension Period|Withdrawal by Subject|7|||
127909058|NCT03032172|460289885|FG006|Open-label Extension Period|Withdrawal by Subject|11|||
127909059|NCT03032172|460289886|FG007|Open-label Extension Period|Withdrawal by Subject|4|||
127909060|NCT02869867|460289889|FG000|Overall Study|Protocol Violation|1|||
127909061|NCT02869867|460289890|FG001|Overall Study|Protocol Violation|0|||
127909062|NCT02869867|460289889|FG000|Overall Study|Lost to Follow-up|5|||
127909063|NCT02869867|460289890|FG001|Overall Study|Lost to Follow-up|5|||
127909064|NCT06284525|460289891|FG000|Overall Study|Withdrawal by Subject|1|||
127909065|NCT04516967|460289892|FG000|Core Phase|Adverse Event|2|||
127909066|NCT04516967|460289893|FG001|Core Phase|Adverse Event|1|||
127909067|NCT04516967|460289894|FG002|Core Phase|Adverse Event|0|||
127909068|NCT04516967|460289892|FG000|Core Phase|Physician Decision|1|||
127909069|NCT04516967|460289893|FG001|Core Phase|Physician Decision|1|||
127909070|NCT04516967|460289894|FG002|Core Phase|Physician Decision|0|||
127909071|NCT04516967|460289892|FG000|Core Phase|Lack of Efficacy|7|||
127909072|NCT04516967|460289893|FG001|Core Phase|Lack of Efficacy|18|||
127909073|NCT04516967|460289894|FG002|Core Phase|Lack of Efficacy|0|||
127909074|NCT03570749|460289895|FG000|Overall Study|Ongoing|26|||
127909075|NCT03570749|460289896|FG001|Overall Study|Ongoing|25|||
127909076|NCT03570749|460289897|FG002|Overall Study|Ongoing|25|||
127909077|NCT03570749|460289898|FG003|Overall Study|Ongoing|26|||
127909078|NCT03570749|460289899|FG004|Overall Study|Ongoing|140|||
127909079|NCT03570749|460289900|FG005|Overall Study|Ongoing|142|||
127909080|NCT03570749|460289901|FG006|Overall Study|Ongoing|220|||
127909081|NCT03570749|460289895|FG000|Overall Study|Adverse Event|0|||
127909082|NCT03570749|460289896|FG001|Overall Study|Adverse Event|0|||
127909083|NCT03570749|460289897|FG002|Overall Study|Adverse Event|0|||
127909084|NCT03570749|460289898|FG003|Overall Study|Adverse Event|0|||
127909085|NCT03570749|460289899|FG004|Overall Study|Adverse Event|2|||
127909086|NCT03570749|460289900|FG005|Overall Study|Adverse Event|3|||
127909087|NCT03570749|460289901|FG006|Overall Study|Adverse Event|6|||
127909088|NCT03570749|460289895|FG000|Overall Study|Lack of Efficacy|0|||
127909089|NCT03570749|460289896|FG001|Overall Study|Lack of Efficacy|0|||
127909090|NCT03570749|460289897|FG002|Overall Study|Lack of Efficacy|0|||
127909091|NCT03570749|460289898|FG003|Overall Study|Lack of Efficacy|0|||
127909092|NCT03570749|460289899|FG004|Overall Study|Lack of Efficacy|8|||
127909093|NCT03570749|460289900|FG005|Overall Study|Lack of Efficacy|2|||
127909094|NCT03570749|460289901|FG006|Overall Study|Lack of Efficacy|7|||
127909095|NCT03570749|460289895|FG000|Overall Study|Lost to Follow-up|0|||
127909096|NCT03570749|460289896|FG001|Overall Study|Lost to Follow-up|0|||
127909097|NCT03570749|460289897|FG002|Overall Study|Lost to Follow-up|0|||
127909098|NCT03570749|460289898|FG003|Overall Study|Lost to Follow-up|0|||
127909099|NCT03570749|460289899|FG004|Overall Study|Lost to Follow-up|5|||
127909100|NCT03570749|460289900|FG005|Overall Study|Lost to Follow-up|10|||
127909101|NCT03570749|460289901|FG006|Overall Study|Lost to Follow-up|10|||
127909102|NCT03570749|460289895|FG000|Overall Study|Pregnancy|0|||
127909103|NCT03570749|460289896|FG001|Overall Study|Pregnancy|0|||
127909104|NCT03570749|460289897|FG002|Overall Study|Pregnancy|0|||
127909105|NCT03570749|460289898|FG003|Overall Study|Pregnancy|0|||
127909106|NCT03570749|460289899|FG004|Overall Study|Pregnancy|0|||
127909107|NCT03570749|460289900|FG005|Overall Study|Pregnancy|1|||
127909108|NCT03570749|460289901|FG006|Overall Study|Pregnancy|1|||
127909109|NCT03570749|460289895|FG000|Overall Study|Screen Fail|0|||
127909110|NCT03570749|460289896|FG001|Overall Study|Screen Fail|0|||
127909111|NCT03570749|460289897|FG002|Overall Study|Screen Fail|0|||
127909112|NCT03570749|460289898|FG003|Overall Study|Screen Fail|0|||
127909113|NCT03570749|460289899|FG004|Overall Study|Screen Fail|0|||
127909114|NCT03570749|460289900|FG005|Overall Study|Screen Fail|0|||
127909115|NCT03570749|460289901|FG006|Overall Study|Screen Fail|1|||
127909116|NCT03570749|460289895|FG000|Overall Study|Withdrawal by Subject|2|||
127909117|NCT03570749|460289896|FG001|Overall Study|Withdrawal by Subject|3|||
127909118|NCT03570749|460289897|FG002|Overall Study|Withdrawal by Subject|2|||
127909119|NCT03570749|460289898|FG003|Overall Study|Withdrawal by Subject|1|||
127909120|NCT03570749|460289899|FG004|Overall Study|Withdrawal by Subject|17|||
127909121|NCT03570749|460289900|FG005|Overall Study|Withdrawal by Subject|12|||
127909122|NCT03570749|460289901|FG006|Overall Study|Withdrawal by Subject|15|||
127909123|NCT03570749|460289895|FG000|Overall Study|Other|0|||
127909124|NCT03570749|460289896|FG001|Overall Study|Other|0|||
127909125|NCT03570749|460289897|FG002|Overall Study|Other|0|||
127909126|NCT03570749|460289898|FG003|Overall Study|Other|0|||
127909127|NCT03570749|460289899|FG004|Overall Study|Other|17|||
127909128|NCT03570749|460289900|FG005|Overall Study|Other|14|||
127909129|NCT03570749|460289901|FG006|Overall Study|Other|21|||
127909130|NCT02436005|460289902|FG000|Second Intervention|Adverse Event|0|||
127909131|NCT02436005|460289903|FG001|Second Intervention|Adverse Event|1|||
127909132|NCT01005745|460289905|FG000|Overall Study|No TIL growth|1|||
127909133|NCT01005745|460289905|FG000|Overall Study|Disease progressed during TIL growth|3|||
127909134|NCT01005745|460289905|FG000|Overall Study|Death prior to treatment|1|||
127909135|NCT01005745|460289905|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
127909136|NCT05646251|460289910|FG000|Overall Study|Physician Decision|1|||
127909137|NCT05646251|460289911|FG001|Overall Study|Physician Decision|0|||
127909138|NCT05646251|460289912|FG002|Overall Study|Physician Decision|2|||
127909139|NCT04659603|460289914|FG000|Overall Study|Study terminated by sponsor|0|||
127909140|NCT04659603|460289915|FG001|Overall Study|Study terminated by sponsor|0|||
127909141|NCT04659603|460289916|FG002|Overall Study|Study terminated by sponsor|2|||
127909142|NCT04659603|460289914|FG000|Overall Study|Withdrawal by Subject|0|||
127909143|NCT04659603|460289915|FG001|Overall Study|Withdrawal by Subject|5|||
127909144|NCT04659603|460289916|FG002|Overall Study|Withdrawal by Subject|0|||
127909145|NCT04659603|460289914|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
127909146|NCT04659603|460289915|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
127909147|NCT04659603|460289916|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
127909148|NCT01231906|460289919|FG000|Overall Study|Lack of Efficacy|75|||
127909149|NCT01231906|460289920|FG001|Overall Study|Lack of Efficacy|68|||
127909150|NCT01231906|460289919|FG000|Overall Study|Lost to Follow-up|1|||
127909151|NCT01231906|460289920|FG001|Overall Study|Lost to Follow-up|0|||
127909152|NCT01231906|460289919|FG000|Overall Study|Physician Decision|34|||
127909153|NCT01231906|460289920|FG001|Overall Study|Physician Decision|24|||
127909154|NCT01231906|460289919|FG000|Overall Study|Withdrawal by Subject|0|||
127909155|NCT01231906|460289920|FG001|Overall Study|Withdrawal by Subject|4|||
127909156|NCT01231906|460289919|FG000|Overall Study|Ineligible|10|||
127909157|NCT01231906|460289920|FG001|Overall Study|Ineligible|3|||
127909158|NCT01231906|460289919|FG000|Overall Study|No treatment|1|||
127909159|NCT01231906|460289920|FG001|Overall Study|No treatment|2|||
127909160|NCT01754597|460289927|FG000|Overall Study|Dosage of NT-proBNP not performed|6|||
127909161|NCT01754597|460289928|FG001|Overall Study|Dosage of NT-proBNP not performed|5|||
127909162|NCT01588236|460289929|FG000|Overall Study|Adverse Event|5|||
127909163|NCT01588236|460289930|FG001|Overall Study|Adverse Event|4|||
127909164|NCT01588236|460289931|FG002|Overall Study|Adverse Event|1|||
127909165|NCT01588236|460289929|FG000|Overall Study|Lost to Follow-up|8|||
127909166|NCT01588236|460289930|FG001|Overall Study|Lost to Follow-up|13|||
127909167|NCT01588236|460289931|FG002|Overall Study|Lost to Follow-up|6|||
127909168|NCT01588236|460289929|FG000|Overall Study|Physician Decision|1|||
127909169|NCT01588236|460289930|FG001|Overall Study|Physician Decision|2|||
127909170|NCT01588236|460289931|FG002|Overall Study|Physician Decision|0|||
127909171|NCT01588236|460289929|FG000|Overall Study|Protocol Violation|0|||
127909172|NCT01588236|460289930|FG001|Overall Study|Protocol Violation|1|||
127909173|NCT01588236|460289931|FG002|Overall Study|Protocol Violation|1|||
127909174|NCT01588236|460289929|FG000|Overall Study|Withdrawal by Subject|14|||
127909175|NCT01588236|460289930|FG001|Overall Study|Withdrawal by Subject|16|||
127909176|NCT01588236|460289931|FG002|Overall Study|Withdrawal by Subject|18|||
127909177|NCT01588236|460289929|FG000|Overall Study|Exclusion Criteria met during study|2|||
127909178|NCT01588236|460289930|FG001|Overall Study|Exclusion Criteria met during study|1|||
127909179|NCT01588236|460289931|FG002|Overall Study|Exclusion Criteria met during study|0|||
127909180|NCT01588236|460289929|FG000|Overall Study|sponsor decision|1|||
127909181|NCT01588236|460289930|FG001|Overall Study|sponsor decision|6|||
127909182|NCT01588236|460289931|FG002|Overall Study|sponsor decision|2|||
127909183|NCT04544410|460289932|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
127909184|NCT04544410|460289933|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
127909185|NCT04544410|460289932|FG000|Double-blind Treatment Period|Adverse Event|1|||
127909186|NCT04544410|460289933|FG001|Double-blind Treatment Period|Adverse Event|0|||
127909187|NCT04544410|460289932|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
127909188|NCT04544410|460289933|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
127909189|NCT04544410|460289932|FG000|Double-blind Treatment Period|Protocol Violation|1|||
127909190|NCT04544410|460289933|FG001|Double-blind Treatment Period|Protocol Violation|0|||
127909191|NCT04544410|460289932|FG000|Open-Label Treatment Period|Study Terminated|15|||
127909192|NCT04544410|460289933|FG001|Open-Label Treatment Period|Study Terminated|19|||
127909193|NCT04544410|460289932|FG000|Open-Label Treatment Period|Withdrawal by Subject|6|||
127909194|NCT04544410|460289933|FG001|Open-Label Treatment Period|Withdrawal by Subject|5|||
127909195|NCT04544410|460289932|FG000|Open-Label Treatment Period|Adverse Event|0|||
127909196|NCT04544410|460289933|FG001|Open-Label Treatment Period|Adverse Event|1|||
127909197|NCT04544410|460289932|FG000|Open-Label Treatment Period|Physician Decision|1|||
127909198|NCT04544410|460289933|FG001|Open-Label Treatment Period|Physician Decision|0|||
127909199|NCT04544410|460289932|FG000|Open-Label Treatment Period|Other|0|||
127909200|NCT04544410|460289933|FG001|Open-Label Treatment Period|Other|1|||
127857421|NCT03073200|460094699|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
127857422|NCT03073200|460094700|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
127857423|NCT03073200|460094701|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
127857424|NCT03073200|460094702|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
127857425|NCT03073200|460094703|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
127857426|NCT03073200|460094704|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
127857427|NCT03073200|460094705|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
127857428|NCT03073200|460094706|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
127857429|NCT03073200|460094707|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
127857430|NCT03073200|460094708|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
127857431|NCT03073200|460094709|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
127857432|NCT03073200|460094710|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
127857433|NCT03073200|460094711|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
127857434|NCT03073200|460094712|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
127857435|NCT03073200|460094713|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
127857436|NCT03073200|460094699|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
127857437|NCT03073200|460094700|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
127857438|NCT03073200|460094701|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
127857439|NCT03073200|460094702|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
127857440|NCT03073200|460094703|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
127857441|NCT03073200|460094704|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
127857442|NCT03073200|460094705|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
127857443|NCT03073200|460094706|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
127857444|NCT03073200|460094707|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
127857445|NCT03073200|460094708|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
127857446|NCT03073200|460094709|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
127857447|NCT03073200|460094710|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
127857448|NCT03073200|460094711|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
127857449|NCT03073200|460094712|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
127857450|NCT03073200|460094713|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
127857451|NCT03073200|460094699|FG000|Extension Period|Lost to Follow-up|0|||
127857452|NCT03073200|460094700|FG001|Extension Period|Lost to Follow-up|0|||
127857453|NCT03073200|460094701|FG002|Extension Period|Lost to Follow-up|0|||
127857454|NCT03073200|460094702|FG003|Extension Period|Lost to Follow-up|0|||
127857455|NCT03073200|460094703|FG004|Extension Period|Lost to Follow-up|0|||
127857456|NCT03073200|460094704|FG005|Extension Period|Lost to Follow-up|0|||
127857457|NCT03073200|460094705|FG006|Extension Period|Lost to Follow-up|1|||
127857458|NCT03073200|460094706|FG007|Extension Period|Lost to Follow-up|1|||
127857459|NCT03073200|460094707|FG008|Extension Period|Lost to Follow-up|0|||
127857460|NCT03073200|460094708|FG009|Extension Period|Lost to Follow-up|0|||
127857461|NCT03073200|460094709|FG010|Extension Period|Lost to Follow-up|0|||
127857462|NCT03073200|460094710|FG011|Extension Period|Lost to Follow-up|0|||
127857463|NCT03073200|460094711|FG012|Extension Period|Lost to Follow-up|0|||
127857464|NCT03073200|460094712|FG013|Extension Period|Lost to Follow-up|0|||
127857465|NCT03073200|460094713|FG014|Extension Period|Lost to Follow-up|0|||
127857466|NCT03073200|460094699|FG000|Extension Period|Sponsor Decision|0|||
127857467|NCT03073200|460094700|FG001|Extension Period|Sponsor Decision|0|||
127857468|NCT03073200|460094701|FG002|Extension Period|Sponsor Decision|0|||
127857469|NCT03073200|460094702|FG003|Extension Period|Sponsor Decision|0|||
127857470|NCT03073200|460094703|FG004|Extension Period|Sponsor Decision|0|||
127857471|NCT03073200|460094704|FG005|Extension Period|Sponsor Decision|0|||
127857472|NCT03073200|460094705|FG006|Extension Period|Sponsor Decision|0|||
127857473|NCT03073200|460094706|FG007|Extension Period|Sponsor Decision|0|||
127857474|NCT03073200|460094707|FG008|Extension Period|Sponsor Decision|1|||
127857475|NCT03073200|460094708|FG009|Extension Period|Sponsor Decision|0|||
127857476|NCT03073200|460094709|FG010|Extension Period|Sponsor Decision|0|||
127857477|NCT03073200|460094710|FG011|Extension Period|Sponsor Decision|0|||
127857478|NCT03073200|460094711|FG012|Extension Period|Sponsor Decision|0|||
127857479|NCT03073200|460094712|FG013|Extension Period|Sponsor Decision|0|||
127857480|NCT03073200|460094713|FG014|Extension Period|Sponsor Decision|0|||
127857481|NCT03073200|460094699|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
127857482|NCT03073200|460094700|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
127857483|NCT03073200|460094701|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
127857484|NCT03073200|460094702|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
127857485|NCT03073200|460094703|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
127857486|NCT03073200|460094704|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
127857487|NCT03073200|460094705|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
127857488|NCT03073200|460094706|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
127857489|NCT03073200|460094707|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
127857490|NCT03073200|460094708|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
127857491|NCT03073200|460094709|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
127857492|NCT03073200|460094710|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
127909201|NCT03071575|460290937|FG000|Overall Study|Death|0|||
127909202|NCT03071575|460290938|FG001|Overall Study|Death|1|||
127909203|NCT03071575|460290937|FG000|Overall Study|Lost to Follow-up|5|||
127909204|NCT03071575|460290938|FG001|Overall Study|Lost to Follow-up|11|||
127909205|NCT03071575|460290937|FG000|Overall Study|Withdrawal by Subject|4|||
127909206|NCT03071575|460290938|FG001|Overall Study|Withdrawal by Subject|2|||
127909207|NCT00834795|460290939|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
127909208|NCT00834795|460290940|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
127909209|NCT00834795|460290939|FG000|Second Intervention|Adverse Event|1|||
127909210|NCT00834795|460290940|FG001|Second Intervention|Adverse Event|0|||
127909211|NCT00579345|460290941|FG000|Overall Study|Withdrawal by Subject|2|||
127909212|NCT00579345|460290942|FG001|Overall Study|Withdrawal by Subject|0|||
127909213|NCT00579345|460290943|FG002|Overall Study|Withdrawal by Subject|0|||
127909214|NCT00579345|460290944|FG003|Overall Study|Withdrawal by Subject|0|||
127909215|NCT00579345|460290945|FG004|Overall Study|Withdrawal by Subject|0|||
127909216|NCT00579345|460290946|FG005|Overall Study|Withdrawal by Subject|0|||
127857493|NCT03073200|460094711|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
127857494|NCT03073200|460094712|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
127857495|NCT03073200|460094713|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
127857496|NCT03073200|460094699|FG000|Extension Period|Withdrawal by Subject|0|||
127857497|NCT03073200|460094700|FG001|Extension Period|Withdrawal by Subject|0|||
127857498|NCT03073200|460094701|FG002|Extension Period|Withdrawal by Subject|0|||
127857499|NCT03073200|460094702|FG003|Extension Period|Withdrawal by Subject|0|||
127857500|NCT03073200|460094703|FG004|Extension Period|Withdrawal by Subject|0|||
127857501|NCT03073200|460094704|FG005|Extension Period|Withdrawal by Subject|0|||
127857502|NCT03073200|460094705|FG006|Extension Period|Withdrawal by Subject|1|||
127857503|NCT03073200|460094706|FG007|Extension Period|Withdrawal by Subject|2|||
127857504|NCT03073200|460094707|FG008|Extension Period|Withdrawal by Subject|0|||
127857505|NCT03073200|460094708|FG009|Extension Period|Withdrawal by Subject|0|||
127857506|NCT03073200|460094709|FG010|Extension Period|Withdrawal by Subject|0|||
127857507|NCT03073200|460094710|FG011|Extension Period|Withdrawal by Subject|0|||
127857508|NCT03073200|460094711|FG012|Extension Period|Withdrawal by Subject|0|||
127857509|NCT03073200|460094712|FG013|Extension Period|Withdrawal by Subject|0|||
127857510|NCT03073200|460094713|FG014|Extension Period|Withdrawal by Subject|0|||
127857511|NCT03073200|460094699|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
127857512|NCT03073200|460094700|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
127857513|NCT03073200|460094701|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
127857514|NCT03073200|460094702|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
127857515|NCT03073200|460094703|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
127857516|NCT03073200|460094704|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
127857517|NCT03073200|460094705|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
127857518|NCT03073200|460094706|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
127857519|NCT03073200|460094707|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
127857520|NCT03073200|460094708|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
127857521|NCT03073200|460094709|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
127857522|NCT03073200|460094710|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
127857523|NCT03073200|460094711|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
127857524|NCT03073200|460094712|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
127857525|NCT03073200|460094713|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
127857526|NCT03073200|460094699|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
127857527|NCT03073200|460094700|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
127857528|NCT03073200|460094701|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
127857529|NCT03073200|460094702|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
127857530|NCT03073200|460094703|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
127857531|NCT03073200|460094704|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
127857532|NCT03073200|460094705|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
127857533|NCT03073200|460094706|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
127857534|NCT03073200|460094707|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
127857535|NCT03073200|460094708|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
127857536|NCT03073200|460094709|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
127857537|NCT03073200|460094710|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
127857538|NCT03073200|460094711|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
127857539|NCT03073200|460094712|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
127857540|NCT03073200|460094713|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
127857541|NCT03073200|460094699|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
127857542|NCT03073200|460094700|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
127857543|NCT03073200|460094701|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
127857544|NCT03073200|460094702|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
127857545|NCT03073200|460094703|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
127857546|NCT03073200|460094704|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
127857547|NCT03073200|460094705|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
127857548|NCT03073200|460094706|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
127857549|NCT03073200|460094707|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
127857550|NCT03073200|460094708|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
127857551|NCT03073200|460094709|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
127857552|NCT03073200|460094710|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
127857553|NCT03073200|460094711|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
127857554|NCT03073200|460094712|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
127857555|NCT03073200|460094713|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
127857556|NCT03073200|460094699|FG000|Randomized Withdrawal Period|Adverse Event|0|||
127857557|NCT03073200|460094700|FG001|Randomized Withdrawal Period|Adverse Event|0|||
127857558|NCT03073200|460094701|FG002|Randomized Withdrawal Period|Adverse Event|0|||
127857559|NCT03073200|460094702|FG003|Randomized Withdrawal Period|Adverse Event|0|||
127857560|NCT03073200|460094703|FG004|Randomized Withdrawal Period|Adverse Event|0|||
127857561|NCT03073200|460094704|FG005|Randomized Withdrawal Period|Adverse Event|0|||
127857562|NCT03073200|460094705|FG006|Randomized Withdrawal Period|Adverse Event|0|||
127857563|NCT03073200|460094706|FG007|Randomized Withdrawal Period|Adverse Event|0|||
127857564|NCT03073200|460094707|FG008|Randomized Withdrawal Period|Adverse Event|0|||
127857565|NCT03073200|460094708|FG009|Randomized Withdrawal Period|Adverse Event|0|||
127857566|NCT03073200|460094709|FG010|Randomized Withdrawal Period|Adverse Event|1|||
127857567|NCT03073200|460094710|FG011|Randomized Withdrawal Period|Adverse Event|0|||
127857568|NCT03073200|460094711|FG012|Randomized Withdrawal Period|Adverse Event|0|||
127857569|NCT03073200|460094712|FG013|Randomized Withdrawal Period|Adverse Event|0|||
127857570|NCT03073200|460094713|FG014|Randomized Withdrawal Period|Adverse Event|0|||
127857571|NCT03073200|460094699|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
127857572|NCT03073200|460094700|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
127857573|NCT03073200|460094701|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
127857574|NCT03073200|460094702|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
127857575|NCT03073200|460094703|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
127857576|NCT03073200|460094704|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
127857577|NCT03073200|460094705|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
127857578|NCT03073200|460094706|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
127857579|NCT03073200|460094707|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
127857580|NCT03073200|460094708|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
127857581|NCT03073200|460094709|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
127857582|NCT03073200|460094710|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
127857583|NCT03073200|460094711|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
127857584|NCT03073200|460094712|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
127857585|NCT03073200|460094713|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
127857586|NCT03073200|460094699|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
127857587|NCT03073200|460094700|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
127857588|NCT03073200|460094701|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
127857589|NCT03073200|460094702|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
127857590|NCT03073200|460094703|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
127857591|NCT03073200|460094704|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
127857592|NCT03073200|460094705|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
127857593|NCT03073200|460094706|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
127857594|NCT03073200|460094707|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
127857595|NCT03073200|460094708|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
127857596|NCT03073200|460094709|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
127857597|NCT03073200|460094710|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
127857598|NCT03073200|460094711|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
127857599|NCT03073200|460094712|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
127857600|NCT03073200|460094713|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
127857601|NCT03073200|460094699|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
127857602|NCT03073200|460094700|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
127857603|NCT03073200|460094701|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
127857604|NCT03073200|460094702|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
127857605|NCT03073200|460094703|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
127857606|NCT03073200|460094704|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
127857607|NCT03073200|460094705|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
127857608|NCT03073200|460094706|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
127857609|NCT03073200|460094707|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
127857610|NCT03073200|460094708|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
127857611|NCT03073200|460094709|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
127857612|NCT03073200|460094710|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
127857613|NCT03073200|460094711|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
127909217|NCT00579345|460290947|FG006|Overall Study|Withdrawal by Subject|0|||
127909218|NCT00579345|460290948|FG007|Overall Study|Withdrawal by Subject|1|||
127909219|NCT00579345|460290941|FG000|Overall Study|Lost to Follow-up|1|||
127909220|NCT00579345|460290942|FG001|Overall Study|Lost to Follow-up|0|||
127909221|NCT00579345|460290943|FG002|Overall Study|Lost to Follow-up|0|||
127909222|NCT00579345|460290944|FG003|Overall Study|Lost to Follow-up|0|||
127909223|NCT00579345|460290945|FG004|Overall Study|Lost to Follow-up|0|||
127909224|NCT00579345|460290946|FG005|Overall Study|Lost to Follow-up|0|||
127909225|NCT00579345|460290947|FG006|Overall Study|Lost to Follow-up|0|||
127909226|NCT00579345|460290948|FG007|Overall Study|Lost to Follow-up|0|||
127909227|NCT00579345|460290941|FG000|Overall Study|Adverse Event|0|||
127909228|NCT00579345|460290942|FG001|Overall Study|Adverse Event|0|||
127909229|NCT00579345|460290943|FG002|Overall Study|Adverse Event|1|||
127909230|NCT00579345|460290944|FG003|Overall Study|Adverse Event|0|||
127909231|NCT00579345|460290945|FG004|Overall Study|Adverse Event|0|||
127909232|NCT00579345|460290946|FG005|Overall Study|Adverse Event|0|||
127909233|NCT00579345|460290947|FG006|Overall Study|Adverse Event|0|||
127909234|NCT00579345|460290948|FG007|Overall Study|Adverse Event|0|||
127909235|NCT00579345|460290941|FG000|Overall Study|Protocol Violation|1|||
127909236|NCT00579345|460290942|FG001|Overall Study|Protocol Violation|0|||
127909237|NCT00579345|460290943|FG002|Overall Study|Protocol Violation|0|||
127909238|NCT00579345|460290944|FG003|Overall Study|Protocol Violation|0|||
127909239|NCT00579345|460290945|FG004|Overall Study|Protocol Violation|0|||
127909240|NCT00579345|460290946|FG005|Overall Study|Protocol Violation|0|||
127909241|NCT00579345|460290947|FG006|Overall Study|Protocol Violation|0|||
127909242|NCT00579345|460290948|FG007|Overall Study|Protocol Violation|1|||
127909243|NCT00579345|460290941|FG000|Overall Study|Death|1|||
127909244|NCT00579345|460290942|FG001|Overall Study|Death|1|||
127909245|NCT00579345|460290943|FG002|Overall Study|Death|1|||
127909246|NCT00579345|460290944|FG003|Overall Study|Death|1|||
127909247|NCT00579345|460290945|FG004|Overall Study|Death|0|||
127909248|NCT00579345|460290946|FG005|Overall Study|Death|0|||
127909249|NCT00579345|460290947|FG006|Overall Study|Death|0|||
127909250|NCT00579345|460290948|FG007|Overall Study|Death|0|||
127909251|NCT03255733|460290952|FG000|Overall Study|Lost to Follow-up|4|||
127909252|NCT04299087|460290953|FG000|Overall Study|Lost to Follow-up|2|||
127909253|NCT04299087|460290954|FG001|Overall Study|Lost to Follow-up|1|||
127909254|NCT00594035|460290955|FG000|Overall Study|Lost to Follow-up|1|||
127909255|NCT00594035|460290956|FG001|Overall Study|Lost to Follow-up|1|||
127909256|NCT00594035|460290955|FG000|Overall Study|Withdrawal by Subject|1|||
127909257|NCT00594035|460290956|FG001|Overall Study|Withdrawal by Subject|0|||
127909258|NCT00594035|460290955|FG000|Overall Study|Subject transferred to nursing home|0|||
127909259|NCT00594035|460290956|FG001|Overall Study|Subject transferred to nursing home|1|||
127909260|NCT00594035|460290955|FG000|Overall Study|Subject couldn't return due to job|0|||
127909261|NCT00594035|460290956|FG001|Overall Study|Subject couldn't return due to job|1|||
127909262|NCT00795821|460290957|FG000|Acute Treatment Phase|Adverse Event|23|||
127909263|NCT00795821|460290958|FG001|Acute Treatment Phase|Adverse Event|4|||
127909264|NCT00795821|460290957|FG000|Acute Treatment Phase|Death|1|||
127909265|NCT00795821|460290958|FG001|Acute Treatment Phase|Death|0|||
127909266|NCT00795821|460290957|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
127909267|NCT00795821|460290958|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
127909268|NCT00795821|460290957|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
127909269|NCT00795821|460290958|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
127909270|NCT00795821|460290957|FG000|Acute Treatment Phase|Physician Decision|1|||
127909271|NCT00795821|460290958|FG001|Acute Treatment Phase|Physician Decision|1|||
127909272|NCT00795821|460290957|FG000|Acute Treatment Phase|Protocol Violation|1|||
127909273|NCT00795821|460290958|FG001|Acute Treatment Phase|Protocol Violation|2|||
127909274|NCT00795821|460290957|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
127909275|NCT00795821|460290958|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
127909276|NCT00795821|460290957|FG000|Long-term Extension Phase|Adverse Event|25|||
127909277|NCT00795821|460290958|FG001|Long-term Extension Phase|Adverse Event|32|||
127909278|NCT00795821|460290957|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
127909279|NCT00795821|460290958|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
127909280|NCT00795821|460290957|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
127909281|NCT00795821|460290958|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
127909282|NCT00795821|460290957|FG000|Long-term Extension Phase|Physician Decision|1|||
127909283|NCT00795821|460290958|FG001|Long-term Extension Phase|Physician Decision|2|||
127909284|NCT00795821|460290957|FG000|Long-term Extension Phase|Protocol Violation|3|||
127909285|NCT00795821|460290958|FG001|Long-term Extension Phase|Protocol Violation|5|||
127909286|NCT00795821|460290957|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
127909287|NCT00795821|460290958|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
127909288|NCT00795821|460290957|FG000|Taper Phase|Adverse Event|2|||
127909289|NCT00795821|460290958|FG001|Taper Phase|Adverse Event|0|||
127909290|NCT00795821|460290957|FG000|Taper Phase|Lost to Follow-up|1|||
127909291|NCT00795821|460290958|FG001|Taper Phase|Lost to Follow-up|0|||
127909292|NCT00795821|460290957|FG000|Taper Phase|Physician Decision|2|||
127909293|NCT00795821|460290958|FG001|Taper Phase|Physician Decision|0|||
127909294|NCT00795821|460290957|FG000|Taper Phase|Withdrawal by Subject|4|||
127909295|NCT00795821|460290958|FG001|Taper Phase|Withdrawal by Subject|0|||
127909296|NCT00583453|460290967|FG000|Overall Study|discontinued intervention|0|||
127909297|NCT00583453|460290968|FG001|Overall Study|discontinued intervention|2|||
127909298|NCT03868891|460290971|FG000|Overall Study|Adverse Event|1|||
127909299|NCT03868891|460290972|FG001|Overall Study|Adverse Event|0|||
127909300|NCT03868891|460290971|FG000|Overall Study|Lost to Follow-up|2|||
127909301|NCT03868891|460290972|FG001|Overall Study|Lost to Follow-up|1|||
127909302|NCT03868891|460290971|FG000|Overall Study|COVID-19 Restrictions|1|||
127909303|NCT03868891|460290972|FG001|Overall Study|COVID-19 Restrictions|2|||
127909304|NCT03123094|460290973|FG000|Overall Study|Withdrawal by Subject|0|||
127909305|NCT03123094|460290974|FG001|Overall Study|Withdrawal by Subject|2|||
127909306|NCT03123094|460290975|FG002|Overall Study|Withdrawal by Subject|1|||
127909307|NCT03123094|460290976|FG003|Overall Study|Withdrawal by Subject|0|||
127909308|NCT03123094|460290977|FG004|Overall Study|Withdrawal by Subject|1|||
127909309|NCT02838420|460290978|FG000|Overall Study|Ongoing in Study|113|||
127909310|NCT02838420|460290979|FG001|Overall Study|Ongoing in Study|45|||
127909311|NCT02838420|460290978|FG000|Overall Study|Lost to Follow-up|1|||
127909312|NCT02838420|460290979|FG001|Overall Study|Lost to Follow-up|0|||
127909313|NCT02838420|460290978|FG000|Overall Study|Withdrawal by Subject|3|||
127909314|NCT02838420|460290979|FG001|Overall Study|Withdrawal by Subject|4|||
127909315|NCT02838420|460290978|FG000|Overall Study|Death|8|||
127909316|NCT02838420|460290979|FG001|Overall Study|Death|13|||
127909317|NCT00835536|460290983|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
127909318|NCT00835536|460290984|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
127909319|NCT03173547|460290988|FG000|Overall Study|Adverse Event|2|||
127909320|NCT03173547|460290989|FG001|Overall Study|Adverse Event|0|||
127909321|NCT03173547|460290988|FG000|Overall Study|Withdrawal by Subject|2|||
127909322|NCT03173547|460290989|FG001|Overall Study|Withdrawal by Subject|2|||
127909323|NCT00657553|460290990|FG000|Overall Study|low accrual, no analysis run|5|||
127909324|NCT00657553|460290991|FG001|Overall Study|low accrual, no analysis run|5|||
127909325|NCT00446563|460290992|FG000|Overall Study|Adverse Event|4|||
127909326|NCT00446563|460290993|FG001|Overall Study|Adverse Event|3|||
127857614|NCT03073200|460094712|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
127857615|NCT03073200|460094713|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
127857616|NCT03073200|460094699|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
127857617|NCT03073200|460094700|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
127857618|NCT03073200|460094701|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
127857619|NCT03073200|460094702|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
127857620|NCT03073200|460094703|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
127857621|NCT03073200|460094704|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
127857622|NCT03073200|460094705|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
127857623|NCT03073200|460094706|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
127857624|NCT03073200|460094707|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
127857625|NCT03073200|460094708|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
127857626|NCT03073200|460094709|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
127857627|NCT03073200|460094710|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
127857628|NCT03073200|460094711|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
127857629|NCT03073200|460094712|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
127857630|NCT03073200|460094713|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
127857631|NCT03073200|460094699|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
127857632|NCT03073200|460094700|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
127857633|NCT03073200|460094701|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
127857634|NCT03073200|460094702|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
127857635|NCT03073200|460094703|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
127857636|NCT03073200|460094704|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
127857637|NCT03073200|460094705|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
127857638|NCT03073200|460094706|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
127857639|NCT03073200|460094707|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
127857640|NCT03073200|460094708|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
127857641|NCT03073200|460094709|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
127909327|NCT00446563|460290992|FG000|Overall Study|Abnormal laboratory value(s)|0|||
127909328|NCT00446563|460290993|FG001|Overall Study|Abnormal laboratory value(s)|1|||
127909329|NCT00446563|460290992|FG000|Overall Study|Abnormal test procedure result(s)|1|||
127909330|NCT00446563|460290993|FG001|Overall Study|Abnormal test procedure result(s)|0|||
127909331|NCT00446563|460290992|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
127909332|NCT00446563|460290993|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
127909333|NCT00446563|460290992|FG000|Overall Study|Withdrawal by Subject|2|||
127909334|NCT00446563|460290993|FG001|Overall Study|Withdrawal by Subject|1|||
127909335|NCT00446563|460290992|FG000|Overall Study|Administrative problems|0|||
127909336|NCT00446563|460290993|FG001|Overall Study|Administrative problems|1|||
127909337|NCT03769025|460290994|FG000|Overall Study|Withdrawal by Subject|1|||
127909338|NCT03769025|460290995|FG001|Overall Study|Withdrawal by Subject|1|||
127909339|NCT03769025|460290994|FG000|Overall Study|Lost to Follow-up|4|||
127909340|NCT03769025|460290995|FG001|Overall Study|Lost to Follow-up|3|||
127909341|NCT01169558|460290996|FG000|Overall Study|Disease progression|98|||
127909342|NCT01169558|460290996|FG000|Overall Study|Adverse Event|25|||
127909343|NCT01169558|460290996|FG000|Overall Study|Withdrawal of Consent|8|||
127909344|NCT01169558|460290996|FG000|Overall Study|Medical Decision|7|||
127909345|NCT01169558|460290996|FG000|Overall Study|Stable Disease|4|||
127909346|NCT01169558|460290996|FG000|Overall Study|Lost to Follow-up|4|||
127909347|NCT01169558|460290996|FG000|Overall Study|Need for Surgery|4|||
127909348|NCT01169558|460290996|FG000|Overall Study|Non-compliance|2|||
127909349|NCT01169558|460290996|FG000|Overall Study|Protocol Violation|2|||
127909350|NCT01169558|460290996|FG000|Overall Study|Partial response|2|||
127909351|NCT02409355|460291002|FG000|Overall Study|Withdrawal by Subject|1|||
127909352|NCT02409355|460291003|FG001|Overall Study|Withdrawal by Subject|0|||
127909353|NCT02409355|460291002|FG000|Overall Study|Death|1|||
127909354|NCT02409355|460291003|FG001|Overall Study|Death|1|||
127909355|NCT02409355|460291002|FG000|Overall Study|Study terminated by Sponsor|2|||
127909356|NCT02409355|460291003|FG001|Overall Study|Study terminated by Sponsor|3|||
127909357|NCT00838539|460291004|FG000|Overall Study|Disease Progression|2|||
127909358|NCT00838539|460291005|FG001|Overall Study|Disease Progression|4|||
127909359|NCT00838539|460291006|FG002|Overall Study|Disease Progression|3|||
127909360|NCT00838539|460291007|FG003|Overall Study|Disease Progression|2|||
127909361|NCT00838539|460291008|FG004|Overall Study|Disease Progression|4|||
127909362|NCT00838539|460291009|FG005|Overall Study|Disease Progression|2|||
127909363|NCT00838539|460291010|FG006|Overall Study|Disease Progression|3|||
127909364|NCT00838539|460291011|FG007|Overall Study|Disease Progression|4|||
127909365|NCT00838539|460291012|FG008|Overall Study|Disease Progression|4|||
127909366|NCT00838539|460291013|FG009|Overall Study|Disease Progression|5|||
127909367|NCT00838539|460291014|FG010|Overall Study|Disease Progression|1|||
127909368|NCT00838539|460291015|FG011|Overall Study|Disease Progression|4|||
127909369|NCT00838539|460291004|FG000|Overall Study|Adverse Event|1|||
127909370|NCT00838539|460291005|FG001|Overall Study|Adverse Event|1|||
127909371|NCT00838539|460291006|FG002|Overall Study|Adverse Event|1|||
127909372|NCT00838539|460291007|FG003|Overall Study|Adverse Event|1|||
127909373|NCT00838539|460291008|FG004|Overall Study|Adverse Event|2|||
127909374|NCT00838539|460291009|FG005|Overall Study|Adverse Event|1|||
127909375|NCT00838539|460291010|FG006|Overall Study|Adverse Event|0|||
127909376|NCT00838539|460291011|FG007|Overall Study|Adverse Event|2|||
127909377|NCT00838539|460291012|FG008|Overall Study|Adverse Event|0|||
127909378|NCT00838539|460291013|FG009|Overall Study|Adverse Event|1|||
127909379|NCT00838539|460291014|FG010|Overall Study|Adverse Event|2|||
127909380|NCT00838539|460291015|FG011|Overall Study|Adverse Event|0|||
127909381|NCT00838539|460291004|FG000|Overall Study|Withdrawal by Subject|0|||
127909382|NCT00838539|460291005|FG001|Overall Study|Withdrawal by Subject|1|||
127909383|NCT00838539|460291006|FG002|Overall Study|Withdrawal by Subject|0|||
127909384|NCT00838539|460291007|FG003|Overall Study|Withdrawal by Subject|0|||
127909385|NCT00838539|460291008|FG004|Overall Study|Withdrawal by Subject|0|||
127909386|NCT00838539|460291009|FG005|Overall Study|Withdrawal by Subject|0|||
127909387|NCT00838539|460291010|FG006|Overall Study|Withdrawal by Subject|0|||
127909388|NCT00838539|460291011|FG007|Overall Study|Withdrawal by Subject|0|||
127909389|NCT00838539|460291012|FG008|Overall Study|Withdrawal by Subject|0|||
127909390|NCT00838539|460291013|FG009|Overall Study|Withdrawal by Subject|1|||
127909391|NCT00838539|460291014|FG010|Overall Study|Withdrawal by Subject|2|||
127909392|NCT00838539|460291015|FG011|Overall Study|Withdrawal by Subject|0|||
127909393|NCT00838539|460291004|FG000|Overall Study|Death|0|||
127909394|NCT00838539|460291005|FG001|Overall Study|Death|0|||
127909395|NCT00838539|460291006|FG002|Overall Study|Death|0|||
127909396|NCT00838539|460291007|FG003|Overall Study|Death|0|||
127909397|NCT00838539|460291008|FG004|Overall Study|Death|0|||
127909398|NCT00838539|460291009|FG005|Overall Study|Death|0|||
127909399|NCT00838539|460291010|FG006|Overall Study|Death|1|||
127909400|NCT00838539|460291011|FG007|Overall Study|Death|0|||
127909401|NCT00838539|460291012|FG008|Overall Study|Death|0|||
127909402|NCT00838539|460291013|FG009|Overall Study|Death|0|||
127909403|NCT00838539|460291014|FG010|Overall Study|Death|0|||
127909404|NCT00838539|460291015|FG011|Overall Study|Death|0|||
127909405|NCT00838539|460291004|FG000|Overall Study|Physician Decision|0|||
127909406|NCT00838539|460291005|FG001|Overall Study|Physician Decision|0|||
127909407|NCT00838539|460291006|FG002|Overall Study|Physician Decision|0|||
127909408|NCT00838539|460291007|FG003|Overall Study|Physician Decision|0|||
127909409|NCT00838539|460291008|FG004|Overall Study|Physician Decision|0|||
127909410|NCT00838539|460291009|FG005|Overall Study|Physician Decision|0|||
127909411|NCT00838539|460291010|FG006|Overall Study|Physician Decision|0|||
127909412|NCT00838539|460291011|FG007|Overall Study|Physician Decision|0|||
127909413|NCT00838539|460291012|FG008|Overall Study|Physician Decision|1|||
127909414|NCT00838539|460291013|FG009|Overall Study|Physician Decision|0|||
127909415|NCT00838539|460291014|FG010|Overall Study|Physician Decision|0|||
127909416|NCT00838539|460291015|FG011|Overall Study|Physician Decision|0|||
127909417|NCT00838539|460291004|FG000|Overall Study|Clinical Progression|0|||
127909418|NCT00838539|460291005|FG001|Overall Study|Clinical Progression|0|||
127909419|NCT00838539|460291006|FG002|Overall Study|Clinical Progression|0|||
127909420|NCT00838539|460291007|FG003|Overall Study|Clinical Progression|0|||
127909421|NCT00838539|460291008|FG004|Overall Study|Clinical Progression|0|||
127909422|NCT00838539|460291009|FG005|Overall Study|Clinical Progression|0|||
127909423|NCT00838539|460291010|FG006|Overall Study|Clinical Progression|1|||
127909424|NCT00838539|460291011|FG007|Overall Study|Clinical Progression|0|||
127909425|NCT00838539|460291012|FG008|Overall Study|Clinical Progression|0|||
127909426|NCT00838539|460291013|FG009|Overall Study|Clinical Progression|0|||
127909427|NCT00838539|460291014|FG010|Overall Study|Clinical Progression|0|||
127909428|NCT00838539|460291015|FG011|Overall Study|Clinical Progression|0|||
127909429|NCT00838539|460291004|FG000|Overall Study|Symptomatic Deterioration|0|||
127909430|NCT00838539|460291005|FG001|Overall Study|Symptomatic Deterioration|0|||
127909431|NCT00838539|460291006|FG002|Overall Study|Symptomatic Deterioration|1|||
127909432|NCT00838539|460291007|FG003|Overall Study|Symptomatic Deterioration|1|||
127909433|NCT00838539|460291008|FG004|Overall Study|Symptomatic Deterioration|0|||
127909434|NCT00838539|460291009|FG005|Overall Study|Symptomatic Deterioration|1|||
127909435|NCT00838539|460291010|FG006|Overall Study|Symptomatic Deterioration|0|||
127909436|NCT00838539|460291011|FG007|Overall Study|Symptomatic Deterioration|0|||
127909437|NCT00838539|460291012|FG008|Overall Study|Symptomatic Deterioration|0|||
127909438|NCT00838539|460291013|FG009|Overall Study|Symptomatic Deterioration|1|||
127909439|NCT00838539|460291014|FG010|Overall Study|Symptomatic Deterioration|0|||
127909440|NCT00838539|460291015|FG011|Overall Study|Symptomatic Deterioration|0|||
127909441|NCT01908205|460291016|FG000|Overall Study|Lost to Follow-up|2|||
127909442|NCT01908205|460291017|FG001|Overall Study|Lost to Follow-up|0|||
127909443|NCT01908205|460291016|FG000|Overall Study|Withdrawal by Subject|3|||
127909444|NCT01908205|460291017|FG001|Overall Study|Withdrawal by Subject|1|||
127909445|NCT03134222|460291022|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
127909446|NCT03134222|460291023|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
127909447|NCT03134222|460291024|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
127909448|NCT03134222|460291025|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
127909449|NCT03134222|460291026|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
127909450|NCT03134222|460291022|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
127909451|NCT03134222|460291023|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
127909452|NCT03134222|460291024|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
127909453|NCT03134222|460291025|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
127909454|NCT03134222|460291026|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
127909455|NCT03134222|460291022|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
127909456|NCT03134222|460291023|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
127909457|NCT03134222|460291024|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
127909458|NCT03134222|460291025|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
127909459|NCT03134222|460291026|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
127909460|NCT03134222|460291022|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
127909461|NCT03134222|460291023|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
127909462|NCT03134222|460291024|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
127909463|NCT03134222|460291025|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
127909464|NCT03134222|460291026|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
127909465|NCT03134222|460291022|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
127909466|NCT03134222|460291023|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
127909467|NCT03134222|460291024|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
127909468|NCT03134222|460291025|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
127909469|NCT03134222|460291026|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
127909470|NCT03134222|460291022|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
127909471|NCT03134222|460291023|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
127909472|NCT03134222|460291024|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
127909473|NCT03134222|460291025|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
127909474|NCT03134222|460291026|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
127909475|NCT03134222|460291022|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
127909476|NCT03134222|460291023|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
127909477|NCT03134222|460291024|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
127909478|NCT03134222|460291025|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
127909479|NCT03134222|460291026|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
127909480|NCT03134222|460291022|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
127909481|NCT03134222|460291023|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
127909482|NCT03134222|460291024|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
127909483|NCT03134222|460291025|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
127909484|NCT03134222|460291026|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
127909485|NCT03482882|460291029|FG000|Overall Study|Adverse Event|3|||
127909486|NCT03482882|460291029|FG000|Overall Study|Lost to Follow-up|1|||
127909487|NCT03482882|460291029|FG000|Overall Study|Protocol Violation|2|||
127909488|NCT03482882|460291029|FG000|Overall Study|Not further specified|1|||
127909489|NCT01110005|460291034|FG000|Overall Study|ineligible|1|||
127909490|NCT01110005|460291035|FG001|Overall Study|ineligible|2|||
127909491|NCT01110005|460291034|FG000|Overall Study|missing consent|3|||
127909492|NCT01110005|460291035|FG001|Overall Study|missing consent|2|||
127909493|NCT01110005|460291034|FG000|Overall Study|Withdrawal by Subject|0|||
127909494|NCT01110005|460291035|FG001|Overall Study|Withdrawal by Subject|1|||
127909495|NCT03123471|460291038|FG000|Placebo-controlled Phase|Adverse Event|3|||
127909496|NCT03123471|460291039|FG001|Placebo-controlled Phase|Adverse Event|8|||
127909497|NCT03123471|460291038|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
127909498|NCT03123471|460291039|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
127909499|NCT03123471|460291038|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
127909500|NCT03123471|460291039|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
127909501|NCT03123471|460291038|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
127909502|NCT03123471|460291039|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
127909503|NCT03123471|460291038|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
127909504|NCT03123471|460291039|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
127909505|NCT03123471|460291038|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
127909506|NCT03123471|460291039|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
127909507|NCT03123471|460291038|FG000|Placebo-controlled Phase|Miscellaneous|0|||
127909508|NCT03123471|460291039|FG001|Placebo-controlled Phase|Miscellaneous|1|||
127909509|NCT03123471|460291038|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
127909510|NCT03123471|460291039|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
127909511|NCT03123471|460291038|FG000|Apremilast Extension Phase|Adverse Event|1|||
127909512|NCT03123471|460291039|FG001|Apremilast Extension Phase|Adverse Event|5|||
127909513|NCT03123471|460291038|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
127909514|NCT03123471|460291039|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
127909515|NCT03123471|460291038|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
127909516|NCT03123471|460291039|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
127909517|NCT03681470|460291040|FG000|Overall Study|Lack of Efficacy|3|||
127909518|NCT03681470|460291040|FG000|Overall Study|Lost to Follow-up|1|||
127909519|NCT03681470|460291040|FG000|Overall Study|Protocol Violation|3|||
127909520|NCT03681470|460291040|FG000|Overall Study|Withdrawal by Subject|1|||
127909521|NCT01686477|460291041|FG000|Feeding Intervention|Death|1|||
127909522|NCT01686477|460291042|FG001|Feeding Intervention|Death|0|||
127909523|NCT01686477|460291043|FG002|Feeding Intervention|Death|1|||
127909524|NCT01686477|460291041|FG000|Feeding Intervention|Withdrawal by Subject|0|||
127909525|NCT01686477|460291042|FG001|Feeding Intervention|Withdrawal by Subject|6|||
127909526|NCT01686477|460291043|FG002|Feeding Intervention|Withdrawal by Subject|0|||
127909527|NCT01686477|460291041|FG000|Feeding Intervention|Physician Decision|1|||
127909528|NCT01686477|460291042|FG001|Feeding Intervention|Physician Decision|2|||
127909529|NCT01686477|460291043|FG002|Feeding Intervention|Physician Decision|0|||
127909530|NCT01686477|460291041|FG000|Feeding Intervention|Met pre-defined safety threshold|1|||
127909531|NCT01686477|460291042|FG001|Feeding Intervention|Met pre-defined safety threshold|0|||
127909532|NCT01686477|460291043|FG002|Feeding Intervention|Met pre-defined safety threshold|1|||
127909533|NCT01686477|460291041|FG000|Feeding Intervention|Transfer to a non-participating hospital|0|||
127909534|NCT01686477|460291042|FG001|Feeding Intervention|Transfer to a non-participating hospital|1|||
127909535|NCT01686477|460291043|FG002|Feeding Intervention|Transfer to a non-participating hospital|1|||
127857642|NCT03073200|460094710|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
127857643|NCT03073200|460094711|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
127857644|NCT03073200|460094712|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
127857645|NCT03073200|460094713|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
127857646|NCT03073200|460094699|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
127857647|NCT03073200|460094700|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
127857648|NCT03073200|460094701|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
127857649|NCT03073200|460094702|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
127857650|NCT03073200|460094703|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
127857651|NCT03073200|460094704|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
127857652|NCT03073200|460094705|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
127857653|NCT03073200|460094706|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
127857654|NCT03073200|460094707|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
127857655|NCT03073200|460094708|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
127857656|NCT03073200|460094709|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
127909536|NCT01686477|460291041|FG000|Primary Outcome Term Scan|Withdrawal by Subject|6|||
127909537|NCT01686477|460291042|FG001|Primary Outcome Term Scan|Withdrawal by Subject|5|||
127909538|NCT01686477|460291043|FG002|Primary Outcome Term Scan|Withdrawal by Subject|5|||
127909539|NCT01686477|460291041|FG000|Primary Outcome Term Scan|Lost to Follow-up|1|||
127909540|NCT01686477|460291042|FG001|Primary Outcome Term Scan|Lost to Follow-up|1|||
127909541|NCT01686477|460291043|FG002|Primary Outcome Term Scan|Lost to Follow-up|1|||
127976406|NCT04598451|460536124|FG001|Overall Study|Requires Prohibited Medication|0|||
127909542|NCT01686477|460291041|FG000|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|2|||
127909543|NCT01686477|460291042|FG001|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
127909544|NCT01686477|460291043|FG002|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
127909545|NCT01686477|460291041|FG000|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|7|||
127909546|NCT01686477|460291042|FG001|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|12|||
127909547|NCT01686477|460291043|FG002|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|5|||
127909548|NCT01686477|460291041|FG000|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
127909549|NCT01686477|460291042|FG001|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|2|||
127909550|NCT01686477|460291043|FG002|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
127909551|NCT03290781|460291045|FG000|Overall Study|Adverse Event|5|||
127909552|NCT03290781|460291046|FG001|Overall Study|Adverse Event|7|||
127909553|NCT03290781|460291047|FG002|Overall Study|Adverse Event|4|||
127909554|NCT03290781|460291048|FG003|Overall Study|Adverse Event|1|||
127909555|NCT03290781|460291049|FG004|Overall Study|Adverse Event|0|||
127909556|NCT03290781|460291050|FG005|Overall Study|Adverse Event|0|||
127909557|NCT03290781|460291051|FG006|Overall Study|Adverse Event|0|||
127909558|NCT03290781|460291045|FG000|Overall Study|Death|0|||
127909559|NCT03290781|460291046|FG001|Overall Study|Death|0|||
127909560|NCT03290781|460291047|FG002|Overall Study|Death|1|||
127909561|NCT03290781|460291048|FG003|Overall Study|Death|0|||
127909562|NCT03290781|460291049|FG004|Overall Study|Death|1|||
127909563|NCT03290781|460291050|FG005|Overall Study|Death|0|||
127909564|NCT03290781|460291051|FG006|Overall Study|Death|0|||
127909565|NCT03290781|460291045|FG000|Overall Study|Withdrawal by Subject|6|||
127909566|NCT03290781|460291046|FG001|Overall Study|Withdrawal by Subject|5|||
127909567|NCT03290781|460291047|FG002|Overall Study|Withdrawal by Subject|9|||
127909568|NCT03290781|460291048|FG003|Overall Study|Withdrawal by Subject|10|||
127909569|NCT03290781|460291049|FG004|Overall Study|Withdrawal by Subject|1|||
127909570|NCT03290781|460291050|FG005|Overall Study|Withdrawal by Subject|2|||
127909571|NCT03290781|460291051|FG006|Overall Study|Withdrawal by Subject|0|||
127909572|NCT03290781|460291045|FG000|Overall Study|Physician Decision|0|||
127909573|NCT03290781|460291046|FG001|Overall Study|Physician Decision|1|||
127909574|NCT03290781|460291047|FG002|Overall Study|Physician Decision|0|||
127909575|NCT03290781|460291048|FG003|Overall Study|Physician Decision|0|||
127857657|NCT03073200|460094710|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
127857658|NCT03073200|460094711|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
127857659|NCT03073200|460094712|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
127857660|NCT03073200|460094713|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
127857661|NCT03073200|460094699|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
127857662|NCT03073200|460094700|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
127857663|NCT03073200|460094701|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
127857664|NCT03073200|460094702|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
127857665|NCT03073200|460094703|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
127857666|NCT03073200|460094704|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
127857667|NCT03073200|460094705|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
127857668|NCT03073200|460094706|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
127857669|NCT03073200|460094707|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
127857670|NCT03073200|460094708|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
127857671|NCT03073200|460094709|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
127857672|NCT03073200|460094710|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
127857673|NCT03073200|460094711|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
127857674|NCT03073200|460094712|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
127857675|NCT03073200|460094713|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
127857676|NCT03073200|460094699|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
127857677|NCT03073200|460094700|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
127857678|NCT03073200|460094701|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
127857679|NCT03073200|460094702|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
127857680|NCT03073200|460094703|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
127909576|NCT03290781|460291049|FG004|Overall Study|Physician Decision|0|||
127909577|NCT03290781|460291050|FG005|Overall Study|Physician Decision|0|||
127857681|NCT03073200|460094704|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
127857682|NCT03073200|460094705|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
127909578|NCT03290781|460291051|FG006|Overall Study|Physician Decision|0|||
127857683|NCT03073200|460094706|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
127857684|NCT03073200|460094707|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
127857685|NCT03073200|460094708|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
127857686|NCT03073200|460094709|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
127857687|NCT03073200|460094710|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
127857688|NCT03073200|460094711|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
127857689|NCT03073200|460094712|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
127857690|NCT03073200|460094713|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
127857691|NCT03512275|460094714|FG000|Overall Study|Withdrawal by Subject|1|||
127857692|NCT03512275|460094715|FG001|Overall Study|Withdrawal by Subject|3|||
127857693|NCT03512275|460094714|FG000|Overall Study|Physician Decision|0|||
127857694|NCT03512275|460094715|FG001|Overall Study|Physician Decision|1|||
127857695|NCT03512275|460094714|FG000|Overall Study|Lost to Follow-up|0|||
127857696|NCT03512275|460094715|FG001|Overall Study|Lost to Follow-up|3|||
127857697|NCT03512275|460094714|FG000|Overall Study|Other|1|||
127857698|NCT03512275|460094715|FG001|Overall Study|Other|0|||
127857699|NCT04757376|460094716|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|8|||
127857700|NCT04757376|460094717|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|24|||
127857701|NCT04757376|460094718|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
127857702|NCT04757376|460094719|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
127857703|NCT04757376|460094720|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
127857704|NCT04757376|460094716|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|4|||
127857705|NCT04757376|460094717|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|5|||
127857706|NCT04757376|460094718|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
127857707|NCT04757376|460094719|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
127857708|NCT04757376|460094720|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
127857709|NCT04757376|460094716|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|5|||
127857710|NCT04757376|460094717|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|4|||
127857711|NCT04757376|460094718|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
127857712|NCT04757376|460094719|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
127857713|NCT04757376|460094720|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
127857714|NCT04757376|460094716|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
127857715|NCT04757376|460094717|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|3|||
127857716|NCT04757376|460094718|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
127857717|NCT04757376|460094719|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
127857718|NCT04757376|460094720|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
127857719|NCT04757376|460094716|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|1|||
127857720|NCT04757376|460094717|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
127857721|NCT04757376|460094718|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
127857722|NCT04757376|460094719|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
127857723|NCT04757376|460094720|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
127857724|NCT04757376|460094716|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
127857725|NCT04757376|460094717|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|1|||
127857726|NCT04757376|460094718|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
127857727|NCT04757376|460094719|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
127857728|NCT04757376|460094720|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
127857729|NCT04757376|460094716|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
127857730|NCT04757376|460094717|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
127857731|NCT04757376|460094718|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
127857732|NCT04757376|460094719|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
127857733|NCT04757376|460094720|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
127857734|NCT04757376|460094716|FG000|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
127857735|NCT04757376|460094717|FG001|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
127857736|NCT04757376|460094718|FG002|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|1|||
127857737|NCT04757376|460094719|FG003|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
127857738|NCT04757376|460094720|FG004|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
127857739|NCT05116683|460094723|FG000|Overall Study|Physician Decision|4|||
127857740|NCT01474889|460094725|FG000|Overall Study|Physician Decision|1|||
127857741|NCT01474889|460094726|FG001|Overall Study|Physician Decision|0|||
127857742|NCT01474889|460094727|FG002|Overall Study|Physician Decision|0|||
127857743|NCT01474889|460094725|FG000|Overall Study|Did not meet inclusion|1|||
127909579|NCT03290781|460291045|FG000|Overall Study|Site Terminated by Sponsor|1|||
127909580|NCT03290781|460291046|FG001|Overall Study|Site Terminated by Sponsor|0|||
127909581|NCT03290781|460291047|FG002|Overall Study|Site Terminated by Sponsor|2|||
127909582|NCT03290781|460291048|FG003|Overall Study|Site Terminated by Sponsor|1|||
127909583|NCT03290781|460291049|FG004|Overall Study|Site Terminated by Sponsor|0|||
127909584|NCT03290781|460291050|FG005|Overall Study|Site Terminated by Sponsor|0|||
127909585|NCT03290781|460291051|FG006|Overall Study|Site Terminated by Sponsor|0|||
127909586|NCT03290781|460291045|FG000|Overall Study|Lost to Follow-up|0|||
127909587|NCT03290781|460291046|FG001|Overall Study|Lost to Follow-up|0|||
127909588|NCT03290781|460291047|FG002|Overall Study|Lost to Follow-up|0|||
127909589|NCT03290781|460291048|FG003|Overall Study|Lost to Follow-up|1|||
127909590|NCT03290781|460291049|FG004|Overall Study|Lost to Follow-up|0|||
127909591|NCT03290781|460291050|FG005|Overall Study|Lost to Follow-up|0|||
127909592|NCT03290781|460291051|FG006|Overall Study|Lost to Follow-up|0|||
127909593|NCT03290781|460291045|FG000|Overall Study|Protocol Deviation|2|||
127909594|NCT03290781|460291046|FG001|Overall Study|Protocol Deviation|0|||
127909595|NCT03290781|460291047|FG002|Overall Study|Protocol Deviation|0|||
127909596|NCT03290781|460291048|FG003|Overall Study|Protocol Deviation|1|||
127909597|NCT03290781|460291049|FG004|Overall Study|Protocol Deviation|0|||
127909598|NCT03290781|460291050|FG005|Overall Study|Protocol Deviation|0|||
127909599|NCT03290781|460291051|FG006|Overall Study|Protocol Deviation|0|||
127909600|NCT03290781|460291045|FG000|Overall Study|Disease Relapse|32|||
127909601|NCT03290781|460291046|FG001|Overall Study|Disease Relapse|5|||
127909602|NCT03290781|460291047|FG002|Overall Study|Disease Relapse|38|||
127909603|NCT03290781|460291048|FG003|Overall Study|Disease Relapse|7|||
127909604|NCT03290781|460291049|FG004|Overall Study|Disease Relapse|3|||
127909605|NCT03290781|460291050|FG005|Overall Study|Disease Relapse|1|||
127909606|NCT03290781|460291051|FG006|Overall Study|Disease Relapse|4|||
127909607|NCT03290781|460291045|FG000|Overall Study|Other|3|||
127909608|NCT03290781|460291046|FG001|Overall Study|Other|0|||
127909609|NCT03290781|460291047|FG002|Overall Study|Other|2|||
127909610|NCT03290781|460291048|FG003|Overall Study|Other|2|||
127909611|NCT03290781|460291049|FG004|Overall Study|Other|0|||
127909612|NCT03290781|460291050|FG005|Overall Study|Other|0|||
127909613|NCT03290781|460291051|FG006|Overall Study|Other|0|||
127909614|NCT02957942|460291052|FG000|Overall Study|Withdrawal by Subject|0|||
127909615|NCT02957942|460291053|FG001|Overall Study|Withdrawal by Subject|1|||
127909616|NCT02957942|460291052|FG000|Overall Study|Practicing experiment protocol|0|||
127909617|NCT02957942|460291053|FG001|Overall Study|Practicing experiment protocol|6|||
127909618|NCT01136174|460291054|FG000|Overall Study|Adverse Event|0|||
127909619|NCT01136174|460291055|FG001|Overall Study|Adverse Event|0|||
127909620|NCT01136174|460291056|FG002|Overall Study|Adverse Event|0|||
127909621|NCT01136174|460291057|FG003|Overall Study|Adverse Event|4|||
127909622|NCT03238781|460291058|FG000|Overall Study|Adverse Event|1|||
127909623|NCT03238781|460291059|FG001|Overall Study|Adverse Event|1|||
127909624|NCT03238781|460291060|FG002|Overall Study|Adverse Event|2|||
127909625|NCT03238781|460291058|FG000|Overall Study|Lost to Follow-up|2|||
127909626|NCT03238781|460291059|FG001|Overall Study|Lost to Follow-up|1|||
127909627|NCT03238781|460291060|FG002|Overall Study|Lost to Follow-up|2|||
127909628|NCT03238781|460291058|FG000|Overall Study|Withdrawal by Subject|23|||
127909629|NCT03238781|460291059|FG001|Overall Study|Withdrawal by Subject|14|||
127909630|NCT03238781|460291060|FG002|Overall Study|Withdrawal by Subject|16|||
127909631|NCT03238781|460291058|FG000|Overall Study|Decision by sponsor|0|||
127909632|NCT03238781|460291059|FG001|Overall Study|Decision by sponsor|1|||
127909633|NCT03238781|460291060|FG002|Overall Study|Decision by sponsor|0|||
127909634|NCT03761173|460291062|FG000|Overall Study|Lost to Follow-up|93|||
127909635|NCT03761173|460291062|FG000|Overall Study|Withdrawal by Subject|74|||
127909636|NCT03761173|460291062|FG000|Overall Study|Death|45|||
127909637|NCT03761173|460291062|FG000|Overall Study|Withdrawal for Other Reasons|29|||
127909638|NCT03761173|460291062|FG000|Overall Study|Protocol Violation|1|||
127909639|NCT02301975|460292717|FG000|Overall Study|Adverse Event|8|||
127909640|NCT02301975|460292718|FG001|Overall Study|Adverse Event|3|||
127909641|NCT02301975|460292719|FG002|Overall Study|Adverse Event|2|||
127909642|NCT02301975|460292717|FG000|Overall Study|Lack of Efficacy|1|||
127909643|NCT02301975|460292718|FG001|Overall Study|Lack of Efficacy|1|||
127909644|NCT02301975|460292719|FG002|Overall Study|Lack of Efficacy|1|||
127909645|NCT02301975|460292717|FG000|Overall Study|Protocol Violation|3|||
127909646|NCT02301975|460292718|FG001|Overall Study|Protocol Violation|5|||
127909647|NCT02301975|460292719|FG002|Overall Study|Protocol Violation|3|||
127909648|NCT02301975|460292717|FG000|Overall Study|Lost to Follow-up|0|||
127909649|NCT02301975|460292718|FG001|Overall Study|Lost to Follow-up|2|||
127909650|NCT02301975|460292719|FG002|Overall Study|Lost to Follow-up|2|||
127909651|NCT02301975|460292717|FG000|Overall Study|Physician Decision|4|||
127909652|NCT02301975|460292718|FG001|Overall Study|Physician Decision|2|||
127909653|NCT02301975|460292719|FG002|Overall Study|Physician Decision|3|||
127909654|NCT02301975|460292717|FG000|Overall Study|Withdrawal by Subject|15|||
127909655|NCT02301975|460292718|FG001|Overall Study|Withdrawal by Subject|12|||
127909656|NCT02301975|460292719|FG002|Overall Study|Withdrawal by Subject|11|||
127909657|NCT03606174|460292722|FG000|Overall Study|Death|37|||
127909658|NCT03606174|460292723|FG001|Overall Study|Death|15|||
127909659|NCT03606174|460292724|FG002|Overall Study|Death|15|||
127909660|NCT03606174|460292725|FG003|Overall Study|Death|7|||
127909661|NCT03606174|460292726|FG004|Overall Study|Death|35|||
127909662|NCT03606174|460292727|FG005|Overall Study|Death|12|||
127909663|NCT03606174|460292728|FG006|Overall Study|Death|35|||
127909664|NCT03606174|460292729|FG007|Overall Study|Death|8|||
127909665|NCT03606174|460292730|FG008|Overall Study|Death|5|||
127909666|NCT03606174|460292731|FG009|Overall Study|Death|3|||
127909667|NCT03606174|460292732|FG010|Overall Study|Death|0|||
127909668|NCT03606174|460292722|FG000|Overall Study|Lost to Follow-up|0|||
127909669|NCT03606174|460292723|FG001|Overall Study|Lost to Follow-up|0|||
127909670|NCT03606174|460292724|FG002|Overall Study|Lost to Follow-up|0|||
127909671|NCT03606174|460292725|FG003|Overall Study|Lost to Follow-up|0|||
127909672|NCT03606174|460292726|FG004|Overall Study|Lost to Follow-up|1|||
127909673|NCT03606174|460292727|FG005|Overall Study|Lost to Follow-up|1|||
127909674|NCT03606174|460292728|FG006|Overall Study|Lost to Follow-up|0|||
127909675|NCT03606174|460292729|FG007|Overall Study|Lost to Follow-up|0|||
127909676|NCT03606174|460292730|FG008|Overall Study|Lost to Follow-up|0|||
127909677|NCT03606174|460292731|FG009|Overall Study|Lost to Follow-up|0|||
127909678|NCT03606174|460292732|FG010|Overall Study|Lost to Follow-up|0|||
127909679|NCT03606174|460292722|FG000|Overall Study|Withdrawal by Subject|6|||
127909680|NCT03606174|460292723|FG001|Overall Study|Withdrawal by Subject|0|||
127909681|NCT03606174|460292724|FG002|Overall Study|Withdrawal by Subject|0|||
127909682|NCT03606174|460292725|FG003|Overall Study|Withdrawal by Subject|1|||
127909683|NCT03606174|460292726|FG004|Overall Study|Withdrawal by Subject|2|||
127909684|NCT03606174|460292727|FG005|Overall Study|Withdrawal by Subject|1|||
127909685|NCT03606174|460292728|FG006|Overall Study|Withdrawal by Subject|4|||
127909686|NCT03606174|460292729|FG007|Overall Study|Withdrawal by Subject|0|||
127909687|NCT03606174|460292730|FG008|Overall Study|Withdrawal by Subject|0|||
127909688|NCT03606174|460292731|FG009|Overall Study|Withdrawal by Subject|0|||
127909689|NCT03606174|460292732|FG010|Overall Study|Withdrawal by Subject|1|||
127909690|NCT03606174|460292722|FG000|Overall Study|Study Terminated by Sponsor|5|||
127909691|NCT03606174|460292723|FG001|Overall Study|Study Terminated by Sponsor|7|||
127909692|NCT03606174|460292724|FG002|Overall Study|Study Terminated by Sponsor|3|||
127909693|NCT03606174|460292725|FG003|Overall Study|Study Terminated by Sponsor|0|||
127909694|NCT03606174|460292726|FG004|Overall Study|Study Terminated by Sponsor|11|||
127909695|NCT03606174|460292727|FG005|Overall Study|Study Terminated by Sponsor|6|||
127909696|NCT03606174|460292728|FG006|Overall Study|Study Terminated by Sponsor|12|||
127909697|NCT03606174|460292729|FG007|Overall Study|Study Terminated by Sponsor|1|||
127909698|NCT03606174|460292730|FG008|Overall Study|Study Terminated by Sponsor|3|||
127909699|NCT03606174|460292731|FG009|Overall Study|Study Terminated by Sponsor|1|||
127909700|NCT03606174|460292732|FG010|Overall Study|Study Terminated by Sponsor|2|||
127909701|NCT03606174|460292722|FG000|Overall Study|Miscellaneous|1|||
127909702|NCT03606174|460292723|FG001|Overall Study|Miscellaneous|1|||
127909703|NCT03606174|460292724|FG002|Overall Study|Miscellaneous|0|||
127909704|NCT03606174|460292725|FG003|Overall Study|Miscellaneous|1|||
127909705|NCT03606174|460292726|FG004|Overall Study|Miscellaneous|4|||
127909706|NCT03606174|460292727|FG005|Overall Study|Miscellaneous|7|||
127909707|NCT03606174|460292728|FG006|Overall Study|Miscellaneous|5|||
127909708|NCT03606174|460292729|FG007|Overall Study|Miscellaneous|0|||
127909709|NCT03606174|460292730|FG008|Overall Study|Miscellaneous|0|||
127909710|NCT03606174|460292731|FG009|Overall Study|Miscellaneous|0|||
127909711|NCT03606174|460292732|FG010|Overall Study|Miscellaneous|1|||
127909712|NCT03049748|460292733|FG000|Overall Study|Lost to Follow-up|1|||
127909713|NCT03049748|460292734|FG001|Overall Study|Lost to Follow-up|0|||
127909714|NCT03049748|460292733|FG000|Overall Study|Death|3|||
127909715|NCT03049748|460292734|FG001|Overall Study|Death|0|||
127909716|NCT03049748|460292733|FG000|Overall Study|Withdrawal by Subject|0|||
127909717|NCT03049748|460292734|FG001|Overall Study|Withdrawal by Subject|3|||
127909718|NCT03049748|460292733|FG000|Overall Study|Protocol Violation|0|||
127909719|NCT03049748|460292734|FG001|Overall Study|Protocol Violation|2|||
127909720|NCT03049748|460292733|FG000|Overall Study|Moved out of state (relocation)|0|||
127909721|NCT03049748|460292734|FG001|Overall Study|Moved out of state (relocation)|1|||
127909722|NCT00905840|460292737|FG000|Overall Study|Lost to Follow-up|11|||
127909723|NCT00905840|460292737|FG000|Overall Study|Death|3|||
127909724|NCT00905840|460292737|FG000|Overall Study|Withdrawal by Subject|1|||
127909725|NCT00905840|460292737|FG000|Overall Study|Adverse Event|1|||
127909726|NCT03496623|460292738|FG000|Run-In Period (2 Weeks)|Death|1|||
127909727|NCT03496623|460292739|FG001|Run-In Period (2 Weeks)|Death|0|||
127909728|NCT03496623|460292740|FG002|Run-In Period (2 Weeks)|Death|0|||
127909729|NCT03496623|460292741|FG003|Run-In Period (2 Weeks)|Death|0|||
127909730|NCT03496623|460292742|FG004|Run-In Period (2 Weeks)|Death|0|||
127909731|NCT03496623|460292738|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
127909732|NCT03496623|460292739|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
127909733|NCT03496623|460292740|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
127909734|NCT03496623|460292741|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
127909735|NCT03496623|460292742|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
127857744|NCT01474889|460094726|FG001|Overall Study|Did not meet inclusion|0|||
127857745|NCT01474889|460094727|FG002|Overall Study|Did not meet inclusion|0|||
127857746|NCT01474889|460094725|FG000|Overall Study|Withdrawal by Subject|0|||
127857747|NCT01474889|460094726|FG001|Overall Study|Withdrawal by Subject|1|||
127857748|NCT01474889|460094727|FG002|Overall Study|Withdrawal by Subject|0|||
127857749|NCT04412668|460094731|FG000|Overall Study|Death - multiple comorbidities|2|||
127857750|NCT04412668|460094732|FG001|Overall Study|Death - multiple comorbidities|0|||
127857751|NCT04412668|460094733|FG002|Overall Study|Death - multiple comorbidities|0|||
127857752|NCT04412668|460094731|FG000|Overall Study|Withdrawal by Subject|3|||
127857753|NCT04412668|460094732|FG001|Overall Study|Withdrawal by Subject|0|||
127857754|NCT04412668|460094733|FG002|Overall Study|Withdrawal by Subject|0|||
127857755|NCT04412668|460094731|FG000|Overall Study|Other than Specified|2|||
127857756|NCT04412668|460094732|FG001|Overall Study|Other than Specified|0|||
127857757|NCT04412668|460094733|FG002|Overall Study|Other than Specified|0|||
127857758|NCT00397891|460094734|FG000|Overall Study|Withdrawal by Subject|1|||
127857759|NCT00397891|460094735|FG001|Overall Study|Withdrawal by Subject|0|||
127857760|NCT00397891|460094736|FG002|Overall Study|Withdrawal by Subject|0|||
127857761|NCT00397891|460094737|FG003|Overall Study|Withdrawal by Subject|0|||
127857762|NCT00397891|460094738|FG004|Overall Study|Withdrawal by Subject|1|||
127857763|NCT04964557|460094739|FG000|Overall Study|Withdrawal by Subject|3|||
127857764|NCT04964557|460094740|FG001|Overall Study|Withdrawal by Subject|2|||
127857765|NCT04964557|460094739|FG000|Overall Study|Lost to Follow-up|1|||
127857766|NCT04964557|460094740|FG001|Overall Study|Lost to Follow-up|2|||
127857767|NCT04964557|460094739|FG000|Overall Study|Physician Decision|2|||
127857768|NCT04964557|460094740|FG001|Overall Study|Physician Decision|0|||
127857769|NCT04964557|460094739|FG000|Overall Study|Death|3|||
127857770|NCT04964557|460094740|FG001|Overall Study|Death|0|||
127857771|NCT04964557|460094739|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
127857772|NCT04964557|460094740|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
127857773|NCT03695471|460096063|FG000|Overall Study|Cancellation|1|||
127857774|NCT02859558|460096064|FG000|Step 1|Not Eligible|0|||
127857775|NCT02859558|460096065|FG001|Step 1|Not Eligible|0|||
127857776|NCT02859558|460096066|FG002|Step 1|Not Eligible|0|||
127857777|NCT02859558|460096067|FG003|Step 1|Not Eligible|0|||
127857778|NCT02859558|460096068|FG004|Step 1|Not Eligible|3|||
127857779|NCT02859558|460096064|FG000|Step 1|Lost to Follow-up|1|||
127857780|NCT02859558|460096065|FG001|Step 1|Lost to Follow-up|3|||
127857781|NCT02859558|460096066|FG002|Step 1|Lost to Follow-up|3|||
127857782|NCT02859558|460096067|FG003|Step 1|Lost to Follow-up|0|||
127857783|NCT02859558|460096068|FG004|Step 1|Lost to Follow-up|0|||
127857784|NCT02859558|460096064|FG000|Step 1|Did Not Return to Clinic|2|||
127857785|NCT02859558|460096065|FG001|Step 1|Did Not Return to Clinic|3|||
127857786|NCT02859558|460096066|FG002|Step 1|Did Not Return to Clinic|4|||
127857787|NCT02859558|460096067|FG003|Step 1|Did Not Return to Clinic|0|||
127857788|NCT02859558|460096068|FG004|Step 1|Did Not Return to Clinic|0|||
127857789|NCT02859558|460096064|FG000|Step 1|Moved|0|||
127857790|NCT02859558|460096065|FG001|Step 1|Moved|1|||
127857791|NCT02859558|460096066|FG002|Step 1|Moved|1|||
127857792|NCT02859558|460096067|FG003|Step 1|Moved|0|||
127857793|NCT02859558|460096068|FG004|Step 1|Moved|0|||
127857794|NCT02859558|460096064|FG000|Step 1|Withdrawal By Participant|1|||
127857795|NCT02859558|460096065|FG001|Step 1|Withdrawal By Participant|2|||
127857796|NCT02859558|460096066|FG002|Step 1|Withdrawal By Participant|1|||
127857797|NCT02859558|460096067|FG003|Step 1|Withdrawal By Participant|0|||
127857798|NCT02859558|460096068|FG004|Step 1|Withdrawal By Participant|0|||
127857799|NCT02859558|460096064|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
127857800|NCT02859558|460096065|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
127857801|NCT02859558|460096066|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
127857802|NCT02859558|460096067|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
127857803|NCT02859558|460096068|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
127857804|NCT02859558|460096064|FG000|Step 1|Incarceration|0|||
127857805|NCT02859558|460096065|FG001|Step 1|Incarceration|1|||
127857806|NCT02859558|460096066|FG002|Step 1|Incarceration|0|||
127857807|NCT02859558|460096067|FG003|Step 1|Incarceration|0|||
127857808|NCT02859558|460096068|FG004|Step 1|Incarceration|0|||
127857809|NCT02859558|460096064|FG000|Step 1|Non-Adherence to Study Drug|2|||
127857810|NCT02859558|460096065|FG001|Step 1|Non-Adherence to Study Drug|0|||
127857811|NCT02859558|460096066|FG002|Step 1|Non-Adherence to Study Drug|1|||
127857812|NCT02859558|460096067|FG003|Step 1|Non-Adherence to Study Drug|0|||
127857813|NCT02859558|460096068|FG004|Step 1|Non-Adherence to Study Drug|0|||
127857814|NCT02859558|460096064|FG000|Step 1|Non-Adherence to Study Requirements|3|||
127857815|NCT02859558|460096065|FG001|Step 1|Non-Adherence to Study Requirements|1|||
127857816|NCT02859558|460096066|FG002|Step 1|Non-Adherence to Study Requirements|0|||
127857817|NCT02859558|460096067|FG003|Step 1|Non-Adherence to Study Requirements|0|||
127857818|NCT02859558|460096068|FG004|Step 1|Non-Adherence to Study Requirements|0|||
127857819|NCT02859558|460096064|FG000|Step 1|Virologic Failure|2|||
127857820|NCT02859558|460096065|FG001|Step 1|Virologic Failure|1|||
127909736|NCT03496623|460292738|FG000|Period 1 (12 Weeks)|Death|0|||
127857821|NCT02859558|460096066|FG002|Step 1|Virologic Failure|1|||
127857822|NCT02859558|460096067|FG003|Step 1|Virologic Failure|0|||
127857823|NCT02859558|460096068|FG004|Step 1|Virologic Failure|0|||
127857824|NCT02859558|460096064|FG000|Step 2|Lost to Follow-up|3|||
127857825|NCT02859558|460096065|FG001|Step 2|Lost to Follow-up|3|||
127857826|NCT02859558|460096066|FG002|Step 2|Lost to Follow-up|1|||
127857827|NCT02859558|460096067|FG003|Step 2|Lost to Follow-up|0|||
127857828|NCT02859558|460096068|FG004|Step 2|Lost to Follow-up|0|||
127857829|NCT02859558|460096064|FG000|Step 2|Withdrawal by Subject|0|||
127857830|NCT02859558|460096065|FG001|Step 2|Withdrawal by Subject|1|||
127857831|NCT02859558|460096066|FG002|Step 2|Withdrawal by Subject|1|||
127857832|NCT02859558|460096067|FG003|Step 2|Withdrawal by Subject|0|||
127857833|NCT02859558|460096068|FG004|Step 2|Withdrawal by Subject|0|||
127857834|NCT02859558|460096064|FG000|Step 2|Unexpected Closure of Site|0|||
127857835|NCT02859558|460096065|FG001|Step 2|Unexpected Closure of Site|1|||
127857836|NCT02859558|460096066|FG002|Step 2|Unexpected Closure of Site|1|||
127857837|NCT02859558|460096067|FG003|Step 2|Unexpected Closure of Site|0|||
127857838|NCT02859558|460096068|FG004|Step 2|Unexpected Closure of Site|0|||
127857839|NCT02859558|460096064|FG000|Step 2|Death|1|||
127857840|NCT02859558|460096065|FG001|Step 2|Death|0|||
127857841|NCT02859558|460096066|FG002|Step 2|Death|0|||
127857842|NCT02859558|460096067|FG003|Step 2|Death|0|||
127857843|NCT02859558|460096068|FG004|Step 2|Death|0|||
127857844|NCT02859558|460096064|FG000|Step 2|Incarceration|0|||
127857845|NCT02859558|460096065|FG001|Step 2|Incarceration|0|||
127857846|NCT02859558|460096066|FG002|Step 2|Incarceration|1|||
127857847|NCT02859558|460096067|FG003|Step 2|Incarceration|0|||
127857848|NCT02859558|460096068|FG004|Step 2|Incarceration|0|||
127857849|NCT05665595|460096069|FG000|Overall Study|Ongoing|692|||
127857850|NCT05665595|460096070|FG001|Overall Study|Ongoing|698|||
127857851|NCT05665595|460096069|FG000|Overall Study|Withdrawal by Subject|2|||
127857852|NCT05665595|460096070|FG001|Overall Study|Withdrawal by Subject|2|||
127857853|NCT05665595|460096069|FG000|Overall Study|Lost to Follow-up|1|||
127857854|NCT05665595|460096070|FG001|Overall Study|Lost to Follow-up|0|||
127857855|NCT05665595|460096069|FG000|Overall Study|Death|6|||
127857856|NCT05665595|460096070|FG001|Overall Study|Death|1|||
127857857|NCT00766142|460096071|FG000|Overall Study|Protocol Violation|4|||
127857858|NCT03793010|460096078|FG000|Overall Study|Withdrawal by Subject|5|||
127857859|NCT03793010|460096079|FG001|Overall Study|Withdrawal by Subject|7|||
127857860|NCT03793010|460096078|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
127857861|NCT03793010|460096079|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
127857862|NCT03793010|460096078|FG000|Overall Study|Lost to Follow-up|1|||
127857863|NCT03793010|460096079|FG001|Overall Study|Lost to Follow-up|2|||
127857864|NCT03793010|460096078|FG000|Overall Study|Patient couldn't sit still for injection|1|||
127857865|NCT03793010|460096079|FG001|Overall Study|Patient couldn't sit still for injection|0|||
127857866|NCT03793010|460096078|FG000|Overall Study|Withdrew to pursue other treatment|1|||
127857867|NCT03793010|460096079|FG001|Overall Study|Withdrew to pursue other treatment|0|||
127857868|NCT03793010|460096078|FG000|Overall Study|Did not meet eligibility criteria|1|||
127857869|NCT03793010|460096079|FG001|Overall Study|Did not meet eligibility criteria|0|||
127857870|NCT04924114|460096080|FG000|Overall Study|Withdrawal by Subject|0|||
127857871|NCT04924114|460096081|FG001|Overall Study|Withdrawal by Subject|2|||
127857872|NCT04924114|460096082|FG002|Overall Study|Withdrawal by Subject|2|||
127857873|NCT04924114|460096083|FG003|Overall Study|Withdrawal by Subject|0|||
127857874|NCT04924114|460096084|FG004|Overall Study|Withdrawal by Subject|2|||
127857875|NCT03657576|460096089|FG000|Overall Study|Death|0|||
127857876|NCT03657576|460096090|FG001|Overall Study|Death|1|||
127857877|NCT03657576|460096091|FG002|Overall Study|Death|1|||
127857878|NCT03657576|460096092|FG003|Overall Study|Death|0|||
127857879|NCT03657576|460096093|FG004|Overall Study|Death|0|||
127857880|NCT03657576|460096094|FG005|Overall Study|Death|0|||
127857881|NCT03657576|460096089|FG000|Overall Study|Withdrawal by Subject|0|||
127857882|NCT03657576|460096090|FG001|Overall Study|Withdrawal by Subject|0|||
127857883|NCT03657576|460096091|FG002|Overall Study|Withdrawal by Subject|0|||
127857884|NCT03657576|460096092|FG003|Overall Study|Withdrawal by Subject|1|||
127857885|NCT03657576|460096093|FG004|Overall Study|Withdrawal by Subject|0|||
127857886|NCT03657576|460096094|FG005|Overall Study|Withdrawal by Subject|0|||
127857887|NCT03657576|460096089|FG000|Overall Study|Screen Fail|0|||
127857888|NCT03657576|460096090|FG001|Overall Study|Screen Fail|0|||
127857889|NCT03657576|460096091|FG002|Overall Study|Screen Fail|0|||
127857890|NCT03657576|460096092|FG003|Overall Study|Screen Fail|0|||
127857891|NCT03657576|460096093|FG004|Overall Study|Screen Fail|0|||
127857892|NCT03657576|460096094|FG005|Overall Study|Screen Fail|5|||
127909737|NCT03496623|460292739|FG001|Period 1 (12 Weeks)|Death|3|||
127909738|NCT03496623|460292740|FG002|Period 1 (12 Weeks)|Death|0|||
127909739|NCT03496623|460292741|FG003|Period 1 (12 Weeks)|Death|0|||
127909740|NCT03496623|460292742|FG004|Period 1 (12 Weeks)|Death|0|||
127909741|NCT03496623|460292738|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
127909742|NCT03496623|460292739|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
127909743|NCT03496623|460292740|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
127909744|NCT03496623|460292741|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
127909745|NCT03496623|460292742|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
127909746|NCT03496623|460292738|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
127909747|NCT03496623|460292739|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
127909748|NCT03496623|460292740|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
127909749|NCT03496623|460292741|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
127909750|NCT03496623|460292742|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
127909751|NCT03496623|460292738|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
127909752|NCT03496623|460292739|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
127909753|NCT03496623|460292740|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
127909754|NCT03496623|460292741|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
127909755|NCT03496623|460292742|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
127909756|NCT03496623|460292738|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
127909757|NCT03496623|460292739|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
127909758|NCT03496623|460292740|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
127909759|NCT03496623|460292741|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
127909760|NCT03496623|460292742|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
127909761|NCT03496623|460292738|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
127909762|NCT03496623|460292739|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
127909763|NCT03496623|460292740|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
127909764|NCT03496623|460292741|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
127909765|NCT03496623|460292742|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
127909766|NCT03496623|460292738|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
127909767|NCT03496623|460292739|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
127909768|NCT03496623|460292740|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
127909769|NCT03496623|460292741|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
127909770|NCT03496623|460292742|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
127909771|NCT00794963|460292743|FG000|Overall Study|Withdrawal by Subject|1|||
127909772|NCT00794963|460292744|FG001|Overall Study|Withdrawal by Subject|4|||
127909773|NCT03181594|460292753|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
127909774|NCT03181594|460292753|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
127909775|NCT03181594|460292753|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
127909776|NCT03181594|460292753|FG000|Initial Study Protocol (12-month FU)|Death|1|||
127909777|NCT03181594|460292753|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
127909778|NCT03181594|460292753|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
127909779|NCT01527006|460292754|FG000|Core Study|Adverse Event|0|||
127909780|NCT01527006|460292755|FG001|Core Study|Adverse Event|2|||
127909781|NCT01527006|460292754|FG000|Core Study|Lost to Follow-up|0|||
127909782|NCT01527006|460292755|FG001|Core Study|Lost to Follow-up|1|||
127909783|NCT01527006|460292754|FG000|Core Study|Subject Choice|1|||
127909784|NCT01527006|460292755|FG001|Core Study|Subject Choice|0|||
127909785|NCT01527006|460292754|FG000|Core Study|Inadequate Therapeutic Effect|1|||
127909786|NCT01527006|460292755|FG001|Core Study|Inadequate Therapeutic Effect|0|||
127909787|NCT01527006|460292754|FG000|Core Study|Withdrawal by Subject|0|||
127909788|NCT01527006|460292755|FG001|Core Study|Withdrawal by Subject|1|||
127909789|NCT01527006|460292754|FG000|Core Study|Other|0|||
127909790|NCT01527006|460292755|FG001|Core Study|Other|2|||
127909791|NCT01527006|460292754|FG000|Extension Phase|Adverse Event|4|||
127909792|NCT01527006|460292755|FG001|Extension Phase|Adverse Event|2|||
127909793|NCT01527006|460292754|FG000|Extension Phase|Lost to Follow-up|0|||
127909794|NCT01527006|460292755|FG001|Extension Phase|Lost to Follow-up|1|||
127909795|NCT01527006|460292754|FG000|Extension Phase|Subject Choice|1|||
127909796|NCT01527006|460292755|FG001|Extension Phase|Subject Choice|1|||
127909797|NCT01527006|460292754|FG000|Extension Phase|Inadequate therapeutic effect|1|||
127909798|NCT01527006|460292755|FG001|Extension Phase|Inadequate therapeutic effect|1|||
127909799|NCT01527006|460292754|FG000|Extension Phase|Other|0|||
127909800|NCT01527006|460292755|FG001|Extension Phase|Other|3|||
127909801|NCT03247972|460292756|FG000|High Dose Statin Run-In Period (8 Weeks)|Withdrawal by Subject|4|||
127909802|NCT03247972|460292756|FG000|High Dose Statins + Evolocumab (8 Weeks)|Withdrawal by Subject|2|||
127909803|NCT00123734|460292758|FG000|Overall Study|Death|3|||
127909804|NCT00123734|460292758|FG000|Overall Study|Lost to Follow-up|3|||
127909805|NCT00123734|460292758|FG000|Overall Study|Dropout|1|||
127909806|NCT00123734|460292758|FG000|Overall Study|Withdrawal by Subject|1|||
127909807|NCT01175018|460292760|FG000|Overall Study|Adverse Event|3|||
127909808|NCT01175018|460292761|FG001|Overall Study|Adverse Event|1|||
127909809|NCT00840073|460292765|FG000|Second Intervention|Missed 72 hour blood draw|1|||
127909810|NCT00840073|460292766|FG001|Second Intervention|Missed 72 hour blood draw|1|||
127909811|NCT01103713|460292773|FG000|Overall Study|Lost to Follow-up|2|||
127909812|NCT01103713|460292773|FG000|Overall Study|Withdrawal by Subject|8|||
127909813|NCT01103713|460292773|FG000|Overall Study|Study terminated by sponsor|2|||
127909814|NCT01103713|460292773|FG000|Overall Study|Other|1|||
127909815|NCT00505622|460292774|FG000|Overall Study|Adverse Event|5|||
127909816|NCT00505622|460292775|FG001|Overall Study|Adverse Event|6|||
127909817|NCT00505622|460292776|FG002|Overall Study|Adverse Event|4|||
127909818|NCT00505622|460292774|FG000|Overall Study|Protocol Violation|1|||
127909819|NCT00505622|460292775|FG001|Overall Study|Protocol Violation|1|||
127909820|NCT00505622|460292776|FG002|Overall Study|Protocol Violation|0|||
127909821|NCT00505622|460292774|FG000|Overall Study|Withdrawal by Subject|0|||
127909822|NCT00505622|460292775|FG001|Overall Study|Withdrawal by Subject|3|||
127909823|NCT00505622|460292776|FG002|Overall Study|Withdrawal by Subject|2|||
127909824|NCT00505622|460292774|FG000|Overall Study|Study termination by sponsor|115|||
127909825|NCT00505622|460292775|FG001|Overall Study|Study termination by sponsor|98|||
127909826|NCT00505622|460292776|FG002|Overall Study|Study termination by sponsor|90|||
127909827|NCT03084471|460292777|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
127909828|NCT03084471|460292777|FG000|Overall Study|Condition under investigation worsened|84|||
127909829|NCT03084471|460292777|FG000|Overall Study|Lack of therapeutic response|2|||
127909830|NCT03084471|460292777|FG000|Overall Study|Protocol Violation|1|||
127909831|NCT03084471|460292777|FG000|Overall Study|Adverse Event|73|||
127909832|NCT03084471|460292777|FG000|Overall Study|Withdrawal by Subject|12|||
127909833|NCT03084471|460292777|FG000|Overall Study|Disease relapse|181|||
127909834|NCT03084471|460292777|FG000|Overall Study|Subjective disease progression|359|||
127857893|NCT03657576|460096089|FG000|Overall Study|Disease Progression|1|||
127909835|NCT03084471|460292777|FG000|Overall Study|Other (as recorded)|33|||
127909836|NCT03084471|460292777|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
127909837|NCT01940341|460292782|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
127909838|NCT01940341|460292783|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
127909839|NCT01940341|460292784|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
127909840|NCT01940341|460292785|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
127857894|NCT03657576|460096090|FG001|Overall Study|Disease Progression|1|||
127857895|NCT03657576|460096091|FG002|Overall Study|Disease Progression|0|||
127857896|NCT03657576|460096092|FG003|Overall Study|Disease Progression|5|||
127857897|NCT03657576|460096093|FG004|Overall Study|Disease Progression|0|||
127857898|NCT03657576|460096094|FG005|Overall Study|Disease Progression|0|||
127857899|NCT03657576|460096089|FG000|Overall Study|Insurance Coverage|0|||
127857900|NCT03657576|460096090|FG001|Overall Study|Insurance Coverage|0|||
127857901|NCT03657576|460096091|FG002|Overall Study|Insurance Coverage|0|||
127857902|NCT03657576|460096092|FG003|Overall Study|Insurance Coverage|1|||
127857903|NCT03657576|460096093|FG004|Overall Study|Insurance Coverage|0|||
127857904|NCT03657576|460096094|FG005|Overall Study|Insurance Coverage|0|||
127857905|NCT04284787|460096097|FG000|Overall Study|Disease Progression|9|||
127857906|NCT04284787|460096098|FG001|Overall Study|Disease Progression|12|||
127857907|NCT04284787|460096097|FG000|Overall Study|Physician Decision|12|||
127857908|NCT04284787|460096098|FG001|Overall Study|Physician Decision|7|||
127857909|NCT04284787|460096097|FG000|Overall Study|Transplant|5|||
127857910|NCT04284787|460096098|FG001|Overall Study|Transplant|4|||
127857911|NCT04284787|460096097|FG000|Overall Study|Death|1|||
127857912|NCT04284787|460096098|FG001|Overall Study|Death|2|||
127857913|NCT04284787|460096097|FG000|Overall Study|Adverse Event|0|||
127857914|NCT04284787|460096098|FG001|Overall Study|Adverse Event|4|||
127857915|NCT04284787|460096097|FG000|Overall Study|Non-adherence|2|||
127857916|NCT04284787|460096098|FG001|Overall Study|Non-adherence|0|||
127857917|NCT04284787|460096097|FG000|Overall Study|Lack of Efficacy|2|||
127857918|NCT04284787|460096098|FG001|Overall Study|Lack of Efficacy|0|||
127857919|NCT01874353|460096099|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
127857920|NCT01874353|460096100|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
127857921|NCT01874353|460096101|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
127857922|NCT01874353|460096102|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
127857923|NCT01874353|460096099|FG000|Overall Study|Lost to Follow-up|2|||
127857924|NCT01874353|460096100|FG001|Overall Study|Lost to Follow-up|2|||
127857925|NCT01874353|460096101|FG002|Overall Study|Lost to Follow-up|2|||
127857926|NCT01874353|460096102|FG003|Overall Study|Lost to Follow-up|0|||
127857927|NCT01874353|460096099|FG000|Overall Study|Death|110|||
127857928|NCT01874353|460096100|FG001|Overall Study|Death|60|||
127857929|NCT01874353|460096101|FG002|Overall Study|Death|13|||
127857930|NCT01874353|460096102|FG003|Overall Study|Death|7|||
127857931|NCT01874353|460096099|FG000|Overall Study|Withdrawal by Subject|13|||
127857932|NCT01874353|460096100|FG001|Overall Study|Withdrawal by Subject|11|||
127857933|NCT01874353|460096101|FG002|Overall Study|Withdrawal by Subject|0|||
127857934|NCT01874353|460096102|FG003|Overall Study|Withdrawal by Subject|0|||
127857935|NCT04392154|460096103|FG000|Overall Study|Adverse Event|3|||
127857936|NCT04392154|460096104|FG001|Overall Study|Adverse Event|46|||
127857937|NCT04392154|460096103|FG000|Overall Study|Due to epidemic/pandemic|0|||
127857938|NCT04392154|460096104|FG001|Overall Study|Due to epidemic/pandemic|1|||
127857939|NCT04392154|460096103|FG000|Overall Study|Lack of Efficacy|1|||
127857940|NCT04392154|460096104|FG001|Overall Study|Lack of Efficacy|47|||
127857941|NCT04392154|460096103|FG000|Overall Study|Lost to Follow-up|11|||
127857942|NCT04392154|460096104|FG001|Overall Study|Lost to Follow-up|61|||
127857943|NCT04392154|460096103|FG000|Overall Study|Geopolitical conflict|1|||
127857944|NCT04392154|460096104|FG001|Overall Study|Geopolitical conflict|1|||
127857945|NCT04392154|460096103|FG000|Overall Study|Physician Decision|1|||
127857946|NCT04392154|460096104|FG001|Overall Study|Physician Decision|5|||
127857947|NCT04392154|460096103|FG000|Overall Study|Pregnancy|1|||
127857948|NCT04392154|460096104|FG001|Overall Study|Pregnancy|8|||
127857949|NCT04392154|460096103|FG000|Overall Study|Protocol deviation|1|||
127857950|NCT04392154|460096104|FG001|Overall Study|Protocol deviation|12|||
127857951|NCT04392154|460096103|FG000|Overall Study|Withdrawal by Subject|18|||
127857952|NCT04392154|460096104|FG001|Overall Study|Withdrawal by Subject|138|||
127857953|NCT04392154|460096103|FG000|Overall Study|Sponsor Decision|1|||
127857954|NCT04392154|460096104|FG001|Overall Study|Sponsor Decision|14|||
127857955|NCT04392154|460096103|FG000|Overall Study|Site Closure|0|||
127857956|NCT04392154|460096104|FG001|Overall Study|Site Closure|4|||
127857957|NCT04992507|460096107|FG000|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|5|||
127857958|NCT04992507|460096108|FG001|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|2|||
127857959|NCT04992507|460096107|FG000|Overall Study|Death|0|||
127857960|NCT04992507|460096108|FG001|Overall Study|Death|1|||
127857961|NCT03287830|460096109|FG000|Overall Study|Withdrawal by Subject|1|||
127857962|NCT03287830|460096110|FG001|Overall Study|Withdrawal by Subject|1|||
127857963|NCT03287830|460096109|FG000|Overall Study|not meeting inclusion criteria|5|||
127857964|NCT03287830|460096110|FG001|Overall Study|not meeting inclusion criteria|12|||
127857965|NCT02974621|460096111|FG000|Overall Study|Didn't receive study treatment|1|||
127857966|NCT02974621|460096112|FG001|Overall Study|Didn't receive study treatment|10|||
127857967|NCT03797144|460096113|FG000|Enrollment|Protocol Violation|4|||
127857968|NCT03797144|460096114|FG001|Enrollment|Protocol Violation|1|||
127857969|NCT03797144|460096113|FG000|Surgery|Protocol Violation|1|||
127857970|NCT03797144|460096114|FG001|Surgery|Protocol Violation|0|||
127857971|NCT03797144|460096113|FG000|3 Month|Early termination cut-off date|2|||
127857972|NCT03797144|460096114|FG001|3 Month|Early termination cut-off date|0|||
127857973|NCT03797144|460096113|FG000|12 Month|Early termination cut-off date|8|||
127857974|NCT03797144|460096114|FG001|12 Month|Early termination cut-off date|9|||
127857975|NCT03797144|460096113|FG000|24 Month|Early termination cut-off date|1|||
127857976|NCT03797144|460096114|FG001|24 Month|Early termination cut-off date|1|||
127857977|NCT03083470|460096115|FG000|Overall Study|Lost to Follow-up|0|||
127857978|NCT03083470|460096116|FG001|Overall Study|Lost to Follow-up|0|||
127857979|NCT03083470|460096117|FG002|Overall Study|Lost to Follow-up|0|||
127857980|NCT03083470|460096118|FG003|Overall Study|Lost to Follow-up|0|||
127857981|NCT03083470|460096119|FG004|Overall Study|Lost to Follow-up|1|||
127857982|NCT03083470|460096115|FG000|Overall Study|Withdrawal by Subject|0|||
127857983|NCT03083470|460096116|FG001|Overall Study|Withdrawal by Subject|0|||
127857984|NCT03083470|460096117|FG002|Overall Study|Withdrawal by Subject|0|||
127857985|NCT03083470|460096118|FG003|Overall Study|Withdrawal by Subject|0|||
127857986|NCT03083470|460096119|FG004|Overall Study|Withdrawal by Subject|1|||
127857987|NCT00606229|460096120|FG000|Overall Study|Adverse Event|11|||
127857988|NCT00606229|460096120|FG000|Overall Study|Lack of Efficacy|1|||
127857989|NCT00606229|460096120|FG000|Overall Study|Withdrawal by Subject|4|||
127857990|NCT00606229|460096120|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
127857991|NCT00606229|460096120|FG000|Overall Study|change of residence or other commitments|2|||
127857992|NCT03077711|460096121|FG000|Overall Study|Lost to Follow-up|2|||
127857993|NCT03077711|460096122|FG001|Overall Study|Lost to Follow-up|2|||
127857994|NCT03077711|460096121|FG000|Overall Study|noncompliant taking medication|2|||
127857995|NCT03077711|460096122|FG001|Overall Study|noncompliant taking medication|0|||
127857996|NCT01526928|460096123|FG000|Overall Study|Progressive Disease|35|||
127857997|NCT01526928|460096124|FG001|Overall Study|Progressive Disease|17|||
127857998|NCT01526928|460096125|FG002|Overall Study|Progressive Disease|150|||
127857999|NCT01526928|460096126|FG003|Overall Study|Progressive Disease|182|||
127858000|NCT01526928|460096127|FG004|Overall Study|Progressive Disease|76|||
127858001|NCT01526928|460096128|FG005|Overall Study|Progressive Disease|4|||
127858002|NCT01526928|460096123|FG000|Overall Study|Adverse Event|2|||
127858003|NCT01526928|460096124|FG001|Overall Study|Adverse Event|1|||
127858004|NCT01526928|460096125|FG002|Overall Study|Adverse Event|29|||
127909841|NCT01940341|460292782|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
127909842|NCT01940341|460292783|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
127858005|NCT01526928|460096126|FG003|Overall Study|Adverse Event|40|||
127858006|NCT01526928|460096127|FG004|Overall Study|Adverse Event|13|||
127858007|NCT01526928|460096128|FG005|Overall Study|Adverse Event|2|||
127858008|NCT01526928|460096123|FG000|Overall Study|Death|0|||
127858009|NCT01526928|460096124|FG001|Overall Study|Death|0|||
127858010|NCT01526928|460096125|FG002|Overall Study|Death|3|||
127858011|NCT01526928|460096126|FG003|Overall Study|Death|0|||
127858012|NCT01526928|460096127|FG004|Overall Study|Death|0|||
127858013|NCT01526928|460096128|FG005|Overall Study|Death|0|||
127858014|NCT01526928|460096123|FG000|Overall Study|Withdrawal by Subject|1|||
127858015|NCT01526928|460096124|FG001|Overall Study|Withdrawal by Subject|0|||
127858016|NCT01526928|460096125|FG002|Overall Study|Withdrawal by Subject|13|||
127858017|NCT01526928|460096126|FG003|Overall Study|Withdrawal by Subject|11|||
127858018|NCT01526928|460096127|FG004|Overall Study|Withdrawal by Subject|3|||
127858019|NCT01526928|460096128|FG005|Overall Study|Withdrawal by Subject|0|||
127858020|NCT01526928|460096123|FG000|Overall Study|Physician Decision|0|||
127858021|NCT01526928|460096124|FG001|Overall Study|Physician Decision|0|||
127858022|NCT01526928|460096125|FG002|Overall Study|Physician Decision|2|||
127858023|NCT01526928|460096126|FG003|Overall Study|Physician Decision|5|||
127858024|NCT01526928|460096127|FG004|Overall Study|Physician Decision|0|||
127858025|NCT01526928|460096128|FG005|Overall Study|Physician Decision|0|||
127858026|NCT01526928|460096123|FG000|Overall Study|Other Reason|0|||
127858027|NCT01526928|460096124|FG001|Overall Study|Other Reason|1|||
127858028|NCT01526928|460096125|FG002|Overall Study|Other Reason|11|||
127858029|NCT01526928|460096126|FG003|Overall Study|Other Reason|4|||
127858030|NCT01526928|460096127|FG004|Overall Study|Other Reason|1|||
127858031|NCT01526928|460096128|FG005|Overall Study|Other Reason|0|||
127858032|NCT01526928|460096123|FG000|Overall Study|Lost to Follow-up|0|||
127858033|NCT01526928|460096124|FG001|Overall Study|Lost to Follow-up|0|||
127858034|NCT01526928|460096125|FG002|Overall Study|Lost to Follow-up|0|||
127858035|NCT01526928|460096126|FG003|Overall Study|Lost to Follow-up|1|||
127858036|NCT01526928|460096127|FG004|Overall Study|Lost to Follow-up|0|||
127858037|NCT01526928|460096128|FG005|Overall Study|Lost to Follow-up|0|||
127858038|NCT01526928|460096123|FG000|Overall Study|Protocol Deviation|0|||
127858039|NCT01526928|460096124|FG001|Overall Study|Protocol Deviation|0|||
127858040|NCT01526928|460096125|FG002|Overall Study|Protocol Deviation|0|||
127858041|NCT01526928|460096126|FG003|Overall Study|Protocol Deviation|2|||
127858042|NCT01526928|460096127|FG004|Overall Study|Protocol Deviation|0|||
127858043|NCT01526928|460096128|FG005|Overall Study|Protocol Deviation|0|||
127858044|NCT01526928|460096123|FG000|Overall Study|Missing|0|||
127858045|NCT01526928|460096124|FG001|Overall Study|Missing|0|||
127858046|NCT01526928|460096125|FG002|Overall Study|Missing|1|||
127858047|NCT01526928|460096126|FG003|Overall Study|Missing|0|||
127858048|NCT01526928|460096127|FG004|Overall Study|Missing|2|||
127858049|NCT01526928|460096128|FG005|Overall Study|Missing|0|||
127858050|NCT01108068|460096129|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
127858051|NCT01108068|460096130|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
127858052|NCT00836953|460096131|FG000|Overall Study|Withdrawal by Subject|1|||
127858053|NCT00836953|460096131|FG000|Overall Study|Lost to Follow-up|1|||
127858054|NCT00376675|460096132|FG000|Overall Study|Withdrawal by Subject|9|||
127858055|NCT00376675|460096133|FG001|Overall Study|Withdrawal by Subject|2|||
127858056|NCT00376675|460096132|FG000|Overall Study|Adverse Event|10|||
127858057|NCT00376675|460096133|FG001|Overall Study|Adverse Event|5|||
127858058|NCT00376675|460096132|FG000|Overall Study|Other Reason|1|||
127858059|NCT00376675|460096133|FG001|Overall Study|Other Reason|7|||
127858060|NCT02943668|460096137|FG000|Overall Study|Disease Progression|1|||
127858061|NCT02201251|460096138|FG000|Overall Study|Adverse Event|1|||
127858062|NCT02201251|460096139|FG001|Overall Study|Adverse Event|1|||
127858063|NCT02201251|460096138|FG000|Overall Study|Protocol Violation|1|||
127858064|NCT02201251|460096139|FG001|Overall Study|Protocol Violation|0|||
127858065|NCT02201251|460096138|FG000|Overall Study|Noncompliance with Study Drug|0|||
127858066|NCT02201251|460096139|FG001|Overall Study|Noncompliance with Study Drug|1|||
127858067|NCT02201251|460096138|FG000|Overall Study|Withdrawal by Subject|2|||
127858068|NCT02201251|460096139|FG001|Overall Study|Withdrawal by Subject|1|||
127858069|NCT02877134|460096141|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
127858070|NCT02877134|460096142|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
127858071|NCT02877134|460096143|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
127858072|NCT02877134|460096144|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
127858073|NCT02877134|460096145|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
127858074|NCT02877134|460096146|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
127858075|NCT02877134|460096147|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
127858076|NCT02877134|460096148|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
127858077|NCT02877134|460096149|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
127858078|NCT02877134|460096150|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
127858079|NCT02877134|460096151|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
127858080|NCT02877134|460096152|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
127858081|NCT02877134|460096141|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
127858082|NCT02877134|460096142|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
127858083|NCT02877134|460096143|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
127858084|NCT02877134|460096144|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
127858085|NCT02877134|460096145|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
127858086|NCT02877134|460096146|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
127858087|NCT02877134|460096147|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
127858088|NCT02877134|460096148|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
127858089|NCT02877134|460096149|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
127858090|NCT02877134|460096150|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
127858091|NCT02877134|460096151|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
127909843|NCT01940341|460292784|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
127909844|NCT01940341|460292785|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
127909845|NCT01940341|460292782|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
127909846|NCT01940341|460292783|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
127909847|NCT01940341|460292784|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
127909848|NCT01940341|460292785|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
127909849|NCT01940341|460292782|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
127909850|NCT01940341|460292783|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
127909851|NCT01940341|460292784|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
127909852|NCT01940341|460292785|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
127909853|NCT01940341|460292782|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
127909854|NCT01940341|460292783|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
127909855|NCT01940341|460292784|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
127909856|NCT01940341|460292785|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
127909857|NCT01940341|460292782|FG000|Period 1: Double-blind Phase|Death|0|||
127909858|NCT01940341|460292783|FG001|Period 1: Double-blind Phase|Death|1|||
127909859|NCT01940341|460292784|FG002|Period 1: Double-blind Phase|Death|0|||
127909860|NCT01940341|460292785|FG003|Period 1: Double-blind Phase|Death|0|||
127909861|NCT01940341|460292782|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
127909862|NCT01940341|460292783|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
127909863|NCT01940341|460292784|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
127909864|NCT01940341|460292785|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
127909865|NCT01940341|460292782|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
127909866|NCT01940341|460292783|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
127909867|NCT01940341|460292784|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
127909868|NCT01940341|460292785|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
127909869|NCT01940341|460292782|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
127909870|NCT01940341|460292783|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
127909871|NCT01940341|460292784|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
127909872|NCT01940341|460292785|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
127909873|NCT01940341|460292782|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
127909874|NCT01940341|460292783|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
127909875|NCT01940341|460292784|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
127909876|NCT01940341|460292785|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
127909877|NCT01940341|460292782|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
127909878|NCT01940341|460292783|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
127909879|NCT01940341|460292784|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
127909880|NCT01940341|460292785|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
127909881|NCT01940341|460292782|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
127909882|NCT01940341|460292783|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
127909883|NCT01940341|460292784|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
127909884|NCT01940341|460292785|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
127909885|NCT01940341|460292782|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
127909886|NCT01940341|460292783|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
127909887|NCT01940341|460292784|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
127909888|NCT01940341|460292785|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
127909889|NCT01940341|460292782|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
127909890|NCT01940341|460292783|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
127909891|NCT01940341|460292784|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
127909892|NCT01940341|460292785|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
127909893|NCT01940341|460292782|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
127909894|NCT01940341|460292783|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
127909895|NCT01940341|460292784|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
127909896|NCT01940341|460292785|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
127909897|NCT01940341|460292782|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
127909898|NCT01940341|460292783|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
127909899|NCT01940341|460292784|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
127909900|NCT01940341|460292785|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
127909901|NCT01940341|460292782|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
127909902|NCT01940341|460292783|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
127909903|NCT01940341|460292784|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
127909904|NCT01940341|460292785|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
127909905|NCT01940341|460292782|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
127909906|NCT01940341|460292783|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
127909907|NCT01940341|460292784|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
127909908|NCT01940341|460292785|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
127909909|NCT01940341|460292782|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
127909910|NCT01940341|460292783|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
127909911|NCT01940341|460292784|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
127909912|NCT01940341|460292785|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
127909913|NCT01757392|460292786|FG000|Overall Study|Withdrawal by Subject|1|||
127909914|NCT01757392|460292786|FG000|Overall Study|Screen Fail|3|||
127909915|NCT00841698|460292791|FG000|First Intervention|Withdrawal by Subject|1|||
127909916|NCT00841698|460292792|FG001|First Intervention|Withdrawal by Subject|0|||
127909917|NCT00185458|460292793|FG000|Contraception Phase|Adverse Event|37|||
127909918|NCT00185458|460292793|FG000|Contraception Phase|Lost to Follow-up|10|||
127909919|NCT00185458|460292793|FG000|Contraception Phase|Protocol Violation|2|||
127909920|NCT00185458|460292793|FG000|Contraception Phase|Physician Decision|2|||
127909921|NCT00185458|460292793|FG000|Contraception Phase|Withdrawal by Subject|7|||
127909922|NCT00185458|460292793|FG000|HRT Phase|Adverse Event|18|||
127909923|NCT00185458|460292793|FG000|HRT Phase|Lost to Follow-up|4|||
127909924|NCT00185458|460292793|FG000|HRT Phase|Protocol Violation|2|||
127909925|NCT00185458|460292793|FG000|HRT Phase|Withdrawal by Subject|3|||
127909926|NCT00251979|460292794|FG000|Overall Study|Protocol Violation|3|||
127909927|NCT00251979|460292795|FG001|Overall Study|Protocol Violation|5|||
127909928|NCT00251979|460292794|FG000|Overall Study|Adverse Event|11|||
127909929|NCT00251979|460292795|FG001|Overall Study|Adverse Event|17|||
127909930|NCT00251979|460292794|FG000|Overall Study|Withdrawal by Subject|13|||
127909931|NCT00251979|460292795|FG001|Overall Study|Withdrawal by Subject|7|||
127909932|NCT00251979|460292794|FG000|Overall Study|Lost to Follow-up|8|||
127909933|NCT00251979|460292795|FG001|Overall Study|Lost to Follow-up|6|||
127909934|NCT00251979|460292794|FG000|Overall Study|Death|3|||
127909935|NCT00251979|460292795|FG001|Overall Study|Death|5|||
127909936|NCT01576042|460292796|FG000|Overall Study|Physician Decision|2|||
127909937|NCT01576042|460292797|FG001|Overall Study|Physician Decision|0|||
127909938|NCT01249651|460292804|FG000|Overall Study|Withdrawal by Subject|4|||
127909939|NCT01249651|460292804|FG000|Overall Study|Adverse Event|1|||
127909940|NCT01249651|460292804|FG000|Overall Study|Protocol Violation|1|||
127909941|NCT01249651|460292804|FG000|Overall Study|Sponsor Decision|1|||
127909942|NCT00811655|460292816|FG000|Overall Study|Physician Decision|1|||
127909943|NCT00813592|460292817|FG000|Overall Study|Disease assessment was not completed per|2|||
127909944|NCT02820350|460292820|FG000|Overall Study|Withdrawal by Subject|3|||
127909945|NCT02820350|460292820|FG000|Overall Study|Death|4|||
127909946|NCT03801707|460292823|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
127909947|NCT03873272|460292824|FG000|Overall Study|Withdrawal by Subject|2|||
127909948|NCT03873272|460292825|FG001|Overall Study|Withdrawal by Subject|0|||
127909949|NCT03873272|460292826|FG002|Overall Study|Withdrawal by Subject|1|||
127909950|NCT03873272|460292824|FG000|Overall Study|Death|0|||
127909951|NCT03873272|460292825|FG001|Overall Study|Death|2|||
127909952|NCT03873272|460292826|FG002|Overall Study|Death|1|||
127909953|NCT00787254|460292827|FG000|Overall Study|Adverse Event|24|||
127909954|NCT00787254|460292828|FG001|Overall Study|Adverse Event|23|||
127909955|NCT00787254|460292827|FG000|Overall Study|Protocol Violation|26|||
127909956|NCT00787254|460292828|FG001|Overall Study|Protocol Violation|23|||
127909957|NCT00787254|460292827|FG000|Overall Study|Withdrawal by Subject|16|||
127909958|NCT00787254|460292828|FG001|Overall Study|Withdrawal by Subject|11|||
127909959|NCT00787254|460292827|FG000|Overall Study|Lack of Efficacy|4|||
127909960|NCT00787254|460292828|FG001|Overall Study|Lack of Efficacy|15|||
127909961|NCT00787254|460292827|FG000|Overall Study|NSAIDs discontinuation|1|||
127909962|NCT00787254|460292828|FG001|Overall Study|NSAIDs discontinuation|2|||
127909963|NCT00787254|460292827|FG000|Overall Study|Institution closed|1|||
127909964|NCT00787254|460292828|FG001|Overall Study|Institution closed|0|||
127909965|NCT00787254|460292827|FG000|Overall Study|Physician Decision|4|||
127909966|NCT00787254|460292828|FG001|Overall Study|Physician Decision|8|||
127909967|NCT04852978|460292835|FG000|Overall Study|Physician Decision|0|||
127909968|NCT04852978|460292836|FG001|Overall Study|Physician Decision|1|||
127909969|NCT04852978|460292837|FG002|Overall Study|Physician Decision|0|||
127909970|NCT04852978|460292838|FG003|Overall Study|Physician Decision|0|||
127909971|NCT04852978|460292839|FG004|Overall Study|Physician Decision|0|||
127909972|NCT04852978|460292840|FG005|Overall Study|Physician Decision|0|||
127909973|NCT04852978|460292841|FG006|Overall Study|Physician Decision|0|||
127909974|NCT04852978|460292842|FG007|Overall Study|Physician Decision|2|||
127909975|NCT04852978|460292843|FG008|Overall Study|Physician Decision|0|||
127909976|NCT04852978|460292835|FG000|Overall Study|Sponsor request|0|||
127909977|NCT04852978|460292836|FG001|Overall Study|Sponsor request|0|||
127909978|NCT04852978|460292837|FG002|Overall Study|Sponsor request|1|||
127909979|NCT04852978|460292838|FG003|Overall Study|Sponsor request|0|||
127909980|NCT04852978|460292839|FG004|Overall Study|Sponsor request|0|||
127909981|NCT04852978|460292840|FG005|Overall Study|Sponsor request|0|||
127909982|NCT04852978|460292841|FG006|Overall Study|Sponsor request|0|||
127909983|NCT04852978|460292842|FG007|Overall Study|Sponsor request|0|||
127909984|NCT04852978|460292843|FG008|Overall Study|Sponsor request|0|||
127909985|NCT04852978|460292835|FG000|Overall Study|Death|0|||
127909986|NCT04852978|460292836|FG001|Overall Study|Death|0|||
127909987|NCT04852978|460292837|FG002|Overall Study|Death|0|||
127909988|NCT04852978|460292838|FG003|Overall Study|Death|0|||
127909989|NCT04852978|460292839|FG004|Overall Study|Death|0|||
127909990|NCT04852978|460292840|FG005|Overall Study|Death|0|||
127909991|NCT04852978|460292841|FG006|Overall Study|Death|1|||
127909992|NCT04852978|460292842|FG007|Overall Study|Death|0|||
127909993|NCT04852978|460292843|FG008|Overall Study|Death|0|||
127909994|NCT04852978|460292835|FG000|Overall Study|Lost to Follow-up|3|||
127909995|NCT04852978|460292836|FG001|Overall Study|Lost to Follow-up|2|||
127909996|NCT04852978|460292837|FG002|Overall Study|Lost to Follow-up|2|||
127909997|NCT04852978|460292838|FG003|Overall Study|Lost to Follow-up|0|||
127909998|NCT04852978|460292839|FG004|Overall Study|Lost to Follow-up|2|||
127909999|NCT04852978|460292840|FG005|Overall Study|Lost to Follow-up|4|||
127910000|NCT04852978|460292841|FG006|Overall Study|Lost to Follow-up|1|||
127910001|NCT04852978|460292842|FG007|Overall Study|Lost to Follow-up|2|||
127910002|NCT04852978|460292843|FG008|Overall Study|Lost to Follow-up|2|||
127910003|NCT04852978|460292835|FG000|Overall Study|Withdrawal by Subject|4|||
127910004|NCT04852978|460292836|FG001|Overall Study|Withdrawal by Subject|2|||
127910005|NCT04852978|460292837|FG002|Overall Study|Withdrawal by Subject|2|||
127910006|NCT04852978|460292838|FG003|Overall Study|Withdrawal by Subject|1|||
127910007|NCT04852978|460292839|FG004|Overall Study|Withdrawal by Subject|5|||
127910008|NCT04852978|460292840|FG005|Overall Study|Withdrawal by Subject|3|||
127910009|NCT04852978|460292841|FG006|Overall Study|Withdrawal by Subject|2|||
127910010|NCT04852978|460292842|FG007|Overall Study|Withdrawal by Subject|2|||
127910011|NCT04852978|460292843|FG008|Overall Study|Withdrawal by Subject|1|||
127910012|NCT00859430|460292844|FG000|First Intervention|Withdrawal by Subject|0|||
127910013|NCT00859430|460292845|FG001|First Intervention|Withdrawal by Subject|1|||
127910014|NCT03733730|460295042|FG000|Overall Study|Lost to Follow-up|1|||
127910015|NCT03733730|460295043|FG001|Overall Study|Lost to Follow-up|32|||
127910016|NCT03733730|460295042|FG000|Overall Study|Other|1|||
127910017|NCT03733730|460295043|FG001|Overall Study|Other|0|||
127910018|NCT03733730|460295042|FG000|Overall Study|Adverse Event|0|||
127910019|NCT03733730|460295043|FG001|Overall Study|Adverse Event|4|||
127910020|NCT03733730|460295042|FG000|Overall Study|Death|0|||
127910021|NCT03733730|460295043|FG001|Overall Study|Death|5|||
127910022|NCT03733730|460295042|FG000|Overall Study|Withdrawal by Subject|0|||
127910023|NCT03733730|460295043|FG001|Overall Study|Withdrawal by Subject|8|||
127910024|NCT03635320|460295044|FG000|Overall Study|not implanted the device|1|||
127910025|NCT03635320|460295045|FG001|Overall Study|not implanted the device|2|||
127910026|NCT03635320|460295044|FG000|Overall Study|Withdrawal by Subject|11|||
127910027|NCT03635320|460295045|FG001|Overall Study|Withdrawal by Subject|6|||
127910028|NCT00835575|460295048|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
127910029|NCT00835575|460295049|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
127910030|NCT00113386|460295053|FG000|Overall Study|Withdrawal by Subject|1|||
127910031|NCT00113386|460295054|FG001|Overall Study|Withdrawal by Subject|0|||
127910032|NCT00113386|460295053|FG000|Overall Study|Physician Decision|0|||
127910033|NCT00113386|460295054|FG001|Overall Study|Physician Decision|1|||
127910034|NCT00113386|460295053|FG000|Overall Study|Toxicity|3|||
127910035|NCT00113386|460295054|FG001|Overall Study|Toxicity|0|||
127910036|NCT00113386|460295053|FG000|Overall Study|Ineligible|1|||
127910037|NCT00113386|460295054|FG001|Overall Study|Ineligible|2|||
127910038|NCT00113386|460295053|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
127910039|NCT00113386|460295054|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
127910040|NCT02849457|460295057|FG000|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
127910041|NCT02849457|460295058|FG001|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
127910042|NCT02849457|460295059|FG002|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|12|||
127910043|NCT02849457|460295060|FG003|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
127910044|NCT03673670|460295063|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
127910045|NCT03673670|460295064|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
127910046|NCT03673670|460295065|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
127910047|NCT03673670|460295066|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
127910048|NCT03673670|460295067|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
127910049|NCT03673670|460295068|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
127910050|NCT03673670|460295063|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
127910051|NCT03673670|460295064|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
127910052|NCT03673670|460295065|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
127910053|NCT03673670|460295066|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
127910054|NCT03673670|460295067|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
127910055|NCT03673670|460295068|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
127910056|NCT03673670|460295063|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
127910057|NCT03673670|460295064|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
127910058|NCT03673670|460295065|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
127910059|NCT03673670|460295066|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
127910060|NCT03673670|460295067|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
127910061|NCT03673670|460295068|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
127910062|NCT03673670|460295063|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
127910063|NCT03673670|460295064|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
127910064|NCT03673670|460295065|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
127910065|NCT03673670|460295066|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
127910066|NCT03673670|460295067|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
127910067|NCT03673670|460295068|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
127910068|NCT03673670|460295063|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
127910069|NCT03673670|460295064|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
127910070|NCT03673670|460295065|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
127910071|NCT03673670|460295066|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
127910072|NCT03673670|460295067|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
127910073|NCT03673670|460295068|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
127910074|NCT03673670|460295063|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
127910075|NCT03673670|460295064|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
127910076|NCT03673670|460295065|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
127910077|NCT03673670|460295066|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
127910078|NCT03673670|460295067|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
127910079|NCT03673670|460295068|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
127910080|NCT03673670|460295063|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
127910081|NCT03673670|460295064|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
127910082|NCT03673670|460295065|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
127910083|NCT03673670|460295066|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
127910084|NCT03673670|460295067|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
127910085|NCT03673670|460295068|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
127910086|NCT04408794|460295069|FG000|Overall Study|Adverse Event|43|||
127910087|NCT04408794|460295069|FG000|Overall Study|Infrequent study drug usage|43|||
127910088|NCT04408794|460295069|FG000|Overall Study|Lack of Efficacy|61|||
127910089|NCT04408794|460295069|FG000|Overall Study|Lost to Follow-up|33|||
127910090|NCT04408794|460295069|FG000|Overall Study|Non-compliance|6|||
127910091|NCT04408794|460295069|FG000|Overall Study|Physician Decision|1|||
127910092|NCT04408794|460295069|FG000|Overall Study|Pregnancy|6|||
127910093|NCT04408794|460295069|FG000|Overall Study|Protocol Deviation|9|||
127910094|NCT04408794|460295069|FG000|Overall Study|Sheehan-STS Result|1|||
127910095|NCT04408794|460295069|FG000|Overall Study|Withdrawal by Subject|57|||
127910096|NCT04408794|460295069|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
127910097|NCT04408794|460295069|FG000|Overall Study|Never Treated Migraine|5|||
127910098|NCT04238754|460295074|FG000|Washout - 1 Week|Lost to Follow-up|1|||
127910099|NCT04238754|460295075|FG001|Washout - 1 Week|Lost to Follow-up|0|||
127910100|NCT01518972|460295079|FG000|Overall Study|Lost to Follow-up|2|||
127910101|NCT01518972|460295080|FG001|Overall Study|Lost to Follow-up|1|||
127910102|NCT01518972|460295079|FG000|Overall Study|Withdrawal by Subject|1|||
127910103|NCT01518972|460295080|FG001|Overall Study|Withdrawal by Subject|0|||
127910104|NCT01518972|460295079|FG000|Overall Study|Moved from area|1|||
127910105|NCT01518972|460295080|FG001|Overall Study|Moved from area|0|||
127910106|NCT01518972|460295079|FG000|Overall Study|Transportation problems|1|||
127910107|NCT01518972|460295080|FG001|Overall Study|Transportation problems|0|||
127910108|NCT01518972|460295079|FG000|Overall Study|Exclusionary medical condition|1|||
127910109|NCT01518972|460295080|FG001|Overall Study|Exclusionary medical condition|0|||
127910110|NCT01518972|460295079|FG000|Overall Study|Missed safety visits|0|||
127910111|NCT01518972|460295080|FG001|Overall Study|Missed safety visits|1|||
127910112|NCT01518972|460295079|FG000|Overall Study|Exclusionary medication|0|||
127910113|NCT01518972|460295080|FG001|Overall Study|Exclusionary medication|1|||
127910114|NCT01518972|460295079|FG000|Overall Study|Declined medication starting on day 12|0|||
127910115|NCT01518972|460295080|FG001|Overall Study|Declined medication starting on day 12|1|||
127910116|NCT03733444|460295082|FG000|Overall Study|Adverse Event|8|||
127910117|NCT03733444|460295083|FG001|Overall Study|Adverse Event|10|||
127910118|NCT03733444|460295084|FG002|Overall Study|Adverse Event|5|||
127910119|NCT03733444|460295082|FG000|Overall Study|Death|20|||
127910120|NCT03733444|460295083|FG001|Overall Study|Death|19|||
127910121|NCT03733444|460295084|FG002|Overall Study|Death|11|||
127910122|NCT03733444|460295082|FG000|Overall Study|Lost to Follow-up|3|||
127910123|NCT03733444|460295083|FG001|Overall Study|Lost to Follow-up|0|||
127910124|NCT03733444|460295084|FG002|Overall Study|Lost to Follow-up|1|||
127910125|NCT03733444|460295082|FG000|Overall Study|Lack of Efficacy|0|||
127910126|NCT03733444|460295083|FG001|Overall Study|Lack of Efficacy|1|||
127910127|NCT03733444|460295084|FG002|Overall Study|Lack of Efficacy|1|||
127910128|NCT03733444|460295082|FG000|Overall Study|Physician Decision|2|||
127910129|NCT03733444|460295083|FG001|Overall Study|Physician Decision|1|||
127910130|NCT03733444|460295084|FG002|Overall Study|Physician Decision|0|||
127910131|NCT03733444|460295082|FG000|Overall Study|Protocol Violation|2|||
127910132|NCT03733444|460295083|FG001|Overall Study|Protocol Violation|1|||
127910133|NCT03733444|460295084|FG002|Overall Study|Protocol Violation|0|||
127910134|NCT03733444|460295082|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
127910135|NCT03733444|460295083|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
127910136|NCT03733444|460295084|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
127910137|NCT03733444|460295082|FG000|Overall Study|Study Terminated by Sponsor|203|||
127910138|NCT03733444|460295083|FG001|Overall Study|Study Terminated by Sponsor|209|||
127910139|NCT03733444|460295084|FG002|Overall Study|Study Terminated by Sponsor|221|||
127910140|NCT03733444|460295082|FG000|Overall Study|Withdrawal by Subject|19|||
127910141|NCT03733444|460295083|FG001|Overall Study|Withdrawal by Subject|18|||
127910142|NCT03733444|460295084|FG002|Overall Study|Withdrawal by Subject|16|||
127910143|NCT03733444|460295082|FG000|Overall Study|Miscellaneous|1|||
127910144|NCT03733444|460295083|FG001|Overall Study|Miscellaneous|0|||
127910145|NCT03733444|460295084|FG002|Overall Study|Miscellaneous|1|||
127910146|NCT03733444|460295082|FG000|Overall Study|Not Treated|1|||
127910147|NCT03733444|460295083|FG001|Overall Study|Not Treated|2|||
127910148|NCT03733444|460295084|FG002|Overall Study|Not Treated|1|||
127910149|NCT00556322|460295085|FG000|Overall Study|Insufficient therapeutic response|158|||
127910150|NCT00556322|460295086|FG001|Overall Study|Insufficient therapeutic response|168|||
127910151|NCT00556322|460295085|FG000|Overall Study|Adverse Event|7|||
127910152|NCT00556322|460295086|FG001|Overall Study|Adverse Event|4|||
127910153|NCT00556322|460295085|FG000|Overall Study|Other|4|||
127910154|NCT00556322|460295086|FG001|Overall Study|Other|1|||
127910155|NCT00556322|460295085|FG000|Overall Study|Lost to Follow-up|5|||
127910156|NCT00556322|460295086|FG001|Overall Study|Lost to Follow-up|3|||
127910157|NCT00556322|460295085|FG000|Overall Study|Withdrawal by Subject|19|||
127910158|NCT00556322|460295086|FG001|Overall Study|Withdrawal by Subject|7|||
127910159|NCT00556322|460295085|FG000|Overall Study|Protocol Violation|5|||
127910160|NCT00556322|460295086|FG001|Overall Study|Protocol Violation|1|||
127910161|NCT00556322|460295085|FG000|Overall Study|Ongoing at data cutoff|3|||
127910162|NCT00556322|460295086|FG001|Overall Study|Ongoing at data cutoff|5|||
127910163|NCT00556322|460295085|FG000|Overall Study|Death|20|||
127910164|NCT00556322|460295086|FG001|Overall Study|Death|14|||
127910165|NCT01788423|460295087|FG000|Overall Study|See Comments in Completed (above)|0|||
127910166|NCT01788423|460295088|FG001|Overall Study|See Comments in Completed (above)|4|||
127910167|NCT01788423|460295089|FG002|Overall Study|See Comments in Completed (above)|5|||
127910168|NCT03637764|460295090|FG000|Overall Study|Adverse Event|2|||
127910169|NCT03637764|460295091|FG001|Overall Study|Adverse Event|0|||
127910170|NCT03637764|460295092|FG002|Overall Study|Adverse Event|0|||
127910171|NCT03637764|460295093|FG003|Overall Study|Adverse Event|1|||
127910172|NCT03637764|460295090|FG000|Overall Study|Progressive Disease|23|||
127910173|NCT03637764|460295091|FG001|Overall Study|Progressive Disease|23|||
127910174|NCT03637764|460295092|FG002|Overall Study|Progressive Disease|18|||
127910175|NCT03637764|460295093|FG003|Overall Study|Progressive Disease|31|||
127910176|NCT03637764|460295090|FG000|Overall Study|Withdrawal by Subject|1|||
127910177|NCT03637764|460295091|FG001|Overall Study|Withdrawal by Subject|3|||
127910178|NCT03637764|460295092|FG002|Overall Study|Withdrawal by Subject|0|||
127910179|NCT03637764|460295093|FG003|Overall Study|Withdrawal by Subject|1|||
127910180|NCT02760927|460295098|FG000|Overall Study|Tube Slippage from Device|1|||
127910181|NCT02105272|460295099|FG000|Overall Study|Adverse Event|1|||
127910182|NCT02105272|460295100|FG001|Overall Study|Adverse Event|2|||
127910183|NCT02105272|460295099|FG000|Overall Study|Physician Decision|0|||
127910184|NCT02105272|460295100|FG001|Overall Study|Physician Decision|1|||
127858092|NCT02877134|460096152|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
127858093|NCT02877134|460096141|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
127858094|NCT02877134|460096142|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
127858095|NCT02877134|460096143|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
127858096|NCT02877134|460096144|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
127858097|NCT02877134|460096145|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
127858098|NCT02877134|460096146|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
127858099|NCT02877134|460096147|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
127858100|NCT02877134|460096148|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
127858101|NCT02877134|460096149|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
127858102|NCT02877134|460096150|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
127858103|NCT02877134|460096151|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
127858104|NCT02877134|460096152|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
127858105|NCT02877134|460096141|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
127858106|NCT02877134|460096142|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
127858107|NCT02877134|460096143|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
127858108|NCT02877134|460096144|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
127858109|NCT02877134|460096145|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
127858110|NCT02877134|460096146|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
127858111|NCT02877134|460096147|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
127858112|NCT02877134|460096148|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
127858113|NCT02877134|460096149|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
127858114|NCT02877134|460096150|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
127858115|NCT02877134|460096151|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
127858116|NCT02877134|460096152|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
127858117|NCT02877134|460096141|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
127858118|NCT02877134|460096142|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
127858119|NCT02877134|460096143|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
127858120|NCT02877134|460096144|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
127858121|NCT02877134|460096145|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
127858122|NCT02877134|460096146|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
127858123|NCT02877134|460096147|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
127858124|NCT02877134|460096148|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
127858125|NCT02877134|460096149|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
127858126|NCT02877134|460096150|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
127858127|NCT02877134|460096151|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
127858128|NCT02877134|460096152|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
127858129|NCT02877134|460096141|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
127858130|NCT02877134|460096142|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
127858131|NCT02877134|460096143|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
127858132|NCT02877134|460096144|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
127858133|NCT02877134|460096145|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
127858134|NCT02877134|460096146|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
127858135|NCT02877134|460096147|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
127858136|NCT02877134|460096148|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
127858137|NCT02877134|460096149|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
127858138|NCT02877134|460096150|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
127858139|NCT02877134|460096151|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
127858140|NCT02877134|460096152|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
127858141|NCT02877134|460096141|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
127858142|NCT02877134|460096142|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
127858143|NCT02877134|460096143|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
127858144|NCT02877134|460096144|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
127858145|NCT02877134|460096145|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
127858146|NCT02877134|460096146|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
127858147|NCT02877134|460096147|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
127858148|NCT02877134|460096148|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
127858149|NCT02877134|460096149|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
127858150|NCT02877134|460096150|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
127858151|NCT02877134|460096151|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
127858152|NCT02877134|460096152|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
127858153|NCT02877134|460096141|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
127910185|NCT02105272|460295099|FG000|Overall Study|Protocol Violation|2|||
127910186|NCT02105272|460295100|FG001|Overall Study|Protocol Violation|0|||
127910187|NCT02105272|460295099|FG000|Overall Study|Withdrawal by Subject|2|||
127910188|NCT02105272|460295100|FG001|Overall Study|Withdrawal by Subject|0|||
127910189|NCT03190915|460295102|FG000|Overall Study|Physician Determines It Is In Patient's Best Interest|4|||
127910190|NCT03190915|460295102|FG000|Overall Study|Progressive Disease|3|||
127910191|NCT02964039|460295103|FG000|Overall Study|Medical reason unrelated to study participation|1|||
127910192|NCT02964039|460295104|FG001|Overall Study|Medical reason unrelated to study participation|0|||
127910193|NCT02964039|460295105|FG002|Overall Study|Medical reason unrelated to study participation|3|||
127910194|NCT02964039|460295103|FG000|Overall Study|Research shutdown due to pandemic|2|||
127910195|NCT02964039|460295104|FG001|Overall Study|Research shutdown due to pandemic|0|||
127910196|NCT02964039|460295105|FG002|Overall Study|Research shutdown due to pandemic|1|||
127910197|NCT02964039|460295103|FG000|Overall Study|Withdrawal by Subject|0|||
127910198|NCT02964039|460295104|FG001|Overall Study|Withdrawal by Subject|1|||
127910199|NCT02964039|460295105|FG002|Overall Study|Withdrawal by Subject|0|||
127910200|NCT02964039|460295103|FG000|Overall Study|Lost to Follow-up|1|||
127910201|NCT02964039|460295104|FG001|Overall Study|Lost to Follow-up|0|||
127910202|NCT02964039|460295105|FG002|Overall Study|Lost to Follow-up|1|||
127910203|NCT00796653|460295108|FG000|Overall Study|Adverse Event|19|||
127910204|NCT00796653|460295109|FG001|Overall Study|Adverse Event|16|||
127910205|NCT00796653|460295110|FG002|Overall Study|Adverse Event|16|||
127910206|NCT00796653|460295111|FG003|Overall Study|Adverse Event|16|||
127910207|NCT00796653|460295108|FG000|Overall Study|Lost to Follow-up|2|||
127910208|NCT00796653|460295109|FG001|Overall Study|Lost to Follow-up|1|||
127910209|NCT00796653|460295110|FG002|Overall Study|Lost to Follow-up|2|||
127910210|NCT00796653|460295111|FG003|Overall Study|Lost to Follow-up|3|||
127910211|NCT00796653|460295108|FG000|Overall Study|Withdrawal by Subject|16|||
127910212|NCT00796653|460295109|FG001|Overall Study|Withdrawal by Subject|8|||
127910213|NCT00796653|460295110|FG002|Overall Study|Withdrawal by Subject|8|||
127910214|NCT00796653|460295111|FG003|Overall Study|Withdrawal by Subject|13|||
127910215|NCT00796653|460295108|FG000|Overall Study|Lack of Efficacy|8|||
127910216|NCT00796653|460295109|FG001|Overall Study|Lack of Efficacy|1|||
127910217|NCT00796653|460295110|FG002|Overall Study|Lack of Efficacy|3|||
127910218|NCT00796653|460295111|FG003|Overall Study|Lack of Efficacy|2|||
127910219|NCT00796653|460295108|FG000|Overall Study|Non compliance with protocol|2|||
127910220|NCT00796653|460295109|FG001|Overall Study|Non compliance with protocol|2|||
127910221|NCT00796653|460295110|FG002|Overall Study|Non compliance with protocol|0|||
127910222|NCT00796653|460295111|FG003|Overall Study|Non compliance with protocol|2|||
127910223|NCT00796653|460295108|FG000|Overall Study|Other reason not described above|4|||
127910224|NCT00796653|460295109|FG001|Overall Study|Other reason not described above|9|||
127858154|NCT02877134|460096142|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
127858155|NCT02877134|460096143|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
127858156|NCT02877134|460096144|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
127858157|NCT02877134|460096145|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
127858158|NCT02877134|460096146|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
127858159|NCT02877134|460096147|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
127858160|NCT02877134|460096148|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
127858161|NCT02877134|460096149|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
127858162|NCT02877134|460096150|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
127858163|NCT02877134|460096151|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
127858164|NCT02877134|460096152|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
127858165|NCT01332851|460096153|FG000|Overall Study|Withdrawal by Subject|4|||
127858166|NCT01332851|460096154|FG001|Overall Study|Withdrawal by Subject|2|||
127858167|NCT01332851|460096153|FG000|Overall Study|Lost to Follow-up|7|||
127858168|NCT01332851|460096154|FG001|Overall Study|Lost to Follow-up|11|||
127858169|NCT00255008|460096155|FG000|Overall Study|Adverse Event|1|||
127858170|NCT00255008|460096156|FG001|Overall Study|Adverse Event|1|||
127858171|NCT00255008|460096157|FG002|Overall Study|Adverse Event|2|||
127858172|NCT00255008|460096158|FG003|Overall Study|Adverse Event|0|||
127858173|NCT00255008|460096155|FG000|Overall Study|Lost to Follow-up|1|||
127858174|NCT00255008|460096156|FG001|Overall Study|Lost to Follow-up|0|||
127858175|NCT00255008|460096157|FG002|Overall Study|Lost to Follow-up|1|||
127858176|NCT00255008|460096158|FG003|Overall Study|Lost to Follow-up|2|||
127858177|NCT00255008|460096155|FG000|Overall Study|Did not meet viral reduction criteria|4|||
127910225|NCT00796653|460295110|FG002|Overall Study|Other reason not described above|7|||
127910226|NCT00796653|460295111|FG003|Overall Study|Other reason not described above|4|||
127910227|NCT01848938|460295120|FG000|Overall Study|Lost to Follow-up|1|||
127910228|NCT01848938|460295121|FG001|Overall Study|Lost to Follow-up|1|||
127910229|NCT00207090|460295124|FG000|Overall Study|Study drug toxicity|3|||
127858178|NCT00255008|460096156|FG001|Overall Study|Did not meet viral reduction criteria|5|||
127858179|NCT00255008|460096157|FG002|Overall Study|Did not meet viral reduction criteria|0|||
127858180|NCT00255008|460096158|FG003|Overall Study|Did not meet viral reduction criteria|1|||
127858181|NCT00255008|460096155|FG000|Overall Study|Withdrew consent|0|||
127858182|NCT00255008|460096156|FG001|Overall Study|Withdrew consent|0|||
127858183|NCT00255008|460096157|FG002|Overall Study|Withdrew consent|2|||
127858184|NCT00255008|460096158|FG003|Overall Study|Withdrew consent|0|||
127858185|NCT00255008|460096155|FG000|Overall Study|Sponsor request|18|||
127858186|NCT00255008|460096156|FG001|Overall Study|Sponsor request|3|||
127858187|NCT00255008|460096157|FG002|Overall Study|Sponsor request|8|||
127858188|NCT00255008|460096158|FG003|Overall Study|Sponsor request|17|||
127858189|NCT00255008|460096155|FG000|Overall Study|Adverse lab experience|1|||
127858190|NCT00255008|460096156|FG001|Overall Study|Adverse lab experience|0|||
127858191|NCT00255008|460096157|FG002|Overall Study|Adverse lab experience|0|||
127858192|NCT00255008|460096158|FG003|Overall Study|Adverse lab experience|0|||
127858193|NCT00255008|460096155|FG000|Overall Study|Other|7|||
127858194|NCT00255008|460096156|FG001|Overall Study|Other|0|||
127858195|NCT00255008|460096157|FG002|Overall Study|Other|3|||
127858196|NCT00255008|460096158|FG003|Overall Study|Other|2|||
127858197|NCT02996500|460096159|FG000|Overall Study|Adverse Event|1|||
127858198|NCT02996500|460096160|FG001|Overall Study|Adverse Event|1|||
127858199|NCT02996500|460096161|FG002|Overall Study|Adverse Event|4|||
127858200|NCT02996500|460096162|FG003|Overall Study|Adverse Event|3|||
127858201|NCT02996500|460096163|FG004|Overall Study|Adverse Event|1|||
127858202|NCT02996500|460096164|FG005|Overall Study|Adverse Event|2|||
127858203|NCT02996500|460096159|FG000|Overall Study|Lack of Efficacy|0|||
127858204|NCT02996500|460096160|FG001|Overall Study|Lack of Efficacy|0|||
127858205|NCT02996500|460096161|FG002|Overall Study|Lack of Efficacy|0|||
127858206|NCT02996500|460096162|FG003|Overall Study|Lack of Efficacy|0|||
127858207|NCT02996500|460096163|FG004|Overall Study|Lack of Efficacy|2|||
127858208|NCT02996500|460096164|FG005|Overall Study|Lack of Efficacy|0|||
127858209|NCT02996500|460096159|FG000|Overall Study|Lost to Follow-up|1|||
127858210|NCT02996500|460096160|FG001|Overall Study|Lost to Follow-up|0|||
127858211|NCT02996500|460096161|FG002|Overall Study|Lost to Follow-up|0|||
127858212|NCT02996500|460096162|FG003|Overall Study|Lost to Follow-up|0|||
127858213|NCT02996500|460096163|FG004|Overall Study|Lost to Follow-up|0|||
127858214|NCT02996500|460096164|FG005|Overall Study|Lost to Follow-up|1|||
127858215|NCT02996500|460096159|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
127858216|NCT02996500|460096160|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
127858217|NCT02996500|460096161|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
127858218|NCT02996500|460096162|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
127858219|NCT02996500|460096163|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
127858220|NCT02996500|460096164|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
127858221|NCT02996500|460096159|FG000|Overall Study|Non-Compliance With Study Drug|0|||
127858222|NCT02996500|460096160|FG001|Overall Study|Non-Compliance With Study Drug|0|||
127858223|NCT02996500|460096161|FG002|Overall Study|Non-Compliance With Study Drug|0|||
127858224|NCT02996500|460096162|FG003|Overall Study|Non-Compliance With Study Drug|0|||
127858225|NCT02996500|460096163|FG004|Overall Study|Non-Compliance With Study Drug|0|||
127858226|NCT02996500|460096164|FG005|Overall Study|Non-Compliance With Study Drug|1|||
127858227|NCT02996500|460096159|FG000|Overall Study|Progressive Disease|1|||
127858228|NCT02996500|460096160|FG001|Overall Study|Progressive Disease|0|||
127858229|NCT02996500|460096161|FG002|Overall Study|Progressive Disease|0|||
127858230|NCT02996500|460096162|FG003|Overall Study|Progressive Disease|0|||
127858231|NCT02996500|460096163|FG004|Overall Study|Progressive Disease|0|||
127858232|NCT02996500|460096164|FG005|Overall Study|Progressive Disease|0|||
127858233|NCT02996500|460096159|FG000|Overall Study|Other|2|||
127858234|NCT02996500|460096160|FG001|Overall Study|Other|0|||
127858235|NCT02996500|460096161|FG002|Overall Study|Other|2|||
127858236|NCT02996500|460096162|FG003|Overall Study|Other|0|||
127858237|NCT02996500|460096163|FG004|Overall Study|Other|0|||
127858238|NCT02996500|460096164|FG005|Overall Study|Other|0|||
127858239|NCT02996500|460096159|FG000|Overall Study|Protocol Violation|0|||
127858240|NCT02996500|460096160|FG001|Overall Study|Protocol Violation|0|||
127858241|NCT02996500|460096161|FG002|Overall Study|Protocol Violation|0|||
127858242|NCT02996500|460096162|FG003|Overall Study|Protocol Violation|1|||
127858243|NCT02996500|460096163|FG004|Overall Study|Protocol Violation|0|||
127858244|NCT02996500|460096164|FG005|Overall Study|Protocol Violation|0|||
127858245|NCT02996500|460096159|FG000|Overall Study|Withdrawal by Subject|3|||
127858246|NCT02996500|460096160|FG001|Overall Study|Withdrawal by Subject|0|||
127858247|NCT02996500|460096161|FG002|Overall Study|Withdrawal by Subject|3|||
127858248|NCT02996500|460096162|FG003|Overall Study|Withdrawal by Subject|0|||
127858249|NCT02996500|460096163|FG004|Overall Study|Withdrawal by Subject|2|||
127858250|NCT02996500|460096164|FG005|Overall Study|Withdrawal by Subject|0|||
127858251|NCT00707486|460096165|FG000|Overall Study|Withdrawal by Subject|1|||
127858252|NCT02774291|460096171|FG000|Overall Study|Lost to Follow-up|1|||
127858253|NCT00126425|460096172|FG000|Overall Study|Withdrawal by Subject|17|||
127858254|NCT00126425|460096173|FG001|Overall Study|Withdrawal by Subject|1|||
127858255|NCT00126425|460096172|FG000|Overall Study|Lost to Follow-up|8|||
127858256|NCT00126425|460096173|FG001|Overall Study|Lost to Follow-up|4|||
127910230|NCT00207090|460295124|FG000|Overall Study|Chest wall mass larger|1|||
127910231|NCT00207090|460295124|FG000|Overall Study|Disease progression/relapse|2|||
127910232|NCT00207090|460295124|FG000|Overall Study|Physician Decision|1|||
127910233|NCT00651820|460295135|FG000|Overall Study|Lost to Follow-up|2|||
127910234|NCT01911676|460295136|FG000|Period 1 of Study|Withdrawal by Subject|4|||
127910235|NCT01911676|460295137|FG001|Period 1 of Study|Withdrawal by Subject|2|||
127910236|NCT01911676|460295138|FG002|Period 1 of Study|Withdrawal by Subject|1|||
127910237|NCT01911676|460295139|FG003|Period 1 of Study|Withdrawal by Subject|2|||
127910238|NCT01911676|460295136|FG000|Period 1 of Study|Physician Decision|2|||
127910239|NCT01911676|460295137|FG001|Period 1 of Study|Physician Decision|0|||
127910240|NCT01911676|460295138|FG002|Period 1 of Study|Physician Decision|0|||
127910241|NCT01911676|460295139|FG003|Period 1 of Study|Physician Decision|1|||
127910242|NCT01911676|460295136|FG000|Period 2 of Study|Physician Decision|2|||
127910243|NCT01911676|460295137|FG001|Period 2 of Study|Physician Decision|0|||
127910244|NCT01911676|460295138|FG002|Period 2 of Study|Physician Decision|0|||
127910245|NCT01911676|460295139|FG003|Period 2 of Study|Physician Decision|1|||
127910246|NCT01911676|460295136|FG000|Period 2 of Study|Lost to Follow-up|0|||
127910247|NCT01911676|460295137|FG001|Period 2 of Study|Lost to Follow-up|0|||
127858257|NCT00126425|460096172|FG000|Overall Study|Protocol Violation|9|||
127858258|NCT00126425|460096173|FG001|Overall Study|Protocol Violation|6|||
127858259|NCT00126425|460096172|FG000|Overall Study|Adverse Event|1|||
127858260|NCT00126425|460096173|FG001|Overall Study|Adverse Event|0|||
127858261|NCT00126425|460096172|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
127858262|NCT00126425|460096173|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
127858263|NCT00126425|460096172|FG000|Overall Study|Other|5|||
127858264|NCT00126425|460096173|FG001|Overall Study|Other|0|||
127858265|NCT00471315|460096174|FG000|Overall Study|Adverse Event|7|||
127858266|NCT00471315|460096174|FG000|Overall Study|Withdrawal by Subject|1|||
127858267|NCT04474366|460096175|FG000|Overall Study|Lost to Follow-up|2|||
127858268|NCT04474366|460096176|FG001|Overall Study|Lost to Follow-up|5|||
127858269|NCT00320190|460096177|FG000|First 12 Months|Completed but did not enter extension|5|||
127858270|NCT00320190|460096178|FG001|First 12 Months|Completed but did not enter extension|3|||
127858271|NCT00320190|460096177|FG000|First 12 Months|Sponsor terminated study|2|||
127858272|NCT00320190|460096178|FG001|First 12 Months|Sponsor terminated study|2|||
127858273|NCT00320190|460096177|FG000|First 12 Months|Lost to Follow-up|0|||
127858274|NCT00320190|460096178|FG001|First 12 Months|Lost to Follow-up|1|||
127858275|NCT00320190|460096177|FG000|First 12 Months|Enrollment failure|0|||
127858276|NCT00320190|460096178|FG001|First 12 Months|Enrollment failure|1|||
127858277|NCT00320190|460096177|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
127858278|NCT00320190|460096178|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
127858279|NCT00320190|460096177|FG000|First 12 Months|Investigator request|0|||
127858280|NCT00320190|460096178|FG001|First 12 Months|Investigator request|1|||
127858281|NCT00320190|460096177|FG000|First 12 Months|Study drug toxicity|0|||
127858282|NCT00320190|460096178|FG001|First 12 Months|Study drug toxicity|1|||
127858283|NCT00320190|460096177|FG000|First 12 Months|Withdrawal by Subject|0|||
127858284|NCT00320190|460096178|FG001|First 12 Months|Withdrawal by Subject|1|||
127858285|NCT00320190|460096177|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
127858286|NCT00320190|460096178|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
127858287|NCT00320190|460096177|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
127858288|NCT00320190|460096178|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
127858289|NCT00320190|460096177|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
127910248|NCT01911676|460295138|FG002|Period 2 of Study|Lost to Follow-up|0|||
127910249|NCT01911676|460295139|FG003|Period 2 of Study|Lost to Follow-up|1|||
127858290|NCT00320190|460096178|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
127858291|NCT00712270|460096179|FG000|Overall Study|Withdrawal by Subject|11|||
127858292|NCT00712270|460096179|FG000|Overall Study|Screen Failure|3|||
127858293|NCT01365091|460096188|FG000|Period 1|Adverse Event|1|||
127858294|NCT01365091|460096189|FG001|Period 1|Adverse Event|0|||
127858295|NCT01365091|460096190|FG002|Period 1|Adverse Event|2|||
127858296|NCT01365091|460096191|FG003|Period 1|Adverse Event|3|||
127858297|NCT01365091|460096188|FG000|Period 1|Positive test result for drugs of abuse|1|||
127858298|NCT01365091|460096189|FG001|Period 1|Positive test result for drugs of abuse|0|||
127858299|NCT01365091|460096190|FG002|Period 1|Positive test result for drugs of abuse|0|||
127910250|NCT00773253|460295140|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
127910251|NCT00773253|460295141|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
127910252|NCT01878292|460295142|FG000|Randomized|Protocol Violation|1|||
127910253|NCT01878292|460295143|FG001|Randomized|Protocol Violation|0|||
127910254|NCT01878292|460295144|FG002|Randomized|Protocol Violation|0|||
127910255|NCT01878292|460295142|FG000|Randomized|Lost to Follow-up|1|||
127910256|NCT01878292|460295143|FG001|Randomized|Lost to Follow-up|0|||
127910257|NCT01878292|460295144|FG002|Randomized|Lost to Follow-up|0|||
127910258|NCT01878292|460295142|FG000|Randomized|Adverse Event|1|||
127910259|NCT01878292|460295143|FG001|Randomized|Adverse Event|0|||
127910260|NCT01878292|460295144|FG002|Randomized|Adverse Event|0|||
127910261|NCT01878292|460295142|FG000|Double-blind Treatment Period|Other Reasons|2|||
127910262|NCT01878292|460295143|FG001|Double-blind Treatment Period|Other Reasons|0|||
127910263|NCT01878292|460295144|FG002|Double-blind Treatment Period|Other Reasons|0|||
127910264|NCT01878292|460295142|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
127910265|NCT01878292|460295143|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
127910266|NCT01878292|460295144|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
127910267|NCT01878292|460295142|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
127910268|NCT01878292|460295143|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
127910269|NCT01878292|460295144|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
127910270|NCT01878292|460295142|FG000|Double-blind Treatment Period|Protocol Violation|3|||
127910271|NCT01878292|460295143|FG001|Double-blind Treatment Period|Protocol Violation|4|||
127910272|NCT01878292|460295144|FG002|Double-blind Treatment Period|Protocol Violation|2|||
127910273|NCT01878292|460295142|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
127910274|NCT01878292|460295143|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
127910275|NCT01878292|460295144|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
127910276|NCT01878292|460295142|FG000|Double-blind Treatment Period|Adverse Event|4|||
127910277|NCT01878292|460295143|FG001|Double-blind Treatment Period|Adverse Event|9|||
127910278|NCT01878292|460295144|FG002|Double-blind Treatment Period|Adverse Event|8|||
127910279|NCT01878292|460295142|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
127910280|NCT01878292|460295143|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
127910281|NCT01878292|460295144|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
127910282|NCT01566721|460295145|FG000|Treatment Period|Withdrawal by Subject|35|||
127910283|NCT01566721|460295146|FG001|Treatment Period|Withdrawal by Subject|9|||
127910284|NCT01566721|460295145|FG000|Treatment Period|Disease Progression/Recurrence|37|||
127910285|NCT01566721|460295146|FG001|Treatment Period|Disease Progression/Recurrence|13|||
127910286|NCT01566721|460295145|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
127910287|NCT01566721|460295146|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
127910288|NCT01566721|460295145|FG000|Treatment Period|Other|13|||
127910289|NCT01566721|460295146|FG001|Treatment Period|Other|2|||
127910290|NCT01566721|460295145|FG000|Treatment Period|Lack of Compliance|5|||
127910291|NCT01566721|460295146|FG001|Treatment Period|Lack of Compliance|1|||
127910292|NCT01566721|460295145|FG000|Treatment Period|Adverse Event|100|||
127910293|NCT01566721|460295146|FG001|Treatment Period|Adverse Event|30|||
127910294|NCT01566721|460295145|FG000|Treatment Period|Pregnancy|1|||
127910295|NCT01566721|460295146|FG001|Treatment Period|Pregnancy|0|||
127910296|NCT01566721|460295145|FG000|Safety Follow-up|Physician Decision|6|||
127910297|NCT01566721|460295146|FG001|Safety Follow-up|Physician Decision|4|||
127910298|NCT01566721|460295145|FG000|Safety Follow-up|Lost to Follow-up|101|||
127858300|NCT01365091|460096191|FG003|Period 1|Positive test result for drugs of abuse|0|||
127858301|NCT01365091|460096188|FG000|Period 1|No longer met study criteria|0|||
127858302|NCT01365091|460096189|FG001|Period 1|No longer met study criteria|1|||
127858303|NCT01365091|460096190|FG002|Period 1|No longer met study criteria|0|||
127858304|NCT01365091|460096191|FG003|Period 1|No longer met study criteria|0|||
127858305|NCT01365091|460096188|FG000|Period 1|Withdrawal by Subject|0|||
127858306|NCT01365091|460096189|FG001|Period 1|Withdrawal by Subject|1|||
127858307|NCT01365091|460096190|FG002|Period 1|Withdrawal by Subject|0|||
127858308|NCT01365091|460096191|FG003|Period 1|Withdrawal by Subject|0|||
127858309|NCT01365091|460096188|FG000|Period 1|Personal reasons|0|||
127858310|NCT01365091|460096189|FG001|Period 1|Personal reasons|0|||
127910299|NCT01566721|460295146|FG001|Safety Follow-up|Lost to Follow-up|48|||
127910300|NCT01566721|460295145|FG000|Safety Follow-up|Withdrawal by Subject|155|||
127910301|NCT01566721|460295146|FG001|Safety Follow-up|Withdrawal by Subject|49|||
127910302|NCT01566721|460295145|FG000|Safety Follow-up|Death|28|||
127910303|NCT01566721|460295146|FG001|Safety Follow-up|Death|4|||
127858311|NCT01365091|460096190|FG002|Period 1|Personal reasons|1|||
127910304|NCT01566721|460295145|FG000|Safety Follow-up|Non-compliance|7|||
127858312|NCT01365091|460096191|FG003|Period 1|Personal reasons|0|||
127858313|NCT01365091|460096188|FG000|Period 2|Withdrawal by Subject|1|||
127858314|NCT01365091|460096189|FG001|Period 2|Withdrawal by Subject|0|||
127910305|NCT01566721|460295146|FG001|Safety Follow-up|Non-compliance|3|||
127910306|NCT01566721|460295145|FG000|Safety Follow-up|Protocol Violation|7|||
127910307|NCT01566721|460295146|FG001|Safety Follow-up|Protocol Violation|0|||
127910308|NCT01566721|460295145|FG000|Safety Follow-up|Site closure|2|||
127910309|NCT01566721|460295146|FG001|Safety Follow-up|Site closure|3|||
127910310|NCT01566721|460295145|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
127910311|NCT01566721|460295146|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
127910312|NCT01566721|460295145|FG000|Safety Follow-up|Missing|7|||
127910313|NCT01566721|460295146|FG001|Safety Follow-up|Missing|2|||
127910314|NCT01566721|460295145|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
127910315|NCT01566721|460295146|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
127910316|NCT01566721|460295145|FG000|Safety Follow-up|Sponsor decision|1|||
127910317|NCT01566721|460295146|FG001|Safety Follow-up|Sponsor decision|0|||
127910318|NCT01566721|460295145|FG000|Safety Follow-up|Adverse Event|8|||
127910319|NCT01566721|460295146|FG001|Safety Follow-up|Adverse Event|4|||
127910320|NCT01302548|460295151|FG000|Overall Study|Lost to Follow-up|2|||
127910321|NCT01302548|460295152|FG001|Overall Study|Lost to Follow-up|1|||
127910322|NCT01237054|460295153|FG000|Overall Study|imaging 10C0096|1|||
127910323|NCT02619682|460295154|FG000|Overall Study|Withdrawal by Subject|3|||
127910324|NCT02619682|460295154|FG000|Overall Study|Lack of Efficacy|8|||
127910325|NCT02619682|460295154|FG000|Overall Study|new secondary cancer|1|||
127910326|NCT02619682|460295154|FG000|Overall Study|post surgery complications|2|||
127910327|NCT00268203|460295157|FG000|Overall Study|Lost to Follow-up|92|||
127910328|NCT00268203|460295157|FG000|Overall Study|Withdrawal by Subject|9|||
127910329|NCT00268203|460295157|FG000|Overall Study|Received Other NHL Therapy|7|||
127910330|NCT00268203|460295157|FG000|Overall Study|Progressive Disease|359|||
127910331|NCT00268203|460295157|FG000|Overall Study|Death|84|||
127910332|NCT00268203|460295157|FG000|Overall Study|Reason Not Specified|34|||
127910333|NCT00268203|460295157|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
127910334|NCT00730691|460295164|FG000|Overall Study|Adverse Event|4|||
127910335|NCT00730691|460295165|FG001|Overall Study|Adverse Event|8|||
127910336|NCT00730691|460295166|FG002|Overall Study|Adverse Event|11|||
127910337|NCT00730691|460295167|FG003|Overall Study|Adverse Event|11|||
127910338|NCT00730691|460295168|FG004|Overall Study|Adverse Event|23|||
127910339|NCT00730691|460295164|FG000|Overall Study|Lack of Efficacy|4|||
127910340|NCT00730691|460295165|FG001|Overall Study|Lack of Efficacy|4|||
127910341|NCT00730691|460295166|FG002|Overall Study|Lack of Efficacy|2|||
127910342|NCT00730691|460295167|FG003|Overall Study|Lack of Efficacy|1|||
127910343|NCT00730691|460295168|FG004|Overall Study|Lack of Efficacy|1|||
127910344|NCT00730691|460295164|FG000|Overall Study|Non-compliance with Study Drug|6|||
127910345|NCT00730691|460295165|FG001|Overall Study|Non-compliance with Study Drug|1|||
127910346|NCT00730691|460295166|FG002|Overall Study|Non-compliance with Study Drug|6|||
127910347|NCT00730691|460295167|FG003|Overall Study|Non-compliance with Study Drug|3|||
127910348|NCT00730691|460295168|FG004|Overall Study|Non-compliance with Study Drug|3|||
127910349|NCT00730691|460295164|FG000|Overall Study|Protocol Deviations|3|||
127910350|NCT00730691|460295165|FG001|Overall Study|Protocol Deviations|5|||
127910351|NCT00730691|460295166|FG002|Overall Study|Protocol Deviations|3|||
127910352|NCT00730691|460295167|FG003|Overall Study|Protocol Deviations|7|||
127910353|NCT00730691|460295168|FG004|Overall Study|Protocol Deviations|5|||
127910354|NCT00730691|460295164|FG000|Overall Study|Withdrawal of Consent|7|||
127910355|NCT00730691|460295165|FG001|Overall Study|Withdrawal of Consent|9|||
127910356|NCT00730691|460295166|FG002|Overall Study|Withdrawal of Consent|3|||
127910357|NCT00730691|460295167|FG003|Overall Study|Withdrawal of Consent|6|||
127910358|NCT00730691|460295168|FG004|Overall Study|Withdrawal of Consent|3|||
127910359|NCT00730691|460295164|FG000|Overall Study|Lost to Follow-up|11|||
127910360|NCT00730691|460295165|FG001|Overall Study|Lost to Follow-up|8|||
127910361|NCT00730691|460295166|FG002|Overall Study|Lost to Follow-up|13|||
127910362|NCT00730691|460295167|FG003|Overall Study|Lost to Follow-up|15|||
127910363|NCT00730691|460295168|FG004|Overall Study|Lost to Follow-up|13|||
127910364|NCT00730691|460295164|FG000|Overall Study|Other|1|||
127910365|NCT00730691|460295165|FG001|Overall Study|Other|1|||
127910366|NCT00730691|460295166|FG002|Overall Study|Other|1|||
127910367|NCT00730691|460295167|FG003|Overall Study|Other|2|||
127910368|NCT00730691|460295168|FG004|Overall Study|Other|2|||
127910369|NCT02178787|460295169|FG000|Overall Study|Lost to Follow-up|1|||
127910370|NCT02178787|460295170|FG001|Overall Study|Lost to Follow-up|0|||
127910371|NCT02178787|460295169|FG000|Overall Study|Withdrawal by Subject|0|||
127910372|NCT02178787|460295170|FG001|Overall Study|Withdrawal by Subject|2|||
127910373|NCT02178787|460295169|FG000|Overall Study|No TCD window|3|||
127910374|NCT02178787|460295170|FG001|Overall Study|No TCD window|7|||
127910375|NCT02178787|460295169|FG000|Overall Study|Physician Decision|1|||
127910376|NCT02178787|460295170|FG001|Overall Study|Physician Decision|0|||
127910377|NCT02554890|460295171|FG000|Double-blind|Adverse Event|45|||
127910378|NCT02554890|460295172|FG001|Double-blind|Adverse Event|51|||
127910379|NCT02554890|460295171|FG000|Double-blind|Death|6|||
127910380|NCT02554890|460295172|FG001|Double-blind|Death|4|||
127910381|NCT02554890|460295171|FG000|Double-blind|Protocol Violation|1|||
127910382|NCT02554890|460295172|FG001|Double-blind|Protocol Violation|1|||
127910383|NCT02554890|460295171|FG000|Double-blind|Physician Decision|4|||
127910384|NCT02554890|460295172|FG001|Double-blind|Physician Decision|3|||
127910385|NCT02554890|460295171|FG000|Double-blind|Subject/Guardian decision|21|||
127910386|NCT02554890|460295172|FG001|Double-blind|Subject/Guardian decision|16|||
127910387|NCT02554890|460295171|FG000|Double-blind|Lost to Follow-up|7|||
127910388|NCT02554890|460295172|FG001|Double-blind|Lost to Follow-up|5|||
127910389|NCT02554890|460295171|FG000|Double-blind|Technical problems|1|||
127910390|NCT02554890|460295172|FG001|Double-blind|Technical problems|0|||
127910391|NCT02554890|460295171|FG000|Double-blind|Withdrawal by Subject|5|||
127910392|NCT02554890|460295172|FG001|Double-blind|Withdrawal by Subject|6|||
127910393|NCT02554890|460295171|FG000|Double-blind|Noncompliance with study treatment|6|||
127910394|NCT02554890|460295172|FG001|Double-blind|Noncompliance with study treatment|5|||
127910395|NCT02554890|460295171|FG000|Open-label|Adverse Event|0|||
127910396|NCT02554890|460295172|FG001|Open-label|Adverse Event|30|||
127910397|NCT02554890|460295171|FG000|Open-label|Death|0|||
127910398|NCT02554890|460295172|FG001|Open-label|Death|1|||
127910399|NCT02554890|460295171|FG000|Open-label|Physician Decision|0|||
127910400|NCT02554890|460295172|FG001|Open-label|Physician Decision|1|||
127910401|NCT02554890|460295171|FG000|Open-label|Subject/Guardian decision|0|||
127910402|NCT02554890|460295172|FG001|Open-label|Subject/Guardian decision|11|||
127910403|NCT02554890|460295171|FG000|Open-label|Lost to Follow-up|0|||
127910404|NCT02554890|460295172|FG001|Open-label|Lost to Follow-up|7|||
127910405|NCT02554890|460295171|FG000|Open-label|Technical problems|0|||
127910406|NCT02554890|460295172|FG001|Open-label|Technical problems|1|||
127910407|NCT02554890|460295171|FG000|Open-label|Withdrawal by Subject|0|||
127910408|NCT02554890|460295172|FG001|Open-label|Withdrawal by Subject|1|||
127910409|NCT03649477|460295173|FG000|Overall Study|Adverse Event|2|||
127910410|NCT03649477|460295174|FG001|Overall Study|Adverse Event|0|||
127910411|NCT03649477|460295175|FG002|Overall Study|Adverse Event|0|||
127910412|NCT02430480|460295176|FG000|Overall Study|Death|1|||
127910413|NCT02430480|460295176|FG000|Overall Study|Anesthesia concerns|1|||
127910414|NCT02430480|460295176|FG000|Overall Study|Progressed on treatment|1|||
127910415|NCT01097577|460295184|FG000|Overall Study|Adverse Event|0|||
127910416|NCT01097577|460295185|FG001|Overall Study|Adverse Event|1|||
127910417|NCT00316186|460295188|FG000|Overall Study|Adverse Event|6|||
127910418|NCT00316186|460295188|FG000|Overall Study|Disease Progression|4|||
127910419|NCT00316186|460295188|FG000|Overall Study|Lost to Follow-up|1|||
127910420|NCT00316186|460295188|FG000|Overall Study|Other|1|||
127910421|NCT04493684|460295189|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
127910422|NCT04493684|460295190|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
127910423|NCT04493684|460295191|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
127910424|NCT04493684|460295192|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
127910425|NCT04493684|460295193|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
127910426|NCT04493684|460295194|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
127910427|NCT04493684|460295195|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
127910428|NCT04493684|460295196|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
127910429|NCT04493684|460295197|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
127910430|NCT04493684|460295198|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
127910431|NCT04493684|460295199|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
127910432|NCT04493684|460295200|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
127910433|NCT04493684|460295201|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
127910434|NCT04493684|460295202|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
127910435|NCT04493684|460295203|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
127910436|NCT04493684|460295204|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
127910437|NCT04493684|460295205|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
127910438|NCT04493684|460295189|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
127910439|NCT04493684|460295190|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
127910440|NCT04493684|460295191|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
127910441|NCT04493684|460295192|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
127910442|NCT04493684|460295193|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
127910443|NCT04493684|460295194|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
127910444|NCT04493684|460295195|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
127910445|NCT04493684|460295196|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
127910446|NCT04493684|460295197|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
127910447|NCT04493684|460295198|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
127910448|NCT04493684|460295199|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
127910449|NCT04493684|460295200|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
127910450|NCT04493684|460295201|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
127910451|NCT04493684|460295202|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
127910452|NCT04493684|460295203|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
127910453|NCT04493684|460295204|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
127910454|NCT04493684|460295205|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
127910455|NCT04493684|460295189|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
127910456|NCT04493684|460295190|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
127910457|NCT04493684|460295191|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
127910458|NCT04493684|460295192|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
127910459|NCT04493684|460295193|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
127910460|NCT04493684|460295194|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
127910461|NCT04493684|460295195|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
127910462|NCT04493684|460295196|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
127910463|NCT04493684|460295197|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
127910464|NCT04493684|460295198|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
127910465|NCT04493684|460295199|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
127910466|NCT04493684|460295200|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
127910467|NCT04493684|460295201|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
127910468|NCT04493684|460295202|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
127910469|NCT04493684|460295203|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
127910470|NCT04493684|460295204|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
127910471|NCT04493684|460295205|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
127910472|NCT04493684|460295189|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
127910473|NCT04493684|460295190|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
127910474|NCT04493684|460295191|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
127910475|NCT04493684|460295192|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
127910476|NCT04493684|460295193|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
127910477|NCT04493684|460295194|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
127910478|NCT04493684|460295195|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
127910479|NCT04493684|460295196|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
127910480|NCT04493684|460295197|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
127910481|NCT04493684|460295198|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
127910482|NCT04493684|460295199|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
127910483|NCT04493684|460295200|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
127910484|NCT04493684|460295201|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
127910485|NCT04493684|460295202|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
127910486|NCT04493684|460295203|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
127910487|NCT04493684|460295204|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
127910488|NCT04493684|460295205|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
127910489|NCT04493684|460295189|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
127910490|NCT04493684|460295190|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
127910491|NCT04493684|460295191|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
127910492|NCT04493684|460295192|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
127910493|NCT04493684|460295193|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
127910494|NCT04493684|460295194|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
127910495|NCT04493684|460295195|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
127910496|NCT04493684|460295196|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
127910497|NCT04493684|460295197|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
127910498|NCT04493684|460295198|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
127910499|NCT04493684|460295199|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
127910500|NCT04493684|460295200|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
127910501|NCT04493684|460295201|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
127910502|NCT04493684|460295202|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
127910503|NCT04493684|460295203|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
127910504|NCT04493684|460295204|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
127910505|NCT04493684|460295205|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
127910506|NCT04493684|460295189|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
127910507|NCT04493684|460295190|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
127910508|NCT04493684|460295191|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
127910509|NCT04493684|460295192|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
127910510|NCT04493684|460295193|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
127910511|NCT04493684|460295194|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
127910512|NCT04493684|460295195|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
127910513|NCT04493684|460295196|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
127910514|NCT04493684|460295197|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
127910515|NCT04493684|460295198|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
127910516|NCT04493684|460295199|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
127910517|NCT04493684|460295200|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
127910518|NCT04493684|460295201|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
127910519|NCT04493684|460295202|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
127910520|NCT04493684|460295203|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
127910521|NCT04493684|460295204|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
127910522|NCT04493684|460295205|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
127910523|NCT04493684|460295189|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
127910524|NCT04493684|460295190|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
127910525|NCT04493684|460295191|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
127910526|NCT04493684|460295192|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
127910527|NCT04493684|460295193|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
127910528|NCT04493684|460295194|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
127910529|NCT04493684|460295195|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
127910530|NCT04493684|460295196|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
127910531|NCT04493684|460295197|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
127910532|NCT04493684|460295198|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
127910533|NCT04493684|460295199|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
127910534|NCT04493684|460295200|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
127910535|NCT04493684|460295201|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
127910536|NCT04493684|460295202|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
127910537|NCT04493684|460295203|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
127910538|NCT04493684|460295204|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
127910539|NCT04493684|460295205|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
127910540|NCT04493684|460295189|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
127910541|NCT04493684|460295190|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
127910542|NCT04493684|460295191|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
127910543|NCT04493684|460295192|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
127910544|NCT04493684|460295193|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
127910545|NCT04493684|460295194|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
127910546|NCT04493684|460295195|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
127910547|NCT04493684|460295196|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
127910548|NCT04493684|460295197|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
127910549|NCT04493684|460295198|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
127910550|NCT04493684|460295199|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
127910551|NCT04493684|460295200|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
127910552|NCT04493684|460295201|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
127910553|NCT04493684|460295202|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
127910554|NCT04493684|460295203|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
127910555|NCT04493684|460295204|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
127910556|NCT04493684|460295205|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
127910557|NCT05152576|460295208|FG000|Overall Study|Lost to Follow-up|3|||
127910558|NCT05152576|460295209|FG001|Overall Study|Lost to Follow-up|0|||
127910559|NCT05152576|460295210|FG002|Overall Study|Lost to Follow-up|0|||
127910560|NCT05152576|460295211|FG003|Overall Study|Lost to Follow-up|1|||
127910561|NCT05152576|460295208|FG000|Overall Study|Withdrawal by Subject|0|||
127910562|NCT05152576|460295209|FG001|Overall Study|Withdrawal by Subject|1|||
127910563|NCT05152576|460295210|FG002|Overall Study|Withdrawal by Subject|0|||
127910564|NCT05152576|460295211|FG003|Overall Study|Withdrawal by Subject|1|||
127910565|NCT05152576|460295208|FG000|Overall Study|Other|2|||
127910566|NCT05152576|460295209|FG001|Overall Study|Other|0|||
127910567|NCT05152576|460295210|FG002|Overall Study|Other|0|||
127910568|NCT05152576|460295211|FG003|Overall Study|Other|0|||
127910569|NCT02057835|460297476|FG000|Overall Study|Withdrawal by Subject|0|||
127910570|NCT02057835|460297477|FG001|Overall Study|Withdrawal by Subject|2|||
127910571|NCT02057835|460297478|FG002|Overall Study|Withdrawal by Subject|0|||
127910572|NCT02057835|460297479|FG003|Overall Study|Withdrawal by Subject|0|||
127910573|NCT02057835|460297480|FG004|Overall Study|Withdrawal by Subject|0|||
127910574|NCT02057835|460297481|FG005|Overall Study|Withdrawal by Subject|0|||
127910575|NCT02057835|460297482|FG006|Overall Study|Withdrawal by Subject|0|||
127910576|NCT02057835|460297483|FG007|Overall Study|Withdrawal by Subject|0|||
127910577|NCT02057835|460297484|FG008|Overall Study|Withdrawal by Subject|0|||
127910578|NCT02057835|460297485|FG009|Overall Study|Withdrawal by Subject|0|||
127910579|NCT04278560|460297486|FG000|Overall Study|Adverse Event|1|||
127910580|NCT04278560|460297487|FG001|Overall Study|Adverse Event|2|||
127910581|NCT04278560|460297486|FG000|Overall Study|Withdrawal by Subject|0|||
127910582|NCT04278560|460297487|FG001|Overall Study|Withdrawal by Subject|1|||
127910583|NCT02832063|460297488|FG000|Overall Study|Adverse Event|2|||
127910584|NCT02832063|460297489|FG001|Overall Study|Adverse Event|1|||
127910585|NCT02832063|460297488|FG000|Overall Study|Physician Decision|5|||
127910586|NCT02832063|460297489|FG001|Overall Study|Physician Decision|7|||
127910587|NCT02832063|460297488|FG000|Overall Study|Lost to Follow-up|15|||
127910588|NCT02832063|460297489|FG001|Overall Study|Lost to Follow-up|8|||
127910589|NCT02832063|460297488|FG000|Overall Study|Withdrawal by Subject|10|||
127910590|NCT02832063|460297489|FG001|Overall Study|Withdrawal by Subject|21|||
127910591|NCT02832063|460297488|FG000|Overall Study|Other|2|||
127910592|NCT02832063|460297489|FG001|Overall Study|Other|1|||
127910593|NCT01531894|460297494|FG000|Overall Study|Physician Decision|8|||
127910594|NCT01531894|460297494|FG000|Overall Study|Death|1|||
127910595|NCT03086460|460297495|FG000|Study Participants|Lost to Follow-up|2|||
127910596|NCT03086460|460297495|FG000|Study Participants|Protocol Violation|1|||
127910597|NCT03086460|460297495|FG000|Study Participants|Withdrawal by Subject|6|||
127910598|NCT03086460|460297495|FG000|Treatment A|Lost to Follow-up|1|||
127910599|NCT03086460|460297495|FG000|Treatment A|Protocol Violation|1|||
127910600|NCT03086460|460297495|FG000|Treatment A|Withdrawal by Subject|2|||
127910601|NCT03086460|460297495|FG000|Treatment C|Withdrawal by Subject|2|||
127910602|NCT03086460|460297495|FG000|Treatment E|Lost to Follow-up|1|||
127910603|NCT03086460|460297495|FG000|Treatment E|Withdrawal by Subject|3|||
127910604|NCT01440803|460297496|FG000|Overall Study|Met study stopping rule|2|||
127910605|NCT01440803|460297497|FG001|Overall Study|Met study stopping rule|1|||
127910606|NCT01440803|460297496|FG000|Overall Study|Lost to Follow-up|0|||
127910607|NCT01440803|460297497|FG001|Overall Study|Lost to Follow-up|2|||
127910608|NCT01440803|460297496|FG000|Overall Study|Withdrawal by Subject|0|||
127910609|NCT01440803|460297497|FG001|Overall Study|Withdrawal by Subject|1|||
127910610|NCT01609257|460297498|FG000|Overall Study|Lost to Follow-up|2|||
127910611|NCT01609257|460297499|FG001|Overall Study|Lost to Follow-up|1|||
127910612|NCT01609257|460297498|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
127910613|NCT01609257|460297499|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
127910614|NCT01609257|460297498|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
127910615|NCT01609257|460297499|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
127910616|NCT02125461|460297502|FG000|Overall Study|Withdrawal by Subject|30|||
127910617|NCT02125461|460297503|FG001|Overall Study|Withdrawal by Subject|16|||
127910618|NCT02125461|460297502|FG000|Overall Study|Lost to Follow-up|8|||
127910619|NCT02125461|460297503|FG001|Overall Study|Lost to Follow-up|3|||
127910620|NCT02125461|460297502|FG000|Overall Study|Death|260|||
127910621|NCT02125461|460297503|FG001|Overall Study|Death|149|||
127910622|NCT02125461|460297502|FG000|Overall Study|Missing Termination Reason|0|||
127910623|NCT02125461|460297503|FG001|Overall Study|Missing Termination Reason|1|||
127910624|NCT04994535|460297506|FG000|Overall Study|Lost to Follow-up|7|||
127910625|NCT04994535|460297507|FG001|Overall Study|Lost to Follow-up|7|||
127910626|NCT04994535|460297506|FG000|Overall Study|Withdrawal by Subject|10|||
127910627|NCT04994535|460297507|FG001|Overall Study|Withdrawal by Subject|7|||
127910628|NCT04994535|460297506|FG000|Overall Study|Other|1|||
127910629|NCT04994535|460297507|FG001|Overall Study|Other|1|||
127910630|NCT01158118|460297508|FG000|Overall Study|Screen failure|1|||
127910631|NCT01158118|460297509|FG001|Overall Study|Screen failure|0|||
127910632|NCT01158118|460297508|FG000|Overall Study|Donor match was a screen failure|0|||
127910633|NCT01158118|460297509|FG001|Overall Study|Donor match was a screen failure|1|||
127910634|NCT01158118|460297508|FG000|Overall Study|Suffered stroke prior to transplant|0|||
127910635|NCT01158118|460297509|FG001|Overall Study|Suffered stroke prior to transplant|1|||
127910636|NCT01158118|460297508|FG000|Overall Study|Death|0|||
127910637|NCT01158118|460297509|FG001|Overall Study|Death|1|||
127910638|NCT01015287|460297510|FG000|Overall Study|Death|21|||
127910639|NCT01015287|460297511|FG001|Overall Study|Death|16|||
127910640|NCT01015287|460297510|FG000|Overall Study|Adverse Event|1|||
127910641|NCT01015287|460297511|FG001|Overall Study|Adverse Event|0|||
127910642|NCT01015287|460297510|FG000|Overall Study|Sponsor Decision|3|||
127910643|NCT01015287|460297511|FG001|Overall Study|Sponsor Decision|7|||
127910644|NCT01015287|460297510|FG000|Overall Study|Physician Decision|19|||
127910645|NCT01015287|460297511|FG001|Overall Study|Physician Decision|21|||
127910646|NCT01015287|460297510|FG000|Overall Study|Withdrawal by Subject|14|||
127910647|NCT01015287|460297511|FG001|Overall Study|Withdrawal by Subject|19|||
127910648|NCT01015287|460297510|FG000|Overall Study|Entry Criteria not Met|11|||
127910649|NCT01015287|460297511|FG001|Overall Study|Entry Criteria not Met|14|||
127910650|NCT01015287|460297510|FG000|Overall Study|Lost to Follow-up|2|||
127910651|NCT01015287|460297511|FG001|Overall Study|Lost to Follow-up|1|||
127910652|NCT01015287|460297510|FG000|Overall Study|Protocol Violation|1|||
127910653|NCT01015287|460297511|FG001|Overall Study|Protocol Violation|1|||
127910654|NCT00469898|460297512|FG000|Overall Study|Adverse Event|7|||
127910655|NCT00469898|460297512|FG000|Overall Study|Withdrawal by Subject|4|||
127910656|NCT00469898|460297512|FG000|Overall Study|Death|4|||
127910657|NCT00469898|460297512|FG000|Overall Study|Disease progression|9|||
127910658|NCT00469898|460297512|FG000|Overall Study|Decreased performance status|1|||
127910659|NCT01370317|460297513|FG000|Overall Study|Participant withdrew consent|1|||
127910660|NCT01370317|460297514|FG001|Overall Study|Participant withdrew consent|0|||
127910661|NCT01370317|460297513|FG000|Overall Study|Protocol deviation|0|||
127910662|NCT01370317|460297514|FG001|Overall Study|Protocol deviation|1|||
127910663|NCT00834340|460297519|FG000|Washout|Adverse Event|1|||
127910664|NCT00834340|460297520|FG001|Washout|Adverse Event|0|||
127910665|NCT00834340|460297519|FG000|Washout|Withdrawal by Subject|1|||
127910666|NCT00834340|460297520|FG001|Washout|Withdrawal by Subject|0|||
127910667|NCT02294786|460297523|FG000|Overall Study|Withdrawal by Subject|0|||
127910668|NCT02294786|460297524|FG001|Overall Study|Withdrawal by Subject|1|||
127910669|NCT02294786|460297523|FG000|Overall Study|Physician Decision|6|||
127910670|NCT02294786|460297524|FG001|Overall Study|Physician Decision|7|||
127910671|NCT02294786|460297523|FG000|Overall Study|Lost to Follow-up|1|||
127910672|NCT02294786|460297524|FG001|Overall Study|Lost to Follow-up|2|||
127910673|NCT02294786|460297523|FG000|Overall Study|Protocol Violation|1|||
127910674|NCT02294786|460297524|FG001|Overall Study|Protocol Violation|0|||
127910675|NCT02294786|460297523|FG000|Overall Study|Adverse Event|1|||
127910676|NCT02294786|460297524|FG001|Overall Study|Adverse Event|1|||
127910677|NCT02294786|460297523|FG000|Overall Study|Death|2|||
127910678|NCT02294786|460297524|FG001|Overall Study|Death|3|||
127910679|NCT01778010|460297525|FG000|Overall Study|Withdrawal by Subject|2|||
127910680|NCT01778010|460297525|FG000|Overall Study|abnormal ECG before meds|1|||
127910681|NCT01778010|460297525|FG000|Overall Study|Arrested|1|||
127910682|NCT01778010|460297525|FG000|Overall Study|rash while on placebo|1|||
127910683|NCT01667679|460297526|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
127910684|NCT01667679|460297527|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
127910685|NCT01667679|460297526|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
127910686|NCT01667679|460297527|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
127910687|NCT01667679|460297526|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
127910688|NCT01667679|460297527|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
127910689|NCT01667679|460297526|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
127910690|NCT01667679|460297527|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
127910691|NCT01667679|460297526|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
127910692|NCT01667679|460297527|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
127910693|NCT01667679|460297526|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
127910694|NCT01667679|460297527|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
127910695|NCT01667679|460297526|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
127910696|NCT01667679|460297527|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
127910697|NCT01667679|460297526|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
127910698|NCT01667679|460297527|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
127910699|NCT01667679|460297526|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
127910700|NCT01667679|460297527|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
127910701|NCT01667679|460297526|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
127910702|NCT01667679|460297527|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
127910703|NCT01667679|460297526|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
127910704|NCT01667679|460297527|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
127910705|NCT01667679|460297526|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
127858315|NCT01365091|460096190|FG002|Period 2|Withdrawal by Subject|0|||
127858316|NCT01365091|460096191|FG003|Period 2|Withdrawal by Subject|0|||
127858317|NCT01365091|460096188|FG000|Period 2|Adverse Event|0|||
127858318|NCT01365091|460096189|FG001|Period 2|Adverse Event|0|||
127858319|NCT01365091|460096190|FG002|Period 2|Adverse Event|1|||
127858320|NCT01365091|460096191|FG003|Period 2|Adverse Event|0|||
127858321|NCT03954704|460096194|FG000|Overall Study|Death|1|||
127858322|NCT03954704|460096195|FG001|Overall Study|Death|1|||
127858323|NCT03954704|460096196|FG002|Overall Study|Death|1|||
127858324|NCT03954704|460096197|FG003|Overall Study|Death|3|||
127858325|NCT03954704|460096198|FG004|Overall Study|Death|2|||
127858326|NCT03954704|460096199|FG005|Overall Study|Death|2|||
127858327|NCT03954704|460096200|FG006|Overall Study|Death|0|||
127858328|NCT03954704|460096194|FG000|Overall Study|Withdrew Consent|0|||
127858329|NCT03954704|460096195|FG001|Overall Study|Withdrew Consent|0|||
127858330|NCT03954704|460096196|FG002|Overall Study|Withdrew Consent|1|||
127858331|NCT03954704|460096197|FG003|Overall Study|Withdrew Consent|0|||
127858332|NCT03954704|460096198|FG004|Overall Study|Withdrew Consent|0|||
127858333|NCT03954704|460096199|FG005|Overall Study|Withdrew Consent|1|||
127858334|NCT03954704|460096200|FG006|Overall Study|Withdrew Consent|0|||
127858335|NCT03954704|460096194|FG000|Overall Study|Lost to Follow-up|0|||
127858336|NCT03954704|460096195|FG001|Overall Study|Lost to Follow-up|0|||
127858337|NCT03954704|460096196|FG002|Overall Study|Lost to Follow-up|0|||
127858338|NCT03954704|460096197|FG003|Overall Study|Lost to Follow-up|0|||
127858339|NCT03954704|460096198|FG004|Overall Study|Lost to Follow-up|0|||
127858340|NCT03954704|460096199|FG005|Overall Study|Lost to Follow-up|0|||
127858341|NCT03954704|460096200|FG006|Overall Study|Lost to Follow-up|1|||
127858342|NCT03954704|460096194|FG000|Overall Study|Study Terminated by Sponsor|0|||
127858343|NCT03954704|460096195|FG001|Overall Study|Study Terminated by Sponsor|0|||
127858344|NCT03954704|460096196|FG002|Overall Study|Study Terminated by Sponsor|1|||
127858345|NCT03954704|460096197|FG003|Overall Study|Study Terminated by Sponsor|0|||
127858346|NCT03954704|460096198|FG004|Overall Study|Study Terminated by Sponsor|1|||
127858347|NCT03954704|460096199|FG005|Overall Study|Study Terminated by Sponsor|4|||
127858348|NCT03954704|460096200|FG006|Overall Study|Study Terminated by Sponsor|2|||
127858349|NCT03954704|460096194|FG000|Overall Study|Enrolled but not Treated|0|||
127858350|NCT03954704|460096195|FG001|Overall Study|Enrolled but not Treated|0|||
127858351|NCT03954704|460096196|FG002|Overall Study|Enrolled but not Treated|0|||
127858352|NCT03954704|460096197|FG003|Overall Study|Enrolled but not Treated|0|||
127858353|NCT03954704|460096198|FG004|Overall Study|Enrolled but not Treated|0|||
127858354|NCT03954704|460096199|FG005|Overall Study|Enrolled but not Treated|1|||
127858355|NCT03954704|460096200|FG006|Overall Study|Enrolled but not Treated|0|||
127858356|NCT00102804|460096201|FG000|Overall Study|Progressive Disease (PD)|307|||
127858357|NCT00102804|460096202|FG001|Overall Study|Progressive Disease (PD)|196|||
127858358|NCT00102804|460096201|FG000|Overall Study|Withdrawal by Subject|46|||
127858359|NCT00102804|460096202|FG001|Overall Study|Withdrawal by Subject|7|||
127858360|NCT00102804|460096201|FG000|Overall Study|Adverse Event|37|||
127858361|NCT00102804|460096202|FG001|Overall Study|Adverse Event|3|||
127858362|NCT00102804|460096201|FG000|Overall Study|Physician Decision|24|||
127858363|NCT00102804|460096202|FG001|Overall Study|Physician Decision|6|||
127858364|NCT00102804|460096201|FG000|Overall Study|Death|5|||
127858365|NCT00102804|460096202|FG001|Overall Study|Death|6|||
127858366|NCT00102804|460096201|FG000|Overall Study|Enrollment Criteria Not Met|6|||
127858367|NCT00102804|460096202|FG001|Overall Study|Enrollment Criteria Not Met|0|||
127858368|NCT00102804|460096201|FG000|Overall Study|Lost to Follow-up|4|||
127858369|NCT00102804|460096202|FG001|Overall Study|Lost to Follow-up|1|||
127858370|NCT00102804|460096201|FG000|Overall Study|Protocol Violation|2|||
127858371|NCT00102804|460096202|FG001|Overall Study|Protocol Violation|1|||
127858372|NCT00102804|460096201|FG000|Overall Study|Satisfactory Response|2|||
127858373|NCT00102804|460096202|FG001|Overall Study|Satisfactory Response|0|||
127858374|NCT00102804|460096201|FG000|Overall Study|Sponsor Decision|1|||
127858375|NCT00102804|460096202|FG001|Overall Study|Sponsor Decision|0|||
127858376|NCT00102804|460096201|FG000|Overall Study|Alive, Receiving Treatment|7|||
127858377|NCT00102804|460096202|FG001|Overall Study|Alive, Receiving Treatment|2|||
127858378|NCT00683774|460096208|FG000|Overall Study|Withdrawal by Subject|0|||
127858379|NCT00683774|460096209|FG001|Overall Study|Withdrawal by Subject|1|||
127858380|NCT00683774|460096208|FG000|Overall Study|Physician Decision|3|||
127858381|NCT00683774|460096209|FG001|Overall Study|Physician Decision|0|||
127858382|NCT00691054|460096210|FG000|Overall Study|Withdrawal by Subject|1|||
127858383|NCT02735044|460096211|FG000|Overall Study|Adverse Event|3|||
127858384|NCT02735044|460096212|FG001|Overall Study|Adverse Event|3|||
127858385|NCT02735044|460096211|FG000|Overall Study|Lack of Efficacy|1|||
127858386|NCT02735044|460096212|FG001|Overall Study|Lack of Efficacy|0|||
127858387|NCT02735044|460096211|FG000|Overall Study|Poor compliance to protocol|7|||
127858388|NCT02735044|460096212|FG001|Overall Study|Poor compliance to protocol|7|||
127858389|NCT02735044|460096211|FG000|Overall Study|Randomized and not treated|0|||
127858390|NCT02735044|460096212|FG001|Overall Study|Randomized and not treated|2|||
127858391|NCT02735044|460096211|FG000|Overall Study|Other, not specified above|5|||
127858392|NCT02735044|460096212|FG001|Overall Study|Other, not specified above|11|||
127858393|NCT02632344|460097971|FG000|Overall Study|Adverse Event|3|||
127910706|NCT01667679|460297527|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
127910707|NCT01667679|460297526|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
127910708|NCT01667679|460297527|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
127910709|NCT01667679|460297526|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
127910710|NCT01667679|460297527|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
127910711|NCT01667679|460297526|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
127910712|NCT01667679|460297527|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
127910713|NCT01667679|460297526|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
127910714|NCT01667679|460297527|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
127910715|NCT01667679|460297526|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
127910716|NCT01667679|460297527|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
127910717|NCT01667679|460297526|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
127910718|NCT01667679|460297527|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
127910719|NCT01667679|460297526|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
127910720|NCT01667679|460297527|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
127910721|NCT01667679|460297526|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
127910722|NCT01667679|460297527|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
127910723|NCT01667679|460297526|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
127910724|NCT01667679|460297527|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
127910725|NCT02159183|460297528|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
127910726|NCT02159183|460297529|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
127910727|NCT02159183|460297528|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
127910728|NCT02159183|460297529|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
127910729|NCT02159183|460297528|FG000|Analysis After the 36 Months Follow-up|Death|0|||
127910730|NCT02159183|460297529|FG001|Analysis After the 36 Months Follow-up|Death|1|||
127910731|NCT02159183|460297528|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
127910732|NCT02159183|460297529|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
127910733|NCT02159183|460297528|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
127910734|NCT02159183|460297529|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
127910735|NCT01294917|460297533|FG000|Overall Study|Relocation|5|||
127910736|NCT01294917|460297533|FG000|Overall Study|Inconvenience|1|||
127910737|NCT02519348|460297534|FG000|Overall Study|Death|31|||
127910738|NCT02519348|460297535|FG001|Overall Study|Death|74|||
127910739|NCT02519348|460297536|FG002|Overall Study|Death|47|||
127910740|NCT02519348|460297537|FG003|Overall Study|Death|54|||
127910741|NCT02519348|460297538|FG004|Overall Study|Death|63|||
127910742|NCT02519348|460297539|FG005|Overall Study|Death|18|||
127910743|NCT02519348|460297540|FG006|Overall Study|Death|2|||
127910744|NCT02519348|460297541|FG007|Overall Study|Death|5|||
127910745|NCT02519348|460297542|FG008|Overall Study|Death|5|||
127910746|NCT02519348|460297534|FG000|Overall Study|Withdrawal by Subject|4|||
127910747|NCT02519348|460297535|FG001|Overall Study|Withdrawal by Subject|7|||
127910748|NCT02519348|460297536|FG002|Overall Study|Withdrawal by Subject|4|||
127910749|NCT02519348|460297537|FG003|Overall Study|Withdrawal by Subject|3|||
127910750|NCT02519348|460297538|FG004|Overall Study|Withdrawal by Subject|3|||
127910751|NCT02519348|460297539|FG005|Overall Study|Withdrawal by Subject|2|||
127910752|NCT02519348|460297540|FG006|Overall Study|Withdrawal by Subject|0|||
127910753|NCT02519348|460297541|FG007|Overall Study|Withdrawal by Subject|0|||
127910754|NCT02519348|460297542|FG008|Overall Study|Withdrawal by Subject|1|||
127910755|NCT02519348|460297534|FG000|Overall Study|Lost to Follow-up|0|||
127910756|NCT02519348|460297535|FG001|Overall Study|Lost to Follow-up|0|||
127910757|NCT02519348|460297536|FG002|Overall Study|Lost to Follow-up|1|||
127910758|NCT02519348|460297537|FG003|Overall Study|Lost to Follow-up|0|||
127910759|NCT02519348|460297538|FG004|Overall Study|Lost to Follow-up|2|||
127910760|NCT02519348|460297539|FG005|Overall Study|Lost to Follow-up|1|||
127910761|NCT02519348|460297540|FG006|Overall Study|Lost to Follow-up|1|||
127910762|NCT02519348|460297541|FG007|Overall Study|Lost to Follow-up|0|||
127910763|NCT02519348|460297542|FG008|Overall Study|Lost to Follow-up|0|||
127910764|NCT02519348|460297534|FG000|Overall Study|Other|0|||
127910765|NCT02519348|460297535|FG001|Overall Study|Other|3|||
127910766|NCT02519348|460297536|FG002|Overall Study|Other|0|||
127910767|NCT02519348|460297537|FG003|Overall Study|Other|0|||
127910768|NCT02519348|460297538|FG004|Overall Study|Other|1|||
127910769|NCT02519348|460297539|FG005|Overall Study|Other|0|||
127910770|NCT02519348|460297540|FG006|Overall Study|Other|0|||
127910771|NCT02519348|460297541|FG007|Overall Study|Other|0|||
127858394|NCT02632344|460097971|FG000|Overall Study|Lack of Efficacy|3|||
127858395|NCT02632344|460097971|FG000|Overall Study|Withdrawal by Subject|2|||
127858396|NCT04076579|460097973|FG000|Overall Study|Adverse Event|2|||
127858397|NCT04076579|460097974|FG001|Overall Study|Adverse Event|0|||
127858398|NCT04076579|460097973|FG000|Overall Study|discontinued due to toxicity|1|||
127858399|NCT04076579|460097974|FG001|Overall Study|discontinued due to toxicity|0|||
127858400|NCT04076579|460097973|FG000|Overall Study|Physician Decision|1|||
127858401|NCT04076579|460097974|FG001|Overall Study|Physician Decision|0|||
127858402|NCT04076579|460097973|FG000|Overall Study|Patient was deemed ineligible before starting study treatment|0|||
127858403|NCT04076579|460097974|FG001|Overall Study|Patient was deemed ineligible before starting study treatment|1|||
127858404|NCT04076579|460097973|FG000|Overall Study|Noncompliance|0|||
127858405|NCT04076579|460097974|FG001|Overall Study|Noncompliance|1|||
127858406|NCT04076579|460097973|FG000|Overall Study|Withdrawal by Subject|0|||
127858407|NCT04076579|460097974|FG001|Overall Study|Withdrawal by Subject|2|||
127858408|NCT02903966|460097975|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
127858409|NCT02903966|460097976|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
127858410|NCT02903966|460097975|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
127858411|NCT02903966|460097976|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
127858412|NCT02903966|460097975|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
127858413|NCT02903966|460097976|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
127858414|NCT04423718|460097979|FG000|Main Study|Adverse Event|9|||
127858415|NCT04423718|460097980|FG001|Main Study|Adverse Event|5|||
127858416|NCT04423718|460097981|FG002|Main Study|Adverse Event|8|||
127858417|NCT04423718|460097979|FG000|Main Study|Physician Decision|3|||
127858418|NCT04423718|460097980|FG001|Main Study|Physician Decision|3|||
127858419|NCT04423718|460097981|FG002|Main Study|Physician Decision|2|||
127858420|NCT04423718|460097979|FG000|Main Study|Protocol Violation|0|||
127858421|NCT04423718|460097980|FG001|Main Study|Protocol Violation|0|||
127858422|NCT04423718|460097981|FG002|Main Study|Protocol Violation|1|||
127858423|NCT04423718|460097979|FG000|Main Study|Lost to Follow-up|3|||
127858424|NCT04423718|460097980|FG001|Main Study|Lost to Follow-up|3|||
127858425|NCT04423718|460097981|FG002|Main Study|Lost to Follow-up|4|||
127858426|NCT04423718|460097979|FG000|Main Study|Lack of Efficacy|2|||
127858427|NCT04423718|460097980|FG001|Main Study|Lack of Efficacy|1|||
127858428|NCT04423718|460097981|FG002|Main Study|Lack of Efficacy|0|||
127858429|NCT04423718|460097979|FG000|Main Study|Withdrawal by Subject|14|||
127858430|NCT04423718|460097980|FG001|Main Study|Withdrawal by Subject|20|||
127858431|NCT04423718|460097981|FG002|Main Study|Withdrawal by Subject|20|||
127858432|NCT04423718|460097979|FG000|Main Study|Death|10|||
127858433|NCT04423718|460097980|FG001|Main Study|Death|7|||
127858434|NCT04423718|460097981|FG002|Main Study|Death|7|||
127858435|NCT04423718|460097979|FG000|Main Study|COVID-19 pandemic|2|||
127858436|NCT04423718|460097980|FG001|Main Study|COVID-19 pandemic|2|||
127858437|NCT04423718|460097981|FG002|Main Study|COVID-19 pandemic|2|||
127858438|NCT04423718|460097979|FG000|Main Study|Other|7|||
127858439|NCT04423718|460097980|FG001|Main Study|Other|3|||
127858440|NCT04423718|460097981|FG002|Main Study|Other|2|||
127858441|NCT04423718|460097979|FG000|Extension Phase|Other|1|||
127858442|NCT04423718|460097980|FG001|Extension Phase|Other|0|||
127858443|NCT04423718|460097981|FG002|Extension Phase|Other|0|||
127858444|NCT04423718|460097979|FG000|Extension Phase|Logistical problems|0|||
127858445|NCT04423718|460097980|FG001|Extension Phase|Logistical problems|1|||
127858446|NCT04423718|460097981|FG002|Extension Phase|Logistical problems|1|||
127858447|NCT04423718|460097979|FG000|Extension Phase|Physician Decision|1|||
127858448|NCT04423718|460097980|FG001|Extension Phase|Physician Decision|0|||
127858449|NCT04423718|460097981|FG002|Extension Phase|Physician Decision|1|||
127858450|NCT04423718|460097979|FG000|Extension Phase|Lack of Efficacy|2|||
127858451|NCT04423718|460097980|FG001|Extension Phase|Lack of Efficacy|0|||
127858452|NCT04423718|460097981|FG002|Extension Phase|Lack of Efficacy|1|||
127858453|NCT04423718|460097979|FG000|Extension Phase|Lost to Follow-up|0|||
127858454|NCT04423718|460097980|FG001|Extension Phase|Lost to Follow-up|2|||
127858455|NCT04423718|460097981|FG002|Extension Phase|Lost to Follow-up|3|||
127858456|NCT04423718|460097979|FG000|Extension Phase|Adverse Event|2|||
127858457|NCT04423718|460097980|FG001|Extension Phase|Adverse Event|3|||
127858458|NCT04423718|460097981|FG002|Extension Phase|Adverse Event|1|||
127858459|NCT04423718|460097979|FG000|Extension Phase|Death|4|||
127858460|NCT04423718|460097980|FG001|Extension Phase|Death|7|||
127910772|NCT02519348|460297542|FG008|Overall Study|Other|0|||
127858461|NCT04423718|460097981|FG002|Extension Phase|Death|2|||
127858462|NCT04423718|460097979|FG000|Extension Phase|Withdrawal by Subject|11|||
127858463|NCT04423718|460097980|FG001|Extension Phase|Withdrawal by Subject|11|||
127858464|NCT04423718|460097981|FG002|Extension Phase|Withdrawal by Subject|7|||
127858465|NCT00425945|460097982|FG000|Overall Study|Concern about Supplement|2|||
127858466|NCT00425945|460097983|FG001|Overall Study|Concern about Supplement|0|||
127858467|NCT00425945|460097982|FG000|Overall Study|Inconvenience|0|||
127858468|NCT00425945|460097983|FG001|Overall Study|Inconvenience|2|||
127858469|NCT00425945|460097982|FG000|Overall Study|Lost to Follow-up|0|||
127858470|NCT00425945|460097983|FG001|Overall Study|Lost to Follow-up|2|||
127858471|NCT00425945|460097982|FG000|Overall Study|Began hypertension medication|1|||
127858472|NCT00425945|460097983|FG001|Overall Study|Began hypertension medication|0|||
127858473|NCT00425945|460097982|FG000|Overall Study|Began cancer treatments|1|||
127858474|NCT00425945|460097983|FG001|Overall Study|Began cancer treatments|0|||
127858475|NCT00425945|460097982|FG000|Overall Study|Moved from area|0|||
127858476|NCT00425945|460097983|FG001|Overall Study|Moved from area|1|||
127858477|NCT03991936|460097984|FG000|Overall Study|Lost to Follow-up|1|||
127858478|NCT03991936|460097985|FG001|Overall Study|Lost to Follow-up|1|||
127858479|NCT03991936|460097986|FG002|Overall Study|Lost to Follow-up|1|||
127858480|NCT03991936|460097987|FG003|Overall Study|Lost to Follow-up|1|||
127858481|NCT03991936|460097988|FG004|Overall Study|Lost to Follow-up|1|||
127858482|NCT00939055|460097989|FG000|Overall Study|Discontinuation prior to procedure|4|||
127858483|NCT00939055|460097990|FG001|Overall Study|Discontinuation prior to procedure|0|||
127858484|NCT00584987|460097993|FG000|Overall Study|Protocol Violation|1|||
127858485|NCT00584987|460097994|FG001|Overall Study|Protocol Violation|1|||
127858486|NCT00584987|460097995|FG002|Overall Study|Protocol Violation|1|||
127858487|NCT00584987|460097996|FG003|Overall Study|Protocol Violation|0|||
127858488|NCT00584987|460097993|FG000|Overall Study|Adverse Event|0|||
127858489|NCT00584987|460097994|FG001|Overall Study|Adverse Event|0|||
127858490|NCT00584987|460097995|FG002|Overall Study|Adverse Event|0|||
127858491|NCT00584987|460097996|FG003|Overall Study|Adverse Event|1|||
127858492|NCT02881151|460097997|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
127858493|NCT03225833|460097998|FG000|Overall Study|Adverse Event|0|||
127858494|NCT03225833|460097999|FG001|Overall Study|Adverse Event|1|||
127858495|NCT03225833|460098000|FG002|Overall Study|Adverse Event|2|||
127858496|NCT03225833|460098001|FG003|Overall Study|Adverse Event|0|||
127858497|NCT03225833|460098002|FG004|Overall Study|Adverse Event|0|||
127858498|NCT03225833|460098003|FG005|Overall Study|Adverse Event|2|||
127858499|NCT03225833|460097998|FG000|Overall Study|Withdrawal by Subject|1|||
127858500|NCT03225833|460097999|FG001|Overall Study|Withdrawal by Subject|0|||
127858501|NCT03225833|460098000|FG002|Overall Study|Withdrawal by Subject|0|||
127858502|NCT03225833|460098001|FG003|Overall Study|Withdrawal by Subject|0|||
127858503|NCT03225833|460098002|FG004|Overall Study|Withdrawal by Subject|1|||
127858504|NCT03225833|460098003|FG005|Overall Study|Withdrawal by Subject|0|||
127858505|NCT03225833|460097998|FG000|Overall Study|Termination of Study by Sponsor|4|||
127858506|NCT03225833|460097999|FG001|Overall Study|Termination of Study by Sponsor|0|||
127858507|NCT03225833|460098000|FG002|Overall Study|Termination of Study by Sponsor|0|||
127858508|NCT03225833|460098001|FG003|Overall Study|Termination of Study by Sponsor|0|||
127858509|NCT03225833|460098002|FG004|Overall Study|Termination of Study by Sponsor|0|||
127858510|NCT03225833|460098003|FG005|Overall Study|Termination of Study by Sponsor|7|||
127858511|NCT03225833|460097998|FG000|Overall Study|Sponsor Decision|0|||
127858512|NCT03225833|460097999|FG001|Overall Study|Sponsor Decision|0|||
127910773|NCT02519348|460297534|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
127858513|NCT03225833|460098000|FG002|Overall Study|Sponsor Decision|0|||
127858514|NCT03225833|460098001|FG003|Overall Study|Sponsor Decision|0|||
127858515|NCT03225833|460098002|FG004|Overall Study|Sponsor Decision|0|||
127858516|NCT03225833|460098003|FG005|Overall Study|Sponsor Decision|1|||
127858517|NCT03258593|460098004|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
127858518|NCT03258593|460098005|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
127858519|NCT03258593|460098006|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
127858520|NCT03258593|460098007|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
127858521|NCT03258593|460098004|FG000|Run-In Maintenance Phase|Disease progression|3|||
127858522|NCT03258593|460098005|FG001|Run-In Maintenance Phase|Disease progression|0|||
127858523|NCT03258593|460098006|FG002|Run-In Maintenance Phase|Disease progression|0|||
127858524|NCT03258593|460098007|FG003|Run-In Maintenance Phase|Disease progression|0|||
127858525|NCT03258593|460098004|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
127910774|NCT02519348|460297535|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
127910775|NCT02519348|460297536|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
127910776|NCT02519348|460297537|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
127910777|NCT02519348|460297538|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
127910778|NCT02519348|460297539|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
127910779|NCT02519348|460297540|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
127910780|NCT02519348|460297541|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
127910781|NCT02519348|460297542|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
127910782|NCT01444378|460297543|FG000|Overall Study|Lost to Follow-up|1|||
127910783|NCT01444378|460297543|FG000|Overall Study|Withdrawal by Subject|1|||
127910784|NCT01444378|460297543|FG000|Overall Study|Death|3|||
127910785|NCT01444378|460297543|FG000|Overall Study|Administrative Closure Of The Study|2|||
127910786|NCT01444378|460297543|FG000|Overall Study|Missed Visits|10|||
127910787|NCT02911792|460297544|FG000|Overall Study|Lost to Follow-up|3|||
127910788|NCT02911792|460297545|FG001|Overall Study|Lost to Follow-up|3|||
127910789|NCT02911792|460297546|FG002|Overall Study|Lost to Follow-up|3|||
127910790|NCT02911792|460297547|FG003|Overall Study|Lost to Follow-up|3|||
127910791|NCT01244620|460297550|FG000|Overall Study|Study terminated|4|||
127910792|NCT01244620|460297551|FG001|Overall Study|Study terminated|4|||
127910793|NCT01244620|460297552|FG002|Overall Study|Study terminated|4|||
127910794|NCT01244620|460297553|FG003|Overall Study|Study terminated|4|||
127910795|NCT02321098|460297555|FG000|12 Weeks Treament|Lost to Follow-up|1|||
127910796|NCT02321098|460297556|FG001|12 Weeks Treament|Lost to Follow-up|1|||
127910797|NCT02321098|460297557|FG002|12 Weeks Treament|Lost to Follow-up|0|||
127910798|NCT02321098|460297555|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
127910799|NCT02321098|460297556|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
127910800|NCT02321098|460297557|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
127910801|NCT02321098|460297555|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
127910802|NCT02321098|460297556|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
127910803|NCT02321098|460297557|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
127910804|NCT02321098|460297555|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
127910805|NCT02321098|460297556|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
127910806|NCT02321098|460297557|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
127910807|NCT01663233|460297558|FG000|Overall Study|Withdrawal by Subject|3|||
127910808|NCT01663233|460297559|FG001|Overall Study|Withdrawal by Subject|2|||
127910809|NCT01663233|460297558|FG000|Overall Study|Protocol Deviation|1|||
127910810|NCT01663233|460297559|FG001|Overall Study|Protocol Deviation|4|||
127910811|NCT01663233|460297558|FG000|Overall Study|Lost to Follow-up|0|||
127910812|NCT01663233|460297559|FG001|Overall Study|Lost to Follow-up|1|||
127910813|NCT05630885|460297566|FG000|Study Completion|Took prohibited medications|2|||
127910814|NCT05630885|460297567|FG001|Study Completion|Took prohibited medications|0|||
127910815|NCT05630885|460297566|FG000|Study Completion|Non-compliance with study drug|1|||
127910816|NCT05630885|460297567|FG001|Study Completion|Non-compliance with study drug|0|||
127910817|NCT05630885|460297566|FG000|Study Completion|Adverse Event|1|||
127910818|NCT05630885|460297567|FG001|Study Completion|Adverse Event|0|||
127910819|NCT05630885|460297566|FG000|Efficacy Analysis Population Set|Took prohibited medications|3|||
127910820|NCT05630885|460297567|FG001|Efficacy Analysis Population Set|Took prohibited medications|1|||
127910821|NCT05630885|460297566|FG000|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|8|||
127910822|NCT05630885|460297567|FG001|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|1|||
127910823|NCT01370733|460297568|FG000|Overall Study|Withdrawal by Subject|8|||
127910824|NCT01370733|460297569|FG001|Overall Study|Withdrawal by Subject|8|||
127910825|NCT01370733|460297568|FG000|Overall Study|Lost to Follow-up|3|||
127910826|NCT01370733|460297569|FG001|Overall Study|Lost to Follow-up|0|||
127910827|NCT01370733|460297568|FG000|Overall Study|Adverse Event|2|||
127910828|NCT01370733|460297569|FG001|Overall Study|Adverse Event|4|||
127910829|NCT01370733|460297568|FG000|Overall Study|Lack of Efficacy|3|||
127910830|NCT01370733|460297569|FG001|Overall Study|Lack of Efficacy|5|||
127910831|NCT01370733|460297568|FG000|Overall Study|Physician Decision|0|||
127910832|NCT01370733|460297569|FG001|Overall Study|Physician Decision|2|||
127910833|NCT01370733|460297568|FG000|Overall Study|Protocol Violation|1|||
127910834|NCT01370733|460297569|FG001|Overall Study|Protocol Violation|3|||
127910835|NCT06539676|460297570|FG000|Overall Study|Early study termination|1|||
127910836|NCT06539676|460297571|FG001|Overall Study|Early study termination|0|||
127910837|NCT06539676|460297572|FG002|Overall Study|Early study termination|6|||
127910838|NCT02645409|460297573|FG000|Overall Study|Withdrawal by Subject|3|||
127910839|NCT02645409|460297574|FG001|Overall Study|Withdrawal by Subject|0|||
127910840|NCT02645409|460297573|FG000|Overall Study|Physician Decision|1|||
127910841|NCT02645409|460297574|FG001|Overall Study|Physician Decision|0|||
127910842|NCT03419403|460297575|FG000|Overall Study|Withdrawal by Subject|5|||
127910843|NCT03419403|460297576|FG001|Overall Study|Withdrawal by Subject|2|||
127910844|NCT03419403|460297577|FG002|Overall Study|Withdrawal by Subject|5|||
127910845|NCT03419403|460297578|FG003|Overall Study|Withdrawal by Subject|1|||
127910846|NCT03419403|460297575|FG000|Overall Study|Progressive disease (per protocol)|0|||
127910847|NCT03419403|460297576|FG001|Overall Study|Progressive disease (per protocol)|2|||
127910848|NCT03419403|460297577|FG002|Overall Study|Progressive disease (per protocol)|2|||
127910849|NCT03419403|460297578|FG003|Overall Study|Progressive disease (per protocol)|0|||
127910850|NCT03419403|460297575|FG000|Overall Study|Other, not specified|6|||
127910851|NCT03419403|460297576|FG001|Overall Study|Other, not specified|4|||
127910852|NCT03419403|460297577|FG002|Overall Study|Other, not specified|5|||
127910853|NCT03419403|460297578|FG003|Overall Study|Other, not specified|1|||
127910854|NCT03419403|460297575|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
127910855|NCT03419403|460297576|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
127910856|NCT03419403|460297577|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
127910857|NCT03419403|460297578|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
127910858|NCT02089685|460297583|FG000|Overall Study|Adverse Event|1|||
127910859|NCT02089685|460297584|FG001|Overall Study|Adverse Event|0|||
127910860|NCT02089685|460297585|FG002|Overall Study|Adverse Event|0|||
127910861|NCT02089685|460297586|FG003|Overall Study|Adverse Event|0|||
127910862|NCT02089685|460297587|FG004|Overall Study|Adverse Event|1|||
127910863|NCT02089685|460297588|FG005|Overall Study|Adverse Event|0|||
127910864|NCT02089685|460297583|FG000|Overall Study|Clinical Progression|4|||
127910865|NCT02089685|460297584|FG001|Overall Study|Clinical Progression|0|||
127910866|NCT02089685|460297585|FG002|Overall Study|Clinical Progression|0|||
127910867|NCT02089685|460297586|FG003|Overall Study|Clinical Progression|5|||
127910868|NCT02089685|460297587|FG004|Overall Study|Clinical Progression|1|||
127910869|NCT02089685|460297588|FG005|Overall Study|Clinical Progression|2|||
127910870|NCT02089685|460297583|FG000|Overall Study|Excluded Medication|1|||
127910871|NCT02089685|460297584|FG001|Overall Study|Excluded Medication|0|||
127910872|NCT02089685|460297585|FG002|Overall Study|Excluded Medication|0|||
127910873|NCT02089685|460297586|FG003|Overall Study|Excluded Medication|11|||
127910874|NCT02089685|460297587|FG004|Overall Study|Excluded Medication|2|||
127910875|NCT02089685|460297588|FG005|Overall Study|Excluded Medication|1|||
127910876|NCT02089685|460297583|FG000|Overall Study|Progressive disease|13|||
127910877|NCT02089685|460297584|FG001|Overall Study|Progressive disease|10|||
127910878|NCT02089685|460297585|FG002|Overall Study|Progressive disease|3|||
127910879|NCT02089685|460297586|FG003|Overall Study|Progressive disease|51|||
127910880|NCT02089685|460297587|FG004|Overall Study|Progressive disease|17|||
127910881|NCT02089685|460297588|FG005|Overall Study|Progressive disease|12|||
127910882|NCT02089685|460297583|FG000|Overall Study|Follow up ended by sponsor|2|||
127910883|NCT02089685|460297584|FG001|Overall Study|Follow up ended by sponsor|2|||
127910884|NCT02089685|460297585|FG002|Overall Study|Follow up ended by sponsor|0|||
127910885|NCT02089685|460297586|FG003|Overall Study|Follow up ended by sponsor|70|||
127910886|NCT02089685|460297587|FG004|Overall Study|Follow up ended by sponsor|26|||
127910887|NCT02089685|460297588|FG005|Overall Study|Follow up ended by sponsor|26|||
127910888|NCT02089685|460297583|FG000|Overall Study|Withdrawal by Subject|0|||
127910889|NCT02089685|460297584|FG001|Overall Study|Withdrawal by Subject|2|||
127910890|NCT02089685|460297585|FG002|Overall Study|Withdrawal by Subject|0|||
127910891|NCT02089685|460297586|FG003|Overall Study|Withdrawal by Subject|8|||
127910892|NCT02089685|460297587|FG004|Overall Study|Withdrawal by Subject|1|||
127910893|NCT02089685|460297588|FG005|Overall Study|Withdrawal by Subject|1|||
127910894|NCT02089685|460297583|FG000|Overall Study|Status not recorded|1|||
127910895|NCT02089685|460297584|FG001|Overall Study|Status not recorded|0|||
127910896|NCT02089685|460297585|FG002|Overall Study|Status not recorded|0|||
127910897|NCT02089685|460297586|FG003|Overall Study|Status not recorded|0|||
127910898|NCT02089685|460297587|FG004|Overall Study|Status not recorded|1|||
127910899|NCT02089685|460297588|FG005|Overall Study|Status not recorded|0|||
127910900|NCT02089685|460297583|FG000|Overall Study|Death|0|||
127910901|NCT02089685|460297584|FG001|Overall Study|Death|0|||
127910902|NCT02089685|460297585|FG002|Overall Study|Death|0|||
127910903|NCT02089685|460297586|FG003|Overall Study|Death|7|||
127910904|NCT02089685|460297587|FG004|Overall Study|Death|2|||
127910905|NCT02089685|460297588|FG005|Overall Study|Death|5|||
127910906|NCT02089685|460297583|FG000|Overall Study|Lost to Follow-up|0|||
127910907|NCT02089685|460297584|FG001|Overall Study|Lost to Follow-up|0|||
127910908|NCT02089685|460297585|FG002|Overall Study|Lost to Follow-up|0|||
127910909|NCT02089685|460297586|FG003|Overall Study|Lost to Follow-up|1|||
127910910|NCT02089685|460297587|FG004|Overall Study|Lost to Follow-up|0|||
127910911|NCT02089685|460297588|FG005|Overall Study|Lost to Follow-up|0|||
127910912|NCT02089685|460297583|FG000|Overall Study|Physician Decision|0|||
127910913|NCT02089685|460297584|FG001|Overall Study|Physician Decision|0|||
127910914|NCT02089685|460297585|FG002|Overall Study|Physician Decision|0|||
127910915|NCT02089685|460297586|FG003|Overall Study|Physician Decision|0|||
127910916|NCT02089685|460297587|FG004|Overall Study|Physician Decision|0|||
127910917|NCT02089685|460297588|FG005|Overall Study|Physician Decision|4|||
127910918|NCT02089685|460297583|FG000|Overall Study|Screen failure|1|||
127910919|NCT02089685|460297584|FG001|Overall Study|Screen failure|0|||
127910920|NCT02089685|460297585|FG002|Overall Study|Screen failure|0|||
127910921|NCT02089685|460297586|FG003|Overall Study|Screen failure|0|||
127910922|NCT02089685|460297587|FG004|Overall Study|Screen failure|0|||
127910923|NCT02089685|460297588|FG005|Overall Study|Screen failure|0|||
127910924|NCT00318461|460297589|FG000|Double-Blind, 6 Months|Adverse Event|11|||
127910925|NCT00318461|460297590|FG001|Double-Blind, 6 Months|Adverse Event|23|||
127910926|NCT00318461|460297591|FG002|Double-Blind, 6 Months|Adverse Event|29|||
127910927|NCT00318461|460297592|FG003|Double-Blind, 6 Months|Adverse Event|2|||
127910928|NCT00318461|460297593|FG004|Double-Blind, 6 Months|Adverse Event|8|||
127910929|NCT00318461|460297589|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
127910930|NCT00318461|460297590|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
127910931|NCT00318461|460297591|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
127910932|NCT00318461|460297592|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
127910933|NCT00318461|460297593|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
127910934|NCT00318461|460297589|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
127910935|NCT00318461|460297590|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
127910936|NCT00318461|460297591|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
127910937|NCT00318461|460297592|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
127910938|NCT00318461|460297593|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
127910939|NCT00318461|460297589|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
127910940|NCT00318461|460297590|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
127910941|NCT00318461|460297591|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
127910942|NCT00318461|460297592|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
127910943|NCT00318461|460297593|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
127910944|NCT00318461|460297589|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
127910945|NCT00318461|460297590|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
127910946|NCT00318461|460297591|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
127910947|NCT00318461|460297592|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
127910948|NCT00318461|460297593|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
127910949|NCT00318461|460297589|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
127910950|NCT00318461|460297590|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
127910951|NCT00318461|460297591|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
127910952|NCT00318461|460297592|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
127910953|NCT00318461|460297593|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
127910954|NCT00318461|460297589|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
127910955|NCT00318461|460297590|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
127910956|NCT00318461|460297591|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
127910957|NCT00318461|460297592|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
127910958|NCT00318461|460297593|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
127910959|NCT00318461|460297589|FG000|Double-Blind, 6 Months|Move|0|||
127910960|NCT00318461|460297590|FG001|Double-Blind, 6 Months|Move|1|||
127910961|NCT00318461|460297591|FG002|Double-Blind, 6 Months|Move|0|||
127910962|NCT00318461|460297592|FG003|Double-Blind, 6 Months|Move|0|||
127910963|NCT00318461|460297593|FG004|Double-Blind, 6 Months|Move|0|||
127910964|NCT00318461|460297589|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
127910965|NCT00318461|460297590|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
127910966|NCT00318461|460297591|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
127910967|NCT00318461|460297592|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
127910968|NCT00318461|460297593|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
127910969|NCT00318461|460297589|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
127910970|NCT00318461|460297590|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
127910971|NCT00318461|460297591|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
127910972|NCT00318461|460297592|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
127910973|NCT00318461|460297593|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
127910974|NCT00318461|460297589|FG000|Double-Blind, 6 Months|Work commitment|0|||
127910975|NCT00318461|460297590|FG001|Double-Blind, 6 Months|Work commitment|0|||
127910976|NCT00318461|460297591|FG002|Double-Blind, 6 Months|Work commitment|0|||
127910977|NCT00318461|460297592|FG003|Double-Blind, 6 Months|Work commitment|0|||
127910978|NCT00318461|460297593|FG004|Double-Blind, 6 Months|Work commitment|1|||
127910979|NCT00318461|460297589|FG000|Double-Blind, 6 Months|Investigator decision|0|||
127910980|NCT00318461|460297590|FG001|Double-Blind, 6 Months|Investigator decision|0|||
127910981|NCT00318461|460297591|FG002|Double-Blind, 6 Months|Investigator decision|0|||
127910982|NCT00318461|460297592|FG003|Double-Blind, 6 Months|Investigator decision|0|||
127910983|NCT00318461|460297593|FG004|Double-Blind, 6 Months|Investigator decision|1|||
127910984|NCT00318461|460297589|FG000|Double-Blind, 6 Months|Lack of time|1|||
127910985|NCT00318461|460297590|FG001|Double-Blind, 6 Months|Lack of time|0|||
127910986|NCT00318461|460297591|FG002|Double-Blind, 6 Months|Lack of time|0|||
127910987|NCT00318461|460297592|FG003|Double-Blind, 6 Months|Lack of time|0|||
127910988|NCT00318461|460297593|FG004|Double-Blind, 6 Months|Lack of time|0|||
127910989|NCT00318461|460297589|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
127910990|NCT00318461|460297590|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
127910991|NCT00318461|460297591|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
127910992|NCT00318461|460297592|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
127910993|NCT00318461|460297593|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
127910994|NCT00318461|460297589|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
127910995|NCT00318461|460297590|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
127910996|NCT00318461|460297591|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
127910997|NCT00318461|460297592|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
127910998|NCT00318461|460297593|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
127910999|NCT00318461|460297589|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
127911000|NCT00318461|460297590|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
127911001|NCT00318461|460297591|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
127911002|NCT00318461|460297592|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
127911003|NCT00318461|460297593|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
127911004|NCT00318461|460297589|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
127911005|NCT00318461|460297590|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
127911006|NCT00318461|460297591|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
127911007|NCT00318461|460297592|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
127911008|NCT00318461|460297593|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
127911009|NCT00318461|460297589|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
127911010|NCT00318461|460297590|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
127911011|NCT00318461|460297591|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
127911012|NCT00318461|460297592|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
127911013|NCT00318461|460297593|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
127911014|NCT00318461|460297589|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
127911015|NCT00318461|460297590|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
127911016|NCT00318461|460297591|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
127911017|NCT00318461|460297592|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
127911018|NCT00318461|460297593|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
127911019|NCT00318461|460297589|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
127911020|NCT00318461|460297590|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
127911021|NCT00318461|460297591|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
127911022|NCT00318461|460297592|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
127911023|NCT00318461|460297593|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
127911024|NCT00318461|460297589|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
127911025|NCT00318461|460297590|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
127911026|NCT00318461|460297591|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
127911027|NCT00318461|460297592|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
127911028|NCT00318461|460297593|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
127911029|NCT01929863|460297600|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
127911030|NCT01929863|460297601|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
127911031|NCT01929863|460297600|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
127911032|NCT01929863|460297601|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
127911033|NCT01929863|460297600|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
127911034|NCT01929863|460297601|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
127911035|NCT00323882|460297602|FG000|Overall Study|Adverse Event|2|||
127911036|NCT00323882|460297603|FG001|Overall Study|Adverse Event|1|||
127911037|NCT00323882|460297604|FG002|Overall Study|Adverse Event|1|||
127911038|NCT00323882|460297605|FG003|Overall Study|Adverse Event|1|||
127911039|NCT00323882|460297606|FG004|Overall Study|Adverse Event|3|||
127911040|NCT00323882|460297602|FG000|Overall Study|Disease Progression|6|||
127911041|NCT00323882|460297603|FG001|Overall Study|Disease Progression|4|||
127911042|NCT00323882|460297604|FG002|Overall Study|Disease Progression|10|||
127911043|NCT00323882|460297605|FG003|Overall Study|Disease Progression|5|||
127911044|NCT00323882|460297606|FG004|Overall Study|Disease Progression|22|||
127911045|NCT00323882|460297602|FG000|Overall Study|Death|0|||
127911046|NCT00323882|460297603|FG001|Overall Study|Death|1|||
127911047|NCT00323882|460297604|FG002|Overall Study|Death|1|||
127911048|NCT00323882|460297605|FG003|Overall Study|Death|0|||
127911049|NCT00323882|460297606|FG004|Overall Study|Death|5|||
127911050|NCT00323882|460297602|FG000|Overall Study|Lost to Follow-up|0|||
127911051|NCT00323882|460297603|FG001|Overall Study|Lost to Follow-up|0|||
127911052|NCT00323882|460297604|FG002|Overall Study|Lost to Follow-up|1|||
127911053|NCT00323882|460297605|FG003|Overall Study|Lost to Follow-up|0|||
127911054|NCT00323882|460297606|FG004|Overall Study|Lost to Follow-up|1|||
127911055|NCT00323882|460297602|FG000|Overall Study|Other|0|||
127911056|NCT00323882|460297603|FG001|Overall Study|Other|0|||
127911057|NCT00323882|460297604|FG002|Overall Study|Other|0|||
127911058|NCT00323882|460297605|FG003|Overall Study|Other|1|||
127911059|NCT00323882|460297606|FG004|Overall Study|Other|1|||
127911060|NCT02911701|460297607|FG000|Overall Study|Withdrawal by Subject|2|||
127911061|NCT02911701|460297608|FG001|Overall Study|Withdrawal by Subject|4|||
127911062|NCT02911701|460297607|FG000|Overall Study|Adverse Event|1|||
127911063|NCT02911701|460297608|FG001|Overall Study|Adverse Event|0|||
127911064|NCT00830024|460297609|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
127858526|NCT03258593|460098005|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
127858527|NCT03258593|460098006|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
127858528|NCT03258593|460098007|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
127858529|NCT03258593|460098004|FG000|Expansion Maintenance Phase|Physician Decision|0|||
127858530|NCT03258593|460098005|FG001|Expansion Maintenance Phase|Physician Decision|1|||
127858531|NCT03258593|460098006|FG002|Expansion Maintenance Phase|Physician Decision|0|||
127858532|NCT03258593|460098007|FG003|Expansion Maintenance Phase|Physician Decision|0|||
127858533|NCT05318183|460098008|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
127858534|NCT05318183|460098009|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|3|||
127858535|NCT05318183|460098008|FG000|First Intervention (2 Weeks)|Lost to Follow-up|2|||
127858536|NCT05318183|460098009|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
127858537|NCT03381274|460098010|FG000|Overall Study|Death|2|||
127858538|NCT03381274|460098011|FG001|Overall Study|Death|9|||
127858539|NCT03381274|460098012|FG002|Overall Study|Death|3|||
127858540|NCT03381274|460098013|FG003|Overall Study|Death|2|||
127858541|NCT03381274|460098014|FG004|Overall Study|Death|3|||
127858542|NCT03381274|460098010|FG000|Overall Study|Lost to Follow-up|0|||
127858543|NCT03381274|460098011|FG001|Overall Study|Lost to Follow-up|0|||
127858544|NCT03381274|460098012|FG002|Overall Study|Lost to Follow-up|0|||
127858545|NCT03381274|460098013|FG003|Overall Study|Lost to Follow-up|1|||
127858546|NCT03381274|460098014|FG004|Overall Study|Lost to Follow-up|0|||
127858547|NCT03381274|460098010|FG000|Overall Study|Withdrawal by Subject|2|||
127858548|NCT03381274|460098011|FG001|Overall Study|Withdrawal by Subject|1|||
127858549|NCT03381274|460098012|FG002|Overall Study|Withdrawal by Subject|3|||
127858550|NCT03381274|460098013|FG003|Overall Study|Withdrawal by Subject|1|||
127858551|NCT03381274|460098014|FG004|Overall Study|Withdrawal by Subject|0|||
127858552|NCT03381274|460098010|FG000|Overall Study|Other|1|||
127858553|NCT03381274|460098011|FG001|Overall Study|Other|11|||
127858554|NCT03381274|460098012|FG002|Overall Study|Other|0|||
127858555|NCT03381274|460098013|FG003|Overall Study|Other|2|||
127858556|NCT03381274|460098014|FG004|Overall Study|Other|2|||
127858557|NCT05180721|460098015|FG000|Overall Study|Lost to Follow-up|4|||
127858558|NCT01996865|460098017|FG000|Induction Period|Protocol Violation|1|||
127858559|NCT01996865|460098018|FG001|Induction Period|Protocol Violation|0|||
127858560|NCT01996865|460098019|FG002|Induction Period|Protocol Violation|0|||
127858561|NCT01996865|460098017|FG000|Induction Period|Progressive Disease|4|||
127858562|NCT01996865|460098018|FG001|Induction Period|Progressive Disease|0|||
127858563|NCT01996865|460098019|FG002|Induction Period|Progressive Disease|0|||
127858564|NCT01996865|460098017|FG000|Induction Period|Lost to Follow-up|10|||
127858565|NCT01996865|460098018|FG001|Induction Period|Lost to Follow-up|0|||
127858566|NCT01996865|460098019|FG002|Induction Period|Lost to Follow-up|0|||
127858567|NCT01996865|460098017|FG000|Induction Period|Other Reasons|13|||
127858568|NCT01996865|460098018|FG001|Induction Period|Other Reasons|0|||
127858569|NCT01996865|460098019|FG002|Induction Period|Other Reasons|0|||
127858570|NCT01996865|460098017|FG000|Induction Period|Adverse Event|20|||
127858571|NCT01996865|460098018|FG001|Induction Period|Adverse Event|0|||
127858572|NCT01996865|460098019|FG002|Induction Period|Adverse Event|0|||
127858573|NCT01996865|460098017|FG000|Induction Period|Withdrawal by Subject|60|||
127858574|NCT01996865|460098018|FG001|Induction Period|Withdrawal by Subject|0|||
127858575|NCT01996865|460098019|FG002|Induction Period|Withdrawal by Subject|0|||
127858576|NCT01996865|460098017|FG000|Induction Period|Death|111|||
127858577|NCT01996865|460098018|FG001|Induction Period|Death|0|||
127858578|NCT01996865|460098019|FG002|Induction Period|Death|0|||
127858579|NCT01996865|460098017|FG000|Maintenance Period|Protocol Violation|0|||
127858580|NCT01996865|460098018|FG001|Maintenance Period|Protocol Violation|1|||
127858581|NCT01996865|460098019|FG002|Maintenance Period|Protocol Violation|1|||
127858582|NCT01996865|460098017|FG000|Maintenance Period|Other reasons|0|||
127858583|NCT01996865|460098018|FG001|Maintenance Period|Other reasons|8|||
127858584|NCT01996865|460098019|FG002|Maintenance Period|Other reasons|5|||
127858585|NCT01996865|460098017|FG000|Maintenance Period|Progressive Disease|0|||
127858586|NCT01996865|460098018|FG001|Maintenance Period|Progressive Disease|6|||
127858587|NCT01996865|460098019|FG002|Maintenance Period|Progressive Disease|23|||
127858588|NCT01996865|460098017|FG000|Maintenance Period|Withdrawal by Subject|0|||
127858589|NCT01996865|460098018|FG001|Maintenance Period|Withdrawal by Subject|18|||
127911065|NCT00830024|460297610|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
127911066|NCT01983969|460297611|FG000|Overall Study|Disease Progression|0|||
127911067|NCT01983969|460297612|FG001|Overall Study|Disease Progression|1|||
127911068|NCT01983969|460297613|FG002|Overall Study|Disease Progression|0|||
127911069|NCT00436163|460297614|FG000|Overall Study|Lost to Follow-up|2|||
127911070|NCT00436163|460297614|FG000|Overall Study|Adverse Event|1|||
127911071|NCT02530905|460297615|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
127911072|NCT02530905|460297616|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
127911073|NCT02530905|460297617|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
127911074|NCT00950989|460297618|FG000|Overall Study|Death|0|||
127911075|NCT00950989|460297619|FG001|Overall Study|Death|0|||
127911076|NCT00950989|460297620|FG002|Overall Study|Death|1|||
127911077|NCT00950989|460297621|FG003|Overall Study|Death|0|||
127911078|NCT00950989|460297618|FG000|Overall Study|Administrative Decision|0|||
127911079|NCT00950989|460297619|FG001|Overall Study|Administrative Decision|1|||
127911080|NCT00950989|460297620|FG002|Overall Study|Administrative Decision|0|||
127911081|NCT00950989|460297621|FG003|Overall Study|Administrative Decision|0|||
127911082|NCT00950989|460297618|FG000|Overall Study|Disease Progression|0|||
127911083|NCT00950989|460297619|FG001|Overall Study|Disease Progression|0|||
127911084|NCT00950989|460297620|FG002|Overall Study|Disease Progression|1|||
127911085|NCT00950989|460297621|FG003|Overall Study|Disease Progression|0|||
127911086|NCT00950989|460297618|FG000|Overall Study|Withdrawal by Subject|2|||
127911087|NCT00950989|460297619|FG001|Overall Study|Withdrawal by Subject|1|||
127911088|NCT00950989|460297620|FG002|Overall Study|Withdrawal by Subject|0|||
127911089|NCT00950989|460297621|FG003|Overall Study|Withdrawal by Subject|0|||
127911090|NCT00950989|460297618|FG000|Overall Study|Adverse Event|2|||
127911091|NCT00950989|460297619|FG001|Overall Study|Adverse Event|1|||
127911092|NCT00950989|460297620|FG002|Overall Study|Adverse Event|1|||
127911093|NCT00950989|460297621|FG003|Overall Study|Adverse Event|0|||
127911094|NCT01841554|460297622|FG000|Overall Study|Death|7|||
127911095|NCT01841554|460297622|FG000|Overall Study|No Implantation|1|||
127911096|NCT01841554|460297622|FG000|Overall Study|Discontinued Follow Up|5|||
127911097|NCT01841554|460297622|FG000|Overall Study|Study exit due to secondary intervention|6|||
127911098|NCT03804983|460297626|FG000|Overall Study|Adverse Event|0|||
127911099|NCT03804983|460297627|FG001|Overall Study|Adverse Event|1|||
127911100|NCT03804983|460297626|FG000|Overall Study|Family Obligation|1|||
127911101|NCT03804983|460297627|FG001|Overall Study|Family Obligation|0|||
127911102|NCT03600376|460297628|FG000|Overall Study|Adverse Event|1|||
127911103|NCT03600376|460297629|FG001|Overall Study|Adverse Event|1|||
127911104|NCT03600376|460297628|FG000|Overall Study|Transferred to other facility|1|||
127911105|NCT03600376|460297629|FG001|Overall Study|Transferred to other facility|0|||
127911106|NCT03600376|460297628|FG000|Overall Study|Investigator Decision|0|||
127911107|NCT03600376|460297629|FG001|Overall Study|Investigator Decision|4|||
127911108|NCT03600376|460297628|FG000|Overall Study|Determined to be ineligible for study|0|||
127911109|NCT03600376|460297629|FG001|Overall Study|Determined to be ineligible for study|1|||
127911110|NCT02152163|460297630|FG000|Overall Study|Physician Decision|12|||
127911111|NCT02152163|460297631|FG001|Overall Study|Physician Decision|13|||
127911112|NCT00796562|460297632|FG000|Overall Study|Death|49|||
127911113|NCT00424047|460297633|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
127911114|NCT00424047|460297634|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
127911115|NCT00424047|460297633|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
127911116|NCT00424047|460297634|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
127911117|NCT00424047|460297633|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
127911118|NCT00424047|460297634|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
127911119|NCT00424047|460297633|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
127911120|NCT00424047|460297634|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
127911121|NCT00424047|460297633|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
127911122|NCT00424047|460297634|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
127911123|NCT00424047|460297633|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
127911124|NCT00424047|460297634|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
127911125|NCT00424047|460297633|FG000|On Study at Time of Unblinding|Adverse Event|22|||
127911126|NCT00424047|460297634|FG001|On Study at Time of Unblinding|Adverse Event|12|||
127911127|NCT00424047|460297633|FG000|On Study at Time of Unblinding|Progression of disease|92|||
127911128|NCT00424047|460297634|FG001|On Study at Time of Unblinding|Progression of disease|128|||
127911129|NCT00424047|460297633|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
127911130|NCT00424047|460297634|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
127911131|NCT00424047|460297633|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
127911132|NCT00424047|460297634|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
127911133|NCT00424047|460297633|FG000|On Study at Time of Unblinding|Death|11|||
127911134|NCT00424047|460297634|FG001|On Study at Time of Unblinding|Death|11|||
127911135|NCT00424047|460297633|FG000|On Study at Time of Unblinding|Other|5|||
127911136|NCT00424047|460297634|FG001|On Study at Time of Unblinding|Other|4|||
127911137|NCT00424047|460297633|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
127911138|NCT00424047|460297634|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
127911139|NCT00424047|460297633|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
127911140|NCT00424047|460297634|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
127911141|NCT00424047|460297633|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
127911142|NCT00424047|460297634|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
127911143|NCT00424047|460297633|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
127911144|NCT00424047|460297634|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
127911145|NCT00424047|460297633|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
127911146|NCT00424047|460297634|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
127911147|NCT00312897|460297635|FG000|Overall Study|Adverse Event|1|||
127911148|NCT00312897|460297636|FG001|Overall Study|Adverse Event|0|||
127911149|NCT00312897|460297635|FG000|Overall Study|Lost to Follow-up|2|||
127911150|NCT00312897|460297636|FG001|Overall Study|Lost to Follow-up|0|||
127911151|NCT00312897|460297635|FG000|Overall Study|Physician Decision|1|||
127911152|NCT00312897|460297636|FG001|Overall Study|Physician Decision|0|||
127911153|NCT00312897|460297635|FG000|Overall Study|Withdrawal by Subject|1|||
127911154|NCT00312897|460297636|FG001|Overall Study|Withdrawal by Subject|3|||
127911155|NCT00312897|460297635|FG000|Overall Study|Pregnancy|1|||
127911156|NCT00312897|460297636|FG001|Overall Study|Pregnancy|0|||
127911157|NCT00312897|460297635|FG000|Overall Study|discontinued prior to getting treatment|0|||
127911158|NCT00312897|460297636|FG001|Overall Study|discontinued prior to getting treatment|3|||
127911159|NCT03100344|460297637|FG000|Overall Study|Adverse Event|0|||
127911160|NCT03100344|460297638|FG001|Overall Study|Adverse Event|3|||
127911161|NCT03100344|460297639|FG002|Overall Study|Adverse Event|2|||
127911162|NCT03100344|460297640|FG003|Overall Study|Adverse Event|3|||
127911163|NCT03100344|460297637|FG000|Overall Study|Lack of Efficacy|2|||
127911164|NCT03100344|460297638|FG001|Overall Study|Lack of Efficacy|0|||
127911165|NCT03100344|460297639|FG002|Overall Study|Lack of Efficacy|0|||
127911166|NCT03100344|460297640|FG003|Overall Study|Lack of Efficacy|0|||
127911167|NCT03100344|460297637|FG000|Overall Study|Protocol Violation|1|||
127911168|NCT03100344|460297638|FG001|Overall Study|Protocol Violation|0|||
127911169|NCT03100344|460297639|FG002|Overall Study|Protocol Violation|0|||
127911170|NCT03100344|460297640|FG003|Overall Study|Protocol Violation|0|||
127911171|NCT03100344|460297637|FG000|Overall Study|Withdrawal by Subject|10|||
127911172|NCT03100344|460297638|FG001|Overall Study|Withdrawal by Subject|7|||
127911173|NCT03100344|460297639|FG002|Overall Study|Withdrawal by Subject|4|||
127911174|NCT03100344|460297640|FG003|Overall Study|Withdrawal by Subject|8|||
127911175|NCT03100344|460297637|FG000|Overall Study|Lost to Follow-up|1|||
127911176|NCT03100344|460297638|FG001|Overall Study|Lost to Follow-up|1|||
127911177|NCT03100344|460297639|FG002|Overall Study|Lost to Follow-up|1|||
127911178|NCT03100344|460297640|FG003|Overall Study|Lost to Follow-up|1|||
127911179|NCT01010503|460297641|FG000|Overall Study|Adverse Event|1|||
127911180|NCT01010503|460297641|FG000|Overall Study|Death|1|||
127911181|NCT03043872|460297647|FG000|Overall Study|Withdrawal by Subject|6|||
127911182|NCT03043872|460297648|FG001|Overall Study|Withdrawal by Subject|6|||
127911183|NCT03043872|460297649|FG002|Overall Study|Withdrawal by Subject|15|||
127911184|NCT03043872|460297647|FG000|Overall Study|Lost to Follow-up|2|||
127911185|NCT03043872|460297648|FG001|Overall Study|Lost to Follow-up|1|||
127911186|NCT03043872|460297649|FG002|Overall Study|Lost to Follow-up|1|||
127911187|NCT03043872|460297647|FG000|Overall Study|Death|270|||
127911188|NCT03043872|460297648|FG001|Overall Study|Death|269|||
127911189|NCT03043872|460297649|FG002|Overall Study|Death|296|||
127911190|NCT01154231|460297650|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
127911191|NCT01154231|460297650|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
127911192|NCT01963728|460297651|FG000|Overall Study|Study terminated early|0|||
127911193|NCT01963728|460297652|FG001|Overall Study|Study terminated early|1|||
127911194|NCT04115293|460298717|FG000|Overall Study|Adverse Event|0|||
127911195|NCT04115293|460298718|FG001|Overall Study|Adverse Event|2|||
127911196|NCT04115293|460298717|FG000|Overall Study|Withdrawal by Subject|2|||
127911197|NCT04115293|460298718|FG001|Overall Study|Withdrawal by Subject|1|||
127911198|NCT04115293|460298717|FG000|Overall Study|Physician Decision|1|||
127911199|NCT04115293|460298718|FG001|Overall Study|Physician Decision|0|||
127911200|NCT04115293|460298717|FG000|Overall Study|Death|1|||
127911201|NCT04115293|460298718|FG001|Overall Study|Death|1|||
127911202|NCT00001703|460298719|FG000|Overall Study|progressed disease|2|||
127911203|NCT00001703|460298719|FG000|Overall Study|No evidence of disease|1|||
127911204|NCT00001703|460298719|FG000|Overall Study|recurrent disease|2|||
127911205|NCT02267187|460298724|FG000|Overall Study|Physician Decision|2|||
127911206|NCT02267187|460298724|FG000|Overall Study|Screen fail|3|||
127911207|NCT02222818|460298730|FG000|Period 1|Eligibility criteria not met|0|||
127911208|NCT02222818|460298731|FG001|Period 1|Eligibility criteria not met|3|||
127858590|NCT01996865|460098019|FG002|Maintenance Period|Withdrawal by Subject|4|||
127858591|NCT01996865|460098017|FG000|Maintenance Period|Adverse Event|0|||
127858592|NCT01996865|460098018|FG001|Maintenance Period|Adverse Event|7|||
127858593|NCT01996865|460098019|FG002|Maintenance Period|Adverse Event|7|||
127858594|NCT01996865|460098017|FG000|Maintenance Period|Death|0|||
127858595|NCT01996865|460098018|FG001|Maintenance Period|Death|15|||
127858596|NCT01996865|460098019|FG002|Maintenance Period|Death|3|||
127858597|NCT01996865|460098017|FG000|Maintenance Period|Lost to Follow-up|0|||
127858598|NCT01996865|460098018|FG001|Maintenance Period|Lost to Follow-up|2|||
127858599|NCT01996865|460098019|FG002|Maintenance Period|Lost to Follow-up|0|||
127858600|NCT03575351|460098022|FG000|Overall Study|Adverse Event|1|||
127858601|NCT03575351|460098023|FG001|Overall Study|Adverse Event|0|||
127858602|NCT03575351|460098022|FG000|Overall Study|Death|2|||
127858603|NCT03575351|460098023|FG001|Overall Study|Death|2|||
127858604|NCT03575351|460098022|FG000|Overall Study|Death due to the COVID-19 pandemic|0|||
127858605|NCT03575351|460098023|FG001|Overall Study|Death due to the COVID-19 pandemic|1|||
127858606|NCT03575351|460098022|FG000|Overall Study|Lack of Efficacy|28|||
127858607|NCT03575351|460098023|FG001|Overall Study|Lack of Efficacy|0|||
127858608|NCT03575351|460098022|FG000|Overall Study|Withdrawal by Subject|1|||
127858609|NCT03575351|460098023|FG001|Overall Study|Withdrawal by Subject|1|||
127858610|NCT03575351|460098022|FG000|Overall Study|Physician Decision|3|||
127858611|NCT03575351|460098023|FG001|Overall Study|Physician Decision|0|||
127858612|NCT03575351|460098022|FG000|Overall Study|Disease relapse|15|||
127858613|NCT03575351|460098023|FG001|Overall Study|Disease relapse|6|||
127858614|NCT03575351|460098022|FG000|Overall Study|Study drug manufacturing failure|0|||
127858615|NCT03575351|460098023|FG001|Overall Study|Study drug manufacturing failure|1|||
127858616|NCT03575351|460098022|FG000|Overall Study|other reasons|5|||
127858617|NCT03575351|460098023|FG001|Overall Study|other reasons|0|||
127858618|NCT04288089|460098029|FG000|Overall Study|Ongoing Treatment|2|||
127858619|NCT04288089|460098030|FG001|Overall Study|Ongoing Treatment|1|||
127858620|NCT04288089|460098031|FG002|Overall Study|Ongoing Treatment|1|||
127858621|NCT04288089|460098032|FG003|Overall Study|Ongoing Treatment|4|||
127858622|NCT03715205|460098033|FG000|Overall Study|Death|13|||
127858623|NCT03715205|460098033|FG000|Overall Study|Lost to Follow-up|2|||
127858624|NCT03715205|460098033|FG000|Overall Study|Physician Decision|93|||
127858625|NCT03715205|460098033|FG000|Overall Study|Withdrawal by Subject|26|||
127858626|NCT01426009|460098035|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
127858627|NCT01426009|460098035|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
127858628|NCT01426009|460098035|FG000|Washout 1|Withdrawal by Subject|1|||
127858629|NCT01426009|460098035|FG000|Washout 1|Personal Reasons|1|||
127858630|NCT01426009|460098035|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
127858631|NCT01426009|460098035|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
127858632|NCT01426009|460098035|FG000|Washout 2|electrive surgery|1|||
127858633|NCT01426009|460098035|FG000|Washout 3|personal reasons|1|||
127858634|NCT01426009|460098035|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
127858635|NCT01426009|460098035|FG000|Washout 4|Lost to Follow-up|1|||
127858636|NCT00557323|460098038|FG000|Overall Study|Death|3|||
127858637|NCT00557323|460098038|FG000|Overall Study|Withdrawal by Subject|2|||
127858638|NCT00557323|460098038|FG000|Overall Study|Administrative change|2|||
127858639|NCT01196091|460098043|FG000|Overall Study|Adverse Event|22|||
127858640|NCT01196091|460098044|FG001|Overall Study|Adverse Event|27|||
127858641|NCT01196091|460098045|FG002|Overall Study|Adverse Event|26|||
127858642|NCT01196091|460098043|FG000|Overall Study|Death|3|||
127858643|NCT01196091|460098044|FG001|Overall Study|Death|2|||
127858644|NCT01196091|460098045|FG002|Overall Study|Death|2|||
127858645|NCT01196091|460098043|FG000|Overall Study|Entry Criteria Not Met|11|||
127858646|NCT01196091|460098044|FG001|Overall Study|Entry Criteria Not Met|11|||
127858647|NCT01196091|460098045|FG002|Overall Study|Entry Criteria Not Met|10|||
127858648|NCT01196091|460098043|FG000|Overall Study|Lack of Efficacy|15|||
127858649|NCT01196091|460098044|FG001|Overall Study|Lack of Efficacy|12|||
127858650|NCT01196091|460098045|FG002|Overall Study|Lack of Efficacy|17|||
127858651|NCT01196091|460098043|FG000|Overall Study|Lost to Follow-up|5|||
127858652|NCT01196091|460098044|FG001|Overall Study|Lost to Follow-up|5|||
127858653|NCT01196091|460098045|FG002|Overall Study|Lost to Follow-up|6|||
127858654|NCT01196091|460098043|FG000|Overall Study|Parent/Caregiver Decision|0|||
127858655|NCT01196091|460098044|FG001|Overall Study|Parent/Caregiver Decision|0|||
127858656|NCT01196091|460098045|FG002|Overall Study|Parent/Caregiver Decision|1|||
127858657|NCT01196091|460098043|FG000|Overall Study|Withdrawal by Subject|16|||
127858658|NCT01196091|460098044|FG001|Overall Study|Withdrawal by Subject|19|||
127858659|NCT01196091|460098045|FG002|Overall Study|Withdrawal by Subject|22|||
127858660|NCT01196091|460098043|FG000|Overall Study|Physician Decision|3|||
127858661|NCT01196091|460098044|FG001|Overall Study|Physician Decision|3|||
127858662|NCT01196091|460098045|FG002|Overall Study|Physician Decision|4|||
127858663|NCT01196091|460098043|FG000|Overall Study|Protocol Violation|1|||
127911209|NCT01660243|460298732|FG000|Overall Study|Adverse Event|1|||
127858664|NCT01196091|460098044|FG001|Overall Study|Protocol Violation|3|||
127858665|NCT01196091|460098045|FG002|Overall Study|Protocol Violation|3|||
127858666|NCT01196091|460098043|FG000|Overall Study|Sponsor Decision|6|||
127858667|NCT01196091|460098044|FG001|Overall Study|Sponsor Decision|5|||
127911210|NCT01660243|460298733|FG001|Overall Study|Adverse Event|0|||
127911211|NCT01660243|460298734|FG002|Overall Study|Adverse Event|1|||
127911212|NCT01660243|460298735|FG003|Overall Study|Adverse Event|0|||
127911213|NCT01660243|460298732|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
127911214|NCT01660243|460298733|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
127911215|NCT01660243|460298734|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
127911216|NCT01660243|460298735|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
127911217|NCT01660243|460298732|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
127911218|NCT01660243|460298733|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
127911219|NCT01660243|460298734|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
127911220|NCT01660243|460298735|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
127911221|NCT01660243|460298732|FG000|Overall Study|Randomization error|0|||
127911222|NCT01660243|460298733|FG001|Overall Study|Randomization error|0|||
127911223|NCT01660243|460298734|FG002|Overall Study|Randomization error|0|||
127911224|NCT01660243|460298735|FG003|Overall Study|Randomization error|1|||
127911225|NCT03025087|460298736|FG000|Overall Study|Physician Decision|3|||
127911226|NCT03025087|460298737|FG001|Overall Study|Physician Decision|3|||
127911227|NCT03025087|460298738|FG002|Overall Study|Physician Decision|0|||
127911228|NCT03025087|460298739|FG003|Overall Study|Physician Decision|0|||
127911229|NCT03025087|460298740|FG004|Overall Study|Physician Decision|0|||
127911230|NCT03025087|460298736|FG000|Overall Study|Withdrawal by Subject|1|||
127911231|NCT03025087|460298737|FG001|Overall Study|Withdrawal by Subject|1|||
127911232|NCT03025087|460298738|FG002|Overall Study|Withdrawal by Subject|0|||
127911233|NCT03025087|460298739|FG003|Overall Study|Withdrawal by Subject|0|||
127911234|NCT03025087|460298740|FG004|Overall Study|Withdrawal by Subject|0|||
127858668|NCT01196091|460098045|FG002|Overall Study|Sponsor Decision|4|||
127858669|NCT01196091|460098043|FG000|Overall Study|Excluded Site|5|||
127858670|NCT01196091|460098044|FG001|Overall Study|Excluded Site|11|||
127858671|NCT01196091|460098045|FG002|Overall Study|Excluded Site|8|||
127858672|NCT01196091|460098043|FG000|Overall Study|Randomized, No Study Drug Received|1|||
127858673|NCT01196091|460098044|FG001|Overall Study|Randomized, No Study Drug Received|0|||
127858674|NCT01196091|460098045|FG002|Overall Study|Randomized, No Study Drug Received|1|||
127858675|NCT03733249|460098046|FG000|Overall Study|Death|7|||
127858676|NCT03733249|460098046|FG000|Overall Study|Disease relapse|16|||
127858677|NCT03733249|460098046|FG000|Overall Study|Lost to Follow-up|4|||
127858678|NCT03733249|460098046|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
127858679|NCT03733249|460098046|FG000|Overall Study|Withdrawal by Subject|1|||
127858680|NCT04476108|460098047|FG000|Overall Study|Adverse Event|4|||
127858681|NCT04476108|460098048|FG001|Overall Study|Adverse Event|1|||
127858682|NCT04476108|460098047|FG000|Overall Study|Lost to Follow-up|1|||
127858683|NCT04476108|460098048|FG001|Overall Study|Lost to Follow-up|0|||
127858684|NCT04476108|460098047|FG000|Overall Study|Inadvertent Enrollment|1|||
127858685|NCT04476108|460098048|FG001|Overall Study|Inadvertent Enrollment|0|||
127858686|NCT04476108|460098047|FG000|Overall Study|Protocol Violation|1|||
127858687|NCT04476108|460098048|FG001|Overall Study|Protocol Violation|1|||
127858688|NCT04476108|460098047|FG000|Overall Study|Withdrawal by Subject|1|||
127858689|NCT04476108|460098048|FG001|Overall Study|Withdrawal by Subject|1|||
127858690|NCT02253992|460098049|FG000|Overall Study|Study drug toxicity|1|||
127858691|NCT02253992|460098050|FG001|Overall Study|Study drug toxicity|0|||
127858692|NCT02253992|460098051|FG002|Overall Study|Study drug toxicity|10|||
127858693|NCT02253992|460098049|FG000|Overall Study|Disease progression|4|||
127858694|NCT02253992|460098050|FG001|Overall Study|Disease progression|3|||
127858695|NCT02253992|460098051|FG002|Overall Study|Disease progression|98|||
127858696|NCT02253992|460098049|FG000|Overall Study|Withdrawal by Subject|0|||
127858697|NCT02253992|460098050|FG001|Overall Study|Withdrawal by Subject|0|||
127858698|NCT02253992|460098051|FG002|Overall Study|Withdrawal by Subject|3|||
127858699|NCT02253992|460098049|FG000|Overall Study|Adverse Event|0|||
127858700|NCT02253992|460098050|FG001|Overall Study|Adverse Event|0|||
127858701|NCT02253992|460098051|FG002|Overall Study|Adverse Event|8|||
127858702|NCT02253992|460098049|FG000|Overall Study|Death|0|||
127858703|NCT02253992|460098050|FG001|Overall Study|Death|0|||
127858704|NCT02253992|460098051|FG002|Overall Study|Death|1|||
127858705|NCT02253992|460098049|FG000|Overall Study|Subject discontinued study drug|1|||
127858706|NCT02253992|460098050|FG001|Overall Study|Subject discontinued study drug|0|||
127911235|NCT03025087|460298736|FG000|Overall Study|Unable to complete MRI|2|||
127911236|NCT03025087|460298737|FG001|Overall Study|Unable to complete MRI|2|||
127911237|NCT03025087|460298738|FG002|Overall Study|Unable to complete MRI|0|||
127911238|NCT03025087|460298739|FG003|Overall Study|Unable to complete MRI|0|||
127911239|NCT03025087|460298740|FG004|Overall Study|Unable to complete MRI|0|||
127911240|NCT00712959|460298745|FG000|Overall Study|Protocol Violation|3|||
127911241|NCT00712959|460298746|FG001|Overall Study|Protocol Violation|1|||
127911242|NCT00712959|460298745|FG000|Overall Study|Lost to Follow-up|13|||
127911243|NCT00712959|460298746|FG001|Overall Study|Lost to Follow-up|2|||
127911244|NCT00712959|460298745|FG000|Overall Study|Withdrawal by Subject|3|||
127911245|NCT00712959|460298746|FG001|Overall Study|Withdrawal by Subject|0|||
127911246|NCT01376037|460298754|FG000|Overall Study|Lost to Follow-up|0|||
127911247|NCT01376037|460298755|FG001|Overall Study|Lost to Follow-up|2|||
127911248|NCT02328040|460298757|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
127911249|NCT02328040|460298758|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
127911250|NCT03121586|460298763|FG000|Overall Study|Study terminated by sponsor|0|||
127911251|NCT03121586|460298764|FG001|Overall Study|Study terminated by sponsor|0|||
127911252|NCT03121586|460298765|FG002|Overall Study|Study terminated by sponsor|99|||
127911253|NCT03121586|460298763|FG000|Overall Study|Withdrawal by Subject|37|||
127911254|NCT03121586|460298764|FG001|Overall Study|Withdrawal by Subject|14|||
127911255|NCT03121586|460298765|FG002|Overall Study|Withdrawal by Subject|9|||
127911256|NCT03121586|460298763|FG000|Overall Study|Not further specified|6|||
127911257|NCT03121586|460298764|FG001|Overall Study|Not further specified|11|||
127911258|NCT03121586|460298765|FG002|Overall Study|Not further specified|10|||
127911259|NCT03121586|460298763|FG000|Overall Study|Adverse Event|16|||
127911260|NCT03121586|460298764|FG001|Overall Study|Adverse Event|5|||
127911261|NCT03121586|460298765|FG002|Overall Study|Adverse Event|6|||
127911262|NCT03121586|460298763|FG000|Overall Study|Protocol Violation|0|||
127911263|NCT03121586|460298764|FG001|Overall Study|Protocol Violation|5|||
127911264|NCT03121586|460298765|FG002|Overall Study|Protocol Violation|0|||
127911265|NCT03121586|460298763|FG000|Overall Study|Lack of Efficacy|3|||
127858707|NCT02253992|460098051|FG002|Overall Study|Subject discontinued study drug|1|||
127858708|NCT02253992|460098049|FG000|Overall Study|Completed treatment as per protocol|0|||
127858709|NCT02253992|460098050|FG001|Overall Study|Completed treatment as per protocol|1|||
127858710|NCT02253992|460098051|FG002|Overall Study|Completed treatment as per protocol|22|||
127858711|NCT02253992|460098049|FG000|Overall Study|Other|0|||
127858712|NCT02253992|460098050|FG001|Overall Study|Other|0|||
127858713|NCT02253992|460098051|FG002|Overall Study|Other|1|||
127858714|NCT00772889|460098052|FG000|Overall Study|Adverse Event|7|||
127858715|NCT00772889|460098053|FG001|Overall Study|Adverse Event|4|||
127858716|NCT00772889|460098054|FG002|Overall Study|Adverse Event|0|||
127858717|NCT00772889|460098052|FG000|Overall Study|Withdrawal by Subject|9|||
127858718|NCT00772889|460098053|FG001|Overall Study|Withdrawal by Subject|8|||
127858719|NCT00772889|460098054|FG002|Overall Study|Withdrawal by Subject|9|||
127858720|NCT00772889|460098052|FG000|Overall Study|Lost to Follow-up|6|||
127858721|NCT00772889|460098053|FG001|Overall Study|Lost to Follow-up|6|||
127858722|NCT00772889|460098054|FG002|Overall Study|Lost to Follow-up|7|||
127858723|NCT03323086|460098055|FG000|Overall Study|Lost to Follow-up|3|||
127858724|NCT03323086|460098056|FG001|Overall Study|Lost to Follow-up|2|||
127858725|NCT04247828|460098065|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
127858726|NCT02159365|460098066|FG000|Overall Study|Disease Progression|23|||
127858727|NCT02159365|460098066|FG000|Overall Study|Other reasons|11|||
127858728|NCT02159365|460098066|FG000|Overall Study|Administrative reason by Sponsor|9|||
127858729|NCT02159365|460098066|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
127911266|NCT03121586|460298764|FG001|Overall Study|Lack of Efficacy|3|||
127911267|NCT03121586|460298765|FG002|Overall Study|Lack of Efficacy|1|||
127911268|NCT03121586|460298763|FG000|Overall Study|Physician Decision|2|||
127911269|NCT03121586|460298764|FG001|Overall Study|Physician Decision|2|||
127911270|NCT03121586|460298765|FG002|Overall Study|Physician Decision|0|||
127911271|NCT03121586|460298763|FG000|Overall Study|Noncompliance with study drug|5|||
127911272|NCT03121586|460298764|FG001|Overall Study|Noncompliance with study drug|3|||
127911273|NCT03121586|460298765|FG002|Overall Study|Noncompliance with study drug|5|||
127911274|NCT03121586|460298763|FG000|Overall Study|Lost to Follow-up|4|||
127911275|NCT03121586|460298764|FG001|Overall Study|Lost to Follow-up|2|||
127911276|NCT03121586|460298765|FG002|Overall Study|Lost to Follow-up|0|||
127911277|NCT03121586|460298763|FG000|Overall Study|Death|2|||
127858730|NCT02159365|460098066|FG000|Overall Study|Study drug toxicity|7|||
127858731|NCT02159365|460098066|FG000|Overall Study|Maximum clinical benefit|3|||
127911278|NCT03121586|460298764|FG001|Overall Study|Death|0|||
127911279|NCT03121586|460298765|FG002|Overall Study|Death|0|||
127911280|NCT06381102|460298766|FG000|Washout 5 Days|Withdrawal by Subject|0|||
127911281|NCT06381102|460298767|FG001|Washout 5 Days|Withdrawal by Subject|2|||
127858732|NCT02159365|460098066|FG000|Overall Study|Subject request to discontinue treatment|3|||
127858733|NCT02159365|460098066|FG000|Overall Study|Subject withdrew consent|3|||
127858734|NCT02159365|460098066|FG000|Overall Study|Death|1|||
127911282|NCT01987765|460298769|FG000|Overall Study|Protocol Violation|65|||
127911283|NCT01987765|460298769|FG000|Overall Study|Lost to Follow-up|37|||
127911284|NCT01528696|460298770|FG000|Overall Study|See detailed description|18|||
127911285|NCT01528696|460298771|FG001|Overall Study|See detailed description|19|||
127911286|NCT03600805|460298772|FG000|Overall Study|Adverse Event|2|||
127911287|NCT03600805|460298773|FG001|Overall Study|Adverse Event|1|||
127911288|NCT03600805|460298774|FG002|Overall Study|Adverse Event|1|||
127911289|NCT03600805|460298775|FG003|Overall Study|Adverse Event|7|||
127911290|NCT03600805|460298772|FG000|Overall Study|Lack of Efficacy|2|||
127911291|NCT03600805|460298773|FG001|Overall Study|Lack of Efficacy|1|||
127911292|NCT03600805|460298774|FG002|Overall Study|Lack of Efficacy|0|||
127911293|NCT03600805|460298775|FG003|Overall Study|Lack of Efficacy|0|||
127911294|NCT03600805|460298772|FG000|Overall Study|Withdrawal by Subject|1|||
127911295|NCT03600805|460298773|FG001|Overall Study|Withdrawal by Subject|0|||
127911296|NCT03600805|460298774|FG002|Overall Study|Withdrawal by Subject|0|||
127911297|NCT03600805|460298775|FG003|Overall Study|Withdrawal by Subject|1|||
127911298|NCT03600805|460298772|FG000|Overall Study|Other unspecified|14|||
127911299|NCT03600805|460298773|FG001|Overall Study|Other unspecified|6|||
127911300|NCT03600805|460298774|FG002|Overall Study|Other unspecified|7|||
127911301|NCT03600805|460298775|FG003|Overall Study|Other unspecified|11|||
127911302|NCT06195579|460298776|FG000|Overall Study|Withdrawal by Subject|1|||
127911303|NCT02545283|460298777|FG000|Overall Study|Lost to Follow-up|2|||
127911304|NCT02545283|460298778|FG001|Overall Study|Lost to Follow-up|4|||
127911305|NCT02545283|460298777|FG000|Overall Study|Withdrawal by Subject|5|||
127911306|NCT02545283|460298778|FG001|Overall Study|Withdrawal by Subject|9|||
127911307|NCT02545283|460298777|FG000|Overall Study|Death|109|||
127911308|NCT02545283|460298778|FG001|Overall Study|Death|211|||
127911309|NCT02545283|460298777|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
127911310|NCT02545283|460298778|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
127911311|NCT02545283|460298777|FG000|Overall Study|Study Terminated By Sponsor|33|||
127911312|NCT02545283|460298778|FG001|Overall Study|Study Terminated By Sponsor|71|||
127911313|NCT03502811|460298783|FG000|Overall Study|Death|157|||
127911314|NCT03502811|460298783|FG000|Overall Study|Withdrawal by Subject|105|||
127911315|NCT03502811|460298783|FG000|Overall Study|Lost to Follow-up|26|||
127911316|NCT03502811|460298783|FG000|Overall Study|No Visits (Missed)|31|||
127911317|NCT01735994|460298784|FG000|Overall Study|Withdrawal by Subject|6|||
127911318|NCT01735994|460298785|FG001|Overall Study|Withdrawal by Subject|4|||
127911319|NCT01735994|460298784|FG000|Overall Study|Injury|2|||
127911320|NCT01735994|460298785|FG001|Overall Study|Injury|0|||
127911321|NCT01735994|460298784|FG000|Overall Study|Kicked off team|5|||
127911322|NCT01735994|460298785|FG001|Overall Study|Kicked off team|0|||
127911323|NCT01735994|460298784|FG000|Overall Study|Lost to Follow-up|50|||
127911324|NCT01735994|460298785|FG001|Overall Study|Lost to Follow-up|62|||
127911325|NCT00604162|460298788|FG000|Overall Study|Physician Decision|3|||
127911326|NCT00604162|460298788|FG000|Overall Study|Withdrawal by Subject|1|||
127911327|NCT02241551|460298789|FG000|Overall Study|Adverse Event|1|||
127911328|NCT02241551|460298790|FG001|Overall Study|Adverse Event|0|||
127911329|NCT01205035|460298796|FG000|Overall Study|Withdrawal by Subject|1|||
127911330|NCT01205035|460298797|FG001|Overall Study|Withdrawal by Subject|0|||
127911331|NCT01205035|460298796|FG000|Overall Study|Physician Decision|1|||
127911332|NCT01205035|460298797|FG001|Overall Study|Physician Decision|0|||
127911333|NCT00392665|460298799|FG000|Overall Study|Death|16|||
127911334|NCT00392665|460298800|FG001|Overall Study|Death|14|||
127911335|NCT00392665|460298799|FG000|Overall Study|Lost to Follow-up|1|||
127911336|NCT00392665|460298800|FG001|Overall Study|Lost to Follow-up|1|||
127911337|NCT00927069|460298801|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
127911338|NCT00927069|460298802|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
127911339|NCT00927069|460298803|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
127911340|NCT00927069|460298804|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
127911341|NCT00927069|460298801|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
127911342|NCT00927069|460298802|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
127911343|NCT00927069|460298803|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
127911344|NCT00927069|460298804|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
127911345|NCT00927069|460298801|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
127911346|NCT00927069|460298802|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
127911347|NCT00927069|460298803|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
127911348|NCT00927069|460298804|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
127911349|NCT00927069|460298801|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
127911350|NCT00927069|460298802|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
127911351|NCT00927069|460298803|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
127911352|NCT00927069|460298804|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
127911353|NCT00927069|460298801|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
127911354|NCT00927069|460298802|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
127911355|NCT00927069|460298803|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
127911356|NCT00927069|460298804|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
127911357|NCT02558491|460298805|FG000|First Invention|Withdrawal by Subject|3|||
127911358|NCT02558491|460298806|FG001|First Invention|Withdrawal by Subject|1|||
127911359|NCT02558491|460298805|FG000|First Invention|Data collection issues|1|||
127911360|NCT02558491|460298806|FG001|First Invention|Data collection issues|0|||
127911361|NCT02558491|460298805|FG000|First Invention|Stopping criteria|0|||
127911362|NCT02558491|460298806|FG001|First Invention|Stopping criteria|1|||
127911363|NCT02558491|460298805|FG000|First Invention|Changed parameters during trial|1|||
127911364|NCT02558491|460298806|FG001|First Invention|Changed parameters during trial|0|||
127911365|NCT02558491|460298805|FG000|Second Intervention|Withdrawal by Subject|1|||
127911366|NCT02558491|460298806|FG001|Second Intervention|Withdrawal by Subject|0|||
127911367|NCT02558491|460298805|FG000|Second Intervention|Stopping Criteria|1|||
127911368|NCT02558491|460298806|FG001|Second Intervention|Stopping Criteria|0|||
127911369|NCT00834431|460298809|FG000|First Intervention|Adverse Event|0|||
127911370|NCT00834431|460298810|FG001|First Intervention|Adverse Event|1|||
127911371|NCT00834431|460298809|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
127911372|NCT00834431|460298810|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
127911373|NCT03249454|460298811|FG000|Overall Study|Withdrawal by Subject|0|||
127911374|NCT03249454|460298812|FG001|Overall Study|Withdrawal by Subject|0|||
127911375|NCT03249454|460298813|FG002|Overall Study|Withdrawal by Subject|0|||
127911376|NCT03249454|460298814|FG003|Overall Study|Withdrawal by Subject|0|||
127911377|NCT03249454|460298815|FG004|Overall Study|Withdrawal by Subject|0|||
127911378|NCT03249454|460298816|FG005|Overall Study|Withdrawal by Subject|0|||
127911379|NCT03249454|460298817|FG006|Overall Study|Withdrawal by Subject|0|||
127911380|NCT03249454|460298818|FG007|Overall Study|Withdrawal by Subject|0|||
127911381|NCT03249454|460298819|FG008|Overall Study|Withdrawal by Subject|0|||
127911382|NCT03249454|460298820|FG009|Overall Study|Withdrawal by Subject|1|||
127911383|NCT03249454|460298821|FG010|Overall Study|Withdrawal by Subject|1|||
127911384|NCT01913405|460298822|FG000|Overall Study|Withdrawal by Subject|1|||
127911385|NCT01913405|460298822|FG000|Overall Study|Adverse Event|1|||
127911386|NCT01020474|460298825|FG000|Overall Study|Adverse Event|4|||
127911387|NCT01020474|460298826|FG001|Overall Study|Adverse Event|4|||
127911388|NCT01020474|460298825|FG000|Overall Study|Protocol Violation|0|||
127911389|NCT01020474|460298826|FG001|Overall Study|Protocol Violation|2|||
127911390|NCT01020474|460298825|FG000|Overall Study|Withdrawal by Subject|5|||
127911391|NCT01020474|460298826|FG001|Overall Study|Withdrawal by Subject|7|||
127911392|NCT01020474|460298825|FG000|Overall Study|Other Reasons|1|||
127911393|NCT01020474|460298826|FG001|Overall Study|Other Reasons|1|||
127911394|NCT01020474|460298825|FG000|Overall Study|Insufficient Clinical Response|0|||
127911395|NCT01020474|460298826|FG001|Overall Study|Insufficient Clinical Response|3|||
127911396|NCT03199963|460298829|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
127911397|NCT03199963|460298830|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
127911398|NCT03199963|460298829|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
127911399|NCT03199963|460298830|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
127911400|NCT03199963|460298829|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
127911401|NCT03199963|460298830|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
127911402|NCT03199963|460298829|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
127911403|NCT03199963|460298830|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
127911404|NCT03199963|460298829|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
127911405|NCT03199963|460298830|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
127911406|NCT03199963|460298829|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
127911407|NCT03199963|460298830|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
127911408|NCT00466167|460298831|FG000|Overall Study|Adverse Event|8|||
127911409|NCT00466167|460298832|FG001|Overall Study|Adverse Event|8|||
127911410|NCT00466167|460298833|FG002|Overall Study|Adverse Event|7|||
127911411|NCT00466167|460298831|FG000|Overall Study|Lack of Efficacy|2|||
127911412|NCT00466167|460298832|FG001|Overall Study|Lack of Efficacy|0|||
127911413|NCT00466167|460298833|FG002|Overall Study|Lack of Efficacy|3|||
127911414|NCT00466167|460298831|FG000|Overall Study|Protocol Violation|1|||
127911415|NCT00466167|460298832|FG001|Overall Study|Protocol Violation|1|||
127911416|NCT00466167|460298833|FG002|Overall Study|Protocol Violation|2|||
127911417|NCT00466167|460298831|FG000|Overall Study|Lost to Follow-up|3|||
127911418|NCT00466167|460298832|FG001|Overall Study|Lost to Follow-up|2|||
127911419|NCT00466167|460298833|FG002|Overall Study|Lost to Follow-up|2|||
127911420|NCT00466167|460298831|FG000|Overall Study|Withdrawal by Subject|4|||
127911421|NCT00466167|460298832|FG001|Overall Study|Withdrawal by Subject|1|||
127911422|NCT00466167|460298833|FG002|Overall Study|Withdrawal by Subject|6|||
127911423|NCT00466167|460298831|FG000|Overall Study|patient did not meet inclusion criteria|1|||
127911424|NCT00466167|460298832|FG001|Overall Study|patient did not meet inclusion criteria|0|||
127911425|NCT00466167|460298833|FG002|Overall Study|patient did not meet inclusion criteria|1|||
127911426|NCT00466167|460298831|FG000|Overall Study|Not treated|1|||
127911427|NCT00466167|460298832|FG001|Overall Study|Not treated|0|||
127911428|NCT00466167|460298833|FG002|Overall Study|Not treated|0|||
127911429|NCT00429416|460298842|FG000|Overall Study|Death|1|||
127911430|NCT04633564|460298846|FG000|Period 1|Adverse Event|28|||
127911431|NCT04633564|460298847|FG001|Period 1|Adverse Event|19|||
127858735|NCT02159365|460098066|FG000|Overall Study|Lost to Follow-up|1|||
127858736|NCT00796549|460098067|FG000|Overall Study|Adverse Event|11|||
127858737|NCT00796549|460098067|FG000|Overall Study|not entered|149|||
127858738|NCT00796549|460098067|FG000|Overall Study|Other|2|||
127858739|NCT00796549|460098067|FG000|Overall Study|Progressive disease|56|||
127858740|NCT01878175|460098069|FG000|Overall Study|Developed contraindicated health problem|2|||
127858741|NCT01197794|460098072|FG000|Overall Study|Adverse Event|3|||
127858742|NCT01197794|460098073|FG001|Overall Study|Adverse Event|2|||
127858743|NCT01197794|460098074|FG002|Overall Study|Adverse Event|4|||
127858744|NCT01197794|460098075|FG003|Overall Study|Adverse Event|4|||
127858745|NCT01197794|460098076|FG004|Overall Study|Adverse Event|4|||
127858746|NCT01197794|460098077|FG005|Overall Study|Adverse Event|2|||
127858747|NCT01197794|460098078|FG006|Overall Study|Adverse Event|3|||
127858748|NCT01197794|460098072|FG000|Overall Study|Protocol Violation|0|||
127858749|NCT01197794|460098073|FG001|Overall Study|Protocol Violation|0|||
127858750|NCT01197794|460098074|FG002|Overall Study|Protocol Violation|0|||
127858751|NCT01197794|460098075|FG003|Overall Study|Protocol Violation|0|||
127858752|NCT01197794|460098076|FG004|Overall Study|Protocol Violation|2|||
127858753|NCT01197794|460098077|FG005|Overall Study|Protocol Violation|0|||
127858754|NCT01197794|460098078|FG006|Overall Study|Protocol Violation|1|||
127858755|NCT01197794|460098072|FG000|Overall Study|Development of study withdrawal criteria|3|||
127858756|NCT01197794|460098073|FG001|Overall Study|Development of study withdrawal criteria|0|||
127858757|NCT01197794|460098074|FG002|Overall Study|Development of study withdrawal criteria|0|||
127858758|NCT01197794|460098075|FG003|Overall Study|Development of study withdrawal criteria|1|||
127858759|NCT01197794|460098076|FG004|Overall Study|Development of study withdrawal criteria|0|||
127858760|NCT01197794|460098077|FG005|Overall Study|Development of study withdrawal criteria|0|||
127858761|NCT01197794|460098078|FG006|Overall Study|Development of study withdrawal criteria|1|||
127858762|NCT01197794|460098072|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
127858763|NCT01197794|460098073|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
127858764|NCT01197794|460098074|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
127858765|NCT01197794|460098075|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
127858766|NCT01197794|460098076|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
127858767|NCT01197794|460098077|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
127858768|NCT01197794|460098078|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
127858769|NCT01197794|460098072|FG000|Overall Study|Withdrawal by Subject|3|||
127858770|NCT01197794|460098073|FG001|Overall Study|Withdrawal by Subject|3|||
127858771|NCT01197794|460098074|FG002|Overall Study|Withdrawal by Subject|4|||
127858772|NCT01197794|460098075|FG003|Overall Study|Withdrawal by Subject|1|||
127858773|NCT01197794|460098076|FG004|Overall Study|Withdrawal by Subject|1|||
127858774|NCT01197794|460098077|FG005|Overall Study|Withdrawal by Subject|5|||
127858775|NCT01197794|460098078|FG006|Overall Study|Withdrawal by Subject|6|||
127858776|NCT01197794|460098072|FG000|Overall Study|Lost to Follow-up|1|||
127858777|NCT01197794|460098073|FG001|Overall Study|Lost to Follow-up|1|||
127858778|NCT01197794|460098074|FG002|Overall Study|Lost to Follow-up|0|||
127858779|NCT01197794|460098075|FG003|Overall Study|Lost to Follow-up|1|||
127858780|NCT01197794|460098076|FG004|Overall Study|Lost to Follow-up|0|||
127858781|NCT01197794|460098077|FG005|Overall Study|Lost to Follow-up|1|||
127858782|NCT01197794|460098078|FG006|Overall Study|Lost to Follow-up|0|||
127858783|NCT01197794|460098072|FG000|Overall Study|Other|1|||
127858784|NCT01197794|460098073|FG001|Overall Study|Other|1|||
127858785|NCT01197794|460098074|FG002|Overall Study|Other|3|||
127858786|NCT01197794|460098075|FG003|Overall Study|Other|0|||
127858787|NCT01197794|460098076|FG004|Overall Study|Other|2|||
127858788|NCT01197794|460098077|FG005|Overall Study|Other|2|||
127858789|NCT01197794|460098078|FG006|Overall Study|Other|4|||
127858790|NCT01055457|460098079|FG000|Overall Study|Lost to Follow-up|0|||
127858791|NCT01055457|460098080|FG001|Overall Study|Lost to Follow-up|1|||
127858792|NCT01055457|460098081|FG002|Overall Study|Lost to Follow-up|0|||
127858793|NCT01055457|460098082|FG003|Overall Study|Lost to Follow-up|0|||
127858794|NCT01055457|460098083|FG004|Overall Study|Lost to Follow-up|0|||
127858795|NCT01055457|460098084|FG005|Overall Study|Lost to Follow-up|1|||
127858796|NCT01055457|460098085|FG006|Overall Study|Lost to Follow-up|0|||
127858797|NCT01055457|460098086|FG007|Overall Study|Lost to Follow-up|0|||
127858798|NCT01055457|460098087|FG008|Overall Study|Lost to Follow-up|0|||
127858799|NCT01055457|460098088|FG009|Overall Study|Lost to Follow-up|0|||
127858800|NCT01055457|460098079|FG000|Overall Study|Protocol Violation|0|||
127858801|NCT01055457|460098080|FG001|Overall Study|Protocol Violation|0|||
127858802|NCT01055457|460098081|FG002|Overall Study|Protocol Violation|1|||
127858803|NCT01055457|460098082|FG003|Overall Study|Protocol Violation|1|||
127858804|NCT01055457|460098083|FG004|Overall Study|Protocol Violation|1|||
127858805|NCT01055457|460098084|FG005|Overall Study|Protocol Violation|2|||
127858806|NCT01055457|460098085|FG006|Overall Study|Protocol Violation|1|||
127858807|NCT01055457|460098086|FG007|Overall Study|Protocol Violation|0|||
127858808|NCT01055457|460098087|FG008|Overall Study|Protocol Violation|0|||
127858809|NCT01055457|460098088|FG009|Overall Study|Protocol Violation|1|||
127858810|NCT01055457|460098079|FG000|Overall Study|Subject Disinterest|0|||
127858811|NCT01055457|460098080|FG001|Overall Study|Subject Disinterest|0|||
127858812|NCT01055457|460098081|FG002|Overall Study|Subject Disinterest|0|||
127858813|NCT01055457|460098082|FG003|Overall Study|Subject Disinterest|0|||
127858814|NCT01055457|460098083|FG004|Overall Study|Subject Disinterest|0|||
127858815|NCT01055457|460098084|FG005|Overall Study|Subject Disinterest|0|||
127858816|NCT01055457|460098085|FG006|Overall Study|Subject Disinterest|0|||
127858817|NCT01055457|460098086|FG007|Overall Study|Subject Disinterest|1|||
127858818|NCT01055457|460098087|FG008|Overall Study|Subject Disinterest|0|||
127858819|NCT01055457|460098088|FG009|Overall Study|Subject Disinterest|0|||
127858820|NCT01055457|460098079|FG000|Overall Study|Subject Ineligible|1|||
127858821|NCT01055457|460098080|FG001|Overall Study|Subject Ineligible|0|||
127858822|NCT01055457|460098081|FG002|Overall Study|Subject Ineligible|1|||
127858823|NCT01055457|460098082|FG003|Overall Study|Subject Ineligible|0|||
127858824|NCT01055457|460098083|FG004|Overall Study|Subject Ineligible|1|||
127858825|NCT01055457|460098084|FG005|Overall Study|Subject Ineligible|0|||
127858826|NCT01055457|460098085|FG006|Overall Study|Subject Ineligible|0|||
127858827|NCT01055457|460098086|FG007|Overall Study|Subject Ineligible|0|||
127858828|NCT01055457|460098087|FG008|Overall Study|Subject Ineligible|0|||
127858829|NCT01055457|460098088|FG009|Overall Study|Subject Ineligible|0|||
127858830|NCT01055457|460098079|FG000|Overall Study|Discomfort|0|||
127858831|NCT01055457|460098080|FG001|Overall Study|Discomfort|0|||
127858832|NCT01055457|460098081|FG002|Overall Study|Discomfort|0|||
127858833|NCT01055457|460098082|FG003|Overall Study|Discomfort|0|||
127858834|NCT01055457|460098083|FG004|Overall Study|Discomfort|1|||
127858835|NCT01055457|460098084|FG005|Overall Study|Discomfort|0|||
127858836|NCT01055457|460098085|FG006|Overall Study|Discomfort|0|||
127858837|NCT01055457|460098086|FG007|Overall Study|Discomfort|0|||
127858838|NCT01055457|460098087|FG008|Overall Study|Discomfort|0|||
127858839|NCT01055457|460098088|FG009|Overall Study|Discomfort|0|||
127858840|NCT01055457|460098079|FG000|Overall Study|Pregnancy|0|||
127858841|NCT01055457|460098080|FG001|Overall Study|Pregnancy|0|||
127858842|NCT01055457|460098081|FG002|Overall Study|Pregnancy|0|||
127858843|NCT01055457|460098082|FG003|Overall Study|Pregnancy|1|||
127858844|NCT01055457|460098083|FG004|Overall Study|Pregnancy|0|||
127858845|NCT01055457|460098084|FG005|Overall Study|Pregnancy|0|||
127858846|NCT01055457|460098085|FG006|Overall Study|Pregnancy|0|||
127858847|NCT01055457|460098086|FG007|Overall Study|Pregnancy|0|||
127858848|NCT01055457|460098087|FG008|Overall Study|Pregnancy|0|||
127858849|NCT01055457|460098088|FG009|Overall Study|Pregnancy|0|||
127858850|NCT01055457|460098079|FG000|Overall Study|Adverse Event|0|||
127858851|NCT01055457|460098080|FG001|Overall Study|Adverse Event|0|||
127858852|NCT01055457|460098081|FG002|Overall Study|Adverse Event|0|||
127858853|NCT01055457|460098082|FG003|Overall Study|Adverse Event|1|||
127858854|NCT01055457|460098083|FG004|Overall Study|Adverse Event|0|||
127858855|NCT01055457|460098084|FG005|Overall Study|Adverse Event|0|||
127858856|NCT01055457|460098085|FG006|Overall Study|Adverse Event|0|||
127858857|NCT01055457|460098086|FG007|Overall Study|Adverse Event|0|||
127858858|NCT01055457|460098087|FG008|Overall Study|Adverse Event|0|||
127858859|NCT01055457|460098088|FG009|Overall Study|Adverse Event|0|||
127858860|NCT03630016|460098097|FG000|Overall Study|Poor Sensor Placement|1|||
127858861|NCT01833806|460098098|FG000|Overall Study|Alternative treatment|2|||
127858862|NCT01833806|460098098|FG000|Overall Study|Death|5|||
127858863|NCT01833806|460098098|FG000|Overall Study|Physician Decision|1|||
127858864|NCT01833806|460098098|FG000|Overall Study|Lost to Follow-up|1|||
127858865|NCT02724111|460098099|FG000|Overall Study|Protocol Violation|2|||
127858866|NCT02724111|460098100|FG001|Overall Study|Protocol Violation|5|||
127858867|NCT01828567|460098101|FG000|Overall Study|Lost to Follow-up|27|||
127858868|NCT01828567|460098102|FG001|Overall Study|Lost to Follow-up|9|||
127858869|NCT01828567|460098101|FG000|Overall Study|Excluded - did not meet criteria|4|||
127858870|NCT01828567|460098102|FG001|Overall Study|Excluded - did not meet criteria|1|||
127858871|NCT04063865|460098103|FG000|Overall Study|Physician Decision|1|||
127858872|NCT04063865|460098104|FG001|Overall Study|Physician Decision|3|||
127858873|NCT04063865|460098103|FG000|Overall Study|Study Closed Prior to Completion|4|||
127858874|NCT04063865|460098104|FG001|Overall Study|Study Closed Prior to Completion|4|||
127858875|NCT04063865|460098103|FG000|Overall Study|Withdrawal by Subject|1|||
127858876|NCT04063865|460098104|FG001|Overall Study|Withdrawal by Subject|1|||
127858877|NCT03898323|460098105|FG000|Overall Study|Physician Decision|1|||
127858878|NCT00374127|460098107|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
127858879|NCT00374127|460098107|FG000|Overall Study|Blood could not be drawn.|2|||
127858880|NCT00374127|460098107|FG000|Overall Study|Protocol Violation|5|||
127858881|NCT00374127|460098107|FG000|Overall Study|Pregnancy|1|||
127858882|NCT01868594|460098111|FG000|Overall Study|Do not meet inclusion criteria|4|||
127858883|NCT01868594|460098112|FG001|Overall Study|Do not meet inclusion criteria|3|||
127858884|NCT01201967|460098115|FG000|Overall Study|Lost to Follow-up|6|||
127858885|NCT01201967|460098116|FG001|Overall Study|Lost to Follow-up|5|||
127858886|NCT02659098|460098119|FG000|Overall Study|Withdrawal by Subject|7|||
127858887|NCT04363944|460098120|FG000|Overall Study|Withdrawal by Subject|2|||
127858888|NCT04363944|460098121|FG001|Overall Study|Withdrawal by Subject|0|||
127858889|NCT01693562|460100230|FG000|Escalation Phase|Withdrawal by Subject|0|||
127858890|NCT01693562|460100231|FG001|Escalation Phase|Withdrawal by Subject|1|||
127858891|NCT01693562|460100232|FG002|Escalation Phase|Withdrawal by Subject|0|||
127858892|NCT01693562|460100233|FG003|Escalation Phase|Withdrawal by Subject|0|||
127858893|NCT01693562|460100234|FG004|Escalation Phase|Withdrawal by Subject|0|||
127858894|NCT01693562|460100235|FG005|Escalation Phase|Withdrawal by Subject|2|||
127858895|NCT01693562|460100236|FG006|Escalation Phase|Withdrawal by Subject|0|||
127858896|NCT01693562|460100237|FG007|Escalation Phase|Withdrawal by Subject|0|||
127858897|NCT01693562|460100238|FG008|Escalation Phase|Withdrawal by Subject|0|||
127858898|NCT01693562|460100239|FG009|Escalation Phase|Withdrawal by Subject|0|||
127858899|NCT01693562|460100240|FG010|Escalation Phase|Withdrawal by Subject|0|||
127858900|NCT01693562|460100241|FG011|Escalation Phase|Withdrawal by Subject|0|||
127858901|NCT01693562|460100242|FG012|Escalation Phase|Withdrawal by Subject|0|||
127858902|NCT01693562|460100243|FG013|Escalation Phase|Withdrawal by Subject|0|||
127858903|NCT01693562|460100244|FG014|Escalation Phase|Withdrawal by Subject|0|||
127858904|NCT01693562|460100245|FG015|Escalation Phase|Withdrawal by Subject|0|||
127858905|NCT01693562|460100246|FG016|Escalation Phase|Withdrawal by Subject|0|||
127858906|NCT01693562|460100247|FG017|Escalation Phase|Withdrawal by Subject|0|||
127858907|NCT01693562|460100248|FG018|Escalation Phase|Withdrawal by Subject|0|||
127858908|NCT01693562|460100249|FG019|Escalation Phase|Withdrawal by Subject|0|||
127858909|NCT01693562|460100250|FG020|Escalation Phase|Withdrawal by Subject|0|||
127858910|NCT01693562|460100251|FG021|Escalation Phase|Withdrawal by Subject|0|||
127858911|NCT01693562|460100252|FG022|Escalation Phase|Withdrawal by Subject|0|||
127858912|NCT01693562|460100230|FG000|Escalation Phase|Death|4|||
127911432|NCT04633564|460298846|FG000|Period 1|Death|8|||
127858913|NCT01693562|460100231|FG001|Escalation Phase|Death|2|||
127858914|NCT01693562|460100232|FG002|Escalation Phase|Death|0|||
127858915|NCT01693562|460100233|FG003|Escalation Phase|Death|3|||
127858916|NCT01693562|460100234|FG004|Escalation Phase|Death|6|||
127858917|NCT01693562|460100235|FG005|Escalation Phase|Death|4|||
127858918|NCT01693562|460100236|FG006|Escalation Phase|Death|0|||
127858919|NCT01693562|460100237|FG007|Escalation Phase|Death|0|||
127858920|NCT01693562|460100238|FG008|Escalation Phase|Death|0|||
127858921|NCT01693562|460100239|FG009|Escalation Phase|Death|0|||
127858922|NCT01693562|460100240|FG010|Escalation Phase|Death|0|||
127858923|NCT01693562|460100241|FG011|Escalation Phase|Death|0|||
127858924|NCT01693562|460100242|FG012|Escalation Phase|Death|0|||
127858925|NCT01693562|460100243|FG013|Escalation Phase|Death|0|||
127858926|NCT01693562|460100244|FG014|Escalation Phase|Death|0|||
127858927|NCT01693562|460100245|FG015|Escalation Phase|Death|0|||
127858928|NCT01693562|460100246|FG016|Escalation Phase|Death|0|||
127858929|NCT01693562|460100247|FG017|Escalation Phase|Death|0|||
127858930|NCT01693562|460100248|FG018|Escalation Phase|Death|0|||
127858931|NCT01693562|460100249|FG019|Escalation Phase|Death|0|||
127858932|NCT01693562|460100250|FG020|Escalation Phase|Death|0|||
127858933|NCT01693562|460100251|FG021|Escalation Phase|Death|0|||
127858934|NCT01693562|460100252|FG022|Escalation Phase|Death|0|||
127858935|NCT01693562|460100230|FG000|Escalation Phase|Lost to Follow-up|0|||
127911433|NCT04633564|460298847|FG001|Period 1|Death|7|||
127858936|NCT01693562|460100231|FG001|Escalation Phase|Lost to Follow-up|1|||
127858937|NCT01693562|460100232|FG002|Escalation Phase|Lost to Follow-up|1|||
127858938|NCT01693562|460100233|FG003|Escalation Phase|Lost to Follow-up|0|||
127858939|NCT01693562|460100234|FG004|Escalation Phase|Lost to Follow-up|0|||
127858940|NCT01693562|460100235|FG005|Escalation Phase|Lost to Follow-up|0|||
127858941|NCT01693562|460100236|FG006|Escalation Phase|Lost to Follow-up|0|||
127858942|NCT01693562|460100237|FG007|Escalation Phase|Lost to Follow-up|0|||
127858943|NCT01693562|460100238|FG008|Escalation Phase|Lost to Follow-up|0|||
127858944|NCT01693562|460100239|FG009|Escalation Phase|Lost to Follow-up|0|||
127858945|NCT01693562|460100240|FG010|Escalation Phase|Lost to Follow-up|0|||
127858946|NCT01693562|460100241|FG011|Escalation Phase|Lost to Follow-up|0|||
127858947|NCT01693562|460100242|FG012|Escalation Phase|Lost to Follow-up|0|||
127858948|NCT01693562|460100243|FG013|Escalation Phase|Lost to Follow-up|0|||
127858949|NCT01693562|460100244|FG014|Escalation Phase|Lost to Follow-up|0|||
127858950|NCT01693562|460100245|FG015|Escalation Phase|Lost to Follow-up|0|||
127858951|NCT01693562|460100246|FG016|Escalation Phase|Lost to Follow-up|0|||
127858952|NCT01693562|460100247|FG017|Escalation Phase|Lost to Follow-up|0|||
127858953|NCT01693562|460100248|FG018|Escalation Phase|Lost to Follow-up|0|||
127858954|NCT01693562|460100249|FG019|Escalation Phase|Lost to Follow-up|0|||
127858955|NCT01693562|460100250|FG020|Escalation Phase|Lost to Follow-up|0|||
127858956|NCT01693562|460100251|FG021|Escalation Phase|Lost to Follow-up|0|||
127858957|NCT01693562|460100252|FG022|Escalation Phase|Lost to Follow-up|0|||
127858958|NCT01693562|460100230|FG000|Escalation Phase|Other|0|||
127858959|NCT01693562|460100231|FG001|Escalation Phase|Other|0|||
127858960|NCT01693562|460100232|FG002|Escalation Phase|Other|2|||
127858961|NCT01693562|460100233|FG003|Escalation Phase|Other|0|||
127858962|NCT01693562|460100234|FG004|Escalation Phase|Other|0|||
127858963|NCT01693562|460100235|FG005|Escalation Phase|Other|1|||
127858964|NCT01693562|460100236|FG006|Escalation Phase|Other|0|||
127858965|NCT01693562|460100237|FG007|Escalation Phase|Other|0|||
127858966|NCT01693562|460100238|FG008|Escalation Phase|Other|0|||
127858967|NCT01693562|460100239|FG009|Escalation Phase|Other|0|||
127858968|NCT01693562|460100240|FG010|Escalation Phase|Other|0|||
127858969|NCT01693562|460100241|FG011|Escalation Phase|Other|0|||
127858970|NCT01693562|460100242|FG012|Escalation Phase|Other|0|||
127858971|NCT01693562|460100243|FG013|Escalation Phase|Other|0|||
127858972|NCT01693562|460100244|FG014|Escalation Phase|Other|0|||
127858973|NCT01693562|460100245|FG015|Escalation Phase|Other|0|||
127858974|NCT01693562|460100246|FG016|Escalation Phase|Other|0|||
127858975|NCT01693562|460100247|FG017|Escalation Phase|Other|0|||
127858976|NCT01693562|460100248|FG018|Escalation Phase|Other|0|||
127858977|NCT01693562|460100249|FG019|Escalation Phase|Other|0|||
127858978|NCT01693562|460100250|FG020|Escalation Phase|Other|0|||
127858979|NCT01693562|460100251|FG021|Escalation Phase|Other|0|||
127858980|NCT01693562|460100252|FG022|Escalation Phase|Other|0|||
127858981|NCT01693562|460100230|FG000|Exploration Phase|Withdrawal by Subject|0|||
127858982|NCT01693562|460100231|FG001|Exploration Phase|Withdrawal by Subject|0|||
127858983|NCT01693562|460100232|FG002|Exploration Phase|Withdrawal by Subject|0|||
127858984|NCT01693562|460100233|FG003|Exploration Phase|Withdrawal by Subject|0|||
127858985|NCT01693562|460100234|FG004|Exploration Phase|Withdrawal by Subject|0|||
127858986|NCT01693562|460100235|FG005|Exploration Phase|Withdrawal by Subject|0|||
127858987|NCT01693562|460100236|FG006|Exploration Phase|Withdrawal by Subject|2|||
127858988|NCT01693562|460100237|FG007|Exploration Phase|Withdrawal by Subject|0|||
127858989|NCT01693562|460100238|FG008|Exploration Phase|Withdrawal by Subject|0|||
127858990|NCT01693562|460100239|FG009|Exploration Phase|Withdrawal by Subject|0|||
127858991|NCT01693562|460100240|FG010|Exploration Phase|Withdrawal by Subject|0|||
127858992|NCT01693562|460100241|FG011|Exploration Phase|Withdrawal by Subject|0|||
127858993|NCT01693562|460100242|FG012|Exploration Phase|Withdrawal by Subject|0|||
127858994|NCT01693562|460100243|FG013|Exploration Phase|Withdrawal by Subject|0|||
127858995|NCT01693562|460100244|FG014|Exploration Phase|Withdrawal by Subject|0|||
127858996|NCT01693562|460100245|FG015|Exploration Phase|Withdrawal by Subject|0|||
127858997|NCT01693562|460100246|FG016|Exploration Phase|Withdrawal by Subject|0|||
127858998|NCT01693562|460100247|FG017|Exploration Phase|Withdrawal by Subject|0|||
127858999|NCT01693562|460100248|FG018|Exploration Phase|Withdrawal by Subject|0|||
127859000|NCT01693562|460100249|FG019|Exploration Phase|Withdrawal by Subject|0|||
127859001|NCT01693562|460100250|FG020|Exploration Phase|Withdrawal by Subject|0|||
127859002|NCT01693562|460100251|FG021|Exploration Phase|Withdrawal by Subject|0|||
127859003|NCT01693562|460100252|FG022|Exploration Phase|Withdrawal by Subject|0|||
127859004|NCT01693562|460100230|FG000|Exploration Phase|Death|0|||
127859005|NCT01693562|460100231|FG001|Exploration Phase|Death|0|||
127859006|NCT01693562|460100232|FG002|Exploration Phase|Death|0|||
127859007|NCT01693562|460100233|FG003|Exploration Phase|Death|0|||
127859008|NCT01693562|460100234|FG004|Exploration Phase|Death|0|||
127859009|NCT01693562|460100235|FG005|Exploration Phase|Death|0|||
127859010|NCT01693562|460100236|FG006|Exploration Phase|Death|17|||
127859011|NCT01693562|460100237|FG007|Exploration Phase|Death|0|||
127859012|NCT01693562|460100238|FG008|Exploration Phase|Death|0|||
127859013|NCT01693562|460100239|FG009|Exploration Phase|Death|0|||
127859014|NCT01693562|460100240|FG010|Exploration Phase|Death|0|||
127859015|NCT01693562|460100241|FG011|Exploration Phase|Death|0|||
127859016|NCT01693562|460100242|FG012|Exploration Phase|Death|0|||
127859017|NCT01693562|460100243|FG013|Exploration Phase|Death|0|||
127859018|NCT01693562|460100244|FG014|Exploration Phase|Death|0|||
127859019|NCT01693562|460100245|FG015|Exploration Phase|Death|0|||
127859020|NCT01693562|460100246|FG016|Exploration Phase|Death|0|||
127859021|NCT01693562|460100247|FG017|Exploration Phase|Death|0|||
127859022|NCT01693562|460100248|FG018|Exploration Phase|Death|0|||
127859023|NCT01693562|460100249|FG019|Exploration Phase|Death|0|||
127859024|NCT01693562|460100250|FG020|Exploration Phase|Death|0|||
127859025|NCT01693562|460100251|FG021|Exploration Phase|Death|0|||
127859026|NCT01693562|460100252|FG022|Exploration Phase|Death|0|||
127859027|NCT01693562|460100230|FG000|Exploration Phase|Other|0|||
127859028|NCT01693562|460100231|FG001|Exploration Phase|Other|0|||
127859029|NCT01693562|460100232|FG002|Exploration Phase|Other|0|||
127859030|NCT01693562|460100233|FG003|Exploration Phase|Other|0|||
127859031|NCT01693562|460100234|FG004|Exploration Phase|Other|0|||
127859032|NCT01693562|460100235|FG005|Exploration Phase|Other|0|||
127859033|NCT01693562|460100236|FG006|Exploration Phase|Other|2|||
127859034|NCT01693562|460100237|FG007|Exploration Phase|Other|0|||
127859035|NCT01693562|460100238|FG008|Exploration Phase|Other|0|||
127859036|NCT01693562|460100239|FG009|Exploration Phase|Other|0|||
127859037|NCT01693562|460100240|FG010|Exploration Phase|Other|0|||
127859038|NCT01693562|460100241|FG011|Exploration Phase|Other|0|||
127859039|NCT01693562|460100242|FG012|Exploration Phase|Other|0|||
127859040|NCT01693562|460100243|FG013|Exploration Phase|Other|0|||
127859041|NCT01693562|460100244|FG014|Exploration Phase|Other|0|||
127859042|NCT01693562|460100245|FG015|Exploration Phase|Other|0|||
127859043|NCT01693562|460100246|FG016|Exploration Phase|Other|0|||
127859044|NCT01693562|460100247|FG017|Exploration Phase|Other|0|||
127859045|NCT01693562|460100248|FG018|Exploration Phase|Other|0|||
127859046|NCT01693562|460100249|FG019|Exploration Phase|Other|0|||
127859047|NCT01693562|460100250|FG020|Exploration Phase|Other|0|||
127859048|NCT01693562|460100251|FG021|Exploration Phase|Other|0|||
127859049|NCT01693562|460100252|FG022|Exploration Phase|Other|0|||
127859050|NCT01693562|460100230|FG000|Expansion Phase|Withdrawal by Subject|0|||
127859051|NCT01693562|460100231|FG001|Expansion Phase|Withdrawal by Subject|0|||
127859052|NCT01693562|460100232|FG002|Expansion Phase|Withdrawal by Subject|0|||
127859053|NCT01693562|460100233|FG003|Expansion Phase|Withdrawal by Subject|0|||
127859054|NCT01693562|460100234|FG004|Expansion Phase|Withdrawal by Subject|0|||
127859055|NCT01693562|460100235|FG005|Expansion Phase|Withdrawal by Subject|0|||
127859056|NCT01693562|460100236|FG006|Expansion Phase|Withdrawal by Subject|0|||
127859057|NCT01693562|460100237|FG007|Expansion Phase|Withdrawal by Subject|16|||
127859058|NCT01693562|460100238|FG008|Expansion Phase|Withdrawal by Subject|2|||
127859059|NCT01693562|460100239|FG009|Expansion Phase|Withdrawal by Subject|54|||
127859060|NCT01693562|460100240|FG010|Expansion Phase|Withdrawal by Subject|2|||
127859061|NCT01693562|460100241|FG011|Expansion Phase|Withdrawal by Subject|2|||
127859062|NCT01693562|460100242|FG012|Expansion Phase|Withdrawal by Subject|3|||
127859063|NCT01693562|460100243|FG013|Expansion Phase|Withdrawal by Subject|5|||
127859064|NCT01693562|460100244|FG014|Expansion Phase|Withdrawal by Subject|16|||
127859065|NCT01693562|460100245|FG015|Expansion Phase|Withdrawal by Subject|7|||
127859066|NCT01693562|460100246|FG016|Expansion Phase|Withdrawal by Subject|40|||
127859067|NCT01693562|460100247|FG017|Expansion Phase|Withdrawal by Subject|4|||
127859068|NCT01693562|460100248|FG018|Expansion Phase|Withdrawal by Subject|8|||
127859069|NCT01693562|460100249|FG019|Expansion Phase|Withdrawal by Subject|3|||
127859070|NCT01693562|460100250|FG020|Expansion Phase|Withdrawal by Subject|1|||
127859071|NCT01693562|460100251|FG021|Expansion Phase|Withdrawal by Subject|8|||
127859072|NCT01693562|460100252|FG022|Expansion Phase|Withdrawal by Subject|1|||
127859073|NCT01693562|460100230|FG000|Expansion Phase|Death|0|||
127859074|NCT01693562|460100231|FG001|Expansion Phase|Death|0|||
127859075|NCT01693562|460100232|FG002|Expansion Phase|Death|0|||
127859076|NCT01693562|460100233|FG003|Expansion Phase|Death|0|||
127859077|NCT01693562|460100234|FG004|Expansion Phase|Death|0|||
127859078|NCT01693562|460100235|FG005|Expansion Phase|Death|0|||
127859079|NCT01693562|460100236|FG006|Expansion Phase|Death|0|||
127859080|NCT01693562|460100237|FG007|Expansion Phase|Death|42|||
127859081|NCT01693562|460100238|FG008|Expansion Phase|Death|17|||
127859082|NCT01693562|460100239|FG009|Expansion Phase|Death|208|||
127859083|NCT01693562|460100240|FG010|Expansion Phase|Death|30|||
127859084|NCT01693562|460100241|FG011|Expansion Phase|Death|8|||
127859085|NCT01693562|460100242|FG012|Expansion Phase|Death|19|||
127911434|NCT04633564|460298846|FG000|Period 1|Lost to Follow-up|3|||
127859086|NCT01693562|460100243|FG013|Expansion Phase|Death|42|||
127859087|NCT01693562|460100244|FG014|Expansion Phase|Death|23|||
127859088|NCT01693562|460100245|FG015|Expansion Phase|Death|23|||
127859089|NCT01693562|460100246|FG016|Expansion Phase|Death|128|||
127859090|NCT01693562|460100247|FG017|Expansion Phase|Death|16|||
127859091|NCT01693562|460100248|FG018|Expansion Phase|Death|36|||
127859092|NCT01693562|460100249|FG019|Expansion Phase|Death|16|||
127859093|NCT01693562|460100250|FG020|Expansion Phase|Death|17|||
127859094|NCT01693562|460100251|FG021|Expansion Phase|Death|35|||
127859095|NCT01693562|460100252|FG022|Expansion Phase|Death|7|||
127859096|NCT01693562|460100230|FG000|Expansion Phase|Lost to Follow-up|0|||
127859097|NCT01693562|460100231|FG001|Expansion Phase|Lost to Follow-up|0|||
127859098|NCT01693562|460100232|FG002|Expansion Phase|Lost to Follow-up|0|||
127859099|NCT01693562|460100233|FG003|Expansion Phase|Lost to Follow-up|0|||
127859100|NCT01693562|460100234|FG004|Expansion Phase|Lost to Follow-up|0|||
127859101|NCT01693562|460100235|FG005|Expansion Phase|Lost to Follow-up|0|||
127859102|NCT01693562|460100236|FG006|Expansion Phase|Lost to Follow-up|0|||
127859103|NCT01693562|460100237|FG007|Expansion Phase|Lost to Follow-up|1|||
127859104|NCT01693562|460100238|FG008|Expansion Phase|Lost to Follow-up|2|||
127859105|NCT01693562|460100239|FG009|Expansion Phase|Lost to Follow-up|10|||
127859106|NCT01693562|460100240|FG010|Expansion Phase|Lost to Follow-up|4|||
127859107|NCT01693562|460100241|FG011|Expansion Phase|Lost to Follow-up|4|||
127859108|NCT01693562|460100242|FG012|Expansion Phase|Lost to Follow-up|1|||
127859109|NCT01693562|460100243|FG013|Expansion Phase|Lost to Follow-up|3|||
127859110|NCT01693562|460100244|FG014|Expansion Phase|Lost to Follow-up|0|||
127859111|NCT01693562|460100245|FG015|Expansion Phase|Lost to Follow-up|1|||
127859112|NCT01693562|460100246|FG016|Expansion Phase|Lost to Follow-up|1|||
127859113|NCT01693562|460100247|FG017|Expansion Phase|Lost to Follow-up|0|||
127859114|NCT01693562|460100248|FG018|Expansion Phase|Lost to Follow-up|2|||
127859115|NCT01693562|460100249|FG019|Expansion Phase|Lost to Follow-up|1|||
127859116|NCT01693562|460100250|FG020|Expansion Phase|Lost to Follow-up|2|||
127859117|NCT01693562|460100251|FG021|Expansion Phase|Lost to Follow-up|2|||
127859118|NCT01693562|460100252|FG022|Expansion Phase|Lost to Follow-up|1|||
127859119|NCT01693562|460100230|FG000|Expansion Phase|Other|0|||
127859120|NCT01693562|460100231|FG001|Expansion Phase|Other|0|||
127859121|NCT01693562|460100232|FG002|Expansion Phase|Other|0|||
127859122|NCT01693562|460100233|FG003|Expansion Phase|Other|0|||
127859123|NCT01693562|460100234|FG004|Expansion Phase|Other|0|||
127859124|NCT01693562|460100235|FG005|Expansion Phase|Other|0|||
127859125|NCT01693562|460100236|FG006|Expansion Phase|Other|0|||
127859126|NCT01693562|460100237|FG007|Expansion Phase|Other|3|||
127859127|NCT01693562|460100238|FG008|Expansion Phase|Other|1|||
127859128|NCT01693562|460100239|FG009|Expansion Phase|Other|28|||
127859129|NCT01693562|460100240|FG010|Expansion Phase|Other|4|||
127859130|NCT01693562|460100241|FG011|Expansion Phase|Other|7|||
127859131|NCT01693562|460100242|FG012|Expansion Phase|Other|0|||
127859132|NCT01693562|460100243|FG013|Expansion Phase|Other|1|||
127859133|NCT01693562|460100244|FG014|Expansion Phase|Other|1|||
127859134|NCT01693562|460100245|FG015|Expansion Phase|Other|0|||
127859135|NCT01693562|460100246|FG016|Expansion Phase|Other|28|||
127859136|NCT01693562|460100247|FG017|Expansion Phase|Other|0|||
127859137|NCT01693562|460100248|FG018|Expansion Phase|Other|1|||
127859138|NCT01693562|460100249|FG019|Expansion Phase|Other|0|||
127859139|NCT01693562|460100250|FG020|Expansion Phase|Other|1|||
127859140|NCT01693562|460100251|FG021|Expansion Phase|Other|17|||
127859141|NCT01693562|460100252|FG022|Expansion Phase|Other|1|||
127859142|NCT05618808|460100257|FG000|Overall Study|Withdrawal by Subject|3|||
127859143|NCT05618808|460100258|FG001|Overall Study|Withdrawal by Subject|1|||
127859144|NCT05618808|460100259|FG002|Overall Study|Withdrawal by Subject|3|||
127859145|NCT05298774|460100266|FG000|Overall Study|Physician Decision|3|||
127859146|NCT05298774|460100266|FG000|Overall Study|Withdrawal by Subject|2|||
127859147|NCT05298774|460100266|FG000|Overall Study|Lost to Follow-up|3|||
127859148|NCT05298774|460100266|FG000|Overall Study|Screen failure|1|||
127911435|NCT04633564|460298847|FG001|Period 1|Lost to Follow-up|5|||
127911436|NCT04633564|460298846|FG000|Period 1|Physician Decision|4|||
127911437|NCT04633564|460298847|FG001|Period 1|Physician Decision|12|||
127758397|NCT05384938|459740496|FG000|Overall Study|One participant included in study but not included in analysis as did not meet eligibility criteria|1|||
127859149|NCT06048367|460100275|FG000|Overall Study|Withdrawal by Subject|0|||
127859150|NCT06048367|460100276|FG001|Overall Study|Withdrawal by Subject|1|||
127859151|NCT06048367|460100277|FG002|Overall Study|Withdrawal by Subject|0|||
127859152|NCT06048367|460100278|FG003|Overall Study|Withdrawal by Subject|0|||
127859153|NCT06048367|460100279|FG004|Overall Study|Withdrawal by Subject|0|||
127859154|NCT06048367|460100275|FG000|Overall Study|Withdrawal by Subject|0|||
127859155|NCT06048367|460100276|FG001|Overall Study|Withdrawal by Subject|0|||
127859156|NCT06048367|460100277|FG002|Overall Study|Withdrawal by Subject|1|||
127859157|NCT06048367|460100278|FG003|Overall Study|Withdrawal by Subject|0|||
127859158|NCT06048367|460100279|FG004|Overall Study|Withdrawal by Subject|0|||
127859159|NCT06048367|460100275|FG000|Overall Study|Withdrawal by Subject|0|||
127859160|NCT06048367|460100276|FG001|Overall Study|Withdrawal by Subject|0|||
127859161|NCT06048367|460100277|FG002|Overall Study|Withdrawal by Subject|0|||
127859162|NCT06048367|460100278|FG003|Overall Study|Withdrawal by Subject|1|||
127859163|NCT06048367|460100279|FG004|Overall Study|Withdrawal by Subject|0|||
127859164|NCT06048367|460100275|FG000|Overall Study|Withdrawal by Subject|0|||
127859165|NCT06048367|460100276|FG001|Overall Study|Withdrawal by Subject|0|||
127859166|NCT06048367|460100277|FG002|Overall Study|Withdrawal by Subject|0|||
127859167|NCT06048367|460100278|FG003|Overall Study|Withdrawal by Subject|1|||
127859168|NCT06048367|460100279|FG004|Overall Study|Withdrawal by Subject|0|||
127859169|NCT01327573|460100280|FG000|Overall Study|Physician Decision|3|||
127859170|NCT01327573|460100281|FG001|Overall Study|Physician Decision|1|||
127859171|NCT02136134|460100282|FG000|Overall Study|Death|170|||
127859172|NCT02136134|460100283|FG001|Overall Study|Death|148|||
127859173|NCT02136134|460100282|FG000|Overall Study|Withdrawal by Subject|19|||
127859174|NCT02136134|460100283|FG001|Overall Study|Withdrawal by Subject|10|||
127859175|NCT02136134|460100282|FG000|Overall Study|Lost to Follow-up|3|||
127859176|NCT02136134|460100283|FG001|Overall Study|Lost to Follow-up|3|||
127859177|NCT02136134|460100282|FG000|Overall Study|Uspecified|55|||
127859178|NCT02136134|460100283|FG001|Overall Study|Uspecified|90|||
127859179|NCT03070119|460100286|FG000|Overall Study|Adverse Event|0|||
127859180|NCT03070119|460100287|FG001|Overall Study|Adverse Event|0|||
127859181|NCT03070119|460100288|FG002|Overall Study|Adverse Event|1|||
127859182|NCT03070119|460100286|FG000|Overall Study|Lost to Follow-up|0|||
127859183|NCT03070119|460100287|FG001|Overall Study|Lost to Follow-up|1|||
127859184|NCT03070119|460100288|FG002|Overall Study|Lost to Follow-up|0|||
127859185|NCT03070119|460100286|FG000|Overall Study|Consent Withdrawn|6|||
127859186|NCT03070119|460100287|FG001|Overall Study|Consent Withdrawn|5|||
127859187|NCT03070119|460100288|FG002|Overall Study|Consent Withdrawn|3|||
127859188|NCT03070119|460100286|FG000|Overall Study|Investigator Decision|0|||
127859189|NCT03070119|460100287|FG001|Overall Study|Investigator Decision|0|||
127859190|NCT03070119|460100288|FG002|Overall Study|Investigator Decision|1|||
127859191|NCT03070119|460100286|FG000|Overall Study|Death|7|||
127859192|NCT03070119|460100287|FG001|Overall Study|Death|14|||
127859193|NCT03070119|460100288|FG002|Overall Study|Death|5|||
127859194|NCT03070119|460100286|FG000|Overall Study|Disease Progression|5|||
127859195|NCT03070119|460100287|FG001|Overall Study|Disease Progression|7|||
127859196|NCT03070119|460100288|FG002|Overall Study|Disease Progression|7|||
127859197|NCT03070119|460100286|FG000|Overall Study|Reason not Specified|2|||
127859198|NCT03070119|460100287|FG001|Overall Study|Reason not Specified|2|||
127859199|NCT03070119|460100288|FG002|Overall Study|Reason not Specified|1|||
127859200|NCT00732472|460100289|FG000|Overall Study|Adverse Event|0|||
127859201|NCT00732472|460100290|FG001|Overall Study|Adverse Event|1|||
127859202|NCT00732472|460100291|FG002|Overall Study|Adverse Event|1|||
127859203|NCT00732472|460100292|FG003|Overall Study|Adverse Event|1|||
127859204|NCT00732472|460100289|FG000|Overall Study|Protocol Violation|0|||
127859205|NCT00732472|460100290|FG001|Overall Study|Protocol Violation|0|||
127859206|NCT00732472|460100291|FG002|Overall Study|Protocol Violation|0|||
127859207|NCT00732472|460100292|FG003|Overall Study|Protocol Violation|1|||
127859208|NCT00732472|460100289|FG000|Overall Study|Withdrawal by Subject|0|||
127859209|NCT00732472|460100290|FG001|Overall Study|Withdrawal by Subject|2|||
127859210|NCT00732472|460100291|FG002|Overall Study|Withdrawal by Subject|0|||
127859211|NCT00732472|460100292|FG003|Overall Study|Withdrawal by Subject|1|||
127859212|NCT01058395|460100294|FG000|Overall Study|Death|2|||
127859213|NCT01058395|460100295|FG001|Overall Study|Death|1|||
127859214|NCT01058395|460100294|FG000|Overall Study|Lost to Follow-up|1|||
127859215|NCT01058395|460100295|FG001|Overall Study|Lost to Follow-up|0|||
127859216|NCT01266876|460100296|FG000|Overall Study|Adverse Event|0|||
127859217|NCT01266876|460100297|FG001|Overall Study|Adverse Event|0|||
127859218|NCT01266876|460100298|FG002|Overall Study|Adverse Event|0|||
127859219|NCT01266876|460100299|FG003|Overall Study|Adverse Event|1|||
127859220|NCT01266876|460100300|FG004|Overall Study|Adverse Event|0|||
127859221|NCT04083781|460100301|FG000|Main Part|Physician Decision|0|||
127859222|NCT04083781|460100302|FG001|Main Part|Physician Decision|1|||
127859223|NCT04083781|460100303|FG002|Main Part|Physician Decision|2|||
127859224|NCT04083781|460100304|FG003|Main Part|Physician Decision|0|||
127859225|NCT04083781|460100301|FG000|Main Part|Death|1|||
127859226|NCT04083781|460100302|FG001|Main Part|Death|3|||
127859227|NCT04083781|460100303|FG002|Main Part|Death|1|||
127859228|NCT04083781|460100304|FG003|Main Part|Death|0|||
127859229|NCT04083781|460100301|FG000|Main Part|Withdrawal by Subject|5|||
127859230|NCT04083781|460100302|FG001|Main Part|Withdrawal by Subject|2|||
127859231|NCT04083781|460100303|FG002|Main Part|Withdrawal by Subject|3|||
127859232|NCT04083781|460100304|FG003|Main Part|Withdrawal by Subject|7|||
127859233|NCT04083781|460100301|FG000|Extension Part|Physician Decision|0|||
127859234|NCT04083781|460100302|FG001|Extension Part|Physician Decision|0|||
127859235|NCT04083781|460100303|FG002|Extension Part|Physician Decision|0|||
127859236|NCT04083781|460100304|FG003|Extension Part|Physician Decision|1|||
127859237|NCT04083781|460100301|FG000|Extension Part|Death|0|||
127859238|NCT04083781|460100302|FG001|Extension Part|Death|1|||
127859239|NCT04083781|460100303|FG002|Extension Part|Death|0|||
127859240|NCT04083781|460100304|FG003|Extension Part|Death|1|||
127859241|NCT04083781|460100301|FG000|Extension Part|Withdrawal by Subject|0|||
127859242|NCT04083781|460100302|FG001|Extension Part|Withdrawal by Subject|1|||
127859243|NCT04083781|460100303|FG002|Extension Part|Withdrawal by Subject|0|||
127859244|NCT04083781|460100304|FG003|Extension Part|Withdrawal by Subject|0|||
127859245|NCT04083781|460100301|FG000|Extension Part|Ongoing|13|||
127859246|NCT04083781|460100302|FG001|Extension Part|Ongoing|25|||
127859247|NCT04083781|460100303|FG002|Extension Part|Ongoing|15|||
127859248|NCT04083781|460100304|FG003|Extension Part|Ongoing|51|||
127859249|NCT05304611|460100305|FG000|Pediatric Efficacy Study|Lost to Follow-up|0|||
127859250|NCT05304611|460100306|FG001|Pediatric Efficacy Study|Lost to Follow-up|0|||
127859251|NCT05304611|460100307|FG002|Pediatric Efficacy Study|Lost to Follow-up|0|||
127859252|NCT05304611|460100308|FG003|Pediatric Efficacy Study|Lost to Follow-up|0|||
127859253|NCT05304611|460100309|FG004|Pediatric Efficacy Study|Lost to Follow-up|0|||
127859254|NCT05304611|460100310|FG005|Pediatric Efficacy Study|Lost to Follow-up|0|||
127859255|NCT05304611|460100311|FG006|Pediatric Efficacy Study|Lost to Follow-up|1|||
127859256|NCT05304611|460100312|FG007|Pediatric Efficacy Study|Lost to Follow-up|0|||
127859257|NCT05304611|460100313|FG008|Pediatric Efficacy Study|Lost to Follow-up|1|||
127859258|NCT05304611|460100314|FG009|Pediatric Efficacy Study|Lost to Follow-up|0|||
127859259|NCT05304611|460100315|FG010|Pediatric Efficacy Study|Lost to Follow-up|0|||
127859260|NCT05304611|460100316|FG011|Pediatric Efficacy Study|Lost to Follow-up|0|||
127859261|NCT05304611|460100305|FG000|Pediatric Efficacy Study|Withdrew consent|0|||
127859262|NCT05304611|460100306|FG001|Pediatric Efficacy Study|Withdrew consent|0|||
127859263|NCT05304611|460100307|FG002|Pediatric Efficacy Study|Withdrew consent|0|||
127859264|NCT05304611|460100308|FG003|Pediatric Efficacy Study|Withdrew consent|0|||
127859265|NCT05304611|460100309|FG004|Pediatric Efficacy Study|Withdrew consent|0|||
127859266|NCT05304611|460100310|FG005|Pediatric Efficacy Study|Withdrew consent|0|||
127859267|NCT05304611|460100311|FG006|Pediatric Efficacy Study|Withdrew consent|1|||
127859268|NCT05304611|460100312|FG007|Pediatric Efficacy Study|Withdrew consent|1|||
127859269|NCT05304611|460100313|FG008|Pediatric Efficacy Study|Withdrew consent|2|||
127859270|NCT05304611|460100314|FG009|Pediatric Efficacy Study|Withdrew consent|0|||
127859271|NCT05304611|460100315|FG010|Pediatric Efficacy Study|Withdrew consent|0|||
127859272|NCT05304611|460100316|FG011|Pediatric Efficacy Study|Withdrew consent|0|||
127859273|NCT05304611|460100305|FG000|Pediatric Extension Study|Withdrawal by Subject|0|||
127859274|NCT05304611|460100306|FG001|Pediatric Extension Study|Withdrawal by Subject|0|||
127859275|NCT05304611|460100307|FG002|Pediatric Extension Study|Withdrawal by Subject|0|||
127859276|NCT05304611|460100308|FG003|Pediatric Extension Study|Withdrawal by Subject|0|||
127859277|NCT05304611|460100309|FG004|Pediatric Extension Study|Withdrawal by Subject|0|||
127859278|NCT05304611|460100310|FG005|Pediatric Extension Study|Withdrawal by Subject|0|||
127859279|NCT05304611|460100311|FG006|Pediatric Extension Study|Withdrawal by Subject|0|||
127859280|NCT05304611|460100312|FG007|Pediatric Extension Study|Withdrawal by Subject|0|||
127859281|NCT05304611|460100313|FG008|Pediatric Extension Study|Withdrawal by Subject|0|||
127859282|NCT05304611|460100314|FG009|Pediatric Extension Study|Withdrawal by Subject|0|||
127859283|NCT05304611|460100315|FG010|Pediatric Extension Study|Withdrawal by Subject|1|||
127859284|NCT05304611|460100316|FG011|Pediatric Extension Study|Withdrawal by Subject|2|||
127859285|NCT00963820|460100317|FG000|Dose Escalation Phase|Progressive Disease|3|||
127859286|NCT00963820|460100318|FG001|Dose Escalation Phase|Progressive Disease|3|||
127859287|NCT00963820|460100319|FG002|Dose Escalation Phase|Progressive Disease|3|||
127859288|NCT00963820|460100320|FG003|Dose Escalation Phase|Progressive Disease|3|||
127859289|NCT00963820|460100321|FG004|Dose Escalation Phase|Progressive Disease|4|||
127859290|NCT00963820|460100322|FG005|Dose Escalation Phase|Progressive Disease|3|||
127859291|NCT00963820|460100323|FG006|Dose Escalation Phase|Progressive Disease|3|||
127859292|NCT00963820|460100324|FG007|Dose Escalation Phase|Progressive Disease|2|||
127859293|NCT00963820|460100325|FG008|Dose Escalation Phase|Progressive Disease|0|||
127859294|NCT00963820|460100326|FG009|Dose Escalation Phase|Progressive Disease|0|||
127859295|NCT00963820|460100327|FG010|Dose Escalation Phase|Progressive Disease|0|||
127859296|NCT00963820|460100328|FG011|Dose Escalation Phase|Progressive Disease|0|||
127859297|NCT00963820|460100317|FG000|Dose Escalation Phase|Adverse Event|0|||
127859298|NCT00963820|460100318|FG001|Dose Escalation Phase|Adverse Event|0|||
127859299|NCT00963820|460100319|FG002|Dose Escalation Phase|Adverse Event|0|||
127859300|NCT00963820|460100320|FG003|Dose Escalation Phase|Adverse Event|0|||
127859301|NCT00963820|460100321|FG004|Dose Escalation Phase|Adverse Event|0|||
127859302|NCT00963820|460100322|FG005|Dose Escalation Phase|Adverse Event|0|||
127859303|NCT00963820|460100323|FG006|Dose Escalation Phase|Adverse Event|3|||
127859304|NCT00963820|460100324|FG007|Dose Escalation Phase|Adverse Event|1|||
127859305|NCT00963820|460100325|FG008|Dose Escalation Phase|Adverse Event|0|||
127859306|NCT00963820|460100326|FG009|Dose Escalation Phase|Adverse Event|0|||
127859307|NCT00963820|460100327|FG010|Dose Escalation Phase|Adverse Event|0|||
127859308|NCT00963820|460100328|FG011|Dose Escalation Phase|Adverse Event|0|||
127859309|NCT00963820|460100317|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
127859310|NCT00963820|460100318|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
127859311|NCT00963820|460100319|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
127859312|NCT00963820|460100320|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
127859313|NCT00963820|460100321|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
127859314|NCT00963820|460100322|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
127911438|NCT04633564|460298846|FG000|Period 1|Protocol Violation|0|||
127911439|NCT04633564|460298847|FG001|Period 1|Protocol Violation|1|||
127911440|NCT04633564|460298846|FG000|Period 1|Withdrawal by Subject|10|||
127911441|NCT04633564|460298847|FG001|Period 1|Withdrawal by Subject|8|||
127911442|NCT04633564|460298846|FG000|Period 1|Progressive disease|47|||
127911443|NCT04633564|460298847|FG001|Period 1|Progressive disease|51|||
127911444|NCT04633564|460298846|FG000|Period 1|Terminated by Sponsor|8|||
127911445|NCT04633564|460298847|FG001|Period 1|Terminated by Sponsor|6|||
127911446|NCT04633564|460298846|FG000|Period 2|Adverse Event|3|||
127911447|NCT04633564|460298847|FG001|Period 2|Adverse Event|4|||
127911448|NCT04633564|460298846|FG000|Period 2|Death|0|||
127911449|NCT04633564|460298847|FG001|Period 2|Death|2|||
127911450|NCT04633564|460298846|FG000|Period 2|Lost to Follow-up|0|||
127911451|NCT04633564|460298847|FG001|Period 2|Lost to Follow-up|1|||
127911452|NCT04633564|460298846|FG000|Period 2|Physician Decision|2|||
127911453|NCT04633564|460298847|FG001|Period 2|Physician Decision|4|||
127911454|NCT04633564|460298846|FG000|Period 2|Withdrawal by Subject|5|||
127911455|NCT04633564|460298847|FG001|Period 2|Withdrawal by Subject|1|||
127911456|NCT04633564|460298846|FG000|Period 2|Progressive Disease|74|||
127911457|NCT04633564|460298847|FG001|Period 2|Progressive Disease|82|||
127911458|NCT04633564|460298846|FG000|Period 2|Terminated by Sponsor|9|||
127911459|NCT04633564|460298847|FG001|Period 2|Terminated by Sponsor|3|||
127911460|NCT04025229|460300264|FG000|Overall Study|Adverse Event|1|||
127911461|NCT04025229|460300265|FG001|Overall Study|Adverse Event|0|||
127911462|NCT04025229|460300264|FG000|Overall Study|Withdrawal by Subject|0|||
127911463|NCT04025229|460300265|FG001|Overall Study|Withdrawal by Subject|2|||
127911464|NCT04025229|460300264|FG000|Overall Study|Death|0|||
127911465|NCT04025229|460300265|FG001|Overall Study|Death|1|||
127911466|NCT04025229|460300264|FG000|Overall Study|Physician Decision|0|||
127911467|NCT04025229|460300265|FG001|Overall Study|Physician Decision|1|||
127911468|NCT02571907|460300266|FG000|Overall Study|Death|4|||
127911469|NCT02571907|460300266|FG000|Overall Study|Lost to Follow-up|3|||
127911470|NCT02571907|460300266|FG000|Overall Study|Withdrawal by Subject|3|||
127911471|NCT02286739|460300271|FG000|Overall Study|Verasense type posterior stabilizing (PS)|37|||
127911472|NCT02286739|460300272|FG001|Overall Study|Verasense type posterior stabilizing (PS)|16|||
127911473|NCT02286739|460300271|FG000|Overall Study|No Verasense type documented|0|||
127911474|NCT02286739|460300272|FG001|Overall Study|No Verasense type documented|23|||
127911475|NCT02286739|460300271|FG000|Overall Study|Adverse Event|1|||
127911476|NCT02286739|460300272|FG001|Overall Study|Adverse Event|2|||
127911477|NCT02286739|460300271|FG000|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|86|||
127911478|NCT02286739|460300272|FG001|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|112|||
127911479|NCT03447353|460300273|FG000|Overall Study|Failure at Screening Visit|2|||
127911480|NCT03447353|460300273|FG000|Overall Study|Lost to Follow-up|4|||
127911481|NCT03447353|460300273|FG000|Overall Study|Scheduling Conflicts|3|||
127911482|NCT03447353|460300273|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
127911483|NCT02642653|460300279|FG000|Overall Study|Adverse Event|2|||
127911484|NCT02642653|460300280|FG001|Overall Study|Adverse Event|0|||
127911485|NCT00834717|460300281|FG000|First Intervention|Adverse Event|1|||
127911486|NCT00834717|460300282|FG001|First Intervention|Adverse Event|0|||
127911487|NCT00834717|460300281|FG000|First Intervention|Withdrawal by Subject|0|||
127911488|NCT00834717|460300282|FG001|First Intervention|Withdrawal by Subject|1|||
127911489|NCT00508651|460300285|FG000|Overall Study|Lost to Follow-up|3|||
127911490|NCT00508651|460300286|FG001|Overall Study|Lost to Follow-up|1|||
127911491|NCT00508651|460300285|FG000|Overall Study|Withdrawal by Subject|1|||
127911492|NCT00508651|460300286|FG001|Overall Study|Withdrawal by Subject|1|||
127911493|NCT02255149|460300291|FG000|Overall Study|Lost to Follow-up|2|||
127911494|NCT02255149|460300291|FG000|Overall Study|Withdrawal by Subject|1|||
127911495|NCT02255149|460300291|FG000|Overall Study|Withdrawal by PI|1|||
127911496|NCT02255149|460300291|FG000|Overall Study|Implant Failure|1|||
127911497|NCT05710718|460300297|FG000|Overall Study|Withdrawal by Subject|5|||
127911498|NCT05710718|460300298|FG001|Overall Study|Withdrawal by Subject|1|||
127911499|NCT05710718|460300297|FG000|Overall Study|Lost to Follow-up|0|||
127911500|NCT05710718|460300298|FG001|Overall Study|Lost to Follow-up|1|||
127911501|NCT05710718|460300297|FG000|Overall Study|Death|0|||
127911502|NCT05710718|460300298|FG001|Overall Study|Death|1|||
127911503|NCT00446966|460300307|FG000|Overall Study|Lost to Follow-up|10|||
127911504|NCT00446966|460300308|FG001|Overall Study|Lost to Follow-up|7|||
127911505|NCT00443651|460300309|FG000|Overall Study|Death|1|||
127911506|NCT00443651|460300310|FG001|Overall Study|Death|5|||
127911507|NCT00443651|460300309|FG000|Overall Study|Adverse Event|5|||
127911508|NCT00443651|460300310|FG001|Overall Study|Adverse Event|6|||
127911509|NCT00443651|460300309|FG000|Overall Study|Lost to Follow-up|18|||
127911510|NCT00443651|460300310|FG001|Overall Study|Lost to Follow-up|12|||
127911511|NCT00443651|460300309|FG000|Overall Study|Patient's/Guardian's Decision|58|||
127911512|NCT00443651|460300310|FG001|Overall Study|Patient's/Guardian's Decision|30|||
127911513|NCT00443651|460300309|FG000|Overall Study|Physician Decision|13|||
127911514|NCT00443651|460300310|FG001|Overall Study|Physician Decision|4|||
127911515|NCT00443651|460300309|FG000|Overall Study|Pregnancy|0|||
127911516|NCT00443651|460300310|FG001|Overall Study|Pregnancy|1|||
127911517|NCT00859521|460300313|FG000|Washout|Withdrawal by Subject|0|||
127911518|NCT00859521|460300314|FG001|Washout|Withdrawal by Subject|1|||
127859315|NCT00963820|460100323|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
127859316|NCT00963820|460100324|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
127859317|NCT00963820|460100325|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
127859318|NCT00963820|460100326|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
127911519|NCT01547286|460300321|FG000|Overall Study|Did not meet all eligibility criteria|1|||
127911520|NCT01547286|460300321|FG000|Overall Study|Physician Decision|1|||
127911521|NCT03415308|460300324|FG000|Overall Study|Lost to Follow-up|0|||
127911522|NCT03415308|460300325|FG001|Overall Study|Lost to Follow-up|0|||
127911523|NCT03415308|460300326|FG002|Overall Study|Lost to Follow-up|1|||
127911524|NCT03415308|460300324|FG000|Overall Study|Scheduling Conflicts|0|||
127911525|NCT03415308|460300325|FG001|Overall Study|Scheduling Conflicts|0|||
127911526|NCT03415308|460300326|FG002|Overall Study|Scheduling Conflicts|7|||
127911527|NCT01471353|460300327|FG000|Overall Study|remain on study|3|||
127911528|NCT00836472|460300328|FG000|Washout|Adverse Event|1|||
127911529|NCT00836472|460300329|FG001|Washout|Adverse Event|2|||
127911530|NCT00836472|460300328|FG000|Washout|Withdrawal by Subject|1|||
127911531|NCT00836472|460300329|FG001|Washout|Withdrawal by Subject|1|||
127911532|NCT01695239|460300330|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
127911533|NCT01695239|460300331|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
127911534|NCT01695239|460300332|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
127911535|NCT01695239|460300333|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
127911536|NCT01695239|460300334|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
127911537|NCT01695239|460300335|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
127911538|NCT01695239|460300336|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
127911539|NCT01695239|460300337|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
127911540|NCT01695239|460300338|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
127911541|NCT01695239|460300339|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
127911542|NCT01695239|460300340|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
127911543|NCT01695239|460300341|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
127911544|NCT01695239|460300342|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
127911545|NCT01695239|460300343|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
127911546|NCT01695239|460300330|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
127911547|NCT01695239|460300331|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
127911548|NCT01695239|460300332|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
127911549|NCT01695239|460300333|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
127911550|NCT01695239|460300334|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
127911551|NCT01695239|460300335|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
127911552|NCT01695239|460300336|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
127911553|NCT01695239|460300337|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
127911554|NCT01695239|460300338|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
127911555|NCT01695239|460300339|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
127911556|NCT01695239|460300340|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
127911557|NCT01695239|460300341|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
127911558|NCT01695239|460300342|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
127911559|NCT01695239|460300343|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
127911560|NCT01695239|460300330|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
127911561|NCT01695239|460300331|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
127911562|NCT01695239|460300332|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
127911563|NCT01695239|460300333|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
127911564|NCT01695239|460300334|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
127911565|NCT01695239|460300335|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
127911566|NCT01695239|460300336|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
127911567|NCT01695239|460300337|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
127911568|NCT01695239|460300338|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
127911569|NCT01695239|460300339|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
127911570|NCT01695239|460300340|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
127911571|NCT01695239|460300341|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
127911572|NCT01695239|460300342|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
127911573|NCT01695239|460300343|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
127911574|NCT01695239|460300330|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
127911575|NCT01695239|460300331|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
127911576|NCT01695239|460300332|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
127911577|NCT01695239|460300333|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
127911578|NCT01695239|460300334|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
127911579|NCT01695239|460300335|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
127911580|NCT01695239|460300336|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
127911581|NCT01695239|460300337|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
127911582|NCT01695239|460300338|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
127911583|NCT01695239|460300339|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
127911584|NCT01695239|460300340|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
127911585|NCT01695239|460300341|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
127911586|NCT01695239|460300342|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
127911587|NCT01695239|460300343|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
127859319|NCT00963820|460100327|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
127859320|NCT00963820|460100328|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
127859321|NCT00963820|460100317|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
127859322|NCT00963820|460100318|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
127859323|NCT00963820|460100319|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
127859324|NCT00963820|460100320|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
127859325|NCT00963820|460100321|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
127859326|NCT00963820|460100322|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
127859327|NCT00963820|460100323|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
127859328|NCT00963820|460100324|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
127859329|NCT00963820|460100325|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
127859330|NCT00963820|460100326|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
127859331|NCT00963820|460100327|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
127859332|NCT00963820|460100328|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
127859333|NCT00963820|460100317|FG000|Expansion Phase|Progressive Disease|0|||
127859334|NCT00963820|460100318|FG001|Expansion Phase|Progressive Disease|0|||
127859335|NCT00963820|460100319|FG002|Expansion Phase|Progressive Disease|0|||
127859336|NCT00963820|460100320|FG003|Expansion Phase|Progressive Disease|0|||
127859337|NCT00963820|460100321|FG004|Expansion Phase|Progressive Disease|0|||
127859338|NCT00963820|460100322|FG005|Expansion Phase|Progressive Disease|0|||
127859339|NCT00963820|460100323|FG006|Expansion Phase|Progressive Disease|0|||
127859340|NCT00963820|460100324|FG007|Expansion Phase|Progressive Disease|0|||
127859341|NCT00963820|460100325|FG008|Expansion Phase|Progressive Disease|8|||
127859342|NCT00963820|460100326|FG009|Expansion Phase|Progressive Disease|6|||
127859343|NCT00963820|460100327|FG010|Expansion Phase|Progressive Disease|4|||
127859344|NCT00963820|460100328|FG011|Expansion Phase|Progressive Disease|2|||
127859345|NCT00963820|460100317|FG000|Expansion Phase|Adverse Event|0|||
127859346|NCT00963820|460100318|FG001|Expansion Phase|Adverse Event|0|||
127859347|NCT00963820|460100319|FG002|Expansion Phase|Adverse Event|0|||
127859348|NCT00963820|460100320|FG003|Expansion Phase|Adverse Event|0|||
127859349|NCT00963820|460100321|FG004|Expansion Phase|Adverse Event|0|||
127859350|NCT00963820|460100322|FG005|Expansion Phase|Adverse Event|0|||
127859351|NCT00963820|460100323|FG006|Expansion Phase|Adverse Event|0|||
127859352|NCT00963820|460100324|FG007|Expansion Phase|Adverse Event|0|||
127859353|NCT00963820|460100325|FG008|Expansion Phase|Adverse Event|1|||
127859354|NCT00963820|460100326|FG009|Expansion Phase|Adverse Event|3|||
127859355|NCT00963820|460100327|FG010|Expansion Phase|Adverse Event|0|||
127859356|NCT00963820|460100328|FG011|Expansion Phase|Adverse Event|0|||
127859357|NCT00963820|460100317|FG000|Expansion Phase|Withdrawal by Subject|0|||
127859358|NCT00963820|460100318|FG001|Expansion Phase|Withdrawal by Subject|0|||
127859359|NCT00963820|460100319|FG002|Expansion Phase|Withdrawal by Subject|0|||
127859360|NCT00963820|460100320|FG003|Expansion Phase|Withdrawal by Subject|0|||
127859361|NCT00963820|460100321|FG004|Expansion Phase|Withdrawal by Subject|0|||
127859362|NCT00963820|460100322|FG005|Expansion Phase|Withdrawal by Subject|0|||
127859363|NCT00963820|460100323|FG006|Expansion Phase|Withdrawal by Subject|0|||
127859364|NCT00963820|460100324|FG007|Expansion Phase|Withdrawal by Subject|0|||
127859365|NCT00963820|460100325|FG008|Expansion Phase|Withdrawal by Subject|1|||
127859366|NCT00963820|460100326|FG009|Expansion Phase|Withdrawal by Subject|0|||
127859367|NCT00963820|460100327|FG010|Expansion Phase|Withdrawal by Subject|1|||
127859368|NCT00963820|460100328|FG011|Expansion Phase|Withdrawal by Subject|1|||
127859369|NCT00963820|460100317|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
127859370|NCT00963820|460100318|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
127859371|NCT00963820|460100319|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
127859372|NCT00963820|460100320|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
127859373|NCT00963820|460100321|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
127859374|NCT00963820|460100322|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
127859375|NCT00963820|460100323|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
127859376|NCT00963820|460100324|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
127859377|NCT00963820|460100325|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
127911588|NCT01695239|460300330|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
127911589|NCT01695239|460300331|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
127911590|NCT01695239|460300332|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
127911591|NCT01695239|460300333|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
127911592|NCT01695239|460300334|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
127911593|NCT01695239|460300335|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
127911594|NCT01695239|460300336|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
127911595|NCT01695239|460300337|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
127911596|NCT01695239|460300338|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
127911597|NCT01695239|460300339|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
127911598|NCT01695239|460300340|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
127911599|NCT01695239|460300341|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
127911600|NCT01695239|460300342|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
127911601|NCT01695239|460300343|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
127911602|NCT01695239|460300330|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
127911603|NCT01695239|460300331|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
127911604|NCT01695239|460300332|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
127911605|NCT01695239|460300333|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
127911606|NCT01695239|460300334|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
127911607|NCT01695239|460300335|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
127911608|NCT01695239|460300336|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
127911609|NCT01695239|460300337|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
127911610|NCT01695239|460300338|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
127911611|NCT01695239|460300339|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
127911612|NCT01695239|460300340|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
127911613|NCT01695239|460300341|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
127911614|NCT01695239|460300342|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
127911615|NCT01695239|460300343|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
127911616|NCT01695239|460300330|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
127911617|NCT01695239|460300331|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
127911618|NCT01695239|460300332|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
127911619|NCT01695239|460300333|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
127911620|NCT01695239|460300334|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
127911621|NCT01695239|460300335|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
127911622|NCT01695239|460300336|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
127911623|NCT01695239|460300337|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
127911624|NCT01695239|460300338|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
127911625|NCT01695239|460300339|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
127911626|NCT01695239|460300340|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
127911627|NCT01695239|460300341|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
127911628|NCT01695239|460300342|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
127911629|NCT01695239|460300343|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
127911630|NCT01695239|460300330|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
127911631|NCT01695239|460300331|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
127911632|NCT01695239|460300332|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
127911633|NCT01695239|460300333|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
127911634|NCT01695239|460300334|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
127911635|NCT01695239|460300335|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
127911636|NCT01695239|460300336|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
127911637|NCT01695239|460300337|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
127911638|NCT01695239|460300338|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
127911639|NCT01695239|460300339|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
127911640|NCT01695239|460300340|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
127911641|NCT01695239|460300341|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
127911642|NCT01695239|460300342|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
127911643|NCT01695239|460300343|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
127911644|NCT01695239|460300330|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
127911645|NCT01695239|460300331|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
127911646|NCT01695239|460300332|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
127911647|NCT01695239|460300333|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
127911648|NCT01695239|460300334|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
127911649|NCT01695239|460300335|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
127911650|NCT01695239|460300336|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
127911651|NCT01695239|460300337|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
127859378|NCT00963820|460100326|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
127859379|NCT00963820|460100327|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
127859380|NCT00963820|460100328|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
127911652|NCT01695239|460300338|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
127911653|NCT01695239|460300339|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
127911654|NCT01695239|460300340|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
127911655|NCT01695239|460300341|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
127911656|NCT01695239|460300342|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
127911657|NCT01695239|460300343|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
127911658|NCT01695239|460300330|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
127911659|NCT01695239|460300331|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
127911660|NCT01695239|460300332|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
127911661|NCT01695239|460300333|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
127911662|NCT01695239|460300334|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
127911663|NCT01695239|460300335|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
127911664|NCT01695239|460300336|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
127911665|NCT01695239|460300337|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
127911666|NCT01695239|460300338|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
127911667|NCT01695239|460300339|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
127911668|NCT01695239|460300340|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
127911669|NCT01695239|460300341|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
127911670|NCT01695239|460300342|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
127911671|NCT01695239|460300343|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
127911672|NCT01695239|460300330|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
127911673|NCT01695239|460300331|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
127911674|NCT01695239|460300332|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
127911675|NCT01695239|460300333|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
127911676|NCT01695239|460300334|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
127911677|NCT01695239|460300335|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
127911678|NCT01695239|460300336|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
127911679|NCT01695239|460300337|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
127911680|NCT01695239|460300338|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
127911681|NCT01695239|460300339|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
127911682|NCT01695239|460300340|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
127911683|NCT01695239|460300341|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
127911684|NCT01695239|460300342|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
127911685|NCT01695239|460300343|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
127911686|NCT01695239|460300330|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
127911687|NCT01695239|460300331|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
127911688|NCT01695239|460300332|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
127911689|NCT01695239|460300333|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
127911690|NCT01695239|460300334|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
127911691|NCT01695239|460300335|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
127911692|NCT01695239|460300336|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
127911693|NCT01695239|460300337|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
127911694|NCT01695239|460300338|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
127911695|NCT01695239|460300339|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
127911696|NCT01695239|460300340|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
127911697|NCT01695239|460300341|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
127911698|NCT01695239|460300342|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
127911699|NCT01695239|460300343|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
127911700|NCT01695239|460300330|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
127911701|NCT01695239|460300331|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
127911702|NCT01695239|460300332|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
127911703|NCT01695239|460300333|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
127911704|NCT01695239|460300334|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
127911705|NCT01695239|460300335|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
127911706|NCT01695239|460300336|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
127911707|NCT01695239|460300337|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
127911708|NCT01695239|460300338|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
127911709|NCT01695239|460300339|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
127911710|NCT01695239|460300340|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
127911711|NCT01695239|460300341|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
127911712|NCT01695239|460300342|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
127911713|NCT01695239|460300343|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
127911714|NCT01695239|460300330|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
127911715|NCT01695239|460300331|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
127911716|NCT01695239|460300332|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
127911717|NCT01695239|460300333|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
127911718|NCT01695239|460300334|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
127911719|NCT01695239|460300335|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
127911720|NCT01695239|460300336|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
127911721|NCT01695239|460300337|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
127911722|NCT01695239|460300338|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
127911723|NCT01695239|460300339|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
127911724|NCT01695239|460300340|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
127911725|NCT01695239|460300341|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
127911726|NCT01695239|460300342|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
127911727|NCT01695239|460300343|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
127911728|NCT01695239|460300330|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
127911729|NCT01695239|460300331|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
127911730|NCT01695239|460300332|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
127911731|NCT01695239|460300333|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
127911732|NCT01695239|460300334|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
127911733|NCT01695239|460300335|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
127911734|NCT01695239|460300336|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
127911735|NCT01695239|460300337|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
127911736|NCT01695239|460300338|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
127911737|NCT01695239|460300339|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
127911738|NCT01695239|460300340|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
127911739|NCT01695239|460300341|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
127911740|NCT01695239|460300342|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
127911741|NCT01695239|460300343|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
127911742|NCT01695239|460300330|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
127911743|NCT01695239|460300331|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
127911744|NCT01695239|460300332|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
127911745|NCT01695239|460300333|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
127911746|NCT01695239|460300334|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
127911747|NCT01695239|460300335|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
127911748|NCT01695239|460300336|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
127911749|NCT01695239|460300337|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
127911750|NCT01695239|460300338|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
127911751|NCT01695239|460300339|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
127911752|NCT01695239|460300340|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
127911753|NCT01695239|460300341|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
127911754|NCT01695239|460300342|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
127911755|NCT01695239|460300343|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
127911756|NCT01695239|460300330|FG000|Extension Long-Term Extension Periods|Death|0|||
127911757|NCT01695239|460300331|FG001|Extension Long-Term Extension Periods|Death|0|||
127911758|NCT01695239|460300332|FG002|Extension Long-Term Extension Periods|Death|0|||
127911759|NCT01695239|460300333|FG003|Extension Long-Term Extension Periods|Death|0|||
127911760|NCT01695239|460300334|FG004|Extension Long-Term Extension Periods|Death|0|||
127911761|NCT01695239|460300335|FG005|Extension Long-Term Extension Periods|Death|0|||
127911762|NCT01695239|460300336|FG006|Extension Long-Term Extension Periods|Death|0|||
127911763|NCT01695239|460300337|FG007|Extension Long-Term Extension Periods|Death|0|||
127911764|NCT01695239|460300338|FG008|Extension Long-Term Extension Periods|Death|1|||
127911765|NCT01695239|460300339|FG009|Extension Long-Term Extension Periods|Death|0|||
127911766|NCT01695239|460300340|FG010|Extension Long-Term Extension Periods|Death|0|||
127911767|NCT01695239|460300341|FG011|Extension Long-Term Extension Periods|Death|0|||
127911768|NCT01695239|460300342|FG012|Extension Long-Term Extension Periods|Death|0|||
127911769|NCT01695239|460300343|FG013|Extension Long-Term Extension Periods|Death|0|||
127911770|NCT01695239|460300330|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
127911771|NCT01695239|460300331|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
127911772|NCT01695239|460300332|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
127911773|NCT01695239|460300333|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
127911774|NCT01695239|460300334|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
127911775|NCT01695239|460300335|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
127911776|NCT01695239|460300336|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
127911777|NCT01695239|460300337|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
127911778|NCT01695239|460300338|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
127911779|NCT01695239|460300339|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
127911780|NCT01695239|460300340|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
127911781|NCT01695239|460300341|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
127911782|NCT01695239|460300342|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
127911783|NCT01695239|460300343|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
127911784|NCT01695239|460300330|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
127911785|NCT01695239|460300331|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
127911786|NCT01695239|460300332|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
127911787|NCT01695239|460300333|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
127911788|NCT01695239|460300334|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
127911789|NCT01695239|460300335|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
127911790|NCT01695239|460300336|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
127911791|NCT01695239|460300337|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
127911792|NCT01695239|460300338|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
127911793|NCT01695239|460300339|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
127911794|NCT01695239|460300340|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
127911795|NCT01695239|460300341|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
127911796|NCT01695239|460300342|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
127911797|NCT01695239|460300343|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
127911798|NCT01695239|460300330|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
127911799|NCT01695239|460300331|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
127911800|NCT01695239|460300332|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
127911801|NCT01695239|460300333|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
127911802|NCT01695239|460300334|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
127911803|NCT01695239|460300335|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
127911804|NCT01695239|460300336|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
127911805|NCT01695239|460300337|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
127911806|NCT01695239|460300338|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
127911807|NCT01695239|460300339|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
127911808|NCT01695239|460300340|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
127911809|NCT01695239|460300341|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
127911810|NCT01695239|460300342|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
127911811|NCT01695239|460300343|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
127911812|NCT01695239|460300330|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
127911813|NCT01695239|460300331|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
127911814|NCT01695239|460300332|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
127911815|NCT01695239|460300333|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
127911816|NCT01695239|460300334|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
127911817|NCT01695239|460300335|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
127911818|NCT01695239|460300336|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
127911819|NCT01695239|460300337|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
127911820|NCT01695239|460300338|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
127911821|NCT01695239|460300339|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
127911822|NCT01695239|460300340|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
127911823|NCT01695239|460300341|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
127911824|NCT01695239|460300342|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
127859381|NCT02354690|460100329|FG000|Overall Study|Physician Decision|1|||
127859382|NCT04556175|460100337|FG000|Overall Study|Study terminated due to COVID-19|8|||
127859383|NCT04556175|460100338|FG001|Overall Study|Study terminated due to COVID-19|8|||
127859384|NCT05549505|460100340|FG000|Overall Study|Lost to Follow-up|2|||
127859385|NCT05549505|460100341|FG001|Overall Study|Lost to Follow-up|0|||
127859386|NCT05549505|460100340|FG000|Overall Study|Withdrawal by Subject|3|||
127859387|NCT05549505|460100341|FG001|Overall Study|Withdrawal by Subject|3|||
127859388|NCT05549505|460100340|FG000|Overall Study|Other: Miscellaneous|3|||
127859389|NCT05549505|460100341|FG001|Overall Study|Other: Miscellaneous|6|||
127859390|NCT01602822|460100344|FG000|Overall Study|Adverse Event|11|||
127859391|NCT05492877|460100348|FG000|Overall Study|Adverse Event|11|||
127859392|NCT05492877|460100349|FG001|Overall Study|Adverse Event|7|||
127859393|NCT05492877|460100348|FG000|Overall Study|Death|1|||
127859394|NCT05492877|460100349|FG001|Overall Study|Death|0|||
127859395|NCT05492877|460100348|FG000|Overall Study|Lost to Follow-up|1|||
127859396|NCT05492877|460100349|FG001|Overall Study|Lost to Follow-up|1|||
127859397|NCT05492877|460100348|FG000|Overall Study|Physician Decision|1|||
127859398|NCT05492877|460100349|FG001|Overall Study|Physician Decision|2|||
127911825|NCT01695239|460300343|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
127859399|NCT05492877|460100348|FG000|Overall Study|Protocol Violation|1|||
127859400|NCT05492877|460100349|FG001|Overall Study|Protocol Violation|1|||
127859401|NCT05492877|460100348|FG000|Overall Study|Withdrawal by Subject|3|||
127859402|NCT05492877|460100349|FG001|Overall Study|Withdrawal by Subject|7|||
127859403|NCT05492877|460100348|FG000|Overall Study|Reason not specified|6|||
127859404|NCT05492877|460100349|FG001|Overall Study|Reason not specified|4|||
127859405|NCT02286089|460100350|FG000|Overall Study|Ongoing in Study|1|||
127859406|NCT02286089|460100351|FG001|Overall Study|Ongoing in Study|1|||
127859407|NCT02286089|460100352|FG002|Overall Study|Ongoing in Study|4|||
127859408|NCT02286089|460100353|FG003|Overall Study|Ongoing in Study|10|||
127859409|NCT02286089|460100350|FG000|Overall Study|Withdrawal by Subject|0|||
127859410|NCT02286089|460100351|FG001|Overall Study|Withdrawal by Subject|0|||
127859411|NCT02286089|460100352|FG002|Overall Study|Withdrawal by Subject|2|||
127859412|NCT02286089|460100353|FG003|Overall Study|Withdrawal by Subject|2|||
127859413|NCT00129376|460100354|FG000|Overall Study|Adverse Event|1|||
127859414|NCT00129376|460100354|FG000|Overall Study|Lack of Efficacy|1|||
127859415|NCT03218826|460100361|FG000|Overall Study|Non-compliance with protocol|1|||
127859416|NCT03218826|460100362|FG001|Overall Study|Non-compliance with protocol|0|||
127859417|NCT03218826|460100363|FG002|Overall Study|Non-compliance with protocol|2|||
127859418|NCT03218826|460100364|FG003|Overall Study|Non-compliance with protocol|1|||
127859419|NCT03218826|460100365|FG004|Overall Study|Non-compliance with protocol|1|||
127859420|NCT00355615|460100370|FG000|Randomized Double Blind Period|Adverse Event|1|||
127859421|NCT00355615|460100371|FG001|Randomized Double Blind Period|Adverse Event|0|||
127859422|NCT00355615|460100372|FG002|Randomized Double Blind Period|Adverse Event|0|||
127859423|NCT00355615|460100373|FG003|Randomized Double Blind Period|Adverse Event|0|||
127859424|NCT00355615|460100374|FG004|Randomized Double Blind Period|Adverse Event|0|||
127859425|NCT00355615|460100370|FG000|Randomized Double Blind Period|Protocol Violation|0|||
127859426|NCT00355615|460100371|FG001|Randomized Double Blind Period|Protocol Violation|0|||
127859427|NCT00355615|460100372|FG002|Randomized Double Blind Period|Protocol Violation|1|||
127859428|NCT00355615|460100373|FG003|Randomized Double Blind Period|Protocol Violation|1|||
127859429|NCT00355615|460100374|FG004|Randomized Double Blind Period|Protocol Violation|0|||
127859430|NCT00355615|460100370|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
127859431|NCT00355615|460100371|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
127859432|NCT00355615|460100372|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
127859433|NCT00355615|460100373|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
127859434|NCT00355615|460100374|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
127859435|NCT00355615|460100370|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
127859436|NCT00355615|460100371|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
127859437|NCT00355615|460100372|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
127859438|NCT00355615|460100373|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
127859439|NCT00355615|460100374|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
127859440|NCT00355615|460100370|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
127859441|NCT00355615|460100371|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
127859442|NCT00355615|460100372|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
127859443|NCT00355615|460100373|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
127859444|NCT00355615|460100374|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
127859445|NCT00355615|460100370|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
127859446|NCT00355615|460100371|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
127859447|NCT00355615|460100372|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
127859448|NCT00355615|460100373|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
127859449|NCT00355615|460100374|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
127859450|NCT03523715|460100375|FG000|Overall Study|Lost to Follow-up|11|||
127859451|NCT03523715|460100376|FG001|Overall Study|Lost to Follow-up|14|||
127859452|NCT03523715|460100375|FG000|Overall Study|Did not meet inclusion criteria|1|||
127859453|NCT03523715|460100376|FG001|Overall Study|Did not meet inclusion criteria|0|||
127859454|NCT03523715|460100375|FG000|Overall Study|Internally inconsistent reporting|0|||
127859455|NCT03523715|460100376|FG001|Overall Study|Internally inconsistent reporting|2|||
127859456|NCT01842334|460100377|FG000|Overall Study|Withdrawal by Subject|3|||
127859457|NCT01842334|460100378|FG001|Overall Study|Withdrawal by Subject|3|||
127859458|NCT01842334|460100377|FG000|Overall Study|Moved away mid-study|0|||
127859459|NCT01842334|460100378|FG001|Overall Study|Moved away mid-study|1|||
127859460|NCT03299166|460100386|FG000|Overall Study|Adverse Event|9|||
127859461|NCT03299166|460100387|FG001|Overall Study|Adverse Event|4|||
127859462|NCT03299166|460100386|FG000|Overall Study|Withdrawal by Subject|6|||
127859463|NCT03299166|460100387|FG001|Overall Study|Withdrawal by Subject|5|||
127859464|NCT03299166|460100386|FG000|Overall Study|Physician Decision|1|||
127859465|NCT03299166|460100387|FG001|Overall Study|Physician Decision|1|||
127859466|NCT03299166|460100386|FG000|Overall Study|Sponsor Decision|3|||
127859467|NCT03299166|460100387|FG001|Overall Study|Sponsor Decision|0|||
127859468|NCT03299166|460100386|FG000|Overall Study|Lost to Follow-up|2|||
127859469|NCT03299166|460100387|FG001|Overall Study|Lost to Follow-up|4|||
127859470|NCT03299166|460100386|FG000|Overall Study|Randomization Error|0|||
127859471|NCT03299166|460100387|FG001|Overall Study|Randomization Error|1|||
127859472|NCT03299166|460100386|FG000|Overall Study|Subject unable to return due to COVID|1|||
127859473|NCT03299166|460100387|FG001|Overall Study|Subject unable to return due to COVID|0|||
127859474|NCT03299166|460100386|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
127859475|NCT03299166|460100387|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
127911826|NCT05239195|460300345|FG000|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|2|||
127911827|NCT05239195|460300346|FG001|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|1|||
127911828|NCT03552484|460300347|FG000|Overall Study|Death|6|||
127911829|NCT03552484|460300348|FG001|Overall Study|Death|4|||
127911830|NCT03552484|460300347|FG000|Overall Study|Lost to Follow-up|0|||
127911831|NCT03552484|460300348|FG001|Overall Study|Lost to Follow-up|16|||
127911832|NCT02663349|460300354|FG000|Overall Study|Withdrawal by Subject|6|||
127911833|NCT00488774|460300355|FG000|Overall Study|Withdrawal of consent|2|||
127911834|NCT00488774|460300356|FG001|Overall Study|Withdrawal of consent|2|||
127911835|NCT00488774|460300357|FG002|Overall Study|Withdrawal of consent|2|||
127911836|NCT00488774|460300358|FG003|Overall Study|Withdrawal of consent|0|||
127911837|NCT00488774|460300355|FG000|Overall Study|Other|6|||
127911838|NCT00488774|460300356|FG001|Overall Study|Other|3|||
127911839|NCT00488774|460300357|FG002|Overall Study|Other|2|||
127911840|NCT00488774|460300358|FG003|Overall Study|Other|2|||
127911841|NCT00488774|460300355|FG000|Overall Study|Lost to Follow-up|0|||
127911842|NCT00488774|460300356|FG001|Overall Study|Lost to Follow-up|0|||
127911843|NCT00488774|460300357|FG002|Overall Study|Lost to Follow-up|1|||
127911844|NCT00488774|460300358|FG003|Overall Study|Lost to Follow-up|1|||
127911845|NCT01204294|460300359|FG000|Overall Study|Adverse Event|2|||
127911846|NCT01204294|460300360|FG001|Overall Study|Adverse Event|6|||
127911847|NCT01204294|460300361|FG002|Overall Study|Adverse Event|0|||
127911848|NCT01204294|460300362|FG003|Overall Study|Adverse Event|7|||
127911849|NCT01204294|460300363|FG004|Overall Study|Adverse Event|1|||
127911850|NCT01204294|460300364|FG005|Overall Study|Adverse Event|4|||
127911851|NCT01204294|460300365|FG006|Overall Study|Adverse Event|0|||
127911852|NCT01204294|460300359|FG000|Overall Study|Protocol Violation|1|||
127911853|NCT01204294|460300360|FG001|Overall Study|Protocol Violation|0|||
127911854|NCT01204294|460300361|FG002|Overall Study|Protocol Violation|2|||
127911855|NCT01204294|460300362|FG003|Overall Study|Protocol Violation|1|||
127911856|NCT01204294|460300363|FG004|Overall Study|Protocol Violation|0|||
127911857|NCT01204294|460300364|FG005|Overall Study|Protocol Violation|0|||
127911858|NCT01204294|460300365|FG006|Overall Study|Protocol Violation|0|||
127911859|NCT01204294|460300359|FG000|Overall Study|Withdrawal by Subject|0|||
127911860|NCT01204294|460300360|FG001|Overall Study|Withdrawal by Subject|2|||
127911861|NCT01204294|460300361|FG002|Overall Study|Withdrawal by Subject|2|||
127911862|NCT01204294|460300362|FG003|Overall Study|Withdrawal by Subject|1|||
127911863|NCT01204294|460300363|FG004|Overall Study|Withdrawal by Subject|1|||
127911864|NCT01204294|460300364|FG005|Overall Study|Withdrawal by Subject|1|||
127911865|NCT01204294|460300365|FG006|Overall Study|Withdrawal by Subject|2|||
127911866|NCT01204294|460300359|FG000|Overall Study|Lack of Efficacy|0|||
127911867|NCT01204294|460300360|FG001|Overall Study|Lack of Efficacy|0|||
127911868|NCT01204294|460300361|FG002|Overall Study|Lack of Efficacy|0|||
127911869|NCT01204294|460300362|FG003|Overall Study|Lack of Efficacy|2|||
127911870|NCT01204294|460300363|FG004|Overall Study|Lack of Efficacy|0|||
127911871|NCT01204294|460300364|FG005|Overall Study|Lack of Efficacy|0|||
127911872|NCT01204294|460300365|FG006|Overall Study|Lack of Efficacy|0|||
127911873|NCT01204294|460300359|FG000|Overall Study|Other (house moving)|0|||
127911874|NCT01204294|460300360|FG001|Overall Study|Other (house moving)|0|||
127911875|NCT01204294|460300361|FG002|Overall Study|Other (house moving)|1|||
127911876|NCT01204294|460300362|FG003|Overall Study|Other (house moving)|0|||
127911877|NCT01204294|460300363|FG004|Overall Study|Other (house moving)|0|||
127911878|NCT01204294|460300364|FG005|Overall Study|Other (house moving)|0|||
127911879|NCT01204294|460300365|FG006|Overall Study|Other (house moving)|0|||
127911880|NCT03128723|460300368|FG000|Overall Study|Withdrawal by Subject|2|||
127911881|NCT00673660|460300369|FG000|Overall Study|Lost to Follow-up|107|||
127911882|NCT00245063|460300370|FG000|Overall Study|Adverse Event|6|||
127911883|NCT00245063|460300371|FG001|Overall Study|Adverse Event|5|||
127911884|NCT00245063|460300370|FG000|Overall Study|Death|1|||
127911885|NCT00245063|460300371|FG001|Overall Study|Death|0|||
127859476|NCT04055844|460100388|FG000|Overall Study|Adverse Event|12|||
127859477|NCT04055844|460100388|FG000|Overall Study|Poor Performance|1|||
127859478|NCT04055844|460100388|FG000|Overall Study|Death|1|||
127859479|NCT00572728|460100389|FG000|Overall Study|Withdrawal by Subject|10|||
127859480|NCT00572728|460100389|FG000|Overall Study|Ineligible|3|||
127859481|NCT00572728|460100389|FG000|Overall Study|Enrolled under Amendment 4|5|||
127859482|NCT00572728|460100389|FG000|Overall Study|Offstudy due to complicating disease|1|||
127859483|NCT00572728|460100389|FG000|Overall Study|FLT1 not completed|4|||
127859484|NCT00572728|460100389|FG000|Overall Study|First Chemotherapy not initiated|2|||
127859485|NCT00572728|460100389|FG000|Overall Study|FLT2 not completed|5|||
127859486|NCT00572728|460100389|FG000|Overall Study|Second chemotherapy not initiated|1|||
127859487|NCT00572728|460100389|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
127859488|NCT00572728|460100389|FG000|Overall Study|Pathology missing|1|||
127859489|NCT00002981|460100390|FG000|Overall Study|Inevaluable|6|||
127859490|NCT03457636|460100393|FG000|Overall Study|Lost to Follow-up|2|||
127859491|NCT01885104|460100394|FG000|Overall Study|Withdrawal of Consent|1|||
127859492|NCT01885104|460100395|FG001|Overall Study|Withdrawal of Consent|0|||
127859493|NCT01885104|460100394|FG000|Overall Study|Lost to Follow-up|0|||
127859494|NCT01885104|460100395|FG001|Overall Study|Lost to Follow-up|1|||
127859495|NCT01885104|460100394|FG000|Overall Study|Physician Decision|1|||
127859496|NCT01885104|460100395|FG001|Overall Study|Physician Decision|0|||
127859497|NCT00113555|460100396|FG000|Overall Study|Baseline Failure|59|||
127859498|NCT00113555|460100396|FG000|Overall Study|Permanently Explanted|7|||
127859499|NCT00113555|460100396|FG000|Overall Study|Death|1|||
127859500|NCT00113555|460100396|FG000|Overall Study|Missed Followup|4|||
127859501|NCT00113555|460100396|FG000|Overall Study|Lost to Follow-up|8|||
127859502|NCT04035473|460100407|FG000|Screening/Baseline|Death|0|||
127859503|NCT04035473|460100408|FG001|Screening/Baseline|Death|1|||
127859504|NCT04035473|460100407|FG000|Screening/Baseline|Adverse Event|0|||
127859505|NCT04035473|460100408|FG001|Screening/Baseline|Adverse Event|1|||
127859506|NCT04035473|460100407|FG000|Follow-up Period|Adverse Event|2|||
127859507|NCT04035473|460100408|FG001|Follow-up Period|Adverse Event|0|||
127859508|NCT00112840|460100409|FG000|Overall Study|Physician Decision|1|||
127859509|NCT00112840|460100410|FG001|Overall Study|Physician Decision|0|||
127859510|NCT00112840|460100411|FG002|Overall Study|Physician Decision|0|||
127859511|NCT00112840|460100409|FG000|Overall Study|Withdrawal by Subject|1|||
127859512|NCT00112840|460100410|FG001|Overall Study|Withdrawal by Subject|0|||
127859513|NCT00112840|460100411|FG002|Overall Study|Withdrawal by Subject|1|||
127859514|NCT00112840|460100409|FG000|Overall Study|Protocol Violation|0|||
127859515|NCT00112840|460100410|FG001|Overall Study|Protocol Violation|0|||
127859516|NCT00112840|460100411|FG002|Overall Study|Protocol Violation|5|||
127859517|NCT02299206|460100412|FG000|Overall Study|Lost to Follow-up|1|||
127859518|NCT02299206|460100412|FG000|Overall Study|Withdrawal by Subject|1|||
127859519|NCT02875366|460100413|FG000|Overall Study|Adverse Event|0|||
127859520|NCT02875366|460100414|FG001|Overall Study|Adverse Event|2|||
127859521|NCT02875366|460100413|FG000|Overall Study|Noncompliance|0|||
127859522|NCT02875366|460100414|FG001|Overall Study|Noncompliance|1|||
127859523|NCT03595176|460100415|FG000|Overall Study|Death|0|||
127859524|NCT03595176|460100416|FG001|Overall Study|Death|2|||
127859525|NCT03595176|460100415|FG000|Overall Study|Lost to Follow-up|0|||
127859526|NCT03595176|460100416|FG001|Overall Study|Lost to Follow-up|1|||
127859527|NCT02141854|460100420|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
127859528|NCT02141854|460100421|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
127859529|NCT02141854|460100422|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
127859530|NCT02141854|460100423|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
127859531|NCT02141854|460100424|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
127859532|NCT02141854|460100425|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
127859533|NCT02141854|460100420|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
127859534|NCT02141854|460100421|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
127859535|NCT02141854|460100422|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
127859536|NCT02141854|460100423|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
127859537|NCT02141854|460100424|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
127859538|NCT02141854|460100425|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
127859539|NCT02141854|460100420|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
127859540|NCT02141854|460100421|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
127859541|NCT02141854|460100422|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
127859542|NCT02141854|460100423|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
127859543|NCT02141854|460100424|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
127859544|NCT02141854|460100425|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
127859545|NCT02141854|460100420|FG000|Run-In Period (Pre-assignment)|Other|14|||
127859546|NCT02141854|460100421|FG001|Run-In Period (Pre-assignment)|Other|0|||
127859547|NCT02141854|460100422|FG002|Run-In Period (Pre-assignment)|Other|0|||
127911886|NCT05099380|460300373|FG000|Overall Study|Subject enrolled in error|1|||
127911887|NCT05099380|460300374|FG001|Overall Study|Subject enrolled in error|0|||
127911888|NCT05099380|460300373|FG000|Overall Study|Study Procedure|1|||
127911889|NCT05099380|460300374|FG001|Overall Study|Study Procedure|0|||
127911890|NCT05099380|460300373|FG000|Overall Study|Protocol Violation|1|||
127911891|NCT05099380|460300374|FG001|Overall Study|Protocol Violation|0|||
127911892|NCT05099380|460300373|FG000|Overall Study|Adverse Event|1|||
127911893|NCT05099380|460300374|FG001|Overall Study|Adverse Event|1|||
127911894|NCT05099380|460300373|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
127911895|NCT05099380|460300374|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
127911896|NCT01839279|460300375|FG000|Overall Study|Adverse Event|4|||
127911897|NCT01839279|460300376|FG001|Overall Study|Adverse Event|1|||
127911898|NCT01839279|460300377|FG002|Overall Study|Adverse Event|1|||
127911899|NCT01839279|460300375|FG000|Overall Study|Withdrawal by Subject|4|||
127911900|NCT01839279|460300376|FG001|Overall Study|Withdrawal by Subject|1|||
127911901|NCT01839279|460300377|FG002|Overall Study|Withdrawal by Subject|1|||
127911902|NCT01839279|460300375|FG000|Overall Study|Classified as 'Other'|5|||
127911903|NCT01839279|460300376|FG001|Overall Study|Classified as 'Other'|0|||
127911904|NCT01839279|460300377|FG002|Overall Study|Classified as 'Other'|0|||
127911905|NCT03276754|460300378|FG000|Overall Study|Withdrawal of informed consent|4|||
127911906|NCT03276754|460300378|FG000|Overall Study|Presence of any immunosuppressive condition|8|||
127911907|NCT03276754|460300378|FG000|Overall Study|Lost to Follow-up|27|||
127911908|NCT03276754|460300378|FG000|Overall Study|No data reported at Month 24|31|||
127911909|NCT03276754|460300378|FG000|Overall Study|Death|39|||
127911910|NCT00316277|460300380|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
127911911|NCT00316277|460300381|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
127911912|NCT00316277|460300380|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
127911913|NCT00316277|460300381|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
127911914|NCT00316277|460300380|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
127911915|NCT00316277|460300381|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
127911916|NCT00316277|460300380|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
127911917|NCT00316277|460300381|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
127911918|NCT00316277|460300380|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
127911919|NCT00316277|460300381|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
127911920|NCT00835263|460300382|FG000|Second Intervention|Adverse Event|1|||
127911921|NCT00835263|460300383|FG001|Second Intervention|Adverse Event|0|||
127911922|NCT03669861|460300384|FG000|Overall Study|Disease Flare|5|||
127911923|NCT03669861|460300384|FG000|Overall Study|Lack of Efficacy|2|||
127911924|NCT01604941|460300387|FG000|Overall Study|Adverse Event|1|||
127911925|NCT01604941|460300388|FG001|Overall Study|Adverse Event|2|||
127911926|NCT01604941|460300389|FG002|Overall Study|Adverse Event|0|||
127911927|NCT01604941|460300390|FG003|Overall Study|Adverse Event|0|||
127911928|NCT01604941|460300391|FG004|Overall Study|Adverse Event|1|||
127911929|NCT01604941|460300392|FG005|Overall Study|Adverse Event|5|||
127911930|NCT01604941|460300387|FG000|Overall Study|Non-compliance|1|||
127911931|NCT01604941|460300388|FG001|Overall Study|Non-compliance|0|||
127911932|NCT01604941|460300389|FG002|Overall Study|Non-compliance|0|||
127911933|NCT01604941|460300390|FG003|Overall Study|Non-compliance|0|||
127911934|NCT01604941|460300391|FG004|Overall Study|Non-compliance|0|||
127911935|NCT01604941|460300392|FG005|Overall Study|Non-compliance|0|||
127911936|NCT01604941|460300387|FG000|Overall Study|Participant Decision|0|||
127859548|NCT02141854|460100423|FG003|Run-In Period (Pre-assignment)|Other|0|||
127859549|NCT02141854|460100424|FG004|Run-In Period (Pre-assignment)|Other|0|||
127859550|NCT02141854|460100425|FG005|Run-In Period (Pre-assignment)|Other|0|||
127859551|NCT02141854|460100420|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
127859552|NCT02141854|460100421|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
127859553|NCT02141854|460100422|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
127859554|NCT02141854|460100423|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
127859555|NCT02141854|460100424|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
127859556|NCT02141854|460100425|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
127859557|NCT02141854|460100420|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
127859558|NCT02141854|460100421|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
127859559|NCT02141854|460100422|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
127859560|NCT02141854|460100423|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
127859561|NCT02141854|460100424|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
127859562|NCT02141854|460100425|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
127859563|NCT02141854|460100420|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
127859564|NCT02141854|460100421|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
127859565|NCT02141854|460100422|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
127859566|NCT02141854|460100423|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
127859567|NCT02141854|460100424|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
127859568|NCT02141854|460100425|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
127859569|NCT02141854|460100420|FG000|Treatment Period|Protocol Violation|0|||
127859570|NCT02141854|460100421|FG001|Treatment Period|Protocol Violation|1|||
127859571|NCT02141854|460100422|FG002|Treatment Period|Protocol Violation|0|||
127859572|NCT02141854|460100423|FG003|Treatment Period|Protocol Violation|2|||
127859573|NCT02141854|460100424|FG004|Treatment Period|Protocol Violation|2|||
127859574|NCT02141854|460100425|FG005|Treatment Period|Protocol Violation|1|||
127859575|NCT02141854|460100420|FG000|Treatment Period|Noncompliance|0|||
127859576|NCT02141854|460100421|FG001|Treatment Period|Noncompliance|0|||
127859577|NCT02141854|460100422|FG002|Treatment Period|Noncompliance|0|||
127859578|NCT02141854|460100423|FG003|Treatment Period|Noncompliance|1|||
127859579|NCT02141854|460100424|FG004|Treatment Period|Noncompliance|0|||
127859580|NCT02141854|460100425|FG005|Treatment Period|Noncompliance|0|||
127859581|NCT02141854|460100420|FG000|Treatment Period|Lack of Efficacy|0|||
127859582|NCT02141854|460100421|FG001|Treatment Period|Lack of Efficacy|0|||
127859583|NCT02141854|460100422|FG002|Treatment Period|Lack of Efficacy|0|||
127859584|NCT02141854|460100423|FG003|Treatment Period|Lack of Efficacy|1|||
127859585|NCT02141854|460100424|FG004|Treatment Period|Lack of Efficacy|1|||
127859586|NCT02141854|460100425|FG005|Treatment Period|Lack of Efficacy|7|||
127859587|NCT02141854|460100420|FG000|Treatment Period|Pregnancy|0|||
127859588|NCT02141854|460100421|FG001|Treatment Period|Pregnancy|1|||
127859589|NCT02141854|460100422|FG002|Treatment Period|Pregnancy|0|||
127859590|NCT02141854|460100423|FG003|Treatment Period|Pregnancy|0|||
127859591|NCT02141854|460100424|FG004|Treatment Period|Pregnancy|0|||
127859592|NCT02141854|460100425|FG005|Treatment Period|Pregnancy|0|||
127859593|NCT02141854|460100420|FG000|Treatment Period|Other|0|||
127859594|NCT02141854|460100421|FG001|Treatment Period|Other|1|||
127859595|NCT02141854|460100422|FG002|Treatment Period|Other|2|||
127859596|NCT02141854|460100423|FG003|Treatment Period|Other|0|||
127859597|NCT02141854|460100424|FG004|Treatment Period|Other|1|||
127859598|NCT02141854|460100425|FG005|Treatment Period|Other|2|||
127859599|NCT02141854|460100420|FG000|Treatment Period|Adverse Event|0|||
127859600|NCT02141854|460100421|FG001|Treatment Period|Adverse Event|2|||
127859601|NCT02141854|460100422|FG002|Treatment Period|Adverse Event|2|||
127859602|NCT02141854|460100423|FG003|Treatment Period|Adverse Event|0|||
127859603|NCT02141854|460100424|FG004|Treatment Period|Adverse Event|2|||
127859604|NCT02141854|460100425|FG005|Treatment Period|Adverse Event|2|||
127859605|NCT02141854|460100420|FG000|Treatment Period|Withdrawal by Subject|0|||
127859606|NCT02141854|460100421|FG001|Treatment Period|Withdrawal by Subject|2|||
127859607|NCT02141854|460100422|FG002|Treatment Period|Withdrawal by Subject|3|||
127859608|NCT02141854|460100423|FG003|Treatment Period|Withdrawal by Subject|3|||
127859609|NCT02141854|460100424|FG004|Treatment Period|Withdrawal by Subject|4|||
127859610|NCT02141854|460100425|FG005|Treatment Period|Withdrawal by Subject|7|||
127859611|NCT02141854|460100420|FG000|Treatment Period|Disease progression|0|||
127859612|NCT02141854|460100421|FG001|Treatment Period|Disease progression|2|||
127859613|NCT02141854|460100422|FG002|Treatment Period|Disease progression|1|||
127859614|NCT02141854|460100423|FG003|Treatment Period|Disease progression|3|||
127911937|NCT01604941|460300388|FG001|Overall Study|Participant Decision|0|||
127911938|NCT01604941|460300389|FG002|Overall Study|Participant Decision|0|||
127911939|NCT01604941|460300390|FG003|Overall Study|Participant Decision|0|||
127911940|NCT01604941|460300391|FG004|Overall Study|Participant Decision|0|||
127911941|NCT01604941|460300392|FG005|Overall Study|Participant Decision|2|||
127911942|NCT01604941|460300387|FG000|Overall Study|Early Study Termination|9|||
127911943|NCT01604941|460300388|FG001|Overall Study|Early Study Termination|2|||
127911944|NCT01604941|460300389|FG002|Overall Study|Early Study Termination|3|||
127911945|NCT01604941|460300390|FG003|Overall Study|Early Study Termination|3|||
127911946|NCT01604941|460300391|FG004|Overall Study|Early Study Termination|0|||
127911947|NCT01604941|460300392|FG005|Overall Study|Early Study Termination|0|||
127911948|NCT05479058|460300393|FG000|Overall Study|Withdrawal by Subject|1|||
127911949|NCT05479058|460300394|FG001|Overall Study|Withdrawal by Subject|1|||
127911950|NCT05479058|460300393|FG000|Overall Study|Study terminated by sponsor|10|||
127911951|NCT05479058|460300394|FG001|Overall Study|Study terminated by sponsor|10|||
127911952|NCT04078022|460300399|FG000|Vaccination Phase|Withdrawal prior to challenge|2|||
127911953|NCT04078022|460300400|FG001|Vaccination Phase|Withdrawal prior to challenge|3|||
127911954|NCT00463684|460300401|FG000|Overall Study|Withdrawal by Subject|1|||
127911955|NCT00463684|460300401|FG000|Overall Study|Lost to Follow-up|3|||
127911956|NCT00191815|460300402|FG000|Overall Study|Adverse Event|2|||
127911957|NCT00191815|460300402|FG000|Overall Study|Disease progression or relapse|24|||
127911958|NCT00191815|460300402|FG000|Overall Study|Death|2|||
127911959|NCT00191815|460300402|FG000|Overall Study|Protocol Violation|3|||
127911960|NCT00191815|460300402|FG000|Overall Study|Physician Decision|2|||
127911961|NCT00191815|460300402|FG000|Overall Study|Withdrawal by Subject|7|||
127911962|NCT01075282|460300403|FG000|Overall Study|Withdrawal by Subject|11|||
127911963|NCT01075282|460300404|FG001|Overall Study|Withdrawal by Subject|7|||
127911964|NCT01075282|460300405|FG002|Overall Study|Withdrawal by Subject|11|||
127911965|NCT01075282|460300403|FG000|Overall Study|Adverse Event|9|||
127911966|NCT01075282|460300404|FG001|Overall Study|Adverse Event|8|||
127911967|NCT01075282|460300405|FG002|Overall Study|Adverse Event|5|||
127911968|NCT01075282|460300403|FG000|Overall Study|Entry Criteria Not Met|3|||
127911969|NCT01075282|460300404|FG001|Overall Study|Entry Criteria Not Met|2|||
127911970|NCT01075282|460300405|FG002|Overall Study|Entry Criteria Not Met|0|||
127911971|NCT01075282|460300403|FG000|Overall Study|Lost to Follow-up|3|||
127911972|NCT01075282|460300404|FG001|Overall Study|Lost to Follow-up|3|||
127911973|NCT01075282|460300405|FG002|Overall Study|Lost to Follow-up|3|||
127911974|NCT01075282|460300403|FG000|Overall Study|Physician Decision|3|||
127911975|NCT01075282|460300404|FG001|Overall Study|Physician Decision|3|||
127911976|NCT01075282|460300405|FG002|Overall Study|Physician Decision|3|||
127911977|NCT01075282|460300403|FG000|Overall Study|Lack of Efficacy|1|||
127911978|NCT01075282|460300404|FG001|Overall Study|Lack of Efficacy|1|||
127911979|NCT01075282|460300405|FG002|Overall Study|Lack of Efficacy|0|||
127911980|NCT01075282|460300403|FG000|Overall Study|Treatment Non-compliance|1|||
127911981|NCT01075282|460300404|FG001|Overall Study|Treatment Non-compliance|2|||
127911982|NCT01075282|460300405|FG002|Overall Study|Treatment Non-compliance|2|||
127911983|NCT01075282|460300403|FG000|Overall Study|Protocol Violation|0|||
127911984|NCT01075282|460300404|FG001|Overall Study|Protocol Violation|2|||
127911985|NCT01075282|460300405|FG002|Overall Study|Protocol Violation|1|||
127911986|NCT01075282|460300403|FG000|Overall Study|Death|0|||
127911987|NCT01075282|460300404|FG001|Overall Study|Death|1|||
127911988|NCT01075282|460300405|FG002|Overall Study|Death|2|||
127911989|NCT00003470|460300406|FG000|Overall Study|Not evaluable|6|||
127911990|NCT01794845|460300408|FG000|Overall Study|Withdrawal by Subject|1|||
127911991|NCT02139826|460300409|FG000|Overall Study|Adverse Event|1|||
127911992|NCT01456221|460300410|FG000|Overall Study|Withdrawal by Subject|56|||
127911993|NCT01456221|460300411|FG001|Overall Study|Withdrawal by Subject|49|||
127911994|NCT01456221|460300410|FG000|Overall Study|Lost to Follow-up|1|||
127911995|NCT01456221|460300411|FG001|Overall Study|Lost to Follow-up|4|||
127911996|NCT01456221|460300410|FG000|Overall Study|Received medication|3|||
127911997|NCT01456221|460300411|FG001|Overall Study|Received medication|2|||
127911998|NCT01456221|460300410|FG000|Overall Study|Incomplete data|4|||
127911999|NCT01456221|460300411|FG001|Overall Study|Incomplete data|2|||
127912000|NCT06647173|460300414|FG000|Overall Study|Lost to Follow-up|24|||
127912001|NCT01473953|460300415|FG000|Overall Study|Other|1|||
127912002|NCT01473953|460300416|FG001|Overall Study|Other|0|||
127912003|NCT01473953|460300417|FG002|Overall Study|Other|0|||
127912004|NCT01473953|460300418|FG003|Overall Study|Other|0|||
127912005|NCT01473953|460300419|FG004|Overall Study|Other|0|||
127912006|NCT01494532|460300420|FG000|Overall Study|Adverse Event|4|||
127912007|NCT01494532|460300421|FG001|Overall Study|Adverse Event|1|||
127912008|NCT01494532|460300422|FG002|Overall Study|Adverse Event|8|||
127912009|NCT01494532|460300423|FG003|Overall Study|Adverse Event|6|||
127912010|NCT01494532|460300424|FG004|Overall Study|Adverse Event|5|||
127912011|NCT01494532|460300425|FG005|Overall Study|Adverse Event|0|||
127912012|NCT01494532|460300420|FG000|Overall Study|Lack of Efficacy|0|||
127912013|NCT01494532|460300421|FG001|Overall Study|Lack of Efficacy|0|||
127912014|NCT01494532|460300422|FG002|Overall Study|Lack of Efficacy|0|||
127912015|NCT01494532|460300423|FG003|Overall Study|Lack of Efficacy|0|||
127912016|NCT01494532|460300424|FG004|Overall Study|Lack of Efficacy|2|||
127912017|NCT01494532|460300425|FG005|Overall Study|Lack of Efficacy|0|||
127912018|NCT01494532|460300420|FG000|Overall Study|Protocol deviation|2|||
127912019|NCT01494532|460300421|FG001|Overall Study|Protocol deviation|1|||
127912020|NCT01494532|460300422|FG002|Overall Study|Protocol deviation|3|||
127912021|NCT01494532|460300423|FG003|Overall Study|Protocol deviation|2|||
127912022|NCT01494532|460300424|FG004|Overall Study|Protocol deviation|3|||
127912023|NCT01494532|460300425|FG005|Overall Study|Protocol deviation|0|||
127912024|NCT01494532|460300420|FG000|Overall Study|Protocol-defined stopping criteria|0|||
127912025|NCT01494532|460300421|FG001|Overall Study|Protocol-defined stopping criteria|0|||
127912026|NCT01494532|460300422|FG002|Overall Study|Protocol-defined stopping criteria|1|||
127912027|NCT01494532|460300423|FG003|Overall Study|Protocol-defined stopping criteria|0|||
127912028|NCT01494532|460300424|FG004|Overall Study|Protocol-defined stopping criteria|0|||
127912029|NCT01494532|460300425|FG005|Overall Study|Protocol-defined stopping criteria|0|||
127912030|NCT01494532|460300420|FG000|Overall Study|Lost to Follow-up|1|||
127912031|NCT01494532|460300421|FG001|Overall Study|Lost to Follow-up|0|||
127912032|NCT01494532|460300422|FG002|Overall Study|Lost to Follow-up|0|||
127912033|NCT01494532|460300423|FG003|Overall Study|Lost to Follow-up|2|||
127912034|NCT01494532|460300424|FG004|Overall Study|Lost to Follow-up|0|||
127912035|NCT01494532|460300425|FG005|Overall Study|Lost to Follow-up|0|||
127912036|NCT01494532|460300420|FG000|Overall Study|Physician Decision|0|||
127912037|NCT01494532|460300421|FG001|Overall Study|Physician Decision|1|||
127912038|NCT01494532|460300422|FG002|Overall Study|Physician Decision|1|||
127912039|NCT01494532|460300423|FG003|Overall Study|Physician Decision|2|||
127912040|NCT01494532|460300424|FG004|Overall Study|Physician Decision|0|||
127912041|NCT01494532|460300425|FG005|Overall Study|Physician Decision|0|||
127912042|NCT01494532|460300420|FG000|Overall Study|Withdrawal by Subject|3|||
127912043|NCT01494532|460300421|FG001|Overall Study|Withdrawal by Subject|1|||
127912044|NCT01494532|460300422|FG002|Overall Study|Withdrawal by Subject|4|||
127912045|NCT01494532|460300423|FG003|Overall Study|Withdrawal by Subject|3|||
127912046|NCT01494532|460300424|FG004|Overall Study|Withdrawal by Subject|2|||
127912047|NCT01494532|460300425|FG005|Overall Study|Withdrawal by Subject|0|||
127912048|NCT06999265|460300426|FG000|Overall Study|Lost to Follow-up|1|||
127912049|NCT06999265|460300427|FG001|Overall Study|Lost to Follow-up|1|||
127912050|NCT01319383|460301636|FG000|Overall Study|No ex vivo or in vivo response|4|||
127912051|NCT01319383|460301637|FG001|Overall Study|No ex vivo or in vivo response|0|||
127912052|NCT01319383|460301636|FG000|Overall Study|Physician Decision|3|||
127912053|NCT01319383|460301637|FG001|Overall Study|Physician Decision|0|||
127912054|NCT01319383|460301636|FG000|Overall Study|Lack of Efficacy|5|||
127912055|NCT01319383|460301637|FG001|Overall Study|Lack of Efficacy|9|||
127912056|NCT01319383|460301636|FG000|Overall Study|No in vivo response to interval doses|0|||
127912057|NCT01319383|460301637|FG001|Overall Study|No in vivo response to interval doses|1|||
127912058|NCT00772603|460301638|FG000|Overall Study|Withdrawal by Subject|11|||
127912059|NCT00772603|460301639|FG001|Overall Study|Withdrawal by Subject|10|||
127912060|NCT00772603|460301640|FG002|Overall Study|Withdrawal by Subject|6|||
127912061|NCT00772603|460301638|FG000|Overall Study|Adverse Event|37|||
127912062|NCT00772603|460301639|FG001|Overall Study|Adverse Event|18|||
127912063|NCT00772603|460301640|FG002|Overall Study|Adverse Event|10|||
127912064|NCT00772603|460301638|FG000|Overall Study|Subject Non-compliance|1|||
127912065|NCT00772603|460301639|FG001|Overall Study|Subject Non-compliance|6|||
127912066|NCT00772603|460301640|FG002|Overall Study|Subject Non-compliance|4|||
127912067|NCT00772603|460301638|FG000|Overall Study|Protocol Violation|0|||
127912068|NCT00772603|460301639|FG001|Overall Study|Protocol Violation|1|||
127912069|NCT00772603|460301640|FG002|Overall Study|Protocol Violation|1|||
127912070|NCT00772603|460301638|FG000|Overall Study|Lost to Follow-up|1|||
127912071|NCT00772603|460301639|FG001|Overall Study|Lost to Follow-up|5|||
127912072|NCT00772603|460301640|FG002|Overall Study|Lost to Follow-up|2|||
127912073|NCT00772603|460301638|FG000|Overall Study|Physician Decision|0|||
127912074|NCT00772603|460301639|FG001|Overall Study|Physician Decision|0|||
127912075|NCT00772603|460301640|FG002|Overall Study|Physician Decision|1|||
127912076|NCT00772603|460301638|FG000|Overall Study|Other|2|||
127912077|NCT00772603|460301639|FG001|Overall Study|Other|0|||
127912078|NCT00772603|460301640|FG002|Overall Study|Other|2|||
127912079|NCT01056484|460301643|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
127912080|NCT01056484|460301644|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
127912081|NCT01056484|460301643|FG000|Randomized Controlled Trial|Physician Decision|1|||
127912082|NCT01056484|460301644|FG001|Randomized Controlled Trial|Physician Decision|0|||
127912083|NCT01056484|460301643|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
127912084|NCT01056484|460301644|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
127912085|NCT01564394|460301647|FG000|Overall Study|Withdrawal by Subject|6|||
127912086|NCT01564394|460301648|FG001|Overall Study|Withdrawal by Subject|10|||
127912087|NCT02888756|460301650|FG000|Analytical Treatment Interruption|Physician Decision|10|||
127912088|NCT02888756|460301651|FG001|Analytical Treatment Interruption|Physician Decision|6|||
127912089|NCT02888756|460301652|FG002|Analytical Treatment Interruption|Physician Decision|5|||
127912090|NCT04590027|460301655|FG000|Overall Study|Lost to Follow-up|17|||
127912091|NCT04590027|460301656|FG001|Overall Study|Lost to Follow-up|14|||
127912092|NCT04590027|460301655|FG000|Overall Study|Protocol Violation|0|||
127912093|NCT04590027|460301656|FG001|Overall Study|Protocol Violation|3|||
127912094|NCT02682238|460301657|FG000|Overall Study|Lost to Follow-up|0|||
127912095|NCT02682238|460301658|FG001|Overall Study|Lost to Follow-up|2|||
127912096|NCT02682238|460301657|FG000|Overall Study|Withdrawal by Subject|1|||
127912097|NCT02682238|460301658|FG001|Overall Study|Withdrawal by Subject|0|||
127912098|NCT02682238|460301657|FG000|Overall Study|Adverse Event|1|||
127912099|NCT02682238|460301658|FG001|Overall Study|Adverse Event|0|||
127912100|NCT02682238|460301657|FG000|Overall Study|Non-compliance with Study Drug|1|||
127912101|NCT02682238|460301658|FG001|Overall Study|Non-compliance with Study Drug|0|||
127912102|NCT02682238|460301657|FG000|Overall Study|Non-compliance with Protocol|0|||
127912103|NCT02682238|460301658|FG001|Overall Study|Non-compliance with Protocol|2|||
127912104|NCT02909907|460301659|FG000|Overall Study|Withdrawal by Subject|0|||
127912105|NCT02909907|460301660|FG001|Overall Study|Withdrawal by Subject|1|||
127912106|NCT00075478|460301661|FG000|Overall Study|not eligible|1|||
127912107|NCT00075478|460301662|FG001|Overall Study|not eligible|0|||
127912108|NCT00075478|460301661|FG000|Overall Study|Physician Decision|0|||
127912109|NCT00075478|460301662|FG001|Overall Study|Physician Decision|1|||
127912110|NCT02075463|460301664|FG000|Overall Study|Adverse Event|3|||
127912111|NCT02075463|460301664|FG000|Overall Study|Par. reached stopping criteria|4|||
127912112|NCT02075463|460301664|FG000|Overall Study|Withdrawal by Subject|1|||
127912113|NCT01383486|460301666|FG000|Overall Study|Lost to Follow-up|10|||
127912114|NCT01383486|460301666|FG000|Overall Study|Incomplete information for analysis|2|||
127912115|NCT01383486|460301666|FG000|Overall Study|Did not take any product|6|||
127912116|NCT03437265|460301667|FG000|Overall Study|Protocol Violation|6|||
127912117|NCT00848536|460301676|FG000|Overall Study|Adverse Event|2|||
127912118|NCT00848536|460301677|FG001|Overall Study|Adverse Event|2|||
127912119|NCT00848536|460301676|FG000|Overall Study|Withdrawal by Subject|0|||
127912120|NCT00848536|460301677|FG001|Overall Study|Withdrawal by Subject|1|||
127912121|NCT00848536|460301676|FG000|Overall Study|Protocol Violation|0|||
127912122|NCT00848536|460301677|FG001|Overall Study|Protocol Violation|1|||
127912123|NCT00848536|460301676|FG000|Overall Study|Noncompliance|1|||
127912124|NCT00848536|460301677|FG001|Overall Study|Noncompliance|0|||
127912125|NCT00848536|460301676|FG000|Overall Study|Inadequate Control of IOP|1|||
127912126|NCT00848536|460301677|FG001|Overall Study|Inadequate Control of IOP|1|||
127912127|NCT00848536|460301676|FG000|Overall Study|Patient Moved|0|||
127912128|NCT00848536|460301677|FG001|Overall Study|Patient Moved|2|||
127912129|NCT03987191|460301678|FG000|Overall Study|COVID-19 related research disruption|0|||
127912130|NCT03987191|460301679|FG001|Overall Study|COVID-19 related research disruption|2|||
127912131|NCT03261167|460301680|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
127912132|NCT03261167|460301681|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
127912133|NCT03261167|460301680|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
127912134|NCT03261167|460301681|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
127912135|NCT03261167|460301680|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
127912136|NCT03261167|460301681|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
127912137|NCT03261167|460301680|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
127912138|NCT03261167|460301681|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
127912139|NCT03261167|460301680|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
127912140|NCT03261167|460301681|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
127912141|NCT01572662|460301682|FG000|Overall Study|Withdrawal by Subject|1|||
127912142|NCT01572662|460301683|FG001|Overall Study|Withdrawal by Subject|0|||
127912143|NCT01572662|460301682|FG000|Overall Study|Physician Decision|0|||
127912144|NCT01572662|460301683|FG001|Overall Study|Physician Decision|1|||
127912145|NCT03364192|460301684|FG000|Overall Study|Ineligible|10|||
127912146|NCT03364192|460301684|FG000|Overall Study|Withdrawal by Subject|5|||
127912147|NCT03364192|460301684|FG000|Overall Study|Lost to Follow-up|1|||
127912148|NCT00918645|460301685|FG000|Overall Study|Withdrawal by Subject|1|||
127912149|NCT05133180|460301686|FG000|Overall Study|Withdrawal of consent|1|||
127912150|NCT05133180|460301687|FG001|Overall Study|Withdrawal of consent|1|||
127912151|NCT05133180|460301686|FG000|Overall Study|Lost to Follow-up|1|||
127912152|NCT05133180|460301687|FG001|Overall Study|Lost to Follow-up|1|||
127912153|NCT05133180|460301686|FG000|Overall Study|Documented disease progression|0|||
127912154|NCT05133180|460301687|FG001|Overall Study|Documented disease progression|1|||
127912155|NCT03446768|460301688|FG000|Overall Study|Withdrawal by Subject|0|||
127912156|NCT03446768|460301689|FG001|Overall Study|Withdrawal by Subject|1|||
127912157|NCT01535222|460301690|FG000|Overall Study|Inclusion/exclusion|0|||
127912158|NCT01535222|460301691|FG001|Overall Study|Inclusion/exclusion|0|||
127912159|NCT01535222|460301692|FG002|Overall Study|Inclusion/exclusion|1|||
127912160|NCT01535222|460301693|FG003|Overall Study|Inclusion/exclusion|0|||
127912161|NCT01535222|460301694|FG004|Overall Study|Inclusion/exclusion|0|||
127912162|NCT01535222|460301695|FG005|Overall Study|Inclusion/exclusion|0|||
127912163|NCT00935012|460301696|FG000|Overall Study|Death|19|||
127912164|NCT00935012|460301696|FG000|Overall Study|Withdrawal by Subject|3|||
127912165|NCT00935012|460301696|FG000|Overall Study|Other|5|||
127912166|NCT00935012|460301696|FG000|Overall Study|Adverse Event|2|||
127912167|NCT01442155|460301697|FG000|Overall Study|Complete remission|35|||
127912168|NCT01442155|460301697|FG000|Overall Study|Recurrence|26|||
127912169|NCT01442155|460301697|FG000|Overall Study|Adverse Event|2|||
127912170|NCT01442155|460301697|FG000|Overall Study|Lost to Follow-up|2|||
127912171|NCT00705666|460301698|FG000|Overall Study|No post-treatment questionnaire|279|||
127912172|NCT00705666|460301698|FG000|Overall Study|Withdrawal by Subject|21|||
127912173|NCT00705666|460301698|FG000|Overall Study|Physician Decision|7|||
127912174|NCT00705666|460301698|FG000|Overall Study|Lost to Follow-up|5|||
127912175|NCT00705666|460301698|FG000|Overall Study|Death|1|||
127912176|NCT00705666|460301698|FG000|Overall Study|Adverse Event|4|||
127912177|NCT00705666|460301698|FG000|Overall Study|Other|12|||
127912178|NCT00705666|460301698|FG000|Overall Study|Other|2|||
127912179|NCT00705666|460301698|FG000|Overall Study|Lack of data|3|||
127912180|NCT00705666|460301698|FG000|Overall Study|Untreated|5|||
127912181|NCT01590563|460301707|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
127912182|NCT03256695|460301708|FG000|Overall Study|Adverse Event|8|||
127912183|NCT03256695|460301708|FG000|Overall Study|Death|2|||
127912184|NCT03256695|460301708|FG000|Overall Study|Withdrawal by Subject|14|||
127912185|NCT03256695|460301708|FG000|Overall Study|Non-compliance with study drug|1|||
127912186|NCT03256695|460301708|FG000|Overall Study|Lost to Follow-up|3|||
127912187|NCT03256695|460301708|FG000|Overall Study|Lack of Efficacy|3|||
127912188|NCT03256695|460301708|FG000|Overall Study|Protocol Violation|5|||
127912189|NCT03256695|460301708|FG000|Overall Study|Other than specified|3|||
127912190|NCT03930732|460301709|FG000|Overall Study|Adverse Event|9|||
127912191|NCT03930732|460301710|FG001|Overall Study|Adverse Event|7|||
127912192|NCT03930732|460301709|FG000|Overall Study|Poor compliance to protocol|0|||
127912193|NCT03930732|460301710|FG001|Overall Study|Poor compliance to protocol|1|||
127912194|NCT03930732|460301709|FG000|Overall Study|Withdrawal by Subject|23|||
127912195|NCT03930732|460301710|FG001|Overall Study|Withdrawal by Subject|11|||
127912196|NCT03930732|460301709|FG000|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|0|||
127912197|NCT03930732|460301710|FG001|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|1|||
127912198|NCT03930732|460301709|FG000|Overall Study|Other reason not related to COVID-19|5|||
127912199|NCT03930732|460301710|FG001|Overall Study|Other reason not related to COVID-19|8|||
127912200|NCT03406156|460301711|FG000|Overall Study|Death|9|||
127912201|NCT03406156|460301712|FG001|Overall Study|Death|3|||
127912202|NCT03406156|460301711|FG000|Overall Study|Withdrawal by Subject|1|||
127912203|NCT03406156|460301712|FG001|Overall Study|Withdrawal by Subject|2|||
127912204|NCT03406156|460301711|FG000|Overall Study|COVID-19 infection|1|||
127912205|NCT03406156|460301712|FG001|Overall Study|COVID-19 infection|0|||
127912206|NCT03406156|460301711|FG000|Overall Study|Non-compliance with study procedures|1|||
127912207|NCT03406156|460301712|FG001|Overall Study|Non-compliance with study procedures|1|||
127912208|NCT03406156|460301711|FG000|Overall Study|Lost to Follow-up|0|||
127912209|NCT03406156|460301712|FG001|Overall Study|Lost to Follow-up|2|||
127912210|NCT03406156|460301711|FG000|Overall Study|Other, not specified|72|||
127912211|NCT03406156|460301712|FG001|Overall Study|Other, not specified|28|||
127912212|NCT03366792|460301715|FG000|Overall Study|Withdrawal by Subject|7|||
127912213|NCT03366792|460301715|FG000|Overall Study|Lost to Follow-up|2|||
127912214|NCT03366792|460301715|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
127912215|NCT03366792|460301715|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
127912216|NCT02450539|460301716|FG000|Overall Study|Withdrawal by Subject|12|||
127912217|NCT02450539|460301717|FG001|Overall Study|Withdrawal by Subject|6|||
127912218|NCT02450539|460301716|FG000|Overall Study|Lost to Follow-up|4|||
127912219|NCT02450539|460301717|FG001|Overall Study|Lost to Follow-up|1|||
127912220|NCT02699463|460301718|FG000|Overall Study|Lost to Follow-up|11|||
127912221|NCT02699463|460301719|FG001|Overall Study|Lost to Follow-up|8|||
127912222|NCT02699463|460301718|FG000|Overall Study|Withdrawal by Subject|4|||
127912223|NCT02699463|460301719|FG001|Overall Study|Withdrawal by Subject|1|||
127912224|NCT00585286|460301723|FG000|Overall Study|Lost to Follow-up|1|||
127912225|NCT00918684|460301726|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
127912226|NCT00918684|460301726|FG000|Treatment Phase|Lack of Efficacy|6|||
127912227|NCT00918684|460301726|FG000|Treatment Phase|Lost to Follow-up|2|||
127912228|NCT00918684|460301726|FG000|Treatment Phase|Physician Decision|8|||
127859615|NCT02141854|460100424|FG004|Treatment Period|Disease progression|0|||
127859616|NCT02141854|460100425|FG005|Treatment Period|Disease progression|18|||
127859617|NCT02141854|460100420|FG000|Treatment Period|Lost to Follow-up|0|||
127859618|NCT02141854|460100421|FG001|Treatment Period|Lost to Follow-up|1|||
127859619|NCT02141854|460100422|FG002|Treatment Period|Lost to Follow-up|1|||
127859620|NCT02141854|460100423|FG003|Treatment Period|Lost to Follow-up|1|||
127859621|NCT02141854|460100424|FG004|Treatment Period|Lost to Follow-up|0|||
127859622|NCT02141854|460100425|FG005|Treatment Period|Lost to Follow-up|1|||
127859623|NCT03128307|460100428|FG000|Overall Study|Lost to Follow-up|29|||
127859624|NCT03128307|460100428|FG000|Overall Study|Withdrawal by Subject|5|||
127859625|NCT05815758|460101948|FG000|Overall Study|Adverse Event|6|||
127859626|NCT05815758|460101949|FG001|Overall Study|Adverse Event|2|||
127859627|NCT05815758|460101948|FG000|Overall Study|Lost to Follow-up|14|||
127859628|NCT05815758|460101949|FG001|Overall Study|Lost to Follow-up|1|||
127859629|NCT05815758|460101948|FG000|Overall Study|Withdrawal by Subject|6|||
127859630|NCT05815758|460101949|FG001|Overall Study|Withdrawal by Subject|6|||
127859631|NCT05815758|460101948|FG000|Overall Study|Protocol Violation|1|||
127859632|NCT05815758|460101949|FG001|Overall Study|Protocol Violation|1|||
127859633|NCT05815758|460101948|FG000|Overall Study|Discontinued|4|||
127859634|NCT05815758|460101949|FG001|Overall Study|Discontinued|4|||
127859635|NCT02987205|460101950|FG000|Overall Study|Adverse Event|1|||
127859636|NCT02987205|460101950|FG000|Overall Study|Withdrawal by Subject|3|||
127859637|NCT04167514|460101953|FG000|Overall Study|Adverse event, not serious|0|||
127859638|NCT04167514|460101954|FG001|Overall Study|Adverse event, not serious|1|||
127859639|NCT04167514|460101953|FG000|Overall Study|Lost to Follow-up|1|||
127859640|NCT04167514|460101954|FG001|Overall Study|Lost to Follow-up|0|||
127859641|NCT04167514|460101953|FG000|Overall Study|Participant Decision|2|||
127859642|NCT04167514|460101954|FG001|Overall Study|Participant Decision|4|||
127859643|NCT04167514|460101953|FG000|Overall Study|Physician Decision|3|||
127859644|NCT04167514|460101954|FG001|Overall Study|Physician Decision|2|||
127859645|NCT04167514|460101953|FG000|Overall Study|Death|14|||
127859646|NCT04167514|460101954|FG001|Overall Study|Death|18|||
127859647|NCT04167514|460101953|FG000|Overall Study|Enrolled but treatment not administered|2|||
127859648|NCT04167514|460101954|FG001|Overall Study|Enrolled but treatment not administered|0|||
127859649|NCT04167514|460101953|FG000|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|3|||
127859650|NCT04167514|460101954|FG001|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|1|||
127859651|NCT04167514|460101953|FG000|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|2|||
127859652|NCT04167514|460101954|FG001|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|4|||
127859653|NCT03345849|460101955|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
127859654|NCT03345849|460101956|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
127859655|NCT03345849|460101957|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
127859656|NCT03345849|460101958|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
127859657|NCT03345849|460101955|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
127859658|NCT03345849|460101956|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
127859659|NCT03345849|460101957|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
127859660|NCT03345849|460101958|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
127859661|NCT03345849|460101955|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
127859662|NCT03345849|460101956|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
127859663|NCT03345849|460101957|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
127859664|NCT03345849|460101958|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
127859665|NCT03345849|460101955|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
127859666|NCT03345849|460101956|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
127859667|NCT03345849|460101957|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
127859668|NCT03345849|460101958|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
127859669|NCT03345849|460101955|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
127859670|NCT03345849|460101956|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
127859671|NCT03345849|460101957|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
127859672|NCT03345849|460101958|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
127859673|NCT03345849|460101955|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
127859674|NCT03345849|460101956|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
127859675|NCT03345849|460101957|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
127859676|NCT03345849|460101958|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
127859677|NCT03345849|460101955|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
127859678|NCT03345849|460101956|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
127859679|NCT03345849|460101957|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
127859680|NCT03345849|460101958|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
127859681|NCT03345849|460101955|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
127912229|NCT00918684|460301726|FG000|Treatment Phase|Protocol Violation|1|||
127912230|NCT00918684|460301726|FG000|Treatment Phase|Withdrawal by Subject|8|||
127912231|NCT00909038|460301727|FG000|Overall Study|Protocol Violation|187|||
127912232|NCT00909038|460301727|FG000|Overall Study|Non-evaluable Subjects|230|||
127912233|NCT00484679|460301728|FG000|Overall Study|Withdrawal by Subject|3|||
127912234|NCT00402103|460301729|FG000|Overall Study|Adverse Event|60|||
127912235|NCT00402103|460301730|FG001|Overall Study|Adverse Event|7|||
127912236|NCT00402103|460301729|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
127912237|NCT00402103|460301730|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
127912238|NCT00402103|460301729|FG000|Overall Study|Condition no longer requires study drug|2|||
127912239|NCT00402103|460301730|FG001|Overall Study|Condition no longer requires study drug|0|||
127912240|NCT00402103|460301729|FG000|Overall Study|Protocol Deviation|8|||
127912241|NCT00402103|460301730|FG001|Overall Study|Protocol Deviation|0|||
127912242|NCT00402103|460301729|FG000|Overall Study|Patient withdrew consent|12|||
127912243|NCT00402103|460301730|FG001|Overall Study|Patient withdrew consent|1|||
127912244|NCT00402103|460301729|FG000|Overall Study|Lost to Follow-up|6|||
127912245|NCT00402103|460301730|FG001|Overall Study|Lost to Follow-up|3|||
127912246|NCT00402103|460301729|FG000|Overall Study|Administrative problems|2|||
127912247|NCT00402103|460301730|FG001|Overall Study|Administrative problems|0|||
127912248|NCT00835692|460301731|FG000|First Intervention|Withdrawal by Subject|1|||
127912249|NCT00835692|460301732|FG001|First Intervention|Withdrawal by Subject|0|||
127912250|NCT04345653|460301735|FG000|Overall Study|Withdrawal by Subject|2|||
127912251|NCT01895335|460301740|FG000|Overall Study|Adverse Event|106|||
127912252|NCT01895335|460301740|FG000|Overall Study|Lack of Efficacy|53|||
127912253|NCT01895335|460301740|FG000|Overall Study|Poor Compliance to Protocol|11|||
127912254|NCT01895335|460301740|FG000|Overall Study|Included But Not treated|1|||
127912255|NCT01895335|460301740|FG000|Overall Study|Other than Specified Above|44|||
127912256|NCT00418938|460301741|FG000|Overall Study|Reimbursement|1|||
127912257|NCT00418938|460301742|FG001|Overall Study|Reimbursement|0|||
127912258|NCT00418938|460301741|FG000|Overall Study|Administrative decision|3|||
127912259|NCT00418938|460301742|FG001|Overall Study|Administrative decision|3|||
127912260|NCT00418938|460301741|FG000|Overall Study|Withdrawal by Subject|16|||
127912261|NCT00418938|460301742|FG001|Overall Study|Withdrawal by Subject|15|||
127912262|NCT00418938|460301741|FG000|Overall Study|Lost to Follow-up|1|||
127912263|NCT00418938|460301742|FG001|Overall Study|Lost to Follow-up|3|||
127912264|NCT00418938|460301741|FG000|Overall Study|Adverse Event|1|||
127912265|NCT00418938|460301742|FG001|Overall Study|Adverse Event|1|||
127912266|NCT00418938|460301741|FG000|Overall Study|On-going|1|||
127912267|NCT00418938|460301742|FG001|Overall Study|On-going|1|||
127912268|NCT00418938|460301741|FG000|Overall Study|Ineligibility Determined|1|||
127912269|NCT00418938|460301742|FG001|Overall Study|Ineligibility Determined|0|||
127912270|NCT00115063|460301743|FG000|Overall Study|Lost to Follow-up|98|||
127912271|NCT00115063|460301744|FG001|Overall Study|Lost to Follow-up|104|||
127912272|NCT00115063|460301743|FG000|Overall Study|Death|1|||
127912273|NCT00115063|460301744|FG001|Overall Study|Death|0|||
127912274|NCT03808376|460301745|FG000|Overall Study|Withdrawal by Subject|10|||
127912275|NCT03644550|460301746|FG000|Overall Study|Withdrawal by Subject|3|||
127912276|NCT03644550|460301746|FG000|Overall Study|Progressive disease|15|||
127912277|NCT01316055|460301754|FG000|Overall Study|Lost to Follow-up|1|||
127912278|NCT01316055|460301755|FG001|Overall Study|Lost to Follow-up|0|||
127912279|NCT01316055|460301756|FG002|Overall Study|Lost to Follow-up|0|||
127912280|NCT01348789|460301757|FG000|Overall Study|Protocol Violation|2|||
127912281|NCT01348789|460301757|FG000|Overall Study|Withdrawal by Subject|2|||
127912282|NCT03503318|460301760|FG000|Overall Study|Death|1|||
127912283|NCT03503318|460301761|FG001|Overall Study|Death|0|||
127912284|NCT03503318|460301762|FG002|Overall Study|Death|4|||
127912285|NCT03503318|460301760|FG000|Overall Study|Adverse Event|3|||
127912286|NCT03503318|460301761|FG001|Overall Study|Adverse Event|4|||
127912287|NCT03503318|460301762|FG002|Overall Study|Adverse Event|2|||
127912288|NCT03503318|460301760|FG000|Overall Study|Withdrawal by Subject|12|||
127912289|NCT03503318|460301761|FG001|Overall Study|Withdrawal by Subject|17|||
127912290|NCT03503318|460301762|FG002|Overall Study|Withdrawal by Subject|16|||
127912291|NCT03503318|460301760|FG000|Overall Study|Protocol Violation|5|||
127912292|NCT03503318|460301761|FG001|Overall Study|Protocol Violation|0|||
127912293|NCT03503318|460301762|FG002|Overall Study|Protocol Violation|3|||
127912294|NCT03503318|460301760|FG000|Overall Study|Lost to Follow-up|17|||
127912295|NCT03503318|460301761|FG001|Overall Study|Lost to Follow-up|15|||
127912296|NCT03503318|460301762|FG002|Overall Study|Lost to Follow-up|12|||
127912297|NCT03503318|460301760|FG000|Overall Study|Other than specified|1|||
127912298|NCT03503318|460301761|FG001|Overall Study|Other than specified|3|||
127912299|NCT03503318|460301762|FG002|Overall Study|Other than specified|3|||
127912300|NCT01825798|460301768|FG000|Overall Study|Adverse Event|1|||
127912301|NCT01825798|460301769|FG001|Overall Study|Adverse Event|5|||
127912302|NCT01825798|460301768|FG000|Overall Study|Lost to Follow-up|1|||
127912303|NCT01825798|460301769|FG001|Overall Study|Lost to Follow-up|0|||
127912304|NCT00834873|460301771|FG000|First Intervention|Adverse Event|0|||
127912305|NCT00834873|460301772|FG001|First Intervention|Adverse Event|1|||
127912306|NCT02358538|460301775|FG000|Through Week 26|Adverse Event|0|||
127912307|NCT02358538|460301776|FG001|Through Week 26|Adverse Event|1|||
127859682|NCT03345849|460101956|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
127859683|NCT03345849|460101957|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
127859684|NCT03345849|460101958|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
127859685|NCT03345849|460101955|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
127859686|NCT03345849|460101956|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
127859687|NCT03345849|460101957|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
127859688|NCT03345849|460101958|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
127859689|NCT03345849|460101955|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
127859690|NCT03345849|460101956|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
127859691|NCT03345849|460101957|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
127859692|NCT03345849|460101958|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
127859693|NCT03345849|460101955|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
127859694|NCT03345849|460101956|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
127859695|NCT03345849|460101957|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
127859696|NCT03345849|460101958|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
127859697|NCT04437511|460101961|FG000|Overall Study|Adverse Event|50|||
127859698|NCT04437511|460101962|FG001|Overall Study|Adverse Event|21|||
127859699|NCT04437511|460101961|FG000|Overall Study|Death|15|||
127859700|NCT04437511|460101962|FG001|Overall Study|Death|10|||
127859701|NCT04437511|460101961|FG000|Overall Study|Lost to Follow-up|11|||
127859702|NCT04437511|460101962|FG001|Overall Study|Lost to Follow-up|11|||
127859703|NCT04437511|460101961|FG000|Overall Study|Physician Decision|19|||
127859704|NCT04437511|460101962|FG001|Overall Study|Physician Decision|10|||
127859705|NCT04437511|460101961|FG000|Overall Study|Progressive Disease|4|||
127859706|NCT04437511|460101962|FG001|Overall Study|Progressive Disease|7|||
127859707|NCT04437511|460101961|FG000|Overall Study|Withdrawal by Subject|111|||
127859708|NCT04437511|460101962|FG001|Overall Study|Withdrawal by Subject|94|||
127859709|NCT04437511|460101961|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|21|||
127859710|NCT04437511|460101962|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|20|||
127859711|NCT04437511|460101961|FG000|Overall Study|Continuing Study|7|||
127859712|NCT04437511|460101962|FG001|Overall Study|Continuing Study|5|||
127859713|NCT03093350|460101967|FG000|Overall Study|Death|1|||
127859714|NCT03093350|460101967|FG000|Overall Study|Signed consent, never began treartment|1|||
127859715|NCT04517253|460101983|FG000|Primary Treatment Period|Adverse Event|1|||
127859716|NCT04517253|460101984|FG001|Primary Treatment Period|Adverse Event|0|||
127859717|NCT04517253|460101985|FG002|Primary Treatment Period|Adverse Event|0|||
127859718|NCT04517253|460101983|FG000|Primary Treatment Period|Death|0|||
127859719|NCT04517253|460101984|FG001|Primary Treatment Period|Death|1|||
127859720|NCT04517253|460101985|FG002|Primary Treatment Period|Death|0|||
127859721|NCT04517253|460101983|FG000|Maintenance Period|Withdrawal by Subject|1|||
127859722|NCT04517253|460101984|FG001|Maintenance Period|Withdrawal by Subject|0|||
127859723|NCT04517253|460101985|FG002|Maintenance Period|Withdrawal by Subject|0|||
127859724|NCT04517253|460101983|FG000|Maintenance Period|Study Terminated by Sponsor|3|||
127859725|NCT04517253|460101984|FG001|Maintenance Period|Study Terminated by Sponsor|2|||
127859726|NCT04517253|460101985|FG002|Maintenance Period|Study Terminated by Sponsor|2|||
127859727|NCT05564039|460101988|FG000|Overall Study|Adverse Event|1|||
127859728|NCT05564039|460101989|FG001|Overall Study|Adverse Event|0|||
127859729|NCT05564039|460101988|FG000|Overall Study|Death|1|||
127859730|NCT05564039|460101989|FG001|Overall Study|Death|1|||
127859731|NCT05564039|460101988|FG000|Overall Study|Lost to Follow-up|3|||
127859732|NCT05564039|460101989|FG001|Overall Study|Lost to Follow-up|2|||
127859733|NCT05564039|460101988|FG000|Overall Study|Withdrawal by Subject|2|||
127859734|NCT05564039|460101989|FG001|Overall Study|Withdrawal by Subject|0|||
127859735|NCT05564039|460101988|FG000|Overall Study|Inadvertent enrollment|3|||
127859736|NCT05564039|460101989|FG001|Overall Study|Inadvertent enrollment|6|||
127859737|NCT04785144|460101990|FG000|Overall Study|Withdrawal by Subject|4|||
127859738|NCT04785144|460101991|FG001|Overall Study|Withdrawal by Subject|1|||
127859739|NCT04785144|460101992|FG002|Overall Study|Withdrawal by Subject|0|||
127859740|NCT04785144|460101993|FG003|Overall Study|Withdrawal by Subject|0|||
127859741|NCT04785144|460101994|FG004|Overall Study|Withdrawal by Subject|0|||
127859742|NCT04785144|460101995|FG005|Overall Study|Withdrawal by Subject|2|||
127859743|NCT04785144|460101996|FG006|Overall Study|Withdrawal by Subject|2|||
127859744|NCT04785144|460101997|FG007|Overall Study|Withdrawal by Subject|0|||
127859745|NCT04785144|460101998|FG008|Overall Study|Withdrawal by Subject|1|||
127859746|NCT04785144|460101999|FG009|Overall Study|Withdrawal by Subject|0|||
127859747|NCT04785144|460101990|FG000|Overall Study|Lost to Follow-up|1|||
127859748|NCT04785144|460101991|FG001|Overall Study|Lost to Follow-up|0|||
127859749|NCT04785144|460101992|FG002|Overall Study|Lost to Follow-up|0|||
127859750|NCT04785144|460101993|FG003|Overall Study|Lost to Follow-up|0|||
127859751|NCT04785144|460101994|FG004|Overall Study|Lost to Follow-up|1|||
127859752|NCT04785144|460101995|FG005|Overall Study|Lost to Follow-up|2|||
127859753|NCT04785144|460101996|FG006|Overall Study|Lost to Follow-up|1|||
127859754|NCT04785144|460101997|FG007|Overall Study|Lost to Follow-up|2|||
127859755|NCT04785144|460101998|FG008|Overall Study|Lost to Follow-up|4|||
127859756|NCT04785144|460101999|FG009|Overall Study|Lost to Follow-up|1|||
127859757|NCT04785144|460101990|FG000|Overall Study|Protocol Violation|0|||
127859758|NCT04785144|460101991|FG001|Overall Study|Protocol Violation|0|||
127859759|NCT04785144|460101992|FG002|Overall Study|Protocol Violation|0|||
127859760|NCT04785144|460101993|FG003|Overall Study|Protocol Violation|0|||
127859761|NCT04785144|460101994|FG004|Overall Study|Protocol Violation|0|||
127859762|NCT04785144|460101995|FG005|Overall Study|Protocol Violation|0|||
127859763|NCT04785144|460101996|FG006|Overall Study|Protocol Violation|1|||
127859764|NCT04785144|460101997|FG007|Overall Study|Protocol Violation|0|||
127859765|NCT04785144|460101998|FG008|Overall Study|Protocol Violation|0|||
127859766|NCT04785144|460101999|FG009|Overall Study|Protocol Violation|0|||
127859767|NCT04785144|460101990|FG000|Overall Study|Physician Decision|0|||
127859768|NCT04785144|460101991|FG001|Overall Study|Physician Decision|0|||
127859769|NCT04785144|460101992|FG002|Overall Study|Physician Decision|0|||
127859770|NCT04785144|460101993|FG003|Overall Study|Physician Decision|0|||
127859771|NCT04785144|460101994|FG004|Overall Study|Physician Decision|0|||
127859772|NCT04785144|460101995|FG005|Overall Study|Physician Decision|0|||
127859773|NCT04785144|460101996|FG006|Overall Study|Physician Decision|0|||
127859774|NCT04785144|460101997|FG007|Overall Study|Physician Decision|0|||
127859775|NCT04785144|460101998|FG008|Overall Study|Physician Decision|0|||
127859776|NCT04785144|460101999|FG009|Overall Study|Physician Decision|1|||
127859777|NCT04785144|460101990|FG000|Overall Study|Unable to continue due to work schedule|0|||
127859778|NCT04785144|460101991|FG001|Overall Study|Unable to continue due to work schedule|0|||
127859779|NCT04785144|460101992|FG002|Overall Study|Unable to continue due to work schedule|0|||
127859780|NCT04785144|460101993|FG003|Overall Study|Unable to continue due to work schedule|0|||
127859781|NCT04785144|460101994|FG004|Overall Study|Unable to continue due to work schedule|0|||
127859782|NCT04785144|460101995|FG005|Overall Study|Unable to continue due to work schedule|0|||
127859783|NCT04785144|460101996|FG006|Overall Study|Unable to continue due to work schedule|0|||
127859784|NCT04785144|460101997|FG007|Overall Study|Unable to continue due to work schedule|0|||
127859785|NCT04785144|460101998|FG008|Overall Study|Unable to continue due to work schedule|0|||
127859786|NCT04785144|460101999|FG009|Overall Study|Unable to continue due to work schedule|1|||
127859787|NCT01263470|460102002|FG000|Overall Study|Adverse Event|2|||
127859788|NCT01263470|460102003|FG001|Overall Study|Adverse Event|2|||
127859789|NCT01263470|460102004|FG002|Overall Study|Adverse Event|1|||
127859790|NCT01263470|460102005|FG003|Overall Study|Adverse Event|1|||
127859791|NCT01263470|460102006|FG004|Overall Study|Adverse Event|2|||
127859792|NCT01263470|460102007|FG005|Overall Study|Adverse Event|2|||
127859793|NCT01263470|460102002|FG000|Overall Study|Protocol Violation|0|||
127859794|NCT01263470|460102003|FG001|Overall Study|Protocol Violation|1|||
127859795|NCT01263470|460102004|FG002|Overall Study|Protocol Violation|0|||
127859796|NCT01263470|460102005|FG003|Overall Study|Protocol Violation|0|||
127859797|NCT01263470|460102006|FG004|Overall Study|Protocol Violation|0|||
127859798|NCT01263470|460102007|FG005|Overall Study|Protocol Violation|1|||
127859799|NCT01263470|460102002|FG000|Overall Study|Withdrawal by Subject|0|||
127859800|NCT01263470|460102003|FG001|Overall Study|Withdrawal by Subject|1|||
127859801|NCT01263470|460102004|FG002|Overall Study|Withdrawal by Subject|1|||
127859802|NCT01263470|460102005|FG003|Overall Study|Withdrawal by Subject|2|||
127859803|NCT01263470|460102006|FG004|Overall Study|Withdrawal by Subject|0|||
127859804|NCT01263470|460102007|FG005|Overall Study|Withdrawal by Subject|2|||
127859805|NCT01263470|460102002|FG000|Overall Study|Lack of Efficacy|0|||
127859806|NCT01263470|460102003|FG001|Overall Study|Lack of Efficacy|0|||
127859807|NCT01263470|460102004|FG002|Overall Study|Lack of Efficacy|2|||
127859808|NCT01263470|460102005|FG003|Overall Study|Lack of Efficacy|0|||
127859809|NCT01263470|460102006|FG004|Overall Study|Lack of Efficacy|0|||
127859810|NCT01263470|460102007|FG005|Overall Study|Lack of Efficacy|0|||
127859811|NCT01263470|460102002|FG000|Overall Study|Participant Unavailability|0|||
127859812|NCT01263470|460102003|FG001|Overall Study|Participant Unavailability|1|||
127859813|NCT01263470|460102004|FG002|Overall Study|Participant Unavailability|0|||
127912308|NCT02358538|460301777|FG002|Through Week 26|Adverse Event|1|||
127912309|NCT02358538|460301778|FG003|Through Week 26|Adverse Event|2|||
127912310|NCT02358538|460301775|FG000|Through Week 26|Lack of Efficacy|1|||
127912311|NCT02358538|460301776|FG001|Through Week 26|Lack of Efficacy|1|||
127912312|NCT02358538|460301777|FG002|Through Week 26|Lack of Efficacy|3|||
127912313|NCT02358538|460301778|FG003|Through Week 26|Lack of Efficacy|3|||
127912314|NCT02358538|460301775|FG000|Through Week 26|Withdrawal by Subject|1|||
127912315|NCT02358538|460301776|FG001|Through Week 26|Withdrawal by Subject|0|||
127912316|NCT02358538|460301777|FG002|Through Week 26|Withdrawal by Subject|0|||
127912317|NCT02358538|460301778|FG003|Through Week 26|Withdrawal by Subject|0|||
127912318|NCT02358538|460301775|FG000|Through Week 26|Non-Compliance|0|||
127912319|NCT02358538|460301776|FG001|Through Week 26|Non-Compliance|0|||
127912320|NCT02358538|460301777|FG002|Through Week 26|Non-Compliance|1|||
127912321|NCT02358538|460301778|FG003|Through Week 26|Non-Compliance|0|||
127912322|NCT02358538|460301775|FG000|Through Week 26|Family did not see benefit from IP|1|||
127912323|NCT02358538|460301776|FG001|Through Week 26|Family did not see benefit from IP|0|||
127912324|NCT02358538|460301777|FG002|Through Week 26|Family did not see benefit from IP|0|||
127912325|NCT02358538|460301778|FG003|Through Week 26|Family did not see benefit from IP|0|||
127912326|NCT02358538|460301775|FG000|52 Week Extension Period|Lack of Efficacy|0|||
127912327|NCT02358538|460301776|FG001|52 Week Extension Period|Lack of Efficacy|0|||
127912328|NCT02358538|460301777|FG002|52 Week Extension Period|Lack of Efficacy|2|||
127912329|NCT02358538|460301778|FG003|52 Week Extension Period|Lack of Efficacy|4|||
127912330|NCT03500094|460301781|FG000|Overall Study|Withdrawal by Subject|1|||
127912331|NCT03500094|460301781|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
127912332|NCT03500094|460301781|FG000|Overall Study|Lost to Follow-up|1|||
127912333|NCT03114891|460301782|FG000|First Treatment Round|Lost to Follow-up|0|||
127912334|NCT03114891|460301783|FG001|First Treatment Round|Lost to Follow-up|1|||
127912335|NCT03114891|460301784|FG002|First Treatment Round|Lost to Follow-up|1|||
127912336|NCT03114891|460301785|FG003|First Treatment Round|Lost to Follow-up|0|||
127912337|NCT03114891|460301782|FG000|First Treatment Round|Withdrawal by Subject|0|||
127912338|NCT03114891|460301783|FG001|First Treatment Round|Withdrawal by Subject|2|||
127912339|NCT03114891|460301784|FG002|First Treatment Round|Withdrawal by Subject|0|||
127912340|NCT03114891|460301785|FG003|First Treatment Round|Withdrawal by Subject|1|||
127912341|NCT03114891|460301782|FG000|3 Week Break|Lost to Follow-up|1|||
127912342|NCT03114891|460301783|FG001|3 Week Break|Lost to Follow-up|0|||
127912343|NCT03114891|460301784|FG002|3 Week Break|Lost to Follow-up|0|||
127912344|NCT03114891|460301785|FG003|3 Week Break|Lost to Follow-up|1|||
127912345|NCT03114891|460301782|FG000|3 Week Break|Withdrawal by Subject|0|||
127912346|NCT03114891|460301783|FG001|3 Week Break|Withdrawal by Subject|1|||
127912347|NCT03114891|460301784|FG002|3 Week Break|Withdrawal by Subject|0|||
127912348|NCT03114891|460301785|FG003|3 Week Break|Withdrawal by Subject|0|||
127912349|NCT03114891|460301782|FG000|Second Treatment Round|Lost to Follow-up|1|||
127912350|NCT03114891|460301783|FG001|Second Treatment Round|Lost to Follow-up|0|||
127912351|NCT03114891|460301784|FG002|Second Treatment Round|Lost to Follow-up|0|||
127912352|NCT03114891|460301785|FG003|Second Treatment Round|Lost to Follow-up|0|||
127912353|NCT03114891|460301782|FG000|Second Treatment Round|Physician Decision|1|||
127912354|NCT03114891|460301783|FG001|Second Treatment Round|Physician Decision|0|||
127912355|NCT03114891|460301784|FG002|Second Treatment Round|Physician Decision|0|||
127912356|NCT03114891|460301785|FG003|Second Treatment Round|Physician Decision|0|||
127912357|NCT02068794|460303633|FG000|Overall Study|Withdrawal by Subject|0|||
127912358|NCT02068794|460303634|FG001|Overall Study|Withdrawal by Subject|1|||
127912359|NCT02068794|460303635|FG002|Overall Study|Withdrawal by Subject|2|||
127912360|NCT02068794|460303633|FG000|Overall Study|Early Progression|1|||
127912361|NCT02068794|460303634|FG001|Overall Study|Early Progression|0|||
127912362|NCT02068794|460303635|FG002|Overall Study|Early Progression|1|||
127912363|NCT02068794|460303633|FG000|Overall Study|Ineligible|0|||
127912364|NCT02068794|460303634|FG001|Overall Study|Ineligible|0|||
127912365|NCT02068794|460303635|FG002|Overall Study|Ineligible|1|||
127912366|NCT02316548|460303636|FG000|Overall Study|Protocol Violation|0|||
127912367|NCT02316548|460303637|FG001|Overall Study|Protocol Violation|1|||
127912368|NCT01958294|460303638|FG000|Overall Study|Clinical Circumstances|2|||
127912369|NCT02566850|460303640|FG000|Overall Study|Protocol Violation|1|||
127912370|NCT00830258|460303643|FG000|First Intervention|Adverse Event|1|||
127912371|NCT00830258|460303644|FG001|First Intervention|Adverse Event|0|||
127912372|NCT00830258|460303643|FG000|Washout: 7 Days|Protocol Violation|1|||
127912373|NCT00830258|460303644|FG001|Washout: 7 Days|Protocol Violation|0|||
127912374|NCT00682461|460303648|FG000|Overall Study|Adverse Event|5|||
127912375|NCT00682461|460303649|FG001|Overall Study|Adverse Event|7|||
127912376|NCT00682461|460303648|FG000|Overall Study|Lost to Follow-up|8|||
127912377|NCT00682461|460303649|FG001|Overall Study|Lost to Follow-up|5|||
127912378|NCT00682461|460303648|FG000|Overall Study|Withdrawal by Subject|12|||
127912379|NCT00682461|460303649|FG001|Overall Study|Withdrawal by Subject|19|||
127912380|NCT04035187|460303652|FG000|Overall Study|Withdrawal by Subject|2|||
127912381|NCT04035187|460303653|FG001|Overall Study|Withdrawal by Subject|1|||
127912382|NCT04035187|460303654|FG002|Overall Study|Withdrawal by Subject|0|||
127912383|NCT04035187|460303655|FG003|Overall Study|Withdrawal by Subject|0|||
127859814|NCT01263470|460102005|FG003|Overall Study|Participant Unavailability|0|||
127859815|NCT01263470|460102006|FG004|Overall Study|Participant Unavailability|0|||
127859816|NCT01263470|460102007|FG005|Overall Study|Participant Unavailability|0|||
127859817|NCT01263470|460102002|FG000|Overall Study|Study Drug Non-compliance|0|||
127859818|NCT01263470|460102003|FG001|Overall Study|Study Drug Non-compliance|0|||
127859819|NCT01263470|460102004|FG002|Overall Study|Study Drug Non-compliance|0|||
127859820|NCT01263470|460102005|FG003|Overall Study|Study Drug Non-compliance|0|||
127859821|NCT01263470|460102006|FG004|Overall Study|Study Drug Non-compliance|1|||
127859822|NCT01263470|460102007|FG005|Overall Study|Study Drug Non-compliance|0|||
127859823|NCT00610714|460102008|FG000|Overall Study|Adverse Event|3|||
127859824|NCT00610714|460102009|FG001|Overall Study|Adverse Event|1|||
127859825|NCT00610714|460102008|FG000|Overall Study|Death|12|||
127859826|NCT00610714|460102009|FG001|Overall Study|Death|18|||
127859827|NCT00610714|460102008|FG000|Overall Study|Withdrawal by Subject|9|||
127859828|NCT00610714|460102009|FG001|Overall Study|Withdrawal by Subject|3|||
127859829|NCT00610714|460102008|FG000|Overall Study|Study completion at 120 PFS events|2|||
127859830|NCT00610714|460102009|FG001|Overall Study|Study completion at 120 PFS events|2|||
127859831|NCT00712712|460102010|FG000|Overall Study|Protocol Violation|11|||
127859832|NCT00712712|460102010|FG000|Overall Study|Radiofrequency not done|3|||
127859833|NCT00712712|460102010|FG000|Overall Study|Death|8|||
127859834|NCT00712712|460102010|FG000|Overall Study|Withdrawal by Subject|1|||
127859835|NCT03598140|460102011|FG000|Overall Study|enrolled but didn't start|1|||
127859836|NCT03598140|460102012|FG001|Overall Study|enrolled but didn't start|0|||
127859837|NCT05245071|460102016|FG000|Overall Study|Progressive disease|18|||
127859838|NCT05245071|460102016|FG000|Overall Study|Adverse event not related to Coronavirus Disease 2019|2|||
127859839|NCT05245071|460102016|FG000|Overall Study|Not related to Coronavirus Disease 2019|2|||
127859840|NCT02871791|460102017|FG000|Phase 1b|Death|0|||
127859841|NCT02871791|460102018|FG001|Phase 1b|Death|1|||
127859842|NCT02871791|460102017|FG000|Phase 1b|progressive disease|6|||
127859843|NCT02871791|460102018|FG001|Phase 1b|progressive disease|2|||
127859844|NCT02871791|460102017|FG000|Phase 2|Death|1|||
127859845|NCT02871791|460102018|FG001|Phase 2|Death|0|||
127859846|NCT02871791|460102017|FG000|Phase 2|Lost to Follow-up|2|||
127859847|NCT02871791|460102018|FG001|Phase 2|Lost to Follow-up|0|||
127859848|NCT04005755|460102019|FG000|Overall Study|Adverse Event|6|||
127859849|NCT04005755|460102019|FG000|Overall Study|Physician Decision|3|||
127859850|NCT04005755|460102019|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
127859851|NCT04005755|460102019|FG000|Overall Study|Withdrawal by Subject|3|||
127859852|NCT04005755|460102019|FG000|Overall Study|Lost to Follow-up|1|||
127859853|NCT02723019|460102020|FG000|Overall Study|Death|17|||
127859854|NCT02723019|460102021|FG001|Overall Study|Death|13|||
127859855|NCT02723019|460102020|FG000|Overall Study|Withdrawal by Subject|11|||
127859856|NCT02723019|460102021|FG001|Overall Study|Withdrawal by Subject|7|||
127859857|NCT02723019|460102020|FG000|Overall Study|Lost to Follow-up|57|||
127859858|NCT02723019|460102021|FG001|Overall Study|Lost to Follow-up|70|||
127859859|NCT00515099|460102022|FG000|Overall Study|Lost to Follow-up|0|||
127859860|NCT00515099|460102023|FG001|Overall Study|Lost to Follow-up|4|||
127859861|NCT00515099|460102022|FG000|Overall Study|Withdrawal by Subject|2|||
127859862|NCT00515099|460102023|FG001|Overall Study|Withdrawal by Subject|0|||
127859863|NCT00515099|460102022|FG000|Overall Study|IRB Recommendation|1|||
127859864|NCT00515099|460102023|FG001|Overall Study|IRB Recommendation|0|||
127859865|NCT05333289|460102025|FG000|Overall Study|Other|1|||
127859866|NCT05333289|460102026|FG001|Overall Study|Other|0|||
127859867|NCT05333289|460102027|FG002|Overall Study|Other|0|||
127859868|NCT05333289|460102028|FG003|Overall Study|Other|1|||
127859869|NCT05333289|460102029|FG004|Overall Study|Other|1|||
127859870|NCT05333289|460102030|FG005|Overall Study|Other|2|||
127859871|NCT05333289|460102031|FG006|Overall Study|Other|2|||
127859872|NCT05333289|460102032|FG007|Overall Study|Other|0|||
127859873|NCT05333289|460102025|FG000|Overall Study|Withdrawal by Subject|1|||
127859874|NCT05333289|460102026|FG001|Overall Study|Withdrawal by Subject|2|||
127859875|NCT05333289|460102027|FG002|Overall Study|Withdrawal by Subject|2|||
127859876|NCT05333289|460102028|FG003|Overall Study|Withdrawal by Subject|1|||
127859877|NCT05333289|460102029|FG004|Overall Study|Withdrawal by Subject|1|||
127859878|NCT05333289|460102030|FG005|Overall Study|Withdrawal by Subject|2|||
127859879|NCT05333289|460102031|FG006|Overall Study|Withdrawal by Subject|1|||
127859880|NCT05333289|460102032|FG007|Overall Study|Withdrawal by Subject|3|||
127859881|NCT05333289|460102025|FG000|Overall Study|Protocol Violation|1|||
127859882|NCT05333289|460102026|FG001|Overall Study|Protocol Violation|0|||
127859883|NCT05333289|460102027|FG002|Overall Study|Protocol Violation|0|||
127859884|NCT05333289|460102028|FG003|Overall Study|Protocol Violation|0|||
127859885|NCT05333289|460102029|FG004|Overall Study|Protocol Violation|0|||
127859886|NCT05333289|460102030|FG005|Overall Study|Protocol Violation|0|||
127859887|NCT05333289|460102031|FG006|Overall Study|Protocol Violation|0|||
127859888|NCT05333289|460102032|FG007|Overall Study|Protocol Violation|0|||
127859889|NCT05333289|460102025|FG000|Overall Study|Physician Decision|0|||
127859890|NCT05333289|460102026|FG001|Overall Study|Physician Decision|0|||
127859891|NCT05333289|460102027|FG002|Overall Study|Physician Decision|1|||
127859892|NCT05333289|460102028|FG003|Overall Study|Physician Decision|0|||
127912384|NCT04035187|460303652|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
127912385|NCT04035187|460303653|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
127912386|NCT04035187|460303654|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
127912387|NCT04035187|460303655|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
127912388|NCT01116739|460303656|FG000|Overall Study|Child had 2 years of HS|110|||
127912389|NCT01116739|460303657|FG001|Overall Study|Child had 2 years of HS|128|||
127912390|NCT01116739|460303656|FG000|Overall Study|Withdrawal by Subject|6|||
127912391|NCT01116739|460303657|FG001|Overall Study|Withdrawal by Subject|0|||
127912392|NCT01116739|460303656|FG000|Overall Study|child too young|2|||
127912393|NCT01116739|460303657|FG001|Overall Study|child too young|6|||
127912394|NCT01116739|460303656|FG000|Overall Study|child not enrolled in head start|10|||
127912395|NCT01116739|460303657|FG001|Overall Study|child not enrolled in head start|2|||
127912396|NCT01116739|460303656|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
127912397|NCT01116739|460303657|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
127912398|NCT05511935|460303658|FG000|Overall Study|Lost to Follow-up|9|||
127912399|NCT05511935|460303659|FG001|Overall Study|Lost to Follow-up|27|||
127912400|NCT05090839|460303662|FG000|Overall Study|Lost to Follow-up|2|||
127912401|NCT05090839|460303663|FG001|Overall Study|Lost to Follow-up|3|||
127912402|NCT05090839|460303664|FG002|Overall Study|Lost to Follow-up|1|||
127912403|NCT05090839|460303665|FG003|Overall Study|Lost to Follow-up|1|||
127912404|NCT03913377|460303666|FG000|Period 1|Test Article no longer available|0|||
127912405|NCT03913377|460303667|FG001|Period 1|Test Article no longer available|1|||
127912406|NCT03913377|460303668|FG002|Period 1|Test Article no longer available|0|||
127912407|NCT03913377|460303666|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
127912408|NCT03913377|460303667|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
127912409|NCT03913377|460303668|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
127912410|NCT03499353|460303669|FG000|Treatment|Adverse Event|3|||
127912411|NCT03499353|460303669|FG000|Treatment|Progressive Disease|10|||
127912412|NCT03499353|460303669|FG000|Treatment|Other|1|||
127912413|NCT03499353|460303669|FG000|Treatment|Withdrawal by Subject|2|||
127912414|NCT03499353|460303669|FG000|Long-Term Follow-up|Death|2|||
127912415|NCT03499353|460303669|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
127912416|NCT03499353|460303669|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
127912417|NCT01117623|460303670|FG000|Overall Study|Adverse Event|0|||
127912418|NCT01117623|460303671|FG001|Overall Study|Adverse Event|2|||
127912419|NCT01117623|460303672|FG002|Overall Study|Adverse Event|4|||
127912420|NCT01117623|460303673|FG003|Overall Study|Adverse Event|0|||
127912421|NCT01117623|460303674|FG004|Overall Study|Adverse Event|2|||
127912422|NCT01117623|460303675|FG005|Overall Study|Adverse Event|0|||
127912423|NCT01117623|460303676|FG006|Overall Study|Adverse Event|0|||
127912424|NCT01117623|460303677|FG007|Overall Study|Adverse Event|2|||
127912425|NCT01117623|460303670|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
127912426|NCT01117623|460303671|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
127912427|NCT01117623|460303672|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
127912428|NCT01117623|460303673|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
127912429|NCT01117623|460303674|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
127912430|NCT01117623|460303675|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
127912431|NCT01117623|460303676|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
127912432|NCT01117623|460303677|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
127912433|NCT01117623|460303670|FG000|Overall Study|Withdrawal by Subject|0|||
127912434|NCT01117623|460303671|FG001|Overall Study|Withdrawal by Subject|0|||
127912435|NCT01117623|460303672|FG002|Overall Study|Withdrawal by Subject|2|||
127912436|NCT01117623|460303673|FG003|Overall Study|Withdrawal by Subject|0|||
127912437|NCT01117623|460303674|FG004|Overall Study|Withdrawal by Subject|0|||
127912438|NCT01117623|460303675|FG005|Overall Study|Withdrawal by Subject|1|||
127912439|NCT01117623|460303676|FG006|Overall Study|Withdrawal by Subject|1|||
127912440|NCT01117623|460303677|FG007|Overall Study|Withdrawal by Subject|1|||
127912441|NCT01117623|460303670|FG000|Overall Study|Non-compliance with study medication|0|||
127912442|NCT01117623|460303671|FG001|Overall Study|Non-compliance with study medication|0|||
127912443|NCT01117623|460303672|FG002|Overall Study|Non-compliance with study medication|0|||
127912444|NCT01117623|460303673|FG003|Overall Study|Non-compliance with study medication|0|||
127912445|NCT01117623|460303674|FG004|Overall Study|Non-compliance with study medication|0|||
127912446|NCT01117623|460303675|FG005|Overall Study|Non-compliance with study medication|0|||
127912447|NCT01117623|460303676|FG006|Overall Study|Non-compliance with study medication|0|||
127912448|NCT01117623|460303677|FG007|Overall Study|Non-compliance with study medication|1|||
127912449|NCT01117623|460303670|FG000|Overall Study|Invest. text: completed all planned txs|0|||
127912450|NCT01117623|460303671|FG001|Overall Study|Invest. text: completed all planned txs|0|||
127912451|NCT01117623|460303672|FG002|Overall Study|Invest. text: completed all planned txs|0|||
127912452|NCT01117623|460303673|FG003|Overall Study|Invest. text: completed all planned txs|0|||
127912453|NCT01117623|460303674|FG004|Overall Study|Invest. text: completed all planned txs|0|||
127912454|NCT01117623|460303675|FG005|Overall Study|Invest. text: completed all planned txs|1|||
127912455|NCT01117623|460303676|FG006|Overall Study|Invest. text: completed all planned txs|0|||
127912456|NCT01117623|460303677|FG007|Overall Study|Invest. text: completed all planned txs|0|||
127912457|NCT00736190|460303682|FG000|Overall Study|Pregnancy|1|||
127912458|NCT00736190|460303682|FG000|Overall Study|Withdrawal by Subject|1|||
127912459|NCT00736190|460303682|FG000|Overall Study|Adverse Event|1|||
127912460|NCT03246503|460303683|FG000|Overall Study|Lost to Follow-up|23|||
127912461|NCT03246503|460303683|FG000|Overall Study|Withdrawal by Subject|20|||
127912462|NCT03246503|460303683|FG000|Overall Study|Physician Decision|5|||
127912463|NCT03246503|460303683|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
127912464|NCT01896934|460303685|FG000|Overall Study|Adverse Event|1|||
127859893|NCT05333289|460102029|FG004|Overall Study|Physician Decision|0|||
127859894|NCT05333289|460102030|FG005|Overall Study|Physician Decision|2|||
127912465|NCT01896934|460303685|FG000|Overall Study|Withdrawal by Subject|1|||
127912466|NCT01492439|460303686|FG000|Overall Study|Withdrew from RTE|4|||
127912467|NCT01492439|460303687|FG001|Overall Study|Withdrew from RTE|9|||
127912468|NCT00716625|460303688|FG000|Overall Study|Safety was not Assessable|1|||
127912469|NCT00824291|460303690|FG000|Overall Study|Adverse Event|15|||
127912470|NCT00824291|460303691|FG001|Overall Study|Adverse Event|6|||
127912471|NCT00824291|460303690|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
127912472|NCT00824291|460303691|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
127912473|NCT00824291|460303690|FG000|Overall Study|Lost to Follow-up|11|||
127912474|NCT00824291|460303691|FG001|Overall Study|Lost to Follow-up|9|||
127859895|NCT05333289|460102031|FG006|Overall Study|Physician Decision|0|||
127859896|NCT05333289|460102032|FG007|Overall Study|Physician Decision|0|||
127859897|NCT05333289|460102025|FG000|Overall Study|Lost to Follow-up|6|||
127859898|NCT05333289|460102026|FG001|Overall Study|Lost to Follow-up|0|||
127859899|NCT05333289|460102027|FG002|Overall Study|Lost to Follow-up|1|||
127859900|NCT05333289|460102028|FG003|Overall Study|Lost to Follow-up|6|||
127859901|NCT05333289|460102029|FG004|Overall Study|Lost to Follow-up|3|||
127859902|NCT05333289|460102030|FG005|Overall Study|Lost to Follow-up|3|||
127859903|NCT05333289|460102031|FG006|Overall Study|Lost to Follow-up|2|||
127859904|NCT05333289|460102032|FG007|Overall Study|Lost to Follow-up|1|||
127859905|NCT05333289|460102025|FG000|Overall Study|Death|1|||
127859906|NCT05333289|460102026|FG001|Overall Study|Death|0|||
127859907|NCT05333289|460102027|FG002|Overall Study|Death|0|||
127859908|NCT05333289|460102028|FG003|Overall Study|Death|0|||
127859909|NCT05333289|460102029|FG004|Overall Study|Death|0|||
127859910|NCT05333289|460102030|FG005|Overall Study|Death|0|||
127859911|NCT05333289|460102031|FG006|Overall Study|Death|0|||
127859912|NCT05333289|460102032|FG007|Overall Study|Death|0|||
127859913|NCT02750501|460102035|FG000|Overall Study|Adverse Event|4|||
127859914|NCT02750501|460102035|FG000|Overall Study|Physician Decision|1|||
127859915|NCT02750501|460102035|FG000|Overall Study|Protocol Violation|1|||
127859916|NCT02750501|460102035|FG000|Overall Study|G-tube came out|1|||
127859917|NCT02750501|460102035|FG000|Overall Study|Non-compliant use of PERT|1|||
127859918|NCT03685643|460102036|FG000|Overall Study|Lost to Follow-up|14|||
127859919|NCT03685643|460102037|FG001|Overall Study|Lost to Follow-up|22|||
127859920|NCT00403390|460102038|FG000|Overall Study|Withdrawal by Subject|1|||
127859921|NCT00403390|460102039|FG001|Overall Study|Withdrawal by Subject|0|||
127859922|NCT00403390|460102038|FG000|Overall Study|samples lost|1|||
127859923|NCT00403390|460102039|FG001|Overall Study|samples lost|0|||
127859924|NCT00403390|460102038|FG000|Overall Study|non-compliant|1|||
127859925|NCT00403390|460102039|FG001|Overall Study|non-compliant|0|||
127859926|NCT04430036|460102040|FG000|Safety Run in Phase|Progression of disease|2|||
127912475|NCT00824291|460303690|FG000|Overall Study|Non-compliance|1|||
127912476|NCT00824291|460303691|FG001|Overall Study|Non-compliance|1|||
127912477|NCT00824291|460303690|FG000|Overall Study|Protocol Violation|4|||
127912478|NCT00824291|460303691|FG001|Overall Study|Protocol Violation|1|||
127912479|NCT00824291|460303690|FG000|Overall Study|Withdrawal by Subject|14|||
127912480|NCT00824291|460303691|FG001|Overall Study|Withdrawal by Subject|8|||
127859927|NCT01347840|460102048|FG000|Overall Study|Withdrawal by Subject|1|||
127859928|NCT01060124|460102051|FG000|Overall Study|Other|16|||
127859929|NCT01060124|460102051|FG000|Overall Study|Adverse Event|14|||
127859930|NCT01060124|460102051|FG000|Overall Study|Withdrawal by Subject|7|||
127859931|NCT05307523|460102052|FG000|First Condition (3 Weeks)|Lost to Follow-up|1|||
127859932|NCT05307523|460102053|FG001|First Condition (3 Weeks)|Lost to Follow-up|0|||
127859933|NCT05307523|460102052|FG000|First Condition (3 Weeks)|Withdrawal by Subject|1|||
127859934|NCT05307523|460102053|FG001|First Condition (3 Weeks)|Withdrawal by Subject|0|||
127859935|NCT03858686|460102055|FG000|Period 1|Adverse Event|1|||
127859936|NCT03858686|460102056|FG001|Period 1|Adverse Event|1|||
127912481|NCT00824291|460303690|FG000|Overall Study|Lack of Efficacy|7|||
127912482|NCT00824291|460303691|FG001|Overall Study|Lack of Efficacy|8|||
127912483|NCT00824291|460303690|FG000|Overall Study|Participant on prohibited medication|1|||
127912484|NCT00824291|460303691|FG001|Overall Study|Participant on prohibited medication|0|||
127912485|NCT00933686|460303692|FG000|Overall Study|Protocol Violation|0|||
127912486|NCT00933686|460303693|FG001|Overall Study|Protocol Violation|1|||
127912487|NCT00933686|460303692|FG000|Overall Study|Lost to Follow-up|2|||
127912488|NCT00933686|460303693|FG001|Overall Study|Lost to Follow-up|2|||
127912489|NCT00933686|460303692|FG000|Overall Study|Withdrawal by Subject|6|||
127912490|NCT00933686|460303693|FG001|Overall Study|Withdrawal by Subject|5|||
127912491|NCT00933686|460303692|FG000|Overall Study|Adverse Event|1|||
127912492|NCT00933686|460303693|FG001|Overall Study|Adverse Event|1|||
127912493|NCT00933686|460303692|FG000|Overall Study|Physician Decision|1|||
127912494|NCT00933686|460303693|FG001|Overall Study|Physician Decision|0|||
127912495|NCT00933686|460303692|FG000|Overall Study|Failure to show up at endpoint visits|0|||
127912496|NCT00933686|460303693|FG001|Overall Study|Failure to show up at endpoint visits|2|||
127912497|NCT00395694|460303696|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
127912498|NCT00395694|460303697|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
127912499|NCT00395694|460303696|FG000|Continuation Phase|Adverse Event|1|||
127912500|NCT00395694|460303697|FG001|Continuation Phase|Adverse Event|0|||
127912501|NCT00395694|460303696|FG000|Continuation Phase|Lack of Efficacy|12|||
127912502|NCT00395694|460303697|FG001|Continuation Phase|Lack of Efficacy|11|||
127912503|NCT00395694|460303696|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
127912504|NCT00395694|460303697|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
127912505|NCT00395694|460303696|FG000|Continuation Phase|Poor Compliance|1|||
127912506|NCT00395694|460303697|FG001|Continuation Phase|Poor Compliance|0|||
127912507|NCT00395694|460303696|FG000|Continuation Phase|Withdrawal by Subject|0|||
127912508|NCT00395694|460303697|FG001|Continuation Phase|Withdrawal by Subject|2|||
127912509|NCT01648582|460303698|FG000|Overall Study|Adverse Event|6|||
127912510|NCT01648582|460303699|FG001|Overall Study|Adverse Event|11|||
127912511|NCT01648582|460303700|FG002|Overall Study|Adverse Event|2|||
127912512|NCT01648582|460303698|FG000|Overall Study|Lost to Follow-up|9|||
127912513|NCT01648582|460303699|FG001|Overall Study|Lost to Follow-up|6|||
127912514|NCT01648582|460303700|FG002|Overall Study|Lost to Follow-up|8|||
127912515|NCT01648582|460303698|FG000|Overall Study|Protocol Violation|1|||
127912516|NCT01648582|460303699|FG001|Overall Study|Protocol Violation|2|||
127912517|NCT01648582|460303700|FG002|Overall Study|Protocol Violation|1|||
127912518|NCT01648582|460303698|FG000|Overall Study|Withdrawal by Subject|15|||
127912519|NCT01648582|460303699|FG001|Overall Study|Withdrawal by Subject|17|||
127912520|NCT01648582|460303700|FG002|Overall Study|Withdrawal by Subject|17|||
127912521|NCT01648582|460303698|FG000|Overall Study|Physician Decision|0|||
127912522|NCT01648582|460303699|FG001|Overall Study|Physician Decision|1|||
127912523|NCT01648582|460303700|FG002|Overall Study|Physician Decision|3|||
127912524|NCT01648582|460303698|FG000|Overall Study|Death|1|||
127912525|NCT01648582|460303699|FG001|Overall Study|Death|0|||
127912526|NCT01648582|460303700|FG002|Overall Study|Death|0|||
127912527|NCT01648582|460303698|FG000|Overall Study|Sponsor Decision|0|||
127912528|NCT01648582|460303699|FG001|Overall Study|Sponsor Decision|1|||
127912529|NCT01648582|460303700|FG002|Overall Study|Sponsor Decision|1|||
127912530|NCT02699866|460303701|FG000|Overall Study|Withdrawal by Subject|3|||
127912531|NCT02699866|460303701|FG000|Overall Study|Physician Decision|2|||
127912532|NCT02699866|460303701|FG000|Overall Study|Adverse Event|3|||
127912533|NCT01959672|460303705|FG000|Overall Study|Death|1|||
127912534|NCT00840216|460303706|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
127912535|NCT00840216|460303707|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
127912536|NCT01058668|460303708|FG000|Double-blind Treatment Phase|Adverse Event|8|||
127912537|NCT01058668|460303709|FG001|Double-blind Treatment Phase|Adverse Event|15|||
127912538|NCT01058668|460303710|FG002|Double-blind Treatment Phase|Adverse Event|25|||
127912539|NCT01058668|460303708|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
127912540|NCT01058668|460303709|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
127912541|NCT01058668|460303710|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
127912542|NCT01058668|460303708|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
127912543|NCT01058668|460303709|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
127912544|NCT01058668|460303710|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
127912545|NCT01058668|460303708|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
127912546|NCT01058668|460303709|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
127912547|NCT01058668|460303710|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
127912548|NCT01058668|460303708|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
127912549|NCT01058668|460303709|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
127912550|NCT01058668|460303710|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
127912551|NCT01058668|460303708|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
127912552|NCT01058668|460303709|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
127912553|NCT01058668|460303710|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
127912554|NCT05041361|460303717|FG000|Overall Study|Lost to Follow-up|1|||
127912555|NCT05041361|460303718|FG001|Overall Study|Lost to Follow-up|3|||
127912556|NCT01642277|460303719|FG000|Overall Study|Adverse Event|10|||
127859937|NCT03858686|460102055|FG000|Period 1|Lack of compliance|0|||
127859938|NCT03858686|460102056|FG001|Period 1|Lack of compliance|1|||
127859939|NCT03858686|460102055|FG000|Period 1|Adverse Event|0|||
127859940|NCT03858686|460102056|FG001|Period 1|Adverse Event|1|||
127859941|NCT03858686|460102055|FG000|Period 2|Adverse Event|0|||
127859942|NCT03858686|460102056|FG001|Period 2|Adverse Event|1|||
127859943|NCT03231228|460102058|FG000|Overall Study|Lost to Follow-up|2|||
127859944|NCT03231228|460102059|FG001|Overall Study|Lost to Follow-up|0|||
127859945|NCT03231228|460102058|FG000|Overall Study|Physician Decision|1|||
127859946|NCT03231228|460102059|FG001|Overall Study|Physician Decision|0|||
127859947|NCT01682759|460102061|FG000|Overall Study|Death|2|||
127859948|NCT01682759|460102062|FG001|Overall Study|Death|1|||
127859949|NCT01682759|460102061|FG000|Overall Study|Lost to Follow-up|10|||
127859950|NCT01682759|460102062|FG001|Overall Study|Lost to Follow-up|13|||
127859951|NCT01682759|460102061|FG000|Overall Study|Physician Decision|1|||
127859952|NCT01682759|460102062|FG001|Overall Study|Physician Decision|1|||
127859953|NCT01682759|460102061|FG000|Overall Study|Withdrawal by Subject|56|||
127859954|NCT01682759|460102062|FG001|Overall Study|Withdrawal by Subject|55|||
127859955|NCT04191096|460102063|FG000|Overall Study|Death|102|||
127859956|NCT04191096|460102064|FG001|Overall Study|Death|89|||
127859957|NCT04191096|460102063|FG000|Overall Study|Lost to Follow-up|1|||
127859958|NCT04191096|460102064|FG001|Overall Study|Lost to Follow-up|1|||
127859959|NCT04191096|460102063|FG000|Overall Study|Withdrawal by Subject|5|||
127859960|NCT04191096|460102064|FG001|Overall Study|Withdrawal by Subject|5|||
127859961|NCT04191096|460102063|FG000|Overall Study|Participants Ongoing|518|||
127859962|NCT04191096|460102064|FG001|Overall Study|Participants Ongoing|530|||
127859963|NCT02683668|460102069|FG000|Period 2|Withdrawal by Subject|0|||
127859964|NCT02683668|460102070|FG001|Period 2|Withdrawal by Subject|1|||
127859965|NCT02683668|460102071|FG002|Period 2|Withdrawal by Subject|0|||
127859966|NCT03893630|460102072|FG000|Overall Study|Lost to Follow-up|5|||
127859967|NCT03893630|460102073|FG001|Overall Study|Lost to Follow-up|4|||
127859968|NCT03893630|460102074|FG002|Overall Study|Lost to Follow-up|2|||
127859969|NCT03893630|460102072|FG000|Overall Study|Withdrawal by Subject|3|||
127859970|NCT03893630|460102073|FG001|Overall Study|Withdrawal by Subject|6|||
127859971|NCT03893630|460102074|FG002|Overall Study|Withdrawal by Subject|3|||
127859972|NCT03893630|460102072|FG000|Overall Study|Discontinued Intervention|0|||
127859973|NCT03893630|460102073|FG001|Overall Study|Discontinued Intervention|4|||
127859974|NCT03893630|460102074|FG002|Overall Study|Discontinued Intervention|2|||
127859975|NCT02554721|460103539|FG000|Overall Study|Adverse Event|1|||
127859976|NCT02554721|460103540|FG001|Overall Study|Adverse Event|0|||
127859977|NCT02554721|460103541|FG002|Overall Study|Adverse Event|0|||
127859978|NCT02554721|460103542|FG003|Overall Study|Adverse Event|0|||
127859979|NCT02554721|460103543|FG004|Overall Study|Adverse Event|1|||
127859980|NCT02554721|460103539|FG000|Overall Study|Noncompliance|0|||
127859981|NCT02554721|460103540|FG001|Overall Study|Noncompliance|0|||
127859982|NCT02554721|460103541|FG002|Overall Study|Noncompliance|0|||
127859983|NCT02554721|460103542|FG003|Overall Study|Noncompliance|0|||
127859984|NCT02554721|460103543|FG004|Overall Study|Noncompliance|1|||
127859985|NCT01888965|460103545|FG000|Overall Study|Adverse Event|5|||
127859986|NCT01888965|460103545|FG000|Overall Study|Lack of Efficacy|4|||
127859987|NCT00908895|460103546|FG000|Overall Study|Lost to Follow-up|1|||
127859988|NCT00908895|460103547|FG001|Overall Study|Lost to Follow-up|3|||
127859989|NCT00908895|460103546|FG000|Overall Study|algodystrophy|2|||
127859990|NCT00908895|460103547|FG001|Overall Study|algodystrophy|2|||
127859991|NCT00908895|460103546|FG000|Overall Study|Adverse Event|1|||
127859992|NCT00908895|460103547|FG001|Overall Study|Adverse Event|1|||
127859993|NCT00887822|460103549|FG000|Overall Study|Insufficient therapeutic response|53|||
127859994|NCT00887822|460103550|FG001|Overall Study|Insufficient therapeutic response|55|||
127859995|NCT00887822|460103549|FG000|Overall Study|Adverse Event|14|||
127859996|NCT00887822|460103550|FG001|Overall Study|Adverse Event|17|||
127859997|NCT00887822|460103549|FG000|Overall Study|Failure to return|11|||
127859998|NCT00887822|460103550|FG001|Overall Study|Failure to return|11|||
127859999|NCT00887822|460103549|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
127860000|NCT00887822|460103550|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
127860001|NCT00887822|460103549|FG000|Overall Study|Administrative/Other than specified|5|||
127860002|NCT00887822|460103550|FG001|Overall Study|Administrative/Other than specified|4|||
127860003|NCT00887822|460103549|FG000|Overall Study|Death|2|||
127860004|NCT00887822|460103550|FG001|Overall Study|Death|3|||
127860005|NCT00887822|460103549|FG000|Overall Study|Protocol Violation|0|||
127860006|NCT00887822|460103550|FG001|Overall Study|Protocol Violation|1|||
127860007|NCT00887822|460103549|FG000|Overall Study|Randomized but not treated|0|||
127860008|NCT00887822|460103550|FG001|Overall Study|Randomized but not treated|1|||
127860009|NCT03661983|460103551|FG000|Open Label Stabilization Phase|Adverse Event|5|||
127860010|NCT03661983|460103552|FG001|Open Label Stabilization Phase|Adverse Event|0|||
127860011|NCT03661983|460103553|FG002|Open Label Stabilization Phase|Adverse Event|0|||
127860012|NCT03661983|460103554|FG003|Open Label Stabilization Phase|Adverse Event|0|||
127912557|NCT01642277|460303720|FG001|Overall Study|Adverse Event|0|||
127912558|NCT01642277|460303719|FG000|Overall Study|Physician Decision|2|||
127860013|NCT03661983|460103551|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
127860014|NCT03661983|460103552|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
127860015|NCT03661983|460103553|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
127860016|NCT03661983|460103554|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
127860017|NCT03661983|460103551|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
127860018|NCT03661983|460103552|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
127860019|NCT03661983|460103553|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
127860020|NCT03661983|460103554|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
127860021|NCT03661983|460103551|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
127860022|NCT03661983|460103552|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
127860023|NCT03661983|460103553|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
127860024|NCT03661983|460103554|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
127860025|NCT03661983|460103551|FG000|Double-blind Randomized Phase|Adverse Event|0|||
127860026|NCT03661983|460103552|FG001|Double-blind Randomized Phase|Adverse Event|1|||
127860027|NCT03661983|460103553|FG002|Double-blind Randomized Phase|Adverse Event|0|||
127860028|NCT03661983|460103554|FG003|Double-blind Randomized Phase|Adverse Event|0|||
127860029|NCT03661983|460103551|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
127860030|NCT03661983|460103552|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
127860031|NCT03661983|460103553|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
127860032|NCT03661983|460103554|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
127860033|NCT03661983|460103551|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
127860034|NCT03661983|460103552|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
127860035|NCT03661983|460103553|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
127860036|NCT03661983|460103554|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
127860037|NCT03661983|460103551|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
127860038|NCT03661983|460103552|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
127860039|NCT03661983|460103553|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
127860040|NCT03661983|460103554|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
127860041|NCT02045979|460103555|FG000|Overall Study|Informed Consent Withdrawn|2|||
127860042|NCT02045979|460103556|FG001|Overall Study|Informed Consent Withdrawn|0|||
127860043|NCT02045979|460103557|FG002|Overall Study|Informed Consent Withdrawn|1|||
127860044|NCT02045979|460103555|FG000|Overall Study|not specified above|0|||
127860045|NCT02045979|460103556|FG001|Overall Study|not specified above|1|||
127860046|NCT02045979|460103557|FG002|Overall Study|not specified above|0|||
127860047|NCT02425891|460103558|FG000|Overall Study|Death|333|||
127860048|NCT02425891|460103559|FG001|Overall Study|Death|314|||
127860049|NCT02425891|460103558|FG000|Overall Study|Lost to Follow-up|4|||
127860050|NCT02425891|460103559|FG001|Overall Study|Lost to Follow-up|6|||
127860051|NCT02425891|460103558|FG000|Overall Study|Non-Compliance|1|||
127860052|NCT02425891|460103559|FG001|Overall Study|Non-Compliance|1|||
127860053|NCT02425891|460103558|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
127860054|NCT02425891|460103559|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
127860055|NCT02425891|460103558|FG000|Overall Study|Physician Decision|0|||
127860056|NCT02425891|460103559|FG001|Overall Study|Physician Decision|1|||
127860057|NCT02425891|460103558|FG000|Overall Study|Protocol Violation|1|||
127860058|NCT02425891|460103559|FG001|Overall Study|Protocol Violation|1|||
127912559|NCT01642277|460303720|FG001|Overall Study|Physician Decision|0|||
127912560|NCT01642277|460303719|FG000|Overall Study|Protocol Violation|1|||
127860059|NCT02425891|460103558|FG000|Overall Study|Study Terminated By Sponsor|85|||
127860060|NCT02425891|460103559|FG001|Overall Study|Study Terminated By Sponsor|95|||
127860061|NCT02425891|460103558|FG000|Overall Study|Withdrawal by Subject|27|||
127860062|NCT02425891|460103559|FG001|Overall Study|Withdrawal by Subject|32|||
127860063|NCT04124952|460103560|FG000|Overall Study|Lost to Follow-up|1|||
127860064|NCT01654224|460103564|FG000|Overall Study|Lost to Follow-up|2|||
127860065|NCT01654224|460103565|FG001|Overall Study|Lost to Follow-up|2|||
127912561|NCT01642277|460303720|FG001|Overall Study|Protocol Violation|0|||
127860066|NCT01654224|460103564|FG000|Overall Study|Did not receive allocation|1|||
127860067|NCT01654224|460103565|FG001|Overall Study|Did not receive allocation|8|||
127860068|NCT01654224|460103564|FG000|Overall Study|Insufficient blood sample|3|||
127912562|NCT01642277|460303719|FG000|Overall Study|Withdrawal by Subject|11|||
127912563|NCT01642277|460303720|FG001|Overall Study|Withdrawal by Subject|0|||
127912564|NCT03605342|460303721|FG000|Overall Study|Withdrawal by Subject|9|||
127912565|NCT03605342|460303722|FG001|Overall Study|Withdrawal by Subject|7|||
127912566|NCT03605342|460303721|FG000|Overall Study|Lost to Follow-up|1|||
127912567|NCT03605342|460303722|FG001|Overall Study|Lost to Follow-up|1|||
127912568|NCT00796328|460303725|FG000|Overall Study|experienced hypotension requiring tx|6|||
127912569|NCT02842853|460303726|FG000|Overall Study|Non-compliance with the protocol|3|||
127912570|NCT02842853|460303727|FG001|Overall Study|Non-compliance with the protocol|7|||
127912571|NCT02842853|460303728|FG002|Overall Study|Non-compliance with the protocol|2|||
127912572|NCT02842853|460303729|FG003|Overall Study|Non-compliance with the protocol|5|||
127912573|NCT02842853|460303726|FG000|Overall Study|Subject met exclusion criteria|0|||
127912574|NCT02842853|460303727|FG001|Overall Study|Subject met exclusion criteria|1|||
127912575|NCT02842853|460303728|FG002|Overall Study|Subject met exclusion criteria|0|||
127912576|NCT02842853|460303729|FG003|Overall Study|Subject met exclusion criteria|0|||
127912577|NCT02842853|460303726|FG000|Overall Study|Withdrawal by Subject|11|||
127912578|NCT02842853|460303727|FG001|Overall Study|Withdrawal by Subject|13|||
127912579|NCT02842853|460303728|FG002|Overall Study|Withdrawal by Subject|9|||
127912580|NCT02842853|460303729|FG003|Overall Study|Withdrawal by Subject|8|||
127912581|NCT02842853|460303726|FG000|Overall Study|Lost to Follow-up|9|||
127912582|NCT02842853|460303727|FG001|Overall Study|Lost to Follow-up|13|||
127912583|NCT02842853|460303728|FG002|Overall Study|Lost to Follow-up|10|||
127912584|NCT02842853|460303729|FG003|Overall Study|Lost to Follow-up|11|||
127912585|NCT04089553|460303730|FG000|Overall Study|Death|1|||
127912586|NCT04089553|460303731|FG001|Overall Study|Death|1|||
127912587|NCT04089553|460303730|FG000|Overall Study|Progressive disease - objective (AZD4635)|13|||
127912588|NCT04089553|460303731|FG001|Overall Study|Progressive disease - objective (AZD4635)|20|||
127912589|NCT04089553|460303730|FG000|Overall Study|Withdrawal by Subject|3|||
127912590|NCT04089553|460303731|FG001|Overall Study|Withdrawal by Subject|3|||
127912591|NCT04089553|460303730|FG000|Overall Study|Physician Decision|1|||
127912592|NCT04089553|460303731|FG001|Overall Study|Physician Decision|0|||
127912593|NCT04089553|460303730|FG000|Overall Study|Progressive disease - subjective (AZD4635)|6|||
127912594|NCT04089553|460303731|FG001|Overall Study|Progressive disease - subjective (AZD4635)|3|||
127912595|NCT04089553|460303730|FG000|Overall Study|Other|1|||
127912596|NCT04089553|460303731|FG001|Overall Study|Other|0|||
127912597|NCT04089553|460303730|FG000|Overall Study|Adverse Event|1|||
127912598|NCT04089553|460303731|FG001|Overall Study|Adverse Event|1|||
127912599|NCT01403194|460303739|FG000|Overall Study|Screen Failure|2|||
127912600|NCT01403194|460303739|FG000|Overall Study|Lost to Follow-up|8|||
127912601|NCT00107991|460303744|FG000|Eligibility Assessment|Disease not severe enough|7|||
127912602|NCT00107991|460303744|FG000|Eligibility Assessment|Unwilling to participate|7|||
127912603|NCT00107991|460303744|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
127912604|NCT00107991|460303744|FG000|Eligibility Assessment|Abnormal labs|2|||
127912605|NCT00107991|460303744|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
127912606|NCT00107991|460303744|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
127912607|NCT00107991|460303744|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
127912608|NCT00107991|460303744|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
127912609|NCT00107991|460303744|FG000|12 Week Treatment Period|Adverse Event|1|||
127912610|NCT00107991|460303744|FG000|12 Week Treatment Period|Protocol Violation|1|||
127912611|NCT00107991|460303744|FG000|12 Week Treatment Period|Incarcerated|1|||
127912612|NCT00107991|460303744|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
127912613|NCT00506831|460303751|FG000|Overall Study|Death|1|||
127912614|NCT00506831|460303751|FG000|Overall Study|Withdrawal by Subject|1|||
127912615|NCT01808651|460303755|FG000|Study Period 1|Lost to Follow-up|1|||
127912616|NCT01808651|460303756|FG001|Study Period 1|Lost to Follow-up|3|||
127912617|NCT01808651|460303757|FG002|Study Period 1|Lost to Follow-up|0|||
127912618|NCT01808651|460303755|FG000|Study Period 1|Protocol Violation|1|||
127912619|NCT01808651|460303756|FG001|Study Period 1|Protocol Violation|0|||
127912620|NCT01808651|460303757|FG002|Study Period 1|Protocol Violation|1|||
127912621|NCT01808651|460303755|FG000|Study Period 1|Physician Decision|3|||
127912622|NCT01808651|460303756|FG001|Study Period 1|Physician Decision|2|||
127912623|NCT01808651|460303757|FG002|Study Period 1|Physician Decision|0|||
127912624|NCT01808651|460303755|FG000|Study Period 1|Lack of Efficacy|2|||
127912625|NCT01808651|460303756|FG001|Study Period 1|Lack of Efficacy|1|||
127912626|NCT01808651|460303757|FG002|Study Period 1|Lack of Efficacy|0|||
127912627|NCT01808651|460303755|FG000|Study Period 1|Adverse Event|10|||
127912628|NCT01808651|460303756|FG001|Study Period 1|Adverse Event|4|||
127912629|NCT01808651|460303757|FG002|Study Period 1|Adverse Event|1|||
127912630|NCT01808651|460303755|FG000|Study Period 1|Participant Decision|9|||
127912631|NCT01808651|460303756|FG001|Study Period 1|Participant Decision|7|||
127912632|NCT01808651|460303757|FG002|Study Period 1|Participant Decision|3|||
127912633|NCT02488239|460303758|FG000|Overall Study|Death|3|||
127912634|NCT02488239|460303758|FG000|Overall Study|Withdrawal by Subject|3|||
127912635|NCT02488239|460303758|FG000|Overall Study|Physician Decision|2|||
127912636|NCT02488239|460303758|FG000|Overall Study|Consent ineligible|1|||
127912637|NCT02488239|460303758|FG000|Overall Study|Did not undergo implant procedure|1|||
127860069|NCT01654224|460103565|FG001|Overall Study|Insufficient blood sample|2|||
127860070|NCT00166504|460103566|FG000|Overall Study|Adverse Event|3|||
127860071|NCT00166504|460103567|FG001|Overall Study|Adverse Event|3|||
127860072|NCT00166504|460103566|FG000|Overall Study|Lost to Follow-up|1|||
127860073|NCT00166504|460103567|FG001|Overall Study|Lost to Follow-up|1|||
127860074|NCT00166504|460103566|FG000|Overall Study|Withdrawal by Subject|1|||
127860075|NCT00166504|460103567|FG001|Overall Study|Withdrawal by Subject|0|||
127860076|NCT02094612|460103568|FG000|Overall Study|Lost to Follow-up|47|||
127860077|NCT02094612|460103569|FG001|Overall Study|Lost to Follow-up|47|||
127860078|NCT02094612|460103568|FG000|Overall Study|Never started ADHD medication|32|||
127860079|NCT02094612|460103569|FG001|Overall Study|Never started ADHD medication|23|||
127860080|NCT03261037|460103570|FG000|Overall Study|Withdrawal by Subject|2|||
127860081|NCT03261037|460103571|FG001|Overall Study|Withdrawal by Subject|13|||
127860082|NCT03261037|460103572|FG002|Overall Study|Withdrawal by Subject|0|||
127860083|NCT03261037|460103573|FG003|Overall Study|Withdrawal by Subject|18|||
127860084|NCT03261037|460103570|FG000|Overall Study|Non-compliance with study procedures|0|||
127912638|NCT00700739|460303761|FG000|Overall Study|Lost to Follow-up|4|||
127912639|NCT00700739|460303762|FG001|Overall Study|Lost to Follow-up|4|||
127912640|NCT02336074|460303763|FG000|Overall Study|Adverse Event|0|||
127912641|NCT02336074|460303764|FG001|Overall Study|Adverse Event|2|||
127912642|NCT02679729|460303765|FG000|Overall Study|Lost to Follow-up|0|||
127912643|NCT02679729|460303766|FG001|Overall Study|Lost to Follow-up|1|||
127912644|NCT02679729|460303767|FG002|Overall Study|Lost to Follow-up|0|||
127912645|NCT02679729|460303768|FG003|Overall Study|Lost to Follow-up|0|||
127912646|NCT02679729|460303769|FG004|Overall Study|Lost to Follow-up|1|||
127912647|NCT02679729|460303770|FG005|Overall Study|Lost to Follow-up|0|||
127912648|NCT02679729|460303771|FG006|Overall Study|Lost to Follow-up|0|||
127912649|NCT02679729|460303772|FG007|Overall Study|Lost to Follow-up|0|||
127912650|NCT02679729|460303773|FG008|Overall Study|Lost to Follow-up|0|||
127912651|NCT02679729|460303765|FG000|Overall Study|Participant decision|0|||
127912652|NCT02679729|460303766|FG001|Overall Study|Participant decision|1|||
127912653|NCT02679729|460303767|FG002|Overall Study|Participant decision|0|||
127912654|NCT02679729|460303768|FG003|Overall Study|Participant decision|0|||
127912655|NCT02679729|460303769|FG004|Overall Study|Participant decision|0|||
127912656|NCT02679729|460303770|FG005|Overall Study|Participant decision|0|||
127912657|NCT02679729|460303771|FG006|Overall Study|Participant decision|1|||
127912658|NCT02679729|460303772|FG007|Overall Study|Participant decision|0|||
127912659|NCT02679729|460303773|FG008|Overall Study|Participant decision|0|||
127912660|NCT03488108|460303780|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
127912661|NCT03488108|460303781|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
127912662|NCT03488108|460303780|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
127912663|NCT03488108|460303781|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
127912664|NCT01297504|460303786|FG000|Overall Study|Invalid Consent|1|||
127912665|NCT01297504|460303786|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
127912666|NCT01297504|460303786|FG000|Overall Study|No Study Visits|4|||
127912667|NCT01297504|460303786|FG000|Overall Study|Death|3|||
127912668|NCT01297504|460303786|FG000|Overall Study|Lost to Follow-up|43|||
127912669|NCT01297504|460303786|FG000|Overall Study|Withdrawal by Subject|9|||
127912670|NCT01297504|460303786|FG000|Overall Study|Site Closure|3|||
127912671|NCT01297504|460303786|FG000|Overall Study|Protocol Violation|3|||
127912672|NCT03602339|460303787|FG000|Overall Study|Withdrawal by Subject|9|||
127912673|NCT03602339|460303787|FG000|Overall Study|Physician Decision|2|||
127912674|NCT03602339|460303787|FG000|Overall Study|Other reason|4|||
127912675|NCT04827394|460303789|FG000|Overall Study|Physician Decision|0|||
127912676|NCT04827394|460303790|FG001|Overall Study|Physician Decision|2|||
127912677|NCT01030133|460303793|FG000|Overall Study|failed to experience pain at level 7/10|2|||
127912678|NCT01030133|460303794|FG001|Overall Study|failed to experience pain at level 7/10|2|||
127912679|NCT00477594|460303799|FG000|Year 1 and Year 2|Adverse Event|4|||
127912680|NCT00477594|460303800|FG001|Year 1 and Year 2|Adverse Event|2|||
127912681|NCT00477594|460303799|FG000|Year 1 and Year 2|Physician Decision|2|||
127912682|NCT00477594|460303800|FG001|Year 1 and Year 2|Physician Decision|1|||
127912683|NCT00477594|460303799|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
127912684|NCT00477594|460303800|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
127912685|NCT00477594|460303799|FG000|Year 1 and Year 2|Other|1|||
127912686|NCT00477594|460303800|FG001|Year 1 and Year 2|Other|0|||
127912687|NCT00477594|460303799|FG000|Year 3|Adverse Event|1|||
127912688|NCT00477594|460303800|FG001|Year 3|Adverse Event|0|||
127912689|NCT00477594|460303799|FG000|Year 3|Withdrawal by Subject|1|||
127912690|NCT00477594|460303800|FG001|Year 3|Withdrawal by Subject|0|||
127912691|NCT00477594|460303799|FG000|Follow-up Period|Withdrawal by Subject|2|||
127912692|NCT00477594|460303800|FG001|Follow-up Period|Withdrawal by Subject|1|||
127912693|NCT00477594|460303799|FG000|Follow-up Period|Other|1|||
127912694|NCT00477594|460303800|FG001|Follow-up Period|Other|0|||
127912695|NCT02635750|460305945|FG000|Part 1, Period 2|Adverse Event|1|||
127912696|NCT02635750|460305946|FG001|Part 1, Period 2|Adverse Event|0|||
127912697|NCT02635750|460305947|FG002|Part 1, Period 2|Adverse Event|0|||
127912698|NCT02875392|460305949|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
127912699|NCT02875392|460305950|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
127912700|NCT03599193|460305951|FG000|Overall Study|Adverse Event|0|||
127912701|NCT03599193|460305952|FG001|Overall Study|Adverse Event|2|||
127912702|NCT03599193|460305951|FG000|Overall Study|Withdrawal by Subject|1|||
127912703|NCT03599193|460305952|FG001|Overall Study|Withdrawal by Subject|0|||
127912704|NCT03599193|460305951|FG000|Overall Study|Protocol Violation|1|||
127912705|NCT03599193|460305952|FG001|Overall Study|Protocol Violation|0|||
127912706|NCT03599193|460305951|FG000|Overall Study|Lost to Follow-up|0|||
127912707|NCT03599193|460305952|FG001|Overall Study|Lost to Follow-up|1|||
127912708|NCT00835705|460305953|FG000|First Intervention|Difficulty with vein|1|||
127912709|NCT00835705|460305954|FG001|First Intervention|Difficulty with vein|0|||
127912710|NCT00835705|460305953|FG000|Second Intervention|Difficulty with vein|1|||
127912711|NCT00835705|460305954|FG001|Second Intervention|Difficulty with vein|0|||
127912712|NCT01750294|460305955|FG000|Overall Study|Withdrawal by Subject|1|||
127912713|NCT01750294|460305955|FG000|Overall Study|Safety Endpoint|1|||
127912714|NCT00665925|460305956|FG000|Overall Study|Lack of Efficacy|10|||
127912715|NCT00665925|460305957|FG001|Overall Study|Lack of Efficacy|8|||
127912716|NCT00665925|460305958|FG002|Overall Study|Lack of Efficacy|9|||
127912717|NCT00665925|460305959|FG003|Overall Study|Lack of Efficacy|8|||
127912718|NCT00665925|460305956|FG000|Overall Study|Lost to Follow-up|1|||
127912719|NCT00665925|460305957|FG001|Overall Study|Lost to Follow-up|2|||
127912720|NCT00665925|460305958|FG002|Overall Study|Lost to Follow-up|2|||
127912721|NCT00665925|460305959|FG003|Overall Study|Lost to Follow-up|2|||
127912722|NCT00665925|460305956|FG000|Overall Study|Withdrawal by Subject|2|||
127912723|NCT00665925|460305957|FG001|Overall Study|Withdrawal by Subject|2|||
127912724|NCT00665925|460305958|FG002|Overall Study|Withdrawal by Subject|3|||
127912725|NCT00665925|460305959|FG003|Overall Study|Withdrawal by Subject|2|||
127912726|NCT00665925|460305956|FG000|Overall Study|Physician Decision|0|||
127912727|NCT00665925|460305957|FG001|Overall Study|Physician Decision|0|||
127912728|NCT00665925|460305958|FG002|Overall Study|Physician Decision|1|||
127912729|NCT00665925|460305959|FG003|Overall Study|Physician Decision|2|||
127912730|NCT00665925|460305956|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
127912731|NCT00665925|460305957|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
127912732|NCT00665925|460305958|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
127912733|NCT00665925|460305959|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
127912734|NCT00665925|460305956|FG000|Overall Study|Adverse Event|1|||
127912735|NCT00665925|460305957|FG001|Overall Study|Adverse Event|5|||
127912736|NCT00665925|460305958|FG002|Overall Study|Adverse Event|10|||
127912737|NCT00665925|460305959|FG003|Overall Study|Adverse Event|5|||
127912738|NCT00665925|460305956|FG000|Overall Study|Enrolled by mistake|0|||
127912739|NCT00665925|460305957|FG001|Overall Study|Enrolled by mistake|0|||
127912740|NCT00665925|460305958|FG002|Overall Study|Enrolled by mistake|0|||
127912741|NCT00665925|460305959|FG003|Overall Study|Enrolled by mistake|1|||
127912742|NCT00665925|460305956|FG000|Overall Study|Due to exclusion criteria|1|||
127912743|NCT00665925|460305957|FG001|Overall Study|Due to exclusion criteria|0|||
127912744|NCT00665925|460305958|FG002|Overall Study|Due to exclusion criteria|0|||
127912745|NCT00665925|460305959|FG003|Overall Study|Due to exclusion criteria|0|||
127912746|NCT01592240|460305960|FG000|Overall Study|Adverse Event|1|||
127912747|NCT01592240|460305961|FG001|Overall Study|Adverse Event|0|||
127912748|NCT01592240|460305962|FG002|Overall Study|Adverse Event|0|||
127912749|NCT01592240|460305963|FG003|Overall Study|Adverse Event|1|||
127912750|NCT01592240|460305964|FG004|Overall Study|Adverse Event|1|||
127912751|NCT01592240|460305965|FG005|Overall Study|Adverse Event|0|||
127912752|NCT01592240|460305966|FG006|Overall Study|Adverse Event|0|||
127912753|NCT01592240|460305960|FG000|Overall Study|Death|0|||
127912754|NCT01592240|460305961|FG001|Overall Study|Death|1|||
127912755|NCT01592240|460305962|FG002|Overall Study|Death|0|||
127912756|NCT01592240|460305963|FG003|Overall Study|Death|0|||
127912757|NCT01592240|460305964|FG004|Overall Study|Death|0|||
127912758|NCT01592240|460305965|FG005|Overall Study|Death|0|||
127912759|NCT01592240|460305966|FG006|Overall Study|Death|0|||
127912760|NCT01592240|460305960|FG000|Overall Study|Lost to Follow-up|1|||
127912761|NCT01592240|460305961|FG001|Overall Study|Lost to Follow-up|3|||
127912762|NCT01592240|460305962|FG002|Overall Study|Lost to Follow-up|1|||
127912763|NCT01592240|460305963|FG003|Overall Study|Lost to Follow-up|0|||
127912764|NCT01592240|460305964|FG004|Overall Study|Lost to Follow-up|3|||
127912765|NCT01592240|460305965|FG005|Overall Study|Lost to Follow-up|2|||
127912766|NCT01592240|460305966|FG006|Overall Study|Lost to Follow-up|0|||
127912767|NCT01592240|460305960|FG000|Overall Study|Protocol Violation|0|||
127912768|NCT01592240|460305961|FG001|Overall Study|Protocol Violation|0|||
127912769|NCT01592240|460305962|FG002|Overall Study|Protocol Violation|0|||
127912770|NCT01592240|460305963|FG003|Overall Study|Protocol Violation|0|||
127912771|NCT01592240|460305964|FG004|Overall Study|Protocol Violation|0|||
127912772|NCT01592240|460305965|FG005|Overall Study|Protocol Violation|1|||
127912773|NCT01592240|460305966|FG006|Overall Study|Protocol Violation|0|||
127912774|NCT01592240|460305960|FG000|Overall Study|Withdrawal by Subject|0|||
127912775|NCT01592240|460305961|FG001|Overall Study|Withdrawal by Subject|4|||
127912776|NCT01592240|460305962|FG002|Overall Study|Withdrawal by Subject|4|||
127912777|NCT01592240|460305963|FG003|Overall Study|Withdrawal by Subject|1|||
127912778|NCT01592240|460305964|FG004|Overall Study|Withdrawal by Subject|3|||
127912779|NCT01592240|460305965|FG005|Overall Study|Withdrawal by Subject|0|||
127912780|NCT01592240|460305966|FG006|Overall Study|Withdrawal by Subject|2|||
127912781|NCT01592240|460305960|FG000|Overall Study|Other|0|||
127912782|NCT01592240|460305961|FG001|Overall Study|Other|3|||
127912783|NCT01592240|460305962|FG002|Overall Study|Other|1|||
127912784|NCT01592240|460305963|FG003|Overall Study|Other|1|||
127912785|NCT01592240|460305964|FG004|Overall Study|Other|0|||
127912786|NCT01592240|460305965|FG005|Overall Study|Other|0|||
127912787|NCT01592240|460305966|FG006|Overall Study|Other|1|||
127912788|NCT01592240|460305960|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
127912789|NCT01592240|460305961|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
127912790|NCT01592240|460305962|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
127912791|NCT01592240|460305963|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
127912792|NCT01592240|460305964|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
127912793|NCT01592240|460305965|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
127912794|NCT01592240|460305966|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
127912795|NCT02751424|460305970|FG000|Part 2|Adverse Event|0|||
127912796|NCT02751424|460305971|FG001|Part 2|Adverse Event|0|||
127912797|NCT02751424|460305972|FG002|Part 2|Adverse Event|0|||
127912798|NCT02751424|460305973|FG003|Part 2|Adverse Event|0|||
127912799|NCT02751424|460305974|FG004|Part 2|Adverse Event|0|||
127912800|NCT02751424|460305975|FG005|Part 2|Adverse Event|0|||
127912801|NCT02751424|460305976|FG006|Part 2|Adverse Event|0|||
127912802|NCT02751424|460305977|FG007|Part 2|Adverse Event|5|||
127912803|NCT02751424|460305978|FG008|Part 2|Adverse Event|0|||
127912804|NCT02197416|460305979|FG000|Overall Study|Other reasons|0|||
127912805|NCT02197416|460305980|FG001|Overall Study|Other reasons|2|||
127912806|NCT02197416|460305981|FG002|Overall Study|Other reasons|5|||
127912807|NCT02197416|460305979|FG000|Overall Study|Withdrawal by Subject|0|||
127912808|NCT02197416|460305980|FG001|Overall Study|Withdrawal by Subject|2|||
127912809|NCT02197416|460305981|FG002|Overall Study|Withdrawal by Subject|1|||
127912810|NCT02197416|460305979|FG000|Overall Study|Protocol Violation|1|||
127912811|NCT02197416|460305980|FG001|Overall Study|Protocol Violation|0|||
127912812|NCT02197416|460305981|FG002|Overall Study|Protocol Violation|1|||
127912813|NCT02197416|460305979|FG000|Overall Study|Adverse Event|0|||
127912814|NCT02197416|460305980|FG001|Overall Study|Adverse Event|0|||
127860085|NCT03261037|460103571|FG001|Overall Study|Non-compliance with study procedures|2|||
127860086|NCT03261037|460103572|FG002|Overall Study|Non-compliance with study procedures|0|||
127860087|NCT03261037|460103573|FG003|Overall Study|Non-compliance with study procedures|6|||
127860088|NCT03261037|460103570|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
127860089|NCT03261037|460103571|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
127860090|NCT03261037|460103572|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
127860091|NCT03261037|460103573|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
127860092|NCT03261037|460103570|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
127860093|NCT03261037|460103571|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
127860094|NCT03261037|460103572|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
127860095|NCT03261037|460103573|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
127860096|NCT03261037|460103570|FG000|Overall Study|Diagnosed but protocol deviation|1|||
127860097|NCT03261037|460103571|FG001|Overall Study|Diagnosed but protocol deviation|0|||
127860098|NCT03261037|460103572|FG002|Overall Study|Diagnosed but protocol deviation|0|||
127860099|NCT03261037|460103573|FG003|Overall Study|Diagnosed but protocol deviation|0|||
127860100|NCT03261037|460103570|FG000|Overall Study|Participant did not want to continue the study|0|||
127860101|NCT03261037|460103571|FG001|Overall Study|Participant did not want to continue the study|1|||
127860102|NCT03261037|460103572|FG002|Overall Study|Participant did not want to continue the study|0|||
127860103|NCT03261037|460103573|FG003|Overall Study|Participant did not want to continue the study|0|||
127860104|NCT03261037|460103570|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
127860105|NCT03261037|460103571|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
127860106|NCT03261037|460103572|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
127860107|NCT03261037|460103573|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
127860108|NCT03261037|460103570|FG000|Overall Study|Participant presented clinical improvement|0|||
127860109|NCT03261037|460103571|FG001|Overall Study|Participant presented clinical improvement|2|||
127860110|NCT03261037|460103572|FG002|Overall Study|Participant presented clinical improvement|0|||
127860111|NCT03261037|460103573|FG003|Overall Study|Participant presented clinical improvement|0|||
127860112|NCT03261037|460103570|FG000|Overall Study|Technical difficulties|0|||
127860113|NCT03261037|460103571|FG001|Overall Study|Technical difficulties|0|||
127860114|NCT03261037|460103572|FG002|Overall Study|Technical difficulties|0|||
127860115|NCT03261037|460103573|FG003|Overall Study|Technical difficulties|1|||
127860116|NCT03261037|460103570|FG000|Overall Study|Equipment failed to work|0|||
127860117|NCT03261037|460103571|FG001|Overall Study|Equipment failed to work|0|||
127860118|NCT03261037|460103572|FG002|Overall Study|Equipment failed to work|0|||
127860119|NCT03261037|460103573|FG003|Overall Study|Equipment failed to work|1|||
127860120|NCT03261037|460103570|FG000|Overall Study|End of study for participant and no follow up|0|||
127860121|NCT03261037|460103571|FG001|Overall Study|End of study for participant and no follow up|0|||
127860122|NCT03261037|460103572|FG002|Overall Study|End of study for participant and no follow up|0|||
127860123|NCT03261037|460103573|FG003|Overall Study|End of study for participant and no follow up|1|||
127860124|NCT03261037|460103570|FG000|Overall Study|Participant was too weak to continue in study|1|||
127860125|NCT03261037|460103571|FG001|Overall Study|Participant was too weak to continue in study|0|||
127860126|NCT03261037|460103572|FG002|Overall Study|Participant was too weak to continue in study|0|||
127860127|NCT03261037|460103573|FG003|Overall Study|Participant was too weak to continue in study|0|||
127860128|NCT02943577|460103574|FG000|Overall Study|Protocol Violation|0|||
127860129|NCT02943577|460103575|FG001|Overall Study|Protocol Violation|1|||
127860130|NCT02943577|460103574|FG000|Overall Study|Adverse Event|3|||
127860131|NCT02943577|460103575|FG001|Overall Study|Adverse Event|2|||
127860132|NCT02943577|460103574|FG000|Overall Study|Lost to Follow-up|0|||
127860133|NCT02943577|460103575|FG001|Overall Study|Lost to Follow-up|1|||
127860134|NCT02943577|460103574|FG000|Overall Study|Withdrawal by Subject|1|||
127860135|NCT02943577|460103575|FG001|Overall Study|Withdrawal by Subject|1|||
127860136|NCT02943577|460103574|FG000|Overall Study|Pregnancy|1|||
127860137|NCT02943577|460103575|FG001|Overall Study|Pregnancy|0|||
127860138|NCT04654468|460103582|FG000|Overall Study|Death|1|||
127860139|NCT04654468|460103582|FG000|Overall Study|Ongoing in the Study|50|||
127860140|NCT00081263|460103583|FG000|Overall Study|clerical error|1|||
127860141|NCT00081263|460103584|FG001|Overall Study|clerical error|0|||
127860142|NCT00081263|460103583|FG000|Overall Study|wrong cell type|7|||
127860143|NCT00081263|460103584|FG001|Overall Study|wrong cell type|5|||
127860144|NCT00081263|460103583|FG000|Overall Study|improper pre-protocol therapy|0|||
127860145|NCT00081263|460103584|FG001|Overall Study|improper pre-protocol therapy|1|||
127860146|NCT00081263|460103583|FG000|Overall Study|Inadequate pathology|0|||
127860147|NCT00081263|460103584|FG001|Overall Study|Inadequate pathology|1|||
127860148|NCT00081263|460103583|FG000|Overall Study|Never treated|4|||
127860149|NCT00081263|460103584|FG001|Overall Study|Never treated|5|||
127860150|NCT00081263|460103583|FG000|Overall Study|Inadequate data|5|||
127860151|NCT00081263|460103584|FG001|Overall Study|Inadequate data|10|||
127860152|NCT04564027|460103589|FG000|Overall Study|Ongoing treatment at Data cut off|0|||
127912815|NCT02197416|460305981|FG002|Overall Study|Adverse Event|1|||
127912816|NCT03206749|460305982|FG000|Overall Study|Withdrawal of consent|5|||
127912817|NCT03206749|460305983|FG001|Overall Study|Withdrawal of consent|3|||
127912818|NCT03206749|460305984|FG002|Overall Study|Withdrawal of consent|6|||
127912819|NCT03206749|460305982|FG000|Overall Study|Lost to Follow-up|0|||
127912820|NCT03206749|460305983|FG001|Overall Study|Lost to Follow-up|0|||
127912821|NCT03206749|460305984|FG002|Overall Study|Lost to Follow-up|1|||
127912822|NCT02451696|460305985|FG000|Overall Study|Surgery postponed|1|||
127912823|NCT02451696|460305986|FG001|Overall Study|Surgery postponed|0|||
127912824|NCT05014828|460305987|FG000|Overall Study|Study Completed by Sponsor|16|||
127912825|NCT05014828|460305988|FG001|Overall Study|Study Completed by Sponsor|16|||
127912826|NCT05014828|460305989|FG002|Overall Study|Study Completed by Sponsor|3|||
127912827|NCT05014828|460305990|FG003|Overall Study|Study Completed by Sponsor|3|||
127912828|NCT05014828|460305987|FG000|Overall Study|Death|11|||
127912829|NCT05014828|460305988|FG001|Overall Study|Death|6|||
127912830|NCT05014828|460305989|FG002|Overall Study|Death|0|||
127912831|NCT05014828|460305990|FG003|Overall Study|Death|0|||
127912832|NCT05014828|460305987|FG000|Overall Study|Lost to Follow-up|0|||
127912833|NCT05014828|460305988|FG001|Overall Study|Lost to Follow-up|0|||
127912834|NCT05014828|460305989|FG002|Overall Study|Lost to Follow-up|2|||
127912835|NCT05014828|460305990|FG003|Overall Study|Lost to Follow-up|0|||
127912836|NCT05014828|460305987|FG000|Overall Study|Miscellaneous.|0|||
127912837|NCT05014828|460305988|FG001|Overall Study|Miscellaneous.|1|||
127912838|NCT05014828|460305989|FG002|Overall Study|Miscellaneous.|0|||
127912839|NCT05014828|460305990|FG003|Overall Study|Miscellaneous.|0|||
127912840|NCT05523895|460305992|FG000|Overall Study|Adverse Event|2|||
127912841|NCT05523895|460305993|FG001|Overall Study|Adverse Event|1|||
127912842|NCT05523895|460305994|FG002|Overall Study|Adverse Event|1|||
127912843|NCT05523895|460305992|FG000|Overall Study|Lost to Follow-up|0|||
127912844|NCT05523895|460305993|FG001|Overall Study|Lost to Follow-up|1|||
127912845|NCT05523895|460305994|FG002|Overall Study|Lost to Follow-up|2|||
127912846|NCT05523895|460305992|FG000|Overall Study|Noncompliance with study drug|1|||
127912847|NCT05523895|460305993|FG001|Overall Study|Noncompliance with study drug|1|||
127912848|NCT05523895|460305994|FG002|Overall Study|Noncompliance with study drug|1|||
127912849|NCT05523895|460305992|FG000|Overall Study|Protocol Violation|0|||
127912850|NCT05523895|460305993|FG001|Overall Study|Protocol Violation|2|||
127912851|NCT05523895|460305994|FG002|Overall Study|Protocol Violation|0|||
127912852|NCT05523895|460305992|FG000|Overall Study|Withdrawal by Subject|1|||
127912853|NCT05523895|460305993|FG001|Overall Study|Withdrawal by Subject|3|||
127912854|NCT05523895|460305994|FG002|Overall Study|Withdrawal by Subject|1|||
127912855|NCT05523895|460305992|FG000|Overall Study|Not further specified|0|||
127912856|NCT05523895|460305993|FG001|Overall Study|Not further specified|3|||
127912857|NCT05523895|460305994|FG002|Overall Study|Not further specified|1|||
127912858|NCT03674892|460305995|FG000|Overall Study|Lack of Efficacy|5|||
127912859|NCT03674892|460305995|FG000|Overall Study|Lost to Follow-up|3|||
127912860|NCT03674892|460305995|FG000|Overall Study|Migraine|2|||
127912861|NCT03674892|460305995|FG000|Overall Study|Excessive Tearing|1|||
127912862|NCT03674892|460305995|FG000|Overall Study|Increased Eye Pain|1|||
127912863|NCT03674892|460305995|FG000|Overall Study|Increased Facial Pain|1|||
127912864|NCT03674892|460305995|FG000|Overall Study|Sinus Irritation|1|||
127912865|NCT03674892|460305995|FG000|Overall Study|Sinus Infection|1|||
127912866|NCT03779334|460305999|FG000|Overall Study|Withdrawal by Subject|3|||
127912867|NCT03779334|460306000|FG001|Overall Study|Withdrawal by Subject|0|||
127912868|NCT03779334|460306001|FG002|Overall Study|Withdrawal by Subject|0|||
127912869|NCT03779334|460305999|FG000|Overall Study|Ongoing in Study|5|||
127912870|NCT03779334|460306000|FG001|Overall Study|Ongoing in Study|13|||
127912871|NCT03779334|460306001|FG002|Overall Study|Ongoing in Study|5|||
127912872|NCT01175135|460306002|FG000|Overall Study|Adverse Event|2|||
127912873|NCT01175135|460306003|FG001|Overall Study|Adverse Event|5|||
127912874|NCT01175135|460306004|FG002|Overall Study|Adverse Event|3|||
127912875|NCT01175135|460306005|FG003|Overall Study|Adverse Event|4|||
127912876|NCT01175135|460306002|FG000|Overall Study|Death|1|||
127912877|NCT01175135|460306003|FG001|Overall Study|Death|0|||
127912878|NCT01175135|460306004|FG002|Overall Study|Death|0|||
127912879|NCT01175135|460306005|FG003|Overall Study|Death|0|||
127912880|NCT01175135|460306002|FG000|Overall Study|Lack of Efficacy|4|||
127912881|NCT01175135|460306003|FG001|Overall Study|Lack of Efficacy|5|||
127912882|NCT01175135|460306004|FG002|Overall Study|Lack of Efficacy|0|||
127912883|NCT01175135|460306005|FG003|Overall Study|Lack of Efficacy|5|||
127860153|NCT04564027|460103590|FG001|Overall Study|Ongoing treatment at Data cut off|3|||
127860154|NCT04564027|460103591|FG002|Overall Study|Ongoing treatment at Data cut off|0|||
127860155|NCT04564027|460103592|FG003|Overall Study|Ongoing treatment at Data cut off|0|||
127860156|NCT00777036|460103593|FG000|On Treatment|Reached 18 years of age and transitioned to commercial drug|13|||
127860157|NCT00777036|460103594|FG001|On Treatment|Reached 18 years of age and transitioned to commercial drug|7|||
127860158|NCT00777036|460103595|FG002|On Treatment|Reached 18 years of age and transitioned to commercial drug|42|||
127860159|NCT00777036|460103596|FG003|On Treatment|Reached 18 years of age and transitioned to commercial drug|0|||
127860160|NCT00777036|460103593|FG000|On Treatment|Administrative Reason By Sponsor|1|||
127860161|NCT00777036|460103594|FG001|On Treatment|Administrative Reason By Sponsor|0|||
127860162|NCT00777036|460103595|FG002|On Treatment|Administrative Reason By Sponsor|9|||
127860163|NCT00777036|460103596|FG003|On Treatment|Administrative Reason By Sponsor|0|||
127860164|NCT00777036|460103593|FG000|On Treatment|Failure to Meet Study Criteria|0|||
127860165|NCT00777036|460103594|FG001|On Treatment|Failure to Meet Study Criteria|1|||
127860166|NCT00777036|460103595|FG002|On Treatment|Failure to Meet Study Criteria|4|||
127860167|NCT00777036|460103596|FG003|On Treatment|Failure to Meet Study Criteria|0|||
127860168|NCT00777036|460103593|FG000|On Treatment|Pregnancy|1|||
127860169|NCT00777036|460103594|FG001|On Treatment|Pregnancy|0|||
127860170|NCT00777036|460103595|FG002|On Treatment|Pregnancy|1|||
127860171|NCT00777036|460103596|FG003|On Treatment|Pregnancy|0|||
127860172|NCT00777036|460103593|FG000|On Treatment|Non-compliance with Study Drug|1|||
127860173|NCT00777036|460103594|FG001|On Treatment|Non-compliance with Study Drug|0|||
127860174|NCT00777036|460103595|FG002|On Treatment|Non-compliance with Study Drug|1|||
127860175|NCT00777036|460103596|FG003|On Treatment|Non-compliance with Study Drug|0|||
127860176|NCT00777036|460103593|FG000|On Treatment|Maximum Clinical Benefit|2|||
127860177|NCT00777036|460103594|FG001|On Treatment|Maximum Clinical Benefit|0|||
127860178|NCT00777036|460103595|FG002|On Treatment|Maximum Clinical Benefit|5|||
127912884|NCT01175135|460306002|FG000|Overall Study|Lost to Follow-up|1|||
127860179|NCT00777036|460103596|FG003|On Treatment|Maximum Clinical Benefit|0|||
127912885|NCT01175135|460306003|FG001|Overall Study|Lost to Follow-up|2|||
127912886|NCT01175135|460306004|FG002|Overall Study|Lost to Follow-up|0|||
127860180|NCT00777036|460103593|FG000|On Treatment|Withdrawal by Subject|0|||
127860181|NCT00777036|460103594|FG001|On Treatment|Withdrawal by Subject|2|||
127860182|NCT00777036|460103595|FG002|On Treatment|Withdrawal by Subject|2|||
127860183|NCT00777036|460103596|FG003|On Treatment|Withdrawal by Subject|0|||
127860184|NCT00777036|460103593|FG000|On Treatment|Participant Request to Discontinue Study Treatment|4|||
127860185|NCT00777036|460103594|FG001|On Treatment|Participant Request to Discontinue Study Treatment|0|||
127860186|NCT00777036|460103595|FG002|On Treatment|Participant Request to Discontinue Study Treatment|6|||
127860187|NCT00777036|460103596|FG003|On Treatment|Participant Request to Discontinue Study Treatment|0|||
127860188|NCT00777036|460103593|FG000|On Treatment|Death|0|||
127860189|NCT00777036|460103594|FG001|On Treatment|Death|2|||
127860190|NCT00777036|460103595|FG002|On Treatment|Death|0|||
127860191|NCT00777036|460103596|FG003|On Treatment|Death|0|||
127860192|NCT00777036|460103593|FG000|On Treatment|Study Drug Toxicity|1|||
127860193|NCT00777036|460103594|FG001|On Treatment|Study Drug Toxicity|0|||
127860194|NCT00777036|460103595|FG002|On Treatment|Study Drug Toxicity|4|||
127860195|NCT00777036|460103596|FG003|On Treatment|Study Drug Toxicity|0|||
127860196|NCT00777036|460103593|FG000|On Treatment|Progressive Disease|6|||
127860197|NCT00777036|460103594|FG001|On Treatment|Progressive Disease|4|||
127860198|NCT00777036|460103595|FG002|On Treatment|Progressive Disease|7|||
127860199|NCT00777036|460103596|FG003|On Treatment|Progressive Disease|0|||
127860200|NCT00777036|460103593|FG000|On Treatment|Not Reported|0|||
127860201|NCT00777036|460103594|FG001|On Treatment|Not Reported|0|||
127860202|NCT00777036|460103595|FG002|On Treatment|Not Reported|2|||
127860203|NCT00777036|460103596|FG003|On Treatment|Not Reported|0|||
127860204|NCT00777036|460103593|FG000|On Treatment|Site Closed|0|||
127860205|NCT00777036|460103594|FG001|On Treatment|Site Closed|1|||
127860206|NCT00777036|460103595|FG002|On Treatment|Site Closed|1|||
127860207|NCT00777036|460103596|FG003|On Treatment|Site Closed|0|||
127860208|NCT00777036|460103593|FG000|Follow-Up|Withdrawal by Subject|0|||
127860209|NCT00777036|460103594|FG001|Follow-Up|Withdrawal by Subject|0|||
127860210|NCT00777036|460103595|FG002|Follow-Up|Withdrawal by Subject|5|||
127860211|NCT00777036|460103596|FG003|Follow-Up|Withdrawal by Subject|0|||
127860212|NCT00777036|460103593|FG000|Follow-Up|Death|1|||
127860213|NCT00777036|460103594|FG001|Follow-Up|Death|9|||
127860214|NCT00777036|460103595|FG002|Follow-Up|Death|0|||
127860215|NCT00777036|460103596|FG003|Follow-Up|Death|0|||
127860216|NCT00777036|460103593|FG000|Follow-Up|Lost to Follow-up|3|||
127860217|NCT00777036|460103594|FG001|Follow-Up|Lost to Follow-up|0|||
127860218|NCT00777036|460103595|FG002|Follow-Up|Lost to Follow-up|0|||
127860219|NCT00777036|460103596|FG003|Follow-Up|Lost to Follow-up|0|||
127860220|NCT00777036|460103593|FG000|Follow-Up|Reason Not Specified|4|||
127860221|NCT00777036|460103594|FG001|Follow-Up|Reason Not Specified|0|||
127860222|NCT00777036|460103595|FG002|Follow-Up|Reason Not Specified|13|||
127860223|NCT00777036|460103596|FG003|Follow-Up|Reason Not Specified|0|||
127860224|NCT00777036|460103593|FG000|Follow-Up|Missing - Administrative Reasons in Russia|1|||
127860225|NCT00777036|460103594|FG001|Follow-Up|Missing - Administrative Reasons in Russia|0|||
127860226|NCT00777036|460103595|FG002|Follow-Up|Missing - Administrative Reasons in Russia|4|||
127860227|NCT00777036|460103596|FG003|Follow-Up|Missing - Administrative Reasons in Russia|0|||
127860228|NCT01267955|460103597|FG000|Stage 1 (6 Months)|Death|3|||
127860229|NCT01267955|460103597|FG000|Stage 2 (6 Months)|Death|5|||
127860230|NCT01267955|460103597|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
127860231|NCT05827978|460103598|FG000|Overall Study|Adverse Event|1|||
127860232|NCT05827978|460103599|FG001|Overall Study|Adverse Event|0|||
127860233|NCT05827978|460103600|FG002|Overall Study|Adverse Event|0|||
127860234|NCT05827978|460103601|FG003|Overall Study|Adverse Event|1|||
127860235|NCT05827978|460103602|FG004|Overall Study|Adverse Event|0|||
127860236|NCT05827978|460103603|FG005|Overall Study|Adverse Event|0|||
127860237|NCT05827978|460103598|FG000|Overall Study|Death|1|||
127860238|NCT05827978|460103599|FG001|Overall Study|Death|5|||
127860239|NCT05827978|460103600|FG002|Overall Study|Death|2|||
127860240|NCT05827978|460103601|FG003|Overall Study|Death|3|||
127860241|NCT05827978|460103602|FG004|Overall Study|Death|1|||
127860242|NCT05827978|460103603|FG005|Overall Study|Death|3|||
127860243|NCT05827978|460103598|FG000|Overall Study|Lost to Follow-up|57|||
127860244|NCT05827978|460103599|FG001|Overall Study|Lost to Follow-up|88|||
127860245|NCT05827978|460103600|FG002|Overall Study|Lost to Follow-up|54|||
127860246|NCT05827978|460103601|FG003|Overall Study|Lost to Follow-up|47|||
127860247|NCT05827978|460103602|FG004|Overall Study|Lost to Follow-up|25|||
127860248|NCT05827978|460103603|FG005|Overall Study|Lost to Follow-up|10|||
127860249|NCT05827978|460103598|FG000|Overall Study|Noncompliance with Study Procedures|0|||
127860250|NCT05827978|460103599|FG001|Overall Study|Noncompliance with Study Procedures|1|||
127860251|NCT05827978|460103600|FG002|Overall Study|Noncompliance with Study Procedures|1|||
127860252|NCT05827978|460103601|FG003|Overall Study|Noncompliance with Study Procedures|1|||
127860253|NCT05827978|460103602|FG004|Overall Study|Noncompliance with Study Procedures|1|||
127860254|NCT05827978|460103603|FG005|Overall Study|Noncompliance with Study Procedures|0|||
127860255|NCT05827978|460103598|FG000|Overall Study|Physician Decision|2|||
127860256|NCT05827978|460103599|FG001|Overall Study|Physician Decision|0|||
127860257|NCT05827978|460103600|FG002|Overall Study|Physician Decision|1|||
127860258|NCT05827978|460103601|FG003|Overall Study|Physician Decision|2|||
127860259|NCT05827978|460103602|FG004|Overall Study|Physician Decision|1|||
127860260|NCT05827978|460103603|FG005|Overall Study|Physician Decision|1|||
127860261|NCT05827978|460103598|FG000|Overall Study|Protocol Violation|5|||
127860262|NCT05827978|460103599|FG001|Overall Study|Protocol Violation|2|||
127860263|NCT05827978|460103600|FG002|Overall Study|Protocol Violation|0|||
127860264|NCT05827978|460103601|FG003|Overall Study|Protocol Violation|0|||
127860265|NCT05827978|460103602|FG004|Overall Study|Protocol Violation|0|||
127860266|NCT05827978|460103603|FG005|Overall Study|Protocol Violation|0|||
127860267|NCT05827978|460103598|FG000|Overall Study|Withdrawal by Subject|17|||
127860268|NCT05827978|460103599|FG001|Overall Study|Withdrawal by Subject|16|||
127860269|NCT05827978|460103600|FG002|Overall Study|Withdrawal by Subject|10|||
127860270|NCT05827978|460103601|FG003|Overall Study|Withdrawal by Subject|12|||
127860271|NCT05827978|460103602|FG004|Overall Study|Withdrawal by Subject|10|||
127860272|NCT05827978|460103603|FG005|Overall Study|Withdrawal by Subject|9|||
127860273|NCT05827978|460103598|FG000|Overall Study|Other Than Specified|0|||
127860274|NCT05827978|460103599|FG001|Overall Study|Other Than Specified|0|||
127860275|NCT05827978|460103600|FG002|Overall Study|Other Than Specified|1|||
127860276|NCT05827978|460103601|FG003|Overall Study|Other Than Specified|0|||
127860277|NCT05827978|460103602|FG004|Overall Study|Other Than Specified|2|||
127860278|NCT05827978|460103603|FG005|Overall Study|Other Than Specified|0|||
127860279|NCT04651777|460103604|FG000|Overall Study|Adverse Event|1|||
127860280|NCT04651777|460103604|FG000|Overall Study|Withdrawal by Subject|2|||
127860281|NCT04566445|460103605|FG000|Overall Study|Death|4|||
127860282|NCT04566445|460103606|FG001|Overall Study|Death|1|||
127860283|NCT04566445|460103607|FG002|Overall Study|Death|1|||
127860284|NCT04566445|460103605|FG000|Overall Study|Lost to Follow-up|3|||
127860285|NCT04566445|460103606|FG001|Overall Study|Lost to Follow-up|1|||
127860286|NCT04566445|460103607|FG002|Overall Study|Lost to Follow-up|1|||
127860287|NCT04566445|460103605|FG000|Overall Study|Study terminated by sponsor|11|||
127860288|NCT04566445|460103606|FG001|Overall Study|Study terminated by sponsor|17|||
127860289|NCT04566445|460103607|FG002|Overall Study|Study terminated by sponsor|32|||
127860290|NCT04566445|460103605|FG000|Overall Study|Withdrawal by Subject|12|||
127860291|NCT04566445|460103606|FG001|Overall Study|Withdrawal by Subject|14|||
127860292|NCT04566445|460103607|FG002|Overall Study|Withdrawal by Subject|13|||
127860293|NCT04566445|460103605|FG000|Overall Study|Randomized but not treated due to AE|2|||
127860294|NCT04566445|460103606|FG001|Overall Study|Randomized but not treated due to AE|1|||
127860295|NCT04566445|460103607|FG002|Overall Study|Randomized but not treated due to AE|0|||
127860296|NCT04566445|460103605|FG000|Overall Study|Adverse Event|1|||
127860297|NCT04566445|460103606|FG001|Overall Study|Adverse Event|1|||
127860298|NCT04566445|460103607|FG002|Overall Study|Adverse Event|0|||
127860299|NCT02421939|460103608|FG000|Randomization Period: Up to 3 Years|Progressive disease|76|||
127860300|NCT02421939|460103609|FG001|Randomization Period: Up to 3 Years|Progressive disease|16|||
127860301|NCT02421939|460103608|FG000|Randomization Period: Up to 3 Years|Lack of Efficacy|21|||
127860302|NCT02421939|460103609|FG001|Randomization Period: Up to 3 Years|Lack of Efficacy|31|||
127860303|NCT02421939|460103608|FG000|Randomization Period: Up to 3 Years|Death|38|||
127860304|NCT02421939|460103609|FG001|Randomization Period: Up to 3 Years|Death|10|||
127860305|NCT02421939|460103608|FG000|Randomization Period: Up to 3 Years|Disease relapse|37|||
127860306|NCT02421939|460103609|FG001|Randomization Period: Up to 3 Years|Disease relapse|2|||
127860307|NCT02421939|460103608|FG000|Randomization Period: Up to 3 Years|Adverse Event|32|||
127860308|NCT02421939|460103609|FG001|Randomization Period: Up to 3 Years|Adverse Event|5|||
127860309|NCT02421939|460103608|FG000|Randomization Period: Up to 3 Years|Withdrawal by Subject|9|||
127860310|NCT02421939|460103609|FG001|Randomization Period: Up to 3 Years|Withdrawal by Subject|24|||
127860311|NCT02421939|460103608|FG000|Randomization Period: Up to 3 Years|Physician Decision|13|||
127860312|NCT02421939|460103609|FG001|Randomization Period: Up to 3 Years|Physician Decision|11|||
127860313|NCT02421939|460103608|FG000|Randomization Period: Up to 3 Years|Protocol deviation|1|||
127860314|NCT02421939|460103609|FG001|Randomization Period: Up to 3 Years|Protocol deviation|1|||
127860315|NCT02421939|460103608|FG000|Randomization Period: Up to 3 Years|Miscellaneous|20|||
127860316|NCT02421939|460103609|FG001|Randomization Period: Up to 3 Years|Miscellaneous|5|||
127860317|NCT02421939|460103608|FG000|Long Term Follow up: up to 3 Years|Withdrawal by Subject|4|||
127860318|NCT02421939|460103609|FG001|Long Term Follow up: up to 3 Years|Withdrawal by Subject|5|||
127860319|NCT02421939|460103608|FG000|Long Term Follow up: up to 3 Years|Lost to Follow-up|1|||
127860320|NCT02421939|460103609|FG001|Long Term Follow up: up to 3 Years|Lost to Follow-up|2|||
127860321|NCT02421939|460103608|FG000|Long Term Follow up: up to 3 Years|Death|118|||
127860322|NCT02421939|460103609|FG001|Long Term Follow up: up to 3 Years|Death|65|||
127860323|NCT02421939|460103608|FG000|Long Term Follow up: up to 3 Years|Miscellaneous|10|||
127860324|NCT02421939|460103609|FG001|Long Term Follow up: up to 3 Years|Miscellaneous|1|||
127860325|NCT00729560|460103610|FG000|Overall Study|Withdrawal by Subject|3|||
127860326|NCT00103207|460103611|FG000|Overall Study|Adverse Event|3|||
127860327|NCT00103207|460103611|FG000|Overall Study|Death|1|||
127860328|NCT00103207|460103611|FG000|Overall Study|Withdrawal by Subject|2|||
127860329|NCT00103207|460103611|FG000|Overall Study|Other complicating disease|1|||
127860330|NCT00103207|460103611|FG000|Overall Study|Ineligible|4|||
127860331|NCT00103207|460103611|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
127860332|NCT03662789|460103612|FG000|Overall Study|Lost to Follow-up|1|||
127860333|NCT03662789|460103613|FG001|Overall Study|Lost to Follow-up|2|||
127860334|NCT03662789|460103612|FG000|Overall Study|Could not perform treadmill test|4|||
127860335|NCT03662789|460103613|FG001|Overall Study|Could not perform treadmill test|4|||
127860336|NCT03662789|460103612|FG000|Overall Study|Death|0|||
127860337|NCT03662789|460103613|FG001|Overall Study|Death|1|||
127860338|NCT01029691|460103614|FG000|Continued APAP to Delivery|Death|0|||
127860339|NCT01029691|460103615|FG001|Continued APAP to Delivery|Death|0|||
127860340|NCT01029691|460103616|FG002|Continued APAP to Delivery|Death|1|||
127860341|NCT01023516|460103617|FG000|Overall Study|Voluntary discontinuation|7|||
127860342|NCT01023516|460103618|FG001|Overall Study|Voluntary discontinuation|5|||
127860343|NCT01023516|460103617|FG000|Overall Study|Adverse Event|9|||
127860344|NCT01023516|460103618|FG001|Overall Study|Adverse Event|6|||
127860345|NCT01023516|460103617|FG000|Overall Study|Safety reason|0|||
127860346|NCT01023516|460103618|FG001|Overall Study|Safety reason|3|||
127860347|NCT01023516|460103617|FG000|Overall Study|Study-specific criteria|4|||
127860348|NCT01023516|460103618|FG001|Overall Study|Study-specific criteria|2|||
127860349|NCT01023516|460103617|FG000|Overall Study|Incorrect enrolment|4|||
127860350|NCT01023516|460103618|FG001|Overall Study|Incorrect enrolment|2|||
127860351|NCT02559115|460103619|FG000|Overall Study|Withdrawal by Subject|3|||
127860352|NCT02060903|460103622|FG000|Overall Study|Lost to Follow-up|4|||
127860353|NCT02060903|460103623|FG001|Overall Study|Lost to Follow-up|0|||
127860354|NCT02060903|460103622|FG000|Overall Study|Withdrawal by Subject|0|||
127860355|NCT02060903|460103623|FG001|Overall Study|Withdrawal by Subject|7|||
127860356|NCT00137267|460103624|FG000|Overall Study|Lost to Follow-up|15|||
127860357|NCT00137267|460103625|FG001|Overall Study|Lost to Follow-up|21|||
127860358|NCT00638989|460103626|FG000|Overall Study|Lost to Follow-up|0|||
127860359|NCT00638989|460103627|FG001|Overall Study|Lost to Follow-up|0|||
127860360|NCT00638989|460103628|FG002|Overall Study|Lost to Follow-up|1|||
127860361|NCT00592072|460103636|FG000|Wash Out Period|Lost to Follow-up|1|||
127860362|NCT00592072|460103637|FG001|Wash Out Period|Lost to Follow-up|1|||
127860363|NCT01738594|460103640|FG000|Registration and Treatment Start|Adverse Event|0|||
127860364|NCT01738594|460103641|FG001|Registration and Treatment Start|Adverse Event|1|||
127860365|NCT01738594|460103642|FG002|Registration and Treatment Start|Adverse Event|0|||
127860366|NCT01738594|460103643|FG003|Registration and Treatment Start|Adverse Event|0|||
127860367|NCT01738594|460103644|FG004|Registration and Treatment Start|Adverse Event|0|||
127860368|NCT01738594|460103645|FG005|Registration and Treatment Start|Adverse Event|0|||
127860369|NCT01738594|460103646|FG006|Registration and Treatment Start|Adverse Event|0|||
127860370|NCT01738594|460103647|FG007|Registration and Treatment Start|Adverse Event|0|||
127860371|NCT01738594|460103640|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
127860372|NCT01738594|460103641|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
127860373|NCT01738594|460103642|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
127860374|NCT01738594|460103643|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
127860375|NCT01738594|460103644|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
127860376|NCT01738594|460103645|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
127860377|NCT01738594|460103646|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
127860378|NCT01738594|460103647|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
127860379|NCT01738594|460103640|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
127860380|NCT01738594|460103641|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
127860381|NCT01738594|460103642|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
127860382|NCT01738594|460103643|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
127912887|NCT01175135|460306005|FG003|Overall Study|Lost to Follow-up|0|||
127860383|NCT01738594|460103644|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
127860384|NCT01738594|460103645|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
127860385|NCT01738594|460103646|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
127860386|NCT01738594|460103647|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
127860387|NCT01738594|460103640|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
127860388|NCT01738594|460103641|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
127860389|NCT01738594|460103642|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
127860390|NCT01738594|460103643|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
127860391|NCT01738594|460103644|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
127860392|NCT01738594|460103645|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
127860393|NCT01738594|460103646|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
127860394|NCT01738594|460103647|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
127860395|NCT01738594|460103640|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
127860396|NCT01738594|460103641|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
127860397|NCT01738594|460103642|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
127860398|NCT01738594|460103643|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
127860399|NCT01738594|460103644|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
127860400|NCT01738594|460103645|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
127860401|NCT01738594|460103646|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
127860402|NCT01738594|460103647|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
127860403|NCT01738594|460103640|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
127860404|NCT01738594|460103641|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
127860405|NCT01738594|460103642|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
127860406|NCT01738594|460103643|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
127860407|NCT01738594|460103644|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
127860408|NCT01738594|460103645|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
127912888|NCT01175135|460306002|FG000|Overall Study|Protocol Violation|1|||
127912889|NCT01175135|460306003|FG001|Overall Study|Protocol Violation|1|||
127912890|NCT01175135|460306004|FG002|Overall Study|Protocol Violation|0|||
127860409|NCT01738594|460103646|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
127912891|NCT01175135|460306005|FG003|Overall Study|Protocol Violation|0|||
127860410|NCT01738594|460103647|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
127860411|NCT01738594|460103640|FG000|Follow up for 1 Year|Death|0|||
127860412|NCT01738594|460103641|FG001|Follow up for 1 Year|Death|0|||
127860413|NCT01738594|460103642|FG002|Follow up for 1 Year|Death|0|||
127860414|NCT01738594|460103643|FG003|Follow up for 1 Year|Death|0|||
127860415|NCT01738594|460103644|FG004|Follow up for 1 Year|Death|0|||
127860416|NCT01738594|460103645|FG005|Follow up for 1 Year|Death|1|||
127860417|NCT01738594|460103646|FG006|Follow up for 1 Year|Death|0|||
127860418|NCT01738594|460103647|FG007|Follow up for 1 Year|Death|0|||
127860419|NCT01738594|460103640|FG000|Follow up for 1 Year|Other|0|||
127860420|NCT01738594|460103641|FG001|Follow up for 1 Year|Other|0|||
127860421|NCT01738594|460103642|FG002|Follow up for 1 Year|Other|0|||
127860422|NCT01738594|460103643|FG003|Follow up for 1 Year|Other|0|||
127860423|NCT01738594|460103644|FG004|Follow up for 1 Year|Other|0|||
127860424|NCT01738594|460103645|FG005|Follow up for 1 Year|Other|2|||
127860425|NCT01738594|460103646|FG006|Follow up for 1 Year|Other|0|||
127860426|NCT01738594|460103647|FG007|Follow up for 1 Year|Other|0|||
127860427|NCT01708915|460103659|FG000|Overall Study|Adverse Event|1|||
127860428|NCT01708915|460103660|FG001|Overall Study|Adverse Event|0|||
127860429|NCT01708915|460103661|FG002|Overall Study|Adverse Event|9|||
127860430|NCT01708915|460103662|FG003|Overall Study|Adverse Event|13|||
127860431|NCT01708915|460103659|FG000|Overall Study|Lack of Efficacy|84|||
127860432|NCT01708915|460103660|FG001|Overall Study|Lack of Efficacy|60|||
127860433|NCT01708915|460103661|FG002|Overall Study|Lack of Efficacy|35|||
127860434|NCT01708915|460103662|FG003|Overall Study|Lack of Efficacy|15|||
127860435|NCT01708915|460103659|FG000|Overall Study|Protocol Violation|0|||
127860436|NCT01708915|460103660|FG001|Overall Study|Protocol Violation|0|||
127860437|NCT01708915|460103661|FG002|Overall Study|Protocol Violation|0|||
127860438|NCT01708915|460103662|FG003|Overall Study|Protocol Violation|1|||
127860439|NCT01708915|460103659|FG000|Overall Study|Withdrawal by Subject|0|||
127860440|NCT01708915|460103660|FG001|Overall Study|Withdrawal by Subject|1|||
127860441|NCT01708915|460103661|FG002|Overall Study|Withdrawal by Subject|2|||
127860442|NCT01708915|460103662|FG003|Overall Study|Withdrawal by Subject|2|||
127860443|NCT01708915|460103659|FG000|Overall Study|Other reasons than stated above|1|||
127860444|NCT01708915|460103660|FG001|Overall Study|Other reasons than stated above|1|||
127860445|NCT01708915|460103661|FG002|Overall Study|Other reasons than stated above|0|||
127860446|NCT01708915|460103662|FG003|Overall Study|Other reasons than stated above|2|||
127860447|NCT01432938|460103663|FG000|First Intervention|Protocol Violation|1|||
127860448|NCT01432938|460103664|FG001|First Intervention|Protocol Violation|0|||
127860449|NCT01432938|460103663|FG000|First Intervention|Physician Decision|1|||
127860450|NCT01432938|460103664|FG001|First Intervention|Physician Decision|0|||
127860451|NCT01432938|460103663|FG000|Second Intervention|Adverse Event|1|||
127860452|NCT01432938|460103664|FG001|Second Intervention|Adverse Event|0|||
127860453|NCT04223778|460103665|FG000|Overall Study|Death|1|||
127860454|NCT04223778|460103666|FG001|Overall Study|Death|1|||
127860455|NCT04223778|460103665|FG000|Overall Study|Lost to Follow-up|4|||
127860456|NCT04223778|460103666|FG001|Overall Study|Lost to Follow-up|5|||
127860457|NCT04223778|460103665|FG000|Overall Study|Physician Decision|10|||
127860458|NCT04223778|460103666|FG001|Overall Study|Physician Decision|6|||
127860459|NCT04223778|460103665|FG000|Overall Study|Withdrawal by Subject|35|||
127860460|NCT04223778|460103666|FG001|Overall Study|Withdrawal by Subject|17|||
127860461|NCT04223778|460103665|FG000|Overall Study|Not Reported|7|||
127860462|NCT04223778|460103666|FG001|Overall Study|Not Reported|8|||
127860463|NCT04418427|460105182|FG000|Overall Study|Death|0|||
127860464|NCT04418427|460105183|FG001|Overall Study|Death|1|||
127860465|NCT04418427|460105184|FG002|Overall Study|Death|0|||
127860466|NCT04418427|460105182|FG000|Overall Study|Lost to Follow-up|0|||
127860467|NCT04418427|460105183|FG001|Overall Study|Lost to Follow-up|2|||
127860468|NCT04418427|460105184|FG002|Overall Study|Lost to Follow-up|2|||
127860469|NCT04418427|460105182|FG000|Overall Study|Subject Discontinued by the Sponsor|1|||
127860470|NCT04418427|460105183|FG001|Overall Study|Subject Discontinued by the Sponsor|0|||
127860471|NCT04418427|460105184|FG002|Overall Study|Subject Discontinued by the Sponsor|1|||
127860472|NCT04418427|460105182|FG000|Overall Study|Pre-existing medical condition|0|||
127860473|NCT04418427|460105183|FG001|Overall Study|Pre-existing medical condition|1|||
127860474|NCT04418427|460105184|FG002|Overall Study|Pre-existing medical condition|0|||
127860475|NCT02059174|460105193|FG000|Period 1|Withdrawal by Subject|0|||
127912892|NCT01175135|460306002|FG000|Overall Study|Withdrawal by Subject|4|||
127912893|NCT01175135|460306003|FG001|Overall Study|Withdrawal by Subject|8|||
127912894|NCT01175135|460306004|FG002|Overall Study|Withdrawal by Subject|5|||
127912895|NCT01175135|460306005|FG003|Overall Study|Withdrawal by Subject|5|||
127912896|NCT01175135|460306002|FG000|Overall Study|Other|3|||
127912897|NCT01175135|460306003|FG001|Overall Study|Other|1|||
127912898|NCT01175135|460306004|FG002|Overall Study|Other|3|||
127912899|NCT01175135|460306005|FG003|Overall Study|Other|0|||
127912900|NCT01175135|460306002|FG000|Overall Study|Randomized But Not Treated|0|||
127912901|NCT01175135|460306003|FG001|Overall Study|Randomized But Not Treated|0|||
127912902|NCT01175135|460306004|FG002|Overall Study|Randomized But Not Treated|1|||
127912903|NCT01175135|460306005|FG003|Overall Study|Randomized But Not Treated|0|||
127912904|NCT04692155|460306009|FG000|Overall Study|Death|1|||
127912905|NCT03957551|460306011|FG000|Overall Study|Adverse Event|2|||
127912906|NCT03957551|460306012|FG001|Overall Study|Adverse Event|2|||
127912907|NCT03957551|460306013|FG002|Overall Study|Adverse Event|6|||
127912908|NCT03957551|460306011|FG000|Overall Study|Physician Decision|1|||
127912909|NCT03957551|460306012|FG001|Overall Study|Physician Decision|0|||
127912910|NCT03957551|460306013|FG002|Overall Study|Physician Decision|2|||
127912911|NCT03957551|460306011|FG000|Overall Study|Withdrawal by Subject|1|||
127912912|NCT03957551|460306012|FG001|Overall Study|Withdrawal by Subject|0|||
127912913|NCT03957551|460306013|FG002|Overall Study|Withdrawal by Subject|2|||
127912914|NCT03957551|460306011|FG000|Overall Study|Disease progression|1|||
127912915|NCT03957551|460306012|FG001|Overall Study|Disease progression|0|||
127912916|NCT03957551|460306013|FG002|Overall Study|Disease progression|8|||
127912917|NCT00608322|460306017|FG000|Overall Study|Death|2|||
127912918|NCT00608322|460306018|FG001|Overall Study|Death|1|||
127912919|NCT00834444|460306019|FG000|First Intervention|Adverse Event|1|||
127912920|NCT00834444|460306020|FG001|First Intervention|Adverse Event|0|||
127912921|NCT00834444|460306019|FG000|First Intervention|Intolerance to Venopuncture|0|||
127912922|NCT00834444|460306020|FG001|First Intervention|Intolerance to Venopuncture|1|||
127912923|NCT00834444|460306019|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
127912924|NCT00834444|460306020|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
127912925|NCT00834444|460306019|FG000|Second Intervention|Adverse Event|1|||
127912926|NCT00834444|460306020|FG001|Second Intervention|Adverse Event|0|||
127912927|NCT00606281|460306023|FG000|Overall Study|Adverse Event|11|||
127912928|NCT00606281|460306024|FG001|Overall Study|Adverse Event|12|||
127912929|NCT00606281|460306023|FG000|Overall Study|Death|1|||
127912930|NCT00606281|460306024|FG001|Overall Study|Death|0|||
127912931|NCT00606281|460306023|FG000|Overall Study|Lack of Efficacy|28|||
127912932|NCT00606281|460306024|FG001|Overall Study|Lack of Efficacy|35|||
127912933|NCT00606281|460306023|FG000|Overall Study|Physician Decision|0|||
127912934|NCT00606281|460306024|FG001|Overall Study|Physician Decision|1|||
127912935|NCT00606281|460306023|FG000|Overall Study|Protocol Violation|3|||
127912936|NCT00606281|460306024|FG001|Overall Study|Protocol Violation|3|||
127912937|NCT00606281|460306023|FG000|Overall Study|Withdrawal by Subject|11|||
127912938|NCT00606281|460306024|FG001|Overall Study|Withdrawal by Subject|13|||
127912939|NCT00606281|460306023|FG000|Overall Study|Progression to depressive phase|1|||
127912940|NCT00606281|460306024|FG001|Overall Study|Progression to depressive phase|1|||
127912941|NCT00606281|460306023|FG000|Overall Study|Change of residence or other commitments|1|||
127912942|NCT00606281|460306024|FG001|Overall Study|Change of residence or other commitments|1|||
127912943|NCT02294981|460306025|FG000|Overall Study|Lost to Follow-up|1|||
127912944|NCT00829712|460306026|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
127912945|NCT00829712|460306027|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
127912946|NCT02213263|460306031|FG000|Overall Study|Insufficient clinical response|4|||
127912947|NCT02213263|460306032|FG001|Overall Study|Insufficient clinical response|3|||
127912948|NCT02213263|460306031|FG000|Overall Study|Lost to Follow-up|0|||
127912949|NCT02213263|460306032|FG001|Overall Study|Lost to Follow-up|1|||
127912950|NCT02213263|460306031|FG000|Overall Study|No longer willing to participate|3|||
127912951|NCT02213263|460306032|FG001|Overall Study|No longer willing to participate|4|||
127912952|NCT02213263|460306031|FG000|Overall Study|Progressive disease|20|||
127912953|NCT02213263|460306032|FG001|Overall Study|Progressive disease|14|||
127912954|NCT02213263|460306031|FG000|Overall Study|Protocol Violation|0|||
127912955|NCT02213263|460306032|FG001|Overall Study|Protocol Violation|1|||
127912956|NCT02213263|460306031|FG000|Overall Study|Adverse Event|1|||
127912957|NCT02213263|460306032|FG001|Overall Study|Adverse Event|3|||
127912958|NCT05752721|460306033|FG000|Overall Study|Lost to Follow-up|22|||
127912959|NCT05752721|460306034|FG001|Overall Study|Lost to Follow-up|20|||
127912960|NCT05752721|460306033|FG000|Overall Study|Withdrawal by Subject|15|||
127912961|NCT05752721|460306034|FG001|Overall Study|Withdrawal by Subject|12|||
127912962|NCT01188681|460306035|FG000|Overall Study|bladder cancer|0|||
127912963|NCT01188681|460306036|FG001|Overall Study|bladder cancer|0|||
127912964|NCT01188681|460306037|FG002|Overall Study|bladder cancer|1|||
127912965|NCT01188681|460306038|FG003|Overall Study|bladder cancer|0|||
127912966|NCT01188681|460306035|FG000|Overall Study|Withdrawal by Subject|0|||
127912967|NCT01188681|460306036|FG001|Overall Study|Withdrawal by Subject|0|||
127912968|NCT01188681|460306037|FG002|Overall Study|Withdrawal by Subject|0|||
127912969|NCT01188681|460306038|FG003|Overall Study|Withdrawal by Subject|1|||
127860476|NCT02059174|460105194|FG001|Period 1|Withdrawal by Subject|2|||
127860477|NCT02059174|460105193|FG000|Period 2|Withdrawal by Subject|0|||
127860478|NCT02059174|460105194|FG001|Period 2|Withdrawal by Subject|2|||
127860479|NCT02059174|460105193|FG000|Period 2|Protocol Violation|1|||
127860480|NCT02059174|460105194|FG001|Period 2|Protocol Violation|0|||
127860481|NCT02059174|460105193|FG000|Period 3|Physician Decision|1|||
127860482|NCT02059174|460105194|FG001|Period 3|Physician Decision|0|||
127860483|NCT02306148|460105195|FG000|Overall Study|Adverse Event|12|||
127860484|NCT02306148|460105196|FG001|Overall Study|Adverse Event|6|||
127860485|NCT02306148|460105195|FG000|Overall Study|Lost to Follow-up|1|||
127860486|NCT02306148|460105196|FG001|Overall Study|Lost to Follow-up|4|||
127860487|NCT00087594|460105197|FG000|Overall Study|Adverse Event|2|||
127860488|NCT00087594|460105198|FG001|Overall Study|Adverse Event|3|||
127860489|NCT00087594|460105197|FG000|Overall Study|Lost to Follow-up|0|||
127860490|NCT00087594|460105198|FG001|Overall Study|Lost to Follow-up|2|||
127860491|NCT00087594|460105197|FG000|Overall Study|Withdrawal by Subject|4|||
127860492|NCT00087594|460105198|FG001|Overall Study|Withdrawal by Subject|2|||
127860493|NCT00087594|460105197|FG000|Overall Study|Lack of Efficacy|2|||
127860494|NCT00087594|460105198|FG001|Overall Study|Lack of Efficacy|5|||
127860495|NCT01952041|460105199|FG000|Overall Study|Lost to Follow-up|9|||
127860496|NCT01952041|460105200|FG001|Overall Study|Lost to Follow-up|16|||
127860497|NCT01952041|460105199|FG000|Overall Study|Withdrawal by Subject|7|||
127860498|NCT01952041|460105200|FG001|Overall Study|Withdrawal by Subject|5|||
127860499|NCT01952041|460105199|FG000|Overall Study|Death|1|||
127860500|NCT01952041|460105200|FG001|Overall Study|Death|0|||
127860501|NCT00186121|460105201|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
127860502|NCT00186121|460105201|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
127860503|NCT00186121|460105201|FG000|Overall Study|Not eligible (no treatment)|1|||
127860504|NCT03650387|460105202|FG000|Overall Study|Withdrawal by Subject|13|||
127860505|NCT03650387|460105202|FG000|Overall Study|Lost to Follow-up|12|||
127860506|NCT03650387|460105202|FG000|Overall Study|Adverse Event (Not related)|1|||
127860507|NCT03650387|460105202|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
127860508|NCT01569568|460105203|FG000|Overall Study|Physician Decision|0|||
127860509|NCT01569568|460105204|FG001|Overall Study|Physician Decision|2|||
127860510|NCT01370499|460105205|FG000|Overall Study|Adverse Event|38|||
127860511|NCT01370499|460105206|FG001|Overall Study|Adverse Event|12|||
127860512|NCT01370499|460105205|FG000|Overall Study|Lack of Efficacy|4|||
127860513|NCT01370499|460105206|FG001|Overall Study|Lack of Efficacy|2|||
127860514|NCT01370499|460105205|FG000|Overall Study|Lost to Follow-up|2|||
127860515|NCT01370499|460105206|FG001|Overall Study|Lost to Follow-up|1|||
127860516|NCT01370499|460105205|FG000|Overall Study|Physician Decision|3|||
127860517|NCT01370499|460105206|FG001|Overall Study|Physician Decision|3|||
127860518|NCT01370499|460105205|FG000|Overall Study|Protocol Violation|5|||
127860519|NCT01370499|460105206|FG001|Overall Study|Protocol Violation|4|||
127860520|NCT01370499|460105205|FG000|Overall Study|Withdrawal by Subject|18|||
127860521|NCT01370499|460105206|FG001|Overall Study|Withdrawal by Subject|7|||
127860522|NCT01370499|460105205|FG000|Overall Study|Sponsor Decision|41|||
127860523|NCT01370499|460105206|FG001|Overall Study|Sponsor Decision|15|||
127860524|NCT03558503|460105208|FG000|Overall Study|Adverse Event|1|||
127860525|NCT03558503|460105208|FG000|Overall Study|Death|1|||
127860526|NCT03558503|460105208|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
127860527|NCT02145429|460105209|FG000|Overall Study|Death|4|||
127860528|NCT02145429|460105210|FG001|Overall Study|Death|5|||
127860529|NCT02145429|460105209|FG000|Overall Study|Lost to Follow-up|4|||
127860530|NCT02145429|460105210|FG001|Overall Study|Lost to Follow-up|3|||
127860531|NCT02145429|460105209|FG000|Overall Study|Withdrawal by Subject|8|||
127860532|NCT02145429|460105210|FG001|Overall Study|Withdrawal by Subject|3|||
127860533|NCT01944462|460105211|FG000|PPPP Educational Program|Lost to Follow-up|60|||
127860534|NCT01222767|460105212|FG000|Overall Study|Progressive disease|13|||
127860535|NCT01222767|460105212|FG000|Overall Study|Adverse Event|2|||
127860536|NCT01222767|460105212|FG000|Overall Study|Surgical resection|1|||
127860537|NCT01222767|460105212|FG000|Overall Study|Never treated|1|||
127860538|NCT00723489|460105213|FG000|Overall Study|Physician Decision|0|||
127860539|NCT00723489|460105214|FG001|Overall Study|Physician Decision|1|||
127860540|NCT00723489|460105215|FG002|Overall Study|Physician Decision|0|||
127860541|NCT00723489|460105216|FG003|Overall Study|Physician Decision|0|||
127860542|NCT00723489|460105213|FG000|Overall Study|Pregnancy|0|||
127860543|NCT00723489|460105214|FG001|Overall Study|Pregnancy|0|||
127860544|NCT00723489|460105215|FG002|Overall Study|Pregnancy|0|||
127860545|NCT00723489|460105216|FG003|Overall Study|Pregnancy|1|||
127860546|NCT00723489|460105213|FG000|Overall Study|Withdrawal by Subject|0|||
127860547|NCT00723489|460105214|FG001|Overall Study|Withdrawal by Subject|0|||
127860548|NCT00723489|460105215|FG002|Overall Study|Withdrawal by Subject|0|||
127860549|NCT00723489|460105216|FG003|Overall Study|Withdrawal by Subject|1|||
127860550|NCT00723489|460105213|FG000|Overall Study|Seropositive at baseline|1|||
127860551|NCT00723489|460105214|FG001|Overall Study|Seropositive at baseline|0|||
127860552|NCT00723489|460105215|FG002|Overall Study|Seropositive at baseline|0|||
127860553|NCT00723489|460105216|FG003|Overall Study|Seropositive at baseline|0|||
127860554|NCT00723489|460105213|FG000|Overall Study|Prohibited Medication|0|||
127912970|NCT02280863|460306039|FG000|Integrated Platform|Met stopping criteria|0|||
127912971|NCT02280863|460306040|FG001|Integrated Platform|Met stopping criteria|1|||
127912972|NCT00263588|460306041|FG000|Overall Study|Death|54|||
127912973|NCT00263588|460306042|FG001|Overall Study|Death|90|||
127912974|NCT00263588|460306041|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
127912975|NCT00263588|460306042|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
127912976|NCT00263588|460306041|FG000|Overall Study|Lost to Follow-up|7|||
127912977|NCT00263588|460306042|FG001|Overall Study|Lost to Follow-up|10|||
127912978|NCT00263588|460306041|FG000|Overall Study|Withdrawal by Subject|3|||
127912979|NCT00263588|460306042|FG001|Overall Study|Withdrawal by Subject|4|||
127912980|NCT00263588|460306041|FG000|Overall Study|Protocol Violation|0|||
127912981|NCT00263588|460306042|FG001|Overall Study|Protocol Violation|1|||
127912982|NCT00263588|460306041|FG000|Overall Study|Investigator decision|7|||
127912983|NCT00263588|460306042|FG001|Overall Study|Investigator decision|15|||
127912984|NCT00263588|460306041|FG000|Overall Study|Sponsor terminated study|0|||
127912985|NCT00263588|460306042|FG001|Overall Study|Sponsor terminated study|1|||
127912986|NCT02622386|460306043|FG000|First Assignment|Withdrawal by Subject|3|||
127912987|NCT02622386|460306044|FG001|First Assignment|Withdrawal by Subject|2|||
127912988|NCT02622386|460306043|FG000|Washout|Withdrawal by Subject|4|||
127912989|NCT02622386|460306044|FG001|Washout|Withdrawal by Subject|4|||
127912990|NCT02622386|460306043|FG000|Second Assignment|Withdrawal by Subject|0|||
127912991|NCT02622386|460306044|FG001|Second Assignment|Withdrawal by Subject|2|||
127912992|NCT03236311|460306045|FG000|Overall Study|Study terminated by sponsor|0|||
127912993|NCT03236311|460306046|FG001|Overall Study|Study terminated by sponsor|2|||
127912994|NCT03236311|460306045|FG000|Overall Study|Adverse Event|0|||
127912995|NCT03236311|460306046|FG001|Overall Study|Adverse Event|1|||
127912996|NCT00367133|460306051|FG000|2 Years|Death|20|||
127912997|NCT00367133|460306052|FG001|2 Years|Death|12|||
127912998|NCT00367133|460306053|FG002|2 Years|Death|12|||
127912999|NCT00367133|460306051|FG000|2 Years|Dropped|34|||
127913000|NCT00367133|460306052|FG001|2 Years|Dropped|19|||
127913001|NCT00367133|460306053|FG002|2 Years|Dropped|33|||
127913002|NCT00367133|460306051|FG000|2 Years|Missed visit|4|||
127913003|NCT00367133|460306052|FG001|2 Years|Missed visit|5|||
127913004|NCT00367133|460306053|FG002|2 Years|Missed visit|4|||
127913005|NCT00906399|460306055|FG000|Year 1|Randomized But Not Treated|0|||
127913006|NCT00906399|460306056|FG001|Year 1|Randomized But Not Treated|1|||
127913007|NCT00906399|460306057|FG002|Year 1|Randomized But Not Treated|3|||
127913008|NCT00906399|460306058|FG003|Year 1|Randomized But Not Treated|0|||
127913009|NCT00906399|460306059|FG004|Year 1|Randomized But Not Treated|0|||
127913010|NCT00906399|460306060|FG005|Year 1|Randomized But Not Treated|0|||
127913011|NCT00906399|460306061|FG006|Year 1|Randomized But Not Treated|0|||
127913012|NCT00906399|460306055|FG000|Year 1|Adverse Event|4|||
127913013|NCT00906399|460306056|FG001|Year 1|Adverse Event|22|||
127913014|NCT00906399|460306057|FG002|Year 1|Adverse Event|24|||
127913015|NCT00906399|460306058|FG003|Year 1|Adverse Event|0|||
127913016|NCT00906399|460306059|FG004|Year 1|Adverse Event|0|||
127913017|NCT00906399|460306060|FG005|Year 1|Adverse Event|0|||
127913018|NCT00906399|460306061|FG006|Year 1|Adverse Event|0|||
127913019|NCT00906399|460306055|FG000|Year 1|Lost to Follow-up|4|||
127913020|NCT00906399|460306056|FG001|Year 1|Lost to Follow-up|4|||
127913021|NCT00906399|460306057|FG002|Year 1|Lost to Follow-up|2|||
127913022|NCT00906399|460306058|FG003|Year 1|Lost to Follow-up|0|||
127913023|NCT00906399|460306059|FG004|Year 1|Lost to Follow-up|0|||
127913024|NCT00906399|460306060|FG005|Year 1|Lost to Follow-up|0|||
127913025|NCT00906399|460306061|FG006|Year 1|Lost to Follow-up|0|||
127913026|NCT00906399|460306055|FG000|Year 1|Withdrawal by Subject|30|||
127913027|NCT00906399|460306056|FG001|Year 1|Withdrawal by Subject|32|||
127913028|NCT00906399|460306057|FG002|Year 1|Withdrawal by Subject|36|||
127913029|NCT00906399|460306058|FG003|Year 1|Withdrawal by Subject|0|||
127913030|NCT00906399|460306059|FG004|Year 1|Withdrawal by Subject|0|||
127913031|NCT00906399|460306060|FG005|Year 1|Withdrawal by Subject|0|||
127913032|NCT00906399|460306061|FG006|Year 1|Withdrawal by Subject|0|||
127913033|NCT00906399|460306055|FG000|Year 1|Physician Decision|0|||
127913034|NCT00906399|460306056|FG001|Year 1|Physician Decision|1|||
127913035|NCT00906399|460306057|FG002|Year 1|Physician Decision|3|||
127913036|NCT00906399|460306058|FG003|Year 1|Physician Decision|0|||
127913037|NCT00906399|460306059|FG004|Year 1|Physician Decision|0|||
127913038|NCT00906399|460306060|FG005|Year 1|Physician Decision|0|||
127913039|NCT00906399|460306061|FG006|Year 1|Physician Decision|0|||
127913040|NCT00906399|460306055|FG000|Year 1|Death|2|||
127913041|NCT00906399|460306056|FG001|Year 1|Death|1|||
127913042|NCT00906399|460306057|FG002|Year 1|Death|1|||
127913043|NCT00906399|460306058|FG003|Year 1|Death|0|||
127913044|NCT00906399|460306059|FG004|Year 1|Death|0|||
127913045|NCT00906399|460306060|FG005|Year 1|Death|0|||
127913046|NCT00906399|460306061|FG006|Year 1|Death|0|||
127913047|NCT00906399|460306055|FG000|Year 1|Other|4|||
127913048|NCT00906399|460306056|FG001|Year 1|Other|2|||
127860555|NCT00723489|460105214|FG001|Overall Study|Prohibited Medication|0|||
127860556|NCT00723489|460105215|FG002|Overall Study|Prohibited Medication|0|||
127860557|NCT00723489|460105216|FG003|Overall Study|Prohibited Medication|1|||
127860558|NCT00723489|460105213|FG000|Overall Study|Samples Collected Out of Window|0|||
127860559|NCT00723489|460105214|FG001|Overall Study|Samples Collected Out of Window|3|||
127860560|NCT00723489|460105215|FG002|Overall Study|Samples Collected Out of Window|0|||
127860561|NCT00723489|460105216|FG003|Overall Study|Samples Collected Out of Window|0|||
127860562|NCT01599585|460105217|FG000|Overall Study|Withdrawal by Subject|16|||
127860563|NCT01599585|460105218|FG001|Overall Study|Withdrawal by Subject|9|||
127860564|NCT01599585|460105217|FG000|Overall Study|Lost to Follow-up|3|||
127860565|NCT01599585|460105218|FG001|Overall Study|Lost to Follow-up|5|||
127860566|NCT01599585|460105217|FG000|Overall Study|randomized did not start treatment|3|||
127860567|NCT01599585|460105218|FG001|Overall Study|randomized did not start treatment|3|||
127860568|NCT00853112|460105220|FG000|Overall Study|Randomized but not treated|0|||
127860569|NCT00853112|460105221|FG001|Overall Study|Randomized but not treated|1|||
127860570|NCT00853112|460105222|FG002|Overall Study|Randomized but not treated|0|||
127860571|NCT00853112|460105223|FG003|Overall Study|Randomized but not treated|2|||
127860572|NCT00853112|460105224|FG004|Overall Study|Randomized but not treated|0|||
127860573|NCT00853112|460105225|FG005|Overall Study|Randomized but not treated|0|||
127860574|NCT00853112|460105226|FG006|Overall Study|Randomized but not treated|1|||
127860575|NCT01553591|460105227|FG000|Overall Study|Voluntarily withdrew|94|||
127860576|NCT01553591|460105228|FG001|Overall Study|Voluntarily withdrew|79|||
127860577|NCT01553591|460105229|FG002|Overall Study|Voluntarily withdrew|96|||
127860578|NCT01553591|460105227|FG000|Overall Study|Adverse Event|36|||
127860579|NCT01553591|460105228|FG001|Overall Study|Adverse Event|45|||
127860580|NCT01553591|460105229|FG002|Overall Study|Adverse Event|16|||
127860581|NCT01553591|460105227|FG000|Overall Study|Lost to Follow-up|25|||
127860582|NCT01553591|460105228|FG001|Overall Study|Lost to Follow-up|23|||
127860583|NCT01553591|460105229|FG002|Overall Study|Lost to Follow-up|16|||
127860584|NCT01553591|460105227|FG000|Overall Study|Physician decision: other|11|||
127860585|NCT01553591|460105228|FG001|Overall Study|Physician decision: other|14|||
127860586|NCT01553591|460105229|FG002|Overall Study|Physician decision: other|16|||
127860587|NCT01553591|460105227|FG000|Overall Study|Physician decision: lack of efficacy|2|||
127860588|NCT01553591|460105228|FG001|Overall Study|Physician decision: lack of efficacy|3|||
127860589|NCT01553591|460105229|FG002|Overall Study|Physician decision: lack of efficacy|7|||
127860590|NCT01553591|460105227|FG000|Overall Study|Protocol Violation|3|||
127860591|NCT01553591|460105228|FG001|Overall Study|Protocol Violation|4|||
127860592|NCT01553591|460105229|FG002|Overall Study|Protocol Violation|4|||
127860593|NCT01553591|460105227|FG000|Overall Study|Sponsor decision|1|||
127860594|NCT01553591|460105228|FG001|Overall Study|Sponsor decision|0|||
127860595|NCT01553591|460105229|FG002|Overall Study|Sponsor decision|3|||
127860596|NCT01553591|460105227|FG000|Overall Study|Randomized and never dispensed drug|0|||
127860597|NCT01553591|460105228|FG001|Overall Study|Randomized and never dispensed drug|1|||
127860598|NCT01553591|460105229|FG002|Overall Study|Randomized and never dispensed drug|0|||
127860599|NCT01818765|460105232|FG000|Overall Study|Death|2|||
127860600|NCT02010567|460105233|FG000|Overall Study|Adverse Event|0|||
127860601|NCT02010567|460105234|FG001|Overall Study|Adverse Event|0|||
127860602|NCT02010567|460105235|FG002|Overall Study|Adverse Event|1|||
127860603|NCT02010567|460105236|FG003|Overall Study|Adverse Event|0|||
127860604|NCT02010567|460105237|FG004|Overall Study|Adverse Event|1|||
127860605|NCT02005211|460105238|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
127860606|NCT02005211|460105239|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
127860607|NCT02005211|460105240|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
127860608|NCT02005211|460105241|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
127860609|NCT02005211|460105242|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
127913049|NCT00906399|460306057|FG002|Year 1|Other|7|||
127913050|NCT00906399|460306058|FG003|Year 1|Other|0|||
127860610|NCT02005211|460105243|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
127860611|NCT02005211|460105244|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
127913051|NCT00906399|460306059|FG004|Year 1|Other|0|||
127913052|NCT00906399|460306060|FG005|Year 1|Other|0|||
127913053|NCT00906399|460306061|FG006|Year 1|Other|0|||
127913054|NCT00906399|460306055|FG000|Year 2|Adverse Event|0|||
127913055|NCT00906399|460306056|FG001|Year 2|Adverse Event|0|||
127913056|NCT00906399|460306057|FG002|Year 2|Adverse Event|0|||
127913057|NCT00906399|460306058|FG003|Year 2|Adverse Event|9|||
127913058|NCT00906399|460306059|FG004|Year 2|Adverse Event|8|||
127913059|NCT00906399|460306060|FG005|Year 2|Adverse Event|11|||
127913060|NCT00906399|460306061|FG006|Year 2|Adverse Event|6|||
127913061|NCT00906399|460306055|FG000|Year 2|Lost to Follow-up|0|||
127913062|NCT00906399|460306056|FG001|Year 2|Lost to Follow-up|0|||
127913063|NCT00906399|460306057|FG002|Year 2|Lost to Follow-up|0|||
127913064|NCT00906399|460306058|FG003|Year 2|Lost to Follow-up|1|||
127913065|NCT00906399|460306059|FG004|Year 2|Lost to Follow-up|4|||
127913066|NCT00906399|460306060|FG005|Year 2|Lost to Follow-up|2|||
127913067|NCT00906399|460306061|FG006|Year 2|Lost to Follow-up|4|||
127913068|NCT00906399|460306055|FG000|Year 2|Withdrawal by Subject|0|||
127913069|NCT00906399|460306056|FG001|Year 2|Withdrawal by Subject|0|||
127913070|NCT00906399|460306057|FG002|Year 2|Withdrawal by Subject|0|||
127913071|NCT00906399|460306058|FG003|Year 2|Withdrawal by Subject|17|||
127913072|NCT00906399|460306059|FG004|Year 2|Withdrawal by Subject|18|||
127913073|NCT00906399|460306060|FG005|Year 2|Withdrawal by Subject|27|||
127913074|NCT00906399|460306061|FG006|Year 2|Withdrawal by Subject|13|||
127913075|NCT00906399|460306055|FG000|Year 2|Physician Decision|0|||
127913076|NCT00906399|460306056|FG001|Year 2|Physician Decision|0|||
127913077|NCT00906399|460306057|FG002|Year 2|Physician Decision|0|||
127913078|NCT00906399|460306058|FG003|Year 2|Physician Decision|0|||
127913079|NCT00906399|460306059|FG004|Year 2|Physician Decision|2|||
127913080|NCT00906399|460306060|FG005|Year 2|Physician Decision|6|||
127913081|NCT00906399|460306061|FG006|Year 2|Physician Decision|3|||
127913082|NCT00906399|460306055|FG000|Year 2|Death|0|||
127913083|NCT00906399|460306056|FG001|Year 2|Death|0|||
127913084|NCT00906399|460306057|FG002|Year 2|Death|0|||
127913085|NCT00906399|460306058|FG003|Year 2|Death|1|||
127913086|NCT00906399|460306059|FG004|Year 2|Death|0|||
127913087|NCT00906399|460306060|FG005|Year 2|Death|0|||
127913088|NCT00906399|460306061|FG006|Year 2|Death|3|||
127913089|NCT00906399|460306055|FG000|Year 2|Other|0|||
127913090|NCT00906399|460306056|FG001|Year 2|Other|0|||
127913091|NCT00906399|460306057|FG002|Year 2|Other|0|||
127913092|NCT00906399|460306058|FG003|Year 2|Other|2|||
127913093|NCT00906399|460306059|FG004|Year 2|Other|3|||
127913094|NCT00906399|460306060|FG005|Year 2|Other|1|||
127913095|NCT00906399|460306061|FG006|Year 2|Other|0|||
127913096|NCT00858780|460306069|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
127913097|NCT00858780|460306070|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
127913098|NCT00858780|460306071|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
127913099|NCT00858780|460306072|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
127913100|NCT00858780|460306073|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
127913101|NCT00858780|460306069|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
127913102|NCT00858780|460306070|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
127913103|NCT00858780|460306071|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
127913104|NCT00858780|460306072|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
127913105|NCT00858780|460306073|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
127913106|NCT00858780|460306069|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
127913107|NCT00858780|460306070|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
127913108|NCT00858780|460306071|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
127913109|NCT00858780|460306072|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
127913110|NCT00858780|460306073|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
127913111|NCT00858780|460306069|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
127913112|NCT00858780|460306070|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
127913113|NCT00858780|460306071|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
127913114|NCT00858780|460306072|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
127913115|NCT00858780|460306073|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
127913116|NCT00858780|460306069|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
127913117|NCT00858780|460306070|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
127913118|NCT00858780|460306071|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
127913119|NCT00858780|460306072|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
127913120|NCT00858780|460306073|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
127913121|NCT00858780|460306069|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
127913122|NCT00858780|460306070|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
127913123|NCT00858780|460306071|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
127913124|NCT00858780|460306072|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
127913125|NCT00858780|460306073|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
127913126|NCT00863330|460306074|FG000|Overall Study|study terminated early due to administra|6|||
127913127|NCT02615249|460306075|FG000|Overall Study|Withdrawal by Subject|1|||
127860612|NCT00397631|460105247|FG000|Overall Study|Adverse Event|5|||
127860613|NCT00397631|460105248|FG001|Overall Study|Adverse Event|6|||
127860614|NCT00397631|460105247|FG000|Overall Study|Lack of Efficacy|7|||
127860615|NCT00397631|460105248|FG001|Overall Study|Lack of Efficacy|10|||
127860616|NCT00397631|460105247|FG000|Overall Study|Lost to Follow-up|8|||
127860617|NCT00397631|460105248|FG001|Overall Study|Lost to Follow-up|9|||
127860618|NCT00397631|460105247|FG000|Overall Study|Physician Decision|2|||
127860619|NCT00397631|460105248|FG001|Overall Study|Physician Decision|0|||
127860620|NCT00397631|460105247|FG000|Overall Study|Protocol Violation|0|||
127860621|NCT00397631|460105248|FG001|Overall Study|Protocol Violation|1|||
127860622|NCT00397631|460105247|FG000|Overall Study|Withdrawal by Subject|7|||
127860623|NCT00397631|460105248|FG001|Overall Study|Withdrawal by Subject|14|||
127860624|NCT00397631|460105247|FG000|Overall Study|protocol discontinuation criteria|1|||
127860625|NCT00397631|460105248|FG001|Overall Study|protocol discontinuation criteria|4|||
127860626|NCT02202161|460105249|FG000|Overall Study|Adverse Event|1|||
127860627|NCT02202161|460105250|FG001|Overall Study|Adverse Event|1|||
127860628|NCT02202161|460105251|FG002|Overall Study|Adverse Event|0|||
127860629|NCT02202161|460105252|FG003|Overall Study|Adverse Event|0|||
127860630|NCT02202161|460105253|FG004|Overall Study|Adverse Event|0|||
127860631|NCT02202161|460105254|FG005|Overall Study|Adverse Event|1|||
127860632|NCT02202161|460105255|FG006|Overall Study|Adverse Event|0|||
127860633|NCT02202161|460105256|FG007|Overall Study|Adverse Event|0|||
127860634|NCT02202161|460105249|FG000|Overall Study|Did not meet continuation criteria|0|||
127860635|NCT02202161|460105250|FG001|Overall Study|Did not meet continuation criteria|0|||
127860636|NCT02202161|460105251|FG002|Overall Study|Did not meet continuation criteria|0|||
127860637|NCT02202161|460105252|FG003|Overall Study|Did not meet continuation criteria|0|||
127860638|NCT02202161|460105253|FG004|Overall Study|Did not meet continuation criteria|0|||
127860639|NCT02202161|460105254|FG005|Overall Study|Did not meet continuation criteria|0|||
127860640|NCT02202161|460105255|FG006|Overall Study|Did not meet continuation criteria|0|||
127860641|NCT02202161|460105256|FG007|Overall Study|Did not meet continuation criteria|3|||
127860642|NCT02202161|460105249|FG000|Overall Study|Physician Decision|0|||
127860643|NCT02202161|460105250|FG001|Overall Study|Physician Decision|0|||
127860644|NCT02202161|460105251|FG002|Overall Study|Physician Decision|0|||
127860645|NCT02202161|460105252|FG003|Overall Study|Physician Decision|0|||
127860646|NCT02202161|460105253|FG004|Overall Study|Physician Decision|0|||
127860647|NCT02202161|460105254|FG005|Overall Study|Physician Decision|0|||
127860648|NCT02202161|460105255|FG006|Overall Study|Physician Decision|0|||
127860649|NCT02202161|460105256|FG007|Overall Study|Physician Decision|3|||
127860650|NCT02202161|460105249|FG000|Overall Study|Withdrawal by Subject|0|||
127860651|NCT02202161|460105250|FG001|Overall Study|Withdrawal by Subject|0|||
127860652|NCT02202161|460105251|FG002|Overall Study|Withdrawal by Subject|0|||
127860653|NCT02202161|460105252|FG003|Overall Study|Withdrawal by Subject|0|||
127860654|NCT02202161|460105253|FG004|Overall Study|Withdrawal by Subject|1|||
127860655|NCT02202161|460105254|FG005|Overall Study|Withdrawal by Subject|0|||
127860656|NCT02202161|460105255|FG006|Overall Study|Withdrawal by Subject|0|||
127860657|NCT02202161|460105256|FG007|Overall Study|Withdrawal by Subject|0|||
127860658|NCT00832091|460105257|FG000|Overall Study|Adverse Event|1|||
127860659|NCT00832091|460105258|FG001|Overall Study|Adverse Event|1|||
127860660|NCT00832091|460105257|FG000|Overall Study|Protocol Violation|1|||
127860661|NCT00832091|460105258|FG001|Overall Study|Protocol Violation|0|||
127860662|NCT00832091|460105257|FG000|Overall Study|Withdrawal by Subject|2|||
127860663|NCT00832091|460105258|FG001|Overall Study|Withdrawal by Subject|1|||
127860664|NCT00832091|460105257|FG000|Overall Study|Prohibited Medication|1|||
127860665|NCT00832091|460105258|FG001|Overall Study|Prohibited Medication|0|||
127860666|NCT00942422|460105259|FG000|Overall Study|Withdrawal by Subject|1|||
127860667|NCT00942422|460105259|FG000|Overall Study|Death|1|||
127860668|NCT00942422|460105259|FG000|Overall Study|Progressive diease|1|||
127860669|NCT02711553|460105262|FG000|Overall Study|Withdrawal by Subject|2|||
127860670|NCT02711553|460105263|FG001|Overall Study|Withdrawal by Subject|1|||
127860671|NCT02711553|460105264|FG002|Overall Study|Withdrawal by Subject|1|||
127860672|NCT02711553|460105265|FG003|Overall Study|Withdrawal by Subject|0|||
127860673|NCT02711553|460105262|FG000|Overall Study|Lost to Follow-up|3|||
127860674|NCT02711553|460105263|FG001|Overall Study|Lost to Follow-up|3|||
127860675|NCT02711553|460105264|FG002|Overall Study|Lost to Follow-up|6|||
127860676|NCT02711553|460105265|FG003|Overall Study|Lost to Follow-up|3|||
127860677|NCT02711553|460105262|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
127860678|NCT02711553|460105263|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
127860679|NCT02711553|460105264|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
127860680|NCT02711553|460105265|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
127860681|NCT05559203|460105266|FG000|Overall Study|Intervention not implemented at their care home due to insufficient staff|14|||
127860682|NCT03117309|460105267|FG000|Overall Study|Not meeting inclusion criteria|0|||
127860683|NCT03117309|460105268|FG001|Overall Study|Not meeting inclusion criteria|1|||
127860684|NCT04048876|460105269|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
127860685|NCT04048876|460105270|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
127860686|NCT04048876|460105271|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
127860687|NCT04048876|460105272|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
127913128|NCT00574847|460306076|FG000|Overall Study|Adverse Event|2|||
127913129|NCT00574847|460306077|FG001|Overall Study|Adverse Event|0|||
127913130|NCT00574847|460306076|FG000|Overall Study|Death|1|||
127913131|NCT00574847|460306077|FG001|Overall Study|Death|0|||
127913132|NCT00574847|460306076|FG000|Overall Study|Withdrawal by Subject|2|||
127913133|NCT00574847|460306077|FG001|Overall Study|Withdrawal by Subject|2|||
127913134|NCT00574847|460306076|FG000|Overall Study|Physician Decision|1|||
127913135|NCT00574847|460306077|FG001|Overall Study|Physician Decision|0|||
127913136|NCT00574847|460306076|FG000|Overall Study|Did not receive medication (declined)|2|||
127913137|NCT00574847|460306077|FG001|Overall Study|Did not receive medication (declined)|5|||
127913138|NCT02055547|460306079|FG000|Overall Study|Protocol Violation|0|||
127913139|NCT02055547|460306080|FG001|Overall Study|Protocol Violation|0|||
127913140|NCT02055547|460306081|FG002|Overall Study|Protocol Violation|1|||
127913141|NCT02055547|460306082|FG003|Overall Study|Protocol Violation|0|||
127913142|NCT02055547|460306083|FG004|Overall Study|Protocol Violation|0|||
127913143|NCT02055547|460306084|FG005|Overall Study|Protocol Violation|0|||
127913144|NCT02055547|460306085|FG006|Overall Study|Protocol Violation|1|||
127913145|NCT02055547|460306086|FG007|Overall Study|Protocol Violation|0|||
127913146|NCT02055547|460306087|FG008|Overall Study|Protocol Violation|0|||
127913147|NCT02055547|460306088|FG009|Overall Study|Protocol Violation|0|||
127913148|NCT02055547|460306089|FG010|Overall Study|Protocol Violation|0|||
127913149|NCT02055547|460306090|FG011|Overall Study|Protocol Violation|0|||
127913150|NCT02055547|460306091|FG012|Overall Study|Protocol Violation|0|||
127913151|NCT02055547|460306092|FG013|Overall Study|Protocol Violation|0|||
127913152|NCT02055547|460306093|FG014|Overall Study|Protocol Violation|0|||
127913153|NCT02055547|460306094|FG015|Overall Study|Protocol Violation|0|||
127913154|NCT02055547|460306095|FG016|Overall Study|Protocol Violation|0|||
127913155|NCT02055547|460306096|FG017|Overall Study|Protocol Violation|0|||
127913156|NCT02055547|460306097|FG018|Overall Study|Protocol Violation|0|||
127913157|NCT02055547|460306079|FG000|Overall Study|Physician Decision|0|||
127913158|NCT02055547|460306080|FG001|Overall Study|Physician Decision|1|||
127913159|NCT02055547|460306081|FG002|Overall Study|Physician Decision|1|||
127913160|NCT02055547|460306082|FG003|Overall Study|Physician Decision|0|||
127913161|NCT02055547|460306083|FG004|Overall Study|Physician Decision|1|||
127913162|NCT02055547|460306084|FG005|Overall Study|Physician Decision|0|||
127913163|NCT02055547|460306085|FG006|Overall Study|Physician Decision|0|||
127913164|NCT02055547|460306086|FG007|Overall Study|Physician Decision|0|||
127913165|NCT02055547|460306087|FG008|Overall Study|Physician Decision|0|||
127913166|NCT02055547|460306088|FG009|Overall Study|Physician Decision|1|||
127913167|NCT02055547|460306089|FG010|Overall Study|Physician Decision|1|||
127913168|NCT02055547|460306090|FG011|Overall Study|Physician Decision|0|||
127913169|NCT02055547|460306091|FG012|Overall Study|Physician Decision|0|||
127913170|NCT02055547|460306092|FG013|Overall Study|Physician Decision|0|||
127913171|NCT02055547|460306093|FG014|Overall Study|Physician Decision|0|||
127913172|NCT02055547|460306094|FG015|Overall Study|Physician Decision|0|||
127913173|NCT02055547|460306095|FG016|Overall Study|Physician Decision|0|||
127913174|NCT02055547|460306096|FG017|Overall Study|Physician Decision|0|||
127913175|NCT02055547|460306097|FG018|Overall Study|Physician Decision|0|||
127913176|NCT02055547|460306079|FG000|Overall Study|Adverse Event|0|||
127913177|NCT02055547|460306080|FG001|Overall Study|Adverse Event|0|||
127913178|NCT02055547|460306081|FG002|Overall Study|Adverse Event|0|||
127913179|NCT02055547|460306082|FG003|Overall Study|Adverse Event|0|||
127913180|NCT02055547|460306083|FG004|Overall Study|Adverse Event|0|||
127913181|NCT02055547|460306084|FG005|Overall Study|Adverse Event|0|||
127913182|NCT02055547|460306085|FG006|Overall Study|Adverse Event|1|||
127913183|NCT02055547|460306086|FG007|Overall Study|Adverse Event|0|||
127913184|NCT02055547|460306087|FG008|Overall Study|Adverse Event|1|||
127913185|NCT02055547|460306088|FG009|Overall Study|Adverse Event|0|||
127913186|NCT02055547|460306089|FG010|Overall Study|Adverse Event|0|||
127913187|NCT02055547|460306090|FG011|Overall Study|Adverse Event|0|||
127913188|NCT02055547|460306091|FG012|Overall Study|Adverse Event|0|||
127913189|NCT02055547|460306092|FG013|Overall Study|Adverse Event|0|||
127913190|NCT02055547|460306093|FG014|Overall Study|Adverse Event|0|||
127913191|NCT02055547|460306094|FG015|Overall Study|Adverse Event|0|||
127913192|NCT02055547|460306095|FG016|Overall Study|Adverse Event|0|||
127913193|NCT02055547|460306096|FG017|Overall Study|Adverse Event|0|||
127913194|NCT02055547|460306097|FG018|Overall Study|Adverse Event|0|||
127913195|NCT02055547|460306079|FG000|Overall Study|Withdrawal by Subject|0|||
127913196|NCT02055547|460306080|FG001|Overall Study|Withdrawal by Subject|0|||
127913197|NCT02055547|460306081|FG002|Overall Study|Withdrawal by Subject|0|||
127913198|NCT02055547|460306082|FG003|Overall Study|Withdrawal by Subject|0|||
127913199|NCT02055547|460306083|FG004|Overall Study|Withdrawal by Subject|0|||
127913200|NCT02055547|460306084|FG005|Overall Study|Withdrawal by Subject|1|||
127913201|NCT02055547|460306085|FG006|Overall Study|Withdrawal by Subject|0|||
127913202|NCT02055547|460306086|FG007|Overall Study|Withdrawal by Subject|0|||
127860688|NCT04048876|460105269|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
127860689|NCT04048876|460105270|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
127860690|NCT04048876|460105271|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
127913203|NCT02055547|460306087|FG008|Overall Study|Withdrawal by Subject|1|||
127913204|NCT02055547|460306088|FG009|Overall Study|Withdrawal by Subject|0|||
127913205|NCT02055547|460306089|FG010|Overall Study|Withdrawal by Subject|0|||
127913206|NCT02055547|460306090|FG011|Overall Study|Withdrawal by Subject|0|||
127913207|NCT02055547|460306091|FG012|Overall Study|Withdrawal by Subject|0|||
127913208|NCT02055547|460306092|FG013|Overall Study|Withdrawal by Subject|1|||
127913209|NCT02055547|460306093|FG014|Overall Study|Withdrawal by Subject|0|||
127913210|NCT02055547|460306094|FG015|Overall Study|Withdrawal by Subject|1|||
127913211|NCT02055547|460306095|FG016|Overall Study|Withdrawal by Subject|0|||
127913212|NCT02055547|460306096|FG017|Overall Study|Withdrawal by Subject|0|||
127913213|NCT02055547|460306097|FG018|Overall Study|Withdrawal by Subject|0|||
127913214|NCT02055547|460306079|FG000|Overall Study|Lost to Follow-up|0|||
127913215|NCT02055547|460306080|FG001|Overall Study|Lost to Follow-up|0|||
127913216|NCT02055547|460306081|FG002|Overall Study|Lost to Follow-up|1|||
127913217|NCT02055547|460306082|FG003|Overall Study|Lost to Follow-up|0|||
127913218|NCT02055547|460306083|FG004|Overall Study|Lost to Follow-up|0|||
127913219|NCT02055547|460306084|FG005|Overall Study|Lost to Follow-up|0|||
127913220|NCT02055547|460306085|FG006|Overall Study|Lost to Follow-up|0|||
127913221|NCT02055547|460306086|FG007|Overall Study|Lost to Follow-up|0|||
127913222|NCT02055547|460306087|FG008|Overall Study|Lost to Follow-up|0|||
127913223|NCT02055547|460306088|FG009|Overall Study|Lost to Follow-up|0|||
127913224|NCT02055547|460306089|FG010|Overall Study|Lost to Follow-up|0|||
127913225|NCT02055547|460306090|FG011|Overall Study|Lost to Follow-up|0|||
127913226|NCT02055547|460306091|FG012|Overall Study|Lost to Follow-up|0|||
127913227|NCT02055547|460306092|FG013|Overall Study|Lost to Follow-up|0|||
127913228|NCT02055547|460306093|FG014|Overall Study|Lost to Follow-up|0|||
127913229|NCT02055547|460306094|FG015|Overall Study|Lost to Follow-up|0|||
127913230|NCT02055547|460306095|FG016|Overall Study|Lost to Follow-up|0|||
127913231|NCT02055547|460306096|FG017|Overall Study|Lost to Follow-up|0|||
127913232|NCT02055547|460306097|FG018|Overall Study|Lost to Follow-up|0|||
127913233|NCT05098743|460306098|FG000|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|1|||
127913234|NCT05098743|460306099|FG001|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|0|||
127913235|NCT05098743|460306098|FG000|Overall Study|Lost to Follow-up|1|||
127913236|NCT05098743|460306099|FG001|Overall Study|Lost to Follow-up|2|||
127913237|NCT03719040|460306100|FG000|Overall Study|Withdrawal by Subject|177|||
127913238|NCT03719040|460306100|FG000|Overall Study|Lost to Follow-up|26|||
127913239|NCT02923349|460306102|FG000|Overall Study|Other|1|||
127913240|NCT02923349|460306103|FG001|Overall Study|Other|2|||
127913241|NCT02923349|460306104|FG002|Overall Study|Other|4|||
127913242|NCT02923349|460306105|FG003|Overall Study|Other|1|||
127913243|NCT02923349|460306106|FG004|Overall Study|Other|3|||
127913244|NCT02923349|460306107|FG005|Overall Study|Other|0|||
127913245|NCT02923349|460306108|FG006|Overall Study|Other|1|||
127913246|NCT02923349|460306102|FG000|Overall Study|Withdrawal by Subject|2|||
127913247|NCT02923349|460306103|FG001|Overall Study|Withdrawal by Subject|2|||
127913248|NCT02923349|460306104|FG002|Overall Study|Withdrawal by Subject|8|||
127913249|NCT02923349|460306105|FG003|Overall Study|Withdrawal by Subject|10|||
127913250|NCT02923349|460306106|FG004|Overall Study|Withdrawal by Subject|12|||
127913251|NCT02923349|460306107|FG005|Overall Study|Withdrawal by Subject|3|||
127913252|NCT02923349|460306108|FG006|Overall Study|Withdrawal by Subject|0|||
127913253|NCT02923349|460306102|FG000|Overall Study|Physician Decision|0|||
127913254|NCT02923349|460306103|FG001|Overall Study|Physician Decision|0|||
127913255|NCT02923349|460306104|FG002|Overall Study|Physician Decision|0|||
127913256|NCT02923349|460306105|FG003|Overall Study|Physician Decision|1|||
127913257|NCT02923349|460306106|FG004|Overall Study|Physician Decision|1|||
127913258|NCT02923349|460306107|FG005|Overall Study|Physician Decision|0|||
127860691|NCT04048876|460105272|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
127860692|NCT04048876|460105269|FG000|Placebo Controlled Phase|Adverse Event|0|||
127860693|NCT04048876|460105270|FG001|Placebo Controlled Phase|Adverse Event|1|||
127860694|NCT04048876|460105271|FG002|Placebo Controlled Phase|Adverse Event|0|||
127860695|NCT04048876|460105272|FG003|Placebo Controlled Phase|Adverse Event|0|||
127913259|NCT02923349|460306108|FG006|Overall Study|Physician Decision|2|||
127913260|NCT02923349|460306102|FG000|Overall Study|Lost to Follow-up|0|||
127913261|NCT02923349|460306103|FG001|Overall Study|Lost to Follow-up|0|||
127913262|NCT02923349|460306104|FG002|Overall Study|Lost to Follow-up|3|||
127913263|NCT02923349|460306105|FG003|Overall Study|Lost to Follow-up|0|||
127913264|NCT02923349|460306106|FG004|Overall Study|Lost to Follow-up|1|||
127913265|NCT02923349|460306107|FG005|Overall Study|Lost to Follow-up|1|||
127913266|NCT02923349|460306108|FG006|Overall Study|Lost to Follow-up|0|||
127913267|NCT02923349|460306102|FG000|Overall Study|Death|1|||
127913268|NCT02923349|460306103|FG001|Overall Study|Death|0|||
127913269|NCT02923349|460306104|FG002|Overall Study|Death|2|||
127913270|NCT02923349|460306105|FG003|Overall Study|Death|4|||
127860696|NCT04048876|460105269|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
127913271|NCT02923349|460306106|FG004|Overall Study|Death|2|||
127860697|NCT04048876|460105270|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
127860698|NCT04048876|460105271|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
127860699|NCT04048876|460105272|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
127860700|NCT02187224|460105273|FG000|Overall Study|Did not show up for test day|1|||
127860701|NCT02187224|460105274|FG001|Overall Study|Did not show up for test day|0|||
127860702|NCT01010776|460105275|FG000|Main Phase|Withdrawal by Subject|14|||
127860703|NCT01010776|460105275|FG000|Main Phase|Lack of Efficacy|8|||
127860704|NCT01010776|460105275|FG000|Main Phase|Adverse Event|7|||
127860705|NCT01010776|460105275|FG000|Main Phase|Lost to Follow-up|6|||
127860706|NCT01010776|460105275|FG000|Main Phase|Non-compliance to study medication|5|||
127860707|NCT01010776|460105275|FG000|Main Phase|Selection failure|2|||
127860708|NCT01010776|460105275|FG000|Main Phase|Inform consent withdrawal|1|||
127860709|NCT01010776|460105275|FG000|Main Phase|Other|1|||
127860710|NCT01010776|460105275|FG000|Main Phase|Did not received study medication|5|||
127860711|NCT01010776|460105275|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
127860712|NCT01010776|460105275|FG000|Extension Phase|Other|3|||
127860713|NCT01012037|460105281|FG000|Overall Study|Adverse Event|0|||
127860714|NCT01012037|460105282|FG001|Overall Study|Adverse Event|8|||
127860715|NCT01012037|460105283|FG002|Overall Study|Adverse Event|3|||
127860716|NCT01012037|460105281|FG000|Overall Study|Protocol Violation|0|||
127860717|NCT01012037|460105282|FG001|Overall Study|Protocol Violation|3|||
127860718|NCT01012037|460105283|FG002|Overall Study|Protocol Violation|5|||
127860719|NCT01012037|460105281|FG000|Overall Study|Withdrawal by Subject|0|||
127860720|NCT01012037|460105282|FG001|Overall Study|Withdrawal by Subject|4|||
127860721|NCT01012037|460105283|FG002|Overall Study|Withdrawal by Subject|1|||
127860722|NCT01012037|460105281|FG000|Overall Study|Other reason (not specified)|1|||
127860723|NCT01012037|460105282|FG001|Overall Study|Other reason (not specified)|1|||
127860724|NCT01012037|460105283|FG002|Overall Study|Other reason (not specified)|1|||
127860725|NCT02583711|460105284|FG000|Overall Study|Withdrawal by Subject|0|||
127860726|NCT02583711|460105285|FG001|Overall Study|Withdrawal by Subject|10|||
127860727|NCT02583711|460105286|FG002|Overall Study|Withdrawal by Subject|0|||
127860728|NCT00415623|460105288|FG000|Overall Study|Adverse Event|3|||
127860729|NCT00415623|460105289|FG001|Overall Study|Adverse Event|4|||
127860730|NCT00415623|460105288|FG000|Overall Study|Death|1|||
127860731|NCT00415623|460105289|FG001|Overall Study|Death|0|||
127860732|NCT00415623|460105288|FG000|Overall Study|Withdrawal by Subject|1|||
127860733|NCT00415623|460105289|FG001|Overall Study|Withdrawal by Subject|1|||
127860734|NCT00542425|460105290|FG000|Initial 24 Weeks|Administrative reasons|0|||
127860735|NCT00542425|460105291|FG001|Initial 24 Weeks|Administrative reasons|0|||
127860736|NCT00542425|460105292|FG002|Initial 24 Weeks|Administrative reasons|1|||
127860737|NCT00542425|460105293|FG003|Initial 24 Weeks|Administrative reasons|1|||
127860738|NCT00542425|460105294|FG004|Initial 24 Weeks|Administrative reasons|0|||
127860739|NCT00542425|460105290|FG000|Initial 24 Weeks|Adverse Event|0|||
127860740|NCT00542425|460105291|FG001|Initial 24 Weeks|Adverse Event|1|||
127860741|NCT00542425|460105292|FG002|Initial 24 Weeks|Adverse Event|1|||
127860742|NCT00542425|460105293|FG003|Initial 24 Weeks|Adverse Event|3|||
127860743|NCT00542425|460105294|FG004|Initial 24 Weeks|Adverse Event|2|||
127860744|NCT00542425|460105290|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
127860745|NCT00542425|460105291|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
127860746|NCT00542425|460105292|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
127860747|NCT00542425|460105293|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
127860748|NCT00542425|460105294|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
127860749|NCT00542425|460105290|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
127860750|NCT00542425|460105291|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
127860751|NCT00542425|460105292|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
127860752|NCT00542425|460105293|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
127860753|NCT00542425|460105294|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
127860754|NCT00542425|460105290|FG000|Initial 24 Weeks|Non-compliance|0|||
127860755|NCT00542425|460105291|FG001|Initial 24 Weeks|Non-compliance|0|||
127860756|NCT00542425|460105292|FG002|Initial 24 Weeks|Non-compliance|0|||
127860757|NCT00542425|460105293|FG003|Initial 24 Weeks|Non-compliance|1|||
127860758|NCT00542425|460105294|FG004|Initial 24 Weeks|Non-compliance|1|||
127860759|NCT00542425|460105290|FG000|Initial 24 Weeks|Protocol Violation|0|||
127860760|NCT00542425|460105291|FG001|Initial 24 Weeks|Protocol Violation|0|||
127860761|NCT00542425|460105292|FG002|Initial 24 Weeks|Protocol Violation|0|||
127860762|NCT00542425|460105293|FG003|Initial 24 Weeks|Protocol Violation|1|||
127860763|NCT00542425|460105294|FG004|Initial 24 Weeks|Protocol Violation|0|||
127860764|NCT00542425|460105290|FG000|Initial 24 Weeks|Refusal of treatment|2|||
127860765|NCT00542425|460105291|FG001|Initial 24 Weeks|Refusal of treatment|2|||
127860766|NCT00542425|460105292|FG002|Initial 24 Weeks|Refusal of treatment|1|||
127860767|NCT00542425|460105293|FG003|Initial 24 Weeks|Refusal of treatment|4|||
127860768|NCT00542425|460105294|FG004|Initial 24 Weeks|Refusal of treatment|1|||
127860769|NCT00542425|460105290|FG000|Initial 24 Weeks|Other|0|||
127860770|NCT00542425|460105291|FG001|Initial 24 Weeks|Other|2|||
127860771|NCT00542425|460105292|FG002|Initial 24 Weeks|Other|1|||
127860772|NCT00542425|460105293|FG003|Initial 24 Weeks|Other|0|||
127860773|NCT00542425|460105294|FG004|Initial 24 Weeks|Other|0|||
127860774|NCT00542425|460105290|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
127860775|NCT00542425|460105291|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
127860776|NCT00542425|460105292|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
127860777|NCT00542425|460105293|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
127860778|NCT00542425|460105294|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
127860779|NCT00542425|460105290|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
127860780|NCT00542425|460105291|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
127860781|NCT00542425|460105292|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
127860782|NCT00542425|460105293|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
127860783|NCT00542425|460105294|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
127860784|NCT00542425|460105290|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
127860785|NCT00542425|460105291|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
127860786|NCT00542425|460105292|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
127860787|NCT00542425|460105293|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
127860788|NCT00542425|460105294|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
127913272|NCT02923349|460306107|FG005|Overall Study|Death|3|||
127913273|NCT02923349|460306108|FG006|Overall Study|Death|0|||
127913274|NCT04063878|460306111|FG000|Overall Study|Withdrawal by Subject|2|||
127913275|NCT04063878|460306111|FG000|Overall Study|Subject not fulfilling study eligibility criteria|14|||
127913276|NCT02751827|460306112|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
127913277|NCT02751827|460306113|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
127913278|NCT02751827|460306114|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
127913279|NCT01248728|460306115|FG000|Overall Study|Adverse Event|1|||
127913280|NCT01248728|460306116|FG001|Overall Study|Adverse Event|1|||
127913281|NCT01248728|460306115|FG000|Overall Study|Withdrawal by Subject|2|||
127860789|NCT00542425|460105290|FG000|Extended 24 Weeks of Treatment|Other|1|||
127860790|NCT00542425|460105291|FG001|Extended 24 Weeks of Treatment|Other|1|||
127860791|NCT00542425|460105292|FG002|Extended 24 Weeks of Treatment|Other|0|||
127860792|NCT00542425|460105293|FG003|Extended 24 Weeks of Treatment|Other|0|||
127860793|NCT00542425|460105294|FG004|Extended 24 Weeks of Treatment|Other|1|||
127860794|NCT01601873|460105295|FG000|Overall Study|Lost to Follow-up|2|||
127860795|NCT01601873|460105296|FG001|Overall Study|Lost to Follow-up|3|||
127860796|NCT02096471|460105297|FG000|Overall Study|Adverse Event|1|||
127860797|NCT02096471|460105297|FG000|Overall Study|Lack of Efficacy|7|||
127860798|NCT02096471|460105297|FG000|Overall Study|Withdrawal by Subject|3|||
127860799|NCT02096471|460105297|FG000|Overall Study|Non-Compliant|2|||
127860800|NCT02449915|460105298|FG000|Overall Study|Exclusion criteria - drug use|1|||
127860801|NCT02449915|460105299|FG001|Overall Study|Exclusion criteria - drug use|0|||
127860802|NCT02449915|460105298|FG000|Overall Study|Withdrawal by Subject|0|||
127860803|NCT02449915|460105299|FG001|Overall Study|Withdrawal by Subject|2|||
127860804|NCT02449915|460105298|FG000|Overall Study|Intraoperative surgical findings|1|||
127860805|NCT02449915|460105299|FG001|Overall Study|Intraoperative surgical findings|1|||
127860806|NCT02449915|460105298|FG000|Overall Study|Abnormal preop lab|0|||
127860807|NCT02449915|460105299|FG001|Overall Study|Abnormal preop lab|1|||
127860808|NCT01855919|460107372|FG000|Overall Study|Adverse Event|16|||
127860809|NCT01855919|460107373|FG001|Overall Study|Adverse Event|8|||
127860810|NCT01855919|460107372|FG000|Overall Study|Lack of Efficacy|1|||
127860811|NCT01855919|460107373|FG001|Overall Study|Lack of Efficacy|3|||
127860812|NCT01855919|460107372|FG000|Overall Study|Withdrawal by Subject|4|||
127860813|NCT01855919|460107373|FG001|Overall Study|Withdrawal by Subject|10|||
127860814|NCT01855919|460107372|FG000|Overall Study|Entry Criteria Not Met|1|||
127860815|NCT01855919|460107373|FG001|Overall Study|Entry Criteria Not Met|1|||
127860816|NCT01855919|460107372|FG000|Overall Study|Protocol Violation|1|||
127860817|NCT01855919|460107373|FG001|Overall Study|Protocol Violation|4|||
127860818|NCT04459416|460107374|FG000|Overall Study|Lost to Follow-up|2|||
127860819|NCT04459416|460107375|FG001|Overall Study|Lost to Follow-up|0|||
127860820|NCT04459416|460107374|FG000|Overall Study|Withdrawal by Subject|8|||
127860821|NCT04459416|460107375|FG001|Overall Study|Withdrawal by Subject|10|||
127860822|NCT04459416|460107374|FG000|Overall Study|Disease progression|0|||
127860823|NCT04459416|460107375|FG001|Overall Study|Disease progression|3|||
127860824|NCT03455530|460107376|FG000|Overall Study|Withdrawal by Subject|9|||
127860825|NCT03455530|460107377|FG001|Overall Study|Withdrawal by Subject|1|||
127860826|NCT03455530|460107378|FG002|Overall Study|Withdrawal by Subject|3|||
127913282|NCT01248728|460306116|FG001|Overall Study|Withdrawal by Subject|1|||
127913283|NCT01248728|460306115|FG000|Overall Study|Lack of Efficacy|1|||
127913284|NCT01248728|460306116|FG001|Overall Study|Lack of Efficacy|0|||
127860827|NCT03455530|460107379|FG003|Overall Study|Withdrawal by Subject|3|||
127860828|NCT01592773|460107384|FG000|Overall Study|Study Terminated by Sponsor|582|||
127860829|NCT01592773|460107384|FG000|Overall Study|Withdrawal by Subject|35|||
127913285|NCT01624233|460307933|FG000|Period 2 - Induction|Adverse Event|1|||
127913286|NCT01624233|460307933|FG000|Period 3 - Maintenance|Adverse Event|2|||
127860830|NCT01592773|460107384|FG000|Overall Study|Lost to Follow-up|19|||
127860831|NCT01592773|460107384|FG000|Overall Study|Adverse Event|17|||
127860832|NCT01592773|460107384|FG000|Overall Study|Lack of Efficacy|9|||
127860833|NCT01592773|460107384|FG000|Overall Study|Protocol Violation|2|||
127860834|NCT01592773|460107384|FG000|Overall Study|Inclusion/exclusion not meet|1|||
127860835|NCT01592773|460107384|FG000|Overall Study|Other Reason|1|||
127860836|NCT00740116|460107389|FG000|Overall Study|Withdrawal by Subject|1|||
127860837|NCT00740116|460107390|FG001|Overall Study|Withdrawal by Subject|1|||
127860838|NCT00740116|460107389|FG000|Overall Study|Protocol Violation|1|||
127860839|NCT00740116|460107390|FG001|Overall Study|Protocol Violation|4|||
127860840|NCT03037489|460107391|FG000|Overall Study|Adverse Event|4|||
127860841|NCT03037489|460107392|FG001|Overall Study|Adverse Event|0|||
127860842|NCT03037489|460107391|FG000|Overall Study|Withdrawal by Subject|3|||
127860843|NCT03037489|460107392|FG001|Overall Study|Withdrawal by Subject|0|||
127860844|NCT00121485|460107393|FG000|Overall Study|Not implanted|1|||
127860845|NCT00121485|460107394|FG001|Overall Study|Not implanted|5|||
127860846|NCT00121485|460107393|FG000|Overall Study|Crossover|0|||
127860847|NCT00121485|460107394|FG001|Overall Study|Crossover|2|||
127860848|NCT00724243|460107397|FG000|Overall Study|Lack of Efficacy|10|||
127860849|NCT00724243|460107397|FG000|Overall Study|Adverse Event|5|||
127860850|NCT03031327|460107398|FG000|Overall Study|Withdrawal by Subject|0|||
127860851|NCT03031327|460107399|FG001|Overall Study|Withdrawal by Subject|1|||
127860852|NCT03031327|460107400|FG002|Overall Study|Withdrawal by Subject|1|||
127860853|NCT01004861|460107401|FG000|Overall Study|Disease progression|3|||
127860854|NCT01004861|460107402|FG001|Overall Study|Disease progression|4|||
127860855|NCT01004861|460107403|FG002|Overall Study|Disease progression|5|||
127860856|NCT01004861|460107404|FG003|Overall Study|Disease progression|4|||
127860857|NCT01004861|460107405|FG004|Overall Study|Disease progression|4|||
127860858|NCT01004861|460107406|FG005|Overall Study|Disease progression|4|||
127860859|NCT01004861|460107407|FG006|Overall Study|Disease progression|5|||
127860860|NCT01004861|460107408|FG007|Overall Study|Disease progression|1|||
127860861|NCT01004861|460107409|FG008|Overall Study|Disease progression|4|||
127860862|NCT01004861|460107410|FG009|Overall Study|Disease progression|7|||
127860863|NCT01004861|460107411|FG010|Overall Study|Disease progression|6|||
127860864|NCT01004861|460107412|FG011|Overall Study|Disease progression|3|||
127860865|NCT01004861|460107413|FG012|Overall Study|Disease progression|8|||
127860866|NCT01004861|460107401|FG000|Overall Study|Physician Decision|0|||
127860867|NCT01004861|460107402|FG001|Overall Study|Physician Decision|2|||
127860868|NCT01004861|460107403|FG002|Overall Study|Physician Decision|1|||
127860869|NCT01004861|460107404|FG003|Overall Study|Physician Decision|1|||
127860870|NCT01004861|460107405|FG004|Overall Study|Physician Decision|1|||
127860871|NCT01004861|460107406|FG005|Overall Study|Physician Decision|0|||
127860872|NCT01004861|460107407|FG006|Overall Study|Physician Decision|0|||
127860873|NCT01004861|460107408|FG007|Overall Study|Physician Decision|1|||
127860874|NCT01004861|460107409|FG008|Overall Study|Physician Decision|0|||
127860875|NCT01004861|460107410|FG009|Overall Study|Physician Decision|0|||
127860876|NCT01004861|460107411|FG010|Overall Study|Physician Decision|0|||
127860877|NCT01004861|460107412|FG011|Overall Study|Physician Decision|0|||
127860878|NCT01004861|460107413|FG012|Overall Study|Physician Decision|3|||
127860879|NCT01004861|460107401|FG000|Overall Study|Adverse Event|0|||
127860880|NCT01004861|460107402|FG001|Overall Study|Adverse Event|0|||
127860881|NCT01004861|460107403|FG002|Overall Study|Adverse Event|0|||
127860882|NCT01004861|460107404|FG003|Overall Study|Adverse Event|1|||
127860883|NCT01004861|460107405|FG004|Overall Study|Adverse Event|0|||
127860884|NCT01004861|460107406|FG005|Overall Study|Adverse Event|2|||
127860885|NCT01004861|460107407|FG006|Overall Study|Adverse Event|1|||
127860886|NCT01004861|460107408|FG007|Overall Study|Adverse Event|1|||
127860887|NCT01004861|460107409|FG008|Overall Study|Adverse Event|13|||
127860888|NCT01004861|460107410|FG009|Overall Study|Adverse Event|1|||
127860889|NCT01004861|460107411|FG010|Overall Study|Adverse Event|1|||
127860890|NCT01004861|460107412|FG011|Overall Study|Adverse Event|0|||
127860891|NCT01004861|460107413|FG012|Overall Study|Adverse Event|2|||
127860892|NCT01004861|460107401|FG000|Overall Study|Protocol Violation|0|||
127860893|NCT01004861|460107402|FG001|Overall Study|Protocol Violation|0|||
127860894|NCT01004861|460107403|FG002|Overall Study|Protocol Violation|0|||
127860895|NCT01004861|460107404|FG003|Overall Study|Protocol Violation|0|||
127860896|NCT01004861|460107405|FG004|Overall Study|Protocol Violation|1|||
127860897|NCT01004861|460107406|FG005|Overall Study|Protocol Violation|0|||
127860898|NCT01004861|460107407|FG006|Overall Study|Protocol Violation|0|||
127860899|NCT01004861|460107408|FG007|Overall Study|Protocol Violation|0|||
127860900|NCT01004861|460107409|FG008|Overall Study|Protocol Violation|0|||
127860901|NCT01004861|460107410|FG009|Overall Study|Protocol Violation|0|||
127860902|NCT01004861|460107411|FG010|Overall Study|Protocol Violation|0|||
127860903|NCT01004861|460107412|FG011|Overall Study|Protocol Violation|0|||
127860904|NCT01004861|460107413|FG012|Overall Study|Protocol Violation|0|||
127860905|NCT01004861|460107401|FG000|Overall Study|Lost to Follow-up|0|||
127860906|NCT01004861|460107402|FG001|Overall Study|Lost to Follow-up|0|||
127860907|NCT01004861|460107403|FG002|Overall Study|Lost to Follow-up|0|||
127860908|NCT01004861|460107404|FG003|Overall Study|Lost to Follow-up|0|||
127860909|NCT01004861|460107405|FG004|Overall Study|Lost to Follow-up|0|||
127860910|NCT01004861|460107406|FG005|Overall Study|Lost to Follow-up|0|||
127860911|NCT01004861|460107407|FG006|Overall Study|Lost to Follow-up|0|||
127860912|NCT01004861|460107408|FG007|Overall Study|Lost to Follow-up|1|||
127913287|NCT01624233|460307933|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
127913288|NCT01624233|460307933|FG000|Period 3 - Maintenance|Physician Decision|2|||
127913289|NCT01624233|460307933|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
127913290|NCT01624233|460307933|FG000|Period 4 - Drug Free Period|Relapsed|61|||
127913291|NCT01624233|460307933|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
127913292|NCT01624233|460307933|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
127913293|NCT01624233|460307933|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
127913294|NCT01624233|460307933|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
127913295|NCT01624233|460307933|FG000|Period 6: Follow-up|Adverse Event|3|||
127913296|NCT01624233|460307933|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
127913297|NCT01624233|460307933|FG000|Period 6: Follow-up|Physician Decision|1|||
127913298|NCT01624233|460307933|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
127913299|NCT04372238|460307934|FG000|Overall Study|Duplicate|3|||
127913300|NCT04372238|460307935|FG001|Overall Study|Duplicate|3|||
127913301|NCT04372238|460307934|FG000|Overall Study|Did not consent for data linkage|6|||
127913302|NCT04372238|460307935|FG001|Overall Study|Did not consent for data linkage|10|||
127913303|NCT00334815|460307936|FG000|Overall Study|Adverse Event|3|||
127913304|NCT00334815|460307937|FG001|Overall Study|Adverse Event|2|||
127913305|NCT00334815|460307936|FG000|Overall Study|Death|0|||
127913306|NCT00334815|460307937|FG001|Overall Study|Death|2|||
127913307|NCT00334815|460307936|FG000|Overall Study|Progression|1|||
127913308|NCT00334815|460307937|FG001|Overall Study|Progression|0|||
127913309|NCT00334815|460307936|FG000|Overall Study|ineligible|1|||
127913310|NCT00334815|460307937|FG001|Overall Study|ineligible|1|||
127913311|NCT00334815|460307936|FG000|Overall Study|patient refused treatment|0|||
127913312|NCT00334815|460307937|FG001|Overall Study|patient refused treatment|1|||
127913313|NCT00334815|460307936|FG000|Overall Study|Physician Decision|2|||
127913314|NCT00334815|460307937|FG001|Overall Study|Physician Decision|4|||
127913315|NCT03325881|460307945|FG000|Overall Study|Protocol Violation|0|||
127913316|NCT03325881|460307946|FG001|Overall Study|Protocol Violation|1|||
127913317|NCT03325881|460307945|FG000|Overall Study|Withdrawal by Subject|0|||
127913318|NCT03325881|460307946|FG001|Overall Study|Withdrawal by Subject|2|||
127913319|NCT03325881|460307945|FG000|Overall Study|Lack of Efficacy|2|||
127913320|NCT03325881|460307946|FG001|Overall Study|Lack of Efficacy|0|||
127913321|NCT03325881|460307945|FG000|Overall Study|Not treated|1|||
127913322|NCT03325881|460307946|FG001|Overall Study|Not treated|0|||
127913323|NCT03676634|460307947|FG000|Overall Study|Red blood cell loss|1|||
127913324|NCT03676634|460307947|FG000|Overall Study|Out-of-limit pulse|2|||
127913325|NCT03131895|460307955|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
127913326|NCT03131895|460307956|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
127913327|NCT03131895|460307957|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
127913328|NCT03131895|460307958|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
127913329|NCT03131895|460307955|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
127913330|NCT03131895|460307956|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
127913331|NCT03131895|460307957|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
127913332|NCT03131895|460307958|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
127913333|NCT03131895|460307955|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
127913334|NCT03131895|460307956|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
127913335|NCT03131895|460307957|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
127913336|NCT03131895|460307958|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
127913337|NCT03131895|460307955|FG000|Washout Period (at Least 5 Days)|Other|0|||
127913338|NCT03131895|460307956|FG001|Washout Period (at Least 5 Days)|Other|0|||
127913339|NCT03131895|460307957|FG002|Washout Period (at Least 5 Days)|Other|2|||
127913340|NCT03131895|460307958|FG003|Washout Period (at Least 5 Days)|Other|0|||
127913341|NCT03131895|460307955|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
127913342|NCT03131895|460307956|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
127913343|NCT03131895|460307957|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
127913344|NCT03131895|460307958|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
127913345|NCT03131895|460307955|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
127913346|NCT03131895|460307956|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
127913347|NCT03131895|460307957|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
127913348|NCT03131895|460307958|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
127860913|NCT01004861|460107409|FG008|Overall Study|Lost to Follow-up|3|||
127860914|NCT01004861|460107410|FG009|Overall Study|Lost to Follow-up|0|||
127860915|NCT01004861|460107411|FG010|Overall Study|Lost to Follow-up|0|||
127860916|NCT01004861|460107412|FG011|Overall Study|Lost to Follow-up|1|||
127860917|NCT01004861|460107413|FG012|Overall Study|Lost to Follow-up|0|||
127860918|NCT01004861|460107401|FG000|Overall Study|Non-compliance|0|||
127860919|NCT01004861|460107402|FG001|Overall Study|Non-compliance|0|||
127913349|NCT00540423|460307959|FG000|Double-Blind Treatment Period|Adverse Event|0|||
127860920|NCT01004861|460107403|FG002|Overall Study|Non-compliance|0|||
127913350|NCT00540423|460307960|FG001|Double-Blind Treatment Period|Adverse Event|1|||
127913351|NCT00540423|460307961|FG002|Double-Blind Treatment Period|Adverse Event|0|||
127913352|NCT00540423|460307959|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
127913353|NCT00540423|460307960|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
127913354|NCT00540423|460307961|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
127913355|NCT00216736|460307970|FG000|Overall Study|Lost to Follow-up|1|||
127913356|NCT00216736|460307971|FG001|Overall Study|Lost to Follow-up|1|||
127913357|NCT00909753|460307972|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
127913358|NCT00909753|460307973|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
127913359|NCT00909753|460307972|FG000|Period: Second Intervention|Protocol Violation|1|||
127913360|NCT00909753|460307973|FG001|Period: Second Intervention|Protocol Violation|0|||
127913361|NCT00418145|460307976|FG000|Overall Study|study terminated|6|||
127913362|NCT03214588|460307977|FG000|Overall Study|Adverse Event|1|||
127913363|NCT03214588|460307978|FG001|Overall Study|Adverse Event|0|||
127913364|NCT03214588|460307979|FG002|Overall Study|Adverse Event|2|||
127913365|NCT03214588|460307977|FG000|Overall Study|Reason Not Specified|0|||
127913366|NCT03214588|460307978|FG001|Overall Study|Reason Not Specified|1|||
127913367|NCT03214588|460307979|FG002|Overall Study|Reason Not Specified|0|||
127913368|NCT03480763|460307984|FG000|Overall Study|Withdrawal by Subject|18|||
127913369|NCT03480763|460307985|FG001|Overall Study|Withdrawal by Subject|10|||
127913370|NCT03480763|460307984|FG000|Overall Study|Lost to Follow-up|4|||
127913371|NCT03480763|460307985|FG001|Overall Study|Lost to Follow-up|7|||
127913372|NCT03480763|460307984|FG000|Overall Study|non-study pneumococcal vaccine|1|||
127913373|NCT03480763|460307985|FG001|Overall Study|non-study pneumococcal vaccine|0|||
127913374|NCT03480763|460307984|FG000|Overall Study|oncological treatment|0|||
127913375|NCT03480763|460307985|FG001|Overall Study|oncological treatment|2|||
127913376|NCT03480763|460307984|FG000|Overall Study|pain with vaccination|1|||
127913377|NCT03480763|460307985|FG001|Overall Study|pain with vaccination|0|||
127913378|NCT03629054|460307987|FG000|Period 2 (4 Days)|Not treated|0|||
127913379|NCT03629054|460307988|FG001|Period 2 (4 Days)|Not treated|1|||
127913380|NCT00205777|460307989|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
127913381|NCT00205777|460307990|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
127913382|NCT00205777|460307991|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
127913383|NCT00205777|460307992|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
127913384|NCT00205777|460307993|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
127913385|NCT00205777|460307994|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
127913386|NCT00205777|460307989|FG000|Core Study (Up to 3 Years)|Death|9|||
127913387|NCT00205777|460307990|FG001|Core Study (Up to 3 Years)|Death|7|||
127913388|NCT00205777|460307991|FG002|Core Study (Up to 3 Years)|Death|14|||
127913389|NCT00205777|460307992|FG003|Core Study (Up to 3 Years)|Death|7|||
127913390|NCT00205777|460307993|FG004|Core Study (Up to 3 Years)|Death|0|||
127913391|NCT00205777|460307994|FG005|Core Study (Up to 3 Years)|Death|0|||
127913392|NCT00205777|460307989|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
127913393|NCT00205777|460307990|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
127913394|NCT00205777|460307991|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
127913395|NCT00205777|460307992|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
127913396|NCT00205777|460307993|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
127913397|NCT00205777|460307994|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
127913398|NCT00205777|460307989|FG000|Core Study (Up to 3 Years)|Other Event|49|||
127913399|NCT00205777|460307990|FG001|Core Study (Up to 3 Years)|Other Event|52|||
127913400|NCT00205777|460307991|FG002|Core Study (Up to 3 Years)|Other Event|41|||
127913401|NCT00205777|460307992|FG003|Core Study (Up to 3 Years)|Other Event|58|||
127913402|NCT00205777|460307993|FG004|Core Study (Up to 3 Years)|Other Event|0|||
127913403|NCT00205777|460307994|FG005|Core Study (Up to 3 Years)|Other Event|0|||
127913404|NCT00205777|460307989|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
127913405|NCT00205777|460307990|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
127913406|NCT00205777|460307991|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
127913407|NCT00205777|460307992|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
127913408|NCT00205777|460307993|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
127913409|NCT00205777|460307994|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
127913410|NCT00205777|460307989|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
127913411|NCT00205777|460307990|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
127913412|NCT00205777|460307991|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
127913413|NCT00205777|460307992|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
127913414|NCT00205777|460307993|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
127913415|NCT00205777|460307994|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
127913416|NCT00205777|460307989|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
127913417|NCT00205777|460307990|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
127913418|NCT00205777|460307991|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
127913419|NCT00205777|460307992|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
127913420|NCT00205777|460307993|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
127860921|NCT01004861|460107404|FG003|Overall Study|Non-compliance|0|||
127860922|NCT01004861|460107405|FG004|Overall Study|Non-compliance|0|||
127860923|NCT01004861|460107406|FG005|Overall Study|Non-compliance|0|||
127860924|NCT01004861|460107407|FG006|Overall Study|Non-compliance|0|||
127860925|NCT01004861|460107408|FG007|Overall Study|Non-compliance|0|||
127860926|NCT01004861|460107409|FG008|Overall Study|Non-compliance|5|||
127860927|NCT01004861|460107410|FG009|Overall Study|Non-compliance|0|||
127860928|NCT01004861|460107411|FG010|Overall Study|Non-compliance|0|||
127860929|NCT01004861|460107412|FG011|Overall Study|Non-compliance|0|||
127860930|NCT01004861|460107413|FG012|Overall Study|Non-compliance|1|||
127860931|NCT01004861|460107401|FG000|Overall Study|Other|0|||
127860932|NCT01004861|460107402|FG001|Overall Study|Other|0|||
127860933|NCT01004861|460107403|FG002|Overall Study|Other|0|||
127860934|NCT01004861|460107404|FG003|Overall Study|Other|0|||
127860935|NCT01004861|460107405|FG004|Overall Study|Other|0|||
127860936|NCT01004861|460107406|FG005|Overall Study|Other|0|||
127860937|NCT01004861|460107407|FG006|Overall Study|Other|0|||
127860938|NCT01004861|460107408|FG007|Overall Study|Other|0|||
127860939|NCT01004861|460107409|FG008|Overall Study|Other|0|||
127860940|NCT01004861|460107410|FG009|Overall Study|Other|2|||
127860941|NCT01004861|460107411|FG010|Overall Study|Other|1|||
127860942|NCT01004861|460107412|FG011|Overall Study|Other|2|||
127860943|NCT01004861|460107413|FG012|Overall Study|Other|3|||
127860944|NCT01004861|460107401|FG000|Overall Study|Patient decision|0|||
127860945|NCT01004861|460107402|FG001|Overall Study|Patient decision|0|||
127860946|NCT01004861|460107403|FG002|Overall Study|Patient decision|0|||
127860947|NCT01004861|460107404|FG003|Overall Study|Patient decision|0|||
127860948|NCT01004861|460107405|FG004|Overall Study|Patient decision|1|||
127860949|NCT01004861|460107406|FG005|Overall Study|Patient decision|0|||
127860950|NCT01004861|460107407|FG006|Overall Study|Patient decision|1|||
127860951|NCT01004861|460107408|FG007|Overall Study|Patient decision|0|||
127860952|NCT01004861|460107409|FG008|Overall Study|Patient decision|7|||
127860953|NCT01004861|460107410|FG009|Overall Study|Patient decision|1|||
127860954|NCT01004861|460107411|FG010|Overall Study|Patient decision|1|||
127860955|NCT01004861|460107412|FG011|Overall Study|Patient decision|2|||
127860956|NCT01004861|460107413|FG012|Overall Study|Patient decision|3|||
127860957|NCT01004861|460107401|FG000|Overall Study|Transitioned to Phase 4 study|0|||
127860958|NCT01004861|460107402|FG001|Overall Study|Transitioned to Phase 4 study|0|||
127860959|NCT01004861|460107403|FG002|Overall Study|Transitioned to Phase 4 study|0|||
127860960|NCT01004861|460107404|FG003|Overall Study|Transitioned to Phase 4 study|0|||
127860961|NCT01004861|460107405|FG004|Overall Study|Transitioned to Phase 4 study|0|||
127860962|NCT01004861|460107406|FG005|Overall Study|Transitioned to Phase 4 study|0|||
127860963|NCT01004861|460107407|FG006|Overall Study|Transitioned to Phase 4 study|0|||
127860964|NCT01004861|460107408|FG007|Overall Study|Transitioned to Phase 4 study|0|||
127860965|NCT01004861|460107409|FG008|Overall Study|Transitioned to Phase 4 study|2|||
127860966|NCT01004861|460107410|FG009|Overall Study|Transitioned to Phase 4 study|0|||
127860967|NCT01004861|460107411|FG010|Overall Study|Transitioned to Phase 4 study|0|||
127860968|NCT01004861|460107412|FG011|Overall Study|Transitioned to Phase 4 study|0|||
127860969|NCT01004861|460107413|FG012|Overall Study|Transitioned to Phase 4 study|0|||
127860970|NCT01004861|460107401|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
127860971|NCT01004861|460107402|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
127860972|NCT01004861|460107403|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
127860973|NCT01004861|460107404|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
127860974|NCT01004861|460107405|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
127860975|NCT01004861|460107406|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
127860976|NCT01004861|460107407|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
127860977|NCT01004861|460107408|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
127860978|NCT01004861|460107409|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
127860979|NCT01004861|460107410|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
127860980|NCT01004861|460107411|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
127860981|NCT01004861|460107412|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
127860982|NCT01004861|460107413|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
127860983|NCT01004861|460107401|FG000|Overall Study|Patient withdrew|0|||
127860984|NCT01004861|460107402|FG001|Overall Study|Patient withdrew|0|||
127860985|NCT01004861|460107403|FG002|Overall Study|Patient withdrew|0|||
127860986|NCT01004861|460107404|FG003|Overall Study|Patient withdrew|0|||
127860987|NCT01004861|460107405|FG004|Overall Study|Patient withdrew|0|||
127860988|NCT01004861|460107406|FG005|Overall Study|Patient withdrew|0|||
127860989|NCT01004861|460107407|FG006|Overall Study|Patient withdrew|0|||
127860990|NCT01004861|460107408|FG007|Overall Study|Patient withdrew|0|||
127860991|NCT01004861|460107409|FG008|Overall Study|Patient withdrew|1|||
127860992|NCT01004861|460107410|FG009|Overall Study|Patient withdrew|0|||
127860993|NCT01004861|460107411|FG010|Overall Study|Patient withdrew|0|||
127860994|NCT01004861|460107412|FG011|Overall Study|Patient withdrew|0|||
127860995|NCT01004861|460107413|FG012|Overall Study|Patient withdrew|0|||
127860996|NCT01004861|460107401|FG000|Overall Study|Surgical resection|0|||
127860997|NCT01004861|460107402|FG001|Overall Study|Surgical resection|0|||
127860998|NCT01004861|460107403|FG002|Overall Study|Surgical resection|0|||
127860999|NCT01004861|460107404|FG003|Overall Study|Surgical resection|0|||
127861000|NCT01004861|460107405|FG004|Overall Study|Surgical resection|0|||
127861001|NCT01004861|460107406|FG005|Overall Study|Surgical resection|0|||
127861002|NCT01004861|460107407|FG006|Overall Study|Surgical resection|0|||
127861003|NCT01004861|460107408|FG007|Overall Study|Surgical resection|0|||
127861004|NCT01004861|460107409|FG008|Overall Study|Surgical resection|1|||
127861005|NCT01004861|460107410|FG009|Overall Study|Surgical resection|0|||
127861006|NCT01004861|460107411|FG010|Overall Study|Surgical resection|0|||
127861007|NCT01004861|460107412|FG011|Overall Study|Surgical resection|0|||
127861008|NCT01004861|460107413|FG012|Overall Study|Surgical resection|0|||
127861009|NCT01004861|460107401|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
127861010|NCT01004861|460107402|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
127861011|NCT01004861|460107403|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
127861012|NCT01004861|460107404|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
127861013|NCT01004861|460107405|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
127861014|NCT01004861|460107406|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
127861015|NCT01004861|460107407|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
127861016|NCT01004861|460107408|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
127861017|NCT01004861|460107409|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
127861018|NCT01004861|460107410|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
127861019|NCT01004861|460107411|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
127861020|NCT01004861|460107412|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
127861021|NCT01004861|460107413|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
127861022|NCT01004861|460107401|FG000|Overall Study|Study termination by Sponsor|0|||
127861023|NCT01004861|460107402|FG001|Overall Study|Study termination by Sponsor|0|||
127861024|NCT01004861|460107403|FG002|Overall Study|Study termination by Sponsor|0|||
127861025|NCT01004861|460107404|FG003|Overall Study|Study termination by Sponsor|0|||
127861026|NCT01004861|460107405|FG004|Overall Study|Study termination by Sponsor|0|||
127861027|NCT01004861|460107406|FG005|Overall Study|Study termination by Sponsor|0|||
127861028|NCT01004861|460107407|FG006|Overall Study|Study termination by Sponsor|0|||
127861029|NCT01004861|460107408|FG007|Overall Study|Study termination by Sponsor|0|||
127861030|NCT01004861|460107409|FG008|Overall Study|Study termination by Sponsor|1|||
127861031|NCT01004861|460107410|FG009|Overall Study|Study termination by Sponsor|0|||
127861032|NCT01004861|460107411|FG010|Overall Study|Study termination by Sponsor|0|||
127861033|NCT01004861|460107412|FG011|Overall Study|Study termination by Sponsor|0|||
127861034|NCT01004861|460107413|FG012|Overall Study|Study termination by Sponsor|0|||
127861035|NCT00686699|460107415|FG000|Treatment Period 1|Adverse Event|0|||
127861036|NCT00686699|460107416|FG001|Treatment Period 1|Adverse Event|2|||
127861037|NCT04610827|460107417|FG000|Overall Study|Withdrawal by Subject|1|||
127861038|NCT04610827|460107418|FG001|Overall Study|Withdrawal by Subject|1|||
127861039|NCT04610827|460107419|FG002|Overall Study|Withdrawal by Subject|0|||
127861040|NCT04657003|460107448|FG000|Overall Study|Adverse Event|5|||
127861041|NCT04657003|460107449|FG001|Overall Study|Adverse Event|1|||
127861042|NCT04657003|460107450|FG002|Overall Study|Adverse Event|5|||
127861043|NCT04657003|460107448|FG000|Overall Study|Death|0|||
127861044|NCT04657003|460107449|FG001|Overall Study|Death|2|||
127861045|NCT04657003|460107450|FG002|Overall Study|Death|0|||
127861046|NCT04657003|460107448|FG000|Overall Study|Lost to Follow-up|8|||
127861047|NCT04657003|460107449|FG001|Overall Study|Lost to Follow-up|4|||
127861048|NCT04657003|460107450|FG002|Overall Study|Lost to Follow-up|10|||
127861049|NCT04657003|460107448|FG000|Overall Study|Other - As Reported by Investigator|3|||
127861050|NCT04657003|460107449|FG001|Overall Study|Other - As Reported by Investigator|2|||
127861051|NCT04657003|460107450|FG002|Overall Study|Other - As Reported by Investigator|2|||
127861052|NCT04657003|460107448|FG000|Overall Study|Pregnancy|2|||
127861053|NCT04657003|460107449|FG001|Overall Study|Pregnancy|0|||
127861054|NCT04657003|460107450|FG002|Overall Study|Pregnancy|2|||
127861055|NCT04657003|460107448|FG000|Overall Study|Withdrawal by Subject|16|||
127861056|NCT04657003|460107449|FG001|Overall Study|Withdrawal by Subject|7|||
127861057|NCT04657003|460107450|FG002|Overall Study|Withdrawal by Subject|10|||
127861058|NCT01736176|460107451|FG000|Overall Study|Adverse Event|3|||
127861059|NCT01736176|460107451|FG000|Overall Study|Withdrawal by Subject|4|||
127861060|NCT01736176|460107451|FG000|Overall Study|Lack of Efficacy|3|||
127861061|NCT01736176|460107451|FG000|Overall Study|Unable to Complete PEG Placement|1|||
127861062|NCT00934791|460107452|FG000|Overall Study|Withdrawal by Subject|1|||
127861063|NCT00934791|460107453|FG001|Overall Study|Withdrawal by Subject|0|||
127861064|NCT03763942|460107455|FG000|Overall Study|Lost to Follow-up|114|||
127861065|NCT03763942|460107456|FG001|Overall Study|Lost to Follow-up|54|||
127861066|NCT03763942|460107455|FG000|Overall Study|Protocol Violation|1|||
127861067|NCT03763942|460107456|FG001|Overall Study|Protocol Violation|0|||
127861068|NCT03763942|460107455|FG000|Overall Study|Withdrawal by Subject|2|||
127861069|NCT03763942|460107456|FG001|Overall Study|Withdrawal by Subject|0|||
127861070|NCT03763942|460107455|FG000|Overall Study|Other|2|||
127861071|NCT03763942|460107456|FG001|Overall Study|Other|3|||
127861072|NCT02646891|460107457|FG000|Overall Study|Adverse Event|0|||
127861073|NCT02646891|460107458|FG001|Overall Study|Adverse Event|1|||
127861074|NCT02646891|460107459|FG002|Overall Study|Adverse Event|0|||
127861075|NCT02646891|460107460|FG003|Overall Study|Adverse Event|0|||
127861076|NCT02646891|460107461|FG004|Overall Study|Adverse Event|0|||
127861077|NCT02646891|460107462|FG005|Overall Study|Adverse Event|0|||
127861078|NCT02646891|460107463|FG006|Overall Study|Adverse Event|0|||
127861079|NCT02646891|460107464|FG007|Overall Study|Adverse Event|0|||
127861080|NCT02646891|460107465|FG008|Overall Study|Adverse Event|0|||
127861081|NCT02646891|460107466|FG009|Overall Study|Adverse Event|0|||
127861082|NCT02646891|460107457|FG000|Overall Study|Lost to Follow-up|0|||
127861083|NCT02646891|460107458|FG001|Overall Study|Lost to Follow-up|0|||
127861084|NCT02646891|460107459|FG002|Overall Study|Lost to Follow-up|0|||
127861085|NCT02646891|460107460|FG003|Overall Study|Lost to Follow-up|0|||
127861086|NCT02646891|460107461|FG004|Overall Study|Lost to Follow-up|0|||
127861087|NCT02646891|460107462|FG005|Overall Study|Lost to Follow-up|0|||
127861088|NCT02646891|460107463|FG006|Overall Study|Lost to Follow-up|2|||
127861089|NCT02646891|460107464|FG007|Overall Study|Lost to Follow-up|2|||
127861090|NCT02646891|460107465|FG008|Overall Study|Lost to Follow-up|2|||
127861091|NCT02646891|460107466|FG009|Overall Study|Lost to Follow-up|2|||
127861092|NCT02646891|460107457|FG000|Overall Study|Protocol Violation|0|||
127861093|NCT02646891|460107458|FG001|Overall Study|Protocol Violation|0|||
127861094|NCT02646891|460107459|FG002|Overall Study|Protocol Violation|0|||
127861095|NCT02646891|460107460|FG003|Overall Study|Protocol Violation|0|||
127861096|NCT02646891|460107461|FG004|Overall Study|Protocol Violation|0|||
127861097|NCT02646891|460107462|FG005|Overall Study|Protocol Violation|0|||
127861098|NCT02646891|460107463|FG006|Overall Study|Protocol Violation|1|||
127861099|NCT02646891|460107464|FG007|Overall Study|Protocol Violation|1|||
127861100|NCT02646891|460107465|FG008|Overall Study|Protocol Violation|0|||
127861101|NCT02646891|460107466|FG009|Overall Study|Protocol Violation|0|||
127861102|NCT02646891|460107457|FG000|Overall Study|Withdrawal by Subject|2|||
127861103|NCT02646891|460107458|FG001|Overall Study|Withdrawal by Subject|0|||
127861104|NCT02646891|460107459|FG002|Overall Study|Withdrawal by Subject|1|||
127861105|NCT02646891|460107460|FG003|Overall Study|Withdrawal by Subject|0|||
127861106|NCT02646891|460107461|FG004|Overall Study|Withdrawal by Subject|0|||
127861107|NCT02646891|460107462|FG005|Overall Study|Withdrawal by Subject|0|||
127861108|NCT02646891|460107463|FG006|Overall Study|Withdrawal by Subject|5|||
127861109|NCT02646891|460107464|FG007|Overall Study|Withdrawal by Subject|9|||
127861110|NCT02646891|460107465|FG008|Overall Study|Withdrawal by Subject|7|||
127861111|NCT02646891|460107466|FG009|Overall Study|Withdrawal by Subject|3|||
127861112|NCT02646891|460107457|FG000|Overall Study|Death|0|||
127861113|NCT02646891|460107458|FG001|Overall Study|Death|0|||
127861114|NCT02646891|460107459|FG002|Overall Study|Death|0|||
127861115|NCT02646891|460107460|FG003|Overall Study|Death|0|||
127861116|NCT02646891|460107461|FG004|Overall Study|Death|0|||
127861117|NCT02646891|460107462|FG005|Overall Study|Death|0|||
127861118|NCT02646891|460107463|FG006|Overall Study|Death|1|||
127861119|NCT02646891|460107464|FG007|Overall Study|Death|1|||
127861120|NCT02646891|460107465|FG008|Overall Study|Death|1|||
127861121|NCT02646891|460107466|FG009|Overall Study|Death|0|||
127861122|NCT02274311|460107467|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
127861123|NCT02477800|460107468|FG000|Placebo-Controlled Period|Adverse Event|16|||
127861124|NCT02477800|460107469|FG001|Placebo-Controlled Period|Adverse Event|25|||
127861125|NCT02477800|460107470|FG002|Placebo-Controlled Period|Adverse Event|28|||
127861126|NCT02477800|460107471|FG003|Placebo-Controlled Period|Adverse Event|0|||
127861127|NCT02477800|460107472|FG004|Placebo-Controlled Period|Adverse Event|0|||
127861128|NCT02477800|460107473|FG005|Placebo-Controlled Period|Adverse Event|0|||
127861129|NCT02477800|460107474|FG006|Placebo-Controlled Period|Adverse Event|0|||
127861130|NCT02477800|460107468|FG000|Placebo-Controlled Period|Change of Treatment|1|||
127861131|NCT02477800|460107469|FG001|Placebo-Controlled Period|Change of Treatment|2|||
127861132|NCT02477800|460107470|FG002|Placebo-Controlled Period|Change of Treatment|1|||
127861133|NCT02477800|460107471|FG003|Placebo-Controlled Period|Change of Treatment|0|||
127861134|NCT02477800|460107472|FG004|Placebo-Controlled Period|Change of Treatment|0|||
127861135|NCT02477800|460107473|FG005|Placebo-Controlled Period|Change of Treatment|0|||
127861136|NCT02477800|460107474|FG006|Placebo-Controlled Period|Change of Treatment|0|||
127861137|NCT02477800|460107468|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
127861138|NCT02477800|460107469|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
127861139|NCT02477800|460107470|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
127861140|NCT02477800|460107471|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
127861141|NCT02477800|460107472|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
127861142|NCT02477800|460107473|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
127861143|NCT02477800|460107474|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
127861144|NCT02477800|460107468|FG000|Placebo-Controlled Period|Death|0|||
127861145|NCT02477800|460107469|FG001|Placebo-Controlled Period|Death|3|||
127861146|NCT02477800|460107470|FG002|Placebo-Controlled Period|Death|2|||
127861147|NCT02477800|460107471|FG003|Placebo-Controlled Period|Death|0|||
127861148|NCT02477800|460107472|FG004|Placebo-Controlled Period|Death|0|||
127861149|NCT02477800|460107473|FG005|Placebo-Controlled Period|Death|0|||
127861150|NCT02477800|460107474|FG006|Placebo-Controlled Period|Death|0|||
127861151|NCT02477800|460107468|FG000|Placebo-Controlled Period|Disease Progression|1|||
127861152|NCT02477800|460107469|FG001|Placebo-Controlled Period|Disease Progression|0|||
127861153|NCT02477800|460107470|FG002|Placebo-Controlled Period|Disease Progression|1|||
127861154|NCT02477800|460107471|FG003|Placebo-Controlled Period|Disease Progression|0|||
127861155|NCT02477800|460107472|FG004|Placebo-Controlled Period|Disease Progression|0|||
127861156|NCT02477800|460107473|FG005|Placebo-Controlled Period|Disease Progression|0|||
127861157|NCT02477800|460107474|FG006|Placebo-Controlled Period|Disease Progression|0|||
127861158|NCT02477800|460107468|FG000|Placebo-Controlled Period|Investigator Decision|3|||
127861159|NCT02477800|460107469|FG001|Placebo-Controlled Period|Investigator Decision|2|||
127861160|NCT02477800|460107470|FG002|Placebo-Controlled Period|Investigator Decision|1|||
127861161|NCT02477800|460107471|FG003|Placebo-Controlled Period|Investigator Decision|0|||
127861162|NCT02477800|460107472|FG004|Placebo-Controlled Period|Investigator Decision|0|||
127861163|NCT02477800|460107473|FG005|Placebo-Controlled Period|Investigator Decision|0|||
127861164|NCT02477800|460107474|FG006|Placebo-Controlled Period|Investigator Decision|0|||
127861165|NCT02477800|460107468|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
127861166|NCT02477800|460107469|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
127861167|NCT02477800|460107470|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
127861168|NCT02477800|460107471|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
127861169|NCT02477800|460107472|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
127861170|NCT02477800|460107473|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
127861171|NCT02477800|460107474|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
127861172|NCT02477800|460107468|FG000|Placebo-Controlled Period|Relocation|2|||
127861173|NCT02477800|460107469|FG001|Placebo-Controlled Period|Relocation|0|||
127861174|NCT02477800|460107470|FG002|Placebo-Controlled Period|Relocation|0|||
127861175|NCT02477800|460107471|FG003|Placebo-Controlled Period|Relocation|0|||
127861176|NCT02477800|460107472|FG004|Placebo-Controlled Period|Relocation|0|||
127861177|NCT02477800|460107473|FG005|Placebo-Controlled Period|Relocation|0|||
127861178|NCT02477800|460107474|FG006|Placebo-Controlled Period|Relocation|0|||
127861179|NCT02477800|460107468|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
127861180|NCT02477800|460107469|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
127861181|NCT02477800|460107470|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
127861182|NCT02477800|460107471|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
127861183|NCT02477800|460107472|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
127861184|NCT02477800|460107473|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
127861185|NCT02477800|460107474|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
127861186|NCT02477800|460107468|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
127861187|NCT02477800|460107469|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
127861188|NCT02477800|460107470|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
127861189|NCT02477800|460107471|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
127861190|NCT02477800|460107472|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
127861191|NCT02477800|460107473|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
127861192|NCT02477800|460107474|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
127861193|NCT02477800|460107468|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
127861194|NCT02477800|460107469|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
127861195|NCT02477800|460107470|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
127861196|NCT02477800|460107471|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
127861197|NCT02477800|460107472|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
127861198|NCT02477800|460107473|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
127861199|NCT02477800|460107474|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
127861200|NCT02477800|460107468|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
127861201|NCT02477800|460107469|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
127861202|NCT02477800|460107470|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
127861203|NCT02477800|460107471|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
127861204|NCT02477800|460107472|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
127861205|NCT02477800|460107473|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
127913421|NCT00205777|460307994|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
127913422|NCT00205777|460307989|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
127913423|NCT00205777|460307990|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
127913424|NCT00205777|460307991|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
127913425|NCT00205777|460307992|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
127913426|NCT00205777|460307993|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
127913427|NCT00205777|460307994|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
127913428|NCT00205777|460307989|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
127913429|NCT00205777|460307990|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
127913430|NCT00205777|460307991|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
127913431|NCT00205777|460307992|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
127913432|NCT00205777|460307993|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
127913433|NCT00205777|460307994|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
127913434|NCT00205777|460307989|FG000|Completed Core Study, Entered SE I|Other Event|52|||
127913435|NCT00205777|460307990|FG001|Completed Core Study, Entered SE I|Other Event|46|||
127913436|NCT00205777|460307991|FG002|Completed Core Study, Entered SE I|Other Event|47|||
127913437|NCT00205777|460307992|FG003|Completed Core Study, Entered SE I|Other Event|50|||
127913438|NCT00205777|460307993|FG004|Completed Core Study, Entered SE I|Other Event|0|||
127913439|NCT00205777|460307994|FG005|Completed Core Study, Entered SE I|Other Event|0|||
127913440|NCT00205777|460307989|FG000|Study Extension I|Adverse Event|57|||
127913441|NCT00205777|460307990|FG001|Study Extension I|Adverse Event|0|||
127913442|NCT00205777|460307991|FG002|Study Extension I|Adverse Event|0|||
127913443|NCT00205777|460307992|FG003|Study Extension I|Adverse Event|61|||
127913444|NCT00205777|460307993|FG004|Study Extension I|Adverse Event|58|||
127913445|NCT00205777|460307994|FG005|Study Extension I|Adverse Event|0|||
127913446|NCT00205777|460307989|FG000|Study Extension I|Death|5|||
127913447|NCT00205777|460307990|FG001|Study Extension I|Death|0|||
127913448|NCT00205777|460307991|FG002|Study Extension I|Death|0|||
127913449|NCT00205777|460307992|FG003|Study Extension I|Death|1|||
127913450|NCT00205777|460307993|FG004|Study Extension I|Death|2|||
127913451|NCT00205777|460307994|FG005|Study Extension I|Death|0|||
127913452|NCT00205777|460307989|FG000|Study Extension I|Withdrawal by Subject|99|||
127913453|NCT00205777|460307990|FG001|Study Extension I|Withdrawal by Subject|0|||
127913454|NCT00205777|460307991|FG002|Study Extension I|Withdrawal by Subject|0|||
127913455|NCT00205777|460307992|FG003|Study Extension I|Withdrawal by Subject|106|||
127913456|NCT00205777|460307993|FG004|Study Extension I|Withdrawal by Subject|89|||
127913457|NCT00205777|460307994|FG005|Study Extension I|Withdrawal by Subject|0|||
127913458|NCT00205777|460307989|FG000|Study Extension I|Protocol Violation|4|||
127913459|NCT00205777|460307990|FG001|Study Extension I|Protocol Violation|0|||
127913460|NCT00205777|460307991|FG002|Study Extension I|Protocol Violation|0|||
127913461|NCT00205777|460307992|FG003|Study Extension I|Protocol Violation|8|||
127913462|NCT00205777|460307993|FG004|Study Extension I|Protocol Violation|8|||
127913463|NCT00205777|460307994|FG005|Study Extension I|Protocol Violation|0|||
127913464|NCT00205777|460307989|FG000|Study Extension I|Lack of Efficacy|0|||
127913465|NCT00205777|460307990|FG001|Study Extension I|Lack of Efficacy|0|||
127913466|NCT00205777|460307991|FG002|Study Extension I|Lack of Efficacy|0|||
127913467|NCT00205777|460307992|FG003|Study Extension I|Lack of Efficacy|1|||
127913468|NCT00205777|460307993|FG004|Study Extension I|Lack of Efficacy|2|||
127913469|NCT00205777|460307994|FG005|Study Extension I|Lack of Efficacy|0|||
127913470|NCT00205777|460307989|FG000|Study Extension I|Failed to return|15|||
127913471|NCT00205777|460307990|FG001|Study Extension I|Failed to return|0|||
127913472|NCT00205777|460307991|FG002|Study Extension I|Failed to return|0|||
127913473|NCT00205777|460307992|FG003|Study Extension I|Failed to return|17|||
127913474|NCT00205777|460307993|FG004|Study Extension I|Failed to return|13|||
127913475|NCT00205777|460307994|FG005|Study Extension I|Failed to return|0|||
127913476|NCT00205777|460307989|FG000|Study Extension I|Other Event|34|||
127913477|NCT00205777|460307990|FG001|Study Extension I|Other Event|0|||
127913478|NCT00205777|460307991|FG002|Study Extension I|Other Event|0|||
127913479|NCT00205777|460307992|FG003|Study Extension I|Other Event|34|||
127913480|NCT00205777|460307993|FG004|Study Extension I|Other Event|29|||
127913481|NCT00205777|460307994|FG005|Study Extension I|Other Event|0|||
127913482|NCT00205777|460307989|FG000|Study Extension I|Withdrawn as per protocol|0|||
127913483|NCT00205777|460307990|FG001|Study Extension I|Withdrawn as per protocol|0|||
127913484|NCT00205777|460307991|FG002|Study Extension I|Withdrawn as per protocol|1070|||
127913485|NCT00205777|460307992|FG003|Study Extension I|Withdrawn as per protocol|0|||
127913486|NCT00205777|460307993|FG004|Study Extension I|Withdrawn as per protocol|0|||
127913487|NCT00205777|460307994|FG005|Study Extension I|Withdrawn as per protocol|0|||
127913488|NCT00205777|460307989|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
127913489|NCT00205777|460307990|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
127913490|NCT00205777|460307991|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
127913491|NCT00205777|460307992|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
127913492|NCT00205777|460307993|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
127913493|NCT00205777|460307994|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
127913494|NCT00205777|460307989|FG000|Study Extension II|Adverse Event|0|||
127913495|NCT00205777|460307990|FG001|Study Extension II|Adverse Event|0|||
127913496|NCT00205777|460307991|FG002|Study Extension II|Adverse Event|0|||
127913497|NCT00205777|460307992|FG003|Study Extension II|Adverse Event|14|||
127913498|NCT00205777|460307993|FG004|Study Extension II|Adverse Event|0|||
127913499|NCT00205777|460307994|FG005|Study Extension II|Adverse Event|30|||
127913500|NCT00205777|460307989|FG000|Study Extension II|Death|0|||
127913501|NCT00205777|460307990|FG001|Study Extension II|Death|0|||
127913502|NCT00205777|460307991|FG002|Study Extension II|Death|0|||
127913503|NCT00205777|460307992|FG003|Study Extension II|Death|2|||
127913504|NCT00205777|460307993|FG004|Study Extension II|Death|0|||
127913505|NCT00205777|460307994|FG005|Study Extension II|Death|5|||
127913506|NCT00205777|460307989|FG000|Study Extension II|Withdrawal by Subject|0|||
127913507|NCT00205777|460307990|FG001|Study Extension II|Withdrawal by Subject|0|||
127861206|NCT02477800|460107474|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
127861207|NCT02477800|460107468|FG000|Placebo-Controlled Period|Reason not Specified|161|||
127861208|NCT02477800|460107469|FG001|Placebo-Controlled Period|Reason not Specified|161|||
127861209|NCT02477800|460107470|FG002|Placebo-Controlled Period|Reason not Specified|189|||
127861210|NCT02477800|460107471|FG003|Placebo-Controlled Period|Reason not Specified|0|||
127861211|NCT02477800|460107472|FG004|Placebo-Controlled Period|Reason not Specified|0|||
127861212|NCT02477800|460107473|FG005|Placebo-Controlled Period|Reason not Specified|0|||
127861213|NCT02477800|460107474|FG006|Placebo-Controlled Period|Reason not Specified|0|||
127861214|NCT02477800|460107468|FG000|Long Term Extension Period|Adverse Event|0|||
127861215|NCT02477800|460107469|FG001|Long Term Extension Period|Adverse Event|0|||
127861216|NCT02477800|460107470|FG002|Long Term Extension Period|Adverse Event|0|||
127861217|NCT02477800|460107471|FG003|Long Term Extension Period|Adverse Event|6|||
127861218|NCT02477800|460107472|FG004|Long Term Extension Period|Adverse Event|2|||
127861219|NCT02477800|460107473|FG005|Long Term Extension Period|Adverse Event|4|||
127861220|NCT02477800|460107474|FG006|Long Term Extension Period|Adverse Event|3|||
127861221|NCT02477800|460107468|FG000|Long Term Extension Period|Death|0|||
127861222|NCT02477800|460107469|FG001|Long Term Extension Period|Death|0|||
127861223|NCT02477800|460107470|FG002|Long Term Extension Period|Death|0|||
127861224|NCT02477800|460107471|FG003|Long Term Extension Period|Death|1|||
127861225|NCT02477800|460107472|FG004|Long Term Extension Period|Death|1|||
127861226|NCT02477800|460107473|FG005|Long Term Extension Period|Death|1|||
127861227|NCT02477800|460107474|FG006|Long Term Extension Period|Death|2|||
127861228|NCT02477800|460107468|FG000|Long Term Extension Period|Consent Withdrawn|0|||
127913508|NCT00205777|460307991|FG002|Study Extension II|Withdrawal by Subject|0|||
127913509|NCT00205777|460307992|FG003|Study Extension II|Withdrawal by Subject|35|||
127913510|NCT00205777|460307993|FG004|Study Extension II|Withdrawal by Subject|0|||
127913511|NCT00205777|460307994|FG005|Study Extension II|Withdrawal by Subject|59|||
127913512|NCT00205777|460307989|FG000|Study Extension II|Protocol Violation|0|||
127913513|NCT00205777|460307990|FG001|Study Extension II|Protocol Violation|0|||
127913514|NCT00205777|460307991|FG002|Study Extension II|Protocol Violation|0|||
127861229|NCT02477800|460107469|FG001|Long Term Extension Period|Consent Withdrawn|0|||
127861230|NCT02477800|460107470|FG002|Long Term Extension Period|Consent Withdrawn|0|||
127861231|NCT02477800|460107471|FG003|Long Term Extension Period|Consent Withdrawn|10|||
127913515|NCT00205777|460307992|FG003|Study Extension II|Protocol Violation|1|||
127913516|NCT00205777|460307993|FG004|Study Extension II|Protocol Violation|0|||
127913517|NCT00205777|460307994|FG005|Study Extension II|Protocol Violation|10|||
127913518|NCT00205777|460307989|FG000|Study Extension II|Lack of Efficacy|0|||
127913519|NCT00205777|460307990|FG001|Study Extension II|Lack of Efficacy|0|||
127913520|NCT00205777|460307991|FG002|Study Extension II|Lack of Efficacy|0|||
127913521|NCT00205777|460307992|FG003|Study Extension II|Lack of Efficacy|0|||
127913522|NCT00205777|460307993|FG004|Study Extension II|Lack of Efficacy|0|||
127913523|NCT00205777|460307994|FG005|Study Extension II|Lack of Efficacy|1|||
127913524|NCT00205777|460307989|FG000|Study Extension II|Failed to return|0|||
127913525|NCT00205777|460307990|FG001|Study Extension II|Failed to return|0|||
127913526|NCT00205777|460307991|FG002|Study Extension II|Failed to return|0|||
127861232|NCT02477800|460107472|FG004|Long Term Extension Period|Consent Withdrawn|4|||
127861233|NCT02477800|460107473|FG005|Long Term Extension Period|Consent Withdrawn|13|||
127861234|NCT02477800|460107474|FG006|Long Term Extension Period|Consent Withdrawn|16|||
127861235|NCT02477800|460107468|FG000|Long Term Extension Period|Disease Progression|0|||
127861236|NCT02477800|460107469|FG001|Long Term Extension Period|Disease Progression|0|||
127861237|NCT02477800|460107470|FG002|Long Term Extension Period|Disease Progression|0|||
127861238|NCT02477800|460107471|FG003|Long Term Extension Period|Disease Progression|3|||
127861239|NCT02477800|460107472|FG004|Long Term Extension Period|Disease Progression|1|||
127861240|NCT02477800|460107473|FG005|Long Term Extension Period|Disease Progression|1|||
127861241|NCT02477800|460107474|FG006|Long Term Extension Period|Disease Progression|0|||
127861242|NCT02477800|460107468|FG000|Long Term Extension Period|Investigator Decision|0|||
127861243|NCT02477800|460107469|FG001|Long Term Extension Period|Investigator Decision|0|||
127861244|NCT02477800|460107470|FG002|Long Term Extension Period|Investigator Decision|0|||
127861245|NCT02477800|460107471|FG003|Long Term Extension Period|Investigator Decision|0|||
127861246|NCT02477800|460107472|FG004|Long Term Extension Period|Investigator Decision|0|||
127861247|NCT02477800|460107473|FG005|Long Term Extension Period|Investigator Decision|0|||
127861248|NCT02477800|460107474|FG006|Long Term Extension Period|Investigator Decision|2|||
127861249|NCT02477800|460107468|FG000|Long Term Extension Period|Lost to Follow-up|0|||
127861250|NCT02477800|460107469|FG001|Long Term Extension Period|Lost to Follow-up|0|||
127861251|NCT02477800|460107470|FG002|Long Term Extension Period|Lost to Follow-up|0|||
127861252|NCT02477800|460107471|FG003|Long Term Extension Period|Lost to Follow-up|0|||
127861253|NCT02477800|460107472|FG004|Long Term Extension Period|Lost to Follow-up|1|||
127861254|NCT02477800|460107473|FG005|Long Term Extension Period|Lost to Follow-up|3|||
127861255|NCT02477800|460107474|FG006|Long Term Extension Period|Lost to Follow-up|0|||
127861256|NCT02477800|460107468|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
127861257|NCT02477800|460107469|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
127861258|NCT02477800|460107470|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
127861259|NCT02477800|460107471|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
127861260|NCT02477800|460107472|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
127861261|NCT02477800|460107473|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
127861262|NCT02477800|460107474|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
127861263|NCT02477800|460107468|FG000|Long Term Extension Period|Study Visit Burden|0|||
127861264|NCT02477800|460107469|FG001|Long Term Extension Period|Study Visit Burden|0|||
127861265|NCT02477800|460107470|FG002|Long Term Extension Period|Study Visit Burden|0|||
127861266|NCT02477800|460107471|FG003|Long Term Extension Period|Study Visit Burden|3|||
127861267|NCT02477800|460107472|FG004|Long Term Extension Period|Study Visit Burden|0|||
127861268|NCT02477800|460107473|FG005|Long Term Extension Period|Study Visit Burden|2|||
127861269|NCT02477800|460107474|FG006|Long Term Extension Period|Study Visit Burden|2|||
127861270|NCT02477800|460107468|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
127861271|NCT02477800|460107469|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
127861272|NCT02477800|460107470|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
127861273|NCT02477800|460107471|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
127861274|NCT02477800|460107472|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
127861275|NCT02477800|460107473|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
127861276|NCT02477800|460107474|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
127861277|NCT02477800|460107468|FG000|Long Term Extension Period|Reason not Specified|0|||
127861278|NCT02477800|460107469|FG001|Long Term Extension Period|Reason not Specified|0|||
127861279|NCT02477800|460107470|FG002|Long Term Extension Period|Reason not Specified|0|||
127861280|NCT02477800|460107471|FG003|Long Term Extension Period|Reason not Specified|126|||
127861281|NCT02477800|460107472|FG004|Long Term Extension Period|Reason not Specified|140|||
127861282|NCT02477800|460107473|FG005|Long Term Extension Period|Reason not Specified|270|||
127861283|NCT02477800|460107474|FG006|Long Term Extension Period|Reason not Specified|224|||
127861284|NCT00958191|460107479|FG000|Overall Study|Death|4|||
127861285|NCT00958191|460107479|FG000|Overall Study|Lost to Follow-up|5|||
127861286|NCT00958191|460107479|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
127861287|NCT00958191|460107479|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
127861288|NCT00958191|460107479|FG000|Overall Study|Revision of study device|4|||
127861289|NCT00958191|460107479|FG000|Overall Study|Site termination|11|||
127861290|NCT00958191|460107479|FG000|Overall Study|No 5 yr x-rays|56|||
127913527|NCT00205777|460307992|FG003|Study Extension II|Failed to return|14|||
127913528|NCT00205777|460307993|FG004|Study Extension II|Failed to return|0|||
127913529|NCT00205777|460307994|FG005|Study Extension II|Failed to return|26|||
127913530|NCT00205777|460307989|FG000|Study Extension II|Other Event|0|||
127913531|NCT00205777|460307990|FG001|Study Extension II|Other Event|0|||
127913532|NCT00205777|460307991|FG002|Study Extension II|Other Event|0|||
127913533|NCT00205777|460307992|FG003|Study Extension II|Other Event|12|||
127913534|NCT00205777|460307993|FG004|Study Extension II|Other Event|0|||
127913535|NCT00205777|460307994|FG005|Study Extension II|Other Event|20|||
127913536|NCT00205777|460307989|FG000|Study Extension II|Enrolled but not treated|0|||
127913537|NCT00205777|460307990|FG001|Study Extension II|Enrolled but not treated|0|||
127913538|NCT00205777|460307991|FG002|Study Extension II|Enrolled but not treated|0|||
127913539|NCT00205777|460307992|FG003|Study Extension II|Enrolled but not treated|71|||
127913540|NCT00205777|460307993|FG004|Study Extension II|Enrolled but not treated|0|||
127913541|NCT00205777|460307994|FG005|Study Extension II|Enrolled but not treated|131|||
127913542|NCT00842309|460308004|FG000|Overall Study|Withdrawal by Subject|3|||
127913543|NCT00842309|460308005|FG001|Overall Study|Withdrawal by Subject|1|||
127913544|NCT02911025|460308006|FG000|Overall Study|Lost to Follow-up|3|||
127913545|NCT03218787|460308007|FG000|Overall Study|Lost to Follow-up|12|||
127913546|NCT03218787|460308007|FG000|Overall Study|Withdrawal by Subject|72|||
127913547|NCT03218787|460308007|FG000|Overall Study|Physician Decision|11|||
127913548|NCT03218787|460308007|FG000|Overall Study|Death|111|||
127913549|NCT02264977|460308008|FG000|Overall Study|Death|3|||
127913550|NCT02264977|460308008|FG000|Overall Study|Physician Decision|1|||
127913551|NCT02264977|460308008|FG000|Overall Study|Refuse to return|1|||
127913552|NCT03573544|460308009|FG000|Overall Study|Adverse Event|0|||
127913553|NCT03573544|460308010|FG001|Overall Study|Adverse Event|0|||
127913554|NCT03573544|460308011|FG002|Overall Study|Adverse Event|0|||
127913555|NCT03573544|460308012|FG003|Overall Study|Adverse Event|3|||
127913556|NCT03573544|460308013|FG004|Overall Study|Adverse Event|1|||
127913557|NCT03573544|460308014|FG005|Overall Study|Adverse Event|0|||
127913558|NCT03573544|460308015|FG006|Overall Study|Adverse Event|2|||
127913559|NCT03573544|460308016|FG007|Overall Study|Adverse Event|0|||
127913560|NCT03573544|460308009|FG000|Overall Study|Physician Decision|0|||
127913561|NCT03573544|460308010|FG001|Overall Study|Physician Decision|0|||
127913562|NCT03573544|460308011|FG002|Overall Study|Physician Decision|0|||
127913563|NCT03573544|460308012|FG003|Overall Study|Physician Decision|0|||
127913564|NCT03573544|460308013|FG004|Overall Study|Physician Decision|0|||
127913565|NCT03573544|460308014|FG005|Overall Study|Physician Decision|0|||
127913566|NCT03573544|460308015|FG006|Overall Study|Physician Decision|1|||
127913567|NCT03573544|460308016|FG007|Overall Study|Physician Decision|0|||
127913568|NCT03573544|460308009|FG000|Overall Study|Withdrawal by Subject|2|||
127913569|NCT03573544|460308010|FG001|Overall Study|Withdrawal by Subject|0|||
127913570|NCT03573544|460308011|FG002|Overall Study|Withdrawal by Subject|0|||
127913571|NCT03573544|460308012|FG003|Overall Study|Withdrawal by Subject|1|||
127913572|NCT03573544|460308013|FG004|Overall Study|Withdrawal by Subject|1|||
127913573|NCT03573544|460308014|FG005|Overall Study|Withdrawal by Subject|1|||
127913574|NCT03573544|460308015|FG006|Overall Study|Withdrawal by Subject|0|||
127913575|NCT03573544|460308016|FG007|Overall Study|Withdrawal by Subject|1|||
127913576|NCT03573544|460308009|FG000|Overall Study|Disease progression|3|||
127913577|NCT03573544|460308010|FG001|Overall Study|Disease progression|3|||
127913578|NCT03573544|460308011|FG002|Overall Study|Disease progression|6|||
127913579|NCT03573544|460308012|FG003|Overall Study|Disease progression|4|||
127913580|NCT03573544|460308013|FG004|Overall Study|Disease progression|5|||
127913581|NCT03573544|460308014|FG005|Overall Study|Disease progression|7|||
127913582|NCT03573544|460308015|FG006|Overall Study|Disease progression|6|||
127913583|NCT03573544|460308016|FG007|Overall Study|Disease progression|7|||
127913584|NCT03846193|460308017|FG000|Overall Study|Physician Decision|0|||
127913585|NCT03846193|460308018|FG001|Overall Study|Physician Decision|0|||
127913586|NCT03846193|460308019|FG002|Overall Study|Physician Decision|1|||
127913587|NCT03846193|460308020|FG003|Overall Study|Physician Decision|0|||
127913588|NCT03846193|460308021|FG004|Overall Study|Physician Decision|0|||
127913589|NCT03846193|460308017|FG000|Overall Study|Lost to Follow-up|0|||
127913590|NCT03846193|460308018|FG001|Overall Study|Lost to Follow-up|0|||
127913591|NCT03846193|460308019|FG002|Overall Study|Lost to Follow-up|0|||
127913592|NCT03846193|460308020|FG003|Overall Study|Lost to Follow-up|0|||
127913593|NCT03846193|460308021|FG004|Overall Study|Lost to Follow-up|1|||
127913594|NCT03846193|460308017|FG000|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
127913595|NCT03846193|460308018|FG001|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
127913596|NCT03846193|460308019|FG002|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
127913597|NCT03846193|460308020|FG003|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|2|||
127913598|NCT03846193|460308021|FG004|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
127913599|NCT00147498|460308022|FG000|Overall Study|Adverse Event|1|||
127913600|NCT00147498|460308023|FG001|Overall Study|Adverse Event|6|||
127913601|NCT00147498|460308024|FG002|Overall Study|Adverse Event|7|||
127913602|NCT00147498|460308025|FG003|Overall Study|Adverse Event|3|||
127913603|NCT00147498|460308022|FG000|Overall Study|Lack of Efficacy|1|||
127913604|NCT00147498|460308023|FG001|Overall Study|Lack of Efficacy|1|||
127913605|NCT00147498|460308024|FG002|Overall Study|Lack of Efficacy|1|||
127913606|NCT00147498|460308025|FG003|Overall Study|Lack of Efficacy|8|||
127913607|NCT00147498|460308022|FG000|Overall Study|Laboratory abnormality|0|||
127913608|NCT00147498|460308023|FG001|Overall Study|Laboratory abnormality|0|||
127913609|NCT00147498|460308024|FG002|Overall Study|Laboratory abnormality|2|||
127913610|NCT00147498|460308025|FG003|Overall Study|Laboratory abnormality|0|||
127913611|NCT00147498|460308022|FG000|Overall Study|Participant defaulted|0|||
127913612|NCT00147498|460308023|FG001|Overall Study|Participant defaulted|1|||
127913613|NCT00147498|460308024|FG002|Overall Study|Participant defaulted|4|||
127913614|NCT00147498|460308025|FG003|Overall Study|Participant defaulted|3|||
127913615|NCT00147498|460308022|FG000|Overall Study|Other|1|||
127913616|NCT00147498|460308023|FG001|Overall Study|Other|1|||
127913617|NCT00147498|460308024|FG002|Overall Study|Other|3|||
127913618|NCT00147498|460308025|FG003|Overall Study|Other|3|||
127913619|NCT01838681|460308026|FG000|Period A|Adverse Event|39|||
127913620|NCT01838681|460308027|FG001|Period A|Adverse Event|0|||
127913621|NCT01838681|460308028|FG002|Period A|Adverse Event|0|||
127913622|NCT01838681|460308029|FG003|Period A|Adverse Event|0|||
127861291|NCT00611767|460107480|FG000|Overall Study|Withdrawal by Subject|4|||
127861292|NCT00611767|460107481|FG001|Overall Study|Withdrawal by Subject|1|||
127861293|NCT00611767|460107480|FG000|Overall Study|Thiopental not available|3|||
127861294|NCT00611767|460107481|FG001|Overall Study|Thiopental not available|0|||
127861295|NCT00611767|460107480|FG000|Overall Study|didn't like the medication|1|||
127861296|NCT00611767|460107481|FG001|Overall Study|didn't like the medication|1|||
127861297|NCT00611767|460107480|FG000|Overall Study|Physician Decision|1|||
127861298|NCT00611767|460107481|FG001|Overall Study|Physician Decision|0|||
127861299|NCT00170846|460107486|FG000|Overall Study|Subject withdrew Informed Consent|5|||
127861300|NCT00170846|460107487|FG001|Overall Study|Subject withdrew Informed Consent|12|||
127861301|NCT00170846|460107488|FG002|Overall Study|Subject withdrew Informed Consent|8|||
127861302|NCT00170846|460107486|FG000|Overall Study|Lost to Follow-up|6|||
127861303|NCT00170846|460107487|FG001|Overall Study|Lost to Follow-up|3|||
127861304|NCT00170846|460107488|FG002|Overall Study|Lost to Follow-up|2|||
127861305|NCT00170846|460107486|FG000|Overall Study|Death|0|||
127861306|NCT00170846|460107487|FG001|Overall Study|Death|3|||
127861307|NCT00170846|460107488|FG002|Overall Study|Death|3|||
127861308|NCT00170846|460107486|FG000|Overall Study|Reason Missing|0|||
127861309|NCT00170846|460107487|FG001|Overall Study|Reason Missing|1|||
127861310|NCT00170846|460107488|FG002|Overall Study|Reason Missing|0|||
127861311|NCT00118040|460107489|FG000|Overall Study|Adverse Event|0|||
127861312|NCT00118040|460107490|FG001|Overall Study|Adverse Event|1|||
127861313|NCT00118040|460107491|FG002|Overall Study|Adverse Event|0|||
127861314|NCT00118040|460107489|FG000|Overall Study|Withdrawal by Subject|0|||
127861315|NCT00118040|460107490|FG001|Overall Study|Withdrawal by Subject|0|||
127861316|NCT00118040|460107491|FG002|Overall Study|Withdrawal by Subject|2|||
127861317|NCT00118040|460107489|FG000|Overall Study|Medical Contraindication|0|||
127861318|NCT00118040|460107490|FG001|Overall Study|Medical Contraindication|0|||
127861319|NCT00118040|460107491|FG002|Overall Study|Medical Contraindication|1|||
127861320|NCT00118040|460107489|FG000|Overall Study|Non-Compliant Participant|1|||
127913623|NCT01838681|460308026|FG000|Period A|Lack of Efficacy|21|||
127913624|NCT01838681|460308027|FG001|Period A|Lack of Efficacy|0|||
127913625|NCT01838681|460308028|FG002|Period A|Lack of Efficacy|0|||
127913626|NCT01838681|460308029|FG003|Period A|Lack of Efficacy|0|||
127913627|NCT01838681|460308026|FG000|Period A|Early response|148|||
127913628|NCT01838681|460308027|FG001|Period A|Early response|0|||
127913629|NCT01838681|460308028|FG002|Period A|Early response|0|||
127913630|NCT01838681|460308029|FG003|Period A|Early response|0|||
127913631|NCT01838681|460308026|FG000|Period A|Withdrawal by Subject|70|||
127913632|NCT01838681|460308027|FG001|Period A|Withdrawal by Subject|0|||
127913633|NCT01838681|460308028|FG002|Period A|Withdrawal by Subject|0|||
127913634|NCT01838681|460308029|FG003|Period A|Withdrawal by Subject|0|||
127913635|NCT01838681|460308026|FG000|Period A|Protocol Violation|16|||
127913636|NCT01838681|460308027|FG001|Period A|Protocol Violation|0|||
127913637|NCT01838681|460308028|FG002|Period A|Protocol Violation|0|||
127913638|NCT01838681|460308029|FG003|Period A|Protocol Violation|0|||
127913639|NCT01838681|460308026|FG000|Period A|Non-compliance with IMP|6|||
127913640|NCT01838681|460308027|FG001|Period A|Non-compliance with IMP|0|||
127913641|NCT01838681|460308028|FG002|Period A|Non-compliance with IMP|0|||
127913642|NCT01838681|460308029|FG003|Period A|Non-compliance with IMP|0|||
127913643|NCT01838681|460308026|FG000|Period A|Lost to Follow-up|4|||
127913644|NCT01838681|460308027|FG001|Period A|Lost to Follow-up|0|||
127913645|NCT01838681|460308028|FG002|Period A|Lost to Follow-up|0|||
127913646|NCT01838681|460308029|FG003|Period A|Lost to Follow-up|0|||
127913647|NCT01838681|460308026|FG000|Period A|Withdrawal before treatment|4|||
127913648|NCT01838681|460308027|FG001|Period A|Withdrawal before treatment|0|||
127913649|NCT01838681|460308028|FG002|Period A|Withdrawal before treatment|0|||
127913650|NCT01838681|460308029|FG003|Period A|Withdrawal before treatment|0|||
127913651|NCT01838681|460308026|FG000|Period A|Administrative or other reasons|17|||
127913652|NCT01838681|460308027|FG001|Period A|Administrative or other reasons|0|||
127913653|NCT01838681|460308028|FG002|Period A|Administrative or other reasons|0|||
127913654|NCT01838681|460308029|FG003|Period A|Administrative or other reasons|0|||
127913655|NCT01838681|460308026|FG000|Period B/A+|Adverse Event|0|||
127913656|NCT01838681|460308027|FG001|Period B/A+|Adverse Event|13|||
127913657|NCT01838681|460308028|FG002|Period B/A+|Adverse Event|27|||
127913658|NCT01838681|460308029|FG003|Period B/A+|Adverse Event|16|||
127913659|NCT01838681|460308026|FG000|Period B/A+|Lack of Efficacy|0|||
127913660|NCT01838681|460308027|FG001|Period B/A+|Lack of Efficacy|9|||
127913661|NCT01838681|460308028|FG002|Period B/A+|Lack of Efficacy|11|||
127913662|NCT01838681|460308029|FG003|Period B/A+|Lack of Efficacy|6|||
127913663|NCT01838681|460308026|FG000|Period B/A+|Withdrawal by Subject|0|||
127913664|NCT01838681|460308027|FG001|Period B/A+|Withdrawal by Subject|28|||
127913665|NCT01838681|460308028|FG002|Period B/A+|Withdrawal by Subject|35|||
127913666|NCT01838681|460308029|FG003|Period B/A+|Withdrawal by Subject|47|||
127913667|NCT01838681|460308026|FG000|Period B/A+|Protocol Violation|0|||
127913668|NCT01838681|460308027|FG001|Period B/A+|Protocol Violation|1|||
127913669|NCT01838681|460308028|FG002|Period B/A+|Protocol Violation|4|||
127913670|NCT01838681|460308029|FG003|Period B/A+|Protocol Violation|6|||
127913671|NCT01838681|460308026|FG000|Period B/A+|Non-compliance with IMP|0|||
127913672|NCT01838681|460308027|FG001|Period B/A+|Non-compliance with IMP|2|||
127913673|NCT01838681|460308028|FG002|Period B/A+|Non-compliance with IMP|3|||
127913674|NCT01838681|460308029|FG003|Period B/A+|Non-compliance with IMP|3|||
127913675|NCT01838681|460308026|FG000|Period B/A+|Lost to Follow-up|0|||
127913676|NCT01838681|460308027|FG001|Period B/A+|Lost to Follow-up|2|||
127913677|NCT01838681|460308028|FG002|Period B/A+|Lost to Follow-up|5|||
127913678|NCT01838681|460308029|FG003|Period B/A+|Lost to Follow-up|11|||
127913679|NCT01838681|460308026|FG000|Period B/A+|Withdrawal before treatment|0|||
127913680|NCT01838681|460308027|FG001|Period B/A+|Withdrawal before treatment|1|||
127913681|NCT01838681|460308028|FG002|Period B/A+|Withdrawal before treatment|0|||
127913682|NCT01838681|460308029|FG003|Period B/A+|Withdrawal before treatment|0|||
127913683|NCT01838681|460308026|FG000|Period B/A+|Administrative or other reasons|0|||
127913684|NCT01838681|460308027|FG001|Period B/A+|Administrative or other reasons|6|||
127913685|NCT01838681|460308028|FG002|Period B/A+|Administrative or other reasons|10|||
127913686|NCT01838681|460308029|FG003|Period B/A+|Administrative or other reasons|28|||
127913687|NCT01229150|460308032|FG000|Overall Study|Toxicity|2|||
127913688|NCT01229150|460308033|FG001|Overall Study|Toxicity|2|||
127913689|NCT01229150|460308034|FG002|Overall Study|Toxicity|0|||
127913690|NCT01229150|460308035|FG003|Overall Study|Toxicity|0|||
127913691|NCT02011945|460308036|FG000|Overall Study|Participant requested to Discontinue|0|||
127913692|NCT02011945|460308037|FG001|Overall Study|Participant requested to Discontinue|1|||
127913693|NCT02011945|460308038|FG002|Overall Study|Participant requested to Discontinue|1|||
127913694|NCT02011945|460308036|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
127913695|NCT02011945|460308037|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
127913696|NCT02011945|460308038|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
127913697|NCT02011945|460308036|FG000|Overall Study|Study Drug Toxicity|0|||
127913698|NCT02011945|460308037|FG001|Overall Study|Study Drug Toxicity|0|||
127913699|NCT02011945|460308038|FG002|Overall Study|Study Drug Toxicity|1|||
127913700|NCT02011945|460308036|FG000|Overall Study|Treatment Failure|0|||
127913701|NCT02011945|460308037|FG001|Overall Study|Treatment Failure|7|||
127913702|NCT02011945|460308038|FG002|Overall Study|Treatment Failure|6|||
127913703|NCT02011945|460308036|FG000|Overall Study|No Longer Meets Study Criteria|1|||
127913704|NCT02011945|460308037|FG001|Overall Study|No Longer Meets Study Criteria|0|||
127913705|NCT02011945|460308038|FG002|Overall Study|No Longer Meets Study Criteria|0|||
127913706|NCT02011945|460308036|FG000|Overall Study|Proceeded to stem cell transplant|0|||
127861321|NCT00118040|460107490|FG001|Overall Study|Non-Compliant Participant|1|||
127861322|NCT00118040|460107491|FG002|Overall Study|Non-Compliant Participant|2|||
127861323|NCT00118040|460107489|FG000|Overall Study|Other|0|||
127861324|NCT00118040|460107490|FG001|Overall Study|Other|0|||
127861325|NCT00118040|460107491|FG002|Overall Study|Other|1|||
127861326|NCT02607865|460107494|FG000|Overall Study|Lost to Follow-up|9|||
127861327|NCT02607865|460107495|FG001|Overall Study|Lost to Follow-up|7|||
127861328|NCT02607865|460107496|FG002|Overall Study|Lost to Follow-up|7|||
127861329|NCT02607865|460107497|FG003|Overall Study|Lost to Follow-up|5|||
127861330|NCT02607865|460107494|FG000|Overall Study|Withdrawal by Subject|18|||
127861331|NCT02607865|460107495|FG001|Overall Study|Withdrawal by Subject|18|||
127861332|NCT02607865|460107496|FG002|Overall Study|Withdrawal by Subject|17|||
127861333|NCT02607865|460107497|FG003|Overall Study|Withdrawal by Subject|8|||
127861334|NCT02607865|460107494|FG000|Overall Study|Death|5|||
127861335|NCT02607865|460107495|FG001|Overall Study|Death|4|||
127861336|NCT02607865|460107496|FG002|Overall Study|Death|1|||
127861337|NCT02607865|460107497|FG003|Overall Study|Death|3|||
127861338|NCT02607865|460107494|FG000|Overall Study|Unclassified|1|||
127861339|NCT02607865|460107495|FG001|Overall Study|Unclassified|1|||
127861340|NCT02607865|460107496|FG002|Overall Study|Unclassified|2|||
127861341|NCT02607865|460107497|FG003|Overall Study|Unclassified|0|||
127861342|NCT00528840|460107498|FG000|Overall Study|Lost to Follow-up|10|||
127861343|NCT00528840|460107498|FG000|Overall Study|Adverse Event|1|||
127861344|NCT00528840|460107498|FG000|Overall Study|Withdrawal by Subject|17|||
127861345|NCT00528840|460107498|FG000|Overall Study|Death|2|||
127861346|NCT00528840|460107498|FG000|Overall Study|Administrative Reasons|1|||
127861347|NCT00528840|460107498|FG000|Overall Study|Other|2|||
127861348|NCT01756833|460107507|FG000|Overall Study|Withdrawal by Subject|4|||
127861349|NCT01756833|460107508|FG001|Overall Study|Withdrawal by Subject|3|||
127861350|NCT01766401|460107509|FG000|Overall Study|Adverse Event|7|||
127861351|NCT01766401|460107510|FG001|Overall Study|Adverse Event|22|||
127861352|NCT01766401|460107509|FG000|Overall Study|Lack of Efficacy|1|||
127861353|NCT01766401|460107510|FG001|Overall Study|Lack of Efficacy|2|||
127861354|NCT01766401|460107509|FG000|Overall Study|Protocol Violation|3|||
127861355|NCT01766401|460107510|FG001|Overall Study|Protocol Violation|8|||
127861356|NCT01766401|460107509|FG000|Overall Study|Withdrawal by Subject|15|||
127861357|NCT01766401|460107510|FG001|Overall Study|Withdrawal by Subject|12|||
127861358|NCT01766401|460107509|FG000|Overall Study|Lost to Follow-up|10|||
127861359|NCT01766401|460107510|FG001|Overall Study|Lost to Follow-up|11|||
127861360|NCT01766401|460107509|FG000|Overall Study|Pregnancy|1|||
127861361|NCT01766401|460107510|FG001|Overall Study|Pregnancy|1|||
127861362|NCT00398086|460107515|FG000|Overall Study|Unacceptable Toxicity|2|||
127861363|NCT00398086|460107516|FG001|Overall Study|Unacceptable Toxicity|8|||
127861364|NCT00398086|460107517|FG002|Overall Study|Unacceptable Toxicity|2|||
127861365|NCT00398086|460107515|FG000|Overall Study|Adverse Event|1|||
127861366|NCT00398086|460107516|FG001|Overall Study|Adverse Event|4|||
127861367|NCT00398086|460107517|FG002|Overall Study|Adverse Event|0|||
127861368|NCT00398086|460107515|FG000|Overall Study|Physician Decision|1|||
127861369|NCT00398086|460107516|FG001|Overall Study|Physician Decision|4|||
127861370|NCT00398086|460107517|FG002|Overall Study|Physician Decision|0|||
127861371|NCT00398086|460107515|FG000|Overall Study|Withdrawal by Subject|5|||
127861372|NCT00398086|460107516|FG001|Overall Study|Withdrawal by Subject|7|||
127861373|NCT00398086|460107517|FG002|Overall Study|Withdrawal by Subject|0|||
127861374|NCT01950364|460107518|FG000|Overall Study|Adverse Event|3|||
127861375|NCT01950364|460107519|FG001|Overall Study|Adverse Event|0|||
127861376|NCT01950364|460107518|FG000|Overall Study|Stem Cell Transplant|2|||
127861377|NCT01950364|460107519|FG001|Overall Study|Stem Cell Transplant|6|||
127861378|NCT01950364|460107518|FG000|Overall Study|Disease Progression|5|||
127861379|NCT01950364|460107519|FG001|Overall Study|Disease Progression|2|||
127861380|NCT01950364|460107518|FG000|Overall Study|Withdrawal by Subject|0|||
127861381|NCT01950364|460107519|FG001|Overall Study|Withdrawal by Subject|1|||
127861382|NCT01950364|460107518|FG000|Overall Study|Protocol Violation|0|||
127861383|NCT01950364|460107519|FG001|Overall Study|Protocol Violation|1|||
127861384|NCT01700140|460107520|FG000|Overall Study|Use of rescue drugs|3|||
127861385|NCT01700140|460107521|FG001|Overall Study|Use of rescue drugs|3|||
127861386|NCT01700140|460107522|FG002|Overall Study|Use of rescue drugs|1|||
127861387|NCT01700140|460107520|FG000|Overall Study|Discontinuation of radiotherapy|1|||
127861388|NCT01700140|460107521|FG001|Overall Study|Discontinuation of radiotherapy|0|||
127861389|NCT01700140|460107522|FG002|Overall Study|Discontinuation of radiotherapy|0|||
127861390|NCT01700140|460107520|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
127861391|NCT01700140|460107521|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
127861392|NCT01700140|460107522|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
127861393|NCT01700140|460107520|FG000|Overall Study|Aggravation of symptoms|1|||
127861394|NCT01700140|460107521|FG001|Overall Study|Aggravation of symptoms|0|||
127913707|NCT02011945|460308037|FG001|Overall Study|Proceeded to stem cell transplant|0|||
127913708|NCT02011945|460308038|FG002|Overall Study|Proceeded to stem cell transplant|1|||
127913709|NCT02011945|460308036|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
127913710|NCT02011945|460308037|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
127913711|NCT02011945|460308038|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
127913712|NCT00902538|460308039|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
127913713|NCT00902538|460308040|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
127913714|NCT00902538|460308041|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
127913715|NCT00902538|460308042|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
127913716|NCT00902538|460308043|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
127913717|NCT00902538|460308044|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
127913718|NCT00902538|460308039|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
127913719|NCT00902538|460308040|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
127913720|NCT00902538|460308041|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
127913721|NCT00902538|460308042|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
127913722|NCT00902538|460308043|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
127913723|NCT00902538|460308044|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
127913724|NCT00902538|460308039|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
127913725|NCT00902538|460308040|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
127913726|NCT00902538|460308041|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
127913727|NCT00902538|460308042|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
127913728|NCT00902538|460308043|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
127913729|NCT00902538|460308044|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
127913730|NCT00902538|460308039|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
127913731|NCT00902538|460308040|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
127913732|NCT00902538|460308041|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
127913733|NCT00902538|460308042|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
127913734|NCT00902538|460308043|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
127913735|NCT00902538|460308044|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
127913736|NCT00902538|460308039|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
127913737|NCT00902538|460308040|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
127913738|NCT00902538|460308041|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
127913739|NCT00902538|460308042|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
127913740|NCT00902538|460308043|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
127913741|NCT00902538|460308044|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
127913742|NCT00902538|460308039|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
127913743|NCT00902538|460308040|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
127913744|NCT00902538|460308041|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
127913745|NCT00902538|460308042|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
127913746|NCT00902538|460308043|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
127913747|NCT00902538|460308044|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
127913748|NCT00902538|460308039|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
127913749|NCT00902538|460308040|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
127913750|NCT00902538|460308041|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
127913751|NCT00902538|460308042|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
127913752|NCT00902538|460308043|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
127913753|NCT00902538|460308044|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
127913754|NCT00902538|460308039|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
127913755|NCT00902538|460308040|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
127913756|NCT00902538|460308041|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
127913757|NCT00902538|460308042|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
127913758|NCT00902538|460308043|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
127913759|NCT00902538|460308044|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
127913760|NCT00902538|460308039|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
127913761|NCT00902538|460308040|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
127913762|NCT00902538|460308041|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
127913763|NCT00902538|460308042|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
127913764|NCT00902538|460308043|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
127913765|NCT00902538|460308044|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
127913766|NCT00902538|460308039|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
127913767|NCT00902538|460308040|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
127913768|NCT00902538|460308041|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
127913769|NCT00902538|460308042|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
127913770|NCT00902538|460308043|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
127913771|NCT00902538|460308044|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
127861395|NCT01700140|460107522|FG002|Overall Study|Aggravation of symptoms|0|||
127861396|NCT01700140|460107520|FG000|Overall Study|Adverse Event|0|||
127861397|NCT01700140|460107521|FG001|Overall Study|Adverse Event|1|||
127861398|NCT01700140|460107522|FG002|Overall Study|Adverse Event|0|||
127861399|NCT01700140|460107520|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
127861400|NCT01700140|460107521|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
127861401|NCT01700140|460107522|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
127861402|NCT02573012|460107523|FG000|Overall Study|Adverse Event|5|||
127861403|NCT02573012|460107524|FG001|Overall Study|Adverse Event|5|||
127861404|NCT02573012|460107523|FG000|Overall Study|Lack of Efficacy|5|||
127861405|NCT02573012|460107524|FG001|Overall Study|Lack of Efficacy|4|||
127861406|NCT02573012|460107523|FG000|Overall Study|Non-compliance|1|||
127861407|NCT02573012|460107524|FG001|Overall Study|Non-compliance|2|||
127861408|NCT02573012|460107523|FG000|Overall Study|Withdrawal by Subject|2|||
127861409|NCT02573012|460107524|FG001|Overall Study|Withdrawal by Subject|2|||
127861410|NCT02573012|460107523|FG000|Overall Study|Study Ended per Protocol|1|||
127861411|NCT02573012|460107524|FG001|Overall Study|Study Ended per Protocol|0|||
127861412|NCT02573012|460107523|FG000|Overall Study|Physician Decision|1|||
127861413|NCT02573012|460107524|FG001|Overall Study|Physician Decision|2|||
127861414|NCT01610414|460107525|FG000|Study Start - Month 13|Serious Adverse Event|65|||
127861415|NCT01610414|460107526|FG001|Study Start - Month 13|Serious Adverse Event|67|||
127861416|NCT01610414|460107525|FG000|Study Start - Month 13|Adverse Event|14|||
127861417|NCT01610414|460107526|FG001|Study Start - Month 13|Adverse Event|14|||
127861418|NCT01610414|460107525|FG000|Study Start - Month 13|Protocol Violation|3|||
127861419|NCT01610414|460107526|FG001|Study Start - Month 13|Protocol Violation|1|||
127861420|NCT01610414|460107525|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
127861421|NCT01610414|460107526|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
127861422|NCT01610414|460107525|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
127861423|NCT01610414|460107526|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
127861424|NCT01610414|460107525|FG000|Study Start - Month 13|Lost to Follow-up|4|||
127861425|NCT01610414|460107526|FG001|Study Start - Month 13|Lost to Follow-up|6|||
127861426|NCT01610414|460107525|FG000|Study Start - Month 13|Suspected HZ episode|1|||
127861427|NCT01610414|460107526|FG001|Study Start - Month 13|Suspected HZ episode|3|||
127861428|NCT01610414|460107525|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
127861429|NCT01610414|460107526|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
127861430|NCT01610414|460107525|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
127861431|NCT01610414|460107526|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
127861432|NCT01610414|460107525|FG000|Month 13 - Month 25|Adverse Event|8|||
127861433|NCT01610414|460107526|FG001|Month 13 - Month 25|Adverse Event|4|||
127861434|NCT01610414|460107525|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
127861435|NCT01610414|460107526|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
127861436|NCT01610414|460107525|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
127861437|NCT01610414|460107526|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
127861438|NCT01610414|460107525|FG000|Month 13 - Month 25|Protocol Violation|0|||
127861439|NCT01610414|460107526|FG001|Month 13 - Month 25|Protocol Violation|2|||
127861440|NCT01610414|460107525|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
127861441|NCT01610414|460107526|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
127861442|NCT01610414|460107525|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
127861443|NCT01610414|460107526|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
127861444|NCT01610414|460107525|FG000|After Month 25|Study end not reached|48|||
127861445|NCT01610414|460107526|FG001|After Month 25|Study end not reached|53|||
127861446|NCT02736474|460107527|FG000|Overall Study|Lost to Follow-up|0|||
127861447|NCT02736474|460107528|FG001|Overall Study|Lost to Follow-up|1|||
127861448|NCT02483611|460107529|FG000|Overall Study|Protocol Violation|0|||
127861449|NCT02483611|460107530|FG001|Overall Study|Protocol Violation|0|||
127861450|NCT02483611|460107531|FG002|Overall Study|Protocol Violation|1|||
127861451|NCT02382276|460107532|FG000|Overall Study|Withdrawal by Subject|4|||
127861452|NCT02382276|460107533|FG001|Overall Study|Withdrawal by Subject|8|||
127861453|NCT02382276|460107534|FG002|Overall Study|Withdrawal by Subject|5|||
127861454|NCT02382276|460107532|FG000|Overall Study|Adverse Event|7|||
127861455|NCT02382276|460107533|FG001|Overall Study|Adverse Event|2|||
127861456|NCT02382276|460107534|FG002|Overall Study|Adverse Event|32|||
127861457|NCT02382276|460107532|FG000|Overall Study|Physician Decision|0|||
127861458|NCT02382276|460107533|FG001|Overall Study|Physician Decision|0|||
127861459|NCT02382276|460107534|FG002|Overall Study|Physician Decision|2|||
127861460|NCT01222416|460107535|FG000|Overall Study|ineligible;metastasis|3|||
127861461|NCT01222416|460107536|FG001|Overall Study|ineligible;metastasis|0|||
127861462|NCT01222416|460107535|FG000|Overall Study|Adverse Event|4|||
127861463|NCT01222416|460107536|FG001|Overall Study|Adverse Event|0|||
127861464|NCT01222416|460107535|FG000|Overall Study|Withdrawal by Subject|5|||
127861465|NCT01222416|460107536|FG001|Overall Study|Withdrawal by Subject|0|||
127861466|NCT01222416|460107535|FG000|Overall Study|scheduling|6|||
127861467|NCT01222416|460107536|FG001|Overall Study|scheduling|0|||
127861468|NCT01222416|460107535|FG000|Overall Study|missed view/scan|1|||
127861469|NCT01222416|460107536|FG001|Overall Study|missed view/scan|0|||
127861470|NCT01222416|460107535|FG000|Overall Study|Death|1|||
127913772|NCT00902538|460308039|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
127861471|NCT01222416|460107536|FG001|Overall Study|Death|0|||
127861472|NCT00518336|460107537|FG000|Year 7|Lost to Follow-up|2|||
127861473|NCT00518336|460107538|FG001|Year 7|Lost to Follow-up|0|||
127861474|NCT00518336|460107537|FG000|Year 7|Could not attend in time|0|||
127861475|NCT00518336|460107538|FG001|Year 7|Could not attend in time|3|||
127861476|NCT00518336|460107537|FG000|Year 8|Lost to Follow-up|1|||
127861477|NCT00518336|460107538|FG001|Year 8|Lost to Follow-up|1|||
127913773|NCT00902538|460308040|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
127913774|NCT00902538|460308041|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
127913775|NCT00902538|460308042|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
127913776|NCT00902538|460308043|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
127861478|NCT00518336|460107537|FG000|Year 8|Could not attend in time|0|||
127861479|NCT00518336|460107538|FG001|Year 8|Could not attend in time|1|||
127861480|NCT00518336|460107537|FG000|Year 9|Migrated/moved from study area|1|||
127861481|NCT00518336|460107538|FG001|Year 9|Migrated/moved from study area|1|||
127861482|NCT00518336|460107537|FG000|Year 9|Lost to Follow-up|3|||
127861483|NCT00518336|460107538|FG001|Year 9|Lost to Follow-up|0|||
127861484|NCT00518336|460107537|FG000|Year 9|Personal reasons|1|||
127861485|NCT00518336|460107538|FG001|Year 9|Personal reasons|0|||
127861486|NCT00125268|460107539|FG000|Overall Study|Withdrawal by Subject|1|||
127861487|NCT00125268|460107540|FG001|Overall Study|Withdrawal by Subject|1|||
127861488|NCT00286156|460107541|FG000|Overall Study|Missed 12 month visit|0|||
127861489|NCT00286156|460107542|FG001|Overall Study|Missed 12 month visit|0|||
127861490|NCT00286156|460107543|FG002|Overall Study|Missed 12 month visit|1|||
127861491|NCT00286156|460107541|FG000|Overall Study|AE: pulmonary embolus|0|||
127861492|NCT00286156|460107542|FG001|Overall Study|AE: pulmonary embolus|1|||
127861493|NCT00286156|460107543|FG002|Overall Study|AE: pulmonary embolus|0|||
127861494|NCT00286156|460107541|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
127861495|NCT00286156|460107542|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
127861496|NCT00286156|460107543|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
127861497|NCT00286156|460107541|FG000|Overall Study|AE: pneumonia|1|||
127861498|NCT00286156|460107542|FG001|Overall Study|AE: pneumonia|0|||
127861499|NCT00286156|460107543|FG002|Overall Study|AE: pneumonia|0|||
127861500|NCT01108263|460108925|FG000|Overall Study|Adverse Event|0|||
127861501|NCT01108263|460108926|FG001|Overall Study|Adverse Event|1|||
127861502|NCT01685372|460108927|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
127861503|NCT01685372|460108928|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
127861504|NCT01488994|460108931|FG000|Overall Study|Withdrawal by Subject|0|||
127861505|NCT01488994|460108932|FG001|Overall Study|Withdrawal by Subject|1|||
127861506|NCT00829010|460108933|FG000|Overall Study|Adverse Event|1|||
127861507|NCT00829010|460108934|FG001|Overall Study|Adverse Event|0|||
127861508|NCT00829010|460108935|FG002|Overall Study|Adverse Event|0|||
127861509|NCT00829010|460108936|FG003|Overall Study|Adverse Event|0|||
127861510|NCT00829010|460108937|FG004|Overall Study|Adverse Event|0|||
127861511|NCT00829010|460108933|FG000|Overall Study|Withdrawal by Subject|0|||
127861512|NCT00829010|460108934|FG001|Overall Study|Withdrawal by Subject|1|||
127861513|NCT00829010|460108935|FG002|Overall Study|Withdrawal by Subject|1|||
127861514|NCT00829010|460108936|FG003|Overall Study|Withdrawal by Subject|0|||
127861515|NCT00829010|460108937|FG004|Overall Study|Withdrawal by Subject|2|||
127861516|NCT00829010|460108933|FG000|Overall Study|Lost to Follow-up|1|||
127861517|NCT00829010|460108934|FG001|Overall Study|Lost to Follow-up|0|||
127861518|NCT00829010|460108935|FG002|Overall Study|Lost to Follow-up|2|||
127861519|NCT00829010|460108936|FG003|Overall Study|Lost to Follow-up|0|||
127861520|NCT00829010|460108937|FG004|Overall Study|Lost to Follow-up|0|||
127861521|NCT00829010|460108933|FG000|Overall Study|Fatality|5|||
127913777|NCT00902538|460308044|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
127913778|NCT00902538|460308039|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
127913779|NCT00902538|460308040|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
127913780|NCT00902538|460308041|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
127913781|NCT00902538|460308042|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
127913782|NCT00902538|460308043|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
127913783|NCT00902538|460308044|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
127861522|NCT00829010|460108934|FG001|Overall Study|Fatality|4|||
127861523|NCT00829010|460108935|FG002|Overall Study|Fatality|0|||
127861524|NCT00829010|460108936|FG003|Overall Study|Fatality|3|||
127861525|NCT00829010|460108937|FG004|Overall Study|Fatality|0|||
127861526|NCT00829010|460108933|FG000|Overall Study|Migrated/Moved from study area|3|||
127861527|NCT00829010|460108934|FG001|Overall Study|Migrated/Moved from study area|4|||
127861528|NCT00829010|460108935|FG002|Overall Study|Migrated/Moved from study area|0|||
127861529|NCT00829010|460108936|FG003|Overall Study|Migrated/Moved from study area|5|||
127861530|NCT00829010|460108937|FG004|Overall Study|Migrated/Moved from study area|0|||
127861531|NCT00474539|460108940|FG000|Infant Series|Withdrawal by Subject|3|||
127861532|NCT00474539|460108941|FG001|Infant Series|Withdrawal by Subject|4|||
127861533|NCT00474539|460108940|FG000|Infant Series|Randomization error|5|||
127861534|NCT00474539|460108941|FG001|Infant Series|Randomization error|0|||
127861535|NCT00474539|460108940|FG000|Infant Series|Lost to Follow-up|2|||
127861536|NCT00474539|460108941|FG001|Infant Series|Lost to Follow-up|1|||
127861537|NCT00474539|460108940|FG000|Infant Series|Protocol Violation|0|||
127861538|NCT00474539|460108941|FG001|Infant Series|Protocol Violation|1|||
127861539|NCT00474539|460108940|FG000|After Infant Series|Lost to Follow-up|3|||
127861540|NCT00474539|460108941|FG001|After Infant Series|Lost to Follow-up|0|||
127861541|NCT00474539|460108940|FG000|After Infant Series|Withdrawal by Subject|1|||
127861542|NCT00474539|460108941|FG001|After Infant Series|Withdrawal by Subject|0|||
127861543|NCT00474539|460108940|FG000|Toddler Dose|Protocol Violation|1|||
127861544|NCT00474539|460108941|FG001|Toddler Dose|Protocol Violation|0|||
127861545|NCT02061540|460108942|FG000|Overall Study|Adverse Event|2|||
127861546|NCT02061540|460108942|FG000|Overall Study|Withdrawal by Subject|2|||
127861547|NCT02289833|460108944|FG000|Overall Study|Study discontinuation|0|||
127861548|NCT02289833|460108945|FG001|Overall Study|Study discontinuation|1|||
127861549|NCT02289833|460108944|FG000|Overall Study|Lost to Follow-up|4|||
127861550|NCT02289833|460108945|FG001|Overall Study|Lost to Follow-up|0|||
127861551|NCT02289833|460108944|FG000|Overall Study|Death|23|||
127861552|NCT02289833|460108945|FG001|Overall Study|Death|16|||
127861553|NCT01227252|460108946|FG000|Overall Study|Sponsor Decision|0|||
127861554|NCT01227252|460108947|FG001|Overall Study|Sponsor Decision|1|||
127861555|NCT01227252|460108948|FG002|Overall Study|Sponsor Decision|0|||
127861556|NCT01227252|460108949|FG003|Overall Study|Sponsor Decision|0|||
127913784|NCT00902538|460308039|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
127913785|NCT00902538|460308040|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
127913786|NCT00902538|460308041|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
127913787|NCT00902538|460308042|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
127861557|NCT01227252|460108946|FG000|Overall Study|Lost to Follow-up|0|||
127861558|NCT01227252|460108947|FG001|Overall Study|Lost to Follow-up|1|||
127913788|NCT00902538|460308043|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
127913789|NCT00902538|460308044|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
127913790|NCT00902538|460308039|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
127913791|NCT00902538|460308040|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
127913792|NCT00902538|460308041|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
127913793|NCT00902538|460308042|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
127913794|NCT00902538|460308043|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
127913795|NCT00902538|460308044|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
127913796|NCT00902538|460308039|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
127913797|NCT00902538|460308040|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
127913798|NCT00902538|460308041|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
127913799|NCT00902538|460308042|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
127913800|NCT00902538|460308043|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
127913801|NCT00902538|460308044|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
127913802|NCT00902538|460308039|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
127913803|NCT00902538|460308040|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
127913804|NCT00902538|460308041|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
127913805|NCT00902538|460308042|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
127913806|NCT00902538|460308043|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
127913807|NCT00902538|460308044|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
127913808|NCT00902538|460308039|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
127913809|NCT00902538|460308040|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
127861559|NCT01227252|460108948|FG002|Overall Study|Lost to Follow-up|0|||
127861560|NCT01227252|460108949|FG003|Overall Study|Lost to Follow-up|0|||
127861561|NCT01227252|460108946|FG000|Overall Study|Withdrawal by Subject|0|||
127861562|NCT01227252|460108947|FG001|Overall Study|Withdrawal by Subject|1|||
127861563|NCT01227252|460108948|FG002|Overall Study|Withdrawal by Subject|0|||
127861564|NCT01227252|460108949|FG003|Overall Study|Withdrawal by Subject|0|||
127861565|NCT02561273|460108956|FG000|Overall Study|Protocol Violation|1|||
127861566|NCT02561273|460108957|FG001|Overall Study|Protocol Violation|0|||
127861567|NCT03442595|460108958|FG000|Overall Study|Lost to Follow-up|94|||
127861568|NCT03442595|460108959|FG001|Overall Study|Lost to Follow-up|0|||
127861569|NCT00811395|460108960|FG000|Extension Treatment|Adverse Event|1|||
127861570|NCT00811395|460108961|FG001|Extension Treatment|Adverse Event|2|||
127861571|NCT00811395|460108962|FG002|Extension Treatment|Adverse Event|2|||
127861572|NCT00811395|460108963|FG003|Extension Treatment|Adverse Event|2|||
127861573|NCT00811395|460108964|FG004|Extension Treatment|Adverse Event|0|||
127861574|NCT00811395|460108965|FG005|Extension Treatment|Adverse Event|1|||
127861575|NCT00811395|460108960|FG000|Extension Treatment|Progressive disease|1|||
127861576|NCT00811395|460108961|FG001|Extension Treatment|Progressive disease|1|||
127861577|NCT00811395|460108962|FG002|Extension Treatment|Progressive disease|0|||
127861578|NCT00811395|460108963|FG003|Extension Treatment|Progressive disease|0|||
127861579|NCT00811395|460108964|FG004|Extension Treatment|Progressive disease|0|||
127861580|NCT00811395|460108965|FG005|Extension Treatment|Progressive disease|0|||
127861581|NCT00811395|460108960|FG000|Extension Treatment|Participant did not wish to continue|0|||
127861582|NCT00811395|460108961|FG001|Extension Treatment|Participant did not wish to continue|3|||
127861583|NCT00811395|460108962|FG002|Extension Treatment|Participant did not wish to continue|0|||
127861584|NCT00811395|460108963|FG003|Extension Treatment|Participant did not wish to continue|1|||
127861585|NCT00811395|460108964|FG004|Extension Treatment|Participant did not wish to continue|0|||
127861586|NCT00811395|460108965|FG005|Extension Treatment|Participant did not wish to continue|1|||
127861587|NCT00811395|460108960|FG000|Extension Treatment|Other than above|0|||
127861588|NCT00811395|460108961|FG001|Extension Treatment|Other than above|0|||
127861589|NCT00811395|460108962|FG002|Extension Treatment|Other than above|1|||
127861590|NCT00811395|460108963|FG003|Extension Treatment|Other than above|0|||
127861591|NCT00811395|460108964|FG004|Extension Treatment|Other than above|0|||
127861592|NCT00811395|460108965|FG005|Extension Treatment|Other than above|0|||
127861593|NCT03227692|460108974|FG000|Overall Study|Protocol Violation|1|||
127913810|NCT00902538|460308041|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
127861594|NCT03227692|460108975|FG001|Overall Study|Protocol Violation|1|||
127861595|NCT03227692|460108974|FG000|Overall Study|Lost to Follow-up|4|||
127861596|NCT03227692|460108975|FG001|Overall Study|Lost to Follow-up|2|||
127861597|NCT03227692|460108974|FG000|Overall Study|Adverse Event|0|||
127861598|NCT03227692|460108975|FG001|Overall Study|Adverse Event|2|||
127861599|NCT01970540|460108976|FG000|Overall Study|Non-treatment-related AE|0|||
127861600|NCT01970540|460108977|FG001|Overall Study|Non-treatment-related AE|0|||
127861601|NCT01970540|460108978|FG002|Overall Study|Non-treatment-related AE|1|||
127861602|NCT01970540|460108976|FG000|Overall Study|Progressive disease|55|||
127861603|NCT01970540|460108977|FG001|Overall Study|Progressive disease|23|||
127861604|NCT01970540|460108978|FG002|Overall Study|Progressive disease|10|||
127861605|NCT01970540|460108976|FG000|Overall Study|Treatment delay over protocol|0|||
127861606|NCT01970540|460108977|FG001|Overall Study|Treatment delay over protocol|0|||
127861607|NCT01970540|460108978|FG002|Overall Study|Treatment delay over protocol|1|||
127861608|NCT01970540|460108976|FG000|Overall Study|Physician Decision|7|||
127861609|NCT01970540|460108977|FG001|Overall Study|Physician Decision|2|||
127861610|NCT01970540|460108978|FG002|Overall Study|Physician Decision|0|||
127861611|NCT01970540|460108976|FG000|Overall Study|Clinical progression|0|||
127861612|NCT01970540|460108977|FG001|Overall Study|Clinical progression|1|||
127861613|NCT01970540|460108978|FG002|Overall Study|Clinical progression|1|||
127861614|NCT01970540|460108976|FG000|Overall Study|End of study|2|||
127861615|NCT01970540|460108977|FG001|Overall Study|End of study|0|||
127861616|NCT01970540|460108978|FG002|Overall Study|End of study|2|||
127861617|NCT01970540|460108976|FG000|Overall Study|Adverse Event|0|||
127861618|NCT01970540|460108977|FG001|Overall Study|Adverse Event|2|||
127861619|NCT01970540|460108978|FG002|Overall Study|Adverse Event|1|||
127861620|NCT01970540|460108976|FG000|Overall Study|Treatment-related AE|4|||
127861621|NCT01970540|460108977|FG001|Overall Study|Treatment-related AE|0|||
127861622|NCT01970540|460108978|FG002|Overall Study|Treatment-related AE|2|||
127861623|NCT01970540|460108976|FG000|Overall Study|Withdrawal by Subject|4|||
127861624|NCT01970540|460108977|FG001|Overall Study|Withdrawal by Subject|0|||
127861625|NCT01970540|460108978|FG002|Overall Study|Withdrawal by Subject|1|||
127861626|NCT01970540|460108976|FG000|Overall Study|Clinical deterioration|1|||
127861627|NCT01970540|460108977|FG001|Overall Study|Clinical deterioration|0|||
127861628|NCT01970540|460108978|FG002|Overall Study|Clinical deterioration|0|||
127861629|NCT00952588|460108979|FG000|Overall Study|Death|28|||
127861630|NCT00952588|460108980|FG001|Overall Study|Death|13|||
127861631|NCT00952588|460108979|FG000|Overall Study|Withdrawal by Subject|2|||
127861632|NCT00952588|460108980|FG001|Overall Study|Withdrawal by Subject|5|||
127861633|NCT00952588|460108979|FG000|Overall Study|Adverse Event|2|||
127861634|NCT00952588|460108980|FG001|Overall Study|Adverse Event|3|||
127861635|NCT00952588|460108979|FG000|Overall Study|Lost to Follow-up|2|||
127861636|NCT00952588|460108980|FG001|Overall Study|Lost to Follow-up|0|||
127861637|NCT00952588|460108979|FG000|Overall Study|Physician Decision|0|||
127861638|NCT00952588|460108980|FG001|Overall Study|Physician Decision|1|||
127861639|NCT00952588|460108979|FG000|Overall Study|Lack of Efficacy|2|||
127861640|NCT00952588|460108980|FG001|Overall Study|Lack of Efficacy|2|||
127861641|NCT01796106|460108981|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
127861642|NCT01796106|460108982|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
127861643|NCT02795182|460108983|FG000|Overall Study|Death|5|||
127861644|NCT02795182|460108984|FG001|Overall Study|Death|4|||
127861645|NCT02795182|460108985|FG002|Overall Study|Death|4|||
127861646|NCT02795182|460108986|FG003|Overall Study|Death|18|||
127861647|NCT02795182|460108983|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
127861648|NCT02795182|460108984|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
127861649|NCT02795182|460108985|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
127861650|NCT02795182|460108986|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
127861651|NCT02795182|460108983|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
127861652|NCT02795182|460108984|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
127861653|NCT02795182|460108985|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
127861654|NCT02795182|460108986|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
127861655|NCT02795182|460108983|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
127861656|NCT02795182|460108984|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
127861657|NCT02795182|460108985|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
127861658|NCT02795182|460108986|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
127861659|NCT02795182|460108983|FG000|Overall Study|Withdrawal by Subject|4|||
127861660|NCT02795182|460108984|FG001|Overall Study|Withdrawal by Subject|0|||
127861661|NCT02795182|460108985|FG002|Overall Study|Withdrawal by Subject|0|||
127861662|NCT02795182|460108986|FG003|Overall Study|Withdrawal by Subject|3|||
127861663|NCT02795182|460108983|FG000|Overall Study|Lost to Follow-up|0|||
127861664|NCT02795182|460108984|FG001|Overall Study|Lost to Follow-up|0|||
127861665|NCT02795182|460108985|FG002|Overall Study|Lost to Follow-up|1|||
127861666|NCT02795182|460108986|FG003|Overall Study|Lost to Follow-up|1|||
127861667|NCT02795182|460108983|FG000|Overall Study|Roll Over to Long Term Extension|3|||
127861668|NCT02795182|460108984|FG001|Overall Study|Roll Over to Long Term Extension|3|||
127861669|NCT02795182|460108985|FG002|Overall Study|Roll Over to Long Term Extension|2|||
127861670|NCT02795182|460108986|FG003|Overall Study|Roll Over to Long Term Extension|5|||
127861671|NCT02795182|460108983|FG000|Overall Study|Progressive Disease|0|||
127861672|NCT02795182|460108984|FG001|Overall Study|Progressive Disease|1|||
127861673|NCT02795182|460108985|FG002|Overall Study|Progressive Disease|0|||
127861674|NCT02795182|460108986|FG003|Overall Study|Progressive Disease|4|||
127861675|NCT02795182|460108983|FG000|Overall Study|Physician Decision|0|||
127861676|NCT02795182|460108984|FG001|Overall Study|Physician Decision|0|||
127861677|NCT02795182|460108985|FG002|Overall Study|Physician Decision|0|||
127861678|NCT02795182|460108986|FG003|Overall Study|Physician Decision|1|||
127861679|NCT04107935|460108987|FG000|Overall Study|Death|1|||
127861680|NCT04107935|460108988|FG001|Overall Study|Death|0|||
127861681|NCT01021553|460108989|FG000|Overall Study|Adverse Event|1|||
127861682|NCT01021553|460108990|FG001|Overall Study|Adverse Event|0|||
127861683|NCT01021553|460108991|FG002|Overall Study|Adverse Event|0|||
127861684|NCT01021553|460108989|FG000|Overall Study|Lack of Efficacy|2|||
127861685|NCT01021553|460108990|FG001|Overall Study|Lack of Efficacy|2|||
127861686|NCT01021553|460108991|FG002|Overall Study|Lack of Efficacy|0|||
127861687|NCT01021553|460108989|FG000|Overall Study|Protocol Violation|0|||
127861688|NCT01021553|460108990|FG001|Overall Study|Protocol Violation|2|||
127861689|NCT01021553|460108991|FG002|Overall Study|Protocol Violation|2|||
127861690|NCT01021553|460108989|FG000|Overall Study|Lost to Follow-up|0|||
127861691|NCT01021553|460108990|FG001|Overall Study|Lost to Follow-up|0|||
127861692|NCT01021553|460108991|FG002|Overall Study|Lost to Follow-up|1|||
127861693|NCT01021553|460108989|FG000|Overall Study|Withdrawal by Subject|1|||
127861694|NCT01021553|460108990|FG001|Overall Study|Withdrawal by Subject|1|||
127861695|NCT01021553|460108991|FG002|Overall Study|Withdrawal by Subject|0|||
127861696|NCT00033293|460108992|FG000|Overall Study|Death|0|||
127861697|NCT00033293|460108993|FG001|Overall Study|Death|1|||
127861698|NCT00033293|460108992|FG000|Overall Study|Lack of Efficacy|5|||
127861699|NCT00033293|460108993|FG001|Overall Study|Lack of Efficacy|8|||
127861700|NCT00033293|460108992|FG000|Overall Study|Lost to Follow-up|0|||
127861701|NCT00033293|460108993|FG001|Overall Study|Lost to Follow-up|1|||
127861702|NCT00033293|460108992|FG000|Overall Study|Physician Decision|3|||
127861703|NCT00033293|460108993|FG001|Overall Study|Physician Decision|1|||
127861704|NCT00033293|460108992|FG000|Overall Study|Withdrawal by Subject|1|||
127861705|NCT00033293|460108993|FG001|Overall Study|Withdrawal by Subject|0|||
127861706|NCT00033293|460108992|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
127861707|NCT00033293|460108993|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
127861708|NCT00033293|460108992|FG000|Overall Study|Treatment refused|0|||
127861709|NCT00033293|460108993|FG001|Overall Study|Treatment refused|6|||
127861710|NCT00935701|460108994|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
127861711|NCT00998985|460108998|FG000|Overall Study|Withdrawal by Subject|0|||
127861712|NCT00998985|460108999|FG001|Overall Study|Withdrawal by Subject|0|||
127861713|NCT00998985|460109000|FG002|Overall Study|Withdrawal by Subject|0|||
127861714|NCT00998985|460109001|FG003|Overall Study|Withdrawal by Subject|0|||
127861715|NCT00998985|460109002|FG004|Overall Study|Withdrawal by Subject|0|||
127861716|NCT00998985|460109003|FG005|Overall Study|Withdrawal by Subject|0|||
127861717|NCT00998985|460109004|FG006|Overall Study|Withdrawal by Subject|0|||
127861718|NCT00998985|460109005|FG007|Overall Study|Withdrawal by Subject|0|||
127861719|NCT00998985|460109006|FG008|Overall Study|Withdrawal by Subject|1|||
127861720|NCT00998985|460109007|FG009|Overall Study|Withdrawal by Subject|0|||
127861721|NCT00998985|460109008|FG010|Overall Study|Withdrawal by Subject|0|||
127861722|NCT00998985|460109009|FG011|Overall Study|Withdrawal by Subject|0|||
127861723|NCT00998985|460109010|FG012|Overall Study|Withdrawal by Subject|0|||
127861724|NCT00998985|460109011|FG013|Overall Study|Withdrawal by Subject|0|||
127861725|NCT00998985|460108998|FG000|Overall Study|Protocol Violation|0|||
127861726|NCT00998985|460108999|FG001|Overall Study|Protocol Violation|0|||
127861727|NCT00998985|460109000|FG002|Overall Study|Protocol Violation|0|||
127861728|NCT00998985|460109001|FG003|Overall Study|Protocol Violation|0|||
127861729|NCT00998985|460109002|FG004|Overall Study|Protocol Violation|0|||
127861730|NCT00998985|460109003|FG005|Overall Study|Protocol Violation|1|||
127861731|NCT00998985|460109004|FG006|Overall Study|Protocol Violation|0|||
127861732|NCT00998985|460109005|FG007|Overall Study|Protocol Violation|0|||
127861733|NCT00998985|460109006|FG008|Overall Study|Protocol Violation|0|||
127861734|NCT00998985|460109007|FG009|Overall Study|Protocol Violation|0|||
127861735|NCT00998985|460109008|FG010|Overall Study|Protocol Violation|0|||
127861736|NCT00998985|460109009|FG011|Overall Study|Protocol Violation|0|||
127861737|NCT00998985|460109010|FG012|Overall Study|Protocol Violation|0|||
127861738|NCT00998985|460109011|FG013|Overall Study|Protocol Violation|0|||
127861739|NCT01040728|460109013|FG000|Overall Study|Adverse Event|4|||
127861740|NCT01040728|460109014|FG001|Overall Study|Adverse Event|8|||
127861741|NCT01040728|460109015|FG002|Overall Study|Adverse Event|0|||
127861742|NCT01040728|460109016|FG003|Overall Study|Adverse Event|4|||
127861743|NCT01040728|460109013|FG000|Overall Study|Withdrawal by Subject|0|||
127861744|NCT01040728|460109014|FG001|Overall Study|Withdrawal by Subject|1|||
127861745|NCT01040728|460109015|FG002|Overall Study|Withdrawal by Subject|1|||
127861746|NCT01040728|460109016|FG003|Overall Study|Withdrawal by Subject|0|||
127861747|NCT01040728|460109013|FG000|Overall Study|Protocol Violation|0|||
127861748|NCT01040728|460109014|FG001|Overall Study|Protocol Violation|0|||
127861749|NCT01040728|460109015|FG002|Overall Study|Protocol Violation|0|||
127861750|NCT01040728|460109016|FG003|Overall Study|Protocol Violation|1|||
127861751|NCT01040728|460109013|FG000|Overall Study|Lack of Efficacy|0|||
127861752|NCT01040728|460109014|FG001|Overall Study|Lack of Efficacy|1|||
127861753|NCT01040728|460109015|FG002|Overall Study|Lack of Efficacy|0|||
127861754|NCT01040728|460109016|FG003|Overall Study|Lack of Efficacy|1|||
127861755|NCT01040728|460109013|FG000|Overall Study|Other reasons not listed above|0|||
127861756|NCT01040728|460109014|FG001|Overall Study|Other reasons not listed above|1|||
127861757|NCT01040728|460109015|FG002|Overall Study|Other reasons not listed above|0|||
127861758|NCT01040728|460109016|FG003|Overall Study|Other reasons not listed above|0|||
127861759|NCT00590031|460109019|FG000|Overall Study|Adverse Event|3|||
127861760|NCT00590031|460109019|FG000|Overall Study|Withdrawal by Subject|1|||
127861761|NCT00590031|460109019|FG000|Overall Study|Metastatic Disease|1|||
127861762|NCT00590031|460109019|FG000|Overall Study|Admin Hold|1|||
127861763|NCT01875874|460109020|FG000|Overall Study|Death|3|||
127861764|NCT00826540|460109027|FG000|Overall Study|ineligible|3|||
127861765|NCT00826540|460109027|FG000|Overall Study|Withdrawal by Subject|1|||
127861766|NCT01166386|460109028|FG000|Overall Study|Withdrawal by Subject|3|||
127861767|NCT01166386|460109029|FG001|Overall Study|Withdrawal by Subject|5|||
127861768|NCT02178592|460109032|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
127861769|NCT02178592|460109033|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
127861770|NCT02178592|460109032|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
127861771|NCT02178592|460109033|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
127861772|NCT02178592|460109032|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
127861773|NCT02178592|460109033|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
127861774|NCT02178592|460109032|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
127861775|NCT02178592|460109033|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
127861776|NCT02178592|460109032|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
127861777|NCT02178592|460109033|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
127861778|NCT02178592|460109032|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
127861779|NCT02178592|460109033|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
127861780|NCT02178592|460109032|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
127861781|NCT02178592|460109033|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
127861782|NCT02178592|460109032|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
127861783|NCT02178592|460109033|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
127861784|NCT02178592|460109032|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
127861785|NCT02178592|460109033|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
127861786|NCT02178592|460109032|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
127861787|NCT02178592|460109033|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
127861788|NCT02178592|460109032|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
127861789|NCT02178592|460109033|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
127861790|NCT02178592|460109032|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
127861791|NCT02178592|460109033|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
127861792|NCT02520141|460109036|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
127861793|NCT00703781|460109037|FG000|Overall Study|Withdrawal by Subject|1|||
127861794|NCT00703781|460109038|FG001|Overall Study|Withdrawal by Subject|2|||
127861795|NCT00703781|460109037|FG000|Overall Study|Cancelled surgery|1|||
127861796|NCT00703781|460109038|FG001|Overall Study|Cancelled surgery|0|||
127861797|NCT03452397|460109041|FG000|Overall Study|Adverse Event|1|||
127861798|NCT03452397|460109042|FG001|Overall Study|Adverse Event|0|||
127861799|NCT03452397|460109043|FG002|Overall Study|Adverse Event|0|||
127861800|NCT03452397|460109044|FG003|Overall Study|Adverse Event|0|||
127861801|NCT03452397|460109041|FG000|Overall Study|Administrative reason|0|||
127861802|NCT03452397|460109042|FG001|Overall Study|Administrative reason|0|||
127861803|NCT03452397|460109043|FG002|Overall Study|Administrative reason|1|||
127861804|NCT03452397|460109044|FG003|Overall Study|Administrative reason|1|||
127861805|NCT03452397|460109041|FG000|Overall Study|Withdrawal by Subject|0|||
127861806|NCT03452397|460109042|FG001|Overall Study|Withdrawal by Subject|0|||
127861807|NCT03452397|460109043|FG002|Overall Study|Withdrawal by Subject|1|||
127861808|NCT03452397|460109044|FG003|Overall Study|Withdrawal by Subject|0|||
127861809|NCT02691468|460109046|FG000|Overall Study|Bronchial blocker use|2|||
127861810|NCT02691468|460109047|FG001|Overall Study|Bronchial blocker use|1|||
127861811|NCT02691468|460109046|FG000|Overall Study|Lost to Follow-up|2|||
127861812|NCT02691468|460109047|FG001|Overall Study|Lost to Follow-up|1|||
127861813|NCT02691468|460109046|FG000|Overall Study|Failure to advance FOB|2|||
127861814|NCT02691468|460109047|FG001|Overall Study|Failure to advance FOB|0|||
127861815|NCT06334055|460109048|FG000|Overall Study|Adverse Event|4|||
127861816|NCT06334055|460109048|FG000|Overall Study|Disqualified|72|||
127913811|NCT00902538|460308042|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
127913812|NCT00902538|460308043|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
127913813|NCT00902538|460308044|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
127913814|NCT03531827|460308045|FG000|Overall Study|Adverse Event|2|||
127913815|NCT03531827|460308046|FG001|Overall Study|Adverse Event|0|||
127913816|NCT03531827|460308045|FG000|Overall Study|Progressive disease|1|||
127913817|NCT03531827|460308046|FG001|Overall Study|Progressive disease|0|||
127913818|NCT00849797|460308047|FG000|First Intervention|bad veins|1|||
127861817|NCT02545049|460109049|FG000|Overall Study|Withdrawal by Subject|1|||
127861818|NCT02545049|460109050|FG001|Overall Study|Withdrawal by Subject|7|||
127861819|NCT02545049|460109049|FG000|Overall Study|Lost to Follow-up|4|||
127861820|NCT02545049|460109050|FG001|Overall Study|Lost to Follow-up|6|||
127861821|NCT02545049|460109049|FG000|Overall Study|GCP violations|37|||
127861822|NCT02545049|460109050|FG001|Overall Study|GCP violations|48|||
127861823|NCT02972658|460110555|FG000|Overall Study|Adverse Event|0|||
127861824|NCT02972658|460110556|FG001|Overall Study|Adverse Event|3|||
127861825|NCT02972658|460110557|FG002|Overall Study|Adverse Event|0|||
127861826|NCT02972658|460110558|FG003|Overall Study|Adverse Event|2|||
127861827|NCT02972658|460110555|FG000|Overall Study|Other-determined by Investigator|1|||
127861828|NCT02972658|460110556|FG001|Overall Study|Other-determined by Investigator|1|||
127861829|NCT02972658|460110557|FG002|Overall Study|Other-determined by Investigator|0|||
127861830|NCT02972658|460110558|FG003|Overall Study|Other-determined by Investigator|0|||
127861831|NCT02972658|460110555|FG000|Overall Study|Death|0|||
127861832|NCT02972658|460110556|FG001|Overall Study|Death|0|||
127861833|NCT02972658|460110557|FG002|Overall Study|Death|0|||
127861834|NCT02972658|460110558|FG003|Overall Study|Death|1|||
127861835|NCT02972658|460110555|FG000|Overall Study|Lost to Follow-up|0|||
127861836|NCT02972658|460110556|FG001|Overall Study|Lost to Follow-up|1|||
127861837|NCT02972658|460110557|FG002|Overall Study|Lost to Follow-up|1|||
127861838|NCT02972658|460110558|FG003|Overall Study|Lost to Follow-up|2|||
127861839|NCT02972658|460110555|FG000|Overall Study|Progressive Disease|0|||
127861840|NCT02972658|460110556|FG001|Overall Study|Progressive Disease|1|||
127861841|NCT02972658|460110557|FG002|Overall Study|Progressive Disease|0|||
127861842|NCT02972658|460110558|FG003|Overall Study|Progressive Disease|1|||
127861843|NCT02972658|460110555|FG000|Overall Study|Withdrawal by Subject|4|||
127861844|NCT02972658|460110556|FG001|Overall Study|Withdrawal by Subject|4|||
127861845|NCT02972658|460110557|FG002|Overall Study|Withdrawal by Subject|1|||
127861846|NCT02972658|460110558|FG003|Overall Study|Withdrawal by Subject|6|||
127861847|NCT02972658|460110555|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
127861848|NCT02972658|460110556|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
127861849|NCT02972658|460110557|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
127861850|NCT02972658|460110558|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
127861851|NCT02972658|460110555|FG000|Overall Study|Sponsor Decision|70|||
127861852|NCT02972658|460110556|FG001|Overall Study|Sponsor Decision|127|||
127861853|NCT02972658|460110557|FG002|Overall Study|Sponsor Decision|72|||
127861854|NCT02972658|460110558|FG003|Overall Study|Sponsor Decision|119|||
127861855|NCT03958149|460110559|FG000|Overall Study|Withdrawal by Subject|0|||
127861856|NCT03958149|460110560|FG001|Overall Study|Withdrawal by Subject|1|||
127861857|NCT02785588|460110561|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
127913819|NCT00849797|460308048|FG001|First Intervention|bad veins|0|||
127861858|NCT02785588|460110561|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
127861859|NCT00621764|460110563|FG000|Overall Study|Protocol Violation|0|||
127913820|NCT00849797|460308047|FG000|First Intervention|Adverse Event|0|||
127913821|NCT00849797|460308048|FG001|First Intervention|Adverse Event|1|||
127913822|NCT00849797|460308047|FG000|Washout: One Week|Withdrawal by Subject|0|||
127861860|NCT00621764|460110564|FG001|Overall Study|Protocol Violation|0|||
127861861|NCT00621764|460110565|FG002|Overall Study|Protocol Violation|0|||
127861862|NCT00621764|460110566|FG003|Overall Study|Protocol Violation|1|||
127913823|NCT00849797|460308048|FG001|Washout: One Week|Withdrawal by Subject|2|||
127913824|NCT00679081|460308049|FG000|Overall Study|Lost to Follow-up|1|||
127861863|NCT02499172|460110567|FG000|Overall Study|Financial reason|0|||
127861864|NCT02499172|460110568|FG001|Overall Study|Financial reason|0|||
127861865|NCT02499172|460110569|FG002|Overall Study|Financial reason|523|||
127861866|NCT02499172|460110570|FG003|Overall Study|Financial reason|436|||
127861867|NCT02499172|460110567|FG000|Overall Study|Lost to Follow-up|65|||
127913825|NCT00725322|460308050|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
127861868|NCT02499172|460110568|FG001|Overall Study|Lost to Follow-up|64|||
127861869|NCT02499172|460110569|FG002|Overall Study|Lost to Follow-up|0|||
127861870|NCT02499172|460110570|FG003|Overall Study|Lost to Follow-up|0|||
127861871|NCT01293123|460110571|FG000|Overall Study|Lost to Follow-up|0|||
127861872|NCT01293123|460110572|FG001|Overall Study|Lost to Follow-up|1|||
127861873|NCT00211536|460110575|FG000|Overall Study|Withdrawal by Subject|2|||
127861874|NCT00211536|460110576|FG001|Overall Study|Withdrawal by Subject|2|||
127861875|NCT00211536|460110575|FG000|Overall Study|Physician Decision|0|||
127861876|NCT00211536|460110576|FG001|Overall Study|Physician Decision|5|||
127861877|NCT00211536|460110575|FG000|Overall Study|Adverse Event|2|||
127861878|NCT00211536|460110576|FG001|Overall Study|Adverse Event|0|||
127861879|NCT00003389|460110577|FG000|Overall Study|Disease progression|6|||
127861880|NCT00003389|460110578|FG001|Overall Study|Disease progression|1|||
127861881|NCT00003389|460110577|FG000|Overall Study|Adverse Event|13|||
127861882|NCT00003389|460110578|FG001|Overall Study|Adverse Event|2|||
127861883|NCT00003389|460110577|FG000|Overall Study|Death|0|||
127861884|NCT00003389|460110578|FG001|Overall Study|Death|3|||
127861885|NCT00003389|460110577|FG000|Overall Study|Withdrawal by Subject|12|||
127861886|NCT00003389|460110578|FG001|Overall Study|Withdrawal by Subject|5|||
127861887|NCT00003389|460110577|FG000|Overall Study|Alternative therapy|2|||
127861888|NCT00003389|460110578|FG001|Overall Study|Alternative therapy|1|||
127861889|NCT00003389|460110577|FG000|Overall Study|Complicating disease|1|||
127861890|NCT00003389|460110578|FG001|Overall Study|Complicating disease|0|||
127861891|NCT00003389|460110577|FG000|Overall Study|Off-treatment reason missing|31|||
127861892|NCT00003389|460110578|FG001|Overall Study|Off-treatment reason missing|21|||
127861893|NCT00003389|460110577|FG000|Overall Study|Ineligible|33|||
127861894|NCT00003389|460110578|FG001|Overall Study|Ineligible|27|||
127861895|NCT01997892|460110581|FG000|Overall Study|Physician Decision|2|||
127861896|NCT01997892|460110581|FG000|Overall Study|Lost to Follow-up|6|||
127861897|NCT01997892|460110581|FG000|Overall Study|Death|14|||
127861898|NCT01997892|460110581|FG000|Overall Study|Renal transplant|8|||
127861899|NCT01997892|460110581|FG000|Overall Study|Other|3|||
127861900|NCT01997892|460110581|FG000|Overall Study|Study completion data not recorded|35|||
127861901|NCT02710422|460110582|FG000|Overall Study|Termination of study|9|||
127861902|NCT02710422|460110583|FG001|Overall Study|Termination of study|9|||
127861903|NCT02608099|460110584|FG000|Overall Study|Ablation procedure not initiated|3|||
127861904|NCT02608099|460110585|FG001|Overall Study|Ablation procedure not initiated|2|||
127861905|NCT00768040|460110588|FG000|Overall Study|Adverse Event|3|||
127861906|NCT00768040|460110589|FG001|Overall Study|Adverse Event|2|||
127861907|NCT00768040|460110588|FG000|Overall Study|Abnormal laboratory value|1|||
127861908|NCT00768040|460110589|FG001|Overall Study|Abnormal laboratory value|1|||
127861909|NCT00417248|460110591|FG000|Overall Study|Study Terminated|6|||
127861910|NCT00417248|460110591|FG000|Overall Study|Death|1|||
127861911|NCT00417248|460110591|FG000|Overall Study|Lack of Efficacy|1|||
127861912|NCT02185040|460110592|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
127861913|NCT02185040|460110593|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
127861914|NCT02185040|460110594|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
127861915|NCT02185040|460110595|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
127861916|NCT02185040|460110596|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
127861917|NCT02185040|460110597|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
127861918|NCT02185040|460110598|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
127861919|NCT02185040|460110592|FG000|Part 1 Treatment Phase|Adverse Event|1|||
127861920|NCT02185040|460110593|FG001|Part 1 Treatment Phase|Adverse Event|0|||
127861921|NCT02185040|460110594|FG002|Part 1 Treatment Phase|Adverse Event|0|||
127861922|NCT02185040|460110595|FG003|Part 1 Treatment Phase|Adverse Event|2|||
127861923|NCT02185040|460110596|FG004|Part 1 Treatment Phase|Adverse Event|3|||
127861924|NCT02185040|460110597|FG005|Part 1 Treatment Phase|Adverse Event|0|||
127861925|NCT02185040|460110598|FG006|Part 1 Treatment Phase|Adverse Event|0|||
127861926|NCT02185040|460110592|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
127913826|NCT00725322|460308051|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
127913827|NCT00725322|460308050|FG000|Washout (28 Days)|Protocol Violation|0|||
127861927|NCT02185040|460110593|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
127861928|NCT02185040|460110594|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
127861929|NCT02185040|460110595|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
127861930|NCT02185040|460110596|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
127913828|NCT00725322|460308051|FG001|Washout (28 Days)|Protocol Violation|1|||
127861931|NCT02185040|460110597|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
127861932|NCT02185040|460110598|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
127861933|NCT02185040|460110592|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
127861934|NCT02185040|460110593|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
127861935|NCT02185040|460110594|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
127861936|NCT02185040|460110595|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
127861937|NCT02185040|460110596|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
127861938|NCT02185040|460110597|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
127861939|NCT02185040|460110598|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
127861940|NCT02185040|460110592|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
127861941|NCT02185040|460110593|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
127861942|NCT02185040|460110594|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
127861943|NCT02185040|460110595|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
127861944|NCT02185040|460110596|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
127861945|NCT02185040|460110597|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
127861946|NCT02185040|460110598|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
127861947|NCT02185040|460110592|FG000|Active Treatment Extension Phase|Adverse Event|0|||
127861948|NCT02185040|460110593|FG001|Active Treatment Extension Phase|Adverse Event|0|||
127861949|NCT02185040|460110594|FG002|Active Treatment Extension Phase|Adverse Event|0|||
127861950|NCT02185040|460110595|FG003|Active Treatment Extension Phase|Adverse Event|0|||
127861951|NCT02185040|460110596|FG004|Active Treatment Extension Phase|Adverse Event|0|||
127861952|NCT02185040|460110597|FG005|Active Treatment Extension Phase|Adverse Event|1|||
127861953|NCT02185040|460110598|FG006|Active Treatment Extension Phase|Adverse Event|4|||
127861954|NCT02185040|460110592|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
127861955|NCT02185040|460110593|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
127861956|NCT02185040|460110594|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
127861957|NCT02185040|460110595|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
127861958|NCT02185040|460110596|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
127861959|NCT02185040|460110597|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
127861960|NCT02185040|460110598|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
127861961|NCT02185040|460110592|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
127861962|NCT02185040|460110593|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
127861963|NCT02185040|460110594|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
127861964|NCT02185040|460110595|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
127861965|NCT02185040|460110596|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
127861966|NCT02185040|460110597|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
127861967|NCT02185040|460110598|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
127861968|NCT03347279|460110599|FG000|Overall Study|Withdrawal by Subject|8|||
127861969|NCT03347279|460110600|FG001|Overall Study|Withdrawal by Subject|15|||
127861970|NCT03347279|460110599|FG000|Overall Study|Death|0|||
127861971|NCT03347279|460110600|FG001|Overall Study|Death|2|||
127861972|NCT03347279|460110599|FG000|Overall Study|Lost to Follow-up|5|||
127861973|NCT03347279|460110600|FG001|Overall Study|Lost to Follow-up|2|||
127861974|NCT03347279|460110599|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
127861975|NCT03347279|460110600|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
127861976|NCT03818399|460110603|FG000|Overall Study|Lost to Follow-up|11|||
127861977|NCT03818399|460110603|FG000|Overall Study|Withdrawal by Subject|1|||
127861978|NCT03818399|460110603|FG000|Overall Study|Protocol Violation|2|||
127861979|NCT03557801|460110606|FG000|Overall Study|Protocol Violation|1|||
127913829|NCT01279486|460308052|FG000|Overall Study|Lost to Follow-up|1|||
127913830|NCT04198363|460308056|FG000|Overall Study|Adverse Event|1|||
127913831|NCT04198363|460308057|FG001|Overall Study|Adverse Event|1|||
127913832|NCT04198363|460308056|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
127913833|NCT04198363|460308057|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
127913834|NCT04198363|460308056|FG000|Overall Study|Reason not Specified|1|||
127913835|NCT04198363|460308057|FG001|Overall Study|Reason not Specified|0|||
127913836|NCT03067987|460308059|FG000|Overall Study|Lost to Follow-up|7|||
127913837|NCT03067987|460308060|FG001|Overall Study|Lost to Follow-up|10|||
127913838|NCT03067987|460308059|FG000|Overall Study|Protocol Violation|1|||
127913839|NCT03067987|460308060|FG001|Overall Study|Protocol Violation|2|||
127913840|NCT03067987|460308059|FG000|Overall Study|Withdrawal by Subject|2|||
127913841|NCT03067987|460308060|FG001|Overall Study|Withdrawal by Subject|1|||
127913842|NCT01404988|460308063|FG000|Overall Study|Death|2|||
127913843|NCT01404988|460308064|FG001|Overall Study|Death|0|||
127861980|NCT03557801|460110607|FG001|Overall Study|Protocol Violation|0|||
127861981|NCT03557801|460110608|FG002|Overall Study|Protocol Violation|0|||
127861982|NCT03557801|460110606|FG000|Overall Study|Withdrawal by Subject|1|||
127861983|NCT03557801|460110607|FG001|Overall Study|Withdrawal by Subject|0|||
127861984|NCT03557801|460110608|FG002|Overall Study|Withdrawal by Subject|3|||
127861985|NCT03557801|460110606|FG000|Overall Study|Lost to Follow-up|0|||
127861986|NCT03557801|460110607|FG001|Overall Study|Lost to Follow-up|1|||
127861987|NCT03557801|460110608|FG002|Overall Study|Lost to Follow-up|0|||
127913844|NCT01404988|460308065|FG002|Overall Study|Death|2|||
127913845|NCT01404988|460308063|FG000|Overall Study|Adverse Event|1|||
127913846|NCT01404988|460308064|FG001|Overall Study|Adverse Event|0|||
127861988|NCT00141297|460110609|FG000|Overall Study|Adverse Event|0|||
127861989|NCT00141297|460110610|FG001|Overall Study|Adverse Event|0|||
127861990|NCT00141297|460110611|FG002|Overall Study|Adverse Event|1|||
127913847|NCT01404988|460308065|FG002|Overall Study|Adverse Event|0|||
127913848|NCT01404988|460308063|FG000|Overall Study|Withdrawal by Subject|2|||
127913849|NCT01404988|460308064|FG001|Overall Study|Withdrawal by Subject|2|||
127913850|NCT01404988|460308065|FG002|Overall Study|Withdrawal by Subject|0|||
127913851|NCT01404988|460308063|FG000|Overall Study|Lost to Follow-up|1|||
127913852|NCT01404988|460308064|FG001|Overall Study|Lost to Follow-up|2|||
127913853|NCT01404988|460308065|FG002|Overall Study|Lost to Follow-up|1|||
127913854|NCT00829764|460308066|FG000|First Intervention|Adverse Event|1|||
127913855|NCT00829764|460308067|FG001|First Intervention|Adverse Event|0|||
127913856|NCT00829764|460308066|FG000|First Intervention|Withdrawal by Subject|1|||
127913857|NCT00829764|460308067|FG001|First Intervention|Withdrawal by Subject|1|||
127913858|NCT04594252|460308068|FG000|Overall Study|Adverse Event|0|||
127913859|NCT04594252|460308069|FG001|Overall Study|Adverse Event|2|||
127913860|NCT03578809|460310439|FG000|Overall Study|Death|0|||
127913861|NCT03578809|460310440|FG001|Overall Study|Death|2|||
127913862|NCT03578809|460310441|FG002|Overall Study|Death|0|||
127913863|NCT03578809|460310442|FG003|Overall Study|Death|1|||
127913864|NCT03578809|460310439|FG000|Overall Study|Lost to Follow-up|0|||
127913865|NCT03578809|460310440|FG001|Overall Study|Lost to Follow-up|1|||
127913866|NCT03578809|460310441|FG002|Overall Study|Lost to Follow-up|0|||
127913867|NCT03578809|460310442|FG003|Overall Study|Lost to Follow-up|0|||
127913868|NCT03578809|460310439|FG000|Overall Study|Withdrawal by Subject|3|||
127913869|NCT03578809|460310440|FG001|Overall Study|Withdrawal by Subject|5|||
127913870|NCT03578809|460310441|FG002|Overall Study|Withdrawal by Subject|2|||
127913871|NCT03578809|460310442|FG003|Overall Study|Withdrawal by Subject|0|||
127913872|NCT03578809|460310439|FG000|Overall Study|Other|3|||
127913873|NCT03578809|460310440|FG001|Overall Study|Other|6|||
127913874|NCT03578809|460310441|FG002|Overall Study|Other|2|||
127913875|NCT03578809|460310442|FG003|Overall Study|Other|8|||
127913876|NCT02997176|460310447|FG000|Overall Study|Adverse Event|0|||
127913877|NCT02997176|460310448|FG001|Overall Study|Adverse Event|0|||
127913878|NCT02997176|460310449|FG002|Overall Study|Adverse Event|0|||
127913879|NCT02997176|460310450|FG003|Overall Study|Adverse Event|8|||
127913880|NCT02997176|460310447|FG000|Overall Study|Progressive Disease|1|||
127913881|NCT02997176|460310448|FG001|Overall Study|Progressive Disease|0|||
127913882|NCT02997176|460310449|FG002|Overall Study|Progressive Disease|1|||
127913883|NCT02997176|460310450|FG003|Overall Study|Progressive Disease|1|||
127913884|NCT02997176|460310447|FG000|Overall Study|Death|0|||
127913885|NCT02997176|460310448|FG001|Overall Study|Death|0|||
127913886|NCT02997176|460310449|FG002|Overall Study|Death|1|||
127913887|NCT02997176|460310450|FG003|Overall Study|Death|1|||
127913888|NCT02997176|460310447|FG000|Overall Study|Withdrawal by Subject|0|||
127913889|NCT02997176|460310448|FG001|Overall Study|Withdrawal by Subject|2|||
127913890|NCT02997176|460310449|FG002|Overall Study|Withdrawal by Subject|0|||
127913891|NCT02997176|460310450|FG003|Overall Study|Withdrawal by Subject|1|||
127913892|NCT00373256|460310451|FG000|Overall Study|Adverse Event (AE)|1|||
127913893|NCT00373256|460310452|FG001|Overall Study|Adverse Event (AE)|5|||
127913894|NCT00373256|460310451|FG000|Overall Study|Lost to Follow-up|2|||
127913895|NCT00373256|460310452|FG001|Overall Study|Lost to Follow-up|1|||
127913896|NCT00373256|460310451|FG000|Overall Study|Death|9|||
127913897|NCT00373256|460310452|FG001|Overall Study|Death|8|||
127913898|NCT00373256|460310451|FG000|Overall Study|Objective Progression or Relapse|111|||
127913899|NCT00373256|460310452|FG001|Overall Study|Objective Progression or Relapse|104|||
127913900|NCT00373256|460310451|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
127913901|NCT00373256|460310452|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
127913902|NCT00373256|460310451|FG000|Overall Study|Other|73|||
127913903|NCT00373256|460310452|FG001|Overall Study|Other|107|||
127913904|NCT00373256|460310451|FG000|Overall Study|Protocol Violation|0|||
127913905|NCT00373256|460310452|FG001|Overall Study|Protocol Violation|2|||
127913906|NCT00373256|460310451|FG000|Overall Study|Study Terminated by Sponsor|41|||
127913907|NCT00373256|460310452|FG001|Overall Study|Study Terminated by Sponsor|13|||
127913908|NCT04241458|460310453|FG000|Overall Study|Withdrawal by Subject|0|||
127913909|NCT04241458|460310454|FG001|Overall Study|Withdrawal by Subject|0|||
127913910|NCT04241458|460310455|FG002|Overall Study|Withdrawal by Subject|0|||
127913911|NCT04241458|460310456|FG003|Overall Study|Withdrawal by Subject|0|||
127913912|NCT04241458|460310457|FG004|Overall Study|Withdrawal by Subject|1|||
127913913|NCT06144424|460310458|FG000|Overall Study|Withdrawal by Subject|2|||
127913914|NCT06144424|460310459|FG001|Overall Study|Withdrawal by Subject|0|||
127913915|NCT06144424|460310458|FG000|Overall Study|Incarceration|1|||
127913916|NCT06144424|460310459|FG001|Overall Study|Incarceration|0|||
127913917|NCT02727192|460310460|FG000|Overall Study|Lost to Follow-up|1|||
127913918|NCT02727192|460310461|FG001|Overall Study|Lost to Follow-up|0|||
127913919|NCT02727192|460310462|FG002|Overall Study|Lost to Follow-up|0|||
127913920|NCT00928057|460310463|FG000|Overall Study|Adverse Event|1|||
127913921|NCT00928057|460310464|FG001|Overall Study|Adverse Event|2|||
127913922|NCT00928057|460310463|FG000|Overall Study|Withdrawal by Subject|1|||
127913923|NCT00928057|460310464|FG001|Overall Study|Withdrawal by Subject|0|||
127913924|NCT00928057|460310463|FG000|Overall Study|Lost to Follow-up|0|||
127913925|NCT00928057|460310464|FG001|Overall Study|Lost to Follow-up|1|||
127913926|NCT00928057|460310463|FG000|Overall Study|Protocol Violation|0|||
127913927|NCT00928057|460310464|FG001|Overall Study|Protocol Violation|1|||
127913928|NCT05497557|460310473|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
127913929|NCT05497557|460310474|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
127913930|NCT05497557|460310475|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
127913931|NCT02752074|460310476|FG000|Overall Study|Lost to Follow-up|1|||
127913932|NCT02752074|460310477|FG001|Overall Study|Lost to Follow-up|4|||
127913933|NCT02752074|460310476|FG000|Overall Study|Death|146|||
127913934|NCT02752074|460310477|FG001|Overall Study|Death|129|||
127913935|NCT02752074|460310476|FG000|Overall Study|Withdrawal by Subject|9|||
127913936|NCT02752074|460310477|FG001|Overall Study|Withdrawal by Subject|10|||
127913937|NCT02392195|460310480|FG000|Overall Study|Lost to Follow-up|4|||
127913938|NCT02392195|460310480|FG000|Overall Study|Withdrawal by Subject|4|||
127913939|NCT00545792|460310483|FG000|Overall Study|Withdrawal by Subject|1|||
127913940|NCT03679598|460310485|FG000|Overall Study|Adverse Event|2|||
127913941|NCT03679598|460310486|FG001|Overall Study|Adverse Event|0|||
127913942|NCT01380782|460310491|FG000|Overall Study|Adverse Event|0|||
127913943|NCT01380782|460310492|FG001|Overall Study|Adverse Event|1|||
127913944|NCT01380782|460310493|FG002|Overall Study|Adverse Event|0|||
127913945|NCT01380782|460310494|FG003|Overall Study|Adverse Event|0|||
127913946|NCT01380782|460310491|FG000|Overall Study|Death|1|||
127913947|NCT01380782|460310492|FG001|Overall Study|Death|0|||
127913948|NCT01380782|460310493|FG002|Overall Study|Death|0|||
127913949|NCT01380782|460310494|FG003|Overall Study|Death|0|||
127913950|NCT01380782|460310491|FG000|Overall Study|Lack of Efficacy|10|||
127913951|NCT01380782|460310492|FG001|Overall Study|Lack of Efficacy|9|||
127913952|NCT01380782|460310493|FG002|Overall Study|Lack of Efficacy|10|||
127913953|NCT01380782|460310494|FG003|Overall Study|Lack of Efficacy|3|||
127913954|NCT01380782|460310491|FG000|Overall Study|Physician Decision|1|||
127913955|NCT01380782|460310492|FG001|Overall Study|Physician Decision|0|||
127913956|NCT01380782|460310493|FG002|Overall Study|Physician Decision|0|||
127913957|NCT01380782|460310494|FG003|Overall Study|Physician Decision|0|||
127913958|NCT01380782|460310491|FG000|Overall Study|Withdrawal by Subject|0|||
127913959|NCT01380782|460310492|FG001|Overall Study|Withdrawal by Subject|0|||
127913960|NCT01380782|460310493|FG002|Overall Study|Withdrawal by Subject|1|||
127913961|NCT01380782|460310494|FG003|Overall Study|Withdrawal by Subject|1|||
127913962|NCT01701063|460310497|FG000|Overall Study|Lost to Follow-up|0|||
127913963|NCT01701063|460310498|FG001|Overall Study|Lost to Follow-up|1|||
127913964|NCT01701063|460310499|FG002|Overall Study|Lost to Follow-up|0|||
127913965|NCT01701063|460310497|FG000|Overall Study|Withdrawal by Subject|0|||
127913966|NCT01701063|460310498|FG001|Overall Study|Withdrawal by Subject|0|||
127913967|NCT01701063|460310499|FG002|Overall Study|Withdrawal by Subject|1|||
127913968|NCT01701063|460310497|FG000|Overall Study|Other|0|||
127913969|NCT01701063|460310498|FG001|Overall Study|Other|0|||
127913970|NCT01701063|460310499|FG002|Overall Study|Other|1|||
127913971|NCT05387408|460310500|FG000|Overall Study|Lack of time and access to participants to complete the survey by the health fund administrators|4939|||
127913972|NCT03428750|460310501|FG000|Overall Study|Withdrawal by Subject|11|||
127913973|NCT03428750|460310502|FG001|Overall Study|Withdrawal by Subject|10|||
127913974|NCT03428750|460310501|FG000|Overall Study|Lost to Follow-up|3|||
127913975|NCT03428750|460310502|FG001|Overall Study|Lost to Follow-up|9|||
127913976|NCT03428750|460310501|FG000|Overall Study|Adverse Event|9|||
127913977|NCT03428750|460310502|FG001|Overall Study|Adverse Event|1|||
127913978|NCT03428750|460310501|FG000|Overall Study|Protocol Violation|1|||
127913979|NCT03428750|460310502|FG001|Overall Study|Protocol Violation|0|||
127913980|NCT03428750|460310501|FG000|Overall Study|Administrative|0|||
127913981|NCT03428750|460310502|FG001|Overall Study|Administrative|1|||
127913982|NCT01919112|460310503|FG000|Secondary Analysis-day 30|Death|1|||
127913983|NCT01919112|460310504|FG001|Secondary Analysis-day 30|Death|1|||
127913984|NCT01919112|460310505|FG002|Secondary Analysis-day 30|Death|1|||
127913985|NCT01919112|460310503|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
127913986|NCT01919112|460310504|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
127913987|NCT01919112|460310505|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
127913988|NCT02554877|460310506|FG000|Overall Study|Adverse Event|2|||
127913989|NCT02554877|460310507|FG001|Overall Study|Adverse Event|0|||
127913990|NCT02554877|460310508|FG002|Overall Study|Adverse Event|0|||
127913991|NCT02554877|460310509|FG003|Overall Study|Adverse Event|1|||
127913992|NCT02554877|460310506|FG000|Overall Study|Lost to Follow-up|1|||
127913993|NCT02554877|460310507|FG001|Overall Study|Lost to Follow-up|1|||
127913994|NCT02554877|460310508|FG002|Overall Study|Lost to Follow-up|1|||
127861991|NCT00141297|460110612|FG003|Overall Study|Adverse Event|0|||
127861992|NCT00141297|460110613|FG004|Overall Study|Adverse Event|1|||
127861993|NCT00141297|460110614|FG005|Overall Study|Adverse Event|1|||
127861994|NCT00141297|460110615|FG006|Overall Study|Adverse Event|0|||
127861995|NCT00141297|460110616|FG007|Overall Study|Adverse Event|1|||
127861996|NCT00141297|460110617|FG008|Overall Study|Adverse Event|1|||
127861997|NCT00141297|460110618|FG009|Overall Study|Adverse Event|0|||
127861998|NCT00141297|460110609|FG000|Overall Study|Death|1|||
127861999|NCT00141297|460110610|FG001|Overall Study|Death|0|||
127862000|NCT00141297|460110611|FG002|Overall Study|Death|0|||
127862001|NCT00141297|460110612|FG003|Overall Study|Death|0|||
127862002|NCT00141297|460110613|FG004|Overall Study|Death|0|||
127862003|NCT00141297|460110614|FG005|Overall Study|Death|0|||
127862004|NCT00141297|460110615|FG006|Overall Study|Death|0|||
127862005|NCT00141297|460110616|FG007|Overall Study|Death|0|||
127862006|NCT00141297|460110617|FG008|Overall Study|Death|1|||
127862007|NCT00141297|460110618|FG009|Overall Study|Death|0|||
127862008|NCT00141297|460110609|FG000|Overall Study|Withdrawal by Subject|0|||
127862009|NCT00141297|460110610|FG001|Overall Study|Withdrawal by Subject|0|||
127862010|NCT00141297|460110611|FG002|Overall Study|Withdrawal by Subject|0|||
127862011|NCT00141297|460110612|FG003|Overall Study|Withdrawal by Subject|0|||
127862012|NCT00141297|460110613|FG004|Overall Study|Withdrawal by Subject|0|||
127862013|NCT00141297|460110614|FG005|Overall Study|Withdrawal by Subject|0|||
127862014|NCT00141297|460110615|FG006|Overall Study|Withdrawal by Subject|0|||
127862015|NCT00141297|460110616|FG007|Overall Study|Withdrawal by Subject|0|||
127862016|NCT00141297|460110617|FG008|Overall Study|Withdrawal by Subject|1|||
127862017|NCT00141297|460110618|FG009|Overall Study|Withdrawal by Subject|0|||
127862018|NCT00141297|460110609|FG000|Overall Study|Other|0|||
127862019|NCT00141297|460110610|FG001|Overall Study|Other|0|||
127862020|NCT00141297|460110611|FG002|Overall Study|Other|0|||
127862021|NCT00141297|460110612|FG003|Overall Study|Other|1|||
127862022|NCT00141297|460110613|FG004|Overall Study|Other|5|||
127862023|NCT00141297|460110614|FG005|Overall Study|Other|0|||
127862024|NCT00141297|460110615|FG006|Overall Study|Other|0|||
127862025|NCT00141297|460110616|FG007|Overall Study|Other|0|||
127862026|NCT00141297|460110617|FG008|Overall Study|Other|2|||
127862027|NCT00141297|460110618|FG009|Overall Study|Other|0|||
127862028|NCT00141297|460110609|FG000|Overall Study|Progressive Disease|2|||
127862029|NCT00141297|460110610|FG001|Overall Study|Progressive Disease|3|||
127862030|NCT00141297|460110611|FG002|Overall Study|Progressive Disease|6|||
127862031|NCT00141297|460110612|FG003|Overall Study|Progressive Disease|2|||
127862032|NCT00141297|460110613|FG004|Overall Study|Progressive Disease|15|||
127862033|NCT00141297|460110614|FG005|Overall Study|Progressive Disease|2|||
127862034|NCT00141297|460110615|FG006|Overall Study|Progressive Disease|3|||
127862035|NCT00141297|460110616|FG007|Overall Study|Progressive Disease|3|||
127862036|NCT00141297|460110617|FG008|Overall Study|Progressive Disease|15|||
127862037|NCT00141297|460110618|FG009|Overall Study|Progressive Disease|6|||
127862038|NCT00141297|460110609|FG000|Overall Study|Transitioned|0|||
127862039|NCT00141297|460110610|FG001|Overall Study|Transitioned|0|||
127862040|NCT00141297|460110611|FG002|Overall Study|Transitioned|0|||
127862041|NCT00141297|460110612|FG003|Overall Study|Transitioned|0|||
127862042|NCT00141297|460110613|FG004|Overall Study|Transitioned|1|||
127862043|NCT00141297|460110614|FG005|Overall Study|Transitioned|0|||
127862044|NCT00141297|460110615|FG006|Overall Study|Transitioned|0|||
127862045|NCT00141297|460110616|FG007|Overall Study|Transitioned|0|||
127862046|NCT00141297|460110617|FG008|Overall Study|Transitioned|0|||
127862047|NCT00141297|460110618|FG009|Overall Study|Transitioned|0|||
127862048|NCT02200510|460110619|FG000|Overall Study|Death|1|||
127862049|NCT02200510|460110620|FG001|Overall Study|Death|1|||
127862050|NCT02200510|460110619|FG000|Overall Study|Protocol Violation|0|||
127862051|NCT02200510|460110620|FG001|Overall Study|Protocol Violation|1|||
127862052|NCT02200510|460110619|FG000|Overall Study|Lost to Follow-up|7|||
127862053|NCT02200510|460110620|FG001|Overall Study|Lost to Follow-up|1|||
127862054|NCT02200510|460110619|FG000|Overall Study|potential COI - joined study team|1|||
127862055|NCT02200510|460110620|FG001|Overall Study|potential COI - joined study team|0|||
127862056|NCT00290355|460110621|FG000|Overall Study|Serious adverse event|7|||
127862057|NCT00290355|460110622|FG001|Overall Study|Serious adverse event|4|||
127862058|NCT00290355|460110621|FG000|Overall Study|Study product reactogenicity|1|||
127862059|NCT00290355|460110622|FG001|Overall Study|Study product reactogenicity|0|||
127862060|NCT00290355|460110621|FG000|Overall Study|Protocol Violation|1|||
127862061|NCT00290355|460110622|FG001|Overall Study|Protocol Violation|0|||
127862062|NCT00290355|460110621|FG000|Overall Study|Withdrawal by Subject|2|||
127862063|NCT00290355|460110622|FG001|Overall Study|Withdrawal by Subject|0|||
127862064|NCT00290355|460110621|FG000|Overall Study|Migrated / moved from the study area|1|||
127862065|NCT00290355|460110622|FG001|Overall Study|Migrated / moved from the study area|0|||
127862066|NCT00290355|460110621|FG000|Overall Study|Lost to Follow-up|3|||
127862067|NCT00290355|460110622|FG001|Overall Study|Lost to Follow-up|1|||
127862068|NCT00290355|460110621|FG000|Overall Study|Other|2|||
127862069|NCT00290355|460110622|FG001|Overall Study|Other|0|||
127862070|NCT01542632|460110623|FG000|Overall Study|Withdrawal of Consent|0|||
127862071|NCT01542632|460110624|FG001|Overall Study|Withdrawal of Consent|0|||
127862072|NCT01542632|460110625|FG002|Overall Study|Withdrawal of Consent|0|||
127862073|NCT01542632|460110626|FG003|Overall Study|Withdrawal of Consent|2|||
127862074|NCT01542632|460110627|FG004|Overall Study|Withdrawal of Consent|3|||
127862075|NCT01542632|460110628|FG005|Overall Study|Withdrawal of Consent|0|||
127862076|NCT01542632|460110623|FG000|Overall Study|Adverse Event|0|||
127862077|NCT01542632|460110624|FG001|Overall Study|Adverse Event|0|||
127862078|NCT01542632|460110625|FG002|Overall Study|Adverse Event|1|||
127862079|NCT01542632|460110626|FG003|Overall Study|Adverse Event|0|||
127862080|NCT01542632|460110627|FG004|Overall Study|Adverse Event|0|||
127862081|NCT01542632|460110628|FG005|Overall Study|Adverse Event|0|||
127862082|NCT01542632|460110623|FG000|Overall Study|Lost to Follow-up|0|||
127862083|NCT01542632|460110624|FG001|Overall Study|Lost to Follow-up|1|||
127862084|NCT01542632|460110625|FG002|Overall Study|Lost to Follow-up|0|||
127862085|NCT01542632|460110626|FG003|Overall Study|Lost to Follow-up|0|||
127862086|NCT01542632|460110627|FG004|Overall Study|Lost to Follow-up|0|||
127862087|NCT01542632|460110628|FG005|Overall Study|Lost to Follow-up|0|||
127862088|NCT01542632|460110623|FG000|Overall Study|Sponsor/Investigator Decision|0|||
127862089|NCT01542632|460110624|FG001|Overall Study|Sponsor/Investigator Decision|0|||
127862090|NCT01542632|460110625|FG002|Overall Study|Sponsor/Investigator Decision|0|||
127862091|NCT01542632|460110626|FG003|Overall Study|Sponsor/Investigator Decision|0|||
127862092|NCT01542632|460110627|FG004|Overall Study|Sponsor/Investigator Decision|1|||
127862093|NCT01542632|460110628|FG005|Overall Study|Sponsor/Investigator Decision|0|||
127862094|NCT00033514|460110629|FG000|Overall Study|Lost to Follow-up|1|||
127862095|NCT00033514|460110630|FG001|Overall Study|Lost to Follow-up|1|||
127862096|NCT00033514|460110629|FG000|Overall Study|Withdrawal by Subject|0|||
127862097|NCT00033514|460110630|FG001|Overall Study|Withdrawal by Subject|3|||
127862098|NCT01072500|460110636|FG000|Overall Study|Death|2|||
127862099|NCT01072500|460110637|FG001|Overall Study|Death|2|||
127862100|NCT01072500|460110636|FG000|Overall Study|Lost to Follow-up|5|||
127862101|NCT01072500|460110637|FG001|Overall Study|Lost to Follow-up|2|||
127862102|NCT01072500|460110636|FG000|Overall Study|Withdrawal by Subject|17|||
127862103|NCT01072500|460110637|FG001|Overall Study|Withdrawal by Subject|10|||
127862104|NCT03798366|460110638|FG000|Overall Study|Lost to Follow-up|0|||
127862105|NCT03798366|460110639|FG001|Overall Study|Lost to Follow-up|1|||
127862106|NCT01642004|460110640|FG000|Randomization|Adverse Event unrelated to study drug|1|||
127862107|NCT01642004|460110641|FG001|Randomization|Adverse Event unrelated to study drug|0|||
127862108|NCT01642004|460110640|FG000|Randomization|Participant withdrew consent|1|||
127862109|NCT01642004|460110641|FG001|Randomization|Participant withdrew consent|6|||
127862110|NCT01642004|460110640|FG000|Randomization|No longer meets study criteria|2|||
127862111|NCT01642004|460110641|FG001|Randomization|No longer meets study criteria|2|||
127862112|NCT01642004|460110640|FG000|Treatment|Disease progression|95|||
127862113|NCT01642004|460110641|FG001|Treatment|Disease progression|79|||
127862114|NCT01642004|460110640|FG000|Treatment|Study drug toxicity|10|||
127862115|NCT01642004|460110641|FG001|Treatment|Study drug toxicity|13|||
127862116|NCT01642004|460110640|FG000|Treatment|Death|1|||
127862117|NCT01642004|460110641|FG001|Treatment|Death|1|||
127862118|NCT01642004|460110640|FG000|Treatment|Adverse event unrelated to study drug|9|||
127862119|NCT01642004|460110641|FG001|Treatment|Adverse event unrelated to study drug|13|||
127862120|NCT01642004|460110640|FG000|Treatment|Maximum clinical benefit|1|||
127862121|NCT01642004|460110641|FG001|Treatment|Maximum clinical benefit|9|||
127862122|NCT01642004|460110640|FG000|Treatment|Poor/non-compliance|1|||
127862123|NCT01642004|460110641|FG001|Treatment|Poor/non-compliance|0|||
127862124|NCT01642004|460110640|FG000|Treatment|No longer meets study criteria|1|||
127862125|NCT01642004|460110641|FG001|Treatment|No longer meets study criteria|2|||
127862126|NCT01642004|460110640|FG000|Treatment|Other reasons|2|||
127862127|NCT01642004|460110641|FG001|Treatment|Other reasons|0|||
127862128|NCT01642004|460110640|FG000|Treatment|Not reported|0|||
127862129|NCT01642004|460110641|FG001|Treatment|Not reported|3|||
127862130|NCT01642004|460110640|FG000|Treatment|Participant request to discontinue study treatment|6|||
127862131|NCT01642004|460110641|FG001|Treatment|Participant request to discontinue study treatment|4|||
127862132|NCT01642004|460110640|FG000|Treatment|Participant withdrew consent|5|||
127862133|NCT01642004|460110641|FG001|Treatment|Participant withdrew consent|5|||
127862134|NCT02192190|460110642|FG000|Overall Study|Adverse Event|1|||
127862135|NCT02192190|460110643|FG001|Overall Study|Adverse Event|1|||
127862136|NCT02192190|460110644|FG002|Overall Study|Adverse Event|0|||
127862137|NCT02192190|460110645|FG003|Overall Study|Adverse Event|0|||
127862138|NCT02192190|460110646|FG004|Overall Study|Adverse Event|0|||
127862139|NCT02192190|460110647|FG005|Overall Study|Adverse Event|0|||
127862140|NCT02192190|460110642|FG000|Overall Study|Lost to Follow-up|3|||
127862141|NCT02192190|460110643|FG001|Overall Study|Lost to Follow-up|3|||
127862142|NCT02192190|460110644|FG002|Overall Study|Lost to Follow-up|2|||
127862143|NCT02192190|460110645|FG003|Overall Study|Lost to Follow-up|1|||
127862144|NCT02192190|460110646|FG004|Overall Study|Lost to Follow-up|4|||
127862145|NCT02192190|460110647|FG005|Overall Study|Lost to Follow-up|3|||
127862146|NCT02192190|460110642|FG000|Overall Study|Physician Decision|2|||
127862147|NCT02192190|460110643|FG001|Overall Study|Physician Decision|0|||
127862148|NCT02192190|460110644|FG002|Overall Study|Physician Decision|0|||
127862149|NCT02192190|460110645|FG003|Overall Study|Physician Decision|0|||
127862150|NCT02192190|460110646|FG004|Overall Study|Physician Decision|0|||
127862151|NCT02192190|460110647|FG005|Overall Study|Physician Decision|0|||
127862152|NCT02192190|460110642|FG000|Overall Study|Terminated by Sponsor|43|||
127862153|NCT02192190|460110643|FG001|Overall Study|Terminated by Sponsor|23|||
127862154|NCT02192190|460110644|FG002|Overall Study|Terminated by Sponsor|20|||
127862155|NCT02192190|460110645|FG003|Overall Study|Terminated by Sponsor|23|||
127862156|NCT02192190|460110646|FG004|Overall Study|Terminated by Sponsor|21|||
127862157|NCT02192190|460110647|FG005|Overall Study|Terminated by Sponsor|23|||
127862158|NCT02192190|460110642|FG000|Overall Study|Withdrawal by Subject|4|||
127862159|NCT02192190|460110643|FG001|Overall Study|Withdrawal by Subject|1|||
127862160|NCT02192190|460110644|FG002|Overall Study|Withdrawal by Subject|2|||
127862161|NCT02192190|460110645|FG003|Overall Study|Withdrawal by Subject|1|||
127862162|NCT02192190|460110646|FG004|Overall Study|Withdrawal by Subject|5|||
127862163|NCT02192190|460110647|FG005|Overall Study|Withdrawal by Subject|3|||
127862164|NCT02192190|460110642|FG000|Overall Study|Could not Keep Visit Schedule|1|||
127862165|NCT02192190|460110643|FG001|Overall Study|Could not Keep Visit Schedule|0|||
127862166|NCT02192190|460110644|FG002|Overall Study|Could not Keep Visit Schedule|0|||
127862167|NCT02192190|460110645|FG003|Overall Study|Could not Keep Visit Schedule|0|||
127862168|NCT02192190|460110646|FG004|Overall Study|Could not Keep Visit Schedule|0|||
127862169|NCT02192190|460110647|FG005|Overall Study|Could not Keep Visit Schedule|0|||
127862170|NCT02192190|460110642|FG000|Overall Study|Positive Drug Screen|0|||
127862171|NCT02192190|460110643|FG001|Overall Study|Positive Drug Screen|0|||
127862172|NCT02192190|460110644|FG002|Overall Study|Positive Drug Screen|0|||
127862173|NCT02192190|460110645|FG003|Overall Study|Positive Drug Screen|1|||
127862174|NCT02192190|460110646|FG004|Overall Study|Positive Drug Screen|0|||
127862175|NCT02192190|460110647|FG005|Overall Study|Positive Drug Screen|0|||
127862176|NCT02192190|460110642|FG000|Overall Study|Inadequate Pain Relief|0|||
127862177|NCT02192190|460110643|FG001|Overall Study|Inadequate Pain Relief|1|||
127862178|NCT02192190|460110644|FG002|Overall Study|Inadequate Pain Relief|1|||
127862179|NCT02192190|460110645|FG003|Overall Study|Inadequate Pain Relief|0|||
127862180|NCT02192190|460110646|FG004|Overall Study|Inadequate Pain Relief|0|||
127862181|NCT02192190|460110647|FG005|Overall Study|Inadequate Pain Relief|0|||
127862182|NCT01657253|460110648|FG000|Overall Study|Lost to Follow-up|6|||
127862183|NCT01657253|460110649|FG001|Overall Study|Lost to Follow-up|5|||
127862184|NCT01657253|460110648|FG000|Overall Study|Withdrawal by Subject|11|||
127862185|NCT01657253|460110649|FG001|Overall Study|Withdrawal by Subject|12|||
127862186|NCT01657253|460110648|FG000|Overall Study|Adverse Event|0|||
127862187|NCT01657253|460110649|FG001|Overall Study|Adverse Event|1|||
127862188|NCT02447952|460110650|FG000|Overall Study|Adverse Event|2|||
127862189|NCT02447952|460110650|FG000|Overall Study|Physician Decision|1|||
127862190|NCT02447952|460110650|FG000|Overall Study|Withdrawal by Subject|4|||
127862191|NCT01603628|460110653|FG000|Overall Study|Personal Reasons|1|||
127862192|NCT01603628|460110654|FG001|Overall Study|Personal Reasons|1|||
127862193|NCT01603628|460110655|FG002|Overall Study|Personal Reasons|2|||
127862194|NCT01603628|460110653|FG000|Overall Study|Protocol Violation|1|||
127862195|NCT01603628|460110654|FG001|Overall Study|Protocol Violation|1|||
127862196|NCT01603628|460110655|FG002|Overall Study|Protocol Violation|0|||
127862197|NCT01603628|460110653|FG000|Overall Study|Lost to Follow-up|0|||
127862198|NCT01603628|460110654|FG001|Overall Study|Lost to Follow-up|1|||
127862199|NCT01603628|460110655|FG002|Overall Study|Lost to Follow-up|0|||
127862200|NCT01603628|460110653|FG000|Overall Study|Other Miscellaneous Reason|1|||
127862201|NCT01603628|460110654|FG001|Overall Study|Other Miscellaneous Reason|0|||
127862202|NCT01603628|460110655|FG002|Overall Study|Other Miscellaneous Reason|0|||
127862203|NCT00890201|460110657|FG000|Overall Study|Protocol Violation|5|||
127862204|NCT00890201|460110658|FG001|Overall Study|Protocol Violation|56|||
127862205|NCT02087241|460110659|FG000|Overall Study|Death|2|||
127862206|NCT02087241|460110660|FG001|Overall Study|Death|1|||
127862207|NCT02087241|460110661|FG002|Overall Study|Death|1|||
127862208|NCT02087241|460110662|FG003|Overall Study|Death|1|||
127862209|NCT02087241|460110659|FG000|Overall Study|Withdrawal by Subject|1|||
127862210|NCT02087241|460110660|FG001|Overall Study|Withdrawal by Subject|0|||
127862211|NCT02087241|460110661|FG002|Overall Study|Withdrawal by Subject|0|||
127913995|NCT02554877|460310509|FG003|Overall Study|Lost to Follow-up|2|||
127862212|NCT02087241|460110662|FG003|Overall Study|Withdrawal by Subject|1|||
127862213|NCT02087241|460110659|FG000|Overall Study|Progressive Disease|0|||
127862214|NCT02087241|460110660|FG001|Overall Study|Progressive Disease|0|||
127862215|NCT02087241|460110661|FG002|Overall Study|Progressive Disease|0|||
127862216|NCT02087241|460110662|FG003|Overall Study|Progressive Disease|1|||
127862217|NCT02087241|460110659|FG000|Overall Study|Study Terminated by Sponsor|0|||
127862218|NCT02087241|460110660|FG001|Overall Study|Study Terminated by Sponsor|2|||
127862219|NCT02087241|460110661|FG002|Overall Study|Study Terminated by Sponsor|0|||
127862220|NCT02087241|460110662|FG003|Overall Study|Study Terminated by Sponsor|4|||
127862221|NCT02181504|460110663|FG000|Overall Study|Adverse Event|1|||
127862222|NCT02181504|460110664|FG001|Overall Study|Adverse Event|1|||
127862223|NCT02181504|460110665|FG002|Overall Study|Adverse Event|1|||
127862224|NCT01289028|460110670|FG000|Overall Study|Progressive Disease|49|||
127862225|NCT01289028|460110670|FG000|Overall Study|Adverse Event|14|||
127862226|NCT01289028|460110670|FG000|Overall Study|Withdrawal by Subject|6|||
127862227|NCT01289028|460110670|FG000|Overall Study|Death|4|||
127862228|NCT01289028|460110670|FG000|Overall Study|Lack of Efficacy|2|||
127862229|NCT01289028|460110670|FG000|Overall Study|No longer required|2|||
127862230|NCT01289028|460110670|FG000|Overall Study|Lost to Follow-up|2|||
127862231|NCT01289028|460110670|FG000|Overall Study|New Cancer Therapy|2|||
127862232|NCT01289028|460110670|FG000|Overall Study|Abnormal Lab Value|1|||
127862233|NCT01289028|460110670|FG000|Overall Study|Missing reason for discon|1|||
127862234|NCT02120469|460110671|FG000|Overall Study|HER-2/neu-amplified|1|||
127862235|NCT02120469|460110672|FG001|Overall Study|HER-2/neu-amplified|0|||
127862236|NCT02120469|460110673|FG002|Overall Study|HER-2/neu-amplified|1|||
127862237|NCT03267576|460110678|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
127862238|NCT03267576|460110679|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
127862239|NCT03267576|460110678|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
127862240|NCT03267576|460110679|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
127862241|NCT01369069|460110680|FG000|Overall Study|Lost to Follow-up|8|||
127862242|NCT01369069|460110681|FG001|Overall Study|Lost to Follow-up|9|||
127862243|NCT01369069|460110680|FG000|Overall Study|Withdrawal by Subject|9|||
127862244|NCT01369069|460110681|FG001|Overall Study|Withdrawal by Subject|7|||
127862245|NCT00882362|460110682|FG000|Overall Study|Adverse Event|13|||
127862246|NCT00882362|460110683|FG001|Overall Study|Adverse Event|10|||
127862247|NCT00882362|460110682|FG000|Overall Study|Withdrawal by Subject|13|||
127862248|NCT00882362|460110683|FG001|Overall Study|Withdrawal by Subject|10|||
127862249|NCT00882362|460110682|FG000|Overall Study|Lack of Efficacy|3|||
127862250|NCT00882362|460110683|FG001|Overall Study|Lack of Efficacy|0|||
127862251|NCT00882362|460110682|FG000|Overall Study|Protocol Violation|7|||
127862252|NCT00882362|460110683|FG001|Overall Study|Protocol Violation|2|||
127862253|NCT00882362|460110682|FG000|Overall Study|Pregnancy|1|||
127862254|NCT00882362|460110683|FG001|Overall Study|Pregnancy|0|||
127862255|NCT00882362|460110682|FG000|Overall Study|Physician Decision|5|||
127862256|NCT00882362|460110683|FG001|Overall Study|Physician Decision|1|||
127862257|NCT00882362|460110682|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
127862258|NCT00882362|460110683|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
127862259|NCT00882362|460110682|FG000|Overall Study|change of residence or other commitments|5|||
127862260|NCT00882362|460110683|FG001|Overall Study|change of residence or other commitments|0|||
127862261|NCT01846208|460110684|FG000|Overall Study|Withdrew prior to treatment|1|||
127862262|NCT01846208|460110685|FG001|Overall Study|Withdrew prior to treatment|1|||
127862263|NCT01846208|460110686|FG002|Overall Study|Withdrew prior to treatment|1|||
127862264|NCT01846208|460110684|FG000|Overall Study|Dosing Symptoms|1|||
127862265|NCT01846208|460110685|FG001|Overall Study|Dosing Symptoms|2|||
127862266|NCT01846208|460110686|FG002|Overall Study|Dosing Symptoms|6|||
127862267|NCT01846208|460110684|FG000|Overall Study|Withdrawal by Subject|5|||
127862268|NCT01846208|460110685|FG001|Overall Study|Withdrawal by Subject|0|||
127862269|NCT01846208|460110686|FG002|Overall Study|Withdrawal by Subject|0|||
127862270|NCT01846208|460110684|FG000|Overall Study|Non-compliance|1|||
127862271|NCT01846208|460110685|FG001|Overall Study|Non-compliance|1|||
127862272|NCT01846208|460110686|FG002|Overall Study|Non-compliance|0|||
127862273|NCT01846208|460110684|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
127862274|NCT01846208|460110685|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
127862275|NCT01846208|460110686|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
127862276|NCT01846208|460110684|FG000|Overall Study|Refused SU OFC|0|||
127862277|NCT01846208|460110685|FG001|Overall Study|Refused SU OFC|0|||
127862278|NCT01846208|460110686|FG002|Overall Study|Refused SU OFC|1|||
127862279|NCT01268514|460110687|FG000|Overall Study|Adverse Event|20|||
127862280|NCT01268514|460110687|FG000|Overall Study|Death|8|||
127862281|NCT01268514|460110687|FG000|Overall Study|Lost to Follow-up|5|||
127862282|NCT01268514|460110687|FG000|Overall Study|Withdrawal by Subject|3|||
127862283|NCT01268514|460110687|FG000|Overall Study|Withdrawal by Surgeon|5|||
127862284|NCT01424306|460110688|FG000|Overall Study|Protocol Violation|0|||
127862285|NCT01424306|460110689|FG001|Overall Study|Protocol Violation|0|||
127862286|NCT01424306|460110690|FG002|Overall Study|Protocol Violation|0|||
127862287|NCT01424306|460110691|FG003|Overall Study|Protocol Violation|0|||
127862288|NCT01424306|460110692|FG004|Overall Study|Protocol Violation|1|||
127862289|NCT01424306|460110693|FG005|Overall Study|Protocol Violation|0|||
127862290|NCT01809327|460110701|FG000|Overall Study|Lost to Follow-up|5|||
127862291|NCT01809327|460110702|FG001|Overall Study|Lost to Follow-up|2|||
127862292|NCT01809327|460110703|FG002|Overall Study|Lost to Follow-up|4|||
127862293|NCT01809327|460110704|FG003|Overall Study|Lost to Follow-up|2|||
127862294|NCT01809327|460110705|FG004|Overall Study|Lost to Follow-up|3|||
127862295|NCT01809327|460110701|FG000|Overall Study|Withdrawal by Subject|6|||
127862296|NCT01809327|460110702|FG001|Overall Study|Withdrawal by Subject|4|||
127862297|NCT01809327|460110703|FG002|Overall Study|Withdrawal by Subject|4|||
127862298|NCT01809327|460110704|FG003|Overall Study|Withdrawal by Subject|2|||
127862299|NCT01809327|460110705|FG004|Overall Study|Withdrawal by Subject|5|||
127862300|NCT01809327|460110701|FG000|Overall Study|Adverse Event|4|||
127862301|NCT01809327|460110702|FG001|Overall Study|Adverse Event|3|||
127862302|NCT01809327|460110703|FG002|Overall Study|Adverse Event|7|||
127862303|NCT01809327|460110704|FG003|Overall Study|Adverse Event|4|||
127862304|NCT01809327|460110705|FG004|Overall Study|Adverse Event|8|||
127862305|NCT01809327|460110701|FG000|Overall Study|Death|1|||
127862306|NCT01809327|460110702|FG001|Overall Study|Death|0|||
127862307|NCT01809327|460110703|FG002|Overall Study|Death|0|||
127862308|NCT01809327|460110704|FG003|Overall Study|Death|0|||
127862309|NCT01809327|460110705|FG004|Overall Study|Death|0|||
127862310|NCT01809327|460110701|FG000|Overall Study|Protocol Violation|0|||
127862311|NCT01809327|460110702|FG001|Overall Study|Protocol Violation|1|||
127862312|NCT01809327|460110703|FG002|Overall Study|Protocol Violation|0|||
127862313|NCT01809327|460110704|FG003|Overall Study|Protocol Violation|0|||
127862314|NCT01809327|460110705|FG004|Overall Study|Protocol Violation|0|||
127862315|NCT01809327|460110701|FG000|Overall Study|Physician Decision|1|||
127862316|NCT01809327|460110702|FG001|Overall Study|Physician Decision|1|||
127862317|NCT01809327|460110703|FG002|Overall Study|Physician Decision|0|||
127862318|NCT01809327|460110704|FG003|Overall Study|Physician Decision|0|||
127862319|NCT01809327|460110705|FG004|Overall Study|Physician Decision|0|||
127913996|NCT02554877|460310506|FG000|Overall Study|Did not meet entrance criteria|0|||
127913997|NCT02554877|460310507|FG001|Overall Study|Did not meet entrance criteria|0|||
127913998|NCT02554877|460310508|FG002|Overall Study|Did not meet entrance criteria|1|||
127913999|NCT02554877|460310509|FG003|Overall Study|Did not meet entrance criteria|0|||
127914000|NCT02554877|460310506|FG000|Overall Study|No longer met eligibility criteria|1|||
127914001|NCT02554877|460310507|FG001|Overall Study|No longer met eligibility criteria|0|||
127914002|NCT02554877|460310508|FG002|Overall Study|No longer met eligibility criteria|1|||
127914003|NCT02554877|460310509|FG003|Overall Study|No longer met eligibility criteria|1|||
127914004|NCT02554877|460310506|FG000|Overall Study|Protocol Violation|3|||
127914005|NCT02554877|460310507|FG001|Overall Study|Protocol Violation|1|||
127914006|NCT02554877|460310508|FG002|Overall Study|Protocol Violation|1|||
127914007|NCT02554877|460310509|FG003|Overall Study|Protocol Violation|0|||
127914008|NCT02554877|460310506|FG000|Overall Study|Other|1|||
127914009|NCT02554877|460310507|FG001|Overall Study|Other|3|||
127914010|NCT02554877|460310508|FG002|Overall Study|Other|0|||
127914011|NCT02554877|460310509|FG003|Overall Study|Other|3|||
127914012|NCT02554877|460310506|FG000|Overall Study|Insufficient clinical response|4|||
127914013|NCT02554877|460310507|FG001|Overall Study|Insufficient clinical response|0|||
127914014|NCT02554877|460310508|FG002|Overall Study|Insufficient clinical response|0|||
127914015|NCT02554877|460310509|FG003|Overall Study|Insufficient clinical response|0|||
127914016|NCT02554877|460310506|FG000|Overall Study|No longer willing to participate|0|||
127914017|NCT02554877|460310507|FG001|Overall Study|No longer willing to participate|2|||
127914018|NCT02554877|460310508|FG002|Overall Study|No longer willing to participate|2|||
127914019|NCT02554877|460310509|FG003|Overall Study|No longer willing to participate|0|||
127914020|NCT00274651|460310510|FG000|Overall Study|Adverse Event|6|||
127914021|NCT00274651|460310511|FG001|Overall Study|Adverse Event|3|||
127914022|NCT00274651|460310510|FG000|Overall Study|Lack of Efficacy|13|||
127914023|NCT00274651|460310511|FG001|Overall Study|Lack of Efficacy|6|||
127914024|NCT00274651|460310510|FG000|Overall Study|Death|1|||
127914025|NCT00274651|460310511|FG001|Overall Study|Death|3|||
127914026|NCT00274651|460310510|FG000|Overall Study|Withdrawal by Subject|0|||
127914027|NCT00274651|460310511|FG001|Overall Study|Withdrawal by Subject|1|||
127914028|NCT00274651|460310510|FG000|Overall Study|Physician Decision|8|||
127914029|NCT00274651|460310511|FG001|Overall Study|Physician Decision|7|||
127914030|NCT04474405|460310512|FG000|Overall Study|Withdrawal by Subject|0|||
127914031|NCT04474405|460310513|FG001|Overall Study|Withdrawal by Subject|0|||
127862320|NCT01809327|460110701|FG000|Overall Study|Pregnancy|1|||
127862321|NCT01809327|460110702|FG001|Overall Study|Pregnancy|0|||
127914032|NCT04474405|460310514|FG002|Overall Study|Withdrawal by Subject|1|||
127914033|NCT04474405|460310515|FG003|Overall Study|Withdrawal by Subject|0|||
127914034|NCT04474405|460310516|FG004|Overall Study|Withdrawal by Subject|1|||
127914035|NCT04474405|460310517|FG005|Overall Study|Withdrawal by Subject|0|||
127914036|NCT04474405|460310512|FG000|Overall Study|Other|0|||
127914037|NCT04474405|460310513|FG001|Overall Study|Other|0|||
127914038|NCT04474405|460310514|FG002|Overall Study|Other|0|||
127914039|NCT04474405|460310515|FG003|Overall Study|Other|0|||
127914040|NCT04474405|460310516|FG004|Overall Study|Other|3|||
127914041|NCT04474405|460310517|FG005|Overall Study|Other|0|||
127914042|NCT00635648|460310518|FG000|Overall Study|Adverse Event|12|||
127914043|NCT00635648|460310518|FG000|Overall Study|Withdrawal by Subject|9|||
127914044|NCT00635648|460310518|FG000|Overall Study|Physician Decision|4|||
127914045|NCT00635648|460310518|FG000|Overall Study|Rapid progression of baseline disease|4|||
127862322|NCT01809327|460110703|FG002|Overall Study|Pregnancy|0|||
127862323|NCT01809327|460110704|FG003|Overall Study|Pregnancy|0|||
127862324|NCT01809327|460110705|FG004|Overall Study|Pregnancy|0|||
127862325|NCT01809327|460110701|FG000|Overall Study|Other|14|||
127862326|NCT01809327|460110702|FG001|Overall Study|Other|15|||
127914046|NCT00635648|460310518|FG000|Overall Study|Use of other antifungal agent needed|1|||
127862327|NCT01809327|460110703|FG002|Overall Study|Other|7|||
127862328|NCT01809327|460110704|FG003|Overall Study|Other|4|||
127862329|NCT01809327|460110705|FG004|Overall Study|Other|9|||
127862330|NCT03196973|460110706|FG000|Overall Study|Adverse Event|1|||
127914047|NCT00635648|460310518|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
127914048|NCT00635648|460310518|FG000|Overall Study|Noncompliance with protocol|1|||
127914049|NCT00635648|460310518|FG000|Overall Study|Other reason|2|||
127914050|NCT04547192|460310519|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
127914051|NCT04547192|460310520|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
127914052|NCT04547192|460310521|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
127914053|NCT04547192|460310522|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
127914054|NCT04547192|460310519|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
127914055|NCT04547192|460310520|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
127914056|NCT04547192|460310521|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
127914057|NCT04547192|460310522|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
127914058|NCT04547192|460310519|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
127914059|NCT04547192|460310520|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
127914060|NCT04547192|460310521|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
127914061|NCT04547192|460310522|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
127914062|NCT04547192|460310519|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
127914063|NCT04547192|460310520|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
127914064|NCT04547192|460310521|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
127914065|NCT04547192|460310522|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
127914066|NCT04547192|460310519|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
127914067|NCT04547192|460310520|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
127914068|NCT04547192|460310521|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
127914069|NCT04547192|460310522|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
127914070|NCT04194801|460310523|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
127914071|NCT04194801|460310524|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
127914072|NCT04194801|460310525|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
127914073|NCT04194801|460310523|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
127914074|NCT04194801|460310524|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
127914075|NCT04194801|460310525|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
127914076|NCT04194801|460310523|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
127914077|NCT04194801|460310524|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
127914078|NCT04194801|460310525|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
127914079|NCT04194801|460310523|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
127914080|NCT04194801|460310524|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
127914081|NCT04194801|460310525|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
127914082|NCT04194801|460310523|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
127914083|NCT04194801|460310524|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
127914084|NCT04194801|460310525|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
127914085|NCT04194801|460310523|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
127914086|NCT04194801|460310524|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
127914087|NCT04194801|460310525|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
127914088|NCT04194801|460310523|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
127914089|NCT04194801|460310524|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
127914090|NCT04194801|460310525|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
127914091|NCT04194801|460310523|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
127914092|NCT04194801|460310524|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
127914093|NCT04194801|460310525|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
127914094|NCT04194801|460310523|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
127914095|NCT04194801|460310524|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
127914096|NCT04194801|460310525|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
127914097|NCT04194801|460310523|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
127914098|NCT04194801|460310524|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
127914099|NCT04194801|460310525|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
127914100|NCT04194801|460310523|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
127914101|NCT04194801|460310524|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
127914102|NCT04194801|460310525|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
127914103|NCT04194801|460310523|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
127914104|NCT04194801|460310524|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
127914105|NCT04194801|460310525|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
127914106|NCT04194801|460310523|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
127914107|NCT04194801|460310524|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
127914108|NCT04194801|460310525|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
127914109|NCT04194801|460310523|FG000|Part Ib/II End of Study|Death|2|||
127914110|NCT04194801|460310524|FG001|Part Ib/II End of Study|Death|3|||
127914111|NCT04194801|460310525|FG002|Part Ib/II End of Study|Death|3|||
127914112|NCT04194801|460310523|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
127914113|NCT04194801|460310524|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
127862331|NCT03196973|460110707|FG001|Overall Study|Adverse Event|1|||
127862332|NCT03196973|460110708|FG002|Overall Study|Adverse Event|2|||
127862333|NCT03196973|460110706|FG000|Overall Study|Lack of Efficacy|2|||
127862334|NCT03196973|460110707|FG001|Overall Study|Lack of Efficacy|6|||
127862335|NCT03196973|460110708|FG002|Overall Study|Lack of Efficacy|1|||
127862336|NCT03196973|460110706|FG000|Overall Study|Lost to Follow-up|4|||
127862337|NCT03196973|460110707|FG001|Overall Study|Lost to Follow-up|3|||
127862338|NCT03196973|460110708|FG002|Overall Study|Lost to Follow-up|2|||
127862339|NCT03196973|460110706|FG000|Overall Study|Consent withdrawn|2|||
127862340|NCT03196973|460110707|FG001|Overall Study|Consent withdrawn|1|||
127862341|NCT03196973|460110708|FG002|Overall Study|Consent withdrawn|0|||
127862342|NCT03196973|460110706|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
127862343|NCT03196973|460110707|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
127862344|NCT03196973|460110708|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
127862345|NCT03344562|460110709|FG000|Overall Study|Withdrawal by Subject|2|||
127862346|NCT03344562|460110710|FG001|Overall Study|Withdrawal by Subject|0|||
127862347|NCT02463331|460110719|FG000|Overall Study|Adverse Event|4|||
127862348|NCT02463331|460110720|FG001|Overall Study|Adverse Event|2|||
127862349|NCT02463331|460110719|FG000|Overall Study|Lost to Follow-up|1|||
127862350|NCT02463331|460110720|FG001|Overall Study|Lost to Follow-up|1|||
127862351|NCT02463331|460110719|FG000|Overall Study|Pregnancy|2|||
127862352|NCT02463331|460110720|FG001|Overall Study|Pregnancy|3|||
127862353|NCT02463331|460110719|FG000|Overall Study|Lack of Efficacy|6|||
127862354|NCT02463331|460110720|FG001|Overall Study|Lack of Efficacy|0|||
127862355|NCT02463331|460110719|FG000|Overall Study|Physician Decision|3|||
127862356|NCT02463331|460110720|FG001|Overall Study|Physician Decision|0|||
127862357|NCT02274766|460110721|FG000|Overall Study|Withdrawal by Subject|3|||
127862358|NCT02274766|460110722|FG001|Overall Study|Withdrawal by Subject|6|||
127862359|NCT02274766|460110721|FG000|Overall Study|Did Not Receive Study Drug|1|||
127862360|NCT02274766|460110722|FG001|Overall Study|Did Not Receive Study Drug|1|||
127862361|NCT02274766|460110721|FG000|Overall Study|Subject Unwilling to Proceed|0|||
127862362|NCT02274766|460110722|FG001|Overall Study|Subject Unwilling to Proceed|1|||
127862363|NCT02274766|460110721|FG000|Overall Study|Adverse Event|0|||
127862364|NCT02274766|460110722|FG001|Overall Study|Adverse Event|1|||
127862365|NCT02583399|460112532|FG000|Overall Study|Able to be discharged|3|||
127862366|NCT02583399|460112532|FG000|Overall Study|Wanted to use a restricted medication|3|||
127862367|NCT02759939|460112537|FG000|Overall Study|Missing data on first outcome assessed|11|||
127862368|NCT02759939|460112538|FG001|Overall Study|Missing data on first outcome assessed|2|||
127862369|NCT02759939|460112539|FG002|Overall Study|Missing data on first outcome assessed|5|||
127862370|NCT02759939|460112540|FG003|Overall Study|Missing data on first outcome assessed|2|||
127862371|NCT02759939|460112537|FG000|Overall Study|Ineligible for T2 and T3|310|||
127862372|NCT02759939|460112538|FG001|Overall Study|Ineligible for T2 and T3|179|||
127862373|NCT02759939|460112539|FG002|Overall Study|Ineligible for T2 and T3|366|||
127862374|NCT02759939|460112540|FG003|Overall Study|Ineligible for T2 and T3|391|||
127862375|NCT02759939|460112537|FG000|Overall Study|Lost to Follow-up|735|||
127862376|NCT02759939|460112538|FG001|Overall Study|Lost to Follow-up|791|||
127862377|NCT02759939|460112539|FG002|Overall Study|Lost to Follow-up|783|||
127862378|NCT02759939|460112540|FG003|Overall Study|Lost to Follow-up|650|||
127862379|NCT00535236|460112542|FG000|Overall Study|Adverse Event|1|||
127862380|NCT00535236|460112543|FG001|Overall Study|Adverse Event|0|||
127862381|NCT00535236|460112544|FG002|Overall Study|Adverse Event|9|||
127862382|NCT00535236|460112545|FG003|Overall Study|Adverse Event|3|||
127862383|NCT00535236|460112546|FG004|Overall Study|Adverse Event|3|||
127862384|NCT00535236|460112547|FG005|Overall Study|Adverse Event|0|||
127862385|NCT00535236|460112548|FG006|Overall Study|Adverse Event|5|||
127862386|NCT00535236|460112549|FG007|Overall Study|Adverse Event|1|||
127862387|NCT00535236|460112550|FG008|Overall Study|Adverse Event|2|||
127862388|NCT00535236|460112551|FG009|Overall Study|Adverse Event|1|||
127862389|NCT00535236|460112542|FG000|Overall Study|Lost to Follow-up|1|||
127862390|NCT00535236|460112543|FG001|Overall Study|Lost to Follow-up|2|||
127862391|NCT00535236|460112544|FG002|Overall Study|Lost to Follow-up|0|||
127862392|NCT00535236|460112545|FG003|Overall Study|Lost to Follow-up|0|||
127862393|NCT00535236|460112546|FG004|Overall Study|Lost to Follow-up|2|||
127862394|NCT00535236|460112547|FG005|Overall Study|Lost to Follow-up|0|||
127862395|NCT00535236|460112548|FG006|Overall Study|Lost to Follow-up|0|||
127862396|NCT00535236|460112549|FG007|Overall Study|Lost to Follow-up|0|||
127862397|NCT00535236|460112550|FG008|Overall Study|Lost to Follow-up|6|||
127862398|NCT00535236|460112551|FG009|Overall Study|Lost to Follow-up|1|||
127862399|NCT00535236|460112542|FG000|Overall Study|Physician Decision|0|||
127862400|NCT00535236|460112543|FG001|Overall Study|Physician Decision|0|||
127862401|NCT00535236|460112544|FG002|Overall Study|Physician Decision|0|||
127862402|NCT00535236|460112545|FG003|Overall Study|Physician Decision|0|||
127862403|NCT00535236|460112546|FG004|Overall Study|Physician Decision|1|||
127862404|NCT00535236|460112547|FG005|Overall Study|Physician Decision|0|||
127862405|NCT00535236|460112548|FG006|Overall Study|Physician Decision|1|||
127862406|NCT00535236|460112549|FG007|Overall Study|Physician Decision|0|||
127862407|NCT00535236|460112550|FG008|Overall Study|Physician Decision|0|||
127862408|NCT00535236|460112551|FG009|Overall Study|Physician Decision|0|||
127862409|NCT00535236|460112542|FG000|Overall Study|Protocol Violation|2|||
127862410|NCT00535236|460112543|FG001|Overall Study|Protocol Violation|0|||
127862411|NCT00535236|460112544|FG002|Overall Study|Protocol Violation|1|||
127862412|NCT00535236|460112545|FG003|Overall Study|Protocol Violation|0|||
127862413|NCT00535236|460112546|FG004|Overall Study|Protocol Violation|0|||
127862414|NCT00535236|460112547|FG005|Overall Study|Protocol Violation|0|||
127862415|NCT00535236|460112548|FG006|Overall Study|Protocol Violation|0|||
127862416|NCT00535236|460112549|FG007|Overall Study|Protocol Violation|0|||
127862417|NCT00535236|460112550|FG008|Overall Study|Protocol Violation|1|||
127862418|NCT00535236|460112551|FG009|Overall Study|Protocol Violation|0|||
127862419|NCT00535236|460112542|FG000|Overall Study|Withdrawal by Subject|3|||
127862420|NCT00535236|460112543|FG001|Overall Study|Withdrawal by Subject|0|||
127862421|NCT00535236|460112544|FG002|Overall Study|Withdrawal by Subject|2|||
127862422|NCT00535236|460112545|FG003|Overall Study|Withdrawal by Subject|1|||
127862423|NCT00535236|460112546|FG004|Overall Study|Withdrawal by Subject|6|||
127862424|NCT00535236|460112547|FG005|Overall Study|Withdrawal by Subject|1|||
127862425|NCT00535236|460112548|FG006|Overall Study|Withdrawal by Subject|5|||
127862426|NCT00535236|460112549|FG007|Overall Study|Withdrawal by Subject|0|||
127862427|NCT00535236|460112550|FG008|Overall Study|Withdrawal by Subject|4|||
127862428|NCT00535236|460112551|FG009|Overall Study|Withdrawal by Subject|2|||
127862429|NCT04554394|460112553|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
127862430|NCT04554394|460112554|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
127862431|NCT04554394|460112553|FG000|Overall Study|Withdrawal by Subject|2|||
127862432|NCT04554394|460112554|FG001|Overall Study|Withdrawal by Subject|2|||
127862433|NCT04554394|460112553|FG000|Overall Study|Lost to Follow-up|2|||
127862434|NCT04554394|460112554|FG001|Overall Study|Lost to Follow-up|2|||
127862435|NCT04554394|460112553|FG000|Overall Study|Physician Decision|1|||
127862436|NCT04554394|460112554|FG001|Overall Study|Physician Decision|1|||
127862437|NCT00886587|460112555|FG000|Overall Study|Adverse Event|2|||
127862438|NCT00886587|460112556|FG001|Overall Study|Adverse Event|1|||
127862439|NCT00886587|460112555|FG000|Overall Study|Protocol Violation|2|||
127862440|NCT00886587|460112556|FG001|Overall Study|Protocol Violation|0|||
127862441|NCT00886587|460112555|FG000|Overall Study|Withdrawal by Subject|0|||
127862442|NCT00886587|460112556|FG001|Overall Study|Withdrawal by Subject|1|||
127862443|NCT03099304|460112558|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
127862444|NCT03099304|460112559|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
127862445|NCT03099304|460112560|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
127862446|NCT03099304|460112561|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
127862447|NCT03099304|460112562|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
127862448|NCT03099304|460112563|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
127862449|NCT03099304|460112558|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
127862450|NCT03099304|460112559|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
127862451|NCT03099304|460112560|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
127862452|NCT03099304|460112561|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
127862453|NCT03099304|460112562|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
127862454|NCT03099304|460112563|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
127862455|NCT03099304|460112558|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
127862456|NCT03099304|460112559|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
127862457|NCT03099304|460112560|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
127862458|NCT03099304|460112561|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
127862459|NCT03099304|460112562|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
127862460|NCT03099304|460112563|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
127862461|NCT03099304|460112558|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
127862462|NCT03099304|460112559|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
127862463|NCT03099304|460112560|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
127862464|NCT03099304|460112561|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
127862465|NCT03099304|460112562|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
127862466|NCT03099304|460112563|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
127862467|NCT03099304|460112558|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
127862468|NCT03099304|460112559|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
127862469|NCT03099304|460112560|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
127862470|NCT03099304|460112561|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
127862471|NCT03099304|460112562|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
127862472|NCT03099304|460112563|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
127862473|NCT03099304|460112558|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
127862474|NCT03099304|460112559|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
127862475|NCT03099304|460112560|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
127862476|NCT03099304|460112561|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
127862477|NCT03099304|460112562|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
127862478|NCT03099304|460112563|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
127862479|NCT03099304|460112558|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
127862480|NCT03099304|460112559|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
127862481|NCT03099304|460112560|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
127862482|NCT03099304|460112561|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
127862483|NCT03099304|460112562|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
127862484|NCT03099304|460112563|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
127862485|NCT03099304|460112558|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
127862486|NCT03099304|460112559|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
127862487|NCT03099304|460112560|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
127862488|NCT03099304|460112561|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
127862489|NCT03099304|460112562|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
127862490|NCT03099304|460112563|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
127862491|NCT03099304|460112558|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
127862492|NCT03099304|460112559|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
127862493|NCT03099304|460112560|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
127862494|NCT03099304|460112561|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
127862495|NCT03099304|460112562|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
127862496|NCT03099304|460112563|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
127862497|NCT03099304|460112558|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
127862498|NCT03099304|460112559|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
127862499|NCT03099304|460112560|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
127862500|NCT03099304|460112561|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
127862501|NCT03099304|460112562|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
127862502|NCT03099304|460112563|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
127862503|NCT03099304|460112558|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
127862504|NCT03099304|460112559|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
127862505|NCT03099304|460112560|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
127862506|NCT03099304|460112561|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
127862507|NCT03099304|460112562|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
127862508|NCT03099304|460112563|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
127862509|NCT03099304|460112558|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
127862510|NCT03099304|460112559|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
127862511|NCT03099304|460112560|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
127862512|NCT03099304|460112561|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
127862513|NCT03099304|460112562|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
127862514|NCT03099304|460112563|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
127862515|NCT03099304|460112558|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
127862516|NCT03099304|460112559|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
127862517|NCT03099304|460112560|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
127862518|NCT03099304|460112561|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
127862519|NCT03099304|460112562|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
127862520|NCT03099304|460112563|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
127862521|NCT03099304|460112558|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
127862522|NCT03099304|460112559|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
127862523|NCT03099304|460112560|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
127862524|NCT03099304|460112561|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
127862525|NCT03099304|460112562|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
127862526|NCT03099304|460112563|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
127862527|NCT03099304|460112558|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
127862528|NCT03099304|460112559|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
127862529|NCT03099304|460112560|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
127862530|NCT03099304|460112561|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
127862531|NCT03099304|460112562|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
127862532|NCT03099304|460112563|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
127862533|NCT03099304|460112558|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
127862534|NCT03099304|460112559|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
127862535|NCT03099304|460112560|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
127862536|NCT03099304|460112561|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
127862537|NCT03099304|460112562|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
127862538|NCT03099304|460112563|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
127862539|NCT03099304|460112558|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
127862540|NCT03099304|460112559|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
127862541|NCT03099304|460112560|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
127862542|NCT03099304|460112561|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
127862543|NCT03099304|460112562|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
127862544|NCT03099304|460112563|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
127862545|NCT02390362|460112569|FG000|Overall Study|Withdrawal by Subject|0|||
127862546|NCT02390362|460112570|FG001|Overall Study|Withdrawal by Subject|1|||
127862547|NCT04009824|460112571|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
127914114|NCT04194801|460310525|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
127914115|NCT04194801|460310523|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
127914116|NCT04194801|460310524|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
127914117|NCT04194801|460310525|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
127914118|NCT04194801|460310523|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
127914119|NCT04194801|460310524|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
127914120|NCT04194801|460310525|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
127914121|NCT04194801|460310523|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
127914122|NCT04194801|460310524|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
127914123|NCT04194801|460310525|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
127914124|NCT01923740|460310526|FG000|Overall Study|Lost to Follow-up|4|||
127914125|NCT01923740|460310527|FG001|Overall Study|Lost to Follow-up|9|||
127914126|NCT01923740|460310526|FG000|Overall Study|Withdrawal by Subject|2|||
127914127|NCT01923740|460310527|FG001|Overall Study|Withdrawal by Subject|0|||
127914128|NCT04723693|460310528|FG000|Overall Study|Withdrawal by Subject|2|||
127914129|NCT01410227|460310529|FG000|Overall Study|Adverse Event|1|||
127914130|NCT01410227|460310530|FG001|Overall Study|Adverse Event|0|||
127914131|NCT01410227|460310531|FG002|Overall Study|Adverse Event|0|||
127914132|NCT01410227|460310532|FG003|Overall Study|Adverse Event|0|||
127914133|NCT01410227|460310529|FG000|Overall Study|Withdrawal by Subject|3|||
127914134|NCT01410227|460310530|FG001|Overall Study|Withdrawal by Subject|0|||
127914135|NCT01410227|460310531|FG002|Overall Study|Withdrawal by Subject|1|||
127914136|NCT01410227|460310532|FG003|Overall Study|Withdrawal by Subject|0|||
127914137|NCT01410227|460310529|FG000|Overall Study|Pregnancy|0|||
127914138|NCT01410227|460310530|FG001|Overall Study|Pregnancy|0|||
127914139|NCT01410227|460310531|FG002|Overall Study|Pregnancy|0|||
127914140|NCT01410227|460310532|FG003|Overall Study|Pregnancy|1|||
127914141|NCT01410227|460310529|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
127914142|NCT01410227|460310530|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
127914143|NCT01410227|460310531|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
127914144|NCT01410227|460310532|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
127914145|NCT02890992|460310533|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
127914146|NCT02890992|460310534|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
127914147|NCT02890992|460310535|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
127914148|NCT02890992|460310536|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
127914149|NCT02890992|460310537|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
127914150|NCT02890992|460310538|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
127914151|NCT02890992|460310539|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
127914152|NCT02890992|460310540|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
127914153|NCT02890992|460310533|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
127914154|NCT02890992|460310534|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
127914155|NCT02890992|460310535|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
127914156|NCT02890992|460310536|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
127914157|NCT02890992|460310537|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
127914158|NCT02890992|460310538|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
127914159|NCT02890992|460310539|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
127914160|NCT02890992|460310540|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
127914161|NCT02890992|460310533|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
127914162|NCT02890992|460310534|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
127914163|NCT02890992|460310535|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
127914164|NCT02890992|460310536|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
127914165|NCT02890992|460310537|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
127914166|NCT02890992|460310538|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
127914167|NCT02890992|460310539|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
127914168|NCT02890992|460310540|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
127914169|NCT00669162|460310541|FG000|Overall Study|Withdrawal by Subject|1|||
127914170|NCT00807495|460310545|FG000|Overall Study|Adverse Event|6|||
127914171|NCT00807495|460310546|FG001|Overall Study|Adverse Event|3|||
127914172|NCT00807495|460310547|FG002|Overall Study|Adverse Event|1|||
127914173|NCT00807495|460310548|FG003|Overall Study|Adverse Event|1|||
127914174|NCT00807495|460310549|FG004|Overall Study|Adverse Event|2|||
127914175|NCT00807495|460310545|FG000|Overall Study|Withdrawal by Patient|2|||
127914176|NCT00807495|460310546|FG001|Overall Study|Withdrawal by Patient|0|||
127914177|NCT00807495|460310547|FG002|Overall Study|Withdrawal by Patient|1|||
127914178|NCT00807495|460310548|FG003|Overall Study|Withdrawal by Patient|0|||
127914179|NCT00807495|460310549|FG004|Overall Study|Withdrawal by Patient|0|||
127914180|NCT00807495|460310545|FG000|Overall Study|Reason Not Specified|0|||
127914181|NCT00807495|460310546|FG001|Overall Study|Reason Not Specified|3|||
127914182|NCT00807495|460310547|FG002|Overall Study|Reason Not Specified|2|||
127914183|NCT00807495|460310548|FG003|Overall Study|Reason Not Specified|0|||
127914184|NCT00807495|460310549|FG004|Overall Study|Reason Not Specified|3|||
127914185|NCT02412852|460310550|FG000|Overall Study|Withdrawal by Subject|0|||
127914186|NCT02412852|460310551|FG001|Overall Study|Withdrawal by Subject|1|||
127914187|NCT02412852|460310552|FG002|Overall Study|Withdrawal by Subject|0|||
127914188|NCT02412852|460310553|FG003|Overall Study|Withdrawal by Subject|0|||
127914189|NCT02412852|460310550|FG000|Overall Study|Physician Decision|0|||
127914190|NCT02412852|460310551|FG001|Overall Study|Physician Decision|0|||
127914191|NCT02412852|460310552|FG002|Overall Study|Physician Decision|0|||
127914192|NCT02412852|460310553|FG003|Overall Study|Physician Decision|1|||
127914193|NCT01174186|460310554|FG000|Overall Study|Lost to Follow-up|0|||
127914194|NCT01174186|460310555|FG001|Overall Study|Lost to Follow-up|1|||
127914195|NCT01174186|460310554|FG000|Overall Study|Withdrawal by Subject|0|||
127914196|NCT01174186|460310555|FG001|Overall Study|Withdrawal by Subject|2|||
127914197|NCT05274763|460310556|FG000|Overall Study|Lost to Follow-up|1|||
127914198|NCT01647828|460310558|FG000|Overall Study|Death|3|||
127914199|NCT01647828|460310559|FG001|Overall Study|Death|4|||
127914200|NCT01647828|460310560|FG002|Overall Study|Death|4|||
127914201|NCT01647828|460310561|FG003|Overall Study|Death|5|||
127914202|NCT01647828|460310562|FG004|Overall Study|Death|6|||
127914203|NCT01647828|460310563|FG005|Overall Study|Death|3|||
127914204|NCT01647828|460310564|FG006|Overall Study|Death|10|||
127914205|NCT01647828|460310565|FG007|Overall Study|Death|60|||
127914206|NCT01647828|460310566|FG008|Overall Study|Death|71|||
127914207|NCT01647828|460310558|FG000|Overall Study|Withdrawal by Subject|2|||
127914208|NCT01647828|460310559|FG001|Overall Study|Withdrawal by Subject|0|||
127914209|NCT01647828|460310560|FG002|Overall Study|Withdrawal by Subject|0|||
127914210|NCT01647828|460310561|FG003|Overall Study|Withdrawal by Subject|1|||
127862548|NCT04009824|460112572|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
127862549|NCT04009824|460112573|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
127862550|NCT04009824|460112574|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
127862551|NCT04009824|460112575|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
127862552|NCT01024946|460112576|FG000|Overall Study|Screen Failure|3|||
127862553|NCT01024946|460112576|FG000|Overall Study|Withdrawal by Subject|1|||
127862554|NCT01024946|460112576|FG000|Overall Study|Adverse Event|1|||
127862555|NCT01142791|460112588|FG000|Overall Study|Alternative Treatment|1|||
127862556|NCT01142791|460112589|FG001|Overall Study|Alternative Treatment|0|||
127862557|NCT01142791|460112588|FG000|Overall Study|Lost to Follow-up|1|||
127862558|NCT01142791|460112589|FG001|Overall Study|Lost to Follow-up|0|||
127862559|NCT01142791|460112588|FG000|Overall Study|Withdrawal by Subject|5|||
127862560|NCT01142791|460112589|FG001|Overall Study|Withdrawal by Subject|0|||
127862561|NCT01142791|460112588|FG000|Overall Study|Received only 1 sonication|0|||
127862562|NCT01142791|460112589|FG001|Overall Study|Received only 1 sonication|6|||
127862563|NCT02608892|460112590|FG000|Overall Study|Lost to Follow-up|1|||
127862564|NCT02608892|460112591|FG001|Overall Study|Lost to Follow-up|0|||
127862565|NCT03032523|460112592|FG000|Overall Study|Withdrawal by Subject|2|||
127862566|NCT03032523|460112593|FG001|Overall Study|Withdrawal by Subject|2|||
127862567|NCT03032523|460112592|FG000|Overall Study|Physician Decision|1|||
127862568|NCT03032523|460112593|FG001|Overall Study|Physician Decision|0|||
127862569|NCT02590406|460112594|FG000|Overall Study|Adverse Event|1|||
127862570|NCT02590406|460112595|FG001|Overall Study|Adverse Event|0|||
127862571|NCT02590406|460112594|FG000|Overall Study|Saturometer malfunction|0|||
127862572|NCT02590406|460112595|FG001|Overall Study|Saturometer malfunction|1|||
127862573|NCT00957723|460112598|FG000|Overall Study|Death|3|||
127862574|NCT00957723|460112598|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
127862575|NCT00957723|460112598|FG000|Overall Study|Lost to Follow-up|8|||
127862576|NCT00957723|460112598|FG000|Overall Study|Withdrawal by Subject|24|||
127862577|NCT00957723|460112598|FG000|Overall Study|Investigative Site Terminated|61|||
127862578|NCT00957723|460112598|FG000|Overall Study|Intercurrent Illness|2|||
127862579|NCT00957723|460112598|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
127862580|NCT05375838|460112599|FG000|Overall Study|Other|0|||
127862581|NCT05375838|460112600|FG001|Overall Study|Other|0|||
127862582|NCT05375838|460112601|FG002|Overall Study|Other|0|||
127862583|NCT05375838|460112602|FG003|Overall Study|Other|1|||
127862584|NCT05375838|460112603|FG004|Overall Study|Other|1|||
127862585|NCT05375838|460112604|FG005|Overall Study|Other|0|||
127862586|NCT05375838|460112599|FG000|Overall Study|Withdrawal by Subject|2|||
127862587|NCT05375838|460112600|FG001|Overall Study|Withdrawal by Subject|1|||
127862588|NCT05375838|460112601|FG002|Overall Study|Withdrawal by Subject|3|||
127862589|NCT05375838|460112602|FG003|Overall Study|Withdrawal by Subject|2|||
127862590|NCT05375838|460112603|FG004|Overall Study|Withdrawal by Subject|2|||
127862591|NCT05375838|460112604|FG005|Overall Study|Withdrawal by Subject|0|||
127862592|NCT05375838|460112599|FG000|Overall Study|Protocol Violation|0|||
127862593|NCT05375838|460112600|FG001|Overall Study|Protocol Violation|0|||
127862594|NCT05375838|460112601|FG002|Overall Study|Protocol Violation|0|||
127862595|NCT05375838|460112602|FG003|Overall Study|Protocol Violation|0|||
127862596|NCT05375838|460112603|FG004|Overall Study|Protocol Violation|1|||
127862597|NCT05375838|460112604|FG005|Overall Study|Protocol Violation|0|||
127862598|NCT05375838|460112599|FG000|Overall Study|Physician Decision|0|||
127862599|NCT05375838|460112600|FG001|Overall Study|Physician Decision|1|||
127862600|NCT05375838|460112601|FG002|Overall Study|Physician Decision|0|||
127862601|NCT05375838|460112602|FG003|Overall Study|Physician Decision|0|||
127862602|NCT05375838|460112603|FG004|Overall Study|Physician Decision|0|||
127862603|NCT05375838|460112604|FG005|Overall Study|Physician Decision|1|||
127862604|NCT05375838|460112599|FG000|Overall Study|Lost to Follow-up|2|||
127862605|NCT05375838|460112600|FG001|Overall Study|Lost to Follow-up|7|||
127862606|NCT05375838|460112601|FG002|Overall Study|Lost to Follow-up|0|||
127862607|NCT05375838|460112602|FG003|Overall Study|Lost to Follow-up|4|||
127862608|NCT05375838|460112603|FG004|Overall Study|Lost to Follow-up|2|||
127862609|NCT05375838|460112604|FG005|Overall Study|Lost to Follow-up|3|||
127862610|NCT00984009|460112605|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
127862611|NCT00281528|460112606|FG000|Overall Study|Progressive Disease|28|||
127862612|NCT00281528|460112607|FG001|Overall Study|Progressive Disease|18|||
127862613|NCT00281528|460112608|FG002|Overall Study|Progressive Disease|27|||
127862614|NCT00281528|460112606|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
127862615|NCT00281528|460112607|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
127862616|NCT00281528|460112608|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
127862617|NCT00281528|460112606|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
127862618|NCT00281528|460112607|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
127862619|NCT00281528|460112608|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
127862620|NCT00281528|460112606|FG000|Overall Study|Physician Decision|11|||
127862621|NCT00281528|460112607|FG001|Overall Study|Physician Decision|4|||
127862622|NCT00281528|460112608|FG002|Overall Study|Physician Decision|5|||
127862623|NCT00281528|460112606|FG000|Overall Study|Protocol Violation|1|||
127914211|NCT01647828|460310562|FG004|Overall Study|Withdrawal by Subject|0|||
127914212|NCT01647828|460310563|FG005|Overall Study|Withdrawal by Subject|0|||
127914213|NCT01647828|460310564|FG006|Overall Study|Withdrawal by Subject|1|||
127914214|NCT01647828|460310565|FG007|Overall Study|Withdrawal by Subject|0|||
127914215|NCT01647828|460310566|FG008|Overall Study|Withdrawal by Subject|2|||
127914216|NCT01647828|460310558|FG000|Overall Study|Study terminated by Sponsor|0|||
127914217|NCT01647828|460310559|FG001|Overall Study|Study terminated by Sponsor|0|||
127914218|NCT01647828|460310560|FG002|Overall Study|Study terminated by Sponsor|0|||
127914219|NCT01647828|460310561|FG003|Overall Study|Study terminated by Sponsor|0|||
127914220|NCT01647828|460310562|FG004|Overall Study|Study terminated by Sponsor|0|||
127914221|NCT01647828|460310563|FG005|Overall Study|Study terminated by Sponsor|0|||
127914222|NCT01647828|460310564|FG006|Overall Study|Study terminated by Sponsor|1|||
127914223|NCT01647828|460310565|FG007|Overall Study|Study terminated by Sponsor|26|||
127914224|NCT01647828|460310566|FG008|Overall Study|Study terminated by Sponsor|16|||
127914225|NCT01647828|460310558|FG000|Overall Study|Lost to Follow-up|0|||
127914226|NCT01647828|460310559|FG001|Overall Study|Lost to Follow-up|0|||
127914227|NCT01647828|460310560|FG002|Overall Study|Lost to Follow-up|0|||
127914228|NCT01647828|460310561|FG003|Overall Study|Lost to Follow-up|0|||
127914229|NCT01647828|460310562|FG004|Overall Study|Lost to Follow-up|0|||
127914230|NCT01647828|460310563|FG005|Overall Study|Lost to Follow-up|0|||
127914231|NCT01647828|460310564|FG006|Overall Study|Lost to Follow-up|0|||
127914232|NCT01647828|460310565|FG007|Overall Study|Lost to Follow-up|2|||
127914233|NCT01647828|460310566|FG008|Overall Study|Lost to Follow-up|0|||
127914234|NCT01906372|460310567|FG000|Overall Study|Withdrawal by Subject|2|||
127914235|NCT00624286|460310577|FG000|Overall Study|Protocol Deviation|7|||
127914236|NCT00624286|460310578|FG001|Overall Study|Protocol Deviation|9|||
127914237|NCT00624286|460310577|FG000|Overall Study|Adverse Event|6|||
127914238|NCT00624286|460310578|FG001|Overall Study|Adverse Event|3|||
127914239|NCT00624286|460310577|FG000|Overall Study|Withdrawal by Subject|5|||
127914240|NCT00624286|460310578|FG001|Overall Study|Withdrawal by Subject|4|||
127914241|NCT00624286|460310577|FG000|Overall Study|Lost to Follow-up|3|||
127914242|NCT00624286|460310578|FG001|Overall Study|Lost to Follow-up|2|||
127914243|NCT00624286|460310577|FG000|Overall Study|Administrative problems|3|||
127914244|NCT00624286|460310578|FG001|Overall Study|Administrative problems|0|||
127914245|NCT00624286|460310577|FG000|Overall Study|Lack of Efficacy|1|||
127914246|NCT00624286|460310578|FG001|Overall Study|Lack of Efficacy|6|||
127914247|NCT00624286|460310577|FG000|Overall Study|Not stated|0|||
127914248|NCT00624286|460310578|FG001|Overall Study|Not stated|1|||
127914249|NCT00624286|460310577|FG000|Overall Study|Abnormal test procedure result(s)|0|||
127914250|NCT00624286|460310578|FG001|Overall Study|Abnormal test procedure result(s)|1|||
127914251|NCT00624286|460310577|FG000|Overall Study|Death|0|||
127914252|NCT00624286|460310578|FG001|Overall Study|Death|1|||
127914253|NCT00841659|460310582|FG000|Washout: 2 Weeks|Protocol Violation|1|||
127914254|NCT00841659|460310583|FG001|Washout: 2 Weeks|Protocol Violation|0|||
127914255|NCT02054715|460310584|FG000|Baseline/Follow-up 1|Refused|1|||
127914256|NCT02054715|460310585|FG001|Baseline/Follow-up 1|Refused|3|||
127914257|NCT02054715|460310584|FG000|Baseline/Follow-up 1|Medical|0|||
127914258|NCT02054715|460310585|FG001|Baseline/Follow-up 1|Medical|1|||
127914259|NCT02054715|460310584|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
127914260|NCT02054715|460310585|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
127914261|NCT02054715|460310584|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
127914262|NCT02054715|460310585|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
127914263|NCT02054715|460310584|FG000|Baseline/Follow-up 1|No Reason|0|||
127914264|NCT02054715|460310585|FG001|Baseline/Follow-up 1|No Reason|1|||
127914265|NCT02054715|460310584|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
127914266|NCT02054715|460310585|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
127914267|NCT02054715|460310584|FG000|Baseline/Follow-up 1|Ineligible|3|||
127914268|NCT02054715|460310585|FG001|Baseline/Follow-up 1|Ineligible|0|||
127914269|NCT02054715|460310584|FG000|Baseline/Follow-up 1|Hospitalization|1|||
127914270|NCT02054715|460310585|FG001|Baseline/Follow-up 1|Hospitalization|0|||
127914271|NCT02054715|460310584|FG000|Baseline/Follow-up 1|Changed Mind|1|||
127914272|NCT02054715|460310585|FG001|Baseline/Follow-up 1|Changed Mind|0|||
127914273|NCT02054715|460310584|FG000|Follow-up 2|Lost to Followup|3|||
127914274|NCT02054715|460310585|FG001|Follow-up 2|Lost to Followup|1|||
127914275|NCT02054715|460310584|FG000|Follow-up 2|Refused|3|||
127914276|NCT02054715|460310585|FG001|Follow-up 2|Refused|2|||
127914277|NCT02054715|460310584|FG000|Follow-up 2|Followup Not Completed|3|||
127914278|NCT02054715|460310585|FG001|Follow-up 2|Followup Not Completed|4|||
127914279|NCT02054715|460310584|FG000|Follow-up 2|Ineligible|4|||
127914280|NCT02054715|460310585|FG001|Follow-up 2|Ineligible|5|||
127914281|NCT02054715|460310584|FG000|Follow-up 2|Death|3|||
127914282|NCT02054715|460310585|FG001|Follow-up 2|Death|3|||
127914283|NCT02054715|460310584|FG000|Follow-up 2|Hospitalization|0|||
127914284|NCT02054715|460310585|FG001|Follow-up 2|Hospitalization|2|||
127914285|NCT02054715|460310584|FG000|Follow-up 2|Changed MD/Facility|0|||
127914286|NCT02054715|460310585|FG001|Follow-up 2|Changed MD/Facility|1|||
127914287|NCT02054715|460310584|FG000|Follow-up 2|Changed Mind|0|||
127914288|NCT02054715|460310585|FG001|Follow-up 2|Changed Mind|1|||
127914289|NCT02054715|460310584|FG000|Follow-up 2|No Reason|2|||
127914290|NCT02054715|460310585|FG001|Follow-up 2|No Reason|0|||
127862624|NCT00281528|460112607|FG001|Overall Study|Protocol Violation|0|||
127862625|NCT00281528|460112608|FG002|Overall Study|Protocol Violation|1|||
127862626|NCT00281528|460112606|FG000|Overall Study|Withdrawal by Subject|5|||
127862627|NCT00281528|460112607|FG001|Overall Study|Withdrawal by Subject|5|||
127862628|NCT00281528|460112608|FG002|Overall Study|Withdrawal by Subject|7|||
127862629|NCT00281528|460112606|FG000|Overall Study|Other|6|||
127862630|NCT00281528|460112607|FG001|Overall Study|Other|3|||
127862631|NCT00281528|460112608|FG002|Overall Study|Other|5|||
127862632|NCT02036476|460112620|FG000|Overall Study|Withdrawal by Subject|2|||
127862633|NCT02036476|460112620|FG000|Overall Study|Progressive Disease|4|||
127862634|NCT02036476|460112620|FG000|Overall Study|Unacceptable Toxicity|2|||
127862635|NCT02168816|460112621|FG000|Overall Study|Lost to Follow-up|2|||
127862636|NCT02168816|460112622|FG001|Overall Study|Lost to Follow-up|2|||
127862637|NCT01984294|460112625|FG000|Overall Study|Randomized but Never Treated|0|||
127862638|NCT01984294|460112626|FG001|Overall Study|Randomized but Never Treated|0|||
127862639|NCT01984294|460112627|FG002|Overall Study|Randomized but Never Treated|1|||
127862640|NCT01984294|460112625|FG000|Overall Study|Lack of Efficacy|4|||
127862641|NCT01984294|460112626|FG001|Overall Study|Lack of Efficacy|2|||
127862642|NCT01984294|460112627|FG002|Overall Study|Lack of Efficacy|6|||
127862643|NCT01984294|460112625|FG000|Overall Study|Adverse Event|0|||
127862644|NCT01984294|460112626|FG001|Overall Study|Adverse Event|1|||
127862645|NCT01984294|460112627|FG002|Overall Study|Adverse Event|0|||
127862646|NCT02993783|460112630|FG000|Overall Study|Reason not Specified|6|||
127862647|NCT02993783|460112631|FG001|Overall Study|Reason not Specified|9|||
127862648|NCT01987609|460112634|FG000|Overall Study|Adverse Event|1|||
127862649|NCT02610231|460112635|FG000|Overall Study|Withdrawal by Subject|27|||
127862650|NCT02610231|460112635|FG000|Overall Study|Adverse Event|20|||
127862651|NCT02610231|460112635|FG000|Overall Study|Death|5|||
127862652|NCT02610231|460112635|FG000|Overall Study|Surgery|2|||
127862653|NCT02610231|460112635|FG000|Overall Study|Physician Decision|1|||
127862654|NCT02610231|460112635|FG000|Overall Study|Non Compliance|2|||
127862655|NCT02610231|460112635|FG000|Overall Study|Other|3|||
127862656|NCT00806494|460112636|FG000|Overall Study|Adverse Event|29|||
127862657|NCT00806494|460112636|FG000|Overall Study|Lack of Efficacy|6|||
127862658|NCT00806494|460112636|FG000|Overall Study|Lost to Follow-up|10|||
127862659|NCT00806494|460112636|FG000|Overall Study|Other|30|||
127862660|NCT00806494|460112636|FG000|Overall Study|Withdrawal by Subject|5|||
127862661|NCT01279954|460112637|FG000|Overall Study|Lack of Efficacy|3|||
127862662|NCT01279954|460112638|FG001|Overall Study|Lack of Efficacy|4|||
127862663|NCT02709889|460112639|FG000|Overall Study|Withdrawal by Subject|11|||
127862664|NCT02709889|460112640|FG001|Overall Study|Withdrawal by Subject|10|||
127862665|NCT02709889|460112641|FG002|Overall Study|Withdrawal by Subject|2|||
127862666|NCT02709889|460112642|FG003|Overall Study|Withdrawal by Subject|12|||
127862667|NCT02709889|460112639|FG000|Overall Study|Death|25|||
127862668|NCT02709889|460112640|FG001|Overall Study|Death|38|||
127862669|NCT02709889|460112641|FG002|Overall Study|Death|4|||
127862670|NCT02709889|460112642|FG003|Overall Study|Death|44|||
127862671|NCT02709889|460112639|FG000|Overall Study|Physician Decision|1|||
127862672|NCT02709889|460112640|FG001|Overall Study|Physician Decision|2|||
127862673|NCT02709889|460112641|FG002|Overall Study|Physician Decision|3|||
127862674|NCT02709889|460112642|FG003|Overall Study|Physician Decision|5|||
127862675|NCT02709889|460112639|FG000|Overall Study|Lost to Follow-up|2|||
127862676|NCT02709889|460112640|FG001|Overall Study|Lost to Follow-up|0|||
127862677|NCT02709889|460112641|FG002|Overall Study|Lost to Follow-up|0|||
127862678|NCT02709889|460112642|FG003|Overall Study|Lost to Follow-up|4|||
127862679|NCT02709889|460112639|FG000|Overall Study|Study Terminated by Sponsor|4|||
127862680|NCT02709889|460112640|FG001|Overall Study|Study Terminated by Sponsor|6|||
127862681|NCT02709889|460112641|FG002|Overall Study|Study Terminated by Sponsor|2|||
127862682|NCT02709889|460112642|FG003|Overall Study|Study Terminated by Sponsor|17|||
127862683|NCT02709889|460112639|FG000|Overall Study|Other, Not Specified|0|||
127862684|NCT02709889|460112640|FG001|Overall Study|Other, Not Specified|1|||
127862685|NCT02709889|460112641|FG002|Overall Study|Other, Not Specified|1|||
127862686|NCT02709889|460112642|FG003|Overall Study|Other, Not Specified|6|||
127862687|NCT03258762|460112643|FG000|Overall Study|Lost to Follow-up|0|||
127862688|NCT03258762|460112644|FG001|Overall Study|Lost to Follow-up|1|||
127862689|NCT01711359|460112645|FG000|Treatment Period|Withdrawal by Subject|18|||
127862690|NCT01711359|460112646|FG001|Treatment Period|Withdrawal by Subject|7|||
127862691|NCT01711359|460112647|FG002|Treatment Period|Withdrawal by Subject|13|||
127862692|NCT01711359|460112645|FG000|Treatment Period|Lack of Efficacy|13|||
127862693|NCT01711359|460112646|FG001|Treatment Period|Lack of Efficacy|2|||
127862694|NCT01711359|460112647|FG002|Treatment Period|Lack of Efficacy|2|||
127862695|NCT01711359|460112645|FG000|Treatment Period|Adverse Event|8|||
127862696|NCT01711359|460112646|FG001|Treatment Period|Adverse Event|10|||
127862697|NCT01711359|460112647|FG002|Treatment Period|Adverse Event|24|||
127862698|NCT01711359|460112645|FG000|Treatment Period|Physician Decision|4|||
127862699|NCT01711359|460112646|FG001|Treatment Period|Physician Decision|3|||
127862700|NCT01711359|460112647|FG002|Treatment Period|Physician Decision|2|||
127862701|NCT01711359|460112645|FG000|Treatment Period|Death|3|||
127862702|NCT01711359|460112646|FG001|Treatment Period|Death|0|||
127862703|NCT01711359|460112647|FG002|Treatment Period|Death|0|||
127914291|NCT02054715|460310584|FG000|Follow-up 2|Treatment Change or Delay|1|||
127914292|NCT02054715|460310585|FG001|Follow-up 2|Treatment Change or Delay|0|||
127914293|NCT00073307|460310593|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
127914294|NCT00073307|460310594|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
127914295|NCT00073307|460310595|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
127914296|NCT00073307|460310593|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
127914297|NCT00073307|460310594|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
127914298|NCT00073307|460310595|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
127914299|NCT00073307|460310593|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
127914300|NCT00073307|460310594|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
127914301|NCT00073307|460310595|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
127914302|NCT00073307|460310593|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
127914303|NCT00073307|460310594|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
127914304|NCT00073307|460310595|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
127914305|NCT00073307|460310593|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
127914306|NCT00073307|460310594|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
127914307|NCT00073307|460310595|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
127914308|NCT00073307|460310593|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
127914309|NCT00073307|460310594|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
127914310|NCT00073307|460310595|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
127914311|NCT00073307|460310593|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
127914312|NCT00073307|460310594|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
127914313|NCT00073307|460310595|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
127862704|NCT01711359|460112645|FG000|Treatment Period|Entry Criteria Not Met|1|||
127862705|NCT01711359|460112646|FG001|Treatment Period|Entry Criteria Not Met|0|||
127862706|NCT01711359|460112647|FG002|Treatment Period|Entry Criteria Not Met|0|||
127862707|NCT01711359|460112645|FG000|Treatment Period|Sponsor Decision|1|||
127862708|NCT01711359|460112646|FG001|Treatment Period|Sponsor Decision|0|||
127862709|NCT01711359|460112647|FG002|Treatment Period|Sponsor Decision|0|||
127862710|NCT01711359|460112645|FG000|Treatment Period|Lost to Follow-up|1|||
127862711|NCT01711359|460112646|FG001|Treatment Period|Lost to Follow-up|1|||
127862712|NCT01711359|460112647|FG002|Treatment Period|Lost to Follow-up|1|||
127862713|NCT01711359|460112645|FG000|Treatment Period|Randomized, Not Treated|3|||
127862714|NCT01711359|460112646|FG001|Treatment Period|Randomized, Not Treated|1|||
127862715|NCT01711359|460112647|FG002|Treatment Period|Randomized, Not Treated|0|||
127862716|NCT02698176|460112648|FG000|Overall Study|Progressive disease|4|||
127862717|NCT02698176|460112649|FG001|Overall Study|Progressive disease|3|||
127862718|NCT02698176|460112650|FG002|Overall Study|Progressive disease|1|||
127862719|NCT02698176|460112651|FG003|Overall Study|Progressive disease|0|||
127862720|NCT02698176|460112648|FG000|Overall Study|Adverse Event|2|||
127862721|NCT02698176|460112649|FG001|Overall Study|Adverse Event|0|||
127862722|NCT02698176|460112650|FG002|Overall Study|Adverse Event|0|||
127862723|NCT02698176|460112651|FG003|Overall Study|Adverse Event|0|||
127862724|NCT02698176|460112648|FG000|Overall Study|Clinical progression|3|||
127862725|NCT02698176|460112649|FG001|Overall Study|Clinical progression|0|||
127862726|NCT02698176|460112650|FG002|Overall Study|Clinical progression|0|||
127862727|NCT02698176|460112651|FG003|Overall Study|Clinical progression|0|||
127862728|NCT02561572|460112654|FG000|Overall Study|Inadequate time before surgery|2|||
127862729|NCT02561572|460112655|FG001|Overall Study|Inadequate time before surgery|1|||
127862730|NCT02561572|460112654|FG000|Overall Study|Protocol Violation|0|||
127862731|NCT02561572|460112655|FG001|Overall Study|Protocol Violation|1|||
127862732|NCT00795717|460112656|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
127862733|NCT00795717|460112657|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
127862734|NCT00795717|460112656|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
127862735|NCT00795717|460112657|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
127862736|NCT00795717|460112656|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
127862737|NCT00795717|460112657|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
127862738|NCT00795717|460112656|FG000|Phase II|too busy|0|||
127862739|NCT00795717|460112657|FG001|Phase II|too busy|1|||
127862740|NCT02985684|460112663|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
127862741|NCT02985684|460112663|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
127914314|NCT00073307|460310593|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
127914315|NCT00073307|460310594|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
127914316|NCT00073307|460310595|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
127862742|NCT02985684|460112663|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
127862743|NCT00424463|460112664|FG000|Overall Study|Adverse Event|2|||
127862744|NCT00424463|460112665|FG001|Overall Study|Adverse Event|3|||
127862745|NCT00424463|460112666|FG002|Overall Study|Adverse Event|2|||
127914317|NCT00073307|460310593|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
127862746|NCT00424463|460112664|FG000|Overall Study|Physician Decision|0|||
127862747|NCT00424463|460112665|FG001|Overall Study|Physician Decision|2|||
127862748|NCT00424463|460112666|FG002|Overall Study|Physician Decision|2|||
127862749|NCT00424463|460112664|FG000|Overall Study|Withdrawal by Subject|4|||
127862750|NCT00424463|460112665|FG001|Overall Study|Withdrawal by Subject|2|||
127862751|NCT00424463|460112666|FG002|Overall Study|Withdrawal by Subject|5|||
127862752|NCT00424463|460112664|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
127862753|NCT00424463|460112665|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
127862754|NCT00424463|460112666|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
127862755|NCT00424463|460112664|FG000|Overall Study|Patient's convenience|0|||
127862756|NCT00424463|460112665|FG001|Overall Study|Patient's convenience|0|||
127862757|NCT00424463|460112666|FG002|Overall Study|Patient's convenience|1|||
127862758|NCT01436357|460112667|FG000|Overall Study|Death|5|||
127862759|NCT01436357|460112668|FG001|Overall Study|Death|1|||
127862760|NCT01436357|460112667|FG000|Overall Study|Enrolled but not vaccinated|1|||
127862761|NCT01436357|460112668|FG001|Overall Study|Enrolled but not vaccinated|1|||
127862762|NCT01436357|460112667|FG000|Overall Study|Incarceration|18|||
127862763|NCT01436357|460112668|FG001|Overall Study|Incarceration|20|||
127862764|NCT01436357|460112667|FG000|Overall Study|Lost to Follow-up|67|||
127862765|NCT01436357|460112668|FG001|Overall Study|Lost to Follow-up|61|||
127862766|NCT01436357|460112667|FG000|Overall Study|Protocol Violation|1|||
127862767|NCT01436357|460112668|FG001|Overall Study|Protocol Violation|0|||
127862768|NCT01436357|460112667|FG000|Overall Study|Withdrawal by Subject|26|||
127862769|NCT01436357|460112668|FG001|Overall Study|Withdrawal by Subject|38|||
127862770|NCT01436357|460112667|FG000|Overall Study|Physician Decision|3|||
127862771|NCT01436357|460112668|FG001|Overall Study|Physician Decision|4|||
127862772|NCT01436357|460112667|FG000|Overall Study|Moved out of area|1|||
127862773|NCT01436357|460112668|FG001|Overall Study|Moved out of area|2|||
127862774|NCT01436357|460112667|FG000|Overall Study|Subject in rehab|0|||
127862775|NCT01436357|460112668|FG001|Overall Study|Subject in rehab|1|||
127862776|NCT00656799|460112669|FG000|Overall Study|Death|2|||
127862777|NCT05281094|460112670|FG000|Overall Study|Adverse Event|1|||
127862778|NCT05281094|460112671|FG001|Overall Study|Adverse Event|0|||
127862779|NCT05281094|460112670|FG000|Overall Study|Lost to Follow-up|29|||
127862780|NCT05281094|460112671|FG001|Overall Study|Lost to Follow-up|22|||
127862781|NCT05281094|460112670|FG000|Overall Study|Withdrawal by Legally Authorized Representative|122|||
127862782|NCT05281094|460112671|FG001|Overall Study|Withdrawal by Legally Authorized Representative|103|||
127862783|NCT05281094|460112670|FG000|Overall Study|Death|1|||
127862784|NCT05281094|460112671|FG001|Overall Study|Death|2|||
127862785|NCT05281094|460112670|FG000|Overall Study|Not pre-specified reason|8|||
127862786|NCT05281094|460112671|FG001|Overall Study|Not pre-specified reason|5|||
127862787|NCT00631969|460112676|FG000|Overall Study|Adverse Event|3|||
127862788|NCT00631969|460112677|FG001|Overall Study|Adverse Event|1|||
127862789|NCT00631969|460112676|FG000|Overall Study|Lack of Efficacy|2|||
127862790|NCT00631969|460112677|FG001|Overall Study|Lack of Efficacy|8|||
127862791|NCT00631969|460112676|FG000|Overall Study|Lost to Follow-up|2|||
127862792|NCT00631969|460112677|FG001|Overall Study|Lost to Follow-up|1|||
127862793|NCT00631969|460112676|FG000|Overall Study|Protocol Violation|1|||
127862794|NCT00631969|460112677|FG001|Overall Study|Protocol Violation|1|||
127862795|NCT00631969|460112676|FG000|Overall Study|Consent Withdrawn|5|||
127862796|NCT00631969|460112677|FG001|Overall Study|Consent Withdrawn|7|||
127862797|NCT00631969|460112676|FG000|Overall Study|Noncompliant With Study Medication|0|||
127862798|NCT00631969|460112677|FG001|Overall Study|Noncompliant With Study Medication|1|||
127862799|NCT00631969|460112676|FG000|Overall Study|No Drug Exposure|2|||
127862800|NCT00631969|460112677|FG001|Overall Study|No Drug Exposure|2|||
127862801|NCT05315297|460112678|FG000|Overall Study|Lost to Follow-up|6|||
127862802|NCT05315297|460112679|FG001|Overall Study|Lost to Follow-up|4|||
127862803|NCT05315297|460112678|FG000|Overall Study|Withdrawal by Subject|0|||
127862804|NCT05315297|460112679|FG001|Overall Study|Withdrawal by Subject|1|||
127862805|NCT03053180|460114406|FG000|Overall Study|Failure to Return|1|||
127862806|NCT04144140|460114411|FG000|Overall Study|Other|0|||
127862807|NCT04144140|460114412|FG001|Overall Study|Other|0|||
127862808|NCT04144140|460114413|FG002|Overall Study|Other|0|||
127862809|NCT04144140|460114414|FG003|Overall Study|Other|0|||
127862810|NCT04144140|460114415|FG004|Overall Study|Other|0|||
127862811|NCT04144140|460114416|FG005|Overall Study|Other|1|||
127862812|NCT04144140|460114417|FG006|Overall Study|Other|0|||
127862813|NCT01465958|460114418|FG000|Run-in Phase|Protocol Violation|1|||
127862814|NCT01465958|460114419|FG001|Run-in Phase|Protocol Violation|0|||
127862815|NCT01465958|460114418|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
127862816|NCT01465958|460114419|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
127862817|NCT00669240|460114428|FG000|Overall Study|Lack of Efficacy|33|||
127862818|NCT00669240|460114428|FG000|Overall Study|Withdrawal by Subject|42|||
127862819|NCT00669240|460114428|FG000|Overall Study|Lost to Follow-up|34|||
127862820|NCT00669240|460114428|FG000|Overall Study|Adverse Event|21|||
127862821|NCT00669240|460114428|FG000|Overall Study|Other|19|||
127862822|NCT00669240|460114428|FG000|Overall Study|Enrolled but not treated|15|||
127862823|NCT00669240|460114428|FG000|Overall Study|Enrolled but no dosing record|1|||
127862824|NCT00959192|460114433|FG000|Overall Study|Adverse Event|1|||
127914318|NCT00073307|460310594|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
127914319|NCT00073307|460310595|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
127914320|NCT00073307|460310593|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
127914321|NCT00073307|460310594|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
127914322|NCT00073307|460310595|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
127914323|NCT00073307|460310593|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
127914324|NCT00073307|460310594|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
127914325|NCT00073307|460310595|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
127914326|NCT00073307|460310593|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
127914327|NCT00073307|460310594|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
127914328|NCT00073307|460310595|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
127914329|NCT00073307|460310593|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
127914330|NCT00073307|460310594|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
127914331|NCT00073307|460310595|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
127914332|NCT00073307|460310593|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
127914333|NCT00073307|460310594|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
127914334|NCT00073307|460310595|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
127914335|NCT00073307|460310593|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
127914336|NCT00073307|460310594|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
127914337|NCT00073307|460310595|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
127914338|NCT00073307|460310593|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
127914339|NCT00073307|460310594|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
127914340|NCT00073307|460310595|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
127914341|NCT00073307|460310593|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
127914342|NCT00073307|460310594|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
127914343|NCT00073307|460310595|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
127914344|NCT00073307|460310593|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
127914345|NCT00073307|460310594|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
127862825|NCT00959192|460114434|FG001|Overall Study|Adverse Event|1|||
127862826|NCT00959192|460114435|FG002|Overall Study|Adverse Event|1|||
127862827|NCT00959192|460114436|FG003|Overall Study|Adverse Event|0|||
127862828|NCT00959192|460114433|FG000|Overall Study|Investigator Request|1|||
127862829|NCT00959192|460114434|FG001|Overall Study|Investigator Request|0|||
127862830|NCT00959192|460114435|FG002|Overall Study|Investigator Request|0|||
127862831|NCT00959192|460114436|FG003|Overall Study|Investigator Request|0|||
127862832|NCT00959192|460114433|FG000|Overall Study|Caregiver Request|0|||
127862833|NCT00959192|460114434|FG001|Overall Study|Caregiver Request|0|||
127862834|NCT00959192|460114435|FG002|Overall Study|Caregiver Request|2|||
127862835|NCT00959192|460114436|FG003|Overall Study|Caregiver Request|1|||
127862836|NCT00532441|460114437|FG000|Overall Study|Death|1|||
127862837|NCT00532441|460114438|FG001|Overall Study|Death|0|||
127862838|NCT01967134|460114439|FG000|Overall Study|Lost to Follow-up|0|||
127862839|NCT01967134|460114440|FG001|Overall Study|Lost to Follow-up|1|||
127862840|NCT01967134|460114441|FG002|Overall Study|Lost to Follow-up|0|||
127914346|NCT00073307|460310595|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
127914347|NCT00073307|460310593|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
127914348|NCT00073307|460310594|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
127914349|NCT00073307|460310595|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
127914350|NCT01438060|460310596|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
127914351|NCT01438060|460310597|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
127914352|NCT01438060|460310596|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
127914353|NCT01438060|460310597|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
127914354|NCT01438060|460310596|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
127914355|NCT01438060|460310597|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
127914356|NCT01438060|460310596|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
127914357|NCT01438060|460310597|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
127914358|NCT01438060|460310596|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
127914359|NCT01438060|460310597|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
127914360|NCT01438060|460310596|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
127914361|NCT01438060|460310597|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
127914362|NCT01438060|460310596|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
127914363|NCT01438060|460310597|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
127914364|NCT01438060|460310596|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
127914365|NCT01438060|460310597|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
127914366|NCT01438060|460310596|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
127862841|NCT00443534|460114442|FG000|Overall Study|Lack of Efficacy|67|||
127862842|NCT00443534|460114442|FG000|Overall Study|Adverse Event|16|||
127862843|NCT00443534|460114442|FG000|Overall Study|Death|9|||
127862844|NCT00443534|460114442|FG000|Overall Study|Withdrawal by Subject|8|||
127862845|NCT00443534|460114442|FG000|Overall Study|Study Terminated by Sponsor|12|||
127862846|NCT00443534|460114442|FG000|Overall Study|Other|10|||
127914367|NCT01438060|460310597|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
127914368|NCT01438060|460310596|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
127914369|NCT01438060|460310597|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
127914370|NCT01438060|460310596|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
127914371|NCT01438060|460310597|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
127862847|NCT00443534|460114442|FG000|Overall Study|Enrolled, Not Treated|1|||
127862848|NCT00364611|460114443|FG000|Overall Study|Did not receive study medication|0|||
127914372|NCT01438060|460310596|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
127914373|NCT01438060|460310597|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
127862849|NCT00364611|460114444|FG001|Overall Study|Did not receive study medication|1|||
127862850|NCT00364611|460114443|FG000|Overall Study|Adverse Event|7|||
127862851|NCT00364611|460114444|FG001|Overall Study|Adverse Event|4|||
127862852|NCT00364611|460114443|FG000|Overall Study|Participant's Request|3|||
127862853|NCT00364611|460114444|FG001|Overall Study|Participant's Request|4|||
127862854|NCT00364611|460114443|FG000|Overall Study|Disease Progression|38|||
127862855|NCT00364611|460114444|FG001|Overall Study|Disease Progression|8|||
127862856|NCT00364611|460114443|FG000|Overall Study|Investigator decision|2|||
127862857|NCT00364611|460114444|FG001|Overall Study|Investigator decision|2|||
127862858|NCT00364611|460114443|FG000|Overall Study|Found Ineligible|1|||
127862859|NCT00364611|460114444|FG001|Overall Study|Found Ineligible|0|||
127862860|NCT00364611|460114443|FG000|Overall Study|Presumed CR on Study|0|||
127862861|NCT00364611|460114444|FG001|Overall Study|Presumed CR on Study|1|||
127862862|NCT00364611|460114443|FG000|Overall Study|Receiving Liver Ablation|0|||
127862863|NCT00364611|460114444|FG001|Overall Study|Receiving Liver Ablation|1|||
127862864|NCT05466240|460114446|FG000|Overall Study|Adverse Event|1|||
127862865|NCT05466240|460114447|FG001|Overall Study|Adverse Event|0|||
127862866|NCT05466240|460114446|FG000|Overall Study|Withdrawal by Subject|1|||
127862867|NCT05466240|460114447|FG001|Overall Study|Withdrawal by Subject|0|||
127862868|NCT00305773|460114448|FG000|Overall Study|Death|3|||
127862869|NCT00305773|460114449|FG001|Overall Study|Death|2|||
127862870|NCT00305773|460114448|FG000|Overall Study|Adverse Event|1|||
127862871|NCT00305773|460114449|FG001|Overall Study|Adverse Event|2|||
127862872|NCT00305773|460114448|FG000|Overall Study|Alternative Treatment|4|||
127862873|NCT00305773|460114449|FG001|Overall Study|Alternative Treatment|4|||
127862874|NCT00305773|460114448|FG000|Overall Study|Physician Decision|1|||
127862875|NCT00305773|460114449|FG001|Overall Study|Physician Decision|1|||
127862876|NCT00305773|460114448|FG000|Overall Study|Withdrawal by Subject|1|||
127862877|NCT00305773|460114449|FG001|Overall Study|Withdrawal by Subject|4|||
127862878|NCT00305773|460114448|FG000|Overall Study|Disease Progression|1|||
127862879|NCT00305773|460114449|FG001|Overall Study|Disease Progression|3|||
127862880|NCT00305773|460114448|FG000|Overall Study|All other reasons|3|||
127862881|NCT00305773|460114449|FG001|Overall Study|All other reasons|2|||
127862882|NCT02679222|460114450|FG000|Overall Study|No time for project|1|||
127862883|NCT04097925|460114451|FG000|Overall Study|Withdrawal by Subject|1|||
127862884|NCT04735432|460114456|FG000|Overall Study|Other - due to personal reason|1|||
127862885|NCT04735432|460114457|FG001|Overall Study|Other - due to personal reason|0|||
127862886|NCT04735432|460114456|FG000|Overall Study|Adverse Event|2|||
127862887|NCT04735432|460114457|FG001|Overall Study|Adverse Event|0|||
127862888|NCT04397757|460114458|FG000|Overall Study|Death|3|||
127862889|NCT04397757|460114459|FG001|Overall Study|Death|11|||
127862890|NCT04397757|460114458|FG000|Overall Study|Withdrawal by Subject|2|||
127862891|NCT04397757|460114459|FG001|Overall Study|Withdrawal by Subject|0|||
127862892|NCT04397757|460114458|FG000|Overall Study|Lost to Follow-up|4|||
127862893|NCT04397757|460114459|FG001|Overall Study|Lost to Follow-up|3|||
127862894|NCT03288987|460114466|FG000|Overall Study|Protocol Violation|10|||
127862895|NCT03288987|460114467|FG001|Overall Study|Protocol Violation|4|||
127862896|NCT04905563|460114470|FG000|Overall Study|Withdrawal by Subject|1|||
127862897|NCT04905563|460114471|FG001|Overall Study|Withdrawal by Subject|0|||
127862898|NCT04905563|460114470|FG000|Overall Study|Standard of care orders entered by resident|1|||
127862899|NCT04905563|460114471|FG001|Overall Study|Standard of care orders entered by resident|0|||
127862900|NCT04905563|460114470|FG000|Overall Study|Patient discharged from PACU. No study meds adinistered|0|||
127862901|NCT04905563|460114471|FG001|Overall Study|Patient discharged from PACU. No study meds adinistered|1|||
127862902|NCT04905563|460114470|FG000|Overall Study|Withdrawal by Subject|0|||
127862903|NCT04905563|460114471|FG001|Overall Study|Withdrawal by Subject|1|||
127862904|NCT04652102|460114482|FG000|Overall Study|Adverse Event|14|||
127862905|NCT04652102|460114483|FG001|Overall Study|Adverse Event|13|||
127862906|NCT04652102|460114482|FG000|Overall Study|Subject Received Alternative Authorised Vaccine|1407|||
127862907|NCT04652102|460114483|FG001|Overall Study|Subject Received Alternative Authorised Vaccine|6552|||
127862908|NCT04652102|460114482|FG000|Overall Study|Physician Decision|78|||
127862909|NCT04652102|460114483|FG001|Overall Study|Physician Decision|40|||
127862910|NCT04652102|460114482|FG000|Overall Study|Study Ended by Sponsor|64|||
127862911|NCT04652102|460114483|FG001|Overall Study|Study Ended by Sponsor|17|||
127862912|NCT04652102|460114482|FG000|Overall Study|Withdrawal by Subject|4625|||
127862913|NCT04652102|460114483|FG001|Overall Study|Withdrawal by Subject|5594|||
127862914|NCT04652102|460114482|FG000|Overall Study|Lost to Follow-up|2019|||
127862915|NCT04652102|460114483|FG001|Overall Study|Lost to Follow-up|1082|||
127862916|NCT04652102|460114482|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|49|||
127862917|NCT04652102|460114483|FG001|Overall Study|Protocol Specified Withdrawal Criterion Met|2230|||
127862918|NCT04652102|460114482|FG000|Overall Study|Miscellaneous|80|||
127862919|NCT04652102|460114483|FG001|Overall Study|Miscellaneous|64|||
127862920|NCT00696774|460114492|FG000|Period II|Adverse Event|0|||
127862921|NCT00696774|460114493|FG001|Period II|Adverse Event|0|||
127862922|NCT00696774|460114494|FG002|Period II|Adverse Event|15|||
127862923|NCT00696774|460114492|FG000|Period II|Lost to Follow-up|0|||
127862924|NCT00696774|460114493|FG001|Period II|Lost to Follow-up|0|||
127862925|NCT00696774|460114494|FG002|Period II|Lost to Follow-up|4|||
127862926|NCT00696774|460114492|FG000|Period II|Protocol Violation|0|||
127862927|NCT00696774|460114493|FG001|Period II|Protocol Violation|0|||
127862928|NCT00696774|460114494|FG002|Period II|Protocol Violation|11|||
127862929|NCT00696774|460114492|FG000|Period II|Withdrawal by Subject|0|||
127862930|NCT00696774|460114493|FG001|Period II|Withdrawal by Subject|0|||
127862931|NCT00696774|460114494|FG002|Period II|Withdrawal by Subject|4|||
127862932|NCT00696774|460114492|FG000|Period II|Sponsor Decision|0|||
127862933|NCT00696774|460114493|FG001|Period II|Sponsor Decision|0|||
127862934|NCT00696774|460114494|FG002|Period II|Sponsor Decision|0|||
127862935|NCT00696774|460114492|FG000|Period II|Lack of Efficacy|0|||
127862936|NCT00696774|460114493|FG001|Period II|Lack of Efficacy|0|||
127862937|NCT00696774|460114494|FG002|Period II|Lack of Efficacy|2|||
127862938|NCT00696774|460114492|FG000|Period III|Adverse Event|1|||
127862939|NCT00696774|460114493|FG001|Period III|Adverse Event|1|||
127862940|NCT00696774|460114494|FG002|Period III|Adverse Event|0|||
127862941|NCT00696774|460114492|FG000|Period III|Lost to Follow-up|2|||
127862942|NCT00696774|460114493|FG001|Period III|Lost to Follow-up|1|||
127862943|NCT00696774|460114494|FG002|Period III|Lost to Follow-up|0|||
127862944|NCT00696774|460114492|FG000|Period III|Protocol Violation|1|||
127862945|NCT00696774|460114493|FG001|Period III|Protocol Violation|1|||
127862946|NCT00696774|460114494|FG002|Period III|Protocol Violation|0|||
127862947|NCT00696774|460114492|FG000|Period III|Withdrawal by Subject|1|||
127862948|NCT00696774|460114493|FG001|Period III|Withdrawal by Subject|2|||
127862949|NCT00696774|460114494|FG002|Period III|Withdrawal by Subject|0|||
127862950|NCT00696774|460114492|FG000|Period III|Sponsor Decision|2|||
127862951|NCT00696774|460114493|FG001|Period III|Sponsor Decision|0|||
127862952|NCT00696774|460114494|FG002|Period III|Sponsor Decision|0|||
127862953|NCT00696774|460114492|FG000|Period III|Lack of Efficacy|0|||
127862954|NCT00696774|460114493|FG001|Period III|Lack of Efficacy|2|||
127862955|NCT00696774|460114494|FG002|Period III|Lack of Efficacy|0|||
127862956|NCT03490734|460114502|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
127862957|NCT03490734|460114503|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
127862958|NCT03490734|460114504|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
127862959|NCT03490734|460114505|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
127862960|NCT03490734|460114502|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
127862961|NCT03490734|460114503|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
127862962|NCT03490734|460114504|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
127862963|NCT03490734|460114505|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
127862964|NCT03490734|460114502|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
127862965|NCT03490734|460114503|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
127862966|NCT03490734|460114504|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
127862967|NCT03490734|460114505|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
127862968|NCT03490734|460114502|FG000|Post-intervention Scan Visit|Adverse Event|2|||
127862969|NCT03490734|460114503|FG001|Post-intervention Scan Visit|Adverse Event|0|||
127914374|NCT01438060|460310596|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
127914375|NCT01438060|460310597|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
127914376|NCT01438060|460310596|FG000|On Study Beyond Week 140|Adverse Event|0|||
127914377|NCT01438060|460310597|FG001|On Study Beyond Week 140|Adverse Event|2|||
127914378|NCT01438060|460310596|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
127914379|NCT01438060|460310597|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
127914380|NCT01438060|460310596|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
127914381|NCT01438060|460310597|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
127914382|NCT01438060|460310596|FG000|On Study Beyond Week 140|Death|0|||
127914383|NCT01438060|460310597|FG001|On Study Beyond Week 140|Death|1|||
127914384|NCT01438060|460310596|FG000|On Study Beyond Week 140|Other Reason|0|||
127914385|NCT01438060|460310597|FG001|On Study Beyond Week 140|Other Reason|3|||
127914386|NCT01442376|460310599|FG000|Overall Study|Adverse Event|0|||
127914387|NCT01442376|460310600|FG001|Overall Study|Adverse Event|3|||
127914388|NCT01442376|460310601|FG002|Overall Study|Adverse Event|2|||
127914389|NCT01442376|460310599|FG000|Overall Study|Death|0|||
127914390|NCT01442376|460310600|FG001|Overall Study|Death|1|||
127862970|NCT03490734|460114504|FG002|Post-intervention Scan Visit|Adverse Event|0|||
127862971|NCT03490734|460114505|FG003|Post-intervention Scan Visit|Adverse Event|0|||
127862972|NCT03490734|460114502|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
127862973|NCT03490734|460114503|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
127862974|NCT03490734|460114504|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
127862975|NCT03490734|460114505|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
127862976|NCT03490734|460114502|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
127862977|NCT03490734|460114503|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
127862978|NCT03490734|460114504|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
127862979|NCT03490734|460114505|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
127862980|NCT00887913|460114506|FG000|Overall Study|Withdrawal by Subject|6|||
127862981|NCT02442765|460114509|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
127862982|NCT02442765|460114510|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
127862983|NCT02442765|460114511|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
127862984|NCT02442765|460114512|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
127862985|NCT02442765|460114513|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
127862986|NCT02442765|460114514|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
127862987|NCT02442765|460114515|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
127862988|NCT02442765|460114516|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
127862989|NCT02442765|460114509|FG000|Stage 2- (Days 43 to 85)|Death|0|||
127862990|NCT02442765|460114510|FG001|Stage 2- (Days 43 to 85)|Death|0|||
127862991|NCT02442765|460114511|FG002|Stage 2- (Days 43 to 85)|Death|0|||
127862992|NCT02442765|460114512|FG003|Stage 2- (Days 43 to 85)|Death|1|||
127862993|NCT02442765|460114513|FG004|Stage 2- (Days 43 to 85)|Death|1|||
127862994|NCT02442765|460114514|FG005|Stage 2- (Days 43 to 85)|Death|0|||
127862995|NCT02442765|460114515|FG006|Stage 2- (Days 43 to 85)|Death|2|||
127862996|NCT02442765|460114516|FG007|Stage 2- (Days 43 to 85)|Death|0|||
127862997|NCT02442765|460114509|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
127862998|NCT02442765|460114510|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
127862999|NCT02442765|460114511|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
127863000|NCT02442765|460114512|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
127863001|NCT02442765|460114513|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
127863002|NCT02442765|460114514|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
127863003|NCT02442765|460114515|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
127863004|NCT02442765|460114516|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
127863005|NCT02442765|460114509|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
127863006|NCT02442765|460114510|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
127863007|NCT02442765|460114511|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
127863008|NCT02442765|460114512|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
127863009|NCT02442765|460114513|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
127863010|NCT02442765|460114514|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
127914391|NCT01442376|460310601|FG002|Overall Study|Death|1|||
127914392|NCT01442376|460310599|FG000|Overall Study|Withdrawal of consent|0|||
127914393|NCT01442376|460310600|FG001|Overall Study|Withdrawal of consent|0|||
127914394|NCT01442376|460310601|FG002|Overall Study|Withdrawal of consent|1|||
127914395|NCT01442376|460310599|FG000|Overall Study|Patients not treated|2|||
127914396|NCT01442376|460310600|FG001|Overall Study|Patients not treated|3|||
127863011|NCT02442765|460114515|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
127863012|NCT02442765|460114516|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
127863013|NCT02442765|460114509|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
127863014|NCT02442765|460114510|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
127863015|NCT02442765|460114511|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
127914397|NCT01442376|460310601|FG002|Overall Study|Patients not treated|1|||
127914398|NCT01442376|460310599|FG000|Overall Study|Not eligible for subsequent cycles|1|||
127914399|NCT01442376|460310600|FG001|Overall Study|Not eligible for subsequent cycles|2|||
127914400|NCT01442376|460310601|FG002|Overall Study|Not eligible for subsequent cycles|0|||
127914401|NCT03499873|460310602|FG000|Overall Study|Withdrawal by Subject|4|||
127914402|NCT03499873|460310603|FG001|Overall Study|Withdrawal by Subject|6|||
127914403|NCT03499873|460310604|FG002|Overall Study|Withdrawal by Subject|1|||
127914404|NCT03499873|460310602|FG000|Overall Study|Subjects condition worsened|0|||
127914405|NCT03499873|460310603|FG001|Overall Study|Subjects condition worsened|3|||
127914406|NCT03499873|460310604|FG002|Overall Study|Subjects condition worsened|11|||
127914407|NCT03499873|460310602|FG000|Overall Study|Adverse Event|8|||
127914408|NCT03499873|460310603|FG001|Overall Study|Adverse Event|3|||
127914409|NCT03499873|460310604|FG002|Overall Study|Adverse Event|6|||
127914410|NCT03499873|460310602|FG000|Overall Study|Physician Decision|1|||
127914411|NCT03499873|460310603|FG001|Overall Study|Physician Decision|0|||
127914412|NCT03499873|460310604|FG002|Overall Study|Physician Decision|0|||
127914413|NCT03499873|460310602|FG000|Overall Study|Administrative reasons|0|||
127914414|NCT03499873|460310603|FG001|Overall Study|Administrative reasons|1|||
127914415|NCT03499873|460310604|FG002|Overall Study|Administrative reasons|0|||
127914416|NCT03499873|460310602|FG000|Overall Study|Concomitant therapy|5|||
127914417|NCT03499873|460310603|FG001|Overall Study|Concomitant therapy|4|||
127914418|NCT03499873|460310604|FG002|Overall Study|Concomitant therapy|7|||
127914419|NCT03499873|460310602|FG000|Overall Study|Miscellaneous|1|||
127914420|NCT03499873|460310603|FG001|Overall Study|Miscellaneous|2|||
127914421|NCT03499873|460310604|FG002|Overall Study|Miscellaneous|2|||
127914422|NCT03499873|460310602|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
127914423|NCT03499873|460310603|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
127914424|NCT03499873|460310604|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
127914425|NCT01964950|460310605|FG000|Overall Study|Protocol Violation|25|||
127914426|NCT04404725|460310606|FG000|First Intervention|Withdrawal by Subject|0|||
127914427|NCT04404725|460310607|FG001|First Intervention|Withdrawal by Subject|2|||
127914428|NCT04404725|460310606|FG000|Second Intervention|Adverse Event|1|||
127914429|NCT04404725|460310607|FG001|Second Intervention|Adverse Event|1|||
127914430|NCT04404725|460310606|FG000|Second Intervention|Withdrawal by Subject|0|||
127914431|NCT04404725|460310607|FG001|Second Intervention|Withdrawal by Subject|1|||
127914432|NCT01075516|460310608|FG000|Overall Study|Death|5|||
127914433|NCT01075516|460310609|FG001|Overall Study|Death|9|||
127914434|NCT01075516|460310608|FG000|Overall Study|Lost to Follow-up|10|||
127914435|NCT01075516|460310609|FG001|Overall Study|Lost to Follow-up|2|||
127914436|NCT01075516|460310608|FG000|Overall Study|Withdrawal by Subject|3|||
127914437|NCT01075516|460310609|FG001|Overall Study|Withdrawal by Subject|5|||
127914438|NCT02252016|460310612|FG000|Overall Study|Lost to Follow-up|2|||
127914439|NCT02252016|460310613|FG001|Overall Study|Lost to Follow-up|1|||
127914440|NCT02252016|460310612|FG000|Overall Study|Physician Decision|1|||
127914441|NCT02252016|460310613|FG001|Overall Study|Physician Decision|0|||
127914442|NCT02252016|460310612|FG000|Overall Study|Withdrawal by Subject|0|||
127914443|NCT02252016|460310613|FG001|Overall Study|Withdrawal by Subject|2|||
127914444|NCT04631562|460310624|FG000|Overall Study|Withdrawal by Subject|0|||
127914445|NCT04631562|460310625|FG001|Overall Study|Withdrawal by Subject|0|||
127914446|NCT04631562|460310626|FG002|Overall Study|Withdrawal by Subject|0|||
127914447|NCT04631562|460310627|FG003|Overall Study|Withdrawal by Subject|0|||
127914448|NCT04631562|460310628|FG004|Overall Study|Withdrawal by Subject|0|||
127914449|NCT04631562|460310629|FG005|Overall Study|Withdrawal by Subject|0|||
127914450|NCT04631562|460310630|FG006|Overall Study|Withdrawal by Subject|0|||
127914451|NCT04631562|460310631|FG007|Overall Study|Withdrawal by Subject|1|||
127914452|NCT04631562|460310632|FG008|Overall Study|Withdrawal by Subject|0|||
127914453|NCT04631562|460310624|FG000|Overall Study|Other|0|||
127914454|NCT04631562|460310625|FG001|Overall Study|Other|0|||
127914455|NCT04631562|460310626|FG002|Overall Study|Other|0|||
127914456|NCT04631562|460310627|FG003|Overall Study|Other|0|||
127914457|NCT04631562|460310628|FG004|Overall Study|Other|0|||
127914458|NCT04631562|460310629|FG005|Overall Study|Other|0|||
127914459|NCT04631562|460310630|FG006|Overall Study|Other|0|||
127914460|NCT04631562|460310631|FG007|Overall Study|Other|0|||
127914461|NCT04631562|460310632|FG008|Overall Study|Other|1|||
127914462|NCT04631562|460310624|FG000|Overall Study|Lost to Follow-up|0|||
127914463|NCT04631562|460310625|FG001|Overall Study|Lost to Follow-up|0|||
127914464|NCT04631562|460310626|FG002|Overall Study|Lost to Follow-up|0|||
127914465|NCT04631562|460310627|FG003|Overall Study|Lost to Follow-up|1|||
127914466|NCT04631562|460310628|FG004|Overall Study|Lost to Follow-up|0|||
127914467|NCT04631562|460310629|FG005|Overall Study|Lost to Follow-up|0|||
127914468|NCT04631562|460310630|FG006|Overall Study|Lost to Follow-up|0|||
127914469|NCT04631562|460310631|FG007|Overall Study|Lost to Follow-up|0|||
127914470|NCT04631562|460310632|FG008|Overall Study|Lost to Follow-up|0|||
127914471|NCT04631562|460310624|FG000|Overall Study|Adverse Event|0|||
127914472|NCT04631562|460310625|FG001|Overall Study|Adverse Event|0|||
127863016|NCT02442765|460114512|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
127863017|NCT02442765|460114513|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
127863018|NCT02442765|460114514|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
127863019|NCT02442765|460114515|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
127863020|NCT02442765|460114516|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
127863021|NCT02442765|460114509|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
127863022|NCT02442765|460114510|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
127863023|NCT02442765|460114511|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
127863024|NCT02442765|460114512|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
127863025|NCT02442765|460114513|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
127863026|NCT02442765|460114514|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
127863027|NCT02442765|460114515|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
127863028|NCT02442765|460114516|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
127863029|NCT02442765|460114509|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
127863030|NCT02442765|460114510|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
127863031|NCT02442765|460114511|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
127863032|NCT02442765|460114512|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
127863033|NCT02442765|460114513|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
127863034|NCT02442765|460114514|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
127863035|NCT02442765|460114515|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
127863036|NCT02442765|460114516|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
127863037|NCT02442765|460114509|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
127863038|NCT02442765|460114510|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
127863039|NCT02442765|460114511|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
127863040|NCT02442765|460114512|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
127863041|NCT02442765|460114513|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
127863042|NCT02442765|460114514|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
127863043|NCT02442765|460114515|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
127863044|NCT02442765|460114516|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
127863045|NCT01200758|460114517|FG000|Stage I|Death|0|||
127863046|NCT01200758|460114518|FG001|Stage I|Death|1|||
127863047|NCT01200758|460114519|FG002|Stage I|Death|0|||
127863048|NCT01200758|460114520|FG003|Stage I|Death|0|||
127863049|NCT01200758|460114517|FG000|Stage I|Physician Decision|1|||
127863050|NCT01200758|460114518|FG001|Stage I|Physician Decision|1|||
127863051|NCT01200758|460114519|FG002|Stage I|Physician Decision|0|||
127863052|NCT01200758|460114520|FG003|Stage I|Physician Decision|0|||
127863053|NCT01200758|460114517|FG000|Stage I|Lack of Efficacy|2|||
127863054|NCT01200758|460114518|FG001|Stage I|Lack of Efficacy|1|||
127863055|NCT01200758|460114519|FG002|Stage I|Lack of Efficacy|0|||
127863056|NCT01200758|460114520|FG003|Stage I|Lack of Efficacy|0|||
127863057|NCT01200758|460114517|FG000|Stage I|Adverse Event|5|||
127863058|NCT01200758|460114518|FG001|Stage I|Adverse Event|5|||
127863059|NCT01200758|460114519|FG002|Stage I|Adverse Event|0|||
127863060|NCT01200758|460114520|FG003|Stage I|Adverse Event|0|||
127863061|NCT01200758|460114517|FG000|Stage I|Withdrawal by Subject|1|||
127863062|NCT01200758|460114518|FG001|Stage I|Withdrawal by Subject|2|||
127863063|NCT01200758|460114519|FG002|Stage I|Withdrawal by Subject|0|||
127863064|NCT01200758|460114520|FG003|Stage I|Withdrawal by Subject|0|||
127863065|NCT01200758|460114517|FG000|Stage I|Disease Progression|9|||
127863066|NCT01200758|460114518|FG001|Stage I|Disease Progression|7|||
127863067|NCT01200758|460114519|FG002|Stage I|Disease Progression|0|||
127863068|NCT01200758|460114520|FG003|Stage I|Disease Progression|0|||
127863069|NCT01200758|460114517|FG000|Stage 2|Disease Progression|0|||
127863070|NCT01200758|460114518|FG001|Stage 2|Disease Progression|0|||
127863071|NCT01200758|460114519|FG002|Stage 2|Disease Progression|16|||
127863072|NCT01200758|460114520|FG003|Stage 2|Disease Progression|21|||
127863073|NCT01200758|460114517|FG000|Stage 2|Lack of Efficacy|0|||
127863074|NCT01200758|460114518|FG001|Stage 2|Lack of Efficacy|0|||
127863075|NCT01200758|460114519|FG002|Stage 2|Lack of Efficacy|4|||
127863076|NCT01200758|460114520|FG003|Stage 2|Lack of Efficacy|2|||
127863077|NCT01200758|460114517|FG000|Stage 2|Physician Decision|0|||
127863078|NCT01200758|460114518|FG001|Stage 2|Physician Decision|0|||
127863079|NCT01200758|460114519|FG002|Stage 2|Physician Decision|5|||
127863080|NCT01200758|460114520|FG003|Stage 2|Physician Decision|7|||
127863081|NCT01200758|460114517|FG000|Stage 2|Adverse Event|0|||
127863082|NCT01200758|460114518|FG001|Stage 2|Adverse Event|0|||
127863083|NCT01200758|460114519|FG002|Stage 2|Adverse Event|5|||
127863084|NCT01200758|460114520|FG003|Stage 2|Adverse Event|9|||
127863085|NCT01200758|460114517|FG000|Stage 2|Withdrawal by Subject|0|||
127863086|NCT01200758|460114518|FG001|Stage 2|Withdrawal by Subject|0|||
127863087|NCT01200758|460114519|FG002|Stage 2|Withdrawal by Subject|4|||
127863088|NCT01200758|460114520|FG003|Stage 2|Withdrawal by Subject|1|||
127863089|NCT01200758|460114517|FG000|Stage 2|Lost to Follow-up|0|||
127863090|NCT01200758|460114518|FG001|Stage 2|Lost to Follow-up|0|||
127863091|NCT01200758|460114519|FG002|Stage 2|Lost to Follow-up|3|||
127863092|NCT01200758|460114520|FG003|Stage 2|Lost to Follow-up|1|||
127863093|NCT01200758|460114517|FG000|Stage 2|Protocol Violation|0|||
127863094|NCT01200758|460114518|FG001|Stage 2|Protocol Violation|0|||
127863095|NCT01200758|460114519|FG002|Stage 2|Protocol Violation|1|||
127863096|NCT01200758|460114520|FG003|Stage 2|Protocol Violation|4|||
127863097|NCT01200758|460114517|FG000|Stage 2|Death|0|||
127863098|NCT01200758|460114518|FG001|Stage 2|Death|0|||
127863099|NCT01200758|460114519|FG002|Stage 2|Death|3|||
127863100|NCT01200758|460114520|FG003|Stage 2|Death|5|||
127863101|NCT01371721|460114521|FG000|Overall Study|Adverse Event|5|||
127863102|NCT01371721|460114522|FG001|Overall Study|Adverse Event|4|||
127863103|NCT01371721|460114523|FG002|Overall Study|Adverse Event|5|||
127863104|NCT01371721|460114521|FG000|Overall Study|Protocol Violation|6|||
127863105|NCT01371721|460114522|FG001|Overall Study|Protocol Violation|4|||
127863106|NCT01371721|460114523|FG002|Overall Study|Protocol Violation|5|||
127863107|NCT01371721|460114521|FG000|Overall Study|Lost to Follow-up|8|||
127863108|NCT01371721|460114522|FG001|Overall Study|Lost to Follow-up|2|||
127863109|NCT01371721|460114523|FG002|Overall Study|Lost to Follow-up|6|||
127863110|NCT01371721|460114521|FG000|Overall Study|Withdrawal by Subject|5|||
127863111|NCT01371721|460114522|FG001|Overall Study|Withdrawal by Subject|7|||
127863112|NCT01371721|460114523|FG002|Overall Study|Withdrawal by Subject|11|||
127863113|NCT01371721|460114521|FG000|Overall Study|Other|2|||
127863114|NCT01371721|460114522|FG001|Overall Study|Other|3|||
127863115|NCT01371721|460114523|FG002|Overall Study|Other|0|||
127863116|NCT01371721|460114521|FG000|Overall Study|Lack of Efficacy|2|||
127863117|NCT01371721|460114522|FG001|Overall Study|Lack of Efficacy|4|||
127863118|NCT01371721|460114523|FG002|Overall Study|Lack of Efficacy|3|||
127863119|NCT01371721|460114521|FG000|Overall Study|Randomized but not treated|1|||
127863120|NCT01371721|460114522|FG001|Overall Study|Randomized but not treated|0|||
127863121|NCT01371721|460114523|FG002|Overall Study|Randomized but not treated|0|||
127863122|NCT00545584|460114524|FG000|Overall Study|Only one reason for discontinuation|62|||
127863123|NCT00545584|460114525|FG001|Overall Study|Only one reason for discontinuation|61|||
127863124|NCT00545584|460114526|FG002|Overall Study|Only one reason for discontinuation|48|||
127863125|NCT00545584|460114524|FG000|Overall Study|Two or more reasons for discontinuation|17|||
127863126|NCT00545584|460114525|FG001|Overall Study|Two or more reasons for discontinuation|19|||
127863127|NCT00545584|460114526|FG002|Overall Study|Two or more reasons for discontinuation|8|||
127863128|NCT03525613|460114529|FG000|Overall Study|Adverse Event|11|||
127863129|NCT03525613|460114530|FG001|Overall Study|Adverse Event|8|||
127863130|NCT03525613|460114531|FG002|Overall Study|Adverse Event|3|||
127863131|NCT03525613|460114532|FG003|Overall Study|Adverse Event|3|||
127863132|NCT03525613|460114529|FG000|Overall Study|Lost to Follow-up|4|||
127863133|NCT03525613|460114530|FG001|Overall Study|Lost to Follow-up|5|||
127863134|NCT03525613|460114531|FG002|Overall Study|Lost to Follow-up|3|||
127863135|NCT03525613|460114532|FG003|Overall Study|Lost to Follow-up|2|||
127863136|NCT03525613|460114529|FG000|Overall Study|Physician Decision|0|||
127863137|NCT03525613|460114530|FG001|Overall Study|Physician Decision|1|||
127863138|NCT03525613|460114531|FG002|Overall Study|Physician Decision|0|||
127863139|NCT03525613|460114532|FG003|Overall Study|Physician Decision|1|||
127863140|NCT03525613|460114529|FG000|Overall Study|Consent Withdrawal|25|||
127863141|NCT03525613|460114530|FG001|Overall Study|Consent Withdrawal|16|||
127863142|NCT03525613|460114531|FG002|Overall Study|Consent Withdrawal|12|||
127863143|NCT03525613|460114532|FG003|Overall Study|Consent Withdrawal|9|||
127863144|NCT03525613|460114529|FG000|Overall Study|Death|20|||
127863145|NCT03525613|460114530|FG001|Overall Study|Death|9|||
127863146|NCT03525613|460114531|FG002|Overall Study|Death|7|||
127863147|NCT03525613|460114532|FG003|Overall Study|Death|1|||
127863148|NCT03525613|460114529|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
127863149|NCT03525613|460114530|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
127863150|NCT03525613|460114531|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
127863151|NCT03525613|460114532|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
127863152|NCT02584660|460114536|FG000|Overall Study|Adverse Event|4|||
127863153|NCT02584660|460114537|FG001|Overall Study|Adverse Event|0|||
127863154|NCT02584660|460114536|FG000|Overall Study|Lost to Follow-up|3|||
127914473|NCT04631562|460310626|FG002|Overall Study|Adverse Event|0|||
127863155|NCT02584660|460114537|FG001|Overall Study|Lost to Follow-up|4|||
127863156|NCT02584660|460114536|FG000|Overall Study|Protocol Violation|0|||
127863157|NCT02584660|460114537|FG001|Overall Study|Protocol Violation|1|||
127863158|NCT02584660|460114536|FG000|Overall Study|Withdrawal by Subject|0|||
127863159|NCT02584660|460114537|FG001|Overall Study|Withdrawal by Subject|2|||
127863160|NCT02584660|460114536|FG000|Overall Study|Other|0|||
127914474|NCT04631562|460310627|FG003|Overall Study|Adverse Event|0|||
127863161|NCT02584660|460114537|FG001|Overall Study|Other|1|||
127863162|NCT00461552|460114538|FG000|Overall Study|Drug Dispensing error|0|||
127863163|NCT00461552|460114539|FG001|Overall Study|Drug Dispensing error|2|||
127863164|NCT00374452|460114540|FG000|Overall Study|Left clinic before intervention started|4|||
127863165|NCT00374452|460114541|FG001|Overall Study|Left clinic before intervention started|1|||
127863166|NCT00374452|460114540|FG000|Overall Study|Change in job role before intervention|0|||
127863167|NCT00374452|460114541|FG001|Overall Study|Change in job role before intervention|1|||
127863168|NCT00374452|460114540|FG000|Overall Study|Left clinic after intervention started|1|||
127863169|NCT00374452|460114541|FG001|Overall Study|Left clinic after intervention started|1|||
127863170|NCT00374452|460114540|FG000|Overall Study|Withdrawal by Subject|0|||
127863171|NCT00374452|460114541|FG001|Overall Study|Withdrawal by Subject|2|||
127863172|NCT00523744|460114542|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
127863173|NCT00523744|460114542|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
127863174|NCT00523744|460114542|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
127863175|NCT00523744|460114542|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
127863176|NCT00523744|460114542|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
127863177|NCT00523744|460114542|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
127863178|NCT00715949|460114547|FG000|Overall Study|could not finish first test|4|||
127863179|NCT00537810|460114549|FG000|Overall Study|Withdrawal by Subject|4|||
127863180|NCT00537810|460114550|FG001|Overall Study|Withdrawal by Subject|11|||
127863181|NCT00537810|460114551|FG002|Overall Study|Withdrawal by Subject|4|||
127863182|NCT00537810|460114552|FG003|Overall Study|Withdrawal by Subject|3|||
127863183|NCT00537810|460114549|FG000|Overall Study|Medically withdrawn|2|||
127863184|NCT00537810|460114550|FG001|Overall Study|Medically withdrawn|2|||
127863185|NCT00537810|460114551|FG002|Overall Study|Medically withdrawn|0|||
127863186|NCT00537810|460114552|FG003|Overall Study|Medically withdrawn|1|||
127863187|NCT01066546|460114553|FG000|Overall Study|Study terminated by sponsor|5|||
127863188|NCT01385098|460114562|FG000|Overall Study|Adverse Event|10|||
127863189|NCT01385098|460114562|FG000|Overall Study|Lost to Follow-up|4|||
127863190|NCT00554840|460114563|FG000|Overall Study|Physician Decision|0|||
127863191|NCT00554840|460114564|FG001|Overall Study|Physician Decision|1|||
127863192|NCT00925522|460114565|FG000|Overall Study|study closed -- business decision|20|||
127863193|NCT00410514|460114570|FG000|Overall Study|Adverse Event|2|||
127863194|NCT00410514|460114571|FG001|Overall Study|Adverse Event|2|||
127863195|NCT00410514|460114572|FG002|Overall Study|Adverse Event|2|||
127863196|NCT00410514|460114570|FG000|Overall Study|Protocol Violation|0|||
127863197|NCT00410514|460114571|FG001|Overall Study|Protocol Violation|1|||
127863198|NCT00410514|460114572|FG002|Overall Study|Protocol Violation|1|||
127863199|NCT00410514|460114570|FG000|Overall Study|Lost to Follow-up|0|||
127863200|NCT00410514|460114571|FG001|Overall Study|Lost to Follow-up|0|||
127863201|NCT00410514|460114572|FG002|Overall Study|Lost to Follow-up|2|||
127863202|NCT00410514|460114570|FG000|Overall Study|Non-compliant with study procedures|0|||
127863203|NCT00410514|460114571|FG001|Overall Study|Non-compliant with study procedures|0|||
127863204|NCT00410514|460114572|FG002|Overall Study|Non-compliant with study procedures|2|||
127863205|NCT00945945|460116338|FG000|Overall Study|Adverse Event|15|||
127863206|NCT00945945|460116339|FG001|Overall Study|Adverse Event|35|||
127863207|NCT00945945|460116338|FG000|Overall Study|Withdrawal by Subject|7|||
127914475|NCT04631562|460310628|FG004|Overall Study|Adverse Event|0|||
127914476|NCT04631562|460310629|FG005|Overall Study|Adverse Event|0|||
127914477|NCT04631562|460310630|FG006|Overall Study|Adverse Event|1|||
127914478|NCT04631562|460310631|FG007|Overall Study|Adverse Event|0|||
127914479|NCT04631562|460310632|FG008|Overall Study|Adverse Event|0|||
127914480|NCT01190865|460310638|FG000|Overall Study|Withdrawal by Subject|1|||
127914481|NCT01190865|460310638|FG000|Overall Study|Non-compliance|2|||
127914482|NCT02436200|460310645|FG000|Overall Study|Significant outlier|1|||
127914483|NCT02471807|460310646|FG000|Overall Study|Death|14|||
127914484|NCT02471807|460310646|FG000|Overall Study|Withdrawal by Subject|2|||
127914485|NCT02471807|460310646|FG000|Overall Study|Explant|5|||
127914486|NCT02471807|460310646|FG000|Overall Study|Lost to Follow-up|1|||
127914487|NCT00957021|460310647|FG000|Overall Study|Death|5|||
127914488|NCT00957021|460310647|FG000|Overall Study|Lost to Follow-up|8|||
127914489|NCT00957021|460310647|FG000|Overall Study|Withdrawal by Subject|34|||
127914490|NCT00957021|460310647|FG000|Overall Study|No 2 yr ROM data|35|||
127914491|NCT00957021|460310647|FG000|Overall Study|Revised study component by 2 yr visit|8|||
127914492|NCT00957021|460310647|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
127914493|NCT00957021|460310647|FG000|Overall Study|Surgery Cancelled|9|||
127914494|NCT00957021|460310647|FG000|Overall Study|Termination due to language issue|2|||
127914495|NCT01483820|460310662|FG000|Overall Study|Lack of Efficacy|6|||
127914496|NCT01483820|460310662|FG000|Overall Study|Adverse Event|1|||
127914497|NCT01483820|460310662|FG000|Overall Study|Death|1|||
127914498|NCT00867360|460310663|FG000|Overall Study|Withdrawal by Subject|1|||
127914499|NCT00867360|460310664|FG001|Overall Study|Withdrawal by Subject|0|||
127914500|NCT00867360|460310663|FG000|Overall Study|Physician Decision|0|||
127914501|NCT00867360|460310664|FG001|Overall Study|Physician Decision|1|||
127914502|NCT00112437|460310668|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
127914503|NCT00112437|460310669|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
127914504|NCT00112437|460310670|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
127914505|NCT00112437|460310671|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
127914506|NCT00112437|460310672|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
127914507|NCT00112437|460310673|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
127914508|NCT00112437|460310674|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
127914509|NCT00112437|460310675|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
127914510|NCT00112437|460310676|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
127914511|NCT00112437|460310677|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
127914512|NCT00112437|460310678|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
127914513|NCT00112437|460310679|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
127914514|NCT00112437|460310680|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
127914515|NCT00112437|460310681|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
127914516|NCT00112437|460310682|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
127914517|NCT00112437|460310683|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
127914518|NCT00112437|460310684|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
127914519|NCT00112437|460310685|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
127914520|NCT00112437|460310686|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
127914521|NCT00112437|460310687|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
127914522|NCT00112437|460310688|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
127914523|NCT00112437|460310689|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
127914524|NCT00112437|460310690|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
127914525|NCT00112437|460310691|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
127914526|NCT00112437|460310692|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
127914527|NCT00112437|460310693|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
127914528|NCT00112437|460310668|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
127914529|NCT00112437|460310669|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
127914530|NCT00112437|460310670|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
127914531|NCT00112437|460310671|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
127914532|NCT00112437|460310672|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
127914533|NCT00112437|460310673|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
127914534|NCT00112437|460310674|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
127914535|NCT00112437|460310675|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
127914536|NCT00112437|460310676|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
127914537|NCT00112437|460310677|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
127914538|NCT00112437|460310678|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
127914539|NCT00112437|460310679|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
127914540|NCT00112437|460310680|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
127914541|NCT00112437|460310681|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
127914542|NCT00112437|460310682|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
127914543|NCT00112437|460310683|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
127914544|NCT00112437|460310684|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
127914545|NCT00112437|460310685|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
127914546|NCT00112437|460310686|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
127914547|NCT00112437|460310687|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
127863208|NCT00945945|460116339|FG001|Overall Study|Withdrawal by Subject|10|||
127863209|NCT00945945|460116338|FG000|Overall Study|Lost to Follow-up|4|||
127863210|NCT00945945|460116339|FG001|Overall Study|Lost to Follow-up|5|||
127863211|NCT00945945|460116338|FG000|Overall Study|Lack of Efficacy|6|||
127863212|NCT00945945|460116339|FG001|Overall Study|Lack of Efficacy|2|||
127863213|NCT00945945|460116338|FG000|Overall Study|Protocol Violation|4|||
127863214|NCT00945945|460116339|FG001|Overall Study|Protocol Violation|2|||
127863215|NCT00945945|460116338|FG000|Overall Study|Entry Criteria Not Met|0|||
127863216|NCT00945945|460116339|FG001|Overall Study|Entry Criteria Not Met|1|||
127863217|NCT00626327|460116340|FG000|Overall Study|Withdrawal by Subject|21|||
127863218|NCT00626327|460116341|FG001|Overall Study|Withdrawal by Subject|29|||
127863219|NCT00626327|460116342|FG002|Overall Study|Withdrawal by Subject|30|||
127863220|NCT00626327|460116340|FG000|Overall Study|Adverse Event|1|||
127863221|NCT00626327|460116341|FG001|Overall Study|Adverse Event|0|||
127863222|NCT00626327|460116342|FG002|Overall Study|Adverse Event|0|||
127863223|NCT00626327|460116340|FG000|Overall Study|Lost to Follow-up|24|||
127863224|NCT00626327|460116341|FG001|Overall Study|Lost to Follow-up|21|||
127863225|NCT00626327|460116342|FG002|Overall Study|Lost to Follow-up|23|||
127863226|NCT00626327|460116340|FG000|Overall Study|Inappropriate enrollment|4|||
127863227|NCT00626327|460116341|FG001|Overall Study|Inappropriate enrollment|5|||
127863228|NCT00626327|460116342|FG002|Overall Study|Inappropriate enrollment|3|||
127863229|NCT00626327|460116340|FG000|Overall Study|Administrative Reason|2|||
127863230|NCT00626327|460116341|FG001|Overall Study|Administrative Reason|0|||
127863231|NCT00626327|460116342|FG002|Overall Study|Administrative Reason|6|||
127863232|NCT00626327|460116340|FG000|Overall Study|Protocol Violation|26|||
127863233|NCT00626327|460116341|FG001|Overall Study|Protocol Violation|4|||
127863234|NCT00626327|460116342|FG002|Overall Study|Protocol Violation|26|||
127863235|NCT01823991|460116343|FG000|Overall Study|Withdrawal by Subject|8|||
127863236|NCT01823991|460116344|FG001|Overall Study|Withdrawal by Subject|5|||
127863237|NCT05158244|460116345|FG000|Overall Study|Withdrawal by principal investigator due to protocol deviation|1|||
127863238|NCT05158244|460116346|FG001|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
127863239|NCT05158244|460116347|FG002|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
127863240|NCT05158244|460116348|FG003|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
127863241|NCT05158244|460116349|FG004|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
127863242|NCT05158244|460116345|FG000|Overall Study|Withdrawal by Subject|0|||
127863243|NCT05158244|460116346|FG001|Overall Study|Withdrawal by Subject|0|||
127863244|NCT05158244|460116347|FG002|Overall Study|Withdrawal by Subject|1|||
127863245|NCT05158244|460116348|FG003|Overall Study|Withdrawal by Subject|0|||
127863246|NCT05158244|460116349|FG004|Overall Study|Withdrawal by Subject|0|||
127863247|NCT01066819|460116350|FG000|Overall Study|Adverse Event|18|||
127863248|NCT01066819|460116351|FG001|Overall Study|Adverse Event|1|||
127863249|NCT01066819|460116352|FG002|Overall Study|Adverse Event|6|||
127863250|NCT01066819|460116353|FG003|Overall Study|Adverse Event|0|||
127863251|NCT01066819|460116354|FG004|Overall Study|Adverse Event|0|||
127863252|NCT01066819|460116355|FG005|Overall Study|Adverse Event|0|||
127863253|NCT01066819|460116350|FG000|Overall Study|Death|5|||
127863254|NCT01066819|460116351|FG001|Overall Study|Death|0|||
127863255|NCT01066819|460116352|FG002|Overall Study|Death|1|||
127863256|NCT01066819|460116353|FG003|Overall Study|Death|0|||
127863257|NCT01066819|460116354|FG004|Overall Study|Death|0|||
127863258|NCT01066819|460116355|FG005|Overall Study|Death|0|||
127863259|NCT01066819|460116350|FG000|Overall Study|Lack of Efficacy|22|||
127863260|NCT01066819|460116351|FG001|Overall Study|Lack of Efficacy|1|||
127863261|NCT01066819|460116352|FG002|Overall Study|Lack of Efficacy|2|||
127863262|NCT01066819|460116353|FG003|Overall Study|Lack of Efficacy|1|||
127863263|NCT01066819|460116354|FG004|Overall Study|Lack of Efficacy|0|||
127863264|NCT01066819|460116355|FG005|Overall Study|Lack of Efficacy|0|||
127863265|NCT01066819|460116350|FG000|Overall Study|Physician Decision|6|||
127863266|NCT01066819|460116351|FG001|Overall Study|Physician Decision|2|||
127863267|NCT01066819|460116352|FG002|Overall Study|Physician Decision|3|||
127863268|NCT01066819|460116353|FG003|Overall Study|Physician Decision|0|||
127863269|NCT01066819|460116354|FG004|Overall Study|Physician Decision|0|||
127863270|NCT01066819|460116355|FG005|Overall Study|Physician Decision|0|||
127863271|NCT01066819|460116350|FG000|Overall Study|Protocol Violation|12|||
127863272|NCT01066819|460116351|FG001|Overall Study|Protocol Violation|6|||
127863273|NCT01066819|460116352|FG002|Overall Study|Protocol Violation|0|||
127863274|NCT01066819|460116353|FG003|Overall Study|Protocol Violation|0|||
127863275|NCT01066819|460116354|FG004|Overall Study|Protocol Violation|0|||
127863276|NCT01066819|460116355|FG005|Overall Study|Protocol Violation|0|||
127863277|NCT01066819|460116350|FG000|Overall Study|Withdrawal by Subject|29|||
127863278|NCT01066819|460116351|FG001|Overall Study|Withdrawal by Subject|11|||
127863279|NCT01066819|460116352|FG002|Overall Study|Withdrawal by Subject|6|||
127863280|NCT01066819|460116353|FG003|Overall Study|Withdrawal by Subject|0|||
127863281|NCT01066819|460116354|FG004|Overall Study|Withdrawal by Subject|0|||
127863282|NCT01066819|460116355|FG005|Overall Study|Withdrawal by Subject|0|||
127863283|NCT01066819|460116350|FG000|Overall Study|Administrative|6|||
127863284|NCT01066819|460116351|FG001|Overall Study|Administrative|4|||
127863285|NCT01066819|460116352|FG002|Overall Study|Administrative|2|||
127863286|NCT01066819|460116353|FG003|Overall Study|Administrative|0|||
127863287|NCT01066819|460116354|FG004|Overall Study|Administrative|0|||
127863288|NCT01066819|460116355|FG005|Overall Study|Administrative|0|||
127863289|NCT01066819|460116350|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
127863290|NCT01066819|460116351|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
127863291|NCT01066819|460116352|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
127863292|NCT01066819|460116353|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
127863293|NCT01066819|460116354|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
127863294|NCT01066819|460116355|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
127863295|NCT01066819|460116350|FG000|Overall Study|Early termination|2|||
127863296|NCT01066819|460116351|FG001|Overall Study|Early termination|0|||
127863297|NCT01066819|460116352|FG002|Overall Study|Early termination|0|||
127863298|NCT01066819|460116353|FG003|Overall Study|Early termination|0|||
127863299|NCT01066819|460116354|FG004|Overall Study|Early termination|0|||
127863300|NCT01066819|460116355|FG005|Overall Study|Early termination|0|||
127863301|NCT01066819|460116350|FG000|Overall Study|Failed to return|298|||
127863302|NCT01066819|460116351|FG001|Overall Study|Failed to return|107|||
127863303|NCT01066819|460116352|FG002|Overall Study|Failed to return|68|||
127863304|NCT01066819|460116353|FG003|Overall Study|Failed to return|7|||
127863305|NCT01066819|460116354|FG004|Overall Study|Failed to return|2|||
127863306|NCT01066819|460116355|FG005|Overall Study|Failed to return|3|||
127863307|NCT01066819|460116350|FG000|Overall Study|Lab test not done|9|||
127863308|NCT01066819|460116351|FG001|Overall Study|Lab test not done|0|||
127863309|NCT01066819|460116352|FG002|Overall Study|Lab test not done|2|||
127863310|NCT01066819|460116353|FG003|Overall Study|Lab test not done|1|||
127863311|NCT01066819|460116354|FG004|Overall Study|Lab test not done|0|||
127863312|NCT01066819|460116355|FG005|Overall Study|Lab test not done|0|||
127863313|NCT01066819|460116350|FG000|Overall Study|Miscellaneous|28|||
127863314|NCT01066819|460116351|FG001|Overall Study|Miscellaneous|10|||
127863315|NCT01066819|460116352|FG002|Overall Study|Miscellaneous|18|||
127863316|NCT01066819|460116353|FG003|Overall Study|Miscellaneous|1|||
127863317|NCT01066819|460116354|FG004|Overall Study|Miscellaneous|0|||
127863318|NCT01066819|460116355|FG005|Overall Study|Miscellaneous|0|||
127863319|NCT01066819|460116350|FG000|Overall Study|Non responders|123|||
127863320|NCT01066819|460116351|FG001|Overall Study|Non responders|2|||
127863321|NCT01066819|460116352|FG002|Overall Study|Non responders|7|||
127863322|NCT01066819|460116353|FG003|Overall Study|Non responders|2|||
127863323|NCT01066819|460116354|FG004|Overall Study|Non responders|0|||
127863324|NCT01066819|460116355|FG005|Overall Study|Non responders|1|||
127863325|NCT01066819|460116350|FG000|Overall Study|Not categorised|9|||
127863326|NCT01066819|460116351|FG001|Overall Study|Not categorised|2|||
127863327|NCT01066819|460116352|FG002|Overall Study|Not categorised|6|||
127863328|NCT01066819|460116353|FG003|Overall Study|Not categorised|1|||
127863329|NCT01066819|460116354|FG004|Overall Study|Not categorised|0|||
127863330|NCT01066819|460116355|FG005|Overall Study|Not categorised|0|||
127914548|NCT00112437|460310688|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
127914549|NCT00112437|460310689|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
127914550|NCT00112437|460310690|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
127914551|NCT00112437|460310691|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
127914552|NCT00112437|460310692|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
127914553|NCT00112437|460310693|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
127914554|NCT00112437|460310668|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
127914555|NCT00112437|460310669|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
127914556|NCT00112437|460310670|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
127863331|NCT01066819|460116350|FG000|Overall Study|Relapse|16|||
127863332|NCT01066819|460116351|FG001|Overall Study|Relapse|4|||
127863333|NCT01066819|460116352|FG002|Overall Study|Relapse|3|||
127863334|NCT01066819|460116353|FG003|Overall Study|Relapse|0|||
127863335|NCT01066819|460116354|FG004|Overall Study|Relapse|0|||
127863336|NCT01066819|460116355|FG005|Overall Study|Relapse|0|||
127863337|NCT01066819|460116350|FG000|Overall Study|Results not available|1|||
127863338|NCT01066819|460116351|FG001|Overall Study|Results not available|0|||
127863339|NCT01066819|460116352|FG002|Overall Study|Results not available|0|||
127863340|NCT01066819|460116353|FG003|Overall Study|Results not available|0|||
127914557|NCT00112437|460310671|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
127914558|NCT00112437|460310672|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
127863341|NCT01066819|460116354|FG004|Overall Study|Results not available|0|||
127914559|NCT00112437|460310673|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
127863342|NCT01066819|460116355|FG005|Overall Study|Results not available|0|||
127863343|NCT01066819|460116350|FG000|Overall Study|Screen failure|1|||
127863344|NCT01066819|460116351|FG001|Overall Study|Screen failure|0|||
127863345|NCT01066819|460116352|FG002|Overall Study|Screen failure|0|||
127863346|NCT01066819|460116353|FG003|Overall Study|Screen failure|0|||
127863347|NCT01066819|460116354|FG004|Overall Study|Screen failure|0|||
127863348|NCT01066819|460116355|FG005|Overall Study|Screen failure|0|||
127863349|NCT01066819|460116350|FG000|Overall Study|Spontaneous cure|1|||
127863350|NCT01066819|460116351|FG001|Overall Study|Spontaneous cure|0|||
127863351|NCT01066819|460116352|FG002|Overall Study|Spontaneous cure|0|||
127863352|NCT01066819|460116353|FG003|Overall Study|Spontaneous cure|0|||
127863353|NCT01066819|460116354|FG004|Overall Study|Spontaneous cure|0|||
127863354|NCT01066819|460116355|FG005|Overall Study|Spontaneous cure|0|||
127863355|NCT01066819|460116350|FG000|Overall Study|Treatment never started|85|||
127863356|NCT01066819|460116351|FG001|Overall Study|Treatment never started|19|||
127863357|NCT01066819|460116352|FG002|Overall Study|Treatment never started|19|||
127863358|NCT01066819|460116353|FG003|Overall Study|Treatment never started|3|||
127863359|NCT01066819|460116354|FG004|Overall Study|Treatment never started|2|||
127863360|NCT01066819|460116355|FG005|Overall Study|Treatment never started|2|||
127863361|NCT01066819|460116350|FG000|Overall Study|Treatment stopped|12|||
127863362|NCT01066819|460116351|FG001|Overall Study|Treatment stopped|1|||
127863363|NCT01066819|460116352|FG002|Overall Study|Treatment stopped|2|||
127863364|NCT01066819|460116353|FG003|Overall Study|Treatment stopped|1|||
127863365|NCT01066819|460116354|FG004|Overall Study|Treatment stopped|0|||
127914560|NCT00112437|460310674|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
127914561|NCT00112437|460310675|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
127914562|NCT00112437|460310676|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
127914563|NCT00112437|460310677|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
127914564|NCT00112437|460310678|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
127914565|NCT00112437|460310679|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
127914566|NCT00112437|460310680|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
127914567|NCT00112437|460310681|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
127914568|NCT00112437|460310682|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
127914569|NCT00112437|460310683|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
127914570|NCT00112437|460310684|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
127914571|NCT00112437|460310685|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
127914572|NCT00112437|460310686|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
127914573|NCT00112437|460310687|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
127914574|NCT00112437|460310688|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
127914575|NCT00112437|460310689|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
127914576|NCT00112437|460310690|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
127914577|NCT00112437|460310691|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
127914578|NCT00112437|460310692|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
127914579|NCT00112437|460310693|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
127914580|NCT00112437|460310668|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
127914581|NCT00112437|460310669|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
127914582|NCT00112437|460310670|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
127914583|NCT00112437|460310671|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
127914584|NCT00112437|460310672|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
127914585|NCT00112437|460310673|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
127914586|NCT00112437|460310674|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
127914587|NCT00112437|460310675|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
127914588|NCT00112437|460310676|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
127914589|NCT00112437|460310677|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
127914590|NCT00112437|460310678|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
127914591|NCT00112437|460310679|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
127914592|NCT00112437|460310680|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
127914593|NCT00112437|460310681|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
127914594|NCT00112437|460310682|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
127914595|NCT00112437|460310683|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
127914596|NCT00112437|460310684|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
127914597|NCT00112437|460310685|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
127914598|NCT00112437|460310686|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
127914599|NCT00112437|460310687|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
127914600|NCT00112437|460310688|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
127863366|NCT01066819|460116355|FG005|Overall Study|Treatment stopped|0|||
127863367|NCT01066819|460116350|FG000|Overall Study|Other|5|||
127863368|NCT01066819|460116351|FG001|Overall Study|Other|1|||
127863369|NCT01066819|460116352|FG002|Overall Study|Other|1|||
127863370|NCT01066819|460116353|FG003|Overall Study|Other|0|||
127863371|NCT01066819|460116354|FG004|Overall Study|Other|0|||
127863372|NCT01066819|460116355|FG005|Overall Study|Other|0|||
127863373|NCT00805194|460116357|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
127863374|NCT00805194|460116358|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
127863375|NCT00805194|460116357|FG000|Overall Study|Worsening or AE of underlying disease|64|||
127863376|NCT00805194|460116358|FG001|Overall Study|Worsening or AE of underlying disease|70|||
127863377|NCT00805194|460116357|FG000|Overall Study|Other AE|84|||
127863378|NCT00805194|460116358|FG001|Overall Study|Other AE|73|||
127863379|NCT00805194|460116357|FG000|Overall Study|Protocol Violation|9|||
127863380|NCT00805194|460116358|FG001|Overall Study|Protocol Violation|9|||
127863381|NCT00805194|460116357|FG000|Overall Study|Lost to Follow-up|5|||
127863382|NCT00805194|460116358|FG001|Overall Study|Lost to Follow-up|5|||
127863383|NCT00805194|460116357|FG000|Overall Study|Withdrawal by Subject|60|||
127863384|NCT00805194|460116358|FG001|Overall Study|Withdrawal by Subject|42|||
127863385|NCT00805194|460116357|FG000|Overall Study|Not treated|3|||
127863386|NCT00805194|460116358|FG001|Overall Study|Not treated|4|||
127863387|NCT00805194|460116357|FG000|Overall Study|Reasons other than stated above|20|||
127863388|NCT00805194|460116358|FG001|Overall Study|Reasons other than stated above|16|||
127914601|NCT00112437|460310689|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
127914602|NCT00112437|460310690|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
127863389|NCT02275052|460116365|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
127863390|NCT02275052|460116366|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
127863391|NCT02275052|460116367|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
127863392|NCT02275052|460116368|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
127863393|NCT02275052|460116365|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
127863394|NCT02275052|460116366|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
127863395|NCT02275052|460116367|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
127863396|NCT02275052|460116368|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
127863397|NCT02275052|460116365|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
127863398|NCT02275052|460116366|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
127863399|NCT02275052|460116367|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
127863400|NCT02275052|460116368|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
127863401|NCT02275052|460116365|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
127863402|NCT02275052|460116366|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
127863403|NCT02275052|460116367|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
127863404|NCT02275052|460116368|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
127863405|NCT02275052|460116365|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
127863406|NCT02275052|460116366|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
127863407|NCT02275052|460116367|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
127863408|NCT02275052|460116368|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
127863409|NCT02275052|460116365|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
127863410|NCT02275052|460116366|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
127863411|NCT02275052|460116367|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
127863412|NCT02275052|460116368|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
127863413|NCT02275052|460116365|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
127863414|NCT02275052|460116366|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
127863415|NCT02275052|460116367|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
127863416|NCT02275052|460116368|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
127863417|NCT02275052|460116365|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
127863418|NCT02275052|460116366|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
127863419|NCT02275052|460116367|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
127863420|NCT02275052|460116368|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
127863421|NCT02275052|460116365|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
127863422|NCT02275052|460116366|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
127863423|NCT02275052|460116367|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
127863424|NCT02275052|460116368|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
127863425|NCT02275052|460116365|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
127863426|NCT02275052|460116366|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
127863427|NCT02275052|460116367|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
127863428|NCT02275052|460116368|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
127863429|NCT02275052|460116365|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
127863430|NCT02275052|460116366|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
127863431|NCT02275052|460116367|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
127863432|NCT02275052|460116368|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
127863433|NCT02807376|460116371|FG000|Overall Study|Intra-operative exclusion criteria|3|||
127863434|NCT02807376|460116372|FG001|Overall Study|Intra-operative exclusion criteria|0|||
127863435|NCT02807376|460116371|FG000|Overall Study|Lost to Follow-up|0|||
127863436|NCT02807376|460116372|FG001|Overall Study|Lost to Follow-up|1|||
127863437|NCT00846027|460116373|FG000|Overall Study|Death|3|||
127863438|NCT00846027|460116373|FG000|Overall Study|Disease Progression|30|||
127863439|NCT00846027|460116373|FG000|Overall Study|Toxicity|12|||
127863440|NCT00846027|460116373|FG000|Overall Study|Patient Decision|7|||
127863441|NCT00846027|460116373|FG000|Overall Study|Investigator Discretion|29|||
127863442|NCT00846027|460116373|FG000|Overall Study|Protocol Violation|2|||
127863443|NCT00846027|460116373|FG000|Overall Study|Subject Not Treated|7|||
127863444|NCT00808028|460116376|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
127863445|NCT00808028|460116377|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
127863446|NCT00808028|460116378|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
127863447|NCT00808028|460116379|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
127863448|NCT00808028|460116376|FG000|Stage 1 (6 Months)|Other|1|||
127863449|NCT00808028|460116377|FG001|Stage 1 (6 Months)|Other|0|||
127863450|NCT00808028|460116378|FG002|Stage 1 (6 Months)|Other|2|||
127863451|NCT00808028|460116379|FG003|Stage 1 (6 Months)|Other|4|||
127863452|NCT00808028|460116376|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
127863453|NCT00808028|460116377|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
127863454|NCT00808028|460116378|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
127863455|NCT00808028|460116379|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
127863456|NCT00808028|460116376|FG000|Stage 1 (6 Months)|Adverse Event|0|||
127863457|NCT00808028|460116377|FG001|Stage 1 (6 Months)|Adverse Event|0|||
127863458|NCT00808028|460116378|FG002|Stage 1 (6 Months)|Adverse Event|1|||
127863459|NCT00808028|460116379|FG003|Stage 1 (6 Months)|Adverse Event|2|||
127863460|NCT00808028|460116376|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
127863461|NCT00808028|460116377|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
127863462|NCT00808028|460116378|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
127863463|NCT00808028|460116379|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
127863464|NCT00808028|460116376|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
127863465|NCT00808028|460116377|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
127863466|NCT00808028|460116378|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
127863467|NCT00808028|460116379|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
127863468|NCT00808028|460116376|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
127863469|NCT00808028|460116377|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
127863470|NCT00808028|460116378|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
127863471|NCT00808028|460116379|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
127863472|NCT00808028|460116376|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
127863473|NCT00808028|460116377|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
127863474|NCT00808028|460116378|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
127863475|NCT00808028|460116379|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
127863476|NCT00808028|460116376|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
127863477|NCT00808028|460116377|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
127863478|NCT00808028|460116378|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
127863479|NCT00808028|460116379|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
127863480|NCT00808028|460116376|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
127863481|NCT00808028|460116377|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
127863482|NCT00808028|460116378|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
127863483|NCT00808028|460116379|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
127863484|NCT00808028|460116376|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
127863485|NCT00808028|460116377|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
127863486|NCT00808028|460116378|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
127863487|NCT00808028|460116379|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
127863488|NCT00808028|460116376|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
127863489|NCT00808028|460116377|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
127863490|NCT00808028|460116378|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
127863491|NCT00808028|460116379|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
127863492|NCT00808028|460116376|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
127863493|NCT00808028|460116377|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
127863494|NCT00808028|460116378|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
127863495|NCT00808028|460116379|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
127863496|NCT00808028|460116376|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
127863497|NCT00808028|460116377|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
127863498|NCT00808028|460116378|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
127863499|NCT00808028|460116379|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
127863500|NCT00808028|460116376|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
127863501|NCT00808028|460116377|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
127863502|NCT00808028|460116378|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
127863503|NCT00808028|460116379|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
127863504|NCT01797302|460116380|FG000|Overall Study|Lost to Follow-up|16|||
127863505|NCT01797302|460116381|FG001|Overall Study|Lost to Follow-up|23|||
127863506|NCT01797302|460116382|FG002|Overall Study|Lost to Follow-up|22|||
127863507|NCT01797302|460116380|FG000|Overall Study|Withdrawal by Subject|1|||
127863508|NCT01797302|460116381|FG001|Overall Study|Withdrawal by Subject|3|||
127863509|NCT01797302|460116382|FG002|Overall Study|Withdrawal by Subject|4|||
127863510|NCT03228836|460116383|FG000|Overall Study|Adverse Event|3|||
127863511|NCT03228836|460116383|FG000|Overall Study|Withdrawal by Subject|1|||
127863512|NCT03228836|460116383|FG000|Overall Study|Death|1|||
127863513|NCT03228836|460116383|FG000|Overall Study|Physician Decision|1|||
127863514|NCT03228836|460116383|FG000|Overall Study|Disease Progression|7|||
127863515|NCT03228836|460116383|FG000|Overall Study|Other|4|||
127863516|NCT02773849|460116385|FG000|Overall Study|Lost to Follow-up|11|||
127863517|NCT02773849|460116385|FG000|Overall Study|Death|26|||
127863518|NCT02773849|460116385|FG000|Overall Study|Withdrawal by Subject|5|||
127863519|NCT02773849|460116385|FG000|Overall Study|Withdrawal of Consent|9|||
127863520|NCT02773849|460116385|FG000|Overall Study|Other: not due to lack of tolerability|11|||
127863521|NCT00948389|460116386|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
127863522|NCT00948389|460116387|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
127863523|NCT00948389|460116388|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
127863524|NCT00948389|460116389|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
127863525|NCT00948389|460116390|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
127863526|NCT00948389|460116386|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
127863527|NCT00948389|460116387|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
127914603|NCT00112437|460310691|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
127914604|NCT00112437|460310692|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
127914605|NCT00112437|460310693|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
127914606|NCT00112437|460310668|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
127914607|NCT00112437|460310669|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
127914608|NCT00112437|460310670|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
127914609|NCT00112437|460310671|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
127914610|NCT00112437|460310672|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
127914611|NCT00112437|460310673|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
127914612|NCT00112437|460310674|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
127914613|NCT00112437|460310675|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
127914614|NCT00112437|460310676|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
127914615|NCT00112437|460310677|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
127914616|NCT00112437|460310678|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
127914617|NCT00112437|460310679|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
127914618|NCT00112437|460310680|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
127914619|NCT00112437|460310681|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
127914620|NCT00112437|460310682|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
127914621|NCT00112437|460310683|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
127914622|NCT00112437|460310684|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
127914623|NCT00112437|460310685|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
127914624|NCT00112437|460310686|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
127914625|NCT00112437|460310687|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
127914626|NCT00112437|460310688|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
127914627|NCT00112437|460310689|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
127914628|NCT00112437|460310690|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
127914629|NCT00112437|460310691|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
127914630|NCT00112437|460310692|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
127914631|NCT00112437|460310693|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
127914632|NCT00112437|460310668|FG000|Year 1 (12-Month Base Study)|moved|0|||
127914633|NCT00112437|460310669|FG001|Year 1 (12-Month Base Study)|moved|1|||
127914634|NCT00112437|460310670|FG002|Year 1 (12-Month Base Study)|moved|1|||
127914635|NCT00112437|460310671|FG003|Year 1 (12-Month Base Study)|moved|0|||
127914636|NCT00112437|460310672|FG004|Year 1 (12-Month Base Study)|moved|0|||
127914637|NCT00112437|460310673|FG005|Year 1 (12-Month Base Study)|moved|0|||
127914638|NCT00112437|460310674|FG006|Year 1 (12-Month Base Study)|moved|0|||
127914639|NCT00112437|460310675|FG007|Year 1 (12-Month Base Study)|moved|0|||
127914640|NCT00112437|460310676|FG008|Year 1 (12-Month Base Study)|moved|0|||
127914641|NCT00112437|460310677|FG009|Year 1 (12-Month Base Study)|moved|0|||
127914642|NCT00112437|460310678|FG010|Year 1 (12-Month Base Study)|moved|0|||
127914643|NCT00112437|460310679|FG011|Year 1 (12-Month Base Study)|moved|0|||
127914644|NCT00112437|460310680|FG012|Year 1 (12-Month Base Study)|moved|0|||
127914645|NCT00112437|460310681|FG013|Year 1 (12-Month Base Study)|moved|0|||
127914646|NCT00112437|460310682|FG014|Year 1 (12-Month Base Study)|moved|0|||
127914647|NCT00112437|460310683|FG015|Year 1 (12-Month Base Study)|moved|0|||
127863528|NCT00948389|460116388|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
127863529|NCT00948389|460116389|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
127863530|NCT00948389|460116390|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
127863531|NCT00948389|460116386|FG000|Overall Study|Both Progression and Toxicity|1|||
127863532|NCT00948389|460116387|FG001|Overall Study|Both Progression and Toxicity|0|||
127863533|NCT00948389|460116388|FG002|Overall Study|Both Progression and Toxicity|0|||
127863534|NCT00948389|460116389|FG003|Overall Study|Both Progression and Toxicity|0|||
127863535|NCT00948389|460116390|FG004|Overall Study|Both Progression and Toxicity|0|||
127863536|NCT02418000|460116395|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
127863537|NCT02418000|460116396|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
127863538|NCT02418000|460116397|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
127863539|NCT02418000|460116398|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
127863540|NCT02418000|460116399|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
127863541|NCT02418000|460116395|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
127863542|NCT02418000|460116396|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
127863543|NCT02418000|460116397|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
127914648|NCT00112437|460310684|FG016|Year 1 (12-Month Base Study)|moved|0|||
127914649|NCT00112437|460310685|FG017|Year 1 (12-Month Base Study)|moved|0|||
127914650|NCT00112437|460310686|FG018|Year 1 (12-Month Base Study)|moved|0|||
127914651|NCT00112437|460310687|FG019|Year 1 (12-Month Base Study)|moved|0|||
127863544|NCT02418000|460116398|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
127863545|NCT02418000|460116399|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
127863546|NCT02418000|460116395|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
127863547|NCT02418000|460116396|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
127863548|NCT02418000|460116397|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
127863549|NCT02418000|460116398|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
127863550|NCT02418000|460116399|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
127863551|NCT02418000|460116395|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
127863552|NCT02418000|460116396|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
127863553|NCT02418000|460116397|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
127863554|NCT02418000|460116398|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
127863555|NCT02418000|460116399|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
127863556|NCT02418000|460116395|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
127863557|NCT02418000|460116396|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
127863558|NCT02418000|460116397|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
127863559|NCT02418000|460116398|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
127863560|NCT02418000|460116399|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
127863561|NCT02418000|460116395|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
127863562|NCT02418000|460116396|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
127863563|NCT02418000|460116397|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
127863564|NCT02418000|460116398|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
127863565|NCT02418000|460116399|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
127863566|NCT02418000|460116395|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
127863567|NCT02418000|460116396|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
127863568|NCT02418000|460116397|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
127863569|NCT02418000|460116398|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
127863570|NCT02418000|460116399|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
127863571|NCT02418000|460116395|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
127863572|NCT02418000|460116396|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
127863573|NCT02418000|460116397|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
127863574|NCT02418000|460116398|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
127863575|NCT02418000|460116399|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
127863576|NCT02418000|460116395|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
127863577|NCT02418000|460116396|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
127863578|NCT02418000|460116397|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
127863579|NCT02418000|460116398|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
127863580|NCT02418000|460116399|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
127863581|NCT00508001|460116400|FG000|Overall Study|Adverse Event|2|||
127863582|NCT00508001|460116401|FG001|Overall Study|Adverse Event|0|||
127863583|NCT00508001|460116402|FG002|Overall Study|Adverse Event|4|||
127863584|NCT00508001|460116400|FG000|Overall Study|condition under investigation worsened|13|||
127863585|NCT00508001|460116401|FG001|Overall Study|condition under investigation worsened|7|||
127863586|NCT00508001|460116402|FG002|Overall Study|condition under investigation worsened|1|||
127863587|NCT00508001|460116400|FG000|Overall Study|Death|0|||
127863588|NCT00508001|460116401|FG001|Overall Study|Death|1|||
127863589|NCT00508001|460116402|FG002|Overall Study|Death|1|||
127863590|NCT00508001|460116400|FG000|Overall Study|Withdrawal by Subject|4|||
127863591|NCT00508001|460116401|FG001|Overall Study|Withdrawal by Subject|4|||
127863592|NCT00508001|460116402|FG002|Overall Study|Withdrawal by Subject|1|||
127863593|NCT01051856|460116424|FG000|Overall Study|Withdrawal by Subject|1|||
127863594|NCT01051856|460116425|FG001|Overall Study|Withdrawal by Subject|0|||
127863595|NCT02381795|460116426|FG000|Overall Study|Withdrawal by Subject|1|||
127863596|NCT02381795|460116426|FG000|Overall Study|Study Terminated|2|||
127863597|NCT02176226|460116427|FG000|Overall Study|Lost to Follow-up|3|||
127863598|NCT02176226|460116427|FG000|Overall Study|Withdrew prior to treatment|6|||
127863599|NCT02908841|460116434|FG000|Overall Study|Physician Decision|4|||
127863600|NCT02908841|460116435|FG001|Overall Study|Physician Decision|0|||
127863601|NCT01611558|460116436|FG000|Induction Phase|Study drug toxicity|15|||
127863602|NCT01611558|460116436|FG000|Induction Phase|Disease progression|18|||
127863603|NCT01611558|460116436|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
127863604|NCT01611558|460116436|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
127863605|NCT01611558|460116436|FG000|Induction Phase|Death|1|||
127863606|NCT01611558|460116436|FG000|Maintenance Phase|Withdrawal by Subject|1|||
127863607|NCT01611558|460116436|FG000|Maintenance Phase|Elevated Uric acid|1|||
127863608|NCT04005885|460116442|FG000|First Intervention|Withdrawal by Subject|1|||
127863609|NCT04005885|460116443|FG001|First Intervention|Withdrawal by Subject|1|||
127863610|NCT04005885|460116442|FG000|Second Intervention|Withdrawal by Subject|0|||
127863611|NCT04005885|460116443|FG001|Second Intervention|Withdrawal by Subject|2|||
127863612|NCT01412333|460116444|FG000|Overall Study|Adverse Event|40|||
127863613|NCT01412333|460116445|FG001|Overall Study|Adverse Event|42|||
127914652|NCT00112437|460310688|FG020|Year 1 (12-Month Base Study)|moved|0|||
127914653|NCT00112437|460310689|FG021|Year 1 (12-Month Base Study)|moved|0|||
127914654|NCT00112437|460310690|FG022|Year 1 (12-Month Base Study)|moved|0|||
127914655|NCT00112437|460310691|FG023|Year 1 (12-Month Base Study)|moved|0|||
127914656|NCT00112437|460310692|FG024|Year 1 (12-Month Base Study)|moved|0|||
127914657|NCT00112437|460310693|FG025|Year 1 (12-Month Base Study)|moved|0|||
127914658|NCT00112437|460310668|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
127914659|NCT00112437|460310669|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
127914660|NCT00112437|460310670|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
127914661|NCT00112437|460310671|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
127914662|NCT00112437|460310672|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
127914663|NCT00112437|460310673|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
127914664|NCT00112437|460310674|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
127914665|NCT00112437|460310675|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
127914666|NCT00112437|460310676|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
127914667|NCT00112437|460310677|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
127914668|NCT00112437|460310678|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
127914669|NCT00112437|460310679|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
127914670|NCT00112437|460310680|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
127914671|NCT00112437|460310681|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
127914672|NCT00112437|460310682|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
127914673|NCT00112437|460310683|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
127914674|NCT00112437|460310684|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
127914675|NCT00112437|460310685|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
127914676|NCT00112437|460310686|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
127914677|NCT00112437|460310687|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
127914678|NCT00112437|460310688|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
127914679|NCT00112437|460310689|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
127914680|NCT00112437|460310690|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
127914681|NCT00112437|460310691|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
127914682|NCT00112437|460310692|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
127914683|NCT00112437|460310693|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
127914684|NCT00112437|460310668|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
127914685|NCT00112437|460310669|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
127914686|NCT00112437|460310670|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
127914687|NCT00112437|460310671|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
127914688|NCT00112437|460310672|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
127914689|NCT00112437|460310673|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
127914690|NCT00112437|460310674|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
127914691|NCT00112437|460310675|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
127914692|NCT00112437|460310676|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
127914693|NCT00112437|460310677|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
127914694|NCT00112437|460310678|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
127914695|NCT00112437|460310679|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
127914696|NCT00112437|460310680|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
127914697|NCT00112437|460310681|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
127914698|NCT00112437|460310682|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
127914699|NCT00112437|460310683|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
127914700|NCT00112437|460310684|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
127914701|NCT00112437|460310685|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
127914702|NCT00112437|460310686|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
127914703|NCT00112437|460310687|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
127914704|NCT00112437|460310688|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
127863614|NCT01412333|460116444|FG000|Overall Study|Death|5|||
127863615|NCT01412333|460116445|FG001|Overall Study|Death|6|||
127863616|NCT01412333|460116444|FG000|Overall Study|Lack of Efficacy|22|||
127863617|NCT01412333|460116445|FG001|Overall Study|Lack of Efficacy|10|||
127863618|NCT01412333|460116444|FG000|Overall Study|Lost to Follow-up|15|||
127863619|NCT01412333|460116445|FG001|Overall Study|Lost to Follow-up|12|||
127863620|NCT01412333|460116444|FG000|Overall Study|Non-Compliance|3|||
127863621|NCT01412333|460116445|FG001|Overall Study|Non-Compliance|7|||
127863622|NCT01412333|460116444|FG000|Overall Study|Non-Compliance With Study Drug|1|||
127863623|NCT01412333|460116445|FG001|Overall Study|Non-Compliance With Study Drug|1|||
127863624|NCT01412333|460116444|FG000|Overall Study|Other|30|||
127863625|NCT01412333|460116445|FG001|Overall Study|Other|33|||
127863626|NCT01412333|460116444|FG000|Overall Study|Physician Decision|11|||
127863627|NCT01412333|460116445|FG001|Overall Study|Physician Decision|16|||
127863628|NCT01412333|460116444|FG000|Overall Study|Pregnancy|6|||
127863629|NCT01412333|460116445|FG001|Overall Study|Pregnancy|4|||
127863630|NCT01412333|460116444|FG000|Overall Study|Protocol Violation|1|||
127863631|NCT01412333|460116445|FG001|Overall Study|Protocol Violation|2|||
127863632|NCT01412333|460116444|FG000|Overall Study|Study Terminated By Sponsor|3|||
127863633|NCT01412333|460116445|FG001|Overall Study|Study Terminated By Sponsor|2|||
127863634|NCT01412333|460116444|FG000|Overall Study|Withdrawal by Subject|51|||
127863635|NCT01412333|460116445|FG001|Overall Study|Withdrawal by Subject|54|||
127863636|NCT01412333|460116444|FG000|Overall Study|Missing|1|||
127863637|NCT01412333|460116445|FG001|Overall Study|Missing|3|||
127863638|NCT00750867|460116447|FG000|Overall Study|Adverse Event|2|||
127863639|NCT02718625|460116448|FG000|Overall Study|Adverse Event|0|||
127863640|NCT02718625|460116449|FG001|Overall Study|Adverse Event|1|||
127863641|NCT02718625|460116448|FG000|Overall Study|Termination of Study by Sponsor|0|||
127863642|NCT02718625|460116449|FG001|Overall Study|Termination of Study by Sponsor|1|||
127863643|NCT01947127|460116454|FG000|Overall Study|Protocol Violation|18|||
127863644|NCT01947127|460116455|FG001|Overall Study|Protocol Violation|38|||
127863645|NCT01947127|460116454|FG000|Overall Study|Withdrawal by Subject|1|||
127863646|NCT01947127|460116455|FG001|Overall Study|Withdrawal by Subject|1|||
127863647|NCT01947127|460116454|FG000|Overall Study|Data loss|4|||
127863648|NCT01947127|460116455|FG001|Overall Study|Data loss|4|||
127863649|NCT01836549|460116456|FG000|Overall Study|Did not receive study drug|0|||
127863650|NCT01836549|460116457|FG001|Overall Study|Did not receive study drug|0|||
127863651|NCT01836549|460116458|FG002|Overall Study|Did not receive study drug|1|||
127863652|NCT01836549|460116459|FG003|Overall Study|Did not receive study drug|0|||
127863653|NCT01836549|460116460|FG004|Overall Study|Did not receive study drug|0|||
127863654|NCT01836549|460116461|FG005|Overall Study|Did not receive study drug|0|||
127863655|NCT01836549|460116462|FG006|Overall Study|Did not receive study drug|0|||
127863656|NCT01836549|460116456|FG000|Overall Study|Patient declared ineligible|0|||
127863657|NCT01836549|460116457|FG001|Overall Study|Patient declared ineligible|0|||
127863658|NCT01836549|460116458|FG002|Overall Study|Patient declared ineligible|0|||
127863659|NCT01836549|460116459|FG003|Overall Study|Patient declared ineligible|1|||
127863660|NCT01836549|460116460|FG004|Overall Study|Patient declared ineligible|0|||
127863661|NCT01836549|460116461|FG005|Overall Study|Patient declared ineligible|0|||
127863662|NCT01836549|460116462|FG006|Overall Study|Patient declared ineligible|0|||
127863663|NCT01836549|460116456|FG000|Overall Study|Patient inevaluable to start therapy|0|||
127863664|NCT01836549|460116457|FG001|Overall Study|Patient inevaluable to start therapy|0|||
127863665|NCT01836549|460116458|FG002|Overall Study|Patient inevaluable to start therapy|0|||
127863666|NCT01836549|460116459|FG003|Overall Study|Patient inevaluable to start therapy|0|||
127863667|NCT01836549|460116460|FG004|Overall Study|Patient inevaluable to start therapy|0|||
127863668|NCT01836549|460116461|FG005|Overall Study|Patient inevaluable to start therapy|0|||
127863669|NCT01836549|460116462|FG006|Overall Study|Patient inevaluable to start therapy|1|||
127863670|NCT02516306|460116463|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
127863671|NCT02516306|460116464|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
127863672|NCT01969565|460116468|FG000|Overall Study|Withdrawal by Subject|1|||
127863673|NCT00242710|460116469|FG000|Core Study (up to Year 1)|Adverse Event|30|||
127863674|NCT00242710|460116470|FG001|Core Study (up to Year 1)|Adverse Event|25|||
127863675|NCT00242710|460116471|FG002|Core Study (up to Year 1)|Adverse Event|23|||
127863676|NCT00242710|460116472|FG003|Core Study (up to Year 1)|Adverse Event|14|||
127863677|NCT00242710|460116469|FG000|Core Study (up to Year 1)|Death|0|||
127863678|NCT00242710|460116470|FG001|Core Study (up to Year 1)|Death|0|||
127863679|NCT00242710|460116471|FG002|Core Study (up to Year 1)|Death|1|||
127863680|NCT00242710|460116472|FG003|Core Study (up to Year 1)|Death|0|||
127863681|NCT00242710|460116469|FG000|Core Study (up to Year 1)|Physician Decision|0|||
127863682|NCT00242710|460116470|FG001|Core Study (up to Year 1)|Physician Decision|1|||
127863683|NCT00242710|460116471|FG002|Core Study (up to Year 1)|Physician Decision|0|||
127863684|NCT00242710|460116472|FG003|Core Study (up to Year 1)|Physician Decision|1|||
127863685|NCT00242710|460116469|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
127863686|NCT00242710|460116470|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
127863687|NCT00242710|460116471|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
127863688|NCT00242710|460116472|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
127863689|NCT00242710|460116469|FG000|Core Study (up to Year 1)|Other|6|||
127914705|NCT00112437|460310689|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
127914706|NCT00112437|460310690|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
127914707|NCT00112437|460310691|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
127914708|NCT00112437|460310692|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
127914709|NCT00112437|460310693|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
127914710|NCT00112437|460310668|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
127914711|NCT00112437|460310669|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
127914712|NCT00112437|460310670|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
127914713|NCT00112437|460310671|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
127914714|NCT00112437|460310672|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
127914715|NCT00112437|460310673|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
127914716|NCT00112437|460310674|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
127914717|NCT00112437|460310675|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
127914718|NCT00112437|460310676|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
127914719|NCT00112437|460310677|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
127914720|NCT00112437|460310678|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
127914721|NCT00112437|460310679|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
127914722|NCT00112437|460310680|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
127914723|NCT00112437|460310681|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
127914724|NCT00112437|460310682|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
127914725|NCT00112437|460310683|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
127914726|NCT00112437|460310684|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
127914727|NCT00112437|460310685|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
127914728|NCT00112437|460310686|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
127914729|NCT00112437|460310687|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
127914730|NCT00112437|460310688|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
127914731|NCT00112437|460310689|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
127914732|NCT00112437|460310690|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
127914733|NCT00112437|460310691|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
127914734|NCT00112437|460310692|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
127914735|NCT00112437|460310693|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
127914736|NCT00112437|460310668|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
127914737|NCT00112437|460310669|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
127914738|NCT00112437|460310670|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
127914739|NCT00112437|460310671|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
127914740|NCT00112437|460310672|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
127914741|NCT00112437|460310673|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
127914742|NCT00112437|460310674|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
127914743|NCT00112437|460310675|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
127914744|NCT00112437|460310676|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
127914745|NCT00112437|460310677|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
127863690|NCT00242710|460116470|FG001|Core Study (up to Year 1)|Other|1|||
127863691|NCT00242710|460116471|FG002|Core Study (up to Year 1)|Other|0|||
127863692|NCT00242710|460116472|FG003|Core Study (up to Year 1)|Other|2|||
127863693|NCT00242710|460116469|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
127863694|NCT00242710|460116470|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
127863695|NCT00242710|460116471|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
127863696|NCT00242710|460116472|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
127863697|NCT00242710|460116469|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
127863698|NCT00242710|460116470|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
127863699|NCT00242710|460116471|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
127863700|NCT00242710|460116472|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
127863701|NCT00242710|460116469|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
127863702|NCT00242710|460116470|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
127863703|NCT00242710|460116471|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
127863704|NCT00242710|460116472|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
127863705|NCT00242710|460116469|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
127863706|NCT00242710|460116470|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
127863707|NCT00242710|460116471|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
127863708|NCT00242710|460116472|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
127863709|NCT00242710|460116469|FG000|Period Between Core Study and Extension|Adverse Event|2|||
127863710|NCT00242710|460116470|FG001|Period Between Core Study and Extension|Adverse Event|3|||
127863711|NCT00242710|460116471|FG002|Period Between Core Study and Extension|Adverse Event|5|||
127863712|NCT00242710|460116472|FG003|Period Between Core Study and Extension|Adverse Event|2|||
127863713|NCT00242710|460116469|FG000|Period Between Core Study and Extension|Physician Decision|1|||
127863714|NCT00242710|460116470|FG001|Period Between Core Study and Extension|Physician Decision|1|||
127863715|NCT00242710|460116471|FG002|Period Between Core Study and Extension|Physician Decision|0|||
127863716|NCT00242710|460116472|FG003|Period Between Core Study and Extension|Physician Decision|0|||
127863717|NCT00242710|460116469|FG000|Period Between Core Study and Extension|Other|24|||
127863718|NCT00242710|460116470|FG001|Period Between Core Study and Extension|Other|24|||
127863719|NCT00242710|460116471|FG002|Period Between Core Study and Extension|Other|9|||
127863720|NCT00242710|460116472|FG003|Period Between Core Study and Extension|Other|11|||
127863721|NCT00242710|460116469|FG000|Period Between Core Study and Extension|Extension not Available|17|||
127863722|NCT00242710|460116470|FG001|Period Between Core Study and Extension|Extension not Available|21|||
127863723|NCT00242710|460116471|FG002|Period Between Core Study and Extension|Extension not Available|8|||
127863724|NCT00242710|460116472|FG003|Period Between Core Study and Extension|Extension not Available|7|||
127863725|NCT00242710|460116469|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
127863726|NCT00242710|460116470|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
127863727|NCT00242710|460116471|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
127863728|NCT00242710|460116472|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
127863729|NCT00242710|460116469|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
127863730|NCT00242710|460116470|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
127863731|NCT00242710|460116471|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
127863732|NCT00242710|460116472|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
127863733|NCT00242710|460116469|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
127863734|NCT00242710|460116470|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
127863735|NCT00242710|460116471|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
127863736|NCT00242710|460116472|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
127863737|NCT00242710|460116469|FG000|Study Extension (up to Year 2)|Death|0|||
127863738|NCT00242710|460116470|FG001|Study Extension (up to Year 2)|Death|0|||
127863739|NCT00242710|460116471|FG002|Study Extension (up to Year 2)|Death|0|||
127863740|NCT00242710|460116472|FG003|Study Extension (up to Year 2)|Death|1|||
127863741|NCT00242710|460116469|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
127863742|NCT00242710|460116470|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
127863743|NCT00242710|460116471|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
127863744|NCT00242710|460116472|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
127863745|NCT00242710|460116469|FG000|Study Extension (up to Year 2)|Other|3|||
127863746|NCT00242710|460116470|FG001|Study Extension (up to Year 2)|Other|5|||
127863747|NCT00242710|460116471|FG002|Study Extension (up to Year 2)|Other|4|||
127863748|NCT00242710|460116472|FG003|Study Extension (up to Year 2)|Other|3|||
127863749|NCT00242710|460116469|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
127863750|NCT00242710|460116470|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
127863751|NCT00242710|460116471|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
127863752|NCT00242710|460116472|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
127863753|NCT00242710|460116469|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
127863754|NCT00242710|460116470|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
127863755|NCT00242710|460116471|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
127863756|NCT00242710|460116472|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
127863757|NCT00579527|460116473|FG000|Overall Study|Death|4|||
127863758|NCT03961529|460116474|FG000|Overall Study|Adverse Event|13|||
127863759|NCT03961529|460116475|FG001|Overall Study|Adverse Event|5|||
127863760|NCT03961529|460116476|FG002|Overall Study|Adverse Event|2|||
127863761|NCT03961529|460116474|FG000|Overall Study|Withdrawal by Subject|17|||
127863762|NCT03961529|460116475|FG001|Overall Study|Withdrawal by Subject|2|||
127863763|NCT03961529|460116476|FG002|Overall Study|Withdrawal by Subject|1|||
127863764|NCT03961529|460116474|FG000|Overall Study|Withdrawal by parent/guardian|0|||
127863765|NCT03961529|460116475|FG001|Overall Study|Withdrawal by parent/guardian|7|||
127863766|NCT03961529|460116476|FG002|Overall Study|Withdrawal by parent/guardian|0|||
127863767|NCT03961529|460116474|FG000|Overall Study|Physician Decision|2|||
127863768|NCT03961529|460116475|FG001|Overall Study|Physician Decision|1|||
127863769|NCT03961529|460116476|FG002|Overall Study|Physician Decision|1|||
127863770|NCT03961529|460116474|FG000|Overall Study|Lost to Follow-up|2|||
127863771|NCT03961529|460116475|FG001|Overall Study|Lost to Follow-up|1|||
127863772|NCT03961529|460116476|FG002|Overall Study|Lost to Follow-up|0|||
127863773|NCT03961529|460116474|FG000|Overall Study|Lack of Efficacy|2|||
127914746|NCT00112437|460310678|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
127863774|NCT03961529|460116475|FG001|Overall Study|Lack of Efficacy|0|||
127863775|NCT03961529|460116476|FG002|Overall Study|Lack of Efficacy|1|||
127863776|NCT03961529|460116474|FG000|Overall Study|Other|6|||
127863777|NCT03961529|460116475|FG001|Overall Study|Other|1|||
127863778|NCT03961529|460116476|FG002|Overall Study|Other|0|||
127914747|NCT00112437|460310679|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
127914748|NCT00112437|460310680|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
127914749|NCT00112437|460310681|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
127914750|NCT00112437|460310682|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
127914751|NCT00112437|460310683|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
127914752|NCT00112437|460310684|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
127914753|NCT00112437|460310685|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
127914754|NCT00112437|460310686|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
127914755|NCT00112437|460310687|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
127914756|NCT00112437|460310688|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
127914757|NCT00112437|460310689|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
127914758|NCT00112437|460310690|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
127914759|NCT00112437|460310691|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
127914760|NCT00112437|460310692|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
127914761|NCT00112437|460310693|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
127914762|NCT00112437|460310668|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
127914763|NCT00112437|460310669|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
127914764|NCT00112437|460310670|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
127914765|NCT00112437|460310671|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
127914766|NCT00112437|460310672|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
127914767|NCT00112437|460310673|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
127914768|NCT00112437|460310674|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
127914769|NCT00112437|460310675|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
127914770|NCT00112437|460310676|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
127914771|NCT00112437|460310677|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
127914772|NCT00112437|460310678|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
127914773|NCT00112437|460310679|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
127914774|NCT00112437|460310680|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
127914775|NCT00112437|460310681|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
127914776|NCT00112437|460310682|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
127914777|NCT00112437|460310683|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
127914778|NCT00112437|460310684|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
127914779|NCT00112437|460310685|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
127914780|NCT00112437|460310686|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
127914781|NCT00112437|460310687|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
127914782|NCT00112437|460310688|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
127914783|NCT00112437|460310689|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
127914784|NCT00112437|460310690|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
127914785|NCT00112437|460310691|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
127914786|NCT00112437|460310692|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
127914787|NCT00112437|460310693|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
127914788|NCT00112437|460310668|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
127914789|NCT00112437|460310669|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
127914790|NCT00112437|460310670|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
127914791|NCT00112437|460310671|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
127914792|NCT00112437|460310672|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
127914793|NCT00112437|460310673|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
127914794|NCT00112437|460310674|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
127914795|NCT00112437|460310675|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
127914796|NCT00112437|460310676|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
127914797|NCT00112437|460310677|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
127914798|NCT00112437|460310678|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
127914799|NCT00112437|460310679|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
127914800|NCT00112437|460310680|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
127914801|NCT00112437|460310681|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
127914802|NCT00112437|460310682|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
127863779|NCT03644173|460116477|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
127863780|NCT03644173|460116477|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
127863781|NCT03644173|460116477|FG000|Participants at the 1-month Follow up|Death|2|||
127863782|NCT03644173|460116477|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
127863783|NCT00381706|460116480|FG000|Overall Study|Never treated|7|||
127863784|NCT00381706|460116481|FG001|Overall Study|Never treated|2|||
127863785|NCT00381706|460116482|FG002|Overall Study|Never treated|1|||
127863786|NCT00472043|460116484|FG000|Overall Study|Withdrawal by Subject|1|||
127863787|NCT00472043|460116485|FG001|Overall Study|Withdrawal by Subject|0|||
127863788|NCT00472043|460116484|FG000|Overall Study|Death|1|||
127863789|NCT00472043|460116485|FG001|Overall Study|Death|0|||
127863790|NCT03922711|460116486|FG000|Overall Study|Adverse Event|3|||
127863791|NCT03922711|460116487|FG001|Overall Study|Adverse Event|2|||
127863792|NCT03922711|460116488|FG002|Overall Study|Adverse Event|2|||
127863793|NCT03922711|460116486|FG000|Overall Study|Protocol Violation|1|||
127863794|NCT03922711|460116487|FG001|Overall Study|Protocol Violation|0|||
127863795|NCT03922711|460116488|FG002|Overall Study|Protocol Violation|0|||
127863796|NCT03922711|460116486|FG000|Overall Study|Withdrawal by Subject|0|||
127863797|NCT03922711|460116487|FG001|Overall Study|Withdrawal by Subject|3|||
127863798|NCT03922711|460116488|FG002|Overall Study|Withdrawal by Subject|1|||
127863799|NCT03922711|460116486|FG000|Overall Study|Not further specified|0|||
127863800|NCT03922711|460116487|FG001|Overall Study|Not further specified|0|||
127863801|NCT03922711|460116488|FG002|Overall Study|Not further specified|1|||
127863802|NCT00877890|460116493|FG000|Overall Study|Adverse Event|6|||
127863803|NCT00877890|460116494|FG001|Overall Study|Adverse Event|6|||
127863804|NCT00877890|460116493|FG000|Overall Study|Lost to Follow-up|5|||
127863805|NCT00877890|460116494|FG001|Overall Study|Lost to Follow-up|5|||
127863806|NCT00877890|460116493|FG000|Overall Study|Protocol Violation|0|||
127863807|NCT00877890|460116494|FG001|Overall Study|Protocol Violation|1|||
127863808|NCT00877890|460116493|FG000|Overall Study|Withdrawal of Consent|6|||
127863809|NCT00877890|460116494|FG001|Overall Study|Withdrawal of Consent|12|||
127863810|NCT00877890|460116493|FG000|Overall Study|Investigator Decision|0|||
127863811|NCT00877890|460116494|FG001|Overall Study|Investigator Decision|2|||
127863812|NCT00877890|460116493|FG000|Overall Study|Loss of Glucose Control|3|||
127863813|NCT00877890|460116494|FG001|Overall Study|Loss of Glucose Control|4|||
127863814|NCT00606021|460116500|FG000|Induction Phase|Death|73|||
127863815|NCT00606021|460116501|FG001|Induction Phase|Death|0|||
127863816|NCT00606021|460116502|FG002|Induction Phase|Death|0|||
127863817|NCT00606021|460116500|FG000|Induction Phase|Physician Decision|2|||
127863818|NCT00606021|460116501|FG001|Induction Phase|Physician Decision|0|||
127863819|NCT00606021|460116502|FG002|Induction Phase|Physician Decision|0|||
127863820|NCT00606021|460116500|FG000|Induction Phase|Withdrawal by Subject|2|||
127863821|NCT00606021|460116501|FG001|Induction Phase|Withdrawal by Subject|0|||
127863822|NCT00606021|460116502|FG002|Induction Phase|Withdrawal by Subject|0|||
127863823|NCT00606021|460116500|FG000|Induction Phase|Lost to Follow-up|10|||
127863824|NCT00606021|460116501|FG001|Induction Phase|Lost to Follow-up|0|||
127863825|NCT00606021|460116502|FG002|Induction Phase|Lost to Follow-up|0|||
127863826|NCT00606021|460116500|FG000|Maintenance Phase|Death|0|||
127863827|NCT00606021|460116501|FG001|Maintenance Phase|Death|17|||
127863828|NCT00606021|460116502|FG002|Maintenance Phase|Death|15|||
127863829|NCT00606021|460116500|FG000|Maintenance Phase|Physician Decision|0|||
127863830|NCT00606021|460116501|FG001|Maintenance Phase|Physician Decision|1|||
127863831|NCT00606021|460116502|FG002|Maintenance Phase|Physician Decision|0|||
127863832|NCT00606021|460116500|FG000|Maintenance Phase|Lost to Follow-up|0|||
127863833|NCT00606021|460116501|FG001|Maintenance Phase|Lost to Follow-up|5|||
127863834|NCT00606021|460116502|FG002|Maintenance Phase|Lost to Follow-up|2|||
127863835|NCT03049852|460116503|FG000|Overall Study|Lost to Follow-up|0|||
127863836|NCT03049852|460116504|FG001|Overall Study|Lost to Follow-up|1|||
127863837|NCT03049852|460116505|FG002|Overall Study|Lost to Follow-up|0|||
127863838|NCT02067104|460116506|FG000|Overall Study|Study termination due to low accrual|4|||
127863839|NCT02067104|460116507|FG001|Overall Study|Study termination due to low accrual|5|||
127863840|NCT04728815|460116521|FG000|Overall Study|Lost to Follow-up|3|||
127863841|NCT04728815|460116522|FG001|Overall Study|Lost to Follow-up|0|||
127863842|NCT04728815|460116523|FG002|Overall Study|Lost to Follow-up|0|||
127863843|NCT04728815|460116524|FG003|Overall Study|Lost to Follow-up|1|||
127863844|NCT04728815|460116525|FG004|Overall Study|Lost to Follow-up|1|||
127863845|NCT04728815|460116526|FG005|Overall Study|Lost to Follow-up|0|||
127863846|NCT04728815|460116527|FG006|Overall Study|Lost to Follow-up|2|||
127863847|NCT04728815|460116528|FG007|Overall Study|Lost to Follow-up|0|||
127863848|NCT04728815|460116521|FG000|Overall Study|Physician Decision|0|||
127863849|NCT04728815|460116522|FG001|Overall Study|Physician Decision|0|||
127863850|NCT04728815|460116523|FG002|Overall Study|Physician Decision|1|||
127863851|NCT04728815|460116524|FG003|Overall Study|Physician Decision|0|||
127863852|NCT04728815|460116525|FG004|Overall Study|Physician Decision|0|||
127863853|NCT04728815|460116526|FG005|Overall Study|Physician Decision|0|||
127863854|NCT04728815|460116527|FG006|Overall Study|Physician Decision|0|||
127863855|NCT04728815|460116528|FG007|Overall Study|Physician Decision|0|||
127863856|NCT04728815|460116521|FG000|Overall Study|Treatment drop|0|||
127863857|NCT04728815|460116522|FG001|Overall Study|Treatment drop|2|||
127863858|NCT04728815|460116523|FG002|Overall Study|Treatment drop|1|||
127863859|NCT04728815|460116524|FG003|Overall Study|Treatment drop|0|||
127863860|NCT04728815|460116525|FG004|Overall Study|Treatment drop|3|||
127863861|NCT04728815|460116526|FG005|Overall Study|Treatment drop|1|||
127863862|NCT04728815|460116527|FG006|Overall Study|Treatment drop|3|||
127863863|NCT04728815|460116528|FG007|Overall Study|Treatment drop|0|||
127863864|NCT04728815|460116521|FG000|Overall Study|Study drop|0|||
127863865|NCT04728815|460116522|FG001|Overall Study|Study drop|3|||
127863866|NCT04728815|460116523|FG002|Overall Study|Study drop|3|||
127863867|NCT04728815|460116524|FG003|Overall Study|Study drop|0|||
127863868|NCT04728815|460116525|FG004|Overall Study|Study drop|0|||
127863869|NCT04728815|460116526|FG005|Overall Study|Study drop|0|||
127863870|NCT04728815|460116527|FG006|Overall Study|Study drop|7|||
127863871|NCT04728815|460116528|FG007|Overall Study|Study drop|0|||
127863872|NCT00957034|460116529|FG000|Overall Study|Adverse Event|0|||
127863873|NCT00957034|460116530|FG001|Overall Study|Adverse Event|1|||
127863874|NCT00957034|460116531|FG002|Overall Study|Adverse Event|1|||
127863875|NCT00957034|460116529|FG000|Overall Study|Sponsor Terminated Study|6|||
127863876|NCT00957034|460116530|FG001|Overall Study|Sponsor Terminated Study|1|||
127863877|NCT00957034|460116531|FG002|Overall Study|Sponsor Terminated Study|5|||
127863878|NCT00957034|460116529|FG000|Overall Study|Withdrawal by Subject|0|||
127863879|NCT00957034|460116530|FG001|Overall Study|Withdrawal by Subject|2|||
127863880|NCT00957034|460116531|FG002|Overall Study|Withdrawal by Subject|0|||
127863881|NCT02390167|460118957|FG000|Overall Study|Lost to Follow-up|1|||
127863882|NCT02033369|460118958|FG000|Overall Study|Physician Decision|1|||
127863883|NCT02033369|460118959|FG001|Overall Study|Physician Decision|2|||
127863884|NCT02033369|460118958|FG000|Overall Study|Not a good demographic match|0|||
127914803|NCT00112437|460310683|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
127914804|NCT00112437|460310684|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
127914805|NCT00112437|460310685|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
127914806|NCT00112437|460310686|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
127914807|NCT00112437|460310687|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
127914808|NCT00112437|460310688|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
127914809|NCT00112437|460310689|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
127914810|NCT00112437|460310690|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
127914811|NCT00112437|460310691|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
127914812|NCT00112437|460310692|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
127914813|NCT00112437|460310693|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
127914814|NCT00112437|460310668|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
127914815|NCT00112437|460310669|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
127914816|NCT00112437|460310670|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
127914817|NCT00112437|460310671|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
127914818|NCT00112437|460310672|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
127914819|NCT00112437|460310673|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
127914820|NCT00112437|460310674|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
127914821|NCT00112437|460310675|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
127914822|NCT00112437|460310676|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
127914823|NCT00112437|460310677|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
127914824|NCT00112437|460310678|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
127914825|NCT00112437|460310679|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
127914826|NCT00112437|460310680|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
127914827|NCT00112437|460310681|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
127914828|NCT00112437|460310682|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
127914829|NCT00112437|460310683|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
127914830|NCT00112437|460310684|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
127914831|NCT00112437|460310685|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
127914832|NCT00112437|460310686|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
127914833|NCT00112437|460310687|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
127914834|NCT00112437|460310688|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
127914835|NCT00112437|460310689|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
127914836|NCT00112437|460310690|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
127914837|NCT00112437|460310691|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
127914838|NCT00112437|460310692|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
127914839|NCT00112437|460310693|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
127914840|NCT00112437|460310668|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
127914841|NCT00112437|460310669|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
127914842|NCT00112437|460310670|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
127914843|NCT00112437|460310671|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
127914844|NCT00112437|460310672|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
127914845|NCT00112437|460310673|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
127914846|NCT00112437|460310674|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
127914847|NCT00112437|460310675|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
127914848|NCT00112437|460310676|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
127914849|NCT00112437|460310677|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
127914850|NCT00112437|460310678|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
127914851|NCT00112437|460310679|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
127914852|NCT00112437|460310680|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
127914853|NCT00112437|460310681|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
127914854|NCT00112437|460310682|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
127914855|NCT00112437|460310683|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
127914856|NCT00112437|460310684|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
127914857|NCT00112437|460310685|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
127914858|NCT00112437|460310686|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
127914859|NCT00112437|460310687|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
127914860|NCT00112437|460310688|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
127914861|NCT00112437|460310689|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
127914862|NCT00112437|460310690|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
127914863|NCT00112437|460310691|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
127914864|NCT00112437|460310692|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
127914865|NCT00112437|460310693|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
127914866|NCT00112437|460310668|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
127914867|NCT00112437|460310669|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
127914868|NCT00112437|460310670|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
127914869|NCT00112437|460310671|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
127914870|NCT00112437|460310672|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
127914871|NCT00112437|460310673|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
127914872|NCT00112437|460310674|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
127914873|NCT00112437|460310675|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
127914874|NCT00112437|460310676|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
127914875|NCT00112437|460310677|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
127914876|NCT00112437|460310678|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
127914877|NCT00112437|460310679|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
127914878|NCT00112437|460310680|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
127914879|NCT00112437|460310681|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
127914880|NCT00112437|460310682|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
127914881|NCT00112437|460310683|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
127914882|NCT00112437|460310684|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
127914883|NCT00112437|460310685|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
127914884|NCT00112437|460310686|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
127914885|NCT00112437|460310687|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
127914886|NCT00112437|460310688|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
127914887|NCT00112437|460310689|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
127863885|NCT02033369|460118959|FG001|Overall Study|Not a good demographic match|2|||
127863886|NCT02033369|460118958|FG000|Overall Study|Withdrawal by Subject|1|||
127863887|NCT02033369|460118959|FG001|Overall Study|Withdrawal by Subject|1|||
127863888|NCT02033369|460118958|FG000|Overall Study|Lost to Follow-up|1|||
127863889|NCT02033369|460118959|FG001|Overall Study|Lost to Follow-up|0|||
127863890|NCT02033369|460118958|FG000|Overall Study|Protocol Violation|2|||
127863891|NCT02033369|460118959|FG001|Overall Study|Protocol Violation|0|||
127863892|NCT01265719|460118965|FG000|Overall Study|Does not meet entrance criteria|0|||
127863893|NCT01265719|460118966|FG001|Overall Study|Does not meet entrance criteria|3|||
127863894|NCT01265719|460118965|FG000|Overall Study|Other reasons|2|||
127863895|NCT01265719|460118966|FG001|Overall Study|Other reasons|0|||
127863896|NCT01265719|460118965|FG000|Overall Study|Withdrawal by Subject|8|||
127863897|NCT01265719|460118966|FG001|Overall Study|Withdrawal by Subject|3|||
127863898|NCT01265719|460118965|FG000|Overall Study|Lost to Follow-up|2|||
127863899|NCT01265719|460118966|FG001|Overall Study|Lost to Follow-up|7|||
127863900|NCT01265719|460118965|FG000|Overall Study|Adverse Event|2|||
127863901|NCT01265719|460118966|FG001|Overall Study|Adverse Event|0|||
127863902|NCT04335929|460118967|FG000|Overall Study|Lost to Follow-up|10|||
127863903|NCT00413231|460118968|FG000|0 to 30-day Post Treatment|Death|5|||
127863904|NCT00413231|460118968|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
127863905|NCT00413231|460118968|FG000|30-day to 365-day Post Treatment|Death|13|||
127863906|NCT00413231|460118968|FG000|365-day to 60-month Post Treatment|Death|36|||
127863907|NCT00413231|460118968|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
127863908|NCT00413231|460118968|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
127863909|NCT00413231|460118968|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
127863910|NCT02408016|460118969|FG000|Overall Study|Death|6|||
127863911|NCT02408016|460118970|FG001|Overall Study|Death|1|||
127863912|NCT02408016|460118971|FG002|Overall Study|Death|0|||
127863913|NCT02408016|460118969|FG000|Overall Study|Physician Decision|0|||
127863914|NCT02408016|460118970|FG001|Overall Study|Physician Decision|2|||
127863915|NCT02408016|460118971|FG002|Overall Study|Physician Decision|0|||
127863916|NCT02967562|460118973|FG000|Overall Study|Consent not obtained|1|||
127863917|NCT02967562|460118974|FG001|Overall Study|Consent not obtained|0|||
127863918|NCT02967562|460118973|FG000|Overall Study|High leak precluding analysis|1|||
127863919|NCT02967562|460118974|FG001|Overall Study|High leak precluding analysis|1|||
127863920|NCT00106626|460118975|FG000|Overall Study|Adverse Event|5|||
127863921|NCT00106626|460118976|FG001|Overall Study|Adverse Event|4|||
127863922|NCT00106626|460118977|FG002|Overall Study|Adverse Event|3|||
127863923|NCT00106626|460118978|FG003|Overall Study|Adverse Event|3|||
127863924|NCT00106626|460118975|FG000|Overall Study|Progressive Disease|4|||
127863925|NCT00106626|460118976|FG001|Overall Study|Progressive Disease|1|||
127863926|NCT00106626|460118977|FG002|Overall Study|Progressive Disease|9|||
127863927|NCT00106626|460118978|FG003|Overall Study|Progressive Disease|10|||
127863928|NCT00106626|460118975|FG000|Overall Study|Received radiation on new therapy|1|||
127863929|NCT00106626|460118976|FG001|Overall Study|Received radiation on new therapy|0|||
127863930|NCT00106626|460118977|FG002|Overall Study|Received radiation on new therapy|0|||
127863931|NCT00106626|460118978|FG003|Overall Study|Received radiation on new therapy|0|||
127914888|NCT00112437|460310690|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
127914889|NCT00112437|460310691|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
127914890|NCT00112437|460310692|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
127914891|NCT00112437|460310693|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
127914892|NCT00112437|460310668|FG000|Year 2 (12-Month Extension)|Moved|0|||
127914893|NCT00112437|460310669|FG001|Year 2 (12-Month Extension)|Moved|0|||
127914894|NCT00112437|460310670|FG002|Year 2 (12-Month Extension)|Moved|0|||
127914895|NCT00112437|460310671|FG003|Year 2 (12-Month Extension)|Moved|0|||
127914896|NCT00112437|460310672|FG004|Year 2 (12-Month Extension)|Moved|0|||
127914897|NCT00112437|460310673|FG005|Year 2 (12-Month Extension)|Moved|0|||
127914898|NCT00112437|460310674|FG006|Year 2 (12-Month Extension)|Moved|0|||
127914899|NCT00112437|460310675|FG007|Year 2 (12-Month Extension)|Moved|0|||
127914900|NCT00112437|460310676|FG008|Year 2 (12-Month Extension)|Moved|0|||
127914901|NCT00112437|460310677|FG009|Year 2 (12-Month Extension)|Moved|1|||
127914902|NCT00112437|460310678|FG010|Year 2 (12-Month Extension)|Moved|0|||
127914903|NCT00112437|460310679|FG011|Year 2 (12-Month Extension)|Moved|0|||
127914904|NCT00112437|460310680|FG012|Year 2 (12-Month Extension)|Moved|0|||
127914905|NCT00112437|460310681|FG013|Year 2 (12-Month Extension)|Moved|0|||
127914906|NCT00112437|460310682|FG014|Year 2 (12-Month Extension)|Moved|0|||
127914907|NCT00112437|460310683|FG015|Year 2 (12-Month Extension)|Moved|0|||
127914908|NCT00112437|460310684|FG016|Year 2 (12-Month Extension)|Moved|0|||
127914909|NCT00112437|460310685|FG017|Year 2 (12-Month Extension)|Moved|0|||
127914910|NCT00112437|460310686|FG018|Year 2 (12-Month Extension)|Moved|0|||
127914911|NCT00112437|460310687|FG019|Year 2 (12-Month Extension)|Moved|0|||
127914912|NCT00112437|460310688|FG020|Year 2 (12-Month Extension)|Moved|0|||
127914913|NCT00112437|460310689|FG021|Year 2 (12-Month Extension)|Moved|0|||
127914914|NCT00112437|460310690|FG022|Year 2 (12-Month Extension)|Moved|0|||
127914915|NCT00112437|460310691|FG023|Year 2 (12-Month Extension)|Moved|0|||
127914916|NCT00112437|460310692|FG024|Year 2 (12-Month Extension)|Moved|0|||
127914917|NCT00112437|460310693|FG025|Year 2 (12-Month Extension)|Moved|0|||
127914918|NCT00112437|460310668|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
127914919|NCT00112437|460310669|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
127914920|NCT00112437|460310670|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
127914921|NCT00112437|460310671|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
127914922|NCT00112437|460310672|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
127914923|NCT00112437|460310673|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
127914924|NCT00112437|460310674|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
127914925|NCT00112437|460310675|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
127914926|NCT00112437|460310676|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
127914927|NCT00112437|460310677|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
127914928|NCT00112437|460310678|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
127914929|NCT00112437|460310679|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
127914930|NCT00112437|460310680|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
127914931|NCT00112437|460310681|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
127914932|NCT00112437|460310682|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
127914933|NCT00112437|460310683|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
127914934|NCT00112437|460310684|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
127914935|NCT00112437|460310685|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
127914936|NCT00112437|460310686|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
127914937|NCT00112437|460310687|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
127914938|NCT00112437|460310688|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
127914939|NCT00112437|460310689|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
127914940|NCT00112437|460310690|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
127914941|NCT00112437|460310691|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
127863932|NCT00106626|460118975|FG000|Overall Study|> 14 day delay in therapy start|0|||
127863933|NCT00106626|460118976|FG001|Overall Study|> 14 day delay in therapy start|1|||
127863934|NCT00106626|460118977|FG002|Overall Study|> 14 day delay in therapy start|0|||
127863935|NCT00106626|460118978|FG003|Overall Study|> 14 day delay in therapy start|0|||
127863936|NCT00732199|460118979|FG000|Overall Study|Withdrawal by Subject|25|||
127863937|NCT00732199|460118980|FG001|Overall Study|Withdrawal by Subject|18|||
127863938|NCT00732199|460118979|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
127863939|NCT00732199|460118980|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
127914942|NCT00112437|460310692|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
127914943|NCT00112437|460310693|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
127914944|NCT00112437|460310668|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
127914945|NCT00112437|460310669|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
127914946|NCT00112437|460310670|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
127914947|NCT00112437|460310671|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
127914948|NCT00112437|460310672|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
127914949|NCT00112437|460310673|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
127914950|NCT00112437|460310674|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
127914951|NCT00112437|460310675|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
127914952|NCT00112437|460310676|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
127914953|NCT00112437|460310677|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
127914954|NCT00112437|460310678|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
127914955|NCT00112437|460310679|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
127914956|NCT00112437|460310680|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
127914957|NCT00112437|460310681|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
127914958|NCT00112437|460310682|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
127914959|NCT00112437|460310683|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
127914960|NCT00112437|460310684|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
127914961|NCT00112437|460310685|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
127914962|NCT00112437|460310686|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
127914963|NCT00112437|460310687|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
127914964|NCT00112437|460310688|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
127914965|NCT00112437|460310689|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
127914966|NCT00112437|460310690|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
127914967|NCT00112437|460310691|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
127914968|NCT00112437|460310692|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
127914969|NCT00112437|460310693|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
127914970|NCT00112437|460310668|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
127914971|NCT00112437|460310669|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
127914972|NCT00112437|460310670|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
127914973|NCT00112437|460310671|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
127914974|NCT00112437|460310672|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
127914975|NCT00112437|460310673|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
127914976|NCT00112437|460310674|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
127914977|NCT00112437|460310675|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
127914978|NCT00112437|460310676|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
127914979|NCT00112437|460310677|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
127914980|NCT00112437|460310678|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
127914981|NCT00112437|460310679|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
127914982|NCT00112437|460310680|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
127914983|NCT00112437|460310681|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
127914984|NCT00112437|460310682|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
127914985|NCT00112437|460310683|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
127914986|NCT00112437|460310684|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
127914987|NCT00112437|460310685|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
127914988|NCT00112437|460310686|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
127914989|NCT00112437|460310687|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
127914990|NCT00112437|460310688|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
127914991|NCT00112437|460310689|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
127914992|NCT00112437|460310690|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
127914993|NCT00112437|460310691|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
127914994|NCT00112437|460310692|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
127914995|NCT00112437|460310693|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
127914996|NCT00112437|460310668|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
127914997|NCT00112437|460310669|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
127914998|NCT00112437|460310670|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
127914999|NCT00112437|460310671|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
127915000|NCT00112437|460310672|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
127915001|NCT00112437|460310673|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
127915002|NCT00112437|460310674|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
127915003|NCT00112437|460310675|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
127915004|NCT00112437|460310676|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
127915005|NCT00112437|460310677|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
127915006|NCT00112437|460310678|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
127915007|NCT00112437|460310679|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
127915008|NCT00112437|460310680|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
127915009|NCT00112437|460310681|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
127915010|NCT00112437|460310682|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
127915011|NCT00112437|460310683|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
127915012|NCT00112437|460310684|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
127915013|NCT00112437|460310685|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
127915014|NCT00112437|460310686|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
127915015|NCT00112437|460310687|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
127915016|NCT00112437|460310688|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
127915017|NCT00112437|460310689|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
127915018|NCT00112437|460310690|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
127915019|NCT00112437|460310691|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
127915020|NCT00112437|460310692|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
127915021|NCT00112437|460310693|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
127915022|NCT00112437|460310668|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
127863940|NCT02870348|460118985|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
127863941|NCT00672139|460118986|FG000|Overall Study|Death|14|||
127863942|NCT00672139|460118987|FG001|Overall Study|Death|23|||
127863943|NCT00672139|460118986|FG000|Overall Study|Withdrawal by Subject|2|||
127863944|NCT00672139|460118987|FG001|Overall Study|Withdrawal by Subject|11|||
127863945|NCT00672139|460118986|FG000|Overall Study|Adverse Event|4|||
127863946|NCT00672139|460118987|FG001|Overall Study|Adverse Event|7|||
127863947|NCT00672139|460118986|FG000|Overall Study|Physician Decision|2|||
127863948|NCT00672139|460118987|FG001|Overall Study|Physician Decision|0|||
127863949|NCT00672139|460118986|FG000|Overall Study|Lack of Efficacy|4|||
127863950|NCT00672139|460118987|FG001|Overall Study|Lack of Efficacy|1|||
127863951|NCT00672139|460118986|FG000|Overall Study|Protocol Violation|1|||
127863952|NCT00672139|460118987|FG001|Overall Study|Protocol Violation|1|||
127863953|NCT00672139|460118986|FG000|Overall Study|hospice discharge, caregiver requests|3|||
127863954|NCT00672139|460118987|FG001|Overall Study|hospice discharge, caregiver requests|2|||
127863955|NCT01562327|460118994|FG000|Overall Study|Adverse Event|2|||
127863956|NCT01562327|460118994|FG000|Overall Study|Lack of Efficacy|1|||
127863957|NCT01562327|460118994|FG000|Overall Study|Participant drop-out|1|||
127863958|NCT01562327|460118994|FG000|Overall Study|Infusion not received at 6 month window|4|||
127863959|NCT01957111|460118995|FG000|Overall Study|Withdrawal by Subject|1|||
127863960|NCT01957111|460118996|FG001|Overall Study|Withdrawal by Subject|1|||
127863961|NCT01057394|460118997|FG000|Overall Study|Not eligible|0|||
127863962|NCT01057394|460118998|FG001|Overall Study|Not eligible|2|||
127863963|NCT00256204|460118999|FG000|Overall Study|Adverse Event|10|||
127863964|NCT00256204|460119000|FG001|Overall Study|Adverse Event|14|||
127863965|NCT00256204|460119001|FG002|Overall Study|Adverse Event|16|||
127863966|NCT00256204|460119002|FG003|Overall Study|Adverse Event|14|||
127863967|NCT00256204|460118999|FG000|Overall Study|Death|0|||
127863968|NCT00256204|460119000|FG001|Overall Study|Death|1|||
127863969|NCT00256204|460119001|FG002|Overall Study|Death|0|||
127863970|NCT00256204|460119002|FG003|Overall Study|Death|0|||
127863971|NCT00256204|460118999|FG000|Overall Study|Lost to Follow-up|1|||
127863972|NCT00256204|460119000|FG001|Overall Study|Lost to Follow-up|1|||
127863973|NCT00256204|460119001|FG002|Overall Study|Lost to Follow-up|1|||
127863974|NCT00256204|460119002|FG003|Overall Study|Lost to Follow-up|2|||
127863975|NCT00256204|460118999|FG000|Overall Study|Protocol Violation|1|||
127863976|NCT00256204|460119000|FG001|Overall Study|Protocol Violation|0|||
127863977|NCT00256204|460119001|FG002|Overall Study|Protocol Violation|2|||
127863978|NCT00256204|460119002|FG003|Overall Study|Protocol Violation|1|||
127863979|NCT00256204|460118999|FG000|Overall Study|Physician Decision|0|||
127863980|NCT00256204|460119000|FG001|Overall Study|Physician Decision|0|||
127863981|NCT00256204|460119001|FG002|Overall Study|Physician Decision|1|||
127863982|NCT00256204|460119002|FG003|Overall Study|Physician Decision|2|||
127863983|NCT00256204|460118999|FG000|Overall Study|Withdrawal by Subject|17|||
127863984|NCT00256204|460119000|FG001|Overall Study|Withdrawal by Subject|6|||
127863985|NCT00256204|460119001|FG002|Overall Study|Withdrawal by Subject|7|||
127863986|NCT00256204|460119002|FG003|Overall Study|Withdrawal by Subject|5|||
127863987|NCT00256204|460118999|FG000|Overall Study|Need for additional prohibited treatment|38|||
127863988|NCT00256204|460119000|FG001|Overall Study|Need for additional prohibited treatment|28|||
127863989|NCT00256204|460119001|FG002|Overall Study|Need for additional prohibited treatment|27|||
127863990|NCT00256204|460119002|FG003|Overall Study|Need for additional prohibited treatment|25|||
127863991|NCT00808132|460119005|FG000|Overall Study|Adverse Event|34|||
127863992|NCT00808132|460119006|FG001|Overall Study|Adverse Event|33|||
127863993|NCT00808132|460119007|FG002|Overall Study|Adverse Event|16|||
127863994|NCT00808132|460119008|FG003|Overall Study|Adverse Event|31|||
127863995|NCT00808132|460119009|FG004|Overall Study|Adverse Event|33|||
127863996|NCT00808132|460119005|FG000|Overall Study|Death|0|||
127863997|NCT00808132|460119006|FG001|Overall Study|Death|0|||
127863998|NCT00808132|460119007|FG002|Overall Study|Death|0|||
127863999|NCT00808132|460119008|FG003|Overall Study|Death|0|||
127864000|NCT00808132|460119009|FG004|Overall Study|Death|1|||
127864001|NCT00808132|460119005|FG000|Overall Study|Physician Decision|0|||
127864002|NCT00808132|460119006|FG001|Overall Study|Physician Decision|1|||
127864003|NCT00808132|460119007|FG002|Overall Study|Physician Decision|0|||
127864004|NCT00808132|460119008|FG003|Overall Study|Physician Decision|0|||
127864005|NCT00808132|460119009|FG004|Overall Study|Physician Decision|0|||
127864006|NCT00808132|460119005|FG000|Overall Study|Lost to Follow-up|8|||
127864007|NCT00808132|460119006|FG001|Overall Study|Lost to Follow-up|10|||
127864008|NCT00808132|460119007|FG002|Overall Study|Lost to Follow-up|11|||
127864009|NCT00808132|460119008|FG003|Overall Study|Lost to Follow-up|8|||
127864010|NCT00808132|460119009|FG004|Overall Study|Lost to Follow-up|9|||
127864011|NCT00808132|460119005|FG000|Overall Study|Protocol Violation|8|||
127864012|NCT00808132|460119006|FG001|Overall Study|Protocol Violation|9|||
127864013|NCT00808132|460119007|FG002|Overall Study|Protocol Violation|4|||
127864014|NCT00808132|460119008|FG003|Overall Study|Protocol Violation|9|||
127864015|NCT00808132|460119009|FG004|Overall Study|Protocol Violation|5|||
127864016|NCT00808132|460119005|FG000|Overall Study|Withdrawal by Subject|27|||
127864017|NCT00808132|460119006|FG001|Overall Study|Withdrawal by Subject|18|||
127864018|NCT00808132|460119007|FG002|Overall Study|Withdrawal by Subject|2|||
127864019|NCT00808132|460119008|FG003|Overall Study|Withdrawal by Subject|7|||
127864020|NCT00808132|460119009|FG004|Overall Study|Withdrawal by Subject|16|||
127864021|NCT00808132|460119005|FG000|Overall Study|Other|6|||
127864022|NCT00808132|460119006|FG001|Overall Study|Other|4|||
127864023|NCT00808132|460119007|FG002|Overall Study|Other|6|||
127864024|NCT00808132|460119008|FG003|Overall Study|Other|2|||
127864025|NCT00808132|460119009|FG004|Overall Study|Other|15|||
127864026|NCT00808132|460119005|FG000|Overall Study|Randomized, but not treated|10|||
127864027|NCT00808132|460119006|FG001|Overall Study|Randomized, but not treated|7|||
127864028|NCT00808132|460119007|FG002|Overall Study|Randomized, but not treated|9|||
127864029|NCT00808132|460119008|FG003|Overall Study|Randomized, but not treated|8|||
127864030|NCT00808132|460119009|FG004|Overall Study|Randomized, but not treated|9|||
127864031|NCT00808132|460119005|FG000|Overall Study|Unsatisfactory response|5|||
127864032|NCT00808132|460119006|FG001|Overall Study|Unsatisfactory response|6|||
127864033|NCT00808132|460119007|FG002|Overall Study|Unsatisfactory response|6|||
127864034|NCT00808132|460119008|FG003|Overall Study|Unsatisfactory response|4|||
127864035|NCT00808132|460119009|FG004|Overall Study|Unsatisfactory response|12|||
127864036|NCT00550615|460119010|FG000|Overall Study|Withdrawal by Subject|0|||
127864037|NCT00550615|460119011|FG001|Overall Study|Withdrawal by Subject|0|||
127864038|NCT00550615|460119012|FG002|Overall Study|Withdrawal by Subject|2|||
127864039|NCT00550615|460119013|FG003|Overall Study|Withdrawal by Subject|3|||
127864040|NCT00550615|460119010|FG000|Overall Study|Not evaluable|0|||
127864041|NCT00550615|460119011|FG001|Overall Study|Not evaluable|0|||
127864042|NCT00550615|460119012|FG002|Overall Study|Not evaluable|2|||
127864043|NCT00550615|460119013|FG003|Overall Study|Not evaluable|7|||
127864044|NCT02405091|460119016|FG000|Overall Study|Adverse Event|16|||
127864045|NCT02405091|460119017|FG001|Overall Study|Adverse Event|10|||
127864046|NCT02405091|460119018|FG002|Overall Study|Adverse Event|0|||
127864047|NCT02405091|460119016|FG000|Overall Study|Protocol Violation|1|||
127864048|NCT02405091|460119017|FG001|Overall Study|Protocol Violation|0|||
127864049|NCT02405091|460119018|FG002|Overall Study|Protocol Violation|0|||
127864050|NCT02405091|460119016|FG000|Overall Study|Noncompliance|1|||
127864051|NCT02405091|460119017|FG001|Overall Study|Noncompliance|6|||
127864052|NCT02405091|460119018|FG002|Overall Study|Noncompliance|2|||
127864053|NCT02405091|460119016|FG000|Overall Study|Withdrawal by Subject|4|||
127864054|NCT02405091|460119017|FG001|Overall Study|Withdrawal by Subject|8|||
127864055|NCT02405091|460119018|FG002|Overall Study|Withdrawal by Subject|0|||
127864056|NCT02405091|460119016|FG000|Overall Study|Death|0|||
127864057|NCT02405091|460119017|FG001|Overall Study|Death|1|||
127864058|NCT02405091|460119018|FG002|Overall Study|Death|0|||
127864059|NCT02405091|460119016|FG000|Overall Study|Lost to Follow-up|5|||
127864060|NCT02405091|460119017|FG001|Overall Study|Lost to Follow-up|6|||
127864061|NCT02405091|460119018|FG002|Overall Study|Lost to Follow-up|0|||
127864062|NCT02405091|460119016|FG000|Overall Study|Physician Decision|2|||
127864063|NCT02405091|460119017|FG001|Overall Study|Physician Decision|2|||
127864064|NCT02405091|460119018|FG002|Overall Study|Physician Decision|0|||
127864065|NCT01948791|460119025|FG000|Overall Study|Adverse Event|12|||
127864066|NCT01948791|460119025|FG000|Overall Study|Lack of Efficacy|3|||
127864067|NCT01948791|460119025|FG000|Overall Study|Protocol Violation|2|||
127864068|NCT01948791|460119025|FG000|Overall Study|Withdrawal by Subject|5|||
127864069|NCT01948791|460119025|FG000|Overall Study|Lost to Follow-up|6|||
127864070|NCT01948791|460119025|FG000|Overall Study|Management issues|1|||
127864071|NCT01948791|460119025|FG000|Overall Study|Others|7|||
127864072|NCT01948791|460119025|FG000|Overall Study|Screening failure|35|||
127864073|NCT01955005|460119037|FG000|Overall Study|Withdrawal by Subject|3|||
127864074|NCT01955005|460119038|FG001|Overall Study|Withdrawal by Subject|5|||
127864075|NCT02555722|460119039|FG000|Week 2|Adverse Event|0|||
127864076|NCT02555722|460119040|FG001|Week 2|Adverse Event|1|||
127864077|NCT02555722|460119039|FG000|Week 2|Withdrawal by Subject|1|||
127864078|NCT02555722|460119040|FG001|Week 2|Withdrawal by Subject|0|||
127864079|NCT02555722|460119039|FG000|Month 1|Lens Discomfort|1|||
127864080|NCT02555722|460119040|FG001|Month 1|Lens Discomfort|0|||
127864081|NCT02555722|460119039|FG000|Month 2|Withdrawal by Subject|3|||
127864082|NCT02555722|460119040|FG001|Month 2|Withdrawal by Subject|0|||
127864083|NCT02555722|460119039|FG000|Month 2|Lost to Follow-up|1|||
127864084|NCT02555722|460119040|FG001|Month 2|Lost to Follow-up|0|||
127864085|NCT00352027|460119045|FG000|Overall Study|Progressive disease|3|||
127864086|NCT00702949|460119046|FG000|Overall Study|Refusal|3|||
127864087|NCT00702949|460119047|FG001|Overall Study|Refusal|2|||
127864088|NCT00702949|460119048|FG002|Overall Study|Refusal|2|||
127864089|NCT00702949|460119046|FG000|Overall Study|Adverse Event|1|||
127864090|NCT00702949|460119047|FG001|Overall Study|Adverse Event|6|||
127864091|NCT00702949|460119048|FG002|Overall Study|Adverse Event|3|||
127864092|NCT00702949|460119046|FG000|Overall Study|Other Medical Reason/unknown|1|||
127864093|NCT00702949|460119047|FG001|Overall Study|Other Medical Reason/unknown|1|||
127864094|NCT00702949|460119048|FG002|Overall Study|Other Medical Reason/unknown|3|||
127864095|NCT04491591|460119050|FG000|Overall Study|Accidently randomized|3|||
127864096|NCT04491591|460119051|FG001|Overall Study|Accidently randomized|1|||
127864097|NCT04491591|460119052|FG002|Overall Study|Accidently randomized|0|||
127864098|NCT04491591|460119050|FG000|Overall Study|Did not complete survey|28|||
127864099|NCT04491591|460119051|FG001|Overall Study|Did not complete survey|20|||
127864100|NCT04491591|460119052|FG002|Overall Study|Did not complete survey|3|||
127864101|NCT00135694|460119053|FG000|Overall Study|Adverse Event|17|||
127864102|NCT00135694|460119054|FG001|Overall Study|Adverse Event|4|||
127864103|NCT00135694|460119055|FG002|Overall Study|Adverse Event|0|||
127864104|NCT00135694|460119053|FG000|Overall Study|Death|14|||
127864105|NCT00135694|460119054|FG001|Overall Study|Death|1|||
127864106|NCT00135694|460119055|FG002|Overall Study|Death|2|||
127864107|NCT00135694|460119053|FG000|Overall Study|Lost to Follow-up|8|||
127864108|NCT00135694|460119054|FG001|Overall Study|Lost to Follow-up|7|||
127864109|NCT00135694|460119055|FG002|Overall Study|Lost to Follow-up|1|||
127864110|NCT00135694|460119053|FG000|Overall Study|Withdrawal by Subject|41|||
127864111|NCT00135694|460119054|FG001|Overall Study|Withdrawal by Subject|7|||
127864112|NCT00135694|460119055|FG002|Overall Study|Withdrawal by Subject|4|||
127864113|NCT00135694|460119053|FG000|Overall Study|Protocol Violation|19|||
127864114|NCT00135694|460119054|FG001|Overall Study|Protocol Violation|1|||
127864115|NCT00135694|460119055|FG002|Overall Study|Protocol Violation|0|||
127864116|NCT00135694|460119053|FG000|Overall Study|Hepatitis C related reasons|39|||
127864117|NCT00135694|460119054|FG001|Overall Study|Hepatitis C related reasons|1|||
127864118|NCT00135694|460119055|FG002|Overall Study|Hepatitis C related reasons|0|||
127864119|NCT00135694|460119053|FG000|Overall Study|Ineligible for Random assignment|42|||
127864120|NCT00135694|460119054|FG001|Overall Study|Ineligible for Random assignment|0|||
127864121|NCT00135694|460119055|FG002|Overall Study|Ineligible for Random assignment|0|||
127864122|NCT02802735|460119057|FG000|Overall Study|Withdrawal by Subject|0|||
127864123|NCT02802735|460119058|FG001|Overall Study|Withdrawal by Subject|1|||
127864124|NCT02802735|460119059|FG002|Overall Study|Withdrawal by Subject|0|||
127864125|NCT02802735|460119060|FG003|Overall Study|Withdrawal by Subject|0|||
127864126|NCT02802735|460119061|FG004|Overall Study|Withdrawal by Subject|0|||
127864127|NCT02975206|460119062|FG000|Overall Study|Withdrawal by Subject|14|||
127864128|NCT02975206|460119063|FG001|Overall Study|Withdrawal by Subject|11|||
127864129|NCT02975206|460119064|FG002|Overall Study|Withdrawal by Subject|11|||
127864130|NCT02975206|460119062|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
127864131|NCT02975206|460119063|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
127864132|NCT02975206|460119064|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
127864133|NCT00866606|460119066|FG000|Overall Study|Lost to Follow-up|3|||
127864134|NCT00866606|460119066|FG000|Overall Study|Adverse Event|1|||
127864135|NCT01058356|460119079|FG000|Overall Study|Adverse Event|5|||
127864136|NCT01058356|460119079|FG000|Overall Study|Administration of contraindicated drugs|12|||
127864137|NCT01058356|460119079|FG000|Overall Study|Withdrawal by Subject|21|||
127864138|NCT01058356|460119079|FG000|Overall Study|Lost to Follow-up|4|||
127864139|NCT00392210|460119084|FG000|First Voiding Trial|Physician Decision|2|||
127864140|NCT00392210|460119085|FG001|First Voiding Trial|Physician Decision|2|||
127864141|NCT02140762|460119090|FG000|Overall Study|Adverse Event|1|||
127864142|NCT02140762|460119091|FG001|Overall Study|Adverse Event|1|||
127864143|NCT02140762|460119090|FG000|Overall Study|Lost to Follow-up|9|||
127915023|NCT00112437|460310669|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
127864144|NCT02140762|460119091|FG001|Overall Study|Lost to Follow-up|5|||
127864145|NCT02140762|460119090|FG000|Overall Study|Protocol Violation|1|||
127864146|NCT02140762|460119091|FG001|Overall Study|Protocol Violation|1|||
127864147|NCT02140762|460119090|FG000|Overall Study|Withdrawal by Subject|6|||
127864148|NCT02140762|460119091|FG001|Overall Study|Withdrawal by Subject|4|||
127864149|NCT02140762|460119090|FG000|Overall Study|Other|0|||
127864150|NCT02140762|460119091|FG001|Overall Study|Other|1|||
127864151|NCT04815291|460119092|FG000|Overall Study|Lost to Follow-up|1|||
127864152|NCT04815291|460119092|FG000|Overall Study|Physician Decision|4|||
127864153|NCT04815291|460119092|FG000|Overall Study|Surgery not planned and subject not operated.|3|||
127864154|NCT00989664|460119096|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
127864155|NCT00989664|460119096|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
127864156|NCT00989664|460119096|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
127864157|NCT00989664|460119096|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
127864158|NCT00989664|460119096|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
127864159|NCT00989664|460119096|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
127864160|NCT00989664|460119096|FG000|Long-Term Follow-Up|Death|3|||
127864161|NCT00095836|460119097|FG000|Overall Study|Lost to Follow-up|1|||
127864162|NCT00095836|460119097|FG000|Overall Study|Adverse Event|1|||
127864163|NCT00095836|460119097|FG000|Overall Study|Death|2|||
127864164|NCT00962780|460119099|FG000|Overall Study|Death|0|||
127864165|NCT00962780|460119100|FG001|Overall Study|Death|1|||
127864166|NCT00962780|460119099|FG000|Overall Study|Protocol Violation|9|||
127864167|NCT00962780|460119100|FG001|Overall Study|Protocol Violation|4|||
127864168|NCT00962780|460119099|FG000|Overall Study|Withdrawal by Subject|1|||
127864169|NCT00962780|460119100|FG001|Overall Study|Withdrawal by Subject|8|||
127864170|NCT00962780|460119099|FG000|Overall Study|Other|0|||
127864171|NCT00962780|460119100|FG001|Overall Study|Other|1|||
127864172|NCT02055976|460119101|FG000|Overall Study|Other|0|||
127864173|NCT02055976|460119102|FG001|Overall Study|Other|0|||
127864174|NCT02055976|460119103|FG002|Overall Study|Other|1|||
127864175|NCT02055976|460119104|FG003|Overall Study|Other|0|||
127864176|NCT02055976|460119105|FG004|Overall Study|Other|0|||
127864177|NCT02055976|460119106|FG005|Overall Study|Other|0|||
127864178|NCT02055976|460119107|FG006|Overall Study|Other|0|||
127864179|NCT02055976|460119108|FG007|Overall Study|Other|0|||
127864180|NCT02055976|460119109|FG008|Overall Study|Other|0|||
127864181|NCT02055976|460119101|FG000|Overall Study|Adverse Event|0|||
127864182|NCT02055976|460119102|FG001|Overall Study|Adverse Event|0|||
127864183|NCT02055976|460119103|FG002|Overall Study|Adverse Event|0|||
127864184|NCT02055976|460119104|FG003|Overall Study|Adverse Event|0|||
127864185|NCT02055976|460119105|FG004|Overall Study|Adverse Event|0|||
127864186|NCT02055976|460119106|FG005|Overall Study|Adverse Event|1|||
127864187|NCT02055976|460119107|FG006|Overall Study|Adverse Event|1|||
127864188|NCT02055976|460119108|FG007|Overall Study|Adverse Event|0|||
127864189|NCT02055976|460119109|FG008|Overall Study|Adverse Event|0|||
127864190|NCT02055976|460119101|FG000|Overall Study|Does not meet entrance criteria|0|||
127864191|NCT02055976|460119102|FG001|Overall Study|Does not meet entrance criteria|0|||
127864192|NCT02055976|460119103|FG002|Overall Study|Does not meet entrance criteria|0|||
127864193|NCT02055976|460119104|FG003|Overall Study|Does not meet entrance criteria|0|||
127864194|NCT02055976|460119105|FG004|Overall Study|Does not meet entrance criteria|0|||
127864195|NCT02055976|460119106|FG005|Overall Study|Does not meet entrance criteria|0|||
127864196|NCT02055976|460119107|FG006|Overall Study|Does not meet entrance criteria|1|||
127864197|NCT02055976|460119108|FG007|Overall Study|Does not meet entrance criteria|0|||
127864198|NCT02055976|460119109|FG008|Overall Study|Does not meet entrance criteria|0|||
127864199|NCT02055976|460119101|FG000|Overall Study|Lost to Follow-up|0|||
127864200|NCT02055976|460119102|FG001|Overall Study|Lost to Follow-up|0|||
127864201|NCT02055976|460119103|FG002|Overall Study|Lost to Follow-up|0|||
127864202|NCT02055976|460119104|FG003|Overall Study|Lost to Follow-up|1|||
127864203|NCT02055976|460119105|FG004|Overall Study|Lost to Follow-up|0|||
127864204|NCT02055976|460119106|FG005|Overall Study|Lost to Follow-up|0|||
127864205|NCT02055976|460119107|FG006|Overall Study|Lost to Follow-up|0|||
127864206|NCT02055976|460119108|FG007|Overall Study|Lost to Follow-up|0|||
127864207|NCT02055976|460119109|FG008|Overall Study|Lost to Follow-up|0|||
127864208|NCT01230827|460119110|FG000|Overall Study|Lost to Follow-up|0|||
127864209|NCT01230827|460119111|FG001|Overall Study|Lost to Follow-up|0|||
127864210|NCT01230827|460119112|FG002|Overall Study|Lost to Follow-up|1|||
127864211|NCT01230827|460119113|FG003|Overall Study|Lost to Follow-up|3|||
127864212|NCT01230827|460119110|FG000|Overall Study|Withdrawal by Subject|1|||
127864213|NCT01230827|460119111|FG001|Overall Study|Withdrawal by Subject|0|||
127864214|NCT01230827|460119112|FG002|Overall Study|Withdrawal by Subject|3|||
127864215|NCT01230827|460119113|FG003|Overall Study|Withdrawal by Subject|2|||
127864216|NCT01230827|460119110|FG000|Overall Study|Lack of Efficacy|14|||
127864217|NCT01230827|460119111|FG001|Overall Study|Lack of Efficacy|1|||
127864218|NCT01230827|460119112|FG002|Overall Study|Lack of Efficacy|2|||
127864219|NCT01230827|460119113|FG003|Overall Study|Lack of Efficacy|3|||
127864220|NCT01230827|460119110|FG000|Overall Study|Adverse Event|4|||
127864221|NCT01230827|460119111|FG001|Overall Study|Adverse Event|2|||
127864222|NCT01230827|460119112|FG002|Overall Study|Adverse Event|3|||
127864223|NCT01230827|460119113|FG003|Overall Study|Adverse Event|7|||
127864224|NCT01230827|460119110|FG000|Overall Study|Recovery|0|||
127864225|NCT01230827|460119111|FG001|Overall Study|Recovery|6|||
127864226|NCT01230827|460119112|FG002|Overall Study|Recovery|0|||
127864227|NCT01230827|460119113|FG003|Overall Study|Recovery|0|||
127864228|NCT01230827|460119110|FG000|Overall Study|Study terminated by Sponsor|0|||
127864229|NCT01230827|460119111|FG001|Overall Study|Study terminated by Sponsor|2|||
127864230|NCT01230827|460119112|FG002|Overall Study|Study terminated by Sponsor|56|||
127864231|NCT01230827|460119113|FG003|Overall Study|Study terminated by Sponsor|63|||
127864232|NCT00805142|460119114|FG000|Titration Period|Adverse Event|3|||
127915024|NCT00112437|460310670|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
127915025|NCT00112437|460310671|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
127915026|NCT00112437|460310672|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
127915027|NCT00112437|460310673|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
127915028|NCT00112437|460310674|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
127915029|NCT00112437|460310675|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
127915030|NCT00112437|460310676|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
127915031|NCT00112437|460310677|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
127915032|NCT00112437|460310678|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
127915033|NCT00112437|460310679|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
127915034|NCT00112437|460310680|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
127915035|NCT00112437|460310681|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
127915036|NCT00112437|460310682|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
127915037|NCT00112437|460310683|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
127915038|NCT00112437|460310684|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
127915039|NCT00112437|460310685|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
127915040|NCT00112437|460310686|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
127915041|NCT00112437|460310687|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
127915042|NCT00112437|460310688|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
127915043|NCT00112437|460310689|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
127915044|NCT00112437|460310690|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
127915045|NCT00112437|460310691|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
127915046|NCT00112437|460310692|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
127915047|NCT00112437|460310693|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
127915048|NCT00112437|460310668|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
127915049|NCT00112437|460310669|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
127915050|NCT00112437|460310670|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
127915051|NCT00112437|460310671|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
127915052|NCT00112437|460310672|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
127915053|NCT00112437|460310673|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
127915054|NCT00112437|460310674|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
127915055|NCT00112437|460310675|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
127915056|NCT00112437|460310676|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
127915057|NCT00112437|460310677|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
127915058|NCT00112437|460310678|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
127915059|NCT00112437|460310679|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
127915060|NCT00112437|460310680|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
127915061|NCT00112437|460310681|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
127915062|NCT00112437|460310682|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
127915063|NCT00112437|460310683|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
127915064|NCT00112437|460310684|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
127915065|NCT00112437|460310685|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
127915066|NCT00112437|460310686|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
127915067|NCT00112437|460310687|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
127915068|NCT00112437|460310688|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
127915069|NCT00112437|460310689|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
127915070|NCT00112437|460310690|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
127915071|NCT00112437|460310691|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
127915072|NCT00112437|460310692|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
127915073|NCT00112437|460310693|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
127915074|NCT00112437|460310668|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
127915075|NCT00112437|460310669|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
127915076|NCT00112437|460310670|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
127915077|NCT00112437|460310671|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
127915078|NCT00112437|460310672|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
127915079|NCT00112437|460310673|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
127915080|NCT00112437|460310674|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
127915081|NCT00112437|460310675|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
127915082|NCT00112437|460310676|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
127915083|NCT00112437|460310677|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
127915084|NCT00112437|460310678|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
127915085|NCT00112437|460310679|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
127915086|NCT00112437|460310680|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
127915087|NCT00112437|460310681|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
127915088|NCT00112437|460310682|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
127864233|NCT00805142|460119115|FG001|Titration Period|Adverse Event|3|||
127864234|NCT00805142|460119114|FG000|Titration Period|Lack of Efficacy|1|||
127864235|NCT00805142|460119115|FG001|Titration Period|Lack of Efficacy|1|||
127864236|NCT00805142|460119114|FG000|Titration Period|Lost to Follow-up|0|||
127864237|NCT00805142|460119115|FG001|Titration Period|Lost to Follow-up|1|||
127864238|NCT00805142|460119114|FG000|Titration Period|Disease Progression|2|||
127864239|NCT00805142|460119115|FG001|Titration Period|Disease Progression|1|||
127864240|NCT00805142|460119114|FG000|Titration Period|Withdrawal of consent|0|||
127864241|NCT00805142|460119115|FG001|Titration Period|Withdrawal of consent|1|||
127864242|NCT00805142|460119114|FG000|Titration Period|Other|0|||
127864243|NCT00805142|460119115|FG001|Titration Period|Other|3|||
127864244|NCT00805142|460119114|FG000|Maintenance Period|Adverse Event|0|||
127864245|NCT00805142|460119115|FG001|Maintenance Period|Adverse Event|1|||
127864246|NCT00805142|460119114|FG000|Maintenance Period|Other|0|||
127864247|NCT00805142|460119115|FG001|Maintenance Period|Other|1|||
127864248|NCT01021423|460119117|FG000|Overall Study|Study terminated|4|||
127864249|NCT01021423|460119118|FG001|Overall Study|Study terminated|5|||
127864250|NCT00122317|460119119|FG000|Overall Study|Death|3|||
127864251|NCT00122317|460119119|FG000|Overall Study|Adverse Event|4|||
127864252|NCT00122317|460119119|FG000|Overall Study|Physician Decision|2|||
127864253|NCT00122317|460119119|FG000|Overall Study|patient non-compliance|1|||
127864254|NCT00122317|460119119|FG000|Overall Study|Withdrawal by Subject|1|||
127864255|NCT02886338|460119120|FG000|Overall Study|Withdrawal by Subject|1|||
127864256|NCT00394654|460119121|FG000|Overall Study|Lost to Follow-up|1|||
127864257|NCT00394654|460119122|FG001|Overall Study|Lost to Follow-up|0|||
127864258|NCT00394654|460119121|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
127864259|NCT00394654|460119122|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
127864260|NCT03756285|460119124|FG000|Overall Study|Lost to Follow-up|0|||
127864261|NCT03756285|460119125|FG001|Overall Study|Lost to Follow-up|1|||
127864262|NCT03756285|460119124|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
127864263|NCT03756285|460119125|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
127864264|NCT03756285|460119124|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
127864265|NCT03756285|460119125|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
127864266|NCT01021293|460119128|FG000|Overall Study|Serious Adverse Event|2|||
127864267|NCT01021293|460119129|FG001|Overall Study|Serious Adverse Event|1|||
127864268|NCT01021293|460119128|FG000|Overall Study|Adverse Event|2|||
127864269|NCT01021293|460119129|FG001|Overall Study|Adverse Event|1|||
127864270|NCT01021293|460119128|FG000|Overall Study|Withdrawal by Subject|1|||
127864271|NCT01021293|460119129|FG001|Overall Study|Withdrawal by Subject|3|||
127864272|NCT01021293|460119128|FG000|Overall Study|Migrated/moved from study area|6|||
127864273|NCT01021293|460119129|FG001|Overall Study|Migrated/moved from study area|18|||
127864274|NCT01021293|460119128|FG000|Overall Study|Lost to Follow-up|1|||
127864275|NCT01021293|460119129|FG001|Overall Study|Lost to Follow-up|1|||
127864276|NCT00027846|460121799|FG000|Overall Study|Lost to Follow-up|0|||
127864277|NCT00027846|460121800|FG001|Overall Study|Lost to Follow-up|41|||
127864278|NCT00027846|460121801|FG002|Overall Study|Lost to Follow-up|9|||
127864279|NCT00027846|460121799|FG000|Overall Study|Withdrawal by Subject|0|||
127864280|NCT00027846|460121800|FG001|Overall Study|Withdrawal by Subject|14|||
127864281|NCT00027846|460121801|FG002|Overall Study|Withdrawal by Subject|7|||
127864282|NCT00027846|460121799|FG000|Overall Study|Ineligible for study|2|||
127864283|NCT00027846|460121800|FG001|Overall Study|Ineligible for study|6|||
127864284|NCT00027846|460121801|FG002|Overall Study|Ineligible for study|14|||
127864285|NCT00027846|460121799|FG000|Overall Study|Entry into another COG therapeutic study|0|||
127864286|NCT00027846|460121800|FG001|Overall Study|Entry into another COG therapeutic study|5|||
127864287|NCT00027846|460121801|FG002|Overall Study|Entry into another COG therapeutic study|2|||
127864288|NCT00027846|460121799|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
127864289|NCT00027846|460121800|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
127864290|NCT00027846|460121801|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
127864291|NCT05604781|460121806|FG000|Overall Study|Lost to Follow-up|3|||
127864292|NCT05604781|460121806|FG000|Overall Study|Adverse Event|1|||
127864293|NCT02889861|460121817|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
127864294|NCT01005966|460121818|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
127864295|NCT01005966|460121819|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
127864296|NCT01005966|460121820|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
127864297|NCT01005966|460121821|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
127864298|NCT01005966|460121822|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
127864299|NCT01005966|460121818|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
127864300|NCT01005966|460121819|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
127864301|NCT01005966|460121820|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
127864302|NCT01005966|460121821|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
127864303|NCT01005966|460121822|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
127864304|NCT01005966|460121818|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
127864305|NCT01005966|460121819|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
127915089|NCT00112437|460310683|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
127915090|NCT00112437|460310684|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
127915091|NCT00112437|460310685|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
127915092|NCT00112437|460310686|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
127915093|NCT00112437|460310687|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
127915094|NCT00112437|460310688|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
127915095|NCT00112437|460310689|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
127915096|NCT00112437|460310690|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
127915097|NCT00112437|460310691|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
127915098|NCT00112437|460310692|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
127915099|NCT00112437|460310693|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
127915100|NCT00112437|460310668|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
127915101|NCT00112437|460310669|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
127915102|NCT00112437|460310670|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
127915103|NCT00112437|460310671|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
127915104|NCT00112437|460310672|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
127915105|NCT00112437|460310673|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
127864306|NCT01005966|460121820|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
127864307|NCT01005966|460121821|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
127864308|NCT01005966|460121822|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
127864309|NCT01005966|460121818|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
127864310|NCT01005966|460121819|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
127864311|NCT01005966|460121820|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
127864312|NCT01005966|460121821|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
127864313|NCT01005966|460121822|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
127864314|NCT01005966|460121818|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
127864315|NCT01005966|460121819|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
127864316|NCT01005966|460121820|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
127864317|NCT01005966|460121821|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
127864318|NCT01005966|460121822|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
127864319|NCT01005966|460121818|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
127864320|NCT01005966|460121819|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
127864321|NCT01005966|460121820|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
127864322|NCT01005966|460121821|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
127864323|NCT01005966|460121822|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
127864324|NCT01005966|460121818|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
127864325|NCT01005966|460121819|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
127864326|NCT01005966|460121820|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
127864327|NCT01005966|460121821|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
127864328|NCT01005966|460121822|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
127864329|NCT01005966|460121818|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
127864330|NCT01005966|460121819|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
127864331|NCT01005966|460121820|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
127864332|NCT01005966|460121821|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
127864333|NCT01005966|460121822|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
127864334|NCT01005966|460121818|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
127864335|NCT01005966|460121819|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
127864336|NCT01005966|460121820|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
127864337|NCT01005966|460121821|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
127864338|NCT01005966|460121822|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
127864339|NCT01451203|460121823|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
127864340|NCT01451203|460121824|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
127864341|NCT01451203|460121823|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
127864342|NCT01451203|460121824|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
127864343|NCT01451203|460121823|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
127864344|NCT01451203|460121824|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
127915106|NCT00112437|460310674|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
127915107|NCT00112437|460310675|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
127864345|NCT01451203|460121823|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
127864346|NCT01451203|460121824|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
127864347|NCT01451203|460121823|FG000|Double-blind Treatment Period|Adverse Event|6|||
127864348|NCT01451203|460121824|FG001|Double-blind Treatment Period|Adverse Event|9|||
127864349|NCT01451203|460121823|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
127864350|NCT01451203|460121824|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
127864351|NCT01451203|460121823|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
127864352|NCT01451203|460121824|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
127864353|NCT01451203|460121823|FG000|Double-blind Treatment Period|Investigator decision|2|||
127864354|NCT01451203|460121824|FG001|Double-blind Treatment Period|Investigator decision|0|||
127864355|NCT01451203|460121823|FG000|Post-treatment Period|Consent withdrawn|2|||
127864356|NCT01451203|460121824|FG001|Post-treatment Period|Consent withdrawn|4|||
127864357|NCT01451203|460121823|FG000|Post-treatment Period|Lack of Efficacy|12|||
127864358|NCT01451203|460121824|FG001|Post-treatment Period|Lack of Efficacy|28|||
127915108|NCT00112437|460310676|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
127915109|NCT00112437|460310677|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
127915110|NCT00112437|460310678|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
127915111|NCT00112437|460310679|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
127915112|NCT00112437|460310680|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
127915113|NCT00112437|460310681|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
127915114|NCT00112437|460310682|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
127915115|NCT00112437|460310683|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
127915116|NCT00112437|460310684|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
127915117|NCT00112437|460310685|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
127915118|NCT00112437|460310686|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
127915119|NCT00112437|460310687|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
127915120|NCT00112437|460310688|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
127915121|NCT00112437|460310689|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
127915122|NCT00112437|460310690|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
127915123|NCT00112437|460310691|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
127915124|NCT00112437|460310692|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
127915125|NCT00112437|460310693|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
127915126|NCT00112437|460310668|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
127915127|NCT00112437|460310669|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
127915128|NCT00112437|460310670|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
127915129|NCT00112437|460310671|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
127915130|NCT00112437|460310672|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
127915131|NCT00112437|460310673|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
127915132|NCT00112437|460310674|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
127915133|NCT00112437|460310675|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
127915134|NCT00112437|460310676|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
127864359|NCT01451203|460121823|FG000|Post-treatment Period|Adverse Event|0|||
127915135|NCT00112437|460310677|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
127915136|NCT00112437|460310678|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
127915137|NCT00112437|460310679|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
127915138|NCT00112437|460310680|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
127915139|NCT00112437|460310681|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
127915140|NCT00112437|460310682|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
127915141|NCT00112437|460310683|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
127915142|NCT00112437|460310684|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
127915143|NCT00112437|460310685|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
127915144|NCT00112437|460310686|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
127915145|NCT00112437|460310687|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
127915146|NCT00112437|460310688|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
127915147|NCT00112437|460310689|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
127915148|NCT00112437|460310690|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
127915149|NCT00112437|460310691|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
127915150|NCT00112437|460310692|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
127915151|NCT00112437|460310693|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
127915152|NCT00112437|460310668|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
127915153|NCT00112437|460310669|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
127915154|NCT00112437|460310670|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
127915155|NCT00112437|460310671|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
127864360|NCT01451203|460121824|FG001|Post-treatment Period|Adverse Event|1|||
127864361|NCT01451203|460121823|FG000|Post-treatment Period|Investigator decision|0|||
127915156|NCT00112437|460310672|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
127915157|NCT00112437|460310673|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
127915158|NCT00112437|460310674|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
127915159|NCT00112437|460310675|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
127915160|NCT00112437|460310676|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
127915161|NCT00112437|460310677|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
127915162|NCT00112437|460310678|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
127915163|NCT00112437|460310679|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
127915164|NCT00112437|460310680|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
127915165|NCT00112437|460310681|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
127915166|NCT00112437|460310682|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
127915167|NCT00112437|460310683|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
127915168|NCT00112437|460310684|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
127915169|NCT00112437|460310685|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
127915170|NCT00112437|460310686|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
127864362|NCT01451203|460121824|FG001|Post-treatment Period|Investigator decision|1|||
127864363|NCT03890731|460121825|FG000|Overall Study|Progressive disease|1|||
127864364|NCT03890731|460121825|FG000|Overall Study|Patient's decision|1|||
127864365|NCT03890731|460121825|FG000|Overall Study|Adverse Event|4|||
127864366|NCT00027027|460121829|FG000|Overall Study|Adverse Event|0|||
127864367|NCT00027027|460121830|FG001|Overall Study|Adverse Event|0|||
127864368|NCT00027027|460121831|FG002|Overall Study|Adverse Event|1|||
127864369|NCT00027027|460121832|FG003|Overall Study|Adverse Event|0|||
127864370|NCT00027027|460121833|FG004|Overall Study|Adverse Event|1|||
127864371|NCT00027027|460121829|FG000|Overall Study|Admitted for Signs of PD|0|||
127864372|NCT00027027|460121830|FG001|Overall Study|Admitted for Signs of PD|0|||
127864373|NCT00027027|460121831|FG002|Overall Study|Admitted for Signs of PD|0|||
127864374|NCT00027027|460121832|FG003|Overall Study|Admitted for Signs of PD|0|||
127864375|NCT00027027|460121833|FG004|Overall Study|Admitted for Signs of PD|1|||
127864376|NCT00027027|460121829|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
127864377|NCT00027027|460121830|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
127864378|NCT00027027|460121831|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
127864379|NCT00027027|460121832|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
127864380|NCT00027027|460121833|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
127864381|NCT00027027|460121829|FG000|Overall Study|PD Requiring Surgery|0|||
127864382|NCT00027027|460121830|FG001|Overall Study|PD Requiring Surgery|0|||
127864383|NCT00027027|460121831|FG002|Overall Study|PD Requiring Surgery|1|||
127864384|NCT00027027|460121832|FG003|Overall Study|PD Requiring Surgery|0|||
127864385|NCT00027027|460121833|FG004|Overall Study|PD Requiring Surgery|0|||
127864386|NCT00027027|460121829|FG000|Overall Study|Physician Decision Due To PD|2|||
127864387|NCT00027027|460121830|FG001|Overall Study|Physician Decision Due To PD|3|||
127864388|NCT00027027|460121831|FG002|Overall Study|Physician Decision Due To PD|2|||
127864389|NCT00027027|460121832|FG003|Overall Study|Physician Decision Due To PD|3|||
127864390|NCT00027027|460121833|FG004|Overall Study|Physician Decision Due To PD|5|||
127864391|NCT00027027|460121829|FG000|Overall Study|Withdrawal by Subject|0|||
127864392|NCT00027027|460121830|FG001|Overall Study|Withdrawal by Subject|0|||
127864393|NCT00027027|460121831|FG002|Overall Study|Withdrawal by Subject|0|||
127864394|NCT00027027|460121832|FG003|Overall Study|Withdrawal by Subject|0|||
127864395|NCT00027027|460121833|FG004|Overall Study|Withdrawal by Subject|1|||
127864396|NCT02039687|460121839|FG000|Overall Study|Adverse Event|0|||
127864397|NCT02039687|460121840|FG001|Overall Study|Adverse Event|0|||
127864398|NCT02039687|460121841|FG002|Overall Study|Adverse Event|1|||
127864399|NCT02039687|460121842|FG003|Overall Study|Adverse Event|0|||
127864400|NCT02039687|460121839|FG000|Overall Study|Withdrawal by Subject|0|||
127864401|NCT02039687|460121840|FG001|Overall Study|Withdrawal by Subject|1|||
127864402|NCT02039687|460121841|FG002|Overall Study|Withdrawal by Subject|0|||
127864403|NCT02039687|460121842|FG003|Overall Study|Withdrawal by Subject|0|||
127864404|NCT02039687|460121839|FG000|Overall Study|treatment assignment could not be confir|0|||
127864405|NCT02039687|460121840|FG001|Overall Study|treatment assignment could not be confir|0|||
127864406|NCT02039687|460121841|FG002|Overall Study|treatment assignment could not be confir|2|||
127864407|NCT02039687|460121842|FG003|Overall Study|treatment assignment could not be confir|0|||
127864408|NCT00303329|460121854|FG000|Overall Study|Adverse Event|7|||
127864409|NCT00303329|460121855|FG001|Overall Study|Adverse Event|14|||
127864410|NCT00303329|460121854|FG000|Overall Study|Abnormal Laboratory Values|0|||
127864411|NCT00303329|460121855|FG001|Overall Study|Abnormal Laboratory Values|1|||
127864412|NCT00303329|460121854|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
127864413|NCT00303329|460121855|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
127864414|NCT00303329|460121854|FG000|Overall Study|Condition no longer requires study drug|0|||
127915171|NCT00112437|460310687|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
127915172|NCT00112437|460310688|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
127915173|NCT00112437|460310689|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
127915174|NCT00112437|460310690|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
127915175|NCT00112437|460310691|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
127915176|NCT00112437|460310692|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
127915177|NCT00112437|460310693|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
127915178|NCT00112437|460310668|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
127915179|NCT00112437|460310669|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
127915180|NCT00112437|460310670|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
127915181|NCT00112437|460310671|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
127915182|NCT00112437|460310672|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
127915183|NCT00112437|460310673|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
127915184|NCT00112437|460310674|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
127915185|NCT00112437|460310675|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
127915186|NCT00112437|460310676|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
127915187|NCT00112437|460310677|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
127864415|NCT00303329|460121855|FG001|Overall Study|Condition no longer requires study drug|8|||
127864416|NCT00303329|460121854|FG000|Overall Study|Protocol Violation|3|||
127864417|NCT00303329|460121855|FG001|Overall Study|Protocol Violation|0|||
127864418|NCT00303329|460121854|FG000|Overall Study|Withdrawal by Subject|9|||
127864419|NCT00303329|460121855|FG001|Overall Study|Withdrawal by Subject|15|||
127864420|NCT00303329|460121854|FG000|Overall Study|Lost to Follow-up|0|||
127864421|NCT00303329|460121855|FG001|Overall Study|Lost to Follow-up|1|||
127864422|NCT00303329|460121854|FG000|Overall Study|Administrative problems|1|||
127864423|NCT00303329|460121855|FG001|Overall Study|Administrative problems|0|||
127864424|NCT00303329|460121854|FG000|Overall Study|Death|2|||
127864425|NCT00303329|460121855|FG001|Overall Study|Death|12|||
127864426|NCT00303329|460121854|FG000|Overall Study|Stopped at end of core|3|||
127864427|NCT00303329|460121855|FG001|Overall Study|Stopped at end of core|9|||
127864428|NCT00303329|460121854|FG000|Overall Study|Stopped at end of extension 1|1|||
127864429|NCT00303329|460121855|FG001|Overall Study|Stopped at end of extension 1|0|||
127864430|NCT03055806|460121857|FG000|Overall Study|Adverse Event|0|||
127864431|NCT03055806|460121858|FG001|Overall Study|Adverse Event|0|||
127864432|NCT03055806|460121859|FG002|Overall Study|Adverse Event|1|||
127864433|NCT03055806|460121860|FG003|Overall Study|Adverse Event|1|||
127864434|NCT03055806|460121857|FG000|Overall Study|Lost to Follow-up|0|||
127864435|NCT03055806|460121858|FG001|Overall Study|Lost to Follow-up|3|||
127864436|NCT03055806|460121859|FG002|Overall Study|Lost to Follow-up|6|||
127864437|NCT03055806|460121860|FG003|Overall Study|Lost to Follow-up|7|||
127864438|NCT03055806|460121857|FG000|Overall Study|Physician Decision|1|||
127864439|NCT03055806|460121858|FG001|Overall Study|Physician Decision|0|||
127864440|NCT03055806|460121859|FG002|Overall Study|Physician Decision|0|||
127864441|NCT03055806|460121860|FG003|Overall Study|Physician Decision|1|||
127864442|NCT03055806|460121857|FG000|Overall Study|Protocol Violation|1|||
127864443|NCT03055806|460121858|FG001|Overall Study|Protocol Violation|0|||
127864444|NCT03055806|460121859|FG002|Overall Study|Protocol Violation|0|||
127864445|NCT03055806|460121860|FG003|Overall Study|Protocol Violation|0|||
127864446|NCT03055806|460121857|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
127864447|NCT03055806|460121858|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
127864448|NCT03055806|460121859|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
127864449|NCT03055806|460121860|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
127864450|NCT03055806|460121857|FG000|Overall Study|Withdrawal of consent to continue study|2|||
127864451|NCT03055806|460121858|FG001|Overall Study|Withdrawal of consent to continue study|3|||
127864452|NCT03055806|460121859|FG002|Overall Study|Withdrawal of consent to continue study|4|||
127864453|NCT03055806|460121860|FG003|Overall Study|Withdrawal of consent to continue study|6|||
127864454|NCT03055806|460121857|FG000|Overall Study|Partner not willing to try intercourse|1|||
127864455|NCT03055806|460121858|FG001|Overall Study|Partner not willing to try intercourse|0|||
127864456|NCT03055806|460121859|FG002|Overall Study|Partner not willing to try intercourse|0|||
127864457|NCT03055806|460121860|FG003|Overall Study|Partner not willing to try intercourse|0|||
127864458|NCT00125138|460121861|FG000|Overall Study|Adverse Event|1|||
127864459|NCT00125138|460121862|FG001|Overall Study|Adverse Event|0|||
127864460|NCT00125138|460121863|FG002|Overall Study|Adverse Event|3|||
127864461|NCT00125138|460121864|FG003|Overall Study|Adverse Event|2|||
127864462|NCT00125138|460121861|FG000|Overall Study|Withdrawal by Subject|2|||
127864463|NCT00125138|460121862|FG001|Overall Study|Withdrawal by Subject|3|||
127864464|NCT00125138|460121863|FG002|Overall Study|Withdrawal by Subject|1|||
127864465|NCT00125138|460121864|FG003|Overall Study|Withdrawal by Subject|1|||
127864466|NCT00125138|460121861|FG000|Overall Study|Lack of Efficacy|0|||
127864467|NCT00125138|460121862|FG001|Overall Study|Lack of Efficacy|0|||
127864468|NCT00125138|460121863|FG002|Overall Study|Lack of Efficacy|0|||
127864469|NCT00125138|460121864|FG003|Overall Study|Lack of Efficacy|1|||
127864470|NCT00125138|460121861|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
127864471|NCT00125138|460121862|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
127864472|NCT00125138|460121863|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
127864473|NCT00125138|460121864|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
127864474|NCT00348686|460121869|FG000|Overall Study|Withdrawal by Subject|45|||
127864475|NCT00348686|460121869|FG000|Overall Study|Adverse Event|5|||
127864476|NCT00348686|460121869|FG000|Overall Study|Protocol Violation|6|||
127864477|NCT00348686|460121869|FG000|Overall Study|Lost to Follow-up|2|||
127864478|NCT00348686|460121869|FG000|Overall Study|Multiple Reasons|8|||
127864479|NCT01258738|460121870|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
127864480|NCT01258738|460121871|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
127864481|NCT01258738|460121870|FG000|Double-blind Period|Withdrawal by Subject|2|||
127864482|NCT01258738|460121871|FG001|Double-blind Period|Withdrawal by Subject|2|||
127864483|NCT01258738|460121870|FG000|Double-blind Period|Protocol Violation|1|||
127864484|NCT01258738|460121871|FG001|Double-blind Period|Protocol Violation|1|||
127864485|NCT01258738|460121870|FG000|Double-blind Period|Adverse Event|3|||
127864486|NCT01258738|460121871|FG001|Double-blind Period|Adverse Event|1|||
127864487|NCT01258738|460121870|FG000|Open-label Period|Did not meet inclusion criteria|0|||
127864488|NCT01258738|460121871|FG001|Open-label Period|Did not meet inclusion criteria|1|||
127864489|NCT01258738|460121870|FG000|Open-label Period|Insufficient clinical response|5|||
127864490|NCT01258738|460121871|FG001|Open-label Period|Insufficient clinical response|3|||
127864491|NCT01258738|460121870|FG000|Open-label Period|Lost to Follow-up|0|||
127864492|NCT01258738|460121871|FG001|Open-label Period|Lost to Follow-up|2|||
127864493|NCT01258738|460121870|FG000|Open-label Period|Withdrawal by Subject|5|||
127864494|NCT01258738|460121871|FG001|Open-label Period|Withdrawal by Subject|6|||
127864495|NCT01258738|460121870|FG000|Open-label Period|Protocol Violation|2|||
127864496|NCT01258738|460121871|FG001|Open-label Period|Protocol Violation|2|||
127864497|NCT01258738|460121870|FG000|Open-label Period|Adverse Event|4|||
127864498|NCT01258738|460121871|FG001|Open-label Period|Adverse Event|5|||
127864499|NCT01258738|460121870|FG000|Open-label Period|Other Reasons|0|||
127864500|NCT01258738|460121871|FG001|Open-label Period|Other Reasons|1|||
127864501|NCT01258738|460121870|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
127864502|NCT01258738|460121871|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
127864503|NCT00689611|460121872|FG000|Overall Study|Death|6|||
127864504|NCT00689611|460121873|FG001|Overall Study|Death|9|||
127864505|NCT00689611|460121872|FG000|Overall Study|Withdrawal by Subject|8|||
127864506|NCT00689611|460121873|FG001|Overall Study|Withdrawal by Subject|9|||
127864507|NCT00689611|460121872|FG000|Overall Study|Lost to Follow-up|27|||
127864508|NCT00689611|460121873|FG001|Overall Study|Lost to Follow-up|28|||
127864509|NCT00568399|460121874|FG000|Overall Study|Death|2|||
127864510|NCT00568399|460121874|FG000|Overall Study|Adverse Event|5|||
127864511|NCT00568399|460121874|FG000|Overall Study|Withdrawal by Subject|8|||
127864512|NCT01904760|460121881|FG000|Overall Study|Protocol Violation|1|||
127864513|NCT01904760|460121882|FG001|Overall Study|Protocol Violation|0|||
127864514|NCT04249076|460121892|FG000|Overall Study|Adverse Event|1|||
127864515|NCT04249076|460121893|FG001|Overall Study|Adverse Event|1|||
127864516|NCT04249076|460121892|FG000|Overall Study|Protocol Violation|1|||
127864517|NCT04249076|460121893|FG001|Overall Study|Protocol Violation|2|||
127864518|NCT04249076|460121892|FG000|Overall Study|Lack of Efficacy|0|||
127864519|NCT04249076|460121893|FG001|Overall Study|Lack of Efficacy|1|||
127864520|NCT04249076|460121892|FG000|Overall Study|Withdrawal by Subject|0|||
127864521|NCT04249076|460121893|FG001|Overall Study|Withdrawal by Subject|1|||
127864522|NCT00783263|460121894|FG000|Overall Study|Adverse Event|3|||
127864523|NCT00783263|460121895|FG001|Overall Study|Adverse Event|0|||
127864524|NCT00783263|460121896|FG002|Overall Study|Adverse Event|2|||
127864525|NCT00783263|460121897|FG003|Overall Study|Adverse Event|1|||
127915188|NCT00112437|460310678|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
127915189|NCT00112437|460310679|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
127864526|NCT00783263|460121894|FG000|Overall Study|Lost to Follow-up|1|||
127864527|NCT00783263|460121895|FG001|Overall Study|Lost to Follow-up|1|||
127864528|NCT00783263|460121896|FG002|Overall Study|Lost to Follow-up|0|||
127864529|NCT00783263|460121897|FG003|Overall Study|Lost to Follow-up|0|||
127864530|NCT00783263|460121894|FG000|Overall Study|Withdrawal by Subject|0|||
127864531|NCT00783263|460121895|FG001|Overall Study|Withdrawal by Subject|1|||
127864532|NCT00783263|460121896|FG002|Overall Study|Withdrawal by Subject|1|||
127864533|NCT00783263|460121897|FG003|Overall Study|Withdrawal by Subject|2|||
127864534|NCT00405756|460121898|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
127864535|NCT00405756|460121899|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
127864536|NCT00405756|460121900|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
127915190|NCT00112437|460310680|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
127915191|NCT00112437|460310681|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
127915192|NCT00112437|460310682|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
127915193|NCT00112437|460310683|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
127915194|NCT00112437|460310684|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
127915195|NCT00112437|460310685|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
127915196|NCT00112437|460310686|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
127915197|NCT00112437|460310687|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
127915198|NCT00112437|460310688|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
127915199|NCT00112437|460310689|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
127915200|NCT00112437|460310690|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
127915201|NCT00112437|460310691|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
127915202|NCT00112437|460310692|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
127915203|NCT00112437|460310693|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
127915204|NCT00112437|460310668|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
127915205|NCT00112437|460310669|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
127915206|NCT00112437|460310670|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
127915207|NCT00112437|460310671|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
127915208|NCT00112437|460310672|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
127915209|NCT00112437|460310673|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
127915210|NCT00112437|460310674|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
127915211|NCT00112437|460310675|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
127915212|NCT00112437|460310676|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
127915213|NCT00112437|460310677|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
127915214|NCT00112437|460310678|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
127915215|NCT00112437|460310679|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
127915216|NCT00112437|460310680|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
127915217|NCT00112437|460310681|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
127915218|NCT00112437|460310682|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
127915219|NCT00112437|460310683|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
127915220|NCT00112437|460310684|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
127915221|NCT00112437|460310685|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
127915222|NCT00112437|460310686|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
127915223|NCT00112437|460310687|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
127915224|NCT00112437|460310688|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
127915225|NCT00112437|460310689|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
127915226|NCT00112437|460310690|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
127915227|NCT00112437|460310691|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
127915228|NCT00112437|460310692|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
127915229|NCT00112437|460310693|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
127915230|NCT00112437|460310668|FG000|Years 6-10 (60-Month Extension)|Death|0|||
127915231|NCT00112437|460310669|FG001|Years 6-10 (60-Month Extension)|Death|0|||
127915232|NCT00112437|460310670|FG002|Years 6-10 (60-Month Extension)|Death|0|||
127915233|NCT00112437|460310671|FG003|Years 6-10 (60-Month Extension)|Death|0|||
127915234|NCT00112437|460310672|FG004|Years 6-10 (60-Month Extension)|Death|0|||
127915235|NCT00112437|460310673|FG005|Years 6-10 (60-Month Extension)|Death|0|||
127915236|NCT00112437|460310674|FG006|Years 6-10 (60-Month Extension)|Death|0|||
127915237|NCT00112437|460310675|FG007|Years 6-10 (60-Month Extension)|Death|0|||
127915238|NCT00112437|460310676|FG008|Years 6-10 (60-Month Extension)|Death|0|||
127915239|NCT00112437|460310677|FG009|Years 6-10 (60-Month Extension)|Death|0|||
127915240|NCT00112437|460310678|FG010|Years 6-10 (60-Month Extension)|Death|0|||
127915241|NCT00112437|460310679|FG011|Years 6-10 (60-Month Extension)|Death|0|||
127915242|NCT00112437|460310680|FG012|Years 6-10 (60-Month Extension)|Death|0|||
127915243|NCT00112437|460310681|FG013|Years 6-10 (60-Month Extension)|Death|0|||
127915244|NCT00112437|460310682|FG014|Years 6-10 (60-Month Extension)|Death|0|||
127915245|NCT00112437|460310683|FG015|Years 6-10 (60-Month Extension)|Death|0|||
127915246|NCT00112437|460310684|FG016|Years 6-10 (60-Month Extension)|Death|0|||
127915247|NCT00112437|460310685|FG017|Years 6-10 (60-Month Extension)|Death|0|||
127915248|NCT00112437|460310686|FG018|Years 6-10 (60-Month Extension)|Death|0|||
127915249|NCT00112437|460310687|FG019|Years 6-10 (60-Month Extension)|Death|0|||
127915250|NCT00112437|460310688|FG020|Years 6-10 (60-Month Extension)|Death|0|||
127915251|NCT00112437|460310689|FG021|Years 6-10 (60-Month Extension)|Death|0|||
127915252|NCT00112437|460310690|FG022|Years 6-10 (60-Month Extension)|Death|0|||
127915253|NCT00112437|460310691|FG023|Years 6-10 (60-Month Extension)|Death|2|||
127915254|NCT00112437|460310692|FG024|Years 6-10 (60-Month Extension)|Death|0|||
127915255|NCT00112437|460310693|FG025|Years 6-10 (60-Month Extension)|Death|0|||
127915256|NCT00112437|460310668|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
127915257|NCT00112437|460310669|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
127915258|NCT00112437|460310670|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
127915259|NCT00112437|460310671|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
127915260|NCT00112437|460310672|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
127915261|NCT00112437|460310673|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
127915262|NCT00112437|460310674|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
127915263|NCT00112437|460310675|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
127915264|NCT00112437|460310676|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
127915265|NCT00112437|460310677|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
127915266|NCT00112437|460310678|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
127915267|NCT00112437|460310679|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
127915268|NCT00112437|460310680|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
127915269|NCT00112437|460310681|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
127915270|NCT00112437|460310682|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
127915271|NCT00112437|460310683|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
127915272|NCT00112437|460310684|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
127915273|NCT00112437|460310685|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
127915274|NCT00112437|460310686|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
127915275|NCT00112437|460310687|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
127915276|NCT00112437|460310688|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
127915277|NCT00112437|460310689|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
127915278|NCT00112437|460310690|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
127915279|NCT00112437|460310691|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
127915280|NCT00112437|460310692|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
127915281|NCT00112437|460310693|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
127915282|NCT00112437|460310668|FG000|Years 6-10 (60-Month Extension)|Other|0|||
127915283|NCT00112437|460310669|FG001|Years 6-10 (60-Month Extension)|Other|0|||
127915284|NCT00112437|460310670|FG002|Years 6-10 (60-Month Extension)|Other|0|||
127915285|NCT00112437|460310671|FG003|Years 6-10 (60-Month Extension)|Other|0|||
127915286|NCT00112437|460310672|FG004|Years 6-10 (60-Month Extension)|Other|0|||
127915287|NCT00112437|460310673|FG005|Years 6-10 (60-Month Extension)|Other|0|||
127915288|NCT00112437|460310674|FG006|Years 6-10 (60-Month Extension)|Other|0|||
127915289|NCT00112437|460310675|FG007|Years 6-10 (60-Month Extension)|Other|0|||
127915290|NCT00112437|460310676|FG008|Years 6-10 (60-Month Extension)|Other|0|||
127915291|NCT00112437|460310677|FG009|Years 6-10 (60-Month Extension)|Other|0|||
127915292|NCT00112437|460310678|FG010|Years 6-10 (60-Month Extension)|Other|0|||
127915293|NCT00112437|460310679|FG011|Years 6-10 (60-Month Extension)|Other|0|||
127915294|NCT00112437|460310680|FG012|Years 6-10 (60-Month Extension)|Other|0|||
127915295|NCT00112437|460310681|FG013|Years 6-10 (60-Month Extension)|Other|0|||
127915296|NCT00112437|460310682|FG014|Years 6-10 (60-Month Extension)|Other|0|||
127915297|NCT00112437|460310683|FG015|Years 6-10 (60-Month Extension)|Other|0|||
127915298|NCT00112437|460310684|FG016|Years 6-10 (60-Month Extension)|Other|0|||
127915299|NCT00112437|460310685|FG017|Years 6-10 (60-Month Extension)|Other|0|||
127915300|NCT00112437|460310686|FG018|Years 6-10 (60-Month Extension)|Other|0|||
127915301|NCT00112437|460310687|FG019|Years 6-10 (60-Month Extension)|Other|0|||
127915302|NCT00112437|460310688|FG020|Years 6-10 (60-Month Extension)|Other|0|||
127915303|NCT00112437|460310689|FG021|Years 6-10 (60-Month Extension)|Other|0|||
127915304|NCT00112437|460310690|FG022|Years 6-10 (60-Month Extension)|Other|0|||
127915305|NCT00112437|460310691|FG023|Years 6-10 (60-Month Extension)|Other|0|||
127915306|NCT00112437|460310692|FG024|Years 6-10 (60-Month Extension)|Other|1|||
127915307|NCT00112437|460310693|FG025|Years 6-10 (60-Month Extension)|Other|0|||
127915308|NCT00112437|460310668|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
127915309|NCT00112437|460310669|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
127915310|NCT00112437|460310670|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
127915311|NCT00112437|460310671|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
127915312|NCT00112437|460310672|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
127915313|NCT00112437|460310673|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
127915314|NCT00112437|460310674|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
127915315|NCT00112437|460310675|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
127915316|NCT00112437|460310676|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
127915317|NCT00112437|460310677|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
127915318|NCT00112437|460310678|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
127915319|NCT00112437|460310679|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
127915320|NCT00112437|460310680|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
127915321|NCT00112437|460310681|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
127915322|NCT00112437|460310682|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
127915323|NCT00112437|460310683|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
127915324|NCT00112437|460310684|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
127915325|NCT00112437|460310685|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
127915326|NCT00112437|460310686|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
127915327|NCT00112437|460310687|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
127915328|NCT00112437|460310688|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
127915329|NCT00112437|460310689|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
127915330|NCT00112437|460310690|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
127915331|NCT00112437|460310691|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
127915332|NCT00112437|460310692|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
127915333|NCT00112437|460310693|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
127915334|NCT00112437|460310668|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
127915335|NCT00112437|460310669|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
127915336|NCT00112437|460310670|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
127915337|NCT00112437|460310671|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
127915338|NCT00112437|460310672|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
127915339|NCT00112437|460310673|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
127915340|NCT00112437|460310674|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
127915341|NCT00112437|460310675|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
127915342|NCT00112437|460310676|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
127915343|NCT00112437|460310677|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
127915344|NCT00112437|460310678|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
127915345|NCT00112437|460310679|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
127915346|NCT00112437|460310680|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
127915347|NCT00112437|460310681|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
127915348|NCT00112437|460310682|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
127915349|NCT00112437|460310683|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
127915350|NCT00112437|460310684|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
127915351|NCT00112437|460310685|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
127915352|NCT00112437|460310686|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
127915353|NCT00112437|460310687|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
127915354|NCT00112437|460310688|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
127915355|NCT00112437|460310689|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
127915356|NCT00112437|460310690|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
127915357|NCT00112437|460310691|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
127915358|NCT00112437|460310692|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
127915359|NCT00112437|460310693|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
127915360|NCT03541252|460310694|FG000|Overall Study|Withdrawal by Subject|1|||
127915361|NCT00227370|460310695|FG000|Overall Study|Withdrawal by Subject|1|||
127915362|NCT00227370|460310696|FG001|Overall Study|Withdrawal by Subject|2|||
127915363|NCT00227370|460310695|FG000|Overall Study|Death|3|||
127915364|NCT00227370|460310696|FG001|Overall Study|Death|4|||
127915365|NCT00227370|460310695|FG000|Overall Study|Adverse Event|6|||
127915366|NCT00227370|460310696|FG001|Overall Study|Adverse Event|11|||
127915367|NCT00227370|460310695|FG000|Overall Study|Physician Decision|9|||
127915368|NCT00227370|460310696|FG001|Overall Study|Physician Decision|6|||
127915369|NCT00227370|460310695|FG000|Overall Study|Other reasons|2|||
127915370|NCT00227370|460310696|FG001|Overall Study|Other reasons|1|||
127915371|NCT02588339|460310698|FG000|Overall Study|Withdrawal by Subject|1|||
127915372|NCT02588339|460310698|FG000|Overall Study|GVHD Progression prior to treatment|2|||
127915373|NCT01952691|460312235|FG000|Overall Study|Lost to Follow-up|2|||
127915374|NCT00199901|460312236|FG000|Overall Study|Protocol Violation|2|||
127915375|NCT00199901|460312237|FG001|Overall Study|Protocol Violation|0|||
127915376|NCT00199901|460312236|FG000|Overall Study|Withdrawal by Subject|1|||
127915377|NCT00199901|460312237|FG001|Overall Study|Withdrawal by Subject|0|||
127915378|NCT00199901|460312236|FG000|Overall Study|Progressive Disease|24|||
127915379|NCT00199901|460312237|FG001|Overall Study|Progressive Disease|24|||
127915380|NCT05776901|460312238|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
127915381|NCT00660660|460312242|FG000|Overall Study|Adverse Event|1|||
127915382|NCT00660660|460312243|FG001|Overall Study|Adverse Event|0|||
127915383|NCT00660660|460312242|FG000|Overall Study|Lost to Follow-up|0|||
127915384|NCT00660660|460312243|FG001|Overall Study|Lost to Follow-up|6|||
127915385|NCT00660660|460312242|FG000|Overall Study|Lack of Efficacy|0|||
127915386|NCT00660660|460312243|FG001|Overall Study|Lack of Efficacy|2|||
127915387|NCT00660660|460312242|FG000|Overall Study|Withdrawal by Subject|3|||
127915388|NCT00660660|460312243|FG001|Overall Study|Withdrawal by Subject|0|||
127915389|NCT00660660|460312242|FG000|Overall Study|Incorrect enrollment and other|0|||
127915390|NCT00660660|460312243|FG001|Overall Study|Incorrect enrollment and other|1|||
127915391|NCT00660660|460312242|FG000|Overall Study|New medication after randomization|1|||
127915392|NCT00660660|460312243|FG001|Overall Study|New medication after randomization|0|||
127915393|NCT00294047|460312248|FG000|Month 48|Adverse Event|28|||
127915394|NCT00294047|460312249|FG001|Month 48|Adverse Event|13|||
127915395|NCT00294047|460312248|FG000|Month 48|Protocol Violation|4|||
127915396|NCT00294047|460312249|FG001|Month 48|Protocol Violation|4|||
127915397|NCT00294047|460312248|FG000|Month 48|Withdrawal by Subject|111|||
127915398|NCT00294047|460312249|FG001|Month 48|Withdrawal by Subject|115|||
127915399|NCT00294047|460312248|FG000|Month 48|Lost to Follow-up|272|||
127915400|NCT00294047|460312249|FG001|Month 48|Lost to Follow-up|287|||
127915401|NCT00294047|460312248|FG000|Month 48|Other|10|||
127915402|NCT00294047|460312249|FG001|Month 48|Other|14|||
127915403|NCT00294047|460312248|FG000|Month 84|Adverse Event|4|||
127915404|NCT00294047|460312249|FG001|Month 84|Adverse Event|2|||
127915405|NCT00294047|460312248|FG000|Month 84|Protocol Violation|1|||
127915406|NCT00294047|460312249|FG001|Month 84|Protocol Violation|1|||
127915407|NCT00294047|460312248|FG000|Month 84|Withdrawal by Subject|33|||
127915408|NCT00294047|460312249|FG001|Month 84|Withdrawal by Subject|31|||
127915409|NCT00294047|460312248|FG000|Month 84|Lost to Follow-up|187|||
127915410|NCT00294047|460312249|FG001|Month 84|Lost to Follow-up|190|||
127915411|NCT00294047|460312248|FG000|Month 84|Absent Cervix|2|||
127915412|NCT00294047|460312249|FG001|Month 84|Absent Cervix|0|||
127915413|NCT00294047|460312248|FG000|Month 84|Work related reasons|4|||
127915414|NCT00294047|460312249|FG001|Month 84|Work related reasons|2|||
127915415|NCT00294047|460312248|FG000|Month 84|Center closed, subject did not transfer|1|||
127915416|NCT00294047|460312249|FG001|Month 84|Center closed, subject did not transfer|0|||
127915417|NCT00294047|460312248|FG000|Month 84|Family problems|2|||
127915418|NCT00294047|460312249|FG001|Month 84|Family problems|2|||
127915419|NCT00294047|460312248|FG000|Month 84|Lack of time|3|||
127915420|NCT00294047|460312249|FG001|Month 84|Lack of time|1|||
127915421|NCT00294047|460312248|FG000|Month 84|Personal reason|2|||
127915422|NCT00294047|460312249|FG001|Month 84|Personal reason|4|||
127915423|NCT00294047|460312248|FG000|Month 84|Subject does not want male physician|1|||
127915424|NCT00294047|460312249|FG001|Month 84|Subject does not want male physician|0|||
127915425|NCT00294047|460312248|FG000|Month 84|Transport reimbursement delayed|0|||
127915426|NCT00294047|460312249|FG001|Month 84|Transport reimbursement delayed|1|||
127915427|NCT00294047|460312248|FG000|Month 84|Unable to reach study site|1|||
127915428|NCT00294047|460312249|FG001|Month 84|Unable to reach study site|0|||
127915429|NCT00294047|460312248|FG000|Month 84|Under investigation locally|1|||
127915430|NCT00294047|460312249|FG001|Month 84|Under investigation locally|0|||
127915431|NCT00294047|460312248|FG000|Month 84|Visit missed|0|||
127915432|NCT00294047|460312249|FG001|Month 84|Visit missed|1|||
127915433|NCT00294047|460312248|FG000|Month 84|No consent for Month 84 Follow-up|731|||
127915434|NCT00294047|460312249|FG001|Month 84|No consent for Month 84 Follow-up|754|||
127915435|NCT02157974|460312250|FG000|Overall Study|Withdrawal by Subject|0|||
127915436|NCT02157974|460312251|FG001|Overall Study|Withdrawal by Subject|1|||
127915437|NCT02157974|460312252|FG002|Overall Study|Withdrawal by Subject|0|||
127915438|NCT02157974|460312253|FG003|Overall Study|Withdrawal by Subject|0|||
127915439|NCT02157974|460312254|FG004|Overall Study|Withdrawal by Subject|0|||
127864537|NCT00405756|460121898|FG000|Double-blind Treatment|Adverse Event|31|||
127864538|NCT00405756|460121899|FG001|Double-blind Treatment|Adverse Event|27|||
127864539|NCT00405756|460121900|FG002|Double-blind Treatment|Adverse Event|12|||
127864540|NCT00405756|460121898|FG000|Double-blind Treatment|Disease Progression|47|||
127864541|NCT00405756|460121899|FG001|Double-blind Treatment|Disease Progression|81|||
127864542|NCT00405756|460121900|FG002|Double-blind Treatment|Disease Progression|102|||
127864543|NCT00405756|460121898|FG000|Double-blind Treatment|Lack of Efficacy|1|||
127864544|NCT00405756|460121899|FG001|Double-blind Treatment|Lack of Efficacy|4|||
127864545|NCT00405756|460121900|FG002|Double-blind Treatment|Lack of Efficacy|2|||
127864546|NCT00405756|460121898|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
127864547|NCT00405756|460121899|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
127864548|NCT00405756|460121900|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
127864549|NCT00405756|460121898|FG000|Double-blind Treatment|Lost to Follow-up|1|||
127864550|NCT00405756|460121899|FG001|Double-blind Treatment|Lost to Follow-up|0|||
127864551|NCT00405756|460121900|FG002|Double-blind Treatment|Lost to Follow-up|0|||
127864552|NCT00405756|460121898|FG000|Double-blind Treatment|Death|4|||
127864553|NCT00405756|460121899|FG001|Double-blind Treatment|Death|4|||
127915440|NCT02157974|460312250|FG000|Overall Study|Screen Failure|0|||
127915441|NCT02157974|460312251|FG001|Overall Study|Screen Failure|1|||
127915442|NCT02157974|460312252|FG002|Overall Study|Screen Failure|0|||
127915443|NCT02157974|460312253|FG003|Overall Study|Screen Failure|0|||
127915444|NCT02157974|460312254|FG004|Overall Study|Screen Failure|0|||
127864554|NCT00405756|460121900|FG002|Double-blind Treatment|Death|4|||
127915445|NCT02157974|460312250|FG000|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
127915446|NCT02157974|460312251|FG001|Overall Study|Nurse not able to place IV so unable to complete visit|1|||
127915447|NCT02157974|460312252|FG002|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
127915448|NCT02157974|460312253|FG003|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
127864555|NCT00405756|460121898|FG000|Double-blind Treatment|Protocol Violation|1|||
127864556|NCT00405756|460121899|FG001|Double-blind Treatment|Protocol Violation|0|||
127864557|NCT00405756|460121900|FG002|Double-blind Treatment|Protocol Violation|2|||
127864558|NCT00405756|460121898|FG000|Double-blind Treatment|Other|7|||
127864559|NCT00405756|460121899|FG001|Double-blind Treatment|Other|4|||
127864560|NCT00405756|460121900|FG002|Double-blind Treatment|Other|4|||
127915449|NCT02157974|460312254|FG004|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
127915450|NCT03497130|460312257|FG000|Overall Study|Lost to Follow-up|1|||
127915451|NCT03497130|460312258|FG001|Overall Study|Lost to Follow-up|1|||
127915452|NCT04002648|460312259|FG000|Overall Study|Lost to Follow-up|2|||
127864561|NCT00405756|460121898|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
127864562|NCT00405756|460121899|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
127864563|NCT00405756|460121900|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
127864564|NCT00405756|460121898|FG000|Open-label Extension|Adverse Event|1|||
127864565|NCT00405756|460121899|FG001|Open-label Extension|Adverse Event|3|||
127864566|NCT00405756|460121900|FG002|Open-label Extension|Adverse Event|7|||
127864567|NCT00405756|460121898|FG000|Open-label Extension|Disease Progression|8|||
127864568|NCT00405756|460121899|FG001|Open-label Extension|Disease Progression|23|||
127864569|NCT00405756|460121900|FG002|Open-label Extension|Disease Progression|26|||
127864570|NCT00405756|460121898|FG000|Open-label Extension|Withdrawal by Subject|2|||
127864571|NCT00405756|460121899|FG001|Open-label Extension|Withdrawal by Subject|3|||
127864572|NCT00405756|460121900|FG002|Open-label Extension|Withdrawal by Subject|3|||
127864573|NCT00405756|460121898|FG000|Open-label Extension|Death|1|||
127864574|NCT00405756|460121899|FG001|Open-label Extension|Death|2|||
127864575|NCT00405756|460121900|FG002|Open-label Extension|Death|4|||
127864576|NCT00405756|460121898|FG000|Open-label Extension|Other|0|||
127864577|NCT00405756|460121899|FG001|Open-label Extension|Other|1|||
127864578|NCT00405756|460121900|FG002|Open-label Extension|Other|7|||
127864579|NCT00405756|460121898|FG000|Follow-up|Ongoing in Follow-up Period|52|||
127864580|NCT00405756|460121899|FG001|Follow-up|Ongoing in Follow-up Period|51|||
127864581|NCT00405756|460121900|FG002|Follow-up|Ongoing in Follow-up Period|60|||
127864582|NCT00405756|460121898|FG000|Follow-up|Death|21|||
127864583|NCT00405756|460121899|FG001|Follow-up|Death|31|||
127864584|NCT00405756|460121900|FG002|Follow-up|Death|24|||
127864585|NCT00405756|460121898|FG000|Follow-up|Lost to Follow-up|2|||
127864586|NCT00405756|460121899|FG001|Follow-up|Lost to Follow-up|8|||
127864587|NCT00405756|460121900|FG002|Follow-up|Lost to Follow-up|4|||
127864588|NCT01038635|460121901|FG000|Overall Study|Disease Progression|2|||
127864589|NCT01038635|460121902|FG001|Overall Study|Disease Progression|0|||
127864590|NCT01038635|460121903|FG002|Overall Study|Disease Progression|0|||
127864591|NCT01038635|460121904|FG003|Overall Study|Disease Progression|0|||
127864592|NCT01038635|460121905|FG004|Overall Study|Disease Progression|0|||
127864593|NCT01038635|460121906|FG005|Overall Study|Disease Progression|0|||
127864594|NCT01038635|460121907|FG006|Overall Study|Disease Progression|1|||
127864595|NCT01038635|460121908|FG007|Overall Study|Disease Progression|4|||
127864596|NCT01038635|460121909|FG008|Overall Study|Disease Progression|0|||
127864597|NCT01038635|460121901|FG000|Overall Study|Death|0|||
127864598|NCT01038635|460121902|FG001|Overall Study|Death|0|||
127864599|NCT01038635|460121903|FG002|Overall Study|Death|0|||
127864600|NCT01038635|460121904|FG003|Overall Study|Death|0|||
127864601|NCT01038635|460121905|FG004|Overall Study|Death|1|||
127864602|NCT01038635|460121906|FG005|Overall Study|Death|0|||
127864603|NCT01038635|460121907|FG006|Overall Study|Death|1|||
127864604|NCT01038635|460121908|FG007|Overall Study|Death|1|||
127864605|NCT01038635|460121909|FG008|Overall Study|Death|2|||
127864606|NCT01060150|460121910|FG000|Overall Study|Adverse Event|6|||
127864607|NCT01060150|460121910|FG000|Overall Study|Lost to Follow-up|1|||
127864608|NCT01060150|460121910|FG000|Overall Study|Protocol Violation|6|||
127864609|NCT01060150|460121910|FG000|Overall Study|Withdrawal by Subject|8|||
127864610|NCT01060150|460121910|FG000|Overall Study|Enrolled, but not treated|2|||
127864611|NCT03018340|460121911|FG000|Overall Study|Adverse Event|1|||
127864612|NCT03018340|460121912|FG001|Overall Study|Adverse Event|2|||
127864613|NCT03018340|460121911|FG000|Overall Study|Withdrawal by Subject|0|||
127864614|NCT03018340|460121912|FG001|Overall Study|Withdrawal by Subject|8|||
127864615|NCT03018340|460121911|FG000|Overall Study|Lack of Efficacy|0|||
127864616|NCT03018340|460121912|FG001|Overall Study|Lack of Efficacy|1|||
127864617|NCT03018340|460121911|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
127864618|NCT03018340|460121912|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
127864619|NCT03018340|460121911|FG000|Overall Study|Lost to Follow-up|1|||
127864620|NCT03018340|460121912|FG001|Overall Study|Lost to Follow-up|7|||
127864621|NCT03018340|460121911|FG000|Overall Study|Protocol Violation|3|||
127864622|NCT03018340|460121912|FG001|Overall Study|Protocol Violation|7|||
127864623|NCT03018340|460121911|FG000|Overall Study|Not further specified|0|||
127864624|NCT03018340|460121912|FG001|Overall Study|Not further specified|1|||
127864625|NCT01683058|460121917|FG000|Overall Study|Lost to Follow-up|9|||
127864626|NCT01683058|460121917|FG000|Overall Study|Adverse Event|6|||
127864627|NCT01683058|460121917|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
127864628|NCT01683058|460121917|FG000|Overall Study|Withdrawal by Subject|7|||
127864629|NCT01683058|460121917|FG000|Overall Study|Lack of Efficacy|2|||
127864630|NCT04062240|460121918|FG000|Overall Study|equipment malfunction|1|||
127864631|NCT01195636|460121919|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
127864632|NCT01195636|460121920|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
127864633|NCT01195636|460121919|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
127864634|NCT01195636|460121920|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
127864635|NCT01195636|460121919|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
127864636|NCT01195636|460121920|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
127864637|NCT01195636|460121919|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
127864638|NCT01195636|460121920|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
127864639|NCT01195636|460121919|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
127864640|NCT01195636|460121920|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
127864641|NCT01195636|460121919|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
127864642|NCT01195636|460121920|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
127864643|NCT01195636|460121919|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
127864644|NCT01195636|460121920|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
127864645|NCT01195636|460121919|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
127864646|NCT01195636|460121920|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
127864647|NCT03500419|460121921|FG000|Overall Study|Withdrawal by Subject|2|||
127864648|NCT03500419|460121922|FG001|Overall Study|Withdrawal by Subject|25|||
127864649|NCT00203294|460121923|FG000|Overall Study|Withdrawal by Subject|8|||
127864650|NCT00203294|460121924|FG001|Overall Study|Withdrawal by Subject|13|||
127864651|NCT00082628|460121925|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
127864652|NCT00082628|460121926|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
127864653|NCT00082628|460121927|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
127864654|NCT00082628|460121928|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
127864655|NCT00082628|460121929|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
127864656|NCT00082628|460121925|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
127864657|NCT00082628|460121926|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
127864658|NCT00082628|460121927|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
127864659|NCT00082628|460121928|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
127864660|NCT00082628|460121929|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
127864661|NCT00082628|460121925|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
127864662|NCT00082628|460121926|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
127864663|NCT00082628|460121927|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
127864664|NCT00082628|460121928|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
127864665|NCT00082628|460121929|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
127864666|NCT00082628|460121925|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
127864667|NCT00082628|460121926|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
127864668|NCT00082628|460121927|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
127864669|NCT00082628|460121928|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
127864670|NCT00082628|460121929|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
127864671|NCT00082628|460121925|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
127864672|NCT00082628|460121926|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
127864673|NCT00082628|460121927|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
127864674|NCT00082628|460121928|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
127864675|NCT00082628|460121929|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
127864676|NCT00082628|460121925|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
127864677|NCT00082628|460121926|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
127864678|NCT00082628|460121927|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
127864679|NCT00082628|460121928|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
127864680|NCT00082628|460121929|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
127864681|NCT00082628|460121925|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
127864682|NCT00082628|460121926|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
127864683|NCT00082628|460121927|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
127864684|NCT00082628|460121928|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
127864685|NCT00082628|460121929|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
127864686|NCT01566981|460121930|FG000|Overall Study|Lost to Follow-up|5|||
127864687|NCT01566981|460121931|FG001|Overall Study|Lost to Follow-up|8|||
127864688|NCT03481634|460121933|FG000|Overall Study|Withdrawal by Subject|16|||
127915453|NCT04002648|460312260|FG001|Overall Study|Lost to Follow-up|0|||
127864689|NCT03481634|460121934|FG001|Overall Study|Withdrawal by Subject|19|||
127864690|NCT03481634|460121935|FG002|Overall Study|Withdrawal by Subject|14|||
127864691|NCT03481634|460121933|FG000|Overall Study|Protocol Violation|1|||
127864692|NCT03481634|460121934|FG001|Overall Study|Protocol Violation|0|||
127864693|NCT03481634|460121935|FG002|Overall Study|Protocol Violation|1|||
127864694|NCT03481634|460121933|FG000|Overall Study|Progressive disease|0|||
127864695|NCT03481634|460121934|FG001|Overall Study|Progressive disease|1|||
127864696|NCT03481634|460121935|FG002|Overall Study|Progressive disease|0|||
127864697|NCT03481634|460121933|FG000|Overall Study|Physician Decision|3|||
127864698|NCT03481634|460121934|FG001|Overall Study|Physician Decision|0|||
127864699|NCT03481634|460121935|FG002|Overall Study|Physician Decision|1|||
127864700|NCT03481634|460121933|FG000|Overall Study|Lost to Follow-up|3|||
127864701|NCT03481634|460121934|FG001|Overall Study|Lost to Follow-up|4|||
127864702|NCT03481634|460121935|FG002|Overall Study|Lost to Follow-up|4|||
127864703|NCT03481634|460121933|FG000|Overall Study|Death|4|||
127864704|NCT03481634|460121934|FG001|Overall Study|Death|8|||
127864705|NCT03481634|460121935|FG002|Overall Study|Death|7|||
127864706|NCT03481634|460121933|FG000|Overall Study|Adverse Event|6|||
127864707|NCT03481634|460121934|FG001|Overall Study|Adverse Event|3|||
127864708|NCT03481634|460121935|FG002|Overall Study|Adverse Event|7|||
127864709|NCT00994890|460121938|FG000|Overall Study|Adverse Event|13|||
127864710|NCT00994890|460121939|FG001|Overall Study|Adverse Event|9|||
127864711|NCT00994890|460121940|FG002|Overall Study|Adverse Event|11|||
127864712|NCT00994890|460121938|FG000|Overall Study|Lack of Efficacy|0|||
127864713|NCT00994890|460121939|FG001|Overall Study|Lack of Efficacy|0|||
127864714|NCT00994890|460121940|FG002|Overall Study|Lack of Efficacy|1|||
127864715|NCT00994890|460121938|FG000|Overall Study|Lost to Follow-up|6|||
127864716|NCT00994890|460121939|FG001|Overall Study|Lost to Follow-up|1|||
127864717|NCT00994890|460121940|FG002|Overall Study|Lost to Follow-up|3|||
127864718|NCT00994890|460121938|FG000|Overall Study|No longer willing to participate|8|||
127864719|NCT00994890|460121939|FG001|Overall Study|No longer willing to participate|5|||
127864720|NCT00994890|460121940|FG002|Overall Study|No longer willing to participate|13|||
127864721|NCT00994890|460121938|FG000|Overall Study|Protocol Violation|2|||
127864722|NCT00994890|460121939|FG001|Overall Study|Protocol Violation|4|||
127864723|NCT00994890|460121940|FG002|Overall Study|Protocol Violation|0|||
127864724|NCT00994890|460121938|FG000|Overall Study|Study terminated by sponsor|199|||
127864725|NCT00994890|460121939|FG001|Overall Study|Study terminated by sponsor|201|||
127864726|NCT00994890|460121940|FG002|Overall Study|Study terminated by sponsor|197|||
127864727|NCT00994890|460121938|FG000|Overall Study|Randomized, but not treated|1|||
127864728|NCT00994890|460121939|FG001|Overall Study|Randomized, but not treated|0|||
127864729|NCT00994890|460121940|FG002|Overall Study|Randomized, but not treated|0|||
127864730|NCT00994890|460121938|FG000|Overall Study|Other|2|||
127864731|NCT00994890|460121939|FG001|Overall Study|Other|2|||
127864732|NCT00994890|460121940|FG002|Overall Study|Other|1|||
127864733|NCT03323385|460121945|FG000|Overall Study|Withdrawal by Subject|1|||
127864734|NCT03323385|460121946|FG001|Overall Study|Withdrawal by Subject|2|||
127864735|NCT03323385|460121945|FG000|Overall Study|Noncompliance|0|||
127864736|NCT03323385|460121946|FG001|Overall Study|Noncompliance|1|||
127864737|NCT00247962|460121947|FG000|Overall Study|Adverse Event|15|||
127864738|NCT00247962|460121948|FG001|Overall Study|Adverse Event|12|||
127864739|NCT00247962|460121947|FG000|Overall Study|Lost to Follow-up|3|||
127864740|NCT00247962|460121948|FG001|Overall Study|Lost to Follow-up|1|||
127864741|NCT00247962|460121947|FG000|Overall Study|Physician Decision|0|||
127864742|NCT00247962|460121948|FG001|Overall Study|Physician Decision|1|||
127864743|NCT00247962|460121947|FG000|Overall Study|Protocol Violation|1|||
127864744|NCT00247962|460121948|FG001|Overall Study|Protocol Violation|1|||
127864745|NCT00247962|460121947|FG000|Overall Study|Withdrawal by Subject|3|||
127864746|NCT00247962|460121948|FG001|Overall Study|Withdrawal by Subject|2|||
127864747|NCT00247962|460121947|FG000|Overall Study|Lack of Efficacy|4|||
127864748|NCT00247962|460121948|FG001|Overall Study|Lack of Efficacy|2|||
127864749|NCT01849289|460121949|FG000|Overall Study|Adverse Event|3|||
127864750|NCT01849289|460121950|FG001|Overall Study|Adverse Event|3|||
127864751|NCT01849289|460121949|FG000|Overall Study|Protocol Violation|3|||
127864752|NCT01849289|460121950|FG001|Overall Study|Protocol Violation|3|||
127864753|NCT01849289|460121949|FG000|Overall Study|Withdrawal criteria|1|||
127864754|NCT01849289|460121950|FG001|Overall Study|Withdrawal criteria|0|||
127864755|NCT01849289|460121949|FG000|Overall Study|Unclassified|25|||
127864756|NCT01849289|460121950|FG001|Overall Study|Unclassified|18|||
127864757|NCT01469637|460121951|FG000|First Intervention|Unacceptable behavior|0|||
127864758|NCT01469637|460121952|FG001|First Intervention|Unacceptable behavior|1|||
127864759|NCT01469637|460121951|FG000|Second Intervention|Incarcerated|1|||
127864760|NCT01469637|460121952|FG001|Second Intervention|Incarcerated|0|||
127864761|NCT00598585|460121953|FG000|Overall Study|Lost to Follow-up|1|||
127864762|NCT00598585|460121954|FG001|Overall Study|Lost to Follow-up|0|||
127864763|NCT00420212|460121960|FG000|Overall Study|Adverse Event|22|||
127864764|NCT00420212|460121961|FG001|Overall Study|Adverse Event|40|||
127864765|NCT00420212|460121962|FG002|Overall Study|Adverse Event|36|||
127864766|NCT00420212|460121960|FG000|Overall Study|Lost to Follow-up|9|||
127864767|NCT00420212|460121961|FG001|Overall Study|Lost to Follow-up|11|||
127864768|NCT00420212|460121962|FG002|Overall Study|Lost to Follow-up|11|||
127864769|NCT00420212|460121960|FG000|Overall Study|Withdrawal by Subject|31|||
127864770|NCT00420212|460121961|FG001|Overall Study|Withdrawal by Subject|22|||
127864771|NCT00420212|460121962|FG002|Overall Study|Withdrawal by Subject|19|||
127864772|NCT00420212|460121960|FG000|Overall Study|Physician Decision|4|||
127864773|NCT00420212|460121961|FG001|Overall Study|Physician Decision|4|||
127864774|NCT00420212|460121962|FG002|Overall Study|Physician Decision|3|||
127864775|NCT00420212|460121960|FG000|Overall Study|Protocol Violation|4|||
127864776|NCT00420212|460121961|FG001|Overall Study|Protocol Violation|4|||
127864777|NCT00420212|460121962|FG002|Overall Study|Protocol Violation|8|||
127864778|NCT00420212|460121960|FG000|Overall Study|Death|0|||
127864779|NCT00420212|460121961|FG001|Overall Study|Death|0|||
127864780|NCT00420212|460121962|FG002|Overall Study|Death|1|||
127864781|NCT00420212|460121960|FG000|Overall Study|Other-Unspecified|21|||
127864782|NCT00420212|460121961|FG001|Overall Study|Other-Unspecified|14|||
127864783|NCT00420212|460121962|FG002|Overall Study|Other-Unspecified|18|||
127864784|NCT03147495|460121963|FG000|Overall Study|Physician Decision|0|||
127864785|NCT03147495|460121964|FG001|Overall Study|Physician Decision|6|||
127864786|NCT02607735|460121965|FG000|Primary Study|Randomized but Never Treated|1|||
127864787|NCT02607735|460121966|FG001|Primary Study|Randomized but Never Treated|0|||
127864788|NCT02607735|460121967|FG002|Primary Study|Randomized but Never Treated|0|||
127864789|NCT02607735|460121965|FG000|Primary Study|Lost to Follow-up|4|||
127864790|NCT02607735|460121966|FG001|Primary Study|Lost to Follow-up|0|||
127864791|NCT02607735|460121967|FG002|Primary Study|Lost to Follow-up|0|||
127864792|NCT02607735|460121965|FG000|Primary Study|Withdrew Consent|2|||
127864793|NCT02607735|460121966|FG001|Primary Study|Withdrew Consent|0|||
127864794|NCT02607735|460121967|FG002|Primary Study|Withdrew Consent|0|||
127864795|NCT02607735|460121965|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
127864796|NCT02607735|460121966|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
127864797|NCT02607735|460121967|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
127864798|NCT02607735|460121965|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
127864799|NCT02607735|460121966|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
127864800|NCT02607735|460121967|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
127864801|NCT02394028|460121970|FG000|Induction Phase|Adverse Event|2|||
127864802|NCT02394028|460121971|FG001|Induction Phase|Adverse Event|4|||
127864803|NCT02394028|460121972|FG002|Induction Phase|Adverse Event|1|||
127864804|NCT02394028|460121973|FG003|Induction Phase|Adverse Event|2|||
127864805|NCT02394028|460121974|FG004|Induction Phase|Adverse Event|5|||
127864806|NCT02394028|460121975|FG005|Induction Phase|Adverse Event|2|||
127864807|NCT02394028|460121976|FG006|Induction Phase|Adverse Event|0|||
127864808|NCT02394028|460121977|FG007|Induction Phase|Adverse Event|0|||
127864809|NCT02394028|460121978|FG008|Induction Phase|Adverse Event|0|||
127864810|NCT02394028|460121979|FG009|Induction Phase|Adverse Event|0|||
127864811|NCT02394028|460121980|FG010|Induction Phase|Adverse Event|0|||
127864812|NCT02394028|460121970|FG000|Induction Phase|Lack of Efficacy|3|||
127864813|NCT02394028|460121971|FG001|Induction Phase|Lack of Efficacy|6|||
127864814|NCT02394028|460121972|FG002|Induction Phase|Lack of Efficacy|2|||
127864815|NCT02394028|460121973|FG003|Induction Phase|Lack of Efficacy|17|||
127864816|NCT02394028|460121974|FG004|Induction Phase|Lack of Efficacy|14|||
127864817|NCT02394028|460121975|FG005|Induction Phase|Lack of Efficacy|8|||
127864818|NCT02394028|460121976|FG006|Induction Phase|Lack of Efficacy|17|||
127864819|NCT02394028|460121977|FG007|Induction Phase|Lack of Efficacy|23|||
127864820|NCT02394028|460121978|FG008|Induction Phase|Lack of Efficacy|0|||
127864821|NCT02394028|460121979|FG009|Induction Phase|Lack of Efficacy|0|||
127864822|NCT02394028|460121980|FG010|Induction Phase|Lack of Efficacy|0|||
127864823|NCT02394028|460121970|FG000|Induction Phase|Lost to Follow-up|1|||
127864824|NCT02394028|460121971|FG001|Induction Phase|Lost to Follow-up|0|||
127864825|NCT02394028|460121972|FG002|Induction Phase|Lost to Follow-up|0|||
127864826|NCT02394028|460121973|FG003|Induction Phase|Lost to Follow-up|1|||
127864827|NCT02394028|460121974|FG004|Induction Phase|Lost to Follow-up|0|||
127864828|NCT02394028|460121975|FG005|Induction Phase|Lost to Follow-up|0|||
127864829|NCT02394028|460121976|FG006|Induction Phase|Lost to Follow-up|1|||
127864830|NCT02394028|460121977|FG007|Induction Phase|Lost to Follow-up|0|||
127864831|NCT02394028|460121978|FG008|Induction Phase|Lost to Follow-up|0|||
127864832|NCT02394028|460121979|FG009|Induction Phase|Lost to Follow-up|0|||
127864833|NCT02394028|460121980|FG010|Induction Phase|Lost to Follow-up|0|||
127864834|NCT02394028|460121970|FG000|Induction Phase|Non-compliance|0|||
127864835|NCT02394028|460121971|FG001|Induction Phase|Non-compliance|1|||
127864836|NCT02394028|460121972|FG002|Induction Phase|Non-compliance|3|||
127864837|NCT02394028|460121973|FG003|Induction Phase|Non-compliance|1|||
127864838|NCT02394028|460121974|FG004|Induction Phase|Non-compliance|3|||
127864839|NCT02394028|460121975|FG005|Induction Phase|Non-compliance|0|||
127864840|NCT02394028|460121976|FG006|Induction Phase|Non-compliance|1|||
127864841|NCT02394028|460121977|FG007|Induction Phase|Non-compliance|1|||
127864842|NCT02394028|460121978|FG008|Induction Phase|Non-compliance|0|||
127864843|NCT02394028|460121979|FG009|Induction Phase|Non-compliance|0|||
127864844|NCT02394028|460121980|FG010|Induction Phase|Non-compliance|0|||
127864845|NCT02394028|460121970|FG000|Induction Phase|Physician Decision|0|||
127915454|NCT03158727|460312263|FG000|Overall Study|Withdrawal by Subject|2|||
127864846|NCT02394028|460121971|FG001|Induction Phase|Physician Decision|0|||
127864847|NCT02394028|460121972|FG002|Induction Phase|Physician Decision|1|||
127864848|NCT02394028|460121973|FG003|Induction Phase|Physician Decision|4|||
127864849|NCT02394028|460121974|FG004|Induction Phase|Physician Decision|0|||
127864850|NCT02394028|460121975|FG005|Induction Phase|Physician Decision|2|||
127864851|NCT02394028|460121976|FG006|Induction Phase|Physician Decision|1|||
127864852|NCT02394028|460121977|FG007|Induction Phase|Physician Decision|0|||
127864853|NCT02394028|460121978|FG008|Induction Phase|Physician Decision|0|||
127864854|NCT02394028|460121979|FG009|Induction Phase|Physician Decision|0|||
127864855|NCT02394028|460121980|FG010|Induction Phase|Physician Decision|0|||
127864856|NCT02394028|460121970|FG000|Induction Phase|Protocol Violation|0|||
127864857|NCT02394028|460121971|FG001|Induction Phase|Protocol Violation|2|||
127864858|NCT02394028|460121972|FG002|Induction Phase|Protocol Violation|0|||
127864859|NCT02394028|460121973|FG003|Induction Phase|Protocol Violation|3|||
127864860|NCT02394028|460121974|FG004|Induction Phase|Protocol Violation|0|||
127864861|NCT02394028|460121975|FG005|Induction Phase|Protocol Violation|1|||
127864862|NCT02394028|460121976|FG006|Induction Phase|Protocol Violation|1|||
127864863|NCT02394028|460121977|FG007|Induction Phase|Protocol Violation|0|||
127864864|NCT02394028|460121978|FG008|Induction Phase|Protocol Violation|0|||
127864865|NCT02394028|460121979|FG009|Induction Phase|Protocol Violation|0|||
127864866|NCT02394028|460121980|FG010|Induction Phase|Protocol Violation|0|||
127864867|NCT02394028|460121970|FG000|Induction Phase|Withdrawal by Subject|1|||
127864868|NCT02394028|460121971|FG001|Induction Phase|Withdrawal by Subject|2|||
127864869|NCT02394028|460121972|FG002|Induction Phase|Withdrawal by Subject|4|||
127864870|NCT02394028|460121973|FG003|Induction Phase|Withdrawal by Subject|6|||
127864871|NCT02394028|460121974|FG004|Induction Phase|Withdrawal by Subject|7|||
127864872|NCT02394028|460121975|FG005|Induction Phase|Withdrawal by Subject|4|||
127864873|NCT02394028|460121976|FG006|Induction Phase|Withdrawal by Subject|3|||
127864874|NCT02394028|460121977|FG007|Induction Phase|Withdrawal by Subject|6|||
127864875|NCT02394028|460121978|FG008|Induction Phase|Withdrawal by Subject|0|||
127864876|NCT02394028|460121979|FG009|Induction Phase|Withdrawal by Subject|0|||
127864877|NCT02394028|460121980|FG010|Induction Phase|Withdrawal by Subject|0|||
127864878|NCT02394028|460121970|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
127864879|NCT02394028|460121971|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
127864880|NCT02394028|460121972|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
127864881|NCT02394028|460121973|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
127864882|NCT02394028|460121974|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
127864883|NCT02394028|460121975|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
127864884|NCT02394028|460121976|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
127864885|NCT02394028|460121977|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
127864886|NCT02394028|460121978|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
127864887|NCT02394028|460121979|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
127864888|NCT02394028|460121980|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
127864889|NCT02394028|460121970|FG000|Induction Phase|Sponsor decision|0|||
127864890|NCT02394028|460121971|FG001|Induction Phase|Sponsor decision|1|||
127864891|NCT02394028|460121972|FG002|Induction Phase|Sponsor decision|2|||
127864892|NCT02394028|460121973|FG003|Induction Phase|Sponsor decision|0|||
127864893|NCT02394028|460121974|FG004|Induction Phase|Sponsor decision|0|||
127864894|NCT02394028|460121975|FG005|Induction Phase|Sponsor decision|0|||
127864895|NCT02394028|460121976|FG006|Induction Phase|Sponsor decision|0|||
127864896|NCT02394028|460121977|FG007|Induction Phase|Sponsor decision|0|||
127864897|NCT02394028|460121978|FG008|Induction Phase|Sponsor decision|0|||
127864898|NCT02394028|460121979|FG009|Induction Phase|Sponsor decision|0|||
127864899|NCT02394028|460121980|FG010|Induction Phase|Sponsor decision|0|||
127864900|NCT02394028|460121970|FG000|Induction Phase|Technical reason|0|||
127864901|NCT02394028|460121971|FG001|Induction Phase|Technical reason|0|||
127864902|NCT02394028|460121972|FG002|Induction Phase|Technical reason|0|||
127864903|NCT02394028|460121973|FG003|Induction Phase|Technical reason|1|||
127864904|NCT02394028|460121974|FG004|Induction Phase|Technical reason|0|||
127864905|NCT02394028|460121975|FG005|Induction Phase|Technical reason|0|||
127864906|NCT02394028|460121976|FG006|Induction Phase|Technical reason|0|||
127864907|NCT02394028|460121977|FG007|Induction Phase|Technical reason|0|||
127864908|NCT02394028|460121978|FG008|Induction Phase|Technical reason|0|||
127864909|NCT02394028|460121979|FG009|Induction Phase|Technical reason|0|||
127864910|NCT02394028|460121980|FG010|Induction Phase|Technical reason|0|||
127864911|NCT02394028|460121970|FG000|Induction Phase|:ack of calculation|0|||
127864912|NCT02394028|460121971|FG001|Induction Phase|:ack of calculation|0|||
127864913|NCT02394028|460121972|FG002|Induction Phase|:ack of calculation|0|||
127864914|NCT02394028|460121973|FG003|Induction Phase|:ack of calculation|0|||
127915455|NCT03158727|460312264|FG001|Overall Study|Withdrawal by Subject|6|||
127915456|NCT03158727|460312263|FG000|Overall Study|Death|11|||
127915457|NCT03158727|460312264|FG001|Overall Study|Death|12|||
127915458|NCT03158727|460312263|FG000|Overall Study|Lost to Follow-up|1|||
127915459|NCT03158727|460312264|FG001|Overall Study|Lost to Follow-up|0|||
127915460|NCT03158727|460312263|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
127915461|NCT03158727|460312264|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
127915462|NCT03158727|460312263|FG000|Overall Study|Visit 11 not done by mistake|0|||
127915463|NCT03158727|460312264|FG001|Overall Study|Visit 11 not done by mistake|1|||
127915464|NCT03158727|460312263|FG000|Overall Study|Enrolled, not treated|1|||
127915465|NCT03158727|460312264|FG001|Overall Study|Enrolled, not treated|0|||
127915466|NCT00985439|460312265|FG000|Overall Study|Adverse Event|0|||
127915467|NCT00985439|460312266|FG001|Overall Study|Adverse Event|0|||
127915468|NCT00985439|460312267|FG002|Overall Study|Adverse Event|1|||
127915469|NCT00985439|460312268|FG003|Overall Study|Adverse Event|0|||
127915470|NCT01051349|460312269|FG000|Overall Study|Adverse Event|88|||
127915471|NCT01051349|460312269|FG000|Overall Study|Consent Withdrawn|54|||
127915472|NCT01051349|460312269|FG000|Overall Study|Investigator Decision|6|||
127915473|NCT01051349|460312269|FG000|Overall Study|Lost to Follow-up|6|||
127915474|NCT01051349|460312269|FG000|Overall Study|Subject non-compliance|7|||
127915475|NCT01051349|460312269|FG000|Overall Study|Reason not Specified|12|||
127915476|NCT00841542|460312270|FG000|Period 1|Adverse Event|1|||
127915477|NCT00841542|460312271|FG001|Period 1|Adverse Event|0|||
127915478|NCT00472212|460312272|FG000|Overall Study|Lost to Follow-up|6|||
127915479|NCT00472212|460312273|FG001|Overall Study|Lost to Follow-up|4|||
127864915|NCT02394028|460121974|FG004|Induction Phase|:ack of calculation|0|||
127864916|NCT02394028|460121975|FG005|Induction Phase|:ack of calculation|0|||
127864917|NCT02394028|460121976|FG006|Induction Phase|:ack of calculation|0|||
127864918|NCT02394028|460121977|FG007|Induction Phase|:ack of calculation|1|||
127864919|NCT02394028|460121978|FG008|Induction Phase|:ack of calculation|0|||
127864920|NCT02394028|460121979|FG009|Induction Phase|:ack of calculation|0|||
127864921|NCT02394028|460121980|FG010|Induction Phase|:ack of calculation|0|||
127864922|NCT02394028|460121970|FG000|Maintenance Phase|Protocol Violation|0|||
127864923|NCT02394028|460121971|FG001|Maintenance Phase|Protocol Violation|0|||
127864924|NCT02394028|460121972|FG002|Maintenance Phase|Protocol Violation|0|||
127864925|NCT02394028|460121973|FG003|Maintenance Phase|Protocol Violation|0|||
127864926|NCT02394028|460121974|FG004|Maintenance Phase|Protocol Violation|0|||
127864927|NCT02394028|460121975|FG005|Maintenance Phase|Protocol Violation|0|||
127864928|NCT02394028|460121976|FG006|Maintenance Phase|Protocol Violation|0|||
127864929|NCT02394028|460121977|FG007|Maintenance Phase|Protocol Violation|0|||
127864930|NCT02394028|460121978|FG008|Maintenance Phase|Protocol Violation|0|||
127864931|NCT02394028|460121979|FG009|Maintenance Phase|Protocol Violation|0|||
127864932|NCT02394028|460121980|FG010|Maintenance Phase|Protocol Violation|1|||
127864933|NCT02394028|460121970|FG000|Maintenance Phase|Physician Decision|0|||
127864934|NCT02394028|460121971|FG001|Maintenance Phase|Physician Decision|0|||
127864935|NCT02394028|460121972|FG002|Maintenance Phase|Physician Decision|0|||
127864936|NCT02394028|460121973|FG003|Maintenance Phase|Physician Decision|0|||
127864937|NCT02394028|460121974|FG004|Maintenance Phase|Physician Decision|0|||
127864938|NCT02394028|460121975|FG005|Maintenance Phase|Physician Decision|0|||
127864939|NCT02394028|460121976|FG006|Maintenance Phase|Physician Decision|0|||
127864940|NCT02394028|460121977|FG007|Maintenance Phase|Physician Decision|0|||
127864941|NCT02394028|460121978|FG008|Maintenance Phase|Physician Decision|1|||
127864942|NCT02394028|460121979|FG009|Maintenance Phase|Physician Decision|3|||
127864943|NCT02394028|460121980|FG010|Maintenance Phase|Physician Decision|2|||
127864944|NCT02394028|460121970|FG000|Maintenance Phase|Lack of Efficacy|0|||
127864945|NCT02394028|460121971|FG001|Maintenance Phase|Lack of Efficacy|0|||
127864946|NCT02394028|460121972|FG002|Maintenance Phase|Lack of Efficacy|0|||
127864947|NCT02394028|460121973|FG003|Maintenance Phase|Lack of Efficacy|0|||
127864948|NCT02394028|460121974|FG004|Maintenance Phase|Lack of Efficacy|0|||
127864949|NCT02394028|460121975|FG005|Maintenance Phase|Lack of Efficacy|0|||
127915480|NCT02462837|460312274|FG000|Overall Study|pt developed hives|1|||
127864950|NCT02394028|460121976|FG006|Maintenance Phase|Lack of Efficacy|0|||
127864951|NCT02394028|460121977|FG007|Maintenance Phase|Lack of Efficacy|0|||
127864952|NCT02394028|460121978|FG008|Maintenance Phase|Lack of Efficacy|7|||
127864953|NCT02394028|460121979|FG009|Maintenance Phase|Lack of Efficacy|25|||
127864954|NCT02394028|460121980|FG010|Maintenance Phase|Lack of Efficacy|33|||
127864955|NCT02394028|460121970|FG000|Maintenance Phase|Death|0|||
127915481|NCT02462837|460312275|FG001|Overall Study|pt developed hives|0|||
127915482|NCT02462837|460312274|FG000|Overall Study|Withdrawal by Subject|1|||
127915483|NCT02462837|460312275|FG001|Overall Study|Withdrawal by Subject|0|||
127915484|NCT00924638|460312282|FG000|Overall Study|Death|3|||
127864956|NCT02394028|460121971|FG001|Maintenance Phase|Death|0|||
127864957|NCT02394028|460121972|FG002|Maintenance Phase|Death|0|||
127864958|NCT02394028|460121973|FG003|Maintenance Phase|Death|0|||
127864959|NCT02394028|460121974|FG004|Maintenance Phase|Death|0|||
127915485|NCT00924638|460312283|FG001|Overall Study|Death|2|||
127915486|NCT00924638|460312282|FG000|Overall Study|Lost to Follow-up|1|||
127864960|NCT02394028|460121975|FG005|Maintenance Phase|Death|0|||
127864961|NCT02394028|460121976|FG006|Maintenance Phase|Death|0|||
127864962|NCT02394028|460121977|FG007|Maintenance Phase|Death|0|||
127864963|NCT02394028|460121978|FG008|Maintenance Phase|Death|0|||
127864964|NCT02394028|460121979|FG009|Maintenance Phase|Death|0|||
127864965|NCT02394028|460121980|FG010|Maintenance Phase|Death|1|||
127864966|NCT02394028|460121970|FG000|Maintenance Phase|Adverse Event|0|||
127864967|NCT02394028|460121971|FG001|Maintenance Phase|Adverse Event|0|||
127864968|NCT02394028|460121972|FG002|Maintenance Phase|Adverse Event|0|||
127864969|NCT02394028|460121973|FG003|Maintenance Phase|Adverse Event|0|||
127864970|NCT02394028|460121974|FG004|Maintenance Phase|Adverse Event|0|||
127864971|NCT02394028|460121975|FG005|Maintenance Phase|Adverse Event|0|||
127864972|NCT02394028|460121976|FG006|Maintenance Phase|Adverse Event|0|||
127864973|NCT02394028|460121977|FG007|Maintenance Phase|Adverse Event|0|||
127864974|NCT02394028|460121978|FG008|Maintenance Phase|Adverse Event|1|||
127864975|NCT02394028|460121979|FG009|Maintenance Phase|Adverse Event|1|||
127864976|NCT02394028|460121980|FG010|Maintenance Phase|Adverse Event|3|||
127864977|NCT02394028|460121970|FG000|Maintenance Phase|Site closure|0|||
127864978|NCT02394028|460121971|FG001|Maintenance Phase|Site closure|0|||
127864979|NCT02394028|460121972|FG002|Maintenance Phase|Site closure|0|||
127864980|NCT02394028|460121973|FG003|Maintenance Phase|Site closure|0|||
127864981|NCT02394028|460121974|FG004|Maintenance Phase|Site closure|0|||
127864982|NCT02394028|460121975|FG005|Maintenance Phase|Site closure|0|||
127864983|NCT02394028|460121976|FG006|Maintenance Phase|Site closure|0|||
127864984|NCT02394028|460121977|FG007|Maintenance Phase|Site closure|0|||
127864985|NCT02394028|460121978|FG008|Maintenance Phase|Site closure|0|||
127864986|NCT02394028|460121979|FG009|Maintenance Phase|Site closure|1|||
127864987|NCT02394028|460121980|FG010|Maintenance Phase|Site closure|0|||
127864988|NCT02394028|460121970|FG000|Maintenance Phase|Withdrawal by Subject|0|||
127864989|NCT02394028|460121971|FG001|Maintenance Phase|Withdrawal by Subject|0|||
127864990|NCT02394028|460121972|FG002|Maintenance Phase|Withdrawal by Subject|0|||
127864991|NCT02394028|460121973|FG003|Maintenance Phase|Withdrawal by Subject|0|||
127864992|NCT02394028|460121974|FG004|Maintenance Phase|Withdrawal by Subject|0|||
127864993|NCT02394028|460121975|FG005|Maintenance Phase|Withdrawal by Subject|0|||
127864994|NCT02394028|460121976|FG006|Maintenance Phase|Withdrawal by Subject|0|||
127864995|NCT02394028|460121977|FG007|Maintenance Phase|Withdrawal by Subject|0|||
127864996|NCT02394028|460121978|FG008|Maintenance Phase|Withdrawal by Subject|3|||
127864997|NCT02394028|460121979|FG009|Maintenance Phase|Withdrawal by Subject|12|||
127864998|NCT02394028|460121980|FG010|Maintenance Phase|Withdrawal by Subject|12|||
127864999|NCT00742391|460121981|FG000|Overall Study|Adverse Event|2|||
127865000|NCT00742391|460121982|FG001|Overall Study|Adverse Event|1|||
127865001|NCT00742391|460121981|FG000|Overall Study|Lost to Follow-up|1|||
127865002|NCT00742391|460121982|FG001|Overall Study|Lost to Follow-up|0|||
127865003|NCT00742391|460121981|FG000|Overall Study|Protocol Violation|1|||
127865004|NCT00742391|460121982|FG001|Overall Study|Protocol Violation|0|||
127865005|NCT01981096|460121989|FG000|Overall Study|Parent illness|1|||
127865006|NCT01981096|460121990|FG001|Overall Study|Parent illness|0|||
127865007|NCT01981096|460121989|FG000|Overall Study|Withdrawal by Subject|0|||
127865008|NCT01981096|460121990|FG001|Overall Study|Withdrawal by Subject|1|||
127865009|NCT01981096|460121989|FG000|Overall Study|Lost to Follow-up|2|||
127865010|NCT01981096|460121990|FG001|Overall Study|Lost to Follow-up|0|||
127865011|NCT01225211|460121991|FG000|Overall Study|Adverse Event|0|||
127865012|NCT01225211|460121992|FG001|Overall Study|Adverse Event|0|||
127865013|NCT01225211|460121993|FG002|Overall Study|Adverse Event|1|||
127865014|NCT01225211|460121994|FG003|Overall Study|Adverse Event|0|||
127865015|NCT01225211|460121995|FG004|Overall Study|Adverse Event|0|||
127865016|NCT01225211|460121996|FG005|Overall Study|Adverse Event|0|||
127865017|NCT01225211|460121997|FG006|Overall Study|Adverse Event|0|||
127865018|NCT01225211|460121998|FG007|Overall Study|Adverse Event|0|||
127865019|NCT01225211|460121999|FG008|Overall Study|Adverse Event|0|||
127865020|NCT01225211|460122000|FG009|Overall Study|Adverse Event|1|||
127865021|NCT01225211|460121991|FG000|Overall Study|Withdrawal by Subject|0|||
127865022|NCT01225211|460121992|FG001|Overall Study|Withdrawal by Subject|0|||
127865023|NCT01225211|460121993|FG002|Overall Study|Withdrawal by Subject|0|||
127865024|NCT01225211|460121994|FG003|Overall Study|Withdrawal by Subject|0|||
127865025|NCT01225211|460121995|FG004|Overall Study|Withdrawal by Subject|0|||
127865026|NCT01225211|460121996|FG005|Overall Study|Withdrawal by Subject|0|||
127865027|NCT01225211|460121997|FG006|Overall Study|Withdrawal by Subject|1|||
127865028|NCT01225211|460121998|FG007|Overall Study|Withdrawal by Subject|0|||
127865029|NCT01225211|460121999|FG008|Overall Study|Withdrawal by Subject|1|||
127865030|NCT01225211|460122000|FG009|Overall Study|Withdrawal by Subject|3|||
127865031|NCT01225211|460121991|FG000|Overall Study|Other|0|||
127865032|NCT01225211|460121992|FG001|Overall Study|Other|0|||
127865033|NCT01225211|460121993|FG002|Overall Study|Other|0|||
127865034|NCT01225211|460121994|FG003|Overall Study|Other|0|||
127865035|NCT01225211|460121995|FG004|Overall Study|Other|0|||
127865036|NCT01225211|460121996|FG005|Overall Study|Other|0|||
127865037|NCT01225211|460121997|FG006|Overall Study|Other|0|||
127865038|NCT01225211|460121998|FG007|Overall Study|Other|0|||
127865039|NCT01225211|460121999|FG008|Overall Study|Other|0|||
127865040|NCT01225211|460122000|FG009|Overall Study|Other|1|||
127865041|NCT02355665|460122010|FG000|Overall Study|Adverse Event|16|||
127865042|NCT02355665|460122011|FG001|Overall Study|Adverse Event|24|||
127865043|NCT02355665|460122010|FG000|Overall Study|Protocol Violation|2|||
127865044|NCT02355665|460122011|FG001|Overall Study|Protocol Violation|0|||
127865045|NCT02355665|460122010|FG000|Overall Study|Withdrawal by Subject|90|||
127865046|NCT02355665|460122011|FG001|Overall Study|Withdrawal by Subject|100|||
127865047|NCT02355665|460122010|FG000|Overall Study|Lost to Follow-up|131|||
127865048|NCT02355665|460122011|FG001|Overall Study|Lost to Follow-up|103|||
127865049|NCT02355665|460122010|FG000|Overall Study|Death|4|||
127865050|NCT02355665|460122011|FG001|Overall Study|Death|2|||
127865051|NCT02355665|460122010|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
127865052|NCT02355665|460122011|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
127865053|NCT04129242|460122012|FG000|Overall Study|Physician Decision|1|||
127865054|NCT04129242|460122013|FG001|Overall Study|Physician Decision|1|||
127865055|NCT04129242|460122012|FG000|Overall Study|Protocol Violation|0|||
127865056|NCT04129242|460122013|FG001|Overall Study|Protocol Violation|1|||
127865057|NCT02363322|460122014|FG000|Overall Study|Lost to Follow-up|1|||
127865058|NCT02363322|460122015|FG001|Overall Study|Lost to Follow-up|0|||
127865059|NCT01775995|460122016|FG000|Overall Study|Lost to Follow-up|1|||
127865060|NCT01775995|460122017|FG001|Overall Study|Lost to Follow-up|1|||
127865061|NCT03458234|460122018|FG000|Overall Study|Withdrawal by Subject|1|||
127865062|NCT01084096|460123749|FG000|Overall Study|Lost to Follow-up|1501|||
127865063|NCT01084096|460123750|FG001|Overall Study|Lost to Follow-up|1833|||
127865064|NCT01084096|460123749|FG000|Overall Study|Withdrawal by Subject|3|||
127865065|NCT01084096|460123750|FG001|Overall Study|Withdrawal by Subject|0|||
127865066|NCT01084096|460123749|FG000|Overall Study|Woman had a miscarriage|21|||
127865067|NCT01084096|460123750|FG001|Overall Study|Woman had a miscarriage|17|||
127865068|NCT01354964|460123751|FG000|Overall Study|Lost to Follow-up|2|||
127865069|NCT01354964|460123752|FG001|Overall Study|Lost to Follow-up|0|||
127915487|NCT00924638|460312283|FG001|Overall Study|Lost to Follow-up|1|||
127915488|NCT00924638|460312282|FG000|Overall Study|Withdrawal by Subject|5|||
127915489|NCT00924638|460312283|FG001|Overall Study|Withdrawal by Subject|7|||
127915490|NCT00924638|460312282|FG000|Overall Study|Physician Decision|3|||
127915491|NCT00924638|460312283|FG001|Overall Study|Physician Decision|3|||
127915492|NCT00847535|460312284|FG000|Overall Study|Withdrawal by Subject|2|||
127915493|NCT00847535|460312285|FG001|Overall Study|Withdrawal by Subject|1|||
127915494|NCT00847535|460312286|FG002|Overall Study|Withdrawal by Subject|1|||
127915495|NCT00847535|460312284|FG000|Overall Study|Lost to Follow-up|0|||
127915496|NCT00847535|460312285|FG001|Overall Study|Lost to Follow-up|1|||
127915497|NCT00847535|460312286|FG002|Overall Study|Lost to Follow-up|0|||
127865070|NCT01354964|460123751|FG000|Overall Study|IV access issues|1|||
127865071|NCT01354964|460123752|FG001|Overall Study|IV access issues|1|||
127865072|NCT01354964|460123751|FG000|Overall Study|Physician Decision|1|||
127865073|NCT01354964|460123752|FG001|Overall Study|Physician Decision|0|||
127865074|NCT01864746|460123754|FG000|Overall Study|Disease recurrence|25|||
127865075|NCT01864746|460123755|FG001|Overall Study|Disease recurrence|40|||
127865076|NCT01864746|460123754|FG000|Overall Study|Second primary invasive nonbreast|2|||
127865077|NCT01864746|460123755|FG001|Overall Study|Second primary invasive nonbreast|3|||
127865078|NCT01864746|460123754|FG000|Overall Study|Death|2|||
127865079|NCT01864746|460123755|FG001|Overall Study|Death|1|||
127865080|NCT01864746|460123754|FG000|Overall Study|Adverse Event|33|||
127865081|NCT01864746|460123755|FG001|Overall Study|Adverse Event|5|||
127865082|NCT01864746|460123754|FG000|Overall Study|Withdrawal by Subject|56|||
127865083|NCT01864746|460123755|FG001|Overall Study|Withdrawal by Subject|41|||
127865084|NCT01864746|460123754|FG000|Overall Study|Physician Decision|5|||
127915498|NCT01252953|460312288|FG000|Overall Study|Withdrawal by Subject|16|||
127915499|NCT01252953|460312289|FG001|Overall Study|Withdrawal by Subject|17|||
127915500|NCT01252953|460312288|FG000|Overall Study|Lost to Follow-up|22|||
127865085|NCT01864746|460123755|FG001|Overall Study|Physician Decision|6|||
127915501|NCT01252953|460312289|FG001|Overall Study|Lost to Follow-up|21|||
127915502|NCT00958724|460312292|FG000|Overall Study|Disease Progression|6|||
127865086|NCT04450394|460123762|FG000|Overall Study|Adverse Event|2|||
127865087|NCT04450394|460123763|FG001|Overall Study|Adverse Event|0|||
127865088|NCT04450394|460123764|FG002|Overall Study|Adverse Event|0|||
127915503|NCT05604014|460312293|FG000|Overall Study|Lost to Follow-up|13|||
127915504|NCT00840203|460312314|FG000|First Intervention|Protocol Violation|1|||
127915505|NCT00840203|460312315|FG001|First Intervention|Protocol Violation|1|||
127865089|NCT04450394|460123762|FG000|Overall Study|Death|0|||
127865090|NCT04450394|460123763|FG001|Overall Study|Death|1|||
127865091|NCT04450394|460123764|FG002|Overall Study|Death|0|||
127865092|NCT04450394|460123762|FG000|Overall Study|Lost to Follow-up|0|||
127865093|NCT04450394|460123763|FG001|Overall Study|Lost to Follow-up|3|||
127865094|NCT04450394|460123764|FG002|Overall Study|Lost to Follow-up|0|||
127865095|NCT04450394|460123762|FG000|Overall Study|Physician Decision|0|||
127865096|NCT04450394|460123763|FG001|Overall Study|Physician Decision|1|||
127865097|NCT04450394|460123764|FG002|Overall Study|Physician Decision|0|||
127865098|NCT04450394|460123762|FG000|Overall Study|Protocol Violation|2|||
127865099|NCT04450394|460123763|FG001|Overall Study|Protocol Violation|0|||
127865100|NCT04450394|460123764|FG002|Overall Study|Protocol Violation|0|||
127865101|NCT04450394|460123762|FG000|Overall Study|Withdrawal by Subject|6|||
127865102|NCT04450394|460123763|FG001|Overall Study|Withdrawal by Subject|9|||
127865103|NCT04450394|460123764|FG002|Overall Study|Withdrawal by Subject|0|||
127865104|NCT02155660|460123769|FG000|Overall Study|Other Reason|8|||
127865105|NCT02155660|460123770|FG001|Overall Study|Other Reason|6|||
127915506|NCT00840203|460312314|FG000|Washout|Protocol Violation|1|||
127915507|NCT00840203|460312315|FG001|Washout|Protocol Violation|0|||
127915508|NCT02121184|460312316|FG000|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|1|||
127915509|NCT02121184|460312317|FG001|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|0|||
127865106|NCT02155660|460123771|FG002|Overall Study|Other Reason|10|||
127865107|NCT02155660|460123772|FG003|Overall Study|Other Reason|10|||
127865108|NCT02155660|460123769|FG000|Overall Study|Study-specific withdrawal criteria|0|||
127865109|NCT02155660|460123770|FG001|Overall Study|Study-specific withdrawal criteria|1|||
127865110|NCT02155660|460123771|FG002|Overall Study|Study-specific withdrawal criteria|1|||
127865111|NCT02155660|460123772|FG003|Overall Study|Study-specific withdrawal criteria|1|||
127865112|NCT02155660|460123769|FG000|Overall Study|Severe non-compliance|0|||
127865113|NCT02155660|460123770|FG001|Overall Study|Severe non-compliance|4|||
127865114|NCT02155660|460123771|FG002|Overall Study|Severe non-compliance|0|||
127865115|NCT02155660|460123772|FG003|Overall Study|Severe non-compliance|1|||
127865116|NCT02155660|460123769|FG000|Overall Study|Adverse Event|2|||
127865117|NCT02155660|460123770|FG001|Overall Study|Adverse Event|6|||
127865118|NCT02155660|460123771|FG002|Overall Study|Adverse Event|3|||
127865119|NCT02155660|460123772|FG003|Overall Study|Adverse Event|1|||
127865120|NCT02155660|460123769|FG000|Overall Study|Lost to Follow-up|3|||
127865121|NCT02155660|460123770|FG001|Overall Study|Lost to Follow-up|6|||
127865122|NCT02155660|460123771|FG002|Overall Study|Lost to Follow-up|5|||
127865123|NCT02155660|460123772|FG003|Overall Study|Lost to Follow-up|8|||
127865124|NCT02155660|460123769|FG000|Overall Study|Death|17|||
127865125|NCT02155660|460123770|FG001|Overall Study|Death|19|||
127865126|NCT02155660|460123771|FG002|Overall Study|Death|17|||
127865127|NCT02155660|460123772|FG003|Overall Study|Death|19|||
127915510|NCT02121184|460312316|FG000|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|0|||
127915511|NCT02121184|460312317|FG001|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|1|||
127915512|NCT02121184|460312316|FG000|Overall Study|Emergency cesarean section required|0|||
127915513|NCT02121184|460312317|FG001|Overall Study|Emergency cesarean section required|2|||
127915514|NCT02121184|460312316|FG000|Overall Study|Combined spinal epidural completed without notifying study team|1|||
127915515|NCT02121184|460312317|FG001|Overall Study|Combined spinal epidural completed without notifying study team|0|||
127915516|NCT05562011|460312318|FG000|Overall Study|Withdrawal by Subject|3|||
127915517|NCT05562011|460312318|FG000|Overall Study|Lost to Follow-up|1|||
127915518|NCT05562011|460312318|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
127915519|NCT05562011|460312318|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
127915520|NCT05562011|460312318|FG000|Overall Study|Device malfunction|13|||
127915521|NCT04411680|460312323|FG000|Treatment Period|Adverse Event|3|||
127915522|NCT04411680|460312324|FG001|Treatment Period|Adverse Event|0|||
127915523|NCT04411680|460312323|FG000|Treatment Period|Discharged from hospital|18|||
127915524|NCT04411680|460312324|FG001|Treatment Period|Discharged from hospital|7|||
127915525|NCT04411680|460312323|FG000|Treatment Period|Missed 1 or more doses|8|||
127915526|NCT04411680|460312324|FG001|Treatment Period|Missed 1 or more doses|0|||
127915527|NCT04411680|460312323|FG000|Treatment Period|Transferred to another hospital|0|||
127915528|NCT04411680|460312324|FG001|Treatment Period|Transferred to another hospital|1|||
127915529|NCT04411680|460312323|FG000|Follow up Period|Withdrawal by Subject|2|||
127915530|NCT04411680|460312324|FG001|Follow up Period|Withdrawal by Subject|0|||
127915531|NCT04411680|460312323|FG000|Follow up Period|Lost to Follow-up|5|||
127915532|NCT04411680|460312324|FG001|Follow up Period|Lost to Follow-up|6|||
127915533|NCT04411680|460312323|FG000|Follow up Period|Death|11|||
127915534|NCT04411680|460312324|FG001|Follow up Period|Death|8|||
127915535|NCT00748566|460312325|FG000|Overall Study|Adverse Event|49|||
127915536|NCT00748566|460312325|FG000|Overall Study|Death|1|||
127915537|NCT00748566|460312325|FG000|Overall Study|Lack of Efficacy|12|||
127915538|NCT00748566|460312325|FG000|Overall Study|Lost to Follow-up|1|||
127915539|NCT00748566|460312325|FG000|Overall Study|Protocol Violation|13|||
127915540|NCT00748566|460312325|FG000|Overall Study|Withdrawal by Subject|22|||
127915541|NCT00748566|460312325|FG000|Overall Study|Study terminated by sponsor|5|||
127915542|NCT00748566|460312325|FG000|Overall Study|Other|9|||
127915543|NCT02227238|460312326|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
127915544|NCT02227238|460312327|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
127915545|NCT02227238|460312328|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
127865128|NCT02155660|460123769|FG000|Overall Study|Withdrawal by Subject|28|||
127865129|NCT02155660|460123770|FG001|Overall Study|Withdrawal by Subject|31|||
127865130|NCT02155660|460123771|FG002|Overall Study|Withdrawal by Subject|24|||
127865131|NCT02155660|460123772|FG003|Overall Study|Withdrawal by Subject|21|||
127915546|NCT02227238|460312326|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
127915547|NCT02227238|460312327|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
127865132|NCT03812224|460123779|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
127865133|NCT03812224|460123780|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
127865134|NCT03812224|460123779|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
127865135|NCT03812224|460123780|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
127865136|NCT03812224|460123779|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
127865137|NCT03812224|460123780|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
127865138|NCT03812224|460123779|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
127865139|NCT03812224|460123780|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
127865140|NCT00303719|460123781|FG000|Overall Study|Not evaluable, prior therapies|0|||
127865141|NCT00303719|460123782|FG001|Overall Study|Not evaluable, prior therapies|30|||
127865142|NCT00303719|460123781|FG000|Overall Study|Lost to Follow-up|0|||
127865143|NCT00303719|460123782|FG001|Overall Study|Lost to Follow-up|7|||
127865144|NCT01641952|460123783|FG000|Overall Study|Lost to Follow-up|28|||
127865145|NCT01641952|460123783|FG000|Overall Study|Adverse Event|6|||
127865146|NCT02500901|460123784|FG000|Overall Study|Disease ProgressionDD|2|||
127865147|NCT00561912|460123795|FG000|Overall Study|ineligible|1|||
127865148|NCT02643420|460123797|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
127865149|NCT02643420|460123798|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
127865150|NCT02643420|460123797|FG000|Overall Study|Withdrawal by Subject|25|||
127865151|NCT02643420|460123798|FG001|Overall Study|Withdrawal by Subject|19|||
127865152|NCT02643420|460123797|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
127865153|NCT02643420|460123798|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
127865154|NCT02643420|460123797|FG000|Overall Study|Lost to Follow-up|6|||
127865155|NCT02643420|460123798|FG001|Overall Study|Lost to Follow-up|10|||
127865156|NCT02643420|460123797|FG000|Overall Study|Investigator Decision|2|||
127865157|NCT02643420|460123798|FG001|Overall Study|Investigator Decision|4|||
127865158|NCT02643420|460123797|FG000|Overall Study|Sponsor decision|1|||
127865159|NCT02643420|460123798|FG001|Overall Study|Sponsor decision|1|||
127865160|NCT02643420|460123797|FG000|Overall Study|Death|0|||
127865161|NCT02643420|460123798|FG001|Overall Study|Death|2|||
127865162|NCT02643420|460123797|FG000|Overall Study|Reason not Specified|8|||
127865163|NCT02643420|460123798|FG001|Overall Study|Reason not Specified|7|||
127865164|NCT00718887|460123811|FG000|Overall Study|Withdrawal by Subject|3|||
127865165|NCT00718887|460123812|FG001|Overall Study|Withdrawal by Subject|2|||
127865166|NCT00718887|460123811|FG000|Overall Study|Not identified|2|||
127865167|NCT00718887|460123812|FG001|Overall Study|Not identified|7|||
127865168|NCT05102734|460123813|FG000|Overall Study|Did not require vasopressors|1|||
127865169|NCT05102734|460123814|FG001|Overall Study|Did not require vasopressors|0|||
127865170|NCT05102734|460123813|FG000|Overall Study|Did not have functioning PA catheter|1|||
127865171|NCT05102734|460123814|FG001|Overall Study|Did not have functioning PA catheter|0|||
127865172|NCT05102734|460123813|FG000|Overall Study|Inadequate video quality|2|||
127865173|NCT05102734|460123814|FG001|Overall Study|Inadequate video quality|0|||
127865174|NCT00089505|460123815|FG000|Overall Study|Death|4|||
127865175|NCT00089505|460123816|FG001|Overall Study|Death|1|||
127865176|NCT00089505|460123817|FG002|Overall Study|Death|5|||
127865177|NCT00089505|460123818|FG003|Overall Study|Death|8|||
127865178|NCT00089505|460123815|FG000|Overall Study|Withdrawal by Subject|3|||
127865179|NCT00089505|460123816|FG001|Overall Study|Withdrawal by Subject|0|||
127865180|NCT00089505|460123817|FG002|Overall Study|Withdrawal by Subject|6|||
127865181|NCT00089505|460123818|FG003|Overall Study|Withdrawal by Subject|6|||
127865182|NCT00089505|460123815|FG000|Overall Study|Lost to Follow-up|1|||
127865183|NCT00089505|460123816|FG001|Overall Study|Lost to Follow-up|1|||
127865184|NCT00089505|460123817|FG002|Overall Study|Lost to Follow-up|9|||
127865185|NCT00089505|460123818|FG003|Overall Study|Lost to Follow-up|7|||
127865186|NCT00089505|460123815|FG000|Overall Study|Physician Decision|1|||
127865187|NCT00089505|460123816|FG001|Overall Study|Physician Decision|0|||
127865188|NCT00089505|460123817|FG002|Overall Study|Physician Decision|0|||
127865189|NCT00089505|460123818|FG003|Overall Study|Physician Decision|0|||
127865190|NCT00089505|460123815|FG000|Overall Study|Protocol Violation|0|||
127865191|NCT00089505|460123816|FG001|Overall Study|Protocol Violation|0|||
127865192|NCT00089505|460123817|FG002|Overall Study|Protocol Violation|1|||
127865193|NCT00089505|460123818|FG003|Overall Study|Protocol Violation|0|||
127865194|NCT01117428|460123819|FG000|Overall Study|Lack of Efficacy|1|||
127865195|NCT01117428|460123820|FG001|Overall Study|Lack of Efficacy|0|||
127865196|NCT01117428|460123821|FG002|Overall Study|Lack of Efficacy|0|||
127865197|NCT01117428|460123822|FG003|Overall Study|Lack of Efficacy|0|||
127865198|NCT01117428|460123823|FG004|Overall Study|Lack of Efficacy|0|||
127865199|NCT01117428|460123824|FG005|Overall Study|Lack of Efficacy|0|||
127865200|NCT01117428|460123819|FG000|Overall Study|Adverse Event|4|||
127865201|NCT01117428|460123820|FG001|Overall Study|Adverse Event|0|||
127865202|NCT01117428|460123821|FG002|Overall Study|Adverse Event|0|||
127865203|NCT01117428|460123822|FG003|Overall Study|Adverse Event|0|||
127865204|NCT01117428|460123823|FG004|Overall Study|Adverse Event|1|||
127865205|NCT01117428|460123824|FG005|Overall Study|Adverse Event|2|||
127865206|NCT01117428|460123819|FG000|Overall Study|Death|0|||
127865207|NCT01117428|460123820|FG001|Overall Study|Death|1|||
127865208|NCT01117428|460123821|FG002|Overall Study|Death|2|||
127865209|NCT01117428|460123822|FG003|Overall Study|Death|0|||
127865210|NCT01117428|460123823|FG004|Overall Study|Death|0|||
127865211|NCT01117428|460123824|FG005|Overall Study|Death|1|||
127865212|NCT01117428|460123819|FG000|Overall Study|Physician Decision|0|||
127865213|NCT01117428|460123820|FG001|Overall Study|Physician Decision|1|||
127865214|NCT01117428|460123821|FG002|Overall Study|Physician Decision|0|||
127865215|NCT01117428|460123822|FG003|Overall Study|Physician Decision|0|||
127865216|NCT01117428|460123823|FG004|Overall Study|Physician Decision|0|||
127865217|NCT01117428|460123824|FG005|Overall Study|Physician Decision|0|||
127865218|NCT01117428|460123819|FG000|Overall Study|Withdrawal by Subject|0|||
127865219|NCT01117428|460123820|FG001|Overall Study|Withdrawal by Subject|0|||
127865220|NCT01117428|460123821|FG002|Overall Study|Withdrawal by Subject|1|||
127865221|NCT01117428|460123822|FG003|Overall Study|Withdrawal by Subject|0|||
127865222|NCT01117428|460123823|FG004|Overall Study|Withdrawal by Subject|0|||
127865223|NCT01117428|460123824|FG005|Overall Study|Withdrawal by Subject|0|||
127865224|NCT01117428|460123819|FG000|Overall Study|Progressive disease|15|||
127865225|NCT01117428|460123820|FG001|Overall Study|Progressive disease|27|||
127865226|NCT01117428|460123821|FG002|Overall Study|Progressive disease|10|||
127865227|NCT01117428|460123822|FG003|Overall Study|Progressive disease|12|||
127865228|NCT01117428|460123823|FG004|Overall Study|Progressive disease|16|||
127865229|NCT01117428|460123824|FG005|Overall Study|Progressive disease|17|||
127865230|NCT03018028|460123825|FG000|Overall Study|Withdrawal by Subject|3|||
127865231|NCT03018028|460123826|FG001|Overall Study|Withdrawal by Subject|0|||
127865232|NCT03018028|460123827|FG002|Overall Study|Withdrawal by Subject|1|||
127865233|NCT03018028|460123828|FG003|Overall Study|Withdrawal by Subject|2|||
127865234|NCT03018028|460123829|FG004|Overall Study|Withdrawal by Subject|0|||
127865235|NCT02519777|460123831|FG000|Overall Study|Death|1|||
127865236|NCT02519777|460123832|FG001|Overall Study|Death|0|||
127865237|NCT02519777|460123833|FG002|Overall Study|Death|0|||
127865238|NCT02519777|460123831|FG000|Overall Study|Lost to Follow-up|0|||
127865239|NCT02519777|460123832|FG001|Overall Study|Lost to Follow-up|4|||
127865240|NCT02519777|460123833|FG002|Overall Study|Lost to Follow-up|2|||
127865241|NCT02519777|460123831|FG000|Overall Study|Withdrawal by Subject|3|||
127865242|NCT02519777|460123832|FG001|Overall Study|Withdrawal by Subject|1|||
127865243|NCT02519777|460123833|FG002|Overall Study|Withdrawal by Subject|0|||
127865244|NCT02519777|460123831|FG000|Overall Study|Severe Debilitation|1|||
127865245|NCT02519777|460123832|FG001|Overall Study|Severe Debilitation|1|||
127865246|NCT02519777|460123833|FG002|Overall Study|Severe Debilitation|1|||
127865247|NCT02519777|460123831|FG000|Overall Study|Not able to get to clinic|1|||
127865248|NCT02519777|460123832|FG001|Overall Study|Not able to get to clinic|2|||
127865249|NCT02519777|460123833|FG002|Overall Study|Not able to get to clinic|1|||
127865250|NCT02195531|460123834|FG000|Overall Study|Withdrawal by Subject|1|||
127865251|NCT02195531|460123835|FG001|Overall Study|Withdrawal by Subject|1|||
127865252|NCT02195531|460123836|FG002|Overall Study|Withdrawal by Subject|1|||
127865253|NCT02543801|460123838|FG000|Overall Study|Protocol Violation|1|||
127865254|NCT02543801|460123839|FG001|Overall Study|Protocol Violation|2|||
127865255|NCT02543801|460123840|FG002|Overall Study|Protocol Violation|0|||
127865256|NCT02543801|460123841|FG003|Overall Study|Protocol Violation|0|||
127865257|NCT01034709|460123844|FG000|Overall Study|Protocol Violation|9|||
127865258|NCT01034709|460123845|FG001|Overall Study|Protocol Violation|16|||
127865259|NCT02364999|460123857|FG000|Overall Study|Death|136|||
127865260|NCT02364999|460123858|FG001|Overall Study|Death|138|||
127865261|NCT02364999|460123857|FG000|Overall Study|Lost to Follow-up|10|||
127865262|NCT02364999|460123858|FG001|Overall Study|Lost to Follow-up|15|||
127865263|NCT02364999|460123857|FG000|Overall Study|Protocol Violation|3|||
127865264|NCT02364999|460123858|FG001|Overall Study|Protocol Violation|2|||
127865265|NCT02364999|460123857|FG000|Overall Study|Withdrawal by Subject|14|||
127865266|NCT02364999|460123858|FG001|Overall Study|Withdrawal by Subject|14|||
127865267|NCT02364999|460123857|FG000|Overall Study|Other|0|||
127865268|NCT02364999|460123858|FG001|Overall Study|Other|1|||
127865269|NCT02364999|460123857|FG000|Overall Study|Randomized but did not receive treatment|2|||
127865270|NCT02364999|460123858|FG001|Overall Study|Randomized but did not receive treatment|3|||
127865271|NCT01234337|460123859|FG000|Overall Study|Adverse Event|58|||
127865272|NCT01234337|460123860|FG001|Overall Study|Adverse Event|21|||
127865273|NCT01234337|460123859|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
127865274|NCT01234337|460123860|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
127865275|NCT01234337|460123859|FG000|Overall Study|Investi. decision not protocol driven|5|||
127865276|NCT01234337|460123860|FG001|Overall Study|Investi. decision not protocol driven|6|||
127865277|NCT01234337|460123859|FG000|Overall Study|Non-compliant with study medication|3|||
127865278|NCT01234337|460123860|FG001|Overall Study|Non-compliant with study medication|2|||
127865279|NCT01234337|460123859|FG000|Overall Study|Randomized but not treated|6|||
127865280|NCT01234337|460123860|FG001|Overall Study|Randomized but not treated|4|||
127865281|NCT01234337|460123859|FG000|Overall Study|Lost to Follow-up|0|||
127865282|NCT01234337|460123860|FG001|Overall Study|Lost to Follow-up|1|||
127865283|NCT01234337|460123859|FG000|Overall Study|Protocol Violation|2|||
127865284|NCT01234337|460123860|FG001|Overall Study|Protocol Violation|3|||
127865285|NCT01234337|460123859|FG000|Overall Study|Withdrawal by Subject|11|||
127865286|NCT01234337|460123860|FG001|Overall Study|Withdrawal by Subject|9|||
127865287|NCT01234337|460123859|FG000|Overall Study|Death|0|||
127865288|NCT01234337|460123860|FG001|Overall Study|Death|1|||
127865289|NCT01234337|460123859|FG000|Overall Study|Switch to commercial drug|0|||
127865290|NCT01234337|460123860|FG001|Overall Study|Switch to commercial drug|1|||
127865291|NCT04118127|460123861|FG000|Overall Study|Trial terminated by sponsor|0|||
127865292|NCT04118127|460123862|FG001|Overall Study|Trial terminated by sponsor|12|||
127865293|NCT04118127|460123861|FG000|Overall Study|Adverse Event|1|||
127865294|NCT04118127|460123862|FG001|Overall Study|Adverse Event|2|||
127865295|NCT04118127|460123861|FG000|Overall Study|Physician Decision|0|||
127865296|NCT04118127|460123862|FG001|Overall Study|Physician Decision|1|||
127865297|NCT04118127|460123861|FG000|Overall Study|Withdrawal by Subject|2|||
127865298|NCT04118127|460123862|FG001|Overall Study|Withdrawal by Subject|1|||
127865299|NCT03480360|460123863|FG000|Overall Study|Death|2|||
127865300|NCT00660816|460123868|FG000|Overall Study|Adverse Event|1|||
127865301|NCT00660816|460123869|FG001|Overall Study|Adverse Event|2|||
127865302|NCT00660816|460123868|FG000|Overall Study|Withdrawal by Subject|1|||
127865303|NCT00660816|460123869|FG001|Overall Study|Withdrawal by Subject|0|||
127865304|NCT00660816|460123868|FG000|Overall Study|Death|0|||
127865305|NCT00660816|460123869|FG001|Overall Study|Death|2|||
127865306|NCT00660816|460123868|FG000|Overall Study|Lack of Efficacy|1|||
127865307|NCT00660816|460123869|FG001|Overall Study|Lack of Efficacy|0|||
127865308|NCT00660816|460123868|FG000|Overall Study|Physician Decision|0|||
127865309|NCT00660816|460123869|FG001|Overall Study|Physician Decision|2|||
127865310|NCT00660816|460123868|FG000|Overall Study|Protocol Violation|1|||
127865311|NCT00660816|460123869|FG001|Overall Study|Protocol Violation|0|||
127865312|NCT00660816|460123868|FG000|Overall Study|Disease Progression|16|||
127865313|NCT00660816|460123869|FG001|Overall Study|Disease Progression|12|||
127865314|NCT00660816|460123868|FG000|Overall Study|Complicating Disease|0|||
127865315|NCT00660816|460123869|FG001|Overall Study|Complicating Disease|1|||
127865316|NCT02692560|460123870|FG000|Overall Study|Withdrawal by Subject|0|||
127865317|NCT02692560|460123871|FG001|Overall Study|Withdrawal by Subject|6|||
127865318|NCT01326910|460123872|FG000|Overall Study|Withdrawal by Subject|3|||
127865319|NCT01326910|460123873|FG001|Overall Study|Withdrawal by Subject|2|||
127865320|NCT01326910|460123872|FG000|Overall Study|Protocol Violation|1|||
127865321|NCT01326910|460123873|FG001|Overall Study|Protocol Violation|1|||
127865322|NCT01681836|460123876|FG000|Second Intervention|Withdrawal by Subject|0|||
127865323|NCT01681836|460123877|FG001|Second Intervention|Withdrawal by Subject|1|||
127865324|NCT01241318|460123880|FG000|Overall Study|Woman: false pregnancies|27|||
127865325|NCT01241318|460123881|FG001|Overall Study|Woman: false pregnancies|15|||
127865326|NCT01241318|460123880|FG000|Overall Study|Woman: miscarriage/abortion|46|||
127865327|NCT01241318|460123881|FG001|Overall Study|Woman: miscarriage/abortion|38|||
127865328|NCT01241318|460123880|FG000|Overall Study|Withdrawal by Subject|175|||
127865329|NCT01241318|460123881|FG001|Overall Study|Withdrawal by Subject|46|||
127865330|NCT01241318|460123880|FG000|Overall Study|Lost to Follow-up|740|||
127865331|NCT01241318|460123881|FG001|Overall Study|Lost to Follow-up|455|||
127865332|NCT01241318|460123880|FG000|Overall Study|Death|2|||
127865333|NCT01241318|460123881|FG001|Overall Study|Death|4|||
127865334|NCT01241318|460123880|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
127865335|NCT01241318|460123881|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
127865336|NCT01241318|460123880|FG000|Overall Study|Woman: Stillborn infant|129|||
127865337|NCT01241318|460123881|FG001|Overall Study|Woman: Stillborn infant|146|||
127865338|NCT02728804|460123891|FG000|Overall Study|Ineligible|3|||
127865339|NCT02728804|460123891|FG000|Overall Study|Did not complete baseline questionnaire|9|||
127865340|NCT02728804|460123891|FG000|Overall Study|Death|99|||
127865341|NCT02918006|460123897|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
127865342|NCT02918006|460123898|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
127865343|NCT02918006|460123899|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
127865344|NCT02918006|460123897|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
127865345|NCT02918006|460123898|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
127865346|NCT02918006|460123899|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
127865347|NCT02918006|460123897|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
127865348|NCT02918006|460123898|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
127865349|NCT02918006|460123899|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
127865350|NCT02918006|460123897|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
127865351|NCT02918006|460123898|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
127865352|NCT02918006|460123899|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
127865353|NCT02918006|460123897|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
127865354|NCT02918006|460123898|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
127865355|NCT02918006|460123899|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
127865356|NCT02918006|460123897|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
127865357|NCT02918006|460123898|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
127865358|NCT02918006|460123899|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
127865359|NCT02918006|460123897|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
127865360|NCT02918006|460123898|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
127865361|NCT02918006|460123899|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
127865362|NCT02918006|460123897|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
127865363|NCT02918006|460123898|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
127865364|NCT02918006|460123899|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
127865365|NCT02918006|460123897|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
127865366|NCT02918006|460123898|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
127865367|NCT02918006|460123899|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
127865368|NCT02475564|460123903|FG000|Overall Study|Withdrawal by Subject|1|||
127865369|NCT02475564|460123904|FG001|Overall Study|Withdrawal by Subject|0|||
127865370|NCT02475564|460123903|FG000|Overall Study|Lost to Follow-up|2|||
127865371|NCT02475564|460123904|FG001|Overall Study|Lost to Follow-up|1|||
127865372|NCT02475564|460123903|FG000|Overall Study|Intense Menstrual bleeding|1|||
127865373|NCT02475564|460123904|FG001|Overall Study|Intense Menstrual bleeding|0|||
127865374|NCT01156012|460123905|FG000|Overall Study|Adverse Event|3|||
127865375|NCT01156012|460123906|FG001|Overall Study|Adverse Event|1|||
127865376|NCT01156012|460123905|FG000|Overall Study|Lost to Follow-up|1|||
127865377|NCT01156012|460123906|FG001|Overall Study|Lost to Follow-up|0|||
127865378|NCT01156012|460123905|FG000|Overall Study|Withdrawal by Subject|1|||
127865379|NCT01156012|460123906|FG001|Overall Study|Withdrawal by Subject|0|||
127865380|NCT01156012|460123905|FG000|Overall Study|use of commercial drug instead of study|0|||
127865381|NCT01156012|460123906|FG001|Overall Study|use of commercial drug instead of study|1|||
127865382|NCT01156012|460123905|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
127865383|NCT01156012|460123906|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
127865384|NCT02705755|460123908|FG000|Part A (6 Days)|Adverse Event|1|||
127865385|NCT02705755|460123909|FG001|Part A (6 Days)|Adverse Event|0|||
127865386|NCT02705755|460123910|FG002|Part A (6 Days)|Adverse Event|0|||
127865387|NCT02705755|460123911|FG003|Part A (6 Days)|Adverse Event|0|||
127865388|NCT02705755|460123908|FG000|Part A (6 Days)|Physician Decision|3|||
127865389|NCT02705755|460123909|FG001|Part A (6 Days)|Physician Decision|0|||
127865390|NCT02705755|460123910|FG002|Part A (6 Days)|Physician Decision|0|||
127865391|NCT02705755|460123911|FG003|Part A (6 Days)|Physician Decision|0|||
127865392|NCT02705755|460123908|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
127865393|NCT02705755|460123909|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
127865394|NCT02705755|460123910|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
127865395|NCT02705755|460123911|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
127865396|NCT02705755|460123908|FG000|Part C (20 Weeks)|Physician Decision|0|||
127865397|NCT02705755|460123909|FG001|Part C (20 Weeks)|Physician Decision|0|||
127865398|NCT02705755|460123910|FG002|Part C (20 Weeks)|Physician Decision|0|||
127865399|NCT02705755|460123911|FG003|Part C (20 Weeks)|Physician Decision|2|||
127865400|NCT02705755|460123908|FG000|Part C (20 Weeks)|Adverse Event|0|||
127865401|NCT02705755|460123909|FG001|Part C (20 Weeks)|Adverse Event|0|||
127865402|NCT02705755|460123910|FG002|Part C (20 Weeks)|Adverse Event|0|||
127865403|NCT02705755|460123911|FG003|Part C (20 Weeks)|Adverse Event|6|||
127865404|NCT02705755|460123908|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
127865405|NCT02705755|460123909|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
127865406|NCT02705755|460123910|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
127865407|NCT02705755|460123911|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
127865408|NCT01640353|460125567|FG000|Overall Study|Withdrew prior to treatment|10|||
127865409|NCT01640353|460125567|FG000|Overall Study|Withdrawn from analysis at term site|12|||
127865410|NCT01640353|460125567|FG000|Overall Study|Withdrawal by Subject|5|||
127865411|NCT01640353|460125567|FG000|Overall Study|Death|2|||
127865412|NCT01640353|460125567|FG000|Overall Study|Early site termination|3|||
127865413|NCT01640353|460125567|FG000|Overall Study|Lost to Follow-up|12|||
127865414|NCT01640353|460125567|FG000|Overall Study|Physician Decision|1|||
127865415|NCT03758612|460125572|FG000|Washout Period|Withdrawal by Subject|0|||
127865416|NCT03758612|460125573|FG001|Washout Period|Withdrawal by Subject|0|||
127865417|NCT03758612|460125574|FG002|Washout Period|Withdrawal by Subject|2|||
127865418|NCT03758612|460125575|FG003|Washout Period|Withdrawal by Subject|0|||
127865419|NCT03758612|460125576|FG004|Washout Period|Withdrawal by Subject|0|||
127865420|NCT03758612|460125577|FG005|Washout Period|Withdrawal by Subject|0|||
127865421|NCT03758612|460125578|FG006|Washout Period|Withdrawal by Subject|0|||
127865422|NCT03758612|460125579|FG007|Washout Period|Withdrawal by Subject|0|||
127865423|NCT03758612|460125580|FG008|Washout Period|Withdrawal by Subject|0|||
127865424|NCT03758612|460125581|FG009|Washout Period|Withdrawal by Subject|0|||
127865425|NCT03758612|460125582|FG010|Washout Period|Withdrawal by Subject|0|||
127865426|NCT03758612|460125583|FG011|Washout Period|Withdrawal by Subject|0|||
127865427|NCT03758612|460125572|FG000|Period 2|Protocol Violation|0|||
127865428|NCT03758612|460125573|FG001|Period 2|Protocol Violation|0|||
127865429|NCT03758612|460125574|FG002|Period 2|Protocol Violation|0|||
127865430|NCT03758612|460125575|FG003|Period 2|Protocol Violation|0|||
127865431|NCT03758612|460125576|FG004|Period 2|Protocol Violation|1|||
127865432|NCT03758612|460125577|FG005|Period 2|Protocol Violation|0|||
127865433|NCT03758612|460125578|FG006|Period 2|Protocol Violation|0|||
127865434|NCT03758612|460125579|FG007|Period 2|Protocol Violation|0|||
127865435|NCT03758612|460125580|FG008|Period 2|Protocol Violation|0|||
127865436|NCT03758612|460125581|FG009|Period 2|Protocol Violation|0|||
127865437|NCT03758612|460125582|FG010|Period 2|Protocol Violation|0|||
127865438|NCT03758612|460125583|FG011|Period 2|Protocol Violation|0|||
127865439|NCT01603615|460125585|FG000|Overall Study|Did not Receive Treatment|7|||
127865440|NCT01603615|460125585|FG000|Overall Study|Lost to Follow-up|9|||
127865441|NCT01603615|460125585|FG000|Overall Study|Personal Reasons|17|||
127865442|NCT01603615|460125585|FG000|Overall Study|Other Miscellaneous|1|||
127865443|NCT03419741|460125586|FG000|Overall Study|Adverse Event|1|||
127865444|NCT03419741|460125587|FG001|Overall Study|Adverse Event|0|||
127865445|NCT03419741|460125586|FG000|Overall Study|Withdrawal by Subject|1|||
127865446|NCT03419741|460125587|FG001|Overall Study|Withdrawal by Subject|2|||
127865447|NCT04354870|460125588|FG000|Overall Study|Lost to Follow-up|32|||
127865448|NCT04354870|460125589|FG001|Overall Study|Lost to Follow-up|12|||
127865449|NCT04354870|460125588|FG000|Overall Study|Withdrawal by Subject|10|||
127865450|NCT04354870|460125589|FG001|Overall Study|Withdrawal by Subject|16|||
127865451|NCT04354870|460125588|FG000|Overall Study|Did not complete all study visits|6|||
127865452|NCT04354870|460125589|FG001|Overall Study|Did not complete all study visits|5|||
127865453|NCT03384316|460125590|FG000|Overall Study|Screen failure|0|||
127865454|NCT03384316|460125591|FG001|Overall Study|Screen failure|1|||
127865455|NCT02194699|460125602|FG000|Randomised|Did not receive treatment|1|||
127865456|NCT02194699|460125603|FG001|Randomised|Did not receive treatment|5|||
127865457|NCT02194699|460125602|FG000|Randomised|Without potential for 52 weeks of IP|5|||
127865458|NCT02194699|460125603|FG001|Randomised|Without potential for 52 weeks of IP|5|||
127865459|NCT02194699|460125602|FG000|Randomised|Duplicate patient|2|||
127865460|NCT02194699|460125603|FG001|Randomised|Duplicate patient|1|||
127865461|NCT02194699|460125602|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
127865462|NCT02194699|460125603|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
127865463|NCT02194699|460125602|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
127865464|NCT02194699|460125603|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
127865465|NCT02194699|460125602|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
127865466|NCT02194699|460125603|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
127865467|NCT02194699|460125602|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
127865468|NCT02194699|460125603|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
127865469|NCT02194699|460125602|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
127865470|NCT02194699|460125603|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
127865471|NCT02194699|460125602|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
127865472|NCT02194699|460125603|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
127865473|NCT02127970|460125613|FG000|Overall Study|Adverse Event|2|||
127865474|NCT02127970|460125614|FG001|Overall Study|Adverse Event|1|||
127865475|NCT02127970|460125613|FG000|Overall Study|Death|1|||
127865476|NCT02127970|460125614|FG001|Overall Study|Death|1|||
127865477|NCT02127970|460125613|FG000|Overall Study|Lost to Follow-up|14|||
127865478|NCT02127970|460125614|FG001|Overall Study|Lost to Follow-up|14|||
127865479|NCT02127970|460125613|FG000|Overall Study|Reason not Specified|4|||
127865480|NCT02127970|460125614|FG001|Overall Study|Reason not Specified|7|||
127865481|NCT02127970|460125613|FG000|Overall Study|Pregnancy|0|||
127865482|NCT02127970|460125614|FG001|Overall Study|Pregnancy|1|||
127865483|NCT02127970|460125613|FG000|Overall Study|Subject Withdrew Consent|5|||
127865484|NCT02127970|460125614|FG001|Overall Study|Subject Withdrew Consent|3|||
127865485|NCT01710709|460125615|FG000|Overall Study|Lost to Follow-up|29|||
127865486|NCT01710709|460125615|FG000|Overall Study|Adverse Event|48|||
127865487|NCT01710709|460125615|FG000|Overall Study|Participant met withdrawal criteria|33|||
127865488|NCT01710709|460125615|FG000|Overall Study|Participant withdrawn by investigator|2|||
127865489|NCT01710709|460125615|FG000|Overall Study|Withdrawal by Subject|53|||
127865490|NCT01710709|460125615|FG000|Overall Study|Protocol Violation|5|||
127865491|NCT01710709|460125615|FG000|Overall Study|Lack of Efficacy|3|||
127865492|NCT01398176|460125616|FG000|Overall Study|Lost to Follow-up|1|||
127865493|NCT01398176|460125617|FG001|Overall Study|Lost to Follow-up|3|||
127865494|NCT01398176|460125616|FG000|Overall Study|Physician Decision|2|||
127865495|NCT01398176|460125617|FG001|Overall Study|Physician Decision|3|||
127865496|NCT00542321|460125618|FG000|Overall Study|Death|0|||
127865497|NCT00542321|460125619|FG001|Overall Study|Death|1|||
127865498|NCT01977651|460125620|FG000|4 Month Treatment Period|Adverse Event|34|||
127865499|NCT01977651|460125620|FG000|4 Month Treatment Period|Death|3|||
127865500|NCT01977651|460125620|FG000|4 Month Treatment Period|Progressive Disease|43|||
127865501|NCT01977651|460125620|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
127865502|NCT01977651|460125620|FG000|4 Month Treatment Period|Physician Decision|4|||
127865503|NCT01977651|460125620|FG000|1 Year Extension Period|Adverse Event|14|||
127865504|NCT01977651|460125620|FG000|1 Year Extension Period|Death|10|||
127865505|NCT01977651|460125620|FG000|1 Year Extension Period|Lost to Follow-up|2|||
127865506|NCT01977651|460125620|FG000|1 Year Extension Period|Progressive Disease|86|||
127865507|NCT01977651|460125620|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
127865508|NCT01977651|460125620|FG000|1 Year Extension Period|Physician Decision|6|||
127865509|NCT01977651|460125620|FG000|1 Year Extension Period|Miscellaneous|1|||
127865510|NCT01977651|460125620|FG000|Post 1 Year Extension Period|Adverse Event|5|||
127865511|NCT01977651|460125620|FG000|Post 1 Year Extension Period|Death|13|||
127865512|NCT01977651|460125620|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
127865513|NCT01977651|460125620|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
127865514|NCT01977651|460125620|FG000|Post 1 Year Extension Period|Physician Decision|4|||
127865515|NCT01977651|460125620|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
127865516|NCT00253747|460125621|FG000|Overall Study|Lost to Follow-up|13|||
127865517|NCT00253747|460125622|FG001|Overall Study|Lost to Follow-up|14|||
127865518|NCT00253747|460125621|FG000|Overall Study|Withdrawal by Subject|10|||
127865519|NCT00253747|460125622|FG001|Overall Study|Withdrawal by Subject|11|||
127865520|NCT00253747|460125621|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
127865521|NCT00253747|460125622|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
127865522|NCT03287089|460125623|FG000|Overall Study|Lost to Follow-up|0|||
127865523|NCT03287089|460125624|FG001|Overall Study|Lost to Follow-up|2|||
127865524|NCT03287089|460125623|FG000|Overall Study|Physician Decision|0|||
127865525|NCT03287089|460125624|FG001|Overall Study|Physician Decision|2|||
127865526|NCT03287089|460125623|FG000|Overall Study|Withdrawal by Subject|0|||
127865527|NCT03287089|460125624|FG001|Overall Study|Withdrawal by Subject|2|||
127865528|NCT00661362|460125625|FG000|Overall Study|Adverse Event|5|||
127865529|NCT00661362|460125626|FG001|Overall Study|Adverse Event|4|||
127865530|NCT00661362|460125625|FG000|Overall Study|Incorrect enrollment|2|||
127865531|NCT00661362|460125626|FG001|Overall Study|Incorrect enrollment|0|||
127865532|NCT00661362|460125625|FG000|Overall Study|Study specific discontinuation criteria|4|||
127865533|NCT00661362|460125626|FG001|Overall Study|Study specific discontinuation criteria|11|||
127865534|NCT00661362|460125625|FG000|Overall Study|Withdrawal by Subject|13|||
127865535|NCT00661362|460125626|FG001|Overall Study|Withdrawal by Subject|23|||
127865536|NCT00661362|460125625|FG000|Overall Study|Lost to Follow-up|3|||
127865537|NCT00661362|460125626|FG001|Overall Study|Lost to Follow-up|1|||
127865538|NCT00661362|460125625|FG000|Overall Study|Severe non-compliance to protocol|0|||
127865539|NCT00661362|460125626|FG001|Overall Study|Severe non-compliance to protocol|1|||
127865540|NCT00661362|460125625|FG000|Overall Study|Safety reasons|1|||
127865541|NCT00661362|460125626|FG001|Overall Study|Safety reasons|0|||
127865542|NCT00661362|460125625|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
127865543|NCT00661362|460125626|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
127865544|NCT00775138|460125627|FG000|Overall Study|Withdrawal by Subject|0|||
127865545|NCT00775138|460125628|FG001|Overall Study|Withdrawal by Subject|0|||
127865546|NCT00775138|460125629|FG002|Overall Study|Withdrawal by Subject|2|||
127865547|NCT00775138|460125630|FG003|Overall Study|Withdrawal by Subject|2|||
127865548|NCT00775138|460125627|FG000|Overall Study|Adverse Event|0|||
127865549|NCT00775138|460125628|FG001|Overall Study|Adverse Event|0|||
127865550|NCT00775138|460125629|FG002|Overall Study|Adverse Event|1|||
127865551|NCT00775138|460125630|FG003|Overall Study|Adverse Event|0|||
127865552|NCT04880642|460125631|FG000|Randomization|Withdrawal by Subject|2|||
127865553|NCT04880642|460125632|FG001|Randomization|Withdrawal by Subject|3|||
127865554|NCT04880642|460125631|FG000|Treatment Period|Adverse Event|0|||
127865555|NCT04880642|460125632|FG001|Treatment Period|Adverse Event|1|||
127865556|NCT04880642|460125631|FG000|Treatment Period|Death|6|||
127865557|NCT04880642|460125632|FG001|Treatment Period|Death|6|||
127865558|NCT04880642|460125631|FG000|Treatment Period|Lost to Follow-up|1|||
127865559|NCT04880642|460125632|FG001|Treatment Period|Lost to Follow-up|0|||
127865560|NCT04880642|460125631|FG000|Treatment Period|Protocol Violation|0|||
127865561|NCT04880642|460125632|FG001|Treatment Period|Protocol Violation|1|||
127865562|NCT04880642|460125631|FG000|Treatment Period|Withdrawal by Subject|5|||
127865563|NCT04880642|460125632|FG001|Treatment Period|Withdrawal by Subject|3|||
127865564|NCT04880642|460125631|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
127865565|NCT04880642|460125632|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
127865566|NCT04880642|460125631|FG000|Follow-up|Death|4|||
127865567|NCT04880642|460125632|FG001|Follow-up|Death|3|||
127865568|NCT04880642|460125631|FG000|Follow-up|Withdrawal by Subject|1|||
127865569|NCT04880642|460125632|FG001|Follow-up|Withdrawal by Subject|0|||
127865570|NCT00104299|460125633|FG000|Overall Study|Adverse Event|3|||
127865571|NCT00104299|460125634|FG001|Overall Study|Adverse Event|1|||
127865572|NCT00104299|460125633|FG000|Overall Study|Death|2|||
127865573|NCT00104299|460125634|FG001|Overall Study|Death|2|||
127865574|NCT00104299|460125633|FG000|Overall Study|Withdrawal by Subject|2|||
127865575|NCT00104299|460125634|FG001|Overall Study|Withdrawal by Subject|6|||
127865576|NCT00104299|460125633|FG000|Overall Study|Physician Decision|1|||
127865577|NCT00104299|460125634|FG001|Overall Study|Physician Decision|1|||
127865578|NCT00104299|460125633|FG000|Overall Study|To have renal transplant|1|||
127865579|NCT00104299|460125634|FG001|Overall Study|To have renal transplant|0|||
127865580|NCT02906644|460125635|FG000|First 2 Weeks|Withdrawal by Subject|0|||
127865581|NCT02906644|460125636|FG001|First 2 Weeks|Withdrawal by Subject|2|||
127865582|NCT02906644|460125635|FG000|First 2 Weeks|Physician Decision|1|||
127865583|NCT02906644|460125636|FG001|First 2 Weeks|Physician Decision|1|||
127865584|NCT02906644|460125635|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
127865585|NCT02906644|460125636|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
127865586|NCT02906644|460125635|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
127865587|NCT02906644|460125636|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
127865588|NCT02452034|460125637|FG000|Overall Study|Adverse Event|0|||
127865589|NCT02452034|460125638|FG001|Overall Study|Adverse Event|0|||
127865590|NCT02452034|460125639|FG002|Overall Study|Adverse Event|0|||
127915548|NCT02227238|460312328|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
127915549|NCT02227238|460312326|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
127915550|NCT02227238|460312327|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
127915551|NCT02227238|460312328|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
127915552|NCT02227238|460312326|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
127915553|NCT02227238|460312327|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
127915554|NCT02227238|460312328|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
127915555|NCT02227238|460312326|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
127915556|NCT02227238|460312327|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
127915557|NCT02227238|460312328|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
127915558|NCT02227238|460312326|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
127915559|NCT02227238|460312327|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
127915560|NCT02227238|460312328|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
127915561|NCT02227238|460312326|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
127915562|NCT02227238|460312327|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
127915563|NCT02227238|460312328|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
127915564|NCT02227238|460312326|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
127915565|NCT02227238|460312327|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
127915566|NCT02227238|460312328|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
127915567|NCT02227238|460312326|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
127915568|NCT02227238|460312327|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
127915569|NCT02227238|460312328|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
127915570|NCT02227238|460312326|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
127915571|NCT02227238|460312327|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
127915572|NCT02227238|460312328|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
127915573|NCT02227238|460312326|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
127915574|NCT02227238|460312327|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
127915575|NCT02227238|460312328|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
127915576|NCT02227238|460312326|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
127915577|NCT02227238|460312327|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
127915578|NCT02227238|460312328|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
127915579|NCT02227238|460312326|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
127915580|NCT02227238|460312327|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
127915581|NCT02227238|460312328|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
127915582|NCT02227238|460312326|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
127915583|NCT02227238|460312327|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
127915584|NCT02227238|460312328|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
127915585|NCT04025021|460312329|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
127915586|NCT04025021|460312330|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
127915587|NCT03966911|460312332|FG000|Overall Study|Adverse Event|1|||
127915588|NCT03966911|460312333|FG001|Overall Study|Adverse Event|1|||
127915589|NCT03966911|460312332|FG000|Overall Study|Withdrawal by Subject|8|||
127915590|NCT03966911|460312333|FG001|Overall Study|Withdrawal by Subject|2|||
127915591|NCT03966911|460312332|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
127915592|NCT03966911|460312333|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
127915593|NCT00868998|460312334|FG000|Overall Study|Screen Failure|1|||
127915594|NCT00868998|460312334|FG000|Overall Study|Withdrawal by Subject|1|||
127915595|NCT00868998|460312334|FG000|Overall Study|Progression of disease|2|||
127915596|NCT00868998|460312334|FG000|Overall Study|Death|1|||
127915597|NCT01986647|460312336|FG000|Overall Study|Lost to Follow-up|4|||
127915598|NCT01986647|460312337|FG001|Overall Study|Lost to Follow-up|1|||
127915599|NCT01986647|460312338|FG002|Overall Study|Lost to Follow-up|4|||
127915600|NCT01986647|460312339|FG003|Overall Study|Lost to Follow-up|4|||
127915601|NCT01986647|460312336|FG000|Overall Study|Withdrawal by Subject|1|||
127915602|NCT01986647|460312337|FG001|Overall Study|Withdrawal by Subject|3|||
127915603|NCT01986647|460312338|FG002|Overall Study|Withdrawal by Subject|2|||
127915604|NCT01986647|460312339|FG003|Overall Study|Withdrawal by Subject|3|||
127915605|NCT01986647|460312336|FG000|Overall Study|Health|5|||
127915606|NCT01986647|460312337|FG001|Overall Study|Health|3|||
127915607|NCT01986647|460312338|FG002|Overall Study|Health|6|||
127915608|NCT01986647|460312339|FG003|Overall Study|Health|4|||
127915609|NCT02905435|460312340|FG000|Overall Study|Death|2|||
127915610|NCT02905435|460312340|FG000|Overall Study|Physician Decision|1|||
127915611|NCT02905435|460312340|FG000|Overall Study|Lost to Follow-up|4|||
127915612|NCT03498560|460312344|FG000|Overall Study|Found Ineligible|2|||
127915613|NCT03498560|460312344|FG000|Overall Study|Withdrawal by Subject|14|||
127915614|NCT03498560|460312344|FG000|Overall Study|Lost to Follow-up|4|||
127915615|NCT03498560|460312344|FG000|Overall Study|Death|1|||
127915616|NCT01507662|460312345|FG000|Overall Study|Death|26|||
127915617|NCT01507662|460312346|FG001|Overall Study|Death|18|||
127865591|NCT02452034|460125640|FG003|Overall Study|Adverse Event|0|||
127865592|NCT02452034|460125641|FG004|Overall Study|Adverse Event|0|||
127865593|NCT02452034|460125642|FG005|Overall Study|Adverse Event|1|||
127865594|NCT02452034|460125637|FG000|Overall Study|Death|0|||
127865595|NCT02452034|460125638|FG001|Overall Study|Death|0|||
127865596|NCT02452034|460125639|FG002|Overall Study|Death|0|||
127865597|NCT02452034|460125640|FG003|Overall Study|Death|0|||
127865598|NCT02452034|460125641|FG004|Overall Study|Death|1|||
127865599|NCT02452034|460125642|FG005|Overall Study|Death|1|||
127865600|NCT02452034|460125637|FG000|Overall Study|Physician Decision|0|||
127865601|NCT02452034|460125638|FG001|Overall Study|Physician Decision|1|||
127865602|NCT02452034|460125639|FG002|Overall Study|Physician Decision|1|||
127915618|NCT01507662|460312345|FG000|Overall Study|Withdrawal by Subject|290|||
127915619|NCT01507662|460312346|FG001|Overall Study|Withdrawal by Subject|287|||
127915620|NCT01507662|460312345|FG000|Overall Study|Lost to Follow-up|498|||
127915621|NCT01507662|460312346|FG001|Overall Study|Lost to Follow-up|523|||
127915622|NCT01507662|460312345|FG000|Overall Study|Proxy interview done|2|||
127915623|NCT01507662|460312346|FG001|Overall Study|Proxy interview done|3|||
127915624|NCT01004510|460312351|FG000|Overall Study|Adverse Event|1|||
127915625|NCT01960296|460312354|FG000|Overall Study|Postponed surgery|1|||
127915626|NCT01960296|460312355|FG001|Overall Study|Postponed surgery|0|||
127915627|NCT01960296|460312354|FG000|Overall Study|Received different procedure|1|||
127915628|NCT01960296|460312355|FG001|Overall Study|Received different procedure|3|||
127915629|NCT02003391|460312356|FG000|Overall Study|Withdrawal by Subject|2|||
127865603|NCT02452034|460125640|FG003|Overall Study|Physician Decision|0|||
127865604|NCT02452034|460125641|FG004|Overall Study|Physician Decision|0|||
127865605|NCT02452034|460125642|FG005|Overall Study|Physician Decision|0|||
127865606|NCT02452034|460125637|FG000|Overall Study|Protocol Violation|0|||
127865607|NCT02452034|460125638|FG001|Overall Study|Protocol Violation|0|||
127865608|NCT02452034|460125639|FG002|Overall Study|Protocol Violation|0|||
127865609|NCT02452034|460125640|FG003|Overall Study|Protocol Violation|0|||
127865610|NCT02452034|460125641|FG004|Overall Study|Protocol Violation|0|||
127865611|NCT02452034|460125642|FG005|Overall Study|Protocol Violation|1|||
127865612|NCT02452034|460125637|FG000|Overall Study|Screen Failure|1|||
127865613|NCT02452034|460125638|FG001|Overall Study|Screen Failure|0|||
127865614|NCT02452034|460125639|FG002|Overall Study|Screen Failure|0|||
127865615|NCT02452034|460125640|FG003|Overall Study|Screen Failure|1|||
127865616|NCT02452034|460125641|FG004|Overall Study|Screen Failure|0|||
127915630|NCT02003391|460312357|FG001|Overall Study|Withdrawal by Subject|1|||
127915631|NCT02003391|460312356|FG000|Overall Study|Protocol Violation|0|||
127915632|NCT02003391|460312357|FG001|Overall Study|Protocol Violation|1|||
127915633|NCT02003391|460312356|FG000|Overall Study|Adverse Event|1|||
127915634|NCT02003391|460312357|FG001|Overall Study|Adverse Event|0|||
127915635|NCT02272803|460312358|FG000|Overall Study|Disease progression|16|||
127915636|NCT02272803|460312359|FG001|Overall Study|Disease progression|8|||
127915637|NCT02272803|460312358|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
127915638|NCT02272803|460312359|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
127915639|NCT02272803|460312358|FG000|Overall Study|Study drug toxicity|4|||
127915640|NCT02272803|460312359|FG001|Overall Study|Study drug toxicity|9|||
127915641|NCT02272803|460312358|FG000|Overall Study|Participant request to discontinue study treatment|3|||
127915642|NCT02272803|460312359|FG001|Overall Study|Participant request to discontinue study treatment|7|||
127915643|NCT02272803|460312358|FG000|Overall Study|Maximum clinical benefit|4|||
127915644|NCT02272803|460312359|FG001|Overall Study|Maximum clinical benefit|2|||
127915645|NCT02272803|460312358|FG000|Overall Study|Poor/non-compliance|2|||
127915646|NCT02272803|460312359|FG001|Overall Study|Poor/non-compliance|2|||
127915647|NCT02272803|460312358|FG000|Overall Study|Withdrawal by Subject|2|||
127915648|NCT02272803|460312359|FG001|Overall Study|Withdrawal by Subject|1|||
127915649|NCT02272803|460312358|FG000|Overall Study|Death|0|||
127915650|NCT02272803|460312359|FG001|Overall Study|Death|1|||
127915651|NCT02272803|460312358|FG000|Overall Study|Other reasons|1|||
127915652|NCT02272803|460312359|FG001|Overall Study|Other reasons|3|||
127915653|NCT02272803|460312358|FG000|Overall Study|Administrative reason by sponsor|5|||
127915654|NCT02272803|460312359|FG001|Overall Study|Administrative reason by sponsor|4|||
127915655|NCT02302716|460313288|FG000|Overall Study|Adverse Event|1|||
127915656|NCT02302716|460313289|FG001|Overall Study|Adverse Event|1|||
127915657|NCT02302716|460313288|FG000|Overall Study|Death|0|||
127915658|NCT02302716|460313289|FG001|Overall Study|Death|1|||
127865617|NCT02452034|460125642|FG005|Overall Study|Screen Failure|0|||
127865618|NCT02452034|460125637|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
127865619|NCT02452034|460125638|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
127865620|NCT02452034|460125639|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
127865621|NCT02452034|460125640|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
127865622|NCT02452034|460125641|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
127915659|NCT02302716|460313288|FG000|Overall Study|Lack of Efficacy|0|||
127915660|NCT02302716|460313289|FG001|Overall Study|Lack of Efficacy|1|||
127915661|NCT02302716|460313288|FG000|Overall Study|Lost to Follow-up|2|||
127915662|NCT02302716|460313289|FG001|Overall Study|Lost to Follow-up|4|||
127915663|NCT02302716|460313288|FG000|Overall Study|Physician Decision|3|||
127915664|NCT02302716|460313289|FG001|Overall Study|Physician Decision|4|||
127915665|NCT02302716|460313288|FG000|Overall Study|Withdrawal by Subject|13|||
127915666|NCT02302716|460313289|FG001|Overall Study|Withdrawal by Subject|7|||
127915667|NCT02302716|460313288|FG000|Overall Study|Protocol Violation|0|||
127915668|NCT02302716|460313289|FG001|Overall Study|Protocol Violation|1|||
127915669|NCT00557245|460313293|FG000|Overall Study|Lost to Follow-up|7|||
127915670|NCT00557245|460313294|FG001|Overall Study|Lost to Follow-up|8|||
127915671|NCT00557245|460313295|FG002|Overall Study|Lost to Follow-up|10|||
127915672|NCT00557245|460313293|FG000|Overall Study|Ineligible|5|||
127915673|NCT00557245|460313294|FG001|Overall Study|Ineligible|4|||
127915674|NCT00557245|460313295|FG002|Overall Study|Ineligible|2|||
127915675|NCT02316223|460313300|FG000|Overall Study|Lack of Efficacy|0|||
127915676|NCT02316223|460313301|FG001|Overall Study|Lack of Efficacy|1|||
127915677|NCT02316223|460313302|FG002|Overall Study|Lack of Efficacy|1|||
127915678|NCT02316223|460313300|FG000|Overall Study|Lost to Follow-up|27|||
127915679|NCT02316223|460313301|FG001|Overall Study|Lost to Follow-up|34|||
127915680|NCT02316223|460313302|FG002|Overall Study|Lost to Follow-up|36|||
127915681|NCT02316223|460313300|FG000|Overall Study|COPD Diagnosis|3|||
127915682|NCT02316223|460313301|FG001|Overall Study|COPD Diagnosis|2|||
127915683|NCT02316223|460313302|FG002|Overall Study|COPD Diagnosis|3|||
127915684|NCT02316223|460313300|FG000|Overall Study|Reside outside study area|1|||
127915685|NCT02316223|460313301|FG001|Overall Study|Reside outside study area|1|||
127915686|NCT02316223|460313302|FG002|Overall Study|Reside outside study area|1|||
127915687|NCT02316223|460313300|FG000|Overall Study|No asthma|2|||
127915688|NCT02316223|460313301|FG001|Overall Study|No asthma|0|||
127915689|NCT02316223|460313302|FG002|Overall Study|No asthma|0|||
127915690|NCT02316223|460313300|FG000|Overall Study|Discontinued by PI|11|||
127915691|NCT02316223|460313301|FG001|Overall Study|Discontinued by PI|19|||
127915692|NCT02316223|460313302|FG002|Overall Study|Discontinued by PI|3|||
127915693|NCT00529763|460313304|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
127915694|NCT00529763|460313305|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
127915695|NCT00529763|460313306|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
127915696|NCT00529763|460313304|FG000|Overall Study|Death|1|||
127915697|NCT00529763|460313305|FG001|Overall Study|Death|1|||
127915698|NCT00529763|460313306|FG002|Overall Study|Death|1|||
127915699|NCT00529763|460313304|FG000|Overall Study|Disease Progression|10|||
127915700|NCT00529763|460313305|FG001|Overall Study|Disease Progression|16|||
127915701|NCT00529763|460313306|FG002|Overall Study|Disease Progression|11|||
127915702|NCT00529763|460313304|FG000|Overall Study|Lost to Follow-up|1|||
127915703|NCT00529763|460313305|FG001|Overall Study|Lost to Follow-up|2|||
127915704|NCT00529763|460313306|FG002|Overall Study|Lost to Follow-up|3|||
127915705|NCT00529763|460313304|FG000|Overall Study|Stem Cell Transplant|0|||
127915706|NCT00529763|460313305|FG001|Overall Study|Stem Cell Transplant|3|||
127915707|NCT00529763|460313306|FG002|Overall Study|Stem Cell Transplant|1|||
127915708|NCT00529763|460313304|FG000|Overall Study|Study Drug Toxicity|3|||
127915709|NCT00529763|460313305|FG001|Overall Study|Study Drug Toxicity|6|||
127915710|NCT00529763|460313306|FG002|Overall Study|Study Drug Toxicity|4|||
127915711|NCT00529763|460313304|FG000|Overall Study|Participant Withdrew Consent|2|||
127915712|NCT00529763|460313305|FG001|Overall Study|Participant Withdrew Consent|3|||
127915713|NCT00529763|460313306|FG002|Overall Study|Participant Withdrew Consent|4|||
127915714|NCT00529763|460313304|FG000|Overall Study|Other reasons|2|||
127915715|NCT00529763|460313305|FG001|Overall Study|Other reasons|0|||
127915716|NCT00529763|460313306|FG002|Overall Study|Other reasons|2|||
127915717|NCT00529763|460313304|FG000|Overall Study|Participant request to discontinue treatment|1|||
127915718|NCT00529763|460313305|FG001|Overall Study|Participant request to discontinue treatment|1|||
127915719|NCT00529763|460313306|FG002|Overall Study|Participant request to discontinue treatment|3|||
127915720|NCT03669250|460313307|FG000|Overall Study|Adverse Event|0|||
127915721|NCT03669250|460313308|FG001|Overall Study|Adverse Event|0|||
127915722|NCT03669250|460313309|FG002|Overall Study|Adverse Event|0|||
127915723|NCT03669250|460313310|FG003|Overall Study|Adverse Event|0|||
127915724|NCT03669250|460313311|FG004|Overall Study|Adverse Event|1|||
127915725|NCT03669250|460313312|FG005|Overall Study|Adverse Event|0|||
127915726|NCT03669250|460313307|FG000|Overall Study|Withdrawal by Subject|0|||
127915727|NCT03669250|460313308|FG001|Overall Study|Withdrawal by Subject|1|||
127915728|NCT03669250|460313309|FG002|Overall Study|Withdrawal by Subject|0|||
127915729|NCT03669250|460313310|FG003|Overall Study|Withdrawal by Subject|1|||
127915730|NCT03669250|460313311|FG004|Overall Study|Withdrawal by Subject|0|||
127915731|NCT03669250|460313312|FG005|Overall Study|Withdrawal by Subject|0|||
127915732|NCT00828321|460313313|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
127915733|NCT00828321|460313314|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
127915734|NCT00828321|460313313|FG000|Second Intervention|Protocol Violation|0|||
127915735|NCT00828321|460313314|FG001|Second Intervention|Protocol Violation|1|||
127915736|NCT04523480|460313315|FG000|Overall Study|Lost to Follow-up|30|||
127915737|NCT04523480|460313316|FG001|Overall Study|Lost to Follow-up|35|||
127915738|NCT04523480|460313317|FG002|Overall Study|Lost to Follow-up|0|||
127915739|NCT00081653|460313323|FG000|Overall Study|Adverse Event|23|||
127915740|NCT00081653|460313324|FG001|Overall Study|Adverse Event|17|||
127915741|NCT00081653|460313323|FG000|Overall Study|Lost to Follow-up|2|||
127915742|NCT00081653|460313324|FG001|Overall Study|Lost to Follow-up|4|||
127915743|NCT00081653|460313323|FG000|Overall Study|Refused Treatment|18|||
127915744|NCT00081653|460313324|FG001|Overall Study|Refused Treatment|14|||
127915745|NCT00081653|460313323|FG000|Overall Study|Low bone mineral density|1|||
127915746|NCT00081653|460313324|FG001|Overall Study|Low bone mineral density|0|||
127915747|NCT00081653|460313323|FG000|Overall Study|Bone loss|2|||
127915748|NCT00081653|460313324|FG001|Overall Study|Bone loss|0|||
127915749|NCT00081653|460313323|FG000|Overall Study|Participant leaving country|1|||
127915750|NCT00081653|460313324|FG001|Overall Study|Participant leaving country|0|||
127915751|NCT00081653|460313323|FG000|Overall Study|Loss of bone mass|0|||
127915752|NCT00081653|460313324|FG001|Overall Study|Loss of bone mass|2|||
127915753|NCT02694536|460313332|FG000|Overall Study|Progressive Disease|40|||
127915754|NCT02694536|460313332|FG000|Overall Study|Lost to Follow-up|1|||
127915755|NCT02694536|460313332|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
127915756|NCT02694536|460313332|FG000|Overall Study|Withdrawal by Subject|8|||
127915757|NCT02694536|460313332|FG000|Overall Study|Death|8|||
127915758|NCT02694536|460313332|FG000|Overall Study|Other|22|||
127915759|NCT01911429|460313335|FG000|Overall Study|Adverse Event|5|||
127915760|NCT01911429|460313336|FG001|Overall Study|Adverse Event|3|||
127915761|NCT01911429|460313337|FG002|Overall Study|Adverse Event|9|||
127915762|NCT01911429|460313335|FG000|Overall Study|Lack of Efficacy|1|||
127915763|NCT01911429|460313336|FG001|Overall Study|Lack of Efficacy|2|||
127915764|NCT01911429|460313337|FG002|Overall Study|Lack of Efficacy|4|||
127915765|NCT01911429|460313335|FG000|Overall Study|Lost to Follow-up|0|||
127915766|NCT01911429|460313336|FG001|Overall Study|Lost to Follow-up|0|||
127915767|NCT01911429|460313337|FG002|Overall Study|Lost to Follow-up|1|||
127915768|NCT01911429|460313335|FG000|Overall Study|Protocol Violation|0|||
127915769|NCT01911429|460313336|FG001|Overall Study|Protocol Violation|0|||
127915770|NCT01911429|460313337|FG002|Overall Study|Protocol Violation|1|||
127915771|NCT01911429|460313335|FG000|Overall Study|Withdrawal by Subject|5|||
127915772|NCT01911429|460313336|FG001|Overall Study|Withdrawal by Subject|5|||
127915773|NCT01911429|460313337|FG002|Overall Study|Withdrawal by Subject|4|||
127915774|NCT01911429|460313335|FG000|Overall Study|Accidental randomization|0|||
127915775|NCT01911429|460313336|FG001|Overall Study|Accidental randomization|0|||
127915776|NCT01911429|460313337|FG002|Overall Study|Accidental randomization|1|||
127915777|NCT01911429|460313335|FG000|Overall Study|subject left study|1|||
127915778|NCT01911429|460313336|FG001|Overall Study|subject left study|0|||
127915779|NCT01911429|460313337|FG002|Overall Study|subject left study|0|||
127865623|NCT02452034|460125642|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
127865624|NCT00561795|460125644|FG000|Overall Study|Adverse Event|3|||
127865625|NCT00561795|460125645|FG001|Overall Study|Adverse Event|3|||
127865626|NCT00561795|460125646|FG002|Overall Study|Adverse Event|0|||
127865627|NCT00561795|460125647|FG003|Overall Study|Adverse Event|0|||
127865628|NCT00561795|460125644|FG000|Overall Study|Study Closed/Terminated|0|||
127865629|NCT00561795|460125645|FG001|Overall Study|Study Closed/Terminated|3|||
127865630|NCT00561795|460125646|FG002|Overall Study|Study Closed/Terminated|0|||
127865631|NCT00561795|460125647|FG003|Overall Study|Study Closed/Terminated|0|||
127865632|NCT00561795|460125644|FG000|Overall Study|Physician Decision|1|||
127865633|NCT00561795|460125645|FG001|Overall Study|Physician Decision|0|||
127865634|NCT00561795|460125646|FG002|Overall Study|Physician Decision|0|||
127865635|NCT00561795|460125647|FG003|Overall Study|Physician Decision|0|||
127865636|NCT03672006|460125648|FG000|Overall Study|exclusion criteria met|0|||
127865637|NCT03672006|460125649|FG001|Overall Study|exclusion criteria met|1|||
127865638|NCT04235959|460125651|FG000|Overall Study|Protocol Violation|0|||
127865639|NCT04235959|460125652|FG001|Overall Study|Protocol Violation|1|||
127865640|NCT04235959|460125653|FG002|Overall Study|Protocol Violation|0|||
127915780|NCT02043132|460313345|FG000|Overall Study|Lost to Follow-up|1|||
127915781|NCT02043132|460313346|FG001|Overall Study|Lost to Follow-up|1|||
127915782|NCT02043132|460313345|FG000|Overall Study|screen failures|4|||
127915783|NCT02043132|460313346|FG001|Overall Study|screen failures|8|||
127915784|NCT03827395|460313347|FG000|Overall Study|Lost to Follow-up|1|||
127915785|NCT03827395|460313348|FG001|Overall Study|Lost to Follow-up|0|||
127865641|NCT04235959|460125651|FG000|Overall Study|Adverse Event|1|||
127865642|NCT04235959|460125652|FG001|Overall Study|Adverse Event|0|||
127865643|NCT04235959|460125653|FG002|Overall Study|Adverse Event|0|||
127915786|NCT03827395|460313347|FG000|Overall Study|Protocol Violation|1|||
127915787|NCT03827395|460313348|FG001|Overall Study|Protocol Violation|0|||
127865644|NCT00608426|460125654|FG000|Overall Study|Death|32|||
127915788|NCT03827395|460313347|FG000|Overall Study|Became ineligible after enrollment|1|||
127915789|NCT03827395|460313348|FG001|Overall Study|Became ineligible after enrollment|2|||
127915790|NCT01484912|460313350|FG000|Overall Study|Withdrawal by Subject|1|||
127915791|NCT01484912|460313351|FG001|Overall Study|Withdrawal by Subject|0|||
127915792|NCT01484912|460313350|FG000|Overall Study|Physician Decision|0|||
127915793|NCT01484912|460313351|FG001|Overall Study|Physician Decision|1|||
127915794|NCT01168856|460313358|FG000|Overall Study|Lost to Follow-up|4|||
127865645|NCT00608426|460125655|FG001|Overall Study|Death|36|||
127865646|NCT00608426|460125654|FG000|Overall Study|Lost to Follow-up|485|||
127865647|NCT00608426|460125655|FG001|Overall Study|Lost to Follow-up|521|||
127865648|NCT00608426|460125654|FG000|Overall Study|refused, health issues, wrong address|319|||
127865649|NCT00608426|460125655|FG001|Overall Study|refused, health issues, wrong address|348|||
127865650|NCT04601194|460125659|FG000|Overall Study|Lost to Follow-up|7|||
127865651|NCT02630459|460125660|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
127865652|NCT02630459|460125661|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
127865653|NCT02630459|460125662|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
127865654|NCT02630459|460125663|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
127865655|NCT02630459|460125664|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
127865656|NCT02630459|460125665|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
127865657|NCT02630459|460125666|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
127865658|NCT02630459|460125667|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
127865659|NCT02630459|460125660|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
127865660|NCT02630459|460125661|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
127865661|NCT02630459|460125662|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
127865662|NCT02630459|460125663|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
127865663|NCT02630459|460125664|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
127865664|NCT02630459|460125665|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
127865665|NCT02630459|460125666|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
127865666|NCT02630459|460125667|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
127865667|NCT02630459|460125660|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
127865668|NCT02630459|460125661|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
127865669|NCT02630459|460125662|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
127865670|NCT02630459|460125663|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
127865671|NCT02630459|460125664|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
127865672|NCT02630459|460125665|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
127865673|NCT02630459|460125666|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
127865674|NCT02630459|460125667|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
127865675|NCT02630459|460125660|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
127865676|NCT02630459|460125661|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
127865677|NCT02630459|460125662|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
127865678|NCT02630459|460125663|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
127865679|NCT02630459|460125664|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
127865680|NCT02630459|460125665|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
127865681|NCT02630459|460125666|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
127865682|NCT02630459|460125667|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
127865683|NCT02630459|460125660|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
127865684|NCT02630459|460125661|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
127865685|NCT02630459|460125662|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
127865686|NCT02630459|460125663|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
127865687|NCT02630459|460125664|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
127865688|NCT02630459|460125665|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
127865689|NCT02630459|460125666|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
127865690|NCT02630459|460125667|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
127865691|NCT02630459|460125660|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
127865692|NCT02630459|460125661|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
127865693|NCT02630459|460125662|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
127865694|NCT02630459|460125663|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
127865695|NCT02630459|460125664|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
127865696|NCT02630459|460125665|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
127865697|NCT02630459|460125666|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
127865698|NCT02630459|460125667|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
127865699|NCT02630459|460125660|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
127865700|NCT02630459|460125661|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
127865701|NCT02630459|460125662|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
127865702|NCT02630459|460125663|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
127865703|NCT02630459|460125664|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
127865704|NCT02630459|460125665|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
127865705|NCT02630459|460125666|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
127865706|NCT02630459|460125667|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
127865707|NCT01453439|460125668|FG000|Treatment Phase|Withdrawal by Subject|13|||
127865708|NCT01453439|460125669|FG001|Treatment Phase|Withdrawal by Subject|10|||
127865709|NCT01453439|460125668|FG000|Treatment Phase|Suicidal Ideation|2|||
127865710|NCT01453439|460125669|FG001|Treatment Phase|Suicidal Ideation|0|||
127865711|NCT01453439|460125668|FG000|Treatment Phase|Need for higher level of care|1|||
127865712|NCT01453439|460125669|FG001|Treatment Phase|Need for higher level of care|1|||
127865713|NCT01453439|460125668|FG000|Treatment Phase|Therapist conflict of interest|1|||
127865714|NCT01453439|460125669|FG001|Treatment Phase|Therapist conflict of interest|0|||
127865715|NCT01453439|460125668|FG000|Follow-up|Withdrawal by Subject|0|||
127865716|NCT01453439|460125669|FG001|Follow-up|Withdrawal by Subject|1|||
127865717|NCT01453439|460125668|FG000|Follow-up|Lost to Follow-up|5|||
127865718|NCT01453439|460125669|FG001|Follow-up|Lost to Follow-up|10|||
127865719|NCT02135848|460125677|FG000|Overall Study|Adverse Event|2|||
127865720|NCT02135848|460125678|FG001|Overall Study|Adverse Event|0|||
127865721|NCT02135848|460125677|FG000|Overall Study|Withdrawal by Subject|1|||
127865722|NCT02135848|460125678|FG001|Overall Study|Withdrawal by Subject|1|||
127865723|NCT00545740|460125683|FG000|Overall Study|Lack of Efficacy|34|||
127865724|NCT00545740|460125684|FG001|Overall Study|Lack of Efficacy|35|||
127865725|NCT00545740|460125685|FG002|Overall Study|Lack of Efficacy|47|||
127865726|NCT00545740|460125686|FG003|Overall Study|Lack of Efficacy|36|||
127865727|NCT00545740|460125683|FG000|Overall Study|Withdrawal by Subject|17|||
127865728|NCT00545740|460125684|FG001|Overall Study|Withdrawal by Subject|15|||
127865729|NCT00545740|460125685|FG002|Overall Study|Withdrawal by Subject|16|||
127865730|NCT00545740|460125686|FG003|Overall Study|Withdrawal by Subject|18|||
127865731|NCT00545740|460125683|FG000|Overall Study|Adverse Event|10|||
127865732|NCT00545740|460125684|FG001|Overall Study|Adverse Event|18|||
127865733|NCT00545740|460125685|FG002|Overall Study|Adverse Event|19|||
127865734|NCT00545740|460125686|FG003|Overall Study|Adverse Event|9|||
127865735|NCT00545740|460125683|FG000|Overall Study|Lost to Follow-up|7|||
127865736|NCT00545740|460125684|FG001|Overall Study|Lost to Follow-up|5|||
127865737|NCT00545740|460125685|FG002|Overall Study|Lost to Follow-up|5|||
127865738|NCT00545740|460125686|FG003|Overall Study|Lost to Follow-up|6|||
127865739|NCT00545740|460125683|FG000|Overall Study|Protocol Violation|1|||
127865740|NCT00545740|460125684|FG001|Overall Study|Protocol Violation|3|||
127865741|NCT00545740|460125685|FG002|Overall Study|Protocol Violation|1|||
127865742|NCT00545740|460125686|FG003|Overall Study|Protocol Violation|0|||
127865743|NCT00545740|460125683|FG000|Overall Study|Non-compliance|0|||
127865744|NCT00545740|460125684|FG001|Overall Study|Non-compliance|2|||
127865745|NCT00545740|460125685|FG002|Overall Study|Non-compliance|1|||
127865746|NCT00545740|460125686|FG003|Overall Study|Non-compliance|0|||
127865747|NCT00545740|460125683|FG000|Overall Study|Moved|2|||
127865748|NCT00545740|460125684|FG001|Overall Study|Moved|0|||
127865749|NCT00545740|460125685|FG002|Overall Study|Moved|1|||
127865750|NCT00545740|460125686|FG003|Overall Study|Moved|0|||
127865751|NCT00545740|460125683|FG000|Overall Study|Diverticulitis attack|0|||
127865752|NCT00545740|460125684|FG001|Overall Study|Diverticulitis attack|0|||
127865753|NCT00545740|460125685|FG002|Overall Study|Diverticulitis attack|1|||
127865754|NCT00545740|460125686|FG003|Overall Study|Diverticulitis attack|1|||
127865755|NCT00545740|460125683|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
127865756|NCT00545740|460125684|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
127865757|NCT00545740|460125685|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
127865758|NCT00545740|460125686|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
127865759|NCT00545740|460125683|FG000|Overall Study|Site closure|1|||
127865760|NCT00545740|460125684|FG001|Overall Study|Site closure|0|||
127865761|NCT00545740|460125685|FG002|Overall Study|Site closure|0|||
127865762|NCT00545740|460125686|FG003|Overall Study|Site closure|0|||
127865763|NCT00545740|460125683|FG000|Overall Study|Missed visit|1|||
127865764|NCT00545740|460125684|FG001|Overall Study|Missed visit|0|||
127865765|NCT00545740|460125685|FG002|Overall Study|Missed visit|0|||
127865766|NCT00545740|460125686|FG003|Overall Study|Missed visit|0|||
127865767|NCT00545740|460125683|FG000|Overall Study|Physician Decision|0|||
127865768|NCT00545740|460125684|FG001|Overall Study|Physician Decision|0|||
127865769|NCT00545740|460125685|FG002|Overall Study|Physician Decision|3|||
127865770|NCT00545740|460125686|FG003|Overall Study|Physician Decision|0|||
127865771|NCT00545740|460125683|FG000|Overall Study|Accepted only monthly telephone calls|1|||
127865772|NCT00545740|460125684|FG001|Overall Study|Accepted only monthly telephone calls|0|||
127865773|NCT00545740|460125685|FG002|Overall Study|Accepted only monthly telephone calls|0|||
127865774|NCT00545740|460125686|FG003|Overall Study|Accepted only monthly telephone calls|0|||
127865775|NCT00545740|460125683|FG000|Overall Study|Sponsor decision|0|||
127865776|NCT00545740|460125684|FG001|Overall Study|Sponsor decision|1|||
127865777|NCT00545740|460125685|FG002|Overall Study|Sponsor decision|0|||
127865778|NCT00545740|460125686|FG003|Overall Study|Sponsor decision|0|||
127865779|NCT00545740|460125683|FG000|Overall Study|Lack of time|0|||
127865780|NCT00545740|460125684|FG001|Overall Study|Lack of time|1|||
127865781|NCT00545740|460125685|FG002|Overall Study|Lack of time|0|||
127865782|NCT00545740|460125686|FG003|Overall Study|Lack of time|0|||
127865783|NCT00545740|460125683|FG000|Overall Study|Non-adherence to visits|0|||
127865784|NCT00545740|460125684|FG001|Overall Study|Non-adherence to visits|1|||
127865785|NCT00545740|460125685|FG002|Overall Study|Non-adherence to visits|0|||
127865786|NCT00545740|460125686|FG003|Overall Study|Non-adherence to visits|0|||
127865787|NCT00545740|460125683|FG000|Overall Study|Patient difficulties|0|||
127865788|NCT00545740|460125684|FG001|Overall Study|Patient difficulties|1|||
127865789|NCT00545740|460125685|FG002|Overall Study|Patient difficulties|0|||
127865790|NCT00545740|460125686|FG003|Overall Study|Patient difficulties|0|||
127865791|NCT00545740|460125683|FG000|Overall Study|Husband against study|0|||
127865792|NCT00545740|460125684|FG001|Overall Study|Husband against study|0|||
127865793|NCT00545740|460125685|FG002|Overall Study|Husband against study|1|||
127865794|NCT00545740|460125686|FG003|Overall Study|Husband against study|0|||
127865795|NCT02177942|460125693|FG000|Overall Study|Adverse Event|1|||
127865796|NCT02177942|460125694|FG001|Overall Study|Adverse Event|0|||
127865797|NCT02177942|460125693|FG000|Overall Study|Lost to Follow-up|1|||
127865798|NCT02177942|460125694|FG001|Overall Study|Lost to Follow-up|1|||
127865799|NCT02177942|460125693|FG000|Overall Study|Protocol Violation|4|||
127865800|NCT02177942|460125694|FG001|Overall Study|Protocol Violation|6|||
127865801|NCT02177942|460125693|FG000|Overall Study|Withdrawal by Subject|71|||
127865802|NCT02177942|460125694|FG001|Overall Study|Withdrawal by Subject|81|||
127865803|NCT01351415|460125695|FG000|Overall Study|Withdrawal by Subject|15|||
127865804|NCT01351415|460125696|FG001|Overall Study|Withdrawal by Subject|17|||
127865805|NCT01351415|460125695|FG000|Overall Study|Trial termination by the Sponsor|28|||
127865806|NCT01351415|460125696|FG001|Overall Study|Trial termination by the Sponsor|19|||
127865807|NCT01351415|460125695|FG000|Overall Study|Lost to Follow-up|5|||
127865808|NCT01351415|460125696|FG001|Overall Study|Lost to Follow-up|7|||
127865809|NCT01351415|460125695|FG000|Overall Study|Death|190|||
127865810|NCT01351415|460125696|FG001|Overall Study|Death|187|||
127865811|NCT01351415|460125695|FG000|Overall Study|Physician Decision|2|||
127865812|NCT01351415|460125696|FG001|Overall Study|Physician Decision|3|||
127865813|NCT01351415|460125695|FG000|Overall Study|Reason unknown|0|||
127865814|NCT01351415|460125696|FG001|Overall Study|Reason unknown|2|||
127865815|NCT01351415|460125695|FG000|Overall Study|Never Started|5|||
127865816|NCT01351415|460125696|FG001|Overall Study|Never Started|5|||
127865817|NCT00699582|460125702|FG000|Overall Study|Adverse Event|4|||
127865818|NCT00699582|460125703|FG001|Overall Study|Adverse Event|11|||
127865819|NCT00699582|460125704|FG002|Overall Study|Adverse Event|23|||
127865820|NCT00699582|460125702|FG000|Overall Study|Withdrawal by Subject|6|||
127865821|NCT00699582|460125703|FG001|Overall Study|Withdrawal by Subject|7|||
127865822|NCT00699582|460125704|FG002|Overall Study|Withdrawal by Subject|4|||
127865823|NCT00699582|460125702|FG000|Overall Study|Lack of Efficacy|1|||
127865824|NCT00699582|460125703|FG001|Overall Study|Lack of Efficacy|0|||
127865825|NCT00699582|460125704|FG002|Overall Study|Lack of Efficacy|1|||
127865826|NCT00699582|460125702|FG000|Overall Study|Progressive Disease|1|||
127865827|NCT00699582|460125703|FG001|Overall Study|Progressive Disease|0|||
127865828|NCT00699582|460125704|FG002|Overall Study|Progressive Disease|0|||
127865829|NCT00699582|460125702|FG000|Overall Study|Administrative/Other|4|||
127865830|NCT00699582|460125703|FG001|Overall Study|Administrative/Other|3|||
127865831|NCT00699582|460125704|FG002|Overall Study|Administrative/Other|0|||
127865832|NCT00699582|460125702|FG000|Overall Study|Randomized, Not Treated|2|||
127865833|NCT00699582|460125703|FG001|Overall Study|Randomized, Not Treated|1|||
127865834|NCT00699582|460125704|FG002|Overall Study|Randomized, Not Treated|0|||
127865835|NCT01646255|460125707|FG000|Overall Study|Adverse Event|7|||
127865836|NCT01646255|460125708|FG001|Overall Study|Adverse Event|8|||
127865837|NCT01646255|460125707|FG000|Overall Study|Lack of Efficacy|2|||
127865838|NCT01646255|460125708|FG001|Overall Study|Lack of Efficacy|0|||
127865839|NCT01646255|460125707|FG000|Overall Study|Withdrawal by Subject|10|||
127865840|NCT01646255|460125708|FG001|Overall Study|Withdrawal by Subject|6|||
127865841|NCT01646255|460125707|FG000|Overall Study|Compliance is not well|1|||
127865842|NCT01646255|460125708|FG001|Overall Study|Compliance is not well|0|||
127865843|NCT01646255|460125707|FG000|Overall Study|Inclusion Criteria Deviation|1|||
127865844|NCT01646255|460125708|FG001|Overall Study|Inclusion Criteria Deviation|0|||
127865845|NCT00266695|460125711|FG000|Overall Study|Adverse Event|1|||
127865846|NCT00266695|460125711|FG000|Overall Study|Death|9|||
127865847|NCT00266695|460125711|FG000|Overall Study|Physician Decision|1|||
127865848|NCT00266695|460125711|FG000|Overall Study|Lost to Follow-up|3|||
127865849|NCT00266695|460125711|FG000|Overall Study|Withdrawal by Subject|15|||
127865850|NCT02380703|460125712|FG000|Overall Study|Withdrawal by Subject|12|||
127865851|NCT02380703|460125713|FG001|Overall Study|Withdrawal by Subject|9|||
127865852|NCT02380703|460125712|FG000|Overall Study|Lost to Follow-up|12|||
127865853|NCT02380703|460125713|FG001|Overall Study|Lost to Follow-up|12|||
127865854|NCT02380703|460125712|FG000|Overall Study|Caregiver death|1|||
127865855|NCT02380703|460125713|FG001|Overall Study|Caregiver death|0|||
127865856|NCT02380703|460125712|FG000|Overall Study|Person with dementia (PWD) death|7|||
127865857|NCT02380703|460125713|FG001|Overall Study|Person with dementia (PWD) death|8|||
127865858|NCT02380703|460125712|FG000|Overall Study|Entered Long-term Care|4|||
127865859|NCT02380703|460125713|FG001|Overall Study|Entered Long-term Care|7|||
127865860|NCT03480841|460125714|FG000|Overall Study|Lost to Follow-up|2|||
127865861|NCT01362049|460125715|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
127865862|NCT01362049|460125716|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
127865863|NCT01362049|460125717|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
127865864|NCT01362049|460125718|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
127865865|NCT01362049|460125715|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
127865866|NCT01362049|460125716|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
127865867|NCT01362049|460125717|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
127865868|NCT01362049|460125718|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
127865869|NCT03607994|460125719|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
127865870|NCT03607994|460125720|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
127865871|NCT02417935|460125725|FG000|Treatment Period|Adverse Event|12|||
127865872|NCT02417935|460125726|FG001|Treatment Period|Adverse Event|10|||
127865873|NCT02417935|460125725|FG000|Treatment Period|Lost to Follow-up|1|||
127865874|NCT02417935|460125726|FG001|Treatment Period|Lost to Follow-up|0|||
127865875|NCT02417935|460125725|FG000|Treatment Period|Entry Criteria not met|0|||
127865876|NCT02417935|460125726|FG001|Treatment Period|Entry Criteria not met|1|||
127865877|NCT02417935|460125725|FG000|Treatment Period|Protocol Violation|2|||
127865878|NCT02417935|460125726|FG001|Treatment Period|Protocol Violation|1|||
127865879|NCT02417935|460125725|FG000|Treatment Period|Withdrawal by Subject|3|||
127865880|NCT02417935|460125726|FG001|Treatment Period|Withdrawal by Subject|3|||
127865881|NCT02417935|460125725|FG000|Treatment Period|Physician Decision|3|||
127865882|NCT02417935|460125726|FG001|Treatment Period|Physician Decision|1|||
127865883|NCT02850276|460125727|FG000|Overall Study|screen failure|43|||
127865884|NCT02850276|460125727|FG000|Overall Study|Withdrawal by Subject|14|||
127865885|NCT02850276|460125727|FG000|Overall Study|Physician Decision|2|||
127865886|NCT02850276|460125727|FG000|Overall Study|Lost to Follow-up|2|||
127865887|NCT01899729|460125730|FG000|Overall Study|Adverse Event|1|||
127865888|NCT01899729|460125731|FG001|Overall Study|Adverse Event|0|||
127865889|NCT01899729|460125732|FG002|Overall Study|Adverse Event|0|||
127865890|NCT01899729|460125733|FG003|Overall Study|Adverse Event|0|||
127865891|NCT01899729|460125734|FG004|Overall Study|Adverse Event|1|||
127865892|NCT01899729|460125730|FG000|Overall Study|Withdrawal by Subject|1|||
127865893|NCT01899729|460125731|FG001|Overall Study|Withdrawal by Subject|2|||
127865894|NCT01899729|460125732|FG002|Overall Study|Withdrawal by Subject|0|||
127865895|NCT01899729|460125733|FG003|Overall Study|Withdrawal by Subject|0|||
127865896|NCT01899729|460125734|FG004|Overall Study|Withdrawal by Subject|0|||
127865897|NCT01899729|460125730|FG000|Overall Study|Lack of Efficacy|0|||
127865898|NCT01899729|460125731|FG001|Overall Study|Lack of Efficacy|0|||
127865899|NCT01899729|460125732|FG002|Overall Study|Lack of Efficacy|2|||
127865900|NCT01899729|460125733|FG003|Overall Study|Lack of Efficacy|0|||
127865901|NCT01899729|460125734|FG004|Overall Study|Lack of Efficacy|1|||
127865902|NCT01454531|460125735|FG000|Overall Study|Adverse Event|14|||
127865903|NCT01454531|460125735|FG000|Overall Study|Withdrawal by Subject|5|||
127865904|NCT01454531|460125735|FG000|Overall Study|Lost to Follow-up|1|||
127915795|NCT01168856|460313359|FG001|Overall Study|Lost to Follow-up|34|||
127915796|NCT01168856|460313358|FG000|Overall Study|Withdrawal by Subject|6|||
127915797|NCT01168856|460313359|FG001|Overall Study|Withdrawal by Subject|8|||
127915798|NCT01168856|460313358|FG000|Overall Study|Physician Decision|2|||
127915799|NCT01168856|460313359|FG001|Overall Study|Physician Decision|1|||
127915800|NCT01168856|460313358|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
127915801|NCT01168856|460313359|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
127915802|NCT01168856|460313358|FG000|Overall Study|Participant received anti-HCV treatment|1|||
127915803|NCT01168856|460313359|FG001|Overall Study|Participant received anti-HCV treatment|0|||
127915804|NCT01168856|460313358|FG000|Overall Study|Death|0|||
127915805|NCT01168856|460313359|FG001|Overall Study|Death|2|||
127915806|NCT01168856|460313358|FG000|Overall Study|Other|1|||
127915807|NCT01168856|460313359|FG001|Overall Study|Other|291|||
127915808|NCT01168856|460313358|FG000|Overall Study|Protocol Violation|4|||
127915809|NCT01168856|460313359|FG001|Overall Study|Protocol Violation|6|||
127915810|NCT04567329|460313364|FG000|Overall Study|Withdrawal by Subject|5|||
127915811|NCT04567329|460313365|FG001|Overall Study|Withdrawal by Subject|6|||
127915812|NCT04567329|460313364|FG000|Overall Study|Protocol Violation|2|||
127915813|NCT04567329|460313365|FG001|Overall Study|Protocol Violation|3|||
127915814|NCT04567329|460313364|FG000|Overall Study|Discontinued|2|||
127915815|NCT04567329|460313365|FG001|Overall Study|Discontinued|2|||
127915816|NCT04567329|460313364|FG000|Overall Study|Lost to Follow-up|0|||
127915817|NCT04567329|460313365|FG001|Overall Study|Lost to Follow-up|1|||
127915818|NCT04567329|460313364|FG000|Overall Study|Lack of Efficacy|0|||
127865905|NCT01454531|460125735|FG000|Overall Study|Physician Decision|1|||
127865906|NCT01454531|460125735|FG000|Overall Study|Delay in IMP administration|1|||
127865907|NCT01454531|460125735|FG000|Overall Study|Other|1|||
127865908|NCT02504424|460125739|FG000|Overall Study|Withdrawal by Subject|2|||
127865909|NCT00440232|460125742|FG000|Overall Study|Lost to Follow-up|1|||
127865910|NCT00440232|460125743|FG001|Overall Study|Lost to Follow-up|1|||
127865911|NCT00440232|460125742|FG000|Overall Study|Unable to treat within allowed time|0|||
127865912|NCT00440232|460125743|FG001|Overall Study|Unable to treat within allowed time|1|||
127865913|NCT00440232|460125742|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
127865914|NCT00440232|460125743|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
127865915|NCT00426842|460125744|FG000|Overall Study|Lost to Follow-up|1|||
127865916|NCT00362297|460125745|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
127865917|NCT00362297|460125746|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
127865918|NCT01070381|460125747|FG000|Period 2, 1 Week of Wear|Handling|0|||
127865919|NCT01070381|460125748|FG001|Period 2, 1 Week of Wear|Handling|1|||
127865920|NCT01070381|460125747|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
127865921|NCT01070381|460125748|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
127865922|NCT01259388|460125752|FG000|Overall Study|Adverse Event|3|||
127865923|NCT01259388|460125753|FG001|Overall Study|Adverse Event|0|||
127865924|NCT01259388|460125752|FG000|Overall Study|Withdrawal by Subject|1|||
127865925|NCT01259388|460125753|FG001|Overall Study|Withdrawal by Subject|1|||
127865926|NCT01259388|460125752|FG000|Overall Study|Physician Decision|1|||
127865927|NCT01259388|460125753|FG001|Overall Study|Physician Decision|0|||
127865928|NCT02743494|460125754|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
127865929|NCT02743494|460125755|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
127865930|NCT02743494|460125754|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
127865931|NCT02743494|460125755|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
127865932|NCT02743494|460125754|FG000|Treatment Period|Completed treatment|229|||
127865933|NCT02743494|460125755|FG001|Treatment Period|Completed treatment|99|||
127865934|NCT02743494|460125754|FG000|Treatment Period|Disease recurrence|149|||
127865935|NCT02743494|460125755|FG001|Treatment Period|Disease recurrence|113|||
127865936|NCT02743494|460125754|FG000|Treatment Period|Study drug toxicity|57|||
127865937|NCT02743494|460125755|FG001|Treatment Period|Study drug toxicity|8|||
127865938|NCT02743494|460125754|FG000|Treatment Period|Death|1|||
127865939|NCT02743494|460125755|FG001|Treatment Period|Death|0|||
127865940|NCT02743494|460125754|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
127865941|NCT02743494|460125755|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
127865942|NCT02743494|460125754|FG000|Treatment Period|Participant request to discontinue treatment|30|||
127915819|NCT04567329|460313365|FG001|Overall Study|Lack of Efficacy|1|||
127915820|NCT00674128|460313367|FG000|Overall Study|Withdrawal by Subject|25|||
127915821|NCT00674128|460313368|FG001|Overall Study|Withdrawal by Subject|23|||
127915822|NCT00829452|460313372|FG000|First Intervention|Withdrawal by Subject|0|||
127915823|NCT00829452|460313373|FG001|First Intervention|Withdrawal by Subject|1|||
127915824|NCT00829452|460313372|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
127915825|NCT00829452|460313373|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
127915826|NCT00829452|460313372|FG000|Second Intervention|Physician Decision|0|||
127915827|NCT00829452|460313373|FG001|Second Intervention|Physician Decision|1|||
127915828|NCT02705716|460313376|FG000|Overall Study|Adverse Event|0|||
127915829|NCT02705716|460313377|FG001|Overall Study|Adverse Event|1|||
127915830|NCT02705716|460313376|FG000|Overall Study|Protocol Violation|3|||
127915831|NCT02705716|460313377|FG001|Overall Study|Protocol Violation|0|||
127915832|NCT02705716|460313376|FG000|Overall Study|Withdrawal of Consent|1|||
127915833|NCT02705716|460313377|FG001|Overall Study|Withdrawal of Consent|1|||
127915834|NCT00562718|460313379|FG000|Overall Study|Death|1|||
127915835|NCT00562718|460313379|FG000|Overall Study|Withdrawal by Subject|3|||
127915836|NCT00562718|460313379|FG000|Overall Study|Adverse Event|4|||
127915837|NCT00562718|460313379|FG000|Overall Study|Lack of Efficacy|2|||
127915838|NCT00562718|460313379|FG000|Overall Study|not stated|1|||
127915839|NCT01868243|460313380|FG000|Overall Study|Death|0|||
127915840|NCT01868243|460313381|FG001|Overall Study|Death|1|||
127915841|NCT01395017|460313382|FG000|Overall Study|Lost to Follow-up|1|||
127915842|NCT01395017|460313383|FG001|Overall Study|Lost to Follow-up|0|||
127915843|NCT01395017|460313382|FG000|Overall Study|Adverse Event|26|||
127915844|NCT01395017|460313383|FG001|Overall Study|Adverse Event|12|||
127915845|NCT01395017|460313382|FG000|Overall Study|Physician Decision|11|||
127915846|NCT01395017|460313383|FG001|Overall Study|Physician Decision|15|||
127915847|NCT01395017|460313382|FG000|Overall Study|Withdrawal by Subject|14|||
127915848|NCT01395017|460313383|FG001|Overall Study|Withdrawal by Subject|8|||
127915849|NCT01395017|460313382|FG000|Overall Study|Protocol deviation|1|||
127915850|NCT01395017|460313383|FG001|Overall Study|Protocol deviation|2|||
127915851|NCT01395017|460313382|FG000|Overall Study|Death|4|||
127915852|NCT01395017|460313383|FG001|Overall Study|Death|3|||
127915853|NCT01395017|460313382|FG000|Overall Study|Disease progression|42|||
127915854|NCT01395017|460313383|FG001|Overall Study|Disease progression|58|||
127915855|NCT01395017|460313382|FG000|Overall Study|Sponsor discontinued study|1|||
127915856|NCT01395017|460313383|FG001|Overall Study|Sponsor discontinued study|4|||
127915857|NCT00999687|460313387|FG000|First Intervention|Withdrawal by Subject|1|||
127915858|NCT00999687|460313387|FG000|Second Intervention|Withdrawal by Subject|2|||
127915859|NCT00999687|460313387|FG000|Second Intervention|Lack of Efficacy|1|||
127915860|NCT00474188|460313388|FG000|Overall Study|Withdrawal by Subject|1|||
127915861|NCT00474188|460313388|FG000|Overall Study|Study discontinued by sponsor|5|||
127915862|NCT03961204|460313391|FG000|Overall Study|Withdrawal by Subject|2|||
127915863|NCT03961204|460313391|FG000|Overall Study|Lost to Follow-up|3|||
127915864|NCT03961204|460313391|FG000|Overall Study|Other|1|||
127915865|NCT03961204|460313391|FG000|Overall Study|Missing|1|||
127915866|NCT01566435|460313395|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
127915867|NCT03684928|460313396|FG000|First Intervention|Lost to Follow-up|0|||
127915868|NCT03684928|460313397|FG001|First Intervention|Lost to Follow-up|1|||
127915869|NCT03684928|460313396|FG000|First Intervention|Withdrawal by Subject|0|||
127915870|NCT03684928|460313397|FG001|First Intervention|Withdrawal by Subject|2|||
127915871|NCT03684928|460313396|FG000|Second Intervention|Soft Tissue Injury|1|||
127915872|NCT03684928|460313397|FG001|Second Intervention|Soft Tissue Injury|0|||
127915873|NCT03733145|460313401|FG000|Overall Study|screenfail|3|||
127915874|NCT03733145|460313402|FG001|Overall Study|screenfail|3|||
127915875|NCT03733145|460313403|FG002|Overall Study|screenfail|2|||
127915876|NCT00798603|460314774|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
127915877|NCT00798603|460314774|FG000|Overall Study|Withdrawal by Subject|10|||
127915878|NCT00798603|460314774|FG000|Overall Study|Adverse Event|22|||
127915879|NCT00798603|460314774|FG000|Overall Study|Physician Decision|1|||
127915880|NCT00798603|460314774|FG000|Overall Study|Lack of insurance coverage|1|||
127915881|NCT00521586|460314775|FG000|Initial Vaccination (Year 0)|Subject request|8|||
127915882|NCT00521586|460314776|FG001|Initial Vaccination (Year 0)|Subject request|11|||
127915883|NCT00521586|460314775|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
127915884|NCT00521586|460314776|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
127915885|NCT00521586|460314775|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
127915886|NCT00521586|460314776|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
127915887|NCT00521586|460314775|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
127915888|NCT00521586|460314776|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
127915889|NCT00521586|460314775|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
127915890|NCT00521586|460314776|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
127915891|NCT00521586|460314775|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
127915892|NCT00521586|460314776|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
127915893|NCT00521586|460314775|FG000|Initial Vaccination (Year 0)|Death|1|||
127915894|NCT00521586|460314776|FG001|Initial Vaccination (Year 0)|Death|0|||
127915895|NCT00521586|460314775|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
127915896|NCT00521586|460314776|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
127915897|NCT00521586|460314775|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
127865943|NCT02743494|460125755|FG001|Treatment Period|Participant request to discontinue treatment|5|||
127915898|NCT00521586|460314776|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
127915899|NCT00521586|460314775|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
127915900|NCT00521586|460314776|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
127865944|NCT02743494|460125754|FG000|Treatment Period|Participant withdrew consent|12|||
127865945|NCT02743494|460125755|FG001|Treatment Period|Participant withdrew consent|4|||
127865946|NCT02743494|460125754|FG000|Treatment Period|Lost to Follow-up|0|||
127865947|NCT02743494|460125755|FG001|Treatment Period|Lost to Follow-up|1|||
127865948|NCT02743494|460125754|FG000|Treatment Period|Poor/Non-compliance|1|||
127865949|NCT02743494|460125755|FG001|Treatment Period|Poor/Non-compliance|0|||
127865950|NCT02743494|460125754|FG000|Treatment Period|Other reasons|7|||
127865951|NCT02743494|460125755|FG001|Treatment Period|Other reasons|2|||
127865952|NCT03529162|460125756|FG000|Overall Study|Lost to Follow-up|2|||
127915901|NCT00521586|460314775|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
127915902|NCT00521586|460314776|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
127915903|NCT00521586|460314775|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
127915904|NCT00521586|460314776|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
127915905|NCT00521586|460314775|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
127915906|NCT00521586|460314776|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
127915907|NCT00521586|460314775|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
127915908|NCT00521586|460314776|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
127915909|NCT00521586|460314775|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
127915910|NCT00521586|460314776|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
127915911|NCT00521586|460314775|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
127915912|NCT00521586|460314776|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
127915913|NCT00521586|460314775|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
127915914|NCT00521586|460314776|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
127915915|NCT00521586|460314775|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
127915916|NCT00521586|460314776|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
127915917|NCT00521586|460314775|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
127915918|NCT00521586|460314776|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
127915919|NCT03234907|460314777|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
127915920|NCT03234907|460314778|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
127915921|NCT03234907|460314779|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
127915922|NCT03234907|460314780|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
127915923|NCT03234907|460314781|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
127915924|NCT03234907|460314782|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
127915925|NCT03234907|460314777|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
127915926|NCT03234907|460314778|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
127915927|NCT03234907|460314779|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
127915928|NCT03234907|460314780|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
127915929|NCT03234907|460314781|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
127915930|NCT03234907|460314782|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
127915931|NCT03234907|460314777|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
127915932|NCT03234907|460314778|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
127915933|NCT03234907|460314779|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
127915934|NCT03234907|460314780|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
127915935|NCT03234907|460314781|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
127915936|NCT03234907|460314782|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
127915937|NCT03234907|460314777|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
127915938|NCT03234907|460314778|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
127915939|NCT03234907|460314779|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
127915940|NCT03234907|460314780|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
127915941|NCT03234907|460314781|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
127915942|NCT03234907|460314782|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
127865953|NCT03529162|460125757|FG001|Overall Study|Lost to Follow-up|2|||
127865954|NCT00983827|460125758|FG000|Overall Study|Withdrawal by Subject|1|||
127865955|NCT01521494|460125759|FG000|Overall Study|Adverse Event|1|||
127865956|NCT01521494|460125760|FG001|Overall Study|Adverse Event|2|||
127865957|NCT01521494|460125761|FG002|Overall Study|Adverse Event|9|||
127865958|NCT01521494|460125762|FG003|Overall Study|Adverse Event|6|||
127865959|NCT01521494|460125763|FG004|Overall Study|Adverse Event|2|||
127915943|NCT03234907|460314777|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
127915944|NCT03234907|460314778|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
127865960|NCT01521494|460125759|FG000|Overall Study|Lack of Efficacy|0|||
127915945|NCT03234907|460314779|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
127915946|NCT03234907|460314780|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
127915947|NCT03234907|460314781|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
127915948|NCT03234907|460314782|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
127915949|NCT03234907|460314777|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
127915950|NCT03234907|460314778|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
127915951|NCT03234907|460314779|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
127915952|NCT03234907|460314780|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
127915953|NCT03234907|460314781|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
127915954|NCT03234907|460314782|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
127915955|NCT03234907|460314777|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
127915956|NCT03234907|460314778|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
127915957|NCT03234907|460314779|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
127915958|NCT03234907|460314780|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
127915959|NCT03234907|460314781|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
127915960|NCT03234907|460314782|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
127915961|NCT00642993|460314783|FG000|Overall Study|Adverse Event|85|||
127915962|NCT00642993|460314784|FG001|Overall Study|Adverse Event|4|||
127915963|NCT00642993|460314783|FG000|Overall Study|Lost to Follow-up|8|||
127915964|NCT00642993|460314784|FG001|Overall Study|Lost to Follow-up|4|||
127915965|NCT00642993|460314783|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
127915966|NCT00642993|460314784|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
127915967|NCT00642993|460314783|FG000|Overall Study|Protocol Violation|1|||
127915968|NCT00642993|460314784|FG001|Overall Study|Protocol Violation|4|||
127915969|NCT00642993|460314783|FG000|Overall Study|Did not meet protocol eligibility|0|||
127915970|NCT00642993|460314784|FG001|Overall Study|Did not meet protocol eligibility|1|||
127915971|NCT00642993|460314783|FG000|Overall Study|Administrative|1|||
127915972|NCT00642993|460314784|FG001|Overall Study|Administrative|0|||
127915973|NCT02664415|460314785|FG000|Overall Study|Adverse Event|1|||
127915974|NCT02664415|460314786|FG001|Overall Study|Adverse Event|0|||
127915975|NCT02986139|460314790|FG000|Overall Study|Sponsor Decision|1|||
127915976|NCT02986139|460314791|FG001|Overall Study|Sponsor Decision|2|||
127915977|NCT02986139|460314790|FG000|Overall Study|Withdrawal by Subject|0|||
127915978|NCT02986139|460314791|FG001|Overall Study|Withdrawal by Subject|1|||
127915979|NCT02986139|460314790|FG000|Overall Study|Lost to Follow-up|0|||
127915980|NCT02986139|460314791|FG001|Overall Study|Lost to Follow-up|1|||
127915981|NCT00414726|460314792|FG000|Overall Study|Withdrawal by Subject|0|||
127915982|NCT00414726|460314793|FG001|Overall Study|Withdrawal by Subject|1|||
127915983|NCT02107196|460314794|FG000|12-week Treatment Period|Adverse Event|6|||
127915984|NCT02107196|460314795|FG001|12-week Treatment Period|Adverse Event|3|||
127915985|NCT02107196|460314794|FG000|12-week Treatment Period|Lack of Efficacy|2|||
127915986|NCT02107196|460314795|FG001|12-week Treatment Period|Lack of Efficacy|1|||
127915987|NCT02107196|460314794|FG000|12-week Treatment Period|Lost to Follow-up|3|||
127915988|NCT02107196|460314795|FG001|12-week Treatment Period|Lost to Follow-up|6|||
127915989|NCT02107196|460314794|FG000|12-week Treatment Period|Physician Decision|0|||
127915990|NCT02107196|460314795|FG001|12-week Treatment Period|Physician Decision|1|||
127915991|NCT02107196|460314794|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
127915992|NCT02107196|460314795|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
127915993|NCT02107196|460314794|FG000|12-week Treatment Period|Protocol Violation|7|||
127915994|NCT02107196|460314795|FG001|12-week Treatment Period|Protocol Violation|8|||
127915995|NCT02107196|460314794|FG000|12-week Treatment Period|Reason Missing|11|||
127915996|NCT02107196|460314795|FG001|12-week Treatment Period|Reason Missing|8|||
127915997|NCT02107196|460314794|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
127915998|NCT02107196|460314795|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
127915999|NCT02107196|460314794|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
127916000|NCT02107196|460314795|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
127916001|NCT02107196|460314794|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
127916002|NCT02107196|460314795|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
127916003|NCT02107196|460314794|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
127916004|NCT02107196|460314795|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
127916005|NCT00516295|460314796|FG000|Overall Study|Lack of Efficacy|2|||
127916006|NCT00516295|460314797|FG001|Overall Study|Lack of Efficacy|0|||
127916007|NCT00516295|460314798|FG002|Overall Study|Lack of Efficacy|0|||
127916008|NCT00516295|460314796|FG000|Overall Study|Ineligible|1|||
127916009|NCT00516295|460314797|FG001|Overall Study|Ineligible|0|||
127916010|NCT00516295|460314798|FG002|Overall Study|Ineligible|0|||
127916011|NCT02034513|460314799|FG000|Overall Study|Adverse Event|11|||
127916012|NCT02034513|460314800|FG001|Overall Study|Adverse Event|10|||
127916013|NCT02034513|460314799|FG000|Overall Study|Lack of Efficacy|0|||
127916014|NCT02034513|460314800|FG001|Overall Study|Lack of Efficacy|1|||
127916015|NCT02034513|460314799|FG000|Overall Study|Lost to Follow-up|6|||
127916016|NCT02034513|460314800|FG001|Overall Study|Lost to Follow-up|7|||
127865961|NCT01521494|460125760|FG001|Overall Study|Lack of Efficacy|0|||
127865962|NCT01521494|460125761|FG002|Overall Study|Lack of Efficacy|0|||
127865963|NCT01521494|460125762|FG003|Overall Study|Lack of Efficacy|0|||
127865964|NCT01521494|460125763|FG004|Overall Study|Lack of Efficacy|2|||
127865965|NCT01521494|460125759|FG000|Overall Study|Withdrawal by Subject|1|||
127865966|NCT01521494|460125760|FG001|Overall Study|Withdrawal by Subject|1|||
127865967|NCT01521494|460125761|FG002|Overall Study|Withdrawal by Subject|0|||
127865968|NCT01521494|460125762|FG003|Overall Study|Withdrawal by Subject|2|||
127865969|NCT01521494|460125763|FG004|Overall Study|Withdrawal by Subject|0|||
127865970|NCT01521494|460125759|FG000|Overall Study|Decrease in serum phosphate|0|||
127865971|NCT01521494|460125760|FG001|Overall Study|Decrease in serum phosphate|2|||
127865972|NCT01521494|460125761|FG002|Overall Study|Decrease in serum phosphate|3|||
127865973|NCT01521494|460125762|FG003|Overall Study|Decrease in serum phosphate|12|||
127865974|NCT01521494|460125763|FG004|Overall Study|Decrease in serum phosphate|0|||
127865975|NCT01521494|460125759|FG000|Overall Study|Decrease in serum calcium|0|||
127865976|NCT01521494|460125760|FG001|Overall Study|Decrease in serum calcium|0|||
127865977|NCT01521494|460125761|FG002|Overall Study|Decrease in serum calcium|0|||
127865978|NCT01521494|460125762|FG003|Overall Study|Decrease in serum calcium|1|||
127865979|NCT01521494|460125763|FG004|Overall Study|Decrease in serum calcium|1|||
127865980|NCT01521494|460125759|FG000|Overall Study|Physician Decision|0|||
127865981|NCT01521494|460125760|FG001|Overall Study|Physician Decision|0|||
127865982|NCT01521494|460125761|FG002|Overall Study|Physician Decision|0|||
127865983|NCT01521494|460125762|FG003|Overall Study|Physician Decision|0|||
127865984|NCT01521494|460125763|FG004|Overall Study|Physician Decision|2|||
127865985|NCT01503229|460127420|FG000|Overall Study|Withdrew consent|1|||
127865986|NCT01078389|460127421|FG000|Overall Study|Adverse Event|10|||
127865987|NCT01078389|460127422|FG001|Overall Study|Adverse Event|6|||
127865988|NCT01078389|460127421|FG000|Overall Study|Major Protocol Deviation|2|||
127865989|NCT01078389|460127422|FG001|Overall Study|Major Protocol Deviation|0|||
127865990|NCT01078389|460127421|FG000|Overall Study|Lost to Follow-up|23|||
127865991|NCT01078389|460127422|FG001|Overall Study|Lost to Follow-up|23|||
127865992|NCT01078389|460127421|FG000|Overall Study|Voluntary Withdrawal|20|||
127865993|NCT01078389|460127422|FG001|Overall Study|Voluntary Withdrawal|36|||
127865994|NCT01078389|460127421|FG000|Overall Study|Other|9|||
127865995|NCT01078389|460127422|FG001|Overall Study|Other|2|||
127865996|NCT02551874|460127423|FG000|Overall Study|Lost to Follow-up|0|||
127865997|NCT02551874|460127424|FG001|Overall Study|Lost to Follow-up|2|||
127865998|NCT02551874|460127423|FG000|Overall Study|Pregnancy|0|||
127865999|NCT02551874|460127424|FG001|Overall Study|Pregnancy|1|||
127866000|NCT02551874|460127423|FG000|Overall Study|Reason not reported|10|||
127866001|NCT02551874|460127424|FG001|Overall Study|Reason not reported|4|||
127866002|NCT02551874|460127423|FG000|Overall Study|Did not receive randomized treatment|0|||
127866003|NCT02551874|460127424|FG001|Overall Study|Did not receive randomized treatment|7|||
127866004|NCT02551874|460127423|FG000|Overall Study|Did not enter long-term study|18|||
127866005|NCT02551874|460127424|FG001|Overall Study|Did not enter long-term study|25|||
127866006|NCT01524900|460127425|FG000|Overall Study|Lost to Follow-up|3|||
127866007|NCT01524900|460127426|FG001|Overall Study|Lost to Follow-up|12|||
127866008|NCT01524900|460127427|FG002|Overall Study|Lost to Follow-up|1|||
127866009|NCT01524900|460127428|FG003|Overall Study|Lost to Follow-up|0|||
127866010|NCT01524900|460127429|FG004|Overall Study|Lost to Follow-up|0|||
127866011|NCT01524900|460127425|FG000|Overall Study|Other reason than stated above|1|||
127866012|NCT01524900|460127426|FG001|Overall Study|Other reason than stated above|1|||
127866013|NCT01524900|460127427|FG002|Overall Study|Other reason than stated above|0|||
127866014|NCT01524900|460127428|FG003|Overall Study|Other reason than stated above|0|||
127866015|NCT01524900|460127429|FG004|Overall Study|Other reason than stated above|0|||
127866016|NCT01524900|460127425|FG000|Overall Study|No reason documented|2|||
127866017|NCT01524900|460127426|FG001|Overall Study|No reason documented|1|||
127866018|NCT01524900|460127427|FG002|Overall Study|No reason documented|0|||
127866019|NCT01524900|460127428|FG003|Overall Study|No reason documented|1|||
127866020|NCT01524900|460127429|FG004|Overall Study|No reason documented|0|||
127866021|NCT00298766|460127430|FG000|Overall Study|Adverse Event|18|||
127866022|NCT00298766|460127430|FG000|Overall Study|Death|2|||
127866023|NCT00298766|460127430|FG000|Overall Study|Withdrawal by Subject|9|||
127866024|NCT00298766|460127430|FG000|Overall Study|Treatment ongoing|4|||
127866025|NCT00298766|460127430|FG000|Overall Study|Progression of amyloid markers|4|||
127866026|NCT00298766|460127430|FG000|Overall Study|Deterioration in KPS and organ function|1|||
127866027|NCT00298766|460127430|FG000|Overall Study|Subjects overall condition deterioration|4|||
127866028|NCT00298766|460127430|FG000|Overall Study|Other|4|||
127866029|NCT00386152|460127431|FG000|Overall Study|Adverse Event|6|||
127866030|NCT00386152|460127432|FG001|Overall Study|Adverse Event|5|||
127866031|NCT00386152|460127433|FG002|Overall Study|Adverse Event|4|||
127866032|NCT00386152|460127431|FG000|Overall Study|Chang from original chemo stratification|4|||
127866033|NCT00386152|460127432|FG001|Overall Study|Chang from original chemo stratification|5|||
127866034|NCT00386152|460127433|FG002|Overall Study|Chang from original chemo stratification|6|||
127866035|NCT00386152|460127431|FG000|Overall Study|Death|3|||
127866036|NCT00386152|460127432|FG001|Overall Study|Death|0|||
127866037|NCT00386152|460127433|FG002|Overall Study|Death|1|||
127866038|NCT00386152|460127431|FG000|Overall Study|Disease progression|7|||
127866039|NCT00386152|460127432|FG001|Overall Study|Disease progression|4|||
127866040|NCT00386152|460127433|FG002|Overall Study|Disease progression|5|||
127866041|NCT00386152|460127431|FG000|Overall Study|Physician Decision|13|||
127866042|NCT00386152|460127432|FG001|Overall Study|Physician Decision|10|||
127866043|NCT00386152|460127433|FG002|Overall Study|Physician Decision|4|||
127866044|NCT00386152|460127431|FG000|Overall Study|Lost to Follow-up|1|||
127866045|NCT00386152|460127432|FG001|Overall Study|Lost to Follow-up|0|||
127866046|NCT00386152|460127433|FG002|Overall Study|Lost to Follow-up|0|||
127866047|NCT00386152|460127431|FG000|Overall Study|Completed chemotherapy|4|||
127866048|NCT00386152|460127432|FG001|Overall Study|Completed chemotherapy|5|||
127866049|NCT00386152|460127433|FG002|Overall Study|Completed chemotherapy|1|||
127866050|NCT00386152|460127431|FG000|Overall Study|Protocol Violation|3|||
127866051|NCT00386152|460127432|FG001|Overall Study|Protocol Violation|5|||
127866052|NCT00386152|460127433|FG002|Overall Study|Protocol Violation|2|||
127866053|NCT00386152|460127431|FG000|Overall Study|Withdrawal by Subject|3|||
127866054|NCT00386152|460127432|FG001|Overall Study|Withdrawal by Subject|6|||
127866055|NCT00386152|460127433|FG002|Overall Study|Withdrawal by Subject|10|||
127866056|NCT03938857|460127437|FG000|Overall Study|Physician Decision|1|||
127866057|NCT03938857|460127438|FG001|Overall Study|Physician Decision|0|||
127866058|NCT03938857|460127439|FG002|Overall Study|Physician Decision|0|||
127866059|NCT03938857|460127440|FG003|Overall Study|Physician Decision|0|||
127866060|NCT02577107|460127441|FG000|Overall Study|Protocol deviation|0|||
127866061|NCT02577107|460127442|FG001|Overall Study|Protocol deviation|1|||
127866062|NCT00577382|460127443|FG000|Overall Study|Adverse Event|0|||
127866063|NCT00577382|460127444|FG001|Overall Study|Adverse Event|6|||
127866064|NCT00577382|460127443|FG000|Overall Study|Withdrawal by Subject|0|||
127866065|NCT00577382|460127444|FG001|Overall Study|Withdrawal by Subject|1|||
127866066|NCT00577382|460127443|FG000|Overall Study|Progressive Disease|17|||
127866067|NCT00577382|460127444|FG001|Overall Study|Progressive Disease|19|||
127866068|NCT00577382|460127443|FG000|Overall Study|Intercurrent Illness|1|||
127866069|NCT00577382|460127444|FG001|Overall Study|Intercurrent Illness|2|||
127866070|NCT00577382|460127443|FG000|Overall Study|Death|1|||
127866071|NCT00577382|460127444|FG001|Overall Study|Death|1|||
127866072|NCT00577382|460127443|FG000|Overall Study|Lost to Follow-up|2|||
127866073|NCT00577382|460127444|FG001|Overall Study|Lost to Follow-up|2|||
127866074|NCT00508872|460127445|FG000|Overall Study|Lost to Follow-up|1|||
127866075|NCT00508872|460127445|FG000|Overall Study|Physician Decision|1|||
127866076|NCT03007472|460127446|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
127866077|NCT03007472|460127446|FG000|Overall Study|Death|2|||
127866078|NCT03007472|460127446|FG000|Overall Study|Loss to Follow Up|1|||
127866079|NCT02988115|460127450|FG000|Overall Study|Adverse Event|6|||
127866080|NCT02988115|460127451|FG001|Overall Study|Adverse Event|1|||
127866081|NCT02988115|460127450|FG000|Overall Study|Sponsor Decision|5|||
127866082|NCT02988115|460127451|FG001|Overall Study|Sponsor Decision|2|||
127866083|NCT02988115|460127450|FG000|Overall Study|Withdrawal by Subject|1|||
127866084|NCT02988115|460127451|FG001|Overall Study|Withdrawal by Subject|1|||
127866085|NCT02988115|460127450|FG000|Overall Study|Withdrawn by Mistake|1|||
127866086|NCT02988115|460127451|FG001|Overall Study|Withdrawn by Mistake|0|||
127866087|NCT02988115|460127450|FG000|Overall Study|Lost to Follow-up|1|||
127866088|NCT02988115|460127451|FG001|Overall Study|Lost to Follow-up|0|||
127866089|NCT01731951|460127452|FG000|Overall Study|Documented Disease Progression|1|||
127916017|NCT02034513|460314799|FG000|Overall Study|Pregnancy|0|||
127916018|NCT02034513|460314800|FG001|Overall Study|Pregnancy|3|||
127916019|NCT02034513|460314799|FG000|Overall Study|Protocol Violation|7|||
127916020|NCT02034513|460314800|FG001|Overall Study|Protocol Violation|10|||
127916021|NCT02034513|460314799|FG000|Overall Study|Withdrawal by Subject|25|||
127916022|NCT02034513|460314800|FG001|Overall Study|Withdrawal by Subject|25|||
127916023|NCT02034513|460314799|FG000|Overall Study|Unclassified|0|||
127916024|NCT02034513|460314800|FG001|Overall Study|Unclassified|1|||
127916025|NCT03119662|460314803|FG000|Overall Study|Withdrawal by Subject|0|||
127916026|NCT03119662|460314804|FG001|Overall Study|Withdrawal by Subject|1|||
127916027|NCT02218541|460314805|FG000|Overall Study|Lost to Follow-up|2|||
127916028|NCT02218541|460314806|FG001|Overall Study|Lost to Follow-up|1|||
127916029|NCT02218541|460314805|FG000|Overall Study|Implant Failure|4|||
127916030|NCT02218541|460314806|FG001|Overall Study|Implant Failure|1|||
127916031|NCT00385736|460314807|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
127916032|NCT00385736|460314808|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
127916033|NCT00385736|460314809|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
127916034|NCT00385736|460314807|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
127916035|NCT00385736|460314808|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
127916036|NCT00385736|460314809|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
127916037|NCT00385736|460314807|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
127916038|NCT00385736|460314808|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
127916039|NCT00385736|460314809|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
127916040|NCT00385736|460314807|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
127916041|NCT00385736|460314808|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
127916042|NCT00385736|460314809|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
127916043|NCT00385736|460314807|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
127916044|NCT00385736|460314808|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
127916045|NCT00385736|460314809|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
127916046|NCT00385736|460314807|FG000|Efficacy Analysis Set - Induction|Other|0|||
127916047|NCT00385736|460314808|FG001|Efficacy Analysis Set - Induction|Other|0|||
127916048|NCT00385736|460314809|FG002|Efficacy Analysis Set - Induction|Other|1|||
127916049|NCT00385736|460314807|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
127916050|NCT00385736|460314808|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
127866090|NCT01731951|460127453|FG001|Overall Study|Documented Disease Progression|0|||
127866091|NCT01731951|460127454|FG002|Overall Study|Documented Disease Progression|0|||
127866092|NCT01731951|460127455|FG003|Overall Study|Documented Disease Progression|0|||
127866093|NCT01731951|460127456|FG004|Overall Study|Documented Disease Progression|0|||
127866094|NCT01731951|460127457|FG005|Overall Study|Documented Disease Progression|0|||
127866095|NCT01731951|460127452|FG000|Overall Study|Lost to Follow-up|2|||
127866096|NCT01731951|460127453|FG001|Overall Study|Lost to Follow-up|0|||
127866097|NCT01731951|460127454|FG002|Overall Study|Lost to Follow-up|0|||
127866098|NCT01731951|460127455|FG003|Overall Study|Lost to Follow-up|1|||
127866099|NCT01731951|460127456|FG004|Overall Study|Lost to Follow-up|3|||
127866100|NCT01731951|460127457|FG005|Overall Study|Lost to Follow-up|1|||
127866101|NCT01731951|460127452|FG000|Overall Study|Withdrawal of Consent|1|||
127866102|NCT01731951|460127453|FG001|Overall Study|Withdrawal of Consent|0|||
127866103|NCT01731951|460127454|FG002|Overall Study|Withdrawal of Consent|0|||
127866104|NCT01731951|460127455|FG003|Overall Study|Withdrawal of Consent|0|||
127866105|NCT01731951|460127456|FG004|Overall Study|Withdrawal of Consent|0|||
127866106|NCT01731951|460127457|FG005|Overall Study|Withdrawal of Consent|2|||
127866107|NCT01731951|460127452|FG000|Overall Study|Death|13|||
127866108|NCT01731951|460127453|FG001|Overall Study|Death|15|||
127866109|NCT01731951|460127454|FG002|Overall Study|Death|9|||
127866110|NCT01731951|460127455|FG003|Overall Study|Death|8|||
127866111|NCT01731951|460127456|FG004|Overall Study|Death|9|||
127866112|NCT01731951|460127457|FG005|Overall Study|Death|6|||
127866113|NCT01014442|460127458|FG000|Overall Study|Adverse Event|0|||
127866114|NCT01014442|460127459|FG001|Overall Study|Adverse Event|8|||
127866115|NCT01014442|460127458|FG000|Overall Study|Withdrawal by Subject|4|||
127866116|NCT01014442|460127459|FG001|Overall Study|Withdrawal by Subject|4|||
127866117|NCT01014442|460127458|FG000|Overall Study|Protocol Violation|2|||
127866118|NCT01014442|460127459|FG001|Overall Study|Protocol Violation|5|||
127866119|NCT01014442|460127458|FG000|Overall Study|Lack of Compliance|0|||
127866120|NCT01014442|460127459|FG001|Overall Study|Lack of Compliance|1|||
127866121|NCT01014442|460127458|FG000|Overall Study|Unspecified Reason|1|||
127866122|NCT01014442|460127459|FG001|Overall Study|Unspecified Reason|1|||
127866123|NCT01220024|460127466|FG000|Overall Study|Lost to Follow-up|1|||
127866124|NCT01220024|460127467|FG001|Overall Study|Lost to Follow-up|1|||
127866125|NCT00490815|460127468|FG000|Overall Study|Adverse Event|2|||
127866126|NCT00490815|460127469|FG001|Overall Study|Adverse Event|3|||
127866127|NCT00490815|460127468|FG000|Overall Study|Withdrawal by Subject|4|||
127866128|NCT00490815|460127469|FG001|Overall Study|Withdrawal by Subject|0|||
127866129|NCT00490815|460127468|FG000|Overall Study|Lost to Follow-up|1|||
127866130|NCT00490815|460127469|FG001|Overall Study|Lost to Follow-up|3|||
127866131|NCT00490815|460127468|FG000|Overall Study|Death|1|||
127866132|NCT00490815|460127469|FG001|Overall Study|Death|3|||
127866133|NCT01756846|460127470|FG000|Overall Study|Lost to Follow-up|5|||
127866134|NCT01756846|460127471|FG001|Overall Study|Lost to Follow-up|10|||
127866135|NCT01756846|460127470|FG000|Overall Study|Withdrawal by Subject|1|||
127866136|NCT01756846|460127471|FG001|Overall Study|Withdrawal by Subject|2|||
127866137|NCT01284127|460127472|FG000|Overall Study|Adverse Event|2|||
127866138|NCT01284127|460127472|FG000|Overall Study|Withdrawal by Subject|4|||
127866139|NCT01284127|460127472|FG000|Overall Study|Physician Decision|1|||
127866140|NCT04212221|460127475|FG000|Overall Study|Remained on Treatment|0|||
127866141|NCT04212221|460127476|FG001|Overall Study|Remained on Treatment|0|||
127866142|NCT04212221|460127477|FG002|Overall Study|Remained on Treatment|0|||
127866143|NCT04212221|460127478|FG003|Overall Study|Remained on Treatment|1|||
127866144|NCT04212221|460127479|FG004|Overall Study|Remained on Treatment|0|||
127866145|NCT04212221|460127480|FG005|Overall Study|Remained on Treatment|0|||
127866146|NCT04212221|460127481|FG006|Overall Study|Remained on Treatment|3|||
127866147|NCT04212221|460127482|FG007|Overall Study|Remained on Treatment|9|||
127866148|NCT04212221|460127475|FG000|Overall Study|Adverse Event|0|||
127866149|NCT04212221|460127476|FG001|Overall Study|Adverse Event|0|||
127866150|NCT04212221|460127477|FG002|Overall Study|Adverse Event|0|||
127866151|NCT04212221|460127478|FG003|Overall Study|Adverse Event|0|||
127866152|NCT04212221|460127479|FG004|Overall Study|Adverse Event|0|||
127866153|NCT04212221|460127480|FG005|Overall Study|Adverse Event|0|||
127866154|NCT04212221|460127481|FG006|Overall Study|Adverse Event|2|||
127866155|NCT04212221|460127482|FG007|Overall Study|Adverse Event|3|||
127866156|NCT04212221|460127475|FG000|Overall Study|Death|0|||
127866157|NCT04212221|460127476|FG001|Overall Study|Death|0|||
127866158|NCT04212221|460127477|FG002|Overall Study|Death|0|||
127866159|NCT04212221|460127478|FG003|Overall Study|Death|0|||
127866160|NCT04212221|460127479|FG004|Overall Study|Death|0|||
127866161|NCT04212221|460127480|FG005|Overall Study|Death|0|||
127866162|NCT04212221|460127481|FG006|Overall Study|Death|0|||
127866163|NCT04212221|460127482|FG007|Overall Study|Death|2|||
127866164|NCT04212221|460127475|FG000|Overall Study|Disease progression according to irRECIST|1|||
127866165|NCT04212221|460127476|FG001|Overall Study|Disease progression according to irRECIST|2|||
127866166|NCT04212221|460127477|FG002|Overall Study|Disease progression according to irRECIST|3|||
127866167|NCT04212221|460127478|FG003|Overall Study|Disease progression according to irRECIST|3|||
127866168|NCT04212221|460127479|FG004|Overall Study|Disease progression according to irRECIST|2|||
127866169|NCT04212221|460127480|FG005|Overall Study|Disease progression according to irRECIST|2|||
127866170|NCT04212221|460127481|FG006|Overall Study|Disease progression according to irRECIST|21|||
127866171|NCT04212221|460127482|FG007|Overall Study|Disease progression according to irRECIST|17|||
127866172|NCT04212221|460127475|FG000|Overall Study|Global Deterioration of Health Status|0|||
127866173|NCT04212221|460127476|FG001|Overall Study|Global Deterioration of Health Status|0|||
127866174|NCT04212221|460127477|FG002|Overall Study|Global Deterioration of Health Status|0|||
127866175|NCT04212221|460127478|FG003|Overall Study|Global Deterioration of Health Status|0|||
127866176|NCT04212221|460127479|FG004|Overall Study|Global Deterioration of Health Status|0|||
127866177|NCT04212221|460127480|FG005|Overall Study|Global Deterioration of Health Status|0|||
127866178|NCT04212221|460127481|FG006|Overall Study|Global Deterioration of Health Status|0|||
127866179|NCT04212221|460127482|FG007|Overall Study|Global Deterioration of Health Status|2|||
127866180|NCT04212221|460127475|FG000|Overall Study|Investigator's Decision|0|||
127866181|NCT04212221|460127476|FG001|Overall Study|Investigator's Decision|0|||
127866182|NCT04212221|460127477|FG002|Overall Study|Investigator's Decision|0|||
127866183|NCT04212221|460127478|FG003|Overall Study|Investigator's Decision|1|||
127866184|NCT04212221|460127479|FG004|Overall Study|Investigator's Decision|0|||
127866185|NCT04212221|460127480|FG005|Overall Study|Investigator's Decision|0|||
127866186|NCT04212221|460127481|FG006|Overall Study|Investigator's Decision|3|||
127866187|NCT04212221|460127482|FG007|Overall Study|Investigator's Decision|0|||
127866188|NCT04212221|460127475|FG000|Overall Study|Participant refused to continue treatment|0|||
127866189|NCT04212221|460127476|FG001|Overall Study|Participant refused to continue treatment|1|||
127866190|NCT04212221|460127477|FG002|Overall Study|Participant refused to continue treatment|0|||
127866191|NCT04212221|460127478|FG003|Overall Study|Participant refused to continue treatment|1|||
127866192|NCT04212221|460127479|FG004|Overall Study|Participant refused to continue treatment|1|||
127866193|NCT04212221|460127480|FG005|Overall Study|Participant refused to continue treatment|2|||
127866194|NCT04212221|460127481|FG006|Overall Study|Participant refused to continue treatment|4|||
127866195|NCT04212221|460127482|FG007|Overall Study|Participant refused to continue treatment|2|||
127866196|NCT04212221|460127475|FG000|Overall Study|Protocol Violation|0|||
127866197|NCT04212221|460127476|FG001|Overall Study|Protocol Violation|0|||
127866198|NCT04212221|460127477|FG002|Overall Study|Protocol Violation|0|||
127866199|NCT04212221|460127478|FG003|Overall Study|Protocol Violation|0|||
127866200|NCT04212221|460127479|FG004|Overall Study|Protocol Violation|0|||
127866201|NCT04212221|460127480|FG005|Overall Study|Protocol Violation|0|||
127866202|NCT04212221|460127481|FG006|Overall Study|Protocol Violation|0|||
127866203|NCT04212221|460127482|FG007|Overall Study|Protocol Violation|1|||
127916051|NCT00385736|460314809|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
127916052|NCT00385736|460314807|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
127916053|NCT00385736|460314808|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
127916054|NCT00385736|460314809|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
127916055|NCT00385736|460314807|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
127916056|NCT00385736|460314808|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
127916057|NCT00385736|460314809|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
127916058|NCT00385736|460314807|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
127916059|NCT00385736|460314808|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
127916060|NCT00385736|460314809|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
127916061|NCT00385736|460314807|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
127866204|NCT00636506|460127491|FG000|Overall Study|Lost to Follow-up|8|||
127866205|NCT00636506|460127491|FG000|Overall Study|Explanted|1|||
127866206|NCT00636506|460127491|FG000|Overall Study|Withdrawal by Subject|6|||
127866207|NCT00636506|460127491|FG000|Overall Study|Procedure aborted|1|||
127866208|NCT03742271|460127492|FG000|Overall Study|Unsatisfactory Visual Response|1|||
127866209|NCT03742271|460127492|FG000|Overall Study|Withdrawal by Subject|3|||
127866210|NCT03742271|460127492|FG000|Overall Study|Lost to Follow-up|4|||
127866211|NCT03742271|460127492|FG000|Overall Study|Failed Insertion & removal|3|||
127866212|NCT03742271|460127492|FG000|Overall Study|Protocol Violation|1|||
127866213|NCT01624974|460127495|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
127866214|NCT01624974|460127496|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
127866215|NCT01624974|460127495|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
127866216|NCT01624974|460127496|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
127866217|NCT01624974|460127495|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
127866218|NCT01624974|460127496|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
127866219|NCT01624974|460127495|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
127866220|NCT01624974|460127496|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
127866221|NCT01624974|460127495|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
127866222|NCT01624974|460127496|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
127866223|NCT01624974|460127495|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
127866224|NCT01624974|460127496|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
127866225|NCT01624974|460127495|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
127866226|NCT01624974|460127496|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
127866227|NCT01624974|460127495|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
127866228|NCT01624974|460127496|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
127866229|NCT01624974|460127495|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
127866230|NCT01624974|460127496|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
127866231|NCT01624974|460127495|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
127866232|NCT01624974|460127496|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
127866233|NCT01624974|460127495|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
127866234|NCT01624974|460127496|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
127866235|NCT01624974|460127495|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
127866236|NCT01624974|460127496|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
127866237|NCT01376908|460127497|FG000|Overall Study|Protocol Violation|1|||
127866238|NCT01376908|460127498|FG001|Overall Study|Protocol Violation|1|||
127866239|NCT01376908|460127497|FG000|Overall Study|Withdrawal by Subject|1|||
127866240|NCT01376908|460127498|FG001|Overall Study|Withdrawal by Subject|2|||
127866241|NCT01468844|460127499|FG000|Overall Study|Adverse Event|1|||
127866242|NCT01468844|460127500|FG001|Overall Study|Adverse Event|0|||
127866243|NCT01468844|460127499|FG000|Overall Study|Withdrawal by Subject|1|||
127866244|NCT01468844|460127500|FG001|Overall Study|Withdrawal by Subject|0|||
127866245|NCT02142712|460127501|FG000|Overall Study|Lost to Follow-up|1|||
127866246|NCT02142712|460127502|FG001|Overall Study|Lost to Follow-up|1|||
127916062|NCT00385736|460314808|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
127866247|NCT02142712|460127503|FG002|Overall Study|Lost to Follow-up|1|||
127866248|NCT02142712|460127504|FG003|Overall Study|Lost to Follow-up|0|||
127866249|NCT02853318|460127506|FG000|Overall Study|Withdrawal by Subject|1|||
127866250|NCT00252499|460127514|FG000|Overall Study|Lost to Follow-up|1|||
127866251|NCT00252499|460127515|FG001|Overall Study|Lost to Follow-up|0|||
127866252|NCT00252499|460127516|FG002|Overall Study|Lost to Follow-up|0|||
127866253|NCT02646332|460127517|FG000|Overall Study|Lost to Follow-up|0|||
127866254|NCT02646332|460127518|FG001|Overall Study|Lost to Follow-up|3|||
127866255|NCT04490499|460127519|FG000|Overall Study|Withdrawal by Subject|2|||
127866256|NCT01882439|460127522|FG000|Overall Study|Adverse event related to study drug|3|||
127866257|NCT01882439|460127523|FG001|Overall Study|Adverse event related to study drug|8|||
127866258|NCT01882439|460127524|FG002|Overall Study|Adverse event related to study drug|1|||
127866259|NCT01882439|460127525|FG003|Overall Study|Adverse event related to study drug|2|||
127866260|NCT01882439|460127522|FG000|Overall Study|Pregnancy|0|||
127866261|NCT01882439|460127523|FG001|Overall Study|Pregnancy|1|||
127866262|NCT01882439|460127524|FG002|Overall Study|Pregnancy|0|||
127866263|NCT01882439|460127525|FG003|Overall Study|Pregnancy|0|||
127866264|NCT01882439|460127522|FG000|Overall Study|Protocol Violation|2|||
127866265|NCT01882439|460127523|FG001|Overall Study|Protocol Violation|2|||
127866266|NCT01882439|460127524|FG002|Overall Study|Protocol Violation|0|||
127866267|NCT01882439|460127525|FG003|Overall Study|Protocol Violation|1|||
127866268|NCT01882439|460127522|FG000|Overall Study|No longer willing to participate|1|||
127866269|NCT01882439|460127523|FG001|Overall Study|No longer willing to participate|4|||
127866270|NCT01882439|460127524|FG002|Overall Study|No longer willing to participate|2|||
127866271|NCT01882439|460127525|FG003|Overall Study|No longer willing to participate|3|||
127866272|NCT01882439|460127522|FG000|Overall Study|Medication error with no associated AE|0|||
127866273|NCT01882439|460127523|FG001|Overall Study|Medication error with no associated AE|0|||
127866274|NCT01882439|460127524|FG002|Overall Study|Medication error with no associated AE|2|||
127866275|NCT01882439|460127525|FG003|Overall Study|Medication error with no associated AE|0|||
127866276|NCT01882439|460127522|FG000|Overall Study|Insufficient clinical response|1|||
127866277|NCT01882439|460127523|FG001|Overall Study|Insufficient clinical response|4|||
127866278|NCT01882439|460127524|FG002|Overall Study|Insufficient clinical response|4|||
127866279|NCT01882439|460127525|FG003|Overall Study|Insufficient clinical response|2|||
127866280|NCT01882439|460127522|FG000|Overall Study|Adverse event unrelated to study drug|2|||
127866281|NCT01882439|460127523|FG001|Overall Study|Adverse event unrelated to study drug|2|||
127866282|NCT01882439|460127524|FG002|Overall Study|Adverse event unrelated to study drug|1|||
127866283|NCT01882439|460127525|FG003|Overall Study|Adverse event unrelated to study drug|1|||
127866284|NCT03125902|460127528|FG000|Overall Study|Adverse Event|0|||
127866285|NCT03125902|460127529|FG001|Overall Study|Adverse Event|1|||
127866286|NCT03125902|460127528|FG000|Overall Study|Death|119|||
127866287|NCT03125902|460127529|FG001|Overall Study|Death|229|||
127866288|NCT03125902|460127528|FG000|Overall Study|Lost to Follow-up|4|||
127866289|NCT03125902|460127529|FG001|Overall Study|Lost to Follow-up|13|||
127866290|NCT03125902|460127528|FG000|Overall Study|Other|0|||
127866291|NCT03125902|460127529|FG001|Overall Study|Other|4|||
127866292|NCT03125902|460127528|FG000|Overall Study|Physician Decision|2|||
127866293|NCT03125902|460127529|FG001|Overall Study|Physician Decision|1|||
127866294|NCT03125902|460127528|FG000|Overall Study|Progressive Disease|0|||
127866295|NCT03125902|460127529|FG001|Overall Study|Progressive Disease|3|||
127866296|NCT03125902|460127528|FG000|Overall Study|Study Terminated By Sponsor|74|||
127866297|NCT03125902|460127529|FG001|Overall Study|Study Terminated By Sponsor|143|||
127866298|NCT03125902|460127528|FG000|Overall Study|Withdrawal by Subject|21|||
127866299|NCT03125902|460127529|FG001|Overall Study|Withdrawal by Subject|37|||
127866300|NCT01997333|460127530|FG000|Randomization and Treatment|Disease Progression|70|||
127866301|NCT01997333|460127531|FG001|Randomization and Treatment|Disease Progression|159|||
127866302|NCT01997333|460127530|FG000|Randomization and Treatment|Adverse Event|10|||
127866303|NCT01997333|460127531|FG001|Randomization and Treatment|Adverse Event|32|||
127866304|NCT01997333|460127530|FG000|Randomization and Treatment|Physician Decision|0|||
127866305|NCT01997333|460127531|FG001|Randomization and Treatment|Physician Decision|4|||
127866306|NCT01997333|460127530|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
127866307|NCT01997333|460127531|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
127866308|NCT01997333|460127530|FG000|Randomization and Treatment|Did not receive treatment|17|||
127866309|NCT01997333|460127531|FG001|Randomization and Treatment|Did not receive treatment|5|||
127866310|NCT01997333|460127530|FG000|Survival Follow up|Withdrawal by Subject|15|||
127866311|NCT01997333|460127531|FG001|Survival Follow up|Withdrawal by Subject|6|||
127866312|NCT01997333|460127530|FG000|Survival Follow up|Lost to Follow-up|0|||
127866313|NCT01997333|460127531|FG001|Survival Follow up|Lost to Follow-up|6|||
127866314|NCT01997333|460127530|FG000|Survival Follow up|Various|1|||
127866315|NCT01997333|460127531|FG001|Survival Follow up|Various|2|||
127866316|NCT02269709|460127532|FG000|Time of Enrollment|Withdrawal by Subject|3|||
127866317|NCT02269709|460127532|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
127866318|NCT02269709|460127532|FG000|Six Month Follow-up|Lost to Follow-up|12|||
127866319|NCT01843933|460127533|FG000|Overall Study|Data lost|6|||
127866320|NCT01843933|460127534|FG001|Overall Study|Data lost|4|||
127866321|NCT02909504|460127535|FG000|Overall Study|Adverse Event|2|||
127866322|NCT02909504|460127535|FG000|Overall Study|Lack of Efficacy|3|||
127916063|NCT00385736|460314809|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
127866323|NCT02909504|460127535|FG000|Overall Study|Withdrawal by Subject|4|||
127866324|NCT02909504|460127535|FG000|Overall Study|Pregnancy|1|||
127866325|NCT02909504|460127535|FG000|Overall Study|Subject moved|1|||
127866326|NCT02909504|460127535|FG000|Overall Study|Lost to Follow-up|1|||
127866327|NCT04411472|460127537|FG000|Overall Study|Adverse Event|5|||
127866328|NCT04411472|460127538|FG001|Overall Study|Adverse Event|10|||
127866329|NCT04411472|460127539|FG002|Overall Study|Adverse Event|1|||
127866330|NCT04411472|460127540|FG003|Overall Study|Adverse Event|0|||
127866331|NCT04411472|460127541|FG004|Overall Study|Adverse Event|0|||
127866332|NCT04411472|460127542|FG005|Overall Study|Adverse Event|0|||
127866333|NCT04411472|460127537|FG000|Overall Study|Protocol Violation|1|||
127866334|NCT04411472|460127538|FG001|Overall Study|Protocol Violation|0|||
127866335|NCT04411472|460127539|FG002|Overall Study|Protocol Violation|0|||
127866336|NCT04411472|460127540|FG003|Overall Study|Protocol Violation|0|||
127866337|NCT04411472|460127541|FG004|Overall Study|Protocol Violation|0|||
127866338|NCT04411472|460127542|FG005|Overall Study|Protocol Violation|0|||
127866339|NCT04411472|460127537|FG000|Overall Study|Withdrawal by Subject|0|||
127866340|NCT04411472|460127538|FG001|Overall Study|Withdrawal by Subject|1|||
127866341|NCT04411472|460127539|FG002|Overall Study|Withdrawal by Subject|0|||
127866342|NCT04411472|460127540|FG003|Overall Study|Withdrawal by Subject|1|||
127866343|NCT04411472|460127541|FG004|Overall Study|Withdrawal by Subject|0|||
127866344|NCT04411472|460127542|FG005|Overall Study|Withdrawal by Subject|0|||
127866345|NCT04411472|460127537|FG000|Overall Study|Physician Decision|1|||
127866346|NCT04411472|460127538|FG001|Overall Study|Physician Decision|0|||
127866347|NCT04411472|460127539|FG002|Overall Study|Physician Decision|0|||
127866348|NCT04411472|460127540|FG003|Overall Study|Physician Decision|0|||
127866349|NCT04411472|460127541|FG004|Overall Study|Physician Decision|0|||
127866350|NCT04411472|460127542|FG005|Overall Study|Physician Decision|0|||
127866351|NCT04411472|460127537|FG000|Overall Study|Study terminated by sponsor|17|||
127866352|NCT04411472|460127538|FG001|Overall Study|Study terminated by sponsor|20|||
127866353|NCT04411472|460127539|FG002|Overall Study|Study terminated by sponsor|3|||
127866354|NCT04411472|460127540|FG003|Overall Study|Study terminated by sponsor|0|||
127866355|NCT04411472|460127541|FG004|Overall Study|Study terminated by sponsor|0|||
127866356|NCT04411472|460127542|FG005|Overall Study|Study terminated by sponsor|0|||
127866357|NCT05060003|460127543|FG000|Overall Study|ctDNA negative|7|||
127866358|NCT00819052|460127544|FG000|Overall Study|Adverse Event|0|||
127866359|NCT00819052|460127545|FG001|Overall Study|Adverse Event|5|||
127866360|NCT00819052|460127544|FG000|Overall Study|Protocol Violation|1|||
127866361|NCT00819052|460127545|FG001|Overall Study|Protocol Violation|2|||
127866362|NCT00819052|460127544|FG000|Overall Study|Lost to Follow-up|1|||
127866363|NCT00819052|460127545|FG001|Overall Study|Lost to Follow-up|2|||
127866364|NCT00819052|460127544|FG000|Overall Study|Withdrawal by Subject|1|||
127866365|NCT00819052|460127545|FG001|Overall Study|Withdrawal by Subject|2|||
127866366|NCT00819052|460127544|FG000|Overall Study|Lack of Efficacy|1|||
127866367|NCT00819052|460127545|FG001|Overall Study|Lack of Efficacy|1|||
127866368|NCT00819052|460127544|FG000|Overall Study|Pregnancy|1|||
127866369|NCT00819052|460127545|FG001|Overall Study|Pregnancy|2|||
127866370|NCT00819052|460127544|FG000|Overall Study|Death or events leading to death|1|||
127866371|NCT00819052|460127545|FG001|Overall Study|Death or events leading to death|0|||
127866372|NCT01277666|460127550|FG000|Overall Study|Adverse Event|26|||
127866373|NCT01277666|460127551|FG001|Overall Study|Adverse Event|25|||
127866374|NCT01277666|460127552|FG002|Overall Study|Adverse Event|20|||
127866375|NCT01277666|460127550|FG000|Overall Study|Lack of Efficacy|8|||
127866376|NCT01277666|460127551|FG001|Overall Study|Lack of Efficacy|20|||
127866377|NCT01277666|460127552|FG002|Overall Study|Lack of Efficacy|12|||
127866378|NCT01277666|460127550|FG000|Overall Study|Protocol Violation|2|||
127866379|NCT01277666|460127551|FG001|Overall Study|Protocol Violation|3|||
127866380|NCT01277666|460127552|FG002|Overall Study|Protocol Violation|2|||
127866381|NCT01277666|460127550|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
127866382|NCT01277666|460127551|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
127866383|NCT01277666|460127552|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
127866384|NCT01277666|460127550|FG000|Overall Study|Lost to Follow-up|1|||
127866385|NCT01277666|460127551|FG001|Overall Study|Lost to Follow-up|1|||
127866386|NCT01277666|460127552|FG002|Overall Study|Lost to Follow-up|2|||
127866387|NCT01277666|460127550|FG000|Overall Study|Withdrawal by Subject|7|||
127866388|NCT01277666|460127551|FG001|Overall Study|Withdrawal by Subject|8|||
127866389|NCT01277666|460127552|FG002|Overall Study|Withdrawal by Subject|6|||
127866390|NCT01277666|460127550|FG000|Overall Study|Death|0|||
127866391|NCT01277666|460127551|FG001|Overall Study|Death|0|||
127866392|NCT01277666|460127552|FG002|Overall Study|Death|1|||
127866393|NCT01747655|460127553|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
127866394|NCT01747655|460127554|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
127866395|NCT01747655|460127553|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
127866396|NCT01747655|460127554|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
127866397|NCT01747655|460127553|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
127866398|NCT01747655|460127554|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
127866399|NCT00982111|460127555|FG000|Overall Study|Adverse Event|1|||
127866400|NCT00982111|460127556|FG001|Overall Study|Adverse Event|1|||
127916064|NCT00385736|460314807|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
127916065|NCT00385736|460314808|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
127916066|NCT00385736|460314809|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
127916067|NCT00385736|460314807|FG000|Safety Analysis Set|Adverse Event|23|||
127916068|NCT00385736|460314808|FG001|Safety Analysis Set|Adverse Event|15|||
127916069|NCT00385736|460314809|FG002|Safety Analysis Set|Adverse Event|23|||
127916070|NCT00385736|460314807|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
127916071|NCT00385736|460314808|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
127916072|NCT00385736|460314809|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
127916073|NCT00385736|460314807|FG000|Safety Analysis Set|Lost to Follow-up|0|||
127916074|NCT00385736|460314808|FG001|Safety Analysis Set|Lost to Follow-up|2|||
127916075|NCT00385736|460314809|FG002|Safety Analysis Set|Lost to Follow-up|2|||
127916076|NCT00385736|460314807|FG000|Safety Analysis Set|Lack of Efficacy|38|||
127916077|NCT00385736|460314808|FG001|Safety Analysis Set|Lack of Efficacy|16|||
127916078|NCT00385736|460314809|FG002|Safety Analysis Set|Lack of Efficacy|31|||
127916079|NCT00385736|460314807|FG000|Safety Analysis Set|Protocol Violation|2|||
127916080|NCT00385736|460314808|FG001|Safety Analysis Set|Protocol Violation|1|||
127916081|NCT00385736|460314809|FG002|Safety Analysis Set|Protocol Violation|6|||
127916082|NCT00385736|460314807|FG000|Safety Analysis Set|Other|1|||
127916083|NCT00385736|460314808|FG001|Safety Analysis Set|Other|4|||
127916084|NCT00385736|460314809|FG002|Safety Analysis Set|Other|4|||
127916085|NCT01557751|460314810|FG000|Overall Study|Physician Decision|3|||
127916086|NCT00835666|460314811|FG000|Washout|Protocol Violation|1|||
127916087|NCT00835666|460314812|FG001|Washout|Protocol Violation|0|||
127916088|NCT00835666|460314811|FG000|Washout|Withdrawal by Subject|1|||
127916089|NCT00835666|460314812|FG001|Washout|Withdrawal by Subject|0|||
127916090|NCT03599362|460314813|FG000|Overall Study|Screen Failure|3|||
127916091|NCT03707587|460314814|FG000|Overall Study|Death|0|||
127916092|NCT03707587|460314815|FG001|Overall Study|Death|1|||
127916093|NCT04442503|460314824|FG000|Overall Study|Adverse Event|1|||
127916094|NCT04442503|460314825|FG001|Overall Study|Adverse Event|1|||
127916095|NCT04442503|460314824|FG000|Overall Study|Lost to Follow-up|8|||
127916096|NCT04442503|460314825|FG001|Overall Study|Lost to Follow-up|6|||
127916097|NCT04442503|460314824|FG000|Overall Study|Physician Decision|0|||
127916098|NCT04442503|460314825|FG001|Overall Study|Physician Decision|2|||
127916099|NCT04442503|460314824|FG000|Overall Study|Withdrawal by Subject|3|||
127916100|NCT04442503|460314825|FG001|Overall Study|Withdrawal by Subject|4|||
127916101|NCT04442503|460314824|FG000|Overall Study|Reason not Specified|0|||
127916102|NCT04442503|460314825|FG001|Overall Study|Reason not Specified|1|||
127916103|NCT04442503|460314824|FG000|Overall Study|Randomized but not Treated|3|||
127916104|NCT04442503|460314825|FG001|Overall Study|Randomized but not Treated|1|||
127916105|NCT00387153|460314826|FG000|Overall Study|Adverse Event|1|||
127916106|NCT00387153|460314826|FG000|Overall Study|Disease Progression|3|||
127916107|NCT00387153|460314826|FG000|Overall Study|Lack of Response|4|||
127916108|NCT02933060|460314827|FG000|Overall Study|Withdrawal by Subject|0|||
127916109|NCT02933060|460314828|FG001|Overall Study|Withdrawal by Subject|1|||
127916110|NCT01945580|460314829|FG000|Overall Study|Withdrawal by Subject|13|||
127916111|NCT01945580|460314830|FG001|Overall Study|Withdrawal by Subject|35|||
127916112|NCT01945580|460314829|FG000|Overall Study|Physician Decision|3|||
127916113|NCT01945580|460314830|FG001|Overall Study|Physician Decision|2|||
127916114|NCT01945580|460314829|FG000|Overall Study|Lost to Follow-up|26|||
127916115|NCT01945580|460314830|FG001|Overall Study|Lost to Follow-up|39|||
127916116|NCT01945580|460314829|FG000|Overall Study|Death|7|||
127916117|NCT01945580|460314830|FG001|Overall Study|Death|2|||
127916118|NCT01945580|460314829|FG000|Overall Study|Patient moved out of state|0|||
127916119|NCT01945580|460314830|FG001|Overall Study|Patient moved out of state|1|||
127916120|NCT01945580|460314829|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
127916121|NCT01945580|460314830|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
127916122|NCT01945580|460314829|FG000|Overall Study|Family illness - unable to return|0|||
127916123|NCT01945580|460314830|FG001|Overall Study|Family illness - unable to return|1|||
127916124|NCT01945580|460314829|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
127916125|NCT01945580|460314830|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
127916126|NCT01945580|460314829|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
127916127|NCT01945580|460314830|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
127866401|NCT00982111|460127555|FG000|Overall Study|Progressive Disease|46|||
127866402|NCT00982111|460127556|FG001|Overall Study|Progressive Disease|39|||
127866403|NCT00982111|460127555|FG000|Overall Study|Lost to Follow-up|9|||
127866404|NCT00982111|460127556|FG001|Overall Study|Lost to Follow-up|6|||
127866405|NCT00982111|460127555|FG000|Overall Study|New Anti-Cancer Therapy|5|||
127866406|NCT00982111|460127556|FG001|Overall Study|New Anti-Cancer Therapy|5|||
127866407|NCT00982111|460127555|FG000|Overall Study|Medical Decision|1|||
127866408|NCT00982111|460127556|FG001|Overall Study|Medical Decision|0|||
127866409|NCT00982111|460127555|FG000|Overall Study|Withdrawal by Subject|17|||
127866410|NCT00982111|460127556|FG001|Overall Study|Withdrawal by Subject|19|||
127866411|NCT00982111|460127555|FG000|Overall Study|Global Study End|0|||
127866412|NCT00982111|460127556|FG001|Overall Study|Global Study End|1|||
127866413|NCT00982111|460127555|FG000|Overall Study|Sponsor's Decision|0|||
127866414|NCT00982111|460127556|FG001|Overall Study|Sponsor's Decision|1|||
127866415|NCT03512028|460127557|FG000|Overall Study|Withdrawal by Subject|2|||
127866416|NCT03512028|460127558|FG001|Overall Study|Withdrawal by Subject|0|||
127866417|NCT03512028|460127557|FG000|Overall Study|Protocol Violation|2|||
127866418|NCT03512028|460127558|FG001|Overall Study|Protocol Violation|0|||
127866419|NCT01854918|460127561|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
127866420|NCT01854918|460127562|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
127866421|NCT01854918|460127561|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
127866422|NCT01854918|460127562|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
127866423|NCT01854918|460127561|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
127866424|NCT01854918|460127562|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
127866425|NCT01854918|460127561|FG000|SOC-controlled Period (Year 1)|Death|5|||
127866426|NCT01854918|460127562|FG001|SOC-controlled Period (Year 1)|Death|5|||
127866427|NCT01854918|460127561|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
127866428|NCT01854918|460127562|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
127866429|NCT01854918|460127561|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
127866430|NCT01854918|460127562|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
127866431|NCT01854918|460127561|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
127866432|NCT01854918|460127562|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
127866433|NCT01854918|460127561|FG000|All-IP Period (Years 2 and 3)|Death|5|||
127866434|NCT01854918|460127562|FG001|All-IP Period (Years 2 and 3)|Death|16|||
127866435|NCT02146352|460127563|FG000|Overall Study|Death|1|||
127866436|NCT02146352|460127563|FG000|Overall Study|Patient entered hospice care|1|||
127866437|NCT00939094|460127564|FG000|Overall Study|Adverse Event|9|||
127866438|NCT00939094|460127565|FG001|Overall Study|Adverse Event|0|||
127866439|NCT00939094|460127564|FG000|Overall Study|Withdrawal by Subject|1|||
127866440|NCT00939094|460127565|FG001|Overall Study|Withdrawal by Subject|6|||
127866441|NCT00939094|460127564|FG000|Overall Study|Lost to Follow-up|1|||
127866442|NCT00939094|460127565|FG001|Overall Study|Lost to Follow-up|1|||
127866443|NCT00939094|460127564|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
127866444|NCT00939094|460127565|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
127866445|NCT00939094|460127564|FG000|Overall Study|Severe non-compliance to protocol|0|||
127866446|NCT00939094|460127565|FG001|Overall Study|Severe non-compliance to protocol|1|||
127866447|NCT00939094|460127564|FG000|Overall Study|Study stopped by sponsor|0|||
127866448|NCT00939094|460127565|FG001|Overall Study|Study stopped by sponsor|2|||
127866449|NCT00939094|460127564|FG000|Overall Study|Abnormal ECG findings|1|||
127866450|NCT00939094|460127565|FG001|Overall Study|Abnormal ECG findings|0|||
127866451|NCT01906489|460127566|FG000|Overall Study|Adverse Event|10|||
127866452|NCT01906489|460127567|FG001|Overall Study|Adverse Event|3|||
127866453|NCT01906489|460127566|FG000|Overall Study|Worsening of CKD|6|||
127866454|NCT01906489|460127567|FG001|Overall Study|Worsening of CKD|4|||
127866455|NCT01906489|460127566|FG000|Overall Study|Withdrawal by Subject|5|||
127866456|NCT01906489|460127567|FG001|Overall Study|Withdrawal by Subject|0|||
127866457|NCT01906489|460127566|FG000|Overall Study|Worsening of Anemia|1|||
127866458|NCT01906489|460127567|FG001|Overall Study|Worsening of Anemia|0|||
127866459|NCT01906489|460127566|FG000|Overall Study|Protocol Violation|0|||
127866460|NCT01906489|460127567|FG001|Overall Study|Protocol Violation|1|||
127866461|NCT01906489|460127566|FG000|Overall Study|Non- Compliance|1|||
127866462|NCT01906489|460127567|FG001|Overall Study|Non- Compliance|0|||
127866463|NCT01906489|460127566|FG000|Overall Study|Sponsor Decision|1|||
127866464|NCT01906489|460127567|FG001|Overall Study|Sponsor Decision|0|||
127866465|NCT01906489|460127566|FG000|Overall Study|Lost to Follow-up|1|||
127866466|NCT01906489|460127567|FG001|Overall Study|Lost to Follow-up|1|||
127866467|NCT01906489|460127566|FG000|Overall Study|Other|1|||
127866468|NCT01906489|460127567|FG001|Overall Study|Other|0|||
127866469|NCT01002573|460130229|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
127866470|NCT01002573|460130230|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
127866471|NCT02028182|460130231|FG000|Overall Study|Protocol Violation|2|||
127916128|NCT01945580|460314829|FG000|Overall Study|Noncompliance with 36 month visit|1|||
127916129|NCT01945580|460314830|FG001|Overall Study|Noncompliance with 36 month visit|0|||
127916130|NCT01945580|460314829|FG000|Overall Study|The patient moved.|1|||
127916131|NCT01945580|460314830|FG001|Overall Study|The patient moved.|0|||
127916132|NCT01945580|460314829|FG000|Overall Study|No data available|0|||
127916133|NCT01945580|460314830|FG001|Overall Study|No data available|2|||
127916134|NCT05034874|460314833|FG000|Overall Study|Withdrawal by Subject|6|||
127916135|NCT05034874|460314834|FG001|Overall Study|Withdrawal by Subject|6|||
127916136|NCT05034874|460314833|FG000|Overall Study|Lost to Follow-up|18|||
127916137|NCT05034874|460314834|FG001|Overall Study|Lost to Follow-up|8|||
127916138|NCT05034874|460314833|FG000|Overall Study|Physician Decision|0|||
127916139|NCT05034874|460314834|FG001|Overall Study|Physician Decision|1|||
127916140|NCT05034874|460314833|FG000|Overall Study|Skipped final visits, checked into rehab|2|||
127916141|NCT05034874|460314834|FG001|Overall Study|Skipped final visits, checked into rehab|1|||
127916142|NCT00989950|460314835|FG000|Randomized Phase|Protocol Violation|1|||
127916143|NCT00989950|460314836|FG001|Randomized Phase|Protocol Violation|0|||
127916144|NCT00989950|460314837|FG002|Randomized Phase|Protocol Violation|0|||
127916145|NCT00989950|460314838|FG003|Randomized Phase|Protocol Violation|0|||
127916146|NCT00989950|460314835|FG000|Randomized Phase|Adverse Event|0|||
127916147|NCT00989950|460314836|FG001|Randomized Phase|Adverse Event|1|||
127916148|NCT00989950|460314837|FG002|Randomized Phase|Adverse Event|0|||
127916149|NCT00989950|460314838|FG003|Randomized Phase|Adverse Event|0|||
127916150|NCT00101439|460314839|FG000|Period 2|Withdrawal by Subject|0|||
127916151|NCT00101439|460314840|FG001|Period 2|Withdrawal by Subject|2|||
127916152|NCT00840658|460314842|FG000|Overall Study|Death|2|||
127916153|NCT00840658|460314843|FG001|Overall Study|Death|2|||
127916154|NCT00840658|460314844|FG002|Overall Study|Death|3|||
127916155|NCT00840658|460314845|FG003|Overall Study|Death|3|||
127916156|NCT00840658|460314842|FG000|Overall Study|Lost to Follow-up|3|||
127916157|NCT00840658|460314843|FG001|Overall Study|Lost to Follow-up|1|||
127916158|NCT00840658|460314844|FG002|Overall Study|Lost to Follow-up|2|||
127916159|NCT00840658|460314845|FG003|Overall Study|Lost to Follow-up|1|||
127916160|NCT01867658|460314846|FG000|Overall Study|Withdrawal by Subject|6|||
127916161|NCT01867658|460314846|FG000|Overall Study|Death|2|||
127916162|NCT01867658|460314846|FG000|Overall Study|Subject could not be contacted|1|||
127916163|NCT00474058|460314847|FG000|Overall Study|Adverse Event|11|||
127916164|NCT00474058|460314848|FG001|Overall Study|Adverse Event|6|||
127916165|NCT00474058|460314847|FG000|Overall Study|Lack of Efficacy|0|||
127916166|NCT00474058|460314848|FG001|Overall Study|Lack of Efficacy|4|||
127916167|NCT00474058|460314847|FG000|Overall Study|Withdrawal by Subject|11|||
127916168|NCT00474058|460314848|FG001|Overall Study|Withdrawal by Subject|7|||
127916169|NCT00474058|460314847|FG000|Overall Study|Other|2|||
127916170|NCT00474058|460314848|FG001|Overall Study|Other|0|||
127916171|NCT03101358|460314849|FG000|Overall Study|Non-compliance with study schedule|1|||
127916172|NCT03101358|460314850|FG001|Overall Study|Non-compliance with study schedule|0|||
127916173|NCT03101358|460314851|FG002|Overall Study|Non-compliance with study schedule|0|||
127916174|NCT03101358|460314852|FG003|Overall Study|Non-compliance with study schedule|1|||
127916175|NCT03101358|460314849|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
127916176|NCT03101358|460314850|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
127866472|NCT02198040|460130234|FG000|Overall Study|Work reasons|0|||
127866473|NCT02198040|460130235|FG001|Overall Study|Work reasons|1|||
127866474|NCT02198040|460130236|FG002|Overall Study|Work reasons|0|||
127866475|NCT02198040|460130234|FG000|Overall Study|Withdrawal by Subject|0|||
127866476|NCT02198040|460130235|FG001|Overall Study|Withdrawal by Subject|0|||
127866477|NCT02198040|460130236|FG002|Overall Study|Withdrawal by Subject|1|||
127866478|NCT04524663|460130237|FG000|Overall Study|Withdrawal by Subject|0|||
127866479|NCT04524663|460130238|FG001|Overall Study|Withdrawal by Subject|2|||
127866480|NCT00337935|460130239|FG000|Overall Study|Adverse Event|2|||
127866481|NCT00337935|460130240|FG001|Overall Study|Adverse Event|5|||
127866482|NCT00337935|460130239|FG000|Overall Study|Death|2|||
127866483|NCT00337935|460130240|FG001|Overall Study|Death|8|||
127866484|NCT00337935|460130239|FG000|Overall Study|Physician Decision|1|||
127866485|NCT00337935|460130240|FG001|Overall Study|Physician Decision|1|||
127866486|NCT00337935|460130239|FG000|Overall Study|Lost to Follow-up|0|||
127916177|NCT03101358|460314851|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
127916178|NCT03101358|460314852|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
127916179|NCT03101358|460314849|FG000|Overall Study|Physician Decision|1|||
127916180|NCT03101358|460314850|FG001|Overall Study|Physician Decision|0|||
127916181|NCT03101358|460314851|FG002|Overall Study|Physician Decision|0|||
127916182|NCT03101358|460314852|FG003|Overall Study|Physician Decision|3|||
127866487|NCT00337935|460130240|FG001|Overall Study|Lost to Follow-up|1|||
127866488|NCT00337935|460130239|FG000|Overall Study|Protocol Violation|4|||
127866489|NCT00337935|460130240|FG001|Overall Study|Protocol Violation|3|||
127916183|NCT03101358|460314849|FG000|Overall Study|Adverse Event|0|||
127916184|NCT03101358|460314850|FG001|Overall Study|Adverse Event|0|||
127916185|NCT03101358|460314851|FG002|Overall Study|Adverse Event|1|||
127916186|NCT03101358|460314852|FG003|Overall Study|Adverse Event|0|||
127916187|NCT03101358|460314849|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
127916188|NCT03101358|460314850|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
127916189|NCT03101358|460314851|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
127916190|NCT03101358|460314852|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
127916191|NCT03101358|460314849|FG000|Overall Study|Lost to Follow-up|1|||
127916192|NCT03101358|460314850|FG001|Overall Study|Lost to Follow-up|0|||
127916193|NCT03101358|460314851|FG002|Overall Study|Lost to Follow-up|0|||
127916194|NCT03101358|460314852|FG003|Overall Study|Lost to Follow-up|1|||
127916195|NCT05616728|460314853|FG000|Overall Study|Lost to Follow-up|0|||
127916196|NCT05616728|460314854|FG001|Overall Study|Lost to Follow-up|0|||
127916197|NCT05616728|460314855|FG002|Overall Study|Lost to Follow-up|1|||
127916198|NCT05616728|460314853|FG000|Overall Study|Withdrawal by Subject|1|||
127916199|NCT05616728|460314854|FG001|Overall Study|Withdrawal by Subject|1|||
127916200|NCT05616728|460314855|FG002|Overall Study|Withdrawal by Subject|0|||
127916201|NCT05616728|460314853|FG000|Overall Study|Physician Decision|1|||
127916202|NCT05616728|460314854|FG001|Overall Study|Physician Decision|1|||
127916203|NCT05616728|460314855|FG002|Overall Study|Physician Decision|1|||
127916204|NCT05616728|460314853|FG000|Overall Study|Other|0|||
127916205|NCT05616728|460314854|FG001|Overall Study|Other|2|||
127916206|NCT05616728|460314855|FG002|Overall Study|Other|0|||
127916207|NCT01024855|460314858|FG000|Overall Study|Inclusion/exclusion criteria|1|||
127916208|NCT03306277|460314863|FG000|Overall Study|Death|1|||
127916209|NCT03306277|460314863|FG000|Overall Study|Adverse Event|1|||
127916210|NCT03306277|460314863|FG000|Overall Study|Withdrawal by Subject|1|||
127916211|NCT00881751|460314872|FG000|Overall Study|Physician Decision|0|||
127916212|NCT00881751|460314873|FG001|Overall Study|Physician Decision|1|||
127916213|NCT00881751|460314872|FG000|Overall Study|Adverse Event|0|||
127916214|NCT00881751|460314873|FG001|Overall Study|Adverse Event|2|||
127916215|NCT00881751|460314872|FG000|Overall Study|Withdrawal by Subject|0|||
127916216|NCT00881751|460314873|FG001|Overall Study|Withdrawal by Subject|2|||
127916217|NCT02385708|460314875|FG000|Overall Study|Withdrawal by Subject|0|||
127916218|NCT02385708|460314876|FG001|Overall Study|Withdrawal by Subject|2|||
127916219|NCT02385708|460314875|FG000|Overall Study|Withdrawn - surgery canceled|2|||
127916220|NCT02385708|460314876|FG001|Overall Study|Withdrawn - surgery canceled|5|||
127916221|NCT02385708|460314875|FG000|Overall Study|Investigator decision|5|||
127916222|NCT02385708|460314876|FG001|Overall Study|Investigator decision|7|||
127916223|NCT02385708|460314875|FG000|Overall Study|Protocol Violation|1|||
127916224|NCT02385708|460314876|FG001|Overall Study|Protocol Violation|1|||
127916225|NCT01559363|460314883|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
127916226|NCT01559363|460314884|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
127916227|NCT01559363|460314885|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
127916228|NCT01559363|460314886|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
127916229|NCT01559363|460314887|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
127916230|NCT01559363|460314888|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
127916231|NCT01559363|460314883|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
127916232|NCT01559363|460314884|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
127916233|NCT01559363|460314885|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
127916234|NCT01559363|460314886|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
127916235|NCT01559363|460314887|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
127916236|NCT01559363|460314888|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
127916237|NCT01559363|460314883|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
127916238|NCT01559363|460314884|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
127916239|NCT01559363|460314885|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
127866490|NCT00337935|460130239|FG000|Overall Study|Withdrawal by Subject|1|||
127866491|NCT00337935|460130240|FG001|Overall Study|Withdrawal by Subject|7|||
127866492|NCT00337935|460130239|FG000|Overall Study|Other|0|||
127866493|NCT00337935|460130240|FG001|Overall Study|Other|1|||
127866494|NCT00337935|460130239|FG000|Overall Study|Lack of Efficacy|0|||
127866495|NCT00337935|460130240|FG001|Overall Study|Lack of Efficacy|1|||
127866496|NCT01884675|460130241|FG000|Overall Study|Study closed/terminated|3|||
127866497|NCT01884675|460130242|FG001|Overall Study|Study closed/terminated|2|||
127866498|NCT02361307|460130243|FG000|Overall Study|Unstable medical condition.|0|||
127866499|NCT02361307|460130244|FG001|Overall Study|Unstable medical condition.|1|||
127866500|NCT00711009|460130245|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
127866501|NCT00711009|460130246|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
127866502|NCT00711009|460130245|FG000|Overall Study|Withdrawal by Subject|4|||
127866503|NCT00711009|460130246|FG001|Overall Study|Withdrawal by Subject|2|||
127866504|NCT00711009|460130245|FG000|Overall Study|Lost to Follow-up|3|||
127866505|NCT00711009|460130246|FG001|Overall Study|Lost to Follow-up|9|||
127866506|NCT00711009|460130245|FG000|Overall Study|Participant Noncompliant|0|||
127866507|NCT00711009|460130246|FG001|Overall Study|Participant Noncompliant|1|||
127866508|NCT00711009|460130245|FG000|Overall Study|Virologic Failure|2|||
127866509|NCT00711009|460130246|FG001|Overall Study|Virologic Failure|1|||
127866510|NCT00711009|460130245|FG000|Overall Study|Pregnancy|1|||
127866511|NCT00711009|460130246|FG001|Overall Study|Pregnancy|0|||
127866512|NCT00711009|460130245|FG000|Overall Study|Site closing|0|||
127866513|NCT00711009|460130246|FG001|Overall Study|Site closing|1|||
127866514|NCT00711009|460130245|FG000|Overall Study|Dose adjustment|1|||
127866515|NCT00711009|460130246|FG001|Overall Study|Dose adjustment|0|||
127866516|NCT03359811|460130247|FG000|Overall Study|Protocol Violation|2|||
127866517|NCT03359811|460130248|FG001|Overall Study|Protocol Violation|0|||
127866518|NCT01682876|460130249|FG000|Overall Study|Administrative reason|4|||
127866519|NCT01682876|460130250|FG001|Overall Study|Administrative reason|4|||
127866520|NCT01682876|460130251|FG002|Overall Study|Administrative reason|0|||
127866521|NCT01682876|460130252|FG003|Overall Study|Administrative reason|3|||
127866522|NCT01682876|460130249|FG000|Overall Study|Adverse Event|0|||
127866523|NCT01682876|460130250|FG001|Overall Study|Adverse Event|0|||
127866524|NCT01682876|460130251|FG002|Overall Study|Adverse Event|0|||
127866525|NCT01682876|460130252|FG003|Overall Study|Adverse Event|1|||
127866526|NCT01682876|460130249|FG000|Overall Study|Lost to Follow-up|11|||
127866527|NCT01682876|460130250|FG001|Overall Study|Lost to Follow-up|15|||
127866528|NCT01682876|460130251|FG002|Overall Study|Lost to Follow-up|9|||
127866529|NCT01682876|460130252|FG003|Overall Study|Lost to Follow-up|11|||
127866530|NCT01682876|460130249|FG000|Overall Study|Protocol Violation|1|||
127866531|NCT01682876|460130250|FG001|Overall Study|Protocol Violation|1|||
127866532|NCT01682876|460130251|FG002|Overall Study|Protocol Violation|1|||
127866533|NCT01682876|460130252|FG003|Overall Study|Protocol Violation|1|||
127866534|NCT01682876|460130249|FG000|Overall Study|Withdrawal by Subject|4|||
127866535|NCT01682876|460130250|FG001|Overall Study|Withdrawal by Subject|0|||
127866536|NCT01682876|460130251|FG002|Overall Study|Withdrawal by Subject|0|||
127866537|NCT01682876|460130252|FG003|Overall Study|Withdrawal by Subject|2|||
127866538|NCT01682876|460130249|FG000|Overall Study|Other|1|||
127866539|NCT01682876|460130250|FG001|Overall Study|Other|0|||
127866540|NCT01682876|460130251|FG002|Overall Study|Other|1|||
127866541|NCT01682876|460130252|FG003|Overall Study|Other|1|||
127866542|NCT02534324|460130254|FG000|Overall Study|Protocol Violation|4|||
127866543|NCT02534324|460130255|FG001|Overall Study|Protocol Violation|1|||
127866544|NCT02534324|460130254|FG000|Overall Study|Lost to Follow-up|20|||
127866545|NCT02534324|460130255|FG001|Overall Study|Lost to Follow-up|7|||
127866546|NCT02534324|460130254|FG000|Overall Study|Adverse Event|1|||
127866547|NCT02534324|460130255|FG001|Overall Study|Adverse Event|0|||
127866548|NCT01459016|460130258|FG000|Overall Study|Withdrawal by Subject|11|||
127866549|NCT01459016|460130258|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
127866550|NCT00303602|460130262|FG000|Overall Study|Adverse Event|2|||
127866551|NCT00303602|460130263|FG001|Overall Study|Adverse Event|2|||
127866552|NCT00303602|460130262|FG000|Overall Study|Withdrawal by Subject|5|||
127866553|NCT00303602|460130263|FG001|Overall Study|Withdrawal by Subject|6|||
127866554|NCT00303602|460130262|FG000|Overall Study|Lost to Follow-up|5|||
127866555|NCT00303602|460130263|FG001|Overall Study|Lost to Follow-up|2|||
127866556|NCT00303602|460130262|FG000|Overall Study|Protocol entry criteria not met|2|||
127866557|NCT00303602|460130263|FG001|Overall Study|Protocol entry criteria not met|2|||
127866558|NCT00303602|460130262|FG000|Overall Study|Physician Decision|2|||
127866559|NCT00303602|460130263|FG001|Overall Study|Physician Decision|1|||
127866560|NCT00303602|460130262|FG000|Overall Study|Noncompliance|2|||
127866561|NCT00303602|460130263|FG001|Overall Study|Noncompliance|2|||
127866562|NCT00303602|460130262|FG000|Overall Study|Protocol Violation|1|||
127866563|NCT00303602|460130263|FG001|Overall Study|Protocol Violation|0|||
127866564|NCT00240331|460130266|FG000|Overall Study|Withdrawal by Subject|125|||
127866565|NCT00240331|460130267|FG001|Overall Study|Withdrawal by Subject|132|||
127866566|NCT00240331|460130266|FG000|Overall Study|Option selected by investigator|1|||
127866567|NCT00240331|460130267|FG001|Overall Study|Option selected by investigator|2|||
127866568|NCT02491463|460130268|FG000|Overall Study|Withdrawal by Subject|1|||
127866569|NCT02491463|460130269|FG001|Overall Study|Withdrawal by Subject|2|||
127866570|NCT02491463|460130270|FG002|Overall Study|Withdrawal by Subject|0|||
127866571|NCT02491463|460130271|FG003|Overall Study|Withdrawal by Subject|0|||
127866572|NCT02491463|460130268|FG000|Overall Study|Migrated/moved from study area|1|||
127866573|NCT02491463|460130269|FG001|Overall Study|Migrated/moved from study area|5|||
127866574|NCT02491463|460130270|FG002|Overall Study|Migrated/moved from study area|1|||
127866575|NCT02491463|460130271|FG003|Overall Study|Migrated/moved from study area|1|||
127866576|NCT02491463|460130268|FG000|Overall Study|Lost to Follow-up|0|||
127866577|NCT02491463|460130269|FG001|Overall Study|Lost to Follow-up|3|||
127866578|NCT02491463|460130270|FG002|Overall Study|Lost to Follow-up|3|||
127866579|NCT02491463|460130271|FG003|Overall Study|Lost to Follow-up|0|||
127866580|NCT01491802|460130272|FG000|Overall Study|Adverse Event|1|||
127866581|NCT01491802|460130273|FG001|Overall Study|Adverse Event|1|||
127866582|NCT01491802|460130272|FG000|Overall Study|Withdrawal by Subject|0|||
127866583|NCT01491802|460130273|FG001|Overall Study|Withdrawal by Subject|1|||
127866584|NCT00663208|460130276|FG000|Treatment Period|Lost to Follow-up|0|||
127866585|NCT00663208|460130277|FG001|Treatment Period|Lost to Follow-up|1|||
127866586|NCT00663208|460130278|FG002|Treatment Period|Lost to Follow-up|0|||
127866587|NCT00663208|460130279|FG003|Treatment Period|Lost to Follow-up|0|||
127916240|NCT01559363|460314886|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
127916241|NCT01559363|460314887|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
127916242|NCT01559363|460314888|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
127916243|NCT01559363|460314883|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
127916244|NCT01559363|460314884|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
127916245|NCT01559363|460314885|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
127916246|NCT01559363|460314886|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
127916247|NCT01559363|460314887|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
127916248|NCT01559363|460314888|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
127916249|NCT01559363|460314883|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
127916250|NCT01559363|460314884|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
127916251|NCT01559363|460314885|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
127916252|NCT01559363|460314886|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
127916253|NCT01559363|460314887|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
127916254|NCT01559363|460314888|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
127916255|NCT01559363|460314883|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
127916256|NCT01559363|460314884|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
127916257|NCT01559363|460314885|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
127916258|NCT01559363|460314886|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
127916259|NCT01559363|460314887|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
127916260|NCT01559363|460314888|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
127916261|NCT01559363|460314883|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
127916262|NCT01559363|460314884|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
127916263|NCT01559363|460314885|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
127916264|NCT01559363|460314886|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
127916265|NCT01559363|460314887|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
127916266|NCT01559363|460314888|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
127916267|NCT00672984|460314889|FG000|First Intervention|Adverse Event|5|||
127916268|NCT00672984|460314890|FG001|First Intervention|Adverse Event|0|||
127866588|NCT00663208|460130280|FG004|Treatment Period|Lost to Follow-up|0|||
127916269|NCT00672984|460314891|FG002|First Intervention|Adverse Event|0|||
127916270|NCT00672984|460314889|FG000|First Intervention|Withdrawal by Subject|1|||
127916271|NCT00672984|460314890|FG001|First Intervention|Withdrawal by Subject|2|||
127916272|NCT00672984|460314891|FG002|First Intervention|Withdrawal by Subject|2|||
127866589|NCT00663208|460130281|FG005|Treatment Period|Lost to Follow-up|0|||
127866590|NCT00663208|460130282|FG006|Treatment Period|Lost to Follow-up|0|||
127866591|NCT00663208|460130276|FG000|Follow-up Period|Lost to Follow-up|2|||
127866592|NCT00663208|460130277|FG001|Follow-up Period|Lost to Follow-up|0|||
127866593|NCT00663208|460130278|FG002|Follow-up Period|Lost to Follow-up|3|||
127866594|NCT00663208|460130279|FG003|Follow-up Period|Lost to Follow-up|2|||
127866595|NCT00663208|460130280|FG004|Follow-up Period|Lost to Follow-up|0|||
127866596|NCT00663208|460130281|FG005|Follow-up Period|Lost to Follow-up|0|||
127866597|NCT00663208|460130282|FG006|Follow-up Period|Lost to Follow-up|0|||
127866598|NCT00663208|460130276|FG000|Follow-up Period|Other reason|1|||
127866599|NCT00663208|460130277|FG001|Follow-up Period|Other reason|0|||
127866600|NCT00663208|460130278|FG002|Follow-up Period|Other reason|0|||
127866601|NCT00663208|460130279|FG003|Follow-up Period|Other reason|0|||
127866602|NCT00663208|460130280|FG004|Follow-up Period|Other reason|0|||
127866603|NCT00663208|460130281|FG005|Follow-up Period|Other reason|0|||
127866604|NCT00663208|460130282|FG006|Follow-up Period|Other reason|1|||
127866605|NCT04563845|460130284|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
127866606|NCT04563845|460130285|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
127866607|NCT04563845|460130286|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
127866608|NCT04563845|460130287|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
127866609|NCT04563845|460130288|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
127866610|NCT04563845|460130289|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
127866611|NCT04563845|460130290|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
127866612|NCT04563845|460130291|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
127866613|NCT04563845|460130292|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
127866614|NCT04563845|460130293|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
127866615|NCT04563845|460130294|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
127866616|NCT04563845|460130295|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
127866617|NCT04563845|460130296|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
127866618|NCT04563845|460130297|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
127866619|NCT04563845|460130284|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
127866620|NCT04563845|460130285|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
127866621|NCT04563845|460130286|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
127866622|NCT04563845|460130287|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
127866623|NCT04563845|460130288|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
127866624|NCT04563845|460130289|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
127866625|NCT04563845|460130290|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
127866626|NCT04563845|460130291|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
127866627|NCT04563845|460130292|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
127866628|NCT04563845|460130293|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
127866629|NCT04563845|460130294|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
127866630|NCT04563845|460130295|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
127866631|NCT04563845|460130296|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
127866632|NCT04563845|460130297|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
127866633|NCT02927990|460130298|FG000|Overall Study|Protocol Violation|4|||
127866634|NCT02927990|460130298|FG000|Overall Study|Physician Decision|9|||
127866635|NCT02927990|460130298|FG000|Overall Study|Room switched and therefore no study device available|15|||
127866636|NCT02927990|460130298|FG000|Overall Study|No procedure performed, only diagnostic catheterization|28|||
127866637|NCT00960323|460130299|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
127866638|NCT02146274|460130300|FG000|Overall Study|Protocol Violation|73|||
127866639|NCT03824704|460130306|FG000|Overall Study|Study Terminated by Sponsor|1|||
127916273|NCT00672984|460314889|FG000|First Intervention|Sponsor decision|3|||
127916274|NCT00672984|460314890|FG001|First Intervention|Sponsor decision|0|||
127916275|NCT00672984|460314891|FG002|First Intervention|Sponsor decision|0|||
127916276|NCT00672984|460314889|FG000|Second Intervention|Non-compliance with facility policies|0|||
127916277|NCT00672984|460314890|FG001|Second Intervention|Non-compliance with facility policies|2|||
127916278|NCT00672984|460314891|FG002|Second Intervention|Non-compliance with facility policies|0|||
127916279|NCT00672984|460314889|FG000|Second Intervention|Withdrawal by Subject|0|||
127916280|NCT00672984|460314890|FG001|Second Intervention|Withdrawal by Subject|3|||
127916281|NCT00672984|460314891|FG002|Second Intervention|Withdrawal by Subject|0|||
127916282|NCT00672984|460314889|FG000|Second Intervention|Protocol Violation|0|||
127916283|NCT00672984|460314890|FG001|Second Intervention|Protocol Violation|1|||
127916284|NCT00672984|460314891|FG002|Second Intervention|Protocol Violation|1|||
127916285|NCT00672984|460314889|FG000|Third Intervention|Adverse Event|1|||
127916286|NCT00672984|460314890|FG001|Third Intervention|Adverse Event|0|||
127916287|NCT00672984|460314891|FG002|Third Intervention|Adverse Event|1|||
127916288|NCT00645853|460314892|FG000|Overall Study|Adverse Event|18|||
127916289|NCT00645853|460314893|FG001|Overall Study|Adverse Event|7|||
127916290|NCT00645853|460314892|FG000|Overall Study|AZ study closure in Hungary|60|||
127916291|NCT00645853|460314893|FG001|Overall Study|AZ study closure in Hungary|40|||
127916292|NCT00645853|460314892|FG000|Overall Study|Withdrawal by Subject|5|||
127916293|NCT00645853|460314893|FG001|Overall Study|Withdrawal by Subject|2|||
127916294|NCT00645853|460314892|FG000|Overall Study|Protocol Violation|0|||
127916295|NCT00645853|460314893|FG001|Overall Study|Protocol Violation|2|||
127916296|NCT00645853|460314892|FG000|Overall Study|Discontinuation criteria|2|||
127916297|NCT00645853|460314893|FG001|Overall Study|Discontinuation criteria|2|||
127916298|NCT00645853|460314892|FG000|Overall Study|recall of ICF, planned operation, death|7|||
127916299|NCT00645853|460314893|FG001|Overall Study|recall of ICF, planned operation, death|4|||
127916300|NCT04060251|460314894|FG000|Overall Study|Study terminated due to low enrollment.|7|||
127916301|NCT04060251|460314895|FG001|Overall Study|Study terminated due to low enrollment.|5|||
127916302|NCT04060251|460314896|FG002|Overall Study|Study terminated due to low enrollment.|7|||
127916303|NCT04060251|460314894|FG000|Overall Study|Adverse Event|1|||
127916304|NCT04060251|460314895|FG001|Overall Study|Adverse Event|1|||
127916305|NCT04060251|460314896|FG002|Overall Study|Adverse Event|0|||
127916306|NCT00487435|460314897|FG000|Overall Study|Adverse Event|146|||
127916307|NCT00487435|460314897|FG000|Overall Study|Death|2|||
127916308|NCT00487435|460314897|FG000|Overall Study|Lack of Efficacy|33|||
127916309|NCT00487435|460314897|FG000|Overall Study|Lost to Follow-up|54|||
127916310|NCT00487435|460314897|FG000|Overall Study|Pregnancy|2|||
127916311|NCT00487435|460314897|FG000|Overall Study|Withdrawal by Subject|132|||
127916312|NCT00487435|460314897|FG000|Overall Study|Resolution Of Pain|1|||
127916313|NCT00487435|460314897|FG000|Overall Study|Study Medication Non-Compliant|32|||
127916314|NCT00487435|460314897|FG000|Overall Study|Other|83|||
127866640|NCT02719028|460130307|FG000|Overall Study|Adverse Event|2|||
127866641|NCT02719028|460130308|FG001|Overall Study|Adverse Event|1|||
127866642|NCT02719028|460130309|FG002|Overall Study|Adverse Event|4|||
127866643|NCT02719028|460130310|FG003|Overall Study|Adverse Event|8|||
127866644|NCT02719028|460130307|FG000|Overall Study|Physician Decision|0|||
127866645|NCT02719028|460130308|FG001|Overall Study|Physician Decision|1|||
127866646|NCT02719028|460130309|FG002|Overall Study|Physician Decision|1|||
127866647|NCT02719028|460130310|FG003|Overall Study|Physician Decision|1|||
127866648|NCT02719028|460130307|FG000|Overall Study|Use of prohibited medication|0|||
127866649|NCT02719028|460130308|FG001|Overall Study|Use of prohibited medication|0|||
127866650|NCT02719028|460130309|FG002|Overall Study|Use of prohibited medication|1|||
127866651|NCT02719028|460130310|FG003|Overall Study|Use of prohibited medication|0|||
127866652|NCT02719028|460130307|FG000|Overall Study|Protocol Violation|0|||
127866653|NCT02719028|460130308|FG001|Overall Study|Protocol Violation|0|||
127866654|NCT02719028|460130309|FG002|Overall Study|Protocol Violation|0|||
127866655|NCT02719028|460130310|FG003|Overall Study|Protocol Violation|1|||
127866656|NCT01539720|460130312|FG000|Overall Study|Screen Fail|15|||
127866657|NCT01539720|460130313|FG001|Overall Study|Screen Fail|3|||
127866658|NCT01539720|460130312|FG000|Overall Study|Lost to Follow-up|14|||
127866659|NCT01539720|460130313|FG001|Overall Study|Lost to Follow-up|7|||
127866660|NCT03287960|460130314|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
127866661|NCT03287960|460130314|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
127866662|NCT03730987|460130317|FG000|Overall Study|Lost to Follow-up|2|||
127866663|NCT03730987|460130318|FG001|Overall Study|Lost to Follow-up|0|||
127866664|NCT03730987|460130319|FG002|Overall Study|Lost to Follow-up|2|||
127866665|NCT03730987|460130320|FG003|Overall Study|Lost to Follow-up|0|||
127866666|NCT01667731|460130328|FG000|Overall Study|Enrolled but not treated|0|||
127866667|NCT01667731|460130329|FG001|Overall Study|Enrolled but not treated|0|||
127866668|NCT01667731|460130330|FG002|Overall Study|Enrolled but not treated|0|||
127866669|NCT01667731|460130331|FG003|Overall Study|Enrolled but not treated|0|||
127866670|NCT01667731|460130332|FG004|Overall Study|Enrolled but not treated|1|||
127866671|NCT01667731|460130328|FG000|Overall Study|Efficacy Failure|1|||
127866672|NCT01667731|460130329|FG001|Overall Study|Efficacy Failure|12|||
127866673|NCT01667731|460130330|FG002|Overall Study|Efficacy Failure|0|||
127866674|NCT01667731|460130331|FG003|Overall Study|Efficacy Failure|1|||
127866675|NCT01667731|460130332|FG004|Overall Study|Efficacy Failure|24|||
127866676|NCT01667731|460130328|FG000|Overall Study|Lost to Follow-up|2|||
127866677|NCT01667731|460130329|FG001|Overall Study|Lost to Follow-up|3|||
127866678|NCT01667731|460130330|FG002|Overall Study|Lost to Follow-up|1|||
127866679|NCT01667731|460130331|FG003|Overall Study|Lost to Follow-up|1|||
127866680|NCT01667731|460130332|FG004|Overall Study|Lost to Follow-up|2|||
127866681|NCT01667731|460130328|FG000|Overall Study|Subject Withdrew Consent|2|||
127866682|NCT01667731|460130329|FG001|Overall Study|Subject Withdrew Consent|0|||
127866683|NCT01667731|460130330|FG002|Overall Study|Subject Withdrew Consent|1|||
127866684|NCT01667731|460130331|FG003|Overall Study|Subject Withdrew Consent|0|||
127866685|NCT01667731|460130332|FG004|Overall Study|Subject Withdrew Consent|1|||
127866686|NCT01667731|460130328|FG000|Overall Study|Death|0|||
127866687|NCT01667731|460130329|FG001|Overall Study|Death|1|||
127866688|NCT01667731|460130330|FG002|Overall Study|Death|0|||
127866689|NCT01667731|460130331|FG003|Overall Study|Death|0|||
127866690|NCT01667731|460130332|FG004|Overall Study|Death|0|||
127866691|NCT01425268|460130333|FG000|Overall Study|Withdrawal by Subject|2|||
127866692|NCT01425268|460130334|FG001|Overall Study|Withdrawal by Subject|0|||
127866693|NCT01425268|460130333|FG000|Overall Study|Sponsor Decision|5|||
127866694|NCT01425268|460130334|FG001|Overall Study|Sponsor Decision|0|||
127866695|NCT01425268|460130333|FG000|Overall Study|Physician Decision|1|||
127866696|NCT01425268|460130334|FG001|Overall Study|Physician Decision|0|||
127866697|NCT03633461|460130335|FG000|Overall Study|Lost to Follow-up|0|||
127866698|NCT03633461|460130336|FG001|Overall Study|Lost to Follow-up|1|||
127866699|NCT02516605|460130337|FG000|Overall Study|Protocol Violation|0|||
127916315|NCT00985751|460314898|FG000|Overall Study|Adverse Event|0|||
127916316|NCT00985751|460314899|FG001|Overall Study|Adverse Event|0|||
127916317|NCT00985751|460314900|FG002|Overall Study|Adverse Event|0|||
127916318|NCT00985751|460314901|FG003|Overall Study|Adverse Event|0|||
127916319|NCT00985751|460314902|FG004|Overall Study|Adverse Event|1|||
127916320|NCT01451541|460314907|FG000|Overall Study|Adverse Event|4|||
127916321|NCT01451541|460314908|FG001|Overall Study|Adverse Event|3|||
127916322|NCT01451541|460314909|FG002|Overall Study|Adverse Event|6|||
127916323|NCT01451541|460314907|FG000|Overall Study|Lack of Efficacy|2|||
127916324|NCT01451541|460314908|FG001|Overall Study|Lack of Efficacy|0|||
127916325|NCT01451541|460314909|FG002|Overall Study|Lack of Efficacy|0|||
127916326|NCT01451541|460314907|FG000|Overall Study|Lost to Follow-up|4|||
127916327|NCT01451541|460314908|FG001|Overall Study|Lost to Follow-up|4|||
127916328|NCT01451541|460314909|FG002|Overall Study|Lost to Follow-up|7|||
127916329|NCT01451541|460314907|FG000|Overall Study|Withdrawal by Subject|15|||
127916330|NCT01451541|460314908|FG001|Overall Study|Withdrawal by Subject|8|||
127916331|NCT01451541|460314909|FG002|Overall Study|Withdrawal by Subject|6|||
127916332|NCT01451541|460314907|FG000|Overall Study|randomization error, noncompliance|11|||
127916333|NCT01451541|460314908|FG001|Overall Study|randomization error, noncompliance|10|||
127916334|NCT01451541|460314909|FG002|Overall Study|randomization error, noncompliance|8|||
127916335|NCT01018862|460314920|FG000|Overall Study|Adverse Event|2|||
127916336|NCT01018862|460314921|FG001|Overall Study|Adverse Event|0|||
127916337|NCT01018862|460314922|FG002|Overall Study|Adverse Event|6|||
127916338|NCT01018862|460314920|FG000|Overall Study|Lack of Efficacy|1|||
127916339|NCT01018862|460314921|FG001|Overall Study|Lack of Efficacy|0|||
127916340|NCT01018862|460314922|FG002|Overall Study|Lack of Efficacy|2|||
127916341|NCT01018862|460314920|FG000|Overall Study|Lost to Follow-up|3|||
127916342|NCT01018862|460314921|FG001|Overall Study|Lost to Follow-up|1|||
127916343|NCT01018862|460314922|FG002|Overall Study|Lost to Follow-up|0|||
127916344|NCT01018862|460314920|FG000|Overall Study|Protocol Violation|1|||
127916345|NCT01018862|460314921|FG001|Overall Study|Protocol Violation|3|||
127916346|NCT01018862|460314922|FG002|Overall Study|Protocol Violation|3|||
127916347|NCT01018862|460314920|FG000|Overall Study|Withdrawal by Subject|1|||
127916348|NCT01018862|460314921|FG001|Overall Study|Withdrawal by Subject|2|||
127916349|NCT01018862|460314922|FG002|Overall Study|Withdrawal by Subject|1|||
127916350|NCT01018862|460314920|FG000|Overall Study|administrative problems|5|||
127916351|NCT01018862|460314921|FG001|Overall Study|administrative problems|4|||
127916352|NCT01018862|460314922|FG002|Overall Study|administrative problems|4|||
127916353|NCT01968031|460314923|FG000|Overall Study|Adverse Event|13|||
127916354|NCT01968031|460314924|FG001|Overall Study|Adverse Event|10|||
127916355|NCT01968031|460314925|FG002|Overall Study|Adverse Event|22|||
127916356|NCT01968031|460314923|FG000|Overall Study|Withdrawal by Subject|3|||
127916357|NCT01968031|460314924|FG001|Overall Study|Withdrawal by Subject|7|||
127916358|NCT01968031|460314925|FG002|Overall Study|Withdrawal by Subject|3|||
127916359|NCT01968031|460314923|FG000|Overall Study|Did not meet entry criteria|1|||
127916360|NCT01968031|460314924|FG001|Overall Study|Did not meet entry criteria|1|||
127916361|NCT01968031|460314925|FG002|Overall Study|Did not meet entry criteria|1|||
127916362|NCT01968031|460314923|FG000|Overall Study|Noncompliance|0|||
127916363|NCT01968031|460314924|FG001|Overall Study|Noncompliance|0|||
127916364|NCT01968031|460314925|FG002|Overall Study|Noncompliance|2|||
127916365|NCT01968031|460314923|FG000|Overall Study|Failed inclusion criteria|0|||
127916366|NCT01968031|460314924|FG001|Overall Study|Failed inclusion criteria|2|||
127916367|NCT01968031|460314925|FG002|Overall Study|Failed inclusion criteria|0|||
127916368|NCT01968031|460314923|FG000|Overall Study|Death|0|||
127916369|NCT01968031|460314924|FG001|Overall Study|Death|0|||
127916370|NCT01968031|460314925|FG002|Overall Study|Death|1|||
127916371|NCT01968031|460314923|FG000|Overall Study|Prohibited concomitant medication|1|||
127916372|NCT01968031|460314924|FG001|Overall Study|Prohibited concomitant medication|0|||
127916373|NCT01968031|460314925|FG002|Overall Study|Prohibited concomitant medication|0|||
127916374|NCT00840879|460314926|FG000|Second Intervention|Withdrawal by Subject|1|||
127916375|NCT00840879|460314927|FG001|Second Intervention|Withdrawal by Subject|0|||
127916376|NCT04236596|460314928|FG000|Overall Study|Withdrawal by Subject|1|||
127916377|NCT04236596|460314928|FG000|Overall Study|Participants did not retain implant for entire trial|3|||
127916378|NCT04236596|460314928|FG000|Overall Study|Participants did not receive implant at all|4|||
127916379|NCT02957331|460314931|FG000|Overall Study|Protocol Violation|1|||
127916380|NCT02957331|460314932|FG001|Overall Study|Protocol Violation|0|||
127916381|NCT01151280|460316551|FG000|Overall Study|Adverse Event|1|||
127916382|NCT01151280|460316551|FG000|Overall Study|Lack of Efficacy|3|||
127916383|NCT01243151|460316552|FG000|Overall Study|Adverse Event|0|||
127916384|NCT01243151|460316553|FG001|Overall Study|Adverse Event|1|||
127916385|NCT01243151|460316554|FG002|Overall Study|Adverse Event|0|||
127916386|NCT01243151|460316555|FG003|Overall Study|Adverse Event|0|||
127916387|NCT01243151|460316556|FG004|Overall Study|Adverse Event|0|||
127916388|NCT01243151|460316552|FG000|Overall Study|Protocol Violation|0|||
127916389|NCT01243151|460316553|FG001|Overall Study|Protocol Violation|0|||
127916390|NCT01243151|460316554|FG002|Overall Study|Protocol Violation|1|||
127866700|NCT02516605|460130338|FG001|Overall Study|Protocol Violation|0|||
127866701|NCT02516605|460130339|FG002|Overall Study|Protocol Violation|0|||
127866702|NCT02516605|460130340|FG003|Overall Study|Protocol Violation|0|||
127866703|NCT02516605|460130341|FG004|Overall Study|Protocol Violation|1|||
127866704|NCT02516605|460130337|FG000|Overall Study|Withdrawal by Subject|0|||
127866705|NCT02516605|460130338|FG001|Overall Study|Withdrawal by Subject|0|||
127866706|NCT02516605|460130339|FG002|Overall Study|Withdrawal by Subject|0|||
127866707|NCT02516605|460130340|FG003|Overall Study|Withdrawal by Subject|1|||
127866708|NCT02516605|460130341|FG004|Overall Study|Withdrawal by Subject|0|||
127866709|NCT02839330|460130342|FG000|Overall Study|Adverse Event|0|||
127866710|NCT02839330|460130343|FG001|Overall Study|Adverse Event|1|||
127866711|NCT02839330|460130344|FG002|Overall Study|Adverse Event|2|||
127866712|NCT02839330|460130345|FG003|Overall Study|Adverse Event|2|||
127866713|NCT02839330|460130342|FG000|Overall Study|Death|4|||
127866714|NCT02839330|460130343|FG001|Overall Study|Death|6|||
127866715|NCT02839330|460130344|FG002|Overall Study|Death|1|||
127866716|NCT02839330|460130345|FG003|Overall Study|Death|1|||
127866717|NCT02839330|460130342|FG000|Overall Study|Withdrawal by Subject|27|||
127866718|NCT02839330|460130343|FG001|Overall Study|Withdrawal by Subject|19|||
127866719|NCT02839330|460130344|FG002|Overall Study|Withdrawal by Subject|11|||
127866720|NCT02839330|460130345|FG003|Overall Study|Withdrawal by Subject|13|||
127866721|NCT02839330|460130342|FG000|Overall Study|Lost to Follow-up|22|||
127866722|NCT02839330|460130343|FG001|Overall Study|Lost to Follow-up|27|||
127866723|NCT02839330|460130344|FG002|Overall Study|Lost to Follow-up|29|||
127866724|NCT02839330|460130345|FG003|Overall Study|Lost to Follow-up|25|||
127866725|NCT02839330|460130342|FG000|Overall Study|Administrative Reason|0|||
127866726|NCT02839330|460130343|FG001|Overall Study|Administrative Reason|0|||
127866727|NCT02839330|460130344|FG002|Overall Study|Administrative Reason|0|||
127866728|NCT02839330|460130345|FG003|Overall Study|Administrative Reason|1|||
127866729|NCT02839330|460130342|FG000|Overall Study|Protocol Violation|1|||
127866730|NCT02839330|460130343|FG001|Overall Study|Protocol Violation|2|||
127866731|NCT02839330|460130344|FG002|Overall Study|Protocol Violation|2|||
127866732|NCT02839330|460130345|FG003|Overall Study|Protocol Violation|3|||
127866733|NCT02839330|460130342|FG000|Overall Study|Other reason, not specified|4|||
127866734|NCT02839330|460130343|FG001|Overall Study|Other reason, not specified|3|||
127866735|NCT02839330|460130344|FG002|Overall Study|Other reason, not specified|3|||
127866736|NCT02839330|460130345|FG003|Overall Study|Other reason, not specified|6|||
127866737|NCT00579059|460130349|FG000|Overall Study|Study Canceled at 1 Year|21|||
127866738|NCT00579059|460130350|FG001|Overall Study|Study Canceled at 1 Year|10|||
127866739|NCT04047472|460130351|FG000|Overall Study|Adverse Event|3|||
127866740|NCT04047472|460130352|FG001|Overall Study|Adverse Event|3|||
127866741|NCT04047472|460130351|FG000|Overall Study|Death|0|||
127866742|NCT04047472|460130352|FG001|Overall Study|Death|1|||
127866743|NCT04047472|460130351|FG000|Overall Study|Lost to Follow-up|1|||
127866744|NCT04047472|460130352|FG001|Overall Study|Lost to Follow-up|0|||
127866745|NCT04047472|460130351|FG000|Overall Study|Physician Decision|1|||
127866746|NCT04047472|460130352|FG001|Overall Study|Physician Decision|2|||
127866747|NCT04047472|460130351|FG000|Overall Study|Protocol Violation|1|||
127866748|NCT04047472|460130352|FG001|Overall Study|Protocol Violation|0|||
127866749|NCT04047472|460130351|FG000|Overall Study|Withdrawal by Subject|10|||
127866750|NCT04047472|460130352|FG001|Overall Study|Withdrawal by Subject|10|||
127866751|NCT02030067|460130353|FG000|Overall Study|Disease Progression|1|||
127866752|NCT02030067|460130354|FG001|Overall Study|Disease Progression|1|||
127866753|NCT02030067|460130355|FG002|Overall Study|Disease Progression|2|||
127916391|NCT01243151|460316555|FG003|Overall Study|Protocol Violation|0|||
127916392|NCT01243151|460316556|FG004|Overall Study|Protocol Violation|0|||
127916393|NCT01243151|460316552|FG000|Overall Study|Other|0|||
127916394|NCT01243151|460316553|FG001|Overall Study|Other|0|||
127916395|NCT01243151|460316554|FG002|Overall Study|Other|0|||
127916396|NCT01243151|460316555|FG003|Overall Study|Other|1|||
127916397|NCT01243151|460316556|FG004|Overall Study|Other|0|||
127916398|NCT01243151|460316552|FG000|Overall Study|Randomized but not treated|0|||
127916399|NCT01243151|460316553|FG001|Overall Study|Randomized but not treated|0|||
127916400|NCT01243151|460316554|FG002|Overall Study|Randomized but not treated|0|||
127916401|NCT01243151|460316555|FG003|Overall Study|Randomized but not treated|1|||
127916402|NCT01243151|460316556|FG004|Overall Study|Randomized but not treated|0|||
127916403|NCT02308241|460316563|FG000|Overall Study|Withdrawal by Subject|3|||
127916404|NCT01630616|460316564|FG000|Overall Study|Adverse Event|0|||
127916405|NCT01630616|460316565|FG001|Overall Study|Adverse Event|0|||
127916406|NCT01630616|460316566|FG002|Overall Study|Adverse Event|0|||
127916407|NCT01630616|460316567|FG003|Overall Study|Adverse Event|1|||
127916408|NCT01630616|460316568|FG004|Overall Study|Adverse Event|0|||
127916409|NCT01630616|460316569|FG005|Overall Study|Adverse Event|0|||
127916410|NCT01630616|460316564|FG000|Overall Study|Withdrawal by Subject|0|||
127916411|NCT01630616|460316565|FG001|Overall Study|Withdrawal by Subject|0|||
127916412|NCT01630616|460316566|FG002|Overall Study|Withdrawal by Subject|0|||
127916413|NCT01630616|460316567|FG003|Overall Study|Withdrawal by Subject|2|||
127916414|NCT01630616|460316568|FG004|Overall Study|Withdrawal by Subject|0|||
127916415|NCT01630616|460316569|FG005|Overall Study|Withdrawal by Subject|0|||
127916416|NCT00691704|460316570|FG000|Induction Therapy|Disease Progression|1|||
127916417|NCT00691704|460316570|FG000|Induction Therapy|Active Hepatitis|1|||
127916418|NCT00691704|460316570|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
127916419|NCT00691704|460316570|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
127916420|NCT00691704|460316570|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
127916421|NCT01993186|460316571|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
127866754|NCT02030067|460130356|FG003|Overall Study|Disease Progression|2|||
127866755|NCT02030067|460130357|FG004|Overall Study|Disease Progression|3|||
127866756|NCT02030067|460130358|FG005|Overall Study|Disease Progression|2|||
127866757|NCT02030067|460130359|FG006|Overall Study|Disease Progression|3|||
127916422|NCT01993186|460316572|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
127916423|NCT01993186|460316571|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
127916424|NCT01993186|460316572|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
127916425|NCT01993186|460316571|FG000|Open-Label Extension Period|Other, Not Specified|0|||
127916426|NCT01993186|460316572|FG001|Open-Label Extension Period|Other, Not Specified|1|||
127916427|NCT01993186|460316571|FG000|Open-Label Extension Period|Adverse Event|1|||
127866758|NCT02030067|460130360|FG007|Overall Study|Disease Progression|3|||
127866759|NCT02030067|460130361|FG008|Overall Study|Disease Progression|4|||
127866760|NCT02030067|460130362|FG009|Overall Study|Disease Progression|3|||
127866761|NCT02030067|460130363|FG010|Overall Study|Disease Progression|7|||
127866762|NCT02030067|460130364|FG011|Overall Study|Disease Progression|2|||
127916428|NCT01993186|460316572|FG001|Open-Label Extension Period|Adverse Event|0|||
127866763|NCT02030067|460130365|FG012|Overall Study|Disease Progression|59|||
127866764|NCT02030067|460130353|FG000|Overall Study|Withdrawal by Subject|0|||
127916429|NCT01993186|460316571|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
127916430|NCT01993186|460316572|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
127916431|NCT01993186|460316571|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
127916432|NCT01993186|460316572|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
127916433|NCT01993186|460316571|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
127916434|NCT01993186|460316572|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
127916435|NCT04661202|460316574|FG000|Overall Study|Withdrawal by Subject|1|||
127866765|NCT02030067|460130354|FG001|Overall Study|Withdrawal by Subject|0|||
127866766|NCT02030067|460130355|FG002|Overall Study|Withdrawal by Subject|0|||
127866767|NCT02030067|460130356|FG003|Overall Study|Withdrawal by Subject|1|||
127866768|NCT02030067|460130357|FG004|Overall Study|Withdrawal by Subject|0|||
127866769|NCT02030067|460130358|FG005|Overall Study|Withdrawal by Subject|0|||
127866770|NCT02030067|460130359|FG006|Overall Study|Withdrawal by Subject|0|||
127866771|NCT02030067|460130360|FG007|Overall Study|Withdrawal by Subject|1|||
127866772|NCT02030067|460130361|FG008|Overall Study|Withdrawal by Subject|0|||
127866773|NCT02030067|460130362|FG009|Overall Study|Withdrawal by Subject|0|||
127866774|NCT02030067|460130363|FG010|Overall Study|Withdrawal by Subject|3|||
127866775|NCT02030067|460130364|FG011|Overall Study|Withdrawal by Subject|0|||
127866776|NCT02030067|460130365|FG012|Overall Study|Withdrawal by Subject|6|||
127866777|NCT02030067|460130353|FG000|Overall Study|Physician Decision|0|||
127866778|NCT02030067|460130354|FG001|Overall Study|Physician Decision|0|||
127866779|NCT02030067|460130355|FG002|Overall Study|Physician Decision|0|||
127866780|NCT02030067|460130356|FG003|Overall Study|Physician Decision|0|||
127866781|NCT02030067|460130357|FG004|Overall Study|Physician Decision|0|||
127866782|NCT02030067|460130358|FG005|Overall Study|Physician Decision|0|||
127866783|NCT02030067|460130359|FG006|Overall Study|Physician Decision|0|||
127866784|NCT02030067|460130360|FG007|Overall Study|Physician Decision|0|||
127866785|NCT02030067|460130361|FG008|Overall Study|Physician Decision|0|||
127866786|NCT02030067|460130362|FG009|Overall Study|Physician Decision|0|||
127866787|NCT02030067|460130363|FG010|Overall Study|Physician Decision|1|||
127866788|NCT02030067|460130364|FG011|Overall Study|Physician Decision|0|||
127866789|NCT02030067|460130365|FG012|Overall Study|Physician Decision|3|||
127866790|NCT02030067|460130353|FG000|Overall Study|other reasons|0|||
127866791|NCT02030067|460130354|FG001|Overall Study|other reasons|0|||
127866792|NCT02030067|460130355|FG002|Overall Study|other reasons|0|||
127866793|NCT02030067|460130356|FG003|Overall Study|other reasons|0|||
127866794|NCT02030067|460130357|FG004|Overall Study|other reasons|0|||
127866795|NCT02030067|460130358|FG005|Overall Study|other reasons|1|||
127866796|NCT02030067|460130359|FG006|Overall Study|other reasons|0|||
127866797|NCT02030067|460130360|FG007|Overall Study|other reasons|0|||
127866798|NCT02030067|460130361|FG008|Overall Study|other reasons|2|||
127866799|NCT02030067|460130362|FG009|Overall Study|other reasons|0|||
127866800|NCT02030067|460130363|FG010|Overall Study|other reasons|0|||
127866801|NCT02030067|460130364|FG011|Overall Study|other reasons|0|||
127866802|NCT02030067|460130365|FG012|Overall Study|other reasons|4|||
127866803|NCT02030067|460130353|FG000|Overall Study|Adverse Event|0|||
127866804|NCT02030067|460130354|FG001|Overall Study|Adverse Event|0|||
127866805|NCT02030067|460130355|FG002|Overall Study|Adverse Event|0|||
127866806|NCT02030067|460130356|FG003|Overall Study|Adverse Event|0|||
127866807|NCT02030067|460130357|FG004|Overall Study|Adverse Event|0|||
127866808|NCT02030067|460130358|FG005|Overall Study|Adverse Event|0|||
127866809|NCT02030067|460130359|FG006|Overall Study|Adverse Event|0|||
127866810|NCT02030067|460130360|FG007|Overall Study|Adverse Event|0|||
127866811|NCT02030067|460130361|FG008|Overall Study|Adverse Event|0|||
127866812|NCT02030067|460130362|FG009|Overall Study|Adverse Event|0|||
127866813|NCT02030067|460130363|FG010|Overall Study|Adverse Event|0|||
127916436|NCT04661202|460316575|FG001|Overall Study|Withdrawal by Subject|1|||
127916437|NCT04661202|460316574|FG000|Overall Study|Lack of Efficacy|2|||
127916438|NCT04661202|460316575|FG001|Overall Study|Lack of Efficacy|0|||
127916439|NCT02313558|460316576|FG000|Overall Study|Withdrawal by Subject|2|||
127916440|NCT02313558|460316577|FG001|Overall Study|Withdrawal by Subject|0|||
127916441|NCT02313558|460316576|FG000|Overall Study|Lost to Follow-up|4|||
127916442|NCT02313558|460316577|FG001|Overall Study|Lost to Follow-up|4|||
127916443|NCT04158687|460316579|FG000|Overall Study|Adverse Event|2|||
127916444|NCT04158687|460316580|FG001|Overall Study|Adverse Event|3|||
127916445|NCT04158687|460316581|FG002|Overall Study|Adverse Event|0|||
127916446|NCT04158687|460316582|FG003|Overall Study|Adverse Event|3|||
127916447|NCT04158687|460316579|FG000|Overall Study|Lost to Follow-up|5|||
127916448|NCT04158687|460316580|FG001|Overall Study|Lost to Follow-up|12|||
127916449|NCT04158687|460316581|FG002|Overall Study|Lost to Follow-up|4|||
127916450|NCT04158687|460316582|FG003|Overall Study|Lost to Follow-up|5|||
127916451|NCT04158687|460316579|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
127916452|NCT04158687|460316580|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
127916453|NCT04158687|460316581|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
127916454|NCT04158687|460316582|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
127866814|NCT02030067|460130364|FG011|Overall Study|Adverse Event|1|||
127866815|NCT02030067|460130365|FG012|Overall Study|Adverse Event|8|||
127866816|NCT01535638|460130367|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
127866817|NCT01535638|460130368|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
127866818|NCT01535638|460130369|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
127866819|NCT01535638|460130370|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
127866820|NCT01535638|460130371|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
127866821|NCT01535638|460130372|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
127866822|NCT01535638|460130367|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
127866823|NCT01535638|460130368|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
127916455|NCT04158687|460316579|FG000|Overall Study|Non-Compliance with Study Medication|2|||
127866824|NCT01535638|460130369|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
127866825|NCT01535638|460130370|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
127866826|NCT01535638|460130371|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
127866827|NCT01535638|460130372|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
127866828|NCT03769753|460130373|FG000|Overall Study|Not Treated|6|||
127866829|NCT03769753|460130373|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
127866830|NCT01482598|460130374|FG000|Overall Study|Death|7|||
127866831|NCT01482598|460130375|FG001|Overall Study|Death|10|||
127866832|NCT01482598|460130374|FG000|Overall Study|Physician Decision|0|||
127866833|NCT01482598|460130375|FG001|Overall Study|Physician Decision|3|||
127866834|NCT01482598|460130374|FG000|Overall Study|Withdrawal by Subject|4|||
127866835|NCT01482598|460130375|FG001|Overall Study|Withdrawal by Subject|5|||
127866836|NCT01482598|460130374|FG000|Overall Study|Lost to Follow-up|5|||
127866837|NCT01482598|460130375|FG001|Overall Study|Lost to Follow-up|4|||
127866838|NCT01373294|460130376|FG000|Overall Study|Adverse Event|1|||
127866839|NCT01373294|460130377|FG001|Overall Study|Adverse Event|0|||
127866840|NCT03702166|460130378|FG000|Overall Study|Lost to Follow-up|1|||
127866841|NCT03702166|460130378|FG000|Overall Study|Withdrawal by Subject|1|||
127866842|NCT01657903|460130379|FG000|Overall Study|Lost to Follow-up|1|||
127866843|NCT01657903|460130379|FG000|Overall Study|Withdrawal by Subject|1|||
127866844|NCT01920061|460130383|FG000|Overall Study|Death|1|||
127866845|NCT01920061|460130384|FG001|Overall Study|Death|1|||
127866846|NCT01920061|460130385|FG002|Overall Study|Death|0|||
127866847|NCT01920061|460130386|FG003|Overall Study|Death|1|||
127866848|NCT01920061|460130387|FG004|Overall Study|Death|1|||
127866849|NCT01920061|460130388|FG005|Overall Study|Death|0|||
127866850|NCT01920061|460130389|FG006|Overall Study|Death|0|||
127866851|NCT01920061|460130390|FG007|Overall Study|Death|1|||
127866852|NCT01920061|460130391|FG008|Overall Study|Death|0|||
127866853|NCT01920061|460130392|FG009|Overall Study|Death|1|||
127866854|NCT01920061|460130393|FG010|Overall Study|Death|0|||
127866855|NCT01920061|460130394|FG011|Overall Study|Death|1|||
127916456|NCT04158687|460316580|FG001|Overall Study|Non-Compliance with Study Medication|2|||
127916457|NCT04158687|460316581|FG002|Overall Study|Non-Compliance with Study Medication|3|||
127916458|NCT04158687|460316582|FG003|Overall Study|Non-Compliance with Study Medication|0|||
127916459|NCT04158687|460316579|FG000|Overall Study|Investigator Decision|0|||
127866856|NCT01920061|460130395|FG012|Overall Study|Death|0|||
127866857|NCT01920061|460130396|FG013|Overall Study|Death|2|||
127866858|NCT01920061|460130397|FG014|Overall Study|Death|0|||
127866859|NCT01920061|460130398|FG015|Overall Study|Death|0|||
127866860|NCT01920061|460130399|FG016|Overall Study|Death|0|||
127916460|NCT04158687|460316580|FG001|Overall Study|Investigator Decision|0|||
127916461|NCT04158687|460316581|FG002|Overall Study|Investigator Decision|2|||
127916462|NCT04158687|460316582|FG003|Overall Study|Investigator Decision|0|||
127916463|NCT04158687|460316579|FG000|Overall Study|Protocol Violation|0|||
127916464|NCT04158687|460316580|FG001|Overall Study|Protocol Violation|2|||
127866861|NCT01920061|460130400|FG017|Overall Study|Death|0|||
127866862|NCT01920061|460130401|FG018|Overall Study|Death|1|||
127866863|NCT01920061|460130402|FG019|Overall Study|Death|0|||
127916465|NCT04158687|460316581|FG002|Overall Study|Protocol Violation|1|||
127916466|NCT04158687|460316582|FG003|Overall Study|Protocol Violation|0|||
127916467|NCT04158687|460316579|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
127916468|NCT04158687|460316580|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
127916469|NCT04158687|460316581|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
127916470|NCT04158687|460316582|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
127916471|NCT04158687|460316579|FG000|Overall Study|Reason not Specified|3|||
127916472|NCT04158687|460316580|FG001|Overall Study|Reason not Specified|2|||
127916473|NCT04158687|460316581|FG002|Overall Study|Reason not Specified|4|||
127916474|NCT04158687|460316582|FG003|Overall Study|Reason not Specified|4|||
127916475|NCT04102345|460316583|FG000|Overall Study|Withdrawal by Subject|1|||
127916476|NCT04102345|460316584|FG001|Overall Study|Withdrawal by Subject|0|||
127916477|NCT01741545|460316585|FG000|Treatment Period|Lack of Efficacy|0|||
127916478|NCT01741545|460316586|FG001|Treatment Period|Lack of Efficacy|1|||
127916479|NCT01741545|460316585|FG000|Treatment Period|Adverse event, non-fatal|1|||
127916480|NCT01741545|460316586|FG001|Treatment Period|Adverse event, non-fatal|3|||
127916481|NCT01741545|460316585|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
127916482|NCT01741545|460316586|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
127916483|NCT01741545|460316585|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
127916484|NCT01741545|460316586|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
127866864|NCT01920061|460130383|FG000|Overall Study|Lost to Follow-up|0|||
127866865|NCT01920061|460130384|FG001|Overall Study|Lost to Follow-up|2|||
127866866|NCT01920061|460130385|FG002|Overall Study|Lost to Follow-up|0|||
127916485|NCT01853176|460316587|FG000|Overall Study|Study terminated|4|||
127916486|NCT01853176|460316588|FG001|Overall Study|Study terminated|0|||
127916487|NCT00198133|460316589|FG000|Overall Study|Disease progression|2|||
127916488|NCT00198133|460316590|FG001|Overall Study|Disease progression|5|||
127916489|NCT00198133|460316589|FG000|Overall Study|Adverse Event|1|||
127916490|NCT00198133|460316590|FG001|Overall Study|Adverse Event|3|||
127866867|NCT01920061|460130386|FG003|Overall Study|Lost to Follow-up|0|||
127866868|NCT01920061|460130387|FG004|Overall Study|Lost to Follow-up|0|||
127866869|NCT01920061|460130388|FG005|Overall Study|Lost to Follow-up|0|||
127866870|NCT01920061|460130389|FG006|Overall Study|Lost to Follow-up|1|||
127866871|NCT01920061|460130390|FG007|Overall Study|Lost to Follow-up|0|||
127866872|NCT01920061|460130391|FG008|Overall Study|Lost to Follow-up|0|||
127866873|NCT01920061|460130392|FG009|Overall Study|Lost to Follow-up|0|||
127866874|NCT01920061|460130393|FG010|Overall Study|Lost to Follow-up|3|||
127866875|NCT01920061|460130394|FG011|Overall Study|Lost to Follow-up|0|||
127866876|NCT01920061|460130395|FG012|Overall Study|Lost to Follow-up|0|||
127866877|NCT01920061|460130396|FG013|Overall Study|Lost to Follow-up|0|||
127866878|NCT01920061|460130397|FG014|Overall Study|Lost to Follow-up|0|||
127866879|NCT01920061|460130398|FG015|Overall Study|Lost to Follow-up|0|||
127866880|NCT01920061|460130399|FG016|Overall Study|Lost to Follow-up|0|||
127866881|NCT01920061|460130400|FG017|Overall Study|Lost to Follow-up|1|||
127866882|NCT01920061|460130401|FG018|Overall Study|Lost to Follow-up|4|||
127866883|NCT01920061|460130402|FG019|Overall Study|Lost to Follow-up|3|||
127866884|NCT01920061|460130383|FG000|Overall Study|Other|1|||
127866885|NCT01920061|460130384|FG001|Overall Study|Other|1|||
127866886|NCT01920061|460130385|FG002|Overall Study|Other|2|||
127866887|NCT01920061|460130386|FG003|Overall Study|Other|1|||
127866888|NCT01920061|460130387|FG004|Overall Study|Other|0|||
127866889|NCT01920061|460130388|FG005|Overall Study|Other|1|||
127866890|NCT01920061|460130389|FG006|Overall Study|Other|0|||
127866891|NCT01920061|460130390|FG007|Overall Study|Other|0|||
127866892|NCT01920061|460130391|FG008|Overall Study|Other|0|||
127866893|NCT01920061|460130392|FG009|Overall Study|Other|1|||
127916491|NCT00198133|460316589|FG000|Overall Study|Withdrawal by Subject|1|||
127916492|NCT00198133|460316590|FG001|Overall Study|Withdrawal by Subject|0|||
127916493|NCT00198133|460316589|FG000|Overall Study|Physician Decision|1|||
127916494|NCT00198133|460316590|FG001|Overall Study|Physician Decision|0|||
127916495|NCT01537887|460316596|FG000|Period 1|Physician Decision|0|||
127916496|NCT01537887|460316597|FG001|Period 1|Physician Decision|0|||
127866894|NCT01920061|460130393|FG010|Overall Study|Other|1|||
127866895|NCT01920061|460130394|FG011|Overall Study|Other|2|||
127916497|NCT01537887|460316598|FG002|Period 1|Physician Decision|0|||
127866896|NCT01920061|460130395|FG012|Overall Study|Other|1|||
127866897|NCT01920061|460130396|FG013|Overall Study|Other|4|||
127866898|NCT01920061|460130397|FG014|Overall Study|Other|0|||
127866899|NCT01920061|460130398|FG015|Overall Study|Other|1|||
127866900|NCT01920061|460130399|FG016|Overall Study|Other|1|||
127866901|NCT01920061|460130400|FG017|Overall Study|Other|0|||
127866902|NCT01920061|460130401|FG018|Overall Study|Other|1|||
127866903|NCT01920061|460130402|FG019|Overall Study|Other|1|||
127866904|NCT01920061|460130383|FG000|Overall Study|Participant refused further follow-up|0|||
127866905|NCT01920061|460130384|FG001|Overall Study|Participant refused further follow-up|0|||
127866906|NCT01920061|460130385|FG002|Overall Study|Participant refused further follow-up|0|||
127866907|NCT01920061|460130386|FG003|Overall Study|Participant refused further follow-up|0|||
127866908|NCT01920061|460130387|FG004|Overall Study|Participant refused further follow-up|1|||
127866909|NCT01920061|460130388|FG005|Overall Study|Participant refused further follow-up|1|||
127866910|NCT01920061|460130389|FG006|Overall Study|Participant refused further follow-up|0|||
127866911|NCT01920061|460130390|FG007|Overall Study|Participant refused further follow-up|0|||
127866912|NCT01920061|460130391|FG008|Overall Study|Participant refused further follow-up|1|||
127866913|NCT01920061|460130392|FG009|Overall Study|Participant refused further follow-up|0|||
127866914|NCT01920061|460130393|FG010|Overall Study|Participant refused further follow-up|1|||
127866915|NCT01920061|460130394|FG011|Overall Study|Participant refused further follow-up|0|||
127866916|NCT01920061|460130395|FG012|Overall Study|Participant refused further follow-up|1|||
127866917|NCT01920061|460130396|FG013|Overall Study|Participant refused further follow-up|0|||
127866918|NCT01920061|460130397|FG014|Overall Study|Participant refused further follow-up|1|||
127866919|NCT01920061|460130398|FG015|Overall Study|Participant refused further follow-up|2|||
127866920|NCT01920061|460130399|FG016|Overall Study|Participant refused further follow-up|1|||
127916498|NCT01537887|460316599|FG003|Period 1|Physician Decision|0|||
127916499|NCT01537887|460316600|FG004|Period 1|Physician Decision|1|||
127916500|NCT01537887|460316601|FG005|Period 1|Physician Decision|1|||
127916501|NCT01537887|460316596|FG000|Period 1|Did not receive treatment|0|||
127916502|NCT01537887|460316597|FG001|Period 1|Did not receive treatment|0|||
127916503|NCT01537887|460316598|FG002|Period 1|Did not receive treatment|1|||
127916504|NCT01537887|460316599|FG003|Period 1|Did not receive treatment|0|||
127916505|NCT01537887|460316600|FG004|Period 1|Did not receive treatment|0|||
127916506|NCT01537887|460316601|FG005|Period 1|Did not receive treatment|0|||
127916507|NCT01537887|460316596|FG000|Period 2|Withdrawal by Subject|0|||
127916508|NCT01537887|460316597|FG001|Period 2|Withdrawal by Subject|1|||
127916509|NCT01537887|460316598|FG002|Period 2|Withdrawal by Subject|0|||
127866921|NCT01920061|460130400|FG017|Overall Study|Participant refused further follow-up|1|||
127916510|NCT01537887|460316599|FG003|Period 2|Withdrawal by Subject|0|||
127916511|NCT01537887|460316600|FG004|Period 2|Withdrawal by Subject|0|||
127916512|NCT01537887|460316601|FG005|Period 2|Withdrawal by Subject|0|||
127916513|NCT01537887|460316596|FG000|Period 3|Adverse Event|0|||
127916514|NCT01537887|460316597|FG001|Period 3|Adverse Event|0|||
127866922|NCT01920061|460130401|FG018|Overall Study|Participant refused further follow-up|0|||
127866923|NCT01920061|460130402|FG019|Overall Study|Participant refused further follow-up|0|||
127866924|NCT00842829|460130405|FG000|Dose Titration Period|Adverse Event|11|||
127866925|NCT00842829|460130406|FG001|Dose Titration Period|Adverse Event|10|||
127866926|NCT00842829|460130407|FG002|Dose Titration Period|Adverse Event|0|||
127866927|NCT00842829|460130405|FG000|Dose Titration Period|Lack of Efficacy|4|||
127866928|NCT00842829|460130406|FG001|Dose Titration Period|Lack of Efficacy|1|||
127866929|NCT00842829|460130407|FG002|Dose Titration Period|Lack of Efficacy|0|||
127866930|NCT00842829|460130405|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
127866931|NCT00842829|460130406|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
127866932|NCT00842829|460130407|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
127866933|NCT00842829|460130405|FG000|Dose Titration Period|Withdrawal by Subject|2|||
127866934|NCT00842829|460130406|FG001|Dose Titration Period|Withdrawal by Subject|6|||
127866935|NCT00842829|460130407|FG002|Dose Titration Period|Withdrawal by Subject|0|||
127866936|NCT00842829|460130405|FG000|Dose Titration Period|Other|5|||
127866937|NCT00842829|460130406|FG001|Dose Titration Period|Other|4|||
127866938|NCT00842829|460130407|FG002|Dose Titration Period|Other|0|||
127866939|NCT00842829|460130405|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
127916515|NCT01537887|460316598|FG002|Period 3|Adverse Event|1|||
127916516|NCT01537887|460316599|FG003|Period 3|Adverse Event|0|||
127916517|NCT01537887|460316600|FG004|Period 3|Adverse Event|0|||
127916518|NCT01537887|460316601|FG005|Period 3|Adverse Event|0|||
127916519|NCT01537887|460316596|FG000|Period 3|Withdrawal by Subject|0|||
127916520|NCT01537887|460316597|FG001|Period 3|Withdrawal by Subject|1|||
127916521|NCT01537887|460316598|FG002|Period 3|Withdrawal by Subject|0|||
127916522|NCT01537887|460316599|FG003|Period 3|Withdrawal by Subject|0|||
127916523|NCT01537887|460316600|FG004|Period 3|Withdrawal by Subject|0|||
127916524|NCT01537887|460316601|FG005|Period 3|Withdrawal by Subject|0|||
127916525|NCT01370083|460316602|FG000|Overall Study|Lost to Follow-up|2|||
127916526|NCT01370083|460316603|FG001|Overall Study|Lost to Follow-up|0|||
127916527|NCT01370083|460316602|FG000|Overall Study|Adverse Event|0|||
127916528|NCT01370083|460316603|FG001|Overall Study|Adverse Event|1|||
127916529|NCT00731939|460316605|FG000|Overall Study|Adverse Event|6|||
127916530|NCT00731939|460316605|FG000|Overall Study|Lost to Follow-up|15|||
127916531|NCT00731939|460316605|FG000|Overall Study|Not implanted with study device|9|||
127916532|NCT00731939|460316605|FG000|Overall Study|Withdrawal by Subject|2|||
127866940|NCT00842829|460130406|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
127866941|NCT00842829|460130407|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
127866942|NCT00842829|460130405|FG000|Dose Titration Period|Non-compliance to study drug|2|||
127866943|NCT00842829|460130406|FG001|Dose Titration Period|Non-compliance to study drug|1|||
127866944|NCT00842829|460130407|FG002|Dose Titration Period|Non-compliance to study drug|0|||
127866945|NCT00842829|460130405|FG000|Treatment Period|Adverse Event|0|||
127866946|NCT00842829|460130406|FG001|Treatment Period|Adverse Event|0|||
127866947|NCT00842829|460130407|FG002|Treatment Period|Adverse Event|15|||
127866948|NCT00842829|460130405|FG000|Treatment Period|Lack of Efficacy|0|||
127866949|NCT00842829|460130406|FG001|Treatment Period|Lack of Efficacy|0|||
127866950|NCT00842829|460130407|FG002|Treatment Period|Lack of Efficacy|6|||
127866951|NCT00842829|460130405|FG000|Treatment Period|Unstable persistent cancer pain|0|||
127866952|NCT00842829|460130406|FG001|Treatment Period|Unstable persistent cancer pain|0|||
127866953|NCT00842829|460130407|FG002|Treatment Period|Unstable persistent cancer pain|5|||
127866954|NCT00842829|460130405|FG000|Treatment Period|Withdrawal by Subject|0|||
127866955|NCT00842829|460130406|FG001|Treatment Period|Withdrawal by Subject|0|||
127866956|NCT00842829|460130407|FG002|Treatment Period|Withdrawal by Subject|11|||
127866957|NCT00842829|460130405|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
127866958|NCT00842829|460130406|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
127866959|NCT00842829|460130407|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
127866960|NCT00842829|460130405|FG000|Treatment Period|Protocol Violation|0|||
127866961|NCT00842829|460130406|FG001|Treatment Period|Protocol Violation|0|||
127866962|NCT00842829|460130407|FG002|Treatment Period|Protocol Violation|2|||
127866963|NCT00842829|460130405|FG000|Treatment Period|Other|0|||
127866964|NCT00842829|460130406|FG001|Treatment Period|Other|0|||
127866965|NCT00842829|460130407|FG002|Treatment Period|Other|18|||
127866966|NCT00842829|460130405|FG000|Treatment Period|Non-compliance to study procedures|0|||
127866967|NCT00842829|460130406|FG001|Treatment Period|Non-compliance to study procedures|0|||
127866968|NCT00842829|460130407|FG002|Treatment Period|Non-compliance to study procedures|4|||
127866969|NCT00842829|460130405|FG000|Treatment Period|Unclear completion status|0|||
127866970|NCT00842829|460130406|FG001|Treatment Period|Unclear completion status|0|||
127866971|NCT00842829|460130407|FG002|Treatment Period|Unclear completion status|1|||
127866972|NCT00842829|460130405|FG000|Continuation Period|Adverse Event|0|||
127866973|NCT00842829|460130406|FG001|Continuation Period|Adverse Event|0|||
127866974|NCT00842829|460130407|FG002|Continuation Period|Adverse Event|32|||
127866975|NCT00842829|460130405|FG000|Continuation Period|Lack of Efficacy|0|||
127866976|NCT00842829|460130406|FG001|Continuation Period|Lack of Efficacy|0|||
127866977|NCT00842829|460130407|FG002|Continuation Period|Lack of Efficacy|6|||
127866978|NCT00842829|460130405|FG000|Continuation Period|Unstable persistent cancer pain|0|||
127866979|NCT00842829|460130406|FG001|Continuation Period|Unstable persistent cancer pain|0|||
127866980|NCT00842829|460130407|FG002|Continuation Period|Unstable persistent cancer pain|3|||
127866981|NCT00842829|460130405|FG000|Continuation Period|Withdrawal by Subject|0|||
127866982|NCT00842829|460130406|FG001|Continuation Period|Withdrawal by Subject|0|||
127866983|NCT00842829|460130407|FG002|Continuation Period|Withdrawal by Subject|10|||
127866984|NCT00842829|460130405|FG000|Continuation Period|Other|0|||
127866985|NCT00842829|460130406|FG001|Continuation Period|Other|0|||
127866986|NCT00842829|460130407|FG002|Continuation Period|Other|7|||
127866987|NCT00842829|460130405|FG000|Continuation Period|Non-compliance to study procedures|0|||
127866988|NCT00842829|460130406|FG001|Continuation Period|Non-compliance to study procedures|0|||
127866989|NCT00842829|460130407|FG002|Continuation Period|Non-compliance to study procedures|2|||
127866990|NCT00842829|460130405|FG000|Continuation Period|Non-compliance to study drug|0|||
127866991|NCT00842829|460130406|FG001|Continuation Period|Non-compliance to study drug|0|||
127866992|NCT00842829|460130407|FG002|Continuation Period|Non-compliance to study drug|1|||
127866993|NCT03969589|460130408|FG000|Overall Study|Lost to Follow-up|3|||
127866994|NCT03969589|460130409|FG001|Overall Study|Lost to Follow-up|2|||
127866995|NCT03969589|460130408|FG000|Overall Study|Declined Follow-Up|0|||
127866996|NCT03969589|460130409|FG001|Overall Study|Declined Follow-Up|1|||
127866997|NCT00517634|460130410|FG000|Second Treatment Period|Withdrawal by Subject|0|||
127866998|NCT00517634|460130411|FG001|Second Treatment Period|Withdrawal by Subject|0|||
127866999|NCT00517634|460130412|FG002|Second Treatment Period|Withdrawal by Subject|0|||
127867000|NCT00517634|460130413|FG003|Second Treatment Period|Withdrawal by Subject|0|||
127916533|NCT00731939|460316605|FG000|Overall Study|Did not meet enrollment criteria|2|||
127916534|NCT02072096|460316606|FG000|Overall Study|Lack of Efficacy|18|||
127916535|NCT02072096|460316607|FG001|Overall Study|Lack of Efficacy|29|||
127916536|NCT02072096|460316606|FG000|Overall Study|Protocol Violation|7|||
127916537|NCT02072096|460316607|FG001|Overall Study|Protocol Violation|7|||
127867001|NCT00517634|460130414|FG004|Second Treatment Period|Withdrawal by Subject|1|||
127867002|NCT00517634|460130415|FG005|Second Treatment Period|Withdrawal by Subject|0|||
127867003|NCT03091920|460130418|FG000|Overall Study|Adverse Event|0|||
127867004|NCT03091920|460130419|FG001|Overall Study|Adverse Event|1|||
127867005|NCT03091920|460130420|FG002|Overall Study|Adverse Event|0|||
127867006|NCT03143855|460130421|FG000|Overall Study|Withdrawal by Subject|4|||
127867007|NCT03143855|460130422|FG001|Overall Study|Withdrawal by Subject|3|||
127867008|NCT03143855|460130421|FG000|Overall Study|Protocol Violation|1|||
127916538|NCT02072096|460316606|FG000|Overall Study|Withdrawal by Subject|5|||
127916539|NCT02072096|460316607|FG001|Overall Study|Withdrawal by Subject|7|||
127916540|NCT02072096|460316606|FG000|Overall Study|Adverse Event|5|||
127916541|NCT02072096|460316607|FG001|Overall Study|Adverse Event|2|||
127916542|NCT02072096|460316606|FG000|Overall Study|No Reason Provided|4|||
127916543|NCT02072096|460316607|FG001|Overall Study|No Reason Provided|2|||
127916544|NCT02072096|460316606|FG000|Overall Study|Death|2|||
127916545|NCT02072096|460316607|FG001|Overall Study|Death|0|||
127916546|NCT02072096|460316606|FG000|Overall Study|Physician Decision|0|||
127916547|NCT02072096|460316607|FG001|Overall Study|Physician Decision|1|||
127916548|NCT02072096|460316606|FG000|Overall Study|Study Terminated by Sponsor|43|||
127916549|NCT02072096|460316607|FG001|Overall Study|Study Terminated by Sponsor|30|||
127916550|NCT02072096|460316606|FG000|Overall Study|Lost to Follow-up|1|||
127916551|NCT02072096|460316607|FG001|Overall Study|Lost to Follow-up|0|||
127916552|NCT01634139|460316608|FG000|Overall Study|Non compliant with protocol|1|||
127916553|NCT01634139|460316609|FG001|Overall Study|Non compliant with protocol|0|||
127916554|NCT01634139|460316610|FG002|Overall Study|Non compliant with protocol|0|||
127916555|NCT01634139|460316608|FG000|Overall Study|Consent withdrawn not due to AE|4|||
127916556|NCT01634139|460316609|FG001|Overall Study|Consent withdrawn not due to AE|3|||
127916557|NCT01634139|460316610|FG002|Overall Study|Consent withdrawn not due to AE|2|||
127916558|NCT01634139|460316608|FG000|Overall Study|Other|4|||
127916559|NCT01634139|460316609|FG001|Overall Study|Other|0|||
127916560|NCT01634139|460316610|FG002|Overall Study|Other|3|||
127916561|NCT01634139|460316608|FG000|Overall Study|Lost to Follow-up|0|||
127916562|NCT01634139|460316609|FG001|Overall Study|Lost to Follow-up|2|||
127916563|NCT01634139|460316610|FG002|Overall Study|Lost to Follow-up|0|||
127916564|NCT01634139|460316608|FG000|Overall Study|Not treated|1|||
127916565|NCT01634139|460316609|FG001|Overall Study|Not treated|1|||
127916566|NCT01634139|460316610|FG002|Overall Study|Not treated|0|||
127916567|NCT00425308|460316611|FG000|Overall Study|Adverse Event|2|||
127916568|NCT00425308|460316612|FG001|Overall Study|Adverse Event|1|||
127916569|NCT00425308|460316611|FG000|Overall Study|Withdrawal by Subject|1|||
127916570|NCT00425308|460316612|FG001|Overall Study|Withdrawal by Subject|0|||
127916571|NCT00425308|460316611|FG000|Overall Study|Death|1|||
127916572|NCT00425308|460316612|FG001|Overall Study|Death|0|||
127916573|NCT01266902|460316616|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
127916574|NCT01266902|460316617|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
127916575|NCT01266902|460316618|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
127916576|NCT01266902|460316616|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
127916577|NCT01266902|460316617|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
127916578|NCT01266902|460316618|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
127916579|NCT01266902|460316616|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
127916580|NCT01266902|460316617|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
127916581|NCT01266902|460316618|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
127916582|NCT01266902|460316616|FG000|Period 1 (Main Study)|Adverse Event|3|||
127916583|NCT01266902|460316617|FG001|Period 1 (Main Study)|Adverse Event|11|||
127916584|NCT01266902|460316618|FG002|Period 1 (Main Study)|Adverse Event|0|||
127916585|NCT01266902|460316616|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
127916586|NCT01266902|460316617|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
127916587|NCT01266902|460316618|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
127916588|NCT01266902|460316616|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
127916589|NCT01266902|460316617|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
127916590|NCT01266902|460316618|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
127916591|NCT01266902|460316616|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
127916592|NCT01266902|460316617|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
127916593|NCT01266902|460316618|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
127916594|NCT01266902|460316616|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
127916595|NCT01266902|460316617|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
127916596|NCT01266902|460316618|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
127916597|NCT01266902|460316616|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
127916598|NCT01266902|460316617|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
127916599|NCT01266902|460316618|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
127916600|NCT01266902|460316616|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
127916601|NCT01266902|460316617|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
127916602|NCT01266902|460316618|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
127916603|NCT02426918|460316625|FG000|Overall Study|Adverse Event|2|||
127916604|NCT02426918|460316626|FG001|Overall Study|Adverse Event|2|||
127916605|NCT02426918|460316627|FG002|Overall Study|Adverse Event|0|||
127916606|NCT02426918|460316625|FG000|Overall Study|Physician Decision|1|||
127916607|NCT02426918|460316626|FG001|Overall Study|Physician Decision|1|||
127916608|NCT02426918|460316627|FG002|Overall Study|Physician Decision|1|||
127916609|NCT02426918|460316625|FG000|Overall Study|Withdrawal by Subject|5|||
127916610|NCT02426918|460316626|FG001|Overall Study|Withdrawal by Subject|5|||
127916611|NCT02426918|460316627|FG002|Overall Study|Withdrawal by Subject|4|||
127916612|NCT02426918|460316625|FG000|Overall Study|Other|9|||
127916613|NCT02426918|460316626|FG001|Overall Study|Other|11|||
127916614|NCT02426918|460316627|FG002|Overall Study|Other|9|||
127916615|NCT01496118|460316628|FG000|Overall Study|Disease progression|3|||
127916616|NCT01496118|460316629|FG001|Overall Study|Disease progression|2|||
127916617|NCT01496118|460316630|FG002|Overall Study|Disease progression|3|||
127916618|NCT01496118|460316631|FG003|Overall Study|Disease progression|1|||
127916619|NCT01496118|460316632|FG004|Overall Study|Disease progression|2|||
127916620|NCT01496118|460316633|FG005|Overall Study|Disease progression|2|||
127916621|NCT01496118|460316634|FG006|Overall Study|Disease progression|14|||
127916622|NCT01496118|460316635|FG007|Overall Study|Disease progression|10|||
127916623|NCT01496118|460316628|FG000|Overall Study|Physician Decision|0|||
127916624|NCT01496118|460316629|FG001|Overall Study|Physician Decision|0|||
127916625|NCT01496118|460316630|FG002|Overall Study|Physician Decision|0|||
127916626|NCT01496118|460316631|FG003|Overall Study|Physician Decision|0|||
127916627|NCT01496118|460316632|FG004|Overall Study|Physician Decision|1|||
127916628|NCT01496118|460316633|FG005|Overall Study|Physician Decision|0|||
127916629|NCT01496118|460316634|FG006|Overall Study|Physician Decision|3|||
127916630|NCT01496118|460316635|FG007|Overall Study|Physician Decision|6|||
127916631|NCT01496118|460316628|FG000|Overall Study|Adverse Event|1|||
127916632|NCT01496118|460316629|FG001|Overall Study|Adverse Event|1|||
127916633|NCT01496118|460316630|FG002|Overall Study|Adverse Event|0|||
127916634|NCT01496118|460316631|FG003|Overall Study|Adverse Event|0|||
127916635|NCT01496118|460316632|FG004|Overall Study|Adverse Event|0|||
127916636|NCT01496118|460316633|FG005|Overall Study|Adverse Event|0|||
127916637|NCT01496118|460316634|FG006|Overall Study|Adverse Event|6|||
127916638|NCT01496118|460316635|FG007|Overall Study|Adverse Event|10|||
127916639|NCT01496118|460316628|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
127916640|NCT01496118|460316629|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
127916641|NCT01496118|460316630|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
127916642|NCT01496118|460316631|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
127916643|NCT01496118|460316632|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
127916644|NCT01496118|460316633|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
127916645|NCT01496118|460316634|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
127916646|NCT01496118|460316635|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
127916647|NCT01496118|460316628|FG000|Overall Study|Death|0|||
127916648|NCT01496118|460316629|FG001|Overall Study|Death|0|||
127916649|NCT01496118|460316630|FG002|Overall Study|Death|0|||
127916650|NCT01496118|460316631|FG003|Overall Study|Death|0|||
127916651|NCT01496118|460316632|FG004|Overall Study|Death|0|||
127916652|NCT01496118|460316633|FG005|Overall Study|Death|0|||
127916653|NCT01496118|460316634|FG006|Overall Study|Death|1|||
127916654|NCT01496118|460316635|FG007|Overall Study|Death|1|||
127916655|NCT01496118|460316628|FG000|Overall Study|Withdrawal by Subject|0|||
127916656|NCT01496118|460316629|FG001|Overall Study|Withdrawal by Subject|0|||
127916657|NCT01496118|460316630|FG002|Overall Study|Withdrawal by Subject|0|||
127916658|NCT01496118|460316631|FG003|Overall Study|Withdrawal by Subject|2|||
127916659|NCT01496118|460316632|FG004|Overall Study|Withdrawal by Subject|0|||
127916660|NCT01496118|460316633|FG005|Overall Study|Withdrawal by Subject|1|||
127916661|NCT01496118|460316634|FG006|Overall Study|Withdrawal by Subject|6|||
127916662|NCT01496118|460316635|FG007|Overall Study|Withdrawal by Subject|3|||
127916663|NCT02845336|460316636|FG000|Overall Study|Lost to Follow-up|3|||
127916664|NCT02845336|460316637|FG001|Overall Study|Lost to Follow-up|1|||
127916665|NCT02845336|460316636|FG000|Overall Study|Inability to get medication|2|||
127916666|NCT02845336|460316637|FG001|Overall Study|Inability to get medication|0|||
127916667|NCT02420353|460316644|FG000|Overall Study|Withdrawal by Subject|0|||
127916668|NCT02420353|460316645|FG001|Overall Study|Withdrawal by Subject|1|||
127916669|NCT04608448|460316646|FG000|Overall Study|Withdrawal by Subject|1|||
127916670|NCT04608448|460316646|FG000|Overall Study|Adverse Event|1|||
127916671|NCT01149057|460316647|FG000|Overall Study|Lack of Efficacy|16|||
127916672|NCT01149057|460316647|FG000|Overall Study|Adverse Event|13|||
127916673|NCT01149057|460316647|FG000|Overall Study|Withdrawal by Subject|9|||
127916674|NCT01149057|460316647|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
127916675|NCT01149057|460316647|FG000|Overall Study|B Cell Depletion|4|||
127916676|NCT01149057|460316647|FG000|Overall Study|Participant Non-Compliance|2|||
127916677|NCT01149057|460316647|FG000|Overall Study|Lost to Follow-up|1|||
127916678|NCT01149057|460316647|FG000|Overall Study|High Parathyroid Hormone Value|1|||
127916679|NCT01149057|460316647|FG000|Overall Study|Other|6|||
127916680|NCT00654186|460316648|FG000|Overall Study|Withdrawal by Subject|5|||
127916681|NCT00577655|460316649|FG000|Overall Study|Patient Request|0|||
127916682|NCT00577655|460316650|FG001|Overall Study|Patient Request|2|||
127916683|NCT00577655|460316649|FG000|Overall Study|Protocol Violation|0|||
127916684|NCT00577655|460316650|FG001|Overall Study|Protocol Violation|1|||
127916685|NCT00577655|460316649|FG000|Overall Study|Lost to Follow-up|1|||
127916686|NCT00577655|460316650|FG001|Overall Study|Lost to Follow-up|1|||
127916687|NCT00875524|460316652|FG000|Overall Study|Serious adverse event|0|||
127916688|NCT00875524|460316653|FG001|Overall Study|Serious adverse event|1|||
127916689|NCT00875524|460316652|FG000|Overall Study|Protocol Violation|4|||
127916690|NCT00875524|460316653|FG001|Overall Study|Protocol Violation|0|||
127916691|NCT00875524|460316652|FG000|Overall Study|Lost to Follow-up|1|||
127916692|NCT00875524|460316653|FG001|Overall Study|Lost to Follow-up|0|||
127916693|NCT00875524|460316652|FG000|Overall Study|Withdrawal by Subject|3|||
127916694|NCT00875524|460316653|FG001|Overall Study|Withdrawal by Subject|5|||
127916695|NCT01087502|460316654|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
127916696|NCT01087502|460316655|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
127916697|NCT01087502|460316654|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
127916698|NCT01087502|460316655|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
127916699|NCT01087502|460316654|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
127916700|NCT01087502|460316655|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
127916701|NCT01087502|460316654|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
127916702|NCT01087502|460316655|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
127916703|NCT01087502|460316654|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
127916704|NCT01087502|460316655|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
127916705|NCT01087502|460316654|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
127916706|NCT01087502|460316655|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
127916707|NCT01087502|460316654|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
127916708|NCT01087502|460316655|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
127916709|NCT01087502|460316654|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
127916710|NCT01087502|460316655|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
127916711|NCT01087502|460316654|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
127916712|NCT01087502|460316655|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
127916713|NCT01087502|460316654|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
127916714|NCT01087502|460316655|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
127916715|NCT01087502|460316654|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
127916716|NCT01087502|460316655|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
127916717|NCT01087502|460316654|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
127916718|NCT01087502|460316655|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
127916719|NCT01151618|460316656|FG000|Overall Study|Adverse Event|2|||
127916720|NCT01151618|460316656|FG000|Overall Study|Withdrawal by Subject|7|||
127916721|NCT01632306|460316657|FG000|Overall Study|Protocol Violation|1|||
127916722|NCT01632306|460316658|FG001|Overall Study|Protocol Violation|0|||
127916723|NCT01632306|460316659|FG002|Overall Study|Protocol Violation|0|||
127916724|NCT00380588|460316662|FG000|Overall Study|Unequivocal Disease Progression|25|||
127916725|NCT00380588|460316663|FG001|Overall Study|Unequivocal Disease Progression|34|||
127916726|NCT00380588|460316662|FG000|Overall Study|Next Cycle Not Started|4|||
127916727|NCT00380588|460316663|FG001|Overall Study|Next Cycle Not Started|0|||
127916728|NCT00380588|460316662|FG000|Overall Study|Adverse Event|7|||
127916729|NCT00380588|460316663|FG001|Overall Study|Adverse Event|3|||
127916730|NCT00380588|460316662|FG000|Overall Study|Withdrawal by Subject|1|||
127916731|NCT00380588|460316663|FG001|Overall Study|Withdrawal by Subject|3|||
127916732|NCT00380588|460316662|FG000|Overall Study|Physician Decision|2|||
127916733|NCT00380588|460316663|FG001|Overall Study|Physician Decision|0|||
127916734|NCT03366428|460316664|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
127916735|NCT03366428|460316664|FG000|Overall Study|Adverse Event|12|||
127916736|NCT03366428|460316664|FG000|Overall Study|Clinical progression|2|||
127916737|NCT03366428|460316664|FG000|Overall Study|Withdrawal by Subject|4|||
127916738|NCT01824576|460316669|FG000|Overall Study|Device deficiency|2|||
127916739|NCT03727139|460316670|FG000|Overall Study|Protocol Violation|60|||
127916740|NCT00858403|460316671|FG000|Overall Study|Withdrawal by Subject|1|||
127916741|NCT00858403|460316671|FG000|Overall Study|Death|3|||
127916742|NCT00858403|460316671|FG000|Overall Study|Disease Progression|1|||
127916743|NCT01120028|460316674|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
127916744|NCT01120028|460316675|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
127916745|NCT01120028|460316676|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
127916746|NCT01120028|460316677|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
127916747|NCT01120028|460316674|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
127916748|NCT01120028|460316675|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
127916749|NCT01120028|460316676|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
127916750|NCT01120028|460316677|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
127916751|NCT03867760|460316678|FG000|Overall Study|Lost to Follow-up|2|||
127916752|NCT03867760|460316679|FG001|Overall Study|Lost to Follow-up|3|||
127916753|NCT03867760|460316678|FG000|Overall Study|Withdrawal by Subject|1|||
127916754|NCT03867760|460316679|FG001|Overall Study|Withdrawal by Subject|2|||
127916755|NCT03867760|460316678|FG000|Overall Study|subject could not meet study logistics|3|||
127916756|NCT03867760|460316679|FG001|Overall Study|subject could not meet study logistics|3|||
127916757|NCT03247686|460318397|FG000|Overall Study|Withdrawal by Subject|1|||
127916758|NCT03247686|460318398|FG001|Overall Study|Withdrawal by Subject|2|||
127916759|NCT02583048|460318402|FG000|Overall Study|Withdrawal by Subject|0|||
127916760|NCT02583048|460318403|FG001|Overall Study|Withdrawal by Subject|1|||
127916761|NCT02583048|460318404|FG002|Overall Study|Withdrawal by Subject|0|||
127916762|NCT02583048|460318402|FG000|Overall Study|Failed to meet eligibility criterion|0|||
127916763|NCT02583048|460318403|FG001|Overall Study|Failed to meet eligibility criterion|0|||
127916764|NCT02583048|460318404|FG002|Overall Study|Failed to meet eligibility criterion|1|||
127916765|NCT04408924|460318408|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|3|||
127867009|NCT03143855|460130422|FG001|Overall Study|Protocol Violation|0|||
127867010|NCT03143855|460130421|FG000|Overall Study|Participant experienced withdrawal|0|||
127867011|NCT03143855|460130422|FG001|Overall Study|Participant experienced withdrawal|1|||
127867012|NCT00453349|460130423|FG000|Randomized|Adverse Event|12|||
127867013|NCT00453349|460130424|FG001|Randomized|Adverse Event|11|||
127867014|NCT00453349|460130423|FG000|Randomized|Lack of Efficacy|2|||
127867015|NCT00453349|460130424|FG001|Randomized|Lack of Efficacy|1|||
127867016|NCT00453349|460130423|FG000|Randomized|Lost to Follow-up|7|||
127867017|NCT00453349|460130424|FG001|Randomized|Lost to Follow-up|5|||
127867018|NCT00453349|460130423|FG000|Randomized|Protocol Violation|1|||
127916766|NCT04408924|460318408|FG000|Overall Study|Lost to Follow-up|3|||
127867019|NCT00453349|460130424|FG001|Randomized|Protocol Violation|1|||
127916767|NCT04408924|460318408|FG000|Overall Study|Withdrawal by Subject|5|||
127916768|NCT04408924|460318408|FG000|Overall Study|Sponsor Decision|2|||
127916769|NCT02578641|460318409|FG000|Overall Study|Adverse Event|5|||
127867020|NCT00453349|460130423|FG000|Randomized|Withdrawal by Subject|3|||
127867021|NCT00453349|460130424|FG001|Randomized|Withdrawal by Subject|5|||
127867022|NCT00453349|460130423|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
127867023|NCT00453349|460130424|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
127867024|NCT00453349|460130423|FG000|Completed Study|Adverse Event|12|||
127867025|NCT00453349|460130424|FG001|Completed Study|Adverse Event|11|||
127867026|NCT00453349|460130423|FG000|Completed Study|Lack of Efficacy|2|||
127867027|NCT00453349|460130424|FG001|Completed Study|Lack of Efficacy|1|||
127867028|NCT00453349|460130423|FG000|Completed Study|Lost to Follow-up|7|||
127867029|NCT00453349|460130424|FG001|Completed Study|Lost to Follow-up|5|||
127867030|NCT00453349|460130423|FG000|Completed Study|Protocol Violation|1|||
127867031|NCT00453349|460130424|FG001|Completed Study|Protocol Violation|1|||
127867032|NCT00453349|460130423|FG000|Completed Study|Withdrawal by Subject|3|||
127867033|NCT00453349|460130424|FG001|Completed Study|Withdrawal by Subject|5|||
127867034|NCT00453349|460130423|FG000|Completed Study|Lost to follow up after study treatment|2|||
127867035|NCT00453349|460130424|FG001|Completed Study|Lost to follow up after study treatment|11|||
127867036|NCT04369742|460130426|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
127867037|NCT04369742|460130427|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
127867038|NCT04369742|460130426|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
127867039|NCT04369742|460130427|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
127867040|NCT00695318|460130429|FG000|Overall Study|Lost to Follow-up|1|||
127867041|NCT00695318|460130430|FG001|Overall Study|Lost to Follow-up|0|||
127867042|NCT00695318|460130429|FG000|Overall Study|Withdrawal by Subject|2|||
127867043|NCT00695318|460130430|FG001|Overall Study|Withdrawal by Subject|0|||
127867044|NCT00695318|460130429|FG000|Overall Study|Death|1|||
127867045|NCT00695318|460130430|FG001|Overall Study|Death|1|||
127867046|NCT00695318|460130429|FG000|Overall Study|Study Terminated|1|||
127867047|NCT00695318|460130430|FG001|Overall Study|Study Terminated|0|||
127867048|NCT01684930|460132232|FG000|Overall Study|Withdrawal by Subject|3|||
127867049|NCT01684930|460132233|FG001|Overall Study|Withdrawal by Subject|1|||
127867050|NCT00313716|460132243|FG000|Overall Study|Death|3|||
127867051|NCT00313716|460132244|FG001|Overall Study|Death|2|||
127867052|NCT00313716|460132245|FG002|Overall Study|Death|9|||
127867053|NCT00313716|460132246|FG003|Overall Study|Death|3|||
127867054|NCT00313716|460132247|FG004|Overall Study|Death|5|||
127867055|NCT00313716|460132248|FG005|Overall Study|Death|9|||
127867056|NCT00313716|460132243|FG000|Overall Study|Lost to Follow-up|2|||
127867057|NCT00313716|460132244|FG001|Overall Study|Lost to Follow-up|5|||
127867058|NCT00313716|460132245|FG002|Overall Study|Lost to Follow-up|2|||
127867059|NCT00313716|460132246|FG003|Overall Study|Lost to Follow-up|1|||
127867060|NCT00313716|460132247|FG004|Overall Study|Lost to Follow-up|0|||
127867061|NCT00313716|460132248|FG005|Overall Study|Lost to Follow-up|4|||
127867062|NCT00313716|460132243|FG000|Overall Study|Withdrawal by Subject|0|||
127867063|NCT00313716|460132244|FG001|Overall Study|Withdrawal by Subject|1|||
127867064|NCT00313716|460132245|FG002|Overall Study|Withdrawal by Subject|1|||
127867065|NCT00313716|460132246|FG003|Overall Study|Withdrawal by Subject|0|||
127867066|NCT00313716|460132247|FG004|Overall Study|Withdrawal by Subject|1|||
127867067|NCT00313716|460132248|FG005|Overall Study|Withdrawal by Subject|0|||
127867068|NCT01041027|460132249|FG000|Overall Study|Withdrawal by Subject|2|||
127867069|NCT01041027|460132249|FG000|Overall Study|Protocol Violation|1|||
127867070|NCT01041027|460132249|FG000|Overall Study|Delayed Radiation Therapy|1|||
127867071|NCT01041027|460132249|FG000|Overall Study|Adverse Event|4|||
127867072|NCT01249404|460132250|FG000|Overall Study|Study treatment not received|0|||
127867073|NCT01249404|460132251|FG001|Overall Study|Study treatment not received|1|||
127867074|NCT01249404|460132252|FG002|Overall Study|Study treatment not received|2|||
127867075|NCT01249404|460132250|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
127916770|NCT02578641|460318410|FG001|Overall Study|Adverse Event|15|||
127867076|NCT01249404|460132251|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
127867077|NCT01249404|460132252|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
127867078|NCT01249404|460132250|FG000|Overall Study|Adverse Event|2|||
127867079|NCT01249404|460132251|FG001|Overall Study|Adverse Event|2|||
127867080|NCT01249404|460132252|FG002|Overall Study|Adverse Event|2|||
127867081|NCT01249404|460132250|FG000|Overall Study|Withdrawal by Subject|2|||
127867082|NCT01249404|460132251|FG001|Overall Study|Withdrawal by Subject|2|||
127867083|NCT01249404|460132252|FG002|Overall Study|Withdrawal by Subject|0|||
127867084|NCT01249404|460132250|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
127867085|NCT01249404|460132251|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
127867086|NCT01249404|460132252|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
127867087|NCT01249404|460132250|FG000|Overall Study|Non compliance to visit schedule|0|||
127867088|NCT01249404|460132251|FG001|Overall Study|Non compliance to visit schedule|1|||
127867089|NCT01249404|460132252|FG002|Overall Study|Non compliance to visit schedule|0|||
127867090|NCT01345162|460132260|FG000|Overall Study|Protocol Violation|2|||
127867091|NCT01345162|460132261|FG001|Overall Study|Protocol Violation|4|||
127867092|NCT01871870|460132262|FG000|Overall Study|Hardware issues|7|||
127867093|NCT01871870|460132262|FG000|Overall Study|hyperglycemia|2|||
127867094|NCT00883896|460132264|FG000|Overall Study|Lost to Follow-up|0|||
127867095|NCT00883896|460132265|FG001|Overall Study|Lost to Follow-up|0|||
127867096|NCT00883896|460132266|FG002|Overall Study|Lost to Follow-up|0|||
127867097|NCT00883896|460132267|FG003|Overall Study|Lost to Follow-up|2|||
127867098|NCT00883896|460132264|FG000|Overall Study|Withdrawal by Subject|5|||
127867099|NCT00883896|460132265|FG001|Overall Study|Withdrawal by Subject|0|||
127867100|NCT00883896|460132266|FG002|Overall Study|Withdrawal by Subject|1|||
127867101|NCT00883896|460132267|FG003|Overall Study|Withdrawal by Subject|3|||
127867102|NCT00883896|460132264|FG000|Overall Study|Lack of Efficacy|0|||
127867103|NCT00883896|460132265|FG001|Overall Study|Lack of Efficacy|0|||
127867104|NCT00883896|460132266|FG002|Overall Study|Lack of Efficacy|0|||
127867105|NCT00883896|460132267|FG003|Overall Study|Lack of Efficacy|2|||
127867106|NCT00883896|460132264|FG000|Overall Study|Other|1|||
127867107|NCT00883896|460132265|FG001|Overall Study|Other|0|||
127867108|NCT00883896|460132266|FG002|Overall Study|Other|0|||
127867109|NCT00883896|460132267|FG003|Overall Study|Other|0|||
127867110|NCT01856920|460132277|FG000|Overall Study|Disease Progression On Study|3|||
127867111|NCT01856920|460132278|FG001|Overall Study|Disease Progression On Study|4|||
127867112|NCT01856920|460132277|FG000|Overall Study|Disease Progression before Treatment|1|||
127867113|NCT01856920|460132278|FG001|Overall Study|Disease Progression before Treatment|0|||
127867114|NCT01856920|460132277|FG000|Overall Study|Ineligible|0|||
127867115|NCT01856920|460132278|FG001|Overall Study|Ineligible|1|||
127867116|NCT01856920|460132277|FG000|Overall Study|Patient Declined to Participate (before treatment started.)|1|||
127867117|NCT01856920|460132278|FG001|Overall Study|Patient Declined to Participate (before treatment started.)|0|||
127867118|NCT01856920|460132277|FG000|Overall Study|Refused further Treatment|5|||
127867119|NCT01856920|460132278|FG001|Overall Study|Refused further Treatment|1|||
127867120|NCT01856920|460132277|FG000|Overall Study|Other Reasons|0|||
127867121|NCT01856920|460132278|FG001|Overall Study|Other Reasons|1|||
127867122|NCT01856920|460132277|FG000|Overall Study|Completed treatment phase but refused the Protocol-Specified|0|||
127867123|NCT01856920|460132278|FG001|Overall Study|Completed treatment phase but refused the Protocol-Specified|2|||
127867124|NCT02545270|460132279|FG000|Overall Study|technical difficulties|0|||
127867125|NCT02545270|460132280|FG001|Overall Study|technical difficulties|1|||
127867126|NCT02545270|460132281|FG002|Overall Study|technical difficulties|0|||
127867127|NCT02545270|460132279|FG000|Overall Study|Videos being too similar to other|0|||
127867128|NCT02545270|460132280|FG001|Overall Study|Videos being too similar to other|0|||
127867129|NCT02545270|460132281|FG002|Overall Study|Videos being too similar to other|2|||
127867130|NCT00761891|460132282|FG000|Overall Study|Withdrawal by Subject|10|||
127867131|NCT02074059|460132284|FG000|Overall Study|Death|0|||
127867132|NCT02074059|460132285|FG001|Overall Study|Death|0|||
127867133|NCT02074059|460132286|FG002|Overall Study|Death|0|||
127867134|NCT02074059|460132287|FG003|Overall Study|Death|0|||
127867135|NCT02074059|460132288|FG004|Overall Study|Death|1|||
127867136|NCT02074059|460132289|FG005|Overall Study|Death|1|||
127867137|NCT00174460|460132293|FG000|Overall Study|Withdrawal by Subject|0|||
127867138|NCT00174460|460132294|FG001|Overall Study|Withdrawal by Subject|1|||
127867139|NCT00779506|460132296|FG000|Overall Study|Screening Failed|2|||
127867140|NCT00779506|460132296|FG000|Overall Study|Adverse Event|4|||
127867141|NCT00779506|460132296|FG000|Overall Study|Lack of Efficacy|11|||
127867142|NCT00779506|460132296|FG000|Overall Study|Protocol Violation|5|||
127867143|NCT00779506|460132296|FG000|Overall Study|Withdrawal by Subject|6|||
127867144|NCT00779506|460132296|FG000|Overall Study|Lost to Follow-up|1|||
127867145|NCT01632345|460132299|FG000|Treatment: Part I|Adverse Event|1|||
127867146|NCT01632345|460132300|FG001|Treatment: Part I|Adverse Event|4|||
127867147|NCT01632345|460132301|FG002|Treatment: Part I|Adverse Event|2|||
127867148|NCT01632345|460132302|FG003|Treatment: Part I|Adverse Event|1|||
127867149|NCT01632345|460132303|FG004|Treatment: Part I|Adverse Event|3|||
127867150|NCT01632345|460132304|FG005|Treatment: Part I|Adverse Event|0|||
127867151|NCT01632345|460132305|FG006|Treatment: Part I|Adverse Event|0|||
127867152|NCT01632345|460132299|FG000|Treatment: Part I|Lack of Efficacy|0|||
127867153|NCT01632345|460132300|FG001|Treatment: Part I|Lack of Efficacy|1|||
127867154|NCT01632345|460132301|FG002|Treatment: Part I|Lack of Efficacy|0|||
127867155|NCT01632345|460132302|FG003|Treatment: Part I|Lack of Efficacy|1|||
127916771|NCT02578641|460318409|FG000|Overall Study|Death|16|||
127916772|NCT02578641|460318410|FG001|Overall Study|Death|8|||
127916773|NCT02578641|460318409|FG000|Overall Study|Lost to Follow-up|0|||
127916774|NCT02578641|460318410|FG001|Overall Study|Lost to Follow-up|1|||
127916775|NCT02578641|460318409|FG000|Overall Study|Withdrawal by Subject|14|||
127916776|NCT02578641|460318410|FG001|Overall Study|Withdrawal by Subject|7|||
127916777|NCT02578641|460318409|FG000|Overall Study|Progressive Disease|69|||
127916778|NCT02578641|460318410|FG001|Overall Study|Progressive Disease|21|||
127916779|NCT02578641|460318409|FG000|Overall Study|No Study Drug|2|||
127916780|NCT02578641|460318410|FG001|Overall Study|No Study Drug|0|||
127916781|NCT02578641|460318409|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
127916782|NCT02578641|460318410|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
127916783|NCT02578641|460318409|FG000|Overall Study|Non-compliance with Study Schedule|1|||
127916784|NCT02578641|460318410|FG001|Overall Study|Non-compliance with Study Schedule|0|||
127916785|NCT02578641|460318409|FG000|Overall Study|Other|1|||
127916786|NCT02578641|460318410|FG001|Overall Study|Other|10|||
127916787|NCT02578641|460318409|FG000|Overall Study|Not treated|1|||
127916788|NCT02578641|460318410|FG001|Overall Study|Not treated|4|||
127916789|NCT01710358|460318411|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
127916790|NCT01710358|460318412|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
127916791|NCT01710358|460318413|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
127916792|NCT01710358|460318411|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
127916793|NCT01710358|460318412|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
127916794|NCT01710358|460318413|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
127916795|NCT01710358|460318411|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
127916796|NCT01710358|460318412|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
127916797|NCT01710358|460318413|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
127916798|NCT01710358|460318411|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
127916799|NCT01710358|460318412|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
127916800|NCT01710358|460318413|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
127916801|NCT01710358|460318411|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
127916802|NCT01710358|460318412|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
127916803|NCT01710358|460318413|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
127916804|NCT01710358|460318411|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
127916805|NCT01710358|460318412|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
127916806|NCT01710358|460318413|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
127916807|NCT01710358|460318411|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
127916808|NCT01710358|460318412|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
127916809|NCT01710358|460318413|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
127916810|NCT01710358|460318411|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
127916811|NCT01710358|460318412|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
127916812|NCT01710358|460318413|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
127916813|NCT01710358|460318411|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
127916814|NCT01710358|460318412|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
127916815|NCT01710358|460318413|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
127916816|NCT01710358|460318411|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
127916817|NCT01710358|460318412|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
127916818|NCT01710358|460318413|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
127916819|NCT01710358|460318411|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
127916820|NCT01710358|460318412|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
127916821|NCT01710358|460318413|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
127916822|NCT01710358|460318411|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
127916823|NCT01710358|460318412|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
127916824|NCT01710358|460318413|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
127916825|NCT01710358|460318411|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
127916826|NCT01710358|460318412|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
127916827|NCT01710358|460318413|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
127916828|NCT01710358|460318411|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
127916829|NCT01710358|460318412|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
127916830|NCT01710358|460318413|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
127916831|NCT01710358|460318411|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
127916832|NCT01710358|460318412|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
127916833|NCT01710358|460318413|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
127916834|NCT01710358|460318411|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
127916835|NCT01710358|460318412|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
127867156|NCT01632345|460132303|FG004|Treatment: Part I|Lack of Efficacy|1|||
127867157|NCT01632345|460132304|FG005|Treatment: Part I|Lack of Efficacy|0|||
127867158|NCT01632345|460132305|FG006|Treatment: Part I|Lack of Efficacy|0|||
127867159|NCT01632345|460132299|FG000|Treatment: Part I|Lost to Follow-up|3|||
127867160|NCT01632345|460132300|FG001|Treatment: Part I|Lost to Follow-up|2|||
127867161|NCT01632345|460132301|FG002|Treatment: Part I|Lost to Follow-up|1|||
127867162|NCT01632345|460132302|FG003|Treatment: Part I|Lost to Follow-up|3|||
127867163|NCT01632345|460132303|FG004|Treatment: Part I|Lost to Follow-up|4|||
127867164|NCT01632345|460132304|FG005|Treatment: Part I|Lost to Follow-up|0|||
127867165|NCT01632345|460132305|FG006|Treatment: Part I|Lost to Follow-up|0|||
127867166|NCT01632345|460132299|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
127867167|NCT01632345|460132300|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
127867168|NCT01632345|460132301|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
127867169|NCT01632345|460132302|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
127867170|NCT01632345|460132303|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
127867171|NCT01632345|460132304|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
127867172|NCT01632345|460132305|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
127867173|NCT01632345|460132299|FG000|Treatment: Part I|Physician Decision|2|||
127867174|NCT01632345|460132300|FG001|Treatment: Part I|Physician Decision|1|||
127867175|NCT01632345|460132301|FG002|Treatment: Part I|Physician Decision|0|||
127867176|NCT01632345|460132302|FG003|Treatment: Part I|Physician Decision|0|||
127867177|NCT01632345|460132303|FG004|Treatment: Part I|Physician Decision|1|||
127916836|NCT01710358|460318413|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
127916837|NCT01710358|460318411|FG000|Rescue Period|Adverse Event|0|||
127916838|NCT01710358|460318412|FG001|Rescue Period|Adverse Event|15|||
127916839|NCT01710358|460318413|FG002|Rescue Period|Adverse Event|0|||
127916840|NCT01710358|460318411|FG000|Rescue Period|Death|0|||
127916841|NCT01710358|460318412|FG001|Rescue Period|Death|1|||
127916842|NCT01710358|460318413|FG002|Rescue Period|Death|0|||
127916843|NCT01710358|460318411|FG000|Rescue Period|Lack of Efficacy|0|||
127916844|NCT01710358|460318412|FG001|Rescue Period|Lack of Efficacy|7|||
127916845|NCT01710358|460318413|FG002|Rescue Period|Lack of Efficacy|0|||
127916846|NCT01710358|460318411|FG000|Rescue Period|Withdrawal by Subject|0|||
127916847|NCT01710358|460318412|FG001|Rescue Period|Withdrawal by Subject|8|||
127916848|NCT01710358|460318413|FG002|Rescue Period|Withdrawal by Subject|0|||
127916849|NCT00084864|460318418|FG000|Overall Study|Adverse Event|1|||
127916850|NCT00084864|460318419|FG001|Overall Study|Adverse Event|0|||
127916851|NCT00084864|460318420|FG002|Overall Study|Adverse Event|0|||
127916852|NCT00084864|460318421|FG003|Overall Study|Adverse Event|0|||
127916853|NCT01456962|460318422|FG000|Overall Study|Lost to Follow-up|2|||
127916854|NCT01456962|460318423|FG001|Overall Study|Lost to Follow-up|1|||
127916855|NCT03540160|460318425|FG000|Overall Study|Protocol Violation|1|||
127916856|NCT03540160|460318425|FG000|Overall Study|Physician Decision|8|||
127916857|NCT03540160|460318425|FG000|Overall Study|Lack of Efficacy|60|||
127916858|NCT03540160|460318425|FG000|Overall Study|Pregnancy|1|||
127916859|NCT03540160|460318425|FG000|Overall Study|Adverse Event|20|||
127916860|NCT03540160|460318425|FG000|Overall Study|Withdrawal by Subject|68|||
127916861|NCT03540160|460318425|FG000|Overall Study|COVID-19|2|||
127916862|NCT03540160|460318425|FG000|Overall Study|Study Closure|10|||
127916863|NCT03540160|460318425|FG000|Overall Study|Lost to Follow-up|18|||
127916864|NCT03540160|460318425|FG000|Overall Study|Sponsor decision|191|||
127916865|NCT03358147|460318430|FG000|Overall Study|Withdrawal by Subject|13|||
127867178|NCT01632345|460132304|FG005|Treatment: Part I|Physician Decision|0|||
127867179|NCT01632345|460132305|FG006|Treatment: Part I|Physician Decision|0|||
127867180|NCT01632345|460132299|FG000|Treatment: Part I|Pregnancy|0|||
127867181|NCT01632345|460132300|FG001|Treatment: Part I|Pregnancy|1|||
127867182|NCT01632345|460132301|FG002|Treatment: Part I|Pregnancy|0|||
127916866|NCT03358147|460318431|FG001|Overall Study|Withdrawal by Subject|19|||
127916867|NCT03358147|460318432|FG002|Overall Study|Withdrawal by Subject|16|||
127916868|NCT03358147|460318433|FG003|Overall Study|Withdrawal by Subject|10|||
127867183|NCT01632345|460132302|FG003|Treatment: Part I|Pregnancy|0|||
127867184|NCT01632345|460132303|FG004|Treatment: Part I|Pregnancy|0|||
127916869|NCT03358147|460318434|FG004|Overall Study|Withdrawal by Subject|5|||
127916870|NCT03358147|460318430|FG000|Overall Study|Adverse Event|3|||
127916871|NCT03358147|460318431|FG001|Overall Study|Adverse Event|9|||
127916872|NCT03358147|460318432|FG002|Overall Study|Adverse Event|7|||
127916873|NCT03358147|460318433|FG003|Overall Study|Adverse Event|5|||
127916874|NCT03358147|460318434|FG004|Overall Study|Adverse Event|2|||
127916875|NCT03358147|460318430|FG000|Overall Study|Lost to Follow-up|4|||
127916876|NCT03358147|460318431|FG001|Overall Study|Lost to Follow-up|3|||
127916877|NCT03358147|460318432|FG002|Overall Study|Lost to Follow-up|7|||
127916878|NCT03358147|460318433|FG003|Overall Study|Lost to Follow-up|6|||
127916879|NCT03358147|460318434|FG004|Overall Study|Lost to Follow-up|4|||
127916880|NCT03358147|460318430|FG000|Overall Study|Major Protocol Deviation|11|||
127916881|NCT03358147|460318431|FG001|Overall Study|Major Protocol Deviation|3|||
127916882|NCT03358147|460318432|FG002|Overall Study|Major Protocol Deviation|2|||
127916883|NCT03358147|460318433|FG003|Overall Study|Major Protocol Deviation|3|||
127916884|NCT03358147|460318434|FG004|Overall Study|Major Protocol Deviation|1|||
127916885|NCT03358147|460318430|FG000|Overall Study|Protocol specified criteria|2|||
127916886|NCT03358147|460318431|FG001|Overall Study|Protocol specified criteria|3|||
127916887|NCT03358147|460318432|FG002|Overall Study|Protocol specified criteria|0|||
127916888|NCT03358147|460318433|FG003|Overall Study|Protocol specified criteria|3|||
127916889|NCT03358147|460318434|FG004|Overall Study|Protocol specified criteria|1|||
127916890|NCT03358147|460318430|FG000|Overall Study|Physician Decision|1|||
127916891|NCT03358147|460318431|FG001|Overall Study|Physician Decision|0|||
127916892|NCT03358147|460318432|FG002|Overall Study|Physician Decision|1|||
127916893|NCT03358147|460318433|FG003|Overall Study|Physician Decision|6|||
127916894|NCT03358147|460318434|FG004|Overall Study|Physician Decision|1|||
127916895|NCT03358147|460318430|FG000|Overall Study|Administrative reasons|0|||
127916896|NCT03358147|460318431|FG001|Overall Study|Administrative reasons|1|||
127916897|NCT03358147|460318432|FG002|Overall Study|Administrative reasons|0|||
127916898|NCT03358147|460318433|FG003|Overall Study|Administrative reasons|3|||
127916899|NCT03358147|460318434|FG004|Overall Study|Administrative reasons|0|||
127916900|NCT03358147|460318430|FG000|Overall Study|Lack of Efficacy|0|||
127916901|NCT03358147|460318431|FG001|Overall Study|Lack of Efficacy|1|||
127916902|NCT03358147|460318432|FG002|Overall Study|Lack of Efficacy|1|||
127916903|NCT03358147|460318433|FG003|Overall Study|Lack of Efficacy|0|||
127916904|NCT03358147|460318434|FG004|Overall Study|Lack of Efficacy|0|||
127916905|NCT02704091|460318435|FG000|Overall Study|Adverse Event|4|||
127916906|NCT02704091|460318436|FG001|Overall Study|Adverse Event|3|||
127916907|NCT02704091|460318435|FG000|Overall Study|Protocol Violation|5|||
127916908|NCT02704091|460318436|FG001|Overall Study|Protocol Violation|3|||
127916909|NCT02704091|460318435|FG000|Overall Study|Consent withdrawn|4|||
127916910|NCT02704091|460318436|FG001|Overall Study|Consent withdrawn|4|||
127916911|NCT02704091|460318435|FG000|Overall Study|Lost to Follow-up|13|||
127916912|NCT02704091|460318436|FG001|Overall Study|Lost to Follow-up|5|||
127916913|NCT02704091|460318435|FG000|Overall Study|Other|2|||
127916914|NCT02704091|460318436|FG001|Overall Study|Other|8|||
127916915|NCT03073798|460318439|FG000|Overall Study|Adverse Event|1|||
127916916|NCT03073798|460318439|FG000|Overall Study|Withdrawal by Subject|1|||
127916917|NCT02640235|460318443|FG000|Overall Study|Withdrawal by Subject|7|||
127916918|NCT02640235|460318444|FG001|Overall Study|Withdrawal by Subject|6|||
127916919|NCT02640235|460318443|FG000|Overall Study|Lost to Follow-up|4|||
127916920|NCT02640235|460318444|FG001|Overall Study|Lost to Follow-up|3|||
127916921|NCT02640235|460318443|FG000|Overall Study|Death|2|||
127916922|NCT02640235|460318444|FG001|Overall Study|Death|3|||
127916923|NCT02640235|460318443|FG000|Overall Study|Other|1|||
127916924|NCT02640235|460318444|FG001|Overall Study|Other|2|||
127916925|NCT01370863|460318445|FG000|Overall Study|Adverse Event|1|||
127916926|NCT01370863|460318446|FG001|Overall Study|Adverse Event|1|||
127916927|NCT01370863|460318445|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
127916928|NCT01370863|460318446|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
127916929|NCT01370863|460318445|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
127916930|NCT01370863|460318446|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
127916931|NCT00301964|460318447|FG000|Overall Study|Second primary|2|||
127916932|NCT00301964|460318447|FG000|Overall Study|Wrong primary|1|||
127916933|NCT00301964|460318447|FG000|Overall Study|Inadequate pathology|1|||
127916934|NCT01143337|460318448|FG000|Overall Study|Adverse Event|3|||
127916935|NCT01143337|460318449|FG001|Overall Study|Adverse Event|9|||
127916936|NCT01143337|460318450|FG002|Overall Study|Adverse Event|5|||
127916937|NCT01143337|460318448|FG000|Overall Study|Lack of Efficacy|6|||
127916938|NCT01143337|460318449|FG001|Overall Study|Lack of Efficacy|2|||
127916939|NCT01143337|460318450|FG002|Overall Study|Lack of Efficacy|1|||
127916940|NCT01143337|460318448|FG000|Overall Study|Protocol Violation|1|||
127916941|NCT01143337|460318449|FG001|Overall Study|Protocol Violation|0|||
127916942|NCT01143337|460318450|FG002|Overall Study|Protocol Violation|0|||
127916943|NCT01143337|460318448|FG000|Overall Study|Withdrawal by Subject|0|||
127916944|NCT01143337|460318449|FG001|Overall Study|Withdrawal by Subject|0|||
127916945|NCT01143337|460318450|FG002|Overall Study|Withdrawal by Subject|1|||
127867185|NCT01632345|460132304|FG005|Treatment: Part I|Pregnancy|0|||
127867186|NCT01632345|460132305|FG006|Treatment: Part I|Pregnancy|0|||
127867187|NCT01632345|460132299|FG000|Treatment: Part I|Protocol Deviation|0|||
127867188|NCT01632345|460132300|FG001|Treatment: Part I|Protocol Deviation|0|||
127867189|NCT01632345|460132301|FG002|Treatment: Part I|Protocol Deviation|1|||
127867190|NCT01632345|460132302|FG003|Treatment: Part I|Protocol Deviation|1|||
127867191|NCT01632345|460132303|FG004|Treatment: Part I|Protocol Deviation|0|||
127867192|NCT01632345|460132304|FG005|Treatment: Part I|Protocol Deviation|0|||
127867193|NCT01632345|460132305|FG006|Treatment: Part I|Protocol Deviation|0|||
127867194|NCT01632345|460132299|FG000|Treatment: Part I|Withdrawal by Subject|3|||
127867195|NCT01632345|460132300|FG001|Treatment: Part I|Withdrawal by Subject|4|||
127867196|NCT01632345|460132301|FG002|Treatment: Part I|Withdrawal by Subject|4|||
127867197|NCT01632345|460132302|FG003|Treatment: Part I|Withdrawal by Subject|1|||
127867198|NCT01632345|460132303|FG004|Treatment: Part I|Withdrawal by Subject|4|||
127867199|NCT01632345|460132304|FG005|Treatment: Part I|Withdrawal by Subject|0|||
127867200|NCT01632345|460132305|FG006|Treatment: Part I|Withdrawal by Subject|0|||
127867201|NCT01632345|460132299|FG000|Treatment: Part II|Adverse Event|0|||
127867202|NCT01632345|460132300|FG001|Treatment: Part II|Adverse Event|0|||
127867203|NCT01632345|460132301|FG002|Treatment: Part II|Adverse Event|0|||
127867204|NCT01632345|460132302|FG003|Treatment: Part II|Adverse Event|0|||
127867205|NCT01632345|460132303|FG004|Treatment: Part II|Adverse Event|0|||
127867206|NCT01632345|460132304|FG005|Treatment: Part II|Adverse Event|3|||
127867207|NCT01632345|460132305|FG006|Treatment: Part II|Adverse Event|8|||
127867208|NCT01632345|460132299|FG000|Treatment: Part II|Lost to Follow-up|0|||
127867209|NCT01632345|460132300|FG001|Treatment: Part II|Lost to Follow-up|0|||
127867210|NCT01632345|460132301|FG002|Treatment: Part II|Lost to Follow-up|0|||
127867211|NCT01632345|460132302|FG003|Treatment: Part II|Lost to Follow-up|0|||
127867212|NCT01632345|460132303|FG004|Treatment: Part II|Lost to Follow-up|0|||
127867213|NCT01632345|460132304|FG005|Treatment: Part II|Lost to Follow-up|3|||
127867214|NCT01632345|460132305|FG006|Treatment: Part II|Lost to Follow-up|1|||
127867215|NCT01632345|460132299|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
127867216|NCT01632345|460132300|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
127867217|NCT01632345|460132301|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
127867218|NCT01632345|460132302|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
127867219|NCT01632345|460132303|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
127867220|NCT01632345|460132304|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
127867221|NCT01632345|460132305|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
127867222|NCT01632345|460132299|FG000|Treatment: Part II|Withdrawal by Subject|0|||
127867223|NCT01632345|460132300|FG001|Treatment: Part II|Withdrawal by Subject|0|||
127867224|NCT01632345|460132301|FG002|Treatment: Part II|Withdrawal by Subject|0|||
127867225|NCT01632345|460132302|FG003|Treatment: Part II|Withdrawal by Subject|0|||
127867226|NCT01632345|460132303|FG004|Treatment: Part II|Withdrawal by Subject|0|||
127867227|NCT01632345|460132304|FG005|Treatment: Part II|Withdrawal by Subject|2|||
127867228|NCT01632345|460132305|FG006|Treatment: Part II|Withdrawal by Subject|2|||
127867229|NCT03370133|460132315|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
127867230|NCT03370133|460132316|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
127867231|NCT03370133|460132317|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
127867232|NCT03370133|460132318|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
127867233|NCT03370133|460132319|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
127867234|NCT03370133|460132320|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
127867235|NCT03370133|460132315|FG000|Initial Treatment Period (WK 16)|Death|1|||
127867236|NCT03370133|460132316|FG001|Initial Treatment Period (WK 16)|Death|1|||
127867237|NCT03370133|460132317|FG002|Initial Treatment Period (WK 16)|Death|1|||
127867238|NCT03370133|460132318|FG003|Initial Treatment Period (WK 16)|Death|0|||
127867239|NCT03370133|460132319|FG004|Initial Treatment Period (WK 16)|Death|0|||
127867240|NCT03370133|460132320|FG005|Initial Treatment Period (WK 16)|Death|0|||
127867241|NCT03370133|460132315|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
127867242|NCT03370133|460132316|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
127867243|NCT03370133|460132317|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
127867244|NCT03370133|460132318|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
127867245|NCT03370133|460132319|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
127867246|NCT03370133|460132320|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
127867247|NCT03370133|460132315|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
127867248|NCT03370133|460132316|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
127867249|NCT03370133|460132317|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
127867250|NCT03370133|460132318|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
127867251|NCT03370133|460132319|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
127867252|NCT03370133|460132320|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
127867253|NCT03370133|460132315|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
127867254|NCT03370133|460132316|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
127867255|NCT03370133|460132317|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
127867256|NCT03370133|460132318|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
127867257|NCT03370133|460132319|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
127867258|NCT03370133|460132320|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
127867259|NCT03370133|460132315|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
127867260|NCT03370133|460132316|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
127867261|NCT03370133|460132317|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
127867262|NCT03370133|460132318|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
127867263|NCT03370133|460132319|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
127867264|NCT03370133|460132320|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
127867265|NCT03370133|460132315|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
127867266|NCT03370133|460132316|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
127867267|NCT03370133|460132317|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
127867268|NCT03370133|460132318|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
127867269|NCT03370133|460132319|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
127867270|NCT03370133|460132320|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
127867271|NCT03370133|460132315|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
127867272|NCT03370133|460132316|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
127867273|NCT03370133|460132317|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
127867274|NCT03370133|460132318|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
127867275|NCT03370133|460132319|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
127867276|NCT03370133|460132320|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
127867277|NCT03370133|460132315|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
127867278|NCT03370133|460132316|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
127867279|NCT03370133|460132317|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
127867280|NCT03370133|460132318|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
127867281|NCT03370133|460132319|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
127867282|NCT03370133|460132320|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
127867283|NCT03370133|460132315|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
127867284|NCT03370133|460132316|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
127867285|NCT03370133|460132317|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
127867286|NCT03370133|460132318|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
127867287|NCT03370133|460132319|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
127867288|NCT03370133|460132320|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
127867289|NCT03370133|460132315|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
127867290|NCT03370133|460132316|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
127867291|NCT03370133|460132317|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
127867292|NCT03370133|460132318|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
127867293|NCT03370133|460132319|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
127867294|NCT03370133|460132320|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
127867295|NCT03370133|460132315|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
127867296|NCT03370133|460132316|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
127867297|NCT03370133|460132317|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
127867298|NCT03370133|460132318|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
127867299|NCT03370133|460132319|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
127867300|NCT03370133|460132320|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
127867301|NCT03370133|460132315|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
127867302|NCT03370133|460132316|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
127867303|NCT03370133|460132317|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
127867304|NCT03370133|460132318|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
127867305|NCT03370133|460132319|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
127867306|NCT03370133|460132320|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
127867307|NCT03370133|460132315|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
127867308|NCT03370133|460132316|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
127867309|NCT03370133|460132317|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
127867310|NCT03370133|460132318|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
127867311|NCT03370133|460132319|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
127867312|NCT03370133|460132320|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
127867313|NCT03370133|460132315|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
127867314|NCT03370133|460132316|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
127867315|NCT03370133|460132317|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
127867316|NCT03370133|460132318|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
127867317|NCT03370133|460132319|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
127867318|NCT03370133|460132320|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
127867319|NCT03524664|460132321|FG000|Overall Study|Withdrawal by Subject|1|||
127867320|NCT03524664|460132322|FG001|Overall Study|Withdrawal by Subject|2|||
127916946|NCT01143337|460318448|FG000|Overall Study|Other reason|0|||
127916947|NCT01143337|460318449|FG001|Overall Study|Other reason|0|||
127916948|NCT01143337|460318450|FG002|Overall Study|Other reason|5|||
127916949|NCT02761915|460318451|FG000|Overall Study|Death|3|||
127916950|NCT02761915|460318452|FG001|Overall Study|Death|1|||
127916951|NCT02761915|460318453|FG002|Overall Study|Death|1|||
127916952|NCT02761915|460318454|FG003|Overall Study|Death|1|||
127916953|NCT02761915|460318455|FG004|Overall Study|Death|0|||
127916954|NCT02761915|460318456|FG005|Overall Study|Death|1|||
127916955|NCT02761915|460318451|FG000|Overall Study|Withdrawal by Subject|1|||
127916956|NCT02761915|460318452|FG001|Overall Study|Withdrawal by Subject|0|||
127916957|NCT02761915|460318453|FG002|Overall Study|Withdrawal by Subject|0|||
127916958|NCT02761915|460318454|FG003|Overall Study|Withdrawal by Subject|0|||
127916959|NCT02761915|460318455|FG004|Overall Study|Withdrawal by Subject|1|||
127916960|NCT02761915|460318456|FG005|Overall Study|Withdrawal by Subject|2|||
127916961|NCT02761915|460318451|FG000|Overall Study|Disease Progression|0|||
127916962|NCT02761915|460318452|FG001|Overall Study|Disease Progression|0|||
127916963|NCT02761915|460318453|FG002|Overall Study|Disease Progression|0|||
127916964|NCT02761915|460318454|FG003|Overall Study|Disease Progression|2|||
127916965|NCT02761915|460318455|FG004|Overall Study|Disease Progression|2|||
127916966|NCT02761915|460318456|FG005|Overall Study|Disease Progression|2|||
127916967|NCT00819169|460318467|FG000|Overall Study|Withdrawal by Subject|2|||
127916968|NCT00819169|460318468|FG001|Overall Study|Withdrawal by Subject|0|||
127916969|NCT00819169|460318469|FG002|Overall Study|Withdrawal by Subject|0|||
127916970|NCT00819169|460318470|FG003|Overall Study|Withdrawal by Subject|1|||
127916971|NCT00819169|460318471|FG004|Overall Study|Withdrawal by Subject|1|||
127916972|NCT00819169|460318472|FG005|Overall Study|Withdrawal by Subject|1|||
127916973|NCT00819169|460318473|FG006|Overall Study|Withdrawal by Subject|5|||
127916974|NCT00819169|460318474|FG007|Overall Study|Withdrawal by Subject|1|||
127916975|NCT00819169|460318475|FG008|Overall Study|Withdrawal by Subject|4|||
127916976|NCT00819169|460318467|FG000|Overall Study|Lost to Follow-up|0|||
127916977|NCT00819169|460318468|FG001|Overall Study|Lost to Follow-up|2|||
127916978|NCT00819169|460318469|FG002|Overall Study|Lost to Follow-up|0|||
127916979|NCT00819169|460318470|FG003|Overall Study|Lost to Follow-up|1|||
127916980|NCT00819169|460318471|FG004|Overall Study|Lost to Follow-up|0|||
127916981|NCT00819169|460318472|FG005|Overall Study|Lost to Follow-up|6|||
127916982|NCT00819169|460318473|FG006|Overall Study|Lost to Follow-up|2|||
127916983|NCT00819169|460318474|FG007|Overall Study|Lost to Follow-up|2|||
127916984|NCT00819169|460318475|FG008|Overall Study|Lost to Follow-up|1|||
127916985|NCT00819169|460318467|FG000|Overall Study|Death|1|||
127916986|NCT00819169|460318468|FG001|Overall Study|Death|1|||
127916987|NCT00819169|460318469|FG002|Overall Study|Death|3|||
127916988|NCT00819169|460318470|FG003|Overall Study|Death|8|||
127916989|NCT00819169|460318471|FG004|Overall Study|Death|5|||
127916990|NCT00819169|460318472|FG005|Overall Study|Death|7|||
127916991|NCT00819169|460318473|FG006|Overall Study|Death|9|||
127916992|NCT00819169|460318474|FG007|Overall Study|Death|4|||
127916993|NCT00819169|460318475|FG008|Overall Study|Death|7|||
127916994|NCT00819169|460318467|FG000|Overall Study|Ineligibility determined|0|||
127916995|NCT00819169|460318468|FG001|Overall Study|Ineligibility determined|0|||
127916996|NCT00819169|460318469|FG002|Overall Study|Ineligibility determined|0|||
127916997|NCT00819169|460318470|FG003|Overall Study|Ineligibility determined|2|||
127916998|NCT00819169|460318471|FG004|Overall Study|Ineligibility determined|0|||
127916999|NCT00819169|460318472|FG005|Overall Study|Ineligibility determined|0|||
127917000|NCT00819169|460318473|FG006|Overall Study|Ineligibility determined|0|||
127917001|NCT00819169|460318474|FG007|Overall Study|Ineligibility determined|0|||
127917002|NCT00819169|460318475|FG008|Overall Study|Ineligibility determined|1|||
127917003|NCT00819169|460318467|FG000|Overall Study|Adverse Event|0|||
127917004|NCT00819169|460318468|FG001|Overall Study|Adverse Event|0|||
127917005|NCT00819169|460318469|FG002|Overall Study|Adverse Event|0|||
127917006|NCT00819169|460318470|FG003|Overall Study|Adverse Event|0|||
127917007|NCT00819169|460318471|FG004|Overall Study|Adverse Event|1|||
127917008|NCT00819169|460318472|FG005|Overall Study|Adverse Event|0|||
127917009|NCT00819169|460318473|FG006|Overall Study|Adverse Event|0|||
127917010|NCT00819169|460318474|FG007|Overall Study|Adverse Event|0|||
127917011|NCT00819169|460318475|FG008|Overall Study|Adverse Event|0|||
127917012|NCT00819169|460318467|FG000|Overall Study|Administrative Decision|0|||
127917013|NCT00819169|460318468|FG001|Overall Study|Administrative Decision|0|||
127917014|NCT00819169|460318469|FG002|Overall Study|Administrative Decision|0|||
127917015|NCT00819169|460318470|FG003|Overall Study|Administrative Decision|0|||
127917016|NCT00819169|460318471|FG004|Overall Study|Administrative Decision|1|||
127917017|NCT00819169|460318472|FG005|Overall Study|Administrative Decision|2|||
127917018|NCT00819169|460318473|FG006|Overall Study|Administrative Decision|0|||
127917019|NCT00819169|460318474|FG007|Overall Study|Administrative Decision|2|||
127917020|NCT00819169|460318475|FG008|Overall Study|Administrative Decision|0|||
127917021|NCT00406393|460318476|FG000|Overall Study|Did not undergo transplantation|2|||
127917022|NCT00406393|460318477|FG001|Overall Study|Did not undergo transplantation|1|||
127917023|NCT01663896|460318478|FG000|Overall Study|Various reasons|43|||
127917024|NCT01046084|460318480|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
127917025|NCT01046084|460318481|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
127917026|NCT00379353|460318482|FG000|Overall Study|Hospitalization|3|||
127917027|NCT00379353|460318483|FG001|Overall Study|Hospitalization|3|||
127917028|NCT00379353|460318482|FG000|Overall Study|Withdrawal by Subject|5|||
127917029|NCT00379353|460318483|FG001|Overall Study|Withdrawal by Subject|2|||
127917030|NCT00379353|460318482|FG000|Overall Study|Death|1|||
127917031|NCT00379353|460318483|FG001|Overall Study|Death|0|||
127917032|NCT00379353|460318482|FG000|Overall Study|Cardiac Tamponade|1|||
127917033|NCT00379353|460318483|FG001|Overall Study|Cardiac Tamponade|0|||
127917034|NCT00379353|460318482|FG000|Overall Study|Non-compliance|1|||
127917035|NCT00379353|460318483|FG001|Overall Study|Non-compliance|0|||
127917036|NCT00379353|460318482|FG000|Overall Study|Conflicting drug treatment|0|||
127917037|NCT00379353|460318483|FG001|Overall Study|Conflicting drug treatment|1|||
127917038|NCT03614728|460318484|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
127917039|NCT03614728|460318485|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
127917040|NCT03614728|460318486|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
127867321|NCT03524664|460132321|FG000|Overall Study|Lost to Follow-up|4|||
127867322|NCT03524664|460132322|FG001|Overall Study|Lost to Follow-up|13|||
127867323|NCT02694562|460132323|FG000|Overall Study|Death|8|||
127867324|NCT02694562|460132323|FG000|Overall Study|Protocol Violation|4|||
127867325|NCT02694562|460132323|FG000|Overall Study|Lost to Follow-up|3|||
127867326|NCT02694562|460132323|FG000|Overall Study|Screen Failure|2|||
127867327|NCT02694562|460132323|FG000|Overall Study|Physician Decision|1|||
127867328|NCT01333865|460132324|FG000|Overall Study|Adverse Event|2|||
127867329|NCT00684073|460132325|FG000|Selection|Selection/non-selection criteria|3|||
127867330|NCT00684073|460132325|FG000|Selection|Death|1|||
127867331|NCT00684073|460132325|FG000|Selection|noncompliance|1|||
127867332|NCT00684073|460132325|FG000|Selection|Lost to Follow-up|1|||
127867333|NCT00684073|460132325|FG000|Selection|request of the sponsor|1|||
127867334|NCT00684073|460132325|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
127867335|NCT00620815|460132328|FG000|Overall Study|Adverse Event|1|||
127867336|NCT00620815|460132329|FG001|Overall Study|Adverse Event|1|||
127867337|NCT00620815|460132330|FG002|Overall Study|Adverse Event|2|||
127867338|NCT00620815|460132328|FG000|Overall Study|Withdrawal by Subject|1|||
127867339|NCT00620815|460132329|FG001|Overall Study|Withdrawal by Subject|2|||
127867340|NCT00620815|460132330|FG002|Overall Study|Withdrawal by Subject|0|||
127867341|NCT00620815|460132328|FG000|Overall Study|Lost to Follow-up|1|||
127867342|NCT00620815|460132329|FG001|Overall Study|Lost to Follow-up|6|||
127867343|NCT00620815|460132330|FG002|Overall Study|Lost to Follow-up|3|||
127867344|NCT00620815|460132328|FG000|Overall Study|Inappropriate enrolment|0|||
127867345|NCT00620815|460132329|FG001|Overall Study|Inappropriate enrolment|0|||
127867346|NCT00620815|460132330|FG002|Overall Study|Inappropriate enrolment|1|||
127867347|NCT00620815|460132328|FG000|Overall Study|Protocol Violation|1|||
127867348|NCT00620815|460132329|FG001|Overall Study|Protocol Violation|2|||
127867349|NCT00620815|460132330|FG002|Overall Study|Protocol Violation|1|||
127867350|NCT01888367|460132331|FG000|Overall Study|Physician Decision|3|||
127867351|NCT01888367|460132332|FG001|Overall Study|Physician Decision|4|||
127867352|NCT01888367|460132333|FG002|Overall Study|Physician Decision|2|||
127867353|NCT01888367|460132331|FG000|Overall Study|Death|2|||
127867354|NCT01888367|460132332|FG001|Overall Study|Death|0|||
127867355|NCT01888367|460132333|FG002|Overall Study|Death|1|||
127867356|NCT01888367|460132331|FG000|Overall Study|Withdrawal by Subject|1|||
127867357|NCT01888367|460132332|FG001|Overall Study|Withdrawal by Subject|0|||
127867358|NCT01888367|460132333|FG002|Overall Study|Withdrawal by Subject|1|||
127867359|NCT01888367|460132331|FG000|Overall Study|Lost to Follow-up|1|||
127867360|NCT01888367|460132332|FG001|Overall Study|Lost to Follow-up|1|||
127867361|NCT01888367|460132333|FG002|Overall Study|Lost to Follow-up|0|||
127867362|NCT01888367|460132331|FG000|Overall Study|Protocol Violation|0|||
127867363|NCT01888367|460132332|FG001|Overall Study|Protocol Violation|0|||
127867364|NCT01888367|460132333|FG002|Overall Study|Protocol Violation|1|||
127867365|NCT01888367|460132331|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
127867366|NCT01888367|460132332|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
127867367|NCT01888367|460132333|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
127867368|NCT00877929|460132335|FG000|Overall Study|Adverse Event|11|||
127867369|NCT00877929|460132336|FG001|Overall Study|Adverse Event|20|||
127867370|NCT00877929|460132335|FG000|Overall Study|Protocol Violation|3|||
127867371|NCT00877929|460132336|FG001|Overall Study|Protocol Violation|3|||
127867372|NCT00877929|460132335|FG000|Overall Study|Lost to Follow-up|0|||
127867373|NCT00877929|460132336|FG001|Overall Study|Lost to Follow-up|1|||
127867374|NCT00877929|460132335|FG000|Overall Study|Withdrawal by Subject|4|||
127867375|NCT00877929|460132336|FG001|Overall Study|Withdrawal by Subject|4|||
127867376|NCT00877929|460132335|FG000|Overall Study|Lack of Efficacy|0|||
127867377|NCT00877929|460132336|FG001|Overall Study|Lack of Efficacy|1|||
127867378|NCT00877929|460132335|FG000|Overall Study|Other reason (not specified)|2|||
127867379|NCT00877929|460132336|FG001|Overall Study|Other reason (not specified)|6|||
127867380|NCT00689728|460132338|FG000|Double-Blind Treatment|Adverse Event|1|||
127867381|NCT00689728|460132339|FG001|Double-Blind Treatment|Adverse Event|0|||
127867382|NCT00689728|460132340|FG002|Double-Blind Treatment|Adverse Event|0|||
127867383|NCT00689728|460132338|FG000|Double-Blind Treatment|Protocol Violation|0|||
127867384|NCT00689728|460132339|FG001|Double-Blind Treatment|Protocol Violation|0|||
127867385|NCT00689728|460132340|FG002|Double-Blind Treatment|Protocol Violation|1|||
127867386|NCT00689728|460132338|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
127867387|NCT00689728|460132339|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
127867388|NCT00689728|460132340|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
127867389|NCT00689728|460132338|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
127917041|NCT03614728|460318487|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
127917042|NCT03614728|460318484|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
127917043|NCT03614728|460318485|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
127917044|NCT03614728|460318486|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
127917045|NCT03614728|460318487|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
127917046|NCT01958476|460318490|FG000|Overall Study|Parent requested exclusion from analysis|1|||
127917047|NCT01958476|460318491|FG001|Overall Study|Parent requested exclusion from analysis|0|||
127917048|NCT01691612|460318492|FG000|Overall Study|deemed ineligible after 1st visit|6|||
127917049|NCT01691612|460318492|FG000|Overall Study|Adverse Event|1|||
127917050|NCT05412121|460318495|FG000|Overall Study|Withdrawal by Subject|4|||
127917051|NCT05412121|460318495|FG000|Overall Study|Physician Decision|1|||
127917052|NCT05412121|460318495|FG000|Overall Study|Lost to Follow-up|5|||
127917053|NCT00537095|460318496|FG000|Randomized Treatment Period (433 Days)|Adverse Event|24|||
127917054|NCT00537095|460318497|FG001|Randomized Treatment Period (433 Days)|Adverse Event|4|||
127917055|NCT00537095|460318496|FG000|Randomized Treatment Period (433 Days)|Objective Disease Progression|21|||
127917056|NCT00537095|460318497|FG001|Randomized Treatment Period (433 Days)|Objective Disease Progression|48|||
127917057|NCT00537095|460318496|FG000|Randomized Treatment Period (433 Days)|Death|3|||
127917058|NCT00537095|460318497|FG001|Randomized Treatment Period (433 Days)|Death|1|||
127917059|NCT00537095|460318496|FG000|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
127917060|NCT00537095|460318497|FG001|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
127917061|NCT00537095|460318496|FG000|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|1|||
127917062|NCT00537095|460318497|FG001|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|2|||
127917063|NCT00537095|460318496|FG000|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|21|||
127917064|NCT00537095|460318497|FG001|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|16|||
127917065|NCT00537095|460318496|FG000|Open-label Period (590 Days)|Adverse Event|2|||
127917066|NCT00537095|460318497|FG001|Open-label Period (590 Days)|Adverse Event|11|||
127917067|NCT00537095|460318496|FG000|Open-label Period (590 Days)|Objective Disease Progression|2|||
127917068|NCT00537095|460318497|FG001|Open-label Period (590 Days)|Objective Disease Progression|21|||
127917069|NCT00537095|460318496|FG000|Open-label Period (590 Days)|Death|2|||
127917070|NCT00537095|460318497|FG001|Open-label Period (590 Days)|Death|2|||
127917071|NCT00537095|460318496|FG000|Open-label Period (590 Days)|Withdrawal by Subject|1|||
127917072|NCT00537095|460318497|FG001|Open-label Period (590 Days)|Withdrawal by Subject|2|||
127917073|NCT00537095|460318496|FG000|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|5|||
127917074|NCT00537095|460318497|FG001|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|3|||
127917075|NCT00566722|460318498|FG000|Overall Study|Adverse Event|0|||
127917076|NCT00566722|460318499|FG001|Overall Study|Adverse Event|1|||
127917077|NCT00566722|460318500|FG002|Overall Study|Adverse Event|0|||
127917078|NCT00566722|460318498|FG000|Overall Study|Withdrawal by Subject|0|||
127917079|NCT00566722|460318499|FG001|Overall Study|Withdrawal by Subject|0|||
127917080|NCT00566722|460318500|FG002|Overall Study|Withdrawal by Subject|1|||
127867390|NCT00689728|460132339|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
127867391|NCT00689728|460132340|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
127867392|NCT00689728|460132338|FG000|Rescue|Adverse Event|0|||
127867393|NCT00689728|460132339|FG001|Rescue|Adverse Event|1|||
127867394|NCT00689728|460132340|FG002|Rescue|Adverse Event|0|||
127867395|NCT00689728|460132338|FG000|Rescue|Withdrawal by Subject|1|||
127867396|NCT00689728|460132339|FG001|Rescue|Withdrawal by Subject|1|||
127867397|NCT00689728|460132340|FG002|Rescue|Withdrawal by Subject|1|||
127867398|NCT00689728|460132338|FG000|Optional Follow-Up|Adverse Event|1|||
127867399|NCT00689728|460132339|FG001|Optional Follow-Up|Adverse Event|0|||
127867400|NCT00689728|460132340|FG002|Optional Follow-Up|Adverse Event|0|||
127867401|NCT00689728|460132338|FG000|Optional Follow-Up|Lack of Efficacy|0|||
127867402|NCT00689728|460132339|FG001|Optional Follow-Up|Lack of Efficacy|1|||
127867403|NCT00689728|460132340|FG002|Optional Follow-Up|Lack of Efficacy|1|||
127867404|NCT00689728|460132338|FG000|Optional Follow-Up|Lost to Follow-up|0|||
127867405|NCT00689728|460132339|FG001|Optional Follow-Up|Lost to Follow-up|1|||
127867406|NCT00689728|460132340|FG002|Optional Follow-Up|Lost to Follow-up|1|||
127867407|NCT00689728|460132338|FG000|Optional Follow-Up|Protocol Violation|0|||
127867408|NCT00689728|460132339|FG001|Optional Follow-Up|Protocol Violation|0|||
127867409|NCT00689728|460132340|FG002|Optional Follow-Up|Protocol Violation|1|||
127867410|NCT00689728|460132338|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
127867411|NCT00689728|460132339|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
127867412|NCT00689728|460132340|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
127867413|NCT03590613|460132344|FG000|Period 2, 4 Days|Physician Decision|0|||
127867414|NCT03590613|460132345|FG001|Period 2, 4 Days|Physician Decision|0|||
127867415|NCT03590613|460132346|FG002|Period 2, 4 Days|Physician Decision|0|||
127867416|NCT03590613|460132347|FG003|Period 2, 4 Days|Physician Decision|1|||
127867417|NCT00280059|460132348|FG000|Efficacy Assessment Phase|Death|2|||
127867418|NCT00280059|460132349|FG001|Efficacy Assessment Phase|Death|0|||
127867419|NCT00280059|460132348|FG000|Efficacy Assessment Phase|Adverse Event|33|||
127867420|NCT00280059|460132349|FG001|Efficacy Assessment Phase|Adverse Event|31|||
127867421|NCT00280059|460132348|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
127867422|NCT00280059|460132349|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
127867423|NCT00280059|460132348|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
127867424|NCT00280059|460132349|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
127867425|NCT00280059|460132348|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
127867426|NCT00280059|460132349|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
127867427|NCT00280059|460132348|FG000|Efficacy Assessment Phase|Other|7|||
127867428|NCT00280059|460132349|FG001|Efficacy Assessment Phase|Other|8|||
127867429|NCT00280059|460132348|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
127867430|NCT00280059|460132349|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
127867431|NCT01130831|460132354|FG000|Overall Study|Withdrawal by Subject|7|||
127867432|NCT01130831|460132354|FG000|Overall Study|Death|4|||
127867433|NCT01130831|460132354|FG000|Overall Study|Information was missing|3|||
127867434|NCT00951912|460132355|FG000|Overall Study|Lack of Efficacy|1|||
127867435|NCT00951912|460132356|FG001|Overall Study|Lack of Efficacy|0|||
127867436|NCT00951912|460132357|FG002|Overall Study|Lack of Efficacy|0|||
127867437|NCT00951912|460132355|FG000|Overall Study|Adverse Event|0|||
127867438|NCT00951912|460132356|FG001|Overall Study|Adverse Event|1|||
127867439|NCT00951912|460132357|FG002|Overall Study|Adverse Event|1|||
127867440|NCT00951912|460132355|FG000|Overall Study|Lost to Follow-up|2|||
127917081|NCT00566722|460318498|FG000|Overall Study|Lost to Follow-up|1|||
127917082|NCT00566722|460318499|FG001|Overall Study|Lost to Follow-up|1|||
127917083|NCT00566722|460318500|FG002|Overall Study|Lost to Follow-up|1|||
127917084|NCT00566722|460318498|FG000|Overall Study|Lack of Efficacy|1|||
127917085|NCT00566722|460318499|FG001|Overall Study|Lack of Efficacy|2|||
127917086|NCT00566722|460318500|FG002|Overall Study|Lack of Efficacy|4|||
127917087|NCT00566722|460318498|FG000|Overall Study|Did not meet exclusion criteria|0|||
127917088|NCT00566722|460318499|FG001|Overall Study|Did not meet exclusion criteria|0|||
127917089|NCT00566722|460318500|FG002|Overall Study|Did not meet exclusion criteria|2|||
127867441|NCT00951912|460132356|FG001|Overall Study|Lost to Follow-up|2|||
127867442|NCT00951912|460132357|FG002|Overall Study|Lost to Follow-up|0|||
127867443|NCT00951912|460132355|FG000|Overall Study|Physician Decision|1|||
127867444|NCT00951912|460132356|FG001|Overall Study|Physician Decision|0|||
127867445|NCT00951912|460132357|FG002|Overall Study|Physician Decision|1|||
127867446|NCT00951912|460132355|FG000|Overall Study|Withdrawal by Subject|1|||
127867447|NCT00951912|460132356|FG001|Overall Study|Withdrawal by Subject|1|||
127917090|NCT00566722|460318498|FG000|Overall Study|Serious adverse event|0|||
127917091|NCT00566722|460318499|FG001|Overall Study|Serious adverse event|1|||
127867448|NCT00951912|460132357|FG002|Overall Study|Withdrawal by Subject|0|||
127867449|NCT00951912|460132355|FG000|Overall Study|Other:Depression|1|||
127867450|NCT00951912|460132356|FG001|Overall Study|Other:Depression|0|||
127867451|NCT00951912|460132357|FG002|Overall Study|Other:Depression|0|||
127867452|NCT00951912|460132355|FG000|Overall Study|Other: Colon cancer|1|||
127867453|NCT00951912|460132356|FG001|Overall Study|Other: Colon cancer|0|||
127917092|NCT00566722|460318500|FG002|Overall Study|Serious adverse event|0|||
127917093|NCT00566722|460318498|FG000|Overall Study|Noncompliant with drug administration|0|||
127917094|NCT00566722|460318499|FG001|Overall Study|Noncompliant with drug administration|0|||
127917095|NCT00566722|460318500|FG002|Overall Study|Noncompliant with drug administration|1|||
127917096|NCT01390948|460318501|FG000|Overall Study|End of Study|1|||
127917097|NCT01390948|460318502|FG001|Overall Study|End of Study|0|||
127917098|NCT01390948|460318503|FG002|Overall Study|End of Study|0|||
127917099|NCT01390948|460318501|FG000|Overall Study|Withdrew consent|2|||
127917100|NCT01390948|460318502|FG001|Overall Study|Withdrew consent|2|||
127917101|NCT01390948|460318503|FG002|Overall Study|Withdrew consent|0|||
127917102|NCT01390948|460318501|FG000|Overall Study|Progressive Disease|2|||
127917103|NCT01390948|460318502|FG001|Overall Study|Progressive Disease|5|||
127917104|NCT01390948|460318503|FG002|Overall Study|Progressive Disease|0|||
127917105|NCT01390948|460318501|FG000|Overall Study|Death during follow-up|10|||
127917106|NCT01390948|460318502|FG001|Overall Study|Death during follow-up|11|||
127917107|NCT01390948|460318503|FG002|Overall Study|Death during follow-up|1|||
127917108|NCT05315713|460318504|FG000|Overall Study|Death|5|||
127917109|NCT05315713|460318504|FG000|Overall Study|Progressive disease|1|||
127917110|NCT05315713|460318504|FG000|Overall Study|Withdrawal by Subject|1|||
127917111|NCT05315713|460318504|FG000|Overall Study|Study terminated by sponsor|1|||
127917112|NCT00556673|460318507|FG000|Overall Study|Protocol deviation|3|||
127917113|NCT00556673|460318508|FG001|Overall Study|Protocol deviation|2|||
127917114|NCT01401062|460318511|FG000|Overall Study|Death|9|||
127867454|NCT00951912|460132357|FG002|Overall Study|Other: Colon cancer|0|||
127867455|NCT00951912|460132355|FG000|Overall Study|Other: Stroke|0|||
127867456|NCT00951912|460132356|FG001|Overall Study|Other: Stroke|1|||
127867457|NCT00951912|460132357|FG002|Overall Study|Other: Stroke|0|||
127867458|NCT03417999|460132358|FG000|Overall Study|Withdrawal by Subject|1|||
127867459|NCT03417999|460132359|FG001|Overall Study|Withdrawal by Subject|0|||
127867460|NCT03417999|460132360|FG002|Overall Study|Withdrawal by Subject|0|||
127867461|NCT03417999|460132358|FG000|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
127867462|NCT03417999|460132359|FG001|Overall Study|Procedure cancelled; subject did not receive study drug|0|||
127867463|NCT03417999|460132360|FG002|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
127867464|NCT03417999|460132358|FG000|Overall Study|Met exclusion criteria after obtaining consent|0|||
127867465|NCT03417999|460132359|FG001|Overall Study|Met exclusion criteria after obtaining consent|0|||
127867466|NCT03417999|460132360|FG002|Overall Study|Met exclusion criteria after obtaining consent|1|||
127867467|NCT03417999|460132358|FG000|Overall Study|Inadequate study staff available to process samples|0|||
127867468|NCT03417999|460132359|FG001|Overall Study|Inadequate study staff available to process samples|0|||
127867469|NCT03417999|460132360|FG002|Overall Study|Inadequate study staff available to process samples|1|||
127867470|NCT01513460|460132365|FG000|Overall Study|Death|0|||
127867471|NCT01513460|460132366|FG001|Overall Study|Death|0|||
127867472|NCT01513460|460132367|FG002|Overall Study|Death|1|||
127867473|NCT01513460|460132365|FG000|Overall Study|Lost to Follow-up|0|||
127867474|NCT01513460|460132366|FG001|Overall Study|Lost to Follow-up|0|||
127867475|NCT01513460|460132367|FG002|Overall Study|Lost to Follow-up|2|||
127867476|NCT01513460|460132365|FG000|Overall Study|Abnormal laboratory value|1|||
127867477|NCT01513460|460132366|FG001|Overall Study|Abnormal laboratory value|0|||
127867478|NCT01513460|460132367|FG002|Overall Study|Abnormal laboratory value|1|||
127867479|NCT01513460|460132365|FG000|Overall Study|Lack of Efficacy|1|||
127867480|NCT01513460|460132366|FG001|Overall Study|Lack of Efficacy|2|||
127867481|NCT01513460|460132367|FG002|Overall Study|Lack of Efficacy|5|||
127867482|NCT01513460|460132365|FG000|Overall Study|Protocol deviations|3|||
127867483|NCT01513460|460132366|FG001|Overall Study|Protocol deviations|4|||
127867484|NCT01513460|460132367|FG002|Overall Study|Protocol deviations|3|||
127867485|NCT01513460|460132365|FG000|Overall Study|Withdrawal by Subject|7|||
127867486|NCT01513460|460132366|FG001|Overall Study|Withdrawal by Subject|8|||
127867487|NCT01513460|460132367|FG002|Overall Study|Withdrawal by Subject|21|||
127867488|NCT01513460|460132365|FG000|Overall Study|Adverse Event|16|||
127867489|NCT01513460|460132366|FG001|Overall Study|Adverse Event|18|||
127867490|NCT01513460|460132367|FG002|Overall Study|Adverse Event|23|||
127867491|NCT01513460|460132365|FG000|Overall Study|Abnormal test procedure|1|||
127867492|NCT01513460|460132366|FG001|Overall Study|Abnormal test procedure|0|||
127867493|NCT01513460|460132367|FG002|Overall Study|Abnormal test procedure|0|||
127867494|NCT00489216|460132368|FG000|Overall Study|Adverse Event|1|||
127867495|NCT00422942|460132373|FG000|Overall Study|Study terminated by Sponsor|3|||
127867496|NCT02612194|460132374|FG000|Overall Study|Death|5|||
127867497|NCT02612194|460132375|FG001|Overall Study|Death|0|||
127867498|NCT02612194|460132376|FG002|Overall Study|Death|2|||
127867499|NCT02612194|460132374|FG000|Overall Study|Early Study Termination|1|||
127867500|NCT02612194|460132375|FG001|Overall Study|Early Study Termination|0|||
127867501|NCT02612194|460132376|FG002|Overall Study|Early Study Termination|0|||
127867502|NCT02539160|460132377|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
127867503|NCT02539160|460132378|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
127917115|NCT01401062|460318512|FG001|Overall Study|Death|7|||
127917116|NCT01401062|460318511|FG000|Overall Study|Physician Decision|1|||
127917117|NCT01401062|460318512|FG001|Overall Study|Physician Decision|0|||
127867504|NCT02539160|460132379|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
127867505|NCT02539160|460132380|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
127867506|NCT02539160|460132377|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
127867507|NCT02539160|460132378|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
127867508|NCT02539160|460132379|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
127867509|NCT02539160|460132380|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
127867510|NCT02539160|460132377|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
127867511|NCT02539160|460132378|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
127867512|NCT02539160|460132379|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
127867513|NCT02539160|460132380|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
127867514|NCT01681004|460132383|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
127867515|NCT01681004|460132384|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
127867516|NCT01681004|460132383|FG000|Study Completion|Lost to Follow-up|8|||
127867517|NCT01681004|460132384|FG001|Study Completion|Lost to Follow-up|3|||
127867518|NCT01681004|460132383|FG000|Study Completion|Physician Decision|1|||
127867519|NCT01681004|460132384|FG001|Study Completion|Physician Decision|3|||
127867520|NCT01681004|460132383|FG000|Study Completion|Site Termination|2|||
127867521|NCT01681004|460132384|FG001|Study Completion|Site Termination|1|||
127867522|NCT01681004|460132383|FG000|Study Completion|Death|1|||
127867523|NCT01681004|460132384|FG001|Study Completion|Death|1|||
127867524|NCT00372905|460132385|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
127867525|NCT00372905|460132386|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
127867526|NCT00372905|460132387|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
127867527|NCT00372905|460132388|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
127867528|NCT00372905|460132385|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
127867529|NCT00372905|460132386|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
127867530|NCT00372905|460132387|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
127867531|NCT00372905|460132388|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
127867532|NCT00372905|460132385|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
127867533|NCT00372905|460132386|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
127867534|NCT00372905|460132387|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
127867535|NCT00372905|460132388|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
127867536|NCT00372905|460132385|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
127867537|NCT00372905|460132386|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
127867538|NCT00372905|460132387|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
127867539|NCT00372905|460132388|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
127867540|NCT00372905|460132385|FG000|Follow up Until Relapse or Progression|Study closed|0|||
127867541|NCT00372905|460132386|FG001|Follow up Until Relapse or Progression|Study closed|0|||
127867542|NCT00372905|460132387|FG002|Follow up Until Relapse or Progression|Study closed|0|||
127867543|NCT00372905|460132388|FG003|Follow up Until Relapse or Progression|Study closed|3|||
127867544|NCT00372905|460132385|FG000|Follow up Until Relapse or Progression|Other|0|||
127867545|NCT00372905|460132386|FG001|Follow up Until Relapse or Progression|Other|1|||
127867546|NCT00372905|460132387|FG002|Follow up Until Relapse or Progression|Other|0|||
127867547|NCT00372905|460132388|FG003|Follow up Until Relapse or Progression|Other|0|||
127867548|NCT02312934|460132389|FG000|Overall Study|Lost to Follow-up|1|||
127867549|NCT02312934|460132390|FG001|Overall Study|Lost to Follow-up|0|||
127867550|NCT02312934|460132389|FG000|Overall Study|Physician Decision|1|||
127867551|NCT02312934|460132390|FG001|Overall Study|Physician Decision|0|||
127867552|NCT00701064|460132392|FG000|Overall Study|Protocol Violation|1|||
127867553|NCT00701064|460132393|FG001|Overall Study|Protocol Violation|1|||
127867554|NCT00701064|460132392|FG000|Overall Study|Withdrawal by Subject|1|||
127867555|NCT00701064|460132393|FG001|Overall Study|Withdrawal by Subject|1|||
127867556|NCT00701064|460132392|FG000|Overall Study|initiated other PTSD treatment|2|||
127867557|NCT00701064|460132393|FG001|Overall Study|initiated other PTSD treatment|2|||
127867558|NCT00689299|460132394|FG000|Overall Study|Adverse Event|2|||
127867559|NCT00689299|460132395|FG001|Overall Study|Adverse Event|1|||
127867560|NCT00689299|460132396|FG002|Overall Study|Adverse Event|1|||
127867561|NCT00689299|460132394|FG000|Overall Study|Lost to Follow-up|0|||
127867562|NCT00689299|460132395|FG001|Overall Study|Lost to Follow-up|1|||
127867563|NCT00689299|460132396|FG002|Overall Study|Lost to Follow-up|1|||
127867564|NCT00689299|460132394|FG000|Overall Study|Withdrawal by Subject|4|||
127867565|NCT00689299|460132395|FG001|Overall Study|Withdrawal by Subject|1|||
127867566|NCT00689299|460132396|FG002|Overall Study|Withdrawal by Subject|3|||
127867567|NCT00689299|460132394|FG000|Overall Study|Protocol Violation|1|||
127867568|NCT00689299|460132395|FG001|Overall Study|Protocol Violation|0|||
127867569|NCT00689299|460132396|FG002|Overall Study|Protocol Violation|0|||
127867570|NCT02613910|460132399|FG000|Overall Study|Termination of study|1|||
127867571|NCT02098733|460132400|FG000|Overall Study|Data Not Available|5|||
127867572|NCT02098733|460132400|FG000|Overall Study|Lost to Follow-up|5|||
127867573|NCT03395704|460132401|FG000|Overall Study|Adverse Event|2|||
127867574|NCT03395704|460132402|FG001|Overall Study|Adverse Event|1|||
127867575|NCT03395704|460132401|FG000|Overall Study|Withdrawal by Subject|2|||
127867576|NCT03395704|460132402|FG001|Overall Study|Withdrawal by Subject|1|||
127867577|NCT03395704|460132401|FG000|Overall Study|Physician Decision|0|||
127867578|NCT03395704|460132402|FG001|Overall Study|Physician Decision|1|||
127867579|NCT00434876|460132405|FG000|Overall Study|Lost to Follow-up|1|||
127867580|NCT00434876|460132406|FG001|Overall Study|Lost to Follow-up|1|||
127867581|NCT00758394|460132407|FG000|2nd Intervention Order|Lost to Follow-up|0|||
127867582|NCT00758394|460132408|FG001|2nd Intervention Order|Lost to Follow-up|1|||
127867583|NCT00758394|460132409|FG002|2nd Intervention Order|Lost to Follow-up|0|||
127867584|NCT00758394|460132410|FG003|2nd Intervention Order|Lost to Follow-up|0|||
127867585|NCT00758394|460132407|FG000|3rd Intervention|Lost to Follow-up|1|||
127867586|NCT00758394|460132408|FG001|3rd Intervention|Lost to Follow-up|0|||
127867587|NCT00758394|460132409|FG002|3rd Intervention|Lost to Follow-up|0|||
127867588|NCT00758394|460132410|FG003|3rd Intervention|Lost to Follow-up|1|||
127867589|NCT04823494|460133539|FG000|Overall Study|Programming software malfunction.|1|||
127867590|NCT04823494|460133540|FG001|Overall Study|Programming software malfunction.|0|||
127867591|NCT04823494|460133539|FG000|Overall Study|Withdrawal by Subject|1|||
127867592|NCT04823494|460133540|FG001|Overall Study|Withdrawal by Subject|0|||
127867593|NCT04823494|460133539|FG000|Overall Study|Devices lost|0|||
127867594|NCT04823494|460133540|FG001|Overall Study|Devices lost|1|||
127867595|NCT03726320|460133541|FG000|Overall Study|Lost to Follow-up|2|||
127867596|NCT03726320|460133542|FG001|Overall Study|Lost to Follow-up|4|||
127867597|NCT03726320|460133543|FG002|Overall Study|Lost to Follow-up|0|||
127867598|NCT03726320|460133541|FG000|Overall Study|Time Constraints|4|||
127867599|NCT03726320|460133542|FG001|Overall Study|Time Constraints|1|||
127867600|NCT03726320|460133543|FG002|Overall Study|Time Constraints|0|||
127867601|NCT03726320|460133541|FG000|Overall Study|Ineligible after enrollment|3|||
127867602|NCT03726320|460133542|FG001|Overall Study|Ineligible after enrollment|3|||
127867603|NCT03726320|460133543|FG002|Overall Study|Ineligible after enrollment|0|||
127867604|NCT03726320|460133541|FG000|Overall Study|Clinic / insurance issue|2|||
127867605|NCT03726320|460133542|FG001|Overall Study|Clinic / insurance issue|0|||
127867606|NCT03726320|460133543|FG002|Overall Study|Clinic / insurance issue|0|||
127867607|NCT03726320|460133541|FG000|Overall Study|Language barrier|1|||
127867608|NCT03726320|460133542|FG001|Overall Study|Language barrier|0|||
127867609|NCT03726320|460133543|FG002|Overall Study|Language barrier|0|||
127867610|NCT03726320|460133541|FG000|Overall Study|Provider left the clinic|0|||
127867611|NCT03726320|460133542|FG001|Overall Study|Provider left the clinic|0|||
127867612|NCT03726320|460133543|FG002|Overall Study|Provider left the clinic|1|||
127867613|NCT03691831|460133546|FG000|Overall Study|Lost to Follow-up|16|||
127867614|NCT03691831|460133547|FG001|Overall Study|Lost to Follow-up|12|||
127867615|NCT03691831|460133546|FG000|Overall Study|Withdrawal by Subject|9|||
127867616|NCT03691831|460133547|FG001|Overall Study|Withdrawal by Subject|17|||
127867617|NCT03691831|460133546|FG000|Overall Study|Investigator Decision|2|||
127867618|NCT03691831|460133547|FG001|Overall Study|Investigator Decision|2|||
127867619|NCT03922945|460133548|FG000|Overall Study|Adverse Event|1|||
127867620|NCT03922945|460133549|FG001|Overall Study|Adverse Event|1|||
127867621|NCT03922945|460133550|FG002|Overall Study|Adverse Event|2|||
127867622|NCT03922945|460133548|FG000|Overall Study|Lost to Follow-up|13|||
127867623|NCT03922945|460133549|FG001|Overall Study|Lost to Follow-up|9|||
127867624|NCT03922945|460133550|FG002|Overall Study|Lost to Follow-up|20|||
127867625|NCT03922945|460133548|FG000|Overall Study|Lack of Efficacy|2|||
127867626|NCT03922945|460133549|FG001|Overall Study|Lack of Efficacy|0|||
127867627|NCT03922945|460133550|FG002|Overall Study|Lack of Efficacy|1|||
127867628|NCT03922945|460133548|FG000|Overall Study|Protocol Non-Compliance|0|||
127867629|NCT03922945|460133549|FG001|Overall Study|Protocol Non-Compliance|0|||
127867630|NCT03922945|460133550|FG002|Overall Study|Protocol Non-Compliance|1|||
127867631|NCT03922945|460133548|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
127867632|NCT03922945|460133549|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
127917118|NCT01401062|460318511|FG000|Overall Study|Withdrawal by Subject|1|||
127917119|NCT01401062|460318512|FG001|Overall Study|Withdrawal by Subject|1|||
127917120|NCT01131260|460318513|FG000|Overall Study|Randomization error|5|||
127917121|NCT01131260|460318514|FG001|Overall Study|Randomization error|1|||
127867633|NCT03922945|460133550|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
127917122|NCT01131260|460318513|FG000|Overall Study|Declined to continue participation|8|||
127917123|NCT01131260|460318514|FG001|Overall Study|Declined to continue participation|13|||
127917124|NCT01131260|460318513|FG000|Overall Study|Physician Decision|22|||
127917125|NCT01131260|460318514|FG001|Overall Study|Physician Decision|24|||
127917126|NCT01131260|460318513|FG000|Overall Study|Technical problems|7|||
127917127|NCT01131260|460318514|FG001|Overall Study|Technical problems|6|||
127917128|NCT01131260|460318513|FG000|Overall Study|Staff error|2|||
127917129|NCT01131260|460318514|FG001|Overall Study|Staff error|1|||
127917130|NCT01131260|460318513|FG000|Overall Study|Ineligible|0|||
127917131|NCT01131260|460318514|FG001|Overall Study|Ineligible|2|||
127917132|NCT00757172|460318515|FG000|Overall Study|Withdrawal by Subject|4|||
127917133|NCT00757172|460318515|FG000|Overall Study|Physician Decision|3|||
127917134|NCT00757172|460318515|FG000|Overall Study|Progression|4|||
127867634|NCT03922945|460133548|FG000|Overall Study|All Other Personal Reasons|1|||
127867635|NCT03922945|460133549|FG001|Overall Study|All Other Personal Reasons|1|||
127867636|NCT03922945|460133550|FG002|Overall Study|All Other Personal Reasons|2|||
127867637|NCT00039377|460133552|FG000|Initial Registration|Adverse Event|2|||
127867638|NCT00039377|460133553|FG001|Initial Registration|Adverse Event|0|||
127867639|NCT00039377|460133554|FG002|Initial Registration|Adverse Event|0|||
127867640|NCT00039377|460133555|FG003|Initial Registration|Adverse Event|0|||
127867641|NCT00039377|460133552|FG000|Initial Registration|Relapsed|6|||
127867642|NCT00039377|460133553|FG001|Initial Registration|Relapsed|0|||
127867643|NCT00039377|460133554|FG002|Initial Registration|Relapsed|0|||
127867644|NCT00039377|460133555|FG003|Initial Registration|Relapsed|0|||
127867645|NCT00039377|460133552|FG000|Initial Registration|Received non-protocol therapy|11|||
127867646|NCT00039377|460133553|FG001|Initial Registration|Received non-protocol therapy|0|||
127867647|NCT00039377|460133554|FG002|Initial Registration|Received non-protocol therapy|0|||
127867648|NCT00039377|460133555|FG003|Initial Registration|Received non-protocol therapy|0|||
127867649|NCT00039377|460133552|FG000|Initial Registration|Withdrawal by Subject|3|||
127867650|NCT00039377|460133553|FG001|Initial Registration|Withdrawal by Subject|0|||
127867651|NCT00039377|460133554|FG002|Initial Registration|Withdrawal by Subject|0|||
127867652|NCT00039377|460133555|FG003|Initial Registration|Withdrawal by Subject|0|||
127867653|NCT04067310|460133559|FG000|Overall Study|Physician Decision|2|||
127867654|NCT04067310|460133560|FG001|Overall Study|Physician Decision|6|||
127867655|NCT04067310|460133559|FG000|Overall Study|Lost to Follow-up|0|||
127867656|NCT04067310|460133560|FG001|Overall Study|Lost to Follow-up|1|||
127867657|NCT04067310|460133559|FG000|Overall Study|Withdrawal by Subject|3|||
127867658|NCT04067310|460133560|FG001|Overall Study|Withdrawal by Subject|0|||
127867659|NCT01347931|460133561|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
127867660|NCT02493712|460133562|FG000|Overall Study|Withdrawal by Subject|1|||
127867661|NCT02493712|460133563|FG001|Overall Study|Withdrawal by Subject|0|||
127867662|NCT02493712|460133564|FG002|Overall Study|Withdrawal by Subject|2|||
127917135|NCT03555695|460318516|FG000|Overall Study|Withdrawal by Subject|1|||
127917136|NCT03555695|460318516|FG000|Overall Study|Lost to Follow-up|1|||
127917137|NCT03555695|460318516|FG000|Overall Study|appendicitis (unrelated)|1|||
127917138|NCT03555695|460318516|FG000|Overall Study|pre-existing sciatica|1|||
127917139|NCT04194151|460318519|FG000|Overall Study|Physician Decision|1|||
127917140|NCT04194151|460318520|FG001|Overall Study|Physician Decision|1|||
127917141|NCT04194151|460318521|FG002|Overall Study|Physician Decision|1|||
127917142|NCT04194151|460318522|FG003|Overall Study|Physician Decision|1|||
127917143|NCT04194151|460318523|FG004|Overall Study|Physician Decision|0|||
127917144|NCT04194151|460318524|FG005|Overall Study|Physician Decision|1|||
127917145|NCT04194151|460318519|FG000|Overall Study|Monitorization problem|0|||
127917146|NCT04194151|460318520|FG001|Overall Study|Monitorization problem|1|||
127917147|NCT04194151|460318521|FG002|Overall Study|Monitorization problem|0|||
127917148|NCT04194151|460318522|FG003|Overall Study|Monitorization problem|0|||
127867663|NCT02493712|460133562|FG000|Overall Study|Protocol Violation|0|||
127867664|NCT02493712|460133563|FG001|Overall Study|Protocol Violation|0|||
127867665|NCT02493712|460133564|FG002|Overall Study|Protocol Violation|1|||
127917149|NCT04194151|460318523|FG004|Overall Study|Monitorization problem|0|||
127917150|NCT04194151|460318524|FG005|Overall Study|Monitorization problem|0|||
127917151|NCT01499043|460318526|FG000|Overall Study|Progressive disease (radiographic)|2|||
127917152|NCT01499043|460318526|FG000|Overall Study|Progressive disease (clinical)|1|||
127917153|NCT01499043|460318526|FG000|Overall Study|Withdrawal by Subject|2|||
127917154|NCT01499043|460318526|FG000|Overall Study|Adverse Event|1|||
127917155|NCT04203823|460318527|FG000|Overall Study|Withdrawal by Subject|2|||
127917156|NCT04203823|460318528|FG001|Overall Study|Withdrawal by Subject|2|||
127917157|NCT04203823|460318527|FG000|Overall Study|Adverse Event|1|||
127867666|NCT02493712|460133562|FG000|Overall Study|Lost to Follow-up|1|||
127867667|NCT02493712|460133563|FG001|Overall Study|Lost to Follow-up|0|||
127917158|NCT04203823|460318528|FG001|Overall Study|Adverse Event|1|||
127867668|NCT02493712|460133564|FG002|Overall Study|Lost to Follow-up|0|||
127867669|NCT02493712|460133562|FG000|Overall Study|Physician Decision|0|||
127867670|NCT02493712|460133563|FG001|Overall Study|Physician Decision|1|||
127867671|NCT02493712|460133564|FG002|Overall Study|Physician Decision|0|||
127917159|NCT04203823|460318527|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
127917160|NCT04203823|460318528|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
127917161|NCT00438633|460318529|FG000|Overall Study|Withdrawal by Subject|1|||
127917162|NCT00438633|460318530|FG001|Overall Study|Withdrawal by Subject|0|||
127917163|NCT00438633|460318529|FG000|Overall Study|Lost to Follow-up|15|||
127917164|NCT00438633|460318530|FG001|Overall Study|Lost to Follow-up|17|||
127917165|NCT02286466|460318531|FG000|Overall Study|Death|1|||
127917166|NCT02286466|460318532|FG001|Overall Study|Death|3|||
127917167|NCT02286466|460318531|FG000|Overall Study|Withdrawal by Subject|5|||
127917168|NCT02286466|460318532|FG001|Overall Study|Withdrawal by Subject|2|||
127917169|NCT02286466|460318531|FG000|Overall Study|Lost to Follow-up|1|||
127917170|NCT02286466|460318532|FG001|Overall Study|Lost to Follow-up|4|||
127917171|NCT02286466|460318531|FG000|Overall Study|Declined Clinician Assessment|0|||
127917172|NCT02286466|460318532|FG001|Overall Study|Declined Clinician Assessment|1|||
127917173|NCT00835081|460318533|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
127917174|NCT00835081|460318534|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
127917175|NCT00421304|460318535|FG000|Overall Study|Lost to Follow-up|5|||
127917176|NCT00421304|460318536|FG001|Overall Study|Lost to Follow-up|2|||
127917177|NCT00421304|460318537|FG002|Overall Study|Lost to Follow-up|5|||
127917178|NCT00421304|460318535|FG000|Overall Study|Withdrawal by Subject|2|||
127917179|NCT00421304|460318536|FG001|Overall Study|Withdrawal by Subject|2|||
127917180|NCT00421304|460318537|FG002|Overall Study|Withdrawal by Subject|2|||
127867672|NCT02493712|460133562|FG000|Overall Study|Lack of Efficacy|0|||
127917181|NCT00421304|460318535|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
127917182|NCT00421304|460318536|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
127917183|NCT00421304|460318537|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
127917184|NCT00421304|460318535|FG000|Overall Study|Did not attend Day 360 visit|0|||
127917185|NCT00421304|460318536|FG001|Overall Study|Did not attend Day 360 visit|0|||
127917186|NCT00421304|460318537|FG002|Overall Study|Did not attend Day 360 visit|1|||
127917187|NCT03196284|460318538|FG000|Main Part|Withdrawal by Subject|0|||
127917188|NCT03196284|460318539|FG001|Main Part|Withdrawal by Subject|1|||
127867673|NCT02493712|460133563|FG001|Overall Study|Lack of Efficacy|5|||
127867674|NCT02493712|460133564|FG002|Overall Study|Lack of Efficacy|3|||
127867675|NCT01020812|460133565|FG000|Overall Study|Physician Decision|1|||
127867676|NCT01020812|460133565|FG000|Overall Study|Withdrawal by Subject|1|||
127867677|NCT01020812|460133565|FG000|Overall Study|Protocol Violation|1|||
127867678|NCT02528643|460133566|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
127867679|NCT02528643|460133567|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
127867680|NCT02528643|460133566|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
127867681|NCT02528643|460133567|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
127867682|NCT02528643|460133566|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
127867683|NCT02528643|460133567|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
127867684|NCT02528643|460133566|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
127917189|NCT03196284|460318540|FG002|Main Part|Withdrawal by Subject|0|||
127917190|NCT03196284|460318538|FG000|Extension Part|Lack of Efficacy|0|||
127917191|NCT03196284|460318539|FG001|Extension Part|Lack of Efficacy|0|||
127917192|NCT03196284|460318540|FG002|Extension Part|Lack of Efficacy|1|||
127917193|NCT03196284|460318538|FG000|Extension Part|Withdrawal by Subject|0|||
127917194|NCT03196284|460318539|FG001|Extension Part|Withdrawal by Subject|0|||
127917195|NCT03196284|460318540|FG002|Extension Part|Withdrawal by Subject|1|||
127917196|NCT03196284|460318538|FG000|Extension Part|Physician Decision|0|||
127917197|NCT03196284|460318539|FG001|Extension Part|Physician Decision|0|||
127917198|NCT03196284|460318540|FG002|Extension Part|Physician Decision|1|||
127917199|NCT01912807|460318541|FG000|Overall Study|Did not meet elegibility criteria|6|||
127867685|NCT02528643|460133567|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
127917200|NCT01912807|460318542|FG001|Overall Study|Did not meet elegibility criteria|4|||
127917201|NCT01912807|460318541|FG000|Overall Study|Lost to Follow-up|36|||
127867686|NCT02528643|460133566|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
127917202|NCT01912807|460318542|FG001|Overall Study|Lost to Follow-up|37|||
127917203|NCT02535923|460318544|FG000|Overall Study|Lost to Follow-up|5|||
127917204|NCT02535923|460318545|FG001|Overall Study|Lost to Follow-up|5|||
127917205|NCT02535923|460318544|FG000|Overall Study|Withdrawal by Subject|4|||
127917206|NCT02535923|460318545|FG001|Overall Study|Withdrawal by Subject|3|||
127917207|NCT00874276|460318551|FG000|Overall Study|Withdrawal by Subject|1|||
127917208|NCT00874276|460318552|FG001|Overall Study|Withdrawal by Subject|1|||
127917209|NCT01253564|460318555|FG000|Overall Study|Disease Progression|22|||
127867687|NCT02528643|460133567|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
127917210|NCT01253564|460318555|FG000|Overall Study|Withdrawal by Subject|1|||
127917211|NCT01253564|460318555|FG000|Overall Study|Serious Adverse Event|1|||
127917212|NCT03694197|460318558|FG000|Overall Study|Adverse Event|9|||
127867688|NCT02528643|460133566|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
127867689|NCT02528643|460133567|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
127867690|NCT02528643|460133566|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
127867691|NCT02528643|460133567|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
127867692|NCT04120116|460133568|FG000|Overall Study|Lost to Follow-up|0|||
127867693|NCT04120116|460133569|FG001|Overall Study|Lost to Follow-up|1|||
127867694|NCT04120116|460133570|FG002|Overall Study|Lost to Follow-up|0|||
127867695|NCT04120116|460133571|FG003|Overall Study|Lost to Follow-up|2|||
127867696|NCT04120116|460133568|FG000|Overall Study|Withdrawal by Subject|1|||
127867697|NCT04120116|460133569|FG001|Overall Study|Withdrawal by Subject|0|||
127867698|NCT04120116|460133570|FG002|Overall Study|Withdrawal by Subject|1|||
127867699|NCT04120116|460133571|FG003|Overall Study|Withdrawal by Subject|1|||
127867700|NCT04120116|460133568|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
127867701|NCT04120116|460133569|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
127867702|NCT04120116|460133570|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
127867703|NCT04120116|460133571|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
127867704|NCT02087085|460133572|FG000|Overall Study|Adverse Event|10|||
127867705|NCT02087085|460133573|FG001|Overall Study|Adverse Event|14|||
127867706|NCT02087085|460133572|FG000|Overall Study|Lack of Efficacy|4|||
127867707|NCT02087085|460133573|FG001|Overall Study|Lack of Efficacy|3|||
127867708|NCT02087085|460133572|FG000|Overall Study|Lost to Follow-up|6|||
127867709|NCT02087085|460133573|FG001|Overall Study|Lost to Follow-up|4|||
127867710|NCT02087085|460133572|FG000|Overall Study|Withdrawal by Subject|9|||
127867711|NCT02087085|460133573|FG001|Overall Study|Withdrawal by Subject|11|||
127867712|NCT02087085|460133572|FG000|Overall Study|Protocol Violation|1|||
127867713|NCT02087085|460133573|FG001|Overall Study|Protocol Violation|0|||
127867714|NCT02087085|460133572|FG000|Overall Study|Study Terminated by Sponsor|87|||
127867715|NCT02087085|460133573|FG001|Overall Study|Study Terminated by Sponsor|80|||
127867716|NCT02087085|460133572|FG000|Overall Study|Other Miscellaneous Reasons|3|||
127867717|NCT02087085|460133573|FG001|Overall Study|Other Miscellaneous Reasons|4|||
127867718|NCT01191190|460133574|FG000|Overall Study|Withdrawal by Subject|1|||
127867719|NCT03339999|460133582|FG000|Overall Study|Adverse Event|1|||
127867720|NCT03339999|460133583|FG001|Overall Study|Adverse Event|2|||
127867721|NCT03339999|460133584|FG002|Overall Study|Adverse Event|2|||
127867722|NCT03339999|460133585|FG003|Overall Study|Adverse Event|1|||
127867723|NCT03339999|460133582|FG000|Overall Study|Lack of Efficacy|0|||
127867724|NCT03339999|460133583|FG001|Overall Study|Lack of Efficacy|1|||
127867725|NCT03339999|460133584|FG002|Overall Study|Lack of Efficacy|0|||
127867726|NCT03339999|460133585|FG003|Overall Study|Lack of Efficacy|0|||
127867727|NCT03339999|460133582|FG000|Overall Study|Lost to Follow-up|0|||
127867728|NCT03339999|460133583|FG001|Overall Study|Lost to Follow-up|0|||
127867729|NCT03339999|460133584|FG002|Overall Study|Lost to Follow-up|0|||
127867730|NCT03339999|460133585|FG003|Overall Study|Lost to Follow-up|1|||
127867731|NCT03339999|460133582|FG000|Overall Study|Study Terminated by Sponsor|6|||
127867732|NCT03339999|460133583|FG001|Overall Study|Study Terminated by Sponsor|3|||
127867733|NCT03339999|460133584|FG002|Overall Study|Study Terminated by Sponsor|4|||
127867734|NCT03339999|460133585|FG003|Overall Study|Study Terminated by Sponsor|3|||
127867735|NCT01729559|460133591|FG000|Overall Study|Protocol Violation|31|||
127867736|NCT01729559|460133592|FG001|Overall Study|Protocol Violation|28|||
127867737|NCT03764813|460133597|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
127867738|NCT03764813|460133598|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
127867739|NCT03764813|460133599|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
127867740|NCT03764813|460133600|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
127867741|NCT01716585|460133603|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
127867742|NCT01716585|460133604|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
127867743|NCT01716585|460133603|FG000|Double-blind Treatment|Adverse Event|2|||
127867744|NCT01716585|460133604|FG001|Double-blind Treatment|Adverse Event|1|||
127867745|NCT01716585|460133603|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
127867746|NCT01716585|460133604|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
127867747|NCT01716585|460133603|FG000|Double-blind Treatment|Lost to Follow-up|2|||
127867748|NCT01716585|460133604|FG001|Double-blind Treatment|Lost to Follow-up|0|||
127867749|NCT01716585|460133603|FG000|Double-blind Treatment|Subject Noncompliant|1|||
127867750|NCT01716585|460133604|FG001|Double-blind Treatment|Subject Noncompliant|0|||
127867751|NCT01716585|460133603|FG000|Double-blind Treatment|Other|1|||
127867752|NCT01716585|460133604|FG001|Double-blind Treatment|Other|0|||
127917213|NCT03694197|460318558|FG000|Overall Study|Protocol became inconvenient to participate|1|||
127917214|NCT03694197|460318558|FG000|Overall Study|Physician Decision|4|||
127917215|NCT03694197|460318558|FG000|Overall Study|Study terminated by sponsor|1350|||
127917216|NCT03694197|460318558|FG000|Overall Study|Participant moved|5|||
127917217|NCT03694197|460318558|FG000|Overall Study|Participant withdrew consent|10|||
127917218|NCT03694197|460318558|FG000|Overall Study|Related to IMP administration|1|||
127917219|NCT03694197|460318558|FG000|Overall Study|Not disclosed|5|||
127917220|NCT03506633|460319983|FG000|Washout (14 Days)|Withdrawal by Subject|1|||
127917221|NCT03506633|460319984|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
127917222|NCT02435433|460319987|FG000|Overall Study|Withdrawal by Subject|2|||
127917223|NCT02435433|460319988|FG001|Overall Study|Withdrawal by Subject|3|||
127917224|NCT02435433|460319989|FG002|Overall Study|Withdrawal by Subject|1|||
127917225|NCT02435433|460319990|FG003|Overall Study|Withdrawal by Subject|0|||
127917226|NCT02435433|460319991|FG004|Overall Study|Withdrawal by Subject|0|||
127917227|NCT02435433|460319987|FG000|Overall Study|Lost to Follow-up|2|||
127917228|NCT02435433|460319988|FG001|Overall Study|Lost to Follow-up|2|||
127917229|NCT02435433|460319989|FG002|Overall Study|Lost to Follow-up|4|||
127917230|NCT02435433|460319990|FG003|Overall Study|Lost to Follow-up|1|||
127917231|NCT02435433|460319991|FG004|Overall Study|Lost to Follow-up|0|||
127917232|NCT00757705|460319992|FG000|Overall Study|Adverse Event|19|||
127917233|NCT00757705|460319992|FG000|Overall Study|Lost to Follow-up|16|||
127917234|NCT00757705|460319992|FG000|Overall Study|Withdrawal by Subject|25|||
127917235|NCT00757705|460319992|FG000|Overall Study|Insufficient Response|26|||
127917236|NCT00757705|460319992|FG000|Overall Study|Ineligible to continue|8|||
127917237|NCT00757705|460319992|FG000|Overall Study|Non-compliant|9|||
127917238|NCT00757705|460319992|FG000|Overall Study|Other|18|||
127917239|NCT00659815|460319993|FG000|Overall Study|Study related symptoms and complaints|2|||
127917240|NCT00659815|460319994|FG001|Overall Study|Study related symptoms and complaints|1|||
127917241|NCT00659815|460319993|FG000|Overall Study|Inability to maintain wearing schedule|1|||
127867753|NCT01716585|460133603|FG000|Open-label Treatment|Adverse Event|0|||
127867754|NCT01716585|460133604|FG001|Open-label Treatment|Adverse Event|2|||
127867755|NCT01716585|460133603|FG000|Open-label Treatment|Virologic Failure|0|||
127867756|NCT01716585|460133604|FG001|Open-label Treatment|Virologic Failure|2|||
127917242|NCT00659815|460319994|FG001|Overall Study|Inability to maintain wearing schedule|2|||
127917243|NCT00659815|460319993|FG000|Overall Study|Withdrawal by Subject|1|||
127917244|NCT00659815|460319994|FG001|Overall Study|Withdrawal by Subject|1|||
127917245|NCT00735696|460319995|FG000|Overall Study|Withdrawal by Subject|1|||
127917246|NCT00735696|460319995|FG000|Overall Study|Enrolled but never Treated|1|||
127917247|NCT00640393|460320001|FG000|Part 1|Lost to Follow-up|2|||
127867757|NCT01716585|460133603|FG000|Open-label Treatment|Withdrawal by Subject|0|||
127867758|NCT01716585|460133604|FG001|Open-label Treatment|Withdrawal by Subject|3|||
127867759|NCT01707667|460133607|FG000|Period 1|expulsion of colonic sensor catheter|1|||
127867760|NCT01707667|460133608|FG001|Period 1|expulsion of colonic sensor catheter|0|||
127867761|NCT04382066|460133613|FG000|Overall Study|Adverse Event|1|||
127867762|NCT04382066|460133614|FG001|Overall Study|Adverse Event|0|||
127867763|NCT04382066|460133615|FG002|Overall Study|Adverse Event|0|||
127867764|NCT04382066|460133613|FG000|Overall Study|Death|1|||
127867765|NCT04382066|460133614|FG001|Overall Study|Death|0|||
127867766|NCT04382066|460133615|FG002|Overall Study|Death|1|||
127867767|NCT00504595|460133616|FG000|Overall Study|Lack of Efficacy|1|||
127867768|NCT00504595|460133617|FG001|Overall Study|Lack of Efficacy|0|||
127867769|NCT00504595|460133618|FG002|Overall Study|Lack of Efficacy|0|||
127867770|NCT00504595|460133619|FG003|Overall Study|Lack of Efficacy|0|||
127867771|NCT00504595|460133616|FG000|Overall Study|Other|0|||
127867772|NCT00504595|460133617|FG001|Overall Study|Other|0|||
127867773|NCT00504595|460133618|FG002|Overall Study|Other|2|||
127867774|NCT00504595|460133619|FG003|Overall Study|Other|0|||
127867775|NCT02764229|460133622|FG000|Overall Study|Withdrawal by Subject|15|||
127867776|NCT02764229|460133622|FG000|Overall Study|Adverse Event|9|||
127867777|NCT02764229|460133622|FG000|Overall Study|Physician Decision|5|||
127867778|NCT02764229|460133622|FG000|Overall Study|Lost to Follow-up|3|||
127867779|NCT02764229|460133622|FG000|Overall Study|Lack of Efficacy|1|||
127867780|NCT02764229|460133622|FG000|Overall Study|Study Stopped by Sponsor|69|||
127867781|NCT00779142|460133623|FG000|Overall Study|Screen Failures|3|||
127867782|NCT00851721|460133625|FG000|Overall Study|planned surgery|1|||
127867783|NCT00851721|460133626|FG001|Overall Study|planned surgery|0|||
127867784|NCT00851721|460133625|FG000|Overall Study|Death|1|||
127867785|NCT00851721|460133626|FG001|Overall Study|Death|0|||
127867786|NCT00851721|460133625|FG000|Overall Study|Adverse Event|0|||
127867787|NCT00851721|460133626|FG001|Overall Study|Adverse Event|1|||
127867788|NCT03137433|460133628|FG000|Overall Study|Withdrawal by Subject|11|||
127867789|NCT03137433|460133629|FG001|Overall Study|Withdrawal by Subject|11|||
127867790|NCT03137433|460133628|FG000|Overall Study|Lost to Follow-up|5|||
127867791|NCT03137433|460133629|FG001|Overall Study|Lost to Follow-up|6|||
127867792|NCT03137433|460133628|FG000|Overall Study|Physician Decision|2|||
127867793|NCT03137433|460133629|FG001|Overall Study|Physician Decision|0|||
127867794|NCT03137433|460133628|FG000|Overall Study|Moved out of study area|1|||
127867795|NCT03137433|460133629|FG001|Overall Study|Moved out of study area|0|||
127867796|NCT03137433|460133628|FG000|Overall Study|Too far out of window due to COVID|0|||
127867797|NCT03137433|460133629|FG001|Overall Study|Too far out of window due to COVID|1|||
127867798|NCT00265382|460133630|FG000|Overall Study|Adverse Event|21|||
127867799|NCT00265382|460133630|FG000|Overall Study|Laboratory Abnormality|1|||
127867800|NCT00265382|460133630|FG000|Overall Study|Lost to Follow-up|3|||
127867801|NCT00265382|460133630|FG000|Overall Study|Lack of Efficacy|6|||
127867802|NCT00265382|460133630|FG000|Overall Study|Miscellaneous|6|||
127867803|NCT00265382|460133630|FG000|Overall Study|Withdrawal by Subject|13|||
127867804|NCT00265382|460133630|FG000|Overall Study|Study terminated by sponsor|94|||
127867805|NCT00265382|460133630|FG000|Overall Study|Death|1|||
127867806|NCT01724021|460133632|FG000|Overall Study|Adverse Event|11|||
127867807|NCT01724021|460133633|FG001|Overall Study|Adverse Event|6|||
127867808|NCT01724021|460133632|FG000|Overall Study|Death|46|||
127867809|NCT01724021|460133633|FG001|Overall Study|Death|58|||
127867810|NCT01724021|460133632|FG000|Overall Study|Participant request/ Withdrew consent|18|||
127867811|NCT01724021|460133633|FG001|Overall Study|Participant request/ Withdrew consent|14|||
127867812|NCT01724021|460133632|FG000|Overall Study|Lost to Follow-up|15|||
127867813|NCT01724021|460133633|FG001|Overall Study|Lost to Follow-up|15|||
127867814|NCT01724021|460133632|FG000|Overall Study|Reason Not Specified|36|||
127867815|NCT01724021|460133633|FG001|Overall Study|Reason Not Specified|39|||
127867816|NCT01724021|460133632|FG000|Overall Study|Missing|1|||
127917248|NCT00640393|460320002|FG001|Part 1|Lost to Follow-up|0|||
127867817|NCT01724021|460133633|FG001|Overall Study|Missing|1|||
127867818|NCT00529152|460133634|FG000|Overall Study|Adverse Event|2|||
127867819|NCT00529152|460133634|FG000|Overall Study|Withdrawal by Subject|2|||
127867820|NCT00529152|460133634|FG000|Overall Study|Lost to Follow-up|1|||
127867821|NCT00286234|460133636|FG000|Overall Study|Protocol Violation|1|||
127867822|NCT00286234|460133637|FG001|Overall Study|Protocol Violation|2|||
127867823|NCT00286234|460133638|FG002|Overall Study|Protocol Violation|0|||
127917249|NCT00640393|460320003|FG002|Part 1|Lost to Follow-up|0|||
127917250|NCT00640393|460320001|FG000|Part 1|Withdrawal by Subject|3|||
127917251|NCT00640393|460320002|FG001|Part 1|Withdrawal by Subject|0|||
127917252|NCT00640393|460320003|FG002|Part 1|Withdrawal by Subject|0|||
127917253|NCT00640393|460320001|FG000|Randomization|Withdrawn per protocol|17|||
127917254|NCT00640393|460320002|FG001|Randomization|Withdrawn per protocol|0|||
127917255|NCT00640393|460320003|FG002|Randomization|Withdrawn per protocol|0|||
127917256|NCT00640393|460320001|FG000|Randomization|Never randomized by site|2|||
127917257|NCT00640393|460320002|FG001|Randomization|Never randomized by site|0|||
127917258|NCT00640393|460320003|FG002|Randomization|Never randomized by site|0|||
127917259|NCT00640393|460320001|FG000|Part 2|Lost to Follow-up|0|||
127917260|NCT00640393|460320002|FG001|Part 2|Lost to Follow-up|2|||
127917261|NCT00640393|460320003|FG002|Part 2|Lost to Follow-up|2|||
127917262|NCT00640393|460320001|FG000|Part 2|Withdrawal by Subject|0|||
127867824|NCT00286234|460133639|FG003|Overall Study|Protocol Violation|1|||
127867825|NCT00286234|460133636|FG000|Overall Study|Physician Decision|1|||
127867826|NCT00286234|460133637|FG001|Overall Study|Physician Decision|0|||
127867827|NCT00286234|460133638|FG002|Overall Study|Physician Decision|0|||
127867828|NCT00286234|460133639|FG003|Overall Study|Physician Decision|1|||
127867829|NCT00286234|460133636|FG000|Overall Study|Adverse Event|0|||
127867830|NCT00286234|460133637|FG001|Overall Study|Adverse Event|0|||
127867831|NCT00286234|460133638|FG002|Overall Study|Adverse Event|0|||
127867832|NCT00286234|460133639|FG003|Overall Study|Adverse Event|1|||
127867833|NCT00286234|460133636|FG000|Overall Study|Adverse Event|0|||
127867834|NCT00286234|460133637|FG001|Overall Study|Adverse Event|0|||
127867835|NCT00286234|460133638|FG002|Overall Study|Adverse Event|0|||
127867836|NCT00286234|460133639|FG003|Overall Study|Adverse Event|1|||
127867837|NCT01874288|460133641|FG000|Overall Study|Withdrawal by Subject|1|||
127867838|NCT01874288|460133642|FG001|Overall Study|Withdrawal by Subject|0|||
127867839|NCT01874288|460133643|FG002|Overall Study|Withdrawal by Subject|2|||
127867840|NCT01874288|460133644|FG003|Overall Study|Withdrawal by Subject|1|||
127867841|NCT01874288|460133645|FG004|Overall Study|Withdrawal by Subject|1|||
127867842|NCT01874288|460133641|FG000|Overall Study|Physician Decision|0|||
127867843|NCT01874288|460133642|FG001|Overall Study|Physician Decision|0|||
127867844|NCT01874288|460133643|FG002|Overall Study|Physician Decision|0|||
127867845|NCT01874288|460133644|FG003|Overall Study|Physician Decision|1|||
127867846|NCT01874288|460133645|FG004|Overall Study|Physician Decision|0|||
127867847|NCT01874288|460133641|FG000|Overall Study|Progressive disease|2|||
127867848|NCT01874288|460133642|FG001|Overall Study|Progressive disease|0|||
127867849|NCT01874288|460133643|FG002|Overall Study|Progressive disease|3|||
127867850|NCT01874288|460133644|FG003|Overall Study|Progressive disease|5|||
127867851|NCT01874288|460133645|FG004|Overall Study|Progressive disease|1|||
127867852|NCT01365468|460133646|FG000|Overall Study|Physician Decision|1|||
127867853|NCT01365468|460133647|FG001|Overall Study|Physician Decision|0|||
127867854|NCT01365468|460133646|FG000|Overall Study|Disease progression|1|||
127867855|NCT01365468|460133647|FG001|Overall Study|Disease progression|0|||
127867856|NCT01365468|460133646|FG000|Overall Study|Lost to Follow-up|2|||
127867857|NCT01365468|460133647|FG001|Overall Study|Lost to Follow-up|0|||
127867858|NCT00423267|460133648|FG000|Period A|Withdrawal by Subject|0|||
127867859|NCT00423267|460133649|FG001|Period A|Withdrawal by Subject|1|||
127867860|NCT00423267|460133648|FG000|Period A|Non-compliance with protocol|1|||
127867861|NCT00423267|460133649|FG001|Period A|Non-compliance with protocol|0|||
127867862|NCT00423267|460133648|FG000|Period A|Administrative|1|||
127867863|NCT00423267|460133649|FG001|Period A|Administrative|0|||
127867864|NCT00591786|460133652|FG000|Overall Study|Withdrawal of Informed Consent|0|||
127867865|NCT00591786|460133653|FG001|Overall Study|Withdrawal of Informed Consent|0|||
127867866|NCT00591786|460133654|FG002|Overall Study|Withdrawal of Informed Consent|1|||
127867867|NCT00591786|460133655|FG003|Overall Study|Withdrawal of Informed Consent|0|||
127867868|NCT00591786|460133656|FG004|Overall Study|Withdrawal of Informed Consent|0|||
127867869|NCT00591786|460133657|FG005|Overall Study|Withdrawal of Informed Consent|0|||
127867870|NCT00591786|460133658|FG006|Overall Study|Withdrawal of Informed Consent|0|||
127867871|NCT00591786|460133659|FG007|Overall Study|Withdrawal of Informed Consent|0|||
127867872|NCT00591786|460133660|FG008|Overall Study|Withdrawal of Informed Consent|0|||
127917263|NCT00640393|460320002|FG001|Part 2|Withdrawal by Subject|6|||
127917264|NCT00640393|460320003|FG002|Part 2|Withdrawal by Subject|1|||
127917265|NCT00640393|460320001|FG000|Part 2|Non-adherence|0|||
127917266|NCT00640393|460320002|FG001|Part 2|Non-adherence|1|||
127917267|NCT00640393|460320003|FG002|Part 2|Non-adherence|0|||
127917268|NCT00640393|460320001|FG000|Part 2|Adverse Event|0|||
127917269|NCT00640393|460320002|FG001|Part 2|Adverse Event|1|||
127867873|NCT00591786|460133661|FG009|Overall Study|Withdrawal of Informed Consent|0|||
127867874|NCT01140646|460133662|FG000|Overall Study|Adverse Event|4|||
127867875|NCT01140646|460133662|FG000|Overall Study|Refused Further Treatment|5|||
127867876|NCT00784836|460133667|FG000|Overall Study|Early Study Termination|3|||
127867877|NCT00660829|460133668|FG000|Overall Study|Adverse Event|3|||
127917270|NCT00640393|460320003|FG002|Part 2|Adverse Event|0|||
127917271|NCT04406194|460320004|FG000|Period 1|Withdrawal by Subject|0|||
127917272|NCT04406194|460320005|FG001|Period 1|Withdrawal by Subject|1|||
127917273|NCT01664039|460320006|FG000|Overall Study|Adverse Event|3|||
127917274|NCT01664039|460320007|FG001|Overall Study|Adverse Event|4|||
127917275|NCT01664039|460320006|FG000|Overall Study|Lost to Follow-up|1|||
127917276|NCT01664039|460320007|FG001|Overall Study|Lost to Follow-up|1|||
127917277|NCT01664039|460320006|FG000|Overall Study|Withdrawal by Subject|1|||
127917278|NCT01664039|460320007|FG001|Overall Study|Withdrawal by Subject|3|||
127917279|NCT01664039|460320006|FG000|Overall Study|Noncompliance|1|||
127917280|NCT01664039|460320007|FG001|Overall Study|Noncompliance|1|||
127917281|NCT01186458|460320011|FG000|Overall Study|Adverse Event|1|||
127917282|NCT00354835|460320019|FG000|Overall Study|Death|1|||
127917283|NCT00354835|460320020|FG001|Overall Study|Death|1|||
127917284|NCT00354835|460320019|FG000|Overall Study|Physician Decision|8|||
127917285|NCT00354835|460320020|FG001|Overall Study|Physician Decision|13|||
127917286|NCT00354835|460320019|FG000|Overall Study|Withdrawal by Subject|2|||
127917287|NCT00354835|460320020|FG001|Overall Study|Withdrawal by Subject|1|||
127917288|NCT00354835|460320019|FG000|Overall Study|Ineligible|17|||
127917289|NCT00354835|460320020|FG001|Overall Study|Ineligible|16|||
127917290|NCT00354835|460320019|FG000|Overall Study|Disease progression or relapse|15|||
127917291|NCT00354835|460320020|FG001|Overall Study|Disease progression or relapse|22|||
127917292|NCT00354835|460320019|FG000|Overall Study|Adverse Event|6|||
127917293|NCT00354835|460320020|FG001|Overall Study|Adverse Event|0|||
127917294|NCT00354835|460320019|FG000|Overall Study|Refusal of further therapy|3|||
127917295|NCT00354835|460320020|FG001|Overall Study|Refusal of further therapy|8|||
127917296|NCT01968551|460320021|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
127917297|NCT01968551|460320022|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
127917298|NCT01968551|460320023|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
127917299|NCT01968551|460320021|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
127917300|NCT01968551|460320022|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
127917301|NCT01968551|460320023|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
127917302|NCT01968551|460320021|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
127917303|NCT01968551|460320022|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
127917304|NCT01968551|460320023|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
127917305|NCT01968551|460320021|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
127917306|NCT01968551|460320022|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
127917307|NCT01968551|460320023|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
127917308|NCT01968551|460320021|FG000|Extension Phase|Adverse Event|0|||
127917309|NCT01968551|460320022|FG001|Extension Phase|Adverse Event|0|||
127917310|NCT01968551|460320023|FG002|Extension Phase|Adverse Event|2|||
127917311|NCT01968551|460320021|FG000|Extension Phase|Death|0|||
127917312|NCT01968551|460320022|FG001|Extension Phase|Death|1|||
127917313|NCT01968551|460320023|FG002|Extension Phase|Death|0|||
127917314|NCT01968551|460320021|FG000|Extension Phase|Withdrew Consent|0|||
127917315|NCT01968551|460320022|FG001|Extension Phase|Withdrew Consent|0|||
127917316|NCT01968551|460320023|FG002|Extension Phase|Withdrew Consent|1|||
127917317|NCT01968551|460320021|FG000|Extension Phase|Lost to Follow-up|1|||
127917318|NCT01968551|460320022|FG001|Extension Phase|Lost to Follow-up|0|||
127917319|NCT01968551|460320023|FG002|Extension Phase|Lost to Follow-up|1|||
127917320|NCT00573313|460320026|FG000|Overall Study|Protocol Violation|5|||
127917321|NCT00573313|460320027|FG001|Overall Study|Protocol Violation|0|||
127917322|NCT00573313|460320028|FG002|Overall Study|Protocol Violation|6|||
127917323|NCT00573313|460320029|FG003|Overall Study|Protocol Violation|0|||
127917324|NCT01597791|460320036|FG000|Overall Study|Physician Decision|2|||
127917325|NCT01597791|460320037|FG001|Overall Study|Physician Decision|1|||
127917326|NCT01597791|460320036|FG000|Overall Study|Cesarean Section|6|||
127917327|NCT01597791|460320037|FG001|Overall Study|Cesarean Section|7|||
127917328|NCT01597791|460320036|FG000|Overall Study|Subject withdrawal|0|||
127917329|NCT01597791|460320037|FG001|Overall Study|Subject withdrawal|1|||
127917330|NCT01597791|460320036|FG000|Overall Study|Protocol Violation|0|||
127917331|NCT01597791|460320037|FG001|Overall Study|Protocol Violation|1|||
127917332|NCT00467597|460320041|FG000|Overall Study|Withdrawal by Subject|2|||
127917333|NCT00467597|460320042|FG001|Overall Study|Withdrawal by Subject|0|||
127917334|NCT02096705|460320043|FG000|Treatment|Adverse Event|6|||
127917335|NCT02096705|460320044|FG001|Treatment|Adverse Event|3|||
127917336|NCT02096705|460320043|FG000|Treatment|Subject request to discontinue treatment|1|||
127917337|NCT02096705|460320044|FG001|Treatment|Subject request to discontinue treatment|1|||
127917338|NCT02096705|460320043|FG000|Treatment|Withdrawal by Subject|1|||
127917339|NCT02096705|460320044|FG001|Treatment|Withdrawal by Subject|0|||
127917340|NCT02096705|460320043|FG000|Treatment|Other|1|||
127917341|NCT02096705|460320044|FG001|Treatment|Other|1|||
127917342|NCT02096705|460320043|FG000|Follow-up|Withdrawal by Subject|1|||
127917343|NCT02096705|460320044|FG001|Follow-up|Withdrawal by Subject|0|||
127917344|NCT02096705|460320043|FG000|Follow-up|Adverse Event|2|||
127917345|NCT02096705|460320044|FG001|Follow-up|Adverse Event|2|||
127917346|NCT02096705|460320043|FG000|Follow-up|Subjects not reporting status|1|||
127917347|NCT02096705|460320044|FG001|Follow-up|Subjects not reporting status|2|||
127917348|NCT03277248|460320045|FG000|Overall Study|Adverse Event|3|||
127917349|NCT03277248|460320046|FG001|Overall Study|Adverse Event|1|||
127917350|NCT03277248|460320045|FG000|Overall Study|Subject Withdrawal of Consent|6|||
127917351|NCT03277248|460320046|FG001|Overall Study|Subject Withdrawal of Consent|23|||
127867878|NCT00660829|460133669|FG001|Overall Study|Adverse Event|4|||
127867879|NCT00660829|460133668|FG000|Overall Study|Lack of Efficacy|2|||
127867880|NCT00660829|460133669|FG001|Overall Study|Lack of Efficacy|3|||
127867881|NCT00660829|460133668|FG000|Overall Study|Non-Compliance|0|||
127867882|NCT00660829|460133669|FG001|Overall Study|Non-Compliance|4|||
127867883|NCT00660829|460133668|FG000|Overall Study|Withdrawal by Subject|1|||
127867884|NCT00660829|460133669|FG001|Overall Study|Withdrawal by Subject|2|||
127867885|NCT00660829|460133668|FG000|Overall Study|Lost to Follow-up|3|||
127867886|NCT00660829|460133669|FG001|Overall Study|Lost to Follow-up|2|||
127867887|NCT00660829|460133668|FG000|Overall Study|Other|9|||
127867888|NCT00660829|460133669|FG001|Overall Study|Other|4|||
127867889|NCT02127931|460133670|FG000|Overall Study|Glitch in Game|1|||
127867890|NCT00679354|460135264|FG000|Overall Study|Death|3|||
127867891|NCT00679354|460135264|FG000|Overall Study|Lack of Efficacy|22|||
127867892|NCT00679354|460135264|FG000|Overall Study|Physician Decision|4|||
127867893|NCT00679354|460135264|FG000|Overall Study|Ineligible|1|||
127867894|NCT01654666|460135269|FG000|Overall Study|Protocol Violation|7|||
127867895|NCT01654666|460135270|FG001|Overall Study|Protocol Violation|4|||
127867896|NCT01654666|460135271|FG002|Overall Study|Protocol Violation|8|||
127867897|NCT01654666|460135269|FG000|Overall Study|Lost to Follow-up|4|||
127867898|NCT01654666|460135270|FG001|Overall Study|Lost to Follow-up|5|||
127867899|NCT01654666|460135271|FG002|Overall Study|Lost to Follow-up|5|||
127867900|NCT01654666|460135269|FG000|Overall Study|Withdrawal by Subject|4|||
127867901|NCT01654666|460135270|FG001|Overall Study|Withdrawal by Subject|4|||
127867902|NCT01654666|460135271|FG002|Overall Study|Withdrawal by Subject|1|||
127867903|NCT00535262|460135274|FG000|Overall Study|No funding|3|||
127867904|NCT02898662|460135275|FG000|Overall Study|Adverse Event|1|||
127867905|NCT02898662|460135276|FG001|Overall Study|Adverse Event|0|||
127867906|NCT02898662|460135275|FG000|Overall Study|Loss of asthma control|23|||
127867907|NCT02898662|460135276|FG001|Overall Study|Loss of asthma control|24|||
127867908|NCT02898662|460135275|FG000|Overall Study|Withdrawal by Subject|4|||
127867909|NCT02898662|460135276|FG001|Overall Study|Withdrawal by Subject|1|||
127867910|NCT02898662|460135275|FG000|Overall Study|Technical issue|0|||
127867911|NCT02898662|460135276|FG001|Overall Study|Technical issue|1|||
127867912|NCT02898662|460135275|FG000|Overall Study|Randomized in error|0|||
127867913|NCT02898662|460135276|FG001|Overall Study|Randomized in error|1|||
127867914|NCT02898662|460135275|FG000|Overall Study|Subject decision|1|||
127867915|NCT02898662|460135276|FG001|Overall Study|Subject decision|0|||
127867916|NCT02898662|460135275|FG000|Overall Study|Other|0|||
127867917|NCT02898662|460135276|FG001|Overall Study|Other|1|||
127867918|NCT03802331|460135277|FG000|Treatment Period 1 (P1) + Washout|Adverse Event|1|||
127867919|NCT03802331|460135278|FG001|Treatment Period 1 (P1) + Washout|Adverse Event|0|||
127867920|NCT00917553|460135279|FG000|Overall Study|Lost to Follow-up|2|||
127867921|NCT00917553|460135280|FG001|Overall Study|Lost to Follow-up|1|||
127867922|NCT01616173|460135281|FG000|Overall Study|Lost to Follow-up|0|||
127867923|NCT01616173|460135282|FG001|Overall Study|Lost to Follow-up|2|||
127867924|NCT01616173|460135283|FG002|Overall Study|Lost to Follow-up|0|||
127867925|NCT03432819|460135286|FG000|Overall Study|Lost to Follow-up|2|||
127867926|NCT03432819|460135287|FG001|Overall Study|Lost to Follow-up|2|||
127867927|NCT03432819|460135286|FG000|Overall Study|Withdrawal by Subject|5|||
127867928|NCT03432819|460135287|FG001|Overall Study|Withdrawal by Subject|3|||
127867929|NCT03326323|460135289|FG000|Overall Study|Unable to receive ANH protocol|3|||
127867930|NCT04225026|460135291|FG000|Overall Study|Withdrawal by Subject|4|||
127867931|NCT04225026|460135291|FG000|Overall Study|Adverse Event|1|||
127867932|NCT04225026|460135291|FG000|Overall Study|Other|1|||
127867933|NCT04225026|460135291|FG000|Overall Study|Death|11|||
127867934|NCT04225026|460135291|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
127867935|NCT00672490|460135294|FG000|Overall Study|Withdrawal by Subject|8|||
127867936|NCT00672490|460135295|FG001|Overall Study|Withdrawal by Subject|8|||
127867937|NCT00672490|460135294|FG000|Overall Study|Lack of Compliance|2|||
127867938|NCT00672490|460135295|FG001|Overall Study|Lack of Compliance|7|||
127867939|NCT00672490|460135294|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
127867940|NCT00672490|460135295|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
127867941|NCT00672490|460135294|FG000|Overall Study|Adverse Event|5|||
127867942|NCT00672490|460135295|FG001|Overall Study|Adverse Event|8|||
127867943|NCT00672490|460135294|FG000|Overall Study|Violation of Concomitant Medicine|1|||
127867944|NCT00672490|460135295|FG001|Overall Study|Violation of Concomitant Medicine|0|||
127867945|NCT00672490|460135294|FG000|Overall Study|Intolerance|0|||
127867946|NCT00672490|460135295|FG001|Overall Study|Intolerance|2|||
127867947|NCT00672490|460135294|FG000|Overall Study|Lost to Follow-up|1|||
127867948|NCT00672490|460135295|FG001|Overall Study|Lost to Follow-up|5|||
127867949|NCT00672490|460135294|FG000|Overall Study|No reason was provided|6|||
127867950|NCT00672490|460135295|FG001|Overall Study|No reason was provided|2|||
127867951|NCT04738123|460135298|FG000|Overall Study|Changes in condition making participant ineligible for further treatment|1|||
127867952|NCT04738123|460135299|FG001|Overall Study|Changes in condition making participant ineligible for further treatment|0|||
127867953|NCT04738123|460135298|FG000|Overall Study|Progressive Disease|0|||
127867954|NCT04738123|460135299|FG001|Overall Study|Progressive Disease|4|||
127867955|NCT04738123|460135298|FG000|Overall Study|Adverse Event|8|||
127867956|NCT04738123|460135299|FG001|Overall Study|Adverse Event|7|||
127867957|NCT04738123|460135298|FG000|Overall Study|Other Reasons|0|||
127867958|NCT04738123|460135299|FG001|Overall Study|Other Reasons|1|||
127867959|NCT04738123|460135298|FG000|Overall Study|Suicidal or assaultive behavior|0|||
127867960|NCT04738123|460135299|FG001|Overall Study|Suicidal or assaultive behavior|2|||
127867961|NCT04738123|460135298|FG000|Overall Study|Protocol Violation|2|||
127867962|NCT04738123|460135299|FG001|Overall Study|Protocol Violation|2|||
127867963|NCT04738123|460135298|FG000|Overall Study|Consent Withdrawn|35|||
127867964|NCT04738123|460135299|FG001|Overall Study|Consent Withdrawn|22|||
127867965|NCT03604159|460135300|FG000|Overall Study|Lost to Follow-up|6|||
127867966|NCT03604159|460135301|FG001|Overall Study|Lost to Follow-up|7|||
127867967|NCT04533204|460135306|FG000|Overall Study|Unable to understand training instructions|1|||
127867968|NCT04533204|460135307|FG001|Overall Study|Unable to understand training instructions|1|||
127867969|NCT03982069|460135308|FG000|Overall Study|Lost to Follow-up|5|||
127867970|NCT03982069|460135309|FG001|Overall Study|Lost to Follow-up|5|||
127867971|NCT03982069|460135310|FG002|Overall Study|Lost to Follow-up|3|||
127867972|NCT03982069|460135311|FG003|Overall Study|Lost to Follow-up|5|||
127867973|NCT03982069|460135308|FG000|Overall Study|Physician Decision|0|||
127867974|NCT03982069|460135309|FG001|Overall Study|Physician Decision|1|||
127867975|NCT03982069|460135310|FG002|Overall Study|Physician Decision|0|||
127867976|NCT03982069|460135311|FG003|Overall Study|Physician Decision|0|||
127867977|NCT03982069|460135308|FG000|Overall Study|Withdrawal by Subject|2|||
127867978|NCT03982069|460135309|FG001|Overall Study|Withdrawal by Subject|1|||
127867979|NCT03982069|460135310|FG002|Overall Study|Withdrawal by Subject|5|||
127867980|NCT03982069|460135311|FG003|Overall Study|Withdrawal by Subject|2|||
127867981|NCT03982069|460135308|FG000|Overall Study|Specimen loss|3|||
127867982|NCT03982069|460135309|FG001|Overall Study|Specimen loss|3|||
127867983|NCT03982069|460135310|FG002|Overall Study|Specimen loss|1|||
127867984|NCT03982069|460135311|FG003|Overall Study|Specimen loss|1|||
127867985|NCT01218477|460135312|FG000|Overall Study|Disease progression|2|||
127867986|NCT01218477|460135313|FG001|Overall Study|Disease progression|3|||
127867987|NCT01218477|460135314|FG002|Overall Study|Disease progression|6|||
127867988|NCT01218477|460135315|FG003|Overall Study|Disease progression|2|||
127867989|NCT01218477|460135312|FG000|Overall Study|Study drug toxicity|0|||
127867990|NCT01218477|460135313|FG001|Overall Study|Study drug toxicity|2|||
127867991|NCT01218477|460135314|FG002|Overall Study|Study drug toxicity|5|||
127867992|NCT01218477|460135315|FG003|Overall Study|Study drug toxicity|0|||
127867993|NCT01218477|460135312|FG000|Overall Study|No longer meets study criteria|1|||
127867994|NCT01218477|460135313|FG001|Overall Study|No longer meets study criteria|0|||
127867995|NCT01218477|460135314|FG002|Overall Study|No longer meets study criteria|0|||
127867996|NCT01218477|460135315|FG003|Overall Study|No longer meets study criteria|0|||
127867997|NCT01218477|460135312|FG000|Overall Study|Withdrawal by Subject|0|||
127867998|NCT01218477|460135313|FG001|Overall Study|Withdrawal by Subject|0|||
127867999|NCT01218477|460135314|FG002|Overall Study|Withdrawal by Subject|1|||
127868000|NCT01218477|460135315|FG003|Overall Study|Withdrawal by Subject|0|||
127868001|NCT01218477|460135312|FG000|Overall Study|Prepared for cell transplantation|0|||
127868002|NCT01218477|460135313|FG001|Overall Study|Prepared for cell transplantation|1|||
127868003|NCT01218477|460135314|FG002|Overall Study|Prepared for cell transplantation|1|||
127868004|NCT01218477|460135315|FG003|Overall Study|Prepared for cell transplantation|0|||
127868005|NCT01218477|460135312|FG000|Overall Study|Administrative reason by sponsor|0|||
127868006|NCT01218477|460135313|FG001|Overall Study|Administrative reason by sponsor|0|||
127868007|NCT01218477|460135314|FG002|Overall Study|Administrative reason by sponsor|1|||
127868008|NCT01218477|460135315|FG003|Overall Study|Administrative reason by sponsor|0|||
127868009|NCT01218477|460135312|FG000|Overall Study|Maximum clinical benefit|0|||
127868010|NCT01218477|460135313|FG001|Overall Study|Maximum clinical benefit|2|||
127868011|NCT01218477|460135314|FG002|Overall Study|Maximum clinical benefit|0|||
127868012|NCT01218477|460135315|FG003|Overall Study|Maximum clinical benefit|0|||
127868013|NCT00787527|460135316|FG000|Overall Study|Toxicity|3|||
127868014|NCT00083616|460135319|FG000|Overall Study|Disease Progression|16|||
127868015|NCT00083616|460135319|FG000|Overall Study|Lost to Follow-up|1|||
127868016|NCT00083616|460135319|FG000|Overall Study|Physician Decision|2|||
127868017|NCT00083616|460135319|FG000|Overall Study|Withdrawal by Subject|3|||
127868018|NCT00083616|460135319|FG000|Overall Study|Ineligibility determined|2|||
127868019|NCT00083616|460135319|FG000|Overall Study|Non-compliance|1|||
127868020|NCT00083616|460135319|FG000|Overall Study|Other|6|||
127868021|NCT01474993|460135322|FG000|Overall Study|Lost to Follow-up|1|||
127868022|NCT01474993|460135323|FG001|Overall Study|Lost to Follow-up|2|||
127868023|NCT01474993|460135322|FG000|Overall Study|Adverse Event|0|||
127868024|NCT01474993|460135323|FG001|Overall Study|Adverse Event|1|||
127868025|NCT00760994|460135324|FG000|Overall Study|Lost to Follow-up|4|||
127868026|NCT00760994|460135325|FG001|Overall Study|Lost to Follow-up|4|||
127868027|NCT00760994|460135326|FG002|Overall Study|Lost to Follow-up|3|||
127917352|NCT03277248|460320045|FG000|Overall Study|Investigator/Sponsor Decision|2|||
127917353|NCT03277248|460320046|FG001|Overall Study|Investigator/Sponsor Decision|2|||
127917354|NCT03277248|460320045|FG000|Overall Study|Pregnancy|4|||
127917355|NCT03277248|460320046|FG001|Overall Study|Pregnancy|1|||
127917356|NCT03277248|460320045|FG000|Overall Study|Lost to Follow-up|0|||
127917357|NCT03277248|460320046|FG001|Overall Study|Lost to Follow-up|2|||
127917358|NCT03277248|460320045|FG000|Overall Study|Lack of Efficacy|0|||
127917359|NCT03277248|460320046|FG001|Overall Study|Lack of Efficacy|2|||
127917360|NCT03277248|460320045|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
127917361|NCT03277248|460320046|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
127917362|NCT02166606|460320049|FG000|Overall Study|Adverse Event|3|||
127917363|NCT02166606|460320049|FG000|Overall Study|Death|31|||
127917364|NCT02166606|460320049|FG000|Overall Study|Protocol Violation|7|||
127917365|NCT02166606|460320049|FG000|Overall Study|Lost to Follow-up|30|||
127917366|NCT02166606|460320049|FG000|Overall Study|Withdrawal by Subject|1|||
127917367|NCT02166606|460320049|FG000|Overall Study|Physician Decision|1|||
127917368|NCT02166606|460320049|FG000|Overall Study|Device upgrade|1|||
127917369|NCT02166606|460320049|FG000|Overall Study|Enrolled after End of Enrollment|4|||
127917370|NCT00884390|460320052|FG000|Overall Study|Adverse Event|0|||
127917371|NCT00884390|460320053|FG001|Overall Study|Adverse Event|1|||
127917372|NCT00884390|460320052|FG000|Overall Study|Lost to Follow-up|0|||
127917373|NCT00884390|460320053|FG001|Overall Study|Lost to Follow-up|1|||
127917374|NCT00884390|460320052|FG000|Overall Study|Physician Decision|2|||
127917375|NCT00884390|460320053|FG001|Overall Study|Physician Decision|1|||
127917376|NCT00884390|460320052|FG000|Overall Study|Protocol Violation|4|||
127917377|NCT00884390|460320053|FG001|Overall Study|Protocol Violation|1|||
127917378|NCT00884390|460320052|FG000|Overall Study|Withdrawal by Subject|4|||
127917379|NCT00884390|460320053|FG001|Overall Study|Withdrawal by Subject|1|||
127917380|NCT00884390|460320052|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
127917381|NCT00884390|460320053|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
127917382|NCT00884390|460320052|FG000|Overall Study|Other|11|||
127917383|NCT00884390|460320053|FG001|Overall Study|Other|1|||
127917384|NCT02670551|460320058|FG000|Overall Study|Adverse Event|4|||
127917385|NCT02670551|460320059|FG001|Overall Study|Adverse Event|7|||
127917386|NCT02670551|460320060|FG002|Overall Study|Adverse Event|9|||
127917387|NCT02670551|460320058|FG000|Overall Study|Lack of Efficacy|2|||
127917388|NCT02670551|460320059|FG001|Overall Study|Lack of Efficacy|0|||
127917389|NCT02670551|460320060|FG002|Overall Study|Lack of Efficacy|3|||
127917390|NCT02670551|460320058|FG000|Overall Study|Withdrawal of Consent|6|||
127917391|NCT02670551|460320059|FG001|Overall Study|Withdrawal of Consent|3|||
127917392|NCT02670551|460320060|FG002|Overall Study|Withdrawal of Consent|8|||
127917393|NCT02670551|460320058|FG000|Overall Study|Lost to Follow-up|5|||
127917394|NCT02670551|460320059|FG001|Overall Study|Lost to Follow-up|7|||
127917395|NCT02670551|460320060|FG002|Overall Study|Lost to Follow-up|6|||
127917396|NCT02670551|460320058|FG000|Overall Study|Protocol Violation|1|||
127917397|NCT02670551|460320059|FG001|Overall Study|Protocol Violation|0|||
127917398|NCT02670551|460320060|FG002|Overall Study|Protocol Violation|0|||
127917399|NCT02670551|460320058|FG000|Overall Study|Noncompliance with study drug|3|||
127917400|NCT02670551|460320059|FG001|Overall Study|Noncompliance with study drug|3|||
127917401|NCT02670551|460320060|FG002|Overall Study|Noncompliance with study drug|2|||
127917402|NCT02670551|460320058|FG000|Overall Study|Other Miscellaneous Reasons|2|||
127917403|NCT02670551|460320059|FG001|Overall Study|Other Miscellaneous Reasons|3|||
127917404|NCT02670551|460320060|FG002|Overall Study|Other Miscellaneous Reasons|3|||
127917405|NCT02670551|460320058|FG000|Overall Study|Did Not Receive Treatment|5|||
127917406|NCT02670551|460320059|FG001|Overall Study|Did Not Receive Treatment|3|||
127917407|NCT02670551|460320060|FG002|Overall Study|Did Not Receive Treatment|0|||
127917408|NCT01962298|460320062|FG000|Overall Study|Protocol Violation|1|||
127917409|NCT01962298|460320063|FG001|Overall Study|Protocol Violation|0|||
127917410|NCT01962298|460320064|FG002|Overall Study|Protocol Violation|1|||
127917411|NCT01962298|460320065|FG003|Overall Study|Protocol Violation|1|||
127917412|NCT01962298|460320066|FG004|Overall Study|Protocol Violation|0|||
127917413|NCT01962298|460320062|FG000|Overall Study|Data quality insufficient|2|||
127917414|NCT01962298|460320063|FG001|Overall Study|Data quality insufficient|0|||
127917415|NCT01962298|460320064|FG002|Overall Study|Data quality insufficient|3|||
127917416|NCT01962298|460320065|FG003|Overall Study|Data quality insufficient|1|||
127917417|NCT01962298|460320066|FG004|Overall Study|Data quality insufficient|4|||
127917418|NCT01962298|460320062|FG000|Overall Study|Insufficient data|0|||
127917419|NCT01962298|460320063|FG001|Overall Study|Insufficient data|2|||
127917420|NCT01962298|460320064|FG002|Overall Study|Insufficient data|1|||
127917421|NCT01962298|460320065|FG003|Overall Study|Insufficient data|0|||
127917422|NCT01962298|460320066|FG004|Overall Study|Insufficient data|1|||
127917423|NCT01962298|460320062|FG000|Overall Study|Incorrect data recorded|0|||
127917424|NCT01962298|460320063|FG001|Overall Study|Incorrect data recorded|1|||
127917425|NCT01962298|460320064|FG002|Overall Study|Incorrect data recorded|0|||
127917426|NCT01962298|460320065|FG003|Overall Study|Incorrect data recorded|0|||
127917427|NCT01962298|460320066|FG004|Overall Study|Incorrect data recorded|0|||
127917428|NCT01962298|460320062|FG000|Overall Study|Physician Decision|0|||
127917429|NCT01962298|460320063|FG001|Overall Study|Physician Decision|1|||
127917430|NCT01962298|460320064|FG002|Overall Study|Physician Decision|0|||
127917431|NCT01962298|460320065|FG003|Overall Study|Physician Decision|0|||
127917432|NCT01962298|460320066|FG004|Overall Study|Physician Decision|1|||
127917433|NCT01971645|460320067|FG000|Overall Study|Adverse Event|1|||
127917434|NCT01971645|460320068|FG001|Overall Study|Adverse Event|0|||
127917435|NCT01971645|460320069|FG002|Overall Study|Adverse Event|0|||
127917436|NCT01971645|460320067|FG000|Overall Study|Lost to Follow-up|1|||
127917437|NCT01971645|460320068|FG001|Overall Study|Lost to Follow-up|0|||
127917438|NCT01971645|460320069|FG002|Overall Study|Lost to Follow-up|1|||
127917439|NCT01971645|460320067|FG000|Overall Study|Protocol Violation|0|||
127917440|NCT01971645|460320068|FG001|Overall Study|Protocol Violation|0|||
127917441|NCT01971645|460320069|FG002|Overall Study|Protocol Violation|1|||
127917442|NCT04476277|460320070|FG000|Overall Study|Withdrawal by Subject|0|||
127917443|NCT04476277|460320071|FG001|Overall Study|Withdrawal by Subject|0|||
127917444|NCT04476277|460320072|FG002|Overall Study|Withdrawal by Subject|1|||
127917445|NCT04476277|460320073|FG003|Overall Study|Withdrawal by Subject|0|||
127917446|NCT00533507|460320074|FG000|Overall Study|Withdrawal by Subject|1|||
127917447|NCT01576705|460320075|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
127917448|NCT01576705|460320076|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
127917449|NCT01576705|460320077|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
127917450|NCT01576705|460320078|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
127917451|NCT01576705|460320075|FG000|Overall Study|invalid ICF|0|||
127917452|NCT01576705|460320076|FG001|Overall Study|invalid ICF|1|||
127917453|NCT01576705|460320077|FG002|Overall Study|invalid ICF|0|||
127917454|NCT01576705|460320078|FG003|Overall Study|invalid ICF|0|||
127917455|NCT02896296|460320079|FG000|Overall Study|Adverse Event|1|||
127917456|NCT02896296|460320079|FG000|Overall Study|Lost to Follow-up|19|||
127917457|NCT02896296|460320079|FG000|Overall Study|Pregnancy|1|||
127917458|NCT02896296|460320079|FG000|Overall Study|Physician Decision|2|||
127917459|NCT02896296|460320079|FG000|Overall Study|Withdrawal by Subject|10|||
127917460|NCT02896296|460320079|FG000|Overall Study|Site closing|7|||
127917461|NCT02896296|460320079|FG000|Overall Study|Incarceration|1|||
127917462|NCT02896296|460320079|FG000|Overall Study|Relocation|1|||
127917463|NCT02611323|460320080|FG000|Overall Study|Death|3|||
127917464|NCT02611323|460320081|FG001|Overall Study|Death|1|||
127917465|NCT02611323|460320082|FG002|Overall Study|Death|0|||
127917466|NCT02611323|460320083|FG003|Overall Study|Death|0|||
127917467|NCT02611323|460320084|FG004|Overall Study|Death|1|||
127917468|NCT02611323|460320085|FG005|Overall Study|Death|1|||
127917469|NCT02611323|460320086|FG006|Overall Study|Death|8|||
127917470|NCT02611323|460320087|FG007|Overall Study|Death|0|||
127917471|NCT02611323|460320088|FG008|Overall Study|Death|4|||
127917472|NCT02611323|460320089|FG009|Overall Study|Death|6|||
127917473|NCT02611323|460320090|FG010|Overall Study|Death|26|||
127917474|NCT02611323|460320080|FG000|Overall Study|Lost to Follow-up|1|||
127917475|NCT02611323|460320081|FG001|Overall Study|Lost to Follow-up|0|||
127917476|NCT02611323|460320082|FG002|Overall Study|Lost to Follow-up|0|||
127917477|NCT02611323|460320083|FG003|Overall Study|Lost to Follow-up|0|||
127917478|NCT02611323|460320084|FG004|Overall Study|Lost to Follow-up|0|||
127917479|NCT02611323|460320085|FG005|Overall Study|Lost to Follow-up|0|||
127917480|NCT02611323|460320086|FG006|Overall Study|Lost to Follow-up|3|||
127917481|NCT02611323|460320087|FG007|Overall Study|Lost to Follow-up|0|||
127917482|NCT02611323|460320088|FG008|Overall Study|Lost to Follow-up|0|||
127868028|NCT01853397|460135327|FG000|Overall Study|Withdrawal by Subject|0|||
127868029|NCT01853397|460135328|FG001|Overall Study|Withdrawal by Subject|0|||
127868030|NCT01853397|460135329|FG002|Overall Study|Withdrawal by Subject|0|||
127868031|NCT01853397|460135330|FG003|Overall Study|Withdrawal by Subject|1|||
127868032|NCT01853397|460135327|FG000|Overall Study|Subject Noncompliance|0|||
127868033|NCT01853397|460135328|FG001|Overall Study|Subject Noncompliance|0|||
127868034|NCT01853397|460135329|FG002|Overall Study|Subject Noncompliance|0|||
127868035|NCT01853397|460135330|FG003|Overall Study|Subject Noncompliance|1|||
127868036|NCT02132312|460135331|FG000|Overall Study|Adverse Event|2|||
127868037|NCT02132312|460135332|FG001|Overall Study|Adverse Event|0|||
127868038|NCT02132312|460135331|FG000|Overall Study|Physician Decision|1|||
127868039|NCT02132312|460135332|FG001|Overall Study|Physician Decision|1|||
127868040|NCT02132312|460135331|FG000|Overall Study|Protocol Violation|0|||
127868041|NCT02132312|460135332|FG001|Overall Study|Protocol Violation|1|||
127868042|NCT02132312|460135331|FG000|Overall Study|Withdrawal by Subject|1|||
127868043|NCT02132312|460135332|FG001|Overall Study|Withdrawal by Subject|0|||
127868044|NCT02132312|460135331|FG000|Overall Study|Lost to Follow-up|2|||
127917483|NCT02611323|460320089|FG009|Overall Study|Lost to Follow-up|0|||
127917484|NCT02611323|460320090|FG010|Overall Study|Lost to Follow-up|2|||
127917485|NCT02611323|460320080|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
127917486|NCT02611323|460320081|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
127917487|NCT02611323|460320082|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
127868045|NCT02132312|460135332|FG001|Overall Study|Lost to Follow-up|1|||
127868046|NCT03258710|460135333|FG000|Overall Study|Adverse Event|1|||
127917488|NCT02611323|460320083|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
127917489|NCT02611323|460320084|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
127917490|NCT02611323|460320085|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
127868047|NCT03258710|460135333|FG000|Overall Study|Protocol-defined stopping criteria|1|||
127868048|NCT03258710|460135333|FG000|Overall Study|Physician Decision|1|||
127868049|NCT02242305|460135334|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
127868050|NCT02242305|460135335|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
127868051|NCT02242305|460135334|FG000|Overall Study|Adverse Event|1|||
127868052|NCT02242305|460135335|FG001|Overall Study|Adverse Event|0|||
127868053|NCT02242305|460135334|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
127868054|NCT02242305|460135335|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
127868055|NCT02242305|460135334|FG000|Overall Study|Subject withdraws inform consent|0|||
127868056|NCT02242305|460135335|FG001|Overall Study|Subject withdraws inform consent|4|||
127868057|NCT02242305|460135334|FG000|Overall Study|Lost to Follow-up|2|||
127868058|NCT02242305|460135335|FG001|Overall Study|Lost to Follow-up|0|||
127868059|NCT03451630|460135336|FG000|Overall Study|Death|15|||
127868060|NCT03451630|460135337|FG001|Overall Study|Death|16|||
127868061|NCT03451630|460135338|FG002|Overall Study|Death|11|||
127868062|NCT03451630|460135336|FG000|Overall Study|Lost to Follow-up|9|||
127868063|NCT03451630|460135337|FG001|Overall Study|Lost to Follow-up|0|||
127868064|NCT03451630|460135338|FG002|Overall Study|Lost to Follow-up|4|||
127868065|NCT03451630|460135336|FG000|Overall Study|Withdrawal by Subject|0|||
127917491|NCT02611323|460320086|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
127917492|NCT02611323|460320087|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
127917493|NCT02611323|460320088|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
127917494|NCT02611323|460320089|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
127917495|NCT02611323|460320090|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
127917496|NCT02611323|460320080|FG000|Overall Study|Progressive Disease|0|||
127917497|NCT02611323|460320081|FG001|Overall Study|Progressive Disease|0|||
127917498|NCT02611323|460320082|FG002|Overall Study|Progressive Disease|0|||
127917499|NCT02611323|460320083|FG003|Overall Study|Progressive Disease|0|||
127917500|NCT02611323|460320084|FG004|Overall Study|Progressive Disease|0|||
127917501|NCT02611323|460320085|FG005|Overall Study|Progressive Disease|0|||
127917502|NCT02611323|460320086|FG006|Overall Study|Progressive Disease|0|||
127917503|NCT02611323|460320087|FG007|Overall Study|Progressive Disease|0|||
127917504|NCT02611323|460320088|FG008|Overall Study|Progressive Disease|0|||
127917505|NCT02611323|460320089|FG009|Overall Study|Progressive Disease|0|||
127917506|NCT02611323|460320090|FG010|Overall Study|Progressive Disease|1|||
127917507|NCT02611323|460320080|FG000|Overall Study|Withdrawal by Subject|1|||
127917508|NCT02611323|460320081|FG001|Overall Study|Withdrawal by Subject|0|||
127917509|NCT02611323|460320082|FG002|Overall Study|Withdrawal by Subject|0|||
127917510|NCT02611323|460320083|FG003|Overall Study|Withdrawal by Subject|0|||
127917511|NCT02611323|460320084|FG004|Overall Study|Withdrawal by Subject|0|||
127917512|NCT02611323|460320085|FG005|Overall Study|Withdrawal by Subject|0|||
127917513|NCT02611323|460320086|FG006|Overall Study|Withdrawal by Subject|0|||
127917514|NCT02611323|460320087|FG007|Overall Study|Withdrawal by Subject|1|||
127917515|NCT02611323|460320088|FG008|Overall Study|Withdrawal by Subject|0|||
127917516|NCT02611323|460320089|FG009|Overall Study|Withdrawal by Subject|1|||
127917517|NCT02611323|460320090|FG010|Overall Study|Withdrawal by Subject|0|||
127917518|NCT02597049|460320091|FG000|Overall Study|Lost to Follow-up|0|||
127917519|NCT02597049|460320092|FG001|Overall Study|Lost to Follow-up|3|||
127917520|NCT02597049|460320093|FG002|Overall Study|Lost to Follow-up|2|||
127917521|NCT02597049|460320091|FG000|Overall Study|Withdrawal by Subject|2|||
127917522|NCT02597049|460320092|FG001|Overall Study|Withdrawal by Subject|2|||
127917523|NCT02597049|460320093|FG002|Overall Study|Withdrawal by Subject|1|||
127917524|NCT02597049|460320091|FG000|Overall Study|Adverse Event|2|||
127917525|NCT02597049|460320092|FG001|Overall Study|Adverse Event|0|||
127917526|NCT02597049|460320093|FG002|Overall Study|Adverse Event|0|||
127917527|NCT02597049|460320091|FG000|Overall Study|Death|2|||
127917528|NCT02597049|460320092|FG001|Overall Study|Death|0|||
127917529|NCT02597049|460320093|FG002|Overall Study|Death|0|||
127917530|NCT02597049|460320091|FG000|Overall Study|Noncompliant with Study Visits|1|||
127917531|NCT02597049|460320092|FG001|Overall Study|Noncompliant with Study Visits|0|||
127917532|NCT02597049|460320093|FG002|Overall Study|Noncompliant with Study Visits|0|||
127917533|NCT00243347|460320097|FG000|Overall Study|Lack of Efficacy|4|||
127917534|NCT00243347|460320097|FG000|Overall Study|Adverse Event|2|||
127917535|NCT00243347|460320097|FG000|Overall Study|Death|1|||
127917536|NCT00243347|460320097|FG000|Overall Study|Withdrawal by Subject|5|||
127917537|NCT00243347|460320097|FG000|Overall Study|Condition worsened|7|||
127917538|NCT00045162|460320098|FG000|Overall Study|Ineligible|12|||
127868066|NCT03451630|460135337|FG001|Overall Study|Withdrawal by Subject|3|||
127868067|NCT03451630|460135338|FG002|Overall Study|Withdrawal by Subject|0|||
127868068|NCT03451630|460135336|FG000|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
127868069|NCT03451630|460135337|FG001|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|4|||
127868070|NCT03451630|460135338|FG002|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
127917539|NCT00045162|460320099|FG001|Overall Study|Ineligible|8|||
127917540|NCT00045162|460320098|FG000|Overall Study|Not treated|7|||
127917541|NCT00045162|460320099|FG001|Overall Study|Not treated|2|||
127868071|NCT00486720|460135341|FG000|Overall Study|Adverse Event|1|||
127868072|NCT00486720|460135342|FG001|Overall Study|Adverse Event|2|||
127868073|NCT00486720|460135341|FG000|Overall Study|Lack of Efficacy|4|||
127868074|NCT00486720|460135342|FG001|Overall Study|Lack of Efficacy|6|||
127868075|NCT00486720|460135341|FG000|Overall Study|Physician Decision|1|||
127868076|NCT00486720|460135342|FG001|Overall Study|Physician Decision|2|||
127868077|NCT00486720|460135341|FG000|Overall Study|Protocol Violation|1|||
127868078|NCT00486720|460135342|FG001|Overall Study|Protocol Violation|0|||
127868079|NCT00486720|460135341|FG000|Overall Study|Withdrawal by Subject|3|||
127868080|NCT00486720|460135342|FG001|Overall Study|Withdrawal by Subject|1|||
127868081|NCT00486720|460135341|FG000|Overall Study|Progressive Disease|0|||
127868082|NCT00486720|460135342|FG001|Overall Study|Progressive Disease|1|||
127868083|NCT02452892|460135343|FG000|Week 1 Initial Randommization|Adverse Event|1|||
127868084|NCT02452892|460135344|FG001|Week 1 Initial Randommization|Adverse Event|0|||
127868085|NCT02452892|460135345|FG002|Week 1 Initial Randommization|Adverse Event|0|||
127868086|NCT02452892|460135346|FG003|Week 1 Initial Randommization|Adverse Event|0|||
127868087|NCT02452892|460135343|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
127868088|NCT02452892|460135344|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
127868089|NCT02452892|460135345|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
127868090|NCT02452892|460135346|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
127868091|NCT02452892|460135343|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
127868092|NCT02452892|460135344|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
127868093|NCT02452892|460135345|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
127868094|NCT02452892|460135346|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
127868095|NCT02452892|460135343|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
127868096|NCT02452892|460135344|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
127868097|NCT02452892|460135345|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
127868098|NCT02452892|460135346|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
127868099|NCT02452892|460135343|FG000|Follow-up|Withdrawal by Subject|0|||
127868100|NCT02452892|460135344|FG001|Follow-up|Withdrawal by Subject|0|||
127868101|NCT02452892|460135345|FG002|Follow-up|Withdrawal by Subject|0|||
127868102|NCT02452892|460135346|FG003|Follow-up|Withdrawal by Subject|1|||
127868103|NCT02452892|460135343|FG000|Follow-up|Subject left town on Day 42|1|||
127868104|NCT02452892|460135344|FG001|Follow-up|Subject left town on Day 42|0|||
127868105|NCT02452892|460135345|FG002|Follow-up|Subject left town on Day 42|0|||
127868106|NCT02452892|460135346|FG003|Follow-up|Subject left town on Day 42|0|||
127868107|NCT00955682|460135347|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
127868108|NCT00955682|460135348|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
127868109|NCT02041533|460135350|FG000|Pre-Treatment Period|Disease Progression|1|||
127868110|NCT02041533|460135351|FG001|Pre-Treatment Period|Disease Progression|1|||
127868111|NCT02041533|460135350|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
127868112|NCT02041533|460135351|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
127868113|NCT02041533|460135350|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
127868114|NCT02041533|460135351|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
127868115|NCT02041533|460135350|FG000|Treatment Period|Disease progression|189|||
127868116|NCT02041533|460135351|FG001|Treatment Period|Disease progression|146|||
127868117|NCT02041533|460135350|FG000|Treatment Period|Study drug toxicity|30|||
127868118|NCT02041533|460135351|FG001|Treatment Period|Study drug toxicity|34|||
127868119|NCT02041533|460135350|FG000|Treatment Period|Death|1|||
127868120|NCT02041533|460135351|FG001|Treatment Period|Death|0|||
127868121|NCT02041533|460135350|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
127868122|NCT02041533|460135351|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
127868123|NCT02041533|460135350|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
127868124|NCT02041533|460135351|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
127917542|NCT00045162|460320098|FG000|Overall Study|Adverse Event|55|||
127917543|NCT00045162|460320099|FG001|Overall Study|Adverse Event|50|||
127917544|NCT00045162|460320098|FG000|Overall Study|Lack of Efficacy|32|||
127917545|NCT00045162|460320099|FG001|Overall Study|Lack of Efficacy|29|||
127917546|NCT00045162|460320098|FG000|Overall Study|Death|10|||
127917547|NCT00045162|460320099|FG001|Overall Study|Death|10|||
127917548|NCT00045162|460320098|FG000|Overall Study|Withdrawal by Subject|5|||
127917549|NCT00045162|460320099|FG001|Overall Study|Withdrawal by Subject|3|||
127917550|NCT00045162|460320098|FG000|Overall Study|Other|21|||
127917551|NCT00045162|460320099|FG001|Overall Study|Other|16|||
127917552|NCT01044433|460320100|FG000|Overall Study|Lost to Follow-up|3|||
127917553|NCT01044433|460320100|FG000|Overall Study|Withdrawal by Subject|3|||
127917554|NCT01899053|460320102|FG000|Overall Study|Progressive Disease|4|||
127917555|NCT01899053|460320103|FG001|Overall Study|Progressive Disease|0|||
127917556|NCT01899053|460320104|FG002|Overall Study|Progressive Disease|3|||
127917557|NCT01899053|460320105|FG003|Overall Study|Progressive Disease|0|||
127917558|NCT01899053|460320106|FG004|Overall Study|Progressive Disease|3|||
127917559|NCT01899053|460320107|FG005|Overall Study|Progressive Disease|1|||
127917560|NCT01899053|460320108|FG006|Overall Study|Progressive Disease|1|||
127917561|NCT01899053|460320109|FG007|Overall Study|Progressive Disease|1|||
127917562|NCT01899053|460320110|FG008|Overall Study|Progressive Disease|4|||
127917563|NCT01899053|460320111|FG009|Overall Study|Progressive Disease|3|||
127917564|NCT01899053|460320112|FG010|Overall Study|Progressive Disease|12|||
127917565|NCT01899053|460320113|FG011|Overall Study|Progressive Disease|5|||
127917566|NCT01899053|460320114|FG012|Overall Study|Progressive Disease|8|||
127917567|NCT01899053|460320115|FG013|Overall Study|Progressive Disease|17|||
127917568|NCT01899053|460320102|FG000|Overall Study|Adverse Event|1|||
127917569|NCT01899053|460320103|FG001|Overall Study|Adverse Event|1|||
127917570|NCT01899053|460320104|FG002|Overall Study|Adverse Event|1|||
127868125|NCT02041533|460135350|FG000|Treatment Period|Participant withdrew consent|2|||
127868126|NCT02041533|460135351|FG001|Treatment Period|Participant withdrew consent|2|||
127868127|NCT02041533|460135350|FG000|Treatment Period|Maximum clinical benefit|0|||
127868128|NCT02041533|460135351|FG001|Treatment Period|Maximum clinical benefit|18|||
127868129|NCT02041533|460135350|FG000|Treatment Period|Poor/Non-compliance|1|||
127868130|NCT02041533|460135351|FG001|Treatment Period|Poor/Non-compliance|0|||
127868131|NCT02041533|460135350|FG000|Treatment Period|Administrative reason by sponsor|1|||
127868132|NCT02041533|460135351|FG001|Treatment Period|Administrative reason by sponsor|0|||
127868133|NCT02041533|460135350|FG000|Treatment Period|Other reasons|9|||
127868134|NCT02041533|460135351|FG001|Treatment Period|Other reasons|2|||
127868135|NCT02041533|460135350|FG000|Treatment Period|Not Reported|0|||
127868136|NCT02041533|460135351|FG001|Treatment Period|Not Reported|1|||
127868137|NCT02117024|460135352|FG000|Overall Study|Progressive Disease|26|||
127868138|NCT02117024|460135353|FG001|Overall Study|Progressive Disease|9|||
127868139|NCT02117024|460135352|FG000|Overall Study|Significant Clinical Progression|7|||
127868140|NCT02117024|460135353|FG001|Overall Study|Significant Clinical Progression|4|||
127868141|NCT02117024|460135352|FG000|Overall Study|Death|5|||
127868142|NCT02117024|460135353|FG001|Overall Study|Death|0|||
127868143|NCT02117024|460135352|FG000|Overall Study|Withdrawal by Subject|3|||
127868144|NCT02117024|460135353|FG001|Overall Study|Withdrawal by Subject|1|||
127868145|NCT02117024|460135352|FG000|Overall Study|Protocol Violation|1|||
127868146|NCT02117024|460135353|FG001|Overall Study|Protocol Violation|0|||
127868147|NCT02117024|460135352|FG000|Overall Study|Adverse Event|1|||
127868148|NCT02117024|460135353|FG001|Overall Study|Adverse Event|2|||
127868149|NCT02117024|460135352|FG000|Overall Study|Randomized in Error|1|||
127868150|NCT02117024|460135353|FG001|Overall Study|Randomized in Error|0|||
127868151|NCT02117024|460135352|FG000|Overall Study|Patient returned to primary oncologist|0|||
127868152|NCT02117024|460135353|FG001|Overall Study|Patient returned to primary oncologist|1|||
127868153|NCT02117024|460135352|FG000|Overall Study|Patient took treatment break|0|||
127868154|NCT02117024|460135353|FG001|Overall Study|Patient took treatment break|1|||
127868155|NCT02117024|460135352|FG000|Overall Study|Physician Decision|0|||
127868156|NCT02117024|460135353|FG001|Overall Study|Physician Decision|2|||
127868157|NCT00565721|460135356|FG000|Overall Study|Screen Failure|2|||
127868158|NCT00565721|460135356|FG000|Overall Study|Lost to Follow-up|6|||
127868159|NCT00565721|460135356|FG000|Overall Study|Technical Problems|1|||
127868160|NCT00565721|460135356|FG000|Overall Study|Physician Decision|2|||
127868161|NCT00565721|460135356|FG000|Overall Study|Other reasons|6|||
127868162|NCT02813681|460135357|FG000|Overall Study|Physician Decision|5|||
127868163|NCT02813681|460135358|FG001|Overall Study|Physician Decision|5|||
127917571|NCT01899053|460320105|FG003|Overall Study|Adverse Event|3|||
127917572|NCT01899053|460320106|FG004|Overall Study|Adverse Event|1|||
127917573|NCT01899053|460320107|FG005|Overall Study|Adverse Event|1|||
127868164|NCT02813681|460135359|FG002|Overall Study|Physician Decision|0|||
127868165|NCT02813681|460135357|FG000|Overall Study|Lost to Follow-up|0|||
127868166|NCT02813681|460135358|FG001|Overall Study|Lost to Follow-up|1|||
127917574|NCT01899053|460320108|FG006|Overall Study|Adverse Event|1|||
127917575|NCT01899053|460320109|FG007|Overall Study|Adverse Event|0|||
127917576|NCT01899053|460320110|FG008|Overall Study|Adverse Event|2|||
127917577|NCT01899053|460320111|FG009|Overall Study|Adverse Event|0|||
127917578|NCT01899053|460320112|FG010|Overall Study|Adverse Event|3|||
127917579|NCT01899053|460320113|FG011|Overall Study|Adverse Event|1|||
127917580|NCT01899053|460320114|FG012|Overall Study|Adverse Event|2|||
127917581|NCT01899053|460320115|FG013|Overall Study|Adverse Event|2|||
127917582|NCT01899053|460320102|FG000|Overall Study|Reason Not Specified|0|||
127917583|NCT01899053|460320103|FG001|Overall Study|Reason Not Specified|0|||
127917584|NCT01899053|460320104|FG002|Overall Study|Reason Not Specified|0|||
127917585|NCT01899053|460320105|FG003|Overall Study|Reason Not Specified|0|||
127917586|NCT01899053|460320106|FG004|Overall Study|Reason Not Specified|0|||
127917587|NCT01899053|460320107|FG005|Overall Study|Reason Not Specified|0|||
127917588|NCT01899053|460320108|FG006|Overall Study|Reason Not Specified|1|||
127917589|NCT01899053|460320109|FG007|Overall Study|Reason Not Specified|0|||
127917590|NCT01899053|460320110|FG008|Overall Study|Reason Not Specified|0|||
127917591|NCT01899053|460320111|FG009|Overall Study|Reason Not Specified|0|||
127917592|NCT01899053|460320112|FG010|Overall Study|Reason Not Specified|0|||
127917593|NCT01899053|460320113|FG011|Overall Study|Reason Not Specified|0|||
127917594|NCT01899053|460320114|FG012|Overall Study|Reason Not Specified|1|||
127917595|NCT01899053|460320115|FG013|Overall Study|Reason Not Specified|0|||
127917596|NCT01899053|460320102|FG000|Overall Study|Withdrawal by Subject|1|||
127917597|NCT01899053|460320103|FG001|Overall Study|Withdrawal by Subject|1|||
127917598|NCT01899053|460320104|FG002|Overall Study|Withdrawal by Subject|2|||
127917599|NCT01899053|460320105|FG003|Overall Study|Withdrawal by Subject|0|||
127917600|NCT01899053|460320106|FG004|Overall Study|Withdrawal by Subject|2|||
127917601|NCT01899053|460320107|FG005|Overall Study|Withdrawal by Subject|0|||
127917602|NCT01899053|460320108|FG006|Overall Study|Withdrawal by Subject|0|||
127917603|NCT01899053|460320109|FG007|Overall Study|Withdrawal by Subject|1|||
127917604|NCT01899053|460320110|FG008|Overall Study|Withdrawal by Subject|0|||
127917605|NCT01899053|460320111|FG009|Overall Study|Withdrawal by Subject|0|||
127917606|NCT01899053|460320112|FG010|Overall Study|Withdrawal by Subject|0|||
127917607|NCT01899053|460320113|FG011|Overall Study|Withdrawal by Subject|0|||
127917608|NCT01899053|460320114|FG012|Overall Study|Withdrawal by Subject|1|||
127917609|NCT01899053|460320115|FG013|Overall Study|Withdrawal by Subject|1|||
127917610|NCT01899053|460320102|FG000|Overall Study|Protocol Violation|0|||
127917611|NCT01899053|460320103|FG001|Overall Study|Protocol Violation|0|||
127917612|NCT01899053|460320104|FG002|Overall Study|Protocol Violation|1|||
127917613|NCT01899053|460320105|FG003|Overall Study|Protocol Violation|0|||
127917614|NCT01899053|460320106|FG004|Overall Study|Protocol Violation|0|||
127917615|NCT01899053|460320107|FG005|Overall Study|Protocol Violation|0|||
127917616|NCT01899053|460320108|FG006|Overall Study|Protocol Violation|0|||
127917617|NCT01899053|460320109|FG007|Overall Study|Protocol Violation|0|||
127917618|NCT01899053|460320110|FG008|Overall Study|Protocol Violation|0|||
127917619|NCT01899053|460320111|FG009|Overall Study|Protocol Violation|0|||
127917620|NCT01899053|460320112|FG010|Overall Study|Protocol Violation|0|||
127917621|NCT01899053|460320113|FG011|Overall Study|Protocol Violation|0|||
127917622|NCT01899053|460320114|FG012|Overall Study|Protocol Violation|0|||
127917623|NCT01899053|460320115|FG013|Overall Study|Protocol Violation|0|||
127917624|NCT01899053|460320102|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
127917625|NCT01899053|460320103|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
127917626|NCT01899053|460320104|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
127917627|NCT01899053|460320105|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
127917628|NCT01899053|460320106|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
127917629|NCT01899053|460320107|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
127917630|NCT01899053|460320108|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
127917631|NCT01899053|460320109|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
127917632|NCT01899053|460320110|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
127917633|NCT01899053|460320111|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
127917634|NCT01899053|460320112|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
127917635|NCT01899053|460320113|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
127917636|NCT01899053|460320114|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
127917637|NCT01899053|460320115|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
127917638|NCT01899053|460320102|FG000|Overall Study|Symptomatic Deterioration|0|||
127917639|NCT01899053|460320103|FG001|Overall Study|Symptomatic Deterioration|0|||
127917640|NCT01899053|460320104|FG002|Overall Study|Symptomatic Deterioration|0|||
127917641|NCT01899053|460320105|FG003|Overall Study|Symptomatic Deterioration|0|||
127917642|NCT01899053|460320106|FG004|Overall Study|Symptomatic Deterioration|0|||
127917643|NCT01899053|460320107|FG005|Overall Study|Symptomatic Deterioration|1|||
127917644|NCT01899053|460320108|FG006|Overall Study|Symptomatic Deterioration|0|||
127917645|NCT01899053|460320109|FG007|Overall Study|Symptomatic Deterioration|1|||
127917646|NCT01899053|460320110|FG008|Overall Study|Symptomatic Deterioration|0|||
127917647|NCT01899053|460320111|FG009|Overall Study|Symptomatic Deterioration|0|||
127917648|NCT01899053|460320112|FG010|Overall Study|Symptomatic Deterioration|0|||
127917649|NCT01899053|460320113|FG011|Overall Study|Symptomatic Deterioration|1|||
127917650|NCT01899053|460320114|FG012|Overall Study|Symptomatic Deterioration|2|||
127868167|NCT02813681|460135359|FG002|Overall Study|Lost to Follow-up|0|||
127868168|NCT02500706|460135360|FG000|Overall Study|Adverse Event|0|||
127868169|NCT02500706|460135361|FG001|Overall Study|Adverse Event|0|||
127868170|NCT02500706|460135362|FG002|Overall Study|Adverse Event|1|||
127868171|NCT02500706|460135360|FG000|Overall Study|Lost to Follow-up|0|||
127868172|NCT02500706|460135361|FG001|Overall Study|Lost to Follow-up|1|||
127868173|NCT02500706|460135362|FG002|Overall Study|Lost to Follow-up|1|||
127868174|NCT02500706|460135360|FG000|Overall Study|Withdrawal by Subject|4|||
127868175|NCT02500706|460135361|FG001|Overall Study|Withdrawal by Subject|6|||
127868176|NCT02500706|460135362|FG002|Overall Study|Withdrawal by Subject|4|||
127868177|NCT02500706|460135360|FG000|Overall Study|Unclassified|0|||
127917651|NCT01899053|460320115|FG013|Overall Study|Symptomatic Deterioration|0|||
127917652|NCT03105297|460320116|FG000|Baseline Phase (Day 1)|Other|21|||
127917653|NCT03105297|460320116|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
127917654|NCT03105297|460320116|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
127917655|NCT05065619|460320117|FG000|Up to Day 42|Lost to Follow-up|1|||
127917656|NCT05065619|460320118|FG001|Up to Day 42|Lost to Follow-up|0|||
127917657|NCT05065619|460320117|FG000|Up to Day 42|Withdrawal by Subject|1|||
127917658|NCT05065619|460320118|FG001|Up to Day 42|Withdrawal by Subject|0|||
127917659|NCT05065619|460320117|FG000|After Day 43|Lost to Follow-up|1|||
127917660|NCT05065619|460320118|FG001|After Day 43|Lost to Follow-up|0|||
127917661|NCT05065619|460320117|FG000|After Day 43|Physician Decision|3|||
127917662|NCT05065619|460320118|FG001|After Day 43|Physician Decision|0|||
127917663|NCT05065619|460320117|FG000|After Day 43|Withdrawal by Subject|1|||
127917664|NCT05065619|460320118|FG001|After Day 43|Withdrawal by Subject|2|||
127917665|NCT05065619|460320117|FG000|After Day 43|Public vaccination|6|||
127917666|NCT05065619|460320118|FG001|After Day 43|Public vaccination|8|||
127917667|NCT05065619|460320117|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
127917668|NCT05065619|460320118|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
127917669|NCT05065619|460320117|FG000|After Day 43|Study Terminated by Sponsor|88|||
127917670|NCT05065619|460320118|FG001|After Day 43|Study Terminated by Sponsor|16|||
127917671|NCT00714051|460320123|FG000|Overall Study|Withdrawal by Subject|1|||
127917672|NCT00714051|460320124|FG001|Overall Study|Withdrawal by Subject|0|||
127917673|NCT00714051|460320123|FG000|Overall Study|Death|0|||
127917674|NCT00714051|460320124|FG001|Overall Study|Death|1|||
127917675|NCT03868631|460320125|FG000|Baseline to Week 6|Adverse Event|0|||
127917676|NCT03868631|460320126|FG001|Baseline to Week 6|Adverse Event|3|||
127917677|NCT03868631|460320125|FG000|Baseline to Week 6|Protocol Violation|1|||
127917678|NCT03868631|460320126|FG001|Baseline to Week 6|Protocol Violation|1|||
127917679|NCT03868631|460320125|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
127917680|NCT03868631|460320126|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
127917681|NCT03868631|460320125|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
127917682|NCT03868631|460320126|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
127917683|NCT03868631|460320125|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
127917684|NCT03868631|460320126|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
127917685|NCT03868631|460320125|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
127917686|NCT03868631|460320126|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
127917687|NCT03250117|460320129|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
127917688|NCT03250117|460320130|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
127917689|NCT03250117|460320131|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
127917690|NCT03250117|460320132|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
127917691|NCT05740098|460320135|FG000|Overall Study|Lost to Follow-up|26|||
127917692|NCT05740098|460320136|FG001|Overall Study|Lost to Follow-up|17|||
127917693|NCT05740098|460320137|FG002|Overall Study|Lost to Follow-up|21|||
127917694|NCT02452463|460320138|FG000|Overall Study|Death|1|||
127917695|NCT02452463|460320139|FG001|Overall Study|Death|0|||
127917696|NCT02452463|460320140|FG002|Overall Study|Death|0|||
127917697|NCT02452463|460320138|FG000|Overall Study|Study Suspended|1|||
127917698|NCT02452463|460320139|FG001|Overall Study|Study Suspended|0|||
127917699|NCT02452463|460320140|FG002|Overall Study|Study Suspended|0|||
127868178|NCT02500706|460135361|FG001|Overall Study|Unclassified|0|||
127917700|NCT02452463|460320138|FG000|Overall Study|Recommended by DSMB|0|||
127917701|NCT02452463|460320139|FG001|Overall Study|Recommended by DSMB|1|||
127917702|NCT02452463|460320140|FG002|Overall Study|Recommended by DSMB|0|||
127917703|NCT02452463|460320138|FG000|Overall Study|Withdrawal by Subject|0|||
127868179|NCT02500706|460135362|FG002|Overall Study|Unclassified|1|||
127917704|NCT02452463|460320139|FG001|Overall Study|Withdrawal by Subject|1|||
127917705|NCT02452463|460320140|FG002|Overall Study|Withdrawal by Subject|0|||
127917706|NCT04573309|460321951|FG000|Overall Study|Protocol Violation|1|||
127917707|NCT04573309|460321952|FG001|Overall Study|Protocol Violation|0|||
127917708|NCT01894230|460321953|FG000|Overall Study|Lost to Follow-up|2|||
127917709|NCT01894230|460321954|FG001|Overall Study|Lost to Follow-up|2|||
127868180|NCT01497899|460135367|FG000|Double-Blind Phase|Randomized but not Treated|1|||
127917710|NCT01894230|460321953|FG000|Overall Study|Withdrawal by Subject|4|||
127917711|NCT01894230|460321954|FG001|Overall Study|Withdrawal by Subject|4|||
127917712|NCT01894230|460321953|FG000|Overall Study|Non-adherent|0|||
127917713|NCT01894230|460321954|FG001|Overall Study|Non-adherent|1|||
127917714|NCT01894230|460321953|FG000|Overall Study|Death|1|||
127917715|NCT01894230|460321954|FG001|Overall Study|Death|0|||
127917716|NCT01109849|460321955|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
127917717|NCT01109849|460321956|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
127917718|NCT01109849|460321957|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
127917719|NCT01109849|460321958|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
127917720|NCT01109849|460321959|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
127917721|NCT01109849|460321955|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
127917722|NCT01109849|460321956|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
127917723|NCT01109849|460321957|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
127917724|NCT01109849|460321958|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
127917725|NCT01109849|460321959|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
127917726|NCT01109849|460321955|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
127917727|NCT01109849|460321956|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
127917728|NCT01109849|460321957|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
127917729|NCT01109849|460321958|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
127917730|NCT01109849|460321959|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
127917731|NCT01109849|460321955|FG000|Initial Randomization: ADHD Treatment|move away|2|||
127917732|NCT01109849|460321956|FG001|Initial Randomization: ADHD Treatment|move away|7|||
127917733|NCT01109849|460321957|FG002|Initial Randomization: ADHD Treatment|move away|0|||
127917734|NCT01109849|460321958|FG003|Initial Randomization: ADHD Treatment|move away|0|||
127917735|NCT01109849|460321959|FG004|Initial Randomization: ADHD Treatment|move away|0|||
127917736|NCT01109849|460321955|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
127917737|NCT01109849|460321956|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
127917738|NCT01109849|460321957|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
127917739|NCT01109849|460321958|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
127917740|NCT01109849|460321959|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
127917741|NCT01109849|460321955|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
127917742|NCT01109849|460321956|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
127917743|NCT01109849|460321957|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
127917744|NCT01109849|460321958|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
127917745|NCT01109849|460321959|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
127917746|NCT02300987|460321960|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
127917747|NCT02300987|460321961|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
127917748|NCT02300987|460321960|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
127917749|NCT02300987|460321961|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
127917750|NCT02300987|460321960|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
127917751|NCT02300987|460321961|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
127917752|NCT02300987|460321960|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
127917753|NCT02300987|460321961|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
127917754|NCT02300987|460321960|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
127917755|NCT02300987|460321961|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
127917756|NCT02488109|460321962|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
127917757|NCT02488109|460321963|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
127917758|NCT02488109|460321962|FG000|12-month Follow-Up|Lost to Follow-up|4|||
127917759|NCT02488109|460321963|FG001|12-month Follow-Up|Lost to Follow-up|7|||
127917760|NCT03969641|460321964|FG000|Overall Study|Lost to Follow-up|5|||
127917761|NCT03969641|460321965|FG001|Overall Study|Lost to Follow-up|3|||
127917762|NCT03969641|460321964|FG000|Overall Study|Withdrawal by Subject|1|||
127917763|NCT03969641|460321965|FG001|Overall Study|Withdrawal by Subject|2|||
127917764|NCT03969641|460321964|FG000|Overall Study|Found to be ineligible|1|||
127917765|NCT03969641|460321965|FG001|Overall Study|Found to be ineligible|1|||
127917766|NCT03969641|460321964|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
127917767|NCT03969641|460321965|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
127917768|NCT03969641|460321964|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
127917769|NCT03969641|460321965|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
127917770|NCT03969641|460321964|FG000|Overall Study|Elective termination|0|||
127917771|NCT03969641|460321965|FG001|Overall Study|Elective termination|1|||
127917772|NCT01541215|460321966|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
127917773|NCT01541215|460321967|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
127917774|NCT01541215|460321966|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
127917775|NCT01541215|460321967|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
127917776|NCT01541215|460321966|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
127917777|NCT01541215|460321967|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
127917778|NCT01541215|460321966|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
127917779|NCT01541215|460321967|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
127868181|NCT01497899|460135368|FG001|Double-Blind Phase|Randomized but not Treated|0|||
127868182|NCT01497899|460135369|FG002|Double-Blind Phase|Randomized but not Treated|0|||
127868183|NCT01497899|460135370|FG003|Double-Blind Phase|Randomized but not Treated|0|||
127868184|NCT01497899|460135367|FG000|Double-Blind Phase|Adverse Event|1|||
127868185|NCT01497899|460135368|FG001|Double-Blind Phase|Adverse Event|0|||
127868186|NCT01497899|460135369|FG002|Double-Blind Phase|Adverse Event|0|||
127868187|NCT01497899|460135370|FG003|Double-Blind Phase|Adverse Event|0|||
127868188|NCT01497899|460135367|FG000|Double-Blind Phase|Lack of Efficacy|0|||
127868189|NCT01497899|460135368|FG001|Double-Blind Phase|Lack of Efficacy|1|||
127868190|NCT01497899|460135369|FG002|Double-Blind Phase|Lack of Efficacy|0|||
127868191|NCT01497899|460135370|FG003|Double-Blind Phase|Lack of Efficacy|0|||
127868192|NCT01497899|460135367|FG000|Double-Blind Phase|Investigator's Discretion|1|||
127868193|NCT01497899|460135368|FG001|Double-Blind Phase|Investigator's Discretion|0|||
127868194|NCT01497899|460135369|FG002|Double-Blind Phase|Investigator's Discretion|0|||
127868195|NCT01497899|460135370|FG003|Double-Blind Phase|Investigator's Discretion|0|||
127868196|NCT01497899|460135367|FG000|Double-Blind Phase|Withdrew Consent|0|||
127868197|NCT01497899|460135368|FG001|Double-Blind Phase|Withdrew Consent|1|||
127868198|NCT01497899|460135369|FG002|Double-Blind Phase|Withdrew Consent|0|||
127868199|NCT01497899|460135370|FG003|Double-Blind Phase|Withdrew Consent|0|||
127868200|NCT01497899|460135367|FG000|Double-Blind Phase|Lost to Follow-up|3|||
127868201|NCT01497899|460135368|FG001|Double-Blind Phase|Lost to Follow-up|2|||
127868202|NCT01497899|460135369|FG002|Double-Blind Phase|Lost to Follow-up|0|||
127868203|NCT01497899|460135370|FG003|Double-Blind Phase|Lost to Follow-up|0|||
127868204|NCT01497899|460135367|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
127868205|NCT01497899|460135368|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
127868206|NCT01497899|460135369|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
127868207|NCT01497899|460135370|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
127868208|NCT01497899|460135367|FG000|Open-Label Extension Phase|Adverse Event|1|||
127868209|NCT01497899|460135368|FG001|Open-Label Extension Phase|Adverse Event|0|||
127868210|NCT01497899|460135369|FG002|Open-Label Extension Phase|Adverse Event|0|||
127868211|NCT01497899|460135370|FG003|Open-Label Extension Phase|Adverse Event|0|||
127868212|NCT01497899|460135367|FG000|Open-Label Extension Phase|Death|1|||
127868213|NCT01497899|460135368|FG001|Open-Label Extension Phase|Death|0|||
127868214|NCT01497899|460135369|FG002|Open-Label Extension Phase|Death|0|||
127868215|NCT01497899|460135370|FG003|Open-Label Extension Phase|Death|0|||
127868216|NCT01497899|460135367|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
127868217|NCT01497899|460135368|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
127868218|NCT01497899|460135369|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
127868219|NCT01497899|460135370|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
127868220|NCT01497899|460135367|FG000|Open-Label Extension Phase|Pregnancy|0|||
127868221|NCT01497899|460135368|FG001|Open-Label Extension Phase|Pregnancy|1|||
127868222|NCT01497899|460135369|FG002|Open-Label Extension Phase|Pregnancy|1|||
127868223|NCT01497899|460135370|FG003|Open-Label Extension Phase|Pregnancy|0|||
127868224|NCT01497899|460135367|FG000|Open-Label Extension Phase|Protocol Violation|0|||
127868225|NCT01497899|460135368|FG001|Open-Label Extension Phase|Protocol Violation|0|||
127868226|NCT01497899|460135369|FG002|Open-Label Extension Phase|Protocol Violation|1|||
127868227|NCT01497899|460135370|FG003|Open-Label Extension Phase|Protocol Violation|0|||
127868228|NCT01497899|460135367|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
127868229|NCT01497899|460135368|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
127868230|NCT01497899|460135369|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
127868231|NCT01497899|460135370|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
127868232|NCT05047601|460135371|FG000|Overall Study|Lost to Follow-up|9|||
127868233|NCT05047601|460135372|FG001|Overall Study|Lost to Follow-up|11|||
127868234|NCT05047601|460135373|FG002|Overall Study|Lost to Follow-up|7|||
127868235|NCT05047601|460135371|FG000|Overall Study|Withdrawal by Subject|25|||
127868236|NCT05047601|460135372|FG001|Overall Study|Withdrawal by Subject|36|||
127868237|NCT05047601|460135373|FG002|Overall Study|Withdrawal by Subject|23|||
127868238|NCT05047601|460135371|FG000|Overall Study|Other|10|||
127868239|NCT05047601|460135372|FG001|Overall Study|Other|6|||
127868240|NCT05047601|460135373|FG002|Overall Study|Other|5|||
127868241|NCT00283062|460135379|FG000|Overall Study|Did not receive any study medication|5|||
127868242|NCT00283062|460135380|FG001|Overall Study|Did not receive any study medication|4|||
127868243|NCT00283062|460135381|FG002|Overall Study|Did not receive any study medication|36|||
127868244|NCT00283062|460135382|FG003|Overall Study|Did not receive any study medication|45|||
127868245|NCT00283062|460135379|FG000|Overall Study|Adverse Event|2|||
127868246|NCT00283062|460135380|FG001|Overall Study|Adverse Event|0|||
127868247|NCT00283062|460135381|FG002|Overall Study|Adverse Event|1|||
127868248|NCT00283062|460135382|FG003|Overall Study|Adverse Event|0|||
127868249|NCT00283062|460135379|FG000|Overall Study|Lost to Follow-up|1|||
127868250|NCT00283062|460135380|FG001|Overall Study|Lost to Follow-up|0|||
127868251|NCT00283062|460135381|FG002|Overall Study|Lost to Follow-up|1|||
127868252|NCT00283062|460135382|FG003|Overall Study|Lost to Follow-up|0|||
127868253|NCT00283062|460135379|FG000|Overall Study|Progressive disease|0|||
127868254|NCT00283062|460135380|FG001|Overall Study|Progressive disease|0|||
127868255|NCT00283062|460135381|FG002|Overall Study|Progressive disease|1|||
127868256|NCT00283062|460135382|FG003|Overall Study|Progressive disease|0|||
127868257|NCT00283062|460135379|FG000|Overall Study|Participant did not wish to continue|3|||
127868258|NCT00283062|460135380|FG001|Overall Study|Participant did not wish to continue|2|||
127868259|NCT00283062|460135381|FG002|Overall Study|Participant did not wish to continue|1|||
127868260|NCT00283062|460135382|FG003|Overall Study|Participant did not wish to continue|0|||
127868261|NCT00283062|460135379|FG000|Overall Study|Undefined|0|||
127868262|NCT00283062|460135380|FG001|Overall Study|Undefined|1|||
127868263|NCT00283062|460135381|FG002|Overall Study|Undefined|1|||
127868264|NCT00283062|460135382|FG003|Overall Study|Undefined|4|||
127868265|NCT00283062|460135379|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
127868266|NCT00283062|460135380|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
127868267|NCT00283062|460135381|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
127868268|NCT00283062|460135382|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
127868269|NCT03137173|460135383|FG000|Overall Study|Withdrawal by Subject|8|||
127868270|NCT03137173|460135384|FG001|Overall Study|Withdrawal by Subject|13|||
127868271|NCT03137173|460135383|FG000|Overall Study|Death|1|||
127868272|NCT03137173|460135384|FG001|Overall Study|Death|3|||
127868273|NCT03137173|460135383|FG000|Overall Study|Physician Decision|1|||
127868274|NCT03137173|460135384|FG001|Overall Study|Physician Decision|0|||
127868275|NCT03137173|460135383|FG000|Overall Study|Lost to Follow-up|13|||
127868276|NCT03137173|460135384|FG001|Overall Study|Lost to Follow-up|18|||
127868277|NCT03137173|460135383|FG000|Overall Study|Other reasons|3|||
127868278|NCT03137173|460135384|FG001|Overall Study|Other reasons|2|||
127868279|NCT00827112|460135387|FG000|Overall Study|Adverse Event|2|||
127868280|NCT00827112|460135388|FG001|Overall Study|Adverse Event|0|||
127868281|NCT00827112|460135387|FG000|Overall Study|Lack of Efficacy|2|||
127868282|NCT00827112|460135388|FG001|Overall Study|Lack of Efficacy|0|||
127868283|NCT00827112|460135387|FG000|Overall Study|Lost to Follow-up|3|||
127868284|NCT00827112|460135388|FG001|Overall Study|Lost to Follow-up|2|||
127868285|NCT00827112|460135387|FG000|Overall Study|Pregnancy|0|||
127868286|NCT00827112|460135388|FG001|Overall Study|Pregnancy|1|||
127868287|NCT00827112|460135387|FG000|Overall Study|Protocol Violation|0|||
127868288|NCT00827112|460135388|FG001|Overall Study|Protocol Violation|2|||
127868289|NCT00827112|460135387|FG000|Overall Study|Withdrawal by Subject|2|||
127868290|NCT00827112|460135388|FG001|Overall Study|Withdrawal by Subject|1|||
127868291|NCT00827112|460135387|FG000|Overall Study|Randomized but not treated|5|||
127868292|NCT00827112|460135388|FG001|Overall Study|Randomized but not treated|3|||
127868293|NCT00827112|460135387|FG000|Overall Study|Other|1|||
127868294|NCT00827112|460135388|FG001|Overall Study|Other|3|||
127868295|NCT01475214|460135389|FG000|Overall Study|Lost to Follow-up|1|||
127868296|NCT01475214|460135390|FG001|Overall Study|Lost to Follow-up|0|||
127868297|NCT01475214|460135391|FG002|Overall Study|Lost to Follow-up|1|||
127868298|NCT01475214|460135389|FG000|Overall Study|Physician Decision|2|||
127868299|NCT01475214|460135390|FG001|Overall Study|Physician Decision|0|||
127868300|NCT01475214|460135391|FG002|Overall Study|Physician Decision|0|||
127868301|NCT01475214|460135389|FG000|Overall Study|Withdrawal by Subject|2|||
127868302|NCT01475214|460135390|FG001|Overall Study|Withdrawal by Subject|4|||
127868303|NCT01475214|460135391|FG002|Overall Study|Withdrawal by Subject|1|||
127868304|NCT00554229|460135394|FG000|Overall Study|Lost to Follow-up|3|||
127868305|NCT00554229|460135395|FG001|Overall Study|Lost to Follow-up|6|||
127868306|NCT00554229|460135394|FG000|Overall Study|Withdrawal by Subject|29|||
127868307|NCT00554229|460135395|FG001|Overall Study|Withdrawal by Subject|37|||
127868308|NCT00554229|460135394|FG000|Overall Study|Adverse Event|71|||
127868309|NCT00554229|460135395|FG001|Overall Study|Adverse Event|39|||
127868310|NCT00554229|460135394|FG000|Overall Study|Protocol Violation|3|||
127868311|NCT00554229|460135395|FG001|Overall Study|Protocol Violation|3|||
127868312|NCT00554229|460135394|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
127868313|NCT00554229|460135395|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
127868314|NCT00554229|460135394|FG000|Overall Study|Randomised but no treatment received|1|||
127868315|NCT00554229|460135395|FG001|Overall Study|Randomised but no treatment received|0|||
127868316|NCT02828982|460135396|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
127868317|NCT02828982|460135397|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
127868318|NCT03044730|460135408|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
127868319|NCT03044730|460135408|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
127868320|NCT03044730|460135408|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
127868321|NCT03044730|460135408|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
127868322|NCT03044730|460135408|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
127868323|NCT03044730|460135408|FG000|Cycles 4 and Beyond|Adverse Event|1|||
127868324|NCT03044730|460135408|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
127868325|NCT03044730|460135408|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
127868326|NCT03044730|460135408|FG000|On Follow-up for 2 Years|Death|17|||
127868327|NCT00690612|460137306|FG000|Overall Study|Adverse Event|1|||
127868328|NCT00690612|460137306|FG000|Overall Study|Withdrawal by Subject|2|||
127868329|NCT01786707|460137308|FG000|Overall Study|Lost to Follow-up|1|||
127868330|NCT01786707|460137309|FG001|Overall Study|Lost to Follow-up|1|||
127868331|NCT02058940|460137311|FG000|Overall Study|Discharged from Critical Care Unit|1|||
127868332|NCT01519700|460137312|FG000|Overall Study|Death|1|||
127868333|NCT01519700|460137313|FG001|Overall Study|Death|0|||
127868334|NCT01519700|460137314|FG002|Overall Study|Death|0|||
127868335|NCT01519700|460137315|FG003|Overall Study|Death|0|||
127868336|NCT01519700|460137312|FG000|Overall Study|Lost to Follow-up|0|||
127868337|NCT01519700|460137313|FG001|Overall Study|Lost to Follow-up|0|||
127868338|NCT01519700|460137314|FG002|Overall Study|Lost to Follow-up|1|||
127868339|NCT01519700|460137315|FG003|Overall Study|Lost to Follow-up|1|||
127868340|NCT01519700|460137312|FG000|Overall Study|Physician Decision|1|||
127868341|NCT01519700|460137313|FG001|Overall Study|Physician Decision|1|||
127868342|NCT01519700|460137314|FG002|Overall Study|Physician Decision|3|||
127868343|NCT01519700|460137315|FG003|Overall Study|Physician Decision|0|||
127868344|NCT01519700|460137312|FG000|Overall Study|Withdrawal by Subject|5|||
127868345|NCT01519700|460137313|FG001|Overall Study|Withdrawal by Subject|3|||
127868346|NCT01519700|460137314|FG002|Overall Study|Withdrawal by Subject|3|||
127868347|NCT01519700|460137315|FG003|Overall Study|Withdrawal by Subject|2|||
127868348|NCT01519700|460137312|FG000|Overall Study|Other Reason|2|||
127868349|NCT01519700|460137313|FG001|Overall Study|Other Reason|2|||
127868350|NCT01519700|460137314|FG002|Overall Study|Other Reason|0|||
127868351|NCT01519700|460137315|FG003|Overall Study|Other Reason|4|||
127868352|NCT01789476|460137321|FG000|Overall Study|Lack of Efficacy|6|||
127868353|NCT01789476|460137322|FG001|Overall Study|Lack of Efficacy|2|||
127868354|NCT01789476|460137321|FG000|Overall Study|Adverse Event|1|||
127868355|NCT01789476|460137322|FG001|Overall Study|Adverse Event|0|||
127868356|NCT01789476|460137321|FG000|Overall Study|Unable to get IV access|1|||
127868357|NCT01789476|460137322|FG001|Overall Study|Unable to get IV access|0|||
127868358|NCT00965458|460137323|FG000|Overall Study|Adverse Event|1|||
127868359|NCT00965458|460137324|FG001|Overall Study|Adverse Event|0|||
127868360|NCT00965458|460137323|FG000|Overall Study|Lost to Follow-up|1|||
127868361|NCT00965458|460137324|FG001|Overall Study|Lost to Follow-up|3|||
127868362|NCT00965458|460137323|FG000|Overall Study|Withdrawal by Subject|0|||
127868363|NCT00965458|460137324|FG001|Overall Study|Withdrawal by Subject|1|||
127868364|NCT05637515|460137328|FG000|Overall Study|Withdrawal by Subject|17|||
127868365|NCT05637515|460137329|FG001|Overall Study|Withdrawal by Subject|17|||
127868366|NCT03039686|460137330|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
127868367|NCT03039686|460137331|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
127868368|NCT03039686|460137332|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
127868369|NCT03039686|460137330|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
127868370|NCT03039686|460137331|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
127868371|NCT03039686|460137332|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
127868372|NCT03039686|460137330|FG000|Double-blind Period|Withdrawal by Subject|2|||
127868373|NCT03039686|460137331|FG001|Double-blind Period|Withdrawal by Subject|2|||
127868374|NCT03039686|460137332|FG002|Double-blind Period|Withdrawal by Subject|1|||
127868375|NCT03039686|460137330|FG000|Double-blind Period|Death|0|||
127868376|NCT03039686|460137331|FG001|Double-blind Period|Death|0|||
127868377|NCT03039686|460137332|FG002|Double-blind Period|Death|1|||
127868378|NCT03039686|460137330|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
127868379|NCT03039686|460137331|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
127868380|NCT03039686|460137332|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
127868381|NCT03039686|460137330|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
127868382|NCT03039686|460137331|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
127868383|NCT03039686|460137332|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
127868384|NCT03039686|460137330|FG000|Open Label Period|Withdrawal by Subject|0|||
127868385|NCT03039686|460137331|FG001|Open Label Period|Withdrawal by Subject|3|||
127868386|NCT03039686|460137332|FG002|Open Label Period|Withdrawal by Subject|1|||
127868387|NCT02158949|460137333|FG000|Overall Study|Withdrawal by Subject|1|||
127868388|NCT02158949|460137334|FG001|Overall Study|Withdrawal by Subject|0|||
127868389|NCT02158949|460137333|FG000|Overall Study|Lost to Follow-up|5|||
127868390|NCT02158949|460137334|FG001|Overall Study|Lost to Follow-up|11|||
127868391|NCT02079077|460137336|FG000|Overall Study|Lost to Follow-up|5|||
127868392|NCT02079077|460137337|FG001|Overall Study|Lost to Follow-up|7|||
127868393|NCT02079077|460137336|FG000|Overall Study|Became STIs Positive|1|||
127868394|NCT02079077|460137337|FG001|Overall Study|Became STIs Positive|2|||
127868395|NCT00772031|460137338|FG000|Overall Study|Early termination of trial|12|||
127868396|NCT00772031|460137339|FG001|Overall Study|Early termination of trial|10|||
127868397|NCT00772031|460137338|FG000|Overall Study|Lost to Follow-up|20|||
127868398|NCT00772031|460137339|FG001|Overall Study|Lost to Follow-up|33|||
127917780|NCT01541215|460321966|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
127917781|NCT01541215|460321967|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
127917782|NCT01541215|460321966|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
127917783|NCT01541215|460321967|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
127917784|NCT00754052|460321979|FG000|Overall Study|Study terminated by Sponsor|5|||
127917785|NCT00754052|460321980|FG001|Overall Study|Study terminated by Sponsor|3|||
127917786|NCT02658019|460321982|FG000|Overall Study|Adverse Event|1|||
127917787|NCT04364854|460321986|FG000|Overall Study|Withdrawal by Subject|1|||
127917788|NCT04364854|460321987|FG001|Overall Study|Withdrawal by Subject|0|||
127917789|NCT04364854|460321988|FG002|Overall Study|Withdrawal by Subject|1|||
127917790|NCT04364854|460321989|FG003|Overall Study|Withdrawal by Subject|3|||
127917791|NCT04364854|460321986|FG000|Overall Study|Death|1|||
127917792|NCT04364854|460321987|FG001|Overall Study|Death|0|||
127917793|NCT04364854|460321988|FG002|Overall Study|Death|0|||
127917794|NCT04364854|460321989|FG003|Overall Study|Death|0|||
127917795|NCT04364854|460321986|FG000|Overall Study|Lost to Follow-up|0|||
127917796|NCT04364854|460321987|FG001|Overall Study|Lost to Follow-up|0|||
127917797|NCT04364854|460321988|FG002|Overall Study|Lost to Follow-up|0|||
127917798|NCT04364854|460321989|FG003|Overall Study|Lost to Follow-up|1|||
127917799|NCT02651987|460321994|FG000|Overall Study|Adverse Event|2|||
127917800|NCT02651987|460321995|FG001|Overall Study|Adverse Event|2|||
127917801|NCT02651987|460321994|FG000|Overall Study|Consent Withdrawn|2|||
127917802|NCT02651987|460321995|FG001|Overall Study|Consent Withdrawn|0|||
127917803|NCT02651987|460321994|FG000|Overall Study|Local PD|0|||
127917804|NCT02651987|460321995|FG001|Overall Study|Local PD|2|||
127917805|NCT02651987|460321994|FG000|Overall Study|Investigator Decision|1|||
127917806|NCT02651987|460321995|FG001|Overall Study|Investigator Decision|1|||
127917807|NCT00522041|460321996|FG000|Overall Study|Adverse Event|9|||
127917808|NCT00522041|460321997|FG001|Overall Study|Adverse Event|3|||
127917809|NCT00522041|460321996|FG000|Overall Study|Protocol Violation|2|||
127917810|NCT00522041|460321997|FG001|Overall Study|Protocol Violation|0|||
127917811|NCT00522041|460321996|FG000|Overall Study|Lost to Follow-up|1|||
127917812|NCT00522041|460321997|FG001|Overall Study|Lost to Follow-up|4|||
127917813|NCT00522041|460321996|FG000|Overall Study|Voluntary withdrawal|5|||
127917814|NCT00522041|460321997|FG001|Overall Study|Voluntary withdrawal|4|||
127917815|NCT00522041|460321996|FG000|Overall Study|Did not receive treatment|0|||
127917816|NCT00522041|460321997|FG001|Overall Study|Did not receive treatment|1|||
127917817|NCT00486434|460321998|FG000|Overall Study|Withdrawal by Subject|34|||
127917818|NCT00486434|460321999|FG001|Overall Study|Withdrawal by Subject|39|||
127917819|NCT00486434|460321998|FG000|Overall Study|Adverse Event|118|||
127917820|NCT00486434|460321999|FG001|Overall Study|Adverse Event|44|||
127917821|NCT00486434|460321998|FG000|Overall Study|Protocol Violation|22|||
127917822|NCT00486434|460321999|FG001|Overall Study|Protocol Violation|21|||
127917823|NCT00486434|460321998|FG000|Overall Study|Lack of Efficacy|12|||
127917824|NCT00486434|460321999|FG001|Overall Study|Lack of Efficacy|19|||
127917825|NCT00486434|460321998|FG000|Overall Study|Lost to Follow-up|2|||
127917826|NCT00486434|460321999|FG001|Overall Study|Lost to Follow-up|3|||
127917827|NCT00486434|460321998|FG000|Overall Study|Death|1|||
127917828|NCT00486434|460321999|FG001|Overall Study|Death|2|||
127917829|NCT00486434|460321998|FG000|Overall Study|Personal reasons|5|||
127917830|NCT00486434|460321999|FG001|Overall Study|Personal reasons|6|||
127917831|NCT02998541|460322000|FG000|Overall Study|Adverse Event|4|||
127917832|NCT02998541|460322001|FG001|Overall Study|Adverse Event|5|||
127917833|NCT02998541|460322002|FG002|Overall Study|Adverse Event|1|||
127917834|NCT02998541|460322000|FG000|Overall Study|Protocol Violation|1|||
127917835|NCT02998541|460322001|FG001|Overall Study|Protocol Violation|0|||
127917836|NCT02998541|460322002|FG002|Overall Study|Protocol Violation|0|||
127917837|NCT02998541|460322000|FG000|Overall Study|Withdrawal by Subject|3|||
127917838|NCT02998541|460322001|FG001|Overall Study|Withdrawal by Subject|1|||
127917839|NCT02998541|460322002|FG002|Overall Study|Withdrawal by Subject|0|||
127917840|NCT02998541|460322000|FG000|Overall Study|Lost to Follow-up|0|||
127917841|NCT02998541|460322001|FG001|Overall Study|Lost to Follow-up|3|||
127917842|NCT02998541|460322002|FG002|Overall Study|Lost to Follow-up|1|||
127917843|NCT02998541|460322000|FG000|Overall Study|Physician Decision|0|||
127917844|NCT02998541|460322001|FG001|Overall Study|Physician Decision|0|||
127917845|NCT02998541|460322002|FG002|Overall Study|Physician Decision|3|||
127917846|NCT02998541|460322000|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
127917847|NCT02998541|460322001|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
127917848|NCT02998541|460322002|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
127917849|NCT00396162|460322008|FG000|Overall Study|Withdrawal by Subject|2|||
127917850|NCT00396162|460322009|FG001|Overall Study|Withdrawal by Subject|3|||
127917851|NCT01944722|460322013|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
127917852|NCT01944722|460322013|FG000|Overall Study|Specimen Shipping Issues|34|||
127917853|NCT01944722|460322013|FG000|Overall Study|Improper Storage/Transport|5|||
127917854|NCT01944722|460322013|FG000|Overall Study|Insufficient Volume for Test|1|||
127917855|NCT01944722|460322013|FG000|Overall Study|Missing Specimens|3|||
127917856|NCT01944722|460322013|FG000|Overall Study|Specimens Mislabeled|2|||
127917857|NCT01944722|460322013|FG000|Overall Study|Withdrawal by Subject|8|||
127917858|NCT01944722|460322013|FG000|Overall Study|NILM Subjects <30 years old|8106|||
127917859|NCT01944722|460322013|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
127917860|NCT01944722|460322013|FG000|Overall Study|>ASCUS Cytology|1122|||
127917861|NCT02906917|460322014|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
127917862|NCT02906917|460322015|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
127917863|NCT02906917|460322014|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
127917864|NCT02906917|460322015|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
127917865|NCT02906917|460322014|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
127917866|NCT02906917|460322015|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
127917867|NCT02906917|460322014|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
127917868|NCT02906917|460322015|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
127917869|NCT02906917|460322014|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
127917870|NCT02906917|460322015|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
127917871|NCT02906917|460322014|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
127917872|NCT02906917|460322015|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
127917873|NCT02906917|460322014|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
127917874|NCT02906917|460322015|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
127917875|NCT02906917|460322014|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
127917876|NCT02906917|460322015|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
127917877|NCT00210639|460322016|FG000|Overall Study|Lost to Follow-up|37|||
127917878|NCT00210639|460322017|FG001|Overall Study|Lost to Follow-up|29|||
127917879|NCT00210639|460322016|FG000|Overall Study|Withdrawal by Subject|8|||
127917880|NCT00210639|460322017|FG001|Overall Study|Withdrawal by Subject|1|||
127917881|NCT00210639|460322016|FG000|Overall Study|Other|18|||
127917882|NCT00210639|460322017|FG001|Overall Study|Other|12|||
127917883|NCT02854800|460322019|FG000|Overall Study|Protocol Violation|16|||
127917884|NCT02854800|460322020|FG001|Overall Study|Protocol Violation|11|||
127917885|NCT02854800|460322021|FG002|Overall Study|Protocol Violation|3|||
127917886|NCT02854800|460322019|FG000|Overall Study|Withdrawal by Subject|4|||
127868399|NCT00656136|460137340|FG000|Overall Study|Progressive disease|177|||
127868400|NCT00656136|460137341|FG001|Overall Study|Progressive disease|322|||
127868401|NCT00656136|460137340|FG000|Overall Study|Other Adverse Event|5|||
127868402|NCT00656136|460137341|FG001|Overall Study|Other Adverse Event|51|||
127868403|NCT00656136|460137340|FG000|Overall Study|Protocol Violation|2|||
127868404|NCT00656136|460137341|FG001|Overall Study|Protocol Violation|3|||
127868405|NCT00656136|460137340|FG000|Overall Study|Patient refused to take study medication|7|||
127868406|NCT00656136|460137341|FG001|Overall Study|Patient refused to take study medication|10|||
127868407|NCT00656136|460137340|FG000|Overall Study|Unknown and others|4|||
127868408|NCT00656136|460137341|FG001|Overall Study|Unknown and others|4|||
127868409|NCT02505945|460137342|FG000|Overall Study|Withdrawal by Subject|13|||
127868410|NCT02505945|460137343|FG001|Overall Study|Withdrawal by Subject|2|||
127868411|NCT02505945|460137342|FG000|Overall Study|Adverse Event|1|||
127868412|NCT02505945|460137343|FG001|Overall Study|Adverse Event|0|||
127868413|NCT02505945|460137342|FG000|Overall Study|Physician Decision|2|||
127868414|NCT02505945|460137343|FG001|Overall Study|Physician Decision|1|||
127868415|NCT02505945|460137342|FG000|Overall Study|Lost to Follow-up|6|||
127868416|NCT02505945|460137343|FG001|Overall Study|Lost to Follow-up|1|||
127868417|NCT00635804|460137344|FG000|Overall Study|Adverse Event|0|||
127868418|NCT00635804|460137345|FG001|Overall Study|Adverse Event|0|||
127868419|NCT00635804|460137346|FG002|Overall Study|Adverse Event|0|||
127868420|NCT00635804|460137347|FG003|Overall Study|Adverse Event|0|||
127868421|NCT00635804|460137348|FG004|Overall Study|Adverse Event|0|||
127868422|NCT00635804|460137349|FG005|Overall Study|Adverse Event|1|||
127868423|NCT00635804|460137350|FG006|Overall Study|Adverse Event|0|||
127868424|NCT00635804|460137351|FG007|Overall Study|Adverse Event|0|||
127868425|NCT00635804|460137344|FG000|Overall Study|Withdrawal by Subject|1|||
127868426|NCT00635804|460137345|FG001|Overall Study|Withdrawal by Subject|0|||
127868427|NCT00635804|460137346|FG002|Overall Study|Withdrawal by Subject|0|||
127868428|NCT00635804|460137347|FG003|Overall Study|Withdrawal by Subject|0|||
127868429|NCT00635804|460137348|FG004|Overall Study|Withdrawal by Subject|0|||
127868430|NCT00635804|460137349|FG005|Overall Study|Withdrawal by Subject|0|||
127868431|NCT00635804|460137350|FG006|Overall Study|Withdrawal by Subject|0|||
127868432|NCT00635804|460137351|FG007|Overall Study|Withdrawal by Subject|0|||
127868433|NCT02718131|460137352|FG000|Overall Study|Withdrawal by Subject|1|||
127868434|NCT02718131|460137353|FG001|Overall Study|Withdrawal by Subject|0|||
127868435|NCT02718131|460137352|FG000|Overall Study|Adverse Event|1|||
127868436|NCT02718131|460137353|FG001|Overall Study|Adverse Event|0|||
127868437|NCT02718131|460137352|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
127868438|NCT02718131|460137353|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
127868439|NCT01097057|460137354|FG000|Overall Study|Physician Decision|3|||
127868440|NCT01101321|460137355|FG000|Period 1|Withdrawal by Subject|1|||
127917887|NCT02854800|460322020|FG001|Overall Study|Withdrawal by Subject|2|||
127917888|NCT02854800|460322021|FG002|Overall Study|Withdrawal by Subject|3|||
127917889|NCT02627963|460322027|FG000|Overall Study|Randomized but not treated|2|||
127917890|NCT02627963|460322028|FG001|Overall Study|Randomized but not treated|6|||
127917891|NCT05278858|460322029|FG000|Overall Study|Withdrawal by Subject|1|||
127917892|NCT00503867|460322033|FG000|Overall Study|Lost to Follow-up|1|||
127917893|NCT00503867|460322033|FG000|Overall Study|Adverse Event|1|||
127917894|NCT00323258|460322036|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
127917895|NCT00323258|460322037|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
127917896|NCT00323258|460322036|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
127917897|NCT00323258|460322037|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
127917898|NCT00323258|460322036|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
127917899|NCT00323258|460322037|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
127917900|NCT00323258|460322036|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
127917901|NCT00323258|460322037|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
127917902|NCT00323258|460322036|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
127917903|NCT00323258|460322037|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
127917904|NCT00323258|460322036|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
127868441|NCT01101321|460137356|FG001|Period 1|Withdrawal by Subject|1|||
127868442|NCT01101321|460137355|FG000|Period 1|Adverse Event|3|||
127868443|NCT01101321|460137356|FG001|Period 1|Adverse Event|3|||
127868444|NCT02681094|460137357|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
127868445|NCT02681094|460137358|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
127868446|NCT02681094|460137359|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
127868447|NCT02681094|460137357|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
127868448|NCT02681094|460137358|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
127868449|NCT02681094|460137359|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
127868450|NCT02681094|460137357|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
127917905|NCT00323258|460322037|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
127917906|NCT00323258|460322036|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
127917907|NCT00323258|460322037|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
127917908|NCT02372006|460322047|FG000|Overall Study|Progressive disease|8|||
127917909|NCT02372006|460322048|FG001|Overall Study|Progressive disease|7|||
127917910|NCT02372006|460322049|FG002|Overall Study|Progressive disease|34|||
127917911|NCT02372006|460322047|FG000|Overall Study|Dose limiting toxicity|0|||
127917912|NCT02372006|460322048|FG001|Overall Study|Dose limiting toxicity|1|||
127917913|NCT02372006|460322049|FG002|Overall Study|Dose limiting toxicity|0|||
127917914|NCT02372006|460322047|FG000|Overall Study|Adverse Event|0|||
127917915|NCT02372006|460322048|FG001|Overall Study|Adverse Event|0|||
127917916|NCT02372006|460322049|FG002|Overall Study|Adverse Event|3|||
127917917|NCT02372006|460322047|FG000|Overall Study|Withdrawal by Subject|0|||
127917918|NCT02372006|460322048|FG001|Overall Study|Withdrawal by Subject|1|||
127917919|NCT02372006|460322049|FG002|Overall Study|Withdrawal by Subject|1|||
127917920|NCT02372006|460322047|FG000|Overall Study|Other reason for not completing|0|||
127917921|NCT02372006|460322048|FG001|Overall Study|Other reason for not completing|0|||
127917922|NCT02372006|460322049|FG002|Overall Study|Other reason for not completing|1|||
127917923|NCT01859598|460322054|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
127917924|NCT03255980|460322059|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
127917925|NCT03255980|460322060|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
127917926|NCT03255980|460322061|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
127917927|NCT03255980|460322062|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
127917928|NCT03255980|460322059|FG000|Overall Study|Adverse Event|1|||
127917929|NCT03255980|460322060|FG001|Overall Study|Adverse Event|1|||
127917930|NCT03255980|460322061|FG002|Overall Study|Adverse Event|0|||
127917931|NCT03255980|460322062|FG003|Overall Study|Adverse Event|1|||
127917932|NCT03255980|460322059|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
127917933|NCT03255980|460322060|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
127917934|NCT03255980|460322061|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
127917935|NCT03255980|460322062|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
127917936|NCT03255980|460322059|FG000|Overall Study|Lost to Follow-up|1|||
127917937|NCT03255980|460322060|FG001|Overall Study|Lost to Follow-up|1|||
127917938|NCT03255980|460322061|FG002|Overall Study|Lost to Follow-up|0|||
127917939|NCT03255980|460322062|FG003|Overall Study|Lost to Follow-up|3|||
127917940|NCT03255980|460322059|FG000|Overall Study|Withdrawal by Subject|0|||
127917941|NCT03255980|460322060|FG001|Overall Study|Withdrawal by Subject|1|||
127917942|NCT03255980|460322061|FG002|Overall Study|Withdrawal by Subject|0|||
127917943|NCT03255980|460322062|FG003|Overall Study|Withdrawal by Subject|3|||
127917944|NCT03141151|460322073|FG000|Overall Study|Lost to Follow-up|3|||
127917945|NCT03141151|460322074|FG001|Overall Study|Lost to Follow-up|2|||
127917946|NCT03141151|460322073|FG000|Overall Study|Withdrawal by Subject|3|||
127917947|NCT03141151|460322074|FG001|Overall Study|Withdrawal by Subject|2|||
127917948|NCT01874535|460322075|FG000|Overall Study|Lost to Follow-up|10|||
127917949|NCT01874535|460322076|FG001|Overall Study|Lost to Follow-up|9|||
127917950|NCT01874535|460322075|FG000|Overall Study|incomplete symptom resolution|45|||
127917951|NCT01874535|460322076|FG001|Overall Study|incomplete symptom resolution|35|||
127917952|NCT01215721|460322077|FG000|Overall Study|Adverse Event|2|||
127917953|NCT00570128|460322079|FG000|Overall Study|Adverse Event|1|||
127917954|NCT00570128|460322080|FG001|Overall Study|Adverse Event|0|||
127917955|NCT00570128|460322079|FG000|Overall Study|Lost to Follow-up|1|||
127917956|NCT00570128|460322080|FG001|Overall Study|Lost to Follow-up|0|||
127917957|NCT00570128|460322079|FG000|Overall Study|Withdrawal by Subject|2|||
127917958|NCT00570128|460322080|FG001|Overall Study|Withdrawal by Subject|0|||
127917959|NCT01929681|460322081|FG000|Overall Study|Withdrawal by Subject|1|||
127917960|NCT01929681|460322082|FG001|Overall Study|Withdrawal by Subject|0|||
127917961|NCT01929681|460322081|FG000|Overall Study|Physician Decision|1|||
127917962|NCT01929681|460322082|FG001|Overall Study|Physician Decision|1|||
127917963|NCT01073631|460322085|FG000|Overall Study|Death|82|||
127917964|NCT01073631|460322085|FG000|Overall Study|Adverse Event|24|||
127917965|NCT01073631|460322085|FG000|Overall Study|Other|63|||
127917966|NCT01528735|460322086|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
127917967|NCT01528735|460322087|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
127917968|NCT01528735|460322086|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
127917969|NCT01528735|460322087|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
127917970|NCT01971554|460322090|FG000|Overall Study|Lost to Follow-up|1|||
127917971|NCT01971554|460322091|FG001|Overall Study|Lost to Follow-up|0|||
127917972|NCT01971554|460322092|FG002|Overall Study|Lost to Follow-up|0|||
127917973|NCT01971554|460322093|FG003|Overall Study|Lost to Follow-up|0|||
127917974|NCT01426854|460322094|FG000|Overall Study|Adverse Event|1|||
127917975|NCT01426854|460322095|FG001|Overall Study|Adverse Event|5|||
127917976|NCT01426854|460322094|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
127917977|NCT01426854|460322095|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
127917978|NCT01426854|460322094|FG000|Overall Study|Lost to Follow-up|3|||
127917979|NCT01426854|460322095|FG001|Overall Study|Lost to Follow-up|0|||
127868451|NCT02681094|460137358|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
127868452|NCT02681094|460137359|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
127868453|NCT02681094|460137357|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
127868454|NCT02681094|460137358|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
127868455|NCT02681094|460137359|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
127868456|NCT02681094|460137357|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
127868457|NCT02681094|460137358|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
127868458|NCT02681094|460137359|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
127868459|NCT02681094|460137357|FG000|1 -Modified Enrolled Participants Set|Other|6|||
127868460|NCT02681094|460137358|FG001|1 -Modified Enrolled Participants Set|Other|6|||
127868461|NCT02681094|460137359|FG002|1 -Modified Enrolled Participants Set|Other|7|||
127868462|NCT02681094|460137357|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
127868463|NCT02681094|460137358|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
127917980|NCT01426854|460322094|FG000|Overall Study|Noncompliance|0|||
127917981|NCT01426854|460322095|FG001|Overall Study|Noncompliance|1|||
127917982|NCT01426854|460322094|FG000|Overall Study|Treatment Failure|0|||
127917983|NCT01426854|460322095|FG001|Overall Study|Treatment Failure|16|||
127917984|NCT01426854|460322094|FG000|Overall Study|Protocol Deviation|0|||
127917985|NCT01426854|460322095|FG001|Overall Study|Protocol Deviation|1|||
127917986|NCT01426854|460322094|FG000|Overall Study|Other|3|||
127917987|NCT01426854|460322095|FG001|Overall Study|Other|2|||
127917988|NCT01942135|460322099|FG000|Overall Study|Adverse Event|21|||
127917989|NCT01942135|460322100|FG001|Overall Study|Adverse Event|7|||
127917990|NCT01942135|460322099|FG000|Overall Study|Global Deterioration of Health Status|9|||
127917991|NCT01942135|460322100|FG001|Overall Study|Global Deterioration of Health Status|6|||
127917992|NCT01942135|460322099|FG000|Overall Study|Randomized Not Treated|2|||
127917993|NCT01942135|460322100|FG001|Overall Study|Randomized Not Treated|2|||
127917994|NCT01942135|460322099|FG000|Overall Study|Death|2|||
127917995|NCT01942135|460322100|FG001|Overall Study|Death|1|||
127917996|NCT01942135|460322099|FG000|Overall Study|Objective Progression or Relapse + Progressive Disease|279|||
127917997|NCT01942135|460322100|FG001|Overall Study|Objective Progression or Relapse + Progressive Disease|148|||
127917998|NCT01942135|460322099|FG000|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|10|||
127917999|NCT01942135|460322100|FG001|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|3|||
127918000|NCT01942135|460322099|FG000|Overall Study|Withdrawal by Subject|4|||
127918001|NCT01942135|460322100|FG001|Overall Study|Withdrawal by Subject|3|||
127918002|NCT01942135|460322099|FG000|Overall Study|Protocol Violation|1|||
127918003|NCT01942135|460322100|FG001|Overall Study|Protocol Violation|0|||
127918004|NCT01942135|460322099|FG000|Overall Study|Other|19|||
127918005|NCT01942135|460322100|FG001|Overall Study|Other|4|||
127918006|NCT00950300|460322101|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
127918007|NCT00950300|460322102|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
127918008|NCT00950300|460322101|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
127918009|NCT00950300|460322102|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
127918010|NCT00950300|460322101|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
127918011|NCT00950300|460322102|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
127918012|NCT00950300|460322101|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
127918013|NCT00950300|460322102|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
127918014|NCT00950300|460322101|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
127918015|NCT00950300|460322102|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
127918016|NCT00950300|460322101|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
127918017|NCT00950300|460322102|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
127918018|NCT00950300|460322101|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
127918019|NCT00950300|460322102|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
127918020|NCT00950300|460322101|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
127918021|NCT00950300|460322102|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
127868464|NCT02681094|460137359|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
127868465|NCT02681094|460137357|FG000|2 - Enrolled Participants Set|Participant decision|7|||
127868466|NCT02681094|460137358|FG001|2 - Enrolled Participants Set|Participant decision|10|||
127868467|NCT02681094|460137359|FG002|2 - Enrolled Participants Set|Participant decision|9|||
127918022|NCT00950300|460322101|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
127918023|NCT00950300|460322102|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
127918024|NCT00950300|460322101|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
127918025|NCT00950300|460322102|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
127918026|NCT00950300|460322101|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
127918027|NCT00950300|460322102|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
127918028|NCT00950300|460322101|FG000|TFFU Period|Death|4|||
127918029|NCT00950300|460322102|FG001|TFFU Period|Death|1|||
127868468|NCT02681094|460137357|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
127868469|NCT02681094|460137358|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
127868470|NCT02681094|460137359|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
127868471|NCT02681094|460137357|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
127868472|NCT02681094|460137358|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
127868473|NCT02681094|460137359|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
127868474|NCT02681094|460137357|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
127868475|NCT02681094|460137358|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
127868476|NCT02681094|460137359|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
127918030|NCT00950300|460322101|FG000|TFFU Period|Refused Treatment|10|||
127918031|NCT00950300|460322102|FG001|TFFU Period|Refused Treatment|11|||
127918032|NCT00950300|460322101|FG000|TFFU Period|Failure to Return|16|||
127918033|NCT00950300|460322102|FG001|TFFU Period|Failure to Return|16|||
127918034|NCT00950300|460322101|FG000|TFFU Period|Recurrence of Disease|63|||
127918035|NCT00950300|460322102|FG001|TFFU Period|Recurrence of Disease|72|||
127918036|NCT00950300|460322101|FG000|TFFU Period|Other|4|||
127918037|NCT00950300|460322102|FG001|TFFU Period|Other|3|||
127918038|NCT00950300|460322101|FG000|SFU Period|Death|44|||
127918039|NCT00950300|460322102|FG001|SFU Period|Death|42|||
127918040|NCT00950300|460322101|FG000|SFU Period|Lost to Follow-up|30|||
127918041|NCT00950300|460322102|FG001|SFU Period|Lost to Follow-up|28|||
127918042|NCT00950300|460322101|FG000|SFU Period|Withdrawal by Subject|4|||
127918043|NCT00950300|460322102|FG001|SFU Period|Withdrawal by Subject|8|||
127918044|NCT01717040|460322103|FG000|Overall Study|Lost to Follow-up|2|||
127918045|NCT01717040|460322104|FG001|Overall Study|Lost to Follow-up|3|||
127918046|NCT01717040|460322103|FG000|Overall Study|Lack of Efficacy|1|||
127918047|NCT01717040|460322104|FG001|Overall Study|Lack of Efficacy|1|||
127918048|NCT01717040|460322103|FG000|Overall Study|Adverse Event|1|||
127918049|NCT01717040|460322104|FG001|Overall Study|Adverse Event|0|||
127918050|NCT01717040|460322103|FG000|Overall Study|Required Medication Change|0|||
127918051|NCT01717040|460322104|FG001|Overall Study|Required Medication Change|1|||
127918052|NCT01717040|460322103|FG000|Overall Study|New Substance Use Disorder|1|||
127918053|NCT01717040|460322104|FG001|Overall Study|New Substance Use Disorder|0|||
127918054|NCT00494013|460322105|FG000|Overall Study|Adverse Event|0|||
127918055|NCT00494013|460322106|FG001|Overall Study|Adverse Event|1|||
127918056|NCT00494013|460322105|FG000|Overall Study|Entry Criteria Not Met|1|||
127918057|NCT00494013|460322106|FG001|Overall Study|Entry Criteria Not Met|4|||
127918058|NCT00494013|460322105|FG000|Overall Study|Lost to Follow-up|5|||
127918059|NCT00494013|460322106|FG001|Overall Study|Lost to Follow-up|6|||
127918060|NCT00494013|460322105|FG000|Overall Study|Physician Decision|3|||
127918061|NCT00494013|460322106|FG001|Overall Study|Physician Decision|5|||
127918062|NCT00494013|460322105|FG000|Overall Study|Protocol Violation|8|||
127918063|NCT00494013|460322106|FG001|Overall Study|Protocol Violation|5|||
127918064|NCT00494013|460322105|FG000|Overall Study|Withdrawal by Subject|13|||
127918065|NCT00494013|460322106|FG001|Overall Study|Withdrawal by Subject|14|||
127918066|NCT00494013|460322105|FG000|Overall Study|Sponsor Decision|0|||
127918067|NCT00494013|460322106|FG001|Overall Study|Sponsor Decision|1|||
127918068|NCT04750239|460322107|FG000|Overall Study|Withdrawal by Subject|2|||
127918069|NCT04750239|460322107|FG000|Overall Study|Trial terminated by sponsor|1|||
127918070|NCT00903877|460322108|FG000|Overall Study|Did not meet study criteria|33|||
127918071|NCT00903877|460322108|FG000|Overall Study|Withdrawal by Subject|3|||
127918072|NCT00903877|460322108|FG000|Overall Study|Adverse Event|2|||
127918073|NCT00903877|460322108|FG000|Overall Study|Lost to Follow-up|1|||
127918074|NCT00903877|460322108|FG000|Overall Study|Participation put on hold|4|||
127918075|NCT00919711|460322109|FG000|Overall Study|Withdrawal by Subject|15|||
127918076|NCT00919711|460322110|FG001|Overall Study|Withdrawal by Subject|7|||
127918077|NCT00919711|460322109|FG000|Overall Study|Adverse Event|13|||
127918078|NCT00919711|460322110|FG001|Overall Study|Adverse Event|3|||
127918079|NCT00919711|460322109|FG000|Overall Study|Other|1|||
127918080|NCT00919711|460322110|FG001|Overall Study|Other|2|||
127868477|NCT02681094|460137357|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
127868478|NCT02681094|460137358|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
127918081|NCT00919711|460322109|FG000|Overall Study|Administrative Decision|0|||
127918082|NCT00919711|460322110|FG001|Overall Study|Administrative Decision|1|||
127918083|NCT00919711|460322109|FG000|Overall Study|Lost to Follow-up|2|||
127918084|NCT00919711|460322110|FG001|Overall Study|Lost to Follow-up|0|||
127918085|NCT00919711|460322109|FG000|Overall Study|Death|1|||
127918086|NCT00919711|460322110|FG001|Overall Study|Death|0|||
127918087|NCT00919711|460322109|FG000|Overall Study|Noncompliance|1|||
127918088|NCT00919711|460322110|FG001|Overall Study|Noncompliance|0|||
127918089|NCT00087529|460322111|FG000|Overall Study|Death|1|||
127918090|NCT00087529|460322112|FG001|Overall Study|Death|0|||
127918091|NCT00087529|460322111|FG000|Overall Study|Adverse Event|0|||
127918092|NCT00087529|460322112|FG001|Overall Study|Adverse Event|8|||
127918093|NCT00087529|460322111|FG000|Overall Study|Pregnancy|0|||
127918094|NCT00087529|460322112|FG001|Overall Study|Pregnancy|1|||
127918095|NCT00087529|460322111|FG000|Overall Study|Lost to Follow-up|2|||
127918096|NCT00087529|460322112|FG001|Overall Study|Lost to Follow-up|3|||
127868479|NCT02681094|460137359|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
127868480|NCT02681094|460137357|FG000|2 - Enrolled Participants Set|Other|6|||
127868481|NCT02681094|460137358|FG001|2 - Enrolled Participants Set|Other|6|||
127868482|NCT02681094|460137359|FG002|2 - Enrolled Participants Set|Other|7|||
127868483|NCT02681094|460137357|FG000|2 - Enrolled Participants Set|No treatment given|0|||
127868484|NCT02681094|460137358|FG001|2 - Enrolled Participants Set|No treatment given|1|||
127868485|NCT02681094|460137359|FG002|2 - Enrolled Participants Set|No treatment given|1|||
127868486|NCT01270139|460137360|FG000|Overall Study|Adverse Event|8|||
127868487|NCT01270139|460137361|FG001|Overall Study|Adverse Event|17|||
127868488|NCT01270139|460137362|FG002|Overall Study|Adverse Event|18|||
127868489|NCT01270139|460137360|FG000|Overall Study|Lost to Follow-up|10|||
127868490|NCT01270139|460137361|FG001|Overall Study|Lost to Follow-up|9|||
127868491|NCT01270139|460137362|FG002|Overall Study|Lost to Follow-up|2|||
127868492|NCT00134563|460137365|FG000|Overall Study|Not treated due to protocol violation|0|||
127868493|NCT00134563|460137366|FG001|Overall Study|Not treated due to protocol violation|1|||
127868494|NCT00134563|460137367|FG002|Overall Study|Not treated due to protocol violation|1|||
127868495|NCT00134563|460137365|FG000|Overall Study|Adverse Event|29|||
127868496|NCT00134563|460137366|FG001|Overall Study|Adverse Event|37|||
127868497|NCT00134563|460137367|FG002|Overall Study|Adverse Event|38|||
127868498|NCT00134563|460137365|FG000|Overall Study|Lack of Efficacy|24|||
127868499|NCT00134563|460137366|FG001|Overall Study|Lack of Efficacy|14|||
127868500|NCT00134563|460137367|FG002|Overall Study|Lack of Efficacy|17|||
127868501|NCT00134563|460137365|FG000|Overall Study|Protocol Violation|3|||
127868502|NCT00134563|460137366|FG001|Overall Study|Protocol Violation|2|||
127868503|NCT00134563|460137367|FG002|Overall Study|Protocol Violation|5|||
127868504|NCT00134563|460137365|FG000|Overall Study|Lost to Follow-up|4|||
127868505|NCT00134563|460137366|FG001|Overall Study|Lost to Follow-up|0|||
127868506|NCT00134563|460137367|FG002|Overall Study|Lost to Follow-up|2|||
127868507|NCT00134563|460137365|FG000|Overall Study|progressive disease|11|||
127868508|NCT00134563|460137366|FG001|Overall Study|progressive disease|4|||
127868509|NCT00134563|460137367|FG002|Overall Study|progressive disease|2|||
127868510|NCT00134563|460137365|FG000|Overall Study|did not wish to continue|33|||
127868511|NCT00134563|460137366|FG001|Overall Study|did not wish to continue|32|||
127868512|NCT00134563|460137367|FG002|Overall Study|did not wish to continue|26|||
127868513|NCT00134563|460137365|FG000|Overall Study|Reason other than above|0|||
127868514|NCT00134563|460137366|FG001|Overall Study|Reason other than above|2|||
127868515|NCT00134563|460137367|FG002|Overall Study|Reason other than above|5|||
127868516|NCT02452320|460137371|FG000|Overall Study|Adverse Event|0|||
127868517|NCT02452320|460137372|FG001|Overall Study|Adverse Event|1|||
127868518|NCT03382639|460137373|FG000|Overall Study|Adverse Event|2|||
127868519|NCT03382639|460137374|FG001|Overall Study|Adverse Event|0|||
127868520|NCT03382639|460137375|FG002|Overall Study|Adverse Event|1|||
127868521|NCT03382639|460137376|FG003|Overall Study|Adverse Event|1|||
127868522|NCT03382639|460137373|FG000|Overall Study|Lost to Follow-up|1|||
127868523|NCT03382639|460137374|FG001|Overall Study|Lost to Follow-up|0|||
127868524|NCT03382639|460137375|FG002|Overall Study|Lost to Follow-up|0|||
127868525|NCT03382639|460137376|FG003|Overall Study|Lost to Follow-up|0|||
127868526|NCT03382639|460137373|FG000|Overall Study|Withdrawal by Subject|4|||
127868527|NCT03382639|460137374|FG001|Overall Study|Withdrawal by Subject|3|||
127868528|NCT03382639|460137375|FG002|Overall Study|Withdrawal by Subject|2|||
127868529|NCT03382639|460137376|FG003|Overall Study|Withdrawal by Subject|3|||
127868530|NCT03382639|460137373|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
127868531|NCT03382639|460137374|FG001|Overall Study|Unsatisfactory therapeutic response|0|||
127918097|NCT00087529|460322111|FG000|Overall Study|Participant Decision|14|||
127918098|NCT00087529|460322112|FG001|Overall Study|Participant Decision|37|||
127918099|NCT00087529|460322111|FG000|Overall Study|Physician Decision|4|||
127918100|NCT00087529|460322112|FG001|Overall Study|Physician Decision|8|||
127918101|NCT00087529|460322111|FG000|Overall Study|Initiation of Excluded Therapy|0|||
127918102|NCT00087529|460322112|FG001|Overall Study|Initiation of Excluded Therapy|1|||
127918103|NCT00087529|460322111|FG000|Overall Study|Participant Noncompliance|0|||
127918104|NCT00087529|460322112|FG001|Overall Study|Participant Noncompliance|1|||
127918105|NCT00087529|460322111|FG000|Overall Study|Disease Progression|5|||
127918106|NCT00087529|460322112|FG001|Overall Study|Disease Progression|4|||
127918107|NCT00087529|460322111|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
127918108|NCT00087529|460322112|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
127918109|NCT00685334|460322115|FG000|Overall Study|Withdrawal by Subject|5|||
127918110|NCT00685334|460322116|FG001|Overall Study|Withdrawal by Subject|6|||
127918111|NCT00685334|460322115|FG000|Overall Study|Lost to Follow-up|4|||
127918112|NCT00685334|460322116|FG001|Overall Study|Lost to Follow-up|0|||
127918113|NCT00685334|460322115|FG000|Overall Study|Chose to enter hospital|1|||
127918114|NCT00685334|460322116|FG001|Overall Study|Chose to enter hospital|1|||
127918115|NCT01891357|460322117|FG000|Overall Study|Protocol Violation|3|||
127918116|NCT03387462|460323430|FG000|Overall Study|Lost to Follow-up|1|||
127918117|NCT01460628|460323433|FG000|Overall Study|Adverse Event|3|||
127918118|NCT01460628|460323433|FG000|Overall Study|Withdrawal by Subject|2|||
127918119|NCT00874822|460323436|FG000|Overall Study|excluded by criteria|8|||
127918120|NCT04281472|460323438|FG000|Stage A|Lack of Efficacy|8|||
127918121|NCT04281472|460323439|FG001|Stage A|Lack of Efficacy|0|||
127918122|NCT04281472|460323440|FG002|Stage A|Lack of Efficacy|0|||
127918123|NCT04281472|460323438|FG000|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|22|||
127918124|NCT04281472|460323439|FG001|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
127918125|NCT04281472|460323440|FG002|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
127918126|NCT04281472|460323438|FG000|Stage A|Adverse Event|20|||
127918127|NCT04281472|460323439|FG001|Stage A|Adverse Event|0|||
127918128|NCT04281472|460323440|FG002|Stage A|Adverse Event|0|||
127918129|NCT04281472|460323438|FG000|Stage A|Death|1|||
127918130|NCT04281472|460323439|FG001|Stage A|Death|0|||
127918131|NCT04281472|460323440|FG002|Stage A|Death|0|||
127918132|NCT04281472|460323438|FG000|Stage A|Lack of efficacy before end of Stage A|28|||
127918133|NCT04281472|460323439|FG001|Stage A|Lack of efficacy before end of Stage A|0|||
127918134|NCT04281472|460323440|FG002|Stage A|Lack of efficacy before end of Stage A|0|||
127918135|NCT04281472|460323438|FG000|Stage A|Lost to Follow-up|2|||
127918136|NCT04281472|460323439|FG001|Stage A|Lost to Follow-up|0|||
127918137|NCT04281472|460323440|FG002|Stage A|Lost to Follow-up|0|||
127918138|NCT04281472|460323438|FG000|Stage A|Non-compliance with study drug|1|||
127918139|NCT04281472|460323439|FG001|Stage A|Non-compliance with study drug|0|||
127918140|NCT04281472|460323440|FG002|Stage A|Non-compliance with study drug|0|||
127918141|NCT04281472|460323438|FG000|Stage A|Physician Decision|1|||
127918142|NCT04281472|460323439|FG001|Stage A|Physician Decision|0|||
127918143|NCT04281472|460323440|FG002|Stage A|Physician Decision|0|||
127918144|NCT04281472|460323438|FG000|Stage A|Prohibited medications|2|||
127918145|NCT04281472|460323439|FG001|Stage A|Prohibited medications|0|||
127918146|NCT04281472|460323440|FG002|Stage A|Prohibited medications|0|||
127918147|NCT04281472|460323438|FG000|Stage A|Withdrawal by Subject|11|||
127918148|NCT04281472|460323439|FG001|Stage A|Withdrawal by Subject|0|||
127918149|NCT04281472|460323440|FG002|Stage A|Withdrawal by Subject|0|||
127918150|NCT04281472|460323438|FG000|Stage A|Other|5|||
127918151|NCT04281472|460323439|FG001|Stage A|Other|0|||
127918152|NCT04281472|460323440|FG002|Stage A|Other|0|||
127918153|NCT04281472|460323438|FG000|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
127918154|NCT04281472|460323439|FG001|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|35|||
127918155|NCT04281472|460323440|FG002|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|26|||
127918156|NCT04281472|460323438|FG000|Stage B|Adverse Event|0|||
127918157|NCT04281472|460323439|FG001|Stage B|Adverse Event|3|||
127918158|NCT04281472|460323440|FG002|Stage B|Adverse Event|0|||
127918159|NCT04281472|460323438|FG000|Stage B|Death|0|||
127918160|NCT04281472|460323439|FG001|Stage B|Death|0|||
127918161|NCT04281472|460323440|FG002|Stage B|Death|1|||
127918162|NCT04281472|460323438|FG000|Stage B|Lack of Efficacy|0|||
127918163|NCT04281472|460323439|FG001|Stage B|Lack of Efficacy|0|||
127918164|NCT04281472|460323440|FG002|Stage B|Lack of Efficacy|1|||
127918165|NCT04281472|460323438|FG000|Stage B|Lost to Follow-up|0|||
127918166|NCT04281472|460323439|FG001|Stage B|Lost to Follow-up|0|||
127918167|NCT04281472|460323440|FG002|Stage B|Lost to Follow-up|2|||
127918168|NCT04281472|460323438|FG000|Stage B|Prohibited medications|0|||
127918169|NCT04281472|460323439|FG001|Stage B|Prohibited medications|2|||
127918170|NCT04281472|460323440|FG002|Stage B|Prohibited medications|1|||
127918171|NCT04281472|460323438|FG000|Stage B|Protocol Violation|0|||
127918172|NCT04281472|460323439|FG001|Stage B|Protocol Violation|1|||
127918173|NCT04281472|460323440|FG002|Stage B|Protocol Violation|1|||
127918174|NCT04281472|460323438|FG000|Stage B|Sponsor decision|0|||
127918175|NCT04281472|460323439|FG001|Stage B|Sponsor decision|0|||
127918176|NCT04281472|460323440|FG002|Stage B|Sponsor decision|1|||
127918177|NCT04281472|460323438|FG000|Stage B|Withdrawal by Subject|0|||
127918178|NCT04281472|460323439|FG001|Stage B|Withdrawal by Subject|3|||
127918179|NCT04281472|460323440|FG002|Stage B|Withdrawal by Subject|3|||
127918180|NCT04281472|460323438|FG000|Stage B|Other|0|||
127918181|NCT04281472|460323439|FG001|Stage B|Other|3|||
127918182|NCT04281472|460323440|FG002|Stage B|Other|0|||
127918183|NCT00152451|460323443|FG000|Overall Study|Adverse Event|4|||
127918184|NCT04697173|460323446|FG000|Overall Study|Withdrawal by Subject|34|||
127918185|NCT04697173|460323447|FG001|Overall Study|Withdrawal by Subject|38|||
127918186|NCT03807440|460323448|FG000|Overall Study|No documentation of index date 2|320|||
127918187|NCT03807440|460323448|FG000|Overall Study|No informed consent for index date 2|117|||
127918188|NCT01055834|460323450|FG000|Treatment Period I|Adverse Event|1|||
127918189|NCT01055834|460323451|FG001|Treatment Period I|Adverse Event|0|||
127918190|NCT01717313|460323452|FG000|Phase A (Weeks 0 to 24)|Death|0|||
127918191|NCT01717313|460323453|FG001|Phase A (Weeks 0 to 24)|Death|1|||
127918192|NCT01717313|460323452|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
127918193|NCT01717313|460323453|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
127918194|NCT01717313|460323452|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
127918195|NCT01717313|460323453|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
127918196|NCT01717313|460323452|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
127918197|NCT01717313|460323453|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
127918198|NCT01717313|460323452|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
127918199|NCT01717313|460323453|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
127918200|NCT01717313|460323452|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
127918201|NCT01717313|460323453|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
127918202|NCT01717313|460323452|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
127918203|NCT01717313|460323453|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
127918204|NCT01717313|460323452|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
127918205|NCT01717313|460323453|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
127918206|NCT01717313|460323452|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
127918207|NCT01717313|460323453|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
127918208|NCT03504085|460323454|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
127918209|NCT03504085|460323455|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
127918210|NCT03504085|460323454|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
127918211|NCT03504085|460323455|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
127918212|NCT04133311|460323456|FG000|Period 1 Double Masked Treatment Period|Death|1|||
127918213|NCT04133311|460323457|FG001|Period 1 Double Masked Treatment Period|Death|0|||
127918214|NCT04133311|460323458|FG002|Period 1 Double Masked Treatment Period|Death|0|||
127918215|NCT04133311|460323459|FG003|Period 1 Double Masked Treatment Period|Death|0|||
127918216|NCT04133311|460323456|FG000|Period 1 Double Masked Treatment Period|Adverse Event|1|||
127918217|NCT04133311|460323457|FG001|Period 1 Double Masked Treatment Period|Adverse Event|1|||
127918218|NCT04133311|460323458|FG002|Period 1 Double Masked Treatment Period|Adverse Event|0|||
127918219|NCT04133311|460323459|FG003|Period 1 Double Masked Treatment Period|Adverse Event|0|||
127918220|NCT04133311|460323456|FG000|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
127918221|NCT04133311|460323457|FG001|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
127918222|NCT04133311|460323458|FG002|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
127918223|NCT04133311|460323459|FG003|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
127918224|NCT04133311|460323456|FG000|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
127918225|NCT04133311|460323457|FG001|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|1|||
127918226|NCT04133311|460323458|FG002|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
127918227|NCT04133311|460323459|FG003|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
127918228|NCT04133311|460323456|FG000|Period 2 Open Label Treatment Period|Adverse Event|0|||
127918229|NCT04133311|460323457|FG001|Period 2 Open Label Treatment Period|Adverse Event|0|||
127918230|NCT04133311|460323458|FG002|Period 2 Open Label Treatment Period|Adverse Event|0|||
127918231|NCT04133311|460323459|FG003|Period 2 Open Label Treatment Period|Adverse Event|2|||
127918232|NCT04133311|460323456|FG000|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
127918233|NCT04133311|460323457|FG001|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
127918234|NCT04133311|460323458|FG002|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
127918235|NCT04133311|460323459|FG003|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
127918236|NCT04133311|460323456|FG000|Period 2 Open Label Treatment Period|Pregnancy|0|||
127918237|NCT04133311|460323457|FG001|Period 2 Open Label Treatment Period|Pregnancy|0|||
127918238|NCT04133311|460323458|FG002|Period 2 Open Label Treatment Period|Pregnancy|1|||
127918239|NCT04133311|460323459|FG003|Period 2 Open Label Treatment Period|Pregnancy|0|||
127918240|NCT04133311|460323456|FG000|Period 2 Open Label Treatment Period|Early Termination|0|||
127918241|NCT04133311|460323457|FG001|Period 2 Open Label Treatment Period|Early Termination|0|||
127918242|NCT04133311|460323458|FG002|Period 2 Open Label Treatment Period|Early Termination|1|||
127918243|NCT04133311|460323459|FG003|Period 2 Open Label Treatment Period|Early Termination|0|||
127918244|NCT00728754|460323460|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
127918245|NCT00728754|460323461|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
127918246|NCT00728754|460323460|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
127918247|NCT00728754|460323461|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
127918248|NCT00728754|460323460|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
127918249|NCT00728754|460323461|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
127918250|NCT01926119|460323462|FG000|Overall Study|Withdrawal by Subject|1|||
127918251|NCT00009945|460323463|FG000|Overall Study|no follow up data|7|||
127918252|NCT00009945|460323464|FG001|Overall Study|no follow up data|5|||
127918253|NCT00295490|460323471|FG000|Overall Study|Protocol Violation|0|||
127918254|NCT00295490|460323472|FG001|Overall Study|Protocol Violation|0|||
127918255|NCT00295490|460323473|FG002|Overall Study|Protocol Violation|3|||
127918256|NCT00295490|460323474|FG003|Overall Study|Protocol Violation|3|||
127918257|NCT00295490|460323471|FG000|Overall Study|Withdrawal by Subject|0|||
127918258|NCT00295490|460323472|FG001|Overall Study|Withdrawal by Subject|2|||
127918259|NCT00295490|460323473|FG002|Overall Study|Withdrawal by Subject|0|||
127918260|NCT00295490|460323474|FG003|Overall Study|Withdrawal by Subject|1|||
127918261|NCT00295490|460323471|FG000|Overall Study|Lost to Follow-up|0|||
127918262|NCT00295490|460323472|FG001|Overall Study|Lost to Follow-up|0|||
127918263|NCT00295490|460323473|FG002|Overall Study|Lost to Follow-up|1|||
127918264|NCT00295490|460323474|FG003|Overall Study|Lost to Follow-up|0|||
127918265|NCT00295490|460323471|FG000|Overall Study|Adverse Event|1|||
127918266|NCT00295490|460323472|FG001|Overall Study|Adverse Event|0|||
127918267|NCT00295490|460323473|FG002|Overall Study|Adverse Event|0|||
127918268|NCT00295490|460323474|FG003|Overall Study|Adverse Event|0|||
127918269|NCT00295490|460323471|FG000|Overall Study|Other|0|||
127918270|NCT00295490|460323472|FG001|Overall Study|Other|2|||
127918271|NCT00295490|460323473|FG002|Overall Study|Other|0|||
127918272|NCT00295490|460323474|FG003|Overall Study|Other|1|||
127918273|NCT01617096|460323479|FG000|Overall Study|Withdrawal by Subject|96|||
127918274|NCT01617096|460323480|FG001|Overall Study|Withdrawal by Subject|81|||
127918275|NCT01617096|460323479|FG000|Overall Study|Lost to Follow-up|37|||
127918276|NCT01617096|460323480|FG001|Overall Study|Lost to Follow-up|32|||
127918277|NCT01617096|460323479|FG000|Overall Study|Physician Decision|10|||
127918278|NCT01617096|460323480|FG001|Overall Study|Physician Decision|18|||
127918279|NCT01617096|460323479|FG000|Overall Study|Death|4|||
127918280|NCT01617096|460323480|FG001|Overall Study|Death|3|||
127918281|NCT01617096|460323479|FG000|Overall Study|Other|1|||
127918282|NCT01617096|460323480|FG001|Overall Study|Other|3|||
127918283|NCT04473326|460323483|FG000|Overall Study|Death|0|||
127918284|NCT04473326|460323484|FG001|Overall Study|Death|1|||
127918285|NCT04473326|460323483|FG000|Overall Study|Withdrawal by Subject|1|||
127918286|NCT04473326|460323484|FG001|Overall Study|Withdrawal by Subject|2|||
127918287|NCT02611362|460323485|FG000|Overall Study|Withdrawal by Subject|7|||
127918288|NCT02611362|460323486|FG001|Overall Study|Withdrawal by Subject|2|||
127918289|NCT02611362|460323485|FG000|Overall Study|Lost to Follow-up|2|||
127918290|NCT02611362|460323486|FG001|Overall Study|Lost to Follow-up|4|||
127918291|NCT01155531|460323487|FG000|Overall Study|Adverse Event|0|||
127918292|NCT01155531|460323488|FG001|Overall Study|Adverse Event|0|||
127918293|NCT01155531|460323489|FG002|Overall Study|Adverse Event|1|||
127918294|NCT01155531|460323490|FG003|Overall Study|Adverse Event|0|||
127918295|NCT01155531|460323487|FG000|Overall Study|Lost to Follow-up|0|||
127918296|NCT01155531|460323488|FG001|Overall Study|Lost to Follow-up|0|||
127918297|NCT01155531|460323489|FG002|Overall Study|Lost to Follow-up|0|||
127918298|NCT01155531|460323490|FG003|Overall Study|Lost to Follow-up|1|||
127918299|NCT01155531|460323487|FG000|Overall Study|Withdrawal by Subject|1|||
127918300|NCT01155531|460323488|FG001|Overall Study|Withdrawal by Subject|0|||
127918301|NCT01155531|460323489|FG002|Overall Study|Withdrawal by Subject|1|||
127918302|NCT01155531|460323490|FG003|Overall Study|Withdrawal by Subject|0|||
127918303|NCT00354159|460323491|FG000|Randomized Study Period|Withdrawal by Subject|5|||
127918304|NCT00354159|460323492|FG001|Randomized Study Period|Withdrawal by Subject|3|||
127918305|NCT00354159|460323491|FG000|Randomized Study Period|Physician Decision|6|||
127918306|NCT00354159|460323492|FG001|Randomized Study Period|Physician Decision|10|||
127918307|NCT00354159|460323491|FG000|Randomized Study Period|Lost to Follow-up|4|||
127918308|NCT00354159|460323492|FG001|Randomized Study Period|Lost to Follow-up|0|||
127918309|NCT00354159|460323491|FG000|Randomized Study Period|Death|7|||
127918310|NCT00354159|460323492|FG001|Randomized Study Period|Death|9|||
127918311|NCT00354159|460323491|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
127918312|NCT00354159|460323492|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
127918313|NCT00354159|460323491|FG000|Long-term Follow-up|Physician Decision|127|||
127918314|NCT00354159|460323492|FG001|Long-term Follow-up|Physician Decision|122|||
127918315|NCT00354159|460323491|FG000|Long-term Follow-up|Lost to Follow-up|1|||
127918316|NCT00354159|460323492|FG001|Long-term Follow-up|Lost to Follow-up|0|||
127918317|NCT00354159|460323491|FG000|Long-term Follow-up|Death|14|||
127918318|NCT00354159|460323492|FG001|Long-term Follow-up|Death|11|||
127918319|NCT00354159|460323491|FG000|Long-term Follow-up|Study Closed|29|||
127918320|NCT00354159|460323492|FG001|Long-term Follow-up|Study Closed|34|||
127918321|NCT02046122|460323493|FG000|Overall Study|Physician Decision|8|||
127918322|NCT02046122|460323493|FG000|Overall Study|Withdrawal by Subject|1|||
127918323|NCT01653704|460323494|FG000|Overall Study|Technical failure during recording|1|||
127918324|NCT01653704|460323495|FG001|Overall Study|Technical failure during recording|1|||
127918325|NCT01653704|460323494|FG000|Overall Study|Performance not reflective of training|1|||
127918326|NCT01653704|460323495|FG001|Overall Study|Performance not reflective of training|0|||
127918327|NCT01728116|460323498|FG000|Overall Study|Sponsor Terminated Study|106|||
127918328|NCT01728116|460323499|FG001|Overall Study|Sponsor Terminated Study|35|||
127918329|NCT01728116|460323498|FG000|Overall Study|Withdrawal by Subject|16|||
127918330|NCT01728116|460323499|FG001|Overall Study|Withdrawal by Subject|9|||
127918331|NCT01728116|460323498|FG000|Overall Study|Adverse Event|13|||
127918332|NCT01728116|460323499|FG001|Overall Study|Adverse Event|0|||
127918333|NCT01728116|460323498|FG000|Overall Study|Procedure/device failure|7|||
127918334|NCT01728116|460323499|FG001|Overall Study|Procedure/device failure|0|||
127918335|NCT01728116|460323498|FG000|Overall Study|Lost to Follow-up|9|||
127918336|NCT01728116|460323499|FG001|Overall Study|Lost to Follow-up|2|||
127918337|NCT01728116|460323498|FG000|Overall Study|Physician Decision|2|||
127918338|NCT01728116|460323499|FG001|Overall Study|Physician Decision|0|||
127918339|NCT01728116|460323498|FG000|Overall Study|Subject Non-Compliance|2|||
127918340|NCT01728116|460323499|FG001|Overall Study|Subject Non-Compliance|0|||
127918341|NCT01728116|460323498|FG000|Overall Study|Inter-current finding at procedure|1|||
127918342|NCT01728116|460323499|FG001|Overall Study|Inter-current finding at procedure|0|||
127918343|NCT01728116|460323498|FG000|Overall Study|Incorrectly enrolled in Study|0|||
127918344|NCT01728116|460323499|FG001|Overall Study|Incorrectly enrolled in Study|1|||
127918345|NCT01728116|460323498|FG000|Overall Study|various not noted previously|5|||
127918346|NCT01728116|460323499|FG001|Overall Study|various not noted previously|0|||
127918347|NCT01196390|460323500|FG000|Overall Study|Protocol Violation|4|||
127918348|NCT01196390|460323501|FG001|Overall Study|Protocol Violation|5|||
127918349|NCT01532908|460323502|FG000|Overall Study|Not Transplanted|1|||
127918350|NCT01532908|460323503|FG001|Overall Study|Not Transplanted|0|||
127918351|NCT01949532|460323504|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
127918352|NCT01949532|460323505|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
127918353|NCT02943096|460323506|FG000|Overall Study|Lack of Efficacy|0|||
127918354|NCT02943096|460323507|FG001|Overall Study|Lack of Efficacy|1|||
127918355|NCT00939523|460323512|FG000|Overall Study|Lack of Efficacy|1|||
127918356|NCT00939523|460323512|FG000|Overall Study|Physician Decision|2|||
127918357|NCT00024258|460323513|FG000|Overall Study|Withdrawal by Subject|1|||
127918358|NCT00024258|460323513|FG000|Overall Study|Disease Progression|8|||
127918359|NCT01050764|460323514|FG000|Overall Study|Death, before HSCT|1|||
127918360|NCT01050764|460323514|FG000|Overall Study|Donor mobilization failure, death|1|||
127918361|NCT01050764|460323514|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
127918362|NCT02119936|460323523|FG000|Overall Study|Lost to Follow-up|10|||
127918363|NCT04194008|460323526|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
127918364|NCT04194008|460323526|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
127918365|NCT04194008|460323526|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
127918366|NCT04194008|460323526|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
127918367|NCT04194008|460323526|FG000|Treatment Phase With Nerivio|Missing data|4|||
127918368|NCT04194008|460323526|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
127918369|NCT02218216|460323527|FG000|Overall Study|Study terminated before completed|6|||
127918370|NCT02218216|460323528|FG001|Overall Study|Study terminated before completed|0|||
127918371|NCT02218216|460323529|FG002|Overall Study|Study terminated before completed|0|||
127918372|NCT03193021|460323530|FG000|Overall Study|Lost to Follow-up|1|||
127918373|NCT03193021|460323531|FG001|Overall Study|Lost to Follow-up|1|||
127918374|NCT01139762|460323532|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
127918375|NCT01139762|460323533|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
127918376|NCT01139762|460323534|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
127918377|NCT01139762|460323532|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
127918378|NCT01139762|460323533|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
127918379|NCT01139762|460323534|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
127918380|NCT01139762|460323532|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
127918381|NCT01139762|460323533|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
127918382|NCT01139762|460323534|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
127918383|NCT01139762|460323532|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
127918384|NCT01139762|460323533|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
127918385|NCT01139762|460323534|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
127918386|NCT01139762|460323532|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
127918387|NCT01139762|460323533|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
127918388|NCT01139762|460323534|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
127918389|NCT01139762|460323532|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
127918390|NCT01139762|460323533|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
127918391|NCT01139762|460323534|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
127918392|NCT01139762|460323532|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
127918393|NCT01139762|460323533|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
127918394|NCT01139762|460323534|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
127918395|NCT01139762|460323532|FG000|Double-Blind Randomized Active Treatment|Death|0|||
127918396|NCT01139762|460323533|FG001|Double-Blind Randomized Active Treatment|Death|1|||
127918397|NCT01139762|460323534|FG002|Double-Blind Randomized Active Treatment|Death|1|||
127918398|NCT01139762|460323532|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
127918399|NCT01139762|460323533|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
127918400|NCT01139762|460323534|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
127918401|NCT01139762|460323532|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
127918402|NCT01139762|460323533|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
127918403|NCT01139762|460323534|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
127918404|NCT01139762|460323532|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
127918405|NCT01139762|460323533|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
127918406|NCT01139762|460323534|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
127918407|NCT01139762|460323532|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
127918408|NCT01139762|460323533|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
127918409|NCT01139762|460323534|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
127918410|NCT01139762|460323532|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
127918411|NCT01139762|460323533|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
127918412|NCT01139762|460323534|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
127918413|NCT01139762|460323532|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
127918414|NCT01139762|460323533|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
127918415|NCT01139762|460323534|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
127918416|NCT01139762|460323532|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
127918417|NCT01139762|460323533|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
127918418|NCT01139762|460323534|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
127918419|NCT02614196|460323535|FG000|Double Blind Treatment Phase|Adverse Event|8|||
127918420|NCT02614196|460323536|FG001|Double Blind Treatment Phase|Adverse Event|5|||
127918421|NCT02614196|460323537|FG002|Double Blind Treatment Phase|Adverse Event|9|||
127918422|NCT02614196|460323538|FG003|Double Blind Treatment Phase|Adverse Event|0|||
127918423|NCT02614196|460323539|FG004|Double Blind Treatment Phase|Adverse Event|0|||
127918424|NCT02614196|460323540|FG005|Double Blind Treatment Phase|Adverse Event|0|||
127918425|NCT02614196|460323535|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
127918426|NCT02614196|460323536|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
127918427|NCT02614196|460323537|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
127918428|NCT02614196|460323538|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
127918429|NCT02614196|460323539|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
127918430|NCT02614196|460323540|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
127918431|NCT02614196|460323535|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
127918432|NCT02614196|460323536|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
127918433|NCT02614196|460323537|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
127918434|NCT02614196|460323538|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
127918435|NCT02614196|460323539|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
127918436|NCT02614196|460323540|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
127918437|NCT02614196|460323535|FG000|Double Blind Treatment Phase|Physician Decision|4|||
127918438|NCT02614196|460323536|FG001|Double Blind Treatment Phase|Physician Decision|0|||
127918439|NCT02614196|460323537|FG002|Double Blind Treatment Phase|Physician Decision|2|||
127918440|NCT02614196|460323538|FG003|Double Blind Treatment Phase|Physician Decision|0|||
127918441|NCT02614196|460323539|FG004|Double Blind Treatment Phase|Physician Decision|0|||
127918442|NCT02614196|460323540|FG005|Double Blind Treatment Phase|Physician Decision|0|||
127918443|NCT02614196|460323535|FG000|Double Blind Treatment Phase|Pregnancy|1|||
127918444|NCT02614196|460323536|FG001|Double Blind Treatment Phase|Pregnancy|2|||
127918445|NCT02614196|460323537|FG002|Double Blind Treatment Phase|Pregnancy|0|||
127918446|NCT02614196|460323538|FG003|Double Blind Treatment Phase|Pregnancy|0|||
127918447|NCT02614196|460323539|FG004|Double Blind Treatment Phase|Pregnancy|0|||
127918448|NCT02614196|460323540|FG005|Double Blind Treatment Phase|Pregnancy|0|||
127918449|NCT02614196|460323535|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
127918450|NCT02614196|460323536|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
127918451|NCT02614196|460323537|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
127918452|NCT02614196|460323538|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
127918453|NCT02614196|460323539|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
127918454|NCT02614196|460323540|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
127918455|NCT02614196|460323535|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
127918456|NCT02614196|460323536|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
127918457|NCT02614196|460323537|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
127918458|NCT02614196|460323538|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
127918459|NCT02614196|460323539|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
127918460|NCT02614196|460323540|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
127918461|NCT02614196|460323535|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
127918462|NCT02614196|460323536|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
127918463|NCT02614196|460323537|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
127918464|NCT02614196|460323538|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
127918465|NCT02614196|460323539|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
127918466|NCT02614196|460323540|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
127918467|NCT02614196|460323535|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
127918468|NCT02614196|460323536|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
127918469|NCT02614196|460323537|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
127918470|NCT02614196|460323538|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
127918471|NCT02614196|460323539|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
127918472|NCT02614196|460323540|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
127918473|NCT02614196|460323535|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
127918474|NCT02614196|460323536|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
127918475|NCT02614196|460323537|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
127918476|NCT02614196|460323538|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
127918477|NCT02614196|460323539|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
127918478|NCT02614196|460323540|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
127918479|NCT02614196|460323535|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
127918480|NCT02614196|460323536|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
127918481|NCT02614196|460323537|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
127918482|NCT02614196|460323538|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
127918483|NCT02614196|460323539|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
127918484|NCT02614196|460323540|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
127918485|NCT02614196|460323535|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
127918486|NCT02614196|460323536|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
127918487|NCT02614196|460323537|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
127918488|NCT02614196|460323538|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
127918489|NCT02614196|460323539|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
127918490|NCT02614196|460323540|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
127918491|NCT02614196|460323535|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
127918492|NCT02614196|460323536|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
127918493|NCT02614196|460323537|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
127918494|NCT02614196|460323538|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
127918495|NCT02614196|460323539|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
127918496|NCT02614196|460323540|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
127918497|NCT01539239|460323541|FG000|Overall Study|Death|5|||
127918498|NCT01539239|460323542|FG001|Overall Study|Death|5|||
127918499|NCT01539239|460323541|FG000|Overall Study|Lost to Follow-up|7|||
127918500|NCT01539239|460323542|FG001|Overall Study|Lost to Follow-up|12|||
127918501|NCT00660387|460325186|FG000|Overall Study|Adverse Event|1|||
127918502|NCT00660387|460325187|FG001|Overall Study|Adverse Event|2|||
127918503|NCT00660387|460325186|FG000|Overall Study|Lack of Efficacy|0|||
127918504|NCT00660387|460325187|FG001|Overall Study|Lack of Efficacy|1|||
127918505|NCT00660387|460325186|FG000|Overall Study|Protocol Violation|1|||
127918506|NCT00660387|460325187|FG001|Overall Study|Protocol Violation|0|||
127918507|NCT01120899|460325188|FG000|Overall Study|Withdrawal by Subject|3|||
127918508|NCT00820599|460325189|FG000|Overall Study|Death|129|||
127918509|NCT00820599|460325189|FG000|Overall Study|Withdrawal by Subject|2|||
127918510|NCT03686215|460325190|FG000|Overall Study|Adverse Event|0|||
127918511|NCT03686215|460325191|FG001|Overall Study|Adverse Event|0|||
127918512|NCT03686215|460325192|FG002|Overall Study|Adverse Event|7|||
127918513|NCT03686215|460325190|FG000|Overall Study|Physician Decision|0|||
127918514|NCT03686215|460325191|FG001|Overall Study|Physician Decision|0|||
127918515|NCT03686215|460325192|FG002|Overall Study|Physician Decision|1|||
127918516|NCT03686215|460325190|FG000|Overall Study|Protocol Violation|0|||
127918517|NCT03686215|460325191|FG001|Overall Study|Protocol Violation|0|||
127918518|NCT03686215|460325192|FG002|Overall Study|Protocol Violation|4|||
127918519|NCT03686215|460325190|FG000|Overall Study|Device issue|1|||
127918520|NCT03686215|460325191|FG001|Overall Study|Device issue|0|||
127918521|NCT03686215|460325192|FG002|Overall Study|Device issue|2|||
127918522|NCT01813435|460325200|FG000|Overall Study|did not finish experimental regimen|1902|||
127918523|NCT01813435|460325201|FG001|Overall Study|did not finish experimental regimen|770|||
127918524|NCT01813435|460325200|FG000|Overall Study|Lost to Follow-up|268|||
127918525|NCT01813435|460325201|FG001|Overall Study|Lost to Follow-up|237|||
127918526|NCT00452348|460325202|FG000|Overall Study|Adverse Event|6|||
127918527|NCT00452348|460325203|FG001|Overall Study|Adverse Event|9|||
127918528|NCT00452348|460325202|FG000|Overall Study|Lack of Efficacy|10|||
127918529|NCT00452348|460325203|FG001|Overall Study|Lack of Efficacy|9|||
127918530|NCT00452348|460325202|FG000|Overall Study|Lost to Follow-up|14|||
127918531|NCT00452348|460325203|FG001|Overall Study|Lost to Follow-up|8|||
127918532|NCT00452348|460325202|FG000|Overall Study|Protocol Violation|22|||
127918533|NCT00452348|460325203|FG001|Overall Study|Protocol Violation|28|||
127918534|NCT00452348|460325202|FG000|Overall Study|Withdrawal by Subject|18|||
127918535|NCT00452348|460325203|FG001|Overall Study|Withdrawal by Subject|21|||
127918536|NCT00452348|460325202|FG000|Overall Study|Other|9|||
127918537|NCT00452348|460325203|FG001|Overall Study|Other|9|||
127918538|NCT01490190|460325204|FG000|Overall Study|Withdrawal by Subject|9|||
127918539|NCT01490190|460325204|FG000|Overall Study|Adverse Event|17|||
127918540|NCT01490190|460325204|FG000|Overall Study|Protocol Violation|5|||
127918541|NCT01490190|460325204|FG000|Overall Study|Lost to Follow-up|13|||
127918542|NCT01490190|460325204|FG000|Overall Study|Relocation|1|||
127918543|NCT01490190|460325204|FG000|Overall Study|Inconvenience|1|||
127918544|NCT01490190|460325204|FG000|Overall Study|Ring expulsion|2|||
127918545|NCT00960154|460325210|FG000|Overall Study|Study termination|25|||
127918546|NCT00960154|460325211|FG001|Overall Study|Study termination|25|||
127918547|NCT02817828|460325212|FG000|Overall Study|Lost to Follow-up|41|||
127918548|NCT02817828|460325212|FG000|Overall Study|Adverse event not related to bleeding|104|||
127918549|NCT02817828|460325212|FG000|Overall Study|Adverse event related to bleeding|53|||
127918550|NCT02817828|460325212|FG000|Overall Study|Protocol Violation|11|||
127918551|NCT02817828|460325212|FG000|Overall Study|Pregnancy|7|||
127918552|NCT02817828|460325212|FG000|Overall Study|Pregnancy wish|15|||
127918553|NCT02817828|460325212|FG000|Overall Study|Withdrawal by Subject|78|||
127918554|NCT02817828|460325212|FG000|Overall Study|Other|26|||
127918555|NCT00377156|460325216|FG000|Overall Study|Death|23|||
127918556|NCT00377156|460325217|FG001|Overall Study|Death|19|||
127918557|NCT00377156|460325216|FG000|Overall Study|Withdrawal by Subject|16|||
127918558|NCT00377156|460325217|FG001|Overall Study|Withdrawal by Subject|24|||
127918559|NCT00377156|460325216|FG000|Overall Study|Had follow-up <90 d|3|||
127918560|NCT00377156|460325217|FG001|Overall Study|Had follow-up <90 d|6|||
127918561|NCT00377156|460325216|FG000|Overall Study|Cancellation|1|||
127918562|NCT00377156|460325217|FG001|Overall Study|Cancellation|0|||
127918563|NCT00377156|460325216|FG000|Overall Study|Refused testing|0|||
127918564|NCT00377156|460325217|FG001|Overall Study|Refused testing|1|||
127918565|NCT00377156|460325216|FG000|Overall Study|Ineligible|0|||
127918566|NCT00377156|460325217|FG001|Overall Study|Ineligible|1|||
127918567|NCT00377156|460325216|FG000|Overall Study|Disability or language problem|0|||
127918568|NCT00377156|460325217|FG001|Overall Study|Disability or language problem|1|||
127918569|NCT00377156|460325216|FG000|Overall Study|Other|5|||
127918570|NCT00377156|460325217|FG001|Overall Study|Other|2|||
127918571|NCT00544167|460325218|FG000|Overall Study|Adverse Event|21|||
127918572|NCT00544167|460325218|FG000|Overall Study|Physician Decision|8|||
127918573|NCT00856349|460325219|FG000|Overall Study|Death|418|||
127918574|NCT00856349|460325219|FG000|Overall Study|Withdrawal by Subject|116|||
127918575|NCT00856349|460325219|FG000|Overall Study|Lost to Follow-up|91|||
127918576|NCT00856349|460325219|FG000|Overall Study|Protocol Violation|38|||
127918577|NCT00856349|460325219|FG000|Overall Study|Physician Decision|13|||
127918578|NCT00856349|460325219|FG000|Overall Study|Subject relocation|104|||
127918579|NCT00856349|460325219|FG000|Overall Study|Device explant|33|||
127918580|NCT00856349|460325219|FG000|Overall Study|Site closure|78|||
127918581|NCT00856349|460325219|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
127918582|NCT02725515|460325220|FG000|Overall Study|Refused infusion (no study treatment)|1|||
127918583|NCT02725515|460325221|FG001|Overall Study|Refused infusion (no study treatment)|0|||
127918584|NCT02725515|460325220|FG000|Overall Study|Loss of Improvement per Protocol|14|||
127918585|NCT02725515|460325221|FG001|Overall Study|Loss of Improvement per Protocol|25|||
127918586|NCT02725515|460325220|FG000|Overall Study|Withdrawal by Subject|2|||
127918587|NCT02725515|460325221|FG001|Overall Study|Withdrawal by Subject|1|||
127918588|NCT02725515|460325220|FG000|Overall Study|Non-Compliance With Study Drug|0|||
127918589|NCT02725515|460325221|FG001|Overall Study|Non-Compliance With Study Drug|3|||
127918590|NCT02725515|460325220|FG000|Overall Study|Lost to Follow-up|1|||
127918591|NCT02725515|460325221|FG001|Overall Study|Lost to Follow-up|1|||
127918592|NCT02725515|460325220|FG000|Overall Study|Adverse Event|7|||
127918593|NCT02725515|460325221|FG001|Overall Study|Adverse Event|2|||
127918594|NCT02725515|460325220|FG000|Overall Study|No Documented Disease Improvement|0|||
127918595|NCT02725515|460325221|FG001|Overall Study|No Documented Disease Improvement|1|||
127918596|NCT02725515|460325220|FG000|Overall Study|Completed Study Under Original Protocol|0|||
127918597|NCT02725515|460325221|FG001|Overall Study|Completed Study Under Original Protocol|1|||
127918598|NCT02725515|460325220|FG000|Overall Study|Lack of Response|0|||
127918599|NCT02725515|460325221|FG001|Overall Study|Lack of Response|1|||
127918600|NCT00874549|460325222|FG000|Overall Study|Adverse Event|0|||
127918601|NCT00874549|460325223|FG001|Overall Study|Adverse Event|0|||
127918602|NCT00874549|460325224|FG002|Overall Study|Adverse Event|1|||
127918603|NCT00874549|460325225|FG003|Overall Study|Adverse Event|0|||
127918604|NCT00874549|460325222|FG000|Overall Study|Protocol Violation|1|||
127918605|NCT00874549|460325223|FG001|Overall Study|Protocol Violation|0|||
127918606|NCT00874549|460325224|FG002|Overall Study|Protocol Violation|2|||
127918607|NCT00874549|460325225|FG003|Overall Study|Protocol Violation|1|||
127918608|NCT00874549|460325222|FG000|Overall Study|Lost to Follow-up|0|||
127918609|NCT00874549|460325223|FG001|Overall Study|Lost to Follow-up|0|||
127918610|NCT00874549|460325224|FG002|Overall Study|Lost to Follow-up|1|||
127918611|NCT00874549|460325225|FG003|Overall Study|Lost to Follow-up|0|||
127918612|NCT00874549|460325222|FG000|Overall Study|Withdrawal by Subject|0|||
127918613|NCT00874549|460325223|FG001|Overall Study|Withdrawal by Subject|1|||
127918614|NCT00874549|460325224|FG002|Overall Study|Withdrawal by Subject|0|||
127918615|NCT00874549|460325225|FG003|Overall Study|Withdrawal by Subject|1|||
127918616|NCT02697617|460325236|FG000|Overall Study|Withdrawal by Subject|0|||
127918617|NCT02697617|460325237|FG001|Overall Study|Withdrawal by Subject|2|||
127918618|NCT02697617|460325236|FG000|Overall Study|Pregnancy|1|||
127918619|NCT02697617|460325237|FG001|Overall Study|Pregnancy|0|||
127918620|NCT02460835|460325238|FG000|Overall Study|Disease progression prior to treatment|3|||
127918621|NCT02460835|460325238|FG000|Overall Study|Unable to complete planning scans|2|||
127918622|NCT02460835|460325238|FG000|Overall Study|Decrease in performance status|1|||
127918623|NCT02460835|460325238|FG000|Overall Study|Withdrawal by Subject|3|||
127918624|NCT02460835|460325238|FG000|Overall Study|Underwent fractionated RT|10|||
127918625|NCT02460835|460325238|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
127918626|NCT01157234|460325239|FG000|Overall Study|Withdrawal by Subject|1|||
127918627|NCT01157234|460325240|FG001|Overall Study|Withdrawal by Subject|0|||
127918628|NCT00517192|460325244|FG000|Overall Study|Adverse Event|1|||
127918629|NCT00517192|460325245|FG001|Overall Study|Adverse Event|1|||
127918630|NCT00517192|460325244|FG000|Overall Study|Lost to Follow-up|1|||
127918631|NCT00517192|460325245|FG001|Overall Study|Lost to Follow-up|1|||
127918632|NCT00517192|460325244|FG000|Overall Study|Withdrawal by Subject|1|||
127918633|NCT00517192|460325245|FG001|Overall Study|Withdrawal by Subject|0|||
127918634|NCT00517192|460325244|FG000|Overall Study|Early termination of the trial|16|||
127918635|NCT00517192|460325245|FG001|Overall Study|Early termination of the trial|18|||
127918636|NCT02733627|460325247|FG000|Overall Study|Adverse Event|0|||
127918637|NCT02733627|460325248|FG001|Overall Study|Adverse Event|1|||
127918638|NCT02733627|460325249|FG002|Overall Study|Adverse Event|1|||
127918639|NCT02733627|460325250|FG003|Overall Study|Adverse Event|0|||
127918640|NCT02733627|460325247|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
127918641|NCT02733627|460325248|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
127918642|NCT02733627|460325249|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
127918643|NCT02733627|460325250|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
127918644|NCT00183196|460325251|FG000|Overall Study|Withdrawal by Subject|18|||
127918645|NCT00183196|460325252|FG001|Overall Study|Withdrawal by Subject|11|||
127918646|NCT00183196|460325253|FG002|Overall Study|Withdrawal by Subject|13|||
127918647|NCT00183196|460325251|FG000|Overall Study|Adverse Event|1|||
127918648|NCT00183196|460325252|FG001|Overall Study|Adverse Event|2|||
127918649|NCT00183196|460325253|FG002|Overall Study|Adverse Event|2|||
127918650|NCT00183196|460325251|FG000|Overall Study|Legal event|1|||
127918651|NCT00183196|460325252|FG001|Overall Study|Legal event|1|||
127918652|NCT00183196|460325253|FG002|Overall Study|Legal event|1|||
127918653|NCT00183196|460325251|FG000|Overall Study|Required more intensive care|0|||
127918654|NCT00183196|460325252|FG001|Overall Study|Required more intensive care|1|||
127918655|NCT00183196|460325253|FG002|Overall Study|Required more intensive care|2|||
127918656|NCT01513239|460325254|FG000|Period 1: Main Phase|Adverse Event|1|||
127918657|NCT01513239|460325255|FG001|Period 1: Main Phase|Adverse Event|1|||
127918658|NCT01513239|460325256|FG002|Period 1: Main Phase|Adverse Event|2|||
127918659|NCT01513239|460325257|FG003|Period 1: Main Phase|Adverse Event|0|||
127918660|NCT01513239|460325258|FG004|Period 1: Main Phase|Adverse Event|0|||
127918661|NCT01513239|460325259|FG005|Period 1: Main Phase|Adverse Event|0|||
127918662|NCT01513239|460325254|FG000|Period 1: Main Phase|Death|29|||
127918663|NCT01513239|460325255|FG001|Period 1: Main Phase|Death|22|||
127918664|NCT01513239|460325256|FG002|Period 1: Main Phase|Death|32|||
127918665|NCT01513239|460325257|FG003|Period 1: Main Phase|Death|0|||
127918666|NCT01513239|460325258|FG004|Period 1: Main Phase|Death|0|||
127918667|NCT01513239|460325259|FG005|Period 1: Main Phase|Death|0|||
127918668|NCT01513239|460325254|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
127918669|NCT01513239|460325255|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
127918670|NCT01513239|460325256|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
127918671|NCT01513239|460325257|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
127918672|NCT01513239|460325258|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
127918673|NCT01513239|460325259|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
127918674|NCT01513239|460325254|FG000|Period 1: Main Phase|Physician Decision|4|||
127918675|NCT01513239|460325255|FG001|Period 1: Main Phase|Physician Decision|4|||
127918676|NCT01513239|460325256|FG002|Period 1: Main Phase|Physician Decision|4|||
127918677|NCT01513239|460325257|FG003|Period 1: Main Phase|Physician Decision|0|||
127918678|NCT01513239|460325258|FG004|Period 1: Main Phase|Physician Decision|0|||
127918679|NCT01513239|460325259|FG005|Period 1: Main Phase|Physician Decision|0|||
127918680|NCT01513239|460325254|FG000|Period 1: Main Phase|Protocol Violation|2|||
127918681|NCT01513239|460325255|FG001|Period 1: Main Phase|Protocol Violation|2|||
127918682|NCT01513239|460325256|FG002|Period 1: Main Phase|Protocol Violation|2|||
127918683|NCT01513239|460325257|FG003|Period 1: Main Phase|Protocol Violation|0|||
127918684|NCT01513239|460325258|FG004|Period 1: Main Phase|Protocol Violation|0|||
127918685|NCT01513239|460325259|FG005|Period 1: Main Phase|Protocol Violation|0|||
127918686|NCT01513239|460325254|FG000|Period 1: Main Phase|Technical Problems|1|||
127918687|NCT01513239|460325255|FG001|Period 1: Main Phase|Technical Problems|2|||
127918688|NCT01513239|460325256|FG002|Period 1: Main Phase|Technical Problems|0|||
127918689|NCT01513239|460325257|FG003|Period 1: Main Phase|Technical Problems|0|||
127918690|NCT01513239|460325258|FG004|Period 1: Main Phase|Technical Problems|0|||
127918691|NCT01513239|460325259|FG005|Period 1: Main Phase|Technical Problems|0|||
127918692|NCT01513239|460325254|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
127918693|NCT01513239|460325255|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
127918694|NCT01513239|460325256|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
127918695|NCT01513239|460325257|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
127918696|NCT01513239|460325258|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
127918697|NCT01513239|460325259|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
127918698|NCT01513239|460325254|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
127918699|NCT01513239|460325255|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
127918700|NCT01513239|460325256|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
127918701|NCT01513239|460325257|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
127918702|NCT01513239|460325258|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
127918703|NCT01513239|460325259|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
127918704|NCT01513239|460325254|FG000|Period 2: 9 Month Extension Phase|Death|0|||
127918705|NCT01513239|460325255|FG001|Period 2: 9 Month Extension Phase|Death|0|||
127918706|NCT01513239|460325256|FG002|Period 2: 9 Month Extension Phase|Death|0|||
127918707|NCT01513239|460325257|FG003|Period 2: 9 Month Extension Phase|Death|2|||
127918708|NCT01513239|460325258|FG004|Period 2: 9 Month Extension Phase|Death|5|||
127918709|NCT01513239|460325259|FG005|Period 2: 9 Month Extension Phase|Death|2|||
127918710|NCT01513239|460325254|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
127918711|NCT01513239|460325255|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
127918712|NCT01513239|460325256|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
127918713|NCT01513239|460325257|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
127918714|NCT01513239|460325258|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
127918715|NCT01513239|460325259|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
127918716|NCT01513239|460325254|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
127918717|NCT01513239|460325255|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
127918718|NCT01513239|460325256|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
127918719|NCT01513239|460325257|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
127918720|NCT01513239|460325258|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
127918721|NCT01513239|460325259|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
127918722|NCT01513239|460325254|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
127918723|NCT01513239|460325255|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
127918724|NCT01513239|460325256|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
127918725|NCT01513239|460325257|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
127918726|NCT01513239|460325258|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
127918727|NCT01513239|460325259|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
127918728|NCT03167606|460325262|FG000|Overall Study|Lost to Follow-up|73|||
127918729|NCT03167606|460325263|FG001|Overall Study|Lost to Follow-up|64|||
127918730|NCT03167606|460325262|FG000|Overall Study|Withdrawal by Subject|6|||
127918731|NCT03167606|460325263|FG001|Overall Study|Withdrawal by Subject|5|||
127918732|NCT03167606|460325262|FG000|Overall Study|Withdrawal by Investigator|0|||
127918733|NCT03167606|460325263|FG001|Overall Study|Withdrawal by Investigator|2|||
127918734|NCT00059332|460325264|FG000|Overall Study|Withdrawal by Subject|2|||
127918735|NCT00059332|460325265|FG001|Overall Study|Withdrawal by Subject|1|||
127918736|NCT00059332|460325264|FG000|Overall Study|Lost to Follow-up|1|||
127918737|NCT00059332|460325265|FG001|Overall Study|Lost to Follow-up|1|||
127918738|NCT00413049|460325267|FG000|Overall Study|Adverse Event|10|||
127918739|NCT00413049|460325268|FG001|Overall Study|Adverse Event|8|||
127918740|NCT00413049|460325267|FG000|Overall Study|Withdrawal by Subject|7|||
127918741|NCT00413049|460325268|FG001|Overall Study|Withdrawal by Subject|5|||
127918742|NCT00413049|460325267|FG000|Overall Study|Lost to Follow-up|2|||
127918743|NCT00413049|460325268|FG001|Overall Study|Lost to Follow-up|3|||
127918744|NCT00413049|460325267|FG000|Overall Study|Protocol Violation|3|||
127918745|NCT00413049|460325268|FG001|Overall Study|Protocol Violation|1|||
127918746|NCT00413049|460325267|FG000|Overall Study|Subject no longer requires study drug|0|||
127918747|NCT00413049|460325268|FG001|Overall Study|Subject no longer requires study drug|1|||
127918748|NCT00413049|460325267|FG000|Overall Study|Abnormal laboratory value(s)|1|||
127918749|NCT00413049|460325268|FG001|Overall Study|Abnormal laboratory value(s)|0|||
127918750|NCT00413049|460325267|FG000|Overall Study|Lack of Efficacy|1|||
127918751|NCT00413049|460325268|FG001|Overall Study|Lack of Efficacy|0|||
127918752|NCT02587143|460325269|FG000|Overall Study|Adverse Event|1|||
127918753|NCT02587143|460325270|FG001|Overall Study|Adverse Event|0|||
127918754|NCT03314857|460325273|FG000|Overall Study|Death|4|||
127918755|NCT03314857|460325273|FG000|Overall Study|Physician Decision|1|||
127918756|NCT01119625|460325274|FG000|Overall Study|Lost to Follow-up|1|||
127918757|NCT01119625|460325275|FG001|Overall Study|Lost to Follow-up|2|||
127918758|NCT01119625|460325274|FG000|Overall Study|Withdrawal by Subject|2|||
127918759|NCT01119625|460325275|FG001|Overall Study|Withdrawal by Subject|1|||
127918760|NCT01119625|460325274|FG000|Overall Study|Other|0|||
127918761|NCT01119625|460325275|FG001|Overall Study|Other|1|||
127918762|NCT01721772|460325282|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
127918763|NCT01721772|460325283|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
127918764|NCT01721772|460325282|FG000|Pre-Treatment|Poor/non-compliance|0|||
127918765|NCT01721772|460325283|FG001|Pre-Treatment|Poor/non-compliance|1|||
127918766|NCT01721772|460325282|FG000|Pre-Treatment|Participant withdrew consent|0|||
127918767|NCT01721772|460325283|FG001|Pre-Treatment|Participant withdrew consent|1|||
127918768|NCT01721772|460325282|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
127918769|NCT01721772|460325283|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
127918770|NCT01721772|460325282|FG000|Treatment|Disease progression|119|||
127918771|NCT01721772|460325283|FG001|Treatment|Disease progression|168|||
127918772|NCT01721772|460325282|FG000|Treatment|Study drug toxicity|19|||
127918773|NCT01721772|460325283|FG001|Treatment|Study drug toxicity|10|||
127918774|NCT01721772|460325282|FG000|Treatment|Adverse event unrelated to study drug|7|||
127918775|NCT01721772|460325283|FG001|Treatment|Adverse event unrelated to study drug|7|||
127918776|NCT01721772|460325282|FG000|Treatment|Maximum clinical benefit|16|||
127918777|NCT01721772|460325283|FG001|Treatment|Maximum clinical benefit|4|||
127918778|NCT01721772|460325282|FG000|Treatment|Other|19|||
127918779|NCT01721772|460325283|FG001|Treatment|Other|2|||
127918780|NCT01721772|460325282|FG000|Treatment|Participant withdrew consent|2|||
127918781|NCT01721772|460325283|FG001|Treatment|Participant withdrew consent|5|||
127918782|NCT01721772|460325282|FG000|Treatment|Participant request to discontinue study treatment|21|||
127918783|NCT01721772|460325283|FG001|Treatment|Participant request to discontinue study treatment|8|||
127918784|NCT01721772|460325282|FG000|Treatment|Death|1|||
127918785|NCT01721772|460325283|FG001|Treatment|Death|0|||
127918786|NCT01721772|460325282|FG000|Treatment|Not reported|1|||
127918787|NCT01721772|460325283|FG001|Treatment|Not reported|0|||
127918788|NCT01721772|460325282|FG000|Treatment|Poor/non-compliance|1|||
127918789|NCT01721772|460325283|FG001|Treatment|Poor/non-compliance|0|||
127918790|NCT01721772|460325282|FG000|Treatment|Lost to Follow-up|0|||
127918791|NCT01721772|460325283|FG001|Treatment|Lost to Follow-up|1|||
127918792|NCT00397254|460325291|FG000|Overall Study|Lost to Follow-up|2|||
127918793|NCT00397254|460325292|FG001|Overall Study|Lost to Follow-up|2|||
127918794|NCT02340780|460325293|FG000|Overall Study|Ineligible|1|||
127918795|NCT05004649|460325300|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
127918796|NCT05004649|460325300|FG000|Overall Study|Lost to Follow-up|1|||
127918797|NCT05004649|460325300|FG000|Overall Study|Withdrawal by Subject|2|||
127918798|NCT05004649|460325300|FG000|Overall Study|COVID-19|1|||
127918799|NCT02654145|460325301|FG000|Overall Study|Lack of Efficacy|1|||
127918800|NCT02654145|460325301|FG000|Overall Study|Protocol Violation|1|||
127918801|NCT02654145|460325301|FG000|Overall Study|Withdrawal by Subject|5|||
127918802|NCT02637141|460325302|FG000|Overall Study|Adverse Event|1|||
127918803|NCT02637141|460325303|FG001|Overall Study|Adverse Event|1|||
127918804|NCT02637141|460325304|FG002|Overall Study|Adverse Event|0|||
127918805|NCT02637141|460325302|FG000|Overall Study|Withdrawal by Subject|1|||
127918806|NCT02637141|460325303|FG001|Overall Study|Withdrawal by Subject|1|||
127918807|NCT02637141|460325304|FG002|Overall Study|Withdrawal by Subject|1|||
127918808|NCT01943435|460325306|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
127918809|NCT01943435|460325307|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
127918810|NCT01943435|460325308|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
127918811|NCT01943435|460325306|FG000|Intervention Period|Withdrawal by Subject|3|||
127918812|NCT01943435|460325307|FG001|Intervention Period|Withdrawal by Subject|3|||
127918813|NCT01943435|460325308|FG002|Intervention Period|Withdrawal by Subject|4|||
127918814|NCT01943435|460325306|FG000|2 Month Follow up|Lost to Follow-up|2|||
127918815|NCT01943435|460325307|FG001|2 Month Follow up|Lost to Follow-up|3|||
127918816|NCT01943435|460325308|FG002|2 Month Follow up|Lost to Follow-up|0|||
127918817|NCT01943435|460325306|FG000|6 Month Follow up|Lost to Follow-up|12|||
127918818|NCT01943435|460325307|FG001|6 Month Follow up|Lost to Follow-up|7|||
127918819|NCT01943435|460325308|FG002|6 Month Follow up|Lost to Follow-up|15|||
127918820|NCT03885934|460325309|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
127918821|NCT03885934|460325310|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
127918822|NCT03885934|460325311|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
127918823|NCT03885934|460325312|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
127918824|NCT03885934|460325313|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
127918825|NCT03885934|460325314|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
127918826|NCT01559116|460325319|FG000|Overall Study|Adverse Event|10|||
127918827|NCT01559116|460325319|FG000|Overall Study|Lack of Efficacy|1|||
127918828|NCT01559116|460325319|FG000|Overall Study|Lost to Follow-up|1|||
127918829|NCT01559116|460325319|FG000|Overall Study|Protocol Violation|1|||
127918830|NCT01559116|460325319|FG000|Overall Study|Withdrawal by Subject|4|||
127918831|NCT01559116|460325319|FG000|Overall Study|other than stated above|9|||
127918832|NCT04610580|460325320|FG000|Two-way Crossover Period|Adverse Event|1|||
127918833|NCT04610580|460325321|FG001|Two-way Crossover Period|Adverse Event|0|||
127918834|NCT04610580|460325322|FG002|Two-way Crossover Period|Adverse Event|0|||
127918835|NCT04610580|460325323|FG003|Two-way Crossover Period|Adverse Event|0|||
127918836|NCT04610580|460325324|FG004|Two-way Crossover Period|Adverse Event|0|||
127918837|NCT04610580|460325325|FG005|Two-way Crossover Period|Adverse Event|0|||
127918838|NCT04610580|460325320|FG000|Two-way Crossover Period|Physician Decision|1|||
127918839|NCT04610580|460325321|FG001|Two-way Crossover Period|Physician Decision|0|||
127918840|NCT04610580|460325322|FG002|Two-way Crossover Period|Physician Decision|0|||
127918841|NCT04610580|460325323|FG003|Two-way Crossover Period|Physician Decision|0|||
127918842|NCT04610580|460325324|FG004|Two-way Crossover Period|Physician Decision|0|||
127918843|NCT04610580|460325325|FG005|Two-way Crossover Period|Physician Decision|0|||
127918844|NCT04610580|460325320|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
127918845|NCT04610580|460325321|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
127918846|NCT04610580|460325322|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
127918847|NCT04610580|460325323|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
127918848|NCT04610580|460325324|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
127918849|NCT04610580|460325325|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
127918850|NCT04610580|460325320|FG000|Two-way Crossover Period|Other than specified|0|||
127918851|NCT04610580|460325321|FG001|Two-way Crossover Period|Other than specified|1|||
127918852|NCT04610580|460325322|FG002|Two-way Crossover Period|Other than specified|0|||
127918853|NCT04610580|460325323|FG003|Two-way Crossover Period|Other than specified|0|||
127918854|NCT04610580|460325324|FG004|Two-way Crossover Period|Other than specified|0|||
127918855|NCT04610580|460325325|FG005|Two-way Crossover Period|Other than specified|0|||
127918856|NCT04610580|460325320|FG000|Washout Before Extension Period|Other than specified|0|||
127918857|NCT04610580|460325321|FG001|Washout Before Extension Period|Other than specified|1|||
127918858|NCT04610580|460325322|FG002|Washout Before Extension Period|Other than specified|0|||
127918859|NCT04610580|460325323|FG003|Washout Before Extension Period|Other than specified|0|||
127918860|NCT04610580|460325324|FG004|Washout Before Extension Period|Other than specified|0|||
127918861|NCT04610580|460325325|FG005|Washout Before Extension Period|Other than specified|0|||
127918862|NCT04610580|460325320|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
127918863|NCT04610580|460325321|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
127918864|NCT04610580|460325322|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
127918865|NCT04610580|460325323|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
127918866|NCT04610580|460325324|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
127918867|NCT04610580|460325325|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
127918868|NCT04610580|460325320|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
127918869|NCT04610580|460325321|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
127918870|NCT04610580|460325322|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
127918871|NCT04610580|460325323|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
127918872|NCT04610580|460325324|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
127918873|NCT04610580|460325325|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
127918874|NCT01097694|460325326|FG000|Overall Study|Adverse Event|5|||
127918875|NCT01097694|460325327|FG001|Overall Study|Adverse Event|0|||
127918876|NCT01097694|460325326|FG000|Overall Study|Lost to Follow-up|0|||
127918877|NCT01097694|460325327|FG001|Overall Study|Lost to Follow-up|3|||
127918878|NCT01097694|460325326|FG000|Overall Study|Withdrawal by Subject|3|||
127918879|NCT01097694|460325327|FG001|Overall Study|Withdrawal by Subject|1|||
127918880|NCT02377349|460325328|FG000|Overall Study|Serious Adverse Event|1|||
127918881|NCT02377349|460325329|FG001|Overall Study|Serious Adverse Event|0|||
127918882|NCT02377349|460325328|FG000|Overall Study|Protocol Violation|3|||
127918883|NCT02377349|460325329|FG001|Overall Study|Protocol Violation|2|||
127918884|NCT02377349|460325328|FG000|Overall Study|Withdrawal by Subject|5|||
127918885|NCT02377349|460325329|FG001|Overall Study|Withdrawal by Subject|3|||
127918886|NCT02377349|460325328|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
127918887|NCT02377349|460325329|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
127918888|NCT02377349|460325328|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
127918889|NCT02377349|460325329|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
127918890|NCT02377349|460325328|FG000|Overall Study|Other|0|||
127918891|NCT02377349|460325329|FG001|Overall Study|Other|1|||
127918892|NCT03259165|460325330|FG000|Overall Study|COVID 19 pandemic|1|||
127918893|NCT03259165|460325331|FG001|Overall Study|COVID 19 pandemic|1|||
127918894|NCT00021541|460325332|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
127918895|NCT00021541|460325333|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
127918896|NCT00021541|460325332|FG000|Period 1-First Treatment|Adverse Event|2|||
127918897|NCT00021541|460325333|FG001|Period 1-First Treatment|Adverse Event|1|||
127918898|NCT00021541|460325332|FG000|Period 1-First Treatment|non-adherence|3|||
127918899|NCT00021541|460325333|FG001|Period 1-First Treatment|non-adherence|0|||
127918900|NCT00021541|460325332|FG000|Period 1-First Treatment|Death|1|||
127918901|NCT00021541|460325333|FG001|Period 1-First Treatment|Death|0|||
127918902|NCT00021541|460325332|FG000|Period 1-First Treatment|Pts that did not progress|2|||
127918903|NCT00021541|460325333|FG001|Period 1-First Treatment|Pts that did not progress|2|||
127918904|NCT00021541|460325332|FG000|Period 1-First Treatment|Ineligible|0|||
127918905|NCT00021541|460325333|FG001|Period 1-First Treatment|Ineligible|2|||
127918906|NCT00021541|460325332|FG000|Period 2-crossover|refused phase B|2|||
127918907|NCT00021541|460325333|FG001|Period 2-crossover|refused phase B|2|||
127918908|NCT00021541|460325332|FG000|Period 2-crossover|Withdrawal by Subject|3|||
127918909|NCT00021541|460325333|FG001|Period 2-crossover|Withdrawal by Subject|4|||
127918910|NCT00021541|460325332|FG000|Period 2-crossover|Adverse Event|2|||
127918911|NCT00021541|460325333|FG001|Period 2-crossover|Adverse Event|2|||
127918912|NCT00021541|460325332|FG000|Period 2-crossover|non-adherence|1|||
127918913|NCT00021541|460325333|FG001|Period 2-crossover|non-adherence|0|||
127918914|NCT00021541|460325332|FG000|Period 2-crossover|Pts that did not progress|2|||
127918915|NCT00021541|460325333|FG001|Period 2-crossover|Pts that did not progress|3|||
127918916|NCT01547728|460325334|FG000|Overall Study|Change in procedure and equipment|1|||
127918917|NCT01547728|460325334|FG000|Overall Study|Drug not ready for subject|1|||
127918918|NCT01547728|460325334|FG000|Overall Study|Screen failure|39|||
127918919|NCT03828539|460325335|FG000|Overall Study|Adverse Event|3|||
127918920|NCT03828539|460325336|FG001|Overall Study|Adverse Event|12|||
127918921|NCT03828539|460325335|FG000|Overall Study|Patient's/guardian's decision|3|||
127918922|NCT03828539|460325336|FG001|Overall Study|Patient's/guardian's decision|5|||
127918923|NCT03828539|460325335|FG000|Overall Study|Lost to Follow-up|4|||
127918924|NCT03828539|460325336|FG001|Overall Study|Lost to Follow-up|2|||
127918925|NCT03828539|460325335|FG000|Overall Study|Protocol Violation|3|||
127918926|NCT03828539|460325336|FG001|Overall Study|Protocol Violation|2|||
127918927|NCT03828539|460325335|FG000|Overall Study|Withdrawal of informed consent|2|||
127918928|NCT03828539|460325336|FG001|Overall Study|Withdrawal of informed consent|1|||
127918929|NCT03828539|460325335|FG000|Overall Study|New therapy for study indication|1|||
127918930|NCT03828539|460325336|FG001|Overall Study|New therapy for study indication|0|||
127918931|NCT01341405|460325337|FG000|Overall Study|Adverse Event|0|||
127918932|NCT01341405|460325338|FG001|Overall Study|Adverse Event|1|||
127918933|NCT01341405|460325339|FG002|Overall Study|Adverse Event|1|||
127918934|NCT01341405|460325337|FG000|Overall Study|Withdrawal by Subject|3|||
127918935|NCT01341405|460325338|FG001|Overall Study|Withdrawal by Subject|2|||
127918936|NCT01341405|460325339|FG002|Overall Study|Withdrawal by Subject|1|||
127918937|NCT00826241|460325340|FG000|Overall Study|Withdrawal from Follow-up|1|||
127918938|NCT00826241|460325340|FG000|Overall Study|Withdrew consent|2|||
127918939|NCT00826241|460325340|FG000|Overall Study|Death|4|||
127918940|NCT00826241|460325340|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
127918941|NCT00826241|460325340|FG000|Overall Study|Non-compliance|1|||
127918942|NCT00826241|460325340|FG000|Overall Study|Progression of disease|1|||
127918943|NCT00826241|460325340|FG000|Overall Study|Patient refused follow-up|3|||
127918944|NCT00826241|460325340|FG000|Overall Study|Lost to Follow-up|9|||
127918945|NCT00826241|460325340|FG000|Overall Study|Could not obtain records|1|||
127918946|NCT00826241|460325340|FG000|Overall Study|Screen failure|2|||
127918947|NCT00826241|460325340|FG000|Overall Study|Pt unable to proceed to registration|1|||
127918948|NCT00826241|460325340|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
127918949|NCT04142658|460325341|FG000|Overall Study|Death|2|||
127918950|NCT04142658|460325342|FG001|Overall Study|Death|1|||
127918951|NCT04142658|460325341|FG000|Overall Study|Lost to Follow-up|4|||
127918952|NCT04142658|460325342|FG001|Overall Study|Lost to Follow-up|13|||
127918953|NCT04142658|460325341|FG000|Overall Study|Withdrawal by Subject|9|||
127918954|NCT04142658|460325342|FG001|Overall Study|Withdrawal by Subject|16|||
127918955|NCT03201003|460325350|FG000|Overall Study|Adverse Event|14|||
127918956|NCT03201003|460325351|FG001|Overall Study|Adverse Event|1|||
127918957|NCT03201003|460325350|FG000|Overall Study|Other reasons|5|||
127918958|NCT03201003|460325351|FG001|Overall Study|Other reasons|1|||
127918959|NCT03201003|460325350|FG000|Overall Study|Withdrawal by Subject|4|||
127918960|NCT03201003|460325351|FG001|Overall Study|Withdrawal by Subject|1|||
127918961|NCT03201003|460325350|FG000|Overall Study|Lost to Follow-up|2|||
127918962|NCT03201003|460325351|FG001|Overall Study|Lost to Follow-up|0|||
127918963|NCT03201003|460325350|FG000|Overall Study|Protocol Violation|1|||
127918964|NCT03201003|460325351|FG001|Overall Study|Protocol Violation|0|||
127918965|NCT00834613|460325352|FG000|First Intervention|Protocol Violation|1|||
127918966|NCT00834613|460325353|FG001|First Intervention|Protocol Violation|0|||
127918967|NCT01751087|460325354|FG000|Overall Study|Withdrawal by Subject|1|||
127918968|NCT01751087|460325355|FG001|Overall Study|Withdrawal by Subject|0|||
127918969|NCT01751087|460325356|FG002|Overall Study|Withdrawal by Subject|0|||
127918970|NCT01751087|460325354|FG000|Overall Study|Physician Decision|0|||
127918971|NCT01751087|460325355|FG001|Overall Study|Physician Decision|0|||
127918972|NCT01751087|460325356|FG002|Overall Study|Physician Decision|1|||
127918973|NCT00697619|460325357|FG000|Overall Study|Lack of Efficacy|2|||
127918974|NCT00697619|460325358|FG001|Overall Study|Lack of Efficacy|2|||
127918975|NCT00697619|460325357|FG000|Overall Study|Adverse Event|4|||
127918976|NCT00697619|460325358|FG001|Overall Study|Adverse Event|6|||
127918977|NCT00640341|460326852|FG000|Overall Study|Adverse Event|0|||
127918978|NCT00640341|460326853|FG001|Overall Study|Adverse Event|0|||
127918979|NCT00640341|460326854|FG002|Overall Study|Adverse Event|1|||
127918980|NCT00640341|460326852|FG000|Overall Study|Positive Slit Lamp Findings|0|||
127918981|NCT00640341|460326853|FG001|Overall Study|Positive Slit Lamp Findings|0|||
127918982|NCT00640341|460326854|FG002|Overall Study|Positive Slit Lamp Findings|1|||
127918983|NCT00640341|460326852|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
127918984|NCT00640341|460326853|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
127918985|NCT00640341|460326854|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
127918986|NCT00640341|460326852|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
127918987|NCT00640341|460326853|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
127918988|NCT00640341|460326854|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
127918989|NCT00640341|460326852|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
127918990|NCT00640341|460326853|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
127918991|NCT00640341|460326854|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
127918992|NCT00640341|460326852|FG000|Overall Study|Lost to Follow-up|2|||
127918993|NCT00640341|460326853|FG001|Overall Study|Lost to Follow-up|0|||
127918994|NCT00640341|460326854|FG002|Overall Study|Lost to Follow-up|0|||
127918995|NCT00640341|460326852|FG000|Overall Study|Withdrawal by Subject|4|||
127918996|NCT00640341|460326853|FG001|Overall Study|Withdrawal by Subject|0|||
127918997|NCT00640341|460326854|FG002|Overall Study|Withdrawal by Subject|1|||
127918998|NCT00640341|460326852|FG000|Overall Study|Unacceptable Lens Movement|1|||
127918999|NCT00640341|460326853|FG001|Overall Study|Unacceptable Lens Movement|0|||
127919000|NCT00640341|460326854|FG002|Overall Study|Unacceptable Lens Movement|0|||
127919001|NCT00640341|460326852|FG000|Overall Study|Poor fit/Uncomfortable|4|||
127919002|NCT00640341|460326853|FG001|Overall Study|Poor fit/Uncomfortable|0|||
127919003|NCT00640341|460326854|FG002|Overall Study|Poor fit/Uncomfortable|0|||
127919004|NCT00640341|460326852|FG000|Overall Study|Ineligable at Baseline|5|||
127919005|NCT00640341|460326853|FG001|Overall Study|Ineligable at Baseline|3|||
127919006|NCT00640341|460326854|FG002|Overall Study|Ineligable at Baseline|2|||
127919007|NCT00640341|460326852|FG000|Overall Study|Adverse event and positive slit lamp|1|||
127919008|NCT00640341|460326853|FG001|Overall Study|Adverse event and positive slit lamp|0|||
127919009|NCT00640341|460326854|FG002|Overall Study|Adverse event and positive slit lamp|0|||
127919010|NCT00258856|460326857|FG000|Overall Study|Lost to Follow-up|1|||
127919011|NCT00258856|460326858|FG001|Overall Study|Lost to Follow-up|0|||
127919012|NCT00258856|460326859|FG002|Overall Study|Lost to Follow-up|2|||
127919013|NCT00258856|460326860|FG003|Overall Study|Lost to Follow-up|0|||
127919014|NCT00258856|460326857|FG000|Overall Study|Non-compliance|2|||
127919015|NCT00258856|460326858|FG001|Overall Study|Non-compliance|0|||
127919016|NCT00258856|460326859|FG002|Overall Study|Non-compliance|0|||
127919017|NCT00258856|460326860|FG003|Overall Study|Non-compliance|1|||
127919018|NCT01691430|460326861|FG000|Overall Study|Death|17|||
127919019|NCT01691430|460326862|FG001|Overall Study|Death|16|||
127919020|NCT01691430|460326861|FG000|Overall Study|Withdrawal by Subject|5|||
127919021|NCT01691430|460326862|FG001|Overall Study|Withdrawal by Subject|1|||
127919022|NCT01691430|460326861|FG000|Overall Study|Lost to Follow-up|0|||
127919023|NCT01691430|460326862|FG001|Overall Study|Lost to Follow-up|3|||
127919024|NCT02219009|460326868|FG000|Overall Study|Withdrawal by Subject|5|||
127919025|NCT02219009|460326869|FG001|Overall Study|Withdrawal by Subject|1|||
127919026|NCT02219009|460326868|FG000|Overall Study|Adverse Event|2|||
127919027|NCT02219009|460326869|FG001|Overall Study|Adverse Event|4|||
127919028|NCT02219009|460326868|FG000|Overall Study|Lost to Follow-up|2|||
127919029|NCT02219009|460326869|FG001|Overall Study|Lost to Follow-up|2|||
127919030|NCT02219009|460326868|FG000|Overall Study|Protocol deviation|1|||
127919031|NCT02219009|460326869|FG001|Overall Study|Protocol deviation|0|||
127919032|NCT02219009|460326868|FG000|Overall Study|Physician Decision|0|||
127919033|NCT02219009|460326869|FG001|Overall Study|Physician Decision|1|||
127919034|NCT03086135|460326874|FG000|Overall Study|Adverse Event|1|||
127919035|NCT03086135|460326874|FG000|Overall Study|Lost to Follow-up|2|||
127919036|NCT00762411|460326877|FG000|Initial Treatment|Death|7|||
127919037|NCT00762411|460326878|FG001|Initial Treatment|Death|6|||
127919038|NCT00762411|460326877|FG000|Initial Treatment|Adverse Event|132|||
127919039|NCT00762411|460326878|FG001|Initial Treatment|Adverse Event|40|||
127919040|NCT00762411|460326877|FG000|Initial Treatment|Protocol Violation|4|||
127919041|NCT00762411|460326878|FG001|Initial Treatment|Protocol Violation|1|||
127919042|NCT00762411|460326877|FG000|Initial Treatment|Withdrawal by Subject|65|||
127919043|NCT00762411|460326878|FG001|Initial Treatment|Withdrawal by Subject|52|||
127919044|NCT00762411|460326877|FG000|Initial Treatment|Physician Decision|1|||
127919045|NCT00762411|460326878|FG001|Initial Treatment|Physician Decision|0|||
127919046|NCT00762411|460326877|FG000|Initial Treatment|Sponsor Decision|293|||
127919047|NCT00762411|460326878|FG001|Initial Treatment|Sponsor Decision|401|||
127919048|NCT00762411|460326877|FG000|Initial Treatment|Lost to Follow-up|5|||
127919049|NCT00762411|460326878|FG001|Initial Treatment|Lost to Follow-up|0|||
127919050|NCT00762411|460326877|FG000|Initial Treatment|Caregiver Decision|21|||
127919051|NCT00762411|460326878|FG001|Initial Treatment|Caregiver Decision|16|||
127919052|NCT00762411|460326877|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
127919053|NCT00762411|460326878|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
127919054|NCT00762411|460326877|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
127919055|NCT00762411|460326878|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
127919056|NCT00762411|460326877|FG000|Delayed Start|Adverse Event|0|||
127919057|NCT00762411|460326878|FG001|Delayed Start|Adverse Event|4|||
127919058|NCT00762411|460326877|FG000|Delayed Start|Protocol Violation|0|||
127919059|NCT00762411|460326878|FG001|Delayed Start|Protocol Violation|1|||
127919060|NCT00762411|460326877|FG000|Delayed Start|Sponsor Decision|16|||
127919061|NCT00762411|460326878|FG001|Delayed Start|Sponsor Decision|20|||
127919062|NCT00762411|460326877|FG000|Delayed Start|Caregiver Decision|1|||
127919063|NCT00762411|460326878|FG001|Delayed Start|Caregiver Decision|1|||
127919064|NCT00762411|460326877|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
127919065|NCT00762411|460326878|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
127919066|NCT00762411|460326877|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
127919067|NCT00762411|460326878|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
127919068|NCT00762411|460326877|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
127919069|NCT00762411|460326878|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
127919070|NCT00762411|460326877|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
127919071|NCT00762411|460326878|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
127919072|NCT00762411|460326877|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
127919073|NCT00762411|460326878|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
127919074|NCT00762411|460326877|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
127919075|NCT00762411|460326878|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
127919076|NCT01023061|460326879|FG000|Overall Study|Withdrawal prior to treatment|2|||
127919077|NCT02966340|460326880|FG000|Overall Study|Adverse Event|0|||
127919078|NCT02966340|460326881|FG001|Overall Study|Adverse Event|1|||
127919079|NCT02966340|460326880|FG000|Overall Study|Lost to Follow-up|0|||
127919080|NCT02966340|460326881|FG001|Overall Study|Lost to Follow-up|1|||
127919081|NCT02966340|460326880|FG000|Overall Study|Withdrawal by Subject|1|||
127919082|NCT02966340|460326881|FG001|Overall Study|Withdrawal by Subject|0|||
127919083|NCT02966340|460326880|FG000|Overall Study|data acquisition error|1|||
127919084|NCT02966340|460326881|FG001|Overall Study|data acquisition error|0|||
127919085|NCT02966340|460326880|FG000|Overall Study|startle non-responder|1|||
127919086|NCT02966340|460326881|FG001|Overall Study|startle non-responder|1|||
127919087|NCT02259348|460326884|FG000|Overall Study|Donors|6|||
127919088|NCT02259348|460326884|FG000|Overall Study|Death|4|||
127919089|NCT01622660|460326885|FG000|Overall Study|Adverse Event|1|||
127919090|NCT04812548|460326886|FG000|Overall Study|Adverse Event|2|||
127919091|NCT04812548|460326887|FG001|Overall Study|Adverse Event|7|||
127919092|NCT04812548|460326886|FG000|Overall Study|HSCT Planned|2|||
127919093|NCT04812548|460326887|FG001|Overall Study|HSCT Planned|3|||
127919094|NCT04812548|460326886|FG000|Overall Study|Progressive Disease|0|||
127919095|NCT04812548|460326887|FG001|Overall Study|Progressive Disease|2|||
127919096|NCT04812548|460326886|FG000|Overall Study|Death|0|||
127919097|NCT04812548|460326887|FG001|Overall Study|Death|1|||
127919098|NCT04812548|460326886|FG000|Overall Study|Post Study Access to Treatment|0|||
127919099|NCT04812548|460326887|FG001|Overall Study|Post Study Access to Treatment|1|||
127919100|NCT04812548|460326886|FG000|Overall Study|Withdrawal by Subject|0|||
127919101|NCT04812548|460326887|FG001|Overall Study|Withdrawal by Subject|1|||
127919102|NCT04812548|460326886|FG000|Overall Study|Physician Decision|1|||
127919103|NCT04812548|460326887|FG001|Overall Study|Physician Decision|0|||
127919104|NCT04211766|460326888|FG000|Overall Study|Withdrawal by Subject|5|||
127919105|NCT04211766|460326889|FG001|Overall Study|Withdrawal by Subject|1|||
127919106|NCT04556734|460326891|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|4|||
127919107|NCT04556734|460326892|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
127919108|NCT04556734|460326893|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
127919109|NCT04556734|460326894|FG003|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
127919110|NCT04556734|460326895|FG004|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
127919111|NCT04556734|460326896|FG005|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
127919112|NCT04556734|460326897|FG006|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
127919113|NCT04556734|460326898|FG007|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
127919114|NCT04556734|460326891|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
127919115|NCT04556734|460326892|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
127919116|NCT04556734|460326893|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
127919117|NCT04556734|460326894|FG003|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
127919118|NCT04556734|460326895|FG004|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
127919119|NCT04556734|460326896|FG005|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
127919120|NCT04556734|460326897|FG006|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
127919121|NCT04556734|460326898|FG007|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
127919122|NCT04556734|460326891|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
127919123|NCT04556734|460326892|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
127919124|NCT04556734|460326893|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
127919125|NCT04556734|460326894|FG003|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
127919126|NCT04556734|460326895|FG004|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
127919127|NCT04556734|460326896|FG005|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
127919128|NCT04556734|460326897|FG006|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
127919129|NCT04556734|460326898|FG007|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
127919130|NCT04556734|460326891|FG000|DB Treatment Period (24 Weeks)|Adverse Event|1|||
127919131|NCT04556734|460326892|FG001|DB Treatment Period (24 Weeks)|Adverse Event|0|||
127919132|NCT04556734|460326893|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
127919133|NCT04556734|460326894|FG003|DB Treatment Period (24 Weeks)|Adverse Event|0|||
127919134|NCT04556734|460326895|FG004|DB Treatment Period (24 Weeks)|Adverse Event|0|||
127919135|NCT04556734|460326896|FG005|DB Treatment Period (24 Weeks)|Adverse Event|0|||
127919136|NCT04556734|460326897|FG006|DB Treatment Period (24 Weeks)|Adverse Event|0|||
127919137|NCT04556734|460326898|FG007|DB Treatment Period (24 Weeks)|Adverse Event|0|||
127919138|NCT04556734|460326891|FG000|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
127919139|NCT04556734|460326892|FG001|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
127919140|NCT04556734|460326893|FG002|DB Treatment Period (24 Weeks)|Randomized but not treated|1|||
127919141|NCT04556734|460326894|FG003|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
127919142|NCT04556734|460326895|FG004|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
127919143|NCT04556734|460326896|FG005|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
127919144|NCT04556734|460326897|FG006|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
127919145|NCT04556734|460326898|FG007|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
127919146|NCT04556734|460326891|FG000|OLE Period (28 Weeks)|Not reported|0|||
127919147|NCT04556734|460326892|FG001|OLE Period (28 Weeks)|Not reported|0|||
127919148|NCT04556734|460326893|FG002|OLE Period (28 Weeks)|Not reported|0|||
127919149|NCT04556734|460326894|FG003|OLE Period (28 Weeks)|Not reported|0|||
127919150|NCT04556734|460326895|FG004|OLE Period (28 Weeks)|Not reported|0|||
127919151|NCT04556734|460326896|FG005|OLE Period (28 Weeks)|Not reported|1|||
127919152|NCT04556734|460326897|FG006|OLE Period (28 Weeks)|Not reported|0|||
127919153|NCT04556734|460326898|FG007|OLE Period (28 Weeks)|Not reported|0|||
127919154|NCT04556734|460326891|FG000|OLE Period (28 Weeks)|Lost to Follow-up|0|||
127919155|NCT04556734|460326892|FG001|OLE Period (28 Weeks)|Lost to Follow-up|0|||
127919156|NCT04556734|460326893|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
127919157|NCT04556734|460326894|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
127919158|NCT04556734|460326895|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
127919159|NCT04556734|460326896|FG005|OLE Period (28 Weeks)|Lost to Follow-up|0|||
127919160|NCT04556734|460326897|FG006|OLE Period (28 Weeks)|Lost to Follow-up|0|||
127919161|NCT04556734|460326898|FG007|OLE Period (28 Weeks)|Lost to Follow-up|2|||
127919162|NCT04556734|460326891|FG000|OLE Period (28 Weeks)|Adverse Event|0|||
127919163|NCT04556734|460326892|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
127919164|NCT04556734|460326893|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
127919165|NCT04556734|460326894|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
127919166|NCT04556734|460326895|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
127919167|NCT04556734|460326896|FG005|OLE Period (28 Weeks)|Adverse Event|0|||
127919168|NCT04556734|460326897|FG006|OLE Period (28 Weeks)|Adverse Event|0|||
127919169|NCT04556734|460326898|FG007|OLE Period (28 Weeks)|Adverse Event|2|||
127919170|NCT04556734|460326891|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
127919171|NCT04556734|460326892|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
127919172|NCT04556734|460326893|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
127919173|NCT04556734|460326894|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
127919174|NCT04556734|460326895|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
127919175|NCT04556734|460326896|FG005|OLE Period (28 Weeks)|Withdrawal by Subject|2|||
127919176|NCT04556734|460326897|FG006|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
127919177|NCT04556734|460326898|FG007|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
127919178|NCT01680016|460326899|FG000|Overall Study|Adverse Event|0|||
127919179|NCT01680016|460326900|FG001|Overall Study|Adverse Event|0|||
127919180|NCT01680016|460326901|FG002|Overall Study|Adverse Event|1|||
127919181|NCT01680016|460326902|FG003|Overall Study|Adverse Event|4|||
127919182|NCT01680016|460326899|FG000|Overall Study|The Subject went out of The Trial|1|||
127919183|NCT01680016|460326900|FG001|Overall Study|The Subject went out of The Trial|0|||
127919184|NCT01680016|460326901|FG002|Overall Study|The Subject went out of The Trial|3|||
127919185|NCT01680016|460326902|FG003|Overall Study|The Subject went out of The Trial|0|||
127919186|NCT01680016|460326899|FG000|Overall Study|Protocol Violation|0|||
127919187|NCT01680016|460326900|FG001|Overall Study|Protocol Violation|1|||
127919188|NCT01680016|460326901|FG002|Overall Study|Protocol Violation|0|||
127919189|NCT01680016|460326902|FG003|Overall Study|Protocol Violation|0|||
127919190|NCT01680016|460326899|FG000|Overall Study|Withdrawal by Subject|5|||
127919191|NCT01680016|460326900|FG001|Overall Study|Withdrawal by Subject|7|||
127919192|NCT01680016|460326901|FG002|Overall Study|Withdrawal by Subject|1|||
127919193|NCT01680016|460326902|FG003|Overall Study|Withdrawal by Subject|1|||
127919194|NCT00202839|460326903|FG000|Overall Study|Adverse Event|1|||
127919195|NCT00202839|460326904|FG001|Overall Study|Adverse Event|5|||
127919196|NCT00202839|460326903|FG000|Overall Study|Physician Decision|12|||
127919197|NCT00202839|460326904|FG001|Overall Study|Physician Decision|0|||
127919198|NCT00202839|460326903|FG000|Overall Study|Withdrawal by Subject|6|||
127919199|NCT00202839|460326904|FG001|Overall Study|Withdrawal by Subject|2|||
127919200|NCT00202839|460326903|FG000|Overall Study|Protocol Violation|2|||
127919201|NCT00202839|460326904|FG001|Overall Study|Protocol Violation|1|||
127919202|NCT00202839|460326903|FG000|Overall Study|Lost to Follow-up|3|||
127919203|NCT00202839|460326904|FG001|Overall Study|Lost to Follow-up|2|||
127919204|NCT02485158|460326905|FG000|Overall Study|Withdrawal by Subject|3|||
127919205|NCT02485158|460326905|FG000|Overall Study|expected drug side effect|1|||
127919206|NCT01098851|460326908|FG000|Overall Study|Equipment failure|1|||
127919207|NCT01098851|460326909|FG001|Overall Study|Equipment failure|0|||
127919208|NCT00442351|460326910|FG000|Overall Study|Administrative|6|||
127919209|NCT00442351|460326911|FG001|Overall Study|Administrative|5|||
127919210|NCT00442351|460326910|FG000|Overall Study|Did not meet protocol eligibility|1|||
127919211|NCT00442351|460326911|FG001|Overall Study|Did not meet protocol eligibility|0|||
127919212|NCT00442351|460326910|FG000|Overall Study|Other|0|||
127919213|NCT00442351|460326911|FG001|Overall Study|Other|1|||
127919214|NCT03035890|460326912|FG000|Overall Study|Death|1|||
127919215|NCT00288704|460326913|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
127919216|NCT00288704|460326914|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
127919217|NCT00288704|460326915|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
127919218|NCT00288704|460326913|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
127919219|NCT00288704|460326914|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
127919220|NCT00288704|460326915|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
127919221|NCT00288704|460326913|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
127919222|NCT00288704|460326914|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
127919223|NCT00288704|460326915|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
127919224|NCT00288704|460326913|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
127919225|NCT00288704|460326914|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
127919226|NCT00288704|460326915|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
127919227|NCT00288704|460326913|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
127919228|NCT00288704|460326914|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
127919229|NCT00288704|460326915|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
127919230|NCT00288704|460326913|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
127919231|NCT00288704|460326914|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
127919232|NCT00288704|460326915|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
127919233|NCT00288704|460326913|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
127919234|NCT00288704|460326914|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
127919235|NCT00288704|460326915|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
127919236|NCT01579006|460326916|FG000|Overall Study|Lack of Efficacy|10|||
127919237|NCT01579006|460326916|FG000|Overall Study|Adverse Event|13|||
127919238|NCT01579006|460326916|FG000|Overall Study|Withdrawal by Subject|5|||
127919239|NCT01579006|460326916|FG000|Overall Study|Non-compliance|3|||
127919240|NCT01579006|460326916|FG000|Overall Study|Due to participant's health fund|1|||
127919241|NCT01579006|460326916|FG000|Overall Study|Scheduled surgery|1|||
127919242|NCT05061992|460326917|FG000|Overall Study|Excess bowel movements|1|||
127919243|NCT05061992|460326918|FG001|Overall Study|Excess bowel movements|0|||
127919244|NCT05061992|460326917|FG000|Overall Study|Complications of Medical Care|1|||
127919245|NCT05061992|460326918|FG001|Overall Study|Complications of Medical Care|0|||
127919246|NCT05061992|460326917|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
127919247|NCT05061992|460326918|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
127919248|NCT05061992|460326917|FG000|Overall Study|Withdrawal by Subject|0|||
127919249|NCT05061992|460326918|FG001|Overall Study|Withdrawal by Subject|1|||
127919250|NCT02473393|460326919|FG000|Overall Study|Adverse Event|0|||
127919251|NCT02473393|460326920|FG001|Overall Study|Adverse Event|0|||
127919252|NCT02473393|460326921|FG002|Overall Study|Adverse Event|1|||
127919253|NCT02473393|460326922|FG003|Overall Study|Adverse Event|0|||
127919254|NCT02473393|460326919|FG000|Overall Study|Withdrawal by Subject|0|||
127919255|NCT02473393|460326920|FG001|Overall Study|Withdrawal by Subject|0|||
127919256|NCT02473393|460326921|FG002|Overall Study|Withdrawal by Subject|1|||
127919257|NCT02473393|460326922|FG003|Overall Study|Withdrawal by Subject|1|||
127919258|NCT01698554|460326923|FG000|Overall Study|Adverse Event|2|||
127919259|NCT01698554|460326924|FG001|Overall Study|Adverse Event|5|||
127919260|NCT01698554|460326925|FG002|Overall Study|Adverse Event|0|||
127919261|NCT01698554|460326926|FG003|Overall Study|Adverse Event|1|||
127919262|NCT01698554|460326923|FG000|Overall Study|Lost to Follow-up|1|||
127919263|NCT01698554|460326924|FG001|Overall Study|Lost to Follow-up|0|||
127919264|NCT01698554|460326925|FG002|Overall Study|Lost to Follow-up|0|||
127919265|NCT01698554|460326926|FG003|Overall Study|Lost to Follow-up|0|||
127919266|NCT01698554|460326923|FG000|Overall Study|Personal Reasons|0|||
127919267|NCT01698554|460326924|FG001|Overall Study|Personal Reasons|5|||
127919268|NCT01698554|460326925|FG002|Overall Study|Personal Reasons|1|||
127919269|NCT01698554|460326926|FG003|Overall Study|Personal Reasons|1|||
127919270|NCT01698554|460326923|FG000|Overall Study|Protocol Violation|2|||
127919271|NCT01698554|460326924|FG001|Overall Study|Protocol Violation|0|||
127919272|NCT01698554|460326925|FG002|Overall Study|Protocol Violation|1|||
127919273|NCT01698554|460326926|FG003|Overall Study|Protocol Violation|0|||
127919274|NCT01698554|460326923|FG000|Overall Study|Other Miscellaneous Reasons|1|||
127919275|NCT01698554|460326924|FG001|Overall Study|Other Miscellaneous Reasons|0|||
127919276|NCT01698554|460326925|FG002|Overall Study|Other Miscellaneous Reasons|0|||
127919277|NCT01698554|460326926|FG003|Overall Study|Other Miscellaneous Reasons|0|||
127919278|NCT02229084|460326927|FG000|Overall Study|Adverse Event|1|||
127919279|NCT02229084|460326928|FG001|Overall Study|Adverse Event|0|||
127919280|NCT02229084|460326929|FG002|Overall Study|Adverse Event|0|||
127919281|NCT02229084|460326930|FG003|Overall Study|Adverse Event|0|||
127919282|NCT02229084|460326931|FG004|Overall Study|Adverse Event|0|||
127919283|NCT02229084|460326932|FG005|Overall Study|Adverse Event|0|||
127919284|NCT02229084|460326933|FG006|Overall Study|Adverse Event|0|||
127919285|NCT02229084|460326927|FG000|Overall Study|Lost to Follow-up|0|||
127919286|NCT02229084|460326928|FG001|Overall Study|Lost to Follow-up|0|||
127919287|NCT02229084|460326929|FG002|Overall Study|Lost to Follow-up|1|||
127919288|NCT02229084|460326930|FG003|Overall Study|Lost to Follow-up|1|||
127919289|NCT02229084|460326931|FG004|Overall Study|Lost to Follow-up|0|||
127919290|NCT02229084|460326932|FG005|Overall Study|Lost to Follow-up|0|||
127919291|NCT02229084|460326933|FG006|Overall Study|Lost to Follow-up|1|||
127919292|NCT02229084|460326927|FG000|Overall Study|Physician Decision|0|||
127919293|NCT02229084|460326928|FG001|Overall Study|Physician Decision|0|||
127919294|NCT02229084|460326929|FG002|Overall Study|Physician Decision|0|||
127919295|NCT02229084|460326930|FG003|Overall Study|Physician Decision|1|||
127919296|NCT02229084|460326931|FG004|Overall Study|Physician Decision|3|||
127919297|NCT02229084|460326932|FG005|Overall Study|Physician Decision|0|||
127919298|NCT02229084|460326933|FG006|Overall Study|Physician Decision|1|||
127919299|NCT02229084|460326927|FG000|Overall Study|Withdrawal by Subject|0|||
127919300|NCT02229084|460326928|FG001|Overall Study|Withdrawal by Subject|0|||
127919301|NCT02229084|460326929|FG002|Overall Study|Withdrawal by Subject|1|||
127919302|NCT02229084|460326930|FG003|Overall Study|Withdrawal by Subject|0|||
127919303|NCT02229084|460326931|FG004|Overall Study|Withdrawal by Subject|1|||
127919304|NCT02229084|460326932|FG005|Overall Study|Withdrawal by Subject|1|||
127919305|NCT02229084|460326933|FG006|Overall Study|Withdrawal by Subject|1|||
127919306|NCT02229084|460326927|FG000|Overall Study|Death|0|||
127919307|NCT02229084|460326928|FG001|Overall Study|Death|0|||
127919308|NCT02229084|460326929|FG002|Overall Study|Death|0|||
127919309|NCT02229084|460326930|FG003|Overall Study|Death|0|||
127919310|NCT02229084|460326931|FG004|Overall Study|Death|0|||
127919311|NCT02229084|460326932|FG005|Overall Study|Death|0|||
127919312|NCT02229084|460326933|FG006|Overall Study|Death|1|||
127919313|NCT04535986|460326942|FG000|Overall Study|Death|4|||
127919314|NCT04535986|460326943|FG001|Overall Study|Death|5|||
127919315|NCT04535986|460326942|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
127919316|NCT04535986|460326943|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
127919317|NCT04535986|460326942|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
127919318|NCT04535986|460326943|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
127919319|NCT04535986|460326942|FG000|Overall Study|Adverse Event|10|||
127919320|NCT04535986|460326943|FG001|Overall Study|Adverse Event|1|||
127919321|NCT04535986|460326942|FG000|Overall Study|Lack of Efficacy|3|||
127919322|NCT04535986|460326943|FG001|Overall Study|Lack of Efficacy|2|||
127919323|NCT04535986|460326942|FG000|Overall Study|Investigator discretion|3|||
127919324|NCT04535986|460326943|FG001|Overall Study|Investigator discretion|0|||
127919325|NCT04535986|460326942|FG000|Overall Study|Withdrawal by Subject|32|||
127919326|NCT04535986|460326943|FG001|Overall Study|Withdrawal by Subject|14|||
127919327|NCT04535986|460326942|FG000|Overall Study|Lost to Follow-up|5|||
127919328|NCT04535986|460326943|FG001|Overall Study|Lost to Follow-up|3|||
127919329|NCT04535986|460326942|FG000|Overall Study|Other|7|||
127919330|NCT04535986|460326943|FG001|Overall Study|Other|3|||
127919331|NCT02179190|460326944|FG000|Enrollment|Exit Prior to Device Attempt|11|||
127919332|NCT02179190|460326944|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
127919333|NCT02179190|460326944|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
127919334|NCT02179190|460326944|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
127919335|NCT02179190|460326944|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
127919336|NCT02179190|460326944|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
127919337|NCT00881569|460326947|FG000|Overall Study|Disease progression|1|||
127919338|NCT00881569|460326948|FG001|Overall Study|Disease progression|1|||
127919339|NCT01993940|460326959|FG000|Overall Study|Adverse Event|16|||
127919340|NCT01993940|460326960|FG001|Overall Study|Adverse Event|11|||
127919341|NCT01993940|460326959|FG000|Overall Study|Withdrawal by Subject|15|||
127919342|NCT01993940|460326960|FG001|Overall Study|Withdrawal by Subject|19|||
127919343|NCT01993940|460326959|FG000|Overall Study|Lost to Follow-up|2|||
127919344|NCT01993940|460326960|FG001|Overall Study|Lost to Follow-up|5|||
127919345|NCT01993940|460326959|FG000|Overall Study|Protocol Violation|5|||
127919346|NCT01993940|460326960|FG001|Overall Study|Protocol Violation|8|||
127919347|NCT01993940|460326959|FG000|Overall Study|Death|1|||
127919348|NCT01993940|460326960|FG001|Overall Study|Death|0|||
127919349|NCT01993940|460326959|FG000|Overall Study|Other - Miscellaneous|1|||
127919350|NCT01993940|460326960|FG001|Overall Study|Other - Miscellaneous|1|||
127919351|NCT01567527|460326961|FG000|Conversion Phase.|Protocol deviation|3|||
127919352|NCT01567527|460326962|FG001|Conversion Phase.|Protocol deviation|0|||
127919353|NCT01567527|460326963|FG002|Conversion Phase.|Protocol deviation|0|||
127919354|NCT01567527|460326964|FG003|Conversion Phase.|Protocol deviation|0|||
127919355|NCT01567527|460326965|FG004|Conversion Phase.|Protocol deviation|0|||
127919356|NCT01567527|460326961|FG000|Conversion Phase.|Met withdrawal criteria|10|||
127919357|NCT01567527|460326962|FG001|Conversion Phase.|Met withdrawal criteria|0|||
127919358|NCT01567527|460326963|FG002|Conversion Phase.|Met withdrawal criteria|0|||
127919359|NCT01567527|460326964|FG003|Conversion Phase.|Met withdrawal criteria|0|||
127919360|NCT01567527|460326965|FG004|Conversion Phase.|Met withdrawal criteria|0|||
127919361|NCT01567527|460326961|FG000|Conversion Phase.|Withdrawal by Subject|32|||
127919362|NCT01567527|460326962|FG001|Conversion Phase.|Withdrawal by Subject|0|||
127919363|NCT01567527|460326963|FG002|Conversion Phase.|Withdrawal by Subject|0|||
127919364|NCT01567527|460326964|FG003|Conversion Phase.|Withdrawal by Subject|0|||
127919365|NCT01567527|460326965|FG004|Conversion Phase.|Withdrawal by Subject|0|||
127919366|NCT01567527|460326961|FG000|Conversion Phase.|Lost to Follow-up|16|||
127919367|NCT01567527|460326962|FG001|Conversion Phase.|Lost to Follow-up|0|||
127919368|NCT01567527|460326963|FG002|Conversion Phase.|Lost to Follow-up|0|||
127919369|NCT01567527|460326964|FG003|Conversion Phase.|Lost to Follow-up|0|||
127919370|NCT01567527|460326965|FG004|Conversion Phase.|Lost to Follow-up|0|||
127919371|NCT01567527|460326961|FG000|Conversion Phase.|Lack of Efficacy|2|||
127919372|NCT01567527|460326962|FG001|Conversion Phase.|Lack of Efficacy|0|||
127919373|NCT01567527|460326963|FG002|Conversion Phase.|Lack of Efficacy|0|||
127919374|NCT01567527|460326964|FG003|Conversion Phase.|Lack of Efficacy|0|||
127919375|NCT01567527|460326965|FG004|Conversion Phase.|Lack of Efficacy|0|||
127919376|NCT01567527|460326961|FG000|Conversion Phase.|Adverse Event|33|||
127919377|NCT01567527|460326962|FG001|Conversion Phase.|Adverse Event|0|||
127919378|NCT01567527|460326963|FG002|Conversion Phase.|Adverse Event|0|||
127919379|NCT01567527|460326964|FG003|Conversion Phase.|Adverse Event|0|||
127919380|NCT01567527|460326965|FG004|Conversion Phase.|Adverse Event|0|||
127919381|NCT01567527|460326961|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
127919382|NCT01567527|460326962|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
127919383|NCT01567527|460326963|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
127919384|NCT01567527|460326964|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
127919385|NCT01567527|460326965|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
127919386|NCT01567527|460326961|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
127919387|NCT01567527|460326962|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
127919388|NCT01567527|460326963|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
127919389|NCT01567527|460326964|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
127919390|NCT01567527|460326965|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
127919391|NCT01567527|460326961|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
127919392|NCT01567527|460326962|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
127919393|NCT01567527|460326963|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
127919394|NCT01567527|460326964|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
127919395|NCT01567527|460326965|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
127919396|NCT01567527|460326961|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
127919397|NCT01567527|460326962|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
127919398|NCT01567527|460326963|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
127919399|NCT01567527|460326964|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
127919400|NCT01567527|460326965|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
127919401|NCT01567527|460326961|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
127919402|NCT01567527|460326962|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
127919403|NCT01567527|460326963|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
127919404|NCT01567527|460326964|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
127919405|NCT01567527|460326965|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
127919406|NCT01567527|460326961|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
127919407|NCT01567527|460326962|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
127919408|NCT01567527|460326963|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
127919409|NCT01567527|460326964|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
127919410|NCT01567527|460326965|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
127919411|NCT01567527|460326961|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
127919412|NCT01567527|460326962|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
127919413|NCT01567527|460326963|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
127919414|NCT01567527|460326964|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
127919415|NCT01567527|460326965|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
127919416|NCT01567527|460326961|FG000|IM Depot Stabilization.|Protocol deviation|0|||
127919417|NCT01567527|460326962|FG001|IM Depot Stabilization.|Protocol deviation|0|||
127919418|NCT01567527|460326963|FG002|IM Depot Stabilization.|Protocol deviation|5|||
127919419|NCT01567527|460326964|FG003|IM Depot Stabilization.|Protocol deviation|0|||
127919420|NCT01567527|460326965|FG004|IM Depot Stabilization.|Protocol deviation|0|||
127919421|NCT01567527|460326961|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
127919422|NCT01567527|460326962|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
127919423|NCT01567527|460326963|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
127919424|NCT01567527|460326964|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
127919425|NCT01567527|460326965|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
127919426|NCT01567527|460326961|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
127919427|NCT01567527|460326962|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
127919428|NCT01567527|460326963|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
127919429|NCT01567527|460326964|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
127919430|NCT01567527|460326965|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
127919431|NCT01567527|460326961|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
127919432|NCT01567527|460326962|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
127919433|NCT01567527|460326963|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
127919434|NCT01567527|460326964|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
127919435|NCT01567527|460326965|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
127919436|NCT01567527|460326961|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
127919437|NCT01567527|460326962|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
127919438|NCT01567527|460326963|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
127919439|NCT01567527|460326964|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
127919440|NCT01567527|460326965|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
127919441|NCT01567527|460326961|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
127919442|NCT01567527|460326962|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
127919443|NCT01567527|460326963|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
127919444|NCT01567527|460326964|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
127919445|NCT01567527|460326965|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
127919446|NCT01567527|460326961|FG000|IM Depot Stabilization.|Adverse Event|0|||
127919447|NCT01567527|460326962|FG001|IM Depot Stabilization.|Adverse Event|0|||
127919448|NCT01567527|460326963|FG002|IM Depot Stabilization.|Adverse Event|37|||
127919449|NCT01567527|460326964|FG003|IM Depot Stabilization.|Adverse Event|0|||
127919450|NCT01567527|460326965|FG004|IM Depot Stabilization.|Adverse Event|0|||
127919451|NCT01567527|460326961|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
127919452|NCT01567527|460326962|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
127919453|NCT01567527|460326963|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
127919454|NCT01567527|460326964|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
127919455|NCT01567527|460326965|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
127919456|NCT01567527|460326961|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
127919457|NCT01567527|460326962|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
127919458|NCT01567527|460326963|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
127919459|NCT01567527|460326964|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
127919460|NCT01567527|460326965|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
127919461|NCT01567527|460326961|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
127919462|NCT01567527|460326962|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
127919463|NCT01567527|460326963|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
127919464|NCT01567527|460326964|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
127919465|NCT01567527|460326965|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
127919466|NCT01567527|460326961|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
127919467|NCT01567527|460326962|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
127919468|NCT01567527|460326963|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
127919469|NCT01567527|460326964|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
127919470|NCT01567527|460326965|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
127919471|NCT01567527|460326961|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
127919472|NCT01567527|460326962|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
127919473|NCT01567527|460326963|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
127919474|NCT01567527|460326964|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
127919475|NCT01567527|460326965|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
127919476|NCT01567527|460326961|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
127919477|NCT01567527|460326962|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
127919478|NCT01567527|460326963|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
127919479|NCT01567527|460326964|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
127919480|NCT01567527|460326965|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
127919481|NCT01567527|460326961|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
127919482|NCT01567527|460326962|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
127919483|NCT01567527|460326963|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
127919484|NCT01567527|460326964|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
127919485|NCT01567527|460326965|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
127919486|NCT01567527|460326961|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
127919487|NCT01567527|460326962|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
127919488|NCT01567527|460326963|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
127919489|NCT01567527|460326964|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
127919490|NCT01567527|460326965|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
127919491|NCT01567527|460326961|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
127919492|NCT01567527|460326962|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
127919493|NCT01567527|460326963|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
127919494|NCT01567527|460326964|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
127919495|NCT01567527|460326965|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
127919496|NCT02004691|460326966|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
127919497|NCT02004691|460326967|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
127919498|NCT02004691|460326966|FG000|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|1|||
127919499|NCT02004691|460326967|FG001|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|0|||
127919500|NCT02004691|460326966|FG000|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
127919501|NCT02004691|460326967|FG001|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
127919502|NCT02004691|460326966|FG000|ETP: From Week 52 up to 5 Years|Pregnancy|1|||
127919503|NCT02004691|460326967|FG001|ETP: From Week 52 up to 5 Years|Pregnancy|0|||
127919504|NCT02004691|460326966|FG000|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|1|||
127919505|NCT02004691|460326967|FG001|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|0|||
127919506|NCT02004691|460326966|FG000|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|0|||
127919507|NCT02004691|460326967|FG001|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|1|||
127919508|NCT02623218|460326968|FG000|Overall Study|Lost to Follow-up|0|||
127919509|NCT02623218|460326969|FG001|Overall Study|Lost to Follow-up|1|||
127919510|NCT02623218|460326970|FG002|Overall Study|Lost to Follow-up|0|||
127919511|NCT02623218|460326971|FG003|Overall Study|Lost to Follow-up|0|||
127919512|NCT02623218|460326972|FG004|Overall Study|Lost to Follow-up|0|||
127919513|NCT01726803|460326973|FG000|Overall Study|Lost to Follow-up|6|||
127919514|NCT01726803|460326974|FG001|Overall Study|Lost to Follow-up|1|||
127919515|NCT01726803|460326973|FG000|Overall Study|Withdrawal by Subject|1|||
127919516|NCT01726803|460326974|FG001|Overall Study|Withdrawal by Subject|0|||
127919517|NCT01320722|460326976|FG000|Overall Study|Did not Receive Intervention|3|||
127919518|NCT01320722|460326977|FG001|Overall Study|Did not Receive Intervention|2|||
127919519|NCT01320722|460326978|FG002|Overall Study|Did not Receive Intervention|1|||
127919520|NCT01320722|460326979|FG003|Overall Study|Did not Receive Intervention|1|||
127919521|NCT01320722|460326980|FG004|Overall Study|Did not Receive Intervention|2|||
127919522|NCT01320722|460326976|FG000|Overall Study|Lost to Follow-up|0|||
127919523|NCT01320722|460326977|FG001|Overall Study|Lost to Follow-up|1|||
127919524|NCT01320722|460326978|FG002|Overall Study|Lost to Follow-up|0|||
127919525|NCT01320722|460326979|FG003|Overall Study|Lost to Follow-up|1|||
127919526|NCT01320722|460326980|FG004|Overall Study|Lost to Follow-up|3|||
127919527|NCT01320722|460326976|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
127919528|NCT01320722|460326977|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
127919529|NCT01320722|460326978|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
127919530|NCT01320722|460326979|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
127919531|NCT01320722|460326980|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
127919532|NCT01320722|460326976|FG000|Overall Study|Participant Developed a Rash|0|||
127919533|NCT01320722|460326977|FG001|Overall Study|Participant Developed a Rash|0|||
127919534|NCT01320722|460326978|FG002|Overall Study|Participant Developed a Rash|2|||
127919535|NCT01320722|460326979|FG003|Overall Study|Participant Developed a Rash|1|||
127919536|NCT01320722|460326980|FG004|Overall Study|Participant Developed a Rash|1|||
127919537|NCT01320722|460326976|FG000|Overall Study|Non-compliant with Medication|0|||
127919538|NCT01320722|460326977|FG001|Overall Study|Non-compliant with Medication|0|||
127919539|NCT01320722|460326978|FG002|Overall Study|Non-compliant with Medication|1|||
127919540|NCT01320722|460326979|FG003|Overall Study|Non-compliant with Medication|0|||
127919541|NCT01320722|460326980|FG004|Overall Study|Non-compliant with Medication|0|||
127919542|NCT01320722|460326976|FG000|Overall Study|Adverse Event|0|||
127919543|NCT01320722|460326977|FG001|Overall Study|Adverse Event|0|||
127919544|NCT01320722|460326978|FG002|Overall Study|Adverse Event|3|||
127919545|NCT01320722|460326979|FG003|Overall Study|Adverse Event|6|||
127919546|NCT01320722|460326980|FG004|Overall Study|Adverse Event|0|||
127919547|NCT01320722|460326976|FG000|Overall Study|Not Compliant with Study Procedures|0|||
127919548|NCT01320722|460326977|FG001|Overall Study|Not Compliant with Study Procedures|0|||
127919549|NCT01320722|460326978|FG002|Overall Study|Not Compliant with Study Procedures|0|||
127919550|NCT01320722|460326979|FG003|Overall Study|Not Compliant with Study Procedures|4|||
127919551|NCT01320722|460326980|FG004|Overall Study|Not Compliant with Study Procedures|0|||
127919552|NCT01320722|460326976|FG000|Overall Study|Pregnancy|0|||
127919553|NCT01320722|460326977|FG001|Overall Study|Pregnancy|0|||
127919554|NCT01320722|460326978|FG002|Overall Study|Pregnancy|0|||
127919555|NCT01320722|460326979|FG003|Overall Study|Pregnancy|1|||
127919556|NCT01320722|460326980|FG004|Overall Study|Pregnancy|0|||
127919557|NCT01320722|460326976|FG000|Overall Study|Started an Exclusionary Medication|0|||
127919558|NCT01320722|460326977|FG001|Overall Study|Started an Exclusionary Medication|0|||
127919559|NCT01320722|460326978|FG002|Overall Study|Started an Exclusionary Medication|0|||
127919560|NCT01320722|460326979|FG003|Overall Study|Started an Exclusionary Medication|0|||
127919561|NCT01320722|460326980|FG004|Overall Study|Started an Exclusionary Medication|1|||
127919562|NCT01320722|460326976|FG000|Overall Study|Withdrew due to Health Condition|0|||
127919563|NCT01320722|460326977|FG001|Overall Study|Withdrew due to Health Condition|0|||
127919564|NCT01320722|460326978|FG002|Overall Study|Withdrew due to Health Condition|0|||
127919565|NCT01320722|460326979|FG003|Overall Study|Withdrew due to Health Condition|0|||
127919566|NCT01320722|460326980|FG004|Overall Study|Withdrew due to Health Condition|1|||
127919567|NCT02616380|460326993|FG000|Overall Study|Lost to Follow-up|1|||
127919568|NCT02616380|460326993|FG000|Overall Study|Other|2|||
127919569|NCT00057941|460326994|FG000|Overall Study|Death|1|||
127919570|NCT00057941|460326995|FG001|Overall Study|Death|2|||
127919571|NCT00057941|460326994|FG000|Overall Study|Adverse Event|7|||
127919572|NCT00057941|460326995|FG001|Overall Study|Adverse Event|9|||
127919573|NCT00057941|460326994|FG000|Overall Study|Lack of Efficacy|54|||
127919574|NCT00057941|460326995|FG001|Overall Study|Lack of Efficacy|53|||
127919575|NCT00057941|460326994|FG000|Overall Study|Withdrawal by Subject|6|||
127919576|NCT00057941|460326995|FG001|Overall Study|Withdrawal by Subject|1|||
127919577|NCT00057941|460326994|FG000|Overall Study|still on treatment|3|||
127919578|NCT00057941|460326995|FG001|Overall Study|still on treatment|1|||
127919579|NCT00057941|460326994|FG000|Overall Study|insurance, symptomatic deterioration|1|||
127919580|NCT00057941|460326995|FG001|Overall Study|insurance, symptomatic deterioration|3|||
127919581|NCT00057941|460326994|FG000|Overall Study|Ineligible|2|||
127919582|NCT00057941|460326995|FG001|Overall Study|Ineligible|5|||
127919583|NCT03407729|460326996|FG000|Overall Study|Lost to Follow-up|2|||
127919584|NCT03407729|460326997|FG001|Overall Study|Lost to Follow-up|0|||
127919585|NCT03407729|460326996|FG000|Overall Study|Unable to schedule|0|||
127919586|NCT03407729|460326997|FG001|Overall Study|Unable to schedule|3|||
127919587|NCT03950674|460326998|FG000|Overall Study|Death|16|||
127919588|NCT03950674|460326999|FG001|Overall Study|Death|15|||
127919589|NCT03950674|460326998|FG000|Overall Study|Participation in the study terminated by the sponsor|9|||
127919590|NCT03950674|460326999|FG001|Overall Study|Participation in the study terminated by the sponsor|0|||
127919591|NCT00830167|460327002|FG000|Overall Study|Lack of Efficacy|26|||
127919592|NCT00830167|460327003|FG001|Overall Study|Lack of Efficacy|10|||
127919593|NCT00830167|460327002|FG000|Overall Study|Adverse Event|8|||
127919594|NCT00830167|460327003|FG001|Overall Study|Adverse Event|24|||
127919595|NCT00830167|460327002|FG000|Overall Study|Not meeting entrance criteria|2|||
127919596|NCT00830167|460327003|FG001|Overall Study|Not meeting entrance criteria|5|||
127919597|NCT00830167|460327002|FG000|Overall Study|Withdrawal by Subject|2|||
127919598|NCT00830167|460327003|FG001|Overall Study|Withdrawal by Subject|0|||
127919599|NCT00830167|460327002|FG000|Overall Study|Lost to Follow-up|0|||
127919600|NCT00830167|460327003|FG001|Overall Study|Lost to Follow-up|1|||
127919601|NCT00830167|460327002|FG000|Overall Study|Protocol Violation|0|||
127919602|NCT00830167|460327003|FG001|Overall Study|Protocol Violation|1|||
127919603|NCT00830167|460327002|FG000|Overall Study|Other|2|||
127919604|NCT00830167|460327003|FG001|Overall Study|Other|2|||
127919605|NCT00860262|460327006|FG000|Overall Study|Adverse Event|9|||
127919606|NCT00860262|460327007|FG001|Overall Study|Adverse Event|6|||
127919607|NCT00860262|460327008|FG002|Overall Study|Adverse Event|7|||
127919608|NCT00860262|460327006|FG000|Overall Study|Protocol Violation|0|||
127919609|NCT00860262|460327007|FG001|Overall Study|Protocol Violation|1|||
127919610|NCT00860262|460327008|FG002|Overall Study|Protocol Violation|0|||
127919611|NCT00860262|460327006|FG000|Overall Study|Lost to Follow-up|2|||
127919612|NCT00860262|460327007|FG001|Overall Study|Lost to Follow-up|0|||
127919613|NCT00860262|460327008|FG002|Overall Study|Lost to Follow-up|1|||
127919614|NCT00860262|460327006|FG000|Overall Study|Withdrawal by Subject|4|||
127919615|NCT00860262|460327007|FG001|Overall Study|Withdrawal by Subject|8|||
127919616|NCT00860262|460327008|FG002|Overall Study|Withdrawal by Subject|6|||
127919617|NCT00860262|460327006|FG000|Overall Study|Lack of Efficacy|0|||
127919618|NCT00860262|460327007|FG001|Overall Study|Lack of Efficacy|4|||
127919619|NCT00860262|460327008|FG002|Overall Study|Lack of Efficacy|3|||
127919620|NCT00860262|460327006|FG000|Overall Study|Other|5|||
127919621|NCT00860262|460327007|FG001|Overall Study|Other|3|||
127919622|NCT00860262|460327008|FG002|Overall Study|Other|1|||
127919623|NCT00124618|460327009|FG000|Overall Study|Ineligible|1|||
127919624|NCT01223027|460327010|FG000|Overall Study|Adverse Event|20|||
127919625|NCT01223027|460327011|FG001|Overall Study|Adverse Event|10|||
127919626|NCT01223027|460327010|FG000|Overall Study|Death|42|||
127919627|NCT01223027|460327011|FG001|Overall Study|Death|42|||
127919628|NCT01223027|460327010|FG000|Overall Study|Lost to Follow-up|2|||
127919629|NCT01223027|460327011|FG001|Overall Study|Lost to Follow-up|1|||
127919630|NCT01223027|460327010|FG000|Overall Study|Physician Decision|4|||
127919631|NCT01223027|460327011|FG001|Overall Study|Physician Decision|8|||
127919632|NCT01223027|460327010|FG000|Overall Study|Progressive Disease|167|||
127919633|NCT01223027|460327011|FG001|Overall Study|Progressive Disease|183|||
127919634|NCT01223027|460327010|FG000|Overall Study|Protocol Violation|2|||
127919635|NCT01223027|460327011|FG001|Overall Study|Protocol Violation|1|||
127919636|NCT01223027|460327010|FG000|Overall Study|Subject/guardian decicion|18|||
127919637|NCT01223027|460327011|FG001|Overall Study|Subject/guardian decicion|16|||
127919638|NCT01223027|460327010|FG000|Overall Study|New therapy for study indication|17|||
127919639|NCT01223027|460327011|FG001|Overall Study|New therapy for study indication|8|||
127919640|NCT01223027|460327010|FG000|Overall Study|Study terminated by sponsor|2|||
127919641|NCT01223027|460327011|FG001|Overall Study|Study terminated by sponsor|8|||
127919642|NCT00724958|460327012|FG000|Overall Study|Adverse Event|28|||
127919643|NCT00724958|460327012|FG000|Overall Study|Loss of Response|40|||
127919644|NCT00724958|460327012|FG000|Overall Study|No Response|18|||
127919645|NCT00724958|460327012|FG000|Overall Study|Remission|7|||
127919646|NCT00724958|460327012|FG000|Overall Study|Other Reason|76|||
127919647|NCT00724958|460327012|FG000|Overall Study|No documentation for end of therapy|13|||
127919648|NCT01520987|460328650|FG000|Overall Study|Withdrawal by Subject|1|||
127919649|NCT01520987|460328651|FG001|Overall Study|Withdrawal by Subject|0|||
127919650|NCT01520987|460328652|FG002|Overall Study|Withdrawal by Subject|0|||
127919651|NCT01520987|460328653|FG003|Overall Study|Withdrawal by Subject|0|||
127919652|NCT01520987|460328654|FG004|Overall Study|Withdrawal by Subject|0|||
127919653|NCT01520987|460328655|FG005|Overall Study|Withdrawal by Subject|1|||
127919654|NCT01520987|460328656|FG006|Overall Study|Withdrawal by Subject|0|||
127919655|NCT01520987|460328657|FG007|Overall Study|Withdrawal by Subject|0|||
127919656|NCT02005562|460328658|FG000|Overall Study|Death|2|||
127919657|NCT02005562|460328659|FG001|Overall Study|Death|2|||
127919658|NCT02005562|460328658|FG000|Overall Study|Graft loss|7|||
127919659|NCT02005562|460328659|FG001|Overall Study|Graft loss|6|||
127919660|NCT02005562|460328658|FG000|Overall Study|Withdrawal by Subject|2|||
127919661|NCT02005562|460328659|FG001|Overall Study|Withdrawal by Subject|2|||
127919662|NCT02005562|460328658|FG000|Overall Study|No transplant|1|||
127919663|NCT02005562|460328659|FG001|Overall Study|No transplant|4|||
127919664|NCT02005562|460328658|FG000|Overall Study|Physician Decision|0|||
127919665|NCT02005562|460328659|FG001|Overall Study|Physician Decision|1|||
127919666|NCT04729101|460328660|FG000|Overall Study|Adverse Event|1|||
127919667|NCT04729101|460328661|FG001|Overall Study|Adverse Event|0|||
127919668|NCT04729101|460328660|FG000|Overall Study|Physician Decision|1|||
127919669|NCT04729101|460328661|FG001|Overall Study|Physician Decision|0|||
127919670|NCT04729101|460328660|FG000|Overall Study|Withdrawal by Subject|1|||
127919671|NCT04729101|460328661|FG001|Overall Study|Withdrawal by Subject|0|||
127919672|NCT00274625|460328662|FG000|Overall Study|Lost to Follow-up|46|||
127919673|NCT00274625|460328663|FG001|Overall Study|Lost to Follow-up|54|||
127919674|NCT00274625|460328662|FG000|Overall Study|Excluded from analysis|14|||
127919675|NCT00274625|460328663|FG001|Overall Study|Excluded from analysis|8|||
127919676|NCT02940522|460328664|FG000|Overall Study|Lost to Follow-up|1|||
127919677|NCT02940522|460328665|FG001|Overall Study|Lost to Follow-up|2|||
127919678|NCT02940522|460328664|FG000|Overall Study|Withdrawal by Subject|1|||
127919679|NCT02940522|460328665|FG001|Overall Study|Withdrawal by Subject|0|||
127919680|NCT01754376|460328669|FG000|Overall Study|Adverse Event|1|||
127919681|NCT01754376|460328669|FG000|Overall Study|Lack of Efficacy|2|||
127919682|NCT04590781|460328670|FG000|Overall Study|Death|0|||
127919683|NCT04590781|460328671|FG001|Overall Study|Death|2|||
127919684|NCT04590781|460328670|FG000|Overall Study|Withdrawal by Subject|2|||
127919685|NCT04590781|460328671|FG001|Overall Study|Withdrawal by Subject|0|||
127919686|NCT04264819|460328673|FG000|Overall Study|Physician Decision|19|||
127919687|NCT04264819|460328673|FG000|Overall Study|Adverse Event|12|||
127919688|NCT04264819|460328673|FG000|Overall Study|Withdrawal by Subject|11|||
127919689|NCT04264819|460328673|FG000|Overall Study|Lost to Follow-up|2|||
127919690|NCT04264819|460328673|FG000|Overall Study|Death|2|||
127919691|NCT04768296|460328675|FG000|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|1|||
127919692|NCT04768296|460328676|FG001|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|7|||
127919693|NCT03087786|460328679|FG000|Overall Study|Withdrawal by Subject|2|||
127919694|NCT03087786|460328680|FG001|Overall Study|Withdrawal by Subject|0|||
127919695|NCT01453153|460328685|FG000|Overall Study|Physician Decision|0|||
127919696|NCT01453153|460328686|FG001|Overall Study|Physician Decision|0|||
127919697|NCT01453153|460328687|FG002|Overall Study|Physician Decision|1|||
127919698|NCT01453153|460328685|FG000|Overall Study|Progressive Disease|3|||
127919699|NCT01453153|460328686|FG001|Overall Study|Progressive Disease|2|||
127919700|NCT01453153|460328687|FG002|Overall Study|Progressive Disease|16|||
127919701|NCT01453153|460328685|FG000|Overall Study|Withdrawal by Subject|0|||
127919702|NCT01453153|460328686|FG001|Overall Study|Withdrawal by Subject|1|||
127919703|NCT01453153|460328687|FG002|Overall Study|Withdrawal by Subject|2|||
127919704|NCT01453153|460328685|FG000|Overall Study|Adverse Event|1|||
127919705|NCT01453153|460328686|FG001|Overall Study|Adverse Event|1|||
127919706|NCT01453153|460328687|FG002|Overall Study|Adverse Event|1|||
127919707|NCT01802216|460328692|FG000|4 Month Visit|Participant did not show to visit|3|||
127919708|NCT01802216|460328693|FG001|4 Month Visit|Participant did not show to visit|4|||
127919709|NCT01802216|460328692|FG000|8 Month Visit|Participant did not show to visit|3|||
127919710|NCT01802216|460328693|FG001|8 Month Visit|Participant did not show to visit|5|||
127919711|NCT01802216|460328692|FG000|12 Month Visit|Participant did not show to visit|3|||
127919712|NCT01802216|460328693|FG001|12 Month Visit|Participant did not show to visit|4|||
127919713|NCT00799708|460328694|FG000|Overall Study|non-compliance|1|||
127919714|NCT00799708|460328695|FG001|Overall Study|non-compliance|0|||
127919715|NCT00799708|460328696|FG002|Overall Study|non-compliance|0|||
127919716|NCT00880334|460328697|FG000|Randomized Phase|Physician Decision|1|||
127919717|NCT00880334|460328698|FG001|Randomized Phase|Physician Decision|0|||
127919718|NCT00880334|460328697|FG000|Randomized Phase|Withdrawal by Subject|2|||
127919719|NCT00880334|460328698|FG001|Randomized Phase|Withdrawal by Subject|1|||
127919720|NCT00880334|460328697|FG000|Randomized Phase|Inadequate Labs|1|||
127919721|NCT00880334|460328698|FG001|Randomized Phase|Inadequate Labs|1|||
127919722|NCT00880334|460328697|FG000|Randomized Phase|Brain Metastasis|0|||
127919723|NCT00880334|460328698|FG001|Randomized Phase|Brain Metastasis|1|||
127919724|NCT00880334|460328697|FG000|Randomized Phase|Crossover Participants|0|||
127919725|NCT00880334|460328698|FG001|Randomized Phase|Crossover Participants|37|||
127919726|NCT03343639|460328699|FG000|Overall Study|Withdrawal by Subject|10|||
127919727|NCT03343639|460328700|FG001|Overall Study|Withdrawal by Subject|6|||
127919728|NCT03343639|460328699|FG000|Overall Study|Lost to Follow-up|4|||
127919729|NCT03343639|460328700|FG001|Overall Study|Lost to Follow-up|5|||
127919730|NCT03343639|460328699|FG000|Overall Study|Protocol Violation|0|||
127919731|NCT03343639|460328700|FG001|Overall Study|Protocol Violation|1|||
127919732|NCT05393271|460328708|FG000|Overall Study|Physician Decision|0|||
127919733|NCT05393271|460328709|FG001|Overall Study|Physician Decision|0|||
127919734|NCT05393271|460328710|FG002|Overall Study|Physician Decision|0|||
127919735|NCT05393271|460328711|FG003|Overall Study|Physician Decision|0|||
127919736|NCT05393271|460328712|FG004|Overall Study|Physician Decision|0|||
127919737|NCT05393271|460328713|FG005|Overall Study|Physician Decision|0|||
127919738|NCT05393271|460328714|FG006|Overall Study|Physician Decision|1|||
127919739|NCT05393271|460328715|FG007|Overall Study|Physician Decision|0|||
127919740|NCT05393271|460328716|FG008|Overall Study|Physician Decision|0|||
127919741|NCT05393271|460328717|FG009|Overall Study|Physician Decision|0|||
127919742|NCT05393271|460328718|FG010|Overall Study|Physician Decision|0|||
127919743|NCT02483416|460328719|FG000|Overall Study|Other reason|0|||
127919744|NCT02483416|460328720|FG001|Overall Study|Other reason|1|||
127919745|NCT02483416|460328719|FG000|Overall Study|Treatment stop|3|||
127919746|NCT02483416|460328720|FG001|Overall Study|Treatment stop|0|||
127919747|NCT04968925|460328721|FG000|Phase I- Period 1|COVID-19 related|0|||
127919748|NCT04968925|460328722|FG001|Phase I- Period 1|COVID-19 related|1|||
127919749|NCT04968925|460328723|FG002|Phase I- Period 1|COVID-19 related|0|||
127919750|NCT04968925|460328724|FG003|Phase I- Period 1|COVID-19 related|0|||
127919751|NCT04968925|460328721|FG000|Phase I- Period 1|Subject enrolled in error|1|||
127919752|NCT04968925|460328722|FG001|Phase I- Period 1|Subject enrolled in error|1|||
127919753|NCT04968925|460328723|FG002|Phase I- Period 1|Subject enrolled in error|0|||
127919754|NCT04968925|460328724|FG003|Phase I- Period 1|Subject enrolled in error|0|||
127919755|NCT04968925|460328721|FG000|Phase II- Period 1|COVID-19 Related|0|||
127919756|NCT04968925|460328722|FG001|Phase II- Period 1|COVID-19 Related|0|||
127919757|NCT04968925|460328723|FG002|Phase II- Period 1|COVID-19 Related|6|||
127919758|NCT04968925|460328724|FG003|Phase II- Period 1|COVID-19 Related|6|||
127919759|NCT04968925|460328721|FG000|Phase II- Period 1|Subject enrolled in error|0|||
127919760|NCT04968925|460328722|FG001|Phase II- Period 1|Subject enrolled in error|0|||
127919761|NCT04968925|460328723|FG002|Phase II- Period 1|Subject enrolled in error|1|||
127919762|NCT04968925|460328724|FG003|Phase II- Period 1|Subject enrolled in error|0|||
127919763|NCT04968925|460328721|FG000|Phase II -Period 2|COVID-19 related|0|||
127919764|NCT04968925|460328722|FG001|Phase II -Period 2|COVID-19 related|0|||
127919765|NCT04968925|460328723|FG002|Phase II -Period 2|COVID-19 related|4|||
127919766|NCT04968925|460328724|FG003|Phase II -Period 2|COVID-19 related|3|||
127919767|NCT04968925|460328721|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
127919768|NCT04968925|460328722|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
127919769|NCT04968925|460328723|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
127919770|NCT04968925|460328724|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
127919771|NCT00876265|460328729|FG000|Overall Study|Miscellaneous reasons|4|||
127919772|NCT00876265|460328729|FG000|Overall Study|Lost to Follow-up|6|||
127919773|NCT00876265|460328729|FG000|Overall Study|Withdrawal by Subject|2|||
127919774|NCT00487695|460328730|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
127919775|NCT00487695|460328731|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
127919776|NCT00487695|460328730|FG000|First Procedure|active wheezing (did not have procedure)|1|||
127919777|NCT00487695|460328731|FG001|First Procedure|active wheezing (did not have procedure)|0|||
127919778|NCT00487695|460328730|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
127919779|NCT00487695|460328731|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
127919780|NCT00487695|460328730|FG000|Second Procedure|active wheezing|0|||
127919781|NCT00487695|460328731|FG001|Second Procedure|active wheezing|1|||
127919782|NCT00487695|460328730|FG000|Second Procedure|Withdrawal by Subject|1|||
127919783|NCT00487695|460328731|FG001|Second Procedure|Withdrawal by Subject|2|||
127919784|NCT03433703|460328732|FG000|Overall Study|Study terminated by Sponsor|2|||
127919785|NCT01957150|460328733|FG000|Overall Study|Adverse Event|23|||
127919786|NCT01957150|460328734|FG001|Overall Study|Adverse Event|20|||
127919787|NCT01957150|460328733|FG000|Overall Study|Withdrawal by Subject|13|||
127919788|NCT01957150|460328734|FG001|Overall Study|Withdrawal by Subject|17|||
127919789|NCT01957150|460328733|FG000|Overall Study|Physician Decision|3|||
127919790|NCT01957150|460328734|FG001|Overall Study|Physician Decision|6|||
127919791|NCT01957150|460328733|FG000|Overall Study|Lost to Follow-up|4|||
127919792|NCT01957150|460328734|FG001|Overall Study|Lost to Follow-up|4|||
127919793|NCT01957150|460328733|FG000|Overall Study|Protocol Violation|1|||
127919794|NCT01957150|460328734|FG001|Overall Study|Protocol Violation|0|||
127919795|NCT01957150|460328733|FG000|Overall Study|Lack of Efficacy|11|||
127919796|NCT01957150|460328734|FG001|Overall Study|Lack of Efficacy|11|||
127919797|NCT01745094|460328741|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
127919798|NCT01745094|460328742|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
127919799|NCT01745094|460328743|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
127919800|NCT01745094|460328744|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
127919801|NCT01745094|460328741|FG000|Overall Study|Adverse Event|0|||
127919802|NCT01745094|460328742|FG001|Overall Study|Adverse Event|0|||
127919803|NCT01745094|460328743|FG002|Overall Study|Adverse Event|3|||
127919804|NCT01745094|460328744|FG003|Overall Study|Adverse Event|0|||
127919805|NCT01745094|460328741|FG000|Overall Study|Withdrawal by Subject|2|||
127919806|NCT01745094|460328742|FG001|Overall Study|Withdrawal by Subject|0|||
127919807|NCT01745094|460328743|FG002|Overall Study|Withdrawal by Subject|1|||
127919808|NCT01745094|460328744|FG003|Overall Study|Withdrawal by Subject|2|||
127919809|NCT01745094|460328741|FG000|Overall Study|Protocol Violation|1|||
127919810|NCT01745094|460328742|FG001|Overall Study|Protocol Violation|0|||
127919811|NCT01745094|460328743|FG002|Overall Study|Protocol Violation|3|||
127919812|NCT01745094|460328744|FG003|Overall Study|Protocol Violation|1|||
127919813|NCT01745094|460328741|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
127919814|NCT01745094|460328742|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
127919815|NCT01745094|460328743|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
127919816|NCT01745094|460328744|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
127919817|NCT01745094|460328741|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
127919818|NCT01745094|460328742|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
127919819|NCT01745094|460328743|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
127919820|NCT01745094|460328744|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
127919821|NCT01745094|460328741|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
127919822|NCT01745094|460328742|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
127919823|NCT01745094|460328743|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
127919824|NCT01745094|460328744|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
127919825|NCT03414034|460328745|FG000|Overall Study|Adverse Event|6|||
127919826|NCT03414034|460328746|FG001|Overall Study|Adverse Event|1|||
127919827|NCT03414034|460328747|FG002|Overall Study|Adverse Event|1|||
127919828|NCT03414034|460328745|FG000|Overall Study|Death|0|||
127919829|NCT03414034|460328746|FG001|Overall Study|Death|0|||
127919830|NCT03414034|460328747|FG002|Overall Study|Death|1|||
127919831|NCT03414034|460328745|FG000|Overall Study|Non-compliance With Study Drug|0|||
127919832|NCT03414034|460328746|FG001|Overall Study|Non-compliance With Study Drug|0|||
127919833|NCT03414034|460328747|FG002|Overall Study|Non-compliance With Study Drug|1|||
127919834|NCT03414034|460328745|FG000|Overall Study|Physician Decision|1|||
127919835|NCT03414034|460328746|FG001|Overall Study|Physician Decision|3|||
127919836|NCT03414034|460328747|FG002|Overall Study|Physician Decision|2|||
127919837|NCT03414034|460328745|FG000|Overall Study|Withdrawal of Informed Consent|2|||
127919838|NCT03414034|460328746|FG001|Overall Study|Withdrawal of Informed Consent|1|||
127919839|NCT03414034|460328747|FG002|Overall Study|Withdrawal of Informed Consent|4|||
127919840|NCT03414034|460328745|FG000|Overall Study|Progressive Disease|15|||
127919841|NCT03414034|460328746|FG001|Overall Study|Progressive Disease|15|||
127919842|NCT03414034|460328747|FG002|Overall Study|Progressive Disease|17|||
127919843|NCT03414034|460328745|FG000|Overall Study|Miscellaneous|0|||
127919844|NCT03414034|460328746|FG001|Overall Study|Miscellaneous|0|||
127919845|NCT03414034|460328747|FG002|Overall Study|Miscellaneous|2|||
127919846|NCT04010227|460328749|FG000|Overall Study|Death|1|||
127919847|NCT04010227|460328750|FG001|Overall Study|Death|2|||
127919848|NCT04010227|460328749|FG000|Overall Study|Medical Reasons|4|||
127919849|NCT04010227|460328750|FG001|Overall Study|Medical Reasons|3|||
127919850|NCT04010227|460328749|FG000|Overall Study|Withdrawal by Subject|2|||
127919851|NCT04010227|460328750|FG001|Overall Study|Withdrawal by Subject|0|||
127919852|NCT04010227|460328749|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
127919853|NCT04010227|460328750|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
127919854|NCT01841073|460328751|FG000|Overall Study|Adverse Event|1|||
127919855|NCT01841073|460328752|FG001|Overall Study|Adverse Event|1|||
127919856|NCT01841073|460328751|FG000|Overall Study|Physician Decision|1|||
127919857|NCT01841073|460328752|FG001|Overall Study|Physician Decision|0|||
127919858|NCT01841073|460328751|FG000|Overall Study|Lost to Follow-up|0|||
127919859|NCT01841073|460328752|FG001|Overall Study|Lost to Follow-up|2|||
127919860|NCT01670097|460328753|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
127919861|NCT01670097|460328754|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
127919862|NCT01670097|460328753|FG000|Overall Study|Study burden|1|||
127919863|NCT01670097|460328754|FG001|Overall Study|Study burden|0|||
127919864|NCT01670097|460328753|FG000|Overall Study|COPD exacerbation|0|||
127919865|NCT01670097|460328754|FG001|Overall Study|COPD exacerbation|1|||
127919866|NCT01670097|460328753|FG000|Overall Study|Neutropenia|0|||
127919867|NCT01670097|460328754|FG001|Overall Study|Neutropenia|1|||
127919868|NCT01670097|460328753|FG000|Overall Study|Clinical deterioration|0|||
127919869|NCT01670097|460328754|FG001|Overall Study|Clinical deterioration|1|||
127919870|NCT01670097|460328753|FG000|Overall Study|Disease progression|0|||
127919871|NCT01670097|460328754|FG001|Overall Study|Disease progression|1|||
127919872|NCT00550147|460328757|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
127919873|NCT00550147|460328757|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
127919874|NCT00550147|460328757|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
127919875|NCT00550147|460328757|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
127919876|NCT00550147|460328757|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
127919877|NCT04320745|460328758|FG000|Overall Study|Adverse Event|26|||
127919878|NCT04320745|460328758|FG000|Overall Study|Withdrawal by Subject|4|||
127919879|NCT04320745|460328758|FG000|Overall Study|Lost to Follow-up|12|||
127919880|NCT04320745|460328758|FG000|Overall Study|Protocol Deviation|2|||
127919881|NCT04320745|460328758|FG000|Overall Study|Non-compliance With Study Drug|2|||
127919882|NCT04320745|460328758|FG000|Overall Study|Reason Not Specified|1|||
127919883|NCT01824498|460328759|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
127919884|NCT01824498|460328760|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
127919885|NCT01824498|460328761|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
127919886|NCT01824498|460328762|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
127919887|NCT01824498|460328763|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
127919888|NCT01824498|460328764|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
127919889|NCT01277510|460328765|FG000|Double-blind Phase|Non-compliance|0|||
127919890|NCT01277510|460328766|FG001|Double-blind Phase|Non-compliance|1|||
127919891|NCT01277510|460328765|FG000|Double-blind Phase|Adverse Event|1|||
127919892|NCT01277510|460328766|FG001|Double-blind Phase|Adverse Event|0|||
127919893|NCT01277510|460328765|FG000|Double-blind Phase|Withdrawal by Subject|2|||
127919894|NCT01277510|460328766|FG001|Double-blind Phase|Withdrawal by Subject|0|||
127919895|NCT01277510|460328765|FG000|Double-blind Phase|Administrative decision|7|||
127919896|NCT01277510|460328766|FG001|Double-blind Phase|Administrative decision|9|||
127919897|NCT01277510|460328765|FG000|Double-blind Phase|Death|0|||
127919898|NCT01277510|460328766|FG001|Double-blind Phase|Death|1|||
127919899|NCT01277510|460328765|FG000|Double-blind Phase|Protocol-specified criteria|2|||
127919900|NCT01277510|460328766|FG001|Double-blind Phase|Protocol-specified criteria|6|||
127919901|NCT01277510|460328765|FG000|Double-blind Phase|Other|1|||
127919902|NCT01277510|460328766|FG001|Double-blind Phase|Other|1|||
127919903|NCT01277510|460328765|FG000|Open-label Phase|Administrative decision|4|||
127919904|NCT01277510|460328766|FG001|Open-label Phase|Administrative decision|3|||
127919905|NCT01277510|460328765|FG000|Open-label Phase|Protocol-specified criteria|1|||
127919906|NCT01277510|460328766|FG001|Open-label Phase|Protocol-specified criteria|0|||
127919907|NCT01277510|460328765|FG000|Open-label Phase|Never received investigational product|2|||
127919908|NCT01277510|460328766|FG001|Open-label Phase|Never received investigational product|0|||
127919909|NCT01685008|460328767|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
127919910|NCT01685008|460328768|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
127919911|NCT01685008|460328769|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
127919912|NCT01685008|460328770|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
127919913|NCT01685008|460328767|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
127919914|NCT01685008|460328768|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
127919915|NCT01685008|460328769|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
127919916|NCT01685008|460328770|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
127919917|NCT01685008|460328767|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
127919918|NCT01685008|460328768|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
127919919|NCT01685008|460328769|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
127919920|NCT01685008|460328770|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
127919921|NCT01685008|460328767|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
127919922|NCT01685008|460328768|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
127919923|NCT01685008|460328769|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
127919924|NCT01685008|460328770|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
127919925|NCT01685008|460328767|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
127919926|NCT01685008|460328768|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
127919927|NCT01685008|460328769|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
127919928|NCT01685008|460328770|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
127919929|NCT00160524|460328773|FG000|Overall Study|Adverse Event|119|||
127919930|NCT00160524|460328773|FG000|Overall Study|Adverse Event and Other|94|||
127919931|NCT00160524|460328773|FG000|Overall Study|Protocol Violation|16|||
127919932|NCT00160524|460328773|FG000|Overall Study|Protocol Violation and Other|2|||
127919933|NCT00160524|460328773|FG000|Overall Study|Withdrawal by Subject|141|||
127919934|NCT00160524|460328773|FG000|Overall Study|Withdrawal by Subject and Other|17|||
127919935|NCT00160524|460328773|FG000|Overall Study|Physician Decision|27|||
127919936|NCT00160524|460328773|FG000|Overall Study|Physician Decision and Other|6|||
127919937|NCT00160524|460328773|FG000|Overall Study|Lost to Follow-up|13|||
127919938|NCT00160524|460328773|FG000|Overall Study|Lost to Follow-up and Other|1|||
127919939|NCT00160524|460328773|FG000|Overall Study|Lack of Efficacy|21|||
127919940|NCT00160524|460328773|FG000|Overall Study|Lack of Efficacy and Other|1|||
127919941|NCT00160524|460328773|FG000|Overall Study|Other|20|||
127919942|NCT00609154|460328774|FG000|Overall Study|Protocol Violation|1|||
127919943|NCT00609154|460328775|FG001|Overall Study|Protocol Violation|2|||
127919944|NCT00609154|460328774|FG000|Overall Study|Unable to establish IV access|0|||
127919945|NCT00609154|460328775|FG001|Overall Study|Unable to establish IV access|4|||
127919946|NCT00609154|460328774|FG000|Overall Study|Adverse Event|0|||
127919947|NCT00609154|460328775|FG001|Overall Study|Adverse Event|2|||
127919948|NCT02224053|460328776|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
127919949|NCT02224053|460328776|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
127919950|NCT02224053|460328776|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
127919951|NCT02224053|460328776|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
127919952|NCT02224053|460328776|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
127919953|NCT01898598|460328780|FG000|Overall Study|Adverse Event|1|||
127919954|NCT01898598|460328781|FG001|Overall Study|Adverse Event|0|||
127919955|NCT01898598|460328780|FG000|Overall Study|Withdrawal by Subject|3|||
127919956|NCT01898598|460328781|FG001|Overall Study|Withdrawal by Subject|0|||
127919957|NCT01898598|460328780|FG000|Overall Study|Lost to Follow-up|0|||
127919958|NCT01898598|460328781|FG001|Overall Study|Lost to Follow-up|1|||
127919959|NCT01898598|460328780|FG000|Overall Study|Other|0|||
127919960|NCT01898598|460328781|FG001|Overall Study|Other|1|||
127919961|NCT03833427|460328782|FG000|Overall Study|Death|4|||
127919962|NCT03833427|460328783|FG001|Overall Study|Death|2|||
127919963|NCT03833427|460328784|FG002|Overall Study|Death|9|||
127919964|NCT03833427|460328785|FG003|Overall Study|Death|11|||
127919965|NCT03833427|460328786|FG004|Overall Study|Death|0|||
127919966|NCT03833427|460328787|FG005|Overall Study|Death|0|||
127919967|NCT03833427|460328788|FG006|Overall Study|Death|0|||
127919968|NCT03833427|460328782|FG000|Overall Study|Withdrawal by Subject|0|||
127919969|NCT03833427|460328783|FG001|Overall Study|Withdrawal by Subject|1|||
127919970|NCT03833427|460328784|FG002|Overall Study|Withdrawal by Subject|1|||
127919971|NCT03833427|460328785|FG003|Overall Study|Withdrawal by Subject|0|||
127919972|NCT03833427|460328786|FG004|Overall Study|Withdrawal by Subject|0|||
127919973|NCT03833427|460328787|FG005|Overall Study|Withdrawal by Subject|0|||
127919974|NCT03833427|460328788|FG006|Overall Study|Withdrawal by Subject|0|||
127919975|NCT03833427|460328782|FG000|Overall Study|Sponsor Decision|0|||
127919976|NCT03833427|460328783|FG001|Overall Study|Sponsor Decision|0|||
127919977|NCT03833427|460328784|FG002|Overall Study|Sponsor Decision|1|||
127919978|NCT03833427|460328785|FG003|Overall Study|Sponsor Decision|3|||
127919979|NCT03833427|460328786|FG004|Overall Study|Sponsor Decision|0|||
127919980|NCT03833427|460328787|FG005|Overall Study|Sponsor Decision|0|||
127919981|NCT03833427|460328788|FG006|Overall Study|Sponsor Decision|0|||
127919982|NCT01499160|460328790|FG000|Overall Study|Adverse Event|1|||
127919983|NCT01499160|460328790|FG000|Overall Study|Withdrawal by Subject|1|||
127919984|NCT00593827|460328791|FG000|Overall Study|On Active Treatment/Pending|0|||
127919985|NCT00593827|460328792|FG001|Overall Study|On Active Treatment/Pending|2|||
127919986|NCT01596127|460328793|FG000|Overall Study|Patient Ineligible|1|||
127919987|NCT01675596|460328794|FG000|Overall Study|Death|6|||
127919988|NCT01675596|460328794|FG000|Overall Study|Exit with other reason|1|||
127919989|NCT01675596|460328794|FG000|Overall Study|Missed Visit|1|||
127919990|NCT00633022|460328795|FG000|Overall Study|Adverse Event|1|||
127919991|NCT00633022|460328796|FG001|Overall Study|Adverse Event|0|||
127919992|NCT00633022|460328797|FG002|Overall Study|Adverse Event|5|||
127919993|NCT00633022|460328795|FG000|Overall Study|Physician Decision|0|||
127919994|NCT00633022|460328796|FG001|Overall Study|Physician Decision|1|||
127919995|NCT00633022|460328797|FG002|Overall Study|Physician Decision|0|||
127919996|NCT04388787|460328799|FG000|Blinded Period|Patient could not follow instructions|1|||
127919997|NCT04388787|460328799|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
127919998|NCT00688844|460328800|FG000|Overall Study|Lost to Follow-up|10|||
127919999|NCT01374451|460328801|FG000|Overall Study|Administrative problems|1|||
127920000|NCT01374451|460328802|FG001|Overall Study|Administrative problems|0|||
127920001|NCT02061280|460328803|FG000|Overall Study|Protocol Violation|12|||
127920002|NCT02061280|460328804|FG001|Overall Study|Protocol Violation|8|||
127920003|NCT02061280|460328803|FG000|Overall Study|moved out of state|0|||
127920004|NCT02061280|460328804|FG001|Overall Study|moved out of state|1|||
127920005|NCT02061280|460328803|FG000|Overall Study|Withdrawal by Subject|1|||
127920006|NCT02061280|460328804|FG001|Overall Study|Withdrawal by Subject|2|||
127920007|NCT02061280|460328803|FG000|Overall Study|Lost to Follow-up|5|||
127920008|NCT02061280|460328804|FG001|Overall Study|Lost to Follow-up|1|||
127920009|NCT02710214|460330494|FG000|Overall Study|Lost to Follow-up|1|||
127920010|NCT02710214|460330495|FG001|Overall Study|Lost to Follow-up|0|||
127920011|NCT02710214|460330494|FG000|Overall Study|Lack of Efficacy|0|||
127920012|NCT02710214|460330495|FG001|Overall Study|Lack of Efficacy|1|||
127920013|NCT02710214|460330494|FG000|Overall Study|Death|0|||
127920014|NCT02710214|460330495|FG001|Overall Study|Death|1|||
127920015|NCT01188226|460330499|FG000|Overall Study|Withdrawal by Subject|4|||
127920016|NCT02846883|460330500|FG000|Overall Study|Death|0|||
127920017|NCT02846883|460330501|FG001|Overall Study|Death|1|||
127920018|NCT02846883|460330502|FG002|Overall Study|Death|1|||
127920019|NCT02846883|460330500|FG000|Overall Study|Lost to Follow-up|0|||
127920020|NCT02846883|460330501|FG001|Overall Study|Lost to Follow-up|0|||
127920021|NCT02846883|460330502|FG002|Overall Study|Lost to Follow-up|1|||
127920022|NCT02846883|460330500|FG000|Overall Study|Withdrawal by Subject|1|||
127920023|NCT02846883|460330501|FG001|Overall Study|Withdrawal by Subject|0|||
127920024|NCT02846883|460330502|FG002|Overall Study|Withdrawal by Subject|0|||
127920025|NCT02846883|460330500|FG000|Overall Study|Study terminated by VA DSMB due to low enrollment|5|||
127920026|NCT02846883|460330501|FG001|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
127920027|NCT02846883|460330502|FG002|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
127920028|NCT02846883|460330500|FG000|Overall Study|Primary endpoint - endovascular aortic repair|0|||
127920029|NCT02846883|460330501|FG001|Overall Study|Primary endpoint - endovascular aortic repair|0|||
127920030|NCT02846883|460330502|FG002|Overall Study|Primary endpoint - endovascular aortic repair|1|||
127920031|NCT00927251|460330503|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
127920032|NCT02274558|460330507|FG000|Overall Study|Adverse Event|2|||
127920033|NCT02274558|460330508|FG001|Overall Study|Adverse Event|4|||
127920034|NCT02274558|460330509|FG002|Overall Study|Adverse Event|2|||
127920035|NCT02274558|460330507|FG000|Overall Study|Non-compliance|2|||
127920036|NCT02274558|460330508|FG001|Overall Study|Non-compliance|1|||
127920037|NCT02274558|460330509|FG002|Overall Study|Non-compliance|0|||
127920038|NCT02274558|460330507|FG000|Overall Study|Withdrawal by Subject|1|||
127920039|NCT02274558|460330508|FG001|Overall Study|Withdrawal by Subject|5|||
127920040|NCT02274558|460330509|FG002|Overall Study|Withdrawal by Subject|4|||
127920041|NCT02274558|460330507|FG000|Overall Study|Death|0|||
127920042|NCT02274558|460330508|FG001|Overall Study|Death|0|||
127920043|NCT02274558|460330509|FG002|Overall Study|Death|1|||
127920044|NCT02274558|460330507|FG000|Overall Study|Lost to Follow-up|2|||
127920045|NCT02274558|460330508|FG001|Overall Study|Lost to Follow-up|1|||
127920046|NCT02274558|460330509|FG002|Overall Study|Lost to Follow-up|1|||
127920047|NCT02274558|460330507|FG000|Overall Study|Physician Decision|0|||
127920048|NCT02274558|460330508|FG001|Overall Study|Physician Decision|2|||
127920049|NCT02274558|460330509|FG002|Overall Study|Physician Decision|1|||
127920050|NCT02655224|460330510|FG000|Overall Study|Adverse Event|1|||
127920051|NCT02655224|460330511|FG001|Overall Study|Adverse Event|1|||
127920052|NCT04592419|460330512|FG000|Primary Study (Through Year 1)|Adverse Event|10|||
127920053|NCT04592419|460330513|FG001|Primary Study (Through Year 1)|Adverse Event|3|||
127920054|NCT04592419|460330512|FG000|Primary Study (Through Year 1)|Non-compliance with Study Schedule|0|||
127920055|NCT04592419|460330513|FG001|Primary Study (Through Year 1)|Non-compliance with Study Schedule|1|||
127920056|NCT04592419|460330512|FG000|Primary Study (Through Year 1)|Withdrawal by Subject|7|||
127920057|NCT04592419|460330513|FG001|Primary Study (Through Year 1)|Withdrawal by Subject|13|||
127920058|NCT04592419|460330512|FG000|Primary Study (Through Year 1)|Lost to Follow-up|5|||
127920059|NCT04592419|460330513|FG001|Primary Study (Through Year 1)|Lost to Follow-up|5|||
127920060|NCT04592419|460330512|FG000|Primary Study (Through Year 1)|Progressive Disease|1|||
127920061|NCT04592419|460330513|FG001|Primary Study (Through Year 1)|Progressive Disease|1|||
127920062|NCT04592419|460330512|FG000|Primary Study (Through Year 1)|Sponsor Request|4|||
127920063|NCT04592419|460330513|FG001|Primary Study (Through Year 1)|Sponsor Request|5|||
127920064|NCT04592419|460330512|FG000|Primary Study (Through Year 1)|Participant left the country|2|||
127920065|NCT04592419|460330513|FG001|Primary Study (Through Year 1)|Participant left the country|0|||
127920066|NCT04592419|460330512|FG000|Primary Study (Through Year 1)|Participant moved to another city with no available site|0|||
127920067|NCT04592419|460330513|FG001|Primary Study (Through Year 1)|Participant moved to another city with no available site|1|||
127920068|NCT04592419|460330512|FG000|Open-Label Extension Period|Adverse Event|1|||
127920069|NCT04592419|460330513|FG001|Open-Label Extension Period|Adverse Event|2|||
127920070|NCT04592419|460330512|FG000|Open-Label Extension Period|Non-compliance with Study Schedule|1|||
127920071|NCT04592419|460330513|FG001|Open-Label Extension Period|Non-compliance with Study Schedule|0|||
127920072|NCT04592419|460330512|FG000|Open-Label Extension Period|Withdrawal by Subject|5|||
127920073|NCT04592419|460330513|FG001|Open-Label Extension Period|Withdrawal by Subject|7|||
127920074|NCT04592419|460330512|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
127920075|NCT04592419|460330513|FG001|Open-Label Extension Period|Lost to Follow-up|5|||
127920076|NCT04592419|460330512|FG000|Open-Label Extension Period|Sponsor Request|73|||
127920077|NCT04592419|460330513|FG001|Open-Label Extension Period|Sponsor Request|84|||
127920078|NCT02419573|460330525|FG000|Overall Study|Lost to Follow-up|3|||
127920079|NCT02419573|460330526|FG001|Overall Study|Lost to Follow-up|0|||
127920080|NCT02419573|460330525|FG000|Overall Study|Withdrawal by Subject|1|||
127920081|NCT02419573|460330526|FG001|Overall Study|Withdrawal by Subject|0|||
127920082|NCT02943993|460330541|FG000|Overall Study|Withdrawal by Subject|52|||
127920083|NCT02943993|460330541|FG000|Overall Study|Transfer to another institution|6|||
127920084|NCT02943993|460330541|FG000|Overall Study|Lost to Follow-up|135|||
127920085|NCT02943993|460330541|FG000|Overall Study|Death|98|||
127920086|NCT02943993|460330541|FG000|Overall Study|Other reason for premature termination|32|||
127920087|NCT02943993|460330541|FG000|Overall Study|Missing reason for termination|7|||
127920088|NCT01408888|460330545|FG000|First Intervention|Adverse Event|0|||
127920089|NCT01408888|460330546|FG001|First Intervention|Adverse Event|1|||
127920090|NCT01408888|460330545|FG000|First Intervention|Withdrawal by Subject|0|||
127920091|NCT01408888|460330546|FG001|First Intervention|Withdrawal by Subject|2|||
127920092|NCT01408888|460330545|FG000|Second Intervention|Withdrawal by Subject|1|||
127920093|NCT01408888|460330546|FG001|Second Intervention|Withdrawal by Subject|0|||
127920094|NCT01408888|460330545|FG000|Second Intervention|Adverse Event|1|||
127920095|NCT01408888|460330546|FG001|Second Intervention|Adverse Event|0|||
127920096|NCT00695110|460330547|FG000|Treatment Period 1|Adverse Event|1|||
127920097|NCT00695110|460330547|FG000|Treatment Period 1|Withdrawal by Subject|2|||
127920098|NCT00695110|460330547|FG000|Treatment Period 3|Withdrawal by Subject|1|||
127920099|NCT00695110|460330547|FG000|Treatment Period 4|Adverse Event|1|||
127920100|NCT04542694|460330550|FG000|Overall Study|The need for prohibited therapy|2|||
127920101|NCT04542694|460330551|FG001|Overall Study|The need for prohibited therapy|0|||
127920102|NCT04542694|460330550|FG000|Overall Study|Adverse Event|1|||
127920103|NCT04542694|460330551|FG001|Overall Study|Adverse Event|0|||
127920104|NCT04542694|460330550|FG000|Overall Study|Protocol Violation|1|||
127920105|NCT04542694|460330551|FG001|Overall Study|Protocol Violation|0|||
127920106|NCT00969124|460330556|FG000|Overall Study|Protocol Violation|2|||
127920107|NCT00969124|460330556|FG000|Overall Study|Inadequate bowel preparation|15|||
127920108|NCT00969124|460330556|FG000|Overall Study|Inability to reach cecum|9|||
127920109|NCT00969124|460330556|FG000|Overall Study|Previously unrecognized disease|3|||
127920110|NCT00969124|460330556|FG000|Overall Study|Technical error|1|||
127920111|NCT02167594|460330557|FG000|Overall Study|Withdrawal by Subject|2|||
127920112|NCT02167594|460330558|FG001|Overall Study|Withdrawal by Subject|0|||
127920113|NCT02167594|460330559|FG002|Overall Study|Withdrawal by Subject|0|||
127920114|NCT02167594|460330557|FG000|Overall Study|Death|0|||
127920115|NCT02167594|460330558|FG001|Overall Study|Death|1|||
127920116|NCT02167594|460330559|FG002|Overall Study|Death|0|||
127920117|NCT02786953|460330560|FG000|Overall Study|Withdrawal by Subject|3|||
127920118|NCT02786953|460330561|FG001|Overall Study|Withdrawal by Subject|0|||
127920119|NCT02786953|460330560|FG000|Overall Study|Physician Decision|0|||
127920120|NCT02786953|460330561|FG001|Overall Study|Physician Decision|1|||
127920121|NCT00252564|460330562|FG000|Overall Study|Adverse Event|17|||
127920122|NCT00252564|460330563|FG001|Overall Study|Adverse Event|13|||
127920123|NCT00252564|460330562|FG000|Overall Study|Unrelated Complication|2|||
127920124|NCT00252564|460330563|FG001|Overall Study|Unrelated Complication|1|||
127920125|NCT00252564|460330562|FG000|Overall Study|Disease Progression|14|||
127920126|NCT00252564|460330563|FG001|Overall Study|Disease Progression|20|||
127920127|NCT00252564|460330562|FG000|Overall Study|Death|0|||
127920128|NCT00252564|460330563|FG001|Overall Study|Death|3|||
127920129|NCT00252564|460330562|FG000|Overall Study|Physician Decision|1|||
127920130|NCT00252564|460330563|FG001|Overall Study|Physician Decision|0|||
127920131|NCT00252564|460330562|FG000|Overall Study|Lost to Follow-up|1|||
127920132|NCT00252564|460330563|FG001|Overall Study|Lost to Follow-up|0|||
127920133|NCT00252564|460330562|FG000|Overall Study|Patient Request|4|||
127920134|NCT00252564|460330563|FG001|Overall Study|Patient Request|5|||
127920135|NCT00252564|460330562|FG000|Overall Study|Withdrawal by Subject|0|||
127920136|NCT00252564|460330563|FG001|Overall Study|Withdrawal by Subject|2|||
127920137|NCT04561115|460330565|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
127920138|NCT04561115|460330566|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
127920139|NCT04561115|460330565|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
127920140|NCT04561115|460330566|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
127920141|NCT04561115|460330565|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
127920142|NCT04561115|460330566|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
127920143|NCT00743145|460330567|FG000|Overall Study|Withdrawal by Subject|1|||
127920144|NCT00743145|460330567|FG000|Overall Study|Adverse Event|2|||
127920145|NCT00743145|460330567|FG000|Overall Study|Pregnancy|1|||
127920146|NCT01583530|460330568|FG000|Overall Study|Adverse Event|0|||
127920147|NCT01583530|460330569|FG001|Overall Study|Adverse Event|0|||
127920148|NCT01583530|460330570|FG002|Overall Study|Adverse Event|0|||
127920149|NCT01583530|460330571|FG003|Overall Study|Adverse Event|0|||
127920150|NCT01583530|460330572|FG004|Overall Study|Adverse Event|0|||
127920151|NCT01583530|460330573|FG005|Overall Study|Adverse Event|1|||
127920152|NCT01583530|460330568|FG000|Overall Study|Withdrawal by Subject|0|||
127920153|NCT01583530|460330569|FG001|Overall Study|Withdrawal by Subject|3|||
127920154|NCT01583530|460330570|FG002|Overall Study|Withdrawal by Subject|0|||
127920155|NCT01583530|460330571|FG003|Overall Study|Withdrawal by Subject|1|||
127920156|NCT01583530|460330572|FG004|Overall Study|Withdrawal by Subject|1|||
127920157|NCT01583530|460330573|FG005|Overall Study|Withdrawal by Subject|2|||
127920158|NCT01583530|460330568|FG000|Overall Study|Lost to Follow-up|0|||
127920159|NCT01583530|460330569|FG001|Overall Study|Lost to Follow-up|0|||
127920160|NCT01583530|460330570|FG002|Overall Study|Lost to Follow-up|0|||
127920161|NCT01583530|460330571|FG003|Overall Study|Lost to Follow-up|0|||
127920162|NCT01583530|460330572|FG004|Overall Study|Lost to Follow-up|3|||
127920163|NCT01583530|460330573|FG005|Overall Study|Lost to Follow-up|0|||
127920164|NCT01583530|460330568|FG000|Overall Study|Lack of compliance|0|||
127920165|NCT01583530|460330569|FG001|Overall Study|Lack of compliance|0|||
127920166|NCT01583530|460330570|FG002|Overall Study|Lack of compliance|0|||
127920167|NCT01583530|460330571|FG003|Overall Study|Lack of compliance|0|||
127920168|NCT01583530|460330572|FG004|Overall Study|Lack of compliance|1|||
127920169|NCT01583530|460330573|FG005|Overall Study|Lack of compliance|0|||
127920170|NCT02416180|460330574|FG000|Overall Study|Withdrawal by Subject|1|||
127920171|NCT01332968|460330579|FG000|Induction Period|Adverse Event|23|||
127920172|NCT01332968|460330580|FG001|Induction Period|Adverse Event|26|||
127920173|NCT01332968|460330581|FG002|Induction Period|Adverse Event|0|||
127920174|NCT01332968|460330582|FG003|Induction Period|Adverse Event|0|||
127920175|NCT01332968|460330583|FG004|Induction Period|Adverse Event|0|||
127920176|NCT01332968|460330584|FG005|Induction Period|Adverse Event|0|||
127920177|NCT01332968|460330585|FG006|Induction Period|Adverse Event|0|||
127920178|NCT01332968|460330586|FG007|Induction Period|Adverse Event|0|||
127920179|NCT01332968|460330579|FG000|Induction Period|Death|1|||
127920180|NCT01332968|460330580|FG001|Induction Period|Death|4|||
127920181|NCT01332968|460330581|FG002|Induction Period|Death|0|||
127920182|NCT01332968|460330582|FG003|Induction Period|Death|0|||
127920183|NCT01332968|460330583|FG004|Induction Period|Death|0|||
127920184|NCT01332968|460330584|FG005|Induction Period|Death|0|||
127920185|NCT01332968|460330585|FG006|Induction Period|Death|0|||
127920186|NCT01332968|460330586|FG007|Induction Period|Death|0|||
127920187|NCT01332968|460330579|FG000|Induction Period|Non-compliance|1|||
127920188|NCT01332968|460330580|FG001|Induction Period|Non-compliance|0|||
127920189|NCT01332968|460330581|FG002|Induction Period|Non-compliance|0|||
127920190|NCT01332968|460330582|FG003|Induction Period|Non-compliance|0|||
127920191|NCT01332968|460330583|FG004|Induction Period|Non-compliance|0|||
127920192|NCT01332968|460330584|FG005|Induction Period|Non-compliance|0|||
127920193|NCT01332968|460330585|FG006|Induction Period|Non-compliance|0|||
127920194|NCT01332968|460330586|FG007|Induction Period|Non-compliance|0|||
127920195|NCT01332968|460330579|FG000|Induction Period|Other|2|||
127920196|NCT01332968|460330580|FG001|Induction Period|Other|2|||
127920197|NCT01332968|460330581|FG002|Induction Period|Other|0|||
127920198|NCT01332968|460330582|FG003|Induction Period|Other|0|||
127920199|NCT01332968|460330583|FG004|Induction Period|Other|0|||
127920200|NCT01332968|460330584|FG005|Induction Period|Other|0|||
127920201|NCT01332968|460330585|FG006|Induction Period|Other|0|||
127920202|NCT01332968|460330586|FG007|Induction Period|Other|0|||
127920203|NCT01332968|460330579|FG000|Induction Period|Physician Decision|6|||
127920204|NCT01332968|460330580|FG001|Induction Period|Physician Decision|1|||
127920205|NCT01332968|460330581|FG002|Induction Period|Physician Decision|0|||
127920206|NCT01332968|460330582|FG003|Induction Period|Physician Decision|0|||
127920207|NCT01332968|460330583|FG004|Induction Period|Physician Decision|0|||
127920208|NCT01332968|460330584|FG005|Induction Period|Physician Decision|0|||
127920209|NCT01332968|460330585|FG006|Induction Period|Physician Decision|0|||
127920210|NCT01332968|460330586|FG007|Induction Period|Physician Decision|0|||
127920211|NCT01332968|460330579|FG000|Induction Period|Progressive Disease|15|||
127920212|NCT01332968|460330580|FG001|Induction Period|Progressive Disease|7|||
127920213|NCT01332968|460330581|FG002|Induction Period|Progressive Disease|0|||
127920214|NCT01332968|460330582|FG003|Induction Period|Progressive Disease|0|||
127920215|NCT01332968|460330583|FG004|Induction Period|Progressive Disease|0|||
127920216|NCT01332968|460330584|FG005|Induction Period|Progressive Disease|0|||
127920217|NCT01332968|460330585|FG006|Induction Period|Progressive Disease|0|||
127920218|NCT01332968|460330586|FG007|Induction Period|Progressive Disease|0|||
127920219|NCT01332968|460330579|FG000|Induction Period|Protocol Violation|3|||
127920220|NCT01332968|460330580|FG001|Induction Period|Protocol Violation|4|||
127920221|NCT01332968|460330581|FG002|Induction Period|Protocol Violation|0|||
127920222|NCT01332968|460330582|FG003|Induction Period|Protocol Violation|0|||
127920223|NCT01332968|460330583|FG004|Induction Period|Protocol Violation|0|||
127920224|NCT01332968|460330584|FG005|Induction Period|Protocol Violation|0|||
127920225|NCT01332968|460330585|FG006|Induction Period|Protocol Violation|0|||
127920226|NCT01332968|460330586|FG007|Induction Period|Protocol Violation|0|||
127920227|NCT01332968|460330579|FG000|Induction Period|Withdrawal by Subject|3|||
127920228|NCT01332968|460330580|FG001|Induction Period|Withdrawal by Subject|5|||
127920229|NCT01332968|460330581|FG002|Induction Period|Withdrawal by Subject|0|||
127920230|NCT01332968|460330582|FG003|Induction Period|Withdrawal by Subject|0|||
127920231|NCT01332968|460330583|FG004|Induction Period|Withdrawal by Subject|0|||
127920232|NCT01332968|460330584|FG005|Induction Period|Withdrawal by Subject|0|||
127920233|NCT01332968|460330585|FG006|Induction Period|Withdrawal by Subject|0|||
127920234|NCT01332968|460330586|FG007|Induction Period|Withdrawal by Subject|0|||
127920235|NCT01332968|460330579|FG000|Induction Period|Randomised but not treated|4|||
127920236|NCT01332968|460330580|FG001|Induction Period|Randomised but not treated|7|||
127920237|NCT01332968|460330581|FG002|Induction Period|Randomised but not treated|0|||
127920238|NCT01332968|460330582|FG003|Induction Period|Randomised but not treated|0|||
127920239|NCT01332968|460330583|FG004|Induction Period|Randomised but not treated|0|||
127920240|NCT01332968|460330584|FG005|Induction Period|Randomised but not treated|0|||
127920241|NCT01332968|460330585|FG006|Induction Period|Randomised but not treated|0|||
127920242|NCT01332968|460330586|FG007|Induction Period|Randomised but not treated|0|||
127920243|NCT01332968|460330579|FG000|Maintenance/Observation Period|Adverse Event|0|||
127920244|NCT01332968|460330580|FG001|Maintenance/Observation Period|Adverse Event|0|||
127920245|NCT01332968|460330581|FG002|Maintenance/Observation Period|Adverse Event|53|||
127920246|NCT01332968|460330582|FG003|Maintenance/Observation Period|Adverse Event|66|||
127920247|NCT01332968|460330583|FG004|Maintenance/Observation Period|Adverse Event|0|||
127920248|NCT01332968|460330584|FG005|Maintenance/Observation Period|Adverse Event|0|||
127920249|NCT01332968|460330585|FG006|Maintenance/Observation Period|Adverse Event|0|||
127920250|NCT01332968|460330586|FG007|Maintenance/Observation Period|Adverse Event|0|||
127920251|NCT01332968|460330579|FG000|Maintenance/Observation Period|Death|0|||
127920252|NCT01332968|460330580|FG001|Maintenance/Observation Period|Death|0|||
127920253|NCT01332968|460330581|FG002|Maintenance/Observation Period|Death|5|||
127920254|NCT01332968|460330582|FG003|Maintenance/Observation Period|Death|6|||
127920255|NCT01332968|460330583|FG004|Maintenance/Observation Period|Death|0|||
127920256|NCT01332968|460330584|FG005|Maintenance/Observation Period|Death|0|||
127920257|NCT01332968|460330585|FG006|Maintenance/Observation Period|Death|0|||
127920258|NCT01332968|460330586|FG007|Maintenance/Observation Period|Death|0|||
127920259|NCT01332968|460330579|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
127920260|NCT01332968|460330580|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
127920261|NCT01332968|460330581|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
127920262|NCT01332968|460330582|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
127920263|NCT01332968|460330583|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
127920264|NCT01332968|460330584|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
127920265|NCT01332968|460330585|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
127920266|NCT01332968|460330586|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
127920267|NCT01332968|460330579|FG000|Maintenance/Observation Period|Non-compliance|0|||
127920268|NCT01332968|460330580|FG001|Maintenance/Observation Period|Non-compliance|0|||
127920269|NCT01332968|460330581|FG002|Maintenance/Observation Period|Non-compliance|4|||
127920270|NCT01332968|460330582|FG003|Maintenance/Observation Period|Non-compliance|3|||
127920271|NCT01332968|460330583|FG004|Maintenance/Observation Period|Non-compliance|0|||
127920272|NCT01332968|460330584|FG005|Maintenance/Observation Period|Non-compliance|0|||
127920273|NCT01332968|460330585|FG006|Maintenance/Observation Period|Non-compliance|0|||
127920274|NCT01332968|460330586|FG007|Maintenance/Observation Period|Non-compliance|0|||
127920275|NCT01332968|460330579|FG000|Maintenance/Observation Period|Other|0|||
127920276|NCT01332968|460330580|FG001|Maintenance/Observation Period|Other|0|||
127920277|NCT01332968|460330581|FG002|Maintenance/Observation Period|Other|4|||
127920278|NCT01332968|460330582|FG003|Maintenance/Observation Period|Other|7|||
127920279|NCT01332968|460330583|FG004|Maintenance/Observation Period|Other|0|||
127920280|NCT01332968|460330584|FG005|Maintenance/Observation Period|Other|0|||
127920281|NCT01332968|460330585|FG006|Maintenance/Observation Period|Other|0|||
127920282|NCT01332968|460330586|FG007|Maintenance/Observation Period|Other|0|||
127920283|NCT01332968|460330579|FG000|Maintenance/Observation Period|Physician Decision|0|||
127920284|NCT01332968|460330580|FG001|Maintenance/Observation Period|Physician Decision|0|||
127920285|NCT01332968|460330581|FG002|Maintenance/Observation Period|Physician Decision|14|||
127920286|NCT01332968|460330582|FG003|Maintenance/Observation Period|Physician Decision|19|||
127920287|NCT01332968|460330583|FG004|Maintenance/Observation Period|Physician Decision|0|||
127920288|NCT01332968|460330584|FG005|Maintenance/Observation Period|Physician Decision|1|||
127920289|NCT01332968|460330585|FG006|Maintenance/Observation Period|Physician Decision|0|||
127920290|NCT01332968|460330586|FG007|Maintenance/Observation Period|Physician Decision|0|||
127920291|NCT01332968|460330579|FG000|Maintenance/Observation Period|Progressive Disease|0|||
127920292|NCT01332968|460330580|FG001|Maintenance/Observation Period|Progressive Disease|0|||
127920293|NCT01332968|460330581|FG002|Maintenance/Observation Period|Progressive Disease|72|||
127920294|NCT01332968|460330582|FG003|Maintenance/Observation Period|Progressive Disease|40|||
127920295|NCT01332968|460330583|FG004|Maintenance/Observation Period|Progressive Disease|0|||
127920296|NCT01332968|460330584|FG005|Maintenance/Observation Period|Progressive Disease|0|||
127920297|NCT01332968|460330585|FG006|Maintenance/Observation Period|Progressive Disease|0|||
127920298|NCT01332968|460330586|FG007|Maintenance/Observation Period|Progressive Disease|0|||
127920299|NCT01332968|460330579|FG000|Maintenance/Observation Period|Protocol Violation|0|||
127920300|NCT01332968|460330580|FG001|Maintenance/Observation Period|Protocol Violation|0|||
127920301|NCT01332968|460330581|FG002|Maintenance/Observation Period|Protocol Violation|1|||
127920302|NCT01332968|460330582|FG003|Maintenance/Observation Period|Protocol Violation|1|||
127920303|NCT01332968|460330583|FG004|Maintenance/Observation Period|Protocol Violation|0|||
127920304|NCT01332968|460330584|FG005|Maintenance/Observation Period|Protocol Violation|0|||
127920305|NCT01332968|460330585|FG006|Maintenance/Observation Period|Protocol Violation|0|||
127920306|NCT01332968|460330586|FG007|Maintenance/Observation Period|Protocol Violation|0|||
127920307|NCT01332968|460330579|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
127920308|NCT01332968|460330580|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
127920309|NCT01332968|460330581|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
127920310|NCT01332968|460330582|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
127920311|NCT01332968|460330583|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
127920312|NCT01332968|460330584|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
127920313|NCT01332968|460330585|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
127920314|NCT01332968|460330586|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
127920315|NCT01332968|460330579|FG000|Follow-Up Period|Adverse Event|0|||
127920316|NCT01332968|460330580|FG001|Follow-Up Period|Adverse Event|0|||
127920317|NCT01332968|460330581|FG002|Follow-Up Period|Adverse Event|0|||
127920318|NCT01332968|460330582|FG003|Follow-Up Period|Adverse Event|0|||
127920319|NCT01332968|460330583|FG004|Follow-Up Period|Adverse Event|0|||
127920320|NCT01332968|460330584|FG005|Follow-Up Period|Adverse Event|0|||
127920321|NCT01332968|460330585|FG006|Follow-Up Period|Adverse Event|0|||
127920322|NCT01332968|460330586|FG007|Follow-Up Period|Adverse Event|4|||
127920323|NCT01332968|460330579|FG000|Follow-Up Period|Death|0|||
127920324|NCT01332968|460330580|FG001|Follow-Up Period|Death|0|||
127920325|NCT01332968|460330581|FG002|Follow-Up Period|Death|0|||
127920326|NCT01332968|460330582|FG003|Follow-Up Period|Death|0|||
127920327|NCT01332968|460330583|FG004|Follow-Up Period|Death|0|||
127920328|NCT01332968|460330584|FG005|Follow-Up Period|Death|0|||
127920329|NCT01332968|460330585|FG006|Follow-Up Period|Death|27|||
127920330|NCT01332968|460330586|FG007|Follow-Up Period|Death|30|||
127920331|NCT01332968|460330579|FG000|Follow-Up Period|Lost to Follow-up|0|||
127920332|NCT01332968|460330580|FG001|Follow-Up Period|Lost to Follow-up|0|||
127920333|NCT01332968|460330581|FG002|Follow-Up Period|Lost to Follow-up|0|||
127920334|NCT01332968|460330582|FG003|Follow-Up Period|Lost to Follow-up|0|||
127920335|NCT01332968|460330583|FG004|Follow-Up Period|Lost to Follow-up|0|||
127920336|NCT01332968|460330584|FG005|Follow-Up Period|Lost to Follow-up|0|||
127920337|NCT01332968|460330585|FG006|Follow-Up Period|Lost to Follow-up|11|||
127920338|NCT01332968|460330586|FG007|Follow-Up Period|Lost to Follow-up|15|||
127920339|NCT01332968|460330579|FG000|Follow-Up Period|Non-compliance|0|||
127920340|NCT01332968|460330580|FG001|Follow-Up Period|Non-compliance|0|||
127920341|NCT01332968|460330581|FG002|Follow-Up Period|Non-compliance|0|||
127920342|NCT01332968|460330582|FG003|Follow-Up Period|Non-compliance|0|||
127920343|NCT01332968|460330583|FG004|Follow-Up Period|Non-compliance|0|||
127920344|NCT01332968|460330584|FG005|Follow-Up Period|Non-compliance|0|||
127920345|NCT01332968|460330585|FG006|Follow-Up Period|Non-compliance|4|||
127920346|NCT01332968|460330586|FG007|Follow-Up Period|Non-compliance|9|||
127920347|NCT01332968|460330579|FG000|Follow-Up Period|Other|0|||
127920348|NCT01332968|460330580|FG001|Follow-Up Period|Other|0|||
127920349|NCT01332968|460330581|FG002|Follow-Up Period|Other|0|||
127920350|NCT01332968|460330582|FG003|Follow-Up Period|Other|0|||
127920351|NCT01332968|460330583|FG004|Follow-Up Period|Other|0|||
127920352|NCT01332968|460330584|FG005|Follow-Up Period|Other|0|||
127920353|NCT01332968|460330585|FG006|Follow-Up Period|Other|18|||
127920354|NCT01332968|460330586|FG007|Follow-Up Period|Other|21|||
127920355|NCT01332968|460330579|FG000|Follow-Up Period|Physician Decision|0|||
127920356|NCT01332968|460330580|FG001|Follow-Up Period|Physician Decision|0|||
127920357|NCT01332968|460330581|FG002|Follow-Up Period|Physician Decision|0|||
127920358|NCT01332968|460330582|FG003|Follow-Up Period|Physician Decision|0|||
127920359|NCT01332968|460330583|FG004|Follow-Up Period|Physician Decision|0|||
127920360|NCT01332968|460330584|FG005|Follow-Up Period|Physician Decision|0|||
127920361|NCT01332968|460330585|FG006|Follow-Up Period|Physician Decision|12|||
127920362|NCT01332968|460330586|FG007|Follow-Up Period|Physician Decision|15|||
127920363|NCT01332968|460330579|FG000|Follow-Up Period|Progressive Disease|0|||
127920364|NCT01332968|460330580|FG001|Follow-Up Period|Progressive Disease|0|||
127920365|NCT01332968|460330581|FG002|Follow-Up Period|Progressive Disease|0|||
127920366|NCT01332968|460330582|FG003|Follow-Up Period|Progressive Disease|0|||
127920367|NCT01332968|460330583|FG004|Follow-Up Period|Progressive Disease|0|||
127920368|NCT01332968|460330584|FG005|Follow-Up Period|Progressive Disease|0|||
127920369|NCT01332968|460330585|FG006|Follow-Up Period|Progressive Disease|126|||
127920370|NCT01332968|460330586|FG007|Follow-Up Period|Progressive Disease|106|||
127920371|NCT01332968|460330579|FG000|Follow-Up Period|Protocol Violation|0|||
127920372|NCT01332968|460330580|FG001|Follow-Up Period|Protocol Violation|0|||
127920373|NCT01332968|460330581|FG002|Follow-Up Period|Protocol Violation|0|||
127920374|NCT01332968|460330582|FG003|Follow-Up Period|Protocol Violation|0|||
127920375|NCT01332968|460330583|FG004|Follow-Up Period|Protocol Violation|0|||
127920376|NCT01332968|460330584|FG005|Follow-Up Period|Protocol Violation|0|||
127920377|NCT01332968|460330585|FG006|Follow-Up Period|Protocol Violation|1|||
127920378|NCT01332968|460330586|FG007|Follow-Up Period|Protocol Violation|0|||
127920379|NCT01332968|460330579|FG000|Follow-Up Period|Withdrawal by Subject|0|||
127920380|NCT01332968|460330580|FG001|Follow-Up Period|Withdrawal by Subject|0|||
127920381|NCT01332968|460330581|FG002|Follow-Up Period|Withdrawal by Subject|0|||
127920382|NCT01332968|460330582|FG003|Follow-Up Period|Withdrawal by Subject|0|||
127920383|NCT01332968|460330583|FG004|Follow-Up Period|Withdrawal by Subject|0|||
127920384|NCT01332968|460330584|FG005|Follow-Up Period|Withdrawal by Subject|0|||
127920385|NCT01332968|460330585|FG006|Follow-Up Period|Withdrawal by Subject|29|||
127920386|NCT01332968|460330586|FG007|Follow-Up Period|Withdrawal by Subject|32|||
127920387|NCT01332968|460330579|FG000|Follow-Up Period|No reason provided|0|||
127920388|NCT01332968|460330580|FG001|Follow-Up Period|No reason provided|0|||
127920389|NCT01332968|460330581|FG002|Follow-Up Period|No reason provided|0|||
127920390|NCT01332968|460330582|FG003|Follow-Up Period|No reason provided|0|||
127920391|NCT01332968|460330583|FG004|Follow-Up Period|No reason provided|0|||
127920392|NCT01332968|460330584|FG005|Follow-Up Period|No reason provided|0|||
127920393|NCT01332968|460330585|FG006|Follow-Up Period|No reason provided|2|||
127920394|NCT01332968|460330586|FG007|Follow-Up Period|No reason provided|3|||
127920395|NCT03480022|460330587|FG000|Overall Study|Pregnancy|2|||
127920396|NCT03480022|460330588|FG001|Overall Study|Pregnancy|0|||
127920397|NCT03480022|460330587|FG000|Overall Study|Adverse Event|6|||
127920398|NCT03480022|460330588|FG001|Overall Study|Adverse Event|0|||
127920399|NCT03480022|460330587|FG000|Overall Study|Lack of Efficacy|0|||
127920400|NCT03480022|460330588|FG001|Overall Study|Lack of Efficacy|2|||
127920401|NCT03480022|460330587|FG000|Overall Study|Physician Decision|0|||
127920402|NCT03480022|460330588|FG001|Overall Study|Physician Decision|1|||
127920403|NCT03480022|460330587|FG000|Overall Study|Withdrawal by Subject|2|||
127920404|NCT03480022|460330588|FG001|Overall Study|Withdrawal by Subject|0|||
127920405|NCT03480022|460330587|FG000|Overall Study|Medication concerns|1|||
127920406|NCT03480022|460330588|FG001|Overall Study|Medication concerns|0|||
127920407|NCT03480022|460330587|FG000|Overall Study|Family member COVID exposure|0|||
127920408|NCT03480022|460330588|FG001|Overall Study|Family member COVID exposure|1|||
127920409|NCT00640926|460330589|FG000|Overall Study|Adverse Event|2|||
127920410|NCT00640926|460330590|FG001|Overall Study|Adverse Event|3|||
127920411|NCT00640926|460330591|FG002|Overall Study|Adverse Event|2|||
127920412|NCT00640926|460330589|FG000|Overall Study|Lack of Efficacy|0|||
127920413|NCT00640926|460330590|FG001|Overall Study|Lack of Efficacy|2|||
127920414|NCT00640926|460330591|FG002|Overall Study|Lack of Efficacy|1|||
127920415|NCT00640926|460330589|FG000|Overall Study|Protocol Violation|2|||
127920416|NCT00640926|460330590|FG001|Overall Study|Protocol Violation|0|||
127920417|NCT00640926|460330591|FG002|Overall Study|Protocol Violation|2|||
127920418|NCT00640926|460330589|FG000|Overall Study|Lost to Follow-up|3|||
127920419|NCT00640926|460330590|FG001|Overall Study|Lost to Follow-up|1|||
127920420|NCT00640926|460330591|FG002|Overall Study|Lost to Follow-up|2|||
127920421|NCT00640926|460330589|FG000|Overall Study|Withdrawal by Subject|1|||
127920422|NCT00640926|460330590|FG001|Overall Study|Withdrawal by Subject|0|||
127920423|NCT00640926|460330591|FG002|Overall Study|Withdrawal by Subject|1|||
127920424|NCT03922750|460330592|FG000|Overall Study|Unclassified|0|||
127920425|NCT03922750|460330593|FG001|Overall Study|Unclassified|0|||
127920426|NCT03922750|460330594|FG002|Overall Study|Unclassified|1|||
127920427|NCT03922750|460330592|FG000|Overall Study|Adverse Event|0|||
127920428|NCT03922750|460330593|FG001|Overall Study|Adverse Event|1|||
127920429|NCT03922750|460330594|FG002|Overall Study|Adverse Event|0|||
127920430|NCT02985398|460330595|FG000|Overall Study|Adverse Event|1|||
127920431|NCT02985398|460330595|FG000|Overall Study|Lost to Follow-up|4|||
127920432|NCT02985398|460330595|FG000|Overall Study|Withdrawal by Subject|8|||
127920433|NCT02985398|460330595|FG000|Overall Study|Study Burden|9|||
127920434|NCT04164758|460330600|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
127920435|NCT04164758|460330601|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
127920436|NCT04164758|460330602|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
127920437|NCT04164758|460330600|FG000|Overall Study|Adverse Event|0|||
127920438|NCT04164758|460330601|FG001|Overall Study|Adverse Event|1|||
127920439|NCT04164758|460330602|FG002|Overall Study|Adverse Event|0|||
127920440|NCT00697827|460330603|FG000|Overall Study|enrolled but not treated|2|||
127920441|NCT00697827|460330604|FG001|Overall Study|enrolled but not treated|1|||
127920442|NCT02311894|460330605|FG000|Overall Study|Discontinued in error|1|||
127920443|NCT02311894|460330605|FG000|Overall Study|Lost to Follow-up|1|||
127920444|NCT02311894|460330605|FG000|Overall Study|Adverse Event|1|||
127920445|NCT02311894|460330605|FG000|Overall Study|Withdrawal by Subject|1|||
127920446|NCT00702507|460330606|FG000|Initial Treatment Phase|Adverse Event|2|||
127920447|NCT00702507|460330606|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
127920448|NCT00702507|460330606|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
127920449|NCT00702507|460330606|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
127920450|NCT00702507|460330606|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
127920451|NCT00702507|460330606|FG000|Follow-up Phase|Protocol Violation|2|||
127920452|NCT00702507|460330606|FG000|Follow-up Phase|Lost to Follow-up|23|||
127920453|NCT00702507|460330606|FG000|Follow-up Phase|Late Enrollment|1|||
127920454|NCT04049097|460330611|FG000|Overall Study|Adverse Event|18|||
127920455|NCT04049097|460330611|FG000|Overall Study|Death|2|||
127920456|NCT04049097|460330611|FG000|Overall Study|Lost to Follow-up|1|||
127920457|NCT04049097|460330611|FG000|Overall Study|Physician Decision|2|||
127920458|NCT04049097|460330611|FG000|Overall Study|Withdrawal by Subject|9|||
127920459|NCT04049097|460330611|FG000|Overall Study|Protocol Violation|2|||
127920460|NCT04049097|460330611|FG000|Overall Study|Other|1|||
127920461|NCT04049097|460330611|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
127920462|NCT01970592|460330617|FG000|Overall Study|Withdrawal by Subject|4|||
127920463|NCT01970592|460330617|FG000|Overall Study|Physician Decision|1|||
127920464|NCT01970592|460330617|FG000|Overall Study|Adverse Event|1|||
127920465|NCT03980522|460330618|FG000|Treatment Period|Adverse Event|1|||
127920466|NCT03980522|460330619|FG001|Treatment Period|Adverse Event|0|||
127920467|NCT03980522|460330620|FG002|Treatment Period|Adverse Event|0|||
127920468|NCT03980522|460330621|FG003|Treatment Period|Adverse Event|0|||
127920469|NCT03980522|460330622|FG004|Treatment Period|Adverse Event|0|||
127920470|NCT04892147|460330623|FG000|Overall Study|Withdrawal by Subject|2|||
127920471|NCT04892147|460330624|FG001|Overall Study|Withdrawal by Subject|0|||
127920472|NCT05263505|460330625|FG000|Overall Study|Adverse Event|0|||
127920473|NCT05263505|460330626|FG001|Overall Study|Adverse Event|1|||
127920474|NCT02661022|460330628|FG000|Overall Study|Withdrawal by Subject|3|||
127920475|NCT02661022|460330629|FG001|Overall Study|Withdrawal by Subject|0|||
127920476|NCT02661022|460330628|FG000|Overall Study|Adverse Event|1|||
127920477|NCT02661022|460330629|FG001|Overall Study|Adverse Event|1|||
127920478|NCT02661022|460330628|FG000|Overall Study|Physician Decision|1|||
127920479|NCT02661022|460330629|FG001|Overall Study|Physician Decision|0|||
127920480|NCT02661022|460330628|FG000|Overall Study|Progressive Disease|2|||
127920481|NCT02661022|460330629|FG001|Overall Study|Progressive Disease|1|||
127920482|NCT03448692|460330634|FG000|Investigational Treatment Period:Upto24W|Adverse Event|1|||
127920483|NCT03448692|460330635|FG001|Investigational Treatment Period:Upto24W|Adverse Event|0|||
127920484|NCT03448692|460330634|FG000|Investigational Treatment Period:Upto24W|Lack of Efficacy|0|||
127920485|NCT03448692|460330635|FG001|Investigational Treatment Period:Upto24W|Lack of Efficacy|1|||
127920486|NCT03448692|460330634|FG000|Investigational Treatment Period:Upto24W|Physician's decision|0|||
127920487|NCT03448692|460330635|FG001|Investigational Treatment Period:Upto24W|Physician's decision|1|||
127920488|NCT03448692|460330634|FG000|Investigational Treatment Period:Upto24W|Study terminated by sponsor|0|||
127920489|NCT03448692|460330635|FG001|Investigational Treatment Period:Upto24W|Study terminated by sponsor|5|||
127920490|NCT03448692|460330634|FG000|Investigational Treatment Period:Upto24W|Withdrawal by Subject|0|||
127920491|NCT03448692|460330635|FG001|Investigational Treatment Period:Upto24W|Withdrawal by Subject|2|||
127920492|NCT01785615|460330643|FG000|Dietary Phase|Lost to Follow-up|0|||
127920493|NCT01785615|460330644|FG001|Dietary Phase|Lost to Follow-up|0|||
127920494|NCT01785615|460330645|FG002|Dietary Phase|Lost to Follow-up|0|||
127920495|NCT01785615|460330646|FG003|Dietary Phase|Lost to Follow-up|24|||
127920496|NCT03428945|460330647|FG000|Overall Study|Lost to Follow-up|5|||
127920497|NCT03428945|460330648|FG001|Overall Study|Lost to Follow-up|3|||
127920498|NCT03428945|460330647|FG000|Overall Study|Withdrawal by Subject|10|||
127920499|NCT03428945|460330648|FG001|Overall Study|Withdrawal by Subject|10|||
127920500|NCT04553406|460330652|FG000|Overall Study|Study Discontinuation|0|||
127920501|NCT04553406|460330653|FG001|Overall Study|Study Discontinuation|1|||
127920502|NCT00772148|460330654|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
127920503|NCT00772148|460330655|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
127920504|NCT00772148|460330654|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
127920505|NCT00772148|460330655|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
127920506|NCT00772148|460330654|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
127920507|NCT00772148|460330655|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
127920508|NCT00772148|460330654|FG000|Maintenance Phase (Week 52)|Death|2|||
127920509|NCT00772148|460330655|FG001|Maintenance Phase (Week 52)|Death|2|||
127920510|NCT00772148|460330654|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
127920511|NCT00772148|460330655|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
127920512|NCT00772148|460330654|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
127920513|NCT00772148|460330655|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
127920514|NCT00772148|460330654|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
127920515|NCT00772148|460330655|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
127920516|NCT03573336|460330656|FG000|Overall Study|Study terminated|2|||
127920517|NCT03573336|460330657|FG001|Overall Study|Study terminated|4|||
127920518|NCT03573336|460330658|FG002|Overall Study|Study terminated|2|||
127920519|NCT03493919|460330660|FG000|Overall Study|Other|2|||
127920520|NCT03493919|460330661|FG001|Overall Study|Other|0|||
127920521|NCT03493919|460330662|FG002|Overall Study|Other|1|||
127920522|NCT03493919|460330663|FG003|Overall Study|Other|0|||
127920523|NCT03493919|460330660|FG000|Overall Study|Withdrawal by Subject|9|||
127920524|NCT03493919|460330661|FG001|Overall Study|Withdrawal by Subject|3|||
127920525|NCT03493919|460330662|FG002|Overall Study|Withdrawal by Subject|1|||
127920526|NCT03493919|460330663|FG003|Overall Study|Withdrawal by Subject|1|||
127920527|NCT03493919|460330660|FG000|Overall Study|Lost to Follow-up|5|||
127920528|NCT03493919|460330661|FG001|Overall Study|Lost to Follow-up|0|||
127920529|NCT03493919|460330662|FG002|Overall Study|Lost to Follow-up|0|||
127920530|NCT03493919|460330663|FG003|Overall Study|Lost to Follow-up|3|||
127920531|NCT03493919|460330660|FG000|Overall Study|Adverse Event|0|||
127920532|NCT03493919|460330661|FG001|Overall Study|Adverse Event|1|||
127920533|NCT03493919|460330662|FG002|Overall Study|Adverse Event|0|||
127920534|NCT03493919|460330663|FG003|Overall Study|Adverse Event|0|||
127920535|NCT04640194|460330664|FG000|Overall Study|Adverse Event|3|||
127920536|NCT04640194|460330665|FG001|Overall Study|Adverse Event|7|||
127920537|NCT04640194|460330666|FG002|Overall Study|Adverse Event|0|||
127920538|NCT04640194|460330667|FG003|Overall Study|Adverse Event|5|||
127920539|NCT04640194|460330668|FG004|Overall Study|Adverse Event|0|||
127920540|NCT04640194|460330669|FG005|Overall Study|Adverse Event|4|||
127920541|NCT04640194|460330670|FG006|Overall Study|Adverse Event|0|||
127920542|NCT04640194|460330664|FG000|Overall Study|pO2/FIO2 ratio too high|0|||
127920543|NCT04640194|460330665|FG001|Overall Study|pO2/FIO2 ratio too high|0|||
127920544|NCT04640194|460330666|FG002|Overall Study|pO2/FIO2 ratio too high|0|||
127920545|NCT04640194|460330667|FG003|Overall Study|pO2/FIO2 ratio too high|1|||
127920546|NCT04640194|460330668|FG004|Overall Study|pO2/FIO2 ratio too high|0|||
127920547|NCT04640194|460330669|FG005|Overall Study|pO2/FIO2 ratio too high|0|||
127920548|NCT04640194|460330670|FG006|Overall Study|pO2/FIO2 ratio too high|0|||
127920549|NCT04640194|460330664|FG000|Overall Study|fibrinogen level too low|0|||
127920550|NCT04640194|460330665|FG001|Overall Study|fibrinogen level too low|0|||
127920551|NCT04640194|460330666|FG002|Overall Study|fibrinogen level too low|0|||
127920552|NCT04640194|460330667|FG003|Overall Study|fibrinogen level too low|1|||
127920553|NCT04640194|460330668|FG004|Overall Study|fibrinogen level too low|0|||
127920554|NCT04640194|460330669|FG005|Overall Study|fibrinogen level too low|0|||
127920555|NCT04640194|460330670|FG006|Overall Study|fibrinogen level too low|0|||
127920556|NCT04640194|460330664|FG000|Overall Study|mild bleeding|0|||
127920557|NCT04640194|460330665|FG001|Overall Study|mild bleeding|0|||
127920558|NCT04640194|460330666|FG002|Overall Study|mild bleeding|0|||
127920559|NCT04640194|460330667|FG003|Overall Study|mild bleeding|1|||
127920560|NCT04640194|460330668|FG004|Overall Study|mild bleeding|0|||
127920561|NCT04640194|460330669|FG005|Overall Study|mild bleeding|0|||
127920562|NCT04640194|460330670|FG006|Overall Study|mild bleeding|0|||
127920563|NCT04640194|460330664|FG000|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
127920564|NCT04640194|460330665|FG001|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|1|||
127920565|NCT04640194|460330666|FG002|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
127920566|NCT04640194|460330667|FG003|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
127920567|NCT04640194|460330668|FG004|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
127920568|NCT04640194|460330669|FG005|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
127920569|NCT04640194|460330670|FG006|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
127920570|NCT00663234|460330671|FG000|Overall Study|Not willing to adhere to requirements|1|||
127920571|NCT01709903|460330674|FG000|Overall Study|administrative problems|2|||
127920572|NCT01709903|460330675|FG001|Overall Study|administrative problems|6|||
127920573|NCT01709903|460330674|FG000|Overall Study|Abnormal test procedure results|1|||
127920574|NCT01709903|460330675|FG001|Overall Study|Abnormal test procedure results|0|||
127920575|NCT01709903|460330674|FG000|Overall Study|In ability to use device|1|||
127920576|NCT01709903|460330675|FG001|Overall Study|In ability to use device|1|||
127920577|NCT01709903|460330674|FG000|Overall Study|no longer needed study drug|0|||
127920578|NCT01709903|460330675|FG001|Overall Study|no longer needed study drug|1|||
127920579|NCT01709903|460330674|FG000|Overall Study|Lost to Follow-up|0|||
127920580|NCT01709903|460330675|FG001|Overall Study|Lost to Follow-up|2|||
127920581|NCT01709903|460330674|FG000|Overall Study|Death|2|||
127920582|NCT01709903|460330675|FG001|Overall Study|Death|0|||
127920583|NCT01709903|460330674|FG000|Overall Study|Protocol Violation|3|||
127920584|NCT01709903|460330675|FG001|Overall Study|Protocol Violation|2|||
127920585|NCT01709903|460330674|FG000|Overall Study|Lack of Efficacy|3|||
127920586|NCT01709903|460330675|FG001|Overall Study|Lack of Efficacy|3|||
127920587|NCT01709903|460330674|FG000|Overall Study|Withdrawal by Subject|6|||
127920588|NCT01709903|460330675|FG001|Overall Study|Withdrawal by Subject|6|||
127920589|NCT01709903|460330674|FG000|Overall Study|Adverse Event|11|||
127920590|NCT01709903|460330675|FG001|Overall Study|Adverse Event|18|||
127920591|NCT04773600|460330690|FG000|Overall Study|Withdrawal by Subject|15|||
127920592|NCT04773600|460330691|FG001|Overall Study|Withdrawal by Subject|9|||
127920593|NCT04773600|460330690|FG000|Overall Study|Lost to Follow-up|10|||
127920594|NCT04773600|460330691|FG001|Overall Study|Lost to Follow-up|6|||
127920595|NCT04773600|460330690|FG000|Overall Study|Adverse Event|8|||
127920596|NCT04773600|460330691|FG001|Overall Study|Adverse Event|2|||
127920597|NCT04773600|460330690|FG000|Overall Study|Lack of Efficacy|2|||
127920598|NCT04773600|460330691|FG001|Overall Study|Lack of Efficacy|3|||
127920599|NCT04773600|460330690|FG000|Overall Study|Noncompliance|2|||
127920600|NCT04773600|460330691|FG001|Overall Study|Noncompliance|0|||
127920601|NCT04773600|460330690|FG000|Overall Study|Protocol Violation|2|||
127920602|NCT04773600|460330691|FG001|Overall Study|Protocol Violation|0|||
127920603|NCT04773600|460330690|FG000|Overall Study|Physician Decision|0|||
127920604|NCT04773600|460330691|FG001|Overall Study|Physician Decision|1|||
127920605|NCT04773600|460330690|FG000|Overall Study|Caregiver Elected Other Therapy|1|||
127920606|NCT04773600|460330691|FG001|Overall Study|Caregiver Elected Other Therapy|0|||
127920607|NCT04773600|460330690|FG000|Overall Study|Emergency Travel Out of Country|1|||
127920608|NCT04773600|460330691|FG001|Overall Study|Emergency Travel Out of Country|0|||
127920609|NCT05135273|460332369|FG000|Overall Study|Recruited into the army|0|||
127920610|NCT05135273|460332370|FG001|Overall Study|Recruited into the army|0|||
127920611|NCT05135273|460332371|FG002|Overall Study|Recruited into the army|0|||
127920612|NCT05135273|460332372|FG003|Overall Study|Recruited into the army|0|||
127920613|NCT05135273|460332373|FG004|Overall Study|Recruited into the army|1|||
127920614|NCT05135273|460332374|FG005|Overall Study|Recruited into the army|0|||
127920615|NCT05135273|460332375|FG006|Overall Study|Recruited into the army|0|||
127920616|NCT05135273|460332376|FG007|Overall Study|Recruited into the army|0|||
127920617|NCT05135273|460332369|FG000|Overall Study|Moved away from study site|0|||
127920618|NCT05135273|460332370|FG001|Overall Study|Moved away from study site|0|||
127920619|NCT05135273|460332371|FG002|Overall Study|Moved away from study site|0|||
127920620|NCT05135273|460332372|FG003|Overall Study|Moved away from study site|0|||
127920621|NCT05135273|460332373|FG004|Overall Study|Moved away from study site|0|||
127920622|NCT05135273|460332374|FG005|Overall Study|Moved away from study site|1|||
127920623|NCT05135273|460332375|FG006|Overall Study|Moved away from study site|1|||
127920624|NCT05135273|460332376|FG007|Overall Study|Moved away from study site|0|||
127920625|NCT05135273|460332369|FG000|Overall Study|Travel|0|||
127920626|NCT05135273|460332370|FG001|Overall Study|Travel|0|||
127920627|NCT05135273|460332371|FG002|Overall Study|Travel|0|||
127920628|NCT05135273|460332372|FG003|Overall Study|Travel|0|||
127920629|NCT05135273|460332373|FG004|Overall Study|Travel|0|||
127920630|NCT05135273|460332374|FG005|Overall Study|Travel|0|||
127920631|NCT05135273|460332375|FG006|Overall Study|Travel|0|||
127920632|NCT05135273|460332376|FG007|Overall Study|Travel|1|||
127920633|NCT01662024|460332388|FG000|Overall Study|Pregnancy|2|||
127920634|NCT01662024|460332388|FG000|Overall Study|Withdrawal by Subject|3|||
127920635|NCT04980456|460332389|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
127920636|NCT04980456|460332390|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
127920637|NCT04980456|460332389|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
127920638|NCT04980456|460332390|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
127920639|NCT04980456|460332389|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
127920640|NCT04980456|460332390|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
127920641|NCT04980456|460332389|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
127920642|NCT04980456|460332390|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
127920643|NCT04832971|460332391|FG000|Overall Study|Death|1|||
127920644|NCT04832971|460332392|FG001|Overall Study|Death|0|||
127920645|NCT04832971|460332393|FG002|Overall Study|Death|0|||
127920646|NCT04832971|460332394|FG003|Overall Study|Death|0|||
127920647|NCT04832971|460332391|FG000|Overall Study|Lost to Follow-up|1|||
127920648|NCT04832971|460332392|FG001|Overall Study|Lost to Follow-up|1|||
127920649|NCT04832971|460332393|FG002|Overall Study|Lost to Follow-up|1|||
127920650|NCT04832971|460332394|FG003|Overall Study|Lost to Follow-up|0|||
127920651|NCT04832971|460332391|FG000|Overall Study|Withdrawal by Subject|1|||
127920652|NCT04832971|460332392|FG001|Overall Study|Withdrawal by Subject|3|||
127920653|NCT04832971|460332393|FG002|Overall Study|Withdrawal by Subject|2|||
127920654|NCT04832971|460332394|FG003|Overall Study|Withdrawal by Subject|2|||
127920655|NCT04832971|460332391|FG000|Overall Study|Other, Not Specified|0|||
127920656|NCT04832971|460332392|FG001|Overall Study|Other, Not Specified|0|||
127920657|NCT04832971|460332393|FG002|Overall Study|Other, Not Specified|1|||
127920658|NCT04832971|460332394|FG003|Overall Study|Other, Not Specified|0|||
127920659|NCT00500318|460332396|FG000|Overall Study|Adverse Event|3|||
127920660|NCT00500318|460332397|FG001|Overall Study|Adverse Event|8|||
127920661|NCT00500318|460332396|FG000|Overall Study|Protocol Violation|1|||
127920662|NCT00500318|460332397|FG001|Overall Study|Protocol Violation|3|||
127920663|NCT00500318|460332396|FG000|Overall Study|Withdrawal by Subject|1|||
127920664|NCT00500318|460332397|FG001|Overall Study|Withdrawal by Subject|2|||
127920665|NCT00500318|460332396|FG000|Overall Study|Lack of Efficacy|0|||
127920666|NCT00500318|460332397|FG001|Overall Study|Lack of Efficacy|3|||
127920667|NCT00500318|460332396|FG000|Overall Study|Other Reason|0|||
127920668|NCT00500318|460332397|FG001|Overall Study|Other Reason|1|||
127920669|NCT03243396|460332398|FG000|Overall Study|Lost to Follow-up|2|||
127920670|NCT03243396|460332399|FG001|Overall Study|Lost to Follow-up|3|||
127920671|NCT03243396|460332400|FG002|Overall Study|Lost to Follow-up|15|||
127920672|NCT03243396|460332401|FG003|Overall Study|Lost to Follow-up|8|||
127920673|NCT03243396|460332402|FG004|Overall Study|Lost to Follow-up|1|||
127920674|NCT03243396|460332403|FG005|Overall Study|Lost to Follow-up|4|||
127920675|NCT03243396|460332404|FG006|Overall Study|Lost to Follow-up|9|||
127920676|NCT03687242|460332405|FG000|Overall Study|Adverse Event|1|||
127920677|NCT02246764|460332407|FG000|Overall Study|Adverse Event|15|||
127920678|NCT02246764|460332408|FG001|Overall Study|Adverse Event|29|||
127920679|NCT02246764|460332409|FG002|Overall Study|Adverse Event|1|||
127920680|NCT02246764|460332407|FG000|Overall Study|Withdrawal by Subject|0|||
127920681|NCT02246764|460332408|FG001|Overall Study|Withdrawal by Subject|0|||
127920682|NCT02246764|460332409|FG002|Overall Study|Withdrawal by Subject|1|||
127920683|NCT02246764|460332407|FG000|Overall Study|Disallowed Concomitant Medication|1|||
127920684|NCT02246764|460332408|FG001|Overall Study|Disallowed Concomitant Medication|0|||
127920685|NCT02246764|460332409|FG002|Overall Study|Disallowed Concomitant Medication|0|||
127920686|NCT02246764|460332407|FG000|Overall Study|Physician Decision|0|||
127920687|NCT02246764|460332408|FG001|Overall Study|Physician Decision|2|||
127920688|NCT02246764|460332409|FG002|Overall Study|Physician Decision|1|||
127920689|NCT02246764|460332407|FG000|Overall Study|Protocol Violation|2|||
127920690|NCT02246764|460332408|FG001|Overall Study|Protocol Violation|1|||
127920691|NCT02246764|460332409|FG002|Overall Study|Protocol Violation|1|||
127920692|NCT02104817|460332410|FG000|Overall Study|Death|363|||
127920693|NCT02104817|460332411|FG001|Overall Study|Death|330|||
127920694|NCT02104817|460332410|FG000|Overall Study|Lost to Follow-up|3|||
127920695|NCT02104817|460332411|FG001|Overall Study|Lost to Follow-up|2|||
127920696|NCT02104817|460332410|FG000|Overall Study|Protocol Violation|0|||
127920697|NCT02104817|460332411|FG001|Overall Study|Protocol Violation|1|||
127920698|NCT02104817|460332410|FG000|Overall Study|Study terminated by sponsor|5854|||
127920699|NCT02104817|460332411|FG001|Overall Study|Study terminated by sponsor|5901|||
127920700|NCT02104817|460332410|FG000|Overall Study|Withdrawal by Subject|111|||
127920701|NCT02104817|460332411|FG001|Overall Study|Withdrawal by Subject|78|||
127920702|NCT02104817|460332410|FG000|Overall Study|Other reasons|128|||
127920703|NCT02104817|460332411|FG001|Overall Study|Other reasons|135|||
127920704|NCT02575339|460332418|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
127920705|NCT02575339|460332419|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
127920706|NCT02575339|460332420|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
127920707|NCT02575339|460332418|FG000|Study Treatment|Disease Progression|5|||
127920708|NCT02575339|460332419|FG001|Study Treatment|Disease Progression|2|||
127920709|NCT02575339|460332420|FG002|Study Treatment|Disease Progression|0|||
127920710|NCT02575339|460332418|FG000|Study Treatment|Adverse Event|1|||
127920711|NCT02575339|460332419|FG001|Study Treatment|Adverse Event|2|||
127920712|NCT02575339|460332420|FG002|Study Treatment|Adverse Event|0|||
127920713|NCT02575339|460332418|FG000|Follow up|Death|6|||
127920714|NCT02575339|460332419|FG001|Follow up|Death|2|||
127920715|NCT02575339|460332420|FG002|Follow up|Death|0|||
127920716|NCT02575339|460332418|FG000|Follow up|Study Terminated|0|||
127920717|NCT02575339|460332419|FG001|Follow up|Study Terminated|2|||
127920718|NCT02575339|460332420|FG002|Follow up|Study Terminated|0|||
127920719|NCT02575339|460332418|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
127920720|NCT02575339|460332419|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
127920721|NCT02575339|460332420|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
127920722|NCT04633642|460332421|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
127920723|NCT04633642|460332422|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
127920724|NCT04675775|460332423|FG000|Overall Study|Withdrawal by Subject|7|||
127920725|NCT02161549|460332425|FG000|Overall Study|Physician Decision|6|||
127920726|NCT02161549|460332426|FG001|Overall Study|Physician Decision|2|||
127920727|NCT03223909|460332427|FG000|Overall Study|Protocol Violation|48|||
127920728|NCT03223909|460332428|FG001|Overall Study|Protocol Violation|45|||
127920729|NCT03223909|460332429|FG002|Overall Study|Protocol Violation|16|||
127920730|NCT01628549|460332434|FG000|Overall Study|Adverse Event|1|||
127920731|NCT01628549|460332435|FG001|Overall Study|Adverse Event|1|||
127920732|NCT01628549|460332436|FG002|Overall Study|Adverse Event|0|||
127920733|NCT01628549|460332437|FG003|Overall Study|Adverse Event|4|||
127920734|NCT01628549|460332434|FG000|Overall Study|Lost to Follow-up|3|||
127920735|NCT01628549|460332435|FG001|Overall Study|Lost to Follow-up|4|||
127920736|NCT01628549|460332436|FG002|Overall Study|Lost to Follow-up|3|||
127920737|NCT01628549|460332437|FG003|Overall Study|Lost to Follow-up|3|||
127920738|NCT01628549|460332434|FG000|Overall Study|Withdrawal by Subject|3|||
127920739|NCT01628549|460332435|FG001|Overall Study|Withdrawal by Subject|4|||
127920740|NCT01628549|460332436|FG002|Overall Study|Withdrawal by Subject|4|||
127920741|NCT01628549|460332437|FG003|Overall Study|Withdrawal by Subject|1|||
127920742|NCT01628549|460332434|FG000|Overall Study|Protocol Violation|2|||
127920743|NCT01628549|460332435|FG001|Overall Study|Protocol Violation|1|||
127920744|NCT01628549|460332436|FG002|Overall Study|Protocol Violation|1|||
127920745|NCT01628549|460332437|FG003|Overall Study|Protocol Violation|0|||
127920746|NCT01628549|460332434|FG000|Overall Study|withdrawn for noncompliance|0|||
127920747|NCT01628549|460332435|FG001|Overall Study|withdrawn for noncompliance|2|||
127920748|NCT01628549|460332436|FG002|Overall Study|withdrawn for noncompliance|1|||
127920749|NCT01628549|460332437|FG003|Overall Study|withdrawn for noncompliance|0|||
127920750|NCT01628549|460332434|FG000|Overall Study|abnormal laboratory test results|0|||
127920751|NCT01628549|460332435|FG001|Overall Study|abnormal laboratory test results|0|||
127920752|NCT01628549|460332436|FG002|Overall Study|abnormal laboratory test results|1|||
127920753|NCT01628549|460332437|FG003|Overall Study|abnormal laboratory test results|0|||
127920754|NCT01628549|460332434|FG000|Overall Study|positive pregnancy test|0|||
127920755|NCT01628549|460332435|FG001|Overall Study|positive pregnancy test|0|||
127920756|NCT01628549|460332436|FG002|Overall Study|positive pregnancy test|0|||
127920757|NCT01628549|460332437|FG003|Overall Study|positive pregnancy test|1|||
127920758|NCT00177164|460332439|FG000|Overall Study|Protocol Violation|0|||
127920759|NCT00177164|460332440|FG001|Overall Study|Protocol Violation|7|||
127920760|NCT00177164|460332439|FG000|Overall Study|Lost to Follow-up|4|||
127920761|NCT00177164|460332440|FG001|Overall Study|Lost to Follow-up|5|||
127920762|NCT00177164|460332439|FG000|Overall Study|increase in alcohol and drug use|1|||
127920763|NCT00177164|460332440|FG001|Overall Study|increase in alcohol and drug use|2|||
127920764|NCT00177164|460332439|FG000|Overall Study|Adverse Event|1|||
127920765|NCT00177164|460332440|FG001|Overall Study|Adverse Event|0|||
127920766|NCT00177164|460332439|FG000|Overall Study|discharge from hospital|1|||
127920767|NCT00177164|460332440|FG001|Overall Study|discharge from hospital|0|||
127920768|NCT00177164|460332439|FG000|Overall Study|Lack of Efficacy|2|||
127920769|NCT00177164|460332440|FG001|Overall Study|Lack of Efficacy|1|||
127920770|NCT00177164|460332439|FG000|Overall Study|Pregnancy|0|||
127920771|NCT00177164|460332440|FG001|Overall Study|Pregnancy|1|||
127920772|NCT00965757|460332441|FG000|Double-blind Phase|Progression of concomitant disease|1|||
127920773|NCT00965757|460332442|FG001|Double-blind Phase|Progression of concomitant disease|2|||
127920774|NCT00965757|460332443|FG002|Double-blind Phase|Progression of concomitant disease|0|||
127920775|NCT00965757|460332444|FG003|Double-blind Phase|Progression of concomitant disease|0|||
127920776|NCT00965757|460332441|FG000|Double-blind Phase|Adverse drug reaction|2|||
127920777|NCT00965757|460332442|FG001|Double-blind Phase|Adverse drug reaction|1|||
127920778|NCT00965757|460332443|FG002|Double-blind Phase|Adverse drug reaction|0|||
127920779|NCT00965757|460332444|FG003|Double-blind Phase|Adverse drug reaction|0|||
127920780|NCT00965757|460332441|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
127920781|NCT00965757|460332442|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
127920782|NCT00965757|460332443|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
127920783|NCT00965757|460332444|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
127920784|NCT00965757|460332441|FG000|Double-blind Phase|Lack of Efficacy|7|||
127920785|NCT00965757|460332442|FG001|Double-blind Phase|Lack of Efficacy|11|||
127920786|NCT00965757|460332443|FG002|Double-blind Phase|Lack of Efficacy|0|||
127920787|NCT00965757|460332444|FG003|Double-blind Phase|Lack of Efficacy|0|||
127920788|NCT00965757|460332441|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
127920789|NCT00965757|460332442|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
127920790|NCT00965757|460332443|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
127920791|NCT00965757|460332444|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
127920792|NCT00965757|460332441|FG000|Double-blind Phase|Lost to Follow-up|0|||
127920793|NCT00965757|460332442|FG001|Double-blind Phase|Lost to Follow-up|1|||
127920794|NCT00965757|460332443|FG002|Double-blind Phase|Lost to Follow-up|0|||
127920795|NCT00965757|460332444|FG003|Double-blind Phase|Lost to Follow-up|0|||
127920796|NCT00965757|460332441|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
127920797|NCT00965757|460332442|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
127920798|NCT00965757|460332443|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
127920799|NCT00965757|460332444|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
127920800|NCT00965757|460332441|FG000|Double-blind Phase|Other|1|||
127920801|NCT00965757|460332442|FG001|Double-blind Phase|Other|0|||
127920802|NCT00965757|460332443|FG002|Double-blind Phase|Other|0|||
127920803|NCT00965757|460332444|FG003|Double-blind Phase|Other|0|||
127920804|NCT00965757|460332441|FG000|Extension Phase|Progression of concomitant disease|0|||
127920805|NCT00965757|460332442|FG001|Extension Phase|Progression of concomitant disease|0|||
127920806|NCT00965757|460332443|FG002|Extension Phase|Progression of concomitant disease|4|||
127920807|NCT00965757|460332444|FG003|Extension Phase|Progression of concomitant disease|2|||
127920808|NCT00965757|460332441|FG000|Extension Phase|Adverse drug reaction|0|||
127920809|NCT00965757|460332442|FG001|Extension Phase|Adverse drug reaction|0|||
127920810|NCT00965757|460332443|FG002|Extension Phase|Adverse drug reaction|6|||
127920811|NCT00965757|460332444|FG003|Extension Phase|Adverse drug reaction|3|||
127920812|NCT00965757|460332441|FG000|Extension Phase|Abnormal Laboratory Value|0|||
127920813|NCT00965757|460332442|FG001|Extension Phase|Abnormal Laboratory Value|0|||
127920814|NCT00965757|460332443|FG002|Extension Phase|Abnormal Laboratory Value|6|||
127920815|NCT00965757|460332444|FG003|Extension Phase|Abnormal Laboratory Value|1|||
127920816|NCT00965757|460332441|FG000|Extension Phase|Lack of Efficacy|0|||
127920817|NCT00965757|460332442|FG001|Extension Phase|Lack of Efficacy|0|||
127920818|NCT00965757|460332443|FG002|Extension Phase|Lack of Efficacy|8|||
127920819|NCT00965757|460332444|FG003|Extension Phase|Lack of Efficacy|12|||
127920820|NCT00965757|460332441|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
127920821|NCT00965757|460332442|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
127920822|NCT00965757|460332443|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
127920823|NCT00965757|460332444|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
127920824|NCT00965757|460332441|FG000|Extension Phase|Lost to Follow-up|0|||
127920825|NCT00965757|460332442|FG001|Extension Phase|Lost to Follow-up|0|||
127920826|NCT00965757|460332443|FG002|Extension Phase|Lost to Follow-up|0|||
127920827|NCT00965757|460332444|FG003|Extension Phase|Lost to Follow-up|1|||
127920828|NCT00965757|460332441|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
127920829|NCT00965757|460332442|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
127920830|NCT00965757|460332443|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
127920831|NCT00965757|460332444|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
127920832|NCT00965757|460332441|FG000|Extension Phase|Protocol Violation|0|||
127920833|NCT00965757|460332442|FG001|Extension Phase|Protocol Violation|0|||
127920834|NCT00965757|460332443|FG002|Extension Phase|Protocol Violation|0|||
127920835|NCT00965757|460332444|FG003|Extension Phase|Protocol Violation|1|||
127920836|NCT00965757|460332441|FG000|Extension Phase|Other|0|||
127920837|NCT00965757|460332442|FG001|Extension Phase|Other|0|||
127920838|NCT00965757|460332443|FG002|Extension Phase|Other|2|||
127920839|NCT00965757|460332444|FG003|Extension Phase|Other|1|||
127920840|NCT02451358|460332445|FG000|Overall Study|Withdrawal by Subject|1|||
127920841|NCT02451358|460332446|FG001|Overall Study|Withdrawal by Subject|1|||
127920842|NCT02451358|460332447|FG002|Overall Study|Withdrawal by Subject|0|||
127920843|NCT02451358|460332448|FG003|Overall Study|Withdrawal by Subject|0|||
127920844|NCT02451358|460332445|FG000|Overall Study|Protocol Violation|0|||
127920845|NCT02451358|460332446|FG001|Overall Study|Protocol Violation|1|||
127920846|NCT02451358|460332447|FG002|Overall Study|Protocol Violation|1|||
127920847|NCT02451358|460332448|FG003|Overall Study|Protocol Violation|0|||
127920848|NCT01344018|460332459|FG000|Overall Study|Death|22|||
127920849|NCT01344018|460332460|FG001|Overall Study|Death|25|||
127920850|NCT01344018|460332459|FG000|Overall Study|Lost to Follow-up|4|||
127920851|NCT01344018|460332460|FG001|Overall Study|Lost to Follow-up|7|||
127920852|NCT05070754|460332461|FG000|Overall Study|Withdrawal by Subject|0|||
127920853|NCT05070754|460332462|FG001|Overall Study|Withdrawal by Subject|0|||
127920854|NCT05070754|460332463|FG002|Overall Study|Withdrawal by Subject|0|||
127920855|NCT05070754|460332464|FG003|Overall Study|Withdrawal by Subject|1|||
127920856|NCT05070754|460332461|FG000|Overall Study|Protocol Violation|0|||
127920857|NCT05070754|460332462|FG001|Overall Study|Protocol Violation|0|||
127920858|NCT05070754|460332463|FG002|Overall Study|Protocol Violation|0|||
127920859|NCT05070754|460332464|FG003|Overall Study|Protocol Violation|1|||
127920860|NCT01398787|460332465|FG000|Overall Study|Adverse Event|1|||
127920861|NCT02351167|460332466|FG000|Overall Study|Withdrawal by Subject|19|||
127920862|NCT02351167|460332467|FG001|Overall Study|Withdrawal by Subject|18|||
127920863|NCT02351167|460332468|FG002|Overall Study|Withdrawal by Subject|21|||
127920864|NCT00668395|460332469|FG000|Overall Study|Withdrawal by Subject|4|||
127920865|NCT00668395|460332470|FG001|Overall Study|Withdrawal by Subject|4|||
127920866|NCT00668395|460332471|FG002|Overall Study|Withdrawal by Subject|1|||
127920867|NCT00668395|460332469|FG000|Overall Study|Adverse Event|1|||
127920868|NCT00668395|460332470|FG001|Overall Study|Adverse Event|1|||
127920869|NCT00668395|460332471|FG002|Overall Study|Adverse Event|0|||
127920870|NCT00668395|460332469|FG000|Overall Study|Physician Decision|1|||
127920871|NCT00668395|460332470|FG001|Overall Study|Physician Decision|1|||
127920872|NCT00668395|460332471|FG002|Overall Study|Physician Decision|0|||
127920873|NCT02858037|460332472|FG000|Overall Study|Death|1|||
127920874|NCT02858037|460332472|FG000|Overall Study|Withdrawal by Subject|18|||
127920875|NCT02858037|460332472|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
127920876|NCT02858037|460332472|FG000|Overall Study|Lost to Follow-up|3|||
127920877|NCT02858037|460332472|FG000|Overall Study|Other|4|||
127920878|NCT00283842|460332475|FG000|Overall Study|Adverse Event|8|||
127920879|NCT00283842|460332476|FG001|Overall Study|Adverse Event|7|||
127920880|NCT00283842|460332477|FG002|Overall Study|Adverse Event|21|||
127920881|NCT00283842|460332478|FG003|Overall Study|Adverse Event|21|||
127920882|NCT00283842|460332479|FG004|Overall Study|Adverse Event|5|||
127920883|NCT00283842|460332475|FG000|Overall Study|Protocol Violation|1|||
127920884|NCT00283842|460332476|FG001|Overall Study|Protocol Violation|5|||
127920885|NCT00283842|460332477|FG002|Overall Study|Protocol Violation|4|||
127920886|NCT00283842|460332478|FG003|Overall Study|Protocol Violation|0|||
127920887|NCT00283842|460332479|FG004|Overall Study|Protocol Violation|0|||
127920888|NCT00283842|460332475|FG000|Overall Study|Protocol deviation|0|||
127920889|NCT00283842|460332476|FG001|Overall Study|Protocol deviation|0|||
127920890|NCT00283842|460332477|FG002|Overall Study|Protocol deviation|0|||
127920891|NCT00283842|460332478|FG003|Overall Study|Protocol deviation|0|||
127920892|NCT00283842|460332479|FG004|Overall Study|Protocol deviation|2|||
127920893|NCT00283842|460332475|FG000|Overall Study|Withdrawal by Subject|2|||
127920894|NCT00283842|460332476|FG001|Overall Study|Withdrawal by Subject|1|||
127920895|NCT00283842|460332477|FG002|Overall Study|Withdrawal by Subject|1|||
127920896|NCT00283842|460332478|FG003|Overall Study|Withdrawal by Subject|5|||
127920897|NCT00283842|460332479|FG004|Overall Study|Withdrawal by Subject|4|||
127920898|NCT00283842|460332475|FG000|Overall Study|Lack of Efficacy|1|||
127920899|NCT00283842|460332476|FG001|Overall Study|Lack of Efficacy|3|||
127920900|NCT00283842|460332477|FG002|Overall Study|Lack of Efficacy|1|||
127920901|NCT00283842|460332478|FG003|Overall Study|Lack of Efficacy|0|||
127920902|NCT00283842|460332479|FG004|Overall Study|Lack of Efficacy|3|||
127920903|NCT00283842|460332475|FG000|Overall Study|Lost to Follow-up|0|||
127920904|NCT00283842|460332476|FG001|Overall Study|Lost to Follow-up|2|||
127920905|NCT00283842|460332477|FG002|Overall Study|Lost to Follow-up|4|||
127920906|NCT00283842|460332478|FG003|Overall Study|Lost to Follow-up|1|||
127920907|NCT00283842|460332479|FG004|Overall Study|Lost to Follow-up|1|||
127920908|NCT03732833|460332482|FG000|Overall Study|Adverse Event|0|||
127920909|NCT03732833|460332483|FG001|Overall Study|Adverse Event|3|||
127920910|NCT03732833|460332484|FG002|Overall Study|Adverse Event|1|||
127920911|NCT03732833|460332482|FG000|Overall Study|Withdrawal by Subject|11|||
127920912|NCT03732833|460332483|FG001|Overall Study|Withdrawal by Subject|13|||
127920913|NCT03732833|460332484|FG002|Overall Study|Withdrawal by Subject|8|||
127920914|NCT03732833|460332482|FG000|Overall Study|Lost to Follow-up|3|||
127920915|NCT03732833|460332483|FG001|Overall Study|Lost to Follow-up|5|||
127920916|NCT03732833|460332484|FG002|Overall Study|Lost to Follow-up|4|||
127920917|NCT03732833|460332482|FG000|Overall Study|Pregnancy|0|||
127920918|NCT03732833|460332483|FG001|Overall Study|Pregnancy|2|||
127920919|NCT03732833|460332484|FG002|Overall Study|Pregnancy|0|||
127920920|NCT03732833|460332482|FG000|Overall Study|Physician Decision|2|||
127920921|NCT03732833|460332483|FG001|Overall Study|Physician Decision|3|||
127920922|NCT03732833|460332484|FG002|Overall Study|Physician Decision|1|||
127920923|NCT03732833|460332482|FG000|Overall Study|Covid-19 related and other reasons|2|||
127920924|NCT03732833|460332483|FG001|Overall Study|Covid-19 related and other reasons|7|||
127920925|NCT03732833|460332484|FG002|Overall Study|Covid-19 related and other reasons|3|||
127920926|NCT05665387|460332485|FG000|Overall Study|Withdrawal by Subject|1|||
127920927|NCT05665387|460332486|FG001|Overall Study|Withdrawal by Subject|0|||
127920928|NCT05665387|460332487|FG002|Overall Study|Withdrawal by Subject|1|||
127920929|NCT02472639|460332490|FG000|Overall Study|Physician Decision|4|||
127920930|NCT02472639|460332491|FG001|Overall Study|Physician Decision|3|||
127920931|NCT00751023|460332492|FG000|Overall Study|Lost to Follow-up|11|||
127920932|NCT00751023|460332493|FG001|Overall Study|Lost to Follow-up|7|||
127920933|NCT02308696|460332498|FG000|Overall Study|Lost to Follow-up|28|||
127920934|NCT02308696|460332499|FG001|Overall Study|Lost to Follow-up|21|||
127920935|NCT02308696|460332498|FG000|Overall Study|Death|8|||
127920936|NCT02308696|460332499|FG001|Overall Study|Death|4|||
127920937|NCT02308696|460332498|FG000|Overall Study|Moved to a Higher Level of Care|17|||
127920938|NCT02308696|460332499|FG001|Overall Study|Moved to a Higher Level of Care|6|||
127920939|NCT01211262|460332501|FG000|Overall Study|Progressive Disease|18|||
127920940|NCT01211262|460332502|FG001|Overall Study|Progressive Disease|9|||
127920941|NCT01211262|460332501|FG000|Overall Study|Adverse Event|4|||
127920942|NCT01211262|460332502|FG001|Overall Study|Adverse Event|0|||
127920943|NCT01211262|460332501|FG000|Overall Study|Withdrawal of Consent|1|||
127920944|NCT01211262|460332502|FG001|Overall Study|Withdrawal of Consent|0|||
127920945|NCT01211262|460332501|FG000|Overall Study|Other|0|||
127920946|NCT01211262|460332502|FG001|Overall Study|Other|1|||
127920947|NCT04768114|460332503|FG000|Overall Study|Lost to Follow-up|5|||
127920948|NCT04768114|460332504|FG001|Overall Study|Lost to Follow-up|10|||
127920949|NCT04768114|460332503|FG000|Overall Study|Withdrawal by Subject|0|||
127920950|NCT04768114|460332504|FG001|Overall Study|Withdrawal by Subject|1|||
127920951|NCT00715676|460332509|FG000|Overall Study|Adverse Event|3|||
127920952|NCT00715676|460332510|FG001|Overall Study|Adverse Event|5|||
127920953|NCT00715676|460332511|FG002|Overall Study|Adverse Event|21|||
127920954|NCT00715676|460332509|FG000|Overall Study|Withdrawal by Subject|1|||
127920955|NCT00715676|460332510|FG001|Overall Study|Withdrawal by Subject|3|||
127920956|NCT00715676|460332511|FG002|Overall Study|Withdrawal by Subject|8|||
127920957|NCT00715676|460332509|FG000|Overall Study|Lost to Follow-up|1|||
127920958|NCT00715676|460332510|FG001|Overall Study|Lost to Follow-up|2|||
127920959|NCT00715676|460332511|FG002|Overall Study|Lost to Follow-up|1|||
127920960|NCT00715676|460332509|FG000|Overall Study|Terminated by Sponsor|1|||
127920961|NCT00715676|460332510|FG001|Overall Study|Terminated by Sponsor|0|||
127920962|NCT00715676|460332511|FG002|Overall Study|Terminated by Sponsor|0|||
127920963|NCT00715676|460332509|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
127920964|NCT00715676|460332510|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
127920965|NCT00715676|460332511|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
127920966|NCT00715676|460332509|FG000|Overall Study|Use of Exclusionary Medication|0|||
127920967|NCT00715676|460332510|FG001|Overall Study|Use of Exclusionary Medication|0|||
127920968|NCT00715676|460332511|FG002|Overall Study|Use of Exclusionary Medication|1|||
127920969|NCT00715676|460332509|FG000|Overall Study|Elevated Blood Glucose|0|||
127920970|NCT00715676|460332510|FG001|Overall Study|Elevated Blood Glucose|1|||
127920971|NCT00715676|460332511|FG002|Overall Study|Elevated Blood Glucose|0|||
127920972|NCT01091363|460332512|FG000|Overall Study|Withdrawal by Subject|11|||
127920973|NCT01091363|460332513|FG001|Overall Study|Withdrawal by Subject|15|||
127920974|NCT01091363|460332512|FG000|Overall Study|Lost to Follow-up|2|||
127920975|NCT01091363|460332513|FG001|Overall Study|Lost to Follow-up|2|||
127920976|NCT00360490|460332518|FG000|Overall Study|Adverse Event|4|||
127920977|NCT00360490|460332519|FG001|Overall Study|Adverse Event|2|||
127920978|NCT00360490|460332518|FG000|Overall Study|Lost to Follow-up|2|||
127920979|NCT00360490|460332519|FG001|Overall Study|Lost to Follow-up|1|||
127920980|NCT00360490|460332518|FG000|Overall Study|Physician Decision|2|||
127920981|NCT00360490|460332519|FG001|Overall Study|Physician Decision|1|||
127920982|NCT00360490|460332518|FG000|Overall Study|Protocol Violation|0|||
127920983|NCT00360490|460332519|FG001|Overall Study|Protocol Violation|4|||
127920984|NCT00360490|460332518|FG000|Overall Study|Withdrawal by Subject|1|||
127920985|NCT00360490|460332519|FG001|Overall Study|Withdrawal by Subject|3|||
127920986|NCT01517867|460332521|FG000|Overall Study|never started treatment|29|||
127920987|NCT01517867|460332522|FG001|Overall Study|never started treatment|32|||
127920988|NCT01517867|460332521|FG000|Overall Study|Withdrawal by Subject|34|||
127920989|NCT01517867|460332522|FG001|Overall Study|Withdrawal by Subject|30|||
127920990|NCT01517867|460332521|FG000|Overall Study|Still in treatment at study end|0|||
127920991|NCT01517867|460332522|FG001|Overall Study|Still in treatment at study end|3|||
127920992|NCT03294317|460332524|FG000|Overall Study|Physician Decision|1|||
127920993|NCT03294317|460332524|FG000|Overall Study|Withdrawal by Subject|6|||
127920994|NCT03294317|460332524|FG000|Overall Study|Lost to Follow-up|1|||
127920995|NCT03294317|460332524|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
127920996|NCT03294317|460332524|FG000|Overall Study|Failed HB lead implant|8|||
127920997|NCT03294317|460332524|FG000|Overall Study|Received CRT instead|1|||
127920998|NCT03294317|460332524|FG000|Overall Study|Exited after lead revision|2|||
127920999|NCT01266603|460332525|FG000|Overall Study|Adverse Event|1|||
127921000|NCT01266603|460332525|FG000|Overall Study|Lack of Efficacy|14|||
127921001|NCT01266603|460332525|FG000|Overall Study|Withdrawal by Subject|1|||
127921002|NCT01266603|460332525|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
127921003|NCT02387762|460332526|FG000|Overall Study|Withdrawal by Subject|1|||
127921004|NCT02387762|460332527|FG001|Overall Study|Withdrawal by Subject|0|||
127921005|NCT01598896|460332535|FG000|Overall Study|Withdrawal by Subject|0|||
127921006|NCT01598896|460332536|FG001|Overall Study|Withdrawal by Subject|1|||
127921007|NCT01598896|460332535|FG000|Overall Study|Lack of Efficacy|0|||
127921008|NCT01598896|460332536|FG001|Overall Study|Lack of Efficacy|1|||
127921009|NCT01120691|460332537|FG000|Overall Study|Adverse Event|59|||
127921010|NCT01120691|460332538|FG001|Overall Study|Adverse Event|67|||
127921011|NCT01120691|460332539|FG002|Overall Study|Adverse Event|47|||
127921012|NCT01120691|460332537|FG000|Overall Study|Subject withdrew consent|33|||
127921013|NCT01120691|460332538|FG001|Overall Study|Subject withdrew consent|50|||
127921014|NCT01120691|460332539|FG002|Overall Study|Subject withdrew consent|44|||
127921015|NCT01120691|460332537|FG000|Overall Study|Death|21|||
127921016|NCT01120691|460332538|FG001|Overall Study|Death|22|||
127921017|NCT01120691|460332539|FG002|Overall Study|Death|24|||
127921018|NCT01120691|460332537|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
127921019|NCT01120691|460332538|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
127921020|NCT01120691|460332539|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
127921021|NCT01120691|460332537|FG000|Overall Study|Administrative problems|15|||
127921022|NCT01120691|460332538|FG001|Overall Study|Administrative problems|8|||
127921023|NCT01120691|460332539|FG002|Overall Study|Administrative problems|9|||
127921024|NCT01120691|460332537|FG000|Overall Study|Protocol deviation|13|||
127921025|NCT01120691|460332538|FG001|Overall Study|Protocol deviation|12|||
127921026|NCT01120691|460332539|FG002|Overall Study|Protocol deviation|12|||
127921027|NCT01120691|460332537|FG000|Overall Study|Lost to Follow-up|5|||
127921028|NCT01120691|460332538|FG001|Overall Study|Lost to Follow-up|6|||
127921029|NCT01120691|460332539|FG002|Overall Study|Lost to Follow-up|4|||
127921030|NCT01120691|460332537|FG000|Overall Study|Abnormal test procedure result(s)|3|||
127921031|NCT01120691|460332538|FG001|Overall Study|Abnormal test procedure result(s)|2|||
127921032|NCT01120691|460332539|FG002|Overall Study|Abnormal test procedure result(s)|1|||
127921033|NCT01120691|460332537|FG000|Overall Study|Patient's inability to use the device|3|||
127921034|NCT01120691|460332538|FG001|Overall Study|Patient's inability to use the device|1|||
127921035|NCT01120691|460332539|FG002|Overall Study|Patient's inability to use the device|0|||
127921036|NCT01120691|460332537|FG000|Overall Study|Abnormal laboratory value(s)|1|||
127921037|NCT01120691|460332538|FG001|Overall Study|Abnormal laboratory value(s)|3|||
127921038|NCT01120691|460332539|FG002|Overall Study|Abnormal laboratory value(s)|4|||
127921039|NCT03370510|460332540|FG000|Overall Study|COVID-19|2|||
127921040|NCT03370510|460332541|FG001|Overall Study|COVID-19|0|||
127921041|NCT01562613|460332542|FG000|Overall Study|Lost to Follow-up|2|||
127921042|NCT01562613|460332542|FG000|Overall Study|Withdrawal by Subject|2|||
127921043|NCT01525628|460332549|FG000|Overall Study|Adverse Event|1|||
127921044|NCT01525628|460332550|FG001|Overall Study|Adverse Event|1|||
127921045|NCT01525628|460332551|FG002|Overall Study|Adverse Event|2|||
127921046|NCT01525628|460332552|FG003|Overall Study|Adverse Event|0|||
127921047|NCT01525628|460332553|FG004|Overall Study|Adverse Event|1|||
127921048|NCT01525628|460332549|FG000|Overall Study|Lack of Efficacy|0|||
127921049|NCT01525628|460332550|FG001|Overall Study|Lack of Efficacy|2|||
127921050|NCT01525628|460332551|FG002|Overall Study|Lack of Efficacy|2|||
127921051|NCT01525628|460332552|FG003|Overall Study|Lack of Efficacy|1|||
127921052|NCT01525628|460332553|FG004|Overall Study|Lack of Efficacy|2|||
127921053|NCT01525628|460332549|FG000|Overall Study|Protocol Violation|0|||
127921054|NCT01525628|460332550|FG001|Overall Study|Protocol Violation|0|||
127921055|NCT01525628|460332551|FG002|Overall Study|Protocol Violation|1|||
127921056|NCT01525628|460332552|FG003|Overall Study|Protocol Violation|0|||
127921057|NCT01525628|460332553|FG004|Overall Study|Protocol Violation|0|||
127921058|NCT01525628|460332549|FG000|Overall Study|Lost to Follow-up|1|||
127921059|NCT01525628|460332550|FG001|Overall Study|Lost to Follow-up|1|||
127921060|NCT01525628|460332551|FG002|Overall Study|Lost to Follow-up|0|||
127921061|NCT01525628|460332552|FG003|Overall Study|Lost to Follow-up|0|||
127921062|NCT01525628|460332553|FG004|Overall Study|Lost to Follow-up|0|||
127921063|NCT01525628|460332549|FG000|Overall Study|Withdrawal by Subject|0|||
127921064|NCT01525628|460332550|FG001|Overall Study|Withdrawal by Subject|1|||
127921065|NCT01525628|460332551|FG002|Overall Study|Withdrawal by Subject|0|||
127921066|NCT01525628|460332552|FG003|Overall Study|Withdrawal by Subject|0|||
127921067|NCT01525628|460332553|FG004|Overall Study|Withdrawal by Subject|0|||
127921068|NCT01525628|460332549|FG000|Overall Study|Other reason not defined above|0|||
127921069|NCT01525628|460332550|FG001|Overall Study|Other reason not defined above|0|||
127921070|NCT01525628|460332551|FG002|Overall Study|Other reason not defined above|0|||
127921071|NCT01525628|460332552|FG003|Overall Study|Other reason not defined above|3|||
127921072|NCT01525628|460332553|FG004|Overall Study|Other reason not defined above|0|||
127921073|NCT00239005|460332554|FG000|Overall Study|Adverse Event|6|||
127921074|NCT00239005|460332555|FG001|Overall Study|Adverse Event|6|||
127921075|NCT00239005|460332554|FG000|Overall Study|Withdrawal by Subject|3|||
127921076|NCT00239005|460332555|FG001|Overall Study|Withdrawal by Subject|4|||
127921077|NCT00239005|460332554|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
127921078|NCT00239005|460332555|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
127921079|NCT00239005|460332554|FG000|Overall Study|Protocol Violation|1|||
127921080|NCT00239005|460332555|FG001|Overall Study|Protocol Violation|0|||
127921081|NCT00239005|460332554|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
127921082|NCT00239005|460332555|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
127921083|NCT00239005|460332554|FG000|Overall Study|Lost to Follow-up|0|||
127921084|NCT00239005|460332555|FG001|Overall Study|Lost to Follow-up|1|||
127921085|NCT02614898|460332556|FG000|Overall Study|Participated until study termination|10|||
127921086|NCT02614898|460332557|FG001|Overall Study|Participated until study termination|26|||
127921087|NCT02614898|460332556|FG000|Overall Study|Lost to Follow-up|0|||
127921088|NCT02614898|460332557|FG001|Overall Study|Lost to Follow-up|2|||
127921089|NCT02614898|460332556|FG000|Overall Study|Physician Decision|1|||
127921090|NCT02614898|460332557|FG001|Overall Study|Physician Decision|8|||
127921091|NCT02614898|460332556|FG000|Overall Study|Study Terminated by Sponsor|3|||
127921092|NCT02614898|460332557|FG001|Overall Study|Study Terminated by Sponsor|0|||
127921093|NCT02614898|460332556|FG000|Overall Study|Withdrawal by Subject|0|||
127921094|NCT02614898|460332557|FG001|Overall Study|Withdrawal by Subject|2|||
127921095|NCT02614898|460332556|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
127921096|NCT02614898|460332557|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
127921097|NCT02614898|460332556|FG000|Overall Study|Other-Additional Information Unavailable|0|||
127921098|NCT02614898|460332557|FG001|Overall Study|Other-Additional Information Unavailable|11|||
127921099|NCT02614898|460332556|FG000|Overall Study|Missing|0|||
127921100|NCT02614898|460332557|FG001|Overall Study|Missing|1|||
127921101|NCT00787605|460332558|FG000|Overall Study|Administrative Problems|3|||
127921102|NCT00787605|460332559|FG001|Overall Study|Administrative Problems|0|||
127921103|NCT00787605|460332558|FG000|Overall Study|Adverse Event|14|||
127921104|NCT00787605|460332559|FG001|Overall Study|Adverse Event|25|||
127921105|NCT00787605|460332558|FG000|Overall Study|Lost to Follow-up|3|||
127921106|NCT00787605|460332559|FG001|Overall Study|Lost to Follow-up|6|||
127921107|NCT00787605|460332558|FG000|Overall Study|Protocol Violation|7|||
127921108|NCT00787605|460332559|FG001|Overall Study|Protocol Violation|3|||
127921109|NCT00787605|460332558|FG000|Overall Study|Withdrawal by Subject|6|||
127921110|NCT00787605|460332559|FG001|Overall Study|Withdrawal by Subject|13|||
127921111|NCT00787605|460332558|FG000|Overall Study|Lack of Efficacy|13|||
127921112|NCT00787605|460332559|FG001|Overall Study|Lack of Efficacy|9|||
127921113|NCT03382041|460332560|FG000|Overall Study|Consent Form Lost|2|||
127921114|NCT03382041|460332561|FG001|Overall Study|Consent Form Lost|1|||
127921115|NCT03382041|460332560|FG000|Overall Study|Withdrawal by Subject|1|||
127921116|NCT03382041|460332561|FG001|Overall Study|Withdrawal by Subject|4|||
127921117|NCT03382041|460332560|FG000|Overall Study|Lost to Follow-up|1|||
127921118|NCT03382041|460332561|FG001|Overall Study|Lost to Follow-up|4|||
127921119|NCT04428645|460332567|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
127921120|NCT01705717|460334581|FG000|Overall Study|Adverse Event|2|||
127921121|NCT01705717|460334582|FG001|Overall Study|Adverse Event|2|||
127921122|NCT01705717|460334581|FG000|Overall Study|Lack of Efficacy|0|||
127921123|NCT01705717|460334582|FG001|Overall Study|Lack of Efficacy|1|||
127921124|NCT01705717|460334581|FG000|Overall Study|Other|0|||
127921125|NCT01705717|460334582|FG001|Overall Study|Other|2|||
127921126|NCT01257581|460334583|FG000|Overall Study|Early Termination|3|||
127921127|NCT01257581|460334584|FG001|Overall Study|Early Termination|1|||
127921128|NCT01257581|460334585|FG002|Overall Study|Early Termination|2|||
127921129|NCT01257581|460334583|FG000|Overall Study|Death|2|||
127921130|NCT01257581|460334584|FG001|Overall Study|Death|2|||
127921131|NCT01257581|460334585|FG002|Overall Study|Death|4|||
127921132|NCT02754492|460334590|FG000|Overall Study|Protocol Violation|2|||
127921133|NCT02754492|460334591|FG001|Overall Study|Protocol Violation|2|||
127921134|NCT02754492|460334592|FG002|Overall Study|Protocol Violation|0|||
127921135|NCT02754492|460334593|FG003|Overall Study|Protocol Violation|1|||
127921136|NCT02754492|460334590|FG000|Overall Study|Withdrawal by Subject|2|||
127921137|NCT02754492|460334591|FG001|Overall Study|Withdrawal by Subject|0|||
127921138|NCT02754492|460334592|FG002|Overall Study|Withdrawal by Subject|0|||
127921139|NCT02754492|460334593|FG003|Overall Study|Withdrawal by Subject|0|||
127921140|NCT02754492|460334590|FG000|Overall Study|Equipment malfuntion|0|||
127921141|NCT02754492|460334591|FG001|Overall Study|Equipment malfuntion|0|||
127921142|NCT02754492|460334592|FG002|Overall Study|Equipment malfuntion|2|||
127921143|NCT02754492|460334593|FG003|Overall Study|Equipment malfuntion|5|||
127921144|NCT02754492|460334590|FG000|Overall Study|Adverse Event|0|||
127921145|NCT02754492|460334591|FG001|Overall Study|Adverse Event|0|||
127921146|NCT02754492|460334592|FG002|Overall Study|Adverse Event|0|||
127921147|NCT02754492|460334593|FG003|Overall Study|Adverse Event|13|||
127921148|NCT02754492|460334590|FG000|Overall Study|Venous access issues not resulting in AE|0|||
127921149|NCT02754492|460334591|FG001|Overall Study|Venous access issues not resulting in AE|0|||
127921150|NCT02754492|460334592|FG002|Overall Study|Venous access issues not resulting in AE|0|||
127921151|NCT02754492|460334593|FG003|Overall Study|Venous access issues not resulting in AE|4|||
127921152|NCT00611884|460334594|FG000|Overall Study|Adverse Event|1|||
127921153|NCT00611884|460334595|FG001|Overall Study|Adverse Event|0|||
127921154|NCT00611884|460334596|FG002|Overall Study|Adverse Event|0|||
127921155|NCT00611884|460334597|FG003|Overall Study|Adverse Event|1|||
127921156|NCT00611884|460334594|FG000|Overall Study|Non-Compliance|1|||
127921157|NCT00611884|460334595|FG001|Overall Study|Non-Compliance|4|||
127921158|NCT00611884|460334596|FG002|Overall Study|Non-Compliance|2|||
127921159|NCT00611884|460334597|FG003|Overall Study|Non-Compliance|2|||
127921160|NCT00611884|460334594|FG000|Overall Study|Lack of Efficacy|0|||
127921161|NCT00611884|460334595|FG001|Overall Study|Lack of Efficacy|1|||
127921162|NCT00611884|460334596|FG002|Overall Study|Lack of Efficacy|0|||
127921163|NCT00611884|460334597|FG003|Overall Study|Lack of Efficacy|0|||
127921164|NCT00611884|460334594|FG000|Overall Study|Unclassified|7|||
127921165|NCT00611884|460334595|FG001|Overall Study|Unclassified|4|||
127921166|NCT00611884|460334596|FG002|Overall Study|Unclassified|2|||
127921167|NCT00611884|460334597|FG003|Overall Study|Unclassified|3|||
127921168|NCT00981799|460334598|FG000|Overall Study|Adverse Event|1|||
127921169|NCT00981799|460334599|FG001|Overall Study|Adverse Event|1|||
127921170|NCT00981799|460334600|FG002|Overall Study|Adverse Event|0|||
127921171|NCT00981799|460334601|FG003|Overall Study|Adverse Event|0|||
127921172|NCT00687739|460334602|FG000|Overall Study|Lost to Follow-up|2|||
127921173|NCT00687739|460334603|FG001|Overall Study|Lost to Follow-up|2|||
127921174|NCT00687739|460334604|FG002|Overall Study|Lost to Follow-up|1|||
127921175|NCT00687739|460334605|FG003|Overall Study|Lost to Follow-up|2|||
127921176|NCT00687739|460334602|FG000|Overall Study|Adverse Event|0|||
127921177|NCT00687739|460334603|FG001|Overall Study|Adverse Event|1|||
127921178|NCT00687739|460334604|FG002|Overall Study|Adverse Event|1|||
127921179|NCT00687739|460334605|FG003|Overall Study|Adverse Event|0|||
127921180|NCT01190930|460334606|FG000|Induction|Adverse Event|17|||
127921181|NCT01190930|460334607|FG001|Induction|Adverse Event|0|||
127921182|NCT01190930|460334608|FG002|Induction|Adverse Event|0|||
127921183|NCT01190930|460334609|FG003|Induction|Adverse Event|0|||
127921184|NCT01190930|460334610|FG004|Induction|Adverse Event|0|||
127921185|NCT01190930|460334611|FG005|Induction|Adverse Event|0|||
127921186|NCT01190930|460334612|FG006|Induction|Adverse Event|0|||
127921187|NCT01190930|460334613|FG007|Induction|Adverse Event|0|||
127921188|NCT01190930|460334614|FG008|Induction|Adverse Event|0|||
127921189|NCT01190930|460334615|FG009|Induction|Adverse Event|0|||
127921190|NCT01190930|460334606|FG000|Induction|Death|34|||
127921191|NCT01190930|460334607|FG001|Induction|Death|0|||
127921192|NCT01190930|460334608|FG002|Induction|Death|0|||
127921193|NCT01190930|460334609|FG003|Induction|Death|0|||
127921194|NCT01190930|460334610|FG004|Induction|Death|0|||
127921195|NCT01190930|460334611|FG005|Induction|Death|0|||
127921196|NCT01190930|460334612|FG006|Induction|Death|0|||
127921197|NCT01190930|460334613|FG007|Induction|Death|0|||
127921198|NCT01190930|460334614|FG008|Induction|Death|0|||
127921199|NCT01190930|460334615|FG009|Induction|Death|0|||
127921200|NCT01190930|460334606|FG000|Induction|Lost to Follow-up|1|||
127921201|NCT01190930|460334607|FG001|Induction|Lost to Follow-up|0|||
127921202|NCT01190930|460334608|FG002|Induction|Lost to Follow-up|0|||
127921203|NCT01190930|460334609|FG003|Induction|Lost to Follow-up|0|||
127921204|NCT01190930|460334610|FG004|Induction|Lost to Follow-up|0|||
127921205|NCT01190930|460334611|FG005|Induction|Lost to Follow-up|0|||
127921206|NCT01190930|460334612|FG006|Induction|Lost to Follow-up|0|||
127921207|NCT01190930|460334613|FG007|Induction|Lost to Follow-up|0|||
127921208|NCT01190930|460334614|FG008|Induction|Lost to Follow-up|0|||
127921209|NCT01190930|460334615|FG009|Induction|Lost to Follow-up|0|||
127921210|NCT01190930|460334606|FG000|Induction|Physician Decision|125|||
127921211|NCT01190930|460334607|FG001|Induction|Physician Decision|3|||
127921212|NCT01190930|460334608|FG002|Induction|Physician Decision|0|||
127921213|NCT01190930|460334609|FG003|Induction|Physician Decision|0|||
127921214|NCT01190930|460334610|FG004|Induction|Physician Decision|0|||
127921215|NCT01190930|460334611|FG005|Induction|Physician Decision|0|||
127921216|NCT01190930|460334612|FG006|Induction|Physician Decision|0|||
127921217|NCT01190930|460334613|FG007|Induction|Physician Decision|0|||
127921218|NCT01190930|460334614|FG008|Induction|Physician Decision|0|||
127921219|NCT01190930|460334615|FG009|Induction|Physician Decision|0|||
127921220|NCT01190930|460334606|FG000|Induction|Withdrawal by Subject|9|||
127921221|NCT01190930|460334607|FG001|Induction|Withdrawal by Subject|0|||
127921222|NCT01190930|460334608|FG002|Induction|Withdrawal by Subject|0|||
127921223|NCT01190930|460334609|FG003|Induction|Withdrawal by Subject|0|||
127921224|NCT01190930|460334610|FG004|Induction|Withdrawal by Subject|0|||
127921225|NCT01190930|460334611|FG005|Induction|Withdrawal by Subject|0|||
127921226|NCT01190930|460334612|FG006|Induction|Withdrawal by Subject|0|||
127921227|NCT01190930|460334613|FG007|Induction|Withdrawal by Subject|0|||
127921228|NCT01190930|460334614|FG008|Induction|Withdrawal by Subject|0|||
127921229|NCT01190930|460334615|FG009|Induction|Withdrawal by Subject|0|||
127921230|NCT01190930|460334606|FG000|Induction|Refusal|235|||
127921231|NCT01190930|460334607|FG001|Induction|Refusal|0|||
127921232|NCT01190930|460334608|FG002|Induction|Refusal|0|||
127921233|NCT01190930|460334609|FG003|Induction|Refusal|0|||
127921234|NCT01190930|460334610|FG004|Induction|Refusal|0|||
127921235|NCT01190930|460334611|FG005|Induction|Refusal|0|||
127921236|NCT01190930|460334612|FG006|Induction|Refusal|0|||
127921237|NCT01190930|460334613|FG007|Induction|Refusal|0|||
127921238|NCT01190930|460334614|FG008|Induction|Refusal|0|||
127921239|NCT01190930|460334615|FG009|Induction|Refusal|0|||
127921240|NCT01190930|460334606|FG000|Induction|Inevaluable|23|||
127921241|NCT01190930|460334607|FG001|Induction|Inevaluable|1|||
127921242|NCT01190930|460334608|FG002|Induction|Inevaluable|0|||
127921243|NCT01190930|460334609|FG003|Induction|Inevaluable|0|||
127921244|NCT01190930|460334610|FG004|Induction|Inevaluable|0|||
127921245|NCT01190930|460334611|FG005|Induction|Inevaluable|0|||
127921246|NCT01190930|460334612|FG006|Induction|Inevaluable|0|||
127921247|NCT01190930|460334613|FG007|Induction|Inevaluable|0|||
127921248|NCT01190930|460334614|FG008|Induction|Inevaluable|0|||
127921249|NCT01190930|460334615|FG009|Induction|Inevaluable|0|||
127921250|NCT01190930|460334606|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
127921251|NCT01190930|460334607|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
127921252|NCT01190930|460334608|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
127921253|NCT01190930|460334609|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
127921254|NCT01190930|460334610|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
127921255|NCT01190930|460334611|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
127921256|NCT01190930|460334612|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
127921257|NCT01190930|460334613|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
127921258|NCT01190930|460334614|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
127921259|NCT01190930|460334615|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
127921260|NCT01190930|460334606|FG000|Induction|High Risk Downs|80|||
127921261|NCT01190930|460334607|FG001|Induction|High Risk Downs|0|||
127921262|NCT01190930|460334608|FG002|Induction|High Risk Downs|0|||
127921263|NCT01190930|460334609|FG003|Induction|High Risk Downs|0|||
127921264|NCT01190930|460334610|FG004|Induction|High Risk Downs|0|||
127921265|NCT01190930|460334611|FG005|Induction|High Risk Downs|0|||
127921266|NCT01190930|460334612|FG006|Induction|High Risk Downs|0|||
127921267|NCT01190930|460334613|FG007|Induction|High Risk Downs|0|||
127921268|NCT01190930|460334614|FG008|Induction|High Risk Downs|0|||
127921269|NCT01190930|460334615|FG009|Induction|High Risk Downs|0|||
127921270|NCT01190930|460334606|FG000|Induction|Enrollment onto another COG Protocol|1|||
127921271|NCT01190930|460334607|FG001|Induction|Enrollment onto another COG Protocol|0|||
127921272|NCT01190930|460334608|FG002|Induction|Enrollment onto another COG Protocol|0|||
127921273|NCT01190930|460334609|FG003|Induction|Enrollment onto another COG Protocol|0|||
127921274|NCT01190930|460334610|FG004|Induction|Enrollment onto another COG Protocol|0|||
127921275|NCT01190930|460334611|FG005|Induction|Enrollment onto another COG Protocol|0|||
127921276|NCT01190930|460334612|FG006|Induction|Enrollment onto another COG Protocol|0|||
127921277|NCT01190930|460334613|FG007|Induction|Enrollment onto another COG Protocol|0|||
127921278|NCT01190930|460334614|FG008|Induction|Enrollment onto another COG Protocol|0|||
127921279|NCT01190930|460334615|FG009|Induction|Enrollment onto another COG Protocol|0|||
127921280|NCT01190930|460334606|FG000|Induction|Average Risk|1847|||
127921281|NCT01190930|460334607|FG001|Induction|Average Risk|0|||
127921282|NCT01190930|460334608|FG002|Induction|Average Risk|0|||
127921283|NCT01190930|460334609|FG003|Induction|Average Risk|0|||
127921284|NCT01190930|460334610|FG004|Induction|Average Risk|0|||
127921285|NCT01190930|460334611|FG005|Induction|Average Risk|0|||
127921286|NCT01190930|460334612|FG006|Induction|Average Risk|0|||
127921287|NCT01190930|460334613|FG007|Induction|Average Risk|0|||
127921288|NCT01190930|460334614|FG008|Induction|Average Risk|0|||
127921289|NCT01190930|460334615|FG009|Induction|Average Risk|0|||
127921290|NCT01190930|460334606|FG000|Induction|High Risk|1227|||
127921291|NCT01190930|460334607|FG001|Induction|High Risk|0|||
127921292|NCT01190930|460334608|FG002|Induction|High Risk|0|||
127921293|NCT01190930|460334609|FG003|Induction|High Risk|0|||
127921294|NCT01190930|460334610|FG004|Induction|High Risk|0|||
127921295|NCT01190930|460334611|FG005|Induction|High Risk|0|||
127921296|NCT01190930|460334612|FG006|Induction|High Risk|0|||
127921297|NCT01190930|460334613|FG007|Induction|High Risk|0|||
127921298|NCT01190930|460334614|FG008|Induction|High Risk|0|||
127921299|NCT01190930|460334615|FG009|Induction|High Risk|0|||
127921300|NCT01190930|460334606|FG000|Induction|Low Risk|443|||
127921301|NCT01190930|460334607|FG001|Induction|Low Risk|0|||
127921302|NCT01190930|460334608|FG002|Induction|Low Risk|0|||
127921303|NCT01190930|460334609|FG003|Induction|Low Risk|0|||
127921304|NCT01190930|460334610|FG004|Induction|Low Risk|0|||
127921305|NCT01190930|460334611|FG005|Induction|Low Risk|0|||
127921306|NCT01190930|460334612|FG006|Induction|Low Risk|0|||
127921307|NCT01190930|460334613|FG007|Induction|Low Risk|0|||
127921308|NCT01190930|460334614|FG008|Induction|Low Risk|0|||
127921309|NCT01190930|460334615|FG009|Induction|Low Risk|0|||
127921310|NCT01190930|460334606|FG000|Induction|Very High Risk|1012|||
127921311|NCT01190930|460334607|FG001|Induction|Very High Risk|0|||
127921312|NCT01190930|460334608|FG002|Induction|Very High Risk|0|||
127921313|NCT01190930|460334609|FG003|Induction|Very High Risk|0|||
127921314|NCT01190930|460334610|FG004|Induction|Very High Risk|0|||
127921315|NCT01190930|460334611|FG005|Induction|Very High Risk|0|||
127921316|NCT01190930|460334612|FG006|Induction|Very High Risk|0|||
127921317|NCT01190930|460334613|FG007|Induction|Very High Risk|0|||
127921318|NCT01190930|460334614|FG008|Induction|Very High Risk|0|||
127921319|NCT01190930|460334615|FG009|Induction|Very High Risk|0|||
127921320|NCT01190930|460334606|FG000|Induction|Philadelphia chromosome-positive|99|||
127921321|NCT01190930|460334607|FG001|Induction|Philadelphia chromosome-positive|0|||
127921322|NCT01190930|460334608|FG002|Induction|Philadelphia chromosome-positive|0|||
127921323|NCT01190930|460334609|FG003|Induction|Philadelphia chromosome-positive|0|||
127921324|NCT01190930|460334610|FG004|Induction|Philadelphia chromosome-positive|0|||
127921325|NCT01190930|460334611|FG005|Induction|Philadelphia chromosome-positive|0|||
127921326|NCT01190930|460334612|FG006|Induction|Philadelphia chromosome-positive|0|||
127921327|NCT01190930|460334613|FG007|Induction|Philadelphia chromosome-positive|0|||
127921328|NCT01190930|460334614|FG008|Induction|Philadelphia chromosome-positive|0|||
127921329|NCT01190930|460334615|FG009|Induction|Philadelphia chromosome-positive|0|||
127921330|NCT01190930|460334606|FG000|Induction|Incomplete Induction data|63|||
127921331|NCT01190930|460334607|FG001|Induction|Incomplete Induction data|0|||
127921332|NCT01190930|460334608|FG002|Induction|Incomplete Induction data|0|||
127921333|NCT01190930|460334609|FG003|Induction|Incomplete Induction data|0|||
127921334|NCT01190930|460334610|FG004|Induction|Incomplete Induction data|0|||
127921335|NCT01190930|460334611|FG005|Induction|Incomplete Induction data|0|||
127921336|NCT01190930|460334612|FG006|Induction|Incomplete Induction data|0|||
127921337|NCT01190930|460334613|FG007|Induction|Incomplete Induction data|0|||
127921338|NCT01190930|460334614|FG008|Induction|Incomplete Induction data|0|||
127921339|NCT01190930|460334615|FG009|Induction|Incomplete Induction data|0|||
127921340|NCT01190930|460334606|FG000|Induction|Progressive disease|0|||
127921341|NCT01190930|460334607|FG001|Induction|Progressive disease|1|||
127921342|NCT01190930|460334608|FG002|Induction|Progressive disease|0|||
127921343|NCT01190930|460334609|FG003|Induction|Progressive disease|0|||
127921344|NCT01190930|460334610|FG004|Induction|Progressive disease|0|||
127921345|NCT01190930|460334611|FG005|Induction|Progressive disease|0|||
127921346|NCT01190930|460334612|FG006|Induction|Progressive disease|0|||
127921347|NCT01190930|460334613|FG007|Induction|Progressive disease|0|||
127921348|NCT01190930|460334614|FG008|Induction|Progressive disease|0|||
127921349|NCT01190930|460334615|FG009|Induction|Progressive disease|0|||
127921350|NCT01190930|460334606|FG000|Induction|No treatment|3|||
127921351|NCT01190930|460334607|FG001|Induction|No treatment|0|||
127921352|NCT01190930|460334608|FG002|Induction|No treatment|0|||
127921353|NCT01190930|460334609|FG003|Induction|No treatment|0|||
127921354|NCT01190930|460334610|FG004|Induction|No treatment|0|||
127921355|NCT01190930|460334611|FG005|Induction|No treatment|0|||
127921356|NCT01190930|460334612|FG006|Induction|No treatment|0|||
127921357|NCT01190930|460334613|FG007|Induction|No treatment|0|||
127921358|NCT01190930|460334614|FG008|Induction|No treatment|0|||
127921359|NCT01190930|460334615|FG009|Induction|No treatment|0|||
127921360|NCT01190930|460334606|FG000|Induction|Ineligible|69|||
127921361|NCT01190930|460334607|FG001|Induction|Ineligible|4|||
127921362|NCT01190930|460334608|FG002|Induction|Ineligible|0|||
127921363|NCT01190930|460334609|FG003|Induction|Ineligible|0|||
127921364|NCT01190930|460334610|FG004|Induction|Ineligible|0|||
127921365|NCT01190930|460334611|FG005|Induction|Ineligible|0|||
127921366|NCT01190930|460334612|FG006|Induction|Ineligible|0|||
127921367|NCT01190930|460334613|FG007|Induction|Ineligible|0|||
127921368|NCT01190930|460334614|FG008|Induction|Ineligible|0|||
127921369|NCT01190930|460334615|FG009|Induction|Ineligible|0|||
127921370|NCT01190930|460334606|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
127921371|NCT01190930|460334607|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
127921372|NCT01190930|460334608|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
127921373|NCT01190930|460334609|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
127921374|NCT01190930|460334610|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
127921375|NCT01190930|460334611|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
127921376|NCT01190930|460334612|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
127921377|NCT01190930|460334613|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
127921378|NCT01190930|460334614|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
127921379|NCT01190930|460334615|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
127921380|NCT01190930|460334606|FG000|Post Induction Pre-Maintenance|Death|0|||
127921381|NCT01190930|460334607|FG001|Post Induction Pre-Maintenance|Death|0|||
127921382|NCT01190930|460334608|FG002|Post Induction Pre-Maintenance|Death|8|||
127921383|NCT01190930|460334609|FG003|Post Induction Pre-Maintenance|Death|4|||
127921384|NCT01190930|460334610|FG004|Post Induction Pre-Maintenance|Death|0|||
127921385|NCT01190930|460334611|FG005|Post Induction Pre-Maintenance|Death|0|||
127921386|NCT01190930|460334612|FG006|Post Induction Pre-Maintenance|Death|0|||
127921387|NCT01190930|460334613|FG007|Post Induction Pre-Maintenance|Death|0|||
127921388|NCT01190930|460334614|FG008|Post Induction Pre-Maintenance|Death|0|||
127921389|NCT01190930|460334615|FG009|Post Induction Pre-Maintenance|Death|0|||
127921390|NCT01190930|460334606|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
127921391|NCT01190930|460334607|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
127921392|NCT01190930|460334608|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
127921393|NCT01190930|460334609|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
127921394|NCT01190930|460334610|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
127921395|NCT01190930|460334611|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
127921396|NCT01190930|460334612|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
127921397|NCT01190930|460334613|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
127921398|NCT01190930|460334614|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
127921399|NCT01190930|460334615|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
127921400|NCT01190930|460334606|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
127921401|NCT01190930|460334607|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
127921402|NCT01190930|460334608|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
127921403|NCT01190930|460334609|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
127921404|NCT01190930|460334610|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
127921405|NCT01190930|460334611|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
127921406|NCT01190930|460334612|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
127921407|NCT01190930|460334613|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
127921408|NCT01190930|460334614|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
127921409|NCT01190930|460334615|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
127921410|NCT01190930|460334606|FG000|Post Induction Pre-Maintenance|Refusal|0|||
127921411|NCT01190930|460334607|FG001|Post Induction Pre-Maintenance|Refusal|2|||
127921412|NCT01190930|460334608|FG002|Post Induction Pre-Maintenance|Refusal|694|||
127921413|NCT01190930|460334609|FG003|Post Induction Pre-Maintenance|Refusal|4|||
127921414|NCT01190930|460334610|FG004|Post Induction Pre-Maintenance|Refusal|0|||
127921415|NCT01190930|460334611|FG005|Post Induction Pre-Maintenance|Refusal|3|||
127921416|NCT01190930|460334612|FG006|Post Induction Pre-Maintenance|Refusal|0|||
127921417|NCT01190930|460334613|FG007|Post Induction Pre-Maintenance|Refusal|0|||
127921418|NCT01190930|460334614|FG008|Post Induction Pre-Maintenance|Refusal|0|||
127921419|NCT01190930|460334615|FG009|Post Induction Pre-Maintenance|Refusal|0|||
127921420|NCT01190930|460334606|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
127921421|NCT01190930|460334607|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
127921422|NCT01190930|460334608|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
127921423|NCT01190930|460334609|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
127921424|NCT01190930|460334610|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
127921425|NCT01190930|460334611|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
127921426|NCT01190930|460334612|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
127921427|NCT01190930|460334613|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
127921428|NCT01190930|460334614|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
127921429|NCT01190930|460334615|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
127921430|NCT01190930|460334606|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
127921431|NCT01190930|460334607|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
127921432|NCT01190930|460334608|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
127921433|NCT01190930|460334609|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
127921434|NCT01190930|460334610|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
127921435|NCT01190930|460334611|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
127921436|NCT01190930|460334612|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
127921437|NCT01190930|460334613|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
127921438|NCT01190930|460334614|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
127921439|NCT01190930|460334615|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
127921440|NCT01190930|460334606|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
127921441|NCT01190930|460334607|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
127921442|NCT01190930|460334608|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
127921443|NCT01190930|460334609|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
127921444|NCT01190930|460334610|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
127921445|NCT01190930|460334611|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
127921446|NCT01190930|460334612|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
127921447|NCT01190930|460334613|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
127921448|NCT01190930|460334614|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
127921449|NCT01190930|460334615|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
127921450|NCT01190930|460334606|FG000|Post Induction Pre-Maintenance|Relapse|0|||
127921451|NCT01190930|460334607|FG001|Post Induction Pre-Maintenance|Relapse|0|||
127921452|NCT01190930|460334608|FG002|Post Induction Pre-Maintenance|Relapse|1|||
127921453|NCT01190930|460334609|FG003|Post Induction Pre-Maintenance|Relapse|0|||
127921454|NCT01190930|460334610|FG004|Post Induction Pre-Maintenance|Relapse|0|||
127921455|NCT01190930|460334611|FG005|Post Induction Pre-Maintenance|Relapse|0|||
127921456|NCT01190930|460334612|FG006|Post Induction Pre-Maintenance|Relapse|0|||
127921457|NCT01190930|460334613|FG007|Post Induction Pre-Maintenance|Relapse|0|||
127921458|NCT01190930|460334614|FG008|Post Induction Pre-Maintenance|Relapse|0|||
127921459|NCT01190930|460334615|FG009|Post Induction Pre-Maintenance|Relapse|0|||
127921460|NCT01190930|460334606|FG000|Maintenance|Adverse Event|0|||
127921461|NCT01190930|460334607|FG001|Maintenance|Adverse Event|0|||
127921462|NCT01190930|460334608|FG002|Maintenance|Adverse Event|0|||
127921463|NCT01190930|460334609|FG003|Maintenance|Adverse Event|0|||
127921464|NCT01190930|460334610|FG004|Maintenance|Adverse Event|0|||
127921465|NCT01190930|460334611|FG005|Maintenance|Adverse Event|1|||
127921466|NCT01190930|460334612|FG006|Maintenance|Adverse Event|1|||
127921467|NCT01190930|460334613|FG007|Maintenance|Adverse Event|3|||
127921468|NCT01190930|460334614|FG008|Maintenance|Adverse Event|3|||
127921469|NCT01190930|460334615|FG009|Maintenance|Adverse Event|0|||
127921470|NCT01190930|460334606|FG000|Maintenance|Death|0|||
127921471|NCT01190930|460334607|FG001|Maintenance|Death|0|||
127921472|NCT01190930|460334608|FG002|Maintenance|Death|0|||
127921473|NCT01190930|460334609|FG003|Maintenance|Death|1|||
127921474|NCT01190930|460334610|FG004|Maintenance|Death|0|||
127921475|NCT01190930|460334611|FG005|Maintenance|Death|0|||
127921476|NCT01190930|460334612|FG006|Maintenance|Death|2|||
127921477|NCT01190930|460334613|FG007|Maintenance|Death|2|||
127921478|NCT01190930|460334614|FG008|Maintenance|Death|2|||
127921479|NCT01190930|460334615|FG009|Maintenance|Death|2|||
127921480|NCT01190930|460334606|FG000|Maintenance|Lost to Follow-up|0|||
127921481|NCT01190930|460334607|FG001|Maintenance|Lost to Follow-up|0|||
127921482|NCT01190930|460334608|FG002|Maintenance|Lost to Follow-up|0|||
127921483|NCT01190930|460334609|FG003|Maintenance|Lost to Follow-up|0|||
127921484|NCT01190930|460334610|FG004|Maintenance|Lost to Follow-up|0|||
127921485|NCT01190930|460334611|FG005|Maintenance|Lost to Follow-up|0|||
127921486|NCT01190930|460334612|FG006|Maintenance|Lost to Follow-up|1|||
127921487|NCT01190930|460334613|FG007|Maintenance|Lost to Follow-up|1|||
127921488|NCT01190930|460334614|FG008|Maintenance|Lost to Follow-up|1|||
127921489|NCT01190930|460334615|FG009|Maintenance|Lost to Follow-up|0|||
127921490|NCT01190930|460334606|FG000|Maintenance|Physician Decision|0|||
127921491|NCT01190930|460334607|FG001|Maintenance|Physician Decision|1|||
127921492|NCT01190930|460334608|FG002|Maintenance|Physician Decision|0|||
127921493|NCT01190930|460334609|FG003|Maintenance|Physician Decision|5|||
127921494|NCT01190930|460334610|FG004|Maintenance|Physician Decision|9|||
127921495|NCT01190930|460334611|FG005|Maintenance|Physician Decision|4|||
127921496|NCT01190930|460334612|FG006|Maintenance|Physician Decision|8|||
127921497|NCT01190930|460334613|FG007|Maintenance|Physician Decision|8|||
127921498|NCT01190930|460334614|FG008|Maintenance|Physician Decision|10|||
127921499|NCT01190930|460334615|FG009|Maintenance|Physician Decision|17|||
127921500|NCT01190930|460334606|FG000|Maintenance|Withdrawal by Subject|0|||
127921501|NCT01190930|460334607|FG001|Maintenance|Withdrawal by Subject|0|||
127921502|NCT01190930|460334608|FG002|Maintenance|Withdrawal by Subject|0|||
127921503|NCT01190930|460334609|FG003|Maintenance|Withdrawal by Subject|0|||
127921504|NCT01190930|460334610|FG004|Maintenance|Withdrawal by Subject|0|||
127921505|NCT01190930|460334611|FG005|Maintenance|Withdrawal by Subject|0|||
127921506|NCT01190930|460334612|FG006|Maintenance|Withdrawal by Subject|2|||
127921507|NCT01190930|460334613|FG007|Maintenance|Withdrawal by Subject|1|||
127921508|NCT01190930|460334614|FG008|Maintenance|Withdrawal by Subject|4|||
127921509|NCT01190930|460334615|FG009|Maintenance|Withdrawal by Subject|1|||
127921510|NCT01190930|460334606|FG000|Maintenance|Refusal|0|||
127921511|NCT01190930|460334607|FG001|Maintenance|Refusal|1|||
127921512|NCT01190930|460334608|FG002|Maintenance|Refusal|0|||
127921513|NCT01190930|460334609|FG003|Maintenance|Refusal|2|||
127921514|NCT01190930|460334610|FG004|Maintenance|Refusal|0|||
127921515|NCT01190930|460334611|FG005|Maintenance|Refusal|4|||
127921516|NCT01190930|460334612|FG006|Maintenance|Refusal|5|||
127921517|NCT01190930|460334613|FG007|Maintenance|Refusal|17|||
127921518|NCT01190930|460334614|FG008|Maintenance|Refusal|13|||
127921519|NCT01190930|460334615|FG009|Maintenance|Refusal|6|||
127921520|NCT01190930|460334606|FG000|Maintenance|second malignant neoplasm|0|||
127921521|NCT01190930|460334607|FG001|Maintenance|second malignant neoplasm|0|||
127921522|NCT01190930|460334608|FG002|Maintenance|second malignant neoplasm|0|||
127921523|NCT01190930|460334609|FG003|Maintenance|second malignant neoplasm|1|||
127921524|NCT01190930|460334610|FG004|Maintenance|second malignant neoplasm|0|||
127921525|NCT01190930|460334611|FG005|Maintenance|second malignant neoplasm|1|||
127921526|NCT01190930|460334612|FG006|Maintenance|second malignant neoplasm|0|||
127921527|NCT01190930|460334613|FG007|Maintenance|second malignant neoplasm|0|||
127921528|NCT01190930|460334614|FG008|Maintenance|second malignant neoplasm|1|||
127921529|NCT01190930|460334615|FG009|Maintenance|second malignant neoplasm|0|||
127921530|NCT01190930|460334606|FG000|Maintenance|Inevaluable|0|||
127921531|NCT01190930|460334607|FG001|Maintenance|Inevaluable|0|||
127921532|NCT01190930|460334608|FG002|Maintenance|Inevaluable|0|||
127921533|NCT01190930|460334609|FG003|Maintenance|Inevaluable|0|||
127921534|NCT01190930|460334610|FG004|Maintenance|Inevaluable|0|||
127921535|NCT01190930|460334611|FG005|Maintenance|Inevaluable|1|||
127921536|NCT01190930|460334612|FG006|Maintenance|Inevaluable|1|||
127921537|NCT01190930|460334613|FG007|Maintenance|Inevaluable|1|||
127921538|NCT01190930|460334614|FG008|Maintenance|Inevaluable|0|||
127921539|NCT01190930|460334615|FG009|Maintenance|Inevaluable|0|||
127921540|NCT01190930|460334606|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
127921541|NCT01190930|460334607|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
127921542|NCT01190930|460334608|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
127921543|NCT01190930|460334609|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
127921544|NCT01190930|460334610|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
127921545|NCT01190930|460334611|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
127921546|NCT01190930|460334612|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
127921547|NCT01190930|460334613|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
127921548|NCT01190930|460334614|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
127921549|NCT01190930|460334615|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
127921550|NCT01190930|460334606|FG000|Maintenance|Relapse|0|||
127921551|NCT01190930|460334607|FG001|Maintenance|Relapse|0|||
127921552|NCT01190930|460334608|FG002|Maintenance|Relapse|0|||
127921553|NCT01190930|460334609|FG003|Maintenance|Relapse|2|||
127921554|NCT01190930|460334610|FG004|Maintenance|Relapse|0|||
127921555|NCT01190930|460334611|FG005|Maintenance|Relapse|1|||
127921556|NCT01190930|460334612|FG006|Maintenance|Relapse|6|||
127921557|NCT01190930|460334613|FG007|Maintenance|Relapse|13|||
127921558|NCT01190930|460334614|FG008|Maintenance|Relapse|11|||
127921559|NCT01190930|460334615|FG009|Maintenance|Relapse|11|||
127921560|NCT01190930|460334606|FG000|Maintenance|Still on therapy|0|||
127921561|NCT01190930|460334607|FG001|Maintenance|Still on therapy|8|||
127921562|NCT01190930|460334608|FG002|Maintenance|Still on therapy|0|||
127921563|NCT01190930|460334609|FG003|Maintenance|Still on therapy|29|||
127921564|NCT01190930|460334610|FG004|Maintenance|Still on therapy|0|||
127921565|NCT01190930|460334611|FG005|Maintenance|Still on therapy|0|||
127921566|NCT01190930|460334612|FG006|Maintenance|Still on therapy|0|||
127921567|NCT01190930|460334613|FG007|Maintenance|Still on therapy|0|||
127921568|NCT01190930|460334614|FG008|Maintenance|Still on therapy|0|||
127921569|NCT01190930|460334615|FG009|Maintenance|Still on therapy|0|||
127921570|NCT00046839|460334626|FG000|Overall Study|Ineligible / No protocol treatment|0|||
127921571|NCT00046839|460334627|FG001|Overall Study|Ineligible / No protocol treatment|2|||
127921572|NCT00046839|460334626|FG000|Overall Study|Withdrawal of consent|1|||
127921573|NCT00046839|460334627|FG001|Overall Study|Withdrawal of consent|0|||
127921574|NCT00113919|460334630|FG000|Overall Study|Physician Decision|8|||
127921575|NCT00113919|460334630|FG000|Overall Study|Death|6|||
127921576|NCT00372996|460334631|FG000|Overall Study|Death|11|||
127921577|NCT00372996|460334632|FG001|Overall Study|Death|4|||
127921578|NCT00372996|460334633|FG002|Overall Study|Death|8|||
127921579|NCT00372996|460334634|FG003|Overall Study|Death|7|||
127921580|NCT00372996|460334631|FG000|Overall Study|Lost to Follow-up|0|||
127921581|NCT00372996|460334632|FG001|Overall Study|Lost to Follow-up|2|||
127921582|NCT00372996|460334633|FG002|Overall Study|Lost to Follow-up|0|||
127921583|NCT00372996|460334634|FG003|Overall Study|Lost to Follow-up|1|||
127921584|NCT00372996|460334631|FG000|Overall Study|Withdrawal by Subject|12|||
127921585|NCT00372996|460334632|FG001|Overall Study|Withdrawal by Subject|6|||
127921586|NCT00372996|460334633|FG002|Overall Study|Withdrawal by Subject|9|||
127921587|NCT00372996|460334634|FG003|Overall Study|Withdrawal by Subject|5|||
127921588|NCT00372996|460334631|FG000|Overall Study|Study Terminated by Sponsor|4|||
127921589|NCT00372996|460334632|FG001|Overall Study|Study Terminated by Sponsor|0|||
127921590|NCT00372996|460334633|FG002|Overall Study|Study Terminated by Sponsor|4|||
127921591|NCT00372996|460334634|FG003|Overall Study|Study Terminated by Sponsor|0|||
127921592|NCT00372996|460334631|FG000|Overall Study|Other|10|||
127921593|NCT00372996|460334632|FG001|Overall Study|Other|2|||
127921594|NCT00372996|460334633|FG002|Overall Study|Other|7|||
127921595|NCT00372996|460334634|FG003|Overall Study|Other|7|||
127921596|NCT02151149|460334637|FG000|Treatment Period|Death|2|||
127921597|NCT02151149|460334638|FG001|Treatment Period|Death|3|||
127921598|NCT02151149|460334637|FG000|Treatment Period|Adverse Event|17|||
127921599|NCT02151149|460334638|FG001|Treatment Period|Adverse Event|14|||
127921600|NCT02151149|460334637|FG000|Treatment Period|Progressive Disease|25|||
127921601|NCT02151149|460334638|FG001|Treatment Period|Progressive Disease|24|||
127921602|NCT02151149|460334637|FG000|Treatment Period|Symptomatic Deterioration|2|||
127921603|NCT02151149|460334638|FG001|Treatment Period|Symptomatic Deterioration|10|||
127921604|NCT02151149|460334637|FG000|Treatment Period|Withdrawal by Subject|13|||
127921605|NCT02151149|460334638|FG001|Treatment Period|Withdrawal by Subject|11|||
127921606|NCT02151149|460334637|FG000|Treatment Period|Miscellaneous|8|||
127921607|NCT02151149|460334638|FG001|Treatment Period|Miscellaneous|7|||
127921608|NCT02151149|460334637|FG000|Treatment Period|Participants randomized but not treated|3|||
127921609|NCT02151149|460334638|FG001|Treatment Period|Participants randomized but not treated|2|||
127921610|NCT02151149|460334637|FG000|Follow-Up Period|Lost to Follow-up|2|||
127921611|NCT02151149|460334638|FG001|Follow-Up Period|Lost to Follow-up|3|||
127921612|NCT02151149|460334637|FG000|Follow-Up Period|Death|37|||
127921613|NCT02151149|460334638|FG001|Follow-Up Period|Death|34|||
127921614|NCT02760433|460334639|FG000|Overall Study|Lost to Follow-up|1|||
127921615|NCT02760433|460334640|FG001|Overall Study|Lost to Follow-up|0|||
127921616|NCT02760433|460334641|FG002|Overall Study|Lost to Follow-up|1|||
127921617|NCT02760433|460334642|FG003|Overall Study|Lost to Follow-up|0|||
127921618|NCT02760433|460334643|FG004|Overall Study|Lost to Follow-up|0|||
127921619|NCT02760433|460334639|FG000|Overall Study|Withdrawal by Subject|23|||
127921620|NCT02760433|460334640|FG001|Overall Study|Withdrawal by Subject|9|||
127921621|NCT02760433|460334641|FG002|Overall Study|Withdrawal by Subject|0|||
127921622|NCT02760433|460334642|FG003|Overall Study|Withdrawal by Subject|2|||
127921623|NCT02760433|460334643|FG004|Overall Study|Withdrawal by Subject|9|||
127921624|NCT02760433|460334639|FG000|Overall Study|Lack of Response At Week 14|0|||
127921625|NCT02760433|460334640|FG001|Overall Study|Lack of Response At Week 14|0|||
127921626|NCT02760433|460334641|FG002|Overall Study|Lack of Response At Week 14|0|||
127921627|NCT02760433|460334642|FG003|Overall Study|Lack of Response At Week 14|0|||
127921628|NCT02760433|460334643|FG004|Overall Study|Lack of Response At Week 14|1|||
127921629|NCT02760433|460334639|FG000|Overall Study|Subject refused to continue the study|1|||
127921630|NCT02760433|460334640|FG001|Overall Study|Subject refused to continue the study|0|||
127921631|NCT02760433|460334641|FG002|Overall Study|Subject refused to continue the study|0|||
127921632|NCT02760433|460334642|FG003|Overall Study|Subject refused to continue the study|0|||
127921633|NCT02760433|460334643|FG004|Overall Study|Subject refused to continue the study|0|||
127921634|NCT02760433|460334639|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
127921635|NCT02760433|460334640|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
127921636|NCT02760433|460334641|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
127921637|NCT02760433|460334642|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
127921638|NCT02760433|460334643|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
127921639|NCT02760433|460334639|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
127921640|NCT02760433|460334640|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
127921641|NCT02760433|460334641|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
127976445|NCT03535194|460536126|FG001|Induction Period|Withdrawal by Subject|4|||
127976446|NCT03535194|460536127|FG002|Induction Period|Withdrawal by Subject|3|||
127976447|NCT03535194|460536128|FG003|Induction Period|Withdrawal by Subject|2|||
127976448|NCT03535194|460536129|FG004|Induction Period|Withdrawal by Subject|0|||
127976449|NCT03535194|460536125|FG000|Maintenance Period|Adverse Event|6|||
127976450|NCT03535194|460536126|FG001|Maintenance Period|Adverse Event|5|||
127976451|NCT03535194|460536127|FG002|Maintenance Period|Adverse Event|1|||
127976452|NCT03535194|460536128|FG003|Maintenance Period|Adverse Event|11|||
127976453|NCT03535194|460536129|FG004|Maintenance Period|Adverse Event|4|||
127976454|NCT03535194|460536125|FG000|Maintenance Period|Lack of Efficacy|3|||
127976455|NCT03535194|460536126|FG001|Maintenance Period|Lack of Efficacy|2|||
127976456|NCT03535194|460536127|FG002|Maintenance Period|Lack of Efficacy|5|||
127921642|NCT02760433|460334642|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
127921643|NCT02760433|460334643|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
127921644|NCT01292837|460334649|FG000|Overall Study|Adverse Event|1|||
127921645|NCT01292837|460334649|FG000|Overall Study|Further treatment determined|1|||
127921646|NCT05889039|460334650|FG000|Overall Study|error in completing survey|0|||
127921647|NCT05889039|460334651|FG001|Overall Study|error in completing survey|2|||
127921648|NCT05889039|460334652|FG002|Overall Study|error in completing survey|0|||
127921649|NCT05889039|460334653|FG003|Overall Study|error in completing survey|0|||
127921650|NCT05889039|460334650|FG000|Overall Study|Lost to Follow-up|4|||
127921651|NCT05889039|460334651|FG001|Overall Study|Lost to Follow-up|0|||
127921652|NCT05889039|460334652|FG002|Overall Study|Lost to Follow-up|0|||
127921653|NCT05889039|460334653|FG003|Overall Study|Lost to Follow-up|0|||
127921654|NCT04531527|460334654|FG000|Overall Study|Found to be Ineligible|3|||
127921655|NCT01881737|460334658|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
127921656|NCT01881737|460334658|FG000|Overall Study|Withdrawal by Subject|1|||
127921657|NCT01881737|460334658|FG000|Overall Study|Worsening of baseline behavior|1|||
127921658|NCT00982228|460334669|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
127921659|NCT00982228|460334670|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
127921660|NCT00982228|460334669|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
127921661|NCT00982228|460334670|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
127921662|NCT00982228|460334669|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
127921663|NCT00982228|460334670|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
127921664|NCT00982228|460334669|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
127921665|NCT00982228|460334670|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
127921666|NCT00982228|460334669|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
127921667|NCT00982228|460334670|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
127921668|NCT00982228|460334669|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
127921669|NCT00982228|460334670|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
127921670|NCT00982228|460334669|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
127921671|NCT00982228|460334670|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
127921672|NCT00982228|460334669|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
127921673|NCT00982228|460334670|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
127921674|NCT00982228|460334669|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
127921675|NCT00982228|460334670|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
127921676|NCT00982228|460334669|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
127921677|NCT00982228|460334670|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
127921678|NCT02250651|460334671|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
127921679|NCT02250651|460334672|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
127921680|NCT02250651|460334673|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
127921681|NCT02250651|460334671|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
127921682|NCT02250651|460334672|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
127921683|NCT02250651|460334673|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
127921684|NCT02250651|460334671|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
127921685|NCT02250651|460334672|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
127921686|NCT02250651|460334673|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
127921687|NCT02250651|460334671|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
127921688|NCT02250651|460334672|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
127921689|NCT02250651|460334673|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
127921690|NCT02250651|460334671|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
127921691|NCT02250651|460334672|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
127921692|NCT02250651|460334673|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
127921693|NCT02250651|460334671|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
127921694|NCT02250651|460334672|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
127921695|NCT02250651|460334673|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
127921696|NCT02250651|460334671|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
127921697|NCT02250651|460334672|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
127921698|NCT02250651|460334673|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
127921699|NCT02250651|460334671|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
127921700|NCT02250651|460334672|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
127921701|NCT02250651|460334673|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
127921702|NCT02250651|460334671|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
127921703|NCT02250651|460334672|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
127921704|NCT02250651|460334673|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
127921705|NCT02250651|460334671|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
127921706|NCT02250651|460334672|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
127921707|NCT02250651|460334673|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
127921708|NCT02250651|460334671|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
127921709|NCT02250651|460334672|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
127921710|NCT02250651|460334673|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
127921711|NCT02250651|460334671|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
127921712|NCT02250651|460334672|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
127921713|NCT02250651|460334673|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
127921714|NCT02250651|460334671|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
127921715|NCT02250651|460334672|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
127921716|NCT02250651|460334673|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
127921717|NCT02250651|460334671|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
127921718|NCT02250651|460334672|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
127921719|NCT02250651|460334673|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
127921720|NCT02250651|460334671|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
127921721|NCT02250651|460334672|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
127921722|NCT02250651|460334673|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
127921723|NCT03496298|460334674|FG000|Overall Study|Adverse Event|49|||
127921724|NCT03496298|460334675|FG001|Overall Study|Adverse Event|68|||
127921725|NCT03496298|460334676|FG002|Overall Study|Adverse Event|79|||
127921726|NCT03496298|460334674|FG000|Overall Study|Study terminated by Sponsor|1050|||
127921727|NCT03496298|460334675|FG001|Overall Study|Study terminated by Sponsor|1063|||
127921728|NCT03496298|460334676|FG002|Overall Study|Study terminated by Sponsor|1071|||
127921729|NCT03496298|460334674|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
127921730|NCT03496298|460334675|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
127921731|NCT03496298|460334676|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
127921732|NCT03496298|460334674|FG000|Overall Study|Withdrawal by Subject|176|||
127921733|NCT03496298|460334675|FG001|Overall Study|Withdrawal by Subject|154|||
127921734|NCT03496298|460334676|FG002|Overall Study|Withdrawal by Subject|151|||
127921735|NCT03496298|460334674|FG000|Overall Study|Other|29|||
127921736|NCT03496298|460334675|FG001|Overall Study|Other|20|||
127921737|NCT03496298|460334676|FG002|Overall Study|Other|23|||
127921738|NCT03496298|460334674|FG000|Overall Study|Randomized and not treated|1|||
127921739|NCT03496298|460334675|FG001|Overall Study|Randomized and not treated|1|||
127921740|NCT03496298|460334676|FG002|Overall Study|Randomized and not treated|1|||
127921741|NCT01438476|460334679|FG000|Overall Study|Protocol Violation|1|||
127921742|NCT01438476|460334680|FG001|Overall Study|Protocol Violation|0|||
127921743|NCT01438476|460334679|FG000|Overall Study|Withdrawal by Subject|1|||
127921744|NCT01438476|460334680|FG001|Overall Study|Withdrawal by Subject|0|||
127921745|NCT01438476|460334679|FG000|Overall Study|No Surgery- Disease|8|||
127921746|NCT01438476|460334680|FG001|Overall Study|No Surgery- Disease|10|||
127921747|NCT01438476|460334679|FG000|Overall Study|Communication barrier|0|||
127921748|NCT01438476|460334680|FG001|Overall Study|Communication barrier|1|||
127921749|NCT02522780|460334685|FG000|Overall Study|Consent withdrawn by subject|5|||
127921750|NCT02522780|460334686|FG001|Overall Study|Consent withdrawn by subject|7|||
127921751|NCT02522780|460334685|FG000|Overall Study|Protocol deviation|1|||
127921752|NCT02522780|460334686|FG001|Overall Study|Protocol deviation|3|||
127921753|NCT02522780|460334685|FG000|Overall Study|Subject refused endoscopic procedure|0|||
127921754|NCT02522780|460334686|FG001|Overall Study|Subject refused endoscopic procedure|1|||
127921755|NCT02522780|460334685|FG000|Overall Study|Adverse event, non-fatal|11|||
127921756|NCT02522780|460334686|FG001|Overall Study|Adverse event, non-fatal|16|||
127921757|NCT02058160|460334687|FG000|Overall Study|Randomized but not treated|2|||
127921758|NCT02058160|460334688|FG001|Overall Study|Randomized but not treated|4|||
127921759|NCT02058160|460334687|FG000|Overall Study|Poor compliance to protocol|4|||
127921760|NCT02058160|460334688|FG001|Overall Study|Poor compliance to protocol|1|||
127921761|NCT02058160|460334687|FG000|Overall Study|Adverse Event|12|||
127921762|NCT02058160|460334688|FG001|Overall Study|Adverse Event|3|||
127921763|NCT02058160|460334687|FG000|Overall Study|Lost to Follow-up|1|||
127921764|NCT02058160|460334688|FG001|Overall Study|Lost to Follow-up|0|||
127921765|NCT02058160|460334687|FG000|Overall Study|Other than specified above|12|||
127921766|NCT02058160|460334688|FG001|Overall Study|Other than specified above|6|||
127921767|NCT02260635|460334689|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
127921768|NCT02260635|460334690|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
127921769|NCT02260635|460334689|FG000|Open-Label Extension|Study Termination|25|||
127921770|NCT02260635|460334690|FG001|Open-Label Extension|Study Termination|25|||
127921771|NCT02260635|460334689|FG000|Open-Label Extension|Withdrawal by Subject|1|||
127921772|NCT02260635|460334690|FG001|Open-Label Extension|Withdrawal by Subject|0|||
127921773|NCT04106817|460334691|FG000|Overall Study|Lost to Follow-up|1|||
127921774|NCT04106817|460334692|FG001|Overall Study|Lost to Follow-up|0|||
127921775|NCT04106817|460334693|FG002|Overall Study|Lost to Follow-up|0|||
127921776|NCT00152516|460334694|FG000|Overall Study|Adverse Event|18|||
127921777|NCT00152516|460334694|FG000|Overall Study|Lack and Loss of Efficacy|30|||
127921778|NCT00152516|460334694|FG000|Overall Study|Lost to Follow-up|5|||
127921779|NCT00152516|460334694|FG000|Overall Study|Withdrawal by Subject|8|||
127921780|NCT00152516|460334694|FG000|Overall Study|Protocol Violation|3|||
127921781|NCT00152516|460334694|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
127921782|NCT00152516|460334694|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
127921783|NCT00152516|460334694|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
127921784|NCT00152516|460334694|FG000|Overall Study|Other: Non-Compliance|2|||
127921785|NCT00152516|460334694|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
127921786|NCT00152516|460334694|FG000|Overall Study|Other: Moved Out Of State|1|||
127921787|NCT00152516|460334694|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
127921788|NCT00152516|460334694|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
127921789|NCT02289820|460334695|FG000|Overall Study|Withdrawal by Subject|2|||
127921790|NCT02289820|460334696|FG001|Overall Study|Withdrawal by Subject|1|||
127921791|NCT02289820|460334697|FG002|Overall Study|Withdrawal by Subject|2|||
127921792|NCT02289820|460334698|FG003|Overall Study|Withdrawal by Subject|1|||
127921793|NCT02289820|460334699|FG004|Overall Study|Withdrawal by Subject|0|||
127921794|NCT02289820|460334700|FG005|Overall Study|Withdrawal by Subject|0|||
127921795|NCT02289820|460334701|FG006|Overall Study|Withdrawal by Subject|1|||
127921796|NCT02289820|460334695|FG000|Overall Study|Death|0|||
127921797|NCT02289820|460334696|FG001|Overall Study|Death|0|||
127921798|NCT02289820|460334697|FG002|Overall Study|Death|1|||
127921799|NCT02289820|460334698|FG003|Overall Study|Death|0|||
127921800|NCT02289820|460334699|FG004|Overall Study|Death|0|||
127921801|NCT02289820|460334700|FG005|Overall Study|Death|0|||
127921802|NCT02289820|460334701|FG006|Overall Study|Death|0|||
127921803|NCT02289820|460334695|FG000|Overall Study|Lost to Follow-up|0|||
127921804|NCT02289820|460334696|FG001|Overall Study|Lost to Follow-up|0|||
127921805|NCT02289820|460334697|FG002|Overall Study|Lost to Follow-up|3|||
127921806|NCT02289820|460334698|FG003|Overall Study|Lost to Follow-up|1|||
127921807|NCT02289820|460334699|FG004|Overall Study|Lost to Follow-up|0|||
127921808|NCT02289820|460334700|FG005|Overall Study|Lost to Follow-up|1|||
127921809|NCT02289820|460334701|FG006|Overall Study|Lost to Follow-up|1|||
127921810|NCT02289820|460334695|FG000|Overall Study|withdrawal of consent|0|||
127921811|NCT02289820|460334696|FG001|Overall Study|withdrawal of consent|1|||
127921812|NCT02289820|460334697|FG002|Overall Study|withdrawal of consent|0|||
127921813|NCT02289820|460334698|FG003|Overall Study|withdrawal of consent|0|||
127921814|NCT02289820|460334699|FG004|Overall Study|withdrawal of consent|0|||
127921815|NCT02289820|460334700|FG005|Overall Study|withdrawal of consent|0|||
127921816|NCT02289820|460334701|FG006|Overall Study|withdrawal of consent|0|||
127921817|NCT00926367|460334704|FG000|Overall Study|Withdrawal by Subject|0|||
127921818|NCT00926367|460334705|FG001|Overall Study|Withdrawal by Subject|1|||
127921819|NCT00926367|460334704|FG000|Overall Study|Lost to Follow-up|1|||
127921820|NCT00926367|460334705|FG001|Overall Study|Lost to Follow-up|0|||
127921821|NCT00926367|460334704|FG000|Overall Study|Skin Irritation|1|||
127921822|NCT00926367|460334705|FG001|Overall Study|Skin Irritation|2|||
127921823|NCT02725411|460334706|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
127921824|NCT02725411|460334707|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
127921825|NCT02725411|460334708|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
127921826|NCT02725411|460334706|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
127921827|NCT02725411|460334707|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
127921828|NCT02725411|460334708|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
127921829|NCT02725411|460334706|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
127921830|NCT02725411|460334707|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
127921831|NCT02725411|460334708|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
127921832|NCT02725411|460334706|FG000|Treatment Period (56 Weeks)|Other|1|||
127921833|NCT02725411|460334707|FG001|Treatment Period (56 Weeks)|Other|4|||
127921834|NCT02725411|460334708|FG002|Treatment Period (56 Weeks)|Other|5|||
127921835|NCT02725411|460334706|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
127921836|NCT02725411|460334707|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
127921837|NCT02725411|460334708|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
127921838|NCT02725411|460334706|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
127921839|NCT02725411|460334707|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
127921840|NCT02725411|460334708|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
127921841|NCT02725411|460334706|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
127921842|NCT02725411|460334707|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
127921843|NCT02725411|460334708|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
127921844|NCT02725411|460334706|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
127921845|NCT02725411|460334707|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
127921846|NCT02725411|460334708|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
127921847|NCT02725411|460334706|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
127921848|NCT02725411|460334707|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
127921849|NCT02725411|460334708|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
127921850|NCT02725411|460334706|FG000|Follow-up Period (24 Weeks)|Other|1|||
127921851|NCT02725411|460334707|FG001|Follow-up Period (24 Weeks)|Other|4|||
127921852|NCT02725411|460334708|FG002|Follow-up Period (24 Weeks)|Other|2|||
127921853|NCT02725411|460334706|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
127921854|NCT02725411|460334707|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
127921855|NCT02725411|460334708|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
127921856|NCT03847974|460334715|FG000|Overall Study|relocated out of region|3|||
127921857|NCT03847974|460334715|FG000|Overall Study|Withdrawal by Subject|2|||
127921858|NCT03847974|460334715|FG000|Overall Study|Adverse Event|1|||
127921859|NCT01924364|460334716|FG000|Overall Study|Physician Decision|3|||
127921860|NCT01685216|460334717|FG000|Overall Study|Did not receive study drug|1|||
127921861|NCT02911935|460334718|FG000|Overall Study|Lost to Follow-up|5|||
127921862|NCT02911935|460334719|FG001|Overall Study|Lost to Follow-up|7|||
127921863|NCT00685750|460334722|FG000|Overall Study|Tumor sampling failure|0|||
127921864|NCT00685750|460334723|FG001|Overall Study|Tumor sampling failure|0|||
127921865|NCT00685750|460334724|FG002|Overall Study|Tumor sampling failure|1|||
127921866|NCT00685750|460334725|FG003|Overall Study|Tumor sampling failure|0|||
127921867|NCT00685750|460334726|FG004|Overall Study|Tumor sampling failure|0|||
127921868|NCT00685750|460334727|FG005|Overall Study|Tumor sampling failure|0|||
127921869|NCT00685750|460334728|FG006|Overall Study|Tumor sampling failure|0|||
127921870|NCT00685750|460334722|FG000|Overall Study|Patient didn't receive the treatment|0|||
127921871|NCT00685750|460334723|FG001|Overall Study|Patient didn't receive the treatment|0|||
127921872|NCT00685750|460334724|FG002|Overall Study|Patient didn't receive the treatment|0|||
127921873|NCT00685750|460334725|FG003|Overall Study|Patient didn't receive the treatment|0|||
127921874|NCT00685750|460334726|FG004|Overall Study|Patient didn't receive the treatment|0|||
127921875|NCT00685750|460334727|FG005|Overall Study|Patient didn't receive the treatment|0|||
127921876|NCT00685750|460334728|FG006|Overall Study|Patient didn't receive the treatment|1|||
127921877|NCT00685750|460334722|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
127921878|NCT00685750|460334723|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
127921879|NCT00685750|460334724|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
127921880|NCT00685750|460334725|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
127921881|NCT00685750|460334726|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
127921882|NCT00685750|460334727|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
127921883|NCT00685750|460334728|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
127921884|NCT00250705|460334729|FG000|Overall Study|Lack of Efficacy|2|||
127921885|NCT02466386|460334730|FG000|Overall Study|Adverse Event|5|||
127921886|NCT02466386|460334730|FG000|Overall Study|Protocol Violation|2|||
127921887|NCT02466386|460334730|FG000|Overall Study|Withdrawal by Subject|14|||
127921888|NCT02466386|460334730|FG000|Overall Study|Lost to Follow-up|5|||
127921889|NCT02466386|460334730|FG000|Overall Study|Lack of Efficacy|8|||
127921890|NCT02466386|460334730|FG000|Overall Study|Other|10|||
127921891|NCT05317195|460334731|FG000|Randomization|Withdrawal by Subject|1|||
127921892|NCT05317195|460334731|FG000|Randomization|Discontinued|6|||
127921893|NCT05317195|460334731|FG000|Admission|Withdrawal by Subject|2|||
127921894|NCT01688882|460334732|FG000|Overall Study|Adverse Event|1|||
127921895|NCT01688882|460334733|FG001|Overall Study|Adverse Event|0|||
127921896|NCT01688882|460334732|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
127921897|NCT01688882|460334733|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
127921898|NCT01688882|460334732|FG000|Overall Study|Administrative problems|1|||
127921899|NCT01688882|460334733|FG001|Overall Study|Administrative problems|0|||
127921900|NCT00889252|460334735|FG000|Overall Study|Adverse Event|2|||
127921901|NCT00889252|460334736|FG001|Overall Study|Adverse Event|4|||
127921902|NCT00889252|460334735|FG000|Overall Study|Withdrawal by Subject|3|||
127921903|NCT00889252|460334736|FG001|Overall Study|Withdrawal by Subject|0|||
127921904|NCT00889252|460334735|FG000|Overall Study|Protocol Violation|2|||
127921905|NCT00889252|460334736|FG001|Overall Study|Protocol Violation|0|||
127921906|NCT01160640|460334740|FG000|Overall Study|Physician Decision|3|||
127921907|NCT01160640|460334741|FG001|Overall Study|Physician Decision|3|||
127921908|NCT01160640|460334740|FG000|Overall Study|Incarceration|1|||
127921909|NCT01160640|460334741|FG001|Overall Study|Incarceration|0|||
127921910|NCT01160640|460334740|FG000|Overall Study|Withdrawal by Subject|0|||
127921911|NCT01160640|460334741|FG001|Overall Study|Withdrawal by Subject|3|||
127921912|NCT00642811|460334742|FG000|Overall Study|Adverse Event|2|||
127921913|NCT00642811|460334743|FG001|Overall Study|Adverse Event|3|||
127921914|NCT00642811|460334744|FG002|Overall Study|Adverse Event|0|||
127921915|NCT00642811|460334745|FG003|Overall Study|Adverse Event|0|||
127921916|NCT00642811|460334746|FG004|Overall Study|Adverse Event|0|||
127921917|NCT00642811|460334747|FG005|Overall Study|Adverse Event|1|||
127921918|NCT00642811|460334742|FG000|Overall Study|Developement of discontinuation criteria|0|||
127921919|NCT00642811|460334743|FG001|Overall Study|Developement of discontinuation criteria|0|||
127921920|NCT00642811|460334744|FG002|Overall Study|Developement of discontinuation criteria|0|||
127921921|NCT00642811|460334745|FG003|Overall Study|Developement of discontinuation criteria|0|||
127921922|NCT00642811|460334746|FG004|Overall Study|Developement of discontinuation criteria|1|||
127921923|NCT00642811|460334747|FG005|Overall Study|Developement of discontinuation criteria|0|||
127921924|NCT00642811|460334742|FG000|Overall Study|Severe Non-compliance to protocol|1|||
127921925|NCT00642811|460334743|FG001|Overall Study|Severe Non-compliance to protocol|0|||
127921926|NCT00642811|460334744|FG002|Overall Study|Severe Non-compliance to protocol|0|||
127921927|NCT00642811|460334745|FG003|Overall Study|Severe Non-compliance to protocol|0|||
127921928|NCT00642811|460334746|FG004|Overall Study|Severe Non-compliance to protocol|0|||
127921929|NCT00642811|460334747|FG005|Overall Study|Severe Non-compliance to protocol|0|||
127921930|NCT00642811|460334742|FG000|Overall Study|Other|0|||
127921931|NCT00642811|460334743|FG001|Overall Study|Other|1|||
127921932|NCT00642811|460334744|FG002|Overall Study|Other|0|||
127921933|NCT00642811|460334745|FG003|Overall Study|Other|1|||
127921934|NCT00642811|460334746|FG004|Overall Study|Other|0|||
127921935|NCT00642811|460334747|FG005|Overall Study|Other|0|||
127921936|NCT03108820|460334751|FG000|Overall Study|Lost to Follow-up|30|||
127921937|NCT03108820|460334752|FG001|Overall Study|Lost to Follow-up|28|||
127921938|NCT03108820|460334751|FG000|Overall Study|Withdrawal by Subject|32|||
127921939|NCT03108820|460334752|FG001|Overall Study|Withdrawal by Subject|24|||
127921940|NCT03108820|460334751|FG000|Overall Study|Death|6|||
127921941|NCT03108820|460334752|FG001|Overall Study|Death|11|||
127921942|NCT00089973|460334755|FG000|Overall Study|Adverse Event|3|||
127921943|NCT00089973|460334755|FG000|Overall Study|Withdrawal by Subject|1|||
127921944|NCT00089973|460334755|FG000|Overall Study|Disease progression|45|||
127921945|NCT00089973|460334755|FG000|Overall Study|Death|1|||
127921946|NCT01992094|460334756|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
127921947|NCT01992094|460334757|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
127921948|NCT01992094|460334758|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
127921949|NCT01992094|460334756|FG000|Overall Study|Adverse Event|1|||
127921950|NCT01992094|460334757|FG001|Overall Study|Adverse Event|0|||
127921951|NCT01992094|460334758|FG002|Overall Study|Adverse Event|0|||
127921952|NCT01992094|460334756|FG000|Overall Study|Death|5|||
127921953|NCT01992094|460334757|FG001|Overall Study|Death|5|||
127921954|NCT01992094|460334758|FG002|Overall Study|Death|2|||
127921955|NCT01992094|460334756|FG000|Overall Study|Lost to Follow-up|26|||
127921956|NCT01992094|460334757|FG001|Overall Study|Lost to Follow-up|9|||
127921957|NCT01992094|460334758|FG002|Overall Study|Lost to Follow-up|13|||
127921958|NCT01992094|460334756|FG000|Overall Study|OTHER|4|||
127921959|NCT01992094|460334757|FG001|Overall Study|OTHER|0|||
127921960|NCT01992094|460334758|FG002|Overall Study|OTHER|0|||
127921961|NCT01992094|460334756|FG000|Overall Study|Protocol Violation|1|||
127921962|NCT01992094|460334757|FG001|Overall Study|Protocol Violation|0|||
127921963|NCT01992094|460334758|FG002|Overall Study|Protocol Violation|1|||
127921964|NCT01992094|460334756|FG000|Overall Study|Withdrawal by Subject|7|||
127921965|NCT01992094|460334757|FG001|Overall Study|Withdrawal by Subject|3|||
127921966|NCT01992094|460334758|FG002|Overall Study|Withdrawal by Subject|4|||
127921967|NCT01214239|460334759|FG000|Overall Study|Adverse Event|3|||
127921968|NCT01214239|460334760|FG001|Overall Study|Adverse Event|4|||
127921969|NCT01214239|460334759|FG000|Overall Study|Protocol Violation|2|||
127921970|NCT01214239|460334760|FG001|Overall Study|Protocol Violation|1|||
127921971|NCT01214239|460334759|FG000|Overall Study|Lost to Follow-up|1|||
127921972|NCT01214239|460334760|FG001|Overall Study|Lost to Follow-up|1|||
127921973|NCT01214239|460334759|FG000|Overall Study|Withdrawal by Subject|4|||
127921974|NCT01214239|460334760|FG001|Overall Study|Withdrawal by Subject|9|||
127921975|NCT01214239|460334759|FG000|Overall Study|Lack of Efficacy|1|||
127921976|NCT01214239|460334760|FG001|Overall Study|Lack of Efficacy|2|||
127921977|NCT01214239|460334759|FG000|Overall Study|patient's private reason|1|||
127921978|NCT01214239|460334760|FG001|Overall Study|patient's private reason|1|||
127921979|NCT01049581|460334761|FG000|Overall Study|Lost to Follow-up|2|||
127921980|NCT01049581|460334762|FG001|Overall Study|Lost to Follow-up|1|||
127921981|NCT03203642|460334763|FG000|Overall Study|Adverse Event|3|||
127921982|NCT03203642|460334764|FG001|Overall Study|Adverse Event|1|||
127921983|NCT03203642|460334763|FG000|Overall Study|Withdrawal by Subject|6|||
127921984|NCT03203642|460334764|FG001|Overall Study|Withdrawal by Subject|6|||
127921985|NCT03203642|460334763|FG000|Overall Study|Lost to Follow-up|2|||
127921986|NCT03203642|460334764|FG001|Overall Study|Lost to Follow-up|1|||
127921987|NCT03203642|460334763|FG000|Overall Study|Termination of the study by sponsor|1|||
127921988|NCT03203642|460334764|FG001|Overall Study|Termination of the study by sponsor|1|||
127921989|NCT03203642|460334763|FG000|Overall Study|Participant moved|0|||
127921990|NCT03203642|460334764|FG001|Overall Study|Participant moved|1|||
127921991|NCT03203642|460334763|FG000|Overall Study|Investigator's decision|3|||
127921992|NCT03203642|460334764|FG001|Overall Study|Investigator's decision|0|||
127921993|NCT03203642|460334763|FG000|Overall Study|Other than above specified|0|||
127921994|NCT03203642|460334764|FG001|Overall Study|Other than above specified|1|||
127921995|NCT05068284|460334777|FG000|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|2|||
127921996|NCT05068284|460334778|FG001|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|3|||
127921997|NCT05068284|460334779|FG002|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
127921998|NCT05068284|460334780|FG003|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
127921999|NCT05068284|460334781|FG004|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
127922000|NCT05068284|460334782|FG005|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
127922001|NCT05068284|460334783|FG006|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
127922002|NCT05068284|460334784|FG007|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
127922003|NCT05068284|460334777|FG000|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
127922004|NCT05068284|460334778|FG001|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
127922005|NCT05068284|460334779|FG002|Double-Blind Induction (12 Weeks)|Adverse Event|3|||
127922006|NCT05068284|460334780|FG003|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
127922007|NCT05068284|460334781|FG004|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
127922008|NCT05068284|460334782|FG005|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
127922009|NCT05068284|460334783|FG006|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
127922010|NCT05068284|460334784|FG007|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
127922011|NCT05068284|460334777|FG000|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|7|||
127922012|NCT05068284|460334778|FG001|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|2|||
127922013|NCT05068284|460334779|FG002|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|6|||
127922014|NCT05068284|460334780|FG003|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|5|||
127922015|NCT05068284|460334781|FG004|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|10|||
127922016|NCT05068284|460334782|FG005|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
127922017|NCT05068284|460334783|FG006|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
127922018|NCT05068284|460334784|FG007|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
127922019|NCT05068284|460334777|FG000|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
127922020|NCT05068284|460334778|FG001|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
127922021|NCT05068284|460334779|FG002|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
127922022|NCT05068284|460334780|FG003|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
127922023|NCT05068284|460334781|FG004|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
127922024|NCT05068284|460334782|FG005|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
127922025|NCT05068284|460334783|FG006|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
127922026|NCT05068284|460334784|FG007|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
127922027|NCT05068284|460334777|FG000|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
127922028|NCT05068284|460334778|FG001|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
127922029|NCT05068284|460334779|FG002|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
127922030|NCT05068284|460334780|FG003|Double-Blind Re-Induction (12 Weeks)|Adverse Event|2|||
127922031|NCT05068284|460334781|FG004|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
127922032|NCT05068284|460334782|FG005|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
127922033|NCT05068284|460334783|FG006|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
127922034|NCT05068284|460334784|FG007|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
127922035|NCT05068284|460334777|FG000|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
127922036|NCT05068284|460334778|FG001|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
127922037|NCT05068284|460334779|FG002|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|1|||
127922038|NCT05068284|460334780|FG003|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|4|||
127922039|NCT05068284|460334781|FG004|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
127922040|NCT05068284|460334782|FG005|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
127922041|NCT05068284|460334783|FG006|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
127922042|NCT05068284|460334784|FG007|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
127922043|NCT05068284|460334777|FG000|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
127922044|NCT05068284|460334778|FG001|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
127922045|NCT05068284|460334779|FG002|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|2|||
127922046|NCT05068284|460334780|FG003|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
127922047|NCT05068284|460334781|FG004|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
127922048|NCT05068284|460334782|FG005|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
127922049|NCT05068284|460334783|FG006|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
127922050|NCT05068284|460334784|FG007|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
127922051|NCT05068284|460334777|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|1|||
127922052|NCT05068284|460334778|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
127922053|NCT05068284|460334779|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
127922054|NCT05068284|460334780|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
127922055|NCT05068284|460334781|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
127922056|NCT05068284|460334782|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
127922057|NCT05068284|460334783|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
127922058|NCT05068284|460334784|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
127922059|NCT05068284|460334777|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|8|||
127976457|NCT03535194|460536128|FG003|Maintenance Period|Lack of Efficacy|9|||
127922060|NCT05068284|460334778|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
127922061|NCT05068284|460334779|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
127922062|NCT05068284|460334780|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
127922063|NCT05068284|460334781|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
127922064|NCT05068284|460334782|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|3|||
127922065|NCT05068284|460334783|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|1|||
127922066|NCT05068284|460334784|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
127922067|NCT05068284|460334777|FG000|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
127922068|NCT05068284|460334778|FG001|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
127922069|NCT05068284|460334779|FG002|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
127922070|NCT05068284|460334780|FG003|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
127922071|NCT05068284|460334781|FG004|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
127922072|NCT05068284|460334782|FG005|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
127922073|NCT05068284|460334783|FG006|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
127922074|NCT05068284|460334784|FG007|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
127922075|NCT05068284|460334777|FG000|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|1|||
127922076|NCT05068284|460334778|FG001|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
127922077|NCT05068284|460334779|FG002|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
127922078|NCT05068284|460334780|FG003|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
127922079|NCT05068284|460334781|FG004|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
127922080|NCT05068284|460334782|FG005|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
127922081|NCT05068284|460334783|FG006|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
127922082|NCT05068284|460334784|FG007|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
127922083|NCT05068284|460334777|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|1|||
127922084|NCT05068284|460334778|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
127922085|NCT05068284|460334779|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
127922086|NCT05068284|460334780|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
127922087|NCT05068284|460334781|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
127922088|NCT05068284|460334782|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
127922089|NCT05068284|460334783|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
127922090|NCT05068284|460334784|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
127922091|NCT05068284|460334777|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|6|||
127922092|NCT05068284|460334778|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
127922093|NCT05068284|460334779|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
127922094|NCT05068284|460334780|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
127922095|NCT05068284|460334781|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
127922096|NCT05068284|460334782|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|10|||
127922097|NCT05068284|460334783|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|11|||
127922098|NCT05068284|460334784|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|3|||
127922099|NCT05068284|460334777|FG000|Double-Blind Maintenance (40 Weeks)|Other|0|||
127922100|NCT05068284|460334778|FG001|Double-Blind Maintenance (40 Weeks)|Other|0|||
127922101|NCT05068284|460334779|FG002|Double-Blind Maintenance (40 Weeks)|Other|0|||
127922102|NCT05068284|460334780|FG003|Double-Blind Maintenance (40 Weeks)|Other|0|||
127922103|NCT05068284|460334781|FG004|Double-Blind Maintenance (40 Weeks)|Other|0|||
127922104|NCT05068284|460334782|FG005|Double-Blind Maintenance (40 Weeks)|Other|0|||
127922105|NCT05068284|460334783|FG006|Double-Blind Maintenance (40 Weeks)|Other|0|||
127922106|NCT05068284|460334784|FG007|Double-Blind Maintenance (40 Weeks)|Other|1|||
127922107|NCT00965731|460334785|FG000|Overall Study|Death|0|||
127922108|NCT00965731|460334786|FG001|Overall Study|Death|4|||
127922109|NCT00965731|460334785|FG000|Overall Study|Withdrawal by Subject|0|||
127922110|NCT00965731|460334786|FG001|Overall Study|Withdrawal by Subject|1|||
127922111|NCT00965731|460334785|FG000|Overall Study|Other|7|||
127922112|NCT00965731|460334786|FG001|Overall Study|Other|15|||
127922113|NCT02832167|460336878|FG000|Treatment Period 1|Disease progression|90|||
127922114|NCT02832167|460336878|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
127922115|NCT02832167|460336878|FG000|Treatment Period 1|Death|2|||
127922116|NCT02832167|460336878|FG000|Treatment Period 1|Study Drug Toxicity|6|||
127922117|NCT02832167|460336878|FG000|Treatment Period 1|Participant request to discontinue|9|||
127922118|NCT02832167|460336878|FG000|Treatment Period 1|No longer meet study criteria|1|||
127922119|NCT02832167|460336878|FG000|Treatment Period 1|Participant withdrew consent|3|||
127922120|NCT02832167|460336878|FG000|Treatment Period 1|Other reasons|6|||
127922121|NCT02832167|460336878|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
127922122|NCT02832167|460336878|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
127922123|NCT02832167|460336878|FG000|Transition From Period 1 to Period 2|Death|2|||
127922124|NCT02832167|460336878|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
127922125|NCT02832167|460336878|FG000|Treatment Period 2|Disease progression|69|||
127922126|NCT02832167|460336878|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
127922127|NCT02832167|460336878|FG000|Treatment Period 2|Maximum clinical benefit|1|||
127922128|NCT02832167|460336878|FG000|Treatment Period 2|Study Drug Toxicity|5|||
127922129|NCT02832167|460336878|FG000|Treatment Period 2|Participant request to discontinue|2|||
127922130|NCT02832167|460336878|FG000|Treatment Period 2|Participant withdrew consent|3|||
127922131|NCT02832167|460336878|FG000|Treatment Period 2|Other reasons|3|||
127922132|NCT02293460|460336879|FG000|Overall Study|Protocol Violation|1|||
127922133|NCT02293460|460336879|FG000|Overall Study|Lack of Efficacy|2|||
127922134|NCT02293460|460336879|FG000|Overall Study|Adverse Event|2|||
127922135|NCT02293460|460336879|FG000|Overall Study|Withdrawal by Subject|1|||
127922136|NCT01074008|460336883|FG000|Overall Study|Adverse Event|0|||
127922137|NCT01074008|460336884|FG001|Overall Study|Adverse Event|1|||
127922138|NCT01074008|460336885|FG002|Overall Study|Adverse Event|0|||
127922139|NCT01074008|460336886|FG003|Overall Study|Adverse Event|0|||
127922140|NCT01074008|460336887|FG004|Overall Study|Adverse Event|0|||
127922141|NCT01074008|460336888|FG005|Overall Study|Adverse Event|0|||
127922142|NCT01074008|460336889|FG006|Overall Study|Adverse Event|0|||
127922143|NCT01074008|460336890|FG007|Overall Study|Adverse Event|0|||
127922144|NCT01074008|460336891|FG008|Overall Study|Adverse Event|0|||
127922145|NCT01074008|460336883|FG000|Overall Study|Withdrawal by Subject|1|||
127922146|NCT01074008|460336884|FG001|Overall Study|Withdrawal by Subject|1|||
127922147|NCT01074008|460336885|FG002|Overall Study|Withdrawal by Subject|1|||
127922148|NCT01074008|460336886|FG003|Overall Study|Withdrawal by Subject|0|||
127922149|NCT01074008|460336887|FG004|Overall Study|Withdrawal by Subject|1|||
127922150|NCT01074008|460336888|FG005|Overall Study|Withdrawal by Subject|0|||
127922151|NCT01074008|460336889|FG006|Overall Study|Withdrawal by Subject|0|||
127922152|NCT01074008|460336890|FG007|Overall Study|Withdrawal by Subject|0|||
127922153|NCT01074008|460336891|FG008|Overall Study|Withdrawal by Subject|0|||
127922154|NCT01074008|460336883|FG000|Overall Study|Lost to Follow-up|0|||
127922155|NCT01074008|460336884|FG001|Overall Study|Lost to Follow-up|1|||
127922156|NCT01074008|460336885|FG002|Overall Study|Lost to Follow-up|1|||
127922157|NCT01074008|460336886|FG003|Overall Study|Lost to Follow-up|1|||
127922158|NCT01074008|460336887|FG004|Overall Study|Lost to Follow-up|1|||
127922159|NCT01074008|460336888|FG005|Overall Study|Lost to Follow-up|0|||
127922160|NCT01074008|460336889|FG006|Overall Study|Lost to Follow-up|1|||
127922161|NCT01074008|460336890|FG007|Overall Study|Lost to Follow-up|0|||
127922162|NCT01074008|460336891|FG008|Overall Study|Lost to Follow-up|4|||
127922163|NCT00224484|460336892|FG000|Overall Study|Serious Adverse Event|1|||
127922164|NCT00224484|460336893|FG001|Overall Study|Serious Adverse Event|1|||
127922165|NCT00224484|460336894|FG002|Overall Study|Serious Adverse Event|0|||
127922166|NCT00224484|460336892|FG000|Overall Study|Non-Serious Adverse Event|5|||
127922167|NCT00224484|460336893|FG001|Overall Study|Non-Serious Adverse Event|7|||
127922168|NCT00224484|460336894|FG002|Overall Study|Non-Serious Adverse Event|3|||
127922169|NCT00224484|460336892|FG000|Overall Study|Protocol Violation|2|||
127922170|NCT00224484|460336893|FG001|Overall Study|Protocol Violation|2|||
127922171|NCT00224484|460336894|FG002|Overall Study|Protocol Violation|0|||
127922172|NCT00224484|460336892|FG000|Overall Study|Withdrawal by Subject|49|||
127922173|NCT00224484|460336893|FG001|Overall Study|Withdrawal by Subject|18|||
127922174|NCT00224484|460336894|FG002|Overall Study|Withdrawal by Subject|16|||
127922175|NCT00224484|460336892|FG000|Overall Study|Migrated/moved from study area|18|||
127922176|NCT00224484|460336893|FG001|Overall Study|Migrated/moved from study area|5|||
127922177|NCT00224484|460336894|FG002|Overall Study|Migrated/moved from study area|5|||
127922178|NCT00224484|460336892|FG000|Overall Study|Lost to Follow-up|66|||
127922179|NCT00224484|460336893|FG001|Overall Study|Lost to Follow-up|28|||
127922180|NCT00224484|460336894|FG002|Overall Study|Lost to Follow-up|36|||
127922181|NCT00224484|460336892|FG000|Overall Study|Reason not specified|5|||
127922182|NCT00224484|460336893|FG001|Overall Study|Reason not specified|4|||
127922183|NCT00224484|460336894|FG002|Overall Study|Reason not specified|2|||
127922184|NCT02805309|460336895|FG000|Overall Study|Lost to Follow-up|2|||
127922185|NCT02805309|460336896|FG001|Overall Study|Lost to Follow-up|2|||
127922186|NCT02805309|460336897|FG002|Overall Study|Lost to Follow-up|2|||
127922187|NCT02805309|460336895|FG000|Overall Study|Post-Randomization Exclusion|0|||
127922188|NCT02805309|460336896|FG001|Overall Study|Post-Randomization Exclusion|2|||
127922189|NCT02805309|460336897|FG002|Overall Study|Post-Randomization Exclusion|1|||
127922190|NCT00108628|460336905|FG000|Overall Study|Withdrawal by Subject|17|||
127922191|NCT00108628|460336906|FG001|Overall Study|Withdrawal by Subject|9|||
127922192|NCT00108628|460336905|FG000|Overall Study|Lack of Efficacy|2|||
127922193|NCT00108628|460336906|FG001|Overall Study|Lack of Efficacy|1|||
127922194|NCT00108628|460336905|FG000|Overall Study|Death|1|||
127922195|NCT00108628|460336906|FG001|Overall Study|Death|0|||
127922196|NCT01350934|460336907|FG000|Base Study|Adverse Event|6|||
127922197|NCT01350934|460336908|FG001|Base Study|Adverse Event|0|||
127922198|NCT01350934|460336907|FG000|Base Study|Lost to Follow-up|1|||
127922199|NCT01350934|460336908|FG001|Base Study|Lost to Follow-up|0|||
127922200|NCT01350934|460336907|FG000|Base Study|Protocol Violation|1|||
127922201|NCT01350934|460336908|FG001|Base Study|Protocol Violation|1|||
127922202|NCT01350934|460336907|FG000|Base Study|Withdrawal by Subject|1|||
127922203|NCT01350934|460336908|FG001|Base Study|Withdrawal by Subject|2|||
127922204|NCT01350934|460336907|FG000|Base Study|Non-Compliance With Study Drug|2|||
127922205|NCT01350934|460336908|FG001|Base Study|Non-Compliance With Study Drug|0|||
127922206|NCT01350934|460336907|FG000|Extension Study|Adverse Event|2|||
127922207|NCT01350934|460336908|FG001|Extension Study|Adverse Event|1|||
127922208|NCT01350934|460336907|FG000|Extension Study|Lost to Follow-up|2|||
127922209|NCT01350934|460336908|FG001|Extension Study|Lost to Follow-up|0|||
127922210|NCT01350934|460336907|FG000|Extension Study|Protocol Violation|1|||
127922211|NCT01350934|460336908|FG001|Extension Study|Protocol Violation|1|||
127922212|NCT01350934|460336907|FG000|Extension Study|Lack of Efficacy|0|||
127922213|NCT01350934|460336908|FG001|Extension Study|Lack of Efficacy|1|||
127922214|NCT01350934|460336907|FG000|Extension Study|Withdrawal by Subject|0|||
127922215|NCT01350934|460336908|FG001|Extension Study|Withdrawal by Subject|1|||
127922216|NCT03547635|460336911|FG000|Overall Study|Adverse Event|5|||
127922217|NCT03547635|460336912|FG001|Overall Study|Adverse Event|2|||
127922218|NCT03547635|460336913|FG002|Overall Study|Adverse Event|3|||
127922219|NCT03547635|460336911|FG000|Overall Study|Lost to Follow-up|1|||
127922220|NCT03547635|460336912|FG001|Overall Study|Lost to Follow-up|3|||
127922221|NCT03547635|460336913|FG002|Overall Study|Lost to Follow-up|4|||
127922222|NCT03547635|460336911|FG000|Overall Study|Withdrawal by Subject|1|||
127922223|NCT03547635|460336912|FG001|Overall Study|Withdrawal by Subject|0|||
127922224|NCT03547635|460336913|FG002|Overall Study|Withdrawal by Subject|0|||
127922225|NCT03547635|460336911|FG000|Overall Study|Withdrawal By PI|0|||
127922226|NCT03547635|460336912|FG001|Overall Study|Withdrawal By PI|1|||
127922227|NCT03547635|460336913|FG002|Overall Study|Withdrawal By PI|0|||
127922228|NCT03547635|460336911|FG000|Overall Study|Withdrawal by Sponsor|0|||
127922229|NCT03547635|460336912|FG001|Overall Study|Withdrawal by Sponsor|0|||
127922230|NCT03547635|460336913|FG002|Overall Study|Withdrawal by Sponsor|1|||
127922231|NCT03547635|460336911|FG000|Overall Study|Errant Randomization before Treatment|0|||
127922232|NCT03547635|460336912|FG001|Overall Study|Errant Randomization before Treatment|1|||
127922233|NCT03547635|460336913|FG002|Overall Study|Errant Randomization before Treatment|0|||
127922234|NCT03547635|460336911|FG000|Overall Study|Withdrawal by Subject|1|||
127922235|NCT03547635|460336912|FG001|Overall Study|Withdrawal by Subject|0|||
127922236|NCT03547635|460336913|FG002|Overall Study|Withdrawal by Subject|0|||
127922237|NCT04129944|460336916|FG000|Overall Study|Death|0|||
127922238|NCT04129944|460336917|FG001|Overall Study|Death|0|||
127922239|NCT04129944|460336918|FG002|Overall Study|Death|0|||
127922240|NCT04129944|460336919|FG003|Overall Study|Death|1|||
127922241|NCT04129944|460336916|FG000|Overall Study|Lost to Follow-up|1|||
127922242|NCT04129944|460336917|FG001|Overall Study|Lost to Follow-up|0|||
127922243|NCT04129944|460336918|FG002|Overall Study|Lost to Follow-up|0|||
127922244|NCT04129944|460336919|FG003|Overall Study|Lost to Follow-up|0|||
127922245|NCT04129944|460336916|FG000|Overall Study|Withdrawal by Subject|1|||
127922246|NCT04129944|460336917|FG001|Overall Study|Withdrawal by Subject|0|||
127922247|NCT04129944|460336918|FG002|Overall Study|Withdrawal by Subject|1|||
127922248|NCT04129944|460336919|FG003|Overall Study|Withdrawal by Subject|2|||
127922249|NCT00493792|460336920|FG000|Overall Study|Death|55|||
127922250|NCT00493792|460336921|FG001|Overall Study|Death|50|||
127922251|NCT00493792|460336920|FG000|Overall Study|Lost to Follow Up or Lack of Efficacy|36|||
127922252|NCT00493792|460336921|FG001|Overall Study|Lost to Follow Up or Lack of Efficacy|51|||
127922253|NCT00685035|460336922|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
127922254|NCT00685035|460336923|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
127922255|NCT04241133|460336924|FG000|Overall Study|COVID19 Precautions|14|||
127922256|NCT04241133|460336925|FG001|Overall Study|COVID19 Precautions|34|||
127922257|NCT04982445|460336926|FG000|Overall Study|Protocol Violation|1|||
127922258|NCT04982445|460336926|FG000|Overall Study|Withdrawal by Subject|4|||
127922259|NCT04982445|460336926|FG000|Overall Study|Lost to Follow-up|1|||
127922260|NCT00348816|460336928|FG000|Overall Study|Noncompliance with radiation treatment|1|||
127922261|NCT02050321|460336929|FG000|Overall Study|Withdrawal by Subject|1|||
127922262|NCT02050321|460336929|FG000|Overall Study|Adverse Event|1|||
127922263|NCT02005276|460336930|FG000|Overall Study|No longer interested|5|||
127922264|NCT02005276|460336931|FG001|Overall Study|No longer interested|2|||
127922265|NCT02005276|460336932|FG002|Overall Study|No longer interested|3|||
127922266|NCT02005276|460336933|FG003|Overall Study|No longer interested|3|||
127922267|NCT01963260|460336934|FG000|Overall Study|Withdrawal by Subject|2|||
127922268|NCT01963260|460336935|FG001|Overall Study|Withdrawal by Subject|0|||
127922269|NCT01963260|460336936|FG002|Overall Study|Withdrawal by Subject|0|||
127922270|NCT01963260|460336937|FG003|Overall Study|Withdrawal by Subject|1|||
127922271|NCT01963260|460336938|FG004|Overall Study|Withdrawal by Subject|2|||
127922272|NCT01963260|460336939|FG005|Overall Study|Withdrawal by Subject|0|||
127922273|NCT01963260|460336940|FG006|Overall Study|Withdrawal by Subject|0|||
127922274|NCT01963260|460336941|FG007|Overall Study|Withdrawal by Subject|0|||
127922275|NCT01963260|460336942|FG008|Overall Study|Withdrawal by Subject|0|||
127922276|NCT01963260|460336943|FG009|Overall Study|Withdrawal by Subject|0|||
127922277|NCT04994431|460336944|FG000|Overall Study|Adverse Event|1|||
127922278|NCT04994431|460336945|FG001|Overall Study|Adverse Event|0|||
127922279|NCT01067521|460336948|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
127922280|NCT01067521|460336949|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
127922281|NCT01067521|460336948|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
127922282|NCT01067521|460336949|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
127922283|NCT01067521|460336948|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
127922284|NCT01067521|460336949|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
127922285|NCT01067521|460336948|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
127922286|NCT01067521|460336949|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
127922287|NCT01067521|460336948|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
127922288|NCT01067521|460336949|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
127922289|NCT01067521|460336948|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
127922290|NCT01067521|460336949|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
127922291|NCT01067521|460336948|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
127922292|NCT01067521|460336949|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
127922293|NCT01067521|460336948|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
127922294|NCT01067521|460336949|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
127922295|NCT01067521|460336948|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
127922296|NCT01067521|460336949|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
127922297|NCT01067521|460336948|FG000|Open-Label Period|Death|3|||
127922298|NCT01067521|460336949|FG001|Open-Label Period|Death|1|||
127922299|NCT01067521|460336948|FG000|Open-Label Period|Adverse Event|30|||
127922300|NCT01067521|460336949|FG001|Open-Label Period|Adverse Event|28|||
127922301|NCT01067521|460336948|FG000|Open-Label Period|Withdrawal by Subject|160|||
127922302|NCT01067521|460336949|FG001|Open-Label Period|Withdrawal by Subject|88|||
127922303|NCT01067521|460336948|FG000|Open-Label Period|Physician Decision|13|||
127922304|NCT01067521|460336949|FG001|Open-Label Period|Physician Decision|11|||
127922305|NCT01067521|460336948|FG000|Open-Label Period|Non-compliance with study drug|5|||
127922306|NCT01067521|460336949|FG001|Open-Label Period|Non-compliance with study drug|0|||
127922307|NCT01067521|460336948|FG000|Open-Label Period|Protocol Violation|3|||
127922308|NCT01067521|460336949|FG001|Open-Label Period|Protocol Violation|0|||
127922309|NCT01067521|460336948|FG000|Open-Label Period|Pregnancy|14|||
127922310|NCT01067521|460336949|FG001|Open-Label Period|Pregnancy|8|||
127922311|NCT01067521|460336948|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
127922312|NCT01067521|460336949|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
127922313|NCT01067521|460336948|FG000|Open-Label Period|Lost to Follow-up|21|||
127922314|NCT01067521|460336949|FG001|Open-Label Period|Lost to Follow-up|20|||
127922315|NCT00766493|460336950|FG000|30 Days Post-Procedure|Discontinued|7|||
127922316|NCT00766493|460336950|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
127922317|NCT00766493|460336950|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
127922318|NCT03419962|460336953|FG000|Overall Study|Change to other medication|1|||
127922319|NCT03419962|460336953|FG000|Overall Study|Refusal of continuing with trial drug|1|||
127922320|NCT03419962|460336953|FG000|Overall Study|Lost to Follow-up|3|||
127922321|NCT03419962|460336953|FG000|Overall Study|Difficulty in inhaling the doses|1|||
127922322|NCT03419962|460336953|FG000|Overall Study|Missing completion data|31|||
127922323|NCT02914457|460336954|FG000|Overall Study|Withdrawal by Subject|1|||
127922324|NCT02914457|460336954|FG000|Overall Study|Physician Decision|1|||
127922325|NCT02914457|460336954|FG000|Overall Study|No veins available for lead placement|1|||
127922326|NCT02914457|460336954|FG000|Overall Study|Electrical instability of patient|1|||
127922327|NCT02914457|460336954|FG000|Overall Study|ECG acquisition error due to sweating|1|||
127922328|NCT02914457|460336954|FG000|Overall Study|Protocol Violation|1|||
127922329|NCT01849458|460336957|FG000|Overall Study|Lost to Follow-up|4|||
127922330|NCT01781234|460336958|FG000|Overall Study|Adverse Event|2|||
127922331|NCT01781234|460336959|FG001|Overall Study|Adverse Event|0|||
127922332|NCT01781234|460336958|FG000|Overall Study|Protocol Violation|3|||
127922333|NCT01781234|460336959|FG001|Overall Study|Protocol Violation|0|||
127922334|NCT01781234|460336958|FG000|Overall Study|Withdrawal by Subject|4|||
127922335|NCT01781234|460336959|FG001|Overall Study|Withdrawal by Subject|3|||
127922336|NCT03439085|460336960|FG000|Overall Study|Death|2|||
127922337|NCT03439085|460336960|FG000|Overall Study|Screen Failure|20|||
127922338|NCT01863433|460336961|FG000|Overall Study|Protocol Violation|1|||
127922339|NCT01206439|460336962|FG000|Overall Study|subject did not meet inclusion criteria|1|||
127922340|NCT03310619|460336967|FG000|Pre-Treatment Period|Death|1|||
127922341|NCT03310619|460336968|FG001|Pre-Treatment Period|Death|0|||
127922342|NCT03310619|460336969|FG002|Pre-Treatment Period|Death|0|||
127922343|NCT03310619|460336970|FG003|Pre-Treatment Period|Death|0|||
127922344|NCT03310619|460336971|FG004|Pre-Treatment Period|Death|1|||
127922345|NCT03310619|460336972|FG005|Pre-Treatment Period|Death|0|||
127922346|NCT03310619|460336973|FG006|Pre-Treatment Period|Death|0|||
127922347|NCT03310619|460336974|FG007|Pre-Treatment Period|Death|0|||
127922348|NCT03310619|460336967|FG000|Pre-Treatment Period|Other reasons|2|||
127922349|NCT03310619|460336968|FG001|Pre-Treatment Period|Other reasons|1|||
127922350|NCT03310619|460336969|FG002|Pre-Treatment Period|Other reasons|2|||
127922351|NCT03310619|460336970|FG003|Pre-Treatment Period|Other reasons|0|||
127922352|NCT03310619|460336971|FG004|Pre-Treatment Period|Other reasons|0|||
127922353|NCT03310619|460336972|FG005|Pre-Treatment Period|Other reasons|0|||
127922354|NCT03310619|460336973|FG006|Pre-Treatment Period|Other reasons|2|||
127922355|NCT03310619|460336974|FG007|Pre-Treatment Period|Other reasons|0|||
127922356|NCT03310619|460336967|FG000|Treatment Period|Death|1|||
127922357|NCT03310619|460336968|FG001|Treatment Period|Death|2|||
127922358|NCT03310619|460336969|FG002|Treatment Period|Death|0|||
127922359|NCT03310619|460336970|FG003|Treatment Period|Death|0|||
127922360|NCT03310619|460336971|FG004|Treatment Period|Death|1|||
127922361|NCT03310619|460336972|FG005|Treatment Period|Death|0|||
127922362|NCT03310619|460336973|FG006|Treatment Period|Death|2|||
127922363|NCT03310619|460336974|FG007|Treatment Period|Death|0|||
127922364|NCT03310619|460336967|FG000|Treatment Period|Adverse Event|0|||
127922365|NCT03310619|460336968|FG001|Treatment Period|Adverse Event|1|||
127922366|NCT03310619|460336969|FG002|Treatment Period|Adverse Event|4|||
127922367|NCT03310619|460336970|FG003|Treatment Period|Adverse Event|1|||
127922368|NCT03310619|460336971|FG004|Treatment Period|Adverse Event|0|||
127922369|NCT03310619|460336972|FG005|Treatment Period|Adverse Event|0|||
127922370|NCT03310619|460336973|FG006|Treatment Period|Adverse Event|0|||
127922371|NCT03310619|460336974|FG007|Treatment Period|Adverse Event|0|||
127922372|NCT03310619|460336967|FG000|Treatment Period|Withdrawal by participant|0|||
127922373|NCT03310619|460336968|FG001|Treatment Period|Withdrawal by participant|0|||
127922374|NCT03310619|460336969|FG002|Treatment Period|Withdrawal by participant|1|||
127922375|NCT03310619|460336970|FG003|Treatment Period|Withdrawal by participant|0|||
127922376|NCT03310619|460336971|FG004|Treatment Period|Withdrawal by participant|0|||
127922377|NCT03310619|460336972|FG005|Treatment Period|Withdrawal by participant|0|||
127922378|NCT03310619|460336973|FG006|Treatment Period|Withdrawal by participant|0|||
127922379|NCT03310619|460336974|FG007|Treatment Period|Withdrawal by participant|0|||
127922380|NCT03310619|460336967|FG000|Treatment Period|Lost to Follow-up|0|||
127922381|NCT03310619|460336968|FG001|Treatment Period|Lost to Follow-up|0|||
127922382|NCT03310619|460336969|FG002|Treatment Period|Lost to Follow-up|0|||
127922383|NCT03310619|460336970|FG003|Treatment Period|Lost to Follow-up|0|||
127922384|NCT03310619|460336971|FG004|Treatment Period|Lost to Follow-up|0|||
127922385|NCT03310619|460336972|FG005|Treatment Period|Lost to Follow-up|0|||
127922386|NCT03310619|460336973|FG006|Treatment Period|Lost to Follow-up|0|||
127922387|NCT03310619|460336974|FG007|Treatment Period|Lost to Follow-up|1|||
127922388|NCT03310619|460336967|FG000|Treatment Period|Study terminated by sponsor|0|||
127922389|NCT03310619|460336968|FG001|Treatment Period|Study terminated by sponsor|0|||
127922390|NCT03310619|460336969|FG002|Treatment Period|Study terminated by sponsor|0|||
127922391|NCT03310619|460336970|FG003|Treatment Period|Study terminated by sponsor|0|||
127922392|NCT03310619|460336971|FG004|Treatment Period|Study terminated by sponsor|0|||
127922393|NCT03310619|460336972|FG005|Treatment Period|Study terminated by sponsor|0|||
127922394|NCT03310619|460336973|FG006|Treatment Period|Study terminated by sponsor|0|||
127922395|NCT03310619|460336974|FG007|Treatment Period|Study terminated by sponsor|1|||
127922396|NCT03310619|460336967|FG000|Treatment Period|Physician Decision|0|||
127922397|NCT03310619|460336968|FG001|Treatment Period|Physician Decision|0|||
127922398|NCT03310619|460336969|FG002|Treatment Period|Physician Decision|0|||
127922399|NCT03310619|460336970|FG003|Treatment Period|Physician Decision|0|||
127922400|NCT03310619|460336971|FG004|Treatment Period|Physician Decision|3|||
127922401|NCT03310619|460336972|FG005|Treatment Period|Physician Decision|0|||
127922402|NCT03310619|460336973|FG006|Treatment Period|Physician Decision|0|||
127922403|NCT03310619|460336974|FG007|Treatment Period|Physician Decision|0|||
127922404|NCT03310619|460336967|FG000|Treatment Period|Other reasons|1|||
127922405|NCT03310619|460336968|FG001|Treatment Period|Other reasons|0|||
127922406|NCT03310619|460336969|FG002|Treatment Period|Other reasons|2|||
127922407|NCT03310619|460336970|FG003|Treatment Period|Other reasons|0|||
127922408|NCT03310619|460336971|FG004|Treatment Period|Other reasons|0|||
127922409|NCT03310619|460336972|FG005|Treatment Period|Other reasons|0|||
127922410|NCT03310619|460336973|FG006|Treatment Period|Other reasons|0|||
127922411|NCT03310619|460336974|FG007|Treatment Period|Other reasons|0|||
127922412|NCT01115933|460336975|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
127922413|NCT02427399|460336976|FG000|Overall Study|Protocol Violation|14|||
127922414|NCT02427399|460336977|FG001|Overall Study|Protocol Violation|16|||
127922415|NCT02427399|460336978|FG002|Overall Study|Protocol Violation|12|||
127922416|NCT02427399|460336979|FG003|Overall Study|Protocol Violation|18|||
127922417|NCT02427399|460336980|FG004|Overall Study|Protocol Violation|15|||
127922418|NCT00756717|460336981|FG000|Overall Study|Withdrawal by Subject|2|||
127922419|NCT00603512|460336982|FG000|Overall Study|Adverse Event|0|||
127922420|NCT00603512|460336983|FG001|Overall Study|Adverse Event|2|||
127922421|NCT00603512|460336984|FG002|Overall Study|Adverse Event|4|||
127922422|NCT00603512|460336985|FG003|Overall Study|Adverse Event|4|||
127922423|NCT00603512|460336986|FG004|Overall Study|Adverse Event|2|||
127922424|NCT00603512|460336982|FG000|Overall Study|Lack of Efficacy|0|||
127922425|NCT00603512|460336983|FG001|Overall Study|Lack of Efficacy|1|||
127922426|NCT00603512|460336984|FG002|Overall Study|Lack of Efficacy|0|||
127922427|NCT00603512|460336985|FG003|Overall Study|Lack of Efficacy|0|||
127922428|NCT00603512|460336986|FG004|Overall Study|Lack of Efficacy|1|||
127922429|NCT00603512|460336982|FG000|Overall Study|Other|2|||
127922430|NCT00603512|460336983|FG001|Overall Study|Other|1|||
127922431|NCT00603512|460336984|FG002|Overall Study|Other|0|||
127922432|NCT00603512|460336985|FG003|Overall Study|Other|1|||
127922433|NCT00603512|460336986|FG004|Overall Study|Other|1|||
127922434|NCT00603512|460336982|FG000|Overall Study|Withdrawal by Subject|0|||
127922435|NCT00603512|460336983|FG001|Overall Study|Withdrawal by Subject|0|||
127922436|NCT00603512|460336984|FG002|Overall Study|Withdrawal by Subject|0|||
127922437|NCT00603512|460336985|FG003|Overall Study|Withdrawal by Subject|0|||
127922438|NCT00603512|460336986|FG004|Overall Study|Withdrawal by Subject|1|||
127922439|NCT00603512|460336982|FG000|Overall Study|Randomized but not treated|0|||
127922440|NCT00603512|460336983|FG001|Overall Study|Randomized but not treated|1|||
127922441|NCT00603512|460336984|FG002|Overall Study|Randomized but not treated|1|||
127922442|NCT00603512|460336985|FG003|Overall Study|Randomized but not treated|2|||
127922443|NCT00603512|460336986|FG004|Overall Study|Randomized but not treated|0|||
127922444|NCT04979858|460336987|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
127922445|NCT04979858|460336988|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
127922446|NCT02654015|460336989|FG000|Overall Study|Death|12|||
127922447|NCT02654015|460336989|FG000|Overall Study|Lost to Follow-up|3|||
127922448|NCT01896505|460336992|FG000|Overall Study|Adverse Event|1|||
127922449|NCT01896505|460336993|FG001|Overall Study|Adverse Event|0|||
127922450|NCT01896505|460336994|FG002|Overall Study|Adverse Event|2|||
127922451|NCT01896505|460336995|FG003|Overall Study|Adverse Event|1|||
127922452|NCT01896505|460336996|FG004|Overall Study|Adverse Event|1|||
127922453|NCT01896505|460336997|FG005|Overall Study|Adverse Event|0|||
127922454|NCT01896505|460336992|FG000|Overall Study|Physician Decision|1|||
127922455|NCT01896505|460336993|FG001|Overall Study|Physician Decision|3|||
127922456|NCT01896505|460336994|FG002|Overall Study|Physician Decision|2|||
127922457|NCT01896505|460336995|FG003|Overall Study|Physician Decision|0|||
127922458|NCT01896505|460336996|FG004|Overall Study|Physician Decision|0|||
127922459|NCT01896505|460336997|FG005|Overall Study|Physician Decision|1|||
127922460|NCT01896505|460336992|FG000|Overall Study|Withdrawal by Subject|1|||
127922461|NCT01896505|460336993|FG001|Overall Study|Withdrawal by Subject|0|||
127922462|NCT01896505|460336994|FG002|Overall Study|Withdrawal by Subject|3|||
127922463|NCT01896505|460336995|FG003|Overall Study|Withdrawal by Subject|1|||
127922464|NCT01896505|460336996|FG004|Overall Study|Withdrawal by Subject|0|||
127922465|NCT01896505|460336997|FG005|Overall Study|Withdrawal by Subject|0|||
127922466|NCT01896505|460336992|FG000|Overall Study|Disease Progression|7|||
127922467|NCT01896505|460336993|FG001|Overall Study|Disease Progression|5|||
127922468|NCT01896505|460336994|FG002|Overall Study|Disease Progression|8|||
127922469|NCT01896505|460336995|FG003|Overall Study|Disease Progression|4|||
127922470|NCT01896505|460336996|FG004|Overall Study|Disease Progression|4|||
127922471|NCT01896505|460336997|FG005|Overall Study|Disease Progression|4|||
127922472|NCT01896505|460336992|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
127922473|NCT01896505|460336993|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
127922474|NCT01896505|460336994|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
127922475|NCT01896505|460336995|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
127922476|NCT01896505|460336996|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
127922477|NCT01896505|460336997|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
127922478|NCT01896505|460336992|FG000|Overall Study|Intercurrent illness|0|||
127922479|NCT01896505|460336993|FG001|Overall Study|Intercurrent illness|1|||
127922480|NCT01896505|460336994|FG002|Overall Study|Intercurrent illness|0|||
127922481|NCT01896505|460336995|FG003|Overall Study|Intercurrent illness|0|||
127922482|NCT01896505|460336996|FG004|Overall Study|Intercurrent illness|0|||
127922483|NCT01896505|460336997|FG005|Overall Study|Intercurrent illness|0|||
127922484|NCT01896505|460336992|FG000|Overall Study|Death|0|||
127922485|NCT01896505|460336993|FG001|Overall Study|Death|0|||
127922486|NCT01896505|460336994|FG002|Overall Study|Death|1|||
127922487|NCT01896505|460336995|FG003|Overall Study|Death|1|||
127922488|NCT01896505|460336996|FG004|Overall Study|Death|0|||
127922489|NCT01896505|460336997|FG005|Overall Study|Death|1|||
127922490|NCT02418754|460336998|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
127922491|NCT02418754|460336999|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
127922492|NCT02418754|460337000|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
127922493|NCT02418754|460337001|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
127922494|NCT02418754|460337002|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
127922495|NCT02418754|460336998|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
127922496|NCT02418754|460336999|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
127922497|NCT02418754|460337000|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
127922498|NCT02418754|460337001|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
127922499|NCT02418754|460337002|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
127922500|NCT02418754|460336998|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
127922501|NCT02418754|460336999|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
127922502|NCT02418754|460337000|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
127922503|NCT02418754|460337001|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
127922504|NCT02418754|460337002|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
127922505|NCT02418754|460336998|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
127922506|NCT02418754|460336999|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
127922507|NCT02418754|460337000|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
127922508|NCT02418754|460337001|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
127922509|NCT02418754|460337002|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
127922510|NCT02418754|460336998|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
127922511|NCT02418754|460336999|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
127922512|NCT02418754|460337000|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
127922513|NCT02418754|460337001|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
127922514|NCT02418754|460337002|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
127922515|NCT02418754|460336998|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
127922516|NCT02418754|460336999|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
127922517|NCT02418754|460337000|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
127922518|NCT02418754|460337001|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
127922519|NCT02418754|460337002|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
127922520|NCT02418754|460336998|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
127922521|NCT02418754|460336999|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
127922522|NCT02418754|460337000|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
127922523|NCT02418754|460337001|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
127922524|NCT02418754|460337002|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
127922525|NCT02418754|460336998|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
127922526|NCT02418754|460336999|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
127922527|NCT02418754|460337000|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
127922528|NCT02418754|460337001|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
127922529|NCT02418754|460337002|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
127922530|NCT02418754|460336998|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
127922531|NCT02418754|460336999|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
127922532|NCT02418754|460337000|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
127922533|NCT02418754|460337001|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
127922534|NCT02418754|460337002|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
127922535|NCT02418754|460336998|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
127922536|NCT02418754|460336999|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
127922537|NCT02418754|460337000|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
127922538|NCT02418754|460337001|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
127922539|NCT02418754|460337002|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
127922540|NCT02418754|460336998|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
127922541|NCT02418754|460336999|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
127922542|NCT02418754|460337000|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
127922543|NCT02418754|460337001|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
127922544|NCT02418754|460337002|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
127922545|NCT04974580|460337003|FG000|Overall Study|Lost to Follow-up|33|||
127922546|NCT04974580|460337004|FG001|Overall Study|Lost to Follow-up|39|||
127922547|NCT04974580|460337005|FG002|Overall Study|Lost to Follow-up|30|||
127922548|NCT04974580|460337006|FG003|Overall Study|Lost to Follow-up|29|||
127922549|NCT03919695|460337021|FG000|3-month Follow-up|Death|1|||
127922550|NCT03919695|460337022|FG001|3-month Follow-up|Death|1|||
127922551|NCT03919695|460337021|FG000|3-month Follow-up|unable to contact|0|||
127922552|NCT03919695|460337022|FG001|3-month Follow-up|unable to contact|3|||
127922553|NCT03919695|460337021|FG000|3-month Follow-up|in prison|0|||
127922554|NCT03919695|460337022|FG001|3-month Follow-up|in prison|1|||
127922555|NCT03919695|460337021|FG000|6-month Follow-up|Death|0|||
127922556|NCT03919695|460337022|FG001|6-month Follow-up|Death|1|||
127922557|NCT03919695|460337021|FG000|6-month Follow-up|Lost to Follow-up|1|||
127922558|NCT03919695|460337022|FG001|6-month Follow-up|Lost to Follow-up|2|||
127922559|NCT03919695|460337021|FG000|6-month Follow-up|in prison|0|||
127922560|NCT03919695|460337022|FG001|6-month Follow-up|in prison|2|||
127922561|NCT03919695|460337021|FG000|Any Follow-up (3 and/or 6 Month)|Death|1|||
127922562|NCT03919695|460337022|FG001|Any Follow-up (3 and/or 6 Month)|Death|1|||
127922563|NCT03919695|460337021|FG000|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|0|||
127922564|NCT03919695|460337022|FG001|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|2|||
127922565|NCT03259789|460337023|FG000|Overall Study|Adverse Event|3|||
127922566|NCT03259789|460337024|FG001|Overall Study|Adverse Event|2|||
127922567|NCT03259789|460337025|FG002|Overall Study|Adverse Event|1|||
127922568|NCT03259789|460337023|FG000|Overall Study|Withdrawal by Subject|9|||
127922569|NCT03259789|460337024|FG001|Overall Study|Withdrawal by Subject|5|||
127922570|NCT03259789|460337025|FG002|Overall Study|Withdrawal by Subject|1|||
127922571|NCT03259789|460337023|FG000|Overall Study|Lost to Follow-up|5|||
127922572|NCT03259789|460337024|FG001|Overall Study|Lost to Follow-up|9|||
127922573|NCT03259789|460337025|FG002|Overall Study|Lost to Follow-up|4|||
127922574|NCT03259789|460337023|FG000|Overall Study|Physician Decision|0|||
127922575|NCT03259789|460337024|FG001|Overall Study|Physician Decision|1|||
127922576|NCT03259789|460337025|FG002|Overall Study|Physician Decision|0|||
127922577|NCT02063217|460337026|FG000|Overall Study|Withdrawal by Subject|1|||
127922578|NCT02063217|460337027|FG001|Overall Study|Withdrawal by Subject|0|||
127922579|NCT02063217|460337028|FG002|Overall Study|Withdrawal by Subject|0|||
127922580|NCT02416934|460337029|FG000|Overall Study|given steroids|1|||
127922581|NCT02416934|460337030|FG001|Overall Study|given steroids|2|||
127922582|NCT02416934|460337029|FG000|Overall Study|Lost to Follow-up|0|||
127922583|NCT02416934|460337030|FG001|Overall Study|Lost to Follow-up|2|||
127922584|NCT02416934|460337029|FG000|Overall Study|Withdrawal by Subject|1|||
127922585|NCT02416934|460337030|FG001|Overall Study|Withdrawal by Subject|0|||
127922586|NCT02416934|460337029|FG000|Overall Study|recruited during continuing renewal proc|0|||
127922587|NCT02416934|460337030|FG001|Overall Study|recruited during continuing renewal proc|1|||
127922588|NCT02416934|460337029|FG000|Overall Study|Protocol Violation|0|||
127922589|NCT02416934|460337030|FG001|Overall Study|Protocol Violation|1|||
127922590|NCT02416934|460337029|FG000|Overall Study|surgery started late|0|||
127922591|NCT02416934|460337030|FG001|Overall Study|surgery started late|1|||
127922592|NCT02416934|460337029|FG000|Overall Study|re-operation|1|||
127922593|NCT02416934|460337030|FG001|Overall Study|re-operation|0|||
127922594|NCT01020526|460337031|FG000|Overall Study|Withdrawal by Subject|5|||
127922595|NCT01020526|460337031|FG000|Overall Study|Other reasons|3|||
127922596|NCT01020526|460337031|FG000|Overall Study|Insufficient clinical response|3|||
127922597|NCT01020526|460337031|FG000|Overall Study|Lost to Follow-up|1|||
127922598|NCT01020526|460337031|FG000|Overall Study|Adverse Event|2|||
127922599|NCT02169336|460337034|FG000|Overall Study|Lack of Efficacy|1|||
127922600|NCT02169336|460337035|FG001|Overall Study|Lack of Efficacy|1|||
127922601|NCT02169336|460337036|FG002|Overall Study|Lack of Efficacy|0|||
127922602|NCT02169336|460337034|FG000|Overall Study|Adverse Event|2|||
127922603|NCT02169336|460337035|FG001|Overall Study|Adverse Event|3|||
127922604|NCT02169336|460337036|FG002|Overall Study|Adverse Event|1|||
127922605|NCT02169336|460337034|FG000|Overall Study|Withdrawal by Subject|1|||
127922606|NCT02169336|460337035|FG001|Overall Study|Withdrawal by Subject|0|||
127922607|NCT02169336|460337036|FG002|Overall Study|Withdrawal by Subject|0|||
127922608|NCT02169336|460337034|FG000|Overall Study|Physician Decision|0|||
127922609|NCT02169336|460337035|FG001|Overall Study|Physician Decision|0|||
127922610|NCT02169336|460337036|FG002|Overall Study|Physician Decision|1|||
127922611|NCT02169336|460337034|FG000|Overall Study|Subject declined to continue dosing|0|||
127922612|NCT02169336|460337035|FG001|Overall Study|Subject declined to continue dosing|0|||
127922613|NCT02169336|460337036|FG002|Overall Study|Subject declined to continue dosing|1|||
127922614|NCT01148225|460337039|FG000|Overall Study|Other|185|||
127922615|NCT02212457|460337040|FG000|Overall Study|Adverse Event|1|||
127922616|NCT02212457|460337041|FG001|Overall Study|Adverse Event|2|||
127922617|NCT02212457|460337042|FG002|Overall Study|Adverse Event|2|||
127922618|NCT02212457|460337043|FG003|Overall Study|Adverse Event|2|||
127922619|NCT02212457|460337044|FG004|Overall Study|Adverse Event|0|||
127922620|NCT02212457|460337045|FG005|Overall Study|Adverse Event|1|||
127922621|NCT02212457|460337040|FG000|Overall Study|Withdrawal by Subject|8|||
127922622|NCT02212457|460337041|FG001|Overall Study|Withdrawal by Subject|10|||
127922623|NCT02212457|460337042|FG002|Overall Study|Withdrawal by Subject|8|||
127922624|NCT02212457|460337043|FG003|Overall Study|Withdrawal by Subject|6|||
127922625|NCT02212457|460337044|FG004|Overall Study|Withdrawal by Subject|5|||
127922626|NCT02212457|460337045|FG005|Overall Study|Withdrawal by Subject|4|||
127922627|NCT02212457|460337040|FG000|Overall Study|Lost to Follow-up|6|||
127922628|NCT02212457|460337041|FG001|Overall Study|Lost to Follow-up|7|||
127922629|NCT02212457|460337042|FG002|Overall Study|Lost to Follow-up|4|||
127922630|NCT02212457|460337043|FG003|Overall Study|Lost to Follow-up|1|||
127922631|NCT02212457|460337044|FG004|Overall Study|Lost to Follow-up|8|||
127922632|NCT02212457|460337045|FG005|Overall Study|Lost to Follow-up|4|||
127922633|NCT02212457|460337040|FG000|Overall Study|Protocol Violation|2|||
127922634|NCT02212457|460337041|FG001|Overall Study|Protocol Violation|1|||
127922635|NCT02212457|460337042|FG002|Overall Study|Protocol Violation|0|||
127922636|NCT02212457|460337043|FG003|Overall Study|Protocol Violation|1|||
127922637|NCT02212457|460337044|FG004|Overall Study|Protocol Violation|2|||
127922638|NCT02212457|460337045|FG005|Overall Study|Protocol Violation|3|||
127922639|NCT02212457|460337040|FG000|Overall Study|Other|2|||
127922640|NCT02212457|460337041|FG001|Overall Study|Other|1|||
127922641|NCT02212457|460337042|FG002|Overall Study|Other|2|||
127922642|NCT02212457|460337043|FG003|Overall Study|Other|1|||
127922643|NCT02212457|460337044|FG004|Overall Study|Other|0|||
127922644|NCT02212457|460337045|FG005|Overall Study|Other|1|||
127922645|NCT02490800|460337046|FG000|Overall Study|Adverse Event|0|||
127922646|NCT02490800|460337047|FG001|Overall Study|Adverse Event|0|||
127922647|NCT02490800|460337048|FG002|Overall Study|Adverse Event|0|||
127922648|NCT02490800|460337049|FG003|Overall Study|Adverse Event|2|||
127922649|NCT02490800|460337050|FG004|Overall Study|Adverse Event|3|||
127922650|NCT02490800|460337051|FG005|Overall Study|Adverse Event|2|||
127922651|NCT02490800|460337052|FG006|Overall Study|Adverse Event|0|||
127922652|NCT02490800|460337053|FG007|Overall Study|Adverse Event|0|||
127922653|NCT02490800|460337054|FG008|Overall Study|Adverse Event|0|||
127922654|NCT02490800|460337055|FG009|Overall Study|Adverse Event|0|||
127922655|NCT02490800|460337056|FG010|Overall Study|Adverse Event|0|||
127922656|NCT02490800|460337057|FG011|Overall Study|Adverse Event|2|||
127922657|NCT02490800|460337058|FG012|Overall Study|Adverse Event|2|||
127922658|NCT02490800|460337046|FG000|Overall Study|Withdrawal by Subject|0|||
127922659|NCT02490800|460337047|FG001|Overall Study|Withdrawal by Subject|0|||
127922660|NCT02490800|460337048|FG002|Overall Study|Withdrawal by Subject|0|||
127922661|NCT02490800|460337049|FG003|Overall Study|Withdrawal by Subject|1|||
127922662|NCT02490800|460337050|FG004|Overall Study|Withdrawal by Subject|0|||
127922663|NCT02490800|460337051|FG005|Overall Study|Withdrawal by Subject|0|||
127922664|NCT02490800|460337052|FG006|Overall Study|Withdrawal by Subject|0|||
127922665|NCT02490800|460337053|FG007|Overall Study|Withdrawal by Subject|0|||
127922666|NCT02490800|460337054|FG008|Overall Study|Withdrawal by Subject|1|||
127922667|NCT02490800|460337055|FG009|Overall Study|Withdrawal by Subject|0|||
127922668|NCT02490800|460337056|FG010|Overall Study|Withdrawal by Subject|0|||
127922669|NCT02490800|460337057|FG011|Overall Study|Withdrawal by Subject|0|||
127922670|NCT02490800|460337058|FG012|Overall Study|Withdrawal by Subject|0|||
127922671|NCT02490800|460337046|FG000|Overall Study|Progressive disease|3|||
127922672|NCT02490800|460337047|FG001|Overall Study|Progressive disease|3|||
127922673|NCT02490800|460337048|FG002|Overall Study|Progressive disease|3|||
127922674|NCT02490800|460337049|FG003|Overall Study|Progressive disease|4|||
127922675|NCT02490800|460337050|FG004|Overall Study|Progressive disease|4|||
127922676|NCT02490800|460337051|FG005|Overall Study|Progressive disease|1|||
127922677|NCT02490800|460337052|FG006|Overall Study|Progressive disease|4|||
127922678|NCT02490800|460337053|FG007|Overall Study|Progressive disease|3|||
127922679|NCT02490800|460337054|FG008|Overall Study|Progressive disease|6|||
127922680|NCT02490800|460337055|FG009|Overall Study|Progressive disease|2|||
127922681|NCT02490800|460337056|FG010|Overall Study|Progressive disease|7|||
127922682|NCT02490800|460337057|FG011|Overall Study|Progressive disease|1|||
127922683|NCT02490800|460337058|FG012|Overall Study|Progressive disease|10|||
127922684|NCT02490800|460337046|FG000|Overall Study|Patient enrolled in post-trial access|0|||
127922685|NCT02490800|460337047|FG001|Overall Study|Patient enrolled in post-trial access|0|||
127922686|NCT02490800|460337048|FG002|Overall Study|Patient enrolled in post-trial access|0|||
127922687|NCT02490800|460337049|FG003|Overall Study|Patient enrolled in post-trial access|0|||
127922688|NCT02490800|460337050|FG004|Overall Study|Patient enrolled in post-trial access|0|||
127922689|NCT02490800|460337051|FG005|Overall Study|Patient enrolled in post-trial access|0|||
127922690|NCT02490800|460337052|FG006|Overall Study|Patient enrolled in post-trial access|0|||
127922691|NCT02490800|460337053|FG007|Overall Study|Patient enrolled in post-trial access|0|||
127922692|NCT02490800|460337054|FG008|Overall Study|Patient enrolled in post-trial access|0|||
127922693|NCT02490800|460337055|FG009|Overall Study|Patient enrolled in post-trial access|1|||
127922694|NCT02490800|460337056|FG010|Overall Study|Patient enrolled in post-trial access|1|||
127922695|NCT02490800|460337057|FG011|Overall Study|Patient enrolled in post-trial access|0|||
127922696|NCT02490800|460337058|FG012|Overall Study|Patient enrolled in post-trial access|6|||
127922697|NCT00654641|460337060|FG000|Overall Study|Lost to Follow-up|2|||
127922698|NCT00654641|460337061|FG001|Overall Study|Lost to Follow-up|3|||
127922699|NCT01337596|460337062|FG000|Overall Study|Withdrawal by Subject|0|||
127922700|NCT01337596|460337063|FG001|Overall Study|Withdrawal by Subject|0|||
127922701|NCT01337596|460337064|FG002|Overall Study|Withdrawal by Subject|0|||
127922702|NCT01337596|460337065|FG003|Overall Study|Withdrawal by Subject|0|||
127922703|NCT01337596|460337066|FG004|Overall Study|Withdrawal by Subject|2|||
127922704|NCT01337596|460337067|FG005|Overall Study|Withdrawal by Subject|0|||
127922705|NCT01337596|460337068|FG006|Overall Study|Withdrawal by Subject|0|||
127922706|NCT01337596|460337069|FG007|Overall Study|Withdrawal by Subject|0|||
127922707|NCT01337596|460337070|FG008|Overall Study|Withdrawal by Subject|0|||
127922708|NCT03693950|460337071|FG000|Overall Study|Withdrawal by Subject|1|||
127922709|NCT03693950|460337072|FG001|Overall Study|Withdrawal by Subject|0|||
127922710|NCT00559637|460338731|FG000|Overall Study|Adverse Event|22|||
127922711|NCT00559637|460338731|FG000|Overall Study|Withdrawal by Subject|4|||
127922712|NCT00559637|460338731|FG000|Overall Study|Protocol Violation|6|||
127922713|NCT00559637|460338731|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
127922714|NCT00559637|460338731|FG000|Overall Study|Failure to return|6|||
127922715|NCT00559637|460338731|FG000|Overall Study|Insufficient response|3|||
127922716|NCT00559637|460338731|FG000|Overall Study|Started requiring dialysis after month 7|2|||
127922717|NCT00559637|460338731|FG000|Overall Study|Suspected lung cancer|1|||
127922718|NCT00559637|460338731|FG000|Overall Study|Participation in another study|1|||
127922719|NCT00559637|460338731|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
127922720|NCT00559637|460338731|FG000|Overall Study|Change of center|1|||
127922721|NCT00559637|460338731|FG000|Overall Study|Change of home|1|||
127922722|NCT00559637|460338731|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
127922723|NCT01958060|460338734|FG000|Overall Study|Not treated|2|||
127922724|NCT01958060|460338735|FG001|Overall Study|Not treated|0|||
127922725|NCT01958060|460338736|FG002|Overall Study|Not treated|0|||
127922726|NCT01958060|460338737|FG003|Overall Study|Not treated|0|||
127922727|NCT01958060|460338738|FG004|Overall Study|Not treated|1|||
127922728|NCT01958060|460338739|FG005|Overall Study|Not treated|0|||
127922729|NCT02415387|460338767|FG000|Overall Study|Withdrawal by Subject|6|||
127922730|NCT02415387|460338768|FG001|Overall Study|Withdrawal by Subject|1|||
127922731|NCT02415387|460338767|FG000|Overall Study|blood draw problem|0|||
127922732|NCT02415387|460338768|FG001|Overall Study|blood draw problem|1|||
127922733|NCT02415387|460338767|FG000|Overall Study|Protocol Violation|1|||
127922734|NCT02415387|460338768|FG001|Overall Study|Protocol Violation|0|||
127922735|NCT00676650|460338772|FG000|Overall Study|Death|45|||
127922736|NCT00676650|460338773|FG001|Overall Study|Death|14|||
127922737|NCT00676650|460338772|FG000|Overall Study|Adverse Event|159|||
127922738|NCT00676650|460338773|FG001|Overall Study|Adverse Event|21|||
127922739|NCT00676650|460338772|FG000|Overall Study|Global deterioration of health status|66|||
127922740|NCT00676650|460338773|FG001|Overall Study|Global deterioration of health status|31|||
127922741|NCT00676650|460338772|FG000|Overall Study|Lost to Follow-up|0|||
127922742|NCT00676650|460338773|FG001|Overall Study|Lost to Follow-up|1|||
127922743|NCT00676650|460338772|FG000|Overall Study|Objective progression or relapse|189|||
127922744|NCT00676650|460338773|FG001|Overall Study|Objective progression or relapse|140|||
127922745|NCT00676650|460338772|FG000|Overall Study|Other|14|||
127922746|NCT00676650|460338773|FG001|Overall Study|Other|10|||
127922747|NCT00676650|460338772|FG000|Overall Study|Protocol Violation|3|||
127922748|NCT00676650|460338773|FG001|Overall Study|Protocol Violation|1|||
127922749|NCT00676650|460338772|FG000|Overall Study|Study terminated by sponsor|57|||
127922750|NCT00676650|460338773|FG001|Overall Study|Study terminated by sponsor|43|||
127922751|NCT00676650|460338772|FG000|Overall Study|Withdrawal by Subject|48|||
127922752|NCT00676650|460338773|FG001|Overall Study|Withdrawal by Subject|24|||
127922753|NCT00676650|460338772|FG000|Overall Study|Randomized but not treated|3|||
127922754|NCT00676650|460338773|FG001|Overall Study|Randomized but not treated|4|||
127922755|NCT02297841|460338777|FG000|Overall Study|Withdrawal by Subject|1|||
127922756|NCT02297841|460338777|FG000|Overall Study|Protocol Violation|7|||
127922757|NCT00683592|460338778|FG000|Overall Study|Adverse Event|12|||
127922758|NCT00683592|460338779|FG001|Overall Study|Adverse Event|4|||
127922759|NCT00683592|460338778|FG000|Overall Study|Withdrawal by Subject|11|||
127922760|NCT00683592|460338779|FG001|Overall Study|Withdrawal by Subject|11|||
127922761|NCT00683592|460338778|FG000|Overall Study|Lost to Follow-up|17|||
127922762|NCT00683592|460338779|FG001|Overall Study|Lost to Follow-up|17|||
127922763|NCT00683592|460338778|FG000|Overall Study|Lack of Efficacy|3|||
127922764|NCT00683592|460338779|FG001|Overall Study|Lack of Efficacy|7|||
127922765|NCT00683592|460338778|FG000|Overall Study|Physician Decision|0|||
127922766|NCT00683592|460338779|FG001|Overall Study|Physician Decision|1|||
127922767|NCT00683592|460338778|FG000|Overall Study|Non-compliance|3|||
127922768|NCT00683592|460338779|FG001|Overall Study|Non-compliance|5|||
127922769|NCT00683592|460338778|FG000|Overall Study|Other|1|||
127922770|NCT00683592|460338779|FG001|Overall Study|Other|1|||
127922771|NCT01765270|460338787|FG000|Overall Study|Physician Decision|1|||
127922772|NCT01765270|460338788|FG001|Overall Study|Physician Decision|0|||
127922773|NCT01765270|460338787|FG000|Overall Study|Withdrawal by Subject|0|||
127922774|NCT01765270|460338788|FG001|Overall Study|Withdrawal by Subject|1|||
127922775|NCT03431337|460338791|FG000|Overall Study|Lost to Follow-up|21|||
127922776|NCT03431337|460338792|FG001|Overall Study|Lost to Follow-up|19|||
127922777|NCT03431337|460338791|FG000|Overall Study|Withdrawal by Subject|8|||
127922778|NCT03431337|460338792|FG001|Overall Study|Withdrawal by Subject|3|||
127922779|NCT00329160|460338793|FG000|Overall Study|Adverse Event|27|||
127922780|NCT00329160|460338793|FG000|Overall Study|Withdrawal by Subject|13|||
127922781|NCT00329160|460338793|FG000|Overall Study|Protocol Violation|2|||
127922782|NCT00329160|460338793|FG000|Overall Study|Did not Receive Study Drug|1|||
127922783|NCT00329160|460338793|FG000|Overall Study|Incomplete IVUS|45|||
127922784|NCT04501094|460338794|FG000|Overall Study|Death (unrelated to research)|1|||
127922785|NCT04501094|460338795|FG001|Overall Study|Death (unrelated to research)|0|||
127922786|NCT00063258|460338799|FG000|Overall Study|Physician Decision|2|||
127922787|NCT00063258|460338800|FG001|Overall Study|Physician Decision|0|||
127922788|NCT00063258|460338799|FG000|Overall Study|Lack of Efficacy|2|||
127922789|NCT00063258|460338800|FG001|Overall Study|Lack of Efficacy|0|||
127922790|NCT03653026|460338803|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
127922791|NCT03653026|460338804|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
127922792|NCT03653026|460338805|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
127922793|NCT03653026|460338806|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
127922794|NCT03653026|460338803|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
127922795|NCT03653026|460338804|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
127922796|NCT03653026|460338805|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
127922797|NCT03653026|460338806|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
127922798|NCT03653026|460338803|FG000|Part 1: Placebo-controlled Period|Other|0|||
127922799|NCT03653026|460338804|FG001|Part 1: Placebo-controlled Period|Other|3|||
127922800|NCT03653026|460338805|FG002|Part 1: Placebo-controlled Period|Other|0|||
127922801|NCT03653026|460338806|FG003|Part 1: Placebo-controlled Period|Other|0|||
127922802|NCT03653026|460338803|FG000|Part 2: Open-label Extension|Adverse Event|0|||
127922803|NCT03653026|460338804|FG001|Part 2: Open-label Extension|Adverse Event|0|||
127922804|NCT03653026|460338805|FG002|Part 2: Open-label Extension|Adverse Event|1|||
127922805|NCT03653026|460338806|FG003|Part 2: Open-label Extension|Adverse Event|1|||
127922806|NCT03653026|460338803|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
127922807|NCT03653026|460338804|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
127922808|NCT03653026|460338805|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
127922809|NCT03653026|460338806|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
127922810|NCT03653026|460338803|FG000|Part 2: Open-label Extension|Other|0|||
127922811|NCT03653026|460338804|FG001|Part 2: Open-label Extension|Other|0|||
127922812|NCT03653026|460338805|FG002|Part 2: Open-label Extension|Other|1|||
127922813|NCT03653026|460338806|FG003|Part 2: Open-label Extension|Other|2|||
127922814|NCT02457819|460338807|FG000|Overall Study|reason not given|8|||
127922815|NCT02457819|460338807|FG000|Overall Study|Withdrawal by Subject|24|||
127922816|NCT02457819|460338807|FG000|Overall Study|Protocol Violation|1|||
127922817|NCT02457819|460338807|FG000|Overall Study|non compliance with study drug|4|||
127922818|NCT02457819|460338807|FG000|Overall Study|Lost to Follow-up|10|||
127922819|NCT02457819|460338807|FG000|Overall Study|Lack of Efficacy|19|||
127922820|NCT02457819|460338807|FG000|Overall Study|Adverse Event|33|||
127922821|NCT03330236|460338809|FG000|Overall Study|Death|2|||
127922822|NCT03330236|460338810|FG001|Overall Study|Death|1|||
127922823|NCT03330236|460338809|FG000|Overall Study|Withdrawal by Subject|2|||
127922824|NCT03330236|460338810|FG001|Overall Study|Withdrawal by Subject|4|||
127922825|NCT03330236|460338809|FG000|Overall Study|Lost to Follow-up|0|||
127922826|NCT03330236|460338810|FG001|Overall Study|Lost to Follow-up|2|||
127922827|NCT03330236|460338809|FG000|Overall Study|Physician Decision|2|||
127922828|NCT03330236|460338810|FG001|Overall Study|Physician Decision|0|||
127922829|NCT03330236|460338809|FG000|Overall Study|Protocol Violation|4|||
127922830|NCT03330236|460338810|FG001|Overall Study|Protocol Violation|3|||
127922831|NCT03330236|460338809|FG000|Overall Study|SedLine malfunction/blinding|19|||
127922832|NCT03330236|460338810|FG001|Overall Study|SedLine malfunction/blinding|14|||
127922833|NCT03330236|460338809|FG000|Overall Study|Volatile anesthetics used|11|||
127922834|NCT03330236|460338810|FG001|Overall Study|Volatile anesthetics used|8|||
127922835|NCT03330236|460338809|FG000|Overall Study|Surgery aborted/converted to open|60|||
127922836|NCT03330236|460338810|FG001|Overall Study|Surgery aborted/converted to open|52|||
127922837|NCT01901848|460338812|FG000|Randomized and Treated|Lost to Follow-up|3|||
127922838|NCT01901848|460338813|FG001|Randomized and Treated|Lost to Follow-up|6|||
127922839|NCT01901848|460338812|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
127922840|NCT01901848|460338813|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
127922841|NCT00763555|460338814|FG000|Overall Study|Adverse Event|2|||
127922842|NCT00763555|460338815|FG001|Overall Study|Adverse Event|1|||
127922843|NCT00763555|460338814|FG000|Overall Study|Withdrawal by Subject|2|||
127922844|NCT00763555|460338815|FG001|Overall Study|Withdrawal by Subject|6|||
127922845|NCT00763555|460338814|FG000|Overall Study|Lost to Follow-up|0|||
127922846|NCT00763555|460338815|FG001|Overall Study|Lost to Follow-up|3|||
127922847|NCT01729026|460338816|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
127922848|NCT01729026|460338817|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
127922849|NCT01729026|460338816|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
127922850|NCT01729026|460338817|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
127922851|NCT03710590|460338818|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
127922852|NCT03710590|460338819|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
127922853|NCT00852917|460338820|FG000|Overall Study|Adverse Event|13|||
127922854|NCT00852917|460338821|FG001|Overall Study|Adverse Event|20|||
127922855|NCT00852917|460338822|FG002|Overall Study|Adverse Event|35|||
127922856|NCT00852917|460338823|FG003|Overall Study|Adverse Event|17|||
127922857|NCT00852917|460338820|FG000|Overall Study|Lack of Efficacy|21|||
127922858|NCT00852917|460338821|FG001|Overall Study|Lack of Efficacy|11|||
127922859|NCT00852917|460338822|FG002|Overall Study|Lack of Efficacy|11|||
127922860|NCT00852917|460338823|FG003|Overall Study|Lack of Efficacy|47|||
127922861|NCT00852917|460338820|FG000|Overall Study|Withdrawal by Subject|4|||
127922862|NCT00852917|460338821|FG001|Overall Study|Withdrawal by Subject|8|||
127922863|NCT00852917|460338822|FG002|Overall Study|Withdrawal by Subject|10|||
127922864|NCT00852917|460338823|FG003|Overall Study|Withdrawal by Subject|9|||
127922865|NCT00852917|460338820|FG000|Overall Study|Physician Decision|6|||
127922866|NCT00852917|460338821|FG001|Overall Study|Physician Decision|7|||
127922867|NCT00852917|460338822|FG002|Overall Study|Physician Decision|2|||
127922868|NCT00852917|460338823|FG003|Overall Study|Physician Decision|19|||
127922869|NCT00852917|460338820|FG000|Overall Study|Death|0|||
127922870|NCT00852917|460338821|FG001|Overall Study|Death|0|||
127922871|NCT00852917|460338822|FG002|Overall Study|Death|0|||
127922872|NCT00852917|460338823|FG003|Overall Study|Death|1|||
127922873|NCT02488824|460338824|FG000|Overall Study|Adverse Event|1|||
127922874|NCT02488824|460338825|FG001|Overall Study|Adverse Event|1|||
127922875|NCT01201759|460338827|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
127922876|NCT01201759|460338828|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
127922877|NCT01201759|460338827|FG000|Visit 3 - Washout|Adverse Event|0|||
127922878|NCT01201759|460338828|FG001|Visit 3 - Washout|Adverse Event|3|||
127922879|NCT01201759|460338827|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
127922880|NCT01201759|460338828|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
127922881|NCT01201759|460338827|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
127922882|NCT01201759|460338828|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
127922883|NCT00979212|460338831|FG000|Overall Study|Protocol Violation|1|||
127922884|NCT00979212|460338832|FG001|Overall Study|Protocol Violation|8|||
127922885|NCT00979212|460338831|FG000|Overall Study|No protocol therapy received|1|||
127922886|NCT00979212|460338832|FG001|Overall Study|No protocol therapy received|0|||
127922887|NCT04886063|460338837|FG000|Overall Study|Adverse Event|50|||
127922888|NCT04886063|460338837|FG000|Overall Study|Lack of Efficacy|31|||
127922889|NCT04886063|460338837|FG000|Overall Study|Withdrawal by Subject|45|||
127922890|NCT04886063|460338837|FG000|Overall Study|Physician Decision|3|||
127922891|NCT04886063|460338837|FG000|Overall Study|Protocol Violation|3|||
127922892|NCT04886063|460338837|FG000|Overall Study|Site closure|4|||
127922893|NCT04886063|460338837|FG000|Overall Study|Nursing home replacement|3|||
127922894|NCT04886063|460338837|FG000|Overall Study|Lost to Follow-up|5|||
127922895|NCT04886063|460338837|FG000|Overall Study|Early study termination or other undetermined reasons|224|||
127922896|NCT04886063|460338837|FG000|Overall Study|>1 reason|20|||
127922897|NCT02448563|460338842|FG000|Overall Study|Lost to Follow-up|16|||
127922898|NCT02448563|460338843|FG001|Overall Study|Lost to Follow-up|10|||
127922899|NCT02448563|460338842|FG000|Overall Study|Withdrawal by Subject|0|||
127922900|NCT02448563|460338843|FG001|Overall Study|Withdrawal by Subject|1|||
127922901|NCT02174276|460338844|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
127922902|NCT02174276|460338845|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
127922903|NCT02174276|460338846|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
127922904|NCT02174276|460338847|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
127922905|NCT02174276|460338844|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
127922906|NCT02174276|460338845|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
127922907|NCT02174276|460338846|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
127922908|NCT02174276|460338847|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
127922909|NCT02174276|460338844|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
127922910|NCT02174276|460338845|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
127922911|NCT02174276|460338846|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
127922912|NCT02174276|460338847|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
127922913|NCT02174276|460338844|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
127922914|NCT02174276|460338845|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
127922915|NCT02174276|460338846|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
127922916|NCT02174276|460338847|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
127922917|NCT02174276|460338844|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
127922918|NCT02174276|460338845|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
127922919|NCT02174276|460338846|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
127922920|NCT02174276|460338847|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
127922921|NCT02174276|460338844|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
127922922|NCT02174276|460338845|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
127922923|NCT02174276|460338846|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
127922924|NCT02174276|460338847|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
127922925|NCT00434837|460338854|FG000|Overall Study|Lost to Follow-up|20|||
127922926|NCT00434837|460338855|FG001|Overall Study|Lost to Follow-up|23|||
127922927|NCT00434837|460338856|FG002|Overall Study|Lost to Follow-up|30|||
127922928|NCT00515216|460338857|FG000|Overall Study|Withdrawal by Subject|1|||
127922929|NCT02786927|460338859|FG000|Overall Study|Adverse Event|1|||
127922930|NCT02786927|460338859|FG000|Overall Study|Protocol Violation|4|||
127922931|NCT01801917|460338860|FG000|Period 1 - Randomized|Adverse Event|1|||
127922932|NCT01801917|460338861|FG001|Period 1 - Randomized|Adverse Event|0|||
127922933|NCT01801917|460338862|FG002|Period 1 - Randomized|Adverse Event|1|||
127922934|NCT01801917|460338863|FG003|Period 1 - Randomized|Adverse Event|0|||
127922935|NCT04307849|460338864|FG000|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
127922936|NCT04307849|460338865|FG001|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
127922937|NCT04307849|460338866|FG002|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
127922938|NCT04307849|460338867|FG003|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
127922939|NCT04307849|460338868|FG004|Overall Study|Took a paid position and/or work schedule no longer allowed participation|4|||
127922940|NCT04307849|460338869|FG005|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
127922941|NCT04307849|460338864|FG000|Overall Study|Travelled out of Mumbai to natal place/village|0|||
127922942|NCT04307849|460338865|FG001|Overall Study|Travelled out of Mumbai to natal place/village|0|||
127922943|NCT04307849|460338866|FG002|Overall Study|Travelled out of Mumbai to natal place/village|3|||
127922944|NCT04307849|460338867|FG003|Overall Study|Travelled out of Mumbai to natal place/village|0|||
127922945|NCT04307849|460338868|FG004|Overall Study|Travelled out of Mumbai to natal place/village|0|||
127922946|NCT04307849|460338869|FG005|Overall Study|Travelled out of Mumbai to natal place/village|0|||
127922947|NCT04307849|460338864|FG000|Overall Study|Family member did not want them to continue|0|||
127922948|NCT04307849|460338865|FG001|Overall Study|Family member did not want them to continue|0|||
127922949|NCT04307849|460338866|FG002|Overall Study|Family member did not want them to continue|1|||
127922950|NCT04307849|460338867|FG003|Overall Study|Family member did not want them to continue|0|||
127922951|NCT04307849|460338868|FG004|Overall Study|Family member did not want them to continue|0|||
127922952|NCT04307849|460338869|FG005|Overall Study|Family member did not want them to continue|0|||
127922953|NCT04307849|460338864|FG000|Overall Study|Medical reason (gave birth, became ill)|0|||
127922954|NCT04307849|460338865|FG001|Overall Study|Medical reason (gave birth, became ill)|0|||
127922955|NCT04307849|460338866|FG002|Overall Study|Medical reason (gave birth, became ill)|1|||
127922956|NCT04307849|460338867|FG003|Overall Study|Medical reason (gave birth, became ill)|1|||
127922957|NCT04307849|460338868|FG004|Overall Study|Medical reason (gave birth, became ill)|0|||
127922958|NCT04307849|460338869|FG005|Overall Study|Medical reason (gave birth, became ill)|0|||
127922959|NCT05467982|460338870|FG000|Overall Study|Death|0|||
127922960|NCT05467982|460338871|FG001|Overall Study|Death|1|||
127922961|NCT05467982|460338870|FG000|Overall Study|Lost to Follow-up|3|||
127922962|NCT05467982|460338871|FG001|Overall Study|Lost to Follow-up|1|||
127922963|NCT00398073|460338891|FG000|Overall Study|Withdrawal by Subject|1|||
127922964|NCT00398073|460338892|FG001|Overall Study|Withdrawal by Subject|0|||
127922965|NCT01833169|460338893|FG000|Overall Study|Disease Progression|99|||
127922966|NCT01833169|460338893|FG000|Overall Study|Adverse Event|33|||
127922967|NCT01833169|460338893|FG000|Overall Study|Withdrawal by Subject|9|||
127922968|NCT01833169|460338893|FG000|Overall Study|Death|3|||
127922969|NCT01833169|460338893|FG000|Overall Study|Physician Decision|2|||
127922970|NCT00879684|460338897|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
127922971|NCT00879684|460338898|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
127922972|NCT00879684|460338899|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
127922973|NCT00879684|460338900|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
127922974|NCT00879684|460338901|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
127922975|NCT00879684|460338902|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
127922976|NCT00879684|460338903|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
127922977|NCT00879684|460338897|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
127922978|NCT00879684|460338898|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
127922979|NCT00879684|460338899|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
127922980|NCT00879684|460338900|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
127922981|NCT00879684|460338901|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
127922982|NCT00879684|460338902|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
127922983|NCT00879684|460338903|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
127922984|NCT00879684|460338897|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
127922985|NCT00879684|460338898|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
127922986|NCT00879684|460338899|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
127922987|NCT00879684|460338900|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
127922988|NCT00879684|460338901|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
127922989|NCT00879684|460338902|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
127922990|NCT00879684|460338903|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
127922991|NCT00879684|460338897|FG000|Stage 1: Dose Escalation|Death|0|||
127922992|NCT00879684|460338898|FG001|Stage 1: Dose Escalation|Death|0|||
127922993|NCT00879684|460338899|FG002|Stage 1: Dose Escalation|Death|1|||
127922994|NCT00879684|460338900|FG003|Stage 1: Dose Escalation|Death|0|||
127922995|NCT00879684|460338901|FG004|Stage 1: Dose Escalation|Death|0|||
127922996|NCT00879684|460338902|FG005|Stage 1: Dose Escalation|Death|0|||
127922997|NCT00879684|460338903|FG006|Stage 1: Dose Escalation|Death|0|||
127922998|NCT00879684|460338897|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
127922999|NCT00879684|460338898|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
127923000|NCT00879684|460338899|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
127923001|NCT00879684|460338900|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
127923002|NCT00879684|460338901|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
127923003|NCT00879684|460338902|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
127923004|NCT00879684|460338903|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
127923005|NCT00879684|460338897|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
127923006|NCT00879684|460338898|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
127923007|NCT00879684|460338899|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
127923008|NCT00879684|460338900|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
127923009|NCT00879684|460338901|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
127923010|NCT00879684|460338902|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
127923011|NCT00879684|460338903|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
127923012|NCT00879684|460338897|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
127923013|NCT00879684|460338898|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
127923014|NCT00879684|460338899|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
127923015|NCT00879684|460338900|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
127923016|NCT00879684|460338901|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
127923017|NCT00879684|460338902|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
127923018|NCT00879684|460338903|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
127923019|NCT00105157|460338904|FG000|Double-Blind (DB)|Never Treated|1|||
127923020|NCT00105157|460338905|FG001|Double-Blind (DB)|Never Treated|0|||
127923021|NCT00105157|460338906|FG002|Double-Blind (DB)|Never Treated|0|||
127923022|NCT00105157|460338907|FG003|Double-Blind (DB)|Never Treated|0|||
127923023|NCT00105157|460338904|FG000|Double-Blind (DB)|Adverse Event|2|||
127923024|NCT00105157|460338905|FG001|Double-Blind (DB)|Adverse Event|0|||
127923025|NCT00105157|460338906|FG002|Double-Blind (DB)|Adverse Event|1|||
127923026|NCT00105157|460338907|FG003|Double-Blind (DB)|Adverse Event|1|||
127923027|NCT00105157|460338904|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
127923028|NCT00105157|460338905|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
127923029|NCT00105157|460338906|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
127923030|NCT00105157|460338907|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
127923031|NCT00105157|460338904|FG000|Open-Label Continuation of DB|Adverse Event|3|||
127923032|NCT00105157|460338905|FG001|Open-Label Continuation of DB|Adverse Event|1|||
127923033|NCT00105157|460338906|FG002|Open-Label Continuation of DB|Adverse Event|0|||
127923034|NCT00105157|460338907|FG003|Open-Label Continuation of DB|Adverse Event|0|||
127923035|NCT00105157|460338904|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
127923036|NCT00105157|460338905|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
127923037|NCT00105157|460338906|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
127923038|NCT00105157|460338907|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
127923039|NCT00105157|460338904|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
127923040|NCT00105157|460338905|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
127923041|NCT00105157|460338906|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
127923042|NCT00105157|460338907|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
127923043|NCT00105157|460338904|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
127923044|NCT00105157|460338905|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
127923045|NCT00105157|460338906|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
127923046|NCT00105157|460338907|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
127923047|NCT00105157|460338904|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
127923048|NCT00105157|460338905|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
127923049|NCT00105157|460338906|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
127923050|NCT00105157|460338907|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
127923051|NCT00105157|460338904|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
127923052|NCT00105157|460338905|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
127923053|NCT00105157|460338906|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
127923054|NCT00105157|460338907|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
127923055|NCT00105157|460338904|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
127923056|NCT00105157|460338905|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
127923057|NCT00105157|460338906|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
127923058|NCT00105157|460338907|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
127923059|NCT00105157|460338904|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
127923060|NCT00105157|460338905|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
127923061|NCT00105157|460338906|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
127923062|NCT00105157|460338907|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
127923063|NCT00105157|460338904|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
127923064|NCT00105157|460338905|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
127923065|NCT00105157|460338906|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
127923066|NCT00105157|460338907|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
127923067|NCT00105157|460338904|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
127923068|NCT00105157|460338905|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
127923069|NCT00105157|460338906|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
127923070|NCT00105157|460338907|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
127923071|NCT00105157|460338904|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
127923072|NCT00105157|460338905|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
127923073|NCT00105157|460338906|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
127923074|NCT00105157|460338907|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
127923075|NCT01636934|460340037|FG000|Overall Study|Withdrawal by Subject|3|||
127923076|NCT01636934|460340038|FG001|Overall Study|Withdrawal by Subject|2|||
127923077|NCT01636934|460340037|FG000|Overall Study|Chemo cancel|1|||
127923078|NCT01636934|460340038|FG001|Overall Study|Chemo cancel|0|||
127923079|NCT01636934|460340037|FG000|Overall Study|Too ill to continue|1|||
127923080|NCT01636934|460340038|FG001|Overall Study|Too ill to continue|0|||
127923081|NCT01636934|460340037|FG000|Overall Study|Never started study medication|1|||
127923082|NCT01636934|460340038|FG001|Overall Study|Never started study medication|1|||
127923083|NCT01011335|460340041|FG000|Overall Study|Lost to Follow-up|0|||
127923084|NCT01011335|460340042|FG001|Overall Study|Lost to Follow-up|0|||
127923085|NCT01011335|460340043|FG002|Overall Study|Lost to Follow-up|1|||
127923086|NCT01011335|460340044|FG003|Overall Study|Lost to Follow-up|1|||
127923087|NCT01011335|460340045|FG004|Overall Study|Lost to Follow-up|1|||
127923088|NCT01011335|460340046|FG005|Overall Study|Lost to Follow-up|1|||
127923089|NCT01011335|460340047|FG006|Overall Study|Lost to Follow-up|2|||
127923090|NCT01011335|460340048|FG007|Overall Study|Lost to Follow-up|2|||
127923091|NCT01011335|460340049|FG008|Overall Study|Lost to Follow-up|1|||
127923092|NCT01011335|460340050|FG009|Overall Study|Lost to Follow-up|0|||
127923093|NCT01011335|460340051|FG010|Overall Study|Lost to Follow-up|0|||
127923094|NCT01011335|460340052|FG011|Overall Study|Lost to Follow-up|1|||
127923095|NCT01011335|460340053|FG012|Overall Study|Lost to Follow-up|2|||
127923096|NCT01011335|460340041|FG000|Overall Study|Protocol Violation|0|||
127923097|NCT01011335|460340042|FG001|Overall Study|Protocol Violation|1|||
127923098|NCT01011335|460340043|FG002|Overall Study|Protocol Violation|0|||
127923099|NCT01011335|460340044|FG003|Overall Study|Protocol Violation|0|||
127923100|NCT01011335|460340045|FG004|Overall Study|Protocol Violation|0|||
127923101|NCT01011335|460340046|FG005|Overall Study|Protocol Violation|0|||
127923102|NCT01011335|460340047|FG006|Overall Study|Protocol Violation|0|||
127923103|NCT01011335|460340048|FG007|Overall Study|Protocol Violation|0|||
127923104|NCT01011335|460340049|FG008|Overall Study|Protocol Violation|0|||
127923105|NCT01011335|460340050|FG009|Overall Study|Protocol Violation|0|||
127923106|NCT01011335|460340051|FG010|Overall Study|Protocol Violation|0|||
127923107|NCT01011335|460340052|FG011|Overall Study|Protocol Violation|0|||
127923108|NCT01011335|460340053|FG012|Overall Study|Protocol Violation|0|||
127923109|NCT01011335|460340041|FG000|Overall Study|Moved/deployed or no booster|1|||
127923110|NCT01011335|460340042|FG001|Overall Study|Moved/deployed or no booster|0|||
127923111|NCT01011335|460340043|FG002|Overall Study|Moved/deployed or no booster|0|||
127923112|NCT01011335|460340044|FG003|Overall Study|Moved/deployed or no booster|1|||
127923113|NCT01011335|460340045|FG004|Overall Study|Moved/deployed or no booster|0|||
127923114|NCT01011335|460340046|FG005|Overall Study|Moved/deployed or no booster|0|||
127923115|NCT01011335|460340047|FG006|Overall Study|Moved/deployed or no booster|1|||
127923116|NCT01011335|460340048|FG007|Overall Study|Moved/deployed or no booster|0|||
127923117|NCT01011335|460340049|FG008|Overall Study|Moved/deployed or no booster|1|||
127923118|NCT01011335|460340050|FG009|Overall Study|Moved/deployed or no booster|0|||
127923119|NCT01011335|460340051|FG010|Overall Study|Moved/deployed or no booster|2|||
127923120|NCT01011335|460340052|FG011|Overall Study|Moved/deployed or no booster|0|||
127923121|NCT01011335|460340053|FG012|Overall Study|Moved/deployed or no booster|0|||
127923122|NCT01011335|460340041|FG000|Overall Study|Adverse Event|0|||
127923123|NCT01011335|460340042|FG001|Overall Study|Adverse Event|0|||
127923124|NCT01011335|460340043|FG002|Overall Study|Adverse Event|0|||
127923125|NCT01011335|460340044|FG003|Overall Study|Adverse Event|0|||
127923126|NCT01011335|460340045|FG004|Overall Study|Adverse Event|0|||
127923127|NCT01011335|460340046|FG005|Overall Study|Adverse Event|0|||
127923128|NCT01011335|460340047|FG006|Overall Study|Adverse Event|0|||
127923129|NCT01011335|460340048|FG007|Overall Study|Adverse Event|0|||
127923130|NCT01011335|460340049|FG008|Overall Study|Adverse Event|0|||
127923131|NCT01011335|460340050|FG009|Overall Study|Adverse Event|0|||
127923132|NCT01011335|460340051|FG010|Overall Study|Adverse Event|4|||
127923133|NCT01011335|460340052|FG011|Overall Study|Adverse Event|0|||
127923134|NCT01011335|460340053|FG012|Overall Study|Adverse Event|1|||
127923135|NCT01765751|460340058|FG000|Overall Study|Lost to Follow-up|0|||
127923136|NCT01765751|460340059|FG001|Overall Study|Lost to Follow-up|2|||
127923137|NCT01765751|460340060|FG002|Overall Study|Lost to Follow-up|1|||
127923138|NCT03303417|460340061|FG000|Overall Study|Withdrawal by Subject|1|||
127923139|NCT03303417|460340062|FG001|Overall Study|Withdrawal by Subject|1|||
127923140|NCT01848210|460340065|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
127923141|NCT01848210|460340066|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
127923142|NCT01848210|460340065|FG000|Overall Study|Lost to Follow-up|24|||
127923143|NCT01848210|460340066|FG001|Overall Study|Lost to Follow-up|12|||
127923144|NCT01848210|460340065|FG000|Overall Study|Protocol Violation|3|||
127923145|NCT01848210|460340066|FG001|Overall Study|Protocol Violation|5|||
127923146|NCT01848210|460340065|FG000|Overall Study|Use of Forbidden Drugs|9|||
127923147|NCT01848210|460340066|FG001|Overall Study|Use of Forbidden Drugs|10|||
127923148|NCT01848210|460340065|FG000|Overall Study|Impedition Condition|5|||
127923149|NCT01848210|460340066|FG001|Overall Study|Impedition Condition|9|||
127923150|NCT01848210|460340065|FG000|Overall Study|Adverse Event|7|||
127923151|NCT01848210|460340066|FG001|Overall Study|Adverse Event|9|||
127923152|NCT01848210|460340065|FG000|Overall Study|Discontinuation Criterion|5|||
127923153|NCT01848210|460340066|FG001|Overall Study|Discontinuation Criterion|7|||
127923154|NCT01848210|460340065|FG000|Overall Study|Hypesensitivity|1|||
127923155|NCT01848210|460340066|FG001|Overall Study|Hypesensitivity|0|||
127923156|NCT01848210|460340065|FG000|Overall Study|Hepatic Function Alteration|4|||
127923157|NCT01848210|460340066|FG001|Overall Study|Hepatic Function Alteration|0|||
127923158|NCT01848210|460340065|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
127923159|NCT01848210|460340066|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
127923160|NCT01848210|460340065|FG000|Overall Study|Administrative|1|||
127923161|NCT01848210|460340066|FG001|Overall Study|Administrative|0|||
127923162|NCT00784979|460340067|FG000|Overall Study|incomplete data|6|||
127923163|NCT00894933|460340068|FG000|Overall Study|Lost to Follow-up|2|||
127923164|NCT00894933|460340068|FG000|Overall Study|Cancelled Procedure|1|||
127923165|NCT00894933|460340068|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
127923166|NCT01235715|460340073|FG000|Overall Study|Physician Decision|0|||
127923167|NCT01235715|460340074|FG001|Overall Study|Physician Decision|2|||
127923168|NCT02994394|460340075|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
127923169|NCT02994394|460340076|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
127923170|NCT02994394|460340077|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
127923171|NCT02994394|460340078|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
127923172|NCT02994394|460340079|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
127923173|NCT02994394|460340080|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
127923174|NCT02994394|460340075|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
127923175|NCT02994394|460340076|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
127923176|NCT02994394|460340077|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
127923177|NCT02994394|460340078|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
127923178|NCT02994394|460340079|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
127923179|NCT02994394|460340080|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
127923180|NCT03619876|460340081|FG000|Overall Study|Withdrawal by Subject|1|||
127923181|NCT03619876|460340082|FG001|Overall Study|Withdrawal by Subject|2|||
127923182|NCT03619876|460340081|FG000|Overall Study|Withdrawal due to incidental finding|0|||
127923183|NCT03619876|460340082|FG001|Overall Study|Withdrawal due to incidental finding|2|||
127923184|NCT00396630|460340085|FG000|Overall Study|Lost to Follow-up|1|||
127923185|NCT00396630|460340086|FG001|Overall Study|Lost to Follow-up|1|||
127923186|NCT00396630|460340085|FG000|Overall Study|Withdrawal by Subject|1|||
127923187|NCT00396630|460340086|FG001|Overall Study|Withdrawal by Subject|1|||
127923188|NCT00396630|460340085|FG000|Overall Study|Not vaccinated at Visit 3|3|||
127923189|NCT00396630|460340086|FG001|Overall Study|Not vaccinated at Visit 3|3|||
127923190|NCT02327325|460340087|FG000|Overall Study|Withdrawal by Subject|1|||
127923191|NCT02327325|460340088|FG001|Overall Study|Withdrawal by Subject|4|||
127923192|NCT02327325|460340089|FG002|Overall Study|Withdrawal by Subject|4|||
127923193|NCT02327325|460340087|FG000|Overall Study|Excluded by Study Team|0|||
127923194|NCT02327325|460340088|FG001|Overall Study|Excluded by Study Team|0|||
127923195|NCT02327325|460340089|FG002|Overall Study|Excluded by Study Team|1|||
127923196|NCT00996437|460340096|FG000|Overall Study|Death|1|||
127923197|NCT00996437|460340097|FG001|Overall Study|Death|0|||
127923198|NCT00996437|460340096|FG000|Overall Study|Dropped|2|||
127923199|NCT00996437|460340097|FG001|Overall Study|Dropped|2|||
127923200|NCT00996437|460340096|FG000|Overall Study|Missed|2|||
127923201|NCT00996437|460340097|FG001|Overall Study|Missed|5|||
127923202|NCT02576717|460340098|FG000|Overall Study|Other Reasons|16|||
127923203|NCT02576717|460340099|FG001|Overall Study|Other Reasons|18|||
127923204|NCT02576717|460340100|FG002|Overall Study|Other Reasons|15|||
127923205|NCT02576717|460340098|FG000|Overall Study|Covid-19 Pandemic|0|||
127923206|NCT02576717|460340099|FG001|Overall Study|Covid-19 Pandemic|1|||
127923207|NCT02576717|460340100|FG002|Overall Study|Covid-19 Pandemic|1|||
127923208|NCT02576717|460340098|FG000|Overall Study|Sponsor Decision|0|||
127923209|NCT02576717|460340099|FG001|Overall Study|Sponsor Decision|0|||
127923210|NCT02576717|460340100|FG002|Overall Study|Sponsor Decision|1|||
127923211|NCT02576717|460340098|FG000|Overall Study|Physician Decision|3|||
127923212|NCT02576717|460340099|FG001|Overall Study|Physician Decision|8|||
127923213|NCT02576717|460340100|FG002|Overall Study|Physician Decision|9|||
127923214|NCT02576717|460340098|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
127923215|NCT02576717|460340099|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
127923216|NCT02576717|460340100|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
127923217|NCT02576717|460340098|FG000|Overall Study|Death|3|||
127923218|NCT02576717|460340099|FG001|Overall Study|Death|5|||
127923219|NCT02576717|460340100|FG002|Overall Study|Death|3|||
127923220|NCT02576717|460340098|FG000|Overall Study|Lost to Follow-up|9|||
127923221|NCT02576717|460340099|FG001|Overall Study|Lost to Follow-up|10|||
127923222|NCT02576717|460340100|FG002|Overall Study|Lost to Follow-up|19|||
127923223|NCT02576717|460340098|FG000|Overall Study|Protocol Violation|4|||
127923224|NCT02576717|460340099|FG001|Overall Study|Protocol Violation|0|||
127923225|NCT02576717|460340100|FG002|Overall Study|Protocol Violation|5|||
127923226|NCT02576717|460340098|FG000|Overall Study|Lack of Efficacy|24|||
127923227|NCT02576717|460340099|FG001|Overall Study|Lack of Efficacy|28|||
127923228|NCT02576717|460340100|FG002|Overall Study|Lack of Efficacy|20|||
127923229|NCT02576717|460340098|FG000|Overall Study|Adverse Event|26|||
127923230|NCT02576717|460340099|FG001|Overall Study|Adverse Event|32|||
127923231|NCT02576717|460340100|FG002|Overall Study|Adverse Event|26|||
127923232|NCT01755975|460340101|FG000|Overall Study|Adverse Event|0|||
127923233|NCT01755975|460340102|FG001|Overall Study|Adverse Event|0|||
127923234|NCT01755975|460340103|FG002|Overall Study|Adverse Event|1|||
127923235|NCT01755975|460340104|FG003|Overall Study|Adverse Event|0|||
127923236|NCT01755975|460340105|FG004|Overall Study|Adverse Event|2|||
127923237|NCT00399893|460340106|FG000|Overall Study|Withdrawal by Subject|1|||
127923238|NCT00399893|460340107|FG001|Overall Study|Withdrawal by Subject|0|||
127923239|NCT00906373|460340110|FG000|Overall Study|Withdrawal by Subject|0|||
127923240|NCT00906373|460340111|FG001|Overall Study|Withdrawal by Subject|5|||
127923241|NCT00906373|460340110|FG000|Overall Study|Other|0|||
127923242|NCT00906373|460340111|FG001|Overall Study|Other|1|||
127923243|NCT00906373|460340110|FG000|Overall Study|Still on treatment at cutoff date|0|||
127923244|NCT00906373|460340111|FG001|Overall Study|Still on treatment at cutoff date|2|||
127923245|NCT01597479|460340112|FG000|Overall Study|Protocol Violation|1|||
127923246|NCT01597479|460340113|FG001|Overall Study|Protocol Violation|0|||
127923247|NCT01597479|460340112|FG000|Overall Study|Lost to Follow-up|1|||
127923248|NCT01597479|460340113|FG001|Overall Study|Lost to Follow-up|0|||
127923249|NCT01045707|460340115|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
127923250|NCT01045707|460340116|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
127923251|NCT01045707|460340115|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
127923252|NCT01045707|460340116|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
127923253|NCT01045707|460340115|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
127923254|NCT01045707|460340116|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
127923255|NCT01045707|460340115|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
127923256|NCT01045707|460340116|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
127923257|NCT01045707|460340115|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
127923258|NCT01045707|460340116|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
127923259|NCT01045707|460340115|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
127923260|NCT01045707|460340116|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
127923261|NCT01045707|460340115|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
127923262|NCT01045707|460340116|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
127923263|NCT01045707|460340115|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
127923264|NCT01045707|460340116|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
127923265|NCT01045707|460340115|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
127923266|NCT01045707|460340116|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
127923267|NCT00848042|460340120|FG000|Overall Study|Death|1|||
127923268|NCT00848042|460340121|FG001|Overall Study|Death|2|||
127923269|NCT00848042|460340122|FG002|Overall Study|Death|0|||
127923270|NCT00848042|460340120|FG000|Overall Study|Other Therapy|3|||
127923271|NCT00848042|460340121|FG001|Overall Study|Other Therapy|0|||
127923272|NCT00848042|460340122|FG002|Overall Study|Other Therapy|0|||
127923273|NCT04317599|460340123|FG000|Overall Study|ineligible due to inclusion/exclusion criteria|15|||
127923274|NCT04317599|460340123|FG000|Overall Study|treatment outside standard of care|4|||
127923275|NCT02340962|460340125|FG000|Overall Study|Lost to Follow-up|1|||
127923276|NCT02340962|460340126|FG001|Overall Study|Lost to Follow-up|0|||
127923277|NCT01186016|460340127|FG000|Overall Study|Withdrawal by Subject|46|||
127923278|NCT01186016|460340128|FG001|Overall Study|Withdrawal by Subject|29|||
127923279|NCT01098539|460340129|FG000|Overall Study|Adverse Event|26|||
127923280|NCT01098539|460340130|FG001|Overall Study|Adverse Event|26|||
127923281|NCT01098539|460340129|FG000|Overall Study|Protocol Violation|1|||
127923282|NCT01098539|460340130|FG001|Overall Study|Protocol Violation|4|||
127923283|NCT01098539|460340129|FG000|Overall Study|Noncompliance|3|||
127923284|NCT01098539|460340130|FG001|Overall Study|Noncompliance|5|||
127923285|NCT01098539|460340129|FG000|Overall Study|Lost to Follow-up|4|||
127923286|NCT01098539|460340130|FG001|Overall Study|Lost to Follow-up|4|||
127923287|NCT01098539|460340129|FG000|Overall Study|Withdrawal by Subject|12|||
127923288|NCT01098539|460340130|FG001|Overall Study|Withdrawal by Subject|26|||
127923289|NCT01098539|460340129|FG000|Overall Study|Physician Decision|5|||
127923290|NCT01098539|460340130|FG001|Overall Study|Physician Decision|3|||
127923291|NCT00721955|460340131|FG000|Overall Study|Adverse Event|0|||
127923292|NCT00721955|460340132|FG001|Overall Study|Adverse Event|0|||
127923293|NCT00721955|460340133|FG002|Overall Study|Adverse Event|2|||
127923294|NCT01055886|460340135|FG000|Overall Study|Withdrawal by Subject|4|||
127923295|NCT01055886|460340136|FG001|Overall Study|Withdrawal by Subject|9|||
127923296|NCT01055886|460340135|FG000|Overall Study|Lost to Follow-up|1|||
127923297|NCT01055886|460340136|FG001|Overall Study|Lost to Follow-up|1|||
127923298|NCT01055886|460340135|FG000|Overall Study|Withdrawal by PI|0|||
127923299|NCT01055886|460340136|FG001|Overall Study|Withdrawal by PI|1|||
127923300|NCT01077258|460340140|FG000|Overall Study|Lost to Follow-up|1390|||
127923301|NCT01077258|460340140|FG000|Overall Study|Adverse drug reaction|218|||
127923302|NCT01077258|460340140|FG000|Overall Study|Lack of Efficacy|663|||
127923303|NCT01077258|460340140|FG000|Overall Study|Clinical remission|37|||
127923304|NCT01077258|460340140|FG000|Overall Study|Other reasons|260|||
127923305|NCT00726895|460340141|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
127923306|NCT00726895|460340142|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
127923307|NCT00265785|460340145|FG000|Overall Study|Adverse Event|4|||
127923308|NCT00265785|460340145|FG000|Overall Study|Withdrawal by Subject|3|||
127923309|NCT00265785|460340145|FG000|Overall Study|Progression/Relapse|15|||
127923310|NCT00265785|460340145|FG000|Overall Study|Not protocol specified|2|||
127923311|NCT00265785|460340145|FG000|Overall Study|Ineligible|1|||
127923312|NCT00265785|460340145|FG000|Overall Study|Did not receive protocol treatment|2|||
127923313|NCT01294449|460340148|FG000|Overall Study|Death|11|||
127923314|NCT01294449|460340149|FG001|Overall Study|Death|12|||
127923315|NCT01294449|460340148|FG000|Overall Study|Withdrawal by Subject|1|||
127923316|NCT01294449|460340149|FG001|Overall Study|Withdrawal by Subject|3|||
127923317|NCT00420095|460340153|FG000|Overall Study|Adverse Event|1|||
127923318|NCT00420095|460340154|FG001|Overall Study|Adverse Event|0|||
127923319|NCT00420095|460340153|FG000|Overall Study|Protocol Violation|1|||
127923320|NCT00420095|460340154|FG001|Overall Study|Protocol Violation|1|||
127923321|NCT00420095|460340153|FG000|Overall Study|Lost to Follow-up|1|||
127923322|NCT00420095|460340154|FG001|Overall Study|Lost to Follow-up|0|||
127923323|NCT00393705|460340155|FG000|Overall Study|Adverse Event|0|||
127923324|NCT00393705|460340156|FG001|Overall Study|Adverse Event|2|||
127923325|NCT00393705|460340155|FG000|Overall Study|Death|0|||
127923326|NCT00393705|460340156|FG001|Overall Study|Death|1|||
127923327|NCT00393705|460340155|FG000|Overall Study|Lost to Follow-up|2|||
127923328|NCT00393705|460340156|FG001|Overall Study|Lost to Follow-up|2|||
127923329|NCT00393705|460340155|FG000|Overall Study|Entry Criteria Not Met|10|||
127923330|NCT00393705|460340156|FG001|Overall Study|Entry Criteria Not Met|10|||
127923331|NCT00393705|460340155|FG000|Overall Study|Protocol Violation|4|||
127923332|NCT00393705|460340156|FG001|Overall Study|Protocol Violation|3|||
127923333|NCT00393705|460340155|FG000|Overall Study|Withdrawal by Subject|5|||
127923334|NCT00393705|460340156|FG001|Overall Study|Withdrawal by Subject|3|||
127923335|NCT00393705|460340155|FG000|Overall Study|Physician Decision|2|||
127923336|NCT00393705|460340156|FG001|Overall Study|Physician Decision|2|||
127923337|NCT03185741|460340157|FG000|Baseline|Withdrawal by Subject|1|||
127923338|NCT03185741|460340158|FG001|Baseline|Withdrawal by Subject|3|||
127923339|NCT03185741|460340159|FG002|Baseline|Withdrawal by Subject|2|||
127923340|NCT03185741|460340157|FG000|Baseline|Lost to Follow-up|1|||
127923341|NCT03185741|460340158|FG001|Baseline|Lost to Follow-up|2|||
127923342|NCT03185741|460340159|FG002|Baseline|Lost to Follow-up|3|||
127923343|NCT03185741|460340157|FG000|3Month|Death|1|||
127923344|NCT03185741|460340158|FG001|3Month|Death|1|||
127923345|NCT03185741|460340159|FG002|3Month|Death|2|||
127923346|NCT03185741|460340157|FG000|3Month|Withdrawal by Subject|1|||
127923347|NCT03185741|460340158|FG001|3Month|Withdrawal by Subject|5|||
127923348|NCT03185741|460340159|FG002|3Month|Withdrawal by Subject|1|||
127923349|NCT03185741|460340157|FG000|3Month|Lost to Follow-up|7|||
127923350|NCT03185741|460340158|FG001|3Month|Lost to Follow-up|9|||
127923351|NCT03185741|460340159|FG002|3Month|Lost to Follow-up|8|||
127923352|NCT03185741|460340157|FG000|3Month|Unavailable for 3Month|11|||
127923353|NCT03185741|460340158|FG001|3Month|Unavailable for 3Month|10|||
127923354|NCT03185741|460340159|FG002|3Month|Unavailable for 3Month|11|||
127923355|NCT03185741|460340157|FG000|3Month|Protocol Violation|0|||
127923356|NCT03185741|460340158|FG001|3Month|Protocol Violation|0|||
127923357|NCT03185741|460340159|FG002|3Month|Protocol Violation|3|||
127923358|NCT03185741|460340157|FG000|6Month|Death|1|||
127923359|NCT03185741|460340158|FG001|6Month|Death|1|||
127923360|NCT03185741|460340159|FG002|6Month|Death|2|||
127923361|NCT03185741|460340157|FG000|6Month|Withdrawal by Subject|2|||
127923362|NCT03185741|460340158|FG001|6Month|Withdrawal by Subject|3|||
127923363|NCT03185741|460340159|FG002|6Month|Withdrawal by Subject|1|||
127923364|NCT03185741|460340157|FG000|6Month|Lost to Follow-up|16|||
127923365|NCT03185741|460340158|FG001|6Month|Lost to Follow-up|15|||
127923366|NCT03185741|460340159|FG002|6Month|Lost to Follow-up|16|||
127923367|NCT03365791|460340160|FG000|Overall Study|Adverse Event|5|||
127923368|NCT03365791|460340160|FG000|Overall Study|Death|1|||
127923369|NCT03365791|460340160|FG000|Overall Study|Lost to Follow-up|1|||
127923370|NCT03365791|460340160|FG000|Overall Study|Physician Decision|9|||
127923371|NCT03365791|460340160|FG000|Overall Study|Progressive disease|51|||
127923372|NCT03365791|460340160|FG000|Overall Study|Subject/guardian decision|5|||
127923373|NCT01475487|460340161|FG000|Overall Study|had to leave early for personal reasons|2|||
127923374|NCT01475487|460340162|FG001|Overall Study|had to leave early for personal reasons|1|||
127923375|NCT01977456|460340163|FG000|Overall Study|Death|5|||
127923376|NCT01142661|460340164|FG000|Overall Study|Adverse Event|2|||
127923377|NCT01142661|460340164|FG000|Overall Study|Withdrawal by Subject|1|||
127923378|NCT01142661|460340164|FG000|Overall Study|Physician Decision|1|||
127923379|NCT00434590|460340165|FG000|Overall Study|Administrative problems|5|||
127923380|NCT00434590|460340166|FG001|Overall Study|Administrative problems|5|||
127923381|NCT03429049|460342008|FG000|Overall Study|Adverse Event|2|||
127923382|NCT03429049|460342009|FG001|Overall Study|Adverse Event|3|||
127923383|NCT03429049|460342008|FG000|Overall Study|Death|0|||
127923384|NCT03429049|460342009|FG001|Overall Study|Death|1|||
127923385|NCT03429049|460342008|FG000|Overall Study|Lack of Efficacy|4|||
127923386|NCT03429049|460342009|FG001|Overall Study|Lack of Efficacy|2|||
127923387|NCT03429049|460342008|FG000|Overall Study|Lost to Follow-up|9|||
127923388|NCT03429049|460342009|FG001|Overall Study|Lost to Follow-up|8|||
127923389|NCT03429049|460342008|FG000|Overall Study|Physician Decision|1|||
127923390|NCT03429049|460342009|FG001|Overall Study|Physician Decision|0|||
127923391|NCT03429049|460342008|FG000|Overall Study|Protocol Violation|3|||
127923392|NCT03429049|460342009|FG001|Overall Study|Protocol Violation|0|||
127923393|NCT03429049|460342008|FG000|Overall Study|Sponsor Decision|2|||
127923394|NCT03429049|460342009|FG001|Overall Study|Sponsor Decision|0|||
127923395|NCT03429049|460342008|FG000|Overall Study|Withdrawal by Subject|4|||
127923396|NCT03429049|460342009|FG001|Overall Study|Withdrawal by Subject|20|||
127923397|NCT03429049|460342008|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
127923398|NCT03429049|460342009|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
127923399|NCT01841060|460342013|FG000|Overall Study|Protocol Violation|10|||
127923400|NCT02459418|460342017|FG000|Overall Study|Exclusion Criteria|4|||
127923401|NCT02459418|460342018|FG001|Overall Study|Exclusion Criteria|0|||
127923402|NCT02459418|460342017|FG000|Overall Study|Protocol Violation|0|||
127923403|NCT02459418|460342018|FG001|Overall Study|Protocol Violation|2|||
127923404|NCT02459418|460342017|FG000|Overall Study|Physician Decision|0|||
127923405|NCT02459418|460342018|FG001|Overall Study|Physician Decision|2|||
127923406|NCT02459418|460342017|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
127923407|NCT02459418|460342018|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
127923408|NCT02459418|460342017|FG000|Overall Study|Adverse Event|0|||
127923409|NCT02459418|460342018|FG001|Overall Study|Adverse Event|1|||
127923410|NCT02459418|460342017|FG000|Overall Study|Withdrawal by Subject|1|||
127923411|NCT02459418|460342018|FG001|Overall Study|Withdrawal by Subject|1|||
127923412|NCT02459418|460342017|FG000|Overall Study|Elevated Creatine Kinase|1|||
127923413|NCT02459418|460342018|FG001|Overall Study|Elevated Creatine Kinase|0|||
127923414|NCT02459418|460342017|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
127923415|NCT02459418|460342018|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
127923416|NCT01872715|460342019|FG000|Overall Study|Adverse Event|1|||
127923417|NCT01872715|460342019|FG000|Overall Study|Protocol Violation|1|||
127923418|NCT01872715|460342019|FG000|Overall Study|Withdrawal by Subject|2|||
127923419|NCT05258630|460342020|FG000|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
127923420|NCT05258630|460342021|FG001|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
127923421|NCT05258630|460342020|FG000|Overall Study|Lost to Follow-up|0|||
127923422|NCT05258630|460342021|FG001|Overall Study|Lost to Follow-up|2|||
127923423|NCT04167618|460342022|FG000|Overall Study|Trial terminated by sponsor|1|||
127923424|NCT04167618|460342023|FG001|Overall Study|Trial terminated by sponsor|1|||
127923425|NCT00835796|460342025|FG000|First Intervention|Withdrawal by Subject|0|||
127923426|NCT00835796|460342026|FG001|First Intervention|Withdrawal by Subject|1|||
127923427|NCT00651183|460342029|FG000|Overall Study|Lack of Efficacy|1|||
127923428|NCT00651183|460342030|FG001|Overall Study|Lack of Efficacy|0|||
127923429|NCT00651183|460342029|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
127923430|NCT00651183|460342030|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
127923431|NCT00651183|460342029|FG000|Overall Study|Tolerability insufficient|5|||
127923432|NCT00651183|460342030|FG001|Overall Study|Tolerability insufficient|2|||
127923433|NCT00651183|460342029|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
127923434|NCT00651183|460342030|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
127923435|NCT00651183|460342029|FG000|Overall Study|Withdrawal by Subject|6|||
127923436|NCT00651183|460342030|FG001|Overall Study|Withdrawal by Subject|3|||
127923437|NCT00651183|460342029|FG000|Overall Study|Lost to Follow-up|3|||
127923438|NCT00651183|460342030|FG001|Overall Study|Lost to Follow-up|1|||
127923439|NCT00651183|460342029|FG000|Overall Study|Other reasons|4|||
127923440|NCT00651183|460342030|FG001|Overall Study|Other reasons|2|||
127923441|NCT00651183|460342029|FG000|Overall Study|missing|1|||
127923442|NCT00651183|460342030|FG001|Overall Study|missing|0|||
127923443|NCT01363011|460342031|FG000|Main Study|Adverse Event|2|||
127923444|NCT01363011|460342032|FG001|Main Study|Adverse Event|3|||
127923445|NCT01363011|460342031|FG000|Main Study|Investigator's Discretion|1|||
127923446|NCT01363011|460342032|FG001|Main Study|Investigator's Discretion|1|||
127923447|NCT01363011|460342031|FG000|Main Study|Withdrew Consent|1|||
127923448|NCT01363011|460342032|FG001|Main Study|Withdrew Consent|4|||
127923449|NCT01363011|460342031|FG000|Main Study|Protocol Violation|0|||
127923450|NCT01363011|460342032|FG001|Main Study|Protocol Violation|1|||
127923451|NCT01363011|460342031|FG000|Extension Phase|Adverse Event|1|||
127923452|NCT01363011|460342032|FG001|Extension Phase|Adverse Event|1|||
127923453|NCT01363011|460342031|FG000|Extension Phase|Lack of Efficacy|0|||
127923454|NCT01363011|460342032|FG001|Extension Phase|Lack of Efficacy|1|||
127923455|NCT01363011|460342031|FG000|Extension Phase|Investigator's Discretion|2|||
127923456|NCT01363011|460342032|FG001|Extension Phase|Investigator's Discretion|2|||
127923457|NCT01363011|460342031|FG000|Extension Phase|Withdrew Consent|0|||
127923458|NCT01363011|460342032|FG001|Extension Phase|Withdrew Consent|1|||
127923459|NCT01363011|460342031|FG000|Extension Phase|Lost to Follow-up|0|||
127923460|NCT01363011|460342032|FG001|Extension Phase|Lost to Follow-up|2|||
127923461|NCT01363011|460342031|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
127923462|NCT01363011|460342032|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
127923463|NCT01961882|460342034|FG000|Overall Study|Adverse Event|3|||
127923464|NCT01961882|460342035|FG001|Overall Study|Adverse Event|2|||
127923465|NCT01961882|460342034|FG000|Overall Study|Physician Decision|1|||
127923466|NCT01961882|460342035|FG001|Overall Study|Physician Decision|0|||
127923467|NCT01961882|460342034|FG000|Overall Study|Withdrawal by Subject|4|||
127923468|NCT01961882|460342035|FG001|Overall Study|Withdrawal by Subject|1|||
127923469|NCT01961882|460342034|FG000|Overall Study|Relapse of AML|39|||
127923470|NCT01961882|460342035|FG001|Overall Study|Relapse of AML|37|||
127923471|NCT01961882|460342034|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
127923472|NCT01961882|460342035|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
127923473|NCT01961882|460342034|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
127923474|NCT01961882|460342035|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
127923475|NCT00407745|460342039|FG000|Overall Study|Lack of Efficacy|1|||
127923476|NCT00407745|460342040|FG001|Overall Study|Lack of Efficacy|2|||
127923477|NCT00407745|460342039|FG000|Overall Study|Withdrawal by Subject|3|||
127923478|NCT00407745|460342040|FG001|Overall Study|Withdrawal by Subject|3|||
127923479|NCT00407745|460342039|FG000|Overall Study|Protocol Violation|5|||
127923480|NCT00407745|460342040|FG001|Overall Study|Protocol Violation|3|||
127923481|NCT00407745|460342039|FG000|Overall Study|Adverse Event|8|||
127923482|NCT00407745|460342040|FG001|Overall Study|Adverse Event|8|||
127923483|NCT00407745|460342039|FG000|Overall Study|Other|2|||
127923484|NCT00407745|460342040|FG001|Overall Study|Other|0|||
127923485|NCT00407745|460342039|FG000|Overall Study|Randomized, unknown if treated|0|||
127923486|NCT00407745|460342040|FG001|Overall Study|Randomized, unknown if treated|1|||
127923487|NCT00108082|460342041|FG000|Overall Study|Adverse Event|14|||
127923488|NCT00108082|460342042|FG001|Overall Study|Adverse Event|12|||
127923489|NCT00108082|460342043|FG002|Overall Study|Adverse Event|17|||
127923490|NCT00108082|460342041|FG000|Overall Study|Lost to Follow-up|6|||
127923491|NCT00108082|460342042|FG001|Overall Study|Lost to Follow-up|3|||
127923492|NCT00108082|460342043|FG002|Overall Study|Lost to Follow-up|7|||
127923493|NCT00108082|460342041|FG000|Overall Study|Consent Withdrawn|3|||
127923494|NCT00108082|460342042|FG001|Overall Study|Consent Withdrawn|3|||
127923495|NCT00108082|460342043|FG002|Overall Study|Consent Withdrawn|5|||
127923496|NCT00108082|460342041|FG000|Overall Study|Protocol Violation|1|||
127923497|NCT00108082|460342042|FG001|Overall Study|Protocol Violation|2|||
127923498|NCT00108082|460342043|FG002|Overall Study|Protocol Violation|0|||
127923499|NCT00108082|460342041|FG000|Overall Study|Lack of Efficacy|3|||
127923500|NCT00108082|460342042|FG001|Overall Study|Lack of Efficacy|1|||
127923501|NCT00108082|460342043|FG002|Overall Study|Lack of Efficacy|2|||
127923502|NCT00108082|460342041|FG000|Overall Study|Amendment 4: > Month 12|5|||
127923503|NCT00108082|460342042|FG001|Overall Study|Amendment 4: > Month 12|7|||
127923504|NCT00108082|460342043|FG002|Overall Study|Amendment 4: > Month 12|5|||
127923505|NCT00108082|460342041|FG000|Overall Study|Woman of Child-bearing Potential|2|||
127923506|NCT00108082|460342042|FG001|Overall Study|Woman of Child-bearing Potential|0|||
127923507|NCT00108082|460342043|FG002|Overall Study|Woman of Child-bearing Potential|2|||
127923508|NCT00108082|460342041|FG000|Overall Study|Incorrectly Randomized|0|||
127923509|NCT00108082|460342042|FG001|Overall Study|Incorrectly Randomized|0|||
127923510|NCT00108082|460342043|FG002|Overall Study|Incorrectly Randomized|2|||
127923511|NCT00108082|460342041|FG000|Overall Study|Non-compliance|1|||
127923512|NCT00108082|460342042|FG001|Overall Study|Non-compliance|0|||
127923513|NCT00108082|460342043|FG002|Overall Study|Non-compliance|2|||
127923514|NCT00108082|460342041|FG000|Overall Study|Stopped Study Medication|0|||
127923515|NCT00108082|460342042|FG001|Overall Study|Stopped Study Medication|0|||
127923516|NCT00108082|460342043|FG002|Overall Study|Stopped Study Medication|1|||
127923517|NCT00108082|460342041|FG000|Overall Study|Site Closed Study|0|||
127923518|NCT00108082|460342042|FG001|Overall Study|Site Closed Study|2|||
127923519|NCT00108082|460342043|FG002|Overall Study|Site Closed Study|0|||
127923520|NCT00108082|460342041|FG000|Overall Study|Protocol Amendment|0|||
127923521|NCT00108082|460342042|FG001|Overall Study|Protocol Amendment|1|||
127923522|NCT00108082|460342043|FG002|Overall Study|Protocol Amendment|0|||
127923523|NCT00108082|460342041|FG000|Overall Study|Study Medication Not Tapered|0|||
127923524|NCT00108082|460342042|FG001|Overall Study|Study Medication Not Tapered|1|||
127923525|NCT00108082|460342043|FG002|Overall Study|Study Medication Not Tapered|0|||
127923526|NCT00108082|460342041|FG000|Overall Study|Subject Left Site Location|1|||
127923527|NCT00108082|460342042|FG001|Overall Study|Subject Left Site Location|0|||
127923528|NCT00108082|460342043|FG002|Overall Study|Subject Left Site Location|0|||
127923529|NCT00108082|460342041|FG000|Overall Study|Investigator Not at Site|1|||
127923530|NCT00108082|460342042|FG001|Overall Study|Investigator Not at Site|0|||
127923531|NCT00108082|460342043|FG002|Overall Study|Investigator Not at Site|0|||
127923532|NCT00108082|460342041|FG000|Overall Study|Blood Pressure Not Controlled|1|||
127923533|NCT00108082|460342042|FG001|Overall Study|Blood Pressure Not Controlled|0|||
127923534|NCT00108082|460342043|FG002|Overall Study|Blood Pressure Not Controlled|0|||
127923535|NCT02940730|460342048|FG000|Intervention 2|Physician Decision|7|||
127923536|NCT02940730|460342049|FG001|Intervention 2|Physician Decision|0|||
127923537|NCT03036839|460342050|FG000|Overall Study|Adverse Event|0|||
127923538|NCT03036839|460342051|FG001|Overall Study|Adverse Event|0|||
127923539|NCT03036839|460342052|FG002|Overall Study|Adverse Event|1|||
127923540|NCT03036839|460342050|FG000|Overall Study|Death|3|||
127923541|NCT03036839|460342051|FG001|Overall Study|Death|0|||
127923542|NCT03036839|460342052|FG002|Overall Study|Death|3|||
127923543|NCT03036839|460342050|FG000|Overall Study|Withdrew Consent|0|||
127923544|NCT03036839|460342051|FG001|Overall Study|Withdrew Consent|0|||
127923545|NCT03036839|460342052|FG002|Overall Study|Withdrew Consent|1|||
127923546|NCT00412737|460342054|FG000|Overall Study|Death|1|||
127923547|NCT00412737|460342055|FG001|Overall Study|Death|0|||
127923548|NCT00412737|460342054|FG000|Overall Study|Adverse Event|3|||
127923549|NCT00412737|460342055|FG001|Overall Study|Adverse Event|2|||
127923550|NCT00412737|460342054|FG000|Overall Study|Refused Treatment|6|||
127923551|NCT00412737|460342055|FG001|Overall Study|Refused Treatment|2|||
127923552|NCT00412737|460342054|FG000|Overall Study|Failure to Return|6|||
127923553|NCT00412737|460342055|FG001|Overall Study|Failure to Return|2|||
127923554|NCT01064531|460342057|FG000|Overall Study|Lost to Follow-up|0|||
127923555|NCT01064531|460342058|FG001|Overall Study|Lost to Follow-up|2|||
127923556|NCT01064531|460342057|FG000|Overall Study|Physician Decision|0|||
127923557|NCT01064531|460342058|FG001|Overall Study|Physician Decision|1|||
127923558|NCT01064531|460342057|FG000|Overall Study|Withdrawal by Subject|2|||
127923559|NCT01064531|460342058|FG001|Overall Study|Withdrawal by Subject|2|||
127923560|NCT01064531|460342057|FG000|Overall Study|Revision due to femoral stem loosening|1|||
127923561|NCT01064531|460342058|FG001|Overall Study|Revision due to femoral stem loosening|0|||
127923562|NCT01064531|460342057|FG000|Overall Study|Revision due to dislocation|0|||
127923563|NCT01064531|460342058|FG001|Overall Study|Revision due to dislocation|1|||
127923564|NCT01064531|460342057|FG000|Overall Study|Death|0|||
127923565|NCT01064531|460342058|FG001|Overall Study|Death|1|||
127923566|NCT00809965|460342062|FG000|Overall Study|Death|194|||
127923567|NCT00809965|460342063|FG001|Overall Study|Death|147|||
127923568|NCT00809965|460342064|FG002|Overall Study|Death|196|||
127923569|NCT00809965|460342062|FG000|Overall Study|Lost to Follow-up|17|||
127923570|NCT00809965|460342063|FG001|Overall Study|Lost to Follow-up|10|||
127923571|NCT00809965|460342064|FG002|Overall Study|Lost to Follow-up|18|||
127923572|NCT00809965|460342062|FG000|Overall Study|Withdrawal by Subject|405|||
127923573|NCT00809965|460342063|FG001|Overall Study|Withdrawal by Subject|448|||
127923574|NCT00809965|460342064|FG002|Overall Study|Withdrawal by Subject|441|||
127923575|NCT00809965|460342062|FG000|Overall Study|Other Reason|167|||
127923576|NCT00809965|460342063|FG001|Overall Study|Other Reason|170|||
127923577|NCT00809965|460342064|FG002|Overall Study|Other Reason|189|||
127923578|NCT02315066|460342065|FG000|Overall Study|Lost to Follow-up|0|||
127923579|NCT02315066|460342066|FG001|Overall Study|Lost to Follow-up|1|||
127923580|NCT02315066|460342067|FG002|Overall Study|Lost to Follow-up|1|||
127923581|NCT02315066|460342068|FG003|Overall Study|Lost to Follow-up|0|||
127923582|NCT02315066|460342069|FG004|Overall Study|Lost to Follow-up|1|||
127923583|NCT02315066|460342070|FG005|Overall Study|Lost to Follow-up|0|||
127923584|NCT02315066|460342071|FG006|Overall Study|Lost to Follow-up|2|||
127923585|NCT02315066|460342072|FG007|Overall Study|Lost to Follow-up|1|||
127923586|NCT02315066|460342073|FG008|Overall Study|Lost to Follow-up|0|||
127923587|NCT02315066|460342074|FG009|Overall Study|Lost to Follow-up|0|||
127923588|NCT02315066|460342075|FG010|Overall Study|Lost to Follow-up|1|||
127923589|NCT02315066|460342076|FG011|Overall Study|Lost to Follow-up|2|||
127923590|NCT02315066|460342077|FG012|Overall Study|Lost to Follow-up|0|||
127923591|NCT02315066|460342078|FG013|Overall Study|Lost to Follow-up|4|||
127923592|NCT02315066|460342065|FG000|Overall Study|Death|2|||
127923593|NCT02315066|460342066|FG001|Overall Study|Death|7|||
127923594|NCT02315066|460342067|FG002|Overall Study|Death|6|||
127923595|NCT02315066|460342068|FG003|Overall Study|Death|11|||
127923596|NCT02315066|460342069|FG004|Overall Study|Death|10|||
127923597|NCT02315066|460342070|FG005|Overall Study|Death|3|||
127923598|NCT02315066|460342071|FG006|Overall Study|Death|9|||
127923599|NCT02315066|460342072|FG007|Overall Study|Death|9|||
127923600|NCT02315066|460342073|FG008|Overall Study|Death|10|||
127923601|NCT02315066|460342074|FG009|Overall Study|Death|8|||
127923602|NCT02315066|460342075|FG010|Overall Study|Death|10|||
127923603|NCT02315066|460342076|FG011|Overall Study|Death|7|||
127923604|NCT02315066|460342077|FG012|Overall Study|Death|8|||
127923605|NCT02315066|460342078|FG013|Overall Study|Death|21|||
127923606|NCT02315066|460342065|FG000|Overall Study|Other|0|||
127923607|NCT02315066|460342066|FG001|Overall Study|Other|0|||
127923608|NCT02315066|460342067|FG002|Overall Study|Other|0|||
127923609|NCT02315066|460342068|FG003|Overall Study|Other|0|||
127923610|NCT02315066|460342069|FG004|Overall Study|Other|0|||
127923611|NCT02315066|460342070|FG005|Overall Study|Other|0|||
127923612|NCT02315066|460342071|FG006|Overall Study|Other|0|||
127923613|NCT02315066|460342072|FG007|Overall Study|Other|1|||
127923614|NCT02315066|460342073|FG008|Overall Study|Other|1|||
127923615|NCT02315066|460342074|FG009|Overall Study|Other|2|||
127923616|NCT02315066|460342075|FG010|Overall Study|Other|0|||
127923617|NCT02315066|460342076|FG011|Overall Study|Other|0|||
127923618|NCT02315066|460342077|FG012|Overall Study|Other|0|||
127923619|NCT02315066|460342078|FG013|Overall Study|Other|0|||
127923620|NCT02315066|460342065|FG000|Overall Study|Subject refused further follow-up|0|||
127923621|NCT02315066|460342066|FG001|Overall Study|Subject refused further follow-up|2|||
127923622|NCT02315066|460342067|FG002|Overall Study|Subject refused further follow-up|2|||
127923623|NCT02315066|460342068|FG003|Overall Study|Subject refused further follow-up|0|||
127923624|NCT02315066|460342069|FG004|Overall Study|Subject refused further follow-up|0|||
127923625|NCT02315066|460342070|FG005|Overall Study|Subject refused further follow-up|0|||
127923626|NCT02315066|460342071|FG006|Overall Study|Subject refused further follow-up|2|||
127923627|NCT02315066|460342072|FG007|Overall Study|Subject refused further follow-up|3|||
127923628|NCT02315066|460342073|FG008|Overall Study|Subject refused further follow-up|0|||
127923629|NCT02315066|460342074|FG009|Overall Study|Subject refused further follow-up|1|||
127923630|NCT02315066|460342075|FG010|Overall Study|Subject refused further follow-up|1|||
127923631|NCT02315066|460342076|FG011|Overall Study|Subject refused further follow-up|2|||
127923632|NCT02315066|460342077|FG012|Overall Study|Subject refused further follow-up|2|||
127923633|NCT02315066|460342078|FG013|Overall Study|Subject refused further follow-up|4|||
127923634|NCT02315066|460342065|FG000|Overall Study|Study ongoing at date of cut-off|0|||
127923635|NCT02315066|460342066|FG001|Overall Study|Study ongoing at date of cut-off|0|||
127923636|NCT02315066|460342067|FG002|Overall Study|Study ongoing at date of cut-off|0|||
127923637|NCT02315066|460342068|FG003|Overall Study|Study ongoing at date of cut-off|0|||
127923638|NCT02315066|460342069|FG004|Overall Study|Study ongoing at date of cut-off|0|||
127923639|NCT02315066|460342070|FG005|Overall Study|Study ongoing at date of cut-off|0|||
127923640|NCT02315066|460342071|FG006|Overall Study|Study ongoing at date of cut-off|0|||
127923641|NCT02315066|460342072|FG007|Overall Study|Study ongoing at date of cut-off|0|||
127923642|NCT02315066|460342073|FG008|Overall Study|Study ongoing at date of cut-off|0|||
127923643|NCT02315066|460342074|FG009|Overall Study|Study ongoing at date of cut-off|0|||
127923644|NCT02315066|460342075|FG010|Overall Study|Study ongoing at date of cut-off|0|||
127923645|NCT02315066|460342076|FG011|Overall Study|Study ongoing at date of cut-off|0|||
127923646|NCT02315066|460342077|FG012|Overall Study|Study ongoing at date of cut-off|0|||
127923647|NCT02315066|460342078|FG013|Overall Study|Study ongoing at date of cut-off|1|||
127923648|NCT00112294|460342079|FG000|Overall Study|Still on study|5|||
127923649|NCT00112294|460342080|FG001|Overall Study|Still on study|0|||
127923650|NCT01142908|460342081|FG000|Overall Study|Lost to Follow-up|19|||
127923651|NCT01142908|460342082|FG001|Overall Study|Lost to Follow-up|13|||
127923652|NCT01142908|460342081|FG000|Overall Study|Death|1|||
127923653|NCT01142908|460342082|FG001|Overall Study|Death|4|||
127923654|NCT01142908|460342081|FG000|Overall Study|Excluded - did not meet criteria|9|||
127923655|NCT01142908|460342082|FG001|Overall Study|Excluded - did not meet criteria|5|||
127923656|NCT01142908|460342081|FG000|Overall Study|Withdrawal by Subject|3|||
127923657|NCT01142908|460342082|FG001|Overall Study|Withdrawal by Subject|0|||
127923658|NCT00035555|460342083|FG000|Overall Study|Adverse Event|5|||
127923659|NCT00035555|460342084|FG001|Overall Study|Adverse Event|8|||
127923660|NCT00035555|460342085|FG002|Overall Study|Adverse Event|9|||
127923661|NCT00035555|460342083|FG000|Overall Study|Allograft loss|1|||
127923662|NCT00035555|460342084|FG001|Overall Study|Allograft loss|1|||
127923663|NCT00035555|460342085|FG002|Overall Study|Allograft loss|2|||
127923664|NCT00035555|460342083|FG000|Overall Study|Death|0|||
127923665|NCT00035555|460342084|FG001|Overall Study|Death|0|||
127923666|NCT00035555|460342085|FG002|Overall Study|Death|2|||
127923667|NCT00035555|460342083|FG000|Overall Study|Lost to Follow-up|0|||
127923668|NCT00035555|460342084|FG001|Overall Study|Lost to Follow-up|0|||
127923669|NCT00035555|460342085|FG002|Overall Study|Lost to Follow-up|1|||
127923670|NCT00035555|460342083|FG000|Overall Study|Noncompliance|0|||
127923671|NCT00035555|460342084|FG001|Overall Study|Noncompliance|1|||
127923672|NCT00035555|460342085|FG002|Overall Study|Noncompliance|1|||
127923673|NCT00035555|460342083|FG000|Overall Study|Prohibited medication|1|||
127923674|NCT00035555|460342084|FG001|Overall Study|Prohibited medication|1|||
127923675|NCT00035555|460342085|FG002|Overall Study|Prohibited medication|0|||
127923676|NCT00035555|460342083|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
127923677|NCT00035555|460342084|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
127923678|NCT00035555|460342085|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
127923679|NCT00035555|460342083|FG000|Overall Study|Withdrawal by Subject|2|||
127923680|NCT00035555|460342084|FG001|Overall Study|Withdrawal by Subject|0|||
127923681|NCT00035555|460342085|FG002|Overall Study|Withdrawal by Subject|2|||
127923682|NCT00035555|460342083|FG000|Overall Study|Investigator deemed not a good candidate|0|||
127923683|NCT00035555|460342084|FG001|Overall Study|Investigator deemed not a good candidate|0|||
127923684|NCT00035555|460342085|FG002|Overall Study|Investigator deemed not a good candidate|1|||
127923685|NCT00035555|460342083|FG000|Overall Study|Received cyclosporin in error|0|||
127923686|NCT00035555|460342084|FG001|Overall Study|Received cyclosporin in error|0|||
127923687|NCT00035555|460342085|FG002|Overall Study|Received cyclosporin in error|1|||
127923688|NCT02972515|460342088|FG000|Overall Study|Lost to Follow-up|78|||
127923689|NCT01450800|460342089|FG000|Overall Study|Protocol Violation|1|||
127923690|NCT01450800|460342090|FG001|Overall Study|Protocol Violation|3|||
127923691|NCT01086969|460342095|FG000|Overall Study|Withdrawal by Subject|1|||
127923692|NCT01086969|460342096|FG001|Overall Study|Withdrawal by Subject|2|||
127923693|NCT01086969|460342097|FG002|Overall Study|Withdrawal by Subject|0|||
127923694|NCT00585312|460342108|FG000|Overall Study|Adverse Event|3|||
127923695|NCT00585312|460342109|FG001|Overall Study|Adverse Event|0|||
127923696|NCT00585312|460342108|FG000|Overall Study|Lack of Efficacy|6|||
127923697|NCT00585312|460342109|FG001|Overall Study|Lack of Efficacy|11|||
127923698|NCT00585312|460342108|FG000|Overall Study|Lost to Follow-up|1|||
127923699|NCT00585312|460342109|FG001|Overall Study|Lost to Follow-up|1|||
127923700|NCT00585312|460342108|FG000|Overall Study|Reason not specified|2|||
127923701|NCT00585312|460342109|FG001|Overall Study|Reason not specified|0|||
127923702|NCT00585312|460342108|FG000|Overall Study|Withdrawal by Subject|5|||
127923703|NCT00585312|460342109|FG001|Overall Study|Withdrawal by Subject|1|||
127923704|NCT00585312|460342108|FG000|Overall Study|Study terminated by the sponsor|34|||
127923705|NCT00585312|460342109|FG001|Overall Study|Study terminated by the sponsor|31|||
127923706|NCT04291508|460342113|FG000|Overall Study|Withdrawal by Subject|1|||
127923707|NCT04291508|460342114|FG001|Overall Study|Withdrawal by Subject|0|||
127923708|NCT04291508|460342115|FG002|Overall Study|Withdrawal by Subject|1|||
127923709|NCT04291508|460342116|FG003|Overall Study|Withdrawal by Subject|0|||
127923710|NCT04291508|460342113|FG000|Overall Study|lost to follow up|4|||
127923711|NCT04291508|460342114|FG001|Overall Study|lost to follow up|0|||
127923712|NCT04291508|460342115|FG002|Overall Study|lost to follow up|1|||
127923713|NCT04291508|460342116|FG003|Overall Study|lost to follow up|0|||
127923714|NCT03566238|460342117|FG000|Overall Study|Adverse Event|0|||
127923715|NCT03566238|460342118|FG001|Overall Study|Adverse Event|1|||
127923716|NCT03566238|460342119|FG002|Overall Study|Adverse Event|0|||
127923717|NCT03566238|460342117|FG000|Overall Study|Lack of Efficacy|4|||
127923718|NCT03566238|460342118|FG001|Overall Study|Lack of Efficacy|2|||
127923719|NCT03566238|460342119|FG002|Overall Study|Lack of Efficacy|5|||
127923720|NCT03566238|460342117|FG000|Overall Study|Other|1|||
127923721|NCT03566238|460342118|FG001|Overall Study|Other|0|||
127923722|NCT03566238|460342119|FG002|Overall Study|Other|0|||
127923723|NCT04203667|460342126|FG000|Overall Study|Withdrawal by Subject|1|||
127923724|NCT04203667|460342126|FG000|Overall Study|Lost to Follow-up|1|||
127923725|NCT04203667|460342126|FG000|Overall Study|Death|1|||
127923726|NCT04203667|460342126|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
127923727|NCT01183884|460342127|FG000|Overall Study|Progressive Disease|26|||
127923728|NCT01183884|460342127|FG000|Overall Study|Adverse Event|3|||
127923729|NCT01183884|460342127|FG000|Overall Study|Withdrawal by Subject|1|||
127923730|NCT01183884|460342127|FG000|Overall Study|Other Complicating Disease|3|||
127923731|NCT01183884|460342127|FG000|Overall Study|Not Treated|1|||
127923732|NCT01183884|460342127|FG000|Overall Study|Other|4|||
127923733|NCT00127166|460342128|FG000|Period I|Protocol Violation|0|||
127923734|NCT00127166|460342129|FG001|Period I|Protocol Violation|2|||
127923735|NCT00127166|460342128|FG000|Period I|Withdrawal by Subject|2|||
127923736|NCT00127166|460342129|FG001|Period I|Withdrawal by Subject|0|||
127923737|NCT00127166|460342128|FG000|Period I|Patient did not meet inclusion criteria|1|||
127923738|NCT00127166|460342129|FG001|Period I|Patient did not meet inclusion criteria|0|||
127923739|NCT00127166|460342128|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
127923740|NCT00127166|460342129|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
127923741|NCT00127166|460342128|FG000|Period II|Withdrawal by Subject|2|||
127923742|NCT00127166|460342129|FG001|Period II|Withdrawal by Subject|0|||
127923743|NCT00127166|460342128|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
127923744|NCT00127166|460342129|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
127923745|NCT00708682|460342134|FG000|Infant Series|Adverse Event|1|||
127923746|NCT00708682|460342134|FG000|Infant Series|Lost to Follow-up|4|||
127923747|NCT00708682|460342134|FG000|Infant Series|Protocol Violation|1|||
127923748|NCT00708682|460342134|FG000|Infant Series|Parent/legal guardian request|6|||
127923749|NCT00708682|460342134|FG000|Infant Series|Failed to return|2|||
127923750|NCT00708682|460342134|FG000|Infant Series|Other|19|||
127923751|NCT00708682|460342134|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
127923752|NCT00708682|460342134|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
127923753|NCT00708682|460342134|FG000|Toddler Dose|Lost to Follow-up|3|||
127923754|NCT00708682|460342134|FG000|Toddler Dose|Failed to Return|4|||
127923755|NCT03689894|460342136|FG000|Overall Study|Adverse Event|1|||
127923756|NCT01169038|460342145|FG000|Overall Study|Death|1|||
127923757|NCT01169038|460342145|FG000|Overall Study|Adverse Event|5|||
127923758|NCT01169038|460342145|FG000|Overall Study|Required antibiotic administration|1|||
127923759|NCT01634854|460342146|FG000|Overall Study|Cesarean delivery|2|||
127923760|NCT01634854|460342147|FG001|Overall Study|Cesarean delivery|7|||
127923761|NCT01488448|460342148|FG000|Overall Study|Withdrawal by Subject|3|||
127923762|NCT01488448|460342149|FG001|Overall Study|Withdrawal by Subject|1|||
127923763|NCT01488448|460342148|FG000|Overall Study|Adverse Event|9|||
127923764|NCT01488448|460342149|FG001|Overall Study|Adverse Event|4|||
127923765|NCT01488448|460342148|FG000|Overall Study|Physician Decision|4|||
127923766|NCT01488448|460342149|FG001|Overall Study|Physician Decision|9|||
127923767|NCT01488448|460342148|FG000|Overall Study|Protocol Violation|4|||
127923768|NCT01488448|460342149|FG001|Overall Study|Protocol Violation|3|||
127923769|NCT02329431|460342150|FG000|Overall Study|Lost to Follow-up|20|||
127923770|NCT02329431|460342151|FG001|Overall Study|Lost to Follow-up|13|||
127923771|NCT01362296|460342152|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
127923772|NCT01362296|460342153|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
127923773|NCT01362296|460342154|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
127923774|NCT01362296|460342155|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
127923775|NCT01362296|460342152|FG000|Randomized Phase (RP)|Physician Decision|1|||
127923776|NCT01362296|460342153|FG001|Randomized Phase (RP)|Physician Decision|9|||
127923777|NCT01362296|460342154|FG002|Randomized Phase (RP)|Physician Decision|0|||
127923778|NCT01362296|460342155|FG003|Randomized Phase (RP)|Physician Decision|0|||
127923779|NCT01362296|460342152|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
127923780|NCT01362296|460342153|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
127923781|NCT01362296|460342154|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
127923782|NCT01362296|460342155|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
127923783|NCT01362296|460342152|FG000|Randomized Phase (RP)|Adverse Event|20|||
127923784|NCT01362296|460342153|FG001|Randomized Phase (RP)|Adverse Event|4|||
127923785|NCT01362296|460342154|FG002|Randomized Phase (RP)|Adverse Event|0|||
127923786|NCT01362296|460342155|FG003|Randomized Phase (RP)|Adverse Event|0|||
127923787|NCT01362296|460342152|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
127923788|NCT01362296|460342153|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
127923789|NCT01362296|460342154|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
127923790|NCT01362296|460342155|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
127923791|NCT01362296|460342152|FG000|Crossover Phase|PD including Death due to PD|0|||
127923792|NCT01362296|460342153|FG001|Crossover Phase|PD including Death due to PD|0|||
127923793|NCT01362296|460342154|FG002|Crossover Phase|PD including Death due to PD|16|||
127923794|NCT01362296|460342155|FG003|Crossover Phase|PD including Death due to PD|1|||
127923795|NCT01362296|460342152|FG000|Crossover Phase|Withdrawal by Subject|0|||
127923796|NCT01362296|460342153|FG001|Crossover Phase|Withdrawal by Subject|0|||
127923797|NCT01362296|460342154|FG002|Crossover Phase|Withdrawal by Subject|2|||
127923798|NCT01362296|460342155|FG003|Crossover Phase|Withdrawal by Subject|1|||
127923799|NCT01362296|460342152|FG000|Crossover Phase|Adverse Event|0|||
127923800|NCT01362296|460342153|FG001|Crossover Phase|Adverse Event|0|||
127923801|NCT01362296|460342154|FG002|Crossover Phase|Adverse Event|4|||
127923802|NCT01362296|460342155|FG003|Crossover Phase|Adverse Event|0|||
127923803|NCT01362296|460342152|FG000|Crossover Phase|Study Closed/Terminated|0|||
127923804|NCT01362296|460342153|FG001|Crossover Phase|Study Closed/Terminated|0|||
127923805|NCT01362296|460342154|FG002|Crossover Phase|Study Closed/Terminated|1|||
127923806|NCT01362296|460342155|FG003|Crossover Phase|Study Closed/Terminated|0|||
127923807|NCT02625974|460342156|FG000|Part 1|Lost to Follow-up|9|||
127923808|NCT02625974|460342157|FG001|Part 1|Lost to Follow-up|3|||
127923809|NCT02625974|460342156|FG000|Part 2|Lost to Follow-up|4|||
127923810|NCT02625974|460342157|FG001|Part 2|Lost to Follow-up|6|||
127923811|NCT02625974|460342156|FG000|Part 2|Other, including due to the COVID-19 Pandemic|2|||
127923812|NCT02625974|460342157|FG001|Part 2|Other, including due to the COVID-19 Pandemic|1|||
127923813|NCT04149535|460342159|FG000|Overall Study|Death|11|||
127923814|NCT04149535|460342160|FG001|Overall Study|Death|7|||
127923815|NCT04149535|460342159|FG000|Overall Study|Physician Decision|10|||
127923816|NCT04149535|460342160|FG001|Overall Study|Physician Decision|4|||
127923817|NCT04149535|460342159|FG000|Overall Study|Withdrawal by Subject|6|||
127923818|NCT04149535|460342160|FG001|Overall Study|Withdrawal by Subject|7|||
127923819|NCT04149535|460342159|FG000|Overall Study|Not described|2|||
127923820|NCT04149535|460342160|FG001|Overall Study|Not described|0|||
127923821|NCT02175368|460342161|FG000|Overall Study|Lost to Follow-up|1|||
127923822|NCT02875028|460342162|FG000|Washout Period|Withdrawal by Subject|0|||
127923823|NCT02875028|460342163|FG001|Washout Period|Withdrawal by Subject|1|||
127923824|NCT02129062|460343711|FG000|Overall Study|Death|1|||
127923825|NCT02129062|460343711|FG000|Overall Study|Disease Progression|2|||
127923826|NCT02722616|460343712|FG000|Overall Study|Sponsor closed study after one month|2|||
127923827|NCT02722616|460343713|FG001|Overall Study|Sponsor closed study after one month|0|||
127923828|NCT02722616|460343714|FG002|Overall Study|Sponsor closed study after one month|0|||
127923829|NCT01923311|460343715|FG000|Overall Study|Pregnancy|1|||
127923830|NCT01923311|460343716|FG001|Overall Study|Pregnancy|0|||
127923831|NCT01923311|460343715|FG000|Overall Study|Investigator's Discretion|1|||
127923832|NCT01923311|460343716|FG001|Overall Study|Investigator's Discretion|0|||
127923833|NCT01923311|460343715|FG000|Overall Study|Non-Compliance with Study Drug|2|||
127923834|NCT01923311|460343716|FG001|Overall Study|Non-Compliance with Study Drug|1|||
127923835|NCT01923311|460343715|FG000|Overall Study|Withdrew Consent|1|||
127923836|NCT01923311|460343716|FG001|Overall Study|Withdrew Consent|0|||
127923837|NCT01923311|460343715|FG000|Overall Study|Study Terminated by Sponsor|12|||
127923838|NCT01923311|460343716|FG001|Overall Study|Study Terminated by Sponsor|0|||
127923839|NCT02031237|460343717|FG000|Overall Study|Death|1|||
127923840|NCT02031237|460343718|FG001|Overall Study|Death|5|||
127923841|NCT02031237|460343719|FG002|Overall Study|Death|0|||
127923842|NCT02031237|460343717|FG000|Overall Study|Physician Decision|0|||
127923843|NCT02031237|460343718|FG001|Overall Study|Physician Decision|1|||
127923844|NCT02031237|460343719|FG002|Overall Study|Physician Decision|0|||
127923845|NCT02031237|460343717|FG000|Overall Study|Withdrawal by Subject|2|||
127923846|NCT02031237|460343718|FG001|Overall Study|Withdrawal by Subject|2|||
127923847|NCT02031237|460343719|FG002|Overall Study|Withdrawal by Subject|0|||
127923848|NCT02031237|460343717|FG000|Overall Study|Protocol Violation|2|||
127923849|NCT02031237|460343718|FG001|Overall Study|Protocol Violation|6|||
127923850|NCT02031237|460343719|FG002|Overall Study|Protocol Violation|0|||
127923851|NCT02031237|460343717|FG000|Overall Study|Alternate Treatment Given|0|||
127923852|NCT02031237|460343718|FG001|Overall Study|Alternate Treatment Given|0|||
127923853|NCT02031237|460343719|FG002|Overall Study|Alternate Treatment Given|3|||
127923854|NCT00653159|460343720|FG000|Overall Study|Adverse Event|4|||
127923855|NCT00653159|460343721|FG001|Overall Study|Adverse Event|1|||
127923856|NCT00653159|460343720|FG000|Overall Study|Lost to Follow-up|1|||
127923857|NCT00653159|460343721|FG001|Overall Study|Lost to Follow-up|2|||
127923858|NCT00109837|460343722|FG000|Overall Study|Adverse Event|2|||
127923859|NCT00109837|460343722|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
127923860|NCT00109837|460343722|FG000|Overall Study|Death|1|||
127923861|NCT00109837|460343722|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
127923862|NCT00109837|460343722|FG000|Overall Study|Not treated|1|||
127923863|NCT00109837|460343722|FG000|Overall Study|Ineligible|1|||
127923864|NCT00381849|460343723|FG000|Wash Out|Withdrawal by Subject|0|||
127923865|NCT00381849|460343724|FG001|Wash Out|Withdrawal by Subject|1|||
127923866|NCT02426541|460343728|FG000|Overall Study|Protocol Violation|1|||
127923867|NCT02426541|460343729|FG001|Overall Study|Protocol Violation|0|||
127923868|NCT00631007|460343732|FG000|Overall Study|Adverse Event|0|||
127923869|NCT00631007|460343733|FG001|Overall Study|Adverse Event|2|||
127923870|NCT00631007|460343734|FG002|Overall Study|Adverse Event|0|||
127923871|NCT00631007|460343735|FG003|Overall Study|Adverse Event|2|||
127923872|NCT00631007|460343736|FG004|Overall Study|Adverse Event|3|||
127923873|NCT00631007|460343737|FG005|Overall Study|Adverse Event|2|||
127923874|NCT00631007|460343732|FG000|Overall Study|Lost to Follow-up|2|||
127923875|NCT00631007|460343733|FG001|Overall Study|Lost to Follow-up|1|||
127923876|NCT00631007|460343734|FG002|Overall Study|Lost to Follow-up|2|||
127923877|NCT00631007|460343735|FG003|Overall Study|Lost to Follow-up|4|||
127923878|NCT00631007|460343736|FG004|Overall Study|Lost to Follow-up|5|||
127923879|NCT00631007|460343737|FG005|Overall Study|Lost to Follow-up|3|||
127923880|NCT00631007|460343732|FG000|Overall Study|Physician Decision|1|||
127923881|NCT00631007|460343733|FG001|Overall Study|Physician Decision|0|||
127923882|NCT00631007|460343734|FG002|Overall Study|Physician Decision|1|||
127923883|NCT00631007|460343735|FG003|Overall Study|Physician Decision|0|||
127923884|NCT00631007|460343736|FG004|Overall Study|Physician Decision|0|||
127923885|NCT00631007|460343737|FG005|Overall Study|Physician Decision|2|||
127923886|NCT00631007|460343732|FG000|Overall Study|Persistent Hyperglycemia|2|||
127923887|NCT00631007|460343733|FG001|Overall Study|Persistent Hyperglycemia|2|||
127923888|NCT00631007|460343734|FG002|Overall Study|Persistent Hyperglycemia|5|||
127923889|NCT00631007|460343735|FG003|Overall Study|Persistent Hyperglycemia|1|||
127923890|NCT00631007|460343736|FG004|Overall Study|Persistent Hyperglycemia|2|||
127923891|NCT00631007|460343737|FG005|Overall Study|Persistent Hyperglycemia|5|||
127923892|NCT00631007|460343732|FG000|Overall Study|Withdrawal by Subject|4|||
127923893|NCT00631007|460343733|FG001|Overall Study|Withdrawal by Subject|5|||
127923894|NCT00631007|460343734|FG002|Overall Study|Withdrawal by Subject|2|||
127923895|NCT00631007|460343735|FG003|Overall Study|Withdrawal by Subject|2|||
127923896|NCT00631007|460343736|FG004|Overall Study|Withdrawal by Subject|1|||
127923897|NCT00631007|460343737|FG005|Overall Study|Withdrawal by Subject|3|||
127923898|NCT00631007|460343732|FG000|Overall Study|Other|2|||
127923899|NCT00631007|460343733|FG001|Overall Study|Other|1|||
127923900|NCT00631007|460343734|FG002|Overall Study|Other|0|||
127923901|NCT00631007|460343735|FG003|Overall Study|Other|0|||
127923902|NCT00631007|460343736|FG004|Overall Study|Other|1|||
127923903|NCT00631007|460343737|FG005|Overall Study|Other|0|||
127923904|NCT00683787|460343738|FG000|Overall Study|Progression|3|||
127923905|NCT00683787|460343739|FG001|Overall Study|Progression|3|||
127923906|NCT00683787|460343740|FG002|Overall Study|Progression|0|||
127923907|NCT00683787|460343738|FG000|Overall Study|Adverse Event|0|||
127923908|NCT00683787|460343739|FG001|Overall Study|Adverse Event|0|||
127923909|NCT00683787|460343740|FG002|Overall Study|Adverse Event|2|||
127923910|NCT02674633|460343741|FG000|Overall Study|Lost to Follow-up|3|||
127923911|NCT02674633|460343742|FG001|Overall Study|Lost to Follow-up|2|||
127923912|NCT02674633|460343741|FG000|Overall Study|Physician Decision|1|||
127923913|NCT02674633|460343742|FG001|Overall Study|Physician Decision|0|||
127923914|NCT02674633|460343741|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
127923915|NCT02674633|460343742|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
127923916|NCT00460109|460343743|FG000|Overall Study|Death|1|||
127923917|NCT05996198|460343744|FG000|Overall Study|Withdrawal by Subject|1|||
127923918|NCT05996198|460343745|FG001|Overall Study|Withdrawal by Subject|0|||
127923919|NCT02014441|460343746|FG000|Overall Study|Withdrawal by Subject|12|||
127923920|NCT04412057|460343748|FG000|Overall Study|Death|3|||
127923921|NCT04412057|460343749|FG001|Overall Study|Death|7|||
127923922|NCT04412057|460343748|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
127923923|NCT04412057|460343749|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
127923924|NCT03449199|460343759|FG000|Overall Study|Lost to Follow-up|1|||
127923925|NCT03449199|460343760|FG001|Overall Study|Lost to Follow-up|1|||
127923926|NCT03449199|460343761|FG002|Overall Study|Lost to Follow-up|0|||
127923927|NCT03449199|460343759|FG000|Overall Study|Protocol Deviation|0|||
127923928|NCT03449199|460343760|FG001|Overall Study|Protocol Deviation|0|||
127923929|NCT03449199|460343761|FG002|Overall Study|Protocol Deviation|1|||
127923930|NCT03449199|460343759|FG000|Overall Study|Withdrawal by Subject|0|||
127923931|NCT03449199|460343760|FG001|Overall Study|Withdrawal by Subject|0|||
127923932|NCT03449199|460343761|FG002|Overall Study|Withdrawal by Subject|1|||
127923933|NCT01091103|460343762|FG000|Overall Study|Adverse Event|1|||
127923934|NCT01091103|460343762|FG000|Overall Study|Progressive Disease|3|||
127923935|NCT01270620|460343763|FG000|Overall Study|Withdrawal by Subject|1|||
127923936|NCT01270620|460343764|FG001|Overall Study|Withdrawal by Subject|3|||
127923937|NCT02780167|460343765|FG000|Overall Study|Adverse Event|9|||
127923938|NCT02780167|460343766|FG001|Overall Study|Adverse Event|8|||
127923939|NCT02780167|460343767|FG002|Overall Study|Adverse Event|8|||
127923940|NCT02780167|460343768|FG003|Overall Study|Adverse Event|12|||
127923941|NCT02780167|460343769|FG004|Overall Study|Adverse Event|8|||
127923942|NCT02780167|460343765|FG000|Overall Study|Lack of Efficacy|6|||
127923943|NCT02780167|460343766|FG001|Overall Study|Lack of Efficacy|5|||
127923944|NCT02780167|460343767|FG002|Overall Study|Lack of Efficacy|6|||
127923945|NCT02780167|460343768|FG003|Overall Study|Lack of Efficacy|1|||
127923946|NCT02780167|460343769|FG004|Overall Study|Lack of Efficacy|0|||
127923947|NCT02780167|460343765|FG000|Overall Study|Lost to Follow-up|2|||
127923948|NCT02780167|460343766|FG001|Overall Study|Lost to Follow-up|0|||
127923949|NCT02780167|460343767|FG002|Overall Study|Lost to Follow-up|1|||
127923950|NCT02780167|460343768|FG003|Overall Study|Lost to Follow-up|0|||
127923951|NCT02780167|460343769|FG004|Overall Study|Lost to Follow-up|0|||
127923952|NCT02780167|460343765|FG000|Overall Study|Does not meet entrance criteria|0|||
127923953|NCT02780167|460343766|FG001|Overall Study|Does not meet entrance criteria|0|||
127923954|NCT02780167|460343767|FG002|Overall Study|Does not meet entrance criteria|1|||
127923955|NCT02780167|460343768|FG003|Overall Study|Does not meet entrance criteria|0|||
127923956|NCT02780167|460343769|FG004|Overall Study|Does not meet entrance criteria|0|||
127923957|NCT02780167|460343765|FG000|Overall Study|No longer meets eligibility criteria|0|||
127923958|NCT02780167|460343766|FG001|Overall Study|No longer meets eligibility criteria|0|||
127923959|NCT02780167|460343767|FG002|Overall Study|No longer meets eligibility criteria|0|||
127923960|NCT02780167|460343768|FG003|Overall Study|No longer meets eligibility criteria|1|||
127923961|NCT02780167|460343769|FG004|Overall Study|No longer meets eligibility criteria|1|||
127923962|NCT02780167|460343765|FG000|Overall Study|Protocol Violation|5|||
127923963|NCT02780167|460343766|FG001|Overall Study|Protocol Violation|5|||
127923964|NCT02780167|460343767|FG002|Overall Study|Protocol Violation|1|||
127923965|NCT02780167|460343768|FG003|Overall Study|Protocol Violation|1|||
127923966|NCT02780167|460343769|FG004|Overall Study|Protocol Violation|2|||
127923967|NCT02780167|460343765|FG000|Overall Study|Withdrawal by Subject|6|||
127923968|NCT02780167|460343766|FG001|Overall Study|Withdrawal by Subject|4|||
127923969|NCT02780167|460343767|FG002|Overall Study|Withdrawal by Subject|4|||
127923970|NCT02780167|460343768|FG003|Overall Study|Withdrawal by Subject|3|||
127923971|NCT02780167|460343769|FG004|Overall Study|Withdrawal by Subject|4|||
127923972|NCT02780167|460343765|FG000|Overall Study|Other|0|||
127923973|NCT02780167|460343766|FG001|Overall Study|Other|0|||
127923974|NCT02780167|460343767|FG002|Overall Study|Other|3|||
127923975|NCT02780167|460343768|FG003|Overall Study|Other|1|||
127923976|NCT02780167|460343769|FG004|Overall Study|Other|2|||
127923977|NCT03180801|460343770|FG000|Overall Study|Physician Decision|3|||
127923978|NCT03180801|460343771|FG001|Overall Study|Physician Decision|3|||
127923979|NCT03180801|460343772|FG002|Overall Study|Physician Decision|1|||
127923980|NCT03180801|460343770|FG000|Overall Study|Non-compliance|1|||
127923981|NCT03180801|460343771|FG001|Overall Study|Non-compliance|4|||
127923982|NCT03180801|460343772|FG002|Overall Study|Non-compliance|0|||
127923983|NCT03180801|460343770|FG000|Overall Study|Inoculation Target Reached|1|||
127923984|NCT03180801|460343771|FG001|Overall Study|Inoculation Target Reached|1|||
127923985|NCT03180801|460343772|FG002|Overall Study|Inoculation Target Reached|3|||
127923986|NCT03180801|460343770|FG000|Overall Study|Adverse Event|1|||
127923987|NCT03180801|460343771|FG001|Overall Study|Adverse Event|0|||
127923988|NCT03180801|460343772|FG002|Overall Study|Adverse Event|2|||
127923989|NCT03180801|460343770|FG000|Overall Study|Withdrawal by Subject|2|||
127923990|NCT03180801|460343771|FG001|Overall Study|Withdrawal by Subject|2|||
127923991|NCT03180801|460343772|FG002|Overall Study|Withdrawal by Subject|1|||
127923992|NCT03180801|460343770|FG000|Overall Study|Lost to Follow-up|0|||
127923993|NCT03180801|460343771|FG001|Overall Study|Lost to Follow-up|2|||
127923994|NCT03180801|460343772|FG002|Overall Study|Lost to Follow-up|3|||
127923995|NCT02618382|460343775|FG000|Overall Study|Physician Decision|1|||
127923996|NCT02618382|460343775|FG000|Overall Study|Withdrawal by Subject|1|||
127923997|NCT02618382|460343775|FG000|Overall Study|Protocol Violation|1|||
127923998|NCT00309985|460343776|FG000|Overall Study|Disease progression|12|||
127923999|NCT00309985|460343777|FG001|Overall Study|Disease progression|0|||
127924000|NCT00309985|460343776|FG000|Overall Study|Adverse Event|30|||
127924001|NCT00309985|460343777|FG001|Overall Study|Adverse Event|0|||
127924002|NCT00309985|460343776|FG000|Overall Study|Death|2|||
127924003|NCT00309985|460343777|FG001|Overall Study|Death|0|||
127924004|NCT00309985|460343776|FG000|Overall Study|Withdrawal by Subject|5|||
127924005|NCT00309985|460343777|FG001|Overall Study|Withdrawal by Subject|1|||
127924006|NCT00309985|460343776|FG000|Overall Study|Physician Decision|3|||
127924007|NCT00309985|460343777|FG001|Overall Study|Physician Decision|0|||
127924008|NCT00309985|460343776|FG000|Overall Study|Never started treatment|7|||
127924009|NCT00309985|460343777|FG001|Overall Study|Never started treatment|0|||
127924010|NCT00309985|460343776|FG000|Overall Study|Complicating disease|1|||
127924011|NCT00309985|460343777|FG001|Overall Study|Complicating disease|0|||
127924012|NCT00309985|460343776|FG000|Overall Study|Non-compliance|1|||
127924013|NCT00309985|460343777|FG001|Overall Study|Non-compliance|0|||
127924014|NCT00309985|460343776|FG000|Overall Study|Chemotherapy discontinued only|1|||
127924015|NCT00309985|460343777|FG001|Overall Study|Chemotherapy discontinued only|0|||
127924016|NCT03110380|460343778|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
127924017|NCT03110380|460343779|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
127924018|NCT03110380|460343780|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
127924019|NCT03110380|460343781|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
127924020|NCT03110380|460343778|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
127924021|NCT03110380|460343779|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
127924022|NCT03110380|460343780|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
127924023|NCT03110380|460343781|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
127924024|NCT03110380|460343778|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
127924025|NCT03110380|460343779|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
127924026|NCT03110380|460343780|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
127924027|NCT03110380|460343781|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
127924028|NCT03110380|460343778|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
127924029|NCT03110380|460343779|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
127924030|NCT03110380|460343780|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
127924031|NCT03110380|460343781|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
127924032|NCT03110380|460343778|FG000|Double-Blind Treatment Phase|Death|2|||
127924033|NCT03110380|460343779|FG001|Double-Blind Treatment Phase|Death|1|||
127924034|NCT03110380|460343780|FG002|Double-Blind Treatment Phase|Death|0|||
127924035|NCT03110380|460343781|FG003|Double-Blind Treatment Phase|Death|0|||
127924036|NCT03110380|460343778|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
127924037|NCT03110380|460343779|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
127924038|NCT03110380|460343780|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
127924039|NCT03110380|460343781|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
127924040|NCT03110380|460343778|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
127924041|NCT03110380|460343779|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
127924042|NCT03110380|460343780|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
127924043|NCT03110380|460343781|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
127924044|NCT03110380|460343778|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
127924045|NCT03110380|460343779|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
127924046|NCT03110380|460343780|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
127924047|NCT03110380|460343781|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
127924048|NCT03110380|460343778|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
127924049|NCT03110380|460343779|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
127924050|NCT03110380|460343780|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
127924051|NCT03110380|460343781|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
127924052|NCT03110380|460343778|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
127924053|NCT03110380|460343779|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
127924054|NCT03110380|460343780|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
127924055|NCT03110380|460343781|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
127924056|NCT03110380|460343778|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
127924057|NCT03110380|460343779|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
127924058|NCT03110380|460343780|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
127924059|NCT03110380|460343781|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
127924060|NCT03173560|460343784|FG000|Overall Study|Death|70|||
127924061|NCT03173560|460343785|FG001|Overall Study|Death|60|||
127924062|NCT03173560|460343784|FG000|Overall Study|Lost to Follow-up|1|||
127924063|NCT03173560|460343785|FG001|Overall Study|Lost to Follow-up|4|||
127924064|NCT03173560|460343784|FG000|Overall Study|Withdrawal by Subject|10|||
127924065|NCT03173560|460343785|FG001|Overall Study|Withdrawal by Subject|5|||
127924066|NCT03173560|460343784|FG000|Overall Study|Other|0|||
127924067|NCT03173560|460343785|FG001|Overall Study|Other|1|||
127924068|NCT04254809|460343786|FG000|Overall Study|Lost to Follow-up|5|||
127924069|NCT04254809|460343787|FG001|Overall Study|Lost to Follow-up|10|||
127924070|NCT03023137|460343788|FG000|Overall Study|Multiple pregnancy|2|||
127924071|NCT03023137|460343789|FG001|Overall Study|Multiple pregnancy|4|||
127924072|NCT03023137|460343788|FG000|Overall Study|Lost to Follow-up|1|||
127924073|NCT03023137|460343789|FG001|Overall Study|Lost to Follow-up|1|||
127924074|NCT03023137|460343788|FG000|Overall Study|Protocol Violation|0|||
127924075|NCT03023137|460343789|FG001|Overall Study|Protocol Violation|4|||
127924076|NCT03023137|460343788|FG000|Overall Study|Lost the baby in a car accident|1|||
127924077|NCT03023137|460343789|FG001|Overall Study|Lost the baby in a car accident|0|||
127924078|NCT02608476|460343790|FG000|Overall Study|Withdrawal by Subject|30|||
127924079|NCT02608476|460343791|FG001|Overall Study|Withdrawal by Subject|37|||
127924080|NCT02608476|460343790|FG000|Overall Study|Lost to Follow-up|24|||
127924081|NCT02608476|460343791|FG001|Overall Study|Lost to Follow-up|24|||
127924082|NCT02608476|460343790|FG000|Overall Study|Adverse Event|2|||
127924083|NCT02608476|460343791|FG001|Overall Study|Adverse Event|8|||
127924084|NCT02608476|460343790|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
127924085|NCT02608476|460343791|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
127924086|NCT02608476|460343790|FG000|Overall Study|Noncompliance with treatment|1|||
127924087|NCT02608476|460343791|FG001|Overall Study|Noncompliance with treatment|5|||
127924088|NCT02608476|460343790|FG000|Overall Study|Lack of Efficacy|3|||
127924089|NCT02608476|460343791|FG001|Overall Study|Lack of Efficacy|1|||
127924090|NCT02608476|460343790|FG000|Overall Study|Other|0|||
127924091|NCT02608476|460343791|FG001|Overall Study|Other|1|||
127924092|NCT02608476|460343790|FG000|Overall Study|Physician Decision|1|||
127924093|NCT02608476|460343791|FG001|Overall Study|Physician Decision|0|||
127924094|NCT02608476|460343790|FG000|Overall Study|Pregnancy|0|||
127924095|NCT02608476|460343791|FG001|Overall Study|Pregnancy|1|||
127924096|NCT02608476|460343790|FG000|Overall Study|Progressive disease|1|||
127924097|NCT02608476|460343791|FG001|Overall Study|Progressive disease|0|||
127924098|NCT02795676|460343792|FG000|Overall Study|Adverse Event|2|||
127924099|NCT02795676|460343793|FG001|Overall Study|Adverse Event|0|||
127924100|NCT02795676|460343792|FG000|Overall Study|Withdrawal by Subject|3|||
127924101|NCT02795676|460343793|FG001|Overall Study|Withdrawal by Subject|1|||
127924102|NCT01609582|460343799|FG000|Overall Study|Adverse Event|20|||
127924103|NCT01609582|460343800|FG001|Overall Study|Adverse Event|18|||
127924104|NCT01609582|460343799|FG000|Overall Study|Lost to Follow-up|10|||
127924105|NCT01609582|460343800|FG001|Overall Study|Lost to Follow-up|10|||
127924106|NCT01609582|460343799|FG000|Overall Study|Withdrawal by Subject|21|||
127924107|NCT01609582|460343800|FG001|Overall Study|Withdrawal by Subject|15|||
127924108|NCT01609582|460343799|FG000|Overall Study|Study Terminated by Sponsor|1543|||
127924109|NCT01609582|460343800|FG001|Overall Study|Study Terminated by Sponsor|1548|||
127924110|NCT01609582|460343799|FG000|Overall Study|Other|9|||
127924111|NCT01609582|460343800|FG001|Overall Study|Other|10|||
127924112|NCT01609582|460343799|FG000|Overall Study|Randomized, but not treated|0|||
127924113|NCT01609582|460343800|FG001|Overall Study|Randomized, but not treated|3|||
127924114|NCT00819767|460343801|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
127924115|NCT00819767|460343802|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
127924116|NCT04253236|460343812|FG000|Overall Study|Adverse Event|1|||
127924117|NCT04253236|460343813|FG001|Overall Study|Adverse Event|0|||
127924118|NCT04253236|460343812|FG000|Overall Study|Safety Concerns|1|||
127924119|NCT04253236|460343813|FG001|Overall Study|Safety Concerns|0|||
127924120|NCT04253236|460343812|FG000|Overall Study|Study Terminated by Sponsor|1|||
127924121|NCT04253236|460343813|FG001|Overall Study|Study Terminated by Sponsor|0|||
127924122|NCT00808509|460343814|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
127924123|NCT00808509|460343815|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
127924124|NCT00808509|460343814|FG000|Randomized Phase|Reduced methotrexate dose|1|||
127924125|NCT00808509|460343815|FG001|Randomized Phase|Reduced methotrexate dose|2|||
127924126|NCT00808509|460343814|FG000|Randomized Phase|Patient refused rescue therapy|0|||
127924127|NCT00808509|460343815|FG001|Randomized Phase|Patient refused rescue therapy|3|||
127924128|NCT00587431|460343816|FG000|Overall Study|Adverse Event|1|||
127924129|NCT00587431|460343817|FG001|Overall Study|Adverse Event|0|||
127924130|NCT00587431|460343816|FG000|Overall Study|Withdrawal by Subject|0|||
127924131|NCT00587431|460343817|FG001|Overall Study|Withdrawal by Subject|1|||
127924132|NCT02169791|460343818|FG000|Overall Study|Death|6|||
127924133|NCT02169791|460343818|FG000|Overall Study|patient withdrew consent|1|||
127924134|NCT02762994|460343821|FG000|Overall Study|Withdrawal by Subject|0|||
127924135|NCT02762994|460343822|FG001|Overall Study|Withdrawal by Subject|1|||
127924136|NCT02762994|460343823|FG002|Overall Study|Withdrawal by Subject|2|||
127924137|NCT02762994|460343824|FG003|Overall Study|Withdrawal by Subject|0|||
127924138|NCT02762994|460343821|FG000|Overall Study|Protocol Violation|1|||
127924139|NCT02762994|460343822|FG001|Overall Study|Protocol Violation|0|||
127924140|NCT02762994|460343823|FG002|Overall Study|Protocol Violation|0|||
127924141|NCT02762994|460343824|FG003|Overall Study|Protocol Violation|2|||
127924142|NCT04234464|460343825|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
127924143|NCT04234464|460343826|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
127924144|NCT01701973|460343827|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
127924145|NCT01701973|460343828|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
127924146|NCT01701973|460343829|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
127924147|NCT01701973|460343830|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
127924148|NCT01701973|460343831|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
127924149|NCT01701973|460343832|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
127924150|NCT01701973|460343833|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
127924151|NCT01701973|460343834|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
127924152|NCT00373425|460343838|FG000|Overall Study|Relapse of NSCLC|116|||
127924153|NCT00373425|460343839|FG001|Overall Study|Relapse of NSCLC|104|||
127924154|NCT00373425|460343840|FG002|Overall Study|Relapse of NSCLC|19|||
127924155|NCT00373425|460343841|FG003|Overall Study|Relapse of NSCLC|2|||
127924156|NCT00373425|460343842|FG004|Overall Study|Relapse of NSCLC|26|||
127924157|NCT00373425|460343838|FG000|Overall Study|Adverse Event|191|||
127924158|NCT00373425|460343839|FG001|Overall Study|Adverse Event|22|||
127924159|NCT00373425|460343840|FG002|Overall Study|Adverse Event|59|||
127924160|NCT00373425|460343841|FG003|Overall Study|Adverse Event|0|||
127924161|NCT00373425|460343842|FG004|Overall Study|Adverse Event|34|||
127924162|NCT00373425|460343838|FG000|Overall Study|Patient request|35|||
127924163|NCT00373425|460343839|FG001|Overall Study|Patient request|18|||
127924164|NCT00373425|460343840|FG002|Overall Study|Patient request|43|||
127924165|NCT00373425|460343841|FG003|Overall Study|Patient request|6|||
127924166|NCT00373425|460343842|FG004|Overall Study|Patient request|7|||
127924167|NCT00373425|460343838|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
127924168|NCT00373425|460343839|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
127924169|NCT00373425|460343840|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
127924170|NCT00373425|460343841|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
127924171|NCT00373425|460343842|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
127924172|NCT00373425|460343838|FG000|Overall Study|Death|7|||
127924173|NCT00373425|460343839|FG001|Overall Study|Death|0|||
127924174|NCT00373425|460343840|FG002|Overall Study|Death|3|||
127924175|NCT00373425|460343841|FG003|Overall Study|Death|1|||
127924176|NCT00373425|460343842|FG004|Overall Study|Death|0|||
127924177|NCT00551616|460343845|FG000|Overall Study|Lost to Follow-up|48|||
127924178|NCT00551616|460343846|FG001|Overall Study|Lost to Follow-up|40|||
127924179|NCT00569777|460343850|FG000|Overall Study|Withdrawal by Subject|4|||
127924180|NCT00569777|460343851|FG001|Overall Study|Withdrawal by Subject|0|||
127924181|NCT00569777|460343850|FG000|Overall Study|Adverse Event|3|||
127924182|NCT00569777|460343851|FG001|Overall Study|Adverse Event|0|||
127924183|NCT00569777|460343850|FG000|Overall Study|Lost to Follow-up|1|||
127924184|NCT00569777|460343851|FG001|Overall Study|Lost to Follow-up|0|||
127924185|NCT00569777|460343850|FG000|Overall Study|scheduled eye surgery|0|||
127924186|NCT00569777|460343851|FG001|Overall Study|scheduled eye surgery|1|||
127924187|NCT00569777|460343850|FG000|Overall Study|did not meet exclusion criteria|1|||
127924188|NCT00569777|460343851|FG001|Overall Study|did not meet exclusion criteria|2|||
127924189|NCT00569777|460343850|FG000|Overall Study|pregnant|1|||
127924190|NCT00569777|460343851|FG001|Overall Study|pregnant|0|||
127924191|NCT00537017|460343856|FG000|Treatment Phase|Adverse Event|19|||
127924192|NCT00537017|460343856|FG000|Treatment Phase|Withdrawal by Subject|13|||
127924193|NCT00537017|460343856|FG000|Treatment Phase|Protocol Violation|2|||
127924194|NCT00537017|460343856|FG000|Follow-up Phase|Withdrawal by Subject|9|||
127924195|NCT03168906|460343861|FG000|Overall Study|Lack of Efficacy|6|||
127924196|NCT03168906|460343862|FG001|Overall Study|Lack of Efficacy|6|||
127924197|NCT01321697|460343863|FG000|Overall Study|Study Terminated|7|||
127924198|NCT00857818|460343866|FG000|Overall Study|Lack of Efficacy|1|||
127924199|NCT00857818|460343867|FG001|Overall Study|Lack of Efficacy|0|||
127924200|NCT00857818|460343866|FG000|Overall Study|Adverse Event|3|||
127924201|NCT00857818|460343867|FG001|Overall Study|Adverse Event|0|||
127924202|NCT00857818|460343866|FG000|Overall Study|Withdrawal by Subject|0|||
127924203|NCT00857818|460343867|FG001|Overall Study|Withdrawal by Subject|4|||
127924204|NCT00857818|460343866|FG000|Overall Study|Sponsor terminated study|6|||
127924205|NCT00857818|460343867|FG001|Overall Study|Sponsor terminated study|4|||
127924206|NCT00857818|460343866|FG000|Overall Study|Investigator decision|1|||
127924207|NCT00857818|460343867|FG001|Overall Study|Investigator decision|0|||
127924208|NCT02219308|460343868|FG000|Overall Study|Withdrawal by Subject|1|||
127924209|NCT02219308|460343869|FG001|Overall Study|Withdrawal by Subject|2|||
127924210|NCT02839798|460345407|FG000|Overall Study|Withdrawal by Subject|2|||
127924211|NCT02447887|460345408|FG000|Overall Study|Study was terminated|3|||
127924212|NCT00401245|460345411|FG000|Double Blind Titration Phase|Adverse Event|3|||
127924213|NCT00401245|460345412|FG001|Double Blind Titration Phase|Adverse Event|2|||
127924214|NCT00401245|460345413|FG002|Double Blind Titration Phase|Adverse Event|5|||
127924215|NCT00401245|460345414|FG003|Double Blind Titration Phase|Adverse Event|12|||
127924216|NCT00401245|460345415|FG004|Double Blind Titration Phase|Adverse Event|0|||
127924217|NCT00401245|460345416|FG005|Double Blind Titration Phase|Adverse Event|0|||
127924218|NCT00401245|460345417|FG006|Double Blind Titration Phase|Adverse Event|0|||
127924219|NCT00401245|460345418|FG007|Double Blind Titration Phase|Adverse Event|0|||
127924220|NCT00401245|460345411|FG000|Double Blind Titration Phase|Other|0|||
127924221|NCT00401245|460345412|FG001|Double Blind Titration Phase|Other|0|||
127924222|NCT00401245|460345413|FG002|Double Blind Titration Phase|Other|1|||
127924223|NCT00401245|460345414|FG003|Double Blind Titration Phase|Other|0|||
127924224|NCT00401245|460345415|FG004|Double Blind Titration Phase|Other|0|||
127924225|NCT00401245|460345416|FG005|Double Blind Titration Phase|Other|0|||
127924226|NCT00401245|460345417|FG006|Double Blind Titration Phase|Other|0|||
127924227|NCT00401245|460345418|FG007|Double Blind Titration Phase|Other|0|||
127924228|NCT00401245|460345411|FG000|Double Blind Titration Phase|Protocol Violation|0|||
127924229|NCT00401245|460345412|FG001|Double Blind Titration Phase|Protocol Violation|0|||
127924230|NCT00401245|460345413|FG002|Double Blind Titration Phase|Protocol Violation|0|||
127924231|NCT00401245|460345414|FG003|Double Blind Titration Phase|Protocol Violation|1|||
127924232|NCT00401245|460345415|FG004|Double Blind Titration Phase|Protocol Violation|0|||
127924233|NCT00401245|460345416|FG005|Double Blind Titration Phase|Protocol Violation|0|||
127924234|NCT00401245|460345417|FG006|Double Blind Titration Phase|Protocol Violation|0|||
127924235|NCT00401245|460345418|FG007|Double Blind Titration Phase|Protocol Violation|0|||
127924236|NCT00401245|460345411|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
127924237|NCT00401245|460345412|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
127924238|NCT00401245|460345413|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
127924239|NCT00401245|460345414|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
127924240|NCT00401245|460345415|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
127924241|NCT00401245|460345416|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
127924242|NCT00401245|460345417|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
127924243|NCT00401245|460345418|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
127924244|NCT00401245|460345411|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
127924245|NCT00401245|460345412|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
127924246|NCT00401245|460345413|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
127924247|NCT00401245|460345414|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
127924248|NCT00401245|460345415|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
127924249|NCT00401245|460345416|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
127924250|NCT00401245|460345417|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
127924251|NCT00401245|460345418|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
127924252|NCT00401245|460345411|FG000|Open Label Phase|Adverse Event|5|||
127924253|NCT00401245|460345412|FG001|Open Label Phase|Adverse Event|14|||
127924254|NCT00401245|460345413|FG002|Open Label Phase|Adverse Event|6|||
127924255|NCT00401245|460345414|FG003|Open Label Phase|Adverse Event|7|||
127924256|NCT00401245|460345415|FG004|Open Label Phase|Adverse Event|0|||
127924257|NCT00401245|460345416|FG005|Open Label Phase|Adverse Event|0|||
127924258|NCT00401245|460345417|FG006|Open Label Phase|Adverse Event|0|||
127924259|NCT00401245|460345418|FG007|Open Label Phase|Adverse Event|0|||
127924260|NCT00401245|460345411|FG000|Open Label Phase|Lost to Follow-up|5|||
127924261|NCT00401245|460345412|FG001|Open Label Phase|Lost to Follow-up|7|||
127924262|NCT00401245|460345413|FG002|Open Label Phase|Lost to Follow-up|5|||
127924263|NCT00401245|460345414|FG003|Open Label Phase|Lost to Follow-up|4|||
127924264|NCT00401245|460345415|FG004|Open Label Phase|Lost to Follow-up|0|||
127924265|NCT00401245|460345416|FG005|Open Label Phase|Lost to Follow-up|0|||
127924266|NCT00401245|460345417|FG006|Open Label Phase|Lost to Follow-up|0|||
127924267|NCT00401245|460345418|FG007|Open Label Phase|Lost to Follow-up|0|||
127924268|NCT00401245|460345411|FG000|Open Label Phase|Other|4|||
127924269|NCT00401245|460345412|FG001|Open Label Phase|Other|8|||
127924270|NCT00401245|460345413|FG002|Open Label Phase|Other|7|||
127924271|NCT00401245|460345414|FG003|Open Label Phase|Other|8|||
127924272|NCT00401245|460345415|FG004|Open Label Phase|Other|0|||
127924273|NCT00401245|460345416|FG005|Open Label Phase|Other|0|||
127924274|NCT00401245|460345417|FG006|Open Label Phase|Other|0|||
127924275|NCT00401245|460345418|FG007|Open Label Phase|Other|0|||
127924276|NCT00401245|460345411|FG000|Open Label Phase|Protocol Violation|0|||
127924277|NCT00401245|460345412|FG001|Open Label Phase|Protocol Violation|1|||
127924278|NCT00401245|460345413|FG002|Open Label Phase|Protocol Violation|0|||
127924279|NCT00401245|460345414|FG003|Open Label Phase|Protocol Violation|1|||
127924280|NCT00401245|460345415|FG004|Open Label Phase|Protocol Violation|0|||
127924281|NCT00401245|460345416|FG005|Open Label Phase|Protocol Violation|0|||
127924282|NCT00401245|460345417|FG006|Open Label Phase|Protocol Violation|0|||
127924283|NCT00401245|460345418|FG007|Open Label Phase|Protocol Violation|0|||
127924284|NCT00401245|460345411|FG000|Open Label Phase|Withdrawal by Subject|3|||
127924285|NCT00401245|460345412|FG001|Open Label Phase|Withdrawal by Subject|3|||
127924286|NCT00401245|460345413|FG002|Open Label Phase|Withdrawal by Subject|2|||
127924287|NCT00401245|460345414|FG003|Open Label Phase|Withdrawal by Subject|1|||
127924288|NCT00401245|460345415|FG004|Open Label Phase|Withdrawal by Subject|0|||
127924289|NCT00401245|460345416|FG005|Open Label Phase|Withdrawal by Subject|0|||
127924290|NCT00401245|460345417|FG006|Open Label Phase|Withdrawal by Subject|0|||
127924291|NCT00401245|460345418|FG007|Open Label Phase|Withdrawal by Subject|0|||
127924292|NCT00401245|460345411|FG000|Open Label Phase|Lack of Efficacy|4|||
127924293|NCT00401245|460345412|FG001|Open Label Phase|Lack of Efficacy|2|||
127924294|NCT00401245|460345413|FG002|Open Label Phase|Lack of Efficacy|3|||
127924295|NCT00401245|460345414|FG003|Open Label Phase|Lack of Efficacy|0|||
127924296|NCT00401245|460345415|FG004|Open Label Phase|Lack of Efficacy|0|||
127924297|NCT00401245|460345416|FG005|Open Label Phase|Lack of Efficacy|0|||
127924298|NCT00401245|460345417|FG006|Open Label Phase|Lack of Efficacy|0|||
127924299|NCT00401245|460345418|FG007|Open Label Phase|Lack of Efficacy|0|||
127924300|NCT00401245|460345411|FG000|Double Blind Tapering Phase|Adverse Event|0|||
127924301|NCT00401245|460345412|FG001|Double Blind Tapering Phase|Adverse Event|0|||
127924302|NCT00401245|460345413|FG002|Double Blind Tapering Phase|Adverse Event|0|||
127924303|NCT00401245|460345414|FG003|Double Blind Tapering Phase|Adverse Event|0|||
127924304|NCT00401245|460345415|FG004|Double Blind Tapering Phase|Adverse Event|1|||
127924305|NCT00401245|460345416|FG005|Double Blind Tapering Phase|Adverse Event|1|||
127924306|NCT00401245|460345417|FG006|Double Blind Tapering Phase|Adverse Event|2|||
127924307|NCT00401245|460345418|FG007|Double Blind Tapering Phase|Adverse Event|4|||
127924308|NCT00401245|460345411|FG000|Double Blind Tapering Phase|Investigator request|0|||
127924309|NCT00401245|460345412|FG001|Double Blind Tapering Phase|Investigator request|0|||
127924310|NCT00401245|460345413|FG002|Double Blind Tapering Phase|Investigator request|0|||
127924311|NCT00401245|460345414|FG003|Double Blind Tapering Phase|Investigator request|0|||
127924312|NCT00401245|460345415|FG004|Double Blind Tapering Phase|Investigator request|0|||
127924313|NCT00401245|460345416|FG005|Double Blind Tapering Phase|Investigator request|0|||
127924314|NCT00401245|460345417|FG006|Double Blind Tapering Phase|Investigator request|0|||
127924315|NCT00401245|460345418|FG007|Double Blind Tapering Phase|Investigator request|1|||
127924316|NCT00401245|460345411|FG000|Double Blind Tapering Phase|Other|0|||
127924317|NCT00401245|460345412|FG001|Double Blind Tapering Phase|Other|0|||
127924318|NCT00401245|460345413|FG002|Double Blind Tapering Phase|Other|0|||
127924319|NCT00401245|460345414|FG003|Double Blind Tapering Phase|Other|0|||
127924320|NCT00401245|460345415|FG004|Double Blind Tapering Phase|Other|1|||
127924321|NCT00401245|460345416|FG005|Double Blind Tapering Phase|Other|0|||
127924322|NCT00401245|460345417|FG006|Double Blind Tapering Phase|Other|2|||
127924323|NCT00401245|460345418|FG007|Double Blind Tapering Phase|Other|2|||
127924324|NCT00401245|460345411|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
127924325|NCT00401245|460345412|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
127924326|NCT00401245|460345413|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
127924327|NCT00401245|460345414|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
127924328|NCT00401245|460345415|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
127924329|NCT00401245|460345416|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
127924330|NCT00401245|460345417|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
127924331|NCT00401245|460345418|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
127924332|NCT00401245|460345411|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
127924333|NCT00401245|460345412|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
127924334|NCT00401245|460345413|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
127924335|NCT00401245|460345414|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
127924336|NCT00401245|460345415|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
127924337|NCT00401245|460345416|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
127924338|NCT00401245|460345417|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
127924339|NCT00401245|460345418|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
127924340|NCT01989676|460345419|FG000|Overall Study|Death|52|||
127924341|NCT01989676|460345420|FG001|Overall Study|Death|60|||
127924342|NCT01989676|460345419|FG000|Overall Study|Protocol Violation|2|||
127924343|NCT01989676|460345420|FG001|Overall Study|Protocol Violation|1|||
127924344|NCT01989676|460345419|FG000|Overall Study|Lost to Follow-up|8|||
127924345|NCT01989676|460345420|FG001|Overall Study|Lost to Follow-up|18|||
127924346|NCT01989676|460345419|FG000|Overall Study|No longer willing to participate in study|26|||
127924347|NCT01989676|460345420|FG001|Overall Study|No longer willing to participate in study|26|||
127924348|NCT01989676|460345419|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
127924349|NCT01989676|460345420|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
127924350|NCT01989676|460345419|FG000|Overall Study|Other|4|||
127924351|NCT01989676|460345420|FG001|Overall Study|Other|3|||
127924352|NCT03941834|460345421|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
127924353|NCT03941834|460345422|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|1|||
127924354|NCT03941834|460345423|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
127924355|NCT03941834|460345421|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|1|||
127924356|NCT03941834|460345422|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
127924357|NCT03941834|460345423|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
127924358|NCT03941834|460345421|FG000|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
127924359|NCT03941834|460345422|FG001|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
127924360|NCT03941834|460345423|FG002|OLE Phase (12 Weeks)|Study terminated by sponsor|1|||
127924361|NCT03941834|460345421|FG000|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
127924362|NCT03941834|460345422|FG001|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
127924363|NCT03941834|460345423|FG002|OLE Phase (12 Weeks)|Lack of Efficacy|1|||
127924364|NCT03941834|460345421|FG000|OLE Phase (12 Weeks)|Sponsor decision|0|||
127924365|NCT03941834|460345422|FG001|OLE Phase (12 Weeks)|Sponsor decision|0|||
127924366|NCT03941834|460345423|FG002|OLE Phase (12 Weeks)|Sponsor decision|1|||
127924367|NCT03941834|460345421|FG000|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
127924368|NCT03941834|460345422|FG001|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
127924369|NCT03941834|460345423|FG002|OLE Phase (12 Weeks)|Withdrawal by Subject|1|||
127924370|NCT01560819|460345427|FG000|Overall Study|Physician Decision|1|||
127924371|NCT01560819|460345428|FG001|Overall Study|Physician Decision|0|||
127924372|NCT02344745|460345429|FG000|Overall Study|Data collection sheets were lost|2|||
127924373|NCT02344745|460345430|FG001|Overall Study|Data collection sheets were lost|0|||
127924374|NCT02788513|460345431|FG000|Overall Study|Withdrawal by Subject|3|||
127924375|NCT02788513|460345432|FG001|Overall Study|Withdrawal by Subject|0|||
127924376|NCT02788513|460345433|FG002|Overall Study|Withdrawal by Subject|2|||
127924377|NCT02788513|460345434|FG003|Overall Study|Withdrawal by Subject|3|||
127924378|NCT02788513|460345435|FG004|Overall Study|Withdrawal by Subject|1|||
127924379|NCT02788513|460345431|FG000|Overall Study|Lost to Follow-up|1|||
127924380|NCT02788513|460345432|FG001|Overall Study|Lost to Follow-up|0|||
127924381|NCT02788513|460345433|FG002|Overall Study|Lost to Follow-up|0|||
127924382|NCT02788513|460345434|FG003|Overall Study|Lost to Follow-up|0|||
127924383|NCT02788513|460345435|FG004|Overall Study|Lost to Follow-up|1|||
127924384|NCT02788513|460345431|FG000|Overall Study|Adverse Event|5|||
127924385|NCT02788513|460345432|FG001|Overall Study|Adverse Event|8|||
127924386|NCT02788513|460345433|FG002|Overall Study|Adverse Event|4|||
127924387|NCT02788513|460345434|FG003|Overall Study|Adverse Event|2|||
127924388|NCT02788513|460345435|FG004|Overall Study|Adverse Event|2|||
127924389|NCT02788513|460345431|FG000|Overall Study|Protocol Violation|0|||
127924390|NCT02788513|460345432|FG001|Overall Study|Protocol Violation|0|||
127924391|NCT02788513|460345433|FG002|Overall Study|Protocol Violation|1|||
127924392|NCT02788513|460345434|FG003|Overall Study|Protocol Violation|1|||
127924393|NCT02788513|460345435|FG004|Overall Study|Protocol Violation|0|||
127924394|NCT02788513|460345431|FG000|Overall Study|Subject decided to stop taking treatment|0|||
127924395|NCT02788513|460345432|FG001|Overall Study|Subject decided to stop taking treatment|0|||
127924396|NCT02788513|460345433|FG002|Overall Study|Subject decided to stop taking treatment|1|||
127924397|NCT02788513|460345434|FG003|Overall Study|Subject decided to stop taking treatment|0|||
127924398|NCT02788513|460345435|FG004|Overall Study|Subject decided to stop taking treatment|0|||
127924399|NCT02788513|460345431|FG000|Overall Study|Decision by the study team|0|||
127924400|NCT02788513|460345432|FG001|Overall Study|Decision by the study team|0|||
127924401|NCT02788513|460345433|FG002|Overall Study|Decision by the study team|0|||
127924402|NCT02788513|460345434|FG003|Overall Study|Decision by the study team|0|||
127924403|NCT02788513|460345435|FG004|Overall Study|Decision by the study team|1|||
127924404|NCT00114231|460345437|FG000|Overall Study|No consent|2|||
127924405|NCT00114231|460345438|FG001|Overall Study|No consent|0|||
127924406|NCT00114231|460345437|FG000|Overall Study|QARC requirement not met|1|||
127924407|NCT00114231|460345438|FG001|Overall Study|QARC requirement not met|0|||
127924408|NCT00114231|460345437|FG000|Overall Study|Suspected metastatic disease|1|||
127924409|NCT00114231|460345438|FG001|Overall Study|Suspected metastatic disease|0|||
127924410|NCT00114231|460345437|FG000|Overall Study|No adenocarcinoma|1|||
127924411|NCT00114231|460345438|FG001|Overall Study|No adenocarcinoma|0|||
127924412|NCT00114231|460345437|FG000|Overall Study|Low creatinine clearance|0|||
127924413|NCT00114231|460345438|FG001|Overall Study|Low creatinine clearance|1|||
127924414|NCT00114231|460345437|FG000|Overall Study|Tumor size > 4cm|1|||
127924415|NCT00114231|460345438|FG001|Overall Study|Tumor size > 4cm|0|||
127924416|NCT00114231|460345437|FG000|Overall Study|Tumor fixed on digital exam|0|||
127924417|NCT00114231|460345438|FG001|Overall Study|Tumor fixed on digital exam|1|||
127924418|NCT00114231|460345437|FG000|Overall Study|No Absolute Neutrophil Count|2|||
127924419|NCT00114231|460345438|FG001|Overall Study|No Absolute Neutrophil Count|0|||
127924420|NCT00114231|460345437|FG000|Overall Study|Biopsy done after registration|1|||
127924421|NCT00114231|460345438|FG001|Overall Study|Biopsy done after registration|0|||
127924422|NCT01933919|460345439|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
127924423|NCT01933919|460345440|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
127924424|NCT01933919|460345439|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
127924425|NCT01933919|460345440|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
127924426|NCT01933919|460345439|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
127924427|NCT01933919|460345440|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
127924428|NCT01933919|460345439|FG000|Open-label Long-term Phase|Adverse Event|2|||
127924429|NCT01933919|460345440|FG001|Open-label Long-term Phase|Adverse Event|0|||
127924430|NCT01933919|460345439|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
127924431|NCT01933919|460345440|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
127924432|NCT01933919|460345439|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
127924433|NCT01933919|460345440|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
127924434|NCT01933919|460345439|FG000|Open-label Long-term Phase|Other|1|||
127924435|NCT01933919|460345440|FG001|Open-label Long-term Phase|Other|2|||
127924436|NCT02510261|460345447|FG000|Overall Study|Adverse Event|5|||
127924437|NCT02510261|460345448|FG001|Overall Study|Adverse Event|8|||
127924438|NCT02510261|460345449|FG002|Overall Study|Adverse Event|0|||
127924439|NCT02510261|460345447|FG000|Overall Study|Physician Decision|1|||
127924440|NCT02510261|460345448|FG001|Overall Study|Physician Decision|5|||
127924441|NCT02510261|460345449|FG002|Overall Study|Physician Decision|0|||
127924442|NCT02510261|460345447|FG000|Overall Study|Death|19|||
127924443|NCT02510261|460345448|FG001|Overall Study|Death|19|||
127924444|NCT02510261|460345449|FG002|Overall Study|Death|0|||
127924445|NCT02510261|460345447|FG000|Overall Study|Withdrawal by Subject|3|||
127924446|NCT02510261|460345448|FG001|Overall Study|Withdrawal by Subject|10|||
127924447|NCT02510261|460345449|FG002|Overall Study|Withdrawal by Subject|3|||
127924448|NCT01563237|460345450|FG000|Overall Study|Lost to Follow-up|6|||
127924449|NCT01563237|460345451|FG001|Overall Study|Lost to Follow-up|0|||
127924450|NCT01563237|460345450|FG000|Overall Study|Withdrawal by Subject|1|||
127924451|NCT01563237|460345451|FG001|Overall Study|Withdrawal by Subject|0|||
127924452|NCT01563237|460345450|FG000|Overall Study|Adverse Event|1|||
127924453|NCT01563237|460345451|FG001|Overall Study|Adverse Event|0|||
127924454|NCT01563237|460345450|FG000|Overall Study|Medical Reasons|1|||
127924455|NCT01563237|460345451|FG001|Overall Study|Medical Reasons|0|||
127924456|NCT01563237|460345450|FG000|Overall Study|Death|1|||
127924457|NCT01563237|460345451|FG001|Overall Study|Death|0|||
127924458|NCT01124695|460345452|FG000|Overall Study|Disease progression|77|||
127924459|NCT01124695|460345452|FG000|Overall Study|Adverse Event|11|||
127924460|NCT01124695|460345452|FG000|Overall Study|Death|1|||
127924461|NCT01124695|460345452|FG000|Overall Study|Withdrawal by Subject|7|||
127924462|NCT01124695|460345452|FG000|Overall Study|Physician Decision|3|||
127924463|NCT01124695|460345452|FG000|Overall Study|Alternative therapy|9|||
127924464|NCT01124695|460345452|FG000|Overall Study|No documentation that patient went off treatment|4|||
127924465|NCT01124695|460345452|FG000|Overall Study|Ineligible|9|||
127924466|NCT01124695|460345452|FG000|Overall Study|Ineligible and never start treatment|2|||
127924467|NCT02443324|460345456|FG000|Overall Study|Death|4|||
127924468|NCT02443324|460345457|FG001|Overall Study|Death|1|||
127924469|NCT02443324|460345458|FG002|Overall Study|Death|0|||
127924470|NCT02443324|460345459|FG003|Overall Study|Death|3|||
127924471|NCT02443324|460345460|FG004|Overall Study|Death|1|||
127924472|NCT02443324|460345461|FG005|Overall Study|Death|3|||
127924473|NCT02443324|460345462|FG006|Overall Study|Death|2|||
127924474|NCT02443324|460345456|FG000|Overall Study|Lost to Follow-up|0|||
127924475|NCT02443324|460345457|FG001|Overall Study|Lost to Follow-up|0|||
127924476|NCT02443324|460345458|FG002|Overall Study|Lost to Follow-up|0|||
127924477|NCT02443324|460345459|FG003|Overall Study|Lost to Follow-up|1|||
127924478|NCT02443324|460345460|FG004|Overall Study|Lost to Follow-up|0|||
127924479|NCT02443324|460345461|FG005|Overall Study|Lost to Follow-up|1|||
127924480|NCT02443324|460345462|FG006|Overall Study|Lost to Follow-up|0|||
127924481|NCT02443324|460345456|FG000|Overall Study|Physician Decision|0|||
127924482|NCT02443324|460345457|FG001|Overall Study|Physician Decision|3|||
127924483|NCT02443324|460345458|FG002|Overall Study|Physician Decision|5|||
127924484|NCT02443324|460345459|FG003|Overall Study|Physician Decision|1|||
127924485|NCT02443324|460345460|FG004|Overall Study|Physician Decision|1|||
127924486|NCT02443324|460345461|FG005|Overall Study|Physician Decision|0|||
127924487|NCT02443324|460345462|FG006|Overall Study|Physician Decision|2|||
127924488|NCT02443324|460345456|FG000|Overall Study|Progressive Disease|20|||
127924489|NCT02443324|460345457|FG001|Overall Study|Progressive Disease|20|||
127924490|NCT02443324|460345458|FG002|Overall Study|Progressive Disease|13|||
127924491|NCT02443324|460345459|FG003|Overall Study|Progressive Disease|10|||
127924492|NCT02443324|460345460|FG004|Overall Study|Progressive Disease|13|||
127924493|NCT02443324|460345461|FG005|Overall Study|Progressive Disease|17|||
127924494|NCT02443324|460345462|FG006|Overall Study|Progressive Disease|10|||
127924495|NCT02443324|460345456|FG000|Overall Study|Withdrawal by Subject|0|||
127924496|NCT02443324|460345457|FG001|Overall Study|Withdrawal by Subject|0|||
127924497|NCT02443324|460345458|FG002|Overall Study|Withdrawal by Subject|3|||
127924498|NCT02443324|460345459|FG003|Overall Study|Withdrawal by Subject|1|||
127924499|NCT02443324|460345460|FG004|Overall Study|Withdrawal by Subject|1|||
127924500|NCT02443324|460345461|FG005|Overall Study|Withdrawal by Subject|0|||
127924501|NCT02443324|460345462|FG006|Overall Study|Withdrawal by Subject|1|||
127924502|NCT02443324|460345456|FG000|Overall Study|Adverse Event|0|||
127924503|NCT02443324|460345457|FG001|Overall Study|Adverse Event|1|||
127924504|NCT02443324|460345458|FG002|Overall Study|Adverse Event|3|||
127924505|NCT02443324|460345459|FG003|Overall Study|Adverse Event|0|||
127924506|NCT02443324|460345460|FG004|Overall Study|Adverse Event|4|||
127924507|NCT02443324|460345461|FG005|Overall Study|Adverse Event|3|||
127924508|NCT02443324|460345462|FG006|Overall Study|Adverse Event|3|||
127924509|NCT02443324|460345456|FG000|Overall Study|Enrolled but Never Treated|0|||
127924510|NCT02443324|460345457|FG001|Overall Study|Enrolled but Never Treated|0|||
127924511|NCT02443324|460345458|FG002|Overall Study|Enrolled but Never Treated|1|||
127924512|NCT02443324|460345459|FG003|Overall Study|Enrolled but Never Treated|0|||
127924513|NCT02443324|460345460|FG004|Overall Study|Enrolled but Never Treated|1|||
127924514|NCT02443324|460345461|FG005|Overall Study|Enrolled but Never Treated|0|||
127924515|NCT02443324|460345462|FG006|Overall Study|Enrolled but Never Treated|1|||
127924516|NCT00684567|460345463|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
127924517|NCT00684567|460345463|FG000|Monotherapy Period|Adverse Event|2|||
127924518|NCT00684567|460345463|FG000|Monotherapy Period|Death|1|||
127924519|NCT00684567|460345463|FG000|Monotherapy Period|Progression of primary disease|11|||
127924520|NCT00988208|460345468|FG000|Overall Study|Adverse Event|71|||
127924521|NCT00988208|460345469|FG001|Overall Study|Adverse Event|122|||
127924522|NCT00988208|460345468|FG000|Overall Study|Disease Progression|103|||
127924523|NCT00988208|460345469|FG001|Overall Study|Disease Progression|89|||
127924524|NCT00988208|460345468|FG000|Overall Study|Withdrawal by Subject|50|||
127924525|NCT00988208|460345469|FG001|Overall Study|Withdrawal by Subject|57|||
127924526|NCT00988208|460345468|FG000|Overall Study|Death|9|||
127924527|NCT00988208|460345469|FG001|Overall Study|Death|15|||
127924528|NCT00988208|460345468|FG000|Overall Study|Lost to Follow-up|2|||
127924529|NCT00988208|460345469|FG001|Overall Study|Lost to Follow-up|3|||
127924530|NCT00988208|460345468|FG000|Overall Study|Protocol Violation|9|||
127924531|NCT00988208|460345469|FG001|Overall Study|Protocol Violation|2|||
127924532|NCT00988208|460345468|FG000|Overall Study|Sponsor Decision|102|||
127924533|NCT00988208|460345469|FG001|Overall Study|Sponsor Decision|78|||
127924534|NCT00988208|460345468|FG000|Overall Study|Clinical Progression|17|||
127924535|NCT00988208|460345469|FG001|Overall Study|Clinical Progression|16|||
127924536|NCT00988208|460345468|FG000|Overall Study|Biochemical Progression|21|||
127924537|NCT00988208|460345469|FG001|Overall Study|Biochemical Progression|7|||
127924538|NCT00988208|460345468|FG000|Overall Study|Clinical Deterioration|7|||
127924539|NCT00988208|460345469|FG001|Overall Study|Clinical Deterioration|14|||
127924540|NCT00988208|460345468|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
127924541|NCT00988208|460345469|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
127924542|NCT00988208|460345468|FG000|Overall Study|Other|8|||
127924543|NCT00988208|460345469|FG001|Overall Study|Other|3|||
127924544|NCT03235479|460345476|FG000|Overall Study|Lost to Follow-up|8|||
127924545|NCT03235479|460345477|FG001|Overall Study|Lost to Follow-up|11|||
127924546|NCT03235479|460345476|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
127924547|NCT03235479|460345477|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
127924548|NCT03235479|460345476|FG000|Overall Study|Pregnancy|1|||
127924549|NCT03235479|460345477|FG001|Overall Study|Pregnancy|0|||
127924550|NCT03235479|460345476|FG000|Overall Study|Protocol Deviation|1|||
127924551|NCT03235479|460345477|FG001|Overall Study|Protocol Deviation|3|||
127924552|NCT03235479|460345476|FG000|Overall Study|Technical Problems|3|||
127924553|NCT03235479|460345477|FG001|Overall Study|Technical Problems|2|||
127924554|NCT03235479|460345476|FG000|Overall Study|Withdrawal by Subject|2|||
127924555|NCT03235479|460345477|FG001|Overall Study|Withdrawal by Subject|2|||
127924556|NCT03235479|460345476|FG000|Overall Study|Other Reasons|3|||
127924557|NCT03235479|460345477|FG001|Overall Study|Other Reasons|5|||
127924558|NCT01355302|460345491|FG000|Phase 1b|Death|4|||
127924559|NCT01355302|460345492|FG001|Phase 1b|Death|0|||
127924560|NCT01355302|460345493|FG002|Phase 1b|Death|0|||
127924561|NCT01355302|460345491|FG000|Phase 1b|Study terminated by sponsor|2|||
127924562|NCT01355302|460345492|FG001|Phase 1b|Study terminated by sponsor|0|||
127924563|NCT01355302|460345493|FG002|Phase 1b|Study terminated by sponsor|0|||
127924564|NCT00693225|460345494|FG000|Overall Study|Lost to Follow-up|1|||
127924565|NCT00693225|460345495|FG001|Overall Study|Lost to Follow-up|2|||
127924566|NCT00693225|460345494|FG000|Overall Study|Adverse Event|1|||
127924567|NCT00693225|460345495|FG001|Overall Study|Adverse Event|3|||
127924568|NCT01315028|460345496|FG000|Overall Study|Lost to Follow-up|1|||
127924569|NCT01315028|460345497|FG001|Overall Study|Lost to Follow-up|0|||
127924570|NCT01315028|460345496|FG000|Overall Study|Death|0|||
127924571|NCT01315028|460345497|FG001|Overall Study|Death|1|||
127924572|NCT02531594|460345498|FG000|Overall Study|Withdrawal by Subject|7|||
127924573|NCT02531594|460345499|FG001|Overall Study|Withdrawal by Subject|8|||
127924574|NCT03750695|460345501|FG000|Overall Study|Lost to Follow-up|0|||
127924575|NCT03750695|460345502|FG001|Overall Study|Lost to Follow-up|1|||
127924576|NCT03843125|460345503|FG000|Overall Study|Adverse Event|17|||
127924577|NCT03843125|460345504|FG001|Overall Study|Adverse Event|13|||
127924578|NCT03843125|460345505|FG002|Overall Study|Adverse Event|5|||
127924579|NCT03843125|460345506|FG003|Overall Study|Adverse Event|9|||
127924580|NCT03843125|460345503|FG000|Overall Study|Death|0|||
127924581|NCT03843125|460345504|FG001|Overall Study|Death|6|||
127924582|NCT03843125|460345505|FG002|Overall Study|Death|2|||
127924583|NCT03843125|460345506|FG003|Overall Study|Death|0|||
127924584|NCT03843125|460345503|FG000|Overall Study|Lack of Efficacy|14|||
127924585|NCT03843125|460345504|FG001|Overall Study|Lack of Efficacy|11|||
127924586|NCT03843125|460345505|FG002|Overall Study|Lack of Efficacy|9|||
127924587|NCT03843125|460345506|FG003|Overall Study|Lack of Efficacy|4|||
127924588|NCT03843125|460345503|FG000|Overall Study|Lost to Follow-up|3|||
127924589|NCT03843125|460345504|FG001|Overall Study|Lost to Follow-up|4|||
127924590|NCT03843125|460345505|FG002|Overall Study|Lost to Follow-up|0|||
127924591|NCT03843125|460345506|FG003|Overall Study|Lost to Follow-up|2|||
127924592|NCT03843125|460345503|FG000|Overall Study|Other|12|||
127924593|NCT03843125|460345504|FG001|Overall Study|Other|14|||
127924594|NCT03843125|460345505|FG002|Overall Study|Other|3|||
127924595|NCT03843125|460345506|FG003|Overall Study|Other|4|||
127924596|NCT03843125|460345503|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
127924597|NCT03843125|460345504|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
127924598|NCT03843125|460345505|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
127924599|NCT03843125|460345506|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
127924600|NCT03843125|460345503|FG000|Overall Study|Study Terminated by Sponsor|318|||
127924601|NCT03843125|460345504|FG001|Overall Study|Study Terminated by Sponsor|318|||
127924602|NCT03843125|460345505|FG002|Overall Study|Study Terminated by Sponsor|163|||
127924603|NCT03843125|460345506|FG003|Overall Study|Study Terminated by Sponsor|163|||
127924604|NCT03843125|460345503|FG000|Overall Study|Withdrawal by Subject|23|||
127924605|NCT03843125|460345504|FG001|Overall Study|Withdrawal by Subject|12|||
127924606|NCT03843125|460345505|FG002|Overall Study|Withdrawal by Subject|6|||
127924607|NCT03843125|460345506|FG003|Overall Study|Withdrawal by Subject|9|||
127924608|NCT03843125|460345503|FG000|Overall Study|Missing data|0|||
127924609|NCT03843125|460345504|FG001|Overall Study|Missing data|1|||
127924610|NCT03843125|460345505|FG002|Overall Study|Missing data|1|||
127924611|NCT03843125|460345506|FG003|Overall Study|Missing data|0|||
127924612|NCT04480307|460345509|FG000|Overall Study|Withdrawal by Subject|0|||
127924613|NCT04480307|460345510|FG001|Overall Study|Withdrawal by Subject|1|||
127924614|NCT04480307|460345511|FG002|Overall Study|Withdrawal by Subject|0|||
127924615|NCT04480307|460345512|FG003|Overall Study|Withdrawal by Subject|0|||
127924616|NCT04480307|460345509|FG000|Overall Study|Adverse Event|0|||
127924617|NCT04480307|460345510|FG001|Overall Study|Adverse Event|0|||
127924618|NCT04480307|460345511|FG002|Overall Study|Adverse Event|0|||
127924619|NCT04480307|460345512|FG003|Overall Study|Adverse Event|1|||
127924620|NCT01203917|460345514|FG000|Overall Study|Death|29|||
127924621|NCT01203917|460345514|FG000|Overall Study|Lost to Follow-up|2|||
127924622|NCT01203917|460345514|FG000|Overall Study|Withdrawal by Subject|3|||
127924623|NCT01203917|460345514|FG000|Overall Study|Due to objective disease progression|1|||
127924624|NCT01203917|460345514|FG000|Overall Study|Due to EGFR M+I patient|1|||
127924625|NCT00605176|460345515|FG000|Overall Study|Adverse Event|2|||
127924626|NCT00605176|460345516|FG001|Overall Study|Adverse Event|1|||
127924627|NCT00605176|460345517|FG002|Overall Study|Adverse Event|3|||
127924628|NCT00605176|460345515|FG000|Overall Study|Withdrawal by Subject|4|||
127924629|NCT00605176|460345516|FG001|Overall Study|Withdrawal by Subject|2|||
127924630|NCT00605176|460345517|FG002|Overall Study|Withdrawal by Subject|4|||
127924631|NCT00605176|460345515|FG000|Overall Study|Lost to Follow-up|2|||
127924632|NCT00605176|460345516|FG001|Overall Study|Lost to Follow-up|2|||
127924633|NCT00605176|460345517|FG002|Overall Study|Lost to Follow-up|1|||
127924634|NCT00605176|460345515|FG000|Overall Study|Non-complicance with study procedures|1|||
127924635|NCT00605176|460345516|FG001|Overall Study|Non-complicance with study procedures|0|||
127924636|NCT00605176|460345517|FG002|Overall Study|Non-complicance with study procedures|0|||
127924637|NCT00605176|460345515|FG000|Overall Study|Use of concomitant therapy|1|||
127924638|NCT00605176|460345516|FG001|Overall Study|Use of concomitant therapy|0|||
127924639|NCT00605176|460345517|FG002|Overall Study|Use of concomitant therapy|1|||
127924640|NCT00605176|460345515|FG000|Overall Study|Other (not due to AE)|1|||
127924641|NCT00605176|460345516|FG001|Overall Study|Other (not due to AE)|1|||
127924642|NCT00605176|460345517|FG002|Overall Study|Other (not due to AE)|0|||
127924643|NCT00985231|460345518|FG000|Overall Study|ineligible|1|||
127924644|NCT00985231|460345519|FG001|Overall Study|ineligible|0|||
127924645|NCT00985231|460345518|FG000|Overall Study|Protocol Violation|1|||
127924646|NCT00985231|460345519|FG001|Overall Study|Protocol Violation|0|||
127924647|NCT00985231|460345518|FG000|Overall Study|Withdrawal by Subject|1|||
127924648|NCT00985231|460345519|FG001|Overall Study|Withdrawal by Subject|0|||
127924649|NCT00985231|460345518|FG000|Overall Study|Lost to Follow-up|0|||
127924650|NCT00985231|460345519|FG001|Overall Study|Lost to Follow-up|1|||
127924651|NCT00985231|460345518|FG000|Overall Study|Study related symptoms & complaints|0|||
127924652|NCT00985231|460345519|FG001|Overall Study|Study related symptoms & complaints|2|||
127924653|NCT05103657|460345522|FG000|Overall Study|Other reasons than listed|9|||
127924654|NCT05103657|460345523|FG001|Overall Study|Other reasons than listed|8|||
127924655|NCT05103657|460345522|FG000|Overall Study|Protocol deviation|2|||
127924656|NCT05103657|460345523|FG001|Overall Study|Protocol deviation|2|||
127924657|NCT05103657|460345522|FG000|Overall Study|No reason available|5|||
127924658|NCT05103657|460345523|FG001|Overall Study|No reason available|4|||
127924659|NCT05103657|460345522|FG000|Overall Study|Burden of study procedures|3|||
127924660|NCT05103657|460345523|FG001|Overall Study|Burden of study procedures|1|||
127924661|NCT05103657|460345522|FG000|Overall Study|Perceived lack of efficacy|1|||
127924662|NCT05103657|460345523|FG001|Overall Study|Perceived lack of efficacy|1|||
127924663|NCT05103657|460345522|FG000|Overall Study|Adverse Event|6|||
127924664|NCT05103657|460345523|FG001|Overall Study|Adverse Event|14|||
127924665|NCT05103657|460345522|FG000|Overall Study|Not Treated|1|||
127924666|NCT05103657|460345523|FG001|Overall Study|Not Treated|1|||
127924667|NCT03635983|460345527|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
127924668|NCT03635983|460345528|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
127924669|NCT03635983|460345527|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
127924670|NCT03635983|460345528|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
127924671|NCT03635983|460345527|FG000|Pre-Treatment Period|Other reasons|0|||
127924672|NCT03635983|460345528|FG001|Pre-Treatment Period|Other reasons|1|||
127924673|NCT03635983|460345527|FG000|Pre-Treatment Period|Disease Progression|0|||
127924674|NCT03635983|460345528|FG001|Pre-Treatment Period|Disease Progression|1|||
127924675|NCT03635983|460345527|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|2|||
127924676|NCT03635983|460345528|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
127924677|NCT03635983|460345527|FG000|Treatment Period|Participant request to discontinue Study treatment|6|||
127924678|NCT03635983|460345528|FG001|Treatment Period|Participant request to discontinue Study treatment|7|||
127924679|NCT03635983|460345527|FG000|Treatment Period|Withdrawal by Subject|3|||
127924680|NCT03635983|460345528|FG001|Treatment Period|Withdrawal by Subject|5|||
127924681|NCT03635983|460345527|FG000|Treatment Period|Death|3|||
127924682|NCT03635983|460345528|FG001|Treatment Period|Death|5|||
127924683|NCT03635983|460345527|FG000|Treatment Period|Poor/Non-compliance|2|||
127924684|NCT03635983|460345528|FG001|Treatment Period|Poor/Non-compliance|1|||
127924685|NCT03635983|460345527|FG000|Treatment Period|Participant no longer meets Study criteria|1|||
127924686|NCT03635983|460345528|FG001|Treatment Period|Participant no longer meets Study criteria|4|||
127924687|NCT03635983|460345527|FG000|Treatment Period|Other reasons|7|||
127924688|NCT03635983|460345528|FG001|Treatment Period|Other reasons|4|||
127924689|NCT03635983|460345527|FG000|Treatment Period|Disease progression|230|||
127924690|NCT03635983|460345528|FG001|Treatment Period|Disease progression|201|||
127924691|NCT03635983|460345527|FG000|Treatment Period|Study drug toxicity|35|||
127924692|NCT03635983|460345528|FG001|Treatment Period|Study drug toxicity|36|||
127924693|NCT03635983|460345527|FG000|Treatment Period|Adverse event unrelated to Study drug|15|||
127924694|NCT03635983|460345528|FG001|Treatment Period|Adverse event unrelated to Study drug|15|||
127924695|NCT03635983|460345527|FG000|Treatment Period|Maximum clinical benefit|3|||
127924696|NCT03635983|460345528|FG001|Treatment Period|Maximum clinical benefit|5|||
127924697|NCT03635983|460345527|FG000|Treatment Period|Administrative reason by the sponsor|1|||
127924698|NCT03635983|460345528|FG001|Treatment Period|Administrative reason by the sponsor|2|||
127924699|NCT03635983|460345527|FG000|Treatment Period|Lost to Follow-up|0|||
127924700|NCT03635983|460345528|FG001|Treatment Period|Lost to Follow-up|1|||
127924701|NCT04126343|460345530|FG000|Overall Study|Adverse Event|0|||
127924702|NCT04126343|460345531|FG001|Overall Study|Adverse Event|0|||
127924703|NCT04126343|460345532|FG002|Overall Study|Adverse Event|0|||
127924704|NCT04126343|460345533|FG003|Overall Study|Adverse Event|0|||
127924705|NCT04126343|460345534|FG004|Overall Study|Adverse Event|0|||
127924706|NCT04126343|460345535|FG005|Overall Study|Adverse Event|1|||
127924707|NCT04126343|460345530|FG000|Overall Study|Withdrawal by Subject|0|||
127924708|NCT04126343|460345531|FG001|Overall Study|Withdrawal by Subject|0|||
127924709|NCT04126343|460345532|FG002|Overall Study|Withdrawal by Subject|0|||
127924710|NCT04126343|460345533|FG003|Overall Study|Withdrawal by Subject|1|||
127924711|NCT04126343|460345534|FG004|Overall Study|Withdrawal by Subject|0|||
127924712|NCT04126343|460345535|FG005|Overall Study|Withdrawal by Subject|0|||
127924713|NCT04126343|460345530|FG000|Overall Study|Related to COVID-19 pandemic|3|||
127924714|NCT04126343|460345531|FG001|Overall Study|Related to COVID-19 pandemic|4|||
127924715|NCT04126343|460345532|FG002|Overall Study|Related to COVID-19 pandemic|3|||
127924716|NCT04126343|460345533|FG003|Overall Study|Related to COVID-19 pandemic|3|||
127924717|NCT04126343|460345534|FG004|Overall Study|Related to COVID-19 pandemic|3|||
127924718|NCT04126343|460345535|FG005|Overall Study|Related to COVID-19 pandemic|3|||
127924719|NCT03712124|460345536|FG000|Overall Study|Protocol Violation|1|||
127924720|NCT03712124|460345537|FG001|Overall Study|Protocol Violation|0|||
127924721|NCT02412722|460345539|FG000|Overall Study|Adverse Event|0|||
127924722|NCT02412722|460345540|FG001|Overall Study|Adverse Event|2|||
127924723|NCT02412722|460345541|FG002|Overall Study|Adverse Event|0|||
127924724|NCT02412722|460345542|FG003|Overall Study|Adverse Event|3|||
127924725|NCT02412722|460345543|FG004|Overall Study|Adverse Event|0|||
127924726|NCT02412722|460345544|FG005|Overall Study|Adverse Event|3|||
127924727|NCT02412722|460345539|FG000|Overall Study|Progressive Disease|6|||
127924728|NCT02412722|460345540|FG001|Overall Study|Progressive Disease|4|||
127924729|NCT02412722|460345541|FG002|Overall Study|Progressive Disease|4|||
127924730|NCT02412722|460345542|FG003|Overall Study|Progressive Disease|9|||
127924731|NCT02412722|460345543|FG004|Overall Study|Progressive Disease|3|||
127924732|NCT02412722|460345544|FG005|Overall Study|Progressive Disease|3|||
127924733|NCT02412722|460345539|FG000|Overall Study|Withdrawal by Subject|2|||
127924734|NCT02412722|460345540|FG001|Overall Study|Withdrawal by Subject|0|||
127924735|NCT02412722|460345541|FG002|Overall Study|Withdrawal by Subject|1|||
127924736|NCT02412722|460345542|FG003|Overall Study|Withdrawal by Subject|2|||
127924737|NCT02412722|460345543|FG004|Overall Study|Withdrawal by Subject|1|||
127924738|NCT02412722|460345544|FG005|Overall Study|Withdrawal by Subject|1|||
127924739|NCT02412722|460345539|FG000|Overall Study|Lost to Follow-up|0|||
127924740|NCT02412722|460345540|FG001|Overall Study|Lost to Follow-up|0|||
127924741|NCT02412722|460345541|FG002|Overall Study|Lost to Follow-up|0|||
127924742|NCT02412722|460345542|FG003|Overall Study|Lost to Follow-up|0|||
127924743|NCT02412722|460345543|FG004|Overall Study|Lost to Follow-up|1|||
127924744|NCT02412722|460345544|FG005|Overall Study|Lost to Follow-up|0|||
127924745|NCT02412722|460345539|FG000|Overall Study|Received drug in run-in and discontinued|0|||
127924746|NCT02412722|460345540|FG001|Overall Study|Received drug in run-in and discontinued|2|||
127924747|NCT02412722|460345541|FG002|Overall Study|Received drug in run-in and discontinued|0|||
127924748|NCT02412722|460345542|FG003|Overall Study|Received drug in run-in and discontinued|0|||
127924749|NCT02412722|460345543|FG004|Overall Study|Received drug in run-in and discontinued|0|||
127924750|NCT02412722|460345544|FG005|Overall Study|Received drug in run-in and discontinued|0|||
127924751|NCT02412722|460345539|FG000|Overall Study|Reason not Specified|3|||
127924752|NCT02412722|460345540|FG001|Overall Study|Reason not Specified|0|||
127924753|NCT02412722|460345541|FG002|Overall Study|Reason not Specified|2|||
127924754|NCT02412722|460345542|FG003|Overall Study|Reason not Specified|1|||
127924755|NCT02412722|460345543|FG004|Overall Study|Reason not Specified|2|||
127924756|NCT02412722|460345544|FG005|Overall Study|Reason not Specified|6|||
127924757|NCT02941523|460345545|FG000|Monotherapy|Withdrawal by Subject|0|||
127924758|NCT02941523|460345546|FG001|Monotherapy|Withdrawal by Subject|1|||
127924759|NCT02941523|460345545|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
127924760|NCT02941523|460345546|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
127924761|NCT02941523|460345545|FG000|Carboplatin Combination Therapy|Death|1|||
127924762|NCT02941523|460345546|FG001|Carboplatin Combination Therapy|Death|2|||
127924763|NCT02941523|460345545|FG000|Carboplatin Combination Therapy|Disease progression|2|||
127924764|NCT02941523|460345546|FG001|Carboplatin Combination Therapy|Disease progression|0|||
127924765|NCT02941523|460345545|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
127924766|NCT02941523|460345546|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
127924767|NCT04449341|460345547|FG000|Overall Study|Protocol Violation|1|||
127924768|NCT04449341|460345548|FG001|Overall Study|Protocol Violation|0|||
127924769|NCT04330157|460345549|FG000|Overall Study|Protocol Violation|4|||
127924770|NCT04330157|460345549|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
127924771|NCT04499482|460345550|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
127924772|NCT01899326|460345551|FG000|Overall Study|Withdrawal by Subject|1|||
127924773|NCT01899326|460345551|FG000|Overall Study|Adverse Event|2|||
127924774|NCT01899326|460345551|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
127924775|NCT01263561|460345552|FG000|Overall Study|Death|1|||
127924776|NCT01263561|460345553|FG001|Overall Study|Death|2|||
127924777|NCT03942211|460345554|FG000|Overall Study|Death|1|||
127924778|NCT03942211|460345555|FG001|Overall Study|Death|0|||
127924779|NCT03942211|460345554|FG000|Overall Study|Study terminated by sponsor|5|||
127924780|NCT03942211|460345555|FG001|Overall Study|Study terminated by sponsor|3|||
127924781|NCT03942211|460345554|FG000|Overall Study|Adverse Event|0|||
127924782|NCT03942211|460345555|FG001|Overall Study|Adverse Event|1|||
127924783|NCT01396421|460345556|FG000|Overall Study|Lost to Follow-up|0|||
127924784|NCT01396421|460345557|FG001|Overall Study|Lost to Follow-up|0|||
127924785|NCT01396421|460345558|FG002|Overall Study|Lost to Follow-up|0|||
127924786|NCT01396421|460345559|FG003|Overall Study|Lost to Follow-up|1|||
127924787|NCT01396421|460345556|FG000|Overall Study|Adverse Event|17|||
127924788|NCT01396421|460345557|FG001|Overall Study|Adverse Event|15|||
127924789|NCT01396421|460345558|FG002|Overall Study|Adverse Event|12|||
127924790|NCT01396421|460345559|FG003|Overall Study|Adverse Event|32|||
127924791|NCT01396421|460345556|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
127924792|NCT01396421|460345557|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
127924793|NCT01396421|460345558|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
127924794|NCT01396421|460345559|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
127924795|NCT01396421|460345556|FG000|Overall Study|Physician Decision|1|||
127924796|NCT01396421|460345557|FG001|Overall Study|Physician Decision|1|||
127924797|NCT01396421|460345558|FG002|Overall Study|Physician Decision|0|||
127924798|NCT01396421|460345559|FG003|Overall Study|Physician Decision|3|||
127924799|NCT01396421|460345556|FG000|Overall Study|Withdrawal by Subject|31|||
127924800|NCT01396421|460345557|FG001|Overall Study|Withdrawal by Subject|24|||
127924801|NCT01396421|460345558|FG002|Overall Study|Withdrawal by Subject|13|||
127924802|NCT01396421|460345559|FG003|Overall Study|Withdrawal by Subject|21|||
127924803|NCT01396421|460345556|FG000|Overall Study|Protocol Deviation|2|||
127924804|NCT01396421|460345557|FG001|Overall Study|Protocol Deviation|1|||
127924805|NCT01396421|460345558|FG002|Overall Study|Protocol Deviation|1|||
127924806|NCT01396421|460345559|FG003|Overall Study|Protocol Deviation|0|||
127924807|NCT01396421|460345556|FG000|Overall Study|Lack of Efficacy|7|||
127924808|NCT01396421|460345557|FG001|Overall Study|Lack of Efficacy|17|||
127924809|NCT01396421|460345558|FG002|Overall Study|Lack of Efficacy|7|||
127924810|NCT01396421|460345559|FG003|Overall Study|Lack of Efficacy|18|||
127924811|NCT04718129|460345560|FG000|Overall Study|Lost to Follow-up|6|||
127924812|NCT04718129|460345561|FG001|Overall Study|Lost to Follow-up|7|||
127924813|NCT02030535|460345562|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
127924814|NCT01588548|460345563|FG000|Overall Study|Withdrawal by Subject|0|||
127924815|NCT01588548|460345564|FG001|Overall Study|Withdrawal by Subject|1|||
127924816|NCT01588548|460345565|FG002|Overall Study|Withdrawal by Subject|1|||
127924817|NCT01588548|460345566|FG003|Overall Study|Withdrawal by Subject|1|||
127924818|NCT01588548|460345567|FG004|Overall Study|Withdrawal by Subject|2|||
127924819|NCT01588548|460345568|FG005|Overall Study|Withdrawal by Subject|3|||
127924820|NCT01588548|460345563|FG000|Overall Study|Adverse Event|0|||
127924821|NCT01588548|460345564|FG001|Overall Study|Adverse Event|0|||
127924822|NCT01588548|460345565|FG002|Overall Study|Adverse Event|1|||
127924823|NCT01588548|460345566|FG003|Overall Study|Adverse Event|2|||
127924824|NCT01588548|460345567|FG004|Overall Study|Adverse Event|1|||
127924825|NCT01588548|460345568|FG005|Overall Study|Adverse Event|0|||
127924826|NCT01588548|460345563|FG000|Overall Study|Condition Under Investigation Worsened|3|||
127924827|NCT01588548|460345564|FG001|Overall Study|Condition Under Investigation Worsened|6|||
127924828|NCT01588548|460345565|FG002|Overall Study|Condition Under Investigation Worsened|4|||
127924829|NCT01588548|460345566|FG003|Overall Study|Condition Under Investigation Worsened|4|||
127924830|NCT01588548|460345567|FG004|Overall Study|Condition Under Investigation Worsened|3|||
127924831|NCT01588548|460345568|FG005|Overall Study|Condition Under Investigation Worsened|3|||
127924832|NCT01835548|460345569|FG000|Dose Optimization Period|Adverse Event|0|||
127924833|NCT01835548|460345570|FG001|Dose Optimization Period|Adverse Event|0|||
127924834|NCT01835548|460345571|FG002|Dose Optimization Period|Adverse Event|1|||
127924835|NCT01835548|460345569|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
127924836|NCT01835548|460345570|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
127924837|NCT01835548|460345571|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
127924838|NCT01835548|460345569|FG000|Double-Blind Treatment Period|Adverse Event|0|||
127924839|NCT01835548|460345570|FG001|Double-Blind Treatment Period|Adverse Event|1|||
127924840|NCT01835548|460345571|FG002|Double-Blind Treatment Period|Adverse Event|0|||
127924841|NCT01835548|460345569|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
127924842|NCT01835548|460345570|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
127924843|NCT01835548|460345571|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
127924844|NCT03257254|460345572|FG000|Overall Study|Withdrawal by Subject|7|||
127924845|NCT03257254|460345572|FG000|Overall Study|Lost to Follow-up|9|||
127924846|NCT03257254|460345572|FG000|Overall Study|Study discontinued by sponsor|5|||
127924847|NCT03180528|460346789|FG000|Overall Study|Adverse Event|1|||
127924848|NCT03180528|460346789|FG000|Overall Study|Withdrawal by Subject|1|||
127924849|NCT03180528|460346789|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
127924850|NCT04703855|460346790|FG000|Overall Study|Heart Transplant|1|||
127924851|NCT00991510|460346793|FG000|Period I (Days 1-14)|Adverse Event|1|||
127924852|NCT00991510|460346794|FG001|Period I (Days 1-14)|Adverse Event|0|||
127924853|NCT00991510|460346793|FG000|Period III (Days 29-112)|Adverse Event|1|||
127924854|NCT00991510|460346794|FG001|Period III (Days 29-112)|Adverse Event|1|||
127924855|NCT02356211|460346795|FG000|Overall Study|Withdrawal by Subject|2|||
127924856|NCT02356211|460346796|FG001|Overall Study|Withdrawal by Subject|2|||
127924857|NCT02356211|460346795|FG000|Overall Study|ineligible|1|||
127924858|NCT02356211|460346796|FG001|Overall Study|ineligible|8|||
127924859|NCT01976728|460346797|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
127924860|NCT01976728|460346798|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
127924861|NCT01976728|460346799|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
127924862|NCT01976728|460346800|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
127924863|NCT00966381|460346804|FG000|Overall Study|Withdrawal by Subject|2|||
127924864|NCT00966381|460346805|FG001|Overall Study|Withdrawal by Subject|2|||
127924865|NCT00097786|460346809|FG000|Overall Study|lost to follow-up for all-cause death|296|||
127924866|NCT00097786|460346810|FG001|Overall Study|lost to follow-up for all-cause death|292|||
127924867|NCT00097786|460346811|FG002|Overall Study|lost to follow-up for all-cause death|313|||
127924868|NCT00097786|460346812|FG003|Overall Study|lost to follow-up for all-cause death|310|||
127924869|NCT02668822|460346813|FG000|Overall Study|Protocol Violation|2|||
127924870|NCT02668822|460346814|FG001|Overall Study|Protocol Violation|0|||
127924871|NCT02668822|460346813|FG000|Overall Study|Study Terminated by Sponsor|7|||
127924872|NCT02668822|460346814|FG001|Overall Study|Study Terminated by Sponsor|9|||
127924873|NCT01522950|460346815|FG000|Overall Study|Withdrawal by Subject|3|||
127924874|NCT01522950|460346816|FG001|Overall Study|Withdrawal by Subject|2|||
127924875|NCT01522950|460346817|FG002|Overall Study|Withdrawal by Subject|1|||
127924876|NCT01522950|460346815|FG000|Overall Study|Adverse Event|3|||
127924877|NCT01522950|460346816|FG001|Overall Study|Adverse Event|1|||
127924878|NCT01522950|460346817|FG002|Overall Study|Adverse Event|1|||
127924879|NCT01522950|460346815|FG000|Overall Study|Protocol Violation|0|||
127924880|NCT01522950|460346816|FG001|Overall Study|Protocol Violation|0|||
127924881|NCT01522950|460346817|FG002|Overall Study|Protocol Violation|2|||
127924882|NCT01522950|460346815|FG000|Overall Study|Death|0|||
127924883|NCT01522950|460346816|FG001|Overall Study|Death|1|||
127924884|NCT01522950|460346817|FG002|Overall Study|Death|1|||
127924885|NCT01522950|460346815|FG000|Overall Study|Study Medication Sensitivity|0|||
127924886|NCT01522950|460346816|FG001|Overall Study|Study Medication Sensitivity|1|||
127924887|NCT01522950|460346817|FG002|Overall Study|Study Medication Sensitivity|0|||
127924888|NCT00298740|460346818|FG000|Overall Study|Lack of Efficacy|6|||
127924889|NCT00298740|460346818|FG000|Overall Study|Withdrawal by Subject|3|||
127924890|NCT03136406|460346819|FG000|Overall Study|Treatment Discontinued-Investigator Decision|3|||
127924891|NCT02000531|460346824|FG000|Overall Study|Lost to Follow-up|1|||
127924892|NCT02000531|460346825|FG001|Overall Study|Lost to Follow-up|0|||
127924893|NCT02000531|460346824|FG000|Overall Study|Discontinued due to data cut-off|3|||
127924894|NCT02000531|460346825|FG001|Overall Study|Discontinued due to data cut-off|8|||
127924895|NCT01345318|460346828|FG000|Overall Study|Adverse Event|16|||
127924896|NCT01345318|460346828|FG000|Overall Study|Lack of Efficacy|17|||
127924897|NCT01345318|460346828|FG000|Overall Study|Lost to Follow-up|2|||
127924898|NCT01345318|460346828|FG000|Overall Study|Protocol Violation|1|||
127924899|NCT01345318|460346828|FG000|Overall Study|Withdrawal by Subject|41|||
127924900|NCT01345318|460346828|FG000|Overall Study|Other|3|||
127924901|NCT00317642|460346829|FG000|Overall Study|Not Received Either Study Drug|1|||
127924902|NCT00317642|460346830|FG001|Overall Study|Not Received Either Study Drug|3|||
127924903|NCT00317642|460346829|FG000|Overall Study|Physician Decision|15|||
127924904|NCT00317642|460346830|FG001|Overall Study|Physician Decision|7|||
127924905|NCT00317642|460346829|FG000|Overall Study|Participant declined treatment|14|||
127924906|NCT00317642|460346830|FG001|Overall Study|Participant declined treatment|3|||
127924907|NCT00317642|460346829|FG000|Overall Study|Adverse Event|17|||
127924908|NCT00317642|460346830|FG001|Overall Study|Adverse Event|5|||
127924909|NCT00317642|460346829|FG000|Overall Study|Treatment Failure|56|||
127924910|NCT00317642|460346830|FG001|Overall Study|Treatment Failure|102|||
127924911|NCT00317642|460346829|FG000|Overall Study|Disease Recurrence|1|||
127924912|NCT00317642|460346830|FG001|Overall Study|Disease Recurrence|2|||
127924913|NCT00317642|460346829|FG000|Overall Study|Death|14|||
127924914|NCT00317642|460346830|FG001|Overall Study|Death|7|||
127924915|NCT00317642|460346829|FG000|Overall Study|Not Continue to Consolidation|2|||
127924916|NCT00317642|460346830|FG001|Overall Study|Not Continue to Consolidation|0|||
127924917|NCT00317642|460346829|FG000|Overall Study|Withdrawal by Subject|0|||
127924918|NCT00317642|460346830|FG001|Overall Study|Withdrawal by Subject|1|||
127924919|NCT00317642|460346829|FG000|Overall Study|Referred For Transplantation|1|||
127924920|NCT00317642|460346830|FG001|Overall Study|Referred For Transplantation|0|||
127924921|NCT00317642|460346829|FG000|Overall Study|AML Not Centrally Confirmed|1|||
127924922|NCT00317642|460346830|FG001|Overall Study|AML Not Centrally Confirmed|5|||
127924923|NCT01239472|460346835|FG000|Overall Study|Withdrawal by Subject|5|||
127924924|NCT01239472|460346836|FG001|Overall Study|Withdrawal by Subject|1|||
127924925|NCT01239472|460346835|FG000|Overall Study|Adverse Event|0|||
127924926|NCT01239472|460346836|FG001|Overall Study|Adverse Event|1|||
127924927|NCT01239472|460346835|FG000|Overall Study|Lack of Efficacy|0|||
127924928|NCT01239472|460346836|FG001|Overall Study|Lack of Efficacy|1|||
127924929|NCT01049412|460346840|FG000|Period I|Withdrawal by Subject|4|||
127924930|NCT01049412|460346841|FG001|Period I|Withdrawal by Subject|6|||
127924931|NCT01049412|460346840|FG000|Period I|Lost to Follow-up|2|||
127924932|NCT01049412|460346841|FG001|Period I|Lost to Follow-up|2|||
127924933|NCT01049412|460346840|FG000|Period I|Physician Decision|0|||
127924934|NCT01049412|460346841|FG001|Period I|Physician Decision|3|||
127924935|NCT01049412|460346840|FG000|Period I|Protocol Violation|1|||
127924936|NCT01049412|460346841|FG001|Period I|Protocol Violation|2|||
127924937|NCT01049412|460346840|FG000|Period I|Adverse Event|1|||
127924938|NCT01049412|460346841|FG001|Period I|Adverse Event|0|||
127924939|NCT01049412|460346840|FG000|Period II|Withdrawal by Subject|2|||
127924940|NCT01049412|460346841|FG001|Period II|Withdrawal by Subject|3|||
127924941|NCT01049412|460346840|FG000|Period II|Adverse Event|1|||
127924942|NCT01049412|460346841|FG001|Period II|Adverse Event|0|||
127924943|NCT01049412|460346840|FG000|Period II|Lost to Follow-up|1|||
127924944|NCT01049412|460346841|FG001|Period II|Lost to Follow-up|0|||
127924945|NCT03756883|460346842|FG000|Overall Study|Adverse Event|2|||
127924946|NCT03756883|460346843|FG001|Overall Study|Adverse Event|2|||
127924947|NCT03756883|460346844|FG002|Overall Study|Adverse Event|2|||
127924948|NCT03756883|460346842|FG000|Overall Study|Lack of Efficacy|0|||
127924949|NCT03756883|460346843|FG001|Overall Study|Lack of Efficacy|1|||
127924950|NCT03756883|460346844|FG002|Overall Study|Lack of Efficacy|2|||
127924951|NCT03756883|460346842|FG000|Overall Study|Lost to Follow-up|3|||
127924952|NCT03756883|460346843|FG001|Overall Study|Lost to Follow-up|3|||
127924953|NCT03756883|460346844|FG002|Overall Study|Lost to Follow-up|0|||
127924954|NCT03756883|460346842|FG000|Overall Study|Protocol Violation|2|||
127924955|NCT03756883|460346843|FG001|Overall Study|Protocol Violation|0|||
127924956|NCT03756883|460346844|FG002|Overall Study|Protocol Violation|1|||
127924957|NCT03756883|460346842|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
127924958|NCT03756883|460346843|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
127924959|NCT03756883|460346844|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
127924960|NCT03756883|460346842|FG000|Overall Study|Withdrawal by Subject|4|||
127924961|NCT03756883|460346843|FG001|Overall Study|Withdrawal by Subject|1|||
127924962|NCT03756883|460346844|FG002|Overall Study|Withdrawal by Subject|0|||
127924963|NCT03756883|460346842|FG000|Overall Study|Other Reasons|2|||
127924964|NCT03756883|460346843|FG001|Overall Study|Other Reasons|4|||
127924965|NCT03756883|460346844|FG002|Overall Study|Other Reasons|0|||
127924966|NCT01546519|460346851|FG000|Overall Study|Adverse Event|0|||
127924967|NCT01546519|460346852|FG001|Overall Study|Adverse Event|0|||
127924968|NCT01546519|460346853|FG002|Overall Study|Adverse Event|1|||
127924969|NCT01546519|460346854|FG003|Overall Study|Adverse Event|1|||
127924970|NCT01546519|460346851|FG000|Overall Study|Death|0|||
127924971|NCT01546519|460346852|FG001|Overall Study|Death|1|||
127924972|NCT01546519|460346853|FG002|Overall Study|Death|3|||
127924973|NCT01546519|460346854|FG003|Overall Study|Death|1|||
127924974|NCT01546519|460346851|FG000|Overall Study|related to disease progression|2|||
127924975|NCT01546519|460346852|FG001|Overall Study|related to disease progression|2|||
127924976|NCT01546519|460346853|FG002|Overall Study|related to disease progression|2|||
127924977|NCT01546519|460346854|FG003|Overall Study|related to disease progression|1|||
127924978|NCT01546519|460346851|FG000|Overall Study|Physician Decision|6|||
127924979|NCT01546519|460346852|FG001|Overall Study|Physician Decision|5|||
127924980|NCT01546519|460346853|FG002|Overall Study|Physician Decision|2|||
127924981|NCT01546519|460346854|FG003|Overall Study|Physician Decision|3|||
127924982|NCT01546519|460346851|FG000|Overall Study|Withdrawal by Subject|1|||
127924983|NCT01546519|460346852|FG001|Overall Study|Withdrawal by Subject|0|||
127924984|NCT01546519|460346853|FG002|Overall Study|Withdrawal by Subject|0|||
127924985|NCT01546519|460346854|FG003|Overall Study|Withdrawal by Subject|0|||
127924986|NCT00263887|460346857|FG000|Overall Study|Withdrawal by Subject|1|||
127924987|NCT00263887|460346858|FG001|Overall Study|Withdrawal by Subject|1|||
127924988|NCT00263887|460346857|FG000|Overall Study|Lung transplantation|1|||
127924989|NCT00263887|460346858|FG001|Overall Study|Lung transplantation|2|||
127924990|NCT00263887|460346857|FG000|Overall Study|Too ill to attend visit|1|||
127924991|NCT00263887|460346858|FG001|Overall Study|Too ill to attend visit|0|||
127924992|NCT00263887|460346857|FG000|Overall Study|Adverse Event|0|||
127924993|NCT00263887|460346858|FG001|Overall Study|Adverse Event|2|||
127924994|NCT00263887|460346857|FG000|Overall Study|Disease progression|0|||
127924995|NCT00263887|460346858|FG001|Overall Study|Disease progression|1|||
127924996|NCT00263887|460346857|FG000|Overall Study|Lack of Efficacy|0|||
127924997|NCT00263887|460346858|FG001|Overall Study|Lack of Efficacy|1|||
127924998|NCT00707434|460346863|FG000|Overall Study|Adverse Event|1|||
127924999|NCT01386125|460346864|FG000|Overall Study|Lost to Follow-up|3|||
127925000|NCT01386125|460346865|FG001|Overall Study|Lost to Follow-up|9|||
127925001|NCT01386125|460346864|FG000|Overall Study|Physician Decision|0|||
127925002|NCT01386125|460346865|FG001|Overall Study|Physician Decision|1|||
127925003|NCT01386125|460346864|FG000|Overall Study|Protocol Violation|5|||
127925004|NCT01386125|460346865|FG001|Overall Study|Protocol Violation|7|||
127925005|NCT01386125|460346864|FG000|Overall Study|Disease Progress|1|||
127925006|NCT01386125|460346865|FG001|Overall Study|Disease Progress|2|||
127925007|NCT01386125|460346864|FG000|Overall Study|Withdrawal by Subject|13|||
127925008|NCT01386125|460346865|FG001|Overall Study|Withdrawal by Subject|12|||
127925009|NCT01386125|460346864|FG000|Overall Study|Adverse Event|2|||
127925010|NCT01386125|460346865|FG001|Overall Study|Adverse Event|5|||
127925011|NCT01386125|460346864|FG000|Overall Study|Lack of Efficacy|0|||
127925012|NCT01386125|460346865|FG001|Overall Study|Lack of Efficacy|1|||
127925013|NCT01386125|460346864|FG000|Overall Study|Participant Leaving Country|1|||
127925014|NCT01386125|460346865|FG001|Overall Study|Participant Leaving Country|0|||
127925015|NCT00725764|460346867|FG000|Overall Study|Withdrawal by Subject|2|||
127925016|NCT00725764|460346867|FG000|Overall Study|Physician Decision|1|||
127925017|NCT00725764|460346867|FG000|Overall Study|Progressive Disease|7|||
127925018|NCT00725764|460346867|FG000|Overall Study|Lost to Follow-up|1|||
127925019|NCT00725764|460346867|FG000|Overall Study|Death|1|||
127925020|NCT00725764|460346867|FG000|Overall Study|Participant non compliant with protocol|1|||
127925021|NCT00725764|460346867|FG000|Overall Study|Decline in performance status|1|||
127925022|NCT01264835|460346868|FG000|Overall Study|Lost to Follow-up|1|||
127925023|NCT04660032|460346876|FG000|Overall Study|Protocol Violation|1|||
127925024|NCT04660032|460346877|FG001|Overall Study|Protocol Violation|1|||
127925025|NCT00090753|460346878|FG000|First Treatment Period|Adverse Event|20|||
127925026|NCT00090753|460346879|FG001|First Treatment Period|Adverse Event|8|||
127925027|NCT00090753|460346878|FG000|First Treatment Period|Death|88|||
127925028|NCT00090753|460346879|FG001|First Treatment Period|Death|62|||
127925029|NCT00090753|460346878|FG000|First Treatment Period|Lack of Efficacy|2|||
127925030|NCT00090753|460346879|FG001|First Treatment Period|Lack of Efficacy|1|||
127925031|NCT00090753|460346878|FG000|First Treatment Period|Refused Treatment|32|||
127925032|NCT00090753|460346879|FG001|First Treatment Period|Refused Treatment|25|||
127925033|NCT00090753|460346878|FG000|First Treatment Period|Lost to Follow-up|4|||
127925034|NCT00090753|460346879|FG001|First Treatment Period|Lost to Follow-up|4|||
127925035|NCT00090753|460346878|FG000|First Treatment Period|Renal Transplant|70|||
127925036|NCT00090753|460346879|FG001|First Treatment Period|Renal Transplant|50|||
127925037|NCT00090753|460346878|FG000|First Treatment Period|Mircera Commercialization|1|||
127925038|NCT00090753|460346879|FG001|First Treatment Period|Mircera Commercialization|0|||
127925039|NCT00090753|460346878|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
127925040|NCT00090753|460346879|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
127925041|NCT00090753|460346878|FG000|Extended Treatment Period|Adverse Event|11|||
127925042|NCT00090753|460346879|FG001|Extended Treatment Period|Adverse Event|0|||
127925043|NCT00090753|460346878|FG000|Extended Treatment Period|Death|58|||
127925044|NCT00090753|460346879|FG001|Extended Treatment Period|Death|30|||
127925045|NCT00090753|460346878|FG000|Extended Treatment Period|Lack of Efficacy|1|||
127925046|NCT00090753|460346879|FG001|Extended Treatment Period|Lack of Efficacy|0|||
127925047|NCT00090753|460346878|FG000|Extended Treatment Period|Refused Treatment|18|||
127925048|NCT00090753|460346879|FG001|Extended Treatment Period|Refused Treatment|12|||
127925049|NCT00090753|460346878|FG000|Extended Treatment Period|Lost to Follow-up|3|||
127925050|NCT00090753|460346879|FG001|Extended Treatment Period|Lost to Follow-up|1|||
127925051|NCT00090753|460346878|FG000|Extended Treatment Period|Renal Transplant|15|||
127925052|NCT00090753|460346879|FG001|Extended Treatment Period|Renal Transplant|12|||
127925053|NCT00090753|460346878|FG000|Extended Treatment Period|Mircera Commercialization|188|||
127925054|NCT00090753|460346879|FG001|Extended Treatment Period|Mircera Commercialization|93|||
127925055|NCT00090753|460346878|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
127925056|NCT00090753|460346879|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
127925057|NCT01466036|460346896|FG000|Overall Study|Death|1|||
127925058|NCT01466036|460346897|FG001|Overall Study|Death|1|||
127925059|NCT01466036|460346896|FG000|Overall Study|Physician Decision|0|||
127925060|NCT01466036|460346897|FG001|Overall Study|Physician Decision|4|||
127925061|NCT01466036|460346896|FG000|Overall Study|Adverse Event|2|||
127925062|NCT01466036|460346897|FG001|Overall Study|Adverse Event|6|||
127925063|NCT01466036|460346896|FG000|Overall Study|Withdrawal by Subject|2|||
127925064|NCT01466036|460346897|FG001|Overall Study|Withdrawal by Subject|8|||
127925065|NCT01466036|460346896|FG000|Overall Study|progression/relapse|14|||
127925066|NCT01466036|460346897|FG001|Overall Study|progression/relapse|21|||
127925067|NCT01466036|460346896|FG000|Overall Study|prolonged treatment delay|1|||
127925068|NCT01466036|460346897|FG001|Overall Study|prolonged treatment delay|1|||
127925069|NCT00436917|460346904|FG000|Overall Study|Withdrawal by Subject|13|||
127925070|NCT00436917|460346904|FG000|Overall Study|Adverse Event|2|||
127925071|NCT00436917|460346904|FG000|Overall Study|Physician Decision|1|||
127925072|NCT00436917|460346904|FG000|Overall Study|Death|1|||
127925073|NCT00436917|460346904|FG000|Overall Study|Lost to Follow-up|1|||
127925074|NCT00436917|460346904|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
127925075|NCT00436917|460346904|FG000|Overall Study|Increased creatinine|1|||
127925076|NCT00436917|460346904|FG000|Overall Study|Personal conflicts of patient|1|||
127925077|NCT00761176|460346909|FG000|Overall Study|Death|1|||
127925078|NCT00761176|460346910|FG001|Overall Study|Death|0|||
127925079|NCT00761176|460346909|FG000|Overall Study|Withdrawal by Subject|1|||
127925080|NCT00761176|460346910|FG001|Overall Study|Withdrawal by Subject|1|||
127925081|NCT00109850|460346911|FG000|Overall Study|Adverse Event|1|||
127925082|NCT00109850|460346911|FG000|Overall Study|Death|2|||
127925083|NCT00109850|460346911|FG000|Overall Study|Ineligible|1|||
127925084|NCT00476593|460346912|FG000|Overall Study|Lost to Follow-up|10|||
127925085|NCT00476593|460346913|FG001|Overall Study|Lost to Follow-up|2|||
127925086|NCT00476593|460346914|FG002|Overall Study|Lost to Follow-up|8|||
127925087|NCT00476593|460346915|FG003|Overall Study|Lost to Follow-up|22|||
127925088|NCT03430011|460346916|FG000|Pre-Treatment|Death|1|||
127925089|NCT03430011|460346917|FG001|Pre-Treatment|Death|0|||
127925090|NCT03430011|460346918|FG002|Pre-Treatment|Death|0|||
127925091|NCT03430011|460346919|FG003|Pre-Treatment|Death|0|||
127925092|NCT03430011|460346920|FG004|Pre-Treatment|Death|1|||
127925093|NCT03430011|460346921|FG005|Pre-Treatment|Death|0|||
127925094|NCT03430011|460346922|FG006|Pre-Treatment|Death|1|||
127925095|NCT03430011|460346923|FG007|Pre-Treatment|Death|0|||
127925096|NCT03430011|460346916|FG000|Pre-Treatment|Screen Fail|0|||
127925097|NCT03430011|460346917|FG001|Pre-Treatment|Screen Fail|0|||
127925098|NCT03430011|460346918|FG002|Pre-Treatment|Screen Fail|0|||
127925099|NCT03430011|460346919|FG003|Pre-Treatment|Screen Fail|0|||
127925100|NCT03430011|460346920|FG004|Pre-Treatment|Screen Fail|1|||
127925101|NCT03430011|460346921|FG005|Pre-Treatment|Screen Fail|0|||
127925102|NCT03430011|460346922|FG006|Pre-Treatment|Screen Fail|0|||
127925103|NCT03430011|460346923|FG007|Pre-Treatment|Screen Fail|0|||
127925104|NCT03430011|460346916|FG000|Pre-Treatment|No JCARH125 - disease related complications|0|||
127925105|NCT03430011|460346917|FG001|Pre-Treatment|No JCARH125 - disease related complications|0|||
127925106|NCT03430011|460346918|FG002|Pre-Treatment|No JCARH125 - disease related complications|1|||
127925107|NCT03430011|460346919|FG003|Pre-Treatment|No JCARH125 - disease related complications|0|||
127925108|NCT03430011|460346920|FG004|Pre-Treatment|No JCARH125 - disease related complications|0|||
127925109|NCT03430011|460346921|FG005|Pre-Treatment|No JCARH125 - disease related complications|0|||
127925110|NCT03430011|460346922|FG006|Pre-Treatment|No JCARH125 - disease related complications|0|||
127925111|NCT03430011|460346923|FG007|Pre-Treatment|No JCARH125 - disease related complications|0|||
127925112|NCT03430011|460346916|FG000|Pre-Treatment|Participant not eligible - other reasons|0|||
127925113|NCT03430011|460346917|FG001|Pre-Treatment|Participant not eligible - other reasons|0|||
127925114|NCT03430011|460346918|FG002|Pre-Treatment|Participant not eligible - other reasons|0|||
127925115|NCT03430011|460346919|FG003|Pre-Treatment|Participant not eligible - other reasons|1|||
127925116|NCT03430011|460346920|FG004|Pre-Treatment|Participant not eligible - other reasons|0|||
127925117|NCT03430011|460346921|FG005|Pre-Treatment|Participant not eligible - other reasons|0|||
127925118|NCT03430011|460346922|FG006|Pre-Treatment|Participant not eligible - other reasons|0|||
127925119|NCT03430011|460346923|FG007|Pre-Treatment|Participant not eligible - other reasons|0|||
127925120|NCT03430011|460346916|FG000|JCARH125 Treatment|Withdrawal by Subject|1|||
127925121|NCT03430011|460346917|FG001|JCARH125 Treatment|Withdrawal by Subject|1|||
127925122|NCT03430011|460346918|FG002|JCARH125 Treatment|Withdrawal by Subject|5|||
127925123|NCT03430011|460346919|FG003|JCARH125 Treatment|Withdrawal by Subject|5|||
127925124|NCT03430011|460346920|FG004|JCARH125 Treatment|Withdrawal by Subject|3|||
127925125|NCT03430011|460346921|FG005|JCARH125 Treatment|Withdrawal by Subject|4|||
127925126|NCT03430011|460346922|FG006|JCARH125 Treatment|Withdrawal by Subject|5|||
127925127|NCT03430011|460346923|FG007|JCARH125 Treatment|Withdrawal by Subject|3|||
127925128|NCT03430011|460346916|FG000|JCARH125 Treatment|Lost to Follow-up|0|||
127925129|NCT03430011|460346917|FG001|JCARH125 Treatment|Lost to Follow-up|1|||
127925130|NCT03430011|460346918|FG002|JCARH125 Treatment|Lost to Follow-up|0|||
127925131|NCT03430011|460346919|FG003|JCARH125 Treatment|Lost to Follow-up|0|||
127925132|NCT03430011|460346920|FG004|JCARH125 Treatment|Lost to Follow-up|1|||
127925133|NCT03430011|460346921|FG005|JCARH125 Treatment|Lost to Follow-up|0|||
127925134|NCT03430011|460346922|FG006|JCARH125 Treatment|Lost to Follow-up|1|||
127925135|NCT03430011|460346923|FG007|JCARH125 Treatment|Lost to Follow-up|0|||
127925136|NCT03430011|460346916|FG000|JCARH125 Treatment|Death|4|||
127925137|NCT03430011|460346917|FG001|JCARH125 Treatment|Death|19|||
127925138|NCT03430011|460346918|FG002|JCARH125 Treatment|Death|10|||
127925139|NCT03430011|460346919|FG003|JCARH125 Treatment|Death|8|||
127925140|NCT03430011|460346920|FG004|JCARH125 Treatment|Death|5|||
127925141|NCT03430011|460346921|FG005|JCARH125 Treatment|Death|3|||
127925142|NCT03430011|460346922|FG006|JCARH125 Treatment|Death|4|||
127925143|NCT03430011|460346923|FG007|JCARH125 Treatment|Death|2|||
127925144|NCT03430011|460346916|FG000|JCARH125 Treatment|Other reasons|1|||
127925145|NCT03430011|460346917|FG001|JCARH125 Treatment|Other reasons|0|||
127925146|NCT03430011|460346918|FG002|JCARH125 Treatment|Other reasons|4|||
127925147|NCT03430011|460346919|FG003|JCARH125 Treatment|Other reasons|2|||
127925148|NCT03430011|460346920|FG004|JCARH125 Treatment|Other reasons|2|||
127925149|NCT03430011|460346921|FG005|JCARH125 Treatment|Other reasons|1|||
127925150|NCT03430011|460346922|FG006|JCARH125 Treatment|Other reasons|3|||
127925151|NCT03430011|460346923|FG007|JCARH125 Treatment|Other reasons|2|||
127925152|NCT01235442|460346924|FG000|Overall Study|Lost to Follow-up|12|||
127925153|NCT01235442|460346925|FG001|Overall Study|Lost to Follow-up|10|||
127925154|NCT01235442|460346924|FG000|Overall Study|Death|0|||
127925155|NCT01235442|460346925|FG001|Overall Study|Death|2|||
127925156|NCT01235442|460346924|FG000|Overall Study|Pregnancy|1|||
127925157|NCT01235442|460346925|FG001|Overall Study|Pregnancy|1|||
127925158|NCT01235442|460346924|FG000|Overall Study|Ineligibility determined|5|||
127925159|NCT01235442|460346925|FG001|Overall Study|Ineligibility determined|4|||
127925160|NCT01235442|460346924|FG000|Overall Study|Protocol Violation|3|||
127925161|NCT01235442|460346925|FG001|Overall Study|Protocol Violation|3|||
127925162|NCT01235442|460346924|FG000|Overall Study|Adverse Event|4|||
127925163|NCT01235442|460346925|FG001|Overall Study|Adverse Event|6|||
127925164|NCT01235442|460346924|FG000|Overall Study|Withdrawal by Subject|15|||
127925165|NCT01235442|460346925|FG001|Overall Study|Withdrawal by Subject|9|||
127925166|NCT01235442|460346924|FG000|Overall Study|Lack of Efficacy|1|||
127925167|NCT01235442|460346925|FG001|Overall Study|Lack of Efficacy|3|||
127925168|NCT01235442|460346924|FG000|Overall Study|Noncompliance|1|||
127925169|NCT01235442|460346925|FG001|Overall Study|Noncompliance|2|||
127925170|NCT01235442|460346924|FG000|Overall Study|Administrative decision|1|||
127925171|NCT01235442|460346925|FG001|Overall Study|Administrative decision|2|||
127925172|NCT01235442|460346924|FG000|Overall Study|Other unspecified|1|||
127925173|NCT01235442|460346925|FG001|Overall Study|Other unspecified|2|||
127925174|NCT00084799|460346926|FG000|Overall Study|Disease Progression|1|||
127925175|NCT00084799|460346927|FG001|Overall Study|Disease Progression|0|||
127925176|NCT04314843|460346930|FG000|Overall Study|Death|2|||
127925177|NCT04314843|460346931|FG001|Overall Study|Death|2|||
127925178|NCT04314843|460346930|FG000|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
127925179|NCT04314843|460346931|FG001|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
127925180|NCT01083680|460346932|FG000|Overall Study|Lost to Follow-up|2758|||
127925181|NCT01083680|460346932|FG000|Overall Study|Withdrawal by Subject|1086|||
127925182|NCT03840382|460346933|FG000|Overall Study|Lost to Follow-up|11|||
127925183|NCT00802178|460348402|FG000|Overall Study|Lack of Efficacy|36|||
127925184|NCT00802178|460348402|FG000|Overall Study|Insufficient tolerability (IT)|17|||
127925185|NCT00802178|460348402|FG000|Overall Study|Withdrawal by Subject|18|||
127925186|NCT00802178|460348402|FG000|Overall Study|Other|32|||
127925187|NCT00802178|460348402|FG000|Overall Study|Lack of efficacy and patient wish|1|||
127925188|NCT00802178|460348402|FG000|Overall Study|IT and patient wish|8|||
127925189|NCT00802178|460348402|FG000|Overall Study|Patients wish and other reason|1|||
127925190|NCT02916693|460348404|FG000|Overall Study|Lost to Follow-up|7|||
127925191|NCT05966090|460348406|FG000|Overall Study|Lost to Follow-up|6|||
127925192|NCT05966090|460348407|FG001|Overall Study|Lost to Follow-up|6|||
127925193|NCT05966090|460348406|FG000|Overall Study|Adverse Event|1|||
127925194|NCT05966090|460348407|FG001|Overall Study|Adverse Event|1|||
127925195|NCT05966090|460348406|FG000|Overall Study|Withdrawal by Subject|1|||
127925196|NCT05966090|460348407|FG001|Overall Study|Withdrawal by Subject|1|||
127925197|NCT05966090|460348406|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
127925198|NCT05966090|460348407|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
127925199|NCT05966090|460348406|FG000|Overall Study|Other|1|||
127925200|NCT05966090|460348407|FG001|Overall Study|Other|1|||
127925201|NCT00337428|460348408|FG000|Overall Study|Withdrawal by Subject|1|||
127925202|NCT00337428|460348409|FG001|Overall Study|Withdrawal by Subject|2|||
127925203|NCT00337428|460348408|FG000|Overall Study|Lack of Time|1|||
127925204|NCT00337428|460348409|FG001|Overall Study|Lack of Time|1|||
127925205|NCT00337428|460348408|FG000|Overall Study|Unwilling to Continue|1|||
127925206|NCT00337428|460348409|FG001|Overall Study|Unwilling to Continue|0|||
127925207|NCT00337428|460348408|FG000|Overall Study|Anorexia|1|||
127925208|NCT00337428|460348409|FG001|Overall Study|Anorexia|0|||
127925209|NCT02001051|460348410|FG000|Overall Study|Deemed not eligible following enrollment|0|||
127925210|NCT02001051|460348411|FG001|Overall Study|Deemed not eligible following enrollment|1|||
127925211|NCT00779402|460348412|FG000|Treatment Phase 1|Disease Progression|1|||
127925212|NCT00779402|460348413|FG001|Treatment Phase 1|Disease Progression|0|||
127925213|NCT00779402|460348412|FG000|Treatment Phase 1|Adverse Event|2|||
127925214|NCT00779402|460348413|FG001|Treatment Phase 1|Adverse Event|0|||
127925215|NCT00779402|460348412|FG000|Treatment Phase 1|Protocol Violation|1|||
127925216|NCT00779402|460348413|FG001|Treatment Phase 1|Protocol Violation|0|||
127925217|NCT00779402|460348412|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
127925218|NCT00779402|460348413|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
127925219|NCT00779402|460348412|FG000|Treatment Phase 1|Lost to Follow-up|0|||
127925220|NCT00779402|460348413|FG001|Treatment Phase 1|Lost to Follow-up|1|||
127925221|NCT00779402|460348412|FG000|Treatment Phase 1|Death|0|||
127925222|NCT00779402|460348413|FG001|Treatment Phase 1|Death|1|||
127925223|NCT00779402|460348412|FG000|Treatment Phase 1|Intercurrent Illness|1|||
127925224|NCT00779402|460348413|FG001|Treatment Phase 1|Intercurrent Illness|1|||
127925225|NCT00779402|460348412|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
127925226|NCT00779402|460348413|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
127925227|NCT00779402|460348412|FG000|Treatment Phase 1|Other|4|||
127925228|NCT00779402|460348413|FG001|Treatment Phase 1|Other|2|||
127925229|NCT00779402|460348412|FG000|Treatment Phase 1|Closure of Study|3|||
127925230|NCT00779402|460348413|FG001|Treatment Phase 1|Closure of Study|2|||
127925231|NCT00779402|460348412|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
127925232|NCT00779402|460348413|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
127925233|NCT00779402|460348412|FG000|Surveillance Phase|Protocol Violation|0|||
127925234|NCT00779402|460348413|FG001|Surveillance Phase|Protocol Violation|1|||
127925235|NCT00779402|460348412|FG000|Surveillance Phase|Patient refused to continue|22|||
127925236|NCT00779402|460348413|FG001|Surveillance Phase|Patient refused to continue|14|||
127925237|NCT00779402|460348412|FG000|Surveillance Phase|Lost to Follow-up|2|||
127925238|NCT00779402|460348413|FG001|Surveillance Phase|Lost to Follow-up|1|||
127925239|NCT00779402|460348412|FG000|Surveillance Phase|Death|0|||
127925240|NCT00779402|460348413|FG001|Surveillance Phase|Death|1|||
127925241|NCT00779402|460348412|FG000|Surveillance Phase|Intercurrent Illness|2|||
127925242|NCT00779402|460348413|FG001|Surveillance Phase|Intercurrent Illness|0|||
127925243|NCT00779402|460348412|FG000|Surveillance Phase|Other|5|||
127925244|NCT00779402|460348413|FG001|Surveillance Phase|Other|5|||
127925245|NCT00779402|460348412|FG000|Surveillance Phase|Withdrawal by Subject|4|||
127925246|NCT00779402|460348413|FG001|Surveillance Phase|Withdrawal by Subject|1|||
127925247|NCT00779402|460348412|FG000|Surveillance Phase|Closure of study|5|||
127925248|NCT00779402|460348413|FG001|Surveillance Phase|Closure of study|6|||
127925249|NCT00779402|460348412|FG000|Surveillance Phase|Completed Protocol Visits|3|||
127925250|NCT00779402|460348413|FG001|Surveillance Phase|Completed Protocol Visits|2|||
127925251|NCT00779402|460348412|FG000|Long-term Follow-up|Patient refused to continue|2|||
127925252|NCT00779402|460348413|FG001|Long-term Follow-up|Patient refused to continue|0|||
127925253|NCT00779402|460348412|FG000|Long-term Follow-up|Other|5|||
127925254|NCT00779402|460348413|FG001|Long-term Follow-up|Other|0|||
127925255|NCT00779402|460348412|FG000|Long-term Follow-up|Closure of Study|8|||
127925256|NCT00779402|460348413|FG001|Long-term Follow-up|Closure of Study|4|||
127925257|NCT00779402|460348412|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
127925258|NCT00779402|460348413|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
127925259|NCT01519947|460348418|FG000|Overall Study|Death|0|||
127925260|NCT01519947|460348419|FG001|Overall Study|Death|0|||
127925261|NCT01519947|460348420|FG002|Overall Study|Death|0|||
127925262|NCT01519947|460348421|FG003|Overall Study|Death|1|||
127925263|NCT01519947|460348418|FG000|Overall Study|Protocol Violation|0|||
127925264|NCT01519947|460348419|FG001|Overall Study|Protocol Violation|0|||
127925265|NCT01519947|460348420|FG002|Overall Study|Protocol Violation|2|||
127925266|NCT01519947|460348421|FG003|Overall Study|Protocol Violation|1|||
127925267|NCT01519947|460348418|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
127925268|NCT01519947|460348419|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
127925269|NCT01519947|460348420|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
127925270|NCT01519947|460348421|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
127925271|NCT01519947|460348418|FG000|Overall Study|Development of Anemia|0|||
127925272|NCT01519947|460348419|FG001|Overall Study|Development of Anemia|1|||
127925273|NCT01519947|460348420|FG002|Overall Study|Development of Anemia|0|||
127925274|NCT01519947|460348421|FG003|Overall Study|Development of Anemia|1|||
127925275|NCT01519947|460348418|FG000|Overall Study|Blood Transfusion|0|||
127925276|NCT01519947|460348419|FG001|Overall Study|Blood Transfusion|1|||
127925277|NCT01519947|460348420|FG002|Overall Study|Blood Transfusion|1|||
127925278|NCT01519947|460348421|FG003|Overall Study|Blood Transfusion|0|||
127925279|NCT01519947|460348418|FG000|Overall Study|Withdrawal by Subject|0|||
127925280|NCT01519947|460348419|FG001|Overall Study|Withdrawal by Subject|1|||
127925281|NCT01519947|460348420|FG002|Overall Study|Withdrawal by Subject|0|||
127925282|NCT01519947|460348421|FG003|Overall Study|Withdrawal by Subject|1|||
127925283|NCT01519947|460348418|FG000|Overall Study|Lost to Follow-up|0|||
127925284|NCT01519947|460348419|FG001|Overall Study|Lost to Follow-up|0|||
127925285|NCT01519947|460348420|FG002|Overall Study|Lost to Follow-up|3|||
127925286|NCT01519947|460348421|FG003|Overall Study|Lost to Follow-up|2|||
127925287|NCT01519947|460348418|FG000|Overall Study|Poor Response|1|||
127925288|NCT01519947|460348419|FG001|Overall Study|Poor Response|0|||
127925289|NCT01519947|460348420|FG002|Overall Study|Poor Response|0|||
127925290|NCT01519947|460348421|FG003|Overall Study|Poor Response|1|||
127925291|NCT01519947|460348418|FG000|Overall Study|Adverse Event|1|||
127925292|NCT01519947|460348419|FG001|Overall Study|Adverse Event|0|||
127925293|NCT01519947|460348420|FG002|Overall Study|Adverse Event|1|||
127925294|NCT01519947|460348421|FG003|Overall Study|Adverse Event|1|||
127925295|NCT02274948|460348424|FG000|Overall Study|Lost to Follow-up|28|||
127925296|NCT02274948|460348425|FG001|Overall Study|Lost to Follow-up|25|||
127925297|NCT02274948|460348424|FG000|Overall Study|Withdrawal by Subject|64|||
127925298|NCT02274948|460348425|FG001|Overall Study|Withdrawal by Subject|58|||
127925299|NCT02274948|460348424|FG000|Overall Study|Stopped on family Practitioner advice|2|||
127925300|NCT02274948|460348425|FG001|Overall Study|Stopped on family Practitioner advice|5|||
127925301|NCT02274948|460348424|FG000|Overall Study|Left the area|4|||
127925302|NCT02274948|460348425|FG001|Overall Study|Left the area|3|||
127925303|NCT00530348|460348426|FG000|Overall Study|Adverse Event|5|||
127925304|NCT00530348|460348427|FG001|Overall Study|Adverse Event|1|||
127925305|NCT00530348|460348426|FG000|Overall Study|Death|0|||
127925306|NCT00530348|460348427|FG001|Overall Study|Death|1|||
127925307|NCT00530348|460348426|FG000|Overall Study|Lack of Efficacy|2|||
127925308|NCT00530348|460348427|FG001|Overall Study|Lack of Efficacy|0|||
127925309|NCT00530348|460348426|FG000|Overall Study|Lost to Follow-up|0|||
127925310|NCT00530348|460348427|FG001|Overall Study|Lost to Follow-up|2|||
127925311|NCT00530348|460348426|FG000|Overall Study|Physician Decision|1|||
127925312|NCT00530348|460348427|FG001|Overall Study|Physician Decision|2|||
127925313|NCT00530348|460348426|FG000|Overall Study|Pregnancy|1|||
127925314|NCT00530348|460348427|FG001|Overall Study|Pregnancy|0|||
127925315|NCT00530348|460348426|FG000|Overall Study|Withdrawal by Subject|12|||
127925316|NCT00530348|460348427|FG001|Overall Study|Withdrawal by Subject|12|||
127925317|NCT00530348|460348426|FG000|Overall Study|Randomised in error|1|||
127925318|NCT00530348|460348427|FG001|Overall Study|Randomised in error|0|||
127925319|NCT00530348|460348426|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
127925320|NCT00530348|460348427|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
127925321|NCT02359864|460348428|FG000|Overall Study|Withdrawal by Subject|1|||
127925322|NCT02359864|460348429|FG001|Overall Study|Withdrawal by Subject|0|||
127925323|NCT01928615|460348430|FG000|Overall Study|Study Terminated by Sponsor|2|||
127925324|NCT00732160|460348434|FG000|Overall Study|Adverse Event|1|||
127925325|NCT00732160|460348435|FG001|Overall Study|Adverse Event|0|||
127925326|NCT00732160|460348436|FG002|Overall Study|Adverse Event|1|||
127925327|NCT00732160|460348437|FG003|Overall Study|Adverse Event|1|||
127925328|NCT00732160|460348434|FG000|Overall Study|scheduling|4|||
127925329|NCT00732160|460348435|FG001|Overall Study|scheduling|4|||
127925330|NCT00732160|460348436|FG002|Overall Study|scheduling|2|||
127925331|NCT00732160|460348437|FG003|Overall Study|scheduling|1|||
127925332|NCT00676494|460348438|FG000|Overall Study|Missed Visit|8|||
127925333|NCT00676494|460348438|FG000|Overall Study|Withdrawal by Subject|6|||
127925334|NCT01256060|460348442|FG000|Overall Study|Lost to Follow-up|0|||
127925335|NCT01256060|460348443|FG001|Overall Study|Lost to Follow-up|1|||
127925336|NCT01256060|460348444|FG002|Overall Study|Lost to Follow-up|0|||
127925337|NCT01256060|460348445|FG003|Overall Study|Lost to Follow-up|0|||
127925338|NCT01808248|460348446|FG000|Overall Study|Lack of Efficacy|3|||
127925339|NCT01808248|460348446|FG000|Overall Study|Withdrawal by Subject|1|||
127925340|NCT01808248|460348446|FG000|Overall Study|Lost to Follow-up|1|||
127925341|NCT00220727|460348448|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
127925342|NCT00220727|460348449|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
127925343|NCT02020967|460348450|FG000|Overall Study|Withdrawal by Subject|51|||
127925344|NCT03507686|460348451|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
127925345|NCT03507686|460348452|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
127925346|NCT03507686|460348451|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
127925347|NCT03507686|460348452|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
127925348|NCT03507686|460348451|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
127925349|NCT03507686|460348452|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
127925350|NCT03507686|460348451|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
127925351|NCT03507686|460348452|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
127925352|NCT03507686|460348451|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
127925353|NCT03507686|460348452|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
127925354|NCT03507686|460348451|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
127925355|NCT03507686|460348452|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
127925356|NCT02508116|460348453|FG000|Overall Study|Lost to Follow-up|2|||
127925357|NCT02508116|460348454|FG001|Overall Study|Lost to Follow-up|3|||
127925358|NCT02508116|460348453|FG000|Overall Study|Withdrawal by Subject|3|||
127925359|NCT02508116|460348454|FG001|Overall Study|Withdrawal by Subject|2|||
127925360|NCT02508116|460348453|FG000|Overall Study|Protocol Violation|1|||
127925361|NCT02508116|460348454|FG001|Overall Study|Protocol Violation|2|||
127925362|NCT02508116|460348453|FG000|Overall Study|Physician Decision|2|||
127925363|NCT02508116|460348454|FG001|Overall Study|Physician Decision|0|||
127925364|NCT00983528|460348457|FG000|Overall Study|Death|4|||
127925365|NCT00983528|460348457|FG000|Overall Study|Lost to Follow-up|1|||
127925366|NCT00983528|460348457|FG000|Overall Study|Study Terminated|1|||
127925367|NCT00575380|460348458|FG000|Overall Study|Withdrawal by Subject|1|||
127925368|NCT00575380|460348459|FG001|Overall Study|Withdrawal by Subject|0|||
127925369|NCT00575380|460348458|FG000|Overall Study|Adverse Event|0|||
127925370|NCT00575380|460348459|FG001|Overall Study|Adverse Event|1|||
127925371|NCT00575380|460348458|FG000|Overall Study|Various|0|||
127925372|NCT00575380|460348459|FG001|Overall Study|Various|2|||
127925373|NCT00559364|460348460|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
127925374|NCT00559364|460348461|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
127925375|NCT00330460|460348468|FG000|Overall Study|Physician Decision|1|||
127925376|NCT00330460|460348469|FG001|Overall Study|Physician Decision|0|||
127925377|NCT00330460|460348468|FG000|Overall Study|Adverse Event|10|||
127925378|NCT00330460|460348469|FG001|Overall Study|Adverse Event|8|||
127925379|NCT00330460|460348468|FG000|Overall Study|Withdrawal by Subject|18|||
127925380|NCT00330460|460348469|FG001|Overall Study|Withdrawal by Subject|17|||
127925381|NCT00330460|460348468|FG000|Overall Study|Death|1|||
127925382|NCT00330460|460348469|FG001|Overall Study|Death|1|||
127925383|NCT00330460|460348468|FG000|Overall Study|Ineligibility determined|1|||
127925384|NCT00330460|460348469|FG001|Overall Study|Ineligibility determined|3|||
127925385|NCT00330460|460348468|FG000|Overall Study|Lost to Follow-up|8|||
127925386|NCT00330460|460348469|FG001|Overall Study|Lost to Follow-up|3|||
127925387|NCT00330460|460348468|FG000|Overall Study|Noncompliance|2|||
127925388|NCT00330460|460348469|FG001|Overall Study|Noncompliance|1|||
127925389|NCT00330460|460348468|FG000|Overall Study|Other|1|||
127925390|NCT00330460|460348469|FG001|Overall Study|Other|0|||
127925391|NCT02663882|460348470|FG000|Overall Study|Lost to Follow-up|4|||
127925392|NCT02663882|460348471|FG001|Overall Study|Lost to Follow-up|2|||
127925393|NCT00602537|460348472|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
127925394|NCT00602537|460348473|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
127925395|NCT00602537|460348472|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
127925396|NCT00602537|460348473|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
127925397|NCT00602537|460348472|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
127925398|NCT00602537|460348473|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
127925399|NCT00602537|460348472|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
127925400|NCT00602537|460348473|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
127925401|NCT00602537|460348472|FG000|Follow Up Study Comparison|Adverse Event|1|||
127925402|NCT00602537|460348473|FG001|Follow Up Study Comparison|Adverse Event|0|||
127925403|NCT00602537|460348472|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
127925404|NCT00602537|460348473|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
127925405|NCT00602537|460348472|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
127925406|NCT00602537|460348473|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
127925407|NCT00388037|460348474|FG000|Overall Study|Protocol Violation|1|||
127925408|NCT00869440|460348481|FG000|Overall Study|Withdrawal by Subject|1|||
127925409|NCT00869440|460348482|FG001|Overall Study|Withdrawal by Subject|0|||
127925410|NCT00869440|460348483|FG002|Overall Study|Withdrawal by Subject|0|||
127925411|NCT00869440|460348484|FG003|Overall Study|Withdrawal by Subject|0|||
127925412|NCT00869440|460348481|FG000|Overall Study|Physician Decision|1|||
127925413|NCT00869440|460348482|FG001|Overall Study|Physician Decision|1|||
127925414|NCT00869440|460348483|FG002|Overall Study|Physician Decision|0|||
127925415|NCT00869440|460348484|FG003|Overall Study|Physician Decision|0|||
127925416|NCT00613730|460348485|FG000|Overall Study|Disease progression|2|||
127925417|NCT00613730|460348485|FG000|Overall Study|Administrative decision|1|||
127925418|NCT00479388|460348486|FG000|Overall Study|Adverse Event|90|||
127925419|NCT00479388|460348487|FG001|Overall Study|Adverse Event|45|||
127925420|NCT00479388|460348486|FG000|Overall Study|Lost to Follow-up|0|||
127925421|NCT00479388|460348487|FG001|Overall Study|Lost to Follow-up|2|||
127925422|NCT00479388|460348486|FG000|Overall Study|Protocol Violation|10|||
127925423|NCT00479388|460348487|FG001|Overall Study|Protocol Violation|9|||
127925424|NCT00479388|460348486|FG000|Overall Study|Withdrawal by Subject|32|||
127925425|NCT00479388|460348487|FG001|Overall Study|Withdrawal by Subject|17|||
127925426|NCT01955044|460348490|FG000|Overall Study|Death|1|||
127925427|NCT01955044|460348491|FG001|Overall Study|Death|1|||
127925428|NCT01955044|460348492|FG002|Overall Study|Death|0|||
127925429|NCT01876368|460348493|FG000|Overall Study|Adverse Event|2|||
127925430|NCT01876368|460348494|FG001|Overall Study|Adverse Event|5|||
127925431|NCT01876368|460348493|FG000|Overall Study|Lack of Efficacy|1|||
127925432|NCT01876368|460348494|FG001|Overall Study|Lack of Efficacy|0|||
127925433|NCT01876368|460348493|FG000|Overall Study|Lost to Follow-up|0|||
127925434|NCT01876368|460348494|FG001|Overall Study|Lost to Follow-up|1|||
127925435|NCT01876368|460348493|FG000|Overall Study|Non-compliance with study treatment|0|||
127925436|NCT01876368|460348494|FG001|Overall Study|Non-compliance with study treatment|1|||
127925437|NCT01876368|460348493|FG000|Overall Study|Physician Decision|0|||
127925438|NCT01876368|460348494|FG001|Overall Study|Physician Decision|2|||
127925439|NCT01876368|460348493|FG000|Overall Study|Protocol deviation|3|||
127925440|NCT01876368|460348494|FG001|Overall Study|Protocol deviation|3|||
127925441|NCT01876368|460348493|FG000|Overall Study|Subject/guardian decision|3|||
127925442|NCT01876368|460348494|FG001|Overall Study|Subject/guardian decision|1|||
127925443|NCT01644149|460348495|FG000|Overall Study|Withdrawal by Subject|1|||
127925444|NCT01644149|460348496|FG001|Overall Study|Withdrawal by Subject|0|||
127925445|NCT01644149|460348495|FG000|Overall Study|Lost to Follow-up|3|||
127925446|NCT01644149|460348496|FG001|Overall Study|Lost to Follow-up|1|||
127925447|NCT05766787|460348497|FG000|First Wear Period, Approximately 7 Days|Adverse Event|0|||
127925448|NCT05766787|460348498|FG001|First Wear Period, Approximately 7 Days|Adverse Event|1|||
127925449|NCT05766787|460348497|FG000|First Wear Period, Approximately 7 Days|Withdrawal by Subject|1|||
127925450|NCT05766787|460348498|FG001|First Wear Period, Approximately 7 Days|Withdrawal by Subject|2|||
127925451|NCT05766787|460348497|FG000|Second Wear Period, Approximately 7 Days|Adverse Event|0|||
127925452|NCT05766787|460348498|FG001|Second Wear Period, Approximately 7 Days|Adverse Event|1|||
127925453|NCT01378962|460348499|FG000|Overall Study|Death|14|||
127925454|NCT01378962|460348499|FG000|Overall Study|Lost to Follow-up|1|||
127925455|NCT01378962|460348499|FG000|Overall Study|Other|2|||
127925456|NCT01435928|460348500|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
127925457|NCT01435928|460348501|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
127925458|NCT01435928|460348502|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
127925459|NCT01435928|460348500|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
127925460|NCT01435928|460348501|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
127925461|NCT01435928|460348502|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
127925462|NCT01435928|460348500|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
127925463|NCT01435928|460348501|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
127925464|NCT01435928|460348502|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
127925465|NCT01435928|460348500|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
127925466|NCT01435928|460348501|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
127925467|NCT01435928|460348502|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
127925468|NCT01435928|460348500|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
127925469|NCT01435928|460348501|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
127925470|NCT01435928|460348502|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
127925471|NCT01435928|460348500|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
127925472|NCT01435928|460348501|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
127925473|NCT01435928|460348502|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
127925474|NCT01435928|460348500|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
127925475|NCT01435928|460348501|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
127925476|NCT01435928|460348502|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
127925477|NCT01435928|460348500|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
127925478|NCT01435928|460348501|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
127925479|NCT01435928|460348502|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
127925480|NCT01435928|460348500|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
127925481|NCT01435928|460348501|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
127925482|NCT01435928|460348502|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
127925483|NCT01435928|460348500|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
127925484|NCT01435928|460348501|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
127925485|NCT01435928|460348502|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
127925486|NCT01435928|460348500|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
127925487|NCT01435928|460348501|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
127925488|NCT01435928|460348502|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
127925489|NCT01435928|460348500|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
127925490|NCT01435928|460348501|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
127925491|NCT01435928|460348502|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
127925492|NCT01435928|460348500|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
127925493|NCT01435928|460348501|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
127925494|NCT01435928|460348502|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
127925495|NCT01435928|460348500|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
127925496|NCT01435928|460348501|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
127925497|NCT01435928|460348502|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
127925498|NCT01435928|460348500|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
127925499|NCT01435928|460348501|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
127925500|NCT01435928|460348502|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
127925501|NCT01435928|460348500|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
127925502|NCT01435928|460348501|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
127925503|NCT01435928|460348502|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
127925504|NCT00292227|460348504|FG000|Patch Period|Adverse Event|1|||
127925505|NCT00292227|460348505|FG001|Patch Period|Adverse Event|0|||
127925506|NCT00292227|460348506|FG002|Patch Period|Adverse Event|2|||
127925507|NCT00292227|460348504|FG000|Patch Period|Withdrawal by Subject|0|||
127925508|NCT00292227|460348505|FG001|Patch Period|Withdrawal by Subject|0|||
127925509|NCT00292227|460348506|FG002|Patch Period|Withdrawal by Subject|1|||
127925510|NCT02093923|460348507|FG000|Overall Study|Lost to Follow-up|0|||
127925511|NCT02093923|460348508|FG001|Overall Study|Lost to Follow-up|0|||
127925512|NCT02093923|460348509|FG002|Overall Study|Lost to Follow-up|0|||
127925513|NCT02093923|460348510|FG003|Overall Study|Lost to Follow-up|1|||
127925514|NCT02093923|460348511|FG004|Overall Study|Lost to Follow-up|0|||
127925515|NCT02093923|460348507|FG000|Overall Study|Screen failure after randomization|0|||
127925516|NCT02093923|460348508|FG001|Overall Study|Screen failure after randomization|0|||
127925517|NCT02093923|460348509|FG002|Overall Study|Screen failure after randomization|0|||
127925518|NCT02093923|460348510|FG003|Overall Study|Screen failure after randomization|1|||
127925519|NCT02093923|460348511|FG004|Overall Study|Screen failure after randomization|0|||
127925520|NCT00442546|460348514|FG000|Overall Study|Adverse Event|11|||
127925521|NCT00442546|460348515|FG001|Overall Study|Adverse Event|17|||
127925522|NCT00442546|460348516|FG002|Overall Study|Adverse Event|13|||
127925523|NCT00442546|460348514|FG000|Overall Study|Lost to Follow-up|1|||
127925524|NCT00442546|460348515|FG001|Overall Study|Lost to Follow-up|2|||
127925525|NCT00442546|460348516|FG002|Overall Study|Lost to Follow-up|1|||
127925526|NCT00442546|460348514|FG000|Overall Study|Other|4|||
127925527|NCT00442546|460348515|FG001|Overall Study|Other|9|||
127925528|NCT00442546|460348516|FG002|Overall Study|Other|6|||
127925529|NCT00442546|460348514|FG000|Overall Study|Withdrawal by Subject|5|||
127925530|NCT00442546|460348515|FG001|Overall Study|Withdrawal by Subject|5|||
127925531|NCT00442546|460348516|FG002|Overall Study|Withdrawal by Subject|7|||
127925532|NCT00442546|460348514|FG000|Overall Study|Randomized But Not Treated|5|||
127925533|NCT00442546|460348515|FG001|Overall Study|Randomized But Not Treated|4|||
127925534|NCT00442546|460348516|FG002|Overall Study|Randomized But Not Treated|6|||
127925535|NCT00248170|460348517|FG000|Overall Study|Withdrawal by Subject|71|||
127925536|NCT00248170|460348518|FG001|Overall Study|Withdrawal by Subject|79|||
127925537|NCT00248170|460348517|FG000|Overall Study|Protocol Violation|35|||
127925538|NCT00248170|460348518|FG001|Overall Study|Protocol Violation|30|||
127925539|NCT00248170|460348517|FG000|Overall Study|Lost to Follow-up|28|||
127925540|NCT00248170|460348518|FG001|Overall Study|Lost to Follow-up|35|||
127925541|NCT00248170|460348517|FG000|Overall Study|Disease progression|196|||
127925542|NCT00248170|460348518|FG001|Overall Study|Disease progression|216|||
127925543|NCT00248170|460348517|FG000|Overall Study|Death|28|||
127925544|NCT00248170|460348518|FG001|Overall Study|Death|47|||
127925545|NCT00248170|460348517|FG000|Overall Study|Adverse Event|311|||
127925546|NCT00248170|460348518|FG001|Overall Study|Adverse Event|296|||
127925547|NCT00248170|460348517|FG000|Overall Study|Administrative problems|22|||
127925548|NCT00248170|460348518|FG001|Overall Study|Administrative problems|25|||
127925549|NCT00248170|460348517|FG000|Overall Study|Abnormal test procedure(s) result|49|||
127925550|NCT00248170|460348518|FG001|Overall Study|Abnormal test procedure(s) result|61|||
127925551|NCT00248170|460348517|FG000|Overall Study|Abnormal laboratory values|4|||
127925552|NCT00248170|460348518|FG001|Overall Study|Abnormal laboratory values|0|||
127925553|NCT00248170|460348517|FG000|Overall Study|Protocol deviation|17|||
127925554|NCT00248170|460348518|FG001|Overall Study|Protocol deviation|19|||
127925555|NCT01557582|460348519|FG000|Overall Study|Protocol Violation|4|||
127925556|NCT01557582|460348519|FG000|Overall Study|Operator error|2|||
127925557|NCT02843659|460348520|FG000|Overall Study|Subject Withdrew Consent|0|||
127925558|NCT02843659|460348521|FG001|Overall Study|Subject Withdrew Consent|0|||
127925559|NCT02843659|460348522|FG002|Overall Study|Subject Withdrew Consent|1|||
127925560|NCT02843659|460348520|FG000|Overall Study|Administrative Reason by Sponsor|4|||
127925561|NCT02843659|460348521|FG001|Overall Study|Administrative Reason by Sponsor|5|||
127925562|NCT02843659|460348522|FG002|Overall Study|Administrative Reason by Sponsor|4|||
127925563|NCT02843659|460348520|FG000|Overall Study|Adverse Event|0|||
127925564|NCT02843659|460348521|FG001|Overall Study|Adverse Event|1|||
127925565|NCT02843659|460348522|FG002|Overall Study|Adverse Event|0|||
127925566|NCT02413294|460348526|FG000|Overall Study|Withdrawal by Subject|1|||
127925567|NCT01253317|460348533|FG000|Overall Study|Adverse Event|2|||
127925568|NCT00831233|460350488|FG000|Overall Study|Adverse Event|0|||
127925569|NCT00831233|460350489|FG001|Overall Study|Adverse Event|1|||
127925570|NCT00831233|460350488|FG000|Overall Study|Protocol Violation|1|||
127925571|NCT00831233|460350489|FG001|Overall Study|Protocol Violation|0|||
127925572|NCT00831233|460350488|FG000|Overall Study|Selection Criteria Not Met|2|||
127925573|NCT00831233|460350489|FG001|Overall Study|Selection Criteria Not Met|0|||
127925574|NCT02211014|460350490|FG000|Overall Study|Adverse Event|0|||
127925575|NCT02211014|460350491|FG001|Overall Study|Adverse Event|2|||
127925576|NCT02211014|460350490|FG000|Overall Study|Physician Decision|1|||
127925577|NCT02211014|460350491|FG001|Overall Study|Physician Decision|2|||
127925578|NCT02211014|460350490|FG000|Overall Study|Started another cancer therapy|1|||
127925579|NCT02211014|460350491|FG001|Overall Study|Started another cancer therapy|0|||
127925580|NCT02211014|460350490|FG000|Overall Study|Withdrawal by Subject|0|||
127925581|NCT02211014|460350491|FG001|Overall Study|Withdrawal by Subject|1|||
127925582|NCT02211014|460350490|FG000|Overall Study|In agreement with patient, no benefit|0|||
127925583|NCT02211014|460350491|FG001|Overall Study|In agreement with patient, no benefit|1|||
127925584|NCT01844531|460350493|FG000|Overall Study|Withdrawal by Subject|0|||
127925585|NCT01844531|460350494|FG001|Overall Study|Withdrawal by Subject|1|||
127925586|NCT01844531|460350495|FG002|Overall Study|Withdrawal by Subject|0|||
127925587|NCT01844531|460350496|FG003|Overall Study|Withdrawal by Subject|0|||
127925588|NCT02744755|460350497|FG000|Study Period 1|Protocol Violation|2|||
127925589|NCT02744755|460350498|FG001|Study Period 1|Protocol Violation|1|||
127925590|NCT02744755|460350497|FG000|Study Period 1|not defined|0|||
127925591|NCT02744755|460350498|FG001|Study Period 1|not defined|1|||
127925592|NCT02744755|460350497|FG000|Study Period 1|Pregnancy|1|||
127925593|NCT02744755|460350498|FG001|Study Period 1|Pregnancy|0|||
127925594|NCT02744755|460350497|FG000|Study Period 1|Adverse Event|1|||
127925595|NCT02744755|460350498|FG001|Study Period 1|Adverse Event|1|||
127925596|NCT02744755|460350497|FG000|Study Period 1|Lost to Follow-up|1|||
127925597|NCT02744755|460350498|FG001|Study Period 1|Lost to Follow-up|1|||
127925598|NCT02744755|460350497|FG000|Study Period 1|Lack of Efficacy|1|||
127925599|NCT02744755|460350498|FG001|Study Period 1|Lack of Efficacy|0|||
127925600|NCT02744755|460350497|FG000|Study Period 1|Withdrawal by Subject|8|||
127925601|NCT02744755|460350498|FG001|Study Period 1|Withdrawal by Subject|4|||
127925602|NCT02744755|460350497|FG000|Study Period 2|Adverse Event|5|||
127925603|NCT02744755|460350498|FG001|Study Period 2|Adverse Event|0|||
127925604|NCT02744755|460350497|FG000|Study Period 2|Protocol Violation|1|||
127925605|NCT02744755|460350498|FG001|Study Period 2|Protocol Violation|0|||
127925606|NCT02744755|460350497|FG000|Study Period 2|not defined|3|||
127925607|NCT02744755|460350498|FG001|Study Period 2|not defined|2|||
127925608|NCT02744755|460350497|FG000|Study Period 2|Lost to Follow-up|0|||
127925609|NCT02744755|460350498|FG001|Study Period 2|Lost to Follow-up|2|||
127925610|NCT02744755|460350497|FG000|Study Period 2|Withdrawal by Subject|2|||
127925611|NCT02744755|460350498|FG001|Study Period 2|Withdrawal by Subject|2|||
127925612|NCT02744755|460350497|FG000|Study Period 2|Lack of Efficacy|3|||
127925613|NCT02744755|460350498|FG001|Study Period 2|Lack of Efficacy|2|||
127925614|NCT01280617|460350500|FG000|Overall Study|Adverse Event|0|||
127925615|NCT01280617|460350501|FG001|Overall Study|Adverse Event|1|||
127925616|NCT04205162|460350507|FG000|Overall Study|Lost to Follow-up|1|||
127925617|NCT04205162|460350508|FG001|Overall Study|Lost to Follow-up|0|||
127925618|NCT04205162|460350507|FG000|Overall Study|Withdrawal by Subject|2|||
127925619|NCT04205162|460350508|FG001|Overall Study|Withdrawal by Subject|0|||
127925620|NCT04205162|460350507|FG000|Overall Study|University closure due to COVID-19|1|||
127925621|NCT04205162|460350508|FG001|Overall Study|University closure due to COVID-19|0|||
127925622|NCT01011556|460350510|FG000|Overall Study|Adverse Event|1|||
127925623|NCT01011556|460350511|FG001|Overall Study|Adverse Event|3|||
127925624|NCT01011556|460350512|FG002|Overall Study|Adverse Event|2|||
127925625|NCT01011556|460350513|FG003|Overall Study|Adverse Event|1|||
127925626|NCT01011556|460350510|FG000|Overall Study|Lost to Follow-up|1|||
127925627|NCT01011556|460350511|FG001|Overall Study|Lost to Follow-up|0|||
127925628|NCT01011556|460350512|FG002|Overall Study|Lost to Follow-up|0|||
127925629|NCT01011556|460350513|FG003|Overall Study|Lost to Follow-up|0|||
127925630|NCT01011556|460350510|FG000|Overall Study|Physician Decision|1|||
127925631|NCT01011556|460350511|FG001|Overall Study|Physician Decision|0|||
127925632|NCT01011556|460350512|FG002|Overall Study|Physician Decision|0|||
127925633|NCT01011556|460350513|FG003|Overall Study|Physician Decision|1|||
127925634|NCT01011556|460350510|FG000|Overall Study|Protocol Violation|0|||
127925635|NCT01011556|460350511|FG001|Overall Study|Protocol Violation|1|||
127925636|NCT01011556|460350512|FG002|Overall Study|Protocol Violation|0|||
127925637|NCT01011556|460350513|FG003|Overall Study|Protocol Violation|0|||
127925638|NCT01011556|460350510|FG000|Overall Study|Withdrawal by Subject|1|||
127925639|NCT01011556|460350511|FG001|Overall Study|Withdrawal by Subject|2|||
127925640|NCT01011556|460350512|FG002|Overall Study|Withdrawal by Subject|4|||
127925641|NCT01011556|460350513|FG003|Overall Study|Withdrawal by Subject|4|||
127925642|NCT01011556|460350510|FG000|Overall Study|Sponsor decision|0|||
127925643|NCT01011556|460350511|FG001|Overall Study|Sponsor decision|1|||
127925644|NCT01011556|460350512|FG002|Overall Study|Sponsor decision|1|||
127925645|NCT01011556|460350513|FG003|Overall Study|Sponsor decision|2|||
127925646|NCT01011556|460350510|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
127925647|NCT01011556|460350511|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
127925648|NCT01011556|460350512|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
127925649|NCT01011556|460350513|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
127925650|NCT00529217|460350515|FG000|Overall Study|Lack of Efficacy|2|||
127925651|NCT00529217|460350515|FG000|Overall Study|Unable to adhere to study schedule|2|||
127925652|NCT01999894|460350516|FG000|Overall Study|Adverse Event|9|||
127925653|NCT01999894|460350516|FG000|Overall Study|Lack of Efficacy|5|||
127925654|NCT01999894|460350516|FG000|Overall Study|Protocol Violation|1|||
127925655|NCT01999894|460350516|FG000|Overall Study|Withdrawal by Subject|7|||
127925656|NCT01999894|460350516|FG000|Overall Study|Lost to Follow-up|10|||
127925657|NCT01999894|460350516|FG000|Overall Study|Other Reason|3|||
127925658|NCT01999894|460350516|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
127925659|NCT01098110|460350517|FG000|Overall Study|Withdrawal by Subject|14|||
127925660|NCT01098110|460350518|FG001|Overall Study|Withdrawal by Subject|24|||
127925661|NCT01098110|460350519|FG002|Overall Study|Withdrawal by Subject|19|||
127925662|NCT01098110|460350517|FG000|Overall Study|Adverse Event|30|||
127925663|NCT01098110|460350518|FG001|Overall Study|Adverse Event|32|||
127925664|NCT01098110|460350519|FG002|Overall Study|Adverse Event|43|||
127925665|NCT01098110|460350517|FG000|Overall Study|Lack of Efficacy|13|||
127925666|NCT01098110|460350518|FG001|Overall Study|Lack of Efficacy|9|||
127925667|NCT01098110|460350519|FG002|Overall Study|Lack of Efficacy|27|||
127925668|NCT01098110|460350517|FG000|Overall Study|Other|4|||
127925669|NCT01098110|460350518|FG001|Overall Study|Other|7|||
127925670|NCT01098110|460350519|FG002|Overall Study|Other|5|||
127925671|NCT01098110|460350517|FG000|Overall Study|Untreated|1|||
127925672|NCT01098110|460350518|FG001|Overall Study|Untreated|1|||
127925673|NCT01098110|460350519|FG002|Overall Study|Untreated|0|||
127925674|NCT02147587|460350520|FG000|Overall Study|Adverse Event|9|||
127925675|NCT02147587|460350521|FG001|Overall Study|Adverse Event|4|||
127925676|NCT02147587|460350520|FG000|Overall Study|Lack of Efficacy|2|||
127925677|NCT02147587|460350521|FG001|Overall Study|Lack of Efficacy|1|||
127925678|NCT04364763|460350522|FG000|Overall Study|Death|1|||
127925679|NCT04364763|460350523|FG001|Overall Study|Death|2|||
127925680|NCT04364763|460350522|FG000|Overall Study|Lost to Follow-up|1|||
127925681|NCT04364763|460350523|FG001|Overall Study|Lost to Follow-up|0|||
127925682|NCT01740791|460350524|FG000|Overall Study|Randomized but never treated|5|||
127925683|NCT01740791|460350525|FG001|Overall Study|Randomized but never treated|3|||
127925684|NCT01740791|460350526|FG002|Overall Study|Randomized but never treated|2|||
127925685|NCT01740791|460350527|FG003|Overall Study|Randomized but never treated|2|||
127925686|NCT01740791|460350528|FG004|Overall Study|Randomized but never treated|1|||
127925687|NCT01740791|460350529|FG005|Overall Study|Randomized but never treated|3|||
127925688|NCT01740791|460350524|FG000|Overall Study|Lost to Follow-up|2|||
127925689|NCT01740791|460350525|FG001|Overall Study|Lost to Follow-up|0|||
127925690|NCT01740791|460350526|FG002|Overall Study|Lost to Follow-up|2|||
127925691|NCT01740791|460350527|FG003|Overall Study|Lost to Follow-up|3|||
127925692|NCT01740791|460350528|FG004|Overall Study|Lost to Follow-up|2|||
127925693|NCT01740791|460350529|FG005|Overall Study|Lost to Follow-up|3|||
127925694|NCT01740791|460350524|FG000|Overall Study|Withdrew Consent|4|||
127925695|NCT01740791|460350525|FG001|Overall Study|Withdrew Consent|0|||
127925696|NCT01740791|460350526|FG002|Overall Study|Withdrew Consent|1|||
127925697|NCT01740791|460350527|FG003|Overall Study|Withdrew Consent|2|||
127925698|NCT01740791|460350528|FG004|Overall Study|Withdrew Consent|0|||
127925699|NCT01740791|460350529|FG005|Overall Study|Withdrew Consent|3|||
127925700|NCT01740791|460350524|FG000|Overall Study|Investigator's discretion|1|||
127925701|NCT01740791|460350525|FG001|Overall Study|Investigator's discretion|0|||
127925702|NCT01740791|460350526|FG002|Overall Study|Investigator's discretion|1|||
127925703|NCT01740791|460350527|FG003|Overall Study|Investigator's discretion|0|||
127925704|NCT01740791|460350528|FG004|Overall Study|Investigator's discretion|0|||
127925705|NCT01740791|460350529|FG005|Overall Study|Investigator's discretion|1|||
127925706|NCT01740791|460350524|FG000|Overall Study|Adverse Event|0|||
127925707|NCT01740791|460350525|FG001|Overall Study|Adverse Event|0|||
127925708|NCT01740791|460350526|FG002|Overall Study|Adverse Event|0|||
127925709|NCT01740791|460350527|FG003|Overall Study|Adverse Event|0|||
127925710|NCT01740791|460350528|FG004|Overall Study|Adverse Event|0|||
127925711|NCT01740791|460350529|FG005|Overall Study|Adverse Event|1|||
127925712|NCT00931463|460350530|FG000|Overall Study|Death|8|||
127925713|NCT00931463|460350531|FG001|Overall Study|Death|4|||
127925714|NCT00931463|460350530|FG000|Overall Study|Withdrawal by Subject|5|||
127925715|NCT00931463|460350531|FG001|Overall Study|Withdrawal by Subject|0|||
127925716|NCT00931463|460350530|FG000|Overall Study|Lost to Follow-up|4|||
127925717|NCT00931463|460350531|FG001|Overall Study|Lost to Follow-up|1|||
127925718|NCT03170869|460350532|FG000|Overall Study|Protocol Violation|5|||
127925719|NCT03170869|460350532|FG000|Overall Study|Early study termination|3|||
127925720|NCT02539368|460350539|FG000|Overall Study|Death|4|||
127925721|NCT02539368|460350540|FG001|Overall Study|Death|2|||
127925722|NCT02539368|460350541|FG002|Overall Study|Death|1|||
127925723|NCT02539368|460350542|FG003|Overall Study|Death|0|||
127925724|NCT02539368|460350543|FG004|Overall Study|Death|0|||
127925725|NCT02539368|460350539|FG000|Overall Study|Withdrawal by Subject|44|||
127925726|NCT02539368|460350540|FG001|Overall Study|Withdrawal by Subject|35|||
127925727|NCT02539368|460350541|FG002|Overall Study|Withdrawal by Subject|9|||
127925728|NCT02539368|460350542|FG003|Overall Study|Withdrawal by Subject|1|||
127925729|NCT02539368|460350543|FG004|Overall Study|Withdrawal by Subject|3|||
127925730|NCT02539368|460350539|FG000|Overall Study|Physician Decision|49|||
127925731|NCT02539368|460350540|FG001|Overall Study|Physician Decision|15|||
127925732|NCT02539368|460350541|FG002|Overall Study|Physician Decision|7|||
127925733|NCT02539368|460350542|FG003|Overall Study|Physician Decision|0|||
127925734|NCT02539368|460350543|FG004|Overall Study|Physician Decision|2|||
127925735|NCT02539368|460350539|FG000|Overall Study|Lost to Follow-up|96|||
127925736|NCT02539368|460350540|FG001|Overall Study|Lost to Follow-up|21|||
127925737|NCT02539368|460350541|FG002|Overall Study|Lost to Follow-up|16|||
127925738|NCT02539368|460350542|FG003|Overall Study|Lost to Follow-up|4|||
127925739|NCT02539368|460350543|FG004|Overall Study|Lost to Follow-up|3|||
127925740|NCT02539368|460350539|FG000|Overall Study|Adverse Event|44|||
127925741|NCT02539368|460350540|FG001|Overall Study|Adverse Event|5|||
127925742|NCT02539368|460350541|FG002|Overall Study|Adverse Event|9|||
127925743|NCT02539368|460350542|FG003|Overall Study|Adverse Event|0|||
127925744|NCT02539368|460350543|FG004|Overall Study|Adverse Event|3|||
127925745|NCT02539368|460350539|FG000|Overall Study|Participant Non-compliant|13|||
127925746|NCT02539368|460350540|FG001|Overall Study|Participant Non-compliant|2|||
127925747|NCT02539368|460350541|FG002|Overall Study|Participant Non-compliant|1|||
127925748|NCT02539368|460350542|FG003|Overall Study|Participant Non-compliant|1|||
127925749|NCT02539368|460350543|FG004|Overall Study|Participant Non-compliant|0|||
127925750|NCT02539368|460350539|FG000|Overall Study|Other|145|||
127925751|NCT02539368|460350540|FG001|Overall Study|Other|18|||
127925752|NCT02539368|460350541|FG002|Overall Study|Other|24|||
127925753|NCT02539368|460350542|FG003|Overall Study|Other|1|||
127925754|NCT02539368|460350543|FG004|Overall Study|Other|3|||
127925755|NCT02539368|460350539|FG000|Overall Study|Missing|10|||
127925756|NCT02539368|460350540|FG001|Overall Study|Missing|3|||
127925757|NCT02539368|460350541|FG002|Overall Study|Missing|0|||
127925758|NCT02539368|460350542|FG003|Overall Study|Missing|0|||
127925759|NCT02539368|460350543|FG004|Overall Study|Missing|0|||
127925760|NCT03558139|460350544|FG000|Overall Study|Consent Withdrawn|1|||
127925761|NCT03558139|460350545|FG001|Overall Study|Consent Withdrawn|1|||
127925762|NCT03558139|460350546|FG002|Overall Study|Consent Withdrawn|4|||
127925763|NCT03558139|460350544|FG000|Overall Study|Death|5|||
127925764|NCT03558139|460350545|FG001|Overall Study|Death|3|||
127925765|NCT03558139|460350546|FG002|Overall Study|Death|8|||
127925766|NCT03558139|460350544|FG000|Overall Study|Lost to Follow-up|0|||
127925767|NCT03558139|460350545|FG001|Overall Study|Lost to Follow-up|0|||
127925768|NCT03558139|460350546|FG002|Overall Study|Lost to Follow-up|3|||
127925769|NCT03558139|460350544|FG000|Overall Study|Study Ended Per Protocol|0|||
127925770|NCT03558139|460350545|FG001|Overall Study|Study Ended Per Protocol|3|||
127925771|NCT03558139|460350546|FG002|Overall Study|Study Ended Per Protocol|6|||
127925772|NCT02752802|460350547|FG000|Overall Study|Contrast Volume Not Collected|1|||
127925773|NCT02752802|460350548|FG001|Overall Study|Contrast Volume Not Collected|0|||
127925774|NCT03573817|460350549|FG000|Overall Study|Adverse Event|0|||
127925775|NCT03573817|460350550|FG001|Overall Study|Adverse Event|2|||
127925776|NCT03573817|460350549|FG000|Overall Study|Protocol Violation|0|||
127925777|NCT03573817|460350550|FG001|Overall Study|Protocol Violation|1|||
127925778|NCT03573817|460350549|FG000|Overall Study|Withdrawal by Subject|1|||
127925779|NCT03573817|460350550|FG001|Overall Study|Withdrawal by Subject|1|||
127925780|NCT02013531|460350551|FG000|Overall Study|Lost to Follow-up|3|||
127925781|NCT02013531|460350551|FG000|Overall Study|Met Withdrawal Criteria|1|||
127925782|NCT02013531|460350551|FG000|Overall Study|Withdrawal by Subject|1|||
127925783|NCT03546647|460350552|FG000|Overall Study|Adverse Event|1|||
127925784|NCT03546647|460350553|FG001|Overall Study|Adverse Event|0|||
127925785|NCT02400476|460350554|FG000|Overall Study|Adverse Event|57|||
127925786|NCT02400476|460350555|FG001|Overall Study|Adverse Event|10|||
127925787|NCT02400476|460350556|FG002|Overall Study|Adverse Event|22|||
127925788|NCT02400476|460350557|FG003|Overall Study|Adverse Event|19|||
127925789|NCT02400476|460350558|FG004|Overall Study|Adverse Event|5|||
127925790|NCT02400476|460350559|FG005|Overall Study|Adverse Event|8|||
127925791|NCT02400476|460350554|FG000|Overall Study|Withdrawal by Subject|4|||
127925792|NCT02400476|460350555|FG001|Overall Study|Withdrawal by Subject|1|||
127925793|NCT02400476|460350556|FG002|Overall Study|Withdrawal by Subject|12|||
127925794|NCT02400476|460350557|FG003|Overall Study|Withdrawal by Subject|7|||
127925795|NCT02400476|460350558|FG004|Overall Study|Withdrawal by Subject|5|||
127925796|NCT02400476|460350559|FG005|Overall Study|Withdrawal by Subject|5|||
127925797|NCT02400476|460350554|FG000|Overall Study|Lost to Follow-up|0|||
127925798|NCT02400476|460350555|FG001|Overall Study|Lost to Follow-up|0|||
127925799|NCT02400476|460350556|FG002|Overall Study|Lost to Follow-up|0|||
127925800|NCT02400476|460350557|FG003|Overall Study|Lost to Follow-up|1|||
127925801|NCT02400476|460350558|FG004|Overall Study|Lost to Follow-up|3|||
127925802|NCT02400476|460350559|FG005|Overall Study|Lost to Follow-up|1|||
127925803|NCT02400476|460350554|FG000|Overall Study|Physician Decision|0|||
127925804|NCT02400476|460350555|FG001|Overall Study|Physician Decision|0|||
127925805|NCT02400476|460350556|FG002|Overall Study|Physician Decision|1|||
127925806|NCT02400476|460350557|FG003|Overall Study|Physician Decision|1|||
127925807|NCT02400476|460350558|FG004|Overall Study|Physician Decision|0|||
127925808|NCT02400476|460350559|FG005|Overall Study|Physician Decision|1|||
127925809|NCT02400476|460350554|FG000|Overall Study|Other, Disease Progression|0|||
127925810|NCT02400476|460350555|FG001|Overall Study|Other, Disease Progression|1|||
127925811|NCT02400476|460350556|FG002|Overall Study|Other, Disease Progression|2|||
127925812|NCT02400476|460350557|FG003|Overall Study|Other, Disease Progression|1|||
127925813|NCT02400476|460350558|FG004|Overall Study|Other, Disease Progression|2|||
127925814|NCT02400476|460350559|FG005|Overall Study|Other, Disease Progression|1|||
127925815|NCT02400476|460350554|FG000|Overall Study|Other, Decreased Quality of Life|0|||
127925816|NCT02400476|460350555|FG001|Overall Study|Other, Decreased Quality of Life|0|||
127925817|NCT02400476|460350556|FG002|Overall Study|Other, Decreased Quality of Life|2|||
127925818|NCT02400476|460350557|FG003|Overall Study|Other, Decreased Quality of Life|0|||
127925819|NCT02400476|460350558|FG004|Overall Study|Other, Decreased Quality of Life|0|||
127925820|NCT02400476|460350559|FG005|Overall Study|Other, Decreased Quality of Life|0|||
127925821|NCT02400476|460350554|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
127925822|NCT02400476|460350555|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
127925823|NCT02400476|460350556|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
127925824|NCT02400476|460350557|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
127925825|NCT02400476|460350558|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
127925826|NCT02400476|460350559|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
127925827|NCT00612677|460350564|FG000|Overall Study|study closed before treatment started|1|||
127925828|NCT03417830|460350565|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
127925829|NCT03417830|460350566|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
127925830|NCT01684878|460350575|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
127925831|NCT01684878|460350576|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
127925832|NCT01684878|460350577|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
127925833|NCT01684878|460350578|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
127925834|NCT01684878|460350575|FG000|Part 1: Safety Run in Phase|Death|15|||
127925835|NCT01684878|460350576|FG001|Part 1: Safety Run in Phase|Death|20|||
127925836|NCT01684878|460350577|FG002|Part 1: Safety Run in Phase|Death|0|||
127925837|NCT01684878|460350578|FG003|Part 1: Safety Run in Phase|Death|0|||
127925838|NCT01684878|460350575|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
127925839|NCT01684878|460350576|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
127925840|NCT01684878|460350577|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
127925841|NCT01684878|460350578|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
127925842|NCT01684878|460350575|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
127925843|NCT01684878|460350576|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
127925844|NCT01684878|460350577|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
127925845|NCT01684878|460350578|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
127925846|NCT01684878|460350575|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
127925847|NCT01684878|460350576|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
127925848|NCT01684878|460350577|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
127925849|NCT01684878|460350578|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
127925850|NCT01684878|460350575|FG000|Part 2: Randomized Phase|Death|0|||
127925851|NCT01684878|460350576|FG001|Part 2: Randomized Phase|Death|0|||
127925852|NCT01684878|460350577|FG002|Part 2: Randomized Phase|Death|62|||
127925853|NCT01684878|460350578|FG003|Part 2: Randomized Phase|Death|68|||
127925854|NCT01684878|460350575|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
127925855|NCT01684878|460350576|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
127925856|NCT01684878|460350577|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
127925857|NCT01684878|460350578|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
127925858|NCT01684878|460350575|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
127925859|NCT01684878|460350576|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
127925860|NCT01684878|460350577|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
127925861|NCT01684878|460350578|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
127925862|NCT02692482|460350579|FG000|Overall Study|Death|2|||
127925863|NCT02692482|460350580|FG001|Overall Study|Death|2|||
127925864|NCT02692482|460350579|FG000|Overall Study|Withdrawal by Subject|1|||
127925865|NCT02692482|460350580|FG001|Overall Study|Withdrawal by Subject|2|||
127925866|NCT02927834|460350581|FG000|Overall Study|Lost to Follow-up|1|||
127925867|NCT02927834|460350582|FG001|Overall Study|Lost to Follow-up|2|||
127925868|NCT02927834|460350583|FG002|Overall Study|Lost to Follow-up|2|||
127925869|NCT01867606|460350584|FG000|Overall Study|Withdrawal by Subject|10|||
127925870|NCT01867606|460350585|FG001|Overall Study|Withdrawal by Subject|14|||
127925871|NCT01867606|460350584|FG000|Overall Study|Protocol Violation|0|||
127925872|NCT01867606|460350585|FG001|Overall Study|Protocol Violation|1|||
127925873|NCT01662362|460350597|FG000|Overall Study|Lost to Follow-up|38|||
127925874|NCT01181531|460350602|FG000|Overall Study|Other|17|||
127925875|NCT01181531|460350603|FG001|Overall Study|Other|12|||
127925876|NCT01181531|460350602|FG000|Overall Study|Partial consent by subject withdrawn|0|||
127925877|NCT01181531|460350603|FG001|Overall Study|Partial consent by subject withdrawn|1|||
127925878|NCT01181531|460350602|FG000|Overall Study|Physician Decision|3|||
127925879|NCT01181531|460350603|FG001|Overall Study|Physician Decision|1|||
127925880|NCT01181531|460350602|FG000|Overall Study|Noncompliance|2|||
127925881|NCT01181531|460350603|FG001|Overall Study|Noncompliance|2|||
127925882|NCT01181531|460350602|FG000|Overall Study|Ineligibility determined|1|||
127925883|NCT01181531|460350603|FG001|Overall Study|Ineligibility determined|2|||
127925884|NCT01181531|460350602|FG000|Overall Study|Protocol Specified Criteria|15|||
127925885|NCT01181531|460350603|FG001|Overall Study|Protocol Specified Criteria|8|||
127925886|NCT01181531|460350602|FG000|Overall Study|Pregnancy|0|||
127925887|NCT01181531|460350603|FG001|Overall Study|Pregnancy|1|||
127925888|NCT01181531|460350602|FG000|Overall Study|Withdrawal by Subject|8|||
127925889|NCT01181531|460350603|FG001|Overall Study|Withdrawal by Subject|7|||
127925890|NCT01181531|460350602|FG000|Overall Study|Protocol Violation|6|||
127925891|NCT01181531|460350603|FG001|Overall Study|Protocol Violation|6|||
127925892|NCT01181531|460350602|FG000|Overall Study|Death|9|||
127925893|NCT01181531|460350603|FG001|Overall Study|Death|12|||
127925894|NCT01181531|460350602|FG000|Overall Study|Adverse Event|0|||
127925895|NCT01181531|460350603|FG001|Overall Study|Adverse Event|1|||
127925896|NCT00987831|460350604|FG000|Overall Study|Never flared in 12 months|1|||
127925897|NCT00987831|460350605|FG001|Overall Study|Never flared in 12 months|0|||
127925898|NCT00987831|460350606|FG002|Overall Study|Never flared in 12 months|0|||
127925899|NCT00987831|460350604|FG000|Overall Study|Lost to Follow-up|0|||
127925900|NCT00987831|460350605|FG001|Overall Study|Lost to Follow-up|3|||
127925901|NCT00987831|460350606|FG002|Overall Study|Lost to Follow-up|0|||
127925902|NCT00810602|460350608|FG000|Overall Study|Withdrawal by Subject|8|||
127925903|NCT00810602|460350609|FG001|Overall Study|Withdrawal by Subject|3|||
127925904|NCT02792218|460350610|FG000|Overall Study|Patient/guardian decision|15|||
127925905|NCT02792218|460350611|FG001|Overall Study|Patient/guardian decision|42|||
127925906|NCT02792218|460350610|FG000|Overall Study|Adverse Event|15|||
127925907|NCT02792218|460350611|FG001|Overall Study|Adverse Event|14|||
127925908|NCT02792218|460350610|FG000|Overall Study|Lost to Follow-up|10|||
127925909|NCT02792218|460350611|FG001|Overall Study|Lost to Follow-up|5|||
127925910|NCT02792218|460350610|FG000|Overall Study|Lack of Efficacy|1|||
127925911|NCT02792218|460350611|FG001|Overall Study|Lack of Efficacy|12|||
127925912|NCT02792218|460350610|FG000|Overall Study|Physician Decision|4|||
127925913|NCT02792218|460350611|FG001|Overall Study|Physician Decision|4|||
127925914|NCT02792218|460350610|FG000|Overall Study|Protocol deviation|3|||
127925915|NCT02792218|460350611|FG001|Overall Study|Protocol deviation|2|||
127925916|NCT02792218|460350610|FG000|Overall Study|New therapy for study indication|0|||
127925917|NCT02792218|460350611|FG001|Overall Study|New therapy for study indication|1|||
127925918|NCT02792218|460350610|FG000|Overall Study|Non-compliance with study treatment|0|||
127925919|NCT02792218|460350611|FG001|Overall Study|Non-compliance with study treatment|1|||
127925920|NCT02792218|460350610|FG000|Overall Study|Pregnancy|1|||
127925921|NCT02792218|460350611|FG001|Overall Study|Pregnancy|0|||
127925922|NCT00824369|460350615|FG000|Overall Study|Nolonger willing to participate in study|1|||
127925923|NCT00824369|460350616|FG001|Overall Study|Nolonger willing to participate in study|0|||
127925924|NCT00824369|460350617|FG002|Overall Study|Nolonger willing to participate in study|1|||
127925925|NCT00824369|460350618|FG003|Overall Study|Nolonger willing to participate in study|2|||
127925926|NCT00824369|460350619|FG004|Overall Study|Nolonger willing to participate in study|0|||
127925927|NCT00824369|460350620|FG005|Overall Study|Nolonger willing to participate in study|1|||
127925928|NCT00824369|460350615|FG000|Overall Study|Lost to Follow-up|0|||
127925929|NCT00824369|460350616|FG001|Overall Study|Lost to Follow-up|0|||
127925930|NCT00824369|460350617|FG002|Overall Study|Lost to Follow-up|0|||
127925931|NCT00824369|460350618|FG003|Overall Study|Lost to Follow-up|0|||
127925932|NCT00824369|460350619|FG004|Overall Study|Lost to Follow-up|1|||
127925933|NCT00824369|460350620|FG005|Overall Study|Lost to Follow-up|0|||
127976407|NCT04598451|460536123|FG000|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|30|||
127976408|NCT04598451|460536124|FG001|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|19|||
127976409|NCT03535194|460536125|FG000|Induction Period|Adverse Event|2|||
127976410|NCT03535194|460536126|FG001|Induction Period|Adverse Event|2|||
127976411|NCT03535194|460536127|FG002|Induction Period|Adverse Event|1|||
127976412|NCT03535194|460536128|FG003|Induction Period|Adverse Event|3|||
127976413|NCT03535194|460536129|FG004|Induction Period|Adverse Event|0|||
127976414|NCT03535194|460536125|FG000|Induction Period|Death|0|||
127976415|NCT03535194|460536126|FG001|Induction Period|Death|1|||
127976416|NCT03535194|460536127|FG002|Induction Period|Death|0|||
127976417|NCT03535194|460536128|FG003|Induction Period|Death|0|||
127976418|NCT03535194|460536129|FG004|Induction Period|Death|0|||
127976419|NCT03535194|460536125|FG000|Induction Period|Lack of Efficacy|1|||
127976420|NCT03535194|460536126|FG001|Induction Period|Lack of Efficacy|3|||
127976421|NCT03535194|460536127|FG002|Induction Period|Lack of Efficacy|2|||
127925934|NCT01619579|460353290|FG000|Overall Study|Withdrawal by Subject|0|||
127925935|NCT01619579|460353291|FG001|Overall Study|Withdrawal by Subject|3|||
127925936|NCT02124902|460353292|FG000|Overall Study|Adverse Event|7|||
127925937|NCT02124902|460353293|FG001|Overall Study|Adverse Event|2|||
127925938|NCT02124902|460353292|FG000|Overall Study|Went to alternative treatment|4|||
127925939|NCT02124902|460353293|FG001|Overall Study|Went to alternative treatment|0|||
127925940|NCT02124902|460353292|FG000|Overall Study|Withdrawal by Subject|2|||
127925941|NCT02124902|460353293|FG001|Overall Study|Withdrawal by Subject|1|||
127925942|NCT02124902|460353292|FG000|Overall Study|Physician Decision|2|||
127925943|NCT02124902|460353293|FG001|Overall Study|Physician Decision|0|||
127925944|NCT02124902|460353292|FG000|Overall Study|Not eligible|1|||
127925945|NCT02124902|460353293|FG001|Overall Study|Not eligible|0|||
127925946|NCT02124902|460353292|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
127925947|NCT02124902|460353293|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
127925948|NCT02012452|460353297|FG000|Overall Study|Lost to Follow-up|2|||
127925949|NCT02012452|460353298|FG001|Overall Study|Lost to Follow-up|1|||
127925950|NCT02012452|460353297|FG000|Overall Study|Withdrawal by Subject|4|||
127925951|NCT02012452|460353298|FG001|Overall Study|Withdrawal by Subject|0|||
127925952|NCT02688387|460353299|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
127925953|NCT02688387|460353300|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
127925954|NCT02688387|460353301|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
127925955|NCT02688387|460353302|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
127925956|NCT02688387|460353303|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
127925957|NCT02688387|460353304|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
127925958|NCT02688387|460353305|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
127925959|NCT02688387|460353306|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
127925960|NCT02688387|460353307|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
127925961|NCT02688387|460353308|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
127925962|NCT02688387|460353309|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
127925963|NCT02688387|460353310|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
127925964|NCT02688387|460353311|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
127925965|NCT02688387|460353312|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
127925966|NCT02688387|460353313|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
127925967|NCT02688387|460353314|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
127925968|NCT02688387|460353315|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
127925969|NCT02688387|460353316|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
127925970|NCT02688387|460353317|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
127925971|NCT02688387|460353318|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
127925972|NCT02688387|460353319|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
127925973|NCT02688387|460353320|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
127925974|NCT02688387|460353299|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
127925975|NCT02688387|460353300|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
127925976|NCT02688387|460353301|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
127925977|NCT02688387|460353302|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
127925978|NCT02688387|460353303|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
127925979|NCT02688387|460353304|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
127925980|NCT02688387|460353305|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
127925981|NCT02688387|460353306|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
127925982|NCT02688387|460353307|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
127925983|NCT02688387|460353308|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
127925984|NCT02688387|460353309|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
127925985|NCT02688387|460353310|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
127925986|NCT02688387|460353311|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
127925987|NCT02688387|460353312|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
127925988|NCT02688387|460353313|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
127925989|NCT02688387|460353314|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
127925990|NCT02688387|460353315|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
127925991|NCT02688387|460353316|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
127925992|NCT02688387|460353317|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
127925993|NCT02688387|460353318|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
127925994|NCT02688387|460353319|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
127925995|NCT02688387|460353320|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
127925996|NCT02688387|460353299|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
127925997|NCT02688387|460353300|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
127925998|NCT02688387|460353301|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
127925999|NCT02688387|460353302|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
127926000|NCT02688387|460353303|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
127926001|NCT02688387|460353304|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
127926002|NCT02688387|460353305|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
127926003|NCT02688387|460353306|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
127926004|NCT02688387|460353307|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
127926005|NCT02688387|460353308|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
127926006|NCT02688387|460353309|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
127926007|NCT02688387|460353310|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
127926008|NCT02688387|460353311|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
127926009|NCT02688387|460353312|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
127926010|NCT02688387|460353313|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
127926011|NCT02688387|460353314|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
127926012|NCT02688387|460353315|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
127926013|NCT02688387|460353316|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
127926014|NCT02688387|460353317|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
127926015|NCT02688387|460353318|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
127926016|NCT02688387|460353319|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
127926017|NCT02688387|460353320|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
127926018|NCT02688387|460353299|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
127926019|NCT02688387|460353300|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
127926020|NCT02688387|460353301|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
127926021|NCT02688387|460353302|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
127926022|NCT02688387|460353303|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
127926023|NCT02688387|460353304|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
127926024|NCT02688387|460353305|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
127926025|NCT02688387|460353306|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
127926026|NCT02688387|460353307|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
127926027|NCT02688387|460353308|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
127926028|NCT02688387|460353309|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
127926029|NCT02688387|460353310|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
127926030|NCT02688387|460353311|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
127926031|NCT02688387|460353312|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
127926032|NCT02688387|460353313|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
127926033|NCT02688387|460353314|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
127926034|NCT02688387|460353315|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
127926035|NCT02688387|460353316|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
127926036|NCT02688387|460353317|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
127926037|NCT02688387|460353318|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
127926038|NCT02688387|460353319|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
127926039|NCT02688387|460353320|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
127926040|NCT02688387|460353299|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
127926041|NCT02688387|460353300|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
127926042|NCT02688387|460353301|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
127926043|NCT02688387|460353302|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
127926044|NCT02688387|460353303|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
127926045|NCT02688387|460353304|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
127926046|NCT02688387|460353305|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
127926047|NCT02688387|460353306|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
127926048|NCT02688387|460353307|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
127926049|NCT02688387|460353308|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
127926050|NCT02688387|460353309|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
127926051|NCT02688387|460353310|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
127926052|NCT02688387|460353311|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
127926053|NCT02688387|460353312|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
127926054|NCT02688387|460353313|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
127926055|NCT02688387|460353314|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
127926056|NCT02688387|460353315|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
127926057|NCT02688387|460353316|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
127926058|NCT02688387|460353317|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
127926059|NCT02688387|460353318|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
127926060|NCT02688387|460353319|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
127926061|NCT02688387|460353320|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
127926062|NCT02688387|460353299|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
127926063|NCT02688387|460353300|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
127926064|NCT02688387|460353301|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
127926065|NCT02688387|460353302|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
127926066|NCT02688387|460353303|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
127926067|NCT02688387|460353304|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
127926068|NCT02688387|460353305|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
127926069|NCT02688387|460353306|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
127926070|NCT02688387|460353307|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
127926071|NCT02688387|460353308|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
127926072|NCT02688387|460353309|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
127926073|NCT02688387|460353310|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
127926074|NCT02688387|460353311|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
127926075|NCT02688387|460353312|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
127926076|NCT02688387|460353313|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
127926077|NCT02688387|460353314|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
127926078|NCT02688387|460353315|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
127926079|NCT02688387|460353316|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
127926080|NCT02688387|460353317|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
127926081|NCT02688387|460353318|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
127926082|NCT02688387|460353319|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
127926083|NCT02688387|460353320|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
127926084|NCT02688387|460353299|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
127926085|NCT02688387|460353300|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
127926086|NCT02688387|460353301|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
127926087|NCT02688387|460353302|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
127926088|NCT02688387|460353303|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
127926089|NCT02688387|460353304|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
127926090|NCT02688387|460353305|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
127926091|NCT02688387|460353306|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
127926092|NCT02688387|460353307|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
127926093|NCT02688387|460353308|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
127926094|NCT02688387|460353309|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
127926095|NCT02688387|460353310|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
127926096|NCT02688387|460353311|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
127926097|NCT02688387|460353312|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
127926098|NCT02688387|460353313|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
127926099|NCT02688387|460353314|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
127926100|NCT02688387|460353315|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
127926101|NCT02688387|460353316|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
127926102|NCT02688387|460353317|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
127926103|NCT02688387|460353318|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
127926104|NCT02688387|460353319|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
127926105|NCT02688387|460353320|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
127926106|NCT02688387|460353299|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
127926107|NCT02688387|460353300|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
127926108|NCT02688387|460353301|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
127926109|NCT02688387|460353302|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
127926110|NCT02688387|460353303|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
127926111|NCT02688387|460353304|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
127926112|NCT02688387|460353305|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
127926113|NCT02688387|460353306|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
127926114|NCT02688387|460353307|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
127926115|NCT02688387|460353308|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
127926116|NCT02688387|460353309|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
127926117|NCT02688387|460353310|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
127926118|NCT02688387|460353311|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
127926119|NCT02688387|460353312|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
127926120|NCT02688387|460353313|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
127926121|NCT02688387|460353314|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
127926122|NCT02688387|460353315|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
127926123|NCT02688387|460353316|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
127926124|NCT02688387|460353317|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
127926125|NCT02688387|460353318|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
127926126|NCT02688387|460353319|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
127926127|NCT02688387|460353320|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
127926128|NCT02688387|460353299|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
127926129|NCT02688387|460353300|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
127926130|NCT02688387|460353301|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
127926131|NCT02688387|460353302|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
127926132|NCT02688387|460353303|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
127926133|NCT02688387|460353304|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
127926134|NCT02688387|460353305|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
127926135|NCT02688387|460353306|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
127926136|NCT02688387|460353307|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
127926137|NCT02688387|460353308|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
127926138|NCT02688387|460353309|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
127926139|NCT02688387|460353310|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
127926140|NCT02688387|460353311|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
127926141|NCT02688387|460353312|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
127926142|NCT02688387|460353313|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
127926143|NCT02688387|460353314|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
127926144|NCT02688387|460353315|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
127926145|NCT02688387|460353316|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
127926146|NCT02688387|460353317|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
127926147|NCT02688387|460353318|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
127926148|NCT02688387|460353319|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
127926149|NCT02688387|460353320|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
127926150|NCT02688387|460353299|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
127926151|NCT02688387|460353300|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
127926152|NCT02688387|460353301|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
127926153|NCT02688387|460353302|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
127926154|NCT02688387|460353303|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
127926155|NCT02688387|460353304|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
127926156|NCT02688387|460353305|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
127926157|NCT02688387|460353306|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
127926158|NCT02688387|460353307|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
127926159|NCT02688387|460353308|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
127926160|NCT02688387|460353309|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
127926161|NCT02688387|460353310|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
127926162|NCT02688387|460353311|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
127926163|NCT02688387|460353312|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
127926164|NCT02688387|460353313|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
127926165|NCT02688387|460353314|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
127926166|NCT02688387|460353315|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
127926167|NCT02688387|460353316|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
127926168|NCT02688387|460353317|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
127926169|NCT02688387|460353318|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
127926170|NCT02688387|460353319|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
127926171|NCT02688387|460353320|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
127926172|NCT02938442|460353323|FG000|Overall Study|Death|0|||
127926173|NCT02938442|460353324|FG001|Overall Study|Death|1|||
127926174|NCT02938442|460353323|FG000|Overall Study|Lost to Follow-up|0|||
127926175|NCT02938442|460353324|FG001|Overall Study|Lost to Follow-up|1|||
127926176|NCT02938442|460353323|FG000|Overall Study|Physician Decision|0|||
127926177|NCT02938442|460353324|FG001|Overall Study|Physician Decision|1|||
127926178|NCT02938442|460353323|FG000|Overall Study|Withdrawal by Subject|2|||
127926179|NCT02938442|460353324|FG001|Overall Study|Withdrawal by Subject|0|||
127926180|NCT04403399|460353326|FG000|Period 2|Physician Decision|0|||
127926181|NCT04403399|460353327|FG001|Period 2|Physician Decision|1|||
127926182|NCT01606228|460353328|FG000|Overall Study|Lost to Follow-up|20|||
127926183|NCT01606228|460353328|FG000|Overall Study|Withdrawal by Subject|3|||
127926184|NCT01606228|460353328|FG000|Overall Study|Non-compliant|3|||
127926185|NCT01606228|460353328|FG000|Overall Study|Lack of Efficacy|2|||
127926186|NCT01606228|460353328|FG000|Overall Study|Adverse Event|1|||
127926187|NCT04100096|460353330|FG000|Overall Study|Adverse Event|19|||
127926188|NCT04100096|460353331|FG001|Overall Study|Adverse Event|7|||
127926189|NCT04100096|460353330|FG000|Overall Study|Lack of Efficacy|0|||
127926190|NCT04100096|460353331|FG001|Overall Study|Lack of Efficacy|1|||
127926191|NCT04100096|460353330|FG000|Overall Study|Lost to Follow-up|13|||
127926192|NCT04100096|460353331|FG001|Overall Study|Lost to Follow-up|11|||
127926193|NCT04100096|460353330|FG000|Overall Study|Non-Compliance With Study Drug|1|||
127926194|NCT04100096|460353331|FG001|Overall Study|Non-Compliance With Study Drug|3|||
127926195|NCT04100096|460353330|FG000|Overall Study|Protocol Deviation|1|||
127926196|NCT04100096|460353331|FG001|Overall Study|Protocol Deviation|1|||
127926197|NCT04100096|460353330|FG000|Overall Study|Withdrawal by Participant|13|||
127926198|NCT04100096|460353331|FG001|Overall Study|Withdrawal by Participant|15|||
127926199|NCT01647711|460353332|FG000|Overall Study|Progressive disease|6|||
127926200|NCT01647711|460353333|FG001|Overall Study|Progressive disease|2|||
127926201|NCT01647711|460353334|FG002|Overall Study|Progressive disease|6|||
127926202|NCT01647711|460353335|FG003|Overall Study|Progressive disease|8|||
127926203|NCT01647711|460353336|FG004|Overall Study|Progressive disease|2|||
127926204|NCT01647711|460353332|FG000|Overall Study|Other adverse event|0|||
127926205|NCT01647711|460353333|FG001|Overall Study|Other adverse event|0|||
127926206|NCT01647711|460353334|FG002|Overall Study|Other adverse event|2|||
127926207|NCT01647711|460353335|FG003|Overall Study|Other adverse event|0|||
127926208|NCT01647711|460353336|FG004|Overall Study|Other adverse event|2|||
127926209|NCT01647711|460353332|FG000|Overall Study|Protocol Violation|0|||
127926210|NCT01647711|460353333|FG001|Overall Study|Protocol Violation|0|||
127926211|NCT01647711|460353334|FG002|Overall Study|Protocol Violation|0|||
127926212|NCT01647711|460353335|FG003|Overall Study|Protocol Violation|0|||
127926213|NCT01647711|460353336|FG004|Overall Study|Protocol Violation|1|||
127926214|NCT01647711|460353332|FG000|Overall Study|Refused to continue taking medication|0|||
127926215|NCT01647711|460353333|FG001|Overall Study|Refused to continue taking medication|0|||
127926216|NCT01647711|460353334|FG002|Overall Study|Refused to continue taking medication|0|||
127926217|NCT01647711|460353335|FG003|Overall Study|Refused to continue taking medication|2|||
127926218|NCT01647711|460353336|FG004|Overall Study|Refused to continue taking medication|1|||
127926219|NCT01647711|460353332|FG000|Overall Study|Other reason not defined|0|||
127926220|NCT01647711|460353333|FG001|Overall Study|Other reason not defined|1|||
127926221|NCT01647711|460353334|FG002|Overall Study|Other reason not defined|1|||
127926222|NCT01647711|460353335|FG003|Overall Study|Other reason not defined|1|||
127926223|NCT01647711|460353336|FG004|Overall Study|Other reason not defined|0|||
127926224|NCT01796964|460353354|FG000|Overall Study|Adverse Event|1|||
127926225|NCT01796964|460353355|FG001|Overall Study|Adverse Event|1|||
127926226|NCT01796964|460353354|FG000|Overall Study|Death|1|||
127926227|NCT01796964|460353355|FG001|Overall Study|Death|0|||
127926228|NCT01796964|460353354|FG000|Overall Study|Protocol Violation|0|||
127926229|NCT01796964|460353355|FG001|Overall Study|Protocol Violation|1|||
127926230|NCT01796964|460353354|FG000|Overall Study|Withdrawal by Subject|1|||
127926231|NCT01796964|460353355|FG001|Overall Study|Withdrawal by Subject|1|||
127926232|NCT04025684|460353356|FG000|Overall Study|Withdrawal by Subject|1|||
127926233|NCT04025684|460353357|FG001|Overall Study|Withdrawal by Subject|1|||
127926234|NCT04025684|460353358|FG002|Overall Study|Withdrawal by Subject|0|||
127926235|NCT04025684|460353359|FG003|Overall Study|Withdrawal by Subject|0|||
127926236|NCT04025684|460353356|FG000|Overall Study|Multiple reasons|1|||
127926237|NCT04025684|460353357|FG001|Overall Study|Multiple reasons|3|||
127926238|NCT04025684|460353358|FG002|Overall Study|Multiple reasons|0|||
127926239|NCT04025684|460353359|FG003|Overall Study|Multiple reasons|1|||
127926240|NCT02070757|460353360|FG000|Overall Study|Adverse Event|107|||
127926241|NCT02070757|460353361|FG001|Overall Study|Adverse Event|99|||
127926242|NCT02070757|460353360|FG000|Overall Study|Lost to Follow-up|7|||
127926243|NCT02070757|460353361|FG001|Overall Study|Lost to Follow-up|4|||
127926244|NCT02070757|460353360|FG000|Overall Study|Protocol Violation|0|||
127926245|NCT02070757|460353361|FG001|Overall Study|Protocol Violation|4|||
127926246|NCT02070757|460353360|FG000|Overall Study|Withdrawal by Subject|1|||
127926247|NCT02070757|460353361|FG001|Overall Study|Withdrawal by Subject|3|||
127926248|NCT02070757|460353360|FG000|Overall Study|Investigator Decision|0|||
127926249|NCT02070757|460353361|FG001|Overall Study|Investigator Decision|2|||
127926250|NCT02070757|460353360|FG000|Overall Study|Discharged from Study Hospital|2|||
127926251|NCT02070757|460353361|FG001|Overall Study|Discharged from Study Hospital|2|||
127926252|NCT01546922|460353362|FG000|First Period of 10 Weeks|Protocol Violation|3|||
127926253|NCT01546922|460353363|FG001|First Period of 10 Weeks|Protocol Violation|1|||
127926254|NCT01546922|460353362|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
127926255|NCT01546922|460353363|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
127926256|NCT01546922|460353362|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
127926257|NCT01546922|460353363|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
127926258|NCT01546922|460353362|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
127926259|NCT01546922|460353363|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
127926260|NCT01546922|460353362|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
127926261|NCT01546922|460353363|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
127926262|NCT01613378|460353367|FG000|Overall Study|Lack of Efficacy|13|||
127926263|NCT01613378|460353367|FG000|Overall Study|Adverse Event|11|||
127926264|NCT01613378|460353367|FG000|Overall Study|Withdrawal by Subject|8|||
127926265|NCT01613378|460353367|FG000|Overall Study|Death|2|||
127926266|NCT01613378|460353367|FG000|Overall Study|Lost to Follow-up|1|||
127926267|NCT01613378|460353367|FG000|Overall Study|Other Reason|4|||
127926268|NCT00792623|460353377|FG000|Overall Study|Adverse Event|2|||
127926269|NCT00792623|460353377|FG000|Overall Study|Withdrawal by Subject|5|||
127926270|NCT00880087|460353378|FG000|Overall Study|Lost to Follow-up|0|||
127926271|NCT00880087|460353379|FG001|Overall Study|Lost to Follow-up|2|||
127926272|NCT01470417|460353380|FG000|Overall Study|Disease progression|0|||
127926273|NCT01470417|460353381|FG001|Overall Study|Disease progression|2|||
127926274|NCT02973321|460353382|FG000|Overall Study|Other than specified|0|||
127926275|NCT02973321|460353383|FG001|Overall Study|Other than specified|5|||
127926276|NCT02973321|460353384|FG002|Overall Study|Other than specified|3|||
127926277|NCT02973321|460353385|FG003|Overall Study|Other than specified|3|||
127926278|NCT02973321|460353386|FG004|Overall Study|Other than specified|1|||
127926279|NCT02973321|460353382|FG000|Overall Study|Lack of Efficacy|0|||
127926280|NCT02973321|460353383|FG001|Overall Study|Lack of Efficacy|0|||
127926281|NCT02973321|460353384|FG002|Overall Study|Lack of Efficacy|0|||
127926282|NCT02973321|460353385|FG003|Overall Study|Lack of Efficacy|0|||
127926283|NCT02973321|460353386|FG004|Overall Study|Lack of Efficacy|1|||
127926284|NCT02973321|460353382|FG000|Overall Study|Adverse Event|1|||
127926285|NCT02973321|460353383|FG001|Overall Study|Adverse Event|10|||
127926286|NCT02973321|460353384|FG002|Overall Study|Adverse Event|11|||
127926287|NCT02973321|460353385|FG003|Overall Study|Adverse Event|13|||
127926288|NCT02973321|460353386|FG004|Overall Study|Adverse Event|3|||
127926289|NCT01790113|460353393|FG000|Overall Study|Adverse Event|2|||
127926290|NCT01790113|460353394|FG001|Overall Study|Adverse Event|7|||
127926291|NCT01790113|460353393|FG000|Overall Study|Study ended due to FDA clearance|1|||
127926292|NCT01790113|460353394|FG001|Overall Study|Study ended due to FDA clearance|68|||
127926293|NCT00194792|460353395|FG000|Overall Study|Withdrawal by Subject|1|||
127926294|NCT01714739|460353396|FG000|Overall Study|Disease progression|3|||
127926295|NCT01714739|460353397|FG001|Overall Study|Disease progression|5|||
127926296|NCT01714739|460353398|FG002|Overall Study|Disease progression|5|||
127926297|NCT01714739|460353399|FG003|Overall Study|Disease progression|204|||
127926298|NCT01714739|460353400|FG004|Overall Study|Disease progression|1|||
127926299|NCT01714739|460353401|FG005|Overall Study|Disease progression|3|||
127926300|NCT01714739|460353402|FG006|Overall Study|Disease progression|5|||
127926301|NCT01714739|460353396|FG000|Overall Study|Study drug toxicity|1|||
127926302|NCT01714739|460353397|FG001|Overall Study|Study drug toxicity|1|||
127926303|NCT01714739|460353398|FG002|Overall Study|Study drug toxicity|1|||
127926304|NCT01714739|460353399|FG003|Overall Study|Study drug toxicity|15|||
127926305|NCT01714739|460353400|FG004|Overall Study|Study drug toxicity|0|||
127926306|NCT01714739|460353401|FG005|Overall Study|Study drug toxicity|0|||
127926307|NCT01714739|460353402|FG006|Overall Study|Study drug toxicity|5|||
127926308|NCT01714739|460353396|FG000|Overall Study|Death|0|||
127926309|NCT01714739|460353397|FG001|Overall Study|Death|0|||
127926310|NCT01714739|460353398|FG002|Overall Study|Death|0|||
127926311|NCT01714739|460353399|FG003|Overall Study|Death|1|||
127926312|NCT01714739|460353400|FG004|Overall Study|Death|0|||
127926313|NCT01714739|460353401|FG005|Overall Study|Death|0|||
127926314|NCT01714739|460353402|FG006|Overall Study|Death|0|||
127926315|NCT01714739|460353396|FG000|Overall Study|Adverse Event unrelated to drug|0|||
127926316|NCT01714739|460353397|FG001|Overall Study|Adverse Event unrelated to drug|0|||
127926317|NCT01714739|460353398|FG002|Overall Study|Adverse Event unrelated to drug|3|||
127926318|NCT01714739|460353399|FG003|Overall Study|Adverse Event unrelated to drug|21|||
127926319|NCT01714739|460353400|FG004|Overall Study|Adverse Event unrelated to drug|0|||
127926320|NCT01714739|460353401|FG005|Overall Study|Adverse Event unrelated to drug|0|||
127926321|NCT01714739|460353402|FG006|Overall Study|Adverse Event unrelated to drug|0|||
127926322|NCT01714739|460353396|FG000|Overall Study|Participant request to stop therapy|0|||
127926323|NCT01714739|460353397|FG001|Overall Study|Participant request to stop therapy|1|||
127926324|NCT01714739|460353398|FG002|Overall Study|Participant request to stop therapy|0|||
127926325|NCT01714739|460353399|FG003|Overall Study|Participant request to stop therapy|6|||
127926326|NCT01714739|460353400|FG004|Overall Study|Participant request to stop therapy|0|||
127926327|NCT01714739|460353401|FG005|Overall Study|Participant request to stop therapy|0|||
127926328|NCT01714739|460353402|FG006|Overall Study|Participant request to stop therapy|0|||
127926329|NCT01714739|460353396|FG000|Overall Study|Participant withdrew consent|0|||
127926330|NCT01714739|460353397|FG001|Overall Study|Participant withdrew consent|1|||
127926331|NCT01714739|460353398|FG002|Overall Study|Participant withdrew consent|0|||
127926332|NCT01714739|460353399|FG003|Overall Study|Participant withdrew consent|8|||
127926333|NCT01714739|460353400|FG004|Overall Study|Participant withdrew consent|0|||
127926334|NCT01714739|460353401|FG005|Overall Study|Participant withdrew consent|0|||
127926335|NCT01714739|460353402|FG006|Overall Study|Participant withdrew consent|0|||
127926336|NCT01714739|460353396|FG000|Overall Study|Lost to Follow-up|0|||
127926337|NCT01714739|460353397|FG001|Overall Study|Lost to Follow-up|0|||
127926338|NCT01714739|460353398|FG002|Overall Study|Lost to Follow-up|0|||
127926339|NCT01714739|460353399|FG003|Overall Study|Lost to Follow-up|1|||
127926340|NCT01714739|460353400|FG004|Overall Study|Lost to Follow-up|0|||
127926341|NCT01714739|460353401|FG005|Overall Study|Lost to Follow-up|0|||
127926342|NCT01714739|460353402|FG006|Overall Study|Lost to Follow-up|0|||
127926343|NCT01714739|460353396|FG000|Overall Study|Maximum clinical benefit|0|||
127926344|NCT01714739|460353397|FG001|Overall Study|Maximum clinical benefit|1|||
127926345|NCT01714739|460353398|FG002|Overall Study|Maximum clinical benefit|1|||
127926346|NCT01714739|460353399|FG003|Overall Study|Maximum clinical benefit|3|||
127926347|NCT01714739|460353400|FG004|Overall Study|Maximum clinical benefit|0|||
127926348|NCT01714739|460353401|FG005|Overall Study|Maximum clinical benefit|0|||
127926349|NCT01714739|460353402|FG006|Overall Study|Maximum clinical benefit|0|||
127926350|NCT01714739|460353396|FG000|Overall Study|Poor/non-comliance|0|||
127926351|NCT01714739|460353397|FG001|Overall Study|Poor/non-comliance|1|||
127926352|NCT01714739|460353398|FG002|Overall Study|Poor/non-comliance|0|||
127926353|NCT01714739|460353399|FG003|Overall Study|Poor/non-comliance|1|||
127926354|NCT01714739|460353400|FG004|Overall Study|Poor/non-comliance|0|||
127926355|NCT01714739|460353401|FG005|Overall Study|Poor/non-comliance|0|||
127926356|NCT01714739|460353402|FG006|Overall Study|Poor/non-comliance|0|||
127926357|NCT01714739|460353396|FG000|Overall Study|No longer meets study criteria|0|||
127926358|NCT01714739|460353397|FG001|Overall Study|No longer meets study criteria|0|||
127926359|NCT01714739|460353398|FG002|Overall Study|No longer meets study criteria|0|||
127926360|NCT01714739|460353399|FG003|Overall Study|No longer meets study criteria|1|||
127926361|NCT01714739|460353400|FG004|Overall Study|No longer meets study criteria|0|||
127926362|NCT01714739|460353401|FG005|Overall Study|No longer meets study criteria|0|||
127926363|NCT01714739|460353402|FG006|Overall Study|No longer meets study criteria|0|||
127926364|NCT01714739|460353396|FG000|Overall Study|Other reason|0|||
127926365|NCT01714739|460353397|FG001|Overall Study|Other reason|0|||
127926366|NCT01714739|460353398|FG002|Overall Study|Other reason|0|||
127926367|NCT01714739|460353399|FG003|Overall Study|Other reason|3|||
127926368|NCT01714739|460353400|FG004|Overall Study|Other reason|1|||
127926369|NCT01714739|460353401|FG005|Overall Study|Other reason|0|||
127926370|NCT01714739|460353402|FG006|Overall Study|Other reason|0|||
127926371|NCT03585959|460353403|FG000|Overall Study|Physician Decision|1|||
127926372|NCT03585959|460353403|FG000|Overall Study|Unsuccessful Procedure|2|||
127926373|NCT00865514|460353404|FG000|Overall Study|Infusion cost exceeded funding|2|||
127926374|NCT03920280|460353405|FG000|Overall Study|Adverse Event|2|||
127926375|NCT03920280|460353406|FG001|Overall Study|Adverse Event|3|||
127926376|NCT03920280|460353405|FG000|Overall Study|Lost to Follow-up|0|||
127926377|NCT03920280|460353406|FG001|Overall Study|Lost to Follow-up|1|||
127926378|NCT03920280|460353405|FG000|Overall Study|Withdrawal by Subject|1|||
127926379|NCT03920280|460353406|FG001|Overall Study|Withdrawal by Subject|1|||
127926380|NCT03920280|460353405|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
127926381|NCT03920280|460353406|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
127926382|NCT01463982|460353407|FG000|Overall Study|Withdrawal by Subject|0|||
127926383|NCT01463982|460353408|FG001|Overall Study|Withdrawal by Subject|1|||
127926384|NCT01463982|460353409|FG002|Overall Study|Withdrawal by Subject|1|||
127926385|NCT01463982|460353410|FG003|Overall Study|Withdrawal by Subject|0|||
127926386|NCT01463982|460353407|FG000|Overall Study|Treatment delay over 5 week|0|||
127926387|NCT01463982|460353408|FG001|Overall Study|Treatment delay over 5 week|0|||
127926388|NCT01463982|460353409|FG002|Overall Study|Treatment delay over 5 week|1|||
127926389|NCT01463982|460353410|FG003|Overall Study|Treatment delay over 5 week|0|||
127926390|NCT04220775|460353413|FG000|Overall Study|Adverse Event|1|||
127926391|NCT04220775|460353414|FG001|Overall Study|Adverse Event|0|||
127926392|NCT04220775|460353413|FG000|Overall Study|Disease Progression|1|||
127926393|NCT04220775|460353414|FG001|Overall Study|Disease Progression|0|||
127926394|NCT00089076|460353415|FG000|Overall Study|Alternate Therapy|1|||
127926395|NCT00089076|460353415|FG000|Overall Study|Withdrawal by Subject|2|||
127926396|NCT00089076|460353415|FG000|Overall Study|Progression|7|||
127926397|NCT01009515|460353416|FG000|Overall Study|Withdrawal by Subject|3|||
127926398|NCT00983476|460353417|FG000|Overall Study|Did not receive intervention|17|||
127926399|NCT00983476|460353418|FG001|Overall Study|Did not receive intervention|22|||
127926400|NCT00983476|460353419|FG002|Overall Study|Did not receive intervention|0|||
127926401|NCT01175473|460353420|FG000|Overall Study|Adverse Event|2|||
127926402|NCT01175473|460353421|FG001|Overall Study|Adverse Event|2|||
127926403|NCT02808819|460353425|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
127926404|NCT02808819|460353426|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
127926405|NCT02808819|460353425|FG000|Overall Study|Withdrawal by Subject|10|||
127926406|NCT02808819|460353426|FG001|Overall Study|Withdrawal by Subject|13|||
127926407|NCT02808819|460353425|FG000|Overall Study|Site terminated by sponsor|2|||
127926408|NCT02808819|460353426|FG001|Overall Study|Site terminated by sponsor|0|||
127926409|NCT02808819|460353425|FG000|Overall Study|Pregnancy|1|||
127926410|NCT02808819|460353426|FG001|Overall Study|Pregnancy|0|||
127926411|NCT02808819|460353425|FG000|Overall Study|Lost to Follow-up|1|||
127926412|NCT02808819|460353426|FG001|Overall Study|Lost to Follow-up|6|||
127926413|NCT02808819|460353425|FG000|Overall Study|Protocol Violation|0|||
127926414|NCT02808819|460353426|FG001|Overall Study|Protocol Violation|1|||
127926415|NCT02808819|460353425|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
127926416|NCT02808819|460353426|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
127926417|NCT02808819|460353425|FG000|Overall Study|Death|1|||
127926418|NCT02808819|460353426|FG001|Overall Study|Death|0|||
127926419|NCT02808819|460353425|FG000|Overall Study|Adverse Event|3|||
127926420|NCT02808819|460353426|FG001|Overall Study|Adverse Event|4|||
127926421|NCT00003531|460353427|FG000|Overall Study|Not evaluable|10|||
127926422|NCT00588731|460353428|FG000|Overall Study|Withdrawal by Subject|3|||
127926423|NCT00588731|460353429|FG001|Overall Study|Withdrawal by Subject|2|||
127926424|NCT00251316|460353430|FG000|Overall Study|Physician Decision|2|||
127926425|NCT00251316|460353431|FG001|Overall Study|Physician Decision|3|||
127926426|NCT00346164|460353432|FG000|Overall Study|Adverse Event|0|||
127926427|NCT00346164|460353433|FG001|Overall Study|Adverse Event|0|||
127926428|NCT00346164|460353434|FG002|Overall Study|Adverse Event|0|||
127926429|NCT00346164|460353435|FG003|Overall Study|Adverse Event|1|||
127926430|NCT00346164|460353432|FG000|Overall Study|Lack of Efficacy|0|||
127926431|NCT00346164|460353433|FG001|Overall Study|Lack of Efficacy|1|||
127926432|NCT00346164|460353434|FG002|Overall Study|Lack of Efficacy|7|||
127926433|NCT00346164|460353435|FG003|Overall Study|Lack of Efficacy|25|||
127926434|NCT00346164|460353432|FG000|Overall Study|Physician Decision|0|||
127926435|NCT00346164|460353433|FG001|Overall Study|Physician Decision|1|||
127926436|NCT00346164|460353434|FG002|Overall Study|Physician Decision|2|||
127926437|NCT00346164|460353435|FG003|Overall Study|Physician Decision|27|||
127926438|NCT00346164|460353432|FG000|Overall Study|Protocol Violation|6|||
127926439|NCT00346164|460353433|FG001|Overall Study|Protocol Violation|2|||
127926440|NCT00346164|460353434|FG002|Overall Study|Protocol Violation|10|||
127926441|NCT00346164|460353435|FG003|Overall Study|Protocol Violation|4|||
127926442|NCT00346164|460353432|FG000|Overall Study|Withdrawal by Subject|0|||
127926443|NCT00346164|460353433|FG001|Overall Study|Withdrawal by Subject|0|||
127926444|NCT00346164|460353434|FG002|Overall Study|Withdrawal by Subject|2|||
127926445|NCT00346164|460353435|FG003|Overall Study|Withdrawal by Subject|0|||
127926446|NCT00346164|460353432|FG000|Overall Study|Ineligible|11|||
127926447|NCT00346164|460353433|FG001|Overall Study|Ineligible|2|||
127926448|NCT00346164|460353434|FG002|Overall Study|Ineligible|2|||
127926449|NCT00346164|460353435|FG003|Overall Study|Ineligible|23|||
127926450|NCT00346164|460353432|FG000|Overall Study|Refusal of further protocol therapy|0|||
127926451|NCT00346164|460353433|FG001|Overall Study|Refusal of further protocol therapy|1|||
127926452|NCT00346164|460353434|FG002|Overall Study|Refusal of further protocol therapy|3|||
127926453|NCT00346164|460353435|FG003|Overall Study|Refusal of further protocol therapy|15|||
127926454|NCT00346164|460353432|FG000|Overall Study|Inability to start week 16 tx on time|0|||
127926455|NCT00346164|460353433|FG001|Overall Study|Inability to start week 16 tx on time|0|||
127926456|NCT00346164|460353434|FG002|Overall Study|Inability to start week 16 tx on time|0|||
127926457|NCT00346164|460353435|FG003|Overall Study|Inability to start week 16 tx on time|11|||
127926458|NCT01198873|460353436|FG000|Overall Study|Adverse Event|4|||
127926459|NCT01198873|460353437|FG001|Overall Study|Adverse Event|7|||
127926460|NCT01198873|460353436|FG000|Overall Study|Study closure|29|||
127926461|NCT01198873|460353437|FG001|Overall Study|Study closure|23|||
127926462|NCT01198873|460353436|FG000|Overall Study|Other than above|4|||
127926463|NCT01198873|460353437|FG001|Overall Study|Other than above|2|||
127926464|NCT03139240|460353438|FG000|Overall Study|Lost to Follow-up|0|||
127926465|NCT03139240|460353439|FG001|Overall Study|Lost to Follow-up|1|||
127926466|NCT03139240|460353440|FG002|Overall Study|Lost to Follow-up|1|||
127926467|NCT03139240|460353441|FG003|Overall Study|Lost to Follow-up|0|||
127926468|NCT00823199|460353442|FG000|Overall Study|Withdrawal by Subject|2|||
127926469|NCT01998243|460353443|FG000|Overall Study|Pregnancy|0|||
127926470|NCT01998243|460353444|FG001|Overall Study|Pregnancy|1|||
127926471|NCT01998243|460353443|FG000|Overall Study|Protocol Violation|5|||
127926472|NCT01998243|460353444|FG001|Overall Study|Protocol Violation|2|||
127926473|NCT01998243|460353443|FG000|Overall Study|Withdrawal by Subject|3|||
127926474|NCT01998243|460353444|FG001|Overall Study|Withdrawal by Subject|4|||
127926475|NCT00268892|460353445|FG000|Overall Study|Adverse Event|14|||
127926476|NCT00268892|460353446|FG001|Overall Study|Adverse Event|17|||
127926477|NCT00268892|460353447|FG002|Overall Study|Adverse Event|20|||
127926478|NCT00268892|460353445|FG000|Overall Study|Lack of Efficacy|1|||
127926479|NCT00268892|460353446|FG001|Overall Study|Lack of Efficacy|3|||
127926480|NCT00268892|460353447|FG002|Overall Study|Lack of Efficacy|0|||
127926481|NCT00268892|460353445|FG000|Overall Study|Withdrawal by Subject|14|||
127926482|NCT00268892|460353446|FG001|Overall Study|Withdrawal by Subject|15|||
127926483|NCT00268892|460353447|FG002|Overall Study|Withdrawal by Subject|13|||
127926484|NCT00268892|460353445|FG000|Overall Study|Physician Decision|0|||
127926485|NCT00268892|460353446|FG001|Overall Study|Physician Decision|1|||
127926486|NCT00268892|460353447|FG002|Overall Study|Physician Decision|0|||
127926487|NCT00268892|460353445|FG000|Overall Study|Lost to Follow-up|5|||
127926488|NCT00268892|460353446|FG001|Overall Study|Lost to Follow-up|2|||
127926489|NCT00268892|460353447|FG002|Overall Study|Lost to Follow-up|4|||
127926490|NCT00268892|460353445|FG000|Overall Study|Protocol Violation|0|||
127926491|NCT00268892|460353446|FG001|Overall Study|Protocol Violation|1|||
127926492|NCT00268892|460353447|FG002|Overall Study|Protocol Violation|0|||
127926493|NCT00268892|460353445|FG000|Overall Study|Disease Progression|1|||
127926494|NCT00268892|460353446|FG001|Overall Study|Disease Progression|1|||
127926495|NCT00268892|460353447|FG002|Overall Study|Disease Progression|0|||
127926496|NCT00268892|460353445|FG000|Overall Study|Trial Site Closed|4|||
127926497|NCT00268892|460353446|FG001|Overall Study|Trial Site Closed|2|||
127926498|NCT00268892|460353447|FG002|Overall Study|Trial Site Closed|2|||
127926499|NCT04569786|460353448|FG000|Overall Study|Lost to Follow-up|1|||
127926500|NCT04569786|460353449|FG001|Overall Study|Lost to Follow-up|0|||
127926501|NCT04569786|460353450|FG002|Overall Study|Lost to Follow-up|4|||
127926502|NCT04569786|460353451|FG003|Overall Study|Lost to Follow-up|1|||
127926503|NCT04569786|460353452|FG004|Overall Study|Lost to Follow-up|0|||
127926504|NCT04569786|460353448|FG000|Overall Study|Withdrawal by Subject|0|||
127926505|NCT04569786|460353449|FG001|Overall Study|Withdrawal by Subject|0|||
127926506|NCT04569786|460353450|FG002|Overall Study|Withdrawal by Subject|0|||
127926507|NCT04569786|460353451|FG003|Overall Study|Withdrawal by Subject|5|||
127926508|NCT04569786|460353452|FG004|Overall Study|Withdrawal by Subject|1|||
127926509|NCT04569786|460353448|FG000|Overall Study|Physician Decision|0|||
127926510|NCT04569786|460353449|FG001|Overall Study|Physician Decision|0|||
127926511|NCT04569786|460353450|FG002|Overall Study|Physician Decision|0|||
127926512|NCT04569786|460353451|FG003|Overall Study|Physician Decision|1|||
127926513|NCT04569786|460353452|FG004|Overall Study|Physician Decision|0|||
127926514|NCT01640184|460353453|FG000|Overall Study|Death|1|||
127926515|NCT01640184|460353454|FG001|Overall Study|Death|0|||
127926516|NCT01640184|460353455|FG002|Overall Study|Death|0|||
127926517|NCT01640184|460353453|FG000|Overall Study|Lost to Follow-up|4|||
127926518|NCT01640184|460353454|FG001|Overall Study|Lost to Follow-up|1|||
127926519|NCT01640184|460353455|FG002|Overall Study|Lost to Follow-up|0|||
127926520|NCT01640184|460353453|FG000|Overall Study|Physician Decision|3|||
127926521|NCT01640184|460353454|FG001|Overall Study|Physician Decision|0|||
127926522|NCT01640184|460353455|FG002|Overall Study|Physician Decision|0|||
127926523|NCT01640184|460353453|FG000|Overall Study|Withdrawal by Subject|0|||
127926524|NCT01640184|460353454|FG001|Overall Study|Withdrawal by Subject|1|||
127926525|NCT01640184|460353455|FG002|Overall Study|Withdrawal by Subject|1|||
127926526|NCT01640184|460353453|FG000|Overall Study|Protocol Violation|0|||
127926527|NCT01640184|460353454|FG001|Overall Study|Protocol Violation|0|||
127926528|NCT01640184|460353455|FG002|Overall Study|Protocol Violation|1|||
127926529|NCT01435031|460353459|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
127926530|NCT01435031|460353459|FG000|ITT at 1 Month|Death|1|||
127926531|NCT01435031|460353459|FG000|ITT at 1 Month|Lost to Follow-up|4|||
127926532|NCT01435031|460353459|FG000|ITT at 6 Months|Death|2|||
127926533|NCT01435031|460353459|FG000|ITT at 6 Months|Lost to Follow-up|3|||
127926534|NCT01435031|460353459|FG000|ITT at 1 Year|Death|1|||
127926535|NCT01435031|460353459|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
127926536|NCT01435031|460353459|FG000|ITT at 1 Year|Lost to Follow-up|6|||
127926537|NCT01435031|460353459|FG000|ITT at 2 Years|Death|7|||
127926538|NCT01435031|460353459|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
127926539|NCT01435031|460353459|FG000|ITT at 2 Years|Lost to Follow-up|4|||
127926540|NCT01435031|460353459|FG000|ITT at 3 Years|Death|5|||
127926541|NCT01435031|460353459|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
127926542|NCT01435031|460353459|FG000|ITT at 3 Years|Lost to Follow-up|4|||
127926543|NCT01435031|460353459|FG000|ITT at 4 Years|Death|4|||
127926544|NCT01435031|460353459|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
127926545|NCT01435031|460353459|FG000|ITT at 4 Years|Lost to Follow-up|1|||
127926546|NCT02260258|460353462|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
127926547|NCT02260258|460353463|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
127926548|NCT02563769|460353464|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
127926549|NCT02563769|460353465|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
127926550|NCT02563769|460353466|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
127926551|NCT00690482|460353469|FG000|Overall Study|Adverse Event|2|||
127926552|NCT00690482|460353470|FG001|Overall Study|Adverse Event|1|||
127926553|NCT00690482|460353469|FG000|Overall Study|Incorrect enrolment|0|||
127926554|NCT00690482|460353470|FG001|Overall Study|Incorrect enrolment|1|||
127926555|NCT00690482|460353469|FG000|Overall Study|Study-specific discontinuation criteria|1|||
127926556|NCT00690482|460353470|FG001|Overall Study|Study-specific discontinuation criteria|0|||
127926557|NCT00690482|460353469|FG000|Overall Study|Intake of prohibited medicine|1|||
127926558|NCT00690482|460353470|FG001|Overall Study|Intake of prohibited medicine|0|||
127926559|NCT00690482|460353469|FG000|Overall Study|withdrew consent at rand.day|0|||
127926560|NCT00690482|460353470|FG001|Overall Study|withdrew consent at rand.day|1|||
127926561|NCT01610063|460353471|FG000|Overall Study|Lost to Follow-up|42|||
127926562|NCT01610063|460353472|FG001|Overall Study|Lost to Follow-up|20|||
127926563|NCT04405739|460353473|FG000|Overall Study|Adverse Event|0|||
127926564|NCT04405739|460353474|FG001|Overall Study|Adverse Event|1|||
127926565|NCT04405739|460353475|FG002|Overall Study|Adverse Event|0|||
127926566|NCT04405739|460353476|FG003|Overall Study|Adverse Event|0|||
127926567|NCT04405739|460353473|FG000|Overall Study|Lost to Follow-up|0|||
127926568|NCT04405739|460353474|FG001|Overall Study|Lost to Follow-up|2|||
127926569|NCT04405739|460353475|FG002|Overall Study|Lost to Follow-up|1|||
127926570|NCT04405739|460353476|FG003|Overall Study|Lost to Follow-up|3|||
127926571|NCT04405739|460353473|FG000|Overall Study|Withdrawal by Subject|0|||
127926572|NCT04405739|460353474|FG001|Overall Study|Withdrawal by Subject|2|||
127926573|NCT04405739|460353475|FG002|Overall Study|Withdrawal by Subject|1|||
127926574|NCT04405739|460353476|FG003|Overall Study|Withdrawal by Subject|1|||
127926575|NCT04405739|460353473|FG000|Overall Study|Death|0|||
127926576|NCT04405739|460353474|FG001|Overall Study|Death|0|||
127926577|NCT04405739|460353475|FG002|Overall Study|Death|1|||
127926578|NCT04405739|460353476|FG003|Overall Study|Death|0|||
127926579|NCT04405739|460353473|FG000|Overall Study|Transferred to rehab|0|||
127926580|NCT04405739|460353474|FG001|Overall Study|Transferred to rehab|0|||
127926581|NCT04405739|460353475|FG002|Overall Study|Transferred to rehab|0|||
127926582|NCT04405739|460353476|FG003|Overall Study|Transferred to rehab|1|||
127926583|NCT04405739|460353473|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
127926584|NCT04405739|460353474|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
127926585|NCT04405739|460353475|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
127926586|NCT04405739|460353476|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
127926587|NCT01436643|460353477|FG000|2-week Pre-treatment|Abnormal test result|0|||
127926588|NCT01436643|460353478|FG001|2-week Pre-treatment|Abnormal test result|0|||
127926589|NCT01436643|460353479|FG002|2-week Pre-treatment|Abnormal test result|0|||
127926590|NCT01436643|460353480|FG003|2-week Pre-treatment|Abnormal test result|1|||
127926591|NCT01436643|460353477|FG000|2-week Pre-treatment|Adverse Event|0|||
127926592|NCT01436643|460353478|FG001|2-week Pre-treatment|Adverse Event|0|||
127926593|NCT01436643|460353479|FG002|2-week Pre-treatment|Adverse Event|0|||
127926594|NCT01436643|460353480|FG003|2-week Pre-treatment|Adverse Event|5|||
127926595|NCT01436643|460353477|FG000|2-week Pre-treatment|Protocol Violation|0|||
127926596|NCT01436643|460353478|FG001|2-week Pre-treatment|Protocol Violation|0|||
127926597|NCT01436643|460353479|FG002|2-week Pre-treatment|Protocol Violation|0|||
127926598|NCT01436643|460353480|FG003|2-week Pre-treatment|Protocol Violation|4|||
127926599|NCT01436643|460353477|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
127926600|NCT01436643|460353478|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
127926601|NCT01436643|460353479|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
127926602|NCT01436643|460353480|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
127926603|NCT01436643|460353477|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
127926604|NCT01436643|460353478|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
127926605|NCT01436643|460353479|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
127926606|NCT01436643|460353480|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
127926607|NCT01436643|460353477|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
127926608|NCT01436643|460353478|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
127926609|NCT01436643|460353479|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
127926610|NCT01436643|460353480|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
127926611|NCT03718117|460353481|FG000|Overall Study|Death|12|||
127926612|NCT03718117|460353482|FG001|Overall Study|Death|11|||
127926613|NCT03718117|460353483|FG002|Overall Study|Death|0|||
127926614|NCT03718117|460353481|FG000|Overall Study|Other|0|||
127926615|NCT03718117|460353482|FG001|Overall Study|Other|1|||
127926616|NCT03718117|460353483|FG002|Overall Study|Other|0|||
127926617|NCT03718117|460353481|FG000|Overall Study|Withdrawn due to adverse event (AE)|2|||
127926618|NCT03718117|460353482|FG001|Overall Study|Withdrawn due to adverse event (AE)|0|||
127926619|NCT03718117|460353483|FG002|Overall Study|Withdrawn due to adverse event (AE)|0|||
127926620|NCT03718117|460353481|FG000|Overall Study|Participant not met eligibility criteria|0|||
127926621|NCT03718117|460353482|FG001|Overall Study|Participant not met eligibility criteria|0|||
127926622|NCT03718117|460353483|FG002|Overall Study|Participant not met eligibility criteria|2|||
127926623|NCT02056652|460353489|FG000|Overall Study|Withdrawal by Subject|1|||
127926624|NCT02056652|460353490|FG001|Overall Study|Withdrawal by Subject|0|||
127926625|NCT02056652|460353489|FG000|Overall Study|Lost to Follow-up|0|||
127926626|NCT02056652|460353490|FG001|Overall Study|Lost to Follow-up|3|||
127926627|NCT03234608|460353491|FG000|Overall Study|Lost to Follow-up|23|||
127926628|NCT03234608|460353492|FG001|Overall Study|Lost to Follow-up|21|||
127926629|NCT02105701|460353493|FG000|Overall Study|Lost to Follow-up|1|||
127926630|NCT02105701|460353494|FG001|Overall Study|Lost to Follow-up|0|||
127926631|NCT02105701|460353495|FG002|Overall Study|Lost to Follow-up|2|||
127926632|NCT02105701|460353496|FG003|Overall Study|Lost to Follow-up|1|||
127926633|NCT02105701|460353493|FG000|Overall Study|Protocol Violation|0|||
127926634|NCT02105701|460353494|FG001|Overall Study|Protocol Violation|0|||
127926635|NCT02105701|460353495|FG002|Overall Study|Protocol Violation|1|||
127926636|NCT02105701|460353496|FG003|Overall Study|Protocol Violation|0|||
127926637|NCT02105701|460353493|FG000|Overall Study|Withdrawal by Subject|2|||
127926638|NCT02105701|460353494|FG001|Overall Study|Withdrawal by Subject|1|||
127926639|NCT02105701|460353495|FG002|Overall Study|Withdrawal by Subject|0|||
127926640|NCT02105701|460353496|FG003|Overall Study|Withdrawal by Subject|1|||
127926641|NCT02105701|460353493|FG000|Overall Study|Death|1|||
127926642|NCT02105701|460353494|FG001|Overall Study|Death|0|||
127926643|NCT02105701|460353495|FG002|Overall Study|Death|0|||
127926644|NCT02105701|460353496|FG003|Overall Study|Death|0|||
127926645|NCT00739973|460353497|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
127926646|NCT00739973|460353498|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
127926647|NCT00739973|460353499|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
127926648|NCT00739973|460353500|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
127926649|NCT00739973|460353501|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
127926650|NCT00739973|460353502|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
127926651|NCT00739973|460353503|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
127926652|NCT00739973|460353504|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
127926653|NCT00739973|460353505|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
127926654|NCT00739973|460353497|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
127926655|NCT00739973|460353498|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
127926656|NCT00739973|460353499|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
127926657|NCT00739973|460353500|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
127926658|NCT00739973|460353501|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
127926659|NCT00739973|460353502|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
127926660|NCT00739973|460353503|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
127926661|NCT00739973|460353504|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
127926662|NCT00739973|460353505|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
127926663|NCT00739973|460353497|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
127926664|NCT00739973|460353498|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
127926665|NCT00739973|460353499|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
127926666|NCT00739973|460353500|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
127926667|NCT00739973|460353501|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
127926668|NCT00739973|460353502|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
127926669|NCT00739973|460353503|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
127926670|NCT00739973|460353504|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
127926671|NCT00739973|460353505|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
127926672|NCT00739973|460353497|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
127926673|NCT00739973|460353498|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
127926674|NCT00739973|460353499|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
127926675|NCT00739973|460353500|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
127926676|NCT00739973|460353501|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
127926677|NCT00739973|460353502|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
127926678|NCT00739973|460353503|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
127926679|NCT00739973|460353504|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
127926680|NCT00739973|460353505|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
127926681|NCT00739973|460353497|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
127926682|NCT00739973|460353498|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
127926683|NCT00739973|460353499|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
127926684|NCT00739973|460353500|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
127926685|NCT00739973|460353501|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
127926686|NCT00739973|460353502|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
127926687|NCT00739973|460353503|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
127926688|NCT00739973|460353504|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
127926689|NCT00739973|460353505|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
127926690|NCT00739973|460353497|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
127926691|NCT00739973|460353498|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
127926692|NCT00739973|460353499|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
127926693|NCT00739973|460353500|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
127926694|NCT00739973|460353501|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
127926695|NCT00739973|460353502|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
127926696|NCT00739973|460353503|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
127926697|NCT00739973|460353504|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
127926698|NCT00739973|460353505|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
127926699|NCT00739973|460353497|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
127926700|NCT00739973|460353498|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
127926701|NCT00739973|460353499|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
127926702|NCT00739973|460353500|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
127926703|NCT00739973|460353501|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
127926704|NCT00739973|460353502|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
127926705|NCT00739973|460353503|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
127926706|NCT00739973|460353504|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
127926707|NCT00739973|460353505|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
127926708|NCT00739973|460353497|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
127926709|NCT00739973|460353498|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
127926710|NCT00739973|460353499|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
127926711|NCT00739973|460353500|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
127926712|NCT00739973|460353501|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
127926713|NCT00739973|460353502|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
127926714|NCT00739973|460353503|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
127926715|NCT00739973|460353504|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
127926716|NCT00739973|460353505|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
127926717|NCT00739973|460353497|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
127926718|NCT00739973|460353498|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
127926719|NCT00739973|460353499|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
127926720|NCT00739973|460353500|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
127926721|NCT00739973|460353501|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
127926722|NCT00739973|460353502|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
127926723|NCT00739973|460353503|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
127926724|NCT00739973|460353504|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
127926725|NCT00739973|460353505|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
127926726|NCT00739973|460353497|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
127926727|NCT00739973|460353498|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
127926728|NCT00739973|460353499|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
127926729|NCT00739973|460353500|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
127926730|NCT00739973|460353501|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
127926731|NCT00739973|460353502|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
127926732|NCT00739973|460353503|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
127926733|NCT00739973|460353504|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
127926734|NCT00739973|460353505|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
127926735|NCT00739973|460353497|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
127926736|NCT00739973|460353498|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
127926737|NCT00739973|460353499|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
127926738|NCT00739973|460353500|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
127926739|NCT00739973|460353501|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
127926740|NCT00739973|460353502|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
127926741|NCT00739973|460353503|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
127926742|NCT00739973|460353504|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
127926743|NCT00739973|460353505|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
127926744|NCT00739973|460353497|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
127926745|NCT00739973|460353498|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
127926746|NCT00739973|460353499|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
127926747|NCT00739973|460353500|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
127926748|NCT00739973|460353501|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
127926749|NCT00739973|460353502|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
127926750|NCT00739973|460353503|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
127926751|NCT00739973|460353504|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
127926752|NCT00739973|460353505|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
127926753|NCT00739973|460353497|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
127926754|NCT00739973|460353498|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
127926755|NCT00739973|460353499|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
127926756|NCT00739973|460353500|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
127926757|NCT00739973|460353501|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
127926758|NCT00739973|460353502|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
127926759|NCT00739973|460353503|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
127926760|NCT00739973|460353504|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
127926761|NCT00739973|460353505|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
127926762|NCT00739973|460353497|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
127926763|NCT00739973|460353498|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
127926764|NCT00739973|460353499|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
127926765|NCT00739973|460353500|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
127926766|NCT00739973|460353501|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
127926767|NCT00739973|460353502|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
127926768|NCT00739973|460353503|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
127926769|NCT00739973|460353504|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
127926770|NCT00739973|460353505|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
127926771|NCT00739973|460353497|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
127926772|NCT00739973|460353498|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
127926773|NCT00739973|460353499|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
127926774|NCT00739973|460353500|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
127926775|NCT00739973|460353501|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
127926776|NCT00739973|460353502|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
127926777|NCT00739973|460353503|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
127926778|NCT00739973|460353504|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
127926779|NCT00739973|460353505|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
127926780|NCT00739973|460353497|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
127926781|NCT00739973|460353498|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
127926782|NCT00739973|460353499|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
127926783|NCT00739973|460353500|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
127926784|NCT00739973|460353501|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
127926785|NCT00739973|460353502|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
127926786|NCT00739973|460353503|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
127926787|NCT00739973|460353504|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
127926788|NCT00739973|460353505|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
127926789|NCT00739973|460353497|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
127926790|NCT00739973|460353498|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
127926791|NCT00739973|460353499|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
127926792|NCT00739973|460353500|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
127926793|NCT00739973|460353501|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
127926794|NCT00739973|460353502|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
127926795|NCT00739973|460353503|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
127926796|NCT00739973|460353504|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
127926797|NCT00739973|460353505|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
127926798|NCT03078478|460353506|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
127926799|NCT03078478|460353507|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
127926800|NCT03078478|460353506|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
127926801|NCT03078478|460353507|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
127926802|NCT03078478|460353506|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
127926803|NCT03078478|460353507|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
127926804|NCT03078478|460353506|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
127926805|NCT03078478|460353507|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
127926806|NCT03078478|460353506|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
127926807|NCT03078478|460353507|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
127926808|NCT03078478|460353506|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
127926809|NCT03078478|460353507|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
127926810|NCT03078478|460353506|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
127926811|NCT03078478|460353507|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
127926812|NCT03078478|460353506|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
127926813|NCT03078478|460353507|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
127926814|NCT03253094|460353508|FG000|Overall Study|Adverse Event|2|||
127926815|NCT03253094|460353509|FG001|Overall Study|Adverse Event|0|||
127926816|NCT03253094|460353510|FG002|Overall Study|Adverse Event|0|||
127926817|NCT03253094|460353511|FG003|Overall Study|Adverse Event|0|||
127926818|NCT03253094|460353512|FG004|Overall Study|Adverse Event|0|||
127926819|NCT03253094|460353513|FG005|Overall Study|Adverse Event|0|||
127926820|NCT03253094|460353508|FG000|Overall Study|Lack of Efficacy|0|||
127926821|NCT03253094|460353509|FG001|Overall Study|Lack of Efficacy|0|||
127926822|NCT03253094|460353510|FG002|Overall Study|Lack of Efficacy|2|||
127926823|NCT03253094|460353511|FG003|Overall Study|Lack of Efficacy|1|||
127926824|NCT03253094|460353512|FG004|Overall Study|Lack of Efficacy|2|||
127926825|NCT03253094|460353513|FG005|Overall Study|Lack of Efficacy|1|||
127926826|NCT03253094|460353508|FG000|Overall Study|Lost to Follow-up|0|||
127926827|NCT03253094|460353509|FG001|Overall Study|Lost to Follow-up|0|||
127926828|NCT03253094|460353510|FG002|Overall Study|Lost to Follow-up|1|||
127926829|NCT03253094|460353511|FG003|Overall Study|Lost to Follow-up|1|||
127926830|NCT03253094|460353512|FG004|Overall Study|Lost to Follow-up|0|||
127926831|NCT03253094|460353513|FG005|Overall Study|Lost to Follow-up|1|||
127926832|NCT03253094|460353508|FG000|Overall Study|Physician Decision|1|||
127926833|NCT03253094|460353509|FG001|Overall Study|Physician Decision|0|||
127926834|NCT03253094|460353510|FG002|Overall Study|Physician Decision|0|||
127926835|NCT03253094|460353511|FG003|Overall Study|Physician Decision|1|||
127926836|NCT03253094|460353512|FG004|Overall Study|Physician Decision|0|||
127926837|NCT03253094|460353513|FG005|Overall Study|Physician Decision|2|||
127926838|NCT03253094|460353508|FG000|Overall Study|Withdrawal by Subject|1|||
127926839|NCT03253094|460353509|FG001|Overall Study|Withdrawal by Subject|2|||
127926840|NCT03253094|460353510|FG002|Overall Study|Withdrawal by Subject|1|||
127926841|NCT03253094|460353511|FG003|Overall Study|Withdrawal by Subject|0|||
127926842|NCT03253094|460353512|FG004|Overall Study|Withdrawal by Subject|3|||
127926843|NCT03253094|460353513|FG005|Overall Study|Withdrawal by Subject|0|||
127926844|NCT03253094|460353508|FG000|Overall Study|Other|0|||
127926845|NCT03253094|460353509|FG001|Overall Study|Other|1|||
127926846|NCT03253094|460353510|FG002|Overall Study|Other|2|||
127926847|NCT03253094|460353511|FG003|Overall Study|Other|1|||
127926848|NCT03253094|460353512|FG004|Overall Study|Other|0|||
127926849|NCT03253094|460353513|FG005|Overall Study|Other|0|||
127926850|NCT02339090|460353514|FG000|Overall Study|Adverse Event|1|||
127926851|NCT02339090|460353515|FG001|Overall Study|Adverse Event|0|||
127926852|NCT02339090|460353514|FG000|Overall Study|Lost to Follow-up|0|||
127926853|NCT02339090|460353515|FG001|Overall Study|Lost to Follow-up|1|||
127926854|NCT02339090|460353514|FG000|Overall Study|Non-compliance With Study Drug|0|||
127926855|NCT02339090|460353515|FG001|Overall Study|Non-compliance With Study Drug|1|||
127926856|NCT02339090|460353514|FG000|Overall Study|Withdrawal by Subject|2|||
127926857|NCT02339090|460353515|FG001|Overall Study|Withdrawal by Subject|1|||
127926858|NCT02339090|460353514|FG000|Overall Study|Poor Growth|3|||
127926859|NCT02339090|460353515|FG001|Overall Study|Poor Growth|0|||
127926860|NCT02339090|460353514|FG000|Overall Study|Randomized but not treated|0|||
127926861|NCT02339090|460353515|FG001|Overall Study|Randomized but not treated|2|||
127926862|NCT00749411|460353522|FG000|Overall Study|Adverse Event|0|||
127926863|NCT00749411|460353523|FG001|Overall Study|Adverse Event|2|||
127926864|NCT00749411|460353522|FG000|Overall Study|Lack of Efficacy|0|||
127926865|NCT00749411|460353523|FG001|Overall Study|Lack of Efficacy|1|||
127926866|NCT00749411|460353522|FG000|Overall Study|Protocol Violation|1|||
127926867|NCT00749411|460353523|FG001|Overall Study|Protocol Violation|1|||
127926868|NCT00749411|460353522|FG000|Overall Study|Protocol-defined stopping criteria|0|||
127926869|NCT00749411|460353523|FG001|Overall Study|Protocol-defined stopping criteria|1|||
127926870|NCT03183141|460353524|FG000|Overall Study|Withdrawal by Subject|2|||
127926871|NCT03183141|460353525|FG001|Overall Study|Withdrawal by Subject|4|||
127926872|NCT03183141|460353524|FG000|Overall Study|Death|0|||
127926873|NCT03183141|460353525|FG001|Overall Study|Death|8|||
127926874|NCT02756637|460353527|FG000|Overall Study|Not eligible for initial SWOG study|10|||
127926875|NCT02756637|460353528|FG001|Overall Study|Not eligible for initial SWOG study|10|||
127926876|NCT02756637|460353527|FG000|Overall Study|No available NLR value|44|||
127926877|NCT02756637|460353528|FG001|Overall Study|No available NLR value|44|||
127926878|NCT02756637|460353527|FG000|Overall Study|Did not complete curative therapy|33|||
127926879|NCT02756637|460353528|FG001|Overall Study|Did not complete curative therapy|0|||
127926880|NCT01507090|460353529|FG000|Overall Study|incomplete dataset|18|||
127926881|NCT04034355|460353532|FG000|Overall Study|Study terminated by Sponsor|10|||
127926882|NCT04034355|460353533|FG001|Overall Study|Study terminated by Sponsor|17|||
127926883|NCT04034355|460353532|FG000|Overall Study|Withdrawal by Subject|12|||
127926884|NCT04034355|460353533|FG001|Overall Study|Withdrawal by Subject|11|||
127926885|NCT04034355|460353532|FG000|Overall Study|Site terminated by Sponsor|4|||
127926886|NCT04034355|460353533|FG001|Overall Study|Site terminated by Sponsor|5|||
127926887|NCT04034355|460353532|FG000|Overall Study|Adverse Event|2|||
127926888|NCT04034355|460353533|FG001|Overall Study|Adverse Event|0|||
127926889|NCT04034355|460353532|FG000|Overall Study|Death|1|||
127926890|NCT04034355|460353533|FG001|Overall Study|Death|1|||
127926891|NCT04034355|460353532|FG000|Overall Study|Not reported|2|||
127926892|NCT04034355|460353533|FG001|Overall Study|Not reported|0|||
127926893|NCT04034355|460353532|FG000|Overall Study|Lost to Follow-up|1|||
127926894|NCT04034355|460353533|FG001|Overall Study|Lost to Follow-up|0|||
127926895|NCT04034355|460353532|FG000|Overall Study|Physician Decision|1|||
127926896|NCT04034355|460353533|FG001|Overall Study|Physician Decision|0|||
127926897|NCT04034355|460353532|FG000|Overall Study|Protocol Violation|0|||
127926898|NCT04034355|460353533|FG001|Overall Study|Protocol Violation|1|||
127926899|NCT04034355|460353532|FG000|Overall Study|Progressive disease|1|||
127926900|NCT04034355|460353533|FG001|Overall Study|Progressive disease|0|||
127926901|NCT02190279|460355685|FG000|Overall Study|Withdrawal consent|1|||
127926902|NCT02190279|460355686|FG001|Overall Study|Withdrawal consent|0|||
127926903|NCT02190279|460355687|FG002|Overall Study|Withdrawal consent|1|||
127926904|NCT02190279|460355685|FG000|Overall Study|Lost to Follow-up|2|||
127926905|NCT02190279|460355686|FG001|Overall Study|Lost to Follow-up|0|||
127926906|NCT02190279|460355687|FG002|Overall Study|Lost to Follow-up|0|||
127926907|NCT02190279|460355685|FG000|Overall Study|Refused further treatment|0|||
127926908|NCT02190279|460355686|FG001|Overall Study|Refused further treatment|0|||
127926909|NCT02190279|460355687|FG002|Overall Study|Refused further treatment|1|||
127926910|NCT02190279|460355685|FG000|Overall Study|Screening failure|0|||
127926911|NCT02190279|460355686|FG001|Overall Study|Screening failure|0|||
127926912|NCT02190279|460355687|FG002|Overall Study|Screening failure|1|||
127926913|NCT00546910|460355688|FG000|Overall Study|Adverse Event|2|||
127926914|NCT00546910|460355689|FG001|Overall Study|Adverse Event|3|||
127926915|NCT00546910|460355688|FG000|Overall Study|Lack of Efficacy|5|||
127926916|NCT00546910|460355689|FG001|Overall Study|Lack of Efficacy|7|||
127926917|NCT00546910|460355688|FG000|Overall Study|Physician Decision|0|||
127926918|NCT00546910|460355689|FG001|Overall Study|Physician Decision|1|||
127926919|NCT00546910|460355688|FG000|Overall Study|Withdrawal by Subject|2|||
127926920|NCT00546910|460355689|FG001|Overall Study|Withdrawal by Subject|0|||
127926921|NCT01115855|460355690|FG000|Overall Study|Adverse Event|16|||
127926922|NCT01115855|460355691|FG001|Overall Study|Adverse Event|18|||
127926923|NCT01115855|460355690|FG000|Overall Study|Death|6|||
127926924|NCT01115855|460355691|FG001|Overall Study|Death|5|||
127926925|NCT01115855|460355690|FG000|Overall Study|Lab Abnormality|1|||
127926926|NCT01115855|460355691|FG001|Overall Study|Lab Abnormality|1|||
127926927|NCT01115855|460355690|FG000|Overall Study|Protocol Violation|0|||
127926928|NCT01115855|460355691|FG001|Overall Study|Protocol Violation|1|||
127926929|NCT01115855|460355690|FG000|Overall Study|Withdrawal by Subject|5|||
127926930|NCT01115855|460355691|FG001|Overall Study|Withdrawal by Subject|5|||
127926931|NCT01115855|460355690|FG000|Overall Study|Other|8|||
127926932|NCT01115855|460355691|FG001|Overall Study|Other|6|||
127926933|NCT01467479|460355692|FG000|Overall Study|No Study Medication|1|||
127926934|NCT01467479|460355693|FG001|Overall Study|No Study Medication|0|||
127926935|NCT01467479|460355694|FG002|Overall Study|No Study Medication|2|||
127926936|NCT01467479|460355692|FG000|Overall Study|Adverse Event|1|||
127926937|NCT01467479|460355693|FG001|Overall Study|Adverse Event|2|||
127926938|NCT01467479|460355694|FG002|Overall Study|Adverse Event|0|||
127926939|NCT01467479|460355692|FG000|Overall Study|Death|0|||
127926940|NCT01467479|460355693|FG001|Overall Study|Death|0|||
127926941|NCT01467479|460355694|FG002|Overall Study|Death|1|||
127926942|NCT01467479|460355692|FG000|Overall Study|Lost to Follow-up|2|||
127926943|NCT01467479|460355693|FG001|Overall Study|Lost to Follow-up|5|||
127926944|NCT01467479|460355694|FG002|Overall Study|Lost to Follow-up|3|||
127926945|NCT01467479|460355692|FG000|Overall Study|Withdrawal of Consent|3|||
127926946|NCT01467479|460355693|FG001|Overall Study|Withdrawal of Consent|7|||
127926947|NCT01467479|460355694|FG002|Overall Study|Withdrawal of Consent|7|||
127926948|NCT01467479|460355692|FG000|Overall Study|Study Terminated by Sponsor|1|||
127926949|NCT01467479|460355693|FG001|Overall Study|Study Terminated by Sponsor|3|||
127926950|NCT01467479|460355694|FG002|Overall Study|Study Terminated by Sponsor|3|||
127926951|NCT01467479|460355692|FG000|Overall Study|Other|1|||
127926952|NCT01467479|460355693|FG001|Overall Study|Other|0|||
127926953|NCT01467479|460355694|FG002|Overall Study|Other|0|||
127926954|NCT01915940|460355704|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
127926955|NCT01915940|460355705|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
127926956|NCT01915940|460355706|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
127926957|NCT01915940|460355704|FG000|Treatment Period|Decision of Participant|0|||
127926958|NCT01915940|460355705|FG001|Treatment Period|Decision of Participant|1|||
127926959|NCT01915940|460355706|FG002|Treatment Period|Decision of Participant|3|||
127926960|NCT01915940|460355704|FG000|Treatment Period|Adverse Event|0|||
127926961|NCT01915940|460355705|FG001|Treatment Period|Adverse Event|9|||
127926962|NCT01915940|460355706|FG002|Treatment Period|Adverse Event|1|||
127926963|NCT01915940|460355704|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
127926964|NCT01915940|460355705|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
127926965|NCT01915940|460355706|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
127926966|NCT02960438|460355707|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
127926967|NCT02960438|460355708|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
127926968|NCT02960438|460355709|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
127926969|NCT02960438|460355710|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
127926970|NCT02960438|460355707|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
127926971|NCT02960438|460355708|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
127926972|NCT02960438|460355709|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
127926973|NCT02960438|460355710|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
127926974|NCT02960438|460355707|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
127926975|NCT02960438|460355708|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
127926976|NCT02960438|460355709|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
127926977|NCT02960438|460355710|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
127926978|NCT02960438|460355707|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
127926979|NCT02960438|460355708|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
127926980|NCT02960438|460355709|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
127926981|NCT02960438|460355710|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
127926982|NCT02960438|460355707|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
127926983|NCT02960438|460355708|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
127926984|NCT02960438|460355709|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
127926985|NCT02960438|460355710|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
127926986|NCT02960438|460355707|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
127926987|NCT02960438|460355708|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
127926988|NCT02960438|460355709|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
127926989|NCT02960438|460355710|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
127926990|NCT02960438|460355707|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
127926991|NCT02960438|460355708|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
127926992|NCT02960438|460355709|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
127926993|NCT02960438|460355710|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
127926994|NCT02960438|460355707|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
127926995|NCT02960438|460355708|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
127926996|NCT02960438|460355709|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
127926997|NCT02960438|460355710|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
127926998|NCT02960438|460355707|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
127926999|NCT02960438|460355708|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
127927000|NCT02960438|460355709|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
127927001|NCT02960438|460355710|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
127927002|NCT02960438|460355707|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
127927003|NCT02960438|460355708|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
127927004|NCT02960438|460355709|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
127927005|NCT02960438|460355710|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
127927006|NCT02960438|460355707|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
127927007|NCT02960438|460355708|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
127927008|NCT02960438|460355709|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
127927009|NCT02960438|460355710|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
127927010|NCT02960438|460355707|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
127927011|NCT02960438|460355708|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
127927012|NCT02960438|460355709|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
127927013|NCT02960438|460355710|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
127927014|NCT01316419|460355714|FG000|Overall Study|Not treated|103|||
127927015|NCT01316419|460355714|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
127927016|NCT01316419|460355714|FG000|Overall Study|Lost to Follow-up|19|||
127927017|NCT02999984|460355715|FG000|Overall Study|Treatment Failure|1|||
127927018|NCT04039919|460355718|FG000|Treatment Period 1|Withdrawal by Subject|1|||
127927019|NCT04039919|460355719|FG001|Treatment Period 1|Withdrawal by Subject|0|||
127927020|NCT04039919|460355720|FG002|Treatment Period 1|Withdrawal by Subject|0|||
127927021|NCT04039919|460355721|FG003|Treatment Period 1|Withdrawal by Subject|0|||
127927022|NCT04039919|460355722|FG004|Treatment Period 1|Withdrawal by Subject|0|||
127927023|NCT04039919|460355718|FG000|Treatment Period 1|Sponsor's decision|0|||
127927024|NCT04039919|460355719|FG001|Treatment Period 1|Sponsor's decision|0|||
127927025|NCT04039919|460355720|FG002|Treatment Period 1|Sponsor's decision|0|||
127927026|NCT04039919|460355721|FG003|Treatment Period 1|Sponsor's decision|0|||
127927027|NCT04039919|460355722|FG004|Treatment Period 1|Sponsor's decision|16|||
127927028|NCT04039919|460355718|FG000|Treatment Period 5|Withdrawal by Subject|1|||
127927029|NCT04039919|460355719|FG001|Treatment Period 5|Withdrawal by Subject|0|||
127927030|NCT04039919|460355720|FG002|Treatment Period 5|Withdrawal by Subject|0|||
127927031|NCT04039919|460355721|FG003|Treatment Period 5|Withdrawal by Subject|0|||
127927032|NCT04039919|460355722|FG004|Treatment Period 5|Withdrawal by Subject|0|||
127927033|NCT00754013|460355723|FG000|Overall Study|Lost to Follow-up|1|||
127927034|NCT00754013|460355724|FG001|Overall Study|Lost to Follow-up|1|||
127927035|NCT00754013|460355723|FG000|Overall Study|didn't return after study termed|3|||
127927036|NCT00754013|460355724|FG001|Overall Study|didn't return after study termed|4|||
127927037|NCT02310789|460355725|FG000|Overall Study|Adverse Event|1|||
127927038|NCT00983918|460355726|FG000|Overall Study|conversion to open cholecystectomy|0|||
127927039|NCT00983918|460355727|FG001|Overall Study|conversion to open cholecystectomy|2|||
127927040|NCT00983918|460355728|FG002|Overall Study|conversion to open cholecystectomy|2|||
127927041|NCT00983918|460355729|FG003|Overall Study|conversion to open cholecystectomy|2|||
127927042|NCT01197417|460355730|FG000|Overall Study|Physician Decision|3|||
127927043|NCT01197417|460355731|FG001|Overall Study|Physician Decision|2|||
127927044|NCT01197417|460355730|FG000|Overall Study|Withdrawal by Subject|2|||
127927045|NCT01197417|460355731|FG001|Overall Study|Withdrawal by Subject|4|||
127927046|NCT01197417|460355730|FG000|Overall Study|Site miscommunication|0|||
127927047|NCT01197417|460355731|FG001|Overall Study|Site miscommunication|1|||
127927048|NCT01197417|460355730|FG000|Overall Study|Subject transferred to intensive care|0|||
127927049|NCT01197417|460355731|FG001|Overall Study|Subject transferred to intensive care|1|||
127927050|NCT01197417|460355730|FG000|Overall Study|Not consented in time to receive drug|0|||
127927051|NCT01197417|460355731|FG001|Overall Study|Not consented in time to receive drug|1|||
127927052|NCT01197417|460355730|FG000|Overall Study|Hypotension|1|||
127927053|NCT01197417|460355731|FG001|Overall Study|Hypotension|2|||
127927054|NCT01197417|460355730|FG000|Overall Study|Found to be ineligible|2|||
127927055|NCT01197417|460355731|FG001|Overall Study|Found to be ineligible|5|||
127927056|NCT01197417|460355730|FG000|Overall Study|No 25-hour magnesium level|0|||
127927057|NCT01197417|460355731|FG001|Overall Study|No 25-hour magnesium level|2|||
127927058|NCT00794417|460355734|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
127927059|NCT00794417|460355735|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
127927060|NCT00794417|460355736|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
127927061|NCT00794417|460355737|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
127927062|NCT00794417|460355734|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
127927063|NCT00794417|460355735|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
127927064|NCT00794417|460355736|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
127927065|NCT00794417|460355737|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
127927066|NCT00794417|460355734|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
127927067|NCT00794417|460355735|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
127927068|NCT00794417|460355736|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
127927069|NCT00794417|460355737|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
127927070|NCT00794417|460355734|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
127927071|NCT00794417|460355735|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
127976422|NCT03535194|460536128|FG003|Induction Period|Lack of Efficacy|2|||
127868532|NCT03382639|460137375|FG002|Overall Study|Unsatisfactory therapeutic response|0|||
127868533|NCT03382639|460137376|FG003|Overall Study|Unsatisfactory therapeutic response|0|||
127868534|NCT03382639|460137373|FG000|Overall Study|Noncompliance with study drug during the DBTP|1|||
127868535|NCT03382639|460137374|FG001|Overall Study|Noncompliance with study drug during the DBTP|2|||
127868536|NCT03382639|460137375|FG002|Overall Study|Noncompliance with study drug during the DBTP|1|||
127868537|NCT03382639|460137376|FG003|Overall Study|Noncompliance with study drug during the DBTP|1|||
127868538|NCT03382639|460137373|FG000|Overall Study|Other|2|||
127868539|NCT03382639|460137374|FG001|Overall Study|Other|0|||
127868540|NCT03382639|460137375|FG002|Overall Study|Other|0|||
127868541|NCT03382639|460137376|FG003|Overall Study|Other|3|||
127868542|NCT02406586|460137377|FG000|Overall Study|Lost to Follow-up|0|||
127868543|NCT02406586|460137378|FG001|Overall Study|Lost to Follow-up|4|||
127868544|NCT02406586|460137379|FG002|Overall Study|Lost to Follow-up|2|||
127868545|NCT02406586|460137377|FG000|Overall Study|Withdrawal by Subject|1|||
127868546|NCT02406586|460137378|FG001|Overall Study|Withdrawal by Subject|0|||
127868547|NCT02406586|460137379|FG002|Overall Study|Withdrawal by Subject|0|||
127868548|NCT03198559|460137382|FG000|Overall Study|Adverse Event|2|||
127868549|NCT01072175|460137383|FG000|Part A (Drug-Drug Interaction)|Death|1|||
127868550|NCT01072175|460137384|FG001|Part A (Drug-Drug Interaction)|Death|0|||
127868551|NCT01072175|460137385|FG002|Part A (Drug-Drug Interaction)|Death|0|||
127868552|NCT01072175|460137386|FG003|Part A (Drug-Drug Interaction)|Death|0|||
127868553|NCT01072175|460137387|FG004|Part A (Drug-Drug Interaction)|Death|0|||
127868554|NCT01072175|460137388|FG005|Part A (Drug-Drug Interaction)|Death|0|||
127868555|NCT01072175|460137389|FG006|Part A (Drug-Drug Interaction)|Death|0|||
127868556|NCT01072175|460137390|FG007|Part A (Drug-Drug Interaction)|Death|0|||
127868557|NCT01072175|460137391|FG008|Part A (Drug-Drug Interaction)|Death|0|||
127868558|NCT01072175|460137392|FG009|Part A (Drug-Drug Interaction)|Death|0|||
127868559|NCT01072175|460137393|FG010|Part A (Drug-Drug Interaction)|Death|0|||
127868560|NCT01072175|460137394|FG011|Part A (Drug-Drug Interaction)|Death|0|||
127868561|NCT01072175|460137395|FG012|Part A (Drug-Drug Interaction)|Death|0|||
127868562|NCT01072175|460137383|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
127868563|NCT01072175|460137384|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
127868564|NCT01072175|460137385|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
127868565|NCT01072175|460137386|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
127868566|NCT01072175|460137387|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
127868567|NCT01072175|460137388|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
127868568|NCT01072175|460137389|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
127868569|NCT01072175|460137390|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
127868570|NCT01072175|460137391|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
127868571|NCT01072175|460137392|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
127868572|NCT01072175|460137393|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
127868573|NCT01072175|460137394|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
127868574|NCT01072175|460137395|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
127868575|NCT01072175|460137383|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
127868576|NCT01072175|460137384|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
127868577|NCT01072175|460137385|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
127868578|NCT01072175|460137386|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
127868579|NCT01072175|460137387|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
127868580|NCT01072175|460137388|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
127868581|NCT01072175|460137389|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
127868582|NCT01072175|460137390|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
127868583|NCT01072175|460137391|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
127868584|NCT01072175|460137392|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
127868585|NCT01072175|460137393|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
127868586|NCT01072175|460137394|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
127868587|NCT01072175|460137395|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
127868588|NCT01072175|460137383|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
127868589|NCT01072175|460137384|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
127868590|NCT01072175|460137385|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
127868591|NCT01072175|460137386|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
127868592|NCT01072175|460137387|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
127868593|NCT01072175|460137388|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
127868594|NCT01072175|460137389|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
127868595|NCT01072175|460137390|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
127868596|NCT01072175|460137391|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
127868597|NCT01072175|460137392|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
127868598|NCT01072175|460137393|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
127868599|NCT01072175|460137394|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
127868600|NCT01072175|460137395|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
127868601|NCT01072175|460137383|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
127868602|NCT01072175|460137384|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
127868603|NCT01072175|460137385|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
127868604|NCT01072175|460137386|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
127868605|NCT01072175|460137387|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
127927072|NCT00794417|460355736|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
127927073|NCT00794417|460355737|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
127927074|NCT00794417|460355734|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
127927075|NCT00794417|460355735|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
127927076|NCT00794417|460355736|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
127927077|NCT00794417|460355737|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
127927078|NCT00794417|460355734|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
127927079|NCT00794417|460355735|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
127927080|NCT00794417|460355736|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
127927081|NCT00794417|460355737|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
127927082|NCT01223235|460355738|FG000|Overall Study|Withdrawal by Subject|1|||
127927083|NCT04364737|460355739|FG000|Overall Study|Withdrawal by Subject|4|||
127927084|NCT04364737|460355740|FG001|Overall Study|Withdrawal by Subject|9|||
127927085|NCT04364737|460355739|FG000|Overall Study|Lost to Follow-up|1|||
127927086|NCT04364737|460355740|FG001|Overall Study|Lost to Follow-up|1|||
127927087|NCT01220609|460355741|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
127927088|NCT01220609|460355741|FG000|Overall Study|Ineligible- Wrong cell type|1|||
127927089|NCT01220609|460355741|FG000|Overall Study|Ineligible-Never treated|1|||
127927090|NCT02225665|460355742|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
127927091|NCT02225665|460355743|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
127927092|NCT02225665|460355742|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
127927093|NCT02225665|460355743|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
127927094|NCT01311557|460355744|FG000|Overall Study|Serious adverse event|0|||
127927095|NCT01311557|460355745|FG001|Overall Study|Serious adverse event|1|||
127927096|NCT01311557|460355744|FG000|Overall Study|Protocol Violation|4|||
127927097|NCT01311557|460355745|FG001|Overall Study|Protocol Violation|2|||
127927098|NCT01311557|460355744|FG000|Overall Study|Lost to Follow-up|0|||
127927099|NCT01311557|460355745|FG001|Overall Study|Lost to Follow-up|1|||
127927100|NCT01311557|460355744|FG000|Overall Study|Withdrawal by Subject|1|||
127927101|NCT01311557|460355745|FG001|Overall Study|Withdrawal by Subject|2|||
127927102|NCT00572039|460355746|FG000|Overall Study|Withdrawal by Subject|9|||
127927103|NCT00572039|460355747|FG001|Overall Study|Withdrawal by Subject|6|||
127868606|NCT01072175|460137388|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
127868607|NCT01072175|460137389|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
127868608|NCT01072175|460137390|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
127868609|NCT01072175|460137391|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
127868610|NCT01072175|460137392|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
127868611|NCT01072175|460137393|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
127868612|NCT01072175|460137394|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
127868613|NCT01072175|460137395|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
127868614|NCT01072175|460137383|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
127868615|NCT01072175|460137384|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
127868616|NCT01072175|460137385|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
127927104|NCT00572039|460355746|FG000|Overall Study|Death|2|||
127927105|NCT00572039|460355747|FG001|Overall Study|Death|3|||
127927106|NCT00572039|460355746|FG000|Overall Study|Ill|5|||
127927107|NCT00572039|460355747|FG001|Overall Study|Ill|1|||
127927108|NCT02418455|460355752|FG000|48-Week Treatment Period|Other- Not Specified|1|||
127927109|NCT02418455|460355752|FG000|Continuation Period|Sponsor Decision|7|||
127927110|NCT00614822|460355756|FG000|Overall Study|Adverse Event|3|||
127927111|NCT01557920|460355757|FG000|Overall Study|Withdrawal by Subject|2|||
127927112|NCT01557920|460355758|FG001|Overall Study|Withdrawal by Subject|3|||
127927113|NCT01557920|460355757|FG000|Overall Study|Lack of Efficacy|1|||
127927114|NCT01557920|460355758|FG001|Overall Study|Lack of Efficacy|0|||
127927115|NCT01857206|460355760|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
127927116|NCT01857206|460355761|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
127927117|NCT01857206|460355760|FG000|Overall Study|Lost to Follow-up|9|||
127927118|NCT01857206|460355761|FG001|Overall Study|Lost to Follow-up|6|||
127927119|NCT01857206|460355760|FG000|Overall Study|Unclassified|3|||
127927120|NCT01857206|460355761|FG001|Overall Study|Unclassified|3|||
127927121|NCT01857206|460355760|FG000|Overall Study|Withdrawal by Subject|1|||
127927122|NCT01857206|460355761|FG001|Overall Study|Withdrawal by Subject|0|||
127927123|NCT01857973|460355763|FG000|Overall Study|Subject did not meet required BG range|3|||
127927124|NCT01857973|460355763|FG000|Overall Study|drop out after 3 failed attempts|1|||
127927125|NCT01857973|460355763|FG000|Overall Study|Physician Decision|1|||
127927126|NCT01731886|460355772|FG000|Overall Study|Death|1|||
127927127|NCT01731886|460355773|FG001|Overall Study|Death|0|||
127927128|NCT01731886|460355772|FG000|Overall Study|Never started treatment|0|||
127927129|NCT01731886|460355773|FG001|Overall Study|Never started treatment|1|||
127927130|NCT01731886|460355772|FG000|Overall Study|Non-compliant|1|||
127927131|NCT01731886|460355773|FG001|Overall Study|Non-compliant|0|||
127927132|NCT00271024|460355774|FG000|Overall Study|Lost Interest|3|||
127927133|NCT00271024|460355775|FG001|Overall Study|Lost Interest|4|||
127927134|NCT00271024|460355776|FG002|Overall Study|Lost Interest|2|||
127927135|NCT00271024|460355777|FG003|Overall Study|Lost Interest|3|||
127927136|NCT00271024|460355774|FG000|Overall Study|Unknown/Unspecified|11|||
127927137|NCT00271024|460355775|FG001|Overall Study|Unknown/Unspecified|11|||
127927138|NCT00271024|460355776|FG002|Overall Study|Unknown/Unspecified|8|||
127927139|NCT00271024|460355777|FG003|Overall Study|Unknown/Unspecified|4|||
127927140|NCT00271024|460355774|FG000|Overall Study|Protocol Violation|1|||
127927141|NCT00271024|460355775|FG001|Overall Study|Protocol Violation|6|||
127927142|NCT00271024|460355776|FG002|Overall Study|Protocol Violation|5|||
127927143|NCT00271024|460355777|FG003|Overall Study|Protocol Violation|11|||
127927144|NCT00271024|460355774|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
127927145|NCT00271024|460355775|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
127927146|NCT00271024|460355776|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
127927147|NCT00271024|460355777|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
127927148|NCT00271024|460355774|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
127927149|NCT00271024|460355775|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
127927150|NCT00271024|460355776|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
127927151|NCT00271024|460355777|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
127927152|NCT00129116|460355778|FG000|Primary Phase|Lost to Follow-up|1|||
127927153|NCT00129116|460355779|FG001|Primary Phase|Lost to Follow-up|1|||
127927154|NCT00129116|460355780|FG002|Primary Phase|Lost to Follow-up|0|||
127927155|NCT00129116|460355781|FG003|Primary Phase|Lost to Follow-up|1|||
127927156|NCT00129116|460355782|FG004|Primary Phase|Lost to Follow-up|1|||
127927157|NCT00129116|460355778|FG000|Primary Phase|Protocol Violation|0|||
127927158|NCT00129116|460355779|FG001|Primary Phase|Protocol Violation|1|||
127927159|NCT00129116|460355780|FG002|Primary Phase|Protocol Violation|0|||
127927160|NCT00129116|460355781|FG003|Primary Phase|Protocol Violation|0|||
127927161|NCT00129116|460355782|FG004|Primary Phase|Protocol Violation|0|||
127927162|NCT00129116|460355778|FG000|Primary Phase|Adverse Event|1|||
127927163|NCT00129116|460355779|FG001|Primary Phase|Adverse Event|1|||
127927164|NCT00129116|460355780|FG002|Primary Phase|Adverse Event|0|||
127927165|NCT00129116|460355781|FG003|Primary Phase|Adverse Event|0|||
127927166|NCT00129116|460355782|FG004|Primary Phase|Adverse Event|0|||
127927167|NCT00129116|460355778|FG000|Primary Phase|Withdrawal by Subject|0|||
127927168|NCT00129116|460355779|FG001|Primary Phase|Withdrawal by Subject|1|||
127927169|NCT00129116|460355780|FG002|Primary Phase|Withdrawal by Subject|0|||
127927170|NCT00129116|460355781|FG003|Primary Phase|Withdrawal by Subject|0|||
127927171|NCT00129116|460355782|FG004|Primary Phase|Withdrawal by Subject|0|||
127927172|NCT00129116|460355778|FG000|Primary Phase|Other|0|||
127927173|NCT00129116|460355779|FG001|Primary Phase|Other|0|||
127927174|NCT00129116|460355780|FG002|Primary Phase|Other|1|||
127927175|NCT00129116|460355781|FG003|Primary Phase|Other|0|||
127927176|NCT00129116|460355782|FG004|Primary Phase|Other|0|||
127927177|NCT00129116|460355778|FG000|Booster Phase|Lost to Follow-up|2|||
127927178|NCT00129116|460355779|FG001|Booster Phase|Lost to Follow-up|0|||
127927179|NCT00129116|460355780|FG002|Booster Phase|Lost to Follow-up|0|||
127927180|NCT00129116|460355781|FG003|Booster Phase|Lost to Follow-up|0|||
127927181|NCT00129116|460355782|FG004|Booster Phase|Lost to Follow-up|1|||
127927182|NCT01040793|460355783|FG000|Overall Study|Adverse Event|5|||
127927183|NCT01040793|460355784|FG001|Overall Study|Adverse Event|3|||
127927184|NCT01040793|460355785|FG002|Overall Study|Adverse Event|0|||
127927185|NCT01040793|460355786|FG003|Overall Study|Adverse Event|2|||
127927186|NCT01040793|460355787|FG004|Overall Study|Adverse Event|2|||
127927187|NCT01040793|460355788|FG005|Overall Study|Adverse Event|1|||
127927188|NCT01040793|460355783|FG000|Overall Study|Protocol Violation|1|||
127927189|NCT01040793|460355784|FG001|Overall Study|Protocol Violation|1|||
127927190|NCT01040793|460355785|FG002|Overall Study|Protocol Violation|1|||
127927191|NCT01040793|460355786|FG003|Overall Study|Protocol Violation|0|||
127927192|NCT01040793|460355787|FG004|Overall Study|Protocol Violation|1|||
127927193|NCT01040793|460355788|FG005|Overall Study|Protocol Violation|0|||
127927194|NCT01040793|460355783|FG000|Overall Study|Lost to Follow-up|0|||
127927195|NCT01040793|460355784|FG001|Overall Study|Lost to Follow-up|1|||
127927196|NCT01040793|460355785|FG002|Overall Study|Lost to Follow-up|1|||
127927197|NCT01040793|460355786|FG003|Overall Study|Lost to Follow-up|0|||
127927198|NCT01040793|460355787|FG004|Overall Study|Lost to Follow-up|0|||
127927199|NCT01040793|460355788|FG005|Overall Study|Lost to Follow-up|0|||
127927200|NCT01040793|460355783|FG000|Overall Study|Withdrawal by Subject|0|||
127927201|NCT01040793|460355784|FG001|Overall Study|Withdrawal by Subject|0|||
127927202|NCT01040793|460355785|FG002|Overall Study|Withdrawal by Subject|0|||
127927203|NCT01040793|460355786|FG003|Overall Study|Withdrawal by Subject|2|||
127927204|NCT01040793|460355787|FG004|Overall Study|Withdrawal by Subject|0|||
127927205|NCT01040793|460355788|FG005|Overall Study|Withdrawal by Subject|0|||
127927206|NCT01040793|460355783|FG000|Overall Study|Other reasons not listed above|0|||
127927207|NCT01040793|460355784|FG001|Overall Study|Other reasons not listed above|0|||
127927208|NCT01040793|460355785|FG002|Overall Study|Other reasons not listed above|1|||
127927209|NCT01040793|460355786|FG003|Overall Study|Other reasons not listed above|0|||
127927210|NCT01040793|460355787|FG004|Overall Study|Other reasons not listed above|1|||
127927211|NCT01040793|460355788|FG005|Overall Study|Other reasons not listed above|0|||
127927212|NCT00939627|460355797|FG000|Overall Study|Disease Progression|16|||
127927213|NCT00939627|460355798|FG001|Overall Study|Disease Progression|12|||
127927214|NCT00939627|460355799|FG002|Overall Study|Disease Progression|0|||
127927215|NCT00939627|460355797|FG000|Overall Study|Adverse Event|6|||
127927216|NCT00939627|460355798|FG001|Overall Study|Adverse Event|7|||
127927217|NCT00939627|460355799|FG002|Overall Study|Adverse Event|0|||
127927218|NCT00939627|460355797|FG000|Overall Study|Death|0|||
127927219|NCT00939627|460355798|FG001|Overall Study|Death|2|||
127927220|NCT00939627|460355799|FG002|Overall Study|Death|0|||
127927221|NCT00939627|460355797|FG000|Overall Study|Withdrawal by Subject|2|||
127927222|NCT00939627|460355798|FG001|Overall Study|Withdrawal by Subject|4|||
127927223|NCT00939627|460355799|FG002|Overall Study|Withdrawal by Subject|0|||
127927224|NCT00939627|460355797|FG000|Overall Study|Other complicating disease|1|||
127927225|NCT00939627|460355798|FG001|Overall Study|Other complicating disease|1|||
127927226|NCT00939627|460355799|FG002|Overall Study|Other complicating disease|0|||
127927227|NCT00939627|460355797|FG000|Overall Study|Not compliant|2|||
127927228|NCT00939627|460355798|FG001|Overall Study|Not compliant|0|||
127927229|NCT00939627|460355799|FG002|Overall Study|Not compliant|0|||
127927230|NCT00939627|460355797|FG000|Overall Study|No off-tx reason given|0|||
127927231|NCT00939627|460355798|FG001|Overall Study|No off-tx reason given|2|||
127927232|NCT00939627|460355799|FG002|Overall Study|No off-tx reason given|0|||
127927233|NCT02487082|460355800|FG000|Run-In Phase (5 Weeks)|Withdrawal by Subject|1|||
127927234|NCT02487082|460355801|FG001|Run-In Phase (5 Weeks)|Withdrawal by Subject|2|||
127927235|NCT02487082|460355800|FG000|Phase 1 (5 Weeks)|Withdrawal by Subject|1|||
127927236|NCT02487082|460355801|FG001|Phase 1 (5 Weeks)|Withdrawal by Subject|0|||
127927237|NCT02492841|460355802|FG000|Overall Study|Lost to Follow-up|34|||
127927238|NCT02492841|460355803|FG001|Overall Study|Lost to Follow-up|31|||
127927239|NCT02492841|460355804|FG002|Overall Study|Lost to Follow-up|35|||
127927240|NCT00104247|460355816|FG000|Overall Study|Withdrawal by Subject|1|||
127927241|NCT00104247|460355817|FG001|Overall Study|Withdrawal by Subject|0|||
127927242|NCT00104247|460355816|FG000|Overall Study|Noncompliant with dosing|0|||
127927243|NCT00104247|460355817|FG001|Overall Study|Noncompliant with dosing|1|||
127927244|NCT01917968|460355824|FG000|Overall Study|Death|3|||
127927245|NCT01917968|460355825|FG001|Overall Study|Death|2|||
127927246|NCT01917968|460355824|FG000|Overall Study|Lost to Follow-up|21|||
127927247|NCT01917968|460355825|FG001|Overall Study|Lost to Follow-up|39|||
127927248|NCT01917968|460355824|FG000|Overall Study|Physician Decision|1|||
127927249|NCT01917968|460355825|FG001|Overall Study|Physician Decision|2|||
127927250|NCT01917968|460355824|FG000|Overall Study|Withdrawal by Subject|20|||
127927251|NCT01917968|460355825|FG001|Overall Study|Withdrawal by Subject|35|||
127927252|NCT01917968|460355824|FG000|Overall Study|Subject Relocation|5|||
127927253|NCT01917968|460355825|FG001|Overall Study|Subject Relocation|1|||
127927254|NCT01917968|460355824|FG000|Overall Study|36M Missed Visit|3|||
127927255|NCT01917968|460355825|FG001|Overall Study|36M Missed Visit|2|||
127927256|NCT01917968|460355824|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
127927257|NCT01917968|460355825|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
127927258|NCT01917968|460355824|FG000|Overall Study|Change in Family Circumstances|0|||
127927259|NCT01917968|460355825|FG001|Overall Study|Change in Family Circumstances|1|||
127927260|NCT01917968|460355824|FG000|Overall Study|No Data Available|0|||
127927261|NCT01917968|460355825|FG001|Overall Study|No Data Available|2|||
127927262|NCT04232540|460355830|FG000|Overall Study|Lost to Follow-up|1|||
127927263|NCT04232540|460355831|FG001|Overall Study|Lost to Follow-up|0|||
127927264|NCT02148445|460355832|FG000|Overall Study|Death|1|||
127927265|NCT02148445|460355833|FG001|Overall Study|Death|3|||
127927266|NCT03450629|460355834|FG000|Overall Study|Adverse Event|15|||
127927267|NCT03450629|460355835|FG001|Overall Study|Adverse Event|14|||
127927268|NCT03450629|460355834|FG000|Overall Study|Physician Decision|2|||
127927269|NCT03450629|460355835|FG001|Overall Study|Physician Decision|2|||
127927270|NCT03450629|460355834|FG000|Overall Study|Lack of Efficacy|2|||
127927271|NCT03450629|460355835|FG001|Overall Study|Lack of Efficacy|0|||
127927272|NCT03450629|460355834|FG000|Overall Study|Lost to Follow-up|4|||
127927273|NCT03450629|460355835|FG001|Overall Study|Lost to Follow-up|2|||
127927274|NCT03450629|460355834|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
127927275|NCT03450629|460355835|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
127927276|NCT03450629|460355834|FG000|Overall Study|Non-Compliance With Study Drug|2|||
127927277|NCT03450629|460355835|FG001|Overall Study|Non-Compliance With Study Drug|1|||
127927278|NCT03450629|460355834|FG000|Overall Study|Protocol Violation|11|||
127927279|NCT03450629|460355835|FG001|Overall Study|Protocol Violation|8|||
127927280|NCT03450629|460355834|FG000|Overall Study|Withdrawal by Subject|12|||
127927281|NCT03450629|460355835|FG001|Overall Study|Withdrawal by Subject|6|||
127927282|NCT04230876|460355836|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
127927283|NCT04230876|460355837|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
127927284|NCT03438006|460355841|FG000|Overall Study|Adverse Event|1|||
127927285|NCT03438006|460355841|FG000|Overall Study|Lost to Follow-up|67|||
127927286|NCT03438006|460355841|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
127927287|NCT03438006|460355841|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
127927288|NCT02737592|460355853|FG000|Overall Study|Withdrawal by Subject|1|||
127927289|NCT00576303|460355854|FG000|Dose Titration Period|Early withdrawal|17|||
127927290|NCT00576303|460355854|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
127927291|NCT00576303|460355854|FG000|Long Term Safety Period|Early withdrawal|16|||
127927292|NCT00955721|460355855|FG000|Overall Study|Physician Decision|1|||
127927293|NCT00955721|460355856|FG001|Overall Study|Physician Decision|0|||
127927294|NCT00955721|460355855|FG000|Overall Study|Death|1|||
127927295|NCT00955721|460355856|FG001|Overall Study|Death|0|||
127927296|NCT00955721|460355855|FG000|Overall Study|Withdrawal by Subject|1|||
127927297|NCT00955721|460355856|FG001|Overall Study|Withdrawal by Subject|0|||
127927298|NCT03581188|460357165|FG000|Overall Study|Inclusion criteria not met|3|||
127927299|NCT03581188|460357166|FG001|Overall Study|Inclusion criteria not met|2|||
127927300|NCT03581188|460357165|FG000|Overall Study|Lost to Follow-up|5|||
127927301|NCT03581188|460357166|FG001|Overall Study|Lost to Follow-up|5|||
127927302|NCT03581188|460357165|FG000|Overall Study|Discontinued intervention|11|||
127927303|NCT03581188|460357166|FG001|Overall Study|Discontinued intervention|8|||
127927304|NCT03064438|460357167|FG000|Overall Study|Lost to Follow-up|1|||
127927305|NCT03064438|460357168|FG001|Overall Study|Lost to Follow-up|0|||
127927306|NCT03064438|460357167|FG000|Overall Study|Withdrawal by Subject|0|||
127927307|NCT03064438|460357168|FG001|Overall Study|Withdrawal by Subject|1|||
127927308|NCT01937351|460357169|FG000|Overall Study|Withdrawal by Subject|4|||
127927309|NCT01937351|460357170|FG001|Overall Study|Withdrawal by Subject|2|||
127927310|NCT01937351|460357169|FG000|Overall Study|Death|1|||
127927311|NCT01937351|460357170|FG001|Overall Study|Death|0|||
127927312|NCT01937351|460357169|FG000|Overall Study|Not treated w device, per protocol fail|4|||
127927313|NCT01937351|460357170|FG001|Overall Study|Not treated w device, per protocol fail|0|||
127927314|NCT01961687|460357171|FG000|Overall Study|Lost to Follow-up|19|||
127927315|NCT01961687|460357171|FG000|Overall Study|Re-operation|17|||
127927316|NCT01961687|460357171|FG000|Overall Study|Death|7|||
127927317|NCT01961687|460357171|FG000|Overall Study|Withdrawal by Subject|6|||
127927318|NCT01961687|460357171|FG000|Overall Study|Adverse Event|6|||
127927319|NCT01961687|460357171|FG000|Overall Study|Moved to area without study site|2|||
127927320|NCT01961687|460357171|FG000|Overall Study|Sponsor decision|2|||
127927321|NCT01961687|460357171|FG000|Overall Study|Physician Decision|1|||
127927322|NCT01961687|460357171|FG000|Overall Study|Unable to meet follow-up requirements|1|||
127927323|NCT02284347|460357172|FG000|Overall Study|Lost to Follow-up|2|||
127927324|NCT02284347|460357172|FG000|Overall Study|Withdrawn prior to treatment|1|||
127927325|NCT04213209|460357176|FG000|Overall Study|Protocol Violation|1|||
127927326|NCT04213209|460357177|FG001|Overall Study|Protocol Violation|0|||
127927327|NCT04213209|460357178|FG002|Overall Study|Protocol Violation|0|||
127927328|NCT04213209|460357179|FG003|Overall Study|Protocol Violation|0|||
127927329|NCT04213209|460357180|FG004|Overall Study|Protocol Violation|0|||
127927330|NCT04213209|460357181|FG005|Overall Study|Protocol Violation|0|||
127927331|NCT02065713|460357184|FG000|Overall Study|Adverse Event|0|||
127927332|NCT02065713|460357185|FG001|Overall Study|Adverse Event|1|||
127927333|NCT02065713|460357184|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
127927334|NCT02065713|460357185|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
127927335|NCT01652729|460357188|FG000|Overall Study|Withdrawal by Subject|14|||
127927336|NCT01652729|460357189|FG001|Overall Study|Withdrawal by Subject|7|||
127927337|NCT01652729|460357190|FG002|Overall Study|Withdrawal by Subject|7|||
127927338|NCT01652729|460357188|FG000|Overall Study|Adverse Event|4|||
127927339|NCT01652729|460357189|FG001|Overall Study|Adverse Event|0|||
127927340|NCT01652729|460357190|FG002|Overall Study|Adverse Event|3|||
127927341|NCT01652729|460357188|FG000|Overall Study|Physician Decision|1|||
127927342|NCT01652729|460357189|FG001|Overall Study|Physician Decision|0|||
127927343|NCT01652729|460357190|FG002|Overall Study|Physician Decision|1|||
127927344|NCT01652729|460357188|FG000|Overall Study|Protocol Violation|1|||
127927345|NCT01652729|460357189|FG001|Overall Study|Protocol Violation|0|||
127927346|NCT01652729|460357190|FG002|Overall Study|Protocol Violation|0|||
127927347|NCT01652729|460357188|FG000|Overall Study|Lost to Follow-up|6|||
127927348|NCT01652729|460357189|FG001|Overall Study|Lost to Follow-up|6|||
127927349|NCT01652729|460357190|FG002|Overall Study|Lost to Follow-up|3|||
127927350|NCT01652729|460357188|FG000|Overall Study|Administrative|1|||
127927351|NCT01652729|460357189|FG001|Overall Study|Administrative|0|||
127927352|NCT01652729|460357190|FG002|Overall Study|Administrative|0|||
127927353|NCT00483548|460357191|FG000|Overall Study|Randomized; not treated with study drug|1|||
127927354|NCT00483548|460357192|FG001|Overall Study|Randomized; not treated with study drug|3|||
127927355|NCT00483548|460357191|FG000|Overall Study|Adverse Event|25|||
127927356|NCT00483548|460357192|FG001|Overall Study|Adverse Event|14|||
127927357|NCT00483548|460357191|FG000|Overall Study|Laboratory abnormality|1|||
127927358|NCT00483548|460357192|FG001|Overall Study|Laboratory abnormality|2|||
127927359|NCT00483548|460357191|FG000|Overall Study|Lack of Efficacy|4|||
127927360|NCT00483548|460357192|FG001|Overall Study|Lack of Efficacy|8|||
127927361|NCT00483548|460357191|FG000|Overall Study|Protocol Violation|11|||
127927362|NCT00483548|460357192|FG001|Overall Study|Protocol Violation|7|||
127927363|NCT00483548|460357191|FG000|Overall Study|Pregnancy|1|||
127927364|NCT00483548|460357192|FG001|Overall Study|Pregnancy|0|||
127927365|NCT00483548|460357191|FG000|Overall Study|Protocol required discontinuation|6|||
127927366|NCT00483548|460357192|FG001|Overall Study|Protocol required discontinuation|6|||
127927367|NCT00483548|460357191|FG000|Overall Study|Unable to comply with protocol schedule|1|||
127927368|NCT00483548|460357192|FG001|Overall Study|Unable to comply with protocol schedule|0|||
127927369|NCT00483548|460357191|FG000|Overall Study|Non-compliance with medication|2|||
127927370|NCT00483548|460357192|FG001|Overall Study|Non-compliance with medication|0|||
127927371|NCT00483548|460357191|FG000|Overall Study|Lost to Follow-up|3|||
127927372|NCT00483548|460357192|FG001|Overall Study|Lost to Follow-up|4|||
127927373|NCT00483548|460357191|FG000|Overall Study|Withdrawal by Subject|5|||
127927374|NCT00483548|460357192|FG001|Overall Study|Withdrawal by Subject|2|||
127927375|NCT00126126|460357195|FG000|Overall Study|Lost to Follow-up|0|||
127927376|NCT00126126|460357196|FG001|Overall Study|Lost to Follow-up|2|||
127927377|NCT02694549|460357197|FG000|Overall Study|screen failures|2|||
127927378|NCT01534078|460357198|FG000|Overall Study|Death|1|||
127927379|NCT01534078|460357198|FG000|Overall Study|Withdrawal by Subject|1|||
127927380|NCT02459665|460357199|FG000|Overall Study|Withdrawal by Subject|0|||
127927381|NCT02459665|460357200|FG001|Overall Study|Withdrawal by Subject|1|||
127927382|NCT02459665|460357201|FG002|Overall Study|Withdrawal by Subject|1|||
127927383|NCT02459665|460357202|FG003|Overall Study|Withdrawal by Subject|2|||
127927384|NCT00868296|460357206|FG000|Overall Study|Adverse Event|0|||
127927385|NCT00868296|460357207|FG001|Overall Study|Adverse Event|2|||
127927386|NCT00868296|460357206|FG000|Overall Study|Withdrawal by Subject|0|||
127927387|NCT00868296|460357207|FG001|Overall Study|Withdrawal by Subject|1|||
127927388|NCT00986570|460357212|FG000|Overall Study|Lost to Follow-up|6|||
127927389|NCT00986570|460357212|FG000|Overall Study|Potential bias for objective assessment|1|||
127927390|NCT00804141|460357213|FG000|Overall Study|Adverse Event|157|||
127927391|NCT00804141|460357213|FG000|Overall Study|Death|4|||
127927392|NCT00804141|460357213|FG000|Overall Study|Failed to return|96|||
127927393|NCT00804141|460357213|FG000|Overall Study|Investigator request|8|||
127927394|NCT00804141|460357213|FG000|Overall Study|Protocol Violation|85|||
127927395|NCT00804141|460357213|FG000|Overall Study|Withdrawal by Subject|131|||
127927396|NCT00804141|460357213|FG000|Overall Study|Lack of Efficacy|46|||
127927397|NCT00804141|460357213|FG000|Overall Study|Other than specified|30|||
127927398|NCT00804141|460357213|FG000|Overall Study|Enrolled but not treated|6|||
127927399|NCT01501110|460357216|FG000|Overall Study|Death|0|||
127927400|NCT01501110|460357217|FG001|Overall Study|Death|1|||
127927401|NCT02075606|460357218|FG000|Overall Study|Adverse Event|5|||
127927402|NCT02075606|460357218|FG000|Overall Study|Withdrawal by Subject|1|||
127927403|NCT02075606|460357218|FG000|Overall Study|Death|1|||
127927404|NCT02075606|460357218|FG000|Overall Study|Investigator's decision|1|||
127927405|NCT02075606|460357218|FG000|Overall Study|Symptom management|1|||
127927406|NCT02075606|460357218|FG000|Overall Study|Increasing Symptoms|1|||
127927407|NCT02674386|460357221|FG000|Overall Study|Lost to Follow-up|0|||
127927408|NCT02674386|460357222|FG001|Overall Study|Lost to Follow-up|1|||
127927409|NCT02674386|460357223|FG002|Overall Study|Lost to Follow-up|1|||
127927410|NCT02674386|460357221|FG000|Overall Study|Withdrawal by Subject|0|||
127927411|NCT02674386|460357222|FG001|Overall Study|Withdrawal by Subject|4|||
127927412|NCT02674386|460357223|FG002|Overall Study|Withdrawal by Subject|0|||
127927413|NCT02674386|460357221|FG000|Overall Study|Other|0|||
127927414|NCT02674386|460357222|FG001|Overall Study|Other|1|||
127927415|NCT02674386|460357223|FG002|Overall Study|Other|0|||
127927416|NCT02674386|460357221|FG000|Overall Study|Enrolled but not evaluated|0|||
127927417|NCT02674386|460357222|FG001|Overall Study|Enrolled but not evaluated|4|||
127927418|NCT02674386|460357223|FG002|Overall Study|Enrolled but not evaluated|0|||
127927419|NCT02462486|460357224|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
127927420|NCT02462486|460357225|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
127927421|NCT02462486|460357226|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
127927422|NCT02462486|460357224|FG000|Overall Study|Adverse Event|53|||
127927423|NCT02462486|460357225|FG001|Overall Study|Adverse Event|48|||
127927424|NCT02462486|460357226|FG002|Overall Study|Adverse Event|21|||
127927425|NCT02462486|460357224|FG000|Overall Study|Lack of Efficacy|6|||
127927426|NCT02462486|460357225|FG001|Overall Study|Lack of Efficacy|12|||
127927427|NCT02462486|460357226|FG002|Overall Study|Lack of Efficacy|3|||
127927428|NCT02462486|460357224|FG000|Overall Study|Lost to Follow-up|3|||
127927429|NCT02462486|460357225|FG001|Overall Study|Lost to Follow-up|4|||
127927430|NCT02462486|460357226|FG002|Overall Study|Lost to Follow-up|2|||
127927431|NCT02462486|460357224|FG000|Overall Study|Withdrawal by Subject|25|||
127927432|NCT02462486|460357225|FG001|Overall Study|Withdrawal by Subject|22|||
127927433|NCT02462486|460357226|FG002|Overall Study|Withdrawal by Subject|19|||
127927434|NCT02462486|460357224|FG000|Overall Study|Protocol Violation|3|||
127927435|NCT02462486|460357225|FG001|Overall Study|Protocol Violation|1|||
127927436|NCT02462486|460357226|FG002|Overall Study|Protocol Violation|1|||
127927437|NCT02462486|460357224|FG000|Overall Study|Reason not Specified|3|||
127927438|NCT02462486|460357225|FG001|Overall Study|Reason not Specified|4|||
127927439|NCT02462486|460357226|FG002|Overall Study|Reason not Specified|3|||
127927440|NCT01439724|460357231|FG000|Overall Study|missing consultation|9|||
127927441|NCT01439724|460357232|FG001|Overall Study|missing consultation|8|||
127927442|NCT02310763|460357237|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
127927443|NCT02310763|460357238|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
127927444|NCT02310763|460357239|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
127927445|NCT02310763|460357237|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
127927446|NCT02310763|460357238|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
127927447|NCT02310763|460357239|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
127927448|NCT02310763|460357237|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
127927449|NCT02310763|460357238|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
127927450|NCT02310763|460357239|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
127927451|NCT02310763|460357237|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
127927452|NCT02310763|460357238|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
127927453|NCT02310763|460357239|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
127927454|NCT02310763|460357237|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
127927455|NCT02310763|460357238|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
127927456|NCT02310763|460357239|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
127927457|NCT03877926|460357242|FG000|Overall Study|Adverse Event|1|||
127927458|NCT03877926|460357243|FG001|Overall Study|Adverse Event|0|||
127927459|NCT03877926|460357244|FG002|Overall Study|Adverse Event|0|||
127927460|NCT03877926|460357245|FG003|Overall Study|Adverse Event|0|||
127927461|NCT03877926|460357242|FG000|Overall Study|Death|2|||
127927462|NCT03877926|460357243|FG001|Overall Study|Death|2|||
127927463|NCT03877926|460357244|FG002|Overall Study|Death|2|||
127927464|NCT03877926|460357245|FG003|Overall Study|Death|0|||
127927465|NCT03877926|460357242|FG000|Overall Study|Lost to Follow-up|41|||
127927466|NCT03877926|460357243|FG001|Overall Study|Lost to Follow-up|52|||
127927467|NCT03877926|460357244|FG002|Overall Study|Lost to Follow-up|45|||
127927468|NCT03877926|460357245|FG003|Overall Study|Lost to Follow-up|17|||
127927469|NCT03877926|460357242|FG000|Overall Study|Physician Decision|2|||
127927470|NCT03877926|460357243|FG001|Overall Study|Physician Decision|0|||
127927471|NCT03877926|460357244|FG002|Overall Study|Physician Decision|2|||
127927472|NCT03877926|460357245|FG003|Overall Study|Physician Decision|0|||
127927473|NCT03877926|460357242|FG000|Overall Study|Withdrawal by Subject|18|||
127927474|NCT03877926|460357243|FG001|Overall Study|Withdrawal by Subject|21|||
127927475|NCT03877926|460357244|FG002|Overall Study|Withdrawal by Subject|12|||
127927476|NCT03877926|460357245|FG003|Overall Study|Withdrawal by Subject|4|||
127927477|NCT03877926|460357242|FG000|Overall Study|Other - Various|4|||
127927478|NCT03877926|460357243|FG001|Overall Study|Other - Various|1|||
127927479|NCT03877926|460357244|FG002|Overall Study|Other - Various|1|||
127927480|NCT03877926|460357245|FG003|Overall Study|Other - Various|0|||
127927481|NCT03877926|460357242|FG000|Overall Study|Not Treated|3|||
127927482|NCT03877926|460357243|FG001|Overall Study|Not Treated|1|||
127927483|NCT03877926|460357244|FG002|Overall Study|Not Treated|1|||
127927484|NCT03877926|460357245|FG003|Overall Study|Not Treated|0|||
127927485|NCT03554317|460357249|FG000|Overall Study|Withdrawal by Subject|1|||
127927486|NCT03554317|460357249|FG000|Overall Study|PSA Progression|3|||
127927487|NCT03554317|460357249|FG000|Overall Study|Radiographic Progression|4|||
127927488|NCT00124462|460357252|FG000|Overall Study|Lost to Follow-up|3|||
127927489|NCT00124462|460357253|FG001|Overall Study|Lost to Follow-up|3|||
127927490|NCT00124462|460357252|FG000|Overall Study|Physician Decision|3|||
127927491|NCT00124462|460357253|FG001|Overall Study|Physician Decision|4|||
127927492|NCT00124462|460357252|FG000|Overall Study|Withdrawal by Subject|4|||
127927493|NCT00124462|460357253|FG001|Overall Study|Withdrawal by Subject|5|||
127927494|NCT00124462|460357252|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
127927495|NCT00124462|460357253|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
127927496|NCT00537199|460357254|FG000|Overall Study|Study Terminated|1|||
127927497|NCT03297294|460357255|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
127927498|NCT03297294|460357256|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
127927499|NCT03297294|460357257|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
127927500|NCT03297294|460357258|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
127927501|NCT03297294|460357259|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
127927502|NCT03297294|460357255|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
127927503|NCT03297294|460357256|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
127927504|NCT03297294|460357257|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
127927505|NCT03297294|460357258|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
127927506|NCT03297294|460357259|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
127927507|NCT03297294|460357255|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
127927508|NCT03297294|460357256|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
127927509|NCT03297294|460357257|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
127927510|NCT03297294|460357258|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
127927511|NCT03297294|460357259|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
127927512|NCT03297294|460357255|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
127927513|NCT03297294|460357256|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
127927514|NCT03297294|460357257|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
127927515|NCT03297294|460357258|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
127927516|NCT03297294|460357259|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
127927517|NCT03297294|460357255|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
127927518|NCT03297294|460357256|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
127927519|NCT03297294|460357257|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
127927520|NCT03297294|460357258|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
127927521|NCT03297294|460357259|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
127927522|NCT02039063|460357262|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
127927523|NCT02039063|460357263|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
127927524|NCT02039063|460357264|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
127927525|NCT02039063|460357265|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
127927526|NCT02039063|460357262|FG000|Treatment Phase|Progression of disease|0|||
127927527|NCT02039063|460357263|FG001|Treatment Phase|Progression of disease|0|||
127927528|NCT02039063|460357264|FG002|Treatment Phase|Progression of disease|1|||
127927529|NCT02039063|460357265|FG003|Treatment Phase|Progression of disease|1|||
127927530|NCT02039063|460357262|FG000|Extension Phase|Inadequate therapeutic effect|0|||
127927531|NCT02039063|460357263|FG001|Extension Phase|Inadequate therapeutic effect|1|||
127927532|NCT02039063|460357264|FG002|Extension Phase|Inadequate therapeutic effect|2|||
127927533|NCT02039063|460357265|FG003|Extension Phase|Inadequate therapeutic effect|0|||
127927534|NCT02039063|460357262|FG000|Extension Phase|Progression of disease|0|||
127927535|NCT02039063|460357263|FG001|Extension Phase|Progression of disease|0|||
127927536|NCT02039063|460357264|FG002|Extension Phase|Progression of disease|0|||
127927537|NCT02039063|460357265|FG003|Extension Phase|Progression of disease|1|||
127927538|NCT02039063|460357262|FG000|Extension Phase|Adverse Event|0|||
127927539|NCT02039063|460357263|FG001|Extension Phase|Adverse Event|0|||
127927540|NCT02039063|460357264|FG002|Extension Phase|Adverse Event|1|||
127927541|NCT02039063|460357265|FG003|Extension Phase|Adverse Event|0|||
127927542|NCT00467831|460357266|FG000|Overall Study|Death|2|||
127927543|NCT00467831|460357266|FG000|Overall Study|Withdrawal by Subject|1|||
127927544|NCT02776553|460357271|FG000|Overall Study|Lost to Follow-up|1|||
127927545|NCT02776553|460357272|FG001|Overall Study|Lost to Follow-up|0|||
127927546|NCT02776553|460357271|FG000|Overall Study|got liver transplant|1|||
127927547|NCT02776553|460357272|FG001|Overall Study|got liver transplant|2|||
127927548|NCT02776553|460357271|FG000|Overall Study|had other surgery|1|||
127927549|NCT02776553|460357272|FG001|Overall Study|had other surgery|0|||
127927550|NCT02776553|460357271|FG000|Overall Study|Protocol Violation|0|||
127927551|NCT02776553|460357272|FG001|Overall Study|Protocol Violation|1|||
127927552|NCT00171340|460357274|FG000|Overall Study|Adverse Event|46|||
127927553|NCT00171340|460357275|FG001|Overall Study|Adverse Event|42|||
127927554|NCT00171340|460357274|FG000|Overall Study|Lack of Efficacy|29|||
127927555|NCT00171340|460357275|FG001|Overall Study|Lack of Efficacy|41|||
127927556|NCT00171340|460357274|FG000|Overall Study|Protocol Violation|7|||
127927557|NCT00171340|460357275|FG001|Overall Study|Protocol Violation|8|||
127927558|NCT00171340|460357274|FG000|Overall Study|Withdrawal by Subject|22|||
127927559|NCT00171340|460357275|FG001|Overall Study|Withdrawal by Subject|19|||
127927560|NCT00171340|460357274|FG000|Overall Study|Lost to Follow-up|0|||
127927561|NCT00171340|460357275|FG001|Overall Study|Lost to Follow-up|5|||
127927562|NCT00171340|460357274|FG000|Overall Study|Abnormal Laboratory Results|2|||
127927563|NCT00171340|460357275|FG001|Overall Study|Abnormal Laboratory Results|0|||
127927564|NCT00171340|460357274|FG000|Overall Study|Abnormal Test Procedure Results|6|||
127927565|NCT00171340|460357275|FG001|Overall Study|Abnormal Test Procedure Results|11|||
127927566|NCT00171340|460357274|FG000|Overall Study|No Longer Required Study Drug|1|||
127927567|NCT00171340|460357275|FG001|Overall Study|No Longer Required Study Drug|1|||
127927568|NCT00171340|460357274|FG000|Overall Study|Administrative Problems|5|||
127927569|NCT00171340|460357275|FG001|Overall Study|Administrative Problems|2|||
127927570|NCT00171340|460357274|FG000|Overall Study|Death|6|||
127927571|NCT00171340|460357275|FG001|Overall Study|Death|6|||
127927572|NCT01056640|460357276|FG000|Overall Study|Withdrawal by Subject|11|||
127927573|NCT01056640|460357277|FG001|Overall Study|Withdrawal by Subject|8|||
127927574|NCT01056640|460357276|FG000|Overall Study|Death|15|||
127927575|NCT01056640|460357277|FG001|Overall Study|Death|4|||
127927576|NCT01930175|460357278|FG000|Core Study|Lost to Follow-up|0|||
127927577|NCT01930175|460357279|FG001|Core Study|Lost to Follow-up|1|||
127927578|NCT01930175|460357280|FG002|Core Study|Lost to Follow-up|0|||
127927579|NCT01930175|460357278|FG000|Core Study|Adverse Event|0|||
127927580|NCT01930175|460357279|FG001|Core Study|Adverse Event|0|||
127927581|NCT01930175|460357280|FG002|Core Study|Adverse Event|1|||
127927582|NCT00834899|460357281|FG000|Overall Study|Withdrawal by Subject|1|||
127927583|NCT00834899|460357282|FG001|Overall Study|Withdrawal by Subject|1|||
127927584|NCT02820740|460357283|FG000|Overall Study|Did not have procedure|2|||
127927585|NCT00925301|460357286|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
127927586|NCT00925301|460357287|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
127927587|NCT00925301|460357288|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
127927588|NCT00925301|460357289|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
127927589|NCT00925301|460357286|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
127927590|NCT00925301|460357287|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
127927591|NCT00925301|460357288|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
127927592|NCT00925301|460357289|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
127927593|NCT00925301|460357286|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
127927594|NCT00925301|460357287|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
127927595|NCT00925301|460357288|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
127927596|NCT00925301|460357289|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
127927597|NCT00925301|460357286|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
127927598|NCT00925301|460357287|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
127927599|NCT00925301|460357288|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
127927600|NCT00925301|460357289|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
127927601|NCT00925301|460357286|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
127927602|NCT00925301|460357287|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
127927603|NCT00925301|460357288|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
127927604|NCT00925301|460357289|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
127927605|NCT00925301|460357286|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
127927606|NCT00925301|460357287|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
127927607|NCT00925301|460357288|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
127927608|NCT00925301|460357289|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
127927609|NCT00925301|460357286|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
127927610|NCT00925301|460357287|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
127927611|NCT00925301|460357288|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
127927612|NCT00925301|460357289|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
127927613|NCT03043560|460357290|FG000|Overall Study|Discontinued Intervention|1|||
127927614|NCT03043560|460357291|FG001|Overall Study|Discontinued Intervention|2|||
127927615|NCT03043560|460357290|FG000|Overall Study|Lost to Follow-up|0|||
127927616|NCT03043560|460357291|FG001|Overall Study|Lost to Follow-up|1|||
127927617|NCT01117766|460357292|FG000|First Intervention|Adverse Event|0|||
127927618|NCT01117766|460357293|FG001|First Intervention|Adverse Event|1|||
127927619|NCT01117766|460357292|FG000|First Intervention|Protocol Violation|1|||
127927620|NCT01117766|460357293|FG001|First Intervention|Protocol Violation|0|||
127927621|NCT01117766|460357292|FG000|Washout Period|Protocol Violation|0|||
127927622|NCT01117766|460357293|FG001|Washout Period|Protocol Violation|2|||
127927623|NCT01117766|460357292|FG000|Second Intervention|Lost to Follow-up|1|||
127927624|NCT01117766|460357293|FG001|Second Intervention|Lost to Follow-up|0|||
127927625|NCT01117766|460357292|FG000|Second Intervention|Other|1|||
127927626|NCT01117766|460357293|FG001|Second Intervention|Other|2|||
127927627|NCT01117766|460357292|FG000|Second Intervention|Adverse Event|0|||
127927628|NCT01117766|460357293|FG001|Second Intervention|Adverse Event|2|||
127927629|NCT01117766|460357292|FG000|Second Intervention|Withdrawal by Subject|0|||
127927630|NCT01117766|460357293|FG001|Second Intervention|Withdrawal by Subject|1|||
127927631|NCT00438659|460357294|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
127927632|NCT00438659|460357295|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
127927633|NCT00438659|460357294|FG000|Overall Study|Cancel|5|||
127927634|NCT00438659|460357295|FG001|Overall Study|Cancel|2|||
127927635|NCT03069417|460357296|FG000|Overall Study|Lost to Follow-up|2|||
127927636|NCT03069417|460357297|FG001|Overall Study|Lost to Follow-up|0|||
127927637|NCT03069417|460357296|FG000|Overall Study|Reason Unknown|4|||
127927638|NCT03069417|460357297|FG001|Overall Study|Reason Unknown|7|||
127927639|NCT01117987|460357298|FG000|Overall Study|Protocol deviation|0|||
127927640|NCT01117987|460357299|FG001|Overall Study|Protocol deviation|1|||
127927641|NCT01117987|460357298|FG000|Overall Study|Subject no longer requires study drug|1|||
127927642|NCT01117987|460357299|FG001|Overall Study|Subject no longer requires study drug|0|||
127927643|NCT01117987|460357298|FG000|Overall Study|Lost to Follow-up|1|||
127927644|NCT01117987|460357299|FG001|Overall Study|Lost to Follow-up|1|||
127927645|NCT01117987|460357298|FG000|Overall Study|Abnormal test procedure result|2|||
127927646|NCT01117987|460357299|FG001|Overall Study|Abnormal test procedure result|0|||
127927647|NCT01117987|460357298|FG000|Overall Study|Lack of Efficacy|3|||
127927648|NCT01117987|460357299|FG001|Overall Study|Lack of Efficacy|4|||
127927649|NCT01117987|460357298|FG000|Overall Study|Death|5|||
127927650|NCT01117987|460357299|FG001|Overall Study|Death|10|||
127976423|NCT03535194|460536129|FG004|Induction Period|Lack of Efficacy|0|||
127927651|NCT01117987|460357298|FG000|Overall Study|Withdrawal by Subject|5|||
127927652|NCT01117987|460357299|FG001|Overall Study|Withdrawal by Subject|10|||
127927653|NCT01117987|460357298|FG000|Overall Study|Adverse Event|19|||
127927654|NCT01117987|460357299|FG001|Overall Study|Adverse Event|26|||
127927655|NCT01117987|460357298|FG000|Overall Study|Administrative problems|25|||
127927656|NCT01117987|460357299|FG001|Overall Study|Administrative problems|22|||
127927657|NCT02244424|460357300|FG000|Overall Study|Lost to Follow-up|20|||
127927658|NCT02244424|460357301|FG001|Overall Study|Lost to Follow-up|10|||
127927659|NCT04117945|460357302|FG000|Overall Study|Death|1|||
127927660|NCT04117945|460357303|FG001|Overall Study|Death|0|||
127927661|NCT04117945|460357302|FG000|Overall Study|Withdrawal by Subject|3|||
127927662|NCT04117945|460357303|FG001|Overall Study|Withdrawal by Subject|1|||
127927663|NCT04117945|460357302|FG000|Overall Study|Disease Progression|0|||
127927664|NCT04117945|460357303|FG001|Overall Study|Disease Progression|2|||
127927665|NCT04117945|460357302|FG000|Overall Study|Ineligible|8|||
127927666|NCT04117945|460357303|FG001|Overall Study|Ineligible|7|||
127927667|NCT00402025|460357304|FG000|Overall Study|Adverse Event|0|||
127927668|NCT00402025|460357305|FG001|Overall Study|Adverse Event|0|||
127927669|NCT00402025|460357306|FG002|Overall Study|Adverse Event|2|||
127927670|NCT00402025|460357304|FG000|Overall Study|Death|0|||
127927671|NCT00402025|460357305|FG001|Overall Study|Death|1|||
127927672|NCT00402025|460357306|FG002|Overall Study|Death|5|||
127927673|NCT00402025|460357304|FG000|Overall Study|Disease Progression|1|||
127927674|NCT00402025|460357305|FG001|Overall Study|Disease Progression|1|||
127927675|NCT00402025|460357306|FG002|Overall Study|Disease Progression|2|||
127927676|NCT00402025|460357304|FG000|Overall Study|Physician Decision|1|||
127927677|NCT00402025|460357305|FG001|Overall Study|Physician Decision|1|||
127927678|NCT00402025|460357306|FG002|Overall Study|Physician Decision|0|||
127927679|NCT00402025|460357304|FG000|Overall Study|Participant Decision|0|||
127927680|NCT00402025|460357305|FG001|Overall Study|Participant Decision|0|||
127927681|NCT00402025|460357306|FG002|Overall Study|Participant Decision|1|||
127927682|NCT01730040|460358999|FG000|Overall Study|Randomized but not treated|0|||
127927683|NCT01730040|460359000|FG001|Overall Study|Randomized but not treated|0|||
127927684|NCT01730040|460359001|FG002|Overall Study|Randomized but not treated|0|||
127927685|NCT01730040|460359002|FG003|Overall Study|Randomized but not treated|0|||
127927686|NCT01730040|460359003|FG004|Overall Study|Randomized but not treated|0|||
127927687|NCT01730040|460359004|FG005|Overall Study|Randomized but not treated|1|||
127927688|NCT01730040|460359005|FG006|Overall Study|Randomized but not treated|0|||
127927689|NCT01730040|460358999|FG000|Overall Study|Subject moved|0|||
127927690|NCT01730040|460359000|FG001|Overall Study|Subject moved|0|||
127927691|NCT01730040|460359001|FG002|Overall Study|Subject moved|1|||
127927692|NCT01730040|460359002|FG003|Overall Study|Subject moved|0|||
127927693|NCT01730040|460359003|FG004|Overall Study|Subject moved|0|||
127927694|NCT01730040|460359004|FG005|Overall Study|Subject moved|0|||
127927695|NCT01730040|460359005|FG006|Overall Study|Subject moved|1|||
127927696|NCT01730040|460358999|FG000|Overall Study|Physician Decision|0|||
127927697|NCT01730040|460359000|FG001|Overall Study|Physician Decision|0|||
127927698|NCT01730040|460359001|FG002|Overall Study|Physician Decision|0|||
127927699|NCT01730040|460359002|FG003|Overall Study|Physician Decision|0|||
127927700|NCT01730040|460359003|FG004|Overall Study|Physician Decision|0|||
127927701|NCT01730040|460359004|FG005|Overall Study|Physician Decision|1|||
127927702|NCT01730040|460359005|FG006|Overall Study|Physician Decision|1|||
127927703|NCT01730040|460358999|FG000|Overall Study|Other than specified|7|||
127927704|NCT01730040|460359000|FG001|Overall Study|Other than specified|8|||
127927705|NCT01730040|460359001|FG002|Overall Study|Other than specified|5|||
127927706|NCT01730040|460359002|FG003|Overall Study|Other than specified|5|||
127927707|NCT01730040|460359003|FG004|Overall Study|Other than specified|5|||
127927708|NCT01730040|460359004|FG005|Overall Study|Other than specified|4|||
127927709|NCT01730040|460359005|FG006|Overall Study|Other than specified|4|||
127927710|NCT01730040|460358999|FG000|Overall Study|Adverse Event|4|||
127927711|NCT01730040|460359000|FG001|Overall Study|Adverse Event|3|||
127927712|NCT01730040|460359001|FG002|Overall Study|Adverse Event|5|||
127927713|NCT01730040|460359002|FG003|Overall Study|Adverse Event|3|||
127927714|NCT01730040|460359003|FG004|Overall Study|Adverse Event|1|||
127927715|NCT01730040|460359004|FG005|Overall Study|Adverse Event|1|||
127927716|NCT01730040|460359005|FG006|Overall Study|Adverse Event|2|||
127927717|NCT01730040|460358999|FG000|Overall Study|Poor compliance to protocol|2|||
127927718|NCT01730040|460359000|FG001|Overall Study|Poor compliance to protocol|4|||
127927719|NCT01730040|460359001|FG002|Overall Study|Poor compliance to protocol|0|||
127927720|NCT01730040|460359002|FG003|Overall Study|Poor compliance to protocol|0|||
127927721|NCT01730040|460359003|FG004|Overall Study|Poor compliance to protocol|0|||
127927722|NCT01730040|460359004|FG005|Overall Study|Poor compliance to protocol|0|||
127927723|NCT01730040|460359005|FG006|Overall Study|Poor compliance to protocol|1|||
127927724|NCT01684215|460359006|FG000|Phase 1, Part 1|Adverse Event|1|||
127927725|NCT01684215|460359007|FG001|Phase 1, Part 1|Adverse Event|0|||
127927726|NCT01684215|460359008|FG002|Phase 1, Part 1|Adverse Event|0|||
127927727|NCT01684215|460359009|FG003|Phase 1, Part 1|Adverse Event|0|||
127927728|NCT01684215|460359006|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
127927729|NCT01684215|460359007|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
127927730|NCT01684215|460359008|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
127927731|NCT01684215|460359009|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
127927732|NCT01684215|460359006|FG000|Phase 1, Part 2|Adverse Event|0|||
127927733|NCT01684215|460359007|FG001|Phase 1, Part 2|Adverse Event|0|||
127927734|NCT01684215|460359008|FG002|Phase 1, Part 2|Adverse Event|1|||
127927735|NCT01684215|460359009|FG003|Phase 1, Part 2|Adverse Event|0|||
127927736|NCT01684215|460359006|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
127927737|NCT01684215|460359007|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
127927738|NCT01684215|460359008|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
127927739|NCT01684215|460359009|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
127927740|NCT01684215|460359006|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
127927741|NCT01684215|460359007|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
127927742|NCT01684215|460359008|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
127927743|NCT01684215|460359009|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
127927744|NCT01684215|460359006|FG000|Phase 2|Death|0|||
127927745|NCT01684215|460359007|FG001|Phase 2|Death|0|||
127927746|NCT01684215|460359008|FG002|Phase 2|Death|0|||
127927747|NCT01684215|460359009|FG003|Phase 2|Death|8|||
127927748|NCT01684215|460359006|FG000|Phase 2|Study terminated by sponsor|0|||
127927749|NCT01684215|460359007|FG001|Phase 2|Study terminated by sponsor|0|||
127927750|NCT01684215|460359008|FG002|Phase 2|Study terminated by sponsor|0|||
127927751|NCT01684215|460359009|FG003|Phase 2|Study terminated by sponsor|30|||
127927752|NCT01684215|460359006|FG000|Phase 2|Enrolled but not treated|0|||
127927753|NCT01684215|460359007|FG001|Phase 2|Enrolled but not treated|0|||
127927754|NCT01684215|460359008|FG002|Phase 2|Enrolled but not treated|0|||
127927755|NCT01684215|460359009|FG003|Phase 2|Enrolled but not treated|1|||
127927756|NCT01684215|460359006|FG000|Phase 2|Lost to Follow-up|0|||
127927757|NCT01684215|460359007|FG001|Phase 2|Lost to Follow-up|0|||
127927758|NCT01684215|460359008|FG002|Phase 2|Lost to Follow-up|0|||
127927759|NCT01684215|460359009|FG003|Phase 2|Lost to Follow-up|4|||
127927760|NCT01301482|460359010|FG000|Overall Study|Withdrawal by Subject|1|||
127927761|NCT00480324|460359013|FG000|Overall Study|Adverse Event|1|||
127927762|NCT00480324|460359014|FG001|Overall Study|Adverse Event|1|||
127927763|NCT00480324|460359013|FG000|Overall Study|Protocol Violation|0|||
127927764|NCT00480324|460359014|FG001|Overall Study|Protocol Violation|1|||
127927765|NCT00480324|460359013|FG000|Overall Study|Withdrawal by Subject|14|||
127927766|NCT00480324|460359014|FG001|Overall Study|Withdrawal by Subject|5|||
127927767|NCT00480324|460359013|FG000|Overall Study|Lost to Follow-up|17|||
127927768|NCT00480324|460359014|FG001|Overall Study|Lost to Follow-up|8|||
127927769|NCT00480324|460359013|FG000|Overall Study|Subject's mother pregnant|0|||
127927770|NCT00480324|460359014|FG001|Overall Study|Subject's mother pregnant|1|||
127927771|NCT01552369|460359015|FG000|Overall Study|Did not consent to extended follow up|8|||
127927772|NCT01552369|460359016|FG001|Overall Study|Did not consent to extended follow up|9|||
127927773|NCT03346070|460359020|FG000|Overall Study|Death|0|||
127927774|NCT03346070|460359021|FG001|Overall Study|Death|0|||
127927775|NCT03346070|460359022|FG002|Overall Study|Death|0|||
127927776|NCT03346070|460359023|FG003|Overall Study|Death|0|||
127927777|NCT03346070|460359024|FG004|Overall Study|Death|1|||
127927778|NCT03346070|460359020|FG000|Overall Study|Lost to Follow-up|0|||
127927779|NCT03346070|460359021|FG001|Overall Study|Lost to Follow-up|1|||
127927780|NCT03346070|460359022|FG002|Overall Study|Lost to Follow-up|2|||
127927781|NCT03346070|460359023|FG003|Overall Study|Lost to Follow-up|0|||
127927782|NCT03346070|460359024|FG004|Overall Study|Lost to Follow-up|0|||
127927783|NCT03346070|460359020|FG000|Overall Study|Physician Decision|0|||
127927784|NCT03346070|460359021|FG001|Overall Study|Physician Decision|0|||
127927785|NCT03346070|460359022|FG002|Overall Study|Physician Decision|0|||
127927786|NCT03346070|460359023|FG003|Overall Study|Physician Decision|1|||
127927787|NCT03346070|460359024|FG004|Overall Study|Physician Decision|1|||
127927788|NCT03346070|460359020|FG000|Overall Study|Withdrawal by Subject|1|||
127927789|NCT03346070|460359021|FG001|Overall Study|Withdrawal by Subject|0|||
127927790|NCT03346070|460359022|FG002|Overall Study|Withdrawal by Subject|0|||
127927791|NCT03346070|460359023|FG003|Overall Study|Withdrawal by Subject|1|||
127927792|NCT03346070|460359024|FG004|Overall Study|Withdrawal by Subject|0|||
127927793|NCT03346070|460359020|FG000|Overall Study|Study medication not received as planned|2|||
127927794|NCT03346070|460359021|FG001|Overall Study|Study medication not received as planned|3|||
127927795|NCT03346070|460359022|FG002|Overall Study|Study medication not received as planned|2|||
127927796|NCT03346070|460359023|FG003|Overall Study|Study medication not received as planned|3|||
127927797|NCT03346070|460359024|FG004|Overall Study|Study medication not received as planned|2|||
127927798|NCT03346070|460359020|FG000|Overall Study|Screen Failure|0|||
127927799|NCT03346070|460359021|FG001|Overall Study|Screen Failure|0|||
127927800|NCT03346070|460359022|FG002|Overall Study|Screen Failure|0|||
127927801|NCT03346070|460359023|FG003|Overall Study|Screen Failure|1|||
127927802|NCT03346070|460359024|FG004|Overall Study|Screen Failure|1|||
127927803|NCT03919448|460359036|FG000|Overall Study|Withdrawal by Subject|1|||
127927804|NCT03919448|460359037|FG001|Overall Study|Withdrawal by Subject|0|||
127927805|NCT03919448|460359038|FG002|Overall Study|Withdrawal by Subject|0|||
127927806|NCT03438539|460359039|FG000|Overall Study|Lost to Follow-up|8|||
127927807|NCT03438539|460359040|FG001|Overall Study|Lost to Follow-up|4|||
127927808|NCT03438539|460359041|FG002|Overall Study|Lost to Follow-up|10|||
127927809|NCT03438539|460359042|FG003|Overall Study|Lost to Follow-up|9|||
127927810|NCT03438539|460359043|FG004|Overall Study|Lost to Follow-up|3|||
127927811|NCT03438539|460359044|FG005|Overall Study|Lost to Follow-up|8|||
127927812|NCT00493454|460359050|FG000|Overall Study|Withdrawal by Subject|1|||
127927813|NCT00103038|460359051|FG000|Overall Study|Withdrawal by Subject|8|||
127927814|NCT00103038|460359051|FG000|Overall Study|Screen failure|3|||
127927815|NCT00103038|460359051|FG000|Overall Study|Death|1|||
127927816|NCT00103038|460359051|FG000|Overall Study|Physician Decision|1|||
127927817|NCT03649412|460359058|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
127927818|NCT03649412|460359059|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
127927819|NCT03649412|460359058|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
127927820|NCT03649412|460359059|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
127927821|NCT03649412|460359058|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
127927822|NCT03649412|460359059|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
127927823|NCT03649412|460359058|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
127927824|NCT03649412|460359059|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
127927825|NCT03649412|460359058|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
127927826|NCT03649412|460359059|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
127927827|NCT03649412|460359058|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
127927828|NCT03649412|460359059|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
127927829|NCT02865395|460359060|FG000|Overall Study|Physician Decision|6|||
127927830|NCT02865395|460359061|FG001|Overall Study|Physician Decision|10|||
127927831|NCT02865395|460359062|FG002|Overall Study|Physician Decision|7|||
127927832|NCT04019054|460359063|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
127927833|NCT04019054|460359064|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
127927834|NCT04019054|460359063|FG000|Overall Study|Withdrawal by Subject|3|||
127927835|NCT04019054|460359064|FG001|Overall Study|Withdrawal by Subject|1|||
127927836|NCT01682148|460359069|FG000|Overall Study|Withdrawal by Subject|2|||
127927837|NCT01682148|460359070|FG001|Overall Study|Withdrawal by Subject|0|||
127927838|NCT01682148|460359069|FG000|Overall Study|Lost to Follow-up|1|||
127927839|NCT01682148|460359070|FG001|Overall Study|Lost to Follow-up|2|||
127927840|NCT01682148|460359069|FG000|Overall Study|Protocol Violation|1|||
127927841|NCT01682148|460359070|FG001|Overall Study|Protocol Violation|1|||
127927842|NCT03827018|460359073|FG000|Overall Study|Adverse Event|1|||
127927843|NCT03827018|460359074|FG001|Overall Study|Adverse Event|0|||
127927844|NCT03827018|460359073|FG000|Overall Study|Withdrawal by Subject|2|||
127927845|NCT03827018|460359074|FG001|Overall Study|Withdrawal by Subject|2|||
127927846|NCT03827018|460359073|FG000|Overall Study|Lack of Efficacy|0|||
127927847|NCT03827018|460359074|FG001|Overall Study|Lack of Efficacy|1|||
127927848|NCT02087176|460359076|FG000|Overall Study|Withdrawal by Subject|1|||
127927849|NCT02087176|460359076|FG000|Overall Study|Death|10|||
127927850|NCT02087176|460359076|FG000|Overall Study|Censored|19|||
127927851|NCT02087176|460359076|FG000|Overall Study|Study Terminated by Sponsor|2|||
127927852|NCT03648879|460359077|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
127927853|NCT03812991|460359078|FG000|Overall Study|Lost to Follow-up|3|||
127927854|NCT03812991|460359079|FG001|Overall Study|Lost to Follow-up|1|||
127927855|NCT04740931|460359080|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
127927856|NCT04740931|460359081|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|4|||
127927857|NCT04740931|460359080|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
127927858|NCT04740931|460359081|FG001|Part 1 (Baseline up to Week 24)|Death|2|||
127927859|NCT04740931|460359080|FG000|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|2|||
127927860|NCT04740931|460359081|FG001|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|0|||
127927861|NCT04740931|460359080|FG000|Part 1 (Baseline up to Week 24)|Reason Not Specified|2|||
127927862|NCT04740931|460359081|FG001|Part 1 (Baseline up to Week 24)|Reason Not Specified|0|||
127927863|NCT04740931|460359080|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
127927864|NCT04740931|460359081|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
127927865|NCT04740931|460359080|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
127927866|NCT04740931|460359081|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|1|||
127927867|NCT04740931|460359080|FG000|Part 1 (Baseline up to Week 24)|Physician Decision|0|||
127927868|NCT04740931|460359081|FG001|Part 1 (Baseline up to Week 24)|Physician Decision|1|||
127927869|NCT04740931|460359080|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
127927870|NCT04740931|460359081|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|1|||
127927871|NCT04740931|460359080|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
127927872|NCT04740931|460359081|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
127927873|NCT04740931|460359080|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|3|||
127927874|NCT04740931|460359081|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|9|||
127927875|NCT04740931|460359080|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
127927876|NCT04740931|460359081|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
127927877|NCT04740931|460359080|FG000|Part 2 (Week 24 to Week 72)|Death|4|||
127927878|NCT04740931|460359081|FG001|Part 2 (Week 24 to Week 72)|Death|1|||
127927879|NCT04740931|460359080|FG000|Part 2 (Week 24 to Week 72)|Other|1|||
127927880|NCT04740931|460359081|FG001|Part 2 (Week 24 to Week 72)|Other|3|||
127927881|NCT04740931|460359080|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|2|||
127927882|NCT04740931|460359081|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|1|||
127927883|NCT04740931|460359080|FG000|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|1|||
127927884|NCT04740931|460359081|FG001|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|0|||
127927885|NCT04099641|460359084|FG000|Overall Study|Death|46|||
127927886|NCT04099641|460359085|FG001|Overall Study|Death|12|||
127927887|NCT04099641|460359084|FG000|Overall Study|Lost to Follow-up|1|||
127927888|NCT04099641|460359085|FG001|Overall Study|Lost to Follow-up|0|||
127927889|NCT04099641|460359084|FG000|Overall Study|Withdrawal by Subject|2|||
127927890|NCT04099641|460359085|FG001|Overall Study|Withdrawal by Subject|0|||
127927891|NCT00895037|460359086|FG000|Overall Study|Death|0|||
127927892|NCT00895037|460359087|FG001|Overall Study|Death|2|||
127927893|NCT00895037|460359088|FG002|Overall Study|Death|1|||
127927894|NCT04798482|460359104|FG000|Overall Study|Physician Decision|1|||
127927895|NCT04798482|460359104|FG000|Overall Study|Lost eligibility|1|||
127927896|NCT01192399|460359105|FG000|Overall Study|Lack of Efficacy|2|||
127927897|NCT01029392|460359106|FG000|Overall Study|Withdrawal by Subject|18|||
127927898|NCT01029392|460359107|FG001|Overall Study|Withdrawal by Subject|11|||
127927899|NCT01029392|460359106|FG000|Overall Study|Physician Decision|2|||
127927900|NCT01029392|460359107|FG001|Overall Study|Physician Decision|0|||
127927901|NCT00063882|460359108|FG000|Overall Study|Protocol Violation|3|||
127927902|NCT00063882|460359109|FG001|Overall Study|Protocol Violation|3|||
127927903|NCT00063882|460359108|FG000|Overall Study|Withdrawal by Subject|2|||
127927904|NCT00063882|460359109|FG001|Overall Study|Withdrawal by Subject|1|||
127927905|NCT01103479|460359110|FG000|Overall Study|Up to date with CRC screening|1|||
127927906|NCT01103479|460359111|FG001|Overall Study|Up to date with CRC screening|9|||
127927907|NCT01103479|460359112|FG002|Overall Study|Up to date with CRC screening|12|||
127927908|NCT01103479|460359110|FG000|Overall Study|Family history of CRC|1|||
127927909|NCT01103479|460359111|FG001|Overall Study|Family history of CRC|0|||
127927910|NCT01103479|460359112|FG002|Overall Study|Family history of CRC|2|||
127927911|NCT01103479|460359110|FG000|Overall Study|Active cancer|1|||
127927912|NCT01103479|460359111|FG001|Overall Study|Active cancer|0|||
127927913|NCT01103479|460359112|FG002|Overall Study|Active cancer|0|||
127927914|NCT01103479|460359110|FG000|Overall Study|Saw non-study physician|2|||
127927915|NCT01103479|460359111|FG001|Overall Study|Saw non-study physician|0|||
127927916|NCT01103479|460359112|FG002|Overall Study|Saw non-study physician|0|||
127927917|NCT01534637|460359113|FG000|Overall Study|Physician Decision|3|||
127927918|NCT01534637|460359113|FG000|Overall Study|Lack of Efficacy|3|||
127927919|NCT01534637|460359113|FG000|Overall Study|Withdrawal by Subject|1|||
127927920|NCT01534637|460359113|FG000|Overall Study|Adverse Event|1|||
127927921|NCT01534637|460359113|FG000|Overall Study|Liver Mets before treatment|1|||
127927922|NCT00605917|460359114|FG000|Overall Study|Protocol Violation|79|||
127927923|NCT00890552|460359115|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
127927924|NCT00890552|460359115|FG000|On-treatment|Early prog disease/ death|10|||
127927925|NCT03903159|460359119|FG000|Overall Study|Discharged with Staff Approval|2|||
127927926|NCT03903159|460359119|FG000|Overall Study|Discharged at Staff Request|2|||
127927927|NCT03903159|460359119|FG000|Overall Study|Discharged Against Staff Advice|1|||
127927928|NCT02443545|460359120|FG000|Overall Study|Adverse Event|1|||
127927929|NCT02443545|460359121|FG001|Overall Study|Adverse Event|1|||
127927930|NCT02443545|460359120|FG000|Overall Study|Lost to Follow-up|0|||
127927931|NCT02443545|460359121|FG001|Overall Study|Lost to Follow-up|2|||
127927932|NCT02443545|460359120|FG000|Overall Study|Physician Decision|3|||
127927933|NCT02443545|460359121|FG001|Overall Study|Physician Decision|0|||
127927934|NCT02443545|460359120|FG000|Overall Study|Protocol Violation|8|||
127927935|NCT02443545|460359121|FG001|Overall Study|Protocol Violation|1|||
127927936|NCT02443545|460359120|FG000|Overall Study|Pregnancy|1|||
127927937|NCT02443545|460359121|FG001|Overall Study|Pregnancy|1|||
127927938|NCT02443545|460359120|FG000|Overall Study|Withdrawal by Subject|6|||
127927939|NCT02443545|460359121|FG001|Overall Study|Withdrawal by Subject|3|||
127927940|NCT02443545|460359120|FG000|Overall Study|Termination of study|20|||
127927941|NCT02443545|460359121|FG001|Overall Study|Termination of study|11|||
127927942|NCT00724373|460359122|FG000|Overall Study|Adverse Event|41|||
127927943|NCT00724373|460359122|FG000|Overall Study|Lack of Efficacy|82|||
127927944|NCT00724373|460359122|FG000|Overall Study|Lost to Follow-up|7|||
127927945|NCT00724373|460359122|FG000|Overall Study|Non-compliance|2|||
127927946|NCT00724373|460359122|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
127927947|NCT00724373|460359122|FG000|Overall Study|Participant moved away|1|||
127927948|NCT00724373|460359122|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
127927949|NCT00724373|460359122|FG000|Overall Study|Only to have 24 week regimen|1|||
127927950|NCT00724373|460359122|FG000|Overall Study|Viral Relapse|1|||
127927951|NCT00724373|460359122|FG000|Overall Study|Acute HCV infection|1|||
127927952|NCT00724373|460359122|FG000|Overall Study|Drug Relapse|1|||
127927953|NCT00724373|460359122|FG000|Overall Study|Tolerability|23|||
127927954|NCT00536484|460359123|FG000|Overall Study|Adverse Event|21|||
127927955|NCT00536484|460359124|FG001|Overall Study|Adverse Event|34|||
127927956|NCT00536484|460359123|FG000|Overall Study|Withdrawal by Subject|11|||
127927957|NCT00536484|460359124|FG001|Overall Study|Withdrawal by Subject|11|||
127927958|NCT00536484|460359123|FG000|Overall Study|Lost to Follow-up|8|||
127927959|NCT00536484|460359124|FG001|Overall Study|Lost to Follow-up|6|||
127927960|NCT00536484|460359123|FG000|Overall Study|Lack of Efficacy|16|||
127927961|NCT00536484|460359124|FG001|Overall Study|Lack of Efficacy|5|||
127927962|NCT00536484|460359123|FG000|Overall Study|Other|4|||
127927963|NCT00536484|460359124|FG001|Overall Study|Other|0|||
127927964|NCT01506908|460359125|FG000|Overall Study|Adverse Event|1|||
127927965|NCT01506908|460359126|FG001|Overall Study|Adverse Event|0|||
127927966|NCT03314662|460359127|FG000|Overall Study|Withdrawal by Subject|1|||
127927967|NCT03314662|460359128|FG001|Overall Study|Withdrawal by Subject|1|||
127927968|NCT03314662|460359129|FG002|Overall Study|Withdrawal by Subject|1|||
127927969|NCT03314662|460359127|FG000|Overall Study|Lost to Follow-up|5|||
127927970|NCT03314662|460359128|FG001|Overall Study|Lost to Follow-up|4|||
127927971|NCT03314662|460359129|FG002|Overall Study|Lost to Follow-up|4|||
127927972|NCT03314662|460359127|FG000|Overall Study|Death|2|||
127927973|NCT03314662|460359128|FG001|Overall Study|Death|0|||
127927974|NCT03314662|460359129|FG002|Overall Study|Death|0|||
127927975|NCT00440115|460359136|FG000|Overall Study|Death|7|||
127927976|NCT00440115|460359137|FG001|Overall Study|Death|9|||
127927977|NCT00440115|460359138|FG002|Overall Study|Death|5|||
127927978|NCT00440115|460359136|FG000|Overall Study|Incarceration|0|||
127927979|NCT00440115|460359137|FG001|Overall Study|Incarceration|2|||
127927980|NCT00440115|460359138|FG002|Overall Study|Incarceration|1|||
127927981|NCT00206102|460359139|FG000|Overall Study|Adverse Event|119|||
127927982|NCT00206102|460359140|FG001|Overall Study|Adverse Event|82|||
127927983|NCT00206102|460359139|FG000|Overall Study|Protocol Violation|0|||
127927984|NCT00206102|460359140|FG001|Overall Study|Protocol Violation|2|||
127927985|NCT00206102|460359139|FG000|Overall Study|Lack of therapeutic response|16|||
127927986|NCT00206102|460359140|FG001|Overall Study|Lack of therapeutic response|11|||
127927987|NCT00206102|460359139|FG000|Overall Study|Lost to Follow-up|95|||
127927988|NCT00206102|460359140|FG001|Overall Study|Lost to Follow-up|66|||
127927989|NCT00206102|460359139|FG000|Overall Study|Withdrawal by Subject|118|||
127927990|NCT00206102|460359140|FG001|Overall Study|Withdrawal by Subject|101|||
127927991|NCT00206102|460359139|FG000|Overall Study|Study-specific discontinuation criteria|18|||
127927992|NCT00206102|460359140|FG001|Overall Study|Study-specific discontinuation criteria|17|||
127927993|NCT00206102|460359139|FG000|Overall Study|None of those categories|42|||
127927994|NCT00206102|460359140|FG001|Overall Study|None of those categories|36|||
127927995|NCT03366194|460359144|FG000|Overall Study|Lost to Follow-up|2|||
127927996|NCT03123783|460359145|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
127927997|NCT03123783|460359146|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
127927998|NCT03123783|460359147|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
127927999|NCT03123783|460359148|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
127928000|NCT03123783|460359149|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
127928001|NCT03123783|460359150|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
127928002|NCT03123783|460359151|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
127928003|NCT03123783|460359145|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
127928004|NCT03123783|460359146|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
127928005|NCT03123783|460359147|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
127928006|NCT03123783|460359148|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
127928007|NCT03123783|460359149|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
127928008|NCT03123783|460359150|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
127928009|NCT03123783|460359151|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
127928010|NCT03123783|460359145|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
127928011|NCT03123783|460359146|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
127928012|NCT03123783|460359147|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
127928013|NCT03123783|460359148|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
127928014|NCT03123783|460359149|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
127928015|NCT03123783|460359150|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
127928016|NCT03123783|460359151|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
127928017|NCT03123783|460359145|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
127928018|NCT03123783|460359146|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
127928019|NCT03123783|460359147|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
127928020|NCT03123783|460359148|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
127928021|NCT03123783|460359149|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
127928022|NCT03123783|460359150|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
127928023|NCT03123783|460359151|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
127928024|NCT02953678|460359155|FG000|Overall Study|Adverse Event|20|||
127928025|NCT02953678|460359155|FG000|Overall Study|Death|7|||
127928026|NCT02953678|460359155|FG000|Overall Study|Physician Decision|23|||
127928027|NCT02953678|460359155|FG000|Overall Study|Progressive Disease of GVHD|7|||
127928028|NCT02953678|460359155|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
127928029|NCT02953678|460359155|FG000|Overall Study|Withdrawal by participant|3|||
127928030|NCT02953678|460359155|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
127928031|NCT02953678|460359155|FG000|Overall Study|Participants were transferred to commercial product.|3|||
127928032|NCT04678817|460360532|FG000|Overall Study|Lost to Follow-up|28|||
127928033|NCT04678817|460360533|FG001|Overall Study|Lost to Follow-up|0|||
127928034|NCT04678817|460360534|FG002|Overall Study|Lost to Follow-up|0|||
127928035|NCT00784134|460360535|FG000|Overall Study|Lost to Follow-up|3|||
127928036|NCT00784134|460360536|FG001|Overall Study|Lost to Follow-up|6|||
127928037|NCT03785145|460360537|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
127928038|NCT03785145|460360538|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
127928039|NCT03785145|460360537|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
127928040|NCT03785145|460360538|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
127928041|NCT03785145|460360537|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
127928042|NCT03785145|460360538|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
127928043|NCT03785145|460360537|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
127928044|NCT03785145|460360538|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
127928045|NCT03785145|460360537|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
127928046|NCT03785145|460360538|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
127928047|NCT03785145|460360537|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
127928048|NCT03785145|460360538|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
127928049|NCT03785145|460360537|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
127928050|NCT03785145|460360538|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
127928051|NCT03785145|460360537|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
127928052|NCT03785145|460360538|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
127928053|NCT03785145|460360537|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
127928054|NCT03785145|460360538|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
127928055|NCT03785145|460360537|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
127928056|NCT03785145|460360538|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
127928057|NCT03785145|460360537|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
127928058|NCT03785145|460360538|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
127928059|NCT03250299|460360539|FG000|BAL101553 6 mg Cohort|Disease progression|0|||
127928060|NCT03250299|460360540|FG001|BAL101553 6 mg Cohort|Disease progression|1|||
127928061|NCT03250299|460360541|FG002|BAL101553 6 mg Cohort|Disease progression|0|||
127928062|NCT03250299|460360542|FG003|BAL101553 6 mg Cohort|Disease progression|0|||
127928063|NCT03250299|460360543|FG004|BAL101553 6 mg Cohort|Disease progression|0|||
127928064|NCT03250299|460360539|FG000|BAL101553 8 mg Cohort|Adverse Event|0|||
127928065|NCT03250299|460360540|FG001|BAL101553 8 mg Cohort|Adverse Event|0|||
127928066|NCT03250299|460360541|FG002|BAL101553 8 mg Cohort|Adverse Event|1|||
127928067|NCT03250299|460360542|FG003|BAL101553 8 mg Cohort|Adverse Event|0|||
127928068|NCT03250299|460360543|FG004|BAL101553 8 mg Cohort|Adverse Event|0|||
127928069|NCT03250299|460360539|FG000|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
127928070|NCT03250299|460360540|FG001|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
127928071|NCT03250299|460360541|FG002|BAL101553 8 mg Cohort|Withdrawal by Subject|1|||
127928072|NCT03250299|460360542|FG003|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
127928073|NCT03250299|460360543|FG004|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
127928074|NCT03250299|460360539|FG000|BAL101553 12 mg Cohort|Adverse Event|0|||
127928075|NCT03250299|460360540|FG001|BAL101553 12 mg Cohort|Adverse Event|0|||
127928076|NCT03250299|460360541|FG002|BAL101553 12 mg Cohort|Adverse Event|0|||
127928077|NCT03250299|460360542|FG003|BAL101553 12 mg Cohort|Adverse Event|2|||
127928078|NCT03250299|460360543|FG004|BAL101553 12 mg Cohort|Adverse Event|0|||
127928079|NCT00977548|460360548|FG000|Overall Study|Ineligible|4|||
127928080|NCT00977548|460360548|FG000|Overall Study|Adverse Event|8|||
127928081|NCT00977548|460360548|FG000|Overall Study|Withdrawal by Subject|1|||
127928082|NCT04086641|460360549|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
127928083|NCT04086641|460360550|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
127928084|NCT01042535|460360551|FG000|Overall Study|disease progression prior to treatment|3|||
127928085|NCT01042535|460360551|FG000|Overall Study|disease progression during treatment|3|||
127928086|NCT01042535|460360551|FG000|Overall Study|complications from other disease|2|||
127928087|NCT01546142|460360552|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
127928088|NCT01546142|460360553|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
127928089|NCT01546142|460360552|FG000|Overall Study|Subject Noncompliance|1|||
127928090|NCT01546142|460360553|FG001|Overall Study|Subject Noncompliance|1|||
127928091|NCT01546142|460360552|FG000|Overall Study|Adverse Event|6|||
127928092|NCT01546142|460360553|FG001|Overall Study|Adverse Event|3|||
127928093|NCT01546142|460360552|FG000|Overall Study|Lost to Follow-up|20|||
127928094|NCT01546142|460360553|FG001|Overall Study|Lost to Follow-up|15|||
127928095|NCT01546142|460360552|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
127928096|NCT01546142|460360553|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
127928097|NCT01546142|460360552|FG000|Overall Study|Subject Randomized but Not Treated|1|||
127928098|NCT01546142|460360553|FG001|Overall Study|Subject Randomized but Not Treated|0|||
127928099|NCT04776746|460360554|FG000|Overall Study|Study terminated by sponsor|61|||
127928100|NCT04776746|460360554|FG000|Overall Study|Adverse Event|5|||
127928101|NCT04776746|460360554|FG000|Overall Study|Death|4|||
127928102|NCT04776746|460360554|FG000|Overall Study|Lack of Efficacy|3|||
127928103|NCT04776746|460360554|FG000|Overall Study|Noncompliance with study drug|2|||
127928104|NCT04776746|460360554|FG000|Overall Study|Not related to COVID-19|2|||
127928105|NCT00440466|460360555|FG000|Overall Study|Death|3|||
127928106|NCT00440466|460360556|FG001|Overall Study|Death|2|||
127928107|NCT00440466|460360557|FG002|Overall Study|Death|9|||
127928108|NCT00440466|460360555|FG000|Overall Study|Adverse Event|3|||
127928109|NCT00440466|460360556|FG001|Overall Study|Adverse Event|4|||
127928110|NCT00440466|460360557|FG002|Overall Study|Adverse Event|11|||
127928111|NCT00440466|460360555|FG000|Overall Study|Lost to Follow-up|1|||
127928112|NCT00440466|460360556|FG001|Overall Study|Lost to Follow-up|0|||
127928113|NCT00440466|460360557|FG002|Overall Study|Lost to Follow-up|2|||
127928114|NCT00440466|460360555|FG000|Overall Study|Physician Decision|2|||
127928115|NCT00440466|460360556|FG001|Overall Study|Physician Decision|0|||
127928116|NCT00440466|460360557|FG002|Overall Study|Physician Decision|1|||
127928117|NCT00440466|460360555|FG000|Overall Study|Protocol Violation|2|||
127928118|NCT00440466|460360556|FG001|Overall Study|Protocol Violation|0|||
127928119|NCT00440466|460360557|FG002|Overall Study|Protocol Violation|4|||
127928120|NCT00440466|460360555|FG000|Overall Study|Withdrawal by Subject|2|||
127928121|NCT00440466|460360556|FG001|Overall Study|Withdrawal by Subject|5|||
127928122|NCT00440466|460360557|FG002|Overall Study|Withdrawal by Subject|9|||
127928123|NCT00440466|460360555|FG000|Overall Study|Began Dialysis|0|||
127928124|NCT00440466|460360556|FG001|Overall Study|Began Dialysis|0|||
127928125|NCT00440466|460360557|FG002|Overall Study|Began Dialysis|1|||
127928126|NCT00440466|460360555|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
127928127|NCT00440466|460360556|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
127928128|NCT00440466|460360557|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
127928129|NCT00743509|460360558|FG000|Overall Study|Withdrawal by Subject|2|||
127928130|NCT03768726|460360563|FG000|Treatment Phase|Adverse Event|2|||
127928131|NCT03768726|460360564|FG001|Treatment Phase|Adverse Event|2|||
127928132|NCT03768726|460360563|FG000|Treatment Phase|Lost to Follow-up|1|||
127928133|NCT03768726|460360564|FG001|Treatment Phase|Lost to Follow-up|0|||
127928134|NCT03768726|460360563|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
127928135|NCT03768726|460360564|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
127928136|NCT03768726|460360563|FG000|Treatment Phase|Withdrawal by Subject|3|||
127928137|NCT03768726|460360564|FG001|Treatment Phase|Withdrawal by Subject|1|||
127928138|NCT03768726|460360563|FG000|Follow-Up|Adverse Event|2|||
127928139|NCT03768726|460360564|FG001|Follow-Up|Adverse Event|2|||
127928140|NCT03768726|460360563|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
127928141|NCT03768726|460360564|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
127928142|NCT03768726|460360563|FG000|Follow-Up|Withdrawal by Subject|2|||
127928143|NCT03768726|460360564|FG001|Follow-Up|Withdrawal by Subject|0|||
127928144|NCT03768726|460360563|FG000|Follow-Up|Other|1|||
127928145|NCT03768726|460360564|FG001|Follow-Up|Other|0|||
127928146|NCT01286558|460360567|FG000|Overall Study|Adverse Event|1|||
127928147|NCT01286558|460360568|FG001|Overall Study|Adverse Event|1|||
127928148|NCT01286558|460360567|FG000|Overall Study|Withdrawal by Subject|0|||
127928149|NCT01286558|460360568|FG001|Overall Study|Withdrawal by Subject|1|||
127928150|NCT01787279|460360570|FG000|Overall Study|Lost to Follow-up|2|||
127928151|NCT01787279|460360570|FG000|Overall Study|Lack of Efficacy|1|||
127928152|NCT00418522|460360571|FG000|Overall Study|Adverse Event|7|||
127928153|NCT00418522|460360572|FG001|Overall Study|Adverse Event|1|||
127928154|NCT00418522|460360571|FG000|Overall Study|Lack of Efficacy|1|||
127928155|NCT00418522|460360572|FG001|Overall Study|Lack of Efficacy|3|||
127928156|NCT00418522|460360571|FG000|Overall Study|Lost to Follow-up|10|||
127928157|NCT00418522|460360572|FG001|Overall Study|Lost to Follow-up|4|||
127928158|NCT00418522|460360571|FG000|Overall Study|Withdrawal by Subject|31|||
127928159|NCT00418522|460360572|FG001|Overall Study|Withdrawal by Subject|7|||
127928160|NCT00418522|460360571|FG000|Overall Study|Other|27|||
127928161|NCT00418522|460360572|FG001|Overall Study|Other|23|||
127928162|NCT00418522|460360571|FG000|Overall Study|Randomized but did not receive treatment|7|||
127928163|NCT00418522|460360572|FG001|Overall Study|Randomized but did not receive treatment|4|||
127928164|NCT02695719|460360573|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
127928165|NCT02695719|460360574|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
127928166|NCT02695719|460360573|FG000|Overall Study|Significant Protocol Deviation|0|||
127928167|NCT02695719|460360574|FG001|Overall Study|Significant Protocol Deviation|1|||
127928168|NCT02695719|460360573|FG000|Overall Study|Voluntary Withdrawal|1|||
127928169|NCT02695719|460360574|FG001|Overall Study|Voluntary Withdrawal|0|||
127928170|NCT01005329|460360576|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
127928171|NCT04109313|460360581|FG000|Overall Study|Pregnancy|1|||
127928172|NCT04109313|460360581|FG000|Overall Study|Adverse Event|11|||
127928173|NCT04109313|460360581|FG000|Overall Study|Lack of Efficacy|11|||
127928174|NCT04109313|460360581|FG000|Overall Study|Lost to Follow-up|1|||
127928175|NCT04109313|460360581|FG000|Overall Study|Physician Decision|2|||
127928176|NCT04109313|460360581|FG000|Overall Study|Subject Decision|13|||
127928177|NCT04109313|460360581|FG000|Overall Study|Covid-19 situation|2|||
127928178|NCT01272921|460360582|FG000|Overall Study|Protocol Violation|2|||
127928179|NCT01272921|460360583|FG001|Overall Study|Protocol Violation|1|||
127928180|NCT01132664|460360584|FG000|Phase lb|Adverse Event|0|||
127928181|NCT01132664|460360585|FG001|Phase lb|Adverse Event|1|||
127928182|NCT01132664|460360586|FG002|Phase lb|Adverse Event|0|||
127928183|NCT01132664|460360587|FG003|Phase lb|Adverse Event|0|||
127928184|NCT01132664|460360588|FG004|Phase lb|Adverse Event|0|||
127928185|NCT01132664|460360584|FG000|Phase lb|Withdrawal by Subject|1|||
127928186|NCT01132664|460360585|FG001|Phase lb|Withdrawal by Subject|2|||
127928187|NCT01132664|460360586|FG002|Phase lb|Withdrawal by Subject|0|||
127928188|NCT01132664|460360587|FG003|Phase lb|Withdrawal by Subject|0|||
127928189|NCT01132664|460360588|FG004|Phase lb|Withdrawal by Subject|0|||
127928190|NCT01132664|460360584|FG000|Phase lb|Disease Progression|4|||
127928191|NCT01132664|460360585|FG001|Phase lb|Disease Progression|9|||
127928192|NCT01132664|460360586|FG002|Phase lb|Disease Progression|0|||
127928193|NCT01132664|460360587|FG003|Phase lb|Disease Progression|0|||
127928194|NCT01132664|460360588|FG004|Phase lb|Disease Progression|0|||
127928195|NCT01132664|460360584|FG000|Phase ll|Death|0|||
127928196|NCT01132664|460360585|FG001|Phase ll|Death|0|||
127928197|NCT01132664|460360586|FG002|Phase ll|Death|2|||
127928198|NCT01132664|460360587|FG003|Phase ll|Death|0|||
127928199|NCT01132664|460360588|FG004|Phase ll|Death|0|||
127928200|NCT01132664|460360584|FG000|Phase ll|Adverse Event|0|||
127928201|NCT01132664|460360585|FG001|Phase ll|Adverse Event|0|||
127928202|NCT01132664|460360586|FG002|Phase ll|Adverse Event|10|||
127928203|NCT01132664|460360587|FG003|Phase ll|Adverse Event|0|||
127928204|NCT01132664|460360588|FG004|Phase ll|Adverse Event|0|||
127928205|NCT01132664|460360584|FG000|Phase ll|Withdrawal by Subject|0|||
127928206|NCT01132664|460360585|FG001|Phase ll|Withdrawal by Subject|0|||
127928207|NCT01132664|460360586|FG002|Phase ll|Withdrawal by Subject|3|||
127928208|NCT01132664|460360587|FG003|Phase ll|Withdrawal by Subject|0|||
127928209|NCT01132664|460360588|FG004|Phase ll|Withdrawal by Subject|0|||
127928210|NCT01132664|460360584|FG000|Phase ll|Disease progression|0|||
127928211|NCT01132664|460360585|FG001|Phase ll|Disease progression|0|||
127928212|NCT01132664|460360586|FG002|Phase ll|Disease progression|35|||
127928213|NCT01132664|460360587|FG003|Phase ll|Disease progression|0|||
127928214|NCT01132664|460360588|FG004|Phase ll|Disease progression|0|||
127928215|NCT01132664|460360584|FG000|BM Cohort|Disease progression|0|||
127928216|NCT01132664|460360585|FG001|BM Cohort|Disease progression|0|||
127928217|NCT01132664|460360586|FG002|BM Cohort|Disease progression|0|||
127928218|NCT01132664|460360587|FG003|BM Cohort|Disease progression|3|||
127928219|NCT01132664|460360588|FG004|BM Cohort|Disease progression|4|||
127928220|NCT01132664|460360584|FG000|BM Cohort|Adverse Event|0|||
127928221|NCT01132664|460360585|FG001|BM Cohort|Adverse Event|0|||
127928222|NCT01132664|460360586|FG002|BM Cohort|Adverse Event|0|||
127928223|NCT01132664|460360587|FG003|BM Cohort|Adverse Event|0|||
127928224|NCT01132664|460360588|FG004|BM Cohort|Adverse Event|1|||
127928225|NCT01132664|460360584|FG000|BM Cohort|Withdrawal by Subject|0|||
127928226|NCT01132664|460360585|FG001|BM Cohort|Withdrawal by Subject|0|||
127928227|NCT01132664|460360586|FG002|BM Cohort|Withdrawal by Subject|0|||
127928228|NCT01132664|460360587|FG003|BM Cohort|Withdrawal by Subject|0|||
127928229|NCT01132664|460360588|FG004|BM Cohort|Withdrawal by Subject|1|||
127928230|NCT00655850|460360592|FG000|Overall Study|Death|2|||
127928231|NCT00655850|460360592|FG000|Overall Study|Withdrawal by Subject|1|||
127928232|NCT01567826|460360595|FG000|Overall Study|Lost to Follow-up|3|||
127928233|NCT01567826|460360596|FG001|Overall Study|Lost to Follow-up|2|||
127928234|NCT00573170|460360604|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
127928235|NCT00573170|460360605|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
127928236|NCT00573170|460360606|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
127928237|NCT00573170|460360607|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
127928238|NCT00573170|460360608|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
127928239|NCT00573170|460360609|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
127928240|NCT00573170|460360604|FG000|First Washout Period|Adverse Event|1|||
127928241|NCT00573170|460360605|FG001|First Washout Period|Adverse Event|1|||
127928242|NCT00573170|460360606|FG002|First Washout Period|Adverse Event|0|||
127928243|NCT00573170|460360607|FG003|First Washout Period|Adverse Event|0|||
127928244|NCT00573170|460360608|FG004|First Washout Period|Adverse Event|0|||
127928245|NCT00573170|460360609|FG005|First Washout Period|Adverse Event|1|||
127928246|NCT00573170|460360604|FG000|First Washout Period|Lack of Efficacy|0|||
127928247|NCT00573170|460360605|FG001|First Washout Period|Lack of Efficacy|0|||
127928248|NCT00573170|460360606|FG002|First Washout Period|Lack of Efficacy|0|||
127928249|NCT00573170|460360607|FG003|First Washout Period|Lack of Efficacy|0|||
127928250|NCT00573170|460360608|FG004|First Washout Period|Lack of Efficacy|0|||
127928251|NCT00573170|460360609|FG005|First Washout Period|Lack of Efficacy|1|||
127928252|NCT00573170|460360604|FG000|First Washout Period|Lost to Follow-up|1|||
127928253|NCT00573170|460360605|FG001|First Washout Period|Lost to Follow-up|1|||
127928254|NCT00573170|460360606|FG002|First Washout Period|Lost to Follow-up|0|||
127928255|NCT00573170|460360607|FG003|First Washout Period|Lost to Follow-up|2|||
127928256|NCT00573170|460360608|FG004|First Washout Period|Lost to Follow-up|0|||
127928257|NCT00573170|460360609|FG005|First Washout Period|Lost to Follow-up|2|||
127928258|NCT00573170|460360604|FG000|First Washout Period|Withdrawal by Subject|2|||
127928259|NCT00573170|460360605|FG001|First Washout Period|Withdrawal by Subject|0|||
127928260|NCT00573170|460360606|FG002|First Washout Period|Withdrawal by Subject|0|||
127928261|NCT00573170|460360607|FG003|First Washout Period|Withdrawal by Subject|2|||
127928262|NCT00573170|460360608|FG004|First Washout Period|Withdrawal by Subject|3|||
127928263|NCT00573170|460360609|FG005|First Washout Period|Withdrawal by Subject|3|||
127928264|NCT00573170|460360604|FG000|First Washout Period|Other|4|||
127928265|NCT00573170|460360605|FG001|First Washout Period|Other|0|||
127928266|NCT00573170|460360606|FG002|First Washout Period|Other|1|||
127928267|NCT00573170|460360607|FG003|First Washout Period|Other|1|||
127928268|NCT00573170|460360608|FG004|First Washout Period|Other|0|||
127928269|NCT00573170|460360609|FG005|First Washout Period|Other|0|||
127928270|NCT00573170|460360604|FG000|Second Washout Period|Adverse Event|1|||
127928271|NCT00573170|460360605|FG001|Second Washout Period|Adverse Event|0|||
127928272|NCT00573170|460360606|FG002|Second Washout Period|Adverse Event|0|||
127928273|NCT00573170|460360607|FG003|Second Washout Period|Adverse Event|0|||
127928274|NCT00573170|460360608|FG004|Second Washout Period|Adverse Event|1|||
127928275|NCT00573170|460360609|FG005|Second Washout Period|Adverse Event|0|||
127928276|NCT00573170|460360604|FG000|Second Washout Period|Protocol Violation|2|||
127928277|NCT00573170|460360605|FG001|Second Washout Period|Protocol Violation|1|||
127928278|NCT00573170|460360606|FG002|Second Washout Period|Protocol Violation|1|||
127928279|NCT00573170|460360607|FG003|Second Washout Period|Protocol Violation|0|||
127928280|NCT00573170|460360608|FG004|Second Washout Period|Protocol Violation|0|||
127928281|NCT00573170|460360609|FG005|Second Washout Period|Protocol Violation|0|||
127928282|NCT00573170|460360604|FG000|Second Washout Period|Withdrawal by Subject|1|||
127928283|NCT00573170|460360605|FG001|Second Washout Period|Withdrawal by Subject|1|||
127928284|NCT00573170|460360606|FG002|Second Washout Period|Withdrawal by Subject|2|||
127928285|NCT00573170|460360607|FG003|Second Washout Period|Withdrawal by Subject|0|||
127928286|NCT00573170|460360608|FG004|Second Washout Period|Withdrawal by Subject|1|||
127928287|NCT00573170|460360609|FG005|Second Washout Period|Withdrawal by Subject|0|||
127928288|NCT00573170|460360604|FG000|Second Washout Period|Lost to Follow-up|0|||
127928289|NCT00573170|460360605|FG001|Second Washout Period|Lost to Follow-up|0|||
127928290|NCT00573170|460360606|FG002|Second Washout Period|Lost to Follow-up|0|||
127928291|NCT00573170|460360607|FG003|Second Washout Period|Lost to Follow-up|1|||
127928292|NCT00573170|460360608|FG004|Second Washout Period|Lost to Follow-up|0|||
127928293|NCT00573170|460360609|FG005|Second Washout Period|Lost to Follow-up|0|||
127928294|NCT00573170|460360604|FG000|Second Washout Period|Other|1|||
127928295|NCT00573170|460360605|FG001|Second Washout Period|Other|2|||
127928296|NCT00573170|460360606|FG002|Second Washout Period|Other|1|||
127928297|NCT00573170|460360607|FG003|Second Washout Period|Other|4|||
127928298|NCT00573170|460360608|FG004|Second Washout Period|Other|6|||
127928299|NCT00573170|460360609|FG005|Second Washout Period|Other|2|||
127928300|NCT00573170|460360604|FG000|Third Treatment Period|Withdrawal by Subject|1|||
127928301|NCT00573170|460360605|FG001|Third Treatment Period|Withdrawal by Subject|0|||
127928302|NCT00573170|460360606|FG002|Third Treatment Period|Withdrawal by Subject|0|||
127928303|NCT00573170|460360607|FG003|Third Treatment Period|Withdrawal by Subject|0|||
127928304|NCT00573170|460360608|FG004|Third Treatment Period|Withdrawal by Subject|0|||
127928305|NCT00573170|460360609|FG005|Third Treatment Period|Withdrawal by Subject|0|||
127928306|NCT00573170|460360604|FG000|Third Treatment Period|Lost to Follow-up|0|||
127928307|NCT00573170|460360605|FG001|Third Treatment Period|Lost to Follow-up|0|||
127928308|NCT00573170|460360606|FG002|Third Treatment Period|Lost to Follow-up|0|||
127928309|NCT00573170|460360607|FG003|Third Treatment Period|Lost to Follow-up|0|||
127928310|NCT00573170|460360608|FG004|Third Treatment Period|Lost to Follow-up|0|||
127928311|NCT00573170|460360609|FG005|Third Treatment Period|Lost to Follow-up|2|||
127928312|NCT00608517|460360611|FG000|Overall Study|Death|1|||
127928313|NCT00608517|460360612|FG001|Overall Study|Death|0|||
127928314|NCT00608517|460360613|FG002|Overall Study|Death|0|||
127928315|NCT05444543|460360615|FG000|Overall Study|Withdrawal by Subject|1|||
127928316|NCT05444543|460360616|FG001|Overall Study|Withdrawal by Subject|0|||
127928317|NCT05444543|460360615|FG000|Overall Study|Failed to achieve initial remission on therapy|1|||
127928318|NCT05444543|460360616|FG001|Overall Study|Failed to achieve initial remission on therapy|0|||
127928319|NCT05444543|460360615|FG000|Overall Study|Adverse Event|0|||
127928320|NCT05444543|460360616|FG001|Overall Study|Adverse Event|1|||
127928321|NCT05444543|460360615|FG000|Overall Study|Family relocating at a distance from study site|0|||
127928322|NCT05444543|460360616|FG001|Overall Study|Family relocating at a distance from study site|1|||
127928323|NCT01261624|460360617|FG000|Week 0 to Week 12|Disease Progression|1|||
127928324|NCT01261624|460360618|FG001|Week 0 to Week 12|Disease Progression|1|||
127928325|NCT01261624|460360617|FG000|Week 0 to Week 12|Insufficient Response|0|||
127928326|NCT01261624|460360618|FG001|Week 0 to Week 12|Insufficient Response|2|||
127928327|NCT01261624|460360617|FG000|Week 13 to Week 24|Insufficient Response|0|||
127928328|NCT01261624|460360618|FG001|Week 13 to Week 24|Insufficient Response|1|||
127928329|NCT02280187|460360619|FG000|Overall Study|Lost to Follow-up|218|||
127928330|NCT02094261|460360620|FG000|Overall Study|Death|24|||
127928331|NCT02094261|460360620|FG000|Overall Study|Lost to Follow-up|1|||
127928332|NCT02094261|460360620|FG000|Overall Study|Withdrawal by Subject|4|||
127928333|NCT02094261|460360620|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
127928334|NCT04668274|460360621|FG000|Part 1 Study Period 1|Adverse Event|3|||
127928335|NCT04668274|460360622|FG001|Part 1 Study Period 1|Adverse Event|0|||
127928336|NCT04668274|460360623|FG002|Part 1 Study Period 1|Adverse Event|0|||
127928337|NCT04668274|460360624|FG003|Part 1 Study Period 1|Adverse Event|0|||
127928338|NCT04668274|460360621|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
127928339|NCT04668274|460360622|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
127928340|NCT04668274|460360623|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
127928341|NCT04668274|460360624|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
127928342|NCT04668274|460360621|FG000|Part 1 Study Period 2|Other|0|||
127928343|NCT04668274|460360622|FG001|Part 1 Study Period 2|Other|1|||
127928344|NCT04668274|460360623|FG002|Part 1 Study Period 2|Other|0|||
127928345|NCT04668274|460360624|FG003|Part 1 Study Period 2|Other|0|||
127928346|NCT04668274|460360621|FG000|Part 1 Study Period 3|Adverse Event|0|||
127928347|NCT04668274|460360622|FG001|Part 1 Study Period 3|Adverse Event|0|||
127928348|NCT04668274|460360623|FG002|Part 1 Study Period 3|Adverse Event|1|||
127928349|NCT04668274|460360624|FG003|Part 1 Study Period 3|Adverse Event|0|||
127928350|NCT04668274|460360621|FG000|Part 1 Study Period 3|Other|0|||
127928351|NCT04668274|460360622|FG001|Part 1 Study Period 3|Other|0|||
127928352|NCT04668274|460360623|FG002|Part 1 Study Period 3|Other|2|||
127928353|NCT04668274|460360624|FG003|Part 1 Study Period 3|Other|0|||
127928354|NCT04668274|460360621|FG000|Part 2 Study Period 4|Other|0|||
127928355|NCT04668274|460360622|FG001|Part 2 Study Period 4|Other|0|||
127928356|NCT04668274|460360623|FG002|Part 2 Study Period 4|Other|0|||
127928357|NCT04668274|460360624|FG003|Part 2 Study Period 4|Other|1|||
127928358|NCT02363439|460360625|FG000|Overall Study|Lack of Efficacy|4|||
127928359|NCT01719562|460360626|FG000|Overall Study|Lost to Follow-up|1|||
127928360|NCT01719562|460360627|FG001|Overall Study|Lost to Follow-up|0|||
127928361|NCT01719562|460360626|FG000|Overall Study|Death|1|||
127928362|NCT01719562|460360627|FG001|Overall Study|Death|0|||
127928363|NCT01719562|460360626|FG000|Overall Study|New cancer diagnosis|1|||
127928364|NCT01719562|460360627|FG001|Overall Study|New cancer diagnosis|0|||
127928365|NCT00508027|460360628|FG000|Dose Level 1|Lost to Follow-up|4|||
127928366|NCT00508027|460360628|FG000|Dose Level 1|Withdrawal by Subject|2|||
127928367|NCT00508027|460360628|FG000|Dose Level 1|Physician Decision|2|||
127928368|NCT00508027|460360628|FG000|Dose Level 2|Lost to Follow-up|2|||
127928369|NCT00508027|460360628|FG000|Dose Level 2|Withdrawal by Subject|2|||
127928370|NCT00860743|460360631|FG000|Overall Study|Withdrawal by Subject|3|||
127928371|NCT00860743|460360632|FG001|Overall Study|Withdrawal by Subject|0|||
127928372|NCT00941720|460360633|FG000|Overall Study|Withdrawal by Subject|1|||
127928373|NCT00941720|460360633|FG000|Overall Study|Insurance denied participation|11|||
127928374|NCT00941720|460360633|FG000|Overall Study|ineligible|2|||
127928375|NCT01202877|460360634|FG000|Overall Study|Disease Progression|0|||
127928376|NCT01202877|460360635|FG001|Overall Study|Disease Progression|1|||
127928377|NCT01202877|460360636|FG002|Overall Study|Disease Progression|2|||
127928378|NCT01202877|460360634|FG000|Overall Study|Adverse Event|0|||
127928379|NCT01202877|460360635|FG001|Overall Study|Adverse Event|0|||
127928380|NCT01202877|460360636|FG002|Overall Study|Adverse Event|2|||
127928381|NCT01202877|460360634|FG000|Overall Study|Withdrawal by Subject|0|||
127928382|NCT01202877|460360635|FG001|Overall Study|Withdrawal by Subject|0|||
127928383|NCT01202877|460360636|FG002|Overall Study|Withdrawal by Subject|1|||
127928384|NCT01202877|460360634|FG000|Overall Study|Death|0|||
127928385|NCT01202877|460360635|FG001|Overall Study|Death|0|||
127928386|NCT01202877|460360636|FG002|Overall Study|Death|1|||
127928387|NCT00396331|460360637|FG000|Overall Study|Failed to mobilize - no transplant|8|||
127928388|NCT00396331|460360637|FG000|Overall Study|Did not go on to transplant|5|||
127928389|NCT00396331|460360637|FG000|Overall Study|Lost to Follow-up|3|||
127928390|NCT00396331|460360637|FG000|Overall Study|Death|16|||
127928391|NCT00775528|460360638|FG000|Overall Study|Protocol Violation|1|||
127928392|NCT00350402|460360641|FG000|Overall Study|Lost to Follow-up|1|||
127928393|NCT00350402|460360642|FG001|Overall Study|Lost to Follow-up|1|||
127928394|NCT01884688|460360643|FG000|Overall Study|Screen Failure|2|||
127928395|NCT02549573|460360653|FG000|Overall Study|Withdrawal by Subject|0|||
127928396|NCT02549573|460360654|FG001|Overall Study|Withdrawal by Subject|2|||
127928397|NCT02549573|460360653|FG000|Overall Study|Protocol Violation|0|||
127928398|NCT02549573|460360654|FG001|Overall Study|Protocol Violation|1|||
127928399|NCT01382251|460360658|FG000|Overall Study|Surgeries cancelled or delayed|16|||
127928400|NCT01382251|460360659|FG001|Overall Study|Surgeries cancelled or delayed|16|||
127928401|NCT01382251|460360658|FG000|Overall Study|Lost to Follow-up|4|||
127928402|NCT01382251|460360659|FG001|Overall Study|Lost to Follow-up|4|||
127928403|NCT01382251|460360658|FG000|Overall Study|Contacted after study closed|1|||
127928404|NCT01382251|460360659|FG001|Overall Study|Contacted after study closed|1|||
127928405|NCT00562120|460360660|FG000|First Intervention Period|Adverse Event|1|||
127928406|NCT00562120|460360661|FG001|First Intervention Period|Adverse Event|0|||
127928407|NCT00562120|460360662|FG002|First Intervention Period|Adverse Event|0|||
127928408|NCT00562120|460360663|FG003|First Intervention Period|Adverse Event|0|||
127928409|NCT00562120|460360660|FG000|First Intervention Period|Randomized but not Treated|1|||
127928410|NCT00562120|460360661|FG001|First Intervention Period|Randomized but not Treated|0|||
127928411|NCT00562120|460360662|FG002|First Intervention Period|Randomized but not Treated|0|||
127928412|NCT00562120|460360663|FG003|First Intervention Period|Randomized but not Treated|0|||
127928413|NCT00952276|460360664|FG000|Overall Study|Withdrawal by Subject|1|||
127928414|NCT00952276|460360665|FG001|Overall Study|Withdrawal by Subject|0|||
127928415|NCT00952276|460360666|FG002|Overall Study|Withdrawal by Subject|0|||
127928416|NCT00952276|460360667|FG003|Overall Study|Withdrawal by Subject|1|||
127928417|NCT00952276|460360668|FG004|Overall Study|Withdrawal by Subject|0|||
127928418|NCT01010126|460362156|FG000|Overall Study|Withdrawal by Subject|1|||
127928419|NCT01010126|460362157|FG001|Overall Study|Withdrawal by Subject|0|||
127928420|NCT01010126|460362158|FG002|Overall Study|Withdrawal by Subject|1|||
127928421|NCT01010126|460362159|FG003|Overall Study|Withdrawal by Subject|0|||
127928422|NCT01010126|460362160|FG004|Overall Study|Withdrawal by Subject|3|||
127928423|NCT01010126|460362161|FG005|Overall Study|Withdrawal by Subject|0|||
127928424|NCT00595335|460362168|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
127928425|NCT00595335|460362169|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
127928426|NCT00595335|460362168|FG000|Baseline to Six Months|Disease Progression|1|||
127928427|NCT00595335|460362169|FG001|Baseline to Six Months|Disease Progression|1|||
127928428|NCT00595335|460362168|FG000|Baseline to Six Months|Adverse Event|1|||
127928429|NCT00595335|460362169|FG001|Baseline to Six Months|Adverse Event|0|||
127928430|NCT00595335|460362168|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
127928431|NCT00595335|460362169|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
127928432|NCT00595335|460362168|FG000|Six Months to Twelve Months|Disease Progression|1|||
127928433|NCT00595335|460362169|FG001|Six Months to Twelve Months|Disease Progression|0|||
127928434|NCT01647958|460362177|FG000|Initial Study|Lost to Follow-up|2|||
127928435|NCT01647958|460362178|FG001|Initial Study|Lost to Follow-up|3|||
127928436|NCT01647958|460362177|FG000|Continuation Phase|treatment received during Overall Study|39|||
127928437|NCT01647958|460362178|FG001|Continuation Phase|treatment received during Overall Study|0|||
127928438|NCT01647958|460362177|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
127928439|NCT01647958|460362178|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
127928440|NCT00544817|460362179|FG000|Combined Modality|Lack of Efficacy|2|||
127928441|NCT00544817|460362179|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
127928442|NCT00544817|460362179|FG000|Combined Modality|Adverse Event|2|||
127928443|NCT00544817|460362179|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
127928444|NCT00544817|460362179|FG000|No Treatment Interval|Lack of Efficacy|8|||
127928445|NCT00544817|460362179|FG000|No Treatment Interval|Physician Decision|3|||
127928446|NCT00544817|460362179|FG000|No Treatment Interval|Adverse Event|1|||
127928447|NCT00544817|460362179|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
127928448|NCT00544817|460362179|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
127928449|NCT00544817|460362179|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
127928450|NCT01131299|460362180|FG000|Overall Study|Withdrawal by Subject|4|||
127928451|NCT01131299|460362181|FG001|Overall Study|Withdrawal by Subject|7|||
127928452|NCT03686150|460362188|FG000|Overall Study|Withdrawal by Subject|1|||
127928453|NCT03686150|460362189|FG001|Overall Study|Withdrawal by Subject|1|||
127928454|NCT03686150|460362190|FG002|Overall Study|Withdrawal by Subject|1|||
127928455|NCT03686150|460362191|FG003|Overall Study|Withdrawal by Subject|0|||
127928456|NCT03686150|460362192|FG004|Overall Study|Withdrawal by Subject|1|||
127928457|NCT03686150|460362193|FG005|Overall Study|Withdrawal by Subject|2|||
127928458|NCT03686150|460362188|FG000|Overall Study|Physician Decision|1|||
127928459|NCT03686150|460362189|FG001|Overall Study|Physician Decision|0|||
127928460|NCT03686150|460362190|FG002|Overall Study|Physician Decision|0|||
127928461|NCT03686150|460362191|FG003|Overall Study|Physician Decision|0|||
127928462|NCT03686150|460362192|FG004|Overall Study|Physician Decision|0|||
127928463|NCT03686150|460362193|FG005|Overall Study|Physician Decision|1|||
127928464|NCT03686150|460362188|FG000|Overall Study|Lost to Follow-up|0|||
127928465|NCT03686150|460362189|FG001|Overall Study|Lost to Follow-up|1|||
127928466|NCT03686150|460362190|FG002|Overall Study|Lost to Follow-up|0|||
127928467|NCT03686150|460362191|FG003|Overall Study|Lost to Follow-up|0|||
127928468|NCT03686150|460362192|FG004|Overall Study|Lost to Follow-up|0|||
127928469|NCT03686150|460362193|FG005|Overall Study|Lost to Follow-up|0|||
127928470|NCT01213836|460362205|FG000|Period 1, First Intervention|Adverse Event|2|||
127928471|NCT01213836|460362206|FG001|Period 1, First Intervention|Adverse Event|1|||
127928472|NCT01213836|460362205|FG000|Period 1, First Intervention|Protocol Violation|0|||
127928473|NCT01213836|460362206|FG001|Period 1, First Intervention|Protocol Violation|1|||
127928474|NCT01213836|460362205|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
127928475|NCT01213836|460362206|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
127928476|NCT00255151|460362207|FG000|Overall Study|Adverse Event|10|||
127928477|NCT00255151|460362208|FG001|Overall Study|Adverse Event|6|||
127928478|NCT00255151|460362209|FG002|Overall Study|Adverse Event|9|||
127928479|NCT00255151|460362207|FG000|Overall Study|Lost to Follow-up|4|||
127928480|NCT00255151|460362208|FG001|Overall Study|Lost to Follow-up|3|||
127928481|NCT00255151|460362209|FG002|Overall Study|Lost to Follow-up|4|||
127928482|NCT00255151|460362207|FG000|Overall Study|Withdrawal by Subject|18|||
127928483|NCT00255151|460362208|FG001|Overall Study|Withdrawal by Subject|17|||
127928484|NCT00255151|460362209|FG002|Overall Study|Withdrawal by Subject|8|||
127928485|NCT00255151|460362207|FG000|Overall Study|Noncompliance|0|||
127928486|NCT00255151|460362208|FG001|Overall Study|Noncompliance|1|||
127928487|NCT00255151|460362209|FG002|Overall Study|Noncompliance|2|||
127928488|NCT00255151|460362207|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
127928489|NCT00255151|460362208|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
127928490|NCT00255151|460362209|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
127928491|NCT00255151|460362207|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
127928492|NCT00255151|460362208|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
127928493|NCT00255151|460362209|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
127928494|NCT00255151|460362207|FG000|Overall Study|Possible Barrett's Esophagus|1|||
127928495|NCT00255151|460362208|FG001|Overall Study|Possible Barrett's Esophagus|3|||
127928496|NCT00255151|460362209|FG002|Overall Study|Possible Barrett's Esophagus|8|||
127928497|NCT00255151|460362207|FG000|Overall Study|Esophageal Stricture|0|||
127928498|NCT00255151|460362208|FG001|Overall Study|Esophageal Stricture|0|||
127928499|NCT00255151|460362209|FG002|Overall Study|Esophageal Stricture|1|||
127928500|NCT00255151|460362207|FG000|Overall Study|Therapeutic Failure|11|||
127928501|NCT00255151|460362208|FG001|Overall Study|Therapeutic Failure|2|||
127928502|NCT00255151|460362209|FG002|Overall Study|Therapeutic Failure|3|||
127928503|NCT02676284|460362210|FG000|Overall Study|Withdrawal by Subject|1|||
127928504|NCT01685073|460362211|FG000|Overall Study|Lost to Follow-up|6|||
127928505|NCT01685073|460362212|FG001|Overall Study|Lost to Follow-up|8|||
127928506|NCT01685073|460362211|FG000|Overall Study|Withdrawal by Subject|24|||
127928507|NCT01685073|460362212|FG001|Overall Study|Withdrawal by Subject|24|||
127928508|NCT00107042|460362217|FG000|Overall Study|Lost to Follow-up|9|||
127928509|NCT00107042|460362218|FG001|Overall Study|Lost to Follow-up|7|||
127928510|NCT00107042|460362217|FG000|Overall Study|Withdrawal by Subject|6|||
127928511|NCT00107042|460362218|FG001|Overall Study|Withdrawal by Subject|1|||
127928512|NCT00107042|460362217|FG000|Overall Study|Moved out of area|5|||
127928513|NCT00107042|460362218|FG001|Overall Study|Moved out of area|3|||
127928514|NCT00107042|460362217|FG000|Overall Study|Pregnancy|1|||
127928515|NCT00107042|460362218|FG001|Overall Study|Pregnancy|1|||
127928516|NCT00107042|460362217|FG000|Overall Study|Inadvertent enrollment|0|||
127928517|NCT00107042|460362218|FG001|Overall Study|Inadvertent enrollment|1|||
127928518|NCT00107042|460362217|FG000|Overall Study|vaccinated outside window|1|||
127928519|NCT00107042|460362218|FG001|Overall Study|vaccinated outside window|1|||
127928520|NCT00107042|460362217|FG000|Overall Study|Disallowed medications|0|||
127928521|NCT00107042|460362218|FG001|Overall Study|Disallowed medications|2|||
127928522|NCT01221090|460362220|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
127928523|NCT01221090|460362221|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
127928524|NCT01221090|460362222|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
127928525|NCT01221090|460362223|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
127928526|NCT01221090|460362220|FG000|Overall Study|Withdrawal by Subject|0|||
127928527|NCT01221090|460362221|FG001|Overall Study|Withdrawal by Subject|22|||
127928528|NCT01221090|460362222|FG002|Overall Study|Withdrawal by Subject|27|||
127928529|NCT01221090|460362223|FG003|Overall Study|Withdrawal by Subject|2|||
127928530|NCT00708708|460362224|FG000|Overall Study|Another therapy instead of Enbrel|141|||
127928531|NCT00708708|460362224|FG000|Overall Study|Lost to Follow-up|52|||
127928532|NCT00708708|460362224|FG000|Overall Study|Withdrawal by Subject|51|||
127928533|NCT00708708|460362224|FG000|Overall Study|Intolerance|42|||
127928534|NCT00708708|460362224|FG000|Overall Study|Another therapy along with Enbrel|15|||
127928535|NCT00708708|460362224|FG000|Overall Study|Other unspecified|11|||
127928536|NCT00708708|460362224|FG000|Overall Study|Good effectiveness|9|||
127928537|NCT00708708|460362224|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
127928538|NCT00708708|460362224|FG000|Overall Study|Administrative reasons|7|||
127928539|NCT00708708|460362224|FG000|Overall Study|Lack of effectiveness|4|||
127928540|NCT00708708|460362224|FG000|Overall Study|Lack of compliance|3|||
127928541|NCT00708708|460362224|FG000|Overall Study|Pregnancy|3|||
127928542|NCT00708708|460362224|FG000|Overall Study|Adverse Event|3|||
127928543|NCT00708708|460362224|FG000|Overall Study|Missing values|392|||
127928544|NCT00892281|460362231|FG000|Overall Study|Adverse Event|65|||
127928545|NCT00892281|460362232|FG001|Overall Study|Adverse Event|8|||
127928546|NCT00892281|460362231|FG000|Overall Study|Lost to Follow-up|81|||
127928547|NCT00892281|460362232|FG001|Overall Study|Lost to Follow-up|8|||
127928548|NCT00892281|460362231|FG000|Overall Study|Pregnancy|1|||
127928549|NCT00892281|460362232|FG001|Overall Study|Pregnancy|0|||
127928550|NCT00892281|460362231|FG000|Overall Study|Protocol Violation|7|||
127928551|NCT00892281|460362232|FG001|Overall Study|Protocol Violation|2|||
127928552|NCT00892281|460362231|FG000|Overall Study|Withdrawal by Subject|86|||
127928553|NCT00892281|460362232|FG001|Overall Study|Withdrawal by Subject|14|||
127928554|NCT00892281|460362231|FG000|Overall Study|Subject failed to return for final visit|2|||
127928555|NCT00892281|460362232|FG001|Overall Study|Subject failed to return for final visit|0|||
127928556|NCT00892281|460362231|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
127928557|NCT00892281|460362232|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
127928558|NCT00892281|460362231|FG000|Overall Study|Final visit completed 4 weeks late|0|||
127928559|NCT00892281|460362232|FG001|Overall Study|Final visit completed 4 weeks late|1|||
127928560|NCT00892281|460362231|FG000|Overall Study|Subject completed day after study closed|1|||
127928561|NCT00892281|460362232|FG001|Overall Study|Subject completed day after study closed|0|||
127928562|NCT00892281|460362231|FG000|Overall Study|Family emergency|1|||
127928563|NCT00892281|460362232|FG001|Overall Study|Family emergency|0|||
127928564|NCT00892281|460362231|FG000|Overall Study|Last visit not done - death in family|1|||
127928565|NCT00892281|460362232|FG001|Overall Study|Last visit not done - death in family|0|||
127928566|NCT00892281|460362231|FG000|Overall Study|Did not meet incl/excl criteria|1|||
127928567|NCT00892281|460362232|FG001|Overall Study|Did not meet incl/excl criteria|0|||
127928568|NCT00892281|460362231|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
127928569|NCT00892281|460362232|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
127928570|NCT00892281|460362231|FG000|Overall Study|Unable to redeem the drug voucher|1|||
127928571|NCT00892281|460362232|FG001|Overall Study|Unable to redeem the drug voucher|0|||
127928572|NCT00892281|460362231|FG000|Overall Study|Subject not good candidate for study|1|||
127928573|NCT00892281|460362232|FG001|Overall Study|Subject not good candidate for study|0|||
127928574|NCT00892281|460362231|FG000|Overall Study|Subject did not return for any visits|1|||
127928575|NCT00892281|460362232|FG001|Overall Study|Subject did not return for any visits|0|||
127928576|NCT00892281|460362231|FG000|Overall Study|Subject missed several visits/lost meds|1|||
127928577|NCT00892281|460362232|FG001|Overall Study|Subject missed several visits/lost meds|0|||
127928578|NCT00892281|460362231|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
127928579|NCT00892281|460362232|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
127928580|NCT00892281|460362231|FG000|Overall Study|Scheduled for knee replacement|0|||
127928581|NCT00892281|460362232|FG001|Overall Study|Scheduled for knee replacement|1|||
127928582|NCT00892281|460362231|FG000|Overall Study|PI complained of inadequate compensation|3|||
127928583|NCT00892281|460362232|FG001|Overall Study|PI complained of inadequate compensation|0|||
127928584|NCT00892281|460362231|FG000|Overall Study|Subject lost interest in program|0|||
127928585|NCT00892281|460362232|FG001|Overall Study|Subject lost interest in program|1|||
127928586|NCT00892281|460362231|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
127928587|NCT00892281|460362232|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
127928588|NCT00892281|460362231|FG000|Overall Study|Death in family|1|||
127928589|NCT00892281|460362232|FG001|Overall Study|Death in family|0|||
127928590|NCT00892281|460362231|FG000|Overall Study|Lack of efficacy of study product|2|||
127928591|NCT00892281|460362232|FG001|Overall Study|Lack of efficacy of study product|0|||
127928592|NCT00892281|460362231|FG000|Overall Study|Subject not seen by PI at final visit|1|||
127928593|NCT00892281|460362232|FG001|Overall Study|Subject not seen by PI at final visit|0|||
127928594|NCT00892281|460362231|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
127928595|NCT00892281|460362232|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
127928596|NCT00892281|460362231|FG000|Overall Study|Missed multiple visits|1|||
127928597|NCT00892281|460362232|FG001|Overall Study|Missed multiple visits|0|||
127928598|NCT00892281|460362231|FG000|Overall Study|Missed visits rescheduled out of window|1|||
127928599|NCT00892281|460362232|FG001|Overall Study|Missed visits rescheduled out of window|0|||
127928600|NCT00892281|460362231|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
127928601|NCT00892281|460362232|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
127928602|NCT00892281|460362231|FG000|Overall Study|Subject had history of drug abuse|1|||
127928603|NCT00892281|460362232|FG001|Overall Study|Subject had history of drug abuse|0|||
127928604|NCT00892281|460362231|FG000|Overall Study|Rash on hand|1|||
127928605|NCT00892281|460362232|FG001|Overall Study|Rash on hand|0|||
127928606|NCT00892281|460362231|FG000|Overall Study|Visit 4 date out of window|1|||
127928607|NCT00892281|460362232|FG001|Overall Study|Visit 4 date out of window|0|||
127928608|NCT00140413|460362233|FG000|Overall Study|Lost to Follow-up|1|||
127928609|NCT00140413|460362234|FG001|Overall Study|Lost to Follow-up|0|||
127928610|NCT00140413|460362233|FG000|Overall Study|Withdrawal by Subject|2|||
127928611|NCT00140413|460362234|FG001|Overall Study|Withdrawal by Subject|0|||
127928612|NCT00865098|460362235|FG000|Overall Study|Progressive disease|1|||
127928613|NCT01360866|460362243|FG000|Overall Study|Lost to Follow-up|11|||
127928614|NCT01360866|460362244|FG001|Overall Study|Lost to Follow-up|28|||
127928615|NCT01360866|460362245|FG002|Overall Study|Lost to Follow-up|41|||
127928616|NCT01360866|460362246|FG003|Overall Study|Lost to Follow-up|0|||
127928617|NCT01360866|460362243|FG000|Overall Study|Adverse Event|56|||
127928618|NCT01360866|460362244|FG001|Overall Study|Adverse Event|61|||
127928619|NCT01360866|460362245|FG002|Overall Study|Adverse Event|134|||
127928620|NCT01360866|460362246|FG003|Overall Study|Adverse Event|6|||
127928621|NCT01360866|460362243|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
127928622|NCT01360866|460362244|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
127928623|NCT01360866|460362245|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
127928624|NCT01360866|460362246|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
127928625|NCT01360866|460362243|FG000|Overall Study|Withdrawn by Investigator|9|||
127928626|NCT01360866|460362244|FG001|Overall Study|Withdrawn by Investigator|8|||
127928627|NCT01360866|460362245|FG002|Overall Study|Withdrawn by Investigator|31|||
127928628|NCT01360866|460362246|FG003|Overall Study|Withdrawn by Investigator|2|||
127928629|NCT01360866|460362243|FG000|Overall Study|Withdrawal by participant|79|||
127928630|NCT01360866|460362244|FG001|Overall Study|Withdrawal by participant|89|||
127928631|NCT01360866|460362245|FG002|Overall Study|Withdrawal by participant|168|||
127928632|NCT01360866|460362246|FG003|Overall Study|Withdrawal by participant|8|||
127928633|NCT01360866|460362243|FG000|Overall Study|Protocol Deviation|25|||
127928634|NCT01360866|460362244|FG001|Overall Study|Protocol Deviation|33|||
127928635|NCT01360866|460362245|FG002|Overall Study|Protocol Deviation|61|||
127928636|NCT01360866|460362246|FG003|Overall Study|Protocol Deviation|2|||
127928637|NCT01360866|460362243|FG000|Overall Study|Lack of Efficacy|30|||
127928638|NCT01360866|460362244|FG001|Overall Study|Lack of Efficacy|40|||
127928639|NCT01360866|460362245|FG002|Overall Study|Lack of Efficacy|30|||
127928640|NCT01360866|460362246|FG003|Overall Study|Lack of Efficacy|4|||
127928641|NCT03702049|460362250|FG000|Overall Study|Lost to Follow-up|4|||
127928642|NCT03702049|460362250|FG000|Overall Study|Physician Decision|1|||
127928643|NCT01304693|460362251|FG000|Overall Study|Adverse Event|0|||
127928644|NCT01304693|460362252|FG001|Overall Study|Adverse Event|0|||
127928645|NCT01304693|460362253|FG002|Overall Study|Adverse Event|0|||
127928646|NCT01304693|460362254|FG003|Overall Study|Adverse Event|0|||
127928647|NCT01304693|460362255|FG004|Overall Study|Adverse Event|1|||
127928648|NCT01304693|460362251|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
127928649|NCT01304693|460362252|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
127928650|NCT01304693|460362253|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
127928651|NCT01304693|460362254|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
127928652|NCT01304693|460362255|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
127928653|NCT02129647|460362256|FG000|Overall Study|Adverse Event|2|||
127928654|NCT02129647|460362256|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
127928655|NCT01715896|460362257|FG000|Overall Study|Lost to Follow-up|0|||
127928656|NCT01715896|460362258|FG001|Overall Study|Lost to Follow-up|2|||
127928657|NCT01715896|460362257|FG000|Overall Study|Withdrawal by Subject|1|||
127928658|NCT01715896|460362258|FG001|Overall Study|Withdrawal by Subject|4|||
127928659|NCT01715896|460362257|FG000|Overall Study|Other|2|||
127928660|NCT01715896|460362258|FG001|Overall Study|Other|5|||
127928661|NCT01833533|460362264|FG000|Overall Study|Adverse Event|0|||
127928662|NCT01833533|460362265|FG001|Overall Study|Adverse Event|1|||
127928663|NCT01833533|460362264|FG000|Overall Study|Lost to Follow-up|4|||
127928664|NCT01833533|460362265|FG001|Overall Study|Lost to Follow-up|9|||
127928665|NCT01833533|460362264|FG000|Overall Study|To Enter an Extension Study|0|||
127928666|NCT01833533|460362265|FG001|Overall Study|To Enter an Extension Study|4|||
127928667|NCT01833533|460362264|FG000|Overall Study|Other|2|||
127928668|NCT01833533|460362265|FG001|Overall Study|Other|7|||
127928669|NCT01048502|460362266|FG000|Overall Study|Lost to Follow-up|2|||
127928670|NCT01048502|460362267|FG001|Overall Study|Lost to Follow-up|0|||
127928671|NCT01048502|460362268|FG002|Overall Study|Lost to Follow-up|0|||
127928672|NCT01048502|460362269|FG003|Overall Study|Lost to Follow-up|0|||
127928673|NCT01048502|460362266|FG000|Overall Study|Adverse Event|1|||
127928674|NCT01048502|460362267|FG001|Overall Study|Adverse Event|0|||
127928675|NCT01048502|460362268|FG002|Overall Study|Adverse Event|0|||
127928676|NCT01048502|460362269|FG003|Overall Study|Adverse Event|0|||
127928677|NCT01048502|460362266|FG000|Overall Study|Withdrawal by Subject|1|||
127928678|NCT01048502|460362267|FG001|Overall Study|Withdrawal by Subject|4|||
127928679|NCT01048502|460362268|FG002|Overall Study|Withdrawal by Subject|5|||
127928680|NCT01048502|460362269|FG003|Overall Study|Withdrawal by Subject|3|||
127928681|NCT01048502|460362266|FG000|Overall Study|Physician Decision|0|||
127928682|NCT01048502|460362267|FG001|Overall Study|Physician Decision|3|||
127928683|NCT01048502|460362268|FG002|Overall Study|Physician Decision|0|||
127928684|NCT01048502|460362269|FG003|Overall Study|Physician Decision|1|||
127928685|NCT01138826|460362270|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
127928686|NCT01138826|460362271|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
127928687|NCT01138826|460362272|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
127928688|NCT01138826|460362273|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
127928689|NCT01138826|460362274|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
127928690|NCT01138826|460362275|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
127928691|NCT01333072|460362279|FG000|Overall Study|Lost to Follow-up|3|||
127928692|NCT01333072|460362280|FG001|Overall Study|Lost to Follow-up|0|||
127928693|NCT01333072|460362279|FG000|Overall Study|Adverse Event|2|||
127928694|NCT01333072|460362280|FG001|Overall Study|Adverse Event|4|||
127928695|NCT01333072|460362279|FG000|Overall Study|Physician Decision|1|||
127928696|NCT01333072|460362280|FG001|Overall Study|Physician Decision|0|||
127928697|NCT01557842|460362281|FG000|Overall Study|Lost to Follow-up|0|||
127928698|NCT01557842|460362282|FG001|Overall Study|Lost to Follow-up|1|||
127928699|NCT01557842|460362281|FG000|Overall Study|Death|1|||
127928700|NCT01557842|460362282|FG001|Overall Study|Death|0|||
127928701|NCT01557842|460362281|FG000|Overall Study|Lack of Efficacy|0|||
127928702|NCT01557842|460362282|FG001|Overall Study|Lack of Efficacy|1|||
127928703|NCT01557842|460362281|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
127928704|NCT01557842|460362282|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
127928705|NCT01557842|460362281|FG000|Overall Study|Study Terminated by Sponsor|3|||
127928706|NCT01557842|460362282|FG001|Overall Study|Study Terminated by Sponsor|4|||
127928707|NCT01557842|460362281|FG000|Overall Study|Not Ablated|2|||
127928708|NCT01557842|460362282|FG001|Overall Study|Not Ablated|0|||
127928709|NCT02457611|460362286|FG000|Overall Study|Lost to Follow-up|3|||
127928710|NCT00384293|460362287|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
127928711|NCT00384293|460362288|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
127928712|NCT00384293|460362289|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
127928713|NCT00384293|460362287|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
127928714|NCT00384293|460362288|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
127928715|NCT00384293|460362289|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
127928716|NCT00384293|460362287|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
127928717|NCT00384293|460362288|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
127928718|NCT00384293|460362289|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
127928719|NCT00384293|460362287|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
127928720|NCT00384293|460362288|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
127928721|NCT00384293|460362289|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
127928722|NCT00384293|460362287|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
127928723|NCT00384293|460362288|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
127928724|NCT00384293|460362289|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
127928725|NCT00384293|460362287|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
127928726|NCT00384293|460362288|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
127928727|NCT00384293|460362289|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
127928728|NCT00384293|460362287|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
127928729|NCT00384293|460362288|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
127928730|NCT00384293|460362289|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
127928731|NCT00384293|460362287|FG000|Post-randomization Period|Adverse Event|0|||
127928732|NCT00384293|460362288|FG001|Post-randomization Period|Adverse Event|23|||
127928733|NCT00384293|460362289|FG002|Post-randomization Period|Adverse Event|7|||
127928734|NCT00384293|460362287|FG000|Post-randomization Period|Lost to Follow-up|0|||
127928735|NCT00384293|460362288|FG001|Post-randomization Period|Lost to Follow-up|2|||
127928736|NCT00384293|460362289|FG002|Post-randomization Period|Lost to Follow-up|1|||
127928737|NCT00384293|460362287|FG000|Post-randomization Period|Protocol Violation|0|||
127928738|NCT00384293|460362288|FG001|Post-randomization Period|Protocol Violation|1|||
127928739|NCT00384293|460362289|FG002|Post-randomization Period|Protocol Violation|0|||
127928740|NCT00384293|460362287|FG000|Post-randomization Period|Withdrawal by Subject|0|||
127928741|NCT00384293|460362288|FG001|Post-randomization Period|Withdrawal by Subject|8|||
127928742|NCT00384293|460362289|FG002|Post-randomization Period|Withdrawal by Subject|6|||
127928743|NCT00384293|460362287|FG000|Post-randomization Period|Trial Termination|0|||
127928744|NCT00384293|460362288|FG001|Post-randomization Period|Trial Termination|180|||
127928745|NCT00384293|460362289|FG002|Post-randomization Period|Trial Termination|204|||
127928746|NCT00384293|460362287|FG000|Post-randomization Period|Patient Randomized in Error|0|||
127928747|NCT00384293|460362288|FG001|Post-randomization Period|Patient Randomized in Error|0|||
127928748|NCT00384293|460362289|FG002|Post-randomization Period|Patient Randomized in Error|1|||
127928749|NCT03005067|460362290|FG000|Overall Study|Withdrawal by Subject|3|||
127928750|NCT03005067|460362291|FG001|Overall Study|Withdrawal by Subject|2|||
127928751|NCT03005067|460362290|FG000|Overall Study|Adverse Event|4|||
127928752|NCT03005067|460362291|FG001|Overall Study|Adverse Event|3|||
127928753|NCT03005067|460362290|FG000|Overall Study|Other (reason not specified)|3|||
127928754|NCT03005067|460362291|FG001|Overall Study|Other (reason not specified)|1|||
127928755|NCT03005067|460362290|FG000|Overall Study|Protocol Violation|0|||
127928756|NCT03005067|460362291|FG001|Overall Study|Protocol Violation|1|||
127928757|NCT00619359|460362294|FG000|Overall Study|Adverse Event|32|||
127928758|NCT00619359|460362295|FG001|Overall Study|Adverse Event|36|||
127928759|NCT00619359|460362294|FG000|Overall Study|Lost to Follow-up|12|||
127928760|NCT00619359|460362295|FG001|Overall Study|Lost to Follow-up|16|||
127928761|NCT00619359|460362294|FG000|Overall Study|Physician Decision|0|||
127928762|NCT00619359|460362295|FG001|Overall Study|Physician Decision|7|||
127928763|NCT00619359|460362294|FG000|Overall Study|Protocol Violation|1|||
127928764|NCT00619359|460362295|FG001|Overall Study|Protocol Violation|1|||
127928765|NCT00619359|460362294|FG000|Overall Study|Withdrawal by Subject|19|||
127928766|NCT00619359|460362295|FG001|Overall Study|Withdrawal by Subject|20|||
127928767|NCT00619359|460362294|FG000|Overall Study|Progressive Disease|3|||
127928768|NCT00619359|460362295|FG001|Overall Study|Progressive Disease|1|||
127928769|NCT05212883|460362299|FG000|Overall Study|Invalid test result|125|||
127928770|NCT02502734|460362300|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
127928771|NCT02502734|460362301|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
127928772|NCT02502734|460362300|FG000|Washout Period|Adverse Event|1|||
127928773|NCT02502734|460362301|FG001|Washout Period|Adverse Event|0|||
127928774|NCT01483625|460362304|FG000|Overall Study|Adverse Event|1|||
127928775|NCT01483625|460362305|FG001|Overall Study|Adverse Event|1|||
127928776|NCT01483625|460362304|FG000|Overall Study|Refused to continue medication|2|||
127928777|NCT01483625|460362305|FG001|Overall Study|Refused to continue medication|1|||
127928778|NCT01483625|460362304|FG000|Overall Study|Due to other reason|1|||
127928779|NCT01483625|460362305|FG001|Overall Study|Due to other reason|0|||
127928780|NCT03891329|460362321|FG000|Overall Study|Death|5|||
127928781|NCT03891329|460362321|FG000|Overall Study|Lost to Follow-up|4|||
127928782|NCT03891329|460362321|FG000|Overall Study|Physician Decision|4|||
127928783|NCT03891329|460362321|FG000|Overall Study|Device explanted|3|||
127928784|NCT03891329|460362321|FG000|Overall Study|No study device implanted|3|||
127928785|NCT01832402|460362324|FG000|Overall Study|Lost to Follow-up|2|||
127928786|NCT01832402|460362325|FG001|Overall Study|Lost to Follow-up|0|||
127928787|NCT01832402|460362324|FG000|Overall Study|Withdrawal by Subject|3|||
127928788|NCT01832402|460362325|FG001|Overall Study|Withdrawal by Subject|3|||
127928789|NCT01832402|460362324|FG000|Overall Study|Declining Performance status|2|||
127928790|NCT01832402|460362325|FG001|Overall Study|Declining Performance status|1|||
127928791|NCT01803269|460362328|FG000|Overall Study|Withdrawal by Subject|3|||
127928792|NCT01803269|460362329|FG001|Overall Study|Withdrawal by Subject|0|||
127928793|NCT01803269|460362330|FG002|Overall Study|Withdrawal by Subject|0|||
127928794|NCT02377921|460362335|FG000|Overall Study|Subject non-compliance|1|||
127928795|NCT02377921|460362336|FG001|Overall Study|Subject non-compliance|1|||
127928796|NCT00545688|460362341|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
127928797|NCT00545688|460362342|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
127928798|NCT00545688|460362343|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
127928799|NCT00545688|460362344|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
127928800|NCT00545688|460362341|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
127928801|NCT00545688|460362342|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
127928802|NCT00545688|460362343|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
127928803|NCT00545688|460362344|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
127928804|NCT00545688|460362341|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
127928805|NCT00545688|460362342|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
127928806|NCT00545688|460362343|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
127928807|NCT00545688|460362344|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
127928808|NCT00545688|460362341|FG000|Neo-Adjuvant Treatment Period|Death|0|||
127928809|NCT00545688|460362342|FG001|Neo-Adjuvant Treatment Period|Death|1|||
127928810|NCT00545688|460362343|FG002|Neo-Adjuvant Treatment Period|Death|0|||
127928811|NCT00545688|460362344|FG003|Neo-Adjuvant Treatment Period|Death|0|||
127928812|NCT00545688|460362341|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
127928813|NCT00545688|460362342|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
127928814|NCT00545688|460362343|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
127928815|NCT00545688|460362344|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
127928816|NCT00545688|460362341|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
127928817|NCT00545688|460362342|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
127928818|NCT00545688|460362343|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
127928819|NCT00545688|460362344|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
127928820|NCT00545688|460362341|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
127928821|NCT00545688|460362342|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
127928822|NCT00545688|460362343|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
127928823|NCT00545688|460362344|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
127928824|NCT00545688|460362341|FG000|Adjuvant Treatment Period|Disease Progression|3|||
127928825|NCT00545688|460362342|FG001|Adjuvant Treatment Period|Disease Progression|3|||
127928826|NCT00545688|460362343|FG002|Adjuvant Treatment Period|Disease Progression|0|||
127928827|NCT00545688|460362344|FG003|Adjuvant Treatment Period|Disease Progression|7|||
127928828|NCT00545688|460362341|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
127928829|NCT00545688|460362342|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
127928830|NCT00545688|460362343|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
127928831|NCT00545688|460362344|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
127928832|NCT00545688|460362341|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
127928833|NCT00545688|460362342|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
127928834|NCT00545688|460362343|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
127928835|NCT00545688|460362344|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
127928836|NCT00545688|460362341|FG000|Adjuvant Treatment Period|Adverse Event|0|||
127928837|NCT00545688|460362342|FG001|Adjuvant Treatment Period|Adverse Event|3|||
127928838|NCT00545688|460362343|FG002|Adjuvant Treatment Period|Adverse Event|2|||
127928839|NCT00545688|460362344|FG003|Adjuvant Treatment Period|Adverse Event|2|||
127928840|NCT00545688|460362341|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
127928841|NCT00545688|460362342|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
127928842|NCT00545688|460362343|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
127928843|NCT00545688|460362344|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
127928844|NCT00545688|460362341|FG000|Follow-Up Period|Death|4|||
127928845|NCT00545688|460362342|FG001|Follow-Up Period|Death|2|||
127928846|NCT00545688|460362343|FG002|Follow-Up Period|Death|2|||
127928847|NCT00545688|460362344|FG003|Follow-Up Period|Death|6|||
127928848|NCT00545688|460362341|FG000|Follow-Up Period|Disease Progression|6|||
127928849|NCT00545688|460362342|FG001|Follow-Up Period|Disease Progression|5|||
127928850|NCT00545688|460362343|FG002|Follow-Up Period|Disease Progression|9|||
127928851|NCT00545688|460362344|FG003|Follow-Up Period|Disease Progression|9|||
127928852|NCT00545688|460362341|FG000|Follow-Up Period|Refused Treatment|6|||
127928853|NCT00545688|460362342|FG001|Follow-Up Period|Refused Treatment|2|||
127928854|NCT00545688|460362343|FG002|Follow-Up Period|Refused Treatment|0|||
127928855|NCT00545688|460362344|FG003|Follow-Up Period|Refused Treatment|2|||
127928856|NCT00545688|460362341|FG000|Follow-Up Period|Lost to Follow-up|3|||
127928857|NCT00545688|460362342|FG001|Follow-Up Period|Lost to Follow-up|3|||
127928858|NCT00545688|460362343|FG002|Follow-Up Period|Lost to Follow-up|3|||
127928859|NCT00545688|460362344|FG003|Follow-Up Period|Lost to Follow-up|1|||
127928860|NCT00545688|460362341|FG000|Follow-Up Period|Unspecified Reason|2|||
127928861|NCT00545688|460362342|FG001|Follow-Up Period|Unspecified Reason|5|||
127928862|NCT00545688|460362343|FG002|Follow-Up Period|Unspecified Reason|6|||
127928863|NCT00545688|460362344|FG003|Follow-Up Period|Unspecified Reason|8|||
127928864|NCT00545688|460362341|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
127928865|NCT00545688|460362342|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
127928866|NCT00545688|460362343|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
127928867|NCT00545688|460362344|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
127928868|NCT02813421|460364095|FG000|Overall Study|Withdrawal by Subject|1|||
127928869|NCT02813421|460364096|FG001|Overall Study|Withdrawal by Subject|2|||
127928870|NCT02813421|460364095|FG000|Overall Study|Lost to Follow-up|1|||
127928871|NCT02813421|460364096|FG001|Overall Study|Lost to Follow-up|1|||
127928872|NCT00706095|460364105|FG000|Overall Study|Progressive Disease|4|||
127928873|NCT00706095|460364106|FG001|Overall Study|Progressive Disease|5|||
127928874|NCT00706095|460364107|FG002|Overall Study|Progressive Disease|3|||
127928875|NCT00706095|460364105|FG000|Overall Study|Clinical Progression|1|||
127928876|NCT00706095|460364106|FG001|Overall Study|Clinical Progression|2|||
127928877|NCT00706095|460364107|FG002|Overall Study|Clinical Progression|2|||
127928878|NCT00706095|460364105|FG000|Overall Study|Withdrawal by Subject|1|||
127928879|NCT00706095|460364106|FG001|Overall Study|Withdrawal by Subject|0|||
127928880|NCT00706095|460364107|FG002|Overall Study|Withdrawal by Subject|0|||
127928881|NCT00856830|460364108|FG000|Irinotecan & Bendamustine|Death|0|||
127928882|NCT00856830|460364109|FG001|Irinotecan & Bendamustine|Death|0|||
127928883|NCT00856830|460364110|FG002|Irinotecan & Bendamustine|Death|0|||
127928884|NCT00856830|460364111|FG003|Irinotecan & Bendamustine|Death|2|||
127928885|NCT00856830|460364108|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
127928886|NCT00856830|460364109|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
127928887|NCT00856830|460364110|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
127928888|NCT00856830|460364111|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
127928889|NCT00918463|460364112|FG000|Overall Study|Death|1|||
127928890|NCT00918463|460364112|FG000|Overall Study|Lack of Efficacy|1|||
127928891|NCT01014624|460364116|FG000|Overall Study|Adverse Event|0|||
127928892|NCT01014624|460364117|FG001|Overall Study|Adverse Event|1|||
127928893|NCT01014624|460364116|FG000|Overall Study|Protocol Violation|1|||
127928894|NCT01014624|460364117|FG001|Overall Study|Protocol Violation|0|||
127928895|NCT01014624|460364116|FG000|Overall Study|Withdrawal by Subject|1|||
127928896|NCT01014624|460364117|FG001|Overall Study|Withdrawal by Subject|0|||
127928897|NCT02954159|460364119|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
127928898|NCT02954159|460364120|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
127928899|NCT02954159|460364119|FG000|Overall Study|Withdrawal by Subject|0|||
127928900|NCT02954159|460364120|FG001|Overall Study|Withdrawal by Subject|1|||
127928901|NCT01117337|460364124|FG000|Overall Study|Lost to Follow-up|4|||
127928902|NCT01117337|460364125|FG001|Overall Study|Lost to Follow-up|0|||
127928903|NCT03575871|460364126|FG000|Overall Study|Adverse Event|5|||
127928904|NCT03575871|460364127|FG001|Overall Study|Adverse Event|5|||
127928905|NCT03575871|460364128|FG002|Overall Study|Adverse Event|8|||
127928906|NCT03575871|460364126|FG000|Overall Study|Death|1|||
127928907|NCT03575871|460364127|FG001|Overall Study|Death|0|||
127928908|NCT03575871|460364128|FG002|Overall Study|Death|0|||
127928909|NCT03575871|460364126|FG000|Overall Study|Lack of Efficacy|5|||
127928910|NCT03575871|460364127|FG001|Overall Study|Lack of Efficacy|4|||
127928911|NCT03575871|460364128|FG002|Overall Study|Lack of Efficacy|7|||
127928912|NCT03575871|460364126|FG000|Overall Study|Lost to Follow-up|1|||
127928913|NCT03575871|460364127|FG001|Overall Study|Lost to Follow-up|1|||
127928914|NCT03575871|460364128|FG002|Overall Study|Lost to Follow-up|1|||
127928915|NCT03575871|460364126|FG000|Overall Study|Protocol Deviation|1|||
127928916|NCT03575871|460364127|FG001|Overall Study|Protocol Deviation|1|||
127928917|NCT03575871|460364128|FG002|Overall Study|Protocol Deviation|1|||
127928918|NCT03575871|460364126|FG000|Overall Study|Withdrawal by Subject|6|||
127928919|NCT03575871|460364127|FG001|Overall Study|Withdrawal by Subject|1|||
127928920|NCT03575871|460364128|FG002|Overall Study|Withdrawal by Subject|9|||
127928921|NCT03575871|460364126|FG000|Overall Study|Other than specified|2|||
127928922|NCT03575871|460364127|FG001|Overall Study|Other than specified|2|||
127928923|NCT03575871|460364128|FG002|Overall Study|Other than specified|0|||
127928924|NCT01744093|460364132|FG000|Overall Study|Withdrawal by Subject|6|||
127928925|NCT01744093|460364133|FG001|Overall Study|Withdrawal by Subject|1|||
127928926|NCT01570283|460364134|FG000|Cohort 1: Dose Level 1|Death|0|||
127928927|NCT01570283|460364135|FG001|Cohort 1: Dose Level 1|Death|1|||
127928928|NCT01570283|460364136|FG002|Cohort 1: Dose Level 1|Death|0|||
127928929|NCT01570283|460364137|FG003|Cohort 1: Dose Level 1|Death|0|||
127928930|NCT01570283|460364138|FG004|Cohort 1: Dose Level 1|Death|0|||
127928931|NCT01570283|460364139|FG005|Cohort 1: Dose Level 1|Death|0|||
127928932|NCT01570283|460364134|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
127928933|NCT01570283|460364135|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
127928934|NCT01570283|460364136|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
127928935|NCT01570283|460364137|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
127928936|NCT01570283|460364138|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
127928937|NCT01570283|460364139|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
127928938|NCT01570283|460364134|FG000|Cohort 2: Dose Level 2|Death|0|||
127928939|NCT01570283|460364135|FG001|Cohort 2: Dose Level 2|Death|0|||
127928940|NCT01570283|460364136|FG002|Cohort 2: Dose Level 2|Death|1|||
127928941|NCT01570283|460364137|FG003|Cohort 2: Dose Level 2|Death|0|||
127928942|NCT01570283|460364138|FG004|Cohort 2: Dose Level 2|Death|0|||
127928943|NCT01570283|460364139|FG005|Cohort 2: Dose Level 2|Death|0|||
127928944|NCT01570283|460364134|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
127928945|NCT01570283|460364135|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
127928946|NCT01570283|460364136|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
127928947|NCT01570283|460364137|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
127928948|NCT01570283|460364138|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
127928949|NCT01570283|460364139|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
127928950|NCT01570283|460364134|FG000|Cohort 3: Dose Level 3|Death|0|||
127928951|NCT01570283|460364135|FG001|Cohort 3: Dose Level 3|Death|0|||
127928952|NCT01570283|460364136|FG002|Cohort 3: Dose Level 3|Death|0|||
127928953|NCT01570283|460364137|FG003|Cohort 3: Dose Level 3|Death|0|||
127928954|NCT01570283|460364138|FG004|Cohort 3: Dose Level 3|Death|0|||
127928955|NCT01570283|460364139|FG005|Cohort 3: Dose Level 3|Death|1|||
127928956|NCT01570283|460364134|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
127928957|NCT01570283|460364135|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
127928958|NCT01570283|460364136|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
127928959|NCT01570283|460364137|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
127928960|NCT01570283|460364138|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
127928961|NCT01570283|460364139|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
127928962|NCT01173471|460364142|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
127928963|NCT01173471|460364143|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
127928964|NCT01173471|460364144|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
127928965|NCT01173471|460364145|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
127928966|NCT01173471|460364142|FG000|Overall Study|Condition under investigation worsened|2|||
127928967|NCT01173471|460364143|FG001|Overall Study|Condition under investigation worsened|0|||
127928968|NCT01173471|460364144|FG002|Overall Study|Condition under investigation worsened|0|||
127928969|NCT01173471|460364145|FG003|Overall Study|Condition under investigation worsened|0|||
127928970|NCT01173471|460364142|FG000|Overall Study|Lost to Follow-up|0|||
127928971|NCT01173471|460364143|FG001|Overall Study|Lost to Follow-up|0|||
127928972|NCT01173471|460364144|FG002|Overall Study|Lost to Follow-up|1|||
127928973|NCT01173471|460364145|FG003|Overall Study|Lost to Follow-up|0|||
127928974|NCT01173471|460364142|FG000|Overall Study|Reason given as Other|0|||
127928975|NCT01173471|460364143|FG001|Overall Study|Reason given as Other|0|||
127928976|NCT01173471|460364144|FG002|Overall Study|Reason given as Other|1|||
127928977|NCT01173471|460364145|FG003|Overall Study|Reason given as Other|0|||
127928978|NCT03028740|460364146|FG000|Overall Study|Did not Receive Study Drug|4|||
127928979|NCT03028740|460364147|FG001|Overall Study|Did not Receive Study Drug|5|||
127928980|NCT03028740|460364146|FG000|Overall Study|Adverse Event|8|||
127928981|NCT03028740|460364147|FG001|Overall Study|Adverse Event|26|||
127928982|NCT03028740|460364146|FG000|Overall Study|Lack of Efficacy|0|||
127928983|NCT03028740|460364147|FG001|Overall Study|Lack of Efficacy|1|||
127928984|NCT03028740|460364146|FG000|Overall Study|Withdrawal by Subject|48|||
127928985|NCT03028740|460364147|FG001|Overall Study|Withdrawal by Subject|101|||
127928986|NCT03028740|460364146|FG000|Overall Study|Lost to Follow-up|30|||
127928987|NCT03028740|460364147|FG001|Overall Study|Lost to Follow-up|54|||
127928988|NCT03028740|460364146|FG000|Overall Study|Physician Decision|4|||
127928989|NCT03028740|460364147|FG001|Overall Study|Physician Decision|11|||
127928990|NCT03028740|460364146|FG000|Overall Study|Protocol Violation|4|||
127928991|NCT03028740|460364147|FG001|Overall Study|Protocol Violation|8|||
127928992|NCT03028740|460364146|FG000|Overall Study|Non-compliance with Study Drug|0|||
127928993|NCT03028740|460364147|FG001|Overall Study|Non-compliance with Study Drug|2|||
127928994|NCT03028740|460364146|FG000|Overall Study|Study Terminated by Sponsor|467|||
127928995|NCT03028740|460364147|FG001|Overall Study|Study Terminated by Sponsor|917|||
127928996|NCT03028740|460364146|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
127928997|NCT03028740|460364147|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
127928998|NCT03028740|460364146|FG000|Overall Study|Reason not Specified|1|||
127928999|NCT03028740|460364147|FG001|Overall Study|Reason not Specified|5|||
127929000|NCT00685802|460364155|FG000|Washout Period of 7 Days|Protocol Violation|2|||
127929001|NCT00685802|460364156|FG001|Washout Period of 7 Days|Protocol Violation|0|||
127929002|NCT00685802|460364155|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
127929003|NCT00685802|460364156|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
127929004|NCT03336242|460364160|FG000|Overall Study|Adverse Event|0|||
127929005|NCT03336242|460364161|FG001|Overall Study|Adverse Event|1|||
127929006|NCT02224573|460364163|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
127929007|NCT02224573|460364164|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
127929008|NCT02224573|460364163|FG000|Treatment Phase|Started on Other IMP|1|||
127929009|NCT02224573|460364164|FG001|Treatment Phase|Started on Other IMP|0|||
127929010|NCT02224573|460364163|FG000|Treatment Phase|Participant Discontinued IMP|0|||
127929011|NCT02224573|460364164|FG001|Treatment Phase|Participant Discontinued IMP|1|||
127929012|NCT02224573|460364163|FG000|Treatment Phase|Lack of Efficacy|15|||
127929013|NCT02224573|460364164|FG001|Treatment Phase|Lack of Efficacy|8|||
127929014|NCT02224573|460364163|FG000|Treatment Phase|Began Commercial Product|1|||
127929015|NCT02224573|460364164|FG001|Treatment Phase|Began Commercial Product|0|||
127929016|NCT02224573|460364163|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
127929017|NCT02224573|460364164|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
127929018|NCT02224573|460364163|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
127929019|NCT02224573|460364164|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
127929020|NCT02224573|460364163|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
127929021|NCT02224573|460364164|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
127929022|NCT02224573|460364163|FG000|Treatment Phase|Continued Compassionate Use|1|||
127929023|NCT02224573|460364164|FG001|Treatment Phase|Continued Compassionate Use|0|||
127929024|NCT02224573|460364163|FG000|Treatment Phase|Lack of Efficiency|2|||
127929025|NCT02224573|460364164|FG001|Treatment Phase|Lack of Efficiency|1|||
127929026|NCT02224573|460364163|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
127929027|NCT02224573|460364164|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
127929028|NCT02224573|460364163|FG000|Treatment Phase|Participant Moved|2|||
127929029|NCT02224573|460364164|FG001|Treatment Phase|Participant Moved|0|||
127929030|NCT02224573|460364163|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
127929031|NCT02224573|460364164|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
127929032|NCT02224573|460364163|FG000|Treatment Phase|Refused Medication|1|||
127929033|NCT02224573|460364164|FG001|Treatment Phase|Refused Medication|1|||
127929034|NCT02224573|460364163|FG000|Treatment Phase|Adverse Event|26|||
127929035|NCT02224573|460364164|FG001|Treatment Phase|Adverse Event|38|||
127929036|NCT02224573|460364163|FG000|Treatment Phase|Placed in Group Home|0|||
127929037|NCT02224573|460364164|FG001|Treatment Phase|Placed in Group Home|1|||
127929038|NCT02224573|460364163|FG000|Treatment Phase|Pursued Other Trials|1|||
127929039|NCT02224573|460364164|FG001|Treatment Phase|Pursued Other Trials|0|||
127929040|NCT02224573|460364163|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
127929041|NCT02224573|460364164|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
127929042|NCT02224573|460364163|FG000|Treatment Phase|Lost to Follow-up|2|||
127929043|NCT02224573|460364164|FG001|Treatment Phase|Lost to Follow-up|1|||
127929044|NCT02224573|460364163|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
127929045|NCT02224573|460364164|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
127929046|NCT02224573|460364163|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
127929047|NCT02224573|460364164|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
127929048|NCT02224573|460364163|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
127929049|NCT02224573|460364164|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
127929050|NCT02224573|460364163|FG000|Taper Phase|Adverse Event|1|||
127929051|NCT02224573|460364164|FG001|Taper Phase|Adverse Event|1|||
127929052|NCT02546362|460364165|FG000|4-week Treatment Period|Lost to Follow-up|1|||
127929053|NCT02546362|460364165|FG000|4-week Treatment Period|Change in medication|2|||
127929054|NCT02546362|460364165|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
127929055|NCT02546362|460364165|FG000|12-week Treatment Period|Lost to Follow-up|2|||
127929056|NCT02546362|460364165|FG000|12-week Treatment Period|Change in medication|1|||
127929057|NCT05206448|460364166|FG000|Overall Study|Lost to Follow-up|2|||
127929058|NCT05206448|460364167|FG001|Overall Study|Lost to Follow-up|2|||
127929059|NCT05206448|460364166|FG000|Overall Study|Withdrawal by Subject|2|||
127929060|NCT05206448|460364167|FG001|Overall Study|Withdrawal by Subject|0|||
127929061|NCT05206448|460364166|FG000|Overall Study|found ineligible after randomization|1|||
127929062|NCT05206448|460364167|FG001|Overall Study|found ineligible after randomization|1|||
127929063|NCT05206448|460364166|FG000|Overall Study|unable to complete study due to personal constraints|1|||
127929064|NCT05206448|460364167|FG001|Overall Study|unable to complete study due to personal constraints|0|||
127929065|NCT05206448|460364166|FG000|Overall Study|Became pregnant during gap in treatment after pregnancy loss|0|||
127929066|NCT05206448|460364167|FG001|Overall Study|Became pregnant during gap in treatment after pregnancy loss|1|||
127929067|NCT01661881|460364169|FG000|Overall Study|Disease Progression|1|||
127929068|NCT00949988|460364174|FG000|Overall Study|Withdrawal by Subject|3|||
127929069|NCT01351350|460364179|FG000|Overall Study|Disease Progression|5|||
127929070|NCT01351350|460364180|FG001|Overall Study|Disease Progression|13|||
127929071|NCT01351350|460364181|FG002|Overall Study|Disease Progression|6|||
127929072|NCT01351350|460364182|FG003|Overall Study|Disease Progression|8|||
127929073|NCT01351350|460364183|FG004|Overall Study|Disease Progression|5|||
127929074|NCT01351350|460364179|FG000|Overall Study|Adverse Event|1|||
127929075|NCT01351350|460364180|FG001|Overall Study|Adverse Event|10|||
127929076|NCT01351350|460364181|FG002|Overall Study|Adverse Event|1|||
127929077|NCT01351350|460364182|FG003|Overall Study|Adverse Event|2|||
127929078|NCT01351350|460364183|FG004|Overall Study|Adverse Event|0|||
127929079|NCT01351350|460364179|FG000|Overall Study|Participant Decision|2|||
127929080|NCT01351350|460364180|FG001|Overall Study|Participant Decision|6|||
127929081|NCT01351350|460364181|FG002|Overall Study|Participant Decision|3|||
127929082|NCT01351350|460364182|FG003|Overall Study|Participant Decision|3|||
127929083|NCT01351350|460364183|FG004|Overall Study|Participant Decision|2|||
127929084|NCT01351350|460364179|FG000|Overall Study|Enrolled but not Treated|0|||
127929085|NCT01351350|460364180|FG001|Overall Study|Enrolled but not Treated|0|||
127929086|NCT01351350|460364181|FG002|Overall Study|Enrolled but not Treated|1|||
127929087|NCT01351350|460364182|FG003|Overall Study|Enrolled but not Treated|0|||
127929088|NCT01351350|460364183|FG004|Overall Study|Enrolled but not Treated|0|||
127929089|NCT04647383|460364184|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
127929090|NCT04647383|460364185|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
127929091|NCT04647383|460364186|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
127929092|NCT04647383|460364187|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
127929093|NCT00873119|460364195|FG000|Overall Study|Patient request|4|||
127929094|NCT00873119|460364196|FG001|Overall Study|Patient request|2|||
127929095|NCT00873119|460364195|FG000|Overall Study|Adverse Event|8|||
127929096|NCT00873119|460364196|FG001|Overall Study|Adverse Event|0|||
127929097|NCT00873119|460364195|FG000|Overall Study|Progressive disease|26|||
127929098|NCT00873119|460364196|FG001|Overall Study|Progressive disease|18|||
127929099|NCT00873119|460364195|FG000|Overall Study|Death|2|||
127929100|NCT00873119|460364196|FG001|Overall Study|Death|1|||
127929101|NCT00873119|460364195|FG000|Overall Study|Other|2|||
127929102|NCT00873119|460364196|FG001|Overall Study|Other|5|||
127929103|NCT00873119|460364195|FG000|Overall Study|Not treated|2|||
127929104|NCT00873119|460364196|FG001|Overall Study|Not treated|0|||
127929105|NCT00285584|460364197|FG000|Month 3|Lost to Follow-up|3|||
127929106|NCT00285584|460364198|FG001|Month 3|Lost to Follow-up|3|||
127929107|NCT00285584|460364197|FG000|Month 3|Withdrawal by Subject|1|||
127929108|NCT00285584|460364198|FG001|Month 3|Withdrawal by Subject|0|||
127929109|NCT00285584|460364197|FG000|Month 6|Lost to Follow-up|0|||
127929110|NCT00285584|460364198|FG001|Month 6|Lost to Follow-up|1|||
127929111|NCT00466726|460364199|FG000|Overall Study|Not evaluable for response|14|||
127929112|NCT01376310|460364200|FG000|Overall Study|Study closed/terminated|1|||
127929113|NCT01376310|460364201|FG001|Overall Study|Study closed/terminated|2|||
127929114|NCT01376310|460364200|FG000|Overall Study|Withdrawal by Subject|8|||
127929115|NCT01376310|460364201|FG001|Overall Study|Withdrawal by Subject|2|||
127929116|NCT01376310|460364200|FG000|Overall Study|Physician Decision|26|||
127929117|NCT01376310|460364201|FG001|Overall Study|Physician Decision|7|||
127929118|NCT01376310|460364200|FG000|Overall Study|Lost to Follow-up|1|||
127929119|NCT01376310|460364201|FG001|Overall Study|Lost to Follow-up|0|||
127929120|NCT02339740|460364204|FG000|Overall Study|Death|1|||
127929121|NCT02339740|460364205|FG001|Overall Study|Death|0|||
127929122|NCT02339740|460364204|FG000|Overall Study|Physician Decision|0|||
127929123|NCT02339740|460364205|FG001|Overall Study|Physician Decision|2|||
127929124|NCT02339740|460364204|FG000|Overall Study|Withdrawal by Subject|5|||
127929125|NCT02339740|460364205|FG001|Overall Study|Withdrawal by Subject|1|||
127929126|NCT02339740|460364204|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
127929127|NCT02339740|460364205|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
127929128|NCT02096588|460364206|FG000|Overall Study|Lack of Efficacy|2|||
127929129|NCT02096588|460364207|FG001|Overall Study|Lack of Efficacy|0|||
127929130|NCT02096588|460364206|FG000|Overall Study|Withdrawal by Subject|0|||
127929131|NCT02096588|460364207|FG001|Overall Study|Withdrawal by Subject|1|||
127929132|NCT00303667|460364209|FG000|Overall Study|Death|0|||
127929133|NCT00303667|460364210|FG001|Overall Study|Death|4|||
127929134|NCT01258101|460364211|FG000|Overall Study|Adverse Event|5|||
127929135|NCT01258101|460364212|FG001|Overall Study|Adverse Event|6|||
127929136|NCT01258101|460364213|FG002|Overall Study|Adverse Event|0|||
127929137|NCT01258101|460364214|FG003|Overall Study|Adverse Event|0|||
127929138|NCT01258101|460364211|FG000|Overall Study|Extra exclusion criterion amended|2|||
127929139|NCT01258101|460364212|FG001|Overall Study|Extra exclusion criterion amended|1|||
127929140|NCT01258101|460364213|FG002|Overall Study|Extra exclusion criterion amended|1|||
127929141|NCT01258101|460364214|FG003|Overall Study|Extra exclusion criterion amended|1|||
127929142|NCT01258101|460364211|FG000|Overall Study|Informed consent has been withdrawn|2|||
127929143|NCT01258101|460364212|FG001|Overall Study|Informed consent has been withdrawn|2|||
127929144|NCT01258101|460364213|FG002|Overall Study|Informed consent has been withdrawn|1|||
127929145|NCT01258101|460364214|FG003|Overall Study|Informed consent has been withdrawn|1|||
127929146|NCT01258101|460364211|FG000|Overall Study|Patient is not able to attend visits|8|||
127929147|NCT01258101|460364212|FG001|Overall Study|Patient is not able to attend visits|9|||
127929148|NCT01258101|460364213|FG002|Overall Study|Patient is not able to attend visits|7|||
127929149|NCT01258101|460364214|FG003|Overall Study|Patient is not able to attend visits|6|||
127929150|NCT01258101|460364211|FG000|Overall Study|Patient´s compliance|4|||
127929151|NCT01258101|460364212|FG001|Overall Study|Patient´s compliance|3|||
127929152|NCT01258101|460364213|FG002|Overall Study|Patient´s compliance|1|||
127929153|NCT01258101|460364214|FG003|Overall Study|Patient´s compliance|2|||
127929154|NCT01258101|460364211|FG000|Overall Study|Lost to Follow-up|5|||
127929155|NCT01258101|460364212|FG001|Overall Study|Lost to Follow-up|5|||
127929156|NCT01258101|460364213|FG002|Overall Study|Lost to Follow-up|0|||
127929157|NCT01258101|460364214|FG003|Overall Study|Lost to Follow-up|6|||
127929158|NCT01258101|460364211|FG000|Overall Study|PCR positive at week 24|0|||
127929159|NCT01258101|460364212|FG001|Overall Study|PCR positive at week 24|0|||
127929160|NCT01258101|460364213|FG002|Overall Study|PCR positive at week 24|0|||
127929161|NCT01258101|460364214|FG003|Overall Study|PCR positive at week 24|1|||
127929162|NCT01258101|460364211|FG000|Overall Study|Other reason|7|||
127929163|NCT01258101|460364212|FG001|Overall Study|Other reason|8|||
127929164|NCT01258101|460364213|FG002|Overall Study|Other reason|1|||
127929165|NCT01258101|460364214|FG003|Overall Study|Other reason|8|||
127929166|NCT01807117|460364215|FG000|Overall Study|Physician Decision|2|||
127929167|NCT01807117|460364215|FG000|Overall Study|Disease diagnosis not a study disease|1|||
127929168|NCT01298778|460364216|FG000|Overall Study|Lost to Follow-up|2|||
127929169|NCT01298778|460364217|FG001|Overall Study|Lost to Follow-up|3|||
127929170|NCT01298778|460364216|FG000|Overall Study|Incorrect use of VAS|1|||
127929171|NCT01298778|460364217|FG001|Overall Study|Incorrect use of VAS|0|||
127929172|NCT01298778|460364216|FG000|Overall Study|Withdrawal by Subject|0|||
127929173|NCT01298778|460364217|FG001|Overall Study|Withdrawal by Subject|1|||
127929174|NCT01298778|460364216|FG000|Overall Study|Protocol Violation|0|||
127929175|NCT01298778|460364217|FG001|Overall Study|Protocol Violation|1|||
127929176|NCT01298778|460364216|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
127929177|NCT01298778|460364217|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
127929178|NCT04965389|460364218|FG000|Overall Study|Other reasons|1|||
127929179|NCT04965389|460364219|FG001|Overall Study|Other reasons|0|||
127929180|NCT04965389|460364220|FG002|Overall Study|Other reasons|0|||
127929181|NCT04965389|460364221|FG003|Overall Study|Other reasons|0|||
127929182|NCT04965389|460364218|FG000|Overall Study|Participant withdrew consent|0|||
127929183|NCT04965389|460364219|FG001|Overall Study|Participant withdrew consent|1|||
127929184|NCT04965389|460364220|FG002|Overall Study|Participant withdrew consent|0|||
127929185|NCT04965389|460364221|FG003|Overall Study|Participant withdrew consent|0|||
127929186|NCT04965389|460364218|FG000|Overall Study|Poor/Non-compliance|0|||
127929187|NCT04965389|460364219|FG001|Overall Study|Poor/Non-compliance|1|||
127929188|NCT04965389|460364220|FG002|Overall Study|Poor/Non-compliance|0|||
127929189|NCT04965389|460364221|FG003|Overall Study|Poor/Non-compliance|0|||
127929190|NCT02709486|460364222|FG000|Overall Study|Adverse Event|2|||
127929191|NCT02709486|460364223|FG001|Overall Study|Adverse Event|5|||
127929192|NCT02709486|460364224|FG002|Overall Study|Adverse Event|3|||
127929193|NCT02709486|460364222|FG000|Overall Study|Death|0|||
127929194|NCT02709486|460364223|FG001|Overall Study|Death|0|||
127929195|NCT02709486|460364224|FG002|Overall Study|Death|2|||
127929196|NCT02709486|460364222|FG000|Overall Study|Insufficient clinical response|7|||
127929197|NCT02709486|460364223|FG001|Overall Study|Insufficient clinical response|3|||
127929198|NCT02709486|460364224|FG002|Overall Study|Insufficient clinical response|3|||
127929199|NCT02709486|460364222|FG000|Overall Study|Lost to Follow-up|3|||
127929200|NCT02709486|460364223|FG001|Overall Study|Lost to Follow-up|2|||
127929201|NCT02709486|460364224|FG002|Overall Study|Lost to Follow-up|2|||
127929202|NCT02709486|460364222|FG000|Overall Study|Other|0|||
127929203|NCT02709486|460364223|FG001|Overall Study|Other|2|||
127929204|NCT02709486|460364224|FG002|Overall Study|Other|3|||
127929205|NCT02709486|460364222|FG000|Overall Study|Withdrawal by Subject|32|||
127929206|NCT02709486|460364223|FG001|Overall Study|Withdrawal by Subject|22|||
127929207|NCT02709486|460364224|FG002|Overall Study|Withdrawal by Subject|32|||
127929208|NCT00706355|460364233|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
127929209|NCT00706355|460364234|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
127929210|NCT00706355|460364235|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
127929211|NCT00706355|460364236|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
127929212|NCT00706355|460364233|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
127929213|NCT00706355|460364234|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
127929214|NCT00706355|460364235|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
127929215|NCT00706355|460364236|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
127929216|NCT00706355|460364233|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
127929217|NCT00706355|460364234|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
127929218|NCT00706355|460364235|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
127929219|NCT00706355|460364236|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
127929220|NCT00706355|460364233|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
127929221|NCT00706355|460364234|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
127929222|NCT00706355|460364235|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
127929223|NCT00706355|460364236|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
127929224|NCT00706355|460364233|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
127929225|NCT00706355|460364234|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
127929226|NCT00706355|460364235|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
127929227|NCT00706355|460364236|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
127929228|NCT00706355|460364233|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
127929229|NCT00706355|460364234|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
127929230|NCT00706355|460364235|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
127929231|NCT00706355|460364236|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
127929232|NCT00706355|460364233|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
127929233|NCT00706355|460364234|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
127929234|NCT00706355|460364235|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
127929235|NCT00706355|460364236|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
127929236|NCT00706355|460364233|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
127929237|NCT00706355|460364234|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
127929238|NCT00706355|460364235|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
127929239|NCT00706355|460364236|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
127929240|NCT00706355|460364233|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
127929241|NCT00706355|460364234|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
127929242|NCT00706355|460364235|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
127929243|NCT00706355|460364236|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
127929244|NCT01020799|460364245|FG000|Overall Study|Adverse Event|4|||
127929245|NCT01020799|460364246|FG001|Overall Study|Adverse Event|3|||
127929246|NCT01020799|460364247|FG002|Overall Study|Adverse Event|2|||
127929247|NCT01020799|460364245|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
127929248|NCT01020799|460364246|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
127929249|NCT01020799|460364247|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
127929250|NCT01020799|460364245|FG000|Overall Study|Protocol Violation|3|||
127929251|NCT01020799|460364246|FG001|Overall Study|Protocol Violation|2|||
127929252|NCT01020799|460364247|FG002|Overall Study|Protocol Violation|0|||
127929253|NCT01020799|460364245|FG000|Overall Study|Withdrawal by Subject|2|||
127929254|NCT01020799|460364246|FG001|Overall Study|Withdrawal by Subject|2|||
127929255|NCT01020799|460364247|FG002|Overall Study|Withdrawal by Subject|3|||
127929256|NCT01020799|460364245|FG000|Overall Study|Lost to Follow-up|6|||
127929257|NCT01020799|460364246|FG001|Overall Study|Lost to Follow-up|4|||
127929258|NCT01020799|460364247|FG002|Overall Study|Lost to Follow-up|2|||
127929259|NCT04179019|460364248|FG000|Overall Study|Lost to Follow-up|2|||
127929260|NCT04179019|460364248|FG000|Overall Study|Physician Decision|2|||
127929261|NCT04179019|460364248|FG000|Overall Study|Withdrawal by Subject|5|||
127929262|NCT04179019|460364248|FG000|Overall Study|Adverse Event|4|||
127929263|NCT02610816|460364249|FG000|Phase 1|Withdrawal by Subject|2|||
127929264|NCT02610816|460364250|FG001|Phase 1|Withdrawal by Subject|6|||
127929265|NCT02610816|460364251|FG002|Phase 1|Withdrawal by Subject|0|||
127929266|NCT02610816|460364252|FG003|Phase 1|Withdrawal by Subject|0|||
127929267|NCT02610816|460364249|FG000|Phase 1|Lost to Follow-up|2|||
127929268|NCT02610816|460364250|FG001|Phase 1|Lost to Follow-up|1|||
127929269|NCT02610816|460364251|FG002|Phase 1|Lost to Follow-up|0|||
127929270|NCT02610816|460364252|FG003|Phase 1|Lost to Follow-up|0|||
127929271|NCT02610816|460364249|FG000|Phase 1|Physician Decision|0|||
127929272|NCT02610816|460364250|FG001|Phase 1|Physician Decision|1|||
127929273|NCT02610816|460364251|FG002|Phase 1|Physician Decision|0|||
127929274|NCT02610816|460364252|FG003|Phase 1|Physician Decision|0|||
127929275|NCT02610816|460364249|FG000|Phase 2|Withdrawal by Subject|0|||
127929276|NCT02610816|460364250|FG001|Phase 2|Withdrawal by Subject|0|||
127929277|NCT02610816|460364251|FG002|Phase 2|Withdrawal by Subject|9|||
127929278|NCT02610816|460364252|FG003|Phase 2|Withdrawal by Subject|3|||
127929279|NCT02610816|460364249|FG000|Phase 2|Lost to Follow-up|0|||
127929280|NCT02610816|460364250|FG001|Phase 2|Lost to Follow-up|0|||
127929281|NCT02610816|460364251|FG002|Phase 2|Lost to Follow-up|2|||
127929282|NCT02610816|460364252|FG003|Phase 2|Lost to Follow-up|0|||
127929283|NCT02610816|460364249|FG000|Phase 2|Physician Decision|0|||
127929284|NCT02610816|460364250|FG001|Phase 2|Physician Decision|0|||
127929285|NCT02610816|460364251|FG002|Phase 2|Physician Decision|0|||
127929286|NCT02610816|460364252|FG003|Phase 2|Physician Decision|2|||
127929287|NCT02610816|460364249|FG000|Phase 2|Pregnancy|0|||
127929288|NCT02610816|460364250|FG001|Phase 2|Pregnancy|0|||
127929289|NCT02610816|460364251|FG002|Phase 2|Pregnancy|0|||
127929290|NCT02610816|460364252|FG003|Phase 2|Pregnancy|1|||
127929291|NCT01855048|460364255|FG000|Overall Study|Withdrawal by Subject|0|||
127929292|NCT01855048|460364256|FG001|Overall Study|Withdrawal by Subject|1|||
127929293|NCT01855048|460364257|FG002|Overall Study|Withdrawal by Subject|0|||
127929294|NCT01855048|460364258|FG003|Overall Study|Withdrawal by Subject|0|||
127929295|NCT01855048|460364259|FG004|Overall Study|Withdrawal by Subject|1|||
127929296|NCT01855048|460364260|FG005|Overall Study|Withdrawal by Subject|0|||
127929297|NCT02139124|460364261|FG000|Overall Study|Adverse Event|2|||
127929298|NCT02139124|460364262|FG001|Overall Study|Adverse Event|0|||
127929299|NCT02139124|460364263|FG002|Overall Study|Adverse Event|1|||
127929300|NCT02139124|460364264|FG003|Overall Study|Adverse Event|2|||
127929301|NCT02139124|460364265|FG004|Overall Study|Adverse Event|5|||
127929302|NCT02139124|460364261|FG000|Overall Study|Withdrawal by Subject|2|||
127929303|NCT02139124|460364262|FG001|Overall Study|Withdrawal by Subject|2|||
127929304|NCT02139124|460364263|FG002|Overall Study|Withdrawal by Subject|2|||
127929305|NCT02139124|460364264|FG003|Overall Study|Withdrawal by Subject|2|||
127929306|NCT02139124|460364265|FG004|Overall Study|Withdrawal by Subject|3|||
127929307|NCT02139124|460364261|FG000|Overall Study|Protocol Violation|0|||
127929308|NCT02139124|460364262|FG001|Overall Study|Protocol Violation|0|||
127929309|NCT02139124|460364263|FG002|Overall Study|Protocol Violation|0|||
127929310|NCT02139124|460364264|FG003|Overall Study|Protocol Violation|1|||
127929311|NCT02139124|460364265|FG004|Overall Study|Protocol Violation|1|||
127929312|NCT02139124|460364261|FG000|Overall Study|non-compliant|1|||
127929313|NCT02139124|460364262|FG001|Overall Study|non-compliant|0|||
127929314|NCT02139124|460364263|FG002|Overall Study|non-compliant|0|||
127929315|NCT02139124|460364264|FG003|Overall Study|non-compliant|2|||
127929316|NCT02139124|460364265|FG004|Overall Study|non-compliant|0|||
127929317|NCT02139124|460364261|FG000|Overall Study|incarceration|0|||
127929318|NCT02139124|460364262|FG001|Overall Study|incarceration|0|||
127929319|NCT02139124|460364263|FG002|Overall Study|incarceration|1|||
127929320|NCT02139124|460364264|FG003|Overall Study|incarceration|0|||
127929321|NCT02139124|460364265|FG004|Overall Study|incarceration|0|||
127929322|NCT02139124|460364261|FG000|Overall Study|subject moved|1|||
127929323|NCT02139124|460364262|FG001|Overall Study|subject moved|0|||
127929324|NCT02139124|460364263|FG002|Overall Study|subject moved|0|||
127929325|NCT02139124|460364264|FG003|Overall Study|subject moved|0|||
127929326|NCT02139124|460364265|FG004|Overall Study|subject moved|0|||
127929327|NCT02139124|460364261|FG000|Overall Study|Lost to Follow-up|3|||
127929328|NCT02139124|460364262|FG001|Overall Study|Lost to Follow-up|2|||
127929329|NCT02139124|460364263|FG002|Overall Study|Lost to Follow-up|0|||
127929330|NCT02139124|460364264|FG003|Overall Study|Lost to Follow-up|5|||
127929331|NCT02139124|460364265|FG004|Overall Study|Lost to Follow-up|4|||
127929332|NCT02691741|460364266|FG000|Overall Study|Adverse Event|0|||
127929333|NCT02691741|460364267|FG001|Overall Study|Adverse Event|2|||
127929334|NCT02691741|460364266|FG000|Overall Study|Lost to Follow-up|1|||
127929335|NCT02691741|460364267|FG001|Overall Study|Lost to Follow-up|0|||
127929336|NCT02691741|460364266|FG000|Overall Study|Physician Decision|0|||
127929337|NCT02691741|460364267|FG001|Overall Study|Physician Decision|1|||
127929338|NCT02691741|460364266|FG000|Overall Study|Withdrawal by Subject|0|||
127929339|NCT02691741|460364267|FG001|Overall Study|Withdrawal by Subject|4|||
127929340|NCT03465436|460364268|FG000|Period 1|Protocol Violation|0|||
127929341|NCT03465436|460364269|FG001|Period 1|Protocol Violation|0|||
127929342|NCT03465436|460364270|FG002|Period 1|Protocol Violation|1|||
127929343|NCT03465436|460364271|FG003|Period 1|Protocol Violation|0|||
127929344|NCT03465436|460364268|FG000|Period 2|Protocol Violation|0|||
127929345|NCT03465436|460364269|FG001|Period 2|Protocol Violation|1|||
127929346|NCT03465436|460364270|FG002|Period 2|Protocol Violation|0|||
127929347|NCT03465436|460364271|FG003|Period 2|Protocol Violation|0|||
127929348|NCT03465436|460364268|FG000|Period 3|Protocol Violation|1|||
127929349|NCT03465436|460364269|FG001|Period 3|Protocol Violation|1|||
127929350|NCT03465436|460364270|FG002|Period 3|Protocol Violation|0|||
127929351|NCT03465436|460364271|FG003|Period 3|Protocol Violation|0|||
127929352|NCT03465436|460364268|FG000|Period 4|Protocol Violation|0|||
127929353|NCT03465436|460364269|FG001|Period 4|Protocol Violation|0|||
127929354|NCT03465436|460364270|FG002|Period 4|Protocol Violation|1|||
127929355|NCT03465436|460364271|FG003|Period 4|Protocol Violation|0|||
127929356|NCT04974619|460366399|FG000|Overall Study|Lost to Follow-up|0|||
127929357|NCT04974619|460366400|FG001|Overall Study|Lost to Follow-up|0|||
127929358|NCT04974619|460366401|FG002|Overall Study|Lost to Follow-up|1|||
127929359|NCT04974619|460366399|FG000|Overall Study|Withdrawal by Subject|0|||
127929360|NCT04974619|460366400|FG001|Overall Study|Withdrawal by Subject|0|||
127929361|NCT04974619|460366401|FG002|Overall Study|Withdrawal by Subject|1|||
127929362|NCT04974619|460366399|FG000|Overall Study|Protocol Violation|0|||
127929363|NCT04974619|460366400|FG001|Overall Study|Protocol Violation|1|||
127929364|NCT04974619|460366401|FG002|Overall Study|Protocol Violation|0|||
127929365|NCT02658487|460366402|FG000|Overall Study|Death|2|||
127929366|NCT02658487|460366402|FG000|Overall Study|Disease progression|10|||
127929367|NCT02658487|460366402|FG000|Overall Study|Alternative therapy|1|||
127929368|NCT02658487|460366402|FG000|Overall Study|Adverse Event|1|||
127929369|NCT02658487|460366402|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
127929370|NCT02658487|460366402|FG000|Overall Study|Refractory acute myeloid leukemia (AML)|1|||
127929371|NCT00493779|460366403|FG000|Overall Study|Logistical issue at site|1|||
127929372|NCT01885182|460366404|FG000|Overall Study|Adverse Event|11|||
127929373|NCT01885182|460366405|FG001|Overall Study|Adverse Event|13|||
127929374|NCT01885182|460366404|FG000|Overall Study|Withdrawal by Subject|13|||
127929375|NCT01885182|460366405|FG001|Overall Study|Withdrawal by Subject|6|||
127929376|NCT01885182|460366404|FG000|Overall Study|Lost to Follow-up|2|||
127929377|NCT01885182|460366405|FG001|Overall Study|Lost to Follow-up|2|||
127929378|NCT01885182|460366404|FG000|Overall Study|Lack of Efficacy|8|||
127929379|NCT01885182|460366405|FG001|Overall Study|Lack of Efficacy|1|||
127929380|NCT00614926|460366412|FG000|Overall Study|Burden of travel|1|||
127929381|NCT00614926|460366413|FG001|Overall Study|Burden of travel|0|||
127929382|NCT00614926|460366412|FG000|Overall Study|Adverse Event|3|||
127929383|NCT00614926|460366413|FG001|Overall Study|Adverse Event|0|||
127929384|NCT01207440|460366414|FG000|Overall Study|Adverse Event|46|||
127929385|NCT01207440|460366415|FG001|Overall Study|Adverse Event|11|||
127929386|NCT01207440|460366416|FG002|Overall Study|Adverse Event|7|||
127929387|NCT01207440|460366417|FG003|Overall Study|Adverse Event|2|||
127929388|NCT01207440|460366418|FG004|Overall Study|Adverse Event|6|||
127929389|NCT01207440|460366419|FG005|Overall Study|Adverse Event|6|||
127929390|NCT01207440|460366420|FG006|Overall Study|Adverse Event|2|||
127929391|NCT01207440|460366414|FG000|Overall Study|Death|6|||
127929392|NCT01207440|460366415|FG001|Overall Study|Death|3|||
127929393|NCT01207440|460366416|FG002|Overall Study|Death|2|||
127929394|NCT01207440|460366417|FG003|Overall Study|Death|2|||
127929395|NCT01207440|460366418|FG004|Overall Study|Death|7|||
127929396|NCT01207440|460366419|FG005|Overall Study|Death|5|||
127929397|NCT01207440|460366420|FG006|Overall Study|Death|1|||
127929398|NCT01207440|460366414|FG000|Overall Study|Lack of Efficacy|13|||
127929399|NCT01207440|460366415|FG001|Overall Study|Lack of Efficacy|2|||
127929400|NCT01207440|460366416|FG002|Overall Study|Lack of Efficacy|5|||
127929401|NCT01207440|460366417|FG003|Overall Study|Lack of Efficacy|1|||
127929402|NCT01207440|460366418|FG004|Overall Study|Lack of Efficacy|2|||
127929403|NCT01207440|460366419|FG005|Overall Study|Lack of Efficacy|3|||
127929404|NCT01207440|460366420|FG006|Overall Study|Lack of Efficacy|0|||
127929405|NCT01207440|460366414|FG000|Overall Study|Lost to Follow-up|0|||
127929406|NCT01207440|460366415|FG001|Overall Study|Lost to Follow-up|0|||
127929407|NCT01207440|460366416|FG002|Overall Study|Lost to Follow-up|2|||
127929408|NCT01207440|460366417|FG003|Overall Study|Lost to Follow-up|1|||
127929409|NCT01207440|460366418|FG004|Overall Study|Lost to Follow-up|0|||
127929410|NCT01207440|460366419|FG005|Overall Study|Lost to Follow-up|0|||
127929411|NCT01207440|460366420|FG006|Overall Study|Lost to Follow-up|0|||
127929412|NCT01207440|460366414|FG000|Overall Study|Non-compliance with Study Drug|3|||
127929413|NCT01207440|460366415|FG001|Overall Study|Non-compliance with Study Drug|0|||
127929414|NCT01207440|460366416|FG002|Overall Study|Non-compliance with Study Drug|1|||
127929415|NCT01207440|460366417|FG003|Overall Study|Non-compliance with Study Drug|0|||
127929416|NCT01207440|460366418|FG004|Overall Study|Non-compliance with Study Drug|0|||
127929417|NCT01207440|460366419|FG005|Overall Study|Non-compliance with Study Drug|0|||
127929418|NCT01207440|460366420|FG006|Overall Study|Non-compliance with Study Drug|0|||
127929419|NCT01207440|460366414|FG000|Overall Study|Physician Decision|6|||
127929420|NCT01207440|460366415|FG001|Overall Study|Physician Decision|5|||
127929421|NCT01207440|460366416|FG002|Overall Study|Physician Decision|5|||
127929422|NCT01207440|460366417|FG003|Overall Study|Physician Decision|0|||
127929423|NCT01207440|460366418|FG004|Overall Study|Physician Decision|1|||
127929424|NCT01207440|460366419|FG005|Overall Study|Physician Decision|0|||
127929425|NCT01207440|460366420|FG006|Overall Study|Physician Decision|0|||
127929426|NCT01207440|460366414|FG000|Overall Study|Progressive Disease|19|||
127929427|NCT01207440|460366415|FG001|Overall Study|Progressive Disease|10|||
127929428|NCT01207440|460366416|FG002|Overall Study|Progressive Disease|19|||
127929429|NCT01207440|460366417|FG003|Overall Study|Progressive Disease|7|||
127929430|NCT01207440|460366418|FG004|Overall Study|Progressive Disease|23|||
127929431|NCT01207440|460366419|FG005|Overall Study|Progressive Disease|27|||
127929432|NCT01207440|460366420|FG006|Overall Study|Progressive Disease|0|||
127929433|NCT01207440|460366414|FG000|Overall Study|Protocol Violation|2|||
127929434|NCT01207440|460366415|FG001|Overall Study|Protocol Violation|0|||
127929435|NCT01207440|460366416|FG002|Overall Study|Protocol Violation|0|||
127929436|NCT01207440|460366417|FG003|Overall Study|Protocol Violation|0|||
127929437|NCT01207440|460366418|FG004|Overall Study|Protocol Violation|0|||
127929438|NCT01207440|460366419|FG005|Overall Study|Protocol Violation|0|||
127929439|NCT01207440|460366420|FG006|Overall Study|Protocol Violation|0|||
127929440|NCT01207440|460366414|FG000|Overall Study|Site Terminated by Sponsor|69|||
127929441|NCT01207440|460366415|FG001|Overall Study|Site Terminated by Sponsor|19|||
127929442|NCT01207440|460366416|FG002|Overall Study|Site Terminated by Sponsor|12|||
127929443|NCT01207440|460366417|FG003|Overall Study|Site Terminated by Sponsor|2|||
127929444|NCT01207440|460366418|FG004|Overall Study|Site Terminated by Sponsor|3|||
127929445|NCT01207440|460366419|FG005|Overall Study|Site Terminated by Sponsor|0|||
127929446|NCT01207440|460366420|FG006|Overall Study|Site Terminated by Sponsor|2|||
127929447|NCT01207440|460366414|FG000|Overall Study|Withdrawal by Subject|29|||
127929448|NCT01207440|460366415|FG001|Overall Study|Withdrawal by Subject|4|||
127929449|NCT01207440|460366416|FG002|Overall Study|Withdrawal by Subject|5|||
127929450|NCT01207440|460366417|FG003|Overall Study|Withdrawal by Subject|3|||
127929451|NCT01207440|460366418|FG004|Overall Study|Withdrawal by Subject|2|||
127929452|NCT01207440|460366419|FG005|Overall Study|Withdrawal by Subject|2|||
127929453|NCT01207440|460366420|FG006|Overall Study|Withdrawal by Subject|0|||
127929454|NCT01207440|460366414|FG000|Overall Study|Reason Not Specified|10|||
127929455|NCT01207440|460366415|FG001|Overall Study|Reason Not Specified|10|||
127929456|NCT01207440|460366416|FG002|Overall Study|Reason Not Specified|7|||
127929457|NCT01207440|460366417|FG003|Overall Study|Reason Not Specified|0|||
127929458|NCT01207440|460366418|FG004|Overall Study|Reason Not Specified|4|||
127929459|NCT01207440|460366419|FG005|Overall Study|Reason Not Specified|3|||
127929460|NCT01207440|460366420|FG006|Overall Study|Reason Not Specified|0|||
127929461|NCT03341000|460366421|FG000|Overall Study|Adverse Event|1|||
127929462|NCT01475253|460366424|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
127929463|NCT01475253|460366425|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
127929464|NCT01475253|460366426|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
127929465|NCT01475253|460366427|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
127929466|NCT01475253|460366424|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
127929467|NCT01475253|460366425|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
127929468|NCT01475253|460366426|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
127929469|NCT01475253|460366427|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
127929470|NCT03135899|460366428|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
127929471|NCT03135899|460366429|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
127929472|NCT03135899|460366430|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
127929473|NCT03135899|460366431|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
127929474|NCT03135899|460366432|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
127929475|NCT03135899|460366433|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
127929476|NCT03135899|460366434|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
127929477|NCT03135899|460366435|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
127929478|NCT03135899|460366428|FG000|Overall Study|Withdrawal by Subject|0|||
127929479|NCT03135899|460366429|FG001|Overall Study|Withdrawal by Subject|0|||
127929480|NCT03135899|460366430|FG002|Overall Study|Withdrawal by Subject|0|||
127929481|NCT03135899|460366431|FG003|Overall Study|Withdrawal by Subject|0|||
127929482|NCT03135899|460366432|FG004|Overall Study|Withdrawal by Subject|0|||
127929483|NCT03135899|460366433|FG005|Overall Study|Withdrawal by Subject|2|||
127929484|NCT03135899|460366434|FG006|Overall Study|Withdrawal by Subject|0|||
127929485|NCT03135899|460366435|FG007|Overall Study|Withdrawal by Subject|0|||
127929486|NCT04146363|460366436|FG000|Induction Period|Adverse Event|1|||
127929487|NCT04146363|460366437|FG001|Induction Period|Adverse Event|2|||
127929488|NCT04146363|460366438|FG002|Induction Period|Adverse Event|0|||
127929489|NCT04146363|460366439|FG003|Induction Period|Adverse Event|0|||
127929490|NCT04146363|460366440|FG004|Induction Period|Adverse Event|0|||
127929491|NCT04146363|460366441|FG005|Induction Period|Adverse Event|0|||
127929492|NCT04146363|460366442|FG006|Induction Period|Adverse Event|0|||
127929493|NCT04146363|460366443|FG007|Induction Period|Adverse Event|0|||
127929494|NCT04146363|460366444|FG008|Induction Period|Adverse Event|0|||
127929495|NCT04146363|460366445|FG009|Induction Period|Adverse Event|0|||
127929496|NCT04146363|460366446|FG010|Induction Period|Adverse Event|0|||
127929497|NCT04146363|460366436|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
127929498|NCT04146363|460366437|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
127929499|NCT04146363|460366438|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
127929500|NCT04146363|460366439|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
127929501|NCT04146363|460366440|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
127929502|NCT04146363|460366441|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
127929503|NCT04146363|460366442|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
127929504|NCT04146363|460366443|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
127929505|NCT04146363|460366444|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
127929506|NCT04146363|460366445|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
127929507|NCT04146363|460366446|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
127929508|NCT04146363|460366436|FG000|Induction Period|Lack of Efficacy|7|||
127929509|NCT04146363|460366437|FG001|Induction Period|Lack of Efficacy|2|||
127929510|NCT04146363|460366438|FG002|Induction Period|Lack of Efficacy|0|||
127929511|NCT04146363|460366439|FG003|Induction Period|Lack of Efficacy|0|||
127929512|NCT04146363|460366440|FG004|Induction Period|Lack of Efficacy|0|||
127929513|NCT04146363|460366441|FG005|Induction Period|Lack of Efficacy|0|||
127929514|NCT04146363|460366442|FG006|Induction Period|Lack of Efficacy|0|||
127929515|NCT04146363|460366443|FG007|Induction Period|Lack of Efficacy|0|||
127929516|NCT04146363|460366444|FG008|Induction Period|Lack of Efficacy|0|||
127929517|NCT04146363|460366445|FG009|Induction Period|Lack of Efficacy|0|||
127929518|NCT04146363|460366446|FG010|Induction Period|Lack of Efficacy|0|||
127929519|NCT04146363|460366436|FG000|Induction Period|Lost to Follow-up|1|||
127929520|NCT04146363|460366437|FG001|Induction Period|Lost to Follow-up|4|||
127929521|NCT04146363|460366438|FG002|Induction Period|Lost to Follow-up|0|||
127929522|NCT04146363|460366439|FG003|Induction Period|Lost to Follow-up|0|||
127929523|NCT04146363|460366440|FG004|Induction Period|Lost to Follow-up|0|||
127929524|NCT04146363|460366441|FG005|Induction Period|Lost to Follow-up|0|||
127929525|NCT04146363|460366442|FG006|Induction Period|Lost to Follow-up|0|||
127929526|NCT04146363|460366443|FG007|Induction Period|Lost to Follow-up|0|||
127929527|NCT04146363|460366444|FG008|Induction Period|Lost to Follow-up|0|||
127929528|NCT04146363|460366445|FG009|Induction Period|Lost to Follow-up|0|||
127929529|NCT04146363|460366446|FG010|Induction Period|Lost to Follow-up|0|||
127929530|NCT04146363|460366436|FG000|Induction Period|Positive quantiferon test|0|||
127929531|NCT04146363|460366437|FG001|Induction Period|Positive quantiferon test|1|||
127929532|NCT04146363|460366438|FG002|Induction Period|Positive quantiferon test|0|||
127929533|NCT04146363|460366439|FG003|Induction Period|Positive quantiferon test|0|||
127929534|NCT04146363|460366440|FG004|Induction Period|Positive quantiferon test|0|||
127929535|NCT04146363|460366441|FG005|Induction Period|Positive quantiferon test|0|||
127929536|NCT04146363|460366442|FG006|Induction Period|Positive quantiferon test|0|||
127929537|NCT04146363|460366443|FG007|Induction Period|Positive quantiferon test|0|||
127929538|NCT04146363|460366444|FG008|Induction Period|Positive quantiferon test|0|||
127929539|NCT04146363|460366445|FG009|Induction Period|Positive quantiferon test|0|||
127929540|NCT04146363|460366446|FG010|Induction Period|Positive quantiferon test|0|||
127929541|NCT04146363|460366436|FG000|Induction Period|Protocol Deviation|5|||
127929542|NCT04146363|460366437|FG001|Induction Period|Protocol Deviation|6|||
127929543|NCT04146363|460366438|FG002|Induction Period|Protocol Deviation|0|||
127929544|NCT04146363|460366439|FG003|Induction Period|Protocol Deviation|0|||
127929545|NCT04146363|460366440|FG004|Induction Period|Protocol Deviation|0|||
127929546|NCT04146363|460366441|FG005|Induction Period|Protocol Deviation|0|||
127929547|NCT04146363|460366442|FG006|Induction Period|Protocol Deviation|0|||
127929548|NCT04146363|460366443|FG007|Induction Period|Protocol Deviation|0|||
127929549|NCT04146363|460366444|FG008|Induction Period|Protocol Deviation|0|||
127929550|NCT04146363|460366445|FG009|Induction Period|Protocol Deviation|0|||
127929551|NCT04146363|460366446|FG010|Induction Period|Protocol Deviation|0|||
127929552|NCT04146363|460366436|FG000|Induction Period|Withdrawal by Subject|6|||
127929553|NCT04146363|460366437|FG001|Induction Period|Withdrawal by Subject|3|||
127929554|NCT04146363|460366438|FG002|Induction Period|Withdrawal by Subject|0|||
127929555|NCT04146363|460366439|FG003|Induction Period|Withdrawal by Subject|0|||
127929556|NCT04146363|460366440|FG004|Induction Period|Withdrawal by Subject|0|||
127929557|NCT04146363|460366441|FG005|Induction Period|Withdrawal by Subject|0|||
127929558|NCT04146363|460366442|FG006|Induction Period|Withdrawal by Subject|0|||
127929559|NCT04146363|460366443|FG007|Induction Period|Withdrawal by Subject|0|||
127929560|NCT04146363|460366444|FG008|Induction Period|Withdrawal by Subject|0|||
127929561|NCT04146363|460366445|FG009|Induction Period|Withdrawal by Subject|0|||
127929562|NCT04146363|460366446|FG010|Induction Period|Withdrawal by Subject|0|||
127929563|NCT04146363|460366436|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
127929564|NCT04146363|460366437|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
127929565|NCT04146363|460366438|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
127929566|NCT04146363|460366439|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
127929567|NCT04146363|460366440|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
127929568|NCT04146363|460366441|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
127929569|NCT04146363|460366442|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
127929570|NCT04146363|460366443|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
127929571|NCT04146363|460366444|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
127929572|NCT04146363|460366445|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
127929573|NCT04146363|460366446|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
127929574|NCT04146363|460366436|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
127929575|NCT04146363|460366437|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
127929576|NCT04146363|460366438|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
127929577|NCT04146363|460366439|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
127929578|NCT04146363|460366440|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
127929579|NCT04146363|460366441|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
127929580|NCT04146363|460366442|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
127929581|NCT04146363|460366443|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
127929582|NCT04146363|460366444|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
127929583|NCT04146363|460366445|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
127929584|NCT04146363|460366446|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
127929585|NCT04146363|460366436|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
127929586|NCT04146363|460366437|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
127929587|NCT04146363|460366438|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
127929588|NCT04146363|460366439|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
127929589|NCT04146363|460366440|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
127929590|NCT04146363|460366441|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
127929591|NCT04146363|460366442|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
127929592|NCT04146363|460366443|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
127929593|NCT04146363|460366444|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
127929594|NCT04146363|460366445|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
127929595|NCT04146363|460366446|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
127929596|NCT04146363|460366436|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
127929597|NCT04146363|460366437|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
127929598|NCT04146363|460366438|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
127929599|NCT04146363|460366439|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
127929600|NCT04146363|460366440|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
127929601|NCT04146363|460366441|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
127929602|NCT04146363|460366442|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
127929603|NCT04146363|460366443|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
127929604|NCT04146363|460366444|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
127929605|NCT04146363|460366445|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
127929606|NCT04146363|460366446|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
127929607|NCT04146363|460366436|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
127929608|NCT04146363|460366437|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
127929609|NCT04146363|460366438|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
127929610|NCT04146363|460366439|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
127929611|NCT04146363|460366440|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
127929612|NCT04146363|460366441|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
127929613|NCT04146363|460366442|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
127929614|NCT04146363|460366443|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
127929615|NCT04146363|460366444|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
127929616|NCT04146363|460366445|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
127929617|NCT04146363|460366446|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
127929618|NCT04146363|460366436|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
127929619|NCT04146363|460366437|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
127929620|NCT04146363|460366438|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
127929621|NCT04146363|460366439|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
127929622|NCT04146363|460366440|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
127929623|NCT04146363|460366441|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
127929624|NCT04146363|460366442|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
127929625|NCT04146363|460366443|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
127929626|NCT04146363|460366444|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
127929627|NCT04146363|460366445|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
127929628|NCT04146363|460366446|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
127929629|NCT04146363|460366436|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
127929630|NCT04146363|460366437|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
127929631|NCT04146363|460366438|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
127929632|NCT04146363|460366439|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
127929633|NCT04146363|460366440|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
127929634|NCT04146363|460366441|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
127929635|NCT04146363|460366442|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
127929636|NCT04146363|460366443|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
127929637|NCT04146363|460366444|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
127929638|NCT04146363|460366445|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
127929639|NCT04146363|460366446|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
127929640|NCT04146363|460366436|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
127929641|NCT04146363|460366437|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
127929642|NCT04146363|460366438|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
127929643|NCT04146363|460366439|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
127929644|NCT04146363|460366440|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
127929645|NCT04146363|460366441|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
127929646|NCT04146363|460366442|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
127929647|NCT04146363|460366443|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
127929648|NCT04146363|460366444|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
127929649|NCT04146363|460366445|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
127929650|NCT04146363|460366446|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
127929651|NCT04146363|460366436|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
127929652|NCT04146363|460366437|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
127929653|NCT04146363|460366438|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
127929654|NCT04146363|460366439|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
127929655|NCT04146363|460366440|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
127929656|NCT04146363|460366441|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
127929657|NCT04146363|460366442|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
127929658|NCT04146363|460366443|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
127929659|NCT04146363|460366444|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
127929660|NCT04146363|460366445|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
127929661|NCT04146363|460366446|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
127929662|NCT04146363|460366436|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
127929663|NCT04146363|460366437|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
127929664|NCT04146363|460366438|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
127929665|NCT04146363|460366439|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
127929666|NCT04146363|460366440|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
127929667|NCT04146363|460366441|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
127929668|NCT04146363|460366442|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
127929669|NCT04146363|460366443|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
127929670|NCT04146363|460366444|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
127929671|NCT04146363|460366445|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
127929672|NCT04146363|460366446|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
127929673|NCT04146363|460366436|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
127929674|NCT04146363|460366437|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
127929675|NCT04146363|460366438|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
127929676|NCT04146363|460366439|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
127929677|NCT04146363|460366440|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
127929678|NCT04146363|460366441|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
127929679|NCT04146363|460366442|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
127929680|NCT04146363|460366443|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
127929681|NCT04146363|460366444|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
127929682|NCT04146363|460366445|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
127929683|NCT04146363|460366446|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
127929684|NCT04146363|460366436|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
127929685|NCT04146363|460366437|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
127929686|NCT04146363|460366438|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
127929687|NCT04146363|460366439|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
127929688|NCT04146363|460366440|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
127929689|NCT04146363|460366441|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
127929690|NCT04146363|460366442|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
127929691|NCT04146363|460366443|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
127929692|NCT04146363|460366444|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
127929693|NCT04146363|460366445|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
127929694|NCT04146363|460366446|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
127929695|NCT04146363|460366436|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
127929696|NCT04146363|460366437|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
127929697|NCT04146363|460366438|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
127929698|NCT04146363|460366439|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
127929699|NCT04146363|460366440|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
127929700|NCT04146363|460366441|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
127929701|NCT04146363|460366442|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
127929702|NCT04146363|460366443|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
127929703|NCT04146363|460366444|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
127929704|NCT04146363|460366445|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
127929705|NCT04146363|460366446|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
127929706|NCT02914236|460366447|FG000|Overall Study|Lost to Follow-up|1|||
127929707|NCT02148913|460366449|FG000|Overall Study|Death|0|||
127929708|NCT02148913|460366450|FG001|Overall Study|Death|1|||
127929709|NCT02148913|460366451|FG002|Overall Study|Death|0|||
127929710|NCT02148913|460366452|FG003|Overall Study|Death|0|||
127929711|NCT01045993|460366460|FG000|Overall Study|Treated-later found eligibility not met|0|||
127929712|NCT01045993|460366461|FG001|Overall Study|Treated-later found eligibility not met|1|||
127929713|NCT01045993|460366462|FG002|Overall Study|Treated-later found eligibility not met|0|||
127929714|NCT01045993|460366463|FG003|Overall Study|Treated-later found eligibility not met|0|||
127929715|NCT02025010|460366464|FG000|Overall Study|Symptomatic or radiographic progression|36|||
127929716|NCT02025010|460366464|FG000|Overall Study|Adverse Event|6|||
127929717|NCT02025010|460366464|FG000|Overall Study|Physician Decision|7|||
127929718|NCT02025010|460366464|FG000|Overall Study|Withdrawal by Subject|3|||
127929719|NCT02025010|460366464|FG000|Overall Study|Intercurrent illness|3|||
127929720|NCT02025010|460366464|FG000|Overall Study|Patients still on treatment|3|||
127929721|NCT02025010|460366464|FG000|Overall Study|Never initiate the treatment|2|||
127929722|NCT00484419|460366469|FG000|Overall Study|Adverse Event|3|||
127929723|NCT00484419|460366470|FG001|Overall Study|Adverse Event|0|||
127929724|NCT00484419|460366471|FG002|Overall Study|Adverse Event|0|||
127929725|NCT00484419|460366469|FG000|Overall Study|Lost to Follow-up|1|||
127929726|NCT00484419|460366470|FG001|Overall Study|Lost to Follow-up|0|||
127929727|NCT00484419|460366471|FG002|Overall Study|Lost to Follow-up|2|||
127929728|NCT00484419|460366469|FG000|Overall Study|Withdrawal by Subject|3|||
127929729|NCT00484419|460366470|FG001|Overall Study|Withdrawal by Subject|1|||
127929730|NCT00484419|460366471|FG002|Overall Study|Withdrawal by Subject|1|||
127929731|NCT00484419|460366469|FG000|Overall Study|subject met discontinuation criteria|2|||
127929732|NCT00484419|460366470|FG001|Overall Study|subject met discontinuation criteria|2|||
127929733|NCT00484419|460366471|FG002|Overall Study|subject met discontinuation criteria|4|||
127929734|NCT00484419|460366469|FG000|Overall Study|required restricted medication|1|||
127929735|NCT00484419|460366470|FG001|Overall Study|required restricted medication|0|||
127929736|NCT00484419|460366471|FG002|Overall Study|required restricted medication|1|||
127929737|NCT00484419|460366469|FG000|Overall Study|Physician Decision|1|||
127929738|NCT00484419|460366470|FG001|Overall Study|Physician Decision|1|||
127929739|NCT00484419|460366471|FG002|Overall Study|Physician Decision|1|||
127929740|NCT00484419|460366469|FG000|Overall Study|subject unable to receive medication|1|||
127929741|NCT00484419|460366470|FG001|Overall Study|subject unable to receive medication|0|||
127929742|NCT00484419|460366471|FG002|Overall Study|subject unable to receive medication|0|||
127929743|NCT00484419|460366469|FG000|Overall Study|subject relocated|0|||
127929744|NCT00484419|460366470|FG001|Overall Study|subject relocated|1|||
127929745|NCT00484419|460366471|FG002|Overall Study|subject relocated|0|||
127929746|NCT00484419|460366469|FG000|Overall Study|sponsor decision, randomized in error|0|||
127929747|NCT00484419|460366470|FG001|Overall Study|sponsor decision, randomized in error|0|||
127929748|NCT00484419|460366471|FG002|Overall Study|sponsor decision, randomized in error|2|||
127929749|NCT00102687|460366475|FG000|Initial Period|Withdrawal by Subject|6|||
127929750|NCT00102687|460366476|FG001|Initial Period|Withdrawal by Subject|3|||
127929751|NCT00102687|460366477|FG002|Initial Period|Withdrawal by Subject|5|||
127929752|NCT00102687|460366478|FG003|Initial Period|Withdrawal by Subject|0|||
127929753|NCT00102687|460366479|FG004|Initial Period|Withdrawal by Subject|0|||
127929754|NCT00102687|460366475|FG000|Initial Period|Adverse Event|4|||
127929755|NCT00102687|460366476|FG001|Initial Period|Adverse Event|7|||
127929756|NCT00102687|460366477|FG002|Initial Period|Adverse Event|9|||
127929757|NCT00102687|460366478|FG003|Initial Period|Adverse Event|0|||
127929758|NCT00102687|460366479|FG004|Initial Period|Adverse Event|0|||
127929759|NCT00102687|460366475|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
127929760|NCT00102687|460366476|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
127929761|NCT00102687|460366477|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
127929762|NCT00102687|460366478|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
127929763|NCT00102687|460366479|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
127929764|NCT00102687|460366475|FG000|Initial Period|Protocol Violation|0|||
127929765|NCT00102687|460366476|FG001|Initial Period|Protocol Violation|0|||
127929766|NCT00102687|460366477|FG002|Initial Period|Protocol Violation|2|||
127929767|NCT00102687|460366478|FG003|Initial Period|Protocol Violation|0|||
127929768|NCT00102687|460366479|FG004|Initial Period|Protocol Violation|0|||
127929769|NCT00102687|460366475|FG000|Initial Period|Physician Decision|2|||
127929770|NCT00102687|460366476|FG001|Initial Period|Physician Decision|9|||
127929771|NCT00102687|460366477|FG002|Initial Period|Physician Decision|6|||
127929772|NCT00102687|460366478|FG003|Initial Period|Physician Decision|0|||
127929773|NCT00102687|460366479|FG004|Initial Period|Physician Decision|0|||
127929774|NCT00102687|460366475|FG000|Initial Period|Sponsor's decision|0|||
127929775|NCT00102687|460366476|FG001|Initial Period|Sponsor's decision|1|||
127929776|NCT00102687|460366477|FG002|Initial Period|Sponsor's decision|1|||
127929777|NCT00102687|460366478|FG003|Initial Period|Sponsor's decision|0|||
127929778|NCT00102687|460366479|FG004|Initial Period|Sponsor's decision|0|||
127929779|NCT00102687|460366475|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
127929780|NCT00102687|460366476|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
127929781|NCT00102687|460366477|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
127929782|NCT00102687|460366478|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
127929783|NCT00102687|460366479|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
127929784|NCT00102687|460366475|FG000|Initial Period|Death|1|||
127929785|NCT00102687|460366476|FG001|Initial Period|Death|1|||
127929786|NCT00102687|460366477|FG002|Initial Period|Death|1|||
127929787|NCT00102687|460366478|FG003|Initial Period|Death|0|||
127929788|NCT00102687|460366479|FG004|Initial Period|Death|0|||
127929789|NCT00102687|460366475|FG000|Maintenance Period|Withdrawal by Subject|4|||
127929790|NCT00102687|460366476|FG001|Maintenance Period|Withdrawal by Subject|0|||
127929791|NCT00102687|460366477|FG002|Maintenance Period|Withdrawal by Subject|2|||
127929792|NCT00102687|460366478|FG003|Maintenance Period|Withdrawal by Subject|3|||
127929793|NCT00102687|460366479|FG004|Maintenance Period|Withdrawal by Subject|1|||
127929794|NCT00102687|460366475|FG000|Maintenance Period|Adverse Event|1|||
127929795|NCT00102687|460366476|FG001|Maintenance Period|Adverse Event|0|||
127929796|NCT00102687|460366477|FG002|Maintenance Period|Adverse Event|0|||
127929797|NCT00102687|460366478|FG003|Maintenance Period|Adverse Event|1|||
127929798|NCT00102687|460366479|FG004|Maintenance Period|Adverse Event|3|||
127929799|NCT00102687|460366475|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
127929800|NCT00102687|460366476|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
127929801|NCT00102687|460366477|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
127929802|NCT00102687|460366478|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
127929803|NCT00102687|460366479|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
127929804|NCT00102687|460366475|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
127929805|NCT00102687|460366476|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
127929806|NCT00102687|460366477|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
127929807|NCT00102687|460366478|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
127929808|NCT00102687|460366479|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
127929809|NCT00102687|460366475|FG000|Maintenance Period|Death|0|||
127929810|NCT00102687|460366476|FG001|Maintenance Period|Death|0|||
127929811|NCT00102687|460366477|FG002|Maintenance Period|Death|0|||
127929812|NCT00102687|460366478|FG003|Maintenance Period|Death|1|||
127929813|NCT00102687|460366479|FG004|Maintenance Period|Death|1|||
127929814|NCT00102687|460366475|FG000|Maintenance Period|Physician Decision|1|||
127929815|NCT00102687|460366476|FG001|Maintenance Period|Physician Decision|2|||
127929816|NCT00102687|460366477|FG002|Maintenance Period|Physician Decision|3|||
127929817|NCT00102687|460366478|FG003|Maintenance Period|Physician Decision|0|||
127929818|NCT00102687|460366479|FG004|Maintenance Period|Physician Decision|4|||
127929819|NCT00355472|460366480|FG000|Overall Study|Physician Decision|1|||
127929820|NCT03095118|460366481|FG000|Overall Study|Adverse Event|1|||
127929821|NCT03095118|460366481|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
127929822|NCT03847194|460366482|FG000|Overall Study|Lost to Follow-up|2|||
127929823|NCT03847194|460366483|FG001|Overall Study|Lost to Follow-up|5|||
127929824|NCT03847194|460366482|FG000|Overall Study|Withdrawal by Subject|1|||
127929825|NCT03847194|460366483|FG001|Overall Study|Withdrawal by Subject|2|||
127929826|NCT03847194|460366482|FG000|Overall Study|Death|0|||
127929827|NCT03847194|460366483|FG001|Overall Study|Death|1|||
127929828|NCT02408120|460366484|FG000|Overall Study|Withdrawal by Subject|0|||
127929829|NCT02408120|460366485|FG001|Overall Study|Withdrawal by Subject|1|||
127929830|NCT02408120|460366484|FG000|Overall Study|Treatment Refusal|1|||
127929831|NCT02408120|460366485|FG001|Overall Study|Treatment Refusal|0|||
127929832|NCT02408120|460366484|FG000|Overall Study|Received Steroids|1|||
127929833|NCT02408120|460366485|FG001|Overall Study|Received Steroids|1|||
127929834|NCT02408120|460366484|FG000|Overall Study|Discharged same day|1|||
127929835|NCT02408120|460366485|FG001|Overall Study|Discharged same day|1|||
127929836|NCT02408120|460366484|FG000|Overall Study|Did not receive insulin|1|||
127929837|NCT02408120|460366485|FG001|Overall Study|Did not receive insulin|2|||
127929838|NCT01341587|460366486|FG000|Overall Study|Lost to Follow-up|2|||
127929839|NCT01341587|460366487|FG001|Overall Study|Lost to Follow-up|0|||
127929840|NCT01341587|460366486|FG000|Overall Study|stopped using the meters|2|||
127929841|NCT01341587|460366487|FG001|Overall Study|stopped using the meters|10|||
127929842|NCT01144403|460366488|FG000|Overall Study|Lost to Follow-up|3|||
127929843|NCT01144403|460366488|FG000|Overall Study|Death|1|||
127929844|NCT01144403|460366488|FG000|Overall Study|Adverse Event|1|||
127929845|NCT03176784|460366489|FG000|Overall Study|Lost to Follow-up|77|||
127929846|NCT03176784|460366490|FG001|Overall Study|Lost to Follow-up|79|||
127929847|NCT03176784|460366491|FG002|Overall Study|Lost to Follow-up|79|||
127929848|NCT03176784|460366492|FG003|Overall Study|Lost to Follow-up|49|||
127929849|NCT03176784|460366489|FG000|Overall Study|Withdrawal by Subject|28|||
127929850|NCT03176784|460366490|FG001|Overall Study|Withdrawal by Subject|34|||
127929851|NCT03176784|460366491|FG002|Overall Study|Withdrawal by Subject|34|||
127929852|NCT03176784|460366492|FG003|Overall Study|Withdrawal by Subject|21|||
127929853|NCT00680186|460366497|FG000|Overall Study|Adverse Event|47|||
127929854|NCT00680186|460366498|FG001|Overall Study|Adverse Event|44|||
127929855|NCT00680186|460366497|FG000|Overall Study|Protocol Violation|31|||
127929856|NCT00680186|460366498|FG001|Overall Study|Protocol Violation|26|||
127929857|NCT00680186|460366497|FG000|Overall Study|Lost to Follow-up|11|||
127929858|NCT00680186|460366498|FG001|Overall Study|Lost to Follow-up|6|||
127929859|NCT00680186|460366497|FG000|Overall Study|Withdrawal by Subject|32|||
127929860|NCT00680186|460366498|FG001|Overall Study|Withdrawal by Subject|39|||
127929861|NCT00680186|460366497|FG000|Overall Study|Other|4|||
127929862|NCT00680186|460366498|FG001|Overall Study|Other|1|||
127929863|NCT00645944|460366499|FG000|Randomized|Withdrawal by Subject|1|||
127929864|NCT00645944|460366500|FG001|Randomized|Withdrawal by Subject|2|||
127929865|NCT00645944|460366499|FG000|Received Medication|Adverse Event|2|||
127929866|NCT00645944|460366500|FG001|Received Medication|Adverse Event|1|||
127929867|NCT00645944|460366499|FG000|Received Medication|Withdrawal by Subject|1|||
127929868|NCT00645944|460366500|FG001|Received Medication|Withdrawal by Subject|1|||
127929869|NCT00645944|460366499|FG000|Received Medication|Lost to Follow-up|1|||
127929870|NCT00645944|460366500|FG001|Received Medication|Lost to Follow-up|0|||
127929871|NCT00645944|460366499|FG000|Received Medication|Protocol Violation|2|||
127929872|NCT00645944|460366500|FG001|Received Medication|Protocol Violation|1|||
127929873|NCT01523587|460366501|FG000|Overall Study|Other than listed|5|||
127929874|NCT01523587|460366502|FG001|Overall Study|Other than listed|5|||
127929875|NCT01523587|460366501|FG000|Overall Study|Worsening of underlying cancer disease|19|||
127929876|NCT01523587|460366502|FG001|Overall Study|Worsening of underlying cancer disease|34|||
127929877|NCT01523587|460366501|FG000|Overall Study|Adverse Event|68|||
127929878|NCT01523587|460366502|FG001|Overall Study|Adverse Event|52|||
127929879|NCT01523587|460366501|FG000|Overall Study|Protocol Violation|5|||
127929880|NCT01523587|460366502|FG001|Overall Study|Protocol Violation|3|||
127929881|NCT01523587|460366501|FG000|Overall Study|Lost to Follow-up|2|||
127929882|NCT01523587|460366502|FG001|Overall Study|Lost to Follow-up|2|||
127929883|NCT01523587|460366501|FG000|Overall Study|Withdrawal by Subject|28|||
127929884|NCT01523587|460366502|FG001|Overall Study|Withdrawal by Subject|20|||
127929885|NCT01523587|460366501|FG000|Overall Study|Withdrew due to Progressive disease|265|||
127929886|NCT01523587|460366502|FG001|Overall Study|Withdrew due to Progressive disease|279|||
127929887|NCT01523587|460366501|FG000|Overall Study|Randomised but bot treated|6|||
127929888|NCT01523587|460366502|FG001|Overall Study|Randomised but bot treated|2|||
127929889|NCT00606502|460366510|FG000|Randomization|Randomized but not treated|3|||
127929890|NCT00606502|460366511|FG001|Randomization|Randomized but not treated|0|||
127929891|NCT00606502|460366510|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
127929892|NCT00606502|460366511|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
127929893|NCT02083926|460366514|FG000|Overall Study|Withdrawal by Subject|1|||
127929894|NCT02083926|460366515|FG001|Overall Study|Withdrawal by Subject|0|||
127929895|NCT03438227|460366516|FG000|Overall Study|Withdrawal by Subject|10|||
127929896|NCT03438227|460366517|FG001|Overall Study|Withdrawal by Subject|5|||
127929897|NCT01813071|460366518|FG000|Overall Study|Protocol Violation|0|||
127929898|NCT01813071|460366519|FG001|Overall Study|Protocol Violation|0|||
127929899|NCT01813071|460366520|FG002|Overall Study|Protocol Violation|0|||
127929900|NCT01813071|460366521|FG003|Overall Study|Protocol Violation|0|||
127929901|NCT01813071|460366522|FG004|Overall Study|Protocol Violation|1|||
127929902|NCT01813071|460366523|FG005|Overall Study|Protocol Violation|4|||
127929903|NCT01813071|460366524|FG006|Overall Study|Protocol Violation|2|||
127929904|NCT01813071|460366525|FG007|Overall Study|Protocol Violation|4|||
127929905|NCT01813071|460366526|FG008|Overall Study|Protocol Violation|2|||
127929906|NCT01813071|460366518|FG000|Overall Study|Withdrawal by Subject|0|||
127929907|NCT01813071|460366519|FG001|Overall Study|Withdrawal by Subject|0|||
127929908|NCT01813071|460366520|FG002|Overall Study|Withdrawal by Subject|0|||
127929909|NCT01813071|460366521|FG003|Overall Study|Withdrawal by Subject|0|||
127929910|NCT01813071|460366522|FG004|Overall Study|Withdrawal by Subject|0|||
127929911|NCT01813071|460366523|FG005|Overall Study|Withdrawal by Subject|1|||
127929912|NCT01813071|460366524|FG006|Overall Study|Withdrawal by Subject|0|||
127929913|NCT01813071|460366525|FG007|Overall Study|Withdrawal by Subject|0|||
127929914|NCT01813071|460366526|FG008|Overall Study|Withdrawal by Subject|0|||
127929915|NCT01813071|460366518|FG000|Overall Study|Adverse Event|0|||
127929916|NCT01813071|460366519|FG001|Overall Study|Adverse Event|0|||
127929917|NCT01813071|460366520|FG002|Overall Study|Adverse Event|0|||
127929918|NCT01813071|460366521|FG003|Overall Study|Adverse Event|0|||
127929919|NCT01813071|460366522|FG004|Overall Study|Adverse Event|0|||
127929920|NCT01813071|460366523|FG005|Overall Study|Adverse Event|1|||
127929921|NCT01813071|460366524|FG006|Overall Study|Adverse Event|0|||
127929922|NCT01813071|460366525|FG007|Overall Study|Adverse Event|0|||
127929923|NCT01813071|460366526|FG008|Overall Study|Adverse Event|0|||
127929924|NCT01813071|460366518|FG000|Overall Study|Physician Decision|0|||
127929925|NCT01813071|460366519|FG001|Overall Study|Physician Decision|0|||
127929926|NCT01813071|460366520|FG002|Overall Study|Physician Decision|0|||
127929927|NCT01813071|460366521|FG003|Overall Study|Physician Decision|0|||
127929928|NCT01813071|460366522|FG004|Overall Study|Physician Decision|0|||
127929929|NCT01813071|460366523|FG005|Overall Study|Physician Decision|0|||
127929930|NCT01813071|460366524|FG006|Overall Study|Physician Decision|1|||
127929931|NCT01813071|460366525|FG007|Overall Study|Physician Decision|0|||
127929932|NCT01813071|460366526|FG008|Overall Study|Physician Decision|0|||
127929933|NCT01813071|460366518|FG000|Overall Study|Met inc/exc criteria|0|||
127929934|NCT01813071|460366519|FG001|Overall Study|Met inc/exc criteria|0|||
127929935|NCT01813071|460366520|FG002|Overall Study|Met inc/exc criteria|0|||
127929936|NCT01813071|460366521|FG003|Overall Study|Met inc/exc criteria|0|||
127929937|NCT01813071|460366522|FG004|Overall Study|Met inc/exc criteria|0|||
127929938|NCT01813071|460366523|FG005|Overall Study|Met inc/exc criteria|1|||
127929939|NCT01813071|460366524|FG006|Overall Study|Met inc/exc criteria|0|||
127929940|NCT01813071|460366525|FG007|Overall Study|Met inc/exc criteria|1|||
127929941|NCT01813071|460366526|FG008|Overall Study|Met inc/exc criteria|1|||
127929942|NCT01425528|460366527|FG000|Overall Study|Withdrawal by Subject|1|||
127929943|NCT01425528|460366528|FG001|Overall Study|Withdrawal by Subject|1|||
127929944|NCT02697773|460366529|FG000|Overall Study|Adverse Event|2|||
127929945|NCT02697773|460366530|FG001|Overall Study|Adverse Event|1|||
127929946|NCT02697773|460366531|FG002|Overall Study|Adverse Event|2|||
127929947|NCT02697773|460366529|FG000|Overall Study|Death|0|||
127929948|NCT02697773|460366530|FG001|Overall Study|Death|0|||
127929949|NCT02697773|460366531|FG002|Overall Study|Death|2|||
127929950|NCT02697773|460366529|FG000|Overall Study|Lack of Efficacy|4|||
127929951|NCT02697773|460366530|FG001|Overall Study|Lack of Efficacy|6|||
127929952|NCT02697773|460366531|FG002|Overall Study|Lack of Efficacy|6|||
127929953|NCT02697773|460366529|FG000|Overall Study|Lost to Follow-up|5|||
127929954|NCT02697773|460366530|FG001|Overall Study|Lost to Follow-up|5|||
127929955|NCT02697773|460366531|FG002|Overall Study|Lost to Follow-up|7|||
127929956|NCT02697773|460366529|FG000|Overall Study|Other|15|||
127929957|NCT02697773|460366530|FG001|Overall Study|Other|11|||
127929958|NCT02697773|460366531|FG002|Overall Study|Other|10|||
127929959|NCT02697773|460366529|FG000|Overall Study|Protocol Violation|1|||
127929960|NCT02697773|460366530|FG001|Overall Study|Protocol Violation|1|||
127929961|NCT02697773|460366531|FG002|Overall Study|Protocol Violation|0|||
127929962|NCT02697773|460366529|FG000|Overall Study|Withdrawal by Subject|10|||
127929963|NCT02697773|460366530|FG001|Overall Study|Withdrawal by Subject|13|||
127929964|NCT02697773|460366531|FG002|Overall Study|Withdrawal by Subject|13|||
127929965|NCT02697773|460366529|FG000|Overall Study|Randomized but not treated|1|||
127929966|NCT02697773|460366530|FG001|Overall Study|Randomized but not treated|1|||
127929967|NCT02697773|460366531|FG002|Overall Study|Randomized but not treated|0|||
127929968|NCT00613834|460366532|FG000|Overall Study|Withdrawal by Subject|0|||
127929969|NCT00613834|460366533|FG001|Overall Study|Withdrawal by Subject|3|||
127929970|NCT00842530|460366534|FG000|Overall Study|Serious adverse event|0|||
127929971|NCT00842530|460366535|FG001|Overall Study|Serious adverse event|6|||
127929972|NCT00842530|460366534|FG000|Overall Study|Other adverse event|6|||
127929973|NCT00842530|460366535|FG001|Overall Study|Other adverse event|1|||
127929974|NCT00842530|460366534|FG000|Overall Study|Protocol Violation|32|||
127929975|NCT00842530|460366535|FG001|Overall Study|Protocol Violation|14|||
127929976|NCT00842530|460366534|FG000|Overall Study|Lost to Follow-up|6|||
127929977|NCT00842530|460366535|FG001|Overall Study|Lost to Follow-up|8|||
127929978|NCT00842530|460366534|FG000|Overall Study|Withdrawal by Subject|73|||
127929979|NCT00842530|460366535|FG001|Overall Study|Withdrawal by Subject|28|||
127929980|NCT02939950|460366538|FG000|Overall Study|Lost to Follow-up|13|||
127929981|NCT02939950|460366539|FG001|Overall Study|Lost to Follow-up|16|||
127929982|NCT02939950|460366538|FG000|Overall Study|Positive slit lamp findings|0|||
127929983|NCT02939950|460366539|FG001|Overall Study|Positive slit lamp findings|1|||
127929984|NCT02939950|460366538|FG000|Overall Study|Chalazion upper lid|0|||
127929985|NCT02939950|460366539|FG001|Overall Study|Chalazion upper lid|1|||
127929986|NCT02939950|460366538|FG000|Overall Study|Lack of motivation|0|||
127929987|NCT02939950|460366539|FG001|Overall Study|Lack of motivation|2|||
127929988|NCT02939950|460366538|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
127929989|NCT02939950|460366539|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
127929990|NCT02939950|460366538|FG000|Overall Study|Military orders|1|||
127929991|NCT02939950|460366539|FG001|Overall Study|Military orders|0|||
127929992|NCT02939950|460366538|FG000|Overall Study|Participant Relocated|5|||
127929993|NCT02939950|460366539|FG001|Overall Study|Participant Relocated|3|||
127929994|NCT02939950|460366538|FG000|Overall Study|Study related symptoms|8|||
127929995|NCT02939950|460366539|FG001|Overall Study|Study related symptoms|8|||
127929996|NCT02939950|460366538|FG000|Overall Study|Unacceptable lens movement|2|||
127929997|NCT02939950|460366539|FG001|Overall Study|Unacceptable lens movement|0|||
127929998|NCT02939950|460366538|FG000|Overall Study|Protocol Violation|6|||
127929999|NCT02939950|460366539|FG001|Overall Study|Protocol Violation|3|||
127930000|NCT02939950|460366538|FG000|Overall Study|Physician Decision|2|||
127930001|NCT02939950|460366539|FG001|Overall Study|Physician Decision|0|||
127930002|NCT02939950|460366538|FG000|Overall Study|Pregnancy|6|||
127930003|NCT02939950|460366539|FG001|Overall Study|Pregnancy|7|||
127930004|NCT02939950|460366538|FG000|Overall Study|Withdrawal by Subject|12|||
127930005|NCT02939950|460366539|FG001|Overall Study|Withdrawal by Subject|28|||
127930006|NCT02939950|460366538|FG000|Overall Study|Adverse Event|7|||
127930007|NCT02939950|460366539|FG001|Overall Study|Adverse Event|3|||
127930008|NCT02939950|460366538|FG000|Overall Study|Randomized, not dispensed|1|||
127930009|NCT02939950|460366539|FG001|Overall Study|Randomized, not dispensed|0|||
127930010|NCT02939950|460366538|FG000|Overall Study|Ineligible at Baseline|2|||
127930011|NCT02939950|460366539|FG001|Overall Study|Ineligible at Baseline|8|||
127930012|NCT02243293|460366543|FG000|Overall Study|Adverse Event|1|||
127930013|NCT02243293|460366544|FG001|Overall Study|Adverse Event|0|||
127930014|NCT02243293|460366545|FG002|Overall Study|Adverse Event|0|||
127930015|NCT02243293|460366546|FG003|Overall Study|Adverse Event|0|||
127930016|NCT02243293|460366547|FG004|Overall Study|Adverse Event|0|||
127930017|NCT02243293|460366548|FG005|Overall Study|Adverse Event|0|||
127930018|NCT02243293|460366549|FG006|Overall Study|Adverse Event|0|||
127930019|NCT02243293|460366550|FG007|Overall Study|Adverse Event|0|||
127930020|NCT02243293|460366551|FG008|Overall Study|Adverse Event|0|||
127930021|NCT02243293|460366552|FG009|Overall Study|Adverse Event|0|||
127930022|NCT02243293|460366553|FG010|Overall Study|Adverse Event|0|||
127930023|NCT02243293|460366554|FG011|Overall Study|Adverse Event|0|||
127930024|NCT02243293|460366555|FG012|Overall Study|Adverse Event|0|||
127930025|NCT02243293|460366556|FG013|Overall Study|Adverse Event|0|||
127930026|NCT02243293|460366557|FG014|Overall Study|Adverse Event|0|||
127930027|NCT02243293|460366558|FG015|Overall Study|Adverse Event|1|||
127930028|NCT02243293|460366559|FG016|Overall Study|Adverse Event|0|||
127930029|NCT02243293|460366560|FG017|Overall Study|Adverse Event|0|||
127930030|NCT02243293|460366561|FG018|Overall Study|Adverse Event|0|||
127930031|NCT02243293|460366562|FG019|Overall Study|Adverse Event|0|||
127930032|NCT02243293|460366563|FG020|Overall Study|Adverse Event|1|||
127930033|NCT02243293|460366564|FG021|Overall Study|Adverse Event|0|||
127930034|NCT02243293|460366543|FG000|Overall Study|Withdrawal by Subject|1|||
127930035|NCT02243293|460366544|FG001|Overall Study|Withdrawal by Subject|0|||
127930036|NCT02243293|460366545|FG002|Overall Study|Withdrawal by Subject|0|||
127930037|NCT02243293|460366546|FG003|Overall Study|Withdrawal by Subject|0|||
127930038|NCT02243293|460366547|FG004|Overall Study|Withdrawal by Subject|0|||
127930039|NCT02243293|460366548|FG005|Overall Study|Withdrawal by Subject|0|||
127930040|NCT02243293|460366549|FG006|Overall Study|Withdrawal by Subject|0|||
127930041|NCT02243293|460366550|FG007|Overall Study|Withdrawal by Subject|0|||
127930042|NCT02243293|460366551|FG008|Overall Study|Withdrawal by Subject|0|||
127930043|NCT02243293|460366552|FG009|Overall Study|Withdrawal by Subject|1|||
127930044|NCT02243293|460366553|FG010|Overall Study|Withdrawal by Subject|0|||
127930045|NCT02243293|460366554|FG011|Overall Study|Withdrawal by Subject|1|||
127930046|NCT02243293|460366555|FG012|Overall Study|Withdrawal by Subject|0|||
127930047|NCT02243293|460366556|FG013|Overall Study|Withdrawal by Subject|0|||
127930048|NCT02243293|460366557|FG014|Overall Study|Withdrawal by Subject|0|||
127930049|NCT02243293|460366558|FG015|Overall Study|Withdrawal by Subject|0|||
127930050|NCT02243293|460366559|FG016|Overall Study|Withdrawal by Subject|0|||
127930051|NCT02243293|460366560|FG017|Overall Study|Withdrawal by Subject|0|||
127930052|NCT02243293|460366561|FG018|Overall Study|Withdrawal by Subject|0|||
127930053|NCT02243293|460366562|FG019|Overall Study|Withdrawal by Subject|0|||
127930054|NCT02243293|460366563|FG020|Overall Study|Withdrawal by Subject|0|||
127930055|NCT02243293|460366564|FG021|Overall Study|Withdrawal by Subject|1|||
127930056|NCT02243293|460366543|FG000|Overall Study|Lost to Follow-up|0|||
127930057|NCT02243293|460366544|FG001|Overall Study|Lost to Follow-up|1|||
127930058|NCT02243293|460366545|FG002|Overall Study|Lost to Follow-up|1|||
127930059|NCT02243293|460366546|FG003|Overall Study|Lost to Follow-up|1|||
127930060|NCT02243293|460366547|FG004|Overall Study|Lost to Follow-up|0|||
127930061|NCT02243293|460366548|FG005|Overall Study|Lost to Follow-up|0|||
127930062|NCT02243293|460366549|FG006|Overall Study|Lost to Follow-up|3|||
127930063|NCT02243293|460366550|FG007|Overall Study|Lost to Follow-up|0|||
127930064|NCT02243293|460366551|FG008|Overall Study|Lost to Follow-up|0|||
127930065|NCT02243293|460366552|FG009|Overall Study|Lost to Follow-up|0|||
127930066|NCT02243293|460366553|FG010|Overall Study|Lost to Follow-up|0|||
127930067|NCT02243293|460366554|FG011|Overall Study|Lost to Follow-up|2|||
127930068|NCT02243293|460366555|FG012|Overall Study|Lost to Follow-up|0|||
127930069|NCT02243293|460366556|FG013|Overall Study|Lost to Follow-up|0|||
127930070|NCT02243293|460366557|FG014|Overall Study|Lost to Follow-up|0|||
127868617|NCT01072175|460137386|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
127868618|NCT01072175|460137387|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
127868619|NCT01072175|460137388|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
127868620|NCT01072175|460137389|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
127868621|NCT01072175|460137390|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
127868622|NCT01072175|460137391|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
127868623|NCT01072175|460137392|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
127868624|NCT01072175|460137393|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
127868625|NCT01072175|460137394|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
127868626|NCT01072175|460137395|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
127868627|NCT01072175|460137383|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
127868628|NCT01072175|460137384|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
127868629|NCT01072175|460137385|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
127868630|NCT01072175|460137386|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
127868631|NCT01072175|460137387|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
127868632|NCT01072175|460137388|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
127868633|NCT01072175|460137389|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
127868634|NCT01072175|460137390|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
127868635|NCT01072175|460137391|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
127868636|NCT01072175|460137392|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
127868637|NCT01072175|460137393|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
127868638|NCT01072175|460137394|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
127868639|NCT01072175|460137395|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
127868640|NCT01072175|460137383|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
127868641|NCT01072175|460137384|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
127868642|NCT01072175|460137385|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
127868643|NCT01072175|460137386|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
127868644|NCT01072175|460137387|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
127868645|NCT01072175|460137388|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
127868646|NCT01072175|460137389|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
127868647|NCT01072175|460137390|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
127868648|NCT01072175|460137391|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
127868649|NCT01072175|460137392|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
127868650|NCT01072175|460137393|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
127868651|NCT01072175|460137394|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
127868652|NCT01072175|460137395|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
127868653|NCT01072175|460137383|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
127868654|NCT01072175|460137384|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
127930071|NCT02243293|460366558|FG015|Overall Study|Lost to Follow-up|0|||
127930072|NCT02243293|460366559|FG016|Overall Study|Lost to Follow-up|3|||
127930073|NCT02243293|460366560|FG017|Overall Study|Lost to Follow-up|1|||
127930074|NCT02243293|460366561|FG018|Overall Study|Lost to Follow-up|0|||
127930075|NCT02243293|460366562|FG019|Overall Study|Lost to Follow-up|0|||
127930076|NCT02243293|460366563|FG020|Overall Study|Lost to Follow-up|1|||
127930077|NCT02243293|460366564|FG021|Overall Study|Lost to Follow-up|2|||
127930078|NCT02243293|460366543|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
127930079|NCT02243293|460366544|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
127930080|NCT02243293|460366545|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
127930081|NCT02243293|460366546|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
127930082|NCT02243293|460366547|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
127930083|NCT02243293|460366548|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
127930084|NCT02243293|460366549|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
127930085|NCT02243293|460366550|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
127930086|NCT02243293|460366551|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
127930087|NCT02243293|460366552|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
127930088|NCT02243293|460366553|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
127930089|NCT02243293|460366554|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
127930090|NCT02243293|460366555|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
127930091|NCT02243293|460366556|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
127930092|NCT02243293|460366557|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
127930093|NCT02243293|460366558|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
127930094|NCT02243293|460366559|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
127930095|NCT02243293|460366560|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
127930096|NCT02243293|460366561|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
127930097|NCT02243293|460366562|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
127930098|NCT02243293|460366563|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
127930099|NCT02243293|460366564|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
127930100|NCT02243293|460366543|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
127930101|NCT02243293|460366544|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
127930102|NCT02243293|460366545|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
127930103|NCT02243293|460366546|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
127930104|NCT02243293|460366547|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
127930105|NCT02243293|460366548|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
127930106|NCT02243293|460366549|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
127930107|NCT02243293|460366550|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
127930108|NCT02243293|460366551|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
127930109|NCT02243293|460366552|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
127930110|NCT02243293|460366553|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
127930111|NCT02243293|460366554|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
127930112|NCT02243293|460366555|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
127930113|NCT02243293|460366556|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
127930114|NCT02243293|460366557|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
127930115|NCT02243293|460366558|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
127930116|NCT02243293|460366559|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
127930117|NCT02243293|460366560|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
127930118|NCT02243293|460366561|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
127930119|NCT02243293|460366562|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
127930120|NCT02243293|460366563|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
127930121|NCT02243293|460366564|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
127930122|NCT01118117|460366565|FG000|Overall Study|Death|8|||
127930123|NCT01118117|460366566|FG001|Overall Study|Death|0|||
127930124|NCT01118117|460366565|FG000|Overall Study|Lost to Follow-up|6|||
127930125|NCT01118117|460366566|FG001|Overall Study|Lost to Follow-up|0|||
127930126|NCT01118117|460366565|FG000|Overall Study|Missed 12 Month Visit|7|||
127930127|NCT01118117|460366566|FG001|Overall Study|Missed 12 Month Visit|0|||
127930128|NCT01660022|460366567|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
127930129|NCT01660022|460366568|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
127930130|NCT01660022|460366569|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
127930131|NCT01660022|460366570|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
127930132|NCT01660022|460366571|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
127930133|NCT01660022|460366572|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
127930134|NCT01660022|460366567|FG000|First Sequence (7 Days)|Adverse Event|0|||
127930135|NCT01660022|460366568|FG001|First Sequence (7 Days)|Adverse Event|0|||
127930136|NCT01660022|460366569|FG002|First Sequence (7 Days)|Adverse Event|0|||
127930137|NCT01660022|460366570|FG003|First Sequence (7 Days)|Adverse Event|0|||
127930138|NCT01660022|460366571|FG004|First Sequence (7 Days)|Adverse Event|1|||
127930139|NCT01660022|460366572|FG005|First Sequence (7 Days)|Adverse Event|3|||
127930140|NCT01660022|460366567|FG000|First Sequence (7 Days)|Protocol Violation|0|||
127930141|NCT01660022|460366568|FG001|First Sequence (7 Days)|Protocol Violation|0|||
127930142|NCT01660022|460366569|FG002|First Sequence (7 Days)|Protocol Violation|0|||
127930143|NCT01660022|460366570|FG003|First Sequence (7 Days)|Protocol Violation|0|||
127930144|NCT01660022|460366571|FG004|First Sequence (7 Days)|Protocol Violation|0|||
127930145|NCT01660022|460366572|FG005|First Sequence (7 Days)|Protocol Violation|1|||
127930146|NCT02985879|460366583|FG000|Overall Study|Adverse Event|7|||
127930147|NCT02985879|460366584|FG001|Overall Study|Adverse Event|9|||
127930148|NCT02985879|460366585|FG002|Overall Study|Adverse Event|7|||
127930149|NCT02985879|460366583|FG000|Overall Study|Withdrew consent|6|||
127930150|NCT02985879|460366584|FG001|Overall Study|Withdrew consent|8|||
127930151|NCT02985879|460366585|FG002|Overall Study|Withdrew consent|10|||
127930152|NCT02985879|460366583|FG000|Overall Study|Lost to Follow-up|1|||
127930153|NCT02985879|460366584|FG001|Overall Study|Lost to Follow-up|0|||
127930154|NCT02985879|460366585|FG002|Overall Study|Lost to Follow-up|2|||
127930155|NCT02985879|460366583|FG000|Overall Study|Other, not specified|62|||
127930156|NCT02985879|460366584|FG001|Overall Study|Other, not specified|58|||
127930157|NCT02985879|460366585|FG002|Overall Study|Other, not specified|58|||
127930158|NCT02516410|460368850|FG000|Overall Study|Adverse Event|0|||
127930159|NCT02516410|460368851|FG001|Overall Study|Adverse Event|1|||
127930160|NCT02516410|460368850|FG000|Overall Study|Withdrawal by Subject|0|||
127930161|NCT02516410|460368851|FG001|Overall Study|Withdrawal by Subject|1|||
127930162|NCT01432574|460368852|FG000|Overall Study|Moved|2|||
127930163|NCT01432574|460368852|FG000|Overall Study|Not interested|1|||
127930164|NCT02698865|460368861|FG000|Overall Study|Other|11|||
127930165|NCT02698865|460368862|FG001|Overall Study|Other|11|||
127930166|NCT02698865|460368861|FG000|Overall Study|Withdrawal by Subject|20|||
127930167|NCT02698865|460368862|FG001|Overall Study|Withdrawal by Subject|16|||
127930168|NCT02698865|460368861|FG000|Overall Study|Physician Decision|0|||
127930169|NCT02698865|460368862|FG001|Overall Study|Physician Decision|4|||
127930170|NCT02698865|460368861|FG000|Overall Study|Lost to Follow-up|4|||
127930171|NCT02698865|460368862|FG001|Overall Study|Lost to Follow-up|2|||
127930172|NCT00773734|460368863|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
127930173|NCT00773734|460368864|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
127930174|NCT00773734|460368865|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
127930175|NCT00773734|460368866|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
127930176|NCT00773734|460368867|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
127930177|NCT00773734|460368868|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
127930178|NCT00773734|460368863|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
127930179|NCT00773734|460368864|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
127930180|NCT00773734|460368865|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
127930181|NCT00773734|460368866|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
127930182|NCT00773734|460368867|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
127930183|NCT00773734|460368868|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
127930184|NCT00773734|460368863|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
127930185|NCT00773734|460368864|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
127930186|NCT00773734|460368865|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
127930187|NCT00773734|460368866|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
127930188|NCT00773734|460368867|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
127930189|NCT00773734|460368868|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
127930190|NCT00773734|460368863|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
127930191|NCT00773734|460368864|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
127930192|NCT00773734|460368865|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
127930193|NCT00773734|460368866|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
127930194|NCT00773734|460368867|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
127930195|NCT00773734|460368868|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
127930196|NCT00773734|460368863|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
127930197|NCT00773734|460368864|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
127930198|NCT00773734|460368865|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
127930199|NCT00773734|460368866|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
127930200|NCT00773734|460368867|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
127930201|NCT00773734|460368868|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
127930202|NCT00773734|460368863|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
127930203|NCT00773734|460368864|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
127930204|NCT00773734|460368865|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
127930205|NCT00773734|460368866|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
127930206|NCT00773734|460368867|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
127930207|NCT00773734|460368868|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
127930208|NCT00773734|460368863|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
127930209|NCT00773734|460368864|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
127930210|NCT00773734|460368865|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
127930211|NCT00773734|460368866|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
127930212|NCT00773734|460368867|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
127930213|NCT00773734|460368868|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
127930214|NCT00773734|460368863|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
127930215|NCT00773734|460368864|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
127930216|NCT00773734|460368865|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
127930217|NCT00773734|460368866|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
127930218|NCT00773734|460368867|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
127930219|NCT00773734|460368868|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
127930220|NCT00773734|460368863|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
127930221|NCT00773734|460368864|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
127930222|NCT00773734|460368865|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
127930223|NCT00773734|460368866|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
127930224|NCT00773734|460368867|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
127930225|NCT00773734|460368868|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
127930226|NCT00773734|460368863|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
127930227|NCT00773734|460368864|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
127930228|NCT00773734|460368865|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
127930229|NCT00773734|460368866|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
127930230|NCT00773734|460368867|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
127930231|NCT00773734|460368868|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
127930232|NCT00773734|460368863|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
127930233|NCT00773734|460368864|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
127930234|NCT00773734|460368865|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
127930235|NCT00773734|460368866|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
127930236|NCT00773734|460368867|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
127930237|NCT00773734|460368868|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
127930238|NCT00773734|460368863|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
127930239|NCT00773734|460368864|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
127930240|NCT00773734|460368865|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
127930241|NCT00773734|460368866|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
127930242|NCT00773734|460368867|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
127930243|NCT00773734|460368868|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
127930244|NCT00773734|460368863|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
127930245|NCT00773734|460368864|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
127930246|NCT00773734|460368865|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
127930247|NCT00773734|460368866|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
127930248|NCT00773734|460368867|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
127930249|NCT00773734|460368868|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
127930250|NCT00773734|460368863|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
127930251|NCT00773734|460368864|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
127930252|NCT00773734|460368865|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
127930253|NCT00773734|460368866|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
127930254|NCT00773734|460368867|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
127930255|NCT00773734|460368868|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
127930256|NCT00773734|460368863|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
127930257|NCT00773734|460368864|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
127930258|NCT00773734|460368865|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
127930259|NCT00773734|460368866|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
127930260|NCT00773734|460368867|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
127930261|NCT00773734|460368868|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
127930262|NCT00773734|460368863|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
127930263|NCT00773734|460368864|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
127930264|NCT00773734|460368865|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
127930265|NCT00773734|460368866|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
127930266|NCT00773734|460368867|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
127930267|NCT00773734|460368868|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
127930268|NCT00773734|460368863|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
127930269|NCT00773734|460368864|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
127930270|NCT00773734|460368865|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
127930271|NCT00773734|460368866|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
127930272|NCT00773734|460368867|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
127930273|NCT00773734|460368868|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
127930274|NCT00773734|460368863|FG000|Extension: Active Treatment Week 24-52|Other|0|||
127930275|NCT00773734|460368864|FG001|Extension: Active Treatment Week 24-52|Other|0|||
127930276|NCT00773734|460368865|FG002|Extension: Active Treatment Week 24-52|Other|1|||
127930277|NCT00773734|460368866|FG003|Extension: Active Treatment Week 24-52|Other|2|||
127930278|NCT00773734|460368867|FG004|Extension: Active Treatment Week 24-52|Other|0|||
127930279|NCT00773734|460368868|FG005|Extension: Active Treatment Week 24-52|Other|1|||
127930280|NCT00773734|460368863|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
127930281|NCT00773734|460368864|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
127930282|NCT00773734|460368865|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
127930283|NCT00773734|460368866|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
127930284|NCT00773734|460368867|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
127930285|NCT00773734|460368868|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
127930286|NCT00773734|460368863|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
127930287|NCT00773734|460368864|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
127930288|NCT00773734|460368865|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
127930289|NCT00773734|460368866|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
127930290|NCT00773734|460368867|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
127930291|NCT00773734|460368868|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
127930292|NCT00773734|460368863|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
127930293|NCT00773734|460368864|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
127930294|NCT00773734|460368865|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
127930295|NCT00773734|460368866|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
127930296|NCT00773734|460368867|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
127930297|NCT00773734|460368868|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
127930298|NCT00773734|460368863|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
127930299|NCT00773734|460368864|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
127930300|NCT00773734|460368865|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
127930301|NCT00773734|460368866|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
127930302|NCT00773734|460368867|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
127930303|NCT00773734|460368868|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
127930304|NCT05506358|460368869|FG000|Overall Study|Sickle cell disease with transfusion within 3 months|2|||
127930305|NCT05506358|460368870|FG001|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
127930306|NCT05506358|460368871|FG002|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
127930307|NCT05506358|460368872|FG003|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
127930308|NCT05506358|460368873|FG004|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
127930309|NCT05506358|460368869|FG000|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|2|||
127930310|NCT05506358|460368870|FG001|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
127930311|NCT05506358|460368871|FG002|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
127930312|NCT05506358|460368872|FG003|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
127930313|NCT05506358|460368873|FG004|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
127930314|NCT05506358|460368869|FG000|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
127930315|NCT05506358|460368870|FG001|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
127930316|NCT05506358|460368871|FG002|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
127930317|NCT05506358|460368872|FG003|Overall Study|Beta-thalassemia major with transfusion within 2 months|1|||
127930318|NCT05506358|460368873|FG004|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
127930319|NCT05506358|460368869|FG000|Overall Study|Sample hemolysis observed under the microscope|0|||
127930320|NCT05506358|460368870|FG001|Overall Study|Sample hemolysis observed under the microscope|0|||
127930321|NCT05506358|460368871|FG002|Overall Study|Sample hemolysis observed under the microscope|0|||
127930322|NCT05506358|460368872|FG003|Overall Study|Sample hemolysis observed under the microscope|1|||
127930323|NCT05506358|460368873|FG004|Overall Study|Sample hemolysis observed under the microscope|0|||
127930324|NCT05506358|460368869|FG000|Overall Study|HbE trait|0|||
127930325|NCT05506358|460368870|FG001|Overall Study|HbE trait|0|||
127930326|NCT05506358|460368871|FG002|Overall Study|HbE trait|0|||
127930327|NCT05506358|460368872|FG003|Overall Study|HbE trait|1|||
127930328|NCT05506358|460368873|FG004|Overall Study|HbE trait|0|||
127930329|NCT01659736|460368874|FG000|Treatment Period|Adverse Event|1|||
127930330|NCT01659736|460368875|FG001|Treatment Period|Adverse Event|1|||
127930331|NCT01659736|460368874|FG000|Treatment Period|Protocol Violation|3|||
127930332|NCT01659736|460368875|FG001|Treatment Period|Protocol Violation|1|||
127930333|NCT01659736|460368874|FG000|Treatment Period|Withdrawal by Subject|1|||
127930334|NCT01659736|460368875|FG001|Treatment Period|Withdrawal by Subject|0|||
127930335|NCT01659736|460368874|FG000|3-month Follow-up|Lost to Follow-up|0|||
127930336|NCT01659736|460368875|FG001|3-month Follow-up|Lost to Follow-up|1|||
127930337|NCT02581163|460368883|FG000|Overall Study|Failure to return|15|||
127930338|NCT02581163|460368883|FG000|Overall Study|Insufficient virological response|3|||
127930339|NCT02581163|460368883|FG000|Overall Study|Withdrew consent|1|||
127930340|NCT02581163|460368883|FG000|Overall Study|Death|1|||
127930341|NCT02581163|460368883|FG000|Overall Study|Other, not specified|9|||
127930342|NCT02791893|460368884|FG000|Blinded Phase|Lost to Follow-up|2|||
127930343|NCT02791893|460368885|FG001|Blinded Phase|Lost to Follow-up|2|||
127930344|NCT02791893|460368884|FG000|Blinded Phase|Withdrawal by Subject|1|||
127930345|NCT02791893|460368885|FG001|Blinded Phase|Withdrawal by Subject|2|||
127930346|NCT02791893|460368884|FG000|Open Label Phase|Lost to Follow-up|3|||
127930347|NCT02791893|460368885|FG001|Open Label Phase|Lost to Follow-up|0|||
127930348|NCT02791893|460368884|FG000|Open Label Phase|Withdrawal by Subject|0|||
127930349|NCT02791893|460368885|FG001|Open Label Phase|Withdrawal by Subject|2|||
127930350|NCT03438396|460368886|FG000|Overall Study|Reason Not Specified|9|||
127930351|NCT03438396|460368886|FG000|Overall Study|Withdrawal by Subject|5|||
127930352|NCT03438396|460368886|FG000|Overall Study|Lost to Follow-up|2|||
127930353|NCT03438396|460368886|FG000|Overall Study|Death|85|||
127930354|NCT03438396|460368886|FG000|Overall Study|Not treated|1|||
127930355|NCT00262041|460368887|FG000|Overall Study|Withdrawal by Subject|0|||
127930356|NCT00262041|460368888|FG001|Overall Study|Withdrawal by Subject|3|||
127930357|NCT00262041|460368889|FG002|Overall Study|Withdrawal by Subject|1|||
127930358|NCT00262041|460368887|FG000|Overall Study|Lost to Follow-up|1|||
127930359|NCT00262041|460368888|FG001|Overall Study|Lost to Follow-up|1|||
127930360|NCT00262041|460368889|FG002|Overall Study|Lost to Follow-up|5|||
127930361|NCT00262041|460368887|FG000|Overall Study|Unable to classify|1|||
127930362|NCT00262041|460368888|FG001|Overall Study|Unable to classify|0|||
127930363|NCT00262041|460368889|FG002|Overall Study|Unable to classify|0|||
127930364|NCT01421342|460368890|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
127930365|NCT01421342|460368891|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
127930366|NCT01421342|460368892|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
127930367|NCT01421342|460368890|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
127930368|NCT01421342|460368891|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
127930369|NCT01421342|460368892|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
127930370|NCT01421342|460368890|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
127930371|NCT01421342|460368891|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
127930372|NCT01421342|460368892|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
127930373|NCT01421342|460368890|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
127930374|NCT01421342|460368891|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
127930375|NCT01421342|460368892|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
127930376|NCT01421342|460368890|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
127930377|NCT01421342|460368891|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
127930378|NCT01421342|460368892|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
127930379|NCT01421342|460368890|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
127930380|NCT01421342|460368891|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
127930381|NCT01421342|460368892|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
127930382|NCT01421342|460368890|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
127930383|NCT01421342|460368891|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
127930384|NCT01421342|460368892|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
127930385|NCT01421342|460368890|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
127930386|NCT01421342|460368891|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
127930387|NCT01421342|460368892|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
127930388|NCT01421342|460368890|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
127930389|NCT01421342|460368891|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
127930390|NCT01421342|460368892|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
127930391|NCT01421342|460368890|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
127930392|NCT01421342|460368891|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
127930393|NCT01421342|460368892|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
127930394|NCT01421342|460368890|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
127930395|NCT01421342|460368891|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
127930396|NCT01421342|460368892|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
127930397|NCT01421342|460368890|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
127930398|NCT01421342|460368891|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
127930399|NCT01421342|460368892|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
127930400|NCT01421342|460368890|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
127930401|NCT01421342|460368891|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
127930402|NCT01421342|460368892|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
127930403|NCT01421342|460368890|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
127930404|NCT01421342|460368891|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
127930405|NCT01421342|460368892|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
127930406|NCT01421342|460368890|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
127930407|NCT01421342|460368891|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
127930408|NCT01421342|460368892|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
127930409|NCT01421342|460368890|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
127930410|NCT01421342|460368891|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
127930411|NCT01421342|460368892|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
127930412|NCT01421342|460368890|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
127930413|NCT01421342|460368891|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
127930414|NCT01421342|460368892|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
127930415|NCT01421342|460368890|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
127930416|NCT01421342|460368891|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
127930417|NCT01421342|460368892|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
127930418|NCT01421342|460368890|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
127930419|NCT01421342|460368891|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
127930420|NCT01421342|460368892|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
127930421|NCT01421342|460368890|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
127930422|NCT01421342|460368891|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
127930423|NCT01421342|460368892|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
127930424|NCT01421342|460368890|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
127930425|NCT01421342|460368891|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
127930426|NCT01421342|460368892|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
127930427|NCT01421342|460368890|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
127930428|NCT01421342|460368891|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
127930429|NCT01421342|460368892|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
127930430|NCT01421342|460368890|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
127930431|NCT01421342|460368891|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
127930432|NCT01421342|460368892|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
127930433|NCT01421342|460368890|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
127930434|NCT01421342|460368891|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
127930435|NCT01421342|460368892|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
127930436|NCT01421342|460368890|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
127930437|NCT01421342|460368891|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
127930438|NCT01421342|460368892|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
127930439|NCT01421342|460368890|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
127930440|NCT01421342|460368891|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
127930441|NCT01421342|460368892|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
127930442|NCT01421342|460368890|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
127930443|NCT01421342|460368891|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
127930444|NCT01421342|460368892|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
127930445|NCT01421342|460368890|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
127930446|NCT01421342|460368891|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
127930447|NCT01421342|460368892|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
127930448|NCT02384941|460368895|FG000|Overall Study|Adverse Event|11|||
127930449|NCT02384941|460368896|FG001|Overall Study|Adverse Event|13|||
127930450|NCT02384941|460368897|FG002|Overall Study|Adverse Event|17|||
127930451|NCT02384941|460368895|FG000|Overall Study|Lost to Follow-up|3|||
127930452|NCT02384941|460368896|FG001|Overall Study|Lost to Follow-up|2|||
127930453|NCT02384941|460368897|FG002|Overall Study|Lost to Follow-up|1|||
127930454|NCT02384941|460368895|FG000|Overall Study|Non-Compliance With Study Drug|2|||
127930455|NCT02384941|460368896|FG001|Overall Study|Non-Compliance With Study Drug|0|||
127930456|NCT02384941|460368897|FG002|Overall Study|Non-Compliance With Study Drug|1|||
127930457|NCT02384941|460368895|FG000|Overall Study|Physician Decision|1|||
127930458|NCT02384941|460368896|FG001|Overall Study|Physician Decision|1|||
127930459|NCT02384941|460368897|FG002|Overall Study|Physician Decision|0|||
127930460|NCT02384941|460368895|FG000|Overall Study|Protocol Violation|3|||
127930461|NCT02384941|460368896|FG001|Overall Study|Protocol Violation|0|||
127930462|NCT02384941|460368897|FG002|Overall Study|Protocol Violation|0|||
127930463|NCT02384941|460368895|FG000|Overall Study|Withdrawal by Subject|26|||
127930464|NCT02384941|460368896|FG001|Overall Study|Withdrawal by Subject|19|||
127930465|NCT02384941|460368897|FG002|Overall Study|Withdrawal by Subject|20|||
127930466|NCT02384941|460368895|FG000|Overall Study|Pregnancy|0|||
127930467|NCT02384941|460368896|FG001|Overall Study|Pregnancy|0|||
127930468|NCT02384941|460368897|FG002|Overall Study|Pregnancy|1|||
127930469|NCT02384941|460368895|FG000|Overall Study|Other than specified above|4|||
127930470|NCT02384941|460368896|FG001|Overall Study|Other than specified above|0|||
127930471|NCT02384941|460368897|FG002|Overall Study|Other than specified above|1|||
127930472|NCT00252174|460368900|FG000|Overall Study|Withdrawal by Subject|0|||
127930473|NCT00252174|460368901|FG001|Overall Study|Withdrawal by Subject|1|||
127930474|NCT00252174|460368902|FG002|Overall Study|Withdrawal by Subject|0|||
127930475|NCT00351351|460368905|FG000|Overall Study|surgical access pbs; device issues|9|||
127930476|NCT00351351|460368906|FG001|Overall Study|surgical access pbs; device issues|4|||
127930477|NCT02990806|460368907|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
127930478|NCT02990806|460368908|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
127930479|NCT02990806|460368909|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
127930480|NCT02990806|460368910|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
127930481|NCT02990806|460368907|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
127930482|NCT02990806|460368908|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
127930483|NCT02990806|460368909|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
127930484|NCT02990806|460368910|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
127930485|NCT02990806|460368907|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
127930486|NCT02990806|460368908|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
127930487|NCT02990806|460368909|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
127930488|NCT02990806|460368910|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
127930489|NCT02990806|460368907|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
127930490|NCT02990806|460368908|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
127930491|NCT02990806|460368909|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
127930492|NCT02990806|460368910|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
127930493|NCT02990806|460368907|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
127930494|NCT02990806|460368908|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
127930495|NCT02990806|460368909|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
127930496|NCT02990806|460368910|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
127930497|NCT02990806|460368907|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
127930498|NCT02990806|460368908|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
127930499|NCT02990806|460368909|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
127930500|NCT02990806|460368910|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
127930501|NCT02990806|460368907|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
127930502|NCT02990806|460368908|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
127930503|NCT02990806|460368909|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
127930504|NCT02990806|460368910|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
127930505|NCT02990806|460368907|FG000|Stage 1 (22 Weeks)|Death|0|||
127930506|NCT02990806|460368908|FG001|Stage 1 (22 Weeks)|Death|1|||
127930507|NCT02990806|460368909|FG002|Stage 1 (22 Weeks)|Death|0|||
127930508|NCT02990806|460368910|FG003|Stage 1 (22 Weeks)|Death|0|||
127930509|NCT02990806|460368907|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
127930510|NCT02990806|460368908|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
127930511|NCT02990806|460368909|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
127930512|NCT02990806|460368910|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
127930513|NCT02990806|460368907|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
127930514|NCT02990806|460368908|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
127930515|NCT02990806|460368909|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
127930516|NCT02990806|460368910|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
127930517|NCT02990806|460368907|FG000|Stage 1 (22 Weeks)|Other|1|||
127930518|NCT02990806|460368908|FG001|Stage 1 (22 Weeks)|Other|3|||
127930519|NCT02990806|460368909|FG002|Stage 1 (22 Weeks)|Other|0|||
127930520|NCT02990806|460368910|FG003|Stage 1 (22 Weeks)|Other|0|||
127930521|NCT02990806|460368907|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
127930522|NCT02990806|460368908|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
127930523|NCT02990806|460368909|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
127930524|NCT02990806|460368910|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
127930525|NCT02990806|460368907|FG000|Stage 2 (32 Weeks)|Death|1|||
127930526|NCT02990806|460368908|FG001|Stage 2 (32 Weeks)|Death|0|||
127930527|NCT02990806|460368909|FG002|Stage 2 (32 Weeks)|Death|0|||
127930528|NCT02990806|460368910|FG003|Stage 2 (32 Weeks)|Death|0|||
127930529|NCT02990806|460368907|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
127930530|NCT02990806|460368908|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
127930531|NCT02990806|460368909|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
127930532|NCT02990806|460368910|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
127930533|NCT02990806|460368907|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
127930534|NCT02990806|460368908|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
127930535|NCT02990806|460368909|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
127930536|NCT02990806|460368910|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
127930537|NCT02990806|460368907|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
127930538|NCT02990806|460368908|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
127930539|NCT02990806|460368909|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
127930540|NCT02990806|460368910|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
127930541|NCT02990806|460368907|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
127930542|NCT02990806|460368908|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
127930543|NCT02990806|460368909|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
127930544|NCT02990806|460368910|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
127930545|NCT02990806|460368907|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
127930546|NCT02990806|460368908|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
127930547|NCT02990806|460368909|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
127930548|NCT02990806|460368910|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
127930549|NCT02990806|460368907|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
127930550|NCT02990806|460368908|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
127930551|NCT02990806|460368909|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
127930552|NCT02990806|460368910|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
127930553|NCT02990806|460368907|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
127930554|NCT02990806|460368908|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
127930555|NCT02990806|460368909|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
127930556|NCT02990806|460368910|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
127930557|NCT02990806|460368907|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
127930558|NCT02990806|460368908|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
127930559|NCT02990806|460368909|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
127930560|NCT02990806|460368910|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
127930561|NCT02990806|460368907|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
127930562|NCT02990806|460368908|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
127930563|NCT02990806|460368909|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
127930564|NCT02990806|460368910|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
127930565|NCT02990806|460368907|FG000|Stage 2 (32 Weeks)|Other|3|||
127930566|NCT02990806|460368908|FG001|Stage 2 (32 Weeks)|Other|0|||
127930567|NCT02990806|460368909|FG002|Stage 2 (32 Weeks)|Other|4|||
127930568|NCT02990806|460368910|FG003|Stage 2 (32 Weeks)|Other|1|||
127930569|NCT02990806|460368907|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
127930570|NCT02990806|460368908|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
127930571|NCT02990806|460368909|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
127930572|NCT02990806|460368910|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
127930573|NCT02990806|460368907|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
127930574|NCT02990806|460368908|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
127930575|NCT02990806|460368909|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
127930576|NCT02990806|460368910|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
127930577|NCT02990806|460368907|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
127930578|NCT02990806|460368908|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
127930579|NCT02990806|460368909|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
127930580|NCT02990806|460368910|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
127930581|NCT02990806|460368907|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
127930582|NCT02990806|460368908|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
127930583|NCT02990806|460368909|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
127930584|NCT02990806|460368910|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
127930585|NCT02990806|460368907|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
127930586|NCT02990806|460368908|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
127930587|NCT02990806|460368909|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
127930588|NCT02990806|460368910|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
127930589|NCT02990806|460368907|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
127930590|NCT02990806|460368908|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
127930591|NCT02990806|460368909|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
127930592|NCT02990806|460368910|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
127930593|NCT02990806|460368907|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
127930594|NCT02990806|460368908|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
127930595|NCT02990806|460368909|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
127930596|NCT02990806|460368910|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
127930597|NCT02990806|460368907|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
127930598|NCT02990806|460368908|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
127930599|NCT02990806|460368909|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
127930600|NCT02990806|460368910|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
127930601|NCT02990806|460368907|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
127930602|NCT02990806|460368908|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
127930603|NCT02990806|460368909|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
127930604|NCT02990806|460368910|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
127930605|NCT01825837|460368912|FG000|PART I|Withdrawal by Subject|0|||
127930606|NCT01825837|460368913|FG001|PART I|Withdrawal by Subject|0|||
127930607|NCT01825837|460368914|FG002|PART I|Withdrawal by Subject|0|||
127930608|NCT01825837|460368915|FG003|PART I|Withdrawal by Subject|6|||
127930609|NCT01825837|460368912|FG000|PART I|Patient non-compliance|0|||
127930610|NCT01825837|460368913|FG001|PART I|Patient non-compliance|0|||
127930611|NCT01825837|460368914|FG002|PART I|Patient non-compliance|0|||
127930612|NCT01825837|460368915|FG003|PART I|Patient non-compliance|1|||
127930613|NCT01825837|460368912|FG000|PART I|Treatment failure|0|||
127930614|NCT01825837|460368913|FG001|PART I|Treatment failure|0|||
127930615|NCT01825837|460368914|FG002|PART I|Treatment failure|0|||
127930616|NCT01825837|460368915|FG003|PART I|Treatment failure|7|||
127930617|NCT01825837|460368912|FG000|PART I|reason unspecified|0|||
127930618|NCT01825837|460368913|FG001|PART I|reason unspecified|0|||
127930619|NCT01825837|460368914|FG002|PART I|reason unspecified|0|||
127930620|NCT01825837|460368915|FG003|PART I|reason unspecified|3|||
127930621|NCT01825837|460368912|FG000|PART II|Withdrawal by Subject|3|||
127930622|NCT01825837|460368913|FG001|PART II|Withdrawal by Subject|3|||
127930623|NCT01825837|460368914|FG002|PART II|Withdrawal by Subject|7|||
127930624|NCT01825837|460368915|FG003|PART II|Withdrawal by Subject|0|||
127930625|NCT01825837|460368912|FG000|PART II|Patient non-compliance|5|||
127930626|NCT01825837|460368913|FG001|PART II|Patient non-compliance|2|||
127930627|NCT01825837|460368914|FG002|PART II|Patient non-compliance|4|||
127930628|NCT01825837|460368915|FG003|PART II|Patient non-compliance|0|||
127930629|NCT01825837|460368912|FG000|PART II|Adverse Event|3|||
127930630|NCT01825837|460368913|FG001|PART II|Adverse Event|3|||
127930631|NCT01825837|460368914|FG002|PART II|Adverse Event|1|||
127930632|NCT01825837|460368915|FG003|PART II|Adverse Event|0|||
127930633|NCT01825837|460368912|FG000|PART II|Treatment failure|6|||
127930634|NCT01825837|460368913|FG001|PART II|Treatment failure|4|||
127930635|NCT01825837|460368914|FG002|PART II|Treatment failure|5|||
127930636|NCT01825837|460368915|FG003|PART II|Treatment failure|0|||
127930637|NCT01825837|460368912|FG000|PART II|reason unspecified|2|||
127930638|NCT01825837|460368913|FG001|PART II|reason unspecified|2|||
127930639|NCT01825837|460368914|FG002|PART II|reason unspecified|2|||
127930640|NCT01825837|460368915|FG003|PART II|reason unspecified|0|||
127930641|NCT00904748|460368916|FG000|Overall Study|Withdrawal by Subject|1|||
127930642|NCT00904748|460368917|FG001|Overall Study|Withdrawal by Subject|1|||
127930643|NCT00904748|460368918|FG002|Overall Study|Withdrawal by Subject|1|||
127930644|NCT00904748|460368919|FG003|Overall Study|Withdrawal by Subject|2|||
127930645|NCT00904748|460368920|FG004|Overall Study|Withdrawal by Subject|0|||
127930646|NCT00904748|460368921|FG005|Overall Study|Withdrawal by Subject|0|||
127930647|NCT00904748|460368916|FG000|Overall Study|Adverse Event|0|||
127930648|NCT00904748|460368917|FG001|Overall Study|Adverse Event|0|||
127930649|NCT00904748|460368918|FG002|Overall Study|Adverse Event|0|||
127930650|NCT00904748|460368919|FG003|Overall Study|Adverse Event|0|||
127930651|NCT00904748|460368920|FG004|Overall Study|Adverse Event|1|||
127930652|NCT00904748|460368921|FG005|Overall Study|Adverse Event|0|||
127930653|NCT04403763|460368925|FG000|Stage 1|Participant did not dose due to Sponsor decision|1|||
127930654|NCT04403763|460368926|FG001|Stage 1|Participant did not dose due to Sponsor decision|1|||
127930655|NCT04403763|460368927|FG002|Stage 1|Participant did not dose due to Sponsor decision|0|||
127930656|NCT04403763|460368928|FG003|Stage 1|Participant did not dose due to Sponsor decision|0|||
127930657|NCT04403763|460368929|FG004|Stage 1|Participant did not dose due to Sponsor decision|0|||
127930658|NCT04403763|460368930|FG005|Stage 1|Participant did not dose due to Sponsor decision|0|||
127930659|NCT04403763|460368931|FG006|Stage 1|Participant did not dose due to Sponsor decision|0|||
127930660|NCT04403763|460368925|FG000|Stage 1|Early termination due to PK tube failure|0|||
127930661|NCT04403763|460368926|FG001|Stage 1|Early termination due to PK tube failure|0|||
127930662|NCT04403763|460368927|FG002|Stage 1|Early termination due to PK tube failure|1|||
127930663|NCT04403763|460368928|FG003|Stage 1|Early termination due to PK tube failure|0|||
127930664|NCT04403763|460368929|FG004|Stage 1|Early termination due to PK tube failure|0|||
127930665|NCT04403763|460368930|FG005|Stage 1|Early termination due to PK tube failure|0|||
127930666|NCT04403763|460368931|FG006|Stage 1|Early termination due to PK tube failure|0|||
127930667|NCT04403763|460368925|FG000|Stage 2A|Adverse Event|0|||
127930668|NCT04403763|460368926|FG001|Stage 2A|Adverse Event|0|||
127930669|NCT04403763|460368927|FG002|Stage 2A|Adverse Event|0|||
127930670|NCT04403763|460368928|FG003|Stage 2A|Adverse Event|0|||
127930671|NCT04403763|460368929|FG004|Stage 2A|Adverse Event|0|||
127930672|NCT04403763|460368930|FG005|Stage 2A|Adverse Event|0|||
127930673|NCT04403763|460368931|FG006|Stage 2A|Adverse Event|1|||
127930674|NCT02470091|460368932|FG000|Overall Study|Withdrawal by Subject|1|||
127930675|NCT02470091|460368933|FG001|Overall Study|Withdrawal by Subject|0|||
127930676|NCT02470091|460368932|FG000|Overall Study|Ineligible|0|||
127930677|NCT02470091|460368933|FG001|Overall Study|Ineligible|2|||
127930678|NCT02903238|460368936|FG000|Overall Study|Lost to Follow-up|4|||
127930679|NCT00700817|460368940|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
127930680|NCT00700817|460368941|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
127930681|NCT00700817|460368942|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
127930682|NCT00700817|460368943|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
127930683|NCT00700817|460368944|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
127930684|NCT00700817|460368940|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
127930685|NCT00700817|460368941|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
127930686|NCT00700817|460368942|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
127930687|NCT00700817|460368943|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
127930688|NCT00700817|460368944|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
127930689|NCT00700817|460368940|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
127930690|NCT00700817|460368941|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
127930691|NCT00700817|460368942|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
127930692|NCT00700817|460368943|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
127930693|NCT00700817|460368944|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
127930694|NCT00700817|460368940|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
127930695|NCT00700817|460368941|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
127930696|NCT00700817|460368942|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
127930697|NCT00700817|460368943|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
127930698|NCT00700817|460368944|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
127930699|NCT00700817|460368940|FG000|Week 0-26 (Main Period)|Unclassified|14|||
127930700|NCT00700817|460368941|FG001|Week 0-26 (Main Period)|Unclassified|4|||
127930701|NCT00700817|460368942|FG002|Week 0-26 (Main Period)|Unclassified|8|||
127930702|NCT00700817|460368943|FG003|Week 0-26 (Main Period)|Unclassified|0|||
127930703|NCT00700817|460368944|FG004|Week 0-26 (Main Period)|Unclassified|0|||
127930704|NCT00700817|460368940|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
127930705|NCT00700817|460368941|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
127930706|NCT00700817|460368942|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
127930707|NCT00700817|460368943|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
127930708|NCT00700817|460368944|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
127930709|NCT00700817|460368940|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
127930710|NCT00700817|460368941|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
127930711|NCT00700817|460368942|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
127930712|NCT00700817|460368943|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
127930713|NCT00700817|460368944|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
127930714|NCT00700817|460368940|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
127930715|NCT00700817|460368941|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
127930716|NCT00700817|460368942|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
127930717|NCT00700817|460368943|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
127930718|NCT00700817|460368944|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
127930719|NCT00700817|460368940|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
127930720|NCT00700817|460368941|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
127930721|NCT00700817|460368942|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
127930722|NCT00700817|460368943|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
127930723|NCT00700817|460368944|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
127930724|NCT00700817|460368940|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
127930725|NCT00700817|460368941|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
127930726|NCT00700817|460368942|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
127930727|NCT00700817|460368943|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
127930728|NCT00700817|460368944|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
127930729|NCT00700817|460368940|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
127930730|NCT00700817|460368941|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
127930731|NCT00700817|460368942|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
127930732|NCT00700817|460368943|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
127930733|NCT00700817|460368944|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
127930734|NCT00700817|460368940|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
127930735|NCT00700817|460368941|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
127930736|NCT00700817|460368942|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
127930737|NCT00700817|460368943|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
127930738|NCT00700817|460368944|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
127930739|NCT00700817|460368940|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
127930740|NCT00700817|460368941|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
127930741|NCT00700817|460368942|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
127930742|NCT00700817|460368943|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
127930743|NCT00700817|460368944|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
127930744|NCT00700817|460368940|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
127930745|NCT00700817|460368941|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
127930746|NCT00700817|460368942|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
127930747|NCT00700817|460368943|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
127930748|NCT00700817|460368944|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
127930749|NCT00700817|460368940|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
127930750|NCT00700817|460368941|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
127930751|NCT00700817|460368942|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
127930752|NCT00700817|460368943|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
127930753|NCT00700817|460368944|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
127930754|NCT00767520|460368945|FG000|Overall Study|Participants still on treatment|11|||
127930755|NCT00767520|460368946|FG001|Overall Study|Participants still on treatment|15|||
127930756|NCT00767520|460368945|FG000|Overall Study|Randomized in error and Never treated|0|||
127930757|NCT00767520|460368946|FG001|Overall Study|Randomized in error and Never treated|2|||
127930758|NCT00958126|460368949|FG000|Overall Study|Serious Adverse Event|0|||
127930759|NCT00958126|460368950|FG001|Overall Study|Serious Adverse Event|2|||
127930760|NCT00958126|460368951|FG002|Overall Study|Serious Adverse Event|0|||
127930761|NCT00958126|460368952|FG003|Overall Study|Serious Adverse Event|0|||
127930762|NCT00958126|460368953|FG004|Overall Study|Serious Adverse Event|0|||
127930763|NCT00958126|460368954|FG005|Overall Study|Serious Adverse Event|0|||
127930764|NCT00958126|460368955|FG006|Overall Study|Serious Adverse Event|1|||
127930765|NCT00958126|460368956|FG007|Overall Study|Serious Adverse Event|0|||
127930766|NCT00958126|460368949|FG000|Overall Study|Withdrawal by Subject|0|||
127930767|NCT00958126|460368950|FG001|Overall Study|Withdrawal by Subject|2|||
127930768|NCT00958126|460368951|FG002|Overall Study|Withdrawal by Subject|0|||
127930769|NCT00958126|460368952|FG003|Overall Study|Withdrawal by Subject|0|||
127930770|NCT00958126|460368953|FG004|Overall Study|Withdrawal by Subject|0|||
127930771|NCT00958126|460368954|FG005|Overall Study|Withdrawal by Subject|0|||
127930772|NCT00958126|460368955|FG006|Overall Study|Withdrawal by Subject|0|||
127930773|NCT00958126|460368956|FG007|Overall Study|Withdrawal by Subject|0|||
127930774|NCT00958126|460368949|FG000|Overall Study|Moved away from study area|0|||
127930775|NCT00958126|460368950|FG001|Overall Study|Moved away from study area|0|||
127930776|NCT00958126|460368951|FG002|Overall Study|Moved away from study area|1|||
127930777|NCT00958126|460368952|FG003|Overall Study|Moved away from study area|1|||
127930778|NCT00958126|460368953|FG004|Overall Study|Moved away from study area|0|||
127930779|NCT00958126|460368954|FG005|Overall Study|Moved away from study area|0|||
127930780|NCT00958126|460368955|FG006|Overall Study|Moved away from study area|0|||
127930781|NCT00958126|460368956|FG007|Overall Study|Moved away from study area|0|||
127930782|NCT00958126|460368949|FG000|Overall Study|Lost to Follow-up|1|||
127930783|NCT00958126|460368950|FG001|Overall Study|Lost to Follow-up|5|||
127930784|NCT00958126|460368951|FG002|Overall Study|Lost to Follow-up|9|||
127930785|NCT00958126|460368952|FG003|Overall Study|Lost to Follow-up|8|||
127930786|NCT00958126|460368953|FG004|Overall Study|Lost to Follow-up|0|||
127930787|NCT00958126|460368954|FG005|Overall Study|Lost to Follow-up|0|||
127930788|NCT00958126|460368955|FG006|Overall Study|Lost to Follow-up|0|||
127930789|NCT00958126|460368956|FG007|Overall Study|Lost to Follow-up|0|||
127930790|NCT00958126|460368949|FG000|Overall Study|Sponsor/Investigator decision|0|||
127930791|NCT00958126|460368950|FG001|Overall Study|Sponsor/Investigator decision|0|||
127930792|NCT00958126|460368951|FG002|Overall Study|Sponsor/Investigator decision|0|||
127930793|NCT00958126|460368952|FG003|Overall Study|Sponsor/Investigator decision|1|||
127930794|NCT00958126|460368953|FG004|Overall Study|Sponsor/Investigator decision|0|||
127930795|NCT00958126|460368954|FG005|Overall Study|Sponsor/Investigator decision|0|||
127930796|NCT00958126|460368955|FG006|Overall Study|Sponsor/Investigator decision|0|||
127930797|NCT00958126|460368956|FG007|Overall Study|Sponsor/Investigator decision|0|||
127930798|NCT00958126|460368949|FG000|Overall Study|Other Reason|0|||
127930799|NCT00958126|460368950|FG001|Overall Study|Other Reason|0|||
127930800|NCT00958126|460368951|FG002|Overall Study|Other Reason|0|||
127930801|NCT00958126|460368952|FG003|Overall Study|Other Reason|1|||
127930802|NCT00958126|460368953|FG004|Overall Study|Other Reason|0|||
127930803|NCT00958126|460368954|FG005|Overall Study|Other Reason|1|||
127930804|NCT00958126|460368955|FG006|Overall Study|Other Reason|0|||
127930805|NCT00958126|460368956|FG007|Overall Study|Other Reason|0|||
127930806|NCT00720226|460368957|FG000|Overall Study|Withdrawal by Subject|7|||
127930807|NCT00720226|460368958|FG001|Overall Study|Withdrawal by Subject|4|||
127930808|NCT03401073|460368961|FG000|Overall Study|Lost to Follow-up|1|||
127930809|NCT03401073|460368962|FG001|Overall Study|Lost to Follow-up|2|||
127930810|NCT00733369|460368963|FG000|Overall Study|Lost to Follow-up|2|||
127930811|NCT00733369|460368964|FG001|Overall Study|Lost to Follow-up|1|||
127930812|NCT00733369|460368963|FG000|Overall Study|Adverse Event|4|||
127930813|NCT00733369|460368964|FG001|Overall Study|Adverse Event|4|||
127930814|NCT00733369|460368963|FG000|Overall Study|Protocol Violation|4|||
127930815|NCT00733369|460368964|FG001|Overall Study|Protocol Violation|4|||
127930816|NCT01470612|460368968|FG000|Overall Study|Adverse Event|20|||
127930817|NCT01470612|460368969|FG001|Overall Study|Adverse Event|80|||
127930818|NCT01470612|460368968|FG000|Overall Study|Death|0|||
127930819|NCT01470612|460368969|FG001|Overall Study|Death|1|||
127930820|NCT01470612|460368968|FG000|Overall Study|Lack of Efficacy|20|||
127930821|NCT01470612|460368969|FG001|Overall Study|Lack of Efficacy|326|||
127930822|NCT01470612|460368968|FG000|Overall Study|Lost to Follow-up|2|||
127930823|NCT01470612|460368969|FG001|Overall Study|Lost to Follow-up|5|||
127930824|NCT01470612|460368968|FG000|Overall Study|Did not meet entrance criteria|0|||
127930825|NCT01470612|460368969|FG001|Overall Study|Did not meet entrance criteria|1|||
127930826|NCT01470612|460368968|FG000|Overall Study|Pregnancy|2|||
127930827|NCT01470612|460368969|FG001|Overall Study|Pregnancy|10|||
127930828|NCT01470612|460368968|FG000|Overall Study|Protocol Violation|2|||
127930829|NCT01470612|460368969|FG001|Overall Study|Protocol Violation|7|||
127930830|NCT01470612|460368968|FG000|Overall Study|Withdrawal by Subject|24|||
127930831|NCT01470612|460368969|FG001|Overall Study|Withdrawal by Subject|79|||
127930832|NCT01470612|460368968|FG000|Overall Study|Other|14|||
127930833|NCT01470612|460368969|FG001|Overall Study|Other|156|||
127930834|NCT02510014|460368973|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
127930835|NCT02510014|460368974|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
127930836|NCT02510014|460368973|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
127930837|NCT02510014|460368974|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
127930838|NCT02510014|460368973|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
127930839|NCT02510014|460368974|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
127930840|NCT02510014|460368973|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
127930841|NCT02510014|460368974|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
127930842|NCT02510014|460368973|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
127930843|NCT02510014|460368974|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
127930844|NCT02510014|460368973|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
127930845|NCT02510014|460368974|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
127930846|NCT02510014|460368973|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
127930847|NCT02510014|460368974|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
127930848|NCT02510014|460368973|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
127930849|NCT02510014|460368974|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
127930850|NCT02510014|460368973|FG000|Treatment Period|Adverse Event|11|||
127930851|NCT02510014|460368974|FG001|Treatment Period|Adverse Event|4|||
127930852|NCT02510014|460368973|FG000|Treatment Period|Withdrawal symptoms|3|||
127930853|NCT02510014|460368974|FG001|Treatment Period|Withdrawal symptoms|0|||
127930854|NCT02510014|460368973|FG000|Treatment Period|Lost to Follow-up|80|||
127930855|NCT02510014|460368974|FG001|Treatment Period|Lost to Follow-up|19|||
127930856|NCT02510014|460368973|FG000|Treatment Period|Physician Decision|5|||
127930857|NCT02510014|460368974|FG001|Treatment Period|Physician Decision|0|||
127930858|NCT02510014|460368973|FG000|Treatment Period|Withdrawal by Subject|67|||
127930859|NCT02510014|460368974|FG001|Treatment Period|Withdrawal by Subject|24|||
127930860|NCT02510014|460368973|FG000|Treatment Period|Withdrawn by the investigator|7|||
127930861|NCT02510014|460368974|FG001|Treatment Period|Withdrawn by the investigator|1|||
127930862|NCT02510014|460368973|FG000|Treatment Period|Protocol Violation|4|||
127930863|NCT02510014|460368974|FG001|Treatment Period|Protocol Violation|4|||
127930864|NCT02510014|460368973|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
127930865|NCT02510014|460368974|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
127930866|NCT02556307|460368978|FG000|Overall Study|Premature treatment interruption|11|||
127930867|NCT02556307|460368978|FG000|Overall Study|Lost to Follow-up|36|||
127930868|NCT02556307|460368978|FG000|Overall Study|Change to triple therapy|4|||
127930869|NCT02556307|460368978|FG000|Overall Study|Enrolled but not treated|2|||
127930870|NCT00384176|460368982|FG000|Overall Study|Death|239|||
127930871|NCT00384176|460368983|FG001|Overall Study|Death|247|||
127930872|NCT00384176|460368984|FG002|Overall Study|Death|105|||
127930873|NCT00384176|460368982|FG000|Overall Study|Withdrawal by Subject|52|||
127930874|NCT00384176|460368983|FG001|Overall Study|Withdrawal by Subject|48|||
127930875|NCT00384176|460368984|FG002|Overall Study|Withdrawal by Subject|22|||
127930876|NCT00384176|460368982|FG000|Overall Study|Lost to Follow-up|16|||
127930877|NCT00384176|460368983|FG001|Overall Study|Lost to Follow-up|18|||
127930878|NCT00384176|460368984|FG002|Overall Study|Lost to Follow-up|4|||
127930879|NCT00384176|460368982|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
127930880|NCT00384176|460368983|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
127930881|NCT00384176|460368984|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
127930882|NCT00384176|460368982|FG000|Overall Study|Longer QTC as Visit 1|1|||
127930883|NCT00384176|460368983|FG001|Overall Study|Longer QTC as Visit 1|0|||
127930884|NCT00384176|460368984|FG002|Overall Study|Longer QTC as Visit 1|0|||
127930885|NCT00384176|460368982|FG000|Overall Study|Toxicity of treatment|1|||
127930886|NCT00384176|460368983|FG001|Overall Study|Toxicity of treatment|0|||
127930887|NCT00384176|460368984|FG002|Overall Study|Toxicity of treatment|0|||
127930888|NCT00384176|460368982|FG000|Overall Study|Did not receive study treatment|0|||
127930889|NCT00384176|460368983|FG001|Overall Study|Did not receive study treatment|1|||
127930890|NCT00384176|460368984|FG002|Overall Study|Did not receive study treatment|1|||
127930891|NCT00384176|460368982|FG000|Overall Study|Physician Decision|0|||
127930892|NCT00384176|460368983|FG001|Overall Study|Physician Decision|2|||
127930893|NCT00384176|460368984|FG002|Overall Study|Physician Decision|0|||
127930894|NCT00384176|460368982|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
127930895|NCT00384176|460368983|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
127930896|NCT00384176|460368984|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
127930897|NCT00049842|460368985|FG000|Treatment Phase|Adverse Event|47|||
127930898|NCT00049842|460368986|FG001|Treatment Phase|Adverse Event|12|||
127930899|NCT00049842|460368985|FG000|Treatment Phase|Withdrawal by Subject|35|||
127930900|NCT00049842|460368986|FG001|Treatment Phase|Withdrawal by Subject|46|||
127930901|NCT00049842|460368985|FG000|Treatment Phase|Non-compliance with protocol|7|||
127930902|NCT00049842|460368986|FG001|Treatment Phase|Non-compliance with protocol|8|||
127930903|NCT00049842|460368985|FG000|Treatment Phase|Lost to Follow-up|4|||
127930904|NCT00049842|460368986|FG001|Treatment Phase|Lost to Follow-up|8|||
127930905|NCT00049842|460368985|FG000|Treatment Phase|Administrative|0|||
127930906|NCT00049842|460368986|FG001|Treatment Phase|Administrative|3|||
127930907|NCT00049842|460368985|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
127930908|NCT00049842|460368986|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
127930909|NCT00049842|460368985|FG000|Follow-up Phase|Adverse Event|6|||
127930910|NCT00049842|460368986|FG001|Follow-up Phase|Adverse Event|1|||
127930911|NCT00049842|460368985|FG000|Follow-up Phase|Other|1|||
127930912|NCT00049842|460368986|FG001|Follow-up Phase|Other|4|||
127930913|NCT00307931|460368987|FG000|Overall Study|Adverse Event|1|||
127930914|NCT00854373|460368988|FG000|Overall Study|Withdrawal by Subject|1|||
127930915|NCT00854373|460368989|FG001|Overall Study|Withdrawal by Subject|3|||
127930916|NCT00854373|460368988|FG000|Overall Study|Forgot to take study drug|1|||
127930917|NCT00854373|460368989|FG001|Overall Study|Forgot to take study drug|1|||
127930918|NCT00293202|460368990|FG000|Overall Study|Withdrawal by Subject|1|||
127930919|NCT00293202|460368991|FG001|Overall Study|Withdrawal by Subject|2|||
127930920|NCT00293202|460368990|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
127930921|NCT00293202|460368991|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
127930922|NCT00293202|460368990|FG000|Overall Study|on-hold due to fistula maturation time|1|||
127930923|NCT00293202|460368991|FG001|Overall Study|on-hold due to fistula maturation time|0|||
127930924|NCT02442271|460368992|FG000|Overall Study|Adverse Event|1|||
127930925|NCT02442271|460368992|FG000|Overall Study|Withdrew Consent|1|||
127930926|NCT02442271|460368992|FG000|Overall Study|Lost to Follow-up|1|||
127930927|NCT02442271|460368992|FG000|Overall Study|Other|1|||
127930928|NCT01560507|460368993|FG000|Overall Study|Lost to Follow-up|3|||
127930929|NCT01560507|460368994|FG001|Overall Study|Lost to Follow-up|1|||
127930930|NCT01560507|460368995|FG002|Overall Study|Lost to Follow-up|2|||
127930931|NCT01560507|460368993|FG000|Overall Study|Withdrawal by Subject|1|||
127930932|NCT01560507|460368994|FG001|Overall Study|Withdrawal by Subject|1|||
127930933|NCT01560507|460368995|FG002|Overall Study|Withdrawal by Subject|0|||
127930934|NCT02080832|460368996|FG000|Overall Study|Excluded from analysis by MRI|9|||
127930935|NCT02080832|460368997|FG001|Overall Study|Excluded from analysis by MRI|10|||
127930936|NCT02080832|460368998|FG002|Overall Study|Excluded from analysis by MRI|14|||
127930937|NCT02080832|460368996|FG000|Overall Study|Lost to Follow-up|0|||
127930938|NCT02080832|460368997|FG001|Overall Study|Lost to Follow-up|2|||
127930939|NCT02080832|460368998|FG002|Overall Study|Lost to Follow-up|2|||
127930940|NCT02181296|460369000|FG000|Overall Study|Lost to Follow-up|7|||
127930941|NCT02181296|460369001|FG001|Overall Study|Lost to Follow-up|6|||
127930942|NCT02149121|460369002|FG000|Main Study Period|Lack of Efficacy|2|||
127930943|NCT02149121|460369003|FG001|Main Study Period|Lack of Efficacy|2|||
127930944|NCT02149121|460369004|FG002|Main Study Period|Lack of Efficacy|1|||
127930945|NCT02149121|460369005|FG003|Main Study Period|Lack of Efficacy|0|||
127930946|NCT02149121|460369006|FG004|Main Study Period|Lack of Efficacy|0|||
127930947|NCT02149121|460369007|FG005|Main Study Period|Lack of Efficacy|0|||
127930948|NCT02149121|460369008|FG006|Main Study Period|Lack of Efficacy|0|||
127930949|NCT02149121|460369002|FG000|Main Study Period|Withdrawal by Subject|9|||
127930950|NCT02149121|460369003|FG001|Main Study Period|Withdrawal by Subject|5|||
127930951|NCT02149121|460369004|FG002|Main Study Period|Withdrawal by Subject|1|||
127930952|NCT02149121|460369005|FG003|Main Study Period|Withdrawal by Subject|0|||
127930953|NCT02149121|460369006|FG004|Main Study Period|Withdrawal by Subject|0|||
127930954|NCT02149121|460369007|FG005|Main Study Period|Withdrawal by Subject|0|||
127930955|NCT02149121|460369008|FG006|Main Study Period|Withdrawal by Subject|0|||
127930956|NCT02149121|460369002|FG000|Main Study Period|Adverse Event|2|||
127930957|NCT02149121|460369003|FG001|Main Study Period|Adverse Event|5|||
127930958|NCT02149121|460369004|FG002|Main Study Period|Adverse Event|1|||
127930959|NCT02149121|460369005|FG003|Main Study Period|Adverse Event|0|||
127930960|NCT02149121|460369006|FG004|Main Study Period|Adverse Event|0|||
127930961|NCT02149121|460369007|FG005|Main Study Period|Adverse Event|0|||
127930962|NCT02149121|460369008|FG006|Main Study Period|Adverse Event|0|||
127930963|NCT02149121|460369002|FG000|Main Study Period|Protocol Violation|2|||
127930964|NCT02149121|460369003|FG001|Main Study Period|Protocol Violation|0|||
127930965|NCT02149121|460369004|FG002|Main Study Period|Protocol Violation|0|||
127930966|NCT02149121|460369005|FG003|Main Study Period|Protocol Violation|0|||
127930967|NCT02149121|460369006|FG004|Main Study Period|Protocol Violation|0|||
127930968|NCT02149121|460369007|FG005|Main Study Period|Protocol Violation|0|||
127930969|NCT02149121|460369008|FG006|Main Study Period|Protocol Violation|0|||
127930970|NCT02149121|460369002|FG000|Main Study Period|Lost to Follow-up|2|||
127930971|NCT02149121|460369003|FG001|Main Study Period|Lost to Follow-up|1|||
127930972|NCT02149121|460369004|FG002|Main Study Period|Lost to Follow-up|0|||
127930973|NCT02149121|460369005|FG003|Main Study Period|Lost to Follow-up|0|||
127930974|NCT02149121|460369006|FG004|Main Study Period|Lost to Follow-up|0|||
127930975|NCT02149121|460369007|FG005|Main Study Period|Lost to Follow-up|0|||
127930976|NCT02149121|460369008|FG006|Main Study Period|Lost to Follow-up|0|||
127930977|NCT02149121|460369002|FG000|Main Study Period|Death|1|||
127930978|NCT02149121|460369003|FG001|Main Study Period|Death|0|||
127930979|NCT02149121|460369004|FG002|Main Study Period|Death|0|||
127930980|NCT02149121|460369005|FG003|Main Study Period|Death|0|||
127930981|NCT02149121|460369006|FG004|Main Study Period|Death|0|||
127930982|NCT02149121|460369007|FG005|Main Study Period|Death|0|||
127930983|NCT02149121|460369008|FG006|Main Study Period|Death|0|||
127930984|NCT02149121|460369002|FG000|Main Study Period|Physician Decision|1|||
127930985|NCT02149121|460369003|FG001|Main Study Period|Physician Decision|0|||
127930986|NCT02149121|460369004|FG002|Main Study Period|Physician Decision|0|||
127930987|NCT02149121|460369005|FG003|Main Study Period|Physician Decision|0|||
127930988|NCT02149121|460369006|FG004|Main Study Period|Physician Decision|0|||
127930989|NCT02149121|460369007|FG005|Main Study Period|Physician Decision|0|||
127930990|NCT02149121|460369008|FG006|Main Study Period|Physician Decision|0|||
127930991|NCT02149121|460369002|FG000|Main Study Period|Developed any malignancy|0|||
127930992|NCT02149121|460369003|FG001|Main Study Period|Developed any malignancy|1|||
127930993|NCT02149121|460369004|FG002|Main Study Period|Developed any malignancy|1|||
127930994|NCT02149121|460369005|FG003|Main Study Period|Developed any malignancy|0|||
127930995|NCT02149121|460369006|FG004|Main Study Period|Developed any malignancy|0|||
127930996|NCT02149121|460369007|FG005|Main Study Period|Developed any malignancy|0|||
127930997|NCT02149121|460369008|FG006|Main Study Period|Developed any malignancy|0|||
127930998|NCT02149121|460369002|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
127930999|NCT02149121|460369003|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
127931000|NCT02149121|460369004|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
127931001|NCT02149121|460369005|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
127931002|NCT02149121|460369006|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
127931003|NCT02149121|460369007|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
127931004|NCT02149121|460369008|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
127931005|NCT02149121|460369002|FG000|Main Study Period|Disease progression|0|||
127931006|NCT02149121|460369003|FG001|Main Study Period|Disease progression|1|||
127931007|NCT02149121|460369004|FG002|Main Study Period|Disease progression|0|||
127931008|NCT02149121|460369005|FG003|Main Study Period|Disease progression|0|||
127931009|NCT02149121|460369006|FG004|Main Study Period|Disease progression|0|||
127931010|NCT02149121|460369007|FG005|Main Study Period|Disease progression|0|||
127931011|NCT02149121|460369008|FG006|Main Study Period|Disease progression|0|||
127931012|NCT02149121|460369002|FG000|Extension Study Period|Withdrawal by Subject|0|||
127931013|NCT02149121|460369003|FG001|Extension Study Period|Withdrawal by Subject|0|||
127931014|NCT02149121|460369004|FG002|Extension Study Period|Withdrawal by Subject|0|||
127931015|NCT02149121|460369005|FG003|Extension Study Period|Withdrawal by Subject|1|||
127931016|NCT02149121|460369006|FG004|Extension Study Period|Withdrawal by Subject|0|||
127931017|NCT02149121|460369007|FG005|Extension Study Period|Withdrawal by Subject|2|||
127931018|NCT02149121|460369008|FG006|Extension Study Period|Withdrawal by Subject|0|||
127931019|NCT03166124|460369009|FG000|Treatment Period 1|Adverse Event|0|||
127931020|NCT03166124|460369010|FG001|Treatment Period 1|Adverse Event|0|||
127931021|NCT03166124|460369011|FG002|Treatment Period 1|Adverse Event|1|||
127931022|NCT03166124|460369012|FG003|Treatment Period 1|Adverse Event|0|||
127931023|NCT03166124|460369009|FG000|Wash-out Period|Withdrawal by Subject|0|||
127931024|NCT03166124|460369010|FG001|Wash-out Period|Withdrawal by Subject|1|||
127931025|NCT03166124|460369011|FG002|Wash-out Period|Withdrawal by Subject|0|||
127931026|NCT03166124|460369012|FG003|Wash-out Period|Withdrawal by Subject|1|||
127931027|NCT03166124|460369009|FG000|Wash-out Period|Adverse Event|0|||
127931028|NCT03166124|460369010|FG001|Wash-out Period|Adverse Event|1|||
127931029|NCT03166124|460369011|FG002|Wash-out Period|Adverse Event|1|||
127931030|NCT03166124|460369012|FG003|Wash-out Period|Adverse Event|0|||
127931031|NCT00766831|460369013|FG000|Overall Study|Withdrawal by Subject|4|||
127931032|NCT00766831|460369013|FG000|Overall Study|Lost to Follow-up|3|||
127931033|NCT00766831|460369013|FG000|Overall Study|Adverse Event|20|||
127931034|NCT00766831|460369013|FG000|Overall Study|Protocol Violation|15|||
127931035|NCT00766831|460369013|FG000|Overall Study|Physician Decision|5|||
127931036|NCT00766831|460369013|FG000|Overall Study|Withdrawal of consent|26|||
127931037|NCT00766831|460369013|FG000|Overall Study|Non cooperation by participants|14|||
127931038|NCT00766831|460369013|FG000|Overall Study|Other|28|||
127931039|NCT00094094|460369015|FG000|Overall Study|Death|2|||
127931040|NCT00094094|460369015|FG000|Overall Study|Lack of Efficacy|23|||
127931041|NCT00094094|460369015|FG000|Overall Study|Adverse Event|7|||
127931042|NCT05626803|460370745|FG000|Overall Study|Lost to Follow-up|0|||
127931043|NCT05626803|460370746|FG001|Overall Study|Lost to Follow-up|1|||
127931044|NCT05626803|460370747|FG002|Overall Study|Lost to Follow-up|0|||
127931045|NCT05626803|460370748|FG003|Overall Study|Lost to Follow-up|0|||
127931046|NCT01000610|460370756|FG000|Overall Study|Adverse Event|1|||
127931047|NCT01000610|460370756|FG000|Overall Study|Lost to Follow-up|4|||
127931048|NCT01000610|460370756|FG000|Overall Study|Treatment failure|1|||
127931049|NCT00493246|460370757|FG000|Overall Study|Withdrawal by Subject|0|||
127931050|NCT00493246|460370758|FG001|Overall Study|Withdrawal by Subject|0|||
127931051|NCT00493246|460370759|FG002|Overall Study|Withdrawal by Subject|0|||
127931052|NCT00493246|460370760|FG003|Overall Study|Withdrawal by Subject|0|||
127931053|NCT00493246|460370761|FG004|Overall Study|Withdrawal by Subject|1|||
127931054|NCT00493246|460370762|FG005|Overall Study|Withdrawal by Subject|0|||
127931055|NCT00493246|460370763|FG006|Overall Study|Withdrawal by Subject|0|||
127931056|NCT00493246|460370764|FG007|Overall Study|Withdrawal by Subject|0|||
127931057|NCT00493246|460370757|FG000|Overall Study|No access to draw blood|0|||
127931058|NCT00493246|460370758|FG001|Overall Study|No access to draw blood|0|||
127931059|NCT00493246|460370759|FG002|Overall Study|No access to draw blood|0|||
127931060|NCT00493246|460370760|FG003|Overall Study|No access to draw blood|0|||
127931061|NCT00493246|460370761|FG004|Overall Study|No access to draw blood|0|||
127931062|NCT00493246|460370762|FG005|Overall Study|No access to draw blood|1|||
127931063|NCT00493246|460370763|FG006|Overall Study|No access to draw blood|0|||
127931064|NCT00493246|460370764|FG007|Overall Study|No access to draw blood|0|||
127931065|NCT00493246|460370757|FG000|Overall Study|Lost to Follow-up|0|||
127931066|NCT00493246|460370758|FG001|Overall Study|Lost to Follow-up|0|||
127931067|NCT00493246|460370759|FG002|Overall Study|Lost to Follow-up|0|||
127931068|NCT00493246|460370760|FG003|Overall Study|Lost to Follow-up|0|||
127931069|NCT00493246|460370761|FG004|Overall Study|Lost to Follow-up|0|||
127931070|NCT00493246|460370762|FG005|Overall Study|Lost to Follow-up|0|||
127931071|NCT00493246|460370763|FG006|Overall Study|Lost to Follow-up|1|||
127931072|NCT00493246|460370764|FG007|Overall Study|Lost to Follow-up|0|||
127931073|NCT01592721|460370772|FG000|Long-term Follow-up|Death|1|||
127931074|NCT03861481|460370773|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
127931075|NCT03861481|460370774|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
127931076|NCT03861481|460370773|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
127931077|NCT03861481|460370774|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
127931078|NCT03861481|460370773|FG000|Overall Study|Relapse|1|||
127931079|NCT03861481|460370774|FG001|Overall Study|Relapse|0|||
127931080|NCT03861481|460370773|FG000|Overall Study|Withdrawal by Subject|0|||
127931081|NCT03861481|460370774|FG001|Overall Study|Withdrawal by Subject|1|||
127931082|NCT03861481|460370773|FG000|Overall Study|Lack of Efficacy|4|||
127931083|NCT03861481|460370774|FG001|Overall Study|Lack of Efficacy|5|||
127931084|NCT01220297|460370777|FG000|Overall Study|Death|2|||
127931085|NCT01220297|460370777|FG000|Overall Study|Lost to Follow-up|1|||
127931086|NCT01287039|460370778|FG000|Overall Study|Noncompliance with study procedures|0|||
127931087|NCT01287039|460370779|FG001|Overall Study|Noncompliance with study procedures|1|||
127931088|NCT01287039|460370778|FG000|Overall Study|Change of location/residence|0|||
127931089|NCT01287039|460370779|FG001|Overall Study|Change of location/residence|3|||
127931090|NCT01287039|460370778|FG000|Overall Study|Elective surgery|0|||
127931091|NCT01287039|460370779|FG001|Overall Study|Elective surgery|1|||
127931092|NCT01287039|460370778|FG000|Overall Study|Protocol Violation|2|||
127931093|NCT01287039|460370779|FG001|Overall Study|Protocol Violation|3|||
127931094|NCT01287039|460370778|FG000|Overall Study|Excluded medication taken|1|||
127931095|NCT01287039|460370779|FG001|Overall Study|Excluded medication taken|0|||
127931096|NCT01287039|460370778|FG000|Overall Study|Noncompliance with study medication|0|||
127931097|NCT01287039|460370779|FG001|Overall Study|Noncompliance with study medication|1|||
127931098|NCT01287039|460370778|FG000|Overall Study|Problem with travel|0|||
127931099|NCT01287039|460370779|FG001|Overall Study|Problem with travel|1|||
127931100|NCT01287039|460370778|FG000|Overall Study|Death|1|||
127931101|NCT01287039|460370779|FG001|Overall Study|Death|0|||
127931102|NCT01287039|460370778|FG000|Overall Study|Change of residence|1|||
127931103|NCT01287039|460370779|FG001|Overall Study|Change of residence|0|||
127931104|NCT01287039|460370778|FG000|Overall Study|Adverse Event|7|||
127931105|NCT01287039|460370779|FG001|Overall Study|Adverse Event|4|||
127931106|NCT01287039|460370778|FG000|Overall Study|Withdrawal by Subject|14|||
127931107|NCT01287039|460370779|FG001|Overall Study|Withdrawal by Subject|11|||
127931108|NCT01287039|460370778|FG000|Overall Study|Lost to Follow-up|3|||
127931109|NCT01287039|460370779|FG001|Overall Study|Lost to Follow-up|2|||
127931110|NCT00099268|460370780|FG000|Overall Study|Withdrawal by Subject|46|||
127931111|NCT00099268|460370781|FG001|Overall Study|Withdrawal by Subject|28|||
127931112|NCT00099268|460370780|FG000|Overall Study|Adverse Event|19|||
127931113|NCT00099268|460370781|FG001|Overall Study|Adverse Event|19|||
127931114|NCT00099268|460370780|FG000|Overall Study|Protocol Violation|9|||
127931115|NCT00099268|460370781|FG001|Overall Study|Protocol Violation|8|||
127931116|NCT00099268|460370780|FG000|Overall Study|Lost to Follow-up|6|||
127931117|NCT00099268|460370781|FG001|Overall Study|Lost to Follow-up|4|||
127931118|NCT00099268|460370780|FG000|Overall Study|Lack of Efficacy|5|||
127931119|NCT00099268|460370781|FG001|Overall Study|Lack of Efficacy|18|||
127931120|NCT00099268|460370780|FG000|Overall Study|Administrative problems|4|||
127931121|NCT00099268|460370781|FG001|Overall Study|Administrative problems|4|||
127931122|NCT00099268|460370780|FG000|Overall Study|Death|3|||
127931123|NCT00099268|460370781|FG001|Overall Study|Death|1|||
127931124|NCT05016622|460370782|FG000|1st Booster: 4-6 Month Follow up Visit|Lost to Follow-up|59|||
127931125|NCT05016622|460370782|FG000|2nd Booster: 4 Week Follow up Visit|Declined to Participate|2|||
127931126|NCT02006628|460370784|FG000|Overall Study|Adverse Event|1|||
127931127|NCT02006628|460370785|FG001|Overall Study|Adverse Event|1|||
127931128|NCT02006628|460370784|FG000|Overall Study|Withdrawal by Subject|2|||
127931129|NCT02006628|460370785|FG001|Overall Study|Withdrawal by Subject|1|||
127931130|NCT03578237|460370788|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
127931131|NCT03578237|460370789|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
127931132|NCT02017860|460370792|FG000|Overall Study|Adverse Event|1|||
127931133|NCT02017860|460370792|FG000|Overall Study|Withdrawal by Subject|1|||
127931134|NCT02488330|460370793|FG000|Overall Study|Adverse Event|1|||
127931135|NCT02488330|460370793|FG000|Overall Study|Physician Decision|2|||
127931136|NCT02488330|460370793|FG000|Overall Study|Death|2|||
127931137|NCT02488330|460370793|FG000|Overall Study|Disease Progression|3|||
127931138|NCT02488330|460370793|FG000|Overall Study|Study Termination by Sponsor|4|||
127931139|NCT01206816|460370797|FG000|Overall Study|Protocol Violation|0|||
127931140|NCT01206816|460370798|FG001|Overall Study|Protocol Violation|0|||
127931141|NCT01206816|460370799|FG002|Overall Study|Protocol Violation|1|||
127931142|NCT01206816|460370800|FG003|Overall Study|Protocol Violation|0|||
127931143|NCT01206816|460370801|FG004|Overall Study|Protocol Violation|0|||
127931144|NCT01206816|460370802|FG005|Overall Study|Protocol Violation|0|||
127931145|NCT01206816|460370803|FG006|Overall Study|Protocol Violation|0|||
127931146|NCT01206816|460370797|FG000|Overall Study|Withdrawal by Subject|0|||
127931147|NCT01206816|460370798|FG001|Overall Study|Withdrawal by Subject|0|||
127931148|NCT01206816|460370799|FG002|Overall Study|Withdrawal by Subject|1|||
127931149|NCT01206816|460370800|FG003|Overall Study|Withdrawal by Subject|0|||
127931150|NCT01206816|460370801|FG004|Overall Study|Withdrawal by Subject|0|||
127931151|NCT01206816|460370802|FG005|Overall Study|Withdrawal by Subject|0|||
127931152|NCT01206816|460370803|FG006|Overall Study|Withdrawal by Subject|0|||
127931153|NCT01206816|460370797|FG000|Overall Study|Progressive disease|3|||
127931154|NCT01206816|460370798|FG001|Overall Study|Progressive disease|3|||
127931155|NCT01206816|460370799|FG002|Overall Study|Progressive disease|13|||
127931156|NCT01206816|460370800|FG003|Overall Study|Progressive disease|3|||
127931157|NCT01206816|460370801|FG004|Overall Study|Progressive disease|3|||
127931158|NCT01206816|460370802|FG005|Overall Study|Progressive disease|16|||
127931159|NCT01206816|460370803|FG006|Overall Study|Progressive disease|3|||
127931160|NCT01206816|460370797|FG000|Overall Study|Other AE|0|||
127931161|NCT01206816|460370798|FG001|Overall Study|Other AE|0|||
127931162|NCT01206816|460370799|FG002|Overall Study|Other AE|4|||
127931163|NCT01206816|460370800|FG003|Overall Study|Other AE|0|||
127931164|NCT01206816|460370801|FG004|Overall Study|Other AE|0|||
127931165|NCT01206816|460370802|FG005|Overall Study|Other AE|3|||
127931166|NCT01206816|460370803|FG006|Overall Study|Other AE|2|||
127931167|NCT01206816|460370797|FG000|Overall Study|other than stated above|0|||
127931168|NCT01206816|460370798|FG001|Overall Study|other than stated above|0|||
127931169|NCT01206816|460370799|FG002|Overall Study|other than stated above|1|||
127931170|NCT01206816|460370800|FG003|Overall Study|other than stated above|0|||
127931171|NCT01206816|460370801|FG004|Overall Study|other than stated above|0|||
127931172|NCT01206816|460370802|FG005|Overall Study|other than stated above|0|||
127931173|NCT01206816|460370803|FG006|Overall Study|other than stated above|1|||
127931174|NCT02493777|460370806|FG000|Overall Study|Lost to Follow-up|0|||
127931175|NCT02493777|460370807|FG001|Overall Study|Lost to Follow-up|1|||
127931176|NCT01642914|460370808|FG000|Overall Study|Adverse Event|11|||
127931177|NCT01642914|460370809|FG001|Overall Study|Adverse Event|7|||
127931178|NCT01642914|460370810|FG002|Overall Study|Adverse Event|15|||
127931179|NCT01642914|460370808|FG000|Overall Study|Lack of Efficacy|9|||
127931180|NCT01642914|460370809|FG001|Overall Study|Lack of Efficacy|4|||
127931181|NCT01642914|460370810|FG002|Overall Study|Lack of Efficacy|2|||
127931182|NCT01642914|460370808|FG000|Overall Study|Protocol Violation|15|||
127931183|NCT01642914|460370809|FG001|Overall Study|Protocol Violation|13|||
127931184|NCT01642914|460370810|FG002|Overall Study|Protocol Violation|6|||
127931185|NCT01642914|460370808|FG000|Overall Study|Withdrawal by Subject|5|||
127931186|NCT01642914|460370809|FG001|Overall Study|Withdrawal by Subject|5|||
127931187|NCT01642914|460370810|FG002|Overall Study|Withdrawal by Subject|10|||
127931188|NCT01642914|460370808|FG000|Overall Study|Lost to Follow-up|5|||
127931189|NCT01642914|460370809|FG001|Overall Study|Lost to Follow-up|3|||
127931190|NCT01642914|460370810|FG002|Overall Study|Lost to Follow-up|7|||
127931191|NCT01642914|460370808|FG000|Overall Study|Other Reason|1|||
127931192|NCT01642914|460370809|FG001|Overall Study|Other Reason|0|||
127931193|NCT01642914|460370810|FG002|Overall Study|Other Reason|0|||
127931194|NCT01705236|460370811|FG000|Overall Study|Lost to Follow-up|1|||
127931195|NCT01705236|460370811|FG000|Overall Study|Administrative problems|2|||
127931196|NCT01705236|460370811|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
127931197|NCT01705236|460370811|FG000|Overall Study|Protocol Violation|3|||
127931198|NCT01705236|460370811|FG000|Overall Study|Abnormal test procedure result(s)|4|||
127931199|NCT01705236|460370811|FG000|Overall Study|Abnormal laboratory value(s)|4|||
127931200|NCT01705236|460370811|FG000|Overall Study|Withdrawal by Subject|5|||
127931201|NCT01705236|460370811|FG000|Overall Study|Adverse Event|5|||
127931202|NCT00171301|460370812|FG000|Overall Study|Death|1|||
127931203|NCT00171301|460370813|FG001|Overall Study|Death|2|||
127931204|NCT00171301|460370812|FG000|Overall Study|Adverse Event|1|||
127931205|NCT00171301|460370813|FG001|Overall Study|Adverse Event|2|||
127931206|NCT00171301|460370812|FG000|Overall Study|Lost to Follow-up|6|||
127931207|NCT00171301|460370813|FG001|Overall Study|Lost to Follow-up|2|||
127931208|NCT00171301|460370812|FG000|Overall Study|Protocol Violation|0|||
127931209|NCT00171301|460370813|FG001|Overall Study|Protocol Violation|2|||
127931210|NCT00171301|460370812|FG000|Overall Study|Withdrawal by Subject|0|||
127931211|NCT00171301|460370813|FG001|Overall Study|Withdrawal by Subject|1|||
127931212|NCT04319159|460370814|FG000|Overall Study|Screening failure|13|||
127931213|NCT04319159|460370814|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
127931214|NCT04319159|460370814|FG000|Overall Study|Withdrawal by Subject|1|||
127931215|NCT02100319|460370815|FG000|Overall Study|Case Report Forms Uncollected|11|||
127931216|NCT02100319|460370815|FG000|Overall Study|Protocol Deviation|5|||
127931217|NCT02370914|460370816|FG000|Overall Study|Protocol Violation|2|||
127931218|NCT00754442|460370817|FG000|Overall Study|Withdrawal by Subject|5|||
127931219|NCT00754442|460370818|FG001|Overall Study|Withdrawal by Subject|3|||
127931220|NCT00296491|460370819|FG000|Overall Study|Low Pollen Counts|18|||
127931221|NCT00296491|460370820|FG001|Overall Study|Low Pollen Counts|26|||
127931222|NCT00296491|460370821|FG002|Overall Study|Low Pollen Counts|25|||
127931223|NCT00296491|460370822|FG003|Overall Study|Low Pollen Counts|16|||
127931224|NCT00296491|460370819|FG000|Overall Study|Protocol Violation|4|||
127931225|NCT00296491|460370820|FG001|Overall Study|Protocol Violation|6|||
127931226|NCT00296491|460370821|FG002|Overall Study|Protocol Violation|2|||
127931227|NCT00296491|460370822|FG003|Overall Study|Protocol Violation|3|||
127931228|NCT00296491|460370819|FG000|Overall Study|Adverse Event|1|||
127931229|NCT00296491|460370820|FG001|Overall Study|Adverse Event|3|||
127931230|NCT00296491|460370821|FG002|Overall Study|Adverse Event|1|||
127931231|NCT00296491|460370822|FG003|Overall Study|Adverse Event|4|||
127931232|NCT00296491|460370819|FG000|Overall Study|Withdrawn due to Asthma|0|||
127931233|NCT00296491|460370820|FG001|Overall Study|Withdrawn due to Asthma|0|||
127931234|NCT00296491|460370821|FG002|Overall Study|Withdrawn due to Asthma|0|||
127931235|NCT00296491|460370822|FG003|Overall Study|Withdrawn due to Asthma|4|||
127931236|NCT00296491|460370819|FG000|Overall Study|Withdrawal by Subject|7|||
127931237|NCT00296491|460370820|FG001|Overall Study|Withdrawal by Subject|3|||
127931238|NCT00296491|460370821|FG002|Overall Study|Withdrawal by Subject|3|||
127931239|NCT00296491|460370822|FG003|Overall Study|Withdrawal by Subject|2|||
127931240|NCT00296491|460370819|FG000|Overall Study|Non-Compliance|12|||
127931241|NCT00296491|460370820|FG001|Overall Study|Non-Compliance|13|||
127931242|NCT00296491|460370821|FG002|Overall Study|Non-Compliance|10|||
127931243|NCT00296491|460370822|FG003|Overall Study|Non-Compliance|14|||
127931244|NCT00296491|460370819|FG000|Overall Study|Lost to Follow-up|0|||
127931245|NCT00296491|460370820|FG001|Overall Study|Lost to Follow-up|2|||
127931246|NCT00296491|460370821|FG002|Overall Study|Lost to Follow-up|2|||
127931247|NCT00296491|460370822|FG003|Overall Study|Lost to Follow-up|0|||
127931248|NCT01300052|460370823|FG000|Overall Study|Adverse Event|3|||
127931249|NCT01300052|460370824|FG001|Overall Study|Adverse Event|0|||
127931250|NCT01300052|460370823|FG000|Overall Study|Withdrawal by Subject|2|||
127931251|NCT01300052|460370824|FG001|Overall Study|Withdrawal by Subject|2|||
127931252|NCT01300052|460370823|FG000|Overall Study|Protocol Violation|1|||
127931253|NCT01300052|460370824|FG001|Overall Study|Protocol Violation|1|||
127931254|NCT01231373|460370825|FG000|Overall Study|Withdrew consent prior to randomization|2|||
127931255|NCT01231373|460370826|FG001|Overall Study|Withdrew consent prior to randomization|1|||
127931256|NCT01231373|460370827|FG002|Overall Study|Withdrew consent prior to randomization|0|||
127931257|NCT01231373|460370828|FG003|Overall Study|Withdrew consent prior to randomization|0|||
127931258|NCT01231373|460370825|FG000|Overall Study|Lost to Follow-up|0|||
127931259|NCT01231373|460370826|FG001|Overall Study|Lost to Follow-up|0|||
127931260|NCT01231373|460370827|FG002|Overall Study|Lost to Follow-up|0|||
127931261|NCT01231373|460370828|FG003|Overall Study|Lost to Follow-up|1|||
127931262|NCT01231373|460370825|FG000|Overall Study|Withdrew Consent|1|||
127931263|NCT01231373|460370826|FG001|Overall Study|Withdrew Consent|0|||
127931264|NCT01231373|460370827|FG002|Overall Study|Withdrew Consent|0|||
127931265|NCT01231373|460370828|FG003|Overall Study|Withdrew Consent|0|||
127931266|NCT03451006|460370829|FG000|Overall Study|Withdrawal by Subject|2|||
127931267|NCT03451006|460370830|FG001|Overall Study|Withdrawal by Subject|2|||
127931268|NCT01929395|460370831|FG000|Overall Study|Did not complete - non-related toxicity|1|||
127931269|NCT01929395|460370832|FG001|Overall Study|Did not complete - non-related toxicity|0|||
127931270|NCT01929395|460370833|FG002|Overall Study|Did not complete - non-related toxicity|0|||
127931271|NCT01929395|460370831|FG000|Overall Study|Withdrawal by Subject|0|||
127931272|NCT01929395|460370832|FG001|Overall Study|Withdrawal by Subject|1|||
127931273|NCT01929395|460370833|FG002|Overall Study|Withdrawal by Subject|0|||
127931274|NCT01929395|460370831|FG000|Overall Study|Screen Fail|0|||
127931275|NCT01929395|460370832|FG001|Overall Study|Screen Fail|0|||
127931276|NCT01929395|460370833|FG002|Overall Study|Screen Fail|1|||
127931277|NCT02547766|460370834|FG000|Overall Study|Withdrawal by Subject|1|||
127931278|NCT03604341|460370835|FG000|Overall Study|Withdrawal by Subject|1|||
127931279|NCT03604341|460370836|FG001|Overall Study|Withdrawal by Subject|1|||
127931280|NCT03604341|460370835|FG000|Overall Study|Adverse Event|1|||
127931281|NCT03604341|460370836|FG001|Overall Study|Adverse Event|0|||
127931282|NCT03604341|460370835|FG000|Overall Study|Protocol Violation|0|||
127931283|NCT03604341|460370836|FG001|Overall Study|Protocol Violation|1|||
127931284|NCT01829113|460370840|FG000|Overall Study|Disease Progression|37|||
127931285|NCT01829113|460370841|FG001|Overall Study|Disease Progression|48|||
127931286|NCT01829113|460370840|FG000|Overall Study|Adverse Event|14|||
127931287|NCT01829113|460370841|FG001|Overall Study|Adverse Event|10|||
127931288|NCT01829113|460370840|FG000|Overall Study|Withdrawal by Subject|17|||
127931289|NCT01829113|460370841|FG001|Overall Study|Withdrawal by Subject|10|||
127931290|NCT01829113|460370840|FG000|Overall Study|Death|4|||
127931291|NCT01829113|460370841|FG001|Overall Study|Death|6|||
127931292|NCT01829113|460370840|FG000|Overall Study|Sponsor Decision|1|||
127931293|NCT01829113|460370841|FG001|Overall Study|Sponsor Decision|1|||
127931294|NCT01829113|460370840|FG000|Overall Study|No Study Treatment Received|3|||
127931295|NCT01829113|460370841|FG001|Overall Study|No Study Treatment Received|2|||
127931296|NCT01829113|460370840|FG000|Overall Study|Physician Decision|1|||
127931297|NCT01829113|460370841|FG001|Overall Study|Physician Decision|1|||
127931298|NCT02010255|460370842|FG000|Overall Study|Death|0|||
127931299|NCT02010255|460370843|FG001|Overall Study|Death|1|||
127931300|NCT02010255|460370844|FG002|Overall Study|Death|4|||
127931301|NCT02010255|460370845|FG003|Overall Study|Death|4|||
127931302|NCT02010255|460370846|FG004|Overall Study|Death|2|||
127931303|NCT02010255|460370847|FG005|Overall Study|Death|0|||
127931304|NCT02010255|460370848|FG006|Overall Study|Death|1|||
127931305|NCT02010255|460370849|FG007|Overall Study|Death|1|||
127931306|NCT02010255|460370850|FG008|Overall Study|Death|1|||
127931307|NCT02010255|460370851|FG009|Overall Study|Death|0|||
127931308|NCT02010255|460370852|FG010|Overall Study|Death|1|||
127931309|NCT02010255|460370853|FG011|Overall Study|Death|1|||
127931310|NCT02010255|460370854|FG012|Overall Study|Death|0|||
127931311|NCT02010255|460370855|FG013|Overall Study|Death|0|||
127931312|NCT02010255|460370842|FG000|Overall Study|Lack of Efficacy|4|||
127931313|NCT02010255|460370843|FG001|Overall Study|Lack of Efficacy|1|||
127931314|NCT02010255|460370844|FG002|Overall Study|Lack of Efficacy|2|||
127931315|NCT02010255|460370845|FG003|Overall Study|Lack of Efficacy|1|||
127931316|NCT02010255|460370846|FG004|Overall Study|Lack of Efficacy|1|||
127931317|NCT02010255|460370847|FG005|Overall Study|Lack of Efficacy|0|||
127931318|NCT02010255|460370848|FG006|Overall Study|Lack of Efficacy|0|||
127931319|NCT02010255|460370849|FG007|Overall Study|Lack of Efficacy|0|||
127931320|NCT02010255|460370850|FG008|Overall Study|Lack of Efficacy|0|||
127931321|NCT02010255|460370851|FG009|Overall Study|Lack of Efficacy|0|||
127931322|NCT02010255|460370852|FG010|Overall Study|Lack of Efficacy|1|||
127931323|NCT02010255|460370853|FG011|Overall Study|Lack of Efficacy|0|||
127931324|NCT02010255|460370854|FG012|Overall Study|Lack of Efficacy|0|||
127931325|NCT02010255|460370855|FG013|Overall Study|Lack of Efficacy|0|||
127931326|NCT02010255|460370842|FG000|Overall Study|Withdrew Consent|1|||
127931327|NCT02010255|460370843|FG001|Overall Study|Withdrew Consent|0|||
127931328|NCT02010255|460370844|FG002|Overall Study|Withdrew Consent|0|||
127931329|NCT02010255|460370845|FG003|Overall Study|Withdrew Consent|1|||
127931330|NCT02010255|460370846|FG004|Overall Study|Withdrew Consent|0|||
127931331|NCT02010255|460370847|FG005|Overall Study|Withdrew Consent|0|||
127931332|NCT02010255|460370848|FG006|Overall Study|Withdrew Consent|0|||
127931333|NCT02010255|460370849|FG007|Overall Study|Withdrew Consent|0|||
127931334|NCT02010255|460370850|FG008|Overall Study|Withdrew Consent|0|||
127931335|NCT02010255|460370851|FG009|Overall Study|Withdrew Consent|0|||
127931336|NCT02010255|460370852|FG010|Overall Study|Withdrew Consent|0|||
127931337|NCT02010255|460370853|FG011|Overall Study|Withdrew Consent|0|||
127931338|NCT02010255|460370854|FG012|Overall Study|Withdrew Consent|0|||
127931339|NCT02010255|460370855|FG013|Overall Study|Withdrew Consent|0|||
127931340|NCT02010255|460370842|FG000|Overall Study|Adverse Event|1|||
127931341|NCT02010255|460370843|FG001|Overall Study|Adverse Event|0|||
127931342|NCT02010255|460370844|FG002|Overall Study|Adverse Event|0|||
127931343|NCT02010255|460370845|FG003|Overall Study|Adverse Event|0|||
127931344|NCT02010255|460370846|FG004|Overall Study|Adverse Event|0|||
127931345|NCT02010255|460370847|FG005|Overall Study|Adverse Event|0|||
127931346|NCT02010255|460370848|FG006|Overall Study|Adverse Event|0|||
127931347|NCT02010255|460370849|FG007|Overall Study|Adverse Event|0|||
127931348|NCT02010255|460370850|FG008|Overall Study|Adverse Event|0|||
127931349|NCT02010255|460370851|FG009|Overall Study|Adverse Event|0|||
127931350|NCT02010255|460370852|FG010|Overall Study|Adverse Event|0|||
127931351|NCT02010255|460370853|FG011|Overall Study|Adverse Event|0|||
127931352|NCT02010255|460370854|FG012|Overall Study|Adverse Event|0|||
127931353|NCT02010255|460370855|FG013|Overall Study|Adverse Event|0|||
127931354|NCT02010255|460370842|FG000|Overall Study|Lost to Follow-up|0|||
127931355|NCT02010255|460370843|FG001|Overall Study|Lost to Follow-up|0|||
127931356|NCT02010255|460370844|FG002|Overall Study|Lost to Follow-up|1|||
127931357|NCT02010255|460370845|FG003|Overall Study|Lost to Follow-up|0|||
127931358|NCT02010255|460370846|FG004|Overall Study|Lost to Follow-up|1|||
127931359|NCT02010255|460370847|FG005|Overall Study|Lost to Follow-up|0|||
127931360|NCT02010255|460370848|FG006|Overall Study|Lost to Follow-up|0|||
127931361|NCT02010255|460370849|FG007|Overall Study|Lost to Follow-up|0|||
127931362|NCT02010255|460370850|FG008|Overall Study|Lost to Follow-up|0|||
127931363|NCT02010255|460370851|FG009|Overall Study|Lost to Follow-up|0|||
127931364|NCT02010255|460370852|FG010|Overall Study|Lost to Follow-up|0|||
127931365|NCT02010255|460370853|FG011|Overall Study|Lost to Follow-up|0|||
127931366|NCT02010255|460370854|FG012|Overall Study|Lost to Follow-up|0|||
127931367|NCT02010255|460370855|FG013|Overall Study|Lost to Follow-up|0|||
127931368|NCT02010255|460370842|FG000|Overall Study|Randomized but Not Treated|0|||
127931369|NCT02010255|460370843|FG001|Overall Study|Randomized but Not Treated|0|||
127931370|NCT02010255|460370844|FG002|Overall Study|Randomized but Not Treated|0|||
127931371|NCT02010255|460370845|FG003|Overall Study|Randomized but Not Treated|0|||
127931372|NCT02010255|460370846|FG004|Overall Study|Randomized but Not Treated|0|||
127931373|NCT02010255|460370847|FG005|Overall Study|Randomized but Not Treated|0|||
127931374|NCT02010255|460370848|FG006|Overall Study|Randomized but Not Treated|0|||
127931375|NCT02010255|460370849|FG007|Overall Study|Randomized but Not Treated|0|||
127931376|NCT02010255|460370850|FG008|Overall Study|Randomized but Not Treated|0|||
127931377|NCT02010255|460370851|FG009|Overall Study|Randomized but Not Treated|0|||
127931378|NCT02010255|460370852|FG010|Overall Study|Randomized but Not Treated|0|||
127931379|NCT02010255|460370853|FG011|Overall Study|Randomized but Not Treated|0|||
127931380|NCT02010255|460370854|FG012|Overall Study|Randomized but Not Treated|0|||
127931381|NCT02010255|460370855|FG013|Overall Study|Randomized but Not Treated|1|||
127931382|NCT01010750|460370856|FG000|Second Intervention|Adverse Event|0|||
127931383|NCT01010750|460370857|FG001|Second Intervention|Adverse Event|1|||
127931384|NCT01010750|460370858|FG002|Second Intervention|Adverse Event|0|||
127931385|NCT01010750|460370859|FG003|Second Intervention|Adverse Event|0|||
127931386|NCT01010750|460370860|FG004|Second Intervention|Adverse Event|0|||
127931387|NCT01010750|460370861|FG005|Second Intervention|Adverse Event|0|||
127931388|NCT03739138|460370862|FG000|Overall Study|Death|0|||
127931389|NCT03739138|460370863|FG001|Overall Study|Death|7|||
127931390|NCT03739138|460370864|FG002|Overall Study|Death|4|||
127931391|NCT03739138|460370865|FG003|Overall Study|Death|13|||
127931392|NCT03739138|460370866|FG004|Overall Study|Death|0|||
127931393|NCT03739138|460370862|FG000|Overall Study|Lost to Follow-up|0|||
127931394|NCT03739138|460370863|FG001|Overall Study|Lost to Follow-up|0|||
127931395|NCT03739138|460370864|FG002|Overall Study|Lost to Follow-up|1|||
127931396|NCT03739138|460370865|FG003|Overall Study|Lost to Follow-up|0|||
127931397|NCT03739138|460370866|FG004|Overall Study|Lost to Follow-up|0|||
127931398|NCT03739138|460370862|FG000|Overall Study|Study Terminated By Sponsor|0|||
127931399|NCT03739138|460370863|FG001|Overall Study|Study Terminated By Sponsor|0|||
127931400|NCT03739138|460370864|FG002|Overall Study|Study Terminated By Sponsor|0|||
127931401|NCT03739138|460370865|FG003|Overall Study|Study Terminated By Sponsor|4|||
127931402|NCT03739138|460370866|FG004|Overall Study|Study Terminated By Sponsor|0|||
127931403|NCT03739138|460370862|FG000|Overall Study|Withdrawal by Subject|0|||
127931404|NCT03739138|460370863|FG001|Overall Study|Withdrawal by Subject|0|||
127931405|NCT03739138|460370864|FG002|Overall Study|Withdrawal by Subject|0|||
127931406|NCT03739138|460370865|FG003|Overall Study|Withdrawal by Subject|1|||
127931407|NCT03739138|460370866|FG004|Overall Study|Withdrawal by Subject|0|||
127931408|NCT02654587|460370867|FG000|Overall Study|patient alive at end of study|22|||
127931409|NCT02654587|460370868|FG001|Overall Study|patient alive at end of study|8|||
127931410|NCT02654587|460370867|FG000|Overall Study|Withdrawal by Subject|1|||
127931411|NCT02654587|460370868|FG001|Overall Study|Withdrawal by Subject|7|||
127931412|NCT01338987|460370871|FG000|Overall Study|enrolled on new protocol|0|||
127931413|NCT01338987|460370872|FG001|Overall Study|enrolled on new protocol|0|||
127931414|NCT01338987|460370873|FG002|Overall Study|enrolled on new protocol|1|||
127931415|NCT01338987|460370874|FG003|Overall Study|enrolled on new protocol|0|||
127931416|NCT01338987|460370875|FG004|Overall Study|enrolled on new protocol|0|||
127931417|NCT01338987|460370871|FG000|Overall Study|Disease progression on study|2|||
127931418|NCT01338987|460370872|FG001|Overall Study|Disease progression on study|1|||
127931419|NCT01338987|460370873|FG002|Overall Study|Disease progression on study|1|||
127931420|NCT01338987|460370874|FG003|Overall Study|Disease progression on study|0|||
127931421|NCT01338987|460370875|FG004|Overall Study|Disease progression on study|0|||
127931422|NCT03856593|460370878|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
127931423|NCT03856593|460370879|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
127931424|NCT01949116|460370880|FG000|Overall Study|Death|2|||
127931425|NCT01949116|460370881|FG001|Overall Study|Death|0|||
127931426|NCT01949116|460370880|FG000|Overall Study|Lost to Follow-up|1|||
127931427|NCT01949116|460370881|FG001|Overall Study|Lost to Follow-up|3|||
127931428|NCT01949116|460370880|FG000|Overall Study|Withdrawal by Subject|5|||
127931429|NCT01949116|460370881|FG001|Overall Study|Withdrawal by Subject|3|||
127931430|NCT02427984|460370883|FG000|Overall Study|Lost to Follow-up|13|||
127931431|NCT02427984|460370884|FG001|Overall Study|Lost to Follow-up|5|||
127931432|NCT02427984|460370885|FG002|Overall Study|Lost to Follow-up|18|||
127931433|NCT01524913|460370886|FG000|Overall Study|Lost to Follow-up|4|||
127931434|NCT01524913|460370887|FG001|Overall Study|Lost to Follow-up|0|||
127931435|NCT01524913|460370888|FG002|Overall Study|Lost to Follow-up|0|||
127931436|NCT00788593|460370889|FG000|Placebo Run-in Phase|Adverse Event|2|||
127931437|NCT00788593|460370890|FG001|Placebo Run-in Phase|Adverse Event|0|||
127931438|NCT00788593|460370891|FG002|Placebo Run-in Phase|Adverse Event|0|||
127931439|NCT00788593|460370889|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
127931440|NCT00788593|460370890|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
127931441|NCT00788593|460370891|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
127931442|NCT00788593|460370889|FG000|Placebo Run-in Phase|Protocol Violation|2|||
127931443|NCT00788593|460370890|FG001|Placebo Run-in Phase|Protocol Violation|0|||
127931444|NCT00788593|460370891|FG002|Placebo Run-in Phase|Protocol Violation|0|||
127931445|NCT00788593|460370889|FG000|First Intervention Period|Adverse Event|0|||
127931446|NCT00788593|460370890|FG001|First Intervention Period|Adverse Event|1|||
127931447|NCT00788593|460370891|FG002|First Intervention Period|Adverse Event|0|||
127931448|NCT00788593|460370889|FG000|Second Intervention Period|Lost to Follow-up|0|||
127931449|NCT00788593|460370890|FG001|Second Intervention Period|Lost to Follow-up|1|||
127931450|NCT00788593|460370891|FG002|Second Intervention Period|Lost to Follow-up|0|||
127931451|NCT00788593|460370889|FG000|Second Intervention Period|Other|0|||
127931452|NCT00788593|460370890|FG001|Second Intervention Period|Other|0|||
127931453|NCT00788593|460370891|FG002|Second Intervention Period|Other|1|||
127931454|NCT00515034|460370894|FG000|Overall Study|Adverse Event|2|||
127931455|NCT00515034|460370895|FG001|Overall Study|Adverse Event|0|||
127931456|NCT00515034|460370896|FG002|Overall Study|Adverse Event|1|||
127931457|NCT00515034|460370897|FG003|Overall Study|Adverse Event|0|||
127931458|NCT00515034|460370894|FG000|Overall Study|Death|4|||
127931459|NCT00515034|460370895|FG001|Overall Study|Death|2|||
127931460|NCT00515034|460370896|FG002|Overall Study|Death|1|||
127931461|NCT00515034|460370897|FG003|Overall Study|Death|3|||
127931462|NCT00515034|460370894|FG000|Overall Study|Withdrawal by Subject|1|||
127931463|NCT00515034|460370895|FG001|Overall Study|Withdrawal by Subject|0|||
127931464|NCT00515034|460370896|FG002|Overall Study|Withdrawal by Subject|3|||
127931465|NCT00515034|460370897|FG003|Overall Study|Withdrawal by Subject|0|||
127931466|NCT00515034|460370894|FG000|Overall Study|Physician Decision|0|||
127931467|NCT00515034|460370895|FG001|Overall Study|Physician Decision|0|||
127931468|NCT00515034|460370896|FG002|Overall Study|Physician Decision|1|||
127931469|NCT00515034|460370897|FG003|Overall Study|Physician Decision|1|||
127931470|NCT00515034|460370894|FG000|Overall Study|Other|1|||
127931471|NCT00515034|460370895|FG001|Overall Study|Other|0|||
127931472|NCT00515034|460370896|FG002|Overall Study|Other|2|||
127931473|NCT00515034|460370897|FG003|Overall Study|Other|1|||
127931474|NCT01392326|460370902|FG000|Overall Study|Death|2|||
127931475|NCT01392326|460370903|FG001|Overall Study|Death|0|||
127931476|NCT01392326|460370904|FG002|Overall Study|Death|0|||
127931477|NCT01392326|460370902|FG000|Overall Study|Withdrawal by Subject|12|||
127931478|NCT01392326|460370903|FG001|Overall Study|Withdrawal by Subject|11|||
127931479|NCT01392326|460370904|FG002|Overall Study|Withdrawal by Subject|15|||
127931480|NCT01392326|460370902|FG000|Overall Study|Protocol Violation|2|||
127931481|NCT01392326|460370903|FG001|Overall Study|Protocol Violation|0|||
127931482|NCT01392326|460370904|FG002|Overall Study|Protocol Violation|0|||
127931483|NCT01392326|460370902|FG000|Overall Study|Pregnancy|0|||
127931484|NCT01392326|460370903|FG001|Overall Study|Pregnancy|0|||
127931485|NCT01392326|460370904|FG002|Overall Study|Pregnancy|1|||
127931486|NCT01392326|460370902|FG000|Overall Study|Physician Decision|7|||
127931487|NCT01392326|460370903|FG001|Overall Study|Physician Decision|5|||
127931488|NCT01392326|460370904|FG002|Overall Study|Physician Decision|2|||
127931489|NCT01392326|460370902|FG000|Overall Study|Lost to Follow-up|1|||
127931490|NCT01392326|460370903|FG001|Overall Study|Lost to Follow-up|3|||
127931491|NCT01392326|460370904|FG002|Overall Study|Lost to Follow-up|4|||
127931492|NCT01392326|460370902|FG000|Overall Study|Lack of Efficacy|14|||
127931493|NCT01392326|460370903|FG001|Overall Study|Lack of Efficacy|10|||
127931494|NCT01392326|460370904|FG002|Overall Study|Lack of Efficacy|15|||
127931495|NCT01392326|460370902|FG000|Overall Study|Adverse Event|9|||
127931496|NCT01392326|460370903|FG001|Overall Study|Adverse Event|6|||
127931497|NCT01392326|460370904|FG002|Overall Study|Adverse Event|11|||
127931498|NCT00233987|460370909|FG000|Overall Study|Withdrawal by Subject|1|||
127931499|NCT00233987|460370909|FG000|Overall Study|Lack of Efficacy|2|||
127931500|NCT00233987|460370909|FG000|Overall Study|Reason Under Review|1|||
127931501|NCT00233987|460370909|FG000|Overall Study|Other - Not Protocol Specified|5|||
127931502|NCT00233987|460370909|FG000|Overall Study|Eligible but No Treatment Received|2|||
127931503|NCT00233987|460370909|FG000|Overall Study|Ineligible|4|||
127931504|NCT00518622|460370912|FG000|Overall Study|Lost to Follow-up|0|||
127931505|NCT00518622|460370913|FG001|Overall Study|Lost to Follow-up|0|||
127931506|NCT00518622|460370914|FG002|Overall Study|Lost to Follow-up|1|||
127931507|NCT00518622|460370915|FG003|Overall Study|Lost to Follow-up|0|||
127931508|NCT00518622|460370916|FG004|Overall Study|Lost to Follow-up|0|||
127931509|NCT00518622|460370917|FG005|Overall Study|Lost to Follow-up|0|||
127931510|NCT00518622|460370918|FG006|Overall Study|Lost to Follow-up|0|||
127931511|NCT00518622|460370919|FG007|Overall Study|Lost to Follow-up|0|||
127931512|NCT00518622|460370912|FG000|Overall Study|Study medication taken incorrectly|0|||
127931513|NCT00518622|460370913|FG001|Overall Study|Study medication taken incorrectly|1|||
127931514|NCT00518622|460370914|FG002|Overall Study|Study medication taken incorrectly|0|||
127931515|NCT00518622|460370915|FG003|Overall Study|Study medication taken incorrectly|0|||
127931516|NCT00518622|460370916|FG004|Overall Study|Study medication taken incorrectly|0|||
127931517|NCT00518622|460370917|FG005|Overall Study|Study medication taken incorrectly|0|||
127931518|NCT00518622|460370918|FG006|Overall Study|Study medication taken incorrectly|0|||
127931519|NCT00518622|460370919|FG007|Overall Study|Study medication taken incorrectly|0|||
127931520|NCT01688726|460370920|FG000|Overall Study|Adverse Event|1|||
127931521|NCT01688726|460370921|FG001|Overall Study|Adverse Event|0|||
127931522|NCT01688726|460370920|FG000|Overall Study|Relocated abroad|0|||
127931523|NCT01688726|460370921|FG001|Overall Study|Relocated abroad|1|||
127931524|NCT02631876|460373088|FG000|Overall Study|Death|96|||
127931525|NCT02631876|460373089|FG001|Overall Study|Death|50|||
127931526|NCT02631876|460373088|FG000|Overall Study|Investigator's discretion|1|||
127931527|NCT02631876|460373089|FG001|Overall Study|Investigator's discretion|0|||
127931528|NCT02631876|460373088|FG000|Overall Study|Lost to Follow-up|2|||
127931529|NCT02631876|460373089|FG001|Overall Study|Lost to Follow-up|0|||
127931530|NCT02631876|460373088|FG000|Overall Study|Withdrawal by Subject|16|||
127931531|NCT02631876|460373089|FG001|Overall Study|Withdrawal by Subject|9|||
127931532|NCT02631876|460373088|FG000|Overall Study|Other than specified|4|||
127931533|NCT02631876|460373089|FG001|Overall Study|Other than specified|4|||
127931534|NCT01408563|460373094|FG000|Overall Study|Ineligible after consent/ registration|2|||
127931535|NCT02054130|460373097|FG000|Overall Study|Withdrawal by Subject|4|||
127931536|NCT02054130|460373098|FG001|Overall Study|Withdrawal by Subject|4|||
127931537|NCT02054130|460373099|FG002|Overall Study|Withdrawal by Subject|7|||
127931538|NCT02054130|460373100|FG003|Overall Study|Withdrawal by Subject|10|||
127931539|NCT02054130|460373097|FG000|Overall Study|Death|0|||
127931540|NCT02054130|460373098|FG001|Overall Study|Death|1|||
127931541|NCT02054130|460373099|FG002|Overall Study|Death|0|||
127931542|NCT02054130|460373100|FG003|Overall Study|Death|0|||
127931543|NCT02054130|460373097|FG000|Overall Study|Lost to Follow-up|0|||
127931544|NCT02054130|460373098|FG001|Overall Study|Lost to Follow-up|0|||
127931545|NCT02054130|460373099|FG002|Overall Study|Lost to Follow-up|1|||
127931546|NCT02054130|460373100|FG003|Overall Study|Lost to Follow-up|2|||
127931547|NCT02054130|460373097|FG000|Overall Study|Missed dose|4|||
127931548|NCT02054130|460373098|FG001|Overall Study|Missed dose|6|||
127931549|NCT02054130|460373099|FG002|Overall Study|Missed dose|7|||
127931550|NCT02054130|460373100|FG003|Overall Study|Missed dose|10|||
127931551|NCT00094458|460373101|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
127931552|NCT00094458|460373102|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
127931553|NCT00094458|460373103|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
127931554|NCT00094458|460373104|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
127931555|NCT00094458|460373105|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
127931556|NCT00094458|460373106|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
127931557|NCT00094458|460373101|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
127931558|NCT00094458|460373102|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
127931559|NCT00094458|460373103|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
127931560|NCT00094458|460373104|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
127931561|NCT00094458|460373105|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
127931562|NCT00094458|460373106|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
127931563|NCT00094458|460373101|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
127931564|NCT00094458|460373102|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
127931565|NCT00094458|460373103|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
127931566|NCT00094458|460373104|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
127931567|NCT00094458|460373105|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
127931568|NCT00094458|460373106|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
127931569|NCT00094458|460373101|FG000|Main Study: Through Week 30|Adverse Event|38|||
127931570|NCT00094458|460373102|FG001|Main Study: Through Week 30|Adverse Event|20|||
127931571|NCT00094458|460373103|FG002|Main Study: Through Week 30|Adverse Event|28|||
127931572|NCT00094458|460373104|FG003|Main Study: Through Week 30|Adverse Event|0|||
127931573|NCT00094458|460373105|FG004|Main Study: Through Week 30|Adverse Event|0|||
127931574|NCT00094458|460373106|FG005|Main Study: Through Week 30|Adverse Event|0|||
127931575|NCT00094458|460373101|FG000|Main Study: Through Week 30|Death|1|||
127931576|NCT00094458|460373102|FG001|Main Study: Through Week 30|Death|0|||
127931577|NCT00094458|460373103|FG002|Main Study: Through Week 30|Death|0|||
127931578|NCT00094458|460373104|FG003|Main Study: Through Week 30|Death|0|||
127931579|NCT00094458|460373105|FG004|Main Study: Through Week 30|Death|0|||
127931580|NCT00094458|460373106|FG005|Main Study: Through Week 30|Death|0|||
127931581|NCT00094458|460373101|FG000|Main Study: Through Week 30|Other|19|||
127931582|NCT00094458|460373102|FG001|Main Study: Through Week 30|Other|16|||
127931583|NCT00094458|460373103|FG002|Main Study: Through Week 30|Other|9|||
127931584|NCT00094458|460373104|FG003|Main Study: Through Week 30|Other|0|||
127931585|NCT00094458|460373105|FG004|Main Study: Through Week 30|Other|0|||
127931586|NCT00094458|460373106|FG005|Main Study: Through Week 30|Other|0|||
127931587|NCT00094458|460373101|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
127931588|NCT00094458|460373102|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
127931589|NCT00094458|460373103|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
127931590|NCT00094458|460373104|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
127931591|NCT00094458|460373105|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
127931592|NCT00094458|460373106|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
127931593|NCT00094458|460373101|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
127931594|NCT00094458|460373102|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
127931595|NCT00094458|460373103|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
127931596|NCT00094458|460373104|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
127931597|NCT00094458|460373105|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
127931598|NCT00094458|460373106|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
127931599|NCT00094458|460373101|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
127931600|NCT00094458|460373102|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
127931601|NCT00094458|460373103|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
127931602|NCT00094458|460373104|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
127931603|NCT00094458|460373105|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
127931604|NCT00094458|460373106|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
127931605|NCT00094458|460373101|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
127931606|NCT00094458|460373102|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
127931607|NCT00094458|460373103|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
127931608|NCT00094458|460373104|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
127931609|NCT00094458|460373105|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
127931610|NCT00094458|460373106|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
127931611|NCT00094458|460373101|FG000|OLE: Open-Label Extension|Adverse Event|0|||
127931612|NCT00094458|460373102|FG001|OLE: Open-Label Extension|Adverse Event|0|||
127931613|NCT00094458|460373103|FG002|OLE: Open-Label Extension|Adverse Event|0|||
127931614|NCT00094458|460373104|FG003|OLE: Open-Label Extension|Adverse Event|0|||
127931615|NCT00094458|460373105|FG004|OLE: Open-Label Extension|Adverse Event|3|||
127931616|NCT00094458|460373106|FG005|OLE: Open-Label Extension|Adverse Event|4|||
127931617|NCT00094458|460373101|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
127931618|NCT00094458|460373102|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
127931619|NCT00094458|460373103|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
127931620|NCT00094458|460373104|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
127931621|NCT00094458|460373105|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
127931622|NCT00094458|460373106|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
127931623|NCT00094458|460373101|FG000|OLE: Open-Label Extension|Patient decision|0|||
127931624|NCT00094458|460373102|FG001|OLE: Open-Label Extension|Patient decision|0|||
127931625|NCT00094458|460373103|FG002|OLE: Open-Label Extension|Patient decision|0|||
127931626|NCT00094458|460373104|FG003|OLE: Open-Label Extension|Patient decision|0|||
127931627|NCT00094458|460373105|FG004|OLE: Open-Label Extension|Patient decision|1|||
127931628|NCT00094458|460373106|FG005|OLE: Open-Label Extension|Patient decision|0|||
127931629|NCT00973765|460373107|FG000|Overall Study|Lost to Follow-up|8|||
127931630|NCT00973765|460373108|FG001|Overall Study|Lost to Follow-up|14|||
127931631|NCT02011113|460373109|FG000|Overall Study|Adverse Event|4|||
127931632|NCT02011113|460373109|FG000|Overall Study|Disease Progression (DP)|16|||
127931633|NCT02011113|460373109|FG000|Overall Study|Death|1|||
127931634|NCT02011113|460373109|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
127931635|NCT02011113|460373109|FG000|Overall Study|Investigator's judgement- DP|3|||
127931636|NCT02011113|460373109|FG000|Overall Study|Study terminated by sponsor|11|||
127931637|NCT01892657|460373112|FG000|Overall Study|Withdrawal by Subject|6|||
127931638|NCT01892657|460373112|FG000|Overall Study|Protocol Violation|12|||
127931639|NCT00468728|460373115|FG000|Treatment|criteria for mITT population|4|||
127931640|NCT00468728|460373116|FG001|Treatment|criteria for mITT population|11|||
127931641|NCT00468728|460373115|FG000|Follow-up|mITT failure|34|||
127931642|NCT00468728|460373116|FG001|Follow-up|mITT failure|31|||
127931643|NCT02712333|460373118|FG000|First Period|Withdrawal by Subject|3|||
127931644|NCT02712333|460373119|FG001|First Period|Withdrawal by Subject|2|||
127931645|NCT03463993|460373120|FG000|Overall Study|Lost to Follow-up|7|||
127931646|NCT03463993|460373121|FG001|Overall Study|Lost to Follow-up|8|||
127931647|NCT03463993|460373120|FG000|Overall Study|Withdrawal by Subject|2|||
127931648|NCT03463993|460373121|FG001|Overall Study|Withdrawal by Subject|0|||
127931649|NCT03463993|460373120|FG000|Overall Study|Protocol Violation|4|||
127931650|NCT03463993|460373121|FG001|Overall Study|Protocol Violation|1|||
127931651|NCT03463993|460373120|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
127931652|NCT03463993|460373121|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
127931653|NCT03463993|460373120|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
127931654|NCT03463993|460373121|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
127931655|NCT01478828|460373122|FG000|Overall Study|Adverse Event|1|||
127931656|NCT00897949|460373123|FG000|Overall Study|Adverse Event|1|||
127931657|NCT00897949|460373124|FG001|Overall Study|Adverse Event|1|||
127931658|NCT00897949|460373125|FG002|Overall Study|Adverse Event|0|||
127931659|NCT00897949|460373123|FG000|Overall Study|Lost to Follow-up|0|||
127931660|NCT00897949|460373124|FG001|Overall Study|Lost to Follow-up|2|||
127931661|NCT00897949|460373125|FG002|Overall Study|Lost to Follow-up|1|||
127931662|NCT00897949|460373123|FG000|Overall Study|Protocol Violation|6|||
127931663|NCT00897949|460373124|FG001|Overall Study|Protocol Violation|3|||
127931664|NCT00897949|460373125|FG002|Overall Study|Protocol Violation|1|||
127931665|NCT00897949|460373123|FG000|Overall Study|Withdrawal by Subject|1|||
127931666|NCT00897949|460373124|FG001|Overall Study|Withdrawal by Subject|2|||
127931667|NCT00897949|460373125|FG002|Overall Study|Withdrawal by Subject|0|||
127931668|NCT00897949|460373123|FG000|Overall Study|Patient Uncoorperative|0|||
127931669|NCT00897949|460373124|FG001|Overall Study|Patient Uncoorperative|2|||
127931670|NCT00897949|460373125|FG002|Overall Study|Patient Uncoorperative|1|||
127931671|NCT00897949|460373123|FG000|Overall Study|Lost to Follow-up|30|||
127931672|NCT00897949|460373124|FG001|Overall Study|Lost to Follow-up|23|||
127931673|NCT00897949|460373125|FG002|Overall Study|Lost to Follow-up|17|||
127931674|NCT00897949|460373123|FG000|Overall Study|Withdrawal by Subject|24|||
127931675|NCT00897949|460373124|FG001|Overall Study|Withdrawal by Subject|31|||
127931676|NCT00897949|460373125|FG002|Overall Study|Withdrawal by Subject|17|||
127931677|NCT00897949|460373123|FG000|Overall Study|Abnormal Prestudy Labs|2|||
127931678|NCT00897949|460373124|FG001|Overall Study|Abnormal Prestudy Labs|3|||
127931679|NCT00897949|460373125|FG002|Overall Study|Abnormal Prestudy Labs|4|||
127931680|NCT00897949|460373123|FG000|Overall Study|Abnormal Baseline ECG|2|||
127931681|NCT00897949|460373124|FG001|Overall Study|Abnormal Baseline ECG|2|||
127931682|NCT00897949|460373125|FG002|Overall Study|Abnormal Baseline ECG|4|||
127931683|NCT00897949|460373123|FG000|Overall Study|Need for Concom. Med.|0|||
127931684|NCT00897949|460373124|FG001|Overall Study|Need for Concom. Med.|1|||
127931685|NCT00897949|460373125|FG002|Overall Study|Need for Concom. Med.|1|||
127931686|NCT00897949|460373123|FG000|Overall Study|Lack of Migraine Attack|29|||
127931687|NCT00897949|460373124|FG001|Overall Study|Lack of Migraine Attack|30|||
127931688|NCT00897949|460373125|FG002|Overall Study|Lack of Migraine Attack|19|||
127931689|NCT00897949|460373123|FG000|Overall Study|Did not take study drug|9|||
127931690|NCT00897949|460373124|FG001|Overall Study|Did not take study drug|3|||
127931691|NCT00897949|460373125|FG002|Overall Study|Did not take study drug|4|||
127931692|NCT01553747|460373126|FG000|Overall Study|Protocol Violation|0|||
127931693|NCT01553747|460373127|FG001|Overall Study|Protocol Violation|2|||
127931694|NCT01553747|460373128|FG002|Overall Study|Protocol Violation|0|||
127931695|NCT01553747|460373126|FG000|Overall Study|Voluntarily withdrew|70|||
127931696|NCT01553747|460373127|FG001|Overall Study|Voluntarily withdrew|66|||
127931697|NCT01553747|460373128|FG002|Overall Study|Voluntarily withdrew|74|||
127931698|NCT01553747|460373126|FG000|Overall Study|Adverse event or SAE|32|||
127931699|NCT01553747|460373127|FG001|Overall Study|Adverse event or SAE|28|||
127931700|NCT01553747|460373128|FG002|Overall Study|Adverse event or SAE|19|||
127931701|NCT01553747|460373126|FG000|Overall Study|Physician decision: other|10|||
127931702|NCT01553747|460373127|FG001|Overall Study|Physician decision: other|8|||
127931703|NCT01553747|460373128|FG002|Overall Study|Physician decision: other|7|||
127931704|NCT01553747|460373126|FG000|Overall Study|Lost to Follow-up|11|||
127931705|NCT01553747|460373127|FG001|Overall Study|Lost to Follow-up|5|||
127931706|NCT01553747|460373128|FG002|Overall Study|Lost to Follow-up|6|||
127931707|NCT01553747|460373126|FG000|Overall Study|Sponsor decision, specify|7|||
127931708|NCT01553747|460373127|FG001|Overall Study|Sponsor decision, specify|5|||
127931709|NCT01553747|460373128|FG002|Overall Study|Sponsor decision, specify|0|||
127931710|NCT01553747|460373126|FG000|Overall Study|Physician decision: lack of efficacy|1|||
127931711|NCT01553747|460373127|FG001|Overall Study|Physician decision: lack of efficacy|5|||
127931712|NCT01553747|460373128|FG002|Overall Study|Physician decision: lack of efficacy|3|||
127931713|NCT00977431|460373142|FG000|Overall Study|Other than listed|1|||
127931714|NCT00977431|460373143|FG001|Overall Study|Other than listed|0|||
127931715|NCT00977431|460373144|FG002|Overall Study|Other than listed|0|||
127931716|NCT00977431|460373145|FG003|Overall Study|Other than listed|0|||
127931717|NCT00977431|460373146|FG004|Overall Study|Other than listed|2|||
127931718|NCT00977431|460373142|FG000|Overall Study|Protocol Violation|0|||
127931719|NCT00977431|460373143|FG001|Overall Study|Protocol Violation|0|||
127931720|NCT00977431|460373144|FG002|Overall Study|Protocol Violation|1|||
127931721|NCT00977431|460373145|FG003|Overall Study|Protocol Violation|0|||
127931722|NCT00977431|460373146|FG004|Overall Study|Protocol Violation|0|||
127931723|NCT00977431|460373142|FG000|Overall Study|Adverse Event|3|||
127931724|NCT00977431|460373143|FG001|Overall Study|Adverse Event|0|||
127931725|NCT00977431|460373144|FG002|Overall Study|Adverse Event|4|||
127931726|NCT00977431|460373145|FG003|Overall Study|Adverse Event|0|||
127931727|NCT00977431|460373146|FG004|Overall Study|Adverse Event|6|||
127931728|NCT00977431|460373142|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
127931729|NCT00977431|460373143|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
127931730|NCT00977431|460373144|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
127931731|NCT00977431|460373145|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
127931732|NCT00977431|460373146|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
127931733|NCT00977431|460373142|FG000|Overall Study|Progressive disease|2|||
127931734|NCT00977431|460373143|FG001|Overall Study|Progressive disease|6|||
127931735|NCT00977431|460373144|FG002|Overall Study|Progressive disease|1|||
127931736|NCT00977431|460373145|FG003|Overall Study|Progressive disease|3|||
127931737|NCT00977431|460373146|FG004|Overall Study|Progressive disease|5|||
127931738|NCT02777918|460373148|FG000|Overall Study|Medical reasons|1|||
127931739|NCT02777918|460373149|FG001|Overall Study|Medical reasons|2|||
127931740|NCT02777918|460373148|FG000|Overall Study|Too busy / stressed|1|||
127931741|NCT02777918|460373149|FG001|Overall Study|Too busy / stressed|1|||
127931742|NCT02777918|460373148|FG000|Overall Study|Withdrawal by Subject|1|||
127931743|NCT02777918|460373149|FG001|Overall Study|Withdrawal by Subject|1|||
127931744|NCT00757848|460373150|FG000|Overall Study|Voluntary discontinuation|1|||
127931745|NCT00757848|460373151|FG001|Overall Study|Voluntary discontinuation|0|||
127931746|NCT00757848|460373150|FG000|Overall Study|Adverse Event|1|||
127931747|NCT00757848|460373151|FG001|Overall Study|Adverse Event|2|||
127931748|NCT00757848|460373150|FG000|Overall Study|Incorrect enrolment|1|||
127931749|NCT00757848|460373151|FG001|Overall Study|Incorrect enrolment|0|||
127931750|NCT00058214|460373154|FG000|Overall Study|Adverse Event|1|||
127931751|NCT01875471|460373165|FG000|Overall Study|Adverse Event|0|||
127931752|NCT01875471|460373166|FG001|Overall Study|Adverse Event|1|||
127931753|NCT01875471|460373165|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
127931754|NCT01875471|460373166|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
127931755|NCT03407118|460373168|FG000|Period 2|Withdrawal by Subject|1|||
127931756|NCT03407118|460373169|FG001|Period 2|Withdrawal by Subject|0|||
127931757|NCT02972502|460373172|FG000|Overall Study|Lost to Follow-up|3|||
127931758|NCT02972502|460373173|FG001|Overall Study|Lost to Follow-up|1|||
127931759|NCT02972502|460373172|FG000|Overall Study|Withdrawal by Subject|1|||
127931760|NCT02972502|460373173|FG001|Overall Study|Withdrawal by Subject|1|||
127931761|NCT01347866|460373176|FG000|Overall Study|Death|0|||
127931762|NCT01347866|460373177|FG001|Overall Study|Death|0|||
127931763|NCT01347866|460373178|FG002|Overall Study|Death|0|||
127931764|NCT01347866|460373179|FG003|Overall Study|Death|1|||
127931765|NCT01347866|460373180|FG004|Overall Study|Death|2|||
127931766|NCT01347866|460373181|FG005|Overall Study|Death|2|||
127931767|NCT01347866|460373182|FG006|Overall Study|Death|1|||
127931768|NCT01347866|460373183|FG007|Overall Study|Death|0|||
127931769|NCT01347866|460373184|FG008|Overall Study|Death|4|||
127931770|NCT01347866|460373185|FG009|Overall Study|Death|1|||
127931771|NCT01347866|460373186|FG010|Overall Study|Death|3|||
127931772|NCT01347866|460373187|FG011|Overall Study|Death|1|||
127931773|NCT01347866|460373188|FG012|Overall Study|Death|2|||
127931774|NCT01347866|460373189|FG013|Overall Study|Death|0|||
127931775|NCT01347866|460373190|FG014|Overall Study|Death|0|||
127931776|NCT01347866|460373191|FG015|Overall Study|Death|1|||
127931777|NCT01347866|460373192|FG016|Overall Study|Death|0|||
127931778|NCT01347866|460373176|FG000|Overall Study|Lost to Follow-up|0|||
127931779|NCT01347866|460373177|FG001|Overall Study|Lost to Follow-up|0|||
127931780|NCT01347866|460373178|FG002|Overall Study|Lost to Follow-up|0|||
127931781|NCT01347866|460373179|FG003|Overall Study|Lost to Follow-up|0|||
127931782|NCT01347866|460373180|FG004|Overall Study|Lost to Follow-up|0|||
127931783|NCT01347866|460373181|FG005|Overall Study|Lost to Follow-up|0|||
127931784|NCT01347866|460373182|FG006|Overall Study|Lost to Follow-up|0|||
127931785|NCT01347866|460373183|FG007|Overall Study|Lost to Follow-up|1|||
127931786|NCT01347866|460373184|FG008|Overall Study|Lost to Follow-up|1|||
127931787|NCT01347866|460373185|FG009|Overall Study|Lost to Follow-up|0|||
127931788|NCT01347866|460373186|FG010|Overall Study|Lost to Follow-up|0|||
127931789|NCT01347866|460373187|FG011|Overall Study|Lost to Follow-up|0|||
127931790|NCT01347866|460373188|FG012|Overall Study|Lost to Follow-up|0|||
127931791|NCT01347866|460373189|FG013|Overall Study|Lost to Follow-up|0|||
127931792|NCT01347866|460373190|FG014|Overall Study|Lost to Follow-up|0|||
127931793|NCT01347866|460373191|FG015|Overall Study|Lost to Follow-up|0|||
127931794|NCT01347866|460373192|FG016|Overall Study|Lost to Follow-up|0|||
127931795|NCT01347866|460373176|FG000|Overall Study|Other|3|||
127931796|NCT01347866|460373177|FG001|Overall Study|Other|1|||
127931797|NCT01347866|460373178|FG002|Overall Study|Other|1|||
127931798|NCT01347866|460373179|FG003|Overall Study|Other|4|||
127931799|NCT01347866|460373180|FG004|Overall Study|Other|5|||
127931800|NCT01347866|460373181|FG005|Overall Study|Other|0|||
127931801|NCT01347866|460373182|FG006|Overall Study|Other|5|||
127931802|NCT01347866|460373183|FG007|Overall Study|Other|3|||
127931803|NCT01347866|460373184|FG008|Overall Study|Other|22|||
127931804|NCT01347866|460373185|FG009|Overall Study|Other|5|||
127931805|NCT01347866|460373186|FG010|Overall Study|Other|0|||
127931806|NCT01347866|460373187|FG011|Overall Study|Other|3|||
127931807|NCT01347866|460373188|FG012|Overall Study|Other|4|||
127931808|NCT01347866|460373189|FG013|Overall Study|Other|4|||
127931809|NCT01347866|460373190|FG014|Overall Study|Other|2|||
127931810|NCT01347866|460373191|FG015|Overall Study|Other|3|||
127931811|NCT01347866|460373192|FG016|Overall Study|Other|0|||
127931812|NCT01347866|460373176|FG000|Overall Study|Subject refused further follow-up|2|||
127931813|NCT01347866|460373177|FG001|Overall Study|Subject refused further follow-up|0|||
127931814|NCT01347866|460373178|FG002|Overall Study|Subject refused further follow-up|0|||
127931815|NCT01347866|460373179|FG003|Overall Study|Subject refused further follow-up|2|||
127931816|NCT01347866|460373180|FG004|Overall Study|Subject refused further follow-up|0|||
127931817|NCT01347866|460373181|FG005|Overall Study|Subject refused further follow-up|1|||
127931818|NCT01347866|460373182|FG006|Overall Study|Subject refused further follow-up|0|||
127931819|NCT01347866|460373183|FG007|Overall Study|Subject refused further follow-up|0|||
127931820|NCT01347866|460373184|FG008|Overall Study|Subject refused further follow-up|4|||
127931821|NCT01347866|460373185|FG009|Overall Study|Subject refused further follow-up|1|||
127931822|NCT01347866|460373186|FG010|Overall Study|Subject refused further follow-up|0|||
127931823|NCT01347866|460373187|FG011|Overall Study|Subject refused further follow-up|0|||
127931824|NCT01347866|460373188|FG012|Overall Study|Subject refused further follow-up|1|||
127931825|NCT01347866|460373189|FG013|Overall Study|Subject refused further follow-up|3|||
127931826|NCT01347866|460373190|FG014|Overall Study|Subject refused further follow-up|1|||
127931827|NCT01347866|460373191|FG015|Overall Study|Subject refused further follow-up|0|||
127931828|NCT01347866|460373192|FG016|Overall Study|Subject refused further follow-up|2|||
127931829|NCT00430950|460373193|FG000|Overall Study|Adverse Event|7|||
127931830|NCT00430950|460373194|FG001|Overall Study|Adverse Event|6|||
127931831|NCT00430950|460373193|FG000|Overall Study|Withdrawal by Subject|1|||
127931832|NCT00430950|460373194|FG001|Overall Study|Withdrawal by Subject|0|||
127931833|NCT00430950|460373193|FG000|Overall Study|concomitant medication,etc.|5|||
127931834|NCT00430950|460373194|FG001|Overall Study|concomitant medication,etc.|7|||
127931835|NCT02429934|460373197|FG000|Overall Study|Withdrawal by Subject|0|||
127931836|NCT02429934|460373198|FG001|Overall Study|Withdrawal by Subject|2|||
127931837|NCT02429934|460373197|FG000|Overall Study|Adverse Event|2|||
127931838|NCT02429934|460373198|FG001|Overall Study|Adverse Event|0|||
127931839|NCT02429934|460373197|FG000|Overall Study|Lost to Follow-up|1|||
127931840|NCT02429934|460373198|FG001|Overall Study|Lost to Follow-up|1|||
127931841|NCT02429934|460373197|FG000|Overall Study|Physician Decision|1|||
127931842|NCT02429934|460373198|FG001|Overall Study|Physician Decision|0|||
127931843|NCT03545191|460373199|FG000|Overall Study|Death|1|||
127931844|NCT03545191|460373200|FG001|Overall Study|Death|0|||
127931845|NCT03545191|460373201|FG002|Overall Study|Death|0|||
127931846|NCT03545191|460373199|FG000|Overall Study|Adverse Event|4|||
127931847|NCT03545191|460373200|FG001|Overall Study|Adverse Event|2|||
127931848|NCT03545191|460373201|FG002|Overall Study|Adverse Event|7|||
127931849|NCT03545191|460373199|FG000|Overall Study|Other reasons|3|||
127931850|NCT03545191|460373200|FG001|Overall Study|Other reasons|11|||
127931851|NCT03545191|460373201|FG002|Overall Study|Other reasons|8|||
127931852|NCT03545191|460373199|FG000|Overall Study|Withdrawal by Subject|13|||
127931853|NCT03545191|460373200|FG001|Overall Study|Withdrawal by Subject|10|||
127931854|NCT03545191|460373201|FG002|Overall Study|Withdrawal by Subject|12|||
127931855|NCT03545191|460373199|FG000|Overall Study|Lost to Follow-up|1|||
127931856|NCT03545191|460373200|FG001|Overall Study|Lost to Follow-up|2|||
127931857|NCT03545191|460373201|FG002|Overall Study|Lost to Follow-up|3|||
127931858|NCT01491035|460373205|FG000|Overall Study|Lost to Follow-up|0|||
127931859|NCT01491035|460373206|FG001|Overall Study|Lost to Follow-up|0|||
127931860|NCT01491035|460373207|FG002|Overall Study|Lost to Follow-up|0|||
127931861|NCT01491035|460373208|FG003|Overall Study|Lost to Follow-up|0|||
127931862|NCT01491035|460373209|FG004|Overall Study|Lost to Follow-up|1|||
127931863|NCT01491035|460373210|FG005|Overall Study|Lost to Follow-up|0|||
127931864|NCT01491035|460373211|FG006|Overall Study|Lost to Follow-up|0|||
127931865|NCT01491035|460373212|FG007|Overall Study|Lost to Follow-up|0|||
127931866|NCT02377063|460373214|FG000|Overall Study|Non-compliance|5|||
127931867|NCT01277718|460373220|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
127931868|NCT01277718|460373221|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
127931869|NCT01277718|460373220|FG000|Period 2 - Second Intervention|Physician Decision|0|||
127931870|NCT01277718|460373221|FG001|Period 2 - Second Intervention|Physician Decision|2|||
127931871|NCT03351231|460373238|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
127931872|NCT03351231|460373238|FG000|Combination Therapy Period|Disease progression|2|||
127931873|NCT03351231|460373238|FG000|Combination Therapy Period|Study drug toxicity|1|||
127931874|NCT03351231|460373238|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
127931875|NCT03351231|460373238|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
127931876|NCT03351231|460373238|FG000|Safety Follow-Up Period|Other reason|2|||
127931877|NCT02858726|460373239|FG000|Overall Study|Adverse Event|4|||
127931878|NCT02858726|460373240|FG001|Overall Study|Adverse Event|4|||
127931879|NCT02858726|460373241|FG002|Overall Study|Adverse Event|9|||
127931880|NCT02858726|460373242|FG003|Overall Study|Adverse Event|1|||
127931881|NCT02858726|460373239|FG000|Overall Study|Physician Decision|0|||
127931882|NCT02858726|460373240|FG001|Overall Study|Physician Decision|0|||
127931883|NCT02858726|460373241|FG002|Overall Study|Physician Decision|1|||
127931884|NCT02858726|460373242|FG003|Overall Study|Physician Decision|0|||
127931885|NCT02858726|460373239|FG000|Overall Study|Protocol Violation|0|||
127931886|NCT02858726|460373240|FG001|Overall Study|Protocol Violation|0|||
127931887|NCT02858726|460373241|FG002|Overall Study|Protocol Violation|0|||
127931888|NCT02858726|460373242|FG003|Overall Study|Protocol Violation|1|||
127931889|NCT02858726|460373239|FG000|Overall Study|Study Terminated by Sponsor|0|||
127931890|NCT02858726|460373240|FG001|Overall Study|Study Terminated by Sponsor|0|||
127931891|NCT02858726|460373241|FG002|Overall Study|Study Terminated by Sponsor|0|||
127931892|NCT02858726|460373242|FG003|Overall Study|Study Terminated by Sponsor|1|||
127931893|NCT02858726|460373239|FG000|Overall Study|Withdrawal by Subject|1|||
127931894|NCT02858726|460373240|FG001|Overall Study|Withdrawal by Subject|2|||
127931895|NCT02858726|460373241|FG002|Overall Study|Withdrawal by Subject|1|||
127931896|NCT02858726|460373242|FG003|Overall Study|Withdrawal by Subject|0|||
127931897|NCT02858726|460373239|FG000|Overall Study|Noncompliance|0|||
127931898|NCT02858726|460373240|FG001|Overall Study|Noncompliance|1|||
127931899|NCT02858726|460373241|FG002|Overall Study|Noncompliance|0|||
127931900|NCT02858726|460373242|FG003|Overall Study|Noncompliance|0|||
127931901|NCT02340221|460373243|FG000|Overall Study|Death|100|||
127931902|NCT02340221|460373244|FG001|Overall Study|Death|197|||
127931903|NCT02340221|460373243|FG000|Overall Study|Withdrawal by Participant|24|||
127931904|NCT02340221|460373244|FG001|Overall Study|Withdrawal by Participant|37|||
127931905|NCT02340221|460373243|FG000|Overall Study|Lost to Follow-up|4|||
127931906|NCT02340221|460373244|FG001|Overall Study|Lost to Follow-up|15|||
127931907|NCT02340221|460373243|FG000|Overall Study|Reason Not Specified|85|||
127931908|NCT02340221|460373244|FG001|Overall Study|Reason Not Specified|165|||
127931909|NCT02340221|460373243|FG000|Overall Study|Study Terminated by Sponsor|1|||
127931910|NCT02340221|460373244|FG001|Overall Study|Study Terminated by Sponsor|3|||
127931911|NCT03499119|460373245|FG000|Initial Treatment Phase|Protocol Specified Criteria|0|||
127931912|NCT03499119|460373246|FG001|Initial Treatment Phase|Protocol Specified Criteria|0|||
127931913|NCT03499119|460373247|FG002|Initial Treatment Phase|Protocol Specified Criteria|0|||
127931914|NCT03499119|460373248|FG003|Initial Treatment Phase|Protocol Specified Criteria|1|||
127931915|NCT03499119|460373245|FG000|Initial Treatment Phase|Withdrawal by Subject|0|||
127931916|NCT03499119|460373246|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
127931917|NCT03499119|460373247|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
127931918|NCT03499119|460373248|FG003|Initial Treatment Phase|Withdrawal by Subject|1|||
127931919|NCT03499119|460373245|FG000|Initial Treatment Phase|Decision by Sponsor|1|||
127931920|NCT03499119|460373246|FG001|Initial Treatment Phase|Decision by Sponsor|0|||
127931921|NCT03499119|460373247|FG002|Initial Treatment Phase|Decision by Sponsor|1|||
127931922|NCT03499119|460373248|FG003|Initial Treatment Phase|Decision by Sponsor|1|||
127931923|NCT03499119|460373245|FG000|Optional Extension Phase|Lost to Follow-up|0|||
127931924|NCT03499119|460373246|FG001|Optional Extension Phase|Lost to Follow-up|0|||
127931925|NCT03499119|460373247|FG002|Optional Extension Phase|Lost to Follow-up|0|||
127931926|NCT03499119|460373248|FG003|Optional Extension Phase|Lost to Follow-up|1|||
127931927|NCT03499119|460373245|FG000|Optional Extension Phase|Withdrawal by Subject|0|||
127931928|NCT03499119|460373246|FG001|Optional Extension Phase|Withdrawal by Subject|0|||
127931929|NCT03499119|460373247|FG002|Optional Extension Phase|Withdrawal by Subject|0|||
127931930|NCT03499119|460373248|FG003|Optional Extension Phase|Withdrawal by Subject|5|||
127931931|NCT03499119|460373245|FG000|Optional Extension Phase|Protocol Specified Criteria|0|||
127931932|NCT03499119|460373246|FG001|Optional Extension Phase|Protocol Specified Criteria|1|||
127931933|NCT03499119|460373247|FG002|Optional Extension Phase|Protocol Specified Criteria|0|||
127931934|NCT03499119|460373248|FG003|Optional Extension Phase|Protocol Specified Criteria|0|||
127931935|NCT04553913|460373249|FG000|Overall Study|patient's block resolved prior to PACU|1|||
127931936|NCT04553913|460373249|FG000|Overall Study|did not use the device properly|5|||
127931937|NCT01481324|460373250|FG000|Overall Study|Missing Data|0|||
127931938|NCT01481324|460373251|FG001|Overall Study|Missing Data|2|||
127931939|NCT01481324|460373252|FG002|Overall Study|Missing Data|2|||
127931940|NCT01172821|460373255|FG000|Overall Study|Adverse Event|5|||
127931941|NCT01172821|460373256|FG001|Overall Study|Adverse Event|2|||
127931942|NCT01172821|460373257|FG002|Overall Study|Adverse Event|2|||
127931943|NCT01172821|460373258|FG003|Overall Study|Adverse Event|7|||
127931944|NCT01172821|460373255|FG000|Overall Study|Protocol Violation|0|||
127931945|NCT01172821|460373256|FG001|Overall Study|Protocol Violation|2|||
127931946|NCT01172821|460373257|FG002|Overall Study|Protocol Violation|1|||
127931947|NCT01172821|460373258|FG003|Overall Study|Protocol Violation|2|||
127931948|NCT01172821|460373255|FG000|Overall Study|Lost to Follow-up|4|||
127931949|NCT01172821|460373256|FG001|Overall Study|Lost to Follow-up|1|||
127931950|NCT01172821|460373257|FG002|Overall Study|Lost to Follow-up|2|||
127931951|NCT01172821|460373258|FG003|Overall Study|Lost to Follow-up|2|||
127931952|NCT01172821|460373255|FG000|Overall Study|Withdrawal by Subject|2|||
127931953|NCT01172821|460373256|FG001|Overall Study|Withdrawal by Subject|3|||
127931954|NCT01172821|460373257|FG002|Overall Study|Withdrawal by Subject|3|||
127931955|NCT01172821|460373258|FG003|Overall Study|Withdrawal by Subject|3|||
127931956|NCT01172821|460373255|FG000|Overall Study|Other|3|||
127931957|NCT01172821|460373256|FG001|Overall Study|Other|4|||
127931958|NCT01172821|460373257|FG002|Overall Study|Other|5|||
127931959|NCT01172821|460373258|FG003|Overall Study|Other|3|||
127931960|NCT00710749|460373259|FG000|First Intervention|Withdrawal by Subject|1|||
127931961|NCT00710749|460373260|FG001|First Intervention|Withdrawal by Subject|0|||
127931962|NCT04495283|460375168|FG000|Overall Study|Physician Decision|0|||
127931963|NCT04495283|460375169|FG001|Overall Study|Physician Decision|0|||
127931964|NCT04495283|460375170|FG002|Overall Study|Physician Decision|1|||
127931965|NCT04495283|460375168|FG000|Overall Study|Withdrawal by Subject|0|||
127931966|NCT04495283|460375169|FG001|Overall Study|Withdrawal by Subject|1|||
127931967|NCT04495283|460375170|FG002|Overall Study|Withdrawal by Subject|1|||
127931968|NCT04495283|460375168|FG000|Overall Study|Other|1|||
127931969|NCT04495283|460375169|FG001|Overall Study|Other|0|||
127931970|NCT04495283|460375170|FG002|Overall Study|Other|1|||
127931971|NCT00380692|460375173|FG000|Study Period II - Double Blind|Adverse Event|1|||
127931972|NCT00380692|460375174|FG001|Study Period II - Double Blind|Adverse Event|0|||
127931973|NCT00380692|460375173|FG000|Study Period II - Double Blind|Protocol Violation|2|||
127931974|NCT00380692|460375174|FG001|Study Period II - Double Blind|Protocol Violation|2|||
127931975|NCT00380692|460375173|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
127931976|NCT00380692|460375174|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
127931977|NCT00380692|460375173|FG000|Study Period II - Double Blind|Physician Decision|0|||
127931978|NCT00380692|460375174|FG001|Study Period II - Double Blind|Physician Decision|1|||
127931979|NCT00380692|460375173|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
127931980|NCT00380692|460375174|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
127931981|NCT00380692|460375173|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
127931982|NCT00380692|460375174|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
127931983|NCT00380692|460375173|FG000|Study Period III - Open Label|Adverse Event|5|||
127931984|NCT00380692|460375174|FG001|Study Period III - Open Label|Adverse Event|3|||
127931985|NCT00380692|460375173|FG000|Study Period III - Open Label|Protocol Violation|0|||
127931986|NCT00380692|460375174|FG001|Study Period III - Open Label|Protocol Violation|0|||
127931987|NCT00380692|460375173|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
127931988|NCT00380692|460375174|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
127931989|NCT00380692|460375173|FG000|Study Period III - Open Label|Physician Decision|0|||
127931990|NCT00380692|460375174|FG001|Study Period III - Open Label|Physician Decision|3|||
127931991|NCT00380692|460375173|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
127931992|NCT00380692|460375174|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
127931993|NCT00380692|460375173|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
127931994|NCT00380692|460375174|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
127931995|NCT02177136|460375178|FG000|DB Phase|Withdrawal by Subject|2|||
127931996|NCT02177136|460375179|FG001|DB Phase|Withdrawal by Subject|0|||
127931997|NCT02177136|460375180|FG002|DB Phase|Withdrawal by Subject|0|||
127931998|NCT02177136|460375181|FG003|DB Phase|Withdrawal by Subject|0|||
127931999|NCT02177136|460375178|FG000|DB Phase|Discontinued Due to Pruritus|1|||
127932000|NCT02177136|460375179|FG001|DB Phase|Discontinued Due to Pruritus|3|||
127932001|NCT02177136|460375180|FG002|DB Phase|Discontinued Due to Pruritus|0|||
127932002|NCT02177136|460375181|FG003|DB Phase|Discontinued Due to Pruritus|0|||
127932003|NCT02177136|460375178|FG000|DB Phase|Adverse Event|3|||
127932004|NCT02177136|460375179|FG001|DB Phase|Adverse Event|2|||
127932005|NCT02177136|460375180|FG002|DB Phase|Adverse Event|3|||
127932006|NCT02177136|460375181|FG003|DB Phase|Adverse Event|0|||
127932007|NCT02177136|460375178|FG000|DB Phase|Protocol Violation|0|||
127932008|NCT02177136|460375179|FG001|DB Phase|Protocol Violation|0|||
127932009|NCT02177136|460375180|FG002|DB Phase|Protocol Violation|1|||
127932010|NCT02177136|460375181|FG003|DB Phase|Protocol Violation|0|||
127932011|NCT02177136|460375178|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
127932012|NCT02177136|460375179|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
127932013|NCT02177136|460375180|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
127932014|NCT02177136|460375181|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
127932015|NCT02177136|460375178|FG000|LTSE Phase|Withdrawal by Subject|0|||
127932016|NCT02177136|460375179|FG001|LTSE Phase|Withdrawal by Subject|0|||
127932017|NCT02177136|460375180|FG002|LTSE Phase|Withdrawal by Subject|0|||
127932018|NCT02177136|460375181|FG003|LTSE Phase|Withdrawal by Subject|6|||
127932019|NCT02177136|460375178|FG000|LTSE Phase|Adverse Event|0|||
127932020|NCT02177136|460375179|FG001|LTSE Phase|Adverse Event|0|||
127932021|NCT02177136|460375180|FG002|LTSE Phase|Adverse Event|0|||
127932022|NCT02177136|460375181|FG003|LTSE Phase|Adverse Event|10|||
127932023|NCT02177136|460375178|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
127932024|NCT02177136|460375179|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
127932025|NCT02177136|460375180|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
127932026|NCT02177136|460375181|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
127932027|NCT02177136|460375178|FG000|LTSE Phase|Physician Decision|0|||
127932028|NCT02177136|460375179|FG001|LTSE Phase|Physician Decision|0|||
127932029|NCT02177136|460375180|FG002|LTSE Phase|Physician Decision|0|||
127932030|NCT02177136|460375181|FG003|LTSE Phase|Physician Decision|2|||
127932031|NCT02177136|460375178|FG000|LTSE Phase|Lost to Follow-up|0|||
127932032|NCT02177136|460375179|FG001|LTSE Phase|Lost to Follow-up|0|||
127932033|NCT02177136|460375180|FG002|LTSE Phase|Lost to Follow-up|0|||
127932034|NCT02177136|460375181|FG003|LTSE Phase|Lost to Follow-up|1|||
127932035|NCT02177136|460375178|FG000|LTSE Phase|Participant Moved|0|||
127932036|NCT02177136|460375179|FG001|LTSE Phase|Participant Moved|0|||
127932037|NCT02177136|460375180|FG002|LTSE Phase|Participant Moved|0|||
127932038|NCT02177136|460375181|FG003|LTSE Phase|Participant Moved|1|||
127932039|NCT01386684|460375185|FG000|Overall Study|Lost to Follow-up|51|||
127932040|NCT01386684|460375185|FG000|Overall Study|Other|51|||
127932041|NCT01386684|460375185|FG000|Overall Study|Death|47|||
127932042|NCT01386684|460375185|FG000|Overall Study|Withdrawal of Consent|44|||
127932043|NCT01386684|460375185|FG000|Overall Study|Alternative Therapy Required|37|||
127932044|NCT01386684|460375185|FG000|Overall Study|Disease Progression|28|||
127932045|NCT01386684|460375185|FG000|Overall Study|Adverse Event|20|||
127932046|NCT01386684|460375185|FG000|Overall Study|Noncompliance|8|||
127932047|NCT01386684|460375185|FG000|Overall Study|Protocol Violation|4|||
127932048|NCT01386684|460375185|FG000|Overall Study|Missing|3|||
127932049|NCT01032018|460375186|FG000|Overall Study|Lost to Follow-up|6|||
127932050|NCT01032018|460375187|FG001|Overall Study|Lost to Follow-up|5|||
127932051|NCT01032018|460375186|FG000|Overall Study|Death|0|||
127932052|NCT01032018|460375187|FG001|Overall Study|Death|1|||
127932053|NCT03265288|460375188|FG000|Overall Study|Adverse Event|0|||
127932054|NCT03265288|460375189|FG001|Overall Study|Adverse Event|1|||
127932055|NCT03265288|460375188|FG000|Overall Study|Withdrawal by Subject|13|||
127932056|NCT03265288|460375189|FG001|Overall Study|Withdrawal by Subject|5|||
127932057|NCT03265288|460375188|FG000|Overall Study|Drug Withdrawn|3|||
127932058|NCT03265288|460375189|FG001|Overall Study|Drug Withdrawn|3|||
127932059|NCT03265288|460375188|FG000|Overall Study|Any Other Reason|7|||
127932060|NCT03265288|460375189|FG001|Overall Study|Any Other Reason|3|||
127932061|NCT03197558|460375190|FG000|Overall Study|Tubes not placed|1|||
127932062|NCT02072148|460375194|FG000|Overall Study|withdrew prior to surgery|23|||
127932063|NCT02072148|460375195|FG001|Overall Study|withdrew prior to surgery|0|||
127932064|NCT02072148|460375196|FG002|Overall Study|withdrew prior to surgery|0|||
127932065|NCT02072148|460375194|FG000|Overall Study|Death|0|||
127932066|NCT02072148|460375195|FG001|Overall Study|Death|0|||
127932067|NCT02072148|460375196|FG002|Overall Study|Death|1|||
127932068|NCT02072148|460375194|FG000|Overall Study|Withdrawal by Subject|0|||
127932069|NCT02072148|460375195|FG001|Overall Study|Withdrawal by Subject|13|||
127932070|NCT02072148|460375196|FG002|Overall Study|Withdrawal by Subject|12|||
127932071|NCT01939496|460375197|FG000|Overall Study|Adverse Event|2|||
127932072|NCT01939496|460375198|FG001|Overall Study|Adverse Event|0|||
127932073|NCT01939496|460375199|FG002|Overall Study|Adverse Event|0|||
127932074|NCT01939496|460375197|FG000|Overall Study|Lost to Follow-up|1|||
127932075|NCT01939496|460375198|FG001|Overall Study|Lost to Follow-up|1|||
127932076|NCT01939496|460375199|FG002|Overall Study|Lost to Follow-up|0|||
127932077|NCT01939496|460375197|FG000|Overall Study|Physician Decision|1|||
127932078|NCT01939496|460375198|FG001|Overall Study|Physician Decision|0|||
127932079|NCT01939496|460375199|FG002|Overall Study|Physician Decision|0|||
127932080|NCT01939496|460375197|FG000|Overall Study|Protocol Violation|3|||
127932081|NCT01939496|460375198|FG001|Overall Study|Protocol Violation|0|||
127932082|NCT01939496|460375199|FG002|Overall Study|Protocol Violation|0|||
127932083|NCT01939496|460375197|FG000|Overall Study|Withdrawal by Subject|0|||
127932084|NCT01939496|460375198|FG001|Overall Study|Withdrawal by Subject|1|||
127932085|NCT01939496|460375199|FG002|Overall Study|Withdrawal by Subject|1|||
127932086|NCT01939496|460375197|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
127932087|NCT01939496|460375198|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
127932088|NCT01939496|460375199|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
127932089|NCT01939496|460375197|FG000|Overall Study|Other|2|||
127932090|NCT01939496|460375198|FG001|Overall Study|Other|0|||
127932091|NCT01939496|460375199|FG002|Overall Study|Other|1|||
127932092|NCT03052322|460375200|FG000|Overall Study|Other un-specified|1|||
127932093|NCT03052322|460375201|FG001|Overall Study|Other un-specified|2|||
127932094|NCT03052322|460375200|FG000|Overall Study|Withdrawal by Subject|10|||
127932095|NCT03052322|460375201|FG001|Overall Study|Withdrawal by Subject|9|||
127932096|NCT03052322|460375200|FG000|Overall Study|Death|0|||
127932097|NCT03052322|460375201|FG001|Overall Study|Death|2|||
127932098|NCT03052322|460375200|FG000|Overall Study|Lack of Efficacy|1|||
127932099|NCT03052322|460375201|FG001|Overall Study|Lack of Efficacy|2|||
127932100|NCT03052322|460375200|FG000|Overall Study|Protocol Violation|1|||
127932101|NCT03052322|460375201|FG001|Overall Study|Protocol Violation|0|||
127932102|NCT03052322|460375200|FG000|Overall Study|Lost to Follow-up|2|||
127932103|NCT03052322|460375201|FG001|Overall Study|Lost to Follow-up|4|||
127932104|NCT03052322|460375200|FG000|Overall Study|Adverse Event|6|||
127932105|NCT03052322|460375201|FG001|Overall Study|Adverse Event|13|||
127932106|NCT04920916|460375202|FG000|Phase IIa 60 Day Study|Death|2|||
127932107|NCT04920916|460375203|FG001|Phase IIa 60 Day Study|Death|5|||
127932108|NCT04920916|460375202|FG000|1 Year Follow up (Phone Call)|Death|1|||
127932109|NCT04920916|460375203|FG001|1 Year Follow up (Phone Call)|Death|3|||
127932110|NCT04920916|460375202|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
127932111|NCT04920916|460375203|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
127932112|NCT03251963|460375212|FG000|Overall Study|inappropriate Xa level timing|6|||
127932113|NCT03251963|460375213|FG001|Overall Study|inappropriate Xa level timing|3|||
127932114|NCT03251963|460375212|FG000|Overall Study|no peak Xa level drawn|2|||
127932115|NCT03251963|460375213|FG001|Overall Study|no peak Xa level drawn|0|||
127932116|NCT03251963|460375212|FG000|Overall Study|bled prior to Xa level|1|||
127932117|NCT03251963|460375213|FG001|Overall Study|bled prior to Xa level|2|||
127932118|NCT00136318|460375216|FG000|Overall Study|Adverse Event|5|||
127932119|NCT00136318|460375217|FG001|Overall Study|Adverse Event|5|||
127932120|NCT00136318|460375216|FG000|Overall Study|Withdrawal by Subject|2|||
127932121|NCT00136318|460375217|FG001|Overall Study|Withdrawal by Subject|2|||
127932122|NCT02278718|460375220|FG000|Overall Study|Adverse Event|1|||
127932123|NCT02278718|460375221|FG001|Overall Study|Adverse Event|0|||
127932124|NCT02278718|460375220|FG000|Overall Study|Lost to Follow-up|2|||
127932125|NCT02278718|460375221|FG001|Overall Study|Lost to Follow-up|4|||
127932126|NCT02278718|460375220|FG000|Overall Study|Withdrawal by Subject|1|||
127932127|NCT02278718|460375221|FG001|Overall Study|Withdrawal by Subject|4|||
127932128|NCT02278718|460375220|FG000|Overall Study|The patient was randomised but did not receive study drug treatment|2|||
127932129|NCT02278718|460375221|FG001|Overall Study|The patient was randomised but did not receive study drug treatment|1|||
127932130|NCT02278718|460375220|FG000|Overall Study|Missing|0|||
127932131|NCT02278718|460375221|FG001|Overall Study|Missing|1|||
127932132|NCT01546649|460375222|FG000|Overall Study|Adverse Event|4|||
127932133|NCT01546649|460375223|FG001|Overall Study|Adverse Event|5|||
127932134|NCT01546649|460375222|FG000|Overall Study|Protocol Violation|1|||
127932135|NCT01546649|460375223|FG001|Overall Study|Protocol Violation|0|||
127932136|NCT01546649|460375222|FG000|Overall Study|Lack of Efficacy|1|||
127932137|NCT01546649|460375223|FG001|Overall Study|Lack of Efficacy|0|||
127932138|NCT01546649|460375222|FG000|Overall Study|Recurrence|1|||
127932139|NCT01546649|460375223|FG001|Overall Study|Recurrence|1|||
127932140|NCT01546649|460375222|FG000|Overall Study|Discovery of secondary cancer|0|||
127932141|NCT01546649|460375223|FG001|Overall Study|Discovery of secondary cancer|1|||
127932142|NCT01546649|460375222|FG000|Overall Study|Withdrawal by Subject|1|||
127932143|NCT01546649|460375223|FG001|Overall Study|Withdrawal by Subject|2|||
127932144|NCT04440449|460375224|FG000|Overall Study|Lost to Follow-up|2|||
127932145|NCT04440449|460375225|FG001|Overall Study|Lost to Follow-up|0|||
127932146|NCT01763918|460375226|FG000|Overall Study|Withdrawal by Subject|2|||
127932147|NCT01763918|460375227|FG001|Overall Study|Withdrawal by Subject|1|||
127932148|NCT01763918|460375228|FG002|Overall Study|Withdrawal by Subject|1|||
127932149|NCT01763918|460375229|FG003|Overall Study|Withdrawal by Subject|2|||
127932150|NCT01763918|460375226|FG000|Overall Study|Sponsor Decision|4|||
127932151|NCT01763918|460375227|FG001|Overall Study|Sponsor Decision|0|||
127932152|NCT01763918|460375228|FG002|Overall Study|Sponsor Decision|9|||
127932153|NCT01763918|460375229|FG003|Overall Study|Sponsor Decision|0|||
127932154|NCT01134627|460375236|FG000|Overall Study|Adverse Event|47|||
127932155|NCT01134627|460375237|FG001|Overall Study|Adverse Event|31|||
127932156|NCT01134627|460375236|FG000|Overall Study|Lost to Follow-up|1|||
127932157|NCT01134627|460375237|FG001|Overall Study|Lost to Follow-up|2|||
127932158|NCT01134627|460375236|FG000|Overall Study|Protocol Violation|3|||
127932159|NCT01134627|460375237|FG001|Overall Study|Protocol Violation|5|||
127932160|NCT01134627|460375236|FG000|Overall Study|Lack of Efficacy|2|||
127932161|NCT01134627|460375237|FG001|Overall Study|Lack of Efficacy|12|||
127932162|NCT01134627|460375236|FG000|Overall Study|Withdrawal by Subject|4|||
127932163|NCT01134627|460375237|FG001|Overall Study|Withdrawal by Subject|3|||
127932164|NCT01134627|460375236|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
127932165|NCT01134627|460375237|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
127932166|NCT01134627|460375236|FG000|Overall Study|Other|11|||
127932167|NCT01134627|460375237|FG001|Overall Study|Other|14|||
127932168|NCT00518882|460375243|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
127932169|NCT00518882|460375244|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
127932170|NCT00518882|460375243|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
127932171|NCT00518882|460375244|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
127932172|NCT00518882|460375243|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
127932173|NCT00518882|460375244|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
127932174|NCT00518882|460375243|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
127932175|NCT00518882|460375244|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
127932176|NCT00518882|460375243|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
127932177|NCT00518882|460375244|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
127932178|NCT00518882|460375243|FG000|Double-Blind, Week 0-26|Subject decision|1|||
127932179|NCT00518882|460375244|FG001|Double-Blind, Week 0-26|Subject decision|1|||
127932180|NCT00518882|460375243|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
127932181|NCT00518882|460375244|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
127932182|NCT00518882|460375243|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
127932183|NCT00518882|460375244|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
127932184|NCT00518882|460375243|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
127932185|NCT00518882|460375244|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
127932186|NCT00518882|460375243|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
127932187|NCT00518882|460375244|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
127932188|NCT00518882|460375243|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
127932189|NCT00518882|460375244|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
127932190|NCT00518882|460375243|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
127932191|NCT00518882|460375244|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
127932192|NCT00518882|460375243|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
127932193|NCT00518882|460375244|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
127932194|NCT00518882|460375243|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
127932195|NCT00518882|460375244|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
127932196|NCT00518882|460375243|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
127932197|NCT00518882|460375244|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
127932198|NCT00518882|460375243|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
127932199|NCT00518882|460375244|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
127932200|NCT00518882|460375243|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
127932201|NCT00518882|460375244|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
127932202|NCT00518882|460375243|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
127932203|NCT00518882|460375244|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
127932204|NCT00518882|460375243|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
127932205|NCT00518882|460375244|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
127932206|NCT00518882|460375243|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
127932207|NCT00518882|460375244|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
127932208|NCT00518882|460375243|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
127932209|NCT00518882|460375244|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
127932210|NCT00518882|460375243|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
127932211|NCT00518882|460375244|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
127932212|NCT00518882|460375243|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
127932213|NCT00518882|460375244|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
127932214|NCT00518882|460375243|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
127932215|NCT00518882|460375244|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
127932216|NCT03395639|460375245|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
127932217|NCT03395639|460375246|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
127932218|NCT03395639|460375247|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
127932219|NCT03395639|460375245|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
127932220|NCT03395639|460375246|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
127932221|NCT03395639|460375247|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
127932222|NCT03395639|460375245|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
127932223|NCT03395639|460375246|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
127932224|NCT03395639|460375247|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
127932225|NCT03395639|460375245|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
127932226|NCT03395639|460375246|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
127932227|NCT03395639|460375247|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
127932228|NCT03395639|460375245|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
127932229|NCT03395639|460375246|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
127932230|NCT03395639|460375247|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
127932231|NCT00942331|460375248|FG000|Overall Study|Did not start treatment|15|||
127932232|NCT00942331|460375249|FG001|Overall Study|Did not start treatment|22|||
127932233|NCT00567476|460375254|FG000|Overall Study|Adverse Event|2|||
127932234|NCT00567476|460375255|FG001|Overall Study|Adverse Event|0|||
127932235|NCT00567476|460375254|FG000|Overall Study|Pregnancy|1|||
127932236|NCT00567476|460375255|FG001|Overall Study|Pregnancy|0|||
127932237|NCT00567476|460375254|FG000|Overall Study|Protocol Violation|4|||
127932238|NCT00567476|460375255|FG001|Overall Study|Protocol Violation|1|||
127932239|NCT00567476|460375254|FG000|Overall Study|Lost to Follow-up|0|||
127932240|NCT00567476|460375255|FG001|Overall Study|Lost to Follow-up|1|||
127932241|NCT00567476|460375254|FG000|Overall Study|Administrative issues|1|||
127932242|NCT00567476|460375255|FG001|Overall Study|Administrative issues|0|||
127932243|NCT00567476|460375254|FG000|Overall Study|Medical Decision|0|||
127932244|NCT00567476|460375255|FG001|Overall Study|Medical Decision|1|||
127932245|NCT00567476|460375254|FG000|Overall Study|Non-adherence to protocol|0|||
127932246|NCT00567476|460375255|FG001|Overall Study|Non-adherence to protocol|1|||
127932247|NCT02696031|460375257|FG000|Up to Week 24|Adverse Event|2|||
127932248|NCT02696031|460375258|FG001|Up to Week 24|Adverse Event|4|||
127932249|NCT02696031|460375259|FG002|Up to Week 24|Adverse Event|2|||
127932250|NCT02696031|460375260|FG003|Up to Week 24|Adverse Event|0|||
127932251|NCT02696031|460375261|FG004|Up to Week 24|Adverse Event|0|||
127932252|NCT02696031|460375262|FG005|Up to Week 24|Adverse Event|0|||
127932253|NCT02696031|460375257|FG000|Up to Week 24|Lack of Efficacy|2|||
127932254|NCT02696031|460375258|FG001|Up to Week 24|Lack of Efficacy|1|||
127932255|NCT02696031|460375259|FG002|Up to Week 24|Lack of Efficacy|2|||
127932256|NCT02696031|460375260|FG003|Up to Week 24|Lack of Efficacy|0|||
127932257|NCT02696031|460375261|FG004|Up to Week 24|Lack of Efficacy|0|||
127932258|NCT02696031|460375262|FG005|Up to Week 24|Lack of Efficacy|0|||
127932259|NCT02696031|460375257|FG000|Up to Week 24|Lost to Follow-up|0|||
127932260|NCT02696031|460375258|FG001|Up to Week 24|Lost to Follow-up|1|||
127932261|NCT02696031|460375259|FG002|Up to Week 24|Lost to Follow-up|1|||
127932262|NCT02696031|460375260|FG003|Up to Week 24|Lost to Follow-up|0|||
127932263|NCT02696031|460375261|FG004|Up to Week 24|Lost to Follow-up|0|||
127932264|NCT02696031|460375262|FG005|Up to Week 24|Lost to Follow-up|0|||
127932265|NCT02696031|460375257|FG000|Up to Week 24|Physician Decision|1|||
127932266|NCT02696031|460375258|FG001|Up to Week 24|Physician Decision|0|||
127932267|NCT02696031|460375259|FG002|Up to Week 24|Physician Decision|1|||
127932268|NCT02696031|460375260|FG003|Up to Week 24|Physician Decision|0|||
127932269|NCT02696031|460375261|FG004|Up to Week 24|Physician Decision|0|||
127932270|NCT02696031|460375262|FG005|Up to Week 24|Physician Decision|0|||
127932271|NCT02696031|460375257|FG000|Up to Week 24|Protocol Violation|1|||
127932272|NCT02696031|460375258|FG001|Up to Week 24|Protocol Violation|0|||
127932273|NCT02696031|460375259|FG002|Up to Week 24|Protocol Violation|0|||
127932274|NCT02696031|460375260|FG003|Up to Week 24|Protocol Violation|0|||
127932275|NCT02696031|460375261|FG004|Up to Week 24|Protocol Violation|0|||
127932276|NCT02696031|460375262|FG005|Up to Week 24|Protocol Violation|0|||
127932277|NCT02696031|460375257|FG000|Up to Week 24|Withdrawal by Subject|4|||
127932278|NCT02696031|460375258|FG001|Up to Week 24|Withdrawal by Subject|1|||
127932279|NCT02696031|460375259|FG002|Up to Week 24|Withdrawal by Subject|5|||
127932280|NCT02696031|460375260|FG003|Up to Week 24|Withdrawal by Subject|0|||
127932281|NCT02696031|460375261|FG004|Up to Week 24|Withdrawal by Subject|0|||
127932282|NCT02696031|460375262|FG005|Up to Week 24|Withdrawal by Subject|0|||
127932283|NCT02696031|460375257|FG000|Up to Week 52|Adverse Event|4|||
127932284|NCT02696031|460375258|FG001|Up to Week 52|Adverse Event|5|||
127932285|NCT02696031|460375259|FG002|Up to Week 52|Adverse Event|3|||
127932286|NCT02696031|460375260|FG003|Up to Week 52|Adverse Event|0|||
127932287|NCT02696031|460375261|FG004|Up to Week 52|Adverse Event|0|||
127932288|NCT02696031|460375262|FG005|Up to Week 52|Adverse Event|0|||
127932289|NCT02696031|460375257|FG000|Up to Week 52|Lack of Efficacy|10|||
127932290|NCT02696031|460375258|FG001|Up to Week 52|Lack of Efficacy|7|||
127932291|NCT02696031|460375259|FG002|Up to Week 52|Lack of Efficacy|11|||
127932292|NCT02696031|460375260|FG003|Up to Week 52|Lack of Efficacy|0|||
127932293|NCT02696031|460375261|FG004|Up to Week 52|Lack of Efficacy|0|||
127932294|NCT02696031|460375262|FG005|Up to Week 52|Lack of Efficacy|0|||
127932295|NCT02696031|460375257|FG000|Up to Week 52|Lost to Follow-up|1|||
127932296|NCT02696031|460375258|FG001|Up to Week 52|Lost to Follow-up|1|||
127932297|NCT02696031|460375259|FG002|Up to Week 52|Lost to Follow-up|1|||
127932298|NCT02696031|460375260|FG003|Up to Week 52|Lost to Follow-up|0|||
127932299|NCT02696031|460375261|FG004|Up to Week 52|Lost to Follow-up|0|||
127932300|NCT02696031|460375262|FG005|Up to Week 52|Lost to Follow-up|0|||
127932301|NCT02696031|460375257|FG000|Up to Week 52|Physician Decision|1|||
127932302|NCT02696031|460375258|FG001|Up to Week 52|Physician Decision|1|||
127932303|NCT02696031|460375259|FG002|Up to Week 52|Physician Decision|2|||
127932304|NCT02696031|460375260|FG003|Up to Week 52|Physician Decision|0|||
127932305|NCT02696031|460375261|FG004|Up to Week 52|Physician Decision|0|||
127932306|NCT02696031|460375262|FG005|Up to Week 52|Physician Decision|0|||
127932307|NCT02696031|460375257|FG000|Up to Week 52|Pregnancy|0|||
127932308|NCT02696031|460375258|FG001|Up to Week 52|Pregnancy|2|||
127932309|NCT02696031|460375259|FG002|Up to Week 52|Pregnancy|0|||
127932310|NCT02696031|460375260|FG003|Up to Week 52|Pregnancy|0|||
127932311|NCT02696031|460375261|FG004|Up to Week 52|Pregnancy|0|||
127932312|NCT02696031|460375262|FG005|Up to Week 52|Pregnancy|0|||
127932313|NCT02696031|460375257|FG000|Up to Week 52|Protocol Violation|1|||
127932314|NCT02696031|460375258|FG001|Up to Week 52|Protocol Violation|0|||
127932315|NCT02696031|460375259|FG002|Up to Week 52|Protocol Violation|0|||
127932316|NCT02696031|460375260|FG003|Up to Week 52|Protocol Violation|0|||
127932317|NCT02696031|460375261|FG004|Up to Week 52|Protocol Violation|0|||
127932318|NCT02696031|460375262|FG005|Up to Week 52|Protocol Violation|0|||
127932319|NCT02696031|460375257|FG000|Up to Week 52|Withdrawal by Subject|12|||
127932320|NCT02696031|460375258|FG001|Up to Week 52|Withdrawal by Subject|3|||
127932321|NCT02696031|460375259|FG002|Up to Week 52|Withdrawal by Subject|9|||
127932322|NCT02696031|460375260|FG003|Up to Week 52|Withdrawal by Subject|0|||
127932323|NCT02696031|460375261|FG004|Up to Week 52|Withdrawal by Subject|0|||
127932324|NCT02696031|460375262|FG005|Up to Week 52|Withdrawal by Subject|0|||
127932325|NCT02696031|460375257|FG000|Up to Week 104|Pregnancy|0|||
127932326|NCT02696031|460375258|FG001|Up to Week 104|Pregnancy|2|||
127932327|NCT02696031|460375259|FG002|Up to Week 104|Pregnancy|1|||
127932328|NCT02696031|460375260|FG003|Up to Week 104|Pregnancy|0|||
127932329|NCT02696031|460375261|FG004|Up to Week 104|Pregnancy|0|||
127932330|NCT02696031|460375262|FG005|Up to Week 104|Pregnancy|0|||
127932331|NCT02696031|460375257|FG000|Up to Week 104|Withdrawal by Subject|15|||
127932332|NCT02696031|460375258|FG001|Up to Week 104|Withdrawal by Subject|10|||
127932333|NCT02696031|460375259|FG002|Up to Week 104|Withdrawal by Subject|16|||
127932334|NCT02696031|460375260|FG003|Up to Week 104|Withdrawal by Subject|0|||
127932335|NCT02696031|460375261|FG004|Up to Week 104|Withdrawal by Subject|0|||
127932336|NCT02696031|460375262|FG005|Up to Week 104|Withdrawal by Subject|0|||
127932337|NCT02696031|460375257|FG000|Up to Week 104|Protocol Violation|1|||
127932338|NCT02696031|460375258|FG001|Up to Week 104|Protocol Violation|0|||
127932339|NCT02696031|460375259|FG002|Up to Week 104|Protocol Violation|0|||
127932340|NCT02696031|460375260|FG003|Up to Week 104|Protocol Violation|0|||
127932341|NCT02696031|460375261|FG004|Up to Week 104|Protocol Violation|0|||
127932342|NCT02696031|460375262|FG005|Up to Week 104|Protocol Violation|0|||
127932343|NCT02696031|460375257|FG000|Up to Week 104|Physician Decision|1|||
127932344|NCT02696031|460375258|FG001|Up to Week 104|Physician Decision|2|||
127932345|NCT02696031|460375259|FG002|Up to Week 104|Physician Decision|3|||
127932346|NCT02696031|460375260|FG003|Up to Week 104|Physician Decision|0|||
127932347|NCT02696031|460375261|FG004|Up to Week 104|Physician Decision|0|||
127932348|NCT02696031|460375262|FG005|Up to Week 104|Physician Decision|0|||
127932349|NCT02696031|460375257|FG000|Up to Week 104|Lost to Follow-up|2|||
127932350|NCT02696031|460375258|FG001|Up to Week 104|Lost to Follow-up|3|||
127932351|NCT02696031|460375259|FG002|Up to Week 104|Lost to Follow-up|1|||
127932352|NCT02696031|460375260|FG003|Up to Week 104|Lost to Follow-up|0|||
127932353|NCT02696031|460375261|FG004|Up to Week 104|Lost to Follow-up|0|||
127932354|NCT02696031|460375262|FG005|Up to Week 104|Lost to Follow-up|0|||
127932355|NCT02696031|460375257|FG000|Up to Week 104|Lack of Efficacy|13|||
127932356|NCT02696031|460375258|FG001|Up to Week 104|Lack of Efficacy|12|||
127932357|NCT02696031|460375259|FG002|Up to Week 104|Lack of Efficacy|11|||
127932358|NCT02696031|460375260|FG003|Up to Week 104|Lack of Efficacy|0|||
127932359|NCT02696031|460375261|FG004|Up to Week 104|Lack of Efficacy|0|||
127932360|NCT02696031|460375262|FG005|Up to Week 104|Lack of Efficacy|0|||
127932361|NCT02696031|460375257|FG000|Up to Week 104|Adverse Event|7|||
127932362|NCT02696031|460375258|FG001|Up to Week 104|Adverse Event|11|||
127932363|NCT02696031|460375259|FG002|Up to Week 104|Adverse Event|5|||
127932364|NCT02696031|460375260|FG003|Up to Week 104|Adverse Event|0|||
127932365|NCT02696031|460375261|FG004|Up to Week 104|Adverse Event|0|||
127932366|NCT02696031|460375262|FG005|Up to Week 104|Adverse Event|0|||
127932367|NCT02696031|460375257|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
127932368|NCT02696031|460375258|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
127932369|NCT02696031|460375259|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
127932370|NCT02696031|460375260|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
127932371|NCT02696031|460375261|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
127932372|NCT02696031|460375262|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
127932373|NCT02696031|460375257|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
127932374|NCT02696031|460375258|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
127932375|NCT02696031|460375259|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
127932376|NCT02696031|460375260|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
127932377|NCT02696031|460375261|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
127932378|NCT02696031|460375262|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
127932379|NCT02696031|460375257|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
127932380|NCT02696031|460375258|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
127932381|NCT02696031|460375259|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
127932382|NCT02696031|460375260|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
127932383|NCT02696031|460375261|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
127932384|NCT02696031|460375262|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
127932385|NCT02696031|460375257|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
127932386|NCT02696031|460375258|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
127932387|NCT02696031|460375259|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
127932388|NCT02696031|460375260|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
127932389|NCT02696031|460375261|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
127932390|NCT02696031|460375262|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
127932391|NCT02696031|460375257|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
127932392|NCT02696031|460375258|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
127932393|NCT02696031|460375259|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
127932394|NCT02696031|460375260|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
127932395|NCT02696031|460375261|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
127932396|NCT02696031|460375262|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
127932397|NCT02696031|460375257|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
127932398|NCT02696031|460375258|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
127932399|NCT02696031|460375259|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
127932400|NCT02696031|460375260|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
127932401|NCT02696031|460375261|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
127932402|NCT02696031|460375262|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
127932403|NCT02696031|460375257|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
127932404|NCT02696031|460375258|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
127932405|NCT02696031|460375259|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
127932406|NCT02696031|460375260|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
127932407|NCT02696031|460375261|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
127932408|NCT02696031|460375262|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
127932409|NCT00597116|460375263|FG000|Overall Study|Adverse Event|2|||
127932410|NCT00597116|460375264|FG001|Overall Study|Adverse Event|1|||
127932411|NCT00597116|460375263|FG000|Overall Study|Withdrawal by Subject|0|||
127932412|NCT00597116|460375264|FG001|Overall Study|Withdrawal by Subject|2|||
127932413|NCT00597116|460375263|FG000|Overall Study|Physician Decision|0|||
127932414|NCT00597116|460375264|FG001|Overall Study|Physician Decision|1|||
127932415|NCT00597116|460375263|FG000|Overall Study|Death|0|||
127932416|NCT00597116|460375264|FG001|Overall Study|Death|1|||
127932417|NCT00597116|460375263|FG000|Overall Study|Lost to Follow-up|1|||
127932418|NCT00597116|460375264|FG001|Overall Study|Lost to Follow-up|0|||
127932419|NCT00597116|460375263|FG000|Overall Study|Progressive disease|11|||
127932420|NCT00597116|460375264|FG001|Overall Study|Progressive disease|6|||
127932421|NCT03978091|460375267|FG000|Overall Study|Lost to Follow-up|0|||
127932422|NCT03978091|460375268|FG001|Overall Study|Lost to Follow-up|0|||
127932423|NCT03978091|460375269|FG002|Overall Study|Lost to Follow-up|1|||
127932424|NCT03978091|460375270|FG003|Overall Study|Lost to Follow-up|0|||
127932425|NCT03978091|460375271|FG004|Overall Study|Lost to Follow-up|0|||
127932426|NCT03978091|460375272|FG005|Overall Study|Lost to Follow-up|0|||
127932427|NCT03978091|460375267|FG000|Overall Study|Withdrawal by Subject|0|||
127932428|NCT03978091|460375268|FG001|Overall Study|Withdrawal by Subject|0|||
127932429|NCT03978091|460375269|FG002|Overall Study|Withdrawal by Subject|0|||
127932430|NCT03978091|460375270|FG003|Overall Study|Withdrawal by Subject|1|||
127932431|NCT03978091|460375271|FG004|Overall Study|Withdrawal by Subject|1|||
127932432|NCT03978091|460375272|FG005|Overall Study|Withdrawal by Subject|0|||
127932433|NCT02595008|460375277|FG000|Overall Study|Enrolled In Error|1|||
127932434|NCT02595008|460375278|FG001|Overall Study|Enrolled In Error|0|||
127932435|NCT03078582|460375282|FG000|Overall Study|Adverse Event|0|||
127932436|NCT03078582|460375283|FG001|Overall Study|Adverse Event|8|||
127932437|NCT01843348|460375286|FG000|Overall Study|Withdrawal by Subject|4|||
127932438|NCT01843348|460375287|FG001|Overall Study|Withdrawal by Subject|16|||
127932439|NCT01843348|460375288|FG002|Overall Study|Withdrawal by Subject|18|||
127932440|NCT01843348|460375286|FG000|Overall Study|Lost to Follow-up|5|||
127932441|NCT01843348|460375287|FG001|Overall Study|Lost to Follow-up|4|||
127932442|NCT01843348|460375288|FG002|Overall Study|Lost to Follow-up|2|||
127932443|NCT01843348|460375286|FG000|Overall Study|Death|5|||
127932444|NCT01843348|460375287|FG001|Overall Study|Death|3|||
127932445|NCT01843348|460375288|FG002|Overall Study|Death|4|||
127932446|NCT01843348|460375286|FG000|Overall Study|Graft loss/retransplantation|5|||
127932447|NCT01843348|460375287|FG001|Overall Study|Graft loss/retransplantation|8|||
127932448|NCT01843348|460375288|FG002|Overall Study|Graft loss/retransplantation|11|||
127932449|NCT01843348|460375286|FG000|Overall Study|Various reasons|4|||
127932450|NCT01843348|460375287|FG001|Overall Study|Various reasons|9|||
127932451|NCT01843348|460375288|FG002|Overall Study|Various reasons|6|||
127932452|NCT02039414|460375297|FG000|Overall Study|Delivered|1|||
127932453|NCT02039414|460375298|FG001|Overall Study|Delivered|1|||
127932454|NCT02039414|460375297|FG000|Overall Study|Lost to Follow-up|2|||
127932455|NCT02039414|460375298|FG001|Overall Study|Lost to Follow-up|0|||
127932456|NCT02039414|460375297|FG000|Overall Study|Protocol Violation|3|||
127932457|NCT02039414|460375298|FG001|Overall Study|Protocol Violation|1|||
127932458|NCT03832738|460375299|FG000|Overall Study|Withdrawal by Subject|6|||
127932459|NCT03832738|460375300|FG001|Overall Study|Withdrawal by Subject|7|||
127932460|NCT03832738|460375301|FG002|Overall Study|Withdrawal by Subject|16|||
127932461|NCT03832738|460375299|FG000|Overall Study|Physician Decision|0|||
127932462|NCT03832738|460375300|FG001|Overall Study|Physician Decision|1|||
127932463|NCT03832738|460375301|FG002|Overall Study|Physician Decision|2|||
127932464|NCT03832738|460375299|FG000|Overall Study|Adverse Event|2|||
127932465|NCT03832738|460375300|FG001|Overall Study|Adverse Event|3|||
127932466|NCT03832738|460375301|FG002|Overall Study|Adverse Event|1|||
127932467|NCT03832738|460375299|FG000|Overall Study|Pregnancy|0|||
127932468|NCT03832738|460375300|FG001|Overall Study|Pregnancy|1|||
127932469|NCT03832738|460375301|FG002|Overall Study|Pregnancy|0|||
127932470|NCT03977701|460375302|FG000|Overall Study|COVID-19 pandemic|0|||
127932471|NCT03977701|460375303|FG001|Overall Study|COVID-19 pandemic|0|||
127932472|NCT03977701|460375304|FG002|Overall Study|COVID-19 pandemic|0|||
127932473|NCT03977701|460375305|FG003|Overall Study|COVID-19 pandemic|0|||
127932474|NCT03977701|460375306|FG004|Overall Study|COVID-19 pandemic|0|||
127932475|NCT03977701|460375307|FG005|Overall Study|COVID-19 pandemic|1|||
127932476|NCT03977701|460375308|FG006|Overall Study|COVID-19 pandemic|0|||
127932477|NCT03977701|460375309|FG007|Overall Study|COVID-19 pandemic|1|||
127932478|NCT03977701|460375310|FG008|Overall Study|COVID-19 pandemic|0|||
127932479|NCT03977701|460375311|FG009|Overall Study|COVID-19 pandemic|0|||
127932480|NCT00869024|460375312|FG000|Overall Study|Death|2|||
127932481|NCT00869024|460375313|FG001|Overall Study|Death|3|||
127932482|NCT00869024|460375312|FG000|Overall Study|Lost to Follow-up|0|||
127932483|NCT00869024|460375313|FG001|Overall Study|Lost to Follow-up|1|||
127932484|NCT00869024|460375312|FG000|Overall Study|Protocol Violation|0|||
127932485|NCT00869024|460375313|FG001|Overall Study|Protocol Violation|1|||
127932486|NCT00831623|460375318|FG000|Overall Study|Withdrawal by Subject|9|||
127932487|NCT00831623|460375318|FG000|Overall Study|Lost to Follow-up|1|||
127932488|NCT00831623|460375318|FG000|Overall Study|Not 2 years post-treatment|12|||
127932489|NCT01564459|460375321|FG000|Run-In|Adverse Event|7|||
127932490|NCT01564459|460375322|FG001|Run-In|Adverse Event|0|||
127932491|NCT01564459|460375323|FG002|Run-In|Adverse Event|0|||
127932492|NCT01564459|460375321|FG000|Run-In|Lost to Follow-up|1|||
127932493|NCT01564459|460375322|FG001|Run-In|Lost to Follow-up|0|||
127932494|NCT01564459|460375323|FG002|Run-In|Lost to Follow-up|0|||
127932495|NCT01564459|460375321|FG000|Run-In|Non-compliance with study drug|2|||
127932496|NCT01564459|460375322|FG001|Run-In|Non-compliance with study drug|0|||
127932497|NCT01564459|460375323|FG002|Run-In|Non-compliance with study drug|0|||
127932498|NCT01564459|460375321|FG000|Run-In|Protocol Violation|1|||
127932499|NCT01564459|460375322|FG001|Run-In|Protocol Violation|0|||
127932500|NCT01564459|460375323|FG002|Run-In|Protocol Violation|0|||
127932501|NCT01564459|460375321|FG000|Run-In|Withdrawal by Subject|1|||
127932502|NCT01564459|460375322|FG001|Run-In|Withdrawal by Subject|0|||
127932503|NCT01564459|460375323|FG002|Run-In|Withdrawal by Subject|0|||
127932504|NCT01564459|460375321|FG000|Double-blind Treatment|Adverse Event|0|||
127932505|NCT01564459|460375322|FG001|Double-blind Treatment|Adverse Event|0|||
127932506|NCT01564459|460375323|FG002|Double-blind Treatment|Adverse Event|1|||
127932507|NCT00706992|460375329|FG000|Overall Study|Study termination|5|||
127932508|NCT00706992|460375330|FG001|Overall Study|Study termination|5|||
127932509|NCT00706992|460375331|FG002|Overall Study|Study termination|6|||
127932510|NCT00706992|460375332|FG003|Overall Study|Study termination|2|||
127932511|NCT00706992|460375333|FG004|Overall Study|Study termination|3|||
127932512|NCT00706992|460375334|FG005|Overall Study|Study termination|2|||
127932513|NCT00706992|460375335|FG006|Overall Study|Study termination|3|||
127932514|NCT00706992|460375329|FG000|Overall Study|Disease progression before treatment|0|||
127932515|NCT00706992|460375330|FG001|Overall Study|Disease progression before treatment|0|||
127932516|NCT00706992|460375331|FG002|Overall Study|Disease progression before treatment|0|||
127932517|NCT00706992|460375332|FG003|Overall Study|Disease progression before treatment|0|||
127932518|NCT00706992|460375333|FG004|Overall Study|Disease progression before treatment|1|||
127932519|NCT00706992|460375334|FG005|Overall Study|Disease progression before treatment|0|||
127932520|NCT00706992|460375335|FG006|Overall Study|Disease progression before treatment|0|||
127932521|NCT00702208|460375336|FG000|Overall Study|Lost to Follow-up|28|||
127932522|NCT00702208|460375336|FG000|Overall Study|Did not self-lavage|1|||
127932523|NCT00702208|460375336|FG000|Overall Study|Unsatisfactory colposcopy|2|||
127932524|NCT02746627|460375337|FG000|Overall Study|Withdrawal by Subject|1|||
127932525|NCT02746627|460375338|FG001|Overall Study|Withdrawal by Subject|1|||
127932526|NCT02746627|460375339|FG002|Overall Study|Withdrawal by Subject|1|||
127932527|NCT00588640|460375342|FG000|Overall Study|Physician Decision|1|||
127932528|NCT00588640|460375342|FG000|Overall Study|Ineligible Patient|1|||
127932529|NCT00003138|460377282|FG000|Step 1|Reasons off treatment not documented|60|||
127932530|NCT00003138|460377283|FG001|Step 1|Reasons off treatment not documented|57|||
127932531|NCT00003138|460377282|FG000|Step 1|Never started treatment|1|||
127932532|NCT00003138|460377283|FG001|Step 1|Never started treatment|0|||
127932533|NCT00003138|460377282|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
127932534|NCT00003138|460377283|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
127932535|NCT00003138|460377282|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
127932536|NCT00003138|460377283|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
127932537|NCT00003138|460377282|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
127932538|NCT00003138|460377283|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
127932539|NCT00003138|460377282|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
127932540|NCT00003138|460377283|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
127932541|NCT05142566|460377285|FG000|Overall Study|Protocol Violation|1|||
127932542|NCT04718194|460377286|FG000|Overall Study|Withdrawal by Subject|3|||
127932543|NCT04718194|460377287|FG001|Overall Study|Withdrawal by Subject|0|||
127932544|NCT04718194|460377286|FG000|Overall Study|Lost to Follow-up|3|||
127932545|NCT04718194|460377287|FG001|Overall Study|Lost to Follow-up|0|||
127932546|NCT02091141|460377289|FG000|Overall Study|Death|280|||
127932547|NCT02091141|460377290|FG001|Overall Study|Death|118|||
127932548|NCT02091141|460377291|FG002|Overall Study|Death|46|||
127932549|NCT02091141|460377292|FG003|Overall Study|Death|13|||
127932550|NCT02091141|460377293|FG004|Overall Study|Death|31|||
127932551|NCT02091141|460377294|FG005|Overall Study|Death|16|||
127932552|NCT02091141|460377295|FG006|Overall Study|Death|12|||
127932553|NCT02091141|460377289|FG000|Overall Study|Withdrawal by Subject|21|||
127932554|NCT02091141|460377290|FG001|Overall Study|Withdrawal by Subject|13|||
127932555|NCT02091141|460377291|FG002|Overall Study|Withdrawal by Subject|3|||
127932556|NCT02091141|460377292|FG003|Overall Study|Withdrawal by Subject|2|||
127932557|NCT02091141|460377293|FG004|Overall Study|Withdrawal by Subject|2|||
127932558|NCT02091141|460377294|FG005|Overall Study|Withdrawal by Subject|3|||
127932559|NCT02091141|460377295|FG006|Overall Study|Withdrawal by Subject|0|||
127932560|NCT02091141|460377289|FG000|Overall Study|Lost to Follow-up|21|||
127932561|NCT02091141|460377290|FG001|Overall Study|Lost to Follow-up|5|||
127932562|NCT02091141|460377291|FG002|Overall Study|Lost to Follow-up|1|||
127932563|NCT02091141|460377292|FG003|Overall Study|Lost to Follow-up|0|||
127932564|NCT02091141|460377293|FG004|Overall Study|Lost to Follow-up|1|||
127932565|NCT02091141|460377294|FG005|Overall Study|Lost to Follow-up|2|||
127932566|NCT02091141|460377295|FG006|Overall Study|Lost to Follow-up|0|||
127932567|NCT02091141|460377289|FG000|Overall Study|Reason Not Specified|6|||
127932568|NCT02091141|460377290|FG001|Overall Study|Reason Not Specified|5|||
127932569|NCT02091141|460377291|FG002|Overall Study|Reason Not Specified|2|||
127932570|NCT02091141|460377292|FG003|Overall Study|Reason Not Specified|0|||
127932571|NCT02091141|460377293|FG004|Overall Study|Reason Not Specified|0|||
127932572|NCT02091141|460377294|FG005|Overall Study|Reason Not Specified|0|||
127932573|NCT02091141|460377295|FG006|Overall Study|Reason Not Specified|1|||
127932574|NCT02091141|460377289|FG000|Overall Study|Study Ended by Sponsor|1|||
127932575|NCT02091141|460377290|FG001|Overall Study|Study Ended by Sponsor|9|||
127932576|NCT02091141|460377291|FG002|Overall Study|Study Ended by Sponsor|0|||
127932577|NCT02091141|460377292|FG003|Overall Study|Study Ended by Sponsor|0|||
127932578|NCT02091141|460377293|FG004|Overall Study|Study Ended by Sponsor|0|||
127932579|NCT02091141|460377294|FG005|Overall Study|Study Ended by Sponsor|0|||
127932580|NCT02091141|460377295|FG006|Overall Study|Study Ended by Sponsor|0|||
127932581|NCT02091141|460377289|FG000|Overall Study|Withdrew informed consent before receiving study drug|0|||
127932582|NCT02091141|460377290|FG001|Overall Study|Withdrew informed consent before receiving study drug|1|||
127932583|NCT02091141|460377291|FG002|Overall Study|Withdrew informed consent before receiving study drug|0|||
127932584|NCT02091141|460377292|FG003|Overall Study|Withdrew informed consent before receiving study drug|0|||
127932585|NCT02091141|460377293|FG004|Overall Study|Withdrew informed consent before receiving study drug|0|||
127932586|NCT02091141|460377294|FG005|Overall Study|Withdrew informed consent before receiving study drug|0|||
127932587|NCT02091141|460377295|FG006|Overall Study|Withdrew informed consent before receiving study drug|0|||
127932588|NCT02246439|460377296|FG000|Overall Study|Adverse Event|3|||
127932589|NCT02246439|460377297|FG001|Overall Study|Adverse Event|0|||
127932590|NCT02246439|460377296|FG000|Overall Study|Lost to Follow-up|7|||
127932591|NCT02246439|460377297|FG001|Overall Study|Lost to Follow-up|5|||
127932592|NCT02246439|460377296|FG000|Overall Study|Protocol Violation|0|||
127932593|NCT02246439|460377297|FG001|Overall Study|Protocol Violation|2|||
127932594|NCT02246439|460377296|FG000|Overall Study|Physician Decision|0|||
127932595|NCT02246439|460377297|FG001|Overall Study|Physician Decision|1|||
127932596|NCT02246439|460377296|FG000|Overall Study|Unkonwn|1|||
127932597|NCT02246439|460377297|FG001|Overall Study|Unkonwn|3|||
127932598|NCT02246439|460377296|FG000|Overall Study|Withdrawal by Subject|1|||
127932599|NCT02246439|460377297|FG001|Overall Study|Withdrawal by Subject|0|||
127932600|NCT01553279|460377298|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
127932601|NCT01553279|460377299|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
127932602|NCT01553279|460377298|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
127932603|NCT01553279|460377299|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
127932604|NCT01553279|460377298|FG000|Interim Period|Withdrawal by Subject|2|||
127932605|NCT01553279|460377299|FG001|Interim Period|Withdrawal by Subject|2|||
127932606|NCT01553279|460377298|FG000|Interim Period|Lost to Follow-up|1|||
127932607|NCT01553279|460377299|FG001|Interim Period|Lost to Follow-up|0|||
127932608|NCT01553279|460377298|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
127932609|NCT01553279|460377299|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
127932610|NCT01553279|460377298|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
127932611|NCT01553279|460377299|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
127932612|NCT03955471|460377300|FG000|Overall Study|Death|22|||
127932613|NCT03955471|460377300|FG000|Overall Study|Lost to Follow-up|1|||
127932614|NCT03955471|460377300|FG000|Overall Study|Withdrawal by Subject|6|||
127932615|NCT03955471|460377300|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
127932616|NCT03247517|460377315|FG000|Overall Study|Adverse Event|0|||
127932617|NCT03247517|460377316|FG001|Overall Study|Adverse Event|4|||
127932618|NCT03247517|460377317|FG002|Overall Study|Adverse Event|2|||
127932619|NCT03247517|460377315|FG000|Overall Study|Lost to Follow-up|2|||
127932620|NCT03247517|460377316|FG001|Overall Study|Lost to Follow-up|6|||
127932621|NCT03247517|460377317|FG002|Overall Study|Lost to Follow-up|4|||
127932622|NCT03247517|460377315|FG000|Overall Study|Consent withdrawn by caregiver|1|||
127932623|NCT03247517|460377316|FG001|Overall Study|Consent withdrawn by caregiver|4|||
127932624|NCT03247517|460377317|FG002|Overall Study|Consent withdrawn by caregiver|7|||
127932625|NCT03247517|460377315|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
127932626|NCT03247517|460377316|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
127932627|NCT03247517|460377317|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
127932628|NCT03247517|460377315|FG000|Overall Study|Protocol Violation|0|||
127932629|NCT03247517|460377316|FG001|Overall Study|Protocol Violation|2|||
127932630|NCT03247517|460377317|FG002|Overall Study|Protocol Violation|0|||
127932631|NCT03247517|460377315|FG000|Overall Study|Multiple reasons|3|||
127932632|NCT03247517|460377316|FG001|Overall Study|Multiple reasons|1|||
127932633|NCT03247517|460377317|FG002|Overall Study|Multiple reasons|0|||
127932634|NCT01996332|460377318|FG000|Overall Study|Adverse Event|117|||
127932635|NCT01996332|460377318|FG000|Overall Study|Lack of Efficacy|1245|||
127932636|NCT01996332|460377318|FG000|Overall Study|Death|264|||
127932637|NCT01996332|460377318|FG000|Overall Study|Protocol Violation|9|||
127932638|NCT01996332|460377318|FG000|Overall Study|Withdrawal by Subject|71|||
127932639|NCT01996332|460377318|FG000|Overall Study|Other|20|||
127932640|NCT01996332|460377318|FG000|Overall Study|Clinical Deterioration|28|||
127932641|NCT01996332|460377318|FG000|Overall Study|Physician Decision|17|||
127932642|NCT01996332|460377318|FG000|Overall Study|Lost to Follow-up|34|||
127932643|NCT02113189|460377319|FG000|Overall Study|Lost to follow up|2|||
127932644|NCT02113189|460377320|FG001|Overall Study|Lost to follow up|1|||
127932645|NCT02113189|460377321|FG002|Overall Study|Lost to follow up|3|||
127932646|NCT00430495|460377330|FG000|Overall Study|Adverse Event|2|||
127932647|NCT00430495|460377331|FG001|Overall Study|Adverse Event|3|||
127932648|NCT00430495|460377332|FG002|Overall Study|Adverse Event|2|||
127932649|NCT00430495|460377333|FG003|Overall Study|Adverse Event|0|||
127932650|NCT00430495|460377330|FG000|Overall Study|Death|0|||
127932651|NCT00430495|460377331|FG001|Overall Study|Death|0|||
127932652|NCT00430495|460377332|FG002|Overall Study|Death|1|||
127932653|NCT00430495|460377333|FG003|Overall Study|Death|0|||
127932654|NCT00430495|460377330|FG000|Overall Study|Lost to Follow-up|0|||
127932655|NCT00430495|460377331|FG001|Overall Study|Lost to Follow-up|1|||
127932656|NCT00430495|460377332|FG002|Overall Study|Lost to Follow-up|4|||
127932657|NCT00430495|460377333|FG003|Overall Study|Lost to Follow-up|0|||
127932658|NCT00430495|460377330|FG000|Overall Study|Protocol Violation|1|||
127932659|NCT00430495|460377331|FG001|Overall Study|Protocol Violation|0|||
127932660|NCT00430495|460377332|FG002|Overall Study|Protocol Violation|1|||
127932661|NCT00430495|460377333|FG003|Overall Study|Protocol Violation|0|||
127932662|NCT00430495|460377330|FG000|Overall Study|Disease Progression|1|||
127932663|NCT00430495|460377331|FG001|Overall Study|Disease Progression|1|||
127932664|NCT00430495|460377332|FG002|Overall Study|Disease Progression|0|||
127932665|NCT00430495|460377333|FG003|Overall Study|Disease Progression|0|||
127932666|NCT00430495|460377330|FG000|Overall Study|Other|8|||
127932667|NCT00430495|460377331|FG001|Overall Study|Other|2|||
127932668|NCT00430495|460377332|FG002|Overall Study|Other|5|||
127932669|NCT00430495|460377333|FG003|Overall Study|Other|4|||
127932670|NCT00430495|460377330|FG000|Overall Study|Randomized but not Treated|2|||
127932671|NCT00430495|460377331|FG001|Overall Study|Randomized but not Treated|0|||
127932672|NCT00430495|460377332|FG002|Overall Study|Randomized but not Treated|0|||
127932673|NCT00430495|460377333|FG003|Overall Study|Randomized but not Treated|0|||
127932674|NCT00158756|460377338|FG000|Overall Study|Withdrawal by Subject|5|||
127932675|NCT00158756|460377339|FG001|Overall Study|Withdrawal by Subject|0|||
127932676|NCT00158756|460377340|FG002|Overall Study|Withdrawal by Subject|6|||
127932677|NCT00158756|460377341|FG003|Overall Study|Withdrawal by Subject|1|||
127932678|NCT00158756|460377342|FG004|Overall Study|Withdrawal by Subject|3|||
127932679|NCT00158756|460377338|FG000|Overall Study|Adverse Event|0|||
127932680|NCT00158756|460377339|FG001|Overall Study|Adverse Event|0|||
127932681|NCT00158756|460377340|FG002|Overall Study|Adverse Event|1|||
127932682|NCT00158756|460377341|FG003|Overall Study|Adverse Event|0|||
127932683|NCT00158756|460377342|FG004|Overall Study|Adverse Event|0|||
127932684|NCT00158756|460377338|FG000|Overall Study|Serious adverse event|0|||
127932685|NCT00158756|460377339|FG001|Overall Study|Serious adverse event|0|||
127932686|NCT00158756|460377340|FG002|Overall Study|Serious adverse event|1|||
127932687|NCT00158756|460377341|FG003|Overall Study|Serious adverse event|0|||
127932688|NCT00158756|460377342|FG004|Overall Study|Serious adverse event|0|||
127932689|NCT02145026|460377343|FG000|Overall Study|Adverse Event|2|||
127932690|NCT02145026|460377343|FG000|Overall Study|Death|4|||
127932691|NCT02145026|460377343|FG000|Overall Study|Withdrawal by Subject|2|||
127932692|NCT02145026|460377343|FG000|Overall Study|Physician Decision|4|||
127932693|NCT01429051|460377344|FG000|Titration Phase|Death|1|||
127932694|NCT01429051|460377344|FG000|Titration Phase|Withdrawal by Subject|7|||
127932695|NCT01429051|460377344|FG000|Titration Phase|Physician Decision|1|||
127932696|NCT01429051|460377344|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
127932697|NCT01429051|460377344|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
127932698|NCT01429051|460377344|FG000|Efficacy Phase|Adverse Event|1|||
127932699|NCT01429051|460377344|FG000|Efficacy Phase|Death|1|||
127932700|NCT01429051|460377344|FG000|Tolerability Phase|Death|5|||
127932701|NCT01429051|460377344|FG000|Tolerability Phase|Adverse Event|2|||
127932702|NCT01429051|460377344|FG000|Tolerability Phase|Withdrawal by Subject|5|||
127932703|NCT01429051|460377344|FG000|Tolerability Phase|Physician Decision|1|||
127932704|NCT01429051|460377344|FG000|Tolerability Phase|Other|2|||
127932705|NCT04132336|460377345|FG000|Overall Study|Investigator Decision|0|||
127932706|NCT04132336|460377346|FG001|Overall Study|Investigator Decision|1|||
127932707|NCT04132336|460377347|FG002|Overall Study|Investigator Decision|0|||
127932708|NCT04132336|460377348|FG003|Overall Study|Investigator Decision|0|||
127932709|NCT04132336|460377349|FG004|Overall Study|Investigator Decision|0|||
127932710|NCT04132336|460377350|FG005|Overall Study|Investigator Decision|0|||
127932711|NCT04132336|460377351|FG006|Overall Study|Investigator Decision|0|||
127932712|NCT00857792|460377352|FG000|Overall Study|inadequate image quality for analysis|12|||
127932713|NCT01797835|460377353|FG000|Overall Study|Lost to Follow-up|31|||
127932714|NCT01797835|460377354|FG001|Overall Study|Lost to Follow-up|27|||
127932715|NCT02528123|460377356|FG000|Overall Study|Lost to Follow-up|1|||
127932716|NCT04505293|460377364|FG000|Overall Study|Lost to Follow-up|2|||
127932717|NCT04505293|460377364|FG000|Overall Study|Withdrawal by Subject|6|||
127932718|NCT04505293|460377364|FG000|Overall Study|CT scan unreadable|277|||
127932719|NCT04295135|460377365|FG000|Overall Study|Withdrawal by Subject|2|||
127932720|NCT04295135|460377366|FG001|Overall Study|Withdrawal by Subject|1|||
127932721|NCT04295135|460377365|FG000|Overall Study|Subject left organization|8|||
127932722|NCT04295135|460377366|FG001|Overall Study|Subject left organization|4|||
127932723|NCT03484117|460377368|FG000|Overall Study|Lost to Follow-up|1|||
127932724|NCT03484117|460377369|FG001|Overall Study|Lost to Follow-up|3|||
127932725|NCT03484117|460377368|FG000|Overall Study|Declined participation in exit assess|1|||
127932726|NCT03484117|460377369|FG001|Overall Study|Declined participation in exit assess|1|||
127932727|NCT00289874|460377370|FG000|Overall Study|Adverse Event|1|||
127932728|NCT00289874|460377371|FG001|Overall Study|Adverse Event|5|||
127932729|NCT00289874|460377370|FG000|Overall Study|Lost to Follow-up|1|||
127932730|NCT00289874|460377371|FG001|Overall Study|Lost to Follow-up|1|||
127932731|NCT00289874|460377370|FG000|Overall Study|Protocol Violation|3|||
127932732|NCT00289874|460377371|FG001|Overall Study|Protocol Violation|2|||
127932733|NCT00289874|460377370|FG000|Overall Study|Did not meet eligibility|1|||
127932734|NCT00289874|460377371|FG001|Overall Study|Did not meet eligibility|0|||
127932735|NCT03835325|460377372|FG000|Overall Study|Lack of adherence to protocol procedures|1|||
127932736|NCT03835325|460377372|FG000|Overall Study|Selection failure|1|||
127932737|NCT00775606|460377373|FG000|Overall Study|Study sponsor terminated funding|3|||
127932738|NCT00775606|460377374|FG001|Overall Study|Study sponsor terminated funding|0|||
127932739|NCT03212794|460377375|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
127932740|NCT03212794|460377376|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
127932741|NCT03212794|460377375|FG000|Overall Study|Lost to Follow-up|5|||
127932742|NCT03212794|460377376|FG001|Overall Study|Lost to Follow-up|6|||
127932743|NCT03212794|460377375|FG000|Overall Study|Incarcerated; unable to participate|2|||
127932744|NCT03212794|460377376|FG001|Overall Study|Incarcerated; unable to participate|0|||
127932745|NCT03212794|460377375|FG000|Overall Study|Withdrawal by Subject|1|||
127932746|NCT03212794|460377376|FG001|Overall Study|Withdrawal by Subject|0|||
127932747|NCT03212794|460377375|FG000|Overall Study|Death|0|||
127932748|NCT03212794|460377376|FG001|Overall Study|Death|1|||
127932749|NCT03212794|460377375|FG000|Overall Study|Found to be ineligible after allocation|0|||
127932750|NCT03212794|460377376|FG001|Overall Study|Found to be ineligible after allocation|1|||
127932751|NCT03212794|460377375|FG000|Overall Study|Relocated out of area|2|||
127932752|NCT03212794|460377376|FG001|Overall Study|Relocated out of area|0|||
127932753|NCT01901874|460377377|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
127932754|NCT01901874|460377377|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
127932755|NCT01901874|460377377|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
127932756|NCT01901874|460377377|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
127932757|NCT01901874|460377377|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
127932758|NCT01901874|460377377|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
127932759|NCT00770692|460377382|FG000|Overall Study|Withdrawal by Subject|7|||
127932760|NCT00770692|460377383|FG001|Overall Study|Withdrawal by Subject|9|||
127932761|NCT00770692|460377384|FG002|Overall Study|Withdrawal by Subject|9|||
127932762|NCT00770692|460377385|FG003|Overall Study|Withdrawal by Subject|6|||
127932763|NCT00770692|460377382|FG000|Overall Study|Adverse Event|3|||
127932764|NCT00770692|460377383|FG001|Overall Study|Adverse Event|0|||
127932765|NCT00770692|460377384|FG002|Overall Study|Adverse Event|4|||
127932766|NCT00770692|460377385|FG003|Overall Study|Adverse Event|4|||
127932767|NCT00770692|460377382|FG000|Overall Study|Investigator judgment|2|||
127932768|NCT00770692|460377383|FG001|Overall Study|Investigator judgment|0|||
127932769|NCT00770692|460377384|FG002|Overall Study|Investigator judgment|1|||
127932770|NCT00770692|460377385|FG003|Overall Study|Investigator judgment|1|||
127932771|NCT00560937|460377386|FG000|Overall Study|Withdrawal by Subject|0|||
127932772|NCT00560937|460377387|FG001|Overall Study|Withdrawal by Subject|1|||
127932773|NCT00560937|460377386|FG000|Overall Study|Physician Decision|1|||
127932774|NCT00560937|460377387|FG001|Overall Study|Physician Decision|1|||
127932775|NCT01138111|460377388|FG000|Overall Study|Withdrawal by Subject|5|||
127932776|NCT01138111|460377388|FG000|Overall Study|Adverse Event|1|||
127932777|NCT01138111|460377388|FG000|Overall Study|Death|1|||
127932778|NCT01138111|460377388|FG000|Overall Study|Lost to Follow-up|2|||
127932779|NCT00653991|460377391|FG000|3 Month Follow-up|Participant would not respond|150|||
127932780|NCT00653991|460377392|FG001|3 Month Follow-up|Participant would not respond|157|||
127932781|NCT00653991|460377391|FG000|6 Month Follow-up|Participant would not respond|133|||
127932782|NCT00653991|460377392|FG001|6 Month Follow-up|Participant would not respond|141|||
127932783|NCT01846273|460377393|FG000|Overall Study|Adverse Event|9|||
127932784|NCT01846273|460377394|FG001|Overall Study|Adverse Event|7|||
127932785|NCT01846273|460377395|FG002|Overall Study|Adverse Event|0|||
127932786|NCT01846273|460377393|FG000|Overall Study|Subject withdrew consent|5|||
127932787|NCT01846273|460377394|FG001|Overall Study|Subject withdrew consent|8|||
127932788|NCT01846273|460377395|FG002|Overall Study|Subject withdrew consent|0|||
127932789|NCT01846273|460377393|FG000|Overall Study|Lost to Follow-up|2|||
127932790|NCT01846273|460377394|FG001|Overall Study|Lost to Follow-up|1|||
127932791|NCT01846273|460377395|FG002|Overall Study|Lost to Follow-up|0|||
127932792|NCT01846273|460377393|FG000|Overall Study|Administrative problems|1|||
127932793|NCT01846273|460377394|FG001|Overall Study|Administrative problems|0|||
127932794|NCT01846273|460377395|FG002|Overall Study|Administrative problems|0|||
127932795|NCT01846273|460377393|FG000|Overall Study|Death|2|||
127932796|NCT01846273|460377394|FG001|Overall Study|Death|1|||
127932797|NCT01846273|460377395|FG002|Overall Study|Death|0|||
127932798|NCT01846273|460377393|FG000|Overall Study|Disease Progression|0|||
127932799|NCT01846273|460377394|FG001|Overall Study|Disease Progression|4|||
127932800|NCT01846273|460377395|FG002|Overall Study|Disease Progression|0|||
127932801|NCT01846273|460377393|FG000|Overall Study|Protocol Deviation|2|||
127932802|NCT01846273|460377394|FG001|Overall Study|Protocol Deviation|3|||
127932803|NCT01846273|460377395|FG002|Overall Study|Protocol Deviation|0|||
127932804|NCT01846273|460377393|FG000|Overall Study|Physician Decision|1|||
127932805|NCT01846273|460377394|FG001|Overall Study|Physician Decision|2|||
127932806|NCT01846273|460377395|FG002|Overall Study|Physician Decision|0|||
127932807|NCT02939014|460377398|FG000|Overall Study|Lost to Follow-up|1|||
127932808|NCT02939014|460377399|FG001|Overall Study|Lost to Follow-up|0|||
127932809|NCT02939014|460377398|FG000|Overall Study|Death|4|||
127932810|NCT02939014|460377399|FG001|Overall Study|Death|3|||
127932811|NCT03864042|460377400|FG000|DDI Phase|Adverse Event|2|||
127932812|NCT03864042|460377401|FG001|DDI Phase|Adverse Event|0|||
127932813|NCT03864042|460377402|FG002|DDI Phase|Adverse Event|0|||
127932814|NCT03864042|460377400|FG000|DDI Phase|Physician Decision|1|||
127932815|NCT03864042|460377401|FG001|DDI Phase|Physician Decision|0|||
127932816|NCT03864042|460377402|FG002|DDI Phase|Physician Decision|0|||
127932817|NCT03864042|460377400|FG000|DDI Phase|Progressive Disease|1|||
127932818|NCT03864042|460377401|FG001|DDI Phase|Progressive Disease|0|||
127932819|NCT03864042|460377402|FG002|DDI Phase|Progressive Disease|0|||
127932820|NCT03864042|460377400|FG000|Post-DDI Phase|Adverse Event|5|||
127932821|NCT03864042|460377401|FG001|Post-DDI Phase|Adverse Event|3|||
127932822|NCT03864042|460377402|FG002|Post-DDI Phase|Adverse Event|2|||
127932823|NCT03864042|460377400|FG000|Post-DDI Phase|Progressive Disease|11|||
127932824|NCT03864042|460377401|FG001|Post-DDI Phase|Progressive Disease|6|||
127932825|NCT03864042|460377402|FG002|Post-DDI Phase|Progressive Disease|13|||
127932826|NCT03864042|460377400|FG000|Post-DDI Phase|Discretion of investigator|1|||
127932827|NCT03864042|460377401|FG001|Post-DDI Phase|Discretion of investigator|1|||
127932828|NCT03864042|460377402|FG002|Post-DDI Phase|Discretion of investigator|0|||
127932829|NCT03864042|460377400|FG000|Post-DDI Phase|Study terminated by sponsor|7|||
127932830|NCT03864042|460377401|FG001|Post-DDI Phase|Study terminated by sponsor|0|||
127932831|NCT03864042|460377402|FG002|Post-DDI Phase|Study terminated by sponsor|0|||
127932832|NCT03864042|460377400|FG000|Post-DDI Phase|Withdrawal of consent|1|||
127932833|NCT03864042|460377401|FG001|Post-DDI Phase|Withdrawal of consent|2|||
127932834|NCT03864042|460377402|FG002|Post-DDI Phase|Withdrawal of consent|0|||
127932835|NCT02220725|460377403|FG000|Overall Study|Lost to Follow-up|0|||
127932836|NCT02220725|460377404|FG001|Overall Study|Lost to Follow-up|0|||
127932837|NCT02220725|460377405|FG002|Overall Study|Lost to Follow-up|0|||
127932838|NCT02220725|460377406|FG003|Overall Study|Lost to Follow-up|1|||
127932839|NCT02220725|460377403|FG000|Overall Study|Withdrawal by Subject|0|||
127932840|NCT02220725|460377404|FG001|Overall Study|Withdrawal by Subject|0|||
127932841|NCT02220725|460377405|FG002|Overall Study|Withdrawal by Subject|0|||
127932842|NCT02220725|460377406|FG003|Overall Study|Withdrawal by Subject|1|||
127932843|NCT05069155|460377407|FG000|Overall Study|Withdrawal by Subject|1|||
127932844|NCT05069155|460377408|FG001|Overall Study|Withdrawal by Subject|3|||
127932845|NCT03487848|460377409|FG000|Overall Study|Lost to Follow-up|1|||
127932846|NCT00731549|460377410|FG000|Overall Study|Lost to Follow-up|19|||
127932847|NCT00731549|460377410|FG000|Overall Study|Met withdrawal criteria|24|||
127932848|NCT00731549|460377410|FG000|Overall Study|Physician Decision|16|||
127932849|NCT00731549|460377410|FG000|Overall Study|Withdrawal by Subject|89|||
127932850|NCT00731549|460377410|FG000|Overall Study|Protocol deviation|1|||
127932851|NCT00731549|460377410|FG000|Overall Study|Adverse Event|31|||
127932852|NCT00731549|460377410|FG000|Overall Study|Lack of efficacy with AE|37|||
127932853|NCT00731549|460377410|FG000|Overall Study|Lack of efficacy without AE|6|||
127932854|NCT01393730|460377411|FG000|Overall Study|Withdrawal by Subject|3|||
127932855|NCT01393730|460377411|FG000|Overall Study|Other|2|||
127932856|NCT01393730|460377411|FG000|Overall Study|Adverse Event|1|||
127932857|NCT00103402|460377412|FG000|Overall Study|Adverse Event|3|||
127932858|NCT00103402|460377413|FG001|Overall Study|Adverse Event|4|||
127932859|NCT00103402|460377412|FG000|Overall Study|Lost to Follow-up|8|||
127932860|NCT00103402|460377413|FG001|Overall Study|Lost to Follow-up|7|||
127932861|NCT00103402|460377412|FG000|Overall Study|Dissatisfied/No longer interested|6|||
127932862|NCT00103402|460377413|FG001|Overall Study|Dissatisfied/No longer interested|6|||
127932863|NCT00103402|460377412|FG000|Overall Study|Personal constraints/Other|5|||
127932864|NCT00103402|460377413|FG001|Overall Study|Personal constraints/Other|0|||
127932865|NCT02333487|460377414|FG000|Overall Study|Adverse Event|0|||
127932866|NCT02333487|460377415|FG001|Overall Study|Adverse Event|2|||
127932867|NCT02333487|460377416|FG002|Overall Study|Adverse Event|0|||
127932868|NCT01297322|460377417|FG000|Overall Study|Lost to Follow-up|1|||
127932869|NCT01297322|460377418|FG001|Overall Study|Lost to Follow-up|0|||
127932870|NCT01297322|460377417|FG000|Overall Study|Withdrawal by Subject|0|||
127932871|NCT01297322|460377418|FG001|Overall Study|Withdrawal by Subject|1|||
127932872|NCT01297322|460377417|FG000|Overall Study|Protocol Violation|0|||
127932873|NCT01297322|460377418|FG001|Overall Study|Protocol Violation|3|||
127932874|NCT01111019|460377419|FG000|Overall Study|Withdrew Prematurely|2|||
127932875|NCT01111019|460377419|FG000|Overall Study|Other|1|||
127932876|NCT01583218|460377422|FG000|Overall Study|Withdrawal by Subject|43|||
127932877|NCT01583218|460377423|FG001|Overall Study|Withdrawal by Subject|29|||
127932878|NCT01583218|460377422|FG000|Overall Study|Death|206|||
127932879|NCT01583218|460377423|FG001|Overall Study|Death|211|||
127932880|NCT01583218|460377422|FG000|Overall Study|Lost to Follow-up|11|||
127932881|NCT01583218|460377423|FG001|Overall Study|Lost to Follow-up|17|||
127932882|NCT01583218|460377422|FG000|Overall Study|Adverse event or serious adverse event|3|||
127932883|NCT01583218|460377423|FG001|Overall Study|Adverse event or serious adverse event|3|||
127932884|NCT01583218|460377422|FG000|Overall Study|Patient /Family decision|3|||
127932885|NCT01583218|460377423|FG001|Overall Study|Patient /Family decision|0|||
127932886|NCT01583218|460377422|FG000|Overall Study|Cannot contact patient directly|1|||
127932887|NCT01583218|460377423|FG001|Overall Study|Cannot contact patient directly|2|||
127932888|NCT01583218|460377422|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
127932889|NCT01583218|460377423|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
127932890|NCT01583218|460377422|FG000|Overall Study|Patient did not wish to attend visits|0|||
127932891|NCT01583218|460377423|FG001|Overall Study|Patient did not wish to attend visits|1|||
127932892|NCT01583218|460377422|FG000|Overall Study|Patient randomized but not dosed|17|||
127932893|NCT01583218|460377423|FG001|Overall Study|Patient randomized but not dosed|16|||
127932894|NCT01583218|460377422|FG000|Overall Study|Patient was assessed via phone in person|1|||
127932895|NCT01583218|460377423|FG001|Overall Study|Patient was assessed via phone in person|0|||
127932896|NCT01583218|460377422|FG000|Overall Study|Patient deemed ineligible after random|2|||
127932897|NCT01583218|460377423|FG001|Overall Study|Patient deemed ineligible after random|0|||
127932898|NCT01583218|460377422|FG000|Overall Study|Patient was early terminated from study|0|||
127932899|NCT01583218|460377423|FG001|Overall Study|Patient was early terminated from study|1|||
127932900|NCT01583218|460377422|FG000|Overall Study|Patient was randomized due to mistake|1|||
127932901|NCT01583218|460377423|FG001|Overall Study|Patient was randomized due to mistake|0|||
127932902|NCT01583218|460377422|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
127932903|NCT01583218|460377423|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
127932904|NCT01583218|460377422|FG000|Overall Study|Withdraw of consent on day of random|1|||
127932905|NCT01583218|460377423|FG001|Overall Study|Withdraw of consent on day of random|0|||
127932906|NCT00712985|460377427|FG000|Overall Study|1 withdrew prior to start of drug|1|||
127932907|NCT00712985|460377427|FG000|Overall Study|1 patient moved out of state|1|||
127932908|NCT00712985|460377427|FG000|Overall Study|Lack of Efficacy|3|||
127932909|NCT02674061|460377428|FG000|Overall Study|Death|229|||
127932910|NCT02674061|460377429|FG001|Overall Study|Death|77|||
127932911|NCT02674061|460377428|FG000|Overall Study|Lost to Follow-up|3|||
127932912|NCT02674061|460377429|FG001|Overall Study|Lost to Follow-up|3|||
127932913|NCT02674061|460377428|FG000|Overall Study|Withdrawal by Subject|9|||
127932914|NCT02674061|460377429|FG001|Overall Study|Withdrawal by Subject|1|||
127932915|NCT02674061|460377428|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
127932916|NCT02674061|460377429|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
127932917|NCT01299805|460377432|FG000|Overall Study|Adverse Event|2|||
127932918|NCT01299805|460377433|FG001|Overall Study|Adverse Event|0|||
127932919|NCT00123955|460377437|FG000|Overall Study|Adverse Event|1|||
127932920|NCT00123955|460377438|FG001|Overall Study|Adverse Event|0|||
127932921|NCT00123955|460377437|FG000|Overall Study|Withdrawal by Subject|4|||
127932922|NCT00123955|460377438|FG001|Overall Study|Withdrawal by Subject|3|||
127932923|NCT00123955|460377437|FG000|Overall Study|Death|0|||
127932924|NCT00123955|460377438|FG001|Overall Study|Death|1|||
127932925|NCT03334721|460377439|FG000|Overall Study|Withdrawal by Subject|1|||
127932926|NCT03334721|460377440|FG001|Overall Study|Withdrawal by Subject|0|||
127932927|NCT03334721|460377439|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
127932928|NCT03334721|460377440|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
127932929|NCT04556552|460378701|FG000|Overall Study|Lost to Follow-up|1|||
127932930|NCT04556552|460378702|FG001|Overall Study|Lost to Follow-up|0|||
127932931|NCT04556552|460378701|FG000|Overall Study|Claustrophobia|0|||
127932932|NCT04556552|460378702|FG001|Overall Study|Claustrophobia|1|||
127932933|NCT04556552|460378701|FG000|Overall Study|Inability to continue|0|||
127932934|NCT04556552|460378702|FG001|Overall Study|Inability to continue|1|||
127932935|NCT03439852|460378703|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
127932936|NCT03439852|460378704|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
127932937|NCT03439852|460378703|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
127932938|NCT03439852|460378704|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
127932939|NCT03439852|460378703|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
127932940|NCT03439852|460378704|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
127932941|NCT01215513|460378705|FG000|Overall Study|Not completed CS42|9|||
127932942|NCT01215513|460378705|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
127932943|NCT01215513|460378705|FG000|Overall Study|Adverse event (CS42A)|2|||
127932944|NCT01215513|460378705|FG000|Overall Study|Physician decision (CS42A)|6|||
127932945|NCT01215513|460378705|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
127932946|NCT01215513|460378705|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
127932947|NCT00605865|460378706|FG000|Overall Study|Protocol Violation|115|||
127932948|NCT02858492|460378707|FG000|Overall Study|Withdrawal by Subject|0|||
127932949|NCT02858492|460378708|FG001|Overall Study|Withdrawal by Subject|1|||
127932950|NCT02858492|460378709|FG002|Overall Study|Withdrawal by Subject|0|||
127932951|NCT02858492|460378710|FG003|Overall Study|Withdrawal by Subject|1|||
127932952|NCT02858492|460378707|FG000|Overall Study|Adverse Event|0|||
127932953|NCT02858492|460378708|FG001|Overall Study|Adverse Event|0|||
127932954|NCT02858492|460378709|FG002|Overall Study|Adverse Event|0|||
127932955|NCT02858492|460378710|FG003|Overall Study|Adverse Event|3|||
127932956|NCT02858492|460378707|FG000|Overall Study|Lack of Efficacy|0|||
127932957|NCT02858492|460378708|FG001|Overall Study|Lack of Efficacy|0|||
127932958|NCT02858492|460378709|FG002|Overall Study|Lack of Efficacy|0|||
127932959|NCT02858492|460378710|FG003|Overall Study|Lack of Efficacy|1|||
127932960|NCT02858492|460378707|FG000|Overall Study|Protocol defined stopping criteria|0|||
127932961|NCT02858492|460378708|FG001|Overall Study|Protocol defined stopping criteria|0|||
127932962|NCT02858492|460378709|FG002|Overall Study|Protocol defined stopping criteria|0|||
127932963|NCT02858492|460378710|FG003|Overall Study|Protocol defined stopping criteria|1|||
127932964|NCT02119286|460378713|FG000|Overall Study|Adverse Event|9|||
127932965|NCT02119286|460378714|FG001|Overall Study|Adverse Event|7|||
127932966|NCT02119286|460378715|FG002|Overall Study|Adverse Event|2|||
127932967|NCT02119286|460378713|FG000|Overall Study|Lack of Efficacy|11|||
127932968|NCT02119286|460378714|FG001|Overall Study|Lack of Efficacy|3|||
127932969|NCT02119286|460378715|FG002|Overall Study|Lack of Efficacy|4|||
127932970|NCT02119286|460378713|FG000|Overall Study|Lost to Follow-up|2|||
127932971|NCT02119286|460378714|FG001|Overall Study|Lost to Follow-up|0|||
127932972|NCT02119286|460378715|FG002|Overall Study|Lost to Follow-up|1|||
127932973|NCT02119286|460378713|FG000|Overall Study|Withdrawal by Subject|4|||
127932974|NCT02119286|460378714|FG001|Overall Study|Withdrawal by Subject|1|||
127932975|NCT02119286|460378715|FG002|Overall Study|Withdrawal by Subject|0|||
127932976|NCT00619112|460378716|FG000|Overall Study|Adverse Event|1|||
127932977|NCT00619112|460378717|FG001|Overall Study|Adverse Event|2|||
127932978|NCT02040779|460378718|FG000|Overall Study|Adverse Event|1|||
127932979|NCT02040779|460378719|FG001|Overall Study|Adverse Event|0|||
127932980|NCT02040779|460378720|FG002|Overall Study|Adverse Event|0|||
127932981|NCT02040779|460378718|FG000|Overall Study|Withdrawal by Subject|4|||
127932982|NCT02040779|460378719|FG001|Overall Study|Withdrawal by Subject|1|||
127932983|NCT02040779|460378720|FG002|Overall Study|Withdrawal by Subject|3|||
127932984|NCT02040779|460378718|FG000|Overall Study|Non-compliance|0|||
127932985|NCT02040779|460378719|FG001|Overall Study|Non-compliance|1|||
127932986|NCT02040779|460378720|FG002|Overall Study|Non-compliance|0|||
127932987|NCT02040779|460378718|FG000|Overall Study|Protocol Violation|2|||
127932988|NCT02040779|460378719|FG001|Overall Study|Protocol Violation|1|||
127932989|NCT02040779|460378720|FG002|Overall Study|Protocol Violation|0|||
127932990|NCT02040779|460378718|FG000|Overall Study|Lost to Follow-up|1|||
127932991|NCT02040779|460378719|FG001|Overall Study|Lost to Follow-up|2|||
127932992|NCT02040779|460378720|FG002|Overall Study|Lost to Follow-up|1|||
127932993|NCT02040779|460378718|FG000|Overall Study|Lack of Efficacy|4|||
127932994|NCT02040779|460378719|FG001|Overall Study|Lack of Efficacy|2|||
127932995|NCT02040779|460378720|FG002|Overall Study|Lack of Efficacy|0|||
127932996|NCT02132637|460378721|FG000|Study Period 1|Withdrawal by Subject|0|||
127932997|NCT02132637|460378722|FG001|Study Period 1|Withdrawal by Subject|4|||
127932998|NCT02132637|460378721|FG000|Study Period 1|Physician Decision|1|||
127932999|NCT02132637|460378722|FG001|Study Period 1|Physician Decision|0|||
127933000|NCT02132637|460378721|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
127933001|NCT02132637|460378722|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
127933002|NCT02132637|460378721|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
127933003|NCT02132637|460378722|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
127933004|NCT00652028|460378723|FG000|Overall Study|Adverse Event|1|||
127933005|NCT00652028|460378724|FG001|Overall Study|Adverse Event|0|||
127933006|NCT00652028|460378725|FG002|Overall Study|Adverse Event|0|||
127933007|NCT00652028|460378726|FG003|Overall Study|Adverse Event|0|||
127933008|NCT00652028|460378723|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
127933009|NCT00652028|460378724|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
127933010|NCT00652028|460378725|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
127933011|NCT00652028|460378726|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
127933012|NCT00652028|460378723|FG000|Overall Study|Physician Decision|0|||
127933013|NCT00652028|460378724|FG001|Overall Study|Physician Decision|0|||
127933014|NCT00652028|460378725|FG002|Overall Study|Physician Decision|1|||
127933015|NCT00652028|460378726|FG003|Overall Study|Physician Decision|0|||
127933016|NCT00931268|460378730|FG000|Overall Study|Lost to Follow-up|6|||
127933017|NCT01388166|460378731|FG000|Overall Study|Adverse Event|16|||
127933018|NCT01388166|460378731|FG000|Overall Study|Lost to Follow-up|30|||
127933019|NCT01388166|460378731|FG000|Overall Study|Others than specified above|13|||
127933020|NCT02751359|460378732|FG000|Overall Study|Lost to Follow-up|1|||
127933021|NCT02400671|460378733|FG000|Overall Study|Death|5|||
127933022|NCT02400671|460378734|FG001|Overall Study|Death|3|||
127933023|NCT02400671|460378735|FG002|Overall Study|Death|4|||
127933024|NCT02400671|460378733|FG000|Overall Study|Lost to Follow-up|20|||
127933025|NCT02400671|460378734|FG001|Overall Study|Lost to Follow-up|27|||
127933026|NCT02400671|460378735|FG002|Overall Study|Lost to Follow-up|24|||
127933027|NCT02400671|460378733|FG000|Overall Study|Withdrawal by Subject|2|||
127933028|NCT02400671|460378734|FG001|Overall Study|Withdrawal by Subject|2|||
127933029|NCT02400671|460378735|FG002|Overall Study|Withdrawal by Subject|0|||
127933030|NCT03656874|460378741|FG000|Overall Study|Lost to Follow-up|3|||
127933031|NCT03656874|460378742|FG001|Overall Study|Lost to Follow-up|17|||
127933032|NCT00584844|460378743|FG000|Overall Study|Withdrawal by Subject|59|||
127933033|NCT00584844|460378743|FG000|Overall Study|Screen Failure|20|||
127933034|NCT03001219|460378748|FG000|Proof of Concept|Study Termination by Sponsor|0|||
127933035|NCT03001219|460378749|FG001|Proof of Concept|Study Termination by Sponsor|1|||
127933036|NCT03001219|460378748|FG000|Proof of Concept|Withdrawal by Subject|0|||
127933037|NCT03001219|460378749|FG001|Proof of Concept|Withdrawal by Subject|4|||
127933038|NCT03001219|460378748|FG000|Proof of Concept|Protocol Deviation|0|||
127933039|NCT03001219|460378749|FG001|Proof of Concept|Protocol Deviation|1|||
127933040|NCT03001219|460378748|FG000|Proof of Concept|Adverse Event|1|||
127933041|NCT03001219|460378749|FG001|Proof of Concept|Adverse Event|1|||
127933042|NCT03001219|460378748|FG000|Proof of Concept|Physician Decision|1|||
127933043|NCT03001219|460378749|FG001|Proof of Concept|Physician Decision|0|||
127933044|NCT03001219|460378748|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
127933045|NCT03001219|460378749|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
127933046|NCT03001219|460378748|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
127933047|NCT03001219|460378749|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
127933048|NCT03001219|460378748|FG000|Extension Period Analysis|Physician Decision|0|||
127933049|NCT03001219|460378749|FG001|Extension Period Analysis|Physician Decision|1|||
127933050|NCT03001219|460378748|FG000|Extension Period Analysis|Adverse Event|1|||
127933051|NCT03001219|460378749|FG001|Extension Period Analysis|Adverse Event|1|||
127933052|NCT03001219|460378748|FG000|Extension Period Analysis|Protocol Deviation|0|||
127933053|NCT03001219|460378749|FG001|Extension Period Analysis|Protocol Deviation|1|||
127933054|NCT03001219|460378748|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
127933055|NCT03001219|460378749|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
127933056|NCT01195103|460378750|FG000|Overall Study|Withdrawal by Subject|1|||
127933057|NCT01195103|460378751|FG001|Overall Study|Withdrawal by Subject|0|||
127933058|NCT01195103|460378752|FG002|Overall Study|Withdrawal by Subject|0|||
127933059|NCT03760250|460378753|FG000|Overall Study|Withdrawal by Subject|1|||
127933060|NCT03760250|460378753|FG000|Overall Study|Physician Decision|1|||
127933061|NCT03733210|460378754|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
127933062|NCT03733210|460378755|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
127933063|NCT04421586|460378756|FG000|Overall Study|Death|0|||
127933064|NCT04421586|460378757|FG001|Overall Study|Death|1|||
127933065|NCT04421586|460378756|FG000|Overall Study|Lost to Follow-up|2|||
127933066|NCT04421586|460378757|FG001|Overall Study|Lost to Follow-up|2|||
127933067|NCT04421586|460378756|FG000|Overall Study|Withdrawn by PI|1|||
127933068|NCT04421586|460378757|FG001|Overall Study|Withdrawn by PI|0|||
127933069|NCT04421586|460378756|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
127933070|NCT04421586|460378757|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
127933071|NCT05065983|460378759|FG000|Overall Study|Lost to Follow-up|2|||
127933072|NCT01765582|460378760|FG000|Overall Study|Other|3|||
127933073|NCT01765582|460378761|FG001|Overall Study|Other|6|||
127933074|NCT01765582|460378762|FG002|Overall Study|Other|9|||
127933075|NCT01765582|460378760|FG000|Overall Study|Lost to Follow-up|2|||
127933076|NCT01765582|460378761|FG001|Overall Study|Lost to Follow-up|2|||
127933077|NCT01765582|460378762|FG002|Overall Study|Lost to Follow-up|1|||
127933078|NCT01765582|460378760|FG000|Overall Study|Death|31|||
127933079|NCT01765582|460378761|FG001|Overall Study|Death|36|||
127933080|NCT01765582|460378762|FG002|Overall Study|Death|33|||
127933081|NCT01765582|460378760|FG000|Overall Study|Sponsor Decision|46|||
127933082|NCT01765582|460378761|FG001|Overall Study|Sponsor Decision|42|||
127933083|NCT01765582|460378762|FG002|Overall Study|Sponsor Decision|42|||
127933084|NCT01765582|460378760|FG000|Overall Study|Withdrawal of Consent|11|||
127933085|NCT01765582|460378761|FG001|Overall Study|Withdrawal of Consent|6|||
127933086|NCT01765582|460378762|FG002|Overall Study|Withdrawal of Consent|10|||
127933087|NCT00986180|460378763|FG000|Overall Study|Adverse Event|21|||
127933088|NCT00986180|460378764|FG001|Overall Study|Adverse Event|23|||
127933089|NCT00986180|460378763|FG000|Overall Study|Lack of Efficacy|4|||
127933090|NCT00986180|460378764|FG001|Overall Study|Lack of Efficacy|3|||
127933091|NCT00986180|460378763|FG000|Overall Study|Lost to Follow-up|5|||
127933092|NCT00986180|460378764|FG001|Overall Study|Lost to Follow-up|7|||
127933093|NCT00986180|460378763|FG000|Overall Study|Physician Decision|1|||
127933094|NCT00986180|460378764|FG001|Overall Study|Physician Decision|3|||
127933095|NCT00986180|460378763|FG000|Overall Study|Protocol Violation|2|||
127933096|NCT00986180|460378764|FG001|Overall Study|Protocol Violation|0|||
127933097|NCT00986180|460378763|FG000|Overall Study|Withdrawal by Subject|1|||
127933098|NCT00986180|460378764|FG001|Overall Study|Withdrawal by Subject|9|||
127933099|NCT00986180|460378763|FG000|Overall Study|Miscellanies|10|||
127933100|NCT00986180|460378764|FG001|Overall Study|Miscellanies|11|||
127933101|NCT01691820|460378765|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
127933102|NCT01691820|460378766|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
127933103|NCT01691820|460378765|FG000|Overall Study|Migrated/moved from study area|7|||
127933104|NCT01691820|460378766|FG001|Overall Study|Migrated/moved from study area|4|||
127933105|NCT01691820|460378765|FG000|Overall Study|Lost to Follow-up|6|||
127933106|NCT01691820|460378766|FG001|Overall Study|Lost to Follow-up|17|||
127933107|NCT01691820|460378765|FG000|Overall Study|Other (unspecified)|4|||
127933108|NCT01691820|460378766|FG001|Overall Study|Other (unspecified)|1|||
127933109|NCT00076804|460378769|FG000|Overall Study|Death|9|||
127933110|NCT00076804|460378770|FG001|Overall Study|Death|20|||
127933111|NCT00076804|460378769|FG000|Overall Study|Lost to Follow-up|9|||
127933112|NCT00076804|460378770|FG001|Overall Study|Lost to Follow-up|9|||
127933113|NCT00076804|460378769|FG000|Overall Study|Withdrawal by Subject|10|||
127933114|NCT00076804|460378770|FG001|Overall Study|Withdrawal by Subject|8|||
127933115|NCT00076804|460378769|FG000|Overall Study|Early study Closure|32|||
127933116|NCT00076804|460378770|FG001|Overall Study|Early study Closure|32|||
127933117|NCT03852459|460378775|FG000|Overall Study|Adverse Event|2|||
127933118|NCT03852459|460378776|FG001|Overall Study|Adverse Event|2|||
127933119|NCT03852459|460378775|FG000|Overall Study|Withdrawal by Subject|1|||
127933120|NCT03852459|460378776|FG001|Overall Study|Withdrawal by Subject|1|||
127933121|NCT00257920|460378778|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
127933122|NCT00257920|460378779|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
127933123|NCT00257920|460378778|FG000|Period: Second Intervention|Other|2|||
127933124|NCT00257920|460378779|FG001|Period: Second Intervention|Other|1|||
127933125|NCT03629028|460378783|FG000|Overall Study|Lost to Follow-up|26|||
127933126|NCT03629028|460378784|FG001|Overall Study|Lost to Follow-up|23|||
127933127|NCT03629028|460378783|FG000|Overall Study|Pregnancy|4|||
127933128|NCT03629028|460378784|FG001|Overall Study|Pregnancy|2|||
127933129|NCT03629028|460378783|FG000|Overall Study|intolerance to examination|2|||
127933130|NCT03629028|460378784|FG001|Overall Study|intolerance to examination|0|||
127933131|NCT02025751|460378787|FG000|Overall Study|Lost to Follow-up|1|||
127933132|NCT02025751|460378788|FG001|Overall Study|Lost to Follow-up|0|||
127933133|NCT02025751|460378787|FG000|Overall Study|Adverse Event|0|||
127933134|NCT02025751|460378788|FG001|Overall Study|Adverse Event|1|||
127933135|NCT02025751|460378787|FG000|Overall Study|Physician Decision|0|||
127933136|NCT02025751|460378788|FG001|Overall Study|Physician Decision|1|||
127933137|NCT02025751|460378787|FG000|Overall Study|Withdrawal by Subject|0|||
127933138|NCT02025751|460378788|FG001|Overall Study|Withdrawal by Subject|1|||
127933139|NCT00891839|460378789|FG000|Overall Study|Adverse Event|2|||
127933140|NCT00891839|460378789|FG000|Overall Study|Withdrawal by Subject|2|||
127933141|NCT00891839|460378789|FG000|Overall Study|Disease progression|3|||
127933142|NCT00532935|460378790|FG000|Overall Study|Adverse Event|11|||
127933143|NCT00532935|460378791|FG001|Overall Study|Adverse Event|12|||
127933144|NCT00532935|460378790|FG000|Overall Study|Lack of Efficacy|0|||
127933145|NCT00532935|460378791|FG001|Overall Study|Lack of Efficacy|3|||
127933146|NCT00532935|460378790|FG000|Overall Study|Lost to Follow-up|10|||
127933147|NCT00532935|460378791|FG001|Overall Study|Lost to Follow-up|6|||
127933148|NCT00532935|460378790|FG000|Overall Study|Physician Decision|4|||
127933149|NCT00532935|460378791|FG001|Overall Study|Physician Decision|5|||
127933150|NCT00532935|460378790|FG000|Overall Study|Pregnancy|1|||
127933151|NCT00532935|460378791|FG001|Overall Study|Pregnancy|0|||
127933152|NCT00532935|460378790|FG000|Overall Study|Protocol Violation|4|||
127933153|NCT00532935|460378791|FG001|Overall Study|Protocol Violation|2|||
127933154|NCT00532935|460378790|FG000|Overall Study|Withdrawal by Subject|10|||
127933155|NCT00532935|460378791|FG001|Overall Study|Withdrawal by Subject|9|||
127933156|NCT00532935|460378790|FG000|Overall Study|Protocol Specific Criteria|11|||
127933157|NCT00532935|460378791|FG001|Overall Study|Protocol Specific Criteria|15|||
127933158|NCT00456495|460378792|FG000|Overall Study|Physician Decision|2|||
127933159|NCT01663727|460378795|FG000|Overall Study|Death|161|||
127933160|NCT01663727|460378796|FG001|Overall Study|Death|155|||
127933161|NCT01663727|460378795|FG000|Overall Study|Lost to Follow-up|10|||
127933162|NCT01663727|460378796|FG001|Overall Study|Lost to Follow-up|8|||
127933163|NCT01663727|460378795|FG000|Overall Study|Withdrawal by Subject|18|||
127933164|NCT01663727|460378796|FG001|Overall Study|Withdrawal by Subject|25|||
127933165|NCT01663727|460378795|FG000|Overall Study|Study Terminated|51|||
127933166|NCT01663727|460378796|FG001|Overall Study|Study Terminated|50|||
127933167|NCT01663727|460378795|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
127933168|NCT01663727|460378796|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
127933169|NCT01663727|460378795|FG000|Overall Study|Withdrawal prior to dosing.|1|||
127933170|NCT01663727|460378796|FG001|Overall Study|Withdrawal prior to dosing.|0|||
127933171|NCT04969861|460378798|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
127933172|NCT04969861|460378799|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
127933173|NCT02932228|460378804|FG000|Overall Study|Death|8|||
127933174|NCT02932228|460378805|FG001|Overall Study|Death|23|||
127933175|NCT02932228|460378804|FG000|Overall Study|not eligible upon chart review|2|||
127933176|NCT02932228|460378805|FG001|Overall Study|not eligible upon chart review|5|||
127933177|NCT03340064|460380136|FG000|First Period|Adverse Event, non-fatal|2|||
127933178|NCT03340064|460380137|FG001|First Period|Adverse Event, non-fatal|0|||
127933179|NCT03340064|460380136|FG000|First Period|Lack of Efficacy|3|||
127933180|NCT03340064|460380137|FG001|First Period|Lack of Efficacy|0|||
127933181|NCT03340064|460380136|FG000|Second Period|Adverse Event, non-fatal|1|||
127933182|NCT03340064|460380137|FG001|Second Period|Adverse Event, non-fatal|1|||
127933183|NCT03340064|460380136|FG000|Second Period|Lack of Efficacy|11|||
127933184|NCT03340064|460380137|FG001|Second Period|Lack of Efficacy|0|||
127933185|NCT03340064|460380136|FG000|Second Period|Physician Decision|3|||
127933186|NCT03340064|460380137|FG001|Second Period|Physician Decision|0|||
127933187|NCT03340064|460380136|FG000|Second Period|Withdrawal by Subject|2|||
127933188|NCT03340064|460380137|FG001|Second Period|Withdrawal by Subject|1|||
127933189|NCT03340064|460380136|FG000|Second Period|Approved Drug Available For Indication|1|||
127933190|NCT03340064|460380137|FG001|Second Period|Approved Drug Available For Indication|0|||
127933191|NCT03340064|460380136|FG000|Second Period|Protocol-Specified Withdrawal Criterion Met|1|||
127933192|NCT03340064|460380137|FG001|Second Period|Protocol-Specified Withdrawal Criterion Met|0|||
127933193|NCT02522403|460380138|FG000|Overall Study|Lost to Follow-up|2|||
127933194|NCT02522403|460380139|FG001|Overall Study|Lost to Follow-up|2|||
127933195|NCT02522403|460380138|FG000|Overall Study|Withdrawal by Subject|2|||
127933196|NCT02522403|460380139|FG001|Overall Study|Withdrawal by Subject|4|||
127933197|NCT00856973|460380142|FG000|Overall Study|Adverse Event|5|||
127933198|NCT00856973|460380143|FG001|Overall Study|Adverse Event|5|||
127933199|NCT00856973|460380144|FG002|Overall Study|Adverse Event|3|||
127933200|NCT00856973|460380142|FG000|Overall Study|Lost to Follow-up|6|||
127933201|NCT00856973|460380143|FG001|Overall Study|Lost to Follow-up|3|||
127933202|NCT00856973|460380144|FG002|Overall Study|Lost to Follow-up|5|||
127933203|NCT00856973|460380142|FG000|Overall Study|Physician Decision|0|||
127933204|NCT00856973|460380143|FG001|Overall Study|Physician Decision|3|||
127933205|NCT00856973|460380144|FG002|Overall Study|Physician Decision|1|||
127933206|NCT00856973|460380142|FG000|Overall Study|Protocol Violation|1|||
127933207|NCT00856973|460380143|FG001|Overall Study|Protocol Violation|2|||
127933208|NCT00856973|460380144|FG002|Overall Study|Protocol Violation|1|||
127933209|NCT00856973|460380142|FG000|Overall Study|Withdrawal by Subject|13|||
127933210|NCT00856973|460380143|FG001|Overall Study|Withdrawal by Subject|16|||
127933211|NCT00856973|460380144|FG002|Overall Study|Withdrawal by Subject|15|||
127933212|NCT00856973|460380142|FG000|Overall Study|Other|11|||
127933213|NCT00856973|460380143|FG001|Overall Study|Other|12|||
127933214|NCT00856973|460380144|FG002|Overall Study|Other|13|||
127933215|NCT00793780|460380150|FG000|Overall Study|Withdrawal by Subject|2|||
127933216|NCT00793780|460380151|FG001|Overall Study|Withdrawal by Subject|1|||
127933217|NCT03310411|460380154|FG000|Period 1|Adverse Event|0|||
127933218|NCT03310411|460380155|FG001|Period 1|Adverse Event|0|||
127933219|NCT03310411|460380156|FG002|Period 1|Adverse Event|0|||
127933220|NCT03310411|460380157|FG003|Period 1|Adverse Event|1|||
127933221|NCT03623386|460380160|FG000|Overall Study|Protocol Violation|3|||
127933222|NCT03623386|460380161|FG001|Overall Study|Protocol Violation|2|||
127933223|NCT03623386|460380162|FG002|Overall Study|Protocol Violation|0|||
127933224|NCT03623386|460380160|FG000|Overall Study|Physician Decision|1|||
127933225|NCT03623386|460380161|FG001|Overall Study|Physician Decision|1|||
127933226|NCT03623386|460380162|FG002|Overall Study|Physician Decision|0|||
127933227|NCT03623386|460380160|FG000|Overall Study|Lost to Follow-up|0|||
127933228|NCT03623386|460380161|FG001|Overall Study|Lost to Follow-up|2|||
127933229|NCT03623386|460380162|FG002|Overall Study|Lost to Follow-up|0|||
127933230|NCT03623386|460380160|FG000|Overall Study|COVID-19|0|||
127933231|NCT03623386|460380161|FG001|Overall Study|COVID-19|1|||
127933232|NCT03623386|460380162|FG002|Overall Study|COVID-19|0|||
127933233|NCT04271735|460380167|FG000|Overall Study|Physician Decision|2|||
127933234|NCT04271735|460380168|FG001|Overall Study|Physician Decision|0|||
127933235|NCT00515541|460380169|FG000|Overall Study|Physician Decision|0|||
127933236|NCT00515541|460380170|FG001|Overall Study|Physician Decision|2|||
127933237|NCT00515541|460380171|FG002|Overall Study|Physician Decision|0|||
127933238|NCT00515541|460380172|FG003|Overall Study|Physician Decision|1|||
127933239|NCT00515541|460380169|FG000|Overall Study|No show for appointments|0|||
127933240|NCT00515541|460380170|FG001|Overall Study|No show for appointments|1|||
127933241|NCT00515541|460380171|FG002|Overall Study|No show for appointments|0|||
127933242|NCT00515541|460380172|FG003|Overall Study|No show for appointments|2|||
127933243|NCT00515541|460380169|FG000|Overall Study|Withdrawal by Subject|0|||
127933244|NCT00515541|460380170|FG001|Overall Study|Withdrawal by Subject|2|||
127933245|NCT00515541|460380171|FG002|Overall Study|Withdrawal by Subject|0|||
127933246|NCT00515541|460380172|FG003|Overall Study|Withdrawal by Subject|2|||
127933247|NCT00922272|460380176|FG000|Open-label Phase|Adverse Event|5|||
127933248|NCT00922272|460380177|FG001|Open-label Phase|Adverse Event|0|||
127933249|NCT00922272|460380176|FG000|Open-label Phase|Protocol Violation|1|||
127933250|NCT00922272|460380177|FG001|Open-label Phase|Protocol Violation|0|||
127933251|NCT00922272|460380176|FG000|Open-label Phase|Withdrawal by Subject|11|||
127933252|NCT00922272|460380177|FG001|Open-label Phase|Withdrawal by Subject|0|||
127933253|NCT00922272|460380176|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
127933254|NCT00922272|460380177|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
127933255|NCT00922272|460380176|FG000|Open-label Phase|Withdrawal criteria met|5|||
127933256|NCT00922272|460380177|FG001|Open-label Phase|Withdrawal criteria met|0|||
127933257|NCT00922272|460380176|FG000|Double-blind Phase|Adverse Event|1|||
127933258|NCT00922272|460380177|FG001|Double-blind Phase|Adverse Event|1|||
127933259|NCT00922272|460380176|FG000|Double-blind Phase|Withdrawal by Subject|1|||
127933260|NCT00922272|460380177|FG001|Double-blind Phase|Withdrawal by Subject|1|||
127933261|NCT00922272|460380176|FG000|Double-blind Phase|Lost to Follow-up|2|||
127933262|NCT00922272|460380177|FG001|Double-blind Phase|Lost to Follow-up|1|||
127933263|NCT00922272|460380176|FG000|Double-blind Phase|Withdrawal criteria met|1|||
127933264|NCT00922272|460380177|FG001|Double-blind Phase|Withdrawal criteria met|1|||
127933265|NCT00922272|460380176|FG000|Double-blind Phase|Noncompliance|1|||
127933266|NCT00922272|460380177|FG001|Double-blind Phase|Noncompliance|1|||
127933267|NCT00922272|460380176|FG000|Double-blind Phase|Positive urine drug screen|1|||
127933268|NCT00922272|460380177|FG001|Double-blind Phase|Positive urine drug screen|1|||
127933269|NCT02588950|460380178|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
127933270|NCT02588950|460380179|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
127933271|NCT02588950|460380180|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
127933272|NCT02588950|460380181|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
127933273|NCT02588950|460380178|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
127933274|NCT02588950|460380179|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
127933275|NCT02588950|460380180|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
127933276|NCT02588950|460380181|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
127933277|NCT04397445|460380186|FG000|Overall Study|Withdrawal by Subject|1|||
127933278|NCT04397445|460380187|FG001|Overall Study|Withdrawal by Subject|0|||
127933279|NCT04397445|460380188|FG002|Overall Study|Withdrawal by Subject|0|||
127933280|NCT04397445|460380189|FG003|Overall Study|Withdrawal by Subject|0|||
127933281|NCT02963441|460380191|FG000|Overall Study|Protocol violation or withdrawn|8|||
127933282|NCT02963441|460380191|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
127933283|NCT02963441|460380191|FG000|Overall Study|IDx-DR insufficient quality|33|||
127933284|NCT02669940|460380194|FG000|Overall Study|Failure to return|0|||
127933285|NCT02669940|460380195|FG001|Overall Study|Failure to return|3|||
127933286|NCT02669940|460380194|FG000|Overall Study|Insufficient follow-up data|1|||
127933287|NCT02669940|460380195|FG001|Overall Study|Insufficient follow-up data|0|||
127933288|NCT00361335|460380196|FG000|IV Period: Baseline to E0|Adverse Event|9|||
127933289|NCT00361335|460380197|FG001|IV Period: Baseline to E0|Adverse Event|4|||
127933290|NCT00361335|460380198|FG002|IV Period: Baseline to E0|Adverse Event|5|||
127933291|NCT00361335|460380199|FG003|IV Period: Baseline to E0|Adverse Event|9|||
127933292|NCT00361335|460380200|FG004|IV Period: Baseline to E0|Adverse Event|8|||
127933293|NCT00361335|460380201|FG005|IV Period: Baseline to E0|Adverse Event|0|||
127933294|NCT00361335|460380202|FG006|IV Period: Baseline to E0|Adverse Event|0|||
127933295|NCT00361335|460380196|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
127933296|NCT00361335|460380197|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
127933297|NCT00361335|460380198|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
127933298|NCT00361335|460380199|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
127933299|NCT00361335|460380200|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
127933300|NCT00361335|460380201|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
127933301|NCT00361335|460380202|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
127933302|NCT00361335|460380196|FG000|IV Period: Baseline to E0|Death|1|||
127933303|NCT00361335|460380197|FG001|IV Period: Baseline to E0|Death|1|||
127933304|NCT00361335|460380198|FG002|IV Period: Baseline to E0|Death|1|||
127933305|NCT00361335|460380199|FG003|IV Period: Baseline to E0|Death|1|||
127933306|NCT00361335|460380200|FG004|IV Period: Baseline to E0|Death|0|||
127933307|NCT00361335|460380201|FG005|IV Period: Baseline to E0|Death|0|||
127933308|NCT00361335|460380202|FG006|IV Period: Baseline to E0|Death|0|||
127933309|NCT00361335|460380196|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
127933310|NCT00361335|460380197|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
127933311|NCT00361335|460380198|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
127933312|NCT00361335|460380199|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
127933313|NCT00361335|460380200|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
127933314|NCT00361335|460380201|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
127933315|NCT00361335|460380202|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
127933316|NCT00361335|460380196|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
127933317|NCT00361335|460380197|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
127933318|NCT00361335|460380198|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
127933319|NCT00361335|460380199|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
127933320|NCT00361335|460380200|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
127933321|NCT00361335|460380201|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
127933322|NCT00361335|460380202|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
127933323|NCT00361335|460380196|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
127933324|NCT00361335|460380197|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
127933325|NCT00361335|460380198|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
127933326|NCT00361335|460380199|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
127933327|NCT00361335|460380200|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
127933328|NCT00361335|460380201|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
127933329|NCT00361335|460380202|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
127933330|NCT00361335|460380196|FG000|IV Period: Baseline to E0|Other|2|||
127933331|NCT00361335|460380197|FG001|IV Period: Baseline to E0|Other|9|||
127933332|NCT00361335|460380198|FG002|IV Period: Baseline to E0|Other|9|||
127933333|NCT00361335|460380199|FG003|IV Period: Baseline to E0|Other|3|||
127933334|NCT00361335|460380200|FG004|IV Period: Baseline to E0|Other|2|||
127933335|NCT00361335|460380201|FG005|IV Period: Baseline to E0|Other|0|||
127933336|NCT00361335|460380202|FG006|IV Period: Baseline to E0|Other|0|||
127933337|NCT00361335|460380196|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
127933338|NCT00361335|460380197|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
127933339|NCT00361335|460380198|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
127933340|NCT00361335|460380199|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
127933341|NCT00361335|460380200|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
127933342|NCT00361335|460380201|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
127933343|NCT00361335|460380202|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
127933344|NCT00361335|460380196|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
127933345|NCT00361335|460380197|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
127933346|NCT00361335|460380198|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
127933347|NCT00361335|460380199|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
127933348|NCT00361335|460380200|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
127933349|NCT00361335|460380201|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
127933350|NCT00361335|460380202|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
127933351|NCT00361335|460380196|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
127933352|NCT00361335|460380197|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
127933353|NCT00361335|460380198|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
127933354|NCT00361335|460380199|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
127933355|NCT00361335|460380200|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
127933356|NCT00361335|460380201|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
127933357|NCT00361335|460380202|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
127933358|NCT00361335|460380196|FG000|SC Period: Week E0 to Week E24|Death|0|||
127933359|NCT00361335|460380197|FG001|SC Period: Week E0 to Week E24|Death|0|||
127933360|NCT00361335|460380198|FG002|SC Period: Week E0 to Week E24|Death|0|||
127933361|NCT00361335|460380199|FG003|SC Period: Week E0 to Week E24|Death|0|||
127933362|NCT00361335|460380200|FG004|SC Period: Week E0 to Week E24|Death|0|||
127933363|NCT00361335|460380201|FG005|SC Period: Week E0 to Week E24|Death|0|||
127933364|NCT00361335|460380202|FG006|SC Period: Week E0 to Week E24|Death|1|||
127933365|NCT00361335|460380196|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
127933366|NCT00361335|460380197|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
127933367|NCT00361335|460380198|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
127933368|NCT00361335|460380199|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
127933369|NCT00361335|460380200|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
127933370|NCT00361335|460380201|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
127933371|NCT00361335|460380202|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
127933372|NCT00361335|460380196|FG000|SC Period: Week E0 to Week E24|Other|1|||
127933373|NCT00361335|460380197|FG001|SC Period: Week E0 to Week E24|Other|0|||
127933374|NCT00361335|460380198|FG002|SC Period: Week E0 to Week E24|Other|0|||
127933375|NCT00361335|460380199|FG003|SC Period: Week E0 to Week E24|Other|1|||
127933376|NCT00361335|460380200|FG004|SC Period: Week E0 to Week E24|Other|0|||
127933377|NCT00361335|460380201|FG005|SC Period: Week E0 to Week E24|Other|1|||
127933378|NCT00361335|460380202|FG006|SC Period: Week E0 to Week E24|Other|2|||
127933379|NCT00361335|460380196|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
127933380|NCT00361335|460380197|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
127933381|NCT00361335|460380198|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
127933382|NCT00361335|460380199|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
127933383|NCT00361335|460380200|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
127933384|NCT00361335|460380201|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
127933385|NCT00361335|460380202|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
127933386|NCT02749292|460380207|FG000|Overall Study|Physician Decision|1|||
127933387|NCT02749292|460380208|FG001|Overall Study|Physician Decision|0|||
127933388|NCT02749292|460380207|FG000|Overall Study|Withdrawal by Subject|5|||
127933389|NCT02749292|460380208|FG001|Overall Study|Withdrawal by Subject|7|||
127933390|NCT02749292|460380207|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
127933391|NCT02749292|460380208|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
127933392|NCT02749292|460380207|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
127933393|NCT02749292|460380208|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
127933394|NCT02749292|460380207|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
127933395|NCT02749292|460380208|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
127933396|NCT02749292|460380207|FG000|Overall Study|Adverse Event|4|||
127933397|NCT02749292|460380208|FG001|Overall Study|Adverse Event|1|||
127933398|NCT02749292|460380207|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
127933399|NCT02749292|460380208|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
127933400|NCT02749292|460380207|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
127933401|NCT02749292|460380208|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
127933402|NCT02749292|460380207|FG000|Overall Study|Requiring glucocorticoids|0|||
127933403|NCT02749292|460380208|FG001|Overall Study|Requiring glucocorticoids|3|||
127933404|NCT02749292|460380207|FG000|Overall Study|Cancer|1|||
127933405|NCT02749292|460380208|FG001|Overall Study|Cancer|0|||
127933406|NCT02458092|460380209|FG000|Overall Study|Withdrawal by Subject|1|||
127933407|NCT02458092|460380210|FG001|Overall Study|Withdrawal by Subject|0|||
127933408|NCT00251641|460380213|FG000|Overall Study|Adverse Event|80|||
127933409|NCT00251641|460380214|FG001|Overall Study|Adverse Event|8|||
127933410|NCT00251641|460380213|FG000|Overall Study|Lack of Efficacy|2|||
127933411|NCT00251641|460380214|FG001|Overall Study|Lack of Efficacy|1|||
127933412|NCT00251641|460380213|FG000|Overall Study|Progression of Disease|0|||
127933413|NCT00251641|460380214|FG001|Overall Study|Progression of Disease|2|||
127933414|NCT00251641|460380213|FG000|Overall Study|Lost to Follow-up|3|||
127933415|NCT00251641|460380214|FG001|Overall Study|Lost to Follow-up|3|||
127933416|NCT00251641|460380213|FG000|Overall Study|Withdrawal by Subject|6|||
127933417|NCT00251641|460380214|FG001|Overall Study|Withdrawal by Subject|8|||
127933418|NCT00251641|460380213|FG000|Overall Study|Protocol Violation|10|||
127933419|NCT00251641|460380214|FG001|Overall Study|Protocol Violation|2|||
127933420|NCT00251641|460380213|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
127933421|NCT00251641|460380214|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
127933422|NCT00251641|460380213|FG000|Overall Study|Switched Treatment|9|||
127933423|NCT00251641|460380214|FG001|Overall Study|Switched Treatment|63|||
127933424|NCT02093221|460380217|FG000|Overall Study|Adverse Event|1|||
127933425|NCT02093221|460380218|FG001|Overall Study|Adverse Event|0|||
127933426|NCT02093221|460380219|FG002|Overall Study|Adverse Event|0|||
127933427|NCT02093221|460380220|FG003|Overall Study|Adverse Event|0|||
127933428|NCT02093221|460380221|FG004|Overall Study|Adverse Event|0|||
127933429|NCT02093221|460380217|FG000|Overall Study|Withdrawal by Subject|1|||
127933430|NCT02093221|460380218|FG001|Overall Study|Withdrawal by Subject|1|||
127933431|NCT02093221|460380219|FG002|Overall Study|Withdrawal by Subject|4|||
127933432|NCT02093221|460380220|FG003|Overall Study|Withdrawal by Subject|1|||
127933433|NCT02093221|460380221|FG004|Overall Study|Withdrawal by Subject|1|||
127933434|NCT02093221|460380217|FG000|Overall Study|Lost to Follow-up|2|||
127933435|NCT02093221|460380218|FG001|Overall Study|Lost to Follow-up|0|||
127933436|NCT02093221|460380219|FG002|Overall Study|Lost to Follow-up|1|||
127933437|NCT02093221|460380220|FG003|Overall Study|Lost to Follow-up|1|||
127933438|NCT02093221|460380221|FG004|Overall Study|Lost to Follow-up|0|||
127933439|NCT02093221|460380217|FG000|Overall Study|Death|0|||
127933440|NCT02093221|460380218|FG001|Overall Study|Death|1|||
127933441|NCT02093221|460380219|FG002|Overall Study|Death|0|||
127933442|NCT02093221|460380220|FG003|Overall Study|Death|0|||
127933443|NCT02093221|460380221|FG004|Overall Study|Death|0|||
127933444|NCT02093221|460380217|FG000|Overall Study|Protocol Violation|0|||
127933445|NCT02093221|460380218|FG001|Overall Study|Protocol Violation|1|||
127933446|NCT02093221|460380219|FG002|Overall Study|Protocol Violation|0|||
127933447|NCT02093221|460380220|FG003|Overall Study|Protocol Violation|0|||
127933448|NCT02093221|460380221|FG004|Overall Study|Protocol Violation|0|||
127933449|NCT02093221|460380217|FG000|Overall Study|Study termination|6|||
127933450|NCT02093221|460380218|FG001|Overall Study|Study termination|5|||
127933451|NCT02093221|460380219|FG002|Overall Study|Study termination|4|||
127933452|NCT02093221|460380220|FG003|Overall Study|Study termination|6|||
127933453|NCT02093221|460380221|FG004|Overall Study|Study termination|7|||
127933454|NCT03097588|460380231|FG000|Overall Study|Adverse Event|1|||
127933455|NCT02687360|460380232|FG000|Overall Study|Withdrawal by Subject|3|||
127933456|NCT02687360|460380233|FG001|Overall Study|Withdrawal by Subject|0|||
127933457|NCT03456960|460380234|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
127933458|NCT03456960|460380235|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
127933459|NCT03456960|460380236|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
127933460|NCT03456960|460380237|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
127933461|NCT03456960|460380238|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
127933462|NCT03456960|460380239|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
127933463|NCT03456960|460380234|FG000|Period 2 (1 Day)|Adverse Event|1|||
127933464|NCT03456960|460380235|FG001|Period 2 (1 Day)|Adverse Event|0|||
127933465|NCT03456960|460380236|FG002|Period 2 (1 Day)|Adverse Event|0|||
127933466|NCT03456960|460380237|FG003|Period 2 (1 Day)|Adverse Event|1|||
127933467|NCT03456960|460380238|FG004|Period 2 (1 Day)|Adverse Event|0|||
127933468|NCT03456960|460380239|FG005|Period 2 (1 Day)|Adverse Event|0|||
127933469|NCT02989168|460380240|FG000|Overall Study|Withdrawal by Subject|2|||
127933470|NCT02989168|460380241|FG001|Overall Study|Withdrawal by Subject|0|||
127933471|NCT02989168|460380240|FG000|Overall Study|Physician Decision|0|||
127933472|NCT02989168|460380241|FG001|Overall Study|Physician Decision|1|||
127933473|NCT02989168|460380240|FG000|Overall Study|Adverse Event|1|||
127933474|NCT02989168|460380241|FG001|Overall Study|Adverse Event|2|||
127933475|NCT02989168|460380240|FG000|Overall Study|Sponsor stopped study.|1|||
127933476|NCT02989168|460380241|FG001|Overall Study|Sponsor stopped study.|0|||
127933477|NCT03828448|460380242|FG000|Overall Study|Sponsor's Discretion|34|||
127933478|NCT02037165|460380243|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
127933479|NCT02037165|460380244|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
127933480|NCT02037165|460380245|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
127933481|NCT02037165|460380246|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
127933482|NCT02037165|460380247|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
127933483|NCT01300923|460380248|FG000|Overall Study|Physician Decision|0|||
127933484|NCT01300923|460380249|FG001|Overall Study|Physician Decision|2|||
127933485|NCT01568866|460380250|FG000|Overall Study|Disease Progression|208|||
127933486|NCT01568866|460380251|FG001|Overall Study|Disease Progression|183|||
127933487|NCT01568866|460380250|FG000|Overall Study|Adverse Event|94|||
127933488|NCT01568866|460380251|FG001|Overall Study|Adverse Event|96|||
127933489|NCT01568866|460380250|FG000|Overall Study|Patient Request|55|||
127933490|NCT01568866|460380251|FG001|Overall Study|Patient Request|71|||
127933491|NCT01568866|460380250|FG000|Overall Study|Physician Decision|40|||
127933492|NCT01568866|460380251|FG001|Overall Study|Physician Decision|32|||
127933493|NCT01568866|460380250|FG000|Overall Study|Withdrawal by Subject|19|||
127933494|NCT01568866|460380251|FG001|Overall Study|Withdrawal by Subject|11|||
127933495|NCT01568866|460380250|FG000|Overall Study|Death|10|||
127933496|NCT01568866|460380251|FG001|Overall Study|Death|18|||
127933497|NCT01568866|460380250|FG000|Overall Study|Protocol Non-compliance|2|||
127933498|NCT01568866|460380251|FG001|Overall Study|Protocol Non-compliance|4|||
127933499|NCT01568866|460380250|FG000|Overall Study|Lost to Follow-up|1|||
127933500|NCT01568866|460380251|FG001|Overall Study|Lost to Follow-up|0|||
127933501|NCT01568866|460380250|FG000|Overall Study|Randomized but Not Dosed|9|||
127933502|NCT01568866|460380251|FG001|Overall Study|Randomized but Not Dosed|1|||
127933503|NCT01698775|460380252|FG000|Phase A|Adverse Event|2|||
127933504|NCT01698775|460380253|FG001|Phase A|Adverse Event|1|||
127933505|NCT01698775|460380252|FG000|Phase A|Death|1|||
127933506|NCT01698775|460380253|FG001|Phase A|Death|1|||
127933507|NCT01698775|460380252|FG000|Phase A|Lack of Efficacy|1|||
127933508|NCT01698775|460380253|FG001|Phase A|Lack of Efficacy|0|||
127933509|NCT01698775|460380252|FG000|Phase A|Lost to Follow-up|1|||
127933510|NCT01698775|460380253|FG001|Phase A|Lost to Follow-up|2|||
127933511|NCT01698775|460380252|FG000|Phase A|Protocol Violation|1|||
127933512|NCT01698775|460380253|FG001|Phase A|Protocol Violation|0|||
127933513|NCT01698775|460380252|FG000|Phase A|Withdrawal by Subject|3|||
127933514|NCT01698775|460380253|FG001|Phase A|Withdrawal by Subject|4|||
127933515|NCT01698775|460380252|FG000|Phase A|Kidney [transplant]|0|||
127933516|NCT01698775|460380253|FG001|Phase A|Kidney [transplant]|1|||
127933517|NCT01698775|460380252|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
127933518|NCT01698775|460380253|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
127933519|NCT01698775|460380252|FG000|Phase B|Adverse Event|6|||
127933520|NCT01698775|460380253|FG001|Phase B|Adverse Event|3|||
127933521|NCT01698775|460380252|FG000|Phase B|Death|0|||
127933522|NCT01698775|460380253|FG001|Phase B|Death|1|||
127933523|NCT01698775|460380252|FG000|Phase B|Lack of Efficacy|0|||
127933524|NCT01698775|460380253|FG001|Phase B|Lack of Efficacy|1|||
127933525|NCT01698775|460380252|FG000|Phase B|Lost to Follow-up|0|||
127933526|NCT01698775|460380253|FG001|Phase B|Lost to Follow-up|1|||
127933527|NCT01698775|460380252|FG000|Phase B|Physician Decision|1|||
127933528|NCT01698775|460380253|FG001|Phase B|Physician Decision|1|||
127933529|NCT01698775|460380252|FG000|Phase B|Protocol Violation|1|||
127933530|NCT01698775|460380253|FG001|Phase B|Protocol Violation|1|||
127933531|NCT01698775|460380252|FG000|Phase B|Withdrawal by Subject|6|||
127933532|NCT01698775|460380253|FG001|Phase B|Withdrawal by Subject|2|||
127933533|NCT01244061|460380254|FG000|Overall Study|Death|1|||
127933534|NCT01244061|460380255|FG001|Overall Study|Death|0|||
127933535|NCT01244061|460380254|FG000|Overall Study|Did not meet entrance criteria|1|||
127933536|NCT01244061|460380255|FG001|Overall Study|Did not meet entrance criteria|0|||
127933537|NCT01244061|460380254|FG000|Overall Study|Lack of Efficacy|1|||
127933538|NCT01244061|460380255|FG001|Overall Study|Lack of Efficacy|3|||
127933539|NCT01244061|460380254|FG000|Overall Study|Lost to Follow-up|34|||
127933540|NCT01244061|460380255|FG001|Overall Study|Lost to Follow-up|30|||
127933541|NCT01244061|460380254|FG000|Overall Study|Withdrawal by Subject|29|||
127933542|NCT01244061|460380255|FG001|Overall Study|Withdrawal by Subject|46|||
127933543|NCT01244061|460380254|FG000|Overall Study|Other|8|||
127933544|NCT01244061|460380255|FG001|Overall Study|Other|19|||
127933545|NCT01244061|460380254|FG000|Overall Study|Protocol Violation|1|||
127933546|NCT01244061|460380255|FG001|Overall Study|Protocol Violation|1|||
127933547|NCT01244061|460380254|FG000|Overall Study|Adverse Event|5|||
127933548|NCT01244061|460380255|FG001|Overall Study|Adverse Event|2|||
127933549|NCT01244061|460380254|FG000|Overall Study|Randomized but not treated|2|||
127933550|NCT01244061|460380255|FG001|Overall Study|Randomized but not treated|2|||
127933551|NCT04932941|460380258|FG000|Overall Study|Lost to Follow-up|3|||
127933552|NCT04932941|460380259|FG001|Overall Study|Lost to Follow-up|1|||
127933553|NCT04932941|460380258|FG000|Overall Study|Withdrawal by Subject|7|||
127933554|NCT04932941|460380259|FG001|Overall Study|Withdrawal by Subject|4|||
127933555|NCT04932941|460380258|FG000|Overall Study|Other|4|||
127933556|NCT04932941|460380259|FG001|Overall Study|Other|2|||
127933557|NCT01929031|460380260|FG000|Overall Study|Adverse Event|3|||
127933558|NCT01929031|460380261|FG001|Overall Study|Adverse Event|1|||
127933559|NCT01929031|460380262|FG002|Overall Study|Adverse Event|1|||
127933560|NCT01929031|460380263|FG003|Overall Study|Adverse Event|0|||
127933561|NCT01929031|460380264|FG004|Overall Study|Adverse Event|0|||
127933562|NCT01929031|460380265|FG005|Overall Study|Adverse Event|0|||
127933563|NCT01929031|460380260|FG000|Overall Study|Protocol Violation|1|||
127933564|NCT01929031|460380261|FG001|Overall Study|Protocol Violation|0|||
127933565|NCT01929031|460380262|FG002|Overall Study|Protocol Violation|0|||
127933566|NCT01929031|460380263|FG003|Overall Study|Protocol Violation|0|||
127933567|NCT01929031|460380264|FG004|Overall Study|Protocol Violation|0|||
127933568|NCT01929031|460380265|FG005|Overall Study|Protocol Violation|1|||
127933569|NCT01929031|460380260|FG000|Overall Study|Reason other than specified above|0|||
127933570|NCT01929031|460380261|FG001|Overall Study|Reason other than specified above|1|||
127933571|NCT01929031|460380262|FG002|Overall Study|Reason other than specified above|0|||
127933572|NCT01929031|460380263|FG003|Overall Study|Reason other than specified above|0|||
127933573|NCT01929031|460380264|FG004|Overall Study|Reason other than specified above|1|||
127933574|NCT01929031|460380265|FG005|Overall Study|Reason other than specified above|0|||
127933575|NCT02394730|460380273|FG000|Overall Study|Lost to Follow-up|1|||
127933576|NCT02394730|460380274|FG001|Overall Study|Lost to Follow-up|0|||
127933577|NCT02394730|460380273|FG000|Overall Study|Withdrawal by Subject|0|||
127933578|NCT02394730|460380274|FG001|Overall Study|Withdrawal by Subject|1|||
127933579|NCT02384850|460380276|FG000|Overall Study|Withdrawal by Subject|2|||
127933580|NCT02384850|460380277|FG001|Overall Study|Withdrawal by Subject|2|||
127933581|NCT02013375|460380278|FG000|Overall Study|Did not engraft|1|||
127933582|NCT02013375|460380278|FG000|Overall Study|Did not engraft|1|||
127933583|NCT01334710|460380285|FG000|Overall Study|Trial was terminated|3|||
127933584|NCT01558297|460380286|FG000|Overall Study|Withdrawal by Subject|2|||
127933585|NCT01558297|460380287|FG001|Overall Study|Withdrawal by Subject|2|||
127933586|NCT01558297|460380288|FG002|Overall Study|Withdrawal by Subject|1|||
127933587|NCT00375492|460380289|FG000|Overall Study|Adverse Event|4|||
127933588|NCT00375492|460380290|FG001|Overall Study|Adverse Event|5|||
127933589|NCT00375492|460380289|FG000|Overall Study|Entry Criteria Not Met|0|||
127933590|NCT00375492|460380290|FG001|Overall Study|Entry Criteria Not Met|1|||
127933591|NCT00375492|460380289|FG000|Overall Study|Loss of Glucose Control|0|||
127933592|NCT00375492|460380290|FG001|Overall Study|Loss of Glucose Control|1|||
127933593|NCT00375492|460380289|FG000|Overall Study|Lost to Follow-up|10|||
127933594|NCT00375492|460380290|FG001|Overall Study|Lost to Follow-up|5|||
127933595|NCT00375492|460380289|FG000|Overall Study|Physician Decision|0|||
127933596|NCT00375492|460380290|FG001|Overall Study|Physician Decision|4|||
127933597|NCT00375492|460380289|FG000|Overall Study|Protocol Violation|6|||
127933598|NCT00375492|460380290|FG001|Overall Study|Protocol Violation|3|||
127933599|NCT00375492|460380289|FG000|Overall Study|Sponsor Decision|0|||
127933600|NCT00375492|460380290|FG001|Overall Study|Sponsor Decision|1|||
127933601|NCT00375492|460380289|FG000|Overall Study|Withdrawal by Subject|6|||
127933602|NCT00375492|460380290|FG001|Overall Study|Withdrawal by Subject|6|||
127933603|NCT01902628|460380291|FG000|Overall Study|Withdrawal of participant's consent|7|||
127933604|NCT01902628|460380291|FG000|Overall Study|Adverse Event|41|||
127933605|NCT01902628|460380291|FG000|Overall Study|Lost to Follow-up|35|||
127933606|NCT01232491|460380292|FG000|Overall Study|Adverse Event|13|||
127933607|NCT01232491|460380293|FG001|Overall Study|Adverse Event|8|||
127933608|NCT01232491|460380292|FG000|Overall Study|Lack of Efficacy|1|||
127933609|NCT01232491|460380293|FG001|Overall Study|Lack of Efficacy|5|||
127933610|NCT01232491|460380292|FG000|Overall Study|Protocol Violation|13|||
127933611|NCT01232491|460380293|FG001|Overall Study|Protocol Violation|11|||
127933612|NCT01232491|460380292|FG000|Overall Study|Withdrawal Criteria|12|||
127933613|NCT01232491|460380293|FG001|Overall Study|Withdrawal Criteria|21|||
127933614|NCT01232491|460380292|FG000|Overall Study|Other|21|||
127933615|NCT01232491|460380293|FG001|Overall Study|Other|18|||
127933616|NCT04905290|460382018|FG000|Overall Study|Adverse Event|4|||
127933617|NCT04905290|460382018|FG000|Overall Study|Death|2|||
127933618|NCT04905290|460382018|FG000|Overall Study|Withdrawal by Subject|4|||
127933619|NCT04905290|460382018|FG000|Overall Study|Physician Decision|2|||
127933620|NCT04905290|460382018|FG000|Overall Study|Lost to Follow-up|2|||
127933621|NCT04905290|460382018|FG000|Overall Study|Screen Failure|2|||
127933622|NCT04905290|460382018|FG000|Overall Study|Unsuccessful Procedure|2|||
127933623|NCT00821873|460382019|FG000|Overall Study|Lost to Follow-up|4|||
127933624|NCT01995266|460382021|FG000|Overall Study|Death|1|||
127933625|NCT01995266|460382021|FG000|Overall Study|Lack of Efficacy|6|||
127933626|NCT01995266|460382021|FG000|Overall Study|Adverse Event|2|||
127933627|NCT03596151|460382022|FG000|Overall Study|Withdrawal by Subject|1|||
127933628|NCT00729248|460382024|FG000|Overall Study|Physician Decision|2|||
127933629|NCT03573505|460382029|FG000|Overall Study|Adverse Event|1|||
127933630|NCT03573505|460382030|FG001|Overall Study|Adverse Event|1|||
127933631|NCT03573505|460382029|FG000|Overall Study|Consent withdrawn|0|||
127933632|NCT03573505|460382030|FG001|Overall Study|Consent withdrawn|1|||
127933633|NCT03573505|460382029|FG000|Overall Study|Disease progression|0|||
127933634|NCT03573505|460382030|FG001|Overall Study|Disease progression|1|||
127933635|NCT03573505|460382029|FG000|Overall Study|Site Terminated by Sponsor|1|||
127933636|NCT03573505|460382030|FG001|Overall Study|Site Terminated by Sponsor|1|||
127933637|NCT03573505|460382029|FG000|Overall Study|Study terminated by sponsor|50|||
127933638|NCT03573505|460382030|FG001|Overall Study|Study terminated by sponsor|45|||
127933639|NCT03573505|460382029|FG000|Overall Study|Reason not specified|0|||
127933640|NCT03573505|460382030|FG001|Overall Study|Reason not specified|1|||
127933641|NCT03573505|460382029|FG000|Overall Study|Death|0|||
127933642|NCT03573505|460382030|FG001|Overall Study|Death|4|||
127933643|NCT04280705|460382031|FG000|Overall Study|Enrolled but not treated|4|||
127933644|NCT04280705|460382032|FG001|Overall Study|Enrolled but not treated|10|||
127933645|NCT04280705|460382031|FG000|Overall Study|Physician Decision|1|||
127933646|NCT04280705|460382032|FG001|Overall Study|Physician Decision|0|||
127933647|NCT04280705|460382031|FG000|Overall Study|Withdrawal by Subject|7|||
127933648|NCT04280705|460382032|FG001|Overall Study|Withdrawal by Subject|9|||
127933649|NCT04280705|460382031|FG000|Overall Study|Adverse Event|0|||
127933650|NCT04280705|460382032|FG001|Overall Study|Adverse Event|4|||
127933651|NCT04280705|460382031|FG000|Overall Study|Transferred to another hospital|1|||
127933652|NCT04280705|460382032|FG001|Overall Study|Transferred to another hospital|1|||
127933653|NCT03222583|460382033|FG000|Overall Study|Withdrawal by Subject|3|||
127933654|NCT03222583|460382034|FG001|Overall Study|Withdrawal by Subject|3|||
127933655|NCT03222583|460382033|FG000|Overall Study|Lost to Follow-up|1|||
127933656|NCT03222583|460382034|FG001|Overall Study|Lost to Follow-up|0|||
127933657|NCT03222583|460382033|FG000|Overall Study|Other|1|||
127933658|NCT03222583|460382034|FG001|Overall Study|Other|3|||
127933659|NCT04268316|460382037|FG000|Overall Study|Withdrawal by Subject|2|||
127933660|NCT04268316|460382038|FG001|Overall Study|Withdrawal by Subject|1|||
127933661|NCT04268316|460382039|FG002|Overall Study|Withdrawal by Subject|0|||
127933662|NCT03188718|460382040|FG000|Overall Study|Participant noncompliance|4|||
127933663|NCT03188718|460382040|FG000|Overall Study|Withdrawal by Subject|1|||
127933664|NCT03188718|460382040|FG000|Overall Study|Device failure|3|||
127933665|NCT02072824|460382041|FG000|Overall Study|Insufficient clinical response|1|||
127933666|NCT02072824|460382042|FG001|Overall Study|Insufficient clinical response|0|||
127933667|NCT02072824|460382043|FG002|Overall Study|Insufficient clinical response|1|||
127933668|NCT02072824|460382041|FG000|Overall Study|No longer willing to participate|1|||
127933669|NCT02072824|460382042|FG001|Overall Study|No longer willing to participate|0|||
127933670|NCT02072824|460382043|FG002|Overall Study|No longer willing to participate|1|||
127933671|NCT02072824|460382041|FG000|Overall Study|Medication error|0|||
127933672|NCT02072824|460382042|FG001|Overall Study|Medication error|1|||
127933673|NCT02072824|460382043|FG002|Overall Study|Medication error|0|||
127933674|NCT02072824|460382041|FG000|Overall Study|Adverse Event|0|||
127933675|NCT02072824|460382042|FG001|Overall Study|Adverse Event|0|||
127933676|NCT02072824|460382043|FG002|Overall Study|Adverse Event|1|||
127933677|NCT03084367|460382044|FG000|Overall Study|Lost to Follow-up|32|||
127933678|NCT03084367|460382044|FG000|Overall Study|Withdrawal by Subject|4|||
127933679|NCT03084367|460382044|FG000|Overall Study|Other|1|||
127933680|NCT00841906|460382045|FG000|Overall Study|Withdrawal by Subject|2|||
127933681|NCT00841906|460382046|FG001|Overall Study|Withdrawal by Subject|0|||
127933682|NCT00912093|460382049|FG000|The Controlled Phase|Death|0|||
127933683|NCT00912093|460382050|FG001|The Controlled Phase|Death|1|||
127933684|NCT00912093|460382051|FG002|The Controlled Phase|Death|0|||
127933685|NCT00912093|460382052|FG003|The Controlled Phase|Death|0|||
127933686|NCT00912093|460382053|FG004|The Controlled Phase|Death|0|||
127933687|NCT00912093|460382049|FG000|The Controlled Phase|Medical Condition|0|||
127933688|NCT00912093|460382050|FG001|The Controlled Phase|Medical Condition|1|||
127933689|NCT00912093|460382051|FG002|The Controlled Phase|Medical Condition|0|||
127933690|NCT00912093|460382052|FG003|The Controlled Phase|Medical Condition|0|||
127933691|NCT00912093|460382053|FG004|The Controlled Phase|Medical Condition|0|||
127933692|NCT00912093|460382049|FG000|The Controlled Phase|Lost to Follow-up|0|||
127933693|NCT00912093|460382050|FG001|The Controlled Phase|Lost to Follow-up|0|||
127933694|NCT00912093|460382051|FG002|The Controlled Phase|Lost to Follow-up|0|||
127933695|NCT00912093|460382052|FG003|The Controlled Phase|Lost to Follow-up|0|||
127933696|NCT00912093|460382053|FG004|The Controlled Phase|Lost to Follow-up|1|||
127933697|NCT00127036|460382054|FG000|Overall Study|Insufficient Data for Analysis|6|||
127933698|NCT00127036|460382055|FG001|Overall Study|Insufficient Data for Analysis|11|||
127933699|NCT00127036|460382054|FG000|Overall Study|Screen Failure|2|||
127933700|NCT00127036|460382055|FG001|Overall Study|Screen Failure|0|||
127933701|NCT03921151|460382056|FG000|Overall Study|Withdrawal by Subject|11|||
127933702|NCT03921151|460382057|FG001|Overall Study|Withdrawal by Subject|16|||
127933703|NCT01403064|460382058|FG000|Overall Study|Death|0|||
127933704|NCT01403064|460382059|FG001|Overall Study|Death|0|||
127933705|NCT01403064|460382060|FG002|Overall Study|Death|1|||
127933706|NCT01403064|460382061|FG003|Overall Study|Death|1|||
127933707|NCT01403064|460382058|FG000|Overall Study|Withdrawal by Subject|0|||
127933708|NCT01403064|460382059|FG001|Overall Study|Withdrawal by Subject|0|||
127933709|NCT01403064|460382060|FG002|Overall Study|Withdrawal by Subject|1|||
127933710|NCT01403064|460382061|FG003|Overall Study|Withdrawal by Subject|1|||
127933711|NCT01403064|460382058|FG000|Overall Study|Other|1|||
127933712|NCT01403064|460382059|FG001|Overall Study|Other|0|||
127933713|NCT01403064|460382060|FG002|Overall Study|Other|2|||
127933714|NCT01403064|460382061|FG003|Overall Study|Other|1|||
127933715|NCT04688931|460382062|FG000|Overall Study|Adverse Event|4|||
127933716|NCT04688931|460382063|FG001|Overall Study|Adverse Event|1|||
127933717|NCT04688931|460382062|FG000|Overall Study|Withdrawal by Subject|5|||
127933718|NCT04688931|460382063|FG001|Overall Study|Withdrawal by Subject|16|||
127933719|NCT04688931|460382062|FG000|Overall Study|Physician Decision|3|||
127933720|NCT04688931|460382063|FG001|Overall Study|Physician Decision|5|||
127933721|NCT04688931|460382062|FG000|Overall Study|Noncompliance|0|||
127933722|NCT04688931|460382063|FG001|Overall Study|Noncompliance|1|||
127933723|NCT04688931|460382062|FG000|Overall Study|Lost to Follow-up|1|||
127933724|NCT04688931|460382063|FG001|Overall Study|Lost to Follow-up|3|||
127933725|NCT04688931|460382062|FG000|Overall Study|Randomization Error|3|||
127933726|NCT04688931|460382063|FG001|Overall Study|Randomization Error|0|||
127933727|NCT04688931|460382062|FG000|Overall Study|Not Eligible|1|||
127933728|NCT04688931|460382063|FG001|Overall Study|Not Eligible|3|||
127933729|NCT04688931|460382062|FG000|Overall Study|Disease Progression|0|||
127933730|NCT04688931|460382063|FG001|Overall Study|Disease Progression|2|||
127933731|NCT04688931|460382062|FG000|Overall Study|Sponsor Requirement|1|||
127933732|NCT04688931|460382063|FG001|Overall Study|Sponsor Requirement|1|||
127933733|NCT04688931|460382062|FG000|Overall Study|Other Reason|1|||
127933734|NCT04688931|460382063|FG001|Overall Study|Other Reason|2|||
127933735|NCT00450619|460382064|FG000|Overall Study|refused treatment after randomization|2|||
127933736|NCT00450619|460382065|FG001|Overall Study|refused treatment after randomization|0|||
127933737|NCT00450619|460382064|FG000|Overall Study|did not progress; refused further trmt|1|||
127933738|NCT00450619|460382065|FG001|Overall Study|did not progress; refused further trmt|1|||
127933739|NCT00450619|460382064|FG000|Overall Study|Adverse Event|1|||
127933740|NCT00450619|460382065|FG001|Overall Study|Adverse Event|0|||
127933741|NCT00616941|460382066|FG000|Overall Study|Progressive Disease|1|||
127933742|NCT00616941|460382067|FG001|Overall Study|Progressive Disease|2|||
127933743|NCT00616941|460382068|FG002|Overall Study|Progressive Disease|1|||
127933744|NCT00616941|460382066|FG000|Overall Study|Adverse Event|0|||
127933745|NCT00616941|460382067|FG001|Overall Study|Adverse Event|1|||
127933746|NCT00616941|460382068|FG002|Overall Study|Adverse Event|1|||
127933747|NCT00616941|460382066|FG000|Overall Study|Subject Non-compliance|0|||
127933748|NCT00616941|460382067|FG001|Overall Study|Subject Non-compliance|0|||
127933749|NCT00616941|460382068|FG002|Overall Study|Subject Non-compliance|1|||
127933750|NCT00616941|460382066|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
127933751|NCT00616941|460382067|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
127933752|NCT00616941|460382068|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
127933753|NCT00616941|460382066|FG000|Overall Study|Vaccination Suspended|0|||
127933754|NCT00616941|460382067|FG001|Overall Study|Vaccination Suspended|0|||
127933755|NCT00616941|460382068|FG002|Overall Study|Vaccination Suspended|3|||
127933756|NCT00714493|460382086|FG000|Overall Study|Adverse Event|11|||
127933757|NCT00714493|460382086|FG000|Overall Study|Death|3|||
127933758|NCT00714493|460382086|FG000|Overall Study|Lack of Efficacy|10|||
127933759|NCT00714493|460382086|FG000|Overall Study|Lost to Follow-up|3|||
127933760|NCT00714493|460382086|FG000|Overall Study|Protocol Violation|12|||
127933761|NCT00714493|460382086|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
127933762|NCT00714493|460382086|FG000|Overall Study|OTHER|2|||
127933763|NCT02372071|460382087|FG000|Overall Study|Protocol Violation|18|||
127933764|NCT00506129|460382088|FG000|Overall Study|Disease Progression/Relapse|15|||
127933765|NCT00506129|460382088|FG000|Overall Study|Death|7|||
127933766|NCT00354341|460382089|FG000|Overall Study|Adverse Event|1|||
127933767|NCT00354341|460382090|FG001|Overall Study|Adverse Event|0|||
127933768|NCT00354341|460382089|FG000|Overall Study|Death|0|||
127933769|NCT00354341|460382090|FG001|Overall Study|Death|2|||
127933770|NCT00354341|460382089|FG000|Overall Study|Refused treatment|1|||
127933771|NCT00354341|460382090|FG001|Overall Study|Refused treatment|2|||
127933772|NCT00354341|460382089|FG000|Overall Study|Failure to return|0|||
127933773|NCT00354341|460382090|FG001|Overall Study|Failure to return|1|||
127933774|NCT00354341|460382089|FG000|Overall Study|Other|1|||
127933775|NCT00354341|460382090|FG001|Overall Study|Other|2|||
127933776|NCT00251719|460382091|FG000|Overall Study|Adverse Event|14|||
127933777|NCT00251719|460382092|FG001|Overall Study|Adverse Event|8|||
127933778|NCT00251719|460382093|FG002|Overall Study|Adverse Event|7|||
127933779|NCT00251719|460382091|FG000|Overall Study|Protocol Violation|1|||
127933780|NCT00251719|460382092|FG001|Overall Study|Protocol Violation|1|||
127933781|NCT00251719|460382093|FG002|Overall Study|Protocol Violation|1|||
127933782|NCT00251719|460382091|FG000|Overall Study|Lost to Follow-up|5|||
127933783|NCT00251719|460382092|FG001|Overall Study|Lost to Follow-up|11|||
127933784|NCT00251719|460382093|FG002|Overall Study|Lost to Follow-up|8|||
127933785|NCT00251719|460382091|FG000|Overall Study|Withdrawal by Subject|14|||
127933786|NCT00251719|460382092|FG001|Overall Study|Withdrawal by Subject|12|||
127933787|NCT00251719|460382093|FG002|Overall Study|Withdrawal by Subject|11|||
127933788|NCT00251719|460382091|FG000|Overall Study|Lack of Efficacy|2|||
127933789|NCT00251719|460382092|FG001|Overall Study|Lack of Efficacy|1|||
127933790|NCT00251719|460382093|FG002|Overall Study|Lack of Efficacy|0|||
127933791|NCT00251719|460382091|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
127933792|NCT00251719|460382092|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
127933793|NCT00251719|460382093|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
127933794|NCT00251719|460382091|FG000|Overall Study|Investigator decision|1|||
127933795|NCT00251719|460382092|FG001|Overall Study|Investigator decision|1|||
127933796|NCT00251719|460382093|FG002|Overall Study|Investigator decision|0|||
127933797|NCT00251719|460382091|FG000|Overall Study|Noncompliance|2|||
127933798|NCT00251719|460382092|FG001|Overall Study|Noncompliance|3|||
127933799|NCT00251719|460382093|FG002|Overall Study|Noncompliance|1|||
127933800|NCT00251719|460382091|FG000|Overall Study|Barrett's esophagus|2|||
127933801|NCT00251719|460382092|FG001|Overall Study|Barrett's esophagus|2|||
127933802|NCT00251719|460382093|FG002|Overall Study|Barrett's esophagus|0|||
127933803|NCT04392583|460382096|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
127933804|NCT02408068|460382097|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
127933805|NCT02408068|460382098|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
127933806|NCT02408068|460382099|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
127933807|NCT02408068|460382100|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
127933808|NCT02408068|460382101|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
127933809|NCT02408068|460382102|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
127933810|NCT02303041|460382106|FG000|Overall Study|Adverse Event|1|||
127933811|NCT02303041|460382107|FG001|Overall Study|Adverse Event|2|||
127933812|NCT00857259|460382110|FG000|Overall Study|Protocol Violation|1|||
127933813|NCT00857259|460382111|FG001|Overall Study|Protocol Violation|0|||
127933814|NCT00857259|460382112|FG002|Overall Study|Protocol Violation|1|||
127933815|NCT01370213|460382113|FG000|Overall Study|Early Death|1|||
127933816|NCT01370213|460382114|FG001|Overall Study|Early Death|0|||
127933817|NCT01370213|460382115|FG002|Overall Study|Early Death|0|||
127933818|NCT01370213|460382113|FG000|Overall Study|Not evaluable|0|||
127933819|NCT01370213|460382114|FG001|Overall Study|Not evaluable|2|||
127933820|NCT01370213|460382115|FG002|Overall Study|Not evaluable|0|||
127933821|NCT02701413|460382116|FG000|Overall Study|Withdrawal by Subject|7|||
127933822|NCT02701413|460382117|FG001|Overall Study|Withdrawal by Subject|11|||
127933823|NCT01621191|460382120|FG000|Overall Study|Adverse Event|9|||
127933824|NCT01621191|460382120|FG000|Overall Study|Withdrawal by Subject|8|||
127933825|NCT01621191|460382120|FG000|Overall Study|Lack of Efficacy|6|||
127933826|NCT01621191|460382120|FG000|Overall Study|Lost to Follow-up|1|||
127933827|NCT01621191|460382120|FG000|Overall Study|Site Removed From Study|1|||
127933828|NCT00706381|460382121|FG000|Overall Study|Lost to Follow-up|0|||
127933829|NCT00706381|460382122|FG001|Overall Study|Lost to Follow-up|1|||
127933830|NCT00706381|460382123|FG002|Overall Study|Lost to Follow-up|1|||
127933831|NCT00706381|460382124|FG003|Overall Study|Lost to Follow-up|0|||
127933832|NCT00160641|460382128|FG000|Overall Study|Adverse Event|102|||
127933833|NCT00160641|460382128|FG000|Overall Study|Withdrawal by Subject|87|||
127933834|NCT00160641|460382128|FG000|Overall Study|Lost to Follow-up|8|||
127933835|NCT00160641|460382128|FG000|Overall Study|Lack of Efficacy|12|||
127933836|NCT00160641|460382128|FG000|Overall Study|Protocol Violation|3|||
127933837|NCT00160641|460382128|FG000|Overall Study|Other|9|||
127933838|NCT01782482|460382133|FG000|Overall Study|Adverse Event|2|||
127933839|NCT01782482|460382134|FG001|Overall Study|Adverse Event|1|||
127933840|NCT01782482|460382133|FG000|Overall Study|Lost to Follow-up|2|||
127933841|NCT01782482|460382134|FG001|Overall Study|Lost to Follow-up|3|||
127933842|NCT01782482|460382133|FG000|Overall Study|Physician Decision|1|||
127933843|NCT01782482|460382134|FG001|Overall Study|Physician Decision|0|||
127933844|NCT01782482|460382133|FG000|Overall Study|Protocol Violation|1|||
127933845|NCT01782482|460382134|FG001|Overall Study|Protocol Violation|0|||
127933846|NCT01782482|460382133|FG000|Overall Study|Withdrawal by Subject|2|||
127933847|NCT01782482|460382134|FG001|Overall Study|Withdrawal by Subject|3|||
127933848|NCT01782482|460382133|FG000|Overall Study|Randomized in Error|2|||
127933849|NCT01782482|460382134|FG001|Overall Study|Randomized in Error|2|||
127933850|NCT01782482|460382133|FG000|Overall Study|Habitually wearing toric lens OS|0|||
127933851|NCT01782482|460382134|FG001|Overall Study|Habitually wearing toric lens OS|1|||
127933852|NCT00038649|460382136|FG000|Overall Study|Adverse Event|9|||
127933853|NCT00995085|460382137|FG000|Overall Study|Withdrawal by Subject|5|||
127933854|NCT03096847|460382143|FG000|Overall Study|Other|2|||
127933855|NCT03096847|460382144|FG001|Overall Study|Other|1|||
127933856|NCT03096847|460382145|FG002|Overall Study|Other|2|||
127933857|NCT03096847|460382143|FG000|Overall Study|Lost to Follow-up|1|||
127933858|NCT03096847|460382144|FG001|Overall Study|Lost to Follow-up|0|||
127933859|NCT03096847|460382145|FG002|Overall Study|Lost to Follow-up|1|||
127933860|NCT03096847|460382143|FG000|Overall Study|Death|6|||
127933861|NCT03096847|460382144|FG001|Overall Study|Death|0|||
127933862|NCT03096847|460382145|FG002|Overall Study|Death|2|||
127933863|NCT03096847|460382143|FG000|Overall Study|Protocol Violation|3|||
127933864|NCT03096847|460382144|FG001|Overall Study|Protocol Violation|0|||
127933865|NCT03096847|460382145|FG002|Overall Study|Protocol Violation|6|||
127933866|NCT03096847|460382143|FG000|Overall Study|Physician Decision|12|||
127933867|NCT03096847|460382144|FG001|Overall Study|Physician Decision|2|||
127933868|NCT03096847|460382145|FG002|Overall Study|Physician Decision|8|||
127933869|NCT03096847|460382143|FG000|Overall Study|Withdrawal by Subject|24|||
127933870|NCT03096847|460382144|FG001|Overall Study|Withdrawal by Subject|1|||
127933871|NCT03096847|460382145|FG002|Overall Study|Withdrawal by Subject|12|||
127933872|NCT03096847|460382143|FG000|Overall Study|Adverse Event|72|||
127933873|NCT03096847|460382144|FG001|Overall Study|Adverse Event|6|||
127933874|NCT03096847|460382145|FG002|Overall Study|Adverse Event|28|||
127933875|NCT03096847|460382143|FG000|Overall Study|Progressive disease|97|||
127933876|NCT03096847|460382144|FG001|Overall Study|Progressive disease|10|||
127933877|NCT03096847|460382145|FG002|Overall Study|Progressive disease|78|||
127933878|NCT03096847|460382143|FG000|Overall Study|Non-compliance with study medication|1|||
127933879|NCT03096847|460382144|FG001|Overall Study|Non-compliance with study medication|0|||
127933880|NCT03096847|460382145|FG002|Overall Study|Non-compliance with study medication|0|||
127933881|NCT03096847|460382143|FG000|Overall Study|New therapy for study indication|1|||
127933882|NCT03096847|460382144|FG001|Overall Study|New therapy for study indication|0|||
127933883|NCT03096847|460382145|FG002|Overall Study|New therapy for study indication|1|||
127933884|NCT01640873|460382146|FG000|Overall Study|Protocol Violation|2|||
127933885|NCT01640873|460382147|FG001|Overall Study|Protocol Violation|1|||
127933886|NCT01321008|460382148|FG000|Overall Study|Early Study Termination|1|||
127933887|NCT02192164|460382164|FG000|Overall Study|Other|8|||
127933888|NCT02192164|460382164|FG000|Overall Study|Withdrawal by Subject|1|||
127933889|NCT02192164|460382164|FG000|Overall Study|Physician Decision|4|||
127933890|NCT02192164|460382164|FG000|Overall Study|Did not meet the exclusion criteria|1|||
127933891|NCT00359788|460382167|FG000|Overall Study|Adverse Event|11|||
127933892|NCT00359788|460382168|FG001|Overall Study|Adverse Event|10|||
127933893|NCT00359788|460382167|FG000|Overall Study|Lack of Efficacy|1|||
127933894|NCT00359788|460382168|FG001|Overall Study|Lack of Efficacy|2|||
127933895|NCT00359788|460382167|FG000|Overall Study|Lost to Follow-up|3|||
127933896|NCT00359788|460382168|FG001|Overall Study|Lost to Follow-up|2|||
127933897|NCT00359788|460382167|FG000|Overall Study|Withdrawal by Subject|4|||
127933898|NCT00359788|460382168|FG001|Overall Study|Withdrawal by Subject|1|||
127933899|NCT00359788|460382167|FG000|Overall Study|Protocol Violation|4|||
127933900|NCT00359788|460382168|FG001|Overall Study|Protocol Violation|2|||
127933901|NCT02143583|460382169|FG000|Overall Study|Withdrawal by Subject|1|||
127933902|NCT02143583|460382170|FG001|Overall Study|Withdrawal by Subject|0|||
127933903|NCT02143583|460382171|FG002|Overall Study|Withdrawal by Subject|1|||
127933904|NCT02143583|460382169|FG000|Overall Study|husband illness|0|||
127933905|NCT02143583|460382170|FG001|Overall Study|husband illness|0|||
127933906|NCT02143583|460382171|FG002|Overall Study|husband illness|1|||
127933907|NCT00673933|460382172|FG000|Overall Study|Withdrawal by Subject|2|||
127933908|NCT00673933|460382172|FG000|Overall Study|Lost to Follow-up|1|||
127933909|NCT01366443|460382173|FG000|Overall Study|Lost to Follow-up|2|||
127933910|NCT01366443|460382173|FG000|Overall Study|Under 18 yo|1|||
127933911|NCT05816200|460382174|FG000|Overall Study|Lost to Follow-up|2|||
127933912|NCT05816200|460382175|FG001|Overall Study|Lost to Follow-up|1|||
127933913|NCT00369382|460382176|FG000|Overall Study|Death|0|||
127933914|NCT00369382|460382177|FG001|Overall Study|Death|2|||
127933915|NCT00369382|460382176|FG000|Overall Study|Physician Decision|2|||
127933916|NCT00369382|460382177|FG001|Overall Study|Physician Decision|1|||
127933917|NCT00369382|460382176|FG000|Overall Study|Withdrawal by Subject|5|||
127933918|NCT00369382|460382177|FG001|Overall Study|Withdrawal by Subject|0|||
127933919|NCT00369382|460382176|FG000|Overall Study|Randomized, not treated|2|||
127933920|NCT00369382|460382177|FG001|Overall Study|Randomized, not treated|0|||
127933921|NCT00369382|460382176|FG000|Overall Study|Other|1|||
127933922|NCT00369382|460382177|FG001|Overall Study|Other|0|||
127933923|NCT00507546|460382180|FG000|Overall Study|Withdrawal by Subject|1|||
127933924|NCT00507546|460382181|FG001|Overall Study|Withdrawal by Subject|0|||
127933925|NCT00507546|460382180|FG000|Overall Study|Protocol Violation|1|||
127933926|NCT00507546|460382181|FG001|Overall Study|Protocol Violation|0|||
127933927|NCT00507546|460382180|FG000|Overall Study|Physician Decision|0|||
127933928|NCT00507546|460382181|FG001|Overall Study|Physician Decision|1|||
127933929|NCT01673698|460382182|FG000|Overall Study|Lost to Follow-up|51|||
127933930|NCT01673698|460382183|FG001|Overall Study|Lost to Follow-up|13|||
127933931|NCT00448136|460382184|FG000|Overall Study|Death|3|||
127933932|NCT00448136|460382185|FG001|Overall Study|Death|8|||
127933933|NCT00448136|460382184|FG000|Overall Study|Investigator's decision (progression)|1|||
127933934|NCT00448136|460382185|FG001|Overall Study|Investigator's decision (progression)|0|||
127933935|NCT00609466|460382186|FG000|Overall Study|Withdrawal by Subject|0|||
127933936|NCT00609466|460382187|FG001|Overall Study|Withdrawal by Subject|1|||
127933937|NCT00609466|460382188|FG002|Overall Study|Withdrawal by Subject|1|||
127933938|NCT00609466|460382186|FG000|Overall Study|Adverse Event|2|||
127933939|NCT00609466|460382187|FG001|Overall Study|Adverse Event|3|||
127933940|NCT00609466|460382188|FG002|Overall Study|Adverse Event|1|||
127933941|NCT00609466|460382186|FG000|Overall Study|Lack of Efficacy|0|||
127933942|NCT00609466|460382187|FG001|Overall Study|Lack of Efficacy|2|||
127933943|NCT00609466|460382188|FG002|Overall Study|Lack of Efficacy|2|||
127933944|NCT03407430|460382191|FG000|Washout|Protocol Violation|1|||
127933945|NCT03407430|460382192|FG001|Washout|Protocol Violation|0|||
127933946|NCT03510182|460382193|FG000|Overall Study|Withdrawal by Subject|2|||
127933947|NCT01195272|460382194|FG000|Overall Study|Adverse Event|1|||
127933948|NCT01195272|460382194|FG000|Overall Study|Lack of Efficacy|3|||
127933949|NCT03295318|460383432|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
127933950|NCT03295318|460383433|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
127933951|NCT03295318|460383434|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
127933952|NCT03295318|460383432|FG000|Overall Study|Death|1|||
127933953|NCT03295318|460383433|FG001|Overall Study|Death|1|||
127933954|NCT03295318|460383434|FG002|Overall Study|Death|1|||
127933955|NCT03295318|460383432|FG000|Overall Study|Protocol Violation|4|||
127933956|NCT03295318|460383433|FG001|Overall Study|Protocol Violation|3|||
127933957|NCT03295318|460383434|FG002|Overall Study|Protocol Violation|3|||
127933958|NCT03295318|460383432|FG000|Overall Study|Withdrawal by Subject|0|||
127933959|NCT03295318|460383433|FG001|Overall Study|Withdrawal by Subject|0|||
127933960|NCT03295318|460383434|FG002|Overall Study|Withdrawal by Subject|1|||
127933961|NCT03295318|460383432|FG000|Overall Study|Subject discontinued due to travel|0|||
127933962|NCT03295318|460383433|FG001|Overall Study|Subject discontinued due to travel|1|||
127933963|NCT03295318|460383434|FG002|Overall Study|Subject discontinued due to travel|0|||
127933964|NCT04319718|460383435|FG000|Overall Study|Adverse Event|0|||
127933965|NCT04319718|460383436|FG001|Overall Study|Adverse Event|2|||
127933966|NCT04319718|460383435|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
127933967|NCT04319718|460383436|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
127933968|NCT01288053|460383437|FG000|Overall Study|Death|1|||
127933969|NCT00144781|460383438|FG000|Overall Study|Adverse Event|0|||
127933970|NCT00144781|460383439|FG001|Overall Study|Adverse Event|1|||
127933971|NCT00144781|460383440|FG002|Overall Study|Adverse Event|0|||
127933972|NCT00144781|460383441|FG003|Overall Study|Adverse Event|0|||
127933973|NCT00144781|460383438|FG000|Overall Study|Non-compliant|0|||
127933974|NCT00144781|460383439|FG001|Overall Study|Non-compliant|1|||
127933975|NCT00144781|460383440|FG002|Overall Study|Non-compliant|0|||
127933976|NCT00144781|460383441|FG003|Overall Study|Non-compliant|0|||
127933977|NCT02068092|460383442|FG000|Overall Study|Physician Decision|2|||
127933978|NCT02068092|460383442|FG000|Overall Study|Adverse Event|2|||
127933979|NCT02068092|460383442|FG000|Overall Study|Lost to Follow-up|4|||
127933980|NCT02068092|460383442|FG000|Overall Study|Withdrawal by Subject|2|||
127933981|NCT01045421|460383443|FG000|Phase 1|Progressive Disease|0|||
127933982|NCT01045421|460383444|FG001|Phase 1|Progressive Disease|0|||
127933983|NCT01045421|460383445|FG002|Phase 1|Progressive Disease|0|||
127933984|NCT01045421|460383446|FG003|Phase 1|Progressive Disease|0|||
127933985|NCT01045421|460383447|FG004|Phase 1|Progressive Disease|1|||
127933986|NCT01045421|460383448|FG005|Phase 1|Progressive Disease|0|||
127933987|NCT01045421|460383449|FG006|Phase 1|Progressive Disease|0|||
127933988|NCT01045421|460383450|FG007|Phase 1|Progressive Disease|0|||
127933989|NCT01045421|460383451|FG008|Phase 1|Progressive Disease|0|||
127933990|NCT01045421|460383452|FG009|Phase 1|Progressive Disease|0|||
127933991|NCT01045421|460383453|FG010|Phase 1|Progressive Disease|0|||
127933992|NCT01045421|460383443|FG000|Phase 1|Withdrawal by Subject|0|||
127933993|NCT01045421|460383444|FG001|Phase 1|Withdrawal by Subject|0|||
127933994|NCT01045421|460383445|FG002|Phase 1|Withdrawal by Subject|0|||
127933995|NCT01045421|460383446|FG003|Phase 1|Withdrawal by Subject|1|||
127933996|NCT01045421|460383447|FG004|Phase 1|Withdrawal by Subject|0|||
127933997|NCT01045421|460383448|FG005|Phase 1|Withdrawal by Subject|0|||
127933998|NCT01045421|460383449|FG006|Phase 1|Withdrawal by Subject|0|||
127933999|NCT01045421|460383450|FG007|Phase 1|Withdrawal by Subject|0|||
127934000|NCT01045421|460383451|FG008|Phase 1|Withdrawal by Subject|0|||
127934001|NCT01045421|460383452|FG009|Phase 1|Withdrawal by Subject|0|||
127934002|NCT01045421|460383453|FG010|Phase 1|Withdrawal by Subject|0|||
127934003|NCT01045421|460383443|FG000|Phase 2|Progressive Disease|0|||
127934004|NCT01045421|460383444|FG001|Phase 2|Progressive Disease|0|||
127934005|NCT01045421|460383445|FG002|Phase 2|Progressive Disease|0|||
127934006|NCT01045421|460383446|FG003|Phase 2|Progressive Disease|0|||
127934007|NCT01045421|460383447|FG004|Phase 2|Progressive Disease|0|||
127934008|NCT01045421|460383448|FG005|Phase 2|Progressive Disease|0|||
127934009|NCT01045421|460383449|FG006|Phase 2|Progressive Disease|0|||
127934010|NCT01045421|460383450|FG007|Phase 2|Progressive Disease|1|||
127934011|NCT01045421|460383451|FG008|Phase 2|Progressive Disease|1|||
127934012|NCT01045421|460383452|FG009|Phase 2|Progressive Disease|1|||
127934013|NCT01045421|460383453|FG010|Phase 2|Progressive Disease|1|||
127934014|NCT01045421|460383443|FG000|Phase 2|Death|0|||
127934015|NCT01045421|460383444|FG001|Phase 2|Death|0|||
127934016|NCT01045421|460383445|FG002|Phase 2|Death|0|||
127934017|NCT01045421|460383446|FG003|Phase 2|Death|0|||
127934018|NCT01045421|460383447|FG004|Phase 2|Death|0|||
127934019|NCT01045421|460383448|FG005|Phase 2|Death|0|||
127934020|NCT01045421|460383449|FG006|Phase 2|Death|0|||
127934021|NCT01045421|460383450|FG007|Phase 2|Death|1|||
127934022|NCT01045421|460383451|FG008|Phase 2|Death|1|||
127934023|NCT01045421|460383452|FG009|Phase 2|Death|2|||
127934024|NCT01045421|460383453|FG010|Phase 2|Death|0|||
127934025|NCT01045421|460383443|FG000|Phase 2|Other|0|||
127934026|NCT01045421|460383444|FG001|Phase 2|Other|0|||
127934027|NCT01045421|460383445|FG002|Phase 2|Other|0|||
127934028|NCT01045421|460383446|FG003|Phase 2|Other|0|||
127934029|NCT01045421|460383447|FG004|Phase 2|Other|0|||
127934030|NCT01045421|460383448|FG005|Phase 2|Other|0|||
127934031|NCT01045421|460383449|FG006|Phase 2|Other|0|||
127934032|NCT01045421|460383450|FG007|Phase 2|Other|3|||
127934033|NCT01045421|460383451|FG008|Phase 2|Other|0|||
127934034|NCT01045421|460383452|FG009|Phase 2|Other|0|||
127934035|NCT01045421|460383453|FG010|Phase 2|Other|1|||
127934036|NCT04551911|460383454|FG000|Overall Study|Lost to Follow-up|2|||
127934037|NCT04551911|460383455|FG001|Overall Study|Lost to Follow-up|1|||
127934038|NCT04551911|460383454|FG000|Overall Study|Withdrawal by Subject|10|||
127934039|NCT04551911|460383455|FG001|Overall Study|Withdrawal by Subject|10|||
127934040|NCT04551911|460383454|FG000|Overall Study|Did not receive the study drug|3|||
127934041|NCT04551911|460383455|FG001|Overall Study|Did not receive the study drug|4|||
127934042|NCT01030341|460383456|FG000|Overall Study|Withdrawal by Subject|1|||
127934043|NCT01030341|460383456|FG000|Overall Study|Lost to Follow-up|2|||
127934044|NCT04032158|460383464|FG000|Overall Study|Study Termination|2|||
127934045|NCT04032158|460383465|FG001|Overall Study|Study Termination|1|||
127934046|NCT01196078|460383466|FG000|Overall Study|Withdrawal by Subject|3|||
127934047|NCT01196078|460383467|FG001|Overall Study|Withdrawal by Subject|5|||
127934048|NCT01196078|460383466|FG000|Overall Study|Adverse Event|4|||
127934049|NCT01196078|460383467|FG001|Overall Study|Adverse Event|4|||
127934050|NCT01196078|460383466|FG000|Overall Study|Protocol Violation|2|||
127934051|NCT01196078|460383467|FG001|Overall Study|Protocol Violation|1|||
127934052|NCT01196078|460383466|FG000|Overall Study|Lack of Efficacy|17|||
127934053|NCT01196078|460383467|FG001|Overall Study|Lack of Efficacy|23|||
127934054|NCT01196078|460383466|FG000|Overall Study|Lost to Follow-up|1|||
127934055|NCT01196078|460383467|FG001|Overall Study|Lost to Follow-up|0|||
127934056|NCT01196078|460383466|FG000|Overall Study|Death|6|||
127934057|NCT01196078|460383467|FG001|Overall Study|Death|4|||
127934058|NCT02667288|460383468|FG000|Overall Study|Protocol Violation|5|||
127934059|NCT02667288|460383468|FG000|Overall Study|Lost to Follow-up|3|||
127934060|NCT02667288|460383468|FG000|Overall Study|Withdrawal by Subject|5|||
127934061|NCT00270257|460383471|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
127934062|NCT00270257|460383472|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
127934063|NCT02621034|460383473|FG000|Overall Study|Lost to Follow-up|3|||
127934064|NCT02621034|460383474|FG001|Overall Study|Lost to Follow-up|2|||
127934065|NCT02621034|460383475|FG002|Overall Study|Lost to Follow-up|5|||
127934066|NCT01968694|460383483|FG000|Washout (1 Month)|Lost to Follow-up|0|||
127934067|NCT01968694|460383484|FG001|Washout (1 Month)|Lost to Follow-up|1|||
127934068|NCT01400919|460383485|FG000|Overall Study|Withdrawal by Subject|4|||
127934069|NCT01400919|460383485|FG000|Overall Study|Lost to Follow-up|2|||
127934070|NCT01400919|460383485|FG000|Overall Study|Missed visit|2|||
127934071|NCT01732874|460383486|FG000|Overall Study|Withdrawal by Subject|5|||
127934072|NCT01732874|460383487|FG001|Overall Study|Withdrawal by Subject|1|||
127934073|NCT01732874|460383486|FG000|Overall Study|Death of Infant|3|||
127934074|NCT01732874|460383487|FG001|Overall Study|Death of Infant|2|||
127934075|NCT00557076|460383490|FG000|Overall Study|Unblinding|0|||
127934076|NCT00557076|460383491|FG001|Overall Study|Unblinding|1|||
127934077|NCT00688376|460383492|FG000|Double-Blind Phase|Adverse Event|4|||
127934078|NCT00688376|460383493|FG001|Double-Blind Phase|Adverse Event|4|||
127934079|NCT00688376|460383492|FG000|Double-Blind Phase|Protocol Violation|1|||
127934080|NCT00688376|460383493|FG001|Double-Blind Phase|Protocol Violation|2|||
127934081|NCT00688376|460383492|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
127934082|NCT00688376|460383493|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
127934083|NCT00688376|460383492|FG000|Double-Blind Phase|Not treated|0|||
127934084|NCT00688376|460383493|FG001|Double-Blind Phase|Not treated|1|||
127934085|NCT00688376|460383492|FG000|Blinded Extension Phase|Adverse Event|3|||
127934086|NCT00688376|460383493|FG001|Blinded Extension Phase|Adverse Event|4|||
127934087|NCT00688376|460383492|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
127934088|NCT00688376|460383493|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
127934089|NCT00688376|460383492|FG000|Blinded Extension Phase|Physician Decision|1|||
127934090|NCT00688376|460383493|FG001|Blinded Extension Phase|Physician Decision|0|||
127934091|NCT00688376|460383492|FG000|Blinded Extension Phase|Other|1|||
127934092|NCT00688376|460383493|FG001|Blinded Extension Phase|Other|0|||
127934093|NCT00846521|460383494|FG000|Overall Study|Withdrawal by Subject|5|||
127934094|NCT00846521|460383494|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
127934095|NCT00846521|460383494|FG000|Overall Study|Protocol Violation|1|||
127934096|NCT01246011|460383496|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
127934097|NCT01246011|460383497|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
127934098|NCT01246011|460383498|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
127934099|NCT01246011|460383496|FG000|Overall Study|Withdrawal by Subject|0|||
127934100|NCT01246011|460383497|FG001|Overall Study|Withdrawal by Subject|0|||
127934101|NCT01246011|460383498|FG002|Overall Study|Withdrawal by Subject|1|||
127934102|NCT02792959|460383500|FG000|Overall Study|Protocol Violation|1|||
127934103|NCT01780987|460383509|FG000|Overall Study|Adverse Event|0|||
127934104|NCT01780987|460383510|FG001|Overall Study|Adverse Event|4|||
127934105|NCT01780987|460383509|FG000|Overall Study|Withdrawal by Subject|2|||
127934106|NCT01780987|460383510|FG001|Overall Study|Withdrawal by Subject|0|||
127934107|NCT01780987|460383509|FG000|Overall Study|Request of Changing Hospital|0|||
127934108|NCT01780987|460383510|FG001|Overall Study|Request of Changing Hospital|1|||
127934109|NCT01780987|460383509|FG000|Overall Study|Changing Residence|1|||
127934110|NCT01780987|460383510|FG001|Overall Study|Changing Residence|0|||
127934111|NCT01780987|460383509|FG000|Overall Study|Not Receiving any Study Medication|0|||
127934112|NCT01780987|460383510|FG001|Overall Study|Not Receiving any Study Medication|1|||
127934113|NCT04168190|460383511|FG000|Overall Study|Lost to Follow-up|0|||
127934114|NCT04168190|460383512|FG001|Overall Study|Lost to Follow-up|1|||
127934115|NCT04168190|460383513|FG002|Overall Study|Lost to Follow-up|0|||
127934116|NCT04168190|460383514|FG003|Overall Study|Lost to Follow-up|7|||
127934117|NCT04168190|460383515|FG004|Overall Study|Lost to Follow-up|5|||
127934118|NCT04168190|460383511|FG000|Overall Study|Withdrawal by Subject|1|||
127934119|NCT04168190|460383512|FG001|Overall Study|Withdrawal by Subject|0|||
127934120|NCT04168190|460383513|FG002|Overall Study|Withdrawal by Subject|0|||
127934121|NCT04168190|460383514|FG003|Overall Study|Withdrawal by Subject|2|||
127934122|NCT04168190|460383515|FG004|Overall Study|Withdrawal by Subject|4|||
127934123|NCT04168190|460383511|FG000|Overall Study|Death|0|||
127934124|NCT04168190|460383512|FG001|Overall Study|Death|0|||
127934125|NCT04168190|460383513|FG002|Overall Study|Death|0|||
127934126|NCT04168190|460383514|FG003|Overall Study|Death|1|||
127934127|NCT04168190|460383515|FG004|Overall Study|Death|0|||
127934128|NCT01070771|460383516|FG000|Overall Study|Adverse Event|2|||
127934129|NCT01070771|460383516|FG000|Overall Study|Protocol Violation|1|||
127934130|NCT00629265|460383517|FG000|Overall Study|Lost to Follow-up|4|||
127934131|NCT00629265|460383518|FG001|Overall Study|Lost to Follow-up|5|||
127934132|NCT00629265|460383517|FG000|Overall Study|Withdrawal by Subject|11|||
127934133|NCT00629265|460383518|FG001|Overall Study|Withdrawal by Subject|8|||
127934134|NCT00629265|460383517|FG000|Overall Study|Death|1|||
127934135|NCT00629265|460383518|FG001|Overall Study|Death|0|||
127934136|NCT00629265|460383517|FG000|Overall Study|Adverse Event|2|||
127934137|NCT00629265|460383518|FG001|Overall Study|Adverse Event|0|||
127934138|NCT00629265|460383517|FG000|Overall Study|HNC Recurrence|4|||
127934139|NCT00629265|460383518|FG001|Overall Study|HNC Recurrence|0|||
127934140|NCT00629265|460383517|FG000|Overall Study|Other CA Requiring Treatment|1|||
127934141|NCT00629265|460383518|FG001|Overall Study|Other CA Requiring Treatment|3|||
127934142|NCT00629265|460383517|FG000|Overall Study|Needed Esophageal Dilation|4|||
127934143|NCT00629265|460383518|FG001|Overall Study|Needed Esophageal Dilation|1|||
127934144|NCT00629265|460383517|FG000|Overall Study|Unrelated Medical Complications|3|||
127934145|NCT00629265|460383518|FG001|Overall Study|Unrelated Medical Complications|1|||
127934146|NCT00629265|460383517|FG000|Overall Study|Unknown Reason|2|||
127934147|NCT00629265|460383518|FG001|Overall Study|Unknown Reason|2|||
127934148|NCT04465630|460383519|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
127934149|NCT04465630|460383519|FG000|Overall Study|Screen failure|8|||
127934150|NCT04465630|460383519|FG000|Overall Study|Baseline failure|16|||
127934151|NCT01615263|460383523|FG000|Overall Study|Post-randomization exclusion|0|||
127934152|NCT01615263|460383524|FG001|Overall Study|Post-randomization exclusion|2|||
127934153|NCT02138136|460383525|FG000|Overall Study|Protocol Violation|4|||
127934154|NCT02138136|460383525|FG000|Overall Study|Physician Decision|7|||
127934155|NCT02138136|460383525|FG000|Overall Study|Lack of Efficacy|35|||
127934156|NCT02138136|460383525|FG000|Overall Study|Pregnancy|2|||
127934157|NCT02138136|460383525|FG000|Overall Study|Adverse Event|18|||
127934158|NCT02138136|460383525|FG000|Overall Study|Withdrawal by Subject|36|||
127934159|NCT02138136|460383525|FG000|Overall Study|Lost to Follow-up|32|||
127934160|NCT02138136|460383525|FG000|Overall Study|Withdrawn by Sponsor|5|||
127934161|NCT03979820|460383528|FG000|Overall Study|Protocol Violation|1|||
127934162|NCT03979820|460383529|FG001|Overall Study|Protocol Violation|0|||
127934163|NCT03979820|460383530|FG002|Overall Study|Protocol Violation|0|||
127934164|NCT03979820|460383531|FG003|Overall Study|Protocol Violation|0|||
127934165|NCT03979820|460383528|FG000|Overall Study|Withdrawal by Subject|0|||
127934166|NCT03979820|460383529|FG001|Overall Study|Withdrawal by Subject|0|||
127934167|NCT03979820|460383530|FG002|Overall Study|Withdrawal by Subject|1|||
127934168|NCT03979820|460383531|FG003|Overall Study|Withdrawal by Subject|0|||
127934169|NCT03979820|460383528|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
127934170|NCT03979820|460383529|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
127934171|NCT03979820|460383530|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
127934172|NCT03979820|460383531|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
127934173|NCT04355663|460383532|FG000|Overall Study|Physician Decision|2|||
127934174|NCT04355663|460383533|FG001|Overall Study|Physician Decision|7|||
127934175|NCT04355663|460383534|FG002|Overall Study|Physician Decision|0|||
127934176|NCT04355663|460383532|FG000|Overall Study|Adverse Event|0|||
127934177|NCT04355663|460383533|FG001|Overall Study|Adverse Event|0|||
127934178|NCT04355663|460383534|FG002|Overall Study|Adverse Event|1|||
127934179|NCT04355663|460383532|FG000|Overall Study|Withdrawal by Subject|0|||
127934180|NCT04355663|460383533|FG001|Overall Study|Withdrawal by Subject|8|||
127934181|NCT04355663|460383534|FG002|Overall Study|Withdrawal by Subject|3|||
127934182|NCT01230892|460383535|FG000|Overall Study|Withdrawal by Subject|1|||
127934183|NCT01230892|460383536|FG001|Overall Study|Withdrawal by Subject|1|||
127934184|NCT01230892|460383535|FG000|Overall Study|Lost to Follow-up|2|||
127934185|NCT01230892|460383536|FG001|Overall Study|Lost to Follow-up|0|||
127934186|NCT00679913|460383537|FG000|Overall Study|Protocol Violation|18|||
127934187|NCT00679913|460383538|FG001|Overall Study|Protocol Violation|13|||
127934188|NCT01144364|460383542|FG000|Induction Phase|Disease progression|14|||
127934189|NCT01144364|460383543|FG001|Induction Phase|Disease progression|0|||
127934190|NCT01144364|460383544|FG002|Induction Phase|Disease progression|0|||
127934191|NCT01144364|460383542|FG000|Induction Phase|Adverse Event|9|||
127934192|NCT01144364|460383543|FG001|Induction Phase|Adverse Event|0|||
127934193|NCT01144364|460383544|FG002|Induction Phase|Adverse Event|0|||
127934194|NCT01144364|460383542|FG000|Induction Phase|Death|1|||
127934195|NCT01144364|460383543|FG001|Induction Phase|Death|0|||
127934196|NCT01144364|460383544|FG002|Induction Phase|Death|0|||
127934197|NCT01144364|460383542|FG000|Induction Phase|Withdrawal by Subject|1|||
127934198|NCT01144364|460383543|FG001|Induction Phase|Withdrawal by Subject|0|||
127934199|NCT01144364|460383544|FG002|Induction Phase|Withdrawal by Subject|0|||
127934200|NCT01144364|460383542|FG000|Induction Phase|Lost to Follow-up|2|||
127934201|NCT01144364|460383543|FG001|Induction Phase|Lost to Follow-up|0|||
127934202|NCT01144364|460383544|FG002|Induction Phase|Lost to Follow-up|0|||
127934203|NCT01144364|460383542|FG000|Induction Phase|Physician Decision|1|||
127934204|NCT01144364|460383543|FG001|Induction Phase|Physician Decision|0|||
127934205|NCT01144364|460383544|FG002|Induction Phase|Physician Decision|0|||
127934206|NCT01144364|460383542|FG000|Induction Phase|Stable disease|2|||
127934207|NCT01144364|460383543|FG001|Induction Phase|Stable disease|0|||
127934208|NCT01144364|460383544|FG002|Induction Phase|Stable disease|0|||
127934209|NCT01144364|460383542|FG000|Induction Phase|Secondary neoplasia|1|||
127934210|NCT01144364|460383543|FG001|Induction Phase|Secondary neoplasia|0|||
127934211|NCT01144364|460383544|FG002|Induction Phase|Secondary neoplasia|0|||
127934212|NCT01144364|460383542|FG000|Induction Phase|Protocol Violation|1|||
127934213|NCT01144364|460383543|FG001|Induction Phase|Protocol Violation|0|||
127934214|NCT01144364|460383544|FG002|Induction Phase|Protocol Violation|0|||
127934215|NCT01144364|460383542|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
127934216|NCT01144364|460383543|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
127934217|NCT01144364|460383544|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
127934218|NCT01144364|460383542|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
127934219|NCT01144364|460383543|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
127934220|NCT01144364|460383544|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
127934221|NCT01144364|460383542|FG000|Follow-Up/Maintenance Phase|Death|0|||
127934222|NCT01144364|460383543|FG001|Follow-Up/Maintenance Phase|Death|2|||
127934223|NCT01144364|460383544|FG002|Follow-Up/Maintenance Phase|Death|0|||
127934224|NCT01144364|460383542|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
127934225|NCT01144364|460383543|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
127934226|NCT01144364|460383544|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
127934227|NCT01144364|460383542|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
127934228|NCT01144364|460383543|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
127934229|NCT01144364|460383544|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
127934230|NCT01144364|460383542|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
127934231|NCT01144364|460383543|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
127934232|NCT01144364|460383544|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
127934233|NCT01144364|460383542|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
127934234|NCT01144364|460383543|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
127934235|NCT01144364|460383544|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
127934236|NCT01301508|460383547|FG000|Overall Study|Withdrawal by Subject|1|||
127934237|NCT01301508|460383548|FG001|Overall Study|Withdrawal by Subject|2|||
127934238|NCT01301508|460383547|FG000|Overall Study|Lost to Follow-up|0|||
127934239|NCT01301508|460383548|FG001|Overall Study|Lost to Follow-up|1|||
127934240|NCT00851643|460383549|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
127934241|NCT00851643|460383550|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
127934242|NCT00851643|460383551|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
127934243|NCT00851643|460383552|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
127934244|NCT00851643|460383553|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
127934245|NCT00851643|460383554|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
127934246|NCT00851643|460383549|FG000|Base Study (Up to 12 Months)|Other|0|||
127934247|NCT00851643|460383550|FG001|Base Study (Up to 12 Months)|Other|0|||
127934248|NCT00851643|460383551|FG002|Base Study (Up to 12 Months)|Other|0|||
127934249|NCT00851643|460383552|FG003|Base Study (Up to 12 Months)|Other|0|||
127934250|NCT00851643|460383553|FG004|Base Study (Up to 12 Months)|Other|0|||
127934251|NCT00851643|460383554|FG005|Base Study (Up to 12 Months)|Other|1|||
127934252|NCT00851643|460383549|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
127934253|NCT00851643|460383550|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
127934254|NCT00851643|460383551|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
127934255|NCT00851643|460383552|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
127934256|NCT00851643|460383553|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
127934257|NCT00851643|460383554|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
127934258|NCT00851643|460383549|FG000|Extension Study (Up to 36 Months)|Moved|0|||
127934259|NCT00851643|460383550|FG001|Extension Study (Up to 36 Months)|Moved|2|||
127934260|NCT00851643|460383551|FG002|Extension Study (Up to 36 Months)|Moved|1|||
127934261|NCT00851643|460383552|FG003|Extension Study (Up to 36 Months)|Moved|1|||
127934262|NCT00851643|460383553|FG004|Extension Study (Up to 36 Months)|Moved|0|||
127934263|NCT00851643|460383554|FG005|Extension Study (Up to 36 Months)|Moved|1|||
127934264|NCT02707861|460383557|FG000|Overall Study|Went onto commercial drug|30|||
127934265|NCT02707861|460383558|FG001|Overall Study|Went onto commercial drug|23|||
127934266|NCT02707861|460383557|FG000|Overall Study|Adverse Event|2|||
127934267|NCT02707861|460383558|FG001|Overall Study|Adverse Event|3|||
127934268|NCT02707861|460383557|FG000|Overall Study|Death|5|||
127934269|NCT02707861|460383558|FG001|Overall Study|Death|2|||
127934270|NCT02707861|460383557|FG000|Overall Study|Lack of Efficacy|0|||
127934271|NCT02707861|460383558|FG001|Overall Study|Lack of Efficacy|2|||
127934272|NCT02707861|460383557|FG000|Overall Study|Physician Decision|1|||
127934273|NCT02707861|460383558|FG001|Overall Study|Physician Decision|4|||
127934274|NCT02707861|460383557|FG000|Overall Study|Withdrawal by Subject|2|||
127934275|NCT02707861|460383558|FG001|Overall Study|Withdrawal by Subject|1|||
127934276|NCT02707861|460383557|FG000|Overall Study|Lost to Follow-up|1|||
127934277|NCT02707861|460383558|FG001|Overall Study|Lost to Follow-up|3|||
127934278|NCT01940497|460383559|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
127934279|NCT01940497|460383560|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
127934280|NCT01940497|460383559|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
127934281|NCT01940497|460383560|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
127934282|NCT01940497|460383559|FG000|Overall Study|Violation of Entry Criteria|1|||
127934283|NCT01940497|460383560|FG001|Overall Study|Violation of Entry Criteria|1|||
127934284|NCT01940497|460383559|FG000|Overall Study|Refused Treatment|1|||
127934285|NCT01940497|460383560|FG001|Overall Study|Refused Treatment|3|||
127934286|NCT01940497|460383559|FG000|Overall Study|Withdrew Consent|6|||
127934287|NCT01940497|460383560|FG001|Overall Study|Withdrew Consent|2|||
127934288|NCT01940497|460383559|FG000|Overall Study|Administrative/Other|1|||
127934289|NCT01940497|460383560|FG001|Overall Study|Administrative/Other|1|||
127934290|NCT01641133|460383561|FG000|Overall Study|Protocol Violation|0|||
127934291|NCT01641133|460383562|FG001|Overall Study|Protocol Violation|1|||
127934292|NCT01641133|460383563|FG002|Overall Study|Protocol Violation|1|||
127934293|NCT01641133|460383561|FG000|Overall Study|Migrated/moved from study area|5|||
127934294|NCT01641133|460383562|FG001|Overall Study|Migrated/moved from study area|3|||
127934295|NCT01641133|460383563|FG002|Overall Study|Migrated/moved from study area|1|||
127934296|NCT01641133|460383561|FG000|Overall Study|Adverse Event|0|||
127934297|NCT01641133|460383562|FG001|Overall Study|Adverse Event|0|||
127934298|NCT01641133|460383563|FG002|Overall Study|Adverse Event|1|||
127934299|NCT01641133|460383561|FG000|Overall Study|Withdrawal by Subject|5|||
127934300|NCT01641133|460383562|FG001|Overall Study|Withdrawal by Subject|3|||
127934301|NCT01641133|460383563|FG002|Overall Study|Withdrawal by Subject|3|||
127934302|NCT01641133|460383561|FG000|Overall Study|Lost to Follow-up|0|||
127934303|NCT01641133|460383562|FG001|Overall Study|Lost to Follow-up|2|||
127934304|NCT01641133|460383563|FG002|Overall Study|Lost to Follow-up|2|||
127934305|NCT03123861|460383564|FG000|Overall Study|Protocol Violation|1|||
127934306|NCT03123861|460383565|FG001|Overall Study|Protocol Violation|1|||
127934307|NCT03123861|460383564|FG000|Overall Study|Withdrawal by Subject|2|||
127934308|NCT03123861|460383565|FG001|Overall Study|Withdrawal by Subject|2|||
127934309|NCT02206620|460383566|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
127934310|NCT02206620|460383567|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
127934311|NCT02206620|460383566|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
127934312|NCT02206620|460383567|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
127934313|NCT03512262|460383568|FG000|Overall Study|Adverse Event|8|||
127934314|NCT03512262|460383569|FG001|Overall Study|Adverse Event|3|||
127934315|NCT03512262|460383568|FG000|Overall Study|Death (non-treatment emergent)|1|||
127934316|NCT03512262|460383569|FG001|Overall Study|Death (non-treatment emergent)|0|||
127934317|NCT03512262|460383568|FG000|Overall Study|Withdrawal by Subject|17|||
127934318|NCT03512262|460383569|FG001|Overall Study|Withdrawal by Subject|9|||
127934319|NCT03512262|460383568|FG000|Overall Study|Lost to Follow-up|7|||
127934320|NCT03512262|460383569|FG001|Overall Study|Lost to Follow-up|1|||
127934321|NCT03512262|460383568|FG000|Overall Study|Other than Specified|2|||
127934322|NCT03512262|460383569|FG001|Overall Study|Other than Specified|2|||
127934323|NCT03502707|460385040|FG000|Overall Study|Adverse Event|0|||
127934324|NCT03502707|460385041|FG001|Overall Study|Adverse Event|0|||
127934325|NCT03502707|460385042|FG002|Overall Study|Adverse Event|0|||
127934326|NCT03502707|460385043|FG003|Overall Study|Adverse Event|0|||
127934327|NCT03502707|460385044|FG004|Overall Study|Adverse Event|0|||
127934328|NCT03502707|460385045|FG005|Overall Study|Adverse Event|0|||
127934329|NCT03502707|460385046|FG006|Overall Study|Adverse Event|0|||
127934330|NCT03502707|460385047|FG007|Overall Study|Adverse Event|0|||
127934331|NCT03502707|460385048|FG008|Overall Study|Adverse Event|0|||
127934332|NCT03502707|460385049|FG009|Overall Study|Adverse Event|0|||
127934333|NCT03502707|460385050|FG010|Overall Study|Adverse Event|0|||
127934334|NCT03502707|460385051|FG011|Overall Study|Adverse Event|0|||
127934335|NCT03502707|460385052|FG012|Overall Study|Adverse Event|0|||
127934336|NCT03502707|460385053|FG013|Overall Study|Adverse Event|0|||
127934337|NCT03502707|460385054|FG014|Overall Study|Adverse Event|0|||
127934338|NCT03502707|460385055|FG015|Overall Study|Adverse Event|1|||
127934339|NCT03502707|460385056|FG016|Overall Study|Adverse Event|5|||
127934340|NCT03502707|460385057|FG017|Overall Study|Adverse Event|0|||
127934341|NCT03502707|460385040|FG000|Overall Study|Death|0|||
127934342|NCT03502707|460385041|FG001|Overall Study|Death|0|||
127934343|NCT03502707|460385042|FG002|Overall Study|Death|0|||
127934344|NCT03502707|460385043|FG003|Overall Study|Death|1|||
127934345|NCT03502707|460385044|FG004|Overall Study|Death|0|||
127934346|NCT03502707|460385045|FG005|Overall Study|Death|0|||
127934347|NCT03502707|460385046|FG006|Overall Study|Death|0|||
127934348|NCT03502707|460385047|FG007|Overall Study|Death|0|||
127934349|NCT03502707|460385048|FG008|Overall Study|Death|1|||
127934350|NCT03502707|460385049|FG009|Overall Study|Death|1|||
127934351|NCT03502707|460385050|FG010|Overall Study|Death|0|||
127934352|NCT03502707|460385051|FG011|Overall Study|Death|0|||
127934353|NCT03502707|460385052|FG012|Overall Study|Death|1|||
127934354|NCT03502707|460385053|FG013|Overall Study|Death|0|||
127934355|NCT03502707|460385054|FG014|Overall Study|Death|0|||
127934356|NCT03502707|460385055|FG015|Overall Study|Death|1|||
127934357|NCT03502707|460385056|FG016|Overall Study|Death|0|||
127934358|NCT03502707|460385057|FG017|Overall Study|Death|0|||
127934359|NCT03502707|460385040|FG000|Overall Study|Lost to Follow-up|0|||
127934360|NCT03502707|460385041|FG001|Overall Study|Lost to Follow-up|0|||
127934361|NCT03502707|460385042|FG002|Overall Study|Lost to Follow-up|0|||
127934362|NCT03502707|460385043|FG003|Overall Study|Lost to Follow-up|0|||
127934363|NCT03502707|460385044|FG004|Overall Study|Lost to Follow-up|0|||
127934364|NCT03502707|460385045|FG005|Overall Study|Lost to Follow-up|0|||
127934365|NCT03502707|460385046|FG006|Overall Study|Lost to Follow-up|0|||
127934366|NCT03502707|460385047|FG007|Overall Study|Lost to Follow-up|5|||
127934367|NCT03502707|460385048|FG008|Overall Study|Lost to Follow-up|0|||
127934368|NCT03502707|460385049|FG009|Overall Study|Lost to Follow-up|2|||
127934369|NCT03502707|460385050|FG010|Overall Study|Lost to Follow-up|1|||
127934370|NCT03502707|460385051|FG011|Overall Study|Lost to Follow-up|2|||
127934371|NCT03502707|460385052|FG012|Overall Study|Lost to Follow-up|1|||
127934372|NCT03502707|460385053|FG013|Overall Study|Lost to Follow-up|1|||
127934373|NCT03502707|460385054|FG014|Overall Study|Lost to Follow-up|0|||
127934374|NCT03502707|460385055|FG015|Overall Study|Lost to Follow-up|4|||
127934375|NCT03502707|460385056|FG016|Overall Study|Lost to Follow-up|9|||
127934376|NCT03502707|460385057|FG017|Overall Study|Lost to Follow-up|2|||
127934377|NCT03502707|460385040|FG000|Overall Study|Physician Decision|0|||
127934378|NCT03502707|460385041|FG001|Overall Study|Physician Decision|0|||
127934379|NCT03502707|460385042|FG002|Overall Study|Physician Decision|0|||
127934380|NCT03502707|460385043|FG003|Overall Study|Physician Decision|0|||
127934381|NCT03502707|460385044|FG004|Overall Study|Physician Decision|0|||
127934382|NCT03502707|460385045|FG005|Overall Study|Physician Decision|0|||
127934383|NCT03502707|460385046|FG006|Overall Study|Physician Decision|0|||
127934384|NCT03502707|460385047|FG007|Overall Study|Physician Decision|0|||
127934385|NCT03502707|460385048|FG008|Overall Study|Physician Decision|2|||
127934386|NCT03502707|460385049|FG009|Overall Study|Physician Decision|1|||
127934387|NCT03502707|460385050|FG010|Overall Study|Physician Decision|0|||
127934388|NCT03502707|460385051|FG011|Overall Study|Physician Decision|0|||
127934389|NCT03502707|460385052|FG012|Overall Study|Physician Decision|0|||
127934390|NCT03502707|460385053|FG013|Overall Study|Physician Decision|0|||
127934391|NCT03502707|460385054|FG014|Overall Study|Physician Decision|1|||
127934392|NCT03502707|460385055|FG015|Overall Study|Physician Decision|3|||
127934393|NCT03502707|460385056|FG016|Overall Study|Physician Decision|0|||
127934394|NCT03502707|460385057|FG017|Overall Study|Physician Decision|0|||
127934395|NCT03502707|460385040|FG000|Overall Study|Protocol Violation|0|||
127934396|NCT03502707|460385041|FG001|Overall Study|Protocol Violation|0|||
127934397|NCT03502707|460385042|FG002|Overall Study|Protocol Violation|0|||
127934398|NCT03502707|460385043|FG003|Overall Study|Protocol Violation|0|||
127934399|NCT03502707|460385044|FG004|Overall Study|Protocol Violation|0|||
127934400|NCT03502707|460385045|FG005|Overall Study|Protocol Violation|0|||
127934401|NCT03502707|460385046|FG006|Overall Study|Protocol Violation|0|||
127934402|NCT03502707|460385047|FG007|Overall Study|Protocol Violation|0|||
127934403|NCT03502707|460385048|FG008|Overall Study|Protocol Violation|0|||
127934404|NCT03502707|460385049|FG009|Overall Study|Protocol Violation|0|||
127934405|NCT03502707|460385050|FG010|Overall Study|Protocol Violation|0|||
127934406|NCT03502707|460385051|FG011|Overall Study|Protocol Violation|0|||
127934407|NCT03502707|460385052|FG012|Overall Study|Protocol Violation|0|||
127934408|NCT03502707|460385053|FG013|Overall Study|Protocol Violation|0|||
127934409|NCT03502707|460385054|FG014|Overall Study|Protocol Violation|0|||
127934410|NCT03502707|460385055|FG015|Overall Study|Protocol Violation|1|||
127934411|NCT03502707|460385056|FG016|Overall Study|Protocol Violation|0|||
127934412|NCT03502707|460385057|FG017|Overall Study|Protocol Violation|0|||
127934413|NCT03502707|460385040|FG000|Overall Study|Withdrawal by Subject|1|||
127934414|NCT03502707|460385041|FG001|Overall Study|Withdrawal by Subject|1|||
127934415|NCT03502707|460385042|FG002|Overall Study|Withdrawal by Subject|0|||
127934416|NCT03502707|460385043|FG003|Overall Study|Withdrawal by Subject|0|||
127934417|NCT03502707|460385044|FG004|Overall Study|Withdrawal by Subject|0|||
127934418|NCT03502707|460385045|FG005|Overall Study|Withdrawal by Subject|2|||
127934419|NCT03502707|460385046|FG006|Overall Study|Withdrawal by Subject|0|||
127934420|NCT03502707|460385047|FG007|Overall Study|Withdrawal by Subject|3|||
127934421|NCT03502707|460385048|FG008|Overall Study|Withdrawal by Subject|1|||
127934422|NCT03502707|460385049|FG009|Overall Study|Withdrawal by Subject|2|||
127934423|NCT03502707|460385050|FG010|Overall Study|Withdrawal by Subject|12|||
127934424|NCT03502707|460385051|FG011|Overall Study|Withdrawal by Subject|23|||
127934425|NCT03502707|460385052|FG012|Overall Study|Withdrawal by Subject|5|||
127934426|NCT03502707|460385053|FG013|Overall Study|Withdrawal by Subject|3|||
127934427|NCT03502707|460385054|FG014|Overall Study|Withdrawal by Subject|3|||
127934428|NCT03502707|460385055|FG015|Overall Study|Withdrawal by Subject|43|||
127934429|NCT03502707|460385056|FG016|Overall Study|Withdrawal by Subject|44|||
127934430|NCT03502707|460385057|FG017|Overall Study|Withdrawal by Subject|18|||
127934431|NCT03502707|460385040|FG000|Overall Study|Sponsor's Decision|1|||
127934432|NCT03502707|460385041|FG001|Overall Study|Sponsor's Decision|0|||
127934433|NCT03502707|460385042|FG002|Overall Study|Sponsor's Decision|0|||
127934434|NCT03502707|460385043|FG003|Overall Study|Sponsor's Decision|0|||
127934435|NCT03502707|460385044|FG004|Overall Study|Sponsor's Decision|0|||
127934436|NCT03502707|460385045|FG005|Overall Study|Sponsor's Decision|0|||
127934437|NCT03502707|460385046|FG006|Overall Study|Sponsor's Decision|0|||
127934438|NCT03502707|460385047|FG007|Overall Study|Sponsor's Decision|0|||
127934439|NCT03502707|460385048|FG008|Overall Study|Sponsor's Decision|0|||
127934440|NCT03502707|460385049|FG009|Overall Study|Sponsor's Decision|1|||
127934441|NCT03502707|460385050|FG010|Overall Study|Sponsor's Decision|0|||
127934442|NCT03502707|460385051|FG011|Overall Study|Sponsor's Decision|0|||
127934443|NCT03502707|460385052|FG012|Overall Study|Sponsor's Decision|0|||
127934444|NCT03502707|460385053|FG013|Overall Study|Sponsor's Decision|0|||
127934445|NCT03502707|460385054|FG014|Overall Study|Sponsor's Decision|0|||
127934446|NCT03502707|460385055|FG015|Overall Study|Sponsor's Decision|2|||
127934447|NCT03502707|460385056|FG016|Overall Study|Sponsor's Decision|1|||
127934448|NCT03502707|460385057|FG017|Overall Study|Sponsor's Decision|0|||
127934449|NCT03502707|460385040|FG000|Overall Study|Initiated Prohibited Medication|0|||
127934450|NCT03502707|460385041|FG001|Overall Study|Initiated Prohibited Medication|0|||
127934451|NCT03502707|460385042|FG002|Overall Study|Initiated Prohibited Medication|0|||
127934452|NCT03502707|460385043|FG003|Overall Study|Initiated Prohibited Medication|0|||
127934453|NCT03502707|460385044|FG004|Overall Study|Initiated Prohibited Medication|0|||
127934454|NCT03502707|460385045|FG005|Overall Study|Initiated Prohibited Medication|0|||
127934455|NCT03502707|460385046|FG006|Overall Study|Initiated Prohibited Medication|0|||
127934456|NCT03502707|460385047|FG007|Overall Study|Initiated Prohibited Medication|0|||
127934457|NCT03502707|460385048|FG008|Overall Study|Initiated Prohibited Medication|0|||
127934458|NCT03502707|460385049|FG009|Overall Study|Initiated Prohibited Medication|0|||
127934459|NCT03502707|460385050|FG010|Overall Study|Initiated Prohibited Medication|0|||
127934460|NCT03502707|460385051|FG011|Overall Study|Initiated Prohibited Medication|0|||
127934461|NCT03502707|460385052|FG012|Overall Study|Initiated Prohibited Medication|0|||
127934462|NCT03502707|460385053|FG013|Overall Study|Initiated Prohibited Medication|0|||
127934463|NCT03502707|460385054|FG014|Overall Study|Initiated Prohibited Medication|0|||
127934464|NCT03502707|460385055|FG015|Overall Study|Initiated Prohibited Medication|0|||
127934465|NCT03502707|460385056|FG016|Overall Study|Initiated Prohibited Medication|1|||
127934466|NCT03502707|460385057|FG017|Overall Study|Initiated Prohibited Medication|0|||
127934467|NCT03502707|460385040|FG000|Overall Study|Other|0|||
127934468|NCT03502707|460385041|FG001|Overall Study|Other|0|||
127934469|NCT03502707|460385042|FG002|Overall Study|Other|0|||
127934470|NCT03502707|460385043|FG003|Overall Study|Other|0|||
127934471|NCT03502707|460385044|FG004|Overall Study|Other|0|||
127934472|NCT03502707|460385045|FG005|Overall Study|Other|0|||
127934473|NCT03502707|460385046|FG006|Overall Study|Other|0|||
127934474|NCT03502707|460385047|FG007|Overall Study|Other|0|||
127934475|NCT03502707|460385048|FG008|Overall Study|Other|1|||
127934476|NCT03502707|460385049|FG009|Overall Study|Other|1|||
127934477|NCT03502707|460385050|FG010|Overall Study|Other|2|||
127934478|NCT03502707|460385051|FG011|Overall Study|Other|0|||
127934479|NCT03502707|460385052|FG012|Overall Study|Other|0|||
127934480|NCT03502707|460385053|FG013|Overall Study|Other|0|||
127934481|NCT03502707|460385054|FG014|Overall Study|Other|0|||
127934482|NCT03502707|460385055|FG015|Overall Study|Other|4|||
127934483|NCT03502707|460385056|FG016|Overall Study|Other|1|||
127934484|NCT03502707|460385057|FG017|Overall Study|Other|0|||
127934485|NCT03502707|460385040|FG000|Overall Study|Randomized but not vaccinated|0|||
127934486|NCT03502707|460385041|FG001|Overall Study|Randomized but not vaccinated|0|||
127934487|NCT03502707|460385042|FG002|Overall Study|Randomized but not vaccinated|0|||
127934488|NCT03502707|460385043|FG003|Overall Study|Randomized but not vaccinated|0|||
127934489|NCT03502707|460385044|FG004|Overall Study|Randomized but not vaccinated|0|||
127934490|NCT03502707|460385045|FG005|Overall Study|Randomized but not vaccinated|0|||
127934491|NCT03502707|460385046|FG006|Overall Study|Randomized but not vaccinated|0|||
127934492|NCT03502707|460385047|FG007|Overall Study|Randomized but not vaccinated|0|||
127934493|NCT03502707|460385048|FG008|Overall Study|Randomized but not vaccinated|0|||
127934494|NCT03502707|460385049|FG009|Overall Study|Randomized but not vaccinated|0|||
127934495|NCT03502707|460385050|FG010|Overall Study|Randomized but not vaccinated|0|||
127934496|NCT03502707|460385051|FG011|Overall Study|Randomized but not vaccinated|1|||
127934497|NCT03502707|460385052|FG012|Overall Study|Randomized but not vaccinated|0|||
127934498|NCT03502707|460385053|FG013|Overall Study|Randomized but not vaccinated|0|||
127934499|NCT03502707|460385054|FG014|Overall Study|Randomized but not vaccinated|0|||
127934500|NCT03502707|460385055|FG015|Overall Study|Randomized but not vaccinated|0|||
127934501|NCT03502707|460385056|FG016|Overall Study|Randomized but not vaccinated|0|||
127934502|NCT03502707|460385057|FG017|Overall Study|Randomized but not vaccinated|1|||
127934503|NCT02221037|460385058|FG000|Overall Study|Physician Decision|0|||
127934504|NCT02221037|460385059|FG001|Overall Study|Physician Decision|0|||
127934505|NCT02221037|460385060|FG002|Overall Study|Physician Decision|1|||
127934506|NCT02221037|460385061|FG003|Overall Study|Physician Decision|0|||
127934507|NCT01884311|460385062|FG000|Overall Study|Withdrawal by Subject|3|||
127934508|NCT01884311|460385062|FG000|Overall Study|withdrew consent due to AEs|1|||
127934509|NCT01884311|460385062|FG000|Overall Study|Precautionary measure|1|||
127934510|NCT02307266|460385063|FG000|Overall Study|Adverse Event|3|||
127934511|NCT02307266|460385064|FG001|Overall Study|Adverse Event|1|||
127934512|NCT02307266|460385065|FG002|Overall Study|Adverse Event|5|||
127934513|NCT02307266|460385063|FG000|Overall Study|Withdrawal by Subject|2|||
127934514|NCT02307266|460385064|FG001|Overall Study|Withdrawal by Subject|0|||
127934515|NCT02307266|460385065|FG002|Overall Study|Withdrawal by Subject|1|||
127934516|NCT02307266|460385063|FG000|Overall Study|Lost to Follow-up|3|||
127934517|NCT02307266|460385064|FG001|Overall Study|Lost to Follow-up|0|||
127934518|NCT02307266|460385065|FG002|Overall Study|Lost to Follow-up|0|||
127934519|NCT02031458|460385077|FG000|May 8, 2015 to January 11, 2019|Death|89|||
127934520|NCT02031458|460385078|FG001|May 8, 2015 to January 11, 2019|Death|193|||
127934521|NCT02031458|460385079|FG002|May 8, 2015 to January 11, 2019|Death|198|||
127934522|NCT02031458|460385077|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
127934523|NCT02031458|460385078|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
127934524|NCT02031458|460385079|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
127934525|NCT02031458|460385077|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
127934526|NCT02031458|460385078|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
127934527|NCT02031458|460385079|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
127934528|NCT02031458|460385077|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
127934529|NCT02031458|460385078|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
127934530|NCT02031458|460385079|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
127934531|NCT02031458|460385077|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
127934532|NCT02031458|460385078|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
127934533|NCT02031458|460385079|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
127934534|NCT02031458|460385077|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
127934535|NCT02031458|460385078|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
127934536|NCT02031458|460385079|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
127934537|NCT02031458|460385077|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
127934538|NCT02031458|460385078|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
127934539|NCT02031458|460385079|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
127934540|NCT02031458|460385077|FG000|Baseline to May 8, 2015|Death|36|||
127934541|NCT02031458|460385078|FG001|Baseline to May 8, 2015|Death|87|||
127934542|NCT02031458|460385079|FG002|Baseline to May 8, 2015|Death|100|||
127934543|NCT02031458|460385077|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
127934544|NCT02031458|460385078|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
127934545|NCT02031458|460385079|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
127934546|NCT02031458|460385077|FG000|Baseline to May 8, 2015|Physician Decision|0|||
127934547|NCT02031458|460385078|FG001|Baseline to May 8, 2015|Physician Decision|1|||
127934548|NCT02031458|460385079|FG002|Baseline to May 8, 2015|Physician Decision|0|||
127934549|NCT02031458|460385077|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
127934550|NCT02031458|460385078|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
127934551|NCT02031458|460385079|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
127934552|NCT02031458|460385077|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
127934553|NCT02031458|460385078|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
127934554|NCT02031458|460385079|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
127934555|NCT02031458|460385077|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
127934556|NCT02031458|460385078|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
127934557|NCT02031458|460385079|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
127934558|NCT02031458|460385077|FG000|Baseline to May 8, 2015|On Treatment|43|||
127934559|NCT02031458|460385078|FG001|Baseline to May 8, 2015|On Treatment|81|||
127934560|NCT02031458|460385079|FG002|Baseline to May 8, 2015|On Treatment|73|||
127934561|NCT02031458|460385077|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
127934562|NCT02031458|460385078|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
127934563|NCT02031458|460385079|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
127934564|NCT05855616|460385080|FG000|Overall Study|Lost to Follow-up|1|||
127934565|NCT05855616|460385081|FG001|Overall Study|Lost to Follow-up|2|||
127934566|NCT00059787|460385082|FG000|Overall Study|Adverse Event|13|||
127934567|NCT00059787|460385082|FG000|Overall Study|disease progression|2|||
127934568|NCT00059787|460385082|FG000|Overall Study|ineligible|1|||
127934569|NCT00059787|460385082|FG000|Overall Study|Other|4|||
127934570|NCT00103311|460385091|FG000|Overall Study|Lost to Follow-up|1|||
127934571|NCT00103311|460385092|FG001|Overall Study|Lost to Follow-up|0|||
127934572|NCT00103311|460385091|FG000|Overall Study|Withdrawal by Subject|2|||
127934573|NCT00103311|460385092|FG001|Overall Study|Withdrawal by Subject|1|||
127934574|NCT00103311|460385091|FG000|Overall Study|Adverse Event|1|||
127934575|NCT00103311|460385092|FG001|Overall Study|Adverse Event|0|||
127934576|NCT00974974|460385104|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
127934577|NCT00974974|460385105|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
127934578|NCT00974974|460385104|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
127934579|NCT00974974|460385105|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
127934580|NCT00974974|460385104|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
127934581|NCT00974974|460385105|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
127934582|NCT00974974|460385104|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
127934583|NCT00974974|460385105|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
127934584|NCT00974974|460385104|FG000|IR CD-LD Dose Adjustment|Various|0|||
127934585|NCT00974974|460385105|FG001|IR CD-LD Dose Adjustment|Various|9|||
127934586|NCT00974974|460385104|FG000|IPX066 Dose Conversion|Adverse Event|23|||
127934587|NCT00974974|460385105|FG001|IPX066 Dose Conversion|Adverse Event|0|||
127934588|NCT00974974|460385104|FG000|IPX066 Dose Conversion|Death|2|||
127934589|NCT00974974|460385105|FG001|IPX066 Dose Conversion|Death|0|||
127934590|NCT00974974|460385104|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
127934591|NCT00974974|460385105|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
127934592|NCT00974974|460385104|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
127934593|NCT00974974|460385105|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
127934594|NCT00974974|460385104|FG000|IPX066 Dose Conversion|Various|3|||
127934595|NCT00974974|460385105|FG001|IPX066 Dose Conversion|Various|0|||
127934596|NCT00974974|460385104|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
127934597|NCT00974974|460385105|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
127934598|NCT00974974|460385104|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
127934599|NCT00974974|460385105|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
127934600|NCT00974974|460385104|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
127934601|NCT00974974|460385105|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
127934602|NCT00974974|460385104|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
127934603|NCT00974974|460385105|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
127934604|NCT00974974|460385104|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
127934605|NCT00974974|460385105|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
127934606|NCT00974974|460385104|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
127934607|NCT00974974|460385105|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
127934608|NCT00974974|460385104|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
127934609|NCT00974974|460385105|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
127934610|NCT00974974|460385104|FG000|Maintenance - Double Blind Treatment|Various|4|||
127934611|NCT00974974|460385105|FG001|Maintenance - Double Blind Treatment|Various|0|||
127934612|NCT01959035|460385106|FG000|Overall Study|Adverse Event|5|||
127934613|NCT01959035|460385106|FG000|Overall Study|Withdrawal by Subject|4|||
127934614|NCT01959035|460385106|FG000|Overall Study|Lost to Follow-up|1|||
127934615|NCT01959035|460385106|FG000|Overall Study|Other (no primary reason given)|1|||
127934616|NCT02034058|460385107|FG000|Overall Study|Death|3|||
127934617|NCT03254602|460385108|FG000|Overall Study|Lost to Follow-up|4|||
127934618|NCT02963311|460385113|FG000|Overall Study|Withdrawal by Subject|1|||
127934619|NCT02963311|460385113|FG000|Overall Study|Screen Failure|4|||
127934620|NCT02836496|460385116|FG000|Overall Study|Adverse Event|2|||
127934621|NCT02836496|460385117|FG001|Overall Study|Adverse Event|1|||
127934622|NCT02836496|460385116|FG000|Overall Study|Withdrawal by Subject|0|||
127934623|NCT02836496|460385117|FG001|Overall Study|Withdrawal by Subject|1|||
127934624|NCT03822832|460385118|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
127934625|NCT03822832|460385119|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
127934626|NCT03822832|460385118|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
127934627|NCT03822832|460385119|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
127934628|NCT03822832|460385118|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
127934629|NCT03822832|460385119|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
127934630|NCT03822832|460385118|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
127934631|NCT03822832|460385119|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
127934632|NCT03822832|460385118|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
127934633|NCT03822832|460385119|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
127934634|NCT03822832|460385118|FG000|Re-allocation|Not re-allocated to open label period|2|||
127934635|NCT03822832|460385119|FG001|Re-allocation|Not re-allocated to open label period|6|||
127934636|NCT03822832|460385118|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
127934637|NCT03822832|460385119|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
127934638|NCT03822832|460385118|FG000|Period 2 - Open Label Period|Adverse Event|0|||
127934639|NCT03822832|460385119|FG001|Period 2 - Open Label Period|Adverse Event|3|||
127934640|NCT02923674|460385121|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
127934641|NCT02923674|460385122|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
127934642|NCT02923674|460385123|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
127934643|NCT02923674|460385121|FG000|Overall Study|Lost to Follow-up|7|||
127934644|NCT02923674|460385122|FG001|Overall Study|Lost to Follow-up|12|||
127934645|NCT02923674|460385123|FG002|Overall Study|Lost to Follow-up|7|||
127934646|NCT02923674|460385121|FG000|Overall Study|Problem with intervention|2|||
127934647|NCT02923674|460385122|FG001|Overall Study|Problem with intervention|2|||
127934648|NCT02923674|460385123|FG002|Overall Study|Problem with intervention|1|||
127934649|NCT02923674|460385121|FG000|Overall Study|Adverse Event|3|||
127934650|NCT02923674|460385122|FG001|Overall Study|Adverse Event|1|||
127934651|NCT02923674|460385123|FG002|Overall Study|Adverse Event|1|||
127934652|NCT02923674|460385121|FG000|Overall Study|Withdrawal by Subject|2|||
127934653|NCT02923674|460385122|FG001|Overall Study|Withdrawal by Subject|2|||
127934654|NCT02923674|460385123|FG002|Overall Study|Withdrawal by Subject|2|||
127934655|NCT00158600|460385126|FG000|Overall Study|unable to commit time to study|0|||
127934656|NCT00158600|460385127|FG001|Overall Study|unable to commit time to study|1|||
127934657|NCT00158600|460385126|FG000|Overall Study|Adverse Event|2|||
127934658|NCT00158600|460385127|FG001|Overall Study|Adverse Event|1|||
127934659|NCT00158600|460385126|FG000|Overall Study|Death|1|||
127934660|NCT00158600|460385127|FG001|Overall Study|Death|0|||
127934661|NCT00158600|460385126|FG000|Overall Study|Withdrawal by Subject|2|||
127934662|NCT00158600|460385127|FG001|Overall Study|Withdrawal by Subject|2|||
127934663|NCT02618408|460385136|FG000|Overall Study|Withdrawal by Subject|1|||
127934664|NCT02618408|460385137|FG001|Overall Study|Withdrawal by Subject|0|||
127934665|NCT02618408|460385138|FG002|Overall Study|Withdrawal by Subject|4|||
127934666|NCT02618408|460385136|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
127934667|NCT02618408|460385137|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
127934668|NCT02618408|460385138|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
127934669|NCT02618408|460385136|FG000|Overall Study|Lost to Follow-up|4|||
127934670|NCT02618408|460385137|FG001|Overall Study|Lost to Follow-up|2|||
127934671|NCT02618408|460385138|FG002|Overall Study|Lost to Follow-up|6|||
127934672|NCT02618408|460385136|FG000|Overall Study|Adverse Event|4|||
127934673|NCT02618408|460385137|FG001|Overall Study|Adverse Event|0|||
127934674|NCT02618408|460385138|FG002|Overall Study|Adverse Event|10|||
127934675|NCT02618408|460385136|FG000|Overall Study|Physician Decision|1|||
127934676|NCT02618408|460385137|FG001|Overall Study|Physician Decision|1|||
127934677|NCT02618408|460385138|FG002|Overall Study|Physician Decision|2|||
127934678|NCT02618408|460385136|FG000|Overall Study|Protocol Violation|1|||
127934679|NCT02618408|460385137|FG001|Overall Study|Protocol Violation|1|||
127934680|NCT02618408|460385138|FG002|Overall Study|Protocol Violation|2|||
127934681|NCT02618408|460385136|FG000|Overall Study|Other, Multiple Categories|0|||
127934682|NCT02618408|460385137|FG001|Overall Study|Other, Multiple Categories|0|||
127934683|NCT02618408|460385138|FG002|Overall Study|Other, Multiple Categories|4|||
127934684|NCT04492020|460385139|FG000|Overall Study|Adverse Event|1|||
127934685|NCT04492020|460385140|FG001|Overall Study|Adverse Event|3|||
127934686|NCT04492020|460385139|FG000|Overall Study|Withdrawal by Subject|4|||
127934687|NCT04492020|460385140|FG001|Overall Study|Withdrawal by Subject|3|||
127934688|NCT04492020|460385139|FG000|Overall Study|Lost to Follow-up|4|||
127934689|NCT04492020|460385140|FG001|Overall Study|Lost to Follow-up|3|||
127934690|NCT04492020|460385139|FG000|Overall Study|Protocol Violation|5|||
127934691|NCT04492020|460385140|FG001|Overall Study|Protocol Violation|2|||
127934692|NCT04492020|460385139|FG000|Overall Study|Lack of Qualifying Event|25|||
127934693|NCT04492020|460385140|FG001|Overall Study|Lack of Qualifying Event|27|||
127934694|NCT04492020|460385139|FG000|Overall Study|Non-compliance with Study Drug|2|||
127934695|NCT04492020|460385140|FG001|Overall Study|Non-compliance with Study Drug|1|||
127934696|NCT00003875|460385144|FG000|Overall Study|Screen Failed|1|||
127934697|NCT02032706|460385147|FG000|Overall Study|Did not qualify|5|||
127934698|NCT02032706|460385147|FG000|Overall Study|Protocol Violation|1|||
127934699|NCT00895947|460385148|FG000|Overall Study|Adverse Event|3|||
127934700|NCT00895947|460385149|FG001|Overall Study|Adverse Event|4|||
127934701|NCT00895947|460385148|FG000|Overall Study|Lost to Follow-up|3|||
127934702|NCT00895947|460385149|FG001|Overall Study|Lost to Follow-up|4|||
127934703|NCT00895947|460385148|FG000|Overall Study|Protocol Violation|4|||
127934704|NCT00895947|460385149|FG001|Overall Study|Protocol Violation|2|||
127934705|NCT00895947|460385148|FG000|Overall Study|Withdrawal by Subject|2|||
127934706|NCT00895947|460385149|FG001|Overall Study|Withdrawal by Subject|0|||
127934707|NCT04620135|460385152|FG000|Study Completion|Adverse Event|2|||
127934708|NCT04620135|460385153|FG001|Study Completion|Adverse Event|3|||
127934709|NCT04620135|460385152|FG000|Study Completion|Withdrawal by Subject|2|||
127934710|NCT04620135|460385153|FG001|Study Completion|Withdrawal by Subject|0|||
127934711|NCT02005887|460385154|FG000|Overall Study|Protocol Violation|0|||
127934712|NCT02005887|460385155|FG001|Overall Study|Protocol Violation|2|||
127934713|NCT01550744|460385156|FG000|Open-Label|Lost to Follow-up|7|||
127934714|NCT01550744|460385157|FG001|Open-Label|Lost to Follow-up|0|||
127934715|NCT01550744|460385158|FG002|Open-Label|Lost to Follow-up|0|||
127934716|NCT01550744|460385156|FG000|Open-Label|Withdrawal by Subject|13|||
127934717|NCT01550744|460385157|FG001|Open-Label|Withdrawal by Subject|0|||
127934718|NCT01550744|460385158|FG002|Open-Label|Withdrawal by Subject|0|||
127934719|NCT01550744|460385156|FG000|Open-Label|Adverse Event|11|||
127934720|NCT01550744|460385157|FG001|Open-Label|Adverse Event|0|||
127934721|NCT01550744|460385158|FG002|Open-Label|Adverse Event|0|||
127934722|NCT01550744|460385156|FG000|Open-Label|Lack of Efficacy|4|||
127934723|NCT01550744|460385157|FG001|Open-Label|Lack of Efficacy|0|||
127934724|NCT01550744|460385158|FG002|Open-Label|Lack of Efficacy|0|||
127934725|NCT01550744|460385156|FG000|Open-Label|Protocol Violation|4|||
127934726|NCT01550744|460385157|FG001|Open-Label|Protocol Violation|0|||
127934727|NCT01550744|460385158|FG002|Open-Label|Protocol Violation|0|||
127934728|NCT01550744|460385156|FG000|Open-Label|Not all 3 study drug injections received|2|||
127934729|NCT01550744|460385157|FG001|Open-Label|Not all 3 study drug injections received|0|||
127934730|NCT01550744|460385158|FG002|Open-Label|Not all 3 study drug injections received|0|||
127934731|NCT01550744|460385156|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
127934732|NCT01550744|460385157|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
127934733|NCT01550744|460385158|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
127934734|NCT01550744|460385156|FG000|Open-Label|Other|1|||
127934735|NCT01550744|460385157|FG001|Open-Label|Other|0|||
127934736|NCT01550744|460385158|FG002|Open-Label|Other|0|||
127934737|NCT01550744|460385156|FG000|Double-Blind|Lost to Follow-up|0|||
127934738|NCT01550744|460385157|FG001|Double-Blind|Lost to Follow-up|6|||
127934739|NCT01550744|460385158|FG002|Double-Blind|Lost to Follow-up|12|||
127934740|NCT01550744|460385156|FG000|Double-Blind|Withdrawal by Subject|0|||
127934741|NCT01550744|460385157|FG001|Double-Blind|Withdrawal by Subject|2|||
127934742|NCT01550744|460385158|FG002|Double-Blind|Withdrawal by Subject|15|||
127934743|NCT01550744|460385156|FG000|Double-Blind|Adverse Event|0|||
127934744|NCT01550744|460385157|FG001|Double-Blind|Adverse Event|4|||
127934745|NCT01550744|460385158|FG002|Double-Blind|Adverse Event|15|||
127934746|NCT01550744|460385156|FG000|Double-Blind|Death|0|||
127934747|NCT01550744|460385157|FG001|Double-Blind|Death|1|||
127934748|NCT01550744|460385158|FG002|Double-Blind|Death|0|||
127934749|NCT01550744|460385156|FG000|Double-Blind|Lack of Efficacy|0|||
127934750|NCT01550744|460385157|FG001|Double-Blind|Lack of Efficacy|2|||
127934751|NCT01550744|460385158|FG002|Double-Blind|Lack of Efficacy|8|||
127934752|NCT01550744|460385156|FG000|Double-Blind|Protocol Violation|0|||
127934753|NCT01550744|460385157|FG001|Double-Blind|Protocol Violation|0|||
127934754|NCT01550744|460385158|FG002|Double-Blind|Protocol Violation|4|||
127934755|NCT01550744|460385156|FG000|Double-Blind|Pregnancy|0|||
127934756|NCT01550744|460385157|FG001|Double-Blind|Pregnancy|0|||
127934757|NCT01550744|460385158|FG002|Double-Blind|Pregnancy|3|||
127934758|NCT01550744|460385156|FG000|Double-Blind|Other|0|||
127934759|NCT01550744|460385157|FG001|Double-Blind|Other|2|||
127934760|NCT01550744|460385158|FG002|Double-Blind|Other|10|||
127934761|NCT01660334|460385159|FG000|Overall Study|Lost to Follow-up|1|||
127934762|NCT00311311|460385160|FG000|Overall Study|Adverse Event|3|||
127934763|NCT00311311|460385161|FG001|Overall Study|Adverse Event|2|||
127934764|NCT00311311|460385160|FG000|Overall Study|Withdrawal by Subject|1|||
127934765|NCT00311311|460385161|FG001|Overall Study|Withdrawal by Subject|1|||
127934766|NCT00311311|460385160|FG000|Overall Study|Noncompliance|0|||
127934767|NCT00311311|460385161|FG001|Overall Study|Noncompliance|1|||
127934768|NCT00311311|460385160|FG000|Overall Study|Study Termination by Sponsor|3|||
127934769|NCT00311311|460385161|FG001|Overall Study|Study Termination by Sponsor|4|||
127934770|NCT00311311|460385160|FG000|Overall Study|Death|1|||
127934771|NCT00311311|460385161|FG001|Overall Study|Death|0|||
127934772|NCT00311311|460385160|FG000|Overall Study|Lack of ancillary assistance|0|||
127934773|NCT00311311|460385161|FG001|Overall Study|Lack of ancillary assistance|1|||
127934774|NCT00988065|460385164|FG000|Overall Study|Adverse Event|4|||
127934775|NCT00988065|460385165|FG001|Overall Study|Adverse Event|10|||
127934776|NCT00988065|460385166|FG002|Overall Study|Adverse Event|2|||
127934777|NCT00988065|460385164|FG000|Overall Study|Lost to Follow-up|1|||
127934778|NCT00988065|460385165|FG001|Overall Study|Lost to Follow-up|2|||
127934779|NCT00988065|460385166|FG002|Overall Study|Lost to Follow-up|2|||
127934780|NCT00988065|460385164|FG000|Overall Study|Subject withdrew consent|3|||
127934781|NCT00988065|460385165|FG001|Overall Study|Subject withdrew consent|5|||
127934782|NCT00988065|460385166|FG002|Overall Study|Subject withdrew consent|2|||
127934783|NCT00988065|460385164|FG000|Overall Study|Noncompliance with protocol|5|||
127934784|NCT00988065|460385165|FG001|Overall Study|Noncompliance with protocol|6|||
127934785|NCT00988065|460385166|FG002|Overall Study|Noncompliance with protocol|9|||
127934786|NCT01229735|460385167|FG000|Overall Study|Lack of Efficacy|8|||
127934787|NCT01229735|460385168|FG001|Overall Study|Lack of Efficacy|8|||
127934788|NCT01229735|460385167|FG000|Overall Study|Protocol Violation|13|||
127934789|NCT01229735|460385168|FG001|Overall Study|Protocol Violation|8|||
127934790|NCT01229735|460385167|FG000|Overall Study|Lost to Follow-up|0|||
127934791|NCT01229735|460385168|FG001|Overall Study|Lost to Follow-up|2|||
127934792|NCT01229735|460385167|FG000|Overall Study|Withdrawal by Subject|18|||
127934793|NCT01229735|460385168|FG001|Overall Study|Withdrawal by Subject|17|||
127934794|NCT01229735|460385167|FG000|Overall Study|Other Reason|13|||
127934795|NCT01229735|460385168|FG001|Overall Study|Other Reason|10|||
127934796|NCT01229735|460385167|FG000|Overall Study|SAE, non-fatal|0|||
127934797|NCT01229735|460385168|FG001|Overall Study|SAE, non-fatal|4|||
127934798|NCT01229735|460385167|FG000|Overall Study|AE, non-serious non-fatal|13|||
127934799|NCT01229735|460385168|FG001|Overall Study|AE, non-serious non-fatal|17|||
127934800|NCT01229735|460385167|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
127934801|NCT01229735|460385168|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
127934802|NCT02685202|460385169|FG000|Overall Study|Lost to Follow-up|9|||
127934803|NCT02787408|460385170|FG000|Overall Study|Death|16|||
127934804|NCT02787408|460385170|FG000|Overall Study|Withdrawal by Subject|1|||
127934805|NCT02787408|460385170|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
127934806|NCT00985712|460385171|FG000|Overall Study|Adverse Event|0|||
127934807|NCT00985712|460385172|FG001|Overall Study|Adverse Event|1|||
127934808|NCT00985712|460385171|FG000|Overall Study|Lost to Follow-up|2|||
127934809|NCT00985712|460385172|FG001|Overall Study|Lost to Follow-up|2|||
127934810|NCT00985712|460385171|FG000|Overall Study|Protocol Violation|0|||
127934811|NCT00985712|460385172|FG001|Overall Study|Protocol Violation|1|||
127934812|NCT00985712|460385171|FG000|Overall Study|Withdrawal by Subject|4|||
127934813|NCT00985712|460385172|FG001|Overall Study|Withdrawal by Subject|1|||
127934814|NCT00985712|460385171|FG000|Overall Study|Sponsor decision|0|||
127934815|NCT00985712|460385172|FG001|Overall Study|Sponsor decision|2|||
127934816|NCT00876018|460385175|FG000|Overall Study|Lost to Follow-up|0|||
127934817|NCT00876018|460385176|FG001|Overall Study|Lost to Follow-up|1|||
127934818|NCT00876018|460385177|FG002|Overall Study|Lost to Follow-up|1|||
127934819|NCT00876018|460385175|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
127934820|NCT00876018|460385176|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
127934821|NCT00876018|460385177|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
127934822|NCT00725621|460385178|FG000|Overall Study|Adverse Event|25|||
127934823|NCT00725621|460385178|FG000|Overall Study|Lack of Efficacy|46|||
127934824|NCT00725621|460385178|FG000|Overall Study|Withdrawal by Subject|57|||
127934825|NCT00725621|460385178|FG000|Overall Study|Physician Decision|19|||
127934826|NCT00725621|460385178|FG000|Overall Study|Lost to Follow-up|52|||
127934827|NCT00725621|460385178|FG000|Overall Study|Non-compliance|8|||
127934828|NCT00725621|460385178|FG000|Overall Study|Continued treatment by other physician|6|||
127934829|NCT00725621|460385178|FG000|Overall Study|Switched to other study|1|||
127934830|NCT00725621|460385178|FG000|Overall Study|Switched to other drug|1|||
127934831|NCT00725621|460385178|FG000|Overall Study|Prepared for elective surgery|1|||
127934832|NCT00725621|460385178|FG000|Overall Study|Reason not specified|55|||
127934833|NCT01189500|460385179|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
127934834|NCT01189500|460385179|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
127934835|NCT00062751|460385180|FG000|Overall Study|Disease progression|24|||
127934836|NCT00062751|460385181|FG001|Overall Study|Disease progression|17|||
127934837|NCT00062751|460385182|FG002|Overall Study|Disease progression|24|||
127934838|NCT00062751|460385183|FG003|Overall Study|Disease progression|2|||
127934839|NCT00062751|460385184|FG004|Overall Study|Disease progression|2|||
127934840|NCT00062751|460385180|FG000|Overall Study|Adverse Event|4|||
127934841|NCT00062751|460385181|FG001|Overall Study|Adverse Event|7|||
127934842|NCT00062751|460385182|FG002|Overall Study|Adverse Event|2|||
127934843|NCT00062751|460385183|FG003|Overall Study|Adverse Event|2|||
127934844|NCT00062751|460385184|FG004|Overall Study|Adverse Event|2|||
127934845|NCT00062751|460385180|FG000|Overall Study|Other|2|||
127934846|NCT00062751|460385181|FG001|Overall Study|Other|3|||
127934847|NCT00062751|460385182|FG002|Overall Study|Other|1|||
127934848|NCT00062751|460385183|FG003|Overall Study|Other|0|||
127934849|NCT00062751|460385184|FG004|Overall Study|Other|1|||
127934850|NCT00062751|460385180|FG000|Overall Study|Withdrawal by Subject|1|||
127934851|NCT00062751|460385181|FG001|Overall Study|Withdrawal by Subject|2|||
127934852|NCT00062751|460385182|FG002|Overall Study|Withdrawal by Subject|2|||
127934853|NCT00062751|460385183|FG003|Overall Study|Withdrawal by Subject|1|||
127934854|NCT00062751|460385184|FG004|Overall Study|Withdrawal by Subject|0|||
127934855|NCT00062751|460385180|FG000|Overall Study|Symptomatic deterioration|1|||
127934856|NCT00062751|460385181|FG001|Overall Study|Symptomatic deterioration|1|||
127934857|NCT00062751|460385182|FG002|Overall Study|Symptomatic deterioration|0|||
127934858|NCT00062751|460385183|FG003|Overall Study|Symptomatic deterioration|0|||
127934859|NCT00062751|460385184|FG004|Overall Study|Symptomatic deterioration|1|||
127934860|NCT00062751|460385180|FG000|Overall Study|Death|1|||
127934861|NCT00062751|460385181|FG001|Overall Study|Death|0|||
127934862|NCT00062751|460385182|FG002|Overall Study|Death|1|||
127934863|NCT00062751|460385183|FG003|Overall Study|Death|0|||
127934864|NCT00062751|460385184|FG004|Overall Study|Death|0|||
127934865|NCT01346774|460385185|FG000|Overall Study|Did not take a single dose|6|||
127934866|NCT01346774|460385186|FG001|Overall Study|Did not take a single dose|4|||
127934867|NCT01346774|460385185|FG000|Overall Study|Lost to Follow-up|3|||
127934868|NCT01346774|460385186|FG001|Overall Study|Lost to Follow-up|4|||
127934869|NCT01346774|460385185|FG000|Overall Study|Withdrawal by Subject|1|||
127934870|NCT01346774|460385186|FG001|Overall Study|Withdrawal by Subject|4|||
127934871|NCT01346774|460385185|FG000|Overall Study|Protocol Violation|2|||
127934872|NCT01346774|460385186|FG001|Overall Study|Protocol Violation|3|||
127934873|NCT01346774|460385185|FG000|Overall Study|Adverse Event|1|||
127934874|NCT01346774|460385186|FG001|Overall Study|Adverse Event|2|||
127934875|NCT00321737|460385189|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
127934876|NCT00321737|460385190|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
127934877|NCT00321737|460385191|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
127934878|NCT00321737|460385189|FG000|Overall Study|Adverse Event|11|||
127934879|NCT00321737|460385190|FG001|Overall Study|Adverse Event|3|||
127934880|NCT00321737|460385191|FG002|Overall Study|Adverse Event|6|||
127934881|NCT00321737|460385189|FG000|Overall Study|Lost to Follow-up|5|||
127934882|NCT00321737|460385190|FG001|Overall Study|Lost to Follow-up|5|||
127934883|NCT00321737|460385191|FG002|Overall Study|Lost to Follow-up|6|||
127934884|NCT00321737|460385189|FG000|Overall Study|Withdrawal by Subject|19|||
127934885|NCT00321737|460385190|FG001|Overall Study|Withdrawal by Subject|12|||
127934886|NCT00321737|460385191|FG002|Overall Study|Withdrawal by Subject|17|||
127934887|NCT00321737|460385189|FG000|Overall Study|Protocol Violation|0|||
127934888|NCT00321737|460385190|FG001|Overall Study|Protocol Violation|0|||
127934889|NCT00321737|460385191|FG002|Overall Study|Protocol Violation|1|||
127934890|NCT00321737|460385189|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
127934891|NCT00321737|460385190|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
127934892|NCT00321737|460385191|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
127934893|NCT00321737|460385189|FG000|Overall Study|Possible Barrett's Esophagus|2|||
127934894|NCT00321737|460385190|FG001|Overall Study|Possible Barrett's Esophagus|1|||
127934895|NCT00321737|460385191|FG002|Overall Study|Possible Barrett's Esophagus|1|||
127934896|NCT00321737|460385189|FG000|Overall Study|Therapeutic Failure|6|||
127934897|NCT00321737|460385190|FG001|Overall Study|Therapeutic Failure|0|||
127934898|NCT00321737|460385191|FG002|Overall Study|Therapeutic Failure|2|||
127934899|NCT00321737|460385189|FG000|Overall Study|Pregnancy|0|||
127934900|NCT00321737|460385190|FG001|Overall Study|Pregnancy|2|||
127934901|NCT00321737|460385191|FG002|Overall Study|Pregnancy|0|||
127934902|NCT00321737|460385189|FG000|Overall Study|Noncompliance|2|||
127934903|NCT00321737|460385190|FG001|Overall Study|Noncompliance|0|||
127934904|NCT00321737|460385191|FG002|Overall Study|Noncompliance|0|||
127934905|NCT00321737|460385189|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
127934906|NCT00321737|460385190|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
127934907|NCT00321737|460385191|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
127934908|NCT01769339|460385192|FG000|Overall Study|Lost to Follow-up|42|||
127934909|NCT01769339|460385192|FG000|Overall Study|Adverse Event|1|||
127934910|NCT00290251|460385193|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
127934911|NCT00290251|460385194|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
127934912|NCT00290251|460385195|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
127934913|NCT00290251|460385196|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
127934914|NCT00290251|460385197|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
127934915|NCT00290251|460385198|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
127934916|NCT00290251|460385193|FG000|Treatment 1 (Months 2-4)|headache|0|||
127934917|NCT00290251|460385194|FG001|Treatment 1 (Months 2-4)|headache|0|||
127934918|NCT00290251|460385195|FG002|Treatment 1 (Months 2-4)|headache|0|||
127934919|NCT00290251|460385196|FG003|Treatment 1 (Months 2-4)|headache|0|||
127934920|NCT00290251|460385197|FG004|Treatment 1 (Months 2-4)|headache|1|||
127934921|NCT00290251|460385198|FG005|Treatment 1 (Months 2-4)|headache|0|||
127934922|NCT00290251|460385193|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
127934923|NCT00290251|460385194|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
127934924|NCT00290251|460385195|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
127934925|NCT00290251|460385196|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
127934926|NCT00290251|460385197|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
127934927|NCT00290251|460385198|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
127934928|NCT03188666|460387274|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
127934929|NCT03188666|460387275|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
127934930|NCT03188666|460387276|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
127934931|NCT03188666|460387277|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
127934932|NCT03188666|460387274|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
127934933|NCT03188666|460387275|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
127934934|NCT03188666|460387276|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
127934935|NCT03188666|460387277|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
127934936|NCT03188666|460387274|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
127934937|NCT03188666|460387275|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
127934938|NCT03188666|460387276|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
127934939|NCT03188666|460387277|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
127934940|NCT03188666|460387274|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
127934941|NCT03188666|460387275|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
127934942|NCT03188666|460387276|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
127934943|NCT03188666|460387277|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
127934944|NCT03696953|460387278|FG000|Overall Study|Withdrawal by Subject|6|||
127934945|NCT03696953|460387279|FG001|Overall Study|Withdrawal by Subject|1|||
127934946|NCT03696953|460387278|FG000|Overall Study|missed GBS swabs|2|||
127934947|NCT03696953|460387279|FG001|Overall Study|missed GBS swabs|2|||
127934948|NCT03696953|460387278|FG000|Overall Study|lost study bottle containing capsules|2|||
127934949|NCT03696953|460387279|FG001|Overall Study|lost study bottle containing capsules|0|||
127934950|NCT03696953|460387278|FG000|Overall Study|Premature birth|1|||
127934951|NCT03696953|460387279|FG001|Overall Study|Premature birth|4|||
127934952|NCT03696953|460387278|FG000|Overall Study|Gestational hypertension|1|||
127934953|NCT03696953|460387279|FG001|Overall Study|Gestational hypertension|1|||
127934954|NCT03696953|460387278|FG000|Overall Study|Gestational diabetes|2|||
127934955|NCT03696953|460387279|FG001|Overall Study|Gestational diabetes|1|||
127934956|NCT03696953|460387278|FG000|Overall Study|Fetal demise-Genetic abnormality|1|||
127934957|NCT03696953|460387279|FG001|Overall Study|Fetal demise-Genetic abnormality|0|||
127934958|NCT03696953|460387278|FG000|Overall Study|Changed prenatal provider|1|||
127934959|NCT03696953|460387279|FG001|Overall Study|Changed prenatal provider|1|||
127934960|NCT04908683|460387280|FG000|Overall Study|Failure to meet continuation criteria|34|||
127934961|NCT04908683|460387281|FG001|Overall Study|Failure to meet continuation criteria|22|||
127934962|NCT04908683|460387280|FG000|Overall Study|Initiated prohibited medication|3|||
127934963|NCT04908683|460387281|FG001|Overall Study|Initiated prohibited medication|0|||
127934964|NCT04908683|460387280|FG000|Overall Study|Randomized by mistake|1|||
127934965|NCT04908683|460387281|FG001|Overall Study|Randomized by mistake|0|||
127934966|NCT04908683|460387280|FG000|Overall Study|Lost to Follow-up|679|||
127934967|NCT04908683|460387281|FG001|Overall Study|Lost to Follow-up|341|||
127934968|NCT04908683|460387280|FG000|Overall Study|Participant met eligibility criteria but were not needed|3|||
127934969|NCT04908683|460387281|FG001|Overall Study|Participant met eligibility criteria but were not needed|1|||
127934970|NCT04908683|460387280|FG000|Overall Study|Physician Decision|44|||
127934971|NCT04908683|460387281|FG001|Overall Study|Physician Decision|35|||
127934972|NCT04908683|460387280|FG000|Overall Study|Technical problems|12|||
127934973|NCT04908683|460387281|FG001|Overall Study|Technical problems|9|||
127934974|NCT04908683|460387280|FG000|Overall Study|Withdrawal by legally authorized representative|1|||
127934975|NCT04908683|460387281|FG001|Overall Study|Withdrawal by legally authorized representative|0|||
127934976|NCT04908683|460387280|FG000|Overall Study|Protocol Violation|2|||
127934977|NCT04908683|460387281|FG001|Overall Study|Protocol Violation|0|||
127934978|NCT04908683|460387280|FG000|Overall Study|Withdrawal by Subject|1188|||
127934979|NCT04908683|460387281|FG001|Overall Study|Withdrawal by Subject|570|||
127934980|NCT04908683|460387280|FG000|Overall Study|Site Closure by Sponsor|6|||
127934981|NCT04908683|460387281|FG001|Overall Study|Site Closure by Sponsor|3|||
127934982|NCT04908683|460387280|FG000|Overall Study|Adverse Event|21|||
127934983|NCT04908683|460387281|FG001|Overall Study|Adverse Event|11|||
127934984|NCT04908683|460387280|FG000|Overall Study|Death|101|||
127934985|NCT04908683|460387281|FG001|Overall Study|Death|61|||
127934986|NCT04908683|460387280|FG000|Overall Study|Sponsor's decision|14398|||
127934987|NCT04908683|460387281|FG001|Overall Study|Sponsor's decision|7205|||
127934988|NCT04908683|460387280|FG000|Overall Study|Other|92|||
127934989|NCT04908683|460387281|FG001|Overall Study|Other|50|||
127934990|NCT04908683|460387280|FG000|Overall Study|Randomized not vaccinated|108|||
127934991|NCT04908683|460387281|FG001|Overall Study|Randomized not vaccinated|52|||
127934992|NCT06204887|460387283|FG000|Overall Study|Lost to Follow-up|3|||
127934993|NCT06204887|460387284|FG001|Overall Study|Lost to Follow-up|4|||
127934994|NCT06204887|460387285|FG002|Overall Study|Lost to Follow-up|1|||
127934995|NCT06204887|460387286|FG003|Overall Study|Lost to Follow-up|6|||
127934996|NCT00807248|460387287|FG000|Overall Study|Adverse Event|1|||
127934997|NCT00807248|460387288|FG001|Overall Study|Adverse Event|2|||
127934998|NCT00807248|460387289|FG002|Overall Study|Adverse Event|2|||
127934999|NCT00807248|460387290|FG003|Overall Study|Adverse Event|6|||
127935000|NCT00807248|460387287|FG000|Overall Study|Lack of Efficacy|14|||
127935001|NCT00807248|460387288|FG001|Overall Study|Lack of Efficacy|4|||
127935002|NCT00807248|460387289|FG002|Overall Study|Lack of Efficacy|8|||
127935003|NCT00807248|460387290|FG003|Overall Study|Lack of Efficacy|3|||
127935004|NCT00807248|460387287|FG000|Overall Study|Protocol Violation|0|||
127935005|NCT00807248|460387288|FG001|Overall Study|Protocol Violation|1|||
127935006|NCT00807248|460387289|FG002|Overall Study|Protocol Violation|1|||
127935007|NCT00807248|460387290|FG003|Overall Study|Protocol Violation|0|||
127935008|NCT00807248|460387287|FG000|Overall Study|Withdrawal of Consent|5|||
127935009|NCT00807248|460387288|FG001|Overall Study|Withdrawal of Consent|5|||
127935010|NCT00807248|460387289|FG002|Overall Study|Withdrawal of Consent|5|||
127935011|NCT00807248|460387290|FG003|Overall Study|Withdrawal of Consent|5|||
127935012|NCT00807248|460387287|FG000|Overall Study|Lost to Follow-up|1|||
127935013|NCT00807248|460387288|FG001|Overall Study|Lost to Follow-up|0|||
127935014|NCT00807248|460387289|FG002|Overall Study|Lost to Follow-up|0|||
127935015|NCT00807248|460387290|FG003|Overall Study|Lost to Follow-up|0|||
127935016|NCT00807248|460387287|FG000|Overall Study|Other Reason|0|||
127935017|NCT00807248|460387288|FG001|Overall Study|Other Reason|0|||
127935018|NCT00807248|460387289|FG002|Overall Study|Other Reason|2|||
127935019|NCT00807248|460387290|FG003|Overall Study|Other Reason|0|||
127935020|NCT00210249|460387291|FG000|Overall Study|Lost to Follow-up|5|||
127935021|NCT00210249|460387291|FG000|Overall Study|Protocol Violation|11|||
127935022|NCT02518919|460387292|FG000|Overall Study|Protocol Violation|1|||
127935023|NCT02518919|460387293|FG001|Overall Study|Protocol Violation|1|||
127935024|NCT02518919|460387294|FG002|Overall Study|Protocol Violation|2|||
127935025|NCT00307034|460387296|FG000|Overall Study|Adverse Event|1|||
127935026|NCT00307034|460387297|FG001|Overall Study|Adverse Event|2|||
127935027|NCT00307034|460387296|FG000|Overall Study|Withdrawal by Subject|1|||
127935028|NCT00307034|460387297|FG001|Overall Study|Withdrawal by Subject|2|||
127935029|NCT00307034|460387296|FG000|Overall Study|Lost to Follow-up|0|||
127935030|NCT00307034|460387297|FG001|Overall Study|Lost to Follow-up|3|||
127935031|NCT04442490|460387302|FG000|Overall Study|Withdrawal by Subject|18|||
127935032|NCT04442490|460387303|FG001|Overall Study|Withdrawal by Subject|10|||
127935033|NCT04442490|460387302|FG000|Overall Study|Lost to Follow-up|7|||
127935034|NCT04442490|460387303|FG001|Overall Study|Lost to Follow-up|7|||
127935035|NCT04442490|460387302|FG000|Overall Study|Adverse Event|2|||
127935036|NCT04442490|460387303|FG001|Overall Study|Adverse Event|6|||
127935037|NCT04442490|460387302|FG000|Overall Study|Noncompliance|3|||
127935038|NCT04442490|460387303|FG001|Overall Study|Noncompliance|1|||
127935039|NCT04442490|460387302|FG000|Overall Study|Physician Decision|2|||
127935040|NCT04442490|460387303|FG001|Overall Study|Physician Decision|1|||
127935041|NCT04442490|460387302|FG000|Overall Study|Reason not Specified|2|||
127935042|NCT04442490|460387303|FG001|Overall Study|Reason not Specified|1|||
127935043|NCT04442490|460387302|FG000|Overall Study|Randomized but not Treated|3|||
127935044|NCT04442490|460387303|FG001|Overall Study|Randomized but not Treated|3|||
127935045|NCT02227147|460387304|FG000|Controlled Treatment Period|Adverse Event|4|||
127935046|NCT02227147|460387305|FG001|Controlled Treatment Period|Adverse Event|3|||
127935047|NCT02227147|460387304|FG000|Controlled Treatment Period|Other|2|||
127935048|NCT02227147|460387305|FG001|Controlled Treatment Period|Other|0|||
127935049|NCT02227147|460387304|FG000|Follow-up Period|Other|3|||
127935050|NCT02227147|460387305|FG001|Follow-up Period|Other|5|||
127935051|NCT03514641|460387306|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
127935052|NCT03514641|460387307|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
127935053|NCT03514641|460387308|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
127935054|NCT03514641|460387309|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
127935055|NCT03514641|460387306|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
127935056|NCT03514641|460387307|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
127935057|NCT03514641|460387308|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
127935058|NCT03514641|460387309|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
127935059|NCT03514641|460387306|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
127935060|NCT03514641|460387307|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
127935061|NCT03514641|460387308|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
127935062|NCT03514641|460387309|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
127935063|NCT03514641|460387306|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
127935064|NCT03514641|460387307|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
127935065|NCT03514641|460387308|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
127935066|NCT03514641|460387309|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
127935067|NCT03514641|460387306|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
127935068|NCT03514641|460387307|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
127935069|NCT03514641|460387308|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
127935070|NCT03514641|460387309|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
127935071|NCT03514641|460387306|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
127935072|NCT03514641|460387307|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
127935073|NCT03514641|460387308|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
127935074|NCT03514641|460387309|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
127935075|NCT03514641|460387306|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
127935076|NCT03514641|460387307|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
127935077|NCT03514641|460387308|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
127935078|NCT03514641|460387309|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
127935079|NCT03514641|460387306|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
127935080|NCT03514641|460387307|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
127935081|NCT03514641|460387308|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
127935082|NCT03514641|460387309|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
127935083|NCT03514641|460387306|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
127935084|NCT03514641|460387307|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
127935085|NCT03514641|460387308|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
127935086|NCT03514641|460387309|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
127935087|NCT03514641|460387306|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
127935088|NCT03514641|460387307|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
127935089|NCT03514641|460387308|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
127935090|NCT03514641|460387309|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
127935091|NCT03514641|460387306|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
127935092|NCT03514641|460387307|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
127935093|NCT03514641|460387308|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
127935094|NCT03514641|460387309|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
127935095|NCT03514641|460387306|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
127935096|NCT03514641|460387307|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
127935097|NCT03514641|460387308|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
127935098|NCT03514641|460387309|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
127935099|NCT01449279|460387310|FG000|Overall Study|Lack of Efficacy|5|||
127935100|NCT01449279|460387310|FG000|Overall Study|Toxicity|2|||
127935101|NCT04234984|460387311|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
127935102|NCT04234984|460387311|FG000|Follow-up at the Second Time Point|Death|1|||
127935103|NCT04234984|460387311|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
127935104|NCT01055132|460387312|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
127935105|NCT01055132|460387313|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
127935106|NCT01055132|460387312|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
127935107|NCT01055132|460387313|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
127935108|NCT02038907|460387314|FG000|Overall Study|Protocol Violation|0|||
127935109|NCT02038907|460387315|FG001|Overall Study|Protocol Violation|0|||
127935110|NCT02038907|460387316|FG002|Overall Study|Protocol Violation|0|||
127935111|NCT02038907|460387317|FG003|Overall Study|Protocol Violation|0|||
127935112|NCT02038907|460387318|FG004|Overall Study|Protocol Violation|0|||
127935113|NCT02038907|460387319|FG005|Overall Study|Protocol Violation|0|||
127935114|NCT02038907|460387320|FG006|Overall Study|Protocol Violation|0|||
127935115|NCT02038907|460387321|FG007|Overall Study|Protocol Violation|0|||
127935116|NCT02038907|460387322|FG008|Overall Study|Protocol Violation|0|||
127935117|NCT02038907|460387323|FG009|Overall Study|Protocol Violation|0|||
127935118|NCT02038907|460387324|FG010|Overall Study|Protocol Violation|1|||
127935119|NCT02038907|460387325|FG011|Overall Study|Protocol Violation|0|||
127935120|NCT02038907|460387326|FG012|Overall Study|Protocol Violation|0|||
127935121|NCT02038907|460387327|FG013|Overall Study|Protocol Violation|0|||
127935122|NCT02038907|460387314|FG000|Overall Study|Withdrawal by Subject|0|||
127935123|NCT02038907|460387315|FG001|Overall Study|Withdrawal by Subject|0|||
127935124|NCT02038907|460387316|FG002|Overall Study|Withdrawal by Subject|0|||
127935125|NCT02038907|460387317|FG003|Overall Study|Withdrawal by Subject|0|||
127935126|NCT02038907|460387318|FG004|Overall Study|Withdrawal by Subject|0|||
127935127|NCT02038907|460387319|FG005|Overall Study|Withdrawal by Subject|0|||
127935128|NCT02038907|460387320|FG006|Overall Study|Withdrawal by Subject|0|||
127935129|NCT02038907|460387321|FG007|Overall Study|Withdrawal by Subject|0|||
127935130|NCT02038907|460387322|FG008|Overall Study|Withdrawal by Subject|0|||
127935131|NCT02038907|460387323|FG009|Overall Study|Withdrawal by Subject|0|||
127935132|NCT02038907|460387324|FG010|Overall Study|Withdrawal by Subject|1|||
127935133|NCT02038907|460387325|FG011|Overall Study|Withdrawal by Subject|0|||
127935134|NCT02038907|460387326|FG012|Overall Study|Withdrawal by Subject|0|||
127935135|NCT02038907|460387327|FG013|Overall Study|Withdrawal by Subject|0|||
127935136|NCT03914950|460387331|FG000|Overall Study|Physician Decision|54|||
127935137|NCT02575911|460387335|FG000|Overall Study|Lost to Follow-up|1|||
127935138|NCT01249365|460387336|FG000|Overall Study|Lost to Follow-up|1|||
127935139|NCT01460901|460387337|FG000|Overall Study|Withdrawal by Subject|2|||
127935140|NCT02566993|460387338|FG000|Overall Study|Randomized but not treated|5|||
127935141|NCT02566993|460387339|FG001|Overall Study|Randomized but not treated|16|||
127935142|NCT02566993|460387338|FG000|Overall Study|Progressive disease|213|||
127935143|NCT02566993|460387339|FG001|Overall Study|Progressive disease|152|||
127935144|NCT02566993|460387338|FG000|Overall Study|Withdrawal by Subject|12|||
127935145|NCT02566993|460387339|FG001|Overall Study|Withdrawal by Subject|28|||
127935146|NCT02566993|460387338|FG000|Overall Study|Death|17|||
127935147|NCT02566993|460387339|FG001|Overall Study|Death|23|||
127935148|NCT02566993|460387338|FG000|Overall Study|Physician Decision|10|||
127935149|NCT02566993|460387339|FG001|Overall Study|Physician Decision|17|||
127935150|NCT02566993|460387338|FG000|Overall Study|Study drug-related adverse event|20|||
127935151|NCT02566993|460387339|FG001|Overall Study|Study drug-related adverse event|41|||
127935152|NCT02566993|460387338|FG000|Overall Study|Non study drug-related adverse event|9|||
127935153|NCT02566993|460387339|FG001|Overall Study|Non study drug-related adverse event|9|||
127935154|NCT02566993|460387338|FG000|Overall Study|Symptomatic deterioration|9|||
127935155|NCT02566993|460387339|FG001|Overall Study|Symptomatic deterioration|16|||
127935156|NCT02566993|460387338|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
127935157|NCT02566993|460387339|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
127935158|NCT02566993|460387338|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
127935159|NCT02566993|460387339|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
127935160|NCT02566993|460387338|FG000|Overall Study|Screening failure|2|||
127935161|NCT02566993|460387339|FG001|Overall Study|Screening failure|0|||
127935162|NCT02566993|460387338|FG000|Overall Study|Lost to Follow-up|0|||
127935163|NCT02566993|460387339|FG001|Overall Study|Lost to Follow-up|1|||
127935164|NCT02566993|460387338|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
127935165|NCT02566993|460387339|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
127935166|NCT01169532|460387344|FG000|Overall Study|Withdrawal by Subject|1|||
127935167|NCT03127644|460387352|FG000|Overall Study|Study-specific withdrawal criteria|0|||
127935168|NCT03127644|460387353|FG001|Overall Study|Study-specific withdrawal criteria|0|||
127935169|NCT03127644|460387354|FG002|Overall Study|Study-specific withdrawal criteria|2|||
127935170|NCT01156142|460387355|FG000|Overall Study|Withdrawal by Subject|8|||
127935171|NCT01156142|460387356|FG001|Overall Study|Withdrawal by Subject|6|||
127935172|NCT01156142|460387355|FG000|Overall Study|Ineligible|0|||
127935173|NCT01156142|460387356|FG001|Overall Study|Ineligible|1|||
127935174|NCT00893737|460387357|FG000|Overall Study|Adverse Event|4|||
127935175|NCT00893737|460387357|FG000|Overall Study|Withdrawal by Subject|2|||
127935176|NCT00893737|460387357|FG000|Overall Study|Lost to Follow-up|6|||
127935177|NCT02140411|460387358|FG000|Overall Study|Adverse Event|1|||
127935178|NCT03981419|460387361|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|0|||
127935179|NCT03981419|460387362|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|1|||
127935180|NCT01330459|460387364|FG000|Overall Study|Physician Decision|0|||
127935181|NCT01330459|460387365|FG001|Overall Study|Physician Decision|2|||
127935182|NCT01359644|460387378|FG000|Treatment Period|Lack of Efficacy|0|||
127935183|NCT01359644|460387379|FG001|Treatment Period|Lack of Efficacy|1|||
127935184|NCT01359644|460387380|FG002|Treatment Period|Lack of Efficacy|0|||
127935185|NCT01359644|460387381|FG003|Treatment Period|Lack of Efficacy|0|||
127935186|NCT01359644|460387382|FG004|Treatment Period|Lack of Efficacy|0|||
127935187|NCT01359644|460387383|FG005|Treatment Period|Lack of Efficacy|0|||
127935188|NCT01359644|460387384|FG006|Treatment Period|Lack of Efficacy|0|||
127935189|NCT01359644|460387385|FG007|Treatment Period|Lack of Efficacy|0|||
127935190|NCT01359644|460387386|FG008|Treatment Period|Lack of Efficacy|0|||
127935191|NCT01359644|460387387|FG009|Treatment Period|Lack of Efficacy|0|||
127935192|NCT01359644|460387378|FG000|Treatment Period|Adverse Event|0|||
127935193|NCT01359644|460387379|FG001|Treatment Period|Adverse Event|0|||
127935194|NCT01359644|460387380|FG002|Treatment Period|Adverse Event|1|||
127935195|NCT01359644|460387381|FG003|Treatment Period|Adverse Event|0|||
127935196|NCT01359644|460387382|FG004|Treatment Period|Adverse Event|0|||
127935197|NCT01359644|460387383|FG005|Treatment Period|Adverse Event|1|||
127935198|NCT01359644|460387384|FG006|Treatment Period|Adverse Event|0|||
127935199|NCT01359644|460387385|FG007|Treatment Period|Adverse Event|0|||
127935200|NCT01359644|460387386|FG008|Treatment Period|Adverse Event|0|||
127935201|NCT01359644|460387387|FG009|Treatment Period|Adverse Event|0|||
127935202|NCT01359644|460387378|FG000|Treatment Period|Lost to Follow-up|0|||
127935203|NCT01359644|460387379|FG001|Treatment Period|Lost to Follow-up|0|||
127935204|NCT01359644|460387380|FG002|Treatment Period|Lost to Follow-up|0|||
127935205|NCT01359644|460387381|FG003|Treatment Period|Lost to Follow-up|0|||
127935206|NCT01359644|460387382|FG004|Treatment Period|Lost to Follow-up|0|||
127935207|NCT01359644|460387383|FG005|Treatment Period|Lost to Follow-up|1|||
127935208|NCT01359644|460387384|FG006|Treatment Period|Lost to Follow-up|0|||
127935209|NCT01359644|460387385|FG007|Treatment Period|Lost to Follow-up|0|||
127935210|NCT01359644|460387386|FG008|Treatment Period|Lost to Follow-up|0|||
127935211|NCT01359644|460387387|FG009|Treatment Period|Lost to Follow-up|0|||
127935212|NCT01359644|460387378|FG000|Follow-up Period|Withdrawal by Subject|0|||
127935213|NCT01359644|460387379|FG001|Follow-up Period|Withdrawal by Subject|0|||
127935214|NCT01359644|460387380|FG002|Follow-up Period|Withdrawal by Subject|0|||
127935215|NCT01359644|460387381|FG003|Follow-up Period|Withdrawal by Subject|0|||
127935216|NCT01359644|460387382|FG004|Follow-up Period|Withdrawal by Subject|0|||
127935217|NCT01359644|460387383|FG005|Follow-up Period|Withdrawal by Subject|1|||
127935218|NCT01359644|460387384|FG006|Follow-up Period|Withdrawal by Subject|0|||
127935219|NCT01359644|460387385|FG007|Follow-up Period|Withdrawal by Subject|0|||
127935220|NCT01359644|460387386|FG008|Follow-up Period|Withdrawal by Subject|0|||
127935221|NCT01359644|460387387|FG009|Follow-up Period|Withdrawal by Subject|0|||
127935222|NCT01359644|460387378|FG000|Follow-up Period|Lost to Follow-up|0|||
127935223|NCT01359644|460387379|FG001|Follow-up Period|Lost to Follow-up|0|||
127935224|NCT01359644|460387380|FG002|Follow-up Period|Lost to Follow-up|0|||
127935225|NCT01359644|460387381|FG003|Follow-up Period|Lost to Follow-up|0|||
127935226|NCT01359644|460387382|FG004|Follow-up Period|Lost to Follow-up|0|||
127935227|NCT01359644|460387383|FG005|Follow-up Period|Lost to Follow-up|0|||
127935228|NCT01359644|460387384|FG006|Follow-up Period|Lost to Follow-up|1|||
127935229|NCT01359644|460387385|FG007|Follow-up Period|Lost to Follow-up|2|||
127935230|NCT01359644|460387386|FG008|Follow-up Period|Lost to Follow-up|0|||
127935231|NCT01359644|460387387|FG009|Follow-up Period|Lost to Follow-up|0|||
127935232|NCT02130882|460387388|FG000|Overall Study|Withdrawal by Subject|0|||
127935233|NCT02130882|460387389|FG001|Overall Study|Withdrawal by Subject|1|||
127935234|NCT01194973|460387400|FG000|Screening Period|Screen Failure|3|||
127935235|NCT01194973|460387400|FG000|26 Week Treatment Period|Adverse Event|1|||
127935236|NCT01194973|460387400|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
127935237|NCT01194973|460387400|FG000|26 Week Treatment Period|Pregnancy|1|||
127935238|NCT00359632|460387403|FG000|Overall Study|Death|2|||
127935239|NCT00359632|460387404|FG001|Overall Study|Death|0|||
127935240|NCT00359632|460387403|FG000|Overall Study|Adverse Event|1|||
127935241|NCT00359632|460387404|FG001|Overall Study|Adverse Event|0|||
127935242|NCT00359632|460387403|FG000|Overall Study|Non-compliance with visit schedule|1|||
127935243|NCT00359632|460387404|FG001|Overall Study|Non-compliance with visit schedule|0|||
127935244|NCT02615171|460387405|FG000|Overall Study|Lost to Follow-up|2|||
127935245|NCT02615171|460387406|FG001|Overall Study|Lost to Follow-up|1|||
127935246|NCT01000493|460387414|FG000|Overall Study|Adverse Event|3|||
127935247|NCT01000493|460387415|FG001|Overall Study|Adverse Event|6|||
127935248|NCT01000493|460387414|FG000|Overall Study|Lack of Efficacy|1|||
127935249|NCT01000493|460387415|FG001|Overall Study|Lack of Efficacy|1|||
127935250|NCT01000493|460387414|FG000|Overall Study|Protocol Violation|1|||
127935251|NCT01000493|460387415|FG001|Overall Study|Protocol Violation|8|||
127935252|NCT01000493|460387414|FG000|Overall Study|Study closed/terminated|25|||
127935253|NCT01000493|460387415|FG001|Overall Study|Study closed/terminated|23|||
127935254|NCT01000493|460387414|FG000|Overall Study|Lost to Follow-up|5|||
127935255|NCT01000493|460387415|FG001|Overall Study|Lost to Follow-up|9|||
127935256|NCT01000493|460387414|FG000|Overall Study|Physician Decision|1|||
127935257|NCT01000493|460387415|FG001|Overall Study|Physician Decision|1|||
127935258|NCT01000493|460387414|FG000|Overall Study|Withdrawal by Subject|3|||
127935259|NCT01000493|460387415|FG001|Overall Study|Withdrawal by Subject|7|||
127935260|NCT00502801|460387416|FG000|Treatment Period|Withdrawal by Subject|3|||
127935261|NCT00502801|460387416|FG000|Treatment Period|Adverse Event|7|||
127935262|NCT00502801|460387416|FG000|Treatment Period|Death|14|||
127935263|NCT00502801|460387416|FG000|Treatment Period|OTHER|30|||
127935264|NCT00502801|460387416|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
127935265|NCT00502801|460387416|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
127935266|NCT00502801|460387416|FG000|End of Therapy to Test of Cure|Death|3|||
127935267|NCT00502801|460387416|FG000|End of Therapy to Test of Cure|OTHER|2|||
127935268|NCT00444457|460387422|FG000|Infant Series|Other|0|||
127935269|NCT00444457|460387423|FG001|Infant Series|Other|1|||
127935270|NCT00444457|460387424|FG002|Infant Series|Other|0|||
127935271|NCT00444457|460387425|FG003|Infant Series|Other|0|||
127935272|NCT00444457|460387422|FG000|Infant Series|Parent or legal guardian request|18|||
127935273|NCT00444457|460387423|FG001|Infant Series|Parent or legal guardian request|29|||
127935274|NCT00444457|460387424|FG002|Infant Series|Parent or legal guardian request|34|||
127935275|NCT00444457|460387425|FG003|Infant Series|Parent or legal guardian request|14|||
127935276|NCT00444457|460387422|FG000|Infant Series|Lost to Follow-up|10|||
127935277|NCT00444457|460387423|FG001|Infant Series|Lost to Follow-up|11|||
127935278|NCT00444457|460387424|FG002|Infant Series|Lost to Follow-up|7|||
127935279|NCT00444457|460387425|FG003|Infant Series|Lost to Follow-up|6|||
127935280|NCT00444457|460387422|FG000|Infant Series|Protocol Violation|16|||
127935281|NCT00444457|460387423|FG001|Infant Series|Protocol Violation|8|||
127935282|NCT00444457|460387424|FG002|Infant Series|Protocol Violation|6|||
127935283|NCT00444457|460387425|FG003|Infant Series|Protocol Violation|3|||
127935284|NCT00444457|460387422|FG000|Infant Series|Failed to return|5|||
127935285|NCT00444457|460387423|FG001|Infant Series|Failed to return|4|||
127935286|NCT00444457|460387424|FG002|Infant Series|Failed to return|4|||
127935287|NCT00444457|460387425|FG003|Infant Series|Failed to return|2|||
127935288|NCT00444457|460387422|FG000|Infant Series|Investigator request|4|||
127935289|NCT00444457|460387423|FG001|Infant Series|Investigator request|3|||
127935290|NCT00444457|460387424|FG002|Infant Series|Investigator request|3|||
127935291|NCT00444457|460387425|FG003|Infant Series|Investigator request|2|||
127935292|NCT00444457|460387422|FG000|Infant Series|Other|0|||
127935293|NCT00444457|460387423|FG001|Infant Series|Other|2|||
127935294|NCT00444457|460387424|FG002|Infant Series|Other|4|||
127935295|NCT00444457|460387425|FG003|Infant Series|Other|0|||
127935296|NCT00444457|460387422|FG000|Infant Series|Adverse Event|1|||
127935297|NCT00444457|460387423|FG001|Infant Series|Adverse Event|2|||
127935298|NCT00444457|460387424|FG002|Infant Series|Adverse Event|2|||
127935299|NCT00444457|460387425|FG003|Infant Series|Adverse Event|0|||
127935300|NCT00444457|460387422|FG000|Infant Series|Death|0|||
127935301|NCT00444457|460387423|FG001|Infant Series|Death|1|||
127935302|NCT00444457|460387424|FG002|Infant Series|Death|1|||
127935303|NCT00444457|460387425|FG003|Infant Series|Death|1|||
127935304|NCT00444457|460387422|FG000|After Infant Series|Other|0|||
127935305|NCT00444457|460387423|FG001|After Infant Series|Other|1|||
127935306|NCT00444457|460387424|FG002|After Infant Series|Other|1|||
127935307|NCT00444457|460387425|FG003|After Infant Series|Other|1|||
127935308|NCT00444457|460387422|FG000|After Infant Series|Parent or legal guardian request|4|||
127935309|NCT00444457|460387423|FG001|After Infant Series|Parent or legal guardian request|11|||
127935310|NCT00444457|460387424|FG002|After Infant Series|Parent or legal guardian request|6|||
127935311|NCT00444457|460387425|FG003|After Infant Series|Parent or legal guardian request|3|||
127935312|NCT00444457|460387422|FG000|After Infant Series|Failed to return|7|||
127935313|NCT00444457|460387423|FG001|After Infant Series|Failed to return|6|||
127935314|NCT00444457|460387424|FG002|After Infant Series|Failed to return|5|||
127935315|NCT00444457|460387425|FG003|After Infant Series|Failed to return|1|||
127935316|NCT00444457|460387422|FG000|After Infant Series|Lost to Follow-up|5|||
127935317|NCT00444457|460387423|FG001|After Infant Series|Lost to Follow-up|5|||
127935318|NCT00444457|460387424|FG002|After Infant Series|Lost to Follow-up|5|||
127935319|NCT00444457|460387425|FG003|After Infant Series|Lost to Follow-up|2|||
127935320|NCT00444457|460387422|FG000|After Infant Series|Protocol Violation|2|||
127935321|NCT00444457|460387423|FG001|After Infant Series|Protocol Violation|4|||
127935322|NCT00444457|460387424|FG002|After Infant Series|Protocol Violation|2|||
127935323|NCT00444457|460387425|FG003|After Infant Series|Protocol Violation|2|||
127935324|NCT00444457|460387422|FG000|After Infant Series|Adverse Event|2|||
127935325|NCT00444457|460387423|FG001|After Infant Series|Adverse Event|2|||
127935326|NCT00444457|460387424|FG002|After Infant Series|Adverse Event|0|||
127935327|NCT00444457|460387425|FG003|After Infant Series|Adverse Event|0|||
127935328|NCT00444457|460387422|FG000|After Infant Series|Investigator request|0|||
127935329|NCT00444457|460387423|FG001|After Infant Series|Investigator request|0|||
127935330|NCT00444457|460387424|FG002|After Infant Series|Investigator request|0|||
127935331|NCT00444457|460387425|FG003|After Infant Series|Investigator request|1|||
127935332|NCT00444457|460387422|FG000|After Infant Series|Other|0|||
127935333|NCT00444457|460387423|FG001|After Infant Series|Other|1|||
127935334|NCT00444457|460387424|FG002|After Infant Series|Other|0|||
127935335|NCT00444457|460387425|FG003|After Infant Series|Other|0|||
127935336|NCT00444457|460387422|FG000|Toddler Dose|Lost to Follow-up|4|||
127935337|NCT00444457|460387423|FG001|Toddler Dose|Lost to Follow-up|1|||
127935338|NCT00444457|460387424|FG002|Toddler Dose|Lost to Follow-up|1|||
127935339|NCT00444457|460387425|FG003|Toddler Dose|Lost to Follow-up|3|||
127935340|NCT00444457|460387422|FG000|Toddler Dose|Failed to return|2|||
127935341|NCT00444457|460387423|FG001|Toddler Dose|Failed to return|2|||
127935342|NCT00444457|460387424|FG002|Toddler Dose|Failed to return|1|||
127935343|NCT00444457|460387425|FG003|Toddler Dose|Failed to return|3|||
127935344|NCT00444457|460387422|FG000|Toddler Dose|Parent or legal guardian request|0|||
127935345|NCT00444457|460387423|FG001|Toddler Dose|Parent or legal guardian request|3|||
127935346|NCT00444457|460387424|FG002|Toddler Dose|Parent or legal guardian request|2|||
127935347|NCT00444457|460387425|FG003|Toddler Dose|Parent or legal guardian request|1|||
127935348|NCT00444457|460387422|FG000|Toddler Dose|Protocol Violation|1|||
127935349|NCT00444457|460387423|FG001|Toddler Dose|Protocol Violation|0|||
127935350|NCT00444457|460387424|FG002|Toddler Dose|Protocol Violation|0|||
127935351|NCT00444457|460387425|FG003|Toddler Dose|Protocol Violation|1|||
127935352|NCT01121666|460387428|FG000|Overall Study|Protocol Violation|29|||
127935353|NCT01121666|460387429|FG001|Overall Study|Protocol Violation|10|||
127935354|NCT03176459|460387432|FG000|Overall Study|Lost to Follow-up|5|||
127935355|NCT03176459|460387433|FG001|Overall Study|Lost to Follow-up|7|||
127935356|NCT01602965|460387434|FG000|Overall Study|Lost to Follow-up|4|||
127935357|NCT01602965|460387435|FG001|Overall Study|Lost to Follow-up|2|||
127935358|NCT02283294|460387436|FG000|Overall Study|Lost to Follow-up|1|||
127935359|NCT02283294|460387437|FG001|Overall Study|Lost to Follow-up|1|||
127935360|NCT02283294|460387436|FG000|Overall Study|Withdrawal by Subject|1|||
127935361|NCT02283294|460387437|FG001|Overall Study|Withdrawal by Subject|6|||
127935362|NCT02283294|460387436|FG000|Overall Study|Protocol Violation|1|||
127935363|NCT02283294|460387437|FG001|Overall Study|Protocol Violation|0|||
127935364|NCT02283294|460387436|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
127935365|NCT02283294|460387437|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
127935366|NCT04062448|460390190|FG000|Overall Study|Lost to Follow-up|1|||
127935367|NCT04062448|460390190|FG000|Overall Study|Withdrawal by Subject|2|||
127935368|NCT05101486|460390191|FG000|Overall Study|Death|1|||
127935369|NCT05101486|460390192|FG001|Overall Study|Death|0|||
127935370|NCT05101486|460390193|FG002|Overall Study|Death|1|||
127935371|NCT05101486|460390191|FG000|Overall Study|Lost to Follow-up|12|||
127935372|NCT05101486|460390192|FG001|Overall Study|Lost to Follow-up|8|||
127935373|NCT05101486|460390193|FG002|Overall Study|Lost to Follow-up|17|||
127935374|NCT05101486|460390191|FG000|Overall Study|Physician Decision|1|||
127935375|NCT05101486|460390192|FG001|Overall Study|Physician Decision|0|||
127935376|NCT05101486|460390193|FG002|Overall Study|Physician Decision|0|||
127935377|NCT05101486|460390191|FG000|Overall Study|Protocol Violation|0|||
127935378|NCT05101486|460390192|FG001|Overall Study|Protocol Violation|0|||
127935379|NCT05101486|460390193|FG002|Overall Study|Protocol Violation|1|||
127935380|NCT05101486|460390191|FG000|Overall Study|Withdrawal by Subject|5|||
127935381|NCT05101486|460390192|FG001|Overall Study|Withdrawal by Subject|2|||
127935382|NCT05101486|460390193|FG002|Overall Study|Withdrawal by Subject|4|||
127935383|NCT05101486|460390191|FG000|Overall Study|Randomized but not vaccinated|1|||
127935384|NCT05101486|460390192|FG001|Overall Study|Randomized but not vaccinated|1|||
127935385|NCT05101486|460390193|FG002|Overall Study|Randomized but not vaccinated|1|||
127935386|NCT02788045|460390194|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
127935387|NCT02788045|460390195|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
127935388|NCT02788045|460390196|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
127935389|NCT02788045|460390194|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
127935390|NCT02788045|460390195|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
127935391|NCT02788045|460390196|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
127935392|NCT02788045|460390194|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
127935393|NCT02788045|460390195|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
127935394|NCT02788045|460390196|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
127935395|NCT02788045|460390194|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
127935396|NCT02788045|460390195|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
127935397|NCT02788045|460390196|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
127935398|NCT02788045|460390194|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
127935399|NCT02788045|460390195|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
127935400|NCT02788045|460390196|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
127935401|NCT02788045|460390194|FG000|Main Study (Up to Week 72)|Other|3|||
127935402|NCT02788045|460390195|FG001|Main Study (Up to Week 72)|Other|0|||
127935403|NCT02788045|460390196|FG002|Main Study (Up to Week 72)|Other|0|||
127935404|NCT02788045|460390194|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
127935405|NCT02788045|460390195|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
127935406|NCT02788045|460390196|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
127935407|NCT02788045|460390194|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
127935408|NCT02788045|460390195|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
127935409|NCT02788045|460390196|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
127935410|NCT02788045|460390194|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
127935411|NCT02788045|460390195|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
127935412|NCT02788045|460390196|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
127935413|NCT03047473|460390197|FG000|Overall Study|Lost to Follow-up|2|||
127935414|NCT02935686|460390198|FG000|Main Study (Week 0 up to Week 72)|Adverse Event|1|||
127935415|NCT02935686|460390199|FG001|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
127935416|NCT02935686|460390200|FG002|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
127935417|NCT02935686|460390201|FG003|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
127935418|NCT02935686|460390202|FG004|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
127935419|NCT02935686|460390198|FG000|Main Study (Week 0 up to Week 72)|Lost to Follow-up|4|||
127935420|NCT02935686|460390199|FG001|Main Study (Week 0 up to Week 72)|Lost to Follow-up|1|||
127935421|NCT02935686|460390200|FG002|Main Study (Week 0 up to Week 72)|Lost to Follow-up|2|||
127935422|NCT02935686|460390201|FG003|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
127935423|NCT02935686|460390202|FG004|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
127935424|NCT02935686|460390198|FG000|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
127935425|NCT02935686|460390199|FG001|Main Study (Week 0 up to Week 72)|Pregnancy|2|||
127935426|NCT02935686|460390200|FG002|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
127935427|NCT02935686|460390201|FG003|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
127935428|NCT02935686|460390202|FG004|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
127935429|NCT02935686|460390198|FG000|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|2|||
127935430|NCT02935686|460390199|FG001|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|9|||
127935431|NCT02935686|460390200|FG002|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
127935432|NCT02935686|460390201|FG003|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
127935433|NCT02935686|460390202|FG004|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
127935434|NCT02935686|460390198|FG000|Main Study (Week 0 up to Week 72)|Other|0|||
127935435|NCT02935686|460390199|FG001|Main Study (Week 0 up to Week 72)|Other|1|||
127935436|NCT02935686|460390200|FG002|Main Study (Week 0 up to Week 72)|Other|0|||
127935437|NCT02935686|460390201|FG003|Main Study (Week 0 up to Week 72)|Other|0|||
127935438|NCT02935686|460390202|FG004|Main Study (Week 0 up to Week 72)|Other|0|||
127935439|NCT02935686|460390198|FG000|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
127935440|NCT02935686|460390199|FG001|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|3|||
127935441|NCT02935686|460390200|FG002|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
127935442|NCT02935686|460390201|FG003|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
127935443|NCT02935686|460390202|FG004|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
127935444|NCT02935686|460390198|FG000|Long-term Extension (Week 72 - 216)|Lost to Follow-up|2|||
127935445|NCT02935686|460390199|FG001|Long-term Extension (Week 72 - 216)|Lost to Follow-up|8|||
127935446|NCT02935686|460390200|FG002|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
127935447|NCT02935686|460390201|FG003|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
127935448|NCT02935686|460390202|FG004|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
127935449|NCT02935686|460390198|FG000|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
127935450|NCT02935686|460390199|FG001|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|4|||
127935451|NCT02935686|460390200|FG002|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
127935452|NCT02935686|460390201|FG003|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
127935453|NCT02935686|460390202|FG004|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
127935454|NCT02935686|460390198|FG000|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
127935455|NCT02935686|460390199|FG001|Long-term Extension (Week 72 - 216)|Adverse Event|1|||
127935456|NCT02935686|460390200|FG002|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
127935457|NCT02935686|460390201|FG003|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
127935458|NCT02935686|460390202|FG004|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
127935459|NCT02935686|460390198|FG000|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
127935460|NCT02935686|460390199|FG001|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
127935461|NCT02935686|460390200|FG002|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
127935462|NCT02935686|460390201|FG003|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
127935463|NCT02935686|460390202|FG004|Late Boost Vaccination (Week 192 - 288)|Adverse Event|1|||
127935464|NCT02935686|460390198|FG000|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
127935465|NCT02935686|460390199|FG001|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
127935466|NCT02935686|460390200|FG002|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
127935467|NCT02935686|460390201|FG003|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|2|||
127935468|NCT02935686|460390202|FG004|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|1|||
127935469|NCT00541970|460390208|FG000|Month 7|Protocol Violation|9|||
127935470|NCT00541970|460390209|FG001|Month 7|Protocol Violation|13|||
127935471|NCT00541970|460390210|FG002|Month 7|Protocol Violation|11|||
127935472|NCT00541970|460390211|FG003|Month 7|Protocol Violation|5|||
127935473|NCT00541970|460390208|FG000|Month 12|Adverse Event|0|||
127935474|NCT00541970|460390209|FG001|Month 12|Adverse Event|1|||
127935475|NCT00541970|460390210|FG002|Month 12|Adverse Event|1|||
127935476|NCT00541970|460390211|FG003|Month 12|Adverse Event|1|||
127935477|NCT00541970|460390208|FG000|Month 12|Protocol Violation|12|||
127935478|NCT00541970|460390209|FG001|Month 12|Protocol Violation|21|||
127935479|NCT00541970|460390210|FG002|Month 12|Protocol Violation|20|||
127935480|NCT00541970|460390211|FG003|Month 12|Protocol Violation|15|||
127935481|NCT00541970|460390208|FG000|Month 18|Adverse Event|0|||
127935482|NCT00541970|460390209|FG001|Month 18|Adverse Event|1|||
127935483|NCT00541970|460390210|FG002|Month 18|Adverse Event|1|||
127935484|NCT00541970|460390211|FG003|Month 18|Adverse Event|1|||
127935485|NCT00541970|460390208|FG000|Month 18|Protocol Violation|14|||
127935486|NCT00541970|460390209|FG001|Month 18|Protocol Violation|23|||
127935487|NCT00541970|460390210|FG002|Month 18|Protocol Violation|24|||
127935488|NCT00541970|460390211|FG003|Month 18|Protocol Violation|16|||
127935489|NCT00541970|460390208|FG000|Month 24|Adverse Event|0|||
127935490|NCT00541970|460390209|FG001|Month 24|Adverse Event|1|||
127935491|NCT00541970|460390210|FG002|Month 24|Adverse Event|1|||
127935492|NCT00541970|460390211|FG003|Month 24|Adverse Event|1|||
127935493|NCT00541970|460390208|FG000|Month 24|Protocol Violation|29|||
127935494|NCT00541970|460390209|FG001|Month 24|Protocol Violation|31|||
127935495|NCT00541970|460390210|FG002|Month 24|Protocol Violation|31|||
127935496|NCT00541970|460390211|FG003|Month 24|Protocol Violation|21|||
127935497|NCT00541970|460390208|FG000|Month 36|Protocol Violation|61|||
127935498|NCT00541970|460390209|FG001|Month 36|Protocol Violation|66|||
127935499|NCT00541970|460390210|FG002|Month 36|Protocol Violation|66|||
127935500|NCT00541970|460390211|FG003|Month 36|Protocol Violation|60|||
127935501|NCT00541970|460390208|FG000|Month 48|Withdrawal by Subject|2|||
127935502|NCT00541970|460390209|FG001|Month 48|Withdrawal by Subject|4|||
127935503|NCT00541970|460390210|FG002|Month 48|Withdrawal by Subject|4|||
127935504|NCT00541970|460390211|FG003|Month 48|Withdrawal by Subject|2|||
127935505|NCT00541970|460390208|FG000|Month 48|Other|3|||
127935506|NCT00541970|460390209|FG001|Month 48|Other|1|||
127935507|NCT00541970|460390210|FG002|Month 48|Other|1|||
127935508|NCT00541970|460390211|FG003|Month 48|Other|0|||
127935509|NCT00541970|460390208|FG000|Month 48|Lost to Follow-up|66|||
127935510|NCT00541970|460390209|FG001|Month 48|Lost to Follow-up|68|||
127935511|NCT00541970|460390210|FG002|Month 48|Lost to Follow-up|68|||
127935512|NCT00541970|460390211|FG003|Month 48|Lost to Follow-up|73|||
127935513|NCT00541970|460390208|FG000|Month 60|Protocol Violation|78|||
127935514|NCT00541970|460390209|FG001|Month 60|Protocol Violation|77|||
127935515|NCT00541970|460390210|FG002|Month 60|Protocol Violation|82|||
127935516|NCT00541970|460390211|FG003|Month 60|Protocol Violation|72|||
127935517|NCT00321828|460390212|FG000|Overall Study|Ineligible|3|||
127935518|NCT00321828|460390212|FG000|Overall Study|No follow up data|1|||
127935519|NCT00062010|460390215|FG000|Overall Study|Ineligible|3|||
127935520|NCT02856880|460390216|FG000|Overall Study|Withdrawal of consent|1|||
127935521|NCT00573157|460390217|FG000|Overall Study|Adverse Event|3|||
127935522|NCT00573157|460390218|FG001|Overall Study|Adverse Event|1|||
127935523|NCT00573157|460390217|FG000|Overall Study|Other|1|||
127935524|NCT00573157|460390218|FG001|Overall Study|Other|1|||
127935525|NCT02944383|460390219|FG000|Overall Study|Lost to Follow-up|0|||
127935526|NCT02944383|460390220|FG001|Overall Study|Lost to Follow-up|0|||
127935527|NCT02944383|460390221|FG002|Overall Study|Lost to Follow-up|1|||
127935528|NCT02944383|460390219|FG000|Overall Study|Withdrawal by Subject|1|||
127935529|NCT02944383|460390220|FG001|Overall Study|Withdrawal by Subject|0|||
127935530|NCT02944383|460390221|FG002|Overall Study|Withdrawal by Subject|0|||
127935531|NCT01183221|460390224|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
127935532|NCT01183221|460390225|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
127935533|NCT00858143|460390231|FG000|Overall Study|Adverse Event|16|||
127935534|NCT00858143|460390231|FG000|Overall Study|Lack of Efficacy|4|||
127935535|NCT00858143|460390231|FG000|Overall Study|Death|7|||
127935536|NCT00858143|460390231|FG000|Overall Study|Other|23|||
127935537|NCT03853148|460390232|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
127935538|NCT03853148|460390233|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
127935539|NCT03853148|460390234|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
127935540|NCT03853148|460390235|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
127935541|NCT00852969|460390236|FG000|Overall Study|Adverse Event|0|||
127935542|NCT00852969|460390237|FG001|Overall Study|Adverse Event|1|||
127935543|NCT00852969|460390236|FG000|Overall Study|Lost to Follow-up|0|||
127935544|NCT00852969|460390237|FG001|Overall Study|Lost to Follow-up|1|||
127935545|NCT00658658|460390238|FG000|Overall Study|Withdrawal by Subject|0|||
127935546|NCT00658658|460390239|FG001|Overall Study|Withdrawal by Subject|1|||
127935547|NCT00658658|460390240|FG002|Overall Study|Withdrawal by Subject|0|||
127935548|NCT00658658|460390241|FG003|Overall Study|Withdrawal by Subject|0|||
127935549|NCT00658658|460390242|FG004|Overall Study|Withdrawal by Subject|0|||
127935550|NCT00658658|460390238|FG000|Overall Study|Death|4|||
127935551|NCT00658658|460390239|FG001|Overall Study|Death|0|||
127935552|NCT00658658|460390240|FG002|Overall Study|Death|0|||
127935553|NCT00658658|460390241|FG003|Overall Study|Death|1|||
127935554|NCT00658658|460390242|FG004|Overall Study|Death|1|||
127935555|NCT00658658|460390238|FG000|Overall Study|Disease Progression|0|||
127935556|NCT00658658|460390239|FG001|Overall Study|Disease Progression|1|||
127935557|NCT00658658|460390240|FG002|Overall Study|Disease Progression|0|||
127935558|NCT00658658|460390241|FG003|Overall Study|Disease Progression|1|||
127935559|NCT00658658|460390242|FG004|Overall Study|Disease Progression|3|||
127935560|NCT00658658|460390238|FG000|Overall Study|Protocol-specified Criteria|1|||
127935561|NCT00658658|460390239|FG001|Overall Study|Protocol-specified Criteria|0|||
127935562|NCT00658658|460390240|FG002|Overall Study|Protocol-specified Criteria|0|||
127935563|NCT00658658|460390241|FG003|Overall Study|Protocol-specified Criteria|0|||
127935564|NCT00658658|460390242|FG004|Overall Study|Protocol-specified Criteria|0|||
127935565|NCT00658658|460390238|FG000|Overall Study|Other|0|||
127935566|NCT00658658|460390239|FG001|Overall Study|Other|0|||
127935567|NCT00658658|460390240|FG002|Overall Study|Other|0|||
127935568|NCT00658658|460390241|FG003|Overall Study|Other|0|||
127935569|NCT00658658|460390242|FG004|Overall Study|Other|1|||
127935570|NCT02504671|460390245|FG000|Overall Study|Withdrawal by Subject|1|||
127935571|NCT02504671|460390246|FG001|Overall Study|Withdrawal by Subject|5|||
127935572|NCT02504671|460390247|FG002|Overall Study|Withdrawal by Subject|4|||
127935573|NCT02504671|460390248|FG003|Overall Study|Withdrawal by Subject|4|||
127935574|NCT02504671|460390249|FG004|Overall Study|Withdrawal by Subject|5|||
127935575|NCT02504671|460390250|FG005|Overall Study|Withdrawal by Subject|3|||
127935576|NCT02504671|460390245|FG000|Overall Study|Lack of Efficacy|1|||
127935577|NCT02504671|460390246|FG001|Overall Study|Lack of Efficacy|3|||
127935578|NCT02504671|460390247|FG002|Overall Study|Lack of Efficacy|1|||
127935579|NCT02504671|460390248|FG003|Overall Study|Lack of Efficacy|0|||
127935580|NCT02504671|460390249|FG004|Overall Study|Lack of Efficacy|4|||
127935581|NCT02504671|460390250|FG005|Overall Study|Lack of Efficacy|4|||
127935582|NCT02504671|460390245|FG000|Overall Study|Adverse Event|1|||
127935583|NCT02504671|460390246|FG001|Overall Study|Adverse Event|1|||
127935584|NCT02504671|460390247|FG002|Overall Study|Adverse Event|0|||
127935585|NCT02504671|460390248|FG003|Overall Study|Adverse Event|1|||
127935586|NCT02504671|460390249|FG004|Overall Study|Adverse Event|0|||
127935587|NCT02504671|460390250|FG005|Overall Study|Adverse Event|2|||
127935588|NCT02504671|460390245|FG000|Overall Study|Protocol Violation|2|||
127935589|NCT02504671|460390246|FG001|Overall Study|Protocol Violation|1|||
127935590|NCT02504671|460390247|FG002|Overall Study|Protocol Violation|0|||
127935591|NCT02504671|460390248|FG003|Overall Study|Protocol Violation|0|||
127935592|NCT02504671|460390249|FG004|Overall Study|Protocol Violation|0|||
127935593|NCT02504671|460390250|FG005|Overall Study|Protocol Violation|1|||
127935594|NCT02504671|460390245|FG000|Overall Study|Lost to Follow-up|0|||
127935595|NCT02504671|460390246|FG001|Overall Study|Lost to Follow-up|0|||
127935596|NCT02504671|460390247|FG002|Overall Study|Lost to Follow-up|2|||
127935597|NCT02504671|460390248|FG003|Overall Study|Lost to Follow-up|0|||
127935598|NCT02504671|460390249|FG004|Overall Study|Lost to Follow-up|0|||
127935599|NCT02504671|460390250|FG005|Overall Study|Lost to Follow-up|1|||
127935600|NCT02504671|460390245|FG000|Overall Study|Protocol defined stopping criteria|7|||
127935601|NCT02504671|460390246|FG001|Overall Study|Protocol defined stopping criteria|4|||
127935602|NCT02504671|460390247|FG002|Overall Study|Protocol defined stopping criteria|3|||
127935603|NCT02504671|460390248|FG003|Overall Study|Protocol defined stopping criteria|5|||
127935604|NCT02504671|460390249|FG004|Overall Study|Protocol defined stopping criteria|3|||
127935605|NCT02504671|460390250|FG005|Overall Study|Protocol defined stopping criteria|3|||
127935606|NCT04498403|460390251|FG000|Overall Study|Adverse Event|1|||
127935607|NCT04498403|460390252|FG001|Overall Study|Adverse Event|0|||
127935608|NCT04498403|460390251|FG000|Overall Study|Study Terminated By Sponsor|29|||
127935609|NCT04498403|460390252|FG001|Overall Study|Study Terminated By Sponsor|10|||
127935610|NCT00599521|460390253|FG000|Overall Study|Lack of Efficacy|4|||
127935611|NCT00599521|460390254|FG001|Overall Study|Lack of Efficacy|8|||
127935612|NCT00599521|460390253|FG000|Overall Study|Adverse Event|4|||
127935613|NCT00599521|460390254|FG001|Overall Study|Adverse Event|1|||
127935614|NCT00599521|460390253|FG000|Overall Study|Withdrawal by Subject|28|||
127935615|NCT00599521|460390254|FG001|Overall Study|Withdrawal by Subject|34|||
127935616|NCT00599521|460390253|FG000|Overall Study|Protocol Violation|1|||
127935617|NCT00599521|460390254|FG001|Overall Study|Protocol Violation|1|||
127935618|NCT00599521|460390253|FG000|Overall Study|Lost to Follow-up|23|||
127935619|NCT00599521|460390254|FG001|Overall Study|Lost to Follow-up|23|||
127935620|NCT00599521|460390253|FG000|Overall Study|Pregnancy|0|||
127935621|NCT00599521|460390254|FG001|Overall Study|Pregnancy|2|||
127935622|NCT01951885|460390256|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
127935623|NCT01951885|460390257|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
127935624|NCT01951885|460390256|FG000|Overall Study|Adverse Event|1|||
127935625|NCT01951885|460390257|FG001|Overall Study|Adverse Event|0|||
127935626|NCT01951885|460390256|FG000|Overall Study|Withdrawal by Subject|0|||
127935627|NCT01951885|460390257|FG001|Overall Study|Withdrawal by Subject|1|||
127935628|NCT01951885|460390256|FG000|Overall Study|ineligible due to a change in donor|0|||
127935629|NCT01951885|460390257|FG001|Overall Study|ineligible due to a change in donor|1|||
127935630|NCT01951885|460390256|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
127935631|NCT01951885|460390257|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
127935632|NCT01293539|460390258|FG000|Overall Study|Physician Decision|1|||
127935633|NCT00866658|460390259|FG000|Overall Study|Adverse Event|5|||
127935634|NCT00866658|460390260|FG001|Overall Study|Adverse Event|14|||
127935635|NCT00866658|460390259|FG000|Overall Study|Lack of Efficacy|2|||
127935636|NCT00866658|460390260|FG001|Overall Study|Lack of Efficacy|1|||
127935637|NCT00866658|460390259|FG000|Overall Study|Withdrawal by Subject|1|||
127935638|NCT00866658|460390260|FG001|Overall Study|Withdrawal by Subject|0|||
127935639|NCT00866658|460390259|FG000|Overall Study|Protocol Violation|1|||
127935640|NCT00866658|460390260|FG001|Overall Study|Protocol Violation|1|||
127935641|NCT00866658|460390259|FG000|Overall Study|Familial and Personal Reasons|4|||
127935642|NCT00866658|460390260|FG001|Overall Study|Familial and Personal Reasons|5|||
127935643|NCT00609518|460390261|FG000|Overall Study|Death from Study Disease|32|||
127935644|NCT00609518|460390262|FG001|Overall Study|Death from Study Disease|32|||
127935645|NCT00609518|460390261|FG000|Overall Study|Withdrawal by Subject|5|||
127935646|NCT00609518|460390262|FG001|Overall Study|Withdrawal by Subject|3|||
127935647|NCT00609518|460390261|FG000|Overall Study|Lost to Follow-up|3|||
127935648|NCT00609518|460390262|FG001|Overall Study|Lost to Follow-up|0|||
127935649|NCT00609518|460390261|FG000|Overall Study|Physician Decision|1|||
127935650|NCT00609518|460390262|FG001|Overall Study|Physician Decision|3|||
127935651|NCT00609518|460390261|FG000|Overall Study|Death from Adverse Event|2|||
127935652|NCT00609518|460390262|FG001|Overall Study|Death from Adverse Event|2|||
127935653|NCT01687478|460390263|FG000|Overall Study|Adverse Event|3|||
127935654|NCT01687478|460390264|FG001|Overall Study|Adverse Event|10|||
127935655|NCT01687478|460390263|FG000|Overall Study|Lost to Follow-up|1|||
127935656|NCT01687478|460390264|FG001|Overall Study|Lost to Follow-up|3|||
127935657|NCT01687478|460390263|FG000|Overall Study|Protocol Violation|0|||
127935658|NCT01687478|460390264|FG001|Overall Study|Protocol Violation|2|||
127935659|NCT01687478|460390263|FG000|Overall Study|Withdrawal by Subject|21|||
127935660|NCT01687478|460390264|FG001|Overall Study|Withdrawal by Subject|19|||
127935661|NCT01687478|460390263|FG000|Overall Study|Physician Decision|1|||
127935662|NCT01687478|460390264|FG001|Overall Study|Physician Decision|3|||
127935663|NCT01687478|460390263|FG000|Overall Study|Entry Criteria Not Met|6|||
127935664|NCT01687478|460390264|FG001|Overall Study|Entry Criteria Not Met|2|||
127935665|NCT00292188|460390268|FG000|Single-Blind|Adverse Event|14|||
127935666|NCT00292188|460390269|FG001|Single-Blind|Adverse Event|0|||
127935667|NCT00292188|460390270|FG002|Single-Blind|Adverse Event|0|||
127935668|NCT00292188|460390268|FG000|Single-Blind|Lack of Efficacy|2|||
127935669|NCT00292188|460390269|FG001|Single-Blind|Lack of Efficacy|0|||
127935670|NCT00292188|460390270|FG002|Single-Blind|Lack of Efficacy|0|||
127935671|NCT00292188|460390268|FG000|Single-Blind|Laboratory Abnormality|5|||
127935672|NCT00292188|460390269|FG001|Single-Blind|Laboratory Abnormality|0|||
127935673|NCT00292188|460390270|FG002|Single-Blind|Laboratory Abnormality|0|||
127935674|NCT00292188|460390268|FG000|Single-Blind|Lost to Follow-up|3|||
127935675|NCT00292188|460390269|FG001|Single-Blind|Lost to Follow-up|0|||
127935676|NCT00292188|460390270|FG002|Single-Blind|Lost to Follow-up|0|||
127935677|NCT00292188|460390268|FG000|Single-Blind|Other|77|||
127935678|NCT00292188|460390269|FG001|Single-Blind|Other|0|||
127935679|NCT00292188|460390270|FG002|Single-Blind|Other|0|||
127935680|NCT00292188|460390268|FG000|Single-Blind|Withdrawal by Subject|12|||
127935681|NCT00292188|460390269|FG001|Single-Blind|Withdrawal by Subject|0|||
127935682|NCT00292188|460390270|FG002|Single-Blind|Withdrawal by Subject|0|||
127935683|NCT00292188|460390268|FG000|Single-Blind|Did not receive treatment|1|||
127935684|NCT00292188|460390269|FG001|Single-Blind|Did not receive treatment|0|||
127935685|NCT00292188|460390270|FG002|Single-Blind|Did not receive treatment|0|||
127935686|NCT00292188|460390268|FG000|Double-Blind|Adverse Event|0|||
127935687|NCT00292188|460390269|FG001|Double-Blind|Adverse Event|25|||
127935688|NCT00292188|460390270|FG002|Double-Blind|Adverse Event|9|||
127935689|NCT00292188|460390268|FG000|Double-Blind|Lack of Efficacy|0|||
127935690|NCT00292188|460390269|FG001|Double-Blind|Lack of Efficacy|2|||
127935691|NCT00292188|460390270|FG002|Double-Blind|Lack of Efficacy|12|||
127935692|NCT00292188|460390268|FG000|Double-Blind|Lost to Follow-up|0|||
127935693|NCT00292188|460390269|FG001|Double-Blind|Lost to Follow-up|1|||
127935694|NCT00292188|460390270|FG002|Double-Blind|Lost to Follow-up|0|||
127935695|NCT00292188|460390268|FG000|Double-Blind|Other|0|||
127935696|NCT00292188|460390269|FG001|Double-Blind|Other|3|||
127935697|NCT00292188|460390270|FG002|Double-Blind|Other|4|||
127935698|NCT00292188|460390268|FG000|Double-Blind|Withdrawal by Subject|0|||
127935699|NCT00292188|460390269|FG001|Double-Blind|Withdrawal by Subject|0|||
127935700|NCT00292188|460390270|FG002|Double-Blind|Withdrawal by Subject|3|||
127935701|NCT00292188|460390268|FG000|Double-Blind|Laboratory Abnormality|0|||
127935702|NCT00292188|460390269|FG001|Double-Blind|Laboratory Abnormality|0|||
127935703|NCT00292188|460390270|FG002|Double-Blind|Laboratory Abnormality|1|||
127935704|NCT00824616|460390271|FG000|Overall Study|Adverse Event|2|||
127935705|NCT00824616|460390272|FG001|Overall Study|Adverse Event|1|||
127935706|NCT00824616|460390271|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
127935707|NCT00824616|460390272|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
127935708|NCT00824616|460390271|FG000|Overall Study|Hyperglycemia|1|||
127935709|NCT00824616|460390272|FG001|Overall Study|Hyperglycemia|1|||
127935710|NCT00824616|460390271|FG000|Overall Study|Lack of Efficacy|2|||
127935711|NCT00824616|460390272|FG001|Overall Study|Lack of Efficacy|1|||
127935712|NCT00824616|460390271|FG000|Overall Study|Lost to Follow-up|0|||
127935713|NCT00824616|460390272|FG001|Overall Study|Lost to Follow-up|1|||
127935714|NCT00824616|460390271|FG000|Overall Study|Withdrawal by Subject|1|||
127935715|NCT00824616|460390272|FG001|Overall Study|Withdrawal by Subject|1|||
127935716|NCT04322149|460390273|FG000|Overall Study|Adverse Event|1|||
127935717|NCT04322149|460390274|FG001|Overall Study|Adverse Event|1|||
127935718|NCT04322149|460390275|FG002|Overall Study|Adverse Event|0|||
127935719|NCT04322149|460390276|FG003|Overall Study|Adverse Event|0|||
127935720|NCT04322149|460390273|FG000|Overall Study|Withdrawal by Subject|0|||
127935721|NCT04322149|460390274|FG001|Overall Study|Withdrawal by Subject|0|||
127935722|NCT04322149|460390275|FG002|Overall Study|Withdrawal by Subject|0|||
127935723|NCT04322149|460390276|FG003|Overall Study|Withdrawal by Subject|2|||
127935724|NCT04322149|460390273|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
127935725|NCT04322149|460390274|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
127935726|NCT04322149|460390275|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
127935727|NCT04322149|460390276|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
127935728|NCT01700049|460390279|FG000|Overall Study|Withdrawal by Subject|1|||
127935729|NCT01206101|460390280|FG000|Overall Study|Adverse Event|1|||
127935730|NCT01206101|460390281|FG001|Overall Study|Adverse Event|0|||
127935731|NCT01206101|460390280|FG000|Overall Study|Physician Decision|0|||
127935732|NCT01206101|460390281|FG001|Overall Study|Physician Decision|1|||
127935733|NCT01206101|460390280|FG000|Overall Study|Unclassified|1|||
127935734|NCT01206101|460390281|FG001|Overall Study|Unclassified|0|||
127935735|NCT01248013|460390282|FG000|Overall Study|Withdrawal by Subject|14|||
127935736|NCT01859130|460390283|FG000|Overall Study|Death|4|||
127935737|NCT01859130|460390283|FG000|Overall Study|Lost to Follow-up|16|||
127935738|NCT01859130|460390283|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
127935739|NCT01859130|460390283|FG000|Overall Study|Physician Decision|6|||
127935740|NCT01859130|460390283|FG000|Overall Study|Withdrawal by Subject|17|||
127935741|NCT01859130|460390283|FG000|Overall Study|Adverse Event|11|||
127935742|NCT02746471|460390287|FG000|Overall Study|Death|43|||
127935743|NCT02746471|460390287|FG000|Overall Study|Exited before 36 months|1119|||
127935744|NCT04594707|460390291|FG000|Overall Study|Adverse Event|0|||
127935745|NCT04594707|460390292|FG001|Overall Study|Adverse Event|0|||
127935746|NCT04594707|460390293|FG002|Overall Study|Adverse Event|1|||
127935747|NCT04594707|460390291|FG000|Overall Study|Death|0|||
127935748|NCT04594707|460390292|FG001|Overall Study|Death|2|||
127935749|NCT04594707|460390293|FG002|Overall Study|Death|2|||
127935750|NCT04594707|460390291|FG000|Overall Study|Lung Transplant|0|||
127935751|NCT04594707|460390292|FG001|Overall Study|Lung Transplant|0|||
127935752|NCT04594707|460390293|FG002|Overall Study|Lung Transplant|1|||
127935753|NCT04594707|460390291|FG000|Overall Study|Grade 4 infusion related reaction (IRR)|1|||
127935754|NCT04594707|460390292|FG001|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
127935755|NCT04594707|460390293|FG002|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
127935756|NCT04594707|460390291|FG000|Overall Study|Study Terminated By Sponsor|19|||
127935757|NCT04594707|460390292|FG001|Overall Study|Study Terminated By Sponsor|47|||
127935758|NCT04594707|460390293|FG002|Overall Study|Study Terminated By Sponsor|41|||
127935759|NCT04594707|460390291|FG000|Overall Study|Withdrawal by Subject|1|||
127935760|NCT04594707|460390292|FG001|Overall Study|Withdrawal by Subject|0|||
127935761|NCT04594707|460390293|FG002|Overall Study|Withdrawal by Subject|2|||
127935762|NCT01593696|460390294|FG000|Dose Escalation|Progressive Disease|2|||
127935763|NCT01593696|460390295|FG001|Dose Escalation|Progressive Disease|0|||
127935764|NCT01593696|460390296|FG002|Dose Escalation|Progressive Disease|0|||
127935765|NCT01593696|460390297|FG003|Dose Escalation|Progressive Disease|0|||
127935766|NCT01593696|460390294|FG000|Dose Expansion|Fungal infection|0|||
127935767|NCT01593696|460390295|FG001|Dose Expansion|Fungal infection|0|||
127935768|NCT01593696|460390296|FG002|Dose Expansion|Fungal infection|1|||
127935769|NCT01593696|460390297|FG003|Dose Expansion|Fungal infection|0|||
127935770|NCT01936623|460390298|FG000|Overall Study|Lost to Follow-up|0|||
127935771|NCT01936623|460390299|FG001|Overall Study|Lost to Follow-up|5|||
127935772|NCT03167723|460390300|FG000|Overall Study|Protocol Violation|4|||
127935773|NCT03167723|460390301|FG001|Overall Study|Protocol Violation|6|||
127935774|NCT00928707|460390307|FG000|Overall Study|Protocol Violation|1|||
127935775|NCT00928707|460390308|FG001|Overall Study|Protocol Violation|0|||
127935776|NCT00132028|460390309|FG000|Overall Study|Adverse Event|7|||
127935777|NCT00132028|460390309|FG000|Overall Study|Death|2|||
127935778|NCT00132028|460390309|FG000|Overall Study|Lack of Efficacy|11|||
127935779|NCT00132028|460390309|FG000|Overall Study|Withdrawal by Subject|2|||
127935780|NCT00132028|460390309|FG000|Overall Study|not eligible|2|||
127935781|NCT00132028|460390309|FG000|Overall Study|Physician Decision|3|||
127935782|NCT04647721|460390310|FG000|Overall Study|Withdrawal by Subject|0|||
127935783|NCT04647721|460390311|FG001|Overall Study|Withdrawal by Subject|2|||
127935784|NCT04647721|460390310|FG000|Overall Study|Lost to Follow-up|2|||
127935785|NCT04647721|460390311|FG001|Overall Study|Lost to Follow-up|0|||
127935786|NCT05070546|460390312|FG000|Overall Study|Death|0|||
127935787|NCT05070546|460390313|FG001|Overall Study|Death|0|||
127935788|NCT05070546|460390314|FG002|Overall Study|Death|0|||
127935789|NCT05070546|460390315|FG003|Overall Study|Death|0|||
127935790|NCT05070546|460390316|FG004|Overall Study|Death|0|||
127935791|NCT05070546|460390317|FG005|Overall Study|Death|1|||
127935792|NCT05070546|460390312|FG000|Overall Study|Lost to Follow-up|8|||
127935793|NCT05070546|460390313|FG001|Overall Study|Lost to Follow-up|2|||
127935794|NCT05070546|460390314|FG002|Overall Study|Lost to Follow-up|7|||
127935795|NCT05070546|460390315|FG003|Overall Study|Lost to Follow-up|1|||
127935796|NCT05070546|460390316|FG004|Overall Study|Lost to Follow-up|2|||
127935797|NCT05070546|460390317|FG005|Overall Study|Lost to Follow-up|0|||
127935798|NCT05070546|460390312|FG000|Overall Study|Withdrawal by Subject|1|||
127935799|NCT05070546|460390313|FG001|Overall Study|Withdrawal by Subject|1|||
127935800|NCT05070546|460390314|FG002|Overall Study|Withdrawal by Subject|3|||
127935801|NCT05070546|460390315|FG003|Overall Study|Withdrawal by Subject|0|||
127935802|NCT05070546|460390316|FG004|Overall Study|Withdrawal by Subject|0|||
127935803|NCT05070546|460390317|FG005|Overall Study|Withdrawal by Subject|0|||
127935804|NCT05070546|460390312|FG000|Overall Study|Other|0|||
127935805|NCT05070546|460390313|FG001|Overall Study|Other|0|||
127935806|NCT05070546|460390314|FG002|Overall Study|Other|0|||
127935807|NCT05070546|460390315|FG003|Overall Study|Other|0|||
127935808|NCT05070546|460390316|FG004|Overall Study|Other|3|||
127935809|NCT05070546|460390317|FG005|Overall Study|Other|0|||
127935810|NCT05070546|460390312|FG000|Overall Study|Randomized but not vaccinated|1|||
127935811|NCT05070546|460390313|FG001|Overall Study|Randomized but not vaccinated|0|||
127935812|NCT05070546|460390314|FG002|Overall Study|Randomized but not vaccinated|1|||
127935813|NCT05070546|460390315|FG003|Overall Study|Randomized but not vaccinated|1|||
127935814|NCT05070546|460390316|FG004|Overall Study|Randomized but not vaccinated|3|||
127935815|NCT05070546|460390317|FG005|Overall Study|Randomized but not vaccinated|0|||
127935816|NCT00816361|460390322|FG000|Overall Study|Withdrawal by Subject|0|||
127935817|NCT00816361|460390323|FG001|Overall Study|Withdrawal by Subject|0|||
127935818|NCT00816361|460390324|FG002|Overall Study|Withdrawal by Subject|0|||
127935819|NCT00816361|460390325|FG003|Overall Study|Withdrawal by Subject|0|||
127935820|NCT00816361|460390326|FG004|Overall Study|Withdrawal by Subject|1|||
127935821|NCT00816361|460390327|FG005|Overall Study|Withdrawal by Subject|2|||
127935822|NCT00816361|460390328|FG006|Overall Study|Withdrawal by Subject|0|||
127935823|NCT00816361|460390329|FG007|Overall Study|Withdrawal by Subject|2|||
127935824|NCT00816361|460390330|FG008|Overall Study|Withdrawal by Subject|1|||
127935825|NCT00816361|460390322|FG000|Overall Study|Death|4|||
127935826|NCT00816361|460390323|FG001|Overall Study|Death|3|||
127935827|NCT00816361|460390324|FG002|Overall Study|Death|3|||
127935828|NCT00816361|460390325|FG003|Overall Study|Death|3|||
127935829|NCT00816361|460390326|FG004|Overall Study|Death|1|||
127935830|NCT00816361|460390327|FG005|Overall Study|Death|1|||
127935831|NCT00816361|460390328|FG006|Overall Study|Death|3|||
127935832|NCT00816361|460390329|FG007|Overall Study|Death|7|||
127935833|NCT00816361|460390330|FG008|Overall Study|Death|8|||
127935834|NCT00816361|460390322|FG000|Overall Study|Other|0|||
127935835|NCT00816361|460390323|FG001|Overall Study|Other|0|||
127935836|NCT00816361|460390324|FG002|Overall Study|Other|0|||
127935837|NCT00816361|460390325|FG003|Overall Study|Other|0|||
127935838|NCT00816361|460390326|FG004|Overall Study|Other|0|||
127935839|NCT00816361|460390327|FG005|Overall Study|Other|0|||
127935840|NCT00816361|460390328|FG006|Overall Study|Other|0|||
127935841|NCT00816361|460390329|FG007|Overall Study|Other|0|||
127935842|NCT00816361|460390330|FG008|Overall Study|Other|1|||
127935843|NCT00546572|460390332|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
127935844|NCT00546572|460390333|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
127935845|NCT00546572|460390332|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
127935846|NCT00546572|460390333|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
127935847|NCT00546572|460390332|FG000|Vax 1 / Year 0|Protocol Violation|3|||
127935848|NCT00546572|460390333|FG001|Vax 1 / Year 0|Protocol Violation|4|||
127935849|NCT00546572|460390332|FG000|Vax 1 / Year 0|Death|2|||
127935850|NCT00546572|460390333|FG001|Vax 1 / Year 0|Death|2|||
127935851|NCT00546572|460390332|FG000|Vax 1 / Year 0|Adverse Event|0|||
127935852|NCT00546572|460390333|FG001|Vax 1 / Year 0|Adverse Event|1|||
127935853|NCT00546572|460390332|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
127935854|NCT00546572|460390333|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
127935855|NCT00546572|460390332|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
127935856|NCT00546572|460390333|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
127935857|NCT00546572|460390332|FG000|Vax 2 / Year 1|Other|1|||
127935858|NCT00546572|460390333|FG001|Vax 2 / Year 1|Other|1|||
127935859|NCT00546572|460390332|FG000|Vax 2 / Year 1|Adverse Event|1|||
127935860|NCT00546572|460390333|FG001|Vax 2 / Year 1|Adverse Event|0|||
127935861|NCT00546572|460390332|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
127935862|NCT00546572|460390333|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
127935863|NCT01355159|460390334|FG000|Overall Study|Withdrew consent|39|||
127935864|NCT01355159|460390335|FG001|Overall Study|Withdrew consent|47|||
127935865|NCT01355159|460390334|FG000|Overall Study|No primary outcome data|17|||
127935866|NCT01355159|460390335|FG001|Overall Study|No primary outcome data|11|||
127935867|NCT01355159|460390334|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
127935868|NCT01355159|460390335|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
127935869|NCT01355159|460390334|FG000|Overall Study|Early intrauterine fetal death|6|||
127935870|NCT01355159|460390335|FG001|Overall Study|Early intrauterine fetal death|6|||
127935871|NCT04700280|460390336|FG000|Overall Study|Adverse Event|4|||
127935872|NCT04700280|460390337|FG001|Overall Study|Adverse Event|0|||
127935873|NCT04700280|460390336|FG000|Overall Study|Lack of Efficacy|1|||
127935874|NCT04700280|460390337|FG001|Overall Study|Lack of Efficacy|0|||
127935875|NCT04700280|460390336|FG000|Overall Study|Study terminated by sponsor|5|||
127935876|NCT04700280|460390337|FG001|Overall Study|Study terminated by sponsor|3|||
127935877|NCT04700280|460390336|FG000|Overall Study|Other than specified|1|||
127935878|NCT04700280|460390337|FG001|Overall Study|Other than specified|0|||
127935879|NCT00741936|460390342|FG000|Overall Study|Lost to Follow-up|1|||
127935880|NCT00741936|460390343|FG001|Overall Study|Lost to Follow-up|1|||
127935881|NCT00741936|460390342|FG000|Overall Study|Adverse Event|3|||
127935882|NCT00741936|460390343|FG001|Overall Study|Adverse Event|4|||
127935883|NCT00741936|460390342|FG000|Overall Study|Pregnancy|0|||
127935884|NCT00741936|460390343|FG001|Overall Study|Pregnancy|1|||
127935885|NCT00741936|460390342|FG000|Overall Study|Protocol Violation|2|||
127935886|NCT00741936|460390343|FG001|Overall Study|Protocol Violation|0|||
127935887|NCT00741936|460390342|FG000|Overall Study|Lack of Efficacy|0|||
127935888|NCT00741936|460390343|FG001|Overall Study|Lack of Efficacy|2|||
127935889|NCT00741936|460390342|FG000|Overall Study|Low compliance|3|||
127935890|NCT00741936|460390343|FG001|Overall Study|Low compliance|0|||
127935891|NCT01408628|460390344|FG000|Consented|Withdrawal by Subject|12|||
127935892|NCT01408628|460390344|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
127935893|NCT01408628|460390344|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
127935894|NCT01408628|460390344|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
127935895|NCT01941940|460390345|FG000|Overall Study|Adverse Event|11|||
127935896|NCT01941940|460390345|FG000|Overall Study|Lost to Follow-up|2|||
127935897|NCT01941940|460390345|FG000|Overall Study|Physician Decision|2|||
127935898|NCT01941940|460390345|FG000|Overall Study|Withdrawal by Subject|15|||
127935899|NCT01941940|460390345|FG000|Overall Study|Death|1|||
127935900|NCT01941940|460390345|FG000|Overall Study|Other|1|||
127935901|NCT01941940|460390345|FG000|Overall Study|Other|1|||
127935902|NCT00750308|460390346|FG000|First Treatment|Adverse Event|0|||
127935903|NCT00750308|460390347|FG001|First Treatment|Adverse Event|1|||
127935904|NCT00750308|460390348|FG002|First Treatment|Adverse Event|0|||
127935905|NCT00750308|460390349|FG003|First Treatment|Adverse Event|0|||
127935906|NCT00750308|460390350|FG004|First Treatment|Adverse Event|0|||
127935907|NCT00750308|460390351|FG005|First Treatment|Adverse Event|0|||
127935908|NCT00750308|460390352|FG006|First Treatment|Adverse Event|0|||
127935909|NCT00750308|460390353|FG007|First Treatment|Adverse Event|0|||
127935910|NCT00750308|460390354|FG008|First Treatment|Adverse Event|0|||
127935911|NCT00750308|460390355|FG009|First Treatment|Adverse Event|0|||
127935912|NCT00750308|460390356|FG010|First Treatment|Adverse Event|1|||
127935913|NCT00750308|460390357|FG011|First Treatment|Adverse Event|1|||
127935914|NCT00750308|460390346|FG000|First Treatment|Withdrawal by Subject|0|||
127935915|NCT00750308|460390347|FG001|First Treatment|Withdrawal by Subject|0|||
127935916|NCT00750308|460390348|FG002|First Treatment|Withdrawal by Subject|0|||
127935917|NCT00750308|460390349|FG003|First Treatment|Withdrawal by Subject|1|||
127935918|NCT00750308|460390350|FG004|First Treatment|Withdrawal by Subject|0|||
127935919|NCT00750308|460390351|FG005|First Treatment|Withdrawal by Subject|0|||
127935920|NCT00750308|460390352|FG006|First Treatment|Withdrawal by Subject|0|||
127935921|NCT00750308|460390353|FG007|First Treatment|Withdrawal by Subject|1|||
127935922|NCT00750308|460390354|FG008|First Treatment|Withdrawal by Subject|0|||
127935923|NCT00750308|460390355|FG009|First Treatment|Withdrawal by Subject|0|||
127935924|NCT00750308|460390356|FG010|First Treatment|Withdrawal by Subject|0|||
127935925|NCT00750308|460390357|FG011|First Treatment|Withdrawal by Subject|0|||
127935926|NCT00750308|460390346|FG000|Second Treatment|Adverse Event|0|||
127935927|NCT00750308|460390347|FG001|Second Treatment|Adverse Event|0|||
127935928|NCT00750308|460390348|FG002|Second Treatment|Adverse Event|0|||
127935929|NCT00750308|460390349|FG003|Second Treatment|Adverse Event|0|||
127935930|NCT00750308|460390350|FG004|Second Treatment|Adverse Event|0|||
127935931|NCT00750308|460390351|FG005|Second Treatment|Adverse Event|1|||
127935932|NCT00750308|460390352|FG006|Second Treatment|Adverse Event|0|||
127935933|NCT00750308|460390353|FG007|Second Treatment|Adverse Event|0|||
127935934|NCT00750308|460390354|FG008|Second Treatment|Adverse Event|1|||
127935935|NCT00750308|460390355|FG009|Second Treatment|Adverse Event|0|||
127935936|NCT00750308|460390356|FG010|Second Treatment|Adverse Event|0|||
127935937|NCT00750308|460390357|FG011|Second Treatment|Adverse Event|0|||
127935938|NCT00750308|460390346|FG000|Second Treatment|Withdrawal by Subject|0|||
127935939|NCT00750308|460390347|FG001|Second Treatment|Withdrawal by Subject|0|||
127935940|NCT00750308|460390348|FG002|Second Treatment|Withdrawal by Subject|0|||
127935941|NCT00750308|460390349|FG003|Second Treatment|Withdrawal by Subject|0|||
127935942|NCT00750308|460390350|FG004|Second Treatment|Withdrawal by Subject|1|||
127935943|NCT00750308|460390351|FG005|Second Treatment|Withdrawal by Subject|0|||
127935944|NCT00750308|460390352|FG006|Second Treatment|Withdrawal by Subject|0|||
127935945|NCT00750308|460390353|FG007|Second Treatment|Withdrawal by Subject|0|||
127935946|NCT00750308|460390354|FG008|Second Treatment|Withdrawal by Subject|0|||
127935947|NCT00750308|460390355|FG009|Second Treatment|Withdrawal by Subject|0|||
127935948|NCT00750308|460390356|FG010|Second Treatment|Withdrawal by Subject|0|||
127935949|NCT00750308|460390357|FG011|Second Treatment|Withdrawal by Subject|0|||
127935950|NCT00750308|460390346|FG000|Third Treatment|Withdrawal by Subject|0|||
127935951|NCT00750308|460390347|FG001|Third Treatment|Withdrawal by Subject|1|||
127935952|NCT00750308|460390348|FG002|Third Treatment|Withdrawal by Subject|0|||
127935953|NCT00750308|460390349|FG003|Third Treatment|Withdrawal by Subject|0|||
127935954|NCT00750308|460390350|FG004|Third Treatment|Withdrawal by Subject|0|||
127935955|NCT00750308|460390351|FG005|Third Treatment|Withdrawal by Subject|0|||
127935956|NCT00750308|460390352|FG006|Third Treatment|Withdrawal by Subject|0|||
127935957|NCT00750308|460390353|FG007|Third Treatment|Withdrawal by Subject|0|||
127935958|NCT00750308|460390354|FG008|Third Treatment|Withdrawal by Subject|0|||
127935959|NCT00750308|460390355|FG009|Third Treatment|Withdrawal by Subject|0|||
127935960|NCT00750308|460390356|FG010|Third Treatment|Withdrawal by Subject|0|||
127935961|NCT00750308|460390357|FG011|Third Treatment|Withdrawal by Subject|0|||
127935962|NCT00513682|460390358|FG000|Washout Phase|Adverse Event|2|||
127935963|NCT02450526|460390359|FG000|DB Period (Cycle 1)|Adverse Event|0|||
127935964|NCT02450526|460390360|FG001|DB Period (Cycle 1)|Adverse Event|0|||
127935965|NCT02450526|460390361|FG002|DB Period (Cycle 1)|Adverse Event|2|||
127935966|NCT02450526|460390362|FG003|DB Period (Cycle 1)|Adverse Event|0|||
127935967|NCT02450526|460390363|FG004|DB Period (Cycle 1)|Adverse Event|0|||
127935968|NCT02450526|460390359|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
127935969|NCT02450526|460390360|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
127935970|NCT02450526|460390361|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
127935971|NCT02450526|460390362|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
127935972|NCT02450526|460390363|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
127935973|NCT02450526|460390359|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
127935974|NCT02450526|460390360|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
127935975|NCT02450526|460390361|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
127935976|NCT02450526|460390362|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
127935977|NCT02450526|460390363|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
127935978|NCT02450526|460390359|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
127935979|NCT02450526|460390360|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
127935980|NCT02450526|460390361|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
127935981|NCT02450526|460390362|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
127935982|NCT02450526|460390363|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
127935983|NCT02450526|460390359|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
127935984|NCT02450526|460390360|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
127935985|NCT02450526|460390361|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
127935986|NCT02450526|460390362|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
127935987|NCT02450526|460390363|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
127935988|NCT02450526|460390359|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
127935989|NCT02450526|460390360|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
127935990|NCT02450526|460390361|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
127935991|NCT02450526|460390362|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
127935992|NCT02450526|460390363|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
127935993|NCT02450526|460390359|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
127935994|NCT02450526|460390360|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
127935995|NCT02450526|460390361|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
127935996|NCT02450526|460390362|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
127935997|NCT02450526|460390363|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
127935998|NCT02450526|460390359|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
127935999|NCT02450526|460390360|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
127936000|NCT02450526|460390361|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
127936001|NCT02450526|460390362|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
127936002|NCT02450526|460390363|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
127936003|NCT03212521|460390364|FG000|Overall Study|Adverse Event|1|||
127936004|NCT03212521|460390364|FG000|Overall Study|Lost to Follow-up|4|||
127936005|NCT03212521|460390364|FG000|Overall Study|Withdrawal by Subject|1|||
127936006|NCT03212521|460390364|FG000|Overall Study|Other|1|||
127936007|NCT01970865|460390365|FG000|Overall Study|Death|3|||
127936008|NCT01970865|460390366|FG001|Overall Study|Death|2|||
127936009|NCT01970865|460390367|FG002|Overall Study|Death|3|||
127936010|NCT01970865|460390368|FG003|Overall Study|Death|6|||
127936011|NCT01970865|460390369|FG004|Overall Study|Death|9|||
127936012|NCT01970865|460390370|FG005|Overall Study|Death|3|||
127936013|NCT01970865|460390371|FG006|Overall Study|Death|2|||
127936014|NCT01970865|460390372|FG007|Overall Study|Death|3|||
127936015|NCT01970865|460390373|FG008|Overall Study|Death|2|||
127936016|NCT01970865|460390374|FG009|Overall Study|Death|2|||
127936017|NCT01970865|460390375|FG010|Overall Study|Death|8|||
127936018|NCT01970865|460390376|FG011|Overall Study|Death|13|||
127936019|NCT01970865|460390377|FG012|Overall Study|Death|25|||
127936020|NCT01970865|460390378|FG013|Overall Study|Death|46|||
127936021|NCT01970865|460390379|FG014|Overall Study|Death|37|||
127936022|NCT01970865|460390380|FG015|Overall Study|Death|22|||
127936023|NCT01970865|460390381|FG016|Overall Study|Death|1|||
127936024|NCT01970865|460390382|FG017|Overall Study|Death|17|||
127936025|NCT01970865|460390365|FG000|Overall Study|Lost to Follow-up|0|||
127936026|NCT01970865|460390366|FG001|Overall Study|Lost to Follow-up|0|||
127936027|NCT01970865|460390367|FG002|Overall Study|Lost to Follow-up|0|||
127936028|NCT01970865|460390368|FG003|Overall Study|Lost to Follow-up|1|||
127936029|NCT01970865|460390369|FG004|Overall Study|Lost to Follow-up|1|||
127936030|NCT01970865|460390370|FG005|Overall Study|Lost to Follow-up|0|||
127936031|NCT01970865|460390371|FG006|Overall Study|Lost to Follow-up|0|||
127936032|NCT01970865|460390372|FG007|Overall Study|Lost to Follow-up|0|||
127936033|NCT01970865|460390373|FG008|Overall Study|Lost to Follow-up|0|||
127936034|NCT01970865|460390374|FG009|Overall Study|Lost to Follow-up|0|||
127936035|NCT01970865|460390375|FG010|Overall Study|Lost to Follow-up|1|||
127936036|NCT01970865|460390376|FG011|Overall Study|Lost to Follow-up|0|||
127936037|NCT01970865|460390377|FG012|Overall Study|Lost to Follow-up|2|||
127936038|NCT01970865|460390378|FG013|Overall Study|Lost to Follow-up|0|||
127936039|NCT01970865|460390379|FG014|Overall Study|Lost to Follow-up|1|||
127936040|NCT01970865|460390380|FG015|Overall Study|Lost to Follow-up|4|||
127936041|NCT01970865|460390381|FG016|Overall Study|Lost to Follow-up|0|||
127936042|NCT01970865|460390382|FG017|Overall Study|Lost to Follow-up|1|||
127936043|NCT01970865|460390365|FG000|Overall Study|Other|0|||
127936044|NCT01970865|460390366|FG001|Overall Study|Other|1|||
127936045|NCT01970865|460390367|FG002|Overall Study|Other|0|||
127936046|NCT01970865|460390368|FG003|Overall Study|Other|1|||
127936047|NCT01970865|460390369|FG004|Overall Study|Other|1|||
127936048|NCT01970865|460390370|FG005|Overall Study|Other|0|||
127936049|NCT01970865|460390371|FG006|Overall Study|Other|1|||
127936050|NCT01970865|460390372|FG007|Overall Study|Other|0|||
127936051|NCT01970865|460390373|FG008|Overall Study|Other|0|||
127936052|NCT01970865|460390374|FG009|Overall Study|Other|0|||
127936053|NCT01970865|460390375|FG010|Overall Study|Other|2|||
127936054|NCT01970865|460390376|FG011|Overall Study|Other|3|||
127936055|NCT01970865|460390377|FG012|Overall Study|Other|8|||
127936056|NCT01970865|460390378|FG013|Overall Study|Other|3|||
127936057|NCT01970865|460390379|FG014|Overall Study|Other|2|||
127936058|NCT01970865|460390380|FG015|Overall Study|Other|3|||
127936059|NCT01970865|460390381|FG016|Overall Study|Other|0|||
127936060|NCT01970865|460390382|FG017|Overall Study|Other|2|||
127936061|NCT01970865|460390365|FG000|Overall Study|Participant refused further follow-up|0|||
127936062|NCT01970865|460390366|FG001|Overall Study|Participant refused further follow-up|0|||
127936063|NCT01970865|460390367|FG002|Overall Study|Participant refused further follow-up|0|||
127936064|NCT01970865|460390368|FG003|Overall Study|Participant refused further follow-up|2|||
127936065|NCT01970865|460390369|FG004|Overall Study|Participant refused further follow-up|3|||
127936066|NCT01970865|460390370|FG005|Overall Study|Participant refused further follow-up|0|||
127936067|NCT01970865|460390371|FG006|Overall Study|Participant refused further follow-up|0|||
127936068|NCT01970865|460390372|FG007|Overall Study|Participant refused further follow-up|0|||
127936069|NCT01970865|460390373|FG008|Overall Study|Participant refused further follow-up|0|||
127936070|NCT01970865|460390374|FG009|Overall Study|Participant refused further follow-up|0|||
127936071|NCT01970865|460390375|FG010|Overall Study|Participant refused further follow-up|1|||
127936072|NCT01970865|460390376|FG011|Overall Study|Participant refused further follow-up|4|||
127936073|NCT01970865|460390377|FG012|Overall Study|Participant refused further follow-up|7|||
127936074|NCT01970865|460390378|FG013|Overall Study|Participant refused further follow-up|8|||
127936075|NCT01970865|460390379|FG014|Overall Study|Participant refused further follow-up|3|||
127936076|NCT01970865|460390380|FG015|Overall Study|Participant refused further follow-up|11|||
127936077|NCT01970865|460390381|FG016|Overall Study|Participant refused further follow-up|0|||
127936078|NCT01970865|460390382|FG017|Overall Study|Participant refused further follow-up|6|||
127936079|NCT00678041|460392324|FG000|Overall Study|Physician Decision|5|||
127936080|NCT00678041|460392325|FG001|Overall Study|Physician Decision|5|||
127936081|NCT02358343|460392326|FG000|Screening Intervention|Death|0|||
127936082|NCT02358343|460392327|FG001|Screening Intervention|Death|2|||
127936083|NCT02358343|460392328|FG002|Screening Intervention|Death|0|||
127936084|NCT02358343|460392329|FG003|Screening Intervention|Death|0|||
127936085|NCT02358343|460392330|FG004|Screening Intervention|Death|0|||
127936086|NCT02358343|460392326|FG000|Screening Intervention|Withdrawal by Subject|1|||
127936087|NCT02358343|460392327|FG001|Screening Intervention|Withdrawal by Subject|0|||
127936088|NCT02358343|460392328|FG002|Screening Intervention|Withdrawal by Subject|0|||
127936089|NCT02358343|460392329|FG003|Screening Intervention|Withdrawal by Subject|0|||
127936090|NCT02358343|460392330|FG004|Screening Intervention|Withdrawal by Subject|0|||
127936091|NCT02358343|460392326|FG000|Screening Intervention|Determined Ineligible|5|||
127936092|NCT02358343|460392327|FG001|Screening Intervention|Determined Ineligible|6|||
127936093|NCT02358343|460392328|FG002|Screening Intervention|Determined Ineligible|0|||
127936094|NCT02358343|460392329|FG003|Screening Intervention|Determined Ineligible|0|||
127936095|NCT02358343|460392330|FG004|Screening Intervention|Determined Ineligible|0|||
127936096|NCT02358343|460392326|FG000|Comparative Efficacy Trial / Observation|Death|0|||
127936097|NCT02358343|460392327|FG001|Comparative Efficacy Trial / Observation|Death|0|||
127936098|NCT02358343|460392328|FG002|Comparative Efficacy Trial / Observation|Death|2|||
127936099|NCT02358343|460392329|FG003|Comparative Efficacy Trial / Observation|Death|0|||
127936100|NCT02358343|460392330|FG004|Comparative Efficacy Trial / Observation|Death|0|||
127936101|NCT02358343|460392326|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
127936102|NCT02358343|460392327|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
127936103|NCT02358343|460392328|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
127936104|NCT02358343|460392329|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
127936105|NCT02358343|460392330|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
127936106|NCT02358343|460392326|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
127936107|NCT02358343|460392327|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
127936108|NCT02358343|460392328|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
127936109|NCT02358343|460392329|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
127936110|NCT02358343|460392330|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
127936111|NCT00090610|460392333|FG000|Overall Study|Withdrawal by Subject|1|||
127936112|NCT00090610|460392334|FG001|Overall Study|Withdrawal by Subject|1|||
127936113|NCT02444793|460392335|FG000|Overall Study|Lost to Follow-up|2|||
127936114|NCT02444793|460392336|FG001|Overall Study|Lost to Follow-up|2|||
127936115|NCT02444793|460392337|FG002|Overall Study|Lost to Follow-up|0|||
127936116|NCT02444793|460392338|FG003|Overall Study|Lost to Follow-up|0|||
127936117|NCT02444793|460392335|FG000|Overall Study|Death|0|||
127936118|NCT02444793|460392336|FG001|Overall Study|Death|3|||
127936119|NCT02444793|460392337|FG002|Overall Study|Death|0|||
127936120|NCT02444793|460392338|FG003|Overall Study|Death|0|||
127936121|NCT02444793|460392335|FG000|Overall Study|Other|0|||
127936122|NCT02444793|460392336|FG001|Overall Study|Other|0|||
127936123|NCT02444793|460392337|FG002|Overall Study|Other|2|||
127936124|NCT02444793|460392338|FG003|Overall Study|Other|0|||
127936125|NCT02444793|460392335|FG000|Overall Study|Objective progression or relapse|9|||
127936126|NCT02444793|460392336|FG001|Overall Study|Objective progression or relapse|1|||
127936127|NCT02444793|460392337|FG002|Overall Study|Objective progression or relapse|2|||
127936128|NCT02444793|460392338|FG003|Overall Study|Objective progression or relapse|3|||
127936129|NCT01462318|460392346|FG000|Main Study / TP-DI Study|Other|2|||
127936130|NCT01462318|460392347|FG001|Main Study / TP-DI Study|Other|0|||
127936131|NCT01462318|460392348|FG002|Main Study / TP-DI Study|Other|0|||
127936132|NCT01462318|460392346|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
127936133|NCT01462318|460392347|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
127936134|NCT01462318|460392348|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
127936135|NCT01462318|460392346|FG000|Main Study / TP-DI Study|Adverse Event|4|||
127936136|NCT01462318|460392347|FG001|Main Study / TP-DI Study|Adverse Event|0|||
127936137|NCT01462318|460392348|FG002|Main Study / TP-DI Study|Adverse Event|0|||
127936138|NCT01462318|460392346|FG000|Extension Phase|Lost to Follow-up|0|||
127936139|NCT01462318|460392347|FG001|Extension Phase|Lost to Follow-up|0|||
127936140|NCT01462318|460392348|FG002|Extension Phase|Lost to Follow-up|1|||
127936141|NCT01462318|460392346|FG000|Extension Phase|Other|0|||
127936142|NCT01462318|460392347|FG001|Extension Phase|Other|0|||
127936143|NCT01462318|460392348|FG002|Extension Phase|Other|1|||
127936144|NCT01462318|460392346|FG000|Extension Phase|Disease Progression|0|||
127936145|NCT01462318|460392347|FG001|Extension Phase|Disease Progression|0|||
127936146|NCT01462318|460392348|FG002|Extension Phase|Disease Progression|1|||
127936147|NCT01462318|460392346|FG000|Extension Phase|Withdrawal by Subject|0|||
127936148|NCT01462318|460392347|FG001|Extension Phase|Withdrawal by Subject|0|||
127936149|NCT01462318|460392348|FG002|Extension Phase|Withdrawal by Subject|15|||
127936150|NCT01462318|460392346|FG000|Extension Phase|Investigator Decision|0|||
127936151|NCT01462318|460392347|FG001|Extension Phase|Investigator Decision|0|||
127936152|NCT01462318|460392348|FG002|Extension Phase|Investigator Decision|5|||
127936153|NCT01462318|460392346|FG000|Extension Phase|Adverse Event|0|||
127936154|NCT01462318|460392347|FG001|Extension Phase|Adverse Event|0|||
127936155|NCT01462318|460392348|FG002|Extension Phase|Adverse Event|22|||
127936156|NCT03827564|460392349|FG000|Overall Study|Discontinued due to Study Termination|1|||
127936157|NCT03827564|460392350|FG001|Overall Study|Discontinued due to Study Termination|0|||
127936158|NCT00891371|460392351|FG000|Pre-assignment|Inclusion/exclusion|5|||
127936159|NCT00891371|460392351|FG000|Pre-assignment|Consent withdrawal|1|||
127936160|NCT00891371|460392351|FG000|Treatment|Lack of Efficacy|5|||
127936161|NCT00891371|460392351|FG000|Treatment|Adverse Event|2|||
127936162|NCT00891371|460392351|FG000|Treatment|Death|1|||
127936163|NCT00891371|460392351|FG000|Treatment|Lost to Follow-up|1|||
127936164|NCT02238626|460392352|FG000|Overall Study|Adverse Event|3|||
127936165|NCT02238626|460392353|FG001|Overall Study|Adverse Event|5|||
127936166|NCT02238626|460392354|FG002|Overall Study|Adverse Event|0|||
127936167|NCT02238626|460392355|FG003|Overall Study|Adverse Event|3|||
127936168|NCT02238626|460392352|FG000|Overall Study|Lost to Follow-up|2|||
127936169|NCT02238626|460392353|FG001|Overall Study|Lost to Follow-up|4|||
127936170|NCT02238626|460392354|FG002|Overall Study|Lost to Follow-up|2|||
127936171|NCT02238626|460392355|FG003|Overall Study|Lost to Follow-up|2|||
127936172|NCT02238626|460392352|FG000|Overall Study|Withdrawal by Subject|0|||
127936173|NCT02238626|460392353|FG001|Overall Study|Withdrawal by Subject|3|||
127936174|NCT02238626|460392354|FG002|Overall Study|Withdrawal by Subject|0|||
127936175|NCT02238626|460392355|FG003|Overall Study|Withdrawal by Subject|1|||
127936176|NCT02238626|460392352|FG000|Overall Study|Death|0|||
127936177|NCT02238626|460392353|FG001|Overall Study|Death|0|||
127936178|NCT02238626|460392354|FG002|Overall Study|Death|1|||
127936179|NCT02238626|460392355|FG003|Overall Study|Death|1|||
127936180|NCT02238626|460392352|FG000|Overall Study|Other|0|||
127936181|NCT02238626|460392353|FG001|Overall Study|Other|2|||
127936182|NCT02238626|460392354|FG002|Overall Study|Other|0|||
127936183|NCT02238626|460392355|FG003|Overall Study|Other|0|||
127936184|NCT02622113|460392358|FG000|Overall Study|Adverse Event|4|||
127936185|NCT02622113|460392359|FG001|Overall Study|Adverse Event|4|||
127936186|NCT02622113|460392358|FG000|Overall Study|Physician Decision|0|||
127936187|NCT02622113|460392359|FG001|Overall Study|Physician Decision|1|||
127936188|NCT02622113|460392358|FG000|Overall Study|Withdrawal by Subject|0|||
127936189|NCT02622113|460392359|FG001|Overall Study|Withdrawal by Subject|2|||
127936190|NCT02622113|460392358|FG000|Overall Study|Stopping Criteria|1|||
127936191|NCT02622113|460392359|FG001|Overall Study|Stopping Criteria|3|||
127936192|NCT00667810|460392360|FG000|Overall Study|Adverse Event|13|||
127936193|NCT00667810|460392361|FG001|Overall Study|Adverse Event|14|||
127936194|NCT00667810|460392362|FG002|Overall Study|Adverse Event|19|||
127936195|NCT00667810|460392363|FG003|Overall Study|Adverse Event|1|||
127936196|NCT00667810|460392360|FG000|Overall Study|Death|1|||
127936197|NCT00667810|460392361|FG001|Overall Study|Death|1|||
127936198|NCT00667810|460392362|FG002|Overall Study|Death|3|||
127936199|NCT00667810|460392363|FG003|Overall Study|Death|0|||
127936200|NCT00667810|460392360|FG000|Overall Study|Lack of Efficacy|1|||
127936201|NCT00667810|460392361|FG001|Overall Study|Lack of Efficacy|0|||
127936202|NCT00667810|460392362|FG002|Overall Study|Lack of Efficacy|2|||
127936203|NCT00667810|460392363|FG003|Overall Study|Lack of Efficacy|0|||
127936204|NCT00667810|460392360|FG000|Overall Study|Lost to Follow-up|1|||
127936205|NCT00667810|460392361|FG001|Overall Study|Lost to Follow-up|4|||
127936206|NCT00667810|460392362|FG002|Overall Study|Lost to Follow-up|2|||
127936207|NCT00667810|460392363|FG003|Overall Study|Lost to Follow-up|0|||
127936208|NCT00667810|460392360|FG000|Overall Study|Physician Decision|1|||
127936209|NCT00667810|460392361|FG001|Overall Study|Physician Decision|1|||
127936210|NCT00667810|460392362|FG002|Overall Study|Physician Decision|2|||
127936211|NCT00667810|460392363|FG003|Overall Study|Physician Decision|0|||
127936212|NCT00667810|460392360|FG000|Overall Study|Protocol Violation|0|||
127936213|NCT00667810|460392361|FG001|Overall Study|Protocol Violation|2|||
127936214|NCT00667810|460392362|FG002|Overall Study|Protocol Violation|0|||
127936215|NCT00667810|460392363|FG003|Overall Study|Protocol Violation|0|||
127936216|NCT00667810|460392360|FG000|Overall Study|Withdrawal by Subject|14|||
127936217|NCT00667810|460392361|FG001|Overall Study|Withdrawal by Subject|20|||
127936218|NCT00667810|460392362|FG002|Overall Study|Withdrawal by Subject|29|||
127936219|NCT00667810|460392363|FG003|Overall Study|Withdrawal by Subject|1|||
127936220|NCT00667810|460392360|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
127936221|NCT00667810|460392361|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
127936222|NCT00667810|460392362|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
127936223|NCT00667810|460392363|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
127936224|NCT00667810|460392360|FG000|Overall Study|Failed to Return|0|||
127936225|NCT00667810|460392361|FG001|Overall Study|Failed to Return|0|||
127936226|NCT00667810|460392362|FG002|Overall Study|Failed to Return|2|||
127936227|NCT00667810|460392363|FG003|Overall Study|Failed to Return|0|||
127936228|NCT00667810|460392360|FG000|Overall Study|Loss of Caregiver|0|||
127936229|NCT00667810|460392361|FG001|Overall Study|Loss of Caregiver|1|||
127936230|NCT00667810|460392362|FG002|Overall Study|Loss of Caregiver|3|||
127936231|NCT00667810|460392363|FG003|Overall Study|Loss of Caregiver|0|||
127936232|NCT00667810|460392360|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
127936233|NCT00667810|460392361|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
127936234|NCT00667810|460392362|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
127936235|NCT00667810|460392363|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
127936236|NCT00667810|460392360|FG000|Overall Study|Other|6|||
127936237|NCT00667810|460392361|FG001|Overall Study|Other|6|||
127936238|NCT00667810|460392362|FG002|Overall Study|Other|5|||
127936239|NCT00667810|460392363|FG003|Overall Study|Other|0|||
127936240|NCT00505375|460392366|FG000|Overall Study|Death|1|||
127936241|NCT00505375|460392367|FG001|Overall Study|Death|0|||
127936242|NCT00505375|460392366|FG000|Overall Study|Withdrawal by Subject|2|||
127936243|NCT00505375|460392367|FG001|Overall Study|Withdrawal by Subject|2|||
127936244|NCT00505375|460392366|FG000|Overall Study|Lost to Follow-up|0|||
127936245|NCT00505375|460392367|FG001|Overall Study|Lost to Follow-up|2|||
127936246|NCT00505375|460392366|FG000|Overall Study|Pregnancy|1|||
127936247|NCT00505375|460392367|FG001|Overall Study|Pregnancy|0|||
127936248|NCT00505375|460392366|FG000|Overall Study|Travel issues|0|||
127936249|NCT00505375|460392367|FG001|Overall Study|Travel issues|1|||
127936250|NCT03709823|460392368|FG000|Overall Study|Adverse Event|0|||
127936251|NCT03709823|460392369|FG001|Overall Study|Adverse Event|0|||
127936252|NCT03709823|460392370|FG002|Overall Study|Adverse Event|1|||
127936253|NCT03709823|460392371|FG003|Overall Study|Adverse Event|0|||
127936254|NCT03709823|460392372|FG004|Overall Study|Adverse Event|0|||
127936255|NCT03709823|460392373|FG005|Overall Study|Adverse Event|0|||
127936256|NCT03709823|460392368|FG000|Overall Study|Lost to Follow-up|2|||
127936257|NCT03709823|460392369|FG001|Overall Study|Lost to Follow-up|2|||
127936258|NCT03709823|460392370|FG002|Overall Study|Lost to Follow-up|2|||
127936259|NCT03709823|460392371|FG003|Overall Study|Lost to Follow-up|1|||
127936260|NCT03709823|460392372|FG004|Overall Study|Lost to Follow-up|1|||
127936261|NCT03709823|460392373|FG005|Overall Study|Lost to Follow-up|0|||
127936262|NCT03709823|460392368|FG000|Overall Study|Withdrawal by Subject|1|||
127936263|NCT03709823|460392369|FG001|Overall Study|Withdrawal by Subject|3|||
127936264|NCT03709823|460392370|FG002|Overall Study|Withdrawal by Subject|0|||
127936265|NCT03709823|460392371|FG003|Overall Study|Withdrawal by Subject|0|||
127936266|NCT03709823|460392372|FG004|Overall Study|Withdrawal by Subject|0|||
127936267|NCT03709823|460392373|FG005|Overall Study|Withdrawal by Subject|0|||
127936268|NCT03709823|460392368|FG000|Overall Study|Other, Not Specified|0|||
127936269|NCT03709823|460392369|FG001|Overall Study|Other, Not Specified|0|||
127936270|NCT03709823|460392370|FG002|Overall Study|Other, Not Specified|0|||
127936271|NCT03709823|460392371|FG003|Overall Study|Other, Not Specified|1|||
127936272|NCT03709823|460392372|FG004|Overall Study|Other, Not Specified|0|||
127936273|NCT03709823|460392373|FG005|Overall Study|Other, Not Specified|0|||
127936274|NCT03201250|460392374|FG000|Overall Study|screen failures|3|||
127936275|NCT03201250|460392375|FG001|Overall Study|screen failures|0|||
127936276|NCT03201250|460392376|FG002|Overall Study|screen failures|0|||
127936277|NCT01175811|460392377|FG000|Overall Study|Adverse Event|1|||
127936278|NCT01175811|460392378|FG001|Overall Study|Adverse Event|1|||
127936279|NCT01175811|460392377|FG000|Overall Study|Entry criteria not met|3|||
127936280|NCT01175811|460392378|FG001|Overall Study|Entry criteria not met|1|||
127936281|NCT01175811|460392377|FG000|Overall Study|Lack of Efficacy|1|||
127936282|NCT01175811|460392378|FG001|Overall Study|Lack of Efficacy|0|||
127936283|NCT01175811|460392377|FG000|Overall Study|Lost to Follow-up|3|||
127936284|NCT01175811|460392378|FG001|Overall Study|Lost to Follow-up|2|||
127936285|NCT01175811|460392377|FG000|Overall Study|Physician Decision|1|||
127936286|NCT01175811|460392378|FG001|Overall Study|Physician Decision|1|||
127936287|NCT01175811|460392377|FG000|Overall Study|Protocol Violation|1|||
127936288|NCT01175811|460392378|FG001|Overall Study|Protocol Violation|2|||
127936289|NCT01175811|460392377|FG000|Overall Study|Withdrawal by Subject|6|||
127936290|NCT01175811|460392378|FG001|Overall Study|Withdrawal by Subject|7|||
127936291|NCT03579966|460392379|FG000|Overall Study|Adverse Event|6|||
127936292|NCT03579966|460392379|FG000|Overall Study|Lost to Follow-up|4|||
127936293|NCT03579966|460392379|FG000|Overall Study|Physician Decision|10|||
127936294|NCT03579966|460392379|FG000|Overall Study|Pregnancy|1|||
127936295|NCT03579966|460392379|FG000|Overall Study|Withdrawal by Subject|16|||
127936296|NCT03579966|460392379|FG000|Overall Study|Study terminated by Sponsor|22|||
127936297|NCT03579966|460392379|FG000|Overall Study|Protocol Violation|1|||
127936298|NCT01340768|460392380|FG000|Overall Study|Lost to Follow-up|10|||
127936299|NCT01340768|460392381|FG001|Overall Study|Lost to Follow-up|4|||
127936300|NCT01340768|460392380|FG000|Overall Study|Withdrawal by Subject|5|||
127936301|NCT01340768|460392381|FG001|Overall Study|Withdrawal by Subject|1|||
127936302|NCT01340768|460392380|FG000|Overall Study|Other|2|||
127936303|NCT01340768|460392381|FG001|Overall Study|Other|0|||
127936304|NCT03052959|460392382|FG000|Overall Study|Lost to Follow-up|4|||
127936305|NCT03052959|460392383|FG001|Overall Study|Lost to Follow-up|5|||
127936306|NCT00140426|460392384|FG000|Overall Study|Withdrawal by Subject|0|||
127936307|NCT00140426|460392385|FG001|Overall Study|Withdrawal by Subject|3|||
127936308|NCT02149108|460392386|FG000|Overall Study|Not treated|1|||
127936309|NCT02149108|460392387|FG001|Overall Study|Not treated|2|||
127936310|NCT02149108|460392386|FG000|Overall Study|Progressive Disease (PD)|324|||
127936311|NCT02149108|460392387|FG001|Overall Study|Progressive Disease (PD)|318|||
127936312|NCT02149108|460392386|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
127936313|NCT02149108|460392387|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
127936314|NCT02149108|460392386|FG000|Overall Study|Other Adverse Event (AE)|8|||
127936315|NCT02149108|460392387|FG001|Overall Study|Other Adverse Event (AE)|18|||
127936316|NCT02149108|460392386|FG000|Overall Study|Other not defined above|0|||
127936317|NCT02149108|460392387|FG001|Overall Study|Other not defined above|2|||
127936318|NCT02149108|460392386|FG000|Overall Study|Refusal to continue trial medication|15|||
127936319|NCT02149108|460392387|FG001|Overall Study|Refusal to continue trial medication|11|||
127936320|NCT02149108|460392386|FG000|Overall Study|Lost to Follow-up|1|||
127936321|NCT02149108|460392387|FG001|Overall Study|Lost to Follow-up|0|||
127936322|NCT00950963|460392388|FG000|Overall Study|Lost to Follow-up|29|||
127936323|NCT00950963|460392389|FG001|Overall Study|Lost to Follow-up|24|||
127936324|NCT00848107|460392390|FG000|Overall Study|Lost to Follow-up|2|||
127936325|NCT00848107|460392390|FG000|Overall Study|Withdrawal by Subject|8|||
127936326|NCT00848107|460392390|FG000|Overall Study|Adverse Event|9|||
127936327|NCT00848107|460392390|FG000|Overall Study|Death|1|||
127936328|NCT00848107|460392390|FG000|Overall Study|Pregnancy|1|||
127936329|NCT02335983|460392391|FG000|Overall Study|Sponsor Decision|0|||
127936330|NCT02335983|460392392|FG001|Overall Study|Sponsor Decision|0|||
127936331|NCT02335983|460392393|FG002|Overall Study|Sponsor Decision|1|||
127936332|NCT02335983|460392394|FG003|Overall Study|Sponsor Decision|1|||
127936333|NCT02335983|460392395|FG004|Overall Study|Sponsor Decision|0|||
127936334|NCT02335983|460392396|FG005|Overall Study|Sponsor Decision|1|||
127936335|NCT02335983|460392391|FG000|Overall Study|Withdrawal by Subject|3|||
127936336|NCT02335983|460392392|FG001|Overall Study|Withdrawal by Subject|2|||
127936337|NCT02335983|460392393|FG002|Overall Study|Withdrawal by Subject|2|||
127936338|NCT02335983|460392394|FG003|Overall Study|Withdrawal by Subject|1|||
127936339|NCT02335983|460392395|FG004|Overall Study|Withdrawal by Subject|3|||
127936340|NCT02335983|460392396|FG005|Overall Study|Withdrawal by Subject|9|||
127936341|NCT02335983|460392391|FG000|Overall Study|Death|0|||
127936342|NCT02335983|460392392|FG001|Overall Study|Death|0|||
127936343|NCT02335983|460392393|FG002|Overall Study|Death|2|||
127936344|NCT02335983|460392394|FG003|Overall Study|Death|0|||
127936345|NCT02335983|460392395|FG004|Overall Study|Death|0|||
127936346|NCT02335983|460392396|FG005|Overall Study|Death|0|||
127936347|NCT02335983|460392391|FG000|Overall Study|Lost to Follow-up|0|||
127936348|NCT02335983|460392392|FG001|Overall Study|Lost to Follow-up|0|||
127936349|NCT02335983|460392393|FG002|Overall Study|Lost to Follow-up|0|||
127936350|NCT02335983|460392394|FG003|Overall Study|Lost to Follow-up|0|||
127936351|NCT02335983|460392395|FG004|Overall Study|Lost to Follow-up|0|||
127936352|NCT02335983|460392396|FG005|Overall Study|Lost to Follow-up|1|||
127936353|NCT02335983|460392391|FG000|Overall Study|Protocol Specified Criteria|5|||
127936354|NCT02335983|460392392|FG001|Overall Study|Protocol Specified Criteria|7|||
127936355|NCT02335983|460392393|FG002|Overall Study|Protocol Specified Criteria|27|||
127936356|NCT02335983|460392394|FG003|Overall Study|Protocol Specified Criteria|7|||
127936357|NCT02335983|460392395|FG004|Overall Study|Protocol Specified Criteria|5|||
127936358|NCT02335983|460392396|FG005|Overall Study|Protocol Specified Criteria|21|||
127936359|NCT00987389|460392397|FG000|Overall Study|Ineligible|0|||
127936360|NCT00987389|460392398|FG001|Overall Study|Ineligible|3|||
127936361|NCT00987389|460392399|FG002|Overall Study|Ineligible|0|||
127936362|NCT00987389|460392400|FG003|Overall Study|Ineligible|0|||
127936363|NCT00987389|460392397|FG000|Overall Study|Lost to Follow-up|4|||
127936364|NCT00987389|460392398|FG001|Overall Study|Lost to Follow-up|1|||
127936365|NCT00987389|460392399|FG002|Overall Study|Lost to Follow-up|3|||
127936366|NCT00987389|460392400|FG003|Overall Study|Lost to Follow-up|1|||
127936367|NCT00987389|460392397|FG000|Overall Study|Withdrawal by Subject|4|||
127936368|NCT00987389|460392398|FG001|Overall Study|Withdrawal by Subject|3|||
127936369|NCT00987389|460392399|FG002|Overall Study|Withdrawal by Subject|2|||
127936370|NCT00987389|460392400|FG003|Overall Study|Withdrawal by Subject|1|||
127936371|NCT00987389|460392397|FG000|Overall Study|Withdrawn from Treatment|0|||
127936372|NCT00987389|460392398|FG001|Overall Study|Withdrawn from Treatment|1|||
127936373|NCT00987389|460392399|FG002|Overall Study|Withdrawn from Treatment|0|||
127936374|NCT00987389|460392400|FG003|Overall Study|Withdrawn from Treatment|0|||
127936375|NCT00987389|460392397|FG000|Overall Study|Multiple different reasons|1|||
127936376|NCT00987389|460392398|FG001|Overall Study|Multiple different reasons|0|||
127936377|NCT00987389|460392399|FG002|Overall Study|Multiple different reasons|3|||
127936378|NCT00987389|460392400|FG003|Overall Study|Multiple different reasons|1|||
127936379|NCT00655876|460392401|FG000|Overall Study|Protocol Violation|9|||
127936380|NCT00655876|460392402|FG001|Overall Study|Protocol Violation|7|||
127936381|NCT01831765|460392403|FG000|Overall Study|Lack of Efficacy|1|||
127936382|NCT01831765|460392404|FG001|Overall Study|Lack of Efficacy|0|||
127936383|NCT01831765|460392405|FG002|Overall Study|Lack of Efficacy|0|||
127936384|NCT01831765|460392403|FG000|Overall Study|Other, sponsor withdrew subject|0|||
127936385|NCT01831765|460392404|FG001|Overall Study|Other, sponsor withdrew subject|1|||
127936386|NCT01831765|460392405|FG002|Overall Study|Other, sponsor withdrew subject|0|||
127936387|NCT01831765|460392403|FG000|Overall Study|Pregnancy|1|||
127936388|NCT01831765|460392404|FG001|Overall Study|Pregnancy|1|||
127936389|NCT01831765|460392405|FG002|Overall Study|Pregnancy|2|||
127936390|NCT01831765|460392403|FG000|Overall Study|Death|0|||
127936391|NCT01831765|460392404|FG001|Overall Study|Death|1|||
127936392|NCT01831765|460392405|FG002|Overall Study|Death|1|||
127936393|NCT01831765|460392403|FG000|Overall Study|Other, site closed|1|||
127936394|NCT01831765|460392404|FG001|Overall Study|Other, site closed|1|||
127936395|NCT01831765|460392405|FG002|Overall Study|Other, site closed|0|||
127936396|NCT01831765|460392403|FG000|Overall Study|Adverse Event|5|||
127936397|NCT01831765|460392404|FG001|Overall Study|Adverse Event|3|||
127936398|NCT01831765|460392405|FG002|Overall Study|Adverse Event|3|||
127936399|NCT01831765|460392403|FG000|Overall Study|Withdrawal by Subject|22|||
127936400|NCT01831765|460392404|FG001|Overall Study|Withdrawal by Subject|7|||
127936401|NCT01831765|460392405|FG002|Overall Study|Withdrawal by Subject|17|||
127936402|NCT01831765|460392403|FG000|Overall Study|Withdrawal criteria|12|||
127936403|NCT01831765|460392404|FG001|Overall Study|Withdrawal criteria|10|||
127936404|NCT01831765|460392405|FG002|Overall Study|Withdrawal criteria|16|||
127936405|NCT01831765|460392403|FG000|Overall Study|Lost to Follow-up|2|||
127936406|NCT01831765|460392404|FG001|Overall Study|Lost to Follow-up|3|||
127936407|NCT01831765|460392405|FG002|Overall Study|Lost to Follow-up|3|||
127936408|NCT00326963|460392406|FG000|Overall Study|Adverse Event|2|||
127936409|NCT00326963|460392406|FG000|Overall Study|Injection site reaction|1|||
127936410|NCT00326963|460392406|FG000|Overall Study|Death|1|||
127936411|NCT00326963|460392406|FG000|Overall Study|Failure to return|10|||
127936412|NCT00326963|460392406|FG000|Overall Study|Withdrawal by Subject|10|||
127936413|NCT00326963|460392406|FG000|Overall Study|Refused treatment / did not cooperate|5|||
127936414|NCT00326963|460392406|FG000|Overall Study|Violation of selection criteria at entry|2|||
127936415|NCT00326963|460392406|FG000|Overall Study|Other protocol violation|1|||
127936416|NCT00326963|460392406|FG000|Overall Study|Administrative / other|1|||
127936417|NCT00507130|460392407|FG000|Overall Study|Lost to Follow-up|0|||
127936418|NCT00507130|460392408|FG001|Overall Study|Lost to Follow-up|0|||
127936419|NCT00507130|460392409|FG002|Overall Study|Lost to Follow-up|1|||
127936420|NCT00507130|460392410|FG003|Overall Study|Lost to Follow-up|1|||
127936421|NCT00507130|460392407|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
127936422|NCT00507130|460392408|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
127936423|NCT00507130|460392409|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
127936424|NCT00507130|460392410|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
127936425|NCT00859586|460392411|FG000|Overall Study|Donors|4|||
127936426|NCT00080938|460392416|FG000|Overall Study|Adverse Event|3|||
127936427|NCT00080938|460392416|FG000|Overall Study|Withdrawal by Subject|6|||
127936428|NCT00080938|460392416|FG000|Overall Study|Death|2|||
127936429|NCT00080938|460392416|FG000|Overall Study|Lack of Efficacy|7|||
127936430|NCT00080938|460392416|FG000|Overall Study|other disease|1|||
127936431|NCT00080938|460392416|FG000|Overall Study|Not started protocol therapy|1|||
127936432|NCT00080938|460392416|FG000|Overall Study|Ineligible|4|||
127936433|NCT02992418|460392420|FG000|Overall Study|Withdrawal by Subject|11|||
127936434|NCT02992418|460392421|FG001|Overall Study|Withdrawal by Subject|12|||
127936435|NCT02992418|460392420|FG000|Overall Study|Non-compliance with the protocol|308|||
127936436|NCT02992418|460392421|FG001|Overall Study|Non-compliance with the protocol|308|||
127936437|NCT02992418|460392420|FG000|Overall Study|Lost to Follow-up|27|||
127936438|NCT02992418|460392421|FG001|Overall Study|Lost to Follow-up|22|||
127936439|NCT03246126|460392426|FG000|Overall Study|Withdrawal by Subject|0|||
127936440|NCT03246126|460392427|FG001|Overall Study|Withdrawal by Subject|1|||
127936441|NCT01006135|460392430|FG000|Overall Study|Adverse Event|22|||
127936442|NCT01006135|460392430|FG000|Overall Study|Protocol Violation|14|||
127936443|NCT01006135|460392430|FG000|Overall Study|Lost to Follow-up|32|||
127936444|NCT01006135|460392430|FG000|Overall Study|Other|72|||
127936445|NCT01732484|460392436|FG000|Overall Study|Death|7|||
127936446|NCT01732484|460392436|FG000|Overall Study|Lost to Follow-up|14|||
127936447|NCT01732484|460392436|FG000|Overall Study|chronical illness|5|||
127936448|NCT02266134|460392437|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
127936449|NCT02266134|460392438|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
127936450|NCT02266134|460392439|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
127936451|NCT02266134|460392440|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
127936452|NCT02266134|460392437|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
127936453|NCT02266134|460392438|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
127936454|NCT02266134|460392439|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
127936455|NCT02266134|460392440|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
127936456|NCT02266134|460392437|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
127936457|NCT02266134|460392438|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
127936458|NCT02266134|460392439|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
127936459|NCT02266134|460392440|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
127936460|NCT02266134|460392437|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
127936461|NCT02266134|460392438|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
127936462|NCT02266134|460392439|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
127936463|NCT02266134|460392440|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
127936464|NCT02266134|460392437|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
127936465|NCT02266134|460392438|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
127936466|NCT02266134|460392439|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
127936467|NCT02266134|460392440|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
127936468|NCT02266134|460392437|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
127936469|NCT02266134|460392438|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
127936470|NCT02266134|460392439|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
127936471|NCT02266134|460392440|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
127936472|NCT02731326|460392443|FG000|Overall Study|Withdrawal by Subject|4|||
127936473|NCT02731326|460392444|FG001|Overall Study|Withdrawal by Subject|1|||
127936474|NCT02731326|460392443|FG000|Overall Study|No Cardioversion or Ablation Procedure|1|||
127936475|NCT02731326|460392444|FG001|Overall Study|No Cardioversion or Ablation Procedure|6|||
127936476|NCT02731326|460392443|FG000|Overall Study|Discharged without AliveCor|10|||
127936477|NCT02731326|460392444|FG001|Overall Study|Discharged without AliveCor|0|||
127936478|NCT02731326|460392443|FG000|Overall Study|Duplicate Participant|1|||
127936479|NCT02731326|460392444|FG001|Overall Study|Duplicate Participant|1|||
127936480|NCT02272634|460392445|FG000|Overall Study|Adverse Event|1|||
127936481|NCT02272634|460392446|FG001|Overall Study|Adverse Event|0|||
127936482|NCT02272634|460392447|FG002|Overall Study|Adverse Event|0|||
127936483|NCT02272634|460392445|FG000|Overall Study|Protocol Violation|0|||
127936484|NCT02272634|460392446|FG001|Overall Study|Protocol Violation|0|||
127936485|NCT02272634|460392447|FG002|Overall Study|Protocol Violation|1|||
127936486|NCT02272634|460392445|FG000|Overall Study|Withdrawal by Subject|0|||
127936487|NCT02272634|460392446|FG001|Overall Study|Withdrawal by Subject|1|||
127936488|NCT02272634|460392447|FG002|Overall Study|Withdrawal by Subject|0|||
127936489|NCT01437943|460392451|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
127936490|NCT01437943|460392452|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
127936491|NCT01437943|460392451|FG000|Overall Study|Subject expressed pregnancy plans|1|||
127936492|NCT01437943|460392452|FG001|Overall Study|Subject expressed pregnancy plans|0|||
127936493|NCT01437943|460392451|FG000|Overall Study|Adverse Event|2|||
127936494|NCT01437943|460392452|FG001|Overall Study|Adverse Event|0|||
127936495|NCT00302081|460392453|FG000|Overall Study|Adverse Event|6|||
127936496|NCT00302081|460392454|FG001|Overall Study|Adverse Event|5|||
127936497|NCT00302081|460392455|FG002|Overall Study|Adverse Event|4|||
127936498|NCT00302081|460392453|FG000|Overall Study|Lost to Follow-up|21|||
127936499|NCT00302081|460392454|FG001|Overall Study|Lost to Follow-up|18|||
127936500|NCT00302081|460392455|FG002|Overall Study|Lost to Follow-up|28|||
127936501|NCT00302081|460392453|FG000|Overall Study|Withdrawal by Subject|8|||
127936502|NCT00302081|460392454|FG001|Overall Study|Withdrawal by Subject|12|||
127936503|NCT00302081|460392455|FG002|Overall Study|Withdrawal by Subject|8|||
127936504|NCT00302081|460392453|FG000|Overall Study|Protocol Violation|5|||
127936505|NCT00302081|460392454|FG001|Overall Study|Protocol Violation|1|||
127936506|NCT00302081|460392455|FG002|Overall Study|Protocol Violation|2|||
127936507|NCT00302081|460392453|FG000|Overall Study|Lack of Efficacy|1|||
127936508|NCT00302081|460392454|FG001|Overall Study|Lack of Efficacy|0|||
127936509|NCT00302081|460392455|FG002|Overall Study|Lack of Efficacy|5|||
127936510|NCT00302081|460392453|FG000|Overall Study|Death|2|||
127936511|NCT00302081|460392454|FG001|Overall Study|Death|1|||
127936512|NCT00302081|460392455|FG002|Overall Study|Death|0|||
127936513|NCT00302081|460392453|FG000|Overall Study|Other|13|||
127936514|NCT00302081|460392454|FG001|Overall Study|Other|6|||
127936515|NCT00302081|460392455|FG002|Overall Study|Other|5|||
127936516|NCT04771403|460392456|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
127936517|NCT04771403|460392457|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
127936518|NCT04771403|460392456|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
127936519|NCT04771403|460392457|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
127936520|NCT04771403|460392456|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
127936521|NCT04771403|460392457|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
127936522|NCT04771403|460392456|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
127936523|NCT04771403|460392457|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
127936524|NCT04771403|460392456|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
127936525|NCT04771403|460392457|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
127936526|NCT04771403|460392456|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
127936527|NCT04771403|460392457|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
127936528|NCT04771403|460392456|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
127936529|NCT04771403|460392457|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
127936530|NCT04771403|460392456|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
127936531|NCT04771403|460392457|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
127936532|NCT05442866|460392458|FG000|Overall Study|Death|1|||
127936533|NCT05442866|460392458|FG000|Overall Study|Lost to Follow-up|9|||
127936534|NCT05442866|460392458|FG000|Overall Study|Protocol Violation|1|||
127936535|NCT03819049|460392459|FG000|Overall Study|Lost to Follow-up|1|||
127936536|NCT03819049|460392460|FG001|Overall Study|Lost to Follow-up|2|||
127936537|NCT03819049|460392461|FG002|Overall Study|Lost to Follow-up|9|||
127936538|NCT03819049|460392462|FG003|Overall Study|Lost to Follow-up|0|||
127936539|NCT03819049|460392463|FG004|Overall Study|Lost to Follow-up|3|||
127936540|NCT03819049|460392464|FG005|Overall Study|Lost to Follow-up|1|||
127936541|NCT03819049|460392465|FG006|Overall Study|Lost to Follow-up|0|||
127936542|NCT03819049|460392459|FG000|Overall Study|Withdrawal by Subject|0|||
127936543|NCT03819049|460392460|FG001|Overall Study|Withdrawal by Subject|0|||
127936544|NCT03819049|460392461|FG002|Overall Study|Withdrawal by Subject|18|||
127936545|NCT03819049|460392462|FG003|Overall Study|Withdrawal by Subject|0|||
127936546|NCT03819049|460392463|FG004|Overall Study|Withdrawal by Subject|10|||
127936547|NCT03819049|460392464|FG005|Overall Study|Withdrawal by Subject|9|||
127936548|NCT03819049|460392465|FG006|Overall Study|Withdrawal by Subject|1|||
127936549|NCT03819049|460392459|FG000|Overall Study|Ongoing|0|||
127936550|NCT03819049|460392460|FG001|Overall Study|Ongoing|0|||
127936551|NCT03819049|460392461|FG002|Overall Study|Ongoing|75|||
127936552|NCT03819049|460392462|FG003|Overall Study|Ongoing|0|||
127936553|NCT03819049|460392463|FG004|Overall Study|Ongoing|41|||
127936554|NCT03819049|460392464|FG005|Overall Study|Ongoing|0|||
127936555|NCT03819049|460392465|FG006|Overall Study|Ongoing|0|||
127936556|NCT03819049|460392459|FG000|Overall Study|Other|0|||
127936557|NCT03819049|460392460|FG001|Overall Study|Other|0|||
127936558|NCT03819049|460392461|FG002|Overall Study|Other|2|||
127936559|NCT03819049|460392462|FG003|Overall Study|Other|0|||
127936560|NCT03819049|460392463|FG004|Overall Study|Other|0|||
127936561|NCT03819049|460392464|FG005|Overall Study|Other|0|||
127936562|NCT03819049|460392465|FG006|Overall Study|Other|0|||
127936563|NCT03819049|460392459|FG000|Overall Study|Randomized but not vaccinated|0|||
127936564|NCT03819049|460392460|FG001|Overall Study|Randomized but not vaccinated|0|||
127936565|NCT03819049|460392461|FG002|Overall Study|Randomized but not vaccinated|0|||
127936566|NCT03819049|460392462|FG003|Overall Study|Randomized but not vaccinated|1|||
127936567|NCT03819049|460392463|FG004|Overall Study|Randomized but not vaccinated|0|||
127936568|NCT03819049|460392464|FG005|Overall Study|Randomized but not vaccinated|2|||
127936569|NCT03819049|460392465|FG006|Overall Study|Randomized but not vaccinated|1|||
127936570|NCT03819049|460392459|FG000|Overall Study|Physician Decision|0|||
127936571|NCT03819049|460392460|FG001|Overall Study|Physician Decision|0|||
127936572|NCT03819049|460392461|FG002|Overall Study|Physician Decision|0|||
127936573|NCT03819049|460392462|FG003|Overall Study|Physician Decision|0|||
127936574|NCT03819049|460392463|FG004|Overall Study|Physician Decision|0|||
127936575|NCT03819049|460392464|FG005|Overall Study|Physician Decision|0|||
127936576|NCT03819049|460392465|FG006|Overall Study|Physician Decision|1|||
127936577|NCT01986010|460392466|FG000|Overall Study|Adverse Event|0|||
127936578|NCT01986010|460392467|FG001|Overall Study|Adverse Event|1|||
127936579|NCT01986010|460392468|FG002|Overall Study|Adverse Event|0|||
127936580|NCT01986010|460392469|FG003|Overall Study|Adverse Event|0|||
127936581|NCT01986010|460392470|FG004|Overall Study|Adverse Event|0|||
127936582|NCT01986010|460392471|FG005|Overall Study|Adverse Event|0|||
127936583|NCT01986010|460392472|FG006|Overall Study|Adverse Event|0|||
127936584|NCT01986010|460392473|FG007|Overall Study|Adverse Event|0|||
127936585|NCT01986010|460392474|FG008|Overall Study|Adverse Event|0|||
127936586|NCT01986010|460392475|FG009|Overall Study|Adverse Event|0|||
127936587|NCT01986010|460392476|FG010|Overall Study|Adverse Event|0|||
127936588|NCT01986010|460392477|FG011|Overall Study|Adverse Event|0|||
127936589|NCT01986010|460392478|FG012|Overall Study|Adverse Event|0|||
127936590|NCT01986010|460392479|FG013|Overall Study|Adverse Event|0|||
127936591|NCT01986010|460392480|FG014|Overall Study|Adverse Event|0|||
127936592|NCT01986010|460392481|FG015|Overall Study|Adverse Event|1|||
127936593|NCT01986010|460392482|FG016|Overall Study|Adverse Event|0|||
127936594|NCT01986010|460392466|FG000|Overall Study|Lost to Follow-up|2|||
127936595|NCT01986010|460392467|FG001|Overall Study|Lost to Follow-up|1|||
127936596|NCT01986010|460392468|FG002|Overall Study|Lost to Follow-up|2|||
127936597|NCT01986010|460392469|FG003|Overall Study|Lost to Follow-up|2|||
127936598|NCT01986010|460392470|FG004|Overall Study|Lost to Follow-up|2|||
127936599|NCT01986010|460392471|FG005|Overall Study|Lost to Follow-up|2|||
127936600|NCT01986010|460392472|FG006|Overall Study|Lost to Follow-up|0|||
127936601|NCT01986010|460392473|FG007|Overall Study|Lost to Follow-up|0|||
127936602|NCT01986010|460392474|FG008|Overall Study|Lost to Follow-up|4|||
127936603|NCT01986010|460392475|FG009|Overall Study|Lost to Follow-up|2|||
127936604|NCT01986010|460392476|FG010|Overall Study|Lost to Follow-up|0|||
127936605|NCT01986010|460392477|FG011|Overall Study|Lost to Follow-up|1|||
127936606|NCT01986010|460392478|FG012|Overall Study|Lost to Follow-up|1|||
127936607|NCT01986010|460392479|FG013|Overall Study|Lost to Follow-up|1|||
127936608|NCT01986010|460392480|FG014|Overall Study|Lost to Follow-up|2|||
127936609|NCT01986010|460392481|FG015|Overall Study|Lost to Follow-up|0|||
127936610|NCT01986010|460392482|FG016|Overall Study|Lost to Follow-up|0|||
127936611|NCT01986010|460392466|FG000|Overall Study|Physician Decision|0|||
127936612|NCT01986010|460392467|FG001|Overall Study|Physician Decision|0|||
127936613|NCT01986010|460392468|FG002|Overall Study|Physician Decision|0|||
127936614|NCT01986010|460392469|FG003|Overall Study|Physician Decision|0|||
127936615|NCT01986010|460392470|FG004|Overall Study|Physician Decision|0|||
127936616|NCT01986010|460392471|FG005|Overall Study|Physician Decision|0|||
127936617|NCT01986010|460392472|FG006|Overall Study|Physician Decision|0|||
127936618|NCT01986010|460392473|FG007|Overall Study|Physician Decision|0|||
127936619|NCT01986010|460392474|FG008|Overall Study|Physician Decision|0|||
127936620|NCT01986010|460392475|FG009|Overall Study|Physician Decision|0|||
127936621|NCT01986010|460392476|FG010|Overall Study|Physician Decision|0|||
127936622|NCT01986010|460392477|FG011|Overall Study|Physician Decision|0|||
127936623|NCT01986010|460392478|FG012|Overall Study|Physician Decision|0|||
127936624|NCT01986010|460392479|FG013|Overall Study|Physician Decision|0|||
127936625|NCT01986010|460392480|FG014|Overall Study|Physician Decision|1|||
127936626|NCT01986010|460392481|FG015|Overall Study|Physician Decision|0|||
127936627|NCT01986010|460392482|FG016|Overall Study|Physician Decision|0|||
127936628|NCT01986010|460392466|FG000|Overall Study|Withdrawal by Subject|2|||
127936629|NCT01986010|460392467|FG001|Overall Study|Withdrawal by Subject|2|||
127936630|NCT01986010|460392468|FG002|Overall Study|Withdrawal by Subject|3|||
127936631|NCT01986010|460392469|FG003|Overall Study|Withdrawal by Subject|0|||
127936632|NCT01986010|460392470|FG004|Overall Study|Withdrawal by Subject|2|||
127936633|NCT01986010|460392471|FG005|Overall Study|Withdrawal by Subject|4|||
127936634|NCT01986010|460392472|FG006|Overall Study|Withdrawal by Subject|0|||
127936635|NCT01986010|460392473|FG007|Overall Study|Withdrawal by Subject|0|||
127936636|NCT01986010|460392474|FG008|Overall Study|Withdrawal by Subject|0|||
127936637|NCT01986010|460392475|FG009|Overall Study|Withdrawal by Subject|0|||
127936638|NCT01986010|460392476|FG010|Overall Study|Withdrawal by Subject|0|||
127936639|NCT01986010|460392477|FG011|Overall Study|Withdrawal by Subject|2|||
127936640|NCT01986010|460392478|FG012|Overall Study|Withdrawal by Subject|0|||
127936641|NCT01986010|460392479|FG013|Overall Study|Withdrawal by Subject|1|||
127936642|NCT01986010|460392480|FG014|Overall Study|Withdrawal by Subject|2|||
127936643|NCT01986010|460392481|FG015|Overall Study|Withdrawal by Subject|0|||
127936644|NCT01986010|460392482|FG016|Overall Study|Withdrawal by Subject|0|||
127936645|NCT01986010|460392466|FG000|Overall Study|Status Not Recorded|2|||
127936646|NCT01986010|460392467|FG001|Overall Study|Status Not Recorded|4|||
127936647|NCT01986010|460392468|FG002|Overall Study|Status Not Recorded|2|||
127936648|NCT01986010|460392469|FG003|Overall Study|Status Not Recorded|0|||
127936649|NCT01986010|460392470|FG004|Overall Study|Status Not Recorded|1|||
127936650|NCT01986010|460392471|FG005|Overall Study|Status Not Recorded|2|||
127936651|NCT01986010|460392472|FG006|Overall Study|Status Not Recorded|0|||
127936652|NCT01986010|460392473|FG007|Overall Study|Status Not Recorded|0|||
127936653|NCT01986010|460392474|FG008|Overall Study|Status Not Recorded|2|||
127936654|NCT01986010|460392475|FG009|Overall Study|Status Not Recorded|1|||
127936655|NCT01986010|460392476|FG010|Overall Study|Status Not Recorded|7|||
127936656|NCT01986010|460392477|FG011|Overall Study|Status Not Recorded|7|||
127936657|NCT01986010|460392478|FG012|Overall Study|Status Not Recorded|9|||
127936658|NCT01986010|460392479|FG013|Overall Study|Status Not Recorded|9|||
127936659|NCT01986010|460392480|FG014|Overall Study|Status Not Recorded|5|||
127936660|NCT01986010|460392481|FG015|Overall Study|Status Not Recorded|10|||
127936661|NCT01986010|460392482|FG016|Overall Study|Status Not Recorded|4|||
127936662|NCT01335997|460392483|FG000|Period I and II|Adverse Event|63|||
127936663|NCT01335997|460392484|FG001|Period I and II|Adverse Event|43|||
127936664|NCT01335997|460392483|FG000|Period I and II|Noncompliance with Study Drug|1|||
127936665|NCT01335997|460392484|FG001|Period I and II|Noncompliance with Study Drug|1|||
127936666|NCT01335997|460392483|FG000|Period I and II|Lost to Follow-up|3|||
127936667|NCT01335997|460392484|FG001|Period I and II|Lost to Follow-up|5|||
127936668|NCT01335997|460392483|FG000|Period I and II|Withdrawal by Subject|9|||
127936669|NCT01335997|460392484|FG001|Period I and II|Withdrawal by Subject|4|||
127936670|NCT01335997|460392483|FG000|Period I and II|Study Terminated by Sponsor|406|||
127936671|NCT01335997|460392484|FG001|Period I and II|Study Terminated by Sponsor|415|||
127936672|NCT01335997|460392483|FG000|Period I and II|Protocol Violation|9|||
127936673|NCT01335997|460392484|FG001|Period I and II|Protocol Violation|10|||
127936674|NCT01335997|460392483|FG000|Period I and II|Physician Decision|2|||
127936675|NCT01335997|460392484|FG001|Period I and II|Physician Decision|1|||
127936676|NCT01335997|460392483|FG000|Period III|Adverse Event|0|||
127936677|NCT01335997|460392484|FG001|Period III|Adverse Event|2|||
127936678|NCT01335997|460392483|FG000|Period III|Study Terminated by Sponsor|77|||
127936679|NCT01335997|460392484|FG001|Period III|Study Terminated by Sponsor|76|||
127936680|NCT01335997|460392483|FG000|Period III|Protocol Violation|0|||
127936681|NCT01335997|460392484|FG001|Period III|Protocol Violation|1|||
127936682|NCT01335997|460392483|FG000|Period III|Lost to Follow-up|1|||
127936683|NCT01335997|460392484|FG001|Period III|Lost to Follow-up|0|||
127936684|NCT04740814|460392485|FG000|Overall Study|Adverse Event|3|||
127936685|NCT04740814|460392485|FG000|Overall Study|Protocol Violation|2|||
127936686|NCT04740814|460392485|FG000|Overall Study|Lost to Follow-up|2|||
127936687|NCT04740814|460392485|FG000|Overall Study|Withdrawal by Subject|3|||
127936688|NCT02500641|460392488|FG000|Overall Study|Adverse Event|0|||
127936689|NCT02500641|460392489|FG001|Overall Study|Adverse Event|2|||
127936690|NCT02500641|460392488|FG000|Overall Study|Withdrawal by Subject|4|||
127936691|NCT02500641|460392489|FG001|Overall Study|Withdrawal by Subject|5|||
127936692|NCT02500641|460392488|FG000|Overall Study|Unable to follow study procedures|3|||
127936693|NCT02500641|460392489|FG001|Overall Study|Unable to follow study procedures|2|||
127936694|NCT02500641|460392488|FG000|Overall Study|Protocol Violation|1|||
127936695|NCT02500641|460392489|FG001|Overall Study|Protocol Violation|2|||
127936696|NCT02500641|460392488|FG000|Overall Study|Lost to Follow-up|1|||
127936697|NCT02500641|460392489|FG001|Overall Study|Lost to Follow-up|0|||
127936698|NCT02500641|460392488|FG000|Overall Study|Sponsor decision|1|||
127936699|NCT02500641|460392489|FG001|Overall Study|Sponsor decision|0|||
127936700|NCT02500641|460392488|FG000|Overall Study|Non compliance to study drug|0|||
127936701|NCT02500641|460392489|FG001|Overall Study|Non compliance to study drug|1|||
127936702|NCT01763684|460392491|FG000|Overall Study|Study terminated early due to low enrollment|126|||
127936703|NCT01763684|460392492|FG001|Overall Study|Study terminated early due to low enrollment|127|||
127936704|NCT01763684|460392491|FG000|Overall Study|Study surgery not performed|7|||
127936705|NCT01763684|460392492|FG001|Overall Study|Study surgery not performed|6|||
127936706|NCT00643565|460392493|FG000|Overall Study|Death|12|||
127936707|NCT00643565|460392494|FG001|Overall Study|Death|11|||
127936708|NCT00643565|460392493|FG000|Overall Study|Withdrawal by Subject|4|||
127936709|NCT00643565|460392494|FG001|Overall Study|Withdrawal by Subject|1|||
127936710|NCT00643565|460392493|FG000|Overall Study|Lost to Follow-up|0|||
127936711|NCT00643565|460392494|FG001|Overall Study|Lost to Follow-up|6|||
127936712|NCT00643565|460392493|FG000|Overall Study|Other|7|||
127936713|NCT00643565|460392494|FG001|Overall Study|Other|8|||
127936714|NCT00643565|460392493|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
127936715|NCT00643565|460392494|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
127936716|NCT00643565|460392493|FG000|Overall Study|Recurrence of Disease|2|||
127936717|NCT00643565|460392494|FG001|Overall Study|Recurrence of Disease|1|||
127936718|NCT00643565|460392493|FG000|Overall Study|Progression of Disease|18|||
127936719|NCT00643565|460392494|FG001|Overall Study|Progression of Disease|14|||
127936720|NCT00643565|460392493|FG000|Overall Study|Protocol Violation|3|||
127936721|NCT00643565|460392494|FG001|Overall Study|Protocol Violation|0|||
127936722|NCT00643565|460392493|FG000|Overall Study|Did Not Cooperate|0|||
127936723|NCT00643565|460392494|FG001|Overall Study|Did Not Cooperate|1|||
127936724|NCT00643565|460392493|FG000|Overall Study|Administrative|22|||
127936725|NCT00643565|460392494|FG001|Overall Study|Administrative|16|||
127936726|NCT00643565|460392493|FG000|Overall Study|Adverse Event|5|||
127936727|NCT00643565|460392494|FG001|Overall Study|Adverse Event|8|||
127936728|NCT02317614|460392495|FG000|Overall Study|Lost to Follow-up|1|||
127936729|NCT02317614|460392496|FG001|Overall Study|Lost to Follow-up|1|||
127936730|NCT02317614|460392495|FG000|Overall Study|Withdrawal by Subject|1|||
127936731|NCT02317614|460392496|FG001|Overall Study|Withdrawal by Subject|0|||
127936732|NCT02317614|460392495|FG000|Overall Study|Death|1|||
127936733|NCT02317614|460392496|FG001|Overall Study|Death|1|||
127936734|NCT00669071|460392501|FG000|Overall Study|Lost to Follow-up|3|||
127936735|NCT00669071|460392501|FG000|Overall Study|Final visit 40 days out of window|1|||
127936736|NCT02980874|460392502|FG000|Overall Study|Adverse Event|2|||
127936737|NCT02980874|460392503|FG001|Overall Study|Adverse Event|7|||
127936738|NCT02980874|460392502|FG000|Overall Study|Withdrawal by Subject|7|||
127936739|NCT02980874|460392503|FG001|Overall Study|Withdrawal by Subject|2|||
127936740|NCT02980874|460392502|FG000|Overall Study|Lost to Follow-up|5|||
127936741|NCT02980874|460392503|FG001|Overall Study|Lost to Follow-up|5|||
127936742|NCT02980874|460392502|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
127936743|NCT02980874|460392503|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
127936744|NCT02980874|460392502|FG000|Overall Study|Unknown study completion status|1|||
127936745|NCT02980874|460392503|FG001|Overall Study|Unknown study completion status|0|||
127936746|NCT02435836|460392504|FG000|Overall Study|Lost to Follow-up|21|||
127936747|NCT02435836|460392504|FG000|Overall Study|Lack of Efficacy|1|||
127936748|NCT02435836|460392504|FG000|Overall Study|Withdrawal by Subject|236|||
127936749|NCT02435836|460392504|FG000|Overall Study|Insufficient Clinical Response|26|||
127936750|NCT02435836|460392504|FG000|Overall Study|Adverse Event|44|||
127936751|NCT02435836|460392504|FG000|Overall Study|Sponsor discontinued trial|167|||
127936752|NCT02435836|460392504|FG000|Overall Study|Noncompliance|27|||
127936753|NCT02435836|460392504|FG000|Overall Study|Protocol Violation|6|||
127936754|NCT02435836|460392504|FG000|Overall Study|Met Withdrawal Criteria|7|||
127936755|NCT02435836|460392504|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
127936756|NCT02041091|460392505|FG000|Treatment|Adverse Event|3|||
127936757|NCT02041091|460392506|FG001|Treatment|Adverse Event|3|||
127936758|NCT02041091|460392505|FG000|Treatment|Withdrawal by Subject|2|||
127936759|NCT02041091|460392506|FG001|Treatment|Withdrawal by Subject|4|||
127936760|NCT02041091|460392505|FG000|Treatment|Physician Decision|1|||
127936761|NCT02041091|460392506|FG001|Treatment|Physician Decision|0|||
127936762|NCT02041091|460392505|FG000|Treatment|Sponsor Decision|15|||
127936763|NCT02041091|460392506|FG001|Treatment|Sponsor Decision|16|||
127936764|NCT02041091|460392505|FG000|Treatment|Lost to Follow-up|1|||
127936765|NCT02041091|460392506|FG001|Treatment|Lost to Follow-up|0|||
127936766|NCT02041091|460392505|FG000|Optional Safety Extension Period|Adverse Event|4|||
127936767|NCT02041091|460392506|FG001|Optional Safety Extension Period|Adverse Event|2|||
127936768|NCT02041091|460392505|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
127936769|NCT02041091|460392506|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
127936770|NCT02041091|460392505|FG000|Optional Safety Extension Period|Protocol Violation|2|||
127936771|NCT02041091|460392506|FG001|Optional Safety Extension Period|Protocol Violation|0|||
127936772|NCT02041091|460392505|FG000|Optional Safety Extension Period|Physician Decision|2|||
127936773|NCT02041091|460392506|FG001|Optional Safety Extension Period|Physician Decision|1|||
127936774|NCT02041091|460392505|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
127936775|NCT02041091|460392506|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
127936776|NCT02041091|460392505|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
127936777|NCT02041091|460392506|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
127936778|NCT01855074|460392507|FG000|Overall Study|Adverse Event|1|||
127936779|NCT01855074|460392507|FG000|Overall Study|Lost to Follow-up|4|||
127936780|NCT01855074|460392507|FG000|Overall Study|Withdrawal by Subject|8|||
127936781|NCT01855074|460392507|FG000|Overall Study|Started but not treated|1|||
127936782|NCT01150890|460392508|FG000|Overall Study|Other|0|||
127936783|NCT01150890|460392509|FG001|Overall Study|Other|1|||
127936784|NCT01150890|460392510|FG002|Overall Study|Other|0|||
127936785|NCT01150890|460392511|FG003|Overall Study|Other|2|||
127936786|NCT01150890|460392508|FG000|Overall Study|Pregnancy|0|||
127936787|NCT01150890|460392509|FG001|Overall Study|Pregnancy|0|||
127936788|NCT01150890|460392510|FG002|Overall Study|Pregnancy|0|||
127936789|NCT01150890|460392511|FG003|Overall Study|Pregnancy|1|||
127936790|NCT01150890|460392508|FG000|Overall Study|Administrative Decision|4|||
127936791|NCT01150890|460392509|FG001|Overall Study|Administrative Decision|4|||
127936792|NCT01150890|460392510|FG002|Overall Study|Administrative Decision|5|||
127936793|NCT01150890|460392511|FG003|Overall Study|Administrative Decision|6|||
127936794|NCT01150890|460392508|FG000|Overall Study|Ineligibility determined|0|||
127936795|NCT01150890|460392509|FG001|Overall Study|Ineligibility determined|1|||
127936796|NCT01150890|460392510|FG002|Overall Study|Ineligibility determined|0|||
127936797|NCT01150890|460392511|FG003|Overall Study|Ineligibility determined|0|||
127936798|NCT01150890|460392508|FG000|Overall Study|Adverse Event|0|||
127936799|NCT01150890|460392509|FG001|Overall Study|Adverse Event|0|||
127936800|NCT01150890|460392510|FG002|Overall Study|Adverse Event|2|||
127936801|NCT01150890|460392511|FG003|Overall Study|Adverse Event|0|||
127936802|NCT01150890|460392508|FG000|Overall Study|Withdrawal by Subject|0|||
127936803|NCT01150890|460392509|FG001|Overall Study|Withdrawal by Subject|0|||
127936804|NCT01150890|460392510|FG002|Overall Study|Withdrawal by Subject|2|||
127936805|NCT01150890|460392511|FG003|Overall Study|Withdrawal by Subject|1|||
127936806|NCT01150890|460392508|FG000|Overall Study|Disease progression|0|||
127936807|NCT01150890|460392509|FG001|Overall Study|Disease progression|7|||
127936808|NCT01150890|460392510|FG002|Overall Study|Disease progression|3|||
127936809|NCT01150890|460392511|FG003|Overall Study|Disease progression|7|||
127936810|NCT00922987|460392512|FG000|Overall Study|Insufficient clinical response|1|||
127936811|NCT00922987|460392512|FG000|Overall Study|Protocol Violation|2|||
127936812|NCT00922987|460392512|FG000|Overall Study|Adverse Event|1|||
127936813|NCT00446199|460392513|FG000|Overall Study|Adverse Event|7|||
127936814|NCT00446199|460392514|FG001|Overall Study|Adverse Event|4|||
127936815|NCT00446199|460392515|FG002|Overall Study|Adverse Event|6|||
127936816|NCT00446199|460392516|FG003|Overall Study|Adverse Event|4|||
127936817|NCT00446199|460392513|FG000|Overall Study|Lost to Follow-up|4|||
127936818|NCT00446199|460392514|FG001|Overall Study|Lost to Follow-up|5|||
127936819|NCT00446199|460392515|FG002|Overall Study|Lost to Follow-up|2|||
127936820|NCT00446199|460392516|FG003|Overall Study|Lost to Follow-up|6|||
127936821|NCT00446199|460392513|FG000|Overall Study|Protocol Violation|1|||
127936822|NCT00446199|460392514|FG001|Overall Study|Protocol Violation|2|||
127936823|NCT00446199|460392515|FG002|Overall Study|Protocol Violation|1|||
127936824|NCT00446199|460392516|FG003|Overall Study|Protocol Violation|3|||
127936825|NCT00446199|460392513|FG000|Overall Study|Withdrawal by Subject|2|||
127936826|NCT00446199|460392514|FG001|Overall Study|Withdrawal by Subject|5|||
127936827|NCT00446199|460392515|FG002|Overall Study|Withdrawal by Subject|9|||
127936828|NCT00446199|460392516|FG003|Overall Study|Withdrawal by Subject|10|||
127936829|NCT00446199|460392513|FG000|Overall Study|Site termination|2|||
127936830|NCT00446199|460392514|FG001|Overall Study|Site termination|0|||
127936831|NCT00446199|460392515|FG002|Overall Study|Site termination|0|||
127936832|NCT00446199|460392516|FG003|Overall Study|Site termination|1|||
127936833|NCT00446199|460392513|FG000|Overall Study|Randomization in Error|2|||
127936834|NCT00446199|460392514|FG001|Overall Study|Randomization in Error|0|||
127936835|NCT00446199|460392515|FG002|Overall Study|Randomization in Error|1|||
127936836|NCT00446199|460392516|FG003|Overall Study|Randomization in Error|1|||
127936837|NCT00446199|460392513|FG000|Overall Study|Lack of Efficacy|1|||
127936838|NCT00446199|460392514|FG001|Overall Study|Lack of Efficacy|0|||
127936839|NCT00446199|460392515|FG002|Overall Study|Lack of Efficacy|0|||
127936840|NCT00446199|460392516|FG003|Overall Study|Lack of Efficacy|1|||
127936841|NCT00446199|460392513|FG000|Overall Study|Non-compliant with study drug|1|||
127936842|NCT00446199|460392514|FG001|Overall Study|Non-compliant with study drug|0|||
127936843|NCT00446199|460392515|FG002|Overall Study|Non-compliant with study drug|5|||
127936844|NCT00446199|460392516|FG003|Overall Study|Non-compliant with study drug|0|||
127936845|NCT00446199|460392513|FG000|Overall Study|Non-compliant with visit schedule|1|||
127936846|NCT00446199|460392514|FG001|Overall Study|Non-compliant with visit schedule|1|||
127936847|NCT00446199|460392515|FG002|Overall Study|Non-compliant with visit schedule|1|||
127936848|NCT00446199|460392516|FG003|Overall Study|Non-compliant with visit schedule|2|||
127936849|NCT00446199|460392513|FG000|Overall Study|Hormone fear|0|||
127936850|NCT00446199|460392514|FG001|Overall Study|Hormone fear|0|||
127936851|NCT00446199|460392515|FG002|Overall Study|Hormone fear|0|||
127936852|NCT00446199|460392516|FG003|Overall Study|Hormone fear|1|||
127936853|NCT00446199|460392513|FG000|Overall Study|Lost interest in study participation|0|||
127936854|NCT00446199|460392514|FG001|Overall Study|Lost interest in study participation|1|||
127936855|NCT00446199|460392515|FG002|Overall Study|Lost interest in study participation|0|||
127936856|NCT00446199|460392516|FG003|Overall Study|Lost interest in study participation|0|||
127936857|NCT00446199|460392513|FG000|Overall Study|In-/Exclusion criterion violated|2|||
127936858|NCT00446199|460392514|FG001|Overall Study|In-/Exclusion criterion violated|1|||
127936859|NCT00446199|460392515|FG002|Overall Study|In-/Exclusion criterion violated|2|||
127936860|NCT00446199|460392516|FG003|Overall Study|In-/Exclusion criterion violated|1|||
127936861|NCT00446199|460392513|FG000|Overall Study|Move|0|||
127936862|NCT00446199|460392514|FG001|Overall Study|Move|1|||
127936863|NCT00446199|460392515|FG002|Overall Study|Move|0|||
127936864|NCT00446199|460392516|FG003|Overall Study|Move|0|||
127936865|NCT03071094|460392520|FG000|Overall Study|Death|1|||
127936866|NCT03071094|460392521|FG001|Overall Study|Death|1|||
127936867|NCT03071094|460392520|FG000|Overall Study|Adverse Event|1|||
127936868|NCT03071094|460392521|FG001|Overall Study|Adverse Event|0|||
127936869|NCT02312063|460392522|FG000|Overall Study|Withdrawal by Subject|0|||
127936870|NCT02312063|460392523|FG001|Overall Study|Withdrawal by Subject|1|||
127936871|NCT01079832|460392524|FG000|Overall Study|Withdrawal by Subject|1|||
127936872|NCT06077487|460394669|FG000|Overall Study|Withdrawal by Subject|0|||
127936873|NCT06077487|460394670|FG001|Overall Study|Withdrawal by Subject|1|||
127936874|NCT00759902|460394672|FG000|Overall Study|Adverse Event|0|||
127936875|NCT00759902|460394673|FG001|Overall Study|Adverse Event|1|||
127936876|NCT02128217|460394674|FG000|Overall Study|Lost to Follow-up|0|||
127936877|NCT02128217|460394675|FG001|Overall Study|Lost to Follow-up|1|||
127936878|NCT05071313|460394678|FG000|Overall Study|Lost to Follow-up|17|||
127936879|NCT05071313|460394679|FG001|Overall Study|Lost to Follow-up|10|||
127936880|NCT05071313|460394678|FG000|Overall Study|Physician Decision|1|||
127936881|NCT05071313|460394679|FG001|Overall Study|Physician Decision|6|||
127936882|NCT05071313|460394678|FG000|Overall Study|Death|1|||
127936883|NCT05071313|460394679|FG001|Overall Study|Death|0|||
127936884|NCT05071313|460394678|FG000|Overall Study|Withdrawal by Subject|10|||
127936885|NCT05071313|460394679|FG001|Overall Study|Withdrawal by Subject|15|||
127936886|NCT05071313|460394678|FG000|Overall Study|Other|1|||
127936887|NCT05071313|460394679|FG001|Overall Study|Other|0|||
127936888|NCT05071313|460394678|FG000|Overall Study|Randomized but not vaccinated|4|||
127936889|NCT05071313|460394679|FG001|Overall Study|Randomized but not vaccinated|2|||
127936890|NCT03107026|460394680|FG000|Overall Study|Adverse Event|2|||
127936891|NCT03107026|460394681|FG001|Overall Study|Adverse Event|14|||
127936892|NCT03107026|460394682|FG002|Overall Study|Adverse Event|23|||
127936893|NCT03107026|460394680|FG000|Overall Study|Lost to Follow-up|12|||
127936894|NCT03107026|460394681|FG001|Overall Study|Lost to Follow-up|12|||
127936895|NCT03107026|460394682|FG002|Overall Study|Lost to Follow-up|13|||
127936896|NCT03107026|460394680|FG000|Overall Study|Protocol Violation|1|||
127936897|NCT03107026|460394681|FG001|Overall Study|Protocol Violation|2|||
127936898|NCT03107026|460394682|FG002|Overall Study|Protocol Violation|0|||
127936899|NCT03107026|460394680|FG000|Overall Study|Pregnancy|1|||
127936900|NCT03107026|460394681|FG001|Overall Study|Pregnancy|0|||
127936901|NCT03107026|460394682|FG002|Overall Study|Pregnancy|0|||
127936902|NCT03107026|460394680|FG000|Overall Study|Withdrawal by Subject|13|||
127936903|NCT03107026|460394681|FG001|Overall Study|Withdrawal by Subject|5|||
127936904|NCT03107026|460394682|FG002|Overall Study|Withdrawal by Subject|17|||
127936905|NCT03107026|460394680|FG000|Overall Study|non compliance with study visits|1|||
127936906|NCT03107026|460394681|FG001|Overall Study|non compliance with study visits|2|||
127936907|NCT03107026|460394682|FG002|Overall Study|non compliance with study visits|0|||
127936908|NCT03107026|460394680|FG000|Overall Study|non-compliance with study drug|2|||
127936909|NCT03107026|460394681|FG001|Overall Study|non-compliance with study drug|2|||
127936910|NCT03107026|460394682|FG002|Overall Study|non-compliance with study drug|3|||
127936911|NCT03107026|460394680|FG000|Overall Study|Physician Decision|0|||
127936912|NCT03107026|460394681|FG001|Overall Study|Physician Decision|1|||
127936913|NCT03107026|460394682|FG002|Overall Study|Physician Decision|0|||
127936914|NCT02049450|460394683|FG000|Overall Study|Adverse Event|2|||
127936915|NCT02049450|460394683|FG000|Overall Study|Withdrawal by Subject|1|||
127936916|NCT02049450|460394683|FG000|Overall Study|Patients/guardian decision|1|||
127936917|NCT00577395|460394684|FG000|Overall Study|Study was terminated early by Sponsor|7|||
127936918|NCT00577395|460394685|FG001|Overall Study|Study was terminated early by Sponsor|6|||
127936919|NCT04709835|460394690|FG000|Overall Study|Withdrawal by Subject|0|||
127936920|NCT04709835|460394691|FG001|Overall Study|Withdrawal by Subject|1|||
127936921|NCT04709835|460394692|FG002|Overall Study|Withdrawal by Subject|0|||
127936922|NCT04325204|460394693|FG000|Overall Study|Death|0|||
127936923|NCT04325204|460394694|FG001|Overall Study|Death|1|||
127936924|NCT04325204|460394693|FG000|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|1|||
127936925|NCT04325204|460394694|FG001|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|0|||
127936926|NCT04325204|460394693|FG000|Overall Study|Lost to Follow-up|8|||
127936927|NCT04325204|460394694|FG001|Overall Study|Lost to Follow-up|8|||
127936928|NCT04325204|460394693|FG000|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
127936929|NCT04325204|460394694|FG001|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
127936930|NCT04711902|460394696|FG000|Treatment Period 2 (From Week 16)|Participant decision|0|||
127936931|NCT04711902|460394697|FG001|Treatment Period 2 (From Week 16)|Participant decision|0|||
127936932|NCT04711902|460394698|FG002|Treatment Period 2 (From Week 16)|Participant decision|2|||
127936933|NCT04711902|460394699|FG003|Treatment Period 2 (From Week 16)|Participant decision|0|||
127936934|NCT04711902|460394700|FG004|Treatment Period 2 (From Week 16)|Participant decision|0|||
127936935|NCT04711902|460394701|FG005|Treatment Period 2 (From Week 16)|Participant decision|0|||
127936936|NCT04710979|460394702|FG000|Overall Study|Lost to Follow-up|2|||
127936937|NCT04710979|460394703|FG001|Overall Study|Lost to Follow-up|4|||
127936938|NCT04710979|460394702|FG000|Overall Study|Withdrawal by Subject|1|||
127936939|NCT04710979|460394703|FG001|Overall Study|Withdrawal by Subject|0|||
127936940|NCT01561430|460394709|FG000|Overall Study|Adverse Event|0|||
127936941|NCT01561430|460394710|FG001|Overall Study|Adverse Event|0|||
127936942|NCT01561430|460394711|FG002|Overall Study|Adverse Event|3|||
127936943|NCT01561430|460394712|FG003|Overall Study|Adverse Event|1|||
127936944|NCT01561430|460394709|FG000|Overall Study|Withdrawal by Subject|0|||
127936945|NCT01561430|460394710|FG001|Overall Study|Withdrawal by Subject|0|||
127936946|NCT01561430|460394711|FG002|Overall Study|Withdrawal by Subject|1|||
127936947|NCT01561430|460394712|FG003|Overall Study|Withdrawal by Subject|0|||
127936948|NCT01561430|460394709|FG000|Overall Study|Physician Decision|0|||
127936949|NCT01561430|460394710|FG001|Overall Study|Physician Decision|1|||
127936950|NCT01561430|460394711|FG002|Overall Study|Physician Decision|0|||
127936951|NCT01561430|460394712|FG003|Overall Study|Physician Decision|0|||
127936952|NCT01561430|460394709|FG000|Overall Study|Sponsor Decision|1|||
127936953|NCT01561430|460394710|FG001|Overall Study|Sponsor Decision|14|||
127936954|NCT01561430|460394711|FG002|Overall Study|Sponsor Decision|13|||
127936955|NCT01561430|460394712|FG003|Overall Study|Sponsor Decision|12|||
127936956|NCT03347422|460394713|FG000|Part A (26 Weeks)|Adverse Event|3|||
127936957|NCT03347422|460394714|FG001|Part A (26 Weeks)|Adverse Event|0|||
127936958|NCT03347422|460394713|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
127936959|NCT03347422|460394714|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
127936960|NCT03347422|460394713|FG000|Part B (149 Weeks)|Adverse Event|0|||
127936961|NCT03347422|460394714|FG001|Part B (149 Weeks)|Adverse Event|1|||
127936962|NCT03347422|460394713|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
127936963|NCT03347422|460394714|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
127936964|NCT03347422|460394713|FG000|Part B (149 Weeks)|Other|1|||
127936965|NCT03347422|460394714|FG001|Part B (149 Weeks)|Other|0|||
127936966|NCT00415194|460394718|FG000|Overall Study|Adverse Event|37|||
127936967|NCT00415194|460394719|FG001|Overall Study|Adverse Event|32|||
127936968|NCT00415194|460394718|FG000|Overall Study|Entry Criteria Not Met|4|||
127936969|NCT00415194|460394719|FG001|Overall Study|Entry Criteria Not Met|8|||
127936970|NCT00415194|460394718|FG000|Overall Study|Lost to Follow-up|1|||
127936971|NCT00415194|460394719|FG001|Overall Study|Lost to Follow-up|0|||
127936972|NCT00415194|460394718|FG000|Overall Study|Physician Decision|10|||
127936973|NCT00415194|460394719|FG001|Overall Study|Physician Decision|16|||
127936974|NCT00415194|460394718|FG000|Overall Study|Progressive Disease|180|||
127936975|NCT00415194|460394719|FG001|Overall Study|Progressive Disease|217|||
127936976|NCT00415194|460394718|FG000|Overall Study|Protocol Violation|4|||
127936977|NCT00415194|460394719|FG001|Overall Study|Protocol Violation|2|||
127936978|NCT00415194|460394718|FG000|Overall Study|Withdrawal by Subject|28|||
127936979|NCT00415194|460394719|FG001|Overall Study|Withdrawal by Subject|21|||
127936980|NCT00415194|460394718|FG000|Overall Study|Death Due to Study Disease|26|||
127936981|NCT00415194|460394719|FG001|Overall Study|Death Due to Study Disease|29|||
127936982|NCT00415194|460394718|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
127936983|NCT00415194|460394719|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
127936984|NCT00415194|460394718|FG000|Overall Study|Death Due to Procedural Related AE|0|||
127936985|NCT00415194|460394719|FG001|Overall Study|Death Due to Procedural Related AE|1|||
127936986|NCT00415194|460394718|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
127936987|NCT00415194|460394719|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
127936988|NCT01297465|460394720|FG000|Overall Study|Lack of Ovarian Response|1|||
127936989|NCT01297465|460394721|FG001|Overall Study|Lack of Ovarian Response|1|||
127936990|NCT01297465|460394720|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
127936991|NCT01297465|460394721|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
127936992|NCT01297465|460394720|FG000|Overall Study|No Oocytes Retrieved|1|||
127936993|NCT01297465|460394721|FG001|Overall Study|No Oocytes Retrieved|1|||
127936994|NCT01297465|460394720|FG000|Overall Study|Poor oocyte quality|0|||
127936995|NCT01297465|460394721|FG001|Overall Study|Poor oocyte quality|1|||
127936996|NCT01297465|460394720|FG000|Overall Study|No Fertilization|6|||
127936997|NCT01297465|460394721|FG001|Overall Study|No Fertilization|4|||
127936998|NCT01297465|460394720|FG000|Overall Study|All Embryos Discarded|0|||
127936999|NCT01297465|460394721|FG001|Overall Study|All Embryos Discarded|1|||
127937000|NCT01297465|460394720|FG000|Overall Study|Intention to Freeze all Embryos|0|||
127937001|NCT01297465|460394721|FG001|Overall Study|Intention to Freeze all Embryos|1|||
127937002|NCT00969540|460394722|FG000|Overall Study|Lost to Follow-up|1|||
127937003|NCT00969540|460394723|FG001|Overall Study|Lost to Follow-up|1|||
127937004|NCT02397408|460394724|FG000|Overall Study|Physician Decision|4|||
127937005|NCT02397408|460394724|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
127937006|NCT00369655|460394725|FG000|Overall Study|Refusal of further treatment|2|||
127937007|NCT01683838|460394726|FG000|Overall Study|Adverse Event|12|||
127937008|NCT01683838|460394727|FG001|Overall Study|Adverse Event|2|||
127937009|NCT01683838|460394726|FG000|Overall Study|Protocol Violation|3|||
127937010|NCT01683838|460394727|FG001|Overall Study|Protocol Violation|1|||
127937011|NCT01683838|460394726|FG000|Overall Study|Withdrawal by Subject|6|||
127937012|NCT01683838|460394727|FG001|Overall Study|Withdrawal by Subject|5|||
127937013|NCT01683838|460394726|FG000|Overall Study|Lost to Follow-up|1|||
127937014|NCT01683838|460394727|FG001|Overall Study|Lost to Follow-up|1|||
127937015|NCT01683838|460394726|FG000|Overall Study|Other|4|||
127937016|NCT01683838|460394727|FG001|Overall Study|Other|3|||
127937017|NCT01646138|460394728|FG000|Overall Study|Lost to Follow-up|0|||
127937018|NCT01646138|460394729|FG001|Overall Study|Lost to Follow-up|0|||
127937019|NCT01646138|460394730|FG002|Overall Study|Lost to Follow-up|0|||
127937020|NCT01646138|460394731|FG003|Overall Study|Lost to Follow-up|0|||
127937021|NCT01646138|460394732|FG004|Overall Study|Lost to Follow-up|2|||
127937022|NCT04049617|460394733|FG000|Overall Study|Adverse Event|0|||
127937023|NCT04049617|460394734|FG001|Overall Study|Adverse Event|0|||
127937024|NCT04049617|460394735|FG002|Overall Study|Adverse Event|0|||
127937025|NCT04049617|460394736|FG003|Overall Study|Adverse Event|1|||
127937026|NCT04049617|460394737|FG004|Overall Study|Adverse Event|0|||
127937027|NCT04049617|460394738|FG005|Overall Study|Adverse Event|0|||
127937028|NCT04049617|460394733|FG000|Overall Study|Death|0|||
127937029|NCT04049617|460394734|FG001|Overall Study|Death|0|||
127937030|NCT04049617|460394735|FG002|Overall Study|Death|0|||
127937031|NCT04049617|460394736|FG003|Overall Study|Death|0|||
127937032|NCT04049617|460394737|FG004|Overall Study|Death|0|||
127937033|NCT04049617|460394738|FG005|Overall Study|Death|1|||
127937034|NCT04049617|460394733|FG000|Overall Study|Lost to Follow-up|0|||
127937035|NCT04049617|460394734|FG001|Overall Study|Lost to Follow-up|0|||
127937036|NCT04049617|460394735|FG002|Overall Study|Lost to Follow-up|0|||
127937037|NCT04049617|460394736|FG003|Overall Study|Lost to Follow-up|1|||
127937038|NCT04049617|460394737|FG004|Overall Study|Lost to Follow-up|0|||
127937039|NCT04049617|460394738|FG005|Overall Study|Lost to Follow-up|0|||
127937040|NCT04049617|460394733|FG000|Overall Study|Withdrew consent|0|||
127937041|NCT04049617|460394734|FG001|Overall Study|Withdrew consent|0|||
127937042|NCT04049617|460394735|FG002|Overall Study|Withdrew consent|1|||
127937043|NCT04049617|460394736|FG003|Overall Study|Withdrew consent|0|||
127937044|NCT04049617|460394737|FG004|Overall Study|Withdrew consent|0|||
127937045|NCT04049617|460394738|FG005|Overall Study|Withdrew consent|0|||
127937046|NCT03551496|460394739|FG000|Overall Study|Death|11|||
127937047|NCT03551496|460394740|FG001|Overall Study|Death|7|||
127937048|NCT03551496|460394739|FG000|Overall Study|Withdrawal by Subject|4|||
127937049|NCT03551496|460394740|FG001|Overall Study|Withdrawal by Subject|3|||
127937050|NCT03551496|460394739|FG000|Overall Study|Other Reasons|1|||
127937051|NCT03551496|460394740|FG001|Overall Study|Other Reasons|0|||
127937052|NCT01524679|460394741|FG000|Overall Study|Lost to Follow-up|1|||
127937053|NCT01524679|460394742|FG001|Overall Study|Lost to Follow-up|4|||
127937054|NCT01524679|460394741|FG000|Overall Study|Withdrawal by Subject|4|||
127937055|NCT01524679|460394742|FG001|Overall Study|Withdrawal by Subject|4|||
127937056|NCT01524679|460394741|FG000|Overall Study|Adverse Event|9|||
127937057|NCT01524679|460394742|FG001|Overall Study|Adverse Event|0|||
127937058|NCT01524679|460394741|FG000|Overall Study|Protocol Violation|1|||
127937059|NCT01524679|460394742|FG001|Overall Study|Protocol Violation|0|||
127937060|NCT01524679|460394741|FG000|Overall Study|Lack of Efficacy|2|||
127937061|NCT01524679|460394742|FG001|Overall Study|Lack of Efficacy|0|||
127937062|NCT01524679|460394741|FG000|Overall Study|e.g.wish for children, relocation|6|||
127937063|NCT01524679|460394742|FG001|Overall Study|e.g.wish for children, relocation|1|||
127937064|NCT00801099|460394743|FG000|Overall Study|Lost to Follow-up|101|||
127937065|NCT02455050|460394746|FG000|Treatment Period 1|Lost to Follow-up|1|||
127937066|NCT02455050|460394747|FG001|Treatment Period 1|Lost to Follow-up|1|||
127937067|NCT02455050|460394748|FG002|Treatment Period 1|Lost to Follow-up|1|||
127937068|NCT02455050|460394749|FG003|Treatment Period 1|Lost to Follow-up|2|||
127937069|NCT02455050|460394746|FG000|Treatment Period 2|Lost to Follow-up|1|||
127937070|NCT02455050|460394747|FG001|Treatment Period 2|Lost to Follow-up|0|||
127937071|NCT02455050|460394748|FG002|Treatment Period 2|Lost to Follow-up|2|||
127937072|NCT02455050|460394749|FG003|Treatment Period 2|Lost to Follow-up|1|||
127937073|NCT02981303|460394750|FG000|Overall Study|Progressive Disease|17|||
127937074|NCT02981303|460394751|FG001|Overall Study|Progressive Disease|37|||
127937075|NCT02981303|460394750|FG000|Overall Study|Adverse Event|1|||
127937076|NCT02981303|460394751|FG001|Overall Study|Adverse Event|4|||
127937077|NCT02981303|460394750|FG000|Overall Study|Withdrawal by Subject|0|||
127937078|NCT02981303|460394751|FG001|Overall Study|Withdrawal by Subject|1|||
127937079|NCT02325518|460394752|FG000|Overall Study|Adverse Event|4|||
127937080|NCT02325518|460394753|FG001|Overall Study|Adverse Event|1|||
127937081|NCT02325518|460394752|FG000|Overall Study|Physician Decision|0|||
127937082|NCT02325518|460394753|FG001|Overall Study|Physician Decision|1|||
127937083|NCT02325518|460394752|FG000|Overall Study|Withdrawal by Subject|0|||
127937084|NCT02325518|460394753|FG001|Overall Study|Withdrawal by Subject|1|||
127937085|NCT03393806|460394756|FG000|Overall Study|Physician Decision|1|||
127937086|NCT03393806|460394757|FG001|Overall Study|Physician Decision|0|||
127937087|NCT00886288|460394758|FG000|Overall Study|no respect of the 12 weeks period|657|||
127937088|NCT00886288|460394759|FG001|Overall Study|no respect of the 12 weeks period|227|||
127937089|NCT00886288|460394758|FG000|Overall Study|Lost to Follow-up|86|||
127937090|NCT00886288|460394759|FG001|Overall Study|Lost to Follow-up|0|||
127937091|NCT01259115|460394760|FG000|Period 1|Adverse Event|1|||
127937092|NCT01259115|460394761|FG001|Period 1|Adverse Event|0|||
127937093|NCT01259115|460394760|FG000|Period 1|Protocol Violation|2|||
127937094|NCT01259115|460394761|FG001|Period 1|Protocol Violation|0|||
127937095|NCT01259115|460394760|FG000|Period 1|Lost to Follow-up|0|||
127937096|NCT01259115|460394761|FG001|Period 1|Lost to Follow-up|1|||
127937097|NCT01259115|460394760|FG000|Period 2|Adverse Event|1|||
127937098|NCT01259115|460394761|FG001|Period 2|Adverse Event|0|||
127937099|NCT01675661|460394762|FG000|Overall Study|Lost to Follow-up|22|||
127937100|NCT01675661|460394763|FG001|Overall Study|Lost to Follow-up|23|||
127937101|NCT01675661|460394762|FG000|Overall Study|Practical problems|9|||
127937102|NCT01675661|460394763|FG001|Overall Study|Practical problems|5|||
127937103|NCT01675661|460394762|FG000|Overall Study|Moved away|5|||
127937104|NCT01675661|460394763|FG001|Overall Study|Moved away|6|||
127937105|NCT01675661|460394762|FG000|Overall Study|Withdrawal by Subject|3|||
127937106|NCT01675661|460394763|FG001|Overall Study|Withdrawal by Subject|7|||
127937107|NCT01675661|460394762|FG000|Overall Study|Physician Decision|0|||
127937108|NCT01675661|460394763|FG001|Overall Study|Physician Decision|2|||
127937109|NCT01675661|460394762|FG000|Overall Study|Death|0|||
127937110|NCT01675661|460394763|FG001|Overall Study|Death|1|||
127937111|NCT01675661|460394762|FG000|Overall Study|Other reason|1|||
127937112|NCT01675661|460394763|FG001|Overall Study|Other reason|2|||
127937113|NCT02393248|460394764|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
127937114|NCT02393248|460394765|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
127937115|NCT02393248|460394766|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
127937116|NCT02393248|460394767|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
127937117|NCT02393248|460394768|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
127937118|NCT02393248|460394769|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
127937119|NCT02393248|460394770|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
127937120|NCT02393248|460394771|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
127937121|NCT02393248|460394772|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
127937122|NCT02393248|460394773|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
127937123|NCT02393248|460394774|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
127937124|NCT02393248|460394775|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
127937125|NCT02393248|460394776|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
127937126|NCT02393248|460394777|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
127937127|NCT02393248|460394778|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
127937128|NCT02393248|460394779|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
127937129|NCT02393248|460394780|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
127937130|NCT02393248|460394781|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
127937131|NCT02393248|460394782|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
127937132|NCT02393248|460394783|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
127937133|NCT02393248|460394784|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
127937134|NCT02393248|460394785|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
127937135|NCT02393248|460394786|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
127937136|NCT02393248|460394787|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
127937137|NCT02393248|460394788|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
127937138|NCT02393248|460394764|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
127937139|NCT02393248|460394765|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
127937140|NCT02393248|460394766|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
127937141|NCT02393248|460394767|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
127937142|NCT02393248|460394768|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
127937143|NCT02393248|460394769|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
127937144|NCT02393248|460394770|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
127937145|NCT02393248|460394771|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
127937146|NCT02393248|460394772|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
127937147|NCT02393248|460394773|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
127937148|NCT02393248|460394774|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
127937149|NCT02393248|460394775|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
127937150|NCT02393248|460394776|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
127937151|NCT02393248|460394777|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
127937152|NCT02393248|460394778|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
127937153|NCT02393248|460394779|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
127937154|NCT02393248|460394780|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
127937155|NCT02393248|460394781|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
127937156|NCT02393248|460394782|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
127937157|NCT02393248|460394783|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
127937158|NCT02393248|460394784|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
127937159|NCT02393248|460394785|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
127937160|NCT02393248|460394786|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
127937161|NCT02393248|460394787|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
127937162|NCT02393248|460394788|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
127937163|NCT02393248|460394764|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
127937164|NCT02393248|460394765|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
127937165|NCT02393248|460394766|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
127937166|NCT02393248|460394767|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
127937167|NCT02393248|460394768|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
127937168|NCT02393248|460394769|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
127937169|NCT02393248|460394770|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
127937170|NCT02393248|460394771|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
127937171|NCT02393248|460394772|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
127937172|NCT02393248|460394773|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
127937173|NCT02393248|460394774|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
127937174|NCT02393248|460394775|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
127937175|NCT02393248|460394776|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
127937176|NCT02393248|460394777|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
127937177|NCT02393248|460394778|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
127937178|NCT02393248|460394779|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
127937179|NCT02393248|460394780|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
127937180|NCT02393248|460394781|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
127937181|NCT02393248|460394782|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
127937182|NCT02393248|460394783|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
127937183|NCT02393248|460394784|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
127937184|NCT02393248|460394785|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
127937185|NCT02393248|460394786|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
127937186|NCT02393248|460394787|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
127937187|NCT02393248|460394788|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
127937188|NCT02393248|460394764|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
127937189|NCT02393248|460394765|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
127937190|NCT02393248|460394766|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
127937191|NCT02393248|460394767|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
127937192|NCT02393248|460394768|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
127937193|NCT02393248|460394769|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
127937194|NCT02393248|460394770|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
127937195|NCT02393248|460394771|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
127937196|NCT02393248|460394772|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
127937197|NCT02393248|460394773|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
127937198|NCT02393248|460394774|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
127937199|NCT02393248|460394775|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
127937200|NCT02393248|460394776|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
127937201|NCT02393248|460394777|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
127937202|NCT02393248|460394778|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
127937203|NCT02393248|460394779|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
127937204|NCT02393248|460394780|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
127937205|NCT02393248|460394781|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
127937206|NCT02393248|460394782|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
127937207|NCT02393248|460394783|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
127937208|NCT02393248|460394784|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
127937209|NCT02393248|460394785|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
127937210|NCT02393248|460394786|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
127937211|NCT02393248|460394787|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
127937212|NCT02393248|460394788|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
127937213|NCT02393248|460394764|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
127937214|NCT02393248|460394765|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
127937215|NCT02393248|460394766|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
127937216|NCT02393248|460394767|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
127937217|NCT02393248|460394768|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
127937218|NCT02393248|460394769|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
127937219|NCT02393248|460394770|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
127937220|NCT02393248|460394771|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
127937221|NCT02393248|460394772|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
127937222|NCT02393248|460394773|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
127937223|NCT02393248|460394774|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
127937224|NCT02393248|460394775|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
127937225|NCT02393248|460394776|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
127937226|NCT02393248|460394777|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
127937227|NCT02393248|460394778|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
127937228|NCT02393248|460394779|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
127937229|NCT02393248|460394780|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
127937230|NCT02393248|460394781|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
127937231|NCT02393248|460394782|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
127937232|NCT02393248|460394783|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
127937233|NCT02393248|460394784|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
127937234|NCT02393248|460394785|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
127937235|NCT02393248|460394786|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
127937236|NCT02393248|460394787|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
127937237|NCT02393248|460394788|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
127937238|NCT02393248|460394764|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
127937239|NCT02393248|460394765|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
127937240|NCT02393248|460394766|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
127937241|NCT02393248|460394767|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
127937242|NCT02393248|460394768|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
127937243|NCT02393248|460394769|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
127937244|NCT02393248|460394770|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
127937245|NCT02393248|460394771|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
127937246|NCT02393248|460394772|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
127937247|NCT02393248|460394773|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
127937248|NCT02393248|460394774|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
127937249|NCT02393248|460394775|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
127937250|NCT02393248|460394776|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
127937251|NCT02393248|460394777|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
127937252|NCT02393248|460394778|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
127937253|NCT02393248|460394779|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
127937254|NCT02393248|460394780|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
127937255|NCT02393248|460394781|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
127937256|NCT02393248|460394782|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
127937257|NCT02393248|460394783|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
127937258|NCT02393248|460394784|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
127937259|NCT02393248|460394785|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
127937260|NCT02393248|460394786|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
127937261|NCT02393248|460394787|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
127937262|NCT02393248|460394788|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
127937263|NCT02393248|460394764|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
127937264|NCT02393248|460394765|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
127937265|NCT02393248|460394766|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
127937266|NCT02393248|460394767|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
127937267|NCT02393248|460394768|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
127937268|NCT02393248|460394769|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
127937269|NCT02393248|460394770|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
127937270|NCT02393248|460394771|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
127937271|NCT02393248|460394772|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
127937272|NCT02393248|460394773|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
127937273|NCT02393248|460394774|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
127937274|NCT02393248|460394775|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
127937275|NCT02393248|460394776|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
127937276|NCT02393248|460394777|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
127937277|NCT02393248|460394778|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
127937278|NCT02393248|460394779|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
127937279|NCT02393248|460394780|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
127937280|NCT02393248|460394781|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
127937281|NCT02393248|460394782|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
127937282|NCT02393248|460394783|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
127937283|NCT02393248|460394784|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
127937284|NCT02393248|460394785|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
127937285|NCT02393248|460394786|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
127937286|NCT02393248|460394787|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
127937287|NCT02393248|460394788|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
127937288|NCT02393248|460394764|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
127937289|NCT02393248|460394765|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
127937290|NCT02393248|460394766|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
127937291|NCT02393248|460394767|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
127937292|NCT02393248|460394768|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
127937293|NCT02393248|460394769|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
127937294|NCT02393248|460394770|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
127937295|NCT02393248|460394771|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
127937296|NCT02393248|460394772|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
127937297|NCT02393248|460394773|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
127937298|NCT02393248|460394774|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
127937299|NCT02393248|460394775|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
127937300|NCT02393248|460394776|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
127937301|NCT02393248|460394777|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
127937302|NCT02393248|460394778|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
127937303|NCT02393248|460394779|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
127937304|NCT02393248|460394780|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
127937305|NCT02393248|460394781|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
127937306|NCT02393248|460394782|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
127937307|NCT02393248|460394783|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
127937308|NCT02393248|460394784|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
127937309|NCT02393248|460394785|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
127937310|NCT02393248|460394786|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
127937311|NCT02393248|460394787|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
127937312|NCT02393248|460394788|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
127937313|NCT02393248|460394764|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
127937314|NCT02393248|460394765|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
127937315|NCT02393248|460394766|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
127937316|NCT02393248|460394767|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
127937317|NCT02393248|460394768|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
127937318|NCT02393248|460394769|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
127937319|NCT02393248|460394770|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
127937320|NCT02393248|460394771|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
127937321|NCT02393248|460394772|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
127937322|NCT02393248|460394773|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
127937323|NCT02393248|460394774|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
127937324|NCT02393248|460394775|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
127937325|NCT02393248|460394776|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
127937326|NCT02393248|460394777|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
127937327|NCT02393248|460394778|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
127937328|NCT02393248|460394779|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
127937329|NCT02393248|460394780|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
127937330|NCT02393248|460394781|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
127937331|NCT02393248|460394782|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
127937332|NCT02393248|460394783|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
127937333|NCT02393248|460394784|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
127937334|NCT02393248|460394785|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
127937335|NCT02393248|460394786|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
127937336|NCT02393248|460394787|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
127937337|NCT02393248|460394788|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
127937338|NCT02393248|460394764|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
127937339|NCT02393248|460394765|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
127937340|NCT02393248|460394766|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
127937341|NCT02393248|460394767|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
127937342|NCT02393248|460394768|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
127937343|NCT02393248|460394769|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
127937344|NCT02393248|460394770|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
127937345|NCT02393248|460394771|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
127937346|NCT02393248|460394772|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
127937347|NCT02393248|460394773|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
127937348|NCT02393248|460394774|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
127937349|NCT02393248|460394775|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
127937350|NCT02393248|460394776|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
127937351|NCT02393248|460394777|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
127937352|NCT02393248|460394778|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
127937353|NCT02393248|460394779|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
127937354|NCT02393248|460394780|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
127937355|NCT02393248|460394781|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
127937356|NCT02393248|460394782|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
127937357|NCT02393248|460394783|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
127937358|NCT02393248|460394784|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
127937359|NCT02393248|460394785|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
127937360|NCT02393248|460394786|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
127937361|NCT02393248|460394787|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
127937362|NCT02393248|460394788|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
127937363|NCT02393248|460394764|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
127937364|NCT02393248|460394765|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
127937365|NCT02393248|460394766|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
127937366|NCT02393248|460394767|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
127937367|NCT02393248|460394768|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
127937368|NCT02393248|460394769|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
127937369|NCT02393248|460394770|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
127937370|NCT02393248|460394771|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
127937371|NCT02393248|460394772|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
127937372|NCT02393248|460394773|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
127937373|NCT02393248|460394774|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
127937374|NCT02393248|460394775|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
127937375|NCT02393248|460394776|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
127937376|NCT02393248|460394777|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
127937377|NCT02393248|460394778|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
127937378|NCT02393248|460394779|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
127937379|NCT02393248|460394780|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
127937380|NCT02393248|460394781|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
127937381|NCT02393248|460394782|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
127937382|NCT02393248|460394783|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
127937383|NCT02393248|460394784|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
127937384|NCT02393248|460394785|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
127937385|NCT02393248|460394786|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
127937386|NCT02393248|460394787|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
127937387|NCT02393248|460394788|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
127937388|NCT02393248|460394764|FG000|Part 3: Combination Therapy|Death|0|||
127937389|NCT02393248|460394765|FG001|Part 3: Combination Therapy|Death|0|||
127937390|NCT02393248|460394766|FG002|Part 3: Combination Therapy|Death|0|||
127937391|NCT02393248|460394767|FG003|Part 3: Combination Therapy|Death|0|||
127937392|NCT02393248|460394768|FG004|Part 3: Combination Therapy|Death|0|||
127937393|NCT02393248|460394769|FG005|Part 3: Combination Therapy|Death|0|||
127937394|NCT02393248|460394770|FG006|Part 3: Combination Therapy|Death|0|||
127937395|NCT02393248|460394771|FG007|Part 3: Combination Therapy|Death|0|||
127937396|NCT02393248|460394772|FG008|Part 3: Combination Therapy|Death|0|||
127937397|NCT02393248|460394773|FG009|Part 3: Combination Therapy|Death|0|||
127937398|NCT02393248|460394774|FG010|Part 3: Combination Therapy|Death|0|||
127937399|NCT02393248|460394775|FG011|Part 3: Combination Therapy|Death|0|||
127937400|NCT02393248|460394776|FG012|Part 3: Combination Therapy|Death|0|||
127937401|NCT02393248|460394777|FG013|Part 3: Combination Therapy|Death|0|||
127937402|NCT02393248|460394778|FG014|Part 3: Combination Therapy|Death|0|||
127937403|NCT02393248|460394779|FG015|Part 3: Combination Therapy|Death|1|||
127937404|NCT02393248|460394780|FG016|Part 3: Combination Therapy|Death|7|||
127937405|NCT02393248|460394781|FG017|Part 3: Combination Therapy|Death|5|||
127937406|NCT02393248|460394782|FG018|Part 3: Combination Therapy|Death|5|||
127937407|NCT02393248|460394783|FG019|Part 3: Combination Therapy|Death|3|||
127937408|NCT02393248|460394784|FG020|Part 3: Combination Therapy|Death|7|||
127937409|NCT02393248|460394785|FG021|Part 3: Combination Therapy|Death|5|||
127937410|NCT02393248|460394786|FG022|Part 3: Combination Therapy|Death|6|||
127937411|NCT02393248|460394787|FG023|Part 3: Combination Therapy|Death|3|||
127937412|NCT02393248|460394788|FG024|Part 3: Combination Therapy|Death|0|||
127937413|NCT02393248|460394764|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
127937414|NCT02393248|460394765|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
127937415|NCT02393248|460394766|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
127937416|NCT02393248|460394767|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
127937417|NCT02393248|460394768|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
127937418|NCT02393248|460394769|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
127937419|NCT02393248|460394770|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
127937420|NCT02393248|460394771|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
127937421|NCT02393248|460394772|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
127937422|NCT02393248|460394773|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
127937423|NCT02393248|460394774|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
127937424|NCT02393248|460394775|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
127937425|NCT02393248|460394776|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
127937426|NCT02393248|460394777|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
127937427|NCT02393248|460394778|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
127937428|NCT02393248|460394779|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
127937429|NCT02393248|460394780|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
127937430|NCT02393248|460394781|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
127937431|NCT02393248|460394782|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
127937432|NCT02393248|460394783|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
127937433|NCT02393248|460394784|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
127937434|NCT02393248|460394785|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
127937435|NCT02393248|460394786|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
127937436|NCT02393248|460394787|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
127937437|NCT02393248|460394788|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
127937438|NCT02393248|460394764|FG000|Part 3: Combination Therapy|Disease Progression|0|||
127937439|NCT02393248|460394765|FG001|Part 3: Combination Therapy|Disease Progression|0|||
127937440|NCT02393248|460394766|FG002|Part 3: Combination Therapy|Disease Progression|0|||
127937441|NCT02393248|460394767|FG003|Part 3: Combination Therapy|Disease Progression|0|||
127937442|NCT02393248|460394768|FG004|Part 3: Combination Therapy|Disease Progression|0|||
127937443|NCT02393248|460394769|FG005|Part 3: Combination Therapy|Disease Progression|0|||
127937444|NCT02393248|460394770|FG006|Part 3: Combination Therapy|Disease Progression|0|||
127937445|NCT02393248|460394771|FG007|Part 3: Combination Therapy|Disease Progression|0|||
127937446|NCT02393248|460394772|FG008|Part 3: Combination Therapy|Disease Progression|0|||
127937447|NCT02393248|460394773|FG009|Part 3: Combination Therapy|Disease Progression|0|||
127937448|NCT02393248|460394774|FG010|Part 3: Combination Therapy|Disease Progression|0|||
127937449|NCT02393248|460394775|FG011|Part 3: Combination Therapy|Disease Progression|0|||
127937450|NCT02393248|460394776|FG012|Part 3: Combination Therapy|Disease Progression|0|||
127937451|NCT02393248|460394777|FG013|Part 3: Combination Therapy|Disease Progression|0|||
127937452|NCT02393248|460394778|FG014|Part 3: Combination Therapy|Disease Progression|0|||
127937453|NCT02393248|460394779|FG015|Part 3: Combination Therapy|Disease Progression|0|||
127937454|NCT02393248|460394780|FG016|Part 3: Combination Therapy|Disease Progression|0|||
127937455|NCT02393248|460394781|FG017|Part 3: Combination Therapy|Disease Progression|0|||
127937456|NCT02393248|460394782|FG018|Part 3: Combination Therapy|Disease Progression|0|||
127937457|NCT02393248|460394783|FG019|Part 3: Combination Therapy|Disease Progression|0|||
127937458|NCT02393248|460394784|FG020|Part 3: Combination Therapy|Disease Progression|2|||
127937459|NCT02393248|460394785|FG021|Part 3: Combination Therapy|Disease Progression|1|||
127937460|NCT02393248|460394786|FG022|Part 3: Combination Therapy|Disease Progression|0|||
127937461|NCT02393248|460394787|FG023|Part 3: Combination Therapy|Disease Progression|0|||
127937462|NCT02393248|460394788|FG024|Part 3: Combination Therapy|Disease Progression|0|||
127937463|NCT02393248|460394764|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
127937464|NCT02393248|460394765|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
127937465|NCT02393248|460394766|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
127937466|NCT02393248|460394767|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
127937467|NCT02393248|460394768|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
127937468|NCT02393248|460394769|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
127937469|NCT02393248|460394770|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
127937470|NCT02393248|460394771|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
127937471|NCT02393248|460394772|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
127937472|NCT02393248|460394773|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
127937473|NCT02393248|460394774|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
127937474|NCT02393248|460394775|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
127937475|NCT02393248|460394776|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
127937476|NCT02393248|460394777|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
127937477|NCT02393248|460394778|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
127937478|NCT02393248|460394779|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
127937479|NCT02393248|460394780|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
127937480|NCT02393248|460394781|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
127937481|NCT02393248|460394782|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
127937482|NCT02393248|460394783|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
127937483|NCT02393248|460394784|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
127937484|NCT02393248|460394785|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
127937485|NCT02393248|460394786|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
127937486|NCT02393248|460394787|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
127937487|NCT02393248|460394788|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
127937488|NCT02393248|460394764|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
127937489|NCT02393248|460394765|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
127937490|NCT02393248|460394766|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
127937491|NCT02393248|460394767|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
127937492|NCT02393248|460394768|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
127937493|NCT02393248|460394769|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
127937494|NCT02393248|460394770|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
127937495|NCT02393248|460394771|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
127937496|NCT02393248|460394772|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
127937497|NCT02393248|460394773|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
127937498|NCT02393248|460394774|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
127937499|NCT02393248|460394775|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
127937500|NCT02393248|460394776|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
127937501|NCT02393248|460394777|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
127937502|NCT02393248|460394778|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
127937503|NCT02393248|460394779|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
127937504|NCT02393248|460394780|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
127937505|NCT02393248|460394781|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
127937506|NCT02393248|460394782|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
127937507|NCT02393248|460394783|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
127937508|NCT02393248|460394784|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
127937509|NCT02393248|460394785|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
127937510|NCT02393248|460394786|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
127937511|NCT02393248|460394787|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
127937512|NCT02393248|460394788|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
127937513|NCT02393248|460394764|FG000|Part 3: Combination Therapy|Adverse Event|0|||
127937514|NCT02393248|460394765|FG001|Part 3: Combination Therapy|Adverse Event|0|||
127937515|NCT02393248|460394766|FG002|Part 3: Combination Therapy|Adverse Event|0|||
127937516|NCT02393248|460394767|FG003|Part 3: Combination Therapy|Adverse Event|0|||
127937517|NCT02393248|460394768|FG004|Part 3: Combination Therapy|Adverse Event|0|||
127937518|NCT02393248|460394769|FG005|Part 3: Combination Therapy|Adverse Event|0|||
127937519|NCT02393248|460394770|FG006|Part 3: Combination Therapy|Adverse Event|0|||
127937520|NCT02393248|460394771|FG007|Part 3: Combination Therapy|Adverse Event|0|||
127937521|NCT02393248|460394772|FG008|Part 3: Combination Therapy|Adverse Event|0|||
127937522|NCT02393248|460394773|FG009|Part 3: Combination Therapy|Adverse Event|0|||
127937523|NCT02393248|460394774|FG010|Part 3: Combination Therapy|Adverse Event|0|||
127937524|NCT02393248|460394775|FG011|Part 3: Combination Therapy|Adverse Event|0|||
127937525|NCT02393248|460394776|FG012|Part 3: Combination Therapy|Adverse Event|0|||
127937526|NCT02393248|460394777|FG013|Part 3: Combination Therapy|Adverse Event|0|||
127937527|NCT02393248|460394778|FG014|Part 3: Combination Therapy|Adverse Event|0|||
127937528|NCT02393248|460394779|FG015|Part 3: Combination Therapy|Adverse Event|0|||
127937529|NCT02393248|460394780|FG016|Part 3: Combination Therapy|Adverse Event|0|||
127937530|NCT02393248|460394781|FG017|Part 3: Combination Therapy|Adverse Event|0|||
127937531|NCT02393248|460394782|FG018|Part 3: Combination Therapy|Adverse Event|0|||
127937532|NCT02393248|460394783|FG019|Part 3: Combination Therapy|Adverse Event|0|||
127937533|NCT02393248|460394784|FG020|Part 3: Combination Therapy|Adverse Event|0|||
127937534|NCT02393248|460394785|FG021|Part 3: Combination Therapy|Adverse Event|0|||
127937535|NCT02393248|460394786|FG022|Part 3: Combination Therapy|Adverse Event|0|||
127937536|NCT02393248|460394787|FG023|Part 3: Combination Therapy|Adverse Event|1|||
127937537|NCT02393248|460394788|FG024|Part 3: Combination Therapy|Adverse Event|0|||
127937538|NCT02393248|460394764|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
127937539|NCT02393248|460394765|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
127937540|NCT02393248|460394766|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
127937541|NCT02393248|460394767|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
127937542|NCT02393248|460394768|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
127937543|NCT02393248|460394769|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
127937544|NCT02393248|460394770|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
127937545|NCT02393248|460394771|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
127937546|NCT02393248|460394772|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
127937547|NCT02393248|460394773|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
127937548|NCT02393248|460394774|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
127937549|NCT02393248|460394775|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
127937550|NCT02393248|460394776|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
127937551|NCT02393248|460394777|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
127937552|NCT02393248|460394778|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
127937553|NCT02393248|460394779|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
127937554|NCT02393248|460394780|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
127937555|NCT02393248|460394781|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
127937556|NCT02393248|460394782|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
127937557|NCT02393248|460394783|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
127937558|NCT02393248|460394784|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
127937559|NCT02393248|460394785|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
127937560|NCT02393248|460394786|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
127937561|NCT02393248|460394787|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
127937562|NCT02393248|460394788|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
127937563|NCT04765384|460394789|FG000|Post-baseline: Adults|Lost to Follow-up|0|||
127937564|NCT04765384|460394790|FG001|Post-baseline: Adults|Lost to Follow-up|1|||
127937565|NCT04765384|460394791|FG002|Post-baseline: Adults|Lost to Follow-up|3|||
127937566|NCT04765384|460394792|FG003|Post-baseline: Adults|Lost to Follow-up|0|||
127937567|NCT04765384|460394793|FG004|Post-baseline: Adults|Lost to Follow-up|0|||
127937568|NCT04765384|460394794|FG005|Post-baseline: Adults|Lost to Follow-up|0|||
127937569|NCT04765384|460394789|FG000|Post-baseline: Adults|Withdrawal by Subject|2|||
127937570|NCT04765384|460394790|FG001|Post-baseline: Adults|Withdrawal by Subject|1|||
127937571|NCT04765384|460394791|FG002|Post-baseline: Adults|Withdrawal by Subject|3|||
127937572|NCT04765384|460394792|FG003|Post-baseline: Adults|Withdrawal by Subject|0|||
127937573|NCT04765384|460394793|FG004|Post-baseline: Adults|Withdrawal by Subject|0|||
127937574|NCT04765384|460394794|FG005|Post-baseline: Adults|Withdrawal by Subject|0|||
127937575|NCT04765384|460394789|FG000|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
127937576|NCT04765384|460394790|FG001|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
127937577|NCT04765384|460394791|FG002|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
127937578|NCT04765384|460394792|FG003|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
127937579|NCT04765384|460394793|FG004|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
127937580|NCT04765384|460394794|FG005|Post-natal: Neonates and Infants|Lost to Follow-up|5|||
127937581|NCT04765384|460394789|FG000|Post-natal: Neonates and Infants|Death|0|||
127937582|NCT04765384|460394790|FG001|Post-natal: Neonates and Infants|Death|0|||
127937583|NCT04765384|460394791|FG002|Post-natal: Neonates and Infants|Death|0|||
127937584|NCT04765384|460394792|FG003|Post-natal: Neonates and Infants|Death|1|||
127937585|NCT04765384|460394793|FG004|Post-natal: Neonates and Infants|Death|0|||
127937586|NCT04765384|460394794|FG005|Post-natal: Neonates and Infants|Death|0|||
127937587|NCT04765384|460394789|FG000|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
127937588|NCT04765384|460394790|FG001|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
127937589|NCT04765384|460394791|FG002|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
127937590|NCT04765384|460394792|FG003|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
127937591|NCT04765384|460394793|FG004|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
127937592|NCT04765384|460394794|FG005|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|3|||
127937593|NCT01971970|460394795|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
127937594|NCT01971970|460394796|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
127937595|NCT01971970|460394795|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
127937596|NCT01971970|460394796|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
127937597|NCT01971970|460394795|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
127937598|NCT01971970|460394796|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
127937599|NCT01971970|460394795|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
127937600|NCT01971970|460394796|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
127937601|NCT01971970|460394795|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
127937602|NCT01971970|460394796|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
127937603|NCT01971970|460394795|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
127937604|NCT01971970|460394796|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
127937605|NCT01971970|460394795|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
127937606|NCT01971970|460394796|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
127937607|NCT02524730|460394797|FG000|Overall Study|Lost to Follow-up|5|||
127937608|NCT02524730|460394797|FG000|Overall Study|Withdrawal by Subject|18|||
127937609|NCT02524730|460394797|FG000|Overall Study|Death|10|||
127937610|NCT02524730|460394797|FG000|Overall Study|Adverse Event|8|||
127937611|NCT02524730|460394797|FG000|Overall Study|Protocol Violation|1|||
127937612|NCT02524730|460394797|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
127937613|NCT00977379|460394798|FG000|Overall Study|Withdrawal by Subject|1|||
127937614|NCT00977379|460394799|FG001|Overall Study|Withdrawal by Subject|1|||
127937615|NCT00977379|460394798|FG000|Overall Study|Death|7|||
127937616|NCT00977379|460394799|FG001|Overall Study|Death|9|||
127937617|NCT00977379|460394798|FG000|Overall Study|Premature Study Termination|4|||
127937618|NCT00977379|460394799|FG001|Overall Study|Premature Study Termination|0|||
127937619|NCT00977379|460394798|FG000|Overall Study|Participant Moving House|0|||
127937620|NCT00977379|460394799|FG001|Overall Study|Participant Moving House|1|||
127937621|NCT00977379|460394798|FG000|Overall Study|Randomization Error|0|||
127937622|NCT00977379|460394799|FG001|Overall Study|Randomization Error|1|||
127937623|NCT00706511|460394804|FG000|Overall Study|Withdrawal by Subject|1|||
127937624|NCT00706511|460394805|FG001|Overall Study|Withdrawal by Subject|0|||
127937625|NCT00706511|460394806|FG002|Overall Study|Withdrawal by Subject|0|||
127937626|NCT00706511|460394807|FG003|Overall Study|Withdrawal by Subject|0|||
127937627|NCT05297578|460394811|FG000|Overall Study|Lost to Follow-up|1|||
127937628|NCT05297578|460394812|FG001|Overall Study|Lost to Follow-up|1|||
127937629|NCT05297578|460394813|FG002|Overall Study|Lost to Follow-up|2|||
127937630|NCT05297578|460394814|FG003|Overall Study|Lost to Follow-up|1|||
127937631|NCT05297578|460394811|FG000|Overall Study|Death|0|||
127937632|NCT05297578|460394812|FG001|Overall Study|Death|1|||
127937633|NCT05297578|460394813|FG002|Overall Study|Death|0|||
127937634|NCT05297578|460394814|FG003|Overall Study|Death|0|||
127937635|NCT05297578|460394811|FG000|Overall Study|Withdrawal by Subject|0|||
127937636|NCT05297578|460394812|FG001|Overall Study|Withdrawal by Subject|0|||
127937637|NCT05297578|460394813|FG002|Overall Study|Withdrawal by Subject|1|||
127937638|NCT05297578|460394814|FG003|Overall Study|Withdrawal by Subject|0|||
127937639|NCT01087489|460394815|FG000|Overall Study|enrolled in another VA study|0|||
127937640|NCT01087489|460394816|FG001|Overall Study|enrolled in another VA study|1|||
127937641|NCT01087489|460394815|FG000|Overall Study|Death|0|||
127937642|NCT01087489|460394816|FG001|Overall Study|Death|1|||
127937643|NCT01087489|460394815|FG000|Overall Study|unable to survey by telephone|0|||
127937644|NCT01087489|460394816|FG001|Overall Study|unable to survey by telephone|1|||
127937645|NCT00117325|460394817|FG000|Overall Study|Adverse Event|3|||
127937646|NCT00117325|460394818|FG001|Overall Study|Adverse Event|3|||
127937647|NCT00117325|460394817|FG000|Overall Study|Lost to Follow-up|1|||
127937648|NCT00117325|460394818|FG001|Overall Study|Lost to Follow-up|1|||
127937649|NCT00117325|460394817|FG000|Overall Study|Protocol Violation|2|||
127937650|NCT00117325|460394818|FG001|Overall Study|Protocol Violation|3|||
127937651|NCT00117325|460394817|FG000|Overall Study|Withdrawal by Subject|3|||
127937652|NCT00117325|460394818|FG001|Overall Study|Withdrawal by Subject|2|||
127937653|NCT00117325|460394817|FG000|Overall Study|Lack of Efficacy|1|||
127937654|NCT00117325|460394818|FG001|Overall Study|Lack of Efficacy|0|||
127937655|NCT00117325|460394817|FG000|Overall Study|Use of prohibited medicine|1|||
127937656|NCT00117325|460394818|FG001|Overall Study|Use of prohibited medicine|2|||
127937657|NCT00117325|460394817|FG000|Overall Study|Early termination|1|||
127937658|NCT00117325|460394818|FG001|Overall Study|Early termination|1|||
127937659|NCT00117325|460394817|FG000|Overall Study|Admisnitrative|1|||
127937660|NCT00117325|460394818|FG001|Overall Study|Admisnitrative|0|||
127937661|NCT00338455|460394826|FG000|Overall Study|Death|2|||
127937662|NCT00338455|460394827|FG001|Overall Study|Death|1|||
127937663|NCT00338455|460394826|FG000|Overall Study|Physician Decision|1|||
127937664|NCT00338455|460394827|FG001|Overall Study|Physician Decision|0|||
127937665|NCT05084963|460394828|FG000|Overall Study|Withdrawal by Subject|0|||
127937666|NCT05084963|460394829|FG001|Overall Study|Withdrawal by Subject|0|||
127937667|NCT05084963|460394830|FG002|Overall Study|Withdrawal by Subject|1|||
127937668|NCT01616953|460394831|FG000|Overall Study|Lost to Follow-up|1|||
127937669|NCT01616953|460394832|FG001|Overall Study|Lost to Follow-up|0|||
127937670|NCT01616953|460394831|FG000|Overall Study|lack of bone and soft tissue|1|||
127937671|NCT01616953|460394832|FG001|Overall Study|lack of bone and soft tissue|0|||
127937672|NCT01568320|460394833|FG000|Overall Study|Death|20|||
127937673|NCT01568320|460394833|FG000|Overall Study|Lost to Follow-up|9|||
127937674|NCT01568320|460394833|FG000|Overall Study|Withdrawal by Subject|10|||
127937675|NCT01568320|460394833|FG000|Overall Study|Conversion to open repair|1|||
127937676|NCT01568320|460394833|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
127937677|NCT01394952|460394834|FG000|Overall Study|Lost to Follow-up|0|||
127937678|NCT01394952|460394835|FG001|Overall Study|Lost to Follow-up|5|||
127937679|NCT01394952|460394834|FG000|Overall Study|Withdrawal by Subject|10|||
127937680|NCT01394952|460394835|FG001|Overall Study|Withdrawal by Subject|5|||
127937681|NCT01394952|460394834|FG000|Overall Study|Physician Decision|2|||
127937682|NCT01394952|460394835|FG001|Overall Study|Physician Decision|0|||
127937683|NCT01394952|460394834|FG000|Overall Study|Sponsor Decision|5|||
127937684|NCT01394952|460394835|FG001|Overall Study|Sponsor Decision|7|||
127937685|NCT02283983|460394836|FG000|Overall Study|Inclusion criteria not met|0|||
127937686|NCT02283983|460394837|FG001|Overall Study|Inclusion criteria not met|1|||
127937687|NCT02283983|460394836|FG000|Overall Study|Withdrawal by Subject|4|||
127937688|NCT02283983|460394837|FG001|Overall Study|Withdrawal by Subject|2|||
127937689|NCT02283983|460394836|FG000|Overall Study|Protocol Violation|0|||
127937690|NCT02283983|460394837|FG001|Overall Study|Protocol Violation|4|||
127937691|NCT02283983|460394836|FG000|Overall Study|Physician Decision|2|||
127937692|NCT02283983|460394837|FG001|Overall Study|Physician Decision|4|||
127937693|NCT02283983|460394836|FG000|Overall Study|Death|1|||
127937694|NCT02283983|460394837|FG001|Overall Study|Death|0|||
127937695|NCT02283983|460394836|FG000|Overall Study|Adverse Event|1|||
127937696|NCT02283983|460394837|FG001|Overall Study|Adverse Event|0|||
127937697|NCT02283983|460394836|FG000|Overall Study|Lost to Follow-up|9|||
127937698|NCT02283983|460394837|FG001|Overall Study|Lost to Follow-up|8|||
127937699|NCT02283983|460394836|FG000|Overall Study|Relapse|1|||
127937700|NCT02283983|460394837|FG001|Overall Study|Relapse|0|||
127937701|NCT04453202|460394842|FG000|Overall Study|Adverse Event|0|||
127937702|NCT04453202|460394843|FG001|Overall Study|Adverse Event|0|||
127937703|NCT04453202|460394844|FG002|Overall Study|Adverse Event|0|||
127937704|NCT04453202|460394845|FG003|Overall Study|Adverse Event|0|||
127937705|NCT04453202|460394846|FG004|Overall Study|Adverse Event|0|||
127937706|NCT04453202|460394847|FG005|Overall Study|Adverse Event|0|||
127937707|NCT04453202|460394848|FG006|Overall Study|Adverse Event|1|||
127937708|NCT04453202|460394849|FG007|Overall Study|Adverse Event|0|||
127937709|NCT04453202|460394850|FG008|Overall Study|Adverse Event|0|||
127937710|NCT04453202|460394851|FG009|Overall Study|Adverse Event|0|||
127937711|NCT04453202|460394852|FG010|Overall Study|Adverse Event|0|||
127937712|NCT04453202|460394842|FG000|Overall Study|Death|0|||
127937713|NCT04453202|460394843|FG001|Overall Study|Death|0|||
127937714|NCT04453202|460394844|FG002|Overall Study|Death|0|||
127937715|NCT04453202|460394845|FG003|Overall Study|Death|0|||
127937716|NCT04453202|460394846|FG004|Overall Study|Death|0|||
127937717|NCT04453202|460394847|FG005|Overall Study|Death|0|||
127937718|NCT04453202|460394848|FG006|Overall Study|Death|0|||
127937719|NCT04453202|460394849|FG007|Overall Study|Death|0|||
127937720|NCT04453202|460394850|FG008|Overall Study|Death|0|||
127937721|NCT04453202|460394851|FG009|Overall Study|Death|1|||
127937722|NCT04453202|460394852|FG010|Overall Study|Death|0|||
127937723|NCT04453202|460394842|FG000|Overall Study|Lost to Follow-up|0|||
127937724|NCT04453202|460394843|FG001|Overall Study|Lost to Follow-up|1|||
127937725|NCT04453202|460394844|FG002|Overall Study|Lost to Follow-up|0|||
127937726|NCT04453202|460394845|FG003|Overall Study|Lost to Follow-up|1|||
127937727|NCT04453202|460394846|FG004|Overall Study|Lost to Follow-up|0|||
127937728|NCT04453202|460394847|FG005|Overall Study|Lost to Follow-up|0|||
127937729|NCT04453202|460394848|FG006|Overall Study|Lost to Follow-up|0|||
127937730|NCT04453202|460394849|FG007|Overall Study|Lost to Follow-up|0|||
127937731|NCT04453202|460394850|FG008|Overall Study|Lost to Follow-up|0|||
127937732|NCT04453202|460394851|FG009|Overall Study|Lost to Follow-up|1|||
127937733|NCT04453202|460394852|FG010|Overall Study|Lost to Follow-up|1|||
127937734|NCT04453202|460394842|FG000|Overall Study|Withdrawal by Subject|1|||
127937735|NCT04453202|460394843|FG001|Overall Study|Withdrawal by Subject|2|||
127937736|NCT04453202|460394844|FG002|Overall Study|Withdrawal by Subject|1|||
127937737|NCT04453202|460394845|FG003|Overall Study|Withdrawal by Subject|2|||
127937738|NCT04453202|460394846|FG004|Overall Study|Withdrawal by Subject|1|||
127937739|NCT04453202|460394847|FG005|Overall Study|Withdrawal by Subject|1|||
127937740|NCT04453202|460394848|FG006|Overall Study|Withdrawal by Subject|0|||
127937741|NCT04453202|460394849|FG007|Overall Study|Withdrawal by Subject|0|||
127937742|NCT04453202|460394850|FG008|Overall Study|Withdrawal by Subject|0|||
127937743|NCT04453202|460394851|FG009|Overall Study|Withdrawal by Subject|1|||
127937744|NCT04453202|460394852|FG010|Overall Study|Withdrawal by Subject|0|||
127937745|NCT04453202|460394842|FG000|Overall Study|Adverse Event|0|||
127937746|NCT04453202|460394843|FG001|Overall Study|Adverse Event|0|||
127937747|NCT04453202|460394844|FG002|Overall Study|Adverse Event|0|||
127937748|NCT04453202|460394845|FG003|Overall Study|Adverse Event|0|||
127937749|NCT04453202|460394846|FG004|Overall Study|Adverse Event|0|||
127937750|NCT04453202|460394847|FG005|Overall Study|Adverse Event|1|||
127937751|NCT04453202|460394848|FG006|Overall Study|Adverse Event|0|||
127937752|NCT04453202|460394849|FG007|Overall Study|Adverse Event|0|||
127937753|NCT04453202|460394850|FG008|Overall Study|Adverse Event|0|||
127937754|NCT04453202|460394851|FG009|Overall Study|Adverse Event|0|||
127937755|NCT04453202|460394852|FG010|Overall Study|Adverse Event|0|||
127937756|NCT01157897|460394853|FG000|Overall Study|Lost to Follow-up|2|||
127937757|NCT01157897|460394854|FG001|Overall Study|Lost to Follow-up|0|||
127937758|NCT01157897|460394855|FG002|Overall Study|Lost to Follow-up|0|||
127937759|NCT01157897|460394856|FG003|Overall Study|Lost to Follow-up|1|||
127937760|NCT01157897|460394853|FG000|Overall Study|Relocated|0|||
127937761|NCT01157897|460394854|FG001|Overall Study|Relocated|2|||
127937762|NCT01157897|460394855|FG002|Overall Study|Relocated|0|||
127937763|NCT01157897|460394856|FG003|Overall Study|Relocated|0|||
127937764|NCT03276221|460394857|FG000|Overall Study|Lost to Follow-up|6|||
127937765|NCT03276221|460394858|FG001|Overall Study|Lost to Follow-up|2|||
127937766|NCT03276221|460394859|FG002|Overall Study|Lost to Follow-up|0|||
127937767|NCT03276221|460394857|FG000|Overall Study|Did not abstain from cannabis as per protocol|4|||
127937768|NCT03276221|460394858|FG001|Overall Study|Did not abstain from cannabis as per protocol|0|||
127937769|NCT03276221|460394859|FG002|Overall Study|Did not abstain from cannabis as per protocol|0|||
127937770|NCT00424775|460394860|FG000|Overall Study|Adverse Event|2|||
127937771|NCT00424775|460394861|FG001|Overall Study|Adverse Event|0|||
127937772|NCT00424775|460394860|FG000|Overall Study|Lack of Efficacy|1|||
127937773|NCT00424775|460394861|FG001|Overall Study|Lack of Efficacy|0|||
127937774|NCT02912650|460394862|FG000|Overall Study|Withdrawal by Subject|1|||
127937775|NCT02912650|460394863|FG001|Overall Study|Withdrawal by Subject|0|||
127937776|NCT02912650|460394864|FG002|Overall Study|Withdrawal by Subject|1|||
127937777|NCT02912650|460394865|FG003|Overall Study|Withdrawal by Subject|5|||
127937778|NCT02912650|460394862|FG000|Overall Study|Adverse Event|0|||
127937779|NCT02912650|460394863|FG001|Overall Study|Adverse Event|0|||
127937780|NCT02912650|460394864|FG002|Overall Study|Adverse Event|1|||
127937781|NCT02912650|460394865|FG003|Overall Study|Adverse Event|0|||
127937782|NCT02562482|460394867|FG000|Overall Study|Enrolled, but did not receive product|4|||
127937783|NCT02562482|460394868|FG001|Overall Study|Enrolled, but did not receive product|0|||
127937784|NCT02562482|460394867|FG000|Overall Study|Lost to Follow-up|9|||
127937785|NCT02562482|460394868|FG001|Overall Study|Lost to Follow-up|6|||
127937786|NCT02562482|460394867|FG000|Overall Study|Moved from area|2|||
127937787|NCT02562482|460394868|FG001|Overall Study|Moved from area|3|||
127937788|NCT02562482|460394867|FG000|Overall Study|Withdrawal by Subject|5|||
127937789|NCT02562482|460394868|FG001|Overall Study|Withdrawal by Subject|3|||
127937790|NCT02562482|460394867|FG000|Overall Study|Physician Decision|1|||
127937791|NCT02562482|460394868|FG001|Overall Study|Physician Decision|3|||
127937792|NCT02562482|460394867|FG000|Overall Study|Illness/Injury unrelated to product|0|||
127937793|NCT02562482|460394868|FG001|Overall Study|Illness/Injury unrelated to product|1|||
127937794|NCT01490866|460394873|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
127937795|NCT01490866|460394873|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
127937796|NCT01490866|460394873|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
127937797|NCT01490866|460394873|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
127937798|NCT01490866|460394873|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
127937799|NCT01490866|460394873|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
127937800|NCT01490866|460394873|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
127937801|NCT01490866|460394873|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
127937802|NCT01490866|460394873|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
127937803|NCT01490866|460394873|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
127937804|NCT01490866|460394873|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
127937805|NCT02722148|460394874|FG000|Overall Study|Lost to Follow-up|2|||
127937806|NCT02722148|460394874|FG000|Overall Study|Non compliant with treatment regimen|3|||
127937807|NCT01104779|460394875|FG000|Overall Study|Protocol Violation|1|||
127937808|NCT01104779|460394876|FG001|Overall Study|Protocol Violation|2|||
127937809|NCT01104779|460394877|FG002|Overall Study|Protocol Violation|2|||
127937810|NCT01104779|460394875|FG000|Overall Study|Lack of Efficacy|26|||
127937811|NCT01104779|460394876|FG001|Overall Study|Lack of Efficacy|12|||
127937812|NCT01104779|460394877|FG002|Overall Study|Lack of Efficacy|13|||
127937813|NCT01104779|460394875|FG000|Overall Study|Adverse Event|13|||
127937814|NCT01104779|460394876|FG001|Overall Study|Adverse Event|14|||
127937815|NCT01104779|460394877|FG002|Overall Study|Adverse Event|13|||
127937816|NCT01104779|460394875|FG000|Overall Study|Did not meet inc/exc criteria|1|||
127937817|NCT01104779|460394876|FG001|Overall Study|Did not meet inc/exc criteria|1|||
127937818|NCT01104779|460394877|FG002|Overall Study|Did not meet inc/exc criteria|1|||
127937819|NCT01104779|460394875|FG000|Overall Study|Other reasons|0|||
127937820|NCT01104779|460394876|FG001|Overall Study|Other reasons|1|||
127937821|NCT01104779|460394877|FG002|Overall Study|Other reasons|0|||
127937822|NCT01104779|460394875|FG000|Overall Study|Lost to Follow-up|2|||
127937823|NCT01104779|460394876|FG001|Overall Study|Lost to Follow-up|0|||
127937824|NCT01104779|460394877|FG002|Overall Study|Lost to Follow-up|1|||
127937825|NCT01104779|460394875|FG000|Overall Study|Withdrawal by Subject|16|||
127937826|NCT01104779|460394876|FG001|Overall Study|Withdrawal by Subject|25|||
127937827|NCT01104779|460394877|FG002|Overall Study|Withdrawal by Subject|32|||
127937828|NCT03982199|460394878|FG000|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|152|||
127937829|NCT03982199|460394879|FG001|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|159|||
127937830|NCT03982199|460394880|FG002|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
127937831|NCT03982199|460394881|FG003|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
127937832|NCT03982199|460394882|FG004|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
127937833|NCT03982199|460394883|FG005|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
127937834|NCT03982199|460394884|FG006|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
127937835|NCT03982199|460394885|FG007|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
127937836|NCT03982199|460394886|FG008|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
127937837|NCT03982199|460394887|FG009|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
127937838|NCT03982199|460394888|FG010|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
127937839|NCT03982199|460394889|FG011|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
127937840|NCT03982199|460394890|FG012|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
127937841|NCT03982199|460394891|FG013|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
127937842|NCT03982199|460394878|FG000|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|39|||
127937843|NCT03982199|460394879|FG001|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|33|||
127937844|NCT03982199|460394880|FG002|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
127937845|NCT03982199|460394881|FG003|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
127937846|NCT03982199|460394882|FG004|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
127937847|NCT03982199|460394883|FG005|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
127937848|NCT03982199|460394884|FG006|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
127937849|NCT03982199|460394885|FG007|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
127937850|NCT03982199|460394886|FG008|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
127937851|NCT03982199|460394887|FG009|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
127937852|NCT03982199|460394888|FG010|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
127937853|NCT03982199|460394889|FG011|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
127937854|NCT03982199|460394890|FG012|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
127937855|NCT03982199|460394891|FG013|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
127937856|NCT03982199|460394878|FG000|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|514|||
127937857|NCT03982199|460394879|FG001|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|503|||
127937858|NCT03982199|460394880|FG002|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
127937859|NCT03982199|460394881|FG003|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
127937860|NCT03982199|460394882|FG004|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
127937861|NCT03982199|460394883|FG005|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
127937862|NCT03982199|460394884|FG006|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
127937863|NCT03982199|460394885|FG007|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
127937864|NCT03982199|460394886|FG008|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
127937865|NCT03982199|460394887|FG009|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
127937866|NCT03982199|460394888|FG010|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
127937867|NCT03982199|460394889|FG011|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
127937868|NCT03982199|460394890|FG012|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
127937869|NCT03982199|460394891|FG013|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
127937870|NCT03982199|460394878|FG000|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|12|||
127937871|NCT03982199|460394879|FG001|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|14|||
127937872|NCT03982199|460394880|FG002|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
127937873|NCT03982199|460394881|FG003|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
127937874|NCT03982199|460394882|FG004|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
127937875|NCT03982199|460394883|FG005|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
127937876|NCT03982199|460394884|FG006|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
127937877|NCT03982199|460394885|FG007|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
127937878|NCT03982199|460394886|FG008|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
127937879|NCT03982199|460394887|FG009|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
127937880|NCT03982199|460394888|FG010|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
127937881|NCT03982199|460394889|FG011|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
127937882|NCT03982199|460394890|FG012|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
127937883|NCT03982199|460394891|FG013|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
127937884|NCT03982199|460394878|FG000|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|10|||
127937885|NCT03982199|460394879|FG001|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|8|||
127937886|NCT03982199|460394880|FG002|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
127937887|NCT03982199|460394881|FG003|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
127937888|NCT03982199|460394882|FG004|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
127937889|NCT03982199|460394883|FG005|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
127937890|NCT03982199|460394884|FG006|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
127937891|NCT03982199|460394885|FG007|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
127937892|NCT03982199|460394886|FG008|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
127937893|NCT03982199|460394887|FG009|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
127937894|NCT03982199|460394888|FG010|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
127937895|NCT03982199|460394889|FG011|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
127937896|NCT03982199|460394890|FG012|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
127937897|NCT03982199|460394891|FG013|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
127937898|NCT03982199|460394878|FG000|Main Cohorts (Day 1 up to Day 1095)|Death|39|||
127937899|NCT03982199|460394879|FG001|Main Cohorts (Day 1 up to Day 1095)|Death|38|||
127937900|NCT03982199|460394880|FG002|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
127937901|NCT03982199|460394881|FG003|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
127937902|NCT03982199|460394882|FG004|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
127937903|NCT03982199|460394883|FG005|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
127937904|NCT03982199|460394884|FG006|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
127937905|NCT03982199|460394885|FG007|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
127937906|NCT03982199|460394886|FG008|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
127937907|NCT03982199|460394887|FG009|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
127937908|NCT03982199|460394888|FG010|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
127937909|NCT03982199|460394889|FG011|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
127937910|NCT03982199|460394890|FG012|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
127937911|NCT03982199|460394891|FG013|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
127937912|NCT03982199|460394878|FG000|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|26|||
127937913|NCT03982199|460394879|FG001|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|21|||
127937914|NCT03982199|460394880|FG002|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
127937915|NCT03982199|460394881|FG003|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
127937916|NCT03982199|460394882|FG004|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
127937917|NCT03982199|460394883|FG005|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
127937918|NCT03982199|460394884|FG006|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
127937919|NCT03982199|460394885|FG007|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
127937920|NCT03982199|460394886|FG008|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
127937921|NCT03982199|460394887|FG009|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
127937922|NCT03982199|460394888|FG010|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
127937923|NCT03982199|460394889|FG011|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
127937924|NCT03982199|460394890|FG012|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
127937925|NCT03982199|460394891|FG013|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
127937926|NCT03982199|460394878|FG000|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|129|||
127937927|NCT03982199|460394879|FG001|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|117|||
127937928|NCT03982199|460394880|FG002|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
127937929|NCT03982199|460394881|FG003|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
127937930|NCT03982199|460394882|FG004|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
127937931|NCT03982199|460394883|FG005|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
127937932|NCT03982199|460394884|FG006|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
127937933|NCT03982199|460394885|FG007|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
127937934|NCT03982199|460394886|FG008|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
127937935|NCT03982199|460394887|FG009|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
127937936|NCT03982199|460394888|FG010|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
127937937|NCT03982199|460394889|FG011|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
127937938|NCT03982199|460394890|FG012|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
127937939|NCT03982199|460394891|FG013|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
127937940|NCT03982199|460394878|FG000|Main Cohorts (Day 1 up to Day 1095)|Other|80|||
127937941|NCT03982199|460394879|FG001|Main Cohorts (Day 1 up to Day 1095)|Other|83|||
127937942|NCT03982199|460394880|FG002|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
127937943|NCT03982199|460394881|FG003|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
127937944|NCT03982199|460394882|FG004|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
127937945|NCT03982199|460394883|FG005|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
127937946|NCT03982199|460394884|FG006|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
127937947|NCT03982199|460394885|FG007|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
127937948|NCT03982199|460394886|FG008|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
127937949|NCT03982199|460394887|FG009|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
127937950|NCT03982199|460394888|FG010|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
127937951|NCT03982199|460394889|FG011|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
127937952|NCT03982199|460394890|FG012|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
127937953|NCT03982199|460394891|FG013|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
127937954|NCT03982199|460394878|FG000|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|18|||
127937955|NCT03982199|460394879|FG001|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|15|||
127937956|NCT03982199|460394880|FG002|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
127937957|NCT03982199|460394881|FG003|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
127937958|NCT03982199|460394882|FG004|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
127937959|NCT03982199|460394883|FG005|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
127937960|NCT03982199|460394884|FG006|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
127937961|NCT03982199|460394885|FG007|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
127937962|NCT03982199|460394886|FG008|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
127937963|NCT03982199|460394887|FG009|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
127937964|NCT03982199|460394888|FG010|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
127937965|NCT03982199|460394889|FG011|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
127937966|NCT03982199|460394890|FG012|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
127937967|NCT03982199|460394891|FG013|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
127937968|NCT03982199|460394878|FG000|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|4|||
127937969|NCT03982199|460394879|FG001|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|7|||
127937970|NCT03982199|460394880|FG002|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
127937971|NCT03982199|460394881|FG003|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
127937972|NCT03982199|460394882|FG004|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
127937973|NCT03982199|460394883|FG005|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
127937974|NCT03982199|460394884|FG006|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
127937975|NCT03982199|460394885|FG007|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
127937976|NCT03982199|460394886|FG008|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
127937977|NCT03982199|460394887|FG009|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
127937978|NCT03982199|460394888|FG010|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
127937979|NCT03982199|460394889|FG011|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
127937980|NCT03982199|460394890|FG012|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
127937981|NCT03982199|460394891|FG013|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
127937982|NCT03982199|460394878|FG000|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
127937983|NCT03982199|460394879|FG001|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
127937984|NCT03982199|460394880|FG002|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
127937985|NCT03982199|460394881|FG003|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
127937986|NCT03982199|460394882|FG004|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
127937987|NCT03982199|460394883|FG005|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
127937988|NCT03982199|460394884|FG006|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
127937989|NCT03982199|460394885|FG007|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
127937990|NCT03982199|460394886|FG008|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
127937991|NCT03982199|460394887|FG009|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
127937992|NCT03982199|460394888|FG010|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
127937993|NCT03982199|460394889|FG011|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
127937994|NCT03982199|460394890|FG012|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
127937995|NCT03982199|460394891|FG013|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
127937996|NCT03982199|460394878|FG000|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
127937997|NCT03982199|460394879|FG001|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
127937998|NCT03982199|460394880|FG002|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
127937999|NCT03982199|460394881|FG003|Revacc Subcohorts (From Day 365 to 730)|Other|3|||
127938000|NCT03982199|460394882|FG004|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
127938001|NCT03982199|460394883|FG005|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
127938002|NCT03982199|460394884|FG006|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
127938003|NCT03982199|460394885|FG007|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
127938004|NCT03982199|460394886|FG008|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
127938005|NCT03982199|460394887|FG009|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
127938006|NCT03982199|460394888|FG010|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
127938007|NCT03982199|460394889|FG011|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
127938008|NCT03982199|460394890|FG012|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
127938009|NCT03982199|460394891|FG013|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
127938010|NCT03982199|460394878|FG000|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
127938011|NCT03982199|460394879|FG001|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
127938012|NCT03982199|460394880|FG002|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|1|||
127938013|NCT03982199|460394881|FG003|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
127938014|NCT03982199|460394882|FG004|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
127938015|NCT03982199|460394883|FG005|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
127938016|NCT03982199|460394884|FG006|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
127938017|NCT03982199|460394885|FG007|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
127938018|NCT03982199|460394886|FG008|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
127938019|NCT03982199|460394887|FG009|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
127938020|NCT03982199|460394888|FG010|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
127938021|NCT03982199|460394889|FG011|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
127938022|NCT03982199|460394890|FG012|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
127938023|NCT03982199|460394891|FG013|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
127938024|NCT03982199|460394878|FG000|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
127938025|NCT03982199|460394879|FG001|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
127938026|NCT03982199|460394880|FG002|Revacc Subcohorts (From Day 365 to 730)|Death|1|||
127938027|NCT03982199|460394881|FG003|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
127938028|NCT03982199|460394882|FG004|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
127938029|NCT03982199|460394883|FG005|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
127938030|NCT03982199|460394884|FG006|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
127938031|NCT03982199|460394885|FG007|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
127938032|NCT03982199|460394886|FG008|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
127938033|NCT03982199|460394887|FG009|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
127938034|NCT03982199|460394888|FG010|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
127938035|NCT03982199|460394889|FG011|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
127938036|NCT03982199|460394890|FG012|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
127938037|NCT03982199|460394891|FG013|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
127938038|NCT03982199|460394878|FG000|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
127938039|NCT03982199|460394879|FG001|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
127938040|NCT03982199|460394880|FG002|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|21|||
127938041|NCT03982199|460394881|FG003|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|18|||
127938042|NCT03982199|460394882|FG004|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
127938043|NCT03982199|460394883|FG005|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
127938044|NCT03982199|460394884|FG006|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
127938045|NCT03982199|460394885|FG007|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
127938046|NCT03982199|460394886|FG008|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
127938047|NCT03982199|460394887|FG009|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
127938048|NCT03982199|460394888|FG010|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
127938049|NCT03982199|460394889|FG011|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
127938050|NCT03982199|460394890|FG012|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
127938051|NCT03982199|460394891|FG013|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
127938052|NCT03982199|460394878|FG000|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
127938053|NCT03982199|460394879|FG001|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
127938054|NCT03982199|460394880|FG002|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
127938055|NCT03982199|460394881|FG003|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|1|||
127938056|NCT03982199|460394882|FG004|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
127938057|NCT03982199|460394883|FG005|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
127938058|NCT03982199|460394884|FG006|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
127938059|NCT03982199|460394885|FG007|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
127938060|NCT03982199|460394886|FG008|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
127938061|NCT03982199|460394887|FG009|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
127938062|NCT03982199|460394888|FG010|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
127938063|NCT03982199|460394889|FG011|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
127938064|NCT03982199|460394890|FG012|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
127938065|NCT03982199|460394891|FG013|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
127938066|NCT03982199|460394878|FG000|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
127938067|NCT03982199|460394879|FG001|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
127938068|NCT03982199|460394880|FG002|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|3|||
127938069|NCT03982199|460394881|FG003|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|2|||
127938070|NCT03982199|460394882|FG004|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
127938071|NCT03982199|460394883|FG005|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
127938072|NCT03982199|460394884|FG006|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
127938073|NCT03982199|460394885|FG007|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
127938074|NCT03982199|460394886|FG008|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
127938075|NCT03982199|460394887|FG009|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
127938076|NCT03982199|460394888|FG010|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
127938077|NCT03982199|460394889|FG011|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
127938078|NCT03982199|460394890|FG012|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
127938079|NCT03982199|460394891|FG013|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
127938080|NCT03982199|460394878|FG000|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
127938081|NCT03982199|460394879|FG001|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
127938082|NCT03982199|460394880|FG002|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
127938083|NCT03982199|460394881|FG003|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
127938084|NCT03982199|460394882|FG004|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
127938085|NCT03982199|460394883|FG005|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
127938086|NCT03982199|460394884|FG006|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
127938087|NCT03982199|460394885|FG007|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
127938088|NCT03982199|460394886|FG008|Revacc Subcohorts (From Day 730 to 1095)|Other|5|||
127938089|NCT03982199|460394887|FG009|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
127938090|NCT03982199|460394888|FG010|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
127938091|NCT03982199|460394889|FG011|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
127938092|NCT03982199|460394890|FG012|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
127938093|NCT03982199|460394891|FG013|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
127938094|NCT03982199|460394878|FG000|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
127938095|NCT03982199|460394879|FG001|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
127938096|NCT03982199|460394880|FG002|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
127938097|NCT03982199|460394881|FG003|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
127938098|NCT03982199|460394882|FG004|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
127938099|NCT03982199|460394883|FG005|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
127938100|NCT03982199|460394884|FG006|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
127938101|NCT03982199|460394885|FG007|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
127938102|NCT03982199|460394886|FG008|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|107|||
127938103|NCT03982199|460394887|FG009|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
127938104|NCT03982199|460394888|FG010|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
127938105|NCT03982199|460394889|FG011|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
127938106|NCT03982199|460394890|FG012|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
127938107|NCT03982199|460394891|FG013|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
127938108|NCT03982199|460394878|FG000|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
127938109|NCT03982199|460394879|FG001|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
127938110|NCT03982199|460394880|FG002|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
127938111|NCT03982199|460394881|FG003|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
127938112|NCT03982199|460394882|FG004|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
127938113|NCT03982199|460394883|FG005|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
127938114|NCT03982199|460394884|FG006|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
127938115|NCT03982199|460394885|FG007|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
127938116|NCT03982199|460394886|FG008|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|3|||
127938117|NCT03982199|460394887|FG009|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
127938118|NCT03982199|460394888|FG010|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
127938119|NCT03982199|460394889|FG011|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
127938120|NCT03982199|460394890|FG012|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
127938121|NCT03982199|460394891|FG013|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
127938122|NCT03982199|460394878|FG000|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
127938123|NCT03982199|460394879|FG001|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
127938124|NCT03982199|460394880|FG002|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
127938125|NCT03982199|460394881|FG003|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
127938126|NCT03982199|460394882|FG004|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
127938127|NCT03982199|460394883|FG005|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
127938128|NCT03982199|460394884|FG006|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
127938129|NCT03982199|460394885|FG007|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
127938130|NCT03982199|460394886|FG008|Revacc Subcohorts (From Day 730 to 1095)|Death|2|||
127938131|NCT03982199|460394887|FG009|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
127938132|NCT03982199|460394888|FG010|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
127938133|NCT03982199|460394889|FG011|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
127938134|NCT03982199|460394890|FG012|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
127938135|NCT03982199|460394891|FG013|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
127938136|NCT03982199|460394878|FG000|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
127938137|NCT03982199|460394879|FG001|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
127938138|NCT03982199|460394880|FG002|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
127938139|NCT03982199|460394881|FG003|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
127938140|NCT03982199|460394882|FG004|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
127938141|NCT03982199|460394883|FG005|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
127938142|NCT03982199|460394884|FG006|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
127938143|NCT03982199|460394885|FG007|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
127938144|NCT03982199|460394886|FG008|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|2|||
127938145|NCT03982199|460394887|FG009|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
127938146|NCT03982199|460394888|FG010|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
127938147|NCT03982199|460394889|FG011|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
127938148|NCT03982199|460394890|FG012|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
127938149|NCT03982199|460394891|FG013|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
127938150|NCT03982199|460394878|FG000|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
127938151|NCT03982199|460394879|FG001|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
127938152|NCT03982199|460394880|FG002|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
127938153|NCT03982199|460394881|FG003|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
127938154|NCT03982199|460394882|FG004|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
127938155|NCT03982199|460394883|FG005|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|3|||
127938156|NCT03982199|460394884|FG006|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
127938157|NCT03982199|460394885|FG007|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|7|||
127938158|NCT03982199|460394886|FG008|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|20|||
127938159|NCT03982199|460394887|FG009|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
127938160|NCT03982199|460394888|FG010|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
127938161|NCT03982199|460394889|FG011|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
127938162|NCT03982199|460394890|FG012|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
127938163|NCT03982199|460394891|FG013|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
127938164|NCT03982199|460394878|FG000|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
127938165|NCT03982199|460394879|FG001|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
127938166|NCT03982199|460394880|FG002|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
127938167|NCT03982199|460394881|FG003|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
127938168|NCT03982199|460394882|FG004|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
127938169|NCT03982199|460394883|FG005|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
127938170|NCT03982199|460394884|FG006|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
127938171|NCT03982199|460394885|FG007|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
127938172|NCT03982199|460394886|FG008|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|3|||
127938173|NCT03982199|460394887|FG009|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
127938174|NCT03982199|460394888|FG010|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
127938175|NCT03982199|460394889|FG011|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
127938176|NCT03982199|460394890|FG012|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
127938177|NCT03982199|460394891|FG013|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
127938178|NCT03982199|460394878|FG000|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
127938179|NCT03982199|460394879|FG001|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
127938180|NCT03982199|460394880|FG002|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
127938181|NCT03982199|460394881|FG003|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
127938182|NCT03982199|460394882|FG004|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
127938183|NCT03982199|460394883|FG005|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|1|||
127938184|NCT03982199|460394884|FG006|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
127938185|NCT03982199|460394885|FG007|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|3|||
127938186|NCT03982199|460394886|FG008|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|4|||
127938187|NCT03982199|460394887|FG009|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
127938188|NCT03982199|460394888|FG010|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
127938189|NCT03982199|460394889|FG011|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
127938190|NCT03982199|460394890|FG012|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
127938191|NCT03982199|460394891|FG013|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
127938192|NCT03982199|460394878|FG000|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
127938193|NCT03982199|460394879|FG001|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
127938194|NCT03982199|460394880|FG002|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
127938195|NCT03982199|460394881|FG003|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
127938196|NCT03982199|460394882|FG004|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
127938197|NCT03982199|460394883|FG005|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
127938198|NCT03982199|460394884|FG006|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
127938199|NCT03982199|460394885|FG007|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
127938200|NCT03982199|460394886|FG008|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
127938201|NCT03982199|460394887|FG009|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
127938202|NCT03982199|460394888|FG010|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
127938203|NCT03982199|460394889|FG011|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|35|||
127938204|NCT03982199|460394890|FG012|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|125|||
127938205|NCT03982199|460394891|FG013|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|114|||
127938206|NCT03982199|460394878|FG000|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
127938207|NCT03982199|460394879|FG001|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
127938208|NCT03982199|460394880|FG002|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
127938209|NCT03982199|460394881|FG003|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
127938210|NCT03982199|460394882|FG004|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
127938211|NCT03982199|460394883|FG005|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
127938212|NCT03982199|460394884|FG006|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
127938213|NCT03982199|460394885|FG007|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
127938214|NCT03982199|460394886|FG008|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
127938215|NCT03982199|460394887|FG009|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|1|||
127938216|NCT03982199|460394888|FG010|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
127938217|NCT03982199|460394889|FG011|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
127938218|NCT03982199|460394890|FG012|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
127938219|NCT03982199|460394891|FG013|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
127938220|NCT03982199|460394878|FG000|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
127938221|NCT03982199|460394879|FG001|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
127938222|NCT03982199|460394880|FG002|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
127938223|NCT03982199|460394881|FG003|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
127938224|NCT03982199|460394882|FG004|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
127938225|NCT03982199|460394883|FG005|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
127938226|NCT03982199|460394884|FG006|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
127938227|NCT03982199|460394885|FG007|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
127938228|NCT03982199|460394886|FG008|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
127938229|NCT03982199|460394887|FG009|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
127938230|NCT03982199|460394888|FG010|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
127938231|NCT03982199|460394889|FG011|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
127938232|NCT03982199|460394890|FG012|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
127938233|NCT03982199|460394891|FG013|Revacc Subcohort (From Day 1095 to 1460)|Death|1|||
127938234|NCT03982199|460394878|FG000|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
127938235|NCT03982199|460394879|FG001|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
127938236|NCT03982199|460394880|FG002|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
127938237|NCT03982199|460394881|FG003|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
127938238|NCT03982199|460394882|FG004|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
127938239|NCT03982199|460394883|FG005|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
127938240|NCT03982199|460394884|FG006|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
127938241|NCT03982199|460394885|FG007|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
127938242|NCT03982199|460394886|FG008|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
127938243|NCT03982199|460394887|FG009|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
127938244|NCT03982199|460394888|FG010|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|1|||
127938245|NCT03982199|460394889|FG011|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|2|||
127938246|NCT03982199|460394890|FG012|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|4|||
127938247|NCT03982199|460394891|FG013|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
127938248|NCT03982199|460394878|FG000|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
127938249|NCT03982199|460394879|FG001|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
127938250|NCT03982199|460394880|FG002|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
127938251|NCT03982199|460394881|FG003|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
127938252|NCT03982199|460394882|FG004|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
127938253|NCT03982199|460394883|FG005|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
127938254|NCT03982199|460394884|FG006|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
127938255|NCT03982199|460394885|FG007|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
127938256|NCT03982199|460394886|FG008|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
127938257|NCT03982199|460394887|FG009|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
127938258|NCT03982199|460394888|FG010|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
127938259|NCT03982199|460394889|FG011|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
127938260|NCT03982199|460394890|FG012|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
127938261|NCT03982199|460394891|FG013|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|1|||
127938262|NCT03982199|460394878|FG000|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
127938263|NCT03982199|460394879|FG001|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
127938264|NCT03982199|460394880|FG002|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
127938265|NCT03982199|460394881|FG003|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
127938266|NCT03982199|460394882|FG004|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
127938267|NCT03982199|460394883|FG005|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
127938268|NCT03982199|460394884|FG006|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
127938269|NCT03982199|460394885|FG007|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
127938270|NCT03982199|460394886|FG008|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
127938271|NCT03982199|460394887|FG009|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
127938272|NCT03982199|460394888|FG010|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
127938273|NCT03982199|460394889|FG011|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
127938274|NCT03982199|460394890|FG012|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|1|||
127938275|NCT03982199|460394891|FG013|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|3|||
127938276|NCT03982199|460394878|FG000|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
127938277|NCT03982199|460394879|FG001|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
127938278|NCT03982199|460394880|FG002|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
127938279|NCT03982199|460394881|FG003|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
127938280|NCT03982199|460394882|FG004|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
127938281|NCT03982199|460394883|FG005|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
127938282|NCT03982199|460394884|FG006|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
127938283|NCT03982199|460394885|FG007|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
127938284|NCT03982199|460394886|FG008|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
127938285|NCT03982199|460394887|FG009|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
127938286|NCT03982199|460394888|FG010|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
127938287|NCT03982199|460394889|FG011|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
127938288|NCT03982199|460394890|FG012|Revacc Subcohort (From Day 1095 to 1460)|Other|1|||
127938289|NCT03982199|460394891|FG013|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
127938290|NCT00594646|460394892|FG000|Overall Study|Withdrawal by Subject|1|||
127938291|NCT00594646|460394892|FG000|Overall Study|Lost to Follow-up|15|||
127938292|NCT03907462|460394895|FG000|Overall Study|Physician Decision|1|||
127938293|NCT03907462|460394896|FG001|Overall Study|Physician Decision|3|||
127938294|NCT03907462|460394897|FG002|Overall Study|Physician Decision|1|||
127938295|NCT03907462|460394895|FG000|Overall Study|Withdrawal by Subject|6|||
127938296|NCT03907462|460394896|FG001|Overall Study|Withdrawal by Subject|3|||
127938297|NCT03907462|460394897|FG002|Overall Study|Withdrawal by Subject|3|||
127938298|NCT03907462|460394895|FG000|Overall Study|Pregnancy|4|||
127938299|NCT03907462|460394896|FG001|Overall Study|Pregnancy|2|||
127938300|NCT03907462|460394897|FG002|Overall Study|Pregnancy|6|||
127938301|NCT03907462|460394895|FG000|Overall Study|Lost to Follow-up|16|||
127938302|NCT03907462|460394896|FG001|Overall Study|Lost to Follow-up|18|||
127938303|NCT03907462|460394897|FG002|Overall Study|Lost to Follow-up|22|||
127938304|NCT03548064|460396876|FG000|Overall Study|Withdrawal by Subject|0|||
127938305|NCT03548064|460396877|FG001|Overall Study|Withdrawal by Subject|0|||
127938306|NCT03548064|460396878|FG002|Overall Study|Withdrawal by Subject|0|||
127938307|NCT03548064|460396879|FG003|Overall Study|Withdrawal by Subject|1|||
127938308|NCT03548064|460396880|FG004|Overall Study|Withdrawal by Subject|0|||
127938309|NCT03548064|460396881|FG005|Overall Study|Withdrawal by Subject|0|||
127938310|NCT03548064|460396882|FG006|Overall Study|Withdrawal by Subject|0|||
127938311|NCT03548064|460396883|FG007|Overall Study|Withdrawal by Subject|0|||
127938312|NCT03548064|460396876|FG000|Overall Study|Lost to Follow-up|0|||
127938313|NCT03548064|460396877|FG001|Overall Study|Lost to Follow-up|0|||
127938314|NCT03548064|460396878|FG002|Overall Study|Lost to Follow-up|0|||
127938315|NCT03548064|460396879|FG003|Overall Study|Lost to Follow-up|0|||
127938316|NCT03548064|460396880|FG004|Overall Study|Lost to Follow-up|2|||
127938317|NCT03548064|460396881|FG005|Overall Study|Lost to Follow-up|0|||
127938318|NCT03548064|460396882|FG006|Overall Study|Lost to Follow-up|0|||
127938319|NCT03548064|460396883|FG007|Overall Study|Lost to Follow-up|0|||
127938320|NCT03548064|460396876|FG000|Overall Study|Covid-19 Pandemic|0|||
127938321|NCT03548064|460396877|FG001|Overall Study|Covid-19 Pandemic|0|||
127938322|NCT03548064|460396878|FG002|Overall Study|Covid-19 Pandemic|0|||
127938323|NCT03548064|460396879|FG003|Overall Study|Covid-19 Pandemic|0|||
127938324|NCT03548064|460396880|FG004|Overall Study|Covid-19 Pandemic|10|||
127938325|NCT03548064|460396881|FG005|Overall Study|Covid-19 Pandemic|3|||
127938326|NCT03548064|460396882|FG006|Overall Study|Covid-19 Pandemic|0|||
127938327|NCT03548064|460396883|FG007|Overall Study|Covid-19 Pandemic|0|||
127938330|NCT05011123|460396886|FG000|Overall Study|Withdrawal by Subject|4|||
127938331|NCT05011123|460396887|FG001|Overall Study|Withdrawal by Subject|2|||
127938332|NCT05011123|460396886|FG000|Overall Study|Lost to Follow-up|7|||
127938333|NCT05011123|460396887|FG001|Overall Study|Lost to Follow-up|6|||
127938334|NCT05011123|460396886|FG000|Overall Study|Ongoing at the time of DBL date|36|||
127938335|NCT05011123|460396887|FG001|Overall Study|Ongoing at the time of DBL date|10|||
127938336|NCT05011123|460396886|FG000|Overall Study|Randomized but did not receive vaccination|1|||
127485452|NCT01240863|458741181|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
127938337|NCT05011123|460396887|FG001|Overall Study|Randomized but did not receive vaccination|0|||
127938338|NCT04221789|460396888|FG000|Overall Study|deviation from protoco|22|||
127938339|NCT04221789|460396889|FG001|Overall Study|deviation from protoco|8|||
127938340|NCT04732221|460396890|FG000|Base Period|Death|2|||
127938341|NCT04732221|460396891|FG001|Base Period|Death|0|||
127938342|NCT04732221|460396892|FG002|Base Period|Death|0|||
127938343|NCT04732221|460396893|FG003|Base Period|Death|0|||
127938344|NCT04732221|460396894|FG004|Base Period|Death|0|||
127938345|NCT04732221|460396895|FG005|Base Period|Death|0|||
127938346|NCT04732221|460396896|FG006|Base Period|Death|0|||
127938347|NCT04732221|460396890|FG000|Base Period|Withdrawal by Subject|0|||
127938348|NCT04732221|460396891|FG001|Base Period|Withdrawal by Subject|1|||
127938349|NCT04732221|460396892|FG002|Base Period|Withdrawal by Subject|1|||
127938350|NCT04732221|460396893|FG003|Base Period|Withdrawal by Subject|0|||
127938351|NCT04732221|460396894|FG004|Base Period|Withdrawal by Subject|0|||
127938352|NCT04732221|460396895|FG005|Base Period|Withdrawal by Subject|0|||
127938353|NCT04732221|460396896|FG006|Base Period|Withdrawal by Subject|0|||
127938354|NCT04732221|460396890|FG000|Extension Period|Adverse Event|0|||
127938355|NCT04732221|460396891|FG001|Extension Period|Adverse Event|0|||
127938356|NCT04732221|460396892|FG002|Extension Period|Adverse Event|0|||
127938357|NCT04732221|460396893|FG003|Extension Period|Adverse Event|0|||
127938358|NCT04732221|460396894|FG004|Extension Period|Adverse Event|0|||
127938359|NCT04732221|460396895|FG005|Extension Period|Adverse Event|1|||
127938360|NCT04732221|460396896|FG006|Extension Period|Adverse Event|0|||
127938361|NCT04732221|460396890|FG000|Extension Period|Death|0|||
127938362|NCT04732221|460396891|FG001|Extension Period|Death|0|||
127938363|NCT04732221|460396892|FG002|Extension Period|Death|0|||
127938364|NCT04732221|460396893|FG003|Extension Period|Death|0|||
127938365|NCT04732221|460396894|FG004|Extension Period|Death|1|||
127938366|NCT04732221|460396895|FG005|Extension Period|Death|0|||
127938367|NCT04732221|460396896|FG006|Extension Period|Death|2|||
127938368|NCT04732221|460396890|FG000|Extension Period|Pregnancy|0|||
127938369|NCT04732221|460396891|FG001|Extension Period|Pregnancy|0|||
127938370|NCT04732221|460396892|FG002|Extension Period|Pregnancy|0|||
127938371|NCT04732221|460396893|FG003|Extension Period|Pregnancy|0|||
127938372|NCT04732221|460396894|FG004|Extension Period|Pregnancy|1|||
127938373|NCT04732221|460396895|FG005|Extension Period|Pregnancy|0|||
127938374|NCT04732221|460396896|FG006|Extension Period|Pregnancy|0|||
127938375|NCT04732221|460396890|FG000|Extension Period|Sponsors Decision|0|||
127938376|NCT04732221|460396891|FG001|Extension Period|Sponsors Decision|0|||
127938377|NCT04732221|460396892|FG002|Extension Period|Sponsors Decision|0|||
127938378|NCT04732221|460396893|FG003|Extension Period|Sponsors Decision|0|||
127938379|NCT04732221|460396894|FG004|Extension Period|Sponsors Decision|41|||
127938380|NCT04732221|460396895|FG005|Extension Period|Sponsors Decision|40|||
127938381|NCT04732221|460396896|FG006|Extension Period|Sponsors Decision|40|||
127938382|NCT04732221|460396890|FG000|Extension Period|Withdrawal by Subject|0|||
127938383|NCT04732221|460396891|FG001|Extension Period|Withdrawal by Subject|0|||
127938384|NCT04732221|460396892|FG002|Extension Period|Withdrawal by Subject|0|||
127938385|NCT04732221|460396893|FG003|Extension Period|Withdrawal by Subject|0|||
127938386|NCT04732221|460396894|FG004|Extension Period|Withdrawal by Subject|1|||
127938387|NCT04732221|460396895|FG005|Extension Period|Withdrawal by Subject|5|||
127938388|NCT04732221|460396896|FG006|Extension Period|Withdrawal by Subject|2|||
127938389|NCT03303625|460396897|FG000|Overall Study|Withdrawal by Subject|2|||
127938390|NCT03303625|460396898|FG001|Overall Study|Withdrawal by Subject|0|||
127938391|NCT03303625|460396899|FG002|Overall Study|Withdrawal by Subject|0|||
127938392|NCT03303625|460396900|FG003|Overall Study|Withdrawal by Subject|0|||
127938393|NCT05327816|460396901|FG000|Overall Study|Lost to Follow-up|1|||
127938394|NCT05327816|460396902|FG001|Overall Study|Lost to Follow-up|0|||
127938395|NCT05327816|460396903|FG002|Overall Study|Lost to Follow-up|0|||
127938396|NCT05327816|460396904|FG003|Overall Study|Lost to Follow-up|0|||
127938397|NCT05327816|460396905|FG004|Overall Study|Lost to Follow-up|0|||
127938398|NCT05327816|460396906|FG005|Overall Study|Lost to Follow-up|0|||
127938399|NCT05327816|460396907|FG006|Overall Study|Lost to Follow-up|0|||
127938400|NCT05327816|460396908|FG007|Overall Study|Lost to Follow-up|0|||
127938401|NCT05327816|460396909|FG008|Overall Study|Lost to Follow-up|0|||
127938402|NCT05327816|460396910|FG009|Overall Study|Lost to Follow-up|1|||
127938403|NCT05327816|460396911|FG010|Overall Study|Lost to Follow-up|0|||
127938404|NCT05327816|460396901|FG000|Overall Study|Withdrawal by Subject|0|||
127938405|NCT05327816|460396902|FG001|Overall Study|Withdrawal by Subject|0|||
127938406|NCT05327816|460396903|FG002|Overall Study|Withdrawal by Subject|0|||
127938407|NCT05327816|460396904|FG003|Overall Study|Withdrawal by Subject|0|||
127938408|NCT05327816|460396905|FG004|Overall Study|Withdrawal by Subject|1|||
127938409|NCT05327816|460396906|FG005|Overall Study|Withdrawal by Subject|1|||
127938410|NCT05327816|460396907|FG006|Overall Study|Withdrawal by Subject|0|||
127938411|NCT05327816|460396908|FG007|Overall Study|Withdrawal by Subject|0|||
127938412|NCT05327816|460396909|FG008|Overall Study|Withdrawal by Subject|0|||
127938413|NCT05327816|460396910|FG009|Overall Study|Withdrawal by Subject|0|||
127938414|NCT05327816|460396911|FG010|Overall Study|Withdrawal by Subject|0|||
127938415|NCT05327816|460396901|FG000|Overall Study|Study Terminated by Sponsor|11|||
127938416|NCT05327816|460396902|FG001|Overall Study|Study Terminated by Sponsor|12|||
127938417|NCT05327816|460396903|FG002|Overall Study|Study Terminated by Sponsor|12|||
127938418|NCT05327816|460396904|FG003|Overall Study|Study Terminated by Sponsor|12|||
127938419|NCT05327816|460396905|FG004|Overall Study|Study Terminated by Sponsor|11|||
127938420|NCT05327816|460396906|FG005|Overall Study|Study Terminated by Sponsor|11|||
127938421|NCT05327816|460396907|FG006|Overall Study|Study Terminated by Sponsor|11|||
127938422|NCT05327816|460396908|FG007|Overall Study|Study Terminated by Sponsor|11|||
127938423|NCT05327816|460396909|FG008|Overall Study|Study Terminated by Sponsor|11|||
127938424|NCT05327816|460396910|FG009|Overall Study|Study Terminated by Sponsor|11|||
127938425|NCT05327816|460396911|FG010|Overall Study|Study Terminated by Sponsor|12|||
127938426|NCT05327816|460396901|FG000|Overall Study|Randomized but not treated|0|||
127938427|NCT05327816|460396902|FG001|Overall Study|Randomized but not treated|0|||
127938428|NCT05327816|460396903|FG002|Overall Study|Randomized but not treated|0|||
127938429|NCT05327816|460396904|FG003|Overall Study|Randomized but not treated|0|||
127938430|NCT05327816|460396905|FG004|Overall Study|Randomized but not treated|0|||
127938431|NCT05327816|460396906|FG005|Overall Study|Randomized but not treated|0|||
127938432|NCT05327816|460396907|FG006|Overall Study|Randomized but not treated|1|||
127938433|NCT05327816|460396908|FG007|Overall Study|Randomized but not treated|1|||
127938434|NCT05327816|460396909|FG008|Overall Study|Randomized but not treated|1|||
127938435|NCT05327816|460396910|FG009|Overall Study|Randomized but not treated|0|||
127938436|NCT05327816|460396911|FG010|Overall Study|Randomized but not treated|0|||
127938437|NCT02771795|460396912|FG000|Overall Study|Withdrawal by Subject|47|||
127938438|NCT02771795|460396913|FG001|Overall Study|Withdrawal by Subject|37|||
127938439|NCT02771795|460396912|FG000|Overall Study|Termination by premature discontinuation of study|168|||
127938440|NCT02771795|460396913|FG001|Overall Study|Termination by premature discontinuation of study|185|||
127938441|NCT04112173|460396914|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
127938442|NCT02906930|460396915|FG000|Overall Study|Withdrawal by Subject|0|||
127938443|NCT02906930|460396916|FG001|Overall Study|Withdrawal by Subject|5|||
127938444|NCT02906930|460396917|FG002|Overall Study|Withdrawal by Subject|5|||
127938445|NCT02906930|460396918|FG003|Overall Study|Withdrawal by Subject|4|||
127938446|NCT02906930|460396915|FG000|Overall Study|Lost to Follow-up|5|||
127938447|NCT02906930|460396916|FG001|Overall Study|Lost to Follow-up|7|||
127938448|NCT02906930|460396917|FG002|Overall Study|Lost to Follow-up|5|||
127938449|NCT02906930|460396918|FG003|Overall Study|Lost to Follow-up|2|||
127938450|NCT02906930|460396915|FG000|Overall Study|Death|0|||
127938451|NCT02906930|460396916|FG001|Overall Study|Death|0|||
127938452|NCT02906930|460396917|FG002|Overall Study|Death|1|||
127938453|NCT02906930|460396918|FG003|Overall Study|Death|0|||
127938454|NCT02906930|460396915|FG000|Overall Study|Other|1|||
127938455|NCT02906930|460396916|FG001|Overall Study|Other|2|||
127938456|NCT02906930|460396917|FG002|Overall Study|Other|1|||
127938457|NCT02906930|460396918|FG003|Overall Study|Other|2|||
127938458|NCT02570113|460396921|FG000|Overall Study|Withdrawal by Subject|3|||
127938459|NCT02564211|460396922|FG000|Overall Study|Adverse Event|4|||
127938460|NCT00910091|460396923|FG000|Pre-assignment|Withdrawal by Subject|0|||
127938461|NCT00910091|460396924|FG001|Pre-assignment|Withdrawal by Subject|2|||
127938462|NCT00910091|460396923|FG000|Treatment and Survival|Withdrawal by Subject|3|||
127938463|NCT00910091|460396924|FG001|Treatment and Survival|Withdrawal by Subject|4|||
127938464|NCT00910091|460396923|FG000|Treatment and Survival|Adverse Event|1|||
127938465|NCT00910091|460396924|FG001|Treatment and Survival|Adverse Event|0|||
127938466|NCT00622466|460396925|FG000|Overall Study|Death|1|||
127938467|NCT00622466|460396925|FG000|Overall Study|Adverse Event|1|||
127938468|NCT00622466|460396925|FG000|Overall Study|Withdrawal by Subject|2|||
127938469|NCT01908816|460396926|FG000|Overall Study|Subject's no longer requires study drug|0|||
127938470|NCT01908816|460396927|FG001|Overall Study|Subject's no longer requires study drug|0|||
127938471|NCT01908816|460396928|FG002|Overall Study|Subject's no longer requires study drug|0|||
127938472|NCT01908816|460396929|FG003|Overall Study|Subject's no longer requires study drug|1|||
127938473|NCT01908816|460396926|FG000|Overall Study|Protocol deviation|1|||
127938474|NCT01908816|460396927|FG001|Overall Study|Protocol deviation|2|||
127938475|NCT01908816|460396928|FG002|Overall Study|Protocol deviation|1|||
127938476|NCT01908816|460396929|FG003|Overall Study|Protocol deviation|1|||
127938477|NCT01908816|460396926|FG000|Overall Study|Withdrawal by Subject|0|||
127938478|NCT01908816|460396927|FG001|Overall Study|Withdrawal by Subject|4|||
127938479|NCT01908816|460396928|FG002|Overall Study|Withdrawal by Subject|2|||
127938480|NCT01908816|460396929|FG003|Overall Study|Withdrawal by Subject|2|||
127938481|NCT01908816|460396926|FG000|Overall Study|Lost to Follow-up|3|||
127938482|NCT01908816|460396927|FG001|Overall Study|Lost to Follow-up|5|||
127938483|NCT01908816|460396928|FG002|Overall Study|Lost to Follow-up|4|||
127938484|NCT01908816|460396929|FG003|Overall Study|Lost to Follow-up|2|||
127938485|NCT01908816|460396926|FG000|Overall Study|Death|1|||
127938486|NCT01908816|460396927|FG001|Overall Study|Death|0|||
127485453|NCT01240863|458741182|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
127938487|NCT01908816|460396928|FG002|Overall Study|Death|7|||
127938488|NCT01908816|460396929|FG003|Overall Study|Death|1|||
127938489|NCT01908816|460396926|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
127938490|NCT01908816|460396927|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
127938491|NCT01908816|460396928|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
127938492|NCT01908816|460396929|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
127938493|NCT01908816|460396926|FG000|Overall Study|Early termination|87|||
127938494|NCT01908816|460396927|FG001|Overall Study|Early termination|60|||
127938495|NCT01908816|460396928|FG002|Overall Study|Early termination|43|||
127938496|NCT01908816|460396929|FG003|Overall Study|Early termination|28|||
127938497|NCT05183217|460396930|FG000|Overall Study|Withdrawal by Subject|1|||
127938498|NCT05183217|460396931|FG001|Overall Study|Withdrawal by Subject|1|||
127938499|NCT01155024|460396933|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
127938500|NCT01155024|460396934|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
127938501|NCT01155024|460396933|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
127938502|NCT01155024|460396934|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
127938503|NCT01155024|460396933|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
127938504|NCT01155024|460396934|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
127938505|NCT04585789|460396935|FG000|FU Phase: Week 48 to Week 96|Lost to Follow-up|1|||
127938506|NCT04585789|460396936|FG001|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
127938507|NCT04585789|460396937|FG002|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
127938508|NCT04585789|460396935|FG000|FU Phase: Week 48 to Week 96|Withdrawal by Subject|1|||
127938509|NCT04585789|460396936|FG001|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
127938510|NCT04585789|460396937|FG002|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
127938511|NCT01154816|460396940|FG000|Overall Study|Withdrawal by Subject|1|||
127938512|NCT01154816|460396941|FG001|Overall Study|Withdrawal by Subject|0|||
127938513|NCT01154816|460396942|FG002|Overall Study|Withdrawal by Subject|0|||
127938514|NCT01154816|460396943|FG003|Overall Study|Withdrawal by Subject|1|||
127938515|NCT01154816|460396944|FG004|Overall Study|Withdrawal by Subject|0|||
127938516|NCT01154816|460396945|FG005|Overall Study|Withdrawal by Subject|0|||
127938517|NCT01154816|460396946|FG006|Overall Study|Withdrawal by Subject|0|||
127938518|NCT01154816|460396947|FG007|Overall Study|Withdrawal by Subject|0|||
127938519|NCT01154816|460396948|FG008|Overall Study|Withdrawal by Subject|1|||
127938520|NCT01154816|460396949|FG009|Overall Study|Withdrawal by Subject|3|||
127938521|NCT01154816|460396950|FG010|Overall Study|Withdrawal by Subject|0|||
127938522|NCT01154816|460396951|FG011|Overall Study|Withdrawal by Subject|0|||
127938523|NCT01154816|460396940|FG000|Overall Study|Progressive Disease|13|||
127938524|NCT01154816|460396941|FG001|Overall Study|Progressive Disease|8|||
127938525|NCT01154816|460396942|FG002|Overall Study|Progressive Disease|9|||
127938526|NCT01154816|460396943|FG003|Overall Study|Progressive Disease|9|||
127938527|NCT01154816|460396944|FG004|Overall Study|Progressive Disease|8|||
127938528|NCT01154816|460396945|FG005|Overall Study|Progressive Disease|8|||
127938529|NCT01154816|460396946|FG006|Overall Study|Progressive Disease|5|||
127938530|NCT01154816|460396947|FG007|Overall Study|Progressive Disease|6|||
127938531|NCT01154816|460396948|FG008|Overall Study|Progressive Disease|8|||
127938532|NCT01154816|460396949|FG009|Overall Study|Progressive Disease|6|||
127938533|NCT01154816|460396950|FG010|Overall Study|Progressive Disease|10|||
127938534|NCT01154816|460396951|FG011|Overall Study|Progressive Disease|3|||
127938535|NCT01154816|460396940|FG000|Overall Study|Physician Decision|1|||
127938536|NCT01154816|460396941|FG001|Overall Study|Physician Decision|0|||
127938537|NCT01154816|460396942|FG002|Overall Study|Physician Decision|1|||
127938538|NCT01154816|460396943|FG003|Overall Study|Physician Decision|0|||
127938539|NCT01154816|460396944|FG004|Overall Study|Physician Decision|2|||
127938540|NCT01154816|460396945|FG005|Overall Study|Physician Decision|0|||
127938541|NCT01154816|460396946|FG006|Overall Study|Physician Decision|0|||
127938542|NCT01154816|460396947|FG007|Overall Study|Physician Decision|0|||
127938543|NCT01154816|460396948|FG008|Overall Study|Physician Decision|0|||
127938544|NCT01154816|460396949|FG009|Overall Study|Physician Decision|1|||
127938545|NCT01154816|460396950|FG010|Overall Study|Physician Decision|1|||
127938546|NCT01154816|460396951|FG011|Overall Study|Physician Decision|1|||
127938547|NCT01154816|460396940|FG000|Overall Study|Adverse Event|5|||
127938548|NCT01154816|460396941|FG001|Overall Study|Adverse Event|2|||
127938549|NCT01154816|460396942|FG002|Overall Study|Adverse Event|0|||
127938550|NCT01154816|460396943|FG003|Overall Study|Adverse Event|0|||
127938551|NCT01154816|460396944|FG004|Overall Study|Adverse Event|0|||
127938552|NCT01154816|460396945|FG005|Overall Study|Adverse Event|0|||
127938553|NCT01154816|460396946|FG006|Overall Study|Adverse Event|1|||
127938554|NCT01154816|460396947|FG007|Overall Study|Adverse Event|1|||
127938555|NCT01154816|460396948|FG008|Overall Study|Adverse Event|0|||
127938556|NCT01154816|460396949|FG009|Overall Study|Adverse Event|0|||
127938557|NCT01154816|460396950|FG010|Overall Study|Adverse Event|0|||
127938558|NCT01154816|460396951|FG011|Overall Study|Adverse Event|0|||
127938559|NCT03397771|460396952|FG000|Overall Study|2 erroneously randomized, never treated|3|||
127938560|NCT03397771|460396953|FG001|Overall Study|2 erroneously randomized, never treated|1|||
127938561|NCT03397771|460396952|FG000|Overall Study|Withdrawal by Subject|1|||
127938562|NCT03397771|460396953|FG001|Overall Study|Withdrawal by Subject|3|||
127938563|NCT03397771|460396952|FG000|Overall Study|Protocol Violation|2|||
127938564|NCT03397771|460396953|FG001|Overall Study|Protocol Violation|2|||
127938565|NCT03397771|460396952|FG000|Overall Study|Adverse Event|2|||
127938566|NCT03397771|460396953|FG001|Overall Study|Adverse Event|1|||
127938567|NCT04078126|460396956|FG000|Washout|Study put on hold due to COVID-19|0|||
127938568|NCT04078126|460396957|FG001|Washout|Study put on hold due to COVID-19|2|||
127938569|NCT04078126|460396956|FG000|Period 2|Study put on hold due to COVID-19|1|||
127938570|NCT04078126|460396957|FG001|Period 2|Study put on hold due to COVID-19|1|||
127938571|NCT03321630|460396958|FG000|Overall Study|Adverse Event|1|||
127938572|NCT03321630|460396958|FG000|Overall Study|Investigator Discretion|2|||
127938573|NCT03321630|460396958|FG000|Overall Study|Withdrawal by Subject|1|||
127938574|NCT02669758|460396959|FG000|Overall Study|Withdrawal by Subject|43|||
127938575|NCT02669758|460396959|FG000|Overall Study|Lost to Follow-up|19|||
127938576|NCT02669758|460396959|FG000|Overall Study|Adverse Event|16|||
127938577|NCT02669758|460396959|FG000|Overall Study|Non-Compliance with Study Drug|8|||
127938578|NCT02669758|460396959|FG000|Overall Study|Lack of Efficacy|5|||
127938579|NCT02669758|460396959|FG000|Overall Study|Pregnancy|1|||
127938580|NCT02669758|460396959|FG000|Overall Study|Study noncompliance|1|||
127938581|NCT02669758|460396959|FG000|Overall Study|Protocol Violation|1|||
127938582|NCT02605993|460396962|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
127938583|NCT02605993|460396963|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
127938584|NCT02605993|460396964|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
127938585|NCT02605993|460396965|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
127938586|NCT02603393|460396966|FG000|Overall Study|Patient/guardian decision|32|||
127938587|NCT02603393|460396967|FG001|Overall Study|Patient/guardian decision|18|||
127938588|NCT02603393|460396966|FG000|Overall Study|Adverse Event|17|||
127938589|NCT02603393|460396967|FG001|Overall Study|Adverse Event|15|||
127938590|NCT02603393|460396966|FG000|Overall Study|Technical problems|4|||
127938591|NCT02603393|460396967|FG001|Overall Study|Technical problems|7|||
127938592|NCT02603393|460396966|FG000|Overall Study|Lack of Efficacy|7|||
127938593|NCT02603393|460396967|FG001|Overall Study|Lack of Efficacy|2|||
127938594|NCT02603393|460396966|FG000|Overall Study|Death|3|||
127938595|NCT02603393|460396967|FG001|Overall Study|Death|4|||
127938596|NCT02603393|460396966|FG000|Overall Study|Physician Decision|3|||
127938597|NCT02603393|460396967|FG001|Overall Study|Physician Decision|3|||
127938598|NCT02603393|460396966|FG000|Overall Study|Protocol deviation|2|||
127938599|NCT02603393|460396967|FG001|Overall Study|Protocol deviation|3|||
127938600|NCT02603393|460396966|FG000|Overall Study|Lost to Follow-up|1|||
127938601|NCT02603393|460396967|FG001|Overall Study|Lost to Follow-up|2|||
127938602|NCT02603393|460396966|FG000|Overall Study|Non-compliance with study treatment|1|||
127938603|NCT02603393|460396967|FG001|Overall Study|Non-compliance with study treatment|0|||
127938604|NCT02603393|460396966|FG000|Overall Study|Sponsor decision|1|||
127938605|NCT02603393|460396967|FG001|Overall Study|Sponsor decision|0|||
127938606|NCT01868893|460396970|FG000|Overall Study|Adverse Event|2|||
127938607|NCT01868893|460396970|FG000|Overall Study|Commercial availability of study drug|17|||
127938608|NCT01868893|460396970|FG000|Overall Study|Neutropenia|1|||
127938609|NCT01783548|460396971|FG000|Overall Study|Adverse Event|8|||
127938610|NCT01783548|460396972|FG001|Overall Study|Adverse Event|4|||
127938611|NCT01783548|460396971|FG000|Overall Study|Withdrawal by Subject|11|||
127938612|NCT01783548|460396972|FG001|Overall Study|Withdrawal by Subject|8|||
127938613|NCT01783548|460396971|FG000|Overall Study|Non-compliance|4|||
127938614|NCT01783548|460396972|FG001|Overall Study|Non-compliance|0|||
127938615|NCT01783548|460396971|FG000|Overall Study|Protocol Violation|2|||
127938616|NCT01783548|460396972|FG001|Overall Study|Protocol Violation|2|||
127938617|NCT01783548|460396971|FG000|Overall Study|Lost to Follow-up|8|||
127938618|NCT01783548|460396972|FG001|Overall Study|Lost to Follow-up|3|||
127938619|NCT01783548|460396971|FG000|Overall Study|Lack of Efficacy|1|||
127938620|NCT01783548|460396972|FG001|Overall Study|Lack of Efficacy|1|||
127938621|NCT00988442|460396973|FG000|Overall Study|Death|1|||
127938622|NCT00988442|460396974|FG001|Overall Study|Death|2|||
127938623|NCT00988442|460396973|FG000|Overall Study|Lost to Follow-up|0|||
127938624|NCT00988442|460396974|FG001|Overall Study|Lost to Follow-up|1|||
127938625|NCT00988442|460396973|FG000|Overall Study|Early Study Closure|29|||
127938626|NCT00988442|460396974|FG001|Overall Study|Early Study Closure|25|||
127938627|NCT01212588|460396978|FG000|Overall Study|Physician Decision|0|||
127938628|NCT01212588|460396979|FG001|Overall Study|Physician Decision|1|||
127938629|NCT01212588|460396978|FG000|Overall Study|Protocol Violation|1|||
127938630|NCT01212588|460396979|FG001|Overall Study|Protocol Violation|1|||
127938631|NCT03317834|460396982|FG000|Overall Study|Death|2|||
127938632|NCT03317834|460396982|FG000|Overall Study|Device Revision|5|||
127938633|NCT03317834|460396982|FG000|Overall Study|Withdrawal by Subject|13|||
127938634|NCT03317834|460396982|FG000|Overall Study|Lost to Follow-up|13|||
127938635|NCT03893565|460396983|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
127938636|NCT03893565|460396984|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
127938637|NCT03893565|460396985|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
127938638|NCT03893565|460396986|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
127938639|NCT03893565|460396987|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
127938640|NCT03893565|460396988|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
127938641|NCT03893565|460396989|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
127938642|NCT03893565|460396990|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
127938643|NCT03893565|460396991|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
127938644|NCT03893565|460396983|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
127938645|NCT03893565|460396984|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
127938646|NCT03893565|460396985|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
127938647|NCT03893565|460396986|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
127938648|NCT03893565|460396987|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
127938649|NCT03893565|460396988|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
127938650|NCT03893565|460396989|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
127938651|NCT03893565|460396990|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
127938652|NCT03893565|460396991|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
127938653|NCT03893565|460396983|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
127938654|NCT03893565|460396984|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
127938655|NCT03893565|460396985|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
127938656|NCT03893565|460396986|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
127938657|NCT03893565|460396987|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
127938658|NCT03893565|460396988|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
127938659|NCT03893565|460396989|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
127938660|NCT03893565|460396990|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
127938661|NCT03893565|460396991|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
127938662|NCT03893565|460396983|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
127938663|NCT03893565|460396984|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
127938664|NCT03893565|460396985|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
127938665|NCT03893565|460396986|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
127938666|NCT03893565|460396987|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
127938667|NCT03893565|460396988|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
127938668|NCT03893565|460396989|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
127938669|NCT03893565|460396990|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
127938670|NCT03893565|460396991|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
127938671|NCT03893565|460396983|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
127938672|NCT03893565|460396984|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
127938673|NCT03893565|460396985|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
127938674|NCT03893565|460396986|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
127938675|NCT03893565|460396987|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
127938676|NCT03893565|460396988|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
127938677|NCT03893565|460396989|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
127938678|NCT03893565|460396990|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
127938679|NCT03893565|460396991|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
127938680|NCT03893565|460396983|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
127938681|NCT03893565|460396984|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
127938682|NCT03893565|460396985|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
127938683|NCT03893565|460396986|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
127938684|NCT03893565|460396987|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
127938685|NCT03893565|460396988|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
127938686|NCT03893565|460396989|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
127938687|NCT03893565|460396990|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
127938688|NCT03893565|460396991|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
127938689|NCT03893565|460396983|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
127938690|NCT03893565|460396984|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
127938691|NCT03893565|460396985|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
127938692|NCT03893565|460396986|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
127938693|NCT03893565|460396987|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
127938694|NCT03893565|460396988|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
127938695|NCT03893565|460396989|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
127938696|NCT03893565|460396990|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
127938697|NCT03893565|460396991|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
127938698|NCT03893565|460396983|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
127938699|NCT03893565|460396984|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
127938700|NCT03893565|460396985|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
127938701|NCT03893565|460396986|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
127938702|NCT03893565|460396987|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
127938703|NCT03893565|460396988|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
127938704|NCT03893565|460396989|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
127938705|NCT03893565|460396990|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
127938706|NCT03893565|460396991|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
127938707|NCT03893565|460396983|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
127938708|NCT03893565|460396984|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
127938709|NCT03893565|460396985|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
127938710|NCT03893565|460396986|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
127938711|NCT03893565|460396987|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
127938712|NCT03893565|460396988|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
127938713|NCT03893565|460396989|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
127938714|NCT03893565|460396990|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
127938715|NCT03893565|460396991|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
127938716|NCT03893565|460396983|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
127938717|NCT03893565|460396984|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
127938718|NCT03893565|460396985|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
127938719|NCT03893565|460396986|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
127938720|NCT03893565|460396987|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
127938721|NCT03893565|460396988|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
127938722|NCT03893565|460396989|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
127938723|NCT03893565|460396990|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
127938724|NCT03893565|460396991|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
127938725|NCT03893565|460396983|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
127938726|NCT03893565|460396984|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
127938727|NCT03893565|460396985|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
127938728|NCT03893565|460396986|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
127938729|NCT03893565|460396987|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
127938730|NCT03893565|460396988|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
127938731|NCT03893565|460396989|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
127938732|NCT03893565|460396990|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
127938733|NCT03893565|460396991|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
127938734|NCT03893565|460396983|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
127938735|NCT03893565|460396984|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
127938736|NCT03893565|460396985|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
127938737|NCT03893565|460396986|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
127938738|NCT03893565|460396987|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
127938739|NCT03893565|460396988|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
127938740|NCT03893565|460396989|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
127938741|NCT03893565|460396990|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
127938742|NCT03893565|460396991|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
127938743|NCT03893565|460396983|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
127938744|NCT03893565|460396984|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
127938745|NCT03893565|460396985|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
127938746|NCT03893565|460396986|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
127938747|NCT03893565|460396987|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
127938748|NCT03893565|460396988|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
127938749|NCT03893565|460396989|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
127938750|NCT03893565|460396990|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
127938751|NCT03893565|460396991|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
127938752|NCT03893565|460396983|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
127938753|NCT03893565|460396984|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
127938754|NCT03893565|460396985|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
127938755|NCT03893565|460396986|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
127938756|NCT03893565|460396987|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
127938757|NCT03893565|460396988|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
127938758|NCT03893565|460396989|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
127938759|NCT03893565|460396990|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
127938760|NCT03893565|460396991|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
127938761|NCT03893565|460396983|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
127938762|NCT03893565|460396984|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
127938763|NCT03893565|460396985|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
127938764|NCT03893565|460396986|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
127938765|NCT03893565|460396987|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
127938766|NCT03893565|460396988|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
127485454|NCT01240863|458741183|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
127938767|NCT03893565|460396989|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
127938768|NCT03893565|460396990|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
127938769|NCT03893565|460396991|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
127938770|NCT03893565|460396983|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
127938771|NCT03893565|460396984|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
127938772|NCT03893565|460396985|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
127938773|NCT03893565|460396986|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
127938774|NCT03893565|460396987|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
127938775|NCT03893565|460396988|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
127938776|NCT03893565|460396989|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
127938777|NCT03893565|460396990|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
127938778|NCT03893565|460396991|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
127938779|NCT02387983|460396995|FG000|Overall Study|Adverse Event|4|||
127938780|NCT02387983|460396995|FG000|Overall Study|Protocol Violation|1|||
127938781|NCT02387983|460396995|FG000|Overall Study|Withdrawal by Subject|2|||
127938782|NCT01103466|460396998|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
127938783|NCT01103466|460396999|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
127938784|NCT01103466|460397000|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
127938785|NCT01103466|460396998|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
127938786|NCT01103466|460396999|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
127938787|NCT01103466|460397000|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
127938788|NCT01103466|460396998|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
127938789|NCT01103466|460396999|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
127938790|NCT01103466|460397000|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
127938791|NCT01103466|460396998|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
127938792|NCT01103466|460396999|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
127938793|NCT01103466|460397000|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
127938794|NCT01103466|460396998|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
127938795|NCT01103466|460396999|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
127938796|NCT01103466|460397000|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
127938797|NCT01103466|460396998|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
127938798|NCT01103466|460396999|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
127938799|NCT01103466|460397000|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
127938800|NCT02331368|460397003|FG000|Overall Study|Withdrawal by Subject|3|||
127938801|NCT02302859|460397016|FG000|Overall Study|Lost Phone|1|||
127938802|NCT02302859|460397017|FG001|Overall Study|Lost Phone|1|||
127938803|NCT02302859|460397016|FG000|Overall Study|Withdrawal by Subject|0|||
127938804|NCT02302859|460397017|FG001|Overall Study|Withdrawal by Subject|1|||
127938805|NCT01791153|460397022|FG000|Part 1: Blinded Period|Adverse Event|7|||
127938806|NCT01791153|460397023|FG001|Part 1: Blinded Period|Adverse Event|3|||
127938807|NCT01791153|460397024|FG002|Part 1: Blinded Period|Adverse Event|2|||
127938808|NCT01791153|460397025|FG003|Part 1: Blinded Period|Adverse Event|0|||
127938809|NCT01791153|460397026|FG004|Part 1: Blinded Period|Adverse Event|0|||
127938810|NCT01791153|460397027|FG005|Part 1: Blinded Period|Adverse Event|0|||
127938811|NCT01791153|460397028|FG006|Part 1: Blinded Period|Adverse Event|0|||
127938812|NCT01791153|460397029|FG007|Part 1: Blinded Period|Adverse Event|0|||
127938813|NCT01791153|460397022|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
127938814|NCT01791153|460397023|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
127938815|NCT01791153|460397024|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
127938816|NCT01791153|460397025|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
127938817|NCT01791153|460397026|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
127938818|NCT01791153|460397027|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
127938819|NCT01791153|460397028|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
127938820|NCT01791153|460397029|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
127938821|NCT01791153|460397022|FG000|Part 1: Blinded Period|Non-Compliance|1|||
127938822|NCT01791153|460397023|FG001|Part 1: Blinded Period|Non-Compliance|0|||
127938823|NCT01791153|460397024|FG002|Part 1: Blinded Period|Non-Compliance|0|||
127938824|NCT01791153|460397025|FG003|Part 1: Blinded Period|Non-Compliance|0|||
127938825|NCT01791153|460397026|FG004|Part 1: Blinded Period|Non-Compliance|0|||
127938826|NCT01791153|460397027|FG005|Part 1: Blinded Period|Non-Compliance|0|||
127938827|NCT01791153|460397028|FG006|Part 1: Blinded Period|Non-Compliance|0|||
127938828|NCT01791153|460397029|FG007|Part 1: Blinded Period|Non-Compliance|0|||
127938829|NCT01791153|460397022|FG000|Part 1: Blinded Period|Physician Decision|0|||
127938830|NCT01791153|460397023|FG001|Part 1: Blinded Period|Physician Decision|0|||
127938831|NCT01791153|460397024|FG002|Part 1: Blinded Period|Physician Decision|0|||
127938832|NCT01791153|460397025|FG003|Part 1: Blinded Period|Physician Decision|1|||
127938833|NCT01791153|460397026|FG004|Part 1: Blinded Period|Physician Decision|0|||
127938834|NCT01791153|460397027|FG005|Part 1: Blinded Period|Physician Decision|0|||
127938835|NCT01791153|460397028|FG006|Part 1: Blinded Period|Physician Decision|0|||
127938836|NCT01791153|460397029|FG007|Part 1: Blinded Period|Physician Decision|0|||
127938837|NCT01791153|460397022|FG000|Part 1: Blinded Period|Protocol Violation|0|||
127938838|NCT01791153|460397023|FG001|Part 1: Blinded Period|Protocol Violation|0|||
127938839|NCT01791153|460397024|FG002|Part 1: Blinded Period|Protocol Violation|0|||
127938840|NCT01791153|460397025|FG003|Part 1: Blinded Period|Protocol Violation|1|||
127938841|NCT01791153|460397026|FG004|Part 1: Blinded Period|Protocol Violation|0|||
127938842|NCT01791153|460397027|FG005|Part 1: Blinded Period|Protocol Violation|0|||
127938843|NCT01791153|460397028|FG006|Part 1: Blinded Period|Protocol Violation|0|||
127938844|NCT01791153|460397029|FG007|Part 1: Blinded Period|Protocol Violation|0|||
127938845|NCT01791153|460397022|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
127938846|NCT01791153|460397023|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
127938847|NCT01791153|460397024|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
127938848|NCT01791153|460397025|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
127938849|NCT01791153|460397026|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
127938850|NCT01791153|460397027|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
127938851|NCT01791153|460397028|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
127938852|NCT01791153|460397029|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
127938853|NCT01791153|460397022|FG000|Part 2: Open-label Period|Adverse Event|0|||
127938854|NCT01791153|460397023|FG001|Part 2: Open-label Period|Adverse Event|0|||
127938855|NCT01791153|460397024|FG002|Part 2: Open-label Period|Adverse Event|0|||
127938856|NCT01791153|460397025|FG003|Part 2: Open-label Period|Adverse Event|0|||
127938857|NCT01791153|460397026|FG004|Part 2: Open-label Period|Adverse Event|0|||
127938858|NCT01791153|460397027|FG005|Part 2: Open-label Period|Adverse Event|1|||
127938859|NCT01791153|460397028|FG006|Part 2: Open-label Period|Adverse Event|1|||
127938860|NCT01791153|460397029|FG007|Part 2: Open-label Period|Adverse Event|2|||
127938861|NCT01791153|460397022|FG000|Part 2: Open-label Period|Death|0|||
127938862|NCT01791153|460397023|FG001|Part 2: Open-label Period|Death|0|||
127938863|NCT01791153|460397024|FG002|Part 2: Open-label Period|Death|0|||
127938864|NCT01791153|460397025|FG003|Part 2: Open-label Period|Death|0|||
127938865|NCT01791153|460397026|FG004|Part 2: Open-label Period|Death|0|||
127938866|NCT01791153|460397027|FG005|Part 2: Open-label Period|Death|1|||
127938867|NCT01791153|460397028|FG006|Part 2: Open-label Period|Death|1|||
127938868|NCT01791153|460397029|FG007|Part 2: Open-label Period|Death|1|||
127938869|NCT01791153|460397022|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
127938870|NCT01791153|460397023|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
127938871|NCT01791153|460397024|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
127938872|NCT01791153|460397025|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
127938873|NCT01791153|460397026|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
127938874|NCT01791153|460397027|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
127938875|NCT01791153|460397028|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
127938876|NCT01791153|460397029|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
127938877|NCT01791153|460397022|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
127938878|NCT01791153|460397023|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
127938879|NCT01791153|460397024|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
127938880|NCT01791153|460397025|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
127938881|NCT01791153|460397026|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
127938882|NCT01791153|460397027|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
127938883|NCT01791153|460397028|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
127938884|NCT01791153|460397029|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
127938885|NCT01791153|460397022|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
127938886|NCT01791153|460397023|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
127938887|NCT01791153|460397024|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
127938888|NCT01791153|460397025|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
127938889|NCT01791153|460397026|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
127938890|NCT01791153|460397027|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
127938891|NCT01791153|460397028|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
127938892|NCT01791153|460397029|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
127938893|NCT01791153|460397022|FG000|Part 2: Open-label Period|Physician Decision|0|||
127938894|NCT01791153|460397023|FG001|Part 2: Open-label Period|Physician Decision|0|||
127938895|NCT01791153|460397024|FG002|Part 2: Open-label Period|Physician Decision|0|||
127938896|NCT01791153|460397025|FG003|Part 2: Open-label Period|Physician Decision|0|||
127938897|NCT01791153|460397026|FG004|Part 2: Open-label Period|Physician Decision|1|||
127938898|NCT01791153|460397027|FG005|Part 2: Open-label Period|Physician Decision|1|||
127938899|NCT01791153|460397028|FG006|Part 2: Open-label Period|Physician Decision|0|||
127938900|NCT01791153|460397029|FG007|Part 2: Open-label Period|Physician Decision|0|||
127938901|NCT00975286|460397033|FG000|Overall Study|Adverse Event|9|||
127938902|NCT00975286|460397034|FG001|Overall Study|Adverse Event|19|||
127938903|NCT00975286|460397033|FG000|Overall Study|Protocol Violation|1|||
127938904|NCT00975286|460397034|FG001|Overall Study|Protocol Violation|2|||
127938905|NCT00975286|460397033|FG000|Overall Study|Withdrawal by Subject|0|||
127938906|NCT00975286|460397034|FG001|Overall Study|Withdrawal by Subject|2|||
127938907|NCT00975286|460397033|FG000|Overall Study|Familial and Personal Reasons|2|||
127938908|NCT00975286|460397034|FG001|Overall Study|Familial and Personal Reasons|2|||
127938909|NCT00975286|460397033|FG000|Overall Study|Poor Compliance to Protocol|0|||
127938910|NCT00975286|460397034|FG001|Overall Study|Poor Compliance to Protocol|2|||
127938911|NCT00975286|460397033|FG000|Overall Study|Sponsor Decision|0|||
127938912|NCT00975286|460397034|FG001|Overall Study|Sponsor Decision|2|||
127938913|NCT02357342|460397035|FG000|First 6 Months|Death|2|||
127938914|NCT02357342|460397036|FG001|First 6 Months|Death|0|||
127938915|NCT01674647|460397037|FG000|Treatment Period|Death|4|||
127938916|NCT01674647|460397038|FG001|Treatment Period|Death|1|||
127938917|NCT01674647|460397037|FG000|Treatment Period|Efficacy outcome reached|0|||
127938918|NCT01674647|460397038|FG001|Treatment Period|Efficacy outcome reached|1|||
127938919|NCT01674647|460397037|FG000|Treatment Period|Physician Decision|3|||
127938920|NCT01674647|460397038|FG001|Treatment Period|Physician Decision|1|||
127938921|NCT01674647|460397037|FG000|Treatment Period|Adverse Event|60|||
127938922|NCT01674647|460397038|FG001|Treatment Period|Adverse Event|22|||
127938923|NCT01674647|460397037|FG000|Treatment Period|Non-compliance with study drug|3|||
127938924|NCT01674647|460397038|FG001|Treatment Period|Non-compliance with study drug|0|||
127938925|NCT01674647|460397037|FG000|Treatment Period|Lost to Follow-up|1|||
127938926|NCT01674647|460397038|FG001|Treatment Period|Lost to Follow-up|1|||
127938927|NCT01674647|460397037|FG000|Treatment Period|Withdrawal by Subject|19|||
127938928|NCT01674647|460397038|FG001|Treatment Period|Withdrawal by Subject|16|||
127938929|NCT01674647|460397037|FG000|Treatment Period|Switching to other therapy|5|||
127938930|NCT01674647|460397038|FG001|Treatment Period|Switching to other therapy|2|||
127938931|NCT01674647|460397037|FG000|Treatment Period|Logistical difficulties|5|||
127938932|NCT01674647|460397038|FG001|Treatment Period|Logistical difficulties|8|||
127938933|NCT01674647|460397037|FG000|Treatment Period|Treatment failure|0|||
127938934|NCT01674647|460397038|FG001|Treatment Period|Treatment failure|14|||
127938935|NCT01674647|460397037|FG000|Treatment Period|Protocol Violation|56|||
127938936|NCT01674647|460397038|FG001|Treatment Period|Protocol Violation|36|||
127938937|NCT01674647|460397037|FG000|30-day Safety Follow-up Period|Death|3|||
127938938|NCT01674647|460397038|FG001|30-day Safety Follow-up Period|Death|2|||
127938939|NCT01674647|460397037|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
127938940|NCT01674647|460397038|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
127938941|NCT01674647|460397037|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
127938942|NCT01674647|460397038|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
127938943|NCT01674647|460397037|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
127938944|NCT01674647|460397038|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
127938945|NCT01674647|460397037|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
127938946|NCT01674647|460397038|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
127938947|NCT01674647|460397037|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
127938948|NCT01674647|460397038|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
127938949|NCT04156620|460397040|FG000|Overall Study|Adverse event - TP 1|5|||
127938950|NCT04156620|460397041|FG001|Overall Study|Adverse event - TP 1|2|||
127938951|NCT04156620|460397040|FG000|Overall Study|Lost to follow-up TP 1|1|||
127938952|NCT04156620|460397041|FG001|Overall Study|Lost to follow-up TP 1|1|||
127938953|NCT04156620|460397040|FG000|Overall Study|Progressive disease - TP 1|0|||
127938954|NCT04156620|460397041|FG001|Overall Study|Progressive disease - TP 1|1|||
127938955|NCT04156620|460397040|FG000|Overall Study|Subject decision - TP 1|3|||
127938956|NCT04156620|460397041|FG001|Overall Study|Subject decision - TP 1|5|||
127938957|NCT04156620|460397040|FG000|Overall Study|Adverse event - TP 2|5|||
127938958|NCT04156620|460397041|FG001|Overall Study|Adverse event - TP 2|6|||
127938959|NCT04156620|460397040|FG000|Overall Study|Death - TP 2|1|||
127938960|NCT04156620|460397041|FG001|Overall Study|Death - TP 2|0|||
127938961|NCT04156620|460397040|FG000|Overall Study|Lost to follow-up - TP 2|5|||
127938962|NCT04156620|460397041|FG001|Overall Study|Lost to follow-up - TP 2|2|||
127938963|NCT04156620|460397040|FG000|Overall Study|Physician decision - TP 2|4|||
127938964|NCT04156620|460397041|FG001|Overall Study|Physician decision - TP 2|2|||
127938965|NCT04156620|460397040|FG000|Overall Study|Pregnancy - TP 2|1|||
127938966|NCT04156620|460397041|FG001|Overall Study|Pregnancy - TP 2|1|||
127938967|NCT04156620|460397040|FG000|Overall Study|Subject decision - TP 2|11|||
127938968|NCT04156620|460397041|FG001|Overall Study|Subject decision - TP 2|9|||
127938969|NCT04156620|460397040|FG000|Overall Study|New therapy for study indication - TP 2|1|||
127938970|NCT04156620|460397041|FG001|Overall Study|New therapy for study indication - TP 2|0|||
127938971|NCT01753336|460397043|FG000|Overall Study|Patient decision|12|||
127938972|NCT01753336|460397043|FG000|Overall Study|Lost to Follow-up|3|||
127938973|NCT01753336|460397043|FG000|Overall Study|Physician Decision|2|||
127938974|NCT01753336|460397043|FG000|Overall Study|Sponsor's decision|2|||
127938975|NCT01753336|460397043|FG000|Overall Study|Withdrawal by Subject|1|||
127938976|NCT00914459|460397044|FG000|Overall Study|Protocol Violation|0|||
127938977|NCT00914459|460397045|FG001|Overall Study|Protocol Violation|1|||
127938978|NCT00914459|460397044|FG000|Overall Study|Parent/Legal guardian request|1|||
127938979|NCT00914459|460397045|FG001|Overall Study|Parent/Legal guardian request|0|||
127938980|NCT01661179|460397049|FG000|Overall Study|Death|1|||
127938981|NCT01661179|460397049|FG000|Overall Study|Withdrawal by Subject|1|||
127938982|NCT01661179|460397049|FG000|Overall Study|Other Eligibility criteria|4|||
127938983|NCT01946191|460397050|FG000|Allocation|Did not complete orientation|1|||
127938984|NCT01946191|460397051|FG001|Allocation|Did not complete orientation|1|||
127938985|NCT01946191|460397050|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
127938986|NCT01946191|460397051|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
127938987|NCT01946191|460397050|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
127938988|NCT01946191|460397051|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
127938989|NCT01946191|460397050|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
127938990|NCT01946191|460397051|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
127938991|NCT01629966|460397052|FG000|Overall Study|Pregnancy|0|||
127938992|NCT01629966|460397053|FG001|Overall Study|Pregnancy|1|||
127938993|NCT01629966|460397054|FG002|Overall Study|Pregnancy|0|||
127938994|NCT01629966|460397052|FG000|Overall Study|Lost to Follow-up|10|||
127938995|NCT01629966|460397053|FG001|Overall Study|Lost to Follow-up|13|||
127938996|NCT01629966|460397054|FG002|Overall Study|Lost to Follow-up|9|||
127938997|NCT01629966|460397052|FG000|Overall Study|Withdrawal by Subject|8|||
127938998|NCT01629966|460397053|FG001|Overall Study|Withdrawal by Subject|9|||
127938999|NCT01629966|460397054|FG002|Overall Study|Withdrawal by Subject|16|||
127939000|NCT01629966|460397052|FG000|Overall Study|Protocol Violation|7|||
127939001|NCT01629966|460397053|FG001|Overall Study|Protocol Violation|9|||
127939002|NCT01629966|460397054|FG002|Overall Study|Protocol Violation|7|||
127939003|NCT01629966|460397052|FG000|Overall Study|Lack of Efficacy|5|||
127939004|NCT01629966|460397053|FG001|Overall Study|Lack of Efficacy|2|||
127939005|NCT01629966|460397054|FG002|Overall Study|Lack of Efficacy|4|||
127939006|NCT01629966|460397052|FG000|Overall Study|Adverse Event|11|||
127939007|NCT01629966|460397053|FG001|Overall Study|Adverse Event|18|||
127939008|NCT01629966|460397054|FG002|Overall Study|Adverse Event|30|||
127939009|NCT04188301|460397062|FG000|Month 3|Lost to Follow-up|0|||
127939010|NCT04188301|460397063|FG001|Month 3|Lost to Follow-up|0|||
127939011|NCT04188301|460397064|FG002|Month 3|Lost to Follow-up|1|||
127939012|NCT04188301|460397062|FG000|Month 12|Lost to Follow-up|0|||
127939013|NCT04188301|460397063|FG001|Month 12|Lost to Follow-up|0|||
127939014|NCT04188301|460397064|FG002|Month 12|Lost to Follow-up|2|||
127939015|NCT04188301|460397062|FG000|Month 12|Death|1|||
127939016|NCT04188301|460397063|FG001|Month 12|Death|1|||
127939017|NCT04188301|460397064|FG002|Month 12|Death|0|||
127939018|NCT04188301|460397062|FG000|Month 18|Lost to Follow-up|6|||
127939019|NCT04188301|460397063|FG001|Month 18|Lost to Follow-up|0|||
127939020|NCT04188301|460397064|FG002|Month 18|Lost to Follow-up|0|||
127939021|NCT00006721|460399090|FG000|Overall Study|Adverse Event|0|||
127939022|NCT00006721|460399091|FG001|Overall Study|Adverse Event|4|||
127939023|NCT00006721|460399092|FG002|Overall Study|Adverse Event|4|||
127939024|NCT00006721|460399090|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
127939025|NCT00006721|460399091|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
127939026|NCT00006721|460399092|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
127939027|NCT00006721|460399090|FG000|Overall Study|Progression/Relapse|0|||
127939028|NCT00006721|460399091|FG001|Overall Study|Progression/Relapse|1|||
127939029|NCT00006721|460399092|FG002|Overall Study|Progression/Relapse|2|||
127939030|NCT00006721|460399090|FG000|Overall Study|Death|0|||
127939031|NCT00006721|460399091|FG001|Overall Study|Death|1|||
127939032|NCT00006721|460399092|FG002|Overall Study|Death|2|||
127939033|NCT00006721|460399090|FG000|Overall Study|Other - Not Protocol Specified|0|||
127939034|NCT00006721|460399091|FG001|Overall Study|Other - Not Protocol Specified|7|||
127939035|NCT00006721|460399092|FG002|Overall Study|Other - Not Protocol Specified|7|||
127939036|NCT00006721|460399090|FG000|Overall Study|Ineligible|2|||
127939037|NCT00006721|460399091|FG001|Overall Study|Ineligible|12|||
127939038|NCT00006721|460399092|FG002|Overall Study|Ineligible|10|||
127939039|NCT00006721|460399090|FG000|Overall Study|Eligible but no Treatment Received|1|||
127939040|NCT00006721|460399091|FG001|Overall Study|Eligible but no Treatment Received|0|||
127939041|NCT00006721|460399092|FG002|Overall Study|Eligible but no Treatment Received|0|||
127939042|NCT05091307|460399093|FG000|Overall Study|Death|0|||
127939043|NCT05091307|460399094|FG001|Overall Study|Death|0|||
127939044|NCT05091307|460399095|FG002|Overall Study|Death|1|||
127939045|NCT05091307|460399096|FG003|Overall Study|Death|0|||
127939046|NCT05091307|460399093|FG000|Overall Study|Lost to Follow-up|33|||
127939047|NCT05091307|460399094|FG001|Overall Study|Lost to Follow-up|33|||
127939048|NCT05091307|460399095|FG002|Overall Study|Lost to Follow-up|2|||
127939049|NCT05091307|460399096|FG003|Overall Study|Lost to Follow-up|0|||
127939050|NCT05091307|460399093|FG000|Overall Study|Physician Decision|1|||
127939051|NCT05091307|460399094|FG001|Overall Study|Physician Decision|0|||
127939052|NCT05091307|460399095|FG002|Overall Study|Physician Decision|0|||
127939053|NCT05091307|460399096|FG003|Overall Study|Physician Decision|0|||
127939054|NCT05091307|460399093|FG000|Overall Study|Protocol Violation|1|||
127939055|NCT05091307|460399094|FG001|Overall Study|Protocol Violation|0|||
127939056|NCT05091307|460399095|FG002|Overall Study|Protocol Violation|0|||
127939057|NCT05091307|460399096|FG003|Overall Study|Protocol Violation|0|||
127939058|NCT05091307|460399093|FG000|Overall Study|Withdrawal by Subject|16|||
127939059|NCT05091307|460399094|FG001|Overall Study|Withdrawal by Subject|16|||
127939060|NCT05091307|460399095|FG002|Overall Study|Withdrawal by Subject|0|||
127939061|NCT05091307|460399096|FG003|Overall Study|Withdrawal by Subject|1|||
127939062|NCT05091307|460399093|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
127939063|NCT05091307|460399094|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
127939064|NCT05091307|460399095|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
127939065|NCT05091307|460399096|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
127939066|NCT05091307|460399093|FG000|Overall Study|Initiated Prohibited Medication|1|||
127939067|NCT05091307|460399094|FG001|Overall Study|Initiated Prohibited Medication|0|||
127939068|NCT05091307|460399095|FG002|Overall Study|Initiated Prohibited Medication|0|||
127939069|NCT05091307|460399096|FG003|Overall Study|Initiated Prohibited Medication|0|||
127939070|NCT05091307|460399093|FG000|Overall Study|Other|4|||
127939071|NCT05091307|460399094|FG001|Overall Study|Other|4|||
127939072|NCT05091307|460399095|FG002|Overall Study|Other|0|||
127939073|NCT05091307|460399096|FG003|Overall Study|Other|0|||
127939074|NCT05091307|460399093|FG000|Overall Study|Randomized but not vaccinated|0|||
127939075|NCT05091307|460399094|FG001|Overall Study|Randomized but not vaccinated|2|||
127939076|NCT05091307|460399095|FG002|Overall Study|Randomized but not vaccinated|0|||
127939077|NCT05091307|460399096|FG003|Overall Study|Randomized but not vaccinated|0|||
127939078|NCT03747601|460399097|FG000|Overall Study|COVID halt to visits|4|||
127939079|NCT00112866|460399098|FG000|Overall Study|Protocol Violation|1|||
127939080|NCT00112866|460399099|FG001|Overall Study|Protocol Violation|0|||
127939081|NCT00112866|460399098|FG000|Overall Study|did not start treatment post-op|1|||
127939082|NCT00112866|460399099|FG001|Overall Study|did not start treatment post-op|2|||
127939083|NCT01167257|460399101|FG000|Overall Study|Lost to Follow-up|2|||
127939084|NCT01167257|460399102|FG001|Overall Study|Lost to Follow-up|2|||
127939085|NCT01167257|460399101|FG000|Overall Study|Withdrew consent|1|||
127939086|NCT01167257|460399102|FG001|Overall Study|Withdrew consent|1|||
127939087|NCT04305587|460399103|FG000|Overall Study|Withdrawal by Subject|0|||
127939088|NCT04305587|460399104|FG001|Overall Study|Withdrawal by Subject|0|||
127939089|NCT04305587|460399105|FG002|Overall Study|Withdrawal by Subject|0|||
127939090|NCT04305587|460399106|FG003|Overall Study|Withdrawal by Subject|1|||
127939091|NCT04305587|460399107|FG004|Overall Study|Withdrawal by Subject|0|||
127939092|NCT04305587|460399108|FG005|Overall Study|Withdrawal by Subject|0|||
127939093|NCT04305587|460399109|FG006|Overall Study|Withdrawal by Subject|0|||
127939094|NCT04305587|460399110|FG007|Overall Study|Withdrawal by Subject|0|||
127939095|NCT04305587|460399111|FG008|Overall Study|Withdrawal by Subject|0|||
127939096|NCT01367665|460399112|FG000|Overall Study|Death|102|||
127939097|NCT01367665|460399113|FG001|Overall Study|Death|19|||
127939098|NCT01367665|460399112|FG000|Overall Study|Lost to Follow-up|222|||
127939099|NCT01367665|460399113|FG001|Overall Study|Lost to Follow-up|22|||
127939100|NCT01367665|460399112|FG000|Overall Study|Not Done|118|||
127939101|NCT01367665|460399113|FG001|Overall Study|Not Done|14|||
127939102|NCT02752906|460399114|FG000|Overall Study|Protocol Violation|2|||
127939103|NCT02752906|460399115|FG001|Overall Study|Protocol Violation|1|||
127939104|NCT02752906|460399114|FG000|Overall Study|Withdrawal by Subject|2|||
127939105|NCT02752906|460399115|FG001|Overall Study|Withdrawal by Subject|2|||
127939106|NCT02752906|460399114|FG000|Overall Study|Lost to Follow-up|3|||
127939107|NCT02752906|460399115|FG001|Overall Study|Lost to Follow-up|2|||
127939108|NCT02492880|460399117|FG000|Overall Study|Lost to Follow-up|1|||
127939109|NCT02492880|460399117|FG000|Overall Study|Protocol Violation|1|||
127939110|NCT00554190|460399118|FG000|Overall Study|Termination forms not completed|10|||
127939111|NCT04241315|460399123|FG000|Overall Study|Withdrawal by Subject|0|||
127939112|NCT04241315|460399124|FG001|Overall Study|Withdrawal by Subject|1|||
127939113|NCT00699283|460399125|FG000|Overall Study|Lack of Efficacy|15|||
127939114|NCT00699283|460399126|FG001|Overall Study|Lack of Efficacy|5|||
127939115|NCT00699283|460399125|FG000|Overall Study|Lost to Follow-up|2|||
127939116|NCT00699283|460399126|FG001|Overall Study|Lost to Follow-up|0|||
127939117|NCT00699283|460399125|FG000|Overall Study|Withdrawal by Subject|1|||
127939118|NCT00699283|460399126|FG001|Overall Study|Withdrawal by Subject|0|||
127939119|NCT00699283|460399125|FG000|Overall Study|Other Reason|5|||
127939120|NCT00699283|460399126|FG001|Overall Study|Other Reason|1|||
127939121|NCT00699283|460399125|FG000|Overall Study|SAE, non-fatal|1|||
127939122|NCT00699283|460399126|FG001|Overall Study|SAE, non-fatal|1|||
127939123|NCT00699283|460399125|FG000|Overall Study|AE, non-serious non-fatal|8|||
127939124|NCT00699283|460399126|FG001|Overall Study|AE, non-serious non-fatal|1|||
127939125|NCT00699283|460399125|FG000|Overall Study|AE of unknown type|1|||
127939126|NCT00699283|460399126|FG001|Overall Study|AE of unknown type|0|||
127939127|NCT00394524|460399127|FG000|Overall Study|Protocol Violation|2|||
127939128|NCT00394524|460399128|FG001|Overall Study|Protocol Violation|3|||
127939129|NCT00394524|460399127|FG000|Overall Study|Death|1|||
127939130|NCT00394524|460399128|FG001|Overall Study|Death|0|||
127939131|NCT00394524|460399127|FG000|Overall Study|Withdrawal by Subject|0|||
127939132|NCT00394524|460399128|FG001|Overall Study|Withdrawal by Subject|1|||
127939133|NCT01345175|460399129|FG000|Overall Study|Physician Decision|0|||
127939134|NCT01345175|460399130|FG001|Overall Study|Physician Decision|1|||
127939135|NCT01345175|460399129|FG000|Overall Study|Withdrawal by Subject|1|||
127939136|NCT01345175|460399130|FG001|Overall Study|Withdrawal by Subject|1|||
127939137|NCT01345175|460399129|FG000|Overall Study|Failed to complete BFI|3|||
127939138|NCT01345175|460399130|FG001|Overall Study|Failed to complete BFI|2|||
127939139|NCT01345175|460399129|FG000|Overall Study|Stopped taking medication|2|||
127939140|NCT01345175|460399130|FG001|Overall Study|Stopped taking medication|2|||
127939141|NCT03537599|460399141|FG000|Overall Study|Disease Progression|2|||
127939142|NCT03537599|460399142|FG001|Overall Study|Disease Progression|1|||
127939143|NCT03537599|460399141|FG000|Overall Study|Death|0|||
127939144|NCT03537599|460399142|FG001|Overall Study|Death|1|||
127939145|NCT01383135|460399145|FG000|Overall Study|Not Scanned / Imaged|1|||
127939146|NCT01383135|460399146|FG001|Overall Study|Not Scanned / Imaged|0|||
127939147|NCT01383135|460399147|FG002|Overall Study|Not Scanned / Imaged|1|||
127939148|NCT01383135|460399148|FG003|Overall Study|Not Scanned / Imaged|0|||
127939149|NCT00114166|460399149|FG000|Overall Study|Wrong primary|0|||
127939150|NCT00114166|460399150|FG001|Overall Study|Wrong primary|1|||
127939151|NCT03560986|460399156|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
127939152|NCT03560986|460399157|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
127939153|NCT03560986|460399156|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
127939154|NCT03560986|460399157|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
127939155|NCT03560986|460399156|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
127939156|NCT03560986|460399157|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
127939157|NCT03560986|460399156|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
127939158|NCT03560986|460399157|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
127939159|NCT03560986|460399156|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
127939160|NCT03560986|460399157|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
127939161|NCT03560986|460399156|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
127939162|NCT03560986|460399157|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
127939163|NCT03560986|460399156|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
127939164|NCT03560986|460399157|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
127939165|NCT00593736|460399169|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
127939166|NCT00593736|460399170|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
127939167|NCT00593736|460399171|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
127939168|NCT00593736|460399172|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
127939169|NCT00593736|460399169|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
127939170|NCT00593736|460399170|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
127939171|NCT00593736|460399171|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
127939172|NCT00593736|460399172|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
127939173|NCT00593736|460399169|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
127939174|NCT00593736|460399170|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
127939175|NCT00593736|460399171|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
127939176|NCT00593736|460399172|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
127939177|NCT00593736|460399169|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
127939178|NCT00593736|460399170|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
127939179|NCT00593736|460399171|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
127939180|NCT00593736|460399172|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
127939181|NCT00593736|460399169|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
127939182|NCT00593736|460399170|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
127939183|NCT00593736|460399171|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
127939184|NCT00593736|460399172|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
127939185|NCT00593736|460399169|FG000|Screening Period and Placebo Run-in|Various|0|||
127939186|NCT00593736|460399170|FG001|Screening Period and Placebo Run-in|Various|0|||
127939187|NCT00593736|460399171|FG002|Screening Period and Placebo Run-in|Various|0|||
127939188|NCT00593736|460399172|FG003|Screening Period and Placebo Run-in|Various|25|||
127939189|NCT00593736|460399169|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
127939190|NCT00593736|460399170|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
127939191|NCT00593736|460399171|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
127939192|NCT00593736|460399172|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
127939193|NCT00593736|460399169|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
127939194|NCT00593736|460399170|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
127939195|NCT00593736|460399171|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
127939196|NCT00593736|460399172|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
127939197|NCT00593736|460399169|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
127939198|NCT00593736|460399170|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
127939199|NCT00593736|460399171|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
127939200|NCT00593736|460399172|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
127939201|NCT00593736|460399169|FG000|Treatment Period and Placebo Run-out|Various|1|||
127939202|NCT00593736|460399170|FG001|Treatment Period and Placebo Run-out|Various|1|||
127939203|NCT00593736|460399171|FG002|Treatment Period and Placebo Run-out|Various|1|||
127939204|NCT00593736|460399172|FG003|Treatment Period and Placebo Run-out|Various|0|||
127939205|NCT01857271|460399173|FG000|Overall Study|Lost to Follow-up|1|||
127939206|NCT03493386|460399174|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
127939207|NCT03493386|460399175|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
127939208|NCT03493386|460399176|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
127939209|NCT03493386|460399177|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
127939210|NCT01468818|460399178|FG000|Overall Study|Death during treatment|2|||
127939211|NCT01735955|460399179|FG000|Overall Study|Administrative problems|1|||
127939212|NCT01735955|460399179|FG000|Overall Study|Patient/guardian decision|1|||
127939213|NCT01735955|460399179|FG000|Overall Study|Patient withdrew consent|2|||
127939214|NCT01735955|460399179|FG000|Overall Study|Physician Decision|4|||
127939215|NCT01735955|460399179|FG000|Overall Study|Disease progression|24|||
127939216|NCT01735955|460399179|FG000|Overall Study|Adverse Event|5|||
127939217|NCT05788289|460399191|FG000|Overall Study|Death|3|||
127939218|NCT01974440|460399192|FG000|Overall Study|Lost to Follow-up|7|||
127939219|NCT01974440|460399193|FG001|Overall Study|Lost to Follow-up|7|||
127939220|NCT01974440|460399192|FG000|Overall Study|Withdrawal by Subject|24|||
127939221|NCT01974440|460399193|FG001|Overall Study|Withdrawal by Subject|20|||
127939222|NCT01974440|460399192|FG000|Overall Study|Sponsor decision|109|||
127939223|NCT01974440|460399193|FG001|Overall Study|Sponsor decision|110|||
127939224|NCT00762437|460399194|FG000|Overall Study|Lost to Follow-up|7|||
127939225|NCT00762437|460399194|FG000|Overall Study|Missed final study visit|11|||
127939226|NCT00762437|460399194|FG000|Overall Study|No treatment (unable to attach sleeve to participant)|1|||
127939227|NCT03569228|460399195|FG000|Overall Study|Withdrawal by PI|0|||
127939228|NCT03569228|460399196|FG001|Overall Study|Withdrawal by PI|0|||
127939229|NCT03569228|460399197|FG002|Overall Study|Withdrawal by PI|2|||
127939230|NCT03569228|460399198|FG003|Overall Study|Withdrawal by PI|2|||
127939231|NCT03569228|460399199|FG004|Overall Study|Withdrawal by PI|1|||
127939232|NCT03569228|460399200|FG005|Overall Study|Withdrawal by PI|0|||
127939233|NCT03569228|460399201|FG006|Overall Study|Withdrawal by PI|0|||
127939234|NCT03569228|460399202|FG007|Overall Study|Withdrawal by PI|0|||
127939235|NCT03569228|460399203|FG008|Overall Study|Withdrawal by PI|0|||
127939236|NCT03569228|460399195|FG000|Overall Study|Lost to Follow-up|0|||
127939237|NCT03569228|460399196|FG001|Overall Study|Lost to Follow-up|0|||
127939238|NCT03569228|460399197|FG002|Overall Study|Lost to Follow-up|0|||
127939239|NCT03569228|460399198|FG003|Overall Study|Lost to Follow-up|0|||
127939240|NCT03569228|460399199|FG004|Overall Study|Lost to Follow-up|0|||
127939241|NCT03569228|460399200|FG005|Overall Study|Lost to Follow-up|0|||
127939242|NCT03569228|460399201|FG006|Overall Study|Lost to Follow-up|0|||
127939243|NCT03569228|460399202|FG007|Overall Study|Lost to Follow-up|0|||
127939244|NCT03569228|460399203|FG008|Overall Study|Lost to Follow-up|1|||
127939245|NCT03569228|460399195|FG000|Overall Study|Screen Fail|2|||
127939246|NCT03569228|460399196|FG001|Overall Study|Screen Fail|2|||
127939247|NCT03569228|460399197|FG002|Overall Study|Screen Fail|1|||
127939248|NCT03569228|460399198|FG003|Overall Study|Screen Fail|1|||
127939249|NCT03569228|460399199|FG004|Overall Study|Screen Fail|1|||
127939250|NCT03569228|460399200|FG005|Overall Study|Screen Fail|3|||
127939251|NCT03569228|460399201|FG006|Overall Study|Screen Fail|1|||
127939252|NCT03569228|460399202|FG007|Overall Study|Screen Fail|5|||
127939253|NCT03569228|460399203|FG008|Overall Study|Screen Fail|2|||
127939254|NCT06354998|460399204|FG000|Overall Study|Withdrawal by Subject|3|||
127939255|NCT06354998|460399205|FG001|Overall Study|Withdrawal by Subject|0|||
127939256|NCT00085423|460399210|FG000|Overall Study|Withdrawal by Subject|1|||
127939257|NCT00085423|460399210|FG000|Overall Study|screen failure|1|||
127939258|NCT02440568|460399213|FG000|Overall Study|Death|1|||
127939259|NCT02440568|460399214|FG001|Overall Study|Death|3|||
127939260|NCT02440568|460399215|FG002|Overall Study|Death|4|||
127939261|NCT02440568|460399216|FG003|Overall Study|Death|2|||
127939262|NCT02440568|460399213|FG000|Overall Study|Lack of Efficacy|2|||
127939263|NCT02440568|460399214|FG001|Overall Study|Lack of Efficacy|0|||
127939264|NCT02440568|460399215|FG002|Overall Study|Lack of Efficacy|1|||
127939265|NCT02440568|460399216|FG003|Overall Study|Lack of Efficacy|0|||
127939266|NCT02440568|460399213|FG000|Overall Study|Lost to Follow-up|1|||
127939267|NCT02440568|460399214|FG001|Overall Study|Lost to Follow-up|0|||
127939268|NCT02440568|460399215|FG002|Overall Study|Lost to Follow-up|0|||
127939269|NCT02440568|460399216|FG003|Overall Study|Lost to Follow-up|0|||
127939270|NCT00536263|460399222|FG000|Overall Study|Adverse Event|5|||
127939271|NCT00536263|460399223|FG001|Overall Study|Adverse Event|5|||
127939272|NCT00536263|460399224|FG002|Overall Study|Adverse Event|7|||
127939273|NCT00536263|460399222|FG000|Overall Study|Lost to Follow-up|3|||
127939274|NCT00536263|460399223|FG001|Overall Study|Lost to Follow-up|4|||
127939275|NCT00536263|460399224|FG002|Overall Study|Lost to Follow-up|4|||
127939276|NCT00536263|460399222|FG000|Overall Study|Subject withdrew - not treatment related|2|||
127939277|NCT00536263|460399223|FG001|Overall Study|Subject withdrew - not treatment related|0|||
127939278|NCT00536263|460399224|FG002|Overall Study|Subject withdrew - not treatment related|5|||
127939279|NCT00536263|460399222|FG000|Overall Study|Subject withdrew - treatment related|0|||
127939280|NCT00536263|460399223|FG001|Overall Study|Subject withdrew - treatment related|3|||
127939281|NCT00536263|460399224|FG002|Overall Study|Subject withdrew - treatment related|2|||
127939282|NCT00536263|460399222|FG000|Overall Study|Noncompliance with protocol|0|||
127939283|NCT00536263|460399223|FG001|Overall Study|Noncompliance with protocol|0|||
127939284|NCT00536263|460399224|FG002|Overall Study|Noncompliance with protocol|1|||
127939285|NCT00536263|460399222|FG000|Overall Study|Did not meet protocol eligibility|1|||
127939286|NCT00536263|460399223|FG001|Overall Study|Did not meet protocol eligibility|2|||
127939287|NCT00536263|460399224|FG002|Overall Study|Did not meet protocol eligibility|2|||
127939288|NCT03285308|460399226|FG000|Overall Study|Adverse Event|3|||
127939289|NCT03285308|460399227|FG001|Overall Study|Adverse Event|7|||
127939290|NCT03285308|460399226|FG000|Overall Study|Withdrawal by Subject|8|||
127939291|NCT03285308|460399227|FG001|Overall Study|Withdrawal by Subject|9|||
127939292|NCT03285308|460399226|FG000|Overall Study|Lost to Follow-up|3|||
127939293|NCT03285308|460399227|FG001|Overall Study|Lost to Follow-up|1|||
127939294|NCT03285308|460399226|FG000|Overall Study|Protocol Deviation|6|||
127939295|NCT03285308|460399227|FG001|Overall Study|Protocol Deviation|5|||
127939296|NCT03285308|460399226|FG000|Overall Study|Reason not Specified|0|||
127939297|NCT03285308|460399227|FG001|Overall Study|Reason not Specified|1|||
127939298|NCT03734666|460399231|FG000|Overall Study|Other|7|||
127939299|NCT03734666|460399232|FG001|Overall Study|Other|4|||
127939300|NCT03734666|460399231|FG000|Overall Study|Lost to Follow-up|12|||
127939301|NCT03734666|460399232|FG001|Overall Study|Lost to Follow-up|12|||
127939302|NCT00681590|460399233|FG000|Overall Study|Withdrawal by Subject|2|||
127939303|NCT00681590|460399234|FG001|Overall Study|Withdrawal by Subject|12|||
127939304|NCT01181271|460399235|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
127939305|NCT01181271|460399235|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
127939306|NCT01181271|460399235|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
127939307|NCT01181271|460399235|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
127939308|NCT03118570|460399236|FG000|Overall Study|Adverse Event|2|||
127939309|NCT03118570|460399237|FG001|Overall Study|Adverse Event|0|||
127939310|NCT03118570|460399238|FG002|Overall Study|Adverse Event|0|||
127939311|NCT03118570|460399239|FG003|Overall Study|Adverse Event|0|||
127939312|NCT03118570|460399240|FG004|Overall Study|Adverse Event|3|||
127939313|NCT03118570|460399236|FG000|Overall Study|Withdrawal by Subject|0|||
127939314|NCT03118570|460399237|FG001|Overall Study|Withdrawal by Subject|1|||
127939315|NCT03118570|460399238|FG002|Overall Study|Withdrawal by Subject|4|||
127939316|NCT03118570|460399239|FG003|Overall Study|Withdrawal by Subject|0|||
127939317|NCT03118570|460399240|FG004|Overall Study|Withdrawal by Subject|1|||
127939318|NCT03118570|460399236|FG000|Overall Study|Lost to Follow-up|2|||
127939319|NCT03118570|460399237|FG001|Overall Study|Lost to Follow-up|3|||
127939320|NCT03118570|460399238|FG002|Overall Study|Lost to Follow-up|1|||
127939321|NCT03118570|460399239|FG003|Overall Study|Lost to Follow-up|0|||
127939322|NCT03118570|460399240|FG004|Overall Study|Lost to Follow-up|1|||
127939323|NCT03118570|460399236|FG000|Overall Study|Other, Not Specified|1|||
127939324|NCT03118570|460399237|FG001|Overall Study|Other, Not Specified|3|||
127939325|NCT03118570|460399238|FG002|Overall Study|Other, Not Specified|0|||
127939326|NCT03118570|460399239|FG003|Overall Study|Other, Not Specified|0|||
127939327|NCT03118570|460399240|FG004|Overall Study|Other, Not Specified|0|||
127939328|NCT00477295|460399243|FG000|Overall Study|Adverse Event|31|||
127939329|NCT00477295|460399244|FG001|Overall Study|Adverse Event|35|||
127939330|NCT00477295|460399243|FG000|Overall Study|Withdrawal by Subject|35|||
127939331|NCT00477295|460399244|FG001|Overall Study|Withdrawal by Subject|24|||
127939332|NCT00477295|460399243|FG000|Overall Study|Lack of Efficacy|23|||
127939333|NCT00477295|460399244|FG001|Overall Study|Lack of Efficacy|23|||
127939334|NCT00477295|460399243|FG000|Overall Study|Protocol Violation|3|||
127939335|NCT00477295|460399244|FG001|Overall Study|Protocol Violation|8|||
127939336|NCT00477295|460399243|FG000|Overall Study|Physician Decision|4|||
127939337|NCT00477295|460399244|FG001|Overall Study|Physician Decision|5|||
127939338|NCT00477295|460399243|FG000|Overall Study|Lost to Follow-up|21|||
127939339|NCT00477295|460399244|FG001|Overall Study|Lost to Follow-up|11|||
127939340|NCT00477295|460399243|FG000|Overall Study|Other|4|||
127939341|NCT00477295|460399244|FG001|Overall Study|Other|3|||
127939342|NCT04568031|460399245|FG000|Overall Study|Lost to Follow-up|1|||
127939343|NCT04568031|460399246|FG001|Overall Study|Lost to Follow-up|0|||
127939344|NCT04568031|460399247|FG002|Overall Study|Lost to Follow-up|0|||
127939345|NCT04568031|460399248|FG003|Overall Study|Lost to Follow-up|0|||
127939346|NCT04568031|460399245|FG000|Overall Study|Physician Decision|1|||
127939347|NCT04568031|460399246|FG001|Overall Study|Physician Decision|0|||
127939348|NCT04568031|460399247|FG002|Overall Study|Physician Decision|1|||
127939349|NCT04568031|460399248|FG003|Overall Study|Physician Decision|0|||
127939350|NCT04568031|460399245|FG000|Overall Study|Withdrawal by Subject|1|||
127939351|NCT04568031|460399246|FG001|Overall Study|Withdrawal by Subject|0|||
127939352|NCT04568031|460399247|FG002|Overall Study|Withdrawal by Subject|4|||
127939353|NCT04568031|460399248|FG003|Overall Study|Withdrawal by Subject|1|||
127939354|NCT00228423|460399251|FG000|Overall Study|Adverse Event|2|||
127939355|NCT00228423|460399252|FG001|Overall Study|Adverse Event|5|||
127939356|NCT00228423|460399251|FG000|Overall Study|Withdrawal by Subject|7|||
127939357|NCT00228423|460399252|FG001|Overall Study|Withdrawal by Subject|3|||
127939358|NCT00228423|460399251|FG000|Overall Study|Protocol Violation|1|||
127939359|NCT00228423|460399252|FG001|Overall Study|Protocol Violation|3|||
127939360|NCT00228423|460399251|FG000|Overall Study|Physician Decision|0|||
127939361|NCT00228423|460399252|FG001|Overall Study|Physician Decision|1|||
127939362|NCT03753763|460399274|FG000|Overall Study|Adverse Event|2|||
127939363|NCT03753763|460399275|FG001|Overall Study|Adverse Event|0|||
127939364|NCT03753763|460399274|FG000|Overall Study|Withdrawal by Subject|3|||
127939365|NCT03753763|460399275|FG001|Overall Study|Withdrawal by Subject|1|||
127939366|NCT03753763|460399274|FG000|Overall Study|clinical deterioration|1|||
127939367|NCT03753763|460399275|FG001|Overall Study|clinical deterioration|0|||
127939368|NCT00389831|460399276|FG000|Overall Study|Lack of Efficacy|0|||
127939369|NCT00389831|460399277|FG001|Overall Study|Lack of Efficacy|2|||
127939370|NCT00389831|460399276|FG000|Overall Study|Did not receive treatment.|0|||
127939371|NCT00389831|460399277|FG001|Overall Study|Did not receive treatment.|2|||
127939372|NCT00389831|460399276|FG000|Overall Study|Other reasons|0|||
127939373|NCT00389831|460399277|FG001|Overall Study|Other reasons|2|||
127939374|NCT00389831|460399276|FG000|Overall Study|Lost to Follow-up|0|||
127939375|NCT00389831|460399277|FG001|Overall Study|Lost to Follow-up|1|||
127939376|NCT03433755|460399278|FG000|Overall Study|Lost to Follow-up|1|||
127939377|NCT03433755|460399279|FG001|Overall Study|Lost to Follow-up|0|||
127939378|NCT03433755|460399280|FG002|Overall Study|Lost to Follow-up|0|||
127939379|NCT03433755|460399281|FG003|Overall Study|Lost to Follow-up|0|||
127939380|NCT03433755|460399278|FG000|Overall Study|Decision by Sponsor|1|||
127939381|NCT03433755|460399279|FG001|Overall Study|Decision by Sponsor|0|||
127939382|NCT03433755|460399280|FG002|Overall Study|Decision by Sponsor|0|||
127939383|NCT03433755|460399281|FG003|Overall Study|Decision by Sponsor|0|||
127939384|NCT03190330|460401972|FG000|Overall Study|Adverse Event|2|||
127939385|NCT03190330|460401972|FG000|Overall Study|Death|10|||
127939386|NCT03190330|460401972|FG000|Overall Study|Lost to Follow-up|1|||
127939387|NCT03190330|460401972|FG000|Overall Study|Withdrawal by Subject|6|||
127939388|NCT03190330|460401972|FG000|Overall Study|Progressive Disease|1|||
127939389|NCT04395001|460401981|FG000|Overall Study|Lost to Follow-up|8|||
127939390|NCT04395001|460401982|FG001|Overall Study|Lost to Follow-up|9|||
127939391|NCT04395001|460401983|FG002|Overall Study|Lost to Follow-up|5|||
127939392|NCT04395001|460401981|FG000|Overall Study|Withdrawal by Subject|3|||
127939393|NCT04395001|460401982|FG001|Overall Study|Withdrawal by Subject|1|||
127939394|NCT04395001|460401983|FG002|Overall Study|Withdrawal by Subject|3|||
127939395|NCT04395001|460401981|FG000|Overall Study|missed appointment|7|||
127939396|NCT04395001|460401982|FG001|Overall Study|missed appointment|4|||
127939397|NCT04395001|460401983|FG002|Overall Study|missed appointment|1|||
127939398|NCT04347122|460401984|FG000|Overall Study|Physician Decision|0|||
127939399|NCT04347122|460401985|FG001|Overall Study|Physician Decision|3|||
127939400|NCT04347122|460401986|FG002|Overall Study|Physician Decision|3|||
127939401|NCT04347122|460401987|FG003|Overall Study|Physician Decision|6|||
127939402|NCT04994483|460401988|FG000|Overall Study|Adverse Event|26|||
127939403|NCT04994483|460401989|FG001|Overall Study|Adverse Event|17|||
127939404|NCT04994483|460401988|FG000|Overall Study|Lost to Follow-up|6|||
127939405|NCT04994483|460401989|FG001|Overall Study|Lost to Follow-up|10|||
127939406|NCT04994483|460401988|FG000|Overall Study|Noncompliance with study drug|8|||
127939407|NCT04994483|460401989|FG001|Overall Study|Noncompliance with study drug|5|||
127939408|NCT04994483|460401988|FG000|Overall Study|Physician Decision|5|||
127939409|NCT04994483|460401989|FG001|Overall Study|Physician Decision|0|||
127939410|NCT04994483|460401988|FG000|Overall Study|Withdrawal by Subject|41|||
127939411|NCT04994483|460401989|FG001|Overall Study|Withdrawal by Subject|38|||
127939412|NCT04994483|460401988|FG000|Overall Study|Sponsor requests subject to be withdrawn|2|||
127939413|NCT04994483|460401989|FG001|Overall Study|Sponsor requests subject to be withdrawn|1|||
127939414|NCT04994483|460401988|FG000|Overall Study|Met stopping criteria|1|||
127939415|NCT04994483|460401989|FG001|Overall Study|Met stopping criteria|0|||
127939416|NCT04994483|460401988|FG000|Overall Study|Randomized in error, not treated|4|||
127939417|NCT04994483|460401989|FG001|Overall Study|Randomized in error, not treated|3|||
127939418|NCT04994483|460401988|FG000|Overall Study|Lack of a reliable study partner|0|||
127939419|NCT04994483|460401989|FG001|Overall Study|Lack of a reliable study partner|1|||
127939420|NCT04994483|460401988|FG000|Overall Study|Met MRI exclusion criteria|0|||
127939421|NCT04994483|460401989|FG001|Overall Study|Met MRI exclusion criteria|1|||
127939422|NCT03589768|460401994|FG000|Overall Study|Death|1|||
127939423|NCT03589768|460401995|FG001|Overall Study|Death|0|||
127939424|NCT03589768|460401996|FG002|Overall Study|Death|8|||
127939425|NCT03589768|460401997|FG003|Overall Study|Death|3|||
127939426|NCT03589768|460401994|FG000|Overall Study|Withdrawal by Subject|2|||
127939427|NCT03589768|460401995|FG001|Overall Study|Withdrawal by Subject|0|||
127939428|NCT03589768|460401996|FG002|Overall Study|Withdrawal by Subject|0|||
127939429|NCT03589768|460401997|FG003|Overall Study|Withdrawal by Subject|0|||
127939430|NCT03589768|460401994|FG000|Overall Study|Protocol Violation|1|||
127939431|NCT03589768|460401995|FG001|Overall Study|Protocol Violation|0|||
127939432|NCT03589768|460401996|FG002|Overall Study|Protocol Violation|0|||
127939433|NCT03589768|460401997|FG003|Overall Study|Protocol Violation|0|||
127939434|NCT02213510|460402006|FG000|Overall Study|Death|0|||
127939435|NCT02213510|460402007|FG001|Overall Study|Death|1|||
127939436|NCT02213510|460402006|FG000|Overall Study|Lost to Follow-up|1|||
127939437|NCT02213510|460402007|FG001|Overall Study|Lost to Follow-up|0|||
127939438|NCT01398514|460402016|FG000|Overall Study|Adverse Event|1|||
127939439|NCT01398514|460402017|FG001|Overall Study|Adverse Event|0|||
127939440|NCT01398514|460402016|FG000|Overall Study|Non-compliance with study procedures|2|||
127939441|NCT01398514|460402017|FG001|Overall Study|Non-compliance with study procedures|0|||
127939442|NCT01398514|460402016|FG000|Overall Study|Physiologic non-responsiveness|1|||
127939443|NCT01398514|460402017|FG001|Overall Study|Physiologic non-responsiveness|3|||
127939444|NCT01398514|460402016|FG000|Overall Study|Failure to show a conditioned response|4|||
127939445|NCT01398514|460402017|FG001|Overall Study|Failure to show a conditioned response|3|||
127939446|NCT01007942|460402019|FG000|Overall Study|Adverse Event|29|||
127939447|NCT01007942|460402020|FG001|Overall Study|Adverse Event|14|||
127939448|NCT01007942|460402019|FG000|Overall Study|Abnormal test procedure|0|||
127939449|NCT01007942|460402020|FG001|Overall Study|Abnormal test procedure|1|||
127939450|NCT01007942|460402019|FG000|Overall Study|Disease progression|217|||
127939451|NCT01007942|460402020|FG001|Overall Study|Disease progression|242|||
127939452|NCT01007942|460402019|FG000|Overall Study|New cancer therapy|5|||
127939453|NCT01007942|460402020|FG001|Overall Study|New cancer therapy|1|||
127939454|NCT01007942|460402019|FG000|Overall Study|Protocol Violation|1|||
127939455|NCT01007942|460402020|FG001|Overall Study|Protocol Violation|1|||
127939456|NCT01007942|460402019|FG000|Overall Study|Withdrawal by Subject|19|||
127939457|NCT01007942|460402020|FG001|Overall Study|Withdrawal by Subject|14|||
127939458|NCT01007942|460402019|FG000|Overall Study|Lost to Follow-up|1|||
127939459|NCT01007942|460402020|FG001|Overall Study|Lost to Follow-up|0|||
127939460|NCT01007942|460402019|FG000|Overall Study|Administrative problems|2|||
127939461|NCT01007942|460402020|FG001|Overall Study|Administrative problems|0|||
127939462|NCT01007942|460402019|FG000|Overall Study|Death|3|||
127939463|NCT01007942|460402020|FG001|Overall Study|Death|2|||
127939464|NCT01007942|460402019|FG000|Overall Study|Patients untreated|4|||
127939465|NCT01007942|460402020|FG001|Overall Study|Patients untreated|3|||
127939466|NCT05083585|460402025|FG000|Overall Study|Death|1|||
127939467|NCT05083585|460402026|FG001|Overall Study|Death|1|||
127939468|NCT05083585|460402025|FG000|Overall Study|Lost to Follow-up|1|||
127939469|NCT05083585|460402026|FG001|Overall Study|Lost to Follow-up|1|||
127939470|NCT05083585|460402025|FG000|Overall Study|Withdrawal by Subject|2|||
127939471|NCT05083585|460402026|FG001|Overall Study|Withdrawal by Subject|0|||
127939472|NCT05083585|460402025|FG000|Overall Study|Randomized but not vaccinated|2|||
127939473|NCT05083585|460402026|FG001|Overall Study|Randomized but not vaccinated|0|||
127939474|NCT03929757|460402027|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
127939475|NCT03929757|460402028|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
127939476|NCT03929757|460402029|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
127939477|NCT03929757|460402027|FG000|Main Study: Up to Day 365|Other|1|||
127939478|NCT03929757|460402028|FG001|Main Study: Up to Day 365|Other|0|||
127939479|NCT03929757|460402029|FG002|Main Study: Up to Day 365|Other|0|||
127939480|NCT03929757|460402027|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
127939481|NCT03929757|460402028|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
127939482|NCT03929757|460402029|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
127939483|NCT00806286|460402031|FG000|Overall Study|Adverse Event|5|||
127939484|NCT00806286|460402032|FG001|Overall Study|Adverse Event|2|||
127939485|NCT00806286|460402033|FG002|Overall Study|Adverse Event|0|||
127939486|NCT00806286|460402031|FG000|Overall Study|Disease progression|31|||
127939487|NCT00806286|460402032|FG001|Overall Study|Disease progression|38|||
127939488|NCT00806286|460402033|FG002|Overall Study|Disease progression|1|||
127939489|NCT00806286|460402031|FG000|Overall Study|Death|1|||
127939490|NCT00806286|460402032|FG001|Overall Study|Death|6|||
127939491|NCT00806286|460402033|FG002|Overall Study|Death|0|||
127939492|NCT00806286|460402031|FG000|Overall Study|Lost to Follow-up|0|||
127939493|NCT00806286|460402032|FG001|Overall Study|Lost to Follow-up|1|||
127939494|NCT00806286|460402033|FG002|Overall Study|Lost to Follow-up|0|||
127939495|NCT00806286|460402031|FG000|Overall Study|Withdrawal by Subject|8|||
127939496|NCT00806286|460402032|FG001|Overall Study|Withdrawal by Subject|3|||
127939497|NCT00806286|460402033|FG002|Overall Study|Withdrawal by Subject|1|||
127939498|NCT00806286|460402031|FG000|Overall Study|Physician Decision|2|||
127939499|NCT00806286|460402032|FG001|Overall Study|Physician Decision|2|||
127939500|NCT00806286|460402033|FG002|Overall Study|Physician Decision|0|||
127939501|NCT00806286|460402031|FG000|Overall Study|Due to a variety of reasons|7|||
127939502|NCT00806286|460402032|FG001|Overall Study|Due to a variety of reasons|2|||
127939503|NCT00806286|460402033|FG002|Overall Study|Due to a variety of reasons|1|||
127939504|NCT03402750|460402034|FG000|Overall Study|Lost to Follow-up|2|||
127939505|NCT03402750|460402035|FG001|Overall Study|Lost to Follow-up|1|||
127939506|NCT03469336|460402036|FG000|Overall Study|Adverse Event|1|||
127939507|NCT02628743|460402038|FG000|Overall Study|Other|3|||
127939508|NCT02628743|460402038|FG000|Overall Study|Withdrawal by Subject|50|||
127939509|NCT02628743|460402038|FG000|Overall Study|Study Terminated by Sponsor|76|||
127939510|NCT02628743|460402038|FG000|Overall Study|Physician Decision|2|||
127939511|NCT02534844|460402039|FG000|Part B|Withdrawal by Subject|0|||
127939512|NCT02534844|460402040|FG001|Part B|Withdrawal by Subject|0|||
127939513|NCT02534844|460402041|FG002|Part B|Withdrawal by Subject|0|||
127939514|NCT02534844|460402042|FG003|Part B|Withdrawal by Subject|0|||
127939515|NCT02534844|460402043|FG004|Part B|Withdrawal by Subject|2|||
127939516|NCT02534844|460402044|FG005|Part B|Withdrawal by Subject|1|||
127939517|NCT04645966|460402045|FG000|Vaccination Phase|Adverse Event|1|||
127939518|NCT04645966|460402046|FG001|Vaccination Phase|Adverse Event|0|||
127939519|NCT04645966|460402047|FG002|Vaccination Phase|Adverse Event|0|||
127939520|NCT04645966|460402048|FG003|Vaccination Phase|Adverse Event|0|||
127939521|NCT04645966|460402049|FG004|Vaccination Phase|Adverse Event|0|||
127939522|NCT04645966|460402050|FG005|Vaccination Phase|Adverse Event|0|||
127939523|NCT04645966|460402051|FG006|Vaccination Phase|Adverse Event|1|||
127939524|NCT04645966|460402052|FG007|Vaccination Phase|Adverse Event|0|||
127939525|NCT04645966|460402053|FG008|Vaccination Phase|Adverse Event|0|||
127939526|NCT04645966|460402045|FG000|Vaccination Phase|Death|0|||
127939527|NCT04645966|460402046|FG001|Vaccination Phase|Death|0|||
127939528|NCT04645966|460402047|FG002|Vaccination Phase|Death|0|||
127939529|NCT04645966|460402048|FG003|Vaccination Phase|Death|0|||
127939530|NCT04645966|460402049|FG004|Vaccination Phase|Death|0|||
127939531|NCT04645966|460402050|FG005|Vaccination Phase|Death|1|||
127939532|NCT04645966|460402051|FG006|Vaccination Phase|Death|0|||
127939533|NCT04645966|460402052|FG007|Vaccination Phase|Death|0|||
127939534|NCT04645966|460402053|FG008|Vaccination Phase|Death|0|||
127939535|NCT04645966|460402045|FG000|Vaccination Phase|Protocol Violation|0|||
127939536|NCT04645966|460402046|FG001|Vaccination Phase|Protocol Violation|0|||
127939537|NCT04645966|460402047|FG002|Vaccination Phase|Protocol Violation|0|||
127939538|NCT04645966|460402048|FG003|Vaccination Phase|Protocol Violation|0|||
127939539|NCT04645966|460402049|FG004|Vaccination Phase|Protocol Violation|1|||
127939540|NCT04645966|460402050|FG005|Vaccination Phase|Protocol Violation|0|||
127939541|NCT04645966|460402051|FG006|Vaccination Phase|Protocol Violation|0|||
127939542|NCT04645966|460402052|FG007|Vaccination Phase|Protocol Violation|0|||
127939543|NCT04645966|460402053|FG008|Vaccination Phase|Protocol Violation|0|||
127939544|NCT04645966|460402045|FG000|Vaccination Phase|Study terminated by sponsor|0|||
127939545|NCT04645966|460402046|FG001|Vaccination Phase|Study terminated by sponsor|0|||
127939546|NCT04645966|460402047|FG002|Vaccination Phase|Study terminated by sponsor|14|||
127939547|NCT04645966|460402048|FG003|Vaccination Phase|Study terminated by sponsor|15|||
127939548|NCT04645966|460402049|FG004|Vaccination Phase|Study terminated by sponsor|47|||
127939549|NCT04645966|460402050|FG005|Vaccination Phase|Study terminated by sponsor|43|||
127939550|NCT04645966|460402051|FG006|Vaccination Phase|Study terminated by sponsor|29|||
127939551|NCT04645966|460402052|FG007|Vaccination Phase|Study terminated by sponsor|29|||
127939552|NCT04645966|460402053|FG008|Vaccination Phase|Study terminated by sponsor|12|||
127939553|NCT04645966|460402045|FG000|Vaccination Phase|Withdrawal by parent/guardian|0|||
127939554|NCT04645966|460402046|FG001|Vaccination Phase|Withdrawal by parent/guardian|0|||
127939555|NCT04645966|460402047|FG002|Vaccination Phase|Withdrawal by parent/guardian|2|||
127939556|NCT04645966|460402048|FG003|Vaccination Phase|Withdrawal by parent/guardian|1|||
127939557|NCT04645966|460402049|FG004|Vaccination Phase|Withdrawal by parent/guardian|3|||
127939558|NCT04645966|460402050|FG005|Vaccination Phase|Withdrawal by parent/guardian|4|||
127939559|NCT04645966|460402051|FG006|Vaccination Phase|Withdrawal by parent/guardian|0|||
127939560|NCT04645966|460402052|FG007|Vaccination Phase|Withdrawal by parent/guardian|2|||
127939561|NCT04645966|460402053|FG008|Vaccination Phase|Withdrawal by parent/guardian|0|||
127939562|NCT04645966|460402045|FG000|Vaccination Phase|Other|0|||
127939563|NCT04645966|460402046|FG001|Vaccination Phase|Other|0|||
127485455|NCT01240863|458741181|FG000|Open-label Titration Period|Other|7|||
127939564|NCT04645966|460402047|FG002|Vaccination Phase|Other|0|||
127939565|NCT04645966|460402048|FG003|Vaccination Phase|Other|0|||
127939566|NCT04645966|460402049|FG004|Vaccination Phase|Other|0|||
127939567|NCT04645966|460402050|FG005|Vaccination Phase|Other|2|||
127939568|NCT04645966|460402051|FG006|Vaccination Phase|Other|0|||
127939569|NCT04645966|460402052|FG007|Vaccination Phase|Other|0|||
127939570|NCT04645966|460402053|FG008|Vaccination Phase|Other|0|||
127939571|NCT04645966|460402045|FG000|Vaccination Phase|Lost to Follow-up|0|||
127939572|NCT04645966|460402046|FG001|Vaccination Phase|Lost to Follow-up|0|||
127939573|NCT04645966|460402047|FG002|Vaccination Phase|Lost to Follow-up|0|||
127939574|NCT04645966|460402048|FG003|Vaccination Phase|Lost to Follow-up|0|||
127939575|NCT04645966|460402049|FG004|Vaccination Phase|Lost to Follow-up|0|||
127939576|NCT04645966|460402050|FG005|Vaccination Phase|Lost to Follow-up|0|||
127939577|NCT04645966|460402051|FG006|Vaccination Phase|Lost to Follow-up|0|||
127939578|NCT04645966|460402052|FG007|Vaccination Phase|Lost to Follow-up|1|||
127939579|NCT04645966|460402053|FG008|Vaccination Phase|Lost to Follow-up|0|||
127939580|NCT04645966|460402045|FG000|Vaccination Phase|No longer meets eligibility criteria|0|||
127939581|NCT04645966|460402046|FG001|Vaccination Phase|No longer meets eligibility criteria|0|||
127939582|NCT04645966|460402047|FG002|Vaccination Phase|No longer meets eligibility criteria|0|||
127939583|NCT04645966|460402048|FG003|Vaccination Phase|No longer meets eligibility criteria|0|||
127939584|NCT04645966|460402049|FG004|Vaccination Phase|No longer meets eligibility criteria|0|||
127939585|NCT04645966|460402050|FG005|Vaccination Phase|No longer meets eligibility criteria|0|||
127939586|NCT04645966|460402051|FG006|Vaccination Phase|No longer meets eligibility criteria|0|||
127939587|NCT04645966|460402052|FG007|Vaccination Phase|No longer meets eligibility criteria|1|||
127939588|NCT04645966|460402053|FG008|Vaccination Phase|No longer meets eligibility criteria|0|||
127939589|NCT04645966|460402045|FG000|Follow-up Phase|Lost to Follow-up|0|||
127939590|NCT04645966|460402046|FG001|Follow-up Phase|Lost to Follow-up|0|||
127939591|NCT04645966|460402047|FG002|Follow-up Phase|Lost to Follow-up|0|||
127939592|NCT04645966|460402048|FG003|Follow-up Phase|Lost to Follow-up|0|||
127939593|NCT04645966|460402049|FG004|Follow-up Phase|Lost to Follow-up|0|||
127939594|NCT04645966|460402050|FG005|Follow-up Phase|Lost to Follow-up|0|||
127939595|NCT04645966|460402051|FG006|Follow-up Phase|Lost to Follow-up|0|||
127939596|NCT04645966|460402052|FG007|Follow-up Phase|Lost to Follow-up|1|||
127939597|NCT04645966|460402053|FG008|Follow-up Phase|Lost to Follow-up|0|||
127939598|NCT03825341|460402054|FG000|Overall Study|Withdrawal by Subject|0|||
127939599|NCT03825341|460402055|FG001|Overall Study|Withdrawal by Subject|1|||
127939600|NCT00289536|460402057|FG000|Period 3|Lost to Follow-up|0|||
127939601|NCT00289536|460402058|FG001|Period 3|Lost to Follow-up|0|||
127939602|NCT00289536|460402059|FG002|Period 3|Lost to Follow-up|1|||
127939603|NCT02116608|460402061|FG000|Overall Study|Lost to Follow-up|0|||
127939604|NCT02116608|460402062|FG001|Overall Study|Lost to Follow-up|0|||
127939605|NCT02116608|460402063|FG002|Overall Study|Lost to Follow-up|1|||
127939606|NCT02116608|460402061|FG000|Overall Study|Physician Decision|0|||
127939607|NCT02116608|460402062|FG001|Overall Study|Physician Decision|1|||
127939608|NCT02116608|460402063|FG002|Overall Study|Physician Decision|0|||
127939609|NCT02116608|460402061|FG000|Overall Study|Death|0|||
127939610|NCT02116608|460402062|FG001|Overall Study|Death|1|||
127939611|NCT02116608|460402063|FG002|Overall Study|Death|0|||
127939612|NCT04283500|460402065|FG000|Overall Study|Lost to Follow-up|8|||
127939613|NCT04283500|460402065|FG000|Overall Study|Withdrawn by study team prior to intervention for not meeting post-enrollment inclusion criteria|1|||
127939614|NCT02006693|460402068|FG000|Overall Study|No Reason Specified|6|||
127939615|NCT02006693|460402069|FG001|Overall Study|No Reason Specified|8|||
127939616|NCT02006693|460402068|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
127939617|NCT02006693|460402069|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
127939618|NCT02006693|460402068|FG000|Overall Study|XEN Implant Explantation|0|||
127939619|NCT02006693|460402069|FG001|Overall Study|XEN Implant Explantation|1|||
127939620|NCT02006693|460402068|FG000|Overall Study|Death|2|||
127939621|NCT02006693|460402069|FG001|Overall Study|Death|2|||
127939622|NCT02006693|460402068|FG000|Overall Study|Lost to Follow-up|4|||
127939623|NCT02006693|460402069|FG001|Overall Study|Lost to Follow-up|1|||
127939624|NCT02006693|460402068|FG000|Overall Study|Patient Decision|4|||
127939625|NCT02006693|460402069|FG001|Overall Study|Patient Decision|0|||
127939626|NCT01119508|460402072|FG000|Overall Study|Adverse Event|56|||
127939627|NCT01119508|460402072|FG000|Overall Study|Withdrawal by Subject|2|||
127939628|NCT01119508|460402072|FG000|Overall Study|Died before tumor response evaluation|1|||
127939629|NCT00265395|460402073|FG000|Overall Study|Adverse Event|3|||
127939630|NCT00265395|460402074|FG001|Overall Study|Adverse Event|6|||
127939631|NCT00265395|460402073|FG000|Overall Study|Lost to Follow-up|2|||
127939632|NCT00265395|460402074|FG001|Overall Study|Lost to Follow-up|1|||
127939633|NCT00265395|460402073|FG000|Overall Study|Withdrawal by Subject|1|||
127939634|NCT00265395|460402074|FG001|Overall Study|Withdrawal by Subject|6|||
127939635|NCT00265395|460402073|FG000|Overall Study|Protocol Violation|2|||
127939636|NCT00265395|460402074|FG001|Overall Study|Protocol Violation|2|||
127939637|NCT00265395|460402073|FG000|Overall Study|Lack of Efficacy|0|||
127939638|NCT00265395|460402074|FG001|Overall Study|Lack of Efficacy|1|||
127939639|NCT00265395|460402073|FG000|Overall Study|Administrative|0|||
127939640|NCT00265395|460402074|FG001|Overall Study|Administrative|1|||
127939641|NCT04053465|460402080|FG000|Overall Study|Withdrawal by Subject|4|||
127939642|NCT04053465|460402081|FG001|Overall Study|Withdrawal by Subject|4|||
127939643|NCT02338193|460402083|FG000|Overall Study|Withdrawal by Subject|0|||
127939644|NCT02338193|460402084|FG001|Overall Study|Withdrawal by Subject|0|||
127939645|NCT02338193|460402085|FG002|Overall Study|Withdrawal by Subject|2|||
127939646|NCT02338193|460402083|FG000|Overall Study|Pregnancy|0|||
127939647|NCT02338193|460402084|FG001|Overall Study|Pregnancy|1|||
127939648|NCT02338193|460402085|FG002|Overall Study|Pregnancy|1|||
127939649|NCT02338193|460402083|FG000|Overall Study|Noncompliant with visits|2|||
127939650|NCT02338193|460402084|FG001|Overall Study|Noncompliant with visits|2|||
127939651|NCT02338193|460402085|FG002|Overall Study|Noncompliant with visits|7|||
127939652|NCT02338193|460402083|FG000|Overall Study|moved out of state|0|||
127939653|NCT02338193|460402084|FG001|Overall Study|moved out of state|1|||
127939654|NCT02338193|460402085|FG002|Overall Study|moved out of state|0|||
127939655|NCT02338193|460402083|FG000|Overall Study|intolerant of side effects|1|||
127939656|NCT02338193|460402084|FG001|Overall Study|intolerant of side effects|0|||
127939657|NCT02338193|460402085|FG002|Overall Study|intolerant of side effects|0|||
127939658|NCT00123474|460402086|FG000|Randomized to Treatment|Randomized, never treated|1|||
127939659|NCT00123474|460402087|FG001|Randomized to Treatment|Randomized, never treated|4|||
127939660|NCT00123474|460402088|FG002|Randomized to Treatment|Randomized, never treated|2|||
127939661|NCT00123474|460402089|FG003|Randomized to Treatment|Randomized, never treated|1|||
127939662|NCT00123474|460402086|FG000|As Treated at Study Closure|not reported when site closed|1|||
127939663|NCT00123474|460402087|FG001|As Treated at Study Closure|not reported when site closed|0|||
127939664|NCT00123474|460402088|FG002|As Treated at Study Closure|not reported when site closed|1|||
127939665|NCT00123474|460402089|FG003|As Treated at Study Closure|not reported when site closed|0|||
127939666|NCT00123474|460402086|FG000|As Treated at Study Closure|Adverse Event|10|||
127939667|NCT00123474|460402087|FG001|As Treated at Study Closure|Adverse Event|4|||
127939668|NCT00123474|460402088|FG002|As Treated at Study Closure|Adverse Event|10|||
127939669|NCT00123474|460402089|FG003|As Treated at Study Closure|Adverse Event|8|||
127939670|NCT00123474|460402086|FG000|As Treated at Study Closure|Disease Progression|35|||
127939671|NCT00123474|460402087|FG001|As Treated at Study Closure|Disease Progression|42|||
127939672|NCT00123474|460402088|FG002|As Treated at Study Closure|Disease Progression|29|||
127939673|NCT00123474|460402089|FG003|As Treated at Study Closure|Disease Progression|27|||
127939674|NCT00123474|460402086|FG000|As Treated at Study Closure|Investigator Request|12|||
127939675|NCT00123474|460402087|FG001|As Treated at Study Closure|Investigator Request|6|||
127939676|NCT00123474|460402088|FG002|As Treated at Study Closure|Investigator Request|7|||
127939677|NCT00123474|460402089|FG003|As Treated at Study Closure|Investigator Request|5|||
127939678|NCT00123474|460402086|FG000|As Treated at Study Closure|non-specified|54|||
127939679|NCT00123474|460402087|FG001|As Treated at Study Closure|non-specified|47|||
127939680|NCT00123474|460402088|FG002|As Treated at Study Closure|non-specified|57|||
127939681|NCT00123474|460402089|FG003|As Treated at Study Closure|non-specified|60|||
127939682|NCT00123474|460402086|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
127939683|NCT00123474|460402087|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
127939684|NCT00123474|460402088|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
127939685|NCT00123474|460402089|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
127939686|NCT00123474|460402086|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
127939687|NCT00123474|460402087|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
127939688|NCT00123474|460402088|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
127939689|NCT00123474|460402089|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
127939690|NCT01059344|460402090|FG000|Overall Study|Adverse Event|12|||
127939691|NCT01059344|460402091|FG001|Overall Study|Adverse Event|30|||
127939692|NCT01059344|460402090|FG000|Overall Study|Withdrawal by Subject|6|||
127939693|NCT01059344|460402091|FG001|Overall Study|Withdrawal by Subject|9|||
127939694|NCT01059344|460402090|FG000|Overall Study|Lost to Follow-up|1|||
127939695|NCT01059344|460402091|FG001|Overall Study|Lost to Follow-up|1|||
127939696|NCT01059344|460402090|FG000|Overall Study|Other|3|||
127939697|NCT01059344|460402091|FG001|Overall Study|Other|6|||
127939698|NCT01739348|460402092|FG000|Part I (Base Study)|Adverse Event|41|||
127939699|NCT01739348|460402093|FG001|Part I (Base Study)|Adverse Event|52|||
127939700|NCT01739348|460402094|FG002|Part I (Base Study)|Adverse Event|8|||
127939701|NCT01739348|460402095|FG003|Part I (Base Study)|Adverse Event|33|||
127939702|NCT01739348|460402092|FG000|Part I (Base Study)|Death|10|||
127939703|NCT01739348|460402093|FG001|Part I (Base Study)|Death|7|||
127939704|NCT01739348|460402094|FG002|Part I (Base Study)|Death|2|||
127939705|NCT01739348|460402095|FG003|Part I (Base Study)|Death|8|||
127939706|NCT01739348|460402092|FG000|Part I (Base Study)|Lack of Efficacy|3|||
127939707|NCT01739348|460402093|FG001|Part I (Base Study)|Lack of Efficacy|8|||
127939708|NCT01739348|460402094|FG002|Part I (Base Study)|Lack of Efficacy|0|||
127939709|NCT01739348|460402095|FG003|Part I (Base Study)|Lack of Efficacy|7|||
127939710|NCT01739348|460402092|FG000|Part I (Base Study)|Lost to Follow-up|4|||
127939711|NCT01739348|460402093|FG001|Part I (Base Study)|Lost to Follow-up|2|||
127939712|NCT01739348|460402094|FG002|Part I (Base Study)|Lost to Follow-up|4|||
127939713|NCT01739348|460402095|FG003|Part I (Base Study)|Lost to Follow-up|4|||
127939714|NCT01739348|460402092|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
127939715|NCT01739348|460402093|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
127939716|NCT01739348|460402094|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
127939717|NCT01739348|460402095|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
127939718|NCT01739348|460402092|FG000|Part I (Base Study)|Physician Decision|10|||
127939719|NCT01739348|460402093|FG001|Part I (Base Study)|Physician Decision|7|||
127939720|NCT01739348|460402094|FG002|Part I (Base Study)|Physician Decision|1|||
127939721|NCT01739348|460402095|FG003|Part I (Base Study)|Physician Decision|4|||
127939722|NCT01739348|460402092|FG000|Part I (Base Study)|Protocol Violation|2|||
127939723|NCT01739348|460402093|FG001|Part I (Base Study)|Protocol Violation|0|||
127939724|NCT01739348|460402094|FG002|Part I (Base Study)|Protocol Violation|1|||
127939725|NCT01739348|460402095|FG003|Part I (Base Study)|Protocol Violation|2|||
127939726|NCT01739348|460402092|FG000|Part I (Base Study)|Screen Failure|2|||
127939727|NCT01739348|460402093|FG001|Part I (Base Study)|Screen Failure|0|||
127939728|NCT01739348|460402094|FG002|Part I (Base Study)|Screen Failure|0|||
127939729|NCT01739348|460402095|FG003|Part I (Base Study)|Screen Failure|0|||
127939730|NCT01739348|460402092|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
127939731|NCT01739348|460402093|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
127939732|NCT01739348|460402094|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
127939733|NCT01739348|460402095|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
127939734|NCT01739348|460402092|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
127939735|NCT01739348|460402093|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
127939736|NCT01739348|460402094|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
127939737|NCT01739348|460402095|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
127939738|NCT01739348|460402092|FG000|Part I (Base Study)|Participant Moved|4|||
127939739|NCT01739348|460402093|FG001|Part I (Base Study)|Participant Moved|3|||
127939740|NCT01739348|460402094|FG002|Part I (Base Study)|Participant Moved|1|||
127939741|NCT01739348|460402095|FG003|Part I (Base Study)|Participant Moved|7|||
127939742|NCT01739348|460402092|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
127939743|NCT01739348|460402093|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
127939744|NCT01739348|460402094|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
127939745|NCT01739348|460402095|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
127939746|NCT01739348|460402092|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
127939747|NCT01739348|460402093|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
127939748|NCT01739348|460402094|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
127939749|NCT01739348|460402095|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
127939750|NCT01739348|460402092|FG000|Part II (Extension Study)|Adverse Event|10|||
127939751|NCT01739348|460402093|FG001|Part II (Extension Study)|Adverse Event|11|||
127939752|NCT01739348|460402094|FG002|Part II (Extension Study)|Adverse Event|7|||
127939753|NCT01739348|460402095|FG003|Part II (Extension Study)|Adverse Event|26|||
127939754|NCT01739348|460402092|FG000|Part II (Extension Study)|Death|3|||
127939755|NCT01739348|460402093|FG001|Part II (Extension Study)|Death|3|||
127939756|NCT01739348|460402094|FG002|Part II (Extension Study)|Death|2|||
127939757|NCT01739348|460402095|FG003|Part II (Extension Study)|Death|6|||
127939758|NCT01739348|460402092|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
127939759|NCT01739348|460402093|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
127939760|NCT01739348|460402094|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
127939761|NCT01739348|460402095|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
127939762|NCT01739348|460402092|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
127939763|NCT01739348|460402093|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
127939764|NCT01739348|460402094|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
127939765|NCT01739348|460402095|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
127939766|NCT01739348|460402092|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
127939767|NCT01739348|460402093|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
127939768|NCT01739348|460402094|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
127939769|NCT01739348|460402095|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
127939770|NCT01739348|460402092|FG000|Part II (Extension Study)|Physician Decision|7|||
127939771|NCT01739348|460402093|FG001|Part II (Extension Study)|Physician Decision|11|||
127939772|NCT01739348|460402094|FG002|Part II (Extension Study)|Physician Decision|6|||
127939773|NCT01739348|460402095|FG003|Part II (Extension Study)|Physician Decision|12|||
127939774|NCT01739348|460402092|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
127939775|NCT01739348|460402093|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
127939776|NCT01739348|460402094|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
127939777|NCT01739348|460402095|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
127939778|NCT01739348|460402092|FG000|Part II (Extension Study)|Participant Moved|3|||
127939779|NCT01739348|460402093|FG001|Part II (Extension Study)|Participant Moved|3|||
127939780|NCT01739348|460402094|FG002|Part II (Extension Study)|Participant Moved|0|||
127939781|NCT01739348|460402095|FG003|Part II (Extension Study)|Participant Moved|3|||
127939782|NCT01739348|460402092|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
127939783|NCT01739348|460402093|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
127939784|NCT01739348|460402094|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
127939785|NCT01739348|460402095|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
127939786|NCT01739348|460402092|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
127939787|NCT01739348|460402093|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
127939788|NCT01739348|460402094|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
127939789|NCT01739348|460402095|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
127939790|NCT00742924|460402099|FG000|Overall Study|Adverse Event|0|||
127939791|NCT00742924|460402100|FG001|Overall Study|Adverse Event|0|||
127939792|NCT00742924|460402101|FG002|Overall Study|Adverse Event|1|||
127939793|NCT00742924|460402102|FG003|Overall Study|Adverse Event|1|||
127939794|NCT00742924|460402099|FG000|Overall Study|Lack of Efficacy|5|||
127939795|NCT00742924|460402100|FG001|Overall Study|Lack of Efficacy|1|||
127939796|NCT00742924|460402101|FG002|Overall Study|Lack of Efficacy|2|||
127939797|NCT00742924|460402102|FG003|Overall Study|Lack of Efficacy|4|||
127939798|NCT00742924|460402099|FG000|Overall Study|Physician Decision|0|||
127939799|NCT00742924|460402100|FG001|Overall Study|Physician Decision|0|||
127939800|NCT00742924|460402101|FG002|Overall Study|Physician Decision|0|||
127939801|NCT00742924|460402102|FG003|Overall Study|Physician Decision|1|||
127939802|NCT00742924|460402099|FG000|Overall Study|Withdrawal by Subject|0|||
127939803|NCT00742924|460402100|FG001|Overall Study|Withdrawal by Subject|1|||
127939804|NCT00742924|460402101|FG002|Overall Study|Withdrawal by Subject|1|||
127939805|NCT00742924|460402102|FG003|Overall Study|Withdrawal by Subject|0|||
127939806|NCT00660400|460402103|FG000|Overall Study|Lack of insurance approval|1|||
127939807|NCT00660400|460402103|FG000|Overall Study|Suboptimal organ function|1|||
127939808|NCT00660400|460402103|FG000|Overall Study|Intracranial hemorrhage|1|||
127939809|NCT00660400|460402103|FG000|Overall Study|Withdrawal by Subject|1|||
127939810|NCT01447420|460402104|FG000|Overall Study|Adverse Event|2|||
127939811|NCT01447420|460402105|FG001|Overall Study|Adverse Event|4|||
127939812|NCT01447420|460402106|FG002|Overall Study|Adverse Event|2|||
127939813|NCT01447420|460402104|FG000|Overall Study|Protocol Violation|3|||
127939814|NCT01447420|460402105|FG001|Overall Study|Protocol Violation|3|||
127939815|NCT01447420|460402106|FG002|Overall Study|Protocol Violation|0|||
127939816|NCT01447420|460402104|FG000|Overall Study|Withdrawal by Subject|4|||
127939817|NCT01447420|460402105|FG001|Overall Study|Withdrawal by Subject|1|||
127939818|NCT01447420|460402106|FG002|Overall Study|Withdrawal by Subject|0|||
127939819|NCT01447420|460402104|FG000|Overall Study|Lack of Efficacy|1|||
127939820|NCT01447420|460402105|FG001|Overall Study|Lack of Efficacy|19|||
127939821|NCT01447420|460402106|FG002|Overall Study|Lack of Efficacy|8|||
127939822|NCT02643355|460402107|FG000|Overall Study|Withdrawal by Subject|1|||
127939823|NCT02643355|460402108|FG001|Overall Study|Withdrawal by Subject|3|||
127939824|NCT02643355|460402107|FG000|Overall Study|Protocol Violation|0|||
127939825|NCT02643355|460402108|FG001|Overall Study|Protocol Violation|2|||
127939826|NCT04524364|460402113|FG000|Overall Study|Physician Decision|3|||
127939827|NCT04524364|460402114|FG001|Overall Study|Physician Decision|6|||
127939828|NCT04524364|460402113|FG000|Overall Study|Adverse Event|0|||
127939829|NCT04524364|460402114|FG001|Overall Study|Adverse Event|1|||
127939830|NCT04524364|460402113|FG000|Overall Study|Investigational device deficiency|0|||
127939831|NCT04524364|460402114|FG001|Overall Study|Investigational device deficiency|1|||
127939832|NCT04524364|460402113|FG000|Overall Study|Implantable cardioverter device (ICD) discovered|0|||
127939833|NCT04524364|460402114|FG001|Overall Study|Implantable cardioverter device (ICD) discovered|1|||
127939834|NCT04524364|460402113|FG000|Overall Study|Device unavailability|0|||
127939835|NCT04524364|460402114|FG001|Overall Study|Device unavailability|2|||
127939836|NCT04524364|460402113|FG000|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|1|||
127939837|NCT04524364|460402114|FG001|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|0|||
127939838|NCT04524364|460402113|FG000|Overall Study|Low International normalized ratio (INR)|1|||
127939839|NCT04524364|460402114|FG001|Overall Study|Low International normalized ratio (INR)|0|||
127939840|NCT00826449|460402115|FG000|Overall Study|Disease Progression|4|||
127939841|NCT00826449|460402115|FG000|Overall Study|Withdrawal by Subject|1|||
127939842|NCT02994940|460402116|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
127939843|NCT02994940|460402117|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
127939844|NCT02994940|460402116|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
127939845|NCT02994940|460402117|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
127939846|NCT02994940|460402116|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
127939847|NCT02994940|460402117|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
127939848|NCT03233230|460402118|FG000|Overall Study|Adverse Event|6|||
127939849|NCT03233230|460402119|FG001|Overall Study|Adverse Event|3|||
127939850|NCT03233230|460402120|FG002|Overall Study|Adverse Event|6|||
127939851|NCT03233230|460402121|FG003|Overall Study|Adverse Event|3|||
127939852|NCT03233230|460402118|FG000|Overall Study|Protocol Violation|1|||
127939853|NCT03233230|460402119|FG001|Overall Study|Protocol Violation|2|||
127939854|NCT03233230|460402120|FG002|Overall Study|Protocol Violation|1|||
127939855|NCT03233230|460402121|FG003|Overall Study|Protocol Violation|1|||
127939856|NCT03233230|460402118|FG000|Overall Study|Lack of Efficacy|1|||
127939857|NCT03233230|460402119|FG001|Overall Study|Lack of Efficacy|0|||
127939858|NCT03233230|460402120|FG002|Overall Study|Lack of Efficacy|0|||
127939859|NCT03233230|460402121|FG003|Overall Study|Lack of Efficacy|0|||
127939860|NCT03233230|460402118|FG000|Overall Study|Other|5|||
127939861|NCT03233230|460402119|FG001|Overall Study|Other|5|||
127939862|NCT03233230|460402120|FG002|Overall Study|Other|5|||
127939863|NCT03233230|460402121|FG003|Overall Study|Other|3|||
127939864|NCT03233230|460402118|FG000|Overall Study|Withdrawal by Subject|2|||
127939865|NCT03233230|460402119|FG001|Overall Study|Withdrawal by Subject|2|||
127939866|NCT03233230|460402120|FG002|Overall Study|Withdrawal by Subject|0|||
127939867|NCT03233230|460402121|FG003|Overall Study|Withdrawal by Subject|1|||
127939868|NCT03233230|460402118|FG000|Overall Study|Lost to Follow-up|0|||
127939869|NCT03233230|460402119|FG001|Overall Study|Lost to Follow-up|3|||
127939870|NCT03233230|460402120|FG002|Overall Study|Lost to Follow-up|0|||
127939871|NCT03233230|460402121|FG003|Overall Study|Lost to Follow-up|0|||
127939872|NCT02987959|460402126|FG000|Overall Study|Grantor stopped supply of drugs|6|||
127939873|NCT02853370|460402127|FG000|Overall Study|Physician Decision|1|||
127939874|NCT02853370|460402127|FG000|Overall Study|Lack of Efficacy|2|||
127939875|NCT02853370|460402127|FG000|Overall Study|Death|1|||
127939876|NCT02853370|460402127|FG000|Overall Study|Adverse Event|4|||
127939877|NCT02853370|460402127|FG000|Overall Study|Withdrawal by Subject|3|||
127939878|NCT01898650|460402133|FG000|Overall Study|the subject would not lie still for imaging|1|||
127939879|NCT04135196|460402134|FG000|Overall Study|Lost to Follow-up|8|||
127939880|NCT04135196|460402135|FG001|Overall Study|Lost to Follow-up|7|||
127939881|NCT04135196|460402136|FG002|Overall Study|Lost to Follow-up|8|||
127939882|NCT04135196|460402137|FG003|Overall Study|Lost to Follow-up|9|||
127939883|NCT04135196|460402138|FG004|Overall Study|Lost to Follow-up|1|||
127939884|NCT04135196|460402134|FG000|Overall Study|Pregnancy|0|||
127939885|NCT04135196|460402135|FG001|Overall Study|Pregnancy|0|||
127939886|NCT04135196|460402136|FG002|Overall Study|Pregnancy|1|||
127939887|NCT04135196|460402137|FG003|Overall Study|Pregnancy|0|||
127939888|NCT04135196|460402138|FG004|Overall Study|Pregnancy|0|||
127939889|NCT04135196|460402134|FG000|Overall Study|Withdrawal by Subject|0|||
127939890|NCT04135196|460402135|FG001|Overall Study|Withdrawal by Subject|0|||
127939891|NCT04135196|460402136|FG002|Overall Study|Withdrawal by Subject|0|||
127939892|NCT04135196|460402137|FG003|Overall Study|Withdrawal by Subject|0|||
127939893|NCT04135196|460402138|FG004|Overall Study|Withdrawal by Subject|1|||
127939894|NCT00911807|460402139|FG000|Overall Study|Adverse Event|2|||
127939895|NCT00911807|460402140|FG001|Overall Study|Adverse Event|1|||
127939896|NCT00911807|460402141|FG002|Overall Study|Adverse Event|5|||
127939897|NCT00911807|460402139|FG000|Overall Study|Death|0|||
127939898|NCT00911807|460402140|FG001|Overall Study|Death|0|||
127939899|NCT00911807|460402141|FG002|Overall Study|Death|1|||
127939900|NCT00911807|460402139|FG000|Overall Study|Protocol Violation|6|||
127939901|NCT00911807|460402140|FG001|Overall Study|Protocol Violation|4|||
127939902|NCT00911807|460402141|FG002|Overall Study|Protocol Violation|9|||
127939903|NCT00911807|460402139|FG000|Overall Study|Withdrawal by Subject|8|||
127939904|NCT00911807|460402140|FG001|Overall Study|Withdrawal by Subject|10|||
127939905|NCT00911807|460402141|FG002|Overall Study|Withdrawal by Subject|7|||
127939906|NCT00911807|460402139|FG000|Overall Study|Organizational reasons|1|||
127939907|NCT00911807|460402140|FG001|Overall Study|Organizational reasons|3|||
127939908|NCT00911807|460402141|FG002|Overall Study|Organizational reasons|1|||
127939909|NCT00809159|460402142|FG000|Part 1|Adverse Event|1|||
127939910|NCT00809159|460402143|FG001|Part 1|Adverse Event|1|||
127939911|NCT00809159|460402144|FG002|Part 1|Adverse Event|0|||
127939912|NCT00809159|460402145|FG003|Part 1|Adverse Event|0|||
127939913|NCT00809159|460402146|FG004|Part 1|Adverse Event|0|||
127939914|NCT00809159|460402147|FG005|Part 1|Adverse Event|0|||
127939915|NCT00809159|460402142|FG000|Part 1|Lost to Follow-up|1|||
127939916|NCT00809159|460402143|FG001|Part 1|Lost to Follow-up|0|||
127939917|NCT00809159|460402144|FG002|Part 1|Lost to Follow-up|0|||
127939918|NCT00809159|460402145|FG003|Part 1|Lost to Follow-up|0|||
127939919|NCT00809159|460402146|FG004|Part 1|Lost to Follow-up|0|||
127939920|NCT00809159|460402147|FG005|Part 1|Lost to Follow-up|0|||
127939921|NCT00809159|460402142|FG000|Part 1|Withdrawal by Subject|3|||
127939922|NCT00809159|460402143|FG001|Part 1|Withdrawal by Subject|1|||
127939923|NCT00809159|460402144|FG002|Part 1|Withdrawal by Subject|0|||
127939924|NCT00809159|460402145|FG003|Part 1|Withdrawal by Subject|0|||
127939925|NCT00809159|460402146|FG004|Part 1|Withdrawal by Subject|0|||
127939926|NCT00809159|460402147|FG005|Part 1|Withdrawal by Subject|0|||
127939927|NCT00809159|460402142|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
127485456|NCT01240863|458741182|FG001|Open-label Titration Period|Other|0|||
127939928|NCT00809159|460402143|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
127939929|NCT00809159|460402144|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
127939930|NCT00809159|460402145|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
127939931|NCT00809159|460402146|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
127939932|NCT00809159|460402147|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
127939933|NCT00809159|460402142|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
127939934|NCT00809159|460402143|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
127939935|NCT00809159|460402144|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
127939936|NCT00809159|460402145|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
127939937|NCT00809159|460402146|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
127939938|NCT00809159|460402147|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
127939939|NCT00809159|460402142|FG000|Part 1 and 2|Administrative problems|0|||
127939940|NCT00809159|460402143|FG001|Part 1 and 2|Administrative problems|0|||
127939941|NCT00809159|460402144|FG002|Part 1 and 2|Administrative problems|0|||
127939942|NCT00809159|460402145|FG003|Part 1 and 2|Administrative problems|1|||
127939943|NCT00809159|460402146|FG004|Part 1 and 2|Administrative problems|0|||
127939944|NCT00809159|460402147|FG005|Part 1 and 2|Administrative problems|0|||
127939945|NCT00809159|460402142|FG000|Part 1 and 2|Adverse Event|0|||
127939946|NCT00809159|460402143|FG001|Part 1 and 2|Adverse Event|0|||
127939947|NCT00809159|460402144|FG002|Part 1 and 2|Adverse Event|1|||
127939948|NCT00809159|460402145|FG003|Part 1 and 2|Adverse Event|0|||
127939949|NCT00809159|460402146|FG004|Part 1 and 2|Adverse Event|1|||
127939950|NCT00809159|460402147|FG005|Part 1 and 2|Adverse Event|1|||
127939951|NCT00809159|460402142|FG000|Part 1 and 2|Lost to Follow-up|0|||
127939952|NCT00809159|460402143|FG001|Part 1 and 2|Lost to Follow-up|0|||
127939953|NCT00809159|460402144|FG002|Part 1 and 2|Lost to Follow-up|1|||
127939954|NCT00809159|460402145|FG003|Part 1 and 2|Lost to Follow-up|1|||
127939955|NCT00809159|460402146|FG004|Part 1 and 2|Lost to Follow-up|0|||
127939956|NCT00809159|460402147|FG005|Part 1 and 2|Lost to Follow-up|0|||
127939957|NCT00809159|460402142|FG000|Part 1 and 2|Withdrawal by Subject|0|||
127939958|NCT00809159|460402143|FG001|Part 1 and 2|Withdrawal by Subject|0|||
127939959|NCT00809159|460402144|FG002|Part 1 and 2|Withdrawal by Subject|4|||
127939960|NCT00809159|460402145|FG003|Part 1 and 2|Withdrawal by Subject|0|||
127939961|NCT00809159|460402146|FG004|Part 1 and 2|Withdrawal by Subject|0|||
127939962|NCT00809159|460402147|FG005|Part 1 and 2|Withdrawal by Subject|1|||
127939963|NCT03201211|460402148|FG000|Overall Study|Adverse Event|1|||
127939964|NCT03201211|460402149|FG001|Overall Study|Adverse Event|0|||
127939965|NCT03201211|460402150|FG002|Overall Study|Adverse Event|0|||
127939966|NCT03201211|460402148|FG000|Overall Study|Protocol Violation|1|||
127939967|NCT03201211|460402149|FG001|Overall Study|Protocol Violation|0|||
127939968|NCT03201211|460402150|FG002|Overall Study|Protocol Violation|0|||
127939969|NCT03201211|460402148|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
127939970|NCT03201211|460402149|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
127939971|NCT03201211|460402150|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
127939972|NCT03201211|460402148|FG000|Overall Study|OTHER unknown reasons|0|||
127939973|NCT03201211|460402149|FG001|Overall Study|OTHER unknown reasons|1|||
127939974|NCT03201211|460402150|FG002|Overall Study|OTHER unknown reasons|0|||
127939975|NCT01083810|460402151|FG000|Overall Study|Lost to Follow-up|23|||
127939976|NCT01083810|460402152|FG001|Overall Study|Lost to Follow-up|11|||
127939977|NCT01083810|460402153|FG002|Overall Study|Lost to Follow-up|4|||
127939978|NCT01083810|460402151|FG000|Overall Study|Adverse Event|15|||
127939979|NCT01083810|460402152|FG001|Overall Study|Adverse Event|11|||
127939980|NCT01083810|460402153|FG002|Overall Study|Adverse Event|4|||
127939981|NCT01083810|460402151|FG000|Overall Study|Withdrawal by Subject|7|||
127939982|NCT01083810|460402152|FG001|Overall Study|Withdrawal by Subject|2|||
127939983|NCT01083810|460402153|FG002|Overall Study|Withdrawal by Subject|4|||
127939984|NCT01083810|460402151|FG000|Overall Study|Reason not reported|6|||
127939985|NCT01083810|460402152|FG001|Overall Study|Reason not reported|1|||
127939986|NCT01083810|460402153|FG002|Overall Study|Reason not reported|1|||
127939987|NCT01083810|460402151|FG000|Overall Study|Non-compliance|4|||
127939988|NCT01083810|460402152|FG001|Overall Study|Non-compliance|7|||
127939989|NCT01083810|460402153|FG002|Overall Study|Non-compliance|2|||
127939990|NCT01083810|460402151|FG000|Overall Study|Simplification|4|||
127939991|NCT01083810|460402152|FG001|Overall Study|Simplification|1|||
127939992|NCT01083810|460402153|FG002|Overall Study|Simplification|0|||
127939993|NCT01083810|460402151|FG000|Overall Study|Death|2|||
127939994|NCT01083810|460402152|FG001|Overall Study|Death|2|||
127939995|NCT01083810|460402153|FG002|Overall Study|Death|3|||
127485457|NCT01240863|458741183|FG002|Open-label Titration Period|Other|0|||
127939996|NCT01083810|460402151|FG000|Overall Study|Co-morbidities|1|||
127939997|NCT01083810|460402152|FG001|Overall Study|Co-morbidities|0|||
127939998|NCT01083810|460402153|FG002|Overall Study|Co-morbidities|0|||
127939999|NCT01083810|460402151|FG000|Overall Study|Participation in study|1|||
127940000|NCT01083810|460402152|FG001|Overall Study|Participation in study|0|||
127940001|NCT01083810|460402153|FG002|Overall Study|Participation in study|0|||
127940002|NCT01083810|460402151|FG000|Overall Study|Therapy break|1|||
127940003|NCT01083810|460402152|FG001|Overall Study|Therapy break|2|||
127940004|NCT01083810|460402153|FG002|Overall Study|Therapy break|2|||
127940005|NCT01083810|460402151|FG000|Overall Study|Virologic failure|1|||
127940006|NCT01083810|460402152|FG001|Overall Study|Virologic failure|8|||
127940007|NCT01083810|460402153|FG002|Overall Study|Virologic failure|0|||
127940008|NCT02991430|460402156|FG000|Treatment Period 1|Adverse Event|1|||
127940009|NCT02991430|460402157|FG001|Treatment Period 1|Adverse Event|0|||
127940010|NCT02991430|460402158|FG002|Treatment Period 1|Adverse Event|2|||
127940011|NCT02991430|460402156|FG000|Treatment Period 1|Withdrawal by Subject|0|||
127940012|NCT02991430|460402157|FG001|Treatment Period 1|Withdrawal by Subject|4|||
127940013|NCT02991430|460402158|FG002|Treatment Period 1|Withdrawal by Subject|0|||
127940014|NCT02991430|460402156|FG000|Treatment Period 2|Study Termination|6|||
127940015|NCT02991430|460402157|FG001|Treatment Period 2|Study Termination|3|||
127940016|NCT02991430|460402158|FG002|Treatment Period 2|Study Termination|3|||
127940017|NCT02991430|460402156|FG000|Treatment Period 2|Lost to Follow-up|0|||
127940018|NCT02991430|460402157|FG001|Treatment Period 2|Lost to Follow-up|0|||
127940019|NCT02991430|460402158|FG002|Treatment Period 2|Lost to Follow-up|1|||
127940020|NCT02991430|460402156|FG000|Post-treatment Observation Period|Study Termination|3|||
127940021|NCT02991430|460402157|FG001|Post-treatment Observation Period|Study Termination|6|||
127940022|NCT02991430|460402158|FG002|Post-treatment Observation Period|Study Termination|5|||
127940023|NCT03970837|460402159|FG000|Overall Study|Adverse Event|23|||
127940024|NCT03970837|460402160|FG001|Overall Study|Adverse Event|20|||
127940025|NCT03970837|460402161|FG002|Overall Study|Adverse Event|16|||
127940026|NCT03970837|460402162|FG003|Overall Study|Adverse Event|6|||
127940027|NCT03970837|460402163|FG004|Overall Study|Adverse Event|4|||
127940028|NCT03970837|460402164|FG005|Overall Study|Adverse Event|5|||
127940029|NCT03970837|460402165|FG006|Overall Study|Adverse Event|1|||
127940030|NCT03970837|460402166|FG007|Overall Study|Adverse Event|5|||
127940031|NCT03970837|460402167|FG008|Overall Study|Adverse Event|0|||
127940032|NCT03970837|460402168|FG009|Overall Study|Adverse Event|0|||
127940033|NCT03970837|460402169|FG010|Overall Study|Adverse Event|1|||
127940034|NCT03970837|460402170|FG011|Overall Study|Adverse Event|1|||
127940035|NCT03970837|460402159|FG000|Overall Study|Lack of Efficacy|14|||
127940036|NCT03970837|460402160|FG001|Overall Study|Lack of Efficacy|12|||
127940037|NCT03970837|460402161|FG002|Overall Study|Lack of Efficacy|1|||
127940038|NCT03970837|460402162|FG003|Overall Study|Lack of Efficacy|2|||
127940039|NCT03970837|460402163|FG004|Overall Study|Lack of Efficacy|3|||
127940040|NCT03970837|460402164|FG005|Overall Study|Lack of Efficacy|4|||
127940041|NCT03970837|460402165|FG006|Overall Study|Lack of Efficacy|6|||
127940042|NCT03970837|460402166|FG007|Overall Study|Lack of Efficacy|1|||
127940043|NCT03970837|460402167|FG008|Overall Study|Lack of Efficacy|1|||
127940044|NCT03970837|460402168|FG009|Overall Study|Lack of Efficacy|0|||
127940045|NCT03970837|460402169|FG010|Overall Study|Lack of Efficacy|0|||
127940046|NCT03970837|460402170|FG011|Overall Study|Lack of Efficacy|0|||
127940047|NCT03970837|460402159|FG000|Overall Study|Lost to Follow-up|6|||
127940048|NCT03970837|460402160|FG001|Overall Study|Lost to Follow-up|5|||
127940049|NCT03970837|460402161|FG002|Overall Study|Lost to Follow-up|5|||
127940050|NCT03970837|460402162|FG003|Overall Study|Lost to Follow-up|1|||
127940051|NCT03970837|460402163|FG004|Overall Study|Lost to Follow-up|0|||
127940052|NCT03970837|460402164|FG005|Overall Study|Lost to Follow-up|2|||
127940053|NCT03970837|460402165|FG006|Overall Study|Lost to Follow-up|0|||
127940054|NCT03970837|460402166|FG007|Overall Study|Lost to Follow-up|0|||
127940055|NCT03970837|460402167|FG008|Overall Study|Lost to Follow-up|0|||
127940056|NCT03970837|460402168|FG009|Overall Study|Lost to Follow-up|0|||
127940057|NCT03970837|460402169|FG010|Overall Study|Lost to Follow-up|0|||
127940058|NCT03970837|460402170|FG011|Overall Study|Lost to Follow-up|0|||
127940059|NCT03970837|460402159|FG000|Overall Study|Protocol Violation|1|||
127940060|NCT03970837|460402160|FG001|Overall Study|Protocol Violation|0|||
127940061|NCT03970837|460402161|FG002|Overall Study|Protocol Violation|0|||
127940062|NCT03970837|460402162|FG003|Overall Study|Protocol Violation|0|||
127940063|NCT03970837|460402163|FG004|Overall Study|Protocol Violation|0|||
127940064|NCT03970837|460402164|FG005|Overall Study|Protocol Violation|0|||
127940065|NCT03970837|460402165|FG006|Overall Study|Protocol Violation|0|||
127940066|NCT03970837|460402166|FG007|Overall Study|Protocol Violation|0|||
127940067|NCT03970837|460402167|FG008|Overall Study|Protocol Violation|0|||
127940068|NCT03970837|460402168|FG009|Overall Study|Protocol Violation|0|||
127940069|NCT03970837|460402169|FG010|Overall Study|Protocol Violation|0|||
127940070|NCT03970837|460402170|FG011|Overall Study|Protocol Violation|0|||
127940071|NCT03970837|460402159|FG000|Overall Study|Physician Decision|5|||
127940072|NCT03970837|460402160|FG001|Overall Study|Physician Decision|8|||
127940073|NCT03970837|460402161|FG002|Overall Study|Physician Decision|4|||
127940074|NCT03970837|460402162|FG003|Overall Study|Physician Decision|1|||
127940075|NCT03970837|460402163|FG004|Overall Study|Physician Decision|5|||
127940076|NCT03970837|460402164|FG005|Overall Study|Physician Decision|2|||
127940077|NCT03970837|460402165|FG006|Overall Study|Physician Decision|4|||
127940078|NCT03970837|460402166|FG007|Overall Study|Physician Decision|5|||
127940079|NCT03970837|460402167|FG008|Overall Study|Physician Decision|0|||
127940080|NCT03970837|460402168|FG009|Overall Study|Physician Decision|1|||
127940081|NCT03970837|460402169|FG010|Overall Study|Physician Decision|0|||
127940082|NCT03970837|460402170|FG011|Overall Study|Physician Decision|0|||
127940083|NCT03970837|460402159|FG000|Overall Study|Withdrawal by Subject|32|||
127940084|NCT03970837|460402160|FG001|Overall Study|Withdrawal by Subject|35|||
127940085|NCT03970837|460402161|FG002|Overall Study|Withdrawal by Subject|12|||
127940086|NCT03970837|460402162|FG003|Overall Study|Withdrawal by Subject|8|||
127940087|NCT03970837|460402163|FG004|Overall Study|Withdrawal by Subject|6|||
127940088|NCT03970837|460402164|FG005|Overall Study|Withdrawal by Subject|8|||
127940089|NCT03970837|460402165|FG006|Overall Study|Withdrawal by Subject|2|||
127940090|NCT03970837|460402166|FG007|Overall Study|Withdrawal by Subject|3|||
127940091|NCT03970837|460402167|FG008|Overall Study|Withdrawal by Subject|0|||
127940092|NCT03970837|460402168|FG009|Overall Study|Withdrawal by Subject|0|||
127940093|NCT03970837|460402169|FG010|Overall Study|Withdrawal by Subject|0|||
127940094|NCT03970837|460402170|FG011|Overall Study|Withdrawal by Subject|1|||
127940095|NCT03970837|460402159|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
127940096|NCT03970837|460402160|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
127940097|NCT03970837|460402161|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
127940098|NCT03970837|460402162|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
127940099|NCT03970837|460402163|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
127940100|NCT03970837|460402164|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
127940101|NCT03970837|460402165|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
127940102|NCT03970837|460402166|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
127940103|NCT03970837|460402167|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
127940104|NCT03970837|460402168|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
127940105|NCT03970837|460402169|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
127940106|NCT03970837|460402170|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
127940107|NCT03970837|460402159|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
127940108|NCT03970837|460402160|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
127940109|NCT03970837|460402161|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
127940110|NCT03970837|460402162|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
127940111|NCT03970837|460402163|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
127940112|NCT03970837|460402164|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
127940113|NCT03970837|460402165|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
127940114|NCT03970837|460402166|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
127940115|NCT03970837|460402167|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
127940116|NCT03970837|460402168|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
127940117|NCT03970837|460402169|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
127940118|NCT03970837|460402170|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
127940119|NCT04430855|460402175|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
127940120|NCT04430855|460402176|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
127940121|NCT04430855|460402175|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
127940122|NCT04430855|460402176|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
127940123|NCT04430855|460402175|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
127940124|NCT04430855|460402176|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
127940125|NCT04430855|460402175|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
127940126|NCT04430855|460402176|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
127940127|NCT04430855|460402175|FG000|Period 1 (Weeks 1-12)|Other|0|||
127940128|NCT04430855|460402176|FG001|Period 1 (Weeks 1-12)|Other|1|||
127940129|NCT04430855|460402175|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
127940130|NCT04430855|460402176|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
127940131|NCT04430855|460402175|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
127940132|NCT04430855|460402176|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
127940133|NCT04430855|460402175|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
127940134|NCT04430855|460402176|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
127940135|NCT01425723|460402177|FG000|Overall Study|Lack of Efficacy|0|||
127940136|NCT01425723|460402178|FG001|Overall Study|Lack of Efficacy|1|||
127940137|NCT01425723|460402177|FG000|Overall Study|Withdrawal by Subject|1|||
127940138|NCT01425723|460402178|FG001|Overall Study|Withdrawal by Subject|4|||
127940139|NCT01425723|460402177|FG000|Overall Study|Lost to Follow-up|0|||
127940140|NCT01425723|460402178|FG001|Overall Study|Lost to Follow-up|3|||
127940141|NCT01425723|460402177|FG000|Overall Study|Physician Decision|2|||
127940142|NCT01425723|460402178|FG001|Overall Study|Physician Decision|0|||
127940143|NCT01425723|460402177|FG000|Overall Study|Other|1|||
127940144|NCT01425723|460402178|FG001|Overall Study|Other|10|||
127940145|NCT00186043|460402179|FG000|Overall Study|Lack of Efficacy|1|||
127940146|NCT00186043|460402180|FG001|Overall Study|Lack of Efficacy|3|||
127940147|NCT00186043|460402179|FG000|Overall Study|Lost to Follow-up|4|||
127940148|NCT00186043|460402180|FG001|Overall Study|Lost to Follow-up|6|||
127940149|NCT00186043|460402179|FG000|Overall Study|Withdrawal by Subject|1|||
127940150|NCT00186043|460402180|FG001|Overall Study|Withdrawal by Subject|0|||
127940151|NCT00186043|460402179|FG000|Overall Study|Adverse Event|7|||
127940152|NCT00186043|460402180|FG001|Overall Study|Adverse Event|3|||
127940153|NCT00186043|460402179|FG000|Overall Study|Protocol Violation|2|||
127940154|NCT00186043|460402180|FG001|Overall Study|Protocol Violation|1|||
127940155|NCT04874636|460402181|FG000|Overall Study|Adverse Event|17|||
127940156|NCT04874636|460402182|FG001|Overall Study|Adverse Event|7|||
127940157|NCT04874636|460402181|FG000|Overall Study|Lost to Follow-up|1|||
127940158|NCT04874636|460402182|FG001|Overall Study|Lost to Follow-up|0|||
127940159|NCT04874636|460402181|FG000|Overall Study|Non-Compliance with Study Drug|2|||
127940160|NCT04874636|460402182|FG001|Overall Study|Non-Compliance with Study Drug|0|||
127940161|NCT04874636|460402181|FG000|Overall Study|Physician Decision|1|||
127940162|NCT04874636|460402182|FG001|Overall Study|Physician Decision|0|||
127940163|NCT04874636|460402181|FG000|Overall Study|Withdrawal by Subject|6|||
127940164|NCT04874636|460402182|FG001|Overall Study|Withdrawal by Subject|5|||
127940165|NCT01770392|460402183|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
127940166|NCT04639713|460402186|FG000|Overall Study|Protocol Noncompliance|2|||
127940167|NCT04639713|460402186|FG000|Overall Study|Withdrawal by Subject|1|||
127940168|NCT00390221|460402187|FG000|Overall Study|Lost to Follow-up|0|||
127940169|NCT00390221|460402188|FG001|Overall Study|Lost to Follow-up|3|||
127940170|NCT00390221|460402189|FG002|Overall Study|Lost to Follow-up|0|||
127940171|NCT00390221|460402187|FG000|Overall Study|Adverse Event|1|||
127940172|NCT00390221|460402188|FG001|Overall Study|Adverse Event|4|||
127940173|NCT00390221|460402189|FG002|Overall Study|Adverse Event|3|||
127940174|NCT00390221|460402187|FG000|Overall Study|Investigator Decision|0|||
127940175|NCT00390221|460402188|FG001|Overall Study|Investigator Decision|0|||
127940176|NCT00390221|460402189|FG002|Overall Study|Investigator Decision|1|||
127940177|NCT00390221|460402187|FG000|Overall Study|Withdrawal by Subject|13|||
127940178|NCT00390221|460402188|FG001|Overall Study|Withdrawal by Subject|9|||
127940179|NCT00390221|460402189|FG002|Overall Study|Withdrawal by Subject|7|||
127940180|NCT00390221|460402187|FG000|Overall Study|Subject Non-compliance|1|||
127940181|NCT00390221|460402188|FG001|Overall Study|Subject Non-compliance|0|||
127940182|NCT00390221|460402189|FG002|Overall Study|Subject Non-compliance|2|||
127940183|NCT00390221|460402187|FG000|Overall Study|Other|3|||
127940184|NCT00390221|460402188|FG001|Overall Study|Other|4|||
127940185|NCT00390221|460402189|FG002|Overall Study|Other|2|||
127940186|NCT02533375|460402190|FG000|Overall Study|Lack of Efficacy|3|||
127940187|NCT02533375|460402190|FG000|Overall Study|Adverse Event|2|||
127940188|NCT03870477|460402199|FG000|Overall Study|Early Study Termination|1|||
127940189|NCT03258853|460402200|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
127940190|NCT03258853|460402201|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
127940191|NCT01709838|460402204|FG000|Overall Study|Withdrawal by Subject|21|||
127940192|NCT01709838|460402204|FG000|Overall Study|Lost to Follow-up|16|||
127940193|NCT01709838|460402204|FG000|Overall Study|Pregnancy|10|||
127940194|NCT01709838|460402204|FG000|Overall Study|Subject/guardian decision|8|||
127940195|NCT01709838|460402204|FG000|Overall Study|Adverse Event|4|||
127940196|NCT01709838|460402204|FG000|Overall Study|Physician Decision|4|||
127940197|NCT01709838|460402204|FG000|Overall Study|Death|3|||
127940198|NCT01709838|460402204|FG000|Overall Study|Protocol Violation|1|||
127940199|NCT02081209|460404610|FG000|Overall Study|Withdrawal by Subject|1|||
127940200|NCT01200992|460404617|FG000|Overall Study|Study terminated early|35|||
127940201|NCT01200992|460404618|FG001|Overall Study|Study terminated early|41|||
127940202|NCT01200992|460404617|FG000|Overall Study|Randomized but not treated|2|||
127940203|NCT01200992|460404618|FG001|Overall Study|Randomized but not treated|0|||
127940204|NCT00191113|460404619|FG000|Core Study|Withdrawal by Subject|25|||
127940205|NCT00191113|460404620|FG001|Core Study|Withdrawal by Subject|9|||
127940206|NCT00191113|460404619|FG000|Core Study|Protocol Violation|6|||
127940207|NCT00191113|460404620|FG001|Core Study|Protocol Violation|2|||
127940208|NCT00191113|460404619|FG000|Core Study|Lost to Follow-up|3|||
127940209|NCT00191113|460404620|FG001|Core Study|Lost to Follow-up|0|||
127940210|NCT00191113|460404619|FG000|Core Study|Adverse Event|0|||
127940211|NCT00191113|460404620|FG001|Core Study|Adverse Event|2|||
127940212|NCT00191113|460404619|FG000|Core Study|Lack of Efficacy|0|||
127940213|NCT00191113|460404620|FG001|Core Study|Lack of Efficacy|2|||
127940214|NCT00191113|460404619|FG000|Core Study|Death|1|||
127940215|NCT00191113|460404620|FG001|Core Study|Death|0|||
127940216|NCT02903030|460404624|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
127940217|NCT02903030|460404625|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
127940218|NCT01502410|460404626|FG000|Overall Study|Adverse Event|1|||
127940219|NCT01502410|460404627|FG001|Overall Study|Adverse Event|2|||
127940220|NCT01502410|460404628|FG002|Overall Study|Adverse Event|0|||
127940221|NCT01502410|460404629|FG003|Overall Study|Adverse Event|0|||
127940222|NCT01502410|460404626|FG000|Overall Study|Lack of Efficacy|7|||
127940223|NCT01502410|460404627|FG001|Overall Study|Lack of Efficacy|7|||
127940224|NCT01502410|460404628|FG002|Overall Study|Lack of Efficacy|0|||
127940225|NCT01502410|460404629|FG003|Overall Study|Lack of Efficacy|0|||
127940226|NCT01502410|460404626|FG000|Overall Study|Physician Decision|0|||
127940227|NCT01502410|460404627|FG001|Overall Study|Physician Decision|1|||
127940228|NCT01502410|460404628|FG002|Overall Study|Physician Decision|0|||
127940229|NCT01502410|460404629|FG003|Overall Study|Physician Decision|0|||
127940230|NCT01502410|460404626|FG000|Overall Study|Withdrawal by Subject|2|||
127940231|NCT01502410|460404627|FG001|Overall Study|Withdrawal by Subject|0|||
127940232|NCT01502410|460404628|FG002|Overall Study|Withdrawal by Subject|0|||
127940233|NCT01502410|460404629|FG003|Overall Study|Withdrawal by Subject|0|||
127940234|NCT00368979|460404635|FG000|Overall Study|Adverse Event|9|||
127940235|NCT00368979|460404636|FG001|Overall Study|Adverse Event|16|||
127940236|NCT00368979|460404635|FG000|Overall Study|Lack of Efficacy|5|||
127940237|NCT00368979|460404636|FG001|Overall Study|Lack of Efficacy|3|||
127940238|NCT00368979|460404635|FG000|Overall Study|Other|3|||
127940239|NCT00368979|460404636|FG001|Overall Study|Other|1|||
127940240|NCT00368979|460404635|FG000|Overall Study|Lost to Follow-up|1|||
127940241|NCT00368979|460404636|FG001|Overall Study|Lost to Follow-up|0|||
127940242|NCT00368979|460404635|FG000|Overall Study|Protocol Violation|2|||
127940243|NCT00368979|460404636|FG001|Overall Study|Protocol Violation|1|||
127940244|NCT00368979|460404635|FG000|Overall Study|Withdrawal by Subject|5|||
127940245|NCT00368979|460404636|FG001|Overall Study|Withdrawal by Subject|9|||
127940246|NCT03786718|460404637|FG000|Overall Study|Lost to Follow-up|3|||
127940247|NCT03786718|460404637|FG000|Overall Study|Withdrawal by Subject|1|||
127940248|NCT03786718|460404637|FG000|Overall Study|Did not use the intervention|2|||
127940249|NCT03786718|460404637|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
127940250|NCT00754650|460404647|FG000|Overall Study|Disease Progression|2|||
127940251|NCT00805675|460404648|FG000|Overall Study|Adverse Event|0|||
127940252|NCT00805675|460404649|FG001|Overall Study|Adverse Event|0|||
127940253|NCT00805675|460404650|FG002|Overall Study|Adverse Event|1|||
127940254|NCT00552578|460404659|FG000|Overall Study|Lost to Follow-up|1|||
127940255|NCT00552578|460404660|FG001|Overall Study|Lost to Follow-up|1|||
127940256|NCT01716715|460404661|FG000|Overall Study|Never Treated|2|||
127940257|NCT01716715|460404662|FG001|Overall Study|Never Treated|4|||
127940258|NCT03327792|460404663|FG000|Overall Study|Adverse Event|4|||
127940259|NCT03327792|460404664|FG001|Overall Study|Adverse Event|0|||
127940260|NCT03327792|460404663|FG000|Overall Study|Family/Personal issues|3|||
127940261|NCT03327792|460404664|FG001|Overall Study|Family/Personal issues|2|||
127940262|NCT03327792|460404663|FG000|Overall Study|Lost to Follow-up|0|||
127940263|NCT03327792|460404664|FG001|Overall Study|Lost to Follow-up|1|||
127940264|NCT00626392|460404665|FG000|Run-in Period|Adverse Event|0|||
127940265|NCT00626392|460404666|FG001|Run-in Period|Adverse Event|0|||
127940266|NCT00626392|460404667|FG002|Run-in Period|Adverse Event|1|||
127940267|NCT00626392|460404668|FG003|Run-in Period|Adverse Event|0|||
127940268|NCT00626392|460404669|FG004|Run-in Period|Adverse Event|1|||
127940269|NCT00626392|460404670|FG005|Run-in Period|Adverse Event|0|||
127940270|NCT00626392|460404665|FG000|Run-in Period|Withdrawal by Subject|0|||
127940271|NCT00626392|460404666|FG001|Run-in Period|Withdrawal by Subject|1|||
127940272|NCT00626392|460404667|FG002|Run-in Period|Withdrawal by Subject|1|||
127940273|NCT00626392|460404668|FG003|Run-in Period|Withdrawal by Subject|1|||
127940274|NCT00626392|460404669|FG004|Run-in Period|Withdrawal by Subject|3|||
127940275|NCT00626392|460404670|FG005|Run-in Period|Withdrawal by Subject|1|||
127940276|NCT00626392|460404665|FG000|Run-in Period|Noncompliance|1|||
127940277|NCT00626392|460404666|FG001|Run-in Period|Noncompliance|0|||
127940278|NCT00626392|460404667|FG002|Run-in Period|Noncompliance|1|||
127940279|NCT00626392|460404668|FG003|Run-in Period|Noncompliance|0|||
127940280|NCT00626392|460404669|FG004|Run-in Period|Noncompliance|0|||
127940281|NCT00626392|460404670|FG005|Run-in Period|Noncompliance|0|||
127940282|NCT00626392|460404665|FG000|Coadministration Period|Adverse Event|3|||
127940283|NCT00626392|460404666|FG001|Coadministration Period|Adverse Event|1|||
127940284|NCT00626392|460404667|FG002|Coadministration Period|Adverse Event|7|||
127940285|NCT00626392|460404668|FG003|Coadministration Period|Adverse Event|4|||
127940286|NCT00626392|460404669|FG004|Coadministration Period|Adverse Event|3|||
127940287|NCT00626392|460404670|FG005|Coadministration Period|Adverse Event|4|||
127940288|NCT00626392|460404665|FG000|Coadministration Period|Withdrawal by Subject|1|||
127940289|NCT00626392|460404666|FG001|Coadministration Period|Withdrawal by Subject|1|||
127940290|NCT00626392|460404667|FG002|Coadministration Period|Withdrawal by Subject|0|||
127940291|NCT00626392|460404668|FG003|Coadministration Period|Withdrawal by Subject|1|||
127940292|NCT00626392|460404669|FG004|Coadministration Period|Withdrawal by Subject|0|||
127940293|NCT00626392|460404670|FG005|Coadministration Period|Withdrawal by Subject|1|||
127940294|NCT00626392|460404665|FG000|Coadministration Period|Protocol Violation|0|||
127940295|NCT00626392|460404666|FG001|Coadministration Period|Protocol Violation|1|||
127940296|NCT00626392|460404667|FG002|Coadministration Period|Protocol Violation|0|||
127940297|NCT00626392|460404668|FG003|Coadministration Period|Protocol Violation|1|||
127940298|NCT00626392|460404669|FG004|Coadministration Period|Protocol Violation|1|||
127940299|NCT00626392|460404670|FG005|Coadministration Period|Protocol Violation|0|||
127940300|NCT00626392|460404665|FG000|Coadministration Period|Other|0|||
127940301|NCT00626392|460404666|FG001|Coadministration Period|Other|2|||
127940302|NCT00626392|460404667|FG002|Coadministration Period|Other|3|||
127940303|NCT00626392|460404668|FG003|Coadministration Period|Other|1|||
127940304|NCT00626392|460404669|FG004|Coadministration Period|Other|1|||
127940305|NCT00626392|460404670|FG005|Coadministration Period|Other|1|||
127940306|NCT01085734|460404675|FG000|Overall Study|Adverse Event|0|||
127940307|NCT01085734|460404676|FG001|Overall Study|Adverse Event|2|||
127940308|NCT01085734|460404675|FG000|Overall Study|Death|1|||
127940309|NCT01085734|460404676|FG001|Overall Study|Death|0|||
127940310|NCT01085734|460404675|FG000|Overall Study|Lost to Follow-up|0|||
127940311|NCT01085734|460404676|FG001|Overall Study|Lost to Follow-up|1|||
127940312|NCT01085734|460404675|FG000|Overall Study|Withdrawal by Subject|0|||
127940313|NCT01085734|460404676|FG001|Overall Study|Withdrawal by Subject|1|||
127940314|NCT01715571|460404677|FG000|Overall Study|Lost to Follow-up|8|||
127940315|NCT02196701|460404680|FG000|Overall Study|Adverse Event|1|||
127940316|NCT02196701|460404680|FG000|Overall Study|Lost to Follow-up|1|||
127940317|NCT02196701|460404680|FG000|Overall Study|Non-adherence to Protocol|1|||
127940318|NCT03275064|460404681|FG000|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
127940319|NCT03275064|460404682|FG001|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
127940320|NCT03275064|460404683|FG002|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
127940321|NCT03275064|460404684|FG003|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|1|||
127940322|NCT03275064|460404685|FG004|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
127940323|NCT03275064|460404681|FG000|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|1|||
127940324|NCT03275064|460404682|FG001|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
127940325|NCT03275064|460404683|FG002|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
127940326|NCT03275064|460404684|FG003|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
127940327|NCT03275064|460404685|FG004|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
127940328|NCT03275064|460404681|FG000|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
127940329|NCT03275064|460404682|FG001|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
127940330|NCT03275064|460404683|FG002|Post-treatment Follow-up Parts A and B|Lost to Follow-up|2|||
127940331|NCT03275064|460404684|FG003|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
127940332|NCT03275064|460404685|FG004|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
127940333|NCT03275064|460404681|FG000|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
127940334|NCT03275064|460404682|FG001|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
127940335|NCT03275064|460404683|FG002|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
127940336|NCT03275064|460404684|FG003|Post-treatment Follow-up Parts A and B|No longer required treatment|1|||
127940337|NCT03275064|460404685|FG004|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
127940338|NCT03275064|460404681|FG000|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
127940339|NCT03275064|460404682|FG001|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
127940340|NCT03275064|460404683|FG002|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
127940341|NCT03275064|460404684|FG003|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
127940342|NCT03275064|460404685|FG004|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
127940343|NCT04159935|460404686|FG000|Overall Study|Study terminated due to COVID-19|1|||
127940344|NCT04159935|460404687|FG001|Overall Study|Study terminated due to COVID-19|3|||
127940345|NCT01341782|460404688|FG000|Overall Study|Adverse Event|1|||
127940346|NCT01341782|460404689|FG001|Overall Study|Adverse Event|1|||
127940347|NCT01341782|460404688|FG000|Overall Study|Withdrawal by Subject|6|||
127940348|NCT01341782|460404689|FG001|Overall Study|Withdrawal by Subject|5|||
127940349|NCT01341782|460404688|FG000|Overall Study|Missed 3 consecutive doses|0|||
127940350|NCT01341782|460404689|FG001|Overall Study|Missed 3 consecutive doses|4|||
127940351|NCT01341782|460404688|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
127940352|NCT01341782|460404689|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
127940353|NCT01341782|460404688|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
127940354|NCT01341782|460404689|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
127940355|NCT01341782|460404688|FG000|Overall Study|Other|5|||
127940356|NCT01341782|460404689|FG001|Overall Study|Other|0|||
127940357|NCT00620555|460404690|FG000|Overall Study|Adverse Event|4|||
127940358|NCT00620555|460404690|FG000|Overall Study|Protocol Violation|2|||
127940359|NCT00620555|460404690|FG000|Overall Study|Lack of Efficacy|12|||
127940360|NCT00620555|460404690|FG000|Overall Study|Withdrawal by Subject|1|||
127940361|NCT00620555|460404690|FG000|Overall Study|Choice of other treatment|1|||
127940362|NCT00620555|460404690|FG000|Overall Study|Visit failure against planned|1|||
127940363|NCT01140503|460404691|FG000|Overall Study|Withdrawal by Subject|1|||
127940364|NCT00724048|460404692|FG000|Overall Study|Adverse Event|1|||
127940365|NCT00724048|460404693|FG001|Overall Study|Adverse Event|1|||
127940366|NCT00724048|460404694|FG002|Overall Study|Adverse Event|1|||
127940367|NCT00724048|460404695|FG003|Overall Study|Adverse Event|0|||
127940368|NCT00724048|460404692|FG000|Overall Study|Lost to Follow-up|0|||
127940369|NCT00724048|460404693|FG001|Overall Study|Lost to Follow-up|1|||
127940370|NCT00724048|460404694|FG002|Overall Study|Lost to Follow-up|0|||
127940371|NCT00724048|460404695|FG003|Overall Study|Lost to Follow-up|0|||
127940372|NCT00724048|460404692|FG000|Overall Study|Withdrawal by Subject|1|||
127940373|NCT00724048|460404693|FG001|Overall Study|Withdrawal by Subject|2|||
127940374|NCT00724048|460404694|FG002|Overall Study|Withdrawal by Subject|1|||
127940375|NCT00724048|460404695|FG003|Overall Study|Withdrawal by Subject|2|||
127940376|NCT00724048|460404692|FG000|Overall Study|Investigator decision|0|||
127940377|NCT00724048|460404693|FG001|Overall Study|Investigator decision|0|||
127940378|NCT00724048|460404694|FG002|Overall Study|Investigator decision|1|||
127940379|NCT00724048|460404695|FG003|Overall Study|Investigator decision|0|||
127940380|NCT00724048|460404692|FG000|Overall Study|Did not tolerate study drug|0|||
127940381|NCT00724048|460404693|FG001|Overall Study|Did not tolerate study drug|0|||
127940382|NCT00724048|460404694|FG002|Overall Study|Did not tolerate study drug|0|||
127940383|NCT00724048|460404695|FG003|Overall Study|Did not tolerate study drug|1|||
127940384|NCT00724048|460404692|FG000|Overall Study|Other than specified|1|||
127940385|NCT00724048|460404693|FG001|Overall Study|Other than specified|1|||
127940386|NCT00724048|460404694|FG002|Overall Study|Other than specified|0|||
127940387|NCT00724048|460404695|FG003|Overall Study|Other than specified|0|||
127940388|NCT03923530|460404696|FG000|Overall Study|Withdrawal by Subject|1|||
127940389|NCT03923530|460404696|FG000|Overall Study|screen failure|3|||
127940390|NCT00407758|460404697|FG000|Overall Study|ineligible -improper prior treatment|1|||
127940391|NCT01822275|460404705|FG000|Overall Study|Withdrawal by Subject|3|||
127940392|NCT01822275|460404705|FG000|Overall Study|Adverse Event|3|||
127940393|NCT01822275|460404705|FG000|Overall Study|Progression|14|||
127940394|NCT01822275|460404705|FG000|Overall Study|Physician Decision|2|||
127940395|NCT00073021|460404707|FG000|Overall Study|Protocol Violation|2|||
127940396|NCT00073021|460404708|FG001|Overall Study|Protocol Violation|1|||
127940397|NCT00073021|460404707|FG000|Overall Study|Adverse Event|4|||
127940398|NCT00073021|460404708|FG001|Overall Study|Adverse Event|4|||
127940399|NCT00073021|460404707|FG000|Overall Study|Withdrawal by Subject|6|||
127940400|NCT00073021|460404708|FG001|Overall Study|Withdrawal by Subject|5|||
127940401|NCT00073021|460404707|FG000|Overall Study|Physician Decision|3|||
127940402|NCT00073021|460404708|FG001|Overall Study|Physician Decision|1|||
127940403|NCT00073021|460404707|FG000|Overall Study|Lack of Efficacy|11|||
127940404|NCT00073021|460404708|FG001|Overall Study|Lack of Efficacy|5|||
127940405|NCT01458106|460404709|FG000|Overall Study|Withdrawal by Subject|2|||
127940406|NCT01458106|460404710|FG001|Overall Study|Withdrawal by Subject|0|||
127940407|NCT01458106|460404709|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
127940408|NCT01458106|460404710|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
127940409|NCT01458106|460404709|FG000|Overall Study|Withdrawn Per Protocol|0|||
127940410|NCT01458106|460404710|FG001|Overall Study|Withdrawn Per Protocol|1|||
127940411|NCT00855803|460404711|FG000|Overall Study|Death|2|||
127940412|NCT00855803|460404711|FG000|Overall Study|Lost to Follow-up|2|||
127940413|NCT00855803|460404711|FG000|Overall Study|Technical inability to undergo procedure|2|||
127940414|NCT00855803|460404711|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
127940415|NCT00855803|460404711|FG000|Overall Study|Withdrawal by Subject|3|||
127940416|NCT00855803|460404711|FG000|Overall Study|Physician Decision|3|||
127940417|NCT01672970|460404715|FG000|Overall Study|Lack of Efficacy|12|||
127940418|NCT01672970|460404715|FG000|Overall Study|Adverse Event|18|||
127940419|NCT01672970|460404715|FG000|Overall Study|Withdrawal by Subject|2|||
127940420|NCT01672970|460404715|FG000|Overall Study|Lost to Follow-up|5|||
127940421|NCT01672970|460404715|FG000|Overall Study|Other|9|||
127940422|NCT01672970|460404715|FG000|Overall Study|Enrolled but not treated|1|||
127940423|NCT02132754|460404716|FG000|Overall Study|Adverse Event|0|||
127940424|NCT02132754|460404717|FG001|Overall Study|Adverse Event|0|||
127940425|NCT02132754|460404718|FG002|Overall Study|Adverse Event|0|||
127940426|NCT02132754|460404719|FG003|Overall Study|Adverse Event|0|||
127940427|NCT02132754|460404720|FG004|Overall Study|Adverse Event|0|||
127940428|NCT02132754|460404721|FG005|Overall Study|Adverse Event|0|||
127940429|NCT02132754|460404722|FG006|Overall Study|Adverse Event|0|||
127940430|NCT02132754|460404723|FG007|Overall Study|Adverse Event|0|||
127940431|NCT02132754|460404724|FG008|Overall Study|Adverse Event|0|||
127940432|NCT02132754|460404725|FG009|Overall Study|Adverse Event|0|||
127940433|NCT02132754|460404726|FG010|Overall Study|Adverse Event|0|||
127940434|NCT02132754|460404727|FG011|Overall Study|Adverse Event|0|||
127940435|NCT02132754|460404728|FG012|Overall Study|Adverse Event|0|||
127940436|NCT02132754|460404729|FG013|Overall Study|Adverse Event|0|||
127940437|NCT02132754|460404730|FG014|Overall Study|Adverse Event|0|||
127940438|NCT02132754|460404731|FG015|Overall Study|Adverse Event|0|||
127940439|NCT02132754|460404732|FG016|Overall Study|Adverse Event|0|||
127940440|NCT02132754|460404733|FG017|Overall Study|Adverse Event|1|||
127940441|NCT02132754|460404734|FG018|Overall Study|Adverse Event|0|||
127940442|NCT02132754|460404735|FG019|Overall Study|Adverse Event|0|||
127940443|NCT02132754|460404736|FG020|Overall Study|Adverse Event|0|||
127940444|NCT02132754|460404737|FG021|Overall Study|Adverse Event|0|||
127940445|NCT02132754|460404738|FG022|Overall Study|Adverse Event|0|||
127940446|NCT02132754|460404739|FG023|Overall Study|Adverse Event|0|||
127940447|NCT02132754|460404740|FG024|Overall Study|Adverse Event|0|||
127940448|NCT02132754|460404741|FG025|Overall Study|Adverse Event|1|||
127940449|NCT02132754|460404742|FG026|Overall Study|Adverse Event|1|||
127940450|NCT02132754|460404743|FG027|Overall Study|Adverse Event|0|||
127940451|NCT02132754|460404744|FG028|Overall Study|Adverse Event|0|||
127940452|NCT02132754|460404745|FG029|Overall Study|Adverse Event|0|||
127940453|NCT02132754|460404746|FG030|Overall Study|Adverse Event|1|||
127940454|NCT02132754|460404747|FG031|Overall Study|Adverse Event|0|||
127940455|NCT02132754|460404748|FG032|Overall Study|Adverse Event|1|||
127940456|NCT02132754|460404749|FG033|Overall Study|Adverse Event|1|||
127940457|NCT02132754|460404716|FG000|Overall Study|Clinical Progression|0|||
127940458|NCT02132754|460404717|FG001|Overall Study|Clinical Progression|0|||
127940459|NCT02132754|460404718|FG002|Overall Study|Clinical Progression|0|||
127940460|NCT02132754|460404719|FG003|Overall Study|Clinical Progression|0|||
127940461|NCT02132754|460404720|FG004|Overall Study|Clinical Progression|0|||
127940462|NCT02132754|460404721|FG005|Overall Study|Clinical Progression|0|||
127940463|NCT02132754|460404722|FG006|Overall Study|Clinical Progression|0|||
127940464|NCT02132754|460404723|FG007|Overall Study|Clinical Progression|0|||
127940465|NCT02132754|460404724|FG008|Overall Study|Clinical Progression|0|||
127940466|NCT02132754|460404725|FG009|Overall Study|Clinical Progression|1|||
127940467|NCT02132754|460404726|FG010|Overall Study|Clinical Progression|0|||
127940468|NCT02132754|460404727|FG011|Overall Study|Clinical Progression|0|||
127940469|NCT02132754|460404728|FG012|Overall Study|Clinical Progression|0|||
127940470|NCT02132754|460404729|FG013|Overall Study|Clinical Progression|0|||
127940471|NCT02132754|460404730|FG014|Overall Study|Clinical Progression|0|||
127940472|NCT02132754|460404731|FG015|Overall Study|Clinical Progression|0|||
127940473|NCT02132754|460404732|FG016|Overall Study|Clinical Progression|1|||
127940474|NCT02132754|460404733|FG017|Overall Study|Clinical Progression|1|||
127940475|NCT02132754|460404734|FG018|Overall Study|Clinical Progression|0|||
127940476|NCT02132754|460404735|FG019|Overall Study|Clinical Progression|1|||
127940477|NCT02132754|460404736|FG020|Overall Study|Clinical Progression|0|||
127940478|NCT02132754|460404737|FG021|Overall Study|Clinical Progression|0|||
127940479|NCT02132754|460404738|FG022|Overall Study|Clinical Progression|1|||
127940480|NCT02132754|460404739|FG023|Overall Study|Clinical Progression|0|||
127940481|NCT02132754|460404740|FG024|Overall Study|Clinical Progression|1|||
127940482|NCT02132754|460404741|FG025|Overall Study|Clinical Progression|1|||
127940483|NCT02132754|460404742|FG026|Overall Study|Clinical Progression|0|||
127940484|NCT02132754|460404743|FG027|Overall Study|Clinical Progression|1|||
127940485|NCT02132754|460404744|FG028|Overall Study|Clinical Progression|1|||
127940486|NCT02132754|460404745|FG029|Overall Study|Clinical Progression|0|||
127940487|NCT02132754|460404746|FG030|Overall Study|Clinical Progression|1|||
127940488|NCT02132754|460404747|FG031|Overall Study|Clinical Progression|0|||
127940489|NCT02132754|460404748|FG032|Overall Study|Clinical Progression|0|||
127940490|NCT02132754|460404749|FG033|Overall Study|Clinical Progression|2|||
127940491|NCT02132754|460404716|FG000|Overall Study|Death|0|||
127940492|NCT02132754|460404717|FG001|Overall Study|Death|0|||
127940493|NCT02132754|460404718|FG002|Overall Study|Death|0|||
127940494|NCT02132754|460404719|FG003|Overall Study|Death|0|||
127940495|NCT02132754|460404720|FG004|Overall Study|Death|0|||
127940496|NCT02132754|460404721|FG005|Overall Study|Death|0|||
127940497|NCT02132754|460404722|FG006|Overall Study|Death|0|||
127940498|NCT02132754|460404723|FG007|Overall Study|Death|0|||
127940499|NCT02132754|460404724|FG008|Overall Study|Death|0|||
127940500|NCT02132754|460404725|FG009|Overall Study|Death|0|||
127940501|NCT02132754|460404726|FG010|Overall Study|Death|0|||
127940502|NCT02132754|460404727|FG011|Overall Study|Death|0|||
127940503|NCT02132754|460404728|FG012|Overall Study|Death|0|||
127940504|NCT02132754|460404729|FG013|Overall Study|Death|0|||
127940505|NCT02132754|460404730|FG014|Overall Study|Death|0|||
127940506|NCT02132754|460404731|FG015|Overall Study|Death|1|||
127940507|NCT02132754|460404732|FG016|Overall Study|Death|0|||
127940508|NCT02132754|460404733|FG017|Overall Study|Death|0|||
127940509|NCT02132754|460404734|FG018|Overall Study|Death|0|||
127940510|NCT02132754|460404735|FG019|Overall Study|Death|1|||
127940511|NCT02132754|460404736|FG020|Overall Study|Death|0|||
127940512|NCT02132754|460404737|FG021|Overall Study|Death|1|||
127940513|NCT02132754|460404738|FG022|Overall Study|Death|0|||
127940514|NCT02132754|460404739|FG023|Overall Study|Death|0|||
127940515|NCT02132754|460404740|FG024|Overall Study|Death|0|||
127940516|NCT02132754|460404741|FG025|Overall Study|Death|0|||
127940517|NCT02132754|460404742|FG026|Overall Study|Death|1|||
127940518|NCT02132754|460404743|FG027|Overall Study|Death|0|||
127940519|NCT02132754|460404744|FG028|Overall Study|Death|0|||
127940520|NCT02132754|460404745|FG029|Overall Study|Death|0|||
127940521|NCT02132754|460404746|FG030|Overall Study|Death|0|||
127940522|NCT02132754|460404747|FG031|Overall Study|Death|0|||
127940523|NCT02132754|460404748|FG032|Overall Study|Death|0|||
127940524|NCT02132754|460404749|FG033|Overall Study|Death|2|||
127940525|NCT02132754|460404716|FG000|Overall Study|Excluded Medication|0|||
127940526|NCT02132754|460404717|FG001|Overall Study|Excluded Medication|0|||
127940527|NCT02132754|460404718|FG002|Overall Study|Excluded Medication|0|||
127940528|NCT02132754|460404719|FG003|Overall Study|Excluded Medication|0|||
127940529|NCT02132754|460404720|FG004|Overall Study|Excluded Medication|0|||
127940530|NCT02132754|460404721|FG005|Overall Study|Excluded Medication|0|||
127940531|NCT02132754|460404722|FG006|Overall Study|Excluded Medication|0|||
127940532|NCT02132754|460404723|FG007|Overall Study|Excluded Medication|0|||
127940533|NCT02132754|460404724|FG008|Overall Study|Excluded Medication|0|||
127940534|NCT02132754|460404725|FG009|Overall Study|Excluded Medication|0|||
127940535|NCT02132754|460404726|FG010|Overall Study|Excluded Medication|0|||
127940536|NCT02132754|460404727|FG011|Overall Study|Excluded Medication|0|||
127940537|NCT02132754|460404728|FG012|Overall Study|Excluded Medication|0|||
127940538|NCT02132754|460404729|FG013|Overall Study|Excluded Medication|0|||
127940539|NCT02132754|460404730|FG014|Overall Study|Excluded Medication|0|||
127940540|NCT02132754|460404731|FG015|Overall Study|Excluded Medication|0|||
127940541|NCT02132754|460404732|FG016|Overall Study|Excluded Medication|0|||
127940542|NCT02132754|460404733|FG017|Overall Study|Excluded Medication|0|||
127940543|NCT02132754|460404734|FG018|Overall Study|Excluded Medication|0|||
127940544|NCT02132754|460404735|FG019|Overall Study|Excluded Medication|0|||
127940545|NCT02132754|460404736|FG020|Overall Study|Excluded Medication|1|||
127940546|NCT02132754|460404737|FG021|Overall Study|Excluded Medication|0|||
127940547|NCT02132754|460404738|FG022|Overall Study|Excluded Medication|0|||
127940548|NCT02132754|460404739|FG023|Overall Study|Excluded Medication|0|||
127940549|NCT02132754|460404740|FG024|Overall Study|Excluded Medication|0|||
127940550|NCT02132754|460404741|FG025|Overall Study|Excluded Medication|0|||
127940551|NCT02132754|460404742|FG026|Overall Study|Excluded Medication|0|||
127940552|NCT02132754|460404743|FG027|Overall Study|Excluded Medication|0|||
127940553|NCT02132754|460404744|FG028|Overall Study|Excluded Medication|0|||
127940554|NCT02132754|460404745|FG029|Overall Study|Excluded Medication|0|||
127940555|NCT02132754|460404746|FG030|Overall Study|Excluded Medication|0|||
127940556|NCT02132754|460404747|FG031|Overall Study|Excluded Medication|0|||
127940557|NCT02132754|460404748|FG032|Overall Study|Excluded Medication|0|||
127940558|NCT02132754|460404749|FG033|Overall Study|Excluded Medication|1|||
127940559|NCT02132754|460404716|FG000|Overall Study|Physician Decision|0|||
127940560|NCT02132754|460404717|FG001|Overall Study|Physician Decision|0|||
127940561|NCT02132754|460404718|FG002|Overall Study|Physician Decision|0|||
127940562|NCT02132754|460404719|FG003|Overall Study|Physician Decision|0|||
127940563|NCT02132754|460404720|FG004|Overall Study|Physician Decision|0|||
127940564|NCT02132754|460404721|FG005|Overall Study|Physician Decision|0|||
127940565|NCT02132754|460404722|FG006|Overall Study|Physician Decision|0|||
127940566|NCT02132754|460404723|FG007|Overall Study|Physician Decision|0|||
127940567|NCT02132754|460404724|FG008|Overall Study|Physician Decision|0|||
127940568|NCT02132754|460404725|FG009|Overall Study|Physician Decision|1|||
127940569|NCT02132754|460404726|FG010|Overall Study|Physician Decision|0|||
127940570|NCT02132754|460404727|FG011|Overall Study|Physician Decision|1|||
127940571|NCT02132754|460404728|FG012|Overall Study|Physician Decision|1|||
127940572|NCT02132754|460404729|FG013|Overall Study|Physician Decision|0|||
127940573|NCT02132754|460404730|FG014|Overall Study|Physician Decision|0|||
127940574|NCT02132754|460404731|FG015|Overall Study|Physician Decision|1|||
127940575|NCT02132754|460404732|FG016|Overall Study|Physician Decision|0|||
127940576|NCT02132754|460404733|FG017|Overall Study|Physician Decision|0|||
127940577|NCT02132754|460404734|FG018|Overall Study|Physician Decision|0|||
127940578|NCT02132754|460404735|FG019|Overall Study|Physician Decision|0|||
127940579|NCT02132754|460404736|FG020|Overall Study|Physician Decision|0|||
127940580|NCT02132754|460404737|FG021|Overall Study|Physician Decision|0|||
127940581|NCT02132754|460404738|FG022|Overall Study|Physician Decision|0|||
127940582|NCT02132754|460404739|FG023|Overall Study|Physician Decision|0|||
127940583|NCT02132754|460404740|FG024|Overall Study|Physician Decision|1|||
127940584|NCT02132754|460404741|FG025|Overall Study|Physician Decision|0|||
127940585|NCT02132754|460404742|FG026|Overall Study|Physician Decision|0|||
127940586|NCT02132754|460404743|FG027|Overall Study|Physician Decision|0|||
127940587|NCT02132754|460404744|FG028|Overall Study|Physician Decision|0|||
127940588|NCT02132754|460404745|FG029|Overall Study|Physician Decision|0|||
127940589|NCT02132754|460404746|FG030|Overall Study|Physician Decision|0|||
127940590|NCT02132754|460404747|FG031|Overall Study|Physician Decision|1|||
127940591|NCT02132754|460404748|FG032|Overall Study|Physician Decision|0|||
127940592|NCT02132754|460404749|FG033|Overall Study|Physician Decision|3|||
127940593|NCT02132754|460404716|FG000|Overall Study|Progressive Disease|1|||
127940594|NCT02132754|460404717|FG001|Overall Study|Progressive Disease|1|||
127940595|NCT02132754|460404718|FG002|Overall Study|Progressive Disease|1|||
127940596|NCT02132754|460404719|FG003|Overall Study|Progressive Disease|1|||
127940597|NCT02132754|460404720|FG004|Overall Study|Progressive Disease|1|||
127940598|NCT02132754|460404721|FG005|Overall Study|Progressive Disease|1|||
127940599|NCT02132754|460404722|FG006|Overall Study|Progressive Disease|1|||
127940600|NCT02132754|460404723|FG007|Overall Study|Progressive Disease|1|||
127940601|NCT02132754|460404724|FG008|Overall Study|Progressive Disease|1|||
127940602|NCT02132754|460404725|FG009|Overall Study|Progressive Disease|3|||
127940603|NCT02132754|460404726|FG010|Overall Study|Progressive Disease|3|||
127940604|NCT02132754|460404727|FG011|Overall Study|Progressive Disease|2|||
127940605|NCT02132754|460404728|FG012|Overall Study|Progressive Disease|2|||
127940606|NCT02132754|460404729|FG013|Overall Study|Progressive Disease|3|||
127940607|NCT02132754|460404730|FG014|Overall Study|Progressive Disease|2|||
127940608|NCT02132754|460404731|FG015|Overall Study|Progressive Disease|1|||
127940609|NCT02132754|460404732|FG016|Overall Study|Progressive Disease|2|||
127940610|NCT02132754|460404733|FG017|Overall Study|Progressive Disease|1|||
127940611|NCT02132754|460404734|FG018|Overall Study|Progressive Disease|3|||
127940612|NCT02132754|460404735|FG019|Overall Study|Progressive Disease|1|||
127940613|NCT02132754|460404736|FG020|Overall Study|Progressive Disease|1|||
127940614|NCT02132754|460404737|FG021|Overall Study|Progressive Disease|3|||
127940615|NCT02132754|460404738|FG022|Overall Study|Progressive Disease|2|||
127940616|NCT02132754|460404739|FG023|Overall Study|Progressive Disease|3|||
127940617|NCT02132754|460404740|FG024|Overall Study|Progressive Disease|0|||
127940618|NCT02132754|460404741|FG025|Overall Study|Progressive Disease|1|||
127940619|NCT02132754|460404742|FG026|Overall Study|Progressive Disease|2|||
127940620|NCT02132754|460404743|FG027|Overall Study|Progressive Disease|1|||
127940621|NCT02132754|460404744|FG028|Overall Study|Progressive Disease|2|||
127940622|NCT02132754|460404745|FG029|Overall Study|Progressive Disease|3|||
127940623|NCT02132754|460404746|FG030|Overall Study|Progressive Disease|1|||
127940624|NCT02132754|460404747|FG031|Overall Study|Progressive Disease|1|||
127940625|NCT02132754|460404748|FG032|Overall Study|Progressive Disease|3|||
127940626|NCT02132754|460404749|FG033|Overall Study|Progressive Disease|6|||
127940627|NCT02132754|460404716|FG000|Overall Study|Screen Failure|0|||
127940628|NCT02132754|460404717|FG001|Overall Study|Screen Failure|0|||
127940629|NCT02132754|460404718|FG002|Overall Study|Screen Failure|0|||
127940630|NCT02132754|460404719|FG003|Overall Study|Screen Failure|0|||
127940631|NCT02132754|460404720|FG004|Overall Study|Screen Failure|0|||
127940632|NCT02132754|460404721|FG005|Overall Study|Screen Failure|0|||
127940633|NCT02132754|460404722|FG006|Overall Study|Screen Failure|0|||
127940634|NCT02132754|460404723|FG007|Overall Study|Screen Failure|0|||
127940635|NCT02132754|460404724|FG008|Overall Study|Screen Failure|0|||
127940636|NCT02132754|460404725|FG009|Overall Study|Screen Failure|0|||
127940637|NCT02132754|460404726|FG010|Overall Study|Screen Failure|0|||
127940638|NCT02132754|460404727|FG011|Overall Study|Screen Failure|0|||
127940639|NCT02132754|460404728|FG012|Overall Study|Screen Failure|0|||
127940640|NCT02132754|460404729|FG013|Overall Study|Screen Failure|0|||
127940641|NCT02132754|460404730|FG014|Overall Study|Screen Failure|0|||
127940642|NCT02132754|460404731|FG015|Overall Study|Screen Failure|0|||
127940643|NCT02132754|460404732|FG016|Overall Study|Screen Failure|0|||
127940644|NCT02132754|460404733|FG017|Overall Study|Screen Failure|0|||
127940645|NCT02132754|460404734|FG018|Overall Study|Screen Failure|0|||
127940646|NCT02132754|460404735|FG019|Overall Study|Screen Failure|1|||
127940647|NCT02132754|460404736|FG020|Overall Study|Screen Failure|0|||
127940648|NCT02132754|460404737|FG021|Overall Study|Screen Failure|1|||
127940649|NCT02132754|460404738|FG022|Overall Study|Screen Failure|0|||
127940650|NCT02132754|460404739|FG023|Overall Study|Screen Failure|0|||
127940651|NCT02132754|460404740|FG024|Overall Study|Screen Failure|0|||
127940652|NCT02132754|460404741|FG025|Overall Study|Screen Failure|0|||
127940653|NCT02132754|460404742|FG026|Overall Study|Screen Failure|0|||
127940654|NCT02132754|460404743|FG027|Overall Study|Screen Failure|0|||
127940655|NCT02132754|460404744|FG028|Overall Study|Screen Failure|0|||
127940656|NCT02132754|460404745|FG029|Overall Study|Screen Failure|0|||
127940657|NCT02132754|460404746|FG030|Overall Study|Screen Failure|0|||
127940658|NCT02132754|460404747|FG031|Overall Study|Screen Failure|0|||
127940659|NCT02132754|460404748|FG032|Overall Study|Screen Failure|0|||
127940660|NCT02132754|460404749|FG033|Overall Study|Screen Failure|0|||
127940661|NCT02132754|460404716|FG000|Overall Study|Transferred to Extension Study|0|||
127940662|NCT02132754|460404717|FG001|Overall Study|Transferred to Extension Study|0|||
127940663|NCT02132754|460404718|FG002|Overall Study|Transferred to Extension Study|0|||
127940664|NCT02132754|460404719|FG003|Overall Study|Transferred to Extension Study|0|||
127940665|NCT02132754|460404720|FG004|Overall Study|Transferred to Extension Study|0|||
127940666|NCT02132754|460404721|FG005|Overall Study|Transferred to Extension Study|0|||
127940667|NCT02132754|460404722|FG006|Overall Study|Transferred to Extension Study|0|||
127940668|NCT02132754|460404723|FG007|Overall Study|Transferred to Extension Study|0|||
127940669|NCT02132754|460404724|FG008|Overall Study|Transferred to Extension Study|0|||
127940670|NCT02132754|460404725|FG009|Overall Study|Transferred to Extension Study|0|||
127940671|NCT02132754|460404726|FG010|Overall Study|Transferred to Extension Study|0|||
127940672|NCT02132754|460404727|FG011|Overall Study|Transferred to Extension Study|0|||
127940673|NCT02132754|460404728|FG012|Overall Study|Transferred to Extension Study|0|||
127940674|NCT02132754|460404729|FG013|Overall Study|Transferred to Extension Study|0|||
127940675|NCT02132754|460404730|FG014|Overall Study|Transferred to Extension Study|0|||
127940676|NCT02132754|460404731|FG015|Overall Study|Transferred to Extension Study|0|||
127940677|NCT02132754|460404732|FG016|Overall Study|Transferred to Extension Study|0|||
127940678|NCT02132754|460404733|FG017|Overall Study|Transferred to Extension Study|0|||
127940679|NCT02132754|460404734|FG018|Overall Study|Transferred to Extension Study|0|||
127940680|NCT02132754|460404735|FG019|Overall Study|Transferred to Extension Study|0|||
127940681|NCT02132754|460404736|FG020|Overall Study|Transferred to Extension Study|0|||
127940682|NCT02132754|460404737|FG021|Overall Study|Transferred to Extension Study|0|||
127940683|NCT02132754|460404738|FG022|Overall Study|Transferred to Extension Study|0|||
127940684|NCT02132754|460404739|FG023|Overall Study|Transferred to Extension Study|0|||
127940685|NCT02132754|460404740|FG024|Overall Study|Transferred to Extension Study|0|||
127940686|NCT02132754|460404741|FG025|Overall Study|Transferred to Extension Study|0|||
127940687|NCT02132754|460404742|FG026|Overall Study|Transferred to Extension Study|0|||
127940688|NCT02132754|460404743|FG027|Overall Study|Transferred to Extension Study|0|||
127940689|NCT02132754|460404744|FG028|Overall Study|Transferred to Extension Study|0|||
127940690|NCT02132754|460404745|FG029|Overall Study|Transferred to Extension Study|0|||
127940691|NCT02132754|460404746|FG030|Overall Study|Transferred to Extension Study|0|||
127940692|NCT02132754|460404747|FG031|Overall Study|Transferred to Extension Study|0|||
127940693|NCT02132754|460404748|FG032|Overall Study|Transferred to Extension Study|0|||
127940694|NCT02132754|460404749|FG033|Overall Study|Transferred to Extension Study|6|||
127940695|NCT02132754|460404716|FG000|Overall Study|Withdrawal by Subject|0|||
127940696|NCT02132754|460404717|FG001|Overall Study|Withdrawal by Subject|0|||
127940697|NCT02132754|460404718|FG002|Overall Study|Withdrawal by Subject|0|||
127940698|NCT02132754|460404719|FG003|Overall Study|Withdrawal by Subject|0|||
127940699|NCT02132754|460404720|FG004|Overall Study|Withdrawal by Subject|0|||
127940700|NCT02132754|460404721|FG005|Overall Study|Withdrawal by Subject|0|||
127940701|NCT02132754|460404722|FG006|Overall Study|Withdrawal by Subject|0|||
127940702|NCT02132754|460404723|FG007|Overall Study|Withdrawal by Subject|0|||
127940703|NCT02132754|460404724|FG008|Overall Study|Withdrawal by Subject|0|||
127940704|NCT02132754|460404725|FG009|Overall Study|Withdrawal by Subject|1|||
127940705|NCT02132754|460404726|FG010|Overall Study|Withdrawal by Subject|0|||
127940706|NCT02132754|460404727|FG011|Overall Study|Withdrawal by Subject|0|||
127940707|NCT02132754|460404728|FG012|Overall Study|Withdrawal by Subject|1|||
127940708|NCT02132754|460404729|FG013|Overall Study|Withdrawal by Subject|0|||
127940709|NCT02132754|460404730|FG014|Overall Study|Withdrawal by Subject|1|||
127940710|NCT02132754|460404731|FG015|Overall Study|Withdrawal by Subject|2|||
127940711|NCT02132754|460404732|FG016|Overall Study|Withdrawal by Subject|1|||
127940712|NCT02132754|460404733|FG017|Overall Study|Withdrawal by Subject|0|||
127940713|NCT02132754|460404734|FG018|Overall Study|Withdrawal by Subject|0|||
127940714|NCT02132754|460404735|FG019|Overall Study|Withdrawal by Subject|0|||
127940715|NCT02132754|460404736|FG020|Overall Study|Withdrawal by Subject|1|||
127940716|NCT02132754|460404737|FG021|Overall Study|Withdrawal by Subject|0|||
127940717|NCT02132754|460404738|FG022|Overall Study|Withdrawal by Subject|0|||
127940718|NCT02132754|460404739|FG023|Overall Study|Withdrawal by Subject|0|||
127940719|NCT02132754|460404740|FG024|Overall Study|Withdrawal by Subject|1|||
127940720|NCT02132754|460404741|FG025|Overall Study|Withdrawal by Subject|0|||
127940721|NCT02132754|460404742|FG026|Overall Study|Withdrawal by Subject|0|||
127940722|NCT02132754|460404743|FG027|Overall Study|Withdrawal by Subject|1|||
127940723|NCT02132754|460404744|FG028|Overall Study|Withdrawal by Subject|0|||
127940724|NCT02132754|460404745|FG029|Overall Study|Withdrawal by Subject|0|||
127940725|NCT02132754|460404746|FG030|Overall Study|Withdrawal by Subject|0|||
127940726|NCT02132754|460404747|FG031|Overall Study|Withdrawal by Subject|1|||
127940727|NCT02132754|460404748|FG032|Overall Study|Withdrawal by Subject|0|||
127940728|NCT02132754|460404749|FG033|Overall Study|Withdrawal by Subject|2|||
127940729|NCT03276780|460404752|FG000|Overall Study|Withdrawal by Subject|5|||
127940730|NCT03276780|460404753|FG001|Overall Study|Withdrawal by Subject|3|||
127940731|NCT03276780|460404752|FG000|Overall Study|Lost to Follow-up|3|||
127940732|NCT03276780|460404753|FG001|Overall Study|Lost to Follow-up|5|||
127940733|NCT03276780|460404752|FG000|Overall Study|Moved out of state|1|||
127940734|NCT03276780|460404753|FG001|Overall Study|Moved out of state|1|||
127940735|NCT03276780|460404752|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
127940736|NCT03276780|460404753|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
127940737|NCT03276780|460404752|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
127940738|NCT03276780|460404753|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
127940739|NCT02582866|460404755|FG000|Overall Study|Death|1|||
127940740|NCT02582866|460404755|FG000|Overall Study|Lack of Efficacy|2|||
127940741|NCT02582866|460404755|FG000|Overall Study|Lost to Follow-up|2|||
127940742|NCT02582866|460404755|FG000|Overall Study|Withdrawal by Subject|7|||
127940743|NCT02582866|460404755|FG000|Overall Study|Investigator decision|5|||
127940744|NCT02582866|460404755|FG000|Overall Study|Participant wants to get pregnant|1|||
127940745|NCT02582866|460404755|FG000|Overall Study|Pregnancy|2|||
127940746|NCT02582866|460404755|FG000|Overall Study|Sponsor decision|1|||
127940747|NCT02582866|460404755|FG000|Overall Study|Withdrawal due to personal reasons|1|||
127940748|NCT01193127|460404764|FG000|Randomized|Surgery Cancelled|0|||
127940749|NCT01193127|460404765|FG001|Randomized|Surgery Cancelled|0|||
127940750|NCT01193127|460404766|FG002|Randomized|Surgery Cancelled|0|||
127940751|NCT01193127|460404767|FG003|Randomized|Surgery Cancelled|1|||
127940752|NCT01193127|460404764|FG000|Treated|Withdrawal by Subject|0|||
127940753|NCT01193127|460404765|FG001|Treated|Withdrawal by Subject|0|||
127940754|NCT01193127|460404766|FG002|Treated|Withdrawal by Subject|0|||
127940755|NCT01193127|460404767|FG003|Treated|Withdrawal by Subject|1|||
127940756|NCT03246646|460404768|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
127940757|NCT03246646|460404769|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
127940758|NCT03246646|460404768|FG000|Overall Study|Withdrawal by Subject|3|||
127940759|NCT03246646|460404769|FG001|Overall Study|Withdrawal by Subject|0|||
127940760|NCT03246646|460404768|FG000|Overall Study|Lost to Follow-up|7|||
127940761|NCT03246646|460404769|FG001|Overall Study|Lost to Follow-up|0|||
127940762|NCT02352779|460404772|FG000|Overall Study|Personal Issues|1|||
127940763|NCT02352779|460404773|FG001|Overall Study|Personal Issues|1|||
127940764|NCT02352779|460404774|FG002|Overall Study|Personal Issues|0|||
127940765|NCT02352779|460404772|FG000|Overall Study|Too Many Forms|2|||
127940766|NCT02352779|460404773|FG001|Overall Study|Too Many Forms|0|||
127940767|NCT02352779|460404774|FG002|Overall Study|Too Many Forms|0|||
127940768|NCT02352779|460404772|FG000|Overall Study|Feeling Overwhelmed|1|||
127940769|NCT02352779|460404773|FG001|Overall Study|Feeling Overwhelmed|0|||
127940770|NCT02352779|460404774|FG002|Overall Study|Feeling Overwhelmed|0|||
127940771|NCT02352779|460404772|FG000|Overall Study|Disliked Intervention|1|||
127940772|NCT02352779|460404773|FG001|Overall Study|Disliked Intervention|0|||
127940773|NCT02352779|460404774|FG002|Overall Study|Disliked Intervention|0|||
127940774|NCT02352779|460404772|FG000|Overall Study|Changed Mind|1|||
127940775|NCT02352779|460404773|FG001|Overall Study|Changed Mind|0|||
127940776|NCT02352779|460404774|FG002|Overall Study|Changed Mind|0|||
127940777|NCT02352779|460404772|FG000|Overall Study|Study Related Symptoms|1|||
127940778|NCT02352779|460404773|FG001|Overall Study|Study Related Symptoms|0|||
127940779|NCT02352779|460404774|FG002|Overall Study|Study Related Symptoms|0|||
127940780|NCT02352779|460404772|FG000|Overall Study|Absence of Symptoms|1|||
127940781|NCT02352779|460404773|FG001|Overall Study|Absence of Symptoms|0|||
127940782|NCT02352779|460404774|FG002|Overall Study|Absence of Symptoms|0|||
127940783|NCT02352779|460404772|FG000|Overall Study|Other Medical Reason|0|||
127940784|NCT02352779|460404773|FG001|Overall Study|Other Medical Reason|0|||
127940785|NCT02352779|460404774|FG002|Overall Study|Other Medical Reason|1|||
127940786|NCT02352779|460404772|FG000|Overall Study|No Reason|0|||
127940787|NCT02352779|460404773|FG001|Overall Study|No Reason|0|||
127940788|NCT02352779|460404774|FG002|Overall Study|No Reason|1|||
127940789|NCT00871741|460404779|FG000|Overall Study|Premature study termination|9|||
127940790|NCT00871741|460404780|FG001|Overall Study|Premature study termination|7|||
127940791|NCT01565850|460404781|FG000|Overall Study|Adverse Event|0|||
127940792|NCT01565850|460404782|FG001|Overall Study|Adverse Event|1|||
127940793|NCT01565850|460404781|FG000|Overall Study|Lost to Follow-up|12|||
127940794|NCT01565850|460404782|FG001|Overall Study|Lost to Follow-up|4|||
127940795|NCT01565850|460404781|FG000|Overall Study|Investigator's Discretion|2|||
127940796|NCT01565850|460404782|FG001|Overall Study|Investigator's Discretion|1|||
127940797|NCT01565850|460404781|FG000|Overall Study|Participant noncompliance|2|||
127940798|NCT01565850|460404782|FG001|Overall Study|Participant noncompliance|0|||
127940799|NCT01565850|460404781|FG000|Overall Study|Withdrew Consent|4|||
127940800|NCT01565850|460404782|FG001|Overall Study|Withdrew Consent|2|||
127940801|NCT04941729|460407511|FG000|Overall Study|Death|0|||
127940802|NCT04941729|460407512|FG001|Overall Study|Death|1|||
127940803|NCT04941729|460407511|FG000|Overall Study|Study terminated by sponsor|11|||
127940804|NCT04941729|460407512|FG001|Overall Study|Study terminated by sponsor|10|||
127940805|NCT03845296|460407522|FG000|Overall Study|On Treatment|2|||
127940806|NCT03845296|460407523|FG001|Overall Study|On Treatment|1|||
127940807|NCT03845296|460407522|FG000|Overall Study|Adverse Event|4|||
127940808|NCT03845296|460407523|FG001|Overall Study|Adverse Event|11|||
127940809|NCT03845296|460407522|FG000|Overall Study|Refusal unrelated to adverse event|0|||
127940810|NCT03845296|460407523|FG001|Overall Study|Refusal unrelated to adverse event|1|||
127940811|NCT03845296|460407522|FG000|Overall Study|Progression/relapse|14|||
127940812|NCT03845296|460407523|FG001|Overall Study|Progression/relapse|18|||
127940813|NCT03845296|460407522|FG000|Overall Study|Death|4|||
127940814|NCT03845296|460407523|FG001|Overall Study|Death|0|||
127940815|NCT03845296|460407522|FG000|Overall Study|Other - not protocol specified|1|||
127940816|NCT03845296|460407523|FG001|Overall Study|Other - not protocol specified|3|||
127940817|NCT03611543|460407524|FG000|Overall Study|Withdrawal by Subject|4|||
127940818|NCT03611543|460407525|FG001|Overall Study|Withdrawal by Subject|4|||
127940819|NCT03611543|460407524|FG000|Overall Study|Physician Decision|1|||
127940820|NCT03611543|460407525|FG001|Overall Study|Physician Decision|1|||
127940821|NCT03611543|460407524|FG000|Overall Study|Protocol Violation|2|||
127940822|NCT03611543|460407525|FG001|Overall Study|Protocol Violation|2|||
127940823|NCT03611543|460407524|FG000|Overall Study|Device failure|2|||
127940824|NCT03611543|460407525|FG001|Overall Study|Device failure|2|||
127940825|NCT03611543|460407524|FG000|Overall Study|Missing information|5|||
127940826|NCT03611543|460407525|FG001|Overall Study|Missing information|5|||
127940827|NCT02799095|460407526|FG000|Part A|Adverse Event|1|||
127940828|NCT02799095|460407527|FG001|Part A|Adverse Event|0|||
127940829|NCT02799095|460407528|FG002|Part A|Adverse Event|1|||
127940830|NCT02799095|460407529|FG003|Part A|Adverse Event|4|||
127940831|NCT02799095|460407530|FG004|Part A|Adverse Event|1|||
127940832|NCT02799095|460407531|FG005|Part A|Adverse Event|0|||
127940833|NCT02799095|460407532|FG006|Part A|Adverse Event|0|||
127940834|NCT02799095|460407533|FG007|Part A|Adverse Event|0|||
127940835|NCT02799095|460407534|FG008|Part A|Adverse Event|0|||
127940836|NCT02799095|460407535|FG009|Part A|Adverse Event|0|||
127940837|NCT02799095|460407536|FG010|Part A|Adverse Event|0|||
127940838|NCT02799095|460407537|FG011|Part A|Adverse Event|0|||
127940839|NCT02799095|460407538|FG012|Part A|Adverse Event|0|||
127940840|NCT02799095|460407539|FG013|Part A|Adverse Event|0|||
127940841|NCT02799095|460407540|FG014|Part A|Adverse Event|0|||
127940842|NCT02799095|460407541|FG015|Part A|Adverse Event|0|||
127940843|NCT02799095|460407542|FG016|Part A|Adverse Event|0|||
127940844|NCT02799095|460407526|FG000|Part A|Death|0|||
127940845|NCT02799095|460407527|FG001|Part A|Death|0|||
127940846|NCT02799095|460407528|FG002|Part A|Death|0|||
127940847|NCT02799095|460407529|FG003|Part A|Death|0|||
127940848|NCT02799095|460407530|FG004|Part A|Death|0|||
127940849|NCT02799095|460407531|FG005|Part A|Death|0|||
127940850|NCT02799095|460407532|FG006|Part A|Death|3|||
127940851|NCT02799095|460407533|FG007|Part A|Death|0|||
127940852|NCT02799095|460407534|FG008|Part A|Death|0|||
127940853|NCT02799095|460407535|FG009|Part A|Death|0|||
127940854|NCT02799095|460407536|FG010|Part A|Death|0|||
127940855|NCT02799095|460407537|FG011|Part A|Death|0|||
127940856|NCT02799095|460407538|FG012|Part A|Death|0|||
127940857|NCT02799095|460407539|FG013|Part A|Death|0|||
127940858|NCT02799095|460407540|FG014|Part A|Death|0|||
127940859|NCT02799095|460407541|FG015|Part A|Death|0|||
127940860|NCT02799095|460407542|FG016|Part A|Death|0|||
127940861|NCT02799095|460407526|FG000|Part A|Lost to Follow-up|0|||
127940862|NCT02799095|460407527|FG001|Part A|Lost to Follow-up|1|||
127940863|NCT02799095|460407528|FG002|Part A|Lost to Follow-up|0|||
127940864|NCT02799095|460407529|FG003|Part A|Lost to Follow-up|0|||
127940865|NCT02799095|460407530|FG004|Part A|Lost to Follow-up|0|||
127940866|NCT02799095|460407531|FG005|Part A|Lost to Follow-up|0|||
127940867|NCT02799095|460407532|FG006|Part A|Lost to Follow-up|1|||
127940868|NCT02799095|460407533|FG007|Part A|Lost to Follow-up|0|||
127940869|NCT02799095|460407534|FG008|Part A|Lost to Follow-up|0|||
127940870|NCT02799095|460407535|FG009|Part A|Lost to Follow-up|0|||
127940871|NCT02799095|460407536|FG010|Part A|Lost to Follow-up|0|||
127940872|NCT02799095|460407537|FG011|Part A|Lost to Follow-up|0|||
127940873|NCT02799095|460407538|FG012|Part A|Lost to Follow-up|0|||
127940874|NCT02799095|460407539|FG013|Part A|Lost to Follow-up|0|||
127940875|NCT02799095|460407540|FG014|Part A|Lost to Follow-up|0|||
127940876|NCT02799095|460407541|FG015|Part A|Lost to Follow-up|0|||
127940877|NCT02799095|460407542|FG016|Part A|Lost to Follow-up|0|||
127940878|NCT02799095|460407526|FG000|Part A|Progressive Disease|3|||
127940879|NCT02799095|460407527|FG001|Part A|Progressive Disease|3|||
127940880|NCT02799095|460407528|FG002|Part A|Progressive Disease|3|||
127940881|NCT02799095|460407529|FG003|Part A|Progressive Disease|2|||
127940882|NCT02799095|460407530|FG004|Part A|Progressive Disease|2|||
127940883|NCT02799095|460407531|FG005|Part A|Progressive Disease|0|||
127940884|NCT02799095|460407532|FG006|Part A|Progressive Disease|0|||
127940885|NCT02799095|460407533|FG007|Part A|Progressive Disease|0|||
127940886|NCT02799095|460407534|FG008|Part A|Progressive Disease|0|||
127940887|NCT02799095|460407535|FG009|Part A|Progressive Disease|0|||
127940888|NCT02799095|460407536|FG010|Part A|Progressive Disease|0|||
127940889|NCT02799095|460407537|FG011|Part A|Progressive Disease|0|||
127940890|NCT02799095|460407538|FG012|Part A|Progressive Disease|0|||
127940891|NCT02799095|460407539|FG013|Part A|Progressive Disease|0|||
127940892|NCT02799095|460407540|FG014|Part A|Progressive Disease|0|||
127940893|NCT02799095|460407541|FG015|Part A|Progressive Disease|0|||
127940894|NCT02799095|460407542|FG016|Part A|Progressive Disease|0|||
127940895|NCT02799095|460407526|FG000|Part A|Clinical Progression|1|||
127940896|NCT02799095|460407527|FG001|Part A|Clinical Progression|0|||
127940897|NCT02799095|460407528|FG002|Part A|Clinical Progression|2|||
127940898|NCT02799095|460407529|FG003|Part A|Clinical Progression|1|||
127940899|NCT02799095|460407530|FG004|Part A|Clinical Progression|5|||
127940900|NCT02799095|460407531|FG005|Part A|Clinical Progression|0|||
127940901|NCT02799095|460407532|FG006|Part A|Clinical Progression|0|||
127940902|NCT02799095|460407533|FG007|Part A|Clinical Progression|0|||
127940903|NCT02799095|460407534|FG008|Part A|Clinical Progression|0|||
127940904|NCT02799095|460407535|FG009|Part A|Clinical Progression|0|||
127940905|NCT02799095|460407536|FG010|Part A|Clinical Progression|0|||
127940906|NCT02799095|460407537|FG011|Part A|Clinical Progression|0|||
127940907|NCT02799095|460407538|FG012|Part A|Clinical Progression|0|||
127940908|NCT02799095|460407539|FG013|Part A|Clinical Progression|0|||
127940909|NCT02799095|460407540|FG014|Part A|Clinical Progression|0|||
127940910|NCT02799095|460407541|FG015|Part A|Clinical Progression|0|||
127940911|NCT02799095|460407542|FG016|Part A|Clinical Progression|0|||
127940912|NCT02799095|460407526|FG000|Part A|Protocol Deviation|0|||
127940913|NCT02799095|460407527|FG001|Part A|Protocol Deviation|0|||
127940914|NCT02799095|460407528|FG002|Part A|Protocol Deviation|1|||
127940915|NCT02799095|460407529|FG003|Part A|Protocol Deviation|0|||
127940916|NCT02799095|460407530|FG004|Part A|Protocol Deviation|0|||
127940917|NCT02799095|460407531|FG005|Part A|Protocol Deviation|0|||
127940918|NCT02799095|460407532|FG006|Part A|Protocol Deviation|0|||
127940919|NCT02799095|460407533|FG007|Part A|Protocol Deviation|0|||
127940920|NCT02799095|460407534|FG008|Part A|Protocol Deviation|0|||
127940921|NCT02799095|460407535|FG009|Part A|Protocol Deviation|0|||
127940922|NCT02799095|460407536|FG010|Part A|Protocol Deviation|0|||
127940923|NCT02799095|460407537|FG011|Part A|Protocol Deviation|0|||
127940924|NCT02799095|460407538|FG012|Part A|Protocol Deviation|0|||
127940925|NCT02799095|460407539|FG013|Part A|Protocol Deviation|0|||
127940926|NCT02799095|460407540|FG014|Part A|Protocol Deviation|0|||
127940927|NCT02799095|460407541|FG015|Part A|Protocol Deviation|0|||
127940928|NCT02799095|460407542|FG016|Part A|Protocol Deviation|0|||
127940929|NCT02799095|460407526|FG000|Part A|Withdrawal by Subject|0|||
127940930|NCT02799095|460407527|FG001|Part A|Withdrawal by Subject|0|||
127940931|NCT02799095|460407528|FG002|Part A|Withdrawal by Subject|0|||
127940932|NCT02799095|460407529|FG003|Part A|Withdrawal by Subject|1|||
127940933|NCT02799095|460407530|FG004|Part A|Withdrawal by Subject|3|||
127940934|NCT02799095|460407531|FG005|Part A|Withdrawal by Subject|1|||
127940935|NCT02799095|460407532|FG006|Part A|Withdrawal by Subject|1|||
127940936|NCT02799095|460407533|FG007|Part A|Withdrawal by Subject|0|||
127940937|NCT02799095|460407534|FG008|Part A|Withdrawal by Subject|0|||
127940938|NCT02799095|460407535|FG009|Part A|Withdrawal by Subject|0|||
127940939|NCT02799095|460407536|FG010|Part A|Withdrawal by Subject|0|||
127940940|NCT02799095|460407537|FG011|Part A|Withdrawal by Subject|0|||
127940941|NCT02799095|460407538|FG012|Part A|Withdrawal by Subject|0|||
127940942|NCT02799095|460407539|FG013|Part A|Withdrawal by Subject|0|||
127940943|NCT02799095|460407540|FG014|Part A|Withdrawal by Subject|0|||
127940944|NCT02799095|460407541|FG015|Part A|Withdrawal by Subject|0|||
127940945|NCT02799095|460407542|FG016|Part A|Withdrawal by Subject|0|||
127940946|NCT02799095|460407526|FG000|Part A|Rolled Over to Part C, Cohort 4|0|||
127940947|NCT02799095|460407527|FG001|Part A|Rolled Over to Part C, Cohort 4|0|||
127940948|NCT02799095|460407528|FG002|Part A|Rolled Over to Part C, Cohort 4|0|||
127940949|NCT02799095|460407529|FG003|Part A|Rolled Over to Part C, Cohort 4|0|||
127940950|NCT02799095|460407530|FG004|Part A|Rolled Over to Part C, Cohort 4|1|||
127940951|NCT02799095|460407531|FG005|Part A|Rolled Over to Part C, Cohort 4|2|||
127940952|NCT02799095|460407532|FG006|Part A|Rolled Over to Part C, Cohort 4|2|||
127940953|NCT02799095|460407533|FG007|Part A|Rolled Over to Part C, Cohort 4|0|||
127940954|NCT02799095|460407534|FG008|Part A|Rolled Over to Part C, Cohort 4|0|||
127940955|NCT02799095|460407535|FG009|Part A|Rolled Over to Part C, Cohort 4|0|||
127940956|NCT02799095|460407536|FG010|Part A|Rolled Over to Part C, Cohort 4|0|||
127940957|NCT02799095|460407537|FG011|Part A|Rolled Over to Part C, Cohort 4|0|||
127940958|NCT02799095|460407538|FG012|Part A|Rolled Over to Part C, Cohort 4|0|||
127940959|NCT02799095|460407539|FG013|Part A|Rolled Over to Part C, Cohort 4|0|||
127940960|NCT02799095|460407540|FG014|Part A|Rolled Over to Part C, Cohort 4|0|||
127940961|NCT02799095|460407541|FG015|Part A|Rolled Over to Part C, Cohort 4|0|||
127940962|NCT02799095|460407542|FG016|Part A|Rolled Over to Part C, Cohort 4|0|||
127940963|NCT02799095|460407526|FG000|Part B|Death|0|||
127940964|NCT02799095|460407527|FG001|Part B|Death|0|||
127940965|NCT02799095|460407528|FG002|Part B|Death|0|||
127940966|NCT02799095|460407529|FG003|Part B|Death|0|||
127940967|NCT02799095|460407530|FG004|Part B|Death|0|||
127940968|NCT02799095|460407531|FG005|Part B|Death|0|||
127940969|NCT02799095|460407532|FG006|Part B|Death|0|||
127940970|NCT02799095|460407533|FG007|Part B|Death|7|||
127940971|NCT02799095|460407534|FG008|Part B|Death|7|||
127940972|NCT02799095|460407535|FG009|Part B|Death|0|||
127940973|NCT02799095|460407536|FG010|Part B|Death|0|||
127940974|NCT02799095|460407537|FG011|Part B|Death|0|||
127940975|NCT02799095|460407538|FG012|Part B|Death|0|||
127940976|NCT02799095|460407539|FG013|Part B|Death|0|||
127940977|NCT02799095|460407540|FG014|Part B|Death|0|||
127940978|NCT02799095|460407541|FG015|Part B|Death|0|||
127940979|NCT02799095|460407542|FG016|Part B|Death|0|||
127940980|NCT02799095|460407526|FG000|Part B|Progressive Disease|0|||
127940981|NCT02799095|460407527|FG001|Part B|Progressive Disease|0|||
127940982|NCT02799095|460407528|FG002|Part B|Progressive Disease|0|||
127940983|NCT02799095|460407529|FG003|Part B|Progressive Disease|0|||
127940984|NCT02799095|460407530|FG004|Part B|Progressive Disease|0|||
127940985|NCT02799095|460407531|FG005|Part B|Progressive Disease|0|||
127940986|NCT02799095|460407532|FG006|Part B|Progressive Disease|0|||
127940987|NCT02799095|460407533|FG007|Part B|Progressive Disease|1|||
127940988|NCT02799095|460407534|FG008|Part B|Progressive Disease|0|||
127940989|NCT02799095|460407535|FG009|Part B|Progressive Disease|0|||
127940990|NCT02799095|460407536|FG010|Part B|Progressive Disease|0|||
127940991|NCT02799095|460407537|FG011|Part B|Progressive Disease|0|||
127940992|NCT02799095|460407538|FG012|Part B|Progressive Disease|0|||
127940993|NCT02799095|460407539|FG013|Part B|Progressive Disease|0|||
127940994|NCT02799095|460407540|FG014|Part B|Progressive Disease|0|||
127940995|NCT02799095|460407541|FG015|Part B|Progressive Disease|0|||
127940996|NCT02799095|460407542|FG016|Part B|Progressive Disease|0|||
127940997|NCT02799095|460407526|FG000|Part B|Withdrawal by Subject|0|||
127940998|NCT02799095|460407527|FG001|Part B|Withdrawal by Subject|0|||
127940999|NCT02799095|460407528|FG002|Part B|Withdrawal by Subject|0|||
127941000|NCT02799095|460407529|FG003|Part B|Withdrawal by Subject|0|||
127941001|NCT02799095|460407530|FG004|Part B|Withdrawal by Subject|0|||
127941002|NCT02799095|460407531|FG005|Part B|Withdrawal by Subject|0|||
127941003|NCT02799095|460407532|FG006|Part B|Withdrawal by Subject|0|||
127941004|NCT02799095|460407533|FG007|Part B|Withdrawal by Subject|10|||
127941005|NCT02799095|460407534|FG008|Part B|Withdrawal by Subject|7|||
127941006|NCT02799095|460407535|FG009|Part B|Withdrawal by Subject|0|||
127941007|NCT02799095|460407536|FG010|Part B|Withdrawal by Subject|0|||
127941008|NCT02799095|460407537|FG011|Part B|Withdrawal by Subject|0|||
127941009|NCT02799095|460407538|FG012|Part B|Withdrawal by Subject|0|||
127941010|NCT02799095|460407539|FG013|Part B|Withdrawal by Subject|0|||
127941011|NCT02799095|460407540|FG014|Part B|Withdrawal by Subject|0|||
127941012|NCT02799095|460407541|FG015|Part B|Withdrawal by Subject|0|||
127941013|NCT02799095|460407542|FG016|Part B|Withdrawal by Subject|0|||
127941014|NCT02799095|460407526|FG000|Part B|Rolled Over to Part C, Cohort 4|0|||
127941015|NCT02799095|460407527|FG001|Part B|Rolled Over to Part C, Cohort 4|0|||
127941016|NCT02799095|460407528|FG002|Part B|Rolled Over to Part C, Cohort 4|0|||
127941017|NCT02799095|460407529|FG003|Part B|Rolled Over to Part C, Cohort 4|0|||
127941018|NCT02799095|460407530|FG004|Part B|Rolled Over to Part C, Cohort 4|0|||
127941019|NCT02799095|460407531|FG005|Part B|Rolled Over to Part C, Cohort 4|0|||
127941020|NCT02799095|460407532|FG006|Part B|Rolled Over to Part C, Cohort 4|0|||
127941021|NCT02799095|460407533|FG007|Part B|Rolled Over to Part C, Cohort 4|26|||
127941022|NCT02799095|460407534|FG008|Part B|Rolled Over to Part C, Cohort 4|12|||
127941023|NCT02799095|460407535|FG009|Part B|Rolled Over to Part C, Cohort 4|0|||
127941024|NCT02799095|460407536|FG010|Part B|Rolled Over to Part C, Cohort 4|0|||
127941025|NCT02799095|460407537|FG011|Part B|Rolled Over to Part C, Cohort 4|0|||
127941026|NCT02799095|460407538|FG012|Part B|Rolled Over to Part C, Cohort 4|0|||
127941027|NCT02799095|460407539|FG013|Part B|Rolled Over to Part C, Cohort 4|0|||
127941028|NCT02799095|460407540|FG014|Part B|Rolled Over to Part C, Cohort 4|0|||
127941029|NCT02799095|460407541|FG015|Part B|Rolled Over to Part C, Cohort 4|0|||
127941030|NCT02799095|460407542|FG016|Part B|Rolled Over to Part C, Cohort 4|0|||
127941031|NCT02799095|460407526|FG000|Part C|Adverse Event|0|||
127941032|NCT02799095|460407527|FG001|Part C|Adverse Event|0|||
127941033|NCT02799095|460407528|FG002|Part C|Adverse Event|0|||
127941034|NCT02799095|460407529|FG003|Part C|Adverse Event|0|||
127941035|NCT02799095|460407530|FG004|Part C|Adverse Event|0|||
127941036|NCT02799095|460407531|FG005|Part C|Adverse Event|0|||
127941037|NCT02799095|460407532|FG006|Part C|Adverse Event|0|||
127941038|NCT02799095|460407533|FG007|Part C|Adverse Event|0|||
127941039|NCT02799095|460407534|FG008|Part C|Adverse Event|0|||
127941040|NCT02799095|460407535|FG009|Part C|Adverse Event|0|||
127941041|NCT02799095|460407536|FG010|Part C|Adverse Event|3|||
127941042|NCT02799095|460407537|FG011|Part C|Adverse Event|1|||
127941043|NCT02799095|460407538|FG012|Part C|Adverse Event|0|||
127941044|NCT02799095|460407539|FG013|Part C|Adverse Event|1|||
127941045|NCT02799095|460407540|FG014|Part C|Adverse Event|0|||
127941046|NCT02799095|460407541|FG015|Part C|Adverse Event|0|||
127941047|NCT02799095|460407542|FG016|Part C|Adverse Event|0|||
127941048|NCT02799095|460407526|FG000|Part C|Death|0|||
127941049|NCT02799095|460407527|FG001|Part C|Death|0|||
127941050|NCT02799095|460407528|FG002|Part C|Death|0|||
127941051|NCT02799095|460407529|FG003|Part C|Death|0|||
127941052|NCT02799095|460407530|FG004|Part C|Death|0|||
127941053|NCT02799095|460407531|FG005|Part C|Death|0|||
127941054|NCT02799095|460407532|FG006|Part C|Death|0|||
127941055|NCT02799095|460407533|FG007|Part C|Death|0|||
127941056|NCT02799095|460407534|FG008|Part C|Death|0|||
127941057|NCT02799095|460407535|FG009|Part C|Death|0|||
127941058|NCT02799095|460407536|FG010|Part C|Death|7|||
127941059|NCT02799095|460407537|FG011|Part C|Death|5|||
127941060|NCT02799095|460407538|FG012|Part C|Death|6|||
127941061|NCT02799095|460407539|FG013|Part C|Death|8|||
127941062|NCT02799095|460407540|FG014|Part C|Death|1|||
127941063|NCT02799095|460407541|FG015|Part C|Death|8|||
127941064|NCT02799095|460407542|FG016|Part C|Death|1|||
127941065|NCT02799095|460407526|FG000|Part C|Lost to Follow-up|0|||
127941066|NCT02799095|460407527|FG001|Part C|Lost to Follow-up|0|||
127941067|NCT02799095|460407528|FG002|Part C|Lost to Follow-up|0|||
127941068|NCT02799095|460407529|FG003|Part C|Lost to Follow-up|0|||
127941069|NCT02799095|460407530|FG004|Part C|Lost to Follow-up|0|||
127941070|NCT02799095|460407531|FG005|Part C|Lost to Follow-up|0|||
127941071|NCT02799095|460407532|FG006|Part C|Lost to Follow-up|0|||
127941072|NCT02799095|460407533|FG007|Part C|Lost to Follow-up|0|||
127941073|NCT02799095|460407534|FG008|Part C|Lost to Follow-up|0|||
127941074|NCT02799095|460407535|FG009|Part C|Lost to Follow-up|0|||
127941075|NCT02799095|460407536|FG010|Part C|Lost to Follow-up|1|||
127941076|NCT02799095|460407537|FG011|Part C|Lost to Follow-up|1|||
127941077|NCT02799095|460407538|FG012|Part C|Lost to Follow-up|1|||
127941078|NCT02799095|460407539|FG013|Part C|Lost to Follow-up|3|||
127941079|NCT02799095|460407540|FG014|Part C|Lost to Follow-up|0|||
127941080|NCT02799095|460407541|FG015|Part C|Lost to Follow-up|0|||
127941081|NCT02799095|460407542|FG016|Part C|Lost to Follow-up|0|||
127941082|NCT02799095|460407526|FG000|Part C|Progressive Disease|0|||
127941083|NCT02799095|460407527|FG001|Part C|Progressive Disease|0|||
127941084|NCT02799095|460407528|FG002|Part C|Progressive Disease|0|||
127941085|NCT02799095|460407529|FG003|Part C|Progressive Disease|0|||
127941086|NCT02799095|460407530|FG004|Part C|Progressive Disease|0|||
127941087|NCT02799095|460407531|FG005|Part C|Progressive Disease|0|||
127941088|NCT02799095|460407532|FG006|Part C|Progressive Disease|0|||
127941089|NCT02799095|460407533|FG007|Part C|Progressive Disease|0|||
127941090|NCT02799095|460407534|FG008|Part C|Progressive Disease|0|||
127941091|NCT02799095|460407535|FG009|Part C|Progressive Disease|2|||
127941092|NCT02799095|460407536|FG010|Part C|Progressive Disease|13|||
127941093|NCT02799095|460407537|FG011|Part C|Progressive Disease|2|||
127941094|NCT02799095|460407538|FG012|Part C|Progressive Disease|0|||
127941095|NCT02799095|460407539|FG013|Part C|Progressive Disease|1|||
127941096|NCT02799095|460407540|FG014|Part C|Progressive Disease|0|||
127941097|NCT02799095|460407541|FG015|Part C|Progressive Disease|0|||
127941098|NCT02799095|460407542|FG016|Part C|Progressive Disease|0|||
127941099|NCT02799095|460407526|FG000|Part C|Clinical Progression|0|||
127941100|NCT02799095|460407527|FG001|Part C|Clinical Progression|0|||
127941101|NCT02799095|460407528|FG002|Part C|Clinical Progression|0|||
127941102|NCT02799095|460407529|FG003|Part C|Clinical Progression|0|||
127941103|NCT02799095|460407530|FG004|Part C|Clinical Progression|0|||
127941104|NCT02799095|460407531|FG005|Part C|Clinical Progression|0|||
127941105|NCT02799095|460407532|FG006|Part C|Clinical Progression|0|||
127941106|NCT02799095|460407533|FG007|Part C|Clinical Progression|0|||
127941107|NCT02799095|460407534|FG008|Part C|Clinical Progression|0|||
127941108|NCT02799095|460407535|FG009|Part C|Clinical Progression|1|||
127941109|NCT02799095|460407536|FG010|Part C|Clinical Progression|3|||
127941110|NCT02799095|460407537|FG011|Part C|Clinical Progression|0|||
127941111|NCT02799095|460407538|FG012|Part C|Clinical Progression|0|||
127941112|NCT02799095|460407539|FG013|Part C|Clinical Progression|1|||
127941113|NCT02799095|460407540|FG014|Part C|Clinical Progression|0|||
127941114|NCT02799095|460407541|FG015|Part C|Clinical Progression|0|||
127941115|NCT02799095|460407542|FG016|Part C|Clinical Progression|0|||
127941116|NCT02799095|460407526|FG000|Part C|Withdrawal by Subject|0|||
127941117|NCT02799095|460407527|FG001|Part C|Withdrawal by Subject|0|||
127941118|NCT02799095|460407528|FG002|Part C|Withdrawal by Subject|0|||
127941119|NCT02799095|460407529|FG003|Part C|Withdrawal by Subject|0|||
127941120|NCT02799095|460407530|FG004|Part C|Withdrawal by Subject|0|||
127941121|NCT02799095|460407531|FG005|Part C|Withdrawal by Subject|0|||
127941122|NCT02799095|460407532|FG006|Part C|Withdrawal by Subject|0|||
127941123|NCT02799095|460407533|FG007|Part C|Withdrawal by Subject|0|||
127941124|NCT02799095|460407534|FG008|Part C|Withdrawal by Subject|0|||
127941125|NCT02799095|460407535|FG009|Part C|Withdrawal by Subject|0|||
127941126|NCT02799095|460407536|FG010|Part C|Withdrawal by Subject|13|||
127941127|NCT02799095|460407537|FG011|Part C|Withdrawal by Subject|15|||
127941128|NCT02799095|460407538|FG012|Part C|Withdrawal by Subject|13|||
127941129|NCT02799095|460407539|FG013|Part C|Withdrawal by Subject|21|||
127941130|NCT02799095|460407540|FG014|Part C|Withdrawal by Subject|0|||
127941131|NCT02799095|460407541|FG015|Part C|Withdrawal by Subject|12|||
127941132|NCT02799095|460407542|FG016|Part C|Withdrawal by Subject|1|||
127941133|NCT02799095|460407526|FG000|Part C|Physician Decision|0|||
127941134|NCT02799095|460407527|FG001|Part C|Physician Decision|0|||
127941135|NCT02799095|460407528|FG002|Part C|Physician Decision|0|||
127941136|NCT02799095|460407529|FG003|Part C|Physician Decision|0|||
127941137|NCT02799095|460407530|FG004|Part C|Physician Decision|0|||
127941138|NCT02799095|460407531|FG005|Part C|Physician Decision|0|||
127941139|NCT02799095|460407532|FG006|Part C|Physician Decision|0|||
127941140|NCT02799095|460407533|FG007|Part C|Physician Decision|0|||
127941141|NCT02799095|460407534|FG008|Part C|Physician Decision|0|||
127941142|NCT02799095|460407535|FG009|Part C|Physician Decision|0|||
127941143|NCT02799095|460407536|FG010|Part C|Physician Decision|1|||
127941144|NCT02799095|460407537|FG011|Part C|Physician Decision|0|||
127941145|NCT02799095|460407538|FG012|Part C|Physician Decision|0|||
127941146|NCT02799095|460407539|FG013|Part C|Physician Decision|0|||
127941147|NCT02799095|460407540|FG014|Part C|Physician Decision|0|||
127941148|NCT02799095|460407541|FG015|Part C|Physician Decision|0|||
127941149|NCT02799095|460407542|FG016|Part C|Physician Decision|0|||
127941150|NCT02799095|460407526|FG000|Part C|Other|0|||
127941151|NCT02799095|460407527|FG001|Part C|Other|0|||
127941152|NCT02799095|460407528|FG002|Part C|Other|0|||
127941153|NCT02799095|460407529|FG003|Part C|Other|0|||
127941154|NCT02799095|460407530|FG004|Part C|Other|0|||
127941155|NCT02799095|460407531|FG005|Part C|Other|0|||
127941156|NCT02799095|460407532|FG006|Part C|Other|0|||
127941157|NCT02799095|460407533|FG007|Part C|Other|0|||
127941158|NCT02799095|460407534|FG008|Part C|Other|0|||
127941159|NCT02799095|460407535|FG009|Part C|Other|0|||
127941160|NCT02799095|460407536|FG010|Part C|Other|0|||
127941161|NCT02799095|460407537|FG011|Part C|Other|2|||
127941162|NCT02799095|460407538|FG012|Part C|Other|2|||
127941163|NCT02799095|460407539|FG013|Part C|Other|0|||
127941164|NCT02799095|460407540|FG014|Part C|Other|0|||
127941165|NCT02799095|460407541|FG015|Part C|Other|0|||
127941166|NCT02799095|460407542|FG016|Part C|Other|0|||
127941167|NCT03283319|460407543|FG000|Overall Study|Lost to Follow-up|5|||
127941168|NCT03283319|460407544|FG001|Overall Study|Lost to Follow-up|4|||
127941169|NCT03283319|460407545|FG002|Overall Study|Lost to Follow-up|5|||
127941170|NCT03283319|460407546|FG003|Overall Study|Lost to Follow-up|5|||
127941171|NCT03283319|460407547|FG004|Overall Study|Lost to Follow-up|4|||
127941172|NCT03283319|460407548|FG005|Overall Study|Lost to Follow-up|3|||
127941173|NCT03283319|460407543|FG000|Overall Study|Withdrawal by Subject|2|||
127941174|NCT03283319|460407544|FG001|Overall Study|Withdrawal by Subject|2|||
127941175|NCT03283319|460407545|FG002|Overall Study|Withdrawal by Subject|2|||
127941176|NCT03283319|460407546|FG003|Overall Study|Withdrawal by Subject|1|||
127941177|NCT03283319|460407547|FG004|Overall Study|Withdrawal by Subject|0|||
127941178|NCT03283319|460407548|FG005|Overall Study|Withdrawal by Subject|1|||
127941179|NCT03283319|460407543|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
127941180|NCT03283319|460407544|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
127941181|NCT03283319|460407545|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
127941182|NCT03283319|460407546|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
127941183|NCT03283319|460407547|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
127941184|NCT03283319|460407548|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
127941185|NCT00721630|460407549|FG000|Overall Study|Participant found to be ineligible|1|||
127941186|NCT03186781|460407550|FG000|Overall Study|Lost to Follow-up|0|||
127941187|NCT03186781|460407551|FG001|Overall Study|Lost to Follow-up|0|||
127941188|NCT03186781|460407552|FG002|Overall Study|Lost to Follow-up|1|||
127941189|NCT03186781|460407553|FG003|Overall Study|Lost to Follow-up|0|||
127941190|NCT03186781|460407554|FG004|Overall Study|Lost to Follow-up|1|||
127941191|NCT03186781|460407555|FG005|Overall Study|Lost to Follow-up|0|||
127941192|NCT03186781|460407550|FG000|Overall Study|Moved from Area|0|||
127941193|NCT03186781|460407551|FG001|Overall Study|Moved from Area|0|||
127941194|NCT03186781|460407552|FG002|Overall Study|Moved from Area|0|||
127941195|NCT03186781|460407553|FG003|Overall Study|Moved from Area|0|||
127941196|NCT03186781|460407554|FG004|Overall Study|Moved from Area|1|||
127941197|NCT03186781|460407555|FG005|Overall Study|Moved from Area|0|||
127941198|NCT03186781|460407550|FG000|Overall Study|Withdrawal by Subject|0|||
127941199|NCT03186781|460407551|FG001|Overall Study|Withdrawal by Subject|0|||
127941200|NCT03186781|460407552|FG002|Overall Study|Withdrawal by Subject|0|||
127941201|NCT03186781|460407553|FG003|Overall Study|Withdrawal by Subject|0|||
127941202|NCT03186781|460407554|FG004|Overall Study|Withdrawal by Subject|1|||
127941203|NCT03186781|460407555|FG005|Overall Study|Withdrawal by Subject|0|||
127941204|NCT00792935|460407556|FG000|Overall Study|Adverse Event|2|||
127941205|NCT00792935|460407557|FG001|Overall Study|Adverse Event|1|||
127941206|NCT00792935|460407556|FG000|Overall Study|Lost to Follow-up|0|||
127941207|NCT00792935|460407557|FG001|Overall Study|Lost to Follow-up|1|||
127941208|NCT00792935|460407556|FG000|Overall Study|Protocol Violation|2|||
127941209|NCT00792935|460407557|FG001|Overall Study|Protocol Violation|0|||
127941210|NCT00792935|460407556|FG000|Overall Study|Withdrawal by Subject|0|||
127941211|NCT00792935|460407557|FG001|Overall Study|Withdrawal by Subject|1|||
127941212|NCT04663295|460407558|FG000|Run-in Period|Withdrawal by Subject|3|||
127941213|NCT04663295|460407558|FG000|Overall Study Period|Pregnancy|1|||
127941214|NCT04663295|460407558|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
127941215|NCT00631657|460407561|FG000|6-Month Treatment Period|Adverse Event|47|||
127941216|NCT00631657|460407562|FG001|6-Month Treatment Period|Adverse Event|0|||
127941217|NCT00631657|460407563|FG002|6-Month Treatment Period|Adverse Event|7|||
127941218|NCT00631657|460407561|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
127941219|NCT00631657|460407562|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
127941220|NCT00631657|460407563|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
127941221|NCT00631657|460407561|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
127941222|NCT00631657|460407562|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
127941223|NCT00631657|460407563|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
127941224|NCT00631657|460407561|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
127941225|NCT00631657|460407562|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
127941226|NCT00631657|460407563|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
127941227|NCT00631657|460407561|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
127941228|NCT00631657|460407562|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
127941229|NCT00631657|460407563|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
127941230|NCT00631657|460407561|FG000|6-Month Treatment Period|Other|16|||
127941231|NCT00631657|460407562|FG001|6-Month Treatment Period|Other|0|||
127941232|NCT00631657|460407563|FG002|6-Month Treatment Period|Other|4|||
127941233|NCT00631657|460407561|FG000|6-Month Treatment Period|Not Treated|2|||
127941234|NCT00631657|460407562|FG001|6-Month Treatment Period|Not Treated|0|||
127941235|NCT00631657|460407563|FG002|6-Month Treatment Period|Not Treated|1|||
127941236|NCT00631657|460407561|FG000|7-Day Discontinuation Period|Not Treated|1|||
127941237|NCT00631657|460407562|FG001|7-Day Discontinuation Period|Not Treated|1|||
127941238|NCT00631657|460407563|FG002|7-Day Discontinuation Period|Not Treated|1|||
127941239|NCT00631657|460407561|FG000|7-Day Discontinuation Period|Other|1|||
127941240|NCT00631657|460407562|FG001|7-Day Discontinuation Period|Other|0|||
127941241|NCT00631657|460407563|FG002|7-Day Discontinuation Period|Other|0|||
127941242|NCT00663026|460407564|FG000|Overall Study|Lost to Follow-up|1|||
127941243|NCT00663026|460407565|FG001|Overall Study|Lost to Follow-up|0|||
127941244|NCT00663026|460407566|FG002|Overall Study|Lost to Follow-up|0|||
127941245|NCT00663026|460407564|FG000|Overall Study|Other|1|||
127941246|NCT00663026|460407565|FG001|Overall Study|Other|2|||
127941247|NCT00663026|460407566|FG002|Overall Study|Other|0|||
127941248|NCT00663026|460407564|FG000|Overall Study|Adverse Event|0|||
127941249|NCT00663026|460407565|FG001|Overall Study|Adverse Event|2|||
127941250|NCT00663026|460407566|FG002|Overall Study|Adverse Event|3|||
127941251|NCT00663026|460407564|FG000|Overall Study|Caregiver Request|0|||
127941252|NCT00663026|460407565|FG001|Overall Study|Caregiver Request|2|||
127941253|NCT00663026|460407566|FG002|Overall Study|Caregiver Request|0|||
127941254|NCT00663026|460407564|FG000|Overall Study|Withdrawal by Subject|0|||
127941255|NCT00663026|460407565|FG001|Overall Study|Withdrawal by Subject|0|||
127941256|NCT00663026|460407566|FG002|Overall Study|Withdrawal by Subject|1|||
127941257|NCT01570686|460407567|FG000|Overall Study|Abnormal test procedure result(s)|1|||
127941258|NCT01570686|460407568|FG001|Overall Study|Abnormal test procedure result(s)|1|||
127941259|NCT01570686|460407567|FG000|Overall Study|Administrative problems|0|||
127941260|NCT01570686|460407568|FG001|Overall Study|Administrative problems|1|||
127941261|NCT01570686|460407567|FG000|Overall Study|Adverse Event|8|||
127941262|NCT01570686|460407568|FG001|Overall Study|Adverse Event|6|||
127941263|NCT01570686|460407567|FG000|Overall Study|Lost to Follow-up|4|||
127941264|NCT01570686|460407568|FG001|Overall Study|Lost to Follow-up|3|||
127941265|NCT01570686|460407567|FG000|Overall Study|Protocol Deviation|3|||
127941266|NCT01570686|460407568|FG001|Overall Study|Protocol Deviation|0|||
127941267|NCT01570686|460407567|FG000|Overall Study|Withdrawal by Subject|4|||
127941268|NCT01570686|460407568|FG001|Overall Study|Withdrawal by Subject|4|||
127941269|NCT01570686|460407567|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
127941270|NCT01570686|460407568|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
127941271|NCT00325195|460407569|FG000|Randomized|Not dosed|5|||
127941272|NCT00325195|460407570|FG001|Randomized|Not dosed|5|||
127941273|NCT00325195|460407571|FG002|Randomized|Not dosed|3|||
127941274|NCT00325195|460407569|FG000|Received Intervention: ITT Population|Adverse Event|15|||
127941275|NCT00325195|460407570|FG001|Received Intervention: ITT Population|Adverse Event|17|||
127941276|NCT00325195|460407571|FG002|Received Intervention: ITT Population|Adverse Event|1|||
127941277|NCT00325195|460407569|FG000|Received Intervention: ITT Population|Death|3|||
127941278|NCT00325195|460407570|FG001|Received Intervention: ITT Population|Death|1|||
127941279|NCT00325195|460407571|FG002|Received Intervention: ITT Population|Death|0|||
127941280|NCT00325195|460407569|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
127941281|NCT00325195|460407570|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
127941282|NCT00325195|460407571|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
127941283|NCT00325195|460407569|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
127941284|NCT00325195|460407570|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
127941285|NCT00325195|460407571|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
127941286|NCT00325195|460407569|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
127941287|NCT00325195|460407570|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
127941288|NCT00325195|460407571|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
127941289|NCT00686075|460407573|FG000|Overall Study|Withdrawal by Subject|4|||
127941290|NCT00686075|460407574|FG001|Overall Study|Withdrawal by Subject|3|||
127941291|NCT00686075|460407575|FG002|Overall Study|Withdrawal by Subject|3|||
127941292|NCT00686075|460407576|FG003|Overall Study|Withdrawal by Subject|7|||
127941293|NCT00686075|460407577|FG004|Overall Study|Withdrawal by Subject|1|||
127941294|NCT00686075|460407578|FG005|Overall Study|Withdrawal by Subject|0|||
127941295|NCT00686075|460407579|FG006|Overall Study|Withdrawal by Subject|0|||
127941296|NCT00686075|460407580|FG007|Overall Study|Withdrawal by Subject|2|||
127941297|NCT00686075|460407581|FG008|Overall Study|Withdrawal by Subject|4|||
127941298|NCT00686075|460407582|FG009|Overall Study|Withdrawal by Subject|6|||
127941299|NCT00686075|460407573|FG000|Overall Study|Lost to Follow-up|3|||
127941300|NCT00686075|460407574|FG001|Overall Study|Lost to Follow-up|6|||
127941301|NCT00686075|460407575|FG002|Overall Study|Lost to Follow-up|3|||
127941302|NCT00686075|460407576|FG003|Overall Study|Lost to Follow-up|2|||
127941303|NCT00686075|460407577|FG004|Overall Study|Lost to Follow-up|3|||
127941304|NCT00686075|460407578|FG005|Overall Study|Lost to Follow-up|3|||
127941305|NCT00686075|460407579|FG006|Overall Study|Lost to Follow-up|0|||
127941306|NCT00686075|460407580|FG007|Overall Study|Lost to Follow-up|0|||
127941307|NCT00686075|460407581|FG008|Overall Study|Lost to Follow-up|2|||
127941308|NCT00686075|460407582|FG009|Overall Study|Lost to Follow-up|3|||
127941309|NCT00686075|460407573|FG000|Overall Study|Other|1|||
127941310|NCT00686075|460407574|FG001|Overall Study|Other|1|||
127941311|NCT00686075|460407575|FG002|Overall Study|Other|0|||
127941312|NCT00686075|460407576|FG003|Overall Study|Other|0|||
127941313|NCT00686075|460407577|FG004|Overall Study|Other|0|||
127941314|NCT00686075|460407578|FG005|Overall Study|Other|0|||
127941315|NCT00686075|460407579|FG006|Overall Study|Other|0|||
127941316|NCT00686075|460407580|FG007|Overall Study|Other|0|||
127941317|NCT00686075|460407581|FG008|Overall Study|Other|0|||
127941318|NCT00686075|460407582|FG009|Overall Study|Other|1|||
127941319|NCT04715932|460407583|FG000|Overall Study|Lost to Follow-up|1|||
127941320|NCT04715932|460407584|FG001|Overall Study|Lost to Follow-up|0|||
127941321|NCT02740699|460407596|FG000|Overall Study|Lost to Follow-up|5|||
127941322|NCT02740699|460407596|FG000|Overall Study|Withdrawal by Subject|14|||
127941323|NCT02740699|460407596|FG000|Overall Study|Physician Decision|5|||
127941324|NCT03783039|460407598|FG000|Overall Study|Death|2|||
127941325|NCT03783039|460407599|FG001|Overall Study|Death|1|||
127941326|NCT01682863|460407600|FG000|Overall Study|Subject/guardian decision|19|||
127941327|NCT01682863|460407601|FG001|Overall Study|Subject/guardian decision|12|||
127941328|NCT01682863|460407602|FG002|Overall Study|Subject/guardian decision|10|||
127941329|NCT01682863|460407600|FG000|Overall Study|Lost to Follow-up|5|||
127941330|NCT01682863|460407601|FG001|Overall Study|Lost to Follow-up|1|||
127941331|NCT01682863|460407602|FG002|Overall Study|Lost to Follow-up|6|||
127941332|NCT01682863|460407600|FG000|Overall Study|Death|1|||
127941333|NCT01682863|460407601|FG001|Overall Study|Death|3|||
127941334|NCT01682863|460407602|FG002|Overall Study|Death|4|||
127941335|NCT01682863|460407600|FG000|Overall Study|Protocol deviation|1|||
127941336|NCT01682863|460407601|FG001|Overall Study|Protocol deviation|0|||
127941337|NCT01682863|460407602|FG002|Overall Study|Protocol deviation|1|||
127941338|NCT01682863|460407600|FG000|Overall Study|Technical problems|1|||
127941339|NCT01682863|460407601|FG001|Overall Study|Technical problems|0|||
127941340|NCT01682863|460407602|FG002|Overall Study|Technical problems|0|||
127941341|NCT01682863|460407600|FG000|Overall Study|Adverse Event|0|||
127941342|NCT01682863|460407601|FG001|Overall Study|Adverse Event|1|||
127941343|NCT01682863|460407602|FG002|Overall Study|Adverse Event|2|||
127941344|NCT01682863|460407600|FG000|Overall Study|Physician Decision|0|||
127941345|NCT01682863|460407601|FG001|Overall Study|Physician Decision|0|||
127941346|NCT01682863|460407602|FG002|Overall Study|Physician Decision|1|||
127941347|NCT00918138|460407604|FG000|Overall Study|Subject withdrew consent|1|||
127941348|NCT00918138|460407605|FG001|Overall Study|Subject withdrew consent|1|||
127941349|NCT00918138|460407604|FG000|Overall Study|Death|1|||
127941350|NCT00918138|460407605|FG001|Overall Study|Death|0|||
127941351|NCT00699374|460407606|FG000|Overall Study|Death|93|||
127941352|NCT00699374|460407607|FG001|Overall Study|Death|83|||
127941353|NCT00699374|460407606|FG000|Overall Study|Adverse Event|70|||
127941354|NCT00699374|460407607|FG001|Overall Study|Adverse Event|67|||
127941355|NCT00699374|460407606|FG000|Overall Study|Global deterioration of health status|7|||
127941356|NCT00699374|460407607|FG001|Overall Study|Global deterioration of health status|8|||
127941357|NCT00699374|460407606|FG000|Overall Study|Lost to Follow-up|3|||
127941358|NCT00699374|460407607|FG001|Overall Study|Lost to Follow-up|5|||
127941359|NCT00699374|460407606|FG000|Overall Study|Withdrawal by Subject|34|||
127941360|NCT00699374|460407607|FG001|Overall Study|Withdrawal by Subject|44|||
127941361|NCT00699374|460407606|FG000|Overall Study|Objective progression or relapse|281|||
127941362|NCT00699374|460407607|FG001|Overall Study|Objective progression or relapse|277|||
127941363|NCT00699374|460407606|FG000|Overall Study|Other|18|||
127941364|NCT00699374|460407607|FG001|Overall Study|Other|15|||
127941365|NCT00699374|460407606|FG000|Overall Study|Protocol Violation|2|||
127941366|NCT00699374|460407607|FG001|Overall Study|Protocol Violation|6|||
127941367|NCT00699374|460407606|FG000|Overall Study|Study terminated by sponsor|13|||
127941368|NCT00699374|460407607|FG001|Overall Study|Study terminated by sponsor|28|||
127941369|NCT00699374|460407606|FG000|Overall Study|Randomized but not treated|4|||
127941370|NCT00699374|460407607|FG001|Overall Study|Randomized but not treated|2|||
127941371|NCT00699374|460407606|FG000|Overall Study|Died 28 days after last dose|5|||
127941372|NCT00699374|460407607|FG001|Overall Study|Died 28 days after last dose|9|||
127941373|NCT01136967|460407611|FG000|Overall Study|Adverse Event|9|||
127941374|NCT01136967|460407612|FG001|Overall Study|Adverse Event|12|||
127941375|NCT01136967|460407611|FG000|Overall Study|Participant Choice|8|||
127941376|NCT01136967|460407612|FG001|Overall Study|Participant Choice|3|||
127941377|NCT01136967|460407611|FG000|Overall Study|Lost to Follow-up|0|||
127941378|NCT01136967|460407612|FG001|Overall Study|Lost to Follow-up|1|||
127941379|NCT01136967|460407611|FG000|Overall Study|Withdrawal by Subject|1|||
127941380|NCT01136967|460407612|FG001|Overall Study|Withdrawal by Subject|2|||
127941381|NCT01136967|460407611|FG000|Overall Study|Clinical Progression|3|||
127941382|NCT01136967|460407612|FG001|Overall Study|Clinical Progression|5|||
127941383|NCT01136967|460407611|FG000|Overall Study|Radiation|1|||
127941384|NCT01136967|460407612|FG001|Overall Study|Radiation|0|||
127941385|NCT01136967|460407611|FG000|Overall Study|Non-compliance|1|||
127941386|NCT01136967|460407612|FG001|Overall Study|Non-compliance|0|||
127941387|NCT01136967|460407611|FG000|Overall Study|Investigator's Choice|1|||
127941388|NCT01136967|460407612|FG001|Overall Study|Investigator's Choice|1|||
127941389|NCT01136967|460407611|FG000|Overall Study|Increase in Lesion Size|0|||
127941390|NCT01136967|460407612|FG001|Overall Study|Increase in Lesion Size|2|||
127941391|NCT01136967|460407611|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
127941392|NCT01136967|460407612|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
127941393|NCT02885181|460407613|FG000|Overall Study|Investigator's Discretion|0|||
127941394|NCT02885181|460407614|FG001|Overall Study|Investigator's Discretion|1|||
127941395|NCT02885181|460407615|FG002|Overall Study|Investigator's Discretion|0|||
127941396|NCT02885181|460407616|FG003|Overall Study|Investigator's Discretion|1|||
127941397|NCT02885181|460407613|FG000|Overall Study|Adverse Event|0|||
127941398|NCT02885181|460407614|FG001|Overall Study|Adverse Event|0|||
127941399|NCT02885181|460407615|FG002|Overall Study|Adverse Event|0|||
127941400|NCT02885181|460407616|FG003|Overall Study|Adverse Event|1|||
127941401|NCT02885181|460407613|FG000|Overall Study|Withdrawal by Subject|0|||
127941402|NCT02885181|460407614|FG001|Overall Study|Withdrawal by Subject|0|||
127941403|NCT02885181|460407615|FG002|Overall Study|Withdrawal by Subject|0|||
127941404|NCT02885181|460407616|FG003|Overall Study|Withdrawal by Subject|1|||
127941405|NCT03839823|460407617|FG000|Overall Study|Adverse Event|8|||
127941406|NCT03839823|460407618|FG001|Overall Study|Adverse Event|4|||
127941407|NCT03839823|460407617|FG000|Overall Study|Death|1|||
127941408|NCT03839823|460407618|FG001|Overall Study|Death|0|||
127941409|NCT03839823|460407617|FG000|Overall Study|Physician Decision|1|||
127941410|NCT03839823|460407618|FG001|Overall Study|Physician Decision|5|||
127941411|NCT03839823|460407617|FG000|Overall Study|Progressive Disease (PD)|65|||
127941412|NCT03839823|460407618|FG001|Overall Study|Progressive Disease (PD)|65|||
127941413|NCT03839823|460407617|FG000|Overall Study|Subject Decision|2|||
127941414|NCT03839823|460407618|FG001|Overall Study|Subject Decision|9|||
127941415|NCT03839823|460407617|FG000|Overall Study|Not Treated|0|||
127941416|NCT03839823|460407618|FG001|Overall Study|Not Treated|10|||
127941417|NCT04228783|460407619|FG000|Overall Study|Adverse Event|1|||
127941418|NCT04228783|460407620|FG001|Overall Study|Adverse Event|0|||
127941419|NCT04228783|460407621|FG002|Overall Study|Adverse Event|2|||
127941420|NCT04228783|460407622|FG003|Overall Study|Adverse Event|0|||
127941421|NCT04228783|460407623|FG004|Overall Study|Adverse Event|0|||
127941422|NCT04228783|460407624|FG005|Overall Study|Adverse Event|1|||
127941423|NCT04228783|460407619|FG000|Overall Study|Death|0|||
127941424|NCT04228783|460407620|FG001|Overall Study|Death|0|||
127941425|NCT04228783|460407621|FG002|Overall Study|Death|0|||
127941426|NCT04228783|460407622|FG003|Overall Study|Death|0|||
127941427|NCT04228783|460407623|FG004|Overall Study|Death|1|||
127941428|NCT04228783|460407624|FG005|Overall Study|Death|0|||
127941429|NCT04228783|460407619|FG000|Overall Study|Lost to Follow-up|36|||
127941430|NCT04228783|460407620|FG001|Overall Study|Lost to Follow-up|36|||
127941431|NCT04228783|460407621|FG002|Overall Study|Lost to Follow-up|28|||
127941432|NCT04228783|460407622|FG003|Overall Study|Lost to Follow-up|6|||
127941433|NCT04228783|460407623|FG004|Overall Study|Lost to Follow-up|14|||
127941434|NCT04228783|460407624|FG005|Overall Study|Lost to Follow-up|3|||
127941435|NCT04228783|460407619|FG000|Overall Study|Physician Decision|1|||
127941436|NCT04228783|460407620|FG001|Overall Study|Physician Decision|2|||
127941437|NCT04228783|460407621|FG002|Overall Study|Physician Decision|0|||
127941438|NCT04228783|460407622|FG003|Overall Study|Physician Decision|0|||
127941439|NCT04228783|460407623|FG004|Overall Study|Physician Decision|0|||
127941440|NCT04228783|460407624|FG005|Overall Study|Physician Decision|0|||
127941441|NCT04228783|460407619|FG000|Overall Study|Protocol Violation|0|||
127941442|NCT04228783|460407620|FG001|Overall Study|Protocol Violation|0|||
127941443|NCT04228783|460407621|FG002|Overall Study|Protocol Violation|0|||
127941444|NCT04228783|460407622|FG003|Overall Study|Protocol Violation|1|||
127941445|NCT04228783|460407623|FG004|Overall Study|Protocol Violation|0|||
127941446|NCT04228783|460407624|FG005|Overall Study|Protocol Violation|0|||
127941447|NCT04228783|460407619|FG000|Overall Study|Withdrawal by Subject|6|||
127941448|NCT04228783|460407620|FG001|Overall Study|Withdrawal by Subject|10|||
127941449|NCT04228783|460407621|FG002|Overall Study|Withdrawal by Subject|19|||
127941450|NCT04228783|460407622|FG003|Overall Study|Withdrawal by Subject|1|||
127941451|NCT04228783|460407623|FG004|Overall Study|Withdrawal by Subject|2|||
127941452|NCT04228783|460407624|FG005|Overall Study|Withdrawal by Subject|0|||
127941453|NCT04228783|460407619|FG000|Overall Study|Other|4|||
127941454|NCT04228783|460407620|FG001|Overall Study|Other|3|||
127941455|NCT04228783|460407621|FG002|Overall Study|Other|2|||
127941456|NCT04228783|460407622|FG003|Overall Study|Other|1|||
127941457|NCT04228783|460407623|FG004|Overall Study|Other|0|||
127941458|NCT04228783|460407624|FG005|Overall Study|Other|0|||
127941459|NCT03151811|460407627|FG000|Overall Study|Randomized But Not Treated|18|||
127941460|NCT03151811|460407628|FG001|Overall Study|Randomized But Not Treated|3|||
127941461|NCT03151811|460407627|FG000|Overall Study|Progressive Disease|130|||
127941462|NCT03151811|460407628|FG001|Overall Study|Progressive Disease|170|||
127941463|NCT03151811|460407627|FG000|Overall Study|Adverse Event|49|||
127941464|NCT03151811|460407628|FG001|Overall Study|Adverse Event|40|||
127941465|NCT03151811|460407627|FG000|Overall Study|Lack of Efficacy|6|||
127941466|NCT03151811|460407628|FG001|Overall Study|Lack of Efficacy|8|||
127941467|NCT03151811|460407627|FG000|Overall Study|Physician Decision|21|||
127941468|NCT03151811|460407628|FG001|Overall Study|Physician Decision|9|||
127941469|NCT03151811|460407627|FG000|Overall Study|Withdrawal by Subject|17|||
127941470|NCT03151811|460407628|FG001|Overall Study|Withdrawal by Subject|7|||
127941471|NCT03151811|460407627|FG000|Overall Study|Lost to Follow-up|0|||
127941472|NCT03151811|460407628|FG001|Overall Study|Lost to Follow-up|1|||
127941473|NCT03151811|460407627|FG000|Overall Study|Study Terminated by Sponsor|5|||
127941474|NCT03151811|460407628|FG001|Overall Study|Study Terminated by Sponsor|11|||
127941475|NCT01517373|460407631|FG000|Run-in Period|Death|1|||
127941476|NCT01517373|460407632|FG001|Run-in Period|Death|0|||
127941477|NCT01517373|460407633|FG002|Run-in Period|Death|0|||
127941478|NCT01517373|460407634|FG003|Run-in Period|Death|0|||
127941479|NCT01517373|460407635|FG004|Run-in Period|Death|0|||
127941480|NCT01517373|460407636|FG005|Run-in Period|Death|0|||
127941481|NCT01517373|460407631|FG000|Run-in Period|Adverse Event|5|||
127941482|NCT01517373|460407632|FG001|Run-in Period|Adverse Event|0|||
127941483|NCT01517373|460407633|FG002|Run-in Period|Adverse Event|0|||
127941484|NCT01517373|460407634|FG003|Run-in Period|Adverse Event|0|||
127941485|NCT01517373|460407635|FG004|Run-in Period|Adverse Event|0|||
127941486|NCT01517373|460407636|FG005|Run-in Period|Adverse Event|0|||
127941487|NCT01517373|460407631|FG000|Run-in Period|Did not meet eligibility criteria|34|||
127941488|NCT01517373|460407632|FG001|Run-in Period|Did not meet eligibility criteria|0|||
127941489|NCT01517373|460407633|FG002|Run-in Period|Did not meet eligibility criteria|0|||
127941490|NCT01517373|460407634|FG003|Run-in Period|Did not meet eligibility criteria|0|||
127941491|NCT01517373|460407635|FG004|Run-in Period|Did not meet eligibility criteria|0|||
127941492|NCT01517373|460407636|FG005|Run-in Period|Did not meet eligibility criteria|0|||
127941493|NCT01517373|460407631|FG000|Run-in Period|Lost to Follow-up|1|||
127941494|NCT01517373|460407632|FG001|Run-in Period|Lost to Follow-up|0|||
127941495|NCT01517373|460407633|FG002|Run-in Period|Lost to Follow-up|0|||
127941496|NCT01517373|460407634|FG003|Run-in Period|Lost to Follow-up|0|||
127941497|NCT01517373|460407635|FG004|Run-in Period|Lost to Follow-up|0|||
127941498|NCT01517373|460407636|FG005|Run-in Period|Lost to Follow-up|0|||
127941499|NCT01517373|460407631|FG000|Run-in Period|Withdrawal by Subject|12|||
127941500|NCT01517373|460407632|FG001|Run-in Period|Withdrawal by Subject|0|||
127941501|NCT01517373|460407633|FG002|Run-in Period|Withdrawal by Subject|0|||
127941502|NCT01517373|460407634|FG003|Run-in Period|Withdrawal by Subject|0|||
127941503|NCT01517373|460407635|FG004|Run-in Period|Withdrawal by Subject|0|||
127941504|NCT01517373|460407636|FG005|Run-in Period|Withdrawal by Subject|0|||
127941505|NCT01517373|460407631|FG000|Run-in Period|Sponsor Decision|3|||
127941506|NCT01517373|460407632|FG001|Run-in Period|Sponsor Decision|0|||
127941507|NCT01517373|460407633|FG002|Run-in Period|Sponsor Decision|0|||
127941508|NCT01517373|460407634|FG003|Run-in Period|Sponsor Decision|0|||
127941509|NCT01517373|460407635|FG004|Run-in Period|Sponsor Decision|0|||
127941510|NCT01517373|460407636|FG005|Run-in Period|Sponsor Decision|0|||
127941511|NCT01517373|460407631|FG000|Run-in Period|Other|1|||
127941512|NCT01517373|460407632|FG001|Run-in Period|Other|0|||
127941513|NCT01517373|460407633|FG002|Run-in Period|Other|0|||
127941514|NCT01517373|460407634|FG003|Run-in Period|Other|0|||
127941515|NCT01517373|460407635|FG004|Run-in Period|Other|0|||
127941516|NCT01517373|460407636|FG005|Run-in Period|Other|0|||
127941517|NCT01517373|460407631|FG000|Treatment Period|Adverse Event|0|||
127941518|NCT01517373|460407632|FG001|Treatment Period|Adverse Event|0|||
127941519|NCT01517373|460407633|FG002|Treatment Period|Adverse Event|0|||
127941520|NCT01517373|460407634|FG003|Treatment Period|Adverse Event|0|||
127941521|NCT01517373|460407635|FG004|Treatment Period|Adverse Event|0|||
127941522|NCT01517373|460407636|FG005|Treatment Period|Adverse Event|2|||
127941523|NCT01517373|460407631|FG000|Treatment Period|Lost to Follow-up|0|||
127941524|NCT01517373|460407632|FG001|Treatment Period|Lost to Follow-up|0|||
127941525|NCT01517373|460407633|FG002|Treatment Period|Lost to Follow-up|1|||
127941526|NCT01517373|460407634|FG003|Treatment Period|Lost to Follow-up|1|||
127941527|NCT01517373|460407635|FG004|Treatment Period|Lost to Follow-up|0|||
127941528|NCT01517373|460407636|FG005|Treatment Period|Lost to Follow-up|0|||
127941529|NCT01517373|460407631|FG000|Treatment Period|Withdrawal by Subject|0|||
127941530|NCT01517373|460407632|FG001|Treatment Period|Withdrawal by Subject|3|||
127941531|NCT01517373|460407633|FG002|Treatment Period|Withdrawal by Subject|2|||
127941532|NCT01517373|460407634|FG003|Treatment Period|Withdrawal by Subject|2|||
127941533|NCT01517373|460407635|FG004|Treatment Period|Withdrawal by Subject|2|||
127941534|NCT01517373|460407636|FG005|Treatment Period|Withdrawal by Subject|3|||
127941535|NCT01517373|460407631|FG000|Treatment Period|Other|0|||
127941536|NCT01517373|460407632|FG001|Treatment Period|Other|0|||
127941537|NCT01517373|460407633|FG002|Treatment Period|Other|0|||
127941538|NCT01517373|460407634|FG003|Treatment Period|Other|0|||
127941539|NCT01517373|460407635|FG004|Treatment Period|Other|1|||
127941540|NCT01517373|460407636|FG005|Treatment Period|Other|0|||
127941541|NCT01517373|460407631|FG000|Treatment Period|Protocol Violation|0|||
127941542|NCT01517373|460407632|FG001|Treatment Period|Protocol Violation|0|||
127941543|NCT01517373|460407633|FG002|Treatment Period|Protocol Violation|0|||
127941544|NCT01517373|460407634|FG003|Treatment Period|Protocol Violation|0|||
127941545|NCT01517373|460407635|FG004|Treatment Period|Protocol Violation|1|||
127941546|NCT01517373|460407636|FG005|Treatment Period|Protocol Violation|0|||
127941547|NCT01517373|460407631|FG000|Treatment Period|Lack of Efficacy|0|||
127941548|NCT01517373|460407632|FG001|Treatment Period|Lack of Efficacy|1|||
127941549|NCT01517373|460407633|FG002|Treatment Period|Lack of Efficacy|1|||
127941550|NCT01517373|460407634|FG003|Treatment Period|Lack of Efficacy|3|||
127941551|NCT01517373|460407635|FG004|Treatment Period|Lack of Efficacy|2|||
127941552|NCT01517373|460407636|FG005|Treatment Period|Lack of Efficacy|0|||
127941553|NCT01517373|460407631|FG000|Treatment Period|Medication error without AEs|0|||
127941554|NCT01517373|460407632|FG001|Treatment Period|Medication error without AEs|0|||
127941555|NCT01517373|460407633|FG002|Treatment Period|Medication error without AEs|2|||
127941556|NCT01517373|460407634|FG003|Treatment Period|Medication error without AEs|1|||
127941557|NCT01517373|460407635|FG004|Treatment Period|Medication error without AEs|0|||
127941558|NCT01517373|460407636|FG005|Treatment Period|Medication error without AEs|2|||
127941559|NCT04562155|460407640|FG000|Overall Study|COVID-19 pandemic|0|||
127941560|NCT04562155|460407641|FG001|Overall Study|COVID-19 pandemic|0|||
127941561|NCT04562155|460407642|FG002|Overall Study|COVID-19 pandemic|0|||
127941562|NCT04562155|460407643|FG003|Overall Study|COVID-19 pandemic|1|||
127941563|NCT04562155|460407640|FG000|Overall Study|Adverse Event|7|||
127941564|NCT04562155|460407641|FG001|Overall Study|Adverse Event|3|||
127941565|NCT04562155|460407642|FG002|Overall Study|Adverse Event|8|||
127941566|NCT04562155|460407643|FG003|Overall Study|Adverse Event|1|||
127941567|NCT04562155|460407640|FG000|Overall Study|Withdrawal by Subject|3|||
127941568|NCT04562155|460407641|FG001|Overall Study|Withdrawal by Subject|6|||
127941569|NCT04562155|460407642|FG002|Overall Study|Withdrawal by Subject|3|||
127941570|NCT04562155|460407643|FG003|Overall Study|Withdrawal by Subject|3|||
127941571|NCT04562155|460407640|FG000|Overall Study|Participant personal reason|1|||
127941572|NCT04562155|460407641|FG001|Overall Study|Participant personal reason|0|||
127941573|NCT04562155|460407642|FG002|Overall Study|Participant personal reason|2|||
127941574|NCT04562155|460407643|FG003|Overall Study|Participant personal reason|1|||
127941575|NCT01085201|460407646|FG000|Overall Study|Scheduling conflict|1|||
127941576|NCT01085201|460407647|FG001|Overall Study|Scheduling conflict|0|||
127941577|NCT01085201|460407648|FG002|Overall Study|Scheduling conflict|1|||
127941578|NCT01085201|460407649|FG003|Overall Study|Scheduling conflict|0|||
127941579|NCT01085201|460407650|FG004|Overall Study|Scheduling conflict|0|||
127941580|NCT01085201|460407646|FG000|Overall Study|Unknown- no study drug|2|||
127941581|NCT01085201|460407647|FG001|Overall Study|Unknown- no study drug|0|||
127941582|NCT01085201|460407648|FG002|Overall Study|Unknown- no study drug|0|||
127941583|NCT01085201|460407649|FG003|Overall Study|Unknown- no study drug|0|||
127941584|NCT01085201|460407650|FG004|Overall Study|Unknown- no study drug|0|||
127941585|NCT01085201|460407646|FG000|Overall Study|Fond ineligible after consent|0|||
127941586|NCT01085201|460407647|FG001|Overall Study|Fond ineligible after consent|1|||
127941587|NCT01085201|460407648|FG002|Overall Study|Fond ineligible after consent|1|||
127941588|NCT01085201|460407649|FG003|Overall Study|Fond ineligible after consent|0|||
127941589|NCT01085201|460407650|FG004|Overall Study|Fond ineligible after consent|0|||
127941590|NCT04516759|460407653|FG000|Overall Study|Withdrawal by Subject|1|||
127941591|NCT04516759|460407654|FG001|Overall Study|Withdrawal by Subject|1|||
127941592|NCT04516759|460407653|FG000|Overall Study|Other|0|||
127941593|NCT04516759|460407654|FG001|Overall Study|Other|1|||
127941594|NCT00528411|460407655|FG000|Overall Study|Adverse Event|4|||
127941595|NCT00528411|460407656|FG001|Overall Study|Adverse Event|0|||
127941596|NCT00528411|460407657|FG002|Overall Study|Adverse Event|1|||
127941597|NCT00528411|460407655|FG000|Overall Study|Incorrect Enrolment|1|||
127941598|NCT00528411|460407656|FG001|Overall Study|Incorrect Enrolment|1|||
127941599|NCT00528411|460407657|FG002|Overall Study|Incorrect Enrolment|0|||
127941600|NCT00528411|460407655|FG000|Overall Study|Severe non-compliance to protocol|0|||
127941601|NCT00528411|460407656|FG001|Overall Study|Severe non-compliance to protocol|1|||
127941602|NCT00528411|460407657|FG002|Overall Study|Severe non-compliance to protocol|0|||
127941603|NCT00528411|460407655|FG000|Overall Study|Prior commitment medication|0|||
127941604|NCT00528411|460407656|FG001|Overall Study|Prior commitment medication|1|||
127941605|NCT00528411|460407657|FG002|Overall Study|Prior commitment medication|0|||
127941606|NCT01221363|460407661|FG000|Overall Study|Pregnancy|1|||
127941607|NCT01221363|460407662|FG001|Overall Study|Pregnancy|0|||
127941608|NCT01221363|460407661|FG000|Overall Study|Withdrawal by Subject|11|||
127941609|NCT01221363|460407662|FG001|Overall Study|Withdrawal by Subject|5|||
127941610|NCT02695537|460407663|FG000|Overall Study|Adverse Event|3|||
127941611|NCT02695537|460407663|FG000|Overall Study|Lack of Efficacy|28|||
127941612|NCT02695537|460407663|FG000|Overall Study|Withdrawal by Subject|4|||
127941613|NCT02695537|460407663|FG000|Overall Study|Protocol Violation|3|||
127941614|NCT04480710|460407664|FG000|Overall Study|Adverse Event|0|||
127941615|NCT04480710|460407665|FG001|Overall Study|Adverse Event|2|||
127941616|NCT04480710|460407666|FG002|Overall Study|Adverse Event|0|||
127941617|NCT04480710|460407667|FG003|Overall Study|Adverse Event|0|||
127941618|NCT04480710|460407664|FG000|Overall Study|Withdrawal by Subject|0|||
127941619|NCT04480710|460407665|FG001|Overall Study|Withdrawal by Subject|1|||
127941620|NCT04480710|460407666|FG002|Overall Study|Withdrawal by Subject|0|||
127941621|NCT04480710|460407667|FG003|Overall Study|Withdrawal by Subject|0|||
127941622|NCT04480710|460407664|FG000|Overall Study|Physician Decision|0|||
127941623|NCT04480710|460407665|FG001|Overall Study|Physician Decision|0|||
127941624|NCT04480710|460407666|FG002|Overall Study|Physician Decision|1|||
127941625|NCT04480710|460407667|FG003|Overall Study|Physician Decision|0|||
127941626|NCT04126213|460407668|FG000|Overall Study|Lost to Follow-up|9|||
127941627|NCT04126213|460407669|FG001|Overall Study|Lost to Follow-up|1|||
127941628|NCT04126213|460407670|FG002|Overall Study|Lost to Follow-up|5|||
127941629|NCT04126213|460407671|FG003|Overall Study|Lost to Follow-up|10|||
127941630|NCT04126213|460407672|FG004|Overall Study|Lost to Follow-up|4|||
127941631|NCT04126213|460407673|FG005|Overall Study|Lost to Follow-up|7|||
127941632|NCT04126213|460407668|FG000|Overall Study|Withdrawal by Subject|3|||
127941633|NCT04126213|460407669|FG001|Overall Study|Withdrawal by Subject|2|||
127941634|NCT04126213|460407670|FG002|Overall Study|Withdrawal by Subject|1|||
127941635|NCT04126213|460407671|FG003|Overall Study|Withdrawal by Subject|1|||
127941636|NCT04126213|460407672|FG004|Overall Study|Withdrawal by Subject|1|||
127941637|NCT04126213|460407673|FG005|Overall Study|Withdrawal by Subject|1|||
127941638|NCT04126213|460407668|FG000|Overall Study|Other|0|||
127941639|NCT04126213|460407669|FG001|Overall Study|Other|0|||
127941640|NCT04126213|460407670|FG002|Overall Study|Other|2|||
127941641|NCT04126213|460407671|FG003|Overall Study|Other|2|||
127941642|NCT04126213|460407672|FG004|Overall Study|Other|0|||
127941643|NCT04126213|460407673|FG005|Overall Study|Other|1|||
127941644|NCT04126213|460407668|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127941645|NCT04126213|460407669|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
127941646|NCT04126213|460407670|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
127941647|NCT04126213|460407671|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127941648|NCT04126213|460407672|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
127941649|NCT04126213|460407673|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
127941650|NCT03050060|460407674|FG000|Overall Study|Adverse Event|7|||
127941651|NCT03050060|460407674|FG000|Overall Study|Withdrawal by Subject|1|||
127941652|NCT03050060|460407674|FG000|Overall Study|Progression|7|||
127941653|NCT03835221|460407675|FG000|Methafilcon A|Withdrawal by Subject|1|||
127941654|NCT02823652|460407677|FG000|Step 1: On-line Genetic Education Study|Baseline survey not done|58|||
127941655|NCT02823652|460407678|FG001|Step 1: On-line Genetic Education Study|Baseline survey not done|64|||
127941656|NCT02823652|460407679|FG002|Step 1: On-line Genetic Education Study|Baseline survey not done|7|||
127941657|NCT02823652|460407677|FG000|Step 2: Genetic Counseling Substudy|Ineligible|2|||
127941658|NCT02823652|460407678|FG001|Step 2: Genetic Counseling Substudy|Ineligible|0|||
127941659|NCT02823652|460407679|FG002|Step 2: Genetic Counseling Substudy|Ineligible|0|||
127941660|NCT02823652|460407677|FG000|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|2|||
127941661|NCT02823652|460407678|FG001|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|0|||
127941662|NCT02823652|460407679|FG002|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|1|||
127941663|NCT02823652|460407677|FG000|Step 2: Genetic Counseling Substudy|Other|2|||
127941664|NCT02823652|460407678|FG001|Step 2: Genetic Counseling Substudy|Other|2|||
127941665|NCT02823652|460407679|FG002|Step 2: Genetic Counseling Substudy|Other|1|||
127941666|NCT03567382|460407680|FG000|Overall Study|Lost to Follow-up|1|||
127941667|NCT03567382|460407681|FG001|Overall Study|Lost to Follow-up|21|||
127941668|NCT03567382|460407682|FG002|Overall Study|Lost to Follow-up|1|||
127941669|NCT03567382|460407683|FG003|Overall Study|Lost to Follow-up|21|||
127941670|NCT03567382|460407680|FG000|Overall Study|Withdrawal by Subject|2|||
127941671|NCT03567382|460407681|FG001|Overall Study|Withdrawal by Subject|14|||
127941672|NCT03567382|460407682|FG002|Overall Study|Withdrawal by Subject|1|||
127941673|NCT03567382|460407683|FG003|Overall Study|Withdrawal by Subject|12|||
127941674|NCT00620659|460407686|FG000|Treatment Period 1|Adverse Event|1|||
127941675|NCT00620659|460407687|FG001|Treatment Period 1|Adverse Event|0|||
127941676|NCT00620659|460407688|FG002|Treatment Period 1|Adverse Event|0|||
127941677|NCT00620659|460407689|FG003|Treatment Period 1|Adverse Event|3|||
127941678|NCT00620659|460407690|FG004|Treatment Period 1|Adverse Event|0|||
127941679|NCT00620659|460407691|FG005|Treatment Period 1|Adverse Event|0|||
127941680|NCT00620659|460407686|FG000|Treatment Period 1|Protocol Violation|1|||
127941681|NCT00620659|460407687|FG001|Treatment Period 1|Protocol Violation|0|||
127941682|NCT00620659|460407688|FG002|Treatment Period 1|Protocol Violation|0|||
127941683|NCT00620659|460407689|FG003|Treatment Period 1|Protocol Violation|0|||
127941684|NCT00620659|460407690|FG004|Treatment Period 1|Protocol Violation|0|||
127941685|NCT00620659|460407691|FG005|Treatment Period 1|Protocol Violation|0|||
127941686|NCT00620659|460407686|FG000|Treatment Period 1|Withdrawal by Subject|1|||
127941687|NCT00620659|460407687|FG001|Treatment Period 1|Withdrawal by Subject|0|||
127941688|NCT00620659|460407688|FG002|Treatment Period 1|Withdrawal by Subject|1|||
127941689|NCT00620659|460407689|FG003|Treatment Period 1|Withdrawal by Subject|0|||
127941690|NCT00620659|460407690|FG004|Treatment Period 1|Withdrawal by Subject|1|||
127941691|NCT00620659|460407691|FG005|Treatment Period 1|Withdrawal by Subject|0|||
127941692|NCT00620659|460407686|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
127941693|NCT00620659|460407687|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
127941694|NCT00620659|460407688|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
127941695|NCT00620659|460407689|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
127941696|NCT00620659|460407690|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
127941697|NCT00620659|460407691|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
127941698|NCT00620659|460407686|FG000|Treatment Period 2|Adverse Event|0|||
127941699|NCT00620659|460407687|FG001|Treatment Period 2|Adverse Event|3|||
127941700|NCT00620659|460407688|FG002|Treatment Period 2|Adverse Event|0|||
127941701|NCT00620659|460407689|FG003|Treatment Period 2|Adverse Event|0|||
127941702|NCT00620659|460407690|FG004|Treatment Period 2|Adverse Event|2|||
127941703|NCT00620659|460407691|FG005|Treatment Period 2|Adverse Event|0|||
127941704|NCT00620659|460407686|FG000|Treatment Period 2|Withdrawal by Subject|0|||
127941705|NCT00620659|460407687|FG001|Treatment Period 2|Withdrawal by Subject|0|||
127941706|NCT00620659|460407688|FG002|Treatment Period 2|Withdrawal by Subject|1|||
127941707|NCT00620659|460407689|FG003|Treatment Period 2|Withdrawal by Subject|0|||
127941708|NCT00620659|460407690|FG004|Treatment Period 2|Withdrawal by Subject|3|||
127941709|NCT00620659|460407691|FG005|Treatment Period 2|Withdrawal by Subject|0|||
127941710|NCT00620659|460407686|FG000|Placebo Washout Period 2|Adverse Event|2|||
127941711|NCT00620659|460407687|FG001|Placebo Washout Period 2|Adverse Event|0|||
127941712|NCT00620659|460407688|FG002|Placebo Washout Period 2|Adverse Event|0|||
127941713|NCT00620659|460407689|FG003|Placebo Washout Period 2|Adverse Event|0|||
127941714|NCT00620659|460407690|FG004|Placebo Washout Period 2|Adverse Event|0|||
127941715|NCT00620659|460407691|FG005|Placebo Washout Period 2|Adverse Event|0|||
127941716|NCT00620659|460407686|FG000|Treatment Period 3|Adverse Event|0|||
127941717|NCT00620659|460407687|FG001|Treatment Period 3|Adverse Event|2|||
127941718|NCT00620659|460407688|FG002|Treatment Period 3|Adverse Event|0|||
127941719|NCT00620659|460407689|FG003|Treatment Period 3|Adverse Event|0|||
127941720|NCT00620659|460407690|FG004|Treatment Period 3|Adverse Event|0|||
127941721|NCT00620659|460407691|FG005|Treatment Period 3|Adverse Event|0|||
127941722|NCT00620659|460407686|FG000|Treatment Period 3|Withdrawal by Subject|0|||
127941723|NCT00620659|460407687|FG001|Treatment Period 3|Withdrawal by Subject|0|||
127941724|NCT00620659|460407688|FG002|Treatment Period 3|Withdrawal by Subject|0|||
127941725|NCT00620659|460407689|FG003|Treatment Period 3|Withdrawal by Subject|1|||
127941726|NCT00620659|460407690|FG004|Treatment Period 3|Withdrawal by Subject|0|||
127941727|NCT00620659|460407691|FG005|Treatment Period 3|Withdrawal by Subject|0|||
127941728|NCT01214915|460407693|FG000|Overall Study|Adverse Event|8|||
127941729|NCT01214915|460407693|FG000|Overall Study|Lack of Efficacy|3|||
127941730|NCT02056392|460407694|FG000|Overall Study|Lost to Follow-up|0|||
127941731|NCT02056392|460407695|FG001|Overall Study|Lost to Follow-up|1|||
127941732|NCT02056392|460407696|FG002|Overall Study|Lost to Follow-up|2|||
127941733|NCT02056392|460407697|FG003|Overall Study|Lost to Follow-up|0|||
127941734|NCT02056392|460407698|FG004|Overall Study|Lost to Follow-up|0|||
127941735|NCT02056392|460407699|FG005|Overall Study|Lost to Follow-up|0|||
127941736|NCT02056392|460407694|FG000|Overall Study|Protocol Violation|1|||
127941737|NCT02056392|460407695|FG001|Overall Study|Protocol Violation|0|||
127941738|NCT02056392|460407696|FG002|Overall Study|Protocol Violation|1|||
127941739|NCT02056392|460407697|FG003|Overall Study|Protocol Violation|0|||
127941740|NCT02056392|460407698|FG004|Overall Study|Protocol Violation|0|||
127941741|NCT02056392|460407699|FG005|Overall Study|Protocol Violation|0|||
127941742|NCT02056392|460407694|FG000|Overall Study|Withdrawal by Subject|1|||
127941743|NCT02056392|460407695|FG001|Overall Study|Withdrawal by Subject|0|||
127941744|NCT02056392|460407696|FG002|Overall Study|Withdrawal by Subject|0|||
127941745|NCT02056392|460407697|FG003|Overall Study|Withdrawal by Subject|0|||
127941746|NCT02056392|460407698|FG004|Overall Study|Withdrawal by Subject|1|||
127941747|NCT02056392|460407699|FG005|Overall Study|Withdrawal by Subject|0|||
127941748|NCT04555720|460407702|FG000|Overall Study|Lost to Follow-up|2|||
127941749|NCT04555720|460407703|FG001|Overall Study|Lost to Follow-up|0|||
127941750|NCT04555720|460407704|FG002|Overall Study|Lost to Follow-up|0|||
127941751|NCT04555720|460407705|FG003|Overall Study|Lost to Follow-up|0|||
127941752|NCT04555720|460407702|FG000|Overall Study|Withdrawal by Subject|4|||
127941753|NCT04555720|460407703|FG001|Overall Study|Withdrawal by Subject|6|||
127941754|NCT04555720|460407704|FG002|Overall Study|Withdrawal by Subject|0|||
127941755|NCT04555720|460407705|FG003|Overall Study|Withdrawal by Subject|0|||
127941756|NCT00968799|460407706|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
127941757|NCT00719849|460407707|FG000|Overall Study|Death|0|||
127941758|NCT00719849|460407708|FG001|Overall Study|Death|1|||
127941759|NCT01372774|460407711|FG000|Overall Study|Withdrawal prior to treatment|4|||
127941760|NCT01372774|460407712|FG001|Overall Study|Withdrawal prior to treatment|5|||
127941761|NCT02201290|460407713|FG000|Overall Study|Withdrawal by Subject|2|||
127941762|NCT02201290|460407713|FG000|Overall Study|Lack of Efficacy|2|||
127941763|NCT02201290|460407713|FG000|Overall Study|Adverse Event|1|||
127941764|NCT00633243|460409737|FG000|Overall Study|Withdrawal by Subject|0|||
127941765|NCT00633243|460409738|FG001|Overall Study|Withdrawal by Subject|1|||
127941766|NCT00633243|460409737|FG000|Overall Study|incarceration|0|||
127941767|NCT00633243|460409738|FG001|Overall Study|incarceration|2|||
127941768|NCT00633243|460409737|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
127941769|NCT00633243|460409738|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
127941770|NCT00633243|460409737|FG000|Overall Study|Not comfortable with self-injecting|0|||
127941771|NCT00633243|460409738|FG001|Overall Study|Not comfortable with self-injecting|1|||
127941772|NCT00633243|460409737|FG000|Overall Study|Mental Health--Depression|0|||
127941773|NCT00633243|460409738|FG001|Overall Study|Mental Health--Depression|1|||
127941774|NCT00633243|460409737|FG000|Overall Study|Couldn't tolerate side-effects|1|||
127941775|NCT00633243|460409738|FG001|Overall Study|Couldn't tolerate side-effects|1|||
127941776|NCT02022748|460409739|FG000|Overall Study|Adverse Event|1|||
127941777|NCT02022748|460409740|FG001|Overall Study|Adverse Event|1|||
127941778|NCT02022748|460409741|FG002|Overall Study|Adverse Event|0|||
127941779|NCT02022748|460409739|FG000|Overall Study|Withdrawal by Subject|0|||
127941780|NCT02022748|460409740|FG001|Overall Study|Withdrawal by Subject|1|||
127941781|NCT02022748|460409741|FG002|Overall Study|Withdrawal by Subject|0|||
127941782|NCT03665441|460409742|FG000|Overall Study|survival follow up ongoing|23|||
127941783|NCT03665441|460409743|FG001|Overall Study|survival follow up ongoing|0|||
127941784|NCT03665441|460409742|FG000|Overall Study|Patients ongoing on treatment|9|||
127941785|NCT03665441|460409743|FG001|Overall Study|Patients ongoing on treatment|6|||
127941786|NCT03665441|460409742|FG000|Overall Study|Randomized but not treated|7|||
127941787|NCT03665441|460409743|FG001|Overall Study|Randomized but not treated|11|||
127941788|NCT03954834|460409744|FG000|Overall Study|Adverse Event|1|||
127941789|NCT03954834|460409745|FG001|Overall Study|Adverse Event|3|||
127941790|NCT03954834|460409746|FG002|Overall Study|Adverse Event|1|||
127941791|NCT03954834|460409747|FG003|Overall Study|Adverse Event|1|||
127941792|NCT03954834|460409744|FG000|Overall Study|Death|0|||
127941793|NCT03954834|460409745|FG001|Overall Study|Death|0|||
127941794|NCT03954834|460409746|FG002|Overall Study|Death|0|||
127941795|NCT03954834|460409747|FG003|Overall Study|Death|1|||
127941796|NCT03954834|460409744|FG000|Overall Study|Physician Decision|0|||
127941797|NCT03954834|460409745|FG001|Overall Study|Physician Decision|1|||
127941798|NCT03954834|460409746|FG002|Overall Study|Physician Decision|0|||
127941799|NCT03954834|460409747|FG003|Overall Study|Physician Decision|2|||
127941800|NCT03954834|460409744|FG000|Overall Study|Protocol Violation|1|||
127941801|NCT03954834|460409745|FG001|Overall Study|Protocol Violation|0|||
127941802|NCT03954834|460409746|FG002|Overall Study|Protocol Violation|0|||
127941803|NCT03954834|460409747|FG003|Overall Study|Protocol Violation|1|||
127941804|NCT03954834|460409744|FG000|Overall Study|Withdrawal by Subject|2|||
127941805|NCT03954834|460409745|FG001|Overall Study|Withdrawal by Subject|3|||
127941806|NCT03954834|460409746|FG002|Overall Study|Withdrawal by Subject|13|||
127941807|NCT03954834|460409747|FG003|Overall Study|Withdrawal by Subject|6|||
127941808|NCT03954834|460409744|FG000|Overall Study|Participant left the country|0|||
127941809|NCT03954834|460409745|FG001|Overall Study|Participant left the country|0|||
127941810|NCT03954834|460409746|FG002|Overall Study|Participant left the country|1|||
127941811|NCT03954834|460409747|FG003|Overall Study|Participant left the country|0|||
127941812|NCT03954834|460409744|FG000|Overall Study|Lost to Follow-up|3|||
127941813|NCT03954834|460409745|FG001|Overall Study|Lost to Follow-up|2|||
127941814|NCT03954834|460409746|FG002|Overall Study|Lost to Follow-up|3|||
127941815|NCT03954834|460409747|FG003|Overall Study|Lost to Follow-up|5|||
127941816|NCT03700385|460409748|FG000|Overall Study|Lost to Follow-up|1|||
127941817|NCT01555671|460409752|FG000|Overall Study|Physician Decision|20|||
127941818|NCT01555671|460409753|FG001|Overall Study|Physician Decision|25|||
127941819|NCT00372411|460409754|FG000|Overall Study|Withdrawal by Subject|3|||
127941820|NCT00372411|460409755|FG001|Overall Study|Withdrawal by Subject|4|||
127941821|NCT00372411|460409756|FG002|Overall Study|Withdrawal by Subject|1|||
127941822|NCT00372411|460409754|FG000|Overall Study|Death|0|||
127941823|NCT00372411|460409755|FG001|Overall Study|Death|2|||
127941824|NCT00372411|460409756|FG002|Overall Study|Death|1|||
127941825|NCT00372411|460409754|FG000|Overall Study|Lost to Follow-up|1|||
127941826|NCT00372411|460409755|FG001|Overall Study|Lost to Follow-up|1|||
127941827|NCT00372411|460409756|FG002|Overall Study|Lost to Follow-up|1|||
127941828|NCT00372411|460409754|FG000|Overall Study|Adverse Event|1|||
127941829|NCT00372411|460409755|FG001|Overall Study|Adverse Event|1|||
127941830|NCT00372411|460409756|FG002|Overall Study|Adverse Event|0|||
127941831|NCT04590040|460409760|FG000|Treatment Period|Lost to Follow-up|2|||
127941832|NCT04590040|460409761|FG001|Treatment Period|Lost to Follow-up|5|||
127941833|NCT04590040|460409762|FG002|Treatment Period|Lost to Follow-up|0|||
127941834|NCT04590040|460409760|FG000|Treatment Period|Physician Decision|0|||
127941835|NCT04590040|460409761|FG001|Treatment Period|Physician Decision|0|||
127941836|NCT04590040|460409762|FG002|Treatment Period|Physician Decision|2|||
127941837|NCT01284361|460409763|FG000|Overall Study|Withdrawal by Subject|1|||
127941838|NCT01284361|460409763|FG000|Overall Study|Protocol Violation|5|||
127941839|NCT01284361|460409763|FG000|Overall Study|Adverse Event|1|||
127941840|NCT01284361|460409763|FG000|Overall Study|Lost to Follow-up|2|||
127941841|NCT04003896|460409764|FG000|Overall Study|Withdrawal by Subject|3|||
127941842|NCT04003896|460409764|FG000|Overall Study|Physician Decision|1|||
127941843|NCT01957397|460409765|FG000|Test Period 1|sudden leakage/small bag|1|||
127941844|NCT01957397|460409766|FG001|Test Period 1|sudden leakage/small bag|1|||
127941845|NCT01957397|460409765|FG000|Test Period 1|Withdrawal by Subject|1|||
127941846|NCT01957397|460409766|FG001|Test Period 1|Withdrawal by Subject|0|||
127941847|NCT01957397|460409765|FG000|Test Period 2|Adverse Event|0|||
127941848|NCT01957397|460409766|FG001|Test Period 2|Adverse Event|1|||
127941849|NCT01957397|460409765|FG000|Test Period 3|Adverse Event|1|||
127941850|NCT01957397|460409766|FG001|Test Period 3|Adverse Event|2|||
127941851|NCT01957397|460409765|FG000|Test Period 3|the adhesive did not work|1|||
127941852|NCT01957397|460409766|FG001|Test Period 3|the adhesive did not work|0|||
127941853|NCT00324649|460409767|FG000|Overall Study|Adverse Event|1|||
127941854|NCT00324649|460409768|FG001|Overall Study|Adverse Event|4|||
127941855|NCT00324649|460409767|FG000|Overall Study|Withdrawal by Subject|0|||
127941856|NCT00324649|460409768|FG001|Overall Study|Withdrawal by Subject|1|||
127941857|NCT00324649|460409767|FG000|Overall Study|Noncompliance|1|||
127941858|NCT00324649|460409768|FG001|Overall Study|Noncompliance|0|||
127941859|NCT04713553|460409771|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
127941860|NCT04713553|460409772|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
127941861|NCT04713553|460409773|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
127941862|NCT04713553|460409774|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
127941863|NCT04713553|460409775|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
127941864|NCT04713553|460409776|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
127941865|NCT04713553|460409777|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
127941866|NCT04713553|460409771|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
127941867|NCT04713553|460409772|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
127941868|NCT04713553|460409773|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
127941869|NCT04713553|460409774|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
127941870|NCT04713553|460409775|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
127941871|NCT04713553|460409776|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
127941872|NCT04713553|460409777|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
127941873|NCT04713553|460409771|FG000|Primary Study (2 Months)|Other|1|||
127941874|NCT04713553|460409772|FG001|Primary Study (2 Months)|Other|2|||
127941875|NCT04713553|460409773|FG002|Primary Study (2 Months)|Other|0|||
127941876|NCT04713553|460409774|FG003|Primary Study (2 Months)|Other|0|||
127941877|NCT04713553|460409775|FG004|Primary Study (2 Months)|Other|1|||
127941878|NCT04713553|460409776|FG005|Primary Study (2 Months)|Other|0|||
127941879|NCT04713553|460409777|FG006|Primary Study (2 Months)|Other|0|||
127941880|NCT04713553|460409771|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
127941881|NCT04713553|460409772|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
127941882|NCT04713553|460409773|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
127941883|NCT04713553|460409774|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
127941884|NCT04713553|460409775|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
127941885|NCT04713553|460409776|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
127941886|NCT04713553|460409777|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
127941887|NCT04713553|460409771|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
127941888|NCT04713553|460409772|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
127941889|NCT04713553|460409773|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
127941890|NCT04713553|460409774|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
127941891|NCT04713553|460409775|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
127941892|NCT04713553|460409776|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
127941893|NCT04713553|460409777|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
127941894|NCT02315196|460409781|FG000|Overall Study|Withdrew consent|9|||
127941895|NCT01081834|460409786|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
127941896|NCT01081834|460409787|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
127941897|NCT01081834|460409788|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
127941898|NCT01081834|460409789|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
127941899|NCT01081834|460409790|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
127941900|NCT01081834|460409786|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
127941901|NCT01081834|460409787|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
127941902|NCT01081834|460409788|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
127941903|NCT01081834|460409789|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
127941904|NCT01081834|460409790|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
127941905|NCT01081834|460409786|FG000|Core Period: Baseline to Week 26|Death|1|||
127941906|NCT01081834|460409787|FG001|Core Period: Baseline to Week 26|Death|0|||
127941907|NCT01081834|460409788|FG002|Core Period: Baseline to Week 26|Death|0|||
127941908|NCT01081834|460409789|FG003|Core Period: Baseline to Week 26|Death|0|||
127941909|NCT01081834|460409790|FG004|Core Period: Baseline to Week 26|Death|0|||
127941910|NCT01081834|460409786|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
127941911|NCT01081834|460409787|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
127941912|NCT01081834|460409788|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
127941913|NCT01081834|460409789|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
127941914|NCT01081834|460409790|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
127941915|NCT01081834|460409786|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
127941916|NCT01081834|460409787|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
127941917|NCT01081834|460409788|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
127941918|NCT01081834|460409789|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
127941919|NCT01081834|460409790|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
127941920|NCT01081834|460409786|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
127941921|NCT01081834|460409787|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
127941922|NCT01081834|460409788|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
127941923|NCT01081834|460409789|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
127941924|NCT01081834|460409790|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
127941925|NCT01081834|460409786|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
127941926|NCT01081834|460409787|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
127941927|NCT01081834|460409788|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
127941928|NCT01081834|460409789|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
127941929|NCT01081834|460409790|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
127941930|NCT01081834|460409786|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
127941931|NCT01081834|460409787|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
127941932|NCT01081834|460409788|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
127941933|NCT01081834|460409789|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
127941934|NCT01081834|460409790|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
127941935|NCT01081834|460409786|FG000|Core Period: Baseline to Week 26|Other|4|||
127941936|NCT01081834|460409787|FG001|Core Period: Baseline to Week 26|Other|4|||
127941937|NCT01081834|460409788|FG002|Core Period: Baseline to Week 26|Other|3|||
127941938|NCT01081834|460409789|FG003|Core Period: Baseline to Week 26|Other|1|||
127941939|NCT01081834|460409790|FG004|Core Period: Baseline to Week 26|Other|0|||
127941940|NCT01081834|460409786|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
127941941|NCT01081834|460409787|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
127941942|NCT01081834|460409788|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
127941943|NCT01081834|460409789|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
127941944|NCT01081834|460409790|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
127941945|NCT01081834|460409786|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
127941946|NCT01081834|460409787|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
127941947|NCT01081834|460409788|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
127941948|NCT01081834|460409789|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
127941949|NCT01081834|460409790|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
127941950|NCT01081834|460409786|FG000|Extension Period: Week 26 to Week 52|Death|1|||
127941951|NCT01081834|460409787|FG001|Extension Period: Week 26 to Week 52|Death|0|||
127941952|NCT01081834|460409788|FG002|Extension Period: Week 26 to Week 52|Death|0|||
127941953|NCT01081834|460409789|FG003|Extension Period: Week 26 to Week 52|Death|0|||
127941954|NCT01081834|460409790|FG004|Extension Period: Week 26 to Week 52|Death|0|||
127941955|NCT01081834|460409786|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
127941956|NCT01081834|460409787|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
127941957|NCT01081834|460409788|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
127941958|NCT01081834|460409789|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
127941959|NCT01081834|460409790|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
127941960|NCT01081834|460409786|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
127941961|NCT01081834|460409787|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
127941962|NCT01081834|460409788|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
127941963|NCT01081834|460409789|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
127941964|NCT01081834|460409790|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
127941965|NCT01081834|460409786|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
127941966|NCT01081834|460409787|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
127941967|NCT01081834|460409788|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
127941968|NCT01081834|460409789|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
127941969|NCT01081834|460409790|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
127941970|NCT01081834|460409786|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
127941971|NCT01081834|460409787|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
127941972|NCT01081834|460409788|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
127941973|NCT01081834|460409789|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
127941974|NCT01081834|460409790|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
127941975|NCT01081834|460409786|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
127941976|NCT01081834|460409787|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
127941977|NCT01081834|460409788|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
127941978|NCT01081834|460409789|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
127941979|NCT01081834|460409790|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
127941980|NCT01081834|460409786|FG000|Extension Period: Week 26 to Week 52|Other|4|||
127941981|NCT01081834|460409787|FG001|Extension Period: Week 26 to Week 52|Other|5|||
127941982|NCT01081834|460409788|FG002|Extension Period: Week 26 to Week 52|Other|4|||
127941983|NCT01081834|460409789|FG003|Extension Period: Week 26 to Week 52|Other|0|||
127941984|NCT01081834|460409790|FG004|Extension Period: Week 26 to Week 52|Other|0|||
127941985|NCT01081834|460409786|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
127941986|NCT01081834|460409787|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
127941987|NCT01081834|460409788|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
127941988|NCT01081834|460409789|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
127941989|NCT01081834|460409790|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
127941990|NCT01081834|460409786|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
127941991|NCT01081834|460409787|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
127941992|NCT01081834|460409788|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
127941993|NCT01081834|460409789|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
127941994|NCT01081834|460409790|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
127941995|NCT01001988|460409791|FG000|Overall Study|Protocol Violation|84|||
127941996|NCT01001988|460409791|FG000|Overall Study|Withdrawal by Subject|18|||
127941997|NCT01001988|460409791|FG000|Overall Study|Lost to Follow-up|15|||
127941998|NCT01329549|460409800|FG000|Overall Study|Withdrawal by Subject|1|||
127941999|NCT01329549|460409800|FG000|Overall Study|Adverse Event|1|||
127942000|NCT03597529|460409810|FG000|Overall Study|Lost to Follow-up|10|||
127942001|NCT03597529|460409811|FG001|Overall Study|Lost to Follow-up|12|||
127942002|NCT03597529|460409810|FG000|Overall Study|Physician Decision|3|||
127942003|NCT03597529|460409811|FG001|Overall Study|Physician Decision|1|||
127942004|NCT03597529|460409810|FG000|Overall Study|Withdrawal by Subject|6|||
127942005|NCT03597529|460409811|FG001|Overall Study|Withdrawal by Subject|3|||
127942006|NCT03597529|460409810|FG000|Overall Study|Non-compliant with study activities|1|||
127942007|NCT03597529|460409811|FG001|Overall Study|Non-compliant with study activities|2|||
127942008|NCT01755767|460409814|FG000|Overall Study|Progressive Disease|8|||
127942009|NCT01755767|460409815|FG001|Overall Study|Progressive Disease|7|||
127942010|NCT01755767|460409816|FG002|Overall Study|Progressive Disease|91|||
127942011|NCT01755767|460409817|FG003|Overall Study|Progressive Disease|43|||
127942012|NCT01755767|460409814|FG000|Overall Study|Clinical Disease Progression|4|||
127942013|NCT01755767|460409815|FG001|Overall Study|Clinical Disease Progression|2|||
127942014|NCT01755767|460409816|FG002|Overall Study|Clinical Disease Progression|29|||
127942015|NCT01755767|460409817|FG003|Overall Study|Clinical Disease Progression|20|||
127942016|NCT01755767|460409814|FG000|Overall Study|Radiographic Disease Progression|9|||
127942017|NCT01755767|460409815|FG001|Overall Study|Radiographic Disease Progression|4|||
127942018|NCT01755767|460409816|FG002|Overall Study|Radiographic Disease Progression|44|||
127942019|NCT01755767|460409817|FG003|Overall Study|Radiographic Disease Progression|27|||
127942020|NCT01755767|460409814|FG000|Overall Study|Adverse Event|6|||
127942021|NCT01755767|460409815|FG001|Overall Study|Adverse Event|0|||
127942022|NCT01755767|460409816|FG002|Overall Study|Adverse Event|28|||
127942023|NCT01755767|460409817|FG003|Overall Study|Adverse Event|11|||
127942024|NCT01755767|460409814|FG000|Overall Study|Death|1|||
127942025|NCT01755767|460409815|FG001|Overall Study|Death|2|||
127942026|NCT01755767|460409816|FG002|Overall Study|Death|15|||
127942027|NCT01755767|460409817|FG003|Overall Study|Death|4|||
127942028|NCT01755767|460409814|FG000|Overall Study|Subject Decision|0|||
127942029|NCT01755767|460409815|FG001|Overall Study|Subject Decision|0|||
127942030|NCT01755767|460409816|FG002|Overall Study|Subject Decision|10|||
127942031|NCT01755767|460409817|FG003|Overall Study|Subject Decision|3|||
127942032|NCT01755767|460409814|FG000|Overall Study|Withdrawal by Subject|0|||
127942033|NCT01755767|460409815|FG001|Overall Study|Withdrawal by Subject|0|||
127942034|NCT01755767|460409816|FG002|Overall Study|Withdrawal by Subject|2|||
127942035|NCT01755767|460409817|FG003|Overall Study|Withdrawal by Subject|1|||
127942036|NCT01755767|460409814|FG000|Overall Study|Other|0|||
127942037|NCT01755767|460409815|FG001|Overall Study|Other|0|||
127942038|NCT01755767|460409816|FG002|Overall Study|Other|2|||
127942039|NCT01755767|460409817|FG003|Overall Study|Other|3|||
127942040|NCT01755767|460409814|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
127942041|NCT01755767|460409815|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
127942042|NCT01755767|460409816|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
127942043|NCT01755767|460409817|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
127942044|NCT00191165|460409818|FG000|Overall Study|Adverse Event|2|||
127942045|NCT00191165|460409819|FG001|Overall Study|Adverse Event|0|||
127942046|NCT00191165|460409818|FG000|Overall Study|Protocol Violation|0|||
127942047|NCT00191165|460409819|FG001|Overall Study|Protocol Violation|1|||
127942048|NCT00191165|460409818|FG000|Overall Study|Participant Moved Away|0|||
127942049|NCT00191165|460409819|FG001|Overall Study|Participant Moved Away|1|||
127942050|NCT00998309|460409824|FG000|Overall Study|Protocol Violation|4|||
127942051|NCT02865460|460409825|FG000|Overall Study|Adverse Event|1|||
127942052|NCT02865460|460409826|FG001|Overall Study|Adverse Event|0|||
127942053|NCT02865460|460409825|FG000|Overall Study|Withdrawal by Subject|1|||
127942054|NCT02865460|460409826|FG001|Overall Study|Withdrawal by Subject|1|||
127942055|NCT02865460|460409825|FG000|Overall Study|Lost to Follow-up|7|||
127942056|NCT02865460|460409826|FG001|Overall Study|Lost to Follow-up|4|||
127942057|NCT02865460|460409825|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
127942058|NCT02865460|460409826|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
127942059|NCT02238795|460409841|FG000|Overall Study|Patient without purpura fulminans|1|||
127942060|NCT04480021|460409845|FG000|Overall Study|Lost to Follow-up|3|||
127942061|NCT04480021|460409846|FG001|Overall Study|Lost to Follow-up|4|||
127942062|NCT01292226|460409848|FG000|Overall Study|Adverse Event|5|||
127942063|NCT01292226|460409848|FG000|Overall Study|Death|1|||
127942064|NCT01292226|460409848|FG000|Overall Study|Graft loss|1|||
127942065|NCT01292226|460409848|FG000|Overall Study|Protocol Violation|3|||
127942066|NCT01292226|460409848|FG000|Overall Study|Withdrawal by Subject|1|||
127942067|NCT01292226|460409848|FG000|Overall Study|Other|2|||
127942068|NCT01844505|460409851|FG000|Treatment Period|SUBJECT WITHDREW CONSENT|9|||
127942069|NCT01844505|460409852|FG001|Treatment Period|SUBJECT WITHDREW CONSENT|12|||
127942070|NCT01844505|460409853|FG002|Treatment Period|SUBJECT WITHDREW CONSENT|19|||
127942071|NCT01844505|460409851|FG000|Treatment Period|Other Reasons|120|||
127942072|NCT01844505|460409852|FG001|Treatment Period|Other Reasons|136|||
127942073|NCT01844505|460409853|FG002|Treatment Period|Other Reasons|58|||
127942074|NCT01844505|460409851|FG000|Treatment Period|Lost to Follow-up|9|||
127942075|NCT01844505|460409852|FG001|Treatment Period|Lost to Follow-up|11|||
127942076|NCT01844505|460409853|FG002|Treatment Period|Lost to Follow-up|6|||
127942077|NCT01844505|460409851|FG000|Treatment Period|Death|175|||
127942078|NCT01844505|460409852|FG001|Treatment Period|Death|154|||
127942079|NCT01844505|460409853|FG002|Treatment Period|Death|228|||
127942080|NCT03384654|460409854|FG000|Overall Study|Withdrawal by Subject|0|||
127942081|NCT03384654|460409855|FG001|Overall Study|Withdrawal by Subject|0|||
127942082|NCT03384654|460409856|FG002|Overall Study|Withdrawal by Subject|1|||
127942083|NCT03384654|460409857|FG003|Overall Study|Withdrawal by Subject|0|||
127942084|NCT00423319|460409858|FG000|Overall Study|Death|2|||
127942085|NCT00423319|460409859|FG001|Overall Study|Death|0|||
127942086|NCT00423319|460409858|FG000|Overall Study|Adverse Event|93|||
127942087|NCT00423319|460409859|FG001|Overall Study|Adverse Event|112|||
127942088|NCT00423319|460409858|FG000|Overall Study|Withdrawal by Subject|86|||
127942089|NCT00423319|460409859|FG001|Overall Study|Withdrawal by Subject|99|||
127942090|NCT00423319|460409858|FG000|Overall Study|Lost to Follow-up|4|||
127942091|NCT00423319|460409859|FG001|Overall Study|Lost to Follow-up|3|||
127942092|NCT00423319|460409858|FG000|Overall Study|Poor compliance or noncompliance|1|||
127942093|NCT00423319|460409859|FG001|Overall Study|Poor compliance or noncompliance|1|||
127942094|NCT00423319|460409858|FG000|Overall Study|No longer meets study criteria|15|||
127942095|NCT00423319|460409859|FG001|Overall Study|No longer meets study criteria|15|||
127942096|NCT00423319|460409858|FG000|Overall Study|Other|23|||
127942097|NCT00423319|460409859|FG001|Overall Study|Other|22|||
127942098|NCT01584843|460409860|FG000|First Treatment Period|Adverse Event|0|||
127942099|NCT01584843|460409861|FG001|First Treatment Period|Adverse Event|0|||
127942100|NCT01584843|460409862|FG002|First Treatment Period|Adverse Event|1|||
127942101|NCT01584843|460409863|FG003|First Treatment Period|Adverse Event|0|||
127942102|NCT01584843|460409864|FG004|First Treatment Period|Adverse Event|0|||
127942103|NCT01584843|460409865|FG005|First Treatment Period|Adverse Event|0|||
127942104|NCT01584843|460409860|FG000|First Treatment Period|Protocol Violation|0|||
127942105|NCT01584843|460409861|FG001|First Treatment Period|Protocol Violation|0|||
127942106|NCT01584843|460409862|FG002|First Treatment Period|Protocol Violation|0|||
127942107|NCT01584843|460409863|FG003|First Treatment Period|Protocol Violation|0|||
127942108|NCT01584843|460409864|FG004|First Treatment Period|Protocol Violation|0|||
127942109|NCT01584843|460409865|FG005|First Treatment Period|Protocol Violation|1|||
127942110|NCT01584843|460409860|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
127942111|NCT01584843|460409861|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
127942112|NCT01584843|460409862|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
127942113|NCT01584843|460409863|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
127942114|NCT01584843|460409864|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
127942115|NCT01584843|460409865|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
127942116|NCT01584843|460409860|FG000|Second Treatment Period|Withdrawal by Subject|0|||
127942117|NCT01584843|460409861|FG001|Second Treatment Period|Withdrawal by Subject|0|||
127942118|NCT01584843|460409862|FG002|Second Treatment Period|Withdrawal by Subject|0|||
127942119|NCT01584843|460409863|FG003|Second Treatment Period|Withdrawal by Subject|0|||
127942120|NCT01584843|460409864|FG004|Second Treatment Period|Withdrawal by Subject|0|||
127942121|NCT01584843|460409865|FG005|Second Treatment Period|Withdrawal by Subject|1|||
127942122|NCT00311402|460409866|FG000|Overall Study|Adverse Event|118|||
127942123|NCT00311402|460409867|FG001|Overall Study|Adverse Event|105|||
127942124|NCT00311402|460409866|FG000|Overall Study|Lost to Follow-up|0|||
127942125|NCT00311402|460409867|FG001|Overall Study|Lost to Follow-up|3|||
127942126|NCT00311402|460409866|FG000|Overall Study|Withdrawal by Subject|17|||
127942127|NCT00311402|460409867|FG001|Overall Study|Withdrawal by Subject|18|||
127942128|NCT00311402|460409866|FG000|Overall Study|Lack of Efficacy|58|||
127942129|NCT00311402|460409867|FG001|Overall Study|Lack of Efficacy|42|||
127942130|NCT00311402|460409866|FG000|Overall Study|Protocol Violation|7|||
127942131|NCT00311402|460409867|FG001|Overall Study|Protocol Violation|6|||
127942132|NCT00311402|460409866|FG000|Overall Study|IRB's rejection etc.|10|||
127942133|NCT00311402|460409867|FG001|Overall Study|IRB's rejection etc.|3|||
127942134|NCT02640053|460409868|FG000|Overall Study|Withdrawal by Subject|2|||
127942135|NCT02640053|460409869|FG001|Overall Study|Withdrawal by Subject|1|||
127942136|NCT02640053|460409868|FG000|Overall Study|Adverse Event|1|||
127942137|NCT02640053|460409869|FG001|Overall Study|Adverse Event|1|||
127942138|NCT02640053|460409868|FG000|Overall Study|Alternative Therapy|1|||
127942139|NCT02640053|460409869|FG001|Overall Study|Alternative Therapy|1|||
127942140|NCT02640053|460409868|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
127942141|NCT02640053|460409869|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
127942142|NCT03283761|460409870|FG000|Study Treatment|Patient Non-Compliance|1|||
127942143|NCT03283761|460409870|FG000|Study Treatment|Alternative Cancer Therapy|7|||
127942144|NCT03283761|460409870|FG000|Study Treatment|Disease progression|21|||
127942145|NCT03283761|460409870|FG000|Study Treatment|Adverse Event|3|||
127942146|NCT03283761|460409870|FG000|Study Treatment|Withdrawal by Subject|4|||
127942147|NCT03283761|460409870|FG000|Study Treatment|Pre-existing GI bleed and chronic anemia from that led to hospitalization and going off trial.|1|||
127942148|NCT03283761|460409870|FG000|Study Treatment|Symptomatic Deterioration|1|||
127942149|NCT03283761|460409870|FG000|Study Treatment|Screen Failure Before Therapy Start|1|||
127942150|NCT03283761|460409870|FG000|Follow up|Lost to Follow-up|1|||
127942151|NCT03283761|460409870|FG000|Follow up|Symptomatic Deterioration|1|||
127942152|NCT03283761|460409870|FG000|Follow up|Death|29|||
127942153|NCT03283761|460409870|FG000|Follow up|study terminated|4|||
127942154|NCT03283761|460409870|FG000|Follow up|Primary Investigator Withdrawal|1|||
127942155|NCT03283761|460409870|FG000|Follow up|Switched to alternative therapy|1|||
127942156|NCT03283761|460409870|FG000|Follow up|Subject is now in Hospice|1|||
127942157|NCT02036775|460409871|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
127942158|NCT02036775|460409872|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
127942159|NCT02036775|460409873|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
127942160|NCT02036775|460409874|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
127942161|NCT02036775|460409875|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
127942162|NCT02036775|460409876|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
127942163|NCT01268501|460409877|FG000|Overall Study|Lost to Follow-up|1|||
127942164|NCT01268501|460409877|FG000|Overall Study|Withdrawal by Subject|3|||
127942165|NCT01268501|460409877|FG000|Overall Study|Unacceptable Subjective Vision|3|||
127942166|NCT01268501|460409877|FG000|Overall Study|Handling Difficulties|2|||
127942167|NCT00678886|460409878|FG000|Overall Study|Withdrawal by Subject|0|||
127942168|NCT00678886|460409879|FG001|Overall Study|Withdrawal by Subject|0|||
127942169|NCT00678886|460409880|FG002|Overall Study|Withdrawal by Subject|4|||
127942170|NCT00678886|460409881|FG003|Overall Study|Withdrawal by Subject|6|||
127942171|NCT00678886|460409878|FG000|Overall Study|Physician Decision|0|||
127942172|NCT00678886|460409879|FG001|Overall Study|Physician Decision|0|||
127942173|NCT00678886|460409880|FG002|Overall Study|Physician Decision|1|||
127942174|NCT00678886|460409881|FG003|Overall Study|Physician Decision|1|||
127942175|NCT00678886|460409878|FG000|Overall Study|Lost to Follow-up|0|||
127942176|NCT00678886|460409879|FG001|Overall Study|Lost to Follow-up|0|||
127942177|NCT00678886|460409880|FG002|Overall Study|Lost to Follow-up|3|||
127942178|NCT00678886|460409881|FG003|Overall Study|Lost to Follow-up|2|||
127942179|NCT00678886|460409878|FG000|Overall Study|Other|0|||
127942180|NCT00678886|460409879|FG001|Overall Study|Other|0|||
127942181|NCT00678886|460409880|FG002|Overall Study|Other|1|||
127942182|NCT00678886|460409881|FG003|Overall Study|Other|0|||
127942183|NCT00206323|460409882|FG000|Overall Study|Lack of Efficacy|4|||
127942184|NCT00206323|460409883|FG001|Overall Study|Lack of Efficacy|1|||
127942185|NCT00206323|460409882|FG000|Overall Study|Adverse Event|1|||
127942186|NCT00206323|460409883|FG001|Overall Study|Adverse Event|1|||
127942187|NCT00206323|460409882|FG000|Overall Study|Lost to Follow-up|1|||
127942188|NCT00206323|460409883|FG001|Overall Study|Lost to Follow-up|1|||
127942189|NCT00827632|460409887|FG000|Overall Study|Lost to Follow-up|8|||
127942190|NCT00827632|460409888|FG001|Overall Study|Lost to Follow-up|12|||
127942191|NCT00827632|460409887|FG000|Overall Study|Early withdrawal|14|||
127942192|NCT00827632|460409888|FG001|Overall Study|Early withdrawal|11|||
127942193|NCT01910389|460409889|FG000|Overall Study|Withdrawal by Subject|2|||
127942194|NCT01910389|460409890|FG001|Overall Study|Withdrawal by Subject|0|||
127942195|NCT01910389|460409889|FG000|Overall Study|Study Closed|13|||
127942196|NCT01910389|460409890|FG001|Overall Study|Study Closed|8|||
127942197|NCT04669691|460409895|FG000|Overall Study|Death|0|||
127942198|NCT04669691|460409896|FG001|Overall Study|Death|1|||
127942199|NCT04669691|460409897|FG002|Overall Study|Death|0|||
127942200|NCT04669691|460409898|FG003|Overall Study|Death|0|||
127942201|NCT04669691|460409899|FG004|Overall Study|Death|0|||
127942202|NCT04669691|460409900|FG005|Overall Study|Death|0|||
127942203|NCT02304458|460409901|FG000|Overall Study|Adverse Event|0|||
127942204|NCT02304458|460409902|FG001|Overall Study|Adverse Event|0|||
127942205|NCT02304458|460409903|FG002|Overall Study|Adverse Event|7|||
127942206|NCT02304458|460409904|FG003|Overall Study|Adverse Event|0|||
127942207|NCT02304458|460409905|FG004|Overall Study|Adverse Event|0|||
127942208|NCT02304458|460409906|FG005|Overall Study|Adverse Event|0|||
127942209|NCT02304458|460409907|FG006|Overall Study|Adverse Event|3|||
127942210|NCT02304458|460409908|FG007|Overall Study|Adverse Event|4|||
127942211|NCT02304458|460409901|FG000|Overall Study|Death|0|||
127942212|NCT02304458|460409902|FG001|Overall Study|Death|0|||
127942213|NCT02304458|460409903|FG002|Overall Study|Death|2|||
127942214|NCT02304458|460409904|FG003|Overall Study|Death|0|||
127942215|NCT02304458|460409905|FG004|Overall Study|Death|0|||
127942216|NCT02304458|460409906|FG005|Overall Study|Death|0|||
127942217|NCT02304458|460409907|FG006|Overall Study|Death|1|||
127942218|NCT02304458|460409908|FG007|Overall Study|Death|0|||
127942219|NCT02304458|460409901|FG000|Overall Study|Lack of Efficacy|4|||
127942220|NCT02304458|460409902|FG001|Overall Study|Lack of Efficacy|6|||
127942221|NCT02304458|460409903|FG002|Overall Study|Lack of Efficacy|38|||
127942222|NCT02304458|460409904|FG003|Overall Study|Lack of Efficacy|5|||
127942223|NCT02304458|460409905|FG004|Overall Study|Lack of Efficacy|6|||
127942224|NCT02304458|460409906|FG005|Overall Study|Lack of Efficacy|6|||
127942225|NCT02304458|460409907|FG006|Overall Study|Lack of Efficacy|21|||
127942226|NCT02304458|460409908|FG007|Overall Study|Lack of Efficacy|4|||
127942227|NCT02304458|460409901|FG000|Overall Study|Physician Decision|2|||
127942228|NCT02304458|460409902|FG001|Overall Study|Physician Decision|0|||
127942229|NCT02304458|460409903|FG002|Overall Study|Physician Decision|16|||
127942230|NCT02304458|460409904|FG003|Overall Study|Physician Decision|1|||
127942231|NCT02304458|460409905|FG004|Overall Study|Physician Decision|0|||
127942232|NCT02304458|460409906|FG005|Overall Study|Physician Decision|0|||
127942233|NCT02304458|460409907|FG006|Overall Study|Physician Decision|3|||
127942234|NCT02304458|460409908|FG007|Overall Study|Physician Decision|0|||
127942235|NCT02304458|460409901|FG000|Overall Study|Protocol Violation|0|||
127942236|NCT02304458|460409902|FG001|Overall Study|Protocol Violation|0|||
127942237|NCT02304458|460409903|FG002|Overall Study|Protocol Violation|1|||
127942238|NCT02304458|460409904|FG003|Overall Study|Protocol Violation|0|||
127942239|NCT02304458|460409905|FG004|Overall Study|Protocol Violation|0|||
127942240|NCT02304458|460409906|FG005|Overall Study|Protocol Violation|0|||
127942241|NCT02304458|460409907|FG006|Overall Study|Protocol Violation|0|||
127942242|NCT02304458|460409908|FG007|Overall Study|Protocol Violation|0|||
127942243|NCT02304458|460409901|FG000|Overall Study|Withdrawal by Subject|1|||
127942244|NCT02304458|460409902|FG001|Overall Study|Withdrawal by Subject|0|||
127942245|NCT02304458|460409903|FG002|Overall Study|Withdrawal by Subject|7|||
127942246|NCT02304458|460409904|FG003|Overall Study|Withdrawal by Subject|0|||
127942247|NCT02304458|460409905|FG004|Overall Study|Withdrawal by Subject|0|||
127942248|NCT02304458|460409906|FG005|Overall Study|Withdrawal by Subject|0|||
127942249|NCT02304458|460409907|FG006|Overall Study|Withdrawal by Subject|1|||
127942250|NCT02304458|460409908|FG007|Overall Study|Withdrawal by Subject|0|||
127942251|NCT03401450|460409909|FG000|Overall Study|Lost to Follow-up|4|||
127942252|NCT03401450|460409910|FG001|Overall Study|Lost to Follow-up|6|||
127942253|NCT03401450|460409909|FG000|Overall Study|Anesthesia plan changed|2|||
127942254|NCT03401450|460409910|FG001|Overall Study|Anesthesia plan changed|2|||
127942255|NCT03401450|460409909|FG000|Overall Study|Did not complete medication diary|4|||
127942256|NCT03401450|460409910|FG001|Overall Study|Did not complete medication diary|2|||
127942257|NCT03401450|460409909|FG000|Overall Study|post surgery medication change|2|||
127942258|NCT03401450|460409910|FG001|Overall Study|post surgery medication change|1|||
127942259|NCT03401450|460409909|FG000|Overall Study|Cancelled surgery|0|||
127942260|NCT03401450|460409910|FG001|Overall Study|Cancelled surgery|2|||
127942261|NCT02288182|460409911|FG000|Overall Study|Adverse Event|0|||
127942262|NCT02288182|460409912|FG001|Overall Study|Adverse Event|1|||
127942263|NCT02288182|460409911|FG000|Overall Study|Lost to Follow-up|0|||
127942264|NCT02288182|460409912|FG001|Overall Study|Lost to Follow-up|1|||
127942265|NCT00461253|460411657|FG000|Overall Study|Death|985|||
127942266|NCT00461253|460411658|FG001|Overall Study|Death|0|||
127942267|NCT00461253|460411657|FG000|Overall Study|Protocol Violation|613|||
127942268|NCT00461253|460411658|FG001|Overall Study|Protocol Violation|236|||
127942269|NCT00461253|460411657|FG000|Overall Study|no response|2609|||
127942270|NCT00461253|460411658|FG001|Overall Study|no response|11789|||
127942271|NCT00461253|460411657|FG000|Overall Study|administrative|773|||
127942272|NCT00461253|460411658|FG001|Overall Study|administrative|7773|||
127942273|NCT04240392|460411659|FG000|Overall Study|Withdrawal by Subject|13|||
127942274|NCT04240392|460411660|FG001|Overall Study|Withdrawal by Subject|4|||
127942275|NCT04240392|460411659|FG000|Overall Study|Lost to Follow-up|11|||
127942276|NCT04240392|460411660|FG001|Overall Study|Lost to Follow-up|12|||
127942277|NCT01523457|460411661|FG000|Overall Study|Withdrawal by Subject|7|||
127942278|NCT01523457|460411662|FG001|Overall Study|Withdrawal by Subject|2|||
127942279|NCT04345601|460411663|FG000|Overall Study|Death|0|||
127942280|NCT04345601|460411664|FG001|Overall Study|Death|3|||
127942281|NCT04345601|460411665|FG002|Overall Study|Death|2|||
127942282|NCT04345601|460411663|FG000|Overall Study|Lost to Follow-up|0|||
127942283|NCT04345601|460411664|FG001|Overall Study|Lost to Follow-up|0|||
127942284|NCT04345601|460411665|FG002|Overall Study|Lost to Follow-up|2|||
127942285|NCT03047330|460411668|FG000|Sleep Block 1|Withdrawal by Subject|3|||
127942286|NCT00540293|460411675|FG000|Overall Study|Adverse event related to study drug|10|||
127942287|NCT00540293|460411675|FG000|Overall Study|Adverse event not related to study drug|7|||
127942288|NCT00540293|460411675|FG000|Overall Study|Withdrawal by Subject|6|||
127942289|NCT00540293|460411675|FG000|Overall Study|Protocol violation, & subject schedule|12|||
127942290|NCT02585934|460411678|FG000|Overall Study|Lost to Follow-up|2|||
127942291|NCT02585934|460411679|FG001|Overall Study|Lost to Follow-up|2|||
127942292|NCT02585934|460411678|FG000|Overall Study|Protocol Violation|14|||
127942293|NCT02585934|460411679|FG001|Overall Study|Protocol Violation|11|||
127942294|NCT02585934|460411678|FG000|Overall Study|Adverse Event|21|||
127942295|NCT02585934|460411679|FG001|Overall Study|Adverse Event|22|||
127942296|NCT02585934|460411678|FG000|Overall Study|Physician Decision|3|||
127942297|NCT02585934|460411679|FG001|Overall Study|Physician Decision|2|||
127942298|NCT02585934|460411678|FG000|Overall Study|Withdrawal by Subject|7|||
127942299|NCT02585934|460411679|FG001|Overall Study|Withdrawal by Subject|21|||
127942300|NCT02585934|460411678|FG000|Overall Study|Lack of Efficacy|2|||
127942301|NCT02585934|460411679|FG001|Overall Study|Lack of Efficacy|1|||
127942302|NCT02585934|460411678|FG000|Overall Study|Death|2|||
127942303|NCT02585934|460411679|FG001|Overall Study|Death|0|||
127942304|NCT02585934|460411678|FG000|Overall Study|Caregiver Withdrew Consent|7|||
127942305|NCT02585934|460411679|FG001|Overall Study|Caregiver Withdrew Consent|7|||
127942306|NCT02585934|460411678|FG000|Overall Study|Sponsor Termination|1|||
127942307|NCT02585934|460411679|FG001|Overall Study|Sponsor Termination|2|||
127942308|NCT02585934|460411678|FG000|Overall Study|Another Reason|10|||
127942309|NCT02585934|460411679|FG001|Overall Study|Another Reason|5|||
127942310|NCT02448706|460411680|FG000|Overall Study|Withdrawal by Subject|4|||
127942311|NCT02448706|460411681|FG001|Overall Study|Withdrawal by Subject|3|||
127942312|NCT02448706|460411680|FG000|Overall Study|Protocol Violation|1|||
127942313|NCT02448706|460411681|FG001|Overall Study|Protocol Violation|1|||
127942314|NCT01359969|460411682|FG000|Overall Study|Study continued until at least 20 patients had been treated for at least one treatment.|37|||
127942315|NCT00470067|460411693|FG000|Overall Study|Death|1|||
127942316|NCT00470067|460411693|FG000|Overall Study|Disease Progression|6|||
127942317|NCT03400943|460411694|FG000|Treatment Period 1|Adverse Event|0|||
127942318|NCT03400943|460411695|FG001|Treatment Period 1|Adverse Event|0|||
127942319|NCT03400943|460411696|FG002|Treatment Period 1|Adverse Event|0|||
127942320|NCT03400943|460411697|FG003|Treatment Period 1|Adverse Event|1|||
127942321|NCT03400943|460411694|FG000|Treatment Period 1|Lost to Follow-up|1|||
127942322|NCT03400943|460411695|FG001|Treatment Period 1|Lost to Follow-up|0|||
127942323|NCT03400943|460411696|FG002|Treatment Period 1|Lost to Follow-up|0|||
127942324|NCT03400943|460411697|FG003|Treatment Period 1|Lost to Follow-up|0|||
127942325|NCT03400943|460411694|FG000|Treatment Period 1|Protocol Violation|0|||
127942326|NCT03400943|460411695|FG001|Treatment Period 1|Protocol Violation|1|||
127942327|NCT03400943|460411696|FG002|Treatment Period 1|Protocol Violation|1|||
127942328|NCT03400943|460411697|FG003|Treatment Period 1|Protocol Violation|0|||
127942329|NCT03400943|460411694|FG000|Treatment Period 1|Study terminated by sponsor|2|||
127942330|NCT03400943|460411695|FG001|Treatment Period 1|Study terminated by sponsor|0|||
127942331|NCT03400943|460411696|FG002|Treatment Period 1|Study terminated by sponsor|0|||
127942332|NCT03400943|460411697|FG003|Treatment Period 1|Study terminated by sponsor|1|||
127942333|NCT03400943|460411694|FG000|Treatment Period 1|Withdrawal by Subject|0|||
127942334|NCT03400943|460411695|FG001|Treatment Period 1|Withdrawal by Subject|0|||
127942335|NCT03400943|460411696|FG002|Treatment Period 1|Withdrawal by Subject|3|||
127942336|NCT03400943|460411697|FG003|Treatment Period 1|Withdrawal by Subject|1|||
127942337|NCT03400943|460411694|FG000|Treatment Period 1|Other|2|||
127942338|NCT03400943|460411695|FG001|Treatment Period 1|Other|1|||
127942339|NCT03400943|460411696|FG002|Treatment Period 1|Other|2|||
127942340|NCT03400943|460411697|FG003|Treatment Period 1|Other|2|||
127942341|NCT03400943|460411694|FG000|Post-treatment Period 1|Adverse Event|2|||
127942342|NCT03400943|460411695|FG001|Post-treatment Period 1|Adverse Event|0|||
127942343|NCT03400943|460411696|FG002|Post-treatment Period 1|Adverse Event|0|||
127942344|NCT03400943|460411697|FG003|Post-treatment Period 1|Adverse Event|0|||
127942345|NCT03400943|460411694|FG000|Post-treatment Period 1|Protocol Violation|1|||
127942346|NCT03400943|460411695|FG001|Post-treatment Period 1|Protocol Violation|0|||
127942347|NCT03400943|460411696|FG002|Post-treatment Period 1|Protocol Violation|0|||
127942348|NCT03400943|460411697|FG003|Post-treatment Period 1|Protocol Violation|0|||
127942349|NCT03400943|460411694|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
127942350|NCT03400943|460411695|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
127942351|NCT03400943|460411696|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
127942352|NCT03400943|460411697|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
127942353|NCT03400943|460411694|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
127942354|NCT03400943|460411695|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
127942355|NCT03400943|460411696|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
127942356|NCT03400943|460411697|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
127942357|NCT03400943|460411694|FG000|Post-treatment Period 1|Other|2|||
127942358|NCT03400943|460411695|FG001|Post-treatment Period 1|Other|0|||
127942359|NCT03400943|460411696|FG002|Post-treatment Period 1|Other|4|||
127942360|NCT03400943|460411697|FG003|Post-treatment Period 1|Other|5|||
127942361|NCT03400943|460411694|FG000|Treatment Period 2|Study terminated by sponsor|0|||
127942362|NCT03400943|460411695|FG001|Treatment Period 2|Study terminated by sponsor|1|||
127942363|NCT03400943|460411696|FG002|Treatment Period 2|Study terminated by sponsor|0|||
127942364|NCT03400943|460411697|FG003|Treatment Period 2|Study terminated by sponsor|0|||
127942365|NCT03400943|460411694|FG000|Treatment Period 2|Withdrawal by Subject|0|||
127942366|NCT03400943|460411695|FG001|Treatment Period 2|Withdrawal by Subject|1|||
127942367|NCT03400943|460411696|FG002|Treatment Period 2|Withdrawal by Subject|0|||
127942368|NCT03400943|460411697|FG003|Treatment Period 2|Withdrawal by Subject|0|||
127942369|NCT03400943|460411694|FG000|Treatment Period 2|Other|1|||
127942370|NCT03400943|460411695|FG001|Treatment Period 2|Other|6|||
127942371|NCT03400943|460411696|FG002|Treatment Period 2|Other|0|||
127942372|NCT03400943|460411697|FG003|Treatment Period 2|Other|0|||
127942373|NCT03400943|460411694|FG000|Follow-up Period|Withdrawal by Subject|1|||
127942374|NCT03400943|460411695|FG001|Follow-up Period|Withdrawal by Subject|0|||
127942375|NCT03400943|460411696|FG002|Follow-up Period|Withdrawal by Subject|0|||
127942376|NCT03400943|460411697|FG003|Follow-up Period|Withdrawal by Subject|0|||
127942377|NCT02563106|460411698|FG000|Overall Study|Withdrawal by Subject|7|||
127942378|NCT02563106|460411699|FG001|Overall Study|Withdrawal by Subject|8|||
127942379|NCT02563106|460411698|FG000|Overall Study|Adverse Event|17|||
127942380|NCT02563106|460411699|FG001|Overall Study|Adverse Event|15|||
127942381|NCT02563106|460411698|FG000|Overall Study|Protocol Violation|1|||
127942382|NCT02563106|460411699|FG001|Overall Study|Protocol Violation|0|||
127942383|NCT02563106|460411698|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
127942384|NCT02563106|460411699|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
127942385|NCT02563106|460411698|FG000|Overall Study|Lost to Follow-up|3|||
127942386|NCT02563106|460411699|FG001|Overall Study|Lost to Follow-up|2|||
127942387|NCT02563106|460411698|FG000|Overall Study|Physician Decision|3|||
127942388|NCT02563106|460411699|FG001|Overall Study|Physician Decision|1|||
127942389|NCT02563106|460411698|FG000|Overall Study|Other reason - not specified|2|||
127942390|NCT02563106|460411699|FG001|Overall Study|Other reason - not specified|1|||
127942391|NCT04729309|460411700|FG000|Period 1|Subject unable to return for Period 2|3|||
127942392|NCT04729309|460411701|FG001|Period 1|Subject unable to return for Period 2|0|||
127942393|NCT04729309|460411700|FG000|Period 1|Lost to Follow-up|1|||
127942394|NCT04729309|460411701|FG001|Period 1|Lost to Follow-up|0|||
127942395|NCT01059539|460411702|FG000|Overall Study|Adverse Event|66|||
127942396|NCT01059539|460411702|FG000|Overall Study|Insufficient Therapeutic Response|26|||
127942397|NCT01059539|460411702|FG000|Overall Study|Protocol Violation|55|||
127942398|NCT01059539|460411702|FG000|Overall Study|Withdrawal of Consent|80|||
127942399|NCT01059539|460411702|FG000|Overall Study|Lost to Follow-up|42|||
127942400|NCT01059539|460411702|FG000|Overall Study|Reason Not Specified|2|||
127942401|NCT00537303|460411703|FG000|Overall Study|Adverse Event|1|||
127942402|NCT00537303|460411704|FG001|Overall Study|Adverse Event|4|||
127942403|NCT00537303|460411703|FG000|Overall Study|Lack of Efficacy|6|||
127942404|NCT00537303|460411704|FG001|Overall Study|Lack of Efficacy|7|||
127942405|NCT00537303|460411703|FG000|Overall Study|Protocol Violation|8|||
127942406|NCT00537303|460411704|FG001|Overall Study|Protocol Violation|4|||
127942407|NCT00537303|460411703|FG000|Overall Study|Withdrawal criteria|3|||
127942408|NCT00537303|460411704|FG001|Overall Study|Withdrawal criteria|3|||
127942409|NCT00537303|460411703|FG000|Overall Study|Unclassified|8|||
127942410|NCT00537303|460411704|FG001|Overall Study|Unclassified|7|||
127942411|NCT02085135|460411706|FG000|Overall Study|Adverse Event|4|||
127942412|NCT02085135|460411707|FG001|Overall Study|Adverse Event|7|||
127942413|NCT02085135|460411706|FG000|Overall Study|Lost to Follow-up|2|||
127942414|NCT02085135|460411707|FG001|Overall Study|Lost to Follow-up|2|||
127942415|NCT02085135|460411706|FG000|Overall Study|Withdrawal by Subject|3|||
127942416|NCT02085135|460411707|FG001|Overall Study|Withdrawal by Subject|0|||
127942417|NCT02085135|460411706|FG000|Overall Study|Lack of Efficacy|2|||
127942418|NCT02085135|460411707|FG001|Overall Study|Lack of Efficacy|0|||
127942419|NCT04091659|460411709|FG000|Overall Study|Protocol Violation|3|||
127942420|NCT04091659|460411710|FG001|Overall Study|Protocol Violation|0|||
127942421|NCT04091659|460411709|FG000|Overall Study|Lost to Follow-up|0|||
127942422|NCT04091659|460411710|FG001|Overall Study|Lost to Follow-up|1|||
127942423|NCT03678285|460411715|FG000|Overall Study|Adverse Event|2|||
127942424|NCT03678285|460411715|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
127942425|NCT03678285|460411715|FG000|Overall Study|Dehydrated prior to start of workout|1|||
127942426|NCT00616629|460411716|FG000|Overall Study|Protocol Violation|1|||
127942427|NCT00616629|460411717|FG001|Overall Study|Protocol Violation|2|||
127942428|NCT00616629|460411718|FG002|Overall Study|Protocol Violation|1|||
127942429|NCT00616629|460411719|FG003|Overall Study|Protocol Violation|0|||
127942430|NCT00616629|460411720|FG004|Overall Study|Protocol Violation|0|||
127942431|NCT00616629|460411716|FG000|Overall Study|AV-block|1|||
127942432|NCT00616629|460411717|FG001|Overall Study|AV-block|0|||
127942433|NCT00616629|460411718|FG002|Overall Study|AV-block|0|||
127942434|NCT00616629|460411719|FG003|Overall Study|AV-block|0|||
127942435|NCT00616629|460411720|FG004|Overall Study|AV-block|0|||
127942436|NCT01777620|460411721|FG000|Overall Study|Subject Withdrawal|1|||
127942437|NCT01777620|460411722|FG001|Overall Study|Subject Withdrawal|0|||
127942438|NCT01475097|460411729|FG000|Overall Study|Protocol Violation|1|||
127942439|NCT01475097|460411730|FG001|Overall Study|Protocol Violation|1|||
127942440|NCT04005352|460411742|FG000|Overall Study|Adverse Event|4|||
127942441|NCT04005352|460411743|FG001|Overall Study|Adverse Event|5|||
127942442|NCT04005352|460411742|FG000|Overall Study|Death|4|||
127942443|NCT04005352|460411743|FG001|Overall Study|Death|2|||
127942444|NCT04005352|460411742|FG000|Overall Study|Lost to Follow-up|6|||
127942445|NCT04005352|460411743|FG001|Overall Study|Lost to Follow-up|2|||
127942446|NCT04005352|460411742|FG000|Overall Study|Physician Decision|7|||
127942447|NCT04005352|460411743|FG001|Overall Study|Physician Decision|13|||
127942448|NCT04005352|460411742|FG000|Overall Study|Protocol Violation|0|||
127942449|NCT04005352|460411743|FG001|Overall Study|Protocol Violation|1|||
127942450|NCT04005352|460411742|FG000|Overall Study|Withdrawal by Subject|28|||
127942451|NCT04005352|460411743|FG001|Overall Study|Withdrawal by Subject|38|||
127942452|NCT00936897|460411746|FG000|Overall Study|Withdrawal by Subject|9|||
127942453|NCT00936897|460411747|FG001|Overall Study|Withdrawal by Subject|19|||
127942454|NCT00936897|460411746|FG000|Overall Study|Adverse Event|4|||
127942455|NCT00936897|460411747|FG001|Overall Study|Adverse Event|13|||
127942456|NCT00936897|460411746|FG000|Overall Study|Other|3|||
127942457|NCT00936897|460411747|FG001|Overall Study|Other|9|||
127942458|NCT00936897|460411746|FG000|Overall Study|Lost to Follow-up|1|||
127942459|NCT00936897|460411747|FG001|Overall Study|Lost to Follow-up|10|||
127942460|NCT00936897|460411746|FG000|Overall Study|Administrative Decision|1|||
127942461|NCT00936897|460411747|FG001|Overall Study|Administrative Decision|2|||
127942462|NCT00936897|460411746|FG000|Overall Study|Protocol Violation|1|||
127942463|NCT00936897|460411747|FG001|Overall Study|Protocol Violation|1|||
127942464|NCT00936897|460411746|FG000|Overall Study|Ineligibility Determined|0|||
127942465|NCT00936897|460411747|FG001|Overall Study|Ineligibility Determined|3|||
127942466|NCT00936897|460411746|FG000|Overall Study|Noncompliance|0|||
127942467|NCT00936897|460411747|FG001|Overall Study|Noncompliance|2|||
127942468|NCT00936897|460411746|FG000|Overall Study|Death|0|||
127942469|NCT00936897|460411747|FG001|Overall Study|Death|1|||
127942470|NCT04058067|460411748|FG000|Overall Study|Adverse Event|2|||
127942471|NCT04058067|460411749|FG001|Overall Study|Adverse Event|0|||
127942472|NCT04058067|460411748|FG000|Overall Study|Death|0|||
127942473|NCT04058067|460411749|FG001|Overall Study|Death|1|||
127942474|NCT04058067|460411748|FG000|Overall Study|Physician Decision|3|||
127942475|NCT04058067|460411749|FG001|Overall Study|Physician Decision|1|||
127942476|NCT04058067|460411748|FG000|Overall Study|Protocol Violation|0|||
127942477|NCT04058067|460411749|FG001|Overall Study|Protocol Violation|1|||
127942478|NCT04058067|460411748|FG000|Overall Study|Withdrawal by Subject|7|||
127942479|NCT04058067|460411749|FG001|Overall Study|Withdrawal by Subject|8|||
127942480|NCT00417170|460411750|FG000|Overall Study|Adverse Event|1|||
127942481|NCT00417170|460411751|FG001|Overall Study|Adverse Event|1|||
127942482|NCT00417170|460411750|FG000|Overall Study|Withdrawal by Subject|1|||
127942483|NCT00417170|460411751|FG001|Overall Study|Withdrawal by Subject|1|||
127942484|NCT00417170|460411750|FG000|Overall Study|Lost to Follow-up|0|||
127942485|NCT00417170|460411751|FG001|Overall Study|Lost to Follow-up|1|||
127942486|NCT05005312|460411752|FG000|Overall Study|Enrolled, but not treated|0|||
127942487|NCT05005312|460411753|FG001|Overall Study|Enrolled, but not treated|1|||
127942488|NCT01283035|460411755|FG000|Overall Study|Subject later found ineligible|1|||
127942489|NCT00867503|460411756|FG000|Overall Study|Withdrawal by Subject|1|||
127942490|NCT02704403|460411757|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
127942491|NCT02704403|460411758|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
127942492|NCT02704403|460411757|FG000|Overall Study|Administrative reasons by sponsor|1251|||
127942493|NCT02704403|460411758|FG001|Overall Study|Administrative reasons by sponsor|616|||
127942494|NCT02704403|460411757|FG000|Overall Study|Death|4|||
127942495|NCT02704403|460411758|FG001|Overall Study|Death|3|||
127942496|NCT02704403|460411757|FG000|Overall Study|Endpoint event|52|||
127942497|NCT02704403|460411758|FG001|Overall Study|Endpoint event|24|||
127942498|NCT02704403|460411757|FG000|Overall Study|Lost to Follow-up|22|||
127942499|NCT02704403|460411758|FG001|Overall Study|Lost to Follow-up|11|||
127942500|NCT02704403|460411757|FG000|Overall Study|Protocol Violation|15|||
127942501|NCT02704403|460411758|FG001|Overall Study|Protocol Violation|15|||
127942502|NCT02704403|460411757|FG000|Overall Study|Adverse Event|2|||
127942503|NCT02704403|460411758|FG001|Overall Study|Adverse Event|0|||
127942504|NCT02704403|460411757|FG000|Overall Study|Withdrawal by Subject|85|||
127942505|NCT02704403|460411758|FG001|Overall Study|Withdrawal by Subject|45|||
127942506|NCT02704403|460411757|FG000|Overall Study|Investigator decision|1|||
127942507|NCT02704403|460411758|FG001|Overall Study|Investigator decision|1|||
127942508|NCT02704403|460411757|FG000|Overall Study|Follow-up not possible|1|||
127942509|NCT02704403|460411758|FG001|Overall Study|Follow-up not possible|2|||
127942510|NCT00851318|460411759|FG000|Overall Study|Withdrawal by Subject|7|||
127942511|NCT00851318|460411760|FG001|Overall Study|Withdrawal by Subject|1|||
127942512|NCT00851318|460411761|FG002|Overall Study|Withdrawal by Subject|5|||
127942513|NCT00851318|460411762|FG003|Overall Study|Withdrawal by Subject|3|||
127942514|NCT00851318|460411759|FG000|Overall Study|Adverse Event|13|||
127942515|NCT00851318|460411760|FG001|Overall Study|Adverse Event|2|||
127942516|NCT00851318|460411761|FG002|Overall Study|Adverse Event|9|||
127942517|NCT00851318|460411762|FG003|Overall Study|Adverse Event|12|||
127942518|NCT00851318|460411759|FG000|Overall Study|Pregnancy|0|||
127942519|NCT00851318|460411760|FG001|Overall Study|Pregnancy|0|||
127942520|NCT00851318|460411761|FG002|Overall Study|Pregnancy|1|||
127942521|NCT00851318|460411762|FG003|Overall Study|Pregnancy|1|||
127942522|NCT00851318|460411759|FG000|Overall Study|Lack of Efficacy|8|||
127942523|NCT00851318|460411760|FG001|Overall Study|Lack of Efficacy|2|||
127942524|NCT00851318|460411761|FG002|Overall Study|Lack of Efficacy|4|||
127942525|NCT00851318|460411762|FG003|Overall Study|Lack of Efficacy|2|||
127942526|NCT00851318|460411759|FG000|Overall Study|Non-compliance with Study Procedures|2|||
127942527|NCT00851318|460411760|FG001|Overall Study|Non-compliance with Study Procedures|0|||
127942528|NCT00851318|460411761|FG002|Overall Study|Non-compliance with Study Procedures|1|||
127942529|NCT00851318|460411762|FG003|Overall Study|Non-compliance with Study Procedures|0|||
127942530|NCT00851318|460411759|FG000|Overall Study|Physician Decision|0|||
127942531|NCT00851318|460411760|FG001|Overall Study|Physician Decision|0|||
127942532|NCT00851318|460411761|FG002|Overall Study|Physician Decision|1|||
127942533|NCT00851318|460411762|FG003|Overall Study|Physician Decision|1|||
127942534|NCT01844856|460411769|FG000|Overall Study|Lost to Follow-up|15|||
127942535|NCT01844856|460411770|FG001|Overall Study|Lost to Follow-up|3|||
127942536|NCT01844856|460411769|FG000|Overall Study|Adverse Event|3|||
127942537|NCT01844856|460411770|FG001|Overall Study|Adverse Event|6|||
127942538|NCT01844856|460411769|FG000|Overall Study|Withdrawal by Subject|3|||
127942539|NCT01844856|460411770|FG001|Overall Study|Withdrawal by Subject|2|||
127942540|NCT01844856|460411769|FG000|Overall Study|Noncompliance|2|||
127942541|NCT01844856|460411770|FG001|Overall Study|Noncompliance|3|||
127942542|NCT01844856|460411769|FG000|Overall Study|Enterococcus Resistant|0|||
127942543|NCT01844856|460411770|FG001|Overall Study|Enterococcus Resistant|1|||
127942544|NCT01844856|460411769|FG000|Overall Study|Inadvertently Not Scheduled|1|||
127942545|NCT01844856|460411770|FG001|Overall Study|Inadvertently Not Scheduled|0|||
127942546|NCT01844856|460411769|FG000|Overall Study|Randomized but was a Screen Failure|0|||
127942547|NCT01844856|460411770|FG001|Overall Study|Randomized but was a Screen Failure|1|||
127942548|NCT01442688|460411771|FG000|First Intervention|Withdrawal by Subject|1|||
127942549|NCT01442688|460411772|FG001|First Intervention|Withdrawal by Subject|0|||
127942550|NCT01442688|460411771|FG000|First Intervention|subject incarcerated|1|||
127942551|NCT01442688|460411772|FG001|First Intervention|subject incarcerated|0|||
127942552|NCT01442688|460411771|FG000|Second Intervention|Adverse Event|1|||
127942553|NCT01442688|460411772|FG001|Second Intervention|Adverse Event|0|||
127942554|NCT00927394|460411773|FG000|Overall Study|Adverse Event|14|||
127942555|NCT00927394|460411774|FG001|Overall Study|Adverse Event|9|||
127942556|NCT00927394|460411773|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
127942557|NCT00927394|460411774|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
127942558|NCT00927394|460411773|FG000|Overall Study|Withdrawal by Subject|20|||
127942559|NCT00927394|460411774|FG001|Overall Study|Withdrawal by Subject|24|||
127942560|NCT00927394|460411773|FG000|Overall Study|Lost to Follow-up|8|||
127942561|NCT00927394|460411774|FG001|Overall Study|Lost to Follow-up|14|||
127942562|NCT00927394|460411773|FG000|Overall Study|Administrative Problem|1|||
127942563|NCT00927394|460411774|FG001|Overall Study|Administrative Problem|0|||
127942564|NCT00927394|460411773|FG000|Overall Study|Death|1|||
127942565|NCT00927394|460411774|FG001|Overall Study|Death|1|||
127942566|NCT00927394|460411773|FG000|Overall Study|Protocol deviation|16|||
127942567|NCT00927394|460411774|FG001|Overall Study|Protocol deviation|13|||
127942568|NCT00927394|460411773|FG000|Overall Study|Randomized in error|0|||
127942569|NCT00927394|460411774|FG001|Overall Study|Randomized in error|1|||
127942570|NCT02792699|460411775|FG000|Overall Study|Adverse Event|1|||
127942571|NCT02792699|460411776|FG001|Overall Study|Adverse Event|2|||
127942572|NCT02792699|460411777|FG002|Overall Study|Adverse Event|4|||
127942573|NCT02792699|460411775|FG000|Overall Study|Withdrawal by Subject|4|||
127942574|NCT02792699|460411776|FG001|Overall Study|Withdrawal by Subject|4|||
127942575|NCT02792699|460411777|FG002|Overall Study|Withdrawal by Subject|3|||
127942576|NCT02792699|460411775|FG000|Overall Study|Lost to Follow-up|0|||
127942577|NCT02792699|460411776|FG001|Overall Study|Lost to Follow-up|1|||
127942578|NCT02792699|460411777|FG002|Overall Study|Lost to Follow-up|2|||
127942579|NCT02792699|460411775|FG000|Overall Study|Physician Decision|2|||
127942580|NCT02792699|460411776|FG001|Overall Study|Physician Decision|0|||
127942581|NCT02792699|460411777|FG002|Overall Study|Physician Decision|0|||
127942582|NCT02792699|460411775|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
127942583|NCT02792699|460411776|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
127942584|NCT02792699|460411777|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
127942585|NCT02792699|460411775|FG000|Overall Study|Other|1|||
127942586|NCT02792699|460411776|FG001|Overall Study|Other|0|||
127942587|NCT02792699|460411777|FG002|Overall Study|Other|0|||
127942588|NCT03464630|460411778|FG000|Overall Study|Lost to Follow-up|62|||
127942589|NCT03464630|460411779|FG001|Overall Study|Lost to Follow-up|52|||
127942590|NCT03464630|460411778|FG000|Overall Study|Withdrawal by Subject|16|||
127942591|NCT03464630|460411779|FG001|Overall Study|Withdrawal by Subject|10|||
127942592|NCT03464630|460411778|FG000|Overall Study|Passive Disengagement|8|||
127942593|NCT03464630|460411779|FG001|Overall Study|Passive Disengagement|4|||
127942594|NCT03196635|460411781|FG000|Overall Study|Withdrawal by Subject|1|||
127942595|NCT00380744|460411785|FG000|Overall Study|Death|0|||
127942596|NCT00380744|460411786|FG001|Overall Study|Death|0|||
127942597|NCT00380744|460411787|FG002|Overall Study|Death|0|||
127942598|NCT00380744|460411788|FG003|Overall Study|Death|0|||
127942599|NCT00380744|460411789|FG004|Overall Study|Death|0|||
127942600|NCT00380744|460411790|FG005|Overall Study|Death|0|||
127942601|NCT00380744|460411791|FG006|Overall Study|Death|1|||
127942602|NCT00380744|460411785|FG000|Overall Study|Withdrawal by Subject|1|||
127942603|NCT00380744|460411786|FG001|Overall Study|Withdrawal by Subject|0|||
127942604|NCT00380744|460411787|FG002|Overall Study|Withdrawal by Subject|0|||
127942605|NCT00380744|460411788|FG003|Overall Study|Withdrawal by Subject|0|||
127942606|NCT00380744|460411789|FG004|Overall Study|Withdrawal by Subject|0|||
127942607|NCT00380744|460411790|FG005|Overall Study|Withdrawal by Subject|0|||
127942608|NCT00380744|460411791|FG006|Overall Study|Withdrawal by Subject|0|||
127942609|NCT01338870|460411792|FG000|Overall Study|Lost to Follow-up|0|||
127942610|NCT01338870|460411793|FG001|Overall Study|Lost to Follow-up|0|||
127942611|NCT01338870|460411794|FG002|Overall Study|Lost to Follow-up|1|||
127942612|NCT01338870|460411795|FG003|Overall Study|Lost to Follow-up|0|||
127942613|NCT01338870|460411796|FG004|Overall Study|Lost to Follow-up|1|||
127942614|NCT01338870|460411797|FG005|Overall Study|Lost to Follow-up|0|||
127942615|NCT01338870|460411792|FG000|Overall Study|Withdrawal by Subject|2|||
127942616|NCT01338870|460411793|FG001|Overall Study|Withdrawal by Subject|3|||
127942617|NCT01338870|460411794|FG002|Overall Study|Withdrawal by Subject|4|||
127942618|NCT01338870|460411795|FG003|Overall Study|Withdrawal by Subject|0|||
127942619|NCT01338870|460411796|FG004|Overall Study|Withdrawal by Subject|0|||
127942620|NCT01338870|460411797|FG005|Overall Study|Withdrawal by Subject|2|||
127942621|NCT01338870|460411792|FG000|Overall Study|Other|3|||
127942622|NCT01338870|460411793|FG001|Overall Study|Other|3|||
127942623|NCT01338870|460411794|FG002|Overall Study|Other|3|||
127942624|NCT01338870|460411795|FG003|Overall Study|Other|2|||
127942625|NCT01338870|460411796|FG004|Overall Study|Other|0|||
127942626|NCT01338870|460411797|FG005|Overall Study|Other|2|||
127942627|NCT01338870|460411792|FG000|Overall Study|Protocol Violation|0|||
127942628|NCT01338870|460411793|FG001|Overall Study|Protocol Violation|2|||
127942629|NCT01338870|460411794|FG002|Overall Study|Protocol Violation|2|||
127942630|NCT01338870|460411795|FG003|Overall Study|Protocol Violation|2|||
127942631|NCT01338870|460411796|FG004|Overall Study|Protocol Violation|1|||
127942632|NCT01338870|460411797|FG005|Overall Study|Protocol Violation|1|||
127942633|NCT01338870|460411792|FG000|Overall Study|Adverse Event|4|||
127942634|NCT01338870|460411793|FG001|Overall Study|Adverse Event|4|||
127942635|NCT01338870|460411794|FG002|Overall Study|Adverse Event|1|||
127942636|NCT01338870|460411795|FG003|Overall Study|Adverse Event|5|||
127942637|NCT01338870|460411796|FG004|Overall Study|Adverse Event|4|||
127942638|NCT01338870|460411797|FG005|Overall Study|Adverse Event|1|||
127942639|NCT02348723|460411800|FG000|Overall Study|No ablation|21|||
127942640|NCT02348723|460411801|FG001|Overall Study|No ablation|20|||
127942641|NCT02348723|460411800|FG000|Overall Study|Non-compliant with Protocol|1|||
127942642|NCT02348723|460411801|FG001|Overall Study|Non-compliant with Protocol|0|||
127942643|NCT02348723|460411800|FG000|Overall Study|Lost to Follow-up|1|||
127942644|NCT02348723|460411801|FG001|Overall Study|Lost to Follow-up|1|||
127942645|NCT02348723|460411800|FG000|Overall Study|Consent withdrawn|1|||
127942646|NCT02348723|460411801|FG001|Overall Study|Consent withdrawn|3|||
127942647|NCT02348723|460411800|FG000|Overall Study|Reason other than specified|1|||
127942648|NCT02348723|460411801|FG001|Overall Study|Reason other than specified|1|||
127942649|NCT02348723|460411800|FG000|Overall Study|Adverse Event|3|||
127942650|NCT02348723|460411801|FG001|Overall Study|Adverse Event|1|||
127942651|NCT04874155|460411802|FG000|Overall Study|Lost to Follow-up|1|||
127942652|NCT04874155|460411803|FG001|Overall Study|Lost to Follow-up|1|||
127942653|NCT04874155|460411802|FG000|Overall Study|Withdrawal by Subject|2|||
127942654|NCT04874155|460411803|FG001|Overall Study|Withdrawal by Subject|2|||
127942655|NCT02329847|460411804|FG000|Overall Study|Death|4|||
127942656|NCT02329847|460411805|FG001|Overall Study|Death|4|||
127942657|NCT02329847|460411806|FG002|Overall Study|Death|22|||
127942658|NCT02329847|460411807|FG003|Overall Study|Death|12|||
127942659|NCT02329847|460411808|FG004|Overall Study|Death|20|||
127942660|NCT02329847|460411809|FG005|Overall Study|Death|13|||
127942661|NCT02329847|460411804|FG000|Overall Study|Lost to Follow-up|0|||
127942662|NCT02329847|460411805|FG001|Overall Study|Lost to Follow-up|0|||
127942663|NCT02329847|460411806|FG002|Overall Study|Lost to Follow-up|2|||
127942664|NCT02329847|460411807|FG003|Overall Study|Lost to Follow-up|3|||
127942665|NCT02329847|460411808|FG004|Overall Study|Lost to Follow-up|0|||
127942666|NCT02329847|460411809|FG005|Overall Study|Lost to Follow-up|1|||
127942667|NCT02329847|460411804|FG000|Overall Study|Physician Decision|0|||
127942668|NCT02329847|460411805|FG001|Overall Study|Physician Decision|0|||
127942669|NCT02329847|460411806|FG002|Overall Study|Physician Decision|0|||
127942670|NCT02329847|460411807|FG003|Overall Study|Physician Decision|0|||
127942671|NCT02329847|460411808|FG004|Overall Study|Physician Decision|1|||
127942672|NCT02329847|460411809|FG005|Overall Study|Physician Decision|0|||
127942673|NCT02329847|460411804|FG000|Overall Study|Withdrawal by Subject|2|||
127942674|NCT02329847|460411805|FG001|Overall Study|Withdrawal by Subject|1|||
127942675|NCT02329847|460411806|FG002|Overall Study|Withdrawal by Subject|5|||
127942676|NCT02329847|460411807|FG003|Overall Study|Withdrawal by Subject|7|||
127942677|NCT02329847|460411808|FG004|Overall Study|Withdrawal by Subject|8|||
127942678|NCT02329847|460411809|FG005|Overall Study|Withdrawal by Subject|3|||
127942679|NCT02329847|460411804|FG000|Overall Study|Other|1|||
127942680|NCT02329847|460411805|FG001|Overall Study|Other|2|||
127942681|NCT02329847|460411806|FG002|Overall Study|Other|6|||
127942682|NCT02329847|460411807|FG003|Overall Study|Other|13|||
127942683|NCT02329847|460411808|FG004|Overall Study|Other|10|||
127942684|NCT02329847|460411809|FG005|Overall Study|Other|3|||
127942685|NCT05293639|460411810|FG000|Overall Study|Withdrawal by Subject|1|||
127942686|NCT05293639|460411811|FG001|Overall Study|Withdrawal by Subject|1|||
127942687|NCT05293639|460411812|FG002|Overall Study|Withdrawal by Subject|2|||
127942688|NCT05293639|460411810|FG000|Overall Study|Death|0|||
127942689|NCT05293639|460411811|FG001|Overall Study|Death|1|||
127942690|NCT05293639|460411812|FG002|Overall Study|Death|0|||
127942691|NCT05293639|460411810|FG000|Overall Study|Lost to Follow-up|0|||
127942692|NCT05293639|460411811|FG001|Overall Study|Lost to Follow-up|0|||
127942693|NCT05293639|460411812|FG002|Overall Study|Lost to Follow-up|5|||
127942694|NCT05293639|460411810|FG000|Overall Study|Other|0|||
127942695|NCT05293639|460411811|FG001|Overall Study|Other|0|||
127942696|NCT05293639|460411812|FG002|Overall Study|Other|1|||
127942697|NCT03918109|460411822|FG000|Overall Study|Withdrawal by Subject|0|||
127942698|NCT03918109|460411823|FG001|Overall Study|Withdrawal by Subject|0|||
127942699|NCT03918109|460411824|FG002|Overall Study|Withdrawal by Subject|2|||
127942700|NCT03918109|460411825|FG003|Overall Study|Withdrawal by Subject|1|||
127942701|NCT03918109|460411822|FG000|Overall Study|Lost to Follow-up|0|||
127942702|NCT03918109|460411823|FG001|Overall Study|Lost to Follow-up|0|||
127942703|NCT03918109|460411824|FG002|Overall Study|Lost to Follow-up|0|||
127942704|NCT03918109|460411825|FG003|Overall Study|Lost to Follow-up|1|||
127942705|NCT00638027|460411827|FG000|Overall Study|Adverse Event|0|||
127942706|NCT00638027|460411828|FG001|Overall Study|Adverse Event|2|||
127942707|NCT03014180|460411829|FG000|Overall Study|Protocol Violation|2|||
127942708|NCT02802631|460411832|FG000|Overall Study|Withdrawal by Subject|1|||
127942709|NCT02802631|460411833|FG001|Overall Study|Withdrawal by Subject|0|||
127942710|NCT02802631|460411834|FG002|Overall Study|Withdrawal by Subject|0|||
127942711|NCT02802631|460411835|FG003|Overall Study|Withdrawal by Subject|0|||
127942712|NCT02802631|460411836|FG004|Overall Study|Withdrawal by Subject|0|||
127942713|NCT02802631|460411837|FG005|Overall Study|Withdrawal by Subject|0|||
127942714|NCT02802631|460411838|FG006|Overall Study|Withdrawal by Subject|0|||
127942715|NCT02802631|460411839|FG007|Overall Study|Withdrawal by Subject|0|||
127942716|NCT02802631|460411832|FG000|Overall Study|Physician Decision|1|||
127942717|NCT02802631|460411833|FG001|Overall Study|Physician Decision|0|||
127942718|NCT02802631|460411834|FG002|Overall Study|Physician Decision|0|||
127942719|NCT02802631|460411835|FG003|Overall Study|Physician Decision|0|||
127942720|NCT02802631|460411836|FG004|Overall Study|Physician Decision|0|||
127942721|NCT02802631|460411837|FG005|Overall Study|Physician Decision|0|||
127942722|NCT02802631|460411838|FG006|Overall Study|Physician Decision|1|||
127942723|NCT02802631|460411839|FG007|Overall Study|Physician Decision|0|||
127942724|NCT02802631|460411832|FG000|Overall Study|Adverse Event|0|||
127942725|NCT02802631|460411833|FG001|Overall Study|Adverse Event|2|||
127942726|NCT02802631|460411834|FG002|Overall Study|Adverse Event|0|||
127942727|NCT02802631|460411835|FG003|Overall Study|Adverse Event|1|||
127942728|NCT02802631|460411836|FG004|Overall Study|Adverse Event|6|||
127942729|NCT02802631|460411837|FG005|Overall Study|Adverse Event|1|||
127942730|NCT02802631|460411838|FG006|Overall Study|Adverse Event|4|||
127942731|NCT02802631|460411839|FG007|Overall Study|Adverse Event|0|||
127942732|NCT02802631|460411832|FG000|Overall Study|Sponsor Decision|0|||
127942733|NCT02802631|460411833|FG001|Overall Study|Sponsor Decision|0|||
127942734|NCT02802631|460411834|FG002|Overall Study|Sponsor Decision|6|||
127942735|NCT02802631|460411835|FG003|Overall Study|Sponsor Decision|0|||
127942736|NCT02802631|460411836|FG004|Overall Study|Sponsor Decision|2|||
127942737|NCT02802631|460411837|FG005|Overall Study|Sponsor Decision|0|||
127942738|NCT02802631|460411838|FG006|Overall Study|Sponsor Decision|0|||
127942739|NCT02802631|460411839|FG007|Overall Study|Sponsor Decision|4|||
127942740|NCT03395405|460413204|FG000|Overall Study|Death|0|||
127942741|NCT03395405|460413205|FG001|Overall Study|Death|2|||
127942742|NCT03395405|460413204|FG000|Overall Study|Lost to Follow-up|0|||
127942743|NCT03395405|460413205|FG001|Overall Study|Lost to Follow-up|1|||
127942744|NCT03395405|460413204|FG000|Overall Study|Protocol Violation|0|||
127942745|NCT03395405|460413205|FG001|Overall Study|Protocol Violation|1|||
127942746|NCT03395405|460413204|FG000|Overall Study|Withdrawal by Subject|3|||
127942747|NCT03395405|460413205|FG001|Overall Study|Withdrawal by Subject|1|||
127942748|NCT03395405|460413204|FG000|Overall Study|COVID-19 Pandemic|1|||
127942749|NCT03395405|460413205|FG001|Overall Study|COVID-19 Pandemic|0|||
127942750|NCT00000378|460413206|FG000|Overall Study|Lack of Efficacy|16|||
127942751|NCT00000378|460413207|FG001|Overall Study|Lack of Efficacy|14|||
127942752|NCT02886624|460413209|FG000|12-week Post Treatment Follow-up|Death|1|||
127942753|NCT02886624|460413209|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
127942754|NCT03972163|460413210|FG000|Overall Study|Death|0|||
127942755|NCT03972163|460413211|FG001|Overall Study|Death|1|||
127942756|NCT03257865|460413214|FG000|Overall Study|Adverse Event|4|||
127942757|NCT03257865|460413215|FG001|Overall Study|Adverse Event|8|||
127942758|NCT03257865|460413214|FG000|Overall Study|Lack of Efficacy|1|||
127942759|NCT03257865|460413215|FG001|Overall Study|Lack of Efficacy|2|||
127942760|NCT03257865|460413214|FG000|Overall Study|Non-compliance with Study Drug|0|||
127942761|NCT03257865|460413215|FG001|Overall Study|Non-compliance with Study Drug|2|||
127942762|NCT03257865|460413214|FG000|Overall Study|Withdrawal by Subject|23|||
127942763|NCT03257865|460413215|FG001|Overall Study|Withdrawal by Subject|17|||
127942764|NCT03257865|460413214|FG000|Overall Study|Physician Decision|3|||
127942765|NCT03257865|460413215|FG001|Overall Study|Physician Decision|1|||
127942766|NCT03257865|460413214|FG000|Overall Study|Other|0|||
127942767|NCT03257865|460413215|FG001|Overall Study|Other|1|||
127942768|NCT03257865|460413214|FG000|Overall Study|Lost to Follow-up|4|||
127942769|NCT03257865|460413215|FG001|Overall Study|Lost to Follow-up|4|||
127942770|NCT02538965|460413216|FG000|Treatment Period|Other = Death due to disease progression|1|||
127942771|NCT02538965|460413216|FG000|Treatment Period|Adverse Event|2|||
127942772|NCT02538965|460413216|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
127942773|NCT02538965|460413216|FG000|Treatment Period|Treatment Failure|9|||
127942774|NCT02538965|460413216|FG000|Treatment Period|Disease Progression|1|||
127942775|NCT02538965|460413216|FG000|Treatment Period|Physician Decision|2|||
127942776|NCT02538965|460413216|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
127942777|NCT02538965|460413216|FG000|Follow-Up Period|Withdrawal by Parent|4|||
127942778|NCT04546724|460413217|FG000|Overall Study|Withdrawal by Subject|145|||
127942779|NCT04546724|460413218|FG001|Overall Study|Withdrawal by Subject|41|||
127942780|NCT04546724|460413217|FG000|Overall Study|Adverse Event|1|||
127942781|NCT04546724|460413218|FG001|Overall Study|Adverse Event|1|||
127942782|NCT04546724|460413217|FG000|Overall Study|Lost to Follow-up|186|||
127942783|NCT04546724|460413218|FG001|Overall Study|Lost to Follow-up|63|||
127942784|NCT04546724|460413217|FG000|Overall Study|Physician Decision|8|||
127942785|NCT04546724|460413218|FG001|Overall Study|Physician Decision|2|||
127942786|NCT04546724|460413217|FG000|Overall Study|Death|2|||
127942787|NCT04546724|460413218|FG001|Overall Study|Death|1|||
127942788|NCT04546724|460413217|FG000|Overall Study|subject has been out of town|1|||
127942789|NCT04546724|460413218|FG001|Overall Study|subject has been out of town|0|||
127942790|NCT04546724|460413217|FG000|Overall Study|subject is incarcerated|2|||
127942791|NCT04546724|460413218|FG001|Overall Study|subject is incarcerated|0|||
127942792|NCT04546724|460413217|FG000|Overall Study|subject is relocating|12|||
127942793|NCT04546724|460413218|FG001|Overall Study|subject is relocating|4|||
127942794|NCT04546724|460413217|FG000|Overall Study|Subject in another study|1|||
127942795|NCT04546724|460413218|FG001|Overall Study|Subject in another study|1|||
127942796|NCT00077857|460413220|FG000|Overall Study|Adverse Event|30|||
127942797|NCT00077857|460413221|FG001|Overall Study|Adverse Event|32|||
127942798|NCT00077857|460413220|FG000|Overall Study|Death|7|||
127942799|NCT00077857|460413221|FG001|Overall Study|Death|3|||
127942800|NCT00077857|460413220|FG000|Overall Study|Insufficient therapeutic response|112|||
127942801|NCT00077857|460413221|FG001|Overall Study|Insufficient therapeutic response|128|||
127942802|NCT00077857|460413220|FG000|Overall Study|Violation of selection criteria at entry|3|||
127942803|NCT00077857|460413221|FG001|Overall Study|Violation of selection criteria at entry|1|||
127942804|NCT00077857|460413220|FG000|Overall Study|Other protocol violation|0|||
127942805|NCT00077857|460413221|FG001|Overall Study|Other protocol violation|1|||
127942806|NCT00077857|460413220|FG000|Overall Study|Refused treatment|29|||
127942807|NCT00077857|460413221|FG001|Overall Study|Refused treatment|21|||
127942808|NCT00077857|460413220|FG000|Overall Study|Failure to return|5|||
127942809|NCT00077857|460413221|FG001|Overall Study|Failure to return|5|||
127942810|NCT00077857|460413220|FG000|Overall Study|Other|15|||
127942811|NCT00077857|460413221|FG001|Overall Study|Other|13|||
127942812|NCT00369317|460413227|FG000|Overall Study|Adverse Event|3|||
127942813|NCT00369317|460413227|FG000|Overall Study|Death|1|||
127942814|NCT00369317|460413227|FG000|Overall Study|Lack of Efficacy|5|||
127942815|NCT00369317|460413227|FG000|Overall Study|Physician Decision|2|||
127942816|NCT00369317|460413227|FG000|Overall Study|Withdrawal by Subject|8|||
127942817|NCT00369317|460413227|FG000|Overall Study|Ineligible|1|||
127942818|NCT02365558|460413228|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
127942819|NCT02365558|460413229|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
127942820|NCT02365558|460413228|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
127942821|NCT02365558|460413229|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
127942822|NCT02828241|460413238|FG000|Overall Study|Adverse Event|7|||
127942823|NCT02828241|460413239|FG001|Overall Study|Adverse Event|2|||
127942824|NCT02828241|460413238|FG000|Overall Study|Protocol Violation|1|||
127942825|NCT02828241|460413239|FG001|Overall Study|Protocol Violation|0|||
127942826|NCT03185013|460413242|FG000|Overall Study|Withdrawal by Subject|5|||
127942827|NCT03185013|460413243|FG001|Overall Study|Withdrawal by Subject|3|||
127942828|NCT03185013|460413242|FG000|Overall Study|Adverse Event|1|||
127942829|NCT03185013|460413243|FG001|Overall Study|Adverse Event|0|||
127942830|NCT03185013|460413242|FG000|Overall Study|Progressive Disease|1|||
127942831|NCT03185013|460413243|FG001|Overall Study|Progressive Disease|0|||
127942832|NCT03185013|460413242|FG000|Overall Study|Lost to Follow-up|8|||
127942833|NCT03185013|460413243|FG001|Overall Study|Lost to Follow-up|2|||
127942834|NCT03185013|460413242|FG000|Overall Study|Physician Decision|1|||
127942835|NCT03185013|460413243|FG001|Overall Study|Physician Decision|0|||
127942836|NCT03185013|460413242|FG000|Overall Study|Protocol Deviation|2|||
127942837|NCT03185013|460413243|FG001|Overall Study|Protocol Deviation|0|||
127942838|NCT03185013|460413242|FG000|Overall Study|Reason not Specified|3|||
127942839|NCT03185013|460413243|FG001|Overall Study|Reason not Specified|2|||
127942840|NCT03185013|460413242|FG000|Overall Study|Death|1|||
127942841|NCT03185013|460413243|FG001|Overall Study|Death|0|||
127942842|NCT00510289|460413247|FG000|Overall Study|Withdrawal by Subject|7|||
127942843|NCT00510289|460413247|FG000|Overall Study|Refused bone marrow biopsy|2|||
127942844|NCT00510289|460413247|FG000|Overall Study|Lost to Follow-up|1|||
127942845|NCT00510289|460413247|FG000|Overall Study|Progressed prior to starting drug|2|||
127942846|NCT00673387|460413250|FG000|Overall Study|Withdrawal by Subject|15|||
127942847|NCT00673387|460413251|FG001|Overall Study|Withdrawal by Subject|16|||
127942848|NCT00673387|460413252|FG002|Overall Study|Withdrawal by Subject|20|||
127942849|NCT00673387|460413253|FG003|Overall Study|Withdrawal by Subject|16|||
127942850|NCT00673387|460413254|FG004|Overall Study|Withdrawal by Subject|18|||
127942851|NCT00673387|460413255|FG005|Overall Study|Withdrawal by Subject|21|||
127942852|NCT00673387|460413256|FG006|Overall Study|Withdrawal by Subject|15|||
127942853|NCT00673387|460413257|FG007|Overall Study|Withdrawal by Subject|21|||
127942854|NCT00673387|460413250|FG000|Overall Study|Adverse Event|3|||
127942855|NCT00673387|460413251|FG001|Overall Study|Adverse Event|1|||
127942856|NCT00673387|460413252|FG002|Overall Study|Adverse Event|5|||
127942857|NCT00673387|460413253|FG003|Overall Study|Adverse Event|2|||
127942858|NCT00673387|460413254|FG004|Overall Study|Adverse Event|6|||
127942859|NCT00673387|460413255|FG005|Overall Study|Adverse Event|2|||
127942860|NCT00673387|460413256|FG006|Overall Study|Adverse Event|5|||
127942861|NCT00673387|460413257|FG007|Overall Study|Adverse Event|5|||
127942862|NCT00673387|460413250|FG000|Overall Study|Physician Decision|0|||
127942863|NCT00673387|460413251|FG001|Overall Study|Physician Decision|0|||
127942864|NCT00673387|460413252|FG002|Overall Study|Physician Decision|0|||
127942865|NCT00673387|460413253|FG003|Overall Study|Physician Decision|0|||
127942866|NCT00673387|460413254|FG004|Overall Study|Physician Decision|0|||
127942867|NCT00673387|460413255|FG005|Overall Study|Physician Decision|5|||
127942868|NCT00673387|460413256|FG006|Overall Study|Physician Decision|1|||
127942869|NCT00673387|460413257|FG007|Overall Study|Physician Decision|1|||
127942870|NCT00673387|460413250|FG000|Overall Study|Protocol Violation|3|||
127942871|NCT00673387|460413251|FG001|Overall Study|Protocol Violation|0|||
127942872|NCT00673387|460413252|FG002|Overall Study|Protocol Violation|1|||
127942873|NCT00673387|460413253|FG003|Overall Study|Protocol Violation|2|||
127942874|NCT00673387|460413254|FG004|Overall Study|Protocol Violation|0|||
127942875|NCT00673387|460413255|FG005|Overall Study|Protocol Violation|1|||
127942876|NCT00673387|460413256|FG006|Overall Study|Protocol Violation|1|||
127942877|NCT00673387|460413257|FG007|Overall Study|Protocol Violation|3|||
127942878|NCT00673387|460413250|FG000|Overall Study|Lost to Follow-up|8|||
127942879|NCT00673387|460413251|FG001|Overall Study|Lost to Follow-up|6|||
127942880|NCT00673387|460413252|FG002|Overall Study|Lost to Follow-up|5|||
127942881|NCT00673387|460413253|FG003|Overall Study|Lost to Follow-up|6|||
127942882|NCT00673387|460413254|FG004|Overall Study|Lost to Follow-up|6|||
127942883|NCT00673387|460413255|FG005|Overall Study|Lost to Follow-up|5|||
127942884|NCT00673387|460413256|FG006|Overall Study|Lost to Follow-up|8|||
127942885|NCT00673387|460413257|FG007|Overall Study|Lost to Follow-up|5|||
127942886|NCT00960115|460413258|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
127942887|NCT00960115|460413259|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
127942888|NCT00861198|460413260|FG000|Overall Study|SpyGlass Failed|5|||
127942889|NCT01197755|460413261|FG000|Overall Study|Adverse Event|8|||
127942890|NCT01197755|460413262|FG001|Overall Study|Adverse Event|10|||
127942891|NCT01197755|460413263|FG002|Overall Study|Adverse Event|10|||
127942892|NCT01197755|460413261|FG000|Overall Study|Study-specific discontinuation criteria|2|||
127942893|NCT01197755|460413262|FG001|Overall Study|Study-specific discontinuation criteria|1|||
127942894|NCT01197755|460413263|FG002|Overall Study|Study-specific discontinuation criteria|0|||
127942895|NCT01197755|460413261|FG000|Overall Study|Entered the long-term extension study|18|||
127942896|NCT01197755|460413262|FG001|Overall Study|Entered the long-term extension study|21|||
127942897|NCT01197755|460413263|FG002|Overall Study|Entered the long-term extension study|35|||
127942898|NCT01197755|460413261|FG000|Overall Study|Lack of therapeutic response|0|||
127942899|NCT01197755|460413262|FG001|Overall Study|Lack of therapeutic response|7|||
127942900|NCT01197755|460413263|FG002|Overall Study|Lack of therapeutic response|4|||
127942901|NCT01197755|460413261|FG000|Overall Study|Severe non-compliance to the protocol|2|||
127942902|NCT01197755|460413262|FG001|Overall Study|Severe non-compliance to the protocol|1|||
127942903|NCT01197755|460413263|FG002|Overall Study|Severe non-compliance to the protocol|2|||
127942904|NCT01197755|460413261|FG000|Overall Study|Withdrawal by Subject|1|||
127942905|NCT01197755|460413262|FG001|Overall Study|Withdrawal by Subject|0|||
127942906|NCT01197755|460413263|FG002|Overall Study|Withdrawal by Subject|0|||
127942907|NCT01197755|460413261|FG000|Overall Study|Lost to Follow-up|0|||
127942908|NCT01197755|460413262|FG001|Overall Study|Lost to Follow-up|0|||
127942909|NCT01197755|460413263|FG002|Overall Study|Lost to Follow-up|1|||
127942910|NCT01197755|460413261|FG000|Overall Study|eg, change in circumstances|7|||
127942911|NCT01197755|460413262|FG001|Overall Study|eg, change in circumstances|3|||
127942912|NCT01197755|460413263|FG002|Overall Study|eg, change in circumstances|2|||
127942913|NCT00499174|460413266|FG000|Overall Study|Physician Decision|78|||
127942914|NCT00499174|460413267|FG001|Overall Study|Physician Decision|9|||
127942915|NCT02269163|460413268|FG000|Overall Study|Lost to Follow-up|1|||
127942916|NCT02269163|460413269|FG001|Overall Study|Lost to Follow-up|0|||
127942917|NCT02269163|460413268|FG000|Overall Study|Major protocol violation|0|||
127942918|NCT02269163|460413269|FG001|Overall Study|Major protocol violation|1|||
127942919|NCT02269163|460413268|FG000|Overall Study|Other|2|||
127942920|NCT02269163|460413269|FG001|Overall Study|Other|2|||
127942921|NCT02269163|460413268|FG000|Overall Study|Withdrawal by Subject|0|||
127942922|NCT02269163|460413269|FG001|Overall Study|Withdrawal by Subject|3|||
127942923|NCT02269163|460413268|FG000|Overall Study|Physician Decision|0|||
127942924|NCT02269163|460413269|FG001|Overall Study|Physician Decision|1|||
127942925|NCT00761865|460413272|FG000|Overall Study|Lost to Follow-up|8|||
127942926|NCT00761865|460413273|FG001|Overall Study|Lost to Follow-up|7|||
127942927|NCT00758680|460413276|FG000|Overall Study|Adverse Event|0|||
127942928|NCT00758680|460413277|FG001|Overall Study|Adverse Event|0|||
127942929|NCT00758680|460413278|FG002|Overall Study|Adverse Event|0|||
127942930|NCT00758680|460413279|FG003|Overall Study|Adverse Event|0|||
127942931|NCT00758680|460413280|FG004|Overall Study|Adverse Event|0|||
127942932|NCT00758680|460413281|FG005|Overall Study|Adverse Event|0|||
127942933|NCT00758680|460413282|FG006|Overall Study|Adverse Event|0|||
127942934|NCT00758680|460413283|FG007|Overall Study|Adverse Event|1|||
127942935|NCT00758680|460413284|FG008|Overall Study|Adverse Event|0|||
127942936|NCT00758680|460413285|FG009|Overall Study|Adverse Event|1|||
127942937|NCT00758680|460413276|FG000|Overall Study|Laboratory Adverse Event|0|||
127942938|NCT00758680|460413277|FG001|Overall Study|Laboratory Adverse Event|0|||
127942939|NCT00758680|460413278|FG002|Overall Study|Laboratory Adverse Event|0|||
127942940|NCT00758680|460413279|FG003|Overall Study|Laboratory Adverse Event|0|||
127942941|NCT00758680|460413280|FG004|Overall Study|Laboratory Adverse Event|0|||
127942942|NCT00758680|460413281|FG005|Overall Study|Laboratory Adverse Event|0|||
127942943|NCT00758680|460413282|FG006|Overall Study|Laboratory Adverse Event|0|||
127942944|NCT00758680|460413283|FG007|Overall Study|Laboratory Adverse Event|0|||
127942945|NCT00758680|460413284|FG008|Overall Study|Laboratory Adverse Event|1|||
127942946|NCT00758680|460413285|FG009|Overall Study|Laboratory Adverse Event|0|||
127942947|NCT00758680|460413276|FG000|Overall Study|Withdrawal by Subject|0|||
127942948|NCT00758680|460413277|FG001|Overall Study|Withdrawal by Subject|0|||
127942949|NCT00758680|460413278|FG002|Overall Study|Withdrawal by Subject|0|||
127942950|NCT00758680|460413279|FG003|Overall Study|Withdrawal by Subject|0|||
127942951|NCT00758680|460413280|FG004|Overall Study|Withdrawal by Subject|0|||
127942952|NCT00758680|460413281|FG005|Overall Study|Withdrawal by Subject|0|||
127942953|NCT00758680|460413282|FG006|Overall Study|Withdrawal by Subject|1|||
127942954|NCT00758680|460413283|FG007|Overall Study|Withdrawal by Subject|0|||
127942955|NCT00758680|460413284|FG008|Overall Study|Withdrawal by Subject|1|||
127942956|NCT00758680|460413285|FG009|Overall Study|Withdrawal by Subject|0|||
127942957|NCT01094886|460413286|FG000|Overall Study|Adverse Event|2|||
127942958|NCT01094886|460413286|FG000|Overall Study|Withdrawal by Subject|5|||
127942959|NCT03866902|460413288|FG000|Overall Study|Lost to Follow-up|98|||
127942960|NCT03866902|460413289|FG001|Overall Study|Lost to Follow-up|82|||
127942961|NCT03866902|460413288|FG000|Overall Study|Pregnancy|18|||
127942962|NCT03866902|460413289|FG001|Overall Study|Pregnancy|24|||
127942963|NCT04730349|460413291|FG000|Overall Study|Participant withdrew consent|1|||
127942964|NCT04730349|460413292|FG001|Overall Study|Participant withdrew consent|0|||
127942965|NCT04730349|460413291|FG000|Overall Study|Disease progression|6|||
127942966|NCT04730349|460413292|FG001|Overall Study|Disease progression|4|||
127942967|NCT04730349|460413291|FG000|Overall Study|Study drug toxicity|0|||
127942968|NCT04730349|460413292|FG001|Overall Study|Study drug toxicity|1|||
127942969|NCT01284621|460413294|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
127942970|NCT01284621|460413295|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
127942971|NCT01284621|460413296|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
127942972|NCT01284621|460413297|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
127942973|NCT01284621|460413298|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
127942974|NCT01284621|460413299|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
127942975|NCT02342639|460413300|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
127942976|NCT02342639|460413301|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
127942977|NCT02342639|460413300|FG000|Overall Study|Protocol Violation|0|||
127942978|NCT02342639|460413301|FG001|Overall Study|Protocol Violation|2|||
127942979|NCT03155945|460413302|FG000|Overall Study|Lost to Follow-up|0|||
127942980|NCT03155945|460413303|FG001|Overall Study|Lost to Follow-up|1|||
127942981|NCT03155945|460413302|FG000|Overall Study|Withdrawal by Subject|0|||
127942982|NCT03155945|460413303|FG001|Overall Study|Withdrawal by Subject|1|||
127942983|NCT03155945|460413302|FG000|Overall Study|Other Reason|0|||
127942984|NCT03155945|460413303|FG001|Overall Study|Other Reason|1|||
127942985|NCT02968849|460413305|FG000|Overall Study|Death|8|||
127942986|NCT02968849|460413306|FG001|Overall Study|Death|10|||
127942987|NCT02968849|460413305|FG000|Overall Study|Lost to Follow-up|31|||
127942988|NCT02968849|460413306|FG001|Overall Study|Lost to Follow-up|29|||
127942989|NCT02968849|460413305|FG000|Overall Study|Withdrawal by Subject|73|||
127942990|NCT02968849|460413306|FG001|Overall Study|Withdrawal by Subject|64|||
127942991|NCT02968849|460413305|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
127942992|NCT02968849|460413306|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
127942993|NCT02968849|460413305|FG000|Overall Study|Physician Decision|6|||
127942994|NCT02968849|460413306|FG001|Overall Study|Physician Decision|9|||
127942995|NCT02968849|460413305|FG000|Overall Study|Other|16|||
127942996|NCT02968849|460413306|FG001|Overall Study|Other|10|||
127942997|NCT02013674|460413309|FG000|Overall Study|Death|0|||
127942998|NCT02013674|460413310|FG001|Overall Study|Death|1|||
127942999|NCT02013674|460413309|FG000|Overall Study|Lost to Follow-up|1|||
127943000|NCT02013674|460413310|FG001|Overall Study|Lost to Follow-up|0|||
127943001|NCT00416884|460413312|FG000|Overall Study|Study terminated due to low accrual|1|||
127943002|NCT02203331|460413313|FG000|Overall Study|Pregnancy|1|||
127943003|NCT02203331|460413314|FG001|Overall Study|Pregnancy|0|||
127943004|NCT02203331|460413315|FG002|Overall Study|Pregnancy|0|||
127943005|NCT02203331|460413316|FG003|Overall Study|Pregnancy|0|||
127943006|NCT02203331|460413317|FG004|Overall Study|Pregnancy|2|||
127943007|NCT02203331|460413318|FG005|Overall Study|Pregnancy|0|||
127943008|NCT02203331|460413313|FG000|Overall Study|Withdrawal by Subject|1|||
127943009|NCT02203331|460413314|FG001|Overall Study|Withdrawal by Subject|0|||
127943010|NCT02203331|460413315|FG002|Overall Study|Withdrawal by Subject|1|||
127943011|NCT02203331|460413316|FG003|Overall Study|Withdrawal by Subject|0|||
127943012|NCT02203331|460413317|FG004|Overall Study|Withdrawal by Subject|0|||
127943013|NCT02203331|460413318|FG005|Overall Study|Withdrawal by Subject|3|||
127943014|NCT02203331|460413313|FG000|Overall Study|Adverse Event|4|||
127943015|NCT02203331|460413314|FG001|Overall Study|Adverse Event|8|||
127943016|NCT02203331|460413315|FG002|Overall Study|Adverse Event|3|||
127943017|NCT02203331|460413316|FG003|Overall Study|Adverse Event|4|||
127943018|NCT02203331|460413317|FG004|Overall Study|Adverse Event|3|||
127943019|NCT02203331|460413318|FG005|Overall Study|Adverse Event|3|||
127943020|NCT02203331|460413313|FG000|Overall Study|Other Reasons|1|||
127943021|NCT02203331|460413314|FG001|Overall Study|Other Reasons|2|||
127943022|NCT02203331|460413315|FG002|Overall Study|Other Reasons|0|||
127943023|NCT02203331|460413316|FG003|Overall Study|Other Reasons|2|||
127943024|NCT02203331|460413317|FG004|Overall Study|Other Reasons|0|||
127943025|NCT02203331|460413318|FG005|Overall Study|Other Reasons|0|||
127943026|NCT02203331|460413313|FG000|Overall Study|Lack of Efficacy|0|||
127943027|NCT02203331|460413314|FG001|Overall Study|Lack of Efficacy|2|||
127943028|NCT02203331|460413315|FG002|Overall Study|Lack of Efficacy|1|||
127943029|NCT02203331|460413316|FG003|Overall Study|Lack of Efficacy|0|||
127943030|NCT02203331|460413317|FG004|Overall Study|Lack of Efficacy|0|||
127943031|NCT02203331|460413318|FG005|Overall Study|Lack of Efficacy|1|||
127943032|NCT02203331|460413313|FG000|Overall Study|Protocol Violation|0|||
127943033|NCT02203331|460413314|FG001|Overall Study|Protocol Violation|2|||
127943034|NCT02203331|460413315|FG002|Overall Study|Protocol Violation|0|||
127943035|NCT02203331|460413316|FG003|Overall Study|Protocol Violation|1|||
127943036|NCT02203331|460413317|FG004|Overall Study|Protocol Violation|1|||
127943037|NCT02203331|460413318|FG005|Overall Study|Protocol Violation|0|||
127943038|NCT02203331|460413313|FG000|Overall Study|Lost to Follow-up|0|||
127943039|NCT02203331|460413314|FG001|Overall Study|Lost to Follow-up|0|||
127943040|NCT02203331|460413315|FG002|Overall Study|Lost to Follow-up|0|||
127943041|NCT02203331|460413316|FG003|Overall Study|Lost to Follow-up|0|||
127943042|NCT02203331|460413317|FG004|Overall Study|Lost to Follow-up|1|||
127943043|NCT02203331|460413318|FG005|Overall Study|Lost to Follow-up|0|||
127943044|NCT00704730|460413325|FG000|Overall Study|Adverse Event|35|||
127943045|NCT00704730|460413326|FG001|Overall Study|Adverse Event|9|||
127943046|NCT00704730|460413325|FG000|Overall Study|Death|11|||
127943047|NCT00704730|460413326|FG001|Overall Study|Death|5|||
127943048|NCT00704730|460413325|FG000|Overall Study|Physician Decision|2|||
127943049|NCT00704730|460413326|FG001|Overall Study|Physician Decision|0|||
127943050|NCT00704730|460413325|FG000|Overall Study|Did not receive drug|5|||
127943051|NCT00704730|460413326|FG001|Overall Study|Did not receive drug|2|||
127943052|NCT00704730|460413325|FG000|Overall Study|Disease progression per PI|58|||
127943053|NCT00704730|460413326|FG001|Overall Study|Disease progression per PI|67|||
127943054|NCT00704730|460413325|FG000|Overall Study|data unavailable|1|||
127943055|NCT00704730|460413326|FG001|Overall Study|data unavailable|0|||
127943056|NCT00704730|460413325|FG000|Overall Study|Withdrawal by Subject|9|||
127943057|NCT00704730|460413326|FG001|Overall Study|Withdrawal by Subject|13|||
127943058|NCT02551666|460413328|FG000|Overall Study|Withdrawal by Subject|1|||
127943059|NCT02551666|460413329|FG001|Overall Study|Withdrawal by Subject|3|||
127943060|NCT01177059|460413330|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
127943061|NCT01177059|460413330|FG000|Overall Study|Withdrew consent|2|||
127943062|NCT01177059|460413330|FG000|Overall Study|Lost to Follow-up|18|||
127943063|NCT05307510|460414825|FG000|Overall Study|Lost to Follow-up|3|||
127943064|NCT05307510|460414826|FG001|Overall Study|Lost to Follow-up|6|||
127943065|NCT05307510|460414825|FG000|Overall Study|Withdrawal by Subject|0|||
127943066|NCT05307510|460414826|FG001|Overall Study|Withdrawal by Subject|1|||
127943067|NCT01664130|460414831|FG000|Overall Study|competing secondary disease|2|||
127943068|NCT00554606|460414832|FG000|Overall Study|Adverse Event|3|||
127943069|NCT00554606|460414832|FG000|Overall Study|Abnormal laboratory values|1|||
127943070|NCT00554606|460414832|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
127943071|NCT00554606|460414832|FG000|Overall Study|Subject withdrew consent|2|||
127943072|NCT00554606|460414832|FG000|Overall Study|Lost to Follow-up|2|||
127943073|NCT00554606|460414832|FG000|Overall Study|Administrative problems|60|||
127943074|NCT00554606|460414832|FG000|Overall Study|Death|1|||
127943075|NCT00554606|460414832|FG000|Overall Study|Protocol deviation|2|||
127943076|NCT01161407|460414833|FG000|Overall Study|Protocol Violation|3|||
127943077|NCT01161407|460414834|FG001|Overall Study|Protocol Violation|1|||
127943078|NCT00849186|460414843|FG000|Overall Study|Adverse Event|2|||
127943079|NCT00849186|460414843|FG000|Overall Study|Withdrawal by Subject|1|||
127943080|NCT00849186|460414843|FG000|Overall Study|not treated|6|||
127943081|NCT00849186|460414843|FG000|Overall Study|Other|1|||
127943082|NCT00492024|460414844|FG000|Treatment|Adverse Event|3|||
127943083|NCT00492024|460414845|FG001|Treatment|Adverse Event|1|||
127943084|NCT00492024|460414844|FG000|Treatment|Lack of Efficacy|21|||
127943085|NCT00492024|460414845|FG001|Treatment|Lack of Efficacy|20|||
127943086|NCT00492024|460414844|FG000|Treatment|Lost to Follow-up|3|||
127943087|NCT00492024|460414845|FG001|Treatment|Lost to Follow-up|1|||
127943088|NCT00492024|460414844|FG000|Treatment|Withdrawal by Subject|2|||
127943089|NCT00492024|460414845|FG001|Treatment|Withdrawal by Subject|0|||
127943090|NCT00492024|460414844|FG000|Follow up|Lack of Efficacy|0|||
127943091|NCT00492024|460414845|FG001|Follow up|Lack of Efficacy|1|||
127943092|NCT00492024|460414844|FG000|Follow up|Lost to Follow-up|1|||
127943093|NCT00492024|460414845|FG001|Follow up|Lost to Follow-up|1|||
127943094|NCT03247816|460414848|FG000|Overall Study|Adverse Event|12|||
127943095|NCT03247816|460414848|FG000|Overall Study|Physician Decision|3|||
127943096|NCT03247816|460414848|FG000|Overall Study|Lack of Efficacy|1|||
127943097|NCT03247816|460414848|FG000|Overall Study|Lost to Follow-up|10|||
127943098|NCT03247816|460414848|FG000|Overall Study|Missing Feraccru stop date|3|||
127943099|NCT02677714|460414855|FG000|Overall Study|Withdrawal by Subject|2|||
127943100|NCT02677714|460414856|FG001|Overall Study|Withdrawal by Subject|0|||
127943101|NCT01422187|460414858|FG000|Overall Study|Personal reason|1|||
127943102|NCT01422187|460414859|FG001|Overall Study|Personal reason|0|||
127943103|NCT01422187|460414860|FG002|Overall Study|Personal reason|0|||
127943104|NCT01422187|460414858|FG000|Overall Study|Lost to Follow-up|0|||
127943105|NCT01422187|460414859|FG001|Overall Study|Lost to Follow-up|1|||
127943106|NCT01422187|460414860|FG002|Overall Study|Lost to Follow-up|0|||
127943107|NCT04015908|460414861|FG000|Overall Study|Lost to Follow-up|0|||
127943108|NCT04015908|460414862|FG001|Overall Study|Lost to Follow-up|1|||
127943109|NCT02227446|460414863|FG000|Overall Study|not eligible post randomization|18|||
127943110|NCT02227446|460414864|FG001|Overall Study|not eligible post randomization|29|||
127943111|NCT02227446|460414863|FG000|Overall Study|Withdrawal by Subject|4|||
127943112|NCT02227446|460414864|FG001|Overall Study|Withdrawal by Subject|5|||
127943113|NCT04623086|460414865|FG000|Overall Study|Withdrawal by Subject|0|||
127943114|NCT04623086|460414866|FG001|Overall Study|Withdrawal by Subject|0|||
127943115|NCT04623086|460414867|FG002|Overall Study|Withdrawal by Subject|10|||
127943116|NCT00875797|460414868|FG000|Overall Study|Protocol Violation|6|||
127943117|NCT00875797|460414869|FG001|Overall Study|Protocol Violation|3|||
127943118|NCT00715624|460414870|FG000|Overall Study|Adverse Event|12|||
127943119|NCT00715624|460414871|FG001|Overall Study|Adverse Event|37|||
127943120|NCT00715624|460414870|FG000|Overall Study|Lack of Efficacy|11|||
127943121|NCT00715624|460414871|FG001|Overall Study|Lack of Efficacy|11|||
127943122|NCT00715624|460414870|FG000|Overall Study|Lost to Follow-up|1|||
127943123|NCT00715624|460414871|FG001|Overall Study|Lost to Follow-up|2|||
127943124|NCT00715624|460414870|FG000|Overall Study|Protocol Violation|1|||
127943125|NCT00715624|460414871|FG001|Overall Study|Protocol Violation|0|||
127943126|NCT00715624|460414870|FG000|Overall Study|Withdrawal by Subject|11|||
127943127|NCT00715624|460414871|FG001|Overall Study|Withdrawal by Subject|25|||
127943128|NCT00715624|460414870|FG000|Overall Study|Familial and personal reasons|10|||
127943129|NCT00715624|460414871|FG001|Overall Study|Familial and personal reasons|22|||
127943130|NCT00715624|460414870|FG000|Overall Study|Poor compliance|6|||
127943131|NCT00715624|460414871|FG001|Overall Study|Poor compliance|13|||
127943132|NCT00715624|460414870|FG000|Overall Study|Sponsor decision|0|||
127943133|NCT00715624|460414871|FG001|Overall Study|Sponsor decision|4|||
127943134|NCT00715624|460414870|FG000|Overall Study|Incorrect randomization (not treated)|0|||
127943135|NCT00715624|460414871|FG001|Overall Study|Incorrect randomization (not treated)|1|||
127943136|NCT00715624|460414870|FG000|Overall Study|Other|0|||
127943137|NCT00715624|460414871|FG001|Overall Study|Other|1|||
127943138|NCT03200912|460414872|FG000|Overall Study|Adverse Event|3|||
127943139|NCT03200912|460414873|FG001|Overall Study|Adverse Event|0|||
127943140|NCT03200912|460414874|FG002|Overall Study|Adverse Event|0|||
127943141|NCT03200912|460414872|FG000|Overall Study|Withdrawal by Subject|1|||
127943142|NCT03200912|460414873|FG001|Overall Study|Withdrawal by Subject|2|||
127943143|NCT03200912|460414874|FG002|Overall Study|Withdrawal by Subject|4|||
127943144|NCT03200912|460414872|FG000|Overall Study|Non-compliance with study drug|0|||
127943145|NCT03200912|460414873|FG001|Overall Study|Non-compliance with study drug|1|||
127943146|NCT03200912|460414874|FG002|Overall Study|Non-compliance with study drug|0|||
127943147|NCT03421730|460414883|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
127943148|NCT03421730|460414884|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
127943149|NCT03421730|460414885|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
127943150|NCT03421730|460414886|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
127943151|NCT03421730|460414887|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
127943152|NCT03421730|460414888|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
127943153|NCT03421730|460414889|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
127943154|NCT03421730|460414890|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
127943155|NCT03421730|460414891|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
127943156|NCT03421730|460414892|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
127943157|NCT03421730|460414893|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
127943158|NCT03421730|460414894|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
127943159|NCT03421730|460414883|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
127943160|NCT03421730|460414884|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
127943161|NCT03421730|460414885|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
127943162|NCT03421730|460414886|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
127943163|NCT03421730|460414887|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
127943164|NCT03421730|460414888|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
127943165|NCT03421730|460414889|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
127943166|NCT03421730|460414890|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
127943167|NCT03421730|460414891|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
127943168|NCT03421730|460414892|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
127943169|NCT03421730|460414893|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
127943170|NCT03421730|460414894|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
127943171|NCT02901548|460414899|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
127943172|NCT01955083|460414900|FG000|Overall Study|Lost to Follow-up|1|||
127943173|NCT01955083|460414901|FG001|Overall Study|Lost to Follow-up|1|||
127943174|NCT02871492|460414910|FG000|Overall Study|Lost to Follow-up|6|||
127943175|NCT02871492|460414911|FG001|Overall Study|Lost to Follow-up|3|||
127943176|NCT02871492|460414912|FG002|Overall Study|Lost to Follow-up|5|||
127943177|NCT02871492|460414910|FG000|Overall Study|Withdrawal by Subject|0|||
127943178|NCT02871492|460414911|FG001|Overall Study|Withdrawal by Subject|0|||
127943179|NCT02871492|460414912|FG002|Overall Study|Withdrawal by Subject|1|||
127943180|NCT02256436|460414913|FG000|Overall Study|Adverse Event|9|||
127943181|NCT02256436|460414914|FG001|Overall Study|Adverse Event|14|||
127943182|NCT02256436|460414913|FG000|Overall Study|Death|216|||
127943183|NCT02256436|460414914|FG001|Overall Study|Death|208|||
127943184|NCT02256436|460414913|FG000|Overall Study|Lost to Follow-up|1|||
127943185|NCT02256436|460414914|FG001|Overall Study|Lost to Follow-up|2|||
127943186|NCT02256436|460414913|FG000|Overall Study|Physician Decision|1|||
127943187|NCT02256436|460414914|FG001|Overall Study|Physician Decision|0|||
127943188|NCT02256436|460414913|FG000|Overall Study|Protocol Violation|0|||
127943189|NCT02256436|460414914|FG001|Overall Study|Protocol Violation|1|||
127943190|NCT02256436|460414913|FG000|Overall Study|Withdrawal by Subject|26|||
127943191|NCT02256436|460414914|FG001|Overall Study|Withdrawal by Subject|10|||
127943192|NCT02256436|460414913|FG000|Overall Study|Transferred to Extension Study|11|||
127943193|NCT02256436|460414914|FG001|Overall Study|Transferred to Extension Study|23|||
127943194|NCT02256436|460414913|FG000|Overall Study|Did Not Continue on Extension Study|8|||
127943195|NCT02256436|460414914|FG001|Overall Study|Did Not Continue on Extension Study|12|||
127943196|NCT03583086|460414915|FG000|Overall Study|Death|2|||
127943197|NCT03583086|460414916|FG001|Overall Study|Death|6|||
127943198|NCT03583086|460414917|FG002|Overall Study|Death|12|||
127943199|NCT03583086|460414918|FG003|Overall Study|Death|10|||
127943200|NCT03583086|460414919|FG004|Overall Study|Death|14|||
127943201|NCT03583086|460414920|FG005|Overall Study|Death|14|||
127943202|NCT03583086|460414921|FG006|Overall Study|Death|4|||
127943203|NCT03583086|460414915|FG000|Overall Study|Withdrawal by Subject|0|||
127943204|NCT03583086|460414916|FG001|Overall Study|Withdrawal by Subject|0|||
127943205|NCT03583086|460414917|FG002|Overall Study|Withdrawal by Subject|1|||
127943206|NCT03583086|460414918|FG003|Overall Study|Withdrawal by Subject|0|||
127943207|NCT03583086|460414919|FG004|Overall Study|Withdrawal by Subject|0|||
127943208|NCT03583086|460414920|FG005|Overall Study|Withdrawal by Subject|0|||
127943209|NCT03583086|460414921|FG006|Overall Study|Withdrawal by Subject|1|||
127943210|NCT03583086|460414915|FG000|Overall Study|Refused follow-up|0|||
127943211|NCT03583086|460414916|FG001|Overall Study|Refused follow-up|0|||
127943212|NCT03583086|460414917|FG002|Overall Study|Refused follow-up|1|||
127943213|NCT03583086|460414918|FG003|Overall Study|Refused follow-up|0|||
127943214|NCT03583086|460414919|FG004|Overall Study|Refused follow-up|1|||
127943215|NCT03583086|460414920|FG005|Overall Study|Refused follow-up|0|||
127943216|NCT03583086|460414921|FG006|Overall Study|Refused follow-up|0|||
127943217|NCT03583086|460414915|FG000|Overall Study|Declining Performance Status|0|||
127943218|NCT03583086|460414916|FG001|Overall Study|Declining Performance Status|0|||
127943219|NCT03583086|460414917|FG002|Overall Study|Declining Performance Status|1|||
127943220|NCT03583086|460414918|FG003|Overall Study|Declining Performance Status|0|||
127943221|NCT03583086|460414919|FG004|Overall Study|Declining Performance Status|0|||
127943222|NCT03583086|460414920|FG005|Overall Study|Declining Performance Status|0|||
127943223|NCT03583086|460414921|FG006|Overall Study|Declining Performance Status|0|||
127943224|NCT03583086|460414915|FG000|Overall Study|Still on study|0|||
127943225|NCT03583086|460414916|FG001|Overall Study|Still on study|0|||
127943226|NCT03583086|460414917|FG002|Overall Study|Still on study|0|||
127943227|NCT03583086|460414918|FG003|Overall Study|Still on study|1|||
127943228|NCT03583086|460414919|FG004|Overall Study|Still on study|0|||
127943229|NCT03583086|460414920|FG005|Overall Study|Still on study|0|||
127943230|NCT03583086|460414921|FG006|Overall Study|Still on study|1|||
127943231|NCT03583086|460414915|FG000|Overall Study|Disease progression|0|||
127943232|NCT03583086|460414916|FG001|Overall Study|Disease progression|0|||
127943233|NCT03583086|460414917|FG002|Overall Study|Disease progression|0|||
127943234|NCT03583086|460414918|FG003|Overall Study|Disease progression|0|||
127943235|NCT03583086|460414919|FG004|Overall Study|Disease progression|0|||
127943236|NCT03583086|460414920|FG005|Overall Study|Disease progression|0|||
127943237|NCT03583086|460414921|FG006|Overall Study|Disease progression|1|||
127943238|NCT03583086|460414915|FG000|Overall Study|Undergoing radiation therapy|0|||
127943239|NCT03583086|460414916|FG001|Overall Study|Undergoing radiation therapy|0|||
127943240|NCT03583086|460414917|FG002|Overall Study|Undergoing radiation therapy|0|||
127943241|NCT03583086|460414918|FG003|Overall Study|Undergoing radiation therapy|0|||
127943242|NCT03583086|460414919|FG004|Overall Study|Undergoing radiation therapy|0|||
127943243|NCT03583086|460414920|FG005|Overall Study|Undergoing radiation therapy|0|||
127943244|NCT03583086|460414921|FG006|Overall Study|Undergoing radiation therapy|1|||
127943245|NCT03583086|460414915|FG000|Overall Study|Lost to Follow-up|0|||
127943246|NCT03583086|460414916|FG001|Overall Study|Lost to Follow-up|0|||
127943247|NCT03583086|460414917|FG002|Overall Study|Lost to Follow-up|0|||
127943248|NCT03583086|460414918|FG003|Overall Study|Lost to Follow-up|0|||
127943249|NCT03583086|460414919|FG004|Overall Study|Lost to Follow-up|0|||
127943250|NCT03583086|460414920|FG005|Overall Study|Lost to Follow-up|1|||
127943251|NCT03583086|460414921|FG006|Overall Study|Lost to Follow-up|0|||
127943252|NCT03583086|460414915|FG000|Overall Study|Adverse Event|0|||
127943253|NCT03583086|460414916|FG001|Overall Study|Adverse Event|0|||
127943254|NCT03583086|460414917|FG002|Overall Study|Adverse Event|0|||
127943255|NCT03583086|460414918|FG003|Overall Study|Adverse Event|0|||
127943256|NCT03583086|460414919|FG004|Overall Study|Adverse Event|0|||
127943257|NCT03583086|460414920|FG005|Overall Study|Adverse Event|1|||
127943258|NCT03583086|460414921|FG006|Overall Study|Adverse Event|0|||
127943259|NCT01696279|460414922|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
127943260|NCT01696279|460414923|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
127943261|NCT01696279|460414924|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
127943262|NCT01696279|460414925|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
127943263|NCT01696279|460414922|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
127943264|NCT01696279|460414923|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
127943265|NCT01696279|460414924|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
127943266|NCT01696279|460414925|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
127943267|NCT01696279|460414922|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
127943268|NCT01696279|460414923|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
127943269|NCT01696279|460414924|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
127943270|NCT01696279|460414925|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
127943271|NCT01696279|460414922|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
127943272|NCT01696279|460414923|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
127943273|NCT01696279|460414924|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
127943274|NCT01696279|460414925|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
127943275|NCT01696279|460414922|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
127943276|NCT01696279|460414923|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
127943277|NCT01696279|460414924|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
127943278|NCT01696279|460414925|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
127943279|NCT01696279|460414922|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
127943280|NCT01696279|460414923|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
127943281|NCT01696279|460414924|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
127943282|NCT01696279|460414925|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
127943283|NCT01696279|460414922|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
127943284|NCT01696279|460414923|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
127943285|NCT01696279|460414924|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
127943286|NCT01696279|460414925|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
127943287|NCT01696279|460414922|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
127943288|NCT01696279|460414923|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
127943289|NCT01696279|460414924|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
127943290|NCT01696279|460414925|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
127943291|NCT01696279|460414922|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
127943292|NCT01696279|460414923|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
127943293|NCT01696279|460414924|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
127943294|NCT01696279|460414925|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
127943295|NCT01696279|460414922|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
127943296|NCT01696279|460414923|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
127943297|NCT01696279|460414924|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
127943298|NCT01696279|460414925|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
127943299|NCT01696279|460414922|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
127943300|NCT01696279|460414923|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
127943301|NCT01696279|460414924|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
127943302|NCT01696279|460414925|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
127943303|NCT01441947|460414927|FG000|Overall Study|Withdrawal by Subject|3|||
127943304|NCT01441947|460414928|FG001|Overall Study|Withdrawal by Subject|0|||
127943305|NCT00468650|460414930|FG000|Overall Study|Lost to Follow-up|4|||
127943306|NCT00468650|460414930|FG000|Overall Study|Withdrawal by Subject|2|||
127943307|NCT00468650|460414930|FG000|Overall Study|Protocol Violation|1|||
127943308|NCT02639052|460414931|FG000|Overall Study|Lost to Follow-up|1|||
127943309|NCT00128830|460414933|FG000|Overall Study|Adverse Event|10|||
127943310|NCT00128830|460414933|FG000|Overall Study|Withdrawal by Subject|14|||
127943311|NCT00128830|460414933|FG000|Overall Study|Lost to Follow-up|4|||
127943312|NCT00128830|460414933|FG000|Overall Study|Reached a virologic endpoint|29|||
127943313|NCT00128830|460414933|FG000|Overall Study|Non-compliant|4|||
127943314|NCT00128830|460414933|FG000|Overall Study|Discontinued or ineligible for study|2|||
127943315|NCT00128830|460414933|FG000|Overall Study|Other|9|||
127943316|NCT02730351|460414934|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
127943317|NCT02730351|460414935|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
127943318|NCT02730351|460414934|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
127943319|NCT02730351|460414935|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
127943320|NCT02730351|460414934|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
127943321|NCT02730351|460414935|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
127943322|NCT02730351|460414934|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
127943323|NCT02730351|460414935|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
127943324|NCT02730351|460414934|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
127943325|NCT02730351|460414935|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
127943326|NCT00838435|460414936|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
127943327|NCT00838435|460414936|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
127943328|NCT00838435|460414936|FG000|Part 2 (7 Years)|Adverse Event|2|||
127943329|NCT00838435|460414936|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
127943330|NCT00838435|460414936|FG000|Part 2 (7 Years)|Physician Decision|1|||
127943331|NCT00838435|460414936|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
127943332|NCT00838435|460414936|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
127943333|NCT03796039|460414938|FG000|Overall Study|Death|2|||
127943334|NCT03796039|460414939|FG001|Overall Study|Death|1|||
127943335|NCT03796039|460414938|FG000|Overall Study|Withdrawal by Subject|7|||
127943336|NCT03796039|460414939|FG001|Overall Study|Withdrawal by Subject|4|||
127943337|NCT02927366|460414940|FG000|Overall Study|Adverse Event|1|||
127943338|NCT02927366|460414941|FG001|Overall Study|Adverse Event|0|||
127943339|NCT02927366|460414940|FG000|Overall Study|Patient schedule|1|||
127943340|NCT02927366|460414941|FG001|Overall Study|Patient schedule|0|||
127943341|NCT03477903|460414948|FG000|Overall Study|Study Terminated by Sponsor|1|||
127943342|NCT03201965|460414949|FG000|Overall Study|Death|5|||
127943343|NCT03201965|460414950|FG001|Overall Study|Death|27|||
127943344|NCT03201965|460414951|FG002|Overall Study|Death|27|||
127943345|NCT03201965|460414949|FG000|Overall Study|Lost to Follow-up|0|||
127943346|NCT03201965|460414950|FG001|Overall Study|Lost to Follow-up|1|||
127943347|NCT03201965|460414951|FG002|Overall Study|Lost to Follow-up|0|||
127943348|NCT03201965|460414949|FG000|Overall Study|Withdrawal by Subject|3|||
127943349|NCT03201965|460414950|FG001|Overall Study|Withdrawal by Subject|13|||
127943350|NCT03201965|460414951|FG002|Overall Study|Withdrawal by Subject|4|||
127943351|NCT03201965|460414949|FG000|Overall Study|Ongoing|20|||
127943352|NCT03201965|460414950|FG001|Overall Study|Ongoing|152|||
127943353|NCT03201965|460414951|FG002|Overall Study|Ongoing|164|||
127943354|NCT00426361|460414955|FG000|Overall Study|Lost to Follow-up|3|||
127943355|NCT00426361|460414956|FG001|Overall Study|Lost to Follow-up|2|||
127943356|NCT00426361|460414957|FG002|Overall Study|Lost to Follow-up|5|||
127943357|NCT00426361|460414955|FG000|Overall Study|Withdrawal by Subject|1|||
127943358|NCT00426361|460414956|FG001|Overall Study|Withdrawal by Subject|3|||
127943359|NCT00426361|460414957|FG002|Overall Study|Withdrawal by Subject|0|||
127943360|NCT02478320|460414960|FG000|Overall Study|Adverse Event|2|||
127943361|NCT02478320|460414961|FG001|Overall Study|Adverse Event|0|||
127943362|NCT02478320|460414960|FG000|Overall Study|Death|1|||
127943363|NCT02478320|460414961|FG001|Overall Study|Death|0|||
127943364|NCT02478320|460414960|FG000|Overall Study|Lack of Efficacy|4|||
127943365|NCT02478320|460414961|FG001|Overall Study|Lack of Efficacy|0|||
127943366|NCT02478320|460414960|FG000|Overall Study|Withdrawal by Subject|2|||
127943367|NCT02478320|460414961|FG001|Overall Study|Withdrawal by Subject|0|||
127943368|NCT02478320|460414960|FG000|Overall Study|Screen Failure|3|||
127943369|NCT02478320|460414961|FG001|Overall Study|Screen Failure|0|||
127943370|NCT02011386|460414964|FG000|Overall Study|Non-compliance|2|||
127943371|NCT02011386|460414964|FG000|Overall Study|Lack of Efficacy|3|||
127943372|NCT03255655|460414965|FG000|Overall Study|Lost to Follow-up|7|||
127943373|NCT03255655|460414966|FG001|Overall Study|Lost to Follow-up|4|||
127943374|NCT04428333|460414967|FG000|Overall Study|Physician Decision|5|||
127943375|NCT04428333|460414968|FG001|Overall Study|Physician Decision|6|||
127943376|NCT04428333|460414967|FG000|Overall Study|Withdrawal by Subject|1|||
127943377|NCT04428333|460414968|FG001|Overall Study|Withdrawal by Subject|3|||
127943378|NCT04428333|460414967|FG000|Overall Study|Study Terminated By Sponsor|14|||
127943379|NCT04428333|460414968|FG001|Overall Study|Study Terminated By Sponsor|16|||
127943380|NCT03365011|460414969|FG000|Overall Study|Withdrawal by Subject|1|||
127943381|NCT03365011|460414970|FG001|Overall Study|Withdrawal by Subject|2|||
127943382|NCT04853992|460414971|FG000|Treatment Period A|Adverse Event|0|||
127943383|NCT04853992|460414972|FG001|Treatment Period A|Adverse Event|1|||
127943384|NCT04853992|460414971|FG000|Wash Out|Met exclusion criteria for next treatment phase|1|||
127943385|NCT04853992|460414972|FG001|Wash Out|Met exclusion criteria for next treatment phase|0|||
127943386|NCT03582826|460414973|FG000|Overall Study|Lost to Follow-up|39|||
127943387|NCT03582826|460414974|FG001|Overall Study|Lost to Follow-up|0|||
127943388|NCT03582826|460414973|FG000|Overall Study|Withdrawal by Subject|2|||
127943389|NCT03582826|460414974|FG001|Overall Study|Withdrawal by Subject|0|||
127943390|NCT02351960|460414975|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
127943391|NCT02351960|460414976|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
127943392|NCT02351960|460414975|FG000|Overall Study|Voluntary Withdrawal|5|||
127943393|NCT02351960|460414976|FG001|Overall Study|Voluntary Withdrawal|4|||
127943394|NCT02351960|460414975|FG000|Overall Study|Significant Protocol Deviation|0|||
127943395|NCT02351960|460414976|FG001|Overall Study|Significant Protocol Deviation|5|||
127943396|NCT00319982|460414977|FG000|Overall Study|Withdrawal by Subject|1|||
127943397|NCT00319982|460414978|FG001|Overall Study|Withdrawal by Subject|0|||
127943398|NCT03480386|460414979|FG000|Overall Study|Did not complete measures at 3-months|17|||
127943399|NCT03480386|460414980|FG001|Overall Study|Did not complete measures at 3-months|14|||
127943400|NCT03480386|460414979|FG000|Overall Study|No baseline measures|11|||
127943401|NCT03480386|460414980|FG001|Overall Study|No baseline measures|14|||
127943402|NCT03480386|460414979|FG000|Overall Study|Death|0|||
127943403|NCT03480386|460414980|FG001|Overall Study|Death|5|||
127943404|NCT03480386|460414979|FG000|Overall Study|Withdrawal by Subject|12|||
127943405|NCT03480386|460414980|FG001|Overall Study|Withdrawal by Subject|8|||
127943406|NCT03480386|460414979|FG000|Overall Study|Lost to Follow-up|2|||
127943407|NCT03480386|460414980|FG001|Overall Study|Lost to Follow-up|1|||
127943408|NCT03480386|460414979|FG000|Overall Study|Complicating disease|0|||
127943409|NCT03480386|460414980|FG001|Overall Study|Complicating disease|1|||
127943410|NCT03480386|460414979|FG000|Overall Study|Disease progression|3|||
127943411|NCT03480386|460414980|FG001|Overall Study|Disease progression|0|||
127943412|NCT03480386|460414979|FG000|Overall Study|Became ineligible|0|||
127943413|NCT03480386|460414980|FG001|Overall Study|Became ineligible|2|||
127943414|NCT00574912|460414981|FG000|Overall Study|Could not place IV lines.|3|||
127943415|NCT00574912|460414981|FG000|Overall Study|scheduling conflicts|3|||
127943416|NCT00574912|460414981|FG000|Overall Study|Physician Decision|2|||
127943417|NCT00371397|460414984|FG000|Session 1|Withdrawal by Subject|1|||
127943418|NCT00371397|460414985|FG001|Session 1|Withdrawal by Subject|0|||
127943419|NCT00371397|460414986|FG002|Session 1|Withdrawal by Subject|0|||
127943420|NCT00371397|460414987|FG003|Session 1|Withdrawal by Subject|0|||
127943421|NCT00371397|460414988|FG004|Session 1|Withdrawal by Subject|0|||
127943422|NCT00371397|460414989|FG005|Session 1|Withdrawal by Subject|0|||
127943423|NCT00371397|460414990|FG006|Session 1|Withdrawal by Subject|0|||
127943424|NCT00371397|460414991|FG007|Session 1|Withdrawal by Subject|1|||
127943425|NCT00371397|460414992|FG008|Session 1|Withdrawal by Subject|0|||
127943426|NCT00371397|460414993|FG009|Session 1|Withdrawal by Subject|0|||
127943427|NCT00371397|460414994|FG010|Session 1|Withdrawal by Subject|0|||
127943428|NCT00371397|460414995|FG011|Session 1|Withdrawal by Subject|0|||
127943429|NCT02377427|460414996|FG000|Part A (Up to Week 20)|Physician Decision|1|||
127943430|NCT02377427|460414997|FG001|Part A (Up to Week 20)|Physician Decision|0|||
127943431|NCT02377427|460414998|FG002|Part A (Up to Week 20)|Physician Decision|0|||
127943432|NCT02377427|460414999|FG003|Part A (Up to Week 20)|Physician Decision|0|||
127943433|NCT02377427|460415000|FG004|Part A (Up to Week 20)|Physician Decision|0|||
127943434|NCT02377427|460414996|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
127943435|NCT02377427|460414997|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
127943436|NCT02377427|460414998|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
127943437|NCT02377427|460414999|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
127943438|NCT02377427|460415000|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
127943439|NCT02377427|460414996|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
127943440|NCT02377427|460414997|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
127943441|NCT02377427|460414998|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
127943442|NCT02377427|460414999|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
127943443|NCT02377427|460415000|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
127943444|NCT02377427|460414996|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
127943445|NCT02377427|460414997|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
127943446|NCT02377427|460414998|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
127943447|NCT02377427|460414999|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
127943448|NCT02377427|460415000|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
127943449|NCT02212379|460415001|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
127943450|NCT02212379|460415001|FG000|From Baseline to Week 48|Adverse Event|7|||
127943451|NCT02212379|460415001|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
127943452|NCT02212379|460415001|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
127943453|NCT02212379|460415001|FG000|From Week 48 to Week 96|Adverse Event|1|||
127943454|NCT02212379|460415001|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
127943455|NCT02105974|460415002|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
127943456|NCT02105974|460415003|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
127943457|NCT02105974|460415004|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
127943458|NCT02105974|460415002|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
127943459|NCT02105974|460415003|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
127943460|NCT02105974|460415004|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
127943461|NCT02105974|460415002|FG000|2 Week Run-in Period|Adverse Event|6|||
127943462|NCT02105974|460415003|FG001|2 Week Run-in Period|Adverse Event|0|||
127943463|NCT02105974|460415004|FG002|2 Week Run-in Period|Adverse Event|0|||
127943464|NCT02105974|460415002|FG000|2 Week Run-in Period|Study closed/terminated|1|||
127943465|NCT02105974|460415003|FG001|2 Week Run-in Period|Study closed/terminated|0|||
127943466|NCT02105974|460415004|FG002|2 Week Run-in Period|Study closed/terminated|0|||
127943467|NCT02105974|460415002|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
127943468|NCT02105974|460415003|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
127943469|NCT02105974|460415004|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
127943470|NCT02105974|460415002|FG000|2 Week Run-in Period|Withdrew consent|23|||
127943471|NCT02105974|460415003|FG001|2 Week Run-in Period|Withdrew consent|0|||
127943472|NCT02105974|460415004|FG002|2 Week Run-in Period|Withdrew consent|0|||
127943473|NCT02105974|460415002|FG000|2 Week Run-in Period|Investigator discretion|8|||
127943474|NCT02105974|460415003|FG001|2 Week Run-in Period|Investigator discretion|0|||
127943475|NCT02105974|460415004|FG002|2 Week Run-in Period|Investigator discretion|0|||
127943476|NCT02105974|460415002|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
127943477|NCT02105974|460415003|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
127943478|NCT02105974|460415004|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
127943479|NCT02105974|460415002|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
127943480|NCT02105974|460415003|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
127943481|NCT02105974|460415004|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
127943482|NCT02105974|460415002|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
127943483|NCT02105974|460415003|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
127943484|NCT02105974|460415004|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
127943485|NCT02105974|460415002|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
127943486|NCT02105974|460415003|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
127943487|NCT02105974|460415004|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
127943488|NCT02105974|460415002|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
127943489|NCT02105974|460415003|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
127943490|NCT02105974|460415004|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
127943491|NCT02105974|460415002|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
127943492|NCT02105974|460415003|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
127943493|NCT02105974|460415004|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
127943494|NCT02105974|460415002|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
127943495|NCT02105974|460415003|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
127943496|NCT02105974|460415004|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
127943497|NCT05065567|460415005|FG000|Overall Study|Lost to Follow-up|10|||
127943498|NCT05065567|460415006|FG001|Overall Study|Lost to Follow-up|9|||
127943499|NCT05065567|460415007|FG002|Overall Study|Lost to Follow-up|6|||
127943500|NCT04051619|460415008|FG000|2nd Allocation (Cross Over)|Lost to Follow-up|1|||
127943501|NCT04051619|460415009|FG001|2nd Allocation (Cross Over)|Lost to Follow-up|2|||
127943502|NCT04051619|460415008|FG000|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
127943503|NCT04051619|460415009|FG001|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
127943504|NCT03510598|460416737|FG000|Overall Study|Withdrawal by Subject|1|||
127943505|NCT03610516|460416743|FG000|Treatment Epoch|Adverse Event|3|||
127943506|NCT03610516|460416744|FG001|Treatment Epoch|Adverse Event|1|||
127943507|NCT03610516|460416743|FG000|Treatment Epoch|Death|1|||
127943508|NCT03610516|460416744|FG001|Treatment Epoch|Death|0|||
127943509|NCT03610516|460416743|FG000|Treatment Epoch|Lack of Efficacy|0|||
127943510|NCT03610516|460416744|FG001|Treatment Epoch|Lack of Efficacy|1|||
127943511|NCT03610516|460416743|FG000|Treatment Epoch|No longer requires treatment|1|||
127943512|NCT03610516|460416744|FG001|Treatment Epoch|No longer requires treatment|0|||
127943513|NCT03610516|460416743|FG000|Treatment Epoch|Non-Compliance with study treatment|1|||
127943514|NCT03610516|460416744|FG001|Treatment Epoch|Non-Compliance with study treatment|0|||
127943515|NCT03610516|460416743|FG000|Treatment Epoch|Physician Decision|8|||
127943516|NCT03610516|460416744|FG001|Treatment Epoch|Physician Decision|5|||
127943517|NCT03610516|460416743|FG000|Treatment Epoch|Protocol Deviation|1|||
127943518|NCT03610516|460416744|FG001|Treatment Epoch|Protocol Deviation|0|||
127943519|NCT03610516|460416743|FG000|Treatment Epoch|Withdrawal by Subject|3|||
127943520|NCT03610516|460416744|FG001|Treatment Epoch|Withdrawal by Subject|1|||
127943521|NCT03610516|460416743|FG000|Post-Treatment Follow-up|Subject/Guardian Decision|1|||
127943522|NCT03610516|460416744|FG001|Post-Treatment Follow-up|Subject/Guardian Decision|0|||
127943523|NCT03610516|460416743|FG000|Post-Treatment Follow-up|Death|1|||
127943524|NCT03610516|460416744|FG001|Post-Treatment Follow-up|Death|0|||
127943525|NCT00660907|460416748|FG000|Overall Study|Incorrect Enrollment|1|||
127943526|NCT00660907|460416749|FG001|Overall Study|Incorrect Enrollment|1|||
127943527|NCT00660907|460416748|FG000|Overall Study|Adverse Event|33|||
127943528|NCT00660907|460416749|FG001|Overall Study|Adverse Event|19|||
127943529|NCT00660907|460416748|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
127943530|NCT00660907|460416749|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
127943531|NCT00660907|460416748|FG000|Overall Study|Withdrawal by Subject|23|||
127943532|NCT00660907|460416749|FG001|Overall Study|Withdrawal by Subject|32|||
127943533|NCT00660907|460416748|FG000|Overall Study|Lost to Follow-up|3|||
127943534|NCT00660907|460416749|FG001|Overall Study|Lost to Follow-up|3|||
127943535|NCT00660907|460416748|FG000|Overall Study|Poor/Non-Compliance|5|||
127943536|NCT00660907|460416749|FG001|Overall Study|Poor/Non-Compliance|1|||
127943537|NCT00660907|460416748|FG000|Overall Study|Safety|1|||
127943538|NCT00660907|460416749|FG001|Overall Study|Safety|0|||
127943539|NCT00660907|460416748|FG000|Overall Study|Death|1|||
127943540|NCT00660907|460416749|FG001|Overall Study|Death|3|||
127943541|NCT00660907|460416748|FG000|Overall Study|Various|11|||
127943542|NCT00660907|460416749|FG001|Overall Study|Various|8|||
127943543|NCT04975191|460416752|FG000|Overall Study|Protocol Violation|1|||
127943544|NCT04975191|460416753|FG001|Overall Study|Protocol Violation|2|||
127943545|NCT04975191|460416754|FG002|Overall Study|Protocol Violation|2|||
127943546|NCT04975191|460416755|FG003|Overall Study|Protocol Violation|2|||
127943547|NCT04975191|460416752|FG000|Overall Study|Lost to Follow-up|13|||
127943548|NCT04975191|460416753|FG001|Overall Study|Lost to Follow-up|3|||
127943549|NCT04975191|460416754|FG002|Overall Study|Lost to Follow-up|8|||
127943550|NCT04975191|460416755|FG003|Overall Study|Lost to Follow-up|8|||
127943551|NCT05776862|460416768|FG000|Overall Study|Adverse Event|0|||
127943552|NCT05776862|460416769|FG001|Overall Study|Adverse Event|1|||
127943553|NCT05776862|460416768|FG000|Overall Study|non-compliance|1|||
127943554|NCT05776862|460416769|FG001|Overall Study|non-compliance|0|||
127943555|NCT01199471|460416770|FG000|Overall Study|Protocol Violation|4|||
127943556|NCT01199471|460416770|FG000|Overall Study|Withdrawal by Subject|1|||
127943557|NCT01199471|460416770|FG000|Overall Study|Physician Decision|1|||
127943558|NCT02065700|460416771|FG000|Overall Study|Adverse Event|165|||
127943559|NCT02065700|460416772|FG001|Overall Study|Adverse Event|101|||
127943560|NCT02065700|460416771|FG000|Overall Study|Withdrawal by Subject|90|||
127943561|NCT02065700|460416772|FG001|Overall Study|Withdrawal by Subject|29|||
127943562|NCT02065700|460416771|FG000|Overall Study|Lost to Follow-up|12|||
127943563|NCT02065700|460416772|FG001|Overall Study|Lost to Follow-up|9|||
127943564|NCT02065700|460416771|FG000|Overall Study|Physician Decision|2|||
127943565|NCT02065700|460416772|FG001|Overall Study|Physician Decision|0|||
127943566|NCT02065700|460416771|FG000|Overall Study|Sponsor Request|38|||
127943567|NCT02065700|460416772|FG001|Overall Study|Sponsor Request|15|||
127943568|NCT02065700|460416771|FG000|Overall Study|Treatment Failure|3|||
127943569|NCT02065700|460416772|FG001|Overall Study|Treatment Failure|2|||
127943570|NCT02065700|460416771|FG000|Overall Study|Use of Non-permitted Concurrent Therapy|3|||
127943571|NCT02065700|460416772|FG001|Overall Study|Use of Non-permitted Concurrent Therapy|0|||
127943572|NCT02065700|460416771|FG000|Overall Study|Adverse Event and Treatment Failure|0|||
127943573|NCT02065700|460416772|FG001|Overall Study|Adverse Event and Treatment Failure|2|||
127943574|NCT02065700|460416771|FG000|Overall Study|Non-compliance with Study Procedures|2|||
127943575|NCT02065700|460416772|FG001|Overall Study|Non-compliance with Study Procedures|0|||
127943576|NCT02065700|460416771|FG000|Overall Study|Not Defined|21|||
127943577|NCT02065700|460416772|FG001|Overall Study|Not Defined|3|||
127943578|NCT03323437|460416774|FG000|Overall Study|Withdrawal by Subject|0|||
127943579|NCT03323437|460416775|FG001|Overall Study|Withdrawal by Subject|4|||
127943580|NCT03511326|460416783|FG000|Overall Study|Withdrawal by Subject|1|||
127943581|NCT01305044|460416784|FG000|Overall Study|Withdrawal by Subject|3|||
127943582|NCT01305044|460416785|FG001|Overall Study|Withdrawal by Subject|6|||
127943583|NCT04628793|460416786|FG000|Overall Study|Study terminated by sponsor|0|||
127943584|NCT04628793|460416787|FG001|Overall Study|Study terminated by sponsor|0|||
127943585|NCT04628793|460416788|FG002|Overall Study|Study terminated by sponsor|8|||
127943586|NCT04628793|460416786|FG000|Overall Study|Withdrawal by Subject|2|||
127943587|NCT04628793|460416787|FG001|Overall Study|Withdrawal by Subject|3|||
127943588|NCT04628793|460416788|FG002|Overall Study|Withdrawal by Subject|0|||
127943589|NCT04628793|460416786|FG000|Overall Study|Lost to Follow-up|0|||
127943590|NCT04628793|460416787|FG001|Overall Study|Lost to Follow-up|1|||
127943591|NCT04628793|460416788|FG002|Overall Study|Lost to Follow-up|0|||
127943592|NCT04746794|460416790|FG000|Overall Study|Did not complete any study assessment|50303|||
127943593|NCT04746794|460416791|FG001|Overall Study|Did not complete any study assessment|44997|||
127943594|NCT04040192|460416792|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
127943595|NCT04040192|460416793|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
127943596|NCT04040192|460416794|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
127943597|NCT04040192|460416792|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
127943598|NCT04040192|460416793|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
127943599|NCT04040192|460416794|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
127943600|NCT04040192|460416792|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
127943601|NCT04040192|460416793|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
127943602|NCT04040192|460416794|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
127943603|NCT04040192|460416792|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
127943604|NCT04040192|460416793|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
127943605|NCT04040192|460416794|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
127943606|NCT04040192|460416792|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
127943607|NCT04040192|460416793|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
127943608|NCT04040192|460416794|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
127943609|NCT04040192|460416792|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
127943610|NCT04040192|460416793|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
127943611|NCT04040192|460416794|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
127943612|NCT04040192|460416792|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
127943613|NCT04040192|460416793|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
127943614|NCT04040192|460416794|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
127943615|NCT04040192|460416792|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
127943616|NCT04040192|460416793|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
127943617|NCT04040192|460416794|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
127943618|NCT04040192|460416792|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
127943619|NCT04040192|460416793|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
127943620|NCT04040192|460416794|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
127943621|NCT04040192|460416792|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
127943622|NCT04040192|460416793|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
127943623|NCT04040192|460416794|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
127943624|NCT04040192|460416792|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
127943625|NCT04040192|460416793|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
127943626|NCT04040192|460416794|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
127943627|NCT04040192|460416792|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
127943628|NCT04040192|460416793|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
127943629|NCT04040192|460416794|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
127943630|NCT04040192|460416792|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
127943631|NCT04040192|460416793|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
127943632|NCT04040192|460416794|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
127943633|NCT04040192|460416792|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
127943634|NCT04040192|460416793|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
127943635|NCT04040192|460416794|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
127943636|NCT04040192|460416792|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
127943637|NCT04040192|460416793|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
127943638|NCT04040192|460416794|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
127943639|NCT04040192|460416792|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
127943640|NCT04040192|460416793|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
127943641|NCT04040192|460416794|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
127943642|NCT04040192|460416792|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
127943643|NCT04040192|460416793|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
127943644|NCT04040192|460416794|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
127943645|NCT03207243|460416795|FG000|Overall Study|Adverse Event|2|||
127943646|NCT03207243|460416796|FG001|Overall Study|Adverse Event|2|||
127943647|NCT03207243|460416795|FG000|Overall Study|Loss of Asthma Control|47|||
127943648|NCT03207243|460416796|FG001|Overall Study|Loss of Asthma Control|31|||
127943649|NCT03207243|460416795|FG000|Overall Study|Withdrawal by Subject|2|||
127943650|NCT03207243|460416796|FG001|Overall Study|Withdrawal by Subject|4|||
127943651|NCT03207243|460416795|FG000|Overall Study|Physician Decision|1|||
127943652|NCT03207243|460416796|FG001|Overall Study|Physician Decision|1|||
127943653|NCT03207243|460416795|FG000|Overall Study|Lost to Follow-up|0|||
127943654|NCT03207243|460416796|FG001|Overall Study|Lost to Follow-up|1|||
127943655|NCT03207243|460416795|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
127943656|NCT03207243|460416796|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
127943657|NCT03207243|460416795|FG000|Overall Study|Protocol Violation|0|||
127943658|NCT03207243|460416796|FG001|Overall Study|Protocol Violation|3|||
127943659|NCT00229723|460416797|FG000|Concomitant Phase|Adverse Event|4|||
127943660|NCT00229723|460416798|FG001|Concomitant Phase|Adverse Event|2|||
127943661|NCT00229723|460416799|FG002|Concomitant Phase|Adverse Event|5|||
127943662|NCT00229723|460416800|FG003|Concomitant Phase|Adverse Event|2|||
127943663|NCT00229723|460416801|FG004|Concomitant Phase|Adverse Event|0|||
127943664|NCT00229723|460416802|FG005|Concomitant Phase|Adverse Event|1|||
127943665|NCT00229723|460416803|FG006|Concomitant Phase|Adverse Event|2|||
127943666|NCT00229723|460416797|FG000|Concomitant Phase|Objective disease progression|0|||
127943667|NCT00229723|460416798|FG001|Concomitant Phase|Objective disease progression|0|||
127943668|NCT00229723|460416799|FG002|Concomitant Phase|Objective disease progression|0|||
127943669|NCT00229723|460416800|FG003|Concomitant Phase|Objective disease progression|0|||
127943670|NCT00229723|460416801|FG004|Concomitant Phase|Objective disease progression|0|||
127943671|NCT00229723|460416802|FG005|Concomitant Phase|Objective disease progression|0|||
127943672|NCT00229723|460416803|FG006|Concomitant Phase|Objective disease progression|0|||
127943673|NCT00229723|460416797|FG000|Concomitant Phase|Clinical progression|0|||
127943674|NCT00229723|460416798|FG001|Concomitant Phase|Clinical progression|0|||
127943675|NCT00229723|460416799|FG002|Concomitant Phase|Clinical progression|0|||
127943676|NCT00229723|460416800|FG003|Concomitant Phase|Clinical progression|0|||
127943677|NCT00229723|460416801|FG004|Concomitant Phase|Clinical progression|0|||
127943678|NCT00229723|460416802|FG005|Concomitant Phase|Clinical progression|0|||
127943679|NCT00229723|460416803|FG006|Concomitant Phase|Clinical progression|1|||
127943680|NCT00229723|460416797|FG000|Concomitant Phase|Lost to Follow-up|0|||
127943681|NCT00229723|460416798|FG001|Concomitant Phase|Lost to Follow-up|0|||
127943682|NCT00229723|460416799|FG002|Concomitant Phase|Lost to Follow-up|0|||
127943683|NCT00229723|460416800|FG003|Concomitant Phase|Lost to Follow-up|0|||
127943684|NCT00229723|460416801|FG004|Concomitant Phase|Lost to Follow-up|1|||
127943685|NCT00229723|460416802|FG005|Concomitant Phase|Lost to Follow-up|0|||
127943686|NCT00229723|460416803|FG006|Concomitant Phase|Lost to Follow-up|0|||
127943687|NCT00229723|460416797|FG000|Concomitant Phase|Informed consent withdrawn|3|||
127943688|NCT00229723|460416798|FG001|Concomitant Phase|Informed consent withdrawn|2|||
127943689|NCT00229723|460416799|FG002|Concomitant Phase|Informed consent withdrawn|0|||
127943690|NCT00229723|460416800|FG003|Concomitant Phase|Informed consent withdrawn|2|||
127943691|NCT00229723|460416801|FG004|Concomitant Phase|Informed consent withdrawn|0|||
127943692|NCT00229723|460416802|FG005|Concomitant Phase|Informed consent withdrawn|0|||
127943693|NCT00229723|460416803|FG006|Concomitant Phase|Informed consent withdrawn|0|||
127943694|NCT00229723|460416797|FG000|Concomitant Phase|Severe non-compliance|0|||
127943695|NCT00229723|460416798|FG001|Concomitant Phase|Severe non-compliance|1|||
127943696|NCT00229723|460416799|FG002|Concomitant Phase|Severe non-compliance|0|||
127943697|NCT00229723|460416800|FG003|Concomitant Phase|Severe non-compliance|0|||
127943698|NCT00229723|460416801|FG004|Concomitant Phase|Severe non-compliance|1|||
127943699|NCT00229723|460416802|FG005|Concomitant Phase|Severe non-compliance|0|||
127943700|NCT00229723|460416803|FG006|Concomitant Phase|Severe non-compliance|0|||
127943701|NCT00229723|460416797|FG000|Concomitant Phase|Other|3|||
127943702|NCT00229723|460416798|FG001|Concomitant Phase|Other|0|||
127943703|NCT00229723|460416799|FG002|Concomitant Phase|Other|1|||
127943704|NCT00229723|460416800|FG003|Concomitant Phase|Other|1|||
127943705|NCT00229723|460416801|FG004|Concomitant Phase|Other|0|||
127943706|NCT00229723|460416802|FG005|Concomitant Phase|Other|2|||
127943707|NCT00229723|460416803|FG006|Concomitant Phase|Other|0|||
127943708|NCT00229723|460416797|FG000|Maintenance Phase|Adverse Event|7|||
127943709|NCT00229723|460416798|FG001|Maintenance Phase|Adverse Event|2|||
127943710|NCT00229723|460416799|FG002|Maintenance Phase|Adverse Event|1|||
127943711|NCT00229723|460416800|FG003|Maintenance Phase|Adverse Event|4|||
127943712|NCT00229723|460416801|FG004|Maintenance Phase|Adverse Event|7|||
127943713|NCT00229723|460416802|FG005|Maintenance Phase|Adverse Event|5|||
127943714|NCT00229723|460416803|FG006|Maintenance Phase|Adverse Event|2|||
127943715|NCT00229723|460416797|FG000|Maintenance Phase|Objective disease progression|5|||
127943716|NCT00229723|460416798|FG001|Maintenance Phase|Objective disease progression|5|||
127943717|NCT00229723|460416799|FG002|Maintenance Phase|Objective disease progression|3|||
127943718|NCT00229723|460416800|FG003|Maintenance Phase|Objective disease progression|6|||
127943719|NCT00229723|460416801|FG004|Maintenance Phase|Objective disease progression|2|||
127943720|NCT00229723|460416802|FG005|Maintenance Phase|Objective disease progression|9|||
127943721|NCT00229723|460416803|FG006|Maintenance Phase|Objective disease progression|5|||
127943722|NCT00229723|460416797|FG000|Maintenance Phase|Clinical progression|4|||
127943723|NCT00229723|460416798|FG001|Maintenance Phase|Clinical progression|1|||
127943724|NCT00229723|460416799|FG002|Maintenance Phase|Clinical progression|2|||
127943725|NCT00229723|460416800|FG003|Maintenance Phase|Clinical progression|2|||
127943726|NCT00229723|460416801|FG004|Maintenance Phase|Clinical progression|1|||
127943727|NCT00229723|460416802|FG005|Maintenance Phase|Clinical progression|1|||
127943728|NCT00229723|460416803|FG006|Maintenance Phase|Clinical progression|1|||
127943729|NCT00229723|460416797|FG000|Maintenance Phase|Lost to Follow-up|0|||
127943730|NCT00229723|460416798|FG001|Maintenance Phase|Lost to Follow-up|1|||
127943731|NCT00229723|460416799|FG002|Maintenance Phase|Lost to Follow-up|2|||
127943732|NCT00229723|460416800|FG003|Maintenance Phase|Lost to Follow-up|2|||
127943733|NCT00229723|460416801|FG004|Maintenance Phase|Lost to Follow-up|0|||
127943734|NCT00229723|460416802|FG005|Maintenance Phase|Lost to Follow-up|0|||
127943735|NCT00229723|460416803|FG006|Maintenance Phase|Lost to Follow-up|1|||
127943736|NCT00229723|460416797|FG000|Maintenance Phase|Informed consent withdrawn|1|||
127943737|NCT00229723|460416798|FG001|Maintenance Phase|Informed consent withdrawn|0|||
127943738|NCT00229723|460416799|FG002|Maintenance Phase|Informed consent withdrawn|0|||
127943739|NCT00229723|460416800|FG003|Maintenance Phase|Informed consent withdrawn|1|||
127943740|NCT00229723|460416801|FG004|Maintenance Phase|Informed consent withdrawn|1|||
127943741|NCT00229723|460416802|FG005|Maintenance Phase|Informed consent withdrawn|1|||
127943742|NCT00229723|460416803|FG006|Maintenance Phase|Informed consent withdrawn|0|||
127943743|NCT00229723|460416797|FG000|Maintenance Phase|Severe non-compliance|3|||
127943744|NCT00229723|460416798|FG001|Maintenance Phase|Severe non-compliance|1|||
127943745|NCT00229723|460416799|FG002|Maintenance Phase|Severe non-compliance|0|||
127943746|NCT00229723|460416800|FG003|Maintenance Phase|Severe non-compliance|0|||
127943747|NCT00229723|460416801|FG004|Maintenance Phase|Severe non-compliance|1|||
127943748|NCT00229723|460416802|FG005|Maintenance Phase|Severe non-compliance|0|||
127943749|NCT00229723|460416803|FG006|Maintenance Phase|Severe non-compliance|0|||
127943750|NCT00229723|460416797|FG000|Maintenance Phase|Other|5|||
127943751|NCT00229723|460416798|FG001|Maintenance Phase|Other|4|||
127943752|NCT00229723|460416799|FG002|Maintenance Phase|Other|1|||
127943753|NCT00229723|460416800|FG003|Maintenance Phase|Other|2|||
127943754|NCT00229723|460416801|FG004|Maintenance Phase|Other|3|||
127943755|NCT00229723|460416802|FG005|Maintenance Phase|Other|3|||
127943756|NCT00229723|460416803|FG006|Maintenance Phase|Other|1|||
127943757|NCT02309138|460416804|FG000|Overall Study|Withdrawal by Subject|44|||
127943758|NCT02309138|460416805|FG001|Overall Study|Withdrawal by Subject|15|||
127943759|NCT02309138|460416804|FG000|Overall Study|Protocol Violation|4|||
127943760|NCT02309138|460416805|FG001|Overall Study|Protocol Violation|2|||
127943761|NCT02309138|460416804|FG000|Overall Study|delivered before visit 2|0|||
127943762|NCT02309138|460416805|FG001|Overall Study|delivered before visit 2|1|||
127943763|NCT00735397|460416808|FG000|Overall Study|Adverse Event|194|||
127943764|NCT00735397|460416808|FG000|Overall Study|Lost to Follow-up|33|||
127943765|NCT00735397|460416808|FG000|Overall Study|Participant choice|252|||
127943766|NCT00735397|460416808|FG000|Overall Study|Inadequate therapeutic effect|202|||
127943767|NCT00735397|460416808|FG000|Overall Study|Administrative/Other|502|||
127943768|NCT03016975|460416813|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
127943769|NCT03016975|460416814|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
127943770|NCT03016975|460416815|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
127943771|NCT03016975|460416813|FG000|At 6 Months Follow-up|Death|2|||
127943772|NCT03016975|460416814|FG001|At 6 Months Follow-up|Death|0|||
127943773|NCT03016975|460416815|FG002|At 6 Months Follow-up|Death|0|||
127943774|NCT03016975|460416813|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
127943775|NCT03016975|460416814|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
127943776|NCT03016975|460416815|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
127943777|NCT03016975|460416813|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
127943778|NCT03016975|460416814|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
127943779|NCT03016975|460416815|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
127943780|NCT03016975|460416813|FG000|At 6 Months Follow-up|Aborted implant|1|||
127943781|NCT03016975|460416814|FG001|At 6 Months Follow-up|Aborted implant|0|||
127943782|NCT03016975|460416815|FG002|At 6 Months Follow-up|Aborted implant|0|||
127943783|NCT03016975|460416813|FG000|At 2 Year Follow-up|Death|1|||
127943784|NCT03016975|460416814|FG001|At 2 Year Follow-up|Death|0|||
127943785|NCT03016975|460416815|FG002|At 2 Year Follow-up|Death|0|||
127943786|NCT03016975|460416813|FG000|At 3 Year Follow-up|Death|1|||
127943787|NCT03016975|460416814|FG001|At 3 Year Follow-up|Death|0|||
127943788|NCT03016975|460416815|FG002|At 3 Year Follow-up|Death|0|||
127943789|NCT03016975|460416813|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
127943790|NCT03016975|460416814|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
127943791|NCT03016975|460416815|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
127943792|NCT03016975|460416813|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
127943793|NCT03016975|460416814|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
127943794|NCT03016975|460416815|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
127943795|NCT01590797|460416818|FG000|Overall Study|Adverse Event|4|||
127943796|NCT01590797|460416819|FG001|Overall Study|Adverse Event|3|||
127943797|NCT01590797|460416818|FG000|Overall Study|Lack of Efficacy|0|||
127943798|NCT01590797|460416819|FG001|Overall Study|Lack of Efficacy|2|||
127943799|NCT01590797|460416818|FG000|Overall Study|Lost to Follow-up|0|||
127943800|NCT01590797|460416819|FG001|Overall Study|Lost to Follow-up|1|||
127943801|NCT01590797|460416818|FG000|Overall Study|Protocol Violation|4|||
127943802|NCT01590797|460416819|FG001|Overall Study|Protocol Violation|1|||
127943803|NCT01590797|460416818|FG000|Overall Study|Withdrawal by Subject|7|||
127943804|NCT01590797|460416819|FG001|Overall Study|Withdrawal by Subject|5|||
127943805|NCT01590797|460416818|FG000|Overall Study|Other Protocol Specified Criteria|2|||
127943806|NCT01590797|460416819|FG001|Overall Study|Other Protocol Specified Criteria|4|||
127943807|NCT01559389|460416825|FG000|Overall Study|Withdrawal by Subject|20|||
127943808|NCT01559389|460416826|FG001|Overall Study|Withdrawal by Subject|20|||
127943809|NCT01228019|460416827|FG000|Overall Study|Dose Violation|70|||
127943810|NCT01228019|460416827|FG000|Overall Study|Duplicate enrollment|1|||
127943811|NCT01228019|460416827|FG000|Overall Study|Missing pre-treatment data|72|||
127943812|NCT01228019|460416827|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
127943813|NCT01228019|460416827|FG000|Overall Study|Violation of Entry Criterion|9|||
127943814|NCT01346293|460416828|FG000|Overall Study|Protocol Violation|30|||
127943815|NCT01346293|460416829|FG001|Overall Study|Protocol Violation|9|||
127943816|NCT01346293|460416828|FG000|Overall Study|Lost to Follow-up|21|||
127943817|NCT01346293|460416829|FG001|Overall Study|Lost to Follow-up|8|||
127943818|NCT01346293|460416828|FG000|Overall Study|Withdrawal by Subject|15|||
127943819|NCT01346293|460416829|FG001|Overall Study|Withdrawal by Subject|4|||
127943820|NCT01346293|460416828|FG000|Overall Study|Other|1|||
127943821|NCT01346293|460416829|FG001|Overall Study|Other|0|||
127943822|NCT04106661|460416834|FG000|Overall Study|Protocol Violation|3|||
127943823|NCT04106661|460416835|FG001|Overall Study|Protocol Violation|0|||
127943824|NCT04106661|460416834|FG000|Overall Study|Scheduling difficulties|1|||
127943825|NCT04106661|460416835|FG001|Overall Study|Scheduling difficulties|1|||
127943826|NCT03503864|460416836|FG000|Overall Study|Protocol Violation|6|||
127943827|NCT03503864|460416836|FG000|Overall Study|Withdrawal by Subject|7|||
127943828|NCT00587990|460416839|FG000|Overall Study|Death|0|||
127943829|NCT00587990|460416840|FG001|Overall Study|Death|0|||
127943830|NCT00587990|460416841|FG002|Overall Study|Death|1|||
127943831|NCT02754856|460416842|FG000|Overall Study|Withdrawal by Subject|1|||
127943832|NCT00530218|460416843|FG000|Overall Study|CMV Not Detected|13|||
127943833|NCT00530218|460416843|FG000|Overall Study|Death|12|||
127943834|NCT01147107|460416846|FG000|Overall Study|Lack of Efficacy|5|||
127943835|NCT01147107|460416847|FG001|Overall Study|Lack of Efficacy|0|||
127943836|NCT01147107|460416846|FG000|Overall Study|Withdrawal by Subject|1|||
127943837|NCT01147107|460416847|FG001|Overall Study|Withdrawal by Subject|1|||
127943838|NCT02910063|460416848|FG000|Phase 2|Withdrawal by Subject|3|||
127943839|NCT02910063|460416849|FG001|Phase 2|Withdrawal by Subject|0|||
127943840|NCT02910063|460416850|FG002|Phase 2|Withdrawal by Subject|0|||
127943841|NCT02910063|460416848|FG000|Phase 2|Lost to Follow-up|1|||
127943842|NCT02910063|460416849|FG001|Phase 2|Lost to Follow-up|0|||
127943843|NCT02910063|460416850|FG002|Phase 2|Lost to Follow-up|0|||
127943844|NCT02910063|460416848|FG000|Phase 2|Death|24|||
127943845|NCT02910063|460416849|FG001|Phase 2|Death|0|||
127943846|NCT02910063|460416850|FG002|Phase 2|Death|0|||
127943847|NCT04693416|460416851|FG000|Overall Study|Lost to Follow-up|13|||
127943848|NCT04693416|460416852|FG001|Overall Study|Lost to Follow-up|0|||
127943849|NCT00474266|460416853|FG000|Overall Study|Withdrawal by Subject|7|||
127943850|NCT00474266|460416854|FG001|Overall Study|Withdrawal by Subject|20|||
127943851|NCT00474266|460416855|FG002|Overall Study|Withdrawal by Subject|4|||
127943852|NCT00474266|460416856|FG003|Overall Study|Withdrawal by Subject|7|||
127943853|NCT02774642|460416857|FG000|Overall Study|Lost to Follow-up|9|||
127943854|NCT02774642|460416858|FG001|Overall Study|Lost to Follow-up|7|||
127943855|NCT04642365|460416860|FG000|Overall Study|Death|3|||
127943856|NCT04642365|460416861|FG001|Overall Study|Death|2|||
127943857|NCT04642365|460416862|FG002|Overall Study|Death|4|||
127943858|NCT04642365|460416863|FG003|Overall Study|Death|5|||
127943859|NCT04642365|460416864|FG004|Overall Study|Death|5|||
127943860|NCT04642365|460416865|FG005|Overall Study|Death|3|||
127943861|NCT04642365|460416866|FG006|Overall Study|Death|2|||
127943862|NCT04642365|460416867|FG007|Overall Study|Death|1|||
127943863|NCT04642365|460416860|FG000|Overall Study|Physician Decision|1|||
127943864|NCT04642365|460416861|FG001|Overall Study|Physician Decision|0|||
127943865|NCT04642365|460416862|FG002|Overall Study|Physician Decision|0|||
127943866|NCT04642365|460416863|FG003|Overall Study|Physician Decision|0|||
127943867|NCT04642365|460416864|FG004|Overall Study|Physician Decision|0|||
127943868|NCT04642365|460416865|FG005|Overall Study|Physician Decision|0|||
127943869|NCT04642365|460416866|FG006|Overall Study|Physician Decision|0|||
127943870|NCT04642365|460416867|FG007|Overall Study|Physician Decision|0|||
127943871|NCT04642365|460416860|FG000|Overall Study|Progressive Disease|1|||
127943872|NCT04642365|460416861|FG001|Overall Study|Progressive Disease|1|||
127943873|NCT04642365|460416862|FG002|Overall Study|Progressive Disease|1|||
127943874|NCT04642365|460416863|FG003|Overall Study|Progressive Disease|0|||
127943875|NCT04642365|460416864|FG004|Overall Study|Progressive Disease|0|||
127943876|NCT04642365|460416865|FG005|Overall Study|Progressive Disease|0|||
127943877|NCT04642365|460416866|FG006|Overall Study|Progressive Disease|1|||
127943878|NCT04642365|460416867|FG007|Overall Study|Progressive Disease|0|||
127943879|NCT04642365|460416860|FG000|Overall Study|Study Terminated By Sponsor|0|||
127943880|NCT04642365|460416861|FG001|Overall Study|Study Terminated By Sponsor|2|||
127943881|NCT04642365|460416862|FG002|Overall Study|Study Terminated By Sponsor|1|||
127943882|NCT04642365|460416863|FG003|Overall Study|Study Terminated By Sponsor|1|||
127943883|NCT04642365|460416864|FG004|Overall Study|Study Terminated By Sponsor|1|||
127943884|NCT04642365|460416865|FG005|Overall Study|Study Terminated By Sponsor|2|||
127943885|NCT04642365|460416866|FG006|Overall Study|Study Terminated By Sponsor|2|||
127943886|NCT04642365|460416867|FG007|Overall Study|Study Terminated By Sponsor|1|||
127943887|NCT04642365|460416860|FG000|Overall Study|Symptomatic Deterioration|1|||
127943888|NCT04642365|460416861|FG001|Overall Study|Symptomatic Deterioration|1|||
127943889|NCT04642365|460416862|FG002|Overall Study|Symptomatic Deterioration|0|||
127943890|NCT04642365|460416863|FG003|Overall Study|Symptomatic Deterioration|0|||
127943891|NCT04642365|460416864|FG004|Overall Study|Symptomatic Deterioration|0|||
127943892|NCT04642365|460416865|FG005|Overall Study|Symptomatic Deterioration|1|||
127943893|NCT04642365|460416866|FG006|Overall Study|Symptomatic Deterioration|0|||
127943894|NCT04642365|460416867|FG007|Overall Study|Symptomatic Deterioration|0|||
127943895|NCT04642365|460416860|FG000|Overall Study|Withdrawal by Subject|0|||
127943896|NCT04642365|460416861|FG001|Overall Study|Withdrawal by Subject|0|||
127943897|NCT04642365|460416862|FG002|Overall Study|Withdrawal by Subject|1|||
127943898|NCT04642365|460416863|FG003|Overall Study|Withdrawal by Subject|1|||
127943899|NCT04642365|460416864|FG004|Overall Study|Withdrawal by Subject|0|||
127943900|NCT04642365|460416865|FG005|Overall Study|Withdrawal by Subject|0|||
127943901|NCT04642365|460416866|FG006|Overall Study|Withdrawal by Subject|2|||
127943902|NCT04642365|460416867|FG007|Overall Study|Withdrawal by Subject|0|||
127943903|NCT04642365|460416860|FG000|Overall Study|Adverse Event|0|||
127943904|NCT04642365|460416861|FG001|Overall Study|Adverse Event|0|||
127943905|NCT04642365|460416862|FG002|Overall Study|Adverse Event|0|||
127943906|NCT04642365|460416863|FG003|Overall Study|Adverse Event|0|||
127943907|NCT04642365|460416864|FG004|Overall Study|Adverse Event|0|||
127943908|NCT04642365|460416865|FG005|Overall Study|Adverse Event|0|||
127943909|NCT04642365|460416866|FG006|Overall Study|Adverse Event|0|||
127943910|NCT04642365|460416867|FG007|Overall Study|Adverse Event|1|||
127943911|NCT02099682|460416873|FG000|Overall Study|Data Not Available|51|||
127943912|NCT02099682|460416873|FG000|Overall Study|Lost to Follow-up|31|||
127943913|NCT02099682|460416873|FG000|Overall Study|Other|29|||
127943914|NCT00805467|460418601|FG000|Overall Study|Lack of Efficacy|0|||
127943915|NCT00805467|460418602|FG001|Overall Study|Lack of Efficacy|8|||
127943916|NCT00805467|460418603|FG002|Overall Study|Lack of Efficacy|13|||
127943917|NCT00805467|460418604|FG003|Overall Study|Lack of Efficacy|86|||
127943918|NCT00805467|460418601|FG000|Overall Study|Lost to Follow-up|0|||
127943919|NCT00805467|460418602|FG001|Overall Study|Lost to Follow-up|1|||
127943920|NCT00805467|460418603|FG002|Overall Study|Lost to Follow-up|7|||
127943921|NCT00805467|460418604|FG003|Overall Study|Lost to Follow-up|21|||
127943922|NCT00805467|460418601|FG000|Overall Study|Withdrawal by Subject|0|||
127943923|NCT00805467|460418602|FG001|Overall Study|Withdrawal by Subject|6|||
127943924|NCT00805467|460418603|FG002|Overall Study|Withdrawal by Subject|45|||
127943925|NCT00805467|460418604|FG003|Overall Study|Withdrawal by Subject|50|||
127943926|NCT00805467|460418601|FG000|Overall Study|Protocol Violation|0|||
127943927|NCT00805467|460418602|FG001|Overall Study|Protocol Violation|3|||
127943928|NCT00805467|460418603|FG002|Overall Study|Protocol Violation|0|||
127943929|NCT00805467|460418604|FG003|Overall Study|Protocol Violation|5|||
127943930|NCT00805467|460418601|FG000|Overall Study|Adverse Event|0|||
127943931|NCT00805467|460418602|FG001|Overall Study|Adverse Event|13|||
127943932|NCT00805467|460418603|FG002|Overall Study|Adverse Event|26|||
127943933|NCT00805467|460418604|FG003|Overall Study|Adverse Event|57|||
127943934|NCT00805467|460418601|FG000|Overall Study|Death|0|||
127943935|NCT00805467|460418602|FG001|Overall Study|Death|2|||
127943936|NCT00805467|460418603|FG002|Overall Study|Death|7|||
127943937|NCT00805467|460418604|FG003|Overall Study|Death|5|||
127943938|NCT00805467|460418601|FG000|Overall Study|Physician Decision|0|||
127943939|NCT00805467|460418602|FG001|Overall Study|Physician Decision|1|||
127943940|NCT00805467|460418603|FG002|Overall Study|Physician Decision|2|||
127943941|NCT00805467|460418604|FG003|Overall Study|Physician Decision|6|||
127943942|NCT00805467|460418601|FG000|Overall Study|Not reported|0|||
127943943|NCT00805467|460418602|FG001|Overall Study|Not reported|0|||
127943944|NCT00805467|460418603|FG002|Overall Study|Not reported|3|||
127943945|NCT00805467|460418604|FG003|Overall Study|Not reported|7|||
127943946|NCT00213135|460418605|FG000|Overall Study|Adverse Event|9|||
127943947|NCT00213135|460418606|FG001|Overall Study|Adverse Event|5|||
127943948|NCT00213135|460418607|FG002|Overall Study|Adverse Event|5|||
127943949|NCT00213135|460418605|FG000|Overall Study|Lost to Follow-up|11|||
127943950|NCT00213135|460418606|FG001|Overall Study|Lost to Follow-up|8|||
127943951|NCT00213135|460418607|FG002|Overall Study|Lost to Follow-up|4|||
127943952|NCT00213135|460418605|FG000|Overall Study|Protocol Violation|4|||
127943953|NCT00213135|460418606|FG001|Overall Study|Protocol Violation|4|||
127943954|NCT00213135|460418607|FG002|Overall Study|Protocol Violation|10|||
127943955|NCT00213135|460418605|FG000|Overall Study|Death|1|||
127943956|NCT00213135|460418606|FG001|Overall Study|Death|1|||
127943957|NCT00213135|460418607|FG002|Overall Study|Death|2|||
127943958|NCT00213135|460418605|FG000|Overall Study|Disease progression|4|||
127943959|NCT00213135|460418606|FG001|Overall Study|Disease progression|5|||
127943960|NCT00213135|460418607|FG002|Overall Study|Disease progression|21|||
127943961|NCT00213135|460418605|FG000|Overall Study|Other|21|||
127943962|NCT00213135|460418606|FG001|Overall Study|Other|12|||
127943963|NCT00213135|460418607|FG002|Overall Study|Other|15|||
127943964|NCT01056289|460418616|FG000|Open-label Phase|Adverse Event|29|||
127943965|NCT01056289|460418617|FG001|Open-label Phase|Adverse Event|0|||
127943966|NCT01056289|460418618|FG002|Open-label Phase|Adverse Event|0|||
127943967|NCT01056289|460418619|FG003|Open-label Phase|Adverse Event|0|||
127943968|NCT01056289|460418616|FG000|Open-label Phase|Lost to Follow-up|30|||
127943969|NCT01056289|460418617|FG001|Open-label Phase|Lost to Follow-up|0|||
127943970|NCT01056289|460418618|FG002|Open-label Phase|Lost to Follow-up|0|||
127943971|NCT01056289|460418619|FG003|Open-label Phase|Lost to Follow-up|0|||
127943972|NCT01056289|460418616|FG000|Open-label Phase|Other|9|||
127943973|NCT01056289|460418617|FG001|Open-label Phase|Other|0|||
127943974|NCT01056289|460418618|FG002|Open-label Phase|Other|0|||
127943975|NCT01056289|460418619|FG003|Open-label Phase|Other|0|||
127943976|NCT01056289|460418616|FG000|Open-label Phase|Protocol Violation|6|||
127943977|NCT01056289|460418617|FG001|Open-label Phase|Protocol Violation|0|||
127943978|NCT01056289|460418618|FG002|Open-label Phase|Protocol Violation|0|||
127943979|NCT01056289|460418619|FG003|Open-label Phase|Protocol Violation|0|||
127943980|NCT01056289|460418616|FG000|Open-label Phase|Withdrawal by Subject|26|||
127943981|NCT01056289|460418617|FG001|Open-label Phase|Withdrawal by Subject|0|||
127943982|NCT01056289|460418618|FG002|Open-label Phase|Withdrawal by Subject|0|||
127943983|NCT01056289|460418619|FG003|Open-label Phase|Withdrawal by Subject|0|||
127943984|NCT01056289|460418616|FG000|Open-label Phase|Lack of Efficacy|18|||
127943985|NCT01056289|460418617|FG001|Open-label Phase|Lack of Efficacy|0|||
127943986|NCT01056289|460418618|FG002|Open-label Phase|Lack of Efficacy|0|||
127943987|NCT01056289|460418619|FG003|Open-label Phase|Lack of Efficacy|0|||
127943988|NCT01056289|460418616|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
127943989|NCT01056289|460418617|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
127943990|NCT01056289|460418618|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
127943991|NCT01056289|460418619|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
127943992|NCT01056289|460418616|FG000|Double-blind Phase|Adverse Event|0|||
127943993|NCT01056289|460418617|FG001|Double-blind Phase|Adverse Event|1|||
127943994|NCT01056289|460418618|FG002|Double-blind Phase|Adverse Event|2|||
127943995|NCT01056289|460418619|FG003|Double-blind Phase|Adverse Event|1|||
127943996|NCT01056289|460418616|FG000|Double-blind Phase|Lost to Follow-up|0|||
127943997|NCT01056289|460418617|FG001|Double-blind Phase|Lost to Follow-up|2|||
127943998|NCT01056289|460418618|FG002|Double-blind Phase|Lost to Follow-up|2|||
127943999|NCT01056289|460418619|FG003|Double-blind Phase|Lost to Follow-up|2|||
127944000|NCT01056289|460418616|FG000|Double-blind Phase|Other|0|||
127944001|NCT01056289|460418617|FG001|Double-blind Phase|Other|0|||
127944002|NCT01056289|460418618|FG002|Double-blind Phase|Other|1|||
127944003|NCT01056289|460418619|FG003|Double-blind Phase|Other|2|||
127944004|NCT01056289|460418616|FG000|Double-blind Phase|Protocol Violation|0|||
127944005|NCT01056289|460418617|FG001|Double-blind Phase|Protocol Violation|0|||
127944006|NCT01056289|460418618|FG002|Double-blind Phase|Protocol Violation|1|||
127944007|NCT01056289|460418619|FG003|Double-blind Phase|Protocol Violation|1|||
127944008|NCT01056289|460418616|FG000|Double-blind Phase|Withdrawal by Subject|0|||
127944009|NCT01056289|460418617|FG001|Double-blind Phase|Withdrawal by Subject|0|||
127944010|NCT01056289|460418618|FG002|Double-blind Phase|Withdrawal by Subject|4|||
127944011|NCT01056289|460418619|FG003|Double-blind Phase|Withdrawal by Subject|2|||
127944012|NCT01056289|460418616|FG000|Double-blind Phase|Discontinuation symptom|0|||
127944013|NCT01056289|460418617|FG001|Double-blind Phase|Discontinuation symptom|1|||
127944014|NCT01056289|460418618|FG002|Double-blind Phase|Discontinuation symptom|2|||
127944015|NCT01056289|460418619|FG003|Double-blind Phase|Discontinuation symptom|2|||
127944016|NCT01056289|460418616|FG000|Double-blind Phase|Physician Decision|0|||
127944017|NCT01056289|460418617|FG001|Double-blind Phase|Physician Decision|0|||
127944018|NCT01056289|460418618|FG002|Double-blind Phase|Physician Decision|1|||
127944019|NCT01056289|460418619|FG003|Double-blind Phase|Physician Decision|0|||
127944020|NCT02618759|460418630|FG000|Overall Study|Lost to Follow-up|0|||
127944021|NCT02618759|460418631|FG001|Overall Study|Lost to Follow-up|1|||
127944022|NCT02618759|460418630|FG000|Overall Study|Withdrawal by Subject|1|||
127944023|NCT02618759|460418631|FG001|Overall Study|Withdrawal by Subject|0|||
127944024|NCT02618759|460418630|FG000|Overall Study|Other Reasons|1|||
127944025|NCT02618759|460418631|FG001|Overall Study|Other Reasons|4|||
127944026|NCT02856555|460418634|FG000|Overall Study|Adverse Event|1|||
127944027|NCT02856555|460418635|FG001|Overall Study|Adverse Event|0|||
127944028|NCT02856555|460418636|FG002|Overall Study|Adverse Event|0|||
127944029|NCT02856555|460418634|FG000|Overall Study|Lost to Follow-up|1|||
127944030|NCT02856555|460418635|FG001|Overall Study|Lost to Follow-up|3|||
127944031|NCT02856555|460418636|FG002|Overall Study|Lost to Follow-up|0|||
127944032|NCT02856555|460418634|FG000|Overall Study|Withdrawal by Subject|3|||
127944033|NCT02856555|460418635|FG001|Overall Study|Withdrawal by Subject|0|||
127944034|NCT02856555|460418636|FG002|Overall Study|Withdrawal by Subject|0|||
127944035|NCT02856555|460418634|FG000|Overall Study|Randomized but Never Treated|0|||
127944036|NCT02856555|460418635|FG001|Overall Study|Randomized but Never Treated|1|||
127944037|NCT02856555|460418636|FG002|Overall Study|Randomized but Never Treated|0|||
127944038|NCT03333941|460418637|FG000|Overall Study|Lost to Follow-up|10|||
127944039|NCT03333941|460418637|FG000|Overall Study|Death|2|||
127944040|NCT03333941|460418637|FG000|Overall Study|Adverse Event|1|||
127944041|NCT02932306|460418638|FG000|Overall Study|Withdrawal by Subject|16|||
127944042|NCT02932306|460418639|FG001|Overall Study|Withdrawal by Subject|25|||
127944043|NCT02932306|460418638|FG000|Overall Study|Adverse Event|3|||
127944044|NCT02932306|460418639|FG001|Overall Study|Adverse Event|0|||
127944045|NCT02932306|460418638|FG000|Overall Study|Pregnancy|2|||
127944046|NCT02932306|460418639|FG001|Overall Study|Pregnancy|0|||
127944047|NCT02932306|460418638|FG000|Overall Study|Protocol Violation|1|||
127944048|NCT02932306|460418639|FG001|Overall Study|Protocol Violation|1|||
127944049|NCT02932306|460418638|FG000|Overall Study|Noncompliance with Study Drug|1|||
127944050|NCT02932306|460418639|FG001|Overall Study|Noncompliance with Study Drug|1|||
127944051|NCT02932306|460418638|FG000|Overall Study|Lost to Follow-up|36|||
127944052|NCT02932306|460418639|FG001|Overall Study|Lost to Follow-up|40|||
127944053|NCT02932306|460418638|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
127944054|NCT02932306|460418639|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
127944055|NCT02932306|460418638|FG000|Overall Study|Lack of Efficacy|0|||
127944056|NCT02932306|460418639|FG001|Overall Study|Lack of Efficacy|2|||
127944057|NCT02932306|460418638|FG000|Overall Study|Worsening condition|2|||
127944058|NCT02932306|460418639|FG001|Overall Study|Worsening condition|0|||
127944059|NCT02932306|460418638|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
127944060|NCT02932306|460418639|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
127944061|NCT00605540|460418644|FG000|Overall Study|Death|15|||
127944062|NCT00605540|460418644|FG000|Overall Study|Lost to Follow-up|23|||
127944063|NCT01544179|460418647|FG000|Overall Study|Death|50|||
127944064|NCT01544179|460418648|FG001|Overall Study|Death|37|||
127944065|NCT01544179|460418647|FG000|Overall Study|Lost to Follow-up|0|||
127944066|NCT01544179|460418648|FG001|Overall Study|Lost to Follow-up|1|||
127944067|NCT01544179|460418647|FG000|Overall Study|Adverse Event|0|||
127944068|NCT01544179|460418648|FG001|Overall Study|Adverse Event|1|||
127944069|NCT01544179|460418647|FG000|Overall Study|Withdrawal by Subject|12|||
127944070|NCT01544179|460418648|FG001|Overall Study|Withdrawal by Subject|7|||
127944071|NCT01544179|460418647|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
127944072|NCT01544179|460418648|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
127944073|NCT00049530|460418649|FG000|Overall Study|Lack of Efficacy|25|||
127944074|NCT00049530|460418649|FG000|Overall Study|Adverse Event|2|||
127944075|NCT00049530|460418649|FG000|Overall Study|Death|1|||
127944076|NCT00049530|460418649|FG000|Overall Study|symptomatic deterioration|1|||
127944077|NCT00049530|460418649|FG000|Overall Study|ineligible|3|||
127944078|NCT01635283|460418650|FG000|Overall Study|Tumor Progression|3|||
127944079|NCT01635283|460418650|FG000|Overall Study|Lost to Follow-up|1|||
127944080|NCT01438996|460418651|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
127944081|NCT01438996|460418652|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
127944082|NCT01438996|460418653|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
127944083|NCT01433549|460418654|FG000|Phase 2: Second Study Product|Adverse Event|0|||
127944084|NCT01433549|460418655|FG001|Phase 2: Second Study Product|Adverse Event|1|||
127944085|NCT01696058|460418659|FG000|Overall Study|Adverse Event|21|||
127944086|NCT01696058|460418660|FG001|Overall Study|Adverse Event|11|||
127944087|NCT01696058|460418659|FG000|Overall Study|Lack of Efficacy|2|||
127944088|NCT01696058|460418660|FG001|Overall Study|Lack of Efficacy|3|||
127944089|NCT01696058|460418659|FG000|Overall Study|Protocol Violation|9|||
127944090|NCT01696058|460418660|FG001|Overall Study|Protocol Violation|3|||
127944091|NCT01696058|460418659|FG000|Overall Study|Lost to Follow-up|2|||
127944092|NCT01696058|460418660|FG001|Overall Study|Lost to Follow-up|5|||
127944093|NCT01696058|460418659|FG000|Overall Study|Withdrawal by Subject|4|||
127944094|NCT01696058|460418660|FG001|Overall Study|Withdrawal by Subject|6|||
127944095|NCT01696058|460418659|FG000|Overall Study|Other reason prematurely discontinued|5|||
127944096|NCT01696058|460418660|FG001|Overall Study|Other reason prematurely discontinued|3|||
127944097|NCT02278055|460418661|FG000|Overall Study|Adverse Event|1|||
127944098|NCT02278055|460418661|FG000|Overall Study|Lost to Follow-up|1|||
127944099|NCT02278055|460418661|FG000|Overall Study|Withdrawal by Subject|2|||
127944100|NCT02278055|460418661|FG000|Overall Study|Progressive Disease|4|||
127944101|NCT01934335|460418662|FG000|Overall Study|Withdrawal by Subject|1|||
127944102|NCT01934335|460418663|FG001|Overall Study|Withdrawal by Subject|1|||
127944103|NCT05384171|460418664|FG000|Overall Study|Lost to Follow-up|9|||
127944104|NCT05384171|460418665|FG001|Overall Study|Lost to Follow-up|9|||
127944105|NCT05384171|460418664|FG000|Overall Study|Withdrawal by Subject|3|||
127944106|NCT05384171|460418665|FG001|Overall Study|Withdrawal by Subject|0|||
127944107|NCT01756079|460418668|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
127944108|NCT01756079|460418668|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
127944109|NCT01756079|460418668|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
127944110|NCT01756079|460418668|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
127944111|NCT01756079|460418668|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
127944112|NCT00106964|460418669|FG000|Overall Study|Lost to Follow-up|8|||
127944113|NCT00106964|460418670|FG001|Overall Study|Lost to Follow-up|6|||
127944114|NCT00106964|460418671|FG002|Overall Study|Lost to Follow-up|2|||
127944115|NCT00106964|460418669|FG000|Overall Study|Pregnancy|2|||
127944116|NCT00106964|460418670|FG001|Overall Study|Pregnancy|3|||
127944117|NCT00106964|460418671|FG002|Overall Study|Pregnancy|2|||
127944118|NCT00106964|460418669|FG000|Overall Study|Death|1|||
127944119|NCT00106964|460418670|FG001|Overall Study|Death|1|||
127944120|NCT00106964|460418671|FG002|Overall Study|Death|0|||
127944121|NCT00106964|460418669|FG000|Overall Study|Incarceration|0|||
127944122|NCT00106964|460418670|FG001|Overall Study|Incarceration|1|||
127944123|NCT00106964|460418671|FG002|Overall Study|Incarceration|0|||
127944124|NCT00106964|460418669|FG000|Overall Study|Site Funding Terminated|0|||
127944125|NCT00106964|460418670|FG001|Overall Study|Site Funding Terminated|1|||
127944126|NCT00106964|460418671|FG002|Overall Study|Site Funding Terminated|1|||
127944127|NCT00106964|460418669|FG000|Overall Study|Failure to adhere|2|||
127944128|NCT00106964|460418670|FG001|Overall Study|Failure to adhere|0|||
127944129|NCT00106964|460418671|FG002|Overall Study|Failure to adhere|0|||
127944130|NCT00106964|460418669|FG000|Overall Study|Did not meet eligibility criteria|0|||
127944131|NCT00106964|460418670|FG001|Overall Study|Did not meet eligibility criteria|2|||
127944132|NCT00106964|460418671|FG002|Overall Study|Did not meet eligibility criteria|2|||
127944133|NCT00106964|460418669|FG000|Overall Study|Required disallowed medication|0|||
127944134|NCT00106964|460418670|FG001|Overall Study|Required disallowed medication|1|||
127944135|NCT00106964|460418671|FG002|Overall Study|Required disallowed medication|0|||
127944136|NCT00168818|460418676|FG000|Overall Study|Adverse Event|23|||
127944137|NCT00168818|460418677|FG001|Overall Study|Adverse Event|29|||
127944138|NCT00168818|460418678|FG002|Overall Study|Adverse Event|31|||
127944139|NCT00168818|460418676|FG000|Overall Study|Protocol Violation|16|||
127944140|NCT00168818|460418677|FG001|Overall Study|Protocol Violation|11|||
127944141|NCT00168818|460418678|FG002|Overall Study|Protocol Violation|11|||
127944142|NCT00168818|460418676|FG000|Overall Study|Lost to Follow-up|13|||
127944143|NCT00168818|460418677|FG001|Overall Study|Lost to Follow-up|4|||
127944144|NCT00168818|460418678|FG002|Overall Study|Lost to Follow-up|15|||
127944145|NCT00168818|460418676|FG000|Overall Study|Withdrawal by Subject|43|||
127944146|NCT00168818|460418677|FG001|Overall Study|Withdrawal by Subject|41|||
127944147|NCT00168818|460418678|FG002|Overall Study|Withdrawal by Subject|37|||
127944148|NCT00168818|460418676|FG000|Overall Study|Other|22|||
127944149|NCT00168818|460418677|FG001|Overall Study|Other|24|||
127944150|NCT00168818|460418678|FG002|Overall Study|Other|30|||
127944151|NCT00168818|460418676|FG000|Treatment|Adverse Event|77|||
127944152|NCT00168818|460418677|FG001|Treatment|Adverse Event|89|||
127944153|NCT00168818|460418678|FG002|Treatment|Adverse Event|68|||
127944154|NCT00168818|460418676|FG000|Treatment|Protocol Violation|8|||
127944155|NCT00168818|460418677|FG001|Treatment|Protocol Violation|11|||
127944156|NCT00168818|460418678|FG002|Treatment|Protocol Violation|11|||
127944157|NCT00168818|460418676|FG000|Treatment|Lost to Follow-up|0|||
127944158|NCT00168818|460418677|FG001|Treatment|Lost to Follow-up|2|||
127944159|NCT00168818|460418678|FG002|Treatment|Lost to Follow-up|1|||
127944160|NCT00168818|460418676|FG000|Treatment|Withdrawal by Subject|25|||
127944161|NCT00168818|460418677|FG001|Treatment|Withdrawal by Subject|20|||
127944162|NCT00168818|460418678|FG002|Treatment|Withdrawal by Subject|22|||
127944163|NCT00168818|460418676|FG000|Treatment|Other|23|||
127944164|NCT00168818|460418677|FG001|Treatment|Other|29|||
127944165|NCT00168818|460418678|FG002|Treatment|Other|31|||
127944166|NCT01994291|460418679|FG000|Overall Study|Adverse Event|4|||
127944167|NCT01994291|460418680|FG001|Overall Study|Adverse Event|1|||
127944168|NCT01994291|460418681|FG002|Overall Study|Adverse Event|3|||
127944169|NCT01994291|460418679|FG000|Overall Study|Lost to Follow-up|1|||
127944170|NCT01994291|460418680|FG001|Overall Study|Lost to Follow-up|1|||
127944171|NCT01994291|460418681|FG002|Overall Study|Lost to Follow-up|0|||
127944172|NCT01994291|460418679|FG000|Overall Study|Does not meet entrance criteria|1|||
127944173|NCT01994291|460418680|FG001|Overall Study|Does not meet entrance criteria|0|||
127944174|NCT01994291|460418681|FG002|Overall Study|Does not meet entrance criteria|0|||
127944175|NCT01994291|460418679|FG000|Overall Study|Medication error without associated AE|1|||
127944176|NCT01994291|460418680|FG001|Overall Study|Medication error without associated AE|0|||
127944177|NCT01994291|460418681|FG002|Overall Study|Medication error without associated AE|1|||
127944178|NCT01994291|460418679|FG000|Overall Study|Protocol Violation|1|||
127944179|NCT01994291|460418680|FG001|Overall Study|Protocol Violation|0|||
127944180|NCT01994291|460418681|FG002|Overall Study|Protocol Violation|0|||
127944181|NCT01994291|460418679|FG000|Overall Study|Withdrawal by Subject|6|||
127944182|NCT01994291|460418680|FG001|Overall Study|Withdrawal by Subject|3|||
127944183|NCT01994291|460418681|FG002|Overall Study|Withdrawal by Subject|5|||
127944184|NCT01994291|460418679|FG000|Overall Study|Other|1|||
127944185|NCT01994291|460418680|FG001|Overall Study|Other|2|||
127944186|NCT01994291|460418681|FG002|Overall Study|Other|0|||
127944187|NCT00901576|460418684|FG000|Second Intervention|Withdrawal by Subject|0|||
127944188|NCT00901576|460418685|FG001|Second Intervention|Withdrawal by Subject|0|||
127944189|NCT00901576|460418686|FG002|Second Intervention|Withdrawal by Subject|0|||
127944190|NCT00901576|460418687|FG003|Second Intervention|Withdrawal by Subject|1|||
127944191|NCT00901576|460418688|FG004|Second Intervention|Withdrawal by Subject|0|||
127944192|NCT00901576|460418689|FG005|Second Intervention|Withdrawal by Subject|1|||
127944193|NCT00901576|460418684|FG000|Second Intervention|Physician Decision|1|||
127944194|NCT00901576|460418685|FG001|Second Intervention|Physician Decision|0|||
127944195|NCT00901576|460418686|FG002|Second Intervention|Physician Decision|0|||
127944196|NCT00901576|460418687|FG003|Second Intervention|Physician Decision|0|||
127944197|NCT00901576|460418688|FG004|Second Intervention|Physician Decision|0|||
127944198|NCT00901576|460418689|FG005|Second Intervention|Physician Decision|0|||
127944199|NCT03201445|460418690|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
127944200|NCT03201445|460418691|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
127944201|NCT03201445|460418690|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
127944202|NCT03201445|460418691|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
127944203|NCT03201445|460418690|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
127944204|NCT03201445|460418691|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
127944205|NCT03201445|460418690|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
127944206|NCT03201445|460418691|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
127944207|NCT03201445|460418690|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
127944208|NCT03201445|460418691|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
127944209|NCT03201445|460418690|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
127944210|NCT03201445|460418691|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
127944211|NCT03201445|460418690|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
127944212|NCT03201445|460418691|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
127944213|NCT03201445|460418690|FG000|LTE: DB Study Drug (up to Week 195)|Adverse Event|9|||
127944214|NCT03201445|460418691|FG001|LTE: DB Study Drug (up to Week 195)|Adverse Event|10|||
127944215|NCT03201445|460418690|FG000|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|0|||
127944216|NCT03201445|460418691|FG001|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|1|||
127944217|NCT03201445|460418690|FG000|LTE: DB Study Drug (up to Week 195)|Physician Decision|0|||
127944218|NCT03201445|460418691|FG001|LTE: DB Study Drug (up to Week 195)|Physician Decision|2|||
127944219|NCT03201445|460418690|FG000|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
127944220|NCT03201445|460418691|FG001|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
127944221|NCT03201445|460418690|FG000|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|6|||
127944222|NCT03201445|460418691|FG001|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|7|||
127944223|NCT03201445|460418690|FG000|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|11|||
127944224|NCT03201445|460418691|FG001|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|5|||
127944225|NCT03201445|460418690|FG000|LTE: OL Study Drug (Up to Week 195)|Adverse Event|3|||
127944226|NCT03201445|460418691|FG001|LTE: OL Study Drug (Up to Week 195)|Adverse Event|2|||
127944227|NCT03201445|460418690|FG000|LTE: OL Study Drug (Up to Week 195)|Physician Decision|1|||
127944228|NCT03201445|460418691|FG001|LTE: OL Study Drug (Up to Week 195)|Physician Decision|2|||
127944229|NCT03201445|460418690|FG000|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
127944230|NCT03201445|460418691|FG001|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
127944231|NCT03201445|460418690|FG000|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|5|||
127944232|NCT03201445|460418691|FG001|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|3|||
127944233|NCT03201445|460418690|FG000|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|2|||
127944234|NCT03201445|460418691|FG001|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|0|||
127944235|NCT03201445|460418690|FG000|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
127944236|NCT03201445|460418691|FG001|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
127944237|NCT03201445|460418690|FG000|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
127944238|NCT03201445|460418691|FG001|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
127944239|NCT03201445|460418690|FG000|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|0|||
127944240|NCT03201445|460418691|FG001|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|1|||
127944241|NCT00813800|460418696|FG000|Overall Study|Screen Failure after Consent|2|||
127944242|NCT00813800|460418696|FG000|Overall Study|Adverse Event|1|||
127944243|NCT00813800|460418696|FG000|Overall Study|Worsening of depression|2|||
127944244|NCT00813800|460418696|FG000|Overall Study|Physician Decision|1|||
127944245|NCT03456453|460418697|FG000|Overall Study|Withdrawal by Subject|2|||
127944246|NCT03456453|460418698|FG001|Overall Study|Withdrawal by Subject|0|||
127944247|NCT03456453|460418697|FG000|Overall Study|Not released to community|1|||
127944248|NCT03456453|460418698|FG001|Overall Study|Not released to community|5|||
127944249|NCT03456453|460418697|FG000|Overall Study|Lost to Follow-up|0|||
127944250|NCT03456453|460418698|FG001|Overall Study|Lost to Follow-up|2|||
127944251|NCT00642278|460418699|FG000|Overall Study|Adverse Event|2|||
127944252|NCT00642278|460418700|FG001|Overall Study|Adverse Event|1|||
127944253|NCT00642278|460418701|FG002|Overall Study|Adverse Event|3|||
127944254|NCT00642278|460418702|FG003|Overall Study|Adverse Event|1|||
127944255|NCT00642278|460418703|FG004|Overall Study|Adverse Event|2|||
127944256|NCT00642278|460418704|FG005|Overall Study|Adverse Event|2|||
127944257|NCT00642278|460418705|FG006|Overall Study|Adverse Event|0|||
127944258|NCT00642278|460418699|FG000|Overall Study|Lack of Efficacy|0|||
127944259|NCT00642278|460418700|FG001|Overall Study|Lack of Efficacy|1|||
127944260|NCT00642278|460418701|FG002|Overall Study|Lack of Efficacy|0|||
127944261|NCT00642278|460418702|FG003|Overall Study|Lack of Efficacy|0|||
127944262|NCT00642278|460418703|FG004|Overall Study|Lack of Efficacy|0|||
127944263|NCT00642278|460418704|FG005|Overall Study|Lack of Efficacy|0|||
127944264|NCT00642278|460418705|FG006|Overall Study|Lack of Efficacy|0|||
127944265|NCT00642278|460418699|FG000|Overall Study|Lost to Follow-up|5|||
127944266|NCT00642278|460418700|FG001|Overall Study|Lost to Follow-up|1|||
127944267|NCT00642278|460418701|FG002|Overall Study|Lost to Follow-up|0|||
127944268|NCT00642278|460418702|FG003|Overall Study|Lost to Follow-up|1|||
127944269|NCT00642278|460418703|FG004|Overall Study|Lost to Follow-up|0|||
127944270|NCT00642278|460418704|FG005|Overall Study|Lost to Follow-up|1|||
127944271|NCT00642278|460418705|FG006|Overall Study|Lost to Follow-up|1|||
127944272|NCT00642278|460418699|FG000|Overall Study|Physician Decision|0|||
127944273|NCT00642278|460418700|FG001|Overall Study|Physician Decision|0|||
127944274|NCT00642278|460418701|FG002|Overall Study|Physician Decision|0|||
127944275|NCT00642278|460418702|FG003|Overall Study|Physician Decision|1|||
127944276|NCT00642278|460418703|FG004|Overall Study|Physician Decision|0|||
127944277|NCT00642278|460418704|FG005|Overall Study|Physician Decision|0|||
127944278|NCT00642278|460418705|FG006|Overall Study|Physician Decision|0|||
127944279|NCT00642278|460418699|FG000|Overall Study|Protocol Violation|0|||
127944280|NCT00642278|460418700|FG001|Overall Study|Protocol Violation|0|||
127944281|NCT00642278|460418701|FG002|Overall Study|Protocol Violation|1|||
127944282|NCT00642278|460418702|FG003|Overall Study|Protocol Violation|1|||
127944283|NCT00642278|460418703|FG004|Overall Study|Protocol Violation|0|||
127944284|NCT00642278|460418704|FG005|Overall Study|Protocol Violation|1|||
127944285|NCT00642278|460418705|FG006|Overall Study|Protocol Violation|2|||
127944286|NCT00642278|460418699|FG000|Overall Study|Withdrawal by Subject|1|||
127944287|NCT00642278|460418700|FG001|Overall Study|Withdrawal by Subject|1|||
127944288|NCT00642278|460418701|FG002|Overall Study|Withdrawal by Subject|1|||
127944289|NCT00642278|460418702|FG003|Overall Study|Withdrawal by Subject|3|||
127944290|NCT00642278|460418703|FG004|Overall Study|Withdrawal by Subject|6|||
127944291|NCT00642278|460418704|FG005|Overall Study|Withdrawal by Subject|2|||
127944292|NCT00642278|460418705|FG006|Overall Study|Withdrawal by Subject|2|||
127944293|NCT00642278|460418699|FG000|Overall Study|Noncompliance with study drug regimen|0|||
127944294|NCT00642278|460418700|FG001|Overall Study|Noncompliance with study drug regimen|0|||
127944295|NCT00642278|460418701|FG002|Overall Study|Noncompliance with study drug regimen|0|||
127944296|NCT00642278|460418702|FG003|Overall Study|Noncompliance with study drug regimen|1|||
127944297|NCT00642278|460418703|FG004|Overall Study|Noncompliance with study drug regimen|0|||
127944298|NCT00642278|460418704|FG005|Overall Study|Noncompliance with study drug regimen|0|||
127944299|NCT00642278|460418705|FG006|Overall Study|Noncompliance with study drug regimen|0|||
127944300|NCT00642278|460418699|FG000|Overall Study|Other|2|||
127944301|NCT00642278|460418700|FG001|Overall Study|Other|1|||
127944302|NCT00642278|460418701|FG002|Overall Study|Other|0|||
127944303|NCT00642278|460418702|FG003|Overall Study|Other|1|||
127944304|NCT00642278|460418703|FG004|Overall Study|Other|0|||
127944305|NCT00642278|460418704|FG005|Overall Study|Other|1|||
127944306|NCT00642278|460418705|FG006|Overall Study|Other|0|||
127944307|NCT00090363|460418706|FG000|Overall Study|Lost to Follow-up|1|||
127944308|NCT00090363|460418707|FG001|Overall Study|Lost to Follow-up|2|||
127944309|NCT00090363|460418708|FG002|Overall Study|Lost to Follow-up|1|||
127944310|NCT00090363|460418706|FG000|Overall Study|Withdrawal by Subject|7|||
127944311|NCT00090363|460418707|FG001|Overall Study|Withdrawal by Subject|7|||
127944312|NCT00090363|460418708|FG002|Overall Study|Withdrawal by Subject|6|||
127944313|NCT00090363|460418706|FG000|Overall Study|Study-specific discontinuation criteria|75|||
127944314|NCT00090363|460418707|FG001|Overall Study|Study-specific discontinuation criteria|74|||
127944315|NCT00090363|460418708|FG002|Overall Study|Study-specific discontinuation criteria|62|||
127944316|NCT00090363|460418706|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
127944317|NCT00090363|460418707|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
127944318|NCT00090363|460418708|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
127944319|NCT00090363|460418706|FG000|Overall Study|Consent expired|7|||
127944320|NCT00090363|460418707|FG001|Overall Study|Consent expired|10|||
127944321|NCT00090363|460418708|FG002|Overall Study|Consent expired|9|||
127944322|NCT00090363|460418706|FG000|Overall Study|Reasons not specified|2|||
127944323|NCT00090363|460418707|FG001|Overall Study|Reasons not specified|1|||
127944324|NCT00090363|460418708|FG002|Overall Study|Reasons not specified|1|||
127944325|NCT00090363|460418706|FG000|Overall Study|Continuing on study off treatment|14|||
127944326|NCT00090363|460418707|FG001|Overall Study|Continuing on study off treatment|13|||
127944327|NCT00090363|460418708|FG002|Overall Study|Continuing on study off treatment|16|||
127944328|NCT03713619|460418709|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
127944329|NCT03713619|460418710|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
127944330|NCT03713619|460418711|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
127944331|NCT03713619|460418712|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
127944332|NCT03713619|460418713|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
127944333|NCT03713619|460418709|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|3|||
127944334|NCT03713619|460418710|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
127944335|NCT03713619|460418711|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
127944336|NCT03713619|460418712|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
127944337|NCT03713619|460418713|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
127944338|NCT03713619|460418709|FG000|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
127944339|NCT03713619|460418710|FG001|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
127944340|NCT03713619|460418711|FG002|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
127944341|NCT03713619|460418712|FG003|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
127944342|NCT03713619|460418713|FG004|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
127944343|NCT03713619|460418709|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
127944344|NCT03713619|460418710|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
127944345|NCT03713619|460418711|FG002|Treatment Period 1 (Until Week 16)|Technical problems|0|||
127944346|NCT03713619|460418712|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
127944347|NCT03713619|460418713|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
127944348|NCT03713619|460418709|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|4|||
127944349|NCT03713619|460418710|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|9|||
127944350|NCT03713619|460418711|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|5|||
127944351|NCT03713619|460418712|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
127944352|NCT03713619|460418713|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
127944353|NCT03713619|460418709|FG000|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
127944354|NCT03713619|460418710|FG001|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
127944355|NCT03713619|460418711|FG002|Treatment Period 1 (Until Week 16)|Misrandomized|1|||
127944356|NCT03713619|460418712|FG003|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
127944357|NCT03713619|460418713|FG004|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
127944358|NCT03713619|460418709|FG000|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
127944359|NCT03713619|460418710|FG001|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
127944360|NCT03713619|460418711|FG002|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
127944361|NCT03713619|460418712|FG003|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
127944362|NCT03713619|460418713|FG004|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
127944363|NCT03713619|460418709|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
127944364|NCT03713619|460418710|FG001|Treatment Period 2 (After Week 16)|Adverse Event|5|||
127944365|NCT03713619|460418711|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
127944366|NCT03713619|460418712|FG003|Treatment Period 2 (After Week 16)|Adverse Event|1|||
127944367|NCT03713619|460418713|FG004|Treatment Period 2 (After Week 16)|Adverse Event|2|||
127944368|NCT03713619|460418709|FG000|Treatment Period 2 (After Week 16)|Pregnancy|1|||
127944369|NCT03713619|460418710|FG001|Treatment Period 2 (After Week 16)|Pregnancy|0|||
127944370|NCT03713619|460418711|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
127944371|NCT03713619|460418712|FG003|Treatment Period 2 (After Week 16)|Pregnancy|1|||
127944372|NCT03713619|460418713|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
127944373|NCT03713619|460418709|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|26|||
127944374|NCT03713619|460418710|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|20|||
127944375|NCT03713619|460418711|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
127944376|NCT03713619|460418712|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|10|||
127944377|NCT03713619|460418713|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|6|||
127944378|NCT03713619|460418709|FG000|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
127944379|NCT03713619|460418710|FG001|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
127944380|NCT03713619|460418711|FG002|Treatment Period 2 (After Week 16)|Poor efficacy|0|||
127944381|NCT03713619|460418712|FG003|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
127944382|NCT03713619|460418713|FG004|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
127944383|NCT03713619|460418709|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
127944384|NCT03713619|460418710|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
127944385|NCT03713619|460418711|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
127944386|NCT03713619|460418712|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
127944387|NCT03713619|460418713|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
127944388|NCT03713619|460418709|FG000|Treatment Period 2 (After Week 16)|Physician Decision|0|||
127944389|NCT03713619|460418710|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
127944390|NCT03713619|460418711|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
127944391|NCT03713619|460418712|FG003|Treatment Period 2 (After Week 16)|Physician Decision|1|||
127944392|NCT03713619|460418713|FG004|Treatment Period 2 (After Week 16)|Physician Decision|1|||
127944393|NCT01144715|460418722|FG000|Overall Study|Lost to Follow-up|2|||
127944394|NCT01144715|460418723|FG001|Overall Study|Lost to Follow-up|1|||
127944395|NCT01144715|460418722|FG000|Overall Study|Withdrawal by Subject|2|||
127944396|NCT01144715|460418723|FG001|Overall Study|Withdrawal by Subject|1|||
127944397|NCT01144715|460418722|FG000|Overall Study|Adverse Event|0|||
127944398|NCT01144715|460418723|FG001|Overall Study|Adverse Event|1|||
127944399|NCT06281171|460418724|FG000|Timepoint 2|Lost to Follow-up|6|||
127944400|NCT06281171|460418725|FG001|Timepoint 2|Lost to Follow-up|4|||
127944401|NCT06281171|460418724|FG000|Timepoint 3|Lost to Follow-up|0|||
127944402|NCT06281171|460418725|FG001|Timepoint 3|Lost to Follow-up|5|||
127944403|NCT02552212|460418726|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
127944404|NCT02552212|460418727|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
127944405|NCT02552212|460418728|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
127944406|NCT02552212|460418726|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
127944407|NCT02552212|460418727|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
127944408|NCT02552212|460418728|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
127944409|NCT02552212|460418726|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
127944410|NCT02552212|460418727|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
127944411|NCT02552212|460418728|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
127944412|NCT02552212|460418726|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
127944413|NCT02552212|460418727|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
127944414|NCT02552212|460418728|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
127944415|NCT02552212|460418726|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
127944416|NCT02552212|460418727|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
127944417|NCT02552212|460418728|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
127944418|NCT02552212|460418726|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
127944419|NCT02552212|460418727|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
127944420|NCT02552212|460418728|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
127944421|NCT02552212|460418726|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
127944422|NCT02552212|460418727|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
127944423|NCT02552212|460418728|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
127944424|NCT02552212|460418726|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
127944425|NCT02552212|460418727|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
127944426|NCT02552212|460418728|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
127944427|NCT02552212|460418726|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
127944428|NCT02552212|460418727|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
127944429|NCT02552212|460418728|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
127944430|NCT02552212|460418726|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
127944431|NCT02552212|460418727|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
127944432|NCT02552212|460418728|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
127944433|NCT02552212|460418726|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
127944434|NCT02552212|460418727|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
127944435|NCT02552212|460418728|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
127944436|NCT02552212|460418726|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
127944437|NCT02552212|460418727|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
127944438|NCT02552212|460418728|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
127944439|NCT02552212|460418726|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
127944440|NCT02552212|460418727|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
127944441|NCT02552212|460418728|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
127944442|NCT02552212|460418726|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
127944443|NCT02552212|460418727|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
127944444|NCT02552212|460418728|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
127944445|NCT02552212|460418726|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
127944446|NCT02552212|460418727|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
127944447|NCT02552212|460418728|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
127944448|NCT02552212|460418726|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
127944449|NCT02552212|460418727|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
127944450|NCT02552212|460418728|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
127944451|NCT02552212|460418726|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
127944452|NCT02552212|460418727|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
127944453|NCT02552212|460418728|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
127944454|NCT02552212|460418726|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
127944455|NCT02552212|460418727|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
127944456|NCT02552212|460418728|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
127944457|NCT02552212|460418726|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
127944458|NCT02552212|460418727|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
127944459|NCT02552212|460418728|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
127944460|NCT02552212|460418726|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
127944461|NCT02552212|460418727|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
127944462|NCT02552212|460418728|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
127944463|NCT02552212|460418726|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
127944464|NCT02552212|460418727|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
127944465|NCT02552212|460418728|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
127944466|NCT00205803|460418737|FG000|Infant Series|Lost to Follow-up|10|||
127944467|NCT00205803|460418738|FG001|Infant Series|Lost to Follow-up|4|||
127944468|NCT00205803|460418737|FG000|Infant Series|Withdrawal by Subject|2|||
127944469|NCT00205803|460418738|FG001|Infant Series|Withdrawal by Subject|5|||
127944470|NCT00205803|460418737|FG000|Infant Series|Physician Decision|3|||
127944471|NCT00205803|460418738|FG001|Infant Series|Physician Decision|1|||
127944472|NCT00205803|460418737|FG000|Infant Series|Protocol Violation|1|||
127944473|NCT00205803|460418738|FG001|Infant Series|Protocol Violation|0|||
127944474|NCT00205803|460418737|FG000|Infant Series|Lost Kaiser coverage|0|||
127944475|NCT00205803|460418738|FG001|Infant Series|Lost Kaiser coverage|1|||
127944476|NCT00205803|460418737|FG000|Infant Series|Non-compliant|1|||
127944477|NCT00205803|460418738|FG001|Infant Series|Non-compliant|0|||
127944478|NCT00205803|460418737|FG000|Infant Series|Sponsor request|1|||
127944479|NCT00205803|460418738|FG001|Infant Series|Sponsor request|0|||
127944480|NCT00205803|460418737|FG000|After Infant Series|Adverse Event|1|||
127944481|NCT00205803|460418738|FG001|After Infant Series|Adverse Event|1|||
127944482|NCT00205803|460418737|FG000|After Infant Series|Protocol Violation|1|||
127944483|NCT00205803|460418738|FG001|After Infant Series|Protocol Violation|1|||
127944484|NCT00205803|460418737|FG000|After Infant Series|Lost to Follow-up|2|||
127944485|NCT00205803|460418738|FG001|After Infant Series|Lost to Follow-up|1|||
127944486|NCT00205803|460418737|FG000|After Infant Series|Physician Decision|3|||
127944487|NCT00205803|460418738|FG001|After Infant Series|Physician Decision|2|||
127944488|NCT00205803|460418737|FG000|After Infant Series|Withdrawal by Subject|1|||
127944489|NCT00205803|460418738|FG001|After Infant Series|Withdrawal by Subject|4|||
127944490|NCT00205803|460418737|FG000|After Infant Series|Other|10|||
127944491|NCT00205803|460418738|FG001|After Infant Series|Other|4|||
127944492|NCT00205803|460418737|FG000|Toddler Dose|Lost to Follow-up|2|||
127944493|NCT00205803|460418738|FG001|Toddler Dose|Lost to Follow-up|3|||
127944494|NCT02369458|460418740|FG000|Overall Study|Determined to be not eligible|1|||
127944495|NCT02369458|460418741|FG001|Overall Study|Determined to be not eligible|0|||
127944496|NCT04572893|460418742|FG000|Part A|Adverse Event|1|||
127944497|NCT04572893|460418743|FG001|Part A|Adverse Event|0|||
127944498|NCT04572893|460418744|FG002|Part A|Adverse Event|0|||
127944499|NCT04572893|460418745|FG003|Part A|Adverse Event|0|||
127944500|NCT04572893|460418746|FG004|Part A|Adverse Event|0|||
127944501|NCT04572893|460418747|FG005|Part A|Adverse Event|0|||
127944502|NCT04572893|460418748|FG006|Part A|Adverse Event|0|||
127944503|NCT04572893|460418742|FG000|Part B|Withdrawal by Subject|0|||
127944504|NCT04572893|460418743|FG001|Part B|Withdrawal by Subject|0|||
127944505|NCT04572893|460418744|FG002|Part B|Withdrawal by Subject|0|||
127944506|NCT04572893|460418745|FG003|Part B|Withdrawal by Subject|0|||
127944507|NCT04572893|460418746|FG004|Part B|Withdrawal by Subject|0|||
127944508|NCT04572893|460418747|FG005|Part B|Withdrawal by Subject|1|||
127944509|NCT04572893|460418748|FG006|Part B|Withdrawal by Subject|0|||
127944510|NCT04572893|460418742|FG000|Part B|Study terminated by sponsor|0|||
127944511|NCT04572893|460418743|FG001|Part B|Study terminated by sponsor|0|||
127944512|NCT04572893|460418744|FG002|Part B|Study terminated by sponsor|0|||
127944513|NCT04572893|460418745|FG003|Part B|Study terminated by sponsor|0|||
127944514|NCT04572893|460418746|FG004|Part B|Study terminated by sponsor|7|||
127944515|NCT04572893|460418747|FG005|Part B|Study terminated by sponsor|5|||
127944516|NCT04572893|460418748|FG006|Part B|Study terminated by sponsor|3|||
127944517|NCT04572893|460418742|FG000|Part B|Lost to Follow-up|0|||
127944518|NCT04572893|460418743|FG001|Part B|Lost to Follow-up|0|||
127944519|NCT04572893|460418744|FG002|Part B|Lost to Follow-up|0|||
127944520|NCT04572893|460418745|FG003|Part B|Lost to Follow-up|0|||
127944521|NCT04572893|460418746|FG004|Part B|Lost to Follow-up|0|||
127944522|NCT04572893|460418747|FG005|Part B|Lost to Follow-up|0|||
127944523|NCT04572893|460418748|FG006|Part B|Lost to Follow-up|1|||
127944524|NCT04572893|460418742|FG000|Part B|Adverse Event|0|||
127944525|NCT04572893|460418743|FG001|Part B|Adverse Event|0|||
127944526|NCT04572893|460418744|FG002|Part B|Adverse Event|0|||
127944527|NCT04572893|460418745|FG003|Part B|Adverse Event|0|||
127944528|NCT04572893|460418746|FG004|Part B|Adverse Event|1|||
127944529|NCT04572893|460418747|FG005|Part B|Adverse Event|1|||
127944530|NCT04572893|460418748|FG006|Part B|Adverse Event|0|||
127944531|NCT00121134|460418749|FG000|Overall Study|Progression of Disease|5|||
127944532|NCT00121134|460418750|FG001|Overall Study|Progression of Disease|3|||
127944533|NCT00121134|460418751|FG002|Overall Study|Progression of Disease|4|||
127944534|NCT00121134|460418752|FG003|Overall Study|Progression of Disease|2|||
127944535|NCT00121134|460418749|FG000|Overall Study|Toxicity|4|||
127944536|NCT00121134|460418750|FG001|Overall Study|Toxicity|7|||
127944537|NCT00121134|460418751|FG002|Overall Study|Toxicity|13|||
127944538|NCT00121134|460418752|FG003|Overall Study|Toxicity|5|||
127944539|NCT00121134|460418749|FG000|Overall Study|Physician Decision|6|||
127944540|NCT00121134|460418750|FG001|Overall Study|Physician Decision|4|||
127944541|NCT00121134|460418751|FG002|Overall Study|Physician Decision|4|||
127944542|NCT00121134|460418752|FG003|Overall Study|Physician Decision|1|||
127944543|NCT00121134|460418749|FG000|Overall Study|Treatment Delay|1|||
127944544|NCT00121134|460418750|FG001|Overall Study|Treatment Delay|0|||
127944545|NCT00121134|460418751|FG002|Overall Study|Treatment Delay|0|||
127944546|NCT00121134|460418752|FG003|Overall Study|Treatment Delay|0|||
127944547|NCT00121134|460418749|FG000|Overall Study|Intercurrent Illness|0|||
127944548|NCT00121134|460418750|FG001|Overall Study|Intercurrent Illness|0|||
127944549|NCT00121134|460418751|FG002|Overall Study|Intercurrent Illness|0|||
127944550|NCT00121134|460418752|FG003|Overall Study|Intercurrent Illness|1|||
127944551|NCT00121134|460418749|FG000|Overall Study|Patient Personal Reasons|0|||
127944552|NCT00121134|460418750|FG001|Overall Study|Patient Personal Reasons|1|||
127944553|NCT00121134|460418751|FG002|Overall Study|Patient Personal Reasons|0|||
127944554|NCT00121134|460418752|FG003|Overall Study|Patient Personal Reasons|0|||
127944555|NCT00197496|460418759|FG000|Baseline to Discharge|not interested|1|||
127944556|NCT00197496|460418760|FG001|Baseline to Discharge|not interested|0|||
127944557|NCT00197496|460418759|FG000|Baseline to Discharge|MRSA|1|||
127944558|NCT00197496|460418760|FG001|Baseline to Discharge|MRSA|0|||
127944559|NCT00197496|460418759|FG000|Baseline to Discharge|Physician Decision|0|||
127944560|NCT00197496|460418760|FG001|Baseline to Discharge|Physician Decision|1|||
127944561|NCT00197496|460418759|FG000|Baseline to Discharge|Protocol Violation|0|||
127944562|NCT00197496|460418760|FG001|Baseline to Discharge|Protocol Violation|1|||
127944563|NCT00197496|460418759|FG000|Follow-up|Lost to Follow-up|2|||
127944564|NCT00197496|460418760|FG001|Follow-up|Lost to Follow-up|1|||
127944565|NCT00857584|460418766|FG000|Overall Study|Lack of Efficacy|1|||
127944566|NCT00857584|460418767|FG001|Overall Study|Lack of Efficacy|2|||
127944567|NCT00857584|460418766|FG000|Overall Study|Adverse Event|2|||
127944568|NCT00857584|460418767|FG001|Overall Study|Adverse Event|2|||
127944569|NCT00857584|460418766|FG000|Overall Study|Physician Decision|1|||
127944570|NCT00857584|460418767|FG001|Overall Study|Physician Decision|1|||
127944571|NCT01102374|460418770|FG000|Overall Study|Death|9|||
127944572|NCT01102374|460418771|FG001|Overall Study|Death|13|||
127944573|NCT01102374|460418770|FG000|Overall Study|Lost to Follow-up|7|||
127944574|NCT01102374|460418771|FG001|Overall Study|Lost to Follow-up|6|||
127944575|NCT00418821|460418772|FG000|Overall Study|Fulfils one of the exclusion criteria|1|||
127944576|NCT02071849|460418773|FG000|6-month Primary Endpoint|Did not receive device|4|||
127944577|NCT02071849|460418773|FG000|6-month Primary Endpoint|Adverse Event|1|||
127944578|NCT02071849|460418773|FG000|2-year Extended Follow-up|Adverse Event|1|||
127944579|NCT04619992|460418774|FG000|Overall Study|Withdrawal by Subject|1|||
127944580|NCT04619992|460418775|FG001|Overall Study|Withdrawal by Subject|0|||
127944581|NCT00259272|460418776|FG000|Overall Study|Adverse Event|2|||
127944582|NCT00259272|460418777|FG001|Overall Study|Adverse Event|1|||
127944583|NCT00259272|460418778|FG002|Overall Study|Adverse Event|0|||
127944584|NCT00259272|460418779|FG003|Overall Study|Adverse Event|3|||
127944585|NCT00259272|460418776|FG000|Overall Study|Lack of Efficacy|5|||
127944586|NCT00259272|460418777|FG001|Overall Study|Lack of Efficacy|1|||
127944587|NCT00259272|460418778|FG002|Overall Study|Lack of Efficacy|2|||
127944588|NCT00259272|460418779|FG003|Overall Study|Lack of Efficacy|6|||
127944589|NCT00259272|460418776|FG000|Overall Study|Physician Decision|1|||
127944590|NCT00259272|460418777|FG001|Overall Study|Physician Decision|2|||
127944591|NCT00259272|460418778|FG002|Overall Study|Physician Decision|1|||
127944592|NCT00259272|460418779|FG003|Overall Study|Physician Decision|3|||
127944593|NCT00259272|460418776|FG000|Overall Study|Protocol Violation|2|||
127944594|NCT00259272|460418777|FG001|Overall Study|Protocol Violation|0|||
127944595|NCT00259272|460418778|FG002|Overall Study|Protocol Violation|0|||
127944596|NCT00259272|460418779|FG003|Overall Study|Protocol Violation|1|||
127944597|NCT00259272|460418776|FG000|Overall Study|Sponsor Decision|0|||
127944598|NCT00259272|460418777|FG001|Overall Study|Sponsor Decision|1|||
127944599|NCT00259272|460418778|FG002|Overall Study|Sponsor Decision|0|||
127944600|NCT00259272|460418779|FG003|Overall Study|Sponsor Decision|0|||
127944601|NCT00259272|460418776|FG000|Overall Study|Withdrawal by Subject|4|||
127944602|NCT00259272|460418777|FG001|Overall Study|Withdrawal by Subject|2|||
127944603|NCT00259272|460418778|FG002|Overall Study|Withdrawal by Subject|2|||
127944604|NCT00259272|460418779|FG003|Overall Study|Withdrawal by Subject|7|||
127944605|NCT00259272|460418776|FG000|Overall Study|Lost to Follow-up|1|||
127944606|NCT00259272|460418777|FG001|Overall Study|Lost to Follow-up|0|||
127944607|NCT00259272|460418778|FG002|Overall Study|Lost to Follow-up|0|||
127944608|NCT00259272|460418779|FG003|Overall Study|Lost to Follow-up|1|||
127944609|NCT01908907|460420476|FG000|Overall Study|Physician Decision|1|||
127944610|NCT01908907|460420477|FG001|Overall Study|Physician Decision|0|||
127944611|NCT01908907|460420476|FG000|Overall Study|Protocol Violation|1|||
127944612|NCT01908907|460420477|FG001|Overall Study|Protocol Violation|0|||
127944613|NCT00761657|460420478|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
127944614|NCT00761657|460420479|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
127944615|NCT00761657|460420480|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
127944616|NCT00761657|460420481|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
127944617|NCT00761657|460420482|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
127944618|NCT00761657|460420483|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
127944619|NCT00761657|460420484|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
127944620|NCT00761657|460420485|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
127944621|NCT00761657|460420486|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
127944622|NCT00761657|460420478|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
127944623|NCT00761657|460420479|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
127944624|NCT00761657|460420480|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
127944625|NCT00761657|460420481|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
127944626|NCT00761657|460420482|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
127944627|NCT00761657|460420483|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
127944628|NCT00761657|460420484|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
127944629|NCT00761657|460420485|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
127944630|NCT00761657|460420486|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
127944631|NCT00761657|460420478|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
127944632|NCT00761657|460420479|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
127944633|NCT00761657|460420480|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
127944634|NCT00761657|460420481|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
127944635|NCT00761657|460420482|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
127944636|NCT00761657|460420483|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
127944637|NCT00761657|460420484|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
127944638|NCT00761657|460420485|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
127944639|NCT00761657|460420486|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
127944640|NCT00761657|460420478|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
127944641|NCT00761657|460420479|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
127944642|NCT00761657|460420480|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
127944643|NCT00761657|460420481|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
127944644|NCT00761657|460420482|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
127944645|NCT00761657|460420483|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
127944646|NCT00761657|460420484|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
127944647|NCT00761657|460420485|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
127944648|NCT00761657|460420486|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
127944649|NCT00359801|460420487|FG000|Overall Study|Lost to Follow-up|72|||
127944650|NCT00359801|460420488|FG001|Overall Study|Lost to Follow-up|58|||
127944651|NCT00359801|460420487|FG000|Overall Study|Withdrawal by Subject|143|||
127944652|NCT00359801|460420488|FG001|Overall Study|Withdrawal by Subject|96|||
127944653|NCT00359801|460420487|FG000|Overall Study|Other|66|||
127944654|NCT00359801|460420488|FG001|Overall Study|Other|46|||
127944655|NCT00359801|460420487|FG000|Overall Study|Final Status Unknown: missing data|7|||
127944656|NCT00359801|460420488|FG001|Overall Study|Final Status Unknown: missing data|4|||
127944657|NCT00359801|460420487|FG000|Overall Study|Sponsor Decision|17|||
127944658|NCT00359801|460420488|FG001|Overall Study|Sponsor Decision|16|||
127944659|NCT02500043|460420489|FG000|Overall Study|Randomized, but not Treated|2|||
127944660|NCT02500043|460420490|FG001|Overall Study|Randomized, but not Treated|2|||
127944661|NCT02500043|460420489|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
127944662|NCT02500043|460420490|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
127944663|NCT02500043|460420489|FG000|Overall Study|Adverse Event|33|||
127944664|NCT02500043|460420490|FG001|Overall Study|Adverse Event|11|||
127944665|NCT02500043|460420489|FG000|Overall Study|Clinical Progression|54|||
127944666|NCT02500043|460420490|FG001|Overall Study|Clinical Progression|35|||
127944667|NCT02500043|460420489|FG000|Overall Study|Radiological Progression|192|||
127944668|NCT02500043|460420490|FG001|Overall Study|Radiological Progression|110|||
127944669|NCT02500043|460420489|FG000|Overall Study|Physician's Decision|11|||
127944670|NCT02500043|460420490|FG001|Overall Study|Physician's Decision|3|||
127944671|NCT02500043|460420489|FG000|Overall Study|Withdrawal by Subject|14|||
127944672|NCT02500043|460420490|FG001|Overall Study|Withdrawal by Subject|4|||
127944673|NCT02500043|460420489|FG000|Overall Study|Death|11|||
127944674|NCT02500043|460420490|FG001|Overall Study|Death|2|||
127944675|NCT02500043|460420489|FG000|Overall Study|Protocol Deviation|1|||
127944676|NCT02500043|460420490|FG001|Overall Study|Protocol Deviation|0|||
127944677|NCT03151408|460420491|FG000|Overall Study|Adverse Event|24|||
127944678|NCT03151408|460420492|FG001|Overall Study|Adverse Event|23|||
127944679|NCT03151408|460420491|FG000|Overall Study|Death|46|||
127944680|NCT03151408|460420492|FG001|Overall Study|Death|26|||
127944681|NCT03151408|460420491|FG000|Overall Study|Physician Decision|13|||
127944682|NCT03151408|460420492|FG001|Overall Study|Physician Decision|19|||
127944683|NCT03151408|460420491|FG000|Overall Study|Withdrawal by Subject|16|||
127944684|NCT03151408|460420492|FG001|Overall Study|Withdrawal by Subject|20|||
127944685|NCT03151408|460420491|FG000|Overall Study|Progressive disease|45|||
127944686|NCT03151408|460420492|FG001|Overall Study|Progressive disease|61|||
127944687|NCT03151408|460420491|FG000|Overall Study|non-compliance by patient|1|||
127944688|NCT03151408|460420492|FG001|Overall Study|non-compliance by patient|0|||
127944689|NCT03151408|460420491|FG000|Overall Study|other reasons|56|||
127944690|NCT03151408|460420492|FG001|Overall Study|other reasons|52|||
127944691|NCT03151408|460420491|FG000|Overall Study|randomized and not treated|2|||
127944692|NCT03151408|460420492|FG001|Overall Study|randomized and not treated|2|||
127944693|NCT01473524|460420495|FG000|DB Phase|Adverse Event|4|||
127944694|NCT01473524|460420496|FG001|DB Phase|Adverse Event|8|||
127944695|NCT01473524|460420497|FG002|DB Phase|Adverse Event|2|||
127944696|NCT01473524|460420498|FG003|DB Phase|Adverse Event|0|||
127944697|NCT01473524|460420499|FG004|DB Phase|Adverse Event|0|||
127944698|NCT01473524|460420500|FG005|DB Phase|Adverse Event|0|||
127944699|NCT01473524|460420495|FG000|DB Phase|Death|1|||
127944700|NCT01473524|460420496|FG001|DB Phase|Death|0|||
127944701|NCT01473524|460420497|FG002|DB Phase|Death|0|||
127944702|NCT01473524|460420498|FG003|DB Phase|Death|0|||
127944703|NCT01473524|460420499|FG004|DB Phase|Death|0|||
127944704|NCT01473524|460420500|FG005|DB Phase|Death|0|||
127944705|NCT01473524|460420495|FG000|DB Phase|Withdrawal by Subject|2|||
127944706|NCT01473524|460420496|FG001|DB Phase|Withdrawal by Subject|1|||
127944707|NCT01473524|460420497|FG002|DB Phase|Withdrawal by Subject|1|||
127944708|NCT01473524|460420498|FG003|DB Phase|Withdrawal by Subject|0|||
127944709|NCT01473524|460420499|FG004|DB Phase|Withdrawal by Subject|0|||
127944710|NCT01473524|460420500|FG005|DB Phase|Withdrawal by Subject|0|||
127944711|NCT01473524|460420495|FG000|LTSE Phase|Withdrawal by Subject|0|||
127944712|NCT01473524|460420496|FG001|LTSE Phase|Withdrawal by Subject|0|||
127944713|NCT01473524|460420497|FG002|LTSE Phase|Withdrawal by Subject|0|||
127944714|NCT01473524|460420498|FG003|LTSE Phase|Withdrawal by Subject|3|||
127944715|NCT01473524|460420499|FG004|LTSE Phase|Withdrawal by Subject|3|||
127944716|NCT01473524|460420500|FG005|LTSE Phase|Withdrawal by Subject|6|||
127944717|NCT01473524|460420495|FG000|LTSE Phase|Death|0|||
127944718|NCT01473524|460420496|FG001|LTSE Phase|Death|0|||
127944719|NCT01473524|460420497|FG002|LTSE Phase|Death|0|||
127944720|NCT01473524|460420498|FG003|LTSE Phase|Death|0|||
127944721|NCT01473524|460420499|FG004|LTSE Phase|Death|1|||
127944722|NCT01473524|460420500|FG005|LTSE Phase|Death|0|||
127944723|NCT01473524|460420495|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
127944724|NCT01473524|460420496|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
127944725|NCT01473524|460420497|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
127944726|NCT01473524|460420498|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
127944727|NCT01473524|460420499|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
127944728|NCT01473524|460420500|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
127944729|NCT01473524|460420495|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
127944730|NCT01473524|460420496|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
127944731|NCT01473524|460420497|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
127944732|NCT01473524|460420498|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
127944733|NCT01473524|460420499|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
127944734|NCT01473524|460420500|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
127944735|NCT01473524|460420495|FG000|LTSE Phase|Lost to Follow-up|0|||
127944736|NCT01473524|460420496|FG001|LTSE Phase|Lost to Follow-up|0|||
127944737|NCT01473524|460420497|FG002|LTSE Phase|Lost to Follow-up|0|||
127944738|NCT01473524|460420498|FG003|LTSE Phase|Lost to Follow-up|1|||
127944739|NCT01473524|460420499|FG004|LTSE Phase|Lost to Follow-up|3|||
127944740|NCT01473524|460420500|FG005|LTSE Phase|Lost to Follow-up|2|||
127944741|NCT01473524|460420495|FG000|LTSE Phase|Principal Investigator Decision|0|||
127944742|NCT01473524|460420496|FG001|LTSE Phase|Principal Investigator Decision|0|||
127944743|NCT01473524|460420497|FG002|LTSE Phase|Principal Investigator Decision|0|||
127944744|NCT01473524|460420498|FG003|LTSE Phase|Principal Investigator Decision|1|||
127944745|NCT01473524|460420499|FG004|LTSE Phase|Principal Investigator Decision|1|||
127944746|NCT01473524|460420500|FG005|LTSE Phase|Principal Investigator Decision|3|||
127944747|NCT01473524|460420495|FG000|LTSE Phase|Liver Transplantation|0|||
127944748|NCT01473524|460420496|FG001|LTSE Phase|Liver Transplantation|0|||
127944749|NCT01473524|460420497|FG002|LTSE Phase|Liver Transplantation|0|||
127944750|NCT01473524|460420498|FG003|LTSE Phase|Liver Transplantation|0|||
127944751|NCT01473524|460420499|FG004|LTSE Phase|Liver Transplantation|0|||
127944752|NCT01473524|460420500|FG005|LTSE Phase|Liver Transplantation|1|||
127944753|NCT01473524|460420495|FG000|LTSE Phase|Pregnancy|0|||
127944754|NCT01473524|460420496|FG001|LTSE Phase|Pregnancy|0|||
127944755|NCT01473524|460420497|FG002|LTSE Phase|Pregnancy|0|||
127944756|NCT01473524|460420498|FG003|LTSE Phase|Pregnancy|1|||
127944757|NCT01473524|460420499|FG004|LTSE Phase|Pregnancy|0|||
127944758|NCT01473524|460420500|FG005|LTSE Phase|Pregnancy|0|||
127944759|NCT01473524|460420495|FG000|LTSE Phase|Protocol Violation|0|||
127944760|NCT01473524|460420496|FG001|LTSE Phase|Protocol Violation|0|||
127944761|NCT01473524|460420497|FG002|LTSE Phase|Protocol Violation|0|||
127944762|NCT01473524|460420498|FG003|LTSE Phase|Protocol Violation|0|||
127944763|NCT01473524|460420499|FG004|LTSE Phase|Protocol Violation|0|||
127944764|NCT01473524|460420500|FG005|LTSE Phase|Protocol Violation|1|||
127944765|NCT02383810|460420501|FG000|Overall Study|Physician Decision|1|||
127944766|NCT02383810|460420502|FG001|Overall Study|Physician Decision|1|||
127944767|NCT02383810|460420503|FG002|Overall Study|Physician Decision|0|||
127944768|NCT02383810|460420504|FG003|Overall Study|Physician Decision|0|||
127944769|NCT02383810|460420505|FG004|Overall Study|Physician Decision|0|||
127944770|NCT02383810|460420506|FG005|Overall Study|Physician Decision|0|||
127944771|NCT02383810|460420507|FG006|Overall Study|Physician Decision|0|||
127944772|NCT02383810|460420508|FG007|Overall Study|Physician Decision|0|||
127944773|NCT02383810|460420501|FG000|Overall Study|Withdrawal by Subject|2|||
127944774|NCT02383810|460420502|FG001|Overall Study|Withdrawal by Subject|3|||
127944775|NCT02383810|460420503|FG002|Overall Study|Withdrawal by Subject|3|||
127944776|NCT02383810|460420504|FG003|Overall Study|Withdrawal by Subject|3|||
127944777|NCT02383810|460420505|FG004|Overall Study|Withdrawal by Subject|0|||
127944778|NCT02383810|460420506|FG005|Overall Study|Withdrawal by Subject|0|||
127944779|NCT02383810|460420507|FG006|Overall Study|Withdrawal by Subject|0|||
127944780|NCT02383810|460420508|FG007|Overall Study|Withdrawal by Subject|0|||
127944781|NCT02383810|460420501|FG000|Overall Study|Adverse Event|0|||
127944782|NCT02383810|460420502|FG001|Overall Study|Adverse Event|2|||
127944783|NCT02383810|460420503|FG002|Overall Study|Adverse Event|4|||
127944784|NCT02383810|460420504|FG003|Overall Study|Adverse Event|5|||
127944785|NCT02383810|460420505|FG004|Overall Study|Adverse Event|0|||
127944786|NCT02383810|460420506|FG005|Overall Study|Adverse Event|1|||
127944787|NCT02383810|460420507|FG006|Overall Study|Adverse Event|1|||
127944788|NCT02383810|460420508|FG007|Overall Study|Adverse Event|0|||
127944789|NCT02383810|460420501|FG000|Overall Study|Lost to Follow-up|0|||
127944790|NCT02383810|460420502|FG001|Overall Study|Lost to Follow-up|1|||
127944791|NCT02383810|460420503|FG002|Overall Study|Lost to Follow-up|0|||
127944792|NCT02383810|460420504|FG003|Overall Study|Lost to Follow-up|1|||
127944793|NCT02383810|460420505|FG004|Overall Study|Lost to Follow-up|0|||
127944794|NCT02383810|460420506|FG005|Overall Study|Lost to Follow-up|0|||
127944795|NCT02383810|460420507|FG006|Overall Study|Lost to Follow-up|0|||
127944796|NCT02383810|460420508|FG007|Overall Study|Lost to Follow-up|0|||
127944797|NCT02383810|460420501|FG000|Overall Study|other|0|||
127944798|NCT02383810|460420502|FG001|Overall Study|other|0|||
127944799|NCT02383810|460420503|FG002|Overall Study|other|0|||
127944800|NCT02383810|460420504|FG003|Overall Study|other|2|||
127944801|NCT02383810|460420505|FG004|Overall Study|other|0|||
127944802|NCT02383810|460420506|FG005|Overall Study|other|0|||
127944803|NCT02383810|460420507|FG006|Overall Study|other|0|||
127944804|NCT02383810|460420508|FG007|Overall Study|other|0|||
127944805|NCT02383810|460420501|FG000|Overall Study|subject did not receive study treatment|0|||
127944806|NCT02383810|460420502|FG001|Overall Study|subject did not receive study treatment|1|||
127944807|NCT02383810|460420503|FG002|Overall Study|subject did not receive study treatment|0|||
127944808|NCT02383810|460420504|FG003|Overall Study|subject did not receive study treatment|0|||
127944809|NCT02383810|460420505|FG004|Overall Study|subject did not receive study treatment|0|||
127944810|NCT02383810|460420506|FG005|Overall Study|subject did not receive study treatment|0|||
127944811|NCT02383810|460420507|FG006|Overall Study|subject did not receive study treatment|0|||
127944812|NCT02383810|460420508|FG007|Overall Study|subject did not receive study treatment|0|||
127944813|NCT00282919|460420511|FG000|Overall Study|Lack of Efficacy|4|||
127944814|NCT00282919|460420511|FG000|Overall Study|Withdrawal by Subject|1|||
127944815|NCT00282919|460420511|FG000|Overall Study|Asymptomatic Parasitemia|2|||
127944816|NCT02540850|460420512|FG000|Overall Study|Lost to Follow-up|69|||
127944817|NCT02540850|460420513|FG001|Overall Study|Lost to Follow-up|66|||
127944818|NCT02540850|460420514|FG002|Overall Study|Lost to Follow-up|34|||
127944819|NCT02861014|460420515|FG000|Primary Analysis|Adverse Event|7|||
127944820|NCT02861014|460420515|FG000|Primary Analysis|Death|1|||
127944821|NCT02861014|460420515|FG000|Primary Analysis|Lack of Efficacy|3|||
127944822|NCT02861014|460420515|FG000|Primary Analysis|Physician Decision|2|||
127944823|NCT02861014|460420515|FG000|Primary Analysis|Pregnancy|4|||
127944824|NCT02861014|460420515|FG000|Primary Analysis|Protocol Violation|2|||
127944825|NCT02861014|460420515|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
127944826|NCT02861014|460420515|FG000|Primary Analysis|Withdrawal by Subject|14|||
127944827|NCT02861014|460420515|FG000|Primary Analysis|Commercial ocrelizumab|3|||
127944828|NCT02861014|460420515|FG000|Safety Follow-up|Adverse Event|1|||
127944829|NCT02861014|460420515|FG000|Safety Follow-up|Pregnancy|1|||
127944830|NCT02861014|460420515|FG000|Safety Follow-up|Withdrawal by Subject|9|||
127944831|NCT02861014|460420515|FG000|Safety Follow-up|Study terminated by sponsor|1|||
127944832|NCT02861014|460420515|FG000|Safety Follow-up|Physician Decision|1|||
127944833|NCT02861014|460420515|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
127944834|NCT02861014|460420515|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
127944835|NCT00926783|460420516|FG000|Overall Study|Incomplete CFAE Procedures|3|||
127944836|NCT00926783|460420517|FG001|Overall Study|Incomplete CFAE Procedures|3|||
127944837|NCT02549027|460420519|FG000|Washout After Period 4|Withdrawal by Subject|0|||
127944838|NCT02549027|460420520|FG001|Washout After Period 4|Withdrawal by Subject|1|||
127944839|NCT02549027|460420521|FG002|Washout After Period 4|Withdrawal by Subject|1|||
127944840|NCT02549027|460420522|FG003|Washout After Period 4|Withdrawal by Subject|1|||
127944841|NCT02549027|460420523|FG004|Washout After Period 4|Withdrawal by Subject|0|||
127944842|NCT02549027|460420524|FG005|Washout After Period 4|Withdrawal by Subject|0|||
127944843|NCT02549027|460420519|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
127944844|NCT02549027|460420520|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
127944845|NCT02549027|460420521|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
127944846|NCT02549027|460420522|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
127944847|NCT02549027|460420523|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
127944848|NCT02549027|460420524|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
127944849|NCT02186834|460420525|FG000|Dose Escalation|Death|0|||
127944850|NCT02186834|460420526|FG001|Dose Escalation|Death|0|||
127944851|NCT02186834|460420527|FG002|Dose Escalation|Death|0|||
127944852|NCT02186834|460420528|FG003|Dose Escalation|Death|1|||
127944853|NCT02186834|460420529|FG004|Dose Escalation|Death|0|||
127944854|NCT02186834|460420530|FG005|Dose Escalation|Death|0|||
127944855|NCT02186834|460420525|FG000|Treatment at RP2D|Died prior to treatment|0|||
127944856|NCT02186834|460420526|FG001|Treatment at RP2D|Died prior to treatment|0|||
127944857|NCT02186834|460420527|FG002|Treatment at RP2D|Died prior to treatment|0|||
127944858|NCT02186834|460420528|FG003|Treatment at RP2D|Died prior to treatment|0|||
127944859|NCT02186834|460420529|FG004|Treatment at RP2D|Died prior to treatment|0|||
127944860|NCT02186834|460420530|FG005|Treatment at RP2D|Died prior to treatment|1|||
127944861|NCT01421511|460420536|FG000|Overall Study|Lost to Follow-up|11|||
127944862|NCT01421511|460420537|FG001|Overall Study|Lost to Follow-up|14|||
127944863|NCT01421511|460420536|FG000|Overall Study|Randomized but didn't receive study drug|1|||
127944864|NCT01421511|460420537|FG001|Overall Study|Randomized but didn't receive study drug|7|||
127944865|NCT01421511|460420536|FG000|Overall Study|Physician Decision|0|||
127944866|NCT01421511|460420537|FG001|Overall Study|Physician Decision|1|||
127944867|NCT01421511|460420536|FG000|Overall Study|Withdrawal by Subject|6|||
127944868|NCT01421511|460420537|FG001|Overall Study|Withdrawal by Subject|5|||
127944869|NCT01421511|460420536|FG000|Overall Study|Death|1|||
127944870|NCT01421511|460420537|FG001|Overall Study|Death|1|||
127944871|NCT00749892|460420538|FG000|Overall Study|Withdrawal by Subject|3|||
127944872|NCT04581369|460420539|FG000|Overall Study|Death|7|||
127944873|NCT04581369|460420540|FG001|Overall Study|Death|6|||
127944874|NCT04581369|460420541|FG002|Overall Study|Death|0|||
127944875|NCT04581369|460420539|FG000|Overall Study|Lost to Follow-up|7|||
127944876|NCT04581369|460420540|FG001|Overall Study|Lost to Follow-up|3|||
127944877|NCT04581369|460420541|FG002|Overall Study|Lost to Follow-up|0|||
127944878|NCT04581369|460420539|FG000|Overall Study|liver transplant|2|||
127944879|NCT04581369|460420540|FG001|Overall Study|liver transplant|2|||
127944880|NCT04581369|460420541|FG002|Overall Study|liver transplant|0|||
127944881|NCT04581369|460420539|FG000|Overall Study|transitioned to hospice care|0|||
127944882|NCT04581369|460420540|FG001|Overall Study|transitioned to hospice care|5|||
127944883|NCT04581369|460420541|FG002|Overall Study|transitioned to hospice care|0|||
127944884|NCT00780910|460420542|FG000|Overall Study|Adverse Event|2|||
127944885|NCT01111825|460420543|FG000|Overall Study|Withdrawal by Subject|0|||
127944886|NCT01111825|460420544|FG001|Overall Study|Withdrawal by Subject|0|||
127944887|NCT01111825|460420545|FG002|Overall Study|Withdrawal by Subject|1|||
127944888|NCT01111825|460420546|FG003|Overall Study|Withdrawal by Subject|0|||
127944889|NCT01111825|460420543|FG000|Overall Study|Lost to Follow-up|0|||
127944890|NCT01111825|460420544|FG001|Overall Study|Lost to Follow-up|0|||
127944891|NCT01111825|460420545|FG002|Overall Study|Lost to Follow-up|3|||
127944892|NCT01111825|460420546|FG003|Overall Study|Lost to Follow-up|1|||
127944893|NCT01111825|460420543|FG000|Overall Study|Adverse Event|2|||
127944894|NCT01111825|460420544|FG001|Overall Study|Adverse Event|1|||
127944895|NCT01111825|460420545|FG002|Overall Study|Adverse Event|4|||
127944896|NCT01111825|460420546|FG003|Overall Study|Adverse Event|0|||
127944897|NCT01111825|460420543|FG000|Overall Study|Disease Progression|1|||
127944898|NCT01111825|460420544|FG001|Overall Study|Disease Progression|0|||
127944899|NCT01111825|460420545|FG002|Overall Study|Disease Progression|0|||
127944900|NCT01111825|460420546|FG003|Overall Study|Disease Progression|0|||
127944901|NCT01111825|460420543|FG000|Overall Study|Discontinuation by Sponsor|0|||
127944902|NCT01111825|460420544|FG001|Overall Study|Discontinuation by Sponsor|0|||
127944903|NCT01111825|460420545|FG002|Overall Study|Discontinuation by Sponsor|0|||
127944904|NCT01111825|460420546|FG003|Overall Study|Discontinuation by Sponsor|20|||
127944905|NCT00469144|460420555|FG000|Overall Study|Death|0|||
127944906|NCT00469144|460420556|FG001|Overall Study|Death|1|||
127944907|NCT00469144|460420555|FG000|Overall Study|No Response|5|||
127944908|NCT00469144|460420556|FG001|Overall Study|No Response|5|||
127944909|NCT00469144|460420555|FG000|Overall Study|Progressive Disease|1|||
127944910|NCT00469144|460420556|FG001|Overall Study|Progressive Disease|0|||
127944911|NCT04602546|460420557|FG000|Overall Study|Training|2|||
127944912|NCT04602546|460420558|FG001|Overall Study|Training|2|||
127944913|NCT04602546|460420559|FG002|Overall Study|Training|1|||
127944914|NCT04602546|460420560|FG003|Overall Study|Training|2|||
127944915|NCT04602546|460420561|FG004|Overall Study|Training|0|||
127944916|NCT04602546|460420557|FG000|Overall Study|Randomized with disqualified data|2|||
127944917|NCT04602546|460420558|FG001|Overall Study|Randomized with disqualified data|0|||
127944918|NCT04602546|460420559|FG002|Overall Study|Randomized with disqualified data|2|||
127944919|NCT04602546|460420560|FG003|Overall Study|Randomized with disqualified data|5|||
127944920|NCT04602546|460420561|FG004|Overall Study|Randomized with disqualified data|3|||
127944921|NCT02794246|460420562|FG000|Overall Study|Withdrawal by Subject|2|||
127944922|NCT02794246|460420562|FG000|Overall Study|Physician Decision|4|||
127944923|NCT01775189|460420563|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
127944924|NCT01775189|460420564|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
127944925|NCT01775189|460420565|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
127944926|NCT01775189|460420566|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
127944927|NCT01775189|460420567|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
127944928|NCT01775189|460420568|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
127944929|NCT01775189|460420569|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
127944930|NCT01775189|460420563|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
127944931|NCT01775189|460420564|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
127944932|NCT01775189|460420565|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
127944933|NCT01775189|460420566|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
127944934|NCT01775189|460420567|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
127944935|NCT01775189|460420568|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
127944936|NCT01775189|460420569|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
127944937|NCT01775189|460420563|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
127944938|NCT01775189|460420564|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
127944939|NCT01775189|460420565|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
127944940|NCT01775189|460420566|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
127944941|NCT01775189|460420567|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
127944942|NCT01775189|460420568|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
127944943|NCT01775189|460420569|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
127944944|NCT01775189|460420563|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
127944945|NCT01775189|460420564|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
127944946|NCT01775189|460420565|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
127944947|NCT01775189|460420566|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
127944948|NCT01775189|460420567|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
127944949|NCT01775189|460420568|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
127944950|NCT01775189|460420569|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
127944951|NCT01775189|460420563|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
127944952|NCT01775189|460420564|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
127944953|NCT01775189|460420565|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
127944954|NCT01775189|460420566|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
127944955|NCT01775189|460420567|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
127944956|NCT01775189|460420568|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
127944957|NCT01775189|460420569|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
127944958|NCT01775189|460420563|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
127944959|NCT01775189|460420564|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
127944960|NCT01775189|460420565|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
127944961|NCT01775189|460420566|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
127944962|NCT01775189|460420567|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
127944963|NCT01775189|460420568|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
127944964|NCT01775189|460420569|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
127944965|NCT00856375|460420570|FG000|Overall Study|Other|0|||
127944966|NCT00856375|460420571|FG001|Overall Study|Other|1|||
127944967|NCT00856375|460420570|FG000|Overall Study|Death|32|||
127944968|NCT00856375|460420571|FG001|Overall Study|Death|30|||
127944969|NCT00856375|460420570|FG000|Overall Study|Sponsor Terminated Study|7|||
127944970|NCT00856375|460420571|FG001|Overall Study|Sponsor Terminated Study|7|||
127944971|NCT00856375|460420570|FG000|Overall Study|Withdrawal by Subject|2|||
127944972|NCT00856375|460420571|FG001|Overall Study|Withdrawal by Subject|1|||
127944973|NCT00856375|460420570|FG000|Overall Study|Lost to Follow-up|1|||
127944974|NCT00856375|460420571|FG001|Overall Study|Lost to Follow-up|2|||
127944975|NCT02121392|460420572|FG000|Prior to Intervention|Protocol Violation|40|||
127944976|NCT02121392|460420573|FG001|Prior to Intervention|Protocol Violation|35|||
127944977|NCT02121392|460420572|FG000|Prior to Intervention|Withdrawal by Subject|8|||
127944978|NCT02121392|460420573|FG001|Prior to Intervention|Withdrawal by Subject|6|||
127944979|NCT02121392|460420572|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
127944980|NCT02121392|460420573|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
127944981|NCT02121392|460420572|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
127944982|NCT02121392|460420573|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
127944983|NCT01352416|460420574|FG000|Overall Study|Physician Decision|1|||
127944984|NCT01352416|460420575|FG001|Overall Study|Physician Decision|2|||
127944985|NCT01352416|460420576|FG002|Overall Study|Physician Decision|2|||
127944986|NCT01352416|460420577|FG003|Overall Study|Physician Decision|1|||
127944987|NCT00811928|460420590|FG000|Overall Study|AEs and SAEs Including Death|7|||
127944988|NCT00811928|460420591|FG001|Overall Study|AEs and SAEs Including Death|11|||
127944989|NCT00811928|460420590|FG000|Overall Study|Withdrawal by Subject|18|||
127944990|NCT00811928|460420591|FG001|Overall Study|Withdrawal by Subject|12|||
127944991|NCT00811928|460420590|FG000|Overall Study|Did Not Take Study Drug|3|||
127944992|NCT00811928|460420591|FG001|Overall Study|Did Not Take Study Drug|0|||
127944993|NCT00811928|460420590|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
127944994|NCT00811928|460420591|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
127944995|NCT00811928|460420590|FG000|Overall Study|Investigator Decision|2|||
127944996|NCT00811928|460420591|FG001|Overall Study|Investigator Decision|1|||
127944997|NCT00811928|460420590|FG000|Overall Study|Poor Compliance|2|||
127944998|NCT00811928|460420591|FG001|Overall Study|Poor Compliance|5|||
127944999|NCT00171951|460420592|FG000|Overall Study|Adverse Event|1|||
127945000|NCT00171951|460420592|FG000|Overall Study|Abnormal Laboratory Values|2|||
127945001|NCT00171951|460420592|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
127945002|NCT00171951|460420592|FG000|Overall Study|Participants Withdrew Consent|3|||
127945003|NCT00171951|460420592|FG000|Overall Study|New Cancer Therapy|5|||
127945004|NCT00171951|460420592|FG000|Overall Study|Reason not Specified|2|||
127945005|NCT00396812|460420593|FG000|Overall Study|Physician Decision|1|||
127945006|NCT00233402|460420594|FG000|Overall Study|No pathology data|12|||
127945007|NCT00233402|460420595|FG001|Overall Study|No pathology data|9|||
127945008|NCT00233402|460420594|FG000|Overall Study|No Ta/T1|89|||
127945009|NCT00233402|460420595|FG001|Overall Study|No Ta/T1|94|||
127945010|NCT00233402|460420594|FG000|Overall Study|Lost to follow up etc|3|||
127945011|NCT00233402|460420595|FG001|Overall Study|Lost to follow up etc|21|||
127945012|NCT02087189|460420598|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
127945013|NCT01189487|460420603|FG000|Overall Study|Lack of Efficacy|2|||
127945014|NCT01189487|460420603|FG000|Overall Study|Adverse Event|1|||
127945015|NCT04630158|460420604|FG000|Overall Study|Adverse Event|1|||
127945016|NCT04630158|460420605|FG001|Overall Study|Adverse Event|1|||
127945017|NCT04630158|460420606|FG002|Overall Study|Adverse Event|1|||
127945018|NCT04630158|460420604|FG000|Overall Study|Physician Decision|0|||
127945019|NCT04630158|460420605|FG001|Overall Study|Physician Decision|2|||
127945020|NCT04630158|460420606|FG002|Overall Study|Physician Decision|0|||
127945021|NCT04630158|460420604|FG000|Overall Study|Protocol Violation|1|||
127945022|NCT04630158|460420605|FG001|Overall Study|Protocol Violation|0|||
127945023|NCT04630158|460420606|FG002|Overall Study|Protocol Violation|1|||
127945024|NCT04630158|460420604|FG000|Overall Study|Withdrawal by Subject|2|||
127945025|NCT04630158|460420605|FG001|Overall Study|Withdrawal by Subject|1|||
127945026|NCT04630158|460420606|FG002|Overall Study|Withdrawal by Subject|2|||
127945027|NCT03136965|460420612|FG000|Overall Study|Lost to Follow-up|0|||
127945028|NCT03136965|460420613|FG001|Overall Study|Lost to Follow-up|1|||
127945029|NCT03136965|460420614|FG002|Overall Study|Lost to Follow-up|0|||
127945030|NCT04868968|460420615|FG000|Overall Study|Lost to Follow-up|1|||
127945031|NCT00843635|460420622|FG000|Overall Study|Adverse Event|2|||
127945032|NCT00843635|460420623|FG001|Overall Study|Adverse Event|2|||
127945033|NCT00843635|460420624|FG002|Overall Study|Adverse Event|0|||
127945034|NCT03496610|460420625|FG000|Overall Study|Lost to Follow-up|3|||
127945035|NCT03496610|460420626|FG001|Overall Study|Lost to Follow-up|2|||
127945036|NCT03496610|460420625|FG000|Overall Study|Physician Decision|1|||
127945037|NCT03496610|460420626|FG001|Overall Study|Physician Decision|0|||
127945038|NCT03496610|460420625|FG000|Overall Study|Withdrawal by Subject|1|||
127945039|NCT03496610|460420626|FG001|Overall Study|Withdrawal by Subject|0|||
127945040|NCT02714426|460420627|FG000|Overall Study|Withdrawal by Subject|2|||
127945041|NCT02714426|460420628|FG001|Overall Study|Withdrawal by Subject|2|||
127945042|NCT04435184|460420629|FG000|Overall Study|follow-up blood draws missing|3|||
127945043|NCT04435184|460420630|FG001|Overall Study|follow-up blood draws missing|5|||
127945044|NCT04762277|460420635|FG000|Overall Study|Withdrawal by Subject|0|||
127945045|NCT04762277|460420636|FG001|Overall Study|Withdrawal by Subject|2|||
127945046|NCT04762277|460420635|FG000|Overall Study|Protocol Violation|0|||
127945047|NCT04762277|460420636|FG001|Overall Study|Protocol Violation|1|||
127945048|NCT04762277|460420635|FG000|Overall Study|Adverse Event|1|||
127945049|NCT04762277|460420636|FG001|Overall Study|Adverse Event|0|||
127945050|NCT01860677|460420637|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
127945051|NCT01860677|460420638|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
127945052|NCT00896480|460420639|FG000|Overall Study|Disease progression/recurrence|21|||
127945053|NCT00658021|460420643|FG000|28-Week Treatment Period|Adverse Event|3|||
127945054|NCT00658021|460420644|FG001|28-Week Treatment Period|Adverse Event|1|||
127945055|NCT00658021|460420645|FG002|28-Week Treatment Period|Adverse Event|0|||
127945056|NCT00658021|460420643|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
127945057|NCT00658021|460420644|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
127945058|NCT00658021|460420645|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
127945059|NCT00658021|460420643|FG000|28-Week Treatment Period|Protocol Violation|0|||
127945060|NCT00658021|460420644|FG001|28-Week Treatment Period|Protocol Violation|2|||
127945061|NCT00658021|460420645|FG002|28-Week Treatment Period|Protocol Violation|1|||
127945062|NCT00658021|460420643|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
127945063|NCT00658021|460420644|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
127945064|NCT00658021|460420645|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
127945065|NCT00658021|460420643|FG000|28-Week Treatment Period|Physician Decision|1|||
127945066|NCT00658021|460420644|FG001|28-Week Treatment Period|Physician Decision|2|||
127945067|NCT00658021|460420645|FG002|28-Week Treatment Period|Physician Decision|1|||
127945068|NCT00658021|460420643|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
127945069|NCT00658021|460420644|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
127945070|NCT00658021|460420645|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
127945071|NCT00658021|460420643|FG000|28-Week Treatment Period|Loss of glucose control|1|||
127945072|NCT00658021|460420644|FG001|28-Week Treatment Period|Loss of glucose control|1|||
127945073|NCT00658021|460420645|FG002|28-Week Treatment Period|Loss of glucose control|10|||
127945074|NCT00658021|460420643|FG000|28-Week Treatment Period|Other|2|||
127945075|NCT00658021|460420644|FG001|28-Week Treatment Period|Other|3|||
127945076|NCT00658021|460420645|FG002|28-Week Treatment Period|Other|1|||
127945077|NCT00658021|460420643|FG000|28-Week Treatment Period|Did not receive treatment|2|||
127945078|NCT00658021|460420644|FG001|28-Week Treatment Period|Did not receive treatment|0|||
127945079|NCT00658021|460420645|FG002|28-Week Treatment Period|Did not receive treatment|0|||
127945080|NCT00658021|460420643|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
127945081|NCT00658021|460420644|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
127945082|NCT00658021|460420645|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
127945083|NCT00658021|460420643|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
127945084|NCT00658021|460420644|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
127945085|NCT00658021|460420645|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
127945086|NCT00270855|460422148|FG000|Overall Study|Withdrawal by Subject|8|||
127945087|NCT00270855|460422149|FG001|Overall Study|Withdrawal by Subject|8|||
127945088|NCT01396512|460422154|FG000|Overall Study|Withdrawal by Subject|0|||
127945089|NCT01396512|460422155|FG001|Overall Study|Withdrawal by Subject|1|||
127945090|NCT02755649|460422156|FG000|Overall Study|Transitioned into OLE study|99|||
127945091|NCT02755649|460422157|FG001|Overall Study|Transitioned into OLE study|98|||
127945092|NCT02755649|460422158|FG002|Overall Study|Transitioned into OLE study|100|||
127945093|NCT02755649|460422156|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
127945094|NCT02755649|460422157|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
127945095|NCT02755649|460422158|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
127945096|NCT02755649|460422156|FG000|Overall Study|Physician Decision|0|||
127945097|NCT02755649|460422157|FG001|Overall Study|Physician Decision|0|||
127945098|NCT02755649|460422158|FG002|Overall Study|Physician Decision|2|||
127945099|NCT02755649|460422156|FG000|Overall Study|Withdrawal by Subject|0|||
127945100|NCT02755649|460422157|FG001|Overall Study|Withdrawal by Subject|1|||
127945101|NCT02755649|460422158|FG002|Overall Study|Withdrawal by Subject|0|||
127945102|NCT02755649|460422156|FG000|Overall Study|Undecided|1|||
127945103|NCT02755649|460422157|FG001|Overall Study|Undecided|0|||
127945104|NCT02755649|460422158|FG002|Overall Study|Undecided|0|||
127945105|NCT02152605|460422159|FG000|Overall Study|Adverse Event|6|||
127945106|NCT02152605|460422160|FG001|Overall Study|Adverse Event|8|||
127945107|NCT02152605|460422159|FG000|Overall Study|Lack of Efficacy|7|||
127945108|NCT02152605|460422160|FG001|Overall Study|Lack of Efficacy|4|||
127945109|NCT02152605|460422159|FG000|Overall Study|Protocol deviation|1|||
127945110|NCT02152605|460422160|FG001|Overall Study|Protocol deviation|4|||
127945111|NCT02152605|460422159|FG000|Overall Study|Lost to Follow-up|1|||
127945112|NCT02152605|460422160|FG001|Overall Study|Lost to Follow-up|0|||
127945113|NCT02152605|460422159|FG000|Overall Study|Withdrew consent|4|||
127945114|NCT02152605|460422160|FG001|Overall Study|Withdrew consent|2|||
127945115|NCT03301649|460422161|FG000|Overall Study|Need alternate therapy due to live lice|17|||
127945116|NCT03301649|460422162|FG001|Overall Study|Need alternate therapy due to live lice|25|||
127945117|NCT03301649|460422163|FG002|Overall Study|Need alternate therapy due to live lice|81|||
127945118|NCT03301649|460422161|FG000|Overall Study|Lost to Follow-up|11|||
127945119|NCT03301649|460422162|FG001|Overall Study|Lost to Follow-up|11|||
127945120|NCT03301649|460422163|FG002|Overall Study|Lost to Follow-up|3|||
127945121|NCT03301649|460422161|FG000|Overall Study|Protocol Violation|0|||
127945122|NCT03301649|460422162|FG001|Overall Study|Protocol Violation|1|||
127945123|NCT03301649|460422163|FG002|Overall Study|Protocol Violation|1|||
127945124|NCT03301649|460422161|FG000|Overall Study|Withdrawal by Subject|10|||
127945125|NCT03301649|460422162|FG001|Overall Study|Withdrawal by Subject|4|||
127945126|NCT03301649|460422163|FG002|Overall Study|Withdrawal by Subject|0|||
127945127|NCT03301649|460422161|FG000|Overall Study|Other than specified|5|||
127945128|NCT03301649|460422162|FG001|Overall Study|Other than specified|3|||
127945129|NCT03301649|460422163|FG002|Overall Study|Other than specified|0|||
127945130|NCT00837473|460422164|FG000|Overall Study|Lost to Follow-up|1|||
127945131|NCT00837473|460422164|FG000|Overall Study|Withdrawal by Subject|2|||
127945132|NCT01724489|460422165|FG000|Overall Study|Adverse Event|8|||
127945133|NCT01724489|460422166|FG001|Overall Study|Adverse Event|3|||
127945134|NCT01724489|460422165|FG000|Overall Study|Surgery, medication|1|||
127945135|NCT01724489|460422166|FG001|Overall Study|Surgery, medication|1|||
127945136|NCT01724489|460422165|FG000|Overall Study|Lost to Follow-up|1|||
127945137|NCT01724489|460422166|FG001|Overall Study|Lost to Follow-up|2|||
127945138|NCT01724489|460422165|FG000|Overall Study|Withdrawal by Subject|6|||
127945139|NCT01724489|460422166|FG001|Overall Study|Withdrawal by Subject|6|||
127945140|NCT04576923|460422167|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
127945141|NCT00923273|460422170|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
127945142|NCT00923273|460422171|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
127945143|NCT00923273|460422172|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
127945144|NCT00923273|460422173|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
127945145|NCT00923273|460422174|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
127945146|NCT00923273|460422170|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
127945147|NCT00923273|460422171|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
127945148|NCT00923273|460422172|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
127945149|NCT00923273|460422173|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
127945150|NCT00923273|460422174|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
127945151|NCT02552303|460422181|FG000|Allocation|Withdrawal by Subject|2|||
127945152|NCT02552303|460422182|FG001|Allocation|Withdrawal by Subject|1|||
127945153|NCT02552303|460422183|FG002|Allocation|Withdrawal by Subject|1|||
127945154|NCT02552303|460422184|FG003|Allocation|Withdrawal by Subject|1|||
127945155|NCT02552303|460422181|FG000|Allocation|ineligible|1|||
127945156|NCT02552303|460422182|FG001|Allocation|ineligible|1|||
127945157|NCT02552303|460422183|FG002|Allocation|ineligible|0|||
127945158|NCT02552303|460422184|FG003|Allocation|ineligible|0|||
127945159|NCT02552303|460422181|FG000|Follow-Up|Lost to Follow-up|0|||
127945160|NCT02552303|460422182|FG001|Follow-Up|Lost to Follow-up|0|||
127945161|NCT02552303|460422183|FG002|Follow-Up|Lost to Follow-up|1|||
127945162|NCT02552303|460422184|FG003|Follow-Up|Lost to Follow-up|0|||
127945163|NCT02552303|460422181|FG000|Follow-Up|ineligible|0|||
127945164|NCT02552303|460422182|FG001|Follow-Up|ineligible|2|||
127945165|NCT02552303|460422183|FG002|Follow-Up|ineligible|0|||
127945166|NCT02552303|460422184|FG003|Follow-Up|ineligible|0|||
127945167|NCT01377987|460422185|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
127945168|NCT01377987|460422186|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
127945169|NCT00741286|460422192|FG000|Overall Study|Lost to Follow-up|15|||
127945170|NCT00741286|460422193|FG001|Overall Study|Lost to Follow-up|10|||
127945171|NCT00741286|460422192|FG000|Overall Study|Adverse Event|1|||
127945172|NCT00741286|460422193|FG001|Overall Study|Adverse Event|6|||
127945173|NCT00741286|460422192|FG000|Overall Study|Protocol Violation|3|||
127945174|NCT00741286|460422193|FG001|Overall Study|Protocol Violation|2|||
127945175|NCT00741286|460422192|FG000|Overall Study|Primary Outcome|1|||
127945176|NCT00741286|460422193|FG001|Overall Study|Primary Outcome|1|||
127945177|NCT01831258|460422194|FG000|Overall Study|Withdrawal by Subject|2|||
127945178|NCT01831258|460422195|FG001|Overall Study|Withdrawal by Subject|1|||
127945179|NCT01831258|460422194|FG000|Overall Study|Lost to Follow-up|3|||
127945180|NCT01831258|460422195|FG001|Overall Study|Lost to Follow-up|2|||
127945181|NCT00253448|460422196|FG000|Overall Study|Withdrawal by Subject|1|||
127945182|NCT00314951|460422204|FG000|Treatment|Didn't meet criteria for mITT population|16|||
127945183|NCT00314951|460422205|FG001|Treatment|Didn't meet criteria for mITT population|11|||
127945184|NCT00314951|460422204|FG000|Follow-up|mITT failure|44|||
127945185|NCT00314951|460422205|FG001|Follow-up|mITT failure|34|||
127945186|NCT05320887|460422208|FG000|Overall Study|Lost to Follow-up|0|||
127945187|NCT05320887|460422209|FG001|Overall Study|Lost to Follow-up|3|||
127945188|NCT05320887|460422210|FG002|Overall Study|Lost to Follow-up|0|||
127945189|NCT05320887|460422211|FG003|Overall Study|Lost to Follow-up|0|||
127945190|NCT02015065|460422214|FG000|Overall Study|Death on study|1|||
127945191|NCT02015065|460422215|FG001|Overall Study|Death on study|2|||
127945192|NCT02015065|460422216|FG002|Overall Study|Death on study|1|||
127945193|NCT03485365|460422249|FG000|Overall Study|Protocol Violation|0|||
127945194|NCT03485365|460422250|FG001|Overall Study|Protocol Violation|0|||
127945195|NCT03485365|460422251|FG002|Overall Study|Protocol Violation|0|||
127945196|NCT03485365|460422252|FG003|Overall Study|Protocol Violation|1|||
127945197|NCT03485365|460422253|FG004|Overall Study|Protocol Violation|0|||
127945198|NCT03485365|460422254|FG005|Overall Study|Protocol Violation|0|||
127945199|NCT03485365|460422255|FG006|Overall Study|Protocol Violation|1|||
127945200|NCT03485365|460422256|FG007|Overall Study|Protocol Violation|0|||
127945201|NCT03485365|460422257|FG008|Overall Study|Protocol Violation|0|||
127945202|NCT01547130|460422260|FG000|Overall Study|Lost to Follow-up|9|||
127945203|NCT01547130|460422261|FG001|Overall Study|Lost to Follow-up|5|||
127945204|NCT03553576|460422262|FG000|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
127945205|NCT03553576|460422263|FG001|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
127945206|NCT03553576|460422262|FG000|Overall Study|Unintentional dural puncture during epidural procedure|0|||
127945207|NCT03553576|460422263|FG001|Overall Study|Unintentional dural puncture during epidural procedure|1|||
127945208|NCT03553576|460422262|FG000|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|0|||
127945209|NCT03553576|460422263|FG001|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|1|||
127945210|NCT03553576|460422262|FG000|Overall Study|Fentanyl and or clonidine administered via epidural catheter|1|||
127945211|NCT03553576|460422263|FG001|Overall Study|Fentanyl and or clonidine administered via epidural catheter|2|||
127945212|NCT03553576|460422262|FG000|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
127945213|NCT03553576|460422263|FG001|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
127945214|NCT03553576|460422262|FG000|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|1|||
127945215|NCT03553576|460422263|FG001|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|0|||
127945216|NCT03553576|460422262|FG000|Overall Study|Physician Decision|2|||
127945217|NCT03553576|460422263|FG001|Overall Study|Physician Decision|5|||
127945218|NCT05038800|460422265|FG000|Overall Study|Death|1|||
127945219|NCT05038800|460422266|FG001|Overall Study|Death|1|||
127945220|NCT05038800|460422267|FG002|Overall Study|Death|5|||
127945221|NCT05038800|460422268|FG003|Overall Study|Death|3|||
127945222|NCT05038800|460422269|FG004|Overall Study|Death|1|||
127945223|NCT05038800|460422265|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
127945224|NCT05038800|460422266|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
127945225|NCT05038800|460422267|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
127945226|NCT05038800|460422268|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
127945227|NCT05038800|460422269|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
127945228|NCT05038800|460422265|FG000|Overall Study|Lack of Efficacy|0|||
127945229|NCT05038800|460422266|FG001|Overall Study|Lack of Efficacy|0|||
127945230|NCT05038800|460422267|FG002|Overall Study|Lack of Efficacy|0|||
127945231|NCT05038800|460422268|FG003|Overall Study|Lack of Efficacy|0|||
127945232|NCT05038800|460422269|FG004|Overall Study|Lack of Efficacy|1|||
127945233|NCT01104792|460422270|FG000|Overall Study|Adverse Event|77|||
127945234|NCT01104792|460422270|FG000|Overall Study|Insufficient Therapeutic Response|22|||
127945235|NCT01104792|460422270|FG000|Overall Study|Protocol Violation|45|||
127945236|NCT01104792|460422270|FG000|Overall Study|Withdrawal of Consent|179|||
127945237|NCT01104792|460422270|FG000|Overall Study|Lost to Follow-up|43|||
127945238|NCT01104792|460422270|FG000|Overall Study|Reasons Not Specified|27|||
127945239|NCT01104792|460422270|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
127945240|NCT00103610|460422275|FG000|Overall Study|Entered Rescue Procedure|10|||
127945241|NCT00103610|460422276|FG001|Overall Study|Entered Rescue Procedure|52|||
127945242|NCT00103610|460422275|FG000|Overall Study|Death|16|||
127945243|NCT00103610|460422276|FG001|Overall Study|Death|12|||
127945244|NCT00103610|460422275|FG000|Overall Study|Elective Withdrawal|4|||
127945245|NCT00103610|460422276|FG001|Overall Study|Elective Withdrawal|0|||
127945246|NCT00103610|460422275|FG000|Overall Study|Lost to Follow-up|3|||
127945247|NCT00103610|460422276|FG001|Overall Study|Lost to Follow-up|1|||
127945248|NCT00103610|460422275|FG000|Overall Study|Adverse Event|2|||
127945249|NCT00103610|460422276|FG001|Overall Study|Adverse Event|2|||
127945250|NCT00103610|460422275|FG000|Overall Study|Other|2|||
127945251|NCT00103610|460422276|FG001|Overall Study|Other|7|||
127945252|NCT00103610|460422275|FG000|Overall Study|Failed mobilization|1|||
127945253|NCT00103610|460422276|FG001|Overall Study|Failed mobilization|5|||
127945254|NCT00103610|460422275|FG000|Overall Study|Noncompliance|0|||
127945255|NCT00103610|460422276|FG001|Overall Study|Noncompliance|1|||
127945256|NCT03301623|460422277|FG000|Overall Study|Death|3|||
127945257|NCT03301623|460422278|FG001|Overall Study|Death|1|||
127945258|NCT03301623|460422277|FG000|Overall Study|Withdrawal by Subject|11|||
127945259|NCT03301623|460422278|FG001|Overall Study|Withdrawal by Subject|13|||
127945260|NCT03301623|460422277|FG000|Overall Study|Lost to Follow-up|3|||
127945261|NCT03301623|460422278|FG001|Overall Study|Lost to Follow-up|1|||
127945262|NCT02092467|460422281|FG000|Overall Study|Death|49|||
127945263|NCT02092467|460422282|FG001|Overall Study|Death|66|||
127945264|NCT02092467|460422283|FG002|Overall Study|Death|38|||
127945265|NCT02092467|460422281|FG000|Overall Study|Lost to Follow-up|38|||
127945266|NCT02092467|460422282|FG001|Overall Study|Lost to Follow-up|35|||
127945267|NCT02092467|460422283|FG002|Overall Study|Lost to Follow-up|40|||
127945268|NCT02092467|460422281|FG000|Overall Study|Global Deterioration of Health Status|1|||
127945269|NCT02092467|460422282|FG001|Overall Study|Global Deterioration of Health Status|0|||
127945270|NCT02092467|460422283|FG002|Overall Study|Global Deterioration of Health Status|0|||
127945271|NCT02092467|460422281|FG000|Overall Study|Other|32|||
127945272|NCT02092467|460422282|FG001|Overall Study|Other|30|||
127945273|NCT02092467|460422283|FG002|Overall Study|Other|24|||
127945274|NCT02092467|460422281|FG000|Overall Study|Withdrawal by Subject|282|||
127945275|NCT02092467|460422282|FG001|Overall Study|Withdrawal by Subject|327|||
127945276|NCT02092467|460422283|FG002|Overall Study|Withdrawal by Subject|289|||
127945277|NCT02092467|460422281|FG000|Overall Study|Randomized but not treated|2|||
127945278|NCT02092467|460422282|FG001|Overall Study|Randomized but not treated|1|||
127945279|NCT02092467|460422283|FG002|Overall Study|Randomized but not treated|7|||
127945280|NCT02952898|460422291|FG000|Overall Study|Withdrawal by Subject|10|||
127945281|NCT02952898|460422292|FG001|Overall Study|Withdrawal by Subject|8|||
127945282|NCT02952898|460422293|FG002|Overall Study|Withdrawal by Subject|8|||
127945283|NCT02952898|460422291|FG000|Overall Study|Adverse Event|8|||
127945284|NCT02952898|460422292|FG001|Overall Study|Adverse Event|8|||
127945285|NCT02952898|460422293|FG002|Overall Study|Adverse Event|3|||
127945286|NCT02952898|460422291|FG000|Overall Study|Lost to Follow-up|3|||
127945287|NCT02952898|460422292|FG001|Overall Study|Lost to Follow-up|2|||
127945288|NCT02952898|460422293|FG002|Overall Study|Lost to Follow-up|2|||
127945289|NCT02952898|460422291|FG000|Overall Study|Non-compliance with study drug|1|||
127945290|NCT02952898|460422292|FG001|Overall Study|Non-compliance with study drug|1|||
127945291|NCT02952898|460422293|FG002|Overall Study|Non-compliance with study drug|2|||
127945292|NCT04844762|460422294|FG000|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
127945293|NCT04844762|460422295|FG001|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
127945294|NCT04844762|460422296|FG002|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|2|||
127945295|NCT04844762|460422297|FG003|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
127945296|NCT04844762|460422298|FG004|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
127945297|NCT04844762|460422299|FG005|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
127945298|NCT04844762|460422294|FG000|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
127945299|NCT04844762|460422295|FG001|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
127945300|NCT04844762|460422296|FG002|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
127945301|NCT04844762|460422297|FG003|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
127945302|NCT04844762|460422298|FG004|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
127945303|NCT04844762|460422299|FG005|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
127945304|NCT04844762|460422294|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
127945305|NCT04844762|460422295|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
127945306|NCT04844762|460422296|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
127945307|NCT04844762|460422297|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|3|||
127945308|NCT04844762|460422298|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
127945309|NCT04844762|460422299|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
127945310|NCT04844762|460422294|FG000|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
127945311|NCT04844762|460422295|FG001|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
127945312|NCT04844762|460422296|FG002|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
127945313|NCT04844762|460422297|FG003|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
127945314|NCT04844762|460422298|FG004|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|2|||
127945315|NCT04844762|460422299|FG005|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
127945316|NCT04844762|460422294|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
127945317|NCT04844762|460422295|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|2|||
127945318|NCT04844762|460422296|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
127945319|NCT04844762|460422297|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
127945320|NCT04844762|460422298|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
127945321|NCT04844762|460422299|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
127945322|NCT04844762|460422294|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
127945323|NCT04844762|460422295|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
127945324|NCT04844762|460422296|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
127945325|NCT04844762|460422297|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
127945326|NCT04844762|460422298|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
127945327|NCT04844762|460422299|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
127945328|NCT04844762|460422294|FG000|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
127945329|NCT04844762|460422295|FG001|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
127945330|NCT04844762|460422296|FG002|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
127945331|NCT04844762|460422297|FG003|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
127945332|NCT04844762|460422298|FG004|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|1|||
127945333|NCT04844762|460422299|FG005|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
127945334|NCT04844762|460422294|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
127945335|NCT04844762|460422295|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
127945336|NCT04844762|460422296|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
127945337|NCT04844762|460422297|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
127945338|NCT04844762|460422298|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
127945339|NCT04844762|460422299|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
127945340|NCT04844762|460422294|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
127945341|NCT04844762|460422295|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
127945342|NCT04844762|460422296|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
127945343|NCT04844762|460422297|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
127945344|NCT04844762|460422298|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
127945345|NCT04844762|460422299|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
127945346|NCT04844762|460422294|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
127945347|NCT04844762|460422295|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|1|||
127945348|NCT04844762|460422296|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
127945349|NCT04844762|460422297|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
127945350|NCT04844762|460422298|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
127945351|NCT04844762|460422299|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
127945352|NCT04844762|460422294|FG000|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
127945353|NCT04844762|460422295|FG001|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
127945354|NCT04844762|460422296|FG002|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
127945355|NCT04844762|460422297|FG003|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|1|||
127945356|NCT04844762|460422298|FG004|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
127945357|NCT04844762|460422299|FG005|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
127945358|NCT04400682|460422302|FG000|Period 1|Withdrawal by Subject|1|||
127945359|NCT04400682|460422303|FG001|Period 1|Withdrawal by Subject|4|||
127945360|NCT02293863|460422304|FG000|Overall Study|Death|4|||
127945361|NCT02293863|460422305|FG001|Overall Study|Death|6|||
127945362|NCT02293863|460422306|FG002|Overall Study|Death|4|||
127945363|NCT02293863|460422304|FG000|Overall Study|Lost to Follow-up|2|||
127945364|NCT02293863|460422305|FG001|Overall Study|Lost to Follow-up|2|||
127945365|NCT02293863|460422306|FG002|Overall Study|Lost to Follow-up|2|||
127945366|NCT02293863|460422304|FG000|Overall Study|Withdrawal by Subject|3|||
127945367|NCT02293863|460422305|FG001|Overall Study|Withdrawal by Subject|3|||
127945368|NCT02293863|460422306|FG002|Overall Study|Withdrawal by Subject|1|||
127945369|NCT02293863|460422304|FG000|Overall Study|Reason Not Specified|0|||
127945370|NCT02293863|460422305|FG001|Overall Study|Reason Not Specified|2|||
127945371|NCT02293863|460422306|FG002|Overall Study|Reason Not Specified|2|||
127945372|NCT00477633|460422307|FG000|Overall Study|Did not receive treatment|23|||
127945373|NCT00477633|460422307|FG000|Overall Study|Adverse Event|143|||
127945374|NCT00477633|460422307|FG000|Overall Study|Pregnancy|23|||
127945375|NCT00477633|460422307|FG000|Overall Study|Lost to Follow-up|271|||
127945376|NCT00477633|460422307|FG000|Overall Study|Withdrawal by Subject|149|||
127945377|NCT00477633|460422307|FG000|Overall Study|Protocol Violation|25|||
127945378|NCT00477633|460422307|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
127945379|NCT04123561|460422313|FG000|Overall Study|Lost to Follow-up|20|||
127945380|NCT04123561|460422314|FG001|Overall Study|Lost to Follow-up|12|||
127945381|NCT04123561|460422315|FG002|Overall Study|Lost to Follow-up|5|||
127945382|NCT04123561|460422313|FG000|Overall Study|Withdrawal by Subject|9|||
127945383|NCT04123561|460422314|FG001|Overall Study|Withdrawal by Subject|7|||
127945384|NCT04123561|460422315|FG002|Overall Study|Withdrawal by Subject|9|||
127945385|NCT04123561|460422313|FG000|Overall Study|Lack of Efficacy|7|||
127945386|NCT04123561|460422314|FG001|Overall Study|Lack of Efficacy|8|||
127945387|NCT04123561|460422315|FG002|Overall Study|Lack of Efficacy|6|||
127945388|NCT04123561|460422313|FG000|Overall Study|Adverse Event|5|||
127945389|NCT04123561|460422314|FG001|Overall Study|Adverse Event|2|||
127945390|NCT04123561|460422315|FG002|Overall Study|Adverse Event|3|||
127945391|NCT04123561|460422313|FG000|Overall Study|A surgical procedure or IA administration in the index knee|3|||
127945392|NCT04123561|460422314|FG001|Overall Study|A surgical procedure or IA administration in the index knee|0|||
127945393|NCT04123561|460422315|FG002|Overall Study|A surgical procedure or IA administration in the index knee|1|||
127945394|NCT04123561|460422313|FG000|Overall Study|Death|0|||
127945395|NCT04123561|460422314|FG001|Overall Study|Death|0|||
127945396|NCT04123561|460422315|FG002|Overall Study|Death|1|||
127945397|NCT04123561|460422313|FG000|Overall Study|Protocol Violation|0|||
127945398|NCT04123561|460422314|FG001|Overall Study|Protocol Violation|1|||
127945399|NCT04123561|460422315|FG002|Overall Study|Protocol Violation|0|||
127945400|NCT01374269|460422328|FG000|Overall Study|Withdrawal by Subject|4|||
127945401|NCT01374269|460422329|FG001|Overall Study|Withdrawal by Subject|0|||
127945402|NCT01374269|460422328|FG000|Overall Study|Lost to Follow-up|1|||
127945403|NCT01374269|460422329|FG001|Overall Study|Lost to Follow-up|3|||
127945404|NCT01374269|460422328|FG000|Overall Study|closed research|1|||
127945405|NCT01374269|460422329|FG001|Overall Study|closed research|2|||
127945406|NCT00278889|460422330|FG000|Overall Study|Withdrawal by Subject|0|||
127945407|NCT00278889|460422331|FG001|Overall Study|Withdrawal by Subject|5|||
127945408|NCT00278889|460422332|FG002|Overall Study|Withdrawal by Subject|3|||
127945409|NCT00278889|460422330|FG000|Overall Study|Lost to Follow-up|1|||
127945410|NCT00278889|460422331|FG001|Overall Study|Lost to Follow-up|1|||
127945411|NCT00278889|460422332|FG002|Overall Study|Lost to Follow-up|0|||
127945412|NCT00278889|460422330|FG000|Overall Study|Death|24|||
127945413|NCT00278889|460422331|FG001|Overall Study|Death|21|||
127945414|NCT00278889|460422332|FG002|Overall Study|Death|17|||
127945415|NCT03462459|460422333|FG000|Overall Study|Death|1|||
127945416|NCT03462459|460422334|FG001|Overall Study|Death|0|||
127945417|NCT03462459|460422333|FG000|Overall Study|Lack of Efficacy|2|||
127945418|NCT03462459|460422334|FG001|Overall Study|Lack of Efficacy|4|||
127945419|NCT03462459|460422333|FG000|Overall Study|Lost to Follow-up|1|||
127945420|NCT03462459|460422334|FG001|Overall Study|Lost to Follow-up|3|||
127945421|NCT03462459|460422333|FG000|Overall Study|Unable to complete doses of study drug/placebo|0|||
127945422|NCT03462459|460422334|FG001|Overall Study|Unable to complete doses of study drug/placebo|3|||
127945423|NCT03462459|460422333|FG000|Overall Study|Withdrawal by Subject|3|||
127945424|NCT03462459|460422334|FG001|Overall Study|Withdrawal by Subject|2|||
127945425|NCT03462459|460422333|FG000|Overall Study|Unable to obtain stool samples at visit|0|||
127945426|NCT03462459|460422334|FG001|Overall Study|Unable to obtain stool samples at visit|1|||
127945427|NCT04042376|460422336|FG000|Overall Study|Withdrawal by Subject|1|||
127945428|NCT04042376|460422336|FG000|Overall Study|Death|3|||
127945429|NCT00478244|460424295|FG000|Overall Study|Did not receive transplant|1|||
127945430|NCT02929056|460424296|FG000|Overall Study|Lost to Follow-up|0|||
127945431|NCT02929056|460424297|FG001|Overall Study|Lost to Follow-up|1|||
127945432|NCT03132155|460424298|FG000|Overall Study|Lack of Efficacy|6|||
127945433|NCT03132155|460424298|FG000|Overall Study|Lost to Follow-up|1|||
127945434|NCT03132155|460424298|FG000|Overall Study|Withdrawal by Subject|1|||
127945435|NCT02925403|460424302|FG000|Overall Study|Lost to Follow-up|0|||
127945436|NCT02925403|460424303|FG001|Overall Study|Lost to Follow-up|1|||
127945437|NCT00459043|460424304|FG000|Overall Study|Withdrawal by Subject|1|||
127945438|NCT00459043|460424305|FG001|Overall Study|Withdrawal by Subject|0|||
127945439|NCT02899195|460424306|FG000|Concurrent Durvalumab|Adverse Event|4|||
127945440|NCT02899195|460424306|FG000|Concurrent Durvalumab|Physician Decision|1|||
127945441|NCT02899195|460424306|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
127945442|NCT02899195|460424306|FG000|Concurrent Durvalumab|Progressive Disease|5|||
127945443|NCT02899195|460424306|FG000|Maintenance Durvalumab|Adverse Event|1|||
127945444|NCT02899195|460424306|FG000|Maintenance Durvalumab|Physician Decision|1|||
127945445|NCT02899195|460424306|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
127945446|NCT02899195|460424306|FG000|Maintenance Durvalumab|Progressive Disease|31|||
127945447|NCT03156504|460424308|FG000|Overall Study|Withdrawal by Subject|1|||
127945448|NCT00450801|460424309|FG000|Overall Study|Death|1|||
127945449|NCT03452137|460424310|FG000|Overall Study|Death|67|||
127945450|NCT03452137|460424311|FG001|Overall Study|Death|70|||
127945451|NCT03452137|460424310|FG000|Overall Study|Lost to Follow-up|4|||
127945452|NCT03452137|460424311|FG001|Overall Study|Lost to Follow-up|2|||
127945453|NCT03452137|460424310|FG000|Overall Study|Physician Decision|0|||
127945454|NCT03452137|460424311|FG001|Overall Study|Physician Decision|1|||
127945455|NCT03452137|460424310|FG000|Overall Study|Study Terminated by Sponsor|120|||
127945456|NCT03452137|460424311|FG001|Overall Study|Study Terminated by Sponsor|121|||
127945457|NCT03452137|460424310|FG000|Overall Study|Withdrawal by Subject|12|||
127945458|NCT03452137|460424311|FG001|Overall Study|Withdrawal by Subject|9|||
127945459|NCT02094417|460424319|FG000|Overall Study|Adverse Event|0|||
127945460|NCT02094417|460424320|FG001|Overall Study|Adverse Event|0|||
127945461|NCT02094417|460424321|FG002|Overall Study|Adverse Event|0|||
127945462|NCT02094417|460424322|FG003|Overall Study|Adverse Event|1|||
127945463|NCT02094417|460424319|FG000|Overall Study|Eligibility criteria|0|||
127945464|NCT02094417|460424320|FG001|Overall Study|Eligibility criteria|1|||
127945465|NCT02094417|460424321|FG002|Overall Study|Eligibility criteria|0|||
127945466|NCT02094417|460424322|FG003|Overall Study|Eligibility criteria|0|||
127945467|NCT02094417|460424319|FG000|Overall Study|No responder|4|||
127945468|NCT02094417|460424320|FG001|Overall Study|No responder|4|||
127945469|NCT02094417|460424321|FG002|Overall Study|No responder|4|||
127945470|NCT02094417|460424322|FG003|Overall Study|No responder|3|||
127945471|NCT02094417|460424319|FG000|Overall Study|Unable to conduct observations or assess|0|||
127945472|NCT02094417|460424320|FG001|Overall Study|Unable to conduct observations or assess|1|||
127945473|NCT02094417|460424321|FG002|Overall Study|Unable to conduct observations or assess|0|||
127945474|NCT02094417|460424322|FG003|Overall Study|Unable to conduct observations or assess|0|||
127945475|NCT02094417|460424319|FG000|Overall Study|Withdrawal by Subject|1|||
127945476|NCT02094417|460424320|FG001|Overall Study|Withdrawal by Subject|2|||
127945477|NCT02094417|460424321|FG002|Overall Study|Withdrawal by Subject|1|||
127945478|NCT02094417|460424322|FG003|Overall Study|Withdrawal by Subject|3|||
127945479|NCT01564537|460424325|FG000|Overall Study|Site Terminated by Sponsor|1|||
127945480|NCT01564537|460424326|FG001|Overall Study|Site Terminated by Sponsor|0|||
127945481|NCT01564537|460424325|FG000|Overall Study|Withdrawal by Subject|12|||
127945482|NCT01564537|460424326|FG001|Overall Study|Withdrawal by Subject|14|||
127945483|NCT01564537|460424325|FG000|Overall Study|Lost to Follow-up|7|||
127945484|NCT01564537|460424326|FG001|Overall Study|Lost to Follow-up|3|||
127945485|NCT01564537|460424325|FG000|Overall Study|Reason not specified|81|||
127945486|NCT01564537|460424326|FG001|Overall Study|Reason not specified|82|||
127945487|NCT01635218|460424327|FG000|Overall Study|Lost to Follow-up|3|||
127945488|NCT01635218|460424328|FG001|Overall Study|Lost to Follow-up|7|||
127945489|NCT01635218|460424329|FG002|Overall Study|Lost to Follow-up|6|||
127945490|NCT03559400|460424330|FG000|Overall Study|Lost to Follow-up|9|||
127945491|NCT03559400|460424331|FG001|Overall Study|Lost to Follow-up|7|||
127945492|NCT03559400|460424330|FG000|Overall Study|Death|0|||
127945493|NCT03559400|460424331|FG001|Overall Study|Death|2|||
127945494|NCT03262038|460424332|FG000|Overall Study|Withdrawal by Subject|0|||
127945495|NCT03262038|460424333|FG001|Overall Study|Withdrawal by Subject|1|||
127945496|NCT04933968|460424334|FG000|Overall Study|Adverse Event|0|||
127945497|NCT04933968|460424335|FG001|Overall Study|Adverse Event|0|||
127945498|NCT04933968|460424336|FG002|Overall Study|Adverse Event|1|||
127945499|NCT04933968|460424337|FG003|Overall Study|Adverse Event|1|||
127945500|NCT04933968|460424338|FG004|Overall Study|Adverse Event|0|||
127945501|NCT04933968|460424339|FG005|Overall Study|Adverse Event|0|||
127945502|NCT04933968|460424334|FG000|Overall Study|Lost to Follow-up|1|||
127945503|NCT04933968|460424335|FG001|Overall Study|Lost to Follow-up|0|||
127945504|NCT04933968|460424336|FG002|Overall Study|Lost to Follow-up|1|||
127945505|NCT04933968|460424337|FG003|Overall Study|Lost to Follow-up|0|||
127945506|NCT04933968|460424338|FG004|Overall Study|Lost to Follow-up|0|||
127945507|NCT04933968|460424339|FG005|Overall Study|Lost to Follow-up|0|||
127945508|NCT04933968|460424334|FG000|Overall Study|Randomized not treated|1|||
127945509|NCT04933968|460424335|FG001|Overall Study|Randomized not treated|0|||
127945510|NCT04933968|460424336|FG002|Overall Study|Randomized not treated|0|||
127945511|NCT04933968|460424337|FG003|Overall Study|Randomized not treated|0|||
127945512|NCT04933968|460424338|FG004|Overall Study|Randomized not treated|0|||
127945513|NCT04933968|460424339|FG005|Overall Study|Randomized not treated|0|||
127945514|NCT04933968|460424334|FG000|Overall Study|Sponsor terminated study|0|||
127945515|NCT04933968|460424335|FG001|Overall Study|Sponsor terminated study|0|||
127945516|NCT04933968|460424336|FG002|Overall Study|Sponsor terminated study|0|||
127945517|NCT04933968|460424337|FG003|Overall Study|Sponsor terminated study|1|||
127945518|NCT04933968|460424338|FG004|Overall Study|Sponsor terminated study|2|||
127945519|NCT04933968|460424339|FG005|Overall Study|Sponsor terminated study|0|||
127945520|NCT04933968|460424334|FG000|Overall Study|Other|0|||
127945521|NCT04933968|460424335|FG001|Overall Study|Other|0|||
127945522|NCT04933968|460424336|FG002|Overall Study|Other|0|||
127945523|NCT04933968|460424337|FG003|Overall Study|Other|1|||
127945524|NCT04933968|460424338|FG004|Overall Study|Other|0|||
127945525|NCT04933968|460424339|FG005|Overall Study|Other|0|||
127945526|NCT04933968|460424334|FG000|Overall Study|Missing|1|||
127945527|NCT04933968|460424335|FG001|Overall Study|Missing|3|||
127945528|NCT04933968|460424336|FG002|Overall Study|Missing|2|||
127945529|NCT04933968|460424337|FG003|Overall Study|Missing|1|||
127945530|NCT04933968|460424338|FG004|Overall Study|Missing|1|||
127945531|NCT04933968|460424339|FG005|Overall Study|Missing|0|||
127945532|NCT02679235|460424340|FG000|Overall Study|Withdrawal by Subject|3|||
127945533|NCT02679235|460424340|FG000|Overall Study|Adverse Event|1|||
127945534|NCT00094861|460424341|FG000|Overall Study|Adverse Event|5|||
127945535|NCT00094861|460424342|FG001|Overall Study|Adverse Event|2|||
127945536|NCT00094861|460424341|FG000|Overall Study|Withdrawal by Subject|5|||
127945537|NCT00094861|460424342|FG001|Overall Study|Withdrawal by Subject|3|||
127945538|NCT00094861|460424341|FG000|Overall Study|Physician Decision|1|||
127945539|NCT00094861|460424342|FG001|Overall Study|Physician Decision|1|||
127945540|NCT00094861|460424341|FG000|Overall Study|Lost to Follow-up|0|||
127945541|NCT00094861|460424342|FG001|Overall Study|Lost to Follow-up|1|||
127945542|NCT00094861|460424341|FG000|Overall Study|Death|4|||
127945543|NCT00094861|460424342|FG001|Overall Study|Death|2|||
127945544|NCT00094861|460424341|FG000|Overall Study|Other|3|||
127945545|NCT00094861|460424342|FG001|Overall Study|Other|0|||
127945546|NCT00509366|460424343|FG000|Overall Study|Not Treated (Screen Failure)|1|||
127945547|NCT00509366|460424344|FG001|Overall Study|Not Treated (Screen Failure)|1|||
127945548|NCT00509366|460424345|FG002|Overall Study|Not Treated (Screen Failure)|1|||
127945549|NCT00509366|460424346|FG003|Overall Study|Not Treated (Screen Failure)|0|||
127945550|NCT00509366|460424347|FG004|Overall Study|Not Treated (Screen Failure)|0|||
127945551|NCT02119819|460424348|FG000|Overall Study|Adverse Event|3|||
127945552|NCT02119819|460424349|FG001|Overall Study|Adverse Event|1|||
127945553|NCT02119819|460424350|FG002|Overall Study|Adverse Event|2|||
127945554|NCT02119819|460424351|FG003|Overall Study|Adverse Event|3|||
127945555|NCT02119819|460424352|FG004|Overall Study|Adverse Event|0|||
127945556|NCT02119819|460424353|FG005|Overall Study|Adverse Event|1|||
127945557|NCT02119819|460424348|FG000|Overall Study|Lack of Efficacy|0|||
127945558|NCT02119819|460424349|FG001|Overall Study|Lack of Efficacy|0|||
127945559|NCT02119819|460424350|FG002|Overall Study|Lack of Efficacy|0|||
127945560|NCT02119819|460424351|FG003|Overall Study|Lack of Efficacy|0|||
127945561|NCT02119819|460424352|FG004|Overall Study|Lack of Efficacy|0|||
127945562|NCT02119819|460424353|FG005|Overall Study|Lack of Efficacy|1|||
127945563|NCT02119819|460424348|FG000|Overall Study|Lost to Follow-up|0|||
127945564|NCT02119819|460424349|FG001|Overall Study|Lost to Follow-up|0|||
127945565|NCT02119819|460424350|FG002|Overall Study|Lost to Follow-up|1|||
127945566|NCT02119819|460424351|FG003|Overall Study|Lost to Follow-up|2|||
127945567|NCT02119819|460424352|FG004|Overall Study|Lost to Follow-up|1|||
127945568|NCT02119819|460424353|FG005|Overall Study|Lost to Follow-up|2|||
127945569|NCT02119819|460424348|FG000|Overall Study|Physician Decision|1|||
127945570|NCT02119819|460424349|FG001|Overall Study|Physician Decision|1|||
127945571|NCT02119819|460424350|FG002|Overall Study|Physician Decision|0|||
127945572|NCT02119819|460424351|FG003|Overall Study|Physician Decision|0|||
127945573|NCT02119819|460424352|FG004|Overall Study|Physician Decision|0|||
127945574|NCT02119819|460424353|FG005|Overall Study|Physician Decision|1|||
127945575|NCT02119819|460424348|FG000|Overall Study|Withdrawal by Subject|5|||
127945576|NCT02119819|460424349|FG001|Overall Study|Withdrawal by Subject|3|||
127945577|NCT02119819|460424350|FG002|Overall Study|Withdrawal by Subject|0|||
127945578|NCT02119819|460424351|FG003|Overall Study|Withdrawal by Subject|0|||
127945579|NCT02119819|460424352|FG004|Overall Study|Withdrawal by Subject|6|||
127945580|NCT02119819|460424353|FG005|Overall Study|Withdrawal by Subject|10|||
127945581|NCT02119819|460424348|FG000|Overall Study|Jury Duty|0|||
127945582|NCT02119819|460424349|FG001|Overall Study|Jury Duty|0|||
127945583|NCT02119819|460424350|FG002|Overall Study|Jury Duty|1|||
127945584|NCT02119819|460424351|FG003|Overall Study|Jury Duty|0|||
127945585|NCT02119819|460424352|FG004|Overall Study|Jury Duty|0|||
127945586|NCT02119819|460424353|FG005|Overall Study|Jury Duty|0|||
127945587|NCT02119819|460424348|FG000|Overall Study|Protocol Violation|0|||
127945588|NCT02119819|460424349|FG001|Overall Study|Protocol Violation|0|||
127945589|NCT02119819|460424350|FG002|Overall Study|Protocol Violation|0|||
127945590|NCT02119819|460424351|FG003|Overall Study|Protocol Violation|1|||
127945591|NCT02119819|460424352|FG004|Overall Study|Protocol Violation|0|||
127945592|NCT02119819|460424353|FG005|Overall Study|Protocol Violation|0|||
127945593|NCT02119819|460424348|FG000|Overall Study|Left the city to get a job|0|||
127945594|NCT02119819|460424349|FG001|Overall Study|Left the city to get a job|0|||
127945595|NCT02119819|460424350|FG002|Overall Study|Left the city to get a job|0|||
127945596|NCT02119819|460424351|FG003|Overall Study|Left the city to get a job|1|||
127945597|NCT02119819|460424352|FG004|Overall Study|Left the city to get a job|0|||
127945598|NCT02119819|460424353|FG005|Overall Study|Left the city to get a job|0|||
127945599|NCT02699684|460424354|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
127945600|NCT02699684|460424355|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
127945601|NCT01439009|460424356|FG000|Overall Study|Physician Decision|5|||
127945602|NCT01439009|460424357|FG001|Overall Study|Physician Decision|3|||
127945603|NCT01439009|460424356|FG000|Overall Study|Protocol Violation|2|||
127945604|NCT01439009|460424357|FG001|Overall Study|Protocol Violation|0|||
127945605|NCT01439009|460424356|FG000|Overall Study|Deviation of exclusion criteria|1|||
127945606|NCT01439009|460424357|FG001|Overall Study|Deviation of exclusion criteria|0|||
127945607|NCT01191944|460424362|FG000|Overall Study|Adverse Event|11|||
127945608|NCT01191944|460424363|FG001|Overall Study|Adverse Event|12|||
127945609|NCT01191944|460424362|FG000|Overall Study|Protocol Violation|1|||
127945610|NCT01191944|460424363|FG001|Overall Study|Protocol Violation|2|||
127945611|NCT01191944|460424362|FG000|Overall Study|Withdrawal by Subject|4|||
127945612|NCT01191944|460424363|FG001|Overall Study|Withdrawal by Subject|2|||
127945613|NCT01191944|460424362|FG000|Overall Study|Other|1|||
127945614|NCT01191944|460424363|FG001|Overall Study|Other|3|||
127945615|NCT00603837|460424364|FG000|Overall Study|Physician Decision|3|||
127945616|NCT00603837|460424365|FG001|Overall Study|Physician Decision|0|||
127945617|NCT04611529|460424366|FG000|2-day Follow up|Lost to Follow-up|5|||
127945618|NCT04611529|460424367|FG001|2-day Follow up|Lost to Follow-up|6|||
127945619|NCT04611529|460424368|FG002|2-day Follow up|Lost to Follow-up|3|||
127945620|NCT02564887|460424374|FG000|Overall Study|Lost to Follow-up|6|||
127945621|NCT02564887|460424375|FG001|Overall Study|Lost to Follow-up|0|||
127945622|NCT01851330|460424376|FG000|Overall Study|Lack of Efficacy|10|||
127945623|NCT01851330|460424377|FG001|Overall Study|Lack of Efficacy|9|||
127945624|NCT01851330|460424378|FG002|Overall Study|Lack of Efficacy|2|||
127945625|NCT01851330|460424376|FG000|Overall Study|Lost to Follow-up|1|||
127945626|NCT01851330|460424377|FG001|Overall Study|Lost to Follow-up|6|||
127945627|NCT01851330|460424378|FG002|Overall Study|Lost to Follow-up|9|||
127945628|NCT01851330|460424376|FG000|Overall Study|Withdrew Consent|2|||
127945629|NCT01851330|460424377|FG001|Overall Study|Withdrew Consent|1|||
127945630|NCT01851330|460424378|FG002|Overall Study|Withdrew Consent|0|||
127945631|NCT01851330|460424376|FG000|Overall Study|Investigator's Discretion|0|||
127945632|NCT01851330|460424377|FG001|Overall Study|Investigator's Discretion|0|||
127945633|NCT01851330|460424378|FG002|Overall Study|Investigator's Discretion|1|||
127945634|NCT01199016|460424379|FG000|Overall Study|No longer meets eligibility criteria|4|||
127945635|NCT01199016|460424379|FG000|Overall Study|Entrance criteria|5|||
127945636|NCT01199016|460424379|FG000|Overall Study|Protocol Violation|9|||
127945637|NCT01199016|460424379|FG000|Overall Study|Other|13|||
127945638|NCT01199016|460424379|FG000|Overall Study|Withdrawal by Subject|21|||
127945639|NCT01199016|460424379|FG000|Overall Study|Lost to Follow-up|25|||
127945640|NCT02368314|460424383|FG000|Overall Study|Withdrawal by Subject|2|||
127945641|NCT02368314|460424384|FG001|Overall Study|Withdrawal by Subject|1|||
127945642|NCT02368314|460424383|FG000|Overall Study|Adverse Event|1|||
127945643|NCT02368314|460424384|FG001|Overall Study|Adverse Event|2|||
127945644|NCT02842073|460424389|FG000|Overall Study|Withdrawal by Subject|1|||
127945645|NCT00195338|460424390|FG000|Overall Study|Lost to Follow-up|2|||
127945646|NCT00195338|460424390|FG000|Overall Study|Adverse Event|5|||
127945647|NCT00195338|460424390|FG000|Overall Study|Lack of Efficacy|1|||
127945648|NCT00195338|460424390|FG000|Overall Study|Early closure of the site|4|||
127945649|NCT01333397|460424391|FG000|Overall Study|Lost to Follow-up|1|||
127945650|NCT01333397|460424392|FG001|Overall Study|Lost to Follow-up|0|||
127945651|NCT01333397|460424393|FG002|Overall Study|Lost to Follow-up|0|||
127945652|NCT01333397|460424394|FG003|Overall Study|Lost to Follow-up|1|||
127945653|NCT01333397|460424395|FG004|Overall Study|Lost to Follow-up|0|||
127945654|NCT01085357|460424396|FG000|Overall Study|Adverse Event|1|||
127945655|NCT01085357|460424397|FG001|Overall Study|Adverse Event|1|||
127945656|NCT01085357|460424396|FG000|Overall Study|Subject Decision|4|||
127945657|NCT01085357|460424397|FG001|Overall Study|Subject Decision|3|||
127945658|NCT01085357|460424396|FG000|Overall Study|Investigator Decision|1|||
127945659|NCT01085357|460424397|FG001|Overall Study|Investigator Decision|1|||
127945660|NCT01085357|460424396|FG000|Overall Study|Death|11|||
127945661|NCT01085357|460424397|FG001|Overall Study|Death|1|||
127945662|NCT01085357|460424396|FG000|Overall Study|Lost to Follow-up|2|||
127945663|NCT01085357|460424397|FG001|Overall Study|Lost to Follow-up|0|||
127945664|NCT02289456|460424406|FG000|Induction Period|Death|2|||
127945665|NCT02289456|460424406|FG000|Induction Period|Adverse Event|11|||
127945666|NCT02289456|460424406|FG000|Induction Period|Progressive Disease (PD)|4|||
127945667|NCT02289456|460424406|FG000|Induction Period|Symptomatic Deterioration|4|||
127945668|NCT02289456|460424406|FG000|Induction Period|Withdrawal by Subject|2|||
127945669|NCT02289456|460424406|FG000|Induction Period|Miscellaneous|1|||
127945670|NCT02289456|460424406|FG000|Monotherapy Period|Death|1|||
127945671|NCT02289456|460424406|FG000|Monotherapy Period|Adverse Event|1|||
127945672|NCT02289456|460424406|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
127945673|NCT02289456|460424406|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
127945674|NCT02289456|460424406|FG000|Monotherapy Period|Withdrawal by Subject|2|||
127945675|NCT02289456|460424406|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
127945676|NCT02289456|460424406|FG000|Monotherapy Period|Miscellaneous|1|||
127945677|NCT00920790|460424409|FG000|Overall Study|aggravation of general condition|14|||
127945678|NCT00895414|460424412|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
127945679|NCT00895414|460424413|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
127945680|NCT00895414|460424412|FG000|First Intervention (14 Days)|Physician Decision|0|||
127945681|NCT00895414|460424413|FG001|First Intervention (14 Days)|Physician Decision|1|||
127945682|NCT00252239|460424414|FG000|Overall Study|Withdrawal by Subject|1|||
127945683|NCT00252239|460424415|FG001|Overall Study|Withdrawal by Subject|0|||
127945684|NCT00252239|460424416|FG002|Overall Study|Withdrawal by Subject|0|||
127945685|NCT00252239|460424417|FG003|Overall Study|Withdrawal by Subject|1|||
127945686|NCT00252239|460424414|FG000|Overall Study|Lost to Follow-up|0|||
127945687|NCT00252239|460424415|FG001|Overall Study|Lost to Follow-up|0|||
127945688|NCT00252239|460424416|FG002|Overall Study|Lost to Follow-up|2|||
127945689|NCT00252239|460424417|FG003|Overall Study|Lost to Follow-up|0|||
127945690|NCT00478426|460424418|FG000|Overall Study|Withdrawal by Subject|1|||
127945691|NCT02752087|460424423|FG000|Washout|Physician Decision|1|||
127945692|NCT02752087|460424424|FG001|Washout|Physician Decision|0|||
127945693|NCT02785952|460424425|FG000|Overall Study|Adverse Event|31|||
127945694|NCT02785952|460424426|FG001|Overall Study|Adverse Event|19|||
127945695|NCT02785952|460424425|FG000|Overall Study|Refusal unrelated to adverse events|10|||
127945696|NCT02785952|460424426|FG001|Overall Study|Refusal unrelated to adverse events|5|||
127945697|NCT02785952|460424425|FG000|Overall Study|Disease progression/relapse|61|||
127945698|NCT02785952|460424426|FG001|Overall Study|Disease progression/relapse|89|||
127945699|NCT02785952|460424425|FG000|Overall Study|Death|11|||
127945700|NCT02785952|460424426|FG001|Overall Study|Death|7|||
127945701|NCT02785952|460424425|FG000|Overall Study|Other- not protocol specified|6|||
127945702|NCT02785952|460424426|FG001|Overall Study|Other- not protocol specified|4|||
127945703|NCT02785952|460424425|FG000|Overall Study|On protocol treatment|6|||
127945704|NCT02785952|460424426|FG001|Overall Study|On protocol treatment|3|||
127945705|NCT02728843|460424427|FG000|Overall Study|Adverse Event|0|||
127945706|NCT02728843|460424428|FG001|Overall Study|Adverse Event|2|||
127945707|NCT02728843|460424429|FG002|Overall Study|Adverse Event|3|||
127945708|NCT02728843|460424430|FG003|Overall Study|Adverse Event|1|||
127945709|NCT02728843|460424431|FG004|Overall Study|Adverse Event|2|||
127945710|NCT02728843|460424427|FG000|Overall Study|Lack of Efficacy|0|||
127945711|NCT02728843|460424428|FG001|Overall Study|Lack of Efficacy|1|||
127945712|NCT02728843|460424429|FG002|Overall Study|Lack of Efficacy|1|||
127945713|NCT02728843|460424430|FG003|Overall Study|Lack of Efficacy|0|||
127945714|NCT02728843|460424431|FG004|Overall Study|Lack of Efficacy|0|||
127945715|NCT02728843|460424427|FG000|Overall Study|Protocol Violation|2|||
127945716|NCT02728843|460424428|FG001|Overall Study|Protocol Violation|0|||
127945717|NCT02728843|460424429|FG002|Overall Study|Protocol Violation|4|||
127945718|NCT02728843|460424430|FG003|Overall Study|Protocol Violation|2|||
127945719|NCT02728843|460424431|FG004|Overall Study|Protocol Violation|2|||
127945720|NCT02728843|460424427|FG000|Overall Study|Withdrawal by Subject|1|||
127945721|NCT02728843|460424428|FG001|Overall Study|Withdrawal by Subject|0|||
127945722|NCT02728843|460424429|FG002|Overall Study|Withdrawal by Subject|0|||
127945723|NCT02728843|460424430|FG003|Overall Study|Withdrawal by Subject|1|||
127945724|NCT02728843|460424431|FG004|Overall Study|Withdrawal by Subject|0|||
127945725|NCT02728843|460424427|FG000|Overall Study|Use of rescue medication|0|||
127945726|NCT02728843|460424428|FG001|Overall Study|Use of rescue medication|2|||
127945727|NCT02728843|460424429|FG002|Overall Study|Use of rescue medication|0|||
127945728|NCT02728843|460424430|FG003|Overall Study|Use of rescue medication|2|||
127945729|NCT02728843|460424431|FG004|Overall Study|Use of rescue medication|1|||
127945730|NCT01671332|460424432|FG000|Overall Study|Withdrawal by Subject|1|||
127945731|NCT01671332|460424433|FG001|Overall Study|Withdrawal by Subject|1|||
127945732|NCT00351533|460424434|FG000|Overall Study|Extubated before first BAL|1|||
127945733|NCT00351533|460424435|FG001|Overall Study|Extubated before first BAL|0|||
127945734|NCT00351533|460424434|FG000|Overall Study|Lost to Follow-up|1|||
127945735|NCT00351533|460424435|FG001|Overall Study|Lost to Follow-up|3|||
127945736|NCT00351533|460424434|FG000|Overall Study|Physician Decision|0|||
127945737|NCT00351533|460424435|FG001|Overall Study|Physician Decision|1|||
127945738|NCT00351533|460424434|FG000|Overall Study|Withdrawal by Subject|0|||
127945739|NCT00351533|460424435|FG001|Overall Study|Withdrawal by Subject|1|||
127945740|NCT01806506|460424436|FG000|Overall Study|Lost to Follow-up|2|||
127945741|NCT01806506|460424437|FG001|Overall Study|Lost to Follow-up|1|||
127945742|NCT00996892|460424442|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
127945743|NCT00996892|460424443|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
127945744|NCT00996892|460424444|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
127945745|NCT00996892|460424445|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
127945746|NCT00996892|460424446|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
127945747|NCT00996892|460424447|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
127945748|NCT00996892|460424448|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
127945749|NCT00996892|460424449|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
127945750|NCT00996892|460424450|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
127945751|NCT00996892|460424451|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
127945752|NCT00996892|460424452|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
127945753|NCT00996892|460424453|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
127945754|NCT00996892|460424454|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
127945755|NCT00996892|460424455|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
127945756|NCT00996892|460424456|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
127945757|NCT00996892|460424457|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
127945758|NCT00996892|460424458|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
127945759|NCT00996892|460424459|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
127945760|NCT00996892|460424460|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
127945761|NCT00996892|460424461|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
127945762|NCT00996892|460424442|FG000|Dose-Escalation Stage 1|Death|1|||
127945763|NCT00996892|460424443|FG001|Dose-Escalation Stage 1|Death|0|||
127945764|NCT00996892|460424444|FG002|Dose-Escalation Stage 1|Death|0|||
127945765|NCT00996892|460424445|FG003|Dose-Escalation Stage 1|Death|0|||
127945766|NCT00996892|460424446|FG004|Dose-Escalation Stage 1|Death|0|||
127945767|NCT00996892|460424447|FG005|Dose-Escalation Stage 1|Death|1|||
127945768|NCT00996892|460424448|FG006|Dose-Escalation Stage 1|Death|0|||
127945769|NCT00996892|460424449|FG007|Dose-Escalation Stage 1|Death|0|||
127945770|NCT00996892|460424450|FG008|Dose-Escalation Stage 1|Death|0|||
127945771|NCT00996892|460424451|FG009|Dose-Escalation Stage 1|Death|0|||
127945772|NCT00996892|460424452|FG010|Dose-Escalation Stage 1|Death|0|||
127945773|NCT00996892|460424453|FG011|Dose-Escalation Stage 1|Death|0|||
127945774|NCT00996892|460424454|FG012|Dose-Escalation Stage 1|Death|0|||
127945775|NCT00996892|460424455|FG013|Dose-Escalation Stage 1|Death|0|||
127945776|NCT00996892|460424456|FG014|Dose-Escalation Stage 1|Death|0|||
127945777|NCT00996892|460424457|FG015|Dose-Escalation Stage 1|Death|0|||
127945778|NCT00996892|460424458|FG016|Dose-Escalation Stage 1|Death|0|||
127945779|NCT00996892|460424459|FG017|Dose-Escalation Stage 1|Death|0|||
127945780|NCT00996892|460424460|FG018|Dose-Escalation Stage 1|Death|0|||
127945781|NCT00996892|460424461|FG019|Dose-Escalation Stage 1|Death|0|||
127945782|NCT00996892|460424442|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
127945783|NCT00996892|460424443|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
127945784|NCT00996892|460424444|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
127945785|NCT00996892|460424445|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
127945786|NCT00996892|460424446|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
127945787|NCT00996892|460424447|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
127945788|NCT00996892|460424448|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
127945789|NCT00996892|460424449|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
127945790|NCT00996892|460424450|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
127945791|NCT00996892|460424451|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
127945792|NCT00996892|460424452|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
127945793|NCT00996892|460424453|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
127945794|NCT00996892|460424454|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
127945795|NCT00996892|460424455|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
127945796|NCT00996892|460424456|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
127945797|NCT00996892|460424457|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
127945798|NCT00996892|460424458|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
127945799|NCT00996892|460424459|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
127945800|NCT00996892|460424460|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
127945801|NCT00996892|460424461|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
127945802|NCT00996892|460424442|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
127945803|NCT00996892|460424443|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
127945804|NCT00996892|460424444|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
127945805|NCT00996892|460424445|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
127945806|NCT00996892|460424446|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
127945807|NCT00996892|460424447|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
127945808|NCT00996892|460424448|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
127945809|NCT00996892|460424449|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
127945810|NCT00996892|460424450|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
127945811|NCT00996892|460424451|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
127945812|NCT00996892|460424452|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
127945813|NCT00996892|460424453|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
127945814|NCT00996892|460424454|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
127945815|NCT00996892|460424455|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
127945816|NCT00996892|460424456|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
127945817|NCT00996892|460424457|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
127945818|NCT00996892|460424458|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
127945819|NCT00996892|460424459|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
127945820|NCT00996892|460424460|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
127945821|NCT00996892|460424461|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
127945822|NCT00996892|460424442|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
127945823|NCT00996892|460424443|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
127945824|NCT00996892|460424444|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
127945825|NCT00996892|460424445|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
127945826|NCT00996892|460424446|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
127945827|NCT00996892|460424447|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
127945828|NCT00996892|460424448|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
127945829|NCT00996892|460424449|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
127945830|NCT00996892|460424450|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
127945831|NCT00996892|460424451|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
127945832|NCT00996892|460424452|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
127945833|NCT00996892|460424453|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
127945834|NCT00996892|460424454|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
127945835|NCT00996892|460424455|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
127945836|NCT00996892|460424456|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
127945837|NCT00996892|460424457|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
127945838|NCT00996892|460424458|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
127945839|NCT00996892|460424459|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
127945840|NCT00996892|460424460|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
127945841|NCT00996892|460424461|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
127945842|NCT00996892|460424442|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
127945843|NCT00996892|460424443|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
127945844|NCT00996892|460424444|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
127945845|NCT00996892|460424445|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
127945846|NCT00996892|460424446|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
127945847|NCT00996892|460424447|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
127945848|NCT00996892|460424448|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
127945849|NCT00996892|460424449|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
127945850|NCT00996892|460424450|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
127945851|NCT00996892|460424451|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
127945852|NCT00996892|460424452|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
127945853|NCT00996892|460424453|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
127945854|NCT00996892|460424454|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
127945855|NCT00996892|460424455|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
127945856|NCT00996892|460424456|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
127945857|NCT00996892|460424457|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
127945858|NCT00996892|460424458|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
127945859|NCT00996892|460424459|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
127945860|NCT00996892|460424460|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
127945861|NCT00996892|460424461|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
127945862|NCT00996892|460424442|FG000|Dose-Escalation Stage 1A|Death|0|||
127945863|NCT00996892|460424443|FG001|Dose-Escalation Stage 1A|Death|0|||
127945864|NCT00996892|460424444|FG002|Dose-Escalation Stage 1A|Death|0|||
127945865|NCT00996892|460424445|FG003|Dose-Escalation Stage 1A|Death|0|||
127945866|NCT00996892|460424446|FG004|Dose-Escalation Stage 1A|Death|0|||
127945867|NCT00996892|460424447|FG005|Dose-Escalation Stage 1A|Death|0|||
127945868|NCT00996892|460424448|FG006|Dose-Escalation Stage 1A|Death|0|||
127945869|NCT00996892|460424449|FG007|Dose-Escalation Stage 1A|Death|0|||
127945870|NCT00996892|460424450|FG008|Dose-Escalation Stage 1A|Death|0|||
127945871|NCT00996892|460424451|FG009|Dose-Escalation Stage 1A|Death|2|||
127945872|NCT00996892|460424452|FG010|Dose-Escalation Stage 1A|Death|0|||
127945873|NCT00996892|460424453|FG011|Dose-Escalation Stage 1A|Death|1|||
127945874|NCT00996892|460424454|FG012|Dose-Escalation Stage 1A|Death|1|||
127945875|NCT00996892|460424455|FG013|Dose-Escalation Stage 1A|Death|0|||
127945876|NCT00996892|460424456|FG014|Dose-Escalation Stage 1A|Death|0|||
127945877|NCT00996892|460424457|FG015|Dose-Escalation Stage 1A|Death|0|||
127945878|NCT00996892|460424458|FG016|Dose-Escalation Stage 1A|Death|0|||
127945879|NCT00996892|460424459|FG017|Dose-Escalation Stage 1A|Death|0|||
127945880|NCT00996892|460424460|FG018|Dose-Escalation Stage 1A|Death|0|||
127945881|NCT00996892|460424461|FG019|Dose-Escalation Stage 1A|Death|0|||
127945882|NCT00996892|460424442|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
127945883|NCT00996892|460424443|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
127945884|NCT00996892|460424444|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
127945885|NCT00996892|460424445|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
127945886|NCT00996892|460424446|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
127945887|NCT00996892|460424447|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
127945888|NCT00996892|460424448|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
127945889|NCT00996892|460424449|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
127945890|NCT00996892|460424450|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
127945891|NCT00996892|460424451|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
127945892|NCT00996892|460424452|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
127945893|NCT00996892|460424453|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
127945894|NCT00996892|460424454|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
127945895|NCT00996892|460424455|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
127945896|NCT00996892|460424456|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
127945897|NCT00996892|460424457|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
127945898|NCT00996892|460424458|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
127945899|NCT00996892|460424459|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
127945900|NCT00996892|460424460|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
127945901|NCT00996892|460424461|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
127945902|NCT00996892|460424442|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
127945903|NCT00996892|460424443|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
127945904|NCT00996892|460424444|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
127945905|NCT00996892|460424445|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
127945906|NCT00996892|460424446|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
127945907|NCT00996892|460424447|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
127945908|NCT00996892|460424448|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
127945909|NCT00996892|460424449|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
127945910|NCT00996892|460424450|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
127945911|NCT00996892|460424451|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
127945912|NCT00996892|460424452|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
127945913|NCT00996892|460424453|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
127945914|NCT00996892|460424454|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
127945915|NCT00996892|460424455|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
127945916|NCT00996892|460424456|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
127945917|NCT00996892|460424457|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
127945918|NCT00996892|460424458|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
127945919|NCT00996892|460424459|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
127945920|NCT00996892|460424460|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
127945921|NCT00996892|460424461|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
127945922|NCT00996892|460424442|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
127945923|NCT00996892|460424443|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
127945924|NCT00996892|460424444|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
127945925|NCT00996892|460424445|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
127945926|NCT00996892|460424446|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
127945927|NCT00996892|460424447|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
127945928|NCT00996892|460424448|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
127945929|NCT00996892|460424449|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
127945930|NCT00996892|460424450|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
127945931|NCT00996892|460424451|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
127945932|NCT00996892|460424452|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
127945933|NCT00996892|460424453|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
127945934|NCT00996892|460424454|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
127945935|NCT00996892|460424455|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
127945936|NCT00996892|460424456|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
127945937|NCT00996892|460424457|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
127945938|NCT00996892|460424458|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
127945939|NCT00996892|460424459|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
127945940|NCT00996892|460424460|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
127945941|NCT00996892|460424461|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
127945942|NCT00996892|460424442|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
127945943|NCT00996892|460424443|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
127945944|NCT00996892|460424444|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
127945945|NCT00996892|460424445|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
127945946|NCT00996892|460424446|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
127945947|NCT00996892|460424447|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
127945948|NCT00996892|460424448|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
127945949|NCT00996892|460424449|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
127945950|NCT00996892|460424450|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
127945951|NCT00996892|460424451|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
127945952|NCT00996892|460424452|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
127945953|NCT00996892|460424453|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
127945954|NCT00996892|460424454|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
127945955|NCT00996892|460424455|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
127945956|NCT00996892|460424456|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
127945957|NCT00996892|460424457|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
127945958|NCT00996892|460424458|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
127945959|NCT00996892|460424459|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
127945960|NCT00996892|460424460|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
127945961|NCT00996892|460424461|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
127945962|NCT00996892|460424442|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
127945963|NCT00996892|460424443|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
127945964|NCT00996892|460424444|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
127945965|NCT00996892|460424445|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
127945966|NCT00996892|460424446|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
127945967|NCT00996892|460424447|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
127945968|NCT00996892|460424448|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
127945969|NCT00996892|460424449|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
127945970|NCT00996892|460424450|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
127945971|NCT00996892|460424451|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
127945972|NCT00996892|460424452|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
127945973|NCT00996892|460424453|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
127945974|NCT00996892|460424454|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
127945975|NCT00996892|460424455|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
127945976|NCT00996892|460424456|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
127945977|NCT00996892|460424457|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
127945978|NCT00996892|460424458|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
127945979|NCT00996892|460424459|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
127945980|NCT00996892|460424460|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
127945981|NCT00996892|460424461|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
127945982|NCT00996892|460424442|FG000|Expansion Stage 2|Adverse Event|0|||
127945983|NCT00996892|460424443|FG001|Expansion Stage 2|Adverse Event|0|||
127945984|NCT00996892|460424444|FG002|Expansion Stage 2|Adverse Event|0|||
127945985|NCT00996892|460424445|FG003|Expansion Stage 2|Adverse Event|0|||
127945986|NCT00996892|460424446|FG004|Expansion Stage 2|Adverse Event|0|||
127945987|NCT00996892|460424447|FG005|Expansion Stage 2|Adverse Event|0|||
127945988|NCT00996892|460424448|FG006|Expansion Stage 2|Adverse Event|0|||
127945989|NCT00996892|460424449|FG007|Expansion Stage 2|Adverse Event|0|||
127945990|NCT00996892|460424450|FG008|Expansion Stage 2|Adverse Event|0|||
127945991|NCT00996892|460424451|FG009|Expansion Stage 2|Adverse Event|0|||
127945992|NCT00996892|460424452|FG010|Expansion Stage 2|Adverse Event|0|||
127945993|NCT00996892|460424453|FG011|Expansion Stage 2|Adverse Event|0|||
127945994|NCT00996892|460424454|FG012|Expansion Stage 2|Adverse Event|0|||
127945995|NCT00996892|460424455|FG013|Expansion Stage 2|Adverse Event|0|||
127945996|NCT00996892|460424456|FG014|Expansion Stage 2|Adverse Event|0|||
127945997|NCT00996892|460424457|FG015|Expansion Stage 2|Adverse Event|0|||
127945998|NCT00996892|460424458|FG016|Expansion Stage 2|Adverse Event|0|||
127945999|NCT00996892|460424459|FG017|Expansion Stage 2|Adverse Event|0|||
127946000|NCT00996892|460424460|FG018|Expansion Stage 2|Adverse Event|3|||
127946001|NCT00996892|460424461|FG019|Expansion Stage 2|Adverse Event|0|||
127946002|NCT00996892|460424442|FG000|Expansion Stage 2|Death|0|||
127946003|NCT00996892|460424443|FG001|Expansion Stage 2|Death|0|||
127946004|NCT00996892|460424444|FG002|Expansion Stage 2|Death|0|||
127946005|NCT00996892|460424445|FG003|Expansion Stage 2|Death|0|||
127946006|NCT00996892|460424446|FG004|Expansion Stage 2|Death|0|||
127946007|NCT00996892|460424447|FG005|Expansion Stage 2|Death|0|||
127946008|NCT00996892|460424448|FG006|Expansion Stage 2|Death|0|||
127946009|NCT00996892|460424449|FG007|Expansion Stage 2|Death|0|||
127946010|NCT00996892|460424450|FG008|Expansion Stage 2|Death|0|||
127946011|NCT00996892|460424451|FG009|Expansion Stage 2|Death|0|||
127946012|NCT00996892|460424452|FG010|Expansion Stage 2|Death|0|||
127946013|NCT00996892|460424453|FG011|Expansion Stage 2|Death|0|||
127946014|NCT00996892|460424454|FG012|Expansion Stage 2|Death|0|||
127946015|NCT00996892|460424455|FG013|Expansion Stage 2|Death|0|||
127946016|NCT00996892|460424456|FG014|Expansion Stage 2|Death|0|||
127946017|NCT00996892|460424457|FG015|Expansion Stage 2|Death|0|||
127946018|NCT00996892|460424458|FG016|Expansion Stage 2|Death|0|||
127946019|NCT00996892|460424459|FG017|Expansion Stage 2|Death|0|||
127946020|NCT00996892|460424460|FG018|Expansion Stage 2|Death|2|||
127946021|NCT00996892|460424461|FG019|Expansion Stage 2|Death|0|||
127946022|NCT00996892|460424442|FG000|Expansion Stage 2|Physician Decision|0|||
127946023|NCT00996892|460424443|FG001|Expansion Stage 2|Physician Decision|0|||
127946024|NCT00996892|460424444|FG002|Expansion Stage 2|Physician Decision|0|||
127946025|NCT00996892|460424445|FG003|Expansion Stage 2|Physician Decision|0|||
127946026|NCT00996892|460424446|FG004|Expansion Stage 2|Physician Decision|0|||
127946027|NCT00996892|460424447|FG005|Expansion Stage 2|Physician Decision|0|||
127946028|NCT00996892|460424448|FG006|Expansion Stage 2|Physician Decision|0|||
127946029|NCT00996892|460424449|FG007|Expansion Stage 2|Physician Decision|0|||
127946030|NCT00996892|460424450|FG008|Expansion Stage 2|Physician Decision|0|||
127946031|NCT00996892|460424451|FG009|Expansion Stage 2|Physician Decision|0|||
127946032|NCT00996892|460424452|FG010|Expansion Stage 2|Physician Decision|0|||
127946033|NCT00996892|460424453|FG011|Expansion Stage 2|Physician Decision|0|||
127946034|NCT00996892|460424454|FG012|Expansion Stage 2|Physician Decision|0|||
127946035|NCT00996892|460424455|FG013|Expansion Stage 2|Physician Decision|0|||
127946036|NCT00996892|460424456|FG014|Expansion Stage 2|Physician Decision|0|||
127946037|NCT00996892|460424457|FG015|Expansion Stage 2|Physician Decision|0|||
127946038|NCT00996892|460424458|FG016|Expansion Stage 2|Physician Decision|0|||
127946039|NCT00996892|460424459|FG017|Expansion Stage 2|Physician Decision|0|||
127946040|NCT00996892|460424460|FG018|Expansion Stage 2|Physician Decision|1|||
127946041|NCT00996892|460424461|FG019|Expansion Stage 2|Physician Decision|0|||
127946042|NCT00996892|460424442|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
127946043|NCT00996892|460424443|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
127946044|NCT00996892|460424444|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
127946045|NCT00996892|460424445|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
127946046|NCT00996892|460424446|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
127946047|NCT00996892|460424447|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
127946048|NCT00996892|460424448|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
127946049|NCT00996892|460424449|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
127946050|NCT00996892|460424450|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
127946051|NCT00996892|460424451|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
127946052|NCT00996892|460424452|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
127946053|NCT00996892|460424453|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
127946054|NCT00996892|460424454|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
127946055|NCT00996892|460424455|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
127946056|NCT00996892|460424456|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
127946057|NCT00996892|460424457|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
127946058|NCT00996892|460424458|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
127946059|NCT00996892|460424459|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
127946060|NCT00996892|460424460|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
127946061|NCT00996892|460424461|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
127946062|NCT00996892|460424442|FG000|Expansion Stage 2|Disease Progression|0|||
127946063|NCT00996892|460424443|FG001|Expansion Stage 2|Disease Progression|0|||
127946064|NCT00996892|460424444|FG002|Expansion Stage 2|Disease Progression|0|||
127946065|NCT00996892|460424445|FG003|Expansion Stage 2|Disease Progression|0|||
127946066|NCT00996892|460424446|FG004|Expansion Stage 2|Disease Progression|0|||
127946067|NCT00996892|460424447|FG005|Expansion Stage 2|Disease Progression|0|||
127946068|NCT00996892|460424448|FG006|Expansion Stage 2|Disease Progression|0|||
127946069|NCT00996892|460424449|FG007|Expansion Stage 2|Disease Progression|0|||
127946070|NCT00996892|460424450|FG008|Expansion Stage 2|Disease Progression|0|||
127946071|NCT00996892|460424451|FG009|Expansion Stage 2|Disease Progression|0|||
127946072|NCT00996892|460424452|FG010|Expansion Stage 2|Disease Progression|0|||
127946073|NCT00996892|460424453|FG011|Expansion Stage 2|Disease Progression|0|||
127946074|NCT00996892|460424454|FG012|Expansion Stage 2|Disease Progression|0|||
127946075|NCT00996892|460424455|FG013|Expansion Stage 2|Disease Progression|0|||
127946076|NCT00996892|460424456|FG014|Expansion Stage 2|Disease Progression|0|||
127946077|NCT00996892|460424457|FG015|Expansion Stage 2|Disease Progression|0|||
127946078|NCT00996892|460424458|FG016|Expansion Stage 2|Disease Progression|0|||
127946079|NCT00996892|460424459|FG017|Expansion Stage 2|Disease Progression|0|||
127946080|NCT00996892|460424460|FG018|Expansion Stage 2|Disease Progression|28|||
127946081|NCT00996892|460424461|FG019|Expansion Stage 2|Disease Progression|0|||
127946082|NCT00996892|460424442|FG000|Expansion Stage 2A|Adverse Event|0|||
127946083|NCT00996892|460424443|FG001|Expansion Stage 2A|Adverse Event|0|||
127946084|NCT00996892|460424444|FG002|Expansion Stage 2A|Adverse Event|0|||
127946085|NCT00996892|460424445|FG003|Expansion Stage 2A|Adverse Event|0|||
127946086|NCT00996892|460424446|FG004|Expansion Stage 2A|Adverse Event|0|||
127946087|NCT00996892|460424447|FG005|Expansion Stage 2A|Adverse Event|0|||
127946088|NCT00996892|460424448|FG006|Expansion Stage 2A|Adverse Event|0|||
127946089|NCT00996892|460424449|FG007|Expansion Stage 2A|Adverse Event|0|||
127946090|NCT00996892|460424450|FG008|Expansion Stage 2A|Adverse Event|0|||
127946091|NCT00996892|460424451|FG009|Expansion Stage 2A|Adverse Event|0|||
127946092|NCT00996892|460424452|FG010|Expansion Stage 2A|Adverse Event|0|||
127946093|NCT00996892|460424453|FG011|Expansion Stage 2A|Adverse Event|0|||
127946094|NCT00996892|460424454|FG012|Expansion Stage 2A|Adverse Event|0|||
127946095|NCT00996892|460424455|FG013|Expansion Stage 2A|Adverse Event|0|||
127946096|NCT00996892|460424456|FG014|Expansion Stage 2A|Adverse Event|0|||
127946097|NCT00996892|460424457|FG015|Expansion Stage 2A|Adverse Event|0|||
127946098|NCT00996892|460424458|FG016|Expansion Stage 2A|Adverse Event|0|||
127946099|NCT00996892|460424459|FG017|Expansion Stage 2A|Adverse Event|0|||
127946100|NCT00996892|460424460|FG018|Expansion Stage 2A|Adverse Event|0|||
127946101|NCT00996892|460424461|FG019|Expansion Stage 2A|Adverse Event|8|||
127946102|NCT00996892|460424442|FG000|Expansion Stage 2A|Physician Decision|0|||
127946103|NCT00996892|460424443|FG001|Expansion Stage 2A|Physician Decision|0|||
127946104|NCT00996892|460424444|FG002|Expansion Stage 2A|Physician Decision|0|||
127946105|NCT00996892|460424445|FG003|Expansion Stage 2A|Physician Decision|0|||
127946106|NCT00996892|460424446|FG004|Expansion Stage 2A|Physician Decision|0|||
127946107|NCT00996892|460424447|FG005|Expansion Stage 2A|Physician Decision|0|||
127946108|NCT00996892|460424448|FG006|Expansion Stage 2A|Physician Decision|0|||
127946109|NCT00996892|460424449|FG007|Expansion Stage 2A|Physician Decision|0|||
127946110|NCT00996892|460424450|FG008|Expansion Stage 2A|Physician Decision|0|||
127946111|NCT00996892|460424451|FG009|Expansion Stage 2A|Physician Decision|0|||
127946112|NCT00996892|460424452|FG010|Expansion Stage 2A|Physician Decision|0|||
127946113|NCT00996892|460424453|FG011|Expansion Stage 2A|Physician Decision|0|||
127946114|NCT00996892|460424454|FG012|Expansion Stage 2A|Physician Decision|0|||
127946115|NCT00996892|460424455|FG013|Expansion Stage 2A|Physician Decision|0|||
127946116|NCT00996892|460424456|FG014|Expansion Stage 2A|Physician Decision|0|||
127946117|NCT00996892|460424457|FG015|Expansion Stage 2A|Physician Decision|0|||
127946118|NCT00996892|460424458|FG016|Expansion Stage 2A|Physician Decision|0|||
127946119|NCT00996892|460424459|FG017|Expansion Stage 2A|Physician Decision|0|||
127946120|NCT00996892|460424460|FG018|Expansion Stage 2A|Physician Decision|0|||
127946121|NCT00996892|460424461|FG019|Expansion Stage 2A|Physician Decision|2|||
127946122|NCT00996892|460424442|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
127946123|NCT00996892|460424443|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
127946124|NCT00996892|460424444|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
127946125|NCT00996892|460424445|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
127946126|NCT00996892|460424446|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
127946127|NCT00996892|460424447|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
127946128|NCT00996892|460424448|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
127946129|NCT00996892|460424449|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
127946130|NCT00996892|460424450|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
127946131|NCT00996892|460424451|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
127946132|NCT00996892|460424452|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
127946133|NCT00996892|460424453|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
127946134|NCT00996892|460424454|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
127946135|NCT00996892|460424455|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
127946136|NCT00996892|460424456|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
127946137|NCT00996892|460424457|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
127946138|NCT00996892|460424458|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
127946139|NCT00996892|460424459|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
127946140|NCT00996892|460424460|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
127946141|NCT00996892|460424461|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
127946142|NCT00996892|460424442|FG000|Expansion Stage 2A|Disease Progression|0|||
127946143|NCT00996892|460424443|FG001|Expansion Stage 2A|Disease Progression|0|||
127946144|NCT00996892|460424444|FG002|Expansion Stage 2A|Disease Progression|0|||
127946145|NCT00996892|460424445|FG003|Expansion Stage 2A|Disease Progression|0|||
127946146|NCT00996892|460424446|FG004|Expansion Stage 2A|Disease Progression|0|||
127946147|NCT00996892|460424447|FG005|Expansion Stage 2A|Disease Progression|0|||
127946148|NCT00996892|460424448|FG006|Expansion Stage 2A|Disease Progression|0|||
127946149|NCT00996892|460424449|FG007|Expansion Stage 2A|Disease Progression|0|||
127946150|NCT00996892|460424450|FG008|Expansion Stage 2A|Disease Progression|0|||
127946151|NCT00996892|460424451|FG009|Expansion Stage 2A|Disease Progression|0|||
127946152|NCT00996892|460424452|FG010|Expansion Stage 2A|Disease Progression|0|||
127946153|NCT00996892|460424453|FG011|Expansion Stage 2A|Disease Progression|0|||
127946154|NCT00996892|460424454|FG012|Expansion Stage 2A|Disease Progression|0|||
127946155|NCT00996892|460424455|FG013|Expansion Stage 2A|Disease Progression|0|||
127946156|NCT00996892|460424456|FG014|Expansion Stage 2A|Disease Progression|0|||
127946157|NCT00996892|460424457|FG015|Expansion Stage 2A|Disease Progression|0|||
127946158|NCT00996892|460424458|FG016|Expansion Stage 2A|Disease Progression|0|||
127946159|NCT00996892|460424459|FG017|Expansion Stage 2A|Disease Progression|0|||
127946160|NCT00996892|460424460|FG018|Expansion Stage 2A|Disease Progression|0|||
127946161|NCT00996892|460424461|FG019|Expansion Stage 2A|Disease Progression|31|||
127946162|NCT01653912|460424462|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
127946163|NCT01653912|460424463|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
127946164|NCT01653912|460424464|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
127946165|NCT01653912|460424465|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
127946166|NCT01653912|460424466|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
127946167|NCT01653912|460424467|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
127946168|NCT01653912|460424462|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
127946169|NCT01653912|460424463|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
127946170|NCT01653912|460424464|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
127946171|NCT01653912|460424465|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
127946172|NCT01653912|460424466|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
127946173|NCT01653912|460424467|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
127946174|NCT01653912|460424462|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
127946175|NCT01653912|460424463|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
127946176|NCT01653912|460424464|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
127946177|NCT01653912|460424465|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
127946178|NCT01653912|460424466|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
127946179|NCT01653912|460424467|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
127946180|NCT01653912|460424462|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
127946181|NCT01653912|460424463|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
127946182|NCT01653912|460424464|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
127946183|NCT01653912|460424465|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
127946184|NCT01653912|460424466|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
127946185|NCT01653912|460424467|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
127946186|NCT01653912|460424462|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
127946187|NCT01653912|460424463|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
127946188|NCT01653912|460424464|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
127946189|NCT01653912|460424465|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
127946190|NCT01653912|460424466|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
127946191|NCT01653912|460424467|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
127946192|NCT01653912|460424462|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
127946193|NCT01653912|460424463|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
127946194|NCT01653912|460424464|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
127946195|NCT01653912|460424465|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
127946196|NCT01653912|460424466|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
127946197|NCT01653912|460424467|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
127946198|NCT01653912|460424462|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
127946199|NCT01653912|460424463|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
127946200|NCT01653912|460424464|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
127946201|NCT01653912|460424465|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
127946202|NCT01653912|460424466|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
127946203|NCT01653912|460424467|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
127946204|NCT01987479|460424468|FG000|Overall Study|Protocol Violation|1|||
127946205|NCT01987479|460424468|FG000|Overall Study|Physician Decision|2|||
127946206|NCT01987479|460424468|FG000|Overall Study|Participant/legal guardian decision|1|||
127946207|NCT01987479|460424468|FG000|Overall Study|Other|5|||
127946208|NCT01987479|460424468|FG000|Overall Study|Lost to Follow-up|1|||
127946209|NCT01987479|460424468|FG000|Overall Study|Adverse Event|7|||
127946210|NCT00602641|460426283|FG000|Overall Study|Never started protocol therapy|6|||
127946211|NCT00602641|460426284|FG001|Overall Study|Never started protocol therapy|2|||
127946212|NCT00602641|460426283|FG000|Overall Study|Still on treatment at time of analysis|8|||
127946213|NCT00602641|460426284|FG001|Overall Study|Still on treatment at time of analysis|15|||
127946214|NCT00602641|460426283|FG000|Overall Study|Adverse Event|62|||
127946215|NCT00602641|460426284|FG001|Overall Study|Adverse Event|53|||
127946216|NCT00602641|460426283|FG000|Overall Study|Disease progression|38|||
127946217|NCT00602641|460426284|FG001|Overall Study|Disease progression|55|||
127946218|NCT00602641|460426283|FG000|Overall Study|Death|6|||
127946219|NCT00602641|460426284|FG001|Overall Study|Death|5|||
127946220|NCT00602641|460426283|FG000|Overall Study|Withdrawal by Subject|15|||
127946221|NCT00602641|460426284|FG001|Overall Study|Withdrawal by Subject|12|||
127946222|NCT00602641|460426283|FG000|Overall Study|Alternative therapy|5|||
127946223|NCT00602641|460426284|FG001|Overall Study|Alternative therapy|2|||
127946224|NCT00602641|460426283|FG000|Overall Study|Other Complicating Disease|5|||
127946225|NCT00602641|460426284|FG001|Overall Study|Other Complicating Disease|2|||
127946226|NCT00602641|460426283|FG000|Overall Study|Physician Decision|5|||
127946227|NCT00602641|460426284|FG001|Overall Study|Physician Decision|4|||
127946228|NCT00602641|460426283|FG000|Overall Study|Administrative Closure|1|||
127946229|NCT00602641|460426284|FG001|Overall Study|Administrative Closure|1|||
127946230|NCT00602641|460426283|FG000|Overall Study|Other|3|||
127946231|NCT00602641|460426284|FG001|Overall Study|Other|1|||
127946232|NCT00587860|460426295|FG000|Overall Study|Lost to Follow-up|2|||
127946233|NCT00587860|460426296|FG001|Overall Study|Lost to Follow-up|2|||
127946234|NCT00587860|460426295|FG000|Overall Study|Withdrawal by Subject|3|||
127946235|NCT00587860|460426296|FG001|Overall Study|Withdrawal by Subject|3|||
127946236|NCT00261443|460426297|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
127946237|NCT00261443|460426298|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
127946238|NCT00261443|460426299|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
127946239|NCT00261443|460426297|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
127946240|NCT00261443|460426298|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
127946241|NCT00261443|460426299|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
127946242|NCT00261443|460426297|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
127946243|NCT00261443|460426298|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
127946244|NCT00261443|460426299|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
127946245|NCT00261443|460426297|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
127946246|NCT00261443|460426298|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
127946247|NCT00261443|460426299|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
127946248|NCT00261443|460426297|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
127946249|NCT00261443|460426298|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
127946250|NCT00261443|460426299|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
127946251|NCT00261443|460426297|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
127946252|NCT00261443|460426298|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
127946253|NCT00261443|460426299|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
127946254|NCT00261443|460426297|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
127946255|NCT00261443|460426298|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
127946256|NCT00261443|460426299|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
127946257|NCT00261443|460426297|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
127946258|NCT00261443|460426298|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
127946259|NCT00261443|460426299|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
127946260|NCT00261443|460426297|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
127946261|NCT00261443|460426298|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
127946262|NCT00261443|460426299|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
127946263|NCT00261443|460426297|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
127946264|NCT00261443|460426298|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
127946265|NCT00261443|460426299|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
127946266|NCT00261443|460426297|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
127946267|NCT00261443|460426298|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
127946268|NCT00261443|460426299|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
127946269|NCT00261443|460426297|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
127946270|NCT00261443|460426298|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
127946271|NCT00261443|460426299|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
127946272|NCT00261443|460426297|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
127946273|NCT00261443|460426298|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
127946274|NCT00261443|460426299|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
127946275|NCT00261443|460426297|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
127946276|NCT00261443|460426298|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
127946277|NCT00261443|460426299|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
127946278|NCT00261443|460426297|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
127946279|NCT00261443|460426298|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
127946280|NCT00261443|460426299|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
127946281|NCT00261443|460426297|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
127946282|NCT00261443|460426298|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
127946283|NCT00261443|460426299|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
127946284|NCT00261443|460426297|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
127946285|NCT00261443|460426298|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
127946286|NCT00261443|460426299|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
127946287|NCT00261443|460426297|FG000|3: Assessment of Relapse|Adverse Event|0|||
127946288|NCT00261443|460426298|FG001|3: Assessment of Relapse|Adverse Event|15|||
127946289|NCT00261443|460426299|FG002|3: Assessment of Relapse|Adverse Event|19|||
127946290|NCT00261443|460426297|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
127946291|NCT00261443|460426298|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
127946292|NCT00261443|460426299|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
127946293|NCT00261443|460426297|FG000|3: Assessment of Relapse|Death|0|||
127946294|NCT00261443|460426298|FG001|3: Assessment of Relapse|Death|0|||
127946295|NCT00261443|460426299|FG002|3: Assessment of Relapse|Death|1|||
127946296|NCT00261443|460426297|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
127946297|NCT00261443|460426298|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
127946298|NCT00261443|460426299|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
127946299|NCT00261443|460426297|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
127946300|NCT00261443|460426298|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
127946301|NCT00261443|460426299|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
127946302|NCT00261443|460426297|FG000|3: Assessment of Relapse|Pregnancy|0|||
127946303|NCT00261443|460426298|FG001|3: Assessment of Relapse|Pregnancy|2|||
127946304|NCT00261443|460426299|FG002|3: Assessment of Relapse|Pregnancy|1|||
127946305|NCT00261443|460426297|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
127946306|NCT00261443|460426298|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
127946307|NCT00261443|460426299|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
127946308|NCT00261443|460426297|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
127946309|NCT00261443|460426298|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
127946310|NCT00261443|460426299|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
127946311|NCT00261443|460426297|FG000|3: Assessment of Relapse|Other Reasons|0|||
127946312|NCT00261443|460426298|FG001|3: Assessment of Relapse|Other Reasons|4|||
127946313|NCT00261443|460426299|FG002|3: Assessment of Relapse|Other Reasons|3|||
127946314|NCT00261443|460426297|FG000|4: Extension Phase|Adverse Event|0|||
127946315|NCT00261443|460426298|FG001|4: Extension Phase|Adverse Event|1|||
127946316|NCT00261443|460426299|FG002|4: Extension Phase|Adverse Event|0|||
127946317|NCT00261443|460426297|FG000|4: Extension Phase|Withdrawal by Subject|0|||
127946318|NCT00261443|460426298|FG001|4: Extension Phase|Withdrawal by Subject|1|||
127946319|NCT00261443|460426299|FG002|4: Extension Phase|Withdrawal by Subject|2|||
127946320|NCT00261443|460426297|FG000|4: Extension Phase|Lost to Follow-up|0|||
127946321|NCT00261443|460426298|FG001|4: Extension Phase|Lost to Follow-up|1|||
127946322|NCT00261443|460426299|FG002|4: Extension Phase|Lost to Follow-up|0|||
127946323|NCT01286753|460426302|FG000|Overall Study|Adverse Event|7|||
127946324|NCT01286753|460426303|FG001|Overall Study|Adverse Event|6|||
127946325|NCT01286753|460426302|FG000|Overall Study|Progression|11|||
127946326|NCT01286753|460426303|FG001|Overall Study|Progression|13|||
127946327|NCT01286753|460426302|FG000|Overall Study|Refused Treatment|1|||
127946328|NCT01286753|460426303|FG001|Overall Study|Refused Treatment|0|||
127946329|NCT01286753|460426302|FG000|Overall Study|Withdrawal of Consent|0|||
127946330|NCT01286753|460426303|FG001|Overall Study|Withdrawal of Consent|2|||
127946331|NCT01286753|460426302|FG000|Overall Study|Discontinued to Join Extension Study|6|||
127946332|NCT01286753|460426303|FG001|Overall Study|Discontinued to Join Extension Study|4|||
127946333|NCT01286753|460426302|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
127946334|NCT01286753|460426303|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
127946335|NCT01371747|460426304|FG000|Overall Study|Adverse Event|4|||
127946336|NCT01371747|460426305|FG001|Overall Study|Adverse Event|2|||
127946337|NCT01371747|460426306|FG002|Overall Study|Adverse Event|7|||
127946338|NCT01371747|460426307|FG003|Overall Study|Adverse Event|2|||
127946339|NCT01371747|460426308|FG004|Overall Study|Adverse Event|2|||
127946340|NCT01371747|460426309|FG005|Overall Study|Adverse Event|2|||
127946341|NCT01371747|460426304|FG000|Overall Study|Death|1|||
127946342|NCT01371747|460426305|FG001|Overall Study|Death|0|||
127946343|NCT01371747|460426306|FG002|Overall Study|Death|4|||
127946344|NCT01371747|460426307|FG003|Overall Study|Death|1|||
127946345|NCT01371747|460426308|FG004|Overall Study|Death|2|||
127946346|NCT01371747|460426309|FG005|Overall Study|Death|0|||
127946347|NCT01371747|460426304|FG000|Overall Study|Abnormal Renal Function|0|||
127946348|NCT01371747|460426305|FG001|Overall Study|Abnormal Renal Function|2|||
127946349|NCT01371747|460426306|FG002|Overall Study|Abnormal Renal Function|0|||
127946350|NCT01371747|460426307|FG003|Overall Study|Abnormal Renal Function|1|||
127946351|NCT01371747|460426308|FG004|Overall Study|Abnormal Renal Function|0|||
127946352|NCT01371747|460426309|FG005|Overall Study|Abnormal Renal Function|1|||
127946353|NCT01371747|460426304|FG000|Overall Study|High Serum Potassium Results|1|||
127946354|NCT01371747|460426305|FG001|Overall Study|High Serum Potassium Results|1|||
127946355|NCT01371747|460426306|FG002|Overall Study|High Serum Potassium Results|1|||
127946356|NCT01371747|460426307|FG003|Overall Study|High Serum Potassium Results|2|||
127946357|NCT01371747|460426308|FG004|Overall Study|High Serum Potassium Results|0|||
127946358|NCT01371747|460426309|FG005|Overall Study|High Serum Potassium Results|2|||
127946359|NCT01371747|460426304|FG000|Overall Study|Low Serum Potassium Results|1|||
127946360|NCT01371747|460426305|FG001|Overall Study|Low Serum Potassium Results|1|||
127946361|NCT01371747|460426306|FG002|Overall Study|Low Serum Potassium Results|1|||
127946362|NCT01371747|460426307|FG003|Overall Study|Low Serum Potassium Results|1|||
127946363|NCT01371747|460426308|FG004|Overall Study|Low Serum Potassium Results|0|||
127946364|NCT01371747|460426309|FG005|Overall Study|Low Serum Potassium Results|3|||
127946365|NCT01371747|460426304|FG000|Overall Study|Protocol Violation|0|||
127946366|NCT01371747|460426305|FG001|Overall Study|Protocol Violation|0|||
127946367|NCT01371747|460426306|FG002|Overall Study|Protocol Violation|1|||
127946368|NCT01371747|460426307|FG003|Overall Study|Protocol Violation|0|||
127946369|NCT01371747|460426308|FG004|Overall Study|Protocol Violation|0|||
127946370|NCT01371747|460426309|FG005|Overall Study|Protocol Violation|0|||
127946371|NCT01371747|460426304|FG000|Overall Study|Non-Compliance|3|||
127946372|NCT01371747|460426305|FG001|Overall Study|Non-Compliance|4|||
127946373|NCT01371747|460426306|FG002|Overall Study|Non-Compliance|3|||
127946374|NCT01371747|460426307|FG003|Overall Study|Non-Compliance|0|||
127946375|NCT01371747|460426308|FG004|Overall Study|Non-Compliance|0|||
127946376|NCT01371747|460426309|FG005|Overall Study|Non-Compliance|1|||
127946377|NCT01371747|460426304|FG000|Overall Study|Physician Decision|0|||
127946378|NCT01371747|460426305|FG001|Overall Study|Physician Decision|0|||
127946379|NCT01371747|460426306|FG002|Overall Study|Physician Decision|0|||
127946380|NCT01371747|460426307|FG003|Overall Study|Physician Decision|0|||
127946381|NCT01371747|460426308|FG004|Overall Study|Physician Decision|1|||
127946382|NCT01371747|460426309|FG005|Overall Study|Physician Decision|0|||
127946383|NCT01371747|460426304|FG000|Overall Study|Withdrawal by Subject|6|||
127946384|NCT01371747|460426305|FG001|Overall Study|Withdrawal by Subject|12|||
127946385|NCT01371747|460426306|FG002|Overall Study|Withdrawal by Subject|5|||
127946386|NCT01371747|460426307|FG003|Overall Study|Withdrawal by Subject|2|||
127946387|NCT01371747|460426308|FG004|Overall Study|Withdrawal by Subject|2|||
127946388|NCT01371747|460426309|FG005|Overall Study|Withdrawal by Subject|4|||
127946389|NCT01371747|460426304|FG000|Overall Study|Other Reasons|2|||
127946390|NCT01371747|460426305|FG001|Overall Study|Other Reasons|1|||
127946391|NCT01371747|460426306|FG002|Overall Study|Other Reasons|2|||
127946392|NCT01371747|460426307|FG003|Overall Study|Other Reasons|0|||
127946393|NCT01371747|460426308|FG004|Overall Study|Other Reasons|0|||
127946394|NCT01371747|460426309|FG005|Overall Study|Other Reasons|1|||
127946395|NCT00580788|460426310|FG000|Overall Study|Adverse Event|0|||
127946396|NCT00580788|460426311|FG001|Overall Study|Adverse Event|0|||
127946397|NCT00580788|460426312|FG002|Overall Study|Adverse Event|0|||
127946398|NCT00580788|460426313|FG003|Overall Study|Adverse Event|1|||
127946399|NCT01443728|460426314|FG000|Overall Study|Lost to Follow-up|2|||
127946400|NCT01443728|460426315|FG001|Overall Study|Lost to Follow-up|0|||
127946401|NCT01443728|460426314|FG000|Overall Study|Withdrawal by Subject|1|||
127946402|NCT01443728|460426315|FG001|Overall Study|Withdrawal by Subject|1|||
127946403|NCT01443728|460426314|FG000|Overall Study|Adverse Event|0|||
127946404|NCT01443728|460426315|FG001|Overall Study|Adverse Event|2|||
127946405|NCT04971187|460426316|FG000|Overall Study|Screen failures|2|||
127946406|NCT02906358|460426317|FG000|Overall Study|Withdrawal by Subject|10|||
127946407|NCT02906358|460426318|FG001|Overall Study|Withdrawal by Subject|7|||
127946408|NCT02906358|460426317|FG000|Overall Study|Lost to Follow-up|12|||
127946409|NCT02906358|460426318|FG001|Overall Study|Lost to Follow-up|15|||
127946410|NCT01145508|460426320|FG000|Overall Study|Adverse Event|1|||
127946411|NCT01145508|460426321|FG001|Overall Study|Adverse Event|0|||
127946412|NCT01145508|460426320|FG000|Overall Study|Death|1|||
127946413|NCT01145508|460426321|FG001|Overall Study|Death|0|||
127946414|NCT01145508|460426320|FG000|Overall Study|Physician Decision|2|||
127946415|NCT01145508|460426321|FG001|Overall Study|Physician Decision|1|||
127946416|NCT01145508|460426320|FG000|Overall Study|Never started treatment|1|||
127946417|NCT01145508|460426321|FG001|Overall Study|Never started treatment|1|||
127946418|NCT02045147|460426322|FG000|Overall Study|Withdrawal by Subject|2|||
127946419|NCT02045147|460426323|FG001|Overall Study|Withdrawal by Subject|0|||
127946420|NCT02045147|460426324|FG002|Overall Study|Withdrawal by Subject|0|||
127946421|NCT02045147|460426325|FG003|Overall Study|Withdrawal by Subject|0|||
127946422|NCT02045147|460426326|FG004|Overall Study|Withdrawal by Subject|0|||
127946423|NCT02045147|460426327|FG005|Overall Study|Withdrawal by Subject|0|||
127946424|NCT02045147|460426328|FG006|Overall Study|Withdrawal by Subject|0|||
127946425|NCT02045147|460426329|FG007|Overall Study|Withdrawal by Subject|1|||
127946426|NCT02045147|460426322|FG000|Overall Study|Did not meet inclusion criteria at hospital discharge|9|||
127946427|NCT02045147|460426323|FG001|Overall Study|Did not meet inclusion criteria at hospital discharge|12|||
127946428|NCT02045147|460426324|FG002|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
127946429|NCT02045147|460426325|FG003|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
127946430|NCT02045147|460426326|FG004|Overall Study|Did not meet inclusion criteria at hospital discharge|3|||
127946431|NCT02045147|460426327|FG005|Overall Study|Did not meet inclusion criteria at hospital discharge|10|||
127946432|NCT02045147|460426328|FG006|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
127946433|NCT02045147|460426329|FG007|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
127946434|NCT04839692|460426330|FG000|Overall Study|Withdrawal by Subject|0|||
127946435|NCT04839692|460426331|FG001|Overall Study|Withdrawal by Subject|3|||
127946436|NCT04839692|460426330|FG000|Overall Study|Physician Decision|1|||
127946437|NCT04839692|460426331|FG001|Overall Study|Physician Decision|0|||
127946438|NCT03146962|460426332|FG000|Overall Study|Lost to Follow-up|1|||
127946439|NCT03146962|460426333|FG001|Overall Study|Lost to Follow-up|1|||
127946440|NCT03146962|460426334|FG002|Overall Study|Lost to Follow-up|0|||
127946441|NCT03146962|460426335|FG003|Overall Study|Lost to Follow-up|0|||
127946442|NCT03146962|460426336|FG004|Overall Study|Lost to Follow-up|0|||
127946443|NCT03146962|460426337|FG005|Overall Study|Lost to Follow-up|0|||
127946444|NCT03146962|460426338|FG006|Overall Study|Lost to Follow-up|0|||
127946445|NCT03146962|460426339|FG007|Overall Study|Lost to Follow-up|0|||
127946446|NCT03146962|460426340|FG008|Overall Study|Lost to Follow-up|0|||
127946447|NCT03146962|460426341|FG009|Overall Study|Lost to Follow-up|0|||
127946448|NCT03146962|460426332|FG000|Overall Study|Adverse Event|0|||
127946449|NCT03146962|460426333|FG001|Overall Study|Adverse Event|3|||
127946450|NCT03146962|460426334|FG002|Overall Study|Adverse Event|0|||
127946451|NCT03146962|460426335|FG003|Overall Study|Adverse Event|0|||
127946452|NCT03146962|460426336|FG004|Overall Study|Adverse Event|0|||
127946453|NCT03146962|460426337|FG005|Overall Study|Adverse Event|0|||
127946454|NCT03146962|460426338|FG006|Overall Study|Adverse Event|0|||
127946455|NCT03146962|460426339|FG007|Overall Study|Adverse Event|1|||
127946456|NCT03146962|460426340|FG008|Overall Study|Adverse Event|0|||
127946457|NCT03146962|460426341|FG009|Overall Study|Adverse Event|0|||
127946458|NCT03146962|460426332|FG000|Overall Study|Withdrawal by Subject|0|||
127946459|NCT03146962|460426333|FG001|Overall Study|Withdrawal by Subject|0|||
127946460|NCT03146962|460426334|FG002|Overall Study|Withdrawal by Subject|0|||
127946461|NCT03146962|460426335|FG003|Overall Study|Withdrawal by Subject|0|||
127946462|NCT03146962|460426336|FG004|Overall Study|Withdrawal by Subject|1|||
127946463|NCT03146962|460426337|FG005|Overall Study|Withdrawal by Subject|0|||
127946464|NCT03146962|460426338|FG006|Overall Study|Withdrawal by Subject|0|||
127946465|NCT03146962|460426339|FG007|Overall Study|Withdrawal by Subject|0|||
127946466|NCT03146962|460426340|FG008|Overall Study|Withdrawal by Subject|0|||
127946467|NCT03146962|460426341|FG009|Overall Study|Withdrawal by Subject|0|||
127946468|NCT03146962|460426332|FG000|Overall Study|Death|0|||
127946469|NCT03146962|460426333|FG001|Overall Study|Death|1|||
127946470|NCT03146962|460426334|FG002|Overall Study|Death|0|||
127946471|NCT03146962|460426335|FG003|Overall Study|Death|0|||
127946472|NCT03146962|460426336|FG004|Overall Study|Death|0|||
127946473|NCT03146962|460426337|FG005|Overall Study|Death|0|||
127946474|NCT03146962|460426338|FG006|Overall Study|Death|0|||
127946475|NCT03146962|460426339|FG007|Overall Study|Death|0|||
127946476|NCT03146962|460426340|FG008|Overall Study|Death|0|||
127946477|NCT03146962|460426341|FG009|Overall Study|Death|0|||
127946478|NCT03146962|460426332|FG000|Overall Study|COVID Precautions|1|||
127946479|NCT03146962|460426333|FG001|Overall Study|COVID Precautions|0|||
127946480|NCT03146962|460426334|FG002|Overall Study|COVID Precautions|0|||
127946481|NCT03146962|460426335|FG003|Overall Study|COVID Precautions|0|||
127946482|NCT03146962|460426336|FG004|Overall Study|COVID Precautions|0|||
127946483|NCT03146962|460426337|FG005|Overall Study|COVID Precautions|0|||
127946484|NCT03146962|460426338|FG006|Overall Study|COVID Precautions|0|||
127946485|NCT03146962|460426339|FG007|Overall Study|COVID Precautions|0|||
127946486|NCT03146962|460426340|FG008|Overall Study|COVID Precautions|0|||
127946487|NCT03146962|460426341|FG009|Overall Study|COVID Precautions|0|||
127946488|NCT03146962|460426332|FG000|Overall Study|Physician Decision|0|||
127946489|NCT03146962|460426333|FG001|Overall Study|Physician Decision|0|||
127946490|NCT03146962|460426334|FG002|Overall Study|Physician Decision|0|||
127946491|NCT03146962|460426335|FG003|Overall Study|Physician Decision|0|||
127946492|NCT03146962|460426336|FG004|Overall Study|Physician Decision|0|||
127946493|NCT03146962|460426337|FG005|Overall Study|Physician Decision|0|||
127946494|NCT03146962|460426338|FG006|Overall Study|Physician Decision|0|||
127946495|NCT03146962|460426339|FG007|Overall Study|Physician Decision|0|||
127946496|NCT03146962|460426340|FG008|Overall Study|Physician Decision|0|||
127946497|NCT03146962|460426341|FG009|Overall Study|Physician Decision|1|||
127946498|NCT03146962|460426332|FG000|Overall Study|Started New Treatment|0|||
127946499|NCT03146962|460426333|FG001|Overall Study|Started New Treatment|1|||
127946500|NCT03146962|460426334|FG002|Overall Study|Started New Treatment|0|||
127946501|NCT03146962|460426335|FG003|Overall Study|Started New Treatment|0|||
127946502|NCT03146962|460426336|FG004|Overall Study|Started New Treatment|0|||
127946503|NCT03146962|460426337|FG005|Overall Study|Started New Treatment|0|||
127946504|NCT03146962|460426338|FG006|Overall Study|Started New Treatment|0|||
127946505|NCT03146962|460426339|FG007|Overall Study|Started New Treatment|0|||
127946506|NCT03146962|460426340|FG008|Overall Study|Started New Treatment|0|||
127946507|NCT03146962|460426341|FG009|Overall Study|Started New Treatment|0|||
127946508|NCT00264550|460426344|FG000|Overall Study|Death|0|||
127946509|NCT00264550|460426345|FG001|Overall Study|Death|3|||
127946510|NCT00264550|460426346|FG002|Overall Study|Death|0|||
127946511|NCT00264550|460426347|FG003|Overall Study|Death|0|||
127946512|NCT00264550|460426344|FG000|Overall Study|Lost to Follow-up|3|||
127946513|NCT00264550|460426345|FG001|Overall Study|Lost to Follow-up|1|||
127946514|NCT00264550|460426346|FG002|Overall Study|Lost to Follow-up|1|||
127946515|NCT00264550|460426347|FG003|Overall Study|Lost to Follow-up|1|||
127946516|NCT00264550|460426344|FG000|Overall Study|Adverse Event|23|||
127946517|NCT00264550|460426345|FG001|Overall Study|Adverse Event|18|||
127946518|NCT00264550|460426346|FG002|Overall Study|Adverse Event|9|||
127946519|NCT00264550|460426347|FG003|Overall Study|Adverse Event|14|||
127946520|NCT00264550|460426344|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
127946521|NCT00264550|460426345|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
127946522|NCT00264550|460426346|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
127946523|NCT00264550|460426347|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
127946524|NCT00264550|460426344|FG000|Overall Study|Discontinued oral study agent|0|||
127946525|NCT00264550|460426345|FG001|Overall Study|Discontinued oral study agent|1|||
127946526|NCT00264550|460426346|FG002|Overall Study|Discontinued oral study agent|0|||
127946527|NCT00264550|460426347|FG003|Overall Study|Discontinued oral study agent|0|||
127946528|NCT00264550|460426344|FG000|Overall Study|Other|13|||
127946529|NCT00264550|460426345|FG001|Overall Study|Other|7|||
127946530|NCT00264550|460426346|FG002|Overall Study|Other|3|||
127946531|NCT00264550|460426347|FG003|Overall Study|Other|9|||
127946532|NCT04497948|460426348|FG000|Overall Study|Death|2|||
127946533|NCT02246114|460426351|FG000|Overall Study|miscarriage|1|||
127946534|NCT02246114|460426352|FG001|Overall Study|miscarriage|0|||
127946535|NCT00696787|460426357|FG000|Overall Study|Adverse Event|1|||
127946536|NCT00696787|460426358|FG001|Overall Study|Adverse Event|0|||
127946537|NCT00696787|460426359|FG002|Overall Study|Adverse Event|6|||
127946538|NCT00696787|460426357|FG000|Overall Study|Discontinuation by Sponsor|9|||
127946539|NCT00696787|460426358|FG001|Overall Study|Discontinuation by Sponsor|13|||
127946540|NCT00696787|460426359|FG002|Overall Study|Discontinuation by Sponsor|14|||
127946541|NCT00696787|460426357|FG000|Overall Study|Lack of Efficacy|0|||
127946542|NCT00696787|460426358|FG001|Overall Study|Lack of Efficacy|1|||
127946543|NCT00696787|460426359|FG002|Overall Study|Lack of Efficacy|0|||
127946544|NCT00696787|460426357|FG000|Overall Study|Lost to Follow-up|4|||
127946545|NCT00696787|460426358|FG001|Overall Study|Lost to Follow-up|0|||
127946546|NCT00696787|460426359|FG002|Overall Study|Lost to Follow-up|3|||
127946547|NCT00696787|460426357|FG000|Overall Study|Withdrawal by Subject|0|||
127946548|NCT00696787|460426358|FG001|Overall Study|Withdrawal by Subject|3|||
127946549|NCT00696787|460426359|FG002|Overall Study|Withdrawal by Subject|2|||
127946550|NCT00696787|460426357|FG000|Overall Study|Failed to return|1|||
127946551|NCT00696787|460426358|FG001|Overall Study|Failed to return|3|||
127946552|NCT00696787|460426359|FG002|Overall Study|Failed to return|1|||
127946553|NCT00129389|460426360|FG000|Overall Study|Adverse Event|19|||
127946554|NCT00129389|460426361|FG001|Overall Study|Adverse Event|87|||
127946555|NCT00129389|460426360|FG000|Overall Study|Death|0|||
127946556|NCT00129389|460426361|FG001|Overall Study|Death|1|||
127946557|NCT00129389|460426360|FG000|Overall Study|Lost to Follow-up|2|||
127946558|NCT00129389|460426361|FG001|Overall Study|Lost to Follow-up|1|||
127946559|NCT00129389|460426360|FG000|Overall Study|Physician Decision|0|||
127946560|NCT00129389|460426361|FG001|Overall Study|Physician Decision|4|||
127946561|NCT00129389|460426360|FG000|Overall Study|Protocol Violation|0|||
127946562|NCT00129389|460426361|FG001|Overall Study|Protocol Violation|6|||
127946563|NCT00129389|460426360|FG000|Overall Study|Withdrawal by Subject|9|||
127946564|NCT00129389|460426361|FG001|Overall Study|Withdrawal by Subject|23|||
127946565|NCT00129389|460426360|FG000|Overall Study|Relapse|1|||
127946566|NCT00129389|460426361|FG001|Overall Study|Relapse|0|||
127946567|NCT00129389|460426360|FG000|Overall Study|Not eligible|1|||
127946568|NCT00129389|460426361|FG001|Overall Study|Not eligible|2|||
127946569|NCT00129389|460426360|FG000|Overall Study|Crossed to the other arm|1|||
127946570|NCT00129389|460426361|FG001|Overall Study|Crossed to the other arm|16|||
127946571|NCT03760185|460426362|FG000|Overall Study|Lost to Follow-up|1|||
127946572|NCT03760185|460426363|FG001|Overall Study|Lost to Follow-up|1|||
127946573|NCT00425373|460426429|FG000|Overall Study|Adverse Event|2|||
127946574|NCT00425373|460426430|FG001|Overall Study|Adverse Event|2|||
127946575|NCT00425373|460426431|FG002|Overall Study|Adverse Event|0|||
127946576|NCT00425373|460426432|FG003|Overall Study|Adverse Event|1|||
127946577|NCT00425373|460426433|FG004|Overall Study|Adverse Event|4|||
127946578|NCT00425373|460426434|FG005|Overall Study|Adverse Event|6|||
127946579|NCT00425373|460426435|FG006|Overall Study|Adverse Event|2|||
127946580|NCT00425373|460426436|FG007|Overall Study|Adverse Event|3|||
127946581|NCT00425373|460426437|FG008|Overall Study|Adverse Event|8|||
127946582|NCT00425373|460426429|FG000|Overall Study|Lost to Follow-up|0|||
127946583|NCT00425373|460426430|FG001|Overall Study|Lost to Follow-up|1|||
127946584|NCT00425373|460426431|FG002|Overall Study|Lost to Follow-up|0|||
127946585|NCT00425373|460426432|FG003|Overall Study|Lost to Follow-up|0|||
127946586|NCT00425373|460426433|FG004|Overall Study|Lost to Follow-up|1|||
127946587|NCT00425373|460426434|FG005|Overall Study|Lost to Follow-up|0|||
127946588|NCT00425373|460426435|FG006|Overall Study|Lost to Follow-up|0|||
127946589|NCT00425373|460426436|FG007|Overall Study|Lost to Follow-up|0|||
127946590|NCT00425373|460426437|FG008|Overall Study|Lost to Follow-up|0|||
127946591|NCT00425373|460426429|FG000|Overall Study|Protocol Violation|1|||
127946592|NCT00425373|460426430|FG001|Overall Study|Protocol Violation|0|||
127946593|NCT00425373|460426431|FG002|Overall Study|Protocol Violation|1|||
127946594|NCT00425373|460426432|FG003|Overall Study|Protocol Violation|0|||
127946595|NCT00425373|460426433|FG004|Overall Study|Protocol Violation|0|||
127946596|NCT00425373|460426434|FG005|Overall Study|Protocol Violation|0|||
127946597|NCT00425373|460426435|FG006|Overall Study|Protocol Violation|0|||
127946598|NCT00425373|460426436|FG007|Overall Study|Protocol Violation|5|||
127946599|NCT00425373|460426437|FG008|Overall Study|Protocol Violation|3|||
127946600|NCT00425373|460426429|FG000|Overall Study|Withdrawal by Subject|2|||
127946601|NCT00425373|460426430|FG001|Overall Study|Withdrawal by Subject|0|||
127946602|NCT00425373|460426431|FG002|Overall Study|Withdrawal by Subject|2|||
127946603|NCT00425373|460426432|FG003|Overall Study|Withdrawal by Subject|1|||
127946604|NCT00425373|460426433|FG004|Overall Study|Withdrawal by Subject|4|||
127946605|NCT00425373|460426434|FG005|Overall Study|Withdrawal by Subject|0|||
127946606|NCT00425373|460426435|FG006|Overall Study|Withdrawal by Subject|2|||
127946607|NCT00425373|460426436|FG007|Overall Study|Withdrawal by Subject|2|||
127946608|NCT00425373|460426437|FG008|Overall Study|Withdrawal by Subject|2|||
127946609|NCT00425373|460426429|FG000|Overall Study|Lack of Efficacy|0|||
127946610|NCT00425373|460426430|FG001|Overall Study|Lack of Efficacy|0|||
127946611|NCT00425373|460426431|FG002|Overall Study|Lack of Efficacy|0|||
127946612|NCT00425373|460426432|FG003|Overall Study|Lack of Efficacy|0|||
127946613|NCT00425373|460426433|FG004|Overall Study|Lack of Efficacy|1|||
127946614|NCT00425373|460426434|FG005|Overall Study|Lack of Efficacy|3|||
127946615|NCT00425373|460426435|FG006|Overall Study|Lack of Efficacy|3|||
127946616|NCT00425373|460426436|FG007|Overall Study|Lack of Efficacy|0|||
127946617|NCT00425373|460426437|FG008|Overall Study|Lack of Efficacy|5|||
127946618|NCT02052011|460426438|FG000|Overall Study|Lost to Follow-up|3|||
127946619|NCT02052011|460426439|FG001|Overall Study|Lost to Follow-up|0|||
127946620|NCT02052011|460426438|FG000|Overall Study|Withdrawal by Subject|1|||
127946621|NCT02052011|460426439|FG001|Overall Study|Withdrawal by Subject|2|||
127946622|NCT00000620|460426440|FG000|Overall Study|Death|86|||
127946623|NCT00000620|460426441|FG001|Overall Study|Death|67|||
127946624|NCT00000620|460426442|FG002|Overall Study|Death|112|||
127946625|NCT00000620|460426443|FG003|Overall Study|Death|126|||
127946626|NCT00000620|460426444|FG004|Overall Study|Death|64|||
127946627|NCT00000620|460426445|FG005|Overall Study|Death|77|||
127946628|NCT00000620|460426446|FG006|Overall Study|Death|91|||
127946629|NCT00000620|460426447|FG007|Overall Study|Death|95|||
127946630|NCT00000620|460426440|FG000|Overall Study|Lost to Follow-up|14|||
127946631|NCT00000620|460426441|FG001|Overall Study|Lost to Follow-up|14|||
127946632|NCT00000620|460426442|FG002|Overall Study|Lost to Follow-up|14|||
127946633|NCT00000620|460426443|FG003|Overall Study|Lost to Follow-up|14|||
127946634|NCT00000620|460426444|FG004|Overall Study|Lost to Follow-up|15|||
127946635|NCT00000620|460426445|FG005|Overall Study|Lost to Follow-up|15|||
127946636|NCT00000620|460426446|FG006|Overall Study|Lost to Follow-up|13|||
127946637|NCT00000620|460426447|FG007|Overall Study|Lost to Follow-up|14|||
127946638|NCT00000620|460426440|FG000|Overall Study|Withdrawal by Subject|40|||
127946639|NCT00000620|460426441|FG001|Overall Study|Withdrawal by Subject|27|||
127946640|NCT00000620|460426442|FG002|Overall Study|Withdrawal by Subject|28|||
127946641|NCT00000620|460426443|FG003|Overall Study|Withdrawal by Subject|27|||
127946642|NCT00000620|460426444|FG004|Overall Study|Withdrawal by Subject|30|||
127946643|NCT00000620|460426445|FG005|Overall Study|Withdrawal by Subject|32|||
127946644|NCT00000620|460426446|FG006|Overall Study|Withdrawal by Subject|32|||
127946645|NCT00000620|460426447|FG007|Overall Study|Withdrawal by Subject|21|||
127946646|NCT00000620|460426440|FG000|Overall Study|missed closeout visit|22|||
127946647|NCT00000620|460426441|FG001|Overall Study|missed closeout visit|28|||
127946648|NCT00000620|460426442|FG002|Overall Study|missed closeout visit|16|||
127946649|NCT00000620|460426443|FG003|Overall Study|missed closeout visit|11|||
127946650|NCT00000620|460426444|FG004|Overall Study|missed closeout visit|26|||
127946651|NCT00000620|460426445|FG005|Overall Study|missed closeout visit|28|||
127946652|NCT00000620|460426446|FG006|Overall Study|missed closeout visit|13|||
127946653|NCT00000620|460426447|FG007|Overall Study|missed closeout visit|16|||
127946654|NCT02648932|460426448|FG000|Overall Study|No transplant|3|||
127946655|NCT02648932|460426449|FG001|Overall Study|No transplant|1|||
127946656|NCT02960490|460426450|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
127946657|NCT02960490|460426451|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
127946658|NCT02960490|460426452|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
127946659|NCT02960490|460426453|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
127946660|NCT02960490|460426454|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
127946661|NCT02960490|460426455|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
127946662|NCT02960490|460426456|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
127946663|NCT02960490|460426457|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
127946664|NCT02960490|460426458|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
127946665|NCT02960490|460426459|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
127946666|NCT02960490|460426450|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
127946667|NCT02960490|460426451|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
127946668|NCT02960490|460426452|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
127946669|NCT02960490|460426453|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
127946670|NCT02960490|460426454|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
127946671|NCT02960490|460426455|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
127946672|NCT02960490|460426456|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
127946673|NCT02960490|460426457|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
127946674|NCT02960490|460426458|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
127946675|NCT02960490|460426459|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
127946676|NCT02960490|460426450|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
127946677|NCT02960490|460426451|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
127946678|NCT02960490|460426452|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
127946679|NCT02960490|460426453|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
127946680|NCT02960490|460426454|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
127946681|NCT02960490|460426455|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
127946682|NCT02960490|460426456|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
127946683|NCT02960490|460426457|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
127946684|NCT02960490|460426458|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
127946685|NCT02960490|460426459|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
127946686|NCT02960490|460426450|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
127946687|NCT02960490|460426451|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
127946688|NCT02960490|460426452|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
127946689|NCT02960490|460426453|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
127946690|NCT02960490|460426454|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
127946691|NCT02960490|460426455|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
127946692|NCT02960490|460426456|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
127946693|NCT02960490|460426457|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
127946694|NCT02960490|460426458|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
127946695|NCT02960490|460426459|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
127946696|NCT02960490|460426450|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
127946697|NCT02960490|460426451|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
127946698|NCT02960490|460426452|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
127946699|NCT02960490|460426453|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
127946700|NCT02960490|460426454|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
127946701|NCT02960490|460426455|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
127946702|NCT02960490|460426456|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
127946703|NCT02960490|460426457|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
127946704|NCT02960490|460426458|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
127946705|NCT02960490|460426459|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
127946706|NCT02960490|460426450|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
127946707|NCT02960490|460426451|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
127946708|NCT02960490|460426452|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
127946709|NCT02960490|460426453|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
127946710|NCT02960490|460426454|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
127946711|NCT02960490|460426455|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
127946712|NCT02960490|460426456|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
127946713|NCT02960490|460426457|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
127946714|NCT02960490|460426458|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
127946715|NCT02960490|460426459|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
127946716|NCT02960490|460426450|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
127946717|NCT02960490|460426451|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
127946718|NCT02960490|460426452|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
127946719|NCT02960490|460426453|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
127946720|NCT02960490|460426454|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
127946721|NCT02960490|460426455|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
127946722|NCT02960490|460426456|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
127946723|NCT02960490|460426457|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
127946724|NCT02960490|460426458|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
127946725|NCT02960490|460426459|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
127946726|NCT02960490|460426450|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
127946727|NCT02960490|460426451|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
127946728|NCT02960490|460426452|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
127946729|NCT02960490|460426453|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
127946730|NCT02960490|460426454|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
127946731|NCT02960490|460426455|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
127946732|NCT02960490|460426456|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
127946733|NCT02960490|460426457|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
127946734|NCT02960490|460426458|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
127946735|NCT02960490|460426459|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
127946736|NCT02960490|460426450|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
127946737|NCT02960490|460426451|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
127946738|NCT02960490|460426452|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
127946739|NCT02960490|460426453|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
127946740|NCT02960490|460426454|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
127946741|NCT02960490|460426455|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
127946742|NCT02960490|460426456|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
127946743|NCT02960490|460426457|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
127946744|NCT02960490|460426458|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
127946745|NCT02960490|460426459|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
127946746|NCT02960490|460426450|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
127946747|NCT02960490|460426451|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
127946748|NCT02960490|460426452|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
127946749|NCT02960490|460426453|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
127946750|NCT02960490|460426454|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
127946751|NCT02960490|460426455|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
127946752|NCT02960490|460426456|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
127946753|NCT02960490|460426457|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
127946754|NCT02960490|460426458|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
127946755|NCT02960490|460426459|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
127946756|NCT02960490|460426450|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
127946757|NCT02960490|460426451|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
127946758|NCT02960490|460426452|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
127946759|NCT02960490|460426453|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
127946760|NCT02960490|460426454|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
127946761|NCT02960490|460426455|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
127946762|NCT02960490|460426456|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
127946763|NCT02960490|460426457|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
127946764|NCT02960490|460426458|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
127946765|NCT02960490|460426459|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
127946766|NCT02960490|460426450|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
127946767|NCT02960490|460426451|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
127946768|NCT02960490|460426452|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
127946769|NCT02960490|460426453|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
127946770|NCT02960490|460426454|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
127946771|NCT02960490|460426455|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
127946772|NCT02960490|460426456|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
127946773|NCT02960490|460426457|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
127946774|NCT02960490|460426458|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
127946775|NCT02960490|460426459|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
127946776|NCT01307111|460426462|FG000|IUD Insertion|Lost to Follow-up|2|||
127946777|NCT01307111|460426463|FG001|IUD Insertion|Lost to Follow-up|0|||
127946778|NCT01307111|460426462|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
127946779|NCT01307111|460426463|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
127946780|NCT02952586|460426476|FG000|Lead-In Phase (7 Days)|Death|0|||
127946781|NCT02952586|460426477|FG001|Lead-In Phase (7 Days)|Death|1|||
127946782|NCT02952586|460426476|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
127946783|NCT02952586|460426477|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
127946784|NCT02952586|460426476|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
127946785|NCT02952586|460426477|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
127946786|NCT02952586|460426476|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
127946787|NCT02952586|460426477|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
127946788|NCT02952586|460426476|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
127946789|NCT02952586|460426477|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
127946790|NCT02952586|460426476|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
127946791|NCT02952586|460426477|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
127946792|NCT02952586|460426476|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
127946793|NCT02952586|460426477|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
127946794|NCT02952586|460426476|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
127946795|NCT02952586|460426477|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
127946796|NCT02952586|460426476|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
127946797|NCT02952586|460426477|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
127946798|NCT02952586|460426476|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
127946799|NCT02952586|460426477|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
127946800|NCT02952586|460426476|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
127946801|NCT02952586|460426477|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
127946802|NCT02952586|460426476|FG000|CRT for Cisplatin (63 Days)|Death|3|||
127946803|NCT02952586|460426477|FG001|CRT for Cisplatin (63 Days)|Death|8|||
127946804|NCT02952586|460426476|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
127946805|NCT02952586|460426477|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
127946806|NCT02952586|460426476|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
127946807|NCT02952586|460426477|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
127946808|NCT02952586|460426476|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
127946809|NCT02952586|460426477|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
127946810|NCT02952586|460426476|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
127946811|NCT02952586|460426477|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
127946812|NCT02952586|460426476|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
127946813|NCT02952586|460426477|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
127946814|NCT02952586|460426476|FG000|CRT for Cisplatin (63 Days)|Other|1|||
127946815|NCT02952586|460426477|FG001|CRT for Cisplatin (63 Days)|Other|1|||
127946816|NCT02952586|460426476|FG000|CRT for IMRT (63 Days)|Death|5|||
127946817|NCT02952586|460426477|FG001|CRT for IMRT (63 Days)|Death|8|||
127946818|NCT02952586|460426476|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
127946819|NCT02952586|460426477|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
127946820|NCT02952586|460426476|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
127946821|NCT02952586|460426477|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
127946822|NCT02952586|460426476|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
127946823|NCT02952586|460426477|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
127946824|NCT02952586|460426476|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
127946825|NCT02952586|460426477|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
127946826|NCT02952586|460426476|FG000|CRT for IMRT (63 Days)|Other|1|||
127946827|NCT02952586|460426477|FG001|CRT for IMRT (63 Days)|Other|0|||
127946828|NCT02952586|460426476|FG000|Maintenance Phase (12 Months)|Death|17|||
127946829|NCT02952586|460426477|FG001|Maintenance Phase (12 Months)|Death|11|||
127946830|NCT02952586|460426476|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
127946831|NCT02952586|460426477|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
127946832|NCT02952586|460426476|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
127946833|NCT02952586|460426477|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
127946834|NCT02952586|460426476|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
127946835|NCT02952586|460426477|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
127946836|NCT02952586|460426476|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
127946837|NCT02952586|460426477|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
127946838|NCT02952586|460426476|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
127946839|NCT02952586|460426477|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
127946840|NCT02952586|460426476|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
127946841|NCT02952586|460426477|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
127946842|NCT02952586|460426476|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
127946843|NCT02952586|460426477|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
127946844|NCT02952586|460426476|FG000|Maintenance Phase (12 Months)|Other|2|||
127946845|NCT02952586|460426477|FG001|Maintenance Phase (12 Months)|Other|1|||
127946846|NCT02952586|460426476|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
127946847|NCT02952586|460426477|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
127946848|NCT02952586|460426476|FG000|Follow-Up Phase (90 Days)|Death|12|||
127946849|NCT02952586|460426477|FG001|Follow-Up Phase (90 Days)|Death|10|||
127946850|NCT02952586|460426476|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
127946851|NCT02952586|460426477|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
127946852|NCT02952586|460426476|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
127946853|NCT02952586|460426477|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
127946854|NCT02952586|460426476|FG000|Follow-Up Phase (90 Days)|Other|7|||
127946855|NCT02952586|460426477|FG001|Follow-Up Phase (90 Days)|Other|5|||
127946856|NCT02952586|460426476|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
127946857|NCT02952586|460426477|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
127946858|NCT02952586|460426476|FG000|LT Follow-up (up to 45 Months)|Death|51|||
127946859|NCT02952586|460426477|FG001|LT Follow-up (up to 45 Months)|Death|31|||
127946860|NCT02952586|460426476|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
127946861|NCT02952586|460426477|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
127946862|NCT02952586|460426476|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
127946863|NCT02952586|460426477|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
127946864|NCT02952586|460426476|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
127946865|NCT02952586|460426477|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
127946866|NCT01661062|460426478|FG000|Overall Study|Completed Treatment Off Study|3|||
127946867|NCT01661062|460426478|FG000|Overall Study|Withdrawal by Subject|2|||
127946868|NCT04411914|460426479|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
127946869|NCT04411914|460426480|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
127946870|NCT00789737|460426496|FG000|Overall Study|Withdrawal by Subject|13|||
127946871|NCT00789737|460426497|FG001|Overall Study|Withdrawal by Subject|22|||
127946872|NCT00789737|460426496|FG000|Overall Study|Lost to Follow-up|10|||
127946873|NCT00789737|460426497|FG001|Overall Study|Lost to Follow-up|14|||
127946874|NCT00789737|460426496|FG000|Overall Study|Adverse Event|8|||
127946875|NCT00789737|460426497|FG001|Overall Study|Adverse Event|8|||
127946876|NCT00789737|460426496|FG000|Overall Study|Protocol Violation|3|||
127946877|NCT00789737|460426497|FG001|Overall Study|Protocol Violation|0|||
127946878|NCT00789737|460426496|FG000|Overall Study|Lack of Efficacy|3|||
127946879|NCT00789737|460426497|FG001|Overall Study|Lack of Efficacy|0|||
127946880|NCT00789737|460426496|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
127946881|NCT00789737|460426497|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
127946882|NCT00789737|460426496|FG000|Overall Study|Other|11|||
127946883|NCT00789737|460426497|FG001|Overall Study|Other|7|||
127946884|NCT03489109|460426500|FG000|Overall Study|Lost to Follow-up|1|||
127946885|NCT03489109|460426501|FG001|Overall Study|Lost to Follow-up|2|||
127946886|NCT00384930|460426502|FG000|Overall Study|Adverse Event|5|||
127946887|NCT00384930|460426503|FG001|Overall Study|Adverse Event|4|||
127946888|NCT00384930|460426504|FG002|Overall Study|Adverse Event|12|||
127946889|NCT00384930|460426505|FG003|Overall Study|Adverse Event|11|||
127946890|NCT00384930|460426506|FG004|Overall Study|Adverse Event|14|||
127946891|NCT00384930|460426502|FG000|Overall Study|Entry Criteria Not Met|2|||
127946892|NCT00384930|460426503|FG001|Overall Study|Entry Criteria Not Met|6|||
127946893|NCT00384930|460426504|FG002|Overall Study|Entry Criteria Not Met|7|||
127946894|NCT00384930|460426505|FG003|Overall Study|Entry Criteria Not Met|8|||
127946895|NCT00384930|460426506|FG004|Overall Study|Entry Criteria Not Met|4|||
127946896|NCT00384930|460426502|FG000|Overall Study|Lack of Efficacy|1|||
127946897|NCT00384930|460426503|FG001|Overall Study|Lack of Efficacy|1|||
127946898|NCT00384930|460426504|FG002|Overall Study|Lack of Efficacy|2|||
127946899|NCT00384930|460426505|FG003|Overall Study|Lack of Efficacy|1|||
127946900|NCT00384930|460426506|FG004|Overall Study|Lack of Efficacy|2|||
127946901|NCT00384930|460426502|FG000|Overall Study|Lost to Follow-up|5|||
127946902|NCT00384930|460426503|FG001|Overall Study|Lost to Follow-up|3|||
127946903|NCT00384930|460426504|FG002|Overall Study|Lost to Follow-up|0|||
127946904|NCT00384930|460426505|FG003|Overall Study|Lost to Follow-up|4|||
127946905|NCT00384930|460426506|FG004|Overall Study|Lost to Follow-up|6|||
127946906|NCT00384930|460426502|FG000|Overall Study|Physician Decision|0|||
127946907|NCT00384930|460426503|FG001|Overall Study|Physician Decision|1|||
127946908|NCT00384930|460426504|FG002|Overall Study|Physician Decision|1|||
127946909|NCT00384930|460426505|FG003|Overall Study|Physician Decision|0|||
127946910|NCT00384930|460426506|FG004|Overall Study|Physician Decision|1|||
127946911|NCT00384930|460426502|FG000|Overall Study|Protocol Violation|1|||
127946912|NCT00384930|460426503|FG001|Overall Study|Protocol Violation|0|||
127946913|NCT00384930|460426504|FG002|Overall Study|Protocol Violation|1|||
127946914|NCT00384930|460426505|FG003|Overall Study|Protocol Violation|6|||
127946915|NCT00384930|460426506|FG004|Overall Study|Protocol Violation|4|||
127946916|NCT00384930|460426502|FG000|Overall Study|Sponsor Decision|3|||
127946917|NCT00384930|460426503|FG001|Overall Study|Sponsor Decision|4|||
127946918|NCT00384930|460426504|FG002|Overall Study|Sponsor Decision|0|||
127946919|NCT00384930|460426505|FG003|Overall Study|Sponsor Decision|5|||
127946920|NCT00384930|460426506|FG004|Overall Study|Sponsor Decision|0|||
127946921|NCT00384930|460426502|FG000|Overall Study|Withdrawal by Subject|9|||
127946922|NCT00384930|460426503|FG001|Overall Study|Withdrawal by Subject|7|||
127946923|NCT00384930|460426504|FG002|Overall Study|Withdrawal by Subject|7|||
127946924|NCT00384930|460426505|FG003|Overall Study|Withdrawal by Subject|6|||
127946925|NCT00384930|460426506|FG004|Overall Study|Withdrawal by Subject|16|||
127946926|NCT00384930|460426502|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
127946927|NCT00384930|460426503|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
127946928|NCT00384930|460426504|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
127946929|NCT00384930|460426505|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
127946930|NCT00384930|460426506|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
127946931|NCT02181790|460426507|FG000|Overall Study|study terminated|2|||
127946932|NCT02181790|460426508|FG001|Overall Study|study terminated|0|||
127946933|NCT02613182|460426509|FG000|Overall Study|Death|6|||
127946934|NCT02613182|460426509|FG000|Overall Study|Physician Decision|1|||
127946935|NCT02613182|460426509|FG000|Overall Study|Study Terminated by Sponsor|21|||
127946936|NCT02613182|460426509|FG000|Overall Study|Withdrawal by Subject|6|||
127946937|NCT03968978|460426510|FG000|Overall Study|Adverse Event|1|||
127946938|NCT03968978|460426511|FG001|Overall Study|Adverse Event|0|||
127946939|NCT00908310|460426512|FG000|Overall Study|Death|37|||
127946940|NCT00908310|460426512|FG000|Overall Study|Withdrawal by Subject|7|||
127946941|NCT00908310|460426512|FG000|Overall Study|Lost to Follow-up|7|||
127946942|NCT00908310|460426512|FG000|Overall Study|Screening failure|5|||
127946943|NCT00908310|460426512|FG000|Overall Study|Other reasons|4|||
127946944|NCT01200069|460428752|FG000|Overall Study|Withdrawal by Subject|0|||
127946945|NCT01200069|460428753|FG001|Overall Study|Withdrawal by Subject|1|||
127946946|NCT03408639|460428754|FG000|Overall Study|Death|5|||
127946947|NCT03408639|460428755|FG001|Overall Study|Death|5|||
127946948|NCT03408639|460428754|FG000|Overall Study|Lost to Follow-up|1|||
127946949|NCT03408639|460428755|FG001|Overall Study|Lost to Follow-up|4|||
127946950|NCT03408639|460428754|FG000|Overall Study|Withdrawal by Subject|2|||
127946951|NCT03408639|460428755|FG001|Overall Study|Withdrawal by Subject|7|||
127946952|NCT03408639|460428754|FG000|Overall Study|Physician Decision|3|||
127946953|NCT03408639|460428755|FG001|Overall Study|Physician Decision|6|||
127946954|NCT04998851|460428756|FG000|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
127946955|NCT04998851|460428757|FG001|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
127946956|NCT04998851|460428756|FG000|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
127946957|NCT04998851|460428757|FG001|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
127946958|NCT00070499|460428758|FG000|Overall Study|Adverse Event|6|||
127946959|NCT00070499|460428759|FG001|Overall Study|Adverse Event|6|||
127946960|NCT00070499|460428760|FG002|Overall Study|Adverse Event|19|||
127946961|NCT00070499|460428761|FG003|Overall Study|Adverse Event|15|||
127946962|NCT00070499|460428758|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
127946963|NCT00070499|460428759|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
127946964|NCT00070499|460428760|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
127946965|NCT00070499|460428761|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
127946966|NCT00070499|460428758|FG000|Overall Study|Progression/relapse|4|||
127946967|NCT00070499|460428759|FG001|Overall Study|Progression/relapse|2|||
127946968|NCT00070499|460428760|FG002|Overall Study|Progression/relapse|1|||
127946969|NCT00070499|460428761|FG003|Overall Study|Progression/relapse|4|||
127946970|NCT00070499|460428758|FG000|Overall Study|Death|1|||
127946971|NCT00070499|460428759|FG001|Overall Study|Death|1|||
127946972|NCT00070499|460428760|FG002|Overall Study|Death|1|||
127946973|NCT00070499|460428761|FG003|Overall Study|Death|2|||
127946974|NCT00070499|460428758|FG000|Overall Study|Other - not protocol specified|7|||
127946975|NCT00070499|460428759|FG001|Overall Study|Other - not protocol specified|3|||
127946976|NCT00070499|460428760|FG002|Overall Study|Other - not protocol specified|12|||
127946977|NCT00070499|460428761|FG003|Overall Study|Other - not protocol specified|20|||
127946978|NCT00070499|460428758|FG000|Overall Study|Still on protocol treatment|10|||
127946979|NCT00070499|460428759|FG001|Overall Study|Still on protocol treatment|4|||
127946980|NCT00070499|460428760|FG002|Overall Study|Still on protocol treatment|79|||
127946981|NCT00070499|460428761|FG003|Overall Study|Still on protocol treatment|57|||
127946982|NCT00070499|460428758|FG000|Overall Study|Did not start treatment|1|||
127946983|NCT00070499|460428759|FG001|Overall Study|Did not start treatment|0|||
127946984|NCT00070499|460428760|FG002|Overall Study|Did not start treatment|0|||
127946985|NCT00070499|460428761|FG003|Overall Study|Did not start treatment|2|||
127946986|NCT00070499|460428758|FG000|Overall Study|Not eligible|2|||
127946987|NCT00070499|460428759|FG001|Overall Study|Not eligible|5|||
127946988|NCT00070499|460428760|FG002|Overall Study|Not eligible|3|||
127946989|NCT00070499|460428761|FG003|Overall Study|Not eligible|2|||
127946990|NCT02883049|460428762|FG000|Induction|Adverse Event|52|||
127946991|NCT02883049|460428763|FG001|Induction|Adverse Event|2|||
127946992|NCT02883049|460428764|FG002|Induction|Adverse Event|0|||
127946993|NCT02883049|460428765|FG003|Induction|Adverse Event|0|||
127946994|NCT02883049|460428766|FG004|Induction|Adverse Event|0|||
127946995|NCT02883049|460428767|FG005|Induction|Adverse Event|0|||
127946996|NCT02883049|460428768|FG006|Induction|Adverse Event|0|||
127946997|NCT02883049|460428769|FG007|Induction|Adverse Event|0|||
127946998|NCT02883049|460428770|FG008|Induction|Adverse Event|0|||
127946999|NCT02883049|460428771|FG009|Induction|Adverse Event|0|||
127947000|NCT02883049|460428772|FG010|Induction|Adverse Event|0|||
127947001|NCT02883049|460428773|FG011|Induction|Adverse Event|0|||
127947002|NCT02883049|460428774|FG012|Induction|Adverse Event|0|||
127947003|NCT02883049|460428775|FG013|Induction|Adverse Event|0|||
127947004|NCT02883049|460428776|FG014|Induction|Adverse Event|0|||
127947005|NCT02883049|460428777|FG015|Induction|Adverse Event|0|||
127947006|NCT02883049|460428762|FG000|Induction|Death|76|||
127947007|NCT02883049|460428763|FG001|Induction|Death|8|||
127947008|NCT02883049|460428764|FG002|Induction|Death|0|||
127947009|NCT02883049|460428765|FG003|Induction|Death|0|||
127947010|NCT02883049|460428766|FG004|Induction|Death|0|||
127947011|NCT02883049|460428767|FG005|Induction|Death|0|||
127947012|NCT02883049|460428768|FG006|Induction|Death|0|||
127947013|NCT02883049|460428769|FG007|Induction|Death|0|||
127947014|NCT02883049|460428770|FG008|Induction|Death|0|||
127947015|NCT02883049|460428771|FG009|Induction|Death|0|||
127947016|NCT02883049|460428772|FG010|Induction|Death|0|||
127947017|NCT02883049|460428773|FG011|Induction|Death|0|||
127947018|NCT02883049|460428774|FG012|Induction|Death|0|||
127947019|NCT02883049|460428775|FG013|Induction|Death|0|||
127947020|NCT02883049|460428776|FG014|Induction|Death|0|||
127947021|NCT02883049|460428777|FG015|Induction|Death|0|||
127947022|NCT02883049|460428762|FG000|Induction|Lost to Follow-up|2|||
127947023|NCT02883049|460428763|FG001|Induction|Lost to Follow-up|0|||
127947024|NCT02883049|460428764|FG002|Induction|Lost to Follow-up|0|||
127947025|NCT02883049|460428765|FG003|Induction|Lost to Follow-up|0|||
127947026|NCT02883049|460428766|FG004|Induction|Lost to Follow-up|0|||
127947027|NCT02883049|460428767|FG005|Induction|Lost to Follow-up|0|||
127947028|NCT02883049|460428768|FG006|Induction|Lost to Follow-up|0|||
127947029|NCT02883049|460428769|FG007|Induction|Lost to Follow-up|0|||
127947030|NCT02883049|460428770|FG008|Induction|Lost to Follow-up|0|||
127947031|NCT02883049|460428771|FG009|Induction|Lost to Follow-up|0|||
127947032|NCT02883049|460428772|FG010|Induction|Lost to Follow-up|0|||
127947033|NCT02883049|460428773|FG011|Induction|Lost to Follow-up|0|||
127947034|NCT02883049|460428774|FG012|Induction|Lost to Follow-up|0|||
127947035|NCT02883049|460428775|FG013|Induction|Lost to Follow-up|0|||
127947036|NCT02883049|460428776|FG014|Induction|Lost to Follow-up|0|||
127947037|NCT02883049|460428777|FG015|Induction|Lost to Follow-up|0|||
127947038|NCT02883049|460428762|FG000|Induction|Physician Decision|1407|||
127947039|NCT02883049|460428763|FG001|Induction|Physician Decision|8|||
127947040|NCT02883049|460428764|FG002|Induction|Physician Decision|0|||
127947041|NCT02883049|460428765|FG003|Induction|Physician Decision|0|||
127947042|NCT02883049|460428766|FG004|Induction|Physician Decision|0|||
127947043|NCT02883049|460428767|FG005|Induction|Physician Decision|0|||
127947044|NCT02883049|460428768|FG006|Induction|Physician Decision|0|||
127947045|NCT02883049|460428769|FG007|Induction|Physician Decision|0|||
127947046|NCT02883049|460428770|FG008|Induction|Physician Decision|0|||
127947047|NCT02883049|460428771|FG009|Induction|Physician Decision|0|||
127947048|NCT02883049|460428772|FG010|Induction|Physician Decision|0|||
127947049|NCT02883049|460428773|FG011|Induction|Physician Decision|0|||
127947050|NCT02883049|460428774|FG012|Induction|Physician Decision|0|||
127947051|NCT02883049|460428775|FG013|Induction|Physician Decision|0|||
127947052|NCT02883049|460428776|FG014|Induction|Physician Decision|0|||
127947053|NCT02883049|460428777|FG015|Induction|Physician Decision|0|||
127947054|NCT02883049|460428762|FG000|Induction|Protocol Violation|6|||
127947055|NCT02883049|460428763|FG001|Induction|Protocol Violation|0|||
127947056|NCT02883049|460428764|FG002|Induction|Protocol Violation|0|||
127947057|NCT02883049|460428765|FG003|Induction|Protocol Violation|0|||
127947058|NCT02883049|460428766|FG004|Induction|Protocol Violation|0|||
127947059|NCT02883049|460428767|FG005|Induction|Protocol Violation|0|||
127947060|NCT02883049|460428768|FG006|Induction|Protocol Violation|0|||
127947061|NCT02883049|460428769|FG007|Induction|Protocol Violation|0|||
127947062|NCT02883049|460428770|FG008|Induction|Protocol Violation|0|||
127947063|NCT02883049|460428771|FG009|Induction|Protocol Violation|0|||
127947064|NCT02883049|460428772|FG010|Induction|Protocol Violation|0|||
127947065|NCT02883049|460428773|FG011|Induction|Protocol Violation|0|||
127947066|NCT02883049|460428774|FG012|Induction|Protocol Violation|0|||
127947067|NCT02883049|460428775|FG013|Induction|Protocol Violation|0|||
127947068|NCT02883049|460428776|FG014|Induction|Protocol Violation|0|||
127947069|NCT02883049|460428777|FG015|Induction|Protocol Violation|0|||
127947070|NCT02883049|460428762|FG000|Induction|Withdrawal by Subject|6|||
127947071|NCT02883049|460428763|FG001|Induction|Withdrawal by Subject|0|||
127947072|NCT02883049|460428764|FG002|Induction|Withdrawal by Subject|0|||
127947073|NCT02883049|460428765|FG003|Induction|Withdrawal by Subject|0|||
127947074|NCT02883049|460428766|FG004|Induction|Withdrawal by Subject|0|||
127947075|NCT02883049|460428767|FG005|Induction|Withdrawal by Subject|0|||
127947076|NCT02883049|460428768|FG006|Induction|Withdrawal by Subject|0|||
127947077|NCT02883049|460428769|FG007|Induction|Withdrawal by Subject|0|||
127947078|NCT02883049|460428770|FG008|Induction|Withdrawal by Subject|0|||
127947079|NCT02883049|460428771|FG009|Induction|Withdrawal by Subject|0|||
127947080|NCT02883049|460428772|FG010|Induction|Withdrawal by Subject|0|||
127947081|NCT02883049|460428773|FG011|Induction|Withdrawal by Subject|0|||
127947082|NCT02883049|460428774|FG012|Induction|Withdrawal by Subject|0|||
127947083|NCT02883049|460428775|FG013|Induction|Withdrawal by Subject|0|||
127947084|NCT02883049|460428776|FG014|Induction|Withdrawal by Subject|0|||
127947085|NCT02883049|460428777|FG015|Induction|Withdrawal by Subject|0|||
127947086|NCT02883049|460428762|FG000|Induction|Ineligible|35|||
127947087|NCT02883049|460428763|FG001|Induction|Ineligible|1|||
127947088|NCT02883049|460428764|FG002|Induction|Ineligible|0|||
127947089|NCT02883049|460428765|FG003|Induction|Ineligible|0|||
127947090|NCT02883049|460428766|FG004|Induction|Ineligible|0|||
127947091|NCT02883049|460428767|FG005|Induction|Ineligible|0|||
127947092|NCT02883049|460428768|FG006|Induction|Ineligible|0|||
127947093|NCT02883049|460428769|FG007|Induction|Ineligible|0|||
127947094|NCT02883049|460428770|FG008|Induction|Ineligible|0|||
127947095|NCT02883049|460428771|FG009|Induction|Ineligible|0|||
127947096|NCT02883049|460428772|FG010|Induction|Ineligible|0|||
127947097|NCT02883049|460428773|FG011|Induction|Ineligible|0|||
127947098|NCT02883049|460428774|FG012|Induction|Ineligible|0|||
127947099|NCT02883049|460428775|FG013|Induction|Ineligible|0|||
127947100|NCT02883049|460428776|FG014|Induction|Ineligible|0|||
127947101|NCT02883049|460428777|FG015|Induction|Ineligible|0|||
127947102|NCT02883049|460428762|FG000|Induction|Refusal of further protocol therapy|466|||
127947103|NCT02883049|460428763|FG001|Induction|Refusal of further protocol therapy|2|||
127947104|NCT02883049|460428764|FG002|Induction|Refusal of further protocol therapy|0|||
127947105|NCT02883049|460428765|FG003|Induction|Refusal of further protocol therapy|0|||
127947106|NCT02883049|460428766|FG004|Induction|Refusal of further protocol therapy|0|||
127947107|NCT02883049|460428767|FG005|Induction|Refusal of further protocol therapy|0|||
127947108|NCT02883049|460428768|FG006|Induction|Refusal of further protocol therapy|0|||
127947109|NCT02883049|460428769|FG007|Induction|Refusal of further protocol therapy|0|||
127947110|NCT02883049|460428770|FG008|Induction|Refusal of further protocol therapy|0|||
127947111|NCT02883049|460428771|FG009|Induction|Refusal of further protocol therapy|0|||
127947112|NCT02883049|460428772|FG010|Induction|Refusal of further protocol therapy|0|||
127947113|NCT02883049|460428773|FG011|Induction|Refusal of further protocol therapy|0|||
127947114|NCT02883049|460428774|FG012|Induction|Refusal of further protocol therapy|0|||
127947115|NCT02883049|460428775|FG013|Induction|Refusal of further protocol therapy|0|||
127947116|NCT02883049|460428776|FG014|Induction|Refusal of further protocol therapy|0|||
127947117|NCT02883049|460428777|FG015|Induction|Refusal of further protocol therapy|0|||
127947118|NCT02883049|460428762|FG000|Induction|Identified as Ph+ patients|279|||
127947119|NCT02883049|460428763|FG001|Induction|Identified as Ph+ patients|1|||
127947120|NCT02883049|460428764|FG002|Induction|Identified as Ph+ patients|0|||
127947121|NCT02883049|460428765|FG003|Induction|Identified as Ph+ patients|0|||
127947122|NCT02883049|460428766|FG004|Induction|Identified as Ph+ patients|0|||
127947123|NCT02883049|460428767|FG005|Induction|Identified as Ph+ patients|0|||
127947124|NCT02883049|460428768|FG006|Induction|Identified as Ph+ patients|0|||
127947125|NCT02883049|460428769|FG007|Induction|Identified as Ph+ patients|0|||
127947126|NCT02883049|460428770|FG008|Induction|Identified as Ph+ patients|0|||
127947127|NCT02883049|460428771|FG009|Induction|Identified as Ph+ patients|0|||
127947128|NCT02883049|460428772|FG010|Induction|Identified as Ph+ patients|0|||
127947129|NCT02883049|460428773|FG011|Induction|Identified as Ph+ patients|0|||
127947130|NCT02883049|460428774|FG012|Induction|Identified as Ph+ patients|0|||
127947131|NCT02883049|460428775|FG013|Induction|Identified as Ph+ patients|0|||
127947132|NCT02883049|460428776|FG014|Induction|Identified as Ph+ patients|0|||
127947133|NCT02883049|460428777|FG015|Induction|Identified as Ph+ patients|0|||
127947134|NCT02883049|460428762|FG000|Induction|M3 Marrow at Day29|8|||
127947135|NCT02883049|460428763|FG001|Induction|M3 Marrow at Day29|1|||
127947136|NCT02883049|460428764|FG002|Induction|M3 Marrow at Day29|0|||
127947137|NCT02883049|460428765|FG003|Induction|M3 Marrow at Day29|0|||
127947138|NCT02883049|460428766|FG004|Induction|M3 Marrow at Day29|0|||
127947139|NCT02883049|460428767|FG005|Induction|M3 Marrow at Day29|0|||
127947140|NCT02883049|460428768|FG006|Induction|M3 Marrow at Day29|0|||
127947141|NCT02883049|460428769|FG007|Induction|M3 Marrow at Day29|0|||
127947142|NCT02883049|460428770|FG008|Induction|M3 Marrow at Day29|0|||
127947143|NCT02883049|460428771|FG009|Induction|M3 Marrow at Day29|0|||
127947144|NCT02883049|460428772|FG010|Induction|M3 Marrow at Day29|0|||
127947145|NCT02883049|460428773|FG011|Induction|M3 Marrow at Day29|0|||
127947146|NCT02883049|460428774|FG012|Induction|M3 Marrow at Day29|0|||
127947147|NCT02883049|460428775|FG013|Induction|M3 Marrow at Day29|0|||
127947148|NCT02883049|460428776|FG014|Induction|M3 Marrow at Day29|0|||
127947149|NCT02883049|460428777|FG015|Induction|M3 Marrow at Day29|0|||
127947150|NCT02883049|460428762|FG000|Induction|Inevaluable|33|||
127947151|NCT02883049|460428763|FG001|Induction|Inevaluable|1|||
127947152|NCT02883049|460428764|FG002|Induction|Inevaluable|0|||
127947153|NCT02883049|460428765|FG003|Induction|Inevaluable|0|||
127947154|NCT02883049|460428766|FG004|Induction|Inevaluable|0|||
127947155|NCT02883049|460428767|FG005|Induction|Inevaluable|0|||
127947156|NCT02883049|460428768|FG006|Induction|Inevaluable|0|||
127947157|NCT02883049|460428769|FG007|Induction|Inevaluable|0|||
127947158|NCT02883049|460428770|FG008|Induction|Inevaluable|0|||
127947159|NCT02883049|460428771|FG009|Induction|Inevaluable|0|||
127947160|NCT02883049|460428772|FG010|Induction|Inevaluable|0|||
127947161|NCT02883049|460428773|FG011|Induction|Inevaluable|0|||
127947162|NCT02883049|460428774|FG012|Induction|Inevaluable|0|||
127947163|NCT02883049|460428775|FG013|Induction|Inevaluable|0|||
127947164|NCT02883049|460428776|FG014|Induction|Inevaluable|0|||
127947165|NCT02883049|460428777|FG015|Induction|Inevaluable|0|||
127947166|NCT02883049|460428762|FG000|Induction|Identified as VHR at end of Induction|244|||
127947167|NCT02883049|460428763|FG001|Induction|Identified as VHR at end of Induction|0|||
127947168|NCT02883049|460428764|FG002|Induction|Identified as VHR at end of Induction|0|||
127947169|NCT02883049|460428765|FG003|Induction|Identified as VHR at end of Induction|0|||
127947170|NCT02883049|460428766|FG004|Induction|Identified as VHR at end of Induction|0|||
127947171|NCT02883049|460428767|FG005|Induction|Identified as VHR at end of Induction|0|||
127947172|NCT02883049|460428768|FG006|Induction|Identified as VHR at end of Induction|0|||
127947173|NCT02883049|460428769|FG007|Induction|Identified as VHR at end of Induction|0|||
127947174|NCT02883049|460428770|FG008|Induction|Identified as VHR at end of Induction|0|||
127947175|NCT02883049|460428771|FG009|Induction|Identified as VHR at end of Induction|0|||
127947176|NCT02883049|460428772|FG010|Induction|Identified as VHR at end of Induction|0|||
127947177|NCT02883049|460428773|FG011|Induction|Identified as VHR at end of Induction|0|||
127947178|NCT02883049|460428774|FG012|Induction|Identified as VHR at end of Induction|0|||
127947179|NCT02883049|460428775|FG013|Induction|Identified as VHR at end of Induction|0|||
127947180|NCT02883049|460428776|FG014|Induction|Identified as VHR at end of Induction|0|||
127947181|NCT02883049|460428777|FG015|Induction|Identified as VHR at end of Induction|0|||
127947182|NCT02883049|460428762|FG000|Induction|Moved to another non-COG institution|3|||
127947183|NCT02883049|460428763|FG001|Induction|Moved to another non-COG institution|0|||
127947184|NCT02883049|460428764|FG002|Induction|Moved to another non-COG institution|0|||
127947185|NCT02883049|460428765|FG003|Induction|Moved to another non-COG institution|0|||
127947186|NCT02883049|460428766|FG004|Induction|Moved to another non-COG institution|0|||
127947187|NCT02883049|460428767|FG005|Induction|Moved to another non-COG institution|0|||
127947188|NCT02883049|460428768|FG006|Induction|Moved to another non-COG institution|0|||
127947189|NCT02883049|460428769|FG007|Induction|Moved to another non-COG institution|0|||
127947190|NCT02883049|460428770|FG008|Induction|Moved to another non-COG institution|0|||
127947191|NCT02883049|460428771|FG009|Induction|Moved to another non-COG institution|0|||
127947192|NCT02883049|460428772|FG010|Induction|Moved to another non-COG institution|0|||
127947193|NCT02883049|460428773|FG011|Induction|Moved to another non-COG institution|0|||
127947194|NCT02883049|460428774|FG012|Induction|Moved to another non-COG institution|0|||
127947195|NCT02883049|460428775|FG013|Induction|Moved to another non-COG institution|0|||
127947196|NCT02883049|460428776|FG014|Induction|Moved to another non-COG institution|0|||
127947197|NCT02883049|460428777|FG015|Induction|Moved to another non-COG institution|0|||
127947198|NCT02883049|460428762|FG000|Induction|Randomization closed|41|||
127947199|NCT02883049|460428763|FG001|Induction|Randomization closed|0|||
127947200|NCT02883049|460428764|FG002|Induction|Randomization closed|0|||
127947201|NCT02883049|460428765|FG003|Induction|Randomization closed|0|||
127947202|NCT02883049|460428766|FG004|Induction|Randomization closed|0|||
127947203|NCT02883049|460428767|FG005|Induction|Randomization closed|0|||
127947204|NCT02883049|460428768|FG006|Induction|Randomization closed|0|||
127947205|NCT02883049|460428769|FG007|Induction|Randomization closed|0|||
127947206|NCT02883049|460428770|FG008|Induction|Randomization closed|0|||
127947207|NCT02883049|460428771|FG009|Induction|Randomization closed|0|||
127947208|NCT02883049|460428772|FG010|Induction|Randomization closed|0|||
127947209|NCT02883049|460428773|FG011|Induction|Randomization closed|0|||
127947210|NCT02883049|460428774|FG012|Induction|Randomization closed|0|||
127947211|NCT02883049|460428775|FG013|Induction|Randomization closed|0|||
127947212|NCT02883049|460428776|FG014|Induction|Randomization closed|0|||
127947213|NCT02883049|460428777|FG015|Induction|Randomization closed|0|||
127947214|NCT02883049|460428762|FG000|Induction|MRD negative|36|||
127947215|NCT02883049|460428763|FG001|Induction|MRD negative|0|||
127947216|NCT02883049|460428764|FG002|Induction|MRD negative|0|||
127947217|NCT02883049|460428765|FG003|Induction|MRD negative|0|||
127947218|NCT02883049|460428766|FG004|Induction|MRD negative|0|||
127947219|NCT02883049|460428767|FG005|Induction|MRD negative|0|||
127947220|NCT02883049|460428768|FG006|Induction|MRD negative|0|||
127947221|NCT02883049|460428769|FG007|Induction|MRD negative|0|||
127947222|NCT02883049|460428770|FG008|Induction|MRD negative|0|||
127947223|NCT02883049|460428771|FG009|Induction|MRD negative|0|||
127947224|NCT02883049|460428772|FG010|Induction|MRD negative|0|||
127947225|NCT02883049|460428773|FG011|Induction|MRD negative|0|||
127947226|NCT02883049|460428774|FG012|Induction|MRD negative|0|||
127947227|NCT02883049|460428775|FG013|Induction|MRD negative|0|||
127947228|NCT02883049|460428776|FG014|Induction|MRD negative|0|||
127947229|NCT02883049|460428777|FG015|Induction|MRD negative|0|||
127947230|NCT02883049|460428762|FG000|Induction|Identified as HR patients|165|||
127947231|NCT02883049|460428763|FG001|Induction|Identified as HR patients|0|||
127947232|NCT02883049|460428764|FG002|Induction|Identified as HR patients|0|||
127947233|NCT02883049|460428765|FG003|Induction|Identified as HR patients|0|||
127947234|NCT02883049|460428766|FG004|Induction|Identified as HR patients|0|||
127947235|NCT02883049|460428767|FG005|Induction|Identified as HR patients|0|||
127947236|NCT02883049|460428768|FG006|Induction|Identified as HR patients|0|||
127947237|NCT02883049|460428769|FG007|Induction|Identified as HR patients|0|||
127947238|NCT02883049|460428770|FG008|Induction|Identified as HR patients|0|||
127947239|NCT02883049|460428771|FG009|Induction|Identified as HR patients|0|||
127947240|NCT02883049|460428772|FG010|Induction|Identified as HR patients|0|||
127947241|NCT02883049|460428773|FG011|Induction|Identified as HR patients|0|||
127947242|NCT02883049|460428774|FG012|Induction|Identified as HR patients|0|||
127947243|NCT02883049|460428775|FG013|Induction|Identified as HR patients|0|||
127947244|NCT02883049|460428776|FG014|Induction|Identified as HR patients|0|||
127947245|NCT02883049|460428777|FG015|Induction|Identified as HR patients|0|||
127947246|NCT02883049|460428762|FG000|Induction|Developed SMN|0|||
127947247|NCT02883049|460428763|FG001|Induction|Developed SMN|1|||
127947248|NCT02883049|460428764|FG002|Induction|Developed SMN|0|||
127947249|NCT02883049|460428765|FG003|Induction|Developed SMN|0|||
127947250|NCT02883049|460428766|FG004|Induction|Developed SMN|0|||
127947251|NCT02883049|460428767|FG005|Induction|Developed SMN|0|||
127947252|NCT02883049|460428768|FG006|Induction|Developed SMN|0|||
127947253|NCT02883049|460428769|FG007|Induction|Developed SMN|0|||
127947254|NCT02883049|460428770|FG008|Induction|Developed SMN|0|||
127947255|NCT02883049|460428771|FG009|Induction|Developed SMN|0|||
127947256|NCT02883049|460428772|FG010|Induction|Developed SMN|0|||
127947257|NCT02883049|460428773|FG011|Induction|Developed SMN|0|||
127947258|NCT02883049|460428774|FG012|Induction|Developed SMN|0|||
127947259|NCT02883049|460428775|FG013|Induction|Developed SMN|0|||
127947260|NCT02883049|460428776|FG014|Induction|Developed SMN|0|||
127947261|NCT02883049|460428777|FG015|Induction|Developed SMN|0|||
127947262|NCT02883049|460428762|FG000|Induction|Enrolled onto another COG study|72|||
127947263|NCT02883049|460428763|FG001|Induction|Enrolled onto another COG study|0|||
127947264|NCT02883049|460428764|FG002|Induction|Enrolled onto another COG study|0|||
127947265|NCT02883049|460428765|FG003|Induction|Enrolled onto another COG study|0|||
127947266|NCT02883049|460428766|FG004|Induction|Enrolled onto another COG study|0|||
127947267|NCT02883049|460428767|FG005|Induction|Enrolled onto another COG study|0|||
127947268|NCT02883049|460428768|FG006|Induction|Enrolled onto another COG study|0|||
127947269|NCT02883049|460428769|FG007|Induction|Enrolled onto another COG study|0|||
127947270|NCT02883049|460428770|FG008|Induction|Enrolled onto another COG study|0|||
127947271|NCT02883049|460428771|FG009|Induction|Enrolled onto another COG study|0|||
127947272|NCT02883049|460428772|FG010|Induction|Enrolled onto another COG study|0|||
127947273|NCT02883049|460428773|FG011|Induction|Enrolled onto another COG study|0|||
127947274|NCT02883049|460428774|FG012|Induction|Enrolled onto another COG study|0|||
127947275|NCT02883049|460428775|FG013|Induction|Enrolled onto another COG study|0|||
127947276|NCT02883049|460428776|FG014|Induction|Enrolled onto another COG study|0|||
127947277|NCT02883049|460428777|FG015|Induction|Enrolled onto another COG study|0|||
127947278|NCT02883049|460428762|FG000|Induction|Incomplete induction data|17|||
127947279|NCT02883049|460428763|FG001|Induction|Incomplete induction data|0|||
127947280|NCT02883049|460428764|FG002|Induction|Incomplete induction data|0|||
127947281|NCT02883049|460428765|FG003|Induction|Incomplete induction data|0|||
127947282|NCT02883049|460428766|FG004|Induction|Incomplete induction data|0|||
127947283|NCT02883049|460428767|FG005|Induction|Incomplete induction data|0|||
127947284|NCT02883049|460428768|FG006|Induction|Incomplete induction data|0|||
127947285|NCT02883049|460428769|FG007|Induction|Incomplete induction data|0|||
127947286|NCT02883049|460428770|FG008|Induction|Incomplete induction data|0|||
127947287|NCT02883049|460428771|FG009|Induction|Incomplete induction data|0|||
127947288|NCT02883049|460428772|FG010|Induction|Incomplete induction data|0|||
127947289|NCT02883049|460428773|FG011|Induction|Incomplete induction data|0|||
127947290|NCT02883049|460428774|FG012|Induction|Incomplete induction data|0|||
127947291|NCT02883049|460428775|FG013|Induction|Incomplete induction data|0|||
127947292|NCT02883049|460428776|FG014|Induction|Incomplete induction data|0|||
127947293|NCT02883049|460428777|FG015|Induction|Incomplete induction data|0|||
127947294|NCT02883049|460428762|FG000|Post Induction|Adverse Event|0|||
127947295|NCT02883049|460428763|FG001|Post Induction|Adverse Event|0|||
127947296|NCT02883049|460428764|FG002|Post Induction|Adverse Event|0|||
127947297|NCT02883049|460428765|FG003|Post Induction|Adverse Event|7|||
127947298|NCT02883049|460428766|FG004|Post Induction|Adverse Event|8|||
127947299|NCT02883049|460428767|FG005|Post Induction|Adverse Event|3|||
127947300|NCT02883049|460428768|FG006|Post Induction|Adverse Event|4|||
127947301|NCT02883049|460428769|FG007|Post Induction|Adverse Event|5|||
127947302|NCT02883049|460428770|FG008|Post Induction|Adverse Event|6|||
127947303|NCT02883049|460428771|FG009|Post Induction|Adverse Event|7|||
127947304|NCT02883049|460428772|FG010|Post Induction|Adverse Event|2|||
127947305|NCT02883049|460428773|FG011|Post Induction|Adverse Event|2|||
127947306|NCT02883049|460428774|FG012|Post Induction|Adverse Event|0|||
127947307|NCT02883049|460428775|FG013|Post Induction|Adverse Event|0|||
127947308|NCT02883049|460428776|FG014|Post Induction|Adverse Event|5|||
127947309|NCT02883049|460428777|FG015|Post Induction|Adverse Event|2|||
127947310|NCT02883049|460428762|FG000|Post Induction|Death|0|||
127947311|NCT02883049|460428763|FG001|Post Induction|Death|0|||
127947312|NCT02883049|460428764|FG002|Post Induction|Death|0|||
127947313|NCT02883049|460428765|FG003|Post Induction|Death|9|||
127947314|NCT02883049|460428766|FG004|Post Induction|Death|9|||
127947315|NCT02883049|460428767|FG005|Post Induction|Death|0|||
127947316|NCT02883049|460428768|FG006|Post Induction|Death|1|||
127947317|NCT02883049|460428769|FG007|Post Induction|Death|6|||
127947318|NCT02883049|460428770|FG008|Post Induction|Death|5|||
127947319|NCT02883049|460428771|FG009|Post Induction|Death|3|||
127947320|NCT02883049|460428772|FG010|Post Induction|Death|1|||
127947321|NCT02883049|460428773|FG011|Post Induction|Death|0|||
127947322|NCT02883049|460428774|FG012|Post Induction|Death|1|||
127947323|NCT02883049|460428775|FG013|Post Induction|Death|1|||
127947324|NCT02883049|460428776|FG014|Post Induction|Death|10|||
127947325|NCT02883049|460428777|FG015|Post Induction|Death|2|||
127947326|NCT02883049|460428762|FG000|Post Induction|Lost to Follow-up|0|||
127947327|NCT02883049|460428763|FG001|Post Induction|Lost to Follow-up|0|||
127947328|NCT02883049|460428764|FG002|Post Induction|Lost to Follow-up|0|||
127947329|NCT02883049|460428765|FG003|Post Induction|Lost to Follow-up|0|||
127947330|NCT02883049|460428766|FG004|Post Induction|Lost to Follow-up|1|||
127947331|NCT02883049|460428767|FG005|Post Induction|Lost to Follow-up|1|||
127947332|NCT02883049|460428768|FG006|Post Induction|Lost to Follow-up|0|||
127947333|NCT02883049|460428769|FG007|Post Induction|Lost to Follow-up|0|||
127947334|NCT02883049|460428770|FG008|Post Induction|Lost to Follow-up|3|||
127947335|NCT02883049|460428771|FG009|Post Induction|Lost to Follow-up|0|||
127947336|NCT02883049|460428772|FG010|Post Induction|Lost to Follow-up|1|||
127947337|NCT02883049|460428773|FG011|Post Induction|Lost to Follow-up|0|||
127947338|NCT02883049|460428774|FG012|Post Induction|Lost to Follow-up|0|||
127947339|NCT02883049|460428775|FG013|Post Induction|Lost to Follow-up|0|||
127947340|NCT02883049|460428776|FG014|Post Induction|Lost to Follow-up|0|||
127947341|NCT02883049|460428777|FG015|Post Induction|Lost to Follow-up|0|||
127947342|NCT02883049|460428762|FG000|Post Induction|Physician Decision|0|||
127947343|NCT02883049|460428763|FG001|Post Induction|Physician Decision|0|||
127947344|NCT02883049|460428764|FG002|Post Induction|Physician Decision|0|||
127947345|NCT02883049|460428765|FG003|Post Induction|Physician Decision|27|||
127947346|NCT02883049|460428766|FG004|Post Induction|Physician Decision|27|||
127947347|NCT02883049|460428767|FG005|Post Induction|Physician Decision|23|||
127947348|NCT02883049|460428768|FG006|Post Induction|Physician Decision|30|||
127947349|NCT02883049|460428769|FG007|Post Induction|Physician Decision|56|||
127947350|NCT02883049|460428770|FG008|Post Induction|Physician Decision|85|||
127947351|NCT02883049|460428771|FG009|Post Induction|Physician Decision|12|||
127947352|NCT02883049|460428772|FG010|Post Induction|Physician Decision|5|||
127947353|NCT02883049|460428773|FG011|Post Induction|Physician Decision|14|||
127947354|NCT02883049|460428774|FG012|Post Induction|Physician Decision|1|||
127947355|NCT02883049|460428775|FG013|Post Induction|Physician Decision|11|||
127947356|NCT02883049|460428776|FG014|Post Induction|Physician Decision|19|||
127947357|NCT02883049|460428777|FG015|Post Induction|Physician Decision|5|||
127947358|NCT02883049|460428762|FG000|Post Induction|Protocol Violation|0|||
127947359|NCT02883049|460428763|FG001|Post Induction|Protocol Violation|0|||
127947360|NCT02883049|460428764|FG002|Post Induction|Protocol Violation|0|||
127947361|NCT02883049|460428765|FG003|Post Induction|Protocol Violation|0|||
127947362|NCT02883049|460428766|FG004|Post Induction|Protocol Violation|0|||
127947363|NCT02883049|460428767|FG005|Post Induction|Protocol Violation|0|||
127947364|NCT02883049|460428768|FG006|Post Induction|Protocol Violation|0|||
127947365|NCT02883049|460428769|FG007|Post Induction|Protocol Violation|1|||
127947366|NCT02883049|460428770|FG008|Post Induction|Protocol Violation|0|||
127947367|NCT02883049|460428771|FG009|Post Induction|Protocol Violation|0|||
127947368|NCT02883049|460428772|FG010|Post Induction|Protocol Violation|0|||
127947369|NCT02883049|460428773|FG011|Post Induction|Protocol Violation|0|||
127947370|NCT02883049|460428774|FG012|Post Induction|Protocol Violation|0|||
127947371|NCT02883049|460428775|FG013|Post Induction|Protocol Violation|0|||
127947372|NCT02883049|460428776|FG014|Post Induction|Protocol Violation|0|||
127947373|NCT02883049|460428777|FG015|Post Induction|Protocol Violation|0|||
127947374|NCT02883049|460428762|FG000|Post Induction|Withdrawal by Subject|0|||
127947375|NCT02883049|460428763|FG001|Post Induction|Withdrawal by Subject|0|||
127947376|NCT02883049|460428764|FG002|Post Induction|Withdrawal by Subject|0|||
127947377|NCT02883049|460428765|FG003|Post Induction|Withdrawal by Subject|5|||
127947378|NCT02883049|460428766|FG004|Post Induction|Withdrawal by Subject|2|||
127947379|NCT02883049|460428767|FG005|Post Induction|Withdrawal by Subject|1|||
127947380|NCT02883049|460428768|FG006|Post Induction|Withdrawal by Subject|0|||
127947381|NCT02883049|460428769|FG007|Post Induction|Withdrawal by Subject|0|||
127947382|NCT02883049|460428770|FG008|Post Induction|Withdrawal by Subject|2|||
127947383|NCT02883049|460428771|FG009|Post Induction|Withdrawal by Subject|0|||
127947384|NCT02883049|460428772|FG010|Post Induction|Withdrawal by Subject|1|||
127947385|NCT02883049|460428773|FG011|Post Induction|Withdrawal by Subject|1|||
127947386|NCT02883049|460428774|FG012|Post Induction|Withdrawal by Subject|0|||
127947387|NCT02883049|460428775|FG013|Post Induction|Withdrawal by Subject|0|||
127947388|NCT02883049|460428776|FG014|Post Induction|Withdrawal by Subject|1|||
127947389|NCT02883049|460428777|FG015|Post Induction|Withdrawal by Subject|0|||
127947390|NCT02883049|460428762|FG000|Post Induction|Ineligible|0|||
127947391|NCT02883049|460428763|FG001|Post Induction|Ineligible|0|||
127947392|NCT02883049|460428764|FG002|Post Induction|Ineligible|2|||
127947393|NCT02883049|460428765|FG003|Post Induction|Ineligible|0|||
127947394|NCT02883049|460428766|FG004|Post Induction|Ineligible|0|||
127947395|NCT02883049|460428767|FG005|Post Induction|Ineligible|0|||
127947396|NCT02883049|460428768|FG006|Post Induction|Ineligible|1|||
127947397|NCT02883049|460428769|FG007|Post Induction|Ineligible|0|||
127947398|NCT02883049|460428770|FG008|Post Induction|Ineligible|0|||
127947399|NCT02883049|460428771|FG009|Post Induction|Ineligible|0|||
127947400|NCT02883049|460428772|FG010|Post Induction|Ineligible|1|||
127947401|NCT02883049|460428773|FG011|Post Induction|Ineligible|0|||
127947402|NCT02883049|460428774|FG012|Post Induction|Ineligible|0|||
127947403|NCT02883049|460428775|FG013|Post Induction|Ineligible|0|||
127947404|NCT02883049|460428776|FG014|Post Induction|Ineligible|0|||
127947405|NCT02883049|460428777|FG015|Post Induction|Ineligible|1|||
127947406|NCT02883049|460428762|FG000|Post Induction|Refusal of further protocol therapy|0|||
127947407|NCT02883049|460428763|FG001|Post Induction|Refusal of further protocol therapy|0|||
127947408|NCT02883049|460428764|FG002|Post Induction|Refusal of further protocol therapy|0|||
127947409|NCT02883049|460428765|FG003|Post Induction|Refusal of further protocol therapy|11|||
127947410|NCT02883049|460428766|FG004|Post Induction|Refusal of further protocol therapy|15|||
127947411|NCT02883049|460428767|FG005|Post Induction|Refusal of further protocol therapy|9|||
127947412|NCT02883049|460428768|FG006|Post Induction|Refusal of further protocol therapy|13|||
127947413|NCT02883049|460428769|FG007|Post Induction|Refusal of further protocol therapy|5|||
127947414|NCT02883049|460428770|FG008|Post Induction|Refusal of further protocol therapy|21|||
127947415|NCT02883049|460428771|FG009|Post Induction|Refusal of further protocol therapy|7|||
127947416|NCT02883049|460428772|FG010|Post Induction|Refusal of further protocol therapy|0|||
127947417|NCT02883049|460428773|FG011|Post Induction|Refusal of further protocol therapy|7|||
127947418|NCT02883049|460428774|FG012|Post Induction|Refusal of further protocol therapy|3|||
127947419|NCT02883049|460428775|FG013|Post Induction|Refusal of further protocol therapy|0|||
127947420|NCT02883049|460428776|FG014|Post Induction|Refusal of further protocol therapy|4|||
127947421|NCT02883049|460428777|FG015|Post Induction|Refusal of further protocol therapy|1|||
127947422|NCT02883049|460428762|FG000|Post Induction|Inevaluable|0|||
127947423|NCT02883049|460428763|FG001|Post Induction|Inevaluable|0|||
127947424|NCT02883049|460428764|FG002|Post Induction|Inevaluable|0|||
127947425|NCT02883049|460428765|FG003|Post Induction|Inevaluable|1|||
127947426|NCT02883049|460428766|FG004|Post Induction|Inevaluable|1|||
127947427|NCT02883049|460428767|FG005|Post Induction|Inevaluable|2|||
127947428|NCT02883049|460428768|FG006|Post Induction|Inevaluable|7|||
127947429|NCT02883049|460428769|FG007|Post Induction|Inevaluable|6|||
127947430|NCT02883049|460428770|FG008|Post Induction|Inevaluable|4|||
127947431|NCT02883049|460428771|FG009|Post Induction|Inevaluable|4|||
127947432|NCT02883049|460428772|FG010|Post Induction|Inevaluable|1|||
127947433|NCT02883049|460428773|FG011|Post Induction|Inevaluable|1|||
127947434|NCT02883049|460428774|FG012|Post Induction|Inevaluable|2|||
127947435|NCT02883049|460428775|FG013|Post Induction|Inevaluable|0|||
127947436|NCT02883049|460428776|FG014|Post Induction|Inevaluable|0|||
127947437|NCT02883049|460428777|FG015|Post Induction|Inevaluable|1|||
127947438|NCT02883049|460428762|FG000|Post Induction|Moved to another non-COG institution|0|||
127947439|NCT02883049|460428763|FG001|Post Induction|Moved to another non-COG institution|0|||
127947440|NCT02883049|460428764|FG002|Post Induction|Moved to another non-COG institution|0|||
127947441|NCT02883049|460428765|FG003|Post Induction|Moved to another non-COG institution|0|||
127947442|NCT02883049|460428766|FG004|Post Induction|Moved to another non-COG institution|0|||
127947443|NCT02883049|460428767|FG005|Post Induction|Moved to another non-COG institution|0|||
127947444|NCT02883049|460428768|FG006|Post Induction|Moved to another non-COG institution|0|||
127947445|NCT02883049|460428769|FG007|Post Induction|Moved to another non-COG institution|2|||
127947446|NCT02883049|460428770|FG008|Post Induction|Moved to another non-COG institution|2|||
127947447|NCT02883049|460428771|FG009|Post Induction|Moved to another non-COG institution|0|||
127947448|NCT02883049|460428772|FG010|Post Induction|Moved to another non-COG institution|0|||
127947449|NCT02883049|460428773|FG011|Post Induction|Moved to another non-COG institution|1|||
127947450|NCT02883049|460428774|FG012|Post Induction|Moved to another non-COG institution|0|||
127947451|NCT02883049|460428775|FG013|Post Induction|Moved to another non-COG institution|0|||
127947452|NCT02883049|460428776|FG014|Post Induction|Moved to another non-COG institution|0|||
127947453|NCT02883049|460428777|FG015|Post Induction|Moved to another non-COG institution|0|||
127947454|NCT02883049|460428762|FG000|Post Induction|Randomization closed|0|||
127947455|NCT02883049|460428763|FG001|Post Induction|Randomization closed|0|||
127947456|NCT02883049|460428764|FG002|Post Induction|Randomization closed|0|||
127947457|NCT02883049|460428765|FG003|Post Induction|Randomization closed|0|||
127947458|NCT02883049|460428766|FG004|Post Induction|Randomization closed|0|||
127947459|NCT02883049|460428767|FG005|Post Induction|Randomization closed|0|||
127947460|NCT02883049|460428768|FG006|Post Induction|Randomization closed|0|||
127947461|NCT02883049|460428769|FG007|Post Induction|Randomization closed|20|||
127947462|NCT02883049|460428770|FG008|Post Induction|Randomization closed|0|||
127947463|NCT02883049|460428771|FG009|Post Induction|Randomization closed|0|||
127947464|NCT02883049|460428772|FG010|Post Induction|Randomization closed|0|||
127947465|NCT02883049|460428773|FG011|Post Induction|Randomization closed|0|||
127947466|NCT02883049|460428774|FG012|Post Induction|Randomization closed|0|||
127947467|NCT02883049|460428775|FG013|Post Induction|Randomization closed|0|||
127947468|NCT02883049|460428776|FG014|Post Induction|Randomization closed|0|||
127947469|NCT02883049|460428777|FG015|Post Induction|Randomization closed|0|||
127947470|NCT02883049|460428762|FG000|Post Induction|MRD negative|0|||
127947471|NCT02883049|460428763|FG001|Post Induction|MRD negative|0|||
127947472|NCT02883049|460428764|FG002|Post Induction|MRD negative|0|||
127947473|NCT02883049|460428765|FG003|Post Induction|MRD negative|0|||
127947474|NCT02883049|460428766|FG004|Post Induction|MRD negative|0|||
127947475|NCT02883049|460428767|FG005|Post Induction|MRD negative|0|||
127947476|NCT02883049|460428768|FG006|Post Induction|MRD negative|0|||
127947477|NCT02883049|460428769|FG007|Post Induction|MRD negative|11|||
127947478|NCT02883049|460428770|FG008|Post Induction|MRD negative|0|||
127947479|NCT02883049|460428771|FG009|Post Induction|MRD negative|0|||
127947480|NCT02883049|460428772|FG010|Post Induction|MRD negative|0|||
127947481|NCT02883049|460428773|FG011|Post Induction|MRD negative|0|||
127947482|NCT02883049|460428774|FG012|Post Induction|MRD negative|0|||
127947483|NCT02883049|460428775|FG013|Post Induction|MRD negative|0|||
127947484|NCT02883049|460428776|FG014|Post Induction|MRD negative|0|||
127947485|NCT02883049|460428777|FG015|Post Induction|MRD negative|0|||
127947486|NCT02883049|460428762|FG000|Post Induction|Developed SMN|0|||
127947487|NCT02883049|460428763|FG001|Post Induction|Developed SMN|0|||
127947488|NCT02883049|460428764|FG002|Post Induction|Developed SMN|0|||
127947489|NCT02883049|460428765|FG003|Post Induction|Developed SMN|0|||
127947490|NCT02883049|460428766|FG004|Post Induction|Developed SMN|1|||
127947491|NCT02883049|460428767|FG005|Post Induction|Developed SMN|0|||
127947492|NCT02883049|460428768|FG006|Post Induction|Developed SMN|1|||
127947493|NCT02883049|460428769|FG007|Post Induction|Developed SMN|0|||
127947494|NCT02883049|460428770|FG008|Post Induction|Developed SMN|0|||
127947495|NCT02883049|460428771|FG009|Post Induction|Developed SMN|0|||
127947496|NCT02883049|460428772|FG010|Post Induction|Developed SMN|1|||
127947497|NCT02883049|460428773|FG011|Post Induction|Developed SMN|1|||
127947498|NCT02883049|460428774|FG012|Post Induction|Developed SMN|0|||
127947499|NCT02883049|460428775|FG013|Post Induction|Developed SMN|0|||
127947500|NCT02883049|460428776|FG014|Post Induction|Developed SMN|1|||
127947501|NCT02883049|460428777|FG015|Post Induction|Developed SMN|0|||
127947502|NCT02883049|460428762|FG000|Post Induction|Enrolled onto another COG study|0|||
127947503|NCT02883049|460428763|FG001|Post Induction|Enrolled onto another COG study|0|||
127947504|NCT02883049|460428764|FG002|Post Induction|Enrolled onto another COG study|0|||
127947505|NCT02883049|460428765|FG003|Post Induction|Enrolled onto another COG study|1|||
127947506|NCT02883049|460428766|FG004|Post Induction|Enrolled onto another COG study|1|||
127947507|NCT02883049|460428767|FG005|Post Induction|Enrolled onto another COG study|0|||
127947508|NCT02883049|460428768|FG006|Post Induction|Enrolled onto another COG study|0|||
127947509|NCT02883049|460428769|FG007|Post Induction|Enrolled onto another COG study|4|||
127947510|NCT02883049|460428770|FG008|Post Induction|Enrolled onto another COG study|0|||
127947511|NCT02883049|460428771|FG009|Post Induction|Enrolled onto another COG study|0|||
127947512|NCT02883049|460428772|FG010|Post Induction|Enrolled onto another COG study|0|||
127947513|NCT02883049|460428773|FG011|Post Induction|Enrolled onto another COG study|2|||
127947514|NCT02883049|460428774|FG012|Post Induction|Enrolled onto another COG study|0|||
127947515|NCT02883049|460428775|FG013|Post Induction|Enrolled onto another COG study|1|||
127947516|NCT02883049|460428776|FG014|Post Induction|Enrolled onto another COG study|0|||
127947517|NCT02883049|460428777|FG015|Post Induction|Enrolled onto another COG study|0|||
127947518|NCT02883049|460428762|FG000|Post Induction|Recurrent leukemia|0|||
127947519|NCT02883049|460428763|FG001|Post Induction|Recurrent leukemia|0|||
127947520|NCT02883049|460428764|FG002|Post Induction|Recurrent leukemia|0|||
127947521|NCT02883049|460428765|FG003|Post Induction|Recurrent leukemia|17|||
127947522|NCT02883049|460428766|FG004|Post Induction|Recurrent leukemia|12|||
127947523|NCT02883049|460428767|FG005|Post Induction|Recurrent leukemia|4|||
127947524|NCT02883049|460428768|FG006|Post Induction|Recurrent leukemia|1|||
127947525|NCT02883049|460428769|FG007|Post Induction|Recurrent leukemia|13|||
127947526|NCT02883049|460428770|FG008|Post Induction|Recurrent leukemia|27|||
127947527|NCT02883049|460428771|FG009|Post Induction|Recurrent leukemia|5|||
127947528|NCT02883049|460428772|FG010|Post Induction|Recurrent leukemia|3|||
127947529|NCT02883049|460428773|FG011|Post Induction|Recurrent leukemia|12|||
127947530|NCT02883049|460428774|FG012|Post Induction|Recurrent leukemia|1|||
127947531|NCT02883049|460428775|FG013|Post Induction|Recurrent leukemia|1|||
127947532|NCT02883049|460428776|FG014|Post Induction|Recurrent leukemia|9|||
127947533|NCT02883049|460428777|FG015|Post Induction|Recurrent leukemia|3|||
127947534|NCT02883049|460428762|FG000|Post Induction|Induction Failure|0|||
127947535|NCT02883049|460428763|FG001|Post Induction|Induction Failure|0|||
127947536|NCT02883049|460428764|FG002|Post Induction|Induction Failure|0|||
127947537|NCT02883049|460428765|FG003|Post Induction|Induction Failure|0|||
127947538|NCT02883049|460428766|FG004|Post Induction|Induction Failure|0|||
127947539|NCT02883049|460428767|FG005|Post Induction|Induction Failure|0|||
127947540|NCT02883049|460428768|FG006|Post Induction|Induction Failure|0|||
127947541|NCT02883049|460428769|FG007|Post Induction|Induction Failure|2|||
127947542|NCT02883049|460428770|FG008|Post Induction|Induction Failure|2|||
127947543|NCT02883049|460428771|FG009|Post Induction|Induction Failure|0|||
127947544|NCT02883049|460428772|FG010|Post Induction|Induction Failure|0|||
127947545|NCT02883049|460428773|FG011|Post Induction|Induction Failure|0|||
127947546|NCT02883049|460428774|FG012|Post Induction|Induction Failure|0|||
127947547|NCT02883049|460428775|FG013|Post Induction|Induction Failure|2|||
127947548|NCT02883049|460428776|FG014|Post Induction|Induction Failure|0|||
127947549|NCT02883049|460428777|FG015|Post Induction|Induction Failure|0|||
127947550|NCT01924754|460428783|FG000|Overall Study|Lost to Follow-up|1|||
127947551|NCT01924754|460428784|FG001|Overall Study|Lost to Follow-up|2|||
127947552|NCT01924754|460428785|FG002|Overall Study|Lost to Follow-up|1|||
127947553|NCT01924754|460428783|FG000|Overall Study|Pregnancy|0|||
127947554|NCT01924754|460428784|FG001|Overall Study|Pregnancy|1|||
127947555|NCT01924754|460428785|FG002|Overall Study|Pregnancy|2|||
127947556|NCT02245412|460428788|FG000|Treatment Period|Death|1|||
127947557|NCT02245412|460428789|FG001|Treatment Period|Death|1|||
127947558|NCT02245412|460428790|FG002|Treatment Period|Death|0|||
127947559|NCT02245412|460428788|FG000|Treatment Period|Physician Decision|1|||
127947560|NCT02245412|460428789|FG001|Treatment Period|Physician Decision|1|||
127947561|NCT02245412|460428790|FG002|Treatment Period|Physician Decision|0|||
127947562|NCT02245412|460428788|FG000|Treatment Period|Withdrawal by Subject|2|||
127947563|NCT02245412|460428789|FG001|Treatment Period|Withdrawal by Subject|1|||
127947564|NCT02245412|460428790|FG002|Treatment Period|Withdrawal by Subject|0|||
127947565|NCT02245412|460428788|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
127947566|NCT02245412|460428789|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
127947567|NCT02245412|460428790|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
127947568|NCT02245412|460428788|FG000|Follow-Up Period|Death|4|||
127947569|NCT02245412|460428789|FG001|Follow-Up Period|Death|2|||
127947570|NCT02245412|460428790|FG002|Follow-Up Period|Death|1|||
127947571|NCT02245412|460428788|FG000|Follow-Up Period|Physician Decision|1|||
127947572|NCT02245412|460428789|FG001|Follow-Up Period|Physician Decision|0|||
127947573|NCT02245412|460428790|FG002|Follow-Up Period|Physician Decision|0|||
127947574|NCT02245412|460428788|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
127947575|NCT02245412|460428789|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
127947576|NCT02245412|460428790|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
127947577|NCT01392963|460428791|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
127947578|NCT01392963|460428792|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
127947579|NCT01392963|460428791|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
127947580|NCT01392963|460428792|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
127947581|NCT01392963|460428791|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
127947582|NCT01392963|460428792|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
127947583|NCT00369486|460428793|FG000|4-Week Visit|Missed visit|2|||
127947584|NCT00369486|460428794|FG001|4-Week Visit|Missed visit|2|||
127947585|NCT00369486|460428795|FG002|4-Week Visit|Missed visit|0|||
127947586|NCT00369486|460428796|FG003|4-Week Visit|Missed visit|2|||
127947587|NCT00369486|460428797|FG004|4-Week Visit|Missed visit|1|||
127947588|NCT00369486|460428793|FG000|4-Week Visit|Dropped|0|||
127947589|NCT00369486|460428794|FG001|4-Week Visit|Dropped|0|||
127947590|NCT00369486|460428795|FG002|4-Week Visit|Dropped|1|||
127947591|NCT00369486|460428796|FG003|4-Week Visit|Dropped|0|||
127947592|NCT00369486|460428797|FG004|4-Week Visit|Dropped|0|||
127947593|NCT00369486|460428793|FG000|8-Week Visit|Missed visit|0|||
127947594|NCT00369486|460428794|FG001|8-Week Visit|Missed visit|1|||
127947595|NCT00369486|460428795|FG002|8-Week Visit|Missed visit|0|||
127947596|NCT00369486|460428796|FG003|8-Week Visit|Missed visit|0|||
127947597|NCT00369486|460428797|FG004|8-Week Visit|Missed visit|1|||
127947598|NCT00369486|460428793|FG000|8-Week Visit|Dropped|0|||
127947599|NCT00369486|460428794|FG001|8-Week Visit|Dropped|0|||
127947600|NCT00369486|460428795|FG002|8-Week Visit|Dropped|0|||
127947601|NCT00369486|460428796|FG003|8-Week Visit|Dropped|1|||
127947602|NCT00369486|460428797|FG004|8-Week Visit|Dropped|0|||
127947603|NCT00369486|460428793|FG000|17-Week Visit|Missed visit|0|||
127947604|NCT00369486|460428794|FG001|17-Week Visit|Missed visit|0|||
127947605|NCT00369486|460428795|FG002|17-Week Visit|Missed visit|1|||
127947606|NCT00369486|460428796|FG003|17-Week Visit|Missed visit|1|||
127947607|NCT00369486|460428797|FG004|17-Week Visit|Missed visit|1|||
127947608|NCT00369486|460428793|FG000|34-Week Visit|Dropped|0|||
127947609|NCT00369486|460428794|FG001|34-Week Visit|Dropped|1|||
127947610|NCT00369486|460428795|FG002|34-Week Visit|Dropped|1|||
127947611|NCT00369486|460428796|FG003|34-Week Visit|Dropped|3|||
127947612|NCT00369486|460428797|FG004|34-Week Visit|Dropped|3|||
127947613|NCT00402116|460428798|FG000|Overall Study|Jaw infection after surgery-other|1|||
127947614|NCT00402116|460428799|FG001|Overall Study|Jaw infection after surgery-other|0|||
127947615|NCT00402116|460428800|FG002|Overall Study|Jaw infection after surgery-other|0|||
127947616|NCT00402116|460428798|FG000|Overall Study|Withdrawal by Subject|1|||
127947617|NCT00402116|460428799|FG001|Overall Study|Withdrawal by Subject|0|||
127947618|NCT00402116|460428800|FG002|Overall Study|Withdrawal by Subject|5|||
127947619|NCT00402116|460428798|FG000|Overall Study|Treatment completed per protocol|1|||
127947620|NCT00402116|460428799|FG001|Overall Study|Treatment completed per protocol|1|||
127947621|NCT00402116|460428800|FG002|Overall Study|Treatment completed per protocol|2|||
127947622|NCT00402116|460428798|FG000|Overall Study|other complicating disease|0|||
127947623|NCT00402116|460428799|FG001|Overall Study|other complicating disease|0|||
127947624|NCT00402116|460428800|FG002|Overall Study|other complicating disease|2|||
127947625|NCT00402116|460428798|FG000|Overall Study|Disease Progression|0|||
127947626|NCT00402116|460428799|FG001|Overall Study|Disease Progression|4|||
127947627|NCT00402116|460428800|FG002|Overall Study|Disease Progression|38|||
127947628|NCT00402116|460428798|FG000|Overall Study|mistaken thrombocytopenia|0|||
127947629|NCT00402116|460428799|FG001|Overall Study|mistaken thrombocytopenia|0|||
127947630|NCT00402116|460428800|FG002|Overall Study|mistaken thrombocytopenia|1|||
127947631|NCT00402116|460428798|FG000|Overall Study|decline related hyponatremia/tumor|0|||
127947632|NCT00402116|460428799|FG001|Overall Study|decline related hyponatremia/tumor|0|||
127947633|NCT00402116|460428800|FG002|Overall Study|decline related hyponatremia/tumor|1|||
127947634|NCT00402116|460428798|FG000|Overall Study|Adverse Event|0|||
127947635|NCT00402116|460428799|FG001|Overall Study|Adverse Event|1|||
127947636|NCT00402116|460428800|FG002|Overall Study|Adverse Event|6|||
127947637|NCT04778904|460428801|FG000|Overall Study|Protocol Violation|1|||
127947638|NCT04778904|460428802|FG001|Overall Study|Protocol Violation|0|||
127947639|NCT04778904|460428803|FG002|Overall Study|Protocol Violation|0|||
127947640|NCT04778904|460428804|FG003|Overall Study|Protocol Violation|0|||
127947641|NCT04778904|460428801|FG000|Overall Study|Withdrawal by Subject|0|||
127947642|NCT04778904|460428802|FG001|Overall Study|Withdrawal by Subject|0|||
127947643|NCT04778904|460428803|FG002|Overall Study|Withdrawal by Subject|1|||
127947644|NCT04778904|460428804|FG003|Overall Study|Withdrawal by Subject|0|||
127947645|NCT05048329|460428811|FG000|Overall Study|Withdrawal by Subject|1|||
127947646|NCT05048329|460428811|FG000|Overall Study|Screenfail|1|||
127947647|NCT03772717|460428812|FG000|Overall Study|Withdrawal by Subject|2|||
127947648|NCT02856802|460428813|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
127947649|NCT02856802|460428814|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
127947650|NCT02856802|460428813|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
127947651|NCT02856802|460428814|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
127947652|NCT02856802|460428813|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
127947653|NCT02856802|460428814|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
127947654|NCT02856802|460428813|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
127947655|NCT02856802|460428814|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
127947656|NCT02856802|460428813|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
127947657|NCT02856802|460428814|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
127947658|NCT02856802|460428813|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
127947659|NCT02856802|460428814|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
127947660|NCT04138043|460428815|FG000|Overall Study|Withdrawal by Subject|0|||
127947661|NCT04138043|460428816|FG001|Overall Study|Withdrawal by Subject|1|||
127947662|NCT03092219|460428817|FG000|Overall Study|Protocol Violation|7|||
127947663|NCT03092219|460428818|FG001|Overall Study|Protocol Violation|4|||
127947664|NCT01403051|460428824|FG000|Overall Study|Protocol Violation|2|||
127947665|NCT01403051|460428825|FG001|Overall Study|Protocol Violation|0|||
127947666|NCT01403051|460428824|FG000|Overall Study|Death|1|||
127947667|NCT01403051|460428825|FG001|Overall Study|Death|0|||
127947668|NCT01403051|460428824|FG000|Overall Study|Withdrawal by Subject|2|||
127947669|NCT01403051|460428825|FG001|Overall Study|Withdrawal by Subject|1|||
127947670|NCT01403051|460428824|FG000|Overall Study|Lost to Follow-up|5|||
127947671|NCT01403051|460428825|FG001|Overall Study|Lost to Follow-up|5|||
127947672|NCT00287586|460428835|FG000|Overall Study|Withdrew Consent|19|||
127947673|NCT00287586|460428836|FG001|Overall Study|Withdrew Consent|30|||
127947674|NCT00287586|460428835|FG000|Overall Study|Lost to Follow-up|5|||
127947675|NCT00287586|460428836|FG001|Overall Study|Lost to Follow-up|4|||
127947676|NCT00287586|460428835|FG000|Overall Study|Death|2|||
127947677|NCT00287586|460428836|FG001|Overall Study|Death|3|||
127947678|NCT00287586|460428835|FG000|Overall Study|Elevated Hematocrit|3|||
127947679|NCT00287586|460428836|FG001|Overall Study|Elevated Hematocrit|0|||
127947680|NCT00287586|460428835|FG000|Overall Study|Rash|3|||
127947681|NCT00287586|460428836|FG001|Overall Study|Rash|0|||
127947682|NCT00287586|460428835|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
127947683|NCT00287586|460428836|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
127947684|NCT00287586|460428835|FG000|Overall Study|Stroke|2|||
127947685|NCT00287586|460428836|FG001|Overall Study|Stroke|0|||
127947686|NCT00287586|460428835|FG000|Overall Study|Myocardial Infarction|1|||
127947687|NCT00287586|460428836|FG001|Overall Study|Myocardial Infarction|0|||
127947688|NCT00287586|460428835|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
127947689|NCT00287586|460428836|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
127947690|NCT00287586|460428835|FG000|Overall Study|Cognitive Impairment|1|||
127947691|NCT00287586|460428836|FG001|Overall Study|Cognitive Impairment|0|||
127947692|NCT00287586|460428835|FG000|Overall Study|Pancreatic Cancer|1|||
127947693|NCT00287586|460428836|FG001|Overall Study|Pancreatic Cancer|3|||
127947694|NCT00287586|460428835|FG000|Overall Study|Sleep Apnea|1|||
127947695|NCT00287586|460428836|FG001|Overall Study|Sleep Apnea|0|||
127947696|NCT00287586|460428835|FG000|Overall Study|Shoulder Pain|1|||
127947697|NCT00287586|460428836|FG001|Overall Study|Shoulder Pain|0|||
127947698|NCT00287586|460428835|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
127947699|NCT00287586|460428836|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
127947700|NCT00287586|460428835|FG000|Overall Study|Nonadherence|1|||
127947701|NCT00287586|460428836|FG001|Overall Study|Nonadherence|1|||
127947702|NCT00287586|460428835|FG000|Overall Study|Enrolled in Another Study|1|||
127947703|NCT00287586|460428836|FG001|Overall Study|Enrolled in Another Study|0|||
127947704|NCT00287586|460428835|FG000|Overall Study|Major Depression|0|||
127947705|NCT00287586|460428836|FG001|Overall Study|Major Depression|2|||
127947706|NCT00287586|460428835|FG000|Overall Study|Lung Cancer|0|||
127947707|NCT00287586|460428836|FG001|Overall Study|Lung Cancer|2|||
127947708|NCT00287586|460428835|FG000|Overall Study|Elevated IPSS Score|0|||
127947709|NCT00287586|460428836|FG001|Overall Study|Elevated IPSS Score|1|||
127947710|NCT00287586|460428835|FG000|Overall Study|Retroperitoneal Cancer|0|||
127947711|NCT00287586|460428836|FG001|Overall Study|Retroperitoneal Cancer|1|||
127947712|NCT00287586|460428835|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
127947713|NCT00287586|460428836|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
127947714|NCT00287586|460428835|FG000|Overall Study|Mood Swings and Irritability|0|||
127947715|NCT00287586|460428836|FG001|Overall Study|Mood Swings and Irritability|1|||
127947716|NCT00287586|460428835|FG000|Overall Study|Bradycardia|0|||
127947717|NCT00287586|460428836|FG001|Overall Study|Bradycardia|1|||
127947718|NCT00287586|460428835|FG000|Overall Study|Itchy Swollen Eyes|0|||
127947719|NCT00287586|460428836|FG001|Overall Study|Itchy Swollen Eyes|1|||
127947720|NCT00287586|460428835|FG000|Overall Study|Recurrent Melanoma|0|||
127947721|NCT00287586|460428836|FG001|Overall Study|Recurrent Melanoma|1|||
127947722|NCT03743415|460428838|FG000|Overall Study|Death|5|||
127947723|NCT03743415|460428839|FG001|Overall Study|Death|3|||
127947724|NCT03743415|460428840|FG002|Overall Study|Death|1|||
127947725|NCT03743415|460428841|FG003|Overall Study|Death|4|||
127947726|NCT03743415|460428842|FG004|Overall Study|Death|0|||
127947727|NCT03743415|460428843|FG005|Overall Study|Death|0|||
127947728|NCT03743415|460428844|FG006|Overall Study|Death|0|||
127947729|NCT03743415|460428845|FG007|Overall Study|Death|0|||
127947730|NCT03743415|460428846|FG008|Overall Study|Death|1|||
127947731|NCT03743415|460428847|FG009|Overall Study|Death|0|||
127947732|NCT03743415|460428838|FG000|Overall Study|Withdrawal by Subject|1|||
127947733|NCT03743415|460428839|FG001|Overall Study|Withdrawal by Subject|0|||
127947734|NCT03743415|460428840|FG002|Overall Study|Withdrawal by Subject|4|||
127947735|NCT03743415|460428841|FG003|Overall Study|Withdrawal by Subject|5|||
127947736|NCT03743415|460428842|FG004|Overall Study|Withdrawal by Subject|5|||
127947737|NCT03743415|460428843|FG005|Overall Study|Withdrawal by Subject|2|||
127947738|NCT03743415|460428844|FG006|Overall Study|Withdrawal by Subject|2|||
127947739|NCT03743415|460428845|FG007|Overall Study|Withdrawal by Subject|5|||
127947740|NCT03743415|460428846|FG008|Overall Study|Withdrawal by Subject|9|||
127947741|NCT03743415|460428847|FG009|Overall Study|Withdrawal by Subject|10|||
127947742|NCT03743415|460428838|FG000|Overall Study|Lost to Follow-up|2|||
127947743|NCT03743415|460428839|FG001|Overall Study|Lost to Follow-up|0|||
127947744|NCT03743415|460428840|FG002|Overall Study|Lost to Follow-up|2|||
127947745|NCT03743415|460428841|FG003|Overall Study|Lost to Follow-up|1|||
127947746|NCT03743415|460428842|FG004|Overall Study|Lost to Follow-up|1|||
127947747|NCT03743415|460428843|FG005|Overall Study|Lost to Follow-up|0|||
127947748|NCT03743415|460428844|FG006|Overall Study|Lost to Follow-up|1|||
127947749|NCT03743415|460428845|FG007|Overall Study|Lost to Follow-up|4|||
127947750|NCT03743415|460428846|FG008|Overall Study|Lost to Follow-up|13|||
127947751|NCT03743415|460428847|FG009|Overall Study|Lost to Follow-up|13|||
127947752|NCT02242045|460428851|FG000|Overall Study|Investigator's Discretion|1|||
127947753|NCT02242045|460428851|FG000|Overall Study|Progressive Disease|2|||
127947754|NCT02242045|460428851|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
127947755|NCT02242045|460428851|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
127947756|NCT02473523|460428852|FG000|Overall Study|Death|1|||
127947757|NCT02473523|460428852|FG000|Overall Study|Lost to Follow-up|1|||
127947758|NCT00976911|460428855|FG000|Overall Study|Withdrawal by Subject|4|||
127947759|NCT00976911|460428856|FG001|Overall Study|Withdrawal by Subject|6|||
127947760|NCT00976911|460428855|FG000|Overall Study|Death|138|||
127947761|NCT00976911|460428856|FG001|Overall Study|Death|126|||
127947762|NCT00976911|460428855|FG000|Overall Study|Adverse Event|0|||
127947763|NCT00976911|460428856|FG001|Overall Study|Adverse Event|1|||
127947764|NCT00976911|460428855|FG000|Overall Study|Protocol Violation|2|||
127947765|NCT00976911|460428856|FG001|Overall Study|Protocol Violation|0|||
127947766|NCT00976911|460428855|FG000|Overall Study|Other|8|||
127947767|NCT00976911|460428856|FG001|Overall Study|Other|9|||
127947768|NCT00976911|460428855|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
127947769|NCT00976911|460428856|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
127947770|NCT02954991|460428857|FG000|Overall Study|Death|92|||
127947771|NCT02954991|460428858|FG001|Overall Study|Death|11|||
127947772|NCT02954991|460428859|FG002|Overall Study|Death|2|||
127947773|NCT02954991|460428857|FG000|Overall Study|Lost to Follow-up|3|||
127947774|NCT02954991|460428858|FG001|Overall Study|Lost to Follow-up|2|||
127947775|NCT02954991|460428859|FG002|Overall Study|Lost to Follow-up|0|||
127947776|NCT02954991|460428857|FG000|Overall Study|Withdrawal by Subject|9|||
127947777|NCT02954991|460428858|FG001|Overall Study|Withdrawal by Subject|8|||
127947778|NCT02954991|460428859|FG002|Overall Study|Withdrawal by Subject|1|||
127947779|NCT02954991|460428857|FG000|Overall Study|Study Terminated by Sponsor|18|||
127947780|NCT02954991|460428858|FG001|Overall Study|Study Terminated by Sponsor|10|||
127947781|NCT02954991|460428859|FG002|Overall Study|Study Terminated by Sponsor|1|||
127947782|NCT02954991|460428857|FG000|Overall Study|Miscellaneous|2|||
127947783|NCT02954991|460428858|FG001|Overall Study|Miscellaneous|1|||
127947784|NCT02954991|460428859|FG002|Overall Study|Miscellaneous|1|||
127947785|NCT00576316|460428860|FG000|Overall Study|Adverse Event|9|||
127947786|NCT00576316|460428860|FG000|Overall Study|Withdrawal by Subject|2|||
127947787|NCT00576316|460428860|FG000|Overall Study|Protocol Violation|9|||
127947788|NCT01266031|460428862|FG000|Overall Study|Not treated|0|||
127947789|NCT01266031|460428863|FG001|Overall Study|Not treated|3|||
127947790|NCT01266031|460428864|FG002|Overall Study|Not treated|2|||
127947791|NCT01434810|460428865|FG000|Overall Study|Did not receive treatment|11|||
127947792|NCT01434810|460428866|FG001|Overall Study|Did not receive treatment|3|||
127947793|NCT01434810|460428865|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
127947794|NCT01434810|460428866|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
127947795|NCT04893018|460428868|FG000|Overall Study|Lost to Follow-up|1|||
127947796|NCT04893018|460428869|FG001|Overall Study|Lost to Follow-up|0|||
127947797|NCT04893018|460428868|FG000|Overall Study|Withdrawal by Subject|2|||
127947798|NCT04893018|460428869|FG001|Overall Study|Withdrawal by Subject|0|||
127947799|NCT04893018|460428868|FG000|Overall Study|Study Terminated|1|||
127947800|NCT04893018|460428869|FG001|Overall Study|Study Terminated|2|||
127947801|NCT02252406|460428872|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
127947802|NCT02252406|460428873|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
127947803|NCT02252406|460428872|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
127947804|NCT02252406|460428873|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
127947805|NCT02252406|460428872|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
127947806|NCT02252406|460428873|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
127947807|NCT02252406|460428872|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
127947808|NCT02252406|460428873|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
127947809|NCT02252406|460428872|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
127947810|NCT02252406|460428873|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
127947811|NCT02533180|460428874|FG000|Overall Study|Death|0|||
127947812|NCT02533180|460428875|FG001|Overall Study|Death|2|||
127947813|NCT02533180|460428874|FG000|Overall Study|Lost to Follow-up|0|||
127947814|NCT02533180|460428875|FG001|Overall Study|Lost to Follow-up|1|||
127947815|NCT02533180|460428874|FG000|Overall Study|Physician Decision|0|||
127947816|NCT02533180|460428875|FG001|Overall Study|Physician Decision|1|||
127947817|NCT02533180|460428874|FG000|Overall Study|Withdrawal by Subject|2|||
127947818|NCT02533180|460428875|FG001|Overall Study|Withdrawal by Subject|5|||
127947819|NCT02533180|460428874|FG000|Overall Study|Screen Failure|37|||
127947820|NCT02533180|460428875|FG001|Overall Study|Screen Failure|0|||
127947821|NCT02533180|460428874|FG000|Overall Study|Protocol Deviation|0|||
127947822|NCT02533180|460428875|FG001|Overall Study|Protocol Deviation|1|||
127947823|NCT02533180|460428874|FG000|Overall Study|Non-compliance|0|||
127947824|NCT02533180|460428875|FG001|Overall Study|Non-compliance|1|||
127947825|NCT00447876|460428876|FG000|Overall Study|Withdrawal by Subject|1|||
127947826|NCT00447876|460428877|FG001|Overall Study|Withdrawal by Subject|4|||
127947827|NCT00447876|460428876|FG000|Overall Study|Lost to Follow-up|1|||
127947828|NCT00447876|460428877|FG001|Overall Study|Lost to Follow-up|0|||
127947829|NCT00447876|460428876|FG000|Overall Study|Deterioration of symptomology|1|||
127947830|NCT00447876|460428877|FG001|Overall Study|Deterioration of symptomology|0|||
127947831|NCT00005957|460428880|FG000|Overall Study|No treated|3|||
127947832|NCT00005957|460428881|FG001|Overall Study|No treated|9|||
127947833|NCT00005957|460428880|FG000|Overall Study|Crossover to the other arm|5|||
127947834|NCT00005957|460428881|FG001|Overall Study|Crossover to the other arm|19|||
127947835|NCT01609023|460428882|FG000|Overall Study|Lack of Efficacy|3|||
127947836|NCT01609023|460428882|FG000|Overall Study|Withdrawal by Subject|4|||
127947837|NCT01609023|460428882|FG000|Overall Study|Lost to Follow-up|8|||
127947838|NCT01609023|460428882|FG000|Overall Study|Toxicity|3|||
127947839|NCT01609023|460428882|FG000|Overall Study|Disease progression|10|||
127947840|NCT01609023|460428882|FG000|Overall Study|Physician Decision|2|||
127947841|NCT01609023|460428882|FG000|Overall Study|Death|2|||
127947842|NCT01609023|460428882|FG000|Overall Study|Personal reasons|1|||
127947843|NCT02047734|460428883|FG000|Overall Study|Adverse Event|18|||
127947844|NCT02047734|460428884|FG001|Overall Study|Adverse Event|13|||
127947845|NCT02047734|460428885|FG002|Overall Study|Adverse Event|13|||
127947846|NCT02047734|460428883|FG000|Overall Study|Lack of Efficacy|4|||
127947847|NCT02047734|460428884|FG001|Overall Study|Lack of Efficacy|5|||
127947848|NCT02047734|460428885|FG002|Overall Study|Lack of Efficacy|1|||
127947849|NCT02047734|460428883|FG000|Overall Study|Protocol Violation|3|||
127947850|NCT02047734|460428884|FG001|Overall Study|Protocol Violation|1|||
127947851|NCT02047734|460428885|FG002|Overall Study|Protocol Violation|1|||
127947852|NCT02047734|460428883|FG000|Overall Study|Lost to Follow-up|1|||
127947853|NCT02047734|460428884|FG001|Overall Study|Lost to Follow-up|4|||
127947854|NCT02047734|460428885|FG002|Overall Study|Lost to Follow-up|0|||
127947855|NCT02047734|460428883|FG000|Overall Study|Death|0|||
127947856|NCT02047734|460428884|FG001|Overall Study|Death|1|||
127947857|NCT02047734|460428885|FG002|Overall Study|Death|0|||
127947858|NCT02047734|460428883|FG000|Overall Study|Withdrawal by Subject|30|||
127947859|NCT02047734|460428884|FG001|Overall Study|Withdrawal by Subject|31|||
127947860|NCT02047734|460428885|FG002|Overall Study|Withdrawal by Subject|19|||
127947861|NCT02047734|460428883|FG000|Overall Study|Physician Decision|7|||
127947862|NCT02047734|460428884|FG001|Overall Study|Physician Decision|6|||
127947863|NCT02047734|460428885|FG002|Overall Study|Physician Decision|5|||
127947864|NCT02047734|460428883|FG000|Overall Study|Miscellaneous|2|||
127947865|NCT02047734|460428884|FG001|Overall Study|Miscellaneous|4|||
127947866|NCT02047734|460428885|FG002|Overall Study|Miscellaneous|6|||
127947867|NCT02047734|460428883|FG000|Overall Study|Did Not Receive Study Drug|2|||
127947868|NCT02047734|460428884|FG001|Overall Study|Did Not Receive Study Drug|4|||
127947869|NCT02047734|460428885|FG002|Overall Study|Did Not Receive Study Drug|1|||
127947870|NCT00492778|460428889|FG000|Overall Study|Ineligible by Pathology Review|8|||
127947871|NCT00492778|460428890|FG001|Overall Study|Ineligible by Pathology Review|1|||
127947872|NCT03717012|460428891|FG000|Overall Study|Due to trial termination|1|||
127947873|NCT03717012|460428892|FG001|Overall Study|Due to trial termination|2|||
127947874|NCT03717012|460428891|FG000|Overall Study|Protocol Violation|0|||
127947875|NCT03717012|460428892|FG001|Overall Study|Protocol Violation|2|||
127947876|NCT03717012|460428891|FG000|Overall Study|Adverse Event|0|||
127947877|NCT03717012|460428892|FG001|Overall Study|Adverse Event|1|||
127947878|NCT03717012|460428891|FG000|Overall Study|Lung transplant|0|||
127947879|NCT03717012|460428892|FG001|Overall Study|Lung transplant|1|||
127947880|NCT00789035|460428893|FG000|Overall Study|Adverse Event|0|||
127947881|NCT00789035|460428894|FG001|Overall Study|Adverse Event|2|||
127947882|NCT00789035|460428895|FG002|Overall Study|Adverse Event|0|||
127947883|NCT00789035|460428896|FG003|Overall Study|Adverse Event|1|||
127947884|NCT00789035|460428897|FG004|Overall Study|Adverse Event|3|||
127947885|NCT00789035|460428893|FG000|Overall Study|Lack of Efficacy|3|||
127947886|NCT00789035|460428894|FG001|Overall Study|Lack of Efficacy|0|||
127947887|NCT00789035|460428895|FG002|Overall Study|Lack of Efficacy|0|||
127947888|NCT00789035|460428896|FG003|Overall Study|Lack of Efficacy|0|||
127947889|NCT00789035|460428897|FG004|Overall Study|Lack of Efficacy|2|||
127947890|NCT00789035|460428893|FG000|Overall Study|Protocol Violation|1|||
127947891|NCT00789035|460428894|FG001|Overall Study|Protocol Violation|0|||
127947892|NCT00789035|460428895|FG002|Overall Study|Protocol Violation|0|||
127947893|NCT00789035|460428896|FG003|Overall Study|Protocol Violation|0|||
127947894|NCT00789035|460428897|FG004|Overall Study|Protocol Violation|0|||
127947895|NCT00789035|460428893|FG000|Overall Study|Withdrawal by Subject|0|||
127947896|NCT00789035|460428894|FG001|Overall Study|Withdrawal by Subject|2|||
127947897|NCT00789035|460428895|FG002|Overall Study|Withdrawal by Subject|0|||
127947898|NCT00789035|460428896|FG003|Overall Study|Withdrawal by Subject|0|||
127947899|NCT00789035|460428897|FG004|Overall Study|Withdrawal by Subject|0|||
127947900|NCT00789035|460428893|FG000|Overall Study|Other reason not defined above|2|||
127947901|NCT00789035|460428894|FG001|Overall Study|Other reason not defined above|3|||
127947902|NCT00789035|460428895|FG002|Overall Study|Other reason not defined above|1|||
127947903|NCT00789035|460428896|FG003|Overall Study|Other reason not defined above|0|||
127947904|NCT00789035|460428897|FG004|Overall Study|Other reason not defined above|1|||
127947905|NCT02640690|460428898|FG000|Overall Study|Lost to Follow-up|7|||
127947906|NCT02640690|460428899|FG001|Overall Study|Lost to Follow-up|7|||
127947907|NCT02640690|460428898|FG000|Overall Study|Withdrawal by Subject|16|||
127947908|NCT02640690|460428899|FG001|Overall Study|Withdrawal by Subject|20|||
127947909|NCT02640690|460428898|FG000|Overall Study|Partial completion (insufficient sessions)|2|||
127947910|NCT02640690|460428899|FG001|Overall Study|Partial completion (insufficient sessions)|5|||
127947911|NCT01118975|460428900|FG000|Overall Study|Adverse Event|0|||
127947912|NCT01118975|460428901|FG001|Overall Study|Adverse Event|1|||
127947913|NCT01520870|460428902|FG000|Overall Study|Withdrawal by Subject|2|||
127947914|NCT02463357|460428903|FG000|Overall Study|Withdrawal by Subject|1|||
127947915|NCT02463357|460428904|FG001|Overall Study|Withdrawal by Subject|0|||
127947916|NCT02463357|460428905|FG002|Overall Study|Withdrawal by Subject|0|||
127947917|NCT02463357|460428906|FG003|Overall Study|Withdrawal by Subject|0|||
127947918|NCT02463357|460428907|FG004|Overall Study|Withdrawal by Subject|0|||
127947919|NCT02463357|460428903|FG000|Overall Study|Withdrawal by Subject|0|||
127947920|NCT02463357|460428904|FG001|Overall Study|Withdrawal by Subject|0|||
127947921|NCT02463357|460428905|FG002|Overall Study|Withdrawal by Subject|0|||
127947922|NCT02463357|460428906|FG003|Overall Study|Withdrawal by Subject|0|||
127947923|NCT02463357|460428907|FG004|Overall Study|Withdrawal by Subject|1|||
127947924|NCT01399658|460428908|FG000|Overall Study|Ineligible|1|||
127947925|NCT01399658|460428908|FG000|Overall Study|Machine Technical Issue|3|||
127947926|NCT01399658|460428908|FG000|Overall Study|Alternative therapy|1|||
127947927|NCT01399658|460428908|FG000|Overall Study|No reason given|1|||
127947928|NCT02460679|460428909|FG000|Overall Study|Investigator Decision|1|||
127947929|NCT02460679|460428909|FG000|Overall Study|Withdrawal by Subject|4|||
127947930|NCT02620579|460428910|FG000|Overall Study|Physician Decision|0|||
127947931|NCT02620579|460428911|FG001|Overall Study|Physician Decision|0|||
127947932|NCT02620579|460428912|FG002|Overall Study|Physician Decision|0|||
127947933|NCT02620579|460428913|FG003|Overall Study|Physician Decision|1|||
127947934|NCT02620579|460428910|FG000|Overall Study|Withdrawal by Subject|0|||
127947935|NCT02620579|460428911|FG001|Overall Study|Withdrawal by Subject|1|||
127947936|NCT02620579|460428912|FG002|Overall Study|Withdrawal by Subject|1|||
127947937|NCT02620579|460428913|FG003|Overall Study|Withdrawal by Subject|0|||
127947938|NCT00796107|460428914|FG000|Overall Study|Lack of Efficacy|1|||
127947939|NCT00796107|460428914|FG000|Overall Study|Progressive Disease|5|||
127947940|NCT01721317|460428916|FG000|Overall Study|Study Closed / Terminated|2|||
127947941|NCT01721317|460428917|FG001|Overall Study|Study Closed / Terminated|2|||
127947942|NCT01721317|460428916|FG000|Overall Study|Physician Decision|0|||
127947943|NCT01721317|460428917|FG001|Overall Study|Physician Decision|1|||
127947944|NCT01721317|460428916|FG000|Overall Study|Withdrawal by Subject|0|||
127947945|NCT01721317|460428917|FG001|Overall Study|Withdrawal by Subject|1|||
127947946|NCT02806024|460428925|FG000|Overall Study|Night Delivery|1|||
127947947|NCT02806024|460428926|FG001|Overall Study|Night Delivery|1|||
127947948|NCT02806024|460428925|FG000|Overall Study|DVT during antepartum admission|0|||
127947949|NCT02806024|460428926|FG001|Overall Study|DVT during antepartum admission|1|||
127947950|NCT02892149|460428927|FG000|Overall Study|Death|262|||
127947951|NCT02892149|460428928|FG001|Overall Study|Death|278|||
127947952|NCT02892149|460428927|FG000|Overall Study|Withdrawal by Subject|53|||
127947953|NCT02892149|460428928|FG001|Overall Study|Withdrawal by Subject|47|||
127947954|NCT02892149|460428927|FG000|Overall Study|Lost to Follow-up|37|||
127947955|NCT02892149|460428928|FG001|Overall Study|Lost to Follow-up|31|||
127947956|NCT01994850|460428929|FG000|Overall Study|Physician Decision|1|||
127947957|NCT01994850|460428929|FG000|Overall Study|Withdrawal by Subject|1|||
127947958|NCT00025259|460428931|FG000|Overall Study|Death|1|||
127947959|NCT00025259|460428932|FG001|Overall Study|Death|3|||
127947960|NCT00025259|460428933|FG002|Overall Study|Death|0|||
127947961|NCT00025259|460428934|FG003|Overall Study|Death|3|||
127947962|NCT00025259|460428935|FG004|Overall Study|Death|0|||
127947963|NCT00025259|460428936|FG005|Overall Study|Death|1|||
127947964|NCT00025259|460428937|FG006|Overall Study|Death|2|||
127947965|NCT00025259|460428931|FG000|Overall Study|Lack of Efficacy|2|||
127947966|NCT00025259|460428932|FG001|Overall Study|Lack of Efficacy|46|||
127947967|NCT00025259|460428933|FG002|Overall Study|Lack of Efficacy|60|||
127947968|NCT00025259|460428934|FG003|Overall Study|Lack of Efficacy|78|||
127947969|NCT00025259|460428935|FG004|Overall Study|Lack of Efficacy|11|||
127947970|NCT00025259|460428936|FG005|Overall Study|Lack of Efficacy|30|||
127947971|NCT00025259|460428937|FG006|Overall Study|Lack of Efficacy|38|||
127947972|NCT00025259|460428931|FG000|Overall Study|Lost to Follow-up|2|||
127947973|NCT00025259|460428932|FG001|Overall Study|Lost to Follow-up|9|||
127947974|NCT00025259|460428933|FG002|Overall Study|Lost to Follow-up|13|||
127947975|NCT00025259|460428934|FG003|Overall Study|Lost to Follow-up|13|||
127947976|NCT00025259|460428935|FG004|Overall Study|Lost to Follow-up|1|||
127947977|NCT00025259|460428936|FG005|Overall Study|Lost to Follow-up|3|||
127947978|NCT00025259|460428937|FG006|Overall Study|Lost to Follow-up|1|||
127947979|NCT00025259|460428931|FG000|Overall Study|Physician Decision|12|||
127947980|NCT00025259|460428932|FG001|Overall Study|Physician Decision|1|||
127947981|NCT00025259|460428933|FG002|Overall Study|Physician Decision|0|||
127947982|NCT00025259|460428934|FG003|Overall Study|Physician Decision|5|||
127947983|NCT00025259|460428935|FG004|Overall Study|Physician Decision|4|||
127947984|NCT00025259|460428936|FG005|Overall Study|Physician Decision|2|||
127947985|NCT00025259|460428937|FG006|Overall Study|Physician Decision|1|||
127947986|NCT00025259|460428931|FG000|Overall Study|Protocol Violation|3|||
127947987|NCT00025259|460428932|FG001|Overall Study|Protocol Violation|2|||
127947988|NCT00025259|460428933|FG002|Overall Study|Protocol Violation|2|||
127947989|NCT00025259|460428934|FG003|Overall Study|Protocol Violation|1|||
127947990|NCT00025259|460428935|FG004|Overall Study|Protocol Violation|2|||
127947991|NCT00025259|460428936|FG005|Overall Study|Protocol Violation|1|||
127947992|NCT00025259|460428937|FG006|Overall Study|Protocol Violation|3|||
127947993|NCT00025259|460428931|FG000|Overall Study|Withdrawal by Subject|9|||
127947994|NCT00025259|460428932|FG001|Overall Study|Withdrawal by Subject|27|||
127947995|NCT00025259|460428933|FG002|Overall Study|Withdrawal by Subject|6|||
127947996|NCT00025259|460428934|FG003|Overall Study|Withdrawal by Subject|14|||
127947997|NCT00025259|460428935|FG004|Overall Study|Withdrawal by Subject|11|||
127947998|NCT00025259|460428936|FG005|Overall Study|Withdrawal by Subject|8|||
127947999|NCT00025259|460428937|FG006|Overall Study|Withdrawal by Subject|3|||
127948000|NCT00025259|460428931|FG000|Overall Study|Ineligible|14|||
127948001|NCT00025259|460428932|FG001|Overall Study|Ineligible|1|||
127948002|NCT00025259|460428933|FG002|Overall Study|Ineligible|0|||
127948003|NCT00025259|460428934|FG003|Overall Study|Ineligible|0|||
127948004|NCT00025259|460428935|FG004|Overall Study|Ineligible|6|||
127948005|NCT00025259|460428936|FG005|Overall Study|Ineligible|0|||
127948006|NCT00025259|460428937|FG006|Overall Study|Ineligible|1|||
127948007|NCT00025259|460428931|FG000|Overall Study|Randomization error|1|||
127948008|NCT00025259|460428932|FG001|Overall Study|Randomization error|0|||
127948009|NCT00025259|460428933|FG002|Overall Study|Randomization error|0|||
127948010|NCT00025259|460428934|FG003|Overall Study|Randomization error|0|||
127948011|NCT00025259|460428935|FG004|Overall Study|Randomization error|1|||
127948012|NCT00025259|460428936|FG005|Overall Study|Randomization error|7|||
127948013|NCT00025259|460428937|FG006|Overall Study|Randomization error|2|||
127948014|NCT00025259|460428931|FG000|Overall Study|Adverse Event|1|||
127948015|NCT00025259|460428932|FG001|Overall Study|Adverse Event|0|||
127948016|NCT00025259|460428933|FG002|Overall Study|Adverse Event|0|||
127948017|NCT00025259|460428934|FG003|Overall Study|Adverse Event|0|||
127948018|NCT00025259|460428935|FG004|Overall Study|Adverse Event|0|||
127948019|NCT00025259|460428936|FG005|Overall Study|Adverse Event|0|||
127948020|NCT00025259|460428937|FG006|Overall Study|Adverse Event|0|||
127948021|NCT00863772|460428938|FG000|Overall Study|Adverse Event|1|||
127948022|NCT00863772|460428939|FG001|Overall Study|Adverse Event|4|||
127948023|NCT00863772|460428940|FG002|Overall Study|Adverse Event|0|||
127948024|NCT00863772|460428938|FG000|Overall Study|Lack of Efficacy|4|||
127948025|NCT00863772|460428939|FG001|Overall Study|Lack of Efficacy|2|||
127948026|NCT00863772|460428940|FG002|Overall Study|Lack of Efficacy|4|||
127948027|NCT00863772|460428938|FG000|Overall Study|Lost to Follow-up|5|||
127948028|NCT00863772|460428939|FG001|Overall Study|Lost to Follow-up|1|||
127948029|NCT00863772|460428940|FG002|Overall Study|Lost to Follow-up|1|||
127948030|NCT00863772|460428938|FG000|Overall Study|Protocol Violation|2|||
127948031|NCT00863772|460428939|FG001|Overall Study|Protocol Violation|0|||
127948032|NCT00863772|460428940|FG002|Overall Study|Protocol Violation|2|||
127948033|NCT00863772|460428938|FG000|Overall Study|Withdrawal by Subject|4|||
127948034|NCT00863772|460428939|FG001|Overall Study|Withdrawal by Subject|7|||
127948035|NCT00863772|460428940|FG002|Overall Study|Withdrawal by Subject|5|||
127948036|NCT00863772|460428938|FG000|Overall Study|Study terminated by sponsor|44|||
127948037|NCT00863772|460428939|FG001|Overall Study|Study terminated by sponsor|45|||
127948038|NCT00863772|460428940|FG002|Overall Study|Study terminated by sponsor|36|||
127948039|NCT00863772|460428938|FG000|Overall Study|Entered extension study|6|||
127948040|NCT00863772|460428939|FG001|Overall Study|Entered extension study|4|||
127948041|NCT00863772|460428940|FG002|Overall Study|Entered extension study|9|||
127948042|NCT00863772|460428938|FG000|Overall Study|Other|1|||
127948043|NCT00863772|460428939|FG001|Overall Study|Other|2|||
127948044|NCT00863772|460428940|FG002|Overall Study|Other|4|||
127948045|NCT00863772|460428938|FG000|Overall Study|Randomized but not Treated|1|||
127948046|NCT00863772|460428939|FG001|Overall Study|Randomized but not Treated|0|||
127948047|NCT00863772|460428940|FG002|Overall Study|Randomized but not Treated|0|||
127948048|NCT01449370|460428941|FG000|Overall Study|Disease Progression|5|||
127948049|NCT01449370|460428942|FG001|Overall Study|Disease Progression|4|||
127948050|NCT01449370|460428943|FG002|Overall Study|Disease Progression|8|||
127948051|NCT01449370|460428944|FG003|Overall Study|Disease Progression|3|||
127948052|NCT01449370|460428945|FG004|Overall Study|Disease Progression|3|||
127948053|NCT01449370|460428946|FG005|Overall Study|Disease Progression|3|||
127948054|NCT01449370|460428947|FG006|Overall Study|Disease Progression|3|||
127948055|NCT01449370|460428948|FG007|Overall Study|Disease Progression|2|||
127948056|NCT01449370|460428949|FG008|Overall Study|Disease Progression|9|||
127948057|NCT01449370|460428950|FG009|Overall Study|Disease Progression|1|||
127948058|NCT01449370|460428951|FG010|Overall Study|Disease Progression|3|||
127948059|NCT01449370|460428952|FG011|Overall Study|Disease Progression|3|||
127948060|NCT01449370|460428953|FG012|Overall Study|Disease Progression|2|||
127948061|NCT01449370|460428954|FG013|Overall Study|Disease Progression|8|||
127948062|NCT01449370|460428955|FG014|Overall Study|Disease Progression|3|||
127948063|NCT01449370|460428956|FG015|Overall Study|Disease Progression|1|||
127948064|NCT01449370|460428957|FG016|Overall Study|Disease Progression|4|||
127948065|NCT01449370|460428958|FG017|Overall Study|Disease Progression|3|||
127948066|NCT01449370|460428959|FG018|Overall Study|Disease Progression|1|||
127948067|NCT01449370|460428960|FG019|Overall Study|Disease Progression|2|||
127948068|NCT01449370|460428961|FG020|Overall Study|Disease Progression|5|||
127948069|NCT01449370|460428962|FG021|Overall Study|Disease Progression|2|||
127948070|NCT01449370|460428963|FG022|Overall Study|Disease Progression|3|||
127948071|NCT01449370|460428964|FG023|Overall Study|Disease Progression|7|||
127948072|NCT01449370|460428965|FG024|Overall Study|Disease Progression|3|||
127948073|NCT01449370|460428941|FG000|Overall Study|Adverse Event|1|||
127948074|NCT01449370|460428942|FG001|Overall Study|Adverse Event|2|||
127948075|NCT01449370|460428943|FG002|Overall Study|Adverse Event|0|||
127948076|NCT01449370|460428944|FG003|Overall Study|Adverse Event|1|||
127948077|NCT01449370|460428945|FG004|Overall Study|Adverse Event|0|||
127948078|NCT01449370|460428946|FG005|Overall Study|Adverse Event|0|||
127948079|NCT01449370|460428947|FG006|Overall Study|Adverse Event|0|||
127948080|NCT01449370|460428948|FG007|Overall Study|Adverse Event|0|||
127948081|NCT01449370|460428949|FG008|Overall Study|Adverse Event|1|||
127948082|NCT01449370|460428950|FG009|Overall Study|Adverse Event|1|||
127948083|NCT01449370|460428951|FG010|Overall Study|Adverse Event|0|||
127948084|NCT01449370|460428952|FG011|Overall Study|Adverse Event|0|||
127948085|NCT01449370|460428953|FG012|Overall Study|Adverse Event|0|||
127948086|NCT01449370|460428954|FG013|Overall Study|Adverse Event|2|||
127948087|NCT01449370|460428955|FG014|Overall Study|Adverse Event|0|||
127948088|NCT01449370|460428956|FG015|Overall Study|Adverse Event|1|||
127948089|NCT01449370|460428957|FG016|Overall Study|Adverse Event|0|||
127948090|NCT01449370|460428958|FG017|Overall Study|Adverse Event|0|||
127948091|NCT01449370|460428959|FG018|Overall Study|Adverse Event|1|||
127948092|NCT01449370|460428960|FG019|Overall Study|Adverse Event|1|||
127948093|NCT01449370|460428961|FG020|Overall Study|Adverse Event|0|||
127948094|NCT01449370|460428962|FG021|Overall Study|Adverse Event|1|||
127948095|NCT01449370|460428963|FG022|Overall Study|Adverse Event|0|||
127948096|NCT01449370|460428964|FG023|Overall Study|Adverse Event|1|||
127948097|NCT01449370|460428965|FG024|Overall Study|Adverse Event|3|||
127948098|NCT01449370|460428941|FG000|Overall Study|Participant Decision|0|||
127948099|NCT01449370|460428942|FG001|Overall Study|Participant Decision|0|||
127948100|NCT01449370|460428943|FG002|Overall Study|Participant Decision|0|||
127948101|NCT01449370|460428944|FG003|Overall Study|Participant Decision|0|||
127948102|NCT01449370|460428945|FG004|Overall Study|Participant Decision|0|||
127948103|NCT01449370|460428946|FG005|Overall Study|Participant Decision|0|||
127948104|NCT01449370|460428947|FG006|Overall Study|Participant Decision|0|||
127948105|NCT01449370|460428948|FG007|Overall Study|Participant Decision|1|||
127948106|NCT01449370|460428949|FG008|Overall Study|Participant Decision|1|||
127948107|NCT01449370|460428950|FG009|Overall Study|Participant Decision|0|||
127948108|NCT01449370|460428951|FG010|Overall Study|Participant Decision|0|||
127948109|NCT01449370|460428952|FG011|Overall Study|Participant Decision|0|||
127948110|NCT01449370|460428953|FG012|Overall Study|Participant Decision|1|||
127948111|NCT01449370|460428954|FG013|Overall Study|Participant Decision|1|||
127948112|NCT01449370|460428955|FG014|Overall Study|Participant Decision|0|||
127948113|NCT01449370|460428956|FG015|Overall Study|Participant Decision|1|||
127948114|NCT01449370|460428957|FG016|Overall Study|Participant Decision|3|||
127948115|NCT01449370|460428958|FG017|Overall Study|Participant Decision|0|||
127948116|NCT01449370|460428959|FG018|Overall Study|Participant Decision|1|||
127948117|NCT01449370|460428960|FG019|Overall Study|Participant Decision|0|||
127948118|NCT01449370|460428961|FG020|Overall Study|Participant Decision|0|||
127948119|NCT01449370|460428962|FG021|Overall Study|Participant Decision|1|||
127948120|NCT01449370|460428963|FG022|Overall Study|Participant Decision|0|||
127948121|NCT01449370|460428964|FG023|Overall Study|Participant Decision|0|||
127948122|NCT01449370|460428965|FG024|Overall Study|Participant Decision|1|||
127948123|NCT01449370|460428941|FG000|Overall Study|Lost to Follow-up|0|||
127948124|NCT01449370|460428942|FG001|Overall Study|Lost to Follow-up|0|||
127948125|NCT01449370|460428943|FG002|Overall Study|Lost to Follow-up|0|||
127948126|NCT01449370|460428944|FG003|Overall Study|Lost to Follow-up|0|||
127948127|NCT01449370|460428945|FG004|Overall Study|Lost to Follow-up|0|||
127948128|NCT01449370|460428946|FG005|Overall Study|Lost to Follow-up|0|||
127948129|NCT01449370|460428947|FG006|Overall Study|Lost to Follow-up|0|||
127948130|NCT01449370|460428948|FG007|Overall Study|Lost to Follow-up|0|||
127948131|NCT01449370|460428949|FG008|Overall Study|Lost to Follow-up|0|||
127948132|NCT01449370|460428950|FG009|Overall Study|Lost to Follow-up|0|||
127948133|NCT01449370|460428951|FG010|Overall Study|Lost to Follow-up|0|||
127948134|NCT01449370|460428952|FG011|Overall Study|Lost to Follow-up|0|||
127948135|NCT01449370|460428953|FG012|Overall Study|Lost to Follow-up|0|||
127948136|NCT01449370|460428954|FG013|Overall Study|Lost to Follow-up|0|||
127948137|NCT01449370|460428955|FG014|Overall Study|Lost to Follow-up|0|||
127948138|NCT01449370|460428956|FG015|Overall Study|Lost to Follow-up|0|||
127948139|NCT01449370|460428957|FG016|Overall Study|Lost to Follow-up|0|||
127948140|NCT01449370|460428958|FG017|Overall Study|Lost to Follow-up|0|||
127948141|NCT01449370|460428959|FG018|Overall Study|Lost to Follow-up|0|||
127948142|NCT01449370|460428960|FG019|Overall Study|Lost to Follow-up|0|||
127948143|NCT01449370|460428961|FG020|Overall Study|Lost to Follow-up|1|||
127948144|NCT01449370|460428962|FG021|Overall Study|Lost to Follow-up|0|||
127948145|NCT01449370|460428963|FG022|Overall Study|Lost to Follow-up|0|||
127948146|NCT01449370|460428964|FG023|Overall Study|Lost to Follow-up|0|||
127948147|NCT01449370|460428965|FG024|Overall Study|Lost to Follow-up|0|||
127948148|NCT01449370|460428941|FG000|Overall Study|Other|0|||
127948149|NCT01449370|460428942|FG001|Overall Study|Other|0|||
127948150|NCT01449370|460428943|FG002|Overall Study|Other|0|||
127948151|NCT01449370|460428944|FG003|Overall Study|Other|0|||
127948152|NCT01449370|460428945|FG004|Overall Study|Other|0|||
127948153|NCT01449370|460428946|FG005|Overall Study|Other|0|||
127948154|NCT01449370|460428947|FG006|Overall Study|Other|0|||
127948155|NCT01449370|460428948|FG007|Overall Study|Other|0|||
127948156|NCT01449370|460428949|FG008|Overall Study|Other|1|||
127948157|NCT01449370|460428950|FG009|Overall Study|Other|1|||
127948158|NCT01449370|460428951|FG010|Overall Study|Other|0|||
127948159|NCT01449370|460428952|FG011|Overall Study|Other|0|||
127948160|NCT01449370|460428953|FG012|Overall Study|Other|0|||
127948161|NCT01449370|460428954|FG013|Overall Study|Other|0|||
127948162|NCT01449370|460428955|FG014|Overall Study|Other|0|||
127948163|NCT01449370|460428956|FG015|Overall Study|Other|0|||
127948164|NCT01449370|460428957|FG016|Overall Study|Other|0|||
127948165|NCT01449370|460428958|FG017|Overall Study|Other|0|||
127948166|NCT01449370|460428959|FG018|Overall Study|Other|0|||
127948167|NCT01449370|460428960|FG019|Overall Study|Other|0|||
127948168|NCT01449370|460428961|FG020|Overall Study|Other|0|||
127948169|NCT01449370|460428962|FG021|Overall Study|Other|0|||
127948170|NCT01449370|460428963|FG022|Overall Study|Other|1|||
127948171|NCT01449370|460428964|FG023|Overall Study|Other|1|||
127948172|NCT01449370|460428965|FG024|Overall Study|Other|0|||
127948173|NCT01449370|460428941|FG000|Overall Study|Medication Prohibited by Protocol|0|||
127948174|NCT01449370|460428942|FG001|Overall Study|Medication Prohibited by Protocol|0|||
127948175|NCT01449370|460428943|FG002|Overall Study|Medication Prohibited by Protocol|0|||
127948176|NCT01449370|460428944|FG003|Overall Study|Medication Prohibited by Protocol|0|||
127948177|NCT01449370|460428945|FG004|Overall Study|Medication Prohibited by Protocol|0|||
127948178|NCT01449370|460428946|FG005|Overall Study|Medication Prohibited by Protocol|0|||
127948179|NCT01449370|460428947|FG006|Overall Study|Medication Prohibited by Protocol|0|||
127948180|NCT01449370|460428948|FG007|Overall Study|Medication Prohibited by Protocol|0|||
127948181|NCT01449370|460428949|FG008|Overall Study|Medication Prohibited by Protocol|0|||
127948182|NCT01449370|460428950|FG009|Overall Study|Medication Prohibited by Protocol|0|||
127948183|NCT01449370|460428951|FG010|Overall Study|Medication Prohibited by Protocol|0|||
127948184|NCT01449370|460428952|FG011|Overall Study|Medication Prohibited by Protocol|0|||
127948185|NCT01449370|460428953|FG012|Overall Study|Medication Prohibited by Protocol|0|||
127948186|NCT01449370|460428954|FG013|Overall Study|Medication Prohibited by Protocol|0|||
127948187|NCT01449370|460428955|FG014|Overall Study|Medication Prohibited by Protocol|0|||
127948188|NCT01449370|460428956|FG015|Overall Study|Medication Prohibited by Protocol|0|||
127948189|NCT01449370|460428957|FG016|Overall Study|Medication Prohibited by Protocol|0|||
127948190|NCT01449370|460428958|FG017|Overall Study|Medication Prohibited by Protocol|0|||
127948191|NCT01449370|460428959|FG018|Overall Study|Medication Prohibited by Protocol|0|||
127948192|NCT01449370|460428960|FG019|Overall Study|Medication Prohibited by Protocol|0|||
127948193|NCT01449370|460428961|FG020|Overall Study|Medication Prohibited by Protocol|0|||
127948194|NCT01449370|460428962|FG021|Overall Study|Medication Prohibited by Protocol|0|||
127948195|NCT01449370|460428963|FG022|Overall Study|Medication Prohibited by Protocol|0|||
127948196|NCT01449370|460428964|FG023|Overall Study|Medication Prohibited by Protocol|1|||
127948197|NCT01449370|460428965|FG024|Overall Study|Medication Prohibited by Protocol|0|||
127948198|NCT01449370|460428941|FG000|Overall Study|Death|0|||
127948199|NCT01449370|460428942|FG001|Overall Study|Death|0|||
127948200|NCT01449370|460428943|FG002|Overall Study|Death|0|||
127948201|NCT01449370|460428944|FG003|Overall Study|Death|0|||
127948202|NCT01449370|460428945|FG004|Overall Study|Death|0|||
127948203|NCT01449370|460428946|FG005|Overall Study|Death|0|||
127948204|NCT01449370|460428947|FG006|Overall Study|Death|0|||
127948205|NCT01449370|460428948|FG007|Overall Study|Death|0|||
127948206|NCT01449370|460428949|FG008|Overall Study|Death|0|||
127948207|NCT01449370|460428950|FG009|Overall Study|Death|0|||
127948208|NCT01449370|460428951|FG010|Overall Study|Death|0|||
127948209|NCT01449370|460428952|FG011|Overall Study|Death|0|||
127948210|NCT01449370|460428953|FG012|Overall Study|Death|0|||
127948211|NCT01449370|460428954|FG013|Overall Study|Death|0|||
127948212|NCT01449370|460428955|FG014|Overall Study|Death|0|||
127948213|NCT01449370|460428956|FG015|Overall Study|Death|0|||
127948214|NCT01449370|460428957|FG016|Overall Study|Death|0|||
127948215|NCT01449370|460428958|FG017|Overall Study|Death|0|||
127948216|NCT01449370|460428959|FG018|Overall Study|Death|0|||
127948217|NCT01449370|460428960|FG019|Overall Study|Death|0|||
127948218|NCT01449370|460428961|FG020|Overall Study|Death|0|||
127948219|NCT01449370|460428962|FG021|Overall Study|Death|0|||
127948220|NCT01449370|460428963|FG022|Overall Study|Death|0|||
127948221|NCT01449370|460428964|FG023|Overall Study|Death|0|||
127948222|NCT01449370|460428965|FG024|Overall Study|Death|1|||
127948223|NCT00534404|460428970|FG000|Overall Study|Death|0|||
127948224|NCT00534404|460428971|FG001|Overall Study|Death|0|||
127948225|NCT00534404|460428972|FG002|Overall Study|Death|2|||
127948226|NCT00534404|460428970|FG000|Overall Study|Withdrawal by Subject|8|||
127948227|NCT00534404|460428971|FG001|Overall Study|Withdrawal by Subject|2|||
127948228|NCT00534404|460428972|FG002|Overall Study|Withdrawal by Subject|38|||
127948229|NCT00534404|460428970|FG000|Overall Study|Removed by study staff|2|||
127948230|NCT00534404|460428971|FG001|Overall Study|Removed by study staff|3|||
127948231|NCT00534404|460428972|FG002|Overall Study|Removed by study staff|1|||
127948232|NCT00534404|460428970|FG000|Overall Study|Lost to Follow-up|170|||
127948233|NCT00534404|460428971|FG001|Overall Study|Lost to Follow-up|138|||
127948234|NCT00534404|460428972|FG002|Overall Study|Lost to Follow-up|201|||
127948235|NCT00315731|460428977|FG000|Overall Study|Lost to Follow-up|1|||
127948236|NCT00315731|460428977|FG000|Overall Study|Death|5|||
127948237|NCT04614246|460428978|FG000|Overall Study|Adverse Event|0|||
127948238|NCT04614246|460428979|FG001|Overall Study|Adverse Event|1|||
127948239|NCT04614246|460428980|FG002|Overall Study|Adverse Event|1|||
127948240|NCT04614246|460428981|FG003|Overall Study|Adverse Event|2|||
127948241|NCT04614246|460428982|FG004|Overall Study|Adverse Event|1|||
127948242|NCT04614246|460428978|FG000|Overall Study|Lost to Follow-up|0|||
127948243|NCT04614246|460428979|FG001|Overall Study|Lost to Follow-up|1|||
127948244|NCT04614246|460428980|FG002|Overall Study|Lost to Follow-up|0|||
127948245|NCT04614246|460428981|FG003|Overall Study|Lost to Follow-up|1|||
127948246|NCT04614246|460428982|FG004|Overall Study|Lost to Follow-up|3|||
127948247|NCT04614246|460428978|FG000|Overall Study|Other reason|0|||
127948248|NCT04614246|460428979|FG001|Overall Study|Other reason|1|||
127948249|NCT04614246|460428980|FG002|Overall Study|Other reason|2|||
127948250|NCT04614246|460428981|FG003|Overall Study|Other reason|0|||
127948251|NCT04614246|460428982|FG004|Overall Study|Other reason|0|||
127948252|NCT04614246|460428978|FG000|Overall Study|Withdrawal by Subject|4|||
127948253|NCT04614246|460428979|FG001|Overall Study|Withdrawal by Subject|2|||
127948254|NCT04614246|460428980|FG002|Overall Study|Withdrawal by Subject|4|||
127948255|NCT04614246|460428981|FG003|Overall Study|Withdrawal by Subject|3|||
127948256|NCT04614246|460428982|FG004|Overall Study|Withdrawal by Subject|4|||
127948257|NCT04614246|460428978|FG000|Overall Study|Physician Decision|0|||
127948258|NCT04614246|460428979|FG001|Overall Study|Physician Decision|2|||
127948259|NCT04614246|460428980|FG002|Overall Study|Physician Decision|1|||
127948260|NCT04614246|460428981|FG003|Overall Study|Physician Decision|0|||
127948261|NCT04614246|460428982|FG004|Overall Study|Physician Decision|0|||
127948262|NCT04614246|460428978|FG000|Overall Study|Study terminated by sponsor|10|||
127948263|NCT04614246|460428979|FG001|Overall Study|Study terminated by sponsor|15|||
127948264|NCT04614246|460428980|FG002|Overall Study|Study terminated by sponsor|12|||
127948265|NCT04614246|460428981|FG003|Overall Study|Study terminated by sponsor|13|||
127948266|NCT04614246|460428982|FG004|Overall Study|Study terminated by sponsor|9|||
127948267|NCT04614246|460428978|FG000|Overall Study|Pregnancy|2|||
127948268|NCT04614246|460428979|FG001|Overall Study|Pregnancy|0|||
127948269|NCT04614246|460428980|FG002|Overall Study|Pregnancy|1|||
127948270|NCT04614246|460428981|FG003|Overall Study|Pregnancy|0|||
127948271|NCT04614246|460428982|FG004|Overall Study|Pregnancy|0|||
127948272|NCT01680497|460428983|FG000|Overall Study|Lost to Follow-up|2|||
127948273|NCT00725205|460428984|FG000|Overall Study|Adverse Event|22|||
127948274|NCT00725205|460428984|FG000|Overall Study|Investigator Discontinued|1|||
127948275|NCT00725205|460428984|FG000|Overall Study|Non-compliance With Protocol|14|||
127948276|NCT00725205|460428984|FG000|Overall Study|Other|8|||
127948277|NCT00725205|460428984|FG000|Overall Study|Protocol Defined Clinical Event|1|||
127948278|NCT00725205|460428984|FG000|Overall Study|Treatment Failure|41|||
127948279|NCT04981717|460431090|FG000|Overall Study|Protocol Violation|0|||
127948280|NCT04981717|460431091|FG001|Overall Study|Protocol Violation|3|||
127948281|NCT04981717|460431090|FG000|Overall Study|Adverse Event|1|||
127948282|NCT04981717|460431091|FG001|Overall Study|Adverse Event|3|||
127948283|NCT04981717|460431090|FG000|Overall Study|Pregnancy|1|||
127948284|NCT04981717|460431091|FG001|Overall Study|Pregnancy|0|||
127948285|NCT04981717|460431090|FG000|Overall Study|Physician Decision|1|||
127948286|NCT04981717|460431091|FG001|Overall Study|Physician Decision|0|||
127948287|NCT04981717|460431090|FG000|Overall Study|Sponsor Request|157|||
127948288|NCT04981717|460431091|FG001|Overall Study|Sponsor Request|172|||
127948289|NCT04981717|460431090|FG000|Overall Study|Lost to Follow-up|4|||
127948290|NCT04981717|460431091|FG001|Overall Study|Lost to Follow-up|5|||
127948291|NCT04981717|460431090|FG000|Overall Study|Withdrawal by Subject|50|||
127948292|NCT04981717|460431091|FG001|Overall Study|Withdrawal by Subject|37|||
127948293|NCT02207634|460431092|FG000|Overall Study|Withdrawal by Subject|21|||
127948294|NCT02207634|460431093|FG001|Overall Study|Withdrawal by Subject|31|||
127948295|NCT02207634|460431092|FG000|Overall Study|Lost to Follow-up|1|||
127948296|NCT02207634|460431093|FG001|Overall Study|Lost to Follow-up|0|||
127948297|NCT00887289|460431094|FG000|Overall Study|Lack of Efficacy|14|||
127948298|NCT00887289|460431094|FG000|Overall Study|Adverse Event|27|||
127948299|NCT00887289|460431094|FG000|Overall Study|Withdrawal by Subject|26|||
127948300|NCT00887289|460431094|FG000|Overall Study|Lost to Follow-up|8|||
127948301|NCT00887289|460431094|FG000|Overall Study|Other|20|||
127948302|NCT00591773|460431097|FG000|Overall Study|Adverse Event|9|||
127948303|NCT00591773|460431098|FG001|Overall Study|Adverse Event|9|||
127948304|NCT00591773|460431099|FG002|Overall Study|Adverse Event|6|||
127948305|NCT00591773|460431097|FG000|Overall Study|Protocol Violation|2|||
127948306|NCT00591773|460431098|FG001|Overall Study|Protocol Violation|3|||
127948307|NCT00591773|460431099|FG002|Overall Study|Protocol Violation|0|||
127948308|NCT00591773|460431097|FG000|Overall Study|Lost to Follow-up|1|||
127948309|NCT00591773|460431098|FG001|Overall Study|Lost to Follow-up|4|||
127948310|NCT00591773|460431099|FG002|Overall Study|Lost to Follow-up|1|||
127948311|NCT00591773|460431097|FG000|Overall Study|Withdrawal by Subject|2|||
127948312|NCT00591773|460431098|FG001|Overall Study|Withdrawal by Subject|5|||
127948313|NCT00591773|460431099|FG002|Overall Study|Withdrawal by Subject|3|||
127948314|NCT00591773|460431097|FG000|Overall Study|Lack of Efficacy|1|||
127948315|NCT00591773|460431098|FG001|Overall Study|Lack of Efficacy|2|||
127948316|NCT00591773|460431099|FG002|Overall Study|Lack of Efficacy|2|||
127948317|NCT00591773|460431097|FG000|Overall Study|Other|1|||
127948318|NCT00591773|460431098|FG001|Overall Study|Other|1|||
127948319|NCT00591773|460431099|FG002|Overall Study|Other|4|||
127948320|NCT00459355|460431100|FG000|Overall Study|Subject no longer met inc criteria|20|||
127948321|NCT00459355|460431101|FG001|Overall Study|Subject no longer met inc criteria|18|||
127948322|NCT02135614|460431102|FG000|Overall Study|Randomized but Not Treated|2|||
127948323|NCT02135614|460431103|FG001|Overall Study|Randomized but Not Treated|1|||
127948324|NCT02135614|460431102|FG000|Overall Study|Adverse Event|0|||
127948325|NCT02135614|460431103|FG001|Overall Study|Adverse Event|1|||
127948326|NCT02135614|460431102|FG000|Overall Study|Death|1|||
127948327|NCT02135614|460431103|FG001|Overall Study|Death|0|||
127948328|NCT02135614|460431102|FG000|Overall Study|Investigator's Discretion|0|||
127948329|NCT02135614|460431103|FG001|Overall Study|Investigator's Discretion|1|||
127948330|NCT02135614|460431102|FG000|Overall Study|Withdrew Consent|2|||
127948331|NCT02135614|460431103|FG001|Overall Study|Withdrew Consent|2|||
127948332|NCT02135614|460431102|FG000|Overall Study|Lost to Follow-up|3|||
127948333|NCT02135614|460431103|FG001|Overall Study|Lost to Follow-up|0|||
127948334|NCT01275729|460431109|FG000|Overall Study|Death|3|||
127948335|NCT01275729|460431109|FG000|Overall Study|Withdrawal by Subject|1|||
127948336|NCT00799825|460431110|FG000|Overall Study|Adverse Event|1|||
127948337|NCT00799825|460431110|FG000|Overall Study|Withdrawal by Subject|6|||
127948338|NCT00799825|460431110|FG000|Overall Study|Lost to Follow-up|38|||
127948339|NCT00799825|460431110|FG000|Overall Study|Pregnancy|3|||
127948340|NCT02439970|460431111|FG000|Overall Study|Study Terminated|2|||
127948341|NCT02439970|460431112|FG001|Overall Study|Study Terminated|3|||
127948342|NCT02910011|460431115|FG000|Overall Study|Physician Decision|2|||
127948343|NCT03713632|460431123|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
127948344|NCT03713632|460431124|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
127948345|NCT03713632|460431125|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
127948346|NCT03713632|460431126|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
127948347|NCT03713632|460431127|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
127948348|NCT03713632|460431123|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
127948349|NCT03713632|460431124|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
127948350|NCT03713632|460431125|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
127948351|NCT03713632|460431126|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
127948352|NCT03713632|460431127|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
127948353|NCT03713632|460431123|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
127948354|NCT03713632|460431124|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
127948355|NCT03713632|460431125|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
127948356|NCT03713632|460431126|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
127948357|NCT03713632|460431127|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
127948358|NCT03713632|460431123|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
127948359|NCT03713632|460431124|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
127948360|NCT03713632|460431125|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
127948361|NCT03713632|460431126|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
127948362|NCT03713632|460431127|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
127948363|NCT03713632|460431123|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
127948364|NCT03713632|460431124|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
127948365|NCT03713632|460431125|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
127948366|NCT03713632|460431126|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
127948367|NCT03713632|460431127|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
127948368|NCT03713632|460431123|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
127948369|NCT03713632|460431124|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
127948370|NCT03713632|460431125|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
127948371|NCT03713632|460431126|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
127948372|NCT03713632|460431127|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
127948373|NCT03713632|460431123|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
127948374|NCT03713632|460431124|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
127948375|NCT03713632|460431125|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
127948376|NCT03713632|460431126|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
127948377|NCT03713632|460431127|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
127948378|NCT03713632|460431123|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
127948379|NCT03713632|460431124|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
127948380|NCT03713632|460431125|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
127948381|NCT03713632|460431126|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
127948382|NCT03713632|460431127|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
127948383|NCT03713632|460431123|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
127948384|NCT03713632|460431124|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
127948385|NCT03713632|460431125|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
127948386|NCT03713632|460431126|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
127948387|NCT03713632|460431127|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
127948388|NCT03713632|460431123|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
127948389|NCT03713632|460431124|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
127948390|NCT03713632|460431125|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
127948391|NCT03713632|460431126|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
127948392|NCT03713632|460431127|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
127948393|NCT03713632|460431123|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
127948394|NCT03713632|460431124|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
127948395|NCT03713632|460431125|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
127948396|NCT03713632|460431126|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
127948397|NCT03713632|460431127|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
127948398|NCT03713632|460431123|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
127948399|NCT03713632|460431124|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
127948400|NCT03713632|460431125|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
127948401|NCT03713632|460431126|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
127948402|NCT03713632|460431127|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
127948403|NCT03713632|460431123|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
127948404|NCT03713632|460431124|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
127948405|NCT03713632|460431125|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
127948406|NCT03713632|460431126|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
127948407|NCT03713632|460431127|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
127948408|NCT03713632|460431123|FG000|Treatment Period 2 (After Week 16)|Death|0|||
127948409|NCT03713632|460431124|FG001|Treatment Period 2 (After Week 16)|Death|1|||
127948410|NCT03713632|460431125|FG002|Treatment Period 2 (After Week 16)|Death|0|||
127948411|NCT03713632|460431126|FG003|Treatment Period 2 (After Week 16)|Death|0|||
127948412|NCT03713632|460431127|FG004|Treatment Period 2 (After Week 16)|Death|0|||
127948413|NCT03713632|460431123|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
127948414|NCT03713632|460431124|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
127948415|NCT03713632|460431125|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
127948416|NCT03713632|460431126|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
127948417|NCT03713632|460431127|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
127948418|NCT01098474|460431128|FG000|Active Phase|Other|0|||
127948419|NCT01098474|460431129|FG001|Active Phase|Other|0|||
127948420|NCT01098474|460431130|FG002|Active Phase|Other|3|||
127948421|NCT01098474|460431131|FG003|Active Phase|Other|0|||
127948422|NCT01098474|460431132|FG004|Active Phase|Other|0|||
127948423|NCT01098474|460431133|FG005|Active Phase|Other|0|||
127948424|NCT01098474|460431128|FG000|Active Phase|Withdrawal by Subject|1|||
127948425|NCT01098474|460431129|FG001|Active Phase|Withdrawal by Subject|1|||
127948426|NCT01098474|460431130|FG002|Active Phase|Withdrawal by Subject|2|||
127948427|NCT01098474|460431131|FG003|Active Phase|Withdrawal by Subject|0|||
127948428|NCT01098474|460431132|FG004|Active Phase|Withdrawal by Subject|0|||
127948429|NCT01098474|460431133|FG005|Active Phase|Withdrawal by Subject|0|||
127948430|NCT01098474|460431128|FG000|Active Phase|Lost to Follow-up|1|||
127948431|NCT01098474|460431129|FG001|Active Phase|Lost to Follow-up|0|||
127948432|NCT01098474|460431130|FG002|Active Phase|Lost to Follow-up|0|||
127948433|NCT01098474|460431131|FG003|Active Phase|Lost to Follow-up|0|||
127948434|NCT01098474|460431132|FG004|Active Phase|Lost to Follow-up|0|||
127948435|NCT01098474|460431133|FG005|Active Phase|Lost to Follow-up|0|||
127948436|NCT01098474|460431128|FG000|Follow Up Phase|Travelled out of study area|0|||
127948437|NCT01098474|460431129|FG001|Follow Up Phase|Travelled out of study area|0|||
127948438|NCT01098474|460431130|FG002|Follow Up Phase|Travelled out of study area|0|||
127948439|NCT01098474|460431131|FG003|Follow Up Phase|Travelled out of study area|0|||
127948440|NCT01098474|460431132|FG004|Follow Up Phase|Travelled out of study area|1|||
127948441|NCT01098474|460431133|FG005|Follow Up Phase|Travelled out of study area|0|||
127948442|NCT01098474|460431128|FG000|Follow Up Phase|Other|0|||
127948443|NCT01098474|460431129|FG001|Follow Up Phase|Other|0|||
127948444|NCT01098474|460431130|FG002|Follow Up Phase|Other|0|||
127948445|NCT01098474|460431131|FG003|Follow Up Phase|Other|0|||
127948446|NCT01098474|460431132|FG004|Follow Up Phase|Other|0|||
127948447|NCT01098474|460431133|FG005|Follow Up Phase|Other|4|||
127948448|NCT01098474|460431128|FG000|Follow Up Phase|Withdrawal by Subject|0|||
127948449|NCT01098474|460431129|FG001|Follow Up Phase|Withdrawal by Subject|0|||
127948450|NCT01098474|460431130|FG002|Follow Up Phase|Withdrawal by Subject|0|||
127948451|NCT01098474|460431131|FG003|Follow Up Phase|Withdrawal by Subject|2|||
127948452|NCT01098474|460431132|FG004|Follow Up Phase|Withdrawal by Subject|0|||
127948453|NCT01098474|460431133|FG005|Follow Up Phase|Withdrawal by Subject|1|||
127948454|NCT01098474|460431128|FG000|Follow Up Phase|Lost to Follow-up|0|||
127948455|NCT01098474|460431129|FG001|Follow Up Phase|Lost to Follow-up|0|||
127948456|NCT01098474|460431130|FG002|Follow Up Phase|Lost to Follow-up|0|||
127948457|NCT01098474|460431131|FG003|Follow Up Phase|Lost to Follow-up|0|||
127948458|NCT01098474|460431132|FG004|Follow Up Phase|Lost to Follow-up|1|||
127948459|NCT01098474|460431133|FG005|Follow Up Phase|Lost to Follow-up|0|||
127948460|NCT00595309|460431136|FG000|Overall Study|Lost to Follow-up|1|||
127948461|NCT00595309|460431136|FG000|Overall Study|planned vaccination against yellow fever|1|||
127948462|NCT00595309|460431136|FG000|Overall Study|acute infection after V0|1|||
127948463|NCT00595309|460431136|FG000|Overall Study|personal reason|1|||
127948464|NCT00101283|460431137|FG000|Overall Study|Withdrawal by Subject|0|||
127948465|NCT00101283|460431138|FG001|Overall Study|Withdrawal by Subject|1|||
127948466|NCT00101283|460431137|FG000|Overall Study|Insurance Refusal|0|||
127948467|NCT00101283|460431138|FG001|Overall Study|Insurance Refusal|1|||
127948468|NCT00101283|460431137|FG000|Overall Study|Prostate Cancer Recurrence|0|||
127948469|NCT00101283|460431138|FG001|Overall Study|Prostate Cancer Recurrence|1|||
127948470|NCT00626561|460431139|FG000|Overall Study|Withdrawal by Subject|2|||
127948471|NCT00626561|460431139|FG000|Overall Study|Disease Progression|2|||
127948472|NCT00398866|460431144|FG000|Overall Study|Adverse Event|1|||
127948473|NCT00398866|460431145|FG001|Overall Study|Adverse Event|0|||
127948474|NCT00398866|460431146|FG002|Overall Study|Adverse Event|0|||
127948475|NCT00398866|460431144|FG000|Overall Study|Lack of Efficacy|0|||
127948476|NCT00398866|460431145|FG001|Overall Study|Lack of Efficacy|0|||
127948477|NCT00398866|460431146|FG002|Overall Study|Lack of Efficacy|1|||
127948478|NCT00398866|460431144|FG000|Overall Study|Lost to Follow-up|7|||
127948479|NCT00398866|460431145|FG001|Overall Study|Lost to Follow-up|6|||
127948480|NCT00398866|460431146|FG002|Overall Study|Lost to Follow-up|4|||
127948481|NCT00398866|460431144|FG000|Overall Study|Withdrawal by Subject|5|||
127948482|NCT00398866|460431145|FG001|Overall Study|Withdrawal by Subject|1|||
127948483|NCT00398866|460431146|FG002|Overall Study|Withdrawal by Subject|2|||
127948484|NCT00398866|460431144|FG000|Overall Study|Unable to complete requirements of study|1|||
127948485|NCT00398866|460431145|FG001|Overall Study|Unable to complete requirements of study|1|||
127948486|NCT00398866|460431146|FG002|Overall Study|Unable to complete requirements of study|1|||
127948487|NCT04841577|460431151|FG000|Overall Study|Adverse Event|5|||
127948488|NCT04841577|460431152|FG001|Overall Study|Adverse Event|10|||
127948489|NCT04841577|460431151|FG000|Overall Study|Lost to Follow-up|8|||
127948490|NCT04841577|460431152|FG001|Overall Study|Lost to Follow-up|7|||
127948491|NCT04841577|460431151|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
127948492|NCT04841577|460431152|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
127948493|NCT04841577|460431151|FG000|Overall Study|Other|0|||
127948494|NCT04841577|460431152|FG001|Overall Study|Other|1|||
127948495|NCT00182325|460431153|FG000|Overall Study|Lost to Follow-up|7|||
127948496|NCT00182325|460431154|FG001|Overall Study|Lost to Follow-up|7|||
127948497|NCT00182325|460431153|FG000|Overall Study|Miscarriage|5|||
127948498|NCT00182325|460431154|FG001|Overall Study|Miscarriage|3|||
127948499|NCT00182325|460431153|FG000|Overall Study|Did not complete survey|22|||
127948500|NCT00182325|460431154|FG001|Overall Study|Did not complete survey|43|||
127948501|NCT00339144|460431163|FG000|Overall Study|Disease progression|5|||
127948502|NCT00339144|460431164|FG001|Overall Study|Disease progression|2|||
127948503|NCT00339144|460431165|FG002|Overall Study|Disease progression|2|||
127948504|NCT00339144|460431163|FG000|Overall Study|Study drug toxicity|3|||
127948505|NCT00339144|460431164|FG001|Overall Study|Study drug toxicity|1|||
127948506|NCT00339144|460431165|FG002|Overall Study|Study drug toxicity|1|||
127948507|NCT00339144|460431163|FG000|Overall Study|Participant's request to discontinuation|1|||
127948508|NCT00339144|460431164|FG001|Overall Study|Participant's request to discontinuation|0|||
127948509|NCT00339144|460431165|FG002|Overall Study|Participant's request to discontinuation|1|||
127948510|NCT01890434|460431166|FG000|Overall Study|Adverse Event|8|||
127948511|NCT01890434|460431166|FG000|Overall Study|PCI at external hospital|1|||
127948512|NCT01890434|460431166|FG000|Overall Study|Assessment discrepancy|1|||
127948513|NCT01890434|460431166|FG000|Overall Study|CRC didn't contact participant for FU|1|||
127948514|NCT01890434|460431166|FG000|Overall Study|Could not get whole set of images|1|||
127948515|NCT01890434|460431166|FG000|Overall Study|Decline to return for GSPECT|1|||
127948516|NCT01890434|460431166|FG000|Overall Study|GSPECT at rest was not done|1|||
127948517|NCT01890434|460431166|FG000|Overall Study|Participant didn't complete MRI|1|||
127948518|NCT01890434|460431166|FG000|Overall Study|Uncontactable by phone|1|||
127948519|NCT01890434|460431166|FG000|Overall Study|Moved out of position|1|||
127948520|NCT01890434|460431166|FG000|Overall Study|Unable to contact|1|||
127948521|NCT01890434|460431166|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
127948522|NCT03280381|460431167|FG000|Overall Study|Physician Decision|0|||
127948523|NCT03280381|460431168|FG001|Overall Study|Physician Decision|2|||
127948524|NCT01141205|460431169|FG000|Overall Study|Physician Decision|1|||
127948525|NCT01141205|460431170|FG001|Overall Study|Physician Decision|1|||
127948526|NCT01141205|460431169|FG000|Overall Study|Lost to Follow-up|1|||
127948527|NCT01141205|460431170|FG001|Overall Study|Lost to Follow-up|0|||
127948528|NCT01141205|460431169|FG000|Overall Study|Withdrawal by Subject|1|||
127948529|NCT01141205|460431170|FG001|Overall Study|Withdrawal by Subject|1|||
127948530|NCT02257385|460431172|FG000|Overall Study|Adverse Event|12|||
127948531|NCT02257385|460431173|FG001|Overall Study|Adverse Event|8|||
127948532|NCT02257385|460431172|FG000|Overall Study|Lack of Efficacy|1|||
127948533|NCT02257385|460431173|FG001|Overall Study|Lack of Efficacy|2|||
127948534|NCT02257385|460431172|FG000|Overall Study|Protocol Violation|5|||
127948535|NCT02257385|460431173|FG001|Overall Study|Protocol Violation|7|||
127948536|NCT02257385|460431172|FG000|Overall Study|Lost to Follow-up|0|||
127948537|NCT02257385|460431173|FG001|Overall Study|Lost to Follow-up|1|||
127948538|NCT02257385|460431172|FG000|Overall Study|Withdrawal by Subject|4|||
127948539|NCT02257385|460431173|FG001|Overall Study|Withdrawal by Subject|4|||
127948540|NCT01822366|460431174|FG000|Overall Study|Lost to Follow-up|5|||
127948541|NCT01822366|460431175|FG001|Overall Study|Lost to Follow-up|1|||
127948542|NCT01822366|460431176|FG002|Overall Study|Lost to Follow-up|5|||
127948543|NCT01822366|460431177|FG003|Overall Study|Lost to Follow-up|1|||
127948544|NCT01822366|460431174|FG000|Overall Study|Withdrawal by Subject|0|||
127948545|NCT01822366|460431175|FG001|Overall Study|Withdrawal by Subject|6|||
127948546|NCT01822366|460431176|FG002|Overall Study|Withdrawal by Subject|0|||
127948547|NCT01822366|460431177|FG003|Overall Study|Withdrawal by Subject|6|||
127948548|NCT01822366|460431174|FG000|Overall Study|Partial Intervention Completion|0|||
127948549|NCT01822366|460431175|FG001|Overall Study|Partial Intervention Completion|15|||
127948550|NCT01822366|460431176|FG002|Overall Study|Partial Intervention Completion|0|||
127948551|NCT01822366|460431177|FG003|Overall Study|Partial Intervention Completion|15|||
127948552|NCT03276078|460431179|FG000|Overall Study|Adverse Event|1|||
127948553|NCT02552732|460431180|FG000|Overall Study|Lost to Follow-up|2|||
127948554|NCT02552732|460431180|FG000|Overall Study|Physician Decision|1|||
127948555|NCT02552732|460431180|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
127948556|NCT02552732|460431180|FG000|Overall Study|Withdrawal by Subject|6|||
127948557|NCT04988087|460431183|FG000|Overall Study|Adverse Event|4|||
127948558|NCT04988087|460431184|FG001|Overall Study|Adverse Event|0|||
127948559|NCT04988087|460431185|FG002|Overall Study|Adverse Event|0|||
127948560|NCT04988087|460431186|FG003|Overall Study|Adverse Event|0|||
127948561|NCT04988087|460431183|FG000|Overall Study|Withdrawal by Subject|1|||
127948562|NCT04988087|460431184|FG001|Overall Study|Withdrawal by Subject|1|||
127948563|NCT04988087|460431185|FG002|Overall Study|Withdrawal by Subject|0|||
127948564|NCT04988087|460431186|FG003|Overall Study|Withdrawal by Subject|0|||
127948565|NCT04988087|460431183|FG000|Overall Study|Technical problems|7|||
127948566|NCT04988087|460431184|FG001|Overall Study|Technical problems|9|||
127948567|NCT04988087|460431185|FG002|Overall Study|Technical problems|1|||
127948568|NCT04988087|460431186|FG003|Overall Study|Technical problems|2|||
127948569|NCT02458287|460431187|FG000|Overall Study|Adverse Event|0|||
127948570|NCT02458287|460431188|FG001|Overall Study|Adverse Event|0|||
127948571|NCT02458287|460431189|FG002|Overall Study|Adverse Event|0|||
127948572|NCT02458287|460431190|FG003|Overall Study|Adverse Event|1|||
127948573|NCT02458287|460431187|FG000|Overall Study|Lost to Follow-up|0|||
127948574|NCT02458287|460431188|FG001|Overall Study|Lost to Follow-up|1|||
127948575|NCT02458287|460431189|FG002|Overall Study|Lost to Follow-up|1|||
127948576|NCT02458287|460431190|FG003|Overall Study|Lost to Follow-up|0|||
127948577|NCT02458287|460431187|FG000|Overall Study|Protocol Violation|0|||
127948578|NCT02458287|460431188|FG001|Overall Study|Protocol Violation|1|||
127948579|NCT02458287|460431189|FG002|Overall Study|Protocol Violation|0|||
127948580|NCT02458287|460431190|FG003|Overall Study|Protocol Violation|0|||
127948581|NCT02458287|460431187|FG000|Overall Study|Withdrawal by Subject|0|||
127948582|NCT02458287|460431188|FG001|Overall Study|Withdrawal by Subject|2|||
127948583|NCT02458287|460431189|FG002|Overall Study|Withdrawal by Subject|2|||
127948584|NCT02458287|460431190|FG003|Overall Study|Withdrawal by Subject|1|||
127948585|NCT02458287|460431187|FG000|Overall Study|Relocated Out of State|0|||
127948586|NCT02458287|460431188|FG001|Overall Study|Relocated Out of State|0|||
127948587|NCT02458287|460431189|FG002|Overall Study|Relocated Out of State|0|||
127948588|NCT02458287|460431190|FG003|Overall Study|Relocated Out of State|1|||
127948589|NCT02290223|460431191|FG000|6 Months|Lost to Follow-up|9|||
127948590|NCT02290223|460431192|FG001|6 Months|Lost to Follow-up|6|||
127948591|NCT02290223|460431191|FG000|6 Months|Withdrawal by Subject|5|||
127948592|NCT02290223|460431192|FG001|6 Months|Withdrawal by Subject|0|||
127948593|NCT02290223|460431191|FG000|6 Months|deceased (not related to study)|2|||
127948594|NCT02290223|460431192|FG001|6 Months|deceased (not related to study)|0|||
127948595|NCT02290223|460431191|FG000|12 Months|Lost to Follow-up|16|||
127948596|NCT02290223|460431192|FG001|12 Months|Lost to Follow-up|10|||
127948597|NCT02290223|460431191|FG000|12 Months|Refusal|0|||
127948598|NCT02290223|460431192|FG001|12 Months|Refusal|1|||
127948599|NCT02800642|460431196|FG000|Overall Study|Death|3|||
127948600|NCT02800642|460431196|FG000|Overall Study|Other|10|||
127948601|NCT02800642|460431196|FG000|Overall Study|Physician Decision|2|||
127948602|NCT02800642|460431196|FG000|Overall Study|Adverse Event|6|||
127948603|NCT02800642|460431196|FG000|Overall Study|Withdrawal by Subject|3|||
127948604|NCT02800642|460431196|FG000|Overall Study|Lost to Follow-up|1|||
127948605|NCT01004003|460431197|FG000|Overall Study|Progressive disease|2|||
127948606|NCT01004003|460431198|FG001|Overall Study|Progressive disease|1|||
127948607|NCT01004003|460431199|FG002|Overall Study|Progressive disease|1|||
127948608|NCT01004003|460431200|FG003|Overall Study|Progressive disease|0|||
127948609|NCT01004003|460431201|FG004|Overall Study|Progressive disease|2|||
127948610|NCT01004003|460431202|FG005|Overall Study|Progressive disease|1|||
127948611|NCT01004003|460431203|FG006|Overall Study|Progressive disease|1|||
127948612|NCT01004003|460431204|FG007|Overall Study|Progressive disease|39|||
127948613|NCT01004003|460431205|FG008|Overall Study|Progressive disease|22|||
127948614|NCT01004003|460431197|FG000|Overall Study|Adverse Event|4|||
127948615|NCT01004003|460431198|FG001|Overall Study|Adverse Event|2|||
127948616|NCT01004003|460431199|FG002|Overall Study|Adverse Event|3|||
127948617|NCT01004003|460431200|FG003|Overall Study|Adverse Event|3|||
127948618|NCT01004003|460431201|FG004|Overall Study|Adverse Event|2|||
127948619|NCT01004003|460431202|FG005|Overall Study|Adverse Event|2|||
127948620|NCT01004003|460431203|FG006|Overall Study|Adverse Event|7|||
127948621|NCT01004003|460431204|FG007|Overall Study|Adverse Event|21|||
127948622|NCT01004003|460431205|FG008|Overall Study|Adverse Event|6|||
127948623|NCT01004003|460431197|FG000|Overall Study|Refused to continue taking trial med.|0|||
127948624|NCT01004003|460431198|FG001|Overall Study|Refused to continue taking trial med.|0|||
127948625|NCT01004003|460431199|FG002|Overall Study|Refused to continue taking trial med.|0|||
127948626|NCT01004003|460431200|FG003|Overall Study|Refused to continue taking trial med.|0|||
127948627|NCT01004003|460431201|FG004|Overall Study|Refused to continue taking trial med.|0|||
127948628|NCT01004003|460431202|FG005|Overall Study|Refused to continue taking trial med.|0|||
127948629|NCT01004003|460431203|FG006|Overall Study|Refused to continue taking trial med.|0|||
127948630|NCT01004003|460431204|FG007|Overall Study|Refused to continue taking trial med.|0|||
127948631|NCT01004003|460431205|FG008|Overall Study|Refused to continue taking trial med.|2|||
127948632|NCT01004003|460431197|FG000|Overall Study|Other|0|||
127948633|NCT01004003|460431198|FG001|Overall Study|Other|0|||
127948634|NCT01004003|460431199|FG002|Overall Study|Other|0|||
127948635|NCT01004003|460431200|FG003|Overall Study|Other|0|||
127948636|NCT01004003|460431201|FG004|Overall Study|Other|0|||
127948637|NCT01004003|460431202|FG005|Overall Study|Other|1|||
127948638|NCT01004003|460431203|FG006|Overall Study|Other|0|||
127948639|NCT01004003|460431204|FG007|Overall Study|Other|0|||
127948640|NCT01004003|460431205|FG008|Overall Study|Other|0|||
127948641|NCT01130597|460431212|FG000|Overall Study|Protocol-specified (High K+)|1|||
127948642|NCT01130597|460431212|FG000|Overall Study|Adverse Event|4|||
127948643|NCT01130597|460431212|FG000|Overall Study|Death|1|||
127948644|NCT01130597|460431212|FG000|Overall Study|Protocol Violation|1|||
127948645|NCT03371459|460431213|FG000|Washout|Lost to Follow-up|0|||
127948646|NCT03371459|460431214|FG001|Washout|Lost to Follow-up|1|||
127948647|NCT01589497|460431215|FG000|Overall Study|Withdrawal by Subject|0|||
127948648|NCT01589497|460431216|FG001|Overall Study|Withdrawal by Subject|1|||
127948649|NCT01589497|460431217|FG002|Overall Study|Withdrawal by Subject|0|||
127948650|NCT01589497|460431218|FG003|Overall Study|Withdrawal by Subject|1|||
127948651|NCT01589497|460431215|FG000|Overall Study|Death|1|||
127948652|NCT01589497|460431216|FG001|Overall Study|Death|0|||
127948653|NCT01589497|460431217|FG002|Overall Study|Death|0|||
127948654|NCT01589497|460431218|FG003|Overall Study|Death|0|||
127948655|NCT01589497|460431215|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
127948656|NCT01589497|460431216|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
127948657|NCT01589497|460431217|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
127948658|NCT01589497|460431218|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
127948659|NCT05819203|460431226|FG000|Overall Study|Protocol Violation|1|||
127948660|NCT05819203|460431227|FG001|Overall Study|Protocol Violation|2|||
127948661|NCT05819203|460431226|FG000|Overall Study|Withdrawal by Subject|1|||
127948662|NCT05819203|460431227|FG001|Overall Study|Withdrawal by Subject|0|||
127948663|NCT02185053|460431228|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
127948664|NCT02185053|460431229|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
127948665|NCT02185053|460431230|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
127948666|NCT02185053|460431228|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
127948667|NCT02185053|460431229|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
127948668|NCT02185053|460431230|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
127948669|NCT02185053|460431228|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
127948670|NCT02185053|460431229|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
127948671|NCT02185053|460431230|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
127948672|NCT02185053|460431228|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
127948673|NCT02185053|460431229|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
127948674|NCT02185053|460431230|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
127948675|NCT02185053|460431228|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
127948676|NCT02185053|460431229|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
127948677|NCT02185053|460431230|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
127948678|NCT02185053|460431228|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
127948679|NCT02185053|460431229|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
127948680|NCT02185053|460431230|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
127948681|NCT02185053|460431228|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
127948682|NCT02185053|460431229|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
127948683|NCT02185053|460431230|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
127948684|NCT02185053|460431228|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
127948685|NCT02185053|460431229|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
127948686|NCT02185053|460431230|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
127948687|NCT02521376|460431233|FG000|Overall Study|Enrolled, But Not Treated|1|||
127948688|NCT02521376|460431234|FG001|Overall Study|Enrolled, But Not Treated|0|||
127948689|NCT02521376|460431235|FG002|Overall Study|Enrolled, But Not Treated|0|||
127948690|NCT02521376|460431236|FG003|Overall Study|Enrolled, But Not Treated|0|||
127948691|NCT03597464|460431241|FG000|Overall Study|Withdrawal by Subject|4|||
127948692|NCT03597464|460431242|FG001|Overall Study|Withdrawal by Subject|5|||
127948693|NCT03597464|460431241|FG000|Overall Study|Lost to Follow-up|3|||
127948694|NCT03597464|460431242|FG001|Overall Study|Lost to Follow-up|1|||
127948695|NCT03597464|460431241|FG000|Overall Study|Pregnancy|3|||
127948696|NCT03597464|460431242|FG001|Overall Study|Pregnancy|1|||
127948697|NCT03597464|460431241|FG000|Overall Study|Lack of Efficacy|2|||
127948698|NCT03597464|460431242|FG001|Overall Study|Lack of Efficacy|0|||
127948699|NCT03597464|460431241|FG000|Overall Study|Physician Decision|2|||
127948700|NCT03597464|460431242|FG001|Overall Study|Physician Decision|2|||
127948701|NCT03597464|460431241|FG000|Overall Study|Protocol Violation|1|||
127948702|NCT03597464|460431242|FG001|Overall Study|Protocol Violation|1|||
127948703|NCT03597464|460431241|FG000|Overall Study|Adverse Event|0|||
127948704|NCT03597464|460431242|FG001|Overall Study|Adverse Event|2|||
127948705|NCT03597464|460431241|FG000|Overall Study|Death|0|||
127948706|NCT03597464|460431242|FG001|Overall Study|Death|3|||
127948707|NCT02542605|460431245|FG000|Part B: Challenge Phase|Sponsor decision|1|||
127948708|NCT02542605|460431246|FG001|Part B: Challenge Phase|Sponsor decision|0|||
127948709|NCT02542605|460431247|FG002|Part B: Challenge Phase|Sponsor decision|0|||
127948710|NCT02542605|460431245|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
127948711|NCT02542605|460431246|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
127948712|NCT02542605|460431247|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
127948713|NCT02682927|460431248|FG000|Overall Study|Adverse Event|0|||
127948714|NCT02682927|460431249|FG001|Overall Study|Adverse Event|0|||
127948715|NCT02682927|460431250|FG002|Overall Study|Adverse Event|5|||
127948716|NCT02682927|460431251|FG003|Overall Study|Adverse Event|1|||
127948717|NCT02682927|460431252|FG004|Overall Study|Adverse Event|0|||
127948718|NCT02682927|460431253|FG005|Overall Study|Adverse Event|2|||
127948719|NCT02682927|460431248|FG000|Overall Study|Death|0|||
127948720|NCT02682927|460431249|FG001|Overall Study|Death|0|||
127948721|NCT02682927|460431250|FG002|Overall Study|Death|0|||
127948722|NCT02682927|460431251|FG003|Overall Study|Death|1|||
127948723|NCT02682927|460431252|FG004|Overall Study|Death|0|||
127948724|NCT02682927|460431253|FG005|Overall Study|Death|0|||
127948725|NCT02682927|460431248|FG000|Overall Study|Lack of Efficacy|1|||
127948726|NCT02682927|460431249|FG001|Overall Study|Lack of Efficacy|0|||
127948727|NCT02682927|460431250|FG002|Overall Study|Lack of Efficacy|0|||
127948728|NCT02682927|460431251|FG003|Overall Study|Lack of Efficacy|1|||
127868655|NCT01072175|460137385|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
127868656|NCT01072175|460137386|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
127868657|NCT01072175|460137387|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
127948729|NCT02682927|460431252|FG004|Overall Study|Lack of Efficacy|0|||
127948730|NCT02682927|460431253|FG005|Overall Study|Lack of Efficacy|0|||
127948731|NCT02682927|460431248|FG000|Overall Study|Other|0|||
127948732|NCT02682927|460431249|FG001|Overall Study|Other|0|||
127948733|NCT02682927|460431250|FG002|Overall Study|Other|0|||
127948734|NCT02682927|460431251|FG003|Overall Study|Other|2|||
127948735|NCT02682927|460431252|FG004|Overall Study|Other|0|||
127948736|NCT02682927|460431253|FG005|Overall Study|Other|0|||
127948737|NCT02682927|460431248|FG000|Overall Study|Withdrawal by Subject|2|||
127948738|NCT02682927|460431249|FG001|Overall Study|Withdrawal by Subject|0|||
127948739|NCT02682927|460431250|FG002|Overall Study|Withdrawal by Subject|1|||
127948740|NCT02682927|460431251|FG003|Overall Study|Withdrawal by Subject|0|||
127948741|NCT02682927|460431252|FG004|Overall Study|Withdrawal by Subject|1|||
127948742|NCT02682927|460431253|FG005|Overall Study|Withdrawal by Subject|1|||
127948743|NCT05314816|460431256|FG000|Overall Study|Lost to Follow-up|5|||
127948744|NCT05314816|460431257|FG001|Overall Study|Lost to Follow-up|0|||
127948745|NCT05314816|460431258|FG002|Overall Study|Lost to Follow-up|1|||
127948746|NCT05314816|460431256|FG000|Overall Study|Protocol Violation|13|||
127948747|NCT05314816|460431257|FG001|Overall Study|Protocol Violation|8|||
127948748|NCT05314816|460431258|FG002|Overall Study|Protocol Violation|0|||
127948749|NCT01810302|460432223|FG000|Overall Study|Death|1|||
127948750|NCT01810302|460432224|FG001|Overall Study|Death|0|||
127948751|NCT01810302|460432223|FG000|Overall Study|Physician Decision|0|||
127948752|NCT01810302|460432224|FG001|Overall Study|Physician Decision|1|||
127948753|NCT02126826|460432225|FG000|Overall Study|Withdrawal by Subject|0|||
127948754|NCT02126826|460432226|FG001|Overall Study|Withdrawal by Subject|0|||
127948755|NCT02126826|460432227|FG002|Overall Study|Withdrawal by Subject|0|||
127948756|NCT02126826|460432228|FG003|Overall Study|Withdrawal by Subject|1|||
127948757|NCT02126826|460432229|FG004|Overall Study|Withdrawal by Subject|0|||
127948758|NCT02126826|460432230|FG005|Overall Study|Withdrawal by Subject|0|||
127948759|NCT02126826|460432231|FG006|Overall Study|Withdrawal by Subject|0|||
127948760|NCT03888066|460432232|FG000|Run-in Phase|Randomization Criterion #1|24|||
127948761|NCT03888066|460432233|FG001|Run-in Phase|Randomization Criterion #1|0|||
127948762|NCT03888066|460432232|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
127948763|NCT03888066|460432233|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
127948764|NCT03888066|460432232|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
127948765|NCT03888066|460432233|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
127948766|NCT03888066|460432232|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
127948767|NCT03888066|460432233|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
127948768|NCT03888066|460432232|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
127948769|NCT03888066|460432233|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
127948770|NCT03888066|460432232|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
127948771|NCT03888066|460432233|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
127948772|NCT03888066|460432232|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
127948773|NCT03888066|460432233|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
127948774|NCT03888066|460432232|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
127948775|NCT03888066|460432233|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
127948776|NCT03888066|460432232|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
127948777|NCT03888066|460432233|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
127948778|NCT03888066|460432232|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
127948779|NCT03888066|460432233|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
127948780|NCT03888066|460432232|FG000|Run-in Phase|Randomization Criterion #2|5|||
127948781|NCT03888066|460432233|FG001|Run-in Phase|Randomization Criterion #2|0|||
127948782|NCT03888066|460432232|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
127948783|NCT03888066|460432233|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
127948784|NCT03888066|460432232|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
127948785|NCT03888066|460432233|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
127948786|NCT03888066|460432232|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
127948787|NCT03888066|460432233|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
127948788|NCT03888066|460432232|FG000|Run-in Phase|Randomization Criterion #3|11|||
127948789|NCT03888066|460432233|FG001|Run-in Phase|Randomization Criterion #3|0|||
127948790|NCT03888066|460432232|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
127948791|NCT03888066|460432233|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
127948792|NCT03888066|460432232|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
127948793|NCT03888066|460432233|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
127976424|NCT03535194|460536125|FG000|Induction Period|Lost to Follow-up|3|||
127976425|NCT03535194|460536126|FG001|Induction Period|Lost to Follow-up|5|||
127976426|NCT03535194|460536127|FG002|Induction Period|Lost to Follow-up|2|||
127976427|NCT03535194|460536128|FG003|Induction Period|Lost to Follow-up|3|||
127948794|NCT03888066|460432232|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
127948795|NCT03888066|460432233|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
127948796|NCT03888066|460432232|FG000|Run-in Phase|Randomization Criterion #4|3|||
127948797|NCT03888066|460432233|FG001|Run-in Phase|Randomization Criterion #4|0|||
127948798|NCT03888066|460432232|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
127948799|NCT03888066|460432233|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
127948800|NCT03888066|460432232|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
127948801|NCT03888066|460432233|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
127948802|NCT03888066|460432232|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
127948803|NCT03888066|460432233|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
127948804|NCT03888066|460432232|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
127948805|NCT03888066|460432233|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
127948806|NCT03888066|460432232|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
127948807|NCT03888066|460432233|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
127948808|NCT03888066|460432232|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
127948809|NCT03888066|460432233|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
127948810|NCT03888066|460432232|FG000|Run-in Phase|AE (Adverse Event)|17|||
127948811|NCT03888066|460432233|FG001|Run-in Phase|AE (Adverse Event)|0|||
127948812|NCT03888066|460432232|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
127948813|NCT03888066|460432233|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
127948814|NCT03888066|460432232|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
127948815|NCT03888066|460432233|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
127948816|NCT03888066|460432232|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
127948817|NCT03888066|460432233|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
127948818|NCT03888066|460432232|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
127948819|NCT03888066|460432233|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
127948820|NCT03888066|460432232|FG000|Run-in Phase|Withdrawal by Subject|43|||
127948821|NCT03888066|460432233|FG001|Run-in Phase|Withdrawal by Subject|0|||
127948822|NCT03888066|460432232|FG000|Run-in Phase|AE; Physician Decision|1|||
127948823|NCT03888066|460432233|FG001|Run-in Phase|AE; Physician Decision|0|||
127948824|NCT03888066|460432232|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
127948825|NCT03888066|460432233|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
127948826|NCT03888066|460432232|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
127948827|NCT03888066|460432233|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
127948828|NCT03888066|460432232|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
127948829|NCT03888066|460432233|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
127948830|NCT03888066|460432232|FG000|Run-in Phase|Death|1|||
127948831|NCT03888066|460432233|FG001|Run-in Phase|Death|0|||
127948832|NCT03888066|460432232|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
127948833|NCT03888066|460432233|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
127948834|NCT03888066|460432232|FG000|Run-in Phase|Physician Decision|1|||
127948835|NCT03888066|460432233|FG001|Run-in Phase|Physician Decision|0|||
127948836|NCT03888066|460432232|FG000|Run-in Phase|Protocol Violation|13|||
127948837|NCT03888066|460432233|FG001|Run-in Phase|Protocol Violation|0|||
127948838|NCT03888066|460432232|FG000|Run-in Phase|Sponsor Request|34|||
127948839|NCT03888066|460432233|FG001|Run-in Phase|Sponsor Request|0|||
127948840|NCT03888066|460432232|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
127948841|NCT03888066|460432233|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
127948842|NCT03888066|460432232|FG000|Run-in Phase|Withdrawal Of Consent|1|||
127948843|NCT03888066|460432233|FG001|Run-in Phase|Withdrawal Of Consent|0|||
127948844|NCT03888066|460432232|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
127948845|NCT03888066|460432233|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
127948846|NCT03888066|460432232|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
127948847|NCT03888066|460432233|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
127948848|NCT03888066|460432232|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
127948849|NCT03888066|460432233|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
127948850|NCT03888066|460432232|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
127948851|NCT03888066|460432233|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
127948852|NCT03888066|460432232|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
127948853|NCT03888066|460432233|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
127948854|NCT03888066|460432232|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
127948855|NCT03888066|460432233|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
127948856|NCT03888066|460432232|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
127948857|NCT03888066|460432233|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
127948858|NCT03888066|460432232|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
127948859|NCT03888066|460432233|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
127948860|NCT03888066|460432232|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
127948861|NCT03888066|460432233|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
127948862|NCT03888066|460432232|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
127948863|NCT03888066|460432233|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
127948864|NCT03888066|460432232|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
127948865|NCT03888066|460432233|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
127948866|NCT03888066|460432232|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
127948867|NCT03888066|460432233|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
127948868|NCT03278626|460432234|FG000|Overall Study|Death|2|||
127948869|NCT03278626|460432234|FG000|Overall Study|Toxicity|1|||
127948870|NCT03278626|460432234|FG000|Overall Study|Disease Progression|2|||
127948871|NCT05013008|460432236|FG000|Overall Study|Exclusion from mBFAS|5|||
127948872|NCT05013008|460432237|FG001|Overall Study|Exclusion from mBFAS|25|||
127948873|NCT02111603|460432247|FG000|Overall Study|Withdrawal by Subject|1|||
127948874|NCT03106987|460432248|FG000|Overall Study|Death|37|||
127948875|NCT03106987|460432249|FG001|Overall Study|Death|22|||
127948876|NCT03106987|460432250|FG002|Overall Study|Death|12|||
127948877|NCT03106987|460432251|FG003|Overall Study|Death|8|||
127948878|NCT03106987|460432248|FG000|Overall Study|Lost to Follow-up|2|||
127948879|NCT03106987|460432249|FG001|Overall Study|Lost to Follow-up|0|||
127948880|NCT03106987|460432250|FG002|Overall Study|Lost to Follow-up|2|||
127948881|NCT03106987|460432251|FG003|Overall Study|Lost to Follow-up|2|||
127948882|NCT03106987|460432248|FG000|Overall Study|Withdrawal by Subject|5|||
127948883|NCT03106987|460432249|FG001|Overall Study|Withdrawal by Subject|1|||
127948884|NCT03106987|460432250|FG002|Overall Study|Withdrawal by Subject|4|||
127948885|NCT03106987|460432251|FG003|Overall Study|Withdrawal by Subject|1|||
127948886|NCT02114385|460432253|FG000|Overall Study|Withdrawal by Subject|3|||
127948887|NCT02114385|460432254|FG001|Overall Study|Withdrawal by Subject|2|||
127948888|NCT02114385|460432253|FG000|Overall Study|Lost to Follow-up|0|||
127948889|NCT02114385|460432254|FG001|Overall Study|Lost to Follow-up|6|||
127948890|NCT01174043|460432258|FG000|Overall Study|Disease progression|5|||
127948891|NCT01174043|460432258|FG000|Overall Study|Adverse Event|3|||
127948892|NCT01174043|460432258|FG000|Overall Study|Death|1|||
127948893|NCT01174043|460432258|FG000|Overall Study|Withdrawal by Subject|2|||
127948894|NCT00582010|460432263|FG000|Overall Study|Death|0|||
127948895|NCT00582010|460432264|FG001|Overall Study|Death|1|||
127948896|NCT01371539|460432268|FG000|Period One: One Week|Lost to Follow-up|0|||
127948897|NCT01371539|460432269|FG001|Period One: One Week|Lost to Follow-up|1|||
127948898|NCT01371539|460432268|FG000|Period Two: One Week|Lost to Follow-up|0|||
127948899|NCT01371539|460432269|FG001|Period Two: One Week|Lost to Follow-up|1|||
127948900|NCT01371539|460432268|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
127948901|NCT01371539|460432269|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
127948902|NCT01371539|460432268|FG000|Period Two: One Week|Time/job conflict|0|||
127948903|NCT01371539|460432269|FG001|Period Two: One Week|Time/job conflict|1|||
127948904|NCT02681510|460432277|FG000|Overall Study|Withdrawal by Subject|1|||
127948905|NCT02681510|460432277|FG000|Overall Study|Lost to Follow-up|9|||
127948906|NCT00741338|460432278|FG000|Overall Study|Adverse Event|0|||
127948907|NCT00741338|460432279|FG001|Overall Study|Adverse Event|1|||
127948908|NCT00704132|460432286|FG000|Overall Study|Clinical Adverse Experience|1|||
127948909|NCT00704132|460432287|FG001|Overall Study|Clinical Adverse Experience|0|||
127948910|NCT00704132|460432286|FG000|Overall Study|Lack of Efficacy|0|||
127948911|NCT00704132|460432287|FG001|Overall Study|Lack of Efficacy|1|||
127948912|NCT00704132|460432286|FG000|Overall Study|Withdrawal by Subject|0|||
127948913|NCT00704132|460432287|FG001|Overall Study|Withdrawal by Subject|1|||
127948914|NCT00442962|460432288|FG000|Overall Study|Pregnancy|1|||
127948915|NCT00442962|460432288|FG000|Overall Study|Lost to Follow-up|7|||
127948916|NCT03633825|460432289|FG000|Enrollment|Did not post on network|5066|||
127948917|NCT03633825|460432290|FG001|Enrollment|Did not post on network|5080|||
127948918|NCT03633825|460432289|FG000|Enrollment|Post not classified as crisis|13967|||
127948919|NCT03633825|460432290|FG001|Enrollment|Post not classified as crisis|13757|||
127948920|NCT03633825|460432289|FG000|Follow up|Lost to Follow-up|478|||
127948921|NCT03633825|460432290|FG001|Follow up|Lost to Follow-up|450|||
127948922|NCT01420965|460432291|FG000|Overall Study|Withdrawal by Subject|1|||
127948923|NCT01420965|460432292|FG001|Overall Study|Withdrawal by Subject|0|||
127948924|NCT01420965|460432293|FG002|Overall Study|Withdrawal by Subject|0|||
127948925|NCT01420965|460432291|FG000|Overall Study|Adverse Event|0|||
127948926|NCT01420965|460432292|FG001|Overall Study|Adverse Event|1|||
127948927|NCT01420965|460432293|FG002|Overall Study|Adverse Event|0|||
127948928|NCT02655666|460432294|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
127948929|NCT01267994|460432295|FG000|Overall Study|Adverse Event|2|||
127948930|NCT05199090|460432299|FG000|Overall Study|Adverse Event|1|||
127948931|NCT05199090|460432300|FG001|Overall Study|Adverse Event|4|||
127948932|NCT05199090|460432301|FG002|Overall Study|Adverse Event|0|||
127948933|NCT05199090|460432302|FG003|Overall Study|Adverse Event|0|||
127948934|NCT05199090|460432303|FG004|Overall Study|Adverse Event|0|||
127948935|NCT05199090|460432304|FG005|Overall Study|Adverse Event|0|||
127948936|NCT05199090|460432299|FG000|Overall Study|Lost to Follow-up|1|||
127948937|NCT05199090|460432300|FG001|Overall Study|Lost to Follow-up|0|||
127948938|NCT05199090|460432301|FG002|Overall Study|Lost to Follow-up|1|||
127948939|NCT05199090|460432302|FG003|Overall Study|Lost to Follow-up|4|||
127948940|NCT05199090|460432303|FG004|Overall Study|Lost to Follow-up|0|||
127948941|NCT05199090|460432304|FG005|Overall Study|Lost to Follow-up|5|||
127948942|NCT05199090|460432299|FG000|Overall Study|Physician Decision|0|||
127948943|NCT05199090|460432300|FG001|Overall Study|Physician Decision|0|||
127948944|NCT05199090|460432301|FG002|Overall Study|Physician Decision|0|||
127948945|NCT05199090|460432302|FG003|Overall Study|Physician Decision|0|||
127948946|NCT05199090|460432303|FG004|Overall Study|Physician Decision|0|||
127948947|NCT05199090|460432304|FG005|Overall Study|Physician Decision|1|||
127948948|NCT05199090|460432299|FG000|Overall Study|Study terminated by sponsor|0|||
127948949|NCT05199090|460432300|FG001|Overall Study|Study terminated by sponsor|6|||
127948950|NCT05199090|460432301|FG002|Overall Study|Study terminated by sponsor|0|||
127948951|NCT05199090|460432302|FG003|Overall Study|Study terminated by sponsor|0|||
127948952|NCT05199090|460432303|FG004|Overall Study|Study terminated by sponsor|0|||
127948953|NCT05199090|460432304|FG005|Overall Study|Study terminated by sponsor|5|||
127948954|NCT05199090|460432299|FG000|Overall Study|Subject decision|0|||
127948955|NCT05199090|460432300|FG001|Overall Study|Subject decision|4|||
127948956|NCT05199090|460432301|FG002|Overall Study|Subject decision|0|||
127948957|NCT05199090|460432302|FG003|Overall Study|Subject decision|2|||
127948958|NCT05199090|460432303|FG004|Overall Study|Subject decision|5|||
127948959|NCT05199090|460432304|FG005|Overall Study|Subject decision|2|||
127948960|NCT04759768|460432305|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
127948961|NCT04759768|460432306|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
127948962|NCT04759768|460432305|FG000|Washout (7 Days)|Physician Decision|0|||
127948963|NCT04759768|460432306|FG001|Washout (7 Days)|Physician Decision|1|||
127948964|NCT02027428|460432307|FG000|Induction|Never treated|7|||
127948965|NCT02027428|460432308|FG001|Induction|Never treated|0|||
127948966|NCT02027428|460432309|FG002|Induction|Never treated|0|||
127948967|NCT02027428|460432307|FG000|Induction|Progressive disease|77|||
127948968|NCT02027428|460432308|FG001|Induction|Progressive disease|0|||
127948969|NCT02027428|460432309|FG002|Induction|Progressive disease|0|||
127948970|NCT02027428|460432307|FG000|Induction|Adverse Event|51|||
127948971|NCT02027428|460432308|FG001|Induction|Adverse Event|0|||
127948972|NCT02027428|460432309|FG002|Induction|Adverse Event|0|||
127948973|NCT02027428|460432307|FG000|Induction|Withdrawal by Subject|22|||
127948974|NCT02027428|460432308|FG001|Induction|Withdrawal by Subject|0|||
127948975|NCT02027428|460432309|FG002|Induction|Withdrawal by Subject|0|||
127948976|NCT02027428|460432307|FG000|Induction|Death|21|||
127948977|NCT02027428|460432308|FG001|Induction|Death|0|||
127948978|NCT02027428|460432309|FG002|Induction|Death|0|||
127948979|NCT02027428|460432307|FG000|Induction|Symptomatic deterioration|16|||
127948980|NCT02027428|460432308|FG001|Induction|Symptomatic deterioration|0|||
127948981|NCT02027428|460432309|FG002|Induction|Symptomatic deterioration|0|||
127948982|NCT02027428|460432307|FG000|Induction|Study terminated by sponsor|12|||
127948983|NCT02027428|460432308|FG001|Induction|Study terminated by sponsor|0|||
127948984|NCT02027428|460432309|FG002|Induction|Study terminated by sponsor|0|||
127948985|NCT02027428|460432307|FG000|Induction|Protocol Violation|1|||
127948986|NCT02027428|460432308|FG001|Induction|Protocol Violation|0|||
127948987|NCT02027428|460432309|FG002|Induction|Protocol Violation|0|||
127948988|NCT02027428|460432307|FG000|Induction|Miscellaneous|14|||
127948989|NCT02027428|460432308|FG001|Induction|Miscellaneous|0|||
127948990|NCT02027428|460432309|FG002|Induction|Miscellaneous|0|||
127948991|NCT02027428|460432307|FG000|Induction|Induction Treatment Ongoing|4|||
127948992|NCT02027428|460432308|FG001|Induction|Induction Treatment Ongoing|0|||
127948993|NCT02027428|460432309|FG002|Induction|Induction Treatment Ongoing|0|||
127948994|NCT02027428|460432307|FG000|Maintenance|Death|0|||
127948995|NCT02027428|460432308|FG001|Maintenance|Death|3|||
127948996|NCT02027428|460432309|FG002|Maintenance|Death|2|||
127948997|NCT02027428|460432307|FG000|Maintenance|Adverse Event|0|||
127948998|NCT02027428|460432308|FG001|Maintenance|Adverse Event|21|||
127948999|NCT02027428|460432309|FG002|Maintenance|Adverse Event|1|||
127949000|NCT02027428|460432307|FG000|Maintenance|Progressive disease|0|||
127949001|NCT02027428|460432308|FG001|Maintenance|Progressive disease|84|||
127949002|NCT02027428|460432309|FG002|Maintenance|Progressive disease|47|||
127949003|NCT02027428|460432307|FG000|Maintenance|Symptomatic deterioration|0|||
127949004|NCT02027428|460432308|FG001|Maintenance|Symptomatic deterioration|4|||
127949005|NCT02027428|460432309|FG002|Maintenance|Symptomatic deterioration|1|||
127949006|NCT02027428|460432307|FG000|Maintenance|Withdrawal by Subject|0|||
127949007|NCT02027428|460432308|FG001|Maintenance|Withdrawal by Subject|6|||
127949008|NCT02027428|460432309|FG002|Maintenance|Withdrawal by Subject|5|||
127949009|NCT02027428|460432307|FG000|Maintenance|Protocol Violation|0|||
127949010|NCT02027428|460432308|FG001|Maintenance|Protocol Violation|0|||
127949011|NCT02027428|460432309|FG002|Maintenance|Protocol Violation|1|||
127949012|NCT02027428|460432307|FG000|Maintenance|Other|0|||
127949013|NCT02027428|460432308|FG001|Maintenance|Other|6|||
127949014|NCT02027428|460432309|FG002|Maintenance|Other|3|||
127949015|NCT02027428|460432307|FG000|Survival Follow-up|Death|0|||
127949016|NCT02027428|460432308|FG001|Survival Follow-up|Death|78|||
127949017|NCT02027428|460432309|FG002|Survival Follow-up|Death|45|||
127949018|NCT02027428|460432307|FG000|Survival Follow-up|Lost to Follow-up|0|||
127949019|NCT02027428|460432308|FG001|Survival Follow-up|Lost to Follow-up|1|||
127949020|NCT02027428|460432309|FG002|Survival Follow-up|Lost to Follow-up|1|||
127949021|NCT05794503|460432310|FG000|Overall Study|Operation Cancelled|2|||
127949022|NCT05794503|460432311|FG001|Overall Study|Operation Cancelled|0|||
127949023|NCT05794503|460432310|FG000|Overall Study|Received Neostigmine + Sugammadex|2|||
127949024|NCT05794503|460432311|FG001|Overall Study|Received Neostigmine + Sugammadex|0|||
127949025|NCT05794503|460432310|FG000|Overall Study|Protocol Violation|1|||
127949026|NCT05794503|460432311|FG001|Overall Study|Protocol Violation|0|||
127949027|NCT04784533|460432312|FG000|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|6|||
127949028|NCT04784533|460432313|FG001|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|3|||
127949029|NCT04784533|460432314|FG002|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
127949030|NCT04784533|460432315|FG003|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
127949031|NCT04784533|460432316|FG004|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
127949032|NCT04784533|460432317|FG005|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
127949033|NCT04784533|460432318|FG006|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
127949034|NCT04784533|460432319|FG007|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
127949035|NCT04784533|460432320|FG008|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
127949036|NCT04784533|460432321|FG009|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
127949037|NCT04784533|460432312|FG000|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
127949038|NCT04784533|460432313|FG001|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
127949039|NCT04784533|460432314|FG002|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
127949040|NCT04784533|460432315|FG003|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
127949041|NCT04784533|460432316|FG004|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
127949042|NCT04784533|460432317|FG005|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
127949043|NCT04784533|460432318|FG006|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
127949044|NCT04784533|460432319|FG007|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
127949045|NCT04784533|460432320|FG008|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
127949046|NCT04784533|460432321|FG009|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
127949047|NCT04784533|460432312|FG000|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
127949048|NCT04784533|460432313|FG001|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|2|||
127949049|NCT04784533|460432314|FG002|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
127949050|NCT04784533|460432315|FG003|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
127949051|NCT04784533|460432316|FG004|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
127949052|NCT04784533|460432317|FG005|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
127949053|NCT04784533|460432318|FG006|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
127949054|NCT04784533|460432319|FG007|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
127949055|NCT04784533|460432320|FG008|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
127949056|NCT04784533|460432321|FG009|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
127949057|NCT04784533|460432312|FG000|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|1|||
127949058|NCT04784533|460432313|FG001|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
127949059|NCT04784533|460432314|FG002|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
127949060|NCT04784533|460432315|FG003|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
127949061|NCT04784533|460432316|FG004|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
127949062|NCT04784533|460432317|FG005|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
127949063|NCT04784533|460432318|FG006|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
127949064|NCT04784533|460432319|FG007|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
127949065|NCT04784533|460432320|FG008|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
127949066|NCT04784533|460432321|FG009|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
127949067|NCT04784533|460432312|FG000|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|5|||
127949068|NCT04784533|460432313|FG001|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|7|||
127949069|NCT04784533|460432314|FG002|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
127949070|NCT04784533|460432315|FG003|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
127949071|NCT04784533|460432316|FG004|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
127949072|NCT04784533|460432317|FG005|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
127949073|NCT04784533|460432318|FG006|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
127949074|NCT04784533|460432319|FG007|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
127949075|NCT04784533|460432320|FG008|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
127949076|NCT04784533|460432321|FG009|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
127949077|NCT04784533|460432312|FG000|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|5|||
127949078|NCT04784533|460432313|FG001|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|6|||
127949079|NCT04784533|460432314|FG002|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
127949080|NCT04784533|460432315|FG003|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
127949081|NCT04784533|460432316|FG004|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
127949082|NCT04784533|460432317|FG005|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
127949083|NCT04784533|460432318|FG006|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
127949084|NCT04784533|460432319|FG007|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
127949085|NCT04784533|460432320|FG008|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
127949086|NCT04784533|460432321|FG009|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
127949087|NCT04784533|460432312|FG000|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
127949088|NCT04784533|460432313|FG001|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
127949089|NCT04784533|460432314|FG002|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|1|||
127949090|NCT04784533|460432315|FG003|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
127949091|NCT04784533|460432316|FG004|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
127949092|NCT04784533|460432317|FG005|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
127949093|NCT04784533|460432318|FG006|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
127949094|NCT04784533|460432319|FG007|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
127949095|NCT04784533|460432320|FG008|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
127949096|NCT04784533|460432321|FG009|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
127949097|NCT04784533|460432312|FG000|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
127949098|NCT04784533|460432313|FG001|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
127949099|NCT04784533|460432314|FG002|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
127949100|NCT04784533|460432315|FG003|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
127949101|NCT04784533|460432316|FG004|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
127949102|NCT04784533|460432317|FG005|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
127949103|NCT04784533|460432318|FG006|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
127949104|NCT04784533|460432319|FG007|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
127949105|NCT04784533|460432320|FG008|Part B (Day 1 to Week 24)|Lost to Follow-up|1|||
127949106|NCT04784533|460432321|FG009|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
127949107|NCT04784533|460432312|FG000|Part B (Day 1 to Week 24)|Reason not Specified|0|||
127949108|NCT04784533|460432313|FG001|Part B (Day 1 to Week 24)|Reason not Specified|0|||
127949109|NCT04784533|460432314|FG002|Part B (Day 1 to Week 24)|Reason not Specified|0|||
127949110|NCT04784533|460432315|FG003|Part B (Day 1 to Week 24)|Reason not Specified|0|||
127949111|NCT04784533|460432316|FG004|Part B (Day 1 to Week 24)|Reason not Specified|0|||
127949112|NCT04784533|460432317|FG005|Part B (Day 1 to Week 24)|Reason not Specified|0|||
127949113|NCT04784533|460432318|FG006|Part B (Day 1 to Week 24)|Reason not Specified|0|||
127949114|NCT04784533|460432319|FG007|Part B (Day 1 to Week 24)|Reason not Specified|0|||
127949115|NCT04784533|460432320|FG008|Part B (Day 1 to Week 24)|Reason not Specified|1|||
127949116|NCT04784533|460432321|FG009|Part B (Day 1 to Week 24)|Reason not Specified|1|||
127949117|NCT00307437|460432322|FG000|Controlled Period|Adverse Event|7|||
127949118|NCT00307437|460432323|FG001|Controlled Period|Adverse Event|2|||
127949119|NCT00307437|460432324|FG002|Controlled Period|Adverse Event|5|||
127949120|NCT00307437|460432325|FG003|Controlled Period|Adverse Event|0|||
127949121|NCT00307437|460432326|FG004|Controlled Period|Adverse Event|0|||
127949122|NCT00307437|460432327|FG005|Controlled Period|Adverse Event|0|||
127949123|NCT00307437|460432328|FG006|Controlled Period|Adverse Event|0|||
127949124|NCT00307437|460432322|FG000|Controlled Period|Death|0|||
127949125|NCT00307437|460432323|FG001|Controlled Period|Death|0|||
127949126|NCT00307437|460432324|FG002|Controlled Period|Death|1|||
127949127|NCT00307437|460432325|FG003|Controlled Period|Death|0|||
127949128|NCT00307437|460432326|FG004|Controlled Period|Death|0|||
127949129|NCT00307437|460432327|FG005|Controlled Period|Death|0|||
127949130|NCT00307437|460432328|FG006|Controlled Period|Death|0|||
127949131|NCT00307437|460432322|FG000|Controlled Period|Lack of Efficacy|2|||
127949132|NCT00307437|460432323|FG001|Controlled Period|Lack of Efficacy|0|||
127949133|NCT00307437|460432324|FG002|Controlled Period|Lack of Efficacy|0|||
127949134|NCT00307437|460432325|FG003|Controlled Period|Lack of Efficacy|0|||
127949135|NCT00307437|460432326|FG004|Controlled Period|Lack of Efficacy|0|||
127949136|NCT00307437|460432327|FG005|Controlled Period|Lack of Efficacy|0|||
127949137|NCT00307437|460432328|FG006|Controlled Period|Lack of Efficacy|0|||
127949138|NCT00307437|460432322|FG000|Controlled Period|Lost to Follow-up|2|||
127949139|NCT00307437|460432323|FG001|Controlled Period|Lost to Follow-up|3|||
127949140|NCT00307437|460432324|FG002|Controlled Period|Lost to Follow-up|0|||
127949141|NCT00307437|460432325|FG003|Controlled Period|Lost to Follow-up|0|||
127949142|NCT00307437|460432326|FG004|Controlled Period|Lost to Follow-up|0|||
127949143|NCT00307437|460432327|FG005|Controlled Period|Lost to Follow-up|0|||
127949144|NCT00307437|460432328|FG006|Controlled Period|Lost to Follow-up|0|||
127949145|NCT00307437|460432322|FG000|Controlled Period|Other|5|||
127949146|NCT00307437|460432323|FG001|Controlled Period|Other|1|||
127949147|NCT00307437|460432324|FG002|Controlled Period|Other|3|||
127949148|NCT00307437|460432325|FG003|Controlled Period|Other|0|||
127949149|NCT00307437|460432326|FG004|Controlled Period|Other|0|||
127949150|NCT00307437|460432327|FG005|Controlled Period|Other|0|||
127949151|NCT00307437|460432328|FG006|Controlled Period|Other|0|||
127949152|NCT00307437|460432322|FG000|After Controlled Period|Adverse Event|0|||
127949153|NCT00307437|460432323|FG001|After Controlled Period|Adverse Event|0|||
127949154|NCT00307437|460432324|FG002|After Controlled Period|Adverse Event|0|||
127949155|NCT00307437|460432325|FG003|After Controlled Period|Adverse Event|18|||
127949156|NCT00307437|460432326|FG004|After Controlled Period|Adverse Event|16|||
127949157|NCT00307437|460432327|FG005|After Controlled Period|Adverse Event|31|||
127949158|NCT00307437|460432328|FG006|After Controlled Period|Adverse Event|40|||
127949159|NCT00307437|460432322|FG000|After Controlled Period|Death|0|||
127949160|NCT00307437|460432323|FG001|After Controlled Period|Death|0|||
127949161|NCT00307437|460432324|FG002|After Controlled Period|Death|0|||
127949162|NCT00307437|460432325|FG003|After Controlled Period|Death|3|||
127949163|NCT00307437|460432326|FG004|After Controlled Period|Death|1|||
127949164|NCT00307437|460432327|FG005|After Controlled Period|Death|1|||
127949165|NCT00307437|460432328|FG006|After Controlled Period|Death|3|||
127949166|NCT00307437|460432322|FG000|After Controlled Period|Lack of Efficacy|0|||
127949167|NCT00307437|460432323|FG001|After Controlled Period|Lack of Efficacy|0|||
127949168|NCT00307437|460432324|FG002|After Controlled Period|Lack of Efficacy|0|||
127949169|NCT00307437|460432325|FG003|After Controlled Period|Lack of Efficacy|15|||
127949170|NCT00307437|460432326|FG004|After Controlled Period|Lack of Efficacy|17|||
127949171|NCT00307437|460432327|FG005|After Controlled Period|Lack of Efficacy|37|||
127949172|NCT00307437|460432328|FG006|After Controlled Period|Lack of Efficacy|24|||
127949173|NCT00307437|460432322|FG000|After Controlled Period|Lost to Follow-up|0|||
127949174|NCT00307437|460432323|FG001|After Controlled Period|Lost to Follow-up|0|||
127949175|NCT00307437|460432324|FG002|After Controlled Period|Lost to Follow-up|0|||
127949176|NCT00307437|460432325|FG003|After Controlled Period|Lost to Follow-up|7|||
127949177|NCT00307437|460432326|FG004|After Controlled Period|Lost to Follow-up|12|||
127949178|NCT00307437|460432327|FG005|After Controlled Period|Lost to Follow-up|13|||
127949179|NCT00307437|460432328|FG006|After Controlled Period|Lost to Follow-up|18|||
127949180|NCT00307437|460432322|FG000|After Controlled Period|Other|0|||
127949181|NCT00307437|460432323|FG001|After Controlled Period|Other|0|||
127949182|NCT00307437|460432324|FG002|After Controlled Period|Other|0|||
127949183|NCT00307437|460432325|FG003|After Controlled Period|Other|15|||
127949184|NCT00307437|460432326|FG004|After Controlled Period|Other|9|||
127949185|NCT00307437|460432327|FG005|After Controlled Period|Other|40|||
127949186|NCT00307437|460432328|FG006|After Controlled Period|Other|28|||
127949187|NCT00338728|460432335|FG000|Overall Study|Screen Failure|14|||
127949188|NCT00143247|460432339|FG000|Overall Study|Death|8|||
127949189|NCT00143247|460432339|FG000|Overall Study|Adverse Event|19|||
127949190|NCT00143247|460432339|FG000|Overall Study|Lack of Efficacy|3|||
127949191|NCT00143247|460432339|FG000|Overall Study|Withdrawal by Subject|55|||
127949192|NCT00143247|460432339|FG000|Overall Study|Study terminated by sponsor|31|||
127949193|NCT00143247|460432339|FG000|Overall Study|Protocol Violation|15|||
127949194|NCT00143247|460432339|FG000|Overall Study|Lost to Follow-up|12|||
127949195|NCT00143247|460432339|FG000|Overall Study|following inaccurate lab adverse event|1|||
127949196|NCT00143247|460432339|FG000|Overall Study|Other|12|||
127949197|NCT00340678|460432344|FG000|Overall Study|Lost to Follow-up|1|||
127949198|NCT00340678|460432345|FG001|Overall Study|Lost to Follow-up|0|||
127949199|NCT00340678|460432346|FG002|Overall Study|Lost to Follow-up|0|||
127949200|NCT00340678|460432347|FG003|Overall Study|Lost to Follow-up|0|||
127949201|NCT02766283|460432348|FG000|Overall Study|Lost to Follow-up|27|||
127949202|NCT00708227|460432351|FG000|Overall Study|Physician Decision|0|||
127949203|NCT00708227|460432352|FG001|Overall Study|Physician Decision|3|||
127949204|NCT00708227|460432353|FG002|Overall Study|Physician Decision|1|||
127949205|NCT00708227|460432354|FG003|Overall Study|Physician Decision|2|||
127949206|NCT00708227|460432351|FG000|Overall Study|Withdrawal by Subject|1|||
127949207|NCT00708227|460432352|FG001|Overall Study|Withdrawal by Subject|2|||
127949208|NCT00708227|460432353|FG002|Overall Study|Withdrawal by Subject|0|||
127949209|NCT00708227|460432354|FG003|Overall Study|Withdrawal by Subject|1|||
127949210|NCT04007991|460432359|FG000|Overall Study|Withdrawal by Subject|1|||
127949211|NCT04007991|460432360|FG001|Overall Study|Withdrawal by Subject|1|||
127949212|NCT04007991|460432359|FG000|Overall Study|Physician Decision|1|||
127949213|NCT04007991|460432360|FG001|Overall Study|Physician Decision|1|||
127949214|NCT04007991|460432359|FG000|Overall Study|Non-compliance with Study Drug|0|||
127949215|NCT04007991|460432360|FG001|Overall Study|Non-compliance with Study Drug|1|||
127949216|NCT04007991|460432359|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
127949217|NCT04007991|460432360|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
127949218|NCT04007991|460432359|FG000|Overall Study|Adverse event, non-fatal|5|||
127949219|NCT04007991|460432360|FG001|Overall Study|Adverse event, non-fatal|0|||
127949220|NCT04007991|460432359|FG000|Overall Study|Lost to Follow-up|2|||
127949221|NCT04007991|460432360|FG001|Overall Study|Lost to Follow-up|1|||
127949222|NCT03654599|460432361|FG000|Overall Study|Lost to Follow-up|14|||
127949223|NCT03654599|460432362|FG001|Overall Study|Lost to Follow-up|12|||
127949224|NCT03654599|460432361|FG000|Overall Study|Death|8|||
127949225|NCT03654599|460432362|FG001|Overall Study|Death|6|||
127949226|NCT03654599|460432361|FG000|Overall Study|Withdrawal by Subject|6|||
127949227|NCT03654599|460432362|FG001|Overall Study|Withdrawal by Subject|4|||
127949228|NCT01659125|460434247|FG000|Overall Study|Withdrawal by Subject|2|||
127949229|NCT01659125|460434247|FG000|Overall Study|Lost to Follow-up|7|||
127949230|NCT01659125|460434247|FG000|Overall Study|Technical Problem|1|||
127949231|NCT01659125|460434247|FG000|Overall Study|Time Constraints|2|||
127949232|NCT01659125|460434247|FG000|Overall Study|Failed to Start Treatment|2|||
127949233|NCT01762800|460434248|FG000|Overall Study|Adverse Event|8|||
127949234|NCT01762800|460434249|FG001|Overall Study|Adverse Event|13|||
127949235|NCT01762800|460434248|FG000|Overall Study|Lack of Efficacy|3|||
127949236|NCT01762800|460434249|FG001|Overall Study|Lack of Efficacy|2|||
127949237|NCT01762800|460434248|FG000|Overall Study|Study Closed/Terminated|0|||
127949238|NCT01762800|460434249|FG001|Overall Study|Study Closed/Terminated|1|||
127949239|NCT01762800|460434248|FG000|Overall Study|Physician Decision|1|||
127949240|NCT01762800|460434249|FG001|Overall Study|Physician Decision|1|||
127949241|NCT01762800|460434248|FG000|Overall Study|Withdrawal by Subject|7|||
127949242|NCT01762800|460434249|FG001|Overall Study|Withdrawal by Subject|4|||
127949243|NCT02640482|460434250|FG000|Overall Study|Lost to Follow-up|3|||
127949244|NCT02640482|460434251|FG001|Overall Study|Lost to Follow-up|0|||
127949245|NCT02013817|460434255|FG000|Overall Study|Adverse Event|12|||
127949246|NCT02013817|460434255|FG000|Overall Study|Withdrawal by Subject|4|||
127949247|NCT02013817|460434255|FG000|Overall Study|Death|2|||
127949248|NCT02013817|460434255|FG000|Overall Study|Other|9|||
127949249|NCT03336528|460434258|FG000|Overall Study|Protocol Violation|1|||
127949250|NCT03336528|460434259|FG001|Overall Study|Protocol Violation|1|||
127949251|NCT03336528|460434258|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
127949252|NCT03336528|460434259|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
127949253|NCT03336528|460434258|FG000|Overall Study|Did not receive study medication|1|||
127949254|NCT03336528|460434259|FG001|Overall Study|Did not receive study medication|2|||
127949255|NCT01753297|460434264|FG000|Overall Study|Lost to Follow-up|7|||
127949256|NCT01753297|460434265|FG001|Overall Study|Lost to Follow-up|2|||
127949257|NCT01753297|460434264|FG000|Overall Study|Withdrawal by Subject|26|||
127949258|NCT01753297|460434265|FG001|Overall Study|Withdrawal by Subject|23|||
127949259|NCT01753297|460434264|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
127949260|NCT01753297|460434265|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
127949261|NCT01753297|460434264|FG000|Overall Study|Death|0|||
127949262|NCT01753297|460434265|FG001|Overall Study|Death|2|||
127949263|NCT01753297|460434264|FG000|Overall Study|Did not attend end of study visit|7|||
127949264|NCT01753297|460434265|FG001|Overall Study|Did not attend end of study visit|8|||
127949265|NCT00230178|460434266|FG000|Overall Study|Adverse Event|1|||
127949266|NCT00230178|460434267|FG001|Overall Study|Adverse Event|5|||
127949267|NCT00230178|460434268|FG002|Overall Study|Adverse Event|2|||
127949268|NCT00230178|460434266|FG000|Overall Study|Withdrawal by Subject|0|||
127949269|NCT00230178|460434267|FG001|Overall Study|Withdrawal by Subject|0|||
127949270|NCT00230178|460434268|FG002|Overall Study|Withdrawal by Subject|1|||
127949271|NCT00230178|460434266|FG000|Overall Study|Various other reasons|3|||
127949272|NCT00230178|460434267|FG001|Overall Study|Various other reasons|2|||
127949273|NCT00230178|460434268|FG002|Overall Study|Various other reasons|4|||
127949274|NCT04974749|460434275|FG000|Overall Study|Withdrawal by Subject|2|||
127949275|NCT04974749|460434275|FG000|Overall Study|Gestation|1|||
127949276|NCT01645787|460434276|FG000|Washout (2 Weeks)|Adverse Event|1|||
127949277|NCT01645787|460434277|FG001|Washout (2 Weeks)|Adverse Event|0|||
127949278|NCT04315506|460434279|FG000|Overall Study|Lost to Follow-up|74|||
127949279|NCT04315506|460434280|FG001|Overall Study|Lost to Follow-up|82|||
127949280|NCT04315506|460434279|FG000|Overall Study|Withdrawal by Subject|8|||
127949281|NCT04315506|460434280|FG001|Overall Study|Withdrawal by Subject|8|||
127949282|NCT04315506|460434279|FG000|Overall Study|Physician Decision|0|||
127949283|NCT04315506|460434280|FG001|Overall Study|Physician Decision|1|||
127949284|NCT00958893|460434287|FG000|Overall Study|Study prematurely terminated|4|||
127949285|NCT03593395|460434294|FG000|Overall Study|Lost to Follow-up|48|||
127949286|NCT03593395|460434295|FG001|Overall Study|Lost to Follow-up|3|||
127949287|NCT03593395|460434294|FG000|Overall Study|Withdrawal by Subject|5|||
127949288|NCT03593395|460434295|FG001|Overall Study|Withdrawal by Subject|24|||
127949289|NCT03593395|460434294|FG000|Overall Study|Death|2|||
127949290|NCT03593395|460434295|FG001|Overall Study|Death|3|||
127949291|NCT03593395|460434294|FG000|Overall Study|Physician Decision|0|||
127949292|NCT03593395|460434295|FG001|Overall Study|Physician Decision|6|||
127949293|NCT03593395|460434294|FG000|Overall Study|Participant Relocated|19|||
127949294|NCT03593395|460434295|FG001|Overall Study|Participant Relocated|3|||
127949295|NCT03593395|460434294|FG000|Overall Study|No Information|1|||
127949296|NCT03593395|460434295|FG001|Overall Study|No Information|7|||
127949297|NCT01524978|460434296|FG000|Overall Study|Other|16|||
127949298|NCT01524978|460434297|FG001|Overall Study|Other|2|||
127949299|NCT01524978|460434298|FG002|Overall Study|Other|1|||
127949300|NCT01524978|460434299|FG003|Overall Study|Other|2|||
127949301|NCT01524978|460434300|FG004|Overall Study|Other|1|||
127949302|NCT01524978|460434301|FG005|Overall Study|Other|3|||
127949303|NCT01524978|460434302|FG006|Overall Study|Other|17|||
127949304|NCT01524978|460434303|FG007|Overall Study|Other|1|||
127949305|NCT01524978|460434304|FG008|Overall Study|Other|2|||
127949306|NCT01524978|460434305|FG009|Overall Study|Other|2|||
127949307|NCT01524978|460434306|FG010|Overall Study|Other|5|||
127949308|NCT01524978|460434296|FG000|Overall Study|Withdrawal by Subject|12|||
127949309|NCT01524978|460434297|FG001|Overall Study|Withdrawal by Subject|0|||
127949310|NCT01524978|460434298|FG002|Overall Study|Withdrawal by Subject|1|||
127949311|NCT01524978|460434299|FG003|Overall Study|Withdrawal by Subject|1|||
127949312|NCT01524978|460434300|FG004|Overall Study|Withdrawal by Subject|3|||
127949313|NCT01524978|460434301|FG005|Overall Study|Withdrawal by Subject|1|||
127949314|NCT01524978|460434302|FG006|Overall Study|Withdrawal by Subject|6|||
127949315|NCT01524978|460434303|FG007|Overall Study|Withdrawal by Subject|2|||
127949316|NCT01524978|460434304|FG008|Overall Study|Withdrawal by Subject|4|||
127949317|NCT01524978|460434305|FG009|Overall Study|Withdrawal by Subject|0|||
127949318|NCT01524978|460434306|FG010|Overall Study|Withdrawal by Subject|5|||
127949319|NCT01524978|460434296|FG000|Overall Study|Lost to Follow-up|0|||
127949320|NCT01524978|460434297|FG001|Overall Study|Lost to Follow-up|0|||
127949321|NCT01524978|460434298|FG002|Overall Study|Lost to Follow-up|3|||
127949322|NCT01524978|460434299|FG003|Overall Study|Lost to Follow-up|0|||
127949323|NCT01524978|460434300|FG004|Overall Study|Lost to Follow-up|1|||
127949324|NCT01524978|460434301|FG005|Overall Study|Lost to Follow-up|1|||
127949325|NCT01524978|460434302|FG006|Overall Study|Lost to Follow-up|2|||
127949326|NCT01524978|460434303|FG007|Overall Study|Lost to Follow-up|0|||
127949327|NCT01524978|460434304|FG008|Overall Study|Lost to Follow-up|1|||
127949328|NCT01524978|460434305|FG009|Overall Study|Lost to Follow-up|1|||
127949329|NCT01524978|460434306|FG010|Overall Study|Lost to Follow-up|1|||
127949330|NCT01524978|460434296|FG000|Overall Study|Death|34|||
127949331|NCT01524978|460434297|FG001|Overall Study|Death|2|||
127949332|NCT01524978|460434298|FG002|Overall Study|Death|5|||
127949333|NCT01524978|460434299|FG003|Overall Study|Death|24|||
127949334|NCT01524978|460434300|FG004|Overall Study|Death|4|||
127949335|NCT01524978|460434301|FG005|Overall Study|Death|4|||
127949336|NCT01524978|460434302|FG006|Overall Study|Death|1|||
127949337|NCT01524978|460434303|FG007|Overall Study|Death|9|||
127949338|NCT01524978|460434304|FG008|Overall Study|Death|5|||
127949339|NCT01524978|460434305|FG009|Overall Study|Death|6|||
127949340|NCT01524978|460434306|FG010|Overall Study|Death|17|||
127949341|NCT02165735|460434309|FG000|Overall Study|Lost to Follow-up|12|||
127949342|NCT02165735|460434310|FG001|Overall Study|Lost to Follow-up|10|||
127949343|NCT02165735|460434309|FG000|Overall Study|Withdrawal by Subject|3|||
127949344|NCT02165735|460434310|FG001|Overall Study|Withdrawal by Subject|0|||
127949345|NCT02165735|460434309|FG000|Overall Study|Participant indicated lack of time|1|||
127949346|NCT02165735|460434310|FG001|Overall Study|Participant indicated lack of time|3|||
127949347|NCT02165735|460434309|FG000|Overall Study|Protocol Violation|0|||
127949348|NCT02165735|460434310|FG001|Overall Study|Protocol Violation|1|||
127949349|NCT03066258|460434311|FG000|Overall Study|Death|1|||
127949350|NCT03066258|460434312|FG001|Overall Study|Death|0|||
127949351|NCT03066258|460434313|FG002|Overall Study|Death|0|||
127949352|NCT03066258|460434314|FG003|Overall Study|Death|0|||
127949353|NCT03066258|460434315|FG004|Overall Study|Death|1|||
127949354|NCT02784795|460434316|FG000|Overall Study|Progressive Disease|2|||
127949355|NCT02784795|460434317|FG001|Overall Study|Progressive Disease|1|||
127949356|NCT02784795|460434318|FG002|Overall Study|Progressive Disease|1|||
127949357|NCT02784795|460434319|FG003|Overall Study|Progressive Disease|0|||
127949358|NCT02784795|460434320|FG004|Overall Study|Progressive Disease|2|||
127949359|NCT02784795|460434321|FG005|Overall Study|Progressive Disease|0|||
127949360|NCT02784795|460434322|FG006|Overall Study|Progressive Disease|2|||
127949361|NCT02784795|460434323|FG007|Overall Study|Progressive Disease|0|||
127949362|NCT02784795|460434324|FG008|Overall Study|Progressive Disease|0|||
127949363|NCT02784795|460434325|FG009|Overall Study|Progressive Disease|0|||
127949364|NCT02784795|460434326|FG010|Overall Study|Progressive Disease|1|||
127949365|NCT02784795|460434327|FG011|Overall Study|Progressive Disease|0|||
127949366|NCT02784795|460434316|FG000|Overall Study|Adverse Event|1|||
127949367|NCT02784795|460434317|FG001|Overall Study|Adverse Event|0|||
127949368|NCT02784795|460434318|FG002|Overall Study|Adverse Event|0|||
127949369|NCT02784795|460434319|FG003|Overall Study|Adverse Event|1|||
127949370|NCT02784795|460434320|FG004|Overall Study|Adverse Event|0|||
127949371|NCT02784795|460434321|FG005|Overall Study|Adverse Event|0|||
127949372|NCT02784795|460434322|FG006|Overall Study|Adverse Event|1|||
127949373|NCT02784795|460434323|FG007|Overall Study|Adverse Event|0|||
127949374|NCT02784795|460434324|FG008|Overall Study|Adverse Event|0|||
127949375|NCT02784795|460434325|FG009|Overall Study|Adverse Event|0|||
127949376|NCT02784795|460434326|FG010|Overall Study|Adverse Event|0|||
127949377|NCT02784795|460434327|FG011|Overall Study|Adverse Event|2|||
127949378|NCT02784795|460434316|FG000|Overall Study|Withdrawal by Subject|1|||
127949379|NCT02784795|460434317|FG001|Overall Study|Withdrawal by Subject|0|||
127949380|NCT02784795|460434318|FG002|Overall Study|Withdrawal by Subject|2|||
127949381|NCT02784795|460434319|FG003|Overall Study|Withdrawal by Subject|1|||
127949382|NCT02784795|460434320|FG004|Overall Study|Withdrawal by Subject|3|||
127949383|NCT02784795|460434321|FG005|Overall Study|Withdrawal by Subject|0|||
127949384|NCT02784795|460434322|FG006|Overall Study|Withdrawal by Subject|0|||
127949385|NCT02784795|460434323|FG007|Overall Study|Withdrawal by Subject|1|||
127949386|NCT02784795|460434324|FG008|Overall Study|Withdrawal by Subject|0|||
127949387|NCT02784795|460434325|FG009|Overall Study|Withdrawal by Subject|0|||
127949388|NCT02784795|460434326|FG010|Overall Study|Withdrawal by Subject|0|||
127949389|NCT02784795|460434327|FG011|Overall Study|Withdrawal by Subject|2|||
127949390|NCT02784795|460434316|FG000|Overall Study|Death|0|||
127949391|NCT02784795|460434317|FG001|Overall Study|Death|0|||
127949392|NCT02784795|460434318|FG002|Overall Study|Death|0|||
127949393|NCT02784795|460434319|FG003|Overall Study|Death|0|||
127949394|NCT02784795|460434320|FG004|Overall Study|Death|1|||
127949395|NCT02784795|460434321|FG005|Overall Study|Death|0|||
127949396|NCT02784795|460434322|FG006|Overall Study|Death|0|||
127949397|NCT02784795|460434323|FG007|Overall Study|Death|0|||
127949398|NCT02784795|460434324|FG008|Overall Study|Death|0|||
127949399|NCT02784795|460434325|FG009|Overall Study|Death|0|||
127949400|NCT02784795|460434326|FG010|Overall Study|Death|0|||
127949401|NCT02784795|460434327|FG011|Overall Study|Death|0|||
127949402|NCT02784795|460434316|FG000|Overall Study|Physician Decision|0|||
127949403|NCT02784795|460434317|FG001|Overall Study|Physician Decision|0|||
127949404|NCT02784795|460434318|FG002|Overall Study|Physician Decision|0|||
127949405|NCT02784795|460434319|FG003|Overall Study|Physician Decision|0|||
127949406|NCT02784795|460434320|FG004|Overall Study|Physician Decision|0|||
127949407|NCT02784795|460434321|FG005|Overall Study|Physician Decision|0|||
127949408|NCT02784795|460434322|FG006|Overall Study|Physician Decision|1|||
127949409|NCT02784795|460434323|FG007|Overall Study|Physician Decision|0|||
127949410|NCT02784795|460434324|FG008|Overall Study|Physician Decision|0|||
127949411|NCT02784795|460434325|FG009|Overall Study|Physician Decision|0|||
127949412|NCT02784795|460434326|FG010|Overall Study|Physician Decision|0|||
127949413|NCT02784795|460434327|FG011|Overall Study|Physician Decision|0|||
127949414|NCT00606632|460434330|FG000|Overall Study|Withdrawal by Subject|13|||
127949415|NCT00606632|460434330|FG000|Overall Study|Miscellaneous reasons|9|||
127949416|NCT02481869|460434333|FG000|Overall Study|Lost to Follow-up|3|||
127949417|NCT02481869|460434334|FG001|Overall Study|Lost to Follow-up|4|||
127949418|NCT02481869|460434333|FG000|Overall Study|Withdrawal by Subject|2|||
127949419|NCT02481869|460434334|FG001|Overall Study|Withdrawal by Subject|0|||
127949420|NCT00711880|460434335|FG000|Overall Study|Adverse Event|11|||
127949421|NCT00711880|460434336|FG001|Overall Study|Adverse Event|2|||
127949422|NCT00711880|460434335|FG000|Overall Study|Patient non-compliance|1|||
127949423|NCT00711880|460434336|FG001|Overall Study|Patient non-compliance|0|||
127949424|NCT00711880|460434335|FG000|Overall Study|Lack of Efficacy|1|||
127949425|NCT00711880|460434336|FG001|Overall Study|Lack of Efficacy|5|||
127949426|NCT04238650|460434339|FG000|Overall Study|Withdrawal by Subject|0|||
127949427|NCT04238650|460434340|FG001|Overall Study|Withdrawal by Subject|1|||
127949428|NCT02756208|460434344|FG000|Overall Study|Withdrawal by Subject|1|||
127949429|NCT02756208|460434345|FG001|Overall Study|Withdrawal by Subject|0|||
127949430|NCT02756208|460434346|FG002|Overall Study|Withdrawal by Subject|1|||
127949431|NCT02756208|460434347|FG003|Overall Study|Withdrawal by Subject|3|||
127949432|NCT02756208|460434344|FG000|Overall Study|Lost to Follow-up|3|||
127949433|NCT02756208|460434345|FG001|Overall Study|Lost to Follow-up|1|||
127949434|NCT02756208|460434346|FG002|Overall Study|Lost to Follow-up|1|||
127949435|NCT02756208|460434347|FG003|Overall Study|Lost to Follow-up|1|||
127949436|NCT02756208|460434344|FG000|Overall Study|Physician Decision|1|||
127949437|NCT02756208|460434345|FG001|Overall Study|Physician Decision|0|||
127949438|NCT02756208|460434346|FG002|Overall Study|Physician Decision|0|||
127949439|NCT02756208|460434347|FG003|Overall Study|Physician Decision|0|||
127949440|NCT02756208|460434344|FG000|Overall Study|Protocol Violation|0|||
127949441|NCT02756208|460434345|FG001|Overall Study|Protocol Violation|1|||
127949442|NCT02756208|460434346|FG002|Overall Study|Protocol Violation|0|||
127949443|NCT02756208|460434347|FG003|Overall Study|Protocol Violation|0|||
127949444|NCT02370238|460434348|FG000|Overall Study|Death|42|||
127949445|NCT02370238|460434349|FG001|Overall Study|Death|35|||
127949446|NCT02370238|460434348|FG000|Overall Study|Lost to Follow-up|1|||
127949447|NCT02370238|460434349|FG001|Overall Study|Lost to Follow-up|3|||
127949448|NCT02370238|460434348|FG000|Overall Study|Withdrawal by Subject|2|||
127949449|NCT02370238|460434349|FG001|Overall Study|Withdrawal by Subject|6|||
127949450|NCT02370238|460434348|FG000|Overall Study|Other|2|||
127949451|NCT02370238|460434349|FG001|Overall Study|Other|1|||
127949452|NCT01295320|460434354|FG000|Overall Study|Adverse Event|2|||
127949453|NCT01295320|460434354|FG000|Overall Study|Lost to Follow-up|4|||
127949454|NCT01295320|460434354|FG000|Overall Study|Withdrawal by Subject|2|||
127949455|NCT01295320|460434354|FG000|Overall Study|Subject was bedridden|1|||
127949456|NCT01295320|460434354|FG000|Overall Study|Unable to travel|1|||
127949457|NCT00652340|460434355|FG000|Overall Study|Had not progressed.|4|||
127949458|NCT00652340|460434356|FG001|Overall Study|Had not progressed.|3|||
127949459|NCT03682107|460434357|FG000|Overall Study|Withdrawal by Subject|0|||
127949460|NCT03682107|460434358|FG001|Overall Study|Withdrawal by Subject|1|||
127949461|NCT03682107|460434359|FG002|Overall Study|Withdrawal by Subject|0|||
127949462|NCT03682107|460434360|FG003|Overall Study|Withdrawal by Subject|0|||
127949463|NCT03682107|460434361|FG004|Overall Study|Withdrawal by Subject|0|||
127949464|NCT04342819|460434362|FG000|Overall Study|Declined|4|||
127949465|NCT04342819|460434362|FG000|Overall Study|Not meeeting selection criteria|1|||
127949466|NCT00214383|460434363|FG000|Overall Study|Lost to Follow-up|16|||
127949467|NCT00214383|460434364|FG001|Overall Study|Lost to Follow-up|26|||
127949468|NCT01569295|460434365|FG000|Overall Study|Progressive Disease|75|||
127949469|NCT01569295|460434366|FG001|Overall Study|Progressive Disease|139|||
127949470|NCT01569295|460434365|FG000|Overall Study|Adverse Event|39|||
127949471|NCT01569295|460434366|FG001|Overall Study|Adverse Event|14|||
127949472|NCT01569295|460434365|FG000|Overall Study|Withdrawal by Subject|25|||
127949473|NCT01569295|460434366|FG001|Overall Study|Withdrawal by Subject|12|||
127949474|NCT01569295|460434365|FG000|Overall Study|Death|19|||
127949475|NCT01569295|460434366|FG001|Overall Study|Death|15|||
127949476|NCT01569295|460434365|FG000|Overall Study|Physician Decision|13|||
127949477|NCT01569295|460434366|FG001|Overall Study|Physician Decision|18|||
127949478|NCT01569295|460434365|FG000|Overall Study|Study Terminated by Sponsor|24|||
127949479|NCT01569295|460434366|FG001|Overall Study|Study Terminated by Sponsor|2|||
127949480|NCT01569295|460434365|FG000|Overall Study|Other Reason not Specified|3|||
127949481|NCT01569295|460434366|FG001|Overall Study|Other Reason not Specified|5|||
127949482|NCT01569295|460434365|FG000|Overall Study|Non-Compliance with Study Drug|6|||
127949483|NCT01569295|460434366|FG001|Overall Study|Non-Compliance with Study Drug|1|||
127949484|NCT01569295|460434365|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
127949485|NCT01569295|460434366|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
127949486|NCT01569295|460434365|FG000|Overall Study|Lost to Follow-up|1|||
127949487|NCT01569295|460434366|FG001|Overall Study|Lost to Follow-up|1|||
127949488|NCT00879411|460434367|FG000|Overall Study|lost to follow-up (non-AE)|162|||
127949489|NCT03607487|460434368|FG000|Overall Study|Withdrawal by Subject|2|||
127949490|NCT03607487|460434369|FG001|Overall Study|Withdrawal by Subject|0|||
127949491|NCT03607487|460434370|FG002|Overall Study|Withdrawal by Subject|0|||
127949492|NCT03607487|460434371|FG003|Overall Study|Withdrawal by Subject|1|||
127949493|NCT01884337|460434372|FG000|Treatment|Adverse Event|2|||
127949494|NCT01884337|460434373|FG001|Treatment|Adverse Event|2|||
127949495|NCT01884337|460434372|FG000|Treatment|Subj. request to discont. treatment|2|||
127949496|NCT01884337|460434373|FG001|Treatment|Subj. request to discont. treatment|0|||
127949497|NCT01884337|460434372|FG000|Follow-up Period|Lost to Follow-up|1|||
127949498|NCT01884337|460434373|FG001|Follow-up Period|Lost to Follow-up|1|||
127949499|NCT01038297|460434374|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
127949500|NCT01038297|460434375|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
127949501|NCT01038297|460434376|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
127949502|NCT01973595|460434377|FG000|Washout|Withdrawal by Subject|1|||
127949503|NCT01973595|460434378|FG001|Washout|Withdrawal by Subject|0|||
127949504|NCT01973595|460434379|FG002|Washout|Withdrawal by Subject|1|||
127949505|NCT01973595|460434380|FG003|Washout|Withdrawal by Subject|0|||
127949506|NCT03837743|460434386|FG000|Overall Study|Adverse Event|1|||
127949507|NCT03837743|460434386|FG000|Overall Study|Withdrawal by Subject|2|||
127949508|NCT01210612|460434387|FG000|Overall Study|Withdrawal by Subject|0|||
127949509|NCT01210612|460434388|FG001|Overall Study|Withdrawal by Subject|2|||
127949510|NCT01275430|460434389|FG000|Overall Study|Adverse Event|1|||
127949511|NCT01275430|460434389|FG000|Overall Study|No Contrast Injection|6|||
127949512|NCT01275430|460434389|FG000|Overall Study|Device Malfunction|1|||
127949513|NCT01275430|460434389|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
127949514|NCT00086281|460434392|FG000|Phase 1|Adverse Event|0|||
127949515|NCT00086281|460434393|FG001|Phase 1|Adverse Event|0|||
127949516|NCT00086281|460434394|FG002|Phase 1|Adverse Event|0|||
127949517|NCT00086281|460434395|FG003|Phase 1|Adverse Event|0|||
127949518|NCT00086281|460434396|FG004|Phase 1|Adverse Event|0|||
127949519|NCT00086281|460434397|FG005|Phase 1|Adverse Event|0|||
127949520|NCT00086281|460434398|FG006|Phase 1|Adverse Event|0|||
127949521|NCT00086281|460434399|FG007|Phase 1|Adverse Event|0|||
127949522|NCT00086281|460434400|FG008|Phase 1|Adverse Event|0|||
127949523|NCT00086281|460434401|FG009|Phase 1|Adverse Event|1|||
127949524|NCT00086281|460434402|FG010|Phase 1|Adverse Event|2|||
127949525|NCT00086281|460434403|FG011|Phase 1|Adverse Event|1|||
127949526|NCT00086281|460434404|FG012|Phase 1|Adverse Event|1|||
127949527|NCT00086281|460434405|FG013|Phase 1|Adverse Event|1|||
127949528|NCT00086281|460434406|FG014|Phase 1|Adverse Event|2|||
127949529|NCT00086281|460434392|FG000|Phase 1|Protocol Violation|0|||
127949530|NCT00086281|460434393|FG001|Phase 1|Protocol Violation|0|||
127949531|NCT00086281|460434394|FG002|Phase 1|Protocol Violation|0|||
127949532|NCT00086281|460434395|FG003|Phase 1|Protocol Violation|0|||
127949533|NCT00086281|460434396|FG004|Phase 1|Protocol Violation|0|||
127949534|NCT00086281|460434397|FG005|Phase 1|Protocol Violation|0|||
127949535|NCT00086281|460434398|FG006|Phase 1|Protocol Violation|0|||
127949536|NCT00086281|460434399|FG007|Phase 1|Protocol Violation|0|||
127949537|NCT00086281|460434400|FG008|Phase 1|Protocol Violation|0|||
127949538|NCT00086281|460434401|FG009|Phase 1|Protocol Violation|0|||
127949539|NCT00086281|460434402|FG010|Phase 1|Protocol Violation|1|||
127949540|NCT00086281|460434403|FG011|Phase 1|Protocol Violation|0|||
127949541|NCT00086281|460434404|FG012|Phase 1|Protocol Violation|0|||
127949542|NCT00086281|460434405|FG013|Phase 1|Protocol Violation|0|||
127949543|NCT00086281|460434406|FG014|Phase 1|Protocol Violation|0|||
127949544|NCT00086281|460434392|FG000|Phase 1|Serious Adverse Event|0|||
127949545|NCT00086281|460434393|FG001|Phase 1|Serious Adverse Event|0|||
127949546|NCT00086281|460434394|FG002|Phase 1|Serious Adverse Event|0|||
127949547|NCT00086281|460434395|FG003|Phase 1|Serious Adverse Event|0|||
127949548|NCT00086281|460434396|FG004|Phase 1|Serious Adverse Event|0|||
127949549|NCT00086281|460434397|FG005|Phase 1|Serious Adverse Event|0|||
127949550|NCT00086281|460434398|FG006|Phase 1|Serious Adverse Event|0|||
127949551|NCT00086281|460434399|FG007|Phase 1|Serious Adverse Event|0|||
127949552|NCT00086281|460434400|FG008|Phase 1|Serious Adverse Event|0|||
127949553|NCT00086281|460434401|FG009|Phase 1|Serious Adverse Event|0|||
127949554|NCT00086281|460434402|FG010|Phase 1|Serious Adverse Event|0|||
127949555|NCT00086281|460434403|FG011|Phase 1|Serious Adverse Event|0|||
127949556|NCT00086281|460434404|FG012|Phase 1|Serious Adverse Event|0|||
127949557|NCT00086281|460434405|FG013|Phase 1|Serious Adverse Event|0|||
127949558|NCT00086281|460434406|FG014|Phase 1|Serious Adverse Event|1|||
127949559|NCT00086281|460434392|FG000|Phase 2|Adverse Event|0|||
127949560|NCT00086281|460434393|FG001|Phase 2|Adverse Event|0|||
127949561|NCT00086281|460434394|FG002|Phase 2|Adverse Event|0|||
127949562|NCT00086281|460434395|FG003|Phase 2|Adverse Event|0|||
127949563|NCT00086281|460434396|FG004|Phase 2|Adverse Event|0|||
127949564|NCT00086281|460434397|FG005|Phase 2|Adverse Event|0|||
127949565|NCT00086281|460434398|FG006|Phase 2|Adverse Event|0|||
127949566|NCT00086281|460434399|FG007|Phase 2|Adverse Event|0|||
127949567|NCT00086281|460434400|FG008|Phase 2|Adverse Event|0|||
127949568|NCT00086281|460434401|FG009|Phase 2|Adverse Event|0|||
127949569|NCT00086281|460434402|FG010|Phase 2|Adverse Event|0|||
127949570|NCT00086281|460434403|FG011|Phase 2|Adverse Event|0|||
127949571|NCT00086281|460434404|FG012|Phase 2|Adverse Event|1|||
127949572|NCT00086281|460434405|FG013|Phase 2|Adverse Event|1|||
127949573|NCT00086281|460434406|FG014|Phase 2|Adverse Event|0|||
127949574|NCT02996487|460434407|FG000|Overall Study|Lost to Follow-up|1|||
127949575|NCT02996487|460434408|FG001|Overall Study|Lost to Follow-up|1|||
127949576|NCT02996487|460434409|FG002|Overall Study|Lost to Follow-up|0|||
127949577|NCT02996487|460434407|FG000|Overall Study|Death|0|||
127949578|NCT02996487|460434408|FG001|Overall Study|Death|1|||
127949579|NCT02996487|460434409|FG002|Overall Study|Death|0|||
127949580|NCT02996487|460434407|FG000|Overall Study|Withdrawal by Subject|2|||
127949581|NCT02996487|460434408|FG001|Overall Study|Withdrawal by Subject|3|||
127949582|NCT02996487|460434409|FG002|Overall Study|Withdrawal by Subject|0|||
127949583|NCT04873934|460434412|FG000|Overall Study|Adverse Event|0|||
127949584|NCT04873934|460434413|FG001|Overall Study|Adverse Event|1|||
127949585|NCT04873934|460434412|FG000|Overall Study|Death|0|||
127949586|NCT04873934|460434413|FG001|Overall Study|Death|2|||
127949587|NCT04873934|460434412|FG000|Overall Study|Lost to Follow-up|13|||
127949588|NCT04873934|460434413|FG001|Overall Study|Lost to Follow-up|9|||
127949589|NCT04873934|460434412|FG000|Overall Study|Physician Decision|1|||
127949590|NCT04873934|460434413|FG001|Overall Study|Physician Decision|1|||
127949591|NCT04873934|460434412|FG000|Overall Study|Protocol deviation|2|||
127949592|NCT04873934|460434413|FG001|Overall Study|Protocol deviation|1|||
127949593|NCT04873934|460434412|FG000|Overall Study|Subject decision|1|||
127949594|NCT04873934|460434413|FG001|Overall Study|Subject decision|8|||
127949595|NCT04873934|460434412|FG000|Overall Study|Withdrew consent|0|||
127949596|NCT04873934|460434413|FG001|Overall Study|Withdrew consent|4|||
127949597|NCT04873934|460434412|FG000|Overall Study|Missing|1|||
127949598|NCT04873934|460434413|FG001|Overall Study|Missing|0|||
127949599|NCT02516553|460434414|FG000|Overall Study|Progressive disease|2|||
127949600|NCT02516553|460434415|FG001|Overall Study|Progressive disease|2|||
127949601|NCT02516553|460434416|FG002|Overall Study|Progressive disease|3|||
127949602|NCT02516553|460434417|FG003|Overall Study|Progressive disease|5|||
127949603|NCT02516553|460434418|FG004|Overall Study|Progressive disease|3|||
127949604|NCT02516553|460434419|FG005|Overall Study|Progressive disease|0|||
127949605|NCT02516553|460434420|FG006|Overall Study|Progressive disease|5|||
127949606|NCT02516553|460434421|FG007|Overall Study|Progressive disease|5|||
127949607|NCT02516553|460434422|FG008|Overall Study|Progressive disease|11|||
127949608|NCT02516553|460434423|FG009|Overall Study|Progressive disease|3|||
127949609|NCT02516553|460434424|FG010|Overall Study|Progressive disease|10|||
127949610|NCT02516553|460434425|FG011|Overall Study|Progressive disease|8|||
127949611|NCT02516553|460434426|FG012|Overall Study|Progressive disease|8|||
127949612|NCT02516553|460434427|FG013|Overall Study|Progressive disease|2|||
127949613|NCT02516553|460434428|FG014|Overall Study|Progressive disease|2|||
127949614|NCT02516553|460434429|FG015|Overall Study|Progressive disease|2|||
127949615|NCT02516553|460434430|FG016|Overall Study|Progressive disease|1|||
127949616|NCT02516553|460434431|FG017|Overall Study|Progressive disease|9|||
127949617|NCT02516553|460434432|FG018|Overall Study|Progressive disease|12|||
127949618|NCT02516553|460434433|FG019|Overall Study|Progressive disease|7|||
127949619|NCT02516553|460434434|FG020|Overall Study|Progressive disease|16|||
127949620|NCT02516553|460434435|FG021|Overall Study|Progressive disease|18|||
127949621|NCT02516553|460434414|FG000|Overall Study|Dose limiting toxicity|0|||
127949622|NCT02516553|460434415|FG001|Overall Study|Dose limiting toxicity|0|||
127949623|NCT02516553|460434416|FG002|Overall Study|Dose limiting toxicity|0|||
127949624|NCT02516553|460434417|FG003|Overall Study|Dose limiting toxicity|0|||
127949625|NCT02516553|460434418|FG004|Overall Study|Dose limiting toxicity|3|||
127949626|NCT02516553|460434419|FG005|Overall Study|Dose limiting toxicity|1|||
127949627|NCT02516553|460434420|FG006|Overall Study|Dose limiting toxicity|1|||
127949628|NCT02516553|460434421|FG007|Overall Study|Dose limiting toxicity|0|||
127949629|NCT02516553|460434422|FG008|Overall Study|Dose limiting toxicity|1|||
127949630|NCT02516553|460434423|FG009|Overall Study|Dose limiting toxicity|0|||
127949631|NCT02516553|460434424|FG010|Overall Study|Dose limiting toxicity|0|||
127949632|NCT02516553|460434425|FG011|Overall Study|Dose limiting toxicity|1|||
127949633|NCT02516553|460434426|FG012|Overall Study|Dose limiting toxicity|0|||
127949634|NCT02516553|460434427|FG013|Overall Study|Dose limiting toxicity|1|||
127949635|NCT02516553|460434428|FG014|Overall Study|Dose limiting toxicity|0|||
127949636|NCT02516553|460434429|FG015|Overall Study|Dose limiting toxicity|0|||
127949637|NCT02516553|460434430|FG016|Overall Study|Dose limiting toxicity|1|||
127949638|NCT02516553|460434431|FG017|Overall Study|Dose limiting toxicity|1|||
127949639|NCT02516553|460434432|FG018|Overall Study|Dose limiting toxicity|0|||
127949640|NCT02516553|460434433|FG019|Overall Study|Dose limiting toxicity|2|||
127949641|NCT02516553|460434434|FG020|Overall Study|Dose limiting toxicity|0|||
127949642|NCT02516553|460434435|FG021|Overall Study|Dose limiting toxicity|0|||
127949643|NCT02516553|460434414|FG000|Overall Study|Other Adverse Events|0|||
127949644|NCT02516553|460434415|FG001|Overall Study|Other Adverse Events|0|||
127949645|NCT02516553|460434416|FG002|Overall Study|Other Adverse Events|0|||
127949646|NCT02516553|460434417|FG003|Overall Study|Other Adverse Events|1|||
127949647|NCT02516553|460434418|FG004|Overall Study|Other Adverse Events|0|||
127949648|NCT02516553|460434419|FG005|Overall Study|Other Adverse Events|1|||
127949649|NCT02516553|460434420|FG006|Overall Study|Other Adverse Events|0|||
127949650|NCT02516553|460434421|FG007|Overall Study|Other Adverse Events|0|||
127949651|NCT02516553|460434422|FG008|Overall Study|Other Adverse Events|0|||
127949652|NCT02516553|460434423|FG009|Overall Study|Other Adverse Events|1|||
127949653|NCT02516553|460434424|FG010|Overall Study|Other Adverse Events|3|||
127949654|NCT02516553|460434425|FG011|Overall Study|Other Adverse Events|2|||
127949655|NCT02516553|460434426|FG012|Overall Study|Other Adverse Events|0|||
127949656|NCT02516553|460434427|FG013|Overall Study|Other Adverse Events|1|||
127949657|NCT02516553|460434428|FG014|Overall Study|Other Adverse Events|0|||
127949658|NCT02516553|460434429|FG015|Overall Study|Other Adverse Events|0|||
127949659|NCT02516553|460434430|FG016|Overall Study|Other Adverse Events|0|||
127949660|NCT02516553|460434431|FG017|Overall Study|Other Adverse Events|2|||
127949661|NCT02516553|460434432|FG018|Overall Study|Other Adverse Events|1|||
127949662|NCT02516553|460434433|FG019|Overall Study|Other Adverse Events|2|||
127949663|NCT02516553|460434434|FG020|Overall Study|Other Adverse Events|2|||
127949664|NCT02516553|460434435|FG021|Overall Study|Other Adverse Events|1|||
127949665|NCT02516553|460434414|FG000|Overall Study|Refused to continue trial medication|0|||
127949666|NCT02516553|460434415|FG001|Overall Study|Refused to continue trial medication|0|||
127949667|NCT02516553|460434416|FG002|Overall Study|Refused to continue trial medication|0|||
127949668|NCT02516553|460434417|FG003|Overall Study|Refused to continue trial medication|0|||
127949669|NCT02516553|460434418|FG004|Overall Study|Refused to continue trial medication|0|||
127949670|NCT02516553|460434419|FG005|Overall Study|Refused to continue trial medication|0|||
127949671|NCT02516553|460434420|FG006|Overall Study|Refused to continue trial medication|0|||
127949672|NCT02516553|460434421|FG007|Overall Study|Refused to continue trial medication|0|||
127949673|NCT02516553|460434422|FG008|Overall Study|Refused to continue trial medication|0|||
127949674|NCT02516553|460434423|FG009|Overall Study|Refused to continue trial medication|0|||
127949675|NCT02516553|460434424|FG010|Overall Study|Refused to continue trial medication|1|||
127949676|NCT02516553|460434425|FG011|Overall Study|Refused to continue trial medication|0|||
127949677|NCT02516553|460434426|FG012|Overall Study|Refused to continue trial medication|0|||
127949678|NCT02516553|460434427|FG013|Overall Study|Refused to continue trial medication|0|||
127949679|NCT02516553|460434428|FG014|Overall Study|Refused to continue trial medication|0|||
127949680|NCT02516553|460434429|FG015|Overall Study|Refused to continue trial medication|0|||
127949681|NCT02516553|460434430|FG016|Overall Study|Refused to continue trial medication|0|||
127949682|NCT02516553|460434431|FG017|Overall Study|Refused to continue trial medication|0|||
127949683|NCT02516553|460434432|FG018|Overall Study|Refused to continue trial medication|1|||
127949684|NCT02516553|460434433|FG019|Overall Study|Refused to continue trial medication|0|||
127949685|NCT02516553|460434434|FG020|Overall Study|Refused to continue trial medication|0|||
127949686|NCT02516553|460434435|FG021|Overall Study|Refused to continue trial medication|1|||
127949687|NCT02516553|460434414|FG000|Overall Study|other reasons than listed|0|||
127949688|NCT02516553|460434415|FG001|Overall Study|other reasons than listed|0|||
127949689|NCT02516553|460434416|FG002|Overall Study|other reasons than listed|0|||
127949690|NCT02516553|460434417|FG003|Overall Study|other reasons than listed|0|||
127949691|NCT02516553|460434418|FG004|Overall Study|other reasons than listed|0|||
127949692|NCT02516553|460434419|FG005|Overall Study|other reasons than listed|0|||
127949693|NCT02516553|460434420|FG006|Overall Study|other reasons than listed|0|||
127949694|NCT02516553|460434421|FG007|Overall Study|other reasons than listed|1|||
127949695|NCT02516553|460434422|FG008|Overall Study|other reasons than listed|1|||
127949696|NCT02516553|460434423|FG009|Overall Study|other reasons than listed|0|||
127949697|NCT02516553|460434424|FG010|Overall Study|other reasons than listed|1|||
127949698|NCT02516553|460434425|FG011|Overall Study|other reasons than listed|1|||
127949699|NCT02516553|460434426|FG012|Overall Study|other reasons than listed|0|||
127949700|NCT02516553|460434427|FG013|Overall Study|other reasons than listed|0|||
127949701|NCT02516553|460434428|FG014|Overall Study|other reasons than listed|0|||
127949702|NCT02516553|460434429|FG015|Overall Study|other reasons than listed|0|||
127949703|NCT02516553|460434430|FG016|Overall Study|other reasons than listed|0|||
127949704|NCT02516553|460434431|FG017|Overall Study|other reasons than listed|0|||
127949705|NCT02516553|460434432|FG018|Overall Study|other reasons than listed|0|||
127949706|NCT02516553|460434433|FG019|Overall Study|other reasons than listed|0|||
127949707|NCT02516553|460434434|FG020|Overall Study|other reasons than listed|2|||
127949708|NCT02516553|460434435|FG021|Overall Study|other reasons than listed|2|||
127949709|NCT03052127|460434436|FG000|Overall Study|Withdrawal by Subject|0|||
127949710|NCT03052127|460434437|FG001|Overall Study|Withdrawal by Subject|0|||
127949711|NCT03052127|460434438|FG002|Overall Study|Withdrawal by Subject|0|||
127949712|NCT03052127|460434439|FG003|Overall Study|Withdrawal by Subject|0|||
127949713|NCT03052127|460434440|FG004|Overall Study|Withdrawal by Subject|0|||
127949714|NCT03052127|460434441|FG005|Overall Study|Withdrawal by Subject|0|||
127949715|NCT03052127|460434442|FG006|Overall Study|Withdrawal by Subject|0|||
127949716|NCT03052127|460434443|FG007|Overall Study|Withdrawal by Subject|1|||
127949717|NCT03052127|460434444|FG008|Overall Study|Withdrawal by Subject|1|||
127949718|NCT03052127|460434445|FG009|Overall Study|Withdrawal by Subject|1|||
127949719|NCT03052127|460434446|FG010|Overall Study|Withdrawal by Subject|0|||
127949720|NCT03052127|460434447|FG011|Overall Study|Withdrawal by Subject|0|||
127949721|NCT03052127|460434436|FG000|Overall Study|Discontinuation by Sponsor|0|||
127949722|NCT03052127|460434437|FG001|Overall Study|Discontinuation by Sponsor|0|||
127949723|NCT03052127|460434438|FG002|Overall Study|Discontinuation by Sponsor|0|||
127949724|NCT03052127|460434439|FG003|Overall Study|Discontinuation by Sponsor|0|||
127949725|NCT03052127|460434440|FG004|Overall Study|Discontinuation by Sponsor|0|||
127949726|NCT03052127|460434441|FG005|Overall Study|Discontinuation by Sponsor|0|||
127949727|NCT03052127|460434442|FG006|Overall Study|Discontinuation by Sponsor|0|||
127949728|NCT03052127|460434443|FG007|Overall Study|Discontinuation by Sponsor|0|||
127949729|NCT03052127|460434444|FG008|Overall Study|Discontinuation by Sponsor|4|||
127949730|NCT03052127|460434445|FG009|Overall Study|Discontinuation by Sponsor|2|||
127949731|NCT03052127|460434446|FG010|Overall Study|Discontinuation by Sponsor|5|||
127949732|NCT03052127|460434447|FG011|Overall Study|Discontinuation by Sponsor|13|||
127949733|NCT03052127|460434436|FG000|Overall Study|Inability to comply with trial requirements|0|||
127949734|NCT03052127|460434437|FG001|Overall Study|Inability to comply with trial requirements|0|||
127949735|NCT03052127|460434438|FG002|Overall Study|Inability to comply with trial requirements|1|||
127949736|NCT03052127|460434439|FG003|Overall Study|Inability to comply with trial requirements|0|||
127949737|NCT03052127|460434440|FG004|Overall Study|Inability to comply with trial requirements|0|||
127949738|NCT03052127|460434441|FG005|Overall Study|Inability to comply with trial requirements|0|||
127949739|NCT03052127|460434442|FG006|Overall Study|Inability to comply with trial requirements|0|||
127949740|NCT03052127|460434443|FG007|Overall Study|Inability to comply with trial requirements|0|||
127949741|NCT03052127|460434444|FG008|Overall Study|Inability to comply with trial requirements|0|||
127949742|NCT03052127|460434445|FG009|Overall Study|Inability to comply with trial requirements|0|||
127949743|NCT03052127|460434446|FG010|Overall Study|Inability to comply with trial requirements|0|||
127949744|NCT03052127|460434447|FG011|Overall Study|Inability to comply with trial requirements|0|||
127949745|NCT03052127|460434436|FG000|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
127949746|NCT03052127|460434437|FG001|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
127949747|NCT03052127|460434438|FG002|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
127949748|NCT03052127|460434439|FG003|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
127949749|NCT03052127|460434440|FG004|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
127949750|NCT03052127|460434441|FG005|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
127949751|NCT03052127|460434442|FG006|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
127949752|NCT03052127|460434443|FG007|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
127949753|NCT03052127|460434444|FG008|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
127949754|NCT03052127|460434445|FG009|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
127949755|NCT03052127|460434446|FG010|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
127949756|NCT03052127|460434447|FG011|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
127949757|NCT03694327|460434450|FG000|Overall Study|Lost to Follow-up|13|||
127949758|NCT03694327|460434451|FG001|Overall Study|Lost to Follow-up|23|||
127949759|NCT01464931|460434452|FG000|Overall Study|Withdrawal by Subject|1|||
127949760|NCT01464931|460434453|FG001|Overall Study|Withdrawal by Subject|0|||
127949761|NCT01982812|460434456|FG000|Overall Study|Death|1|||
127949762|NCT01982812|460434457|FG001|Overall Study|Death|5|||
127949763|NCT01982812|460434456|FG000|Overall Study|Adverse Event|0|||
127949764|NCT01982812|460434457|FG001|Overall Study|Adverse Event|5|||
127949765|NCT04803305|460434460|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
127949766|NCT04803305|460434461|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
127949767|NCT04803305|460434460|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
127949768|NCT04803305|460434461|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
127949769|NCT04803305|460434460|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
127949770|NCT04803305|460434461|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
127949771|NCT04803305|460434460|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
127949772|NCT04803305|460434461|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
127949773|NCT04803305|460434460|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
127949774|NCT04803305|460434461|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
127949775|NCT04803305|460434460|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
127949776|NCT04803305|460434461|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
127949777|NCT04803305|460434460|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
127949778|NCT04803305|460434461|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
127949779|NCT04803305|460434460|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
127949780|NCT04803305|460434461|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
127949781|NCT03316547|460434463|FG000|Overall Study|Death|3|||
127949782|NCT03316547|460434464|FG001|Overall Study|Death|1|||
127949783|NCT03316547|460434463|FG000|Overall Study|Lost to Follow-up|6|||
127949784|NCT03316547|460434464|FG001|Overall Study|Lost to Follow-up|6|||
127949785|NCT03316547|460434463|FG000|Overall Study|Withdrawal by Subject|3|||
127949786|NCT03316547|460434464|FG001|Overall Study|Withdrawal by Subject|2|||
127949787|NCT03316547|460434463|FG000|Overall Study|Transfer to another hospital|6|||
127949788|NCT03316547|460434464|FG001|Overall Study|Transfer to another hospital|4|||
127949789|NCT00721227|460434465|FG000|Overall Study|Lost to Follow-up|3|||
127949790|NCT00721227|460434466|FG001|Overall Study|Lost to Follow-up|0|||
127949791|NCT00721227|460434465|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
127949792|NCT00721227|460434466|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
127949793|NCT01243775|460434468|FG000|Overall Study|Withdrawal by Subject|2|||
127949794|NCT03765788|460436916|FG000|Overall Study|Subject decision|2|||
127949795|NCT03765788|460436917|FG001|Overall Study|Subject decision|3|||
127949796|NCT03765788|460436916|FG000|Overall Study|Physician Decision|2|||
127949797|NCT03765788|460436917|FG001|Overall Study|Physician Decision|4|||
127949798|NCT03765788|460436916|FG000|Overall Study|Death|0|||
127949799|NCT03765788|460436917|FG001|Overall Study|Death|1|||
127949800|NCT03765788|460436916|FG000|Overall Study|Lost to Follow-up|1|||
127949801|NCT03765788|460436917|FG001|Overall Study|Lost to Follow-up|0|||
127949802|NCT00517881|460436920|FG000|Overall Study|Protocol Violation|2|||
127949803|NCT00517881|460436920|FG000|Overall Study|Adverse Event|1|||
127949804|NCT00517881|460436920|FG000|Overall Study|Renal transplantation|2|||
127949805|NCT00113763|460436921|FG000|Overall Study|Adverse Event|5|||
127949806|NCT00113763|460436922|FG001|Overall Study|Adverse Event|2|||
127949807|NCT00113763|460436921|FG000|Overall Study|Disease Progression|28|||
127949808|NCT00113763|460436922|FG001|Overall Study|Disease Progression|14|||
127949809|NCT00113763|460436921|FG000|Overall Study|Lost to Follow-up|10|||
127949810|NCT00113763|460436922|FG001|Overall Study|Lost to Follow-up|0|||
127949811|NCT00113763|460436921|FG000|Overall Study|Withdrawal by Subject|1|||
127949812|NCT00113763|460436922|FG001|Overall Study|Withdrawal by Subject|4|||
127949813|NCT00113763|460436921|FG000|Overall Study|Other|27|||
127949814|NCT00113763|460436922|FG001|Overall Study|Other|6|||
127949815|NCT00113763|460436921|FG000|Overall Study|Non-compliance|1|||
127949816|NCT00113763|460436922|FG001|Overall Study|Non-compliance|0|||
127949817|NCT00113763|460436921|FG000|Overall Study|Ongoing|1|||
127949818|NCT00113763|460436922|FG001|Overall Study|Ongoing|0|||
127949819|NCT01383707|460436927|FG000|Overall Study|Consent withdrawal|6|||
127949820|NCT01383707|460436927|FG000|Overall Study|Death|19|||
127949821|NCT01383707|460436927|FG000|Overall Study|Other|8|||
127949822|NCT01383707|460436927|FG000|Overall Study|Sponsor's decision|2|||
127949823|NCT01383707|460436927|FG000|Overall Study|Adverse Event|14|||
127949824|NCT01383707|460436927|FG000|Overall Study|Progressive disease|23|||
127949825|NCT03055624|460436934|FG000|Overall Study|Study closed|9|||
127949826|NCT02794870|460436938|FG000|Overall Study|Withdrawal by Subject|2|||
127949827|NCT02794870|460436939|FG001|Overall Study|Withdrawal by Subject|0|||
127949828|NCT02437903|460436940|FG000|Overall Study|Adverse Event|1|||
127949829|NCT02437903|460436940|FG000|Overall Study|Withdrawal by Subject|1|||
127949830|NCT02437903|460436940|FG000|Overall Study|Lost to Follow-up|3|||
127949831|NCT04414618|460436944|FG000|Overall Study|Death|3|||
127949832|NCT04414618|460436945|FG001|Overall Study|Death|3|||
127949833|NCT04414618|460436944|FG000|Overall Study|Withdrawal by Subject|2|||
127949834|NCT04414618|460436945|FG001|Overall Study|Withdrawal by Subject|1|||
127949835|NCT04414618|460436944|FG000|Overall Study|Lost to Follow-up|2|||
127949836|NCT04414618|460436945|FG001|Overall Study|Lost to Follow-up|3|||
127949837|NCT04414618|460436944|FG000|Overall Study|Physician Decision|1|||
127949838|NCT04414618|460436945|FG001|Overall Study|Physician Decision|0|||
127949839|NCT00658879|460436946|FG000|Overall Study|Protocol Violation|1|||
127949840|NCT00616421|460436947|FG000|Overall Study|Withdrawal by Subject|9|||
127949841|NCT00616421|460436948|FG001|Overall Study|Withdrawal by Subject|11|||
127949842|NCT00616421|460436949|FG002|Overall Study|Withdrawal by Subject|8|||
127949843|NCT00616421|460436947|FG000|Overall Study|Lost to Follow-up|12|||
127949844|NCT00616421|460436948|FG001|Overall Study|Lost to Follow-up|26|||
127949845|NCT00616421|460436949|FG002|Overall Study|Lost to Follow-up|30|||
127949846|NCT00616421|460436947|FG000|Overall Study|Inappropriate enrollment|3|||
127949847|NCT00616421|460436948|FG001|Overall Study|Inappropriate enrollment|0|||
127949848|NCT00616421|460436949|FG002|Overall Study|Inappropriate enrollment|1|||
127949849|NCT00616421|460436947|FG000|Overall Study|Administrative reason|1|||
127949850|NCT00616421|460436948|FG001|Overall Study|Administrative reason|0|||
127949851|NCT00616421|460436949|FG002|Overall Study|Administrative reason|0|||
127949852|NCT00616421|460436947|FG000|Overall Study|Protocol Violation|0|||
127949853|NCT00616421|460436948|FG001|Overall Study|Protocol Violation|1|||
127949854|NCT00616421|460436949|FG002|Overall Study|Protocol Violation|2|||
127949855|NCT00616421|460436947|FG000|Overall Study|Unable to classify|1|||
127949856|NCT00616421|460436948|FG001|Overall Study|Unable to classify|0|||
127949857|NCT00616421|460436949|FG002|Overall Study|Unable to classify|0|||
127949858|NCT02661217|460436950|FG000|Overall Study|Physician Decision|12|||
127949859|NCT02661217|460436951|FG001|Overall Study|Physician Decision|15|||
127949860|NCT02661217|460436950|FG000|Overall Study|Lost to Follow-up|1|||
127949861|NCT02661217|460436951|FG001|Overall Study|Lost to Follow-up|4|||
127949862|NCT02661217|460436950|FG000|Overall Study|Protocol Deviation|0|||
127949863|NCT02661217|460436951|FG001|Overall Study|Protocol Deviation|4|||
127949864|NCT02661217|460436950|FG000|Overall Study|Non-compliance with study treatment|5|||
127949865|NCT02661217|460436951|FG001|Overall Study|Non-compliance with study treatment|5|||
127949866|NCT02661217|460436950|FG000|Overall Study|Death|21|||
127949867|NCT02661217|460436951|FG001|Overall Study|Death|15|||
127949868|NCT02661217|460436950|FG000|Overall Study|Adverse Event|10|||
127949869|NCT02661217|460436951|FG001|Overall Study|Adverse Event|8|||
127949870|NCT02661217|460436950|FG000|Overall Study|Withdrawal by Subject|15|||
127949871|NCT02661217|460436951|FG001|Overall Study|Withdrawal by Subject|19|||
127949872|NCT02661217|460436950|FG000|Overall Study|Did not enter follow-up epoch|7|||
127949873|NCT02661217|460436951|FG001|Overall Study|Did not enter follow-up epoch|10|||
127949874|NCT02661217|460436950|FG000|Overall Study|Death - no study drug received|1|||
127949875|NCT02661217|460436951|FG001|Overall Study|Death - no study drug received|2|||
127949876|NCT02661217|460436950|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
127949877|NCT02661217|460436951|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
127949878|NCT00185588|460436952|FG000|Overall Study|Adverse Event|3|||
127949879|NCT00185588|460436953|FG001|Overall Study|Adverse Event|1|||
127949880|NCT00185588|460436954|FG002|Overall Study|Adverse Event|4|||
127949881|NCT00185588|460436955|FG003|Overall Study|Adverse Event|2|||
127949882|NCT00185588|460436952|FG000|Overall Study|Lost to Follow-up|0|||
127949883|NCT00185588|460436953|FG001|Overall Study|Lost to Follow-up|0|||
127949884|NCT00185588|460436954|FG002|Overall Study|Lost to Follow-up|1|||
127949885|NCT00185588|460436955|FG003|Overall Study|Lost to Follow-up|2|||
127949886|NCT00185588|460436952|FG000|Overall Study|Withdrawal by Subject|0|||
127949887|NCT00185588|460436953|FG001|Overall Study|Withdrawal by Subject|1|||
127949888|NCT00185588|460436954|FG002|Overall Study|Withdrawal by Subject|0|||
127949889|NCT00185588|460436955|FG003|Overall Study|Withdrawal by Subject|0|||
127949890|NCT00185588|460436952|FG000|Overall Study|Physician Decision|0|||
127949891|NCT00185588|460436953|FG001|Overall Study|Physician Decision|0|||
127949892|NCT00185588|460436954|FG002|Overall Study|Physician Decision|1|||
127949893|NCT00185588|460436955|FG003|Overall Study|Physician Decision|0|||
127949894|NCT02604407|460436956|FG000|Overall Study|Adverse Event|0|||
127949895|NCT02604407|460436957|FG001|Overall Study|Adverse Event|7|||
127949896|NCT02604407|460436958|FG002|Overall Study|Adverse Event|5|||
127949897|NCT02604407|460436956|FG000|Overall Study|Protocol Violation|2|||
127949898|NCT02604407|460436957|FG001|Overall Study|Protocol Violation|0|||
127949899|NCT02604407|460436958|FG002|Overall Study|Protocol Violation|0|||
127949900|NCT02604407|460436956|FG000|Overall Study|Withdrawal by Subject|3|||
127949901|NCT02604407|460436957|FG001|Overall Study|Withdrawal by Subject|3|||
127949902|NCT02604407|460436958|FG002|Overall Study|Withdrawal by Subject|5|||
127949903|NCT02604407|460436956|FG000|Overall Study|Lost to Follow-up|2|||
127949904|NCT02604407|460436957|FG001|Overall Study|Lost to Follow-up|1|||
127949905|NCT02604407|460436958|FG002|Overall Study|Lost to Follow-up|2|||
127949906|NCT02604407|460436956|FG000|Overall Study|Lack of Efficacy|1|||
127949907|NCT02604407|460436957|FG001|Overall Study|Lack of Efficacy|0|||
127949908|NCT02604407|460436958|FG002|Overall Study|Lack of Efficacy|0|||
127949909|NCT02604407|460436956|FG000|Overall Study|Other|3|||
127949910|NCT02604407|460436957|FG001|Overall Study|Other|1|||
127949911|NCT02604407|460436958|FG002|Overall Study|Other|4|||
127949912|NCT03908437|460436959|FG000|Overall Study|Death|0|||
127949913|NCT03908437|460436960|FG001|Overall Study|Death|1|||
127949914|NCT03908437|460436959|FG000|Overall Study|Lost to Follow-up|31|||
127949915|NCT03908437|460436960|FG001|Overall Study|Lost to Follow-up|24|||
127949916|NCT05445492|460436961|FG000|Overall Study|Physician Decision|1|||
127949917|NCT00191191|460436962|FG000|Overall Study|Entry Criteria Exclusion|2|||
127949918|NCT00191191|460436963|FG001|Overall Study|Entry Criteria Exclusion|0|||
127949919|NCT00191191|460436962|FG000|Overall Study|Treated with Another Systemic Agent|1|||
127949920|NCT00191191|460436963|FG001|Overall Study|Treated with Another Systemic Agent|1|||
127949921|NCT00191191|460436962|FG000|Overall Study|Adverse Event|11|||
127949922|NCT00191191|460436963|FG001|Overall Study|Adverse Event|21|||
127949923|NCT00191191|460436962|FG000|Overall Study|Progressive Disease|84|||
127949924|NCT00191191|460436963|FG001|Overall Study|Progressive Disease|72|||
127949925|NCT00191191|460436962|FG000|Overall Study|Toxicity After Dose Reduction|7|||
127949926|NCT00191191|460436963|FG001|Overall Study|Toxicity After Dose Reduction|8|||
127949927|NCT00191191|460436962|FG000|Overall Study|Family/Caregiver Decision|5|||
127949928|NCT00191191|460436963|FG001|Overall Study|Family/Caregiver Decision|7|||
127949929|NCT00191191|460436962|FG000|Overall Study|Lost to Follow-up|1|||
127949930|NCT00191191|460436963|FG001|Overall Study|Lost to Follow-up|0|||
127949931|NCT00191191|460436962|FG000|Overall Study|Physician Decision|3|||
127949932|NCT00191191|460436963|FG001|Overall Study|Physician Decision|2|||
127949933|NCT00191191|460436962|FG000|Overall Study|Good Clinical Practice Violation|0|||
127949934|NCT00191191|460436963|FG001|Overall Study|Good Clinical Practice Violation|1|||
127949935|NCT03348163|460436964|FG000|Overall Study|Withdrawal by Subject|2|||
127949936|NCT03348163|460436965|FG001|Overall Study|Withdrawal by Subject|0|||
127949937|NCT03597295|460436969|FG000|Overall Study|Death|70|||
127949938|NCT03597295|460436969|FG000|Overall Study|Lost to Follow-up|7|||
127949939|NCT00428116|460436970|FG000|Overall Study|Death|1|||
127949940|NCT00428116|460436971|FG001|Overall Study|Death|0|||
127949941|NCT00428116|460436970|FG000|Overall Study|Withdrawal by Subject|1|||
127949942|NCT00428116|460436971|FG001|Overall Study|Withdrawal by Subject|0|||
127949943|NCT00428116|460436970|FG000|Overall Study|Lost to Follow-up|1|||
127949944|NCT00428116|460436971|FG001|Overall Study|Lost to Follow-up|0|||
127949945|NCT02455518|460436972|FG000|Overall Study|Protocol Violation|0|||
127949946|NCT02455518|460436973|FG001|Overall Study|Protocol Violation|1|||
127949947|NCT02455518|460436974|FG002|Overall Study|Protocol Violation|1|||
127949948|NCT02455518|460436975|FG003|Overall Study|Protocol Violation|3|||
127949949|NCT02508935|460436978|FG000|Overall Study|Withdrawal by Subject|1|||
127949950|NCT02508935|460436978|FG000|Overall Study|Withdrawal by Caregiver|8|||
127949951|NCT02508935|460436978|FG000|Overall Study|Pain Score <4|1|||
127949952|NCT02508935|460436978|FG000|Overall Study|Emesis|3|||
127949953|NCT02508935|460436978|FG000|Overall Study|Adverse Event|3|||
127949954|NCT02508935|460436978|FG000|Overall Study|Protocol Violation|1|||
127949955|NCT02508935|460436978|FG000|Overall Study|Physician Decision|1|||
127949956|NCT02508935|460436978|FG000|Overall Study|Trial terminated by sponsor|5|||
127949957|NCT02125877|460436979|FG000|Overall Study|Physician Decision|1|||
127949958|NCT02125877|460436980|FG001|Overall Study|Physician Decision|0|||
127949959|NCT02125877|460436979|FG000|Overall Study|Death|0|||
127949960|NCT02125877|460436980|FG001|Overall Study|Death|1|||
127949961|NCT02125877|460436979|FG000|Overall Study|Administrative problems|0|||
127949962|NCT02125877|460436980|FG001|Overall Study|Administrative problems|1|||
127949963|NCT02125877|460436979|FG000|Overall Study|Participant/guardian decision|0|||
127949964|NCT02125877|460436980|FG001|Overall Study|Participant/guardian decision|2|||
127949965|NCT02125877|460436979|FG000|Overall Study|Withdrawal by Subject|2|||
127949966|NCT02125877|460436980|FG001|Overall Study|Withdrawal by Subject|1|||
127949967|NCT02125877|460436979|FG000|Overall Study|Protocol deviation|4|||
127949968|NCT02125877|460436980|FG001|Overall Study|Protocol deviation|1|||
127949969|NCT02125877|460436979|FG000|Overall Study|Adverse Event|6|||
127949970|NCT02125877|460436980|FG001|Overall Study|Adverse Event|4|||
127949971|NCT00710866|460436983|FG000|Overall Study|Protocol Violation|5|||
127949972|NCT00710866|460436984|FG001|Overall Study|Protocol Violation|4|||
127949973|NCT00710866|460436983|FG000|Overall Study|Withdrawal by Subject|2|||
127949974|NCT00710866|460436984|FG001|Overall Study|Withdrawal by Subject|1|||
127949975|NCT00710866|460436983|FG000|Overall Study|Lost to Follow-up|1|||
127949976|NCT00710866|460436984|FG001|Overall Study|Lost to Follow-up|0|||
127949977|NCT00710866|460436983|FG000|Overall Study|Failed to meet eligibility|1|||
127949978|NCT00710866|460436984|FG001|Overall Study|Failed to meet eligibility|1|||
127949979|NCT04036110|460436985|FG000|Overall Study|Lost to Follow-up|3|||
127949980|NCT04036110|460436986|FG001|Overall Study|Lost to Follow-up|2|||
127949981|NCT04036110|460436987|FG002|Overall Study|Lost to Follow-up|1|||
127949982|NCT04036110|460436985|FG000|Overall Study|Study Suspended|4|||
127949983|NCT04036110|460436986|FG001|Overall Study|Study Suspended|5|||
127949984|NCT04036110|460436987|FG002|Overall Study|Study Suspended|1|||
127949985|NCT00396565|460436991|FG000|Overall Study|Physician Decision|3|||
127949986|NCT00396565|460436992|FG001|Overall Study|Physician Decision|1|||
127949987|NCT00396565|460436993|FG002|Overall Study|Physician Decision|2|||
127949988|NCT00396565|460436991|FG000|Overall Study|Adverse Event|5|||
127949989|NCT00396565|460436992|FG001|Overall Study|Adverse Event|13|||
127949990|NCT00396565|460436993|FG002|Overall Study|Adverse Event|3|||
127949991|NCT00396565|460436991|FG000|Overall Study|Withdrawal by Subject|8|||
127949992|NCT00396565|460436992|FG001|Overall Study|Withdrawal by Subject|13|||
127949993|NCT00396565|460436993|FG002|Overall Study|Withdrawal by Subject|1|||
127949994|NCT00396565|460436991|FG000|Overall Study|Lack of Efficacy|32|||
127949995|NCT00396565|460436992|FG001|Overall Study|Lack of Efficacy|64|||
127949996|NCT00396565|460436993|FG002|Overall Study|Lack of Efficacy|11|||
127949997|NCT04324021|460436995|FG000|Overall Study|Adverse Event|1|||
127949998|NCT04324021|460436996|FG001|Overall Study|Adverse Event|0|||
127949999|NCT04324021|460436997|FG002|Overall Study|Adverse Event|0|||
127950000|NCT04324021|460436995|FG000|Overall Study|Lack of Efficacy|0|||
127950001|NCT04324021|460436996|FG001|Overall Study|Lack of Efficacy|0|||
127950002|NCT04324021|460436997|FG002|Overall Study|Lack of Efficacy|1|||
127950003|NCT04324021|460436995|FG000|Overall Study|Death|1|||
127950004|NCT04324021|460436996|FG001|Overall Study|Death|1|||
127950005|NCT04324021|460436997|FG002|Overall Study|Death|0|||
127950006|NCT03097991|460436998|FG000|Overall Study|Didn't meet study criteria|8|||
127950007|NCT03097991|460436999|FG001|Overall Study|Didn't meet study criteria|0|||
127950008|NCT03097991|460436998|FG000|Overall Study|Withdrawal by Subject|12|||
127950009|NCT03097991|460436999|FG001|Overall Study|Withdrawal by Subject|6|||
127950010|NCT03097991|460436998|FG000|Overall Study|Death of Baby|3|||
127950011|NCT03097991|460436999|FG001|Overall Study|Death of Baby|1|||
127950012|NCT03097991|460436998|FG000|Overall Study|Lost to Follow-up|24|||
127950013|NCT03097991|460436999|FG001|Overall Study|Lost to Follow-up|38|||
127950014|NCT03097991|460436998|FG000|Overall Study|Adverse Event|3|||
127950015|NCT03097991|460436999|FG001|Overall Study|Adverse Event|5|||
127950016|NCT00246324|460437000|FG000|Overall Study|Withdrawal by Subject|1|||
127950017|NCT02006732|460437001|FG000|Overall Study|Adverse Event|10|||
127950018|NCT02006732|460437002|FG001|Overall Study|Adverse Event|7|||
127950019|NCT02006732|460437003|FG002|Overall Study|Adverse Event|4|||
127950020|NCT02006732|460437004|FG003|Overall Study|Adverse Event|2|||
127950021|NCT02006732|460437001|FG000|Overall Study|Lack of Efficacy|6|||
127950022|NCT02006732|460437002|FG001|Overall Study|Lack of Efficacy|3|||
127950023|NCT02006732|460437003|FG002|Overall Study|Lack of Efficacy|1|||
127950024|NCT02006732|460437004|FG003|Overall Study|Lack of Efficacy|1|||
127950025|NCT02006732|460437001|FG000|Overall Study|Protocol Violation|1|||
127950026|NCT02006732|460437002|FG001|Overall Study|Protocol Violation|1|||
127950027|NCT02006732|460437003|FG002|Overall Study|Protocol Violation|0|||
127950028|NCT02006732|460437004|FG003|Overall Study|Protocol Violation|0|||
127950029|NCT02006732|460437001|FG000|Overall Study|Lost to Follow-up|0|||
127950030|NCT02006732|460437002|FG001|Overall Study|Lost to Follow-up|1|||
127950031|NCT02006732|460437003|FG002|Overall Study|Lost to Follow-up|0|||
127950032|NCT02006732|460437004|FG003|Overall Study|Lost to Follow-up|0|||
127950033|NCT02006732|460437001|FG000|Overall Study|Withdrawal by Subject|3|||
127950034|NCT02006732|460437002|FG001|Overall Study|Withdrawal by Subject|0|||
127950035|NCT02006732|460437003|FG002|Overall Study|Withdrawal by Subject|4|||
127950036|NCT02006732|460437004|FG003|Overall Study|Withdrawal by Subject|1|||
127950037|NCT00299130|460437005|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
127950038|NCT00299130|460437006|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
127950039|NCT00299130|460437007|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
127950040|NCT00299130|460437005|FG000|Treatment Period (up to 5 Years)|Death|1|||
127950041|NCT00299130|460437006|FG001|Treatment Period (up to 5 Years)|Death|3|||
127950042|NCT00299130|460437007|FG002|Treatment Period (up to 5 Years)|Death|1|||
127950043|NCT00299130|460437005|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
127950044|NCT00299130|460437006|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
127950045|NCT00299130|460437007|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
127950046|NCT00299130|460437005|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
127950047|NCT00299130|460437006|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
127950048|NCT00299130|460437007|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
127950049|NCT00299130|460437005|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
127950050|NCT00299130|460437006|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
127950051|NCT00299130|460437007|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
127950052|NCT00299130|460437005|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
127950053|NCT00299130|460437006|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
127950054|NCT00299130|460437007|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
127950055|NCT00299130|460437005|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
127950056|NCT00299130|460437006|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
127950057|NCT00299130|460437007|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
127950058|NCT00299130|460437005|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
127950059|NCT00299130|460437006|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
127950060|NCT00299130|460437007|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
127950061|NCT00299130|460437005|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
127950062|NCT00299130|460437006|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
127950063|NCT00299130|460437007|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
127950064|NCT00299130|460437005|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
127950065|NCT00299130|460437006|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
127950066|NCT00299130|460437007|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
127950067|NCT00299130|460437005|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
127950068|NCT00299130|460437006|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
127950069|NCT00299130|460437007|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
127950070|NCT00299130|460437005|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
127950071|NCT00299130|460437006|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
127950072|NCT00299130|460437007|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
127950073|NCT00299130|460437005|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
127950074|NCT00299130|460437006|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
127950075|NCT00299130|460437007|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
127950076|NCT00299130|460437005|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
127950077|NCT00299130|460437006|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
127950078|NCT00299130|460437007|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
127950079|NCT00299130|460437005|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
127950080|NCT00299130|460437006|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
127950081|NCT00299130|460437007|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
127950082|NCT00299130|460437005|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
127950083|NCT00299130|460437006|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
127950084|NCT00299130|460437007|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
127950085|NCT00299130|460437005|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
127950086|NCT00299130|460437006|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
127950087|NCT00299130|460437007|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
127950088|NCT01198132|460437008|FG000|Overall Study|Withdrawal by Subject|4|||
127950089|NCT01198132|460437009|FG001|Overall Study|Withdrawal by Subject|5|||
127950090|NCT01198132|460437008|FG000|Overall Study|Physician Decision|5|||
127950091|NCT01198132|460437009|FG001|Overall Study|Physician Decision|4|||
127950092|NCT01198132|460437008|FG000|Overall Study|Other Unspecified|3|||
127950093|NCT01198132|460437009|FG001|Overall Study|Other Unspecified|6|||
127950094|NCT01198132|460437008|FG000|Overall Study|Lack of Efficacy|2|||
127950095|NCT01198132|460437009|FG001|Overall Study|Lack of Efficacy|3|||
127950096|NCT01198132|460437008|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
127950097|NCT01198132|460437009|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
127950098|NCT01198132|460437008|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
127950099|NCT01198132|460437009|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
127950100|NCT01198132|460437008|FG000|Overall Study|Adverse Event|0|||
127950101|NCT01198132|460437009|FG001|Overall Study|Adverse Event|1|||
127950102|NCT01198132|460437008|FG000|Overall Study|Protocol Violation|1|||
127950103|NCT01198132|460437009|FG001|Overall Study|Protocol Violation|0|||
127950104|NCT03516513|460437010|FG000|Overall Study|Withdrawal by Subject|2|||
127950105|NCT03516513|460437011|FG001|Overall Study|Withdrawal by Subject|2|||
127950106|NCT03516513|460437012|FG002|Overall Study|Withdrawal by Subject|0|||
127950107|NCT03516513|460437013|FG003|Overall Study|Withdrawal by Subject|0|||
127950108|NCT01098487|460437015|FG000|Overall Study|Adverse Event|22|||
127950109|NCT01098487|460437015|FG000|Overall Study|Lack of Efficacy|11|||
127950110|NCT01098487|460437015|FG000|Overall Study|Withdrawal by Subject|7|||
127950111|NCT01098487|460437015|FG000|Overall Study|Lost to Follow-up|3|||
127950112|NCT01098487|460437015|FG000|Overall Study|Physician Decision|1|||
127950113|NCT00345631|460437016|FG000|Overall Study|Withdrawal by Subject|1|||
127950114|NCT00345631|460437017|FG001|Overall Study|Withdrawal by Subject|0|||
127950115|NCT00345631|460437018|FG002|Overall Study|Withdrawal by Subject|1|||
127950116|NCT00345631|460437016|FG000|Overall Study|Adverse Event|0|||
127950117|NCT00345631|460437017|FG001|Overall Study|Adverse Event|1|||
127950118|NCT00345631|460437018|FG002|Overall Study|Adverse Event|0|||
127950119|NCT00345631|460437016|FG000|Overall Study|Lost to Follow-up|3|||
127950120|NCT00345631|460437017|FG001|Overall Study|Lost to Follow-up|7|||
127950121|NCT00345631|460437018|FG002|Overall Study|Lost to Follow-up|4|||
127950122|NCT00345631|460437016|FG000|Overall Study|Other reasons|0|||
127950123|NCT00345631|460437017|FG001|Overall Study|Other reasons|0|||
127950124|NCT00345631|460437018|FG002|Overall Study|Other reasons|1|||
127950125|NCT01301729|460437019|FG000|Overall Study|Withdrawal by Subject|2|||
127950126|NCT01301729|460437019|FG000|Overall Study|Participant did not Return for Treatment|1|||
127950127|NCT01301729|460437019|FG000|Overall Study|Violated Selection Criteria|1|||
127950128|NCT03071276|460437020|FG000|Overall Study|Adverse Event|1|||
127950129|NCT03071276|460437020|FG000|Overall Study|Lack of Efficacy|14|||
127950130|NCT03390426|460437021|FG000|Overall Study|Protocol Violation|0|||
127950131|NCT03390426|460437022|FG001|Overall Study|Protocol Violation|1|||
127950132|NCT02924727|460437031|FG000|Overall Study|Withdrawal by Subject|2|||
127950133|NCT02924727|460437032|FG001|Overall Study|Withdrawal by Subject|4|||
127950134|NCT02924727|460437031|FG000|Overall Study|Lost to Follow-up|2|||
127950135|NCT02924727|460437032|FG001|Overall Study|Lost to Follow-up|5|||
127950136|NCT02924727|460437031|FG000|Overall Study|Death|221|||
127950137|NCT02924727|460437032|FG001|Overall Study|Death|247|||
127950138|NCT02924727|460437031|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
127950139|NCT02924727|460437032|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
127950140|NCT00509795|460437035|FG000|Overall Study|Adverse Event|4|||
127950141|NCT00509795|460437036|FG001|Overall Study|Adverse Event|3|||
127950142|NCT00509795|460437037|FG002|Overall Study|Adverse Event|5|||
127950143|NCT00509795|460437038|FG003|Overall Study|Adverse Event|4|||
127950144|NCT00509795|460437035|FG000|Overall Study|Death|3|||
127950145|NCT00509795|460437036|FG001|Overall Study|Death|1|||
127950146|NCT00509795|460437037|FG002|Overall Study|Death|2|||
127950147|NCT00509795|460437038|FG003|Overall Study|Death|7|||
127950148|NCT00509795|460437035|FG000|Overall Study|Lack of Efficacy|0|||
127950149|NCT00509795|460437036|FG001|Overall Study|Lack of Efficacy|0|||
127950150|NCT00509795|460437037|FG002|Overall Study|Lack of Efficacy|2|||
127950151|NCT00509795|460437038|FG003|Overall Study|Lack of Efficacy|2|||
127950152|NCT00509795|460437035|FG000|Overall Study|Lost to Follow-up|1|||
127950153|NCT00509795|460437036|FG001|Overall Study|Lost to Follow-up|2|||
127950154|NCT00509795|460437037|FG002|Overall Study|Lost to Follow-up|4|||
127950155|NCT00509795|460437038|FG003|Overall Study|Lost to Follow-up|4|||
127950156|NCT00509795|460437035|FG000|Overall Study|OTHER|1|||
127950157|NCT00509795|460437036|FG001|Overall Study|OTHER|0|||
127950158|NCT00509795|460437037|FG002|Overall Study|OTHER|4|||
127950159|NCT00509795|460437038|FG003|Overall Study|OTHER|1|||
127950160|NCT00509795|460437035|FG000|Overall Study|Protocol Violation|3|||
127950161|NCT00509795|460437036|FG001|Overall Study|Protocol Violation|0|||
127950162|NCT00509795|460437037|FG002|Overall Study|Protocol Violation|3|||
127950163|NCT00509795|460437038|FG003|Overall Study|Protocol Violation|1|||
127950164|NCT00509795|460437035|FG000|Overall Study|Withdrawal by Subject|10|||
127950165|NCT00509795|460437036|FG001|Overall Study|Withdrawal by Subject|5|||
127950166|NCT00509795|460437037|FG002|Overall Study|Withdrawal by Subject|7|||
127950167|NCT00509795|460437038|FG003|Overall Study|Withdrawal by Subject|8|||
127950168|NCT04102189|460437039|FG000|Overall Study|Withdrawal by Subject|1|||
127950169|NCT04102189|460437040|FG001|Overall Study|Withdrawal by Subject|2|||
127950170|NCT04102189|460437039|FG000|Overall Study|Withdrawal by parent/guardian|0|||
127950171|NCT04102189|460437040|FG001|Overall Study|Withdrawal by parent/guardian|1|||
127950172|NCT04102189|460437039|FG000|Overall Study|Lost to Follow-up|1|||
127950173|NCT04102189|460437040|FG001|Overall Study|Lost to Follow-up|0|||
127950174|NCT02933255|460437043|FG000|Overall Study|Discontinued due to study closure.|1|||
127950175|NCT02933255|460437044|FG001|Overall Study|Discontinued due to study closure.|0|||
127950176|NCT02759692|460437045|FG000|Period 1|Test article no longer available|1|||
127950177|NCT02759692|460437046|FG001|Period 1|Test article no longer available|1|||
127950178|NCT02759692|460437045|FG000|Period 1|No longer meets eligibility criteria.|1|||
127950179|NCT02759692|460437046|FG001|Period 1|No longer meets eligibility criteria.|0|||
127950180|NCT02759692|460437045|FG000|Period 1|Miss-Randomized|1|||
127950181|NCT02759692|460437046|FG001|Period 1|Miss-Randomized|1|||
127950182|NCT02759692|460437045|FG000|Period 2|Lost to Follow-up|1|||
127950183|NCT02759692|460437046|FG001|Period 2|Lost to Follow-up|0|||
127950184|NCT02759692|460437045|FG000|Period 2|Test article no longer available|0|||
127950185|NCT02759692|460437046|FG001|Period 2|Test article no longer available|1|||
127950186|NCT00451178|460437047|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
127950187|NCT00451178|460437048|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
127950188|NCT00451178|460437047|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
127950189|NCT00451178|460437048|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
127950190|NCT00451178|460437047|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
127950191|NCT00451178|460437048|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
127950192|NCT00451178|460437047|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
127950193|NCT00451178|460437048|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
127950194|NCT00451178|460437047|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
127950195|NCT00451178|460437048|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
127950196|NCT00451178|460437047|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
127950197|NCT00451178|460437048|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
127950198|NCT00451178|460437047|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
127950199|NCT00451178|460437048|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
127950200|NCT00451178|460437047|FG000|Prior to Maintenance Therapy|PD|2|||
127950201|NCT00451178|460437048|FG001|Prior to Maintenance Therapy|PD|0|||
127950202|NCT00451178|460437047|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
127950203|NCT00451178|460437048|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
127950204|NCT00451178|460437047|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
127950205|NCT00451178|460437048|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
127950206|NCT00451178|460437047|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
127950207|NCT00451178|460437048|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
127950208|NCT00451178|460437047|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
127950209|NCT00451178|460437048|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
127950210|NCT00451178|460437047|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
127950211|NCT00451178|460437048|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
127950212|NCT00451178|460437047|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
127950213|NCT00451178|460437048|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
127950214|NCT00451178|460437047|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
127950215|NCT00451178|460437048|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
127950216|NCT02447744|460437052|FG000|Overall Study|Withdrawal by Subject|3|||
127950217|NCT02447744|460437053|FG001|Overall Study|Withdrawal by Subject|1|||
127950218|NCT02447744|460437052|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
127950219|NCT02447744|460437053|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
127950220|NCT00912912|460437054|FG000|Overall Study|Withdrawal by Subject|1|||
127950221|NCT00912912|460437054|FG000|Overall Study|Disease Progression|3|||
127950222|NCT03207867|460437055|FG000|Overall Study|Adverse Event|1|||
127950223|NCT03207867|460437056|FG001|Overall Study|Adverse Event|0|||
127950224|NCT03207867|460437057|FG002|Overall Study|Adverse Event|1|||
127950225|NCT03207867|460437058|FG003|Overall Study|Adverse Event|0|||
127950226|NCT03207867|460437059|FG004|Overall Study|Adverse Event|0|||
127950227|NCT03207867|460437060|FG005|Overall Study|Adverse Event|2|||
127950228|NCT03207867|460437061|FG006|Overall Study|Adverse Event|1|||
127950229|NCT03207867|460437062|FG007|Overall Study|Adverse Event|1|||
127950230|NCT03207867|460437063|FG008|Overall Study|Adverse Event|2|||
127950231|NCT03207867|460437064|FG009|Overall Study|Adverse Event|2|||
127950232|NCT03207867|460437065|FG010|Overall Study|Adverse Event|0|||
127950233|NCT03207867|460437066|FG011|Overall Study|Adverse Event|0|||
127950234|NCT03207867|460437067|FG012|Overall Study|Adverse Event|0|||
127950235|NCT03207867|460437068|FG013|Overall Study|Adverse Event|0|||
127950236|NCT03207867|460437069|FG014|Overall Study|Adverse Event|0|||
127950237|NCT03207867|460437070|FG015|Overall Study|Adverse Event|0|||
127950238|NCT03207867|460437071|FG016|Overall Study|Adverse Event|3|||
127950239|NCT03207867|460437072|FG017|Overall Study|Adverse Event|1|||
127950240|NCT03207867|460437073|FG018|Overall Study|Adverse Event|2|||
127950241|NCT03207867|460437074|FG019|Overall Study|Adverse Event|1|||
127950242|NCT03207867|460437075|FG020|Overall Study|Adverse Event|0|||
127950243|NCT03207867|460437076|FG021|Overall Study|Adverse Event|0|||
127950244|NCT03207867|460437077|FG022|Overall Study|Adverse Event|0|||
127950245|NCT03207867|460437078|FG023|Overall Study|Adverse Event|0|||
127950246|NCT03207867|460437055|FG000|Overall Study|Death|0|||
127950247|NCT03207867|460437056|FG001|Overall Study|Death|0|||
127950248|NCT03207867|460437057|FG002|Overall Study|Death|0|||
127950249|NCT03207867|460437058|FG003|Overall Study|Death|0|||
127950250|NCT03207867|460437059|FG004|Overall Study|Death|0|||
127950251|NCT03207867|460437060|FG005|Overall Study|Death|1|||
127950252|NCT03207867|460437061|FG006|Overall Study|Death|0|||
127950253|NCT03207867|460437062|FG007|Overall Study|Death|3|||
127950254|NCT03207867|460437063|FG008|Overall Study|Death|1|||
127950255|NCT03207867|460437064|FG009|Overall Study|Death|2|||
127950256|NCT03207867|460437065|FG010|Overall Study|Death|0|||
127950257|NCT03207867|460437066|FG011|Overall Study|Death|1|||
127950258|NCT03207867|460437067|FG012|Overall Study|Death|0|||
127950259|NCT03207867|460437068|FG013|Overall Study|Death|1|||
127950260|NCT03207867|460437069|FG014|Overall Study|Death|0|||
127950261|NCT03207867|460437070|FG015|Overall Study|Death|0|||
127950262|NCT03207867|460437071|FG016|Overall Study|Death|0|||
127950263|NCT03207867|460437072|FG017|Overall Study|Death|2|||
127950264|NCT03207867|460437073|FG018|Overall Study|Death|0|||
127950265|NCT03207867|460437074|FG019|Overall Study|Death|1|||
127950266|NCT03207867|460437075|FG020|Overall Study|Death|0|||
127950267|NCT03207867|460437076|FG021|Overall Study|Death|0|||
127950268|NCT03207867|460437077|FG022|Overall Study|Death|0|||
127950269|NCT03207867|460437078|FG023|Overall Study|Death|0|||
127950270|NCT03207867|460437055|FG000|Overall Study|Physician Decision|3|||
127950271|NCT03207867|460437056|FG001|Overall Study|Physician Decision|5|||
127950272|NCT03207867|460437057|FG002|Overall Study|Physician Decision|0|||
127950273|NCT03207867|460437058|FG003|Overall Study|Physician Decision|3|||
127950274|NCT03207867|460437059|FG004|Overall Study|Physician Decision|2|||
127950275|NCT03207867|460437060|FG005|Overall Study|Physician Decision|0|||
127950276|NCT03207867|460437061|FG006|Overall Study|Physician Decision|0|||
127950277|NCT03207867|460437062|FG007|Overall Study|Physician Decision|0|||
127950278|NCT03207867|460437063|FG008|Overall Study|Physician Decision|4|||
127950279|NCT03207867|460437064|FG009|Overall Study|Physician Decision|2|||
127950280|NCT03207867|460437065|FG010|Overall Study|Physician Decision|0|||
127950281|NCT03207867|460437066|FG011|Overall Study|Physician Decision|4|||
127950282|NCT03207867|460437067|FG012|Overall Study|Physician Decision|0|||
127950283|NCT03207867|460437068|FG013|Overall Study|Physician Decision|0|||
127950284|NCT03207867|460437069|FG014|Overall Study|Physician Decision|2|||
127950285|NCT03207867|460437070|FG015|Overall Study|Physician Decision|1|||
127950286|NCT03207867|460437071|FG016|Overall Study|Physician Decision|1|||
127950287|NCT03207867|460437072|FG017|Overall Study|Physician Decision|2|||
127950288|NCT03207867|460437073|FG018|Overall Study|Physician Decision|1|||
127950289|NCT03207867|460437074|FG019|Overall Study|Physician Decision|3|||
127950290|NCT03207867|460437075|FG020|Overall Study|Physician Decision|0|||
127950291|NCT03207867|460437076|FG021|Overall Study|Physician Decision|0|||
127950292|NCT03207867|460437077|FG022|Overall Study|Physician Decision|0|||
127950293|NCT03207867|460437078|FG023|Overall Study|Physician Decision|0|||
127950294|NCT03207867|460437055|FG000|Overall Study|Progressive Disease|7|||
127950295|NCT03207867|460437056|FG001|Overall Study|Progressive Disease|7|||
127950296|NCT03207867|460437057|FG002|Overall Study|Progressive Disease|9|||
127950297|NCT03207867|460437058|FG003|Overall Study|Progressive Disease|10|||
127950298|NCT03207867|460437059|FG004|Overall Study|Progressive Disease|11|||
127950299|NCT03207867|460437060|FG005|Overall Study|Progressive Disease|10|||
127950300|NCT03207867|460437061|FG006|Overall Study|Progressive Disease|9|||
127950301|NCT03207867|460437062|FG007|Overall Study|Progressive Disease|8|||
127950302|NCT03207867|460437063|FG008|Overall Study|Progressive Disease|19|||
127950303|NCT03207867|460437064|FG009|Overall Study|Progressive Disease|23|||
127950304|NCT03207867|460437065|FG010|Overall Study|Progressive Disease|2|||
127950305|NCT03207867|460437066|FG011|Overall Study|Progressive Disease|24|||
127950306|NCT03207867|460437067|FG012|Overall Study|Progressive Disease|3|||
127950307|NCT03207867|460437068|FG013|Overall Study|Progressive Disease|11|||
127950308|NCT03207867|460437069|FG014|Overall Study|Progressive Disease|9|||
127950309|NCT03207867|460437070|FG015|Overall Study|Progressive Disease|5|||
127950310|NCT03207867|460437071|FG016|Overall Study|Progressive Disease|10|||
127950311|NCT03207867|460437072|FG017|Overall Study|Progressive Disease|14|||
127950312|NCT03207867|460437073|FG018|Overall Study|Progressive Disease|13|||
127950313|NCT03207867|460437074|FG019|Overall Study|Progressive Disease|14|||
127950314|NCT03207867|460437075|FG020|Overall Study|Progressive Disease|6|||
127950315|NCT03207867|460437076|FG021|Overall Study|Progressive Disease|3|||
127950316|NCT03207867|460437077|FG022|Overall Study|Progressive Disease|3|||
127950317|NCT03207867|460437078|FG023|Overall Study|Progressive Disease|3|||
127950318|NCT03207867|460437055|FG000|Overall Study|Patient/guardian Decision|0|||
127950319|NCT03207867|460437056|FG001|Overall Study|Patient/guardian Decision|0|||
127950320|NCT03207867|460437057|FG002|Overall Study|Patient/guardian Decision|1|||
127950321|NCT03207867|460437058|FG003|Overall Study|Patient/guardian Decision|1|||
127950322|NCT03207867|460437059|FG004|Overall Study|Patient/guardian Decision|1|||
127950323|NCT03207867|460437060|FG005|Overall Study|Patient/guardian Decision|2|||
127950324|NCT03207867|460437061|FG006|Overall Study|Patient/guardian Decision|1|||
127950325|NCT03207867|460437062|FG007|Overall Study|Patient/guardian Decision|0|||
127950326|NCT03207867|460437063|FG008|Overall Study|Patient/guardian Decision|1|||
127950327|NCT03207867|460437064|FG009|Overall Study|Patient/guardian Decision|0|||
127950328|NCT03207867|460437065|FG010|Overall Study|Patient/guardian Decision|0|||
127950329|NCT03207867|460437066|FG011|Overall Study|Patient/guardian Decision|1|||
127950330|NCT03207867|460437067|FG012|Overall Study|Patient/guardian Decision|0|||
127950331|NCT03207867|460437068|FG013|Overall Study|Patient/guardian Decision|1|||
127950332|NCT03207867|460437069|FG014|Overall Study|Patient/guardian Decision|2|||
127950333|NCT03207867|460437070|FG015|Overall Study|Patient/guardian Decision|0|||
127950334|NCT03207867|460437071|FG016|Overall Study|Patient/guardian Decision|1|||
127950335|NCT03207867|460437072|FG017|Overall Study|Patient/guardian Decision|3|||
127950336|NCT03207867|460437073|FG018|Overall Study|Patient/guardian Decision|4|||
127950337|NCT03207867|460437074|FG019|Overall Study|Patient/guardian Decision|1|||
127950338|NCT03207867|460437075|FG020|Overall Study|Patient/guardian Decision|0|||
127950339|NCT03207867|460437076|FG021|Overall Study|Patient/guardian Decision|0|||
127950340|NCT03207867|460437077|FG022|Overall Study|Patient/guardian Decision|0|||
127950341|NCT03207867|460437078|FG023|Overall Study|Patient/guardian Decision|0|||
127950342|NCT00306995|460437079|FG000|Study Part I|Withdrawal by Subject|0|||
127950343|NCT00306995|460437080|FG001|Study Part I|Withdrawal by Subject|0|||
127950344|NCT00306995|460437081|FG002|Study Part I|Withdrawal by Subject|0|||
127950345|NCT00306995|460437082|FG003|Study Part I|Withdrawal by Subject|0|||
127950346|NCT00306995|460437083|FG004|Study Part I|Withdrawal by Subject|0|||
127950347|NCT00306995|460437084|FG005|Study Part I|Withdrawal by Subject|0|||
127950348|NCT00306995|460437085|FG006|Study Part I|Withdrawal by Subject|1|||
127950349|NCT00306995|460437079|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
127950350|NCT00306995|460437080|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
127950351|NCT00306995|460437081|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
127950352|NCT00306995|460437082|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
127950353|NCT00306995|460437083|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
127950354|NCT00306995|460437084|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
127950355|NCT00306995|460437085|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
127950356|NCT05422625|460437086|FG000|Overall Study|Withdrawal by Subject|1|||
127950357|NCT05422625|460437087|FG001|Overall Study|Withdrawal by Subject|0|||
127950358|NCT04324073|460439120|FG000|Overall Study|withdrew consent|0|||
127950359|NCT04324073|460439121|FG001|Overall Study|withdrew consent|4|||
127950360|NCT04324073|460439122|FG002|Overall Study|withdrew consent|2|||
127950361|NCT04324073|460439123|FG003|Overall Study|withdrew consent|8|||
127950362|NCT05833139|460439124|FG000|Study Period 2|Adverse Event|1|||
127950363|NCT03922529|460439125|FG000|Overall Study|Withdrawal by Subject|13|||
127950364|NCT03922529|460439126|FG001|Overall Study|Withdrawal by Subject|12|||
127950365|NCT03922529|460439125|FG000|Overall Study|Death|7|||
127950366|NCT03922529|460439126|FG001|Overall Study|Death|12|||
127950367|NCT03922529|460439125|FG000|Overall Study|Lost to Follow-up|12|||
127950368|NCT03922529|460439126|FG001|Overall Study|Lost to Follow-up|19|||
127950369|NCT03922529|460439125|FG000|Overall Study|Adverse Event|1|||
127950370|NCT03922529|460439126|FG001|Overall Study|Adverse Event|0|||
127950371|NCT03922529|460439125|FG000|Overall Study|Death after withdrawal|1|||
127950372|NCT03922529|460439126|FG001|Overall Study|Death after withdrawal|0|||
127950373|NCT03922529|460439125|FG000|Overall Study|Participant was contacted for final visit and declined to complete|1|||
127950374|NCT03922529|460439126|FG001|Overall Study|Participant was contacted for final visit and declined to complete|0|||
127950375|NCT03922529|460439125|FG000|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|1|||
127950376|NCT03922529|460439126|FG001|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|0|||
127950377|NCT02017015|460439127|FG000|Overall Study|Adverse Event|9|||
127950378|NCT02017015|460439127|FG000|Overall Study|Withdrawal by Subject|21|||
127950379|NCT02017015|460439127|FG000|Overall Study|Death|4|||
127950380|NCT02017015|460439127|FG000|Overall Study|Progressive Disease|31|||
127950381|NCT02017015|460439127|FG000|Overall Study|Non-compliance with study drug|2|||
127950382|NCT02017015|460439127|FG000|Overall Study|Physician Decision|2|||
127950383|NCT01277601|460439130|FG000|Overall Study|Adverse Event|5|||
127950384|NCT01277601|460439131|FG001|Overall Study|Adverse Event|3|||
127950385|NCT01277601|460439132|FG002|Overall Study|Adverse Event|0|||
127950386|NCT01277601|460439133|FG003|Overall Study|Adverse Event|7|||
127950387|NCT01277601|460439130|FG000|Overall Study|Withdrawal by Subject|18|||
127950388|NCT01277601|460439131|FG001|Overall Study|Withdrawal by Subject|21|||
127950389|NCT01277601|460439132|FG002|Overall Study|Withdrawal by Subject|8|||
127950390|NCT01277601|460439133|FG003|Overall Study|Withdrawal by Subject|17|||
127950391|NCT01277601|460439130|FG000|Overall Study|Lost to Follow-up|7|||
127950392|NCT01277601|460439131|FG001|Overall Study|Lost to Follow-up|9|||
127950393|NCT01277601|460439132|FG002|Overall Study|Lost to Follow-up|4|||
127950394|NCT01277601|460439133|FG003|Overall Study|Lost to Follow-up|2|||
127950395|NCT01277601|460439130|FG000|Overall Study|Physician Decision|3|||
127950396|NCT01277601|460439131|FG001|Overall Study|Physician Decision|5|||
127950397|NCT01277601|460439132|FG002|Overall Study|Physician Decision|1|||
127950398|NCT01277601|460439133|FG003|Overall Study|Physician Decision|6|||
127950399|NCT01277601|460439130|FG000|Overall Study|Pregnancy|2|||
127950400|NCT01277601|460439131|FG001|Overall Study|Pregnancy|2|||
127950401|NCT01277601|460439132|FG002|Overall Study|Pregnancy|4|||
127950402|NCT01277601|460439133|FG003|Overall Study|Pregnancy|1|||
127950403|NCT01277601|460439130|FG000|Overall Study|Noncompliance with Study Drug|1|||
127950404|NCT01277601|460439131|FG001|Overall Study|Noncompliance with Study Drug|3|||
127950405|NCT01277601|460439132|FG002|Overall Study|Noncompliance with Study Drug|2|||
127950406|NCT01277601|460439133|FG003|Overall Study|Noncompliance with Study Drug|0|||
127950407|NCT01277601|460439130|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
127950408|NCT01277601|460439131|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
127950409|NCT01277601|460439132|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
127950410|NCT01277601|460439133|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
127950411|NCT01277601|460439130|FG000|Overall Study|Protocol Violation|0|||
127950412|NCT01277601|460439131|FG001|Overall Study|Protocol Violation|2|||
127950413|NCT01277601|460439132|FG002|Overall Study|Protocol Violation|5|||
127950414|NCT01277601|460439133|FG003|Overall Study|Protocol Violation|0|||
127950415|NCT01277601|460439130|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
127950416|NCT01277601|460439131|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
127950417|NCT01277601|460439132|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
127950418|NCT01277601|460439133|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
127950419|NCT04158245|460439134|FG000|Overall Study|Lost to Follow-up|1|||
127950420|NCT03842228|460439137|FG000|Overall Study|Adverse Event|1|||
127950421|NCT03842228|460439138|FG001|Overall Study|Adverse Event|1|||
127950422|NCT03842228|460439139|FG002|Overall Study|Adverse Event|1|||
127950423|NCT03842228|460439140|FG003|Overall Study|Adverse Event|0|||
127950424|NCT03842228|460439141|FG004|Overall Study|Adverse Event|0|||
127950425|NCT03842228|460439142|FG005|Overall Study|Adverse Event|0|||
127950426|NCT03842228|460439143|FG006|Overall Study|Adverse Event|0|||
127950427|NCT03842228|460439137|FG000|Overall Study|Death|0|||
127950428|NCT03842228|460439138|FG001|Overall Study|Death|1|||
127950429|NCT03842228|460439139|FG002|Overall Study|Death|0|||
127950430|NCT03842228|460439140|FG003|Overall Study|Death|0|||
127950431|NCT03842228|460439141|FG004|Overall Study|Death|0|||
127950432|NCT03842228|460439142|FG005|Overall Study|Death|0|||
127950433|NCT03842228|460439143|FG006|Overall Study|Death|0|||
127950434|NCT03842228|460439137|FG000|Overall Study|Withdrawal by Subject|0|||
127950435|NCT03842228|460439138|FG001|Overall Study|Withdrawal by Subject|0|||
127950436|NCT03842228|460439139|FG002|Overall Study|Withdrawal by Subject|2|||
127950437|NCT03842228|460439140|FG003|Overall Study|Withdrawal by Subject|1|||
127950438|NCT03842228|460439141|FG004|Overall Study|Withdrawal by Subject|0|||
127950439|NCT03842228|460439142|FG005|Overall Study|Withdrawal by Subject|0|||
127950440|NCT03842228|460439143|FG006|Overall Study|Withdrawal by Subject|2|||
127950441|NCT03842228|460439137|FG000|Overall Study|Progression|8|||
127950442|NCT03842228|460439138|FG001|Overall Study|Progression|1|||
127950443|NCT03842228|460439139|FG002|Overall Study|Progression|7|||
127950444|NCT03842228|460439140|FG003|Overall Study|Progression|5|||
127950445|NCT03842228|460439141|FG004|Overall Study|Progression|4|||
127950446|NCT03842228|460439142|FG005|Overall Study|Progression|2|||
127950447|NCT03842228|460439143|FG006|Overall Study|Progression|3|||
127950448|NCT02291510|460439144|FG000|Overall Study|Adverse Event|0|||
127950449|NCT02291510|460439145|FG001|Overall Study|Adverse Event|0|||
127950450|NCT02291510|460439146|FG002|Overall Study|Adverse Event|0|||
127950451|NCT02291510|460439147|FG003|Overall Study|Adverse Event|1|||
127950452|NCT02567435|460439148|FG000|Overall Study|Death|1|||
127950453|NCT02567435|460439149|FG001|Overall Study|Death|1|||
127950454|NCT02567435|460439150|FG002|Overall Study|Death|0|||
127950455|NCT02567435|460439151|FG003|Overall Study|Death|0|||
127950456|NCT02567435|460439148|FG000|Overall Study|Ineligible|1|||
127950457|NCT02567435|460439149|FG001|Overall Study|Ineligible|3|||
127950458|NCT02567435|460439150|FG002|Overall Study|Ineligible|0|||
127950459|NCT02567435|460439151|FG003|Overall Study|Ineligible|0|||
127950460|NCT02567435|460439148|FG000|Overall Study|Withdrawal of consent for any further data submissions|4|||
127950461|NCT02567435|460439149|FG001|Overall Study|Withdrawal of consent for any further data submissions|5|||
127950462|NCT02567435|460439150|FG002|Overall Study|Withdrawal of consent for any further data submissions|0|||
127950463|NCT02567435|460439151|FG003|Overall Study|Withdrawal of consent for any further data submissions|1|||
127950464|NCT06390826|460439152|FG000|Overall Study|Never Start Protocol Therapy|1|||
127950465|NCT06390826|460439152|FG000|Overall Study|Adverse Event|1|||
127950466|NCT06390826|460439152|FG000|Overall Study|Disease Progression|8|||
127950467|NCT06390839|460439153|FG000|Overall Study|Ineligible|2|||
127950468|NCT06390839|460439153|FG000|Overall Study|Never start protocol therapy|3|||
127950469|NCT06390839|460439153|FG000|Overall Study|Adverse Event|1|||
127950470|NCT06390839|460439153|FG000|Overall Study|Alternative therapy|2|||
127950471|NCT06390839|460439153|FG000|Overall Study|Death|3|||
127950472|NCT06390839|460439153|FG000|Overall Study|Disease progression|28|||
127950473|NCT06390839|460439153|FG000|Overall Study|Withdrawal by Subject|2|||
127950474|NCT06390839|460439153|FG000|Overall Study|Complicating disease|1|||
127950475|NCT06390839|460439153|FG000|Overall Study|Noncompliance|1|||
127950476|NCT03203850|460439154|FG000|Overall Study|Subject/guardian decision|4|||
127950477|NCT03203850|460439155|FG001|Overall Study|Subject/guardian decision|3|||
127950478|NCT03203850|460439154|FG000|Overall Study|Adverse Event|3|||
127950479|NCT03203850|460439155|FG001|Overall Study|Adverse Event|0|||
127950480|NCT03203850|460439154|FG000|Overall Study|Death|1|||
127950481|NCT03203850|460439155|FG001|Overall Study|Death|0|||
127950482|NCT01272037|460439156|FG000|Overall Study|Death|25|||
127950483|NCT01272037|460439157|FG001|Overall Study|Death|28|||
127950484|NCT01272037|460439156|FG000|Overall Study|Adverse Event|12|||
127950485|NCT01272037|460439157|FG001|Overall Study|Adverse Event|7|||
127950486|NCT01272037|460439156|FG000|Overall Study|Withdrawal by Subject|175|||
127950487|NCT01272037|460439157|FG001|Overall Study|Withdrawal by Subject|93|||
127950488|NCT01272037|460439156|FG000|Overall Study|Disease progression|70|||
127950489|NCT01272037|460439157|FG001|Overall Study|Disease progression|111|||
127950490|NCT01272037|460439156|FG000|Overall Study|Other reason|42|||
127950491|NCT01272037|460439157|FG001|Overall Study|Other reason|41|||
127950492|NCT01272037|460439156|FG000|Overall Study|Delinquent data|24|||
127950493|NCT01272037|460439157|FG001|Overall Study|Delinquent data|19|||
127950494|NCT01272037|460439156|FG000|Overall Study|Reason under review|33|||
127950495|NCT01272037|460439157|FG001|Overall Study|Reason under review|29|||
127950496|NCT01272037|460439156|FG000|Overall Study|On treatment|626|||
127950497|NCT01272037|460439157|FG001|Overall Study|On treatment|632|||
127950498|NCT04856930|460439158|FG000|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|6|||
127950499|NCT04856930|460439159|FG001|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|5|||
127950500|NCT04856930|460439160|FG002|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|4|||
127950501|NCT04856930|460439158|FG000|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|3|||
127950502|NCT04856930|460439159|FG001|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|1|||
127950503|NCT04856930|460439160|FG002|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|0|||
127950504|NCT04856930|460439158|FG000|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
127950505|NCT04856930|460439159|FG001|Placebo-controlled Period (16 Weeks)|Pregnancy|1|||
127950506|NCT04856930|460439160|FG002|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
127950507|NCT04856930|460439158|FG000|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
127950508|NCT04856930|460439159|FG001|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
127950509|NCT04856930|460439160|FG002|Placebo-controlled Period (16 Weeks)|Protocol Violation|1|||
127950510|NCT04856930|460439158|FG000|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
127950511|NCT04856930|460439159|FG001|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
127950512|NCT04856930|460439160|FG002|Placebo-controlled Period (16 Weeks)|Adverse Event|1|||
127950513|NCT04856930|460439158|FG000|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
127950514|NCT04856930|460439159|FG001|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
127950515|NCT04856930|460439160|FG002|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
127950516|NCT04856930|460439158|FG000|Extension Period (16 Weeks)|Withdrawal by Subject|9|||
127950517|NCT04856930|460439159|FG001|Extension Period (16 Weeks)|Withdrawal by Subject|5|||
127950518|NCT04856930|460439160|FG002|Extension Period (16 Weeks)|Withdrawal by Subject|1|||
127950519|NCT04856930|460439158|FG000|Extension Period (16 Weeks)|Lost to Follow-up|2|||
127950520|NCT04856930|460439159|FG001|Extension Period (16 Weeks)|Lost to Follow-up|5|||
127950521|NCT04856930|460439160|FG002|Extension Period (16 Weeks)|Lost to Follow-up|1|||
127950522|NCT04856930|460439158|FG000|Extension Period (16 Weeks)|Adverse Event|1|||
127950523|NCT04856930|460439159|FG001|Extension Period (16 Weeks)|Adverse Event|0|||
127950524|NCT04856930|460439160|FG002|Extension Period (16 Weeks)|Adverse Event|1|||
127950525|NCT04856930|460439158|FG000|Extension Period (16 Weeks)|Pregnancy|0|||
127950526|NCT04856930|460439159|FG001|Extension Period (16 Weeks)|Pregnancy|0|||
127950527|NCT04856930|460439160|FG002|Extension Period (16 Weeks)|Pregnancy|2|||
127950528|NCT04856930|460439158|FG000|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
127950529|NCT04856930|460439159|FG001|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
127950530|NCT04856930|460439160|FG002|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
127950531|NCT04856930|460439158|FG000|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
127950532|NCT04856930|460439159|FG001|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
127950533|NCT04856930|460439160|FG002|Extension Period (16 Weeks)|Stopped participation by Sponsor|2|||
127950534|NCT04856930|460439158|FG000|Extension Period (16 Weeks)|Other than specified|0|||
127950535|NCT04856930|460439159|FG001|Extension Period (16 Weeks)|Other than specified|0|||
127950536|NCT04856930|460439160|FG002|Extension Period (16 Weeks)|Other than specified|1|||
127950537|NCT04856930|460439158|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
127950538|NCT04856930|460439159|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
127950539|NCT04856930|460439160|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
127950540|NCT04856930|460439158|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
127950541|NCT04856930|460439159|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
127950542|NCT04856930|460439160|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|1|||
127950543|NCT04856930|460439158|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
127950544|NCT04856930|460439159|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
127950545|NCT04856930|460439160|FG002|Follow-up Period (8 Weeks)|Adverse Event|1|||
127950546|NCT04856930|460439158|FG000|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
127950547|NCT04856930|460439159|FG001|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
127950548|NCT04856930|460439160|FG002|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|17|||
127950549|NCT00678210|460439162|FG000|Overall Study|Adverse Event|1|||
127950550|NCT00678210|460439163|FG001|Overall Study|Adverse Event|2|||
127950551|NCT00678210|460439164|FG002|Overall Study|Adverse Event|3|||
127950552|NCT00678210|460439165|FG003|Overall Study|Adverse Event|3|||
127950553|NCT00678210|460439162|FG000|Overall Study|Lack of Efficacy|2|||
127950554|NCT00678210|460439163|FG001|Overall Study|Lack of Efficacy|3|||
127950555|NCT00678210|460439164|FG002|Overall Study|Lack of Efficacy|1|||
127950556|NCT00678210|460439165|FG003|Overall Study|Lack of Efficacy|9|||
127950557|NCT00678210|460439162|FG000|Overall Study|Lost to Follow-up|4|||
127950558|NCT00678210|460439163|FG001|Overall Study|Lost to Follow-up|2|||
127950559|NCT00678210|460439164|FG002|Overall Study|Lost to Follow-up|0|||
127950560|NCT00678210|460439165|FG003|Overall Study|Lost to Follow-up|1|||
127950561|NCT00678210|460439162|FG000|Overall Study|Withdrawal by Subject|3|||
127950562|NCT00678210|460439163|FG001|Overall Study|Withdrawal by Subject|4|||
127950563|NCT00678210|460439164|FG002|Overall Study|Withdrawal by Subject|1|||
127950564|NCT00678210|460439165|FG003|Overall Study|Withdrawal by Subject|7|||
127950565|NCT00678210|460439162|FG000|Overall Study|Other|1|||
127950566|NCT00678210|460439163|FG001|Overall Study|Other|0|||
127950567|NCT00678210|460439164|FG002|Overall Study|Other|1|||
127950568|NCT00678210|460439165|FG003|Overall Study|Other|0|||
127950569|NCT04825912|460439166|FG000|Overall Study|Death|3|||
127950570|NCT04825912|460439166|FG000|Overall Study|Withdrawal by Subject|1|||
127950571|NCT02077140|460439167|FG000|Overall Study|Lost to Follow-up|4|||
127950572|NCT02077140|460439168|FG001|Overall Study|Lost to Follow-up|1|||
127950573|NCT02077140|460439169|FG002|Overall Study|Lost to Follow-up|2|||
127950574|NCT02077140|460439170|FG003|Overall Study|Lost to Follow-up|2|||
127950575|NCT02077140|460439171|FG004|Overall Study|Lost to Follow-up|3|||
127950576|NCT02077140|460439167|FG000|Overall Study|Withdrawal by Subject|0|||
127950577|NCT02077140|460439168|FG001|Overall Study|Withdrawal by Subject|1|||
127950578|NCT02077140|460439169|FG002|Overall Study|Withdrawal by Subject|0|||
127950579|NCT02077140|460439170|FG003|Overall Study|Withdrawal by Subject|2|||
127950580|NCT02077140|460439171|FG004|Overall Study|Withdrawal by Subject|2|||
127950581|NCT00974922|460439172|FG000|Overall Study|study terminated|24|||
127950582|NCT03965689|460439173|FG000|Overall Study|Too sick to get study intervention|2|||
127950583|NCT03022084|460439174|FG000|Overall Study|Lost to Follow-up|2|||
127950584|NCT03022084|460439175|FG001|Overall Study|Lost to Follow-up|3|||
127950585|NCT01173120|460439176|FG000|Overall Study|Lack of Efficacy|2|||
127950586|NCT01173120|460439176|FG000|Overall Study|Lost to Follow-up|1|||
127950587|NCT01173120|460439176|FG000|Overall Study|Participant Decision|2|||
127950588|NCT01173120|460439176|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
127950589|NCT01173120|460439176|FG000|Overall Study|Switch-Participant Decision|12|||
127950590|NCT01173120|460439176|FG000|Overall Study|Switch-Difficulty With Device|12|||
127950591|NCT01207583|460439177|FG000|Overall Study|Withdrawal by Subject|0|||
127950592|NCT01207583|460439178|FG001|Overall Study|Withdrawal by Subject|3|||
127950593|NCT01207583|460439179|FG002|Overall Study|Withdrawal by Subject|1|||
127950594|NCT01207583|460439177|FG000|Overall Study|Participant failed to return|1|||
127950595|NCT01207583|460439178|FG001|Overall Study|Participant failed to return|0|||
127950596|NCT01207583|460439179|FG002|Overall Study|Participant failed to return|0|||
127950597|NCT01207583|460439177|FG000|Overall Study|Lost to Follow-up|0|||
127950598|NCT01207583|460439178|FG001|Overall Study|Lost to Follow-up|2|||
127950599|NCT01207583|460439179|FG002|Overall Study|Lost to Follow-up|0|||
127950600|NCT03104400|460439180|FG000|Period 1 (Week 1 - 56)|Adverse Event|5|||
127950601|NCT03104400|460439181|FG001|Period 1 (Week 1 - 56)|Adverse Event|7|||
127950602|NCT03104400|460439182|FG002|Period 1 (Week 1 - 56)|Adverse Event|11|||
127950603|NCT03104400|460439183|FG003|Period 1 (Week 1 - 56)|Adverse Event|9|||
127950604|NCT03104400|460439184|FG004|Period 1 (Week 1 - 56)|Adverse Event|21|||
127950605|NCT03104400|460439185|FG005|Period 1 (Week 1 - 56)|Adverse Event|0|||
127950606|NCT03104400|460439186|FG006|Period 1 (Week 1 - 56)|Adverse Event|0|||
127950607|NCT03104400|460439187|FG007|Period 1 (Week 1 - 56)|Adverse Event|0|||
127950608|NCT03104400|460439188|FG008|Period 1 (Week 1 - 56)|Adverse Event|0|||
127950609|NCT03104400|460439189|FG009|Period 1 (Week 1 - 56)|Adverse Event|0|||
127950610|NCT03104400|460439180|FG000|Period 1 (Week 1 - 56)|Withdrawal by Subject|17|||
127950611|NCT03104400|460439181|FG001|Period 1 (Week 1 - 56)|Withdrawal by Subject|20|||
127950612|NCT03104400|460439182|FG002|Period 1 (Week 1 - 56)|Withdrawal by Subject|29|||
127950613|NCT03104400|460439183|FG003|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
127950614|NCT03104400|460439184|FG004|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
127950615|NCT03104400|460439185|FG005|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
127950616|NCT03104400|460439186|FG006|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
127950617|NCT03104400|460439187|FG007|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
127950618|NCT03104400|460439188|FG008|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
127950619|NCT03104400|460439189|FG009|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
127950620|NCT03104400|460439180|FG000|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
127950621|NCT03104400|460439181|FG001|Period 1 (Week 1 - 56)|Lost to Follow-up|1|||
127950622|NCT03104400|460439182|FG002|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
127950623|NCT03104400|460439183|FG003|Period 1 (Week 1 - 56)|Lost to Follow-up|8|||
127950624|NCT03104400|460439184|FG004|Period 1 (Week 1 - 56)|Lost to Follow-up|7|||
127950625|NCT03104400|460439185|FG005|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
127950626|NCT03104400|460439186|FG006|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
127950627|NCT03104400|460439187|FG007|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
127950628|NCT03104400|460439188|FG008|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
127950629|NCT03104400|460439189|FG009|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
127950630|NCT03104400|460439180|FG000|Period 1 (Week 1 - 56)|Lack of Efficacy|6|||
127950631|NCT03104400|460439181|FG001|Period 1 (Week 1 - 56)|Lack of Efficacy|3|||
127950632|NCT03104400|460439182|FG002|Period 1 (Week 1 - 56)|Lack of Efficacy|8|||
127950633|NCT03104400|460439183|FG003|Period 1 (Week 1 - 56)|Lack of Efficacy|2|||
127950634|NCT03104400|460439184|FG004|Period 1 (Week 1 - 56)|Lack of Efficacy|1|||
127950635|NCT03104400|460439185|FG005|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
127950636|NCT03104400|460439186|FG006|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
127950637|NCT03104400|460439187|FG007|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
127950638|NCT03104400|460439188|FG008|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
127950639|NCT03104400|460439189|FG009|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
127950640|NCT03104400|460439180|FG000|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
127950641|NCT03104400|460439181|FG001|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
127950642|NCT03104400|460439182|FG002|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
127950643|NCT03104400|460439183|FG003|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|1|||
127950644|NCT03104400|460439184|FG004|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
127950645|NCT03104400|460439185|FG005|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
127950646|NCT03104400|460439186|FG006|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
127950647|NCT03104400|460439187|FG007|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
127950648|NCT03104400|460439188|FG008|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
127950649|NCT03104400|460439189|FG009|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
127950650|NCT03104400|460439180|FG000|Period 1 (Week 1 - 56)|Other, not specified|2|||
127950651|NCT03104400|460439181|FG001|Period 1 (Week 1 - 56)|Other, not specified|3|||
127950652|NCT03104400|460439182|FG002|Period 1 (Week 1 - 56)|Other, not specified|7|||
127950653|NCT03104400|460439183|FG003|Period 1 (Week 1 - 56)|Other, not specified|6|||
127950654|NCT03104400|460439184|FG004|Period 1 (Week 1 - 56)|Other, not specified|4|||
127950655|NCT03104400|460439185|FG005|Period 1 (Week 1 - 56)|Other, not specified|0|||
127950656|NCT03104400|460439186|FG006|Period 1 (Week 1 - 56)|Other, not specified|0|||
127950657|NCT03104400|460439187|FG007|Period 1 (Week 1 - 56)|Other, not specified|0|||
127950658|NCT03104400|460439188|FG008|Period 1 (Week 1 - 56)|Other, not specified|0|||
127950659|NCT03104400|460439189|FG009|Period 1 (Week 1 - 56)|Other, not specified|0|||
127950660|NCT03104400|460439180|FG000|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
127950661|NCT03104400|460439181|FG001|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
127950662|NCT03104400|460439182|FG002|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
127950663|NCT03104400|460439183|FG003|Period 1 (Week 1 - 56)|Did not receive study drug|1|||
127950664|NCT03104400|460439184|FG004|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
127950665|NCT03104400|460439185|FG005|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
127950666|NCT03104400|460439186|FG006|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
127950667|NCT03104400|460439187|FG007|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
127950668|NCT03104400|460439188|FG008|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
127950669|NCT03104400|460439189|FG009|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
127950670|NCT03104400|460439180|FG000|Period 2 Week 56 - 260)|Adverse Event|0|||
127950671|NCT03104400|460439181|FG001|Period 2 Week 56 - 260)|Adverse Event|0|||
127950672|NCT03104400|460439182|FG002|Period 2 Week 56 - 260)|Adverse Event|0|||
127950673|NCT03104400|460439183|FG003|Period 2 Week 56 - 260)|Adverse Event|0|||
127950674|NCT03104400|460439184|FG004|Period 2 Week 56 - 260)|Adverse Event|0|||
127950675|NCT03104400|460439185|FG005|Period 2 Week 56 - 260)|Adverse Event|14|||
127950676|NCT03104400|460439186|FG006|Period 2 Week 56 - 260)|Adverse Event|17|||
127950677|NCT03104400|460439187|FG007|Period 2 Week 56 - 260)|Adverse Event|14|||
127950678|NCT03104400|460439188|FG008|Period 2 Week 56 - 260)|Adverse Event|28|||
127950679|NCT03104400|460439189|FG009|Period 2 Week 56 - 260)|Adverse Event|28|||
127950680|NCT03104400|460439180|FG000|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
127950681|NCT03104400|460439181|FG001|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
127950682|NCT03104400|460439182|FG002|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
127950683|NCT03104400|460439183|FG003|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
127950684|NCT03104400|460439184|FG004|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
127950685|NCT03104400|460439185|FG005|Period 2 Week 56 - 260)|Withdrawal by Subject|11|||
127950686|NCT03104400|460439186|FG006|Period 2 Week 56 - 260)|Withdrawal by Subject|21|||
127950687|NCT03104400|460439187|FG007|Period 2 Week 56 - 260)|Withdrawal by Subject|45|||
127950688|NCT03104400|460439188|FG008|Period 2 Week 56 - 260)|Withdrawal by Subject|44|||
127950689|NCT03104400|460439189|FG009|Period 2 Week 56 - 260)|Withdrawal by Subject|32|||
127950690|NCT03104400|460439180|FG000|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
127950691|NCT03104400|460439181|FG001|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
127950692|NCT03104400|460439182|FG002|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
127950693|NCT03104400|460439183|FG003|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
127950694|NCT03104400|460439184|FG004|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
127950695|NCT03104400|460439185|FG005|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
127950696|NCT03104400|460439186|FG006|Period 2 Week 56 - 260)|Lost to Follow-up|6|||
127950697|NCT03104400|460439187|FG007|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
127950698|NCT03104400|460439188|FG008|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
127950699|NCT03104400|460439189|FG009|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
127950700|NCT03104400|460439180|FG000|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
127950701|NCT03104400|460439181|FG001|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
127950702|NCT03104400|460439182|FG002|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
127950703|NCT03104400|460439183|FG003|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
127950704|NCT03104400|460439184|FG004|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
127950705|NCT03104400|460439185|FG005|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
127950706|NCT03104400|460439186|FG006|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
127950707|NCT03104400|460439187|FG007|Period 2 Week 56 - 260)|Lack of Efficacy|9|||
127950708|NCT03104400|460439188|FG008|Period 2 Week 56 - 260)|Lack of Efficacy|6|||
127950709|NCT03104400|460439189|FG009|Period 2 Week 56 - 260)|Lack of Efficacy|7|||
127950710|NCT03104400|460439180|FG000|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
127950711|NCT03104400|460439181|FG001|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
127950712|NCT03104400|460439182|FG002|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
127950713|NCT03104400|460439183|FG003|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
127950714|NCT03104400|460439184|FG004|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
127950715|NCT03104400|460439185|FG005|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
127950716|NCT03104400|460439186|FG006|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
127950717|NCT03104400|460439187|FG007|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
127950718|NCT03104400|460439188|FG008|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
127950719|NCT03104400|460439189|FG009|Period 2 Week 56 - 260)|COVIID-19 infection|3|||
127950720|NCT03104400|460439180|FG000|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
127950721|NCT03104400|460439181|FG001|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
127950722|NCT03104400|460439182|FG002|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
127950723|NCT03104400|460439183|FG003|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
127950724|NCT03104400|460439184|FG004|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
127950725|NCT03104400|460439185|FG005|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
127950726|NCT03104400|460439186|FG006|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
127950727|NCT03104400|460439187|FG007|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
127950728|NCT03104400|460439188|FG008|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
127950729|NCT03104400|460439189|FG009|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
127950730|NCT03104400|460439180|FG000|Period 2 Week 56 - 260)|Other, not specified|0|||
127950731|NCT03104400|460439181|FG001|Period 2 Week 56 - 260)|Other, not specified|0|||
127950732|NCT03104400|460439182|FG002|Period 2 Week 56 - 260)|Other, not specified|0|||
127950733|NCT03104400|460439183|FG003|Period 2 Week 56 - 260)|Other, not specified|0|||
127950734|NCT03104400|460439184|FG004|Period 2 Week 56 - 260)|Other, not specified|0|||
127950735|NCT03104400|460439185|FG005|Period 2 Week 56 - 260)|Other, not specified|10|||
127950736|NCT03104400|460439186|FG006|Period 2 Week 56 - 260)|Other, not specified|7|||
127950737|NCT03104400|460439187|FG007|Period 2 Week 56 - 260)|Other, not specified|17|||
127950738|NCT03104400|460439188|FG008|Period 2 Week 56 - 260)|Other, not specified|12|||
127950739|NCT03104400|460439189|FG009|Period 2 Week 56 - 260)|Other, not specified|18|||
127950740|NCT03104400|460439180|FG000|Period 2 Week 56 - 260)|Other|0|||
127950741|NCT03104400|460439181|FG001|Period 2 Week 56 - 260)|Other|0|||
127950742|NCT03104400|460439182|FG002|Period 2 Week 56 - 260)|Other|0|||
127950743|NCT03104400|460439183|FG003|Period 2 Week 56 - 260)|Other|0|||
127950744|NCT03104400|460439184|FG004|Period 2 Week 56 - 260)|Other|0|||
127950745|NCT03104400|460439185|FG005|Period 2 Week 56 - 260)|Other|0|||
127950746|NCT03104400|460439186|FG006|Period 2 Week 56 - 260)|Other|0|||
127950747|NCT03104400|460439187|FG007|Period 2 Week 56 - 260)|Other|0|||
127950748|NCT03104400|460439188|FG008|Period 2 Week 56 - 260)|Other|1|||
127950749|NCT03104400|460439189|FG009|Period 2 Week 56 - 260)|Other|1|||
127950750|NCT04948333|460439190|FG000|Overall Study|Adverse Event|6|||
127950751|NCT04948333|460439191|FG001|Overall Study|Adverse Event|4|||
127950752|NCT04948333|460439192|FG002|Overall Study|Adverse Event|0|||
127950753|NCT04948333|460439193|FG003|Overall Study|Adverse Event|2|||
127950754|NCT04948333|460439190|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
127950755|NCT04948333|460439191|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
127950756|NCT04948333|460439192|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
127950757|NCT04948333|460439193|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
127950758|NCT04948333|460439190|FG000|Overall Study|Progressive Disease|1|||
127950759|NCT04948333|460439191|FG001|Overall Study|Progressive Disease|5|||
127950760|NCT04948333|460439192|FG002|Overall Study|Progressive Disease|0|||
127950761|NCT04948333|460439193|FG003|Overall Study|Progressive Disease|0|||
127950762|NCT04948333|460439190|FG000|Overall Study|Physician Decision|2|||
127950763|NCT04948333|460439191|FG001|Overall Study|Physician Decision|2|||
127950764|NCT04948333|460439192|FG002|Overall Study|Physician Decision|0|||
127950765|NCT04948333|460439193|FG003|Overall Study|Physician Decision|0|||
127950766|NCT04948333|460439190|FG000|Overall Study|Failure To Meet Continuation Criteria|2|||
127950767|NCT04948333|460439191|FG001|Overall Study|Failure To Meet Continuation Criteria|1|||
127950768|NCT04948333|460439192|FG002|Overall Study|Failure To Meet Continuation Criteria|0|||
127950769|NCT04948333|460439193|FG003|Overall Study|Failure To Meet Continuation Criteria|0|||
127950770|NCT04948333|460439190|FG000|Overall Study|Withdrawal by Subject|2|||
127950771|NCT04948333|460439191|FG001|Overall Study|Withdrawal by Subject|0|||
127950772|NCT04948333|460439192|FG002|Overall Study|Withdrawal by Subject|0|||
127950773|NCT04948333|460439193|FG003|Overall Study|Withdrawal by Subject|1|||
127950774|NCT04948333|460439190|FG000|Overall Study|Protocol Violation|0|||
127950775|NCT04948333|460439191|FG001|Overall Study|Protocol Violation|1|||
127950776|NCT04948333|460439192|FG002|Overall Study|Protocol Violation|0|||
127950777|NCT04948333|460439193|FG003|Overall Study|Protocol Violation|0|||
127950778|NCT04948333|460439190|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
127950779|NCT04948333|460439191|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
127950780|NCT04948333|460439192|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|14|||
127950781|NCT04948333|460439193|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|13|||
127950782|NCT02129608|460439194|FG000|Overall Study|Lost to Follow-up|0|||
127950783|NCT02129608|460439195|FG001|Overall Study|Lost to Follow-up|1|||
127950784|NCT02129608|460439196|FG002|Overall Study|Lost to Follow-up|1|||
127950785|NCT02129608|460439194|FG000|Overall Study|Withdrawal by Subject|0|||
127950786|NCT02129608|460439195|FG001|Overall Study|Withdrawal by Subject|0|||
127950787|NCT02129608|460439196|FG002|Overall Study|Withdrawal by Subject|2|||
127950788|NCT00451204|460439197|FG000|Overall Study|Adverse Event|4|||
127950789|NCT00451204|460439198|FG001|Overall Study|Adverse Event|6|||
127950790|NCT00451204|460439197|FG000|Overall Study|Lack of Efficacy|4|||
127950791|NCT00451204|460439198|FG001|Overall Study|Lack of Efficacy|4|||
127950792|NCT00451204|460439197|FG000|Overall Study|Lost to Follow-up|4|||
127950793|NCT00451204|460439198|FG001|Overall Study|Lost to Follow-up|4|||
127950794|NCT00451204|460439197|FG000|Overall Study|Protocol Violation|1|||
127950795|NCT00451204|460439198|FG001|Overall Study|Protocol Violation|0|||
127950796|NCT00451204|460439197|FG000|Overall Study|Patient refusal|8|||
127950797|NCT00451204|460439198|FG001|Overall Study|Patient refusal|4|||
127950798|NCT00451204|460439197|FG000|Overall Study|Other|1|||
127950799|NCT00451204|460439198|FG001|Overall Study|Other|2|||
127950800|NCT01582152|460439199|FG000|Overall Study|Disease Progression|4|||
127950801|NCT01582152|460439200|FG001|Overall Study|Disease Progression|5|||
127950802|NCT01582152|460439199|FG000|Overall Study|Adverse Event|2|||
127950803|NCT01582152|460439200|FG001|Overall Study|Adverse Event|1|||
127950804|NCT04172597|460439203|FG000|Overall Study|Disease Progression|0|||
127950805|NCT04172597|460439204|FG001|Overall Study|Disease Progression|0|||
127950806|NCT04172597|460439205|FG002|Overall Study|Disease Progression|0|||
127950807|NCT04172597|460439206|FG003|Overall Study|Disease Progression|0|||
127950808|NCT04172597|460439207|FG004|Overall Study|Disease Progression|1|||
127950809|NCT00794339|460439208|FG000|Overall Study|Withdrawal by Subject|3|||
127950810|NCT00794339|460439208|FG000|Overall Study|Ineligible|4|||
127950811|NCT00794339|460439208|FG000|Overall Study|Tx prior to ATSM|3|||
127950812|NCT00794339|460439208|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
127950813|NCT00794339|460439208|FG000|Overall Study|Tx not per protocol|1|||
127950814|NCT01611857|460439209|FG000|Overall Study|Withdrawal by Subject|0|||
127950815|NCT01611857|460439210|FG001|Overall Study|Withdrawal by Subject|2|||
127950816|NCT00362336|460439227|FG000|Overall Study|Serious Adverse Event|1|||
127950817|NCT00362336|460439228|FG001|Overall Study|Serious Adverse Event|0|||
127950818|NCT00362336|460439229|FG002|Overall Study|Serious Adverse Event|1|||
127950819|NCT00362336|460439227|FG000|Overall Study|Protocol Violation|0|||
127950820|NCT00362336|460439228|FG001|Overall Study|Protocol Violation|0|||
127950821|NCT00362336|460439229|FG002|Overall Study|Protocol Violation|1|||
127950822|NCT00362336|460439227|FG000|Overall Study|Lost to Follow-up|6|||
127950823|NCT00362336|460439228|FG001|Overall Study|Lost to Follow-up|4|||
127950824|NCT00362336|460439229|FG002|Overall Study|Lost to Follow-up|0|||
127950825|NCT00362336|460439227|FG000|Overall Study|Withdrawal by Subject|3|||
127950826|NCT00362336|460439228|FG001|Overall Study|Withdrawal by Subject|3|||
127950827|NCT00362336|460439229|FG002|Overall Study|Withdrawal by Subject|1|||
127950828|NCT01121562|460439232|FG000|Overall Study|Objective progression or relapse|8|||
127950829|NCT01121562|460439232|FG000|Overall Study|Withdrawal by Subject|1|||
127950830|NCT01121562|460439232|FG000|Overall Study|Adverse Event|1|||
127950831|NCT01121562|460439232|FG000|Overall Study|Sponsor Decision|1|||
127950832|NCT01121562|460439232|FG000|Overall Study|Met study discontinuation criteria|1|||
127950833|NCT01495702|460439233|FG000|Randomized Phase|Randomized But Not Treated|1|||
127950834|NCT01495702|460439234|FG001|Randomized Phase|Randomized But Not Treated|4|||
127950835|NCT01495702|460439233|FG000|Randomized Phase|Adverse Event|2|||
127950836|NCT01495702|460439234|FG001|Randomized Phase|Adverse Event|2|||
127950837|NCT01495702|460439233|FG000|Randomized Phase|Death|1|||
127950838|NCT01495702|460439234|FG001|Randomized Phase|Death|0|||
127950839|NCT01495702|460439233|FG000|Randomized Phase|Lack of Efficacy|2|||
127950840|NCT01495702|460439234|FG001|Randomized Phase|Lack of Efficacy|0|||
127950841|NCT01495702|460439233|FG000|Randomized Phase|Investigators Discretion|2|||
127950842|NCT01495702|460439234|FG001|Randomized Phase|Investigators Discretion|0|||
127950843|NCT01495702|460439233|FG000|Randomized Phase|Withdrew Consent|10|||
127950844|NCT01495702|460439234|FG001|Randomized Phase|Withdrew Consent|18|||
127950845|NCT01495702|460439233|FG000|Randomized Phase|Lost to Follow-up|4|||
127950846|NCT01495702|460439234|FG001|Randomized Phase|Lost to Follow-up|3|||
127950847|NCT01495702|460439233|FG000|Randomized Phase|Participant Noncompliance|1|||
127950848|NCT01495702|460439234|FG001|Randomized Phase|Participant Noncompliance|0|||
127950849|NCT01495702|460439233|FG000|Randomized Phase|Protocol Violation|3|||
127950850|NCT01495702|460439234|FG001|Randomized Phase|Protocol Violation|1|||
127950851|NCT04152863|460439235|FG000|Overall Study|Death|13|||
127950852|NCT04152863|460439236|FG001|Overall Study|Death|12|||
127950853|NCT04152863|460439237|FG002|Overall Study|Death|7|||
127950854|NCT04152863|460439235|FG000|Overall Study|Physician Decision|1|||
127950855|NCT04152863|460439236|FG001|Overall Study|Physician Decision|1|||
127950856|NCT04152863|460439237|FG002|Overall Study|Physician Decision|1|||
127950857|NCT04152863|460439235|FG000|Overall Study|Participation in Study Terminated by Sponsor|12|||
127950858|NCT04152863|460439236|FG001|Overall Study|Participation in Study Terminated by Sponsor|14|||
127950859|NCT04152863|460439237|FG002|Overall Study|Participation in Study Terminated by Sponsor|18|||
127950860|NCT04152863|460439235|FG000|Overall Study|Withdrawal by Subject|2|||
127950861|NCT04152863|460439236|FG001|Overall Study|Withdrawal by Subject|1|||
127950862|NCT04152863|460439237|FG002|Overall Study|Withdrawal by Subject|3|||
127950863|NCT00196326|460439238|FG000|Overall Study|Did not meet protocol requirements|64|||
127950864|NCT00196326|460439238|FG000|Overall Study|Non-compliance with the protocol|81|||
127950865|NCT00196326|460439238|FG000|Overall Study|Physician Decision|3|||
127950866|NCT00196326|460439238|FG000|Overall Study|Withdrawal by Subject|225|||
127950867|NCT00196326|460439238|FG000|Overall Study|Adverse Event|253|||
127950868|NCT00196326|460439238|FG000|Overall Study|Pregnancy|34|||
127950869|NCT00196326|460439238|FG000|Overall Study|Lost to Follow-up|304|||
127950870|NCT00196326|460439238|FG000|Overall Study|Other|22|||
127950871|NCT02540083|460439239|FG000|Overall Study|Withdrawal by Subject|16|||
127950872|NCT02797171|460439240|FG000|Overall Study|Lost to Follow-up|2|||
127950873|NCT02797171|460439241|FG001|Overall Study|Lost to Follow-up|0|||
127950874|NCT02797171|460439242|FG002|Overall Study|Lost to Follow-up|2|||
127950875|NCT02797171|460439243|FG003|Overall Study|Lost to Follow-up|1|||
127950876|NCT02797171|460439244|FG004|Overall Study|Lost to Follow-up|2|||
127950877|NCT02797171|460439245|FG005|Overall Study|Lost to Follow-up|0|||
127950878|NCT02797171|460439240|FG000|Overall Study|Withdrawal by Subject|1|||
127950879|NCT02797171|460439241|FG001|Overall Study|Withdrawal by Subject|1|||
127950880|NCT02797171|460439242|FG002|Overall Study|Withdrawal by Subject|0|||
127950881|NCT02797171|460439243|FG003|Overall Study|Withdrawal by Subject|0|||
127950882|NCT02797171|460439244|FG004|Overall Study|Withdrawal by Subject|0|||
127950883|NCT02797171|460439245|FG005|Overall Study|Withdrawal by Subject|0|||
127950884|NCT02797171|460439240|FG000|Overall Study|Protocol Violation|1|||
127950885|NCT02797171|460439241|FG001|Overall Study|Protocol Violation|0|||
127950886|NCT02797171|460439242|FG002|Overall Study|Protocol Violation|0|||
127950887|NCT02797171|460439243|FG003|Overall Study|Protocol Violation|0|||
127950888|NCT02797171|460439244|FG004|Overall Study|Protocol Violation|0|||
127950889|NCT02797171|460439245|FG005|Overall Study|Protocol Violation|0|||
127950890|NCT02797171|460439240|FG000|Overall Study|Participant unable to adhere|0|||
127950891|NCT02797171|460439241|FG001|Overall Study|Participant unable to adhere|1|||
127950892|NCT02797171|460439242|FG002|Overall Study|Participant unable to adhere|0|||
127950893|NCT02797171|460439243|FG003|Overall Study|Participant unable to adhere|0|||
127950894|NCT02797171|460439244|FG004|Overall Study|Participant unable to adhere|0|||
127950895|NCT02797171|460439245|FG005|Overall Study|Participant unable to adhere|0|||
127950896|NCT02797171|460439240|FG000|Overall Study|Not Randomized|0|||
127950897|NCT02797171|460439241|FG001|Overall Study|Not Randomized|0|||
127950898|NCT02797171|460439242|FG002|Overall Study|Not Randomized|0|||
127950899|NCT02797171|460439243|FG003|Overall Study|Not Randomized|0|||
127950900|NCT02797171|460439244|FG004|Overall Study|Not Randomized|0|||
127950901|NCT02797171|460439245|FG005|Overall Study|Not Randomized|1|||
127950902|NCT00134901|460439246|FG000|Overall Study|Lost to Follow-up|5|||
127950903|NCT00134901|460439247|FG001|Overall Study|Lost to Follow-up|5|||
127950904|NCT00134901|460439246|FG000|Overall Study|discontinued intervention|12|||
127950905|NCT00134901|460439247|FG001|Overall Study|discontinued intervention|10|||
127950906|NCT04289363|460439252|FG000|Overall Study|Lost to Follow-up|14|||
127950907|NCT04289363|460439253|FG001|Overall Study|Lost to Follow-up|0|||
127950908|NCT02585778|460439254|FG000|Overall Study|Adverse Event|17|||
127950909|NCT02585778|460439255|FG001|Overall Study|Adverse Event|4|||
127950910|NCT02585778|460439254|FG000|Overall Study|Participant did not wish to continue|9|||
127950911|NCT02585778|460439255|FG001|Overall Study|Participant did not wish to continue|4|||
127950912|NCT02585778|460439254|FG000|Overall Study|Poor compliance to study protocol|0|||
127950913|NCT02585778|460439255|FG001|Overall Study|Poor compliance to study protocol|2|||
127950914|NCT02585778|460439254|FG000|Overall Study|Death|0|||
127950915|NCT02585778|460439255|FG001|Overall Study|Death|1|||
127950916|NCT02585778|460439254|FG000|Overall Study|Randomized but not treated|1|||
127950917|NCT02585778|460439255|FG001|Overall Study|Randomized but not treated|2|||
127950918|NCT02585778|460439254|FG000|Overall Study|Other than specified above|6|||
127950919|NCT02585778|460439255|FG001|Overall Study|Other than specified above|2|||
127950920|NCT00445432|460439257|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
127950921|NCT00445432|460439258|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
127950922|NCT00445432|460439259|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
127950923|NCT00445432|460439260|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
127950924|NCT00445432|460439257|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
127950925|NCT00445432|460439258|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
127950926|NCT00445432|460439259|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
127950927|NCT00445432|460439260|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
127950928|NCT00445432|460439257|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
127950929|NCT00445432|460439258|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
127950930|NCT00445432|460439259|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
127950931|NCT00445432|460439260|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
127950932|NCT00445432|460439257|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
127950933|NCT00445432|460439258|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
127950934|NCT00445432|460439259|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
127950935|NCT00445432|460439260|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
127950936|NCT00445432|460439257|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
127950937|NCT00445432|460439258|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
127950938|NCT00445432|460439259|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
127950939|NCT00445432|460439260|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
127950940|NCT00445432|460439257|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
127950941|NCT00445432|460439258|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
127950942|NCT00445432|460439259|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
127950943|NCT00445432|460439260|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
127950944|NCT00445432|460439257|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
127950945|NCT00445432|460439258|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
127950946|NCT00445432|460439259|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
127950947|NCT00445432|460439260|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
127950948|NCT02789137|460439261|FG000|Overall Study|Dropped out/Died|58|||
127950949|NCT01482312|460439262|FG000|Period 1, 90 Minutes of Wear|Other|1|||
127950950|NCT01482312|460439263|FG001|Period 1, 90 Minutes of Wear|Other|0|||
127950951|NCT01482312|460439264|FG002|Period 1, 90 Minutes of Wear|Other|0|||
127950952|NCT01482312|460439262|FG000|Period 2, 90 Minutes of Wear|Other|1|||
127950953|NCT01482312|460439263|FG001|Period 2, 90 Minutes of Wear|Other|0|||
127950954|NCT01482312|460439264|FG002|Period 2, 90 Minutes of Wear|Other|0|||
127950955|NCT01699815|460439265|FG000|Overall Study|Protocol Violation|4|||
127950956|NCT01699815|460439266|FG001|Overall Study|Protocol Violation|7|||
127950957|NCT01699815|460439265|FG000|Overall Study|record could not be located|1|||
127950958|NCT01699815|460439266|FG001|Overall Study|record could not be located|0|||
127950959|NCT01699815|460439265|FG000|Overall Study|Adverse Event|0|||
127950960|NCT01699815|460439266|FG001|Overall Study|Adverse Event|1|||
127950961|NCT00356525|460439267|FG000|Overall Study|Progressive Disease|8|||
127950962|NCT00356525|460439268|FG001|Overall Study|Progressive Disease|5|||
127950963|NCT00356525|460439269|FG002|Overall Study|Progressive Disease|4|||
127950964|NCT00356525|460439270|FG003|Overall Study|Progressive Disease|2|||
127950965|NCT00356525|460439267|FG000|Overall Study|Adverse Event|1|||
127950966|NCT00356525|460439268|FG001|Overall Study|Adverse Event|3|||
127950967|NCT00356525|460439269|FG002|Overall Study|Adverse Event|1|||
127950968|NCT00356525|460439270|FG003|Overall Study|Adverse Event|1|||
127950969|NCT00356525|460439267|FG000|Overall Study|Lost to Follow-up|1|||
127950970|NCT00356525|460439268|FG001|Overall Study|Lost to Follow-up|0|||
127950971|NCT00356525|460439269|FG002|Overall Study|Lost to Follow-up|0|||
127950972|NCT00356525|460439270|FG003|Overall Study|Lost to Follow-up|0|||
127950973|NCT00356525|460439267|FG000|Overall Study|Physician Decision|2|||
127950974|NCT00356525|460439268|FG001|Overall Study|Physician Decision|2|||
127950975|NCT00356525|460439269|FG002|Overall Study|Physician Decision|2|||
127950976|NCT00356525|460439270|FG003|Overall Study|Physician Decision|1|||
127950977|NCT00356525|460439267|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
127950978|NCT00356525|460439268|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
127950979|NCT00356525|460439269|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
127950980|NCT00356525|460439270|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
127950981|NCT00356525|460439267|FG000|Overall Study|Withdrawal by Subject|1|||
127950982|NCT00356525|460439268|FG001|Overall Study|Withdrawal by Subject|1|||
127950983|NCT00356525|460439269|FG002|Overall Study|Withdrawal by Subject|0|||
127950984|NCT00356525|460439270|FG003|Overall Study|Withdrawal by Subject|3|||
127950985|NCT00356525|460439267|FG000|Overall Study|Death|0|||
127950986|NCT00356525|460439268|FG001|Overall Study|Death|0|||
127950987|NCT00356525|460439269|FG002|Overall Study|Death|0|||
127950988|NCT00356525|460439270|FG003|Overall Study|Death|1|||
127950989|NCT00356525|460439267|FG000|Overall Study|Sponsor Decision|0|||
127950990|NCT00356525|460439268|FG001|Overall Study|Sponsor Decision|0|||
127950991|NCT00356525|460439269|FG002|Overall Study|Sponsor Decision|0|||
127950992|NCT00356525|460439270|FG003|Overall Study|Sponsor Decision|1|||
127950993|NCT01685840|460439275|FG000|Overall Study|Death|77|||
127950994|NCT01685840|460439276|FG001|Overall Study|Death|66|||
127950995|NCT01685840|460439275|FG000|Overall Study|Lost to Follow-up|27|||
127950996|NCT01685840|460439276|FG001|Overall Study|Lost to Follow-up|25|||
127950997|NCT01685840|460439275|FG000|Overall Study|Physician Decision|3|||
127950998|NCT01685840|460439276|FG001|Overall Study|Physician Decision|7|||
127950999|NCT01685840|460439275|FG000|Overall Study|Withdrawal by Subject|14|||
127951000|NCT01685840|460439276|FG001|Overall Study|Withdrawal by Subject|17|||
127951001|NCT01685840|460439275|FG000|Overall Study|Futility|197|||
127951002|NCT01685840|460439276|FG001|Overall Study|Futility|200|||
127951003|NCT01685840|460439275|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
127951004|NCT01685840|460439276|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
127951005|NCT01885195|460439287|FG000|Overall Study|Adverse Event|29|||
127951006|NCT01885195|460439287|FG000|Overall Study|Death|1|||
127951007|NCT01885195|460439287|FG000|Overall Study|Disease Progression|67|||
127951008|NCT01885195|460439287|FG000|Overall Study|Protocol Deviation|2|||
127951009|NCT01885195|460439287|FG000|Overall Study|Physician Decision|3|||
127951010|NCT01885195|460439287|FG000|Overall Study|Patient/guardian decision|8|||
127951011|NCT04700137|460439288|FG000|Overall Study|Lost to Follow-up|1|||
127951012|NCT04700137|460439289|FG001|Overall Study|Lost to Follow-up|6|||
127951013|NCT04700137|460439290|FG002|Overall Study|Lost to Follow-up|1|||
127951014|NCT04700137|460439291|FG003|Overall Study|Lost to Follow-up|1|||
127951015|NCT04700137|460439288|FG000|Overall Study|Withdrawal by Subject|0|||
127951016|NCT04700137|460439289|FG001|Overall Study|Withdrawal by Subject|0|||
127951017|NCT04700137|460439290|FG002|Overall Study|Withdrawal by Subject|1|||
127951018|NCT04700137|460439291|FG003|Overall Study|Withdrawal by Subject|0|||
127951019|NCT04700137|460439288|FG000|Overall Study|Death|0|||
127951020|NCT04700137|460439289|FG001|Overall Study|Death|0|||
127951021|NCT04700137|460439290|FG002|Overall Study|Death|1|||
127951022|NCT04700137|460439291|FG003|Overall Study|Death|0|||
127951023|NCT00548093|460439292|FG000|Overall Study|Death|33|||
127951024|NCT00548093|460439293|FG001|Overall Study|Death|13|||
127951025|NCT00548093|460439292|FG000|Overall Study|Lost to Follow-up|3|||
127951026|NCT00548093|460439293|FG001|Overall Study|Lost to Follow-up|1|||
127951027|NCT00548093|460439292|FG000|Overall Study|Objective progression or relapse|1|||
127951028|NCT00548093|460439293|FG001|Overall Study|Objective progression or relapse|1|||
127951029|NCT00548093|460439292|FG000|Overall Study|Other|11|||
127951030|NCT00548093|460439293|FG001|Overall Study|Other|1|||
127951031|NCT00548093|460439292|FG000|Overall Study|Withdrawal by Subject|1|||
127951032|NCT00548093|460439293|FG001|Overall Study|Withdrawal by Subject|0|||
127951033|NCT00548093|460439292|FG000|Overall Study|Completed post-treatment follow-up|1|||
127951034|NCT00548093|460439293|FG001|Overall Study|Completed post-treatment follow-up|0|||
127951035|NCT04386616|460439297|FG000|Overall Study|Death|22|||
127951036|NCT04386616|460439298|FG001|Overall Study|Death|22|||
127951037|NCT04386616|460439299|FG002|Overall Study|Death|21|||
127951038|NCT04386616|460439297|FG000|Overall Study|Lost to Follow-up|5|||
127951039|NCT04386616|460439298|FG001|Overall Study|Lost to Follow-up|8|||
127951040|NCT04386616|460439299|FG002|Overall Study|Lost to Follow-up|6|||
127951041|NCT04386616|460439297|FG000|Overall Study|Withdrawal by Subject|2|||
127951042|NCT04386616|460439298|FG001|Overall Study|Withdrawal by Subject|4|||
127951043|NCT04386616|460439299|FG002|Overall Study|Withdrawal by Subject|1|||
127951044|NCT04386616|460439297|FG000|Overall Study|Adverse Event|1|||
127951045|NCT04386616|460439298|FG001|Overall Study|Adverse Event|1|||
127951046|NCT04386616|460439299|FG002|Overall Study|Adverse Event|0|||
127951047|NCT01862484|460439300|FG000|Overall Study|Lack of Efficacy|1|||
127951048|NCT01862484|460439301|FG001|Overall Study|Lack of Efficacy|1|||
127951049|NCT01862484|460439300|FG000|Overall Study|Lost to Follow-up|1|||
127951050|NCT01862484|460439301|FG001|Overall Study|Lost to Follow-up|2|||
127951051|NCT01862484|460439300|FG000|Overall Study|Protocol Violation|0|||
127951052|NCT01862484|460439301|FG001|Overall Study|Protocol Violation|2|||
127951053|NCT01862484|460439300|FG000|Overall Study|Withdrawal by Subject|0|||
127951054|NCT01862484|460439301|FG001|Overall Study|Withdrawal by Subject|3|||
127951055|NCT01632280|460439302|FG000|Overall Study|Withdrawal by Subject|1|||
127951056|NCT01632280|460439303|FG001|Overall Study|Withdrawal by Subject|0|||
127951057|NCT00993421|460439304|FG000|Overall Study|Adverse Event|2|||
127951058|NCT00993421|460439305|FG001|Overall Study|Adverse Event|7|||
127951059|NCT00993421|460439306|FG002|Overall Study|Adverse Event|6|||
127951060|NCT00993421|460439307|FG003|Overall Study|Adverse Event|9|||
127951061|NCT00993421|460439308|FG004|Overall Study|Adverse Event|5|||
127951062|NCT00993421|460439309|FG005|Overall Study|Adverse Event|7|||
127951063|NCT00993421|460439310|FG006|Overall Study|Adverse Event|1|||
127951064|NCT00993421|460439304|FG000|Overall Study|Sponsor Decision|36|||
127951065|NCT00993421|460439305|FG001|Overall Study|Sponsor Decision|31|||
127951066|NCT00993421|460439306|FG002|Overall Study|Sponsor Decision|28|||
127951067|NCT00993421|460439307|FG003|Overall Study|Sponsor Decision|30|||
127951068|NCT00993421|460439308|FG004|Overall Study|Sponsor Decision|38|||
127951069|NCT00993421|460439309|FG005|Overall Study|Sponsor Decision|30|||
127951070|NCT00993421|460439310|FG006|Overall Study|Sponsor Decision|29|||
127951071|NCT00993421|460439304|FG000|Overall Study|Lost to Follow-up|3|||
127951072|NCT00993421|460439305|FG001|Overall Study|Lost to Follow-up|5|||
127951073|NCT00993421|460439306|FG002|Overall Study|Lost to Follow-up|5|||
127951074|NCT00993421|460439307|FG003|Overall Study|Lost to Follow-up|0|||
127951075|NCT00993421|460439308|FG004|Overall Study|Lost to Follow-up|0|||
127951076|NCT00993421|460439309|FG005|Overall Study|Lost to Follow-up|0|||
127951077|NCT00993421|460439310|FG006|Overall Study|Lost to Follow-up|6|||
127951078|NCT00993421|460439304|FG000|Overall Study|Withdrawal by Subject|3|||
127951079|NCT00993421|460439305|FG001|Overall Study|Withdrawal by Subject|2|||
127951080|NCT00993421|460439306|FG002|Overall Study|Withdrawal by Subject|3|||
127951081|NCT00993421|460439307|FG003|Overall Study|Withdrawal by Subject|3|||
127951082|NCT00993421|460439308|FG004|Overall Study|Withdrawal by Subject|3|||
127951083|NCT00993421|460439309|FG005|Overall Study|Withdrawal by Subject|5|||
127951084|NCT00993421|460439310|FG006|Overall Study|Withdrawal by Subject|3|||
127951085|NCT00993421|460439304|FG000|Overall Study|Death|0|||
127951086|NCT00993421|460439305|FG001|Overall Study|Death|0|||
127951087|NCT00993421|460439306|FG002|Overall Study|Death|0|||
127951088|NCT00993421|460439307|FG003|Overall Study|Death|0|||
127951089|NCT00993421|460439308|FG004|Overall Study|Death|0|||
127951090|NCT00993421|460439309|FG005|Overall Study|Death|0|||
127951091|NCT00993421|460439310|FG006|Overall Study|Death|1|||
127951092|NCT00993421|460439304|FG000|Overall Study|Entry Criteria Exclusion|0|||
127951093|NCT00993421|460439305|FG001|Overall Study|Entry Criteria Exclusion|0|||
127951094|NCT00993421|460439306|FG002|Overall Study|Entry Criteria Exclusion|1|||
127951095|NCT00993421|460439307|FG003|Overall Study|Entry Criteria Exclusion|3|||
127951096|NCT00993421|460439308|FG004|Overall Study|Entry Criteria Exclusion|0|||
127951097|NCT00993421|460439309|FG005|Overall Study|Entry Criteria Exclusion|1|||
127951098|NCT00993421|460439310|FG006|Overall Study|Entry Criteria Exclusion|0|||
127951099|NCT00993421|460439304|FG000|Overall Study|Physician Decision|0|||
127951100|NCT00993421|460439305|FG001|Overall Study|Physician Decision|0|||
127951101|NCT00993421|460439306|FG002|Overall Study|Physician Decision|0|||
127951102|NCT00993421|460439307|FG003|Overall Study|Physician Decision|0|||
127951103|NCT00993421|460439308|FG004|Overall Study|Physician Decision|0|||
127951104|NCT00993421|460439309|FG005|Overall Study|Physician Decision|1|||
127951105|NCT00993421|460439310|FG006|Overall Study|Physician Decision|1|||
127951106|NCT00993421|460439304|FG000|Overall Study|Protocol Violation|0|||
127951107|NCT00993421|460439305|FG001|Overall Study|Protocol Violation|0|||
127951108|NCT00993421|460439306|FG002|Overall Study|Protocol Violation|0|||
127951109|NCT00993421|460439307|FG003|Overall Study|Protocol Violation|0|||
127951110|NCT00993421|460439308|FG004|Overall Study|Protocol Violation|0|||
127951111|NCT00993421|460439309|FG005|Overall Study|Protocol Violation|2|||
127951112|NCT00993421|460439310|FG006|Overall Study|Protocol Violation|1|||
127951113|NCT02215967|460439311|FG000|Overall Study|Patient became ineligible for treatment|0|||
127951114|NCT02215967|460439312|FG001|Overall Study|Patient became ineligible for treatment|0|||
127951115|NCT02215967|460439313|FG002|Overall Study|Patient became ineligible for treatment|0|||
127951116|NCT02215967|460439314|FG003|Overall Study|Patient became ineligible for treatment|3|||
127951117|NCT02215967|460439311|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
127951118|NCT02215967|460439312|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
127951119|NCT02215967|460439313|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
127951120|NCT02215967|460439314|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
127951121|NCT00352417|460439315|FG000|Overall Study|Adverse Event|1|||
127951122|NCT00352417|460439316|FG001|Overall Study|Adverse Event|0|||
127951123|NCT00352417|460439315|FG000|Overall Study|Protocol Violation|0|||
127951124|NCT00352417|460439316|FG001|Overall Study|Protocol Violation|2|||
127951125|NCT00352417|460439315|FG000|Overall Study|Withdrawal by Subject|1|||
127951126|NCT00352417|460439316|FG001|Overall Study|Withdrawal by Subject|2|||
127951127|NCT00352417|460439315|FG000|Overall Study|Lost to Follow-up|1|||
127951128|NCT00352417|460439316|FG001|Overall Study|Lost to Follow-up|0|||
127951129|NCT00352417|460439315|FG000|Overall Study|Schedule Change|2|||
127951130|NCT00352417|460439316|FG001|Overall Study|Schedule Change|1|||
127951131|NCT01496976|460440785|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
127951132|NCT00371033|460440786|FG000|Overall Study|Lost to Follow-up|3|||
127951133|NCT00371033|460440787|FG001|Overall Study|Lost to Follow-up|2|||
127951134|NCT00371033|460440786|FG000|Overall Study|No longer interested|2|||
127951135|NCT00371033|460440787|FG001|Overall Study|No longer interested|0|||
127951136|NCT00371033|460440786|FG000|Overall Study|Uknown|3|||
127951137|NCT00371033|460440787|FG001|Overall Study|Uknown|1|||
127951138|NCT02506153|460440788|FG000|Overall Study|Adverse Event|359|||
127951139|NCT02506153|460440789|FG001|Overall Study|Adverse Event|114|||
127951140|NCT02506153|460440788|FG000|Overall Study|Refused unrelated to adverse event|127|||
127951141|NCT02506153|460440789|FG001|Overall Study|Refused unrelated to adverse event|18|||
127951142|NCT02506153|460440788|FG000|Overall Study|Progression/relapse|91|||
127951143|NCT02506153|460440789|FG001|Overall Study|Progression/relapse|136|||
127951144|NCT02506153|460440788|FG000|Overall Study|Death|2|||
127951145|NCT02506153|460440789|FG001|Overall Study|Death|1|||
127951146|NCT02506153|460440788|FG000|Overall Study|Other - not protocol specified|23|||
127951147|NCT02506153|460440789|FG001|Overall Study|Other - not protocol specified|12|||
127951148|NCT06400238|460440794|FG000|Overall Study|Started Protocol Therapy|2|||
127951149|NCT06400238|460440794|FG000|Overall Study|Adverse Event|1|||
127951150|NCT06400238|460440794|FG000|Overall Study|Death|1|||
127951151|NCT06400238|460440794|FG000|Overall Study|Disease Progression|27|||
127951152|NCT06400238|460440794|FG000|Overall Study|Withdrawal by Subject|2|||
127951153|NCT06400238|460440794|FG000|Overall Study|Physician Decision|2|||
127951154|NCT04034927|460440795|FG000|Overall Study|Adverse Event|4|||
127951155|NCT04034927|460440796|FG001|Overall Study|Adverse Event|9|||
127951156|NCT04034927|460440795|FG000|Overall Study|Death|0|||
127951157|NCT04034927|460440796|FG001|Overall Study|Death|1|||
127951158|NCT04034927|460440795|FG000|Overall Study|Withdrawal by Subject|0|||
127951159|NCT04034927|460440796|FG001|Overall Study|Withdrawal by Subject|3|||
127951160|NCT04034927|460440795|FG000|Overall Study|Still on Treatment|2|||
127951161|NCT04034927|460440796|FG001|Overall Study|Still on Treatment|1|||
127951162|NCT04034927|460440795|FG000|Overall Study|Other|1|||
127951163|NCT04034927|460440796|FG001|Overall Study|Other|1|||
127951164|NCT03996447|460440797|FG000|First MRI Examination|Adverse Event|2|||
127951165|NCT03996447|460440798|FG001|First MRI Examination|Adverse Event|0|||
127951166|NCT03996447|460440797|FG000|First MRI Examination|Withdrawal by Subject|1|||
127951167|NCT03996447|460440798|FG001|First MRI Examination|Withdrawal by Subject|2|||
127951168|NCT03996447|460440797|FG000|First MRI Examination|Protocol Violation|0|||
127951169|NCT03996447|460440798|FG001|First MRI Examination|Protocol Violation|1|||
127951170|NCT03996447|460440797|FG000|Washout|Adverse Event|2|||
127951171|NCT03996447|460440798|FG001|Washout|Adverse Event|0|||
127951172|NCT03996447|460440797|FG000|Washout|Follow-up unavailable due to COVID-19 pandemic|2|||
127951173|NCT03996447|460440798|FG001|Washout|Follow-up unavailable due to COVID-19 pandemic|1|||
127951174|NCT03996447|460440797|FG000|Washout|Withdrawal by Subject|0|||
127951175|NCT03996447|460440798|FG001|Washout|Withdrawal by Subject|1|||
127951176|NCT03996447|460440797|FG000|Washout|Other reason|1|||
127951177|NCT03996447|460440798|FG001|Washout|Other reason|1|||
127951178|NCT04458922|460440799|FG000|Overall Study|Withdrawal by Subject|1|||
127951179|NCT04458922|460440800|FG001|Overall Study|Withdrawal by Subject|0|||
127951180|NCT04458922|460440801|FG002|Overall Study|Withdrawal by Subject|2|||
127951181|NCT04458922|460440799|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
127951182|NCT04458922|460440800|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
127951183|NCT04458922|460440801|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
127951184|NCT04458922|460440799|FG000|Overall Study|Adverse Event|1|||
127951185|NCT04458922|460440800|FG001|Overall Study|Adverse Event|0|||
127951186|NCT04458922|460440801|FG002|Overall Study|Adverse Event|0|||
127951187|NCT04458922|460440799|FG000|Overall Study|Started new study|0|||
127951188|NCT04458922|460440800|FG001|Overall Study|Started new study|0|||
127951189|NCT04458922|460440801|FG002|Overall Study|Started new study|1|||
127951190|NCT04458922|460440799|FG000|Overall Study|Progressive disease|6|||
127951191|NCT04458922|460440800|FG001|Overall Study|Progressive disease|8|||
127951192|NCT04458922|460440801|FG002|Overall Study|Progressive disease|2|||
127951193|NCT04458922|460440799|FG000|Overall Study|Death|1|||
127951194|NCT04458922|460440800|FG001|Overall Study|Death|0|||
127951195|NCT04458922|460440801|FG002|Overall Study|Death|2|||
127951196|NCT04458922|460440799|FG000|Overall Study|Participant started chemotherapy|0|||
127951197|NCT04458922|460440800|FG001|Overall Study|Participant started chemotherapy|1|||
127951198|NCT04458922|460440801|FG002|Overall Study|Participant started chemotherapy|0|||
127951199|NCT01009814|460440802|FG000|Overall Study|No longer met study criteria|1|||
127951200|NCT01009814|460440803|FG001|Overall Study|No longer met study criteria|1|||
127951201|NCT01009814|460440804|FG002|Overall Study|No longer met study criteria|0|||
127951202|NCT01009814|460440805|FG003|Overall Study|No longer met study criteria|0|||
127951203|NCT01009814|460440806|FG004|Overall Study|No longer met study criteria|0|||
127951204|NCT00618371|460440807|FG000|Overall Study|Withdrawal by Subject|2|||
127951205|NCT01625988|460440810|FG000|Overall Study|Lost to Follow-up|5|||
127951206|NCT01625988|460440811|FG001|Overall Study|Lost to Follow-up|6|||
127951207|NCT01625988|460440810|FG000|Overall Study|Withdrawal by Subject|8|||
127951208|NCT01625988|460440811|FG001|Overall Study|Withdrawal by Subject|3|||
127951209|NCT01625988|460440810|FG000|Overall Study|Adverse Event|0|||
127951210|NCT01625988|460440811|FG001|Overall Study|Adverse Event|1|||
127951211|NCT01625988|460440810|FG000|Overall Study|Lack of Efficacy|0|||
127951212|NCT01625988|460440811|FG001|Overall Study|Lack of Efficacy|1|||
127951213|NCT01625988|460440810|FG000|Overall Study|Randomized Inappropriately|1|||
127951214|NCT01625988|460440811|FG001|Overall Study|Randomized Inappropriately|0|||
127951215|NCT01625988|460440810|FG000|Overall Study|Protocol Violation|0|||
127951216|NCT01625988|460440811|FG001|Overall Study|Protocol Violation|2|||
127951217|NCT01644617|460440812|FG000|Overall Study|Withdrawal by Subject|3|||
127951218|NCT01644617|460440813|FG001|Overall Study|Withdrawal by Subject|4|||
127951219|NCT01644617|460440814|FG002|Overall Study|Withdrawal by Subject|1|||
127951220|NCT01644617|460440812|FG000|Overall Study|Lost to Follow-up|0|||
127951221|NCT01644617|460440813|FG001|Overall Study|Lost to Follow-up|1|||
127951222|NCT01644617|460440814|FG002|Overall Study|Lost to Follow-up|0|||
127951223|NCT01644617|460440812|FG000|Overall Study|Adverse Event|3|||
127951224|NCT01644617|460440813|FG001|Overall Study|Adverse Event|0|||
127951225|NCT01644617|460440814|FG002|Overall Study|Adverse Event|6|||
127951226|NCT02075515|460440815|FG000|Overall Study|Serious Adverse Event|1|||
127951227|NCT02075515|460440816|FG001|Overall Study|Serious Adverse Event|1|||
127951228|NCT02075515|460440817|FG002|Overall Study|Serious Adverse Event|1|||
127951229|NCT02075515|460440815|FG000|Overall Study|Non-Serious Adverse Event|0|||
127951230|NCT02075515|460440816|FG001|Overall Study|Non-Serious Adverse Event|1|||
127951231|NCT02075515|460440817|FG002|Overall Study|Non-Serious Adverse Event|0|||
127951232|NCT02075515|460440815|FG000|Overall Study|Withdrawal by Subject|2|||
127951233|NCT02075515|460440816|FG001|Overall Study|Withdrawal by Subject|0|||
127951234|NCT02075515|460440817|FG002|Overall Study|Withdrawal by Subject|1|||
127951235|NCT02075515|460440815|FG000|Overall Study|Lost to Follow-up|1|||
127951236|NCT02075515|460440816|FG001|Overall Study|Lost to Follow-up|3|||
127951237|NCT02075515|460440817|FG002|Overall Study|Lost to Follow-up|6|||
127951238|NCT00378573|460440820|FG000|Treatment Period|Adverse Event|9|||
127951239|NCT00378573|460440820|FG000|Treatment Period|Physician Decision|1|||
127951240|NCT00378573|460440820|FG000|Treatment Period|Withdrawal by Subject|2|||
127951241|NCT00378573|460440820|FG000|Treatment Period|Disease Progression|4|||
127951242|NCT00378573|460440820|FG000|Treatment Period|Sponsor decision to close study|1|||
127951243|NCT00378573|460440820|FG000|Follow-up|Death|12|||
127951244|NCT00378573|460440820|FG000|Follow-up|Lost to Follow-up|1|||
127951245|NCT00378573|460440820|FG000|Follow-up|Withdrawal by Subject|1|||
127951246|NCT01372748|460440824|FG000|Overall Study|Lost to Follow-up|16|||
127951247|NCT01372748|460440825|FG001|Overall Study|Lost to Follow-up|34|||
127951248|NCT01372748|460440824|FG000|Overall Study|Withdrawal by Subject|7|||
127951249|NCT01372748|460440825|FG001|Overall Study|Withdrawal by Subject|5|||
127951250|NCT03993379|460440826|FG000|Overall Study|The study was terminated early due to business decision.|0|||
127951251|NCT03993379|460440827|FG001|Overall Study|The study was terminated early due to business decision.|2|||
127951252|NCT03993379|460440828|FG002|Overall Study|The study was terminated early due to business decision.|0|||
127951253|NCT03993379|460440829|FG003|Overall Study|The study was terminated early due to business decision.|0|||
127951254|NCT03993379|460440826|FG000|Overall Study|Withdrawal by Subject|0|||
127951255|NCT03993379|460440827|FG001|Overall Study|Withdrawal by Subject|1|||
127951256|NCT03993379|460440828|FG002|Overall Study|Withdrawal by Subject|0|||
127951257|NCT03993379|460440829|FG003|Overall Study|Withdrawal by Subject|0|||
127951258|NCT01427608|460440830|FG000|Overall Study|Death|1|||
127951259|NCT01427608|460440831|FG001|Overall Study|Death|0|||
127951260|NCT01427608|460440830|FG000|Overall Study|Withdrawal by Subject|7|||
127951261|NCT01427608|460440831|FG001|Overall Study|Withdrawal by Subject|3|||
127951262|NCT01427608|460440830|FG000|Overall Study|Relapsed-all cause|13|||
127951263|NCT01427608|460440831|FG001|Overall Study|Relapsed-all cause|34|||
127951264|NCT01427608|460440830|FG000|Overall Study|Events not attributed to study meds|0|||
127951265|NCT01427608|460440831|FG001|Overall Study|Events not attributed to study meds|1|||
127951266|NCT01807065|460440832|FG000|Overall Study|Receive no sip-T due to IV access|1|||
127951267|NCT01807065|460440833|FG001|Overall Study|Receive no sip-T due to IV access|1|||
127951268|NCT05246670|460440838|FG000|Overall Study|Withdrawal by Subject|2|||
127951269|NCT05246670|460440839|FG001|Overall Study|Withdrawal by Subject|3|||
127951270|NCT05246670|460440840|FG002|Overall Study|Withdrawal by Subject|0|||
127951271|NCT05246670|460440841|FG003|Overall Study|Withdrawal by Subject|1|||
127951272|NCT05246670|460440838|FG000|Overall Study|Adverse Event|0|||
127951273|NCT05246670|460440839|FG001|Overall Study|Adverse Event|0|||
127951274|NCT05246670|460440840|FG002|Overall Study|Adverse Event|1|||
127951275|NCT05246670|460440841|FG003|Overall Study|Adverse Event|0|||
127951276|NCT05246670|460440838|FG000|Overall Study|Physician Decision|1|||
127951277|NCT05246670|460440839|FG001|Overall Study|Physician Decision|0|||
127951278|NCT05246670|460440840|FG002|Overall Study|Physician Decision|0|||
127951279|NCT05246670|460440841|FG003|Overall Study|Physician Decision|0|||
127951280|NCT05246670|460440838|FG000|Overall Study|Protocol Violation|1|||
127951281|NCT05246670|460440839|FG001|Overall Study|Protocol Violation|0|||
127485458|NCT01240863|458741181|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
127951282|NCT05246670|460440840|FG002|Overall Study|Protocol Violation|0|||
127951283|NCT05246670|460440841|FG003|Overall Study|Protocol Violation|0|||
127951284|NCT00799058|460440847|FG000|Overall Study|Withdrawal by Subject|2|||
127951285|NCT00799058|460440848|FG001|Overall Study|Withdrawal by Subject|2|||
127951286|NCT00799058|460440849|FG002|Overall Study|Withdrawal by Subject|2|||
127951287|NCT00799058|460440847|FG000|Overall Study|Lost to Follow-up|1|||
127951288|NCT00799058|460440848|FG001|Overall Study|Lost to Follow-up|2|||
127951289|NCT00799058|460440849|FG002|Overall Study|Lost to Follow-up|1|||
127951290|NCT00799058|460440847|FG000|Overall Study|Adverse Event|0|||
127951291|NCT00799058|460440848|FG001|Overall Study|Adverse Event|2|||
127951292|NCT00799058|460440849|FG002|Overall Study|Adverse Event|0|||
127951293|NCT00799058|460440847|FG000|Overall Study|Pregnancy|1|||
127951294|NCT00799058|460440848|FG001|Overall Study|Pregnancy|0|||
127951295|NCT00799058|460440849|FG002|Overall Study|Pregnancy|0|||
127951296|NCT00799058|460440847|FG000|Overall Study|Not adherent|3|||
127951297|NCT00799058|460440848|FG001|Overall Study|Not adherent|2|||
127951298|NCT00799058|460440849|FG002|Overall Study|Not adherent|1|||
127951299|NCT00799058|460440847|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
127951300|NCT00799058|460440848|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
127951301|NCT00799058|460440849|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
127951302|NCT00799058|460440847|FG000|Overall Study|IP dispensing error|1|||
127951303|NCT00799058|460440848|FG001|Overall Study|IP dispensing error|0|||
127951304|NCT00799058|460440849|FG002|Overall Study|IP dispensing error|0|||
127951305|NCT00799058|460440847|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
127951306|NCT00799058|460440848|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
127951307|NCT00799058|460440849|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
127951308|NCT00799058|460440847|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
127951309|NCT00799058|460440848|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
127951310|NCT00799058|460440849|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
127951311|NCT00799058|460440847|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
127951312|NCT00799058|460440848|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
127951313|NCT00799058|460440849|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
127951314|NCT00799058|460440847|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
127951315|NCT00799058|460440848|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
127951316|NCT00799058|460440849|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
127951317|NCT03639779|460440850|FG000|Overall Study|Lost to Follow-up|1|||
127951318|NCT02088697|460440851|FG000|Period I|Physician Decision|1|||
127951319|NCT02088697|460440852|FG001|Period I|Physician Decision|4|||
127951320|NCT02088697|460440851|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
127951321|NCT02088697|460440852|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
127951322|NCT00810511|460440853|FG000|Overall Study|Protocol Violation|0|||
127951323|NCT00810511|460440854|FG001|Overall Study|Protocol Violation|1|||
127951324|NCT00810511|460440853|FG000|Overall Study|Lack of Efficacy|9|||
127951325|NCT00810511|460440854|FG001|Overall Study|Lack of Efficacy|1|||
127951326|NCT00810511|460440853|FG000|Overall Study|death in the family|0|||
127951327|NCT00810511|460440854|FG001|Overall Study|death in the family|1|||
127951328|NCT00810511|460440853|FG000|Overall Study|Lost to Follow-up|1|||
127951329|NCT00810511|460440854|FG001|Overall Study|Lost to Follow-up|0|||
127951330|NCT00810511|460440853|FG000|Overall Study|deposits on contact lens|0|||
127951331|NCT00810511|460440854|FG001|Overall Study|deposits on contact lens|1|||
127951332|NCT00462904|460440855|FG000|Overall Study|Lost to Follow-up|1|||
127951333|NCT00911300|460440859|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
127951334|NCT00911300|460440860|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
127951335|NCT00911300|460440859|FG000|Overall Study|Death|1|||
127951336|NCT00911300|460440860|FG001|Overall Study|Death|0|||
127951337|NCT00911300|460440859|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
127951338|NCT00911300|460440860|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
127951339|NCT00911300|460440859|FG000|Overall Study|Adverse Event|14|||
127951340|NCT00911300|460440860|FG001|Overall Study|Adverse Event|6|||
127951341|NCT00911300|460440859|FG000|Overall Study|Protocol Violation|3|||
127951342|NCT00911300|460440860|FG001|Overall Study|Protocol Violation|2|||
127485459|NCT01240863|458741182|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
127951343|NCT00911300|460440859|FG000|Overall Study|Consent Withdrawn|4|||
127951344|NCT00911300|460440860|FG001|Overall Study|Consent Withdrawn|12|||
127951345|NCT00911300|460440859|FG000|Overall Study|Coronary Angiography Performed|1|||
127951346|NCT00911300|460440860|FG001|Overall Study|Coronary Angiography Performed|0|||
127951347|NCT00911300|460440859|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
127951348|NCT00911300|460440860|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
127951349|NCT00911300|460440859|FG000|Overall Study|Received Commercial Treatment|1|||
127951350|NCT00911300|460440860|FG001|Overall Study|Received Commercial Treatment|0|||
127951351|NCT00911300|460440859|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
127951352|NCT00911300|460440860|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
127951353|NCT00911300|460440859|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
127951354|NCT00911300|460440860|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
127951355|NCT00911300|460440859|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
127951356|NCT00911300|460440860|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
127951357|NCT00911300|460440859|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
127951358|NCT00911300|460440860|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
127951359|NCT00911300|460440859|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
127951360|NCT00911300|460440860|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
127951361|NCT00911300|460440859|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
127951362|NCT00911300|460440860|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
127951363|NCT00911300|460440859|FG000|Overall Study|International Normalized Ratio Too High|0|||
127951364|NCT00911300|460440860|FG001|Overall Study|International Normalized Ratio Too High|1|||
127951365|NCT00911300|460440859|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
127951366|NCT00911300|460440860|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
127951367|NCT00911300|460440859|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
127951368|NCT00911300|460440860|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
127951369|NCT00911300|460440859|FG000|Overall Study|Physician Decision|0|||
127951370|NCT00911300|460440860|FG001|Overall Study|Physician Decision|1|||
127951371|NCT00911300|460440859|FG000|Overall Study|Treatment Stopped by Mistake|0|||
127951372|NCT00911300|460440860|FG001|Overall Study|Treatment Stopped by Mistake|1|||
127951373|NCT00911300|460440859|FG000|Overall Study|Randomized; No Study Medication Received|0|||
127951374|NCT00911300|460440860|FG001|Overall Study|Randomized; No Study Medication Received|2|||
127951375|NCT04152291|460440861|FG000|Overall Study|Covid-19 restrictions|27|||
127951376|NCT04152291|460440861|FG000|Overall Study|Withdrawal by Subject|3|||
127951377|NCT05124691|460440862|FG000|Phase II|Eligibility criteria|0|||
127951378|NCT05124691|460440863|FG001|Phase II|Eligibility criteria|1|||
127951379|NCT05124691|460440864|FG002|Phase II|Eligibility criteria|0|||
127951380|NCT05124691|460440862|FG000|Phase II|Withdrawal by Subject|6|||
127951381|NCT05124691|460440863|FG001|Phase II|Withdrawal by Subject|2|||
127951382|NCT05124691|460440864|FG002|Phase II|Withdrawal by Subject|3|||
127951383|NCT05124691|460440862|FG000|Phase III|Withdrawal by Subject|6|||
127951384|NCT05124691|460440863|FG001|Phase III|Withdrawal by Subject|4|||
127951385|NCT05124691|460440864|FG002|Phase III|Withdrawal by Subject|4|||
127951386|NCT05124691|460440862|FG000|Phase III|Lost to Follow-up|1|||
127951387|NCT05124691|460440863|FG001|Phase III|Lost to Follow-up|0|||
127951388|NCT05124691|460440864|FG002|Phase III|Lost to Follow-up|0|||
127951389|NCT01128543|460440877|FG000|Overall Study|Withdrawal by Subject|3|||
127951390|NCT01128543|460440877|FG000|Overall Study|Protocol Violation|1|||
127485460|NCT01240863|458741183|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
127951391|NCT04487067|460440881|FG000|Overall Study|Adverse Event|3|||
127951392|NCT04487067|460440881|FG000|Overall Study|Death Other Than Progressive Disease|60|||
127951393|NCT04487067|460440881|FG000|Overall Study|Death Due To Progressive Disease|40|||
127951394|NCT04487067|460440881|FG000|Overall Study|Lost to Follow-up|3|||
127951395|NCT04487067|460440881|FG000|Overall Study|Progressive Disease|1|||
127951396|NCT04487067|460440881|FG000|Overall Study|Protocol Violation|3|||
127951397|NCT04487067|460440881|FG000|Overall Study|Participant Discontinued From Study as per Protocol|6|||
127951398|NCT04487067|460440881|FG000|Overall Study|Withdrawal by Subject|15|||
127951399|NCT02211417|460440882|FG000|Overall Study|Withdrawal by Subject|11|||
127951400|NCT02211417|460440883|FG001|Overall Study|Withdrawal by Subject|8|||
127951401|NCT02211417|460440882|FG000|Overall Study|Protocol Violation|1|||
127951402|NCT02211417|460440883|FG001|Overall Study|Protocol Violation|0|||
127951403|NCT02211417|460440882|FG000|Overall Study|Pregnancy|0|||
127951404|NCT02211417|460440883|FG001|Overall Study|Pregnancy|1|||
127951405|NCT02211417|460440882|FG000|Overall Study|Lost to Follow-up|2|||
127951406|NCT02211417|460440883|FG001|Overall Study|Lost to Follow-up|3|||
127951407|NCT02211417|460440882|FG000|Overall Study|Adverse Event|1|||
127951408|NCT02211417|460440883|FG001|Overall Study|Adverse Event|4|||
127951409|NCT01755091|460440884|FG000|Overall Study|Withdrawal by Subject|6|||
127951410|NCT01755091|460440885|FG001|Overall Study|Withdrawal by Subject|1|||
127951411|NCT01755091|460440886|FG002|Overall Study|Withdrawal by Subject|3|||
127951412|NCT01755091|460440884|FG000|Overall Study|Adverse Event|1|||
127951413|NCT01755091|460440885|FG001|Overall Study|Adverse Event|1|||
127951414|NCT01755091|460440886|FG002|Overall Study|Adverse Event|1|||
127951415|NCT01755091|460440884|FG000|Overall Study|Lost to Follow-up|1|||
127951416|NCT01755091|460440885|FG001|Overall Study|Lost to Follow-up|0|||
127951417|NCT01755091|460440886|FG002|Overall Study|Lost to Follow-up|1|||
127951418|NCT01755091|460440884|FG000|Overall Study|Physician Decision|1|||
127951419|NCT01755091|460440885|FG001|Overall Study|Physician Decision|1|||
127951420|NCT01755091|460440886|FG002|Overall Study|Physician Decision|2|||
127951421|NCT00490841|460440887|FG000|Overall Study|Death|5|||
127951422|NCT00490841|460440887|FG000|Overall Study|Withdrawal by Subject|4|||
127951423|NCT00490841|460440887|FG000|Overall Study|Lost to Follow-up|1|||
127951424|NCT00490841|460440887|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
127951425|NCT06385483|460440890|FG000|Overall Study|Withdrawal by Subject|2|||
127951426|NCT06385483|460440890|FG000|Overall Study|Never start protocol therapy|2|||
127951427|NCT06385483|460440890|FG000|Overall Study|Disease progression|15|||
127951428|NCT00447993|460440891|FG000|Overall Study|Lost to Follow-up|0|||
127951429|NCT00447993|460440892|FG001|Overall Study|Lost to Follow-up|0|||
127951430|NCT00447993|460440893|FG002|Overall Study|Lost to Follow-up|2|||
127951431|NCT00447993|460440894|FG003|Overall Study|Lost to Follow-up|2|||
127951432|NCT00447993|460440891|FG000|Overall Study|Withdrawal by Subject|0|||
127951433|NCT00447993|460440892|FG001|Overall Study|Withdrawal by Subject|0|||
127951434|NCT00447993|460440893|FG002|Overall Study|Withdrawal by Subject|2|||
127951435|NCT00447993|460440894|FG003|Overall Study|Withdrawal by Subject|2|||
127951436|NCT02503787|460440895|FG000|Enrollment|Withdrawal by Subject|6|||
127951437|NCT02503787|460440895|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
127951438|NCT02503787|460440895|FG000|Enrollment|Physician Decision|2|||
127951439|NCT02503787|460440895|FG000|Enrollment|Insurance issue|2|||
127951440|NCT02503787|460440895|FG000|Enrollment|Lost to Follow-up|1|||
127951441|NCT02503787|460440895|FG000|Enrollment|Study closure|1|||
127951442|NCT02503787|460440895|FG000|Enrollment|Adverse Event|1|||
127951443|NCT02503787|460440895|FG000|Enrollment|Protocol Violation|1|||
127951444|NCT02503787|460440895|FG000|Enrollment|Inability to implant system|1|||
127951445|NCT02503787|460440895|FG000|Enrollment|Unable to be programmed|1|||
127951446|NCT02503787|460440895|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
127951447|NCT02503787|460440895|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
127951448|NCT02503787|460440895|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
127951449|NCT02503787|460440895|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
127951450|NCT02503787|460440895|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
127951451|NCT02503787|460440895|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
127951452|NCT04787627|460440896|FG000|Overall Study|Withdrawal by Subject|3|||
127951453|NCT04787627|460440897|FG001|Overall Study|Withdrawal by Subject|0|||
127951454|NCT04787627|460440896|FG000|Overall Study|Physician Decision|2|||
127951455|NCT04787627|460440897|FG001|Overall Study|Physician Decision|0|||
127951456|NCT04787627|460440896|FG000|Overall Study|Excluded|0|||
127951457|NCT04787627|460440897|FG001|Overall Study|Excluded|1|||
127951458|NCT00174954|460440898|FG000|Overall Study|Adverse Event|2|||
127951459|NCT00174954|460440898|FG000|Overall Study|No tophi found in MRI|1|||
127951460|NCT00174954|460440898|FG000|Overall Study|Physician Decision|1|||
127951461|NCT00839254|460440899|FG000|Overall Study|Protocol Violation|0|||
127951462|NCT00839254|460440900|FG001|Overall Study|Protocol Violation|1|||
127951463|NCT00839254|460440901|FG002|Overall Study|Protocol Violation|1|||
127951464|NCT00839254|460440902|FG003|Overall Study|Protocol Violation|1|||
127951465|NCT00839254|460440903|FG004|Overall Study|Protocol Violation|0|||
127951466|NCT00839254|460440904|FG005|Overall Study|Protocol Violation|0|||
127951467|NCT00839254|460440905|FG006|Overall Study|Protocol Violation|1|||
127951468|NCT00839254|460440906|FG007|Overall Study|Protocol Violation|2|||
127951469|NCT00839254|460440899|FG000|Overall Study|Physician Decision|0|||
127951470|NCT00839254|460440900|FG001|Overall Study|Physician Decision|1|||
127951471|NCT00839254|460440901|FG002|Overall Study|Physician Decision|0|||
127951472|NCT00839254|460440902|FG003|Overall Study|Physician Decision|0|||
127951473|NCT00839254|460440903|FG004|Overall Study|Physician Decision|0|||
127951474|NCT00839254|460440904|FG005|Overall Study|Physician Decision|0|||
127951475|NCT00839254|460440905|FG006|Overall Study|Physician Decision|0|||
127951476|NCT00839254|460440906|FG007|Overall Study|Physician Decision|1|||
127951477|NCT00839254|460440899|FG000|Overall Study|Wrong treatment number allocation|0|||
127951478|NCT00839254|460440900|FG001|Overall Study|Wrong treatment number allocation|1|||
127951479|NCT00839254|460440901|FG002|Overall Study|Wrong treatment number allocation|0|||
127951480|NCT00839254|460440902|FG003|Overall Study|Wrong treatment number allocation|0|||
127951481|NCT00839254|460440903|FG004|Overall Study|Wrong treatment number allocation|0|||
127951482|NCT00839254|460440904|FG005|Overall Study|Wrong treatment number allocation|1|||
127951483|NCT00839254|460440905|FG006|Overall Study|Wrong treatment number allocation|0|||
127951484|NCT00839254|460440906|FG007|Overall Study|Wrong treatment number allocation|0|||
127951485|NCT00839254|460440899|FG000|Overall Study|Adverse Event|12|||
127951486|NCT00839254|460440900|FG001|Overall Study|Adverse Event|6|||
127951487|NCT00839254|460440901|FG002|Overall Study|Adverse Event|3|||
127951488|NCT00839254|460440902|FG003|Overall Study|Adverse Event|5|||
127951489|NCT00839254|460440903|FG004|Overall Study|Adverse Event|2|||
127951490|NCT00839254|460440904|FG005|Overall Study|Adverse Event|1|||
127951491|NCT00839254|460440905|FG006|Overall Study|Adverse Event|0|||
127951492|NCT00839254|460440906|FG007|Overall Study|Adverse Event|1|||
127951493|NCT00839254|460440899|FG000|Overall Study|Withdrawal by Subject|87|||
127951494|NCT00839254|460440900|FG001|Overall Study|Withdrawal by Subject|53|||
127951495|NCT00839254|460440901|FG002|Overall Study|Withdrawal by Subject|54|||
127951496|NCT00839254|460440902|FG003|Overall Study|Withdrawal by Subject|32|||
127951497|NCT00839254|460440903|FG004|Overall Study|Withdrawal by Subject|27|||
127951498|NCT00839254|460440904|FG005|Overall Study|Withdrawal by Subject|15|||
127951499|NCT00839254|460440905|FG006|Overall Study|Withdrawal by Subject|22|||
127951500|NCT00839254|460440906|FG007|Overall Study|Withdrawal by Subject|9|||
127951501|NCT00839254|460440899|FG000|Overall Study|Wrong group allocation|0|||
127951502|NCT00839254|460440900|FG001|Overall Study|Wrong group allocation|0|||
127951503|NCT00839254|460440901|FG002|Overall Study|Wrong group allocation|0|||
127951504|NCT00839254|460440902|FG003|Overall Study|Wrong group allocation|0|||
127951505|NCT00839254|460440903|FG004|Overall Study|Wrong group allocation|0|||
127951506|NCT00839254|460440904|FG005|Overall Study|Wrong group allocation|0|||
127951507|NCT00839254|460440905|FG006|Overall Study|Wrong group allocation|1|||
127951508|NCT00839254|460440906|FG007|Overall Study|Wrong group allocation|0|||
127951509|NCT00839254|460440899|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
127951510|NCT00839254|460440900|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
127951511|NCT00839254|460440901|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
127951512|NCT00839254|460440902|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
127951513|NCT00839254|460440903|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
127951514|NCT00839254|460440904|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
127951515|NCT00839254|460440905|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
127951516|NCT00839254|460440906|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
127951517|NCT00839254|460440899|FG000|Overall Study|Withdrawn due to non-compliance|2|||
127951518|NCT00839254|460440900|FG001|Overall Study|Withdrawn due to non-compliance|0|||
127951519|NCT00839254|460440901|FG002|Overall Study|Withdrawn due to non-compliance|0|||
127951520|NCT00839254|460440902|FG003|Overall Study|Withdrawn due to non-compliance|0|||
127951521|NCT00839254|460440903|FG004|Overall Study|Withdrawn due to non-compliance|0|||
127951522|NCT00839254|460440904|FG005|Overall Study|Withdrawn due to non-compliance|0|||
127951523|NCT00839254|460440905|FG006|Overall Study|Withdrawn due to non-compliance|0|||
127951524|NCT00839254|460440906|FG007|Overall Study|Withdrawn due to non-compliance|0|||
127951525|NCT00839254|460440899|FG000|Overall Study|Lost to Follow-up|51|||
127951526|NCT00839254|460440900|FG001|Overall Study|Lost to Follow-up|30|||
127951527|NCT00839254|460440901|FG002|Overall Study|Lost to Follow-up|32|||
127951528|NCT00839254|460440902|FG003|Overall Study|Lost to Follow-up|24|||
127951529|NCT00839254|460440903|FG004|Overall Study|Lost to Follow-up|8|||
127951530|NCT00839254|460440904|FG005|Overall Study|Lost to Follow-up|8|||
127951531|NCT00839254|460440905|FG006|Overall Study|Lost to Follow-up|4|||
127951532|NCT00839254|460440906|FG007|Overall Study|Lost to Follow-up|2|||
127951533|NCT01320150|460440908|FG000|Overall Study|Protocol Violation|15|||
127951534|NCT01320150|460440908|FG000|Overall Study|Withdrawal by Subject|5|||
127951535|NCT01320150|460440908|FG000|Overall Study|Death|2|||
127951536|NCT01320150|460440908|FG000|Overall Study|Lost to Follow-up|44|||
127951537|NCT00919854|460440909|FG000|Overall Study|Adverse Event|1|||
127951538|NCT02296931|460440918|FG000|Overall Study|Protocol Violation|0|||
127951539|NCT02296931|460440919|FG001|Overall Study|Protocol Violation|2|||
127951540|NCT01590277|460440922|FG000|Overall Study|Withdrawal by Subject|3|||
127951541|NCT01590277|460440922|FG000|Overall Study|Withdrawal by Subject|2|||
127951542|NCT01590277|460440922|FG000|Overall Study|Withdrawal by Subject|1|||
127951543|NCT01590277|460440922|FG000|Overall Study|Withdrawal by Subject|1|||
127951544|NCT00805961|460440925|FG000|Modality Therapy|Withdrawal by Subject|1|||
127951545|NCT00805961|460440925|FG000|Modality Therapy|Adverse Event|1|||
127951546|NCT00805961|460440925|FG000|Modality Therapy|Disease Progression|2|||
127951547|NCT00805961|460440925|FG000|Treatment-Free Interval|Adverse Event|3|||
127951548|NCT00805961|460440925|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
127951549|NCT00805961|460440925|FG000|Treatment-Free Interval|Physician Decision|1|||
127951550|NCT00805961|460440925|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
127951551|NCT00805961|460440925|FG000|Maintenance Treatment|Lack of Efficacy|13|||
127951552|NCT00805961|460440925|FG000|Maintenance Treatment|Intercurrent Illness|7|||
127951553|NCT00805961|460440925|FG000|Maintenance Treatment|Adverse Event|6|||
127951554|NCT00805961|460440925|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
127951555|NCT00805961|460440925|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
127951556|NCT00805961|460440925|FG000|Maintenance Treatment|Withdrawn Consent|1|||
127951557|NCT04380961|460440926|FG000|Overall Study|Lost to Follow-up|17|||
127951558|NCT04380961|460440927|FG001|Overall Study|Lost to Follow-up|11|||
127951559|NCT04380961|460440926|FG000|Overall Study|Withdrawal by Subject|3|||
127951560|NCT04380961|460440927|FG001|Overall Study|Withdrawal by Subject|0|||
127951561|NCT04380961|460440926|FG000|Overall Study|Death|22|||
127951562|NCT04380961|460440927|FG001|Overall Study|Death|16|||
127951563|NCT04380961|460440926|FG000|Overall Study|Other|1|||
127951564|NCT04380961|460440927|FG001|Overall Study|Other|0|||
127951565|NCT04380961|460440926|FG000|Overall Study|Randomized but Not Treated|1|||
127951566|NCT04380961|460440927|FG001|Overall Study|Randomized but Not Treated|2|||
127951567|NCT03736031|460440929|FG000|Overall Study|Death|2|||
127951568|NCT03736031|460440930|FG001|Overall Study|Death|4|||
127951569|NCT03736031|460440929|FG000|Overall Study|Lost to Follow-up|21|||
127951570|NCT03736031|460440930|FG001|Overall Study|Lost to Follow-up|2|||
127951571|NCT03736031|460440929|FG000|Overall Study|Withdrawal by Subject|9|||
127951572|NCT03736031|460440930|FG001|Overall Study|Withdrawal by Subject|0|||
127951573|NCT01954745|460440934|FG000|Overall Study|Radiological Progression|11|||
127951574|NCT01954745|460440934|FG000|Overall Study|Clinical Progression|5|||
127951575|NCT01954745|460440934|FG000|Overall Study|Adverse Event|2|||
127951576|NCT01954745|460440934|FG000|Overall Study|Death|1|||
127951577|NCT05938621|460442336|FG000|Overall Study|Lost to Follow-up|1|||
127951578|NCT05938621|460442337|FG001|Overall Study|Lost to Follow-up|5|||
127951579|NCT05938621|460442338|FG002|Overall Study|Lost to Follow-up|2|||
127951580|NCT05938621|460442339|FG003|Overall Study|Lost to Follow-up|2|||
127951581|NCT03598790|460442340|FG000|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
127951582|NCT03598790|460442341|FG001|Treatment Period (TP): Wk0-Wk144|Adverse Event|33|||
127951583|NCT03598790|460442342|FG002|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
127951584|NCT03598790|460442343|FG003|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
127951585|NCT03598790|460442344|FG004|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
127951586|NCT03598790|460442345|FG005|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
127951587|NCT03598790|460442346|FG006|Treatment Period (TP): Wk0-Wk144|Adverse Event|3|||
127951588|NCT03598790|460442347|FG007|Treatment Period (TP): Wk0-Wk144|Adverse Event|1|||
127951589|NCT03598790|460442348|FG008|Treatment Period (TP): Wk0-Wk144|Adverse Event|2|||
127951590|NCT03598790|460442340|FG000|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|4|||
127951591|NCT03598790|460442341|FG001|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|7|||
127951592|NCT03598790|460442342|FG002|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|5|||
127951593|NCT03598790|460442343|FG003|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
127951594|NCT03598790|460442344|FG004|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
127951595|NCT03598790|460442345|FG005|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
127951596|NCT03598790|460442346|FG006|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|2|||
127951597|NCT03598790|460442347|FG007|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
127951598|NCT03598790|460442348|FG008|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
127951599|NCT03598790|460442340|FG000|Treatment Period (TP): Wk0-Wk144|Protocol Violation|1|||
127951600|NCT03598790|460442341|FG001|Treatment Period (TP): Wk0-Wk144|Protocol Violation|2|||
127951601|NCT03598790|460442342|FG002|Treatment Period (TP): Wk0-Wk144|Protocol Violation|4|||
127951602|NCT03598790|460442343|FG003|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
127951603|NCT03598790|460442344|FG004|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
127951604|NCT03598790|460442345|FG005|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
127951605|NCT03598790|460442346|FG006|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
127951606|NCT03598790|460442347|FG007|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
127951607|NCT03598790|460442348|FG008|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
127951608|NCT03598790|460442340|FG000|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|7|||
127951609|NCT03598790|460442341|FG001|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|11|||
127951610|NCT03598790|460442342|FG002|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|14|||
127951611|NCT03598790|460442343|FG003|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
127951612|NCT03598790|460442344|FG004|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
127951613|NCT03598790|460442345|FG005|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
127951614|NCT03598790|460442346|FG006|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
127951615|NCT03598790|460442347|FG007|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
127951616|NCT03598790|460442348|FG008|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
127951617|NCT03598790|460442340|FG000|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|14|||
127951618|NCT03598790|460442341|FG001|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|26|||
127951619|NCT03598790|460442342|FG002|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|17|||
127951620|NCT03598790|460442343|FG003|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
127951621|NCT03598790|460442344|FG004|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
127951622|NCT03598790|460442345|FG005|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
127951623|NCT03598790|460442346|FG006|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|1|||
127951624|NCT03598790|460442347|FG007|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
127951625|NCT03598790|460442348|FG008|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
127951626|NCT03598790|460442340|FG000|Treatment Period (TP): Wk0-Wk144|Pregnancy|1|||
127951627|NCT03598790|460442341|FG001|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
127951628|NCT03598790|460442342|FG002|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
127951629|NCT03598790|460442343|FG003|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
127951630|NCT03598790|460442344|FG004|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
127951631|NCT03598790|460442345|FG005|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
127951632|NCT03598790|460442346|FG006|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
127951633|NCT03598790|460442347|FG007|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
127951634|NCT03598790|460442348|FG008|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
127951635|NCT03598790|460442340|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
127951636|NCT03598790|460442341|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
127951637|NCT03598790|460442342|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
127951638|NCT03598790|460442343|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
127951639|NCT03598790|460442344|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
127951640|NCT03598790|460442345|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
127951641|NCT03598790|460442346|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
127951642|NCT03598790|460442347|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
127951643|NCT03598790|460442348|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
127951644|NCT03598790|460442340|FG000|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
127951645|NCT03598790|460442341|FG001|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
127951646|NCT03598790|460442342|FG002|Treatment Period (TP): Wk0-Wk144|Physician Decision|1|||
127951647|NCT03598790|460442343|FG003|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
127951648|NCT03598790|460442344|FG004|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
127951649|NCT03598790|460442345|FG005|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
127951650|NCT03598790|460442346|FG006|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
127951651|NCT03598790|460442347|FG007|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
127951652|NCT03598790|460442348|FG008|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
127951653|NCT03598790|460442340|FG000|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|1|||
127951654|NCT03598790|460442341|FG001|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
127951655|NCT03598790|460442342|FG002|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
127951656|NCT03598790|460442343|FG003|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
127951657|NCT03598790|460442344|FG004|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
127951658|NCT03598790|460442345|FG005|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
127951659|NCT03598790|460442346|FG006|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
127951660|NCT03598790|460442347|FG007|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
127951661|NCT03598790|460442348|FG008|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
127951662|NCT03598790|460442340|FG000|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|1|||
127951663|NCT03598790|460442341|FG001|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
127951664|NCT03598790|460442342|FG002|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
127951665|NCT03598790|460442343|FG003|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
127951666|NCT03598790|460442344|FG004|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
127951667|NCT03598790|460442345|FG005|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
127951668|NCT03598790|460442346|FG006|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
127951669|NCT03598790|460442347|FG007|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
127951670|NCT03598790|460442348|FG008|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
127951671|NCT03598790|460442340|FG000|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|1|||
127951672|NCT03598790|460442341|FG001|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
127951673|NCT03598790|460442342|FG002|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
127951674|NCT03598790|460442343|FG003|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
127951675|NCT03598790|460442344|FG004|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
127951676|NCT03598790|460442345|FG005|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
127951677|NCT03598790|460442346|FG006|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
127951678|NCT03598790|460442347|FG007|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
127951679|NCT03598790|460442348|FG008|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
127951680|NCT03598790|460442340|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
127951681|NCT03598790|460442341|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|2|||
127951682|NCT03598790|460442342|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
127951683|NCT03598790|460442343|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
127951684|NCT03598790|460442344|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
127951685|NCT03598790|460442345|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
127951686|NCT03598790|460442346|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
127951687|NCT03598790|460442347|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
127951688|NCT03598790|460442348|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
127951689|NCT03598790|460442340|FG000|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|1|||
127951690|NCT03598790|460442341|FG001|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|2|||
127951691|NCT03598790|460442342|FG002|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
127951692|NCT03598790|460442343|FG003|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
127951693|NCT03598790|460442344|FG004|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
127951694|NCT03598790|460442345|FG005|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
127951695|NCT03598790|460442346|FG006|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
127951696|NCT03598790|460442347|FG007|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
127951697|NCT03598790|460442348|FG008|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
127951698|NCT03598790|460442340|FG000|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
127951699|NCT03598790|460442341|FG001|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|1|||
127951700|NCT03598790|460442342|FG002|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
127951701|NCT03598790|460442343|FG003|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
127951702|NCT03598790|460442344|FG004|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
127951703|NCT03598790|460442345|FG005|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
127951704|NCT03598790|460442346|FG006|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
127951705|NCT03598790|460442347|FG007|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
127951706|NCT03598790|460442348|FG008|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
127951707|NCT03598790|460442340|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
127951708|NCT03598790|460442341|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance|1|||
127951709|NCT03598790|460442342|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
127951710|NCT03598790|460442343|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
127951711|NCT03598790|460442344|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
127951712|NCT03598790|460442345|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
127951713|NCT03598790|460442346|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
127951714|NCT03598790|460442347|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
127951715|NCT03598790|460442348|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
127951716|NCT03598790|460442340|FG000|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
127951717|NCT03598790|460442341|FG001|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
127951718|NCT03598790|460442342|FG002|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|1|||
127951719|NCT03598790|460442343|FG003|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
127951720|NCT03598790|460442344|FG004|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
127951721|NCT03598790|460442345|FG005|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
127951722|NCT03598790|460442346|FG006|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
127951723|NCT03598790|460442347|FG007|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
127951724|NCT03598790|460442348|FG008|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
127951725|NCT03598790|460442340|FG000|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
127951726|NCT03598790|460442341|FG001|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
127951727|NCT03598790|460442342|FG002|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|1|||
127951728|NCT03598790|460442343|FG003|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
127951729|NCT03598790|460442344|FG004|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
127951730|NCT03598790|460442345|FG005|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
127951731|NCT03598790|460442346|FG006|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
127951732|NCT03598790|460442347|FG007|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
127951733|NCT03598790|460442348|FG008|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
127951734|NCT03598790|460442340|FG000|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
127951735|NCT03598790|460442341|FG001|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
127951736|NCT03598790|460442342|FG002|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|1|||
127951737|NCT03598790|460442343|FG003|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
127951738|NCT03598790|460442344|FG004|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
127951739|NCT03598790|460442345|FG005|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
127951740|NCT03598790|460442346|FG006|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
127951741|NCT03598790|460442347|FG007|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
127951742|NCT03598790|460442348|FG008|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
127951743|NCT03598790|460442340|FG000|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
127951744|NCT03598790|460442341|FG001|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
127951745|NCT03598790|460442342|FG002|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
127951746|NCT03598790|460442343|FG003|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
127951747|NCT03598790|460442344|FG004|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
127951748|NCT03598790|460442345|FG005|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
127951749|NCT03598790|460442346|FG006|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|1|||
127951750|NCT03598790|460442347|FG007|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
127951751|NCT03598790|460442348|FG008|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
127951752|NCT03598790|460442340|FG000|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|3|||
127951753|NCT03598790|460442341|FG001|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|1|||
127951754|NCT03598790|460442342|FG002|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
127951755|NCT03598790|460442343|FG003|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
127951756|NCT03598790|460442344|FG004|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
127951757|NCT03598790|460442345|FG005|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
127951758|NCT03598790|460442346|FG006|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
127951759|NCT03598790|460442347|FG007|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
127951760|NCT03598790|460442348|FG008|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
127951761|NCT03598790|460442340|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
127951762|NCT03598790|460442341|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
127951763|NCT03598790|460442342|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|1|||
127951764|NCT03598790|460442343|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
127951765|NCT03598790|460442344|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
127951766|NCT03598790|460442345|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
127951767|NCT03598790|460442346|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
127951768|NCT03598790|460442347|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
127951769|NCT03598790|460442348|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
127951770|NCT03598790|460442340|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
127951771|NCT03598790|460442341|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
127951772|NCT03598790|460442342|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
127951773|NCT03598790|460442343|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
127951774|NCT03598790|460442344|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
127951775|NCT03598790|460442345|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
127951776|NCT03598790|460442346|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
127951777|NCT03598790|460442347|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
127951778|NCT03598790|460442348|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
127951779|NCT03598790|460442340|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
127951780|NCT03598790|460442341|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
127951781|NCT03598790|460442342|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
127951782|NCT03598790|460442343|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|2|||
127951783|NCT03598790|460442344|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
127951784|NCT03598790|460442345|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
127951785|NCT03598790|460442346|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
127951786|NCT03598790|460442347|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
127951787|NCT03598790|460442348|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
127951788|NCT03598790|460442340|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
127951789|NCT03598790|460442341|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
127951790|NCT03598790|460442342|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
127951791|NCT03598790|460442343|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|4|||
127951792|NCT03598790|460442344|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
127951793|NCT03598790|460442345|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
127951794|NCT03598790|460442346|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
127951795|NCT03598790|460442347|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
127951796|NCT03598790|460442348|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
127951797|NCT03598790|460442340|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
127951798|NCT03598790|460442341|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
127951799|NCT03598790|460442342|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
127951800|NCT03598790|460442343|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
127951801|NCT03598790|460442344|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
127951802|NCT03598790|460442345|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
127951803|NCT03598790|460442346|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
127951804|NCT03598790|460442347|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
127951805|NCT03598790|460442348|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
127951806|NCT03598790|460442340|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
127951807|NCT03598790|460442341|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
127951808|NCT03598790|460442342|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
127951809|NCT03598790|460442343|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|1|||
127951810|NCT03598790|460442344|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
127951811|NCT03598790|460442345|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
127951812|NCT03598790|460442346|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
127951813|NCT03598790|460442347|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
127951814|NCT03598790|460442348|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
127951815|NCT05292183|460442359|FG000|Overall Study|Adverse Event|1|||
127951816|NCT02260570|460442362|FG000|Overall Study|Withdrawal by Subject|2|||
127951817|NCT02260570|460442363|FG001|Overall Study|Withdrawal by Subject|1|||
127951818|NCT02260570|460442362|FG000|Overall Study|Physician Decision|1|||
127951819|NCT02260570|460442363|FG001|Overall Study|Physician Decision|1|||
127951820|NCT05026177|460442364|FG000|Overall Study|Adverse Event|33|||
127951821|NCT05026177|460442365|FG001|Overall Study|Adverse Event|33|||
127951822|NCT05026177|460442366|FG002|Overall Study|Adverse Event|17|||
127951823|NCT05026177|460442364|FG000|Overall Study|Lost to Follow-up|7|||
127951824|NCT05026177|460442365|FG001|Overall Study|Lost to Follow-up|6|||
127951825|NCT05026177|460442366|FG002|Overall Study|Lost to Follow-up|8|||
127951826|NCT05026177|460442364|FG000|Overall Study|Noncompliance with study drug|6|||
127951827|NCT05026177|460442365|FG001|Overall Study|Noncompliance with study drug|2|||
127951828|NCT05026177|460442366|FG002|Overall Study|Noncompliance with study drug|1|||
127951829|NCT05026177|460442364|FG000|Overall Study|Physician Decision|4|||
127951830|NCT05026177|460442365|FG001|Overall Study|Physician Decision|1|||
127951831|NCT05026177|460442366|FG002|Overall Study|Physician Decision|0|||
127951832|NCT05026177|460442364|FG000|Overall Study|Sponsor requests subject to be withdrawn|0|||
127951833|NCT05026177|460442365|FG001|Overall Study|Sponsor requests subject to be withdrawn|0|||
127951834|NCT05026177|460442366|FG002|Overall Study|Sponsor requests subject to be withdrawn|3|||
127951835|NCT05026177|460442364|FG000|Overall Study|Withdrawal by Subject|53|||
127951836|NCT05026177|460442365|FG001|Overall Study|Withdrawal by Subject|51|||
127951837|NCT05026177|460442366|FG002|Overall Study|Withdrawal by Subject|55|||
127951838|NCT05026177|460442364|FG000|Overall Study|Protocol Violation|0|||
127951839|NCT05026177|460442365|FG001|Overall Study|Protocol Violation|1|||
127951840|NCT05026177|460442366|FG002|Overall Study|Protocol Violation|0|||
127951841|NCT05026177|460442364|FG000|Overall Study|Study terminated by sponsor|70|||
127951842|NCT05026177|460442365|FG001|Overall Study|Study terminated by sponsor|74|||
127951843|NCT05026177|460442366|FG002|Overall Study|Study terminated by sponsor|67|||
127951844|NCT05026177|460442364|FG000|Overall Study|Unavailability/noncompliance of study partner|2|||
127951845|NCT05026177|460442365|FG001|Overall Study|Unavailability/noncompliance of study partner|1|||
127951846|NCT05026177|460442366|FG002|Overall Study|Unavailability/noncompliance of study partner|1|||
127951847|NCT05026177|460442364|FG000|Overall Study|Starting alternative treatment|0|||
127951848|NCT05026177|460442365|FG001|Overall Study|Starting alternative treatment|1|||
127951849|NCT05026177|460442366|FG002|Overall Study|Starting alternative treatment|1|||
127951850|NCT05026177|460442364|FG000|Overall Study|Noncompliance with study procedures|0|||
127951851|NCT05026177|460442365|FG001|Overall Study|Noncompliance with study procedures|1|||
127951852|NCT05026177|460442366|FG002|Overall Study|Noncompliance with study procedures|1|||
127951853|NCT05026177|460442364|FG000|Overall Study|Met stopping criteria|0|||
127951854|NCT05026177|460442365|FG001|Overall Study|Met stopping criteria|0|||
127951855|NCT05026177|460442366|FG002|Overall Study|Met stopping criteria|1|||
127951856|NCT05026177|460442364|FG000|Overall Study|Health issues preventing continuation|0|||
127951857|NCT05026177|460442365|FG001|Overall Study|Health issues preventing continuation|0|||
127951858|NCT05026177|460442366|FG002|Overall Study|Health issues preventing continuation|1|||
127951859|NCT05026177|460442364|FG000|Overall Study|Randomized in error, not treated|0|||
127951860|NCT05026177|460442365|FG001|Overall Study|Randomized in error, not treated|0|||
127951861|NCT05026177|460442366|FG002|Overall Study|Randomized in error, not treated|2|||
127951862|NCT04856917|460442367|FG000|Overall Study|Withdrawal by Subject|4|||
127951863|NCT04856917|460442368|FG001|Overall Study|Withdrawal by Subject|3|||
127951864|NCT04856917|460442369|FG002|Overall Study|Withdrawal by Subject|1|||
127951865|NCT04856917|460442367|FG000|Overall Study|Lost to Follow-up|3|||
127951866|NCT04856917|460442368|FG001|Overall Study|Lost to Follow-up|1|||
127951867|NCT04856917|460442369|FG002|Overall Study|Lost to Follow-up|1|||
127951868|NCT04856917|460442367|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
127951869|NCT04856917|460442368|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
127951870|NCT04856917|460442369|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
127951871|NCT04856917|460442367|FG000|Overall Study|Other|1|||
127951872|NCT04856917|460442368|FG001|Overall Study|Other|1|||
127951873|NCT04856917|460442369|FG002|Overall Study|Other|0|||
127951874|NCT01169337|460442370|FG000|Overall Study|Lack of Efficacy|5|||
127951875|NCT01169337|460442371|FG001|Overall Study|Lack of Efficacy|7|||
127951876|NCT01169337|460442372|FG002|Overall Study|Lack of Efficacy|0|||
127951877|NCT01169337|460442370|FG000|Overall Study|Adverse Event|12|||
127951878|NCT01169337|460442371|FG001|Overall Study|Adverse Event|18|||
127951879|NCT01169337|460442372|FG002|Overall Study|Adverse Event|0|||
127951880|NCT01169337|460442370|FG000|Overall Study|Death|2|||
127951881|NCT01169337|460442371|FG001|Overall Study|Death|0|||
127951882|NCT01169337|460442372|FG002|Overall Study|Death|0|||
127951883|NCT01169337|460442370|FG000|Overall Study|Withdrawal by Subject|11|||
127951884|NCT01169337|460442371|FG001|Overall Study|Withdrawal by Subject|11|||
127951885|NCT01169337|460442372|FG002|Overall Study|Withdrawal by Subject|6|||
127951886|NCT01169337|460442370|FG000|Overall Study|Noncompliance|2|||
127951887|NCT01169337|460442371|FG001|Overall Study|Noncompliance|0|||
127951888|NCT01169337|460442372|FG002|Overall Study|Noncompliance|0|||
127951889|NCT01169337|460442370|FG000|Overall Study|Other complicating disease|1|||
127951890|NCT01169337|460442371|FG001|Overall Study|Other complicating disease|1|||
127951891|NCT01169337|460442372|FG002|Overall Study|Other complicating disease|0|||
127951892|NCT01169337|460442370|FG000|Overall Study|Physician Decision|1|||
127951893|NCT01169337|460442371|FG001|Overall Study|Physician Decision|5|||
127951894|NCT01169337|460442372|FG002|Overall Study|Physician Decision|0|||
127951895|NCT01169337|460442370|FG000|Overall Study|Alternative therapy|0|||
127951896|NCT01169337|460442371|FG001|Overall Study|Alternative therapy|2|||
127951897|NCT01169337|460442372|FG002|Overall Study|Alternative therapy|0|||
127951898|NCT01169337|460442370|FG000|Overall Study|Changed hospital|0|||
127951899|NCT01169337|460442371|FG001|Overall Study|Changed hospital|1|||
127951900|NCT01169337|460442372|FG002|Overall Study|Changed hospital|0|||
127951901|NCT01169337|460442370|FG000|Overall Study|Never started treatment|0|||
127951902|NCT01169337|460442371|FG001|Overall Study|Never started treatment|2|||
127951903|NCT01169337|460442372|FG002|Overall Study|Never started treatment|0|||
127951904|NCT01169337|460442370|FG000|Overall Study|Reason not reported|1|||
127951905|NCT01169337|460442371|FG001|Overall Study|Reason not reported|0|||
127951906|NCT01169337|460442372|FG002|Overall Study|Reason not reported|0|||
127951907|NCT01169337|460442370|FG000|Overall Study|Continuing lenalidomide|9|||
127951908|NCT01169337|460442371|FG001|Overall Study|Continuing lenalidomide|43|||
127951909|NCT01169337|460442372|FG002|Overall Study|Continuing lenalidomide|0|||
127951910|NCT03560037|460442373|FG000|Overall Study|Protocol Violation|1|||
127951911|NCT03560037|460442374|FG001|Overall Study|Protocol Violation|0|||
127951912|NCT03560037|460442373|FG000|Overall Study|Physician Decision|0|||
127951913|NCT03560037|460442374|FG001|Overall Study|Physician Decision|1|||
127951914|NCT03816878|460442377|FG000|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|1|||
127951915|NCT03816878|460442378|FG001|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|0|||
127951916|NCT03816878|460442377|FG000|Overall Study|Volunteer taken off study due to incarceration|0|||
127951917|NCT03816878|460442378|FG001|Overall Study|Volunteer taken off study due to incarceration|1|||
127951918|NCT03355469|460442379|FG000|Overall Study|COVID-19|3|||
127951919|NCT03355469|460442380|FG001|Overall Study|COVID-19|2|||
127951920|NCT03355469|460442381|FG002|Overall Study|COVID-19|3|||
127951921|NCT03355469|460442382|FG003|Overall Study|COVID-19|3|||
127951922|NCT03355469|460442379|FG000|Overall Study|Lost to Follow-up|1|||
127951923|NCT03355469|460442380|FG001|Overall Study|Lost to Follow-up|0|||
127951924|NCT03355469|460442381|FG002|Overall Study|Lost to Follow-up|1|||
127951925|NCT03355469|460442382|FG003|Overall Study|Lost to Follow-up|0|||
127951926|NCT03355469|460442379|FG000|Overall Study|Withdrawal by Subject|2|||
127951927|NCT03355469|460442380|FG001|Overall Study|Withdrawal by Subject|1|||
127951928|NCT03355469|460442381|FG002|Overall Study|Withdrawal by Subject|0|||
127951929|NCT03355469|460442382|FG003|Overall Study|Withdrawal by Subject|3|||
127951930|NCT01708941|460442383|FG000|Overall Study|Adverse Event|4|||
127951931|NCT01708941|460442384|FG001|Overall Study|Adverse Event|6|||
127951932|NCT01708941|460442385|FG002|Overall Study|Adverse Event|1|||
127951933|NCT01708941|460442386|FG003|Overall Study|Adverse Event|0|||
127951934|NCT01708941|460442383|FG000|Overall Study|Death|1|||
127951935|NCT01708941|460442384|FG001|Overall Study|Death|1|||
127951936|NCT01708941|460442385|FG002|Overall Study|Death|2|||
127951937|NCT01708941|460442386|FG003|Overall Study|Death|14|||
127951938|NCT01708941|460442383|FG000|Overall Study|Withdrawal by Subject|1|||
127951939|NCT01708941|460442384|FG001|Overall Study|Withdrawal by Subject|0|||
127951940|NCT01708941|460442385|FG002|Overall Study|Withdrawal by Subject|3|||
127951941|NCT01708941|460442386|FG003|Overall Study|Withdrawal by Subject|4|||
127951942|NCT01708941|460442383|FG000|Overall Study|Disease progression|9|||
127951943|NCT01708941|460442384|FG001|Overall Study|Disease progression|10|||
127951944|NCT01708941|460442385|FG002|Overall Study|Disease progression|8|||
127951945|NCT01708941|460442386|FG003|Overall Study|Disease progression|0|||
127951946|NCT01708941|460442383|FG000|Overall Study|Alternative therapy|0|||
127951947|NCT01708941|460442384|FG001|Overall Study|Alternative therapy|0|||
127951948|NCT01708941|460442385|FG002|Overall Study|Alternative therapy|2|||
127951949|NCT01708941|460442386|FG003|Overall Study|Alternative therapy|0|||
127951950|NCT01708941|460442383|FG000|Overall Study|Ineligible and never started treatment|1|||
127951951|NCT01708941|460442384|FG001|Overall Study|Ineligible and never started treatment|0|||
127951952|NCT01708941|460442385|FG002|Overall Study|Ineligible and never started treatment|1|||
127951953|NCT01708941|460442386|FG003|Overall Study|Ineligible and never started treatment|0|||
127951954|NCT01708941|460442383|FG000|Overall Study|Never started treatment|2|||
127951955|NCT01708941|460442384|FG001|Overall Study|Never started treatment|1|||
127951956|NCT01708941|460442385|FG002|Overall Study|Never started treatment|0|||
127951957|NCT01708941|460442386|FG003|Overall Study|Never started treatment|0|||
127951958|NCT01708941|460442383|FG000|Overall Study|Ineligible|0|||
127951959|NCT01708941|460442384|FG001|Overall Study|Ineligible|0|||
127951960|NCT01708941|460442385|FG002|Overall Study|Ineligible|2|||
127951961|NCT01708941|460442386|FG003|Overall Study|Ineligible|0|||
127951962|NCT01575548|460442387|FG000|Overall Study|Adverse Event|15|||
127951963|NCT01575548|460442388|FG001|Overall Study|Adverse Event|2|||
127951964|NCT01575548|460442387|FG000|Overall Study|Disease progression|12|||
127951965|NCT01575548|460442388|FG001|Overall Study|Disease progression|25|||
127951966|NCT01575548|460442387|FG000|Overall Study|Death|1|||
127951967|NCT01575548|460442388|FG001|Overall Study|Death|0|||
127951968|NCT01575548|460442387|FG000|Overall Study|Other complicating disease|1|||
127951969|NCT01575548|460442388|FG001|Overall Study|Other complicating disease|0|||
127951970|NCT01575548|460442387|FG000|Overall Study|Withdrawal by Subject|7|||
127951971|NCT01575548|460442388|FG001|Overall Study|Withdrawal by Subject|3|||
127951972|NCT01575548|460442387|FG000|Overall Study|Noncompliance|1|||
127951973|NCT01575548|460442388|FG001|Overall Study|Noncompliance|0|||
127951974|NCT01575548|460442387|FG000|Overall Study|Anticipated surgery|0|||
127951975|NCT01575548|460442388|FG001|Overall Study|Anticipated surgery|1|||
127951976|NCT01575548|460442387|FG000|Overall Study|Never started protocol therapy|3|||
127951977|NCT01575548|460442388|FG001|Overall Study|Never started protocol therapy|2|||
127951978|NCT04175912|460442389|FG000|Overall Study|Disease progression- relapse during active treatment|17|||
127951979|NCT04175912|460442390|FG001|Overall Study|Disease progression- relapse during active treatment|13|||
127951980|NCT04175912|460442389|FG000|Overall Study|Adverse Event|0|||
127951981|NCT04175912|460442390|FG001|Overall Study|Adverse Event|3|||
127951982|NCT04175912|460442389|FG000|Overall Study|Never started treatment|3|||
127951983|NCT04175912|460442390|FG001|Overall Study|Never started treatment|3|||
127951984|NCT04175912|460442389|FG000|Overall Study|Death|0|||
127951985|NCT04175912|460442390|FG001|Overall Study|Death|1|||
127951986|NCT02048813|460442394|FG000|Overall Study|Still on treatment|279|||
127951987|NCT02048813|460442395|FG001|Overall Study|Still on treatment|0|||
127951988|NCT02048813|460442394|FG000|Overall Study|Adverse Event|40|||
127951989|NCT02048813|460442395|FG001|Overall Study|Adverse Event|38|||
127951990|NCT02048813|460442394|FG000|Overall Study|Disease progression|13|||
127951991|NCT02048813|460442395|FG001|Overall Study|Disease progression|3|||
127951992|NCT02048813|460442394|FG000|Overall Study|Withdrawal by Subject|7|||
127951993|NCT02048813|460442395|FG001|Overall Study|Withdrawal by Subject|8|||
127951994|NCT02048813|460442394|FG000|Overall Study|Death|2|||
127951995|NCT02048813|460442395|FG001|Overall Study|Death|1|||
127951996|NCT02048813|460442394|FG000|Overall Study|Complication|2|||
127951997|NCT02048813|460442395|FG001|Overall Study|Complication|2|||
127951998|NCT02048813|460442394|FG000|Overall Study|Non-protocol therapy|0|||
127951999|NCT02048813|460442395|FG001|Overall Study|Non-protocol therapy|1|||
127952000|NCT02048813|460442394|FG000|Overall Study|Second primary cancer|2|||
127952001|NCT02048813|460442395|FG001|Overall Study|Second primary cancer|0|||
127952002|NCT02048813|460442394|FG000|Overall Study|Insurance|2|||
127952003|NCT02048813|460442395|FG001|Overall Study|Insurance|0|||
127952004|NCT02048813|460442394|FG000|Overall Study|Wound infection/healing|2|||
127952005|NCT02048813|460442395|FG001|Overall Study|Wound infection/healing|0|||
127952006|NCT02048813|460442394|FG000|Overall Study|Missed appointment|3|||
127952007|NCT02048813|460442395|FG001|Overall Study|Missed appointment|0|||
127952008|NCT02048813|460442394|FG000|Overall Study|Never started treatment|2|||
127952009|NCT02048813|460442395|FG001|Overall Study|Never started treatment|17|||
127952010|NCT01708954|460442396|FG000|Step 1|Disease progression|26|||
127952011|NCT01708954|460442397|FG001|Step 1|Disease progression|17|||
127952012|NCT01708954|460442398|FG002|Step 1|Disease progression|14|||
127952013|NCT01708954|460442396|FG000|Step 1|Adverse Event|3|||
127952014|NCT01708954|460442397|FG001|Step 1|Adverse Event|11|||
127952015|NCT01708954|460442398|FG002|Step 1|Adverse Event|13|||
127952016|NCT01708954|460442396|FG000|Step 1|Death|3|||
127952017|NCT01708954|460442397|FG001|Step 1|Death|2|||
127952018|NCT01708954|460442398|FG002|Step 1|Death|3|||
127952019|NCT01708954|460442396|FG000|Step 1|Withdrawal by Subject|2|||
127952020|NCT01708954|460442397|FG001|Step 1|Withdrawal by Subject|5|||
127952021|NCT01708954|460442398|FG002|Step 1|Withdrawal by Subject|3|||
127952022|NCT01708954|460442396|FG000|Step 1|Other complicating disease|0|||
127952023|NCT01708954|460442397|FG001|Step 1|Other complicating disease|2|||
127952024|NCT01708954|460442398|FG002|Step 1|Other complicating disease|0|||
127952025|NCT01708954|460442396|FG000|Step 1|Crossed over to Step 2|2|||
127952026|NCT01708954|460442397|FG001|Step 1|Crossed over to Step 2|0|||
127952027|NCT01708954|460442398|FG002|Step 1|Crossed over to Step 2|0|||
127952028|NCT01708954|460442396|FG000|Step 1|Symptomatic deterioration|1|||
127952029|NCT01708954|460442397|FG001|Step 1|Symptomatic deterioration|0|||
127952030|NCT01708954|460442398|FG002|Step 1|Symptomatic deterioration|1|||
127952031|NCT01708954|460442396|FG000|Step 1|Off-treatment reason not submitted|1|||
127952032|NCT01708954|460442397|FG001|Step 1|Off-treatment reason not submitted|1|||
127952033|NCT01708954|460442398|FG002|Step 1|Off-treatment reason not submitted|1|||
127952034|NCT01708954|460442396|FG000|Step 1|Ineligible or never received treatment|4|||
127952035|NCT01708954|460442397|FG001|Step 1|Ineligible or never received treatment|2|||
127952036|NCT01708954|460442398|FG002|Step 1|Ineligible or never received treatment|8|||
127952037|NCT01708954|460442396|FG000|Step 2|Disease progression|9|||
127952038|NCT01708954|460442397|FG001|Step 2|Disease progression|4|||
127952039|NCT01708954|460442398|FG002|Step 2|Disease progression|0|||
127952040|NCT01708954|460442396|FG000|Step 2|Adverse Event|3|||
127952041|NCT01708954|460442397|FG001|Step 2|Adverse Event|2|||
127952042|NCT01708954|460442398|FG002|Step 2|Adverse Event|0|||
127952043|NCT01708954|460442396|FG000|Step 2|Withdrawal by Subject|1|||
127952044|NCT01708954|460442397|FG001|Step 2|Withdrawal by Subject|1|||
127952045|NCT01708954|460442398|FG002|Step 2|Withdrawal by Subject|0|||
127952046|NCT06400251|460442399|FG000|Overall Study|Never Start Protocol Therapy|1|||
127952047|NCT06400251|460442399|FG000|Overall Study|Ineligible|2|||
127952048|NCT06400251|460442399|FG000|Overall Study|Mutation Status Not Confirmed|3|||
127952049|NCT06400251|460442399|FG000|Overall Study|Disease Progression|25|||
127952050|NCT06400251|460442399|FG000|Overall Study|Adverse Event|1|||
127952051|NCT06400251|460442399|FG000|Overall Study|Complicating Disease|1|||
127952052|NCT06400251|460442399|FG000|Overall Study|Physician Decision|2|||
127952053|NCT03631199|460442400|FG000|Overall Study|Progressive disease|9|||
127952054|NCT03631199|460442401|FG001|Overall Study|Progressive disease|5|||
127952055|NCT03631199|460442402|FG002|Overall Study|Progressive disease|5|||
127952056|NCT03631199|460442403|FG003|Overall Study|Progressive disease|149|||
127952057|NCT03631199|460442404|FG004|Overall Study|Progressive disease|148|||
127952058|NCT03631199|460442400|FG000|Overall Study|Physician Decision|0|||
127952059|NCT03631199|460442401|FG001|Overall Study|Physician Decision|2|||
127952060|NCT03631199|460442402|FG002|Overall Study|Physician Decision|3|||
127952061|NCT03631199|460442403|FG003|Overall Study|Physician Decision|19|||
127952062|NCT03631199|460442404|FG004|Overall Study|Physician Decision|13|||
127952063|NCT03631199|460442400|FG000|Overall Study|Adverse Event|1|||
127952064|NCT03631199|460442401|FG001|Overall Study|Adverse Event|1|||
127952065|NCT03631199|460442402|FG002|Overall Study|Adverse Event|0|||
127952066|NCT03631199|460442403|FG003|Overall Study|Adverse Event|28|||
127952067|NCT03631199|460442404|FG004|Overall Study|Adverse Event|29|||
127952068|NCT03631199|460442400|FG000|Overall Study|Death|0|||
127952069|NCT03631199|460442401|FG001|Overall Study|Death|1|||
127952070|NCT03631199|460442402|FG002|Overall Study|Death|0|||
127952071|NCT03631199|460442403|FG003|Overall Study|Death|35|||
127952072|NCT03631199|460442404|FG004|Overall Study|Death|48|||
127952073|NCT03631199|460442400|FG000|Overall Study|Subject decision|0|||
127952074|NCT03631199|460442401|FG001|Overall Study|Subject decision|1|||
127952075|NCT03631199|460442402|FG002|Overall Study|Subject decision|0|||
127952076|NCT03631199|460442403|FG003|Overall Study|Subject decision|12|||
127952077|NCT03631199|460442404|FG004|Overall Study|Subject decision|12|||
127952078|NCT03631199|460442400|FG000|Overall Study|No treated|0|||
127952079|NCT03631199|460442401|FG001|Overall Study|No treated|0|||
127952080|NCT03631199|460442402|FG002|Overall Study|No treated|0|||
127952081|NCT03631199|460442403|FG003|Overall Study|No treated|0|||
127952082|NCT03631199|460442404|FG004|Overall Study|No treated|1|||
127952083|NCT03631199|460442400|FG000|Overall Study|Treatment ongoing|0|||
127952084|NCT03631199|460442401|FG001|Overall Study|Treatment ongoing|1|||
127952085|NCT03631199|460442402|FG002|Overall Study|Treatment ongoing|1|||
127952086|NCT03631199|460442403|FG003|Overall Study|Treatment ongoing|76|||
127952087|NCT03631199|460442404|FG004|Overall Study|Treatment ongoing|71|||
127952088|NCT03631199|460442400|FG000|Overall Study|Guardian decision|0|||
127952089|NCT03631199|460442401|FG001|Overall Study|Guardian decision|0|||
127952090|NCT03631199|460442402|FG002|Overall Study|Guardian decision|0|||
127952091|NCT03631199|460442403|FG003|Overall Study|Guardian decision|1|||
127952092|NCT03631199|460442404|FG004|Overall Study|Guardian decision|1|||
127952093|NCT06351371|460442407|FG000|Overall Study|Mutation Status Not Confirmed|9|||
127952094|NCT06351371|460442407|FG000|Overall Study|Ineligible|1|||
127952095|NCT06351371|460442407|FG000|Overall Study|Adverse Event|4|||
127952096|NCT06351371|460442407|FG000|Overall Study|Death|1|||
127952097|NCT06351371|460442407|FG000|Overall Study|Disease progression|14|||
127952098|NCT06351371|460442407|FG000|Overall Study|Withdrawal by Subject|3|||
127952099|NCT06351371|460442407|FG000|Overall Study|Physician Decision|3|||
127952100|NCT03651700|460442408|FG000|Overall Study|Withdrawal by Subject|1|||
127952101|NCT03651700|460442409|FG001|Overall Study|Withdrawal by Subject|0|||
127952102|NCT03698019|460442411|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
127952103|NCT03698019|460442412|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
127952104|NCT03698019|460442411|FG000|Step 1: Registration|Withdrawal by Subject|7|||
127952105|NCT03698019|460442412|FG001|Step 1: Registration|Withdrawal by Subject|2|||
127952106|NCT03698019|460442411|FG000|Step 1: Registration|Toxicity|0|||
127952107|NCT03698019|460442412|FG001|Step 1: Registration|Toxicity|1|||
127952108|NCT03698019|460442411|FG000|Step 1: Registration|Disease Progression|0|||
127952109|NCT03698019|460442412|FG001|Step 1: Registration|Disease Progression|12|||
127952110|NCT03698019|460442411|FG000|Step 1: Registration|Co-morbidities|0|||
127952111|NCT03698019|460442412|FG001|Step 1: Registration|Co-morbidities|1|||
127952112|NCT03698019|460442411|FG000|Step 1: Registration|Scheduling Issues|1|||
127952113|NCT03698019|460442412|FG001|Step 1: Registration|Scheduling Issues|0|||
127952114|NCT03698019|460442411|FG000|Step 1: Registration|Participant Refusal|0|||
127952115|NCT03698019|460442412|FG001|Step 1: Registration|Participant Refusal|1|||
127952116|NCT03698019|460442411|FG000|Step 2: Surgery|Participant Refusal|2|||
127952117|NCT03698019|460442412|FG001|Step 2: Surgery|Participant Refusal|1|||
127952118|NCT03698019|460442411|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
127952119|NCT03698019|460442412|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
127952120|NCT03698019|460442411|FG000|Step 2: Surgery|Metastatic Disease|16|||
127952121|NCT03698019|460442412|FG001|Step 2: Surgery|Metastatic Disease|9|||
127952122|NCT03698019|460442411|FG000|Step 2: Surgery|Residual Disease|2|||
127952123|NCT03698019|460442412|FG001|Step 2: Surgery|Residual Disease|1|||
127952124|NCT03698019|460442411|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
127952125|NCT03698019|460442412|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
127952126|NCT03698019|460442411|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
127952127|NCT03698019|460442412|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
127952128|NCT03698019|460442411|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
127952129|NCT03698019|460442412|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
127952130|NCT03698019|460442411|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
127952131|NCT03698019|460442412|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
127952132|NCT03698019|460442411|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
127952133|NCT03698019|460442412|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
127952134|NCT03698019|460442411|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
127952135|NCT03698019|460442412|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
127952136|NCT03698019|460442411|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
127952137|NCT03698019|460442412|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
127952138|NCT03698019|460442411|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
127952139|NCT03698019|460442412|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
127952140|NCT00588770|460442413|FG000|Overall Study|Disease progression|85|||
127952141|NCT00588770|460442414|FG001|Overall Study|Disease progression|68|||
127952142|NCT00588770|460442413|FG000|Overall Study|Adverse Event|29|||
127952143|NCT00588770|460442414|FG001|Overall Study|Adverse Event|58|||
127952144|NCT00588770|460442413|FG000|Overall Study|Death|13|||
127952145|NCT00588770|460442414|FG001|Overall Study|Death|22|||
127952146|NCT00588770|460442413|FG000|Overall Study|Withdrawal by Subject|15|||
127952147|NCT00588770|460442414|FG001|Overall Study|Withdrawal by Subject|25|||
127952148|NCT00588770|460442413|FG000|Overall Study|Alternative therapy|2|||
127952149|NCT00588770|460442414|FG001|Overall Study|Alternative therapy|4|||
127952150|NCT00588770|460442413|FG000|Overall Study|Other complicating disease|3|||
127952151|NCT00588770|460442414|FG001|Overall Study|Other complicating disease|2|||
127952152|NCT00588770|460442413|FG000|Overall Study|Not start protocol therapy|0|||
127952153|NCT00588770|460442414|FG001|Overall Study|Not start protocol therapy|9|||
127952154|NCT00588770|460442413|FG000|Overall Study|Lack of Efficacy|8|||
127952155|NCT00588770|460442414|FG001|Overall Study|Lack of Efficacy|10|||
127952156|NCT00588770|460442413|FG000|Overall Study|Physician discretion|2|||
127952157|NCT00588770|460442414|FG001|Overall Study|Physician discretion|0|||
127952158|NCT00588770|460442413|FG000|Overall Study|Patient non-compliance|2|||
127952159|NCT00588770|460442414|FG001|Overall Study|Patient non-compliance|2|||
127952160|NCT01856192|460442415|FG000|Overall Study|Adverse Event|12|||
127952161|NCT01856192|460442416|FG001|Overall Study|Adverse Event|4|||
127952162|NCT01856192|460442415|FG000|Overall Study|Alternative therapy|0|||
127952163|NCT01856192|460442416|FG001|Overall Study|Alternative therapy|3|||
127952164|NCT01856192|460442415|FG000|Overall Study|Death|3|||
127952165|NCT01856192|460442416|FG001|Overall Study|Death|5|||
127952166|NCT01856192|460442415|FG000|Overall Study|Lack of Efficacy|0|||
127952167|NCT01856192|460442416|FG001|Overall Study|Lack of Efficacy|5|||
127952168|NCT01856192|460442415|FG000|Overall Study|Withdrawal by Subject|1|||
127952169|NCT01856192|460442416|FG001|Overall Study|Withdrawal by Subject|1|||
127952170|NCT01856192|460442415|FG000|Overall Study|Other diseases|1|||
127952171|NCT01856192|460442416|FG001|Overall Study|Other diseases|0|||
127952172|NCT01856192|460442415|FG000|Overall Study|Never started treatment|7|||
127952173|NCT01856192|460442416|FG001|Overall Study|Never started treatment|5|||
127952174|NCT01856192|460442415|FG000|Overall Study|Path ineligible|20|||
127952175|NCT01856192|460442416|FG001|Overall Study|Path ineligible|34|||
127952176|NCT01856192|460442415|FG000|Overall Study|Non-path ineligible|2|||
127952177|NCT01856192|460442416|FG001|Overall Study|Non-path ineligible|2|||
127952178|NCT01856192|460442415|FG000|Overall Study|Physician Decision|1|||
127952179|NCT01856192|460442416|FG001|Overall Study|Physician Decision|1|||
127952180|NCT01856192|460442415|FG000|Overall Study|Suspicion of progressive disease|1|||
127952181|NCT01856192|460442416|FG001|Overall Study|Suspicion of progressive disease|0|||
127952182|NCT01856192|460442415|FG000|Overall Study|Non-compliance|1|||
127952183|NCT01856192|460442416|FG001|Overall Study|Non-compliance|0|||
127952184|NCT02642042|460442417|FG000|Overall Study|Adverse Event|22|||
127952185|NCT02642042|460442417|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
127952186|NCT02642042|460442417|FG000|Overall Study|Progression/Relapse|28|||
127952187|NCT02642042|460442417|FG000|Overall Study|Death|1|||
127952188|NCT02642042|460442417|FG000|Overall Study|Not Protocol Specified|2|||
127952189|NCT04976621|460442418|FG000|Overall Study|Lost to Follow-up|2|||
127952190|NCT04976621|460442419|FG001|Overall Study|Lost to Follow-up|1|||
127952191|NCT04976621|460442418|FG000|Overall Study|Withdrawal by Subject|1|||
127952192|NCT04976621|460442419|FG001|Overall Study|Withdrawal by Subject|0|||
127952193|NCT03348631|460442422|FG000|Overall Study|Not Eligible, No treatment|0|||
127952194|NCT03348631|460442423|FG001|Overall Study|Not Eligible, No treatment|1|||
127952195|NCT03348631|460442422|FG000|Overall Study|Not Eligible, Treated|2|||
127952196|NCT03348631|460442423|FG001|Overall Study|Not Eligible, Treated|0|||
127952197|NCT03348631|460442422|FG000|Overall Study|Eligible, No Treatment|1|||
127952198|NCT03348631|460442423|FG001|Overall Study|Eligible, No Treatment|0|||
127952199|NCT05223920|460442431|FG000|Overall Study|Adverse Event|6|||
127952200|NCT05223920|460442432|FG001|Overall Study|Adverse Event|3|||
127952201|NCT05223920|460442431|FG000|Overall Study|Death|2|||
127952202|NCT05223920|460442432|FG001|Overall Study|Death|0|||
127952203|NCT05223920|460442431|FG000|Overall Study|Disease Progression|1|||
127952204|NCT05223920|460442432|FG001|Overall Study|Disease Progression|2|||
127952205|NCT05223920|460442431|FG000|Overall Study|Physician Decision|1|||
127952206|NCT05223920|460442432|FG001|Overall Study|Physician Decision|2|||
127952207|NCT05223920|460442431|FG000|Overall Study|Sponsor decision|11|||
127952208|NCT05223920|460442432|FG001|Overall Study|Sponsor decision|9|||
127952209|NCT05223920|460442431|FG000|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|29|||
127952210|NCT05223920|460442432|FG001|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|7|||
127952211|NCT05223920|460442431|FG000|Overall Study|Subject decision|1|||
127952212|NCT05223920|460442432|FG001|Overall Study|Subject decision|0|||
127952213|NCT05223920|460442431|FG000|Overall Study|Withdrawal by Subject|1|||
127952214|NCT05223920|460442432|FG001|Overall Study|Withdrawal by Subject|6|||
127952215|NCT03790657|460442433|FG000|Overall Study|Adverse Event|1|||
127952216|NCT03790657|460442434|FG001|Overall Study|Adverse Event|1|||
127952217|NCT03790657|460442433|FG000|Overall Study|Withdrawal by Subject|1|||
127952218|NCT03790657|460442434|FG001|Overall Study|Withdrawal by Subject|1|||
127952219|NCT03154125|460442435|FG000|Overall Study|Lost to Follow-up|11|||
127952220|NCT03154125|460442436|FG001|Overall Study|Lost to Follow-up|11|||
127952221|NCT03154125|460442437|FG002|Overall Study|Lost to Follow-up|0|||
127952222|NCT03154125|460442435|FG000|Overall Study|Withdrawal by Subject|49|||
127952223|NCT03154125|460442436|FG001|Overall Study|Withdrawal by Subject|55|||
127952224|NCT03154125|460442437|FG002|Overall Study|Withdrawal by Subject|8|||
127952225|NCT03154125|460442435|FG000|Overall Study|Physician Decision|13|||
127952226|NCT03154125|460442436|FG001|Overall Study|Physician Decision|6|||
127952227|NCT03154125|460442437|FG002|Overall Study|Physician Decision|0|||
127952228|NCT03154125|460442435|FG000|Overall Study|Protocol Violation|3|||
127952229|NCT03154125|460442436|FG001|Overall Study|Protocol Violation|5|||
127952230|NCT03154125|460442437|FG002|Overall Study|Protocol Violation|0|||
127952231|NCT05219448|460442438|FG000|Overall Study|Lost to Follow-up|9|||
127952232|NCT05219448|460442439|FG001|Overall Study|Lost to Follow-up|0|||
127952233|NCT02287922|460442440|FG000|Overall Study|Adverse Event|1|||
127952234|NCT02287922|460442441|FG001|Overall Study|Adverse Event|1|||
127952235|NCT02287922|460442442|FG002|Overall Study|Adverse Event|3|||
127952236|NCT02287922|460442443|FG003|Overall Study|Adverse Event|4|||
127952237|NCT02287922|460442440|FG000|Overall Study|Withdrawal by Subject|1|||
127952238|NCT02287922|460442441|FG001|Overall Study|Withdrawal by Subject|1|||
127952239|NCT02287922|460442442|FG002|Overall Study|Withdrawal by Subject|1|||
127952240|NCT02287922|460442443|FG003|Overall Study|Withdrawal by Subject|2|||
127952241|NCT02287922|460442440|FG000|Overall Study|Lost to Follow-up|0|||
127952242|NCT02287922|460442441|FG001|Overall Study|Lost to Follow-up|0|||
127952243|NCT02287922|460442442|FG002|Overall Study|Lost to Follow-up|1|||
127952244|NCT02287922|460442443|FG003|Overall Study|Lost to Follow-up|0|||
127952245|NCT02287922|460442440|FG000|Overall Study|Sponsor's decision|0|||
127952246|NCT02287922|460442441|FG001|Overall Study|Sponsor's decision|0|||
127952247|NCT02287922|460442442|FG002|Overall Study|Sponsor's decision|0|||
127952248|NCT02287922|460442443|FG003|Overall Study|Sponsor's decision|1|||
127952249|NCT02287922|460442440|FG000|Overall Study|Other|1|||
127952250|NCT02287922|460442441|FG001|Overall Study|Other|0|||
127952251|NCT02287922|460442442|FG002|Overall Study|Other|2|||
127952252|NCT02287922|460442443|FG003|Overall Study|Other|0|||
127952253|NCT04223752|460442446|FG000|Overall Study|Participant enrolled in error|0|||
127952254|NCT04223752|460442447|FG001|Overall Study|Participant enrolled in error|0|||
127952255|NCT04223752|460442448|FG002|Overall Study|Participant enrolled in error|0|||
127952256|NCT04223752|460442449|FG003|Overall Study|Participant enrolled in error|0|||
127952257|NCT04223752|460442450|FG004|Overall Study|Participant enrolled in error|1|||
127952258|NCT04223752|460442446|FG000|Overall Study|Death|0|||
127952259|NCT04223752|460442447|FG001|Overall Study|Death|0|||
127952260|NCT04223752|460442448|FG002|Overall Study|Death|0|||
127952261|NCT04223752|460442449|FG003|Overall Study|Death|2|||
127952262|NCT04223752|460442450|FG004|Overall Study|Death|1|||
127952263|NCT04759703|460442451|FG000|Overall Study|Withdrawal by Subject|4|||
127952264|NCT04759703|460442452|FG001|Overall Study|Withdrawal by Subject|9|||
127952265|NCT04759703|460442451|FG000|Overall Study|Adverse Event|1|||
127952266|NCT04759703|460442452|FG001|Overall Study|Adverse Event|0|||
127952267|NCT04759703|460442451|FG000|Overall Study|Lost to Follow-up|2|||
127952268|NCT04759703|460442452|FG001|Overall Study|Lost to Follow-up|0|||
127952269|NCT04186845|460442453|FG000|Overall Study|Death|2|||
127952270|NCT04186845|460442453|FG000|Overall Study|Lost to Follow-up|1|||
127952271|NCT04186845|460442453|FG000|Overall Study|Physician Decision|1|||
127952272|NCT04186845|460442453|FG000|Overall Study|Protocol Violation|1|||
127952273|NCT04186845|460442453|FG000|Overall Study|Biopsy ordered but area too small to biopsy|1|||
127952274|NCT04186845|460442453|FG000|Overall Study|Biopsy ordered but not done|1|||
127952275|NCT04186845|460442453|FG000|Overall Study|It was previously confirmed|1|||
127952276|NCT04186845|460442453|FG000|Overall Study|Patient cancelled scheduled scans|2|||
127952277|NCT04186845|460442453|FG000|Overall Study|PSMA PET/CT scan show disease within previously Bx area|1|||
127952278|NCT04186845|460442453|FG000|Overall Study|Subject refused confirmatory imaging|1|||
127952279|NCT04186845|460442453|FG000|Overall Study|Too small to biopsy|1|||
127952280|NCT01814553|460442456|FG000|Overall Study|PD per clinical progression|6|||
127952281|NCT01814553|460442457|FG001|Overall Study|PD per clinical progression|8|||
127952282|NCT01814553|460442456|FG000|Overall Study|Other Adverse Event|4|||
127952283|NCT01814553|460442457|FG001|Overall Study|Other Adverse Event|5|||
127952284|NCT01814553|460442456|FG000|Overall Study|Withdrawal by Subject|1|||
127952285|NCT01814553|460442457|FG001|Overall Study|Withdrawal by Subject|1|||
127952286|NCT01814553|460442456|FG000|Overall Study|Other than stated|7|||
127952287|NCT01814553|460442457|FG001|Overall Study|Other than stated|8|||
127952288|NCT02859142|460442458|FG000|Overall Study|Adverse Event|1|||
127952289|NCT02859142|460442459|FG001|Overall Study|Adverse Event|2|||
127952290|NCT02859142|460442458|FG000|Overall Study|Lost to Follow-up|1|||
127952291|NCT02859142|460442459|FG001|Overall Study|Lost to Follow-up|4|||
127952292|NCT02859142|460442458|FG000|Overall Study|Withdrawal by Subject|2|||
127952293|NCT02859142|460442459|FG001|Overall Study|Withdrawal by Subject|0|||
127952294|NCT02859142|460442458|FG000|Overall Study|Scheduling difficulties|0|||
127952295|NCT02859142|460442459|FG001|Overall Study|Scheduling difficulties|3|||
127952296|NCT03290079|460442460|FG000|Overall Study|Death|2|||
127952297|NCT01941498|460442461|FG000|Overall Study|Relocated out of state|1|||
127952298|NCT04697069|460442462|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
127952299|NCT04697069|460442463|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
127952300|NCT04697069|460442462|FG000|Overall Study|Study termination|2|||
127952301|NCT04697069|460442463|FG001|Overall Study|Study termination|1|||
127952302|NCT04739800|460442464|FG000|Overall Study|Adverse Event|2|||
127952303|NCT04739800|460442465|FG001|Overall Study|Adverse Event|1|||
127952304|NCT04739800|460442466|FG002|Overall Study|Adverse Event|4|||
127952305|NCT04739800|460442467|FG003|Overall Study|Adverse Event|5|||
127952306|NCT04739800|460442464|FG000|Overall Study|Never Treated|2|||
127952307|NCT04739800|460442465|FG001|Overall Study|Never Treated|0|||
127952308|NCT04739800|460442466|FG002|Overall Study|Never Treated|1|||
127952309|NCT04739800|460442467|FG003|Overall Study|Never Treated|1|||
127952310|NCT04739800|460442464|FG000|Overall Study|On Treatment|5|||
127952311|NCT04739800|460442465|FG001|Overall Study|On Treatment|9|||
127952312|NCT04739800|460442466|FG002|Overall Study|On Treatment|9|||
127952313|NCT04739800|460442467|FG003|Overall Study|On Treatment|9|||
127952314|NCT04739800|460442464|FG000|Overall Study|Symptomatic Deterioration|1|||
127952315|NCT04739800|460442465|FG001|Overall Study|Symptomatic Deterioration|1|||
127952316|NCT04739800|460442466|FG002|Overall Study|Symptomatic Deterioration|3|||
127952317|NCT04739800|460442467|FG003|Overall Study|Symptomatic Deterioration|0|||
127952318|NCT04739800|460442464|FG000|Overall Study|Withdrawal by Subject|1|||
127952319|NCT04739800|460442465|FG001|Overall Study|Withdrawal by Subject|2|||
127952320|NCT04739800|460442466|FG002|Overall Study|Withdrawal by Subject|1|||
127952321|NCT04739800|460442467|FG003|Overall Study|Withdrawal by Subject|3|||
127952322|NCT04739800|460442464|FG000|Overall Study|Other Reason|1|||
127952323|NCT04739800|460442465|FG001|Overall Study|Other Reason|3|||
127952324|NCT04739800|460442466|FG002|Overall Study|Other Reason|5|||
127952325|NCT04739800|460442467|FG003|Overall Study|Other Reason|4|||
127952326|NCT02779855|460442468|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
127952327|NCT02779855|460442469|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
127952328|NCT02779855|460442470|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
127952329|NCT00985491|460442474|FG000|Overall Study|Adverse Event|8|||
127952330|NCT00985491|460442474|FG000|Overall Study|device migration|7|||
127952331|NCT00985491|460442474|FG000|Overall Study|Withdrawal by Subject|1|||
127952332|NCT00985491|460442474|FG000|Overall Study|implant failure|3|||
127952333|NCT00489827|460442475|FG000|Overall Study|Intraoperative exclusion criteria|1|||
127952334|NCT00489827|460442476|FG001|Overall Study|Intraoperative exclusion criteria|1|||
127952335|NCT00489827|460442475|FG000|Overall Study|Intraoperative exclusion criteria|1|||
127952336|NCT00489827|460442476|FG001|Overall Study|Intraoperative exclusion criteria|1|||
127952337|NCT01377012|460442477|FG000|Core Study|Study terminated by Sponsor|47|||
127952338|NCT01377012|460442478|FG001|Core Study|Study terminated by Sponsor|54|||
127952339|NCT01377012|460442479|FG002|Core Study|Study terminated by Sponsor|46|||
127952340|NCT01377012|460442477|FG000|Core Study|Technical problems|1|||
127952341|NCT01377012|460442478|FG001|Core Study|Technical problems|0|||
127952342|NCT01377012|460442479|FG002|Core Study|Technical problems|0|||
127952343|NCT01377012|460442477|FG000|Core Study|Withdrawal by Subject|15|||
127952344|NCT01377012|460442478|FG001|Core Study|Withdrawal by Subject|23|||
127952345|NCT01377012|460442479|FG002|Core Study|Withdrawal by Subject|18|||
127952346|NCT01377012|460442477|FG000|Core Study|Protocol Violation|7|||
127952347|NCT01377012|460442478|FG001|Core Study|Protocol Violation|3|||
127952348|NCT01377012|460442479|FG002|Core Study|Protocol Violation|2|||
127952349|NCT01377012|460442477|FG000|Core Study|Pregnancy|0|||
127952350|NCT01377012|460442478|FG001|Core Study|Pregnancy|0|||
127952351|NCT01377012|460442479|FG002|Core Study|Pregnancy|1|||
127952352|NCT01377012|460442477|FG000|Core Study|Physician Decision|5|||
127952353|NCT01377012|460442478|FG001|Core Study|Physician Decision|4|||
127952354|NCT01377012|460442479|FG002|Core Study|Physician Decision|10|||
127952355|NCT01377012|460442477|FG000|Core Study|Non-Compliant with study treatment|0|||
127952356|NCT01377012|460442478|FG001|Core Study|Non-Compliant with study treatment|0|||
127952357|NCT01377012|460442479|FG002|Core Study|Non-Compliant with study treatment|1|||
127952358|NCT01377012|460442477|FG000|Core Study|No Longer require treatment|0|||
127952359|NCT01377012|460442478|FG001|Core Study|No Longer require treatment|0|||
127952360|NCT01377012|460442479|FG002|Core Study|No Longer require treatment|1|||
127952361|NCT01377012|460442477|FG000|Core Study|Lost to Follow-up|7|||
127952362|NCT01377012|460442478|FG001|Core Study|Lost to Follow-up|5|||
127952363|NCT01377012|460442479|FG002|Core Study|Lost to Follow-up|4|||
127952364|NCT01377012|460442477|FG000|Core Study|Lack of Efficacy|41|||
127952365|NCT01377012|460442478|FG001|Core Study|Lack of Efficacy|28|||
127952366|NCT01377012|460442479|FG002|Core Study|Lack of Efficacy|37|||
127952367|NCT01377012|460442477|FG000|Core Study|Death|1|||
127952368|NCT01377012|460442478|FG001|Core Study|Death|1|||
127952369|NCT01377012|460442479|FG002|Core Study|Death|1|||
127952370|NCT01377012|460442477|FG000|Core Study|Adverse Event|10|||
127952371|NCT01377012|460442478|FG001|Core Study|Adverse Event|14|||
127952372|NCT01377012|460442479|FG002|Core Study|Adverse Event|13|||
127952373|NCT01377012|460442477|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
127952374|NCT01377012|460442478|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
127952375|NCT01377012|460442479|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
127952376|NCT01377012|460442477|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
127952377|NCT01377012|460442478|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
127952378|NCT01377012|460442479|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
127952379|NCT01377012|460442477|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
127952380|NCT01377012|460442478|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
127952381|NCT01377012|460442479|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
127952382|NCT01377012|460442477|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
127952383|NCT01377012|460442478|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
127952384|NCT01377012|460442479|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
127952385|NCT01377012|460442477|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
127952386|NCT01377012|460442478|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
127952387|NCT01377012|460442479|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
127952388|NCT01377012|460442477|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
127952389|NCT01377012|460442478|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
127952390|NCT01377012|460442479|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
127952391|NCT03514017|460442480|FG000|Overall Study|Death|1|||
127952392|NCT03514017|460442480|FG000|Overall Study|Adverse Event|1|||
127952393|NCT01290302|460443888|FG000|Overall Study|Adverse Event|2|||
127952394|NCT01290302|460443889|FG001|Overall Study|Adverse Event|0|||
127952395|NCT01290302|460443888|FG000|Overall Study|Withdrawal by Subject|1|||
127952396|NCT01290302|460443889|FG001|Overall Study|Withdrawal by Subject|0|||
127952397|NCT01290302|460443888|FG000|Overall Study|Physician Decision|0|||
127952398|NCT01290302|460443889|FG001|Overall Study|Physician Decision|2|||
127952399|NCT01290302|460443888|FG000|Overall Study|Expiration of time for screening window|1|||
127952400|NCT01290302|460443889|FG001|Overall Study|Expiration of time for screening window|0|||
127952401|NCT06419907|460443894|FG000|Overall Study|Protocol Violation|0|||
127952402|NCT06419907|460443895|FG001|Overall Study|Protocol Violation|3|||
127952403|NCT06419907|460443896|FG002|Overall Study|Protocol Violation|0|||
127952404|NCT06419907|460443897|FG003|Overall Study|Protocol Violation|1|||
127952405|NCT06419907|460443894|FG000|Overall Study|Lost to Follow-up|0|||
127952406|NCT06419907|460443895|FG001|Overall Study|Lost to Follow-up|0|||
127952407|NCT06419907|460443896|FG002|Overall Study|Lost to Follow-up|2|||
127952408|NCT06419907|460443897|FG003|Overall Study|Lost to Follow-up|1|||
127952409|NCT05929651|460443900|FG000|Overall Study|Protocol Deviation|1|||
127952410|NCT05929651|460443900|FG000|Overall Study|Withdrawal by participant's parents/legally acceptable representatives|2|||
127952411|NCT02847260|460443903|FG000|Overall Study|Adverse Event|3|||
127952412|NCT02847260|460443903|FG000|Overall Study|Withdrawal by Subject|2|||
127952413|NCT02847260|460443903|FG000|Overall Study|Clinical Deterioration|1|||
127952414|NCT02847260|460443903|FG000|Overall Study|Physician Decision|1|||
127952415|NCT02276807|460443907|FG000|Overall Study|Withdrawal by Subject|8|||
127952416|NCT02276807|460443908|FG001|Overall Study|Withdrawal by Subject|7|||
127952417|NCT02276807|460443907|FG000|Overall Study|Lost to Follow-up|10|||
127952418|NCT02276807|460443908|FG001|Overall Study|Lost to Follow-up|10|||
127952419|NCT03971474|460443909|FG000|Overall Study|Adverse Event|11|||
127952420|NCT03971474|460443910|FG001|Overall Study|Adverse Event|7|||
127952421|NCT03971474|460443909|FG000|Overall Study|Refusal unrelated to adverse event|5|||
127952422|NCT03971474|460443910|FG001|Overall Study|Refusal unrelated to adverse event|1|||
127952423|NCT03971474|460443909|FG000|Overall Study|Progression/relapse|40|||
127952424|NCT03971474|460443910|FG001|Overall Study|Progression/relapse|47|||
127952425|NCT03971474|460443909|FG000|Overall Study|Death|6|||
127952426|NCT03971474|460443910|FG001|Overall Study|Death|3|||
127952427|NCT03971474|460443909|FG000|Overall Study|Other - not protocol specified|5|||
127952428|NCT03971474|460443910|FG001|Overall Study|Other - not protocol specified|4|||
127952429|NCT03971474|460443909|FG000|Overall Study|On treatment|0|||
127952430|NCT03971474|460443910|FG001|Overall Study|On treatment|7|||
127952431|NCT00261950|460443911|FG000|Overall Study|Lost to Follow-up|2|||
127952432|NCT00261950|460443911|FG000|Overall Study|Death|6|||
127952433|NCT00261950|460443911|FG000|Overall Study|Withdrawal by Subject|5|||
127952434|NCT00261950|460443911|FG000|Overall Study|Other|1|||
127952435|NCT00261950|460443911|FG000|Overall Study|Physician Decision|1|||
127952436|NCT00261950|460443911|FG000|Overall Study|Protocol specified Criteria|11|||
127952437|NCT01937871|460443918|FG000|Overall Study|Adverse Event|6|||
127952438|NCT01937871|460443919|FG001|Overall Study|Adverse Event|6|||
127952439|NCT01937871|460443920|FG002|Overall Study|Adverse Event|2|||
127952440|NCT01937871|460443918|FG000|Overall Study|Lost to Follow-up|8|||
127952441|NCT01937871|460443919|FG001|Overall Study|Lost to Follow-up|2|||
127952442|NCT01937871|460443920|FG002|Overall Study|Lost to Follow-up|4|||
127952443|NCT01937871|460443918|FG000|Overall Study|Withdrawal by Subject|9|||
127952444|NCT01937871|460443919|FG001|Overall Study|Withdrawal by Subject|6|||
127952445|NCT01937871|460443920|FG002|Overall Study|Withdrawal by Subject|4|||
127952446|NCT01937871|460443918|FG000|Overall Study|Physician Decision|0|||
127952447|NCT01937871|460443919|FG001|Overall Study|Physician Decision|1|||
127952448|NCT01937871|460443920|FG002|Overall Study|Physician Decision|0|||
127952449|NCT01937871|460443918|FG000|Overall Study|Entry Criteria Not Met|1|||
127952450|NCT01937871|460443919|FG001|Overall Study|Entry Criteria Not Met|2|||
127952451|NCT01937871|460443920|FG002|Overall Study|Entry Criteria Not Met|1|||
127952452|NCT00577863|460443927|FG000|Overall Study|Adverse Event|4|||
127952453|NCT00577863|460443928|FG001|Overall Study|Adverse Event|2|||
127952454|NCT00577863|460443927|FG000|Overall Study|Death|1|||
127952455|NCT00577863|460443928|FG001|Overall Study|Death|0|||
127952456|NCT00577863|460443927|FG000|Overall Study|Lost to Follow-up|2|||
127952457|NCT00577863|460443928|FG001|Overall Study|Lost to Follow-up|2|||
127952458|NCT00577863|460443927|FG000|Overall Study|Entry Criteria Exclusion|1|||
127952459|NCT00577863|460443928|FG001|Overall Study|Entry Criteria Exclusion|0|||
127952460|NCT00577863|460443927|FG000|Overall Study|Withdrawal by Subject|0|||
127952461|NCT00577863|460443928|FG001|Overall Study|Withdrawal by Subject|2|||
127952462|NCT00577863|460443927|FG000|Overall Study|Sponsor Decision|2|||
127952463|NCT00577863|460443928|FG001|Overall Study|Sponsor Decision|7|||
127952464|NCT00577863|460443927|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
127952465|NCT00577863|460443928|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
127952466|NCT00668317|460443929|FG000|Overall Study|Adverse Event|2|||
127952467|NCT03509467|460443933|FG000|Overall Study|Withdrawal by Subject|5|||
127952468|NCT03509467|460443934|FG001|Overall Study|Withdrawal by Subject|1|||
127952469|NCT03509467|460443935|FG002|Overall Study|Withdrawal by Subject|6|||
127952470|NCT03509467|460443936|FG003|Overall Study|Withdrawal by Subject|7|||
127952471|NCT03509467|460443937|FG004|Overall Study|Withdrawal by Subject|10|||
127952472|NCT03509467|460443938|FG005|Overall Study|Withdrawal by Subject|10|||
127952473|NCT03509467|460443939|FG006|Overall Study|Withdrawal by Subject|10|||
127952474|NCT03509467|460443940|FG007|Overall Study|Withdrawal by Subject|10|||
127952475|NCT03509467|460443933|FG000|Overall Study|Death|0|||
127952476|NCT03509467|460443934|FG001|Overall Study|Death|0|||
127952477|NCT03509467|460443935|FG002|Overall Study|Death|2|||
127952478|NCT03509467|460443936|FG003|Overall Study|Death|2|||
127952479|NCT03509467|460443937|FG004|Overall Study|Death|1|||
127952480|NCT03509467|460443938|FG005|Overall Study|Death|0|||
127952481|NCT03509467|460443939|FG006|Overall Study|Death|1|||
127952482|NCT03509467|460443940|FG007|Overall Study|Death|0|||
127952483|NCT03509467|460443933|FG000|Overall Study|Proxy Withdrawal|0|||
127952484|NCT03509467|460443934|FG001|Overall Study|Proxy Withdrawal|0|||
127952485|NCT03509467|460443935|FG002|Overall Study|Proxy Withdrawal|0|||
127952486|NCT03509467|460443936|FG003|Overall Study|Proxy Withdrawal|0|||
127952487|NCT03509467|460443937|FG004|Overall Study|Proxy Withdrawal|0|||
127952488|NCT03509467|460443938|FG005|Overall Study|Proxy Withdrawal|0|||
127952489|NCT03509467|460443939|FG006|Overall Study|Proxy Withdrawal|0|||
127952490|NCT03509467|460443940|FG007|Overall Study|Proxy Withdrawal|1|||
127952491|NCT02829918|460443946|FG000|Overall Study|Death|2|||
127952492|NCT02829918|460443946|FG000|Overall Study|Withdrawal by Subject|4|||
127952493|NCT02829918|460443946|FG000|Overall Study|Adverse Event|1|||
127952494|NCT02829918|460443946|FG000|Overall Study|Progression|1|||
127952495|NCT04138823|460443953|FG000|Overall Study|Clinical disease progression|0|||
127952496|NCT04138823|460443954|FG001|Overall Study|Clinical disease progression|0|||
127952497|NCT04138823|460443955|FG002|Overall Study|Clinical disease progression|1|||
127952498|NCT04138823|460443953|FG000|Overall Study|Objective disease progression|3|||
127952499|NCT04138823|460443954|FG001|Overall Study|Objective disease progression|2|||
127952500|NCT04138823|460443955|FG002|Overall Study|Objective disease progression|5|||
127952501|NCT02466685|460443956|FG000|Overall Study|Adverse Event|5|||
127952502|NCT02466685|460443957|FG001|Overall Study|Adverse Event|2|||
127952503|NCT02466685|460443956|FG000|Overall Study|Lost to Follow-up|1|||
127952504|NCT02466685|460443957|FG001|Overall Study|Lost to Follow-up|1|||
127952505|NCT02466685|460443956|FG000|Overall Study|Withdrawal by Subject|1|||
127952506|NCT02466685|460443957|FG001|Overall Study|Withdrawal by Subject|0|||
127952507|NCT02466685|460443956|FG000|Overall Study|Physician Decision|1|||
127952508|NCT02466685|460443957|FG001|Overall Study|Physician Decision|1|||
127952509|NCT02676765|460443958|FG000|Overall Study|Lost to Follow-up|0|||
127952510|NCT02676765|460443959|FG001|Overall Study|Lost to Follow-up|1|||
127952511|NCT03340974|460443960|FG000|Completion of Study -Long Term Follow up|Death|8|||
127952512|NCT03340974|460443961|FG001|Completion of Study -Long Term Follow up|Death|5|||
127952513|NCT03340974|460443962|FG002|Completion of Study -Long Term Follow up|Death|5|||
127952514|NCT03340974|460443963|FG003|Completion of Study -Long Term Follow up|Death|7|||
127952515|NCT03340974|460443960|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
127952516|NCT03340974|460443961|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
127952517|NCT03340974|460443962|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
127952518|NCT03340974|460443963|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
127952519|NCT03340974|460443960|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
127952520|NCT03340974|460443961|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
127952521|NCT03340974|460443962|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
127952522|NCT03340974|460443963|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
127952523|NCT03340974|460443960|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
127952524|NCT03340974|460443961|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
127952525|NCT03340974|460443962|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
127952526|NCT03340974|460443963|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
127952527|NCT05299528|460443968|FG000|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
127952528|NCT05299528|460443969|FG001|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|4|||
127952529|NCT05299528|460443970|FG002|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
127952530|NCT05299528|460443971|FG003|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
127952531|NCT05299528|460443972|FG004|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
127952532|NCT05299528|460443973|FG005|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
127952533|NCT05299528|460443974|FG006|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
127952534|NCT05299528|460443968|FG000|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
127952535|NCT05299528|460443969|FG001|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
127952536|NCT05299528|460443970|FG002|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
127952537|NCT05299528|460443971|FG003|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
127952538|NCT05299528|460443972|FG004|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
127952539|NCT05299528|460443973|FG005|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|1|||
127952540|NCT05299528|460443974|FG006|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
127952541|NCT05299528|460443968|FG000|Surgeon Follow-up|Lost to Follow-up|0|||
127952542|NCT05299528|460443969|FG001|Surgeon Follow-up|Lost to Follow-up|0|||
127952543|NCT05299528|460443970|FG002|Surgeon Follow-up|Lost to Follow-up|1|||
127952544|NCT05299528|460443971|FG003|Surgeon Follow-up|Lost to Follow-up|0|||
127952545|NCT05299528|460443972|FG004|Surgeon Follow-up|Lost to Follow-up|0|||
127952546|NCT05299528|460443973|FG005|Surgeon Follow-up|Lost to Follow-up|0|||
127952547|NCT05299528|460443974|FG006|Surgeon Follow-up|Lost to Follow-up|0|||
127952548|NCT04877457|460443975|FG000|Overall Study|Early termination of study due to low enrollment|2|||
127952549|NCT04877457|460443976|FG001|Overall Study|Early termination of study due to low enrollment|1|||
127952550|NCT05180227|460443981|FG000|Overall Study|Hypertension at screening|1|||
127952551|NCT05180227|460443981|FG000|Overall Study|Lost to Follow-up|1|||
127952552|NCT01070953|460443982|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
127952553|NCT01070953|460443982|FG000|Participants for Safety Evaluation|Off-label use|283|||
127952554|NCT01070953|460443982|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
127952555|NCT01070953|460443982|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
127952556|NCT01070953|460443982|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
127952557|NCT01070953|460443982|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
127952558|NCT01070953|460443982|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
127952559|NCT01070953|460443982|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
127952560|NCT01070953|460443982|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
127952561|NCT01070953|460443982|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
127952562|NCT04597632|460443983|FG000|Overall Study|Withdrawal by Subject|10|||
127952563|NCT04597632|460443983|FG000|Overall Study|Lost to Follow-up|1|||
127952564|NCT04597632|460443983|FG000|Overall Study|Death|1|||
127952565|NCT04597632|460443983|FG000|Overall Study|Adverse Event|5|||
127952566|NCT04895982|460443984|FG000|Overall Study|Withdrawal by Subject|0|||
127952567|NCT04895982|460443985|FG001|Overall Study|Withdrawal by Subject|0|||
127952568|NCT04895982|460443986|FG002|Overall Study|Withdrawal by Subject|0|||
127952569|NCT04895982|460443987|FG003|Overall Study|Withdrawal by Subject|0|||
127952570|NCT04895982|460443988|FG004|Overall Study|Withdrawal by Subject|0|||
127952571|NCT04895982|460443989|FG005|Overall Study|Withdrawal by Subject|1|||
127952572|NCT04895982|460443990|FG006|Overall Study|Withdrawal by Subject|1|||
127952573|NCT04895982|460443991|FG007|Overall Study|Withdrawal by Subject|0|||
127952574|NCT04895982|460443992|FG008|Overall Study|Withdrawal by Subject|0|||
127952575|NCT04895982|460443993|FG009|Overall Study|Withdrawal by Subject|1|||
127952576|NCT04895982|460443994|FG010|Overall Study|Withdrawal by Subject|0|||
127952577|NCT04895982|460443995|FG011|Overall Study|Withdrawal by Subject|1|||
127952578|NCT04895982|460443984|FG000|Overall Study|Withdrawal by parent/guardian|2|||
127952579|NCT04895982|460443985|FG001|Overall Study|Withdrawal by parent/guardian|3|||
127952580|NCT04895982|460443986|FG002|Overall Study|Withdrawal by parent/guardian|3|||
127952581|NCT04895982|460443987|FG003|Overall Study|Withdrawal by parent/guardian|1|||
127952582|NCT04895982|460443988|FG004|Overall Study|Withdrawal by parent/guardian|3|||
127952583|NCT04895982|460443989|FG005|Overall Study|Withdrawal by parent/guardian|2|||
127952584|NCT04895982|460443990|FG006|Overall Study|Withdrawal by parent/guardian|1|||
127952585|NCT04895982|460443991|FG007|Overall Study|Withdrawal by parent/guardian|0|||
127952586|NCT04895982|460443992|FG008|Overall Study|Withdrawal by parent/guardian|3|||
127952587|NCT04895982|460443993|FG009|Overall Study|Withdrawal by parent/guardian|0|||
127952588|NCT04895982|460443994|FG010|Overall Study|Withdrawal by parent/guardian|0|||
127952589|NCT04895982|460443995|FG011|Overall Study|Withdrawal by parent/guardian|0|||
127952590|NCT04895982|460443984|FG000|Overall Study|Other|0|||
127952591|NCT04895982|460443985|FG001|Overall Study|Other|0|||
127952592|NCT04895982|460443986|FG002|Overall Study|Other|1|||
127952593|NCT04895982|460443987|FG003|Overall Study|Other|1|||
127952594|NCT04895982|460443988|FG004|Overall Study|Other|0|||
127952595|NCT04895982|460443989|FG005|Overall Study|Other|0|||
127952596|NCT04895982|460443990|FG006|Overall Study|Other|0|||
127952597|NCT04895982|460443991|FG007|Overall Study|Other|0|||
127952598|NCT04895982|460443992|FG008|Overall Study|Other|0|||
127952599|NCT04895982|460443993|FG009|Overall Study|Other|1|||
127952600|NCT04895982|460443994|FG010|Overall Study|Other|0|||
127952601|NCT04895982|460443995|FG011|Overall Study|Other|0|||
127952602|NCT04895982|460443984|FG000|Overall Study|Protocol Violation|0|||
127952603|NCT04895982|460443985|FG001|Overall Study|Protocol Violation|0|||
127952604|NCT04895982|460443986|FG002|Overall Study|Protocol Violation|1|||
127952605|NCT04895982|460443987|FG003|Overall Study|Protocol Violation|1|||
127952606|NCT04895982|460443988|FG004|Overall Study|Protocol Violation|1|||
127952607|NCT04895982|460443989|FG005|Overall Study|Protocol Violation|0|||
127952608|NCT04895982|460443990|FG006|Overall Study|Protocol Violation|0|||
127952609|NCT04895982|460443991|FG007|Overall Study|Protocol Violation|1|||
127952610|NCT04895982|460443992|FG008|Overall Study|Protocol Violation|0|||
127952611|NCT04895982|460443993|FG009|Overall Study|Protocol Violation|0|||
127952612|NCT04895982|460443994|FG010|Overall Study|Protocol Violation|0|||
127952613|NCT04895982|460443995|FG011|Overall Study|Protocol Violation|0|||
127952614|NCT04895982|460443984|FG000|Overall Study|Lost to Follow-up|0|||
127952615|NCT04895982|460443985|FG001|Overall Study|Lost to Follow-up|0|||
127952616|NCT04895982|460443986|FG002|Overall Study|Lost to Follow-up|1|||
127952617|NCT04895982|460443987|FG003|Overall Study|Lost to Follow-up|0|||
127952618|NCT04895982|460443988|FG004|Overall Study|Lost to Follow-up|0|||
127952619|NCT04895982|460443989|FG005|Overall Study|Lost to Follow-up|1|||
127952620|NCT04895982|460443990|FG006|Overall Study|Lost to Follow-up|0|||
127952621|NCT04895982|460443991|FG007|Overall Study|Lost to Follow-up|0|||
127952622|NCT04895982|460443992|FG008|Overall Study|Lost to Follow-up|1|||
127952623|NCT04895982|460443993|FG009|Overall Study|Lost to Follow-up|0|||
127952624|NCT04895982|460443994|FG010|Overall Study|Lost to Follow-up|0|||
127952625|NCT04895982|460443995|FG011|Overall Study|Lost to Follow-up|0|||
127952626|NCT04895982|460443984|FG000|Overall Study|Refused further study procedures|0|||
127952627|NCT04895982|460443985|FG001|Overall Study|Refused further study procedures|0|||
127952628|NCT04895982|460443986|FG002|Overall Study|Refused further study procedures|1|||
127952629|NCT04895982|460443987|FG003|Overall Study|Refused further study procedures|0|||
127952630|NCT04895982|460443988|FG004|Overall Study|Refused further study procedures|0|||
127952631|NCT04895982|460443989|FG005|Overall Study|Refused further study procedures|0|||
127952632|NCT04895982|460443990|FG006|Overall Study|Refused further study procedures|0|||
127952633|NCT04895982|460443991|FG007|Overall Study|Refused further study procedures|0|||
127952634|NCT04895982|460443992|FG008|Overall Study|Refused further study procedures|0|||
127952635|NCT04895982|460443993|FG009|Overall Study|Refused further study procedures|0|||
127952636|NCT04895982|460443994|FG010|Overall Study|Refused further study procedures|0|||
127952637|NCT04895982|460443995|FG011|Overall Study|Refused further study procedures|0|||
127952638|NCT01893346|460443998|FG000|Overall Study|Lost to Follow-up|0|||
127952639|NCT01893346|460443999|FG001|Overall Study|Lost to Follow-up|1|||
127952640|NCT01893346|460444000|FG002|Overall Study|Lost to Follow-up|0|||
127952641|NCT01893346|460444001|FG003|Overall Study|Lost to Follow-up|0|||
127952642|NCT01893346|460443998|FG000|Overall Study|Protocol Violation|1|||
127952643|NCT01893346|460443999|FG001|Overall Study|Protocol Violation|0|||
127952644|NCT01893346|460444000|FG002|Overall Study|Protocol Violation|0|||
127952645|NCT01893346|460444001|FG003|Overall Study|Protocol Violation|0|||
127952646|NCT01893346|460443998|FG000|Overall Study|Withdrawal by Subject|2|||
127952647|NCT01893346|460443999|FG001|Overall Study|Withdrawal by Subject|0|||
127952648|NCT01893346|460444000|FG002|Overall Study|Withdrawal by Subject|0|||
127952649|NCT01893346|460444001|FG003|Overall Study|Withdrawal by Subject|0|||
127952650|NCT01449812|460444002|FG000|Overall Study|Migrated/moved from study area|1|||
127952651|NCT01449812|460444003|FG001|Overall Study|Migrated/moved from study area|0|||
127952652|NCT01449812|460444004|FG002|Overall Study|Migrated/moved from study area|0|||
127952653|NCT01449812|460444002|FG000|Overall Study|Withdrawal by Subject|0|||
127952654|NCT01449812|460444003|FG001|Overall Study|Withdrawal by Subject|0|||
127952655|NCT01449812|460444004|FG002|Overall Study|Withdrawal by Subject|1|||
127952656|NCT01449812|460444002|FG000|Overall Study|Lost to Follow-up|1|||
127952657|NCT01449812|460444003|FG001|Overall Study|Lost to Follow-up|0|||
127952658|NCT01449812|460444004|FG002|Overall Study|Lost to Follow-up|0|||
127952659|NCT04239027|460444005|FG000|Overall Study|Adverse Event|4|||
127952660|NCT04239027|460444005|FG000|Overall Study|Withdrawal by Subject|9|||
127952661|NCT04239027|460444005|FG000|Overall Study|Death|1|||
127952662|NCT04239027|460444005|FG000|Overall Study|Physician Decision|9|||
127952663|NCT04239027|460444005|FG000|Overall Study|Lost to Follow-up|2|||
127952664|NCT04239027|460444005|FG000|Overall Study|Lack of Efficacy|1|||
127952665|NCT02839707|460444012|FG000|Phase I|Not eligible for analysis|9|||
127952666|NCT02839707|460444013|FG001|Phase I|Not eligible for analysis|0|||
127952667|NCT02839707|460444014|FG002|Phase I|Not eligible for analysis|0|||
127952668|NCT02839707|460444012|FG000|Phase II|Not treated according to protocol|4|||
127952669|NCT02839707|460444013|FG001|Phase II|Not treated according to protocol|0|||
127952670|NCT02839707|460444014|FG002|Phase II|Not treated according to protocol|2|||
127952671|NCT02839707|460444012|FG000|Phase III|Not treated according to protocol|0|||
127952672|NCT02839707|460444013|FG001|Phase III|Not treated according to protocol|0|||
127952673|NCT02839707|460444014|FG002|Phase III|Not treated according to protocol|4|||
127952674|NCT01059786|460445708|FG000|Overall Study|Did not receive 6 cycles.|0|||
127952675|NCT01059786|460445709|FG001|Overall Study|Did not receive 6 cycles.|0|||
127952676|NCT01059786|460445710|FG002|Overall Study|Did not receive 6 cycles.|4|||
127952677|NCT01059786|460445711|FG003|Overall Study|Did not receive 6 cycles.|1|||
127952678|NCT01059786|460445712|FG004|Overall Study|Did not receive 6 cycles.|0|||
127952679|NCT02586688|460445714|FG000|Overall Study|Lost to Follow-up|2|||
127952680|NCT02586688|460445715|FG001|Overall Study|Lost to Follow-up|1|||
127952681|NCT02586688|460445714|FG000|Overall Study|Withdrawal by Subject|1|||
127952682|NCT02586688|460445715|FG001|Overall Study|Withdrawal by Subject|1|||
127952683|NCT02586688|460445714|FG000|Overall Study|Adverse Event|3|||
127952684|NCT02586688|460445715|FG001|Overall Study|Adverse Event|1|||
127952685|NCT02454608|460445716|FG000|Double-Blind Period|Lack of Efficacy|0|||
127952686|NCT02454608|460445717|FG001|Double-Blind Period|Lack of Efficacy|2|||
127952687|NCT02454608|460445718|FG002|Double-Blind Period|Lack of Efficacy|0|||
127952688|NCT02454608|460445716|FG000|Open Label Period|Lost to Follow-up|0|||
127952689|NCT02454608|460445717|FG001|Open Label Period|Lost to Follow-up|0|||
127952690|NCT02454608|460445718|FG002|Open Label Period|Lost to Follow-up|11|||
127952691|NCT02454608|460445716|FG000|Open Label Period|Withdrawal by Subject|0|||
127952692|NCT02454608|460445717|FG001|Open Label Period|Withdrawal by Subject|0|||
127952693|NCT02454608|460445718|FG002|Open Label Period|Withdrawal by Subject|8|||
127952694|NCT01433055|460445719|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
127952695|NCT01433055|460445720|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
127952696|NCT01433055|460445719|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
127952697|NCT01433055|460445720|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
127952698|NCT03573830|460445724|FG000|Overall Study|Dropped without completing treatment|0|||
127952699|NCT03573830|460445725|FG001|Overall Study|Dropped without completing treatment|7|||
127952700|NCT03573830|460445724|FG000|Overall Study|Lost to Follow-up|4|||
127952701|NCT03573830|460445725|FG001|Overall Study|Lost to Follow-up|0|||
127952702|NCT01769456|460445726|FG000|Overall Study|Lost to Follow-up|19|||
127952703|NCT01769456|460445726|FG000|Overall Study|Withdrawal by Subject|3|||
127952704|NCT01769456|460445726|FG000|Overall Study|Did not receive PCC intervention|6|||
127952705|NCT01769456|460445726|FG000|Overall Study|Moved out of the area|3|||
127952706|NCT01769456|460445726|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
127952707|NCT01769456|460445726|FG000|Overall Study|Parental request to youth to withdraw|1|||
127952708|NCT05244122|460445731|FG000|Overall Study|Withdrawal by Subject|318|||
127952709|NCT02969382|460445740|FG000|Overall Study|Adverse Event|8|||
127952710|NCT02969382|460445741|FG001|Overall Study|Adverse Event|10|||
127952711|NCT02969382|460445740|FG000|Overall Study|Lack of Efficacy|4|||
127952712|NCT02969382|460445741|FG001|Overall Study|Lack of Efficacy|5|||
127952713|NCT02969382|460445740|FG000|Overall Study|Death|0|||
127952714|NCT02969382|460445741|FG001|Overall Study|Death|1|||
127952715|NCT02969382|460445740|FG000|Overall Study|PROTOCOL DEVIATION|0|||
127952716|NCT02969382|460445741|FG001|Overall Study|PROTOCOL DEVIATION|1|||
127952717|NCT02969382|460445740|FG000|Overall Study|Withdrawal by Subject|14|||
127952718|NCT02969382|460445741|FG001|Overall Study|Withdrawal by Subject|9|||
127952719|NCT01692626|460445742|FG000|Overall Study|Death|0|||
127952720|NCT01692626|460445743|FG001|Overall Study|Death|1|||
127952721|NCT01692626|460445742|FG000|Overall Study|Adverse Event|2|||
127952722|NCT01692626|460445743|FG001|Overall Study|Adverse Event|3|||
127952723|NCT01692626|460445742|FG000|Overall Study|Protocol Violation|1|||
127952724|NCT01692626|460445743|FG001|Overall Study|Protocol Violation|2|||
127952725|NCT01692626|460445742|FG000|Overall Study|Withdrawal by Subject|1|||
127952726|NCT01692626|460445743|FG001|Overall Study|Withdrawal by Subject|0|||
127952727|NCT05490771|460445744|FG000|Overall Study|Disease progression|18|||
127952728|NCT05490771|460445744|FG000|Overall Study|Adverse Event|3|||
127952729|NCT05490771|460445744|FG000|Overall Study|Other complicating disease|1|||
127952730|NCT05490771|460445744|FG000|Overall Study|Withdrawal by Subject|3|||
127952731|NCT05490771|460445744|FG000|Overall Study|Physician Decision|1|||
127952732|NCT05490771|460445744|FG000|Overall Study|Still on treatment|2|||
127952733|NCT05490771|460445744|FG000|Overall Study|Never start protocol therapy|5|||
127952734|NCT05490771|460445744|FG000|Overall Study|Ineligible|2|||
127952735|NCT04071405|460445745|FG000|Overall Study|Protocol Violation|3|||
127952736|NCT02422797|460445746|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
127952737|NCT02422797|460445747|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
127952738|NCT02422797|460445746|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
127952739|NCT02422797|460445747|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
127952740|NCT02422797|460445746|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
127952741|NCT02422797|460445747|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
127952742|NCT02422797|460445746|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
127952743|NCT02422797|460445747|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
127952744|NCT02422797|460445746|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
127952745|NCT02422797|460445747|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
127952746|NCT02422797|460445746|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
127952747|NCT02422797|460445747|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
127952748|NCT02422797|460445746|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
127952749|NCT02422797|460445747|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
127952750|NCT02422797|460445746|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
127952751|NCT02422797|460445747|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
127952752|NCT02422797|460445746|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
127952753|NCT02422797|460445747|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
127952754|NCT02422797|460445746|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
127952755|NCT02422797|460445747|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
127952756|NCT02422797|460445746|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
127952757|NCT02422797|460445747|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
127952758|NCT02422797|460445746|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
127952759|NCT02422797|460445747|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
127952760|NCT02422797|460445746|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
127952761|NCT02422797|460445747|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
127952762|NCT02422797|460445746|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
127952763|NCT02422797|460445747|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
127952764|NCT02422797|460445746|FG000|Continuation Phase(Week 148 to Week 410)|Investigator discretion|1|||
127952765|NCT02422797|460445747|FG001|Continuation Phase(Week 148 to Week 410)|Investigator discretion|2|||
127952766|NCT02422797|460445746|FG000|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|0|||
127952767|NCT02422797|460445747|FG001|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|3|||
127952768|NCT02422797|460445746|FG000|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|1|||
127952769|NCT02422797|460445747|FG001|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|0|||
127952770|NCT02422797|460445746|FG000|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|4|||
127952771|NCT02422797|460445747|FG001|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|1|||
127952772|NCT02422797|460445746|FG000|Continuation Phase(Week 148 to Week 410)|Protocol Violation|0|||
127952773|NCT02422797|460445747|FG001|Continuation Phase(Week 148 to Week 410)|Protocol Violation|1|||
127952774|NCT02422797|460445746|FG000|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
127952775|NCT02422797|460445747|FG001|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
127952776|NCT02422797|460445746|FG000|Continuation Phase(Week 148 to Week 410)|Adverse Event|0|||
127952777|NCT02422797|460445747|FG001|Continuation Phase(Week 148 to Week 410)|Adverse Event|2|||
127952778|NCT00369941|460445748|FG000|Overall Study|Never Treated|1|||
127952779|NCT00369941|460445749|FG001|Overall Study|Never Treated|2|||
127952780|NCT00369941|460445748|FG000|Overall Study|Adverse Event|14|||
127952781|NCT00369941|460445749|FG001|Overall Study|Adverse Event|28|||
127952782|NCT00369941|460445748|FG000|Overall Study|Lack of Efficacy|6|||
127952783|NCT00369941|460445749|FG001|Overall Study|Lack of Efficacy|10|||
127952784|NCT00369941|460445748|FG000|Overall Study|Lost to Follow-up|12|||
127952785|NCT00369941|460445749|FG001|Overall Study|Lost to Follow-up|22|||
127952786|NCT00369941|460445748|FG000|Overall Study|Protocol Violation|5|||
127952787|NCT00369941|460445749|FG001|Overall Study|Protocol Violation|3|||
127952788|NCT00369941|460445748|FG000|Overall Study|Withdrawal by Subject|5|||
127952789|NCT00369941|460445749|FG001|Overall Study|Withdrawal by Subject|18|||
127952790|NCT00369941|460445748|FG000|Overall Study|Pregnancy|4|||
127952791|NCT00369941|460445749|FG001|Overall Study|Pregnancy|2|||
127952792|NCT00369941|460445748|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
127952793|NCT00369941|460445749|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
127952794|NCT00369941|460445748|FG000|Overall Study|Moved|11|||
127952795|NCT00369941|460445749|FG001|Overall Study|Moved|5|||
127952796|NCT00369941|460445748|FG000|Overall Study|Treatment with Prohibited Medication|3|||
127952797|NCT00369941|460445749|FG001|Overall Study|Treatment with Prohibited Medication|1|||
127952798|NCT00369941|460445748|FG000|Overall Study|Employment Interfered with Study Visits|1|||
127952799|NCT00369941|460445749|FG001|Overall Study|Employment Interfered with Study Visits|0|||
127952800|NCT00369941|460445748|FG000|Overall Study|Study Site Terminated|2|||
127952801|NCT00369941|460445749|FG001|Overall Study|Study Site Terminated|0|||
127952802|NCT00369941|460445748|FG000|Overall Study|Miscellaneous|3|||
127952803|NCT00369941|460445749|FG001|Overall Study|Miscellaneous|3|||
127952804|NCT00403585|460445753|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
127952805|NCT00403585|460445753|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
127952806|NCT00403585|460445753|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
127952807|NCT00661193|460445754|FG000|Overall Study|Adverse Event|2|||
127952808|NCT00661193|460445755|FG001|Overall Study|Adverse Event|1|||
127952809|NCT00661193|460445754|FG000|Overall Study|Withdrawal by Subject|3|||
127952810|NCT00661193|460445755|FG001|Overall Study|Withdrawal by Subject|1|||
127952811|NCT00661193|460445754|FG000|Overall Study|Progression|27|||
127952812|NCT00661193|460445755|FG001|Overall Study|Progression|24|||
127952813|NCT00661193|460445754|FG000|Overall Study|Not protocol specified|1|||
127952814|NCT00661193|460445755|FG001|Overall Study|Not protocol specified|0|||
127952815|NCT02964312|460445756|FG000|Overall Study|Lost to Follow-up|28|||
127952816|NCT02964312|460445756|FG000|Overall Study|Withdrawal by Subject|11|||
127952817|NCT02964312|460445756|FG000|Overall Study|Lack of Efficacy|10|||
127952818|NCT02964312|460445756|FG000|Overall Study|Did not consent to long-term FU|14|||
127952819|NCT02964312|460445756|FG000|Overall Study|Death|1|||
127952820|NCT02862730|460445765|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
127952821|NCT02862730|460445766|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
127952822|NCT02862730|460445767|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
127952823|NCT02862730|460445768|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
127952824|NCT02862730|460445769|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
127952825|NCT02862730|460445770|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
127952826|NCT02862730|460445771|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
127952827|NCT02862730|460445765|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
127952828|NCT02862730|460445766|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
127952829|NCT02862730|460445767|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
127952830|NCT02862730|460445768|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
127952831|NCT02862730|460445769|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
127952832|NCT02862730|460445770|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
127952833|NCT02862730|460445771|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
127952834|NCT02862730|460445765|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
127952835|NCT02862730|460445766|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
127952836|NCT02862730|460445767|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
127952837|NCT02862730|460445768|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
127952838|NCT02862730|460445769|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
127952839|NCT02862730|460445770|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
127952840|NCT02862730|460445771|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
127952841|NCT02862730|460445765|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
127952842|NCT02862730|460445766|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
127952843|NCT02862730|460445767|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
127952844|NCT02862730|460445768|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
127952845|NCT02862730|460445769|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
127952846|NCT02862730|460445770|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
127952847|NCT02862730|460445771|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
127952848|NCT03685344|460445772|FG000|Overall Study|Withdrawal by Subject|1|||
127952849|NCT03685344|460445773|FG001|Overall Study|Withdrawal by Subject|1|||
127952850|NCT03685344|460445774|FG002|Overall Study|Withdrawal by Subject|2|||
127952851|NCT03685344|460445775|FG003|Overall Study|Withdrawal by Subject|0|||
127952852|NCT03685344|460445772|FG000|Overall Study|Physician Decision|1|||
127952853|NCT03685344|460445773|FG001|Overall Study|Physician Decision|1|||
127952854|NCT03685344|460445774|FG002|Overall Study|Physician Decision|5|||
127952855|NCT03685344|460445775|FG003|Overall Study|Physician Decision|0|||
127952856|NCT03685344|460445772|FG000|Overall Study|Death|1|||
127952857|NCT03685344|460445773|FG001|Overall Study|Death|1|||
127952858|NCT03685344|460445774|FG002|Overall Study|Death|0|||
127952859|NCT03685344|460445775|FG003|Overall Study|Death|0|||
127952860|NCT03126435|460445777|FG000|Overall Study|Death|90|||
127952861|NCT03126435|460445778|FG001|Overall Study|Death|84|||
127952862|NCT03126435|460445777|FG000|Overall Study|Lost to Follow-up|4|||
127952863|NCT03126435|460445778|FG001|Overall Study|Lost to Follow-up|3|||
127952864|NCT03126435|460445777|FG000|Overall Study|Physician Decision|0|||
127952865|NCT03126435|460445778|FG001|Overall Study|Physician Decision|1|||
127952866|NCT03126435|460445777|FG000|Overall Study|Withdrawal by Subject|6|||
127952867|NCT03126435|460445778|FG001|Overall Study|Withdrawal by Subject|12|||
127952868|NCT03126435|460445777|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
127952869|NCT03126435|460445778|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
127952870|NCT01023035|460445780|FG000|Treatment Period|Adverse Event|27|||
127952871|NCT01023035|460445781|FG001|Treatment Period|Adverse Event|32|||
127952872|NCT01023035|460445782|FG002|Treatment Period|Adverse Event|50|||
127952873|NCT01023035|460445780|FG000|Treatment Period|Non-Medical Reasons|19|||
127952874|NCT01023035|460445781|FG001|Treatment Period|Non-Medical Reasons|22|||
127952875|NCT01023035|460445782|FG002|Treatment Period|Non-Medical Reasons|44|||
127952876|NCT01023035|460445780|FG000|Treatment Period|Treatment Failure|26|||
127952877|NCT01023035|460445781|FG001|Treatment Period|Treatment Failure|31|||
127952878|NCT01023035|460445782|FG002|Treatment Period|Treatment Failure|24|||
127952879|NCT01023035|460445780|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
127952880|NCT01023035|460445781|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
127952881|NCT01023035|460445782|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
127952882|NCT01023035|460445780|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
127952883|NCT01023035|460445781|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
127952884|NCT01023035|460445782|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
127952885|NCT00524420|460445783|FG000|Overall Study|Lack of Efficacy|1|||
127952886|NCT00524420|460445784|FG001|Overall Study|Lack of Efficacy|0|||
127952887|NCT01090414|460445785|FG000|Study 101-99|Progressive Disease|28|||
127952888|NCT01090414|460445786|FG001|Study 101-99|Progressive Disease|48|||
127952889|NCT01090414|460445787|FG002|Study 101-99|Progressive Disease|10|||
127952890|NCT01090414|460445788|FG003|Study 101-99|Progressive Disease|4|||
127952891|NCT01090414|460445785|FG000|Study 101-99|Adverse Event|10|||
127952892|NCT01090414|460445786|FG001|Study 101-99|Adverse Event|28|||
127952893|NCT01090414|460445787|FG002|Study 101-99|Adverse Event|18|||
127952894|NCT01090414|460445788|FG003|Study 101-99|Adverse Event|0|||
127952895|NCT01090414|460445785|FG000|Study 101-99|Investigator Request|1|||
127952896|NCT01090414|460445786|FG001|Study 101-99|Investigator Request|11|||
127952897|NCT01090414|460445787|FG002|Study 101-99|Investigator Request|4|||
127952898|NCT01090414|460445788|FG003|Study 101-99|Investigator Request|0|||
127952899|NCT01090414|460445785|FG000|Study 101-99|Death|3|||
127952900|NCT01090414|460445786|FG001|Study 101-99|Death|8|||
127952901|NCT01090414|460445787|FG002|Study 101-99|Death|1|||
127952902|NCT01090414|460445788|FG003|Study 101-99|Death|0|||
127952903|NCT01090414|460445785|FG000|Study 101-99|Sponsor Discontinued Study|0|||
127952904|NCT01090414|460445786|FG001|Study 101-99|Sponsor Discontinued Study|7|||
127952905|NCT01090414|460445787|FG002|Study 101-99|Sponsor Discontinued Study|5|||
127952906|NCT01090414|460445788|FG003|Study 101-99|Sponsor Discontinued Study|0|||
127952907|NCT01090414|460445785|FG000|Study 101-99|Other (Unknown Reasons)|3|||
127952908|NCT01090414|460445786|FG001|Study 101-99|Other (Unknown Reasons)|3|||
127952909|NCT01090414|460445787|FG002|Study 101-99|Other (Unknown Reasons)|0|||
127952910|NCT01090414|460445788|FG003|Study 101-99|Other (Unknown Reasons)|0|||
127952911|NCT01090414|460445785|FG000|Study 101-99|Withdrew Consent|0|||
127952912|NCT01090414|460445786|FG001|Study 101-99|Withdrew Consent|2|||
127952913|NCT01090414|460445787|FG002|Study 101-99|Withdrew Consent|3|||
127952914|NCT01090414|460445788|FG003|Study 101-99|Withdrew Consent|1|||
127952915|NCT01090414|460445785|FG000|Study 101-99|Participant Request|3|||
127952916|NCT01090414|460445786|FG001|Study 101-99|Participant Request|1|||
127952917|NCT01090414|460445787|FG002|Study 101-99|Participant Request|0|||
127952918|NCT01090414|460445788|FG003|Study 101-99|Participant Request|0|||
127952919|NCT02413229|460445795|FG000|Overall Study|Adverse Event|0|||
127952920|NCT02413229|460445796|FG001|Overall Study|Adverse Event|0|||
127952921|NCT02413229|460445797|FG002|Overall Study|Adverse Event|0|||
127952922|NCT02413229|460445798|FG003|Overall Study|Adverse Event|1|||
127952923|NCT02413229|460445799|FG004|Overall Study|Adverse Event|0|||
127952924|NCT02413229|460445800|FG005|Overall Study|Adverse Event|0|||
127952925|NCT02413229|460445801|FG006|Overall Study|Adverse Event|0|||
127952926|NCT02413229|460445802|FG007|Overall Study|Adverse Event|1|||
127952927|NCT02413229|460445795|FG000|Overall Study|Lost to Follow-up|0|||
127952928|NCT02413229|460445796|FG001|Overall Study|Lost to Follow-up|0|||
127952929|NCT02413229|460445797|FG002|Overall Study|Lost to Follow-up|1|||
127952930|NCT02413229|460445798|FG003|Overall Study|Lost to Follow-up|0|||
127952931|NCT02413229|460445799|FG004|Overall Study|Lost to Follow-up|2|||
127952932|NCT02413229|460445800|FG005|Overall Study|Lost to Follow-up|0|||
127952933|NCT02413229|460445801|FG006|Overall Study|Lost to Follow-up|0|||
127952934|NCT02413229|460445802|FG007|Overall Study|Lost to Follow-up|0|||
127952935|NCT02413229|460445795|FG000|Overall Study|Withdrawal by Subject|1|||
127952936|NCT02413229|460445796|FG001|Overall Study|Withdrawal by Subject|1|||
127952937|NCT02413229|460445797|FG002|Overall Study|Withdrawal by Subject|0|||
127952938|NCT02413229|460445798|FG003|Overall Study|Withdrawal by Subject|0|||
127952939|NCT02413229|460445799|FG004|Overall Study|Withdrawal by Subject|1|||
127952940|NCT02413229|460445800|FG005|Overall Study|Withdrawal by Subject|0|||
127952941|NCT02413229|460445801|FG006|Overall Study|Withdrawal by Subject|0|||
127952942|NCT02413229|460445802|FG007|Overall Study|Withdrawal by Subject|2|||
127952943|NCT02413229|460445795|FG000|Overall Study|Progressive Disease|0|||
127952944|NCT02413229|460445796|FG001|Overall Study|Progressive Disease|0|||
127952945|NCT02413229|460445797|FG002|Overall Study|Progressive Disease|0|||
127952946|NCT02413229|460445798|FG003|Overall Study|Progressive Disease|0|||
127952947|NCT02413229|460445799|FG004|Overall Study|Progressive Disease|0|||
127952948|NCT02413229|460445800|FG005|Overall Study|Progressive Disease|0|||
127952949|NCT02413229|460445801|FG006|Overall Study|Progressive Disease|0|||
127952950|NCT02413229|460445802|FG007|Overall Study|Progressive Disease|1|||
127952951|NCT00699816|460445805|FG000|Overall Study|Protocol Violation|1|||
127952952|NCT00699816|460445806|FG001|Overall Study|Protocol Violation|3|||
127952953|NCT02454933|460445807|FG000|Overall Study|Progressive disease|10|||
127952954|NCT02454933|460445808|FG001|Overall Study|Progressive disease|7|||
127952955|NCT02454933|460445807|FG000|Overall Study|Adverse Event|1|||
127952956|NCT02454933|460445808|FG001|Overall Study|Adverse Event|1|||
127952957|NCT02454933|460445807|FG000|Overall Study|Withdrawal by Subject|0|||
127952958|NCT02454933|460445808|FG001|Overall Study|Withdrawal by Subject|3|||
127952959|NCT02454933|460445807|FG000|Overall Study|Lost to Follow-up|1|||
127952960|NCT02454933|460445808|FG001|Overall Study|Lost to Follow-up|0|||
127952961|NCT01526655|460445809|FG000|Overall Study|Withdrawal by Subject|0|||
127952962|NCT01526655|460445810|FG001|Overall Study|Withdrawal by Subject|1|||
127952963|NCT05211726|460445819|FG000|Overall Study|Withdrawal by Subject|2|||
127952964|NCT05211726|460445820|FG001|Overall Study|Withdrawal by Subject|3|||
127952965|NCT05211726|460445819|FG000|Overall Study|Protocol Violation|0|||
127952966|NCT05211726|460445820|FG001|Overall Study|Protocol Violation|1|||
127952967|NCT05061420|460445829|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
127952968|NCT05061420|460445830|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
127952969|NCT05061420|460445831|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
127952970|NCT05061420|460445829|FG000|Overall Study|Progressive disease|11|||
127952971|NCT05061420|460445830|FG001|Overall Study|Progressive disease|15|||
127952972|NCT05061420|460445831|FG002|Overall Study|Progressive disease|14|||
127952973|NCT05061420|460445829|FG000|Overall Study|Withdrawal by Subject|2|||
127952974|NCT05061420|460445830|FG001|Overall Study|Withdrawal by Subject|0|||
127952975|NCT05061420|460445831|FG002|Overall Study|Withdrawal by Subject|1|||
127952976|NCT05061420|460445829|FG000|Overall Study|Not related to COVID-19|2|||
127952977|NCT05061420|460445830|FG001|Overall Study|Not related to COVID-19|0|||
127952978|NCT05061420|460445831|FG002|Overall Study|Not related to COVID-19|0|||
127952979|NCT04868500|460445832|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
127952980|NCT04868500|460445833|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
127952981|NCT04868500|460445832|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
127952982|NCT04868500|460445833|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
127952983|NCT02374346|460445835|FG000|Overall Study|operated or discharged during weekend|48|||
127952984|NCT04807400|460445836|FG000|Overall Study|Adverse Event|2|||
127952985|NCT04807400|460445837|FG001|Overall Study|Adverse Event|3|||
127952986|NCT04807400|460445838|FG002|Overall Study|Adverse Event|3|||
127952987|NCT04807400|460445836|FG000|Overall Study|Death|2|||
127952988|NCT04807400|460445837|FG001|Overall Study|Death|0|||
127952989|NCT04807400|460445838|FG002|Overall Study|Death|0|||
127952990|NCT04807400|460445836|FG000|Overall Study|Lost to Follow-up|8|||
127952991|NCT04807400|460445837|FG001|Overall Study|Lost to Follow-up|6|||
127952992|NCT04807400|460445838|FG002|Overall Study|Lost to Follow-up|6|||
127952993|NCT04807400|460445836|FG000|Overall Study|Non-Compliance With Study Drug|0|||
127952994|NCT04807400|460445837|FG001|Overall Study|Non-Compliance With Study Drug|4|||
127952995|NCT04807400|460445838|FG002|Overall Study|Non-Compliance With Study Drug|1|||
127952996|NCT04807400|460445836|FG000|Overall Study|Participant Decision|20|||
127952997|NCT04807400|460445837|FG001|Overall Study|Participant Decision|19|||
127952998|NCT04807400|460445838|FG002|Overall Study|Participant Decision|26|||
127952999|NCT04807400|460445836|FG000|Overall Study|Physician Decision|0|||
127953000|NCT04807400|460445837|FG001|Overall Study|Physician Decision|1|||
127953001|NCT04807400|460445838|FG002|Overall Study|Physician Decision|0|||
127953002|NCT04807400|460445836|FG000|Overall Study|Protocol Violation|4|||
127953003|NCT04807400|460445837|FG001|Overall Study|Protocol Violation|3|||
127953004|NCT04807400|460445838|FG002|Overall Study|Protocol Violation|7|||
127953005|NCT04807400|460445836|FG000|Overall Study|Withdrawal by Subject|13|||
127953006|NCT04807400|460445837|FG001|Overall Study|Withdrawal by Subject|9|||
127953007|NCT04807400|460445838|FG002|Overall Study|Withdrawal by Subject|20|||
127953008|NCT04807400|460445836|FG000|Overall Study|Mis-randomized|1|||
127953009|NCT04807400|460445837|FG001|Overall Study|Mis-randomized|0|||
127953010|NCT04807400|460445838|FG002|Overall Study|Mis-randomized|0|||
127953011|NCT04650204|460445843|FG000|Overall Study|Study was Terminated|2|||
127953012|NCT04650204|460445844|FG001|Overall Study|Study was Terminated|1|||
127953013|NCT01330303|460445845|FG000|Period 1|Adverse Event|1|||
127953014|NCT01330303|460445846|FG001|Period 1|Adverse Event|0|||
127953015|NCT01330303|460445845|FG000|Period 1|Protocol Violation|0|||
127953016|NCT01330303|460445846|FG001|Period 1|Protocol Violation|1|||
127953017|NCT01330303|460445845|FG000|Period 1|Withdrawal by Subject|0|||
127953018|NCT01330303|460445846|FG001|Period 1|Withdrawal by Subject|1|||
127953019|NCT01107197|460445847|FG000|Overall Study|Death|12|||
127953020|NCT01107197|460445848|FG001|Overall Study|Death|10|||
127953021|NCT01107197|460445847|FG000|Overall Study|Lost to Follow-up|5|||
127953022|NCT01107197|460445848|FG001|Overall Study|Lost to Follow-up|8|||
127953023|NCT01107197|460445847|FG000|Overall Study|Withdrawal by Subject|3|||
127953024|NCT01107197|460445848|FG001|Overall Study|Withdrawal by Subject|5|||
127953025|NCT03548337|460445849|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
127953026|NCT03548337|460445850|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
127953027|NCT03548337|460445849|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
127953028|NCT03548337|460445850|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
127953029|NCT03548337|460445849|FG000|Infant Series|Lost to Follow-up|2|||
127953030|NCT03548337|460445850|FG001|Infant Series|Lost to Follow-up|1|||
127953031|NCT03548337|460445849|FG000|Infant Series|Adverse Event|0|||
127953032|NCT03548337|460445850|FG001|Infant Series|Adverse Event|2|||
127953033|NCT03548337|460445849|FG000|Infant Series|Randomized but Not Vaccinated|1|||
127953034|NCT03548337|460445850|FG001|Infant Series|Randomized but Not Vaccinated|0|||
127953035|NCT03548337|460445849|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
127953036|NCT03548337|460445850|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
127953037|NCT01911273|460445853|FG000|Overall Study|Progression of Disease|1|||
127953038|NCT01911273|460445854|FG001|Overall Study|Progression of Disease|0|||
127953039|NCT01911273|460445853|FG000|Overall Study|Withdrawal by Subject|0|||
127953040|NCT01911273|460445854|FG001|Overall Study|Withdrawal by Subject|2|||
127953041|NCT02445963|460445855|FG000|Overall Study|Lost to Follow-up|1|||
127953042|NCT02445963|460445856|FG001|Overall Study|Lost to Follow-up|0|||
127953043|NCT02445963|460445857|FG002|Overall Study|Lost to Follow-up|0|||
127953044|NCT02445963|460445858|FG003|Overall Study|Lost to Follow-up|0|||
127953045|NCT02445963|460445855|FG000|Overall Study|Change in employment|1|||
127953046|NCT02445963|460445856|FG001|Overall Study|Change in employment|0|||
127953047|NCT02445963|460445857|FG002|Overall Study|Change in employment|0|||
127953048|NCT02445963|460445858|FG003|Overall Study|Change in employment|0|||
127953049|NCT02445963|460445855|FG000|Overall Study|Symptoms post-vaccination|0|||
127953050|NCT02445963|460445856|FG001|Overall Study|Symptoms post-vaccination|0|||
127953051|NCT02445963|460445857|FG002|Overall Study|Symptoms post-vaccination|1|||
127953052|NCT02445963|460445858|FG003|Overall Study|Symptoms post-vaccination|0|||
127953053|NCT01957176|460445862|FG000|Overall Study|Adverse Event|2|||
127953054|NCT01957176|460445863|FG001|Overall Study|Adverse Event|0|||
127953055|NCT01957176|460445862|FG000|Overall Study|Physician Decision|2|||
127953056|NCT01957176|460445863|FG001|Overall Study|Physician Decision|1|||
127953057|NCT01957176|460445862|FG000|Overall Study|Withdrawal by Subject|1|||
127953058|NCT01957176|460445863|FG001|Overall Study|Withdrawal by Subject|0|||
127953059|NCT02359994|460445866|FG000|Overall Population Study|Adverse Event|1|||
127953060|NCT02359994|460445867|FG001|Overall Population Study|Adverse Event|1|||
127953061|NCT02359994|460445866|FG000|Overall Population Study|Death|1|||
127953062|NCT02359994|460445867|FG001|Overall Population Study|Death|5|||
127953063|NCT02359994|460445866|FG000|Overall Population Study|Lost to Follow-up|1|||
127953064|NCT02359994|460445867|FG001|Overall Population Study|Lost to Follow-up|1|||
127953065|NCT02359994|460445866|FG000|Overall Population Study|Withdrawal by Subject|1|||
127953066|NCT02359994|460445867|FG001|Overall Population Study|Withdrawal by Subject|0|||
127953067|NCT02359994|460445866|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
127953068|NCT02359994|460445867|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
127953069|NCT02359994|460445866|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
127953070|NCT02359994|460445867|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
127953071|NCT02359994|460445866|FG000|Extended Oncology 24-Month Survival|Death|19|||
127953072|NCT02359994|460445867|FG001|Extended Oncology 24-Month Survival|Death|21|||
127953073|NCT02359994|460445866|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
127953074|NCT02359994|460445867|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
127953075|NCT01823835|460445868|FG000|Overall Study|Adverse Event|0|||
127953076|NCT01823835|460445869|FG001|Overall Study|Adverse Event|0|||
127953077|NCT01823835|460445870|FG002|Overall Study|Adverse Event|0|||
127953078|NCT01823835|460445871|FG003|Overall Study|Adverse Event|0|||
127953079|NCT01823835|460445872|FG004|Overall Study|Adverse Event|1|||
127953080|NCT01823835|460445873|FG005|Overall Study|Adverse Event|0|||
127953081|NCT01823835|460445874|FG006|Overall Study|Adverse Event|1|||
127953082|NCT01823835|460445875|FG007|Overall Study|Adverse Event|0|||
127953083|NCT01823835|460445876|FG008|Overall Study|Adverse Event|0|||
127953084|NCT01823835|460445877|FG009|Overall Study|Adverse Event|0|||
127953085|NCT01823835|460445878|FG010|Overall Study|Adverse Event|1|||
127953086|NCT01823835|460445879|FG011|Overall Study|Adverse Event|2|||
127953087|NCT01823835|460445880|FG012|Overall Study|Adverse Event|0|||
127953088|NCT01823835|460445881|FG013|Overall Study|Adverse Event|0|||
127953089|NCT01823835|460445882|FG014|Overall Study|Adverse Event|0|||
127953090|NCT01823835|460445868|FG000|Overall Study|Physician Decision|0|||
127953091|NCT01823835|460445869|FG001|Overall Study|Physician Decision|0|||
127953092|NCT01823835|460445870|FG002|Overall Study|Physician Decision|0|||
127953093|NCT01823835|460445871|FG003|Overall Study|Physician Decision|0|||
127953094|NCT01823835|460445872|FG004|Overall Study|Physician Decision|0|||
127953095|NCT01823835|460445873|FG005|Overall Study|Physician Decision|0|||
127953096|NCT01823835|460445874|FG006|Overall Study|Physician Decision|0|||
127953097|NCT01823835|460445875|FG007|Overall Study|Physician Decision|0|||
127953098|NCT01823835|460445876|FG008|Overall Study|Physician Decision|0|||
127953099|NCT01823835|460445877|FG009|Overall Study|Physician Decision|0|||
127953100|NCT01823835|460445878|FG010|Overall Study|Physician Decision|0|||
127953101|NCT01823835|460445879|FG011|Overall Study|Physician Decision|2|||
127953102|NCT01823835|460445880|FG012|Overall Study|Physician Decision|0|||
127953103|NCT01823835|460445881|FG013|Overall Study|Physician Decision|0|||
127953104|NCT01823835|460445882|FG014|Overall Study|Physician Decision|0|||
127953105|NCT01823835|460445868|FG000|Overall Study|Progressive Disease|3|||
127953106|NCT01823835|460445869|FG001|Overall Study|Progressive Disease|4|||
127953107|NCT01823835|460445870|FG002|Overall Study|Progressive Disease|3|||
127953108|NCT01823835|460445871|FG003|Overall Study|Progressive Disease|6|||
127953109|NCT01823835|460445872|FG004|Overall Study|Progressive Disease|4|||
127953110|NCT01823835|460445873|FG005|Overall Study|Progressive Disease|6|||
127953111|NCT01823835|460445874|FG006|Overall Study|Progressive Disease|5|||
127953112|NCT01823835|460445875|FG007|Overall Study|Progressive Disease|3|||
127953113|NCT01823835|460445876|FG008|Overall Study|Progressive Disease|3|||
127953114|NCT01823835|460445877|FG009|Overall Study|Progressive Disease|18|||
127953115|NCT01823835|460445878|FG010|Overall Study|Progressive Disease|8|||
127953116|NCT01823835|460445879|FG011|Overall Study|Progressive Disease|46|||
127953117|NCT01823835|460445880|FG012|Overall Study|Progressive Disease|18|||
127953118|NCT01823835|460445881|FG013|Overall Study|Progressive Disease|4|||
127953119|NCT01823835|460445882|FG014|Overall Study|Progressive Disease|6|||
127953120|NCT01823835|460445868|FG000|Overall Study|Study Termination|0|||
127953121|NCT01823835|460445869|FG001|Overall Study|Study Termination|0|||
127953122|NCT01823835|460445870|FG002|Overall Study|Study Termination|0|||
127953123|NCT01823835|460445871|FG003|Overall Study|Study Termination|0|||
127953124|NCT01823835|460445872|FG004|Overall Study|Study Termination|1|||
127953125|NCT01823835|460445873|FG005|Overall Study|Study Termination|0|||
127953126|NCT01823835|460445874|FG006|Overall Study|Study Termination|0|||
127953127|NCT01823835|460445875|FG007|Overall Study|Study Termination|0|||
127953128|NCT01823835|460445876|FG008|Overall Study|Study Termination|0|||
127953129|NCT01823835|460445877|FG009|Overall Study|Study Termination|0|||
127953130|NCT01823835|460445878|FG010|Overall Study|Study Termination|0|||
127953131|NCT01823835|460445879|FG011|Overall Study|Study Termination|1|||
127953132|NCT01823835|460445880|FG012|Overall Study|Study Termination|0|||
127953133|NCT01823835|460445881|FG013|Overall Study|Study Termination|0|||
127953134|NCT01823835|460445882|FG014|Overall Study|Study Termination|0|||
127953135|NCT01823835|460445868|FG000|Overall Study|Withdrawal by Subject|0|||
127953136|NCT01823835|460445869|FG001|Overall Study|Withdrawal by Subject|0|||
127953137|NCT01823835|460445870|FG002|Overall Study|Withdrawal by Subject|1|||
127953138|NCT01823835|460445871|FG003|Overall Study|Withdrawal by Subject|0|||
127953139|NCT01823835|460445872|FG004|Overall Study|Withdrawal by Subject|0|||
127953140|NCT01823835|460445873|FG005|Overall Study|Withdrawal by Subject|0|||
127953141|NCT01823835|460445874|FG006|Overall Study|Withdrawal by Subject|0|||
127953142|NCT01823835|460445875|FG007|Overall Study|Withdrawal by Subject|0|||
127953143|NCT01823835|460445876|FG008|Overall Study|Withdrawal by Subject|0|||
127953144|NCT01823835|460445877|FG009|Overall Study|Withdrawal by Subject|1|||
127953145|NCT01823835|460445878|FG010|Overall Study|Withdrawal by Subject|1|||
127953146|NCT01823835|460445879|FG011|Overall Study|Withdrawal by Subject|2|||
127953147|NCT01823835|460445880|FG012|Overall Study|Withdrawal by Subject|1|||
127953148|NCT01823835|460445881|FG013|Overall Study|Withdrawal by Subject|0|||
127953149|NCT01823835|460445882|FG014|Overall Study|Withdrawal by Subject|0|||
127953150|NCT03017612|460445883|FG000|Overall Study|Adverse Event|2|||
127953151|NCT04460885|460447974|FG000|Overall Study|Withdrawal by Subject|6|||
127953152|NCT04460885|460447975|FG001|Overall Study|Withdrawal by Subject|8|||
127953153|NCT04460885|460447974|FG000|Overall Study|Site closure|1|||
127953154|NCT04460885|460447975|FG001|Overall Study|Site closure|0|||
127953155|NCT04460885|460447974|FG000|Overall Study|Death|5|||
127953156|NCT04460885|460447975|FG001|Overall Study|Death|4|||
127953157|NCT04460885|460447974|FG000|Overall Study|Physician Decision|2|||
127953158|NCT04460885|460447975|FG001|Overall Study|Physician Decision|1|||
127953159|NCT04460885|460447974|FG000|Overall Study|Lost to Follow-up|4|||
127953160|NCT04460885|460447975|FG001|Overall Study|Lost to Follow-up|4|||
127953161|NCT04559347|460447976|FG000|Overall Study|Death|1|||
127953162|NCT04559347|460447977|FG001|Overall Study|Death|0|||
127953163|NCT04559347|460447976|FG000|Overall Study|Thoracotomy conversion|1|||
127953164|NCT04559347|460447977|FG001|Overall Study|Thoracotomy conversion|1|||
127953165|NCT04559347|460447976|FG000|Overall Study|Provider unavailable|2|||
127953166|NCT04559347|460447977|FG001|Overall Study|Provider unavailable|1|||
127953167|NCT04559347|460447976|FG000|Overall Study|Other|2|||
127953168|NCT04559347|460447977|FG001|Overall Study|Other|1|||
127953169|NCT03999996|460447982|FG000|Prior to Booster|Adverse Event|2|||
127953170|NCT03999996|460447983|FG001|Prior to Booster|Adverse Event|0|||
127953171|NCT03999996|460447984|FG002|Prior to Booster|Adverse Event|0|||
127953172|NCT03999996|460447985|FG003|Prior to Booster|Adverse Event|0|||
127953173|NCT03999996|460447982|FG000|Prior to Booster|Lost to Follow-up|17|||
127953174|NCT03999996|460447983|FG001|Prior to Booster|Lost to Follow-up|22|||
127953175|NCT03999996|460447984|FG002|Prior to Booster|Lost to Follow-up|0|||
127953176|NCT03999996|460447985|FG003|Prior to Booster|Lost to Follow-up|0|||
127953177|NCT03999996|460447982|FG000|Prior to Booster|Withdrawal of Consent|51|||
127953178|NCT03999996|460447983|FG001|Prior to Booster|Withdrawal of Consent|8|||
127953179|NCT03999996|460447984|FG002|Prior to Booster|Withdrawal of Consent|0|||
127953180|NCT03999996|460447985|FG003|Prior to Booster|Withdrawal of Consent|0|||
127953181|NCT03999996|460447982|FG000|Prior to Booster|Death|0|||
127953182|NCT03999996|460447983|FG001|Prior to Booster|Death|1|||
127953183|NCT03999996|460447984|FG002|Prior to Booster|Death|0|||
127953184|NCT03999996|460447985|FG003|Prior to Booster|Death|0|||
127953185|NCT03999996|460447982|FG000|Prior to Booster|Reason Not Specified|27|||
127953186|NCT03999996|460447983|FG001|Prior to Booster|Reason Not Specified|4|||
127953187|NCT03999996|460447984|FG002|Prior to Booster|Reason Not Specified|0|||
127953188|NCT03999996|460447985|FG003|Prior to Booster|Reason Not Specified|0|||
127953189|NCT03999996|460447982|FG000|Booster Phase|Lost to Follow-up|0|||
127953190|NCT03999996|460447983|FG001|Booster Phase|Lost to Follow-up|0|||
127953191|NCT03999996|460447984|FG002|Booster Phase|Lost to Follow-up|3|||
127953192|NCT03999996|460447985|FG003|Booster Phase|Lost to Follow-up|3|||
127953193|NCT03999996|460447982|FG000|Booster Phase|Withdrawal of Consent|0|||
127953194|NCT03999996|460447983|FG001|Booster Phase|Withdrawal of Consent|0|||
127953195|NCT03999996|460447984|FG002|Booster Phase|Withdrawal of Consent|0|||
127953196|NCT03999996|460447985|FG003|Booster Phase|Withdrawal of Consent|1|||
127953197|NCT03999996|460447982|FG000|Booster Phase|Reason Not Specified|0|||
127953198|NCT03999996|460447983|FG001|Booster Phase|Reason Not Specified|0|||
127953199|NCT03999996|460447984|FG002|Booster Phase|Reason Not Specified|0|||
127953200|NCT03999996|460447985|FG003|Booster Phase|Reason Not Specified|1|||
127953201|NCT02717455|460447986|FG000|Overall Study|Adverse Event|1|||
127953202|NCT02717455|460447987|FG001|Overall Study|Adverse Event|0|||
127953203|NCT02717455|460447988|FG002|Overall Study|Adverse Event|0|||
127953204|NCT02717455|460447989|FG003|Overall Study|Adverse Event|2|||
127953205|NCT02717455|460447990|FG004|Overall Study|Adverse Event|2|||
127953206|NCT02717455|460447991|FG005|Overall Study|Adverse Event|2|||
127953207|NCT02717455|460447986|FG000|Overall Study|Withdrawal by Subject|1|||
127953208|NCT02717455|460447987|FG001|Overall Study|Withdrawal by Subject|1|||
127953209|NCT02717455|460447988|FG002|Overall Study|Withdrawal by Subject|0|||
127953210|NCT02717455|460447989|FG003|Overall Study|Withdrawal by Subject|2|||
127953211|NCT02717455|460447990|FG004|Overall Study|Withdrawal by Subject|2|||
127953212|NCT02717455|460447991|FG005|Overall Study|Withdrawal by Subject|1|||
127953213|NCT02717455|460447986|FG000|Overall Study|Death|1|||
127953214|NCT02717455|460447987|FG001|Overall Study|Death|0|||
127953215|NCT02717455|460447988|FG002|Overall Study|Death|0|||
127953216|NCT02717455|460447989|FG003|Overall Study|Death|0|||
127953217|NCT02717455|460447990|FG004|Overall Study|Death|1|||
127953218|NCT02717455|460447991|FG005|Overall Study|Death|0|||
127953219|NCT02717455|460447986|FG000|Overall Study|Did not receive study drug|0|||
127953220|NCT02717455|460447987|FG001|Overall Study|Did not receive study drug|0|||
127953221|NCT02717455|460447988|FG002|Overall Study|Did not receive study drug|0|||
127953222|NCT02717455|460447989|FG003|Overall Study|Did not receive study drug|1|||
127953223|NCT02717455|460447990|FG004|Overall Study|Did not receive study drug|0|||
127953224|NCT02717455|460447991|FG005|Overall Study|Did not receive study drug|1|||
127953225|NCT02717455|460447986|FG000|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
127953226|NCT02717455|460447987|FG001|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
127953227|NCT02717455|460447988|FG002|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
127953228|NCT02717455|460447989|FG003|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
127953229|NCT02717455|460447990|FG004|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
127953230|NCT02717455|460447991|FG005|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|1|||
127953231|NCT02717455|460447986|FG000|Overall Study|Patient off-treatment for other complicating disease|0|||
127953232|NCT02717455|460447987|FG001|Overall Study|Patient off-treatment for other complicating disease|0|||
127953233|NCT02717455|460447988|FG002|Overall Study|Patient off-treatment for other complicating disease|0|||
127953234|NCT02717455|460447989|FG003|Overall Study|Patient off-treatment for other complicating disease|1|||
127953235|NCT02717455|460447990|FG004|Overall Study|Patient off-treatment for other complicating disease|0|||
127953236|NCT02717455|460447991|FG005|Overall Study|Patient off-treatment for other complicating disease|0|||
127953237|NCT00233948|460447994|FG000|Overall Study|Adverse Event|1|||
127953238|NCT00233948|460447995|FG001|Overall Study|Adverse Event|0|||
127953239|NCT00233948|460447996|FG002|Overall Study|Adverse Event|0|||
127953240|NCT00233948|460447997|FG003|Overall Study|Adverse Event|0|||
127953241|NCT00233948|460447998|FG004|Overall Study|Adverse Event|0|||
127953242|NCT00233948|460447999|FG005|Overall Study|Adverse Event|0|||
127953243|NCT00733005|460448004|FG000|Overall Study|Adverse Event|0|||
127953244|NCT00733005|460448005|FG001|Overall Study|Adverse Event|1|||
127953245|NCT00733005|460448004|FG000|Overall Study|Treatment Failure|0|||
127953246|NCT00733005|460448005|FG001|Overall Study|Treatment Failure|1|||
127953247|NCT00733005|460448004|FG000|Overall Study|Withdrawal by Subject|0|||
127953248|NCT00733005|460448005|FG001|Overall Study|Withdrawal by Subject|1|||
127953249|NCT00733005|460448004|FG000|Overall Study|Protocol Violation|2|||
127953250|NCT00733005|460448005|FG001|Overall Study|Protocol Violation|0|||
127953251|NCT02465398|460448006|FG000|Overall Study|Death|7|||
127953252|NCT02465398|460448006|FG000|Overall Study|Revision|7|||
127953253|NCT02465398|460448006|FG000|Overall Study|did not receive study device|1|||
127953254|NCT02465398|460448006|FG000|Overall Study|Withdrawal by Subject|1|||
127953255|NCT02465398|460448006|FG000|Overall Study|Lost to Follow-up|14|||
127953256|NCT00266630|460448007|FG000|Overall Study|Adverse Event|8|||
127953257|NCT00266630|460448008|FG001|Overall Study|Adverse Event|6|||
127953258|NCT00266630|460448007|FG000|Overall Study|Lack of Efficacy|1|||
127953259|NCT00266630|460448008|FG001|Overall Study|Lack of Efficacy|4|||
127953260|NCT00266630|460448007|FG000|Overall Study|Entry Criteria not met|1|||
127953261|NCT00266630|460448008|FG001|Overall Study|Entry Criteria not met|0|||
127953262|NCT00266630|460448007|FG000|Overall Study|Protocol Violation|1|||
127953263|NCT00266630|460448008|FG001|Overall Study|Protocol Violation|3|||
127953264|NCT00266630|460448007|FG000|Overall Study|Physician Decision|1|||
127953265|NCT00266630|460448008|FG001|Overall Study|Physician Decision|2|||
127953266|NCT00266630|460448007|FG000|Overall Study|Withdrawal by Subject|10|||
127953267|NCT00266630|460448008|FG001|Overall Study|Withdrawal by Subject|2|||
127953268|NCT00266630|460448007|FG000|Overall Study|Lost to Follow-up|1|||
127953269|NCT00266630|460448008|FG001|Overall Study|Lost to Follow-up|0|||
127953270|NCT00266630|460448007|FG000|Overall Study|Other|19|||
127953271|NCT00266630|460448008|FG001|Overall Study|Other|11|||
127953272|NCT03410056|460448009|FG000|Overall Study|Decision by Sponsor|0|||
127953273|NCT03410056|460448010|FG001|Overall Study|Decision by Sponsor|0|||
127953274|NCT03410056|460448011|FG002|Overall Study|Decision by Sponsor|3|||
127953275|NCT03410056|460448012|FG003|Overall Study|Decision by Sponsor|0|||
127953276|NCT03410056|460448013|FG004|Overall Study|Decision by Sponsor|0|||
127953277|NCT03410056|460448014|FG005|Overall Study|Decision by Sponsor|0|||
127953278|NCT03410056|460448015|FG006|Overall Study|Decision by Sponsor|0|||
127953279|NCT03410056|460448009|FG000|Overall Study|Withdrawal by Subject|0|||
127953280|NCT03410056|460448010|FG001|Overall Study|Withdrawal by Subject|2|||
127953281|NCT03410056|460448011|FG002|Overall Study|Withdrawal by Subject|5|||
127953282|NCT03410056|460448012|FG003|Overall Study|Withdrawal by Subject|5|||
127953283|NCT03410056|460448013|FG004|Overall Study|Withdrawal by Subject|0|||
127953284|NCT03410056|460448014|FG005|Overall Study|Withdrawal by Subject|0|||
127953285|NCT03410056|460448015|FG006|Overall Study|Withdrawal by Subject|0|||
127953286|NCT00064987|460448020|FG000|Overall Study|Physician Decision|3|||
127953287|NCT00064987|460448021|FG001|Overall Study|Physician Decision|0|||
127953288|NCT00764881|460448022|FG000|Overall Study|Adverse Event|5|||
127953289|NCT00764881|460448023|FG001|Overall Study|Adverse Event|1|||
127953290|NCT00764881|460448022|FG000|Overall Study|Withdrawal by Subject|1|||
127953291|NCT00764881|460448023|FG001|Overall Study|Withdrawal by Subject|3|||
127953292|NCT00764881|460448022|FG000|Overall Study|Protocol Violation|2|||
127953293|NCT00764881|460448023|FG001|Overall Study|Protocol Violation|2|||
127953294|NCT00764881|460448022|FG000|Overall Study|Lost to Follow-up|2|||
127953295|NCT00764881|460448023|FG001|Overall Study|Lost to Follow-up|0|||
127953296|NCT00764881|460448022|FG000|Overall Study|Noncompliant|1|||
127953297|NCT00764881|460448023|FG001|Overall Study|Noncompliant|0|||
127953298|NCT00764881|460448022|FG000|Overall Study|Accidentally discontinued study drug|1|||
127953299|NCT00764881|460448023|FG001|Overall Study|Accidentally discontinued study drug|0|||
127953300|NCT00764881|460448022|FG000|Overall Study|Wished to become pregnant|1|||
127953301|NCT00764881|460448023|FG001|Overall Study|Wished to become pregnant|0|||
127953302|NCT00764881|460448022|FG000|Overall Study|Carcinoma detected|1|||
127953303|NCT00764881|460448023|FG001|Overall Study|Carcinoma detected|0|||
127953304|NCT00764881|460448022|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
127953305|NCT00764881|460448023|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
127953306|NCT00764881|460448022|FG000|Overall Study|no treatment or no observation|2|||
127953307|NCT00764881|460448023|FG001|Overall Study|no treatment or no observation|2|||
127953308|NCT01214655|460448024|FG000|Part A|Progressive Disease|7|||
127953309|NCT01214655|460448025|FG001|Part A|Progressive Disease|0|||
127953310|NCT01214655|460448026|FG002|Part A|Progressive Disease|0|||
127953311|NCT01214655|460448024|FG000|Part A|Physician Decision|1|||
127953312|NCT01214655|460448025|FG001|Part A|Physician Decision|0|||
127953313|NCT01214655|460448026|FG002|Part A|Physician Decision|0|||
127953314|NCT01214655|460448024|FG000|Part B|Progressive disease|0|||
127953315|NCT01214655|460448025|FG001|Part B|Progressive disease|10|||
127953316|NCT01214655|460448026|FG002|Part B|Progressive disease|0|||
127953317|NCT01214655|460448024|FG000|Part B|Death|0|||
127953318|NCT01214655|460448025|FG001|Part B|Death|1|||
127953319|NCT01214655|460448026|FG002|Part B|Death|0|||
127953320|NCT01214655|460448024|FG000|Part B|Withdrawal by Subject|0|||
127953321|NCT01214655|460448025|FG001|Part B|Withdrawal by Subject|2|||
127953322|NCT01214655|460448026|FG002|Part B|Withdrawal by Subject|0|||
127953323|NCT01214655|460448024|FG000|Part C|Progressive Disease|0|||
127953324|NCT01214655|460448025|FG001|Part C|Progressive Disease|0|||
127953325|NCT01214655|460448026|FG002|Part C|Progressive Disease|5|||
127953326|NCT01214655|460448024|FG000|Part C|Death|0|||
127953327|NCT01214655|460448025|FG001|Part C|Death|0|||
127953328|NCT01214655|460448026|FG002|Part C|Death|1|||
127953329|NCT01214655|460448024|FG000|Part C|Physician Decision|0|||
127953330|NCT01214655|460448025|FG001|Part C|Physician Decision|0|||
127953331|NCT01214655|460448026|FG002|Part C|Physician Decision|1|||
127953332|NCT05256134|460448030|FG000|Overall Study|Study Terminated by Sponsor|11|||
127953333|NCT05256134|460448031|FG001|Overall Study|Study Terminated by Sponsor|10|||
127953334|NCT05256134|460448030|FG000|Overall Study|Withdrawal by Subject|1|||
127953335|NCT05256134|460448031|FG001|Overall Study|Withdrawal by Subject|3|||
127953336|NCT01567462|460448032|FG000|Overall Study|Withdrawal by Subject|4|||
127953337|NCT01567462|460448033|FG001|Overall Study|Withdrawal by Subject|7|||
127953338|NCT00886015|460448042|FG000|Overall Study|Death|0|||
127953339|NCT00886015|460448043|FG001|Overall Study|Death|2|||
127953340|NCT01977417|460448044|FG000|Overall Study|Adverse Event|1|||
127953341|NCT01977417|460448045|FG001|Overall Study|Adverse Event|0|||
127953342|NCT01977417|460448044|FG000|Overall Study|Withdrawal by Subject|2|||
127953343|NCT01977417|460448045|FG001|Overall Study|Withdrawal by Subject|4|||
127953344|NCT01977417|460448044|FG000|Overall Study|Female enrollment goal met|0|||
127953345|NCT01977417|460448045|FG001|Overall Study|Female enrollment goal met|2|||
127953346|NCT00855894|460448050|FG000|Overall Study|Death|31|||
127953347|NCT00855894|460448050|FG000|Overall Study|Patient's decision|1|||
127953348|NCT00855894|460448050|FG000|Overall Study|Disease progression|1|||
127953349|NCT02548156|460448055|FG000|Washout Period 1|Lost to Follow-up|0|||
127953350|NCT02548156|460448056|FG001|Washout Period 1|Lost to Follow-up|0|||
127953351|NCT02548156|460448057|FG002|Washout Period 1|Lost to Follow-up|0|||
127953352|NCT02548156|460448058|FG003|Washout Period 1|Lost to Follow-up|0|||
127953353|NCT02548156|460448059|FG004|Washout Period 1|Lost to Follow-up|1|||
127953354|NCT02548156|460448060|FG005|Washout Period 1|Lost to Follow-up|0|||
127953355|NCT01068262|460448065|FG000|Overall Study|Adverse Event|2|||
127953356|NCT01068262|460448066|FG001|Overall Study|Adverse Event|0|||
127953357|NCT01068262|460448067|FG002|Overall Study|Adverse Event|1|||
127953358|NCT01068262|460448068|FG003|Overall Study|Adverse Event|0|||
127953359|NCT01068262|460448065|FG000|Overall Study|Protocol Violation|1|||
127953360|NCT01068262|460448066|FG001|Overall Study|Protocol Violation|0|||
127953361|NCT01068262|460448067|FG002|Overall Study|Protocol Violation|0|||
127953362|NCT01068262|460448068|FG003|Overall Study|Protocol Violation|0|||
127953363|NCT01068262|460448065|FG000|Overall Study|Withdrawal by Subject|0|||
127953364|NCT01068262|460448066|FG001|Overall Study|Withdrawal by Subject|1|||
127953365|NCT01068262|460448067|FG002|Overall Study|Withdrawal by Subject|0|||
127953366|NCT01068262|460448068|FG003|Overall Study|Withdrawal by Subject|0|||
127953367|NCT00444587|460448071|FG000|Overall Study|Death|2|||
127953368|NCT00444587|460448072|FG001|Overall Study|Death|1|||
127953369|NCT00444587|460448071|FG000|Overall Study|Progression of the disease|73|||
127953370|NCT00444587|460448072|FG001|Overall Study|Progression of the disease|8|||
127953371|NCT00444587|460448071|FG000|Overall Study|Refused treatment/did not cooperate|4|||
127953372|NCT00444587|460448072|FG001|Overall Study|Refused treatment/did not cooperate|1|||
127953373|NCT00444587|460448071|FG000|Overall Study|Investigator decision|3|||
127953374|NCT00444587|460448072|FG001|Overall Study|Investigator decision|0|||
127953375|NCT00444587|460448071|FG000|Overall Study|Protocol Violation|1|||
127953376|NCT00444587|460448072|FG001|Overall Study|Protocol Violation|0|||
127953377|NCT00444587|460448071|FG000|Overall Study|Missing|0|||
127953378|NCT00444587|460448072|FG001|Overall Study|Missing|5|||
127953379|NCT01720225|460448081|FG000|Overall Study|Withdrawal by Subject|0|||
127953380|NCT01720225|460448082|FG001|Overall Study|Withdrawal by Subject|1|||
127953381|NCT01720225|460448081|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
127953382|NCT01720225|460448082|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
127953383|NCT01473407|460448083|FG000|Overall Study|Physician Decision|1|||
127953384|NCT01473407|460448084|FG001|Overall Study|Physician Decision|4|||
127953385|NCT01473407|460448083|FG000|Overall Study|Lost to Follow-up|10|||
127953386|NCT01473407|460448084|FG001|Overall Study|Lost to Follow-up|4|||
127953387|NCT01473407|460448083|FG000|Overall Study|Adverse Event|8|||
127953388|NCT01473407|460448084|FG001|Overall Study|Adverse Event|8|||
127953389|NCT01473407|460448083|FG000|Overall Study|Randomization Error|3|||
127953390|NCT01473407|460448084|FG001|Overall Study|Randomization Error|1|||
127953391|NCT01473407|460448083|FG000|Overall Study|Withdrawal by Subject|4|||
127953392|NCT01473407|460448084|FG001|Overall Study|Withdrawal by Subject|7|||
127953393|NCT01473407|460448083|FG000|Overall Study|Kidney Transplant|7|||
127953394|NCT01473407|460448084|FG001|Overall Study|Kidney Transplant|6|||
127953395|NCT01473407|460448083|FG000|Overall Study|Vacation/Travel|1|||
127953396|NCT01473407|460448084|FG001|Overall Study|Vacation/Travel|1|||
127953397|NCT01473407|460448083|FG000|Overall Study|Elevated Hemoglobin|1|||
127953398|NCT01473407|460448084|FG001|Overall Study|Elevated Hemoglobin|0|||
127953399|NCT01473407|460448083|FG000|Overall Study|Patient Received Aranesp|1|||
127953400|NCT01473407|460448084|FG001|Overall Study|Patient Received Aranesp|0|||
127953401|NCT01473407|460448083|FG000|Overall Study|Patient Lost Green Card Status|1|||
127953402|NCT01473407|460448084|FG001|Overall Study|Patient Lost Green Card Status|0|||
127953403|NCT01473407|460448083|FG000|Overall Study|Temperature Excursion|2|||
127953404|NCT01473407|460448084|FG001|Overall Study|Temperature Excursion|3|||
127953405|NCT01473407|460448083|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
127953406|NCT01473407|460448084|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
127953407|NCT01473407|460448083|FG000|Overall Study|Sponsor's Decision|10|||
127953408|NCT01473407|460448084|FG001|Overall Study|Sponsor's Decision|10|||
127953409|NCT01473407|460448083|FG000|Overall Study|Site Closure|1|||
127953410|NCT01473407|460448084|FG001|Overall Study|Site Closure|0|||
127953411|NCT01027702|460448085|FG000|Overall Study|Received subsequent therapy|1|||
127953412|NCT01027702|460448086|FG001|Overall Study|Received subsequent therapy|2|||
127953413|NCT01027702|460448087|FG002|Overall Study|Received subsequent therapy|0|||
127953414|NCT01027702|460448088|FG003|Overall Study|Received subsequent therapy|4|||
127953415|NCT01027702|460448089|FG004|Overall Study|Received subsequent therapy|1|||
127953416|NCT01027702|460448090|FG005|Overall Study|Received subsequent therapy|0|||
127953417|NCT01027702|460448091|FG006|Overall Study|Received subsequent therapy|1|||
127953418|NCT01027702|460448085|FG000|Overall Study|Death|0|||
127953419|NCT01027702|460448086|FG001|Overall Study|Death|0|||
127953420|NCT01027702|460448087|FG002|Overall Study|Death|1|||
127953421|NCT01027702|460448088|FG003|Overall Study|Death|0|||
127953422|NCT01027702|460448089|FG004|Overall Study|Death|0|||
127953423|NCT01027702|460448090|FG005|Overall Study|Death|0|||
127953424|NCT01027702|460448091|FG006|Overall Study|Death|0|||
127953425|NCT02301390|460448092|FG000|Overall Study|Withdrawal by Subject|3|||
127953426|NCT02301390|460448093|FG001|Overall Study|Withdrawal by Subject|5|||
127953427|NCT02301390|460448092|FG000|Overall Study|Protocol Violation|1|||
127953428|NCT02301390|460448093|FG001|Overall Study|Protocol Violation|0|||
127953429|NCT02301390|460448092|FG000|Overall Study|Physician Decision|1|||
127953430|NCT02301390|460448093|FG001|Overall Study|Physician Decision|0|||
127953431|NCT02301390|460448092|FG000|Overall Study|Lost to Follow-up|0|||
127953432|NCT02301390|460448093|FG001|Overall Study|Lost to Follow-up|1|||
127953433|NCT02301390|460448092|FG000|Overall Study|Death|2|||
127953434|NCT02301390|460448093|FG001|Overall Study|Death|2|||
127953435|NCT02301390|460448092|FG000|Overall Study|Procedure not completed|0|||
127953436|NCT02301390|460448093|FG001|Overall Study|Procedure not completed|4|||
127953437|NCT02301390|460448092|FG000|Overall Study|Missed multiple visits|1|||
127953438|NCT02301390|460448093|FG001|Overall Study|Missed multiple visits|1|||
127953439|NCT02301390|460448092|FG000|Overall Study|study terminated|2|||
127953440|NCT02301390|460448093|FG001|Overall Study|study terminated|0|||
127953441|NCT01153425|460448097|FG000|Overall Study|Withdrawal by Subject|3|||
127953442|NCT01153425|460448098|FG001|Overall Study|Withdrawal by Subject|3|||
127953443|NCT02932462|460448104|FG000|Overall Study|Adverse Event|1|||
127953444|NCT02932462|460448105|FG001|Overall Study|Adverse Event|2|||
127953445|NCT02932462|460448104|FG000|Overall Study|Lost to Follow-up|4|||
127953446|NCT02932462|460448105|FG001|Overall Study|Lost to Follow-up|1|||
127953447|NCT02932462|460448104|FG000|Overall Study|Protocol Violation|0|||
127953448|NCT02932462|460448105|FG001|Overall Study|Protocol Violation|5|||
127953449|NCT02932462|460448104|FG000|Overall Study|Withdrawal by Subject|1|||
127953450|NCT02932462|460448105|FG001|Overall Study|Withdrawal by Subject|4|||
127953451|NCT02932462|460448104|FG000|Overall Study|Non-Compliance With Study Drug|0|||
127953452|NCT02932462|460448105|FG001|Overall Study|Non-Compliance With Study Drug|1|||
127953453|NCT02932462|460448104|FG000|Overall Study|Progressive Disease|1|||
127953454|NCT02932462|460448105|FG001|Overall Study|Progressive Disease|0|||
127953455|NCT02652949|460448106|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
127953456|NCT02652949|460448106|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
127953457|NCT02652949|460448106|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
127953458|NCT02652949|460448106|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
127953459|NCT02652949|460448106|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
127953460|NCT02652949|460448106|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
127953461|NCT02652949|460448106|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
127953462|NCT02652949|460448106|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
127953463|NCT02652949|460448106|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
127953464|NCT02652949|460448106|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
127953465|NCT02652949|460448106|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
127953466|NCT02652949|460448106|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
127953467|NCT02652949|460448106|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
127953468|NCT02652949|460448106|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
127953469|NCT02652949|460448106|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
127953470|NCT02652949|460448106|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
127953471|NCT02652949|460448106|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
127953472|NCT03594071|460448107|FG000|Overall Study|Re-operation|3|||
127953473|NCT03594071|460448107|FG000|Overall Study|Missed visit|2|||
127953474|NCT03022370|460448108|FG000|Overall Study|Death|6|||
127953475|NCT03022370|460448109|FG001|Overall Study|Death|12|||
127953476|NCT03022370|460448108|FG000|Overall Study|Lost to Follow-up|174|||
127953477|NCT03022370|460448109|FG001|Overall Study|Lost to Follow-up|109|||
127953478|NCT04753216|460448112|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
127953479|NCT04753216|460448112|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
127953480|NCT04753216|460448112|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
127953481|NCT02001987|460448114|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
127953482|NCT02001987|460448114|FG000|Core Study Period (24 Weeks)|Death|1|||
127953483|NCT02001987|460448114|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
127953484|NCT02001987|460448114|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
127953485|NCT02001987|460448114|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
127953486|NCT02001987|460448114|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
127953487|NCT02001987|460448114|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
127953488|NCT02001987|460448114|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
127953489|NCT02001987|460448114|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
127953490|NCT02001987|460448114|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
127953491|NCT02001987|460448114|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
127953492|NCT02001987|460448114|FG000|LTE Period (52 Weeks)|Other|3|||
127953493|NCT01965860|460448115|FG000|Overall Study|Pregnancy|1|||
127953494|NCT01965860|460448116|FG001|Overall Study|Pregnancy|0|||
127953495|NCT01965860|460448117|FG002|Overall Study|Pregnancy|1|||
127953496|NCT01965860|460448115|FG000|Overall Study|Logistics|1|||
127953497|NCT01965860|460448116|FG001|Overall Study|Logistics|0|||
127953498|NCT01965860|460448117|FG002|Overall Study|Logistics|0|||
127953499|NCT02288325|460448121|FG000|Run-in Period|Adverse Event|48|||
127953500|NCT02288325|460448122|FG001|Run-in Period|Adverse Event|0|||
127953501|NCT02288325|460448123|FG002|Run-in Period|Adverse Event|0|||
127953502|NCT02288325|460448121|FG000|Run-in Period|Lack of Efficacy|16|||
127953503|NCT02288325|460448122|FG001|Run-in Period|Lack of Efficacy|0|||
127953504|NCT02288325|460448123|FG002|Run-in Period|Lack of Efficacy|0|||
127953505|NCT02288325|460448121|FG000|Run-in Period|Withdrawal of Consent|28|||
127953506|NCT02288325|460448122|FG001|Run-in Period|Withdrawal of Consent|0|||
127953507|NCT02288325|460448123|FG002|Run-in Period|Withdrawal of Consent|0|||
127953508|NCT02288325|460448121|FG000|Run-in Period|Lost to Follow-up|25|||
127953509|NCT02288325|460448122|FG001|Run-in Period|Lost to Follow-up|0|||
127953510|NCT02288325|460448123|FG002|Run-in Period|Lost to Follow-up|0|||
127953511|NCT02288325|460448121|FG000|Run-in Period|Protocol Violation|17|||
127953512|NCT02288325|460448122|FG001|Run-in Period|Protocol Violation|0|||
127953513|NCT02288325|460448123|FG002|Run-in Period|Protocol Violation|0|||
127953514|NCT02288325|460448121|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
127953515|NCT02288325|460448122|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
127953516|NCT02288325|460448123|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
127953517|NCT02288325|460448121|FG000|Run-in Period|Reason not Specified|8|||
127953518|NCT02288325|460448122|FG001|Run-in Period|Reason not Specified|0|||
127953519|NCT02288325|460448123|FG002|Run-in Period|Reason not Specified|0|||
127953520|NCT02288325|460448121|FG000|Stabilization Period|Adverse Event|13|||
127953521|NCT02288325|460448122|FG001|Stabilization Period|Adverse Event|0|||
127953522|NCT02288325|460448123|FG002|Stabilization Period|Adverse Event|0|||
127953523|NCT02288325|460448121|FG000|Stabilization Period|Lack of Efficacy|22|||
127953524|NCT02288325|460448122|FG001|Stabilization Period|Lack of Efficacy|0|||
127953525|NCT02288325|460448123|FG002|Stabilization Period|Lack of Efficacy|0|||
127953526|NCT02288325|460448121|FG000|Stabilization Period|Withdrawal of Consent|23|||
127953527|NCT02288325|460448122|FG001|Stabilization Period|Withdrawal of Consent|0|||
127953528|NCT02288325|460448123|FG002|Stabilization Period|Withdrawal of Consent|0|||
127953529|NCT02288325|460448121|FG000|Stabilization Period|Lost to Follow-up|12|||
127953530|NCT02288325|460448122|FG001|Stabilization Period|Lost to Follow-up|0|||
127953531|NCT02288325|460448123|FG002|Stabilization Period|Lost to Follow-up|0|||
127953532|NCT02288325|460448121|FG000|Stabilization Period|Protocol Violation|8|||
127953533|NCT02288325|460448122|FG001|Stabilization Period|Protocol Violation|0|||
127953534|NCT02288325|460448123|FG002|Stabilization Period|Protocol Violation|0|||
127953535|NCT02288325|460448121|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
127953536|NCT02288325|460448122|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
127953537|NCT02288325|460448123|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
127953538|NCT02288325|460448121|FG000|Stabilization Period|Reason not Specified|15|||
127953539|NCT02288325|460448122|FG001|Stabilization Period|Reason not Specified|0|||
127953540|NCT02288325|460448123|FG002|Stabilization Period|Reason not Specified|0|||
127953541|NCT02288325|460448121|FG000|Double-blind Treatment Period|Adverse Event|0|||
127953542|NCT02288325|460448122|FG001|Double-blind Treatment Period|Adverse Event|2|||
127953543|NCT02288325|460448123|FG002|Double-blind Treatment Period|Adverse Event|5|||
127953544|NCT02288325|460448121|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
127953545|NCT02288325|460448122|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
127953546|NCT02288325|460448123|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
127953547|NCT02288325|460448121|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
127953548|NCT02288325|460448122|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
127953549|NCT02288325|460448123|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
127953550|NCT02288325|460448121|FG000|Double-blind Treatment Period|Protocol Violation|0|||
127953551|NCT02288325|460448122|FG001|Double-blind Treatment Period|Protocol Violation|1|||
127953552|NCT02288325|460448123|FG002|Double-blind Treatment Period|Protocol Violation|2|||
127953553|NCT02288325|460448121|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
127953554|NCT02288325|460448122|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
127953555|NCT02288325|460448123|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
127953556|NCT02288325|460448121|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
127953557|NCT02288325|460448122|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
127953558|NCT02288325|460448123|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
127953559|NCT03138655|460448124|FG000|Overall Study|Adverse Event|2|||
127953560|NCT03138655|460448125|FG001|Overall Study|Adverse Event|1|||
127953561|NCT03138655|460448126|FG002|Overall Study|Adverse Event|2|||
127953562|NCT03138655|460448127|FG003|Overall Study|Adverse Event|1|||
127953563|NCT03138655|460448128|FG004|Overall Study|Adverse Event|1|||
127953564|NCT03138655|460448129|FG005|Overall Study|Adverse Event|4|||
127953565|NCT03138655|460448130|FG006|Overall Study|Adverse Event|2|||
127953566|NCT03138655|460448131|FG007|Overall Study|Adverse Event|2|||
127953567|NCT03138655|460448124|FG000|Overall Study|Withdrawal by Subject|0|||
127953568|NCT03138655|460448125|FG001|Overall Study|Withdrawal by Subject|1|||
127953569|NCT03138655|460448126|FG002|Overall Study|Withdrawal by Subject|0|||
127953570|NCT03138655|460448127|FG003|Overall Study|Withdrawal by Subject|0|||
127953571|NCT03138655|460448128|FG004|Overall Study|Withdrawal by Subject|0|||
127953572|NCT03138655|460448129|FG005|Overall Study|Withdrawal by Subject|0|||
127953573|NCT03138655|460448130|FG006|Overall Study|Withdrawal by Subject|1|||
127953574|NCT03138655|460448131|FG007|Overall Study|Withdrawal by Subject|0|||
127953575|NCT03138655|460448124|FG000|Overall Study|Reason not Specified|1|||
127953576|NCT03138655|460448125|FG001|Overall Study|Reason not Specified|0|||
127953577|NCT03138655|460448126|FG002|Overall Study|Reason not Specified|0|||
127953578|NCT03138655|460448127|FG003|Overall Study|Reason not Specified|2|||
127953579|NCT03138655|460448128|FG004|Overall Study|Reason not Specified|1|||
127953580|NCT03138655|460448129|FG005|Overall Study|Reason not Specified|1|||
127953581|NCT03138655|460448130|FG006|Overall Study|Reason not Specified|0|||
127953582|NCT03138655|460448131|FG007|Overall Study|Reason not Specified|0|||
127953583|NCT02565511|460448132|FG000|Overall Study|Study terminated by Sponsor|35|||
127953584|NCT02565511|460448133|FG001|Overall Study|Study terminated by Sponsor|22|||
127953585|NCT02565511|460448134|FG002|Overall Study|Study terminated by Sponsor|235|||
127953586|NCT02565511|460448135|FG003|Overall Study|Study terminated by Sponsor|156|||
127953587|NCT02565511|460448132|FG000|Overall Study|Withdrawal by Subject|3|||
127953588|NCT02565511|460448133|FG001|Overall Study|Withdrawal by Subject|0|||
127953589|NCT02565511|460448134|FG002|Overall Study|Withdrawal by Subject|12|||
127953590|NCT02565511|460448135|FG003|Overall Study|Withdrawal by Subject|5|||
127953591|NCT02565511|460448132|FG000|Overall Study|Adverse Event|0|||
127953592|NCT02565511|460448133|FG001|Overall Study|Adverse Event|0|||
127953593|NCT02565511|460448134|FG002|Overall Study|Adverse Event|1|||
127953594|NCT02565511|460448135|FG003|Overall Study|Adverse Event|1|||
127953595|NCT02565511|460448132|FG000|Overall Study|Lost to Follow-up|4|||
127953596|NCT02565511|460448133|FG001|Overall Study|Lost to Follow-up|1|||
127953597|NCT02565511|460448134|FG002|Overall Study|Lost to Follow-up|0|||
127953598|NCT02565511|460448135|FG003|Overall Study|Lost to Follow-up|1|||
127953599|NCT02565511|460448132|FG000|Overall Study|Physician Decision|0|||
127953600|NCT02565511|460448133|FG001|Overall Study|Physician Decision|0|||
127953601|NCT02565511|460448134|FG002|Overall Study|Physician Decision|0|||
127953602|NCT02565511|460448135|FG003|Overall Study|Physician Decision|1|||
127953603|NCT02565511|460448132|FG000|Overall Study|Protocol deviation|0|||
127953604|NCT02565511|460448133|FG001|Overall Study|Protocol deviation|0|||
127953605|NCT02565511|460448134|FG002|Overall Study|Protocol deviation|3|||
127953606|NCT02565511|460448135|FG003|Overall Study|Protocol deviation|0|||
127953607|NCT03656744|460448136|FG000|Overall Study|Adverse Event|1|||
127953608|NCT03656744|460448137|FG001|Overall Study|Adverse Event|4|||
127953609|NCT03656744|460448138|FG002|Overall Study|Adverse Event|1|||
127953610|NCT03656744|460448136|FG000|Overall Study|Protocol Violation|1|||
127953611|NCT03656744|460448137|FG001|Overall Study|Protocol Violation|0|||
127953612|NCT03656744|460448138|FG002|Overall Study|Protocol Violation|0|||
127953613|NCT03656744|460448136|FG000|Overall Study|Lost to Follow-up|2|||
127953614|NCT03656744|460448137|FG001|Overall Study|Lost to Follow-up|2|||
127953615|NCT03656744|460448138|FG002|Overall Study|Lost to Follow-up|0|||
127953616|NCT03656744|460448136|FG000|Overall Study|Withdrawal by Subject|0|||
127953617|NCT03656744|460448137|FG001|Overall Study|Withdrawal by Subject|1|||
127953618|NCT03656744|460448138|FG002|Overall Study|Withdrawal by Subject|0|||
127953619|NCT03656744|460448136|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
127953620|NCT03656744|460448137|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
127953621|NCT03656744|460448138|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
127953622|NCT01332292|460448143|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
127953623|NCT01332292|460448144|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
127953624|NCT01332292|460448143|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
127953625|NCT01332292|460448144|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
127953626|NCT01332292|460448143|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
127953627|NCT01332292|460448144|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
127953628|NCT00098774|460448146|FG000|Overall Study|Adverse Event|2|||
127953629|NCT00098774|460448146|FG000|Overall Study|Disease Progression|9|||
127953630|NCT00098774|460448146|FG000|Overall Study|Withdrawal by Subject|1|||
127953631|NCT00098774|460448146|FG000|Overall Study|Failed (to respond) during induction|4|||
127953632|NCT00098774|460448146|FG000|Overall Study|Physician Decision|2|||
127953633|NCT03910673|460448147|FG000|Overall Study|Adverse Event|0|||
127953634|NCT03910673|460448148|FG001|Overall Study|Adverse Event|0|||
127953635|NCT03910673|460448149|FG002|Overall Study|Adverse Event|0|||
127953636|NCT03910673|460448150|FG003|Overall Study|Adverse Event|2|||
127953637|NCT03910673|460448151|FG004|Overall Study|Adverse Event|0|||
127953638|NCT01487525|460448152|FG000|Overall Study|Withdrawal by Subject|0|||
127953639|NCT01487525|460448153|FG001|Overall Study|Withdrawal by Subject|1|||
127953640|NCT01950390|460448154|FG000|Overall Study|Never started treatment|3|||
127953641|NCT01950390|460448155|FG001|Overall Study|Never started treatment|2|||
127953642|NCT01950390|460448154|FG000|Overall Study|Disease progression|45|||
127953643|NCT01950390|460448155|FG001|Overall Study|Disease progression|52|||
127953644|NCT01950390|460448154|FG000|Overall Study|Adverse Event|22|||
127953645|NCT01950390|460448155|FG001|Overall Study|Adverse Event|16|||
127953646|NCT01950390|460448154|FG000|Overall Study|Death|5|||
127953647|NCT01950390|460448155|FG001|Overall Study|Death|3|||
127953648|NCT01950390|460448154|FG000|Overall Study|Withdrawal by Subject|5|||
127953649|NCT01950390|460448155|FG001|Overall Study|Withdrawal by Subject|1|||
127953650|NCT01950390|460448154|FG000|Overall Study|Alternative therapy|0|||
127953651|NCT01950390|460448155|FG001|Overall Study|Alternative therapy|3|||
127953652|NCT01950390|460448154|FG000|Overall Study|Complicating disease|1|||
127953653|NCT01950390|460448155|FG001|Overall Study|Complicating disease|0|||
127953654|NCT01950390|460448154|FG000|Overall Study|On treatment|1|||
127953655|NCT01950390|460448155|FG001|Overall Study|On treatment|0|||
127953656|NCT01950390|460448154|FG000|Overall Study|Symptomatic deterioration|2|||
127953657|NCT01950390|460448155|FG001|Overall Study|Symptomatic deterioration|1|||
127953658|NCT01950390|460448154|FG000|Overall Study|Physician Decision|0|||
127953659|NCT01950390|460448155|FG001|Overall Study|Physician Decision|4|||
127953660|NCT01950390|460448154|FG000|Overall Study|Lack of clinical benefit|0|||
127953661|NCT01950390|460448155|FG001|Overall Study|Lack of clinical benefit|1|||
127953662|NCT01950390|460448154|FG000|Overall Study|Maintained PR and moved to observation only|0|||
127953663|NCT01950390|460448155|FG001|Overall Study|Maintained PR and moved to observation only|1|||
127953664|NCT05192889|460448156|FG000|Block 1: All Eligible Patients|Death|2|||
127953665|NCT05192889|460448157|FG001|Block 1: All Eligible Patients|Death|0|||
127953666|NCT05192889|460448158|FG002|Block 1: All Eligible Patients|Death|0|||
127953667|NCT05192889|460448156|FG000|Block 2b - Dose Level 1|Adverse Event|0|||
127953668|NCT05192889|460448157|FG001|Block 2b - Dose Level 1|Adverse Event|0|||
127953669|NCT05192889|460448158|FG002|Block 2b - Dose Level 1|Adverse Event|1|||
127953670|NCT05192889|460448156|FG000|Block 2b - Dose Level 1|Refused Therapy|0|||
127953671|NCT05192889|460448157|FG001|Block 2b - Dose Level 1|Refused Therapy|0|||
127953672|NCT05192889|460448158|FG002|Block 2b - Dose Level 1|Refused Therapy|2|||
127976428|NCT03535194|460536129|FG004|Induction Period|Lost to Follow-up|0|||
127976429|NCT03535194|460536125|FG000|Induction Period|Physician Decision|1|||
127976430|NCT03535194|460536126|FG001|Induction Period|Physician Decision|1|||
127976431|NCT03535194|460536127|FG002|Induction Period|Physician Decision|0|||
127976432|NCT03535194|460536128|FG003|Induction Period|Physician Decision|0|||
127976433|NCT03535194|460536129|FG004|Induction Period|Physician Decision|0|||
127976434|NCT03535194|460536125|FG000|Induction Period|Protocol Violation|1|||
127976435|NCT03535194|460536126|FG001|Induction Period|Protocol Violation|0|||
127976436|NCT03535194|460536127|FG002|Induction Period|Protocol Violation|0|||
127976437|NCT03535194|460536128|FG003|Induction Period|Protocol Violation|1|||
127976438|NCT03535194|460536129|FG004|Induction Period|Protocol Violation|0|||
127976439|NCT03535194|460536125|FG000|Induction Period|Screen Failure|0|||
127953673|NCT03284723|460449718|FG000|Overall Study|Death|0|||
127953674|NCT03284723|460449719|FG001|Overall Study|Death|0|||
127953675|NCT03284723|460449720|FG002|Overall Study|Death|0|||
127953676|NCT03284723|460449721|FG003|Overall Study|Death|1|||
127953677|NCT03284723|460449722|FG004|Overall Study|Death|0|||
127953678|NCT03284723|460449723|FG005|Overall Study|Death|0|||
127953679|NCT03284723|460449724|FG006|Overall Study|Death|1|||
127953680|NCT03284723|460449725|FG007|Overall Study|Death|0|||
127953681|NCT03284723|460449726|FG008|Overall Study|Death|0|||
127953682|NCT03284723|460449727|FG009|Overall Study|Death|2|||
127953683|NCT03284723|460449728|FG010|Overall Study|Death|1|||
127953684|NCT03284723|460449729|FG011|Overall Study|Death|0|||
127953685|NCT03284723|460449718|FG000|Overall Study|Lost to Follow-up|0|||
127953686|NCT03284723|460449719|FG001|Overall Study|Lost to Follow-up|0|||
127953687|NCT03284723|460449720|FG002|Overall Study|Lost to Follow-up|0|||
127953688|NCT03284723|460449721|FG003|Overall Study|Lost to Follow-up|0|||
127953689|NCT03284723|460449722|FG004|Overall Study|Lost to Follow-up|0|||
127953690|NCT03284723|460449723|FG005|Overall Study|Lost to Follow-up|2|||
127953691|NCT03284723|460449724|FG006|Overall Study|Lost to Follow-up|1|||
127953692|NCT03284723|460449725|FG007|Overall Study|Lost to Follow-up|0|||
127953693|NCT03284723|460449726|FG008|Overall Study|Lost to Follow-up|0|||
127953694|NCT03284723|460449727|FG009|Overall Study|Lost to Follow-up|2|||
127953695|NCT03284723|460449728|FG010|Overall Study|Lost to Follow-up|0|||
127953696|NCT03284723|460449729|FG011|Overall Study|Lost to Follow-up|0|||
127953697|NCT03284723|460449718|FG000|Overall Study|Study Terminated By Sponsor|0|||
127953698|NCT03284723|460449719|FG001|Overall Study|Study Terminated By Sponsor|0|||
127953699|NCT03284723|460449720|FG002|Overall Study|Study Terminated By Sponsor|0|||
127953700|NCT03284723|460449721|FG003|Overall Study|Study Terminated By Sponsor|0|||
127953701|NCT03284723|460449722|FG004|Overall Study|Study Terminated By Sponsor|1|||
127953702|NCT03284723|460449723|FG005|Overall Study|Study Terminated By Sponsor|0|||
127953703|NCT03284723|460449724|FG006|Overall Study|Study Terminated By Sponsor|0|||
127953704|NCT03284723|460449725|FG007|Overall Study|Study Terminated By Sponsor|0|||
127953705|NCT03284723|460449726|FG008|Overall Study|Study Terminated By Sponsor|1|||
127953706|NCT03284723|460449727|FG009|Overall Study|Study Terminated By Sponsor|1|||
127953707|NCT03284723|460449728|FG010|Overall Study|Study Terminated By Sponsor|1|||
127953708|NCT03284723|460449729|FG011|Overall Study|Study Terminated By Sponsor|1|||
127953709|NCT03284723|460449718|FG000|Overall Study|Withdrawal by Subject|0|||
127953710|NCT03284723|460449719|FG001|Overall Study|Withdrawal by Subject|0|||
127953711|NCT03284723|460449720|FG002|Overall Study|Withdrawal by Subject|0|||
127953712|NCT03284723|460449721|FG003|Overall Study|Withdrawal by Subject|0|||
127953713|NCT03284723|460449722|FG004|Overall Study|Withdrawal by Subject|5|||
127953714|NCT03284723|460449723|FG005|Overall Study|Withdrawal by Subject|3|||
127953715|NCT03284723|460449724|FG006|Overall Study|Withdrawal by Subject|1|||
127953716|NCT03284723|460449725|FG007|Overall Study|Withdrawal by Subject|0|||
127953717|NCT03284723|460449726|FG008|Overall Study|Withdrawal by Subject|6|||
127953718|NCT03284723|460449727|FG009|Overall Study|Withdrawal by Subject|0|||
127953719|NCT03284723|460449728|FG010|Overall Study|Withdrawal by Subject|3|||
127953720|NCT03284723|460449729|FG011|Overall Study|Withdrawal by Subject|1|||
127953721|NCT03284723|460449718|FG000|Overall Study|Other|1|||
127953722|NCT03284723|460449719|FG001|Overall Study|Other|0|||
127953723|NCT03284723|460449720|FG002|Overall Study|Other|1|||
127953724|NCT03284723|460449721|FG003|Overall Study|Other|0|||
127953725|NCT03284723|460449722|FG004|Overall Study|Other|1|||
127953726|NCT03284723|460449723|FG005|Overall Study|Other|0|||
127953727|NCT03284723|460449724|FG006|Overall Study|Other|0|||
127953728|NCT03284723|460449725|FG007|Overall Study|Other|0|||
127953729|NCT03284723|460449726|FG008|Overall Study|Other|0|||
127953730|NCT03284723|460449727|FG009|Overall Study|Other|0|||
127953731|NCT03284723|460449728|FG010|Overall Study|Other|1|||
127953732|NCT03284723|460449729|FG011|Overall Study|Other|0|||
127953733|NCT03284723|460449718|FG000|Overall Study|Adverse Event|0|||
127953734|NCT03284723|460449719|FG001|Overall Study|Adverse Event|0|||
127953735|NCT03284723|460449720|FG002|Overall Study|Adverse Event|0|||
127953736|NCT03284723|460449721|FG003|Overall Study|Adverse Event|0|||
127953737|NCT03284723|460449722|FG004|Overall Study|Adverse Event|0|||
127953738|NCT03284723|460449723|FG005|Overall Study|Adverse Event|0|||
127953739|NCT03284723|460449724|FG006|Overall Study|Adverse Event|0|||
127953740|NCT03284723|460449725|FG007|Overall Study|Adverse Event|0|||
127953741|NCT03284723|460449726|FG008|Overall Study|Adverse Event|1|||
127953742|NCT03284723|460449727|FG009|Overall Study|Adverse Event|0|||
127953743|NCT03284723|460449728|FG010|Overall Study|Adverse Event|0|||
127953744|NCT03284723|460449729|FG011|Overall Study|Adverse Event|0|||
127953745|NCT00615199|460449730|FG000|Overall Study|Adverse Event|3|||
127953746|NCT00615199|460449731|FG001|Overall Study|Adverse Event|1|||
127953747|NCT00615199|460449732|FG002|Overall Study|Adverse Event|1|||
127953748|NCT00615199|460449733|FG003|Overall Study|Adverse Event|0|||
127953749|NCT00615199|460449730|FG000|Overall Study|Lack of Efficacy|2|||
127953750|NCT00615199|460449731|FG001|Overall Study|Lack of Efficacy|0|||
127953751|NCT00615199|460449732|FG002|Overall Study|Lack of Efficacy|0|||
127953752|NCT00615199|460449733|FG003|Overall Study|Lack of Efficacy|1|||
127953753|NCT00615199|460449730|FG000|Overall Study|Lost to Follow-up|1|||
127953754|NCT00615199|460449731|FG001|Overall Study|Lost to Follow-up|0|||
127953755|NCT00615199|460449732|FG002|Overall Study|Lost to Follow-up|0|||
127953756|NCT00615199|460449733|FG003|Overall Study|Lost to Follow-up|0|||
127953757|NCT00615199|460449730|FG000|Overall Study|Other|0|||
127953758|NCT00615199|460449731|FG001|Overall Study|Other|0|||
127953759|NCT00615199|460449732|FG002|Overall Study|Other|0|||
127953760|NCT00615199|460449733|FG003|Overall Study|Other|1|||
127953761|NCT00615199|460449730|FG000|Overall Study|Withdrawal by Subject|2|||
127953762|NCT00615199|460449731|FG001|Overall Study|Withdrawal by Subject|1|||
127953763|NCT00615199|460449732|FG002|Overall Study|Withdrawal by Subject|0|||
127953764|NCT00615199|460449733|FG003|Overall Study|Withdrawal by Subject|0|||
127953765|NCT02121652|460449736|FG000|Overall Study|Lost to Follow-up|2|||
127953766|NCT02121652|460449737|FG001|Overall Study|Lost to Follow-up|1|||
127953767|NCT02121652|460449736|FG000|Overall Study|Death|1|||
127953768|NCT02121652|460449737|FG001|Overall Study|Death|0|||
127953769|NCT02121652|460449736|FG000|Overall Study|Withdrawal by Subject|3|||
127953770|NCT02121652|460449737|FG001|Overall Study|Withdrawal by Subject|3|||
127953771|NCT01232452|460449738|FG000|Overall Study|Adverse Event|17|||
127953772|NCT01232452|460449739|FG001|Overall Study|Adverse Event|15|||
127953773|NCT01232452|460449738|FG000|Overall Study|Withdrawal by Subject|11|||
127953774|NCT01232452|460449739|FG001|Overall Study|Withdrawal by Subject|8|||
127953775|NCT01232452|460449738|FG000|Overall Study|Physician Decision|8|||
127953776|NCT01232452|460449739|FG001|Overall Study|Physician Decision|12|||
127953777|NCT01232452|460449738|FG000|Overall Study|Protocol entry criterion not met|0|||
127953778|NCT01232452|460449739|FG001|Overall Study|Protocol entry criterion not met|2|||
127953779|NCT01232452|460449738|FG000|Overall Study|Sponsor Decision|3|||
127953780|NCT01232452|460449739|FG001|Overall Study|Sponsor Decision|1|||
127953781|NCT01232452|460449738|FG000|Overall Study|Protocol Violation|0|||
127953782|NCT01232452|460449739|FG001|Overall Study|Protocol Violation|1|||
127953783|NCT05024747|460449740|FG000|Period 1 (Day 1 to 2)|Protocol Violation|1|||
127953784|NCT05024747|460449741|FG001|Period 1 (Day 1 to 2)|Protocol Violation|3|||
127953785|NCT05024747|460449740|FG000|Period 1 (Day 1 to 2)|Adverse Event|0|||
127953786|NCT05024747|460449741|FG001|Period 1 (Day 1 to 2)|Adverse Event|1|||
127953787|NCT05024747|460449740|FG000|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|0|||
127953788|NCT05024747|460449741|FG001|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|1|||
127953789|NCT00662649|460449742|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
127953790|NCT00662649|460449743|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
127953791|NCT00662649|460449744|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
127953792|NCT00662649|460449745|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
127953793|NCT00662649|460449746|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
127953794|NCT00662649|460449742|FG000|Core Study (24 Months)|Adverse Event|22|||
127953795|NCT00662649|460449743|FG001|Core Study (24 Months)|Adverse Event|13|||
127953796|NCT00662649|460449744|FG002|Core Study (24 Months)|Adverse Event|18|||
127953797|NCT00662649|460449745|FG003|Core Study (24 Months)|Adverse Event|0|||
127953798|NCT00662649|460449746|FG004|Core Study (24 Months)|Adverse Event|0|||
127953799|NCT00662649|460449742|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
127953800|NCT00662649|460449743|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
127953801|NCT00662649|460449744|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
127953802|NCT00662649|460449745|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
127953803|NCT00662649|460449746|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
127953804|NCT00662649|460449742|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
127953805|NCT00662649|460449743|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
127953806|NCT00662649|460449744|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
127953807|NCT00662649|460449745|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
127953808|NCT00662649|460449746|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
127953809|NCT00662649|460449742|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
127953810|NCT00662649|460449743|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
127953811|NCT00662649|460449744|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
127953812|NCT00662649|460449745|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
127953813|NCT00662649|460449746|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
127953814|NCT00662649|460449742|FG000|Core Study (24 Months)|Protocol Violation|5|||
127953815|NCT00662649|460449743|FG001|Core Study (24 Months)|Protocol Violation|5|||
127953816|NCT00662649|460449744|FG002|Core Study (24 Months)|Protocol Violation|4|||
127953817|NCT00662649|460449745|FG003|Core Study (24 Months)|Protocol Violation|0|||
127953818|NCT00662649|460449746|FG004|Core Study (24 Months)|Protocol Violation|0|||
127953819|NCT00662649|460449742|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
127953820|NCT00662649|460449743|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
127953821|NCT00662649|460449744|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
127953822|NCT00662649|460449745|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
127953823|NCT00662649|460449746|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
127953824|NCT00662649|460449742|FG000|Core Study (24 Months)|Death|1|||
127953825|NCT00662649|460449743|FG001|Core Study (24 Months)|Death|0|||
127953826|NCT00662649|460449744|FG002|Core Study (24 Months)|Death|2|||
127953827|NCT00662649|460449745|FG003|Core Study (24 Months)|Death|0|||
127953828|NCT00662649|460449746|FG004|Core Study (24 Months)|Death|0|||
127953829|NCT00662649|460449742|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
127953830|NCT00662649|460449743|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
127953831|NCT00662649|460449744|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
127953832|NCT00662649|460449745|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
127953833|NCT00662649|460449746|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
127953834|NCT00662649|460449742|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
127953835|NCT00662649|460449743|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
127953836|NCT00662649|460449744|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
127953837|NCT00662649|460449745|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
127953838|NCT00662649|460449746|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
127953839|NCT00662649|460449742|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
127953840|NCT00662649|460449743|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
127953841|NCT00662649|460449744|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
127953842|NCT00662649|460449745|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
127953843|NCT00662649|460449746|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
127953844|NCT00662649|460449742|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
127953845|NCT00662649|460449743|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
127953846|NCT00662649|460449744|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
127953847|NCT00662649|460449745|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
127953848|NCT00662649|460449746|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
127953849|NCT00662649|460449742|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
127953850|NCT00662649|460449743|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
127953851|NCT00662649|460449744|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
127953852|NCT00662649|460449745|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
127953853|NCT00662649|460449746|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
127953854|NCT00662649|460449742|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
127953855|NCT00662649|460449743|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
127953856|NCT00662649|460449744|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
127953857|NCT00662649|460449745|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
127953858|NCT00662649|460449746|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
127953859|NCT00662649|460449742|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
127953860|NCT00662649|460449743|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
127953861|NCT00662649|460449744|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
127953862|NCT00662649|460449745|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
127953863|NCT00662649|460449746|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
127953864|NCT00662649|460449742|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
127953865|NCT00662649|460449743|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
127953866|NCT00662649|460449744|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
127953867|NCT00662649|460449745|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
127953868|NCT00662649|460449746|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
127953869|NCT00662649|460449742|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
127953870|NCT00662649|460449743|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
127953871|NCT00662649|460449744|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
127953872|NCT00662649|460449745|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
127953873|NCT00662649|460449746|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
127953874|NCT02009722|460449753|FG000|Overall Study|Protocol Violation|1|||
127953875|NCT02009722|460449754|FG001|Overall Study|Protocol Violation|2|||
127953876|NCT02009722|460449753|FG000|Overall Study|Did not receive intervention|0|||
127953877|NCT02009722|460449754|FG001|Overall Study|Did not receive intervention|1|||
127953878|NCT02955212|460449755|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
127953879|NCT02955212|460449756|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
127953880|NCT02955212|460449755|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
127953881|NCT02955212|460449756|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
127953882|NCT02955212|460449755|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
127953883|NCT02955212|460449756|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
127953884|NCT02955212|460449755|FG000|Period 1: Double-blind Treatment Period|Other|3|||
127953885|NCT02955212|460449756|FG001|Period 1: Double-blind Treatment Period|Other|2|||
127953886|NCT02955212|460449755|FG000|Period 2: Open-label Extension|Adverse Event|11|||
127953887|NCT02955212|460449756|FG001|Period 2: Open-label Extension|Adverse Event|7|||
127953888|NCT02955212|460449755|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
127953889|NCT02955212|460449756|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
127953890|NCT02955212|460449755|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
127953891|NCT02955212|460449756|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
127976440|NCT03535194|460536126|FG001|Induction Period|Screen Failure|1|||
127953892|NCT02955212|460449755|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
127953893|NCT02955212|460449756|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
127953894|NCT02955212|460449755|FG000|Period 2: Open-label Extension|Other|2|||
127953895|NCT02955212|460449756|FG001|Period 2: Open-label Extension|Other|4|||
127953896|NCT00545714|460449761|FG000|Induction Phase (6 Months)|Physician Decision|3|||
127953897|NCT00545714|460449761|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
127953898|NCT00545714|460449761|FG000|Induction Phase (6 Months)|Disease Progression|1|||
127953899|NCT00545714|460449761|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
127953900|NCT00545714|460449761|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
127953901|NCT00545714|460449761|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
127953902|NCT00545714|460449761|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
127953903|NCT00545714|460449761|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
127953904|NCT00545714|460449761|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
127953905|NCT00545714|460449761|FG000|Maintenance Phase (36 Months)|Death|2|||
127953906|NCT04428034|460449764|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
127953907|NCT00560391|460449767|FG000|Overall Study|Still on treatment|0|||
127953908|NCT00560391|460449768|FG001|Overall Study|Still on treatment|0|||
127953909|NCT00560391|460449769|FG002|Overall Study|Still on treatment|0|||
127953910|NCT00560391|460449770|FG003|Overall Study|Still on treatment|1|||
127953911|NCT00560391|460449771|FG004|Overall Study|Still on treatment|2|||
127953912|NCT02556801|460449772|FG000|Overall Study|Lost to Follow-up|1|||
127953913|NCT02556801|460449773|FG001|Overall Study|Lost to Follow-up|0|||
127953914|NCT02556801|460449774|FG002|Overall Study|Lost to Follow-up|2|||
127953915|NCT02556801|460449775|FG003|Overall Study|Lost to Follow-up|0|||
127953916|NCT02556801|460449772|FG000|Overall Study|Withdrawal by Subject|1|||
127953917|NCT02556801|460449773|FG001|Overall Study|Withdrawal by Subject|1|||
127953918|NCT02556801|460449774|FG002|Overall Study|Withdrawal by Subject|1|||
127953919|NCT02556801|460449775|FG003|Overall Study|Withdrawal by Subject|0|||
127953920|NCT02556801|460449772|FG000|Overall Study|Protocol Violation|0|||
127953921|NCT02556801|460449773|FG001|Overall Study|Protocol Violation|3|||
127953922|NCT02556801|460449774|FG002|Overall Study|Protocol Violation|1|||
127953923|NCT02556801|460449775|FG003|Overall Study|Protocol Violation|1|||
127953924|NCT02556801|460449772|FG000|Overall Study|Adverse Event|0|||
127953925|NCT02556801|460449773|FG001|Overall Study|Adverse Event|2|||
127953926|NCT02556801|460449774|FG002|Overall Study|Adverse Event|0|||
127953927|NCT02556801|460449775|FG003|Overall Study|Adverse Event|3|||
127953928|NCT02556801|460449772|FG000|Overall Study|Pregnancy|0|||
127953929|NCT02556801|460449773|FG001|Overall Study|Pregnancy|1|||
127953930|NCT02556801|460449774|FG002|Overall Study|Pregnancy|0|||
127953931|NCT02556801|460449775|FG003|Overall Study|Pregnancy|0|||
127953932|NCT02556801|460449772|FG000|Overall Study|Personal reasons patient|0|||
127953933|NCT02556801|460449773|FG001|Overall Study|Personal reasons patient|0|||
127953934|NCT02556801|460449774|FG002|Overall Study|Personal reasons patient|0|||
127953935|NCT02556801|460449775|FG003|Overall Study|Personal reasons patient|1|||
127953936|NCT03668808|460449776|FG000|First Intervention|Withdrawal by Subject|2|||
127953937|NCT03668808|460449777|FG001|First Intervention|Withdrawal by Subject|2|||
127953938|NCT00280735|460449787|FG000|Overall Study|Adverse Event|5|||
127953939|NCT00280735|460449787|FG000|Overall Study|Lack of Efficacy|3|||
127953940|NCT00280735|460449787|FG000|Overall Study|Withdrawal by Subject|8|||
127953941|NCT00280735|460449787|FG000|Overall Study|Intercurrent Illness|2|||
127953942|NCT01895777|460449788|FG000|Overall Study|Adverse Event|1|||
127953943|NCT01895777|460449789|FG001|Overall Study|Adverse Event|2|||
127953944|NCT01895777|460449788|FG000|Overall Study|Lost to Follow-up|2|||
127953945|NCT01895777|460449789|FG001|Overall Study|Lost to Follow-up|0|||
127953946|NCT01895777|460449788|FG000|Overall Study|Not treated|1|||
127953947|NCT01895777|460449789|FG001|Overall Study|Not treated|0|||
127953948|NCT01895777|460449788|FG000|Overall Study|Other reasons|3|||
127953949|NCT01895777|460449789|FG001|Overall Study|Other reasons|2|||
127953950|NCT01895777|460449788|FG000|Overall Study|Non-compliance with the CTP|2|||
127953951|NCT01895777|460449789|FG001|Overall Study|Non-compliance with the CTP|1|||
127953952|NCT03735121|460449795|FG000|Overall Study|Death|3|||
127953953|NCT03735121|460449796|FG001|Overall Study|Death|6|||
127953954|NCT03735121|460449797|FG002|Overall Study|Death|8|||
127953955|NCT03735121|460449798|FG003|Overall Study|Death|37|||
127953956|NCT03735121|460449799|FG004|Overall Study|Death|86|||
127953957|NCT03735121|460449795|FG000|Overall Study|Withdrawal by Subject|1|||
127953958|NCT03735121|460449796|FG001|Overall Study|Withdrawal by Subject|1|||
127953959|NCT03735121|460449797|FG002|Overall Study|Withdrawal by Subject|3|||
127953960|NCT03735121|460449798|FG003|Overall Study|Withdrawal by Subject|4|||
127953961|NCT03735121|460449799|FG004|Overall Study|Withdrawal by Subject|2|||
127953962|NCT03735121|460449795|FG000|Overall Study|Progressive Disease|0|||
127953963|NCT03735121|460449796|FG001|Overall Study|Progressive Disease|0|||
127953964|NCT03735121|460449797|FG002|Overall Study|Progressive Disease|1|||
127953965|NCT03735121|460449798|FG003|Overall Study|Progressive Disease|0|||
127953966|NCT03735121|460449799|FG004|Overall Study|Progressive Disease|0|||
127953967|NCT03735121|460449795|FG000|Overall Study|Lost to Follow-up|0|||
127953968|NCT03735121|460449796|FG001|Overall Study|Lost to Follow-up|0|||
127953969|NCT03735121|460449797|FG002|Overall Study|Lost to Follow-up|0|||
127953970|NCT03735121|460449798|FG003|Overall Study|Lost to Follow-up|0|||
127953971|NCT03735121|460449799|FG004|Overall Study|Lost to Follow-up|1|||
127953972|NCT03735121|460449795|FG000|Overall Study|Ongoing|3|||
127953973|NCT03735121|460449796|FG001|Overall Study|Ongoing|3|||
127953974|NCT03735121|460449797|FG002|Overall Study|Ongoing|26|||
127953975|NCT03735121|460449798|FG003|Overall Study|Ongoing|83|||
127953976|NCT03735121|460449799|FG004|Overall Study|Ongoing|158|||
127953977|NCT00344448|460449803|FG000|Screening|Withdrawal by Subject|0|||
127953978|NCT00344448|460449804|FG001|Screening|Withdrawal by Subject|1|||
127953979|NCT00344448|460449803|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
127953980|NCT00344448|460449804|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
127953981|NCT00344448|460449803|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
127953982|NCT00344448|460449804|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
127953983|NCT00344448|460449803|FG000|Open Label|Withdrawal by Subject|1|||
127953984|NCT00344448|460449804|FG001|Open Label|Withdrawal by Subject|1|||
127953985|NCT00344448|460449803|FG000|Open Label|Study terminated|1|||
127953986|NCT00344448|460449804|FG001|Open Label|Study terminated|0|||
127953987|NCT00796757|460449806|FG000|Overall Study|Withdrawal by Subject|14|||
127953988|NCT00796757|460449806|FG000|Overall Study|Death|61|||
127953989|NCT00796757|460449806|FG000|Overall Study|Protocol Violation|1|||
127953990|NCT00796757|460449806|FG000|Overall Study|Participant noncompliance|1|||
127953991|NCT00796757|460449806|FG000|Overall Study|Investigator's decision|2|||
127953992|NCT00796757|460449806|FG000|Overall Study|Other|7|||
127953993|NCT02324582|460449807|FG000|Overall Study|Screen Failures|0|||
127953994|NCT02324582|460449808|FG001|Overall Study|Screen Failures|5|||
127953995|NCT01277211|460449809|FG000|Overall Study|Adverse Event|60|||
127953996|NCT01277211|460449810|FG001|Overall Study|Adverse Event|22|||
127953997|NCT01277211|460449809|FG000|Overall Study|Pregnancy|9|||
127953998|NCT01277211|460449810|FG001|Overall Study|Pregnancy|4|||
127953999|NCT01277211|460449809|FG000|Overall Study|Lost to Follow-up|14|||
127954000|NCT01277211|460449810|FG001|Overall Study|Lost to Follow-up|9|||
127954001|NCT01277211|460449809|FG000|Overall Study|Did not wish to continue|17|||
127954002|NCT01277211|460449810|FG001|Overall Study|Did not wish to continue|0|||
127954003|NCT01277211|460449809|FG000|Overall Study|Withdrew Consent|9|||
127954004|NCT01277211|460449810|FG001|Overall Study|Withdrew Consent|9|||
127954005|NCT01277211|460449809|FG000|Overall Study|Non-compliance with protocol|13|||
127954006|NCT01277211|460449810|FG001|Overall Study|Non-compliance with protocol|4|||
127954007|NCT01277211|460449809|FG000|Overall Study|Did not meet protocol eligibility|1|||
127954008|NCT01277211|460449810|FG001|Overall Study|Did not meet protocol eligibility|0|||
127954009|NCT01277211|460449809|FG000|Overall Study|Administrative|3|||
127954010|NCT01277211|460449810|FG001|Overall Study|Administrative|0|||
127954011|NCT01277211|460449809|FG000|Overall Study|Pregnancy wish|0|||
127954012|NCT01277211|460449810|FG001|Overall Study|Pregnancy wish|2|||
127954013|NCT01277211|460449809|FG000|Overall Study|Discontinued prior to treatment|24|||
127954014|NCT01277211|460449810|FG001|Overall Study|Discontinued prior to treatment|13|||
127954015|NCT00879086|460449811|FG000|Overall Study|Adverse Event|3|||
127954016|NCT00879086|460449812|FG001|Overall Study|Adverse Event|15|||
127954017|NCT00879086|460449811|FG000|Overall Study|Participant choice|2|||
127954018|NCT00879086|460449812|FG001|Overall Study|Participant choice|2|||
127954019|NCT00879086|460449811|FG000|Overall Study|Progression of disease|40|||
127954020|NCT00879086|460449812|FG001|Overall Study|Progression of disease|26|||
127954021|NCT00879086|460449811|FG000|Overall Study|Withdrawal of consent|2|||
127954022|NCT00879086|460449812|FG001|Overall Study|Withdrawal of consent|1|||
127954023|NCT00879086|460449811|FG000|Overall Study|Other|4|||
127954024|NCT00879086|460449812|FG001|Overall Study|Other|6|||
127954025|NCT00879086|460449811|FG000|Overall Study|Death|1|||
127954026|NCT00879086|460449812|FG001|Overall Study|Death|2|||
127954027|NCT04502212|460449817|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
127954028|NCT04502212|460449817|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
127954029|NCT00111241|460449818|FG000|Overall Study|Lost to Follow-up|1|||
127954030|NCT00111241|460449819|FG001|Overall Study|Lost to Follow-up|0|||
127954031|NCT00111241|460449818|FG000|Overall Study|Withdrawal by Subject|4|||
127954032|NCT00111241|460449819|FG001|Overall Study|Withdrawal by Subject|0|||
127954033|NCT00111241|460449818|FG000|Overall Study|Protocol Violation|9|||
127954034|NCT00111241|460449819|FG001|Overall Study|Protocol Violation|8|||
127954035|NCT00111241|460449818|FG000|Overall Study|Adverse Event|1|||
127954036|NCT00111241|460449819|FG001|Overall Study|Adverse Event|0|||
127954037|NCT01855828|460449821|FG000|Overall Study|Adverse Event|1|||
127954038|NCT01855828|460449821|FG000|Overall Study|Withdrawal by Subject|1|||
127954039|NCT01866098|460449822|FG000|Overall Study|Lost to Follow-up|11|||
127954040|NCT01866098|460449823|FG001|Overall Study|Lost to Follow-up|18|||
127954041|NCT01866098|460449824|FG002|Overall Study|Lost to Follow-up|13|||
127954042|NCT01866098|460449822|FG000|Overall Study|Physician Decision|0|||
127954043|NCT01866098|460449823|FG001|Overall Study|Physician Decision|1|||
127954044|NCT01866098|460449824|FG002|Overall Study|Physician Decision|2|||
127954045|NCT01866098|460449822|FG000|Overall Study|Adverse Event|1|||
127954046|NCT01866098|460449823|FG001|Overall Study|Adverse Event|5|||
127954047|NCT01866098|460449824|FG002|Overall Study|Adverse Event|4|||
127954048|NCT01866098|460449822|FG000|Overall Study|Protocol Violation|1|||
127954049|NCT01866098|460449823|FG001|Overall Study|Protocol Violation|0|||
127954050|NCT01866098|460449824|FG002|Overall Study|Protocol Violation|0|||
127954051|NCT01866098|460449822|FG000|Overall Study|Withdrawal by Subject|1|||
127954052|NCT01866098|460449823|FG001|Overall Study|Withdrawal by Subject|2|||
127954053|NCT01866098|460449824|FG002|Overall Study|Withdrawal by Subject|0|||
127954054|NCT01866098|460449822|FG000|Overall Study|Unrelated Hospitalization|2|||
127954055|NCT01866098|460449823|FG001|Overall Study|Unrelated Hospitalization|0|||
127954056|NCT01866098|460449824|FG002|Overall Study|Unrelated Hospitalization|1|||
127954057|NCT01866098|460449822|FG000|Overall Study|Non-compliance|1|||
127954058|NCT01866098|460449823|FG001|Overall Study|Non-compliance|0|||
127954059|NCT01866098|460449824|FG002|Overall Study|Non-compliance|1|||
127954060|NCT01866098|460449822|FG000|Overall Study|Pregnancy|2|||
127954061|NCT01866098|460449823|FG001|Overall Study|Pregnancy|0|||
127954062|NCT01866098|460449824|FG002|Overall Study|Pregnancy|0|||
127954063|NCT01866098|460449822|FG000|Overall Study|Death|0|||
127954064|NCT01866098|460449823|FG001|Overall Study|Death|1|||
127954065|NCT01866098|460449824|FG002|Overall Study|Death|0|||
127954066|NCT02517463|460449836|FG000|Overall Study|Lost to Follow-up|5|||
127954067|NCT02517463|460449837|FG001|Overall Study|Lost to Follow-up|2|||
127954068|NCT03449446|460449838|FG000|Overall Study|Randomized but Never Treated|0|||
127954069|NCT03449446|460449839|FG001|Overall Study|Randomized but Never Treated|0|||
127954070|NCT03449446|460449840|FG002|Overall Study|Randomized but Never Treated|1|||
127954071|NCT03449446|460449841|FG003|Overall Study|Randomized but Never Treated|1|||
127954072|NCT03449446|460449842|FG004|Overall Study|Randomized but Never Treated|1|||
127954073|NCT03449446|460449843|FG005|Overall Study|Randomized but Never Treated|0|||
127954074|NCT03449446|460449844|FG006|Overall Study|Randomized but Never Treated|0|||
127954075|NCT03449446|460449838|FG000|Overall Study|Unknown Reason|33|||
127954076|NCT03449446|460449839|FG001|Overall Study|Unknown Reason|1|||
127954077|NCT03449446|460449840|FG002|Overall Study|Unknown Reason|1|||
127954078|NCT03449446|460449841|FG003|Overall Study|Unknown Reason|1|||
127954079|NCT03449446|460449842|FG004|Overall Study|Unknown Reason|2|||
127954080|NCT03449446|460449843|FG005|Overall Study|Unknown Reason|2|||
127954081|NCT03449446|460449844|FG006|Overall Study|Unknown Reason|0|||
127954082|NCT03449446|460449838|FG000|Overall Study|Withdrew Consent|1|||
127954083|NCT03449446|460449839|FG001|Overall Study|Withdrew Consent|3|||
127954084|NCT03449446|460449840|FG002|Overall Study|Withdrew Consent|1|||
127954085|NCT03449446|460449841|FG003|Overall Study|Withdrew Consent|4|||
127954086|NCT03449446|460449842|FG004|Overall Study|Withdrew Consent|4|||
127954087|NCT03449446|460449843|FG005|Overall Study|Withdrew Consent|4|||
127954088|NCT03449446|460449844|FG006|Overall Study|Withdrew Consent|1|||
127954089|NCT03449446|460449838|FG000|Overall Study|Adverse Event|1|||
127954090|NCT03449446|460449839|FG001|Overall Study|Adverse Event|2|||
127954091|NCT03449446|460449840|FG002|Overall Study|Adverse Event|1|||
127954092|NCT03449446|460449841|FG003|Overall Study|Adverse Event|0|||
127954093|NCT03449446|460449842|FG004|Overall Study|Adverse Event|0|||
127954094|NCT03449446|460449843|FG005|Overall Study|Adverse Event|2|||
127954095|NCT03449446|460449844|FG006|Overall Study|Adverse Event|0|||
127954096|NCT03449446|460449838|FG000|Overall Study|Lost to Follow-up|0|||
127954097|NCT03449446|460449839|FG001|Overall Study|Lost to Follow-up|0|||
127954098|NCT03449446|460449840|FG002|Overall Study|Lost to Follow-up|2|||
127954099|NCT03449446|460449841|FG003|Overall Study|Lost to Follow-up|1|||
127954100|NCT03449446|460449842|FG004|Overall Study|Lost to Follow-up|3|||
127954101|NCT03449446|460449843|FG005|Overall Study|Lost to Follow-up|0|||
127954102|NCT03449446|460449844|FG006|Overall Study|Lost to Follow-up|0|||
127954103|NCT03449446|460449838|FG000|Overall Study|Investigator's Discretion|0|||
127954104|NCT03449446|460449839|FG001|Overall Study|Investigator's Discretion|1|||
127954105|NCT03449446|460449840|FG002|Overall Study|Investigator's Discretion|1|||
127954106|NCT03449446|460449841|FG003|Overall Study|Investigator's Discretion|2|||
127954107|NCT03449446|460449842|FG004|Overall Study|Investigator's Discretion|0|||
127954108|NCT03449446|460449843|FG005|Overall Study|Investigator's Discretion|0|||
127954109|NCT03449446|460449844|FG006|Overall Study|Investigator's Discretion|0|||
127954110|NCT03449446|460449838|FG000|Overall Study|Non Compliance with Study Drug|1|||
127954111|NCT03449446|460449839|FG001|Overall Study|Non Compliance with Study Drug|0|||
127954112|NCT03449446|460449840|FG002|Overall Study|Non Compliance with Study Drug|0|||
127954113|NCT03449446|460449841|FG003|Overall Study|Non Compliance with Study Drug|0|||
127954114|NCT03449446|460449842|FG004|Overall Study|Non Compliance with Study Drug|0|||
127954115|NCT03449446|460449843|FG005|Overall Study|Non Compliance with Study Drug|0|||
127954116|NCT03449446|460449844|FG006|Overall Study|Non Compliance with Study Drug|0|||
127954117|NCT03449446|460449838|FG000|Overall Study|Protocol Violation|0|||
127954118|NCT03449446|460449839|FG001|Overall Study|Protocol Violation|0|||
127954119|NCT03449446|460449840|FG002|Overall Study|Protocol Violation|0|||
127954120|NCT03449446|460449841|FG003|Overall Study|Protocol Violation|0|||
127954121|NCT03449446|460449842|FG004|Overall Study|Protocol Violation|1|||
127954122|NCT03449446|460449843|FG005|Overall Study|Protocol Violation|1|||
127954123|NCT03449446|460449844|FG006|Overall Study|Protocol Violation|0|||
127954124|NCT03449446|460449838|FG000|Overall Study|Death|0|||
127954125|NCT03449446|460449839|FG001|Overall Study|Death|0|||
127954126|NCT03449446|460449840|FG002|Overall Study|Death|0|||
127954127|NCT03449446|460449841|FG003|Overall Study|Death|0|||
127954128|NCT03449446|460449842|FG004|Overall Study|Death|1|||
127954129|NCT03449446|460449843|FG005|Overall Study|Death|0|||
127954130|NCT03449446|460449844|FG006|Overall Study|Death|0|||
127954131|NCT01450683|460449865|FG000|Overall Study|Adverse Event|2|||
127954132|NCT02108912|460449867|FG000|Overall Study|Lost to Follow-up|1|||
127954133|NCT02108912|460449868|FG001|Overall Study|Lost to Follow-up|1|||
127954134|NCT02108912|460449867|FG000|Overall Study|lack of transportation|1|||
127954135|NCT02108912|460449868|FG001|Overall Study|lack of transportation|0|||
127954136|NCT02108912|460449867|FG000|Overall Study|high blood pressure|1|||
127954137|NCT02108912|460449868|FG001|Overall Study|high blood pressure|0|||
127954138|NCT02890355|460449876|FG000|Overall Study|Adverse Event|5|||
127954139|NCT02890355|460449877|FG001|Overall Study|Adverse Event|5|||
127954140|NCT02890355|460449876|FG000|Overall Study|Refusal unrelated to adverse event|5|||
127954141|NCT02890355|460449877|FG001|Overall Study|Refusal unrelated to adverse event|10|||
127954142|NCT02890355|460449876|FG000|Overall Study|Progression/relapse|46|||
127954143|NCT02890355|460449877|FG001|Overall Study|Progression/relapse|39|||
127954144|NCT02890355|460449876|FG000|Overall Study|Not protocol specified|3|||
127954145|NCT02890355|460449877|FG001|Overall Study|Not protocol specified|4|||
127954146|NCT01128179|460449878|FG000|Overall Study|Death|1|||
127954147|NCT01128179|460449879|FG001|Overall Study|Death|0|||
127954148|NCT01128179|460449878|FG000|Overall Study|Protocol Violation|1|||
127954149|NCT01128179|460449879|FG001|Overall Study|Protocol Violation|0|||
127954150|NCT01682811|460449880|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
127954151|NCT01682811|460449881|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
127954152|NCT01682811|460449882|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
127954153|NCT01682811|460449883|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
127954154|NCT01682811|460449884|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
127954155|NCT01682811|460449885|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
127954156|NCT01682811|460449886|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
127954157|NCT01682811|460449880|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
127954158|NCT01682811|460449881|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
127954159|NCT01682811|460449882|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
127954160|NCT01682811|460449883|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
127954161|NCT01682811|460449884|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
127954162|NCT01682811|460449885|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
127954163|NCT01682811|460449886|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
127954164|NCT01682811|460449880|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
127954165|NCT01682811|460449881|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
127954166|NCT01682811|460449882|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
127954167|NCT01682811|460449883|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
127954168|NCT01682811|460449884|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
127954169|NCT01682811|460449885|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
127954170|NCT01682811|460449886|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
127954171|NCT01682811|460449880|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
127954172|NCT01682811|460449881|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
127954173|NCT01682811|460449882|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
127954174|NCT01682811|460449883|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
127954175|NCT01682811|460449884|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
127954176|NCT01682811|460449885|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
127954177|NCT01682811|460449886|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
127954178|NCT01260701|460449888|FG000|Overall Study|Adverse Event|9|||
127954179|NCT01260701|460449888|FG000|Overall Study|Withdrawal by Subject|2|||
127954180|NCT01260701|460449888|FG000|Overall Study|Progression|53|||
127954181|NCT01260701|460449888|FG000|Overall Study|Death|2|||
127954182|NCT01260701|460449888|FG000|Overall Study|Not protocol specified|3|||
127954183|NCT01260701|460449888|FG000|Overall Study|Under review|1|||
127954184|NCT01260701|460449888|FG000|Overall Study|Ineligible|4|||
127954185|NCT01260701|460449888|FG000|Overall Study|Did not begin protocol therapy|1|||
127954186|NCT00720382|460449889|FG000|Overall Study|Adverse Event|54|||
127954187|NCT00720382|460449890|FG001|Overall Study|Adverse Event|17|||
127954188|NCT00720382|460449889|FG000|Overall Study|Lack of Efficacy|18|||
127954189|NCT00720382|460449890|FG001|Overall Study|Lack of Efficacy|7|||
127954190|NCT00720382|460449889|FG000|Overall Study|Non-Compliance|15|||
127954191|NCT00720382|460449890|FG001|Overall Study|Non-Compliance|5|||
127954192|NCT00720382|460449889|FG000|Overall Study|Withdrawal by Subject|47|||
127954193|NCT00720382|460449890|FG001|Overall Study|Withdrawal by Subject|11|||
127954194|NCT00720382|460449889|FG000|Overall Study|Lost to Follow-up|28|||
127954195|NCT00720382|460449890|FG001|Overall Study|Lost to Follow-up|14|||
127954196|NCT00720382|460449889|FG000|Overall Study|administrative|14|||
127954197|NCT00720382|460449890|FG001|Overall Study|administrative|5|||
127954198|NCT02653625|460452124|FG000|Overall Study|Adverse Event|1|||
127954199|NCT02653625|460452124|FG000|Overall Study|Non-compliance with Study Drug|1|||
127954200|NCT02653625|460452124|FG000|Overall Study|Protocol Violation|1|||
127954201|NCT02653625|460452124|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
127954202|NCT05377749|460452127|FG000|3 Weeks|Lost to Follow-up|2|||
127954203|NCT05377749|460452128|FG001|3 Weeks|Lost to Follow-up|4|||
127954204|NCT05377749|460452127|FG000|3 Weeks|Withdrawal by Subject|1|||
127954205|NCT05377749|460452128|FG001|3 Weeks|Withdrawal by Subject|1|||
127954206|NCT01499095|460452129|FG000|Overall Study|Randomized But Not Treated|1|||
127954207|NCT01499095|460452130|FG001|Overall Study|Randomized But Not Treated|1|||
127954208|NCT01499095|460452129|FG000|Overall Study|Adverse Event|12|||
127954209|NCT01499095|460452130|FG001|Overall Study|Adverse Event|7|||
127954210|NCT01499095|460452129|FG000|Overall Study|Lack of Efficacy|2|||
127954211|NCT01499095|460452130|FG001|Overall Study|Lack of Efficacy|1|||
127954212|NCT01499095|460452129|FG000|Overall Study|Protocol Violation|6|||
127954213|NCT01499095|460452130|FG001|Overall Study|Protocol Violation|7|||
127954214|NCT01499095|460452129|FG000|Overall Study|Received Rescue Therapy|32|||
127954215|NCT01499095|460452130|FG001|Overall Study|Received Rescue Therapy|40|||
127954216|NCT01499095|460452129|FG000|Overall Study|Diverse Reasons|22|||
127954217|NCT01499095|460452130|FG001|Overall Study|Diverse Reasons|25|||
127954218|NCT01499095|460452129|FG000|Overall Study|Lost to Follow-up|6|||
127954219|NCT01499095|460452130|FG001|Overall Study|Lost to Follow-up|4|||
127954220|NCT01499095|460452129|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
127954221|NCT01499095|460452130|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
127954222|NCT01499095|460452129|FG000|Overall Study|Hypoglycemia|3|||
127954223|NCT01499095|460452130|FG001|Overall Study|Hypoglycemia|1|||
127954224|NCT01499095|460452129|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
127954225|NCT01499095|460452130|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
127954226|NCT01499095|460452129|FG000|Overall Study|Change in Injection Schedule|2|||
127954227|NCT01499095|460452130|FG001|Overall Study|Change in Injection Schedule|0|||
127954228|NCT01499095|460452129|FG000|Overall Study|Perceived Lack of Efficacy|1|||
127954229|NCT01499095|460452130|FG001|Overall Study|Perceived Lack of Efficacy|1|||
127954230|NCT02762929|460452131|FG000|Overall Study|Adverse Event|0|||
127954231|NCT02762929|460452132|FG001|Overall Study|Adverse Event|0|||
127954232|NCT02762929|460452133|FG002|Overall Study|Adverse Event|0|||
127954233|NCT02762929|460452134|FG003|Overall Study|Adverse Event|1|||
127954234|NCT02762929|460452135|FG004|Overall Study|Adverse Event|0|||
127954235|NCT02762929|460452136|FG005|Overall Study|Adverse Event|0|||
127954236|NCT02762929|460452131|FG000|Overall Study|Lost to Follow-up|1|||
127954237|NCT02762929|460452132|FG001|Overall Study|Lost to Follow-up|2|||
127954238|NCT02762929|460452133|FG002|Overall Study|Lost to Follow-up|0|||
127954239|NCT02762929|460452134|FG003|Overall Study|Lost to Follow-up|1|||
127954240|NCT02762929|460452135|FG004|Overall Study|Lost to Follow-up|0|||
127954241|NCT02762929|460452136|FG005|Overall Study|Lost to Follow-up|0|||
127954242|NCT02762929|460452131|FG000|Overall Study|Withdrawal by Subject|0|||
127954243|NCT02762929|460452132|FG001|Overall Study|Withdrawal by Subject|1|||
127954244|NCT02762929|460452133|FG002|Overall Study|Withdrawal by Subject|0|||
127954245|NCT02762929|460452134|FG003|Overall Study|Withdrawal by Subject|0|||
127954246|NCT02762929|460452135|FG004|Overall Study|Withdrawal by Subject|0|||
127954247|NCT02762929|460452136|FG005|Overall Study|Withdrawal by Subject|0|||
127954248|NCT02762929|460452131|FG000|Overall Study|exclusionary medication disclosed late|0|||
127954249|NCT02762929|460452132|FG001|Overall Study|exclusionary medication disclosed late|0|||
127954250|NCT02762929|460452133|FG002|Overall Study|exclusionary medication disclosed late|0|||
127954251|NCT02762929|460452134|FG003|Overall Study|exclusionary medication disclosed late|1|||
127954252|NCT02762929|460452135|FG004|Overall Study|exclusionary medication disclosed late|0|||
127954253|NCT02762929|460452136|FG005|Overall Study|exclusionary medication disclosed late|0|||
127954254|NCT02738138|460452139|FG000|Overall Study|Adverse Event|0|||
127954255|NCT02738138|460452140|FG001|Overall Study|Adverse Event|1|||
127954256|NCT02738138|460452139|FG000|Overall Study|Lost to Follow-up|2|||
127954257|NCT02738138|460452140|FG001|Overall Study|Lost to Follow-up|0|||
127954258|NCT02738138|460452139|FG000|Overall Study|Other - not further specified|1|||
127954259|NCT02738138|460452140|FG001|Overall Study|Other - not further specified|0|||
127954260|NCT01995513|460452141|FG000|Period 1: First Open Label Treatment|Other|34|||
127954261|NCT01995513|460452142|FG001|Period 1: First Open Label Treatment|Other|0|||
127954262|NCT01995513|460452143|FG002|Period 1: First Open Label Treatment|Other|0|||
127954263|NCT01995513|460452144|FG003|Period 1: First Open Label Treatment|Other|0|||
127954264|NCT01995513|460452141|FG000|Period 1: First Open Label Treatment|Death|14|||
127954265|NCT01995513|460452142|FG001|Period 1: First Open Label Treatment|Death|0|||
127954266|NCT01995513|460452143|FG002|Period 1: First Open Label Treatment|Death|0|||
127954267|NCT01995513|460452144|FG003|Period 1: First Open Label Treatment|Death|0|||
127954268|NCT01995513|460452141|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
127954269|NCT01995513|460452142|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
127954270|NCT01995513|460452143|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
127954271|NCT01995513|460452144|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
127954272|NCT01995513|460452141|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
127954273|NCT01995513|460452142|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
127954274|NCT01995513|460452143|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
127954275|NCT01995513|460452144|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
127954276|NCT01995513|460452141|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
127954277|NCT01995513|460452142|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
127954278|NCT01995513|460452143|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
127954279|NCT01995513|460452144|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
127954280|NCT01995513|460452141|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
127954281|NCT01995513|460452142|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
127954282|NCT01995513|460452143|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
127954283|NCT01995513|460452144|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
127954284|NCT01995513|460452141|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
127954285|NCT01995513|460452142|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
127954286|NCT01995513|460452143|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
127954287|NCT01995513|460452144|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
127954288|NCT01995513|460452141|FG000|Period 1: Second Open Label Treatment|Other|0|||
127954289|NCT01995513|460452142|FG001|Period 1: Second Open Label Treatment|Other|2|||
127954290|NCT01995513|460452143|FG002|Period 1: Second Open Label Treatment|Other|0|||
127954291|NCT01995513|460452144|FG003|Period 1: Second Open Label Treatment|Other|0|||
127954292|NCT01995513|460452141|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
127954293|NCT01995513|460452142|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
127954294|NCT01995513|460452143|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
127954295|NCT01995513|460452144|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
127954296|NCT01995513|460452141|FG000|Period 2: Double Blind Treatment|Death|0|||
127954297|NCT01995513|460452142|FG001|Period 2: Double Blind Treatment|Death|0|||
127954298|NCT01995513|460452143|FG002|Period 2: Double Blind Treatment|Death|0|||
127954299|NCT01995513|460452144|FG003|Period 2: Double Blind Treatment|Death|1|||
127954300|NCT01995513|460452141|FG000|Period 2: Double Blind Treatment|Other|0|||
127954301|NCT01995513|460452142|FG001|Period 2: Double Blind Treatment|Other|0|||
127954302|NCT01995513|460452143|FG002|Period 2: Double Blind Treatment|Other|3|||
127954303|NCT01995513|460452144|FG003|Period 2: Double Blind Treatment|Other|3|||
127954304|NCT01995513|460452141|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
127954305|NCT01995513|460452142|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
127954306|NCT01995513|460452143|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
127954307|NCT01995513|460452144|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
127954308|NCT01995513|460452141|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
127954309|NCT01995513|460452142|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
127954310|NCT01995513|460452143|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
127954311|NCT01995513|460452144|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
127954312|NCT01995513|460452141|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
127954313|NCT01995513|460452142|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
127954314|NCT01995513|460452143|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
127954315|NCT01995513|460452144|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
127954316|NCT01995513|460452141|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
127954317|NCT01995513|460452142|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
127954318|NCT01995513|460452143|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
127954319|NCT01995513|460452144|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
127954320|NCT04108299|460452149|FG000|Overall Study|Not interested in participating|2|||
127954321|NCT04108299|460452150|FG001|Overall Study|Not interested in participating|1|||
127954322|NCT04108299|460452151|FG002|Overall Study|Not interested in participating|2|||
127954323|NCT04108299|460452152|FG003|Overall Study|Not interested in participating|1|||
127954324|NCT00247676|460452153|FG000|Overall Study|Death|5|||
127954325|NCT00247676|460452153|FG000|Overall Study|Adverse Event|11|||
127954326|NCT00247676|460452153|FG000|Overall Study|Lack of Efficacy|15|||
127954327|NCT00247676|460452153|FG000|Overall Study|Other|3|||
127954328|NCT00247676|460452153|FG000|Overall Study|Withdrawal by Subject|2|||
127954329|NCT04123405|460452154|FG000|Overall Study|Adverse Event|1|||
127954330|NCT04123405|460452155|FG001|Overall Study|Adverse Event|2|||
127954331|NCT04123405|460452156|FG002|Overall Study|Adverse Event|3|||
127954332|NCT04123405|460452157|FG003|Overall Study|Adverse Event|3|||
127954333|NCT04123405|460452154|FG000|Overall Study|Exclusion criteria met|1|||
127954334|NCT04123405|460452155|FG001|Overall Study|Exclusion criteria met|2|||
127954335|NCT04123405|460452156|FG002|Overall Study|Exclusion criteria met|0|||
127954336|NCT04123405|460452157|FG003|Overall Study|Exclusion criteria met|2|||
127954337|NCT04123405|460452154|FG000|Overall Study|Withdrawal by Subject|1|||
127954338|NCT04123405|460452155|FG001|Overall Study|Withdrawal by Subject|3|||
127954339|NCT04123405|460452156|FG002|Overall Study|Withdrawal by Subject|0|||
127954340|NCT04123405|460452157|FG003|Overall Study|Withdrawal by Subject|2|||
127954341|NCT04123405|460452154|FG000|Overall Study|Contact to subject lost|0|||
127954342|NCT04123405|460452155|FG001|Overall Study|Contact to subject lost|0|||
127954343|NCT04123405|460452156|FG002|Overall Study|Contact to subject lost|0|||
127954344|NCT04123405|460452157|FG003|Overall Study|Contact to subject lost|1|||
127954345|NCT04123405|460452154|FG000|Overall Study|screening failure|1|||
127954346|NCT04123405|460452155|FG001|Overall Study|screening failure|0|||
127954347|NCT04123405|460452156|FG002|Overall Study|screening failure|0|||
127954348|NCT04123405|460452157|FG003|Overall Study|screening failure|0|||
127954349|NCT01026194|460452158|FG000|Period 1：Double Blind Period|Adverse Event|2|||
127954350|NCT01026194|460452159|FG001|Period 1：Double Blind Period|Adverse Event|1|||
127954351|NCT01026194|460452158|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
127954352|NCT01026194|460452159|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
127954353|NCT01026194|460452158|FG000|Period 1：Double Blind Period|Physician Decision|0|||
127954354|NCT01026194|460452159|FG001|Period 1：Double Blind Period|Physician Decision|4|||
127954355|NCT01026194|460452158|FG000|Period 2：Open-label Period|Adverse Event|4|||
127954356|NCT01026194|460452159|FG001|Period 2：Open-label Period|Adverse Event|5|||
127954357|NCT01026194|460452158|FG000|Period 2：Open-label Period|Physician Decision|3|||
127954358|NCT01026194|460452159|FG001|Period 2：Open-label Period|Physician Decision|1|||
127954359|NCT01026194|460452158|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
127954360|NCT01026194|460452159|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
127954361|NCT01750190|460452160|FG000|Overall Study|Adverse Event|47|||
127954362|NCT01750190|460452161|FG001|Overall Study|Adverse Event|19|||
127954363|NCT01750190|460452160|FG000|Overall Study|Death|38|||
127954364|NCT01750190|460452161|FG001|Overall Study|Death|11|||
127954365|NCT01750190|460452160|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
127954366|NCT01750190|460452161|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
127954367|NCT01750190|460452160|FG000|Overall Study|Lost to Follow-up|28|||
127954368|NCT01750190|460452161|FG001|Overall Study|Lost to Follow-up|7|||
127954369|NCT01750190|460452160|FG000|Overall Study|Physician Decision|16|||
127954370|NCT01750190|460452161|FG001|Overall Study|Physician Decision|17|||
127954371|NCT01750190|460452160|FG000|Overall Study|Protocol Violation|6|||
127954372|NCT01750190|460452161|FG001|Overall Study|Protocol Violation|5|||
127954373|NCT01750190|460452160|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
127954374|NCT01750190|460452161|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
127954375|NCT01750190|460452160|FG000|Overall Study|Withdrawal by Subject|83|||
127954376|NCT01750190|460452161|FG001|Overall Study|Withdrawal by Subject|89|||
127954377|NCT01750190|460452160|FG000|Overall Study|Kidney Transplant|8|||
127954378|NCT01750190|460452161|FG001|Overall Study|Kidney Transplant|4|||
127954379|NCT01750190|460452160|FG000|Overall Study|Dialysis|22|||
127954380|NCT01750190|460452161|FG001|Overall Study|Dialysis|8|||
127954381|NCT01750190|460452160|FG000|Overall Study|Other than Specified|13|||
127954382|NCT01750190|460452161|FG001|Overall Study|Other than Specified|4|||
127954383|NCT03934541|460452167|FG000|Overall Study|Study Terminated by Sponsor|0|||
127954384|NCT03934541|460452168|FG001|Overall Study|Study Terminated by Sponsor|1|||
127954385|NCT03934541|460452169|FG002|Overall Study|Study Terminated by Sponsor|0|||
127954386|NCT03934541|460452170|FG003|Overall Study|Study Terminated by Sponsor|0|||
127954387|NCT02673775|460452171|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
127954388|NCT02673775|460452172|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
127954389|NCT02673775|460452171|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
127954390|NCT02673775|460452172|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
127954391|NCT02673775|460452171|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
127954392|NCT02673775|460452172|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
127954393|NCT02673775|460452171|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
127954394|NCT02673775|460452172|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
127954395|NCT02441686|460452173|FG000|Induction|Adverse Event|4|||
127954396|NCT02441686|460452173|FG000|Induction|Complicating disease|1|||
127954397|NCT02441686|460452173|FG000|Induction|Physician Decision|1|||
127954398|NCT02441686|460452173|FG000|Induction|Withdrawal by Subject|1|||
127954399|NCT02441686|460452173|FG000|Induction|Did not receive treatment|1|||
127954400|NCT02441686|460452173|FG000|Maintenance|Remaining on Treatment|23|||
127954401|NCT02441686|460452173|FG000|Maintenance|Physician Decision|1|||
127954402|NCT02441686|460452173|FG000|Maintenance|Adverse Event|3|||
127954403|NCT02441686|460452173|FG000|Maintenance|Progressive Disease|10|||
127954404|NCT02441686|460452173|FG000|Maintenance|Withdrawal by Subject|1|||
127954405|NCT03151304|460452174|FG000|Overall Study|Termination of study by Sponsor|23|||
127954406|NCT03151304|460452174|FG000|Overall Study|missing|3|||
127954407|NCT03151304|460452174|FG000|Overall Study|Withdrawal by Subject|8|||
127954408|NCT03151304|460452174|FG000|Overall Study|multiple reasons|30|||
127954409|NCT03519087|460452175|FG000|Clinic Evaluation|Physician Decision|15|||
127954410|NCT03519087|460452176|FG001|Clinic Evaluation|Physician Decision|18|||
127954411|NCT03519087|460452177|FG002|Clinic Evaluation|Physician Decision|0|||
127954412|NCT03519087|460452178|FG003|Clinic Evaluation|Physician Decision|0|||
127954413|NCT03519087|460452179|FG004|Clinic Evaluation|Physician Decision|0|||
127954414|NCT03519087|460452175|FG000|Clinic Evaluation|Protocol Violation|1|||
127954415|NCT03519087|460452176|FG001|Clinic Evaluation|Protocol Violation|0|||
127954416|NCT03519087|460452177|FG002|Clinic Evaluation|Protocol Violation|0|||
127954417|NCT03519087|460452178|FG003|Clinic Evaluation|Protocol Violation|0|||
127954418|NCT03519087|460452179|FG004|Clinic Evaluation|Protocol Violation|0|||
127954419|NCT03519087|460452175|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
127954420|NCT03519087|460452176|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
127954421|NCT03519087|460452177|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
127954422|NCT03519087|460452178|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
127954423|NCT03519087|460452179|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
127954424|NCT03519087|460452175|FG000|Re-randomization for Treatment|Not appropriate|2|||
127954425|NCT03519087|460452176|FG001|Re-randomization for Treatment|Not appropriate|3|||
127954426|NCT03519087|460452177|FG002|Re-randomization for Treatment|Not appropriate|0|||
127954427|NCT03519087|460452178|FG003|Re-randomization for Treatment|Not appropriate|0|||
127954428|NCT03519087|460452179|FG004|Re-randomization for Treatment|Not appropriate|0|||
127954429|NCT03519087|460452175|FG000|Laboratory Testing|Lost to Follow-up|0|||
127954430|NCT03519087|460452176|FG001|Laboratory Testing|Lost to Follow-up|0|||
127954431|NCT03519087|460452177|FG002|Laboratory Testing|Lost to Follow-up|2|||
127954432|NCT03519087|460452178|FG003|Laboratory Testing|Lost to Follow-up|3|||
127954433|NCT03519087|460452179|FG004|Laboratory Testing|Lost to Follow-up|6|||
127954434|NCT03519087|460452175|FG000|Laboratory Testing|Protocol Violation|0|||
127954435|NCT03519087|460452176|FG001|Laboratory Testing|Protocol Violation|0|||
127954436|NCT03519087|460452177|FG002|Laboratory Testing|Protocol Violation|0|||
127954437|NCT03519087|460452178|FG003|Laboratory Testing|Protocol Violation|1|||
127954438|NCT03519087|460452179|FG004|Laboratory Testing|Protocol Violation|0|||
127954439|NCT01137071|460452180|FG000|Overall Study|Disease Progression|11|||
127954440|NCT01137071|460452180|FG000|Overall Study|Withdrawal by Subject|2|||
127954441|NCT01137071|460452180|FG000|Overall Study|Wrongly Included|1|||
127954442|NCT04194645|460452183|FG000|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
127954443|NCT04194645|460452184|FG001|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
127954444|NCT04194645|460452185|FG002|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
127954445|NCT04194645|460452186|FG003|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
127954446|NCT04194645|460452187|FG004|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
127954447|NCT04194645|460452188|FG005|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
127954448|NCT04194645|460452189|FG006|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
127954449|NCT04194645|460452190|FG007|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
127954450|NCT04194645|460452191|FG008|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
127954451|NCT04194645|460452192|FG009|Wash-out Period 2 (BA Part Only)|Adverse Event|1|||
127954452|NCT04194645|460452193|FG010|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
127954453|NCT04194645|460452194|FG011|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
127954454|NCT04194645|460452195|FG012|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
127954455|NCT04194645|460452196|FG013|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
127954456|NCT04194645|460452197|FG014|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
127954457|NCT03076775|460452198|FG000|Overall Study|Lost to Follow-up|1|||
127954458|NCT03076775|460452199|FG001|Overall Study|Lost to Follow-up|0|||
127954459|NCT01783886|460452200|FG000|Overall Study|Lost to Follow-up|0|||
127954460|NCT01783886|460452201|FG001|Overall Study|Lost to Follow-up|3|||
127954461|NCT01783886|460452202|FG002|Overall Study|Lost to Follow-up|0|||
127954462|NCT01783886|460452200|FG000|Overall Study|Protocol deviation|0|||
127954463|NCT01783886|460452201|FG001|Overall Study|Protocol deviation|0|||
127954464|NCT01783886|460452202|FG002|Overall Study|Protocol deviation|2|||
127954465|NCT01783886|460452200|FG000|Overall Study|Withdrawal of consent by participant|1|||
127954466|NCT01783886|460452201|FG001|Overall Study|Withdrawal of consent by participant|3|||
127954467|NCT01783886|460452202|FG002|Overall Study|Withdrawal of consent by participant|4|||
127954468|NCT01783886|460452200|FG000|Overall Study|Adverse Event|4|||
127954469|NCT01783886|460452201|FG001|Overall Study|Adverse Event|5|||
127954470|NCT01783886|460452202|FG002|Overall Study|Adverse Event|4|||
127954471|NCT04542057|460452203|FG000|Overall Study|Death|3|||
127954472|NCT04542057|460452204|FG001|Overall Study|Death|1|||
127954473|NCT04542057|460452203|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
127954474|NCT04542057|460452204|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
127954475|NCT04542057|460452203|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
127954476|NCT04542057|460452204|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
127954477|NCT04542057|460452203|FG000|Overall Study|Adverse Event|15|||
127954478|NCT04542057|460452204|FG001|Overall Study|Adverse Event|6|||
127954479|NCT04542057|460452203|FG000|Overall Study|COVID-19 adverse event|6|||
127954480|NCT04542057|460452204|FG001|Overall Study|COVID-19 adverse event|4|||
127954481|NCT04542057|460452203|FG000|Overall Study|Lack of Efficacy|2|||
127954482|NCT04542057|460452204|FG001|Overall Study|Lack of Efficacy|5|||
127954483|NCT04542057|460452203|FG000|Overall Study|Study terminated by sponsor|1|||
127954484|NCT04542057|460452204|FG001|Overall Study|Study terminated by sponsor|0|||
127954485|NCT04542057|460452203|FG000|Overall Study|Investigator discretion|2|||
127954486|NCT04542057|460452204|FG001|Overall Study|Investigator discretion|1|||
127954487|NCT04542057|460452203|FG000|Overall Study|Withdrawal by Subject|52|||
127954488|NCT04542057|460452204|FG001|Overall Study|Withdrawal by Subject|30|||
127954489|NCT04542057|460452203|FG000|Overall Study|Lost to Follow-up|8|||
127954490|NCT04542057|460452204|FG001|Overall Study|Lost to Follow-up|11|||
127954491|NCT04542057|460452203|FG000|Overall Study|Other|2|||
127954492|NCT04542057|460452204|FG001|Overall Study|Other|2|||
127954493|NCT00104572|460452205|FG000|Overall Study|Withdrawal by Subject|3|||
127954494|NCT00104572|460452206|FG001|Overall Study|Withdrawal by Subject|3|||
127954495|NCT00104572|460452207|FG002|Overall Study|Withdrawal by Subject|0|||
127954496|NCT00940316|460452210|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
127954497|NCT00940316|460452211|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
127954498|NCT00940316|460452212|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
127954499|NCT00940316|460452210|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
127954500|NCT00940316|460452211|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
127954501|NCT00940316|460452212|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
127954502|NCT00940316|460452210|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
127954503|NCT00940316|460452211|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
127954504|NCT00940316|460452212|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
127954505|NCT00940316|460452210|FG000|Treated After Cycle 5|Adverse Event|0|||
127954506|NCT00940316|460452211|FG001|Treated After Cycle 5|Adverse Event|0|||
127954507|NCT00940316|460452212|FG002|Treated After Cycle 5|Adverse Event|1|||
127954508|NCT00940316|460452210|FG000|Treated After Cycle 5|Progressive disease|0|||
127954509|NCT00940316|460452211|FG001|Treated After Cycle 5|Progressive disease|1|||
127954510|NCT00940316|460452212|FG002|Treated After Cycle 5|Progressive disease|0|||
127954511|NCT02290405|460452216|FG000|Overall Study|Withdrawal by Subject|1|||
127954512|NCT02290405|460452217|FG001|Overall Study|Withdrawal by Subject|0|||
127954513|NCT02016183|460452218|FG000|Overall Study|Case Report Forms Uncollected|13|||
127954514|NCT02016183|460452218|FG000|Overall Study|Protocol Violation|52|||
127954515|NCT00996489|460452219|FG000|Overall Study|Device failure|45|||
127954516|NCT00996489|460452219|FG000|Overall Study|Discontinued|116|||
127954517|NCT03142191|460452220|FG000|Placebo Controlled Period|Death|0|||
127954518|NCT03142191|460452221|FG001|Placebo Controlled Period|Death|1|||
127954519|NCT03142191|460452222|FG002|Placebo Controlled Period|Death|1|||
127954520|NCT03142191|460452223|FG003|Placebo Controlled Period|Death|0|||
127954521|NCT03142191|460452224|FG004|Placebo Controlled Period|Death|0|||
127954522|NCT03142191|460452220|FG000|Placebo Controlled Period|Adverse Event|4|||
127954523|NCT03142191|460452221|FG001|Placebo Controlled Period|Adverse Event|5|||
127954524|NCT03142191|460452222|FG002|Placebo Controlled Period|Adverse Event|1|||
127954525|NCT03142191|460452223|FG003|Placebo Controlled Period|Adverse Event|0|||
127954526|NCT03142191|460452224|FG004|Placebo Controlled Period|Adverse Event|0|||
127954527|NCT03142191|460452220|FG000|Placebo Controlled Period|Progressive Disease|1|||
127954528|NCT03142191|460452221|FG001|Placebo Controlled Period|Progressive Disease|0|||
127954529|NCT03142191|460452222|FG002|Placebo Controlled Period|Progressive Disease|1|||
127954530|NCT03142191|460452223|FG003|Placebo Controlled Period|Progressive Disease|0|||
127954531|NCT03142191|460452224|FG004|Placebo Controlled Period|Progressive Disease|0|||
127954532|NCT03142191|460452220|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
127954533|NCT03142191|460452221|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
127954534|NCT03142191|460452222|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
127954535|NCT03142191|460452223|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
127954536|NCT03142191|460452224|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
127954537|NCT03142191|460452220|FG000|Placebo Controlled Period|Other Reasons|1|||
127954538|NCT03142191|460452221|FG001|Placebo Controlled Period|Other Reasons|0|||
127954539|NCT03142191|460452222|FG002|Placebo Controlled Period|Other Reasons|0|||
127954540|NCT03142191|460452223|FG003|Placebo Controlled Period|Other Reasons|0|||
127954541|NCT03142191|460452224|FG004|Placebo Controlled Period|Other Reasons|0|||
127954542|NCT03142191|460452220|FG000|Active Treatment Extension Period|Death|2|||
127954543|NCT03142191|460452221|FG001|Active Treatment Extension Period|Death|1|||
127954544|NCT03142191|460452222|FG002|Active Treatment Extension Period|Death|1|||
127954545|NCT03142191|460452223|FG003|Active Treatment Extension Period|Death|1|||
127954546|NCT03142191|460452224|FG004|Active Treatment Extension Period|Death|0|||
127954547|NCT03142191|460452220|FG000|Active Treatment Extension Period|Adverse Event|6|||
127954548|NCT03142191|460452221|FG001|Active Treatment Extension Period|Adverse Event|5|||
127954549|NCT03142191|460452222|FG002|Active Treatment Extension Period|Adverse Event|4|||
127954550|NCT03142191|460452223|FG003|Active Treatment Extension Period|Adverse Event|1|||
127954551|NCT03142191|460452224|FG004|Active Treatment Extension Period|Adverse Event|0|||
127954552|NCT03142191|460452220|FG000|Active Treatment Extension Period|Progressive Disease|10|||
127954553|NCT03142191|460452221|FG001|Active Treatment Extension Period|Progressive Disease|5|||
127954554|NCT03142191|460452222|FG002|Active Treatment Extension Period|Progressive Disease|4|||
127954555|NCT03142191|460452223|FG003|Active Treatment Extension Period|Progressive Disease|1|||
127954556|NCT03142191|460452224|FG004|Active Treatment Extension Period|Progressive Disease|2|||
127954557|NCT03142191|460452220|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
127954558|NCT03142191|460452221|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
127954559|NCT03142191|460452222|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
127954560|NCT03142191|460452223|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
127954561|NCT03142191|460452224|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
127954562|NCT03142191|460452220|FG000|Active Treatment Extension Period|Physician Decision|2|||
127954563|NCT03142191|460452221|FG001|Active Treatment Extension Period|Physician Decision|0|||
127954564|NCT03142191|460452222|FG002|Active Treatment Extension Period|Physician Decision|0|||
127954565|NCT03142191|460452223|FG003|Active Treatment Extension Period|Physician Decision|0|||
127954566|NCT03142191|460452224|FG004|Active Treatment Extension Period|Physician Decision|0|||
127954567|NCT03142191|460452220|FG000|Active Treatment Extension Period|Other Reasons|3|||
127954568|NCT03142191|460452221|FG001|Active Treatment Extension Period|Other Reasons|3|||
127954569|NCT03142191|460452222|FG002|Active Treatment Extension Period|Other Reasons|3|||
127954570|NCT03142191|460452223|FG003|Active Treatment Extension Period|Other Reasons|8|||
127954571|NCT03142191|460452224|FG004|Active Treatment Extension Period|Other Reasons|3|||
127954572|NCT03142191|460452220|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
127954573|NCT03142191|460452221|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
127954574|NCT03142191|460452222|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
127954575|NCT03142191|460452223|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
127954576|NCT03142191|460452224|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
127954577|NCT00770328|460452227|FG000|Overall Study|Adverse Event|11|||
127954578|NCT00770328|460452228|FG001|Overall Study|Adverse Event|2|||
127954579|NCT00770328|460452227|FG000|Overall Study|Lost to Follow-up|2|||
127954580|NCT00770328|460452228|FG001|Overall Study|Lost to Follow-up|2|||
127954581|NCT03452943|460452229|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
127954582|NCT03452943|460452230|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
127954583|NCT03452943|460452229|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
127954584|NCT03452943|460452230|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
127954585|NCT03452943|460452229|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
127954586|NCT03452943|460452230|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
127954587|NCT03452943|460452229|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
127954588|NCT03452943|460452230|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
127954589|NCT03452943|460452229|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
127954590|NCT03452943|460452230|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
127954591|NCT03452943|460452229|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
127954592|NCT03452943|460452230|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
127954593|NCT01130493|460452231|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
127954594|NCT01130493|460452232|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
127954595|NCT01130493|460452233|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
127954596|NCT01130493|460452231|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
127954597|NCT01130493|460452232|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
127954598|NCT01130493|460452233|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
127954599|NCT01130493|460452231|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
127954600|NCT01130493|460452232|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
127954601|NCT01130493|460452233|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
127954602|NCT01130493|460452231|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
127954603|NCT01130493|460452232|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
127954604|NCT01130493|460452233|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
127954605|NCT01130493|460452231|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
127954606|NCT01130493|460452232|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
127954607|NCT01130493|460452233|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
127954608|NCT01130493|460452231|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
127954609|NCT01130493|460452232|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
127954610|NCT01130493|460452233|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
127954611|NCT01130493|460452231|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
127954612|NCT01130493|460452232|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
127954613|NCT01130493|460452233|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
127954614|NCT01130493|460452231|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
127954615|NCT01130493|460452232|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
127954616|NCT01130493|460452233|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
127954617|NCT01130493|460452231|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
127954618|NCT01130493|460452232|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
127954619|NCT01130493|460452233|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
127954620|NCT01130493|460452231|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
127954621|NCT01130493|460452232|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
127954622|NCT01130493|460452233|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
127954623|NCT01130493|460452231|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
127954624|NCT01130493|460452232|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
127954625|NCT01130493|460452233|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
127954626|NCT01130493|460452231|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
127954627|NCT01130493|460452232|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
127954628|NCT01130493|460452233|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
127954629|NCT01130493|460452231|FG000|Part 2: OLE|Adverse Event|0|||
127954630|NCT01130493|460452232|FG001|Part 2: OLE|Adverse Event|2|||
127954631|NCT01130493|460452233|FG002|Part 2: OLE|Adverse Event|1|||
127954632|NCT01130493|460452231|FG000|Part 2: OLE|Withdrawal by Subject|0|||
127954633|NCT01130493|460452232|FG001|Part 2: OLE|Withdrawal by Subject|1|||
127954634|NCT01130493|460452233|FG002|Part 2: OLE|Withdrawal by Subject|4|||
127954635|NCT03541317|460452236|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
127954636|NCT03541317|460452237|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
127954637|NCT03541317|460452238|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
127954638|NCT03541317|460452239|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
127954639|NCT03541317|460452240|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
127954640|NCT03541317|460452241|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
127954641|NCT02286843|460452242|FG000|Overall Study|Not Treated|4|||
127954642|NCT02286843|460452242|FG000|Overall Study|Protocol Violation|1|||
127954643|NCT02286843|460452242|FG000|Overall Study|Withdrawal by Subject|1|||
127954644|NCT02536846|460452243|FG000|Overall Study|Withdrawal by Subject|1|||
127954645|NCT02593110|460452244|FG000|Overall Study|Withdrawal by Subject|0|||
127954646|NCT02593110|460452245|FG001|Overall Study|Withdrawal by Subject|3|||
127954647|NCT02593110|460452246|FG002|Overall Study|Withdrawal by Subject|3|||
127954648|NCT02593110|460452247|FG003|Overall Study|Withdrawal by Subject|2|||
127954649|NCT02593110|460452244|FG000|Overall Study|Death|0|||
127954650|NCT02593110|460452245|FG001|Overall Study|Death|0|||
127954651|NCT02593110|460452246|FG002|Overall Study|Death|1|||
127954652|NCT02593110|460452247|FG003|Overall Study|Death|0|||
127954653|NCT04388553|460452248|FG000|Overall Study|Protocol Violation|1|||
127954654|NCT04388553|460452249|FG001|Overall Study|Protocol Violation|0|||
127954655|NCT02123446|460452250|FG000|Washout Period (1 Day)|Physician Decision|1|||
127954656|NCT02123446|460452251|FG001|Washout Period (1 Day)|Physician Decision|0|||
127954657|NCT04604795|460452252|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
127954658|NCT04604795|460452253|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
127954659|NCT04604795|460452254|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
127954660|NCT04604795|460452255|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
127954661|NCT04604795|460452256|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
127954662|NCT04604795|460452257|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
127954663|NCT04604795|460452258|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
127954664|NCT04604795|460452259|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
127954665|NCT04604795|460452260|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
127954666|NCT04604795|460452261|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
127954667|NCT04604795|460452252|FG000|Part B: Up to Day 14|Adverse Event|0|||
127954668|NCT04604795|460452253|FG001|Part B: Up to Day 14|Adverse Event|0|||
127954669|NCT04604795|460452254|FG002|Part B: Up to Day 14|Adverse Event|0|||
127954670|NCT04604795|460452255|FG003|Part B: Up to Day 14|Adverse Event|0|||
127954671|NCT04604795|460452256|FG004|Part B: Up to Day 14|Adverse Event|2|||
127954672|NCT04604795|460452257|FG005|Part B: Up to Day 14|Adverse Event|1|||
127954673|NCT04604795|460452258|FG006|Part B: Up to Day 14|Adverse Event|0|||
127954674|NCT04604795|460452259|FG007|Part B: Up to Day 14|Adverse Event|0|||
127954675|NCT04604795|460452260|FG008|Part B: Up to Day 14|Adverse Event|0|||
127954676|NCT04604795|460452261|FG009|Part B: Up to Day 14|Adverse Event|0|||
127954677|NCT04604795|460452252|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
127954678|NCT04604795|460452253|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
127954679|NCT04604795|460452254|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
127954680|NCT04604795|460452255|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
127954681|NCT04604795|460452256|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
127954682|NCT04604795|460452257|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
127954683|NCT04604795|460452258|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
127954684|NCT04604795|460452259|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
127954685|NCT04604795|460452260|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
127954686|NCT04604795|460452261|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
127954687|NCT04604795|460452252|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
127954688|NCT04604795|460452253|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
127954689|NCT04604795|460452254|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
127954690|NCT04604795|460452255|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
127954691|NCT04604795|460452256|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
127954692|NCT04604795|460452257|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
127954693|NCT04604795|460452258|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
127954694|NCT04604795|460452259|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
127954695|NCT04604795|460452260|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
127954696|NCT04604795|460452261|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
127954697|NCT04604795|460452252|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
127954698|NCT04604795|460452253|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
127954699|NCT04604795|460452254|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
127954700|NCT04604795|460452255|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
127954701|NCT04604795|460452256|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
127954702|NCT04604795|460452257|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
127954703|NCT04604795|460452258|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
127954704|NCT04604795|460452259|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
127954705|NCT04604795|460452260|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
127954706|NCT04604795|460452261|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
127954707|NCT04604795|460452252|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
127954708|NCT04604795|460452253|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
127954709|NCT04604795|460452254|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
127954710|NCT04604795|460452255|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
127954711|NCT04604795|460452256|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
127954712|NCT04604795|460452257|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
127954713|NCT04604795|460452258|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
127954714|NCT04604795|460452259|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
127954715|NCT04604795|460452260|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
127954716|NCT04604795|460452261|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
127954717|NCT02096744|460452267|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
127954718|NCT02096744|460452268|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
127954719|NCT02096744|460452267|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
127954720|NCT02096744|460452268|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
127954721|NCT02096744|460452267|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
127954722|NCT02096744|460452268|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
127954723|NCT00952731|460452273|FG000|Overall Study|Drug supply expired|1|||
127954724|NCT00952731|460452274|FG001|Overall Study|Drug supply expired|0|||
127954725|NCT03172494|460452279|FG000|Overall Study|Adverse Event|5|||
127954726|NCT03172494|460452280|FG001|Overall Study|Adverse Event|1|||
127954727|NCT03172494|460452281|FG002|Overall Study|Adverse Event|15|||
127954728|NCT03172494|460452279|FG000|Overall Study|Protocol Violation|3|||
127954729|NCT03172494|460452280|FG001|Overall Study|Protocol Violation|2|||
127954730|NCT03172494|460452281|FG002|Overall Study|Protocol Violation|1|||
127954731|NCT03172494|460452279|FG000|Overall Study|Lack of Efficacy|0|||
127954732|NCT03172494|460452280|FG001|Overall Study|Lack of Efficacy|0|||
127954733|NCT03172494|460452281|FG002|Overall Study|Lack of Efficacy|4|||
127954734|NCT03172494|460452279|FG000|Overall Study|Pregnancy|0|||
127954735|NCT03172494|460452280|FG001|Overall Study|Pregnancy|1|||
127954736|NCT03172494|460452281|FG002|Overall Study|Pregnancy|0|||
127954737|NCT03172494|460452279|FG000|Overall Study|Withdrawal by Subject|10|||
127954738|NCT03172494|460452280|FG001|Overall Study|Withdrawal by Subject|8|||
127954739|NCT03172494|460452281|FG002|Overall Study|Withdrawal by Subject|8|||
127954740|NCT03172494|460452279|FG000|Overall Study|Severe hypoglycaemic episode|0|||
127954741|NCT03172494|460452280|FG001|Overall Study|Severe hypoglycaemic episode|0|||
127954742|NCT03172494|460452281|FG002|Overall Study|Severe hypoglycaemic episode|1|||
127954743|NCT03172494|460452279|FG000|Overall Study|Non-compliance towards treatment|2|||
127954744|NCT03172494|460452280|FG001|Overall Study|Non-compliance towards treatment|0|||
127954745|NCT03172494|460452281|FG002|Overall Study|Non-compliance towards treatment|0|||
127954746|NCT03086551|460452282|FG000|First Intervention|Failure to meet inclusion criterion|1|||
127954747|NCT03086551|460452283|FG001|First Intervention|Failure to meet inclusion criterion|0|||
127954748|NCT03086551|460452282|FG000|First Intervention|Lost to Follow-up|0|||
127954749|NCT03086551|460452283|FG001|First Intervention|Lost to Follow-up|1|||
127954750|NCT03086551|460452282|FG000|Washout|Lost to Follow-up|1|||
127954751|NCT03086551|460452283|FG001|Washout|Lost to Follow-up|2|||
127954752|NCT03086551|460452282|FG000|Washout|Withdrawal by Subject|2|||
127954753|NCT03086551|460452283|FG001|Washout|Withdrawal by Subject|1|||
127954754|NCT02764151|460452284|FG000|Overall Study|Subject refused further follow-up|0|||
127954755|NCT02764151|460452285|FG001|Overall Study|Subject refused further follow-up|0|||
127954756|NCT02764151|460452286|FG002|Overall Study|Subject refused further follow-up|0|||
127954757|NCT02764151|460452287|FG003|Overall Study|Subject refused further follow-up|1|||
127954758|NCT02764151|460452284|FG000|Overall Study|Other|0|||
127954759|NCT02764151|460452285|FG001|Overall Study|Other|0|||
127954760|NCT02764151|460452286|FG002|Overall Study|Other|0|||
127954761|NCT02764151|460452287|FG003|Overall Study|Other|2|||
127954762|NCT00625872|460452290|FG000|Overall Study|Withdrawal by Subject|1|||
127954763|NCT00625872|460452291|FG001|Overall Study|Withdrawal by Subject|0|||
127954764|NCT00625872|460452290|FG000|Overall Study|Does not meet inclusion criteria|1|||
127954765|NCT00625872|460452291|FG001|Overall Study|Does not meet inclusion criteria|0|||
127954766|NCT00625872|460452290|FG000|Overall Study|Terminated by sponsor|2|||
127954767|NCT00625872|460452291|FG001|Overall Study|Terminated by sponsor|5|||
127954768|NCT00625872|460452290|FG000|Overall Study|Randomized but not treated|0|||
127954769|NCT00625872|460452291|FG001|Overall Study|Randomized but not treated|1|||
127954770|NCT04208750|460452292|FG000|Overall Study|Lost to Follow-up|16|||
127954771|NCT04208750|460452293|FG001|Overall Study|Lost to Follow-up|15|||
127954772|NCT02201277|460452294|FG000|Overall Study|Death|3|||
127954773|NCT02201277|460452295|FG001|Overall Study|Death|4|||
127954774|NCT02201277|460452294|FG000|Overall Study|Lost to Follow-up|2|||
127954775|NCT02201277|460452295|FG001|Overall Study|Lost to Follow-up|1|||
127954776|NCT02201277|460452294|FG000|Overall Study|Failed retrieval|1|||
127954777|NCT02201277|460452295|FG001|Overall Study|Failed retrieval|0|||
127954778|NCT02201277|460452294|FG000|Overall Study|Physician Decision|1|||
127954779|NCT02201277|460452295|FG001|Overall Study|Physician Decision|0|||
127954780|NCT03485352|460452296|FG000|Overall Study|Lost to Follow-up|9|||
127954781|NCT01512160|460452297|FG000|Overall Study|Lost to Follow-up|1|||
127954782|NCT01512160|460452298|FG001|Overall Study|Lost to Follow-up|0|||
127954783|NCT01512160|460452299|FG002|Overall Study|Lost to Follow-up|0|||
127954784|NCT01512160|460452300|FG003|Overall Study|Lost to Follow-up|0|||
127954785|NCT01512160|460452297|FG000|Overall Study|Withdrawal by Subject|1|||
127976441|NCT03535194|460536127|FG002|Induction Period|Screen Failure|0|||
127954786|NCT01512160|460452298|FG001|Overall Study|Withdrawal by Subject|0|||
127954787|NCT01512160|460452299|FG002|Overall Study|Withdrawal by Subject|0|||
127954788|NCT01512160|460452300|FG003|Overall Study|Withdrawal by Subject|1|||
127954789|NCT00852202|460452301|FG000|Overall Study|Adverse Event|2|||
127954790|NCT00852202|460452302|FG001|Overall Study|Adverse Event|3|||
127954791|NCT00852202|460452303|FG002|Overall Study|Adverse Event|7|||
127954792|NCT00852202|460452301|FG000|Overall Study|Lack of Efficacy|4|||
127954793|NCT00852202|460452302|FG001|Overall Study|Lack of Efficacy|1|||
127954794|NCT00852202|460452303|FG002|Overall Study|Lack of Efficacy|2|||
127954795|NCT00852202|460452301|FG000|Overall Study|Protocol Violation|2|||
127954796|NCT00852202|460452302|FG001|Overall Study|Protocol Violation|2|||
127954797|NCT00852202|460452303|FG002|Overall Study|Protocol Violation|7|||
127954798|NCT00852202|460452301|FG000|Overall Study|Withdrawal by Subject|3|||
127954799|NCT00852202|460452302|FG001|Overall Study|Withdrawal by Subject|1|||
127954800|NCT00852202|460452303|FG002|Overall Study|Withdrawal by Subject|2|||
127954801|NCT00852202|460452301|FG000|Overall Study|Lost to Follow-up|5|||
127954802|NCT00852202|460452302|FG001|Overall Study|Lost to Follow-up|5|||
127954803|NCT00852202|460452303|FG002|Overall Study|Lost to Follow-up|6|||
127954804|NCT00852202|460452301|FG000|Overall Study|pregnancy,moving away and surgery|1|||
127954805|NCT00852202|460452302|FG001|Overall Study|pregnancy,moving away and surgery|0|||
127954806|NCT00852202|460452303|FG002|Overall Study|pregnancy,moving away and surgery|2|||
127954807|NCT05022212|460452306|FG000|Overall Study|Lost to Follow-up|0|||
127954808|NCT05022212|460452307|FG001|Overall Study|Lost to Follow-up|2|||
127954809|NCT02694328|460452308|FG000|Overall Study|Adverse Event|27|||
127954810|NCT02694328|460452309|FG001|Overall Study|Adverse Event|33|||
127954811|NCT02694328|460452308|FG000|Overall Study|Withdrawal by Subject|27|||
127954812|NCT02694328|460452309|FG001|Overall Study|Withdrawal by Subject|23|||
127954813|NCT02694328|460452308|FG000|Overall Study|Lost to Follow-up|26|||
127954814|NCT02694328|460452309|FG001|Overall Study|Lost to Follow-up|22|||
127954815|NCT02694328|460452308|FG000|Overall Study|Noncompliant with study drug|11|||
127954816|NCT02694328|460452309|FG001|Overall Study|Noncompliant with study drug|8|||
127954817|NCT02694328|460452308|FG000|Overall Study|Incarceration|1|||
127954818|NCT02694328|460452309|FG001|Overall Study|Incarceration|1|||
127954819|NCT02694328|460452308|FG000|Overall Study|Lack of Efficacy|1|||
127954820|NCT02694328|460452309|FG001|Overall Study|Lack of Efficacy|2|||
127954821|NCT02694328|460452308|FG000|Overall Study|Pregnancy|1|||
127954822|NCT02694328|460452309|FG001|Overall Study|Pregnancy|1|||
127954823|NCT02694328|460452308|FG000|Overall Study|Protocol Violation|6|||
127954824|NCT02694328|460452309|FG001|Overall Study|Protocol Violation|5|||
127954825|NCT02694328|460452308|FG000|Overall Study|Abnormal Laboratory Value|0|||
127954826|NCT02694328|460452309|FG001|Overall Study|Abnormal Laboratory Value|3|||
127954827|NCT04205812|460453698|FG000|Randomized Treatment Period|Ongoing|28|||
127954828|NCT04205812|460453699|FG001|Randomized Treatment Period|Ongoing|138|||
127954829|NCT04205812|460453698|FG000|Randomized Treatment Period|Death|94|||
127954830|NCT04205812|460453699|FG001|Randomized Treatment Period|Death|226|||
127954831|NCT04205812|460453698|FG000|Randomized Treatment Period|Lost to Follow-up|5|||
127954832|NCT04205812|460453699|FG001|Randomized Treatment Period|Lost to Follow-up|11|||
127954833|NCT04205812|460453698|FG000|Randomized Treatment Period|Physician Decision|1|||
127954834|NCT04205812|460453699|FG001|Randomized Treatment Period|Physician Decision|4|||
127954835|NCT04205812|460453698|FG000|Randomized Treatment Period|Withdrawal by Subject|4|||
127954836|NCT04205812|460453699|FG001|Randomized Treatment Period|Withdrawal by Subject|11|||
127954837|NCT04205812|460453698|FG000|Randomized Treatment Period|Progressive Disease|0|||
127954838|NCT04205812|460453699|FG001|Randomized Treatment Period|Progressive Disease|1|||
127954839|NCT04205812|460453698|FG000|Randomized Treatment Period|Met Exclusion Criteria|1|||
127954840|NCT04205812|460453699|FG001|Randomized Treatment Period|Met Exclusion Criteria|0|||
127954841|NCT04205812|460453698|FG000|Monotherapy Treatment Period|Ongoing|17|||
127954842|NCT04205812|460453699|FG001|Monotherapy Treatment Period|Ongoing|0|||
127954843|NCT04205812|460453698|FG000|Monotherapy Treatment Period|Death|39|||
127954844|NCT04205812|460453699|FG001|Monotherapy Treatment Period|Death|0|||
127954845|NCT04205812|460453698|FG000|Monotherapy Treatment Period|Lost to Follow-up|2|||
127954846|NCT04205812|460453699|FG001|Monotherapy Treatment Period|Lost to Follow-up|0|||
127954847|NCT04205812|460453698|FG000|Monotherapy Treatment Period|Withdrawal by Subject|1|||
127954848|NCT04205812|460453699|FG001|Monotherapy Treatment Period|Withdrawal by Subject|0|||
127954849|NCT05221320|460453700|FG000|Overall Study|Lack of Efficacy|3|||
127954850|NCT05221320|460453701|FG001|Overall Study|Lack of Efficacy|7|||
127954851|NCT05221320|460453702|FG002|Overall Study|Lack of Efficacy|10|||
127954852|NCT05221320|460453703|FG003|Overall Study|Lack of Efficacy|1|||
127954853|NCT05221320|460453704|FG004|Overall Study|Lack of Efficacy|0|||
127954854|NCT05221320|460453705|FG005|Overall Study|Lack of Efficacy|0|||
127954855|NCT05221320|460453700|FG000|Overall Study|Physician Decision|1|||
127954856|NCT05221320|460453701|FG001|Overall Study|Physician Decision|0|||
127954857|NCT05221320|460453702|FG002|Overall Study|Physician Decision|3|||
127954858|NCT05221320|460453703|FG003|Overall Study|Physician Decision|1|||
127954859|NCT05221320|460453704|FG004|Overall Study|Physician Decision|0|||
127954860|NCT05221320|460453705|FG005|Overall Study|Physician Decision|0|||
127954861|NCT05221320|460453700|FG000|Overall Study|Withdrawal by Subject|0|||
127954862|NCT05221320|460453701|FG001|Overall Study|Withdrawal by Subject|3|||
127954863|NCT05221320|460453702|FG002|Overall Study|Withdrawal by Subject|1|||
127954864|NCT05221320|460453703|FG003|Overall Study|Withdrawal by Subject|0|||
127954865|NCT05221320|460453704|FG004|Overall Study|Withdrawal by Subject|0|||
127954866|NCT05221320|460453705|FG005|Overall Study|Withdrawal by Subject|0|||
127954867|NCT05221320|460453700|FG000|Overall Study|Death|0|||
127954868|NCT05221320|460453701|FG001|Overall Study|Death|5|||
127954869|NCT05221320|460453702|FG002|Overall Study|Death|6|||
127954870|NCT05221320|460453703|FG003|Overall Study|Death|0|||
127954871|NCT05221320|460453704|FG004|Overall Study|Death|1|||
127954872|NCT05221320|460453705|FG005|Overall Study|Death|0|||
127954873|NCT06473519|460453706|FG000|Overall Study|Lost to Follow-up|2|||
127954874|NCT06473519|460453707|FG001|Overall Study|Lost to Follow-up|5|||
127954875|NCT06473519|460453706|FG000|Overall Study|Withdrawal by Subject|1|||
127954876|NCT06473519|460453707|FG001|Overall Study|Withdrawal by Subject|4|||
127954877|NCT06473519|460453706|FG000|Overall Study|Randomized but not vaccinated|1|||
127954878|NCT06473519|460453707|FG001|Overall Study|Randomized but not vaccinated|2|||
127954879|NCT02514447|460453709|FG000|Overall Study|Withdrawal by Subject|3|||
127954880|NCT02514447|460453710|FG001|Overall Study|Withdrawal by Subject|1|||
127954881|NCT02514447|460453711|FG002|Overall Study|Withdrawal by Subject|1|||
127954882|NCT02514447|460453712|FG003|Overall Study|Withdrawal by Subject|0|||
127954883|NCT02514447|460453713|FG004|Overall Study|Withdrawal by Subject|0|||
127954884|NCT02514447|460453714|FG005|Overall Study|Withdrawal by Subject|0|||
127954885|NCT02514447|460453715|FG006|Overall Study|Withdrawal by Subject|0|||
127954886|NCT02514447|460453716|FG007|Overall Study|Withdrawal by Subject|1|||
127954887|NCT02514447|460453717|FG008|Overall Study|Withdrawal by Subject|1|||
127954888|NCT02514447|460453709|FG000|Overall Study|Death|24|||
127954889|NCT02514447|460453710|FG001|Overall Study|Death|28|||
127954890|NCT02514447|460453711|FG002|Overall Study|Death|29|||
127954891|NCT02514447|460453712|FG003|Overall Study|Death|0|||
127954892|NCT02514447|460453713|FG004|Overall Study|Death|3|||
127954893|NCT02514447|460453714|FG005|Overall Study|Death|4|||
127954894|NCT02514447|460453715|FG006|Overall Study|Death|8|||
127954895|NCT02514447|460453716|FG007|Overall Study|Death|6|||
127954896|NCT02514447|460453717|FG008|Overall Study|Death|5|||
127954897|NCT02514447|460453709|FG000|Overall Study|Lost to Follow-up|1|||
127954898|NCT02514447|460453710|FG001|Overall Study|Lost to Follow-up|0|||
127954899|NCT02514447|460453711|FG002|Overall Study|Lost to Follow-up|0|||
127954900|NCT02514447|460453712|FG003|Overall Study|Lost to Follow-up|0|||
127954901|NCT02514447|460453713|FG004|Overall Study|Lost to Follow-up|0|||
127954902|NCT02514447|460453714|FG005|Overall Study|Lost to Follow-up|0|||
127954903|NCT02514447|460453715|FG006|Overall Study|Lost to Follow-up|0|||
127954904|NCT02514447|460453716|FG007|Overall Study|Lost to Follow-up|0|||
127954905|NCT02514447|460453717|FG008|Overall Study|Lost to Follow-up|1|||
127954906|NCT02514447|460453709|FG000|Overall Study|Sponsor Termination of Study|0|||
127954907|NCT02514447|460453710|FG001|Overall Study|Sponsor Termination of Study|1|||
127954908|NCT02514447|460453711|FG002|Overall Study|Sponsor Termination of Study|1|||
127954909|NCT02514447|460453712|FG003|Overall Study|Sponsor Termination of Study|0|||
127954910|NCT02514447|460453713|FG004|Overall Study|Sponsor Termination of Study|0|||
127954911|NCT02514447|460453714|FG005|Overall Study|Sponsor Termination of Study|0|||
127954912|NCT02514447|460453715|FG006|Overall Study|Sponsor Termination of Study|0|||
127954913|NCT02514447|460453716|FG007|Overall Study|Sponsor Termination of Study|0|||
127954914|NCT02514447|460453717|FG008|Overall Study|Sponsor Termination of Study|0|||
127954915|NCT02514447|460453709|FG000|Overall Study|Study completion per Investigator|1|||
127954916|NCT02514447|460453710|FG001|Overall Study|Study completion per Investigator|0|||
127954917|NCT02514447|460453711|FG002|Overall Study|Study completion per Investigator|1|||
127954918|NCT02514447|460453712|FG003|Overall Study|Study completion per Investigator|2|||
127954919|NCT02514447|460453713|FG004|Overall Study|Study completion per Investigator|0|||
127954920|NCT02514447|460453714|FG005|Overall Study|Study completion per Investigator|0|||
127954921|NCT02514447|460453715|FG006|Overall Study|Study completion per Investigator|0|||
127954922|NCT02514447|460453716|FG007|Overall Study|Study completion per Investigator|0|||
127954923|NCT02514447|460453717|FG008|Overall Study|Study completion per Investigator|1|||
127954924|NCT04903288|460453718|FG000|Extension Phase (48 Weeks)|Withdrawal by Subject|1|||
127954925|NCT04903288|460453718|FG000|Extension Phase (48 Weeks)|Ongoing in the Study|3|||
127954926|NCT04903288|460453718|FG000|Long-Term Extension Phase (60 Months)|Withdrawal by Subject|1|||
127954927|NCT04903288|460453718|FG000|Long-Term Extension Phase (60 Months)|Ongoing in the Study|6|||
127954928|NCT04776148|460453719|FG000|Overall Study|Death|249|||
127954929|NCT04776148|460453720|FG001|Overall Study|Death|260|||
127954930|NCT04776148|460453719|FG000|Overall Study|Lost to Follow-up|0|||
127954931|NCT04776148|460453720|FG001|Overall Study|Lost to Follow-up|1|||
127954932|NCT04776148|460453719|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
127954933|NCT04776148|460453720|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
127954934|NCT04776148|460453719|FG000|Overall Study|Withdrawal by Subject|3|||
127954935|NCT04776148|460453720|FG001|Overall Study|Withdrawal by Subject|4|||
127954936|NCT04776148|460453719|FG000|Overall Study|Sponsor Decision|30|||
127954937|NCT04776148|460453720|FG001|Overall Study|Sponsor Decision|15|||
127954938|NCT02731638|460453724|FG000|Overall Study|Lost to Follow-up|6|||
127954939|NCT02731638|460453725|FG001|Overall Study|Lost to Follow-up|9|||
127954940|NCT05626231|460453726|FG000|Provider Enrollment|Worked part-time|4|||
127954941|NCT05626231|460453726|FG000|Provider Enrollment|On leave (e.g., parental leave)|3|||
127954942|NCT05626231|460453726|FG000|Provider Enrollment|Non-clinical employee|1|||
127954943|NCT05626231|460453726|FG000|Provider Enrollment|Provider does not see clients|3|||
127954944|NCT05626231|460453726|FG000|Provider Enrollment|Other|5|||
127954945|NCT05878093|460453727|FG000|Overall Study|Withdrawal by Subject|3|||
127954946|NCT05878093|460453728|FG001|Overall Study|Withdrawal by Subject|1|||
127954947|NCT03690388|460453731|FG000|Overall Study|Adverse Event|8|||
127954948|NCT03690388|460453732|FG001|Overall Study|Adverse Event|1|||
127954949|NCT03690388|460453731|FG000|Overall Study|Radiographic Progression|14|||
127954950|NCT03690388|460453732|FG001|Overall Study|Radiographic Progression|29|||
127954951|NCT03690388|460453731|FG000|Overall Study|Clinical deterioration|10|||
127954952|NCT03690388|460453732|FG001|Overall Study|Clinical deterioration|6|||
127954953|NCT03690388|460453731|FG000|Overall Study|Withdrawal by Subject|2|||
127954954|NCT03690388|460453732|FG001|Overall Study|Withdrawal by Subject|0|||
127954955|NCT03690388|460453731|FG000|Overall Study|Lack of Efficacy|1|||
127954956|NCT03690388|460453732|FG001|Overall Study|Lack of Efficacy|0|||
127954957|NCT03690388|460453731|FG000|Overall Study|Lost to Follow-up|1|||
127954958|NCT03690388|460453732|FG001|Overall Study|Lost to Follow-up|0|||
127954959|NCT04100018|460453734|FG000|Pre-Treatment Period|Not Reported|0|||
127954960|NCT04100018|460453735|FG001|Pre-Treatment Period|Not Reported|4|||
127954961|NCT04100018|460453734|FG000|Pre-Treatment Period|Subject no longer meets study criteria|1|||
127954962|NCT04100018|460453735|FG001|Pre-Treatment Period|Subject no longer meets study criteria|1|||
127954963|NCT04100018|460453734|FG000|Pre-Treatment Period|Poor/Non-compliance|1|||
127954964|NCT04100018|460453735|FG001|Pre-Treatment Period|Poor/Non-compliance|0|||
127954965|NCT04100018|460453734|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
127954966|NCT04100018|460453735|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
127954967|NCT04100018|460453734|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
127954968|NCT04100018|460453735|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
127954969|NCT04100018|460453734|FG000|Treatment Period|Ongoing Treatment|1|||
127954970|NCT04100018|460453735|FG001|Treatment Period|Ongoing Treatment|0|||
127954971|NCT04100018|460453734|FG000|Treatment Period|Other Reason|26|||
127954972|NCT04100018|460453735|FG001|Treatment Period|Other Reason|37|||
127954973|NCT04100018|460453734|FG000|Treatment Period|Completed treatment as per protocol|1|||
127954974|NCT04100018|460453735|FG001|Treatment Period|Completed treatment as per protocol|2|||
127954975|NCT04100018|460453734|FG000|Treatment Period|Maximum clinical benefit|3|||
127954976|NCT04100018|460453735|FG001|Treatment Period|Maximum clinical benefit|0|||
127954977|NCT04100018|460453734|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
127954978|NCT04100018|460453735|FG001|Treatment Period|Adverse event unrelated to study drug|12|||
127954979|NCT04100018|460453734|FG000|Treatment Period|Study drug toxicity|67|||
127954980|NCT04100018|460453735|FG001|Treatment Period|Study drug toxicity|28|||
127954981|NCT04100018|460453734|FG000|Treatment Period|Disease Progression|284|||
127954982|NCT04100018|460453735|FG001|Treatment Period|Disease Progression|327|||
127954983|NCT04100018|460453734|FG000|Treatment Period|Administrative reasons by sponsor|16|||
127954984|NCT04100018|460453735|FG001|Treatment Period|Administrative reasons by sponsor|30|||
127954985|NCT04100018|460453734|FG000|Treatment Period|Poor/Non-Compliance|1|||
127954986|NCT04100018|460453735|FG001|Treatment Period|Poor/Non-Compliance|0|||
127954987|NCT04100018|460453734|FG000|Treatment Period|Lost to Follow-up|2|||
127954988|NCT04100018|460453735|FG001|Treatment Period|Lost to Follow-up|2|||
127954989|NCT04100018|460453734|FG000|Treatment Period|Death|16|||
127954990|NCT04100018|460453735|FG001|Treatment Period|Death|11|||
127954991|NCT04100018|460453734|FG000|Treatment Period|Participant withdrew consent|10|||
127954992|NCT04100018|460453735|FG001|Treatment Period|Participant withdrew consent|10|||
127954993|NCT04100018|460453734|FG000|Treatment Period|Participant request to discontinue study treatment|33|||
127954994|NCT04100018|460453735|FG001|Treatment Period|Participant request to discontinue study treatment|32|||
127954995|NCT04100018|460453734|FG000|Treatment Period|Adverse Event|14|||
127954996|NCT04100018|460453735|FG001|Treatment Period|Adverse Event|6|||
127954997|NCT04100018|460453734|FG000|Treatment Period|Lack of Efficacy|4|||
127954998|NCT04100018|460453735|FG001|Treatment Period|Lack of Efficacy|2|||
127954999|NCT02090725|460453740|FG000|Overall Study|Withdrawal by Subject|1|||
127955000|NCT02090725|460453740|FG000|Overall Study|participants moved from area|3|||
127955001|NCT04358081|460453742|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
127955002|NCT04358081|460453743|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
127955003|NCT04358081|460453744|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
127955004|NCT04358081|460453742|FG000|Treatment Phase of Study|Adverse Event|1|||
127955005|NCT04358081|460453743|FG001|Treatment Phase of Study|Adverse Event|0|||
127955006|NCT04358081|460453744|FG002|Treatment Phase of Study|Adverse Event|1|||
127955007|NCT04358081|460453742|FG000|Treatment Phase of Study|Physician Decision|2|||
127955008|NCT04358081|460453743|FG001|Treatment Phase of Study|Physician Decision|0|||
127955009|NCT04358081|460453744|FG002|Treatment Phase of Study|Physician Decision|1|||
127955010|NCT04358081|460453742|FG000|Treatment Phase of Study|Protocol Violation|1|||
127955011|NCT04358081|460453743|FG001|Treatment Phase of Study|Protocol Violation|0|||
127955012|NCT04358081|460453744|FG002|Treatment Phase of Study|Protocol Violation|0|||
127955013|NCT04358081|460453742|FG000|Study Completion Phase|Death|0|||
127955014|NCT04358081|460453743|FG001|Study Completion Phase|Death|0|||
127955015|NCT04358081|460453744|FG002|Study Completion Phase|Death|1|||
127955016|NCT04358081|460453742|FG000|Study Completion Phase|Lost to Follow-up|1|||
127955017|NCT04358081|460453743|FG001|Study Completion Phase|Lost to Follow-up|0|||
127955018|NCT04358081|460453744|FG002|Study Completion Phase|Lost to Follow-up|1|||
127955019|NCT01130532|460453747|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
127955020|NCT01130532|460453748|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
127955021|NCT01130532|460453749|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
127955022|NCT01130532|460453750|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
127955023|NCT01130532|460453747|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
127955024|NCT01130532|460453748|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
127955025|NCT01130532|460453749|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
127955026|NCT01130532|460453750|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
127955027|NCT01130532|460453747|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
127955028|NCT01130532|460453748|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
127955029|NCT01130532|460453749|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
127955030|NCT01130532|460453750|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
127955031|NCT01130532|460453747|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
127955032|NCT01130532|460453748|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
127955033|NCT01130532|460453749|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
127955034|NCT01130532|460453750|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
127955035|NCT01130532|460453747|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
127955036|NCT01130532|460453748|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
127955037|NCT01130532|460453749|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
127955038|NCT01130532|460453750|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
127955039|NCT01130532|460453747|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
127955040|NCT01130532|460453748|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
127955041|NCT01130532|460453749|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
127955042|NCT01130532|460453750|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
127955043|NCT01130532|460453747|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
127955044|NCT01130532|460453748|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
127955045|NCT01130532|460453749|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
127955046|NCT01130532|460453750|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
127955047|NCT01130532|460453747|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
127955048|NCT01130532|460453748|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
127955049|NCT01130532|460453749|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
127955050|NCT01130532|460453750|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
127955051|NCT01130532|460453747|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
127955052|NCT01130532|460453748|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
127955053|NCT01130532|460453749|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
127955054|NCT01130532|460453750|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
127955055|NCT01130532|460453747|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
127955056|NCT01130532|460453748|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
127955057|NCT01130532|460453749|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
127955058|NCT01130532|460453750|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
127955059|NCT01130532|460453747|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
127955060|NCT01130532|460453748|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
127955061|NCT01130532|460453749|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
127955062|NCT01130532|460453750|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
127955063|NCT02656303|460453751|FG000|Overall Study|Adverse Event|3|||
127955064|NCT02656303|460453752|FG001|Overall Study|Adverse Event|2|||
127955065|NCT02656303|460453753|FG002|Overall Study|Adverse Event|0|||
127955066|NCT02656303|460453751|FG000|Overall Study|Death|12|||
127955067|NCT02656303|460453752|FG001|Overall Study|Death|4|||
127955068|NCT02656303|460453753|FG002|Overall Study|Death|1|||
127955069|NCT02656303|460453751|FG000|Overall Study|Lack of Efficacy|1|||
127955070|NCT02656303|460453752|FG001|Overall Study|Lack of Efficacy|0|||
127955071|NCT02656303|460453753|FG002|Overall Study|Lack of Efficacy|0|||
127955072|NCT02656303|460453751|FG000|Overall Study|Non-Compliance with Study|1|||
127955073|NCT02656303|460453752|FG001|Overall Study|Non-Compliance with Study|1|||
127955074|NCT02656303|460453753|FG002|Overall Study|Non-Compliance with Study|0|||
127955075|NCT02656303|460453751|FG000|Overall Study|Investigator Decision|2|||
127955076|NCT02656303|460453752|FG001|Overall Study|Investigator Decision|1|||
127955077|NCT02656303|460453753|FG002|Overall Study|Investigator Decision|0|||
127955078|NCT02656303|460453751|FG000|Overall Study|Progressive Disease|25|||
127955079|NCT02656303|460453752|FG001|Overall Study|Progressive Disease|14|||
127955080|NCT02656303|460453753|FG002|Overall Study|Progressive Disease|10|||
127955081|NCT02656303|460453751|FG000|Overall Study|Study Terminated by Sponsor|20|||
127955082|NCT02656303|460453752|FG001|Overall Study|Study Terminated by Sponsor|7|||
127955083|NCT02656303|460453753|FG002|Overall Study|Study Terminated by Sponsor|5|||
127955084|NCT02656303|460453751|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
127955085|NCT02656303|460453752|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
127955086|NCT02656303|460453753|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
127955087|NCT02656303|460453751|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
127955088|NCT02656303|460453752|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
127955089|NCT02656303|460453753|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
127955090|NCT02656303|460453751|FG000|Overall Study|Reason not Specified|1|||
127955091|NCT02656303|460453752|FG001|Overall Study|Reason not Specified|1|||
127955092|NCT02656303|460453753|FG002|Overall Study|Reason not Specified|2|||
127955093|NCT03041311|460453754|FG000|Overall Study|Death|39|||
127955094|NCT03041311|460453755|FG001|Overall Study|Death|42|||
127955095|NCT03041311|460453754|FG000|Overall Study|Lost to Follow-up|0|||
127955096|NCT03041311|460453755|FG001|Overall Study|Lost to Follow-up|1|||
127955097|NCT03041311|460453754|FG000|Overall Study|Withdrawal by Subject|8|||
127955098|NCT03041311|460453755|FG001|Overall Study|Withdrawal by Subject|5|||
127955099|NCT03041311|460453754|FG000|Overall Study|Sponsor Terminated Study|2|||
127955100|NCT03041311|460453755|FG001|Overall Study|Sponsor Terminated Study|4|||
127955101|NCT03041311|460453754|FG000|Overall Study|Disease Progression|3|||
127955102|NCT03041311|460453755|FG001|Overall Study|Disease Progression|1|||
127955103|NCT03041311|460453754|FG000|Overall Study|Randomized in error, did not receive drug|2|||
127955104|NCT03041311|460453755|FG001|Overall Study|Randomized in error, did not receive drug|0|||
127955105|NCT01842438|460453756|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
127955106|NCT01842438|460453757|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
127955107|NCT01842438|460453756|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
127955108|NCT01842438|460453757|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
127955109|NCT01842438|460453756|FG000|T2: 6month Follow-up|Death|0|||
127955110|NCT01842438|460453757|FG001|T2: 6month Follow-up|Death|1|||
127955111|NCT00782626|460453761|FG000|Overall Study|Adverse Event|1|||
127955112|NCT00782626|460453761|FG000|Overall Study|Progressive Disease|5|||
127955113|NCT00782626|460453761|FG000|Overall Study|Other Complicating Disease|1|||
127955114|NCT04909853|460453762|FG000|Part 1|Assigned but not treated|0|||
127955115|NCT04909853|460453763|FG001|Part 1|Assigned but not treated|0|||
127955116|NCT04909853|460453764|FG002|Part 1|Assigned but not treated|1|||
127955117|NCT04909853|460453765|FG003|Part 1|Assigned but not treated|0|||
127955118|NCT04909853|460453762|FG000|Part 2|Adverse Event|0|||
127955119|NCT04909853|460453763|FG001|Part 2|Adverse Event|0|||
127955120|NCT04909853|460453764|FG002|Part 2|Adverse Event|0|||
127955121|NCT04909853|460453765|FG003|Part 2|Adverse Event|1|||
127955122|NCT04054765|460453766|FG000|Baseline|Withdrawal by Subject|5|||
127955123|NCT04054765|460453767|FG001|Baseline|Withdrawal by Subject|3|||
127955124|NCT04054765|460453766|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
127955125|NCT04054765|460453767|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
127955126|NCT04054765|460453766|FG000|3-month Follow up|Withdrawal by Subject|0|||
127955127|NCT04054765|460453767|FG001|3-month Follow up|Withdrawal by Subject|3|||
127955128|NCT04054765|460453766|FG000|6-month Follow up|Lost to Follow-up|32|||
127955129|NCT04054765|460453767|FG001|6-month Follow up|Lost to Follow-up|32|||
127955130|NCT04182490|460453769|FG000|Overall Study|Withdrawal by Subject|3|||
127955131|NCT04182490|460453770|FG001|Overall Study|Withdrawal by Subject|3|||
127955132|NCT04182490|460453769|FG000|Overall Study|Lost to Follow-up|0|||
127955133|NCT04182490|460453770|FG001|Overall Study|Lost to Follow-up|1|||
127955134|NCT04182490|460453769|FG000|Overall Study|Physician Decision|0|||
127955135|NCT04182490|460453770|FG001|Overall Study|Physician Decision|1|||
127955136|NCT00853099|460453771|FG000|Double-blind Period|Adverse Event|7|||
127955137|NCT00853099|460453772|FG001|Double-blind Period|Adverse Event|9|||
127955138|NCT00853099|460453773|FG002|Double-blind Period|Adverse Event|13|||
127955139|NCT00853099|460453774|FG003|Double-blind Period|Adverse Event|0|||
127955140|NCT00853099|460453771|FG000|Double-blind Period|Withdrawal by Subject|2|||
127955141|NCT00853099|460453772|FG001|Double-blind Period|Withdrawal by Subject|3|||
127955142|NCT00853099|460453773|FG002|Double-blind Period|Withdrawal by Subject|0|||
127955143|NCT00853099|460453774|FG003|Double-blind Period|Withdrawal by Subject|0|||
127955144|NCT00853099|460453771|FG000|Double-blind Period|Lack of Efficacy|14|||
127955145|NCT00853099|460453772|FG001|Double-blind Period|Lack of Efficacy|17|||
127955146|NCT00853099|460453773|FG002|Double-blind Period|Lack of Efficacy|16|||
127955147|NCT00853099|460453774|FG003|Double-blind Period|Lack of Efficacy|0|||
127955148|NCT00853099|460453771|FG000|Double-blind Period|Other|0|||
127955149|NCT00853099|460453772|FG001|Double-blind Period|Other|0|||
127955150|NCT00853099|460453773|FG002|Double-blind Period|Other|1|||
127955151|NCT00853099|460453774|FG003|Double-blind Period|Other|0|||
127955152|NCT00853099|460453771|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
127955153|NCT00853099|460453772|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
127955154|NCT00853099|460453773|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
127955155|NCT00853099|460453774|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
127955156|NCT00853099|460453771|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
127955157|NCT00853099|460453772|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
127955158|NCT00853099|460453773|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
127955159|NCT00853099|460453774|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
127955160|NCT00853099|460453771|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
127955161|NCT00853099|460453772|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
127955162|NCT00853099|460453773|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
127955163|NCT00853099|460453774|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
127955164|NCT00853099|460453771|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
127955165|NCT00853099|460453772|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
127955166|NCT00853099|460453773|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
127955167|NCT00853099|460453774|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
127955168|NCT00853099|460453771|FG000|Double-blind + Open-label Periods|Other|0|||
127955169|NCT00853099|460453772|FG001|Double-blind + Open-label Periods|Other|0|||
127955170|NCT00853099|460453773|FG002|Double-blind + Open-label Periods|Other|0|||
127955171|NCT00853099|460453774|FG003|Double-blind + Open-label Periods|Other|6|||
127955172|NCT01811472|460453775|FG000|Overall Study|Adverse Event|1|||
127955173|NCT01811472|460453776|FG001|Overall Study|Adverse Event|0|||
127955174|NCT01811472|460453777|FG002|Overall Study|Adverse Event|4|||
127955175|NCT01811472|460453775|FG000|Overall Study|Lost to Follow-up|0|||
127955176|NCT01811472|460453776|FG001|Overall Study|Lost to Follow-up|0|||
127955177|NCT01811472|460453777|FG002|Overall Study|Lost to Follow-up|1|||
127955178|NCT01811472|460453775|FG000|Overall Study|Subject/guardian decision|1|||
127955179|NCT01811472|460453776|FG001|Overall Study|Subject/guardian decision|0|||
127955180|NCT01811472|460453777|FG002|Overall Study|Subject/guardian decision|0|||
127955181|NCT03280264|460453778|FG000|Overall Study|Adverse Event|1|||
127955182|NCT03280264|460453778|FG000|Overall Study|Physician Decision|1|||
127955183|NCT03280264|460453778|FG000|Overall Study|Withdrawal by Subject|1|||
127955184|NCT02071225|460453788|FG000|Overall Study|Withdrawal of Consent|2|||
127955185|NCT02071225|460453788|FG000|Overall Study|Protocol Deviation|1|||
127955186|NCT02071225|460453788|FG000|Overall Study|Lost to Follow-up|2|||
127955187|NCT02071225|460453788|FG000|Overall Study|Death|25|||
127955188|NCT02064296|460453791|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
127955189|NCT02064296|460453792|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
127955190|NCT02064296|460453793|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
127955191|NCT02064296|460453791|FG000|Intervention|Withdrawal by Subject|0|||
127955192|NCT02064296|460453792|FG001|Intervention|Withdrawal by Subject|1|||
127955193|NCT02064296|460453793|FG002|Intervention|Withdrawal by Subject|2|||
127955194|NCT03885661|460453802|FG000|Overall Study|Withdrawal by Subject|0|||
127976442|NCT03535194|460536128|FG003|Induction Period|Screen Failure|0|||
127955195|NCT03885661|460453803|FG001|Overall Study|Withdrawal by Subject|1|||
127955196|NCT03885661|460453802|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
127955197|NCT03885661|460453803|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
127955198|NCT00489255|460453812|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
127955199|NCT00489255|460453813|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
127955200|NCT00489255|460453812|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
127955201|NCT00489255|460453813|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
127955202|NCT00489255|460453812|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
127955203|NCT00489255|460453813|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
127955204|NCT00489255|460453812|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
127955205|NCT00489255|460453813|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
127955206|NCT00489255|460453812|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
127955207|NCT00489255|460453813|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
127955208|NCT00489255|460453812|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
127955209|NCT00489255|460453813|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
127955210|NCT00489255|460453812|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
127955211|NCT00489255|460453813|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
127955212|NCT00489255|460453812|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
127955213|NCT00489255|460453813|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
127955214|NCT00489255|460453812|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
127955215|NCT00489255|460453813|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
127955216|NCT00489255|460453812|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
127955217|NCT00489255|460453813|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
127955218|NCT03130777|460455294|FG000|Overall Study|Death|0|||
127955219|NCT03130777|460455295|FG001|Overall Study|Death|1|||
127955220|NCT03130777|460455294|FG000|Overall Study|Did not meet eligibility criteria|1|||
127955221|NCT03130777|460455295|FG001|Overall Study|Did not meet eligibility criteria|0|||
127955222|NCT02498613|460455297|FG000|Overall Study|Tx Initiation Criteria Not Met|2|||
127955223|NCT02498613|460455298|FG001|Overall Study|Tx Initiation Criteria Not Met|1|||
127955224|NCT02498613|460455299|FG002|Overall Study|Tx Initiation Criteria Not Met|5|||
127955225|NCT02498613|460455300|FG003|Overall Study|Tx Initiation Criteria Not Met|1|||
127955226|NCT02498613|460455297|FG000|Overall Study|Withdrawal by Subject|3|||
127955227|NCT02498613|460455298|FG001|Overall Study|Withdrawal by Subject|1|||
127955228|NCT02498613|460455299|FG002|Overall Study|Withdrawal by Subject|0|||
127955229|NCT02498613|460455300|FG003|Overall Study|Withdrawal by Subject|0|||
127955230|NCT05168202|460455301|FG000|Overall Study|Progressive Disease|4|||
127955231|NCT05168202|460455302|FG001|Overall Study|Progressive Disease|4|||
127955232|NCT05168202|460455303|FG002|Overall Study|Progressive Disease|2|||
127955233|NCT05168202|460455304|FG003|Overall Study|Progressive Disease|3|||
127955234|NCT05168202|460455305|FG004|Overall Study|Progressive Disease|2|||
127955235|NCT05168202|460455306|FG005|Overall Study|Progressive Disease|3|||
127955236|NCT05168202|460455307|FG006|Overall Study|Progressive Disease|2|||
127955237|NCT05168202|460455301|FG000|Overall Study|Adverse Event|2|||
127955238|NCT05168202|460455302|FG001|Overall Study|Adverse Event|1|||
127955239|NCT05168202|460455303|FG002|Overall Study|Adverse Event|4|||
127955240|NCT05168202|460455304|FG003|Overall Study|Adverse Event|4|||
127955241|NCT05168202|460455305|FG004|Overall Study|Adverse Event|3|||
127955242|NCT05168202|460455306|FG005|Overall Study|Adverse Event|2|||
127955243|NCT05168202|460455307|FG006|Overall Study|Adverse Event|0|||
127955244|NCT05168202|460455301|FG000|Overall Study|Lack of Efficacy|0|||
127955245|NCT05168202|460455302|FG001|Overall Study|Lack of Efficacy|1|||
127955246|NCT05168202|460455303|FG002|Overall Study|Lack of Efficacy|1|||
127955247|NCT05168202|460455304|FG003|Overall Study|Lack of Efficacy|0|||
127955248|NCT05168202|460455305|FG004|Overall Study|Lack of Efficacy|1|||
127955249|NCT05168202|460455306|FG005|Overall Study|Lack of Efficacy|2|||
127955250|NCT05168202|460455307|FG006|Overall Study|Lack of Efficacy|2|||
127955251|NCT05168202|460455301|FG000|Overall Study|Withdrawal by Subject|0|||
127955252|NCT05168202|460455302|FG001|Overall Study|Withdrawal by Subject|0|||
127955253|NCT05168202|460455303|FG002|Overall Study|Withdrawal by Subject|1|||
127955254|NCT05168202|460455304|FG003|Overall Study|Withdrawal by Subject|1|||
127955255|NCT05168202|460455305|FG004|Overall Study|Withdrawal by Subject|1|||
127955256|NCT05168202|460455306|FG005|Overall Study|Withdrawal by Subject|1|||
127955257|NCT05168202|460455307|FG006|Overall Study|Withdrawal by Subject|0|||
127955258|NCT05168202|460455301|FG000|Overall Study|Disease Relapse|0|||
127955259|NCT05168202|460455302|FG001|Overall Study|Disease Relapse|1|||
127955260|NCT05168202|460455303|FG002|Overall Study|Disease Relapse|0|||
127955261|NCT05168202|460455304|FG003|Overall Study|Disease Relapse|1|||
127955262|NCT05168202|460455305|FG004|Overall Study|Disease Relapse|1|||
127955263|NCT05168202|460455306|FG005|Overall Study|Disease Relapse|0|||
127955264|NCT05168202|460455307|FG006|Overall Study|Disease Relapse|0|||
127955265|NCT05168202|460455301|FG000|Overall Study|Other Reasons|0|||
127955266|NCT05168202|460455302|FG001|Overall Study|Other Reasons|0|||
127955267|NCT05168202|460455303|FG002|Overall Study|Other Reasons|0|||
127955268|NCT05168202|460455304|FG003|Overall Study|Other Reasons|0|||
127955269|NCT05168202|460455305|FG004|Overall Study|Other Reasons|0|||
127955270|NCT05168202|460455306|FG005|Overall Study|Other Reasons|2|||
127955271|NCT05168202|460455307|FG006|Overall Study|Other Reasons|1|||
127955272|NCT05168202|460455301|FG000|Overall Study|Physician Decision|0|||
127955273|NCT05168202|460455302|FG001|Overall Study|Physician Decision|1|||
127955274|NCT05168202|460455303|FG002|Overall Study|Physician Decision|1|||
127955275|NCT05168202|460455304|FG003|Overall Study|Physician Decision|0|||
127955276|NCT05168202|460455305|FG004|Overall Study|Physician Decision|0|||
127955277|NCT05168202|460455306|FG005|Overall Study|Physician Decision|0|||
127955278|NCT05168202|460455307|FG006|Overall Study|Physician Decision|0|||
127955279|NCT05168202|460455301|FG000|Overall Study|Study Terminated by Sponsor|0|||
127955280|NCT05168202|460455302|FG001|Overall Study|Study Terminated by Sponsor|0|||
127955281|NCT05168202|460455303|FG002|Overall Study|Study Terminated by Sponsor|0|||
127955282|NCT05168202|460455304|FG003|Overall Study|Study Terminated by Sponsor|1|||
127955283|NCT05168202|460455305|FG004|Overall Study|Study Terminated by Sponsor|0|||
127955284|NCT05168202|460455306|FG005|Overall Study|Study Terminated by Sponsor|0|||
127955285|NCT05168202|460455307|FG006|Overall Study|Study Terminated by Sponsor|0|||
127955286|NCT05109611|460455308|FG000|Overall Study|Adverse Event|13|||
127955287|NCT05109611|460455309|FG001|Overall Study|Adverse Event|10|||
127955288|NCT05109611|460455308|FG000|Overall Study|Withdrawal by Subject|1|||
127955289|NCT05109611|460455309|FG001|Overall Study|Withdrawal by Subject|0|||
127955290|NCT05109611|460455308|FG000|Overall Study|Lost to Follow-up|1|||
127955291|NCT05109611|460455309|FG001|Overall Study|Lost to Follow-up|2|||
127955292|NCT05109611|460455308|FG000|Overall Study|Protocol Violation|0|||
127955293|NCT05109611|460455309|FG001|Overall Study|Protocol Violation|4|||
127955294|NCT05109611|460455308|FG000|Overall Study|Information unavailable|1|||
127955295|NCT05109611|460455309|FG001|Overall Study|Information unavailable|1|||
127955296|NCT06195930|460455312|FG000|Overall Study|Adverse Event|4|||
127955297|NCT04995029|460455313|FG000|Induction Phase|Did not meet eligibility criteria|5|||
127955298|NCT04995029|460455314|FG001|Induction Phase|Did not meet eligibility criteria|2|||
127955299|NCT04995029|460455315|FG002|Induction Phase|Did not meet eligibility criteria|0|||
127955300|NCT04995029|460455316|FG003|Induction Phase|Did not meet eligibility criteria|0|||
127955301|NCT04995029|460455313|FG000|Induction Phase|Withdrawal by Subject|85|||
127955302|NCT04995029|460455314|FG001|Induction Phase|Withdrawal by Subject|42|||
127955303|NCT04995029|460455315|FG002|Induction Phase|Withdrawal by Subject|0|||
127955304|NCT04995029|460455316|FG003|Induction Phase|Withdrawal by Subject|0|||
127955305|NCT04995029|460455313|FG000|Induction Phase|Lost to Follow-up|103|||
127955306|NCT04995029|460455314|FG001|Induction Phase|Lost to Follow-up|67|||
127955307|NCT04995029|460455315|FG002|Induction Phase|Lost to Follow-up|0|||
127955308|NCT04995029|460455316|FG003|Induction Phase|Lost to Follow-up|0|||
127955309|NCT04995029|460455313|FG000|Induction Phase|Adverse Event|5|||
127955310|NCT04995029|460455314|FG001|Induction Phase|Adverse Event|3|||
127955311|NCT04995029|460455315|FG002|Induction Phase|Adverse Event|0|||
127955312|NCT04995029|460455316|FG003|Induction Phase|Adverse Event|0|||
127955313|NCT04995029|460455313|FG000|Induction Phase|Physician Decision|11|||
127955314|NCT04995029|460455314|FG001|Induction Phase|Physician Decision|8|||
127955315|NCT04995029|460455315|FG002|Induction Phase|Physician Decision|0|||
127955316|NCT04995029|460455316|FG003|Induction Phase|Physician Decision|0|||
127955317|NCT04995029|460455313|FG000|Induction Phase|Incarceration|6|||
127955318|NCT04995029|460455314|FG001|Induction Phase|Incarceration|3|||
127955319|NCT04995029|460455315|FG002|Induction Phase|Incarceration|0|||
127955320|NCT04995029|460455316|FG003|Induction Phase|Incarceration|0|||
127955321|NCT04995029|460455313|FG000|Induction Phase|Not otherwise described|5|||
127955322|NCT04995029|460455314|FG001|Induction Phase|Not otherwise described|5|||
127955323|NCT04995029|460455315|FG002|Induction Phase|Not otherwise described|0|||
127955324|NCT04995029|460455316|FG003|Induction Phase|Not otherwise described|0|||
127955325|NCT04995029|460455313|FG000|Maintenance Phase|Lost to Follow-up|0|||
127955326|NCT04995029|460455314|FG001|Maintenance Phase|Lost to Follow-up|0|||
127955327|NCT04995029|460455315|FG002|Maintenance Phase|Lost to Follow-up|51|||
127955328|NCT04995029|460455316|FG003|Maintenance Phase|Lost to Follow-up|44|||
127955329|NCT04995029|460455313|FG000|Maintenance Phase|Did not meet eligibility criteria|0|||
127955330|NCT04995029|460455314|FG001|Maintenance Phase|Did not meet eligibility criteria|0|||
127955331|NCT04995029|460455315|FG002|Maintenance Phase|Did not meet eligibility criteria|0|||
127955332|NCT04995029|460455316|FG003|Maintenance Phase|Did not meet eligibility criteria|1|||
127955333|NCT04995029|460455313|FG000|Maintenance Phase|Adverse Event|0|||
127955334|NCT04995029|460455314|FG001|Maintenance Phase|Adverse Event|0|||
127955335|NCT04995029|460455315|FG002|Maintenance Phase|Adverse Event|0|||
127955336|NCT04995029|460455316|FG003|Maintenance Phase|Adverse Event|1|||
127955337|NCT04995029|460455313|FG000|Maintenance Phase|Physician Decision|0|||
127955338|NCT04995029|460455314|FG001|Maintenance Phase|Physician Decision|0|||
127955339|NCT04995029|460455315|FG002|Maintenance Phase|Physician Decision|8|||
127955340|NCT04995029|460455316|FG003|Maintenance Phase|Physician Decision|4|||
127955341|NCT04995029|460455313|FG000|Maintenance Phase|Withdrawal by Subject|0|||
127955342|NCT04995029|460455314|FG001|Maintenance Phase|Withdrawal by Subject|0|||
127955343|NCT04995029|460455315|FG002|Maintenance Phase|Withdrawal by Subject|17|||
127955344|NCT04995029|460455316|FG003|Maintenance Phase|Withdrawal by Subject|31|||
127485461|NCT01240863|458741181|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
127955345|NCT04995029|460455313|FG000|Maintenance Phase|Incarceration|0|||
127955346|NCT04995029|460455314|FG001|Maintenance Phase|Incarceration|0|||
127955347|NCT04995029|460455315|FG002|Maintenance Phase|Incarceration|4|||
127955348|NCT04995029|460455316|FG003|Maintenance Phase|Incarceration|3|||
127955349|NCT04995029|460455313|FG000|Maintenance Phase|Not otherwise described|0|||
127955350|NCT04995029|460455314|FG001|Maintenance Phase|Not otherwise described|0|||
127955351|NCT04995029|460455315|FG002|Maintenance Phase|Not otherwise described|2|||
127955352|NCT04995029|460455316|FG003|Maintenance Phase|Not otherwise described|3|||
127955353|NCT04995029|460455313|FG000|Maintenance Phase|Pregnancy|0|||
127955354|NCT04995029|460455314|FG001|Maintenance Phase|Pregnancy|0|||
127955355|NCT04995029|460455315|FG002|Maintenance Phase|Pregnancy|2|||
127955356|NCT04995029|460455316|FG003|Maintenance Phase|Pregnancy|2|||
127955357|NCT00077207|460455319|FG000|Overall Study|Adverse Event|5|||
127955358|NCT00077207|460455319|FG000|Overall Study|Lack of Efficacy|12|||
127955359|NCT00077207|460455319|FG000|Overall Study|Physician Decision|6|||
127955360|NCT00077207|460455319|FG000|Overall Study|Withdrawal by Subject|6|||
127955361|NCT00077207|460455319|FG000|Overall Study|Ineligible|1|||
127955362|NCT00970593|460455324|FG000|Overall Study|Adverse Event|1|||
127955363|NCT00970593|460455325|FG001|Overall Study|Adverse Event|1|||
127955364|NCT00970593|460455326|FG002|Overall Study|Adverse Event|0|||
127955365|NCT00970593|460455327|FG003|Overall Study|Adverse Event|0|||
127955366|NCT00970593|460455328|FG004|Overall Study|Adverse Event|0|||
127955367|NCT00970593|460455329|FG005|Overall Study|Adverse Event|0|||
127955368|NCT00970593|460455330|FG006|Overall Study|Adverse Event|0|||
127955369|NCT00970593|460455324|FG000|Overall Study|Discontinuation of study by sponsor|0|||
127955370|NCT00970593|460455325|FG001|Overall Study|Discontinuation of study by sponsor|0|||
127955371|NCT00970593|460455326|FG002|Overall Study|Discontinuation of study by sponsor|5|||
127955372|NCT00970593|460455327|FG003|Overall Study|Discontinuation of study by sponsor|0|||
127955373|NCT00970593|460455328|FG004|Overall Study|Discontinuation of study by sponsor|0|||
127955374|NCT00970593|460455329|FG005|Overall Study|Discontinuation of study by sponsor|0|||
127955375|NCT00970593|460455330|FG006|Overall Study|Discontinuation of study by sponsor|2|||
127955376|NCT00970593|460455324|FG000|Overall Study|Withdrawal by Subject|0|||
127955377|NCT00970593|460455325|FG001|Overall Study|Withdrawal by Subject|0|||
127955378|NCT00970593|460455326|FG002|Overall Study|Withdrawal by Subject|1|||
127955379|NCT00970593|460455327|FG003|Overall Study|Withdrawal by Subject|0|||
127955380|NCT00970593|460455328|FG004|Overall Study|Withdrawal by Subject|0|||
127955381|NCT00970593|460455329|FG005|Overall Study|Withdrawal by Subject|0|||
127955382|NCT00970593|460455330|FG006|Overall Study|Withdrawal by Subject|0|||
127955383|NCT01342081|460455346|FG000|Overall Study|Did not receive allocated intervention|0|||
127955384|NCT01342081|460455347|FG001|Overall Study|Did not receive allocated intervention|0|||
127955385|NCT01342081|460455348|FG002|Overall Study|Did not receive allocated intervention|1|||
127955386|NCT01342081|460455346|FG000|Overall Study|Adverse Event|1|||
127955387|NCT01342081|460455347|FG001|Overall Study|Adverse Event|0|||
127955388|NCT01342081|460455348|FG002|Overall Study|Adverse Event|0|||
127955389|NCT01342081|460455346|FG000|Overall Study|Physician Decision|0|||
127955390|NCT01342081|460455347|FG001|Overall Study|Physician Decision|1|||
127955391|NCT01342081|460455348|FG002|Overall Study|Physician Decision|0|||
127955392|NCT01342081|460455346|FG000|Overall Study|Withdrawal by Subject|1|||
127955393|NCT01342081|460455347|FG001|Overall Study|Withdrawal by Subject|1|||
127955394|NCT01342081|460455348|FG002|Overall Study|Withdrawal by Subject|0|||
127955395|NCT01202175|460455349|FG000|Overall Study|Lost to Follow-up|2|||
127955396|NCT01202175|460455349|FG000|Overall Study|Withdrawal by Subject|1|||
127955397|NCT01202175|460455349|FG000|Overall Study|Adverse Event|2|||
127955398|NCT02790437|460455351|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
127955399|NCT02790437|460455352|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
127955400|NCT02790437|460455351|FG000|Overall Study|Adverse Event|1|||
127955401|NCT02790437|460455352|FG001|Overall Study|Adverse Event|0|||
127955402|NCT02790437|460455351|FG000|Overall Study|Withdrawal by Subject|1|||
127955403|NCT02790437|460455352|FG001|Overall Study|Withdrawal by Subject|0|||
127955404|NCT03908125|460455360|FG000|Overall Study|Withdrawal by Subject|92|||
127955405|NCT03908125|460455360|FG000|Overall Study|Lost to Follow-up|8|||
127955406|NCT00114140|460455361|FG000|Overall Study|Protocol Violation|7|||
127955407|NCT00666328|460455362|FG000|Overall Study|Death|2|||
127955408|NCT00666328|460455362|FG000|Overall Study|Lost to Follow-up|2|||
127955409|NCT00666328|460455362|FG000|Overall Study|No longer met eligibility criteria|1|||
127955410|NCT05064397|460455363|FG000|Overall Study|Adverse Event|4|||
127955411|NCT05064397|460455363|FG000|Overall Study|Lack of Efficacy|12|||
127955412|NCT05064397|460455363|FG000|Overall Study|Withdrawal by Subject|3|||
127955413|NCT05064397|460455363|FG000|Overall Study|Lost to Follow-up|1|||
127955414|NCT05064397|460455363|FG000|Overall Study|Other reasons|3|||
127955415|NCT02232984|460455364|FG000|Overall Study|Withdrawal by Subject|5|||
127955416|NCT02232984|460455364|FG000|Overall Study|Death|1|||
127955417|NCT02232984|460455364|FG000|Overall Study|Investigator withdrawal|10|||
127955418|NCT02232984|460455364|FG000|Overall Study|Device implant unsuccessful|53|||
127955419|NCT02232984|460455364|FG000|Overall Study|not disclosed by site|7|||
127955420|NCT02232984|460455364|FG000|Overall Study|Protocol Violation|1|||
127955421|NCT00535405|460455367|FG000|Overall Study|Adverse Event|6|||
127955422|NCT00535405|460455368|FG001|Overall Study|Adverse Event|8|||
127955423|NCT00535405|460455369|FG002|Overall Study|Adverse Event|3|||
127955424|NCT00535405|460455370|FG003|Overall Study|Adverse Event|8|||
127955425|NCT00535405|460455371|FG004|Overall Study|Adverse Event|6|||
127955426|NCT00535405|460455367|FG000|Overall Study|Lost to Follow-up|1|||
127955427|NCT00535405|460455368|FG001|Overall Study|Lost to Follow-up|3|||
127955428|NCT00535405|460455369|FG002|Overall Study|Lost to Follow-up|3|||
127955429|NCT00535405|460455370|FG003|Overall Study|Lost to Follow-up|2|||
127955430|NCT00535405|460455371|FG004|Overall Study|Lost to Follow-up|1|||
127955431|NCT00535405|460455367|FG000|Overall Study|Physician Decision|3|||
127955432|NCT00535405|460455368|FG001|Overall Study|Physician Decision|2|||
127955433|NCT00535405|460455369|FG002|Overall Study|Physician Decision|0|||
127955434|NCT00535405|460455370|FG003|Overall Study|Physician Decision|1|||
127955435|NCT00535405|460455371|FG004|Overall Study|Physician Decision|1|||
127955436|NCT00535405|460455367|FG000|Overall Study|Protocol Violation|2|||
127955437|NCT00535405|460455368|FG001|Overall Study|Protocol Violation|2|||
127955438|NCT00535405|460455369|FG002|Overall Study|Protocol Violation|2|||
127955439|NCT00535405|460455370|FG003|Overall Study|Protocol Violation|1|||
127955440|NCT00535405|460455371|FG004|Overall Study|Protocol Violation|0|||
127955441|NCT00535405|460455367|FG000|Overall Study|Withdrawal by Subject|5|||
127955442|NCT00535405|460455368|FG001|Overall Study|Withdrawal by Subject|11|||
127955443|NCT00535405|460455369|FG002|Overall Study|Withdrawal by Subject|10|||
127955444|NCT00535405|460455370|FG003|Overall Study|Withdrawal by Subject|10|||
127955445|NCT00535405|460455371|FG004|Overall Study|Withdrawal by Subject|8|||
127955446|NCT03404674|460455372|FG000|Overall Study|Inability to Attend Future Visits|0|||
127955447|NCT03404674|460455373|FG001|Overall Study|Inability to Attend Future Visits|1|||
127955448|NCT03404674|460455374|FG002|Overall Study|Inability to Attend Future Visits|1|||
127955449|NCT03404674|460455375|FG003|Overall Study|Inability to Attend Future Visits|0|||
127955450|NCT03404674|460455376|FG004|Overall Study|Inability to Attend Future Visits|0|||
127955451|NCT03404674|460455377|FG005|Overall Study|Inability to Attend Future Visits|0|||
127955452|NCT03404674|460455372|FG000|Overall Study|Behavioral Problems|0|||
127955453|NCT03404674|460455373|FG001|Overall Study|Behavioral Problems|0|||
127955454|NCT03404674|460455374|FG002|Overall Study|Behavioral Problems|1|||
127955455|NCT03404674|460455375|FG003|Overall Study|Behavioral Problems|0|||
127955456|NCT03404674|460455376|FG004|Overall Study|Behavioral Problems|0|||
127955457|NCT03404674|460455377|FG005|Overall Study|Behavioral Problems|0|||
127955458|NCT03404674|460455372|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
127955459|NCT03404674|460455373|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
127955460|NCT03404674|460455374|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
127955461|NCT03404674|460455375|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
127955462|NCT03404674|460455376|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
127955463|NCT03404674|460455377|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
127955464|NCT02969044|460455382|FG000|Overall Study|Withdrawal by Subject|2|||
127955465|NCT02969044|460455383|FG001|Overall Study|Withdrawal by Subject|6|||
127955466|NCT02969044|460455382|FG000|Overall Study|Adverse Event|3|||
127955467|NCT02969044|460455383|FG001|Overall Study|Adverse Event|0|||
127955468|NCT04728802|460455384|FG000|Overall Study|Withdrawal by Subject|4|||
127955469|NCT04728802|460455385|FG001|Overall Study|Withdrawal by Subject|20|||
127955470|NCT04728802|460455384|FG000|Overall Study|Physician Decision|7|||
127955471|NCT04728802|460455385|FG001|Overall Study|Physician Decision|7|||
127955472|NCT04728802|460455384|FG000|Overall Study|Protocol Violation|10|||
127955473|NCT04728802|460455385|FG001|Overall Study|Protocol Violation|4|||
127955474|NCT04728802|460455384|FG000|Overall Study|Transfer|1|||
127955475|NCT04728802|460455385|FG001|Overall Study|Transfer|0|||
127955476|NCT04728802|460455384|FG000|Overall Study|Death|4|||
127955477|NCT04728802|460455385|FG001|Overall Study|Death|5|||
127955478|NCT04728802|460455384|FG000|Overall Study|Other|3|||
127955479|NCT04728802|460455385|FG001|Overall Study|Other|0|||
127955480|NCT01176513|460455386|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
127955481|NCT03164616|460455387|FG000|Overall Study|Death|250|||
127955482|NCT03164616|460455388|FG001|Overall Study|Death|264|||
127955483|NCT03164616|460455389|FG002|Overall Study|Death|279|||
127955484|NCT03164616|460455387|FG000|Overall Study|Lost to Follow-up|2|||
127955485|NCT03164616|460455388|FG001|Overall Study|Lost to Follow-up|2|||
127955486|NCT03164616|460455389|FG002|Overall Study|Lost to Follow-up|2|||
127955487|NCT03164616|460455387|FG000|Overall Study|Withdrawal by Subject|6|||
127955488|NCT03164616|460455388|FG001|Overall Study|Withdrawal by Subject|7|||
127955489|NCT03164616|460455389|FG002|Overall Study|Withdrawal by Subject|16|||
127955490|NCT06018129|460455401|FG000|Overall Study|Death|1|||
127955491|NCT06018129|460455402|FG001|Overall Study|Death|1|||
127955492|NCT06018129|460455403|FG002|Overall Study|Death|2|||
127955493|NCT06018129|460455401|FG000|Overall Study|Sponsor Decision|2|||
127955494|NCT06018129|460455402|FG001|Overall Study|Sponsor Decision|2|||
127955495|NCT06018129|460455403|FG002|Overall Study|Sponsor Decision|1|||
127955496|NCT01959295|460455404|FG000|Overall Study|Adverse Event|2|||
127955497|NCT01959295|460455405|FG001|Overall Study|Adverse Event|0|||
127955498|NCT01959295|460455404|FG000|Overall Study|Lost to Follow-up|0|||
127955499|NCT01959295|460455405|FG001|Overall Study|Lost to Follow-up|2|||
127955500|NCT01959295|460455404|FG000|Overall Study|Physician Decision|2|||
127955501|NCT01959295|460455405|FG001|Overall Study|Physician Decision|3|||
127955502|NCT01959295|460455404|FG000|Overall Study|Protocol Violation|16|||
127955503|NCT01959295|460455405|FG001|Overall Study|Protocol Violation|5|||
127955504|NCT01959295|460455404|FG000|Overall Study|Withdrawal by Subject|3|||
127955505|NCT01959295|460455405|FG001|Overall Study|Withdrawal by Subject|1|||
127955506|NCT01959295|460455404|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|10|||
127955507|NCT01959295|460455405|FG001|Overall Study|Clinical laboratory value is ineligible on day 1|6|||
127955508|NCT04917861|460455407|FG000|Main Study (196 Days)|Adverse Event|0|||
127955509|NCT04917861|460455408|FG001|Main Study (196 Days)|Adverse Event|1|||
127955510|NCT04917861|460455409|FG002|Main Study (196 Days)|Adverse Event|0|||
127955511|NCT04917861|460455410|FG003|Main Study (196 Days)|Adverse Event|0|||
127955512|NCT04917861|460455407|FG000|Main Study (196 Days)|Death|0|||
127955513|NCT04917861|460455408|FG001|Main Study (196 Days)|Death|0|||
127955514|NCT04917861|460455409|FG002|Main Study (196 Days)|Death|0|||
127955515|NCT04917861|460455410|FG003|Main Study (196 Days)|Death|1|||
127955516|NCT04917861|460455407|FG000|Main Study (196 Days)|Lost to Follow-up|14|||
127955517|NCT04917861|460455408|FG001|Main Study (196 Days)|Lost to Follow-up|26|||
127955518|NCT04917861|460455409|FG002|Main Study (196 Days)|Lost to Follow-up|20|||
127955519|NCT04917861|460455410|FG003|Main Study (196 Days)|Lost to Follow-up|11|||
127955520|NCT04917861|460455407|FG000|Main Study (196 Days)|Physician Decision|0|||
127955521|NCT04917861|460455408|FG001|Main Study (196 Days)|Physician Decision|0|||
127955522|NCT04917861|460455409|FG002|Main Study (196 Days)|Physician Decision|0|||
127955523|NCT04917861|460455410|FG003|Main Study (196 Days)|Physician Decision|1|||
127955524|NCT04917861|460455407|FG000|Main Study (196 Days)|Pregnancy|1|||
127955525|NCT04917861|460455408|FG001|Main Study (196 Days)|Pregnancy|1|||
127955526|NCT04917861|460455409|FG002|Main Study (196 Days)|Pregnancy|0|||
127955527|NCT04917861|460455410|FG003|Main Study (196 Days)|Pregnancy|0|||
127955528|NCT04917861|460455407|FG000|Main Study (196 Days)|Withdrawal by Subject|14|||
127955529|NCT04917861|460455408|FG001|Main Study (196 Days)|Withdrawal by Subject|7|||
127955530|NCT04917861|460455409|FG002|Main Study (196 Days)|Withdrawal by Subject|6|||
127955531|NCT04917861|460455410|FG003|Main Study (196 Days)|Withdrawal by Subject|8|||
127955532|NCT04917861|460455407|FG000|Main Study (196 Days)|Other Than Specified|1|||
127955533|NCT04917861|460455408|FG001|Main Study (196 Days)|Other Than Specified|0|||
127955534|NCT04917861|460455409|FG002|Main Study (196 Days)|Other Than Specified|1|||
127955535|NCT04917861|460455410|FG003|Main Study (196 Days)|Other Than Specified|2|||
127955536|NCT04917861|460455407|FG000|Extension Period (Day 197 to Day 700)|Lost to Follow-up|8|||
127955537|NCT04917861|460455408|FG001|Extension Period (Day 197 to Day 700)|Lost to Follow-up|3|||
127955538|NCT04917861|460455409|FG002|Extension Period (Day 197 to Day 700)|Lost to Follow-up|5|||
127955539|NCT04917861|460455410|FG003|Extension Period (Day 197 to Day 700)|Lost to Follow-up|11|||
127955540|NCT04917861|460455407|FG000|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
127955541|NCT04917861|460455408|FG001|Extension Period (Day 197 to Day 700)|Pregnancy|0|||
127955542|NCT04917861|460455409|FG002|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
127955543|NCT04917861|460455410|FG003|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
127955544|NCT04917861|460455407|FG000|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
127955545|NCT04917861|460455408|FG001|Extension Period (Day 197 to Day 700)|Protocol Violation|1|||
127955546|NCT04917861|460455409|FG002|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
127955547|NCT04917861|460455410|FG003|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
127955548|NCT04917861|460455407|FG000|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|6|||
127955549|NCT04917861|460455408|FG001|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
127955550|NCT04917861|460455409|FG002|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
127955551|NCT04917861|460455410|FG003|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|10|||
127955552|NCT04917861|460455407|FG000|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
127955553|NCT04917861|460455408|FG001|Extension Period (Day 197 to Day 700)|Other Than Specified|0|||
127955554|NCT04917861|460455409|FG002|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
127955555|NCT04917861|460455410|FG003|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
127955556|NCT04917861|460455407|FG000|Extension Period (Day 197 to Day 700)|Death|0|||
127955557|NCT04917861|460455408|FG001|Extension Period (Day 197 to Day 700)|Death|1|||
127955558|NCT04917861|460455409|FG002|Extension Period (Day 197 to Day 700)|Death|0|||
127955559|NCT04917861|460455410|FG003|Extension Period (Day 197 to Day 700)|Death|0|||
127955560|NCT06389487|460455411|FG000|Overall Study|Lost to Follow-up|9|||
127955561|NCT06389487|460455412|FG001|Overall Study|Lost to Follow-up|5|||
127955562|NCT06389487|460455413|FG002|Overall Study|Lost to Follow-up|13|||
127955563|NCT06389487|460455411|FG000|Overall Study|Protocol Violation|0|||
127955564|NCT06389487|460455412|FG001|Overall Study|Protocol Violation|0|||
127955565|NCT06389487|460455413|FG002|Overall Study|Protocol Violation|2|||
127955566|NCT06389487|460455411|FG000|Overall Study|Withdrawal by Subject|2|||
127955567|NCT06389487|460455412|FG001|Overall Study|Withdrawal by Subject|2|||
127955568|NCT06389487|460455413|FG002|Overall Study|Withdrawal by Subject|1|||
127955569|NCT06389487|460455411|FG000|Overall Study|Other|1|||
127955570|NCT06389487|460455412|FG001|Overall Study|Other|0|||
127955571|NCT06389487|460455413|FG002|Overall Study|Other|1|||
127955572|NCT05061134|460456692|FG000|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|19|||
127955573|NCT05061134|460456693|FG001|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|3|||
127955574|NCT05061134|460456694|FG002|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|6|||
127955575|NCT05061134|460456692|FG000|Overall Study|Subject not treated|0|||
127955576|NCT05061134|460456693|FG001|Overall Study|Subject not treated|0|||
127955577|NCT05061134|460456694|FG002|Overall Study|Subject not treated|2|||
127955578|NCT05061134|460456692|FG000|Overall Study|Other|0|||
127955579|NCT05061134|460456693|FG001|Overall Study|Other|0|||
127955580|NCT05061134|460456694|FG002|Overall Study|Other|9|||
127955581|NCT05061134|460456692|FG000|Overall Study|Withdrawal by Subject|9|||
127955582|NCT05061134|460456693|FG001|Overall Study|Withdrawal by Subject|8|||
127955583|NCT05061134|460456694|FG002|Overall Study|Withdrawal by Subject|5|||
127955584|NCT05061134|460456692|FG000|Overall Study|Study Terminated by Sponsor|22|||
127955585|NCT05061134|460456693|FG001|Overall Study|Study Terminated by Sponsor|14|||
127955586|NCT05061134|460456694|FG002|Overall Study|Study Terminated by Sponsor|7|||
127955587|NCT05061134|460456692|FG000|Overall Study|Progressive Disease|1|||
127955588|NCT05061134|460456693|FG001|Overall Study|Progressive Disease|2|||
127955589|NCT05061134|460456694|FG002|Overall Study|Progressive Disease|0|||
127955590|NCT05061134|460456692|FG000|Overall Study|Patient Is on Survival Follow Up Beyond DCO|1|||
127955591|NCT05061134|460456693|FG001|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
127955592|NCT05061134|460456694|FG002|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
127955593|NCT05061134|460456692|FG000|Overall Study|Lost to Follow-up|1|||
127955594|NCT05061134|460456693|FG001|Overall Study|Lost to Follow-up|0|||
127955595|NCT05061134|460456694|FG002|Overall Study|Lost to Follow-up|0|||
127955596|NCT05061134|460456692|FG000|Overall Study|Physician Decision|1|||
127955597|NCT05061134|460456693|FG001|Overall Study|Physician Decision|1|||
127955598|NCT05061134|460456694|FG002|Overall Study|Physician Decision|0|||
127955599|NCT05061134|460456692|FG000|Overall Study|Disease progression|1|||
127955600|NCT05061134|460456693|FG001|Overall Study|Disease progression|0|||
127955601|NCT05061134|460456694|FG002|Overall Study|Disease progression|0|||
127955602|NCT05061134|460456692|FG000|Overall Study|Death|43|||
127955603|NCT05061134|460456693|FG001|Overall Study|Death|23|||
127955604|NCT05061134|460456694|FG002|Overall Study|Death|14|||
127955605|NCT05061134|460456692|FG000|Overall Study|Database lock|2|||
127955606|NCT05061134|460456693|FG001|Overall Study|Database lock|0|||
127955607|NCT05061134|460456694|FG002|Overall Study|Database lock|0|||
127955608|NCT00001521|460456700|FG000|Overall Study|Withdrawal by Subject|3|||
127955609|NCT00001521|460456701|FG001|Overall Study|Withdrawal by Subject|3|||
127955610|NCT00001521|460456700|FG000|Overall Study|Physician Decision|1|||
127955611|NCT00001521|460456701|FG001|Overall Study|Physician Decision|1|||
127955612|NCT00001521|460456700|FG000|Overall Study|Noncompliant|6|||
127955613|NCT00001521|460456701|FG001|Overall Study|Noncompliant|3|||
127955614|NCT02366689|460456706|FG000|Overall Study|Withdrawal by Subject|1|||
127955615|NCT02366689|460456707|FG001|Overall Study|Withdrawal by Subject|0|||
127955616|NCT02366689|460456708|FG002|Overall Study|Withdrawal by Subject|1|||
127955617|NCT02366689|460456706|FG000|Overall Study|Lost to Follow-up|3|||
127955618|NCT02366689|460456707|FG001|Overall Study|Lost to Follow-up|2|||
127955619|NCT02366689|460456708|FG002|Overall Study|Lost to Follow-up|0|||
127955620|NCT02366689|460456706|FG000|Overall Study|Pregnancy|0|||
127955621|NCT02366689|460456707|FG001|Overall Study|Pregnancy|1|||
127955622|NCT02366689|460456708|FG002|Overall Study|Pregnancy|1|||
127955623|NCT03283566|460456709|FG000|Overall Study|Lost to Follow-up|1|||
127955624|NCT03283566|460456710|FG001|Overall Study|Lost to Follow-up|2|||
127955625|NCT04882241|460456714|FG000|Overall Study|Ongoing in study|46|||
127955626|NCT04882241|460456715|FG001|Overall Study|Ongoing in study|48|||
127955627|NCT04882241|460456716|FG002|Overall Study|Ongoing in study|0|||
127955628|NCT04882241|460456717|FG003|Overall Study|Ongoing in study|0|||
127955629|NCT04882241|460456714|FG000|Overall Study|Death|13|||
127955630|NCT04882241|460456715|FG001|Overall Study|Death|13|||
127955631|NCT04882241|460456716|FG002|Overall Study|Death|0|||
127955632|NCT04882241|460456717|FG003|Overall Study|Death|0|||
127955633|NCT00470535|460456728|FG000|Overall Study|Disease Progression|13|||
127955634|NCT00470535|460456728|FG000|Overall Study|Withdrawal by Subject|1|||
127955635|NCT00470535|460456728|FG000|Overall Study|Adverse Event|1|||
127955636|NCT00470535|460456728|FG000|Overall Study|Death|1|||
127955637|NCT00470535|460456728|FG000|Overall Study|Other|2|||
127955638|NCT02070965|460456733|FG000|Overall Study|Lost to Follow-up|0|||
127955639|NCT02070965|460456734|FG001|Overall Study|Lost to Follow-up|1|||
127955640|NCT02070965|460456735|FG002|Overall Study|Lost to Follow-up|0|||
127955641|NCT02070965|460456733|FG000|Overall Study|Withdrawal by Subject|1|||
127955642|NCT02070965|460456734|FG001|Overall Study|Withdrawal by Subject|1|||
127955643|NCT02070965|460456735|FG002|Overall Study|Withdrawal by Subject|1|||
127955644|NCT02070965|460456733|FG000|Overall Study|Subject moved|1|||
127955645|NCT02070965|460456734|FG001|Overall Study|Subject moved|0|||
127955646|NCT02070965|460456735|FG002|Overall Study|Subject moved|0|||
127955647|NCT02515331|460456736|FG000|Overall Study|Withdrawal by Subject|0|||
127955648|NCT02515331|460456737|FG001|Overall Study|Withdrawal by Subject|0|||
127955649|NCT02515331|460456738|FG002|Overall Study|Withdrawal by Subject|1|||
127955650|NCT02515331|460456736|FG000|Overall Study|Protocol deviation|0|||
127955651|NCT02515331|460456737|FG001|Overall Study|Protocol deviation|0|||
127955652|NCT02515331|460456738|FG002|Overall Study|Protocol deviation|3|||
127955653|NCT02515331|460456736|FG000|Overall Study|Adverse Event|2|||
127955654|NCT02515331|460456737|FG001|Overall Study|Adverse Event|0|||
127955655|NCT02515331|460456738|FG002|Overall Study|Adverse Event|0|||
127955656|NCT00124748|460456739|FG000|Overall Study|Adverse Event|8|||
127955657|NCT00124748|460456740|FG001|Overall Study|Adverse Event|39|||
127955658|NCT00124748|460456739|FG000|Overall Study|Abnormal laboratory Value|2|||
127955659|NCT00124748|460456740|FG001|Overall Study|Abnormal laboratory Value|2|||
127955660|NCT00124748|460456739|FG000|Overall Study|Abnormal Procedure|0|||
127955661|NCT00124748|460456740|FG001|Overall Study|Abnormal Procedure|1|||
127955662|NCT00124748|460456739|FG000|Overall Study|Lack of Efficacy|20|||
127955663|NCT00124748|460456740|FG001|Overall Study|Lack of Efficacy|41|||
127955664|NCT00124748|460456739|FG000|Overall Study|No longer requires study drug|1|||
127955665|NCT00124748|460456740|FG001|Overall Study|No longer requires study drug|1|||
127955666|NCT00124748|460456739|FG000|Overall Study|Protocol Violation|3|||
127955667|NCT00124748|460456740|FG001|Overall Study|Protocol Violation|1|||
127955668|NCT00124748|460456739|FG000|Overall Study|Withdrawal by Subject|5|||
127955669|NCT00124748|460456740|FG001|Overall Study|Withdrawal by Subject|15|||
127955670|NCT00124748|460456739|FG000|Overall Study|Lost to Follow-up|2|||
127955671|NCT00124748|460456740|FG001|Overall Study|Lost to Follow-up|7|||
127955672|NCT00124748|460456739|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
127955673|NCT00124748|460456740|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
127955674|NCT00124748|460456739|FG000|Overall Study|Death|1|||
127955675|NCT00124748|460456740|FG001|Overall Study|Death|3|||
127955676|NCT00322712|460456741|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
127955677|NCT03889886|460456742|FG000|Overall Study|Other|0|||
127955678|NCT03889886|460456743|FG001|Overall Study|Other|1|||
127955679|NCT03889886|460456744|FG002|Overall Study|Other|0|||
127955680|NCT03889886|460456745|FG003|Overall Study|Other|1|||
127955681|NCT03889886|460456742|FG000|Overall Study|Withdrawal by Subject|0|||
127955682|NCT03889886|460456743|FG001|Overall Study|Withdrawal by Subject|0|||
127955683|NCT03889886|460456744|FG002|Overall Study|Withdrawal by Subject|1|||
127955684|NCT03889886|460456745|FG003|Overall Study|Withdrawal by Subject|0|||
127955685|NCT03889886|460456742|FG000|Overall Study|Adverse Event|0|||
127955686|NCT03889886|460456743|FG001|Overall Study|Adverse Event|0|||
127955687|NCT03889886|460456744|FG002|Overall Study|Adverse Event|0|||
127955688|NCT03889886|460456745|FG003|Overall Study|Adverse Event|6|||
127955689|NCT04176250|460456746|FG000|Overall Study|Adverse Event|0|||
127955690|NCT04176250|460456747|FG001|Overall Study|Adverse Event|1|||
127955691|NCT04176250|460456748|FG002|Overall Study|Adverse Event|0|||
127955692|NCT04176250|460456749|FG003|Overall Study|Adverse Event|1|||
127955693|NCT04176250|460456750|FG004|Overall Study|Adverse Event|0|||
127955694|NCT04176250|460456751|FG005|Overall Study|Adverse Event|1|||
127955695|NCT04176250|460456746|FG000|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
127955696|NCT04176250|460456747|FG001|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
127955697|NCT04176250|460456748|FG002|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
127955698|NCT04176250|460456749|FG003|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
127955699|NCT04176250|460456750|FG004|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
127955700|NCT04176250|460456751|FG005|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
127955701|NCT04176250|460456746|FG000|Overall Study|Withdrawal by Subject|0|||
127955702|NCT04176250|460456747|FG001|Overall Study|Withdrawal by Subject|0|||
127955703|NCT04176250|460456748|FG002|Overall Study|Withdrawal by Subject|0|||
127955704|NCT04176250|460456749|FG003|Overall Study|Withdrawal by Subject|0|||
127955705|NCT04176250|460456750|FG004|Overall Study|Withdrawal by Subject|0|||
127955706|NCT04176250|460456751|FG005|Overall Study|Withdrawal by Subject|1|||
127955707|NCT04176250|460456746|FG000|Overall Study|Randomized in error|0|||
127955708|NCT04176250|460456747|FG001|Overall Study|Randomized in error|0|||
127955709|NCT04176250|460456748|FG002|Overall Study|Randomized in error|0|||
127955710|NCT04176250|460456749|FG003|Overall Study|Randomized in error|0|||
127955711|NCT04176250|460456750|FG004|Overall Study|Randomized in error|1|||
127955712|NCT04176250|460456751|FG005|Overall Study|Randomized in error|0|||
127955713|NCT01942993|460456757|FG000|Overall Study|Lost to Follow-up|1|||
127955714|NCT01942993|460456757|FG000|Overall Study|Physician Decision|1|||
127955715|NCT01350271|460456758|FG000|Overall Study|Lost to Follow-up|21|||
127955716|NCT01350271|460456759|FG001|Overall Study|Lost to Follow-up|17|||
127955717|NCT01350271|460456760|FG002|Overall Study|Lost to Follow-up|26|||
127955718|NCT01349192|460456761|FG000|Overall Study|Protocol Violation|0|||
127955719|NCT01349192|460456762|FG001|Overall Study|Protocol Violation|1|||
127955720|NCT01349192|460456761|FG000|Overall Study|Withdrawal by Subject|0|||
127955721|NCT01349192|460456762|FG001|Overall Study|Withdrawal by Subject|2|||
127955722|NCT01349192|460456761|FG000|Overall Study|Lost to Follow-up|1|||
127955723|NCT01349192|460456762|FG001|Overall Study|Lost to Follow-up|3|||
127955724|NCT01349192|460456761|FG000|Overall Study|Failure to adhere to Protocol|2|||
127955725|NCT01349192|460456762|FG001|Overall Study|Failure to adhere to Protocol|0|||
127955726|NCT02262325|460456764|FG000|Overall Study|Death|16|||
127955727|NCT02262325|460456764|FG000|Overall Study|Lost to Follow-up|1|||
127955728|NCT01071915|460456765|FG000|Overall Study|Adverse Event|3|||
127955729|NCT01071915|460456765|FG000|Overall Study|Physician Decision|2|||
127955730|NCT01071915|460456765|FG000|Overall Study|Withdrawal by Subject|2|||
127955731|NCT01071915|460456765|FG000|Overall Study|Miscellaneous Reasons|2|||
127955732|NCT01269918|460456768|FG000|Overall Study|Did not receive study drug|0|||
127955733|NCT01269918|460456769|FG001|Overall Study|Did not receive study drug|3|||
127955734|NCT00769379|460456772|FG000|Overall Study|No follow up data mapped to Other.|3|||
127955735|NCT00769379|460456773|FG001|Overall Study|No follow up data mapped to Other.|13|||
127955736|NCT01928472|460456774|FG000|Overall Study|Death|0|||
127955737|NCT01928472|460456775|FG001|Overall Study|Death|0|||
127955738|NCT01928472|460456776|FG002|Overall Study|Death|1|||
127955739|NCT01928472|460456777|FG003|Overall Study|Death|0|||
127955740|NCT01928472|460456774|FG000|Overall Study|Withdrawal by Subject|4|||
127955741|NCT01928472|460456775|FG001|Overall Study|Withdrawal by Subject|4|||
127955742|NCT01928472|460456776|FG002|Overall Study|Withdrawal by Subject|1|||
127955743|NCT01928472|460456777|FG003|Overall Study|Withdrawal by Subject|2|||
127955744|NCT01928472|460456774|FG000|Overall Study|Lost to Follow-up|2|||
127955745|NCT01928472|460456775|FG001|Overall Study|Lost to Follow-up|3|||
127955746|NCT01928472|460456776|FG002|Overall Study|Lost to Follow-up|4|||
127955747|NCT01928472|460456777|FG003|Overall Study|Lost to Follow-up|0|||
127955748|NCT01928472|460456774|FG000|Overall Study|Administrative Reason|2|||
127955749|NCT01928472|460456775|FG001|Overall Study|Administrative Reason|1|||
127955750|NCT01928472|460456776|FG002|Overall Study|Administrative Reason|0|||
127955751|NCT01928472|460456777|FG003|Overall Study|Administrative Reason|0|||
127955752|NCT01928472|460456774|FG000|Overall Study|Unclassified|0|||
127955753|NCT01928472|460456775|FG001|Overall Study|Unclassified|0|||
127955754|NCT01928472|460456776|FG002|Overall Study|Unclassified|1|||
127955755|NCT01928472|460456777|FG003|Overall Study|Unclassified|0|||
127955756|NCT01308424|460456778|FG000|Baseline Eligibility|Screen Failures|71|||
127955757|NCT01308424|460456779|FG001|Baseline Eligibility|Screen Failures|0|||
127955758|NCT01308424|460456780|FG002|Baseline Eligibility|Screen Failures|0|||
127955759|NCT01308424|460456778|FG000|Randomization|Adverse Event|0|||
127955760|NCT01308424|460456779|FG001|Randomization|Adverse Event|1|||
127955761|NCT01308424|460456780|FG002|Randomization|Adverse Event|1|||
127955762|NCT01308424|460456778|FG000|Randomization|Lost to Follow-up|0|||
127955763|NCT01308424|460456779|FG001|Randomization|Lost to Follow-up|1|||
127955764|NCT01308424|460456780|FG002|Randomization|Lost to Follow-up|0|||
127955765|NCT01308424|460456778|FG000|Randomization|Physician Decision|0|||
127955766|NCT01308424|460456779|FG001|Randomization|Physician Decision|1|||
127955767|NCT01308424|460456780|FG002|Randomization|Physician Decision|1|||
127955768|NCT04471428|460456784|FG000|Overall Study|Withdrawal by Subject|29|||
127955769|NCT04471428|460456785|FG001|Overall Study|Withdrawal by Subject|1|||
127955770|NCT04471428|460456784|FG000|Overall Study|Physician Decision|0|||
127955771|NCT04471428|460456785|FG001|Overall Study|Physician Decision|1|||
127955772|NCT04471428|460456784|FG000|Overall Study|Reason Not Specified|0|||
127955773|NCT04471428|460456785|FG001|Overall Study|Reason Not Specified|2|||
127955774|NCT04471428|460456784|FG000|Overall Study|Death|106|||
127955775|NCT04471428|460456785|FG001|Overall Study|Death|114|||
127955776|NCT04471428|460456784|FG000|Overall Study|Ongoing in the study|45|||
127955777|NCT04471428|460456785|FG001|Overall Study|Ongoing in the study|68|||
127955778|NCT00129545|460456788|FG000|Overall Study|Death|5|||
127955779|NCT00129545|460456789|FG001|Overall Study|Death|60|||
127955780|NCT00129545|460456790|FG002|Overall Study|Death|44|||
127955781|NCT00129545|460456788|FG000|Overall Study|Withdrawal by Subject|3|||
127955782|NCT00129545|460456789|FG001|Overall Study|Withdrawal by Subject|18|||
127955783|NCT00129545|460456790|FG002|Overall Study|Withdrawal by Subject|44|||
127955784|NCT00129545|460456788|FG000|Overall Study|Lost to Follow-up|2|||
127955785|NCT00129545|460456789|FG001|Overall Study|Lost to Follow-up|22|||
127955786|NCT00129545|460456790|FG002|Overall Study|Lost to Follow-up|13|||
127955787|NCT00129545|460456788|FG000|Overall Study|Physician Decision|0|||
127955788|NCT00129545|460456789|FG001|Overall Study|Physician Decision|3|||
127955789|NCT00129545|460456790|FG002|Overall Study|Physician Decision|10|||
127955790|NCT00129545|460456788|FG000|Overall Study|Device not implanted|16|||
127955791|NCT00129545|460456789|FG001|Overall Study|Device not implanted|61|||
127955792|NCT00129545|460456790|FG002|Overall Study|Device not implanted|0|||
127955793|NCT02308124|460456791|FG000|Overall Study|Lost to Follow-up|6|||
127955794|NCT02308124|460456792|FG001|Overall Study|Lost to Follow-up|6|||
127955795|NCT02308124|460456793|FG002|Overall Study|Lost to Follow-up|6|||
127955796|NCT02308124|460456791|FG000|Overall Study|Adverse Event|0|||
127955797|NCT02308124|460456792|FG001|Overall Study|Adverse Event|2|||
127955798|NCT02308124|460456793|FG002|Overall Study|Adverse Event|2|||
127955799|NCT02553772|460456794|FG000|Overall Study|Adverse Event|2|||
127955800|NCT02553772|460456795|FG001|Overall Study|Adverse Event|3|||
127955801|NCT02553772|460456794|FG000|Overall Study|Lost to Follow-up|2|||
127955802|NCT02553772|460456795|FG001|Overall Study|Lost to Follow-up|1|||
127955803|NCT02553772|460456794|FG000|Overall Study|Withdrawal of Consent|1|||
127955804|NCT02553772|460456795|FG001|Overall Study|Withdrawal of Consent|1|||
127955805|NCT02553772|460456794|FG000|Overall Study|Lack of Efficacy|1|||
127955806|NCT02553772|460456795|FG001|Overall Study|Lack of Efficacy|0|||
127955807|NCT02553772|460456794|FG000|Overall Study|Other Miscellaneous Reasons|0|||
127955808|NCT02553772|460456795|FG001|Overall Study|Other Miscellaneous Reasons|1|||
127955809|NCT01184079|460456799|FG000|Overall Study|Lost to Follow-up|14|||
127955810|NCT01184079|460456800|FG001|Overall Study|Lost to Follow-up|2|||
127955811|NCT04233073|460456805|FG000|Overall Study|Death|5|||
127955812|NCT00143390|460456806|FG000|Overall Study|Death|2|||
127955813|NCT00143390|460456807|FG001|Overall Study|Death|0|||
127955814|NCT00143390|460456806|FG000|Overall Study|Not meeting entry criteria|2|||
127955815|NCT00143390|460456807|FG001|Overall Study|Not meeting entry criteria|5|||
127955816|NCT00143390|460456806|FG000|Overall Study|Withdrawal by Subject|4|||
127955817|NCT00143390|460456807|FG001|Overall Study|Withdrawal by Subject|4|||
127955818|NCT00143390|460456806|FG000|Overall Study|Progressive disease|119|||
127955819|NCT00143390|460456807|FG001|Overall Study|Progressive disease|115|||
127955820|NCT00143390|460456806|FG000|Overall Study|Protocol Violation|2|||
127955821|NCT00143390|460456807|FG001|Overall Study|Protocol Violation|0|||
127955822|NCT00143390|460456806|FG000|Overall Study|Study termination|10|||
127955823|NCT00143390|460456807|FG001|Overall Study|Study termination|15|||
127955824|NCT00143390|460456806|FG000|Overall Study|Adverse Event|9|||
127955825|NCT00143390|460456807|FG001|Overall Study|Adverse Event|8|||
127955826|NCT00143390|460456806|FG000|Overall Study|Other|1|||
127955827|NCT00143390|460456807|FG001|Overall Study|Other|2|||
127955828|NCT00041132|460456808|FG000|Overall Study|Adverse Event|19|||
127955829|NCT00041132|460456808|FG000|Overall Study|Death|1|||
127955830|NCT00041132|460456808|FG000|Overall Study|Not Eligible|7|||
127955831|NCT00041132|460456808|FG000|Overall Study|Withdrawal by Subject|1|||
127955832|NCT00041132|460456808|FG000|Overall Study|Physician Decision|2|||
127955833|NCT00866359|460456811|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
127955834|NCT00866359|460456812|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
127955835|NCT00866359|460456813|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
127955836|NCT00866359|460456814|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
127955837|NCT00866359|460456811|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
127976443|NCT03535194|460536129|FG004|Induction Period|Screen Failure|0|||
127955838|NCT00866359|460456812|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
127955839|NCT00866359|460456813|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
127955840|NCT00866359|460456814|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
127955841|NCT00866359|460456811|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
127955842|NCT00866359|460456812|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
127955843|NCT00866359|460456813|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
127955844|NCT00866359|460456814|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
127955845|NCT00866359|460456811|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
127955846|NCT00866359|460456812|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
127955847|NCT00866359|460456813|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
127955848|NCT00866359|460456814|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
127955849|NCT00866359|460456811|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
127955850|NCT00866359|460456812|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
127955851|NCT00866359|460456813|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
127955852|NCT00866359|460456814|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
127955853|NCT00866359|460456811|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
127955854|NCT00866359|460456812|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
127955855|NCT00866359|460456813|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
127955856|NCT00866359|460456814|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
127955857|NCT02163057|460456815|FG000|Overall Study|Participant Refusal to Continue|2|||
127955858|NCT02163057|460456816|FG001|Overall Study|Participant Refusal to Continue|2|||
127955859|NCT02163057|460456815|FG000|Overall Study|Participant Significant Noncompliance|0|||
127955860|NCT02163057|460456816|FG001|Overall Study|Participant Significant Noncompliance|1|||
127955861|NCT02163057|460456815|FG000|Overall Study|Progression of Disease|1|||
127955862|NCT02163057|460456816|FG001|Overall Study|Progression of Disease|2|||
127955863|NCT01625091|460456817|FG000|Intervention|Death|1|||
127955864|NCT01625091|460456818|FG001|Intervention|Death|1|||
127955865|NCT01625091|460456817|FG000|Intervention|Withdrawal by Subject|4|||
127955866|NCT01625091|460456818|FG001|Intervention|Withdrawal by Subject|1|||
127955867|NCT01625091|460456817|FG000|Intervention|Adverse Event|0|||
127955868|NCT01625091|460456818|FG001|Intervention|Adverse Event|2|||
127955869|NCT01625091|460456817|FG000|Intervention|Lost to Follow-up|4|||
127955870|NCT01625091|460456818|FG001|Intervention|Lost to Follow-up|4|||
127955871|NCT01625091|460456817|FG000|Intervention|Study termination|2|||
127955872|NCT01625091|460456818|FG001|Intervention|Study termination|3|||
127955873|NCT01625091|460456817|FG000|Post-intervention|Death|0|||
127955874|NCT01625091|460456818|FG001|Post-intervention|Death|1|||
127955875|NCT01625091|460456817|FG000|Post-intervention|Lost to Follow-up|2|||
127955876|NCT01625091|460456818|FG001|Post-intervention|Lost to Follow-up|0|||
127955877|NCT01625091|460456817|FG000|Post-intervention|Study termination|2|||
127955878|NCT01625091|460456818|FG001|Post-intervention|Study termination|1|||
127955879|NCT00768248|460456819|FG000|Overall Study|Research coordinator didn't collect data|1|||
127955880|NCT00768248|460456820|FG001|Overall Study|Research coordinator didn't collect data|1|||
127955881|NCT01547390|460456825|FG000|Overall Study|Withdrawal by Subject|10|||
127955882|NCT01547390|460456826|FG001|Overall Study|Withdrawal by Subject|7|||
127955883|NCT01547390|460456825|FG000|Overall Study|termination of pregnancy|0|||
127955884|NCT01547390|460456826|FG001|Overall Study|termination of pregnancy|1|||
127955885|NCT01547390|460456825|FG000|Overall Study|Lost to Follow-up|0|||
127955886|NCT01547390|460456826|FG001|Overall Study|Lost to Follow-up|2|||
127955887|NCT01547390|460456825|FG000|Overall Study|Adverse Event|3|||
127955888|NCT01547390|460456826|FG001|Overall Study|Adverse Event|0|||
127955889|NCT01459783|460456827|FG000|Baseline to 6 Months|Death|1|||
127955890|NCT01459783|460456828|FG001|Baseline to 6 Months|Death|0|||
127955891|NCT01459783|460456827|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
127955892|NCT01459783|460456828|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
127955893|NCT01459783|460456827|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
127955894|NCT01459783|460456828|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
127955895|NCT01459783|460456827|FG000|6 Months to 12 Months|Death|0|||
127955896|NCT01459783|460456828|FG001|6 Months to 12 Months|Death|1|||
127955897|NCT01459783|460456827|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
127955898|NCT01459783|460456828|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
127955899|NCT01459783|460456827|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
127955900|NCT01459783|460456828|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
127955901|NCT01459783|460456827|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
127955902|NCT01459783|460456828|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
127955903|NCT03493685|460458972|FG000|Overall Study|Death|4|||
127955904|NCT03493685|460458973|FG001|Overall Study|Death|3|||
127955905|NCT03493685|460458972|FG000|Overall Study|Lost to Follow-up|3|||
127955906|NCT03493685|460458973|FG001|Overall Study|Lost to Follow-up|2|||
127955907|NCT03493685|460458972|FG000|Overall Study|Physician Decision|2|||
127955908|NCT03493685|460458973|FG001|Overall Study|Physician Decision|0|||
127955909|NCT03493685|460458972|FG000|Overall Study|Withdrawal by Subject|7|||
127955910|NCT03493685|460458973|FG001|Overall Study|Withdrawal by Subject|11|||
127955911|NCT04452669|460458974|FG000|Overall Study|Death|1|||
127955912|NCT04452669|460458975|FG001|Overall Study|Death|4|||
127955913|NCT03300817|460458976|FG000|Overall Study|Withdrawal by Subject|1|||
127955914|NCT03300817|460458976|FG000|Overall Study|Adverse Event|1|||
127955915|NCT03300817|460458976|FG000|Overall Study|Subject Found to be Ineligible|2|||
127955916|NCT03729596|460458979|FG000|Overall Study|Death|3|||
127955917|NCT03729596|460458980|FG001|Overall Study|Death|5|||
127955918|NCT03729596|460458981|FG002|Overall Study|Death|4|||
127955919|NCT03729596|460458982|FG003|Overall Study|Death|1|||
127955920|NCT03729596|460458983|FG004|Overall Study|Death|0|||
127955921|NCT03729596|460458984|FG005|Overall Study|Death|34|||
127955922|NCT03729596|460458985|FG006|Overall Study|Death|18|||
127955923|NCT03729596|460458986|FG007|Overall Study|Death|14|||
127955924|NCT03729596|460458987|FG008|Overall Study|Death|19|||
127955925|NCT03729596|460458988|FG009|Overall Study|Death|9|||
127955926|NCT03729596|460458979|FG000|Overall Study|Lost to Follow-up|0|||
127955927|NCT03729596|460458980|FG001|Overall Study|Lost to Follow-up|0|||
127955928|NCT03729596|460458981|FG002|Overall Study|Lost to Follow-up|0|||
127955929|NCT03729596|460458982|FG003|Overall Study|Lost to Follow-up|0|||
127955930|NCT03729596|460458983|FG004|Overall Study|Lost to Follow-up|0|||
127955931|NCT03729596|460458984|FG005|Overall Study|Lost to Follow-up|0|||
127955932|NCT03729596|460458985|FG006|Overall Study|Lost to Follow-up|1|||
127955933|NCT03729596|460458986|FG007|Overall Study|Lost to Follow-up|0|||
127955934|NCT03729596|460458987|FG008|Overall Study|Lost to Follow-up|0|||
127955935|NCT03729596|460458988|FG009|Overall Study|Lost to Follow-up|1|||
127955936|NCT03729596|460458979|FG000|Overall Study|protocol amendment|0|||
127955937|NCT03729596|460458980|FG001|Overall Study|protocol amendment|1|||
127955938|NCT03729596|460458981|FG002|Overall Study|protocol amendment|3|||
127955939|NCT03729596|460458982|FG003|Overall Study|protocol amendment|6|||
127955940|NCT03729596|460458983|FG004|Overall Study|protocol amendment|5|||
127955941|NCT03729596|460458984|FG005|Overall Study|protocol amendment|0|||
127955942|NCT03729596|460458985|FG006|Overall Study|protocol amendment|0|||
127955943|NCT03729596|460458986|FG007|Overall Study|protocol amendment|0|||
127955944|NCT03729596|460458987|FG008|Overall Study|protocol amendment|0|||
127955945|NCT03729596|460458988|FG009|Overall Study|protocol amendment|0|||
127955946|NCT03729596|460458979|FG000|Overall Study|Withdrawal by Subject|0|||
127955947|NCT03729596|460458980|FG001|Overall Study|Withdrawal by Subject|0|||
127955948|NCT03729596|460458981|FG002|Overall Study|Withdrawal by Subject|0|||
127955949|NCT03729596|460458982|FG003|Overall Study|Withdrawal by Subject|0|||
127955950|NCT03729596|460458983|FG004|Overall Study|Withdrawal by Subject|0|||
127955951|NCT03729596|460458984|FG005|Overall Study|Withdrawal by Subject|4|||
127955952|NCT03729596|460458985|FG006|Overall Study|Withdrawal by Subject|2|||
127955953|NCT03729596|460458986|FG007|Overall Study|Withdrawal by Subject|3|||
127955954|NCT03729596|460458987|FG008|Overall Study|Withdrawal by Subject|2|||
127955955|NCT03729596|460458988|FG009|Overall Study|Withdrawal by Subject|3|||
127955956|NCT03729596|460458979|FG000|Overall Study|study terminated by sponsor|0|||
127955957|NCT03729596|460458980|FG001|Overall Study|study terminated by sponsor|0|||
127955958|NCT03729596|460458981|FG002|Overall Study|study terminated by sponsor|0|||
127955959|NCT03729596|460458982|FG003|Overall Study|study terminated by sponsor|0|||
127955960|NCT03729596|460458983|FG004|Overall Study|study terminated by sponsor|1|||
127955961|NCT03729596|460458984|FG005|Overall Study|study terminated by sponsor|3|||
127955962|NCT03729596|460458985|FG006|Overall Study|study terminated by sponsor|0|||
127955963|NCT03729596|460458986|FG007|Overall Study|study terminated by sponsor|1|||
127955964|NCT03729596|460458987|FG008|Overall Study|study terminated by sponsor|0|||
127955965|NCT03729596|460458988|FG009|Overall Study|study terminated by sponsor|0|||
127955966|NCT03713593|460458989|FG000|Overall Study|Sponsor Decision|73|||
127955967|NCT03713593|460458990|FG001|Overall Study|Sponsor Decision|41|||
127955968|NCT03713593|460458989|FG000|Overall Study|Lost to Follow-up|2|||
127955969|NCT03713593|460458990|FG001|Overall Study|Lost to Follow-up|1|||
127955970|NCT03713593|460458989|FG000|Overall Study|Death|314|||
127955971|NCT03713593|460458990|FG001|Overall Study|Death|349|||
127955972|NCT03713593|460458989|FG000|Overall Study|Withdrawal by Subject|6|||
127955973|NCT03713593|460458990|FG001|Overall Study|Withdrawal by Subject|8|||
127955974|NCT04467840|460458991|FG000|Overall Study|Death|35|||
127955975|NCT04467840|460458992|FG001|Overall Study|Death|39|||
127955976|NCT04467840|460458991|FG000|Overall Study|Withdrawal by Subject|8|||
127955977|NCT04467840|460458992|FG001|Overall Study|Withdrawal by Subject|4|||
127955978|NCT04467840|460458991|FG000|Overall Study|Adverse Event|2|||
127955979|NCT04467840|460458992|FG001|Overall Study|Adverse Event|0|||
127955980|NCT04467840|460458991|FG000|Overall Study|Lost to Follow-up|1|||
127955981|NCT04467840|460458992|FG001|Overall Study|Lost to Follow-up|3|||
127955982|NCT04467840|460458991|FG000|Overall Study|Physician Decision|1|||
127955983|NCT04467840|460458992|FG001|Overall Study|Physician Decision|0|||
127955984|NCT04467840|460458991|FG000|Overall Study|Other|1|||
127955985|NCT04467840|460458992|FG001|Overall Study|Other|5|||
127955986|NCT04467840|460458991|FG000|Overall Study|Missing study completion status|3|||
127955987|NCT04467840|460458992|FG001|Overall Study|Missing study completion status|1|||
127955988|NCT05126693|460458995|FG000|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|2|||
127955989|NCT05126693|460458996|FG001|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|0|||
127955990|NCT05126693|460458995|FG000|Pre-BoNT/ Pre-3DfUS|No 3DGA|4|||
127955991|NCT05126693|460458996|FG001|Pre-BoNT/ Pre-3DfUS|No 3DGA|0|||
127955992|NCT05126693|460458995|FG000|Pre-BoNT/ Pre-3DfUS|Insufficient matching|0|||
127955993|NCT05126693|460458996|FG001|Pre-BoNT/ Pre-3DfUS|Insufficient matching|10|||
127955994|NCT04011722|460459000|FG000|30 Days|Death|5|||
127955995|NCT04011722|460459001|FG001|30 Days|Death|1|||
127955996|NCT04011722|460459000|FG000|1 Year|Death|13|||
127955997|NCT04011722|460459001|FG001|1 Year|Death|5|||
127955998|NCT04011722|460459000|FG000|1 Year|Withdrawal by Subject|8|||
127955999|NCT04011722|460459001|FG001|1 Year|Withdrawal by Subject|2|||
127956000|NCT04011722|460459000|FG000|1 Year|Missed Visit|6|||
127956001|NCT04011722|460459001|FG001|1 Year|Missed Visit|1|||
127956002|NCT04011722|460459000|FG000|1 Year|Pending Visit|0|||
127956003|NCT04011722|460459001|FG001|1 Year|Pending Visit|11|||
127956004|NCT04011722|460459000|FG000|1 Year|Not Yet Due|0|||
127956005|NCT04011722|460459001|FG001|1 Year|Not Yet Due|9|||
127956006|NCT04011722|460459000|FG000|2 Year|Death|16|||
127956007|NCT04011722|460459001|FG001|2 Year|Death|1|||
127956008|NCT04011722|460459000|FG000|2 Year|Withdrawal by Subject|10|||
127956009|NCT04011722|460459001|FG001|2 Year|Withdrawal by Subject|1|||
127956010|NCT04011722|460459000|FG000|2 Year|Missed Visit|9|||
127956011|NCT04011722|460459001|FG001|2 Year|Missed Visit|0|||
127956012|NCT04011722|460459000|FG000|2 Year|Visit Pending|1|||
127956013|NCT04011722|460459001|FG001|2 Year|Visit Pending|3|||
127956014|NCT04011722|460459000|FG000|2 Year|Not Yet Due|43|||
127956015|NCT04011722|460459001|FG001|2 Year|Not Yet Due|54|||
127956016|NCT04011722|460459000|FG000|3 Year|Death|10|||
127956017|NCT04011722|460459001|FG001|3 Year|Death|0|||
127956018|NCT04011722|460459000|FG000|3 Year|Withdrawal by Subject|2|||
127956019|NCT04011722|460459001|FG001|3 Year|Withdrawal by Subject|0|||
127956020|NCT04011722|460459000|FG000|3 Year|Missed Visit|2|||
127956021|NCT04011722|460459001|FG001|3 Year|Missed Visit|0|||
127956022|NCT04011722|460459000|FG000|3 Year|Pending Visit|34|||
127956023|NCT04011722|460459001|FG001|3 Year|Pending Visit|0|||
127956024|NCT04011722|460459000|FG000|3 Year|Not Yet Due|99|||
127956025|NCT04011722|460459001|FG001|3 Year|Not Yet Due|0|||
127956026|NCT06082843|460459002|FG000|Overall Study|Withdrawal by Subject|0|||
127956027|NCT06082843|460459003|FG001|Overall Study|Withdrawal by Subject|2|||
127956028|NCT06082843|460459002|FG000|Overall Study|Study terminated by sponsor|12|||
127956029|NCT06082843|460459003|FG001|Overall Study|Study terminated by sponsor|8|||
127956030|NCT04848480|460459007|FG000|Main Phase (26 Weeks)|Death|1|||
127956031|NCT04848480|460459008|FG001|Main Phase (26 Weeks)|Death|0|||
127956032|NCT04848480|460459007|FG000|Main Phase (26 Weeks)|Lost to Follow-up|1|||
127956033|NCT04848480|460459008|FG001|Main Phase (26 Weeks)|Lost to Follow-up|1|||
127956034|NCT04848480|460459007|FG000|Main Phase (26 Weeks)|Withdrawal by Subject|9|||
127956035|NCT04848480|460459008|FG001|Main Phase (26 Weeks)|Withdrawal by Subject|7|||
127956036|NCT04848480|460459007|FG000|Extension Phase (26 Weeks)|Physician Decision|1|||
127956037|NCT04848480|460459008|FG001|Extension Phase (26 Weeks)|Physician Decision|0|||
127956038|NCT04848480|460459007|FG000|Extension Phase (26 Weeks)|Lost to Follow-up|0|||
127956039|NCT04848480|460459008|FG001|Extension Phase (26 Weeks)|Lost to Follow-up|1|||
127956040|NCT04848480|460459007|FG000|Extension Phase (26 Weeks)|Withdrawal by Subject|4|||
127956041|NCT04848480|460459008|FG001|Extension Phase (26 Weeks)|Withdrawal by Subject|2|||
127956042|NCT03176134|460459009|FG000|Overall Study|Lost to Follow-up|0|||
127956043|NCT03176134|460459010|FG001|Overall Study|Lost to Follow-up|2|||
127956044|NCT03176134|460459011|FG002|Overall Study|Lost to Follow-up|0|||
127956045|NCT03176134|460459012|FG003|Overall Study|Lost to Follow-up|0|||
127956046|NCT03176134|460459013|FG004|Overall Study|Lost to Follow-up|0|||
127956047|NCT03176134|460459014|FG005|Overall Study|Lost to Follow-up|0|||
127956048|NCT03176134|460459015|FG006|Overall Study|Lost to Follow-up|0|||
127956049|NCT03176134|460459016|FG007|Overall Study|Lost to Follow-up|0|||
127956050|NCT03176134|460459009|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
127956051|NCT03176134|460459010|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
127956052|NCT03176134|460459011|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
127956053|NCT03176134|460459012|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
127956054|NCT03176134|460459013|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
127956055|NCT03176134|460459014|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
127956056|NCT03176134|460459015|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
127956057|NCT03176134|460459016|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
127956058|NCT01368497|460459017|FG000|Overall Study|Lost to Follow-up|2|||
127956059|NCT05989672|460459019|FG000|Overall Study|Adverse Event|3|||
127956060|NCT05989672|460459020|FG001|Overall Study|Adverse Event|0|||
127956061|NCT05989672|460459021|FG002|Overall Study|Adverse Event|0|||
127956062|NCT00443729|460459022|FG000|Overall Study|Never Treated|0|||
127956063|NCT00443729|460459023|FG001|Overall Study|Never Treated|1|||
127956064|NCT00443729|460459022|FG000|Overall Study|Lack of Efficacy|4|||
127956065|NCT00443729|460459023|FG001|Overall Study|Lack of Efficacy|2|||
127956066|NCT00443729|460459022|FG000|Overall Study|Lost to Follow-up|0|||
127956067|NCT00443729|460459023|FG001|Overall Study|Lost to Follow-up|1|||
127956068|NCT00443729|460459022|FG000|Overall Study|Physician Decision|2|||
127956069|NCT00443729|460459023|FG001|Overall Study|Physician Decision|1|||
127956070|NCT00443729|460459022|FG000|Overall Study|Protocol Violation|1|||
127956071|NCT00443729|460459023|FG001|Overall Study|Protocol Violation|1|||
127956072|NCT00443729|460459022|FG000|Overall Study|Withdrawal by Subject|3|||
127956073|NCT00443729|460459023|FG001|Overall Study|Withdrawal by Subject|1|||
127956074|NCT03718832|460459026|FG000|Analysis Sample|Withdrawal by Subject|18|||
127956075|NCT03718832|460459027|FG001|Analysis Sample|Withdrawal by Subject|15|||
127956076|NCT03718832|460459026|FG000|Analysis Sample|Legal hold on data|1|||
127956077|NCT03718832|460459027|FG001|Analysis Sample|Legal hold on data|0|||
127956078|NCT03718832|460459026|FG000|Analysis Sample|Participant from treated household|0|||
127956079|NCT03718832|460459027|FG001|Analysis Sample|Participant from treated household|1|||
127956080|NCT03718832|460459026|FG000|6-month HbA1c Sample|Lost to Follow-up|60|||
127956081|NCT03718832|460459027|FG001|6-month HbA1c Sample|Lost to Follow-up|56|||
127956082|NCT03288714|460459031|FG000|Overall Study|Lost to Follow-up|2|||
127956083|NCT03288714|460459032|FG001|Overall Study|Lost to Follow-up|1|||
127956084|NCT03288714|460459031|FG000|Overall Study|Non-compliance with study schedule|2|||
127956085|NCT03288714|460459032|FG001|Overall Study|Non-compliance with study schedule|0|||
127956086|NCT03288714|460459031|FG000|Overall Study|Withdrawal by Subject|3|||
127956087|NCT03288714|460459032|FG001|Overall Study|Withdrawal by Subject|1|||
127956088|NCT03288714|460459031|FG000|Overall Study|Clinical Worsening|2|||
127956089|NCT03288714|460459032|FG001|Overall Study|Clinical Worsening|1|||
127956090|NCT03288714|460459031|FG000|Overall Study|Adverse Event|1|||
127956091|NCT03288714|460459032|FG001|Overall Study|Adverse Event|0|||
127956092|NCT00758524|460459035|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
127956093|NCT00758524|460459036|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
127956094|NCT00758524|460459037|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
127956095|NCT00758524|460459038|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
127956096|NCT00758524|460459039|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
127956097|NCT00758524|460459040|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
127956098|NCT00758524|460459041|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
127956099|NCT00758524|460459042|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
127956100|NCT00758524|460459043|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
127956101|NCT00758524|460459044|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
127956102|NCT00758524|460459045|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
127956103|NCT00758524|460459046|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
127956104|NCT00758524|460459047|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
127956105|NCT00758524|460459048|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
127956106|NCT00758524|460459049|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
127956107|NCT00758524|460459050|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
127956108|NCT00758524|460459051|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
127956109|NCT00758524|460459035|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
127956110|NCT00758524|460459036|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
127956111|NCT00758524|460459037|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
127956112|NCT00758524|460459038|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
127956113|NCT00758524|460459039|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
127956114|NCT00758524|460459040|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
127956115|NCT00758524|460459041|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
127956116|NCT00758524|460459042|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
127956117|NCT00758524|460459043|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
127956118|NCT00758524|460459044|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
127956119|NCT00758524|460459045|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
127956120|NCT00758524|460459046|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
127956121|NCT00758524|460459047|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
127956122|NCT00758524|460459048|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
127956123|NCT00758524|460459049|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
127956124|NCT00758524|460459050|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
127956125|NCT00758524|460459051|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
127956126|NCT00758524|460459035|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
127956127|NCT00758524|460459036|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
127956128|NCT00758524|460459037|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
127956129|NCT00758524|460459038|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
127956130|NCT00758524|460459039|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
127956131|NCT00758524|460459040|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
127956132|NCT00758524|460459041|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
127956133|NCT00758524|460459042|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
127956134|NCT00758524|460459043|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
127956135|NCT00758524|460459044|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
127956136|NCT00758524|460459045|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
127956137|NCT00758524|460459046|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
127956138|NCT00758524|460459047|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
127956139|NCT00758524|460459048|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
127956140|NCT00758524|460459049|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
127956141|NCT00758524|460459050|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
127956142|NCT00758524|460459051|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
127956143|NCT00758524|460459035|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
127956144|NCT00758524|460459036|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
127956145|NCT00758524|460459037|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
127956146|NCT00758524|460459038|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
127956147|NCT00758524|460459039|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
127956148|NCT00758524|460459040|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
127956149|NCT00758524|460459041|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
127956150|NCT00758524|460459042|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
127956151|NCT00758524|460459043|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
127956152|NCT00758524|460459044|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
127956153|NCT00758524|460459045|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
127956154|NCT00758524|460459046|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
127956155|NCT00758524|460459047|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
127956156|NCT00758524|460459048|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
127956157|NCT00758524|460459049|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
127956158|NCT00758524|460459050|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
127956159|NCT00758524|460459051|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
127956160|NCT00758524|460459035|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
127956161|NCT00758524|460459036|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
127956162|NCT00758524|460459037|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
127956163|NCT00758524|460459038|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
127956164|NCT00758524|460459039|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
127956165|NCT00758524|460459040|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
127956166|NCT00758524|460459041|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
127956167|NCT00758524|460459042|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
127956168|NCT00758524|460459043|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
127956169|NCT00758524|460459044|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
127956170|NCT00758524|460459045|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
127956171|NCT00758524|460459046|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
127956172|NCT00758524|460459047|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
127956173|NCT00758524|460459048|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
127956174|NCT00758524|460459049|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
127956175|NCT00758524|460459050|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
127956176|NCT00758524|460459051|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
127956177|NCT00758524|460459035|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
127956178|NCT00758524|460459036|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
127956179|NCT00758524|460459037|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
127956180|NCT00758524|460459038|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
127956181|NCT00758524|460459039|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
127956182|NCT00758524|460459040|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
127956183|NCT00758524|460459041|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
127956184|NCT00758524|460459042|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
127956185|NCT00758524|460459043|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
127956186|NCT00758524|460459044|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
127956187|NCT00758524|460459045|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
127956188|NCT00758524|460459046|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
127956189|NCT00758524|460459047|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
127956190|NCT00758524|460459048|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
127956191|NCT00758524|460459049|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
127956192|NCT00758524|460459050|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
127956193|NCT00758524|460459051|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
127956194|NCT00758524|460459035|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
127956195|NCT00758524|460459036|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
127956196|NCT00758524|460459037|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
127956197|NCT00758524|460459038|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
127956198|NCT00758524|460459039|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
127956199|NCT00758524|460459040|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
127956200|NCT00758524|460459041|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
127956201|NCT00758524|460459042|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
127956202|NCT00758524|460459043|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
127956203|NCT00758524|460459044|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
127956204|NCT00758524|460459045|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
127956205|NCT00758524|460459046|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
127956206|NCT00758524|460459047|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
127956207|NCT00758524|460459048|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
127956208|NCT00758524|460459049|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
127956209|NCT00758524|460459050|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
127956210|NCT00758524|460459051|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
127956211|NCT00758524|460459035|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
127956212|NCT00758524|460459036|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
127956213|NCT00758524|460459037|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
127956214|NCT00758524|460459038|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
127956215|NCT00758524|460459039|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
127956216|NCT00758524|460459040|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
127956217|NCT00758524|460459041|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
127956218|NCT00758524|460459042|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
127956219|NCT00758524|460459043|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
127956220|NCT00758524|460459044|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
127956221|NCT00758524|460459045|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
127956222|NCT00758524|460459046|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
127956223|NCT00758524|460459047|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
127956224|NCT00758524|460459048|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
127956225|NCT00758524|460459049|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
127956226|NCT00758524|460459050|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
127956227|NCT00758524|460459051|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
127956228|NCT00758524|460459035|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
127956229|NCT00758524|460459036|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
127956230|NCT00758524|460459037|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
127956231|NCT00758524|460459038|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
127956232|NCT00758524|460459039|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
127956233|NCT00758524|460459040|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
127956234|NCT00758524|460459041|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
127956235|NCT00758524|460459042|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
127956236|NCT00758524|460459043|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
127956237|NCT00758524|460459044|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
127956238|NCT00758524|460459045|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
127956239|NCT00758524|460459046|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
127956240|NCT00758524|460459047|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
127956241|NCT00758524|460459048|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
127956242|NCT00758524|460459049|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
127956243|NCT00758524|460459050|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
127956244|NCT00758524|460459051|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
127956245|NCT00758524|460459035|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
127956246|NCT00758524|460459036|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
127956247|NCT00758524|460459037|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
127956248|NCT00758524|460459038|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
127956249|NCT00758524|460459039|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
127956250|NCT00758524|460459040|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
127956251|NCT00758524|460459041|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
127956252|NCT00758524|460459042|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
127956253|NCT00758524|460459043|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
127956254|NCT00758524|460459044|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
127956255|NCT00758524|460459045|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
127956256|NCT00758524|460459046|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
127956257|NCT00758524|460459047|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
127956258|NCT00758524|460459048|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
127956259|NCT00758524|460459049|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
127956260|NCT00758524|460459050|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
127956261|NCT00758524|460459051|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
127956262|NCT04747470|460459061|FG000|Overall Study|Death|0|||
127956263|NCT04747470|460459062|FG001|Overall Study|Death|3|||
127956264|NCT04747470|460459063|FG002|Overall Study|Death|2|||
127956265|NCT04747470|460459064|FG003|Overall Study|Death|2|||
127956266|NCT04747470|460459065|FG004|Overall Study|Death|2|||
127956267|NCT04747470|460459066|FG005|Overall Study|Death|0|||
127956268|NCT04747470|460459067|FG006|Overall Study|Death|0|||
127956269|NCT04747470|460459068|FG007|Overall Study|Death|0|||
127956270|NCT04747470|460459069|FG008|Overall Study|Death|0|||
127956271|NCT04747470|460459070|FG009|Overall Study|Death|0|||
127956272|NCT04747470|460459071|FG010|Overall Study|Death|0|||
127956273|NCT04747470|460459061|FG000|Overall Study|Withdrew Consent|0|||
127956274|NCT04747470|460459062|FG001|Overall Study|Withdrew Consent|0|||
127956275|NCT04747470|460459063|FG002|Overall Study|Withdrew Consent|0|||
127956276|NCT04747470|460459064|FG003|Overall Study|Withdrew Consent|1|||
127956277|NCT04747470|460459065|FG004|Overall Study|Withdrew Consent|0|||
127956278|NCT04747470|460459066|FG005|Overall Study|Withdrew Consent|0|||
127956279|NCT04747470|460459067|FG006|Overall Study|Withdrew Consent|0|||
127956280|NCT04747470|460459068|FG007|Overall Study|Withdrew Consent|0|||
127956281|NCT04747470|460459069|FG008|Overall Study|Withdrew Consent|0|||
127956282|NCT04747470|460459070|FG009|Overall Study|Withdrew Consent|0|||
127956283|NCT04747470|460459071|FG010|Overall Study|Withdrew Consent|0|||
127956284|NCT04747470|460459061|FG000|Overall Study|Study Terminated by Sponsor|0|||
127956285|NCT04747470|460459062|FG001|Overall Study|Study Terminated by Sponsor|0|||
127956286|NCT04747470|460459063|FG002|Overall Study|Study Terminated by Sponsor|1|||
127956287|NCT04747470|460459064|FG003|Overall Study|Study Terminated by Sponsor|0|||
127956288|NCT04747470|460459065|FG004|Overall Study|Study Terminated by Sponsor|2|||
127956289|NCT04747470|460459066|FG005|Overall Study|Study Terminated by Sponsor|0|||
127956290|NCT04747470|460459067|FG006|Overall Study|Study Terminated by Sponsor|0|||
127956291|NCT04747470|460459068|FG007|Overall Study|Study Terminated by Sponsor|0|||
127956292|NCT04747470|460459069|FG008|Overall Study|Study Terminated by Sponsor|0|||
127956293|NCT04747470|460459070|FG009|Overall Study|Study Terminated by Sponsor|0|||
127956294|NCT04747470|460459071|FG010|Overall Study|Study Terminated by Sponsor|0|||
127956295|NCT04720053|460459072|FG000|Overall Study|Lost to Follow-up|12|||
127956296|NCT02906670|460459076|FG000|Cohort 1, QW|Radiological Progression|1|||
127956297|NCT02906670|460459077|FG001|Cohort 1, QW|Radiological Progression|0|||
127956298|NCT02906670|460459078|FG002|Cohort 1, QW|Radiological Progression|0|||
127956299|NCT02906670|460459079|FG003|Cohort 1, QW|Radiological Progression|0|||
127956300|NCT02906670|460459080|FG004|Cohort 1, QW|Radiological Progression|0|||
127956301|NCT02906670|460459081|FG005|Cohort 1, QW|Radiological Progression|0|||
127956302|NCT02906670|460459082|FG006|Cohort 1, QW|Radiological Progression|0|||
127956303|NCT02906670|460459083|FG007|Cohort 1, QW|Radiological Progression|0|||
127956304|NCT02906670|460459084|FG008|Cohort 1, QW|Radiological Progression|0|||
127956305|NCT02906670|460459085|FG009|Cohort 1, QW|Radiological Progression|0|||
127956306|NCT02906670|460459076|FG000|Cohort 2, QW|Radiological Progression|0|||
127956307|NCT02906670|460459077|FG001|Cohort 2, QW|Radiological Progression|1|||
127956308|NCT02906670|460459078|FG002|Cohort 2, QW|Radiological Progression|0|||
127956309|NCT02906670|460459079|FG003|Cohort 2, QW|Radiological Progression|0|||
127956310|NCT02906670|460459080|FG004|Cohort 2, QW|Radiological Progression|0|||
127956311|NCT02906670|460459081|FG005|Cohort 2, QW|Radiological Progression|0|||
127956312|NCT02906670|460459082|FG006|Cohort 2, QW|Radiological Progression|0|||
127956313|NCT02906670|460459083|FG007|Cohort 2, QW|Radiological Progression|0|||
127956314|NCT02906670|460459084|FG008|Cohort 2, QW|Radiological Progression|0|||
127956315|NCT02906670|460459085|FG009|Cohort 2, QW|Radiological Progression|0|||
127956316|NCT02906670|460459076|FG000|Cohort 3, QW|Radiological Progression|0|||
127956317|NCT02906670|460459077|FG001|Cohort 3, QW|Radiological Progression|0|||
127956318|NCT02906670|460459078|FG002|Cohort 3, QW|Radiological Progression|2|||
127956319|NCT02906670|460459079|FG003|Cohort 3, QW|Radiological Progression|0|||
127956320|NCT02906670|460459080|FG004|Cohort 3, QW|Radiological Progression|0|||
127956321|NCT02906670|460459081|FG005|Cohort 3, QW|Radiological Progression|0|||
127956322|NCT02906670|460459082|FG006|Cohort 3, QW|Radiological Progression|0|||
127956323|NCT02906670|460459083|FG007|Cohort 3, QW|Radiological Progression|0|||
127956324|NCT02906670|460459084|FG008|Cohort 3, QW|Radiological Progression|0|||
127956325|NCT02906670|460459085|FG009|Cohort 3, QW|Radiological Progression|0|||
127956326|NCT02906670|460459076|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
127956327|NCT02906670|460459077|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
127956328|NCT02906670|460459078|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
127956329|NCT02906670|460459079|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
127956330|NCT02906670|460459080|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
127956331|NCT02906670|460459081|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
127956332|NCT02906670|460459082|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
127956333|NCT02906670|460459083|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
127956334|NCT02906670|460459084|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
127956335|NCT02906670|460459085|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
127956336|NCT02906670|460459076|FG000|Cohort 4, Q2W|Radiological Progression|0|||
127956337|NCT02906670|460459077|FG001|Cohort 4, Q2W|Radiological Progression|0|||
127956338|NCT02906670|460459078|FG002|Cohort 4, Q2W|Radiological Progression|0|||
127956339|NCT02906670|460459079|FG003|Cohort 4, Q2W|Radiological Progression|0|||
127956340|NCT02906670|460459080|FG004|Cohort 4, Q2W|Radiological Progression|0|||
127956341|NCT02906670|460459081|FG005|Cohort 4, Q2W|Radiological Progression|1|||
127956342|NCT02906670|460459082|FG006|Cohort 4, Q2W|Radiological Progression|0|||
127956343|NCT02906670|460459083|FG007|Cohort 4, Q2W|Radiological Progression|0|||
127956344|NCT02906670|460459084|FG008|Cohort 4, Q2W|Radiological Progression|0|||
127956345|NCT02906670|460459085|FG009|Cohort 4, Q2W|Radiological Progression|0|||
127956346|NCT02906670|460459076|FG000|Cohort 4, Q2W|Clinical Progression|0|||
127956347|NCT02906670|460459077|FG001|Cohort 4, Q2W|Clinical Progression|0|||
127956348|NCT02906670|460459078|FG002|Cohort 4, Q2W|Clinical Progression|0|||
127956349|NCT02906670|460459079|FG003|Cohort 4, Q2W|Clinical Progression|0|||
127956350|NCT02906670|460459080|FG004|Cohort 4, Q2W|Clinical Progression|0|||
127956351|NCT02906670|460459081|FG005|Cohort 4, Q2W|Clinical Progression|2|||
127956352|NCT02906670|460459082|FG006|Cohort 4, Q2W|Clinical Progression|0|||
127956353|NCT02906670|460459083|FG007|Cohort 4, Q2W|Clinical Progression|0|||
127956354|NCT02906670|460459084|FG008|Cohort 4, Q2W|Clinical Progression|0|||
127956355|NCT02906670|460459085|FG009|Cohort 4, Q2W|Clinical Progression|0|||
127956356|NCT02906670|460459076|FG000|Cohort 5, Q2W|Radiological Progression|0|||
127956357|NCT02906670|460459077|FG001|Cohort 5, Q2W|Radiological Progression|0|||
127956358|NCT02906670|460459078|FG002|Cohort 5, Q2W|Radiological Progression|0|||
127956359|NCT02906670|460459079|FG003|Cohort 5, Q2W|Radiological Progression|0|||
127956360|NCT02906670|460459080|FG004|Cohort 5, Q2W|Radiological Progression|0|||
127956361|NCT02906670|460459081|FG005|Cohort 5, Q2W|Radiological Progression|0|||
127956362|NCT02906670|460459082|FG006|Cohort 5, Q2W|Radiological Progression|4|||
127956363|NCT02906670|460459083|FG007|Cohort 5, Q2W|Radiological Progression|0|||
127956364|NCT02906670|460459084|FG008|Cohort 5, Q2W|Radiological Progression|0|||
127956365|NCT02906670|460459085|FG009|Cohort 5, Q2W|Radiological Progression|0|||
127956366|NCT02906670|460459076|FG000|Cohort 5, Q2W|Clinical Progression|0|||
127956367|NCT02906670|460459077|FG001|Cohort 5, Q2W|Clinical Progression|0|||
127956368|NCT02906670|460459078|FG002|Cohort 5, Q2W|Clinical Progression|0|||
127956369|NCT02906670|460459079|FG003|Cohort 5, Q2W|Clinical Progression|0|||
127956370|NCT02906670|460459080|FG004|Cohort 5, Q2W|Clinical Progression|0|||
127956371|NCT02906670|460459081|FG005|Cohort 5, Q2W|Clinical Progression|0|||
127956372|NCT02906670|460459082|FG006|Cohort 5, Q2W|Clinical Progression|1|||
127956373|NCT02906670|460459083|FG007|Cohort 5, Q2W|Clinical Progression|0|||
127956374|NCT02906670|460459084|FG008|Cohort 5, Q2W|Clinical Progression|0|||
127956375|NCT02906670|460459085|FG009|Cohort 5, Q2W|Clinical Progression|0|||
127956376|NCT02906670|460459076|FG000|Cohort 5, Q2W|Adverse Event|0|||
127956377|NCT02906670|460459077|FG001|Cohort 5, Q2W|Adverse Event|0|||
127956378|NCT02906670|460459078|FG002|Cohort 5, Q2W|Adverse Event|0|||
127956379|NCT02906670|460459079|FG003|Cohort 5, Q2W|Adverse Event|0|||
127956380|NCT02906670|460459080|FG004|Cohort 5, Q2W|Adverse Event|0|||
127956381|NCT02906670|460459081|FG005|Cohort 5, Q2W|Adverse Event|0|||
127956382|NCT02906670|460459082|FG006|Cohort 5, Q2W|Adverse Event|1|||
127956383|NCT02906670|460459083|FG007|Cohort 5, Q2W|Adverse Event|0|||
127956384|NCT02906670|460459084|FG008|Cohort 5, Q2W|Adverse Event|0|||
127956385|NCT02906670|460459085|FG009|Cohort 5, Q2W|Adverse Event|0|||
127956386|NCT02906670|460459076|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
127956387|NCT02906670|460459077|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
127956388|NCT02906670|460459078|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
127956389|NCT02906670|460459079|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
127956390|NCT02906670|460459080|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
127956391|NCT02906670|460459081|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
127956392|NCT02906670|460459082|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
127956393|NCT02906670|460459083|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
127956394|NCT02906670|460459084|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
127956395|NCT02906670|460459085|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
127956396|NCT02906670|460459076|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
127956397|NCT02906670|460459077|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
127956398|NCT02906670|460459078|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
127956399|NCT02906670|460459079|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
127956400|NCT02906670|460459080|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
127956401|NCT02906670|460459081|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
127956402|NCT02906670|460459082|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
127956403|NCT02906670|460459083|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
127956404|NCT02906670|460459084|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
127956405|NCT02906670|460459085|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
127956406|NCT02906670|460459076|FG000|Cohort 5P, Q2W|Adverse Event|0|||
127956407|NCT02906670|460459077|FG001|Cohort 5P, Q2W|Adverse Event|0|||
127956408|NCT02906670|460459078|FG002|Cohort 5P, Q2W|Adverse Event|0|||
127956409|NCT02906670|460459079|FG003|Cohort 5P, Q2W|Adverse Event|0|||
127956410|NCT02906670|460459080|FG004|Cohort 5P, Q2W|Adverse Event|0|||
127956411|NCT02906670|460459081|FG005|Cohort 5P, Q2W|Adverse Event|0|||
127956412|NCT02906670|460459082|FG006|Cohort 5P, Q2W|Adverse Event|0|||
127956413|NCT02906670|460459083|FG007|Cohort 5P, Q2W|Adverse Event|1|||
127956414|NCT02906670|460459084|FG008|Cohort 5P, Q2W|Adverse Event|0|||
127956415|NCT02906670|460459085|FG009|Cohort 5P, Q2W|Adverse Event|0|||
127956416|NCT02906670|460459076|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
127956417|NCT02906670|460459077|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
127956418|NCT02906670|460459078|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
127956419|NCT02906670|460459079|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
127956420|NCT02906670|460459080|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
127956421|NCT02906670|460459081|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
127956422|NCT02906670|460459082|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
127956423|NCT02906670|460459083|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
127956424|NCT02906670|460459084|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
127956425|NCT02906670|460459085|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
127956426|NCT02906670|460459076|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
127956427|NCT02906670|460459077|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
127956428|NCT02906670|460459078|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
127956429|NCT02906670|460459079|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
127956430|NCT02906670|460459080|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
127956431|NCT02906670|460459081|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
127956432|NCT02906670|460459082|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
127956433|NCT02906670|460459083|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
127956434|NCT02906670|460459084|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
127956435|NCT02906670|460459085|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
127956436|NCT02906670|460459076|FG000|Cohort 4P, QW|Radiological Progression|0|||
127956437|NCT02906670|460459077|FG001|Cohort 4P, QW|Radiological Progression|0|||
127956438|NCT02906670|460459078|FG002|Cohort 4P, QW|Radiological Progression|0|||
127956439|NCT02906670|460459079|FG003|Cohort 4P, QW|Radiological Progression|3|||
127956440|NCT02906670|460459080|FG004|Cohort 4P, QW|Radiological Progression|0|||
127956441|NCT02906670|460459081|FG005|Cohort 4P, QW|Radiological Progression|0|||
127956442|NCT02906670|460459082|FG006|Cohort 4P, QW|Radiological Progression|0|||
127956443|NCT02906670|460459083|FG007|Cohort 4P, QW|Radiological Progression|0|||
127956444|NCT02906670|460459084|FG008|Cohort 4P, QW|Radiological Progression|0|||
127956445|NCT02906670|460459085|FG009|Cohort 4P, QW|Radiological Progression|0|||
127956446|NCT02906670|460459076|FG000|Cohort 7P, Q2W|Adverse Event|0|||
127956447|NCT02906670|460459077|FG001|Cohort 7P, Q2W|Adverse Event|0|||
127956448|NCT02906670|460459078|FG002|Cohort 7P, Q2W|Adverse Event|0|||
127956449|NCT02906670|460459079|FG003|Cohort 7P, Q2W|Adverse Event|0|||
127956450|NCT02906670|460459080|FG004|Cohort 7P, Q2W|Adverse Event|0|||
127956451|NCT02906670|460459081|FG005|Cohort 7P, Q2W|Adverse Event|0|||
127956452|NCT02906670|460459082|FG006|Cohort 7P, Q2W|Adverse Event|0|||
127956453|NCT02906670|460459083|FG007|Cohort 7P, Q2W|Adverse Event|0|||
127956454|NCT02906670|460459084|FG008|Cohort 7P, Q2W|Adverse Event|0|||
127956455|NCT02906670|460459085|FG009|Cohort 7P, Q2W|Adverse Event|1|||
127956456|NCT02906670|460459076|FG000|Cohort 7P, Q2W|Physician Decision|0|||
127956457|NCT02906670|460459077|FG001|Cohort 7P, Q2W|Physician Decision|0|||
127956458|NCT02906670|460459078|FG002|Cohort 7P, Q2W|Physician Decision|0|||
127956459|NCT02906670|460459079|FG003|Cohort 7P, Q2W|Physician Decision|0|||
127956460|NCT02906670|460459080|FG004|Cohort 7P, Q2W|Physician Decision|0|||
127956461|NCT02906670|460459081|FG005|Cohort 7P, Q2W|Physician Decision|0|||
127956462|NCT02906670|460459082|FG006|Cohort 7P, Q2W|Physician Decision|0|||
127956463|NCT02906670|460459083|FG007|Cohort 7P, Q2W|Physician Decision|0|||
127956464|NCT02906670|460459084|FG008|Cohort 7P, Q2W|Physician Decision|0|||
127956465|NCT02906670|460459085|FG009|Cohort 7P, Q2W|Physician Decision|1|||
127956466|NCT02906670|460459076|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
127956467|NCT02906670|460459077|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
127956468|NCT02906670|460459078|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
127956469|NCT02906670|460459079|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
127956470|NCT02906670|460459080|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
127956471|NCT02906670|460459081|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
127956472|NCT02906670|460459082|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
127956473|NCT02906670|460459083|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
127956474|NCT02906670|460459084|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
127956475|NCT02906670|460459085|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
127956476|NCT02906670|460459076|FG000|Cohort 5P, QW|Radiological Progression|0|||
127956477|NCT02906670|460459077|FG001|Cohort 5P, QW|Radiological Progression|0|||
127956478|NCT02906670|460459078|FG002|Cohort 5P, QW|Radiological Progression|0|||
127956479|NCT02906670|460459079|FG003|Cohort 5P, QW|Radiological Progression|0|||
127956480|NCT02906670|460459080|FG004|Cohort 5P, QW|Radiological Progression|3|||
127956481|NCT02906670|460459081|FG005|Cohort 5P, QW|Radiological Progression|0|||
127956482|NCT02906670|460459082|FG006|Cohort 5P, QW|Radiological Progression|0|||
127956483|NCT02906670|460459083|FG007|Cohort 5P, QW|Radiological Progression|0|||
127956484|NCT02906670|460459084|FG008|Cohort 5P, QW|Radiological Progression|0|||
127956485|NCT02906670|460459085|FG009|Cohort 5P, QW|Radiological Progression|0|||
127956486|NCT03749330|460459086|FG000|Overall Study|Clinicians left work in the CICU|0|||
127956487|NCT03749330|460459087|FG001|Overall Study|Clinicians left work in the CICU|2|||
127956488|NCT03749330|460459088|FG002|Overall Study|Clinicians left work in the CICU|0|||
127956489|NCT03749330|460459089|FG003|Overall Study|Clinicians left work in the CICU|0|||
127956490|NCT03749330|460459090|FG004|Overall Study|Clinicians left work in the CICU|0|||
127956491|NCT03749330|460459091|FG005|Overall Study|Clinicians left work in the CICU|0|||
127956492|NCT01973439|460459092|FG000|Overall Study|Lost samples from one PK Day|2|||
127956493|NCT01973439|460459092|FG000|Overall Study|Vomiting after commencing once daily|1|||
127956494|NCT01973439|460459092|FG000|Overall Study|PK curve incomplete|2|||
127956495|NCT02815995|460459093|FG000|Overall Study|Disease Progression|3|||
127956496|NCT02815995|460459094|FG001|Overall Study|Disease Progression|7|||
127956497|NCT02815995|460459095|FG002|Overall Study|Disease Progression|2|||
127956498|NCT02815995|460459096|FG003|Overall Study|Disease Progression|4|||
127956499|NCT02815995|460459097|FG004|Overall Study|Disease Progression|3|||
127956500|NCT02815995|460459098|FG005|Overall Study|Disease Progression|9|||
127956501|NCT02815995|460459099|FG006|Overall Study|Disease Progression|3|||
127956502|NCT02815995|460459100|FG007|Overall Study|Disease Progression|1|||
127956503|NCT02815995|460459093|FG000|Overall Study|Adverse Event|1|||
127956504|NCT02815995|460459094|FG001|Overall Study|Adverse Event|2|||
127956505|NCT02815995|460459095|FG002|Overall Study|Adverse Event|2|||
127956506|NCT02815995|460459096|FG003|Overall Study|Adverse Event|0|||
127956507|NCT02815995|460459097|FG004|Overall Study|Adverse Event|0|||
127956508|NCT02815995|460459098|FG005|Overall Study|Adverse Event|1|||
127956509|NCT02815995|460459099|FG006|Overall Study|Adverse Event|0|||
127956510|NCT02815995|460459100|FG007|Overall Study|Adverse Event|0|||
127956511|NCT02815995|460459093|FG000|Overall Study|Pregnancy|0|||
127956512|NCT02815995|460459094|FG001|Overall Study|Pregnancy|0|||
127956513|NCT02815995|460459095|FG002|Overall Study|Pregnancy|0|||
127956514|NCT02815995|460459096|FG003|Overall Study|Pregnancy|0|||
127956515|NCT02815995|460459097|FG004|Overall Study|Pregnancy|0|||
127956516|NCT02815995|460459098|FG005|Overall Study|Pregnancy|0|||
127956517|NCT02815995|460459099|FG006|Overall Study|Pregnancy|1|||
127956518|NCT02815995|460459100|FG007|Overall Study|Pregnancy|0|||
127956519|NCT03571828|460459101|FG000|Overall Study|Withdrawal by Subject|1|||
127956520|NCT03571828|460459102|FG001|Overall Study|Withdrawal by Subject|0|||
127956521|NCT03571828|460459101|FG000|Overall Study|Decision by sponsor|5|||
127956522|NCT03571828|460459102|FG001|Overall Study|Decision by sponsor|1|||
127956523|NCT03571828|460459101|FG000|Overall Study|Death|2|||
127956524|NCT03571828|460459102|FG001|Overall Study|Death|0|||
127956525|NCT01841593|460459103|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
127956526|NCT01841593|460459104|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
127956527|NCT01841593|460459103|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
127956528|NCT01841593|460459104|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
127956529|NCT00307086|460459105|FG000|Overall Study|ineligible|5|||
127956530|NCT01870778|460459109|FG000|Overall Study|Withdrawal by Subject|8|||
127956531|NCT01870778|460459110|FG001|Overall Study|Withdrawal by Subject|7|||
127956532|NCT01870778|460459109|FG000|Overall Study|Lost to Follow-up|0|||
127956533|NCT01870778|460459110|FG001|Overall Study|Lost to Follow-up|2|||
127956534|NCT00312338|460459111|FG000|Overall Study|Adverse Event|7|||
127956535|NCT00312338|460459112|FG001|Overall Study|Adverse Event|2|||
127956536|NCT00312338|460459111|FG000|Overall Study|Lost to Follow-up|9|||
127956537|NCT00312338|460459112|FG001|Overall Study|Lost to Follow-up|1|||
127956538|NCT00312338|460459111|FG000|Overall Study|Withdrawal by Subject|4|||
127956539|NCT00312338|460459112|FG001|Overall Study|Withdrawal by Subject|0|||
127956540|NCT00312338|460459111|FG000|Overall Study|Subsequent infection|2|||
127956541|NCT00312338|460459112|FG001|Overall Study|Subsequent infection|0|||
127956542|NCT00262028|460459113|FG000|Overall Study|Withdrawal by Subject|6|||
127956543|NCT00262028|460459114|FG001|Overall Study|Withdrawal by Subject|3|||
127956544|NCT00262028|460459115|FG002|Overall Study|Withdrawal by Subject|6|||
127956545|NCT00262028|460459116|FG003|Overall Study|Withdrawal by Subject|5|||
127956546|NCT00262028|460459117|FG004|Overall Study|Withdrawal by Subject|2|||
127956547|NCT00262028|460459118|FG005|Overall Study|Withdrawal by Subject|3|||
127956548|NCT00262028|460459119|FG006|Overall Study|Withdrawal by Subject|5|||
127956549|NCT00262028|460459120|FG007|Overall Study|Withdrawal by Subject|7|||
127956550|NCT00262028|460459121|FG008|Overall Study|Withdrawal by Subject|2|||
127956551|NCT00262028|460459113|FG000|Overall Study|Lost to Follow-up|7|||
127956552|NCT00262028|460459114|FG001|Overall Study|Lost to Follow-up|7|||
127956553|NCT00262028|460459115|FG002|Overall Study|Lost to Follow-up|5|||
127956554|NCT00262028|460459116|FG003|Overall Study|Lost to Follow-up|5|||
127956555|NCT00262028|460459117|FG004|Overall Study|Lost to Follow-up|4|||
127956556|NCT00262028|460459118|FG005|Overall Study|Lost to Follow-up|3|||
127956557|NCT00262028|460459119|FG006|Overall Study|Lost to Follow-up|3|||
127956558|NCT00262028|460459120|FG007|Overall Study|Lost to Follow-up|5|||
127956559|NCT00262028|460459121|FG008|Overall Study|Lost to Follow-up|6|||
127956560|NCT00262028|460459113|FG000|Overall Study|Administrative Reason|11|||
127956561|NCT00262028|460459114|FG001|Overall Study|Administrative Reason|14|||
127956562|NCT00262028|460459115|FG002|Overall Study|Administrative Reason|9|||
127956563|NCT00262028|460459116|FG003|Overall Study|Administrative Reason|12|||
127956564|NCT00262028|460459117|FG004|Overall Study|Administrative Reason|6|||
127956565|NCT00262028|460459118|FG005|Overall Study|Administrative Reason|7|||
127956566|NCT00262028|460459119|FG006|Overall Study|Administrative Reason|4|||
127956567|NCT00262028|460459120|FG007|Overall Study|Administrative Reason|6|||
127956568|NCT00262028|460459121|FG008|Overall Study|Administrative Reason|10|||
127956569|NCT00262028|460459113|FG000|Overall Study|Protocol Violation|0|||
127956570|NCT00262028|460459114|FG001|Overall Study|Protocol Violation|0|||
127956571|NCT00262028|460459115|FG002|Overall Study|Protocol Violation|0|||
127956572|NCT00262028|460459116|FG003|Overall Study|Protocol Violation|1|||
127956573|NCT00262028|460459117|FG004|Overall Study|Protocol Violation|0|||
127956574|NCT00262028|460459118|FG005|Overall Study|Protocol Violation|0|||
127956575|NCT00262028|460459119|FG006|Overall Study|Protocol Violation|0|||
127956576|NCT00262028|460459120|FG007|Overall Study|Protocol Violation|0|||
127956577|NCT00262028|460459121|FG008|Overall Study|Protocol Violation|0|||
127956578|NCT00262028|460459113|FG000|Overall Study|Unable to classify|0|||
127956579|NCT00262028|460459114|FG001|Overall Study|Unable to classify|3|||
127956580|NCT00262028|460459115|FG002|Overall Study|Unable to classify|0|||
127956581|NCT00262028|460459116|FG003|Overall Study|Unable to classify|0|||
127956582|NCT00262028|460459117|FG004|Overall Study|Unable to classify|0|||
127956583|NCT00262028|460459118|FG005|Overall Study|Unable to classify|0|||
127956584|NCT00262028|460459119|FG006|Overall Study|Unable to classify|0|||
127956585|NCT00262028|460459120|FG007|Overall Study|Unable to classify|0|||
127956586|NCT00262028|460459121|FG008|Overall Study|Unable to classify|1|||
127956587|NCT00786409|460459123|FG000|Overall Study|Withdrawal by Subject|2|||
127956588|NCT00786409|460459123|FG000|Overall Study|Adverse Event|2|||
127956589|NCT00786409|460459123|FG000|Overall Study|Pregnancy|2|||
127956590|NCT00786409|460459123|FG000|Overall Study|Lost to Follow-up|1|||
127956591|NCT00610129|460459124|FG000|Overall Study|Not treated since patients ineligible|3|||
127956592|NCT01329900|460459127|FG000|Overall Study|Elevated creatinine/renal function|1|||
127956593|NCT02198963|460459128|FG000|Overall Study|Adverse Event|1|||
127956594|NCT02198963|460459128|FG000|Overall Study|Withdrawal by Subject|6|||
127956595|NCT03180645|460459132|FG000|Overall Study|Adverse Event|0|||
127956596|NCT03180645|460459133|FG001|Overall Study|Adverse Event|1|||
127956597|NCT03180645|460459134|FG002|Overall Study|Adverse Event|2|||
127956598|NCT01808573|460459135|FG000|Overall Study|Death|212|||
127956599|NCT01808573|460459136|FG001|Overall Study|Death|240|||
127956600|NCT01808573|460459135|FG000|Overall Study|Withdrawal by Subject|12|||
127956601|NCT01808573|460459136|FG001|Overall Study|Withdrawal by Subject|10|||
127956602|NCT01808573|460459135|FG000|Overall Study|Lost to Follow-up|3|||
127956603|NCT01808573|460459136|FG001|Overall Study|Lost to Follow-up|0|||
127956604|NCT01808573|460459135|FG000|Overall Study|Discontinuation of study by sponsor|79|||
127956605|NCT01808573|460459136|FG001|Overall Study|Discontinuation of study by sponsor|64|||
127956606|NCT01808573|460459135|FG000|Overall Study|Randomized in Error|1|||
127956607|NCT01808573|460459136|FG001|Overall Study|Randomized in Error|0|||
127956608|NCT00995774|460459137|FG000|Training Period 2|Withdrawal by Subject|2|||
127956609|NCT00995774|460459138|FG001|Training Period 2|Withdrawal by Subject|0|||
127956610|NCT03200717|460459146|FG000|Overall Study|Progressive disease|24|||
127956611|NCT03200717|460459147|FG001|Overall Study|Progressive disease|5|||
127956612|NCT03200717|460459146|FG000|Overall Study|Adverse Event|11|||
127956613|NCT03200717|460459147|FG001|Overall Study|Adverse Event|8|||
127956614|NCT03200717|460459146|FG000|Overall Study|Physician Decision|3|||
127956615|NCT03200717|460459147|FG001|Overall Study|Physician Decision|2|||
127956616|NCT03200717|460459146|FG000|Overall Study|Death|2|||
127956617|NCT03200717|460459147|FG001|Overall Study|Death|0|||
127956618|NCT03200717|460459146|FG000|Overall Study|Subject/Guardian Decision|1|||
127956619|NCT03200717|460459147|FG001|Overall Study|Subject/Guardian Decision|0|||
127956620|NCT01461538|460459148|FG000|Overall Study|Death|15|||
127956621|NCT01461538|460459149|FG001|Overall Study|Death|6|||
127956622|NCT01461538|460459150|FG002|Overall Study|Death|2|||
127956623|NCT01461538|460459148|FG000|Overall Study|Study Stopped by Sponsor|2|||
127956624|NCT01461538|460459149|FG001|Overall Study|Study Stopped by Sponsor|1|||
127956625|NCT01461538|460459150|FG002|Overall Study|Study Stopped by Sponsor|0|||
127956626|NCT01461538|460459148|FG000|Overall Study|Withdrawal by Subject|1|||
127956627|NCT01461538|460459149|FG001|Overall Study|Withdrawal by Subject|1|||
127956628|NCT01461538|460459150|FG002|Overall Study|Withdrawal by Subject|0|||
127956629|NCT00141778|460459151|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
127956630|NCT00141778|460459152|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
127956631|NCT00141778|460459153|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
127956632|NCT00141778|460459151|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
127956633|NCT00141778|460459152|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
127956634|NCT00141778|460459153|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
127956635|NCT00141778|460459151|FG000|Started Study Medication|Withdrawal by Subject|0|||
127956636|NCT00141778|460459152|FG001|Started Study Medication|Withdrawal by Subject|2|||
127956637|NCT00141778|460459153|FG002|Started Study Medication|Withdrawal by Subject|0|||
127956638|NCT00141778|460459151|FG000|Started Study Medication|Difficulty Swallowing|0|||
127956639|NCT00141778|460459152|FG001|Started Study Medication|Difficulty Swallowing|1|||
127956640|NCT00141778|460459153|FG002|Started Study Medication|Difficulty Swallowing|0|||
127956641|NCT00141778|460459151|FG000|Started Study Medication|Chest Discomfort|0|||
127956642|NCT00141778|460459152|FG001|Started Study Medication|Chest Discomfort|0|||
127956643|NCT00141778|460459153|FG002|Started Study Medication|Chest Discomfort|1|||
127956644|NCT02729909|460459154|FG000|Overall Study|Lost to Follow-up|0|||
127956645|NCT02729909|460459155|FG001|Overall Study|Lost to Follow-up|1|||
127956646|NCT02729909|460459154|FG000|Overall Study|Lack of Efficacy|0|||
127956647|NCT02729909|460459155|FG001|Overall Study|Lack of Efficacy|2|||
127956648|NCT02729909|460459154|FG000|Overall Study|Significant Protocol Deviation|0|||
127956649|NCT02729909|460459155|FG001|Overall Study|Significant Protocol Deviation|2|||
127956650|NCT02729909|460459154|FG000|Overall Study|Voluntary Withdrawal|1|||
127956651|NCT02729909|460459155|FG001|Overall Study|Voluntary Withdrawal|0|||
127956652|NCT01245283|460459160|FG000|Overall Study|Lost to Follow-up|14|||
127956653|NCT01245283|460459161|FG001|Overall Study|Lost to Follow-up|11|||
127956654|NCT01245283|460459162|FG002|Overall Study|Lost to Follow-up|11|||
127956655|NCT01610492|460459165|FG000|Overall Study|Adverse Event|1|||
127956656|NCT01610492|460459165|FG000|Overall Study|Lack of Efficacy|3|||
127956657|NCT01610492|460459165|FG000|Overall Study|Other: Reached stopping criteria|1|||
127956658|NCT01610492|460459165|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
127956659|NCT01982955|460459166|FG000|Overall Study|Randomized but not treated|0|||
127956660|NCT01982955|460459167|FG001|Overall Study|Randomized but not treated|0|||
127956661|NCT01982955|460459168|FG002|Overall Study|Randomized but not treated|0|||
127956662|NCT01982955|460459169|FG003|Overall Study|Randomized but not treated|1|||
127956663|NCT01982955|460459170|FG004|Overall Study|Randomized but not treated|0|||
127956664|NCT04211831|460459173|FG000|Overall Study|Withdrawal by Subject|4|||
127956665|NCT04211831|460459174|FG001|Overall Study|Withdrawal by Subject|1|||
127956666|NCT04211831|460459175|FG002|Overall Study|Withdrawal by Subject|1|||
127956667|NCT04211831|460459173|FG000|Overall Study|Protocol Violation|0|||
127956668|NCT04211831|460459174|FG001|Overall Study|Protocol Violation|0|||
127956669|NCT04211831|460459175|FG002|Overall Study|Protocol Violation|1|||
127956670|NCT04211831|460459173|FG000|Overall Study|Adverse Event|0|||
127956671|NCT04211831|460459174|FG001|Overall Study|Adverse Event|1|||
127956672|NCT04211831|460459175|FG002|Overall Study|Adverse Event|0|||
127956673|NCT04211831|460459173|FG000|Overall Study|Lack of Efficacy|0|||
127956674|NCT04211831|460459174|FG001|Overall Study|Lack of Efficacy|0|||
127956675|NCT04211831|460459175|FG002|Overall Study|Lack of Efficacy|1|||
127956676|NCT04211831|460459173|FG000|Overall Study|Lost to Follow-up|0|||
127956677|NCT04211831|460459174|FG001|Overall Study|Lost to Follow-up|0|||
127956678|NCT04211831|460459175|FG002|Overall Study|Lost to Follow-up|2|||
127956679|NCT04211831|460459173|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
127956680|NCT04211831|460459174|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
127956681|NCT04211831|460459175|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
127956682|NCT04211831|460459173|FG000|Overall Study|Other|0|||
127956683|NCT04211831|460459174|FG001|Overall Study|Other|1|||
127956684|NCT04211831|460459175|FG002|Overall Study|Other|0|||
127956685|NCT00397514|460459177|FG000|Overall Study|Withdrawal by Subject|1|||
127956686|NCT00397514|460459177|FG000|Overall Study|Pacing wire malfunction|1|||
127956687|NCT00397514|460459177|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
127956688|NCT00397514|460459177|FG000|Overall Study|early extubation|2|||
127956689|NCT00397514|460459177|FG000|Overall Study|poor echocardiographic windows|1|||
127956690|NCT00640315|460459178|FG000|Overall Study|Withdrawal by Subject|0|||
127956691|NCT00640315|460459179|FG001|Overall Study|Withdrawal by Subject|1|||
127956692|NCT01256879|460459180|FG000|Overall Study|Withdrawal by Subject|1|||
127956693|NCT00265759|460460994|FG000|Overall Study|Withdrawal by Subject|0|||
127956694|NCT00265759|460460995|FG001|Overall Study|Withdrawal by Subject|1|||
127956695|NCT00265759|460460996|FG002|Overall Study|Withdrawal by Subject|2|||
127956696|NCT00265759|460460997|FG003|Overall Study|Withdrawal by Subject|2|||
127956697|NCT00265759|460460994|FG000|Overall Study|Cancel|0|||
127956698|NCT00265759|460460995|FG001|Overall Study|Cancel|0|||
127956699|NCT00265759|460460996|FG002|Overall Study|Cancel|0|||
127956700|NCT00265759|460460997|FG003|Overall Study|Cancel|3|||
127956701|NCT00265759|460460994|FG000|Overall Study|Ineligible|0|||
127956702|NCT00265759|460460995|FG001|Overall Study|Ineligible|0|||
127956703|NCT00265759|460460996|FG002|Overall Study|Ineligible|0|||
127956704|NCT00265759|460460997|FG003|Overall Study|Ineligible|1|||
127956705|NCT00265759|460460994|FG000|Overall Study|Bilateral disease|0|||
127956706|NCT00265759|460460995|FG001|Overall Study|Bilateral disease|0|||
127956707|NCT00265759|460460996|FG002|Overall Study|Bilateral disease|0|||
127956708|NCT00265759|460460997|FG003|Overall Study|Bilateral disease|2|||
127956709|NCT00265759|460460994|FG000|Overall Study|Discontinued due to intolerability|0|||
127956710|NCT00265759|460460995|FG001|Overall Study|Discontinued due to intolerability|0|||
127956711|NCT00265759|460460996|FG002|Overall Study|Discontinued due to intolerability|0|||
127956712|NCT00265759|460460997|FG003|Overall Study|Discontinued due to intolerability|1|||
127956713|NCT05201794|460460998|FG000|Overall Study|Withdrawal by Subject|13|||
127956714|NCT05201794|460460999|FG001|Overall Study|Withdrawal by Subject|12|||
127956715|NCT05201794|460461000|FG002|Overall Study|Withdrawal by Subject|14|||
127956716|NCT05201794|460461001|FG003|Overall Study|Withdrawal by Subject|0|||
127956717|NCT05201794|460460998|FG000|Overall Study|Adverse Event|5|||
127956718|NCT05201794|460460999|FG001|Overall Study|Adverse Event|5|||
127956719|NCT05201794|460461000|FG002|Overall Study|Adverse Event|4|||
127956720|NCT05201794|460461001|FG003|Overall Study|Adverse Event|0|||
127956721|NCT05201794|460460998|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
127956722|NCT05201794|460460999|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
127956723|NCT05201794|460461000|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|4|||
127956724|NCT05201794|460461001|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
127956725|NCT05201794|460460998|FG000|Overall Study|Non-Compliance With Study Drug|2|||
127956726|NCT05201794|460460999|FG001|Overall Study|Non-Compliance With Study Drug|3|||
127956727|NCT05201794|460461000|FG002|Overall Study|Non-Compliance With Study Drug|3|||
127956728|NCT05201794|460461001|FG003|Overall Study|Non-Compliance With Study Drug|0|||
127956729|NCT05201794|460460998|FG000|Overall Study|Physician Decision|1|||
127956730|NCT05201794|460460999|FG001|Overall Study|Physician Decision|3|||
127956731|NCT05201794|460461000|FG002|Overall Study|Physician Decision|2|||
127956732|NCT05201794|460461001|FG003|Overall Study|Physician Decision|0|||
127956733|NCT05201794|460460998|FG000|Overall Study|Lost to Follow-up|2|||
127956734|NCT05201794|460460999|FG001|Overall Study|Lost to Follow-up|2|||
127956735|NCT05201794|460461000|FG002|Overall Study|Lost to Follow-up|0|||
127956736|NCT05201794|460461001|FG003|Overall Study|Lost to Follow-up|0|||
127956737|NCT05201794|460460998|FG000|Overall Study|Non-Compliance With Study Schedule|1|||
127956738|NCT05201794|460460999|FG001|Overall Study|Non-Compliance With Study Schedule|1|||
127956739|NCT05201794|460461000|FG002|Overall Study|Non-Compliance With Study Schedule|1|||
127956740|NCT05201794|460461001|FG003|Overall Study|Non-Compliance With Study Schedule|0|||
127956741|NCT05201794|460460998|FG000|Overall Study|Protocol Violation|2|||
127956742|NCT05201794|460460999|FG001|Overall Study|Protocol Violation|0|||
127956743|NCT05201794|460461000|FG002|Overall Study|Protocol Violation|1|||
127956744|NCT05201794|460461001|FG003|Overall Study|Protocol Violation|0|||
127956745|NCT05201794|460460998|FG000|Overall Study|Death|1|||
127956746|NCT05201794|460460999|FG001|Overall Study|Death|0|||
127956747|NCT05201794|460461000|FG002|Overall Study|Death|0|||
127956748|NCT05201794|460461001|FG003|Overall Study|Death|0|||
127956749|NCT05201794|460460998|FG000|Overall Study|Site Terminated By Sponsor|0|||
127956750|NCT05201794|460460999|FG001|Overall Study|Site Terminated By Sponsor|1|||
127956751|NCT05201794|460461000|FG002|Overall Study|Site Terminated By Sponsor|0|||
127956752|NCT05201794|460461001|FG003|Overall Study|Site Terminated By Sponsor|0|||
127956753|NCT05201794|460460998|FG000|Overall Study|Other|3|||
127956754|NCT05201794|460460999|FG001|Overall Study|Other|3|||
127956755|NCT05201794|460461000|FG002|Overall Study|Other|3|||
127956756|NCT05201794|460461001|FG003|Overall Study|Other|0|||
127956757|NCT05201794|460460998|FG000|Overall Study|Randomized But Not Treated|1|||
127956758|NCT05201794|460460999|FG001|Overall Study|Randomized But Not Treated|2|||
127956759|NCT05201794|460461000|FG002|Overall Study|Randomized But Not Treated|1|||
127956760|NCT05201794|460461001|FG003|Overall Study|Randomized But Not Treated|0|||
127956761|NCT04653454|460461006|FG000|Overall Study|Withdrawal by Subject|1|||
127956762|NCT04653454|460461006|FG000|Overall Study|Physician Decision|40|||
127956763|NCT03620708|460461007|FG000|Overall Study|Lost to Follow-up|1|||
127956764|NCT03620708|460461008|FG001|Overall Study|Lost to Follow-up|1|||
127956765|NCT03620708|460461009|FG002|Overall Study|Lost to Follow-up|2|||
127956766|NCT03620708|460461007|FG000|Overall Study|Withdrawal by Subject|0|||
127956767|NCT03620708|460461008|FG001|Overall Study|Withdrawal by Subject|0|||
127956768|NCT03620708|460461009|FG002|Overall Study|Withdrawal by Subject|1|||
127956769|NCT05525520|460461011|FG000|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|0|||
127956770|NCT05525520|460461012|FG001|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|2|||
127956771|NCT05525520|460461011|FG000|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
127956772|NCT05525520|460461012|FG001|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
127956773|NCT03657797|460461013|FG000|Overall Study|Lost to Follow-up|0|||
127956774|NCT03657797|460461014|FG001|Overall Study|Lost to Follow-up|1|||
127956775|NCT03657797|460461015|FG002|Overall Study|Lost to Follow-up|1|||
127956776|NCT03657797|460461016|FG003|Overall Study|Lost to Follow-up|0|||
127956777|NCT03657797|460461013|FG000|Overall Study|Physician Decision|0|||
127956778|NCT03657797|460461014|FG001|Overall Study|Physician Decision|1|||
127956779|NCT03657797|460461015|FG002|Overall Study|Physician Decision|0|||
127956780|NCT03657797|460461016|FG003|Overall Study|Physician Decision|0|||
127956781|NCT03657797|460461013|FG000|Overall Study|Withdrawal by Subject|0|||
127956782|NCT03657797|460461014|FG001|Overall Study|Withdrawal by Subject|1|||
127956783|NCT03657797|460461015|FG002|Overall Study|Withdrawal by Subject|2|||
127956784|NCT03657797|460461016|FG003|Overall Study|Withdrawal by Subject|0|||
127956785|NCT03657797|460461013|FG000|Overall Study|Adverse Event|0|||
127956786|NCT03657797|460461014|FG001|Overall Study|Adverse Event|0|||
127956787|NCT03657797|460461015|FG002|Overall Study|Adverse Event|2|||
127956788|NCT03657797|460461016|FG003|Overall Study|Adverse Event|0|||
127956789|NCT00118157|460461017|FG000|Overall Study|Adverse Event|2|||
127956790|NCT00118157|460461017|FG000|Overall Study|Death|8|||
127956791|NCT00118157|460461017|FG000|Overall Study|Withdrawal by Subject|2|||
127956792|NCT02760004|460461020|FG000|Overall Study|Lost to Follow-up|13|||
127956793|NCT02760004|460461021|FG001|Overall Study|Lost to Follow-up|22|||
127956794|NCT00276484|460461024|FG000|Overall Study|Adverse Event|4|||
127956795|NCT00276484|460461025|FG001|Overall Study|Adverse Event|7|||
127956796|NCT00276484|460461024|FG000|Overall Study|Lost to Follow-up|1|||
127956797|NCT00276484|460461025|FG001|Overall Study|Lost to Follow-up|1|||
127956798|NCT00276484|460461024|FG000|Overall Study|Protocol Violation|0|||
127956799|NCT00276484|460461025|FG001|Overall Study|Protocol Violation|1|||
127956800|NCT00276484|460461024|FG000|Overall Study|Withdrawal by Subject|4|||
127956801|NCT00276484|460461025|FG001|Overall Study|Withdrawal by Subject|3|||
127956802|NCT00276484|460461024|FG000|Overall Study|Could not take time off work|0|||
127956803|NCT00276484|460461025|FG001|Overall Study|Could not take time off work|1|||
127956804|NCT01626690|460461026|FG000|Overall Study|Protocol Violation|1|||
127956805|NCT01626690|460461027|FG001|Overall Study|Protocol Violation|0|||
127956806|NCT01626690|460461026|FG000|Overall Study|Adverse Event|1|||
127956807|NCT01626690|460461027|FG001|Overall Study|Adverse Event|0|||
127956808|NCT04688671|460461028|FG000|Overall Study|Adverse Event|3|||
127956809|NCT04688671|460461029|FG001|Overall Study|Adverse Event|1|||
127956810|NCT04688671|460461028|FG000|Overall Study|Withdrawal by Subject|3|||
127956811|NCT04688671|460461029|FG001|Overall Study|Withdrawal by Subject|1|||
127956812|NCT04688671|460461028|FG000|Overall Study|Lack of Efficacy|1|||
127956813|NCT04688671|460461029|FG001|Overall Study|Lack of Efficacy|1|||
127956814|NCT04688671|460461028|FG000|Overall Study|Protocol Violation|1|||
127956815|NCT04688671|460461029|FG001|Overall Study|Protocol Violation|0|||
127956816|NCT04688671|460461028|FG000|Overall Study|Lost to Follow-up|0|||
127956817|NCT04688671|460461029|FG001|Overall Study|Lost to Follow-up|1|||
127956818|NCT02038010|460461033|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
127956819|NCT02038010|460461034|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
127956820|NCT02038010|460461035|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
127956821|NCT02038010|460461036|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
127956822|NCT02038010|460461033|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
127956823|NCT02038010|460461034|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
127956824|NCT02038010|460461035|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
127956825|NCT02038010|460461036|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
127956826|NCT02038010|460461033|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
127956827|NCT02038010|460461034|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
127956828|NCT02038010|460461035|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
127956829|NCT02038010|460461036|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
127956830|NCT02038010|460461033|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
127956831|NCT02038010|460461034|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
127956832|NCT02038010|460461035|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
127956833|NCT02038010|460461036|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
127956834|NCT02038010|460461033|FG000|Follow Up|Death|4|||
127956835|NCT02038010|460461034|FG001|Follow Up|Death|3|||
127956836|NCT02038010|460461035|FG002|Follow Up|Death|0|||
127956837|NCT02038010|460461036|FG003|Follow Up|Death|0|||
127956838|NCT02038010|460461033|FG000|Follow Up|Other|3|||
127956839|NCT02038010|460461034|FG001|Follow Up|Other|0|||
127956840|NCT02038010|460461035|FG002|Follow Up|Other|0|||
127956841|NCT02038010|460461036|FG003|Follow Up|Other|0|||
127956842|NCT02414958|460461037|FG000|Overall Study|Adverse Event|6|||
127956843|NCT02414958|460461038|FG001|Overall Study|Adverse Event|6|||
127956844|NCT02414958|460461039|FG002|Overall Study|Adverse Event|3|||
127956845|NCT02414958|460461037|FG000|Overall Study|Protocol Violation|10|||
127956846|NCT02414958|460461038|FG001|Overall Study|Protocol Violation|3|||
127956847|NCT02414958|460461039|FG002|Overall Study|Protocol Violation|1|||
127956848|NCT02414958|460461037|FG000|Overall Study|Lost to Follow-up|7|||
127956849|NCT02414958|460461038|FG001|Overall Study|Lost to Follow-up|4|||
127956850|NCT02414958|460461039|FG002|Overall Study|Lost to Follow-up|0|||
127956851|NCT02414958|460461037|FG000|Overall Study|Withdrawal by Subject|5|||
127956852|NCT02414958|460461038|FG001|Overall Study|Withdrawal by Subject|3|||
127956853|NCT02414958|460461039|FG002|Overall Study|Withdrawal by Subject|5|||
127956854|NCT02414958|460461037|FG000|Overall Study|Other than specified|4|||
127956855|NCT02414958|460461038|FG001|Overall Study|Other than specified|4|||
127956856|NCT02414958|460461039|FG002|Overall Study|Other than specified|5|||
127956857|NCT05767905|460461042|FG000|Overall Study|Adverse Event|0|||
127956858|NCT05767905|460461043|FG001|Overall Study|Adverse Event|0|||
127956859|NCT05767905|460461044|FG002|Overall Study|Adverse Event|1|||
127956860|NCT03762239|460461045|FG000|Overall Study|Appointment to the doctor|1|||
127956861|NCT03762239|460461046|FG001|Overall Study|Appointment to the doctor|1|||
127956862|NCT03645863|460461047|FG000|Overall Study|Withdrawal by Subject|1|||
127956863|NCT03645863|460461048|FG001|Overall Study|Withdrawal by Subject|0|||
127956864|NCT03645863|460461049|FG002|Overall Study|Withdrawal by Subject|0|||
127956865|NCT03624192|460461059|FG000|Overall Study|Lost to Follow-up|1|||
127956866|NCT03624192|460461060|FG001|Overall Study|Lost to Follow-up|1|||
127956867|NCT04660331|460461061|FG000|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
127956868|NCT04660331|460461062|FG001|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
127956869|NCT04660331|460461063|FG002|PROMOTE Intervention (Aim 2)|Lost to Follow-up|5|||
127956870|NCT02635984|460461068|FG000|Overall Study|Lost to Follow-up|2|||
127956871|NCT02635984|460461069|FG001|Overall Study|Lost to Follow-up|4|||
127956872|NCT02635984|460461068|FG000|Overall Study|Study Arm Closed|1|||
127956873|NCT02635984|460461069|FG001|Overall Study|Study Arm Closed|0|||
127956874|NCT01640249|460461071|FG000|Period 1|Withdrawal by Subject|1|||
127956875|NCT01640249|460461072|FG001|Period 1|Withdrawal by Subject|0|||
127956876|NCT01640249|460461073|FG002|Period 1|Withdrawal by Subject|0|||
127956877|NCT01640249|460461074|FG003|Period 1|Withdrawal by Subject|0|||
127956878|NCT01640249|460461075|FG004|Period 1|Withdrawal by Subject|0|||
127956879|NCT01640249|460461076|FG005|Period 1|Withdrawal by Subject|1|||
127956880|NCT01640249|460461077|FG006|Period 1|Withdrawal by Subject|0|||
127956881|NCT01215136|460461080|FG000|Overall Study|Adverse Event|2|||
127956882|NCT01215136|460461081|FG001|Overall Study|Adverse Event|9|||
127956883|NCT01215136|460461080|FG000|Overall Study|Disease Progression|3|||
127956884|NCT01215136|460461081|FG001|Overall Study|Disease Progression|14|||
127956885|NCT01215136|460461080|FG000|Overall Study|Symptomatic Deterioration|1|||
127956886|NCT01215136|460461081|FG001|Overall Study|Symptomatic Deterioration|1|||
127956887|NCT01215136|460461080|FG000|Overall Study|Death|0|||
127956888|NCT01215136|460461081|FG001|Overall Study|Death|2|||
127956889|NCT01215136|460461080|FG000|Overall Study|Withdrawal by Subject|0|||
127956890|NCT01215136|460461081|FG001|Overall Study|Withdrawal by Subject|1|||
127956891|NCT02289729|460461086|FG000|Overall Study|Lack of Efficacy|3|||
127956892|NCT02289729|460461086|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
127956893|NCT02289729|460461086|FG000|Overall Study|Withdrawal by Subject|1|||
127956894|NCT02289729|460461086|FG000|Overall Study|Death|1|||
127956895|NCT04870710|460461092|FG000|Overall Study|Lost to Follow-up|3|||
127956896|NCT00476190|460461093|FG000|Overall Study|Ineligible|1|||
127956897|NCT00476190|460461094|FG001|Overall Study|Ineligible|1|||
127956898|NCT00476190|460461093|FG000|Overall Study|Induction Death|2|||
127956899|NCT00476190|460461094|FG001|Overall Study|Induction Death|0|||
127956900|NCT00476190|460461093|FG000|Overall Study|Induction Failure|2|||
127956901|NCT00476190|460461094|FG001|Overall Study|Induction Failure|4|||
127956902|NCT00476190|460461093|FG000|Overall Study|Lost to Follow-up|1|||
127956903|NCT00476190|460461094|FG001|Overall Study|Lost to Follow-up|0|||
127956904|NCT00476190|460461093|FG000|Overall Study|Relapse/Progression|5|||
127956905|NCT00476190|460461094|FG001|Overall Study|Relapse/Progression|2|||
127956906|NCT00476190|460461093|FG000|Overall Study|Remission Death|0|||
127956907|NCT00476190|460461094|FG001|Overall Study|Remission Death|1|||
127956908|NCT00476190|460461093|FG000|Overall Study|Transplant in first Complete Remission (CR)|15|||
127956909|NCT00476190|460461094|FG001|Overall Study|Transplant in first Complete Remission (CR)|6|||
127956910|NCT00476190|460461093|FG000|Overall Study|Withdrawal by Subject|6|||
127956911|NCT00476190|460461094|FG001|Overall Study|Withdrawal by Subject|2|||
127956912|NCT00476190|460461093|FG000|Overall Study|Other|9|||
127956913|NCT00476190|460461094|FG001|Overall Study|Other|10|||
127956914|NCT05724589|460461097|FG000|Overall Study|Lost to Follow-up|1|||
127956915|NCT01042093|460461106|FG000|Overall Study|Protocol Violation|2|||
127956916|NCT01042093|460461107|FG001|Overall Study|Protocol Violation|2|||
127956917|NCT01042093|460461108|FG002|Overall Study|Protocol Violation|2|||
127956918|NCT01042093|460461109|FG003|Overall Study|Protocol Violation|3|||
127956919|NCT01042093|460461106|FG000|Overall Study|Withdrawal by Subject|0|||
127956920|NCT01042093|460461107|FG001|Overall Study|Withdrawal by Subject|0|||
127956921|NCT01042093|460461108|FG002|Overall Study|Withdrawal by Subject|0|||
127956922|NCT01042093|460461109|FG003|Overall Study|Withdrawal by Subject|1|||
127956923|NCT02273388|460461110|FG000|Overall Study|Adverse Event|0|||
127956924|NCT02273388|460461111|FG001|Overall Study|Adverse Event|0|||
127956925|NCT02273388|460461112|FG002|Overall Study|Adverse Event|0|||
127956926|NCT02273388|460461113|FG003|Overall Study|Adverse Event|0|||
127956927|NCT02273388|460461114|FG004|Overall Study|Adverse Event|0|||
127956928|NCT02273388|460461115|FG005|Overall Study|Adverse Event|0|||
127956929|NCT02273388|460461116|FG006|Overall Study|Adverse Event|1|||
127956930|NCT02273388|460461117|FG007|Overall Study|Adverse Event|2|||
127956931|NCT02273388|460461118|FG008|Overall Study|Adverse Event|0|||
127956932|NCT02273388|460461119|FG009|Overall Study|Adverse Event|0|||
127956933|NCT02273388|460461120|FG010|Overall Study|Adverse Event|0|||
127956934|NCT02273388|460461121|FG011|Overall Study|Adverse Event|0|||
127956935|NCT02273388|460461110|FG000|Overall Study|Adverse Event study disease worse|4|||
127956936|NCT02273388|460461111|FG001|Overall Study|Adverse Event study disease worse|3|||
127956937|NCT02273388|460461112|FG002|Overall Study|Adverse Event study disease worse|3|||
127956938|NCT02273388|460461113|FG003|Overall Study|Adverse Event study disease worse|2|||
127956939|NCT02273388|460461114|FG004|Overall Study|Adverse Event study disease worse|4|||
127956940|NCT02273388|460461115|FG005|Overall Study|Adverse Event study disease worse|3|||
127956941|NCT02273388|460461116|FG006|Overall Study|Adverse Event study disease worse|14|||
127956942|NCT02273388|460461117|FG007|Overall Study|Adverse Event study disease worse|6|||
127956943|NCT02273388|460461118|FG008|Overall Study|Adverse Event study disease worse|6|||
127956944|NCT02273388|460461119|FG009|Overall Study|Adverse Event study disease worse|5|||
127956945|NCT02273388|460461120|FG010|Overall Study|Adverse Event study disease worse|10|||
127956946|NCT02273388|460461121|FG011|Overall Study|Adverse Event study disease worse|1|||
127956947|NCT02273388|460461110|FG000|Overall Study|Sponsor decision|0|||
127956948|NCT02273388|460461111|FG001|Overall Study|Sponsor decision|0|||
127956949|NCT02273388|460461112|FG002|Overall Study|Sponsor decision|0|||
127956950|NCT02273388|460461113|FG003|Overall Study|Sponsor decision|0|||
127956951|NCT02273388|460461114|FG004|Overall Study|Sponsor decision|0|||
127956952|NCT02273388|460461115|FG005|Overall Study|Sponsor decision|0|||
127956953|NCT02273388|460461116|FG006|Overall Study|Sponsor decision|0|||
127956954|NCT02273388|460461117|FG007|Overall Study|Sponsor decision|0|||
127956955|NCT02273388|460461118|FG008|Overall Study|Sponsor decision|0|||
127956956|NCT02273388|460461119|FG009|Overall Study|Sponsor decision|0|||
127956957|NCT02273388|460461120|FG010|Overall Study|Sponsor decision|0|||
127956958|NCT02273388|460461121|FG011|Overall Study|Sponsor decision|1|||
127956959|NCT04331808|460461122|FG000|Overall Study|Withdrew consent|1|||
127956960|NCT04331808|460461123|FG001|Overall Study|Withdrew consent|0|||
127956961|NCT04331808|460461124|FG002|Overall Study|Withdrew consent|2|||
127956962|NCT04331808|460461125|FG003|Overall Study|Withdrew consent|3|||
127956963|NCT00281957|460461132|FG000|Overall Study|Adverse Event|7|||
127956964|NCT00281957|460461133|FG001|Overall Study|Adverse Event|2|||
127956965|NCT00281957|460461132|FG000|Overall Study|Death|1|||
127956966|NCT00281957|460461133|FG001|Overall Study|Death|0|||
127956967|NCT00281957|460461132|FG000|Overall Study|Progression/relapse|47|||
127956968|NCT00281957|460461133|FG001|Overall Study|Progression/relapse|35|||
127956969|NCT00281957|460461132|FG000|Overall Study|Not protocol specified|8|||
127956970|NCT00281957|460461133|FG001|Overall Study|Not protocol specified|1|||
127956971|NCT00281957|460461132|FG000|Overall Study|Not eligible|1|||
127956972|NCT00281957|460461133|FG001|Overall Study|Not eligible|2|||
127956973|NCT00281957|460461132|FG000|Overall Study|Did not start treatment|3|||
127956974|NCT00281957|460461133|FG001|Overall Study|Did not start treatment|1|||
127956975|NCT00281957|460461132|FG000|Overall Study|Refusal unrelated to adverse events|0|||
127956976|NCT00281957|460461133|FG001|Overall Study|Refusal unrelated to adverse events|1|||
127956977|NCT01876446|460461134|FG000|Overall Study|Death|0|||
127956978|NCT01876446|460461135|FG001|Overall Study|Death|1|||
127956979|NCT01876446|460461134|FG000|Overall Study|Withdrawal by Subject|1|||
127956980|NCT01876446|460461135|FG001|Overall Study|Withdrawal by Subject|2|||
127956981|NCT01876446|460461134|FG000|Overall Study|Physician Decision|1|||
127956982|NCT01876446|460461135|FG001|Overall Study|Physician Decision|3|||
127956983|NCT00822692|460461138|FG000|Overall Study|Lost to Follow-up|17|||
127956984|NCT00822692|460461139|FG001|Overall Study|Lost to Follow-up|25|||
127956985|NCT01256502|460461142|FG000|Overall Study|Had scaffold removed|4|||
127956986|NCT01256502|460461142|FG000|Overall Study|Personal reasons|5|||
127956987|NCT01256502|460461142|FG000|Overall Study|Protocol deviation|1|||
127956988|NCT01523002|460461143|FG000|Period 1|Withdrawal by Subject|1|||
127956989|NCT01523002|460461144|FG001|Period 1|Withdrawal by Subject|3|||
127956990|NCT01523002|460461143|FG000|Period 1|Lost to Follow-up|1|||
127956991|NCT01523002|460461144|FG001|Period 1|Lost to Follow-up|0|||
127956992|NCT01523002|460461143|FG000|Period 1|Adverse Event|0|||
127956993|NCT01523002|460461144|FG001|Period 1|Adverse Event|8|||
127956994|NCT01523002|460461143|FG000|Period 2|Withdrawal by Subject|4|||
127956995|NCT01523002|460461144|FG001|Period 2|Withdrawal by Subject|1|||
127956996|NCT01523002|460461143|FG000|Period 2|Adverse Event|2|||
127956997|NCT01523002|460461144|FG001|Period 2|Adverse Event|5|||
127956998|NCT01523002|460461143|FG000|Period 3|Withdrawal by Subject|1|||
127956999|NCT01523002|460461144|FG001|Period 3|Withdrawal by Subject|0|||
127957000|NCT01523002|460461143|FG000|Period 3|Adverse Event|3|||
127957001|NCT01523002|460461144|FG001|Period 3|Adverse Event|0|||
127957002|NCT03953612|460461145|FG000|Overall Study|Randomized but did not start|1|||
127957003|NCT03953612|460461146|FG001|Overall Study|Randomized but did not start|1|||
127957004|NCT03953612|460461147|FG002|Overall Study|Randomized but did not start|1|||
127957005|NCT03953612|460461145|FG000|Overall Study|Withdrawal by Subject|2|||
127957006|NCT03953612|460461146|FG001|Overall Study|Withdrawal by Subject|1|||
127957007|NCT03953612|460461147|FG002|Overall Study|Withdrawal by Subject|0|||
127957008|NCT02603146|460463148|FG000|Overall Study|Lost to Follow-up|5|||
127957009|NCT02603146|460463149|FG001|Overall Study|Lost to Follow-up|6|||
127957010|NCT02603146|460463148|FG000|Overall Study|Withdrawal by Subject|8|||
127957011|NCT02603146|460463149|FG001|Overall Study|Withdrawal by Subject|10|||
127957012|NCT02603146|460463148|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
127957013|NCT02603146|460463149|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
127957014|NCT02603146|460463148|FG000|Overall Study|Participant moved|2|||
127957015|NCT02603146|460463149|FG001|Overall Study|Participant moved|0|||
127957016|NCT02603146|460463148|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
127957017|NCT02603146|460463149|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
127957018|NCT00696423|460463150|FG000|Overall Study|Lost to Follow-up|0|||
127957019|NCT00696423|460463151|FG001|Overall Study|Lost to Follow-up|5|||
127957020|NCT03989102|460463152|FG000|Year 1|Withdrawal by Subject|6|||
127957021|NCT03989102|460463153|FG001|Year 1|Withdrawal by Subject|2|||
127957022|NCT03989102|460463154|FG002|Year 1|Withdrawal by Subject|7|||
127957023|NCT03989102|460463152|FG000|Year 1|Lost to Follow-up|5|||
127957024|NCT03989102|460463153|FG001|Year 1|Lost to Follow-up|2|||
127957025|NCT03989102|460463154|FG002|Year 1|Lost to Follow-up|5|||
127957026|NCT03989102|460463152|FG000|Year 1|Subject met withdrawal criteria|1|||
127957027|NCT03989102|460463153|FG001|Year 1|Subject met withdrawal criteria|0|||
127957028|NCT03989102|460463154|FG002|Year 1|Subject met withdrawal criteria|1|||
127957029|NCT03989102|460463152|FG000|Year 2|Lost to Follow-up|7|||
127957030|NCT03989102|460463153|FG001|Year 2|Lost to Follow-up|3|||
127957031|NCT03989102|460463154|FG002|Year 2|Lost to Follow-up|4|||
127957032|NCT03989102|460463152|FG000|Year 2|Withdrawal by Subject|3|||
127957033|NCT03989102|460463153|FG001|Year 2|Withdrawal by Subject|1|||
127957034|NCT03989102|460463154|FG002|Year 2|Withdrawal by Subject|2|||
127957035|NCT03989102|460463152|FG000|Year 2|Subject non-compliant|3|||
127957036|NCT03989102|460463153|FG001|Year 2|Subject non-compliant|2|||
127957037|NCT03989102|460463154|FG002|Year 2|Subject non-compliant|0|||
127957038|NCT03989102|460463152|FG000|Year 2|Travel|1|||
127957039|NCT03989102|460463153|FG001|Year 2|Travel|0|||
127957040|NCT03989102|460463154|FG002|Year 2|Travel|1|||
127957041|NCT03989102|460463152|FG000|Year 2|P16 missing|4|||
127957042|NCT03989102|460463153|FG001|Year 2|P16 missing|2|||
127957043|NCT03989102|460463154|FG002|Year 2|P16 missing|1|||
127957044|NCT03989102|460463152|FG000|Year 2|P11 missing|1|||
127957045|NCT03989102|460463153|FG001|Year 2|P11 missing|3|||
127957046|NCT03989102|460463154|FG002|Year 2|P11 missing|7|||
127957047|NCT03989102|460463152|FG000|Year 2|Definitive displacement outside the study site|0|||
127957048|NCT03989102|460463153|FG001|Year 2|Definitive displacement outside the study site|1|||
127957049|NCT03989102|460463154|FG002|Year 2|Definitive displacement outside the study site|0|||
127957050|NCT03989102|460463152|FG000|Year 2|Subject missed last study visit|0|||
127957051|NCT03989102|460463153|FG001|Year 2|Subject missed last study visit|1|||
127957052|NCT03989102|460463154|FG002|Year 2|Subject missed last study visit|0|||
127957053|NCT03989102|460463152|FG000|Year 2|Death|0|||
127957054|NCT03989102|460463153|FG001|Year 2|Death|1|||
127957055|NCT03989102|460463154|FG002|Year 2|Death|0|||
127957056|NCT03989102|460463152|FG000|Year 2|Subject not reachable|0|||
127957057|NCT03989102|460463153|FG001|Year 2|Subject not reachable|0|||
127957058|NCT03989102|460463154|FG002|Year 2|Subject not reachable|1|||
127957059|NCT03989102|460463152|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|1|||
127957060|NCT03989102|460463153|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
127957061|NCT03989102|460463154|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
127957062|NCT03989102|460463152|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
127957063|NCT03989102|460463153|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
127957064|NCT03989102|460463154|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
127957065|NCT03989102|460463152|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|1|||
127957066|NCT03989102|460463153|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
127957067|NCT03989102|460463154|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
127957068|NCT03989102|460463152|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|2|||
127957069|NCT03989102|460463153|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|1|||
127957070|NCT03989102|460463154|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|0|||
127957071|NCT03989102|460463152|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
127957072|NCT03989102|460463153|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Travel|3|||
127957073|NCT03989102|460463154|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
127957074|NCT03989102|460463152|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
127957075|NCT03989102|460463153|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
127957076|NCT03989102|460463154|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|1|||
127957077|NCT03642262|460463155|FG000|Period 1|Withdrawal by Subject|1|||
127957078|NCT03642262|460463156|FG001|Period 1|Withdrawal by Subject|1|||
127957079|NCT03642262|460463155|FG000|Period 1|Adverse Event|0|||
127957080|NCT03642262|460463156|FG001|Period 1|Adverse Event|1|||
127957081|NCT02203357|460463159|FG000|Overall Study|Lost to Follow-up|58|||
127957082|NCT02203357|460463160|FG001|Overall Study|Lost to Follow-up|66|||
127957083|NCT02203357|460463161|FG002|Overall Study|Lost to Follow-up|70|||
127957084|NCT01050530|460463162|FG000|Overall Study|Adverse Event|6|||
127957085|NCT01050530|460463163|FG001|Overall Study|Adverse Event|3|||
127957086|NCT01050530|460463162|FG000|Overall Study|Lack of Efficacy|1|||
127957087|NCT01050530|460463163|FG001|Overall Study|Lack of Efficacy|4|||
127957088|NCT01050530|460463162|FG000|Overall Study|Withdrawal by Subject|0|||
127957089|NCT01050530|460463163|FG001|Overall Study|Withdrawal by Subject|3|||
127957090|NCT01050530|460463162|FG000|Overall Study|Protocol Violation|1|||
127957091|NCT01050530|460463163|FG001|Overall Study|Protocol Violation|0|||
127957092|NCT02288312|460463164|FG000|Overall Study|Pregnancy|1|||
127957093|NCT02288312|460463165|FG001|Overall Study|Pregnancy|0|||
127957094|NCT02288312|460463166|FG002|Overall Study|Pregnancy|0|||
127957095|NCT01276041|460463167|FG000|Overall Study|Adverse Event|2|||
127957096|NCT01276041|460463167|FG000|Overall Study|Protocol Violation|1|||
127957097|NCT00485264|460463170|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
127957098|NCT00485264|460463171|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
127957099|NCT00485264|460463172|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
127957100|NCT00485264|460463173|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
127957101|NCT00485264|460463174|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
127957102|NCT00485264|460463175|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
127957103|NCT00485264|460463170|FG000|Overall Study|Death|1|||
127957104|NCT00485264|460463171|FG001|Overall Study|Death|0|||
127957105|NCT00485264|460463172|FG002|Overall Study|Death|0|||
127957106|NCT00485264|460463173|FG003|Overall Study|Death|0|||
127957107|NCT00485264|460463174|FG004|Overall Study|Death|1|||
127957108|NCT00485264|460463175|FG005|Overall Study|Death|0|||
127957109|NCT00485264|460463170|FG000|Overall Study|Adverse Event|1|||
127957110|NCT00485264|460463171|FG001|Overall Study|Adverse Event|0|||
127957111|NCT00485264|460463172|FG002|Overall Study|Adverse Event|2|||
127957112|NCT00485264|460463173|FG003|Overall Study|Adverse Event|3|||
127957113|NCT00485264|460463174|FG004|Overall Study|Adverse Event|1|||
127957114|NCT00485264|460463175|FG005|Overall Study|Adverse Event|3|||
127957115|NCT00485264|460463170|FG000|Overall Study|Pregnancy|4|||
127957116|NCT00485264|460463171|FG001|Overall Study|Pregnancy|0|||
127957117|NCT00485264|460463172|FG002|Overall Study|Pregnancy|0|||
127957118|NCT00485264|460463173|FG003|Overall Study|Pregnancy|0|||
127957119|NCT00485264|460463174|FG004|Overall Study|Pregnancy|0|||
127957120|NCT00485264|460463175|FG005|Overall Study|Pregnancy|0|||
127957121|NCT00485264|460463170|FG000|Overall Study|Disallowed Medication|0|||
127957122|NCT00485264|460463171|FG001|Overall Study|Disallowed Medication|0|||
127957123|NCT00485264|460463172|FG002|Overall Study|Disallowed Medication|0|||
127957124|NCT00485264|460463173|FG003|Overall Study|Disallowed Medication|0|||
127957125|NCT00485264|460463174|FG004|Overall Study|Disallowed Medication|0|||
127957126|NCT00485264|460463175|FG005|Overall Study|Disallowed Medication|1|||
127957127|NCT00485264|460463170|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
127957128|NCT00485264|460463171|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
127957129|NCT00485264|460463172|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
127957130|NCT00485264|460463173|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
127957131|NCT00485264|460463174|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
127957132|NCT00485264|460463175|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
127957133|NCT00485264|460463170|FG000|Overall Study|Lack of Efficacy|0|||
127957134|NCT00485264|460463171|FG001|Overall Study|Lack of Efficacy|1|||
127957135|NCT00485264|460463172|FG002|Overall Study|Lack of Efficacy|0|||
127957136|NCT00485264|460463173|FG003|Overall Study|Lack of Efficacy|0|||
127957137|NCT00485264|460463174|FG004|Overall Study|Lack of Efficacy|0|||
127957138|NCT00485264|460463175|FG005|Overall Study|Lack of Efficacy|0|||
127957139|NCT00485264|460463170|FG000|Overall Study|Guardian Consent Withdrawn|1|||
127957140|NCT00485264|460463171|FG001|Overall Study|Guardian Consent Withdrawn|0|||
127957141|NCT00485264|460463172|FG002|Overall Study|Guardian Consent Withdrawn|0|||
127957142|NCT00485264|460463173|FG003|Overall Study|Guardian Consent Withdrawn|0|||
127957143|NCT00485264|460463174|FG004|Overall Study|Guardian Consent Withdrawn|1|||
127957144|NCT00485264|460463175|FG005|Overall Study|Guardian Consent Withdrawn|0|||
127957145|NCT00485264|460463170|FG000|Overall Study|Physician Decision|0|||
127957146|NCT00485264|460463171|FG001|Overall Study|Physician Decision|2|||
127957147|NCT00485264|460463172|FG002|Overall Study|Physician Decision|0|||
127957148|NCT00485264|460463173|FG003|Overall Study|Physician Decision|0|||
127957149|NCT00485264|460463174|FG004|Overall Study|Physician Decision|0|||
127957150|NCT00485264|460463175|FG005|Overall Study|Physician Decision|0|||
127957151|NCT00485264|460463170|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
127957152|NCT00485264|460463171|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
127957153|NCT00485264|460463172|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
127957154|NCT00485264|460463173|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
127957155|NCT00485264|460463174|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
127957156|NCT00485264|460463175|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
127957157|NCT00485264|460463170|FG000|Overall Study|Not Able to Attend Clinic|5|||
127957158|NCT00485264|460463171|FG001|Overall Study|Not Able to Attend Clinic|0|||
127957159|NCT00485264|460463172|FG002|Overall Study|Not Able to Attend Clinic|0|||
127957160|NCT00485264|460463173|FG003|Overall Study|Not Able to Attend Clinic|1|||
127957161|NCT00485264|460463174|FG004|Overall Study|Not Able to Attend Clinic|1|||
127957162|NCT00485264|460463175|FG005|Overall Study|Not Able to Attend Clinic|2|||
127957163|NCT00485264|460463170|FG000|Overall Study|Non-Compliant|17|||
127957164|NCT00485264|460463171|FG001|Overall Study|Non-Compliant|2|||
127957165|NCT00485264|460463172|FG002|Overall Study|Non-Compliant|1|||
127957166|NCT00485264|460463173|FG003|Overall Study|Non-Compliant|0|||
127957167|NCT00485264|460463174|FG004|Overall Study|Non-Compliant|1|||
127957168|NCT00485264|460463175|FG005|Overall Study|Non-Compliant|0|||
127957169|NCT00485264|460463170|FG000|Overall Study|Lost to Follow-up|2|||
127957170|NCT00485264|460463171|FG001|Overall Study|Lost to Follow-up|1|||
127957171|NCT00485264|460463172|FG002|Overall Study|Lost to Follow-up|1|||
127957172|NCT00485264|460463173|FG003|Overall Study|Lost to Follow-up|0|||
127957173|NCT00485264|460463174|FG004|Overall Study|Lost to Follow-up|0|||
127957174|NCT00485264|460463175|FG005|Overall Study|Lost to Follow-up|1|||
127957175|NCT00485264|460463170|FG000|Overall Study|Other Reason|3|||
127957176|NCT00485264|460463171|FG001|Overall Study|Other Reason|0|||
127957177|NCT00485264|460463172|FG002|Overall Study|Other Reason|0|||
127957178|NCT00485264|460463173|FG003|Overall Study|Other Reason|0|||
127957179|NCT00485264|460463174|FG004|Overall Study|Other Reason|0|||
127957180|NCT00485264|460463175|FG005|Overall Study|Other Reason|0|||
127957181|NCT00654095|460463177|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
127957182|NCT00654095|460463177|FG000|Overall Study|Elevated triglyceride level (2)|1|||
127957183|NCT00654095|460463177|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
127957184|NCT00654095|460463177|FG000|Overall Study|Adverse Event|11|||
127957185|NCT00654095|460463177|FG000|Overall Study|Withdrawal by Subject|5|||
127957186|NCT00654095|460463177|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
127957187|NCT00654095|460463177|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
127957188|NCT00654095|460463177|FG000|Overall Study|Did not meet inclusion criteria|1|||
127957189|NCT02440464|460463178|FG000|Overall Study|Withdrawal by Subject|3|||
127957190|NCT02440464|460463179|FG001|Overall Study|Withdrawal by Subject|2|||
127957191|NCT01431079|460463180|FG000|Overall Study|Lost to Follow-up|35|||
127957192|NCT01431079|460463181|FG001|Overall Study|Lost to Follow-up|39|||
127957193|NCT00110396|460463182|FG000|Overall Study|Adverse Event|15|||
127957194|NCT00110396|460463182|FG000|Overall Study|Lost to Follow-up|1|||
127957195|NCT00110396|460463182|FG000|Overall Study|Administration of plasmapheresis|1|||
127957196|NCT00110396|460463182|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
127957197|NCT00110396|460463182|FG000|Overall Study|Lack of Efficacy|1|||
127957198|NCT00110396|460463182|FG000|Overall Study|Decided not to continue treatment|1|||
127957199|NCT00110396|460463182|FG000|Overall Study|Patient non-compliance|1|||
127957200|NCT00110396|460463182|FG000|Overall Study|Patient refused to continue|1|||
127957201|NCT00110396|460463182|FG000|Overall Study|Patient refused to participate|1|||
127957202|NCT00110396|460463182|FG000|Overall Study|Patient will|1|||
127957203|NCT00110396|460463182|FG000|Overall Study|Patient's decision|1|||
127957204|NCT00110396|460463182|FG000|Overall Study|Participation in MS vaccine study|1|||
127957205|NCT00110396|460463182|FG000|Overall Study|Pregnancy|1|||
127957206|NCT00110396|460463182|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
127957207|NCT00110396|460463182|FG000|Overall Study|Protocol Violation|2|||
127957208|NCT00110396|460463182|FG000|Overall Study|Patient refused to come back|1|||
127957209|NCT00110396|460463182|FG000|Overall Study|The patient has refused|2|||
127957210|NCT00110396|460463182|FG000|Overall Study|The patient has refused to visit site|1|||
127957211|NCT00110396|460463182|FG000|Overall Study|Patient is to be administered copaxone|1|||
127957212|NCT00245466|460463184|FG000|Overall Study|Adverse Event|2|||
127957213|NCT00245466|460463185|FG001|Overall Study|Adverse Event|8|||
127957214|NCT00245466|460463186|FG002|Overall Study|Adverse Event|4|||
127957215|NCT00245466|460463184|FG000|Overall Study|Low prostate specific antigen suppr|16|||
127957216|NCT00245466|460463185|FG001|Overall Study|Low prostate specific antigen suppr|14|||
127957217|NCT00245466|460463186|FG002|Overall Study|Low prostate specific antigen suppr|5|||
127957218|NCT00245466|460463184|FG000|Overall Study|Insufficient testosterone suppr|12|||
127957219|NCT00245466|460463185|FG001|Overall Study|Insufficient testosterone suppr|12|||
127957220|NCT00245466|460463186|FG002|Overall Study|Insufficient testosterone suppr|21|||
127957221|NCT00245466|460463184|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
127957222|NCT00245466|460463185|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
127957223|NCT00245466|460463186|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
127957224|NCT00245466|460463184|FG000|Overall Study|Withdrawal by Subject|2|||
127957225|NCT00245466|460463185|FG001|Overall Study|Withdrawal by Subject|2|||
127957226|NCT00245466|460463186|FG002|Overall Study|Withdrawal by Subject|1|||
127957227|NCT00245466|460463184|FG000|Overall Study|Lost to Follow-up|3|||
127957228|NCT00245466|460463185|FG001|Overall Study|Lost to Follow-up|0|||
127957229|NCT00245466|460463186|FG002|Overall Study|Lost to Follow-up|0|||
127957230|NCT00245466|460463184|FG000|Overall Study|Disease progression|0|||
127957231|NCT00245466|460463185|FG001|Overall Study|Disease progression|3|||
127957232|NCT00245466|460463186|FG002|Overall Study|Disease progression|1|||
127957233|NCT00245466|460463184|FG000|Overall Study|Protocol Violation|1|||
127957234|NCT00245466|460463185|FG001|Overall Study|Protocol Violation|2|||
127957235|NCT00245466|460463186|FG002|Overall Study|Protocol Violation|2|||
127957236|NCT00245466|460463184|FG000|Overall Study|Death|0|||
127957237|NCT00245466|460463185|FG001|Overall Study|Death|2|||
127957238|NCT00245466|460463186|FG002|Overall Study|Death|0|||
127957239|NCT00245466|460463184|FG000|Overall Study|Administrative reasons|0|||
127957240|NCT00245466|460463185|FG001|Overall Study|Administrative reasons|1|||
127957241|NCT00245466|460463186|FG002|Overall Study|Administrative reasons|0|||
127957242|NCT01958437|460463187|FG000|Overall Study|Incidental MRI findings|0|||
127957243|NCT01958437|460463188|FG001|Overall Study|Incidental MRI findings|0|||
127957244|NCT01958437|460463189|FG002|Overall Study|Incidental MRI findings|1|||
127957245|NCT01958437|460463190|FG003|Overall Study|Incidental MRI findings|1|||
127957246|NCT04886596|460463193|FG000|Overall Study|Adverse Event|442|||
127957247|NCT04886596|460463194|FG001|Overall Study|Adverse Event|441|||
127957248|NCT04886596|460463193|FG000|Overall Study|Lost to Follow-up|448|||
127957249|NCT04886596|460463194|FG001|Overall Study|Lost to Follow-up|465|||
127957250|NCT04886596|460463193|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|1715|||
127957251|NCT04886596|460463194|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|1726|||
127957252|NCT04886596|460463193|FG000|Overall Study|Migrated/moved from the study area|201|||
127957253|NCT04886596|460463194|FG001|Overall Study|Migrated/moved from the study area|184|||
127957254|NCT04886596|460463193|FG000|Overall Study|Other|298|||
127957255|NCT04886596|460463194|FG001|Overall Study|Other|326|||
127957256|NCT00948155|460463195|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
127957257|NCT00948155|460463196|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
127957258|NCT00948155|460463195|FG000|Washout 14 Days|Lost to Follow-up|1|||
127957259|NCT00948155|460463196|FG001|Washout 14 Days|Lost to Follow-up|2|||
127957260|NCT03473925|460463197|FG000|Overall Study|Death|48|||
127957261|NCT03473925|460463198|FG001|Overall Study|Death|44|||
127957262|NCT03473925|460463197|FG000|Overall Study|Sponsor Decision|2|||
127957263|NCT03473925|460463198|FG001|Overall Study|Sponsor Decision|7|||
127957264|NCT03473925|460463197|FG000|Overall Study|Withdrawal by Subject|1|||
127957265|NCT03473925|460463198|FG001|Overall Study|Withdrawal by Subject|3|||
127957266|NCT03473925|460463197|FG000|Overall Study|Not Treated|1|||
127957267|NCT03473925|460463198|FG001|Overall Study|Not Treated|1|||
127957268|NCT04661150|460463203|FG000|Overall Study|Ongoing in study|19|||
127957269|NCT04661150|460463204|FG001|Overall Study|Ongoing in study|20|||
127957270|NCT04661150|460463203|FG000|Overall Study|Refused surgery and for personal reasons.|0|||
127957271|NCT04661150|460463204|FG001|Overall Study|Refused surgery and for personal reasons.|1|||
127957272|NCT04661150|460463203|FG000|Overall Study|Death|2|||
127957273|NCT04661150|460463204|FG001|Overall Study|Death|0|||
127957274|NCT05198518|460463205|FG000|Screening Visit|Deemed unable to participate|58|||
127957275|NCT05198518|460463206|FG001|Screening Visit|Deemed unable to participate|0|||
127957276|NCT05198518|460463207|FG002|Screening Visit|Deemed unable to participate|0|||
127957277|NCT03125798|460463209|FG000|Overall Study|Lack of electrosurgical device in the operating room|2|||
127957278|NCT03125798|460463210|FG001|Overall Study|Lack of electrosurgical device in the operating room|0|||
127957279|NCT03125798|460463209|FG000|Overall Study|Conversion to thoracotomy|7|||
127957280|NCT03125798|460463210|FG001|Overall Study|Conversion to thoracotomy|7|||
127957281|NCT00065156|460463214|FG000|Overall Study|Adverse Event|37|||
127957282|NCT00065156|460463214|FG000|Overall Study|Lack of Efficacy|52|||
127957283|NCT00065156|460463214|FG000|Overall Study|Withdrawal by Subject|8|||
127957284|NCT00065156|460463214|FG000|Overall Study|Lost to Follow-up|1|||
127957285|NCT00065156|460463214|FG000|Overall Study|Death|11|||
127957286|NCT00065156|460463214|FG000|Overall Study|Study Closed by Sponsor|2|||
127957287|NCT00065156|460463214|FG000|Overall Study|Disease Progression|7|||
127957288|NCT00065156|460463214|FG000|Overall Study|Investigator Decision|2|||
127957289|NCT00065156|460463214|FG000|Overall Study|Non-Compliance|2|||
127957290|NCT00065156|460463214|FG000|Overall Study|Loss of Response|1|||
127957291|NCT00065156|460463214|FG000|Overall Study|Secondary Malign Disease|1|||
127957292|NCT00613171|460463215|FG000|Overall Study|Adverse Event|7|||
127957293|NCT00613171|460463215|FG000|Overall Study|Withdrawal by Subject|3|||
127957294|NCT00613171|460463215|FG000|Overall Study|Reason not Specified|4|||
127957295|NCT01197911|460463216|FG000|Overall Study|Adverse Event|0|||
127957296|NCT01197911|460463217|FG001|Overall Study|Adverse Event|0|||
127957297|NCT01197911|460463218|FG002|Overall Study|Adverse Event|1|||
127957298|NCT00951496|460463219|FG000|Overall Study|Did not initiate study treatment|10|||
127957299|NCT00951496|460463220|FG001|Overall Study|Did not initiate study treatment|8|||
127957300|NCT00951496|460463221|FG002|Overall Study|Did not initiate study treatment|13|||
127957301|NCT01526057|460463223|FG000|Overall Study|Withdrawal by Subject|3|||
127957302|NCT01526057|460463224|FG001|Overall Study|Withdrawal by Subject|2|||
127957303|NCT01526057|460463225|FG002|Overall Study|Withdrawal by Subject|2|||
127957304|NCT01526057|460463223|FG000|Overall Study|Adverse Event|3|||
127957305|NCT01526057|460463224|FG001|Overall Study|Adverse Event|1|||
127957306|NCT01526057|460463225|FG002|Overall Study|Adverse Event|1|||
127957307|NCT01526057|460463223|FG000|Overall Study|Death|1|||
127957308|NCT01526057|460463224|FG001|Overall Study|Death|0|||
127957309|NCT01526057|460463225|FG002|Overall Study|Death|0|||
127957310|NCT01526057|460463223|FG000|Overall Study|Lost to Follow-up|1|||
127957311|NCT01526057|460463224|FG001|Overall Study|Lost to Follow-up|0|||
127957312|NCT01526057|460463225|FG002|Overall Study|Lost to Follow-up|1|||
127957313|NCT01526057|460463223|FG000|Overall Study|Other|1|||
127957314|NCT01526057|460463224|FG001|Overall Study|Other|0|||
127957315|NCT01526057|460463225|FG002|Overall Study|Other|1|||
127957316|NCT01526057|460463223|FG000|Overall Study|Protocol Violation|0|||
127957317|NCT01526057|460463224|FG001|Overall Study|Protocol Violation|0|||
127957318|NCT01526057|460463225|FG002|Overall Study|Protocol Violation|1|||
127957319|NCT02189837|460463236|FG000|Overall Study|Withdrawal by Subject|2|||
127957320|NCT02189837|460463237|FG001|Overall Study|Withdrawal by Subject|1|||
127957321|NCT02189837|460463238|FG002|Overall Study|Withdrawal by Subject|3|||
127957322|NCT02189837|460463239|FG003|Overall Study|Withdrawal by Subject|1|||
127957323|NCT02189837|460463236|FG000|Overall Study|Sponsor Decision|0|||
127957324|NCT02189837|460463237|FG001|Overall Study|Sponsor Decision|0|||
127957325|NCT02189837|460463238|FG002|Overall Study|Sponsor Decision|0|||
127957326|NCT02189837|460463239|FG003|Overall Study|Sponsor Decision|1|||
127957327|NCT02443740|460463246|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
127957328|NCT02443740|460463247|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
127957329|NCT02443740|460463248|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
127957330|NCT02443740|460463249|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
127957331|NCT02443740|460463250|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
127957332|NCT02443740|460463251|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
127957333|NCT02443740|460463252|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
127957334|NCT02443740|460463253|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
127957335|NCT02443740|460463254|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
127957336|NCT02443740|460463255|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
127957337|NCT02443740|460463256|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
127957338|NCT02443740|460463246|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
127957339|NCT02443740|460463247|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
127957340|NCT02443740|460463248|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
127957341|NCT02443740|460463249|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
127957342|NCT02443740|460463250|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
127957343|NCT02443740|460463251|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
127957344|NCT02443740|460463252|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
127957345|NCT02443740|460463253|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
127957346|NCT02443740|460463254|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
127957347|NCT02443740|460463255|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
127957348|NCT02443740|460463256|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
127957349|NCT02443740|460463246|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
127957350|NCT02443740|460463247|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
127957351|NCT02443740|460463248|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
127957352|NCT02443740|460463249|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
127957353|NCT02443740|460463250|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
127957354|NCT02443740|460463251|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
127957355|NCT02443740|460463252|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
127957356|NCT02443740|460463253|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
127957357|NCT02443740|460463254|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
127957358|NCT02443740|460463255|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
127957359|NCT02443740|460463256|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
127957360|NCT00456300|460463257|FG000|Overall Study|Adverse Event|1|||
127957361|NCT00456300|460463258|FG001|Overall Study|Adverse Event|0|||
127957362|NCT01478373|460463259|FG000|Treatment Phase|Protocol Violation|1|||
127957363|NCT01478373|460463259|FG000|Survival Phase|Adverse Event|8|||
127957364|NCT01478373|460463259|FG000|Survival Phase|Protocol Violation|1|||
127957365|NCT01478373|460463259|FG000|Survival Phase|crossover to another study|2|||
127957366|NCT01478373|460463259|FG000|Survival Phase|Progressive Disease|27|||
127957367|NCT01074944|460463263|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
127957368|NCT01074944|460463264|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
127957369|NCT01074944|460463265|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
127957370|NCT01074944|460463266|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
127957371|NCT01074944|460463267|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
127957372|NCT01074944|460463263|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
127957373|NCT01074944|460463264|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
127957374|NCT01074944|460463265|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
127957375|NCT01074944|460463266|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
127957376|NCT01074944|460463267|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
127957377|NCT01074944|460463263|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
127957378|NCT01074944|460463264|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
127957379|NCT01074944|460463265|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
127957380|NCT01074944|460463266|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
127957381|NCT01074944|460463267|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
127957382|NCT01074944|460463263|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
127957383|NCT01074944|460463264|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
127957384|NCT01074944|460463265|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
127957385|NCT01074944|460463266|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
127957386|NCT01074944|460463267|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
127957387|NCT01074944|460463263|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
127957388|NCT01074944|460463264|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
127957389|NCT01074944|460463265|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
127957390|NCT01074944|460463266|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
127957391|NCT01074944|460463267|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
127957392|NCT01074944|460463263|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
127957393|NCT01074944|460463264|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
127957394|NCT01074944|460463265|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
127957395|NCT01074944|460463266|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
127957396|NCT01074944|460463267|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
127957397|NCT01074944|460463263|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
127957398|NCT01074944|460463264|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
127957399|NCT01074944|460463265|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
127957400|NCT01074944|460463266|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
127957401|NCT01074944|460463267|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
127957402|NCT01074944|460463263|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
127957403|NCT01074944|460463264|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
127957404|NCT01074944|460463265|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
127957405|NCT01074944|460463266|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
127957406|NCT01074944|460463267|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
127957407|NCT01074944|460463263|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
127957408|NCT01074944|460463264|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
127957409|NCT01074944|460463265|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
127957410|NCT01074944|460463266|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
127957411|NCT01074944|460463267|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
127957412|NCT01074944|460463263|FG000|Long Term Treatment|Adverse Event|0|||
127957413|NCT01074944|460463264|FG001|Long Term Treatment|Adverse Event|0|||
127957414|NCT01074944|460463265|FG002|Long Term Treatment|Adverse Event|0|||
127957415|NCT01074944|460463266|FG003|Long Term Treatment|Adverse Event|3|||
127957416|NCT01074944|460463267|FG004|Long Term Treatment|Adverse Event|0|||
127957417|NCT01074944|460463263|FG000|Long Term Treatment|Lost to Follow-up|0|||
127957418|NCT01074944|460463264|FG001|Long Term Treatment|Lost to Follow-up|0|||
127957419|NCT01074944|460463265|FG002|Long Term Treatment|Lost to Follow-up|0|||
127957420|NCT01074944|460463266|FG003|Long Term Treatment|Lost to Follow-up|2|||
127957421|NCT01074944|460463267|FG004|Long Term Treatment|Lost to Follow-up|0|||
127957422|NCT01074944|460463263|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
127957423|NCT01074944|460463264|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
127957424|NCT01074944|460463265|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
127957425|NCT01074944|460463266|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
127957426|NCT01074944|460463267|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
127957427|NCT01074944|460463263|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
127957428|NCT01074944|460463264|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
127957429|NCT01074944|460463265|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
127957430|NCT01074944|460463266|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
127957431|NCT01074944|460463267|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
127957432|NCT01074944|460463263|FG000|Long Term Treatment|Withdrawal by Subject|0|||
127957433|NCT01074944|460463264|FG001|Long Term Treatment|Withdrawal by Subject|0|||
127957434|NCT01074944|460463265|FG002|Long Term Treatment|Withdrawal by Subject|0|||
127957435|NCT01074944|460463266|FG003|Long Term Treatment|Withdrawal by Subject|2|||
127957436|NCT01074944|460463267|FG004|Long Term Treatment|Withdrawal by Subject|0|||
127957437|NCT01074944|460463263|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
127957438|NCT01074944|460463264|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
127957439|NCT01074944|460463265|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
127957440|NCT01074944|460463266|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
127957441|NCT01074944|460463267|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
127957442|NCT01074944|460463263|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
127957443|NCT01074944|460463264|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
127957444|NCT01074944|460463265|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
127957445|NCT01074944|460463266|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
127957446|NCT01074944|460463267|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
127957447|NCT02348112|460463268|FG000|Overall Study|Withdrawal by Subject|32|||
127957448|NCT02348112|460463269|FG001|Overall Study|Withdrawal by Subject|29|||
127957449|NCT02348112|460463268|FG000|Overall Study|Lost to Follow-up|24|||
127957450|NCT02348112|460463269|FG001|Overall Study|Lost to Follow-up|20|||
127957451|NCT02348112|460463268|FG000|Overall Study|Physician Decision|17|||
127957452|NCT02348112|460463269|FG001|Overall Study|Physician Decision|15|||
127957453|NCT02348112|460463268|FG000|Overall Study|Site closed due to PI leaving|0|||
127957454|NCT02348112|460463269|FG001|Overall Study|Site closed due to PI leaving|30|||
127957455|NCT02348112|460463268|FG000|Overall Study|Sponsor withdrawal|0|||
127957456|NCT02348112|460463269|FG001|Overall Study|Sponsor withdrawal|7|||
127957457|NCT02348112|460463268|FG000|Overall Study|Death|0|||
127957458|NCT02348112|460463269|FG001|Overall Study|Death|1|||
127957459|NCT03629184|460463278|FG000|Overall Study|Withdrawal by Subject|2|||
127957460|NCT03629184|460463279|FG001|Overall Study|Withdrawal by Subject|1|||
127957461|NCT03629184|460463278|FG000|Overall Study|Physician Decision|1|||
127957462|NCT03629184|460463279|FG001|Overall Study|Physician Decision|0|||
127957463|NCT02905032|460463281|FG000|Overall Study|Withdrawal by Subject|2|||
127957464|NCT02905032|460463282|FG001|Overall Study|Withdrawal by Subject|0|||
127957465|NCT02905032|460463283|FG002|Overall Study|Withdrawal by Subject|0|||
127957466|NCT02905032|460463281|FG000|Overall Study|Protocol Violation|6|||
127957467|NCT02905032|460463282|FG001|Overall Study|Protocol Violation|12|||
127957468|NCT02905032|460463283|FG002|Overall Study|Protocol Violation|0|||
127957469|NCT03447743|460463284|FG000|Overall Study|Withdrawal by Subject|2|||
127957470|NCT03447743|460463284|FG000|Overall Study|Lost to Follow-up|3|||
127957471|NCT03447743|460463284|FG000|Overall Study|Adverse Event|1|||
127957472|NCT03447743|460463284|FG000|Overall Study|Did not meet criteria to continue|1|||
127957473|NCT02046603|460463285|FG000|Overall Study|Other|11|||
127957474|NCT02046603|460463286|FG001|Overall Study|Other|66|||
127957475|NCT02046603|460463285|FG000|Overall Study|Protocol Violation|0|||
127957476|NCT02046603|460463286|FG001|Overall Study|Protocol Violation|1|||
127957477|NCT02046603|460463285|FG000|Overall Study|Participant/legal guardian decision|1|||
127957478|NCT02046603|460463286|FG001|Overall Study|Participant/legal guardian decision|3|||
127957479|NCT02046603|460463285|FG000|Overall Study|Physician Decision|2|||
127957480|NCT02046603|460463286|FG001|Overall Study|Physician Decision|1|||
127957481|NCT02046603|460463285|FG000|Overall Study|Lost to Follow-up|1|||
127957482|NCT02046603|460463286|FG001|Overall Study|Lost to Follow-up|2|||
127957483|NCT02046603|460463285|FG000|Overall Study|Death|0|||
127957484|NCT02046603|460463286|FG001|Overall Study|Death|1|||
127957485|NCT02046603|460463285|FG000|Overall Study|Adverse Event|0|||
127957486|NCT02046603|460463286|FG001|Overall Study|Adverse Event|1|||
127957487|NCT05101343|460463287|FG000|Overall Study|Withdrawal by Subject|2|||
127957488|NCT05101343|460463288|FG001|Overall Study|Withdrawal by Subject|1|||
127957489|NCT00193050|460463289|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
127957490|NCT00193050|460463289|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
127957491|NCT00193050|460463289|FG000|Neoadjuvant Treatment|Physician Decision|2|||
127957492|NCT00193050|460463289|FG000|Neoadjuvant Treatment|Adverse Event|2|||
127957493|NCT00193050|460463289|FG000|Adjuvant|Physician Decision|5|||
127957494|NCT00193050|460463289|FG000|Adjuvant|Intercurrent Hospitalization|3|||
127957495|NCT00193050|460463289|FG000|Adjuvant|Lack of Efficacy|2|||
127957496|NCT00061932|460463290|FG000|Overall Study|Withdrawal by Subject|13|||
127957497|NCT00061932|460463291|FG001|Overall Study|Withdrawal by Subject|4|||
127957498|NCT02575833|460463292|FG000|Overall Study|Withdrawal by Subject|0|||
127957499|NCT02575833|460463293|FG001|Overall Study|Withdrawal by Subject|1|||
127957500|NCT02575833|460463292|FG000|Overall Study|Lost to Follow-up|1|||
127957501|NCT02575833|460463293|FG001|Overall Study|Lost to Follow-up|0|||
127957502|NCT03093259|460463294|FG000|Overall Study|Adverse Event|1|||
127957503|NCT03093259|460463295|FG001|Overall Study|Adverse Event|0|||
127957504|NCT03093259|460463294|FG000|Overall Study|Withdrawal by Subject|1|||
127957505|NCT03093259|460463295|FG001|Overall Study|Withdrawal by Subject|0|||
127957506|NCT00445146|460463296|FG000|Overall Study|Withdrew Consent|29|||
127957507|NCT00445146|460463296|FG000|Overall Study|Lack of Efficacy|28|||
127957508|NCT00445146|460463296|FG000|Overall Study|Investigator's Discretion|22|||
127957509|NCT00445146|460463296|FG000|Overall Study|Adverse Event|13|||
127957510|NCT00445146|460463296|FG000|Overall Study|Lost to Follow-up|13|||
127957511|NCT00445146|460463296|FG000|Overall Study|Death|9|||
127957512|NCT00445146|460463296|FG000|Overall Study|Protocol Violation|4|||
127957513|NCT00445146|460463296|FG000|Overall Study|Pregnancy|1|||
127957514|NCT00625820|460463297|FG000|Overall Study|Withdrawal by Subject|1|||
127957515|NCT03759392|460463298|FG000|Overall Study|Adverse Event|12|||
127957516|NCT03759392|460463299|FG001|Overall Study|Adverse Event|4|||
127957517|NCT03759392|460463298|FG000|Overall Study|Death|2|||
127957518|NCT03759392|460463299|FG001|Overall Study|Death|1|||
127957519|NCT03759392|460463298|FG000|Overall Study|Withdrawal by Subject|2|||
127957520|NCT03759392|460463299|FG001|Overall Study|Withdrawal by Subject|0|||
127957521|NCT03759392|460463298|FG000|Overall Study|Protocol Violation|2|||
127957522|NCT03759392|460463299|FG001|Overall Study|Protocol Violation|0|||
127957523|NCT03759392|460463298|FG000|Overall Study|Physician Decision|0|||
127957524|NCT03759392|460463299|FG001|Overall Study|Physician Decision|1|||
127957525|NCT03759392|460463298|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
127957526|NCT03759392|460463299|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
127957527|NCT03759392|460463298|FG000|Overall Study|No longer able to take medicines|1|||
127957528|NCT03759392|460463299|FG001|Overall Study|No longer able to take medicines|0|||
127957529|NCT03759392|460463298|FG000|Overall Study|Stopped taking study drug|1|||
127957530|NCT03759392|460463299|FG001|Overall Study|Stopped taking study drug|0|||
127957531|NCT00967330|460463301|FG000|Overall Study|Protocol Violation|3|||
127957532|NCT00967330|460463302|FG001|Overall Study|Protocol Violation|4|||
127957533|NCT00967330|460463301|FG000|Overall Study|Regular|10|||
127957534|NCT00967330|460463302|FG001|Overall Study|Regular|3|||
127957535|NCT00967330|460463301|FG000|Overall Study|Withdrawal by Subject|6|||
127957536|NCT00967330|460463302|FG001|Overall Study|Withdrawal by Subject|0|||
127957537|NCT00967330|460463301|FG000|Overall Study|Lost to Follow-up|1|||
127957538|NCT00967330|460463302|FG001|Overall Study|Lost to Follow-up|1|||
127957539|NCT00967330|460463301|FG000|Overall Study|Death|102|||
127957540|NCT00967330|460463302|FG001|Overall Study|Death|51|||
127957541|NCT00967330|460463301|FG000|Overall Study|Severe protocol deviation|0|||
127957542|NCT00967330|460463302|FG001|Overall Study|Severe protocol deviation|1|||
127957543|NCT02623725|460463303|FG000|Overall Study|Non compliance with protocol|9|||
127957544|NCT02623725|460463304|FG001|Overall Study|Non compliance with protocol|3|||
127957545|NCT02623725|460463303|FG000|Overall Study|Serious adverse event|0|||
127957546|NCT02623725|460463304|FG001|Overall Study|Serious adverse event|2|||
127957547|NCT02623725|460463303|FG000|Overall Study|Withdrawal by Subject|7|||
127957548|NCT02623725|460463304|FG001|Overall Study|Withdrawal by Subject|1|||
127957549|NCT02548143|460463305|FG000|Overall Study|Adverse Event|1|||
127957550|NCT02548143|460463306|FG001|Overall Study|Adverse Event|0|||
127957551|NCT02548143|460463305|FG000|Overall Study|Withdrawal by Subject|0|||
127957552|NCT02548143|460463306|FG001|Overall Study|Withdrawal by Subject|1|||
127957553|NCT01402570|460465385|FG000|Overall Study|Adverse Event|1|||
127957554|NCT01290068|460465392|FG000|Overall Study|Adverse Event|1|||
127957555|NCT01290068|460465393|FG001|Overall Study|Adverse Event|3|||
127957556|NCT01290068|460465392|FG000|Overall Study|Lost to Follow-up|3|||
127957557|NCT01290068|460465393|FG001|Overall Study|Lost to Follow-up|0|||
127957558|NCT01290068|460465392|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
127957559|NCT01290068|460465393|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
127957560|NCT01290068|460465392|FG000|Overall Study|Other|3|||
127957561|NCT01290068|460465393|FG001|Overall Study|Other|1|||
127957562|NCT01417156|460465398|FG000|Overall Study|Adverse Event|12|||
127957563|NCT01417156|460465398|FG000|Overall Study|Protocol Violation|2|||
127957564|NCT00882518|460465419|FG000|Overall Study|Adverse Event|9|||
127957565|NCT00882518|460465420|FG001|Overall Study|Adverse Event|18|||
127957566|NCT00882518|460465419|FG000|Overall Study|Withdrawal by Subject|9|||
127957567|NCT00882518|460465420|FG001|Overall Study|Withdrawal by Subject|13|||
127957568|NCT00882518|460465419|FG000|Overall Study|Lack of Efficacy|12|||
127957569|NCT00882518|460465420|FG001|Overall Study|Lack of Efficacy|9|||
127957570|NCT00882518|460465419|FG000|Overall Study|Severe non-compliance to protocol|3|||
127957571|NCT00882518|460465420|FG001|Overall Study|Severe non-compliance to protocol|1|||
127957572|NCT00882518|460465419|FG000|Overall Study|Incorrect enrolment|4|||
127957573|NCT00882518|460465420|FG001|Overall Study|Incorrect enrolment|2|||
127957574|NCT00882518|460465419|FG000|Overall Study|Central lab closure for National day|1|||
127957575|NCT00882518|460465420|FG001|Overall Study|Central lab closure for National day|0|||
127957576|NCT00882518|460465419|FG000|Overall Study|Allocating random number by mistake|0|||
127957577|NCT00882518|460465420|FG001|Overall Study|Allocating random number by mistake|1|||
127957578|NCT02137252|460465421|FG000|Overall Study|trial terminated early|2|||
127957579|NCT02137252|460465422|FG001|Overall Study|trial terminated early|1|||
127957580|NCT04620746|460465424|FG000|Overall Study|Adverse Event|2|||
127957581|NCT04620746|460465425|FG001|Overall Study|Adverse Event|0|||
127957582|NCT04620746|460465424|FG000|Overall Study|Uniterpretable skin test|1|||
127957583|NCT04620746|460465425|FG001|Overall Study|Uniterpretable skin test|0|||
127957584|NCT04620746|460465424|FG000|Overall Study|Withdrawal by Subject|0|||
127957585|NCT04620746|460465425|FG001|Overall Study|Withdrawal by Subject|1|||
127957586|NCT03411863|460465426|FG000|Overall Study|Withdrawal by Subject|3|||
127957587|NCT03411863|460465427|FG001|Overall Study|Withdrawal by Subject|1|||
127957588|NCT03411863|460465426|FG000|Overall Study|Physician Decision|0|||
127957589|NCT03411863|460465427|FG001|Overall Study|Physician Decision|1|||
127957590|NCT03535740|460465428|FG000|Overall Study|Death|44|||
127957591|NCT03535740|460465428|FG000|Overall Study|Lost to Follow-up|1|||
127957592|NCT03535740|460465428|FG000|Overall Study|Withdrawal by Subject|13|||
127957593|NCT03535740|460465428|FG000|Overall Study|Site terminated by Sponsor|45|||
127957594|NCT02756611|460465435|FG000|Overall Study|Death|70|||
127957595|NCT02756611|460465435|FG000|Overall Study|Withdrawal by Subject|2|||
127957596|NCT02756611|460465435|FG000|Overall Study|Lost to Follow-up|3|||
127957597|NCT02756611|460465435|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
127957598|NCT02756611|460465435|FG000|Overall Study|Other|10|||
127957599|NCT00100828|460465436|FG000|Overall Study|Physician Decision|6|||
127957600|NCT03518008|460465437|FG000|Period 2, Second Week of Wear|Family emergency|0|||
127957601|NCT03518008|460465438|FG001|Period 2, Second Week of Wear|Family emergency|1|||
127957602|NCT01169350|460465439|FG000|Overall Study|Physician Decision|3|||
127957603|NCT01169350|460465439|FG000|Overall Study|Lost to Follow-up|2|||
127957604|NCT04338022|460465440|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|56|||
127957605|NCT04338022|460465441|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|72|||
127957606|NCT04338022|460465440|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|6|||
127957607|NCT04338022|460465441|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|5|||
127957608|NCT04338022|460465440|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|19|||
127957609|NCT04338022|460465441|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|23|||
127957610|NCT04338022|460465440|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|56|||
127957611|NCT04338022|460465441|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|55|||
127957612|NCT04338022|460465440|FG000|Double-blind Treatment Period: 156 Weeks|Death|1|||
127957613|NCT04338022|460465441|FG001|Double-blind Treatment Period: 156 Weeks|Death|1|||
127957614|NCT04338022|460465440|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
127957615|NCT04338022|460465441|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
127957616|NCT04338022|460465440|FG000|Double-blind Treatment Period: 156 Weeks|Other Reason|24|||
127957617|NCT04338022|460465441|FG001|Double-blind Treatment Period: 156 Weeks|Other Reason|14|||
127957618|NCT04338022|460465440|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
127957619|NCT04338022|460465441|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
127957620|NCT04338022|460465440|FG000|Double-blind Extension: 96 Weeks|Lack of Efficacy|1|||
127957621|NCT04338022|460465441|FG001|Double-blind Extension: 96 Weeks|Lack of Efficacy|2|||
127957622|NCT04338022|460465440|FG000|Double-blind Extension: 96 Weeks|Withdrawal by Subject|0|||
127957623|NCT04338022|460465441|FG001|Double-blind Extension: 96 Weeks|Withdrawal by Subject|1|||
127957624|NCT04338022|460465440|FG000|Double-blind Extension: 96 Weeks|Adverse Event|2|||
127957625|NCT04338022|460465441|FG001|Double-blind Extension: 96 Weeks|Adverse Event|0|||
127957626|NCT04338022|460465440|FG000|Double-blind Extension: 96 Weeks|Lost to Follow-up|0|||
127957627|NCT04338022|460465441|FG001|Double-blind Extension: 96 Weeks|Lost to Follow-up|1|||
127957628|NCT04338022|460465440|FG000|Double-blind Extension: 96 Weeks|Other Reason|3|||
127957629|NCT04338022|460465441|FG001|Double-blind Extension: 96 Weeks|Other Reason|9|||
127957630|NCT04338022|460465440|FG000|Open Label Extension: 96 Weeks|Study Termination|0|||
127957631|NCT04338022|460465441|FG001|Open Label Extension: 96 Weeks|Study Termination|3|||
127957632|NCT02860546|460465443|FG000|Overall Study|Clinical Progression|6|||
127957633|NCT02860546|460465443|FG000|Overall Study|Radiological Progression|12|||
127957634|NCT02466321|460465444|FG000|Overall Study|Death|26|||
127957635|NCT02466321|460465444|FG000|Overall Study|Revision|6|||
127957636|NCT02466321|460465444|FG000|Overall Study|Lost to Follow-up|60|||
127957637|NCT02466321|460465444|FG000|Overall Study|Did not receive study device|1|||
127957638|NCT06071754|460465445|FG000|Overall Study|Device rhythm classifications not obtained from subjects due to protocol not being completed|9|||
127957639|NCT00729937|460465446|FG000|Overall Study|Lost to Follow-up|49|||
127957640|NCT00729937|460465447|FG001|Overall Study|Lost to Follow-up|58|||
127957641|NCT00729937|460465448|FG002|Overall Study|Lost to Follow-up|18|||
127957642|NCT00729937|460465449|FG003|Overall Study|Lost to Follow-up|33|||
127957643|NCT00729937|460465450|FG004|Overall Study|Lost to Follow-up|18|||
127957644|NCT00729937|460465451|FG005|Overall Study|Lost to Follow-up|23|||
127957645|NCT00729937|460465446|FG000|Overall Study|Physician Decision|7|||
127957646|NCT00729937|460465447|FG001|Overall Study|Physician Decision|16|||
127957647|NCT00729937|460465448|FG002|Overall Study|Physician Decision|2|||
127957648|NCT00729937|460465449|FG003|Overall Study|Physician Decision|0|||
127957649|NCT00729937|460465450|FG004|Overall Study|Physician Decision|5|||
127957650|NCT00729937|460465451|FG005|Overall Study|Physician Decision|8|||
127957651|NCT00729937|460465446|FG000|Overall Study|Death|1|||
127957652|NCT00729937|460465447|FG001|Overall Study|Death|0|||
127957653|NCT00729937|460465448|FG002|Overall Study|Death|1|||
127957654|NCT00729937|460465449|FG003|Overall Study|Death|0|||
127957655|NCT00729937|460465450|FG004|Overall Study|Death|0|||
127957656|NCT00729937|460465451|FG005|Overall Study|Death|1|||
127957657|NCT00729937|460465446|FG000|Overall Study|Withdrawal by Subject|3|||
127957658|NCT00729937|460465447|FG001|Overall Study|Withdrawal by Subject|5|||
127957659|NCT00729937|460465448|FG002|Overall Study|Withdrawal by Subject|6|||
127957660|NCT00729937|460465449|FG003|Overall Study|Withdrawal by Subject|0|||
127957661|NCT00729937|460465450|FG004|Overall Study|Withdrawal by Subject|4|||
127957662|NCT00729937|460465451|FG005|Overall Study|Withdrawal by Subject|2|||
127957663|NCT00729937|460465446|FG000|Overall Study|Randomized but not treated|12|||
127957664|NCT00729937|460465447|FG001|Overall Study|Randomized but not treated|6|||
127957665|NCT00729937|460465448|FG002|Overall Study|Randomized but not treated|1|||
127957666|NCT00729937|460465449|FG003|Overall Study|Randomized but not treated|0|||
127957667|NCT00729937|460465450|FG004|Overall Study|Randomized but not treated|1|||
127957668|NCT00729937|460465451|FG005|Overall Study|Randomized but not treated|3|||
127957669|NCT00729937|460465446|FG000|Overall Study|Did not meet eligibility criteria|2|||
127957670|NCT00729937|460465447|FG001|Overall Study|Did not meet eligibility criteria|1|||
127957671|NCT00729937|460465448|FG002|Overall Study|Did not meet eligibility criteria|0|||
127957672|NCT00729937|460465449|FG003|Overall Study|Did not meet eligibility criteria|0|||
127957673|NCT00729937|460465450|FG004|Overall Study|Did not meet eligibility criteria|0|||
127957674|NCT00729937|460465451|FG005|Overall Study|Did not meet eligibility criteria|0|||
127957675|NCT00729937|460465446|FG000|Overall Study|Incarcerated|0|||
127957676|NCT00729937|460465447|FG001|Overall Study|Incarcerated|2|||
127957677|NCT00729937|460465448|FG002|Overall Study|Incarcerated|1|||
127957678|NCT00729937|460465449|FG003|Overall Study|Incarcerated|1|||
127957679|NCT00729937|460465450|FG004|Overall Study|Incarcerated|0|||
127957680|NCT00729937|460465451|FG005|Overall Study|Incarcerated|0|||
127957681|NCT00243412|460465452|FG000|Overall Study|Death|0|||
127957682|NCT00243412|460465453|FG001|Overall Study|Death|1|||
127957683|NCT00243412|460465452|FG000|Overall Study|Adverse Event|4|||
127957684|NCT00243412|460465453|FG001|Overall Study|Adverse Event|2|||
127957685|NCT00243412|460465452|FG000|Overall Study|Lost to Follow-up|0|||
127957686|NCT00243412|460465453|FG001|Overall Study|Lost to Follow-up|1|||
127957687|NCT00243412|460465452|FG000|Overall Study|Physician Decision|1|||
127957688|NCT00243412|460465453|FG001|Overall Study|Physician Decision|1|||
127957689|NCT00243412|460465452|FG000|Overall Study|Withdrawal by Subject|4|||
127957690|NCT00243412|460465453|FG001|Overall Study|Withdrawal by Subject|5|||
127957691|NCT00243412|460465452|FG000|Overall Study|Other|1|||
127957692|NCT00243412|460465453|FG001|Overall Study|Other|1|||
127957693|NCT03281876|460465462|FG000|Overall Study|Adverse Event|4|||
127957694|NCT03281876|460465463|FG001|Overall Study|Adverse Event|15|||
127957695|NCT03281876|460465462|FG000|Overall Study|Lost to Follow-up|1|||
127957696|NCT03281876|460465463|FG001|Overall Study|Lost to Follow-up|4|||
127957697|NCT03281876|460465462|FG000|Overall Study|Withdrawal by Subject|11|||
127957698|NCT03281876|460465463|FG001|Overall Study|Withdrawal by Subject|15|||
127957699|NCT03281876|460465462|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
127957700|NCT03281876|460465463|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127957701|NCT03281876|460465462|FG000|Overall Study|OTHER|5|||
127957702|NCT03281876|460465463|FG001|Overall Study|OTHER|5|||
127957703|NCT02208089|460465464|FG000|Overall Study|Withdrawal by Subject|1|||
127957704|NCT02208089|460465465|FG001|Overall Study|Withdrawal by Subject|0|||
127957705|NCT02208089|460465464|FG000|Overall Study|Lost to Follow-up|6|||
127957706|NCT02208089|460465465|FG001|Overall Study|Lost to Follow-up|0|||
127957707|NCT00683657|460465466|FG000|Overall Study|Adverse Event|0|||
127957708|NCT00683657|460465467|FG001|Overall Study|Adverse Event|1|||
127957709|NCT00683657|460465466|FG000|Overall Study|Subject Withdrew Consent|1|||
127957710|NCT00683657|460465467|FG001|Overall Study|Subject Withdrew Consent|0|||
127957711|NCT01408043|460465475|FG000|Overall Study|unable to collect cells|1|||
127957712|NCT01998841|460465476|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
127957713|NCT01998841|460465477|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
127957714|NCT01998841|460465478|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
127957715|NCT01998841|460465479|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
127957716|NCT01998841|460465480|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
127957717|NCT01998841|460465476|FG000|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
127957718|NCT01998841|460465477|FG001|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
127957719|NCT01998841|460465478|FG002|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
127957720|NCT01998841|460465479|FG003|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|7|||
127957721|NCT01998841|460465480|FG004|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|2|||
127957722|NCT00972595|460465481|FG000|Period 1|Adverse Event|1|||
127957723|NCT00972595|460465482|FG001|Period 1|Adverse Event|0|||
127957724|NCT02552121|460465483|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
127957725|NCT02552121|460465484|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
127957726|NCT02552121|460465485|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
127957727|NCT02552121|460465486|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
127957728|NCT02552121|460465487|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
127957729|NCT02552121|460465488|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
127957730|NCT02552121|460465489|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
127957731|NCT02552121|460465490|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
127957732|NCT02552121|460465483|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
127957733|NCT02552121|460465484|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
127957734|NCT02552121|460465485|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
127957735|NCT02552121|460465486|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
127957736|NCT02552121|460465487|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
127957737|NCT02552121|460465488|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
127957738|NCT02552121|460465489|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
127957739|NCT02552121|460465490|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
127957740|NCT02552121|460465483|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
127957741|NCT02552121|460465484|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
127957742|NCT02552121|460465485|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
127957743|NCT02552121|460465486|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
127957744|NCT02552121|460465487|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
127957745|NCT02552121|460465488|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
127957746|NCT02552121|460465489|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
127957747|NCT02552121|460465490|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
127957748|NCT02552121|460465483|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
127957749|NCT02552121|460465484|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
127957750|NCT02552121|460465485|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
127957751|NCT02552121|460465486|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
127957752|NCT02552121|460465487|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
127957753|NCT02552121|460465488|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
127957754|NCT02552121|460465489|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
127957755|NCT02552121|460465490|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
127957756|NCT02552121|460465483|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
127957757|NCT02552121|460465484|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
127957758|NCT02552121|460465485|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
127957759|NCT02552121|460465486|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
127957760|NCT02552121|460465487|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
127957761|NCT02552121|460465488|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
127957762|NCT02552121|460465489|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
127957763|NCT02552121|460465490|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
127957764|NCT02552121|460465483|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
127957765|NCT02552121|460465484|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
127957766|NCT02552121|460465485|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
127957767|NCT02552121|460465486|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
127957768|NCT02552121|460465487|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
127957769|NCT02552121|460465488|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
127957770|NCT02552121|460465489|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
127957771|NCT02552121|460465490|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
127957772|NCT02552121|460465483|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
127957773|NCT02552121|460465484|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
127957774|NCT02552121|460465485|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
127957775|NCT02552121|460465486|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
127868658|NCT01072175|460137388|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
127868659|NCT01072175|460137389|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
127957776|NCT02552121|460465487|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
127957777|NCT02552121|460465488|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
127957778|NCT02552121|460465489|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
127957779|NCT02552121|460465490|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
127957780|NCT02552121|460465483|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
127957781|NCT02552121|460465484|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
127957782|NCT02552121|460465485|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
127957783|NCT02552121|460465486|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
127957784|NCT02552121|460465487|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
127957785|NCT02552121|460465488|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
127957786|NCT02552121|460465489|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
127957787|NCT02552121|460465490|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
127957788|NCT02552121|460465483|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
127957789|NCT02552121|460465484|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
127957790|NCT02552121|460465485|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
127957791|NCT02552121|460465486|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
127957792|NCT02552121|460465487|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
127957793|NCT02552121|460465488|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
127957794|NCT02552121|460465489|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
127957795|NCT02552121|460465490|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
127957796|NCT02552121|460465483|FG000|Part 2: Cohort Expansion|Death|0|||
127957797|NCT02552121|460465484|FG001|Part 2: Cohort Expansion|Death|0|||
127957798|NCT02552121|460465485|FG002|Part 2: Cohort Expansion|Death|1|||
127957799|NCT02552121|460465486|FG003|Part 2: Cohort Expansion|Death|0|||
127957800|NCT02552121|460465487|FG004|Part 2: Cohort Expansion|Death|0|||
127957801|NCT02552121|460465488|FG005|Part 2: Cohort Expansion|Death|0|||
127957802|NCT02552121|460465489|FG006|Part 2: Cohort Expansion|Death|0|||
127957803|NCT02552121|460465490|FG007|Part 2: Cohort Expansion|Death|0|||
127957804|NCT00739063|460465493|FG000|Overall Study|Screen failures|8|||
127957805|NCT04779879|460465494|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
127957806|NCT04779879|460465495|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
127957807|NCT04779879|460465496|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
127957808|NCT04779879|460465497|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
127957809|NCT04779879|460465498|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
127957810|NCT04779879|460465499|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
127957811|NCT04779879|460465494|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
127957812|NCT04779879|460465495|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
127957813|NCT04779879|460465496|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
127957814|NCT04779879|460465497|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
127957815|NCT04779879|460465498|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
127957816|NCT04779879|460465499|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
127957817|NCT04779879|460465494|FG000|Part C: Up to Week 36|Death|0|||
127957818|NCT04779879|460465495|FG001|Part C: Up to Week 36|Death|0|||
127957819|NCT04779879|460465496|FG002|Part C: Up to Week 36|Death|0|||
127957820|NCT04779879|460465497|FG003|Part C: Up to Week 36|Death|0|||
127957821|NCT04779879|460465498|FG004|Part C: Up to Week 36|Death|0|||
127957822|NCT04779879|460465499|FG005|Part C: Up to Week 36|Death|1|||
127957823|NCT04779879|460465494|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
127957824|NCT04779879|460465495|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
127957825|NCT04779879|460465496|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
127957826|NCT04779879|460465497|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
127957827|NCT04779879|460465498|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
127957828|NCT04779879|460465499|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
127957829|NCT02854527|460465500|FG000|Overall Study|Adverse Event|0|||
127957830|NCT02854527|460465501|FG001|Overall Study|Adverse Event|0|||
127957831|NCT02854527|460465502|FG002|Overall Study|Adverse Event|0|||
127957832|NCT02854527|460465503|FG003|Overall Study|Adverse Event|0|||
127957833|NCT02854527|460465504|FG004|Overall Study|Adverse Event|1|||
127957834|NCT02854527|460465505|FG005|Overall Study|Adverse Event|0|||
127957835|NCT02854527|460465506|FG006|Overall Study|Adverse Event|0|||
127957836|NCT02854527|460465507|FG007|Overall Study|Adverse Event|0|||
127957837|NCT02854527|460465508|FG008|Overall Study|Adverse Event|0|||
127957838|NCT02854527|460465509|FG009|Overall Study|Adverse Event|0|||
127957839|NCT02854527|460465500|FG000|Overall Study|Lost to Follow-up|0|||
127957840|NCT02854527|460465501|FG001|Overall Study|Lost to Follow-up|0|||
127957841|NCT02854527|460465502|FG002|Overall Study|Lost to Follow-up|0|||
127957842|NCT02854527|460465503|FG003|Overall Study|Lost to Follow-up|1|||
127957843|NCT02854527|460465504|FG004|Overall Study|Lost to Follow-up|0|||
127957844|NCT02854527|460465505|FG005|Overall Study|Lost to Follow-up|0|||
127957845|NCT02854527|460465506|FG006|Overall Study|Lost to Follow-up|0|||
127957846|NCT02854527|460465507|FG007|Overall Study|Lost to Follow-up|0|||
127957847|NCT02854527|460465508|FG008|Overall Study|Lost to Follow-up|0|||
127957848|NCT02854527|460465509|FG009|Overall Study|Lost to Follow-up|0|||
127957849|NCT02461160|460465510|FG000|Overall Study|Lost to Follow-up|0|||
127957850|NCT02461160|460465511|FG001|Overall Study|Lost to Follow-up|0|||
127957851|NCT02461160|460465512|FG002|Overall Study|Lost to Follow-up|0|||
127957852|NCT02461160|460465513|FG003|Overall Study|Lost to Follow-up|0|||
127957853|NCT02461160|460465514|FG004|Overall Study|Lost to Follow-up|0|||
127957854|NCT02461160|460465515|FG005|Overall Study|Lost to Follow-up|0|||
127957855|NCT02461160|460465516|FG006|Overall Study|Lost to Follow-up|0|||
127957856|NCT02461160|460465517|FG007|Overall Study|Lost to Follow-up|1|||
127957857|NCT02461160|460465518|FG008|Overall Study|Lost to Follow-up|0|||
127957858|NCT02461160|460465519|FG009|Overall Study|Lost to Follow-up|0|||
127957859|NCT02461160|460465520|FG010|Overall Study|Lost to Follow-up|0|||
127957860|NCT02461160|460465521|FG011|Overall Study|Lost to Follow-up|0|||
127957861|NCT02461160|460465522|FG012|Overall Study|Lost to Follow-up|0|||
127957862|NCT02899962|460465523|FG000|Open-label Phase|Adverse Event|2|||
127957863|NCT02899962|460465524|FG001|Open-label Phase|Adverse Event|0|||
127957864|NCT02899962|460465525|FG002|Open-label Phase|Adverse Event|0|||
127957865|NCT02899962|460465523|FG000|Open-label Phase|Lost to Follow-up|9|||
127957866|NCT02899962|460465524|FG001|Open-label Phase|Lost to Follow-up|0|||
127957867|NCT02899962|460465525|FG002|Open-label Phase|Lost to Follow-up|0|||
127957868|NCT02899962|460465523|FG000|Open-label Phase|Other reasons|9|||
127957869|NCT02899962|460465524|FG001|Open-label Phase|Other reasons|0|||
127957870|NCT02899962|460465525|FG002|Open-label Phase|Other reasons|0|||
127957871|NCT02899962|460465523|FG000|Open-label Phase|Withdrawal by Subject|7|||
127957872|NCT02899962|460465524|FG001|Open-label Phase|Withdrawal by Subject|0|||
127957873|NCT02899962|460465525|FG002|Open-label Phase|Withdrawal by Subject|0|||
127957874|NCT02899962|460465523|FG000|Maintenance Phase|Adverse Event|0|||
127957875|NCT02899962|460465524|FG001|Maintenance Phase|Adverse Event|2|||
127957876|NCT02899962|460465525|FG002|Maintenance Phase|Adverse Event|1|||
127957877|NCT02899962|460465523|FG000|Maintenance Phase|Death|0|||
127957878|NCT02899962|460465524|FG001|Maintenance Phase|Death|0|||
127957879|NCT02899962|460465525|FG002|Maintenance Phase|Death|1|||
127957880|NCT02899962|460465523|FG000|Maintenance Phase|Lack of Efficacy|0|||
127957881|NCT02899962|460465524|FG001|Maintenance Phase|Lack of Efficacy|20|||
127957882|NCT02899962|460465525|FG002|Maintenance Phase|Lack of Efficacy|16|||
127957883|NCT02899962|460465523|FG000|Maintenance Phase|Lost to Follow-up|0|||
127957884|NCT02899962|460465524|FG001|Maintenance Phase|Lost to Follow-up|12|||
127957885|NCT02899962|460465525|FG002|Maintenance Phase|Lost to Follow-up|14|||
127957886|NCT02899962|460465523|FG000|Maintenance Phase|Other reasons|0|||
127957887|NCT02899962|460465524|FG001|Maintenance Phase|Other reasons|9|||
127957888|NCT02899962|460465525|FG002|Maintenance Phase|Other reasons|13|||
127957889|NCT02899962|460465523|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
127957890|NCT02899962|460465524|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
127957891|NCT02899962|460465525|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
127957892|NCT02899962|460465523|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
127957893|NCT02899962|460465524|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
127957894|NCT02899962|460465525|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
127957895|NCT02899962|460465523|FG000|Maintenance Phase|Withdrawal by Subject|0|||
127957896|NCT02899962|460465524|FG001|Maintenance Phase|Withdrawal by Subject|30|||
127957897|NCT02899962|460465525|FG002|Maintenance Phase|Withdrawal by Subject|36|||
127957898|NCT03567980|460465532|FG000|Overall Study|Adverse Event|1|||
127957899|NCT01821807|460465534|FG000|Overall Study|Lost to Follow-up|3|||
127957900|NCT01821807|460465535|FG001|Overall Study|Lost to Follow-up|1|||
127957901|NCT00550459|460465537|FG000|Overall Study|Adverse Event|0|||
127957902|NCT00550459|460465538|FG001|Overall Study|Adverse Event|2|||
127957903|NCT00550459|460465537|FG000|Overall Study|Withdrawal by Subject|1|||
127957904|NCT00550459|460465538|FG001|Overall Study|Withdrawal by Subject|1|||
127957905|NCT01742897|460465539|FG000|Overall Study|Adverse Event|3|||
127957906|NCT01742897|460465539|FG000|Overall Study|Withdrawal by Subject|1|||
127957907|NCT01742897|460465539|FG000|Overall Study|Other|1|||
127957908|NCT02404805|460465540|FG000|Overall Study|Withdrawal by Subject|1|||
127957909|NCT02404805|460465541|FG001|Overall Study|Withdrawal by Subject|0|||
127957910|NCT02404805|460465542|FG002|Overall Study|Withdrawal by Subject|0|||
127957911|NCT02404805|460465543|FG003|Overall Study|Withdrawal by Subject|0|||
127957912|NCT02404805|460465544|FG004|Overall Study|Withdrawal by Subject|0|||
127957913|NCT02404805|460465545|FG005|Overall Study|Withdrawal by Subject|0|||
127957914|NCT04871776|460465548|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
127957915|NCT04871776|460465549|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
127957916|NCT04871776|460465550|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
127957917|NCT04871776|460465548|FG000|Overall Study|Did not meet eligibility criteria|1|||
127957918|NCT04871776|460465549|FG001|Overall Study|Did not meet eligibility criteria|1|||
127957919|NCT04871776|460465550|FG002|Overall Study|Did not meet eligibility criteria|1|||
127957920|NCT05620082|460465556|FG000|Overall Study|Discharged before study end|1|||
127957921|NCT05620082|460465557|FG001|Overall Study|Discharged before study end|4|||
127957922|NCT05620082|460465558|FG002|Overall Study|Discharged before study end|0|||
127957923|NCT05620082|460465556|FG000|Overall Study|Moved to a different ward|1|||
127957924|NCT05620082|460465557|FG001|Overall Study|Moved to a different ward|0|||
127957925|NCT05620082|460465558|FG002|Overall Study|Moved to a different ward|0|||
127957926|NCT05620082|460465556|FG000|Overall Study|Feeling too unwell|1|||
127957927|NCT05620082|460465557|FG001|Overall Study|Feeling too unwell|0|||
127957928|NCT05620082|460465558|FG002|Overall Study|Feeling too unwell|0|||
127957929|NCT04075487|460467793|FG000|Overall Study|Withdrawal by Subject|1|||
127957930|NCT02721732|460467796|FG000|Overall Study|Adverse Event|2|||
127957931|NCT02721732|460467797|FG001|Overall Study|Adverse Event|0|||
127957932|NCT02721732|460467798|FG002|Overall Study|Adverse Event|2|||
127957933|NCT02721732|460467799|FG003|Overall Study|Adverse Event|0|||
127957934|NCT02721732|460467800|FG004|Overall Study|Adverse Event|1|||
127957935|NCT02721732|460467801|FG005|Overall Study|Adverse Event|0|||
127957936|NCT02721732|460467802|FG006|Overall Study|Adverse Event|1|||
127957937|NCT02721732|460467803|FG007|Overall Study|Adverse Event|0|||
127957938|NCT02721732|460467804|FG008|Overall Study|Adverse Event|1|||
127957939|NCT02721732|460467805|FG009|Overall Study|Adverse Event|1|||
127957940|NCT02721732|460467796|FG000|Overall Study|Death|0|||
127957941|NCT02721732|460467797|FG001|Overall Study|Death|0|||
127957942|NCT02721732|460467798|FG002|Overall Study|Death|0|||
127957943|NCT02721732|460467799|FG003|Overall Study|Death|0|||
127957944|NCT02721732|460467800|FG004|Overall Study|Death|1|||
127957945|NCT02721732|460467801|FG005|Overall Study|Death|0|||
127957946|NCT02721732|460467802|FG006|Overall Study|Death|1|||
127957947|NCT02721732|460467803|FG007|Overall Study|Death|0|||
127957948|NCT02721732|460467804|FG008|Overall Study|Death|0|||
127957949|NCT02721732|460467805|FG009|Overall Study|Death|1|||
127957950|NCT02721732|460467796|FG000|Overall Study|Lack of Efficacy|12|||
127957951|NCT02721732|460467797|FG001|Overall Study|Lack of Efficacy|11|||
127957952|NCT02721732|460467798|FG002|Overall Study|Lack of Efficacy|18|||
127957953|NCT02721732|460467799|FG003|Overall Study|Lack of Efficacy|5|||
127957954|NCT02721732|460467800|FG004|Overall Study|Lack of Efficacy|21|||
127957955|NCT02721732|460467801|FG005|Overall Study|Lack of Efficacy|2|||
127957956|NCT02721732|460467802|FG006|Overall Study|Lack of Efficacy|8|||
127957957|NCT02721732|460467803|FG007|Overall Study|Lack of Efficacy|11|||
127957958|NCT02721732|460467804|FG008|Overall Study|Lack of Efficacy|10|||
127957959|NCT02721732|460467805|FG009|Overall Study|Lack of Efficacy|20|||
127957960|NCT02721732|460467796|FG000|Overall Study|Physician Decision|0|||
127957961|NCT02721732|460467797|FG001|Overall Study|Physician Decision|0|||
127957962|NCT02721732|460467798|FG002|Overall Study|Physician Decision|1|||
127957963|NCT02721732|460467799|FG003|Overall Study|Physician Decision|0|||
127957964|NCT02721732|460467800|FG004|Overall Study|Physician Decision|0|||
127957965|NCT02721732|460467801|FG005|Overall Study|Physician Decision|0|||
127957966|NCT02721732|460467802|FG006|Overall Study|Physician Decision|0|||
127957967|NCT02721732|460467803|FG007|Overall Study|Physician Decision|0|||
127957968|NCT02721732|460467804|FG008|Overall Study|Physician Decision|0|||
127957969|NCT02721732|460467805|FG009|Overall Study|Physician Decision|0|||
127957970|NCT02721732|460467796|FG000|Overall Study|Withdrawal by Subject|1|||
127957971|NCT02721732|460467797|FG001|Overall Study|Withdrawal by Subject|0|||
127957972|NCT02721732|460467798|FG002|Overall Study|Withdrawal by Subject|0|||
127957973|NCT02721732|460467799|FG003|Overall Study|Withdrawal by Subject|0|||
127957974|NCT02721732|460467800|FG004|Overall Study|Withdrawal by Subject|3|||
127957975|NCT02721732|460467801|FG005|Overall Study|Withdrawal by Subject|0|||
127957976|NCT02721732|460467802|FG006|Overall Study|Withdrawal by Subject|1|||
127957977|NCT02721732|460467803|FG007|Overall Study|Withdrawal by Subject|1|||
127957978|NCT02721732|460467804|FG008|Overall Study|Withdrawal by Subject|0|||
127957979|NCT02721732|460467805|FG009|Overall Study|Withdrawal by Subject|1|||
127957980|NCT02721732|460467796|FG000|Overall Study|Participant Choice|1|||
127957981|NCT02721732|460467797|FG001|Overall Study|Participant Choice|0|||
127957982|NCT02721732|460467798|FG002|Overall Study|Participant Choice|0|||
127957983|NCT02721732|460467799|FG003|Overall Study|Participant Choice|0|||
127957984|NCT02721732|460467800|FG004|Overall Study|Participant Choice|0|||
127957985|NCT02721732|460467801|FG005|Overall Study|Participant Choice|0|||
127957986|NCT02721732|460467802|FG006|Overall Study|Participant Choice|0|||
127957987|NCT02721732|460467803|FG007|Overall Study|Participant Choice|0|||
127957988|NCT02721732|460467804|FG008|Overall Study|Participant Choice|0|||
127957989|NCT02721732|460467805|FG009|Overall Study|Participant Choice|1|||
127868660|NCT01072175|460137390|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
127868661|NCT01072175|460137391|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
127868662|NCT01072175|460137392|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
127868663|NCT01072175|460137393|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
127868664|NCT01072175|460137394|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
127868665|NCT01072175|460137395|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
127868666|NCT01072175|460137383|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
127868667|NCT01072175|460137384|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
127868668|NCT01072175|460137385|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
127868669|NCT01072175|460137386|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
127868670|NCT01072175|460137387|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
127868671|NCT01072175|460137388|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
127868672|NCT01072175|460137389|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
127868673|NCT01072175|460137390|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
127868674|NCT01072175|460137391|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
127868675|NCT01072175|460137392|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
127868676|NCT01072175|460137393|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
127868677|NCT01072175|460137394|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
127868678|NCT01072175|460137395|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
127868679|NCT01072175|460137383|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
127868680|NCT01072175|460137384|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
127868681|NCT01072175|460137385|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
127868682|NCT01072175|460137386|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
127868683|NCT01072175|460137387|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
127868684|NCT01072175|460137388|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
127868685|NCT01072175|460137389|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
127868686|NCT01072175|460137390|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
127868687|NCT01072175|460137391|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
127868688|NCT01072175|460137392|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
127957990|NCT02721732|460467796|FG000|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
127957991|NCT02721732|460467797|FG001|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
127957992|NCT02721732|460467798|FG002|Overall Study|Progression and Exclusion from study due to changed diagnosis|1|||
127957993|NCT02721732|460467799|FG003|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
127957994|NCT02721732|460467800|FG004|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
127957995|NCT02721732|460467801|FG005|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
127957996|NCT02721732|460467802|FG006|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
127957997|NCT02721732|460467803|FG007|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
127957998|NCT02721732|460467804|FG008|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
127957999|NCT02721732|460467805|FG009|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
127958000|NCT02721732|460467796|FG000|Overall Study|Progression and withdrew consent|1|||
127958001|NCT02721732|460467797|FG001|Overall Study|Progression and withdrew consent|1|||
127958002|NCT02721732|460467798|FG002|Overall Study|Progression and withdrew consent|0|||
127958003|NCT02721732|460467799|FG003|Overall Study|Progression and withdrew consent|0|||
127958004|NCT02721732|460467800|FG004|Overall Study|Progression and withdrew consent|0|||
127958005|NCT02721732|460467801|FG005|Overall Study|Progression and withdrew consent|0|||
127958006|NCT02721732|460467802|FG006|Overall Study|Progression and withdrew consent|0|||
127958007|NCT02721732|460467803|FG007|Overall Study|Progression and withdrew consent|0|||
127958008|NCT02721732|460467804|FG008|Overall Study|Progression and withdrew consent|0|||
127958009|NCT02721732|460467805|FG009|Overall Study|Progression and withdrew consent|1|||
127958010|NCT02721732|460467796|FG000|Overall Study|No evidence of tumor following radical surgery|0|||
127958011|NCT02721732|460467797|FG001|Overall Study|No evidence of tumor following radical surgery|0|||
127958012|NCT02721732|460467798|FG002|Overall Study|No evidence of tumor following radical surgery|0|||
127958013|NCT02721732|460467799|FG003|Overall Study|No evidence of tumor following radical surgery|0|||
127958014|NCT02721732|460467800|FG004|Overall Study|No evidence of tumor following radical surgery|0|||
127958015|NCT02721732|460467801|FG005|Overall Study|No evidence of tumor following radical surgery|1|||
127958016|NCT02721732|460467802|FG006|Overall Study|No evidence of tumor following radical surgery|0|||
127958017|NCT02721732|460467803|FG007|Overall Study|No evidence of tumor following radical surgery|0|||
127958018|NCT02721732|460467804|FG008|Overall Study|No evidence of tumor following radical surgery|0|||
127958019|NCT02721732|460467805|FG009|Overall Study|No evidence of tumor following radical surgery|0|||
127958020|NCT02848001|460467806|FG000|Overall Study|other reasons|0|||
127958021|NCT02848001|460467807|FG001|Overall Study|other reasons|0|||
127958022|NCT02848001|460467808|FG002|Overall Study|other reasons|1|||
127958023|NCT02848001|460467809|FG003|Overall Study|other reasons|0|||
127958024|NCT02848001|460467810|FG004|Overall Study|other reasons|4|||
127958025|NCT02848001|460467811|FG005|Overall Study|other reasons|1|||
127958026|NCT02848001|460467812|FG006|Overall Study|other reasons|0|||
127958027|NCT02848001|460467813|FG007|Overall Study|other reasons|2|||
127958028|NCT02848001|460467814|FG008|Overall Study|other reasons|2|||
127958029|NCT02848001|460467815|FG009|Overall Study|other reasons|3|||
127958030|NCT02848001|460467816|FG010|Overall Study|other reasons|0|||
127958031|NCT02848001|460467817|FG011|Overall Study|other reasons|1|||
127958032|NCT02848001|460467818|FG012|Overall Study|other reasons|1|||
127958033|NCT02848001|460467819|FG013|Overall Study|other reasons|0|||
127958034|NCT02848001|460467820|FG014|Overall Study|other reasons|0|||
127958035|NCT02848001|460467821|FG015|Overall Study|other reasons|2|||
127958036|NCT02848001|460467822|FG016|Overall Study|other reasons|1|||
127958037|NCT02848001|460467806|FG000|Overall Study|Lack of Efficacy|0|||
127958038|NCT02848001|460467807|FG001|Overall Study|Lack of Efficacy|1|||
127958039|NCT02848001|460467808|FG002|Overall Study|Lack of Efficacy|1|||
127958040|NCT02848001|460467809|FG003|Overall Study|Lack of Efficacy|2|||
127958041|NCT02848001|460467810|FG004|Overall Study|Lack of Efficacy|3|||
127958042|NCT02848001|460467811|FG005|Overall Study|Lack of Efficacy|0|||
127958043|NCT02848001|460467812|FG006|Overall Study|Lack of Efficacy|1|||
127958044|NCT02848001|460467813|FG007|Overall Study|Lack of Efficacy|0|||
127958045|NCT02848001|460467814|FG008|Overall Study|Lack of Efficacy|0|||
127958046|NCT02848001|460467815|FG009|Overall Study|Lack of Efficacy|1|||
127958047|NCT02848001|460467816|FG010|Overall Study|Lack of Efficacy|0|||
127958048|NCT02848001|460467817|FG011|Overall Study|Lack of Efficacy|2|||
127958049|NCT02848001|460467818|FG012|Overall Study|Lack of Efficacy|0|||
127958050|NCT02848001|460467819|FG013|Overall Study|Lack of Efficacy|2|||
127958051|NCT02848001|460467820|FG014|Overall Study|Lack of Efficacy|2|||
127958052|NCT02848001|460467821|FG015|Overall Study|Lack of Efficacy|0|||
127958053|NCT02848001|460467822|FG016|Overall Study|Lack of Efficacy|0|||
127958054|NCT02848001|460467806|FG000|Overall Study|Progressive Disease|2|||
127958055|NCT02848001|460467807|FG001|Overall Study|Progressive Disease|1|||
127958056|NCT02848001|460467808|FG002|Overall Study|Progressive Disease|0|||
127958057|NCT02848001|460467809|FG003|Overall Study|Progressive Disease|4|||
127958058|NCT02848001|460467810|FG004|Overall Study|Progressive Disease|3|||
127958059|NCT02848001|460467811|FG005|Overall Study|Progressive Disease|0|||
127958060|NCT02848001|460467812|FG006|Overall Study|Progressive Disease|4|||
127958061|NCT02848001|460467813|FG007|Overall Study|Progressive Disease|1|||
127958062|NCT02848001|460467814|FG008|Overall Study|Progressive Disease|0|||
127958063|NCT02848001|460467815|FG009|Overall Study|Progressive Disease|2|||
127958064|NCT02848001|460467816|FG010|Overall Study|Progressive Disease|3|||
127958065|NCT02848001|460467817|FG011|Overall Study|Progressive Disease|2|||
127958066|NCT02848001|460467818|FG012|Overall Study|Progressive Disease|1|||
127958067|NCT02848001|460467819|FG013|Overall Study|Progressive Disease|0|||
127958068|NCT02848001|460467820|FG014|Overall Study|Progressive Disease|2|||
127958069|NCT02848001|460467821|FG015|Overall Study|Progressive Disease|4|||
127958070|NCT02848001|460467822|FG016|Overall Study|Progressive Disease|0|||
127958071|NCT02848001|460467806|FG000|Overall Study|Adverse Event|0|||
127958072|NCT02848001|460467807|FG001|Overall Study|Adverse Event|0|||
127958073|NCT02848001|460467808|FG002|Overall Study|Adverse Event|0|||
127958074|NCT02848001|460467809|FG003|Overall Study|Adverse Event|0|||
127958075|NCT02848001|460467810|FG004|Overall Study|Adverse Event|2|||
127958076|NCT02848001|460467811|FG005|Overall Study|Adverse Event|0|||
127958077|NCT02848001|460467812|FG006|Overall Study|Adverse Event|0|||
127958078|NCT02848001|460467813|FG007|Overall Study|Adverse Event|0|||
127958079|NCT02848001|460467814|FG008|Overall Study|Adverse Event|0|||
127958080|NCT02848001|460467815|FG009|Overall Study|Adverse Event|1|||
127958081|NCT02848001|460467816|FG010|Overall Study|Adverse Event|0|||
127958082|NCT02848001|460467817|FG011|Overall Study|Adverse Event|1|||
127958083|NCT02848001|460467818|FG012|Overall Study|Adverse Event|1|||
127958084|NCT02848001|460467819|FG013|Overall Study|Adverse Event|0|||
127958085|NCT02848001|460467820|FG014|Overall Study|Adverse Event|2|||
127958086|NCT02848001|460467821|FG015|Overall Study|Adverse Event|0|||
127958087|NCT02848001|460467822|FG016|Overall Study|Adverse Event|0|||
127958088|NCT02848001|460467806|FG000|Overall Study|Death|0|||
127958089|NCT02848001|460467807|FG001|Overall Study|Death|0|||
127958090|NCT02848001|460467808|FG002|Overall Study|Death|0|||
127958091|NCT02848001|460467809|FG003|Overall Study|Death|1|||
127958092|NCT02848001|460467810|FG004|Overall Study|Death|3|||
127958093|NCT02848001|460467811|FG005|Overall Study|Death|1|||
127958094|NCT02848001|460467812|FG006|Overall Study|Death|2|||
127958095|NCT02848001|460467813|FG007|Overall Study|Death|3|||
127958096|NCT02848001|460467814|FG008|Overall Study|Death|4|||
127958097|NCT02848001|460467815|FG009|Overall Study|Death|1|||
127958098|NCT02848001|460467816|FG010|Overall Study|Death|0|||
127958099|NCT02848001|460467817|FG011|Overall Study|Death|1|||
127958100|NCT02848001|460467818|FG012|Overall Study|Death|3|||
127958101|NCT02848001|460467819|FG013|Overall Study|Death|0|||
127958102|NCT02848001|460467820|FG014|Overall Study|Death|2|||
127958103|NCT02848001|460467821|FG015|Overall Study|Death|3|||
127958104|NCT02848001|460467822|FG016|Overall Study|Death|0|||
127958105|NCT02848001|460467806|FG000|Overall Study|Physician Decision|0|||
127958106|NCT02848001|460467807|FG001|Overall Study|Physician Decision|0|||
127958107|NCT02848001|460467808|FG002|Overall Study|Physician Decision|0|||
127958108|NCT02848001|460467809|FG003|Overall Study|Physician Decision|0|||
127958109|NCT02848001|460467810|FG004|Overall Study|Physician Decision|0|||
127958110|NCT02848001|460467811|FG005|Overall Study|Physician Decision|0|||
127958111|NCT02848001|460467812|FG006|Overall Study|Physician Decision|0|||
127958112|NCT02848001|460467813|FG007|Overall Study|Physician Decision|0|||
127958113|NCT02848001|460467814|FG008|Overall Study|Physician Decision|1|||
127958114|NCT02848001|460467815|FG009|Overall Study|Physician Decision|1|||
127958115|NCT02848001|460467816|FG010|Overall Study|Physician Decision|0|||
127958116|NCT02848001|460467817|FG011|Overall Study|Physician Decision|0|||
127958117|NCT02848001|460467818|FG012|Overall Study|Physician Decision|2|||
127958118|NCT02848001|460467819|FG013|Overall Study|Physician Decision|0|||
127958119|NCT02848001|460467820|FG014|Overall Study|Physician Decision|0|||
127958120|NCT02848001|460467821|FG015|Overall Study|Physician Decision|0|||
127958121|NCT02848001|460467822|FG016|Overall Study|Physician Decision|0|||
127958122|NCT02848001|460467806|FG000|Overall Study|Withdrawal by Subject|0|||
127958123|NCT02848001|460467807|FG001|Overall Study|Withdrawal by Subject|0|||
127958124|NCT02848001|460467808|FG002|Overall Study|Withdrawal by Subject|0|||
127958125|NCT02848001|460467809|FG003|Overall Study|Withdrawal by Subject|0|||
127958126|NCT02848001|460467810|FG004|Overall Study|Withdrawal by Subject|0|||
127958127|NCT02848001|460467811|FG005|Overall Study|Withdrawal by Subject|1|||
127958128|NCT02848001|460467812|FG006|Overall Study|Withdrawal by Subject|1|||
127958129|NCT02848001|460467813|FG007|Overall Study|Withdrawal by Subject|1|||
127958130|NCT02848001|460467814|FG008|Overall Study|Withdrawal by Subject|0|||
127958131|NCT02848001|460467815|FG009|Overall Study|Withdrawal by Subject|0|||
127958132|NCT02848001|460467816|FG010|Overall Study|Withdrawal by Subject|0|||
127958133|NCT02848001|460467817|FG011|Overall Study|Withdrawal by Subject|0|||
127958134|NCT02848001|460467818|FG012|Overall Study|Withdrawal by Subject|0|||
127958135|NCT02848001|460467819|FG013|Overall Study|Withdrawal by Subject|0|||
127958136|NCT02848001|460467820|FG014|Overall Study|Withdrawal by Subject|0|||
127958137|NCT02848001|460467821|FG015|Overall Study|Withdrawal by Subject|0|||
127958138|NCT02848001|460467822|FG016|Overall Study|Withdrawal by Subject|0|||
127958139|NCT00725283|460467825|FG000|Overall Study|Missing Code|3|||
127958140|NCT00725283|460467825|FG000|Overall Study|Death|5|||
127958141|NCT00725283|460467825|FG000|Overall Study|Other|6|||
127958142|NCT00725283|460467825|FG000|Overall Study|Withdrawal by Subject|10|||
127958143|NCT00711243|460467829|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
127958144|NCT00711243|460467830|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
127958145|NCT00711243|460467831|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
127958146|NCT00711243|460467832|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
127958147|NCT00711243|460467833|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
127958148|NCT00711243|460467834|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
127958149|NCT00711243|460467829|FG000|Reached First Response/4 Cycles|Death|0|||
127958150|NCT00711243|460467830|FG001|Reached First Response/4 Cycles|Death|0|||
127958151|NCT00711243|460467831|FG002|Reached First Response/4 Cycles|Death|0|||
127958152|NCT00711243|460467832|FG003|Reached First Response/4 Cycles|Death|0|||
127958153|NCT00711243|460467833|FG004|Reached First Response/4 Cycles|Death|0|||
127958154|NCT00711243|460467834|FG005|Reached First Response/4 Cycles|Death|2|||
127958155|NCT00711243|460467829|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
127958156|NCT00711243|460467830|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
127958157|NCT00711243|460467831|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
127958158|NCT00711243|460467832|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
127958159|NCT00711243|460467833|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
127958160|NCT00711243|460467834|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
127958161|NCT00711243|460467829|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
127958162|NCT00711243|460467830|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
127958163|NCT00711243|460467831|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
127958164|NCT00711243|460467832|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
127958165|NCT00711243|460467833|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
127958166|NCT00711243|460467834|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
127958167|NCT00711243|460467829|FG000|Treated Cycle 5 After First Response|Death|0|||
127958168|NCT00711243|460467830|FG001|Treated Cycle 5 After First Response|Death|0|||
127958169|NCT00711243|460467831|FG002|Treated Cycle 5 After First Response|Death|0|||
127958170|NCT00711243|460467832|FG003|Treated Cycle 5 After First Response|Death|0|||
127958171|NCT00711243|460467833|FG004|Treated Cycle 5 After First Response|Death|0|||
127958172|NCT00711243|460467834|FG005|Treated Cycle 5 After First Response|Death|2|||
127958173|NCT00711243|460467829|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
127958174|NCT00711243|460467830|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
127958175|NCT00711243|460467831|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
127958176|NCT00711243|460467832|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
127958177|NCT00711243|460467833|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
127958178|NCT00711243|460467834|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
127958179|NCT00711243|460467829|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
127958180|NCT00711243|460467830|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
127958181|NCT00711243|460467831|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
127958182|NCT00711243|460467832|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
127958183|NCT00711243|460467833|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
127958184|NCT00711243|460467834|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
127958185|NCT01962103|460467838|FG000|Phase 1|Adverse Event|4|||
127958186|NCT01962103|460467839|FG001|Phase 1|Adverse Event|0|||
127958187|NCT01962103|460467840|FG002|Phase 1|Adverse Event|2|||
127958188|NCT01962103|460467841|FG003|Phase 1|Adverse Event|1|||
127958189|NCT01962103|460467842|FG004|Phase 1|Adverse Event|2|||
127958190|NCT01962103|460467843|FG005|Phase 1|Adverse Event|2|||
127958191|NCT01962103|460467844|FG006|Phase 1|Adverse Event|0|||
127958192|NCT01962103|460467845|FG007|Phase 1|Adverse Event|0|||
127958193|NCT01962103|460467846|FG008|Phase 1|Adverse Event|0|||
127958194|NCT01962103|460467838|FG000|Phase 1|Progressive Disease|8|||
127958195|NCT01962103|460467839|FG001|Phase 1|Progressive Disease|6|||
127958196|NCT01962103|460467840|FG002|Phase 1|Progressive Disease|8|||
127958197|NCT01962103|460467841|FG003|Phase 1|Progressive Disease|4|||
127958198|NCT01962103|460467842|FG004|Phase 1|Progressive Disease|5|||
127958199|NCT01962103|460467843|FG005|Phase 1|Progressive Disease|4|||
127958200|NCT01962103|460467844|FG006|Phase 1|Progressive Disease|0|||
127958201|NCT01962103|460467845|FG007|Phase 1|Progressive Disease|0|||
127958202|NCT01962103|460467846|FG008|Phase 1|Progressive Disease|0|||
127958203|NCT01962103|460467838|FG000|Phase 1|Withdrawal by Subject|0|||
127958204|NCT01962103|460467839|FG001|Phase 1|Withdrawal by Subject|0|||
127958205|NCT01962103|460467840|FG002|Phase 1|Withdrawal by Subject|0|||
127958206|NCT01962103|460467841|FG003|Phase 1|Withdrawal by Subject|2|||
127958207|NCT01962103|460467842|FG004|Phase 1|Withdrawal by Subject|0|||
127958208|NCT01962103|460467843|FG005|Phase 1|Withdrawal by Subject|0|||
127958209|NCT01962103|460467844|FG006|Phase 1|Withdrawal by Subject|0|||
127958210|NCT01962103|460467845|FG007|Phase 1|Withdrawal by Subject|0|||
127958211|NCT01962103|460467846|FG008|Phase 1|Withdrawal by Subject|0|||
127958212|NCT01962103|460467838|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
127958213|NCT01962103|460467839|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
127958214|NCT01962103|460467840|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
127958215|NCT01962103|460467841|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
127958216|NCT01962103|460467842|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
127958217|NCT01962103|460467843|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
127958218|NCT01962103|460467844|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
127958219|NCT01962103|460467845|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
127958220|NCT01962103|460467846|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
127958221|NCT01962103|460467838|FG000|Phase 1|Physician Decision|0|||
127958222|NCT01962103|460467839|FG001|Phase 1|Physician Decision|0|||
127958223|NCT01962103|460467840|FG002|Phase 1|Physician Decision|0|||
127958224|NCT01962103|460467841|FG003|Phase 1|Physician Decision|1|||
127958225|NCT01962103|460467842|FG004|Phase 1|Physician Decision|0|||
127958226|NCT01962103|460467843|FG005|Phase 1|Physician Decision|0|||
127958227|NCT01962103|460467844|FG006|Phase 1|Physician Decision|0|||
127958228|NCT01962103|460467845|FG007|Phase 1|Physician Decision|0|||
127958229|NCT01962103|460467846|FG008|Phase 1|Physician Decision|0|||
127958230|NCT01962103|460467838|FG000|Phase 1|Symptomatic Deterioration|3|||
127958231|NCT01962103|460467839|FG001|Phase 1|Symptomatic Deterioration|2|||
127958232|NCT01962103|460467840|FG002|Phase 1|Symptomatic Deterioration|2|||
127958233|NCT01962103|460467841|FG003|Phase 1|Symptomatic Deterioration|2|||
127958234|NCT01962103|460467842|FG004|Phase 1|Symptomatic Deterioration|1|||
127958235|NCT01962103|460467843|FG005|Phase 1|Symptomatic Deterioration|1|||
127958236|NCT01962103|460467844|FG006|Phase 1|Symptomatic Deterioration|0|||
127958237|NCT01962103|460467845|FG007|Phase 1|Symptomatic Deterioration|0|||
127958238|NCT01962103|460467846|FG008|Phase 1|Symptomatic Deterioration|0|||
127958239|NCT01962103|460467838|FG000|Phase 1|Miscellaneous|1|||
127958240|NCT01962103|460467839|FG001|Phase 1|Miscellaneous|0|||
127958241|NCT01962103|460467840|FG002|Phase 1|Miscellaneous|0|||
127958242|NCT01962103|460467841|FG003|Phase 1|Miscellaneous|0|||
127958243|NCT01962103|460467842|FG004|Phase 1|Miscellaneous|0|||
127958244|NCT01962103|460467843|FG005|Phase 1|Miscellaneous|0|||
127958245|NCT01962103|460467844|FG006|Phase 1|Miscellaneous|0|||
127958246|NCT01962103|460467845|FG007|Phase 1|Miscellaneous|0|||
127958247|NCT01962103|460467846|FG008|Phase 1|Miscellaneous|0|||
127958248|NCT01962103|460467838|FG000|Phase 2|Adverse Event|0|||
127958249|NCT01962103|460467839|FG001|Phase 2|Adverse Event|0|||
127958250|NCT01962103|460467840|FG002|Phase 2|Adverse Event|0|||
127958251|NCT01962103|460467841|FG003|Phase 2|Adverse Event|0|||
127958252|NCT01962103|460467842|FG004|Phase 2|Adverse Event|0|||
127958253|NCT01962103|460467843|FG005|Phase 2|Adverse Event|0|||
127958254|NCT01962103|460467844|FG006|Phase 2|Adverse Event|1|||
127958255|NCT01962103|460467845|FG007|Phase 2|Adverse Event|0|||
127958256|NCT01962103|460467846|FG008|Phase 2|Adverse Event|3|||
127958257|NCT01962103|460467838|FG000|Phase 2|Progressive Disease|0|||
127958258|NCT01962103|460467839|FG001|Phase 2|Progressive Disease|0|||
127958259|NCT01962103|460467840|FG002|Phase 2|Progressive Disease|0|||
127958260|NCT01962103|460467841|FG003|Phase 2|Progressive Disease|0|||
127958261|NCT01962103|460467842|FG004|Phase 2|Progressive Disease|0|||
127958262|NCT01962103|460467843|FG005|Phase 2|Progressive Disease|0|||
127958263|NCT01962103|460467844|FG006|Phase 2|Progressive Disease|11|||
127958264|NCT01962103|460467845|FG007|Phase 2|Progressive Disease|12|||
127958265|NCT01962103|460467846|FG008|Phase 2|Progressive Disease|11|||
127958266|NCT01962103|460467838|FG000|Phase 2|Symptomatic Deterioration|0|||
127958267|NCT01962103|460467839|FG001|Phase 2|Symptomatic Deterioration|0|||
127958268|NCT01962103|460467840|FG002|Phase 2|Symptomatic Deterioration|0|||
127958269|NCT01962103|460467841|FG003|Phase 2|Symptomatic Deterioration|0|||
127958270|NCT01962103|460467842|FG004|Phase 2|Symptomatic Deterioration|0|||
127958271|NCT01962103|460467843|FG005|Phase 2|Symptomatic Deterioration|0|||
127958272|NCT01962103|460467844|FG006|Phase 2|Symptomatic Deterioration|2|||
127958273|NCT01962103|460467845|FG007|Phase 2|Symptomatic Deterioration|2|||
127958274|NCT01962103|460467846|FG008|Phase 2|Symptomatic Deterioration|0|||
127958275|NCT01321749|460467847|FG000|Overall Study|Lost to Follow-up|4|||
127958276|NCT01321749|460467848|FG001|Overall Study|Lost to Follow-up|11|||
127958277|NCT01321749|460467847|FG000|Overall Study|Protocol Violation|4|||
127958278|NCT01321749|460467848|FG001|Overall Study|Protocol Violation|7|||
127958279|NCT01321749|460467847|FG000|Overall Study|Withdrawal by Subject|5|||
127958280|NCT01321749|460467848|FG001|Overall Study|Withdrawal by Subject|4|||
127958281|NCT04179838|460467852|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
127958282|NCT04179838|460467853|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
127958283|NCT04179838|460467852|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
127958284|NCT04179838|460467853|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
127958285|NCT00818766|460467854|FG000|Overall Study|Could not be Contacted on Day 28|11|||
127958286|NCT00818766|460467855|FG001|Overall Study|Could not be Contacted on Day 28|10|||
127958287|NCT00818766|460467854|FG000|Overall Study|Death|1|||
127958288|NCT00818766|460467855|FG001|Overall Study|Death|0|||
127958289|NCT00818766|460467854|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
127958290|NCT00818766|460467855|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
127958291|NCT00086684|460467857|FG000|Overall Study|Adverse Event|12|||
127958292|NCT00086684|460467858|FG001|Overall Study|Adverse Event|17|||
127958293|NCT00086684|460467859|FG002|Overall Study|Adverse Event|14|||
127958294|NCT00086684|460467857|FG000|Overall Study|Lack of Efficacy|6|||
127958295|NCT00086684|460467858|FG001|Overall Study|Lack of Efficacy|6|||
127958296|NCT00086684|460467859|FG002|Overall Study|Lack of Efficacy|5|||
127958297|NCT00086684|460467857|FG000|Overall Study|Lost to Follow-up|15|||
127958298|NCT00086684|460467858|FG001|Overall Study|Lost to Follow-up|8|||
127958299|NCT00086684|460467859|FG002|Overall Study|Lost to Follow-up|10|||
127958300|NCT00086684|460467857|FG000|Overall Study|Protocol Violation|8|||
127958301|NCT00086684|460467858|FG001|Overall Study|Protocol Violation|3|||
127958302|NCT00086684|460467859|FG002|Overall Study|Protocol Violation|0|||
127958303|NCT00086684|460467857|FG000|Overall Study|Withdrawal by Subject|0|||
127958304|NCT00086684|460467858|FG001|Overall Study|Withdrawal by Subject|4|||
127958305|NCT00086684|460467859|FG002|Overall Study|Withdrawal by Subject|10|||
127958306|NCT00086684|460467857|FG000|Overall Study|NONCOMPLIANCE|5|||
127958307|NCT00086684|460467858|FG001|Overall Study|NONCOMPLIANCE|7|||
127958308|NCT00086684|460467859|FG002|Overall Study|NONCOMPLIANCE|6|||
127958309|NCT00086684|460467857|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
127958310|NCT00086684|460467858|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
127958311|NCT00086684|460467859|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
127958312|NCT00086684|460467857|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
127958313|NCT00086684|460467858|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
127958314|NCT00086684|460467859|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
127958315|NCT00086684|460467857|FG000|Overall Study|Other|4|||
127958316|NCT00086684|460467858|FG001|Overall Study|Other|2|||
127958317|NCT00086684|460467859|FG002|Overall Study|Other|3|||
127958318|NCT01996241|460467860|FG000|Overall Study|Lost to Follow-up|252|||
127958319|NCT01996241|460467861|FG001|Overall Study|Lost to Follow-up|235|||
127958320|NCT04515147|460467864|FG000|Overall Study|Withdrawal by Subject|1|||
127958321|NCT04515147|460467865|FG001|Overall Study|Withdrawal by Subject|0|||
127958322|NCT04515147|460467866|FG002|Overall Study|Withdrawal by Subject|10|||
127958323|NCT04515147|460467867|FG003|Overall Study|Withdrawal by Subject|18|||
127958324|NCT04515147|460467868|FG004|Overall Study|Withdrawal by Subject|1|||
127958325|NCT04515147|460467869|FG005|Overall Study|Withdrawal by Subject|8|||
127958326|NCT04515147|460467864|FG000|Overall Study|Lost to Follow-up|0|||
127958327|NCT04515147|460467865|FG001|Overall Study|Lost to Follow-up|1|||
127958328|NCT04515147|460467866|FG002|Overall Study|Lost to Follow-up|5|||
127958329|NCT04515147|460467867|FG003|Overall Study|Lost to Follow-up|6|||
127958330|NCT04515147|460467868|FG004|Overall Study|Lost to Follow-up|2|||
127958331|NCT04515147|460467869|FG005|Overall Study|Lost to Follow-up|1|||
127958332|NCT04515147|460467864|FG000|Overall Study|Adverse Event|0|||
127958333|NCT04515147|460467865|FG001|Overall Study|Adverse Event|0|||
127958334|NCT04515147|460467866|FG002|Overall Study|Adverse Event|0|||
127958335|NCT04515147|460467867|FG003|Overall Study|Adverse Event|2|||
127958336|NCT04515147|460467868|FG004|Overall Study|Adverse Event|0|||
127958337|NCT04515147|460467869|FG005|Overall Study|Adverse Event|0|||
127958338|NCT04515147|460467864|FG000|Overall Study|Miscellaneous|0|||
127958339|NCT04515147|460467865|FG001|Overall Study|Miscellaneous|0|||
127958340|NCT04515147|460467866|FG002|Overall Study|Miscellaneous|0|||
127958341|NCT04515147|460467867|FG003|Overall Study|Miscellaneous|1|||
127958342|NCT04515147|460467868|FG004|Overall Study|Miscellaneous|0|||
127958343|NCT04515147|460467869|FG005|Overall Study|Miscellaneous|1|||
127958344|NCT03052751|460467870|FG000|Dosing Period 1|Adverse Event|0|||
127958345|NCT03052751|460467871|FG001|Dosing Period 1|Adverse Event|1|||
127958346|NCT03052751|460467872|FG002|Dosing Period 1|Adverse Event|0|||
127958347|NCT03052751|460467873|FG003|Dosing Period 1|Adverse Event|0|||
127958348|NCT03052751|460467874|FG004|Dosing Period 1|Adverse Event|0|||
127958349|NCT03052751|460467875|FG005|Dosing Period 1|Adverse Event|0|||
127958350|NCT03052751|460467870|FG000|Dosing Period 2|Adverse Event|0|||
127958351|NCT03052751|460467871|FG001|Dosing Period 2|Adverse Event|0|||
127958352|NCT03052751|460467872|FG002|Dosing Period 2|Adverse Event|3|||
127958353|NCT03052751|460467873|FG003|Dosing Period 2|Adverse Event|0|||
127958354|NCT03052751|460467874|FG004|Dosing Period 2|Adverse Event|0|||
127958355|NCT03052751|460467875|FG005|Dosing Period 2|Adverse Event|0|||
127958356|NCT03052751|460467870|FG000|Observation Period|Adverse Event|0|||
127958357|NCT03052751|460467871|FG001|Observation Period|Adverse Event|0|||
127958358|NCT03052751|460467872|FG002|Observation Period|Adverse Event|0|||
127958359|NCT03052751|460467873|FG003|Observation Period|Adverse Event|0|||
127958360|NCT03052751|460467874|FG004|Observation Period|Adverse Event|1|||
127958361|NCT03052751|460467875|FG005|Observation Period|Adverse Event|0|||
127958362|NCT01067105|460467876|FG000|Overall Study|Adverse Event|14|||
127958363|NCT01067105|460467876|FG000|Overall Study|Protocol Violation|48|||
127958364|NCT01067105|460467876|FG000|Overall Study|Withdrawal by Subject|36|||
127958365|NCT01067105|460467876|FG000|Overall Study|Lost to Follow-up|6|||
127958366|NCT01067105|460467876|FG000|Overall Study|Physician Decision|6|||
127958367|NCT01067105|460467876|FG000|Overall Study|Other|31|||
127958368|NCT02302833|460467879|FG000|Overall Study|Lost to Follow-up|3|||
127958369|NCT02719184|460467882|FG000|Overall Study|Other than listed|1|||
127958370|NCT02719184|460467883|FG001|Overall Study|Other than listed|12|||
127958371|NCT02719184|460467884|FG002|Overall Study|Other than listed|13|||
127958372|NCT02719184|460467885|FG003|Overall Study|Other than listed|22|||
127958373|NCT02719184|460467886|FG004|Overall Study|Other than listed|9|||
127958374|NCT02719184|460467882|FG000|Overall Study|Withdrawal by Subject|5|||
127958375|NCT02719184|460467883|FG001|Overall Study|Withdrawal by Subject|3|||
127958376|NCT02719184|460467884|FG002|Overall Study|Withdrawal by Subject|6|||
127958377|NCT02719184|460467885|FG003|Overall Study|Withdrawal by Subject|6|||
127958378|NCT02719184|460467886|FG004|Overall Study|Withdrawal by Subject|0|||
127958379|NCT02719184|460467882|FG000|Overall Study|Lost to Follow-up|0|||
127958380|NCT02719184|460467883|FG001|Overall Study|Lost to Follow-up|4|||
127958381|NCT02719184|460467884|FG002|Overall Study|Lost to Follow-up|1|||
127958382|NCT02719184|460467885|FG003|Overall Study|Lost to Follow-up|3|||
127958383|NCT02719184|460467886|FG004|Overall Study|Lost to Follow-up|0|||
127958384|NCT02719184|460467882|FG000|Overall Study|Protocol Violation|0|||
127958385|NCT02719184|460467883|FG001|Overall Study|Protocol Violation|3|||
127958386|NCT02719184|460467884|FG002|Overall Study|Protocol Violation|0|||
127958387|NCT02719184|460467885|FG003|Overall Study|Protocol Violation|2|||
127958388|NCT02719184|460467886|FG004|Overall Study|Protocol Violation|0|||
127958389|NCT02719184|460467882|FG000|Overall Study|Adverse Event|0|||
127958390|NCT02719184|460467883|FG001|Overall Study|Adverse Event|0|||
127958391|NCT02719184|460467884|FG002|Overall Study|Adverse Event|0|||
127958392|NCT02719184|460467885|FG003|Overall Study|Adverse Event|3|||
127958393|NCT02719184|460467886|FG004|Overall Study|Adverse Event|0|||
127958394|NCT02439216|460467887|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
127958395|NCT02439216|460467888|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
127958396|NCT02439216|460467889|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
127958397|NCT02439216|460467890|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
127958398|NCT02439216|460467891|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
127958399|NCT02439216|460467892|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
127958400|NCT02439216|460467893|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
127958401|NCT02439216|460467894|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
127958402|NCT02439216|460467895|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
127958403|NCT02439216|460467887|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
127958404|NCT02439216|460467888|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
127958405|NCT02439216|460467889|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
127958406|NCT02439216|460467890|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
127958407|NCT02439216|460467891|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
127958408|NCT02439216|460467892|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
127958409|NCT02439216|460467893|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
127958410|NCT02439216|460467894|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
127958411|NCT02439216|460467895|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
127958412|NCT02439216|460467887|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
127958413|NCT02439216|460467888|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
127958414|NCT02439216|460467889|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
127958415|NCT02439216|460467890|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
127958416|NCT02439216|460467891|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
127958417|NCT02439216|460467892|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
127958418|NCT02439216|460467893|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
127958419|NCT02439216|460467894|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
127958420|NCT02439216|460467895|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
127958421|NCT02439216|460467887|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
127958422|NCT02439216|460467888|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
127958423|NCT02439216|460467889|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
127958424|NCT02439216|460467890|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
127958425|NCT02439216|460467891|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
127958426|NCT02439216|460467892|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
127958427|NCT02439216|460467893|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
127958428|NCT02439216|460467894|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
127958429|NCT02439216|460467895|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
127958430|NCT02439216|460467887|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
127958431|NCT02439216|460467888|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
127958432|NCT02439216|460467889|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
127958433|NCT02439216|460467890|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
127958434|NCT02439216|460467891|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
127958435|NCT02439216|460467892|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
127958436|NCT02439216|460467893|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
127958437|NCT02439216|460467894|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
127958438|NCT02439216|460467895|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
127958439|NCT02094300|460467896|FG000|Overall Study|Death|7|||
127958440|NCT02094300|460467896|FG000|Overall Study|Lost to Follow-up|10|||
127958441|NCT02094300|460467896|FG000|Overall Study|Still be eligible for follow-up|3|||
127958442|NCT00725491|460467907|FG000|Overall Study|Adverse Event|3|||
127958443|NCT00725491|460467908|FG001|Overall Study|Adverse Event|2|||
127958444|NCT00725491|460467907|FG000|Overall Study|Pregnancy|0|||
127958445|NCT00725491|460467908|FG001|Overall Study|Pregnancy|3|||
127958446|NCT00725491|460467907|FG000|Overall Study|Risk for hyperstimulation|2|||
127958447|NCT00725491|460467908|FG001|Overall Study|Risk for hyperstimulation|9|||
127958448|NCT00725491|460467907|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
127958449|NCT00725491|460467908|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
127958450|NCT00725491|460467907|FG000|Overall Study|Fertilization failure|0|||
127958451|NCT00725491|460467908|FG001|Overall Study|Fertilization failure|1|||
127958452|NCT00725491|460467907|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
127958453|NCT00725491|460467908|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
127958454|NCT01495000|460467909|FG000|Overall Study|Lost to Follow-up|2|||
127958455|NCT01495000|460467910|FG001|Overall Study|Lost to Follow-up|2|||
127958456|NCT01495000|460467909|FG000|Overall Study|Protocol Violation|1|||
127958457|NCT01495000|460467910|FG001|Overall Study|Protocol Violation|0|||
127958458|NCT01495000|460467909|FG000|Overall Study|Withdrawal by Subject|10|||
127958459|NCT01495000|460467910|FG001|Overall Study|Withdrawal by Subject|10|||
127958460|NCT03499067|460467911|FG000|First Intervention|Physician Decision|2|||
127958461|NCT03499067|460467912|FG001|First Intervention|Physician Decision|1|||
127958462|NCT03499067|460467911|FG000|First Intervention|Withdrawal by Subject|3|||
127958463|NCT03499067|460467912|FG001|First Intervention|Withdrawal by Subject|6|||
127958464|NCT02548832|460467913|FG000|Overall Study|Lost to Follow-up|2|||
127958465|NCT02548832|460467914|FG001|Overall Study|Lost to Follow-up|2|||
127958466|NCT02548832|460467915|FG002|Overall Study|Lost to Follow-up|2|||
127958467|NCT03565900|460467916|FG000|Overall Study|Disposition Unknown|4|||
127958468|NCT03565900|460467917|FG001|Overall Study|Disposition Unknown|1|||
127958469|NCT03565900|460467916|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
127958470|NCT03565900|460467917|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
127958471|NCT03565900|460467916|FG000|Overall Study|Withdrawal by Subject|4|||
127958472|NCT03565900|460467917|FG001|Overall Study|Withdrawal by Subject|5|||
127958473|NCT03565900|460467916|FG000|Overall Study|Randomized By Mistake|0|||
127958474|NCT03565900|460467917|FG001|Overall Study|Randomized By Mistake|2|||
127958475|NCT03565900|460467916|FG000|Overall Study|Physician Decision|7|||
127958476|NCT03565900|460467917|FG001|Overall Study|Physician Decision|11|||
127958477|NCT03565900|460467916|FG000|Overall Study|Death|9|||
127958478|NCT03565900|460467917|FG001|Overall Study|Death|7|||
127958479|NCT00942357|460467920|FG000|Overall Study|Ineligible|37|||
127958480|NCT00942357|460467921|FG001|Overall Study|Ineligible|40|||
127958481|NCT01960257|460467922|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
127958482|NCT01960257|460467923|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
127958483|NCT01960257|460467924|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
127958484|NCT01960257|460467922|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
127958485|NCT01960257|460467923|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
127958486|NCT01960257|460467924|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
127958487|NCT01960257|460467922|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
127958488|NCT01960257|460467923|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
127958489|NCT01960257|460467924|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
127958490|NCT02002221|460467925|FG000|Overall Study|Adverse Event|2|||
127958491|NCT02002221|460467926|FG001|Overall Study|Adverse Event|1|||
127958492|NCT02002221|460467925|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
127958493|NCT02002221|460467926|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
127958494|NCT02002221|460467925|FG000|Overall Study|Patient withdrew consent|0|||
127958495|NCT02002221|460467926|FG001|Overall Study|Patient withdrew consent|1|||
127958496|NCT03347110|460467927|FG000|Overall Study|Other (Participant is incarcerated)|1|||
127958497|NCT03347110|460467927|FG000|Overall Study|Withdrawal by Subject|9|||
127958498|NCT03347110|460467927|FG000|Overall Study|Lost to Follow-up|1|||
127958499|NCT03347110|460467927|FG000|Overall Study|Lack of Efficacy|2|||
127958500|NCT03347110|460467927|FG000|Overall Study|Adverse Event, non-fatal|9|||
127958501|NCT01518322|460467929|FG000|Overall Study|FeNO measurement was missing|13|||
127958502|NCT02792517|460467934|FG000|Overall Study|Withdrawal by Subject|10|||
127958503|NCT02792517|460467934|FG000|Overall Study|Decision by Sponsor|7|||
127958504|NCT02792517|460467934|FG000|Overall Study|Lost to Follow-up|3|||
127958505|NCT00856193|460467937|FG000|Period 2|Abnormal test procedure results|0|||
127958506|NCT00856193|460467938|FG001|Period 2|Abnormal test procedure results|1|||
127958507|NCT00856193|460467937|FG000|Period 2|Lost to Follow-up|0|||
127958508|NCT00856193|460467938|FG001|Period 2|Lost to Follow-up|1|||
127958509|NCT02766335|460467940|FG000|Initial Registration|Adverse Event|6|||
127958510|NCT02766335|460467941|FG001|Initial Registration|Adverse Event|3|||
127958511|NCT02766335|460467942|FG002|Initial Registration|Adverse Event|0|||
127958512|NCT02766335|460467940|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
127958513|NCT02766335|460467941|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
127958514|NCT02766335|460467942|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
127958515|NCT02766335|460467940|FG000|Initial Registration|Progression/relapse|49|||
127958516|NCT02766335|460467941|FG001|Initial Registration|Progression/relapse|15|||
127958517|NCT02766335|460467942|FG002|Initial Registration|Progression/relapse|0|||
127958518|NCT02766335|460467940|FG000|Initial Registration|Death|1|||
127958519|NCT02766335|460467941|FG001|Initial Registration|Death|3|||
127958520|NCT02766335|460467942|FG002|Initial Registration|Death|0|||
127958521|NCT02766335|460467940|FG000|Initial Registration|not protocol specified|1|||
127958522|NCT02766335|460467941|FG001|Initial Registration|not protocol specified|9|||
127958523|NCT02766335|460467942|FG002|Initial Registration|not protocol specified|0|||
127958524|NCT02766335|460467940|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
127958525|NCT02766335|460467941|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
127958526|NCT02766335|460467942|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
127958527|NCT02766335|460467940|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
127958528|NCT02766335|460467941|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
127958529|NCT02766335|460467942|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
127958530|NCT04583735|460467949|FG000|Double-masked Treatment Period|Adverse Event|0|||
127958531|NCT04583735|460467950|FG001|Double-masked Treatment Period|Adverse Event|1|||
127958532|NCT04583735|460467949|FG000|Double-masked Treatment Period|Lost to Follow-up|2|||
127958533|NCT04583735|460467950|FG001|Double-masked Treatment Period|Lost to Follow-up|0|||
127958534|NCT04583735|460467949|FG000|Double-masked Treatment Period|Withdrawal by Subject|1|||
127958535|NCT04583735|460467950|FG001|Double-masked Treatment Period|Withdrawal by Subject|0|||
127958536|NCT04583735|460467949|FG000|Open-label Treatment Period|Adverse Event|1|||
127958537|NCT04583735|460467950|FG001|Open-label Treatment Period|Adverse Event|1|||
127958538|NCT04583735|460467949|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
127958539|NCT04583735|460467950|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
127958540|NCT04583735|460467949|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
127958541|NCT04583735|460467950|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
127958542|NCT00124917|460467951|FG000|Overall Study|Physician Decision|3|||
127958543|NCT01515423|460467952|FG000|Open Label Phase|Adverse Event|57|||
127958544|NCT01515423|460467953|FG001|Open Label Phase|Adverse Event|0|||
127958545|NCT01515423|460467954|FG002|Open Label Phase|Adverse Event|0|||
127958546|NCT01515423|460467952|FG000|Open Label Phase|Death|2|||
127958547|NCT01515423|460467953|FG001|Open Label Phase|Death|0|||
127958548|NCT01515423|460467954|FG002|Open Label Phase|Death|0|||
127958549|NCT01515423|460467952|FG000|Open Label Phase|Lack of Efficacy|117|||
127958550|NCT01515423|460467953|FG001|Open Label Phase|Lack of Efficacy|0|||
127958551|NCT01515423|460467954|FG002|Open Label Phase|Lack of Efficacy|0|||
127958552|NCT01515423|460467952|FG000|Open Label Phase|Lost to Follow-up|21|||
127958553|NCT01515423|460467953|FG001|Open Label Phase|Lost to Follow-up|0|||
127958554|NCT01515423|460467954|FG002|Open Label Phase|Lost to Follow-up|0|||
127958555|NCT01515423|460467952|FG000|Open Label Phase|Withdrawal by Subject|118|||
127958556|NCT01515423|460467953|FG001|Open Label Phase|Withdrawal by Subject|0|||
127958557|NCT01515423|460467954|FG002|Open Label Phase|Withdrawal by Subject|0|||
127958558|NCT01515423|460467952|FG000|Open Label Phase|excluded from DB Phase|70|||
127958559|NCT01515423|460467953|FG001|Open Label Phase|excluded from DB Phase|0|||
127958560|NCT01515423|460467954|FG002|Open Label Phase|excluded from DB Phase|0|||
127958561|NCT01515423|460467952|FG000|Open Label Phase|Other|28|||
127958562|NCT01515423|460467953|FG001|Open Label Phase|Other|0|||
127958563|NCT01515423|460467954|FG002|Open Label Phase|Other|0|||
127958564|NCT01515423|460467952|FG000|DOUBLE BLIND|Adverse Event|0|||
127958565|NCT01515423|460467953|FG001|DOUBLE BLIND|Adverse Event|15|||
127958566|NCT01515423|460467954|FG002|DOUBLE BLIND|Adverse Event|13|||
127958567|NCT01515423|460467952|FG000|DOUBLE BLIND|Death|0|||
127958568|NCT01515423|460467953|FG001|DOUBLE BLIND|Death|1|||
127958569|NCT01515423|460467954|FG002|DOUBLE BLIND|Death|2|||
127958570|NCT01515423|460467952|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
127958571|NCT01515423|460467953|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
127958572|NCT01515423|460467954|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
127958573|NCT01515423|460467952|FG000|DOUBLE BLIND|Pregnancy|0|||
127958574|NCT01515423|460467953|FG001|DOUBLE BLIND|Pregnancy|2|||
127958575|NCT01515423|460467954|FG002|DOUBLE BLIND|Pregnancy|0|||
127958576|NCT01515423|460467952|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
127958577|NCT01515423|460467953|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
127958578|NCT01515423|460467954|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
127958579|NCT01515423|460467952|FG000|DOUBLE BLIND|Other|0|||
127958580|NCT01515423|460467953|FG001|DOUBLE BLIND|Other|6|||
127958581|NCT01515423|460467954|FG002|DOUBLE BLIND|Other|12|||
127958582|NCT01515423|460467952|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
127958583|NCT01515423|460467953|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
127958584|NCT01515423|460467954|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
127958585|NCT01125917|460467955|FG000|Overall Study|Adverse Event|43|||
127958586|NCT01125917|460467955|FG000|Overall Study|Lost to Follow-up|23|||
127958587|NCT01125917|460467955|FG000|Overall Study|Withdrawal by Subject|31|||
127958588|NCT01125917|460467955|FG000|Overall Study|Administrative|223|||
127958589|NCT01125917|460467955|FG000|Overall Study|Lack of Efficacy|19|||
127958590|NCT04421131|460467956|FG000|Overall Study|Lost to Follow-up|1|||
127958591|NCT04421131|460467956|FG000|Overall Study|Protocol Violation|2|||
127958592|NCT04421131|460467956|FG000|Overall Study|App crashed|5|||
127958593|NCT02501928|460467959|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
127958594|NCT02501928|460467960|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
127958595|NCT02501928|460467961|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
127958596|NCT02501928|460467962|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
127958597|NCT02501928|460467963|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
127958598|NCT02501928|460467964|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
127958599|NCT00838526|460467972|FG000|Overall Study|Adverse Event|3|||
127958600|NCT00838526|460467973|FG001|Overall Study|Adverse Event|12|||
127958601|NCT00838526|460467972|FG000|Overall Study|Lost to Follow-up|4|||
127958602|NCT00838526|460467973|FG001|Overall Study|Lost to Follow-up|12|||
127958603|NCT00838526|460467972|FG000|Overall Study|Withdrawal by Subject|4|||
127958604|NCT00838526|460467973|FG001|Overall Study|Withdrawal by Subject|5|||
127958605|NCT00838526|460467972|FG000|Overall Study|Lack of Efficacy|2|||
127958606|NCT00838526|460467973|FG001|Overall Study|Lack of Efficacy|3|||
127958607|NCT00838526|460467972|FG000|Overall Study|Other|11|||
127958608|NCT00838526|460467973|FG001|Overall Study|Other|7|||
127958609|NCT01320293|460467974|FG000|Overall Study|Lack of Efficacy|1|||
127958610|NCT01320293|460467974|FG000|Overall Study|Adverse Event|1|||
127958611|NCT00931411|460467975|FG000|First Intervention - 42 Days|Adverse Event|2|||
127958612|NCT00931411|460467976|FG001|First Intervention - 42 Days|Adverse Event|3|||
127958613|NCT00931411|460467975|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
127958614|NCT00931411|460467976|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
127958615|NCT00931411|460467975|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
127958616|NCT00931411|460467976|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
127958617|NCT02586155|460467979|FG000|Overall Study|Adverse Event|2|||
127958618|NCT02586155|460467980|FG001|Overall Study|Adverse Event|3|||
127958619|NCT02586155|460467979|FG000|Overall Study|Withdrawal by Subject|31|||
127958620|NCT02586155|460467980|FG001|Overall Study|Withdrawal by Subject|24|||
127958621|NCT02586155|460467979|FG000|Overall Study|Lost to Follow-up|7|||
127958622|NCT02586155|460467980|FG001|Overall Study|Lost to Follow-up|13|||
127958623|NCT02586155|460467979|FG000|Overall Study|Death|61|||
127958624|NCT02586155|460467980|FG001|Overall Study|Death|72|||
127958625|NCT02586155|460467979|FG000|Overall Study|Other reasons|26|||
127958626|NCT02586155|460467980|FG001|Overall Study|Other reasons|15|||
127958627|NCT02633787|460467981|FG000|Overall Study|Withdrawal by Subject|1|||
127958628|NCT02456740|460467983|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
127958629|NCT02456740|460467984|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
127958630|NCT02456740|460467985|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
127958631|NCT02456740|460467986|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
127958632|NCT02456740|460467987|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
127958633|NCT02456740|460467988|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
127958634|NCT02456740|460467989|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
127958635|NCT02456740|460467990|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
127958636|NCT02456740|460467991|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
127958637|NCT02456740|460467983|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
127958638|NCT02456740|460467984|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
127958639|NCT02456740|460467985|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
127958640|NCT02456740|460467986|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
127958641|NCT02456740|460467987|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
127958642|NCT02456740|460467988|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
127958643|NCT02456740|460467989|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
127958644|NCT02456740|460467990|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
127958645|NCT02456740|460467991|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
127958646|NCT02456740|460467983|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
127958647|NCT02456740|460467984|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
127958648|NCT02456740|460467985|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
127958649|NCT02456740|460467986|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
127958650|NCT02456740|460467987|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
127958651|NCT02456740|460467988|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
127958652|NCT02456740|460467989|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
127958653|NCT02456740|460467990|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
127958654|NCT02456740|460467991|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
127958655|NCT02456740|460467983|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
127958656|NCT02456740|460467984|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
127958657|NCT02456740|460467985|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
127958658|NCT02456740|460467986|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
127958659|NCT02456740|460467987|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
127958660|NCT02456740|460467988|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
127958661|NCT02456740|460467989|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
127958662|NCT02456740|460467990|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
127958663|NCT02456740|460467991|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
127958664|NCT02456740|460467983|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
127958665|NCT02456740|460467984|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
127958666|NCT02456740|460467985|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
127958667|NCT02456740|460467986|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
127958668|NCT02456740|460467987|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
127958669|NCT02456740|460467988|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
127958670|NCT02456740|460467989|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
127958671|NCT02456740|460467990|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
127958672|NCT02456740|460467991|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
127958673|NCT02456740|460467983|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
127958674|NCT02456740|460467984|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
127958675|NCT02456740|460467985|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
127958676|NCT02456740|460467986|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
127958677|NCT02456740|460467987|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
127958678|NCT02456740|460467988|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
127958679|NCT02456740|460467989|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
127958680|NCT02456740|460467990|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
127958681|NCT02456740|460467991|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
127958682|NCT02456740|460467983|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
127958683|NCT02456740|460467984|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
127958684|NCT02456740|460467985|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
127958685|NCT02456740|460467986|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
127958686|NCT02456740|460467987|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
127958687|NCT02456740|460467988|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
127958688|NCT02456740|460467989|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
127958689|NCT02456740|460467990|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
127958690|NCT02456740|460467991|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
127958691|NCT04720105|460467992|FG000|Overall Study|Lack of Efficacy|1|||
127958692|NCT04720105|460467992|FG000|Overall Study|Lost to Follow-up|1|||
127958693|NCT04720105|460467992|FG000|Overall Study|Withdrawal by Subject|3|||
127958694|NCT04135937|460467995|FG000|Overall Study|Lost to Follow-up|2|||
127958695|NCT04135937|460467995|FG000|Overall Study|Withdrawal by Subject|1|||
127958696|NCT00955617|460467998|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
127958697|NCT00955617|460467999|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
127958698|NCT00955617|460467998|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
127958699|NCT00955617|460467999|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
127958700|NCT00955617|460467998|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
127958701|NCT00955617|460467999|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
127958702|NCT00955617|460467998|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
127958703|NCT00955617|460467999|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
127958704|NCT02115269|460469013|FG000|Overall Study|Lost to Follow-up|43|||
127958705|NCT02115269|460469013|FG000|Overall Study|Did not complete patient diary|3|||
127958706|NCT02115269|460469013|FG000|Overall Study|Moved to another city|7|||
127958707|NCT02115269|460469013|FG000|Overall Study|Withdrawal by Subject|2|||
127958708|NCT02115269|460469013|FG000|Overall Study|Didn't take study drug|2|||
127958709|NCT01557504|460469014|FG000|Overall Study|Physician Decision|1|||
127958710|NCT01557504|460469015|FG001|Overall Study|Physician Decision|0|||
127958711|NCT02750618|460469016|FG000|Overall Study|Withdrawal by Subject|1|||
127958712|NCT02572570|460469022|FG000|Overall Study|Study Terminated|27|||
127958713|NCT02763046|460469023|FG000|Overall Study|Adverse Event|5|||
127958714|NCT02763046|460469024|FG001|Overall Study|Adverse Event|4|||
127958715|NCT02763046|460469025|FG002|Overall Study|Adverse Event|0|||
127958716|NCT02763046|460469023|FG000|Overall Study|Lack of Efficacy|1|||
127958717|NCT02763046|460469024|FG001|Overall Study|Lack of Efficacy|1|||
127958718|NCT02763046|460469025|FG002|Overall Study|Lack of Efficacy|3|||
127958719|NCT02763046|460469023|FG000|Overall Study|Physician Decision|1|||
127958720|NCT02763046|460469024|FG001|Overall Study|Physician Decision|0|||
127958721|NCT02763046|460469025|FG002|Overall Study|Physician Decision|1|||
127958722|NCT02763046|460469023|FG000|Overall Study|Subject/guardian decision|2|||
127958723|NCT02763046|460469024|FG001|Overall Study|Subject/guardian decision|0|||
127958724|NCT02763046|460469025|FG002|Overall Study|Subject/guardian decision|4|||
127958725|NCT00513695|460469026|FG000|Overall Study|Discontinued therapy|2|||
127958726|NCT00513695|460469026|FG000|Overall Study|Progression prior to surgery|3|||
127958727|NCT04878432|460469031|FG000|Overall Study|Adverse Event|1|||
127958728|NCT04878432|460469031|FG000|Overall Study|Death|2|||
127958729|NCT04878432|460469031|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
127958730|NCT04878432|460469031|FG000|Overall Study|Withdrawal by Subject|6|||
127958731|NCT04878432|460469031|FG000|Overall Study|Progressive Disease|7|||
127958732|NCT04878432|460469031|FG000|Overall Study|New Therapy for Study Indication|7|||
127958733|NCT04878432|460469031|FG000|Overall Study|Physician Decision|11|||
127958734|NCT05017246|460469032|FG000|Overall Study|Withdrawal by Subject|5|||
127958735|NCT05017246|460469033|FG001|Overall Study|Withdrawal by Subject|3|||
127958736|NCT05017246|460469032|FG000|Overall Study|Determined to be ineligible|0|||
127958737|NCT05017246|460469033|FG001|Overall Study|Determined to be ineligible|1|||
127958738|NCT05017246|460469032|FG000|Overall Study|Withdrawn due to patient being given heparin|0|||
127958739|NCT05017246|460469033|FG001|Overall Study|Withdrawn due to patient being given heparin|1|||
127958740|NCT05017246|460469032|FG000|Overall Study|Technical failure|1|||
127958741|NCT05017246|460469033|FG001|Overall Study|Technical failure|3|||
127958742|NCT01514461|460469034|FG000|Overall Study|Adverse Event|2|||
127958743|NCT01514461|460469035|FG001|Overall Study|Adverse Event|1|||
127958744|NCT01514461|460469036|FG002|Overall Study|Adverse Event|3|||
127958745|NCT01514461|460469034|FG000|Overall Study|Physician Decision|1|||
127958746|NCT01514461|460469035|FG001|Overall Study|Physician Decision|1|||
127958747|NCT01514461|460469036|FG002|Overall Study|Physician Decision|0|||
127958748|NCT01514461|460469034|FG000|Overall Study|Patient/guardian decision|1|||
127958749|NCT01514461|460469035|FG001|Overall Study|Patient/guardian decision|1|||
127958750|NCT01514461|460469036|FG002|Overall Study|Patient/guardian decision|1|||
127958751|NCT01514461|460469034|FG000|Overall Study|Death|1|||
127958752|NCT01514461|460469035|FG001|Overall Study|Death|0|||
127958753|NCT01514461|460469036|FG002|Overall Study|Death|0|||
127958754|NCT02058069|460469037|FG000|Overall Study|Exclusion due to implant size|5|||
127958755|NCT02058069|460469037|FG000|Overall Study|Withdrawal by Subject|6|||
127958756|NCT03472014|460469049|FG000|Overall Study|Lost to Follow-up|4|||
127958757|NCT03743051|460469050|FG000|Overall Study|Adverse Event|5|||
127958758|NCT03743051|460469051|FG001|Overall Study|Adverse Event|9|||
127958759|NCT03743051|460469050|FG000|Overall Study|Death|27|||
127958760|NCT03743051|460469051|FG001|Overall Study|Death|26|||
127958761|NCT03743051|460469050|FG000|Overall Study|Lost to Follow-up|4|||
127958762|NCT03743051|460469051|FG001|Overall Study|Lost to Follow-up|8|||
127958763|NCT03743051|460469050|FG000|Overall Study|Withdrawal by Subject|32|||
127958764|NCT03743051|460469051|FG001|Overall Study|Withdrawal by Subject|19|||
127958765|NCT03743051|460469050|FG000|Overall Study|Physician Decision|10|||
127958766|NCT03743051|460469051|FG001|Overall Study|Physician Decision|15|||
127958767|NCT03743051|460469050|FG000|Overall Study|"Reported as Other in Clinical Study Report"|3|||
127958768|NCT03743051|460469051|FG001|Overall Study|"Reported as Other in Clinical Study Report"|6|||
127958769|NCT00711087|460469054|FG000|Overall Study|Lost to Follow-up|1|||
127958770|NCT00711087|460469055|FG001|Overall Study|Lost to Follow-up|0|||
127958771|NCT00811733|460469056|FG000|Overall Study|Investigator Discretion|10|||
127958772|NCT00811733|460469057|FG001|Overall Study|Investigator Discretion|8|||
127958773|NCT00811733|460469056|FG000|Overall Study|Withdrawal by Subject|1|||
127958774|NCT00811733|460469057|FG001|Overall Study|Withdrawal by Subject|2|||
127958775|NCT00793871|460469058|FG000|Overall Study|Death|50|||
127958776|NCT00793871|460469058|FG000|Overall Study|Lost to Follow-up|3|||
127958777|NCT00793871|460469058|FG000|Overall Study|Study terminated by the Sponsor|7|||
127958778|NCT01113892|460469061|FG000|Overall Study|Lost to Follow-up|2|||
127958779|NCT01113892|460469062|FG001|Overall Study|Lost to Follow-up|2|||
127958780|NCT01113892|460469061|FG000|Overall Study|Withdrawal by Subject|1|||
127958781|NCT01113892|460469062|FG001|Overall Study|Withdrawal by Subject|1|||
127958782|NCT01113892|460469061|FG000|Overall Study|Death|2|||
127958783|NCT01113892|460469062|FG001|Overall Study|Death|4|||
127958784|NCT01113892|460469061|FG000|Overall Study|Graft no longer evaluable|9|||
127958785|NCT01113892|460469062|FG001|Overall Study|Graft no longer evaluable|9|||
127958786|NCT02569801|460469063|FG000|Overall Study|Withdrawal by Subject|9|||
127958787|NCT02569801|460469064|FG001|Overall Study|Withdrawal by Subject|9|||
127958788|NCT02569801|460469063|FG000|Overall Study|Sponsor Decision|13|||
127958789|NCT02569801|460469064|FG001|Overall Study|Sponsor Decision|14|||
127958790|NCT02569801|460469063|FG000|Overall Study|Progressive Disease|2|||
127958791|NCT02569801|460469064|FG001|Overall Study|Progressive Disease|7|||
127958792|NCT02569801|460469063|FG000|Overall Study|Lost to Follow-up|0|||
127958793|NCT02569801|460469064|FG001|Overall Study|Lost to Follow-up|1|||
127958794|NCT02569801|460469063|FG000|Overall Study|Death|12|||
127958795|NCT02569801|460469064|FG001|Overall Study|Death|4|||
127958796|NCT00428246|460469065|FG000|Overall Study|Withdrawal by Subject|0|||
127958797|NCT00428246|460469066|FG001|Overall Study|Withdrawal by Subject|0|||
127958798|NCT00428246|460469067|FG002|Overall Study|Withdrawal by Subject|1|||
127958799|NCT00428246|460469065|FG000|Overall Study|Adverse Event|1|||
127958800|NCT00428246|460469066|FG001|Overall Study|Adverse Event|0|||
127958801|NCT00428246|460469067|FG002|Overall Study|Adverse Event|0|||
127958802|NCT03442751|460469069|FG000|Overall Study|Withdrawal by Subject|3|||
127958803|NCT03442751|460469070|FG001|Overall Study|Withdrawal by Subject|1|||
127958804|NCT03442751|460469069|FG000|Overall Study|Lost to Follow-up|3|||
127958805|NCT03442751|460469070|FG001|Overall Study|Lost to Follow-up|0|||
127958806|NCT02603887|460469071|FG000|Stage 1|Adverse Event|4|||
127958807|NCT02603887|460469071|FG000|Stage 1|Disease progression|1|||
127958808|NCT02603887|460469071|FG000|Stage 2|FDA guidance|1|||
127958809|NCT03483012|460469081|FG000|Overall Study|Lack of Efficacy|6|||
127958810|NCT04782076|460469082|FG000|Overall Study|Family Emergency|1|||
127958811|NCT01949662|460469093|FG000|Overall Study|Death|9|||
127958812|NCT01949662|460469094|FG001|Overall Study|Death|7|||
127958813|NCT01949662|460469093|FG000|Overall Study|Discharged before an agitation event|8|||
127958814|NCT01949662|460469094|FG001|Overall Study|Discharged before an agitation event|3|||
127958815|NCT01949662|460469093|FG000|Overall Study|Dropped out|1|||
127958816|NCT01949662|460469094|FG001|Overall Study|Dropped out|3|||
127958817|NCT01949662|460469093|FG000|Overall Study|Ineligible|0|||
127958818|NCT01949662|460469094|FG001|Overall Study|Ineligible|1|||
127958819|NCT02072980|460469099|FG000|Period 2, Second Wear|Adverse Event|0|||
127958820|NCT02072980|460469100|FG001|Period 2, Second Wear|Adverse Event|1|||
127958821|NCT01757275|460469101|FG000|Overall Study|Lost to Follow-up|1|||
127958822|NCT01757275|460469102|FG001|Overall Study|Lost to Follow-up|2|||
127958823|NCT01757275|460469101|FG000|Overall Study|Adverse Event|3|||
127958824|NCT01757275|460469102|FG001|Overall Study|Adverse Event|3|||
127958825|NCT01757275|460469101|FG000|Overall Study|Withdrawal by Subject|2|||
127958826|NCT01757275|460469102|FG001|Overall Study|Withdrawal by Subject|4|||
127958827|NCT01757275|460469101|FG000|Overall Study|Not treated|3|||
127958828|NCT01757275|460469102|FG001|Overall Study|Not treated|4|||
127958829|NCT01401452|460469105|FG000|Overall Study|Adverse reaction|9|||
127958830|NCT01401452|460469105|FG000|Overall Study|Lost to Follow-up|12|||
127958831|NCT01401452|460469105|FG000|Overall Study|Lack of Efficacy|30|||
127958832|NCT01401452|460469105|FG000|Overall Study|Participant developed breast cancer|1|||
127958833|NCT01401452|460469105|FG000|Overall Study|Tx stopped due to financial reasons|1|||
127958834|NCT01401452|460469105|FG000|Overall Study|Tx stopped by psychiatrist|1|||
127958835|NCT01401452|460469105|FG000|Overall Study|No more visits within the 36 wk followup|4|||
127958836|NCT01401452|460469105|FG000|Overall Study|Subject did not come to follow up visits|2|||
127958837|NCT01401452|460469105|FG000|Overall Study|Subject didn't return for routine visits|1|||
127958838|NCT01401452|460469105|FG000|Overall Study|Subject moved to another city|1|||
127958839|NCT01401452|460469105|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
127958840|NCT01401452|460469105|FG000|Overall Study|Psoriatic arthritis|1|||
127958841|NCT01401452|460469105|FG000|Overall Study|Participant stopped Tx|2|||
127958842|NCT01401452|460469105|FG000|Overall Study|Discontinuation for personal reasons|1|||
127958843|NCT01401452|460469105|FG000|Overall Study|Treatment failure|1|||
127958844|NCT01401452|460469105|FG000|Overall Study|Unsatisfactory output|1|||
127958845|NCT01401452|460469105|FG000|Overall Study|Subject withdrew because of Tx success|1|||
127958846|NCT01401452|460469105|FG000|Overall Study|Subject chose to discontinue treatment|1|||
127958847|NCT01401452|460469105|FG000|Overall Study|Participant withdrew consent|1|||
127958848|NCT02601014|460469106|FG000|Overall Study|Adverse Event|3|||
127958849|NCT02601014|460469107|FG001|Overall Study|Adverse Event|3|||
127958850|NCT02601014|460469106|FG000|Overall Study|Death|3|||
127958851|NCT02601014|460469107|FG001|Overall Study|Death|1|||
127958852|NCT02601014|460469106|FG000|Overall Study|Disease progression|4|||
127958853|NCT02601014|460469107|FG001|Overall Study|Disease progression|8|||
127958854|NCT01168427|460469108|FG000|Overall Study|Patient exited prior to implant|1|||
127958855|NCT01133067|460469113|FG000|Overall Study|Death|136|||
127958856|NCT01133067|460469113|FG000|Overall Study|Lost to Follow-up|3|||
127958857|NCT00420420|460469115|FG000|Overall Study|Adverse Event|5|||
127958858|NCT00420420|460469116|FG001|Overall Study|Adverse Event|3|||
127958859|NCT00420420|460469115|FG000|Overall Study|Protocol Violation|1|||
127958860|NCT00420420|460469116|FG001|Overall Study|Protocol Violation|1|||
127958861|NCT00420420|460469115|FG000|Overall Study|Withdrawal by Subject|1|||
127958862|NCT00420420|460469116|FG001|Overall Study|Withdrawal by Subject|0|||
127958863|NCT00420420|460469115|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
127958864|NCT00420420|460469116|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
127958865|NCT00273182|460469117|FG000|Overall Study|Death|450|||
127958866|NCT00273182|460469117|FG000|Overall Study|Lost to Follow-up|88|||
127958867|NCT00273182|460469117|FG000|Overall Study|Withdrawal by Subject|257|||
127958868|NCT00273182|460469117|FG000|Overall Study|Device/System Explant|154|||
127958869|NCT00273182|460469117|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
127958870|NCT00856492|460469118|FG000|Overall Study|Ineligible or withdrew consent|1|||
127958871|NCT00856492|460469119|FG001|Overall Study|Ineligible or withdrew consent|1|||
127958872|NCT00856492|460469120|FG002|Overall Study|Ineligible or withdrew consent|2|||
127958873|NCT00868530|460469123|FG000|Overall Study|Adverse Event|3|||
127958874|NCT00868530|460469123|FG000|Overall Study|Lost to Follow-up|1|||
127958875|NCT00858273|460469124|FG000|Overall Study|Protocol Violation|3|||
127958876|NCT00858273|460469125|FG001|Overall Study|Protocol Violation|5|||
127958877|NCT00070564|460470875|FG000|Overall Study|Progression|2|||
127958878|NCT00070564|460470876|FG001|Overall Study|Progression|4|||
127958879|NCT00070564|460470877|FG002|Overall Study|Progression|7|||
127958880|NCT00070564|460470878|FG003|Overall Study|Progression|7|||
127958881|NCT00070564|460470879|FG004|Overall Study|Progression|1|||
127958882|NCT00070564|460470880|FG005|Overall Study|Progression|0|||
127958883|NCT00070564|460470875|FG000|Overall Study|Delinquent|1|||
127958884|NCT00070564|460470876|FG001|Overall Study|Delinquent|4|||
127958885|NCT00070564|460470877|FG002|Overall Study|Delinquent|2|||
127958886|NCT00070564|460470878|FG003|Overall Study|Delinquent|0|||
127958887|NCT00070564|460470879|FG004|Overall Study|Delinquent|0|||
127958888|NCT00070564|460470880|FG005|Overall Study|Delinquent|0|||
127958889|NCT00070564|460470875|FG000|Overall Study|Adverse Event|150|||
127958890|NCT00070564|460470876|FG001|Overall Study|Adverse Event|142|||
127958891|NCT00070564|460470877|FG002|Overall Study|Adverse Event|120|||
127958892|NCT00070564|460470878|FG003|Overall Study|Adverse Event|108|||
127958893|NCT00070564|460470879|FG004|Overall Study|Adverse Event|63|||
127958894|NCT00070564|460470880|FG005|Overall Study|Adverse Event|36|||
127958895|NCT00070564|460470875|FG000|Overall Study|Death|4|||
127958896|NCT00070564|460470876|FG001|Overall Study|Death|1|||
127958897|NCT00070564|460470877|FG002|Overall Study|Death|5|||
127958898|NCT00070564|460470878|FG003|Overall Study|Death|3|||
127958899|NCT00070564|460470879|FG004|Overall Study|Death|0|||
127958900|NCT00070564|460470880|FG005|Overall Study|Death|1|||
127958901|NCT00070564|460470875|FG000|Overall Study|Other, not protocol specified|17|||
127958902|NCT00070564|460470876|FG001|Overall Study|Other, not protocol specified|15|||
127958903|NCT00070564|460470877|FG002|Overall Study|Other, not protocol specified|14|||
127958904|NCT00070564|460470878|FG003|Overall Study|Other, not protocol specified|19|||
127958905|NCT00070564|460470879|FG004|Overall Study|Other, not protocol specified|6|||
127958906|NCT00070564|460470880|FG005|Overall Study|Other, not protocol specified|7|||
127958907|NCT00070564|460470875|FG000|Overall Study|Withdrawal by Subject|26|||
127958908|NCT00070564|460470876|FG001|Overall Study|Withdrawal by Subject|37|||
127958909|NCT00070564|460470877|FG002|Overall Study|Withdrawal by Subject|23|||
127958910|NCT00070564|460470878|FG003|Overall Study|Withdrawal by Subject|30|||
127958911|NCT00070564|460470879|FG004|Overall Study|Withdrawal by Subject|8|||
127958912|NCT00070564|460470880|FG005|Overall Study|Withdrawal by Subject|8|||
127958913|NCT00070564|460470875|FG000|Overall Study|Not reported|0|||
127958914|NCT00070564|460470876|FG001|Overall Study|Not reported|0|||
127958915|NCT00070564|460470877|FG002|Overall Study|Not reported|0|||
127958916|NCT00070564|460470878|FG003|Overall Study|Not reported|0|||
127958917|NCT00070564|460470879|FG004|Overall Study|Not reported|1|||
127958918|NCT00070564|460470880|FG005|Overall Study|Not reported|0|||
127958919|NCT00931528|460470881|FG000|Overall Study|Protocol Violation|9|||
127958920|NCT00931528|460470882|FG001|Overall Study|Protocol Violation|12|||
127958921|NCT00931528|460470881|FG000|Overall Study|Withdrawal by Subject|4|||
127958922|NCT00931528|460470882|FG001|Overall Study|Withdrawal by Subject|12|||
127958923|NCT00931528|460470881|FG000|Overall Study|Lost to Follow-up|6|||
127958924|NCT00931528|460470882|FG001|Overall Study|Lost to Follow-up|13|||
127958925|NCT00931528|460470881|FG000|Overall Study|Assessment outside of Time Frame|22|||
127958926|NCT00931528|460470882|FG001|Overall Study|Assessment outside of Time Frame|23|||
127958927|NCT02493660|460470883|FG000|Overall Study|Physician Decision|0|||
127958928|NCT02493660|460470884|FG001|Overall Study|Physician Decision|1|||
127958929|NCT02493660|460470883|FG000|Overall Study|Adverse Event|4|||
127958930|NCT02493660|460470884|FG001|Overall Study|Adverse Event|2|||
127958931|NCT02493660|460470883|FG000|Overall Study|Withdrawal by Subject|2|||
127958932|NCT02493660|460470884|FG001|Overall Study|Withdrawal by Subject|3|||
127958933|NCT02493660|460470883|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
127958934|NCT02493660|460470884|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
127958935|NCT02493660|460470883|FG000|Overall Study|Protocol Violation|0|||
127958936|NCT02493660|460470884|FG001|Overall Study|Protocol Violation|1|||
127958937|NCT02493660|460470883|FG000|Overall Study|Death|0|||
127958938|NCT02493660|460470884|FG001|Overall Study|Death|1|||
127958939|NCT02493660|460470883|FG000|Overall Study|Lost to Follow-up|2|||
127958940|NCT02493660|460470884|FG001|Overall Study|Lost to Follow-up|4|||
127958941|NCT02392481|460470888|FG000|Overall Study|Adverse Event|0|||
127958942|NCT02392481|460470889|FG001|Overall Study|Adverse Event|0|||
127958943|NCT02392481|460470890|FG002|Overall Study|Adverse Event|1|||
127958944|NCT02392481|460470891|FG003|Overall Study|Adverse Event|2|||
127958945|NCT02392481|460470888|FG000|Overall Study|Withdrawal by Subject|0|||
127958946|NCT02392481|460470889|FG001|Overall Study|Withdrawal by Subject|0|||
127958947|NCT02392481|460470890|FG002|Overall Study|Withdrawal by Subject|1|||
127958948|NCT02392481|460470891|FG003|Overall Study|Withdrawal by Subject|0|||
127958949|NCT02502149|460470893|FG000|Intermediate|Discontinued prematurely|1|||
127958950|NCT02502149|460470894|FG001|Intermediate|Discontinued prematurely|0|||
127958951|NCT02502149|460470895|FG002|Intermediate|Discontinued prematurely|0|||
127958952|NCT02502149|460470896|FG003|Intermediate|Discontinued prematurely|0|||
127958953|NCT02502149|460470897|FG004|Intermediate|Discontinued prematurely|0|||
127958954|NCT02968576|460470898|FG000|Overall Study|Pregnancy|0|||
127958955|NCT02968576|460470899|FG001|Overall Study|Pregnancy|1|||
127958956|NCT02222922|460470900|FG000|Overall Study|Death|0|||
127958957|NCT02222922|460470901|FG001|Overall Study|Death|0|||
127958958|NCT02222922|460470902|FG002|Overall Study|Death|0|||
127958959|NCT02222922|460470903|FG003|Overall Study|Death|0|||
127958960|NCT02222922|460470904|FG004|Overall Study|Death|13|||
127958961|NCT02222922|460470905|FG005|Overall Study|Death|0|||
127958962|NCT02222922|460470906|FG006|Overall Study|Death|0|||
127958963|NCT02222922|460470907|FG007|Overall Study|Death|0|||
127958964|NCT02222922|460470908|FG008|Overall Study|Death|2|||
127958965|NCT02222922|460470900|FG000|Overall Study|Lost to Follow-up|0|||
127958966|NCT02222922|460470901|FG001|Overall Study|Lost to Follow-up|0|||
127958967|NCT02222922|460470902|FG002|Overall Study|Lost to Follow-up|1|||
127958968|NCT02222922|460470903|FG003|Overall Study|Lost to Follow-up|0|||
127958969|NCT02222922|460470904|FG004|Overall Study|Lost to Follow-up|9|||
127958970|NCT02222922|460470905|FG005|Overall Study|Lost to Follow-up|1|||
127958971|NCT02222922|460470906|FG006|Overall Study|Lost to Follow-up|0|||
127958972|NCT02222922|460470907|FG007|Overall Study|Lost to Follow-up|0|||
127958973|NCT02222922|460470908|FG008|Overall Study|Lost to Follow-up|0|||
127958974|NCT02222922|460470900|FG000|Overall Study|Other|0|||
127958975|NCT02222922|460470901|FG001|Overall Study|Other|0|||
127958976|NCT02222922|460470902|FG002|Overall Study|Other|0|||
127958977|NCT02222922|460470903|FG003|Overall Study|Other|2|||
127958978|NCT02222922|460470904|FG004|Overall Study|Other|10|||
127958979|NCT02222922|460470905|FG005|Overall Study|Other|2|||
127958980|NCT02222922|460470906|FG006|Overall Study|Other|2|||
127958981|NCT02222922|460470907|FG007|Overall Study|Other|4|||
127958982|NCT02222922|460470908|FG008|Overall Study|Other|1|||
127958983|NCT02222922|460470900|FG000|Overall Study|Participant refused further follow-up|1|||
127958984|NCT02222922|460470901|FG001|Overall Study|Participant refused further follow-up|0|||
127958985|NCT02222922|460470902|FG002|Overall Study|Participant refused further follow-up|0|||
127958986|NCT02222922|460470903|FG003|Overall Study|Participant refused further follow-up|1|||
127958987|NCT02222922|460470904|FG004|Overall Study|Participant refused further follow-up|6|||
127958988|NCT02222922|460470905|FG005|Overall Study|Participant refused further follow-up|0|||
127958989|NCT02222922|460470906|FG006|Overall Study|Participant refused further follow-up|0|||
127958990|NCT02222922|460470907|FG007|Overall Study|Participant refused further follow-up|0|||
127958991|NCT02222922|460470908|FG008|Overall Study|Participant refused further follow-up|3|||
127958992|NCT01254643|460470909|FG000|Overall Study|Withdrawal by Subject|1|||
127958993|NCT03359850|460470912|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
127958994|NCT03359850|460470913|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
127958995|NCT03359850|460470912|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
127958996|NCT03359850|460470913|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
127958997|NCT03359850|460470912|FG000|Extension Phase (Up to 28 Months)|Death|2|||
127958998|NCT03359850|460470913|FG001|Extension Phase (Up to 28 Months)|Death|4|||
127958999|NCT03359850|460470912|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
127959000|NCT03359850|460470913|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
127959001|NCT03359850|460470912|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
127959002|NCT03359850|460470913|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
127959003|NCT00116779|460470920|FG000|Overall Study|Adverse Event|4|||
127959004|NCT00116779|460470921|FG001|Overall Study|Adverse Event|2|||
127959005|NCT00116779|460470920|FG000|Overall Study|Protocol Violation|1|||
127959006|NCT00116779|460470921|FG001|Overall Study|Protocol Violation|4|||
127959007|NCT00116779|460470920|FG000|Overall Study|Withdrawal by Subject|4|||
127959008|NCT00116779|460470921|FG001|Overall Study|Withdrawal by Subject|1|||
127959009|NCT00116779|460470920|FG000|Overall Study|Inadequate testosterone suppression|7|||
127959010|NCT00116779|460470921|FG001|Overall Study|Inadequate testosterone suppression|9|||
127959011|NCT00116779|460470920|FG000|Overall Study|Physician Decision|3|||
127959012|NCT00116779|460470921|FG001|Overall Study|Physician Decision|1|||
127959013|NCT00116779|460470920|FG000|Overall Study|Elevated PSA levels|2|||
127959014|NCT00116779|460470921|FG001|Overall Study|Elevated PSA levels|2|||
127959015|NCT02105467|460470922|FG000|Period 1|Lost to Follow-up|1|||
127959016|NCT02105467|460470923|FG001|Period 1|Lost to Follow-up|0|||
127959017|NCT02105467|460470922|FG000|Period 1|Death|1|||
127959018|NCT02105467|460470923|FG001|Period 1|Death|0|||
127959019|NCT02105467|460470922|FG000|Period 2|Lost to Follow-up|1|||
127959020|NCT02105467|460470923|FG001|Period 2|Lost to Follow-up|0|||
127959021|NCT02105467|460470922|FG000|Period 2|Death|1|||
127959022|NCT02105467|460470923|FG001|Period 2|Death|0|||
127959023|NCT02105467|460470922|FG000|Period 2|Withdrawal by Subject|0|||
127959024|NCT02105467|460470923|FG001|Period 2|Withdrawal by Subject|2|||
127959025|NCT02105467|460470922|FG000|Period 3|Lost to Follow-up|0|||
127959026|NCT02105467|460470923|FG001|Period 3|Lost to Follow-up|1|||
127959027|NCT01037218|460470928|FG000|Overall Study|Adverse Event|4|||
127959028|NCT01037218|460470929|FG001|Overall Study|Adverse Event|2|||
127959029|NCT01037218|460470930|FG002|Overall Study|Adverse Event|2|||
127959030|NCT01037218|460470931|FG003|Overall Study|Adverse Event|1|||
127959031|NCT01037218|460470928|FG000|Overall Study|Lack of Efficacy|0|||
127959032|NCT01037218|460470929|FG001|Overall Study|Lack of Efficacy|2|||
127959033|NCT01037218|460470930|FG002|Overall Study|Lack of Efficacy|1|||
127959034|NCT01037218|460470931|FG003|Overall Study|Lack of Efficacy|5|||
127959035|NCT01037218|460470928|FG000|Overall Study|Lost to Follow-up|3|||
127959036|NCT01037218|460470929|FG001|Overall Study|Lost to Follow-up|5|||
127959037|NCT01037218|460470930|FG002|Overall Study|Lost to Follow-up|4|||
127959038|NCT01037218|460470931|FG003|Overall Study|Lost to Follow-up|2|||
127959039|NCT01037218|460470928|FG000|Overall Study|Withdrawal by Subject|6|||
127959040|NCT01037218|460470929|FG001|Overall Study|Withdrawal by Subject|7|||
127959041|NCT01037218|460470930|FG002|Overall Study|Withdrawal by Subject|7|||
127959042|NCT01037218|460470931|FG003|Overall Study|Withdrawal by Subject|4|||
127959043|NCT01037218|460470928|FG000|Overall Study|Partner Withdrew Consent|0|||
127959044|NCT01037218|460470929|FG001|Overall Study|Partner Withdrew Consent|3|||
127959045|NCT01037218|460470930|FG002|Overall Study|Partner Withdrew Consent|2|||
127959046|NCT01037218|460470931|FG003|Overall Study|Partner Withdrew Consent|1|||
127959047|NCT01037218|460470928|FG000|Overall Study|Protocol Violation|0|||
127959048|NCT01037218|460470929|FG001|Overall Study|Protocol Violation|0|||
127959049|NCT01037218|460470930|FG002|Overall Study|Protocol Violation|2|||
127959050|NCT01037218|460470931|FG003|Overall Study|Protocol Violation|2|||
127959051|NCT01037218|460470928|FG000|Overall Study|Various|3|||
127959052|NCT01037218|460470929|FG001|Overall Study|Various|2|||
127959053|NCT01037218|460470930|FG002|Overall Study|Various|3|||
127959054|NCT01037218|460470931|FG003|Overall Study|Various|1|||
127959055|NCT02676882|460470932|FG000|Overall Study|Adverse Event|1|||
127959056|NCT02676882|460470933|FG001|Overall Study|Adverse Event|0|||
127959057|NCT02676882|460470932|FG000|Overall Study|Lost to Follow-up|1|||
127959058|NCT02676882|460470933|FG001|Overall Study|Lost to Follow-up|0|||
127959059|NCT02676882|460470932|FG000|Overall Study|Withdrawal by Subject|1|||
127959060|NCT02676882|460470933|FG001|Overall Study|Withdrawal by Subject|2|||
127959061|NCT02568072|460470937|FG000|Overall Study|Unavailable for appointment|23|||
127959062|NCT02568072|460470937|FG000|Overall Study|Unable to contact|3|||
127959063|NCT02568072|460470937|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
127959064|NCT02568072|460470937|FG000|Overall Study|Withdrawal by Subject|1|||
127959065|NCT02568072|460470937|FG000|Overall Study|Sustained injury, marathon not run|24|||
127959066|NCT00958828|460470939|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
127959067|NCT00958828|460470940|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
127959068|NCT00958828|460470939|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
127959069|NCT00958828|460470940|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
127959070|NCT02687451|460470942|FG000|Overall Study|Withdrawal by Subject|1|||
127959071|NCT02687451|460470943|FG001|Overall Study|Withdrawal by Subject|0|||
127959072|NCT02687451|460470944|FG002|Overall Study|Withdrawal by Subject|0|||
127959073|NCT02687451|460470945|FG003|Overall Study|Withdrawal by Subject|0|||
127959074|NCT02687451|460470946|FG004|Overall Study|Withdrawal by Subject|0|||
127959075|NCT02687451|460470947|FG005|Overall Study|Withdrawal by Subject|1|||
127959076|NCT00927589|460470948|FG000|Overall Study|Death|1|||
127959077|NCT00927589|460470948|FG000|Overall Study|Physician Decision|1|||
127959078|NCT00927589|460470948|FG000|Overall Study|Withdrawal by Subject|3|||
127959079|NCT00927589|460470948|FG000|Overall Study|Adverse Event|2|||
127959080|NCT00927589|460470948|FG000|Overall Study|Disease Progression|8|||
127959081|NCT00927589|460470948|FG000|Overall Study|Non-compliance|1|||
127959082|NCT01125189|460470949|FG000|Treatment Period|Lack of Efficacy|15|||
127959083|NCT01125189|460470950|FG001|Treatment Period|Lack of Efficacy|18|||
127959084|NCT01125189|460470951|FG002|Treatment Period|Lack of Efficacy|25|||
127959085|NCT01125189|460470949|FG000|Treatment Period|Adverse Event|7|||
127959086|NCT01125189|460470950|FG001|Treatment Period|Adverse Event|8|||
127959087|NCT01125189|460470951|FG002|Treatment Period|Adverse Event|8|||
127959088|NCT01125189|460470949|FG000|Treatment Period|Withdrawal by Subject|3|||
127959089|NCT01125189|460470950|FG001|Treatment Period|Withdrawal by Subject|1|||
127959090|NCT01125189|460470951|FG002|Treatment Period|Withdrawal by Subject|1|||
127959091|NCT01125189|460470949|FG000|Treatment Period|Death|1|||
127959092|NCT01125189|460470950|FG001|Treatment Period|Death|0|||
127959093|NCT01125189|460470951|FG002|Treatment Period|Death|0|||
127959094|NCT01125189|460470949|FG000|Treatment Period|Lost to Follow-up|1|||
127959095|NCT01125189|460470950|FG001|Treatment Period|Lost to Follow-up|2|||
127959096|NCT01125189|460470951|FG002|Treatment Period|Lost to Follow-up|1|||
127959097|NCT01125189|460470949|FG000|Treatment Period|Poor compliance/noncompliance|0|||
127959098|NCT01125189|460470950|FG001|Treatment Period|Poor compliance/noncompliance|1|||
127959099|NCT01125189|460470951|FG002|Treatment Period|Poor compliance/noncompliance|0|||
127959100|NCT01125189|460470949|FG000|Treatment Period|Participants requested to discontinue|1|||
127959101|NCT01125189|460470950|FG001|Treatment Period|Participants requested to discontinue|3|||
127959102|NCT01125189|460470951|FG002|Treatment Period|Participants requested to discontinue|4|||
127959103|NCT01125189|460470949|FG000|Treatment Period|Other reasons|1|||
127959104|NCT01125189|460470950|FG001|Treatment Period|Other reasons|1|||
127959105|NCT01125189|460470951|FG002|Treatment Period|Other reasons|0|||
127959106|NCT01125189|460470949|FG000|Treatment Period|Completed 24 week treatment period only|2|||
127959107|NCT01125189|460470950|FG001|Treatment Period|Completed 24 week treatment period only|1|||
127959108|NCT01125189|460470951|FG002|Treatment Period|Completed 24 week treatment period only|2|||
127959109|NCT01125189|460470949|FG000|Follow up Period|Withdrawal by Subject|3|||
127959110|NCT01125189|460470950|FG001|Follow up Period|Withdrawal by Subject|2|||
127959111|NCT01125189|460470951|FG002|Follow up Period|Withdrawal by Subject|5|||
127959112|NCT01125189|460470949|FG000|Follow up Period|Death|1|||
127959113|NCT01125189|460470950|FG001|Follow up Period|Death|0|||
127959114|NCT01125189|460470951|FG002|Follow up Period|Death|0|||
127959115|NCT01125189|460470949|FG000|Follow up Period|Lost to Follow-up|12|||
127959116|NCT01125189|460470950|FG001|Follow up Period|Lost to Follow-up|9|||
127959117|NCT01125189|460470951|FG002|Follow up Period|Lost to Follow-up|6|||
127959118|NCT01125189|460470949|FG000|Follow up Period|Other reasons|4|||
127959119|NCT01125189|460470950|FG001|Follow up Period|Other reasons|4|||
127959120|NCT01125189|460470951|FG002|Follow up Period|Other reasons|5|||
127959121|NCT00707239|460470952|FG000|Overall Study|Adverse Event|5|||
127959122|NCT00707239|460470953|FG001|Overall Study|Adverse Event|3|||
127959123|NCT00707239|460470954|FG002|Overall Study|Adverse Event|2|||
127959124|NCT00707239|460470952|FG000|Overall Study|Death|3|||
127959125|NCT00707239|460470953|FG001|Overall Study|Death|1|||
127959126|NCT00707239|460470954|FG002|Overall Study|Death|3|||
127959127|NCT00707239|460470952|FG000|Overall Study|Physician Decision|1|||
127959128|NCT00707239|460470953|FG001|Overall Study|Physician Decision|1|||
127959129|NCT00707239|460470954|FG002|Overall Study|Physician Decision|2|||
127959130|NCT00707239|460470952|FG000|Overall Study|Protocol Violation|0|||
127959131|NCT00707239|460470953|FG001|Overall Study|Protocol Violation|0|||
127959132|NCT00707239|460470954|FG002|Overall Study|Protocol Violation|1|||
127959133|NCT00707239|460470952|FG000|Overall Study|Lack of Efficacy|1|||
127959134|NCT00707239|460470953|FG001|Overall Study|Lack of Efficacy|2|||
127959135|NCT00707239|460470954|FG002|Overall Study|Lack of Efficacy|0|||
127959136|NCT00707239|460470952|FG000|Overall Study|Randomized, but not treated|1|||
127959137|NCT00707239|460470953|FG001|Overall Study|Randomized, but not treated|1|||
127959138|NCT00707239|460470954|FG002|Overall Study|Randomized, but not treated|1|||
127959139|NCT00707239|460470952|FG000|Overall Study|Other|8|||
127959140|NCT00707239|460470953|FG001|Overall Study|Other|3|||
127959141|NCT00707239|460470954|FG002|Overall Study|Other|5|||
127959142|NCT01651117|460470957|FG000|Overall Study|Death|2|||
127959143|NCT01651117|460470958|FG001|Overall Study|Death|3|||
127959144|NCT01651117|460470959|FG002|Overall Study|Death|2|||
127959145|NCT01651117|460470960|FG003|Overall Study|Death|2|||
127959146|NCT02714218|460470961|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
127959147|NCT02714218|460470962|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
127959148|NCT02714218|460470963|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
127959149|NCT02714218|460470961|FG000|Pre-Treatment Period|Other reasons|0|||
127959150|NCT02714218|460470962|FG001|Pre-Treatment Period|Other reasons|1|||
127959151|NCT02714218|460470963|FG002|Pre-Treatment Period|Other reasons|0|||
127959152|NCT02714218|460470961|FG000|Treatment Period|Disease Progression|55|||
127959153|NCT02714218|460470962|FG001|Treatment Period|Disease Progression|52|||
127959154|NCT02714218|460470963|FG002|Treatment Period|Disease Progression|14|||
127959155|NCT02714218|460470961|FG000|Treatment Period|Study drug toxicity|46|||
127959156|NCT02714218|460470962|FG001|Treatment Period|Study drug toxicity|70|||
127959157|NCT02714218|460470963|FG002|Treatment Period|Study drug toxicity|6|||
127959158|NCT02714218|460470961|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
127959159|NCT02714218|460470962|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
127959160|NCT02714218|460470963|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
127959161|NCT02714218|460470961|FG000|Treatment Period|Request to discontinue treatment|1|||
127959162|NCT02714218|460470962|FG001|Treatment Period|Request to discontinue treatment|4|||
127959163|NCT02714218|460470963|FG002|Treatment Period|Request to discontinue treatment|1|||
127959164|NCT02714218|460470961|FG000|Treatment Period|Participant withdrew consent|2|||
127959165|NCT02714218|460470962|FG001|Treatment Period|Participant withdrew consent|2|||
127959166|NCT02714218|460470963|FG002|Treatment Period|Participant withdrew consent|0|||
127959167|NCT02714218|460470961|FG000|Treatment Period|Maximum clinical benefit|4|||
127959168|NCT02714218|460470962|FG001|Treatment Period|Maximum clinical benefit|2|||
127959169|NCT02714218|460470963|FG002|Treatment Period|Maximum clinical benefit|0|||
127959170|NCT02714218|460470961|FG000|Treatment Period|Administrative reason by sponsor|2|||
127959171|NCT02714218|460470962|FG001|Treatment Period|Administrative reason by sponsor|1|||
127959172|NCT02714218|460470963|FG002|Treatment Period|Administrative reason by sponsor|0|||
127959173|NCT02714218|460470961|FG000|Treatment Period|Other reasons|6|||
127959174|NCT02714218|460470962|FG001|Treatment Period|Other reasons|6|||
127959175|NCT02714218|460470963|FG002|Treatment Period|Other reasons|0|||
127959176|NCT02714218|460470961|FG000|Treatment Period|Completed treatment as per protocol|36|||
127959177|NCT02714218|460470962|FG001|Treatment Period|Completed treatment as per protocol|27|||
127959178|NCT02714218|460470963|FG002|Treatment Period|Completed treatment as per protocol|3|||
127959179|NCT02714218|460470961|FG000|Treatment Period|Not reported|9|||
127959180|NCT02714218|460470962|FG001|Treatment Period|Not reported|6|||
127959181|NCT02714218|460470963|FG002|Treatment Period|Not reported|0|||
127959182|NCT01433471|460470964|FG000|Overall Study|Withdrawal by Subject|0|||
127959183|NCT01433471|460470965|FG001|Overall Study|Withdrawal by Subject|1|||
127959184|NCT03711188|460470968|FG000|Overall Study|Disease progression|11|||
127959185|NCT03711188|460470968|FG000|Overall Study|Adverse Event|1|||
127959186|NCT03875508|460470969|FG000|Overall Study|Adverse Event|1|||
127959187|NCT03875508|460470969|FG000|Overall Study|Lost to Follow-up|8|||
127959188|NCT03875508|460470969|FG000|Overall Study|Lack of Efficacy|1|||
127959189|NCT03875508|460470969|FG000|Overall Study|Other, not specified|2|||
127959190|NCT03652051|460470973|FG000|Stage 1|Adverse Event|0|||
127959191|NCT03652051|460470974|FG001|Stage 1|Adverse Event|5|||
127959192|NCT03652051|460470975|FG002|Stage 1|Adverse Event|7|||
127959193|NCT03652051|460470976|FG003|Stage 1|Adverse Event|1|||
127959194|NCT03652051|460470973|FG000|Stage 1|Withdrawal by Subject|0|||
127959195|NCT03652051|460470974|FG001|Stage 1|Withdrawal by Subject|0|||
127959196|NCT03652051|460470975|FG002|Stage 1|Withdrawal by Subject|1|||
127959197|NCT03652051|460470976|FG003|Stage 1|Withdrawal by Subject|0|||
127959198|NCT03652051|460470973|FG000|Stage 2|Adverse Event|0|||
127959199|NCT03652051|460470974|FG001|Stage 2|Adverse Event|2|||
127959200|NCT03652051|460470975|FG002|Stage 2|Adverse Event|1|||
127959201|NCT03652051|460470976|FG003|Stage 2|Adverse Event|0|||
127959202|NCT03652051|460470973|FG000|Stage 2|Protocol Violation|0|||
127959203|NCT03652051|460470974|FG001|Stage 2|Protocol Violation|1|||
127959204|NCT03652051|460470975|FG002|Stage 2|Protocol Violation|6|||
127959205|NCT03652051|460470976|FG003|Stage 2|Protocol Violation|0|||
127959206|NCT03652051|460470973|FG000|Stage 2|Lost to Follow-up|0|||
127959207|NCT03652051|460470974|FG001|Stage 2|Lost to Follow-up|2|||
127959208|NCT03652051|460470975|FG002|Stage 2|Lost to Follow-up|0|||
127959209|NCT03652051|460470976|FG003|Stage 2|Lost to Follow-up|3|||
127959210|NCT03652051|460470973|FG000|Stage 2|Withdrawal by Subject|0|||
127959211|NCT03652051|460470974|FG001|Stage 2|Withdrawal by Subject|11|||
127959212|NCT03652051|460470975|FG002|Stage 2|Withdrawal by Subject|9|||
127959213|NCT03652051|460470976|FG003|Stage 2|Withdrawal by Subject|3|||
127959214|NCT03164551|460470982|FG000|Overall Study|Imaging discontinued prior completion|8|||
127959215|NCT03164551|460470983|FG001|Overall Study|Imaging discontinued prior completion|0|||
127959216|NCT03164551|460470982|FG000|Overall Study|Participant was non-compliant|1|||
127959217|NCT03164551|460470983|FG001|Overall Study|Participant was non-compliant|0|||
127959218|NCT03164551|460470982|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
127959219|NCT03164551|460470983|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
127959220|NCT03164551|460470982|FG000|Overall Study|Other|8|||
127959221|NCT03164551|460470983|FG001|Overall Study|Other|2|||
127959222|NCT00470470|460470992|FG000|Overall Study|Adverse Event|2|||
127959223|NCT00470470|460470992|FG000|Overall Study|Death|2|||
127959224|NCT00470470|460470992|FG000|Overall Study|Not treated|1|||
127959225|NCT02452476|460470995|FG000|Overall Study|Death|4|||
127959226|NCT02452476|460470996|FG001|Overall Study|Death|7|||
127959227|NCT02452476|460470995|FG000|Overall Study|Lost to Follow-up|1|||
127959228|NCT02452476|460470996|FG001|Overall Study|Lost to Follow-up|1|||
127959229|NCT02452476|460470995|FG000|Overall Study|Physician Decision|1|||
127959230|NCT02452476|460470996|FG001|Overall Study|Physician Decision|1|||
127959231|NCT02452476|460470995|FG000|Overall Study|Not treated|5|||
127959232|NCT02452476|460470996|FG001|Overall Study|Not treated|1|||
127959233|NCT04052620|460470997|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
127959234|NCT04052620|460470998|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
127959235|NCT04052620|460470997|FG000|Overall Study|Withdrawal by Subject|1|||
127959236|NCT04052620|460470998|FG001|Overall Study|Withdrawal by Subject|0|||
127959237|NCT04052620|460470997|FG000|Overall Study|Lost to Follow-up|1|||
127959238|NCT04052620|460470998|FG001|Overall Study|Lost to Follow-up|1|||
127959239|NCT04052620|460470997|FG000|Overall Study|Adverse Event|1|||
127959240|NCT04052620|460470998|FG001|Overall Study|Adverse Event|0|||
127959241|NCT04052620|460470997|FG000|Overall Study|Subject did not meet study Criteria|0|||
127959242|NCT04052620|460470998|FG001|Overall Study|Subject did not meet study Criteria|1|||
127959243|NCT04052620|460470997|FG000|Overall Study|Screened failure, randomized by mistake|0|||
127959244|NCT04052620|460470998|FG001|Overall Study|Screened failure, randomized by mistake|1|||
127959245|NCT04052620|460470997|FG000|Overall Study|Personal reasons|2|||
127959246|NCT04052620|460470998|FG001|Overall Study|Personal reasons|4|||
127959247|NCT04052620|460470997|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
127959248|NCT04052620|460470998|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
127959249|NCT03552380|460470999|FG000|Study Treatment|Disease Progression|3|||
127959250|NCT03552380|460471000|FG001|Study Treatment|Disease Progression|4|||
127959251|NCT03552380|460470999|FG000|Study Treatment|Adverse Event|2|||
127959252|NCT03552380|460471000|FG001|Study Treatment|Adverse Event|2|||
127959253|NCT03552380|460470999|FG000|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
127959254|NCT03552380|460471000|FG001|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
127959255|NCT03552380|460470999|FG000|Follow up|Death|3|||
127959256|NCT03552380|460471000|FG001|Follow up|Death|4|||
127959257|NCT03552380|460470999|FG000|Follow up|Site IRB terminated|0|||
127959258|NCT03552380|460471000|FG001|Follow up|Site IRB terminated|1|||
127959259|NCT02201784|460471001|FG000|Overall Study|Failure to achieve adequate block|2|||
127959260|NCT02201784|460471002|FG001|Overall Study|Failure to achieve adequate block|0|||
127959261|NCT02431364|460471003|FG000|Overall Study|Adverse Event|0|||
127959262|NCT02431364|460471004|FG001|Overall Study|Adverse Event|1|||
127959263|NCT02431364|460471005|FG002|Overall Study|Adverse Event|0|||
127959264|NCT02431364|460471006|FG003|Overall Study|Adverse Event|0|||
127959265|NCT02431364|460471007|FG004|Overall Study|Adverse Event|0|||
127959266|NCT02431364|460471003|FG000|Overall Study|Randomized but never treated|0|||
127959267|NCT02431364|460471004|FG001|Overall Study|Randomized but never treated|0|||
127959268|NCT02431364|460471005|FG002|Overall Study|Randomized but never treated|0|||
127959269|NCT02431364|460471006|FG003|Overall Study|Randomized but never treated|1|||
127959270|NCT02431364|460471007|FG004|Overall Study|Randomized but never treated|0|||
127959271|NCT00916383|460471008|FG000|Overall Study|Adverse Event|1|||
127959272|NCT00916383|460471008|FG000|Overall Study|Death|1|||
127959273|NCT00916383|460471008|FG000|Overall Study|Protocol Violation|1|||
127959274|NCT00258960|460471009|FG000|Overall Study|Death|2|||
127959275|NCT00258960|460471009|FG000|Overall Study|Disease Progression|7|||
127959276|NCT00258960|460471009|FG000|Overall Study|Adverse Event|4|||
127959277|NCT00258960|460471009|FG000|Overall Study|Physician Decision|1|||
127959278|NCT00258960|460471009|FG000|Overall Study|Withdrawal by Subject|1|||
127959279|NCT00258960|460471009|FG000|Overall Study|Mistake|2|||
127959280|NCT01112059|460471012|FG000|Overall Study|Withdrawal by Subject|1|||
127959281|NCT01112059|460471013|FG001|Overall Study|Withdrawal by Subject|0|||
127959282|NCT02654054|460471014|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
127959283|NCT02654054|460471015|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
127959284|NCT02654054|460471016|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
127959285|NCT02654054|460471014|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
127959286|NCT02654054|460471015|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
127959287|NCT02654054|460471016|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
127959288|NCT02654054|460471014|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
127959289|NCT02654054|460471015|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
127959290|NCT02654054|460471016|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
127959291|NCT02654054|460471014|FG000|Post-Treatment Follow-Up Period|Other|1|||
127959292|NCT02654054|460471015|FG001|Post-Treatment Follow-Up Period|Other|0|||
127959293|NCT02654054|460471016|FG002|Post-Treatment Follow-Up Period|Other|4|||
127959294|NCT02654054|460471014|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
127959295|NCT02654054|460471015|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
127959296|NCT02654054|460471016|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
127959297|NCT04199104|460472551|FG000|Overall Study|Death|148|||
127959298|NCT04199104|460472552|FG001|Overall Study|Death|134|||
127959299|NCT04199104|460472551|FG000|Overall Study|Lost to Follow-up|1|||
127959300|NCT04199104|460472552|FG001|Overall Study|Lost to Follow-up|1|||
127959301|NCT04199104|460472551|FG000|Overall Study|Withdrawal by Subject|4|||
127959302|NCT04199104|460472552|FG001|Overall Study|Withdrawal by Subject|4|||
127959303|NCT04199104|460472551|FG000|Overall Study|Participants Ongoing|103|||
127959304|NCT04199104|460472552|FG001|Overall Study|Participants Ongoing|116|||
127959305|NCT02562235|460472555|FG000|Overall Study|Adverse Event|3|||
127959306|NCT01168232|460472558|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
127959307|NCT01168232|460472558|FG000|Overall Study|Ineligible- Wrong cell type|6|||
127959308|NCT01168232|460472558|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
127959309|NCT04576507|460472562|FG000|Overall Study|Adverse Event|4|||
127959310|NCT04576507|460472562|FG000|Overall Study|Withdrawal by Subject|1|||
127959311|NCT05012098|460472567|FG000|Overall Study|Disease progression|5|||
127959312|NCT05012098|460472568|FG001|Overall Study|Disease progression|2|||
127959313|NCT05012098|460472567|FG000|Overall Study|Adverse Event|1|||
127959314|NCT05012098|460472568|FG001|Overall Study|Adverse Event|0|||
127959315|NCT05012098|460472567|FG000|Overall Study|Withdrawal by Subject|1|||
127959316|NCT05012098|460472568|FG001|Overall Study|Withdrawal by Subject|0|||
127959317|NCT05012098|460472567|FG000|Overall Study|Discontinuation per protocol|1|||
127959318|NCT05012098|460472568|FG001|Overall Study|Discontinuation per protocol|0|||
127959319|NCT01490086|460472570|FG000|Overall Study|Consent withdrawn|4|||
127959320|NCT01490086|460472571|FG001|Overall Study|Consent withdrawn|4|||
127959321|NCT01490086|460472572|FG002|Overall Study|Consent withdrawn|3|||
127959322|NCT01490086|460472573|FG003|Overall Study|Consent withdrawn|0|||
127959323|NCT01490086|460472574|FG004|Overall Study|Consent withdrawn|1|||
127959324|NCT01490086|460472570|FG000|Overall Study|Non-compliance|0|||
127959325|NCT01490086|460472571|FG001|Overall Study|Non-compliance|1|||
127959326|NCT01490086|460472572|FG002|Overall Study|Non-compliance|0|||
127959327|NCT01490086|460472573|FG003|Overall Study|Non-compliance|0|||
127959328|NCT01490086|460472574|FG004|Overall Study|Non-compliance|0|||
127959329|NCT01490086|460472570|FG000|Overall Study|Abnormal laboratory findings|1|||
127959330|NCT01490086|460472571|FG001|Overall Study|Abnormal laboratory findings|0|||
127959331|NCT01490086|460472572|FG002|Overall Study|Abnormal laboratory findings|0|||
127959332|NCT01490086|460472573|FG003|Overall Study|Abnormal laboratory findings|0|||
127959333|NCT01490086|460472574|FG004|Overall Study|Abnormal laboratory findings|0|||
127959334|NCT01490086|460472570|FG000|Overall Study|Lost to Follow-up|0|||
127959335|NCT01490086|460472571|FG001|Overall Study|Lost to Follow-up|0|||
127959336|NCT01490086|460472572|FG002|Overall Study|Lost to Follow-up|0|||
127959337|NCT01490086|460472573|FG003|Overall Study|Lost to Follow-up|0|||
127959338|NCT01490086|460472574|FG004|Overall Study|Lost to Follow-up|1|||
127959339|NCT01490086|460472570|FG000|Overall Study|Physician Decision|3|||
127959340|NCT01490086|460472571|FG001|Overall Study|Physician Decision|4|||
127959341|NCT01490086|460472572|FG002|Overall Study|Physician Decision|2|||
127959342|NCT01490086|460472573|FG003|Overall Study|Physician Decision|3|||
127959343|NCT01490086|460472574|FG004|Overall Study|Physician Decision|1|||
127959344|NCT01490086|460472570|FG000|Overall Study|Adverse Event|0|||
127959345|NCT01490086|460472571|FG001|Overall Study|Adverse Event|0|||
127959346|NCT01490086|460472572|FG002|Overall Study|Adverse Event|1|||
127959347|NCT01490086|460472573|FG003|Overall Study|Adverse Event|2|||
127959348|NCT01490086|460472574|FG004|Overall Study|Adverse Event|0|||
127959349|NCT01490086|460472570|FG000|Overall Study|Lack of Efficacy|0|||
127959350|NCT01490086|460472571|FG001|Overall Study|Lack of Efficacy|3|||
127959351|NCT01490086|460472572|FG002|Overall Study|Lack of Efficacy|1|||
127959352|NCT01490086|460472573|FG003|Overall Study|Lack of Efficacy|0|||
127959353|NCT01490086|460472574|FG004|Overall Study|Lack of Efficacy|8|||
127959354|NCT01490086|460472570|FG000|Overall Study|Worsening of symptoms|0|||
127959355|NCT01490086|460472571|FG001|Overall Study|Worsening of symptoms|1|||
127959356|NCT01490086|460472572|FG002|Overall Study|Worsening of symptoms|0|||
127959357|NCT01490086|460472573|FG003|Overall Study|Worsening of symptoms|1|||
127959358|NCT01490086|460472574|FG004|Overall Study|Worsening of symptoms|0|||
127959359|NCT01490086|460472570|FG000|Overall Study|Subject uncontrollable and abusive|0|||
127959360|NCT01490086|460472571|FG001|Overall Study|Subject uncontrollable and abusive|1|||
127959361|NCT01490086|460472572|FG002|Overall Study|Subject uncontrollable and abusive|0|||
127959362|NCT01490086|460472573|FG003|Overall Study|Subject uncontrollable and abusive|0|||
127959363|NCT01490086|460472574|FG004|Overall Study|Subject uncontrollable and abusive|0|||
127959364|NCT01490086|460472570|FG000|Overall Study|Subject left hospital|0|||
127959365|NCT01490086|460472571|FG001|Overall Study|Subject left hospital|1|||
127959366|NCT01490086|460472572|FG002|Overall Study|Subject left hospital|0|||
127959367|NCT01490086|460472573|FG003|Overall Study|Subject left hospital|1|||
127959368|NCT01490086|460472574|FG004|Overall Study|Subject left hospital|0|||
127959369|NCT05825404|460472575|FG000|First Intervention (Weeks 2-5)|Death|0|||
127959370|NCT05825404|460472576|FG001|First Intervention (Weeks 2-5)|Death|1|||
127959371|NCT05825404|460472575|FG000|Second Intervention (Weeks 8-11)|Death|0|||
127959372|NCT05825404|460472576|FG001|Second Intervention (Weeks 8-11)|Death|1|||
127959373|NCT01749826|460472577|FG000|Overall Study|Study Terminated|20|||
127959374|NCT01749826|460472578|FG001|Overall Study|Study Terminated|0|||
127959375|NCT05842967|460472579|FG000|Period 1: SSA|Adverse Event|1|||
127959376|NCT05842967|460472580|FG001|Period 1: SSA|Adverse Event|1|||
127959377|NCT05842967|460472581|FG002|Period 1: SSA|Adverse Event|0|||
127959378|NCT05842967|460472582|FG003|Period 1: SSA|Adverse Event|0|||
127959379|NCT05842967|460472579|FG000|Period 1: SSA|Death|1|||
127959380|NCT05842967|460472580|FG001|Period 1: SSA|Death|0|||
127959381|NCT05842967|460472581|FG002|Period 1: SSA|Death|0|||
127959382|NCT05842967|460472582|FG003|Period 1: SSA|Death|0|||
127959383|NCT05842967|460472579|FG000|Period 1: SSA|Lost to Follow-up|16|||
127959384|NCT05842967|460472580|FG001|Period 1: SSA|Lost to Follow-up|4|||
127959385|NCT05842967|460472581|FG002|Period 1: SSA|Lost to Follow-up|0|||
127959386|NCT05842967|460472582|FG003|Period 1: SSA|Lost to Follow-up|0|||
127959387|NCT05842967|460472579|FG000|Period 1: SSA|Physician Decision|1|||
127959388|NCT05842967|460472580|FG001|Period 1: SSA|Physician Decision|0|||
127959389|NCT05842967|460472581|FG002|Period 1: SSA|Physician Decision|0|||
127959390|NCT05842967|460472582|FG003|Period 1: SSA|Physician Decision|0|||
127959391|NCT05842967|460472579|FG000|Period 1: SSA|Withdrawal by Subject|2|||
127959392|NCT05842967|460472580|FG001|Period 1: SSA|Withdrawal by Subject|2|||
127959393|NCT05842967|460472581|FG002|Period 1: SSA|Withdrawal by Subject|0|||
127959394|NCT05842967|460472582|FG003|Period 1: SSA|Withdrawal by Subject|0|||
127959395|NCT05842967|460472579|FG000|Period 1: SSA|Randomized but not vaccinated|1|||
127959396|NCT05842967|460472580|FG001|Period 1: SSA|Randomized but not vaccinated|2|||
127959397|NCT05842967|460472581|FG002|Period 1: SSA|Randomized but not vaccinated|0|||
127959398|NCT05842967|460472582|FG003|Period 1: SSA|Randomized but not vaccinated|0|||
127959399|NCT05842967|460472579|FG000|Period 2: SSB|Adverse Event|0|||
127959400|NCT05842967|460472580|FG001|Period 2: SSB|Adverse Event|0|||
127959401|NCT05842967|460472581|FG002|Period 2: SSB|Adverse Event|2|||
127959402|NCT05842967|460472582|FG003|Period 2: SSB|Adverse Event|0|||
127959403|NCT05842967|460472579|FG000|Period 2: SSB|Lost to Follow-up|0|||
127959404|NCT05842967|460472580|FG001|Period 2: SSB|Lost to Follow-up|0|||
127959405|NCT05842967|460472581|FG002|Period 2: SSB|Lost to Follow-up|4|||
127959406|NCT05842967|460472582|FG003|Period 2: SSB|Lost to Follow-up|3|||
127959407|NCT05842967|460472579|FG000|Period 2: SSB|Withdrawal by Subject|0|||
127959408|NCT05842967|460472580|FG001|Period 2: SSB|Withdrawal by Subject|0|||
127959409|NCT05842967|460472581|FG002|Period 2: SSB|Withdrawal by Subject|1|||
127959410|NCT05842967|460472582|FG003|Period 2: SSB|Withdrawal by Subject|0|||
127959411|NCT05842967|460472579|FG000|Period 2: SSB|Enrolled but not vaccinated|0|||
127959412|NCT05842967|460472580|FG001|Period 2: SSB|Enrolled but not vaccinated|0|||
127959413|NCT05842967|460472581|FG002|Period 2: SSB|Enrolled but not vaccinated|5|||
127959414|NCT05842967|460472582|FG003|Period 2: SSB|Enrolled but not vaccinated|9|||
127959415|NCT05842967|460472579|FG000|Period 2: SSB|Protocol Violation|0|||
127959416|NCT05842967|460472580|FG001|Period 2: SSB|Protocol Violation|0|||
127959417|NCT05842967|460472581|FG002|Period 2: SSB|Protocol Violation|0|||
127959418|NCT05842967|460472582|FG003|Period 2: SSB|Protocol Violation|1|||
127959419|NCT01823328|460472584|FG000|Overall Study|Withdrawal by Subject|8|||
127959420|NCT01823328|460472585|FG001|Overall Study|Withdrawal by Subject|6|||
127959421|NCT01103180|460472588|FG000|Overall Study|Withdrawal by Subject|8|||
127959422|NCT01103180|460472589|FG001|Overall Study|Withdrawal by Subject|13|||
127959423|NCT01103180|460472588|FG000|Overall Study|Lost to Follow-up|13|||
127959424|NCT01103180|460472589|FG001|Overall Study|Lost to Follow-up|7|||
127959425|NCT01103180|460472588|FG000|Overall Study|Physician Decision|1|||
127959426|NCT01103180|460472589|FG001|Overall Study|Physician Decision|0|||
127959427|NCT01103180|460472588|FG000|Overall Study|Protocol Violation|0|||
127959428|NCT01103180|460472589|FG001|Overall Study|Protocol Violation|1|||
127959429|NCT01173523|460472590|FG000|Overall Study|Clinical Progression|1|||
127959430|NCT01173523|460472591|FG001|Overall Study|Clinical Progression|1|||
127959431|NCT01173523|460472590|FG000|Overall Study|Progressive Disease|10|||
127959432|NCT01173523|460472591|FG001|Overall Study|Progressive Disease|8|||
127959433|NCT01173523|460472590|FG000|Overall Study|Other|2|||
127959434|NCT01173523|460472591|FG001|Overall Study|Other|3|||
127959435|NCT01439802|460472596|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
127959436|NCT01439802|460472596|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
127959437|NCT01866826|460472597|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
127959438|NCT01866826|460472598|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
127959439|NCT01866826|460472597|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
127959440|NCT01866826|460472598|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
127959441|NCT01866826|460472597|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
127959442|NCT01866826|460472598|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
127959443|NCT00742209|460472603|FG000|Overall Study|Adverse Event|11|||
127959444|NCT00742209|460472604|FG001|Overall Study|Adverse Event|4|||
127959445|NCT00742209|460472605|FG002|Overall Study|Adverse Event|17|||
127959446|NCT00742209|460472606|FG003|Overall Study|Adverse Event|16|||
127959447|NCT00742209|460472607|FG004|Overall Study|Adverse Event|13|||
127959448|NCT00742209|460472603|FG000|Overall Study|Participant Withdrew Consent|8|||
127959449|NCT00742209|460472604|FG001|Overall Study|Participant Withdrew Consent|4|||
127959450|NCT00742209|460472605|FG002|Overall Study|Participant Withdrew Consent|14|||
127959451|NCT00742209|460472606|FG003|Overall Study|Participant Withdrew Consent|7|||
127959452|NCT00742209|460472607|FG004|Overall Study|Participant Withdrew Consent|4|||
127959453|NCT00742209|460472603|FG000|Overall Study|Protocol Violation|6|||
127959454|NCT00742209|460472604|FG001|Overall Study|Protocol Violation|5|||
127959455|NCT00742209|460472605|FG002|Overall Study|Protocol Violation|4|||
127959456|NCT00742209|460472606|FG003|Overall Study|Protocol Violation|5|||
127959457|NCT00742209|460472607|FG004|Overall Study|Protocol Violation|3|||
127959458|NCT00742209|460472603|FG000|Overall Study|Lost to Follow-up|3|||
127959459|NCT00742209|460472604|FG001|Overall Study|Lost to Follow-up|4|||
127959460|NCT00742209|460472605|FG002|Overall Study|Lost to Follow-up|5|||
127959461|NCT00742209|460472606|FG003|Overall Study|Lost to Follow-up|5|||
127959462|NCT00742209|460472607|FG004|Overall Study|Lost to Follow-up|3|||
127959463|NCT00742209|460472603|FG000|Overall Study|Lack of Efficacy|6|||
127959464|NCT00742209|460472604|FG001|Overall Study|Lack of Efficacy|1|||
127959465|NCT00742209|460472605|FG002|Overall Study|Lack of Efficacy|1|||
127959466|NCT00742209|460472606|FG003|Overall Study|Lack of Efficacy|3|||
127959467|NCT00742209|460472607|FG004|Overall Study|Lack of Efficacy|1|||
127959468|NCT00742209|460472603|FG000|Overall Study|Investigator Discretion|0|||
127959469|NCT00742209|460472604|FG001|Overall Study|Investigator Discretion|0|||
127959470|NCT00742209|460472605|FG002|Overall Study|Investigator Discretion|5|||
127959471|NCT00742209|460472606|FG003|Overall Study|Investigator Discretion|1|||
127959472|NCT00742209|460472607|FG004|Overall Study|Investigator Discretion|1|||
127959473|NCT00595621|460472611|FG000|Open Label Run in|Adverse Event|1|||
127959474|NCT00595621|460472612|FG001|Open Label Run in|Adverse Event|0|||
127959475|NCT00595621|460472611|FG000|Open Label Run in|Physician Decision|1|||
127959476|NCT00595621|460472612|FG001|Open Label Run in|Physician Decision|0|||
127959477|NCT00595621|460472611|FG000|Open Label Run in|Withdrawal by Subject|1|||
127959478|NCT00595621|460472612|FG001|Open Label Run in|Withdrawal by Subject|0|||
127959479|NCT00595621|460472611|FG000|Randomization and Study|Adverse Event|2|||
127959480|NCT00595621|460472612|FG001|Randomization and Study|Adverse Event|0|||
127959481|NCT00595621|460472611|FG000|Randomization and Study|Withdrawal by Subject|0|||
127959482|NCT00595621|460472612|FG001|Randomization and Study|Withdrawal by Subject|1|||
127959483|NCT00324987|460472613|FG000|Overall Study|Adverse Event|2|||
127959484|NCT00324987|460472614|FG001|Overall Study|Adverse Event|1|||
127959485|NCT00324987|460472613|FG000|Overall Study|Withdrawal by Subject|1|||
127959486|NCT00324987|460472614|FG001|Overall Study|Withdrawal by Subject|1|||
127959487|NCT00324987|460472613|FG000|Overall Study|Progression|1|||
127959488|NCT00324987|460472614|FG001|Overall Study|Progression|1|||
127959489|NCT00324987|460472613|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
127959490|NCT00324987|460472614|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
127959491|NCT03817125|460472615|FG000|Overall Study|Adverse Event|1|||
127959492|NCT03817125|460472616|FG001|Overall Study|Adverse Event|0|||
127959493|NCT03817125|460472615|FG000|Overall Study|Physician Decision|0|||
127959494|NCT03817125|460472616|FG001|Overall Study|Physician Decision|1|||
127959495|NCT03817125|460472615|FG000|Overall Study|Lack of Efficacy|1|||
127959496|NCT03817125|460472616|FG001|Overall Study|Lack of Efficacy|5|||
127959497|NCT01998919|460472617|FG000|Overall Study|Death|2|||
127959498|NCT01998919|460472618|FG001|Overall Study|Death|2|||
127959499|NCT01998919|460472617|FG000|Overall Study|Adverse Event|0|||
127959500|NCT01998919|460472618|FG001|Overall Study|Adverse Event|5|||
127959501|NCT01998919|460472617|FG000|Overall Study|Disease progression|31|||
127959502|NCT01998919|460472618|FG001|Overall Study|Disease progression|22|||
127959503|NCT01998919|460472617|FG000|Overall Study|Withdrawal by Subject|2|||
127959504|NCT01998919|460472618|FG001|Overall Study|Withdrawal by Subject|4|||
127959505|NCT01998919|460472617|FG000|Overall Study|Lost to Follow-up|2|||
127959506|NCT01998919|460472618|FG001|Overall Study|Lost to Follow-up|0|||
127959507|NCT01998919|460472617|FG000|Overall Study|Other|5|||
127959508|NCT01998919|460472618|FG001|Overall Study|Other|2|||
127959509|NCT00897715|460472622|FG000|Overall Study|Lost to Follow-up|0|||
127959510|NCT00897715|460472623|FG001|Overall Study|Lost to Follow-up|1|||
127959511|NCT00897715|460472622|FG000|Overall Study|Physician Decision|1|||
127959512|NCT00897715|460472623|FG001|Overall Study|Physician Decision|0|||
127959513|NCT00897715|460472622|FG000|Overall Study|increased risk of infection|1|||
127959514|NCT00897715|460472623|FG001|Overall Study|increased risk of infection|0|||
127959515|NCT02088177|460472634|FG000|Overall Study|Lost to Follow-up|3|||
127959516|NCT01778530|460472636|FG000|Overall Study|Progression on study|1|||
127959517|NCT01778530|460472636|FG000|Overall Study|Adverse event/side effect|1|||
127959518|NCT01199939|460472637|FG000|Overall Study|Adverse Event|4|||
127959519|NCT01199939|460472637|FG000|Overall Study|Protocol Violation|3|||
127959520|NCT01199939|460472637|FG000|Overall Study|Lost to Follow-up|2|||
127959521|NCT01199939|460472637|FG000|Overall Study|Reached a virologic endpoint|4|||
127959522|NCT01894919|460472638|FG000|Overall Study|Withdrawal by Subject|1|||
127959523|NCT01894919|460472639|FG001|Overall Study|Withdrawal by Subject|0|||
127959524|NCT01894919|460472640|FG002|Overall Study|Withdrawal by Subject|0|||
127959525|NCT01894919|460472641|FG003|Overall Study|Withdrawal by Subject|0|||
127959526|NCT01894919|460472642|FG004|Overall Study|Withdrawal by Subject|1|||
127959527|NCT01894919|460472643|FG005|Overall Study|Withdrawal by Subject|0|||
127959528|NCT01894919|460472644|FG006|Overall Study|Withdrawal by Subject|0|||
127959529|NCT01894919|460472645|FG007|Overall Study|Withdrawal by Subject|0|||
127959530|NCT01894919|460472646|FG008|Overall Study|Withdrawal by Subject|0|||
127959531|NCT01894919|460472647|FG009|Overall Study|Withdrawal by Subject|1|||
127959532|NCT01894919|460472648|FG010|Overall Study|Withdrawal by Subject|1|||
127959533|NCT01894919|460472649|FG011|Overall Study|Withdrawal by Subject|0|||
127959534|NCT01894919|460472650|FG012|Overall Study|Withdrawal by Subject|0|||
127959535|NCT01894919|460472638|FG000|Overall Study|Adverse Event|0|||
127959536|NCT01894919|460472639|FG001|Overall Study|Adverse Event|0|||
127959537|NCT01894919|460472640|FG002|Overall Study|Adverse Event|0|||
127959538|NCT01894919|460472641|FG003|Overall Study|Adverse Event|0|||
127959539|NCT01894919|460472642|FG004|Overall Study|Adverse Event|0|||
127959540|NCT01894919|460472643|FG005|Overall Study|Adverse Event|0|||
127959541|NCT01894919|460472644|FG006|Overall Study|Adverse Event|0|||
127959542|NCT01894919|460472645|FG007|Overall Study|Adverse Event|0|||
127959543|NCT01894919|460472646|FG008|Overall Study|Adverse Event|0|||
127959544|NCT01894919|460472647|FG009|Overall Study|Adverse Event|0|||
127959545|NCT01894919|460472648|FG010|Overall Study|Adverse Event|1|||
127959546|NCT01894919|460472649|FG011|Overall Study|Adverse Event|0|||
127959547|NCT01894919|460472650|FG012|Overall Study|Adverse Event|0|||
127959548|NCT01894919|460472638|FG000|Overall Study|Other-Unspecified|1|||
127959549|NCT01894919|460472639|FG001|Overall Study|Other-Unspecified|0|||
127959550|NCT01894919|460472640|FG002|Overall Study|Other-Unspecified|0|||
127959551|NCT01894919|460472641|FG003|Overall Study|Other-Unspecified|0|||
127959552|NCT01894919|460472642|FG004|Overall Study|Other-Unspecified|0|||
127959553|NCT01894919|460472643|FG005|Overall Study|Other-Unspecified|0|||
127959554|NCT01894919|460472644|FG006|Overall Study|Other-Unspecified|0|||
127959555|NCT01894919|460472645|FG007|Overall Study|Other-Unspecified|0|||
127959556|NCT01894919|460472646|FG008|Overall Study|Other-Unspecified|0|||
127959557|NCT01894919|460472647|FG009|Overall Study|Other-Unspecified|0|||
127959558|NCT01894919|460472648|FG010|Overall Study|Other-Unspecified|0|||
127959559|NCT01894919|460472649|FG011|Overall Study|Other-Unspecified|0|||
127959560|NCT01894919|460472650|FG012|Overall Study|Other-Unspecified|0|||
127959561|NCT01894919|460472638|FG000|Overall Study|Lost to Follow-up|0|||
127959562|NCT01894919|460472639|FG001|Overall Study|Lost to Follow-up|0|||
127959563|NCT01894919|460472640|FG002|Overall Study|Lost to Follow-up|0|||
127959564|NCT01894919|460472641|FG003|Overall Study|Lost to Follow-up|0|||
127959565|NCT01894919|460472642|FG004|Overall Study|Lost to Follow-up|2|||
127959566|NCT01894919|460472643|FG005|Overall Study|Lost to Follow-up|0|||
127959567|NCT01894919|460472644|FG006|Overall Study|Lost to Follow-up|0|||
127959568|NCT01894919|460472645|FG007|Overall Study|Lost to Follow-up|0|||
127959569|NCT01894919|460472646|FG008|Overall Study|Lost to Follow-up|0|||
127959570|NCT01894919|460472647|FG009|Overall Study|Lost to Follow-up|0|||
127959571|NCT01894919|460472648|FG010|Overall Study|Lost to Follow-up|0|||
127959572|NCT01894919|460472649|FG011|Overall Study|Lost to Follow-up|0|||
127959573|NCT01894919|460472650|FG012|Overall Study|Lost to Follow-up|0|||
127959574|NCT03238651|460472653|FG000|Overall Study|Other|0|||
127959575|NCT03238651|460472654|FG001|Overall Study|Other|0|||
127959576|NCT03238651|460472655|FG002|Overall Study|Other|0|||
127959577|NCT03238651|460472656|FG003|Overall Study|Other|0|||
127959578|NCT03238651|460472657|FG004|Overall Study|Other|1|||
127959579|NCT03238651|460472653|FG000|Overall Study|Progressive Disease|2|||
127959580|NCT03238651|460472654|FG001|Overall Study|Progressive Disease|2|||
127959581|NCT03238651|460472655|FG002|Overall Study|Progressive Disease|2|||
127959582|NCT03238651|460472656|FG003|Overall Study|Progressive Disease|2|||
127959583|NCT03238651|460472657|FG004|Overall Study|Progressive Disease|0|||
127959584|NCT03238651|460472653|FG000|Overall Study|Withdrawal by Subject|0|||
127959585|NCT03238651|460472654|FG001|Overall Study|Withdrawal by Subject|1|||
127959586|NCT03238651|460472655|FG002|Overall Study|Withdrawal by Subject|0|||
127959587|NCT03238651|460472656|FG003|Overall Study|Withdrawal by Subject|1|||
127959588|NCT03238651|460472657|FG004|Overall Study|Withdrawal by Subject|0|||
127959589|NCT03238651|460472653|FG000|Overall Study|Adverse Event|1|||
127959590|NCT03238651|460472654|FG001|Overall Study|Adverse Event|3|||
127959591|NCT03238651|460472655|FG002|Overall Study|Adverse Event|2|||
127959592|NCT03238651|460472656|FG003|Overall Study|Adverse Event|0|||
127959593|NCT03238651|460472657|FG004|Overall Study|Adverse Event|0|||
127959594|NCT02500589|460472658|FG000|Overall Study|Withdrawal by Subject|11|||
127959595|NCT02500589|460472659|FG001|Overall Study|Withdrawal by Subject|14|||
127959596|NCT02500589|460472658|FG000|Overall Study|Lost to Follow-up|10|||
127959597|NCT02500589|460472659|FG001|Overall Study|Lost to Follow-up|12|||
127959598|NCT02500589|460472658|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
127959599|NCT02500589|460472659|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
127959600|NCT02500589|460472658|FG000|Overall Study|Death|7|||
127959601|NCT02500589|460472659|FG001|Overall Study|Death|5|||
127959602|NCT02550561|460472660|FG000|Overall Study|Lost to Follow-up|5|||
127959603|NCT02550561|460472660|FG000|Overall Study|Withdrawal by Subject|1|||
127959604|NCT02394600|460472661|FG000|Overall Study|Adverse Event|3|||
127959605|NCT02394600|460472662|FG001|Overall Study|Adverse Event|0|||
127959606|NCT02394600|460472661|FG000|Overall Study|Lost to Follow-up|0|||
127959607|NCT02394600|460472662|FG001|Overall Study|Lost to Follow-up|1|||
127959608|NCT02394600|460472661|FG000|Overall Study|Withdrawal by Subject|0|||
127959609|NCT02394600|460472662|FG001|Overall Study|Withdrawal by Subject|1|||
127959610|NCT02394600|460472661|FG000|Overall Study|Protocol Violation|1|||
127959611|NCT02394600|460472662|FG001|Overall Study|Protocol Violation|0|||
127959612|NCT01686373|460472663|FG000|Overall Study|Lost to Follow-up|3|||
127959613|NCT01686373|460472664|FG001|Overall Study|Lost to Follow-up|0|||
127959614|NCT01686373|460472663|FG000|Overall Study|Withdrawal by Subject|0|||
127959615|NCT01686373|460472664|FG001|Overall Study|Withdrawal by Subject|1|||
127959616|NCT01686373|460472663|FG000|Overall Study|Adverse Event|0|||
127959617|NCT01686373|460472664|FG001|Overall Study|Adverse Event|1|||
127959618|NCT00791778|460472665|FG000|Double-blind Treatment|Adverse Event|49|||
127959619|NCT00791778|460472666|FG001|Double-blind Treatment|Adverse Event|9|||
127959620|NCT00791778|460472665|FG000|Double-blind Treatment|Physician Decision|6|||
127959621|NCT00791778|460472666|FG001|Double-blind Treatment|Physician Decision|26|||
127959622|NCT00791778|460472665|FG000|Double-blind Treatment|Protocol Violation|0|||
127959623|NCT00791778|460472666|FG001|Double-blind Treatment|Protocol Violation|4|||
127959624|NCT00791778|460472665|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
127959625|NCT00791778|460472666|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
127959626|NCT00791778|460472665|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
127959627|NCT00791778|460472666|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
127959628|NCT00791778|460472665|FG000|Follow-up|Withdrawal by Subject|3|||
127959629|NCT00791778|460472666|FG001|Follow-up|Withdrawal by Subject|0|||
127959630|NCT00791778|460472665|FG000|Follow-up|Lost to Follow-up|2|||
127959631|NCT00791778|460472666|FG001|Follow-up|Lost to Follow-up|1|||
127959632|NCT00235755|460472669|FG000|4-Week Titration Phase|Adverse Event|6|||
127959633|NCT00235755|460472670|FG001|4-Week Titration Phase|Adverse Event|14|||
127959634|NCT00235755|460472671|FG002|4-Week Titration Phase|Adverse Event|20|||
127959635|NCT00235755|460472669|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
127959636|NCT00235755|460472670|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
127959637|NCT00235755|460472671|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
127959638|NCT00235755|460472669|FG000|4-Week Titration Phase|Protocol Violation|2|||
127959639|NCT00235755|460472670|FG001|4-Week Titration Phase|Protocol Violation|2|||
127959640|NCT00235755|460472671|FG002|4-Week Titration Phase|Protocol Violation|1|||
127959641|NCT00235755|460472669|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
127959642|NCT00235755|460472670|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
127959643|NCT00235755|460472671|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
127959644|NCT00235755|460472669|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
127959645|NCT00235755|460472670|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
127959646|NCT00235755|460472671|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
127959647|NCT00235755|460472669|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
127959648|NCT00235755|460472670|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
127959649|NCT00235755|460472671|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
127959650|NCT00235755|460472669|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
127959651|NCT00235755|460472670|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
127959652|NCT00235755|460472671|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
127959653|NCT00235755|460472669|FG000|12-Week Maintenance Phase|Adverse Event|8|||
127959654|NCT00235755|460472670|FG001|12-Week Maintenance Phase|Adverse Event|12|||
127959655|NCT00235755|460472671|FG002|12-Week Maintenance Phase|Adverse Event|26|||
127959656|NCT00235755|460472669|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
127959657|NCT00235755|460472670|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
127959658|NCT00235755|460472671|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
127959659|NCT00235755|460472669|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
127959660|NCT00235755|460472670|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
127959661|NCT00235755|460472671|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
127959662|NCT00235755|460472669|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
127959663|NCT00235755|460472670|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
127959664|NCT00235755|460472671|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
127959665|NCT00235755|460472669|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
127959666|NCT00235755|460472670|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
127959667|NCT00235755|460472671|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
127959668|NCT00235755|460472669|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
127959669|NCT00235755|460472670|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
127959670|NCT00235755|460472671|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
127959671|NCT02314026|460472672|FG000|Overall Study|Protocol Violation|28|||
127959672|NCT01532934|460472673|FG000|Overall Study|Lost to Follow-up|11|||
127959673|NCT01532934|460472674|FG001|Overall Study|Lost to Follow-up|11|||
127959674|NCT01532934|460472673|FG000|Overall Study|In controlled environment|3|||
127959675|NCT01532934|460472674|FG001|Overall Study|In controlled environment|2|||
127959676|NCT01149863|460472675|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
127959677|NCT01406574|460472676|FG000|Overall Study|Adverse Event|0|||
127959678|NCT01406574|460472677|FG001|Overall Study|Adverse Event|0|||
127959679|NCT01406574|460472678|FG002|Overall Study|Adverse Event|1|||
127959680|NCT01406574|460472679|FG003|Overall Study|Adverse Event|3|||
127959681|NCT01406574|460472676|FG000|Overall Study|Physician Decision|0|||
127959682|NCT01406574|460472677|FG001|Overall Study|Physician Decision|0|||
127959683|NCT01406574|460472678|FG002|Overall Study|Physician Decision|0|||
127959684|NCT01406574|460472679|FG003|Overall Study|Physician Decision|1|||
127959685|NCT01406574|460472676|FG000|Overall Study|Withdrawal by Subject|0|||
127959686|NCT01406574|460472677|FG001|Overall Study|Withdrawal by Subject|1|||
127959687|NCT01406574|460472678|FG002|Overall Study|Withdrawal by Subject|0|||
127959688|NCT01406574|460472679|FG003|Overall Study|Withdrawal by Subject|0|||
127959689|NCT01406574|460472676|FG000|Overall Study|Definite progression of primary disease|1|||
127959690|NCT01406574|460472677|FG001|Overall Study|Definite progression of primary disease|0|||
127959691|NCT01406574|460472678|FG002|Overall Study|Definite progression of primary disease|0|||
127959692|NCT01406574|460472679|FG003|Overall Study|Definite progression of primary disease|0|||
127959693|NCT00584454|460472680|FG000|Overall Study|Adverse Event|1|||
127959694|NCT00584454|460472680|FG000|Overall Study|Relocation|1|||
127959695|NCT00584454|460472680|FG000|Overall Study|Clinical Hold|2|||
127959696|NCT00982657|460472681|FG000|Overall Study|Death|1|||
127959697|NCT00982657|460472682|FG001|Overall Study|Death|0|||
127959698|NCT00982657|460472683|FG002|Overall Study|Death|1|||
127959699|NCT00982657|460472684|FG003|Overall Study|Death|1|||
127959700|NCT00982657|460472681|FG000|Overall Study|Withdrawal by Subject|0|||
127959701|NCT00982657|460472682|FG001|Overall Study|Withdrawal by Subject|0|||
127959702|NCT00982657|460472683|FG002|Overall Study|Withdrawal by Subject|1|||
127959703|NCT00982657|460472684|FG003|Overall Study|Withdrawal by Subject|3|||
127959704|NCT00982657|460472681|FG000|Overall Study|Other|0|||
127959705|NCT00982657|460472682|FG001|Overall Study|Other|0|||
127959706|NCT00982657|460472683|FG002|Overall Study|Other|0|||
127959707|NCT00982657|460472684|FG003|Overall Study|Other|4|||
127959708|NCT00982657|460472681|FG000|Overall Study|On going at date of cut-off|0|||
127959709|NCT00982657|460472682|FG001|Overall Study|On going at date of cut-off|0|||
127959710|NCT00982657|460472683|FG002|Overall Study|On going at date of cut-off|0|||
127959711|NCT00982657|460472684|FG003|Overall Study|On going at date of cut-off|1|||
127959712|NCT00725920|460472685|FG000|Overall Study|Lack of Efficacy|3|||
127959713|NCT00725920|460472686|FG001|Overall Study|Lack of Efficacy|6|||
127959714|NCT05373108|460472687|FG000|Overall Study|Withdrawal by Subject|2|||
127959715|NCT03323398|460472692|FG000|Overall Study|Other than Specified|0|||
127959716|NCT03323398|460472693|FG001|Overall Study|Other than Specified|1|||
127959717|NCT03323398|460472694|FG002|Overall Study|Other than Specified|2|||
127959718|NCT03323398|460472695|FG003|Overall Study|Other than Specified|0|||
127959719|NCT03323398|460472696|FG004|Overall Study|Other than Specified|0|||
127959720|NCT03323398|460472697|FG005|Overall Study|Other than Specified|0|||
127959721|NCT03323398|460472698|FG006|Overall Study|Other than Specified|1|||
127959722|NCT03323398|460472699|FG007|Overall Study|Other than Specified|0|||
127959723|NCT03323398|460472700|FG008|Overall Study|Other than Specified|2|||
127959724|NCT03323398|460472692|FG000|Overall Study|Lost to Follow-up|1|||
127959725|NCT03323398|460472693|FG001|Overall Study|Lost to Follow-up|2|||
127959726|NCT03323398|460472694|FG002|Overall Study|Lost to Follow-up|1|||
127959727|NCT03323398|460472695|FG003|Overall Study|Lost to Follow-up|0|||
127959728|NCT03323398|460472696|FG004|Overall Study|Lost to Follow-up|0|||
127959729|NCT03323398|460472697|FG005|Overall Study|Lost to Follow-up|0|||
127959730|NCT03323398|460472698|FG006|Overall Study|Lost to Follow-up|0|||
127959731|NCT03323398|460472699|FG007|Overall Study|Lost to Follow-up|0|||
127959732|NCT03323398|460472700|FG008|Overall Study|Lost to Follow-up|0|||
127959733|NCT03323398|460472692|FG000|Overall Study|Death|4|||
127959734|NCT03323398|460472693|FG001|Overall Study|Death|6|||
127959735|NCT03323398|460472694|FG002|Overall Study|Death|2|||
127959736|NCT03323398|460472695|FG003|Overall Study|Death|2|||
127959737|NCT03323398|460472696|FG004|Overall Study|Death|1|||
127959738|NCT03323398|460472697|FG005|Overall Study|Death|2|||
127959739|NCT03323398|460472698|FG006|Overall Study|Death|0|||
127959740|NCT03323398|460472699|FG007|Overall Study|Death|0|||
127959741|NCT03323398|460472700|FG008|Overall Study|Death|6|||
127959742|NCT03323398|460472692|FG000|Overall Study|Received Alternative Anticancer Therapy|2|||
127959743|NCT03323398|460472693|FG001|Overall Study|Received Alternative Anticancer Therapy|1|||
127959744|NCT03323398|460472694|FG002|Overall Study|Received Alternative Anticancer Therapy|2|||
127959745|NCT03323398|460472695|FG003|Overall Study|Received Alternative Anticancer Therapy|0|||
127959746|NCT03323398|460472696|FG004|Overall Study|Received Alternative Anticancer Therapy|0|||
127959747|NCT03323398|460472697|FG005|Overall Study|Received Alternative Anticancer Therapy|0|||
127959748|NCT03323398|460472698|FG006|Overall Study|Received Alternative Anticancer Therapy|0|||
127959749|NCT03323398|460472699|FG007|Overall Study|Received Alternative Anticancer Therapy|0|||
127959750|NCT03323398|460472700|FG008|Overall Study|Received Alternative Anticancer Therapy|0|||
127959751|NCT03323398|460472692|FG000|Overall Study|Withdrawal by Subject|2|||
127959752|NCT03323398|460472693|FG001|Overall Study|Withdrawal by Subject|1|||
127959753|NCT03323398|460472694|FG002|Overall Study|Withdrawal by Subject|3|||
127959754|NCT03323398|460472695|FG003|Overall Study|Withdrawal by Subject|0|||
127959755|NCT03323398|460472696|FG004|Overall Study|Withdrawal by Subject|0|||
127959756|NCT03323398|460472697|FG005|Overall Study|Withdrawal by Subject|1|||
127959757|NCT03323398|460472698|FG006|Overall Study|Withdrawal by Subject|0|||
127959758|NCT03323398|460472699|FG007|Overall Study|Withdrawal by Subject|0|||
127959759|NCT03323398|460472700|FG008|Overall Study|Withdrawal by Subject|0|||
127959760|NCT03323398|460472692|FG000|Overall Study|Participant was Put on Hospice|0|||
127959761|NCT03323398|460472693|FG001|Overall Study|Participant was Put on Hospice|0|||
127959762|NCT03323398|460472694|FG002|Overall Study|Participant was Put on Hospice|0|||
127959763|NCT03323398|460472695|FG003|Overall Study|Participant was Put on Hospice|0|||
127959764|NCT03323398|460472696|FG004|Overall Study|Participant was Put on Hospice|0|||
127959765|NCT03323398|460472697|FG005|Overall Study|Participant was Put on Hospice|0|||
127959766|NCT03323398|460472698|FG006|Overall Study|Participant was Put on Hospice|1|||
127959767|NCT03323398|460472699|FG007|Overall Study|Participant was Put on Hospice|0|||
127959768|NCT03323398|460472700|FG008|Overall Study|Participant was Put on Hospice|0|||
127959769|NCT03323398|460472692|FG000|Overall Study|Discontinued Following Discussion with Physician|0|||
127959770|NCT03323398|460472693|FG001|Overall Study|Discontinued Following Discussion with Physician|0|||
127959771|NCT03323398|460472694|FG002|Overall Study|Discontinued Following Discussion with Physician|0|||
127959772|NCT03323398|460472695|FG003|Overall Study|Discontinued Following Discussion with Physician|0|||
127959773|NCT03323398|460472696|FG004|Overall Study|Discontinued Following Discussion with Physician|0|||
127959774|NCT03323398|460472697|FG005|Overall Study|Discontinued Following Discussion with Physician|0|||
127959775|NCT03323398|460472698|FG006|Overall Study|Discontinued Following Discussion with Physician|0|||
127959776|NCT03323398|460472699|FG007|Overall Study|Discontinued Following Discussion with Physician|1|||
127959777|NCT03323398|460472700|FG008|Overall Study|Discontinued Following Discussion with Physician|0|||
127959778|NCT02235454|460472701|FG000|Overall Study|Withdrawal by Subject|2|||
127959779|NCT03641469|460472702|FG000|Overall Study|Ineligible|2|||
127959780|NCT03641469|460472702|FG000|Overall Study|Withdrawal by Subject|5|||
127959781|NCT03641469|460472702|FG000|Overall Study|Physician Decision|1|||
127959782|NCT03641469|460472702|FG000|Overall Study|Protocol Violation|1|||
127959783|NCT03641469|460472702|FG000|Overall Study|Lost to Follow-up|2|||
127959784|NCT05655546|460474371|FG000|Overall Study|Withdrawal by Subject|2|||
127959785|NCT05655546|460474372|FG001|Overall Study|Withdrawal by Subject|4|||
127959786|NCT02513160|460474375|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
127959787|NCT02513160|460474376|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
127959788|NCT02513160|460474377|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
127959789|NCT02513160|460474378|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
127959790|NCT02513160|460474375|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
127959791|NCT02513160|460474376|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
127959792|NCT02513160|460474377|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
127959793|NCT02513160|460474378|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
127959794|NCT02513160|460474375|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
127959795|NCT02513160|460474376|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
127959796|NCT02513160|460474377|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
127959797|NCT02513160|460474378|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
127959798|NCT02513160|460474375|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
127959799|NCT02513160|460474376|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
127959800|NCT02513160|460474377|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
127959801|NCT02513160|460474378|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
127959802|NCT02513160|460474375|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
127959803|NCT02513160|460474376|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
127959804|NCT02513160|460474377|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
127959805|NCT02513160|460474378|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
127959806|NCT02513160|460474375|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
127959807|NCT02513160|460474376|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
127959808|NCT02513160|460474377|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
127959809|NCT02513160|460474378|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
127959810|NCT02513160|460474375|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
127959811|NCT02513160|460474376|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
127959812|NCT02513160|460474377|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
127959813|NCT02513160|460474378|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
127959814|NCT02513160|460474375|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
127959815|NCT02513160|460474376|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
127959816|NCT02513160|460474377|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
127959817|NCT02513160|460474378|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
127959818|NCT02513160|460474375|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
127959819|NCT02513160|460474376|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
127959820|NCT02513160|460474377|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
127959821|NCT02513160|460474378|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
127959822|NCT02513160|460474375|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
127959823|NCT02513160|460474376|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
127959824|NCT02513160|460474377|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
127959825|NCT02513160|460474378|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
127959826|NCT02513160|460474375|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
127959827|NCT02513160|460474376|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
127959828|NCT02513160|460474377|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
127959829|NCT02513160|460474378|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
127959830|NCT02513160|460474375|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
127959831|NCT02513160|460474376|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
127959832|NCT02513160|460474377|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
127959833|NCT02513160|460474378|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
127959834|NCT05258773|460474379|FG000|Overall Study|Screen Failure|1|||
127959835|NCT05258773|460474380|FG001|Overall Study|Screen Failure|1|||
127959836|NCT05258773|460474379|FG000|Overall Study|Adverse Event|1|||
127959837|NCT05258773|460474380|FG001|Overall Study|Adverse Event|0|||
127959838|NCT05258773|460474379|FG000|Overall Study|Withdrawal by Subject|0|||
127959839|NCT05258773|460474380|FG001|Overall Study|Withdrawal by Subject|1|||
127959840|NCT06025721|460474385|FG000|Overall Study|Physician Decision|1|||
127959841|NCT06025721|460474385|FG000|Overall Study|Protocol Violation|1|||
127959842|NCT06025721|460474385|FG000|Overall Study|Incarceration|1|||
127959843|NCT04510090|460474386|FG000|FE-HS|Withdrawal by Subject|0|||
127959844|NCT04510090|460474387|FG001|FE-HS|Withdrawal by Subject|0|||
127959845|NCT04510090|460474388|FG002|FE-HS|Withdrawal by Subject|0|||
127959846|NCT04510090|460474389|FG003|FE-HS|Withdrawal by Subject|0|||
127959847|NCT04510090|460474390|FG004|FE-HS|Withdrawal by Subject|1|||
127959848|NCT04510090|460474391|FG005|FE-HS|Withdrawal by Subject|0|||
127959849|NCT04510090|460474392|FG006|FE-HS|Withdrawal by Subject|0|||
127959850|NCT04510090|460474393|FG007|FE-HS|Withdrawal by Subject|0|||
127959851|NCT01127256|460474394|FG000|Overall Study|Adverse Event|13|||
127959852|NCT01127256|460474395|FG001|Overall Study|Adverse Event|13|||
127959853|NCT01127256|460474394|FG000|Overall Study|Lack of Efficacy|4|||
127959854|NCT01127256|460474395|FG001|Overall Study|Lack of Efficacy|0|||
127959855|NCT01127256|460474394|FG000|Overall Study|Lost to Follow-up|16|||
127959856|NCT01127256|460474395|FG001|Overall Study|Lost to Follow-up|17|||
127959857|NCT01127256|460474394|FG000|Overall Study|Withdrawal by Subject|5|||
127959858|NCT01127256|460474395|FG001|Overall Study|Withdrawal by Subject|9|||
127959859|NCT01127256|460474394|FG000|Overall Study|Protocol Violation|1|||
127959860|NCT01127256|460474395|FG001|Overall Study|Protocol Violation|0|||
127959861|NCT01415518|460474396|FG000|Overall Study|Withdrawal by Subject|2|||
127959862|NCT01415518|460474397|FG001|Overall Study|Withdrawal by Subject|12|||
127959863|NCT01415518|460474396|FG000|Overall Study|Protocol Violation|6|||
127959864|NCT01415518|460474397|FG001|Overall Study|Protocol Violation|8|||
127959865|NCT01415518|460474396|FG000|Overall Study|Lost to Follow-up|3|||
127959866|NCT01415518|460474397|FG001|Overall Study|Lost to Follow-up|5|||
127959867|NCT01415518|460474396|FG000|Overall Study|Adverse Event|3|||
127959868|NCT01415518|460474397|FG001|Overall Study|Adverse Event|4|||
127959869|NCT01415518|460474396|FG000|Overall Study|Death|1|||
127959870|NCT01415518|460474397|FG001|Overall Study|Death|1|||
127959871|NCT01415518|460474396|FG000|Overall Study|Condition under Investigation Worsened|1|||
127959872|NCT01415518|460474397|FG001|Overall Study|Condition under Investigation Worsened|1|||
127959873|NCT00679211|460474398|FG000|Overall Study|Progressive disease|82|||
127959874|NCT00679211|460474398|FG000|Overall Study|Adverse Event|7|||
127959875|NCT00679211|460474398|FG000|Overall Study|Withdrawal by Subject|2|||
127959876|NCT00679211|460474398|FG000|Overall Study|Physician Decision|5|||
127959877|NCT00679211|460474398|FG000|Overall Study|Refused to undergo protocol procedures|1|||
127959878|NCT00679211|460474398|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
127959879|NCT00679211|460474398|FG000|Overall Study|Other|1|||
127959880|NCT01730053|460474399|FG000|Overall Study|Participant moved|0|||
127959881|NCT01730053|460474400|FG001|Overall Study|Participant moved|0|||
127959882|NCT01730053|460474401|FG002|Overall Study|Participant moved|1|||
127959883|NCT01730053|460474402|FG003|Overall Study|Participant moved|0|||
127959884|NCT01730053|460474403|FG004|Overall Study|Participant moved|0|||
127959885|NCT01730053|460474404|FG005|Overall Study|Participant moved|0|||
127959886|NCT01730053|460474399|FG000|Overall Study|Physician Decision|0|||
127959887|NCT01730053|460474400|FG001|Overall Study|Physician Decision|0|||
127959888|NCT01730053|460474401|FG002|Overall Study|Physician Decision|0|||
127959889|NCT01730053|460474402|FG003|Overall Study|Physician Decision|1|||
127959890|NCT01730053|460474403|FG004|Overall Study|Physician Decision|0|||
127959891|NCT01730053|460474404|FG005|Overall Study|Physician Decision|0|||
127959892|NCT01730053|460474399|FG000|Overall Study|Adverse Event|2|||
127959893|NCT01730053|460474400|FG001|Overall Study|Adverse Event|6|||
127959894|NCT01730053|460474401|FG002|Overall Study|Adverse Event|3|||
127959895|NCT01730053|460474402|FG003|Overall Study|Adverse Event|3|||
127959896|NCT01730053|460474403|FG004|Overall Study|Adverse Event|2|||
127959897|NCT01730053|460474404|FG005|Overall Study|Adverse Event|2|||
127959898|NCT01730053|460474399|FG000|Overall Study|Poor compliance to protocol|1|||
127959899|NCT01730053|460474400|FG001|Overall Study|Poor compliance to protocol|2|||
127959900|NCT01730053|460474401|FG002|Overall Study|Poor compliance to protocol|2|||
127959901|NCT01730053|460474402|FG003|Overall Study|Poor compliance to protocol|0|||
127959902|NCT01730053|460474403|FG004|Overall Study|Poor compliance to protocol|0|||
127959903|NCT01730053|460474404|FG005|Overall Study|Poor compliance to protocol|2|||
127959904|NCT01730053|460474399|FG000|Overall Study|Other than specified|2|||
127959905|NCT01730053|460474400|FG001|Overall Study|Other than specified|6|||
127959906|NCT01730053|460474401|FG002|Overall Study|Other than specified|5|||
127959907|NCT01730053|460474402|FG003|Overall Study|Other than specified|4|||
127959908|NCT01730053|460474403|FG004|Overall Study|Other than specified|7|||
127959909|NCT01730053|460474404|FG005|Overall Study|Other than specified|9|||
127959910|NCT01470248|460474406|FG000|Overall Study|Withdrawal by Subject|1|||
127959911|NCT05085834|460474407|FG000|Overall Study|Lost to Follow-up|9|||
127959912|NCT05085834|460474408|FG001|Overall Study|Lost to Follow-up|2|||
127959913|NCT05085834|460474407|FG000|Overall Study|Adverse Event|6|||
127959914|NCT05085834|460474408|FG001|Overall Study|Adverse Event|0|||
127959915|NCT05085834|460474407|FG000|Overall Study|Death|1|||
127959916|NCT05085834|460474408|FG001|Overall Study|Death|0|||
127959917|NCT05085834|460474407|FG000|Overall Study|Inability to swallow the pill|0|||
127959918|NCT05085834|460474408|FG001|Overall Study|Inability to swallow the pill|1|||
127959919|NCT02243605|460474409|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
127959920|NCT02243605|460474410|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
127959921|NCT02243605|460474409|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
127959922|NCT02243605|460474410|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
127959923|NCT02243605|460474409|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
127959924|NCT02243605|460474410|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
127959925|NCT02243605|460474409|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
127959926|NCT02243605|460474410|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
127959927|NCT02243605|460474409|FG000|Stage 2 - Final Analysis Population|Progression|0|||
127959928|NCT02243605|460474410|FG001|Stage 2 - Final Analysis Population|Progression|1|||
127959929|NCT02157935|460474411|FG000|Overall Study|Withdrawal by Subject|25|||
127959930|NCT02157935|460474412|FG001|Overall Study|Withdrawal by Subject|39|||
127959931|NCT02157935|460474411|FG000|Overall Study|Screen failure|1|||
127959932|NCT02157935|460474412|FG001|Overall Study|Screen failure|2|||
127959933|NCT02157935|460474411|FG000|Overall Study|Protocol Violation|1|||
127959934|NCT02157935|460474412|FG001|Overall Study|Protocol Violation|0|||
127959935|NCT02157935|460474411|FG000|Overall Study|Progressive disease|0|||
127959936|NCT02157935|460474412|FG001|Overall Study|Progressive disease|2|||
127959937|NCT02157935|460474411|FG000|Overall Study|Other|5|||
127959938|NCT02157935|460474412|FG001|Overall Study|Other|12|||
127959939|NCT02157935|460474411|FG000|Overall Study|Lack of Efficacy|0|||
127959940|NCT02157935|460474412|FG001|Overall Study|Lack of Efficacy|1|||
127959941|NCT02157935|460474411|FG000|Overall Study|Death|4|||
127959942|NCT02157935|460474412|FG001|Overall Study|Death|4|||
127959943|NCT02157935|460474411|FG000|Overall Study|Adverse Event|3|||
127959944|NCT02157935|460474412|FG001|Overall Study|Adverse Event|5|||
127959945|NCT02547428|460474419|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
127959946|NCT02547428|460474420|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
127959947|NCT02547428|460474419|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
127959948|NCT02547428|460474420|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
127959949|NCT02547428|460474419|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
127959950|NCT02547428|460474420|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
127959951|NCT02547428|460474419|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
127959952|NCT02547428|460474420|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
127959953|NCT02547428|460474419|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
127959954|NCT02547428|460474420|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
127959955|NCT02547428|460474419|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
127959956|NCT02547428|460474420|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
127959957|NCT02547428|460474419|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
127959958|NCT02547428|460474420|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
127959959|NCT02547428|460474419|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
127959960|NCT02547428|460474420|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
127959961|NCT01479465|460474421|FG000|Overall Study|Disease Progression|9|||
127959962|NCT01479465|460474422|FG001|Overall Study|Disease Progression|61|||
127959963|NCT01479465|460474423|FG002|Overall Study|Disease Progression|65|||
127959964|NCT01479465|460474424|FG003|Overall Study|Disease Progression|70|||
127959965|NCT01479465|460474421|FG000|Overall Study|Study Discontinued by Sponsor|0|||
127959966|NCT01479465|460474422|FG001|Overall Study|Study Discontinued by Sponsor|7|||
127959967|NCT01479465|460474423|FG002|Overall Study|Study Discontinued by Sponsor|5|||
127959968|NCT01479465|460474424|FG003|Overall Study|Study Discontinued by Sponsor|3|||
127959969|NCT01479465|460474421|FG000|Overall Study|Adverse Event|0|||
127959970|NCT01479465|460474422|FG001|Overall Study|Adverse Event|3|||
127959971|NCT01479465|460474423|FG002|Overall Study|Adverse Event|6|||
127959972|NCT01479465|460474424|FG003|Overall Study|Adverse Event|4|||
127959973|NCT01479465|460474421|FG000|Overall Study|Investigator Discretion|1|||
127959974|NCT01479465|460474422|FG001|Overall Study|Investigator Discretion|4|||
127959975|NCT01479465|460474423|FG002|Overall Study|Investigator Discretion|2|||
127959976|NCT01479465|460474424|FG003|Overall Study|Investigator Discretion|4|||
127959977|NCT01479465|460474421|FG000|Overall Study|Subject Request|1|||
127959978|NCT01479465|460474422|FG001|Overall Study|Subject Request|3|||
127959979|NCT01479465|460474423|FG002|Overall Study|Subject Request|4|||
127959980|NCT01479465|460474424|FG003|Overall Study|Subject Request|2|||
127959981|NCT01479465|460474421|FG000|Overall Study|Subject Withdrew Consent|0|||
127959982|NCT01479465|460474422|FG001|Overall Study|Subject Withdrew Consent|5|||
127959983|NCT01479465|460474423|FG002|Overall Study|Subject Withdrew Consent|2|||
127959984|NCT01479465|460474424|FG003|Overall Study|Subject Withdrew Consent|1|||
127959985|NCT01479465|460474421|FG000|Overall Study|Protocol Violation|0|||
127959986|NCT01479465|460474422|FG001|Overall Study|Protocol Violation|1|||
127959987|NCT01479465|460474423|FG002|Overall Study|Protocol Violation|1|||
127959988|NCT01479465|460474424|FG003|Overall Study|Protocol Violation|0|||
127959989|NCT01479465|460474421|FG000|Overall Study|Death|0|||
127959990|NCT01479465|460474422|FG001|Overall Study|Death|0|||
127959991|NCT01479465|460474423|FG002|Overall Study|Death|0|||
127959992|NCT01479465|460474424|FG003|Overall Study|Death|1|||
127959993|NCT01479465|460474421|FG000|Overall Study|Lost to Follow-up|0|||
127959994|NCT01479465|460474422|FG001|Overall Study|Lost to Follow-up|0|||
127959995|NCT01479465|460474423|FG002|Overall Study|Lost to Follow-up|1|||
127959996|NCT01479465|460474424|FG003|Overall Study|Lost to Follow-up|0|||
127959997|NCT04429503|460474429|FG000|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|2|||
127959998|NCT04429503|460474430|FG001|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|1|||
127959999|NCT04429503|460474431|FG002|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
127960000|NCT04429503|460474432|FG003|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
127960001|NCT04429503|460474433|FG004|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
127960002|NCT04429503|460474434|FG005|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
127960003|NCT04429503|460474429|FG000|Main Study (Up to Wk 96)|Adverse Event|1|||
127960004|NCT04429503|460474430|FG001|Main Study (Up to Wk 96)|Adverse Event|9|||
127960005|NCT04429503|460474431|FG002|Main Study (Up to Wk 96)|Adverse Event|2|||
127960006|NCT04429503|460474432|FG003|Main Study (Up to Wk 96)|Adverse Event|0|||
127960007|NCT04429503|460474433|FG004|Main Study (Up to Wk 96)|Adverse Event|0|||
127960008|NCT04429503|460474434|FG005|Main Study (Up to Wk 96)|Adverse Event|0|||
127960009|NCT04429503|460474429|FG000|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|2|||
127960010|NCT04429503|460474430|FG001|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|9|||
127960011|NCT04429503|460474431|FG002|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|3|||
127960012|NCT04429503|460474432|FG003|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
127960013|NCT04429503|460474433|FG004|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
127960014|NCT04429503|460474434|FG005|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
127960015|NCT04429503|460474429|FG000|Main Study (Up to Wk 96)|Withdrawal by Subject|9|||
127960016|NCT04429503|460474430|FG001|Main Study (Up to Wk 96)|Withdrawal by Subject|17|||
127960017|NCT04429503|460474431|FG002|Main Study (Up to Wk 96)|Withdrawal by Subject|8|||
127960018|NCT04429503|460474432|FG003|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
127960019|NCT04429503|460474433|FG004|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
127960020|NCT04429503|460474434|FG005|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
127960021|NCT04429503|460474429|FG000|Main Study (Up to Wk 96)|Lost to Follow-up|5|||
127960022|NCT04429503|460474430|FG001|Main Study (Up to Wk 96)|Lost to Follow-up|19|||
127960023|NCT04429503|460474431|FG002|Main Study (Up to Wk 96)|Lost to Follow-up|7|||
127960024|NCT04429503|460474432|FG003|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
127960025|NCT04429503|460474433|FG004|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
127960026|NCT04429503|460474434|FG005|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
127960027|NCT04429503|460474429|FG000|Main Study (Up to Wk 96)|Death|9|||
127960028|NCT04429503|460474430|FG001|Main Study (Up to Wk 96)|Death|18|||
127960029|NCT04429503|460474431|FG002|Main Study (Up to Wk 96)|Death|5|||
127960030|NCT04429503|460474432|FG003|Main Study (Up to Wk 96)|Death|0|||
127960031|NCT04429503|460474433|FG004|Main Study (Up to Wk 96)|Death|0|||
127960032|NCT04429503|460474434|FG005|Main Study (Up to Wk 96)|Death|0|||
127960033|NCT04429503|460474429|FG000|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
127960034|NCT04429503|460474430|FG001|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
127960035|NCT04429503|460474431|FG002|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
127960036|NCT04429503|460474432|FG003|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|1|||
127960037|NCT04429503|460474433|FG004|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
127960038|NCT04429503|460474434|FG005|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
127960039|NCT04429503|460474429|FG000|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
127960040|NCT04429503|460474430|FG001|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
127960041|NCT04429503|460474431|FG002|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
127960042|NCT04429503|460474432|FG003|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
127960043|NCT04429503|460474433|FG004|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
127960044|NCT04429503|460474434|FG005|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
127960045|NCT04429503|460474429|FG000|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
127960046|NCT04429503|460474430|FG001|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
127960047|NCT04429503|460474431|FG002|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
127960048|NCT04429503|460474432|FG003|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
127960049|NCT04429503|460474433|FG004|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|3|||
127960050|NCT04429503|460474434|FG005|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|2|||
127960051|NCT04429503|460474429|FG000|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
127960052|NCT04429503|460474430|FG001|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
127960053|NCT04429503|460474431|FG002|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
127960054|NCT04429503|460474432|FG003|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
127960055|NCT04429503|460474433|FG004|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|10|||
127960056|NCT04429503|460474434|FG005|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
127960057|NCT04429503|460474429|FG000|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
127960058|NCT04429503|460474430|FG001|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
127960059|NCT04429503|460474431|FG002|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
127960060|NCT04429503|460474432|FG003|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|3|||
127960061|NCT04429503|460474433|FG004|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
127960062|NCT04429503|460474434|FG005|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
127960063|NCT04429503|460474429|FG000|Extension Phase (Wk 96 to Wk 156)|Death|0|||
127960064|NCT04429503|460474430|FG001|Extension Phase (Wk 96 to Wk 156)|Death|0|||
127960065|NCT04429503|460474431|FG002|Extension Phase (Wk 96 to Wk 156)|Death|0|||
127960066|NCT04429503|460474432|FG003|Extension Phase (Wk 96 to Wk 156)|Death|2|||
127960067|NCT04429503|460474433|FG004|Extension Phase (Wk 96 to Wk 156)|Death|7|||
127960068|NCT04429503|460474434|FG005|Extension Phase (Wk 96 to Wk 156)|Death|2|||
127960069|NCT05516108|460474435|FG000|Overall Study|Time Commitment|3|||
127960070|NCT05516108|460474436|FG001|Overall Study|Time Commitment|1|||
127960071|NCT05516108|460474435|FG000|Overall Study|Reason Unknown|2|||
127960072|NCT05516108|460474436|FG001|Overall Study|Reason Unknown|4|||
127960073|NCT02717507|460474437|FG000|Overall Study|Lost to Follow-up|5|||
127960074|NCT02717507|460474438|FG001|Overall Study|Lost to Follow-up|8|||
127960075|NCT02717507|460474437|FG000|Overall Study|Pregnancy|1|||
127960076|NCT02717507|460474438|FG001|Overall Study|Pregnancy|1|||
127960077|NCT02717507|460474437|FG000|Overall Study|Protocol Violation|2|||
127960078|NCT02717507|460474438|FG001|Overall Study|Protocol Violation|2|||
127960079|NCT02717507|460474437|FG000|Overall Study|Withdrawal by Subject|20|||
127960080|NCT02717507|460474438|FG001|Overall Study|Withdrawal by Subject|20|||
127960081|NCT02717507|460474437|FG000|Overall Study|Relapse|1|||
127960082|NCT02717507|460474438|FG001|Overall Study|Relapse|1|||
127960083|NCT02717507|460474437|FG000|Overall Study|Cardiac Event|2|||
127960084|NCT02717507|460474438|FG001|Overall Study|Cardiac Event|6|||
127960085|NCT00709995|460474439|FG000|Overall Study|Adverse Event|4|||
127960086|NCT00709995|460474440|FG001|Overall Study|Adverse Event|2|||
127960087|NCT00709995|460474439|FG000|Overall Study|Withdrawal by Subject|1|||
127960088|NCT00709995|460474440|FG001|Overall Study|Withdrawal by Subject|3|||
127960089|NCT02003209|460474441|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
127960090|NCT02003209|460474442|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
127960091|NCT00638508|460474443|FG000|Overall Study|Physician Decision|5|||
127960092|NCT00638508|460474444|FG001|Overall Study|Physician Decision|2|||
127960093|NCT00370552|460474445|FG000|Overall Study|Adverse Event|2|||
127960094|NCT00370552|460474446|FG001|Overall Study|Adverse Event|2|||
127960095|NCT00370552|460474447|FG002|Overall Study|Adverse Event|2|||
127960096|NCT00370552|460474445|FG000|Overall Study|Disease progression|23|||
127960097|NCT00370552|460474446|FG001|Overall Study|Disease progression|23|||
127960098|NCT00370552|460474447|FG002|Overall Study|Disease progression|15|||
127960099|NCT00370552|460474445|FG000|Overall Study|Maximum clinical benefit|3|||
127960100|NCT00370552|460474446|FG001|Overall Study|Maximum clinical benefit|5|||
127960101|NCT00370552|460474447|FG002|Overall Study|Maximum clinical benefit|5|||
127960102|NCT00370552|460474445|FG000|Overall Study|Poor or noncompliance|0|||
127960103|NCT00370552|460474446|FG001|Overall Study|Poor or noncompliance|0|||
127960104|NCT00370552|460474447|FG002|Overall Study|Poor or noncompliance|1|||
127960105|NCT00370552|460474445|FG000|Overall Study|Study drug toxicity|11|||
127960106|NCT00370552|460474446|FG001|Overall Study|Study drug toxicity|8|||
127960107|NCT00370552|460474447|FG002|Overall Study|Study drug toxicity|6|||
127960108|NCT00370552|460474445|FG000|Overall Study|Withdrawal by Subject|2|||
127960109|NCT00370552|460474446|FG001|Overall Study|Withdrawal by Subject|0|||
127960110|NCT00370552|460474447|FG002|Overall Study|Withdrawal by Subject|1|||
127960111|NCT00370552|460474445|FG000|Overall Study|Still on treatment|1|||
127960112|NCT00370552|460474446|FG001|Overall Study|Still on treatment|3|||
127960113|NCT00370552|460474447|FG002|Overall Study|Still on treatment|2|||
127960114|NCT00370552|460474445|FG000|Overall Study|Never treated|1|||
127960115|NCT00370552|460474446|FG001|Overall Study|Never treated|0|||
127960116|NCT00370552|460474447|FG002|Overall Study|Never treated|0|||
127960117|NCT00370552|460474445|FG000|Overall Study|Physician Decision|1|||
127960118|NCT00370552|460474446|FG001|Overall Study|Physician Decision|1|||
127960119|NCT00370552|460474447|FG002|Overall Study|Physician Decision|0|||
127960120|NCT00370552|460474445|FG000|Overall Study|Investigator decision|2|||
127960121|NCT00370552|460474446|FG001|Overall Study|Investigator decision|1|||
127960122|NCT00370552|460474447|FG002|Overall Study|Investigator decision|0|||
127960123|NCT00370552|460474445|FG000|Overall Study|High risk of allergic reaction|0|||
127960124|NCT00370552|460474446|FG001|Overall Study|High risk of allergic reaction|1|||
127960125|NCT00370552|460474447|FG002|Overall Study|High risk of allergic reaction|0|||
127960126|NCT00370552|460474445|FG000|Overall Study|Planned radiation for palliation|0|||
127960127|NCT00370552|460474446|FG001|Overall Study|Planned radiation for palliation|1|||
127960128|NCT00370552|460474447|FG002|Overall Study|Planned radiation for palliation|0|||
127960129|NCT03500198|460474448|FG000|Overall Study|Lost to Follow-up|0|||
127960130|NCT03500198|460474449|FG001|Overall Study|Lost to Follow-up|1|||
127960131|NCT00942084|460474461|FG000|Overall Study|Death|2|||
127960132|NCT02285361|460474463|FG000|Overall Study|Protocol Violation|43|||
127960133|NCT02285361|460474463|FG000|Overall Study|Lost to Follow-up|5|||
127960134|NCT02285361|460474463|FG000|Overall Study|Not taken GIOTRIF|2|||
127960135|NCT02285361|460474463|FG000|Overall Study|Consented prior to the contract date|1|||
127960136|NCT05921903|460474464|FG000|Overall Study|Unsolicited non-SAE|0|||
127960137|NCT05921903|460474465|FG001|Overall Study|Unsolicited non-SAE|1|||
127960138|NCT05921903|460474466|FG002|Overall Study|Unsolicited non-SAE|0|||
127960139|NCT05921903|460474464|FG000|Overall Study|SAEs/pIMDs/AESIs specific to SOT|0|||
127960140|NCT05921903|460474465|FG001|Overall Study|SAEs/pIMDs/AESIs specific to SOT|3|||
127960141|NCT05921903|460474466|FG002|Overall Study|SAEs/pIMDs/AESIs specific to SOT|1|||
127960142|NCT05921903|460474464|FG000|Overall Study|Ongoing at the time of Primary Completion Analysis|129|||
127960143|NCT05921903|460474465|FG001|Overall Study|Ongoing at the time of Primary Completion Analysis|126|||
127960144|NCT05921903|460474466|FG002|Overall Study|Ongoing at the time of Primary Completion Analysis|112|||
127960145|NCT05317312|460474467|FG000|Overall Study|Withdrawal by Subject|0|||
127960146|NCT05317312|460474468|FG001|Overall Study|Withdrawal by Subject|1|||
127960147|NCT05317312|460474469|FG002|Overall Study|Withdrawal by Subject|0|||
127960148|NCT05317312|460474470|FG003|Overall Study|Withdrawal by Subject|0|||
127960149|NCT05317312|460474467|FG000|Overall Study|Lost to Follow-up|0|||
127960150|NCT05317312|460474468|FG001|Overall Study|Lost to Follow-up|0|||
127960151|NCT05317312|460474469|FG002|Overall Study|Lost to Follow-up|0|||
127960152|NCT05317312|460474470|FG003|Overall Study|Lost to Follow-up|1|||
127960153|NCT05317312|460474467|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
127960154|NCT05317312|460474468|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
127960155|NCT05317312|460474469|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
127960156|NCT05317312|460474470|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
127960157|NCT02291237|460474471|FG000|Overall Study|Study Terminated by Sponsor|72|||
127960158|NCT02291237|460474472|FG001|Overall Study|Study Terminated by Sponsor|67|||
127960159|NCT02291237|460474471|FG000|Overall Study|Adverse Event|1|||
127960160|NCT02291237|460474472|FG001|Overall Study|Adverse Event|3|||
127960161|NCT02291237|460474471|FG000|Overall Study|Investigator's Discretion|0|||
127960162|NCT02291237|460474472|FG001|Overall Study|Investigator's Discretion|3|||
127960163|NCT02291237|460474471|FG000|Overall Study|Withdrew Consent|11|||
127960164|NCT02291237|460474472|FG001|Overall Study|Withdrew Consent|11|||
127960165|NCT02291237|460474471|FG000|Overall Study|Lost to Follow-up|0|||
127960166|NCT02291237|460474472|FG001|Overall Study|Lost to Follow-up|2|||
127960167|NCT02291237|460474471|FG000|Overall Study|Subject Required Prohibited Medication|2|||
127960168|NCT02291237|460474472|FG001|Overall Study|Subject Required Prohibited Medication|0|||
127960169|NCT01306305|460474473|FG000|Overall Study|Lost to Follow-up|1|||
127960170|NCT01306305|460474474|FG001|Overall Study|Lost to Follow-up|0|||
127960171|NCT01306305|460474473|FG000|Overall Study|Withdrew consent|1|||
127960172|NCT01306305|460474474|FG001|Overall Study|Withdrew consent|0|||
127960173|NCT03326193|460474475|FG000|Overall Study|Sponsor decision|35|||
127960174|NCT00699998|460474477|FG000|Overall Study|Withdrawal by Subject|194|||
127960175|NCT00699998|460474478|FG001|Overall Study|Withdrawal by Subject|83|||
127960176|NCT00699998|460474479|FG002|Overall Study|Withdrawal by Subject|202|||
127960177|NCT00699998|460474480|FG003|Overall Study|Withdrawal by Subject|80|||
127960178|NCT00699998|460474477|FG000|Overall Study|Physician Decision|3|||
127960179|NCT00699998|460474478|FG001|Overall Study|Physician Decision|2|||
127960180|NCT00699998|460474479|FG002|Overall Study|Physician Decision|1|||
127960181|NCT00699998|460474480|FG003|Overall Study|Physician Decision|1|||
127960182|NCT00699998|460474477|FG000|Overall Study|Lost to Follow-up|2|||
127960183|NCT00699998|460474478|FG001|Overall Study|Lost to Follow-up|1|||
127960184|NCT00699998|460474479|FG002|Overall Study|Lost to Follow-up|3|||
127960185|NCT00699998|460474480|FG003|Overall Study|Lost to Follow-up|1|||
127960186|NCT00473590|460474485|FG000|Overall Study|Adverse Event|3|||
127960187|NCT00473590|460474486|FG001|Overall Study|Adverse Event|3|||
127960188|NCT00473590|460474485|FG000|Overall Study|Death|4|||
127960189|NCT00473590|460474486|FG001|Overall Study|Death|2|||
127960190|NCT00473590|460474485|FG000|Overall Study|Progression not resulting in death|24|||
127960191|NCT00473590|460474486|FG001|Overall Study|Progression not resulting in death|20|||
127960192|NCT00473590|460474485|FG000|Overall Study|Non-protocol-specified therapy|7|||
127960193|NCT00473590|460474486|FG001|Overall Study|Non-protocol-specified therapy|5|||
127960194|NCT00473590|460474485|FG000|Overall Study|Physician Decision|2|||
127960195|NCT00473590|460474486|FG001|Overall Study|Physician Decision|4|||
127960196|NCT00473590|460474485|FG000|Overall Study|Withdrawal by Subject|5|||
127960197|NCT00473590|460474486|FG001|Overall Study|Withdrawal by Subject|3|||
127960198|NCT00473590|460474485|FG000|Overall Study|Other|0|||
127960199|NCT00473590|460474486|FG001|Overall Study|Other|1|||
127960200|NCT03367819|460474489|FG000|Overall Study|Adverse Event|4|||
127960201|NCT03367819|460474490|FG001|Overall Study|Adverse Event|4|||
127960202|NCT03367819|460474489|FG000|Overall Study|Progressive Disease|15|||
127960203|NCT03367819|460474490|FG001|Overall Study|Progressive Disease|13|||
127960204|NCT03367819|460474489|FG000|Overall Study|Withdrawal by Subject|1|||
127960205|NCT03367819|460474490|FG001|Overall Study|Withdrawal by Subject|0|||
127960206|NCT03367819|460474489|FG000|Overall Study|Other|4|||
127960207|NCT03367819|460474490|FG001|Overall Study|Other|2|||
127960208|NCT01891864|460474493|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
127960209|NCT01891864|460474494|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
127960210|NCT01891864|460474495|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
127960211|NCT01891864|460474496|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
127960212|NCT01891864|460474497|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
127960213|NCT01891864|460474498|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
127960214|NCT01891864|460474493|FG000|Treatment Period 1|Physician Decision|0|||
127960215|NCT01891864|460474494|FG001|Treatment Period 1|Physician Decision|1|||
127960216|NCT01891864|460474495|FG002|Treatment Period 1|Physician Decision|0|||
127960217|NCT01891864|460474496|FG003|Treatment Period 1|Physician Decision|0|||
127960218|NCT01891864|460474497|FG004|Treatment Period 1|Physician Decision|0|||
127960219|NCT01891864|460474498|FG005|Treatment Period 1|Physician Decision|0|||
127960220|NCT01891864|460474493|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
127960221|NCT01891864|460474494|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
127960222|NCT01891864|460474495|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
127960223|NCT01891864|460474496|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
127960224|NCT01891864|460474497|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
127960225|NCT01891864|460474498|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
127960226|NCT01891864|460474493|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
127960227|NCT01891864|460474494|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
127960228|NCT01891864|460474495|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
127960229|NCT01891864|460474496|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
127960230|NCT01891864|460474497|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
127960231|NCT01891864|460474498|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
127960232|NCT01891864|460474493|FG000|Treatment Period 1|Withdrawal by Subject|2|||
127960233|NCT01891864|460474494|FG001|Treatment Period 1|Withdrawal by Subject|5|||
127960234|NCT01891864|460474495|FG002|Treatment Period 1|Withdrawal by Subject|0|||
127960235|NCT01891864|460474496|FG003|Treatment Period 1|Withdrawal by Subject|0|||
127960236|NCT01891864|460474497|FG004|Treatment Period 1|Withdrawal by Subject|0|||
127960237|NCT01891864|460474498|FG005|Treatment Period 1|Withdrawal by Subject|0|||
127960238|NCT01891864|460474493|FG000|Treatment Period 1|Lost to Follow-up|1|||
127960239|NCT01891864|460474494|FG001|Treatment Period 1|Lost to Follow-up|0|||
127960240|NCT01891864|460474495|FG002|Treatment Period 1|Lost to Follow-up|0|||
127960241|NCT01891864|460474496|FG003|Treatment Period 1|Lost to Follow-up|0|||
127960242|NCT01891864|460474497|FG004|Treatment Period 1|Lost to Follow-up|0|||
127960243|NCT01891864|460474498|FG005|Treatment Period 1|Lost to Follow-up|0|||
127960244|NCT01891864|460474493|FG000|Treatment Period 2|Protocol Violation|0|||
127960245|NCT01891864|460474494|FG001|Treatment Period 2|Protocol Violation|0|||
127960246|NCT01891864|460474495|FG002|Treatment Period 2|Protocol Violation|0|||
127960247|NCT01891864|460474496|FG003|Treatment Period 2|Protocol Violation|1|||
127960248|NCT01891864|460474497|FG004|Treatment Period 2|Protocol Violation|0|||
127960249|NCT01891864|460474498|FG005|Treatment Period 2|Protocol Violation|0|||
127960250|NCT01891864|460474493|FG000|Treatment Period 2|Physician Decision|0|||
127960251|NCT01891864|460474494|FG001|Treatment Period 2|Physician Decision|0|||
127960252|NCT01891864|460474495|FG002|Treatment Period 2|Physician Decision|1|||
127960253|NCT01891864|460474496|FG003|Treatment Period 2|Physician Decision|0|||
127960254|NCT01891864|460474497|FG004|Treatment Period 2|Physician Decision|0|||
127960255|NCT01891864|460474498|FG005|Treatment Period 2|Physician Decision|0|||
127960256|NCT01891864|460474493|FG000|Treatment Period 2|Site Termination|0|||
127960257|NCT01891864|460474494|FG001|Treatment Period 2|Site Termination|0|||
127960258|NCT01891864|460474495|FG002|Treatment Period 2|Site Termination|1|||
127960259|NCT01891864|460474496|FG003|Treatment Period 2|Site Termination|2|||
127960260|NCT01891864|460474497|FG004|Treatment Period 2|Site Termination|0|||
127960261|NCT01891864|460474498|FG005|Treatment Period 2|Site Termination|0|||
127960262|NCT01891864|460474493|FG000|Treatment Period 2|Lack of Efficacy|0|||
127960263|NCT01891864|460474494|FG001|Treatment Period 2|Lack of Efficacy|0|||
127960264|NCT01891864|460474495|FG002|Treatment Period 2|Lack of Efficacy|1|||
127960265|NCT01891864|460474496|FG003|Treatment Period 2|Lack of Efficacy|0|||
127960266|NCT01891864|460474497|FG004|Treatment Period 2|Lack of Efficacy|1|||
127960267|NCT01891864|460474498|FG005|Treatment Period 2|Lack of Efficacy|0|||
127960268|NCT01891864|460474493|FG000|Treatment Period 2|Adverse Event|0|||
127960269|NCT01891864|460474494|FG001|Treatment Period 2|Adverse Event|0|||
127960270|NCT01891864|460474495|FG002|Treatment Period 2|Adverse Event|1|||
127960271|NCT01891864|460474496|FG003|Treatment Period 2|Adverse Event|2|||
127960272|NCT01891864|460474497|FG004|Treatment Period 2|Adverse Event|0|||
127960273|NCT01891864|460474498|FG005|Treatment Period 2|Adverse Event|4|||
127960274|NCT01891864|460474493|FG000|Treatment Period 2|Termination of Site|0|||
127960275|NCT01891864|460474494|FG001|Treatment Period 2|Termination of Site|0|||
127960276|NCT01891864|460474495|FG002|Treatment Period 2|Termination of Site|0|||
127960277|NCT01891864|460474496|FG003|Treatment Period 2|Termination of Site|0|||
127960278|NCT01891864|460474497|FG004|Treatment Period 2|Termination of Site|2|||
127960279|NCT01891864|460474498|FG005|Treatment Period 2|Termination of Site|0|||
127960280|NCT01891864|460474493|FG000|Treatment Period 2|Withdrawal by Subject|0|||
127960281|NCT01891864|460474494|FG001|Treatment Period 2|Withdrawal by Subject|0|||
127960282|NCT01891864|460474495|FG002|Treatment Period 2|Withdrawal by Subject|3|||
127960283|NCT01891864|460474496|FG003|Treatment Period 2|Withdrawal by Subject|4|||
127960284|NCT01891864|460474497|FG004|Treatment Period 2|Withdrawal by Subject|1|||
127960285|NCT01891864|460474498|FG005|Treatment Period 2|Withdrawal by Subject|1|||
127960286|NCT01891864|460474493|FG000|Extension Period|Lack of Efficacy|0|||
127960287|NCT01891864|460474494|FG001|Extension Period|Lack of Efficacy|0|||
127960288|NCT01891864|460474495|FG002|Extension Period|Lack of Efficacy|0|||
127960289|NCT01891864|460474496|FG003|Extension Period|Lack of Efficacy|1|||
127960290|NCT01891864|460474497|FG004|Extension Period|Lack of Efficacy|1|||
127960291|NCT01891864|460474498|FG005|Extension Period|Lack of Efficacy|0|||
127960292|NCT01891864|460474493|FG000|Extension Period|Pregnancy|0|||
127960293|NCT01891864|460474494|FG001|Extension Period|Pregnancy|0|||
127960294|NCT01891864|460474495|FG002|Extension Period|Pregnancy|1|||
127960295|NCT01891864|460474496|FG003|Extension Period|Pregnancy|0|||
127960296|NCT01891864|460474497|FG004|Extension Period|Pregnancy|0|||
127960297|NCT01891864|460474498|FG005|Extension Period|Pregnancy|0|||
127960298|NCT01891864|460474493|FG000|Extension Period|Adverse Event|0|||
127960299|NCT01891864|460474494|FG001|Extension Period|Adverse Event|0|||
127960300|NCT01891864|460474495|FG002|Extension Period|Adverse Event|4|||
127960301|NCT01891864|460474496|FG003|Extension Period|Adverse Event|2|||
127960302|NCT01891864|460474497|FG004|Extension Period|Adverse Event|2|||
127960303|NCT01891864|460474498|FG005|Extension Period|Adverse Event|0|||
127960304|NCT01891864|460474493|FG000|Extension Period|Withdrawal by Subject|0|||
127960305|NCT01891864|460474494|FG001|Extension Period|Withdrawal by Subject|0|||
127960306|NCT01891864|460474495|FG002|Extension Period|Withdrawal by Subject|1|||
127960307|NCT01891864|460474496|FG003|Extension Period|Withdrawal by Subject|2|||
127960308|NCT01891864|460474497|FG004|Extension Period|Withdrawal by Subject|4|||
127960309|NCT01891864|460474498|FG005|Extension Period|Withdrawal by Subject|0|||
127960310|NCT01891864|460474493|FG000|Extension Period|Lost to Follow-up|0|||
127960311|NCT01891864|460474494|FG001|Extension Period|Lost to Follow-up|0|||
127960312|NCT01891864|460474495|FG002|Extension Period|Lost to Follow-up|2|||
127960313|NCT01891864|460474496|FG003|Extension Period|Lost to Follow-up|0|||
127960314|NCT01891864|460474497|FG004|Extension Period|Lost to Follow-up|0|||
127960315|NCT01891864|460474498|FG005|Extension Period|Lost to Follow-up|0|||
127960316|NCT02698163|460474499|FG000|Overall Study|Lost to Follow-up|0|||
127960317|NCT02698163|460474500|FG001|Overall Study|Lost to Follow-up|1|||
127960318|NCT02892331|460474501|FG000|Overall Study|Withdrawal by Subject|0|||
127960319|NCT02892331|460474502|FG001|Overall Study|Withdrawal by Subject|1|||
127960320|NCT02892331|460474503|FG002|Overall Study|Withdrawal by Subject|1|||
127960321|NCT02892331|460474501|FG000|Overall Study|Sick family member|0|||
127960322|NCT02892331|460474502|FG001|Overall Study|Sick family member|0|||
127960323|NCT02892331|460474503|FG002|Overall Study|Sick family member|1|||
127960324|NCT02892331|460474501|FG000|Overall Study|Corona virus pandemic|1|||
127960325|NCT02892331|460474502|FG001|Overall Study|Corona virus pandemic|0|||
127960326|NCT02892331|460474503|FG002|Overall Study|Corona virus pandemic|1|||
127960327|NCT02892331|460474501|FG000|Overall Study|Lost to Follow-up|1|||
127960328|NCT02892331|460474502|FG001|Overall Study|Lost to Follow-up|0|||
127960329|NCT02892331|460474503|FG002|Overall Study|Lost to Follow-up|1|||
127960330|NCT02892331|460474501|FG000|Overall Study|Blood pressure was too elevated|0|||
127960331|NCT02892331|460474502|FG001|Overall Study|Blood pressure was too elevated|1|||
127960332|NCT02892331|460474503|FG002|Overall Study|Blood pressure was too elevated|0|||
127960333|NCT02892331|460474501|FG000|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
127960334|NCT02892331|460474502|FG001|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|1|||
127960335|NCT02892331|460474503|FG002|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
127960336|NCT00752128|460474507|FG000|Overall Study|Withdrawal by Subject|4|||
127960337|NCT00349973|460474508|FG000|Overall Study|Adverse Event|3|||
127960338|NCT00349973|460474509|FG001|Overall Study|Adverse Event|3|||
127960339|NCT00349973|460474508|FG000|Overall Study|Withdrawal by Subject|1|||
127960340|NCT00349973|460474509|FG001|Overall Study|Withdrawal by Subject|0|||
127960341|NCT04314037|460474510|FG000|Treatment Period 2|Adverse Event|1|||
127960342|NCT04314037|460474511|FG001|Treatment Period 2|Adverse Event|0|||
127960343|NCT04314037|460474510|FG000|Treatment Period 3|Protocol Violation|1|||
127960344|NCT04314037|460474511|FG001|Treatment Period 3|Protocol Violation|0|||
127960345|NCT04314037|460474510|FG000|Treatment Period 3|Adverse Event|0|||
127960346|NCT04314037|460474511|FG001|Treatment Period 3|Adverse Event|1|||
127960347|NCT05479435|460474514|FG000|Overall Study|Withdrawal by Subject|1|||
127960348|NCT05479435|460474515|FG001|Overall Study|Withdrawal by Subject|0|||
127960349|NCT05479435|460474516|FG002|Overall Study|Withdrawal by Subject|0|||
127960350|NCT05479435|460474514|FG000|Overall Study|Covid 19|0|||
127960351|NCT05479435|460474515|FG001|Overall Study|Covid 19|0|||
127960352|NCT05479435|460474516|FG002|Overall Study|Covid 19|2|||
127960353|NCT02546986|460476407|FG000|Treatment Period|Progressive Disease|20|||
127960354|NCT02546986|460476408|FG001|Treatment Period|Progressive Disease|22|||
127960355|NCT02546986|460476407|FG000|Treatment Period|Adverse Event|14|||
127960356|NCT02546986|460476408|FG001|Treatment Period|Adverse Event|6|||
127960357|NCT02546986|460476407|FG000|Treatment Period|Symptomatic Deterioration|4|||
127960358|NCT02546986|460476408|FG001|Treatment Period|Symptomatic Deterioration|3|||
127960359|NCT02546986|460476407|FG000|Treatment Period|Death|3|||
127960360|NCT02546986|460476408|FG001|Treatment Period|Death|4|||
127960361|NCT02546986|460476407|FG000|Treatment Period|Physician Decision|1|||
127960362|NCT02546986|460476408|FG001|Treatment Period|Physician Decision|2|||
127960363|NCT02546986|460476407|FG000|Treatment Period|Protocol Violation|1|||
127960364|NCT02546986|460476408|FG001|Treatment Period|Protocol Violation|0|||
127960365|NCT02546986|460476407|FG000|Treatment Period|Withdrawal by Subject|1|||
127960366|NCT02546986|460476408|FG001|Treatment Period|Withdrawal by Subject|1|||
127960367|NCT02546986|460476407|FG000|Treatment Period|Non-compliance with Study Drug|0|||
127960368|NCT02546986|460476408|FG001|Treatment Period|Non-compliance with Study Drug|1|||
127960369|NCT02546986|460476407|FG000|Treatment Period|Study Terminated by Sponsor|0|||
127960370|NCT02546986|460476408|FG001|Treatment Period|Study Terminated by Sponsor|1|||
127960371|NCT02546986|460476407|FG000|Treatment Period|Miscellaneous|7|||
127960372|NCT02546986|460476408|FG001|Treatment Period|Miscellaneous|9|||
127960373|NCT02546986|460476407|FG000|Survival Follow-Up Phase|Missing Status|3|||
127960374|NCT02546986|460476408|FG001|Survival Follow-Up Phase|Missing Status|5|||
127960375|NCT02546986|460476407|FG000|Survival Follow-Up Phase|Death|18|||
127960376|NCT02546986|460476408|FG001|Survival Follow-Up Phase|Death|12|||
127960377|NCT02546986|460476407|FG000|Survival Follow-Up Phase|Alive|13|||
127960378|NCT02546986|460476408|FG001|Survival Follow-Up Phase|Alive|16|||
127960379|NCT02546986|460476407|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
127960380|NCT02546986|460476408|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
127960381|NCT05016960|460476409|FG000|Overall Study|Withdrawal by Subject|1|||
127960382|NCT05016960|460476410|FG001|Overall Study|Withdrawal by Subject|9|||
127960383|NCT04796961|460476411|FG000|Overall Study|Lost to Follow-up|10|||
127960384|NCT04796961|460476411|FG000|Overall Study|Withdrawal by Subject|3|||
127960385|NCT04796961|460476411|FG000|Overall Study|Left Organization|10|||
127960386|NCT02325973|460476412|FG000|Overall Study|Death|5|||
127960387|NCT02325973|460476412|FG000|Overall Study|Withdrawal by subject or investigator|16|||
127960388|NCT03428958|460476416|FG000|Overall Study|Adverse Event|0|||
127960389|NCT03428958|460476417|FG001|Overall Study|Adverse Event|0|||
127960390|NCT03428958|460476418|FG002|Overall Study|Adverse Event|0|||
127960391|NCT03428958|460476419|FG003|Overall Study|Adverse Event|1|||
127960392|NCT03428958|460476420|FG004|Overall Study|Adverse Event|0|||
127960393|NCT03428958|460476421|FG005|Overall Study|Adverse Event|2|||
127960394|NCT03428958|460476422|FG006|Overall Study|Adverse Event|1|||
127960395|NCT03428958|460476423|FG007|Overall Study|Adverse Event|0|||
127960396|NCT03428958|460476424|FG008|Overall Study|Adverse Event|0|||
127960397|NCT03428958|460476425|FG009|Overall Study|Adverse Event|0|||
127960398|NCT03428958|460476426|FG010|Overall Study|Adverse Event|0|||
127960399|NCT03428958|460476427|FG011|Overall Study|Adverse Event|0|||
127960400|NCT03428958|460476428|FG012|Overall Study|Adverse Event|0|||
127960401|NCT03428958|460476429|FG013|Overall Study|Adverse Event|0|||
127960402|NCT03428958|460476430|FG014|Overall Study|Adverse Event|0|||
127960403|NCT03428958|460476431|FG015|Overall Study|Adverse Event|0|||
127960404|NCT03428958|460476432|FG016|Overall Study|Adverse Event|0|||
127960405|NCT03428958|460476416|FG000|Overall Study|Clinical Progression|2|||
127960406|NCT03428958|460476417|FG001|Overall Study|Clinical Progression|3|||
127960407|NCT03428958|460476418|FG002|Overall Study|Clinical Progression|2|||
127960408|NCT03428958|460476419|FG003|Overall Study|Clinical Progression|1|||
127960409|NCT03428958|460476420|FG004|Overall Study|Clinical Progression|0|||
127960410|NCT03428958|460476421|FG005|Overall Study|Clinical Progression|2|||
127960411|NCT03428958|460476422|FG006|Overall Study|Clinical Progression|0|||
127960412|NCT03428958|460476423|FG007|Overall Study|Clinical Progression|0|||
127960413|NCT03428958|460476424|FG008|Overall Study|Clinical Progression|0|||
127960414|NCT03428958|460476425|FG009|Overall Study|Clinical Progression|0|||
127960415|NCT03428958|460476426|FG010|Overall Study|Clinical Progression|0|||
127960416|NCT03428958|460476427|FG011|Overall Study|Clinical Progression|0|||
127960417|NCT03428958|460476428|FG012|Overall Study|Clinical Progression|0|||
127960418|NCT03428958|460476429|FG013|Overall Study|Clinical Progression|0|||
127960419|NCT03428958|460476430|FG014|Overall Study|Clinical Progression|0|||
127960420|NCT03428958|460476431|FG015|Overall Study|Clinical Progression|0|||
127960421|NCT03428958|460476432|FG016|Overall Study|Clinical Progression|0|||
127960422|NCT03428958|460476416|FG000|Overall Study|Progression per RECIST|6|||
127960423|NCT03428958|460476417|FG001|Overall Study|Progression per RECIST|6|||
127960424|NCT03428958|460476418|FG002|Overall Study|Progression per RECIST|7|||
127960425|NCT03428958|460476419|FG003|Overall Study|Progression per RECIST|4|||
127960426|NCT03428958|460476420|FG004|Overall Study|Progression per RECIST|0|||
127960427|NCT03428958|460476421|FG005|Overall Study|Progression per RECIST|7|||
127960428|NCT03428958|460476422|FG006|Overall Study|Progression per RECIST|8|||
127960429|NCT03428958|460476423|FG007|Overall Study|Progression per RECIST|0|||
127960430|NCT03428958|460476424|FG008|Overall Study|Progression per RECIST|0|||
127960431|NCT03428958|460476425|FG009|Overall Study|Progression per RECIST|0|||
127960432|NCT03428958|460476426|FG010|Overall Study|Progression per RECIST|0|||
127960433|NCT03428958|460476427|FG011|Overall Study|Progression per RECIST|0|||
127960434|NCT03428958|460476428|FG012|Overall Study|Progression per RECIST|1|||
127960435|NCT03428958|460476429|FG013|Overall Study|Progression per RECIST|0|||
127960436|NCT03428958|460476430|FG014|Overall Study|Progression per RECIST|0|||
127960437|NCT03428958|460476431|FG015|Overall Study|Progression per RECIST|0|||
127960438|NCT03428958|460476432|FG016|Overall Study|Progression per RECIST|0|||
127960439|NCT03428958|460476416|FG000|Overall Study|Death|2|||
127960440|NCT03428958|460476417|FG001|Overall Study|Death|2|||
127960441|NCT03428958|460476418|FG002|Overall Study|Death|0|||
127960442|NCT03428958|460476419|FG003|Overall Study|Death|0|||
127960443|NCT03428958|460476420|FG004|Overall Study|Death|0|||
127960444|NCT03428958|460476421|FG005|Overall Study|Death|7|||
127960445|NCT03428958|460476422|FG006|Overall Study|Death|9|||
127960446|NCT03428958|460476423|FG007|Overall Study|Death|6|||
127960447|NCT03428958|460476424|FG008|Overall Study|Death|0|||
127960448|NCT03428958|460476425|FG009|Overall Study|Death|0|||
127960449|NCT03428958|460476426|FG010|Overall Study|Death|3|||
127960450|NCT03428958|460476427|FG011|Overall Study|Death|0|||
127960451|NCT03428958|460476428|FG012|Overall Study|Death|4|||
127960452|NCT03428958|460476429|FG013|Overall Study|Death|0|||
127960453|NCT03428958|460476430|FG014|Overall Study|Death|0|||
127960454|NCT03428958|460476431|FG015|Overall Study|Death|0|||
127960455|NCT03428958|460476432|FG016|Overall Study|Death|0|||
127960456|NCT03428958|460476416|FG000|Overall Study|Lost to Follow-up|0|||
127960457|NCT03428958|460476417|FG001|Overall Study|Lost to Follow-up|0|||
127960458|NCT03428958|460476418|FG002|Overall Study|Lost to Follow-up|0|||
127960459|NCT03428958|460476419|FG003|Overall Study|Lost to Follow-up|0|||
127960460|NCT03428958|460476420|FG004|Overall Study|Lost to Follow-up|0|||
127960461|NCT03428958|460476421|FG005|Overall Study|Lost to Follow-up|1|||
127960462|NCT03428958|460476422|FG006|Overall Study|Lost to Follow-up|1|||
127960463|NCT03428958|460476423|FG007|Overall Study|Lost to Follow-up|0|||
127960464|NCT03428958|460476424|FG008|Overall Study|Lost to Follow-up|0|||
127960465|NCT03428958|460476425|FG009|Overall Study|Lost to Follow-up|0|||
127960466|NCT03428958|460476426|FG010|Overall Study|Lost to Follow-up|0|||
127960467|NCT03428958|460476427|FG011|Overall Study|Lost to Follow-up|0|||
127960468|NCT03428958|460476428|FG012|Overall Study|Lost to Follow-up|0|||
127960469|NCT03428958|460476429|FG013|Overall Study|Lost to Follow-up|0|||
127960470|NCT03428958|460476430|FG014|Overall Study|Lost to Follow-up|0|||
127960471|NCT03428958|460476431|FG015|Overall Study|Lost to Follow-up|0|||
127960472|NCT03428958|460476432|FG016|Overall Study|Lost to Follow-up|0|||
127960473|NCT03428958|460476416|FG000|Overall Study|Physician/Sponsor Decision|1|||
127960474|NCT03428958|460476417|FG001|Overall Study|Physician/Sponsor Decision|0|||
127960475|NCT03428958|460476418|FG002|Overall Study|Physician/Sponsor Decision|1|||
127960476|NCT03428958|460476419|FG003|Overall Study|Physician/Sponsor Decision|0|||
127960477|NCT03428958|460476420|FG004|Overall Study|Physician/Sponsor Decision|0|||
127960478|NCT03428958|460476421|FG005|Overall Study|Physician/Sponsor Decision|2|||
127960479|NCT03428958|460476422|FG006|Overall Study|Physician/Sponsor Decision|2|||
127960480|NCT03428958|460476423|FG007|Overall Study|Physician/Sponsor Decision|2|||
127960481|NCT03428958|460476424|FG008|Overall Study|Physician/Sponsor Decision|0|||
127960482|NCT03428958|460476425|FG009|Overall Study|Physician/Sponsor Decision|0|||
127960483|NCT03428958|460476426|FG010|Overall Study|Physician/Sponsor Decision|2|||
127960484|NCT03428958|460476427|FG011|Overall Study|Physician/Sponsor Decision|0|||
127960485|NCT03428958|460476428|FG012|Overall Study|Physician/Sponsor Decision|4|||
127960486|NCT03428958|460476429|FG013|Overall Study|Physician/Sponsor Decision|0|||
127960487|NCT03428958|460476430|FG014|Overall Study|Physician/Sponsor Decision|0|||
127960488|NCT03428958|460476431|FG015|Overall Study|Physician/Sponsor Decision|0|||
127960489|NCT03428958|460476432|FG016|Overall Study|Physician/Sponsor Decision|0|||
127960490|NCT03428958|460476416|FG000|Overall Study|Withdrawal by Subject|0|||
127960491|NCT03428958|460476417|FG001|Overall Study|Withdrawal by Subject|0|||
127960492|NCT03428958|460476418|FG002|Overall Study|Withdrawal by Subject|2|||
127960493|NCT03428958|460476419|FG003|Overall Study|Withdrawal by Subject|0|||
127960494|NCT03428958|460476420|FG004|Overall Study|Withdrawal by Subject|0|||
127960495|NCT03428958|460476421|FG005|Overall Study|Withdrawal by Subject|2|||
127960496|NCT03428958|460476422|FG006|Overall Study|Withdrawal by Subject|4|||
127960497|NCT03428958|460476423|FG007|Overall Study|Withdrawal by Subject|1|||
127960498|NCT03428958|460476424|FG008|Overall Study|Withdrawal by Subject|0|||
127960499|NCT03428958|460476425|FG009|Overall Study|Withdrawal by Subject|0|||
127960500|NCT03428958|460476426|FG010|Overall Study|Withdrawal by Subject|0|||
127960501|NCT03428958|460476427|FG011|Overall Study|Withdrawal by Subject|0|||
127960502|NCT03428958|460476428|FG012|Overall Study|Withdrawal by Subject|0|||
127960503|NCT03428958|460476429|FG013|Overall Study|Withdrawal by Subject|0|||
127960504|NCT03428958|460476430|FG014|Overall Study|Withdrawal by Subject|0|||
127960505|NCT03428958|460476431|FG015|Overall Study|Withdrawal by Subject|0|||
127960506|NCT03428958|460476432|FG016|Overall Study|Withdrawal by Subject|0|||
127960507|NCT03874117|460476433|FG000|First Intervention (4 Weeks)|received kidney transplant|1|||
127960508|NCT03874117|460476434|FG001|First Intervention (4 Weeks)|received kidney transplant|0|||
127960509|NCT03874117|460476433|FG000|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
127960510|NCT03874117|460476434|FG001|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
127960511|NCT03874117|460476433|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
127960512|NCT03874117|460476434|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
127960513|NCT03874117|460476433|FG000|First Intervention (4 Weeks)|hospitalized for infection|0|||
127960514|NCT03874117|460476434|FG001|First Intervention (4 Weeks)|hospitalized for infection|1|||
127960515|NCT03874117|460476433|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
127960516|NCT03874117|460476434|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
127960517|NCT03018288|460476435|FG000|Overall Study|Participants withdrew consent before surgery.|0|||
127960518|NCT03018288|460476436|FG001|Overall Study|Participants withdrew consent before surgery.|0|||
127960519|NCT03018288|460476437|FG002|Overall Study|Participants withdrew consent before surgery.|0|||
127960520|NCT03018288|460476438|FG003|Overall Study|Participants withdrew consent before surgery.|1|||
127960521|NCT03018288|460476435|FG000|Overall Study|Participant withdrew consent.|0|||
127960522|NCT03018288|460476436|FG001|Overall Study|Participant withdrew consent.|0|||
127960523|NCT03018288|460476437|FG002|Overall Study|Participant withdrew consent.|1|||
127960524|NCT03018288|460476438|FG003|Overall Study|Participant withdrew consent.|0|||
127960525|NCT03018288|460476435|FG000|Overall Study|Switched to alternative treatment.|0|||
127960526|NCT03018288|460476436|FG001|Overall Study|Switched to alternative treatment.|0|||
127960527|NCT03018288|460476437|FG002|Overall Study|Switched to alternative treatment.|1|||
127960528|NCT03018288|460476438|FG003|Overall Study|Switched to alternative treatment.|0|||
127960529|NCT03018288|460476435|FG000|Overall Study|Participant withdrew consent for personal reasons.|0|||
127960530|NCT03018288|460476436|FG001|Overall Study|Participant withdrew consent for personal reasons.|0|||
127960531|NCT03018288|460476437|FG002|Overall Study|Participant withdrew consent for personal reasons.|1|||
127960532|NCT03018288|460476438|FG003|Overall Study|Participant withdrew consent for personal reasons.|0|||
127960533|NCT03018288|460476435|FG000|Overall Study|Screen failures|0|||
127960534|NCT03018288|460476436|FG001|Overall Study|Screen failures|0|||
127960535|NCT03018288|460476437|FG002|Overall Study|Screen failures|0|||
127960536|NCT03018288|460476438|FG003|Overall Study|Screen failures|51|||
127960537|NCT03018288|460476435|FG000|Overall Study|Chose treatment outside of UNC|0|||
127960538|NCT03018288|460476436|FG001|Overall Study|Chose treatment outside of UNC|0|||
127960539|NCT03018288|460476437|FG002|Overall Study|Chose treatment outside of UNC|0|||
127960540|NCT03018288|460476438|FG003|Overall Study|Chose treatment outside of UNC|1|||
127960541|NCT03018288|460476435|FG000|Overall Study|Unable to comply with protocol requirements|1|||
127960542|NCT03018288|460476436|FG001|Overall Study|Unable to comply with protocol requirements|1|||
127960543|NCT03018288|460476437|FG002|Overall Study|Unable to comply with protocol requirements|0|||
127960544|NCT03018288|460476438|FG003|Overall Study|Unable to comply with protocol requirements|1|||
127960545|NCT03018288|460476435|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
127960546|NCT03018288|460476436|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
127960547|NCT03018288|460476437|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
127960548|NCT03018288|460476438|FG003|Overall Study|Participant declined to participate (before treatment started)|3|||
127960549|NCT03018288|460476435|FG000|Overall Study|Physician Decision|0|||
127960550|NCT03018288|460476436|FG001|Overall Study|Physician Decision|0|||
127960551|NCT03018288|460476437|FG002|Overall Study|Physician Decision|0|||
127960552|NCT03018288|460476438|FG003|Overall Study|Physician Decision|1|||
127960553|NCT01922037|460476439|FG000|Overall Study|Withdrawal by Subject|2|||
127960554|NCT01922037|460476440|FG001|Overall Study|Withdrawal by Subject|44|||
127960555|NCT01922037|460476439|FG000|Overall Study|Adverse Event|1|||
127960556|NCT01922037|460476440|FG001|Overall Study|Adverse Event|7|||
127960557|NCT01922037|460476439|FG000|Overall Study|Death|0|||
127960558|NCT01922037|460476440|FG001|Overall Study|Death|5|||
127960559|NCT01922037|460476439|FG000|Overall Study|Pregnancy|0|||
127960560|NCT01922037|460476440|FG001|Overall Study|Pregnancy|2|||
127960561|NCT01922037|460476439|FG000|Overall Study|Participant non-compliance|4|||
127960562|NCT01922037|460476440|FG001|Overall Study|Participant non-compliance|46|||
127960563|NCT01922037|460476439|FG000|Overall Study|Investigator/Sponsor decision|1|||
127960564|NCT01922037|460476440|FG001|Overall Study|Investigator/Sponsor decision|4|||
127960565|NCT01922037|460476439|FG000|Overall Study|Other unspecified|2|||
127960566|NCT01922037|460476440|FG001|Overall Study|Other unspecified|66|||
127960567|NCT02068508|460476441|FG000|Overall Study|Case report forms uncollected|27|||
127960568|NCT02068508|460476441|FG000|Overall Study|Patient did not visit the study site|1|||
127960569|NCT02068508|460476441|FG000|Overall Study|Protocol Violation|4|||
127960570|NCT03511105|460476447|FG000|Overall Study|Adverse Event|1|||
127960571|NCT03511105|460476448|FG001|Overall Study|Adverse Event|0|||
127960572|NCT03511105|460476447|FG000|Overall Study|Withdrew consent|1|||
127960573|NCT03511105|460476448|FG001|Overall Study|Withdrew consent|0|||
127960574|NCT02810457|460476449|FG000|Overall Study|Randomised but no treatment received|2|||
127960575|NCT02810457|460476450|FG001|Overall Study|Randomised but no treatment received|1|||
127960576|NCT02810457|460476449|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
127960577|NCT02810457|460476450|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
127960578|NCT02810457|460476449|FG000|Overall Study|Adverse Event|37|||
127960579|NCT02810457|460476450|FG001|Overall Study|Adverse Event|43|||
127960580|NCT02810457|460476449|FG000|Overall Study|Patient decision|31|||
127960581|NCT02810457|460476450|FG001|Overall Study|Patient decision|35|||
127960582|NCT02810457|460476449|FG000|Overall Study|Patient lost to follow-up|2|||
127960583|NCT02810457|460476450|FG001|Overall Study|Patient lost to follow-up|2|||
127960584|NCT02810457|460476449|FG000|Overall Study|Death|39|||
127960585|NCT02810457|460476450|FG001|Overall Study|Death|28|||
127960586|NCT02810457|460476449|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
127960587|NCT02810457|460476450|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
127960588|NCT02810457|460476449|FG000|Overall Study|Clinical progression|15|||
127960589|NCT02810457|460476450|FG001|Overall Study|Clinical progression|16|||
127960590|NCT02810457|460476449|FG000|Overall Study|Investigator decision|3|||
127960591|NCT02810457|460476450|FG001|Overall Study|Investigator decision|2|||
127960592|NCT02810457|460476449|FG000|Overall Study|Patient ineligibility|3|||
127960593|NCT02810457|460476450|FG001|Overall Study|Patient ineligibility|0|||
127960594|NCT02810457|460476449|FG000|Overall Study|Miscalculated PD|1|||
127960595|NCT02810457|460476450|FG001|Overall Study|Miscalculated PD|0|||
127960596|NCT02810457|460476449|FG000|Overall Study|Physician Decision|0|||
127960597|NCT02810457|460476450|FG001|Overall Study|Physician Decision|1|||
127960598|NCT04173507|460476451|FG000|Overall Study|On Treatment|3|||
127960599|NCT04173507|460476451|FG000|Overall Study|Adverse Event|3|||
127960600|NCT04173507|460476451|FG000|Overall Study|Progression/Relapse|34|||
127960601|NCT04173507|460476451|FG000|Overall Study|Death|2|||
127960602|NCT02019472|460476452|FG000|Overall Study|Adverse Event|14|||
127960603|NCT02019472|460476453|FG001|Overall Study|Adverse Event|23|||
127960604|NCT02019472|460476454|FG002|Overall Study|Adverse Event|17|||
127960605|NCT02019472|460476452|FG000|Overall Study|Death|0|||
127960606|NCT02019472|460476453|FG001|Overall Study|Death|1|||
127960607|NCT02019472|460476454|FG002|Overall Study|Death|1|||
127960608|NCT02019472|460476452|FG000|Overall Study|Lack of Efficacy|7|||
127960609|NCT02019472|460476453|FG001|Overall Study|Lack of Efficacy|4|||
127960610|NCT02019472|460476454|FG002|Overall Study|Lack of Efficacy|4|||
127960611|NCT02019472|460476452|FG000|Overall Study|Lost to Follow-up|0|||
127960612|NCT02019472|460476453|FG001|Overall Study|Lost to Follow-up|2|||
127960613|NCT02019472|460476454|FG002|Overall Study|Lost to Follow-up|1|||
127960614|NCT02019472|460476452|FG000|Overall Study|Physician Decision|1|||
127960615|NCT02019472|460476453|FG001|Overall Study|Physician Decision|2|||
127960616|NCT02019472|460476454|FG002|Overall Study|Physician Decision|0|||
127960617|NCT02019472|460476452|FG000|Overall Study|Pregnancy|1|||
127960618|NCT02019472|460476453|FG001|Overall Study|Pregnancy|2|||
127960619|NCT02019472|460476454|FG002|Overall Study|Pregnancy|2|||
127960620|NCT02019472|460476452|FG000|Overall Study|Withdrawal by Subject|11|||
127960621|NCT02019472|460476453|FG001|Overall Study|Withdrawal by Subject|10|||
127960622|NCT02019472|460476454|FG002|Overall Study|Withdrawal by Subject|11|||
127960623|NCT02019472|460476452|FG000|Overall Study|Other|3|||
127960624|NCT02019472|460476453|FG001|Overall Study|Other|8|||
127960625|NCT02019472|460476454|FG002|Overall Study|Other|6|||
127960626|NCT01217112|460476457|FG000|Overall Study|Adverse Event|0|||
127960627|NCT01217112|460476458|FG001|Overall Study|Adverse Event|2|||
127960628|NCT01217112|460476459|FG002|Overall Study|Adverse Event|0|||
127960629|NCT01217112|460476460|FG003|Overall Study|Adverse Event|2|||
127960630|NCT01217112|460476461|FG004|Overall Study|Adverse Event|0|||
127960631|NCT01217112|460476457|FG000|Overall Study|Withdrawal by Subject|0|||
127960632|NCT01217112|460476458|FG001|Overall Study|Withdrawal by Subject|0|||
127960633|NCT01217112|460476459|FG002|Overall Study|Withdrawal by Subject|1|||
127960634|NCT01217112|460476460|FG003|Overall Study|Withdrawal by Subject|0|||
127960635|NCT01217112|460476461|FG004|Overall Study|Withdrawal by Subject|0|||
127960636|NCT01217112|460476457|FG000|Overall Study|Physician Decision|0|||
127960637|NCT01217112|460476458|FG001|Overall Study|Physician Decision|0|||
127960638|NCT01217112|460476459|FG002|Overall Study|Physician Decision|0|||
127960639|NCT01217112|460476460|FG003|Overall Study|Physician Decision|0|||
127960640|NCT01217112|460476461|FG004|Overall Study|Physician Decision|1|||
127960641|NCT03192488|460476462|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
127960642|NCT03192488|460476463|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
127960643|NCT03192488|460476464|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
127960644|NCT03192488|460476465|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
127960645|NCT03192488|460476466|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
127960646|NCT03192488|460476467|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
127960647|NCT03192488|460476462|FG000|Third Intervention (d1)|Adverse Event|0|||
127960648|NCT03192488|460476463|FG001|Third Intervention (d1)|Adverse Event|0|||
127960649|NCT03192488|460476464|FG002|Third Intervention (d1)|Adverse Event|0|||
127960650|NCT03192488|460476465|FG003|Third Intervention (d1)|Adverse Event|0|||
127960651|NCT03192488|460476466|FG004|Third Intervention (d1)|Adverse Event|1|||
127960652|NCT03192488|460476467|FG005|Third Intervention (d1)|Adverse Event|0|||
127960653|NCT01401361|460476468|FG000|Overall Study|Withdrawal by Subject|16|||
127960654|NCT01401361|460476468|FG000|Overall Study|Lack of Efficacy|6|||
127960655|NCT01401361|460476468|FG000|Overall Study|Physician Decision|1|||
127960656|NCT01401361|460476468|FG000|Overall Study|Lost to Follow-up|3|||
127960657|NCT01401361|460476468|FG000|Overall Study|Subject/family decision post procedure|2|||
127960658|NCT02512302|460476470|FG000|Period 1|Adverse Event|0|||
127960659|NCT02512302|460476471|FG001|Period 1|Adverse Event|1|||
127960660|NCT02512302|460476472|FG002|Period 1|Adverse Event|0|||
127960661|NCT02512302|460476473|FG003|Period 1|Adverse Event|0|||
127960662|NCT02512302|460476474|FG004|Period 1|Adverse Event|0|||
127960663|NCT02512302|460476475|FG005|Period 1|Adverse Event|0|||
127960664|NCT02512302|460476476|FG006|Period 1|Adverse Event|0|||
127960665|NCT02512302|460476477|FG007|Period 1|Adverse Event|0|||
127960666|NCT02512302|460476478|FG008|Period 1|Adverse Event|0|||
127960667|NCT02512302|460476479|FG009|Period 1|Adverse Event|0|||
127960668|NCT02512302|460476470|FG000|Period 2|Adverse Event|0|||
127960669|NCT02512302|460476471|FG001|Period 2|Adverse Event|0|||
127960670|NCT02512302|460476472|FG002|Period 2|Adverse Event|0|||
127960671|NCT02512302|460476473|FG003|Period 2|Adverse Event|0|||
127960672|NCT02512302|460476474|FG004|Period 2|Adverse Event|0|||
127960673|NCT02512302|460476475|FG005|Period 2|Adverse Event|0|||
127960674|NCT02512302|460476476|FG006|Period 2|Adverse Event|0|||
127960675|NCT02512302|460476477|FG007|Period 2|Adverse Event|0|||
127960676|NCT02512302|460476478|FG008|Period 2|Adverse Event|0|||
127960677|NCT02512302|460476479|FG009|Period 2|Adverse Event|1|||
127960678|NCT02512302|460476470|FG000|Period 3|Lost to Follow-up|0|||
127960679|NCT02512302|460476471|FG001|Period 3|Lost to Follow-up|0|||
127960680|NCT02512302|460476472|FG002|Period 3|Lost to Follow-up|1|||
127960681|NCT02512302|460476473|FG003|Period 3|Lost to Follow-up|0|||
127960682|NCT02512302|460476474|FG004|Period 3|Lost to Follow-up|0|||
127960683|NCT02512302|460476475|FG005|Period 3|Lost to Follow-up|0|||
127960684|NCT02512302|460476476|FG006|Period 3|Lost to Follow-up|0|||
127960685|NCT02512302|460476477|FG007|Period 3|Lost to Follow-up|0|||
127960686|NCT02512302|460476478|FG008|Period 3|Lost to Follow-up|0|||
127960687|NCT02512302|460476479|FG009|Period 3|Lost to Follow-up|0|||
127960688|NCT02512302|460476470|FG000|Period 4|Adverse Event|0|||
127960689|NCT02512302|460476471|FG001|Period 4|Adverse Event|0|||
127960690|NCT02512302|460476472|FG002|Period 4|Adverse Event|0|||
127960691|NCT02512302|460476473|FG003|Period 4|Adverse Event|0|||
127960692|NCT02512302|460476474|FG004|Period 4|Adverse Event|0|||
127960693|NCT02512302|460476475|FG005|Period 4|Adverse Event|0|||
127960694|NCT02512302|460476476|FG006|Period 4|Adverse Event|1|||
127960695|NCT02512302|460476477|FG007|Period 4|Adverse Event|0|||
127960696|NCT02512302|460476478|FG008|Period 4|Adverse Event|0|||
127960697|NCT02512302|460476479|FG009|Period 4|Adverse Event|0|||
127960698|NCT02764762|460476483|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
127960699|NCT02764762|460476483|FG000|Overall Study|Lost to Follow-up|4|||
127960700|NCT02764762|460476483|FG000|Overall Study|Voluntary Withdrawal|8|||
127960701|NCT02764762|460476483|FG000|Overall Study|Site Termination|1|||
127960702|NCT02764762|460476483|FG000|Overall Study|Lack of Efficacy|16|||
127960703|NCT02764762|460476483|FG000|Overall Study|Reason not Specified|1|||
127960704|NCT01002989|460476484|FG000|Overall Study|exclusion criteria, no consent|5|||
127960705|NCT01892501|460476485|FG000|Overall Study|Protocol Violation|2|||
127960706|NCT01892501|460476485|FG000|Overall Study|Puncture not carried out|9|||
127960707|NCT01892501|460476485|FG000|Overall Study|Radiological monitoring not carried out|5|||
127960708|NCT01892501|460476485|FG000|Overall Study|Non-contributory histological result|12|||
127960709|NCT01321879|460476487|FG000|Overall Study|Lack of Efficacy|5|||
127960710|NCT01321879|460476487|FG000|Overall Study|Adverse Event|5|||
127960711|NCT01321879|460476487|FG000|Overall Study|Death|3|||
127960712|NCT01321879|460476487|FG000|Overall Study|Withdrawal by Subject|1|||
127960713|NCT01641640|460476488|FG000|Overall Study|Enrolled but not treated|1|||
127960714|NCT01641640|460476488|FG000|Overall Study|Efficacy failure|29|||
127960715|NCT01641640|460476488|FG000|Overall Study|Lost to Follow-up|3|||
127960716|NCT01641640|460476488|FG000|Overall Study|Withdrawal by Subject|2|||
127960717|NCT01641640|460476488|FG000|Overall Study|Adverse Event|1|||
127960718|NCT01234350|460476489|FG000|Overall Study|Adverse Event|277|||
127960719|NCT01234350|460476490|FG001|Overall Study|Adverse Event|92|||
127960720|NCT01234350|460476489|FG000|Overall Study|Withdrawal by Subject|61|||
127960721|NCT01234350|460476490|FG001|Overall Study|Withdrawal by Subject|36|||
127960722|NCT01234350|460476489|FG000|Overall Study|Lost to Follow-up|115|||
127960723|NCT01234350|460476490|FG001|Overall Study|Lost to Follow-up|47|||
127960724|NCT01234350|460476489|FG000|Overall Study|Covers a diverse set of reasons|234|||
127960725|NCT01234350|460476490|FG001|Overall Study|Covers a diverse set of reasons|92|||
127960726|NCT04341363|460476493|FG000|Overall Study|Adverse Event|1|||
127960727|NCT04341363|460476493|FG000|Overall Study|Withdrawal by Subject|1|||
127960728|NCT00063934|460476494|FG000|Overall Study|Ineligible|1|||
127960729|NCT00840749|460476495|FG000|Overall Study|Death|1|||
127960730|NCT00840749|460476496|FG001|Overall Study|Death|2|||
127960731|NCT00840749|460476495|FG000|Overall Study|not treated on study arm|11|||
127960732|NCT00840749|460476496|FG001|Overall Study|not treated on study arm|11|||
127960733|NCT00840749|460476495|FG000|Overall Study|study closed|19|||
127960734|NCT00840749|460476496|FG001|Overall Study|study closed|14|||
127960735|NCT01051960|460476497|FG000|Overall Study|Adverse Event|1|||
127960736|NCT01836471|460476506|FG000|Overall Study|Pregnancy|1|||
127960737|NCT01836471|460476507|FG001|Overall Study|Pregnancy|0|||
127960738|NCT01836471|460476508|FG002|Overall Study|Pregnancy|0|||
127960739|NCT01836471|460476509|FG003|Overall Study|Pregnancy|0|||
127960740|NCT01836471|460476510|FG004|Overall Study|Pregnancy|0|||
127960741|NCT01836471|460476506|FG000|Overall Study|Withdrawal by Subject|3|||
127960742|NCT01836471|460476507|FG001|Overall Study|Withdrawal by Subject|4|||
127960743|NCT01836471|460476508|FG002|Overall Study|Withdrawal by Subject|1|||
127960744|NCT01836471|460476509|FG003|Overall Study|Withdrawal by Subject|0|||
127960745|NCT01836471|460476510|FG004|Overall Study|Withdrawal by Subject|2|||
127960746|NCT01836471|460476506|FG000|Overall Study|Physician Decision|0|||
127960747|NCT01836471|460476507|FG001|Overall Study|Physician Decision|1|||
127960748|NCT01836471|460476508|FG002|Overall Study|Physician Decision|0|||
127960749|NCT01836471|460476509|FG003|Overall Study|Physician Decision|0|||
127960750|NCT01836471|460476510|FG004|Overall Study|Physician Decision|0|||
127960751|NCT01836471|460476506|FG000|Overall Study|Lost to Follow-up|0|||
127960752|NCT01836471|460476507|FG001|Overall Study|Lost to Follow-up|0|||
127960753|NCT01836471|460476508|FG002|Overall Study|Lost to Follow-up|0|||
127960754|NCT01836471|460476509|FG003|Overall Study|Lost to Follow-up|1|||
127960755|NCT01836471|460476510|FG004|Overall Study|Lost to Follow-up|1|||
127960756|NCT01836471|460476506|FG000|Overall Study|Adverse Event|6|||
127960757|NCT01836471|460476507|FG001|Overall Study|Adverse Event|3|||
127960758|NCT01836471|460476508|FG002|Overall Study|Adverse Event|1|||
127960759|NCT01836471|460476509|FG003|Overall Study|Adverse Event|1|||
127960760|NCT01836471|460476510|FG004|Overall Study|Adverse Event|2|||
127960761|NCT01836471|460476506|FG000|Overall Study|Non compliance with tx|1|||
127960762|NCT01836471|460476507|FG001|Overall Study|Non compliance with tx|1|||
127960763|NCT01836471|460476508|FG002|Overall Study|Non compliance with tx|0|||
127960764|NCT01836471|460476509|FG003|Overall Study|Non compliance with tx|0|||
127960765|NCT01836471|460476510|FG004|Overall Study|Non compliance with tx|0|||
127960766|NCT01960413|460476513|FG000|Overall Study|Withdrawal by Subject|1|||
127960767|NCT01960413|460476514|FG001|Overall Study|Withdrawal by Subject|1|||
127960768|NCT01960413|460476513|FG000|Overall Study|Physician Decision|1|||
127960769|NCT01960413|460476514|FG001|Overall Study|Physician Decision|0|||
127960770|NCT01960413|460476513|FG000|Overall Study|Lost to Follow-up|2|||
127960771|NCT01960413|460476514|FG001|Overall Study|Lost to Follow-up|0|||
127960772|NCT01082328|460476517|FG000|Overall Study|Adverse Event|1|||
127960773|NCT05506046|460476520|FG000|Overall Study|Lost to Follow-up|89|||
127960774|NCT05506046|460476521|FG001|Overall Study|Lost to Follow-up|101|||
127960775|NCT05506046|460476522|FG002|Overall Study|Lost to Follow-up|102|||
127960776|NCT05506046|460476523|FG003|Overall Study|Lost to Follow-up|99|||
127960777|NCT03776357|460476524|FG000|Overall Study|Lost to Follow-up|3|||
127960778|NCT03335475|460476525|FG000|Overall Study|Did not wear accelerometer|4|||
127960779|NCT03335475|460476526|FG001|Overall Study|Did not wear accelerometer|0|||
127960780|NCT03335475|460476525|FG000|Overall Study|Withdrawal by Subject|0|||
127960781|NCT03335475|460476526|FG001|Overall Study|Withdrawal by Subject|1|||
127960782|NCT02755103|460476527|FG000|Overall Study|Lost to Follow-up|17|||
127960783|NCT02755103|460476528|FG001|Overall Study|Lost to Follow-up|15|||
127960784|NCT02755103|460476527|FG000|Overall Study|Death|0|||
127960785|NCT02755103|460476528|FG001|Overall Study|Death|1|||
127960786|NCT02755103|460476527|FG000|Overall Study|Physician Decision|0|||
127960787|NCT02755103|460476528|FG001|Overall Study|Physician Decision|1|||
127960788|NCT02755103|460476527|FG000|Overall Study|Pregnancy|0|||
127960789|NCT02755103|460476528|FG001|Overall Study|Pregnancy|1|||
127960790|NCT02755103|460476527|FG000|Overall Study|Withdrawal by Subject|3|||
127960791|NCT02755103|460476528|FG001|Overall Study|Withdrawal by Subject|0|||
127960792|NCT05366010|460476536|FG000|Overall Study|Withdrawal by Subject|1|||
127960793|NCT05366010|460476536|FG000|Overall Study|Protocol Violation|1|||
127960794|NCT05366010|460476536|FG000|Overall Study|Lost to Follow-up|2|||
127960795|NCT05366010|460476536|FG000|Overall Study|Screen Failure|2|||
127960796|NCT02224157|460476537|FG000|Overall Study|Severe non-compliance to protocol|2|||
127960797|NCT02224157|460476538|FG001|Overall Study|Severe non-compliance to protocol|2|||
127960798|NCT02224157|460476537|FG000|Overall Study|Other|13|||
127960799|NCT02224157|460476538|FG001|Overall Study|Other|10|||
127960800|NCT02224157|460476537|FG000|Overall Study|Subject decision|58|||
127960801|NCT02224157|460476538|FG001|Overall Study|Subject decision|50|||
127960802|NCT02224157|460476537|FG000|Overall Study|Prematurely closed site|4|||
127960803|NCT02224157|460476538|FG001|Overall Study|Prematurely closed site|2|||
127960804|NCT02224157|460476537|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
127960805|NCT02224157|460476538|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
127960806|NCT02224157|460476537|FG000|Overall Study|Lost to Follow-up|27|||
127960807|NCT02224157|460476538|FG001|Overall Study|Lost to Follow-up|35|||
127960808|NCT02224157|460476537|FG000|Overall Study|Death|1|||
127960809|NCT02224157|460476538|FG001|Overall Study|Death|1|||
127960810|NCT02224157|460476537|FG000|Overall Study|Adverse Event|1|||
127960811|NCT02224157|460476538|FG001|Overall Study|Adverse Event|3|||
127960812|NCT05906628|460476541|FG000|16-Week DBVC Period|Lack of Efficacy|0|||
127960813|NCT05906628|460476542|FG001|16-Week DBVC Period|Lack of Efficacy|1|||
127960814|NCT05906628|460476541|FG000|16-Week DBVC Period|Lost to Follow-up|2|||
127960815|NCT05906628|460476542|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
127960816|NCT05906628|460476541|FG000|16-Week DBVC Period|Protocol Violation|4|||
127960817|NCT05906628|460476542|FG001|16-Week DBVC Period|Protocol Violation|2|||
127960818|NCT05906628|460476541|FG000|16-Week DBVC Period|Withdrawal by Subject|4|||
127960819|NCT05906628|460476542|FG001|16-Week DBVC Period|Withdrawal by Subject|11|||
127960820|NCT05906628|460476541|FG000|16-Week OLE Period|Death|1|||
127960821|NCT05906628|460476542|FG001|16-Week OLE Period|Death|0|||
127960822|NCT05906628|460476541|FG000|16-Week OLE Period|Lost to Follow-up|1|||
127960823|NCT05906628|460476542|FG001|16-Week OLE Period|Lost to Follow-up|1|||
127960824|NCT05906628|460476541|FG000|16-Week OLE Period|Protocol Violation|0|||
127960825|NCT05906628|460476542|FG001|16-Week OLE Period|Protocol Violation|1|||
127960826|NCT05906628|460476541|FG000|16-Week OLE Period|Withdrawal by Subject|6|||
127960827|NCT05906628|460476542|FG001|16-Week OLE Period|Withdrawal by Subject|4|||
127960828|NCT04578535|460476543|FG000|Overall Study|Lost to Follow-up|1|||
127960829|NCT04578535|460476544|FG001|Overall Study|Lost to Follow-up|0|||
127960830|NCT04578535|460476545|FG002|Overall Study|Lost to Follow-up|0|||
127960831|NCT04578535|460476546|FG003|Overall Study|Lost to Follow-up|1|||
127960832|NCT04578535|460476547|FG004|Overall Study|Lost to Follow-up|0|||
127960833|NCT04578535|460476548|FG005|Overall Study|Lost to Follow-up|2|||
127960834|NCT04578535|460476543|FG000|Overall Study|Pregnancy|1|||
127960835|NCT04578535|460476544|FG001|Overall Study|Pregnancy|0|||
127960836|NCT04578535|460476545|FG002|Overall Study|Pregnancy|0|||
127960837|NCT04578535|460476546|FG003|Overall Study|Pregnancy|0|||
127960838|NCT04578535|460476547|FG004|Overall Study|Pregnancy|0|||
127960839|NCT04578535|460476548|FG005|Overall Study|Pregnancy|0|||
127960840|NCT04578535|460476543|FG000|Overall Study|Withdrawal by Subject|0|||
127960841|NCT04578535|460476544|FG001|Overall Study|Withdrawal by Subject|0|||
127960842|NCT04578535|460476545|FG002|Overall Study|Withdrawal by Subject|0|||
127960843|NCT04578535|460476546|FG003|Overall Study|Withdrawal by Subject|1|||
127960844|NCT04578535|460476547|FG004|Overall Study|Withdrawal by Subject|1|||
127960845|NCT04578535|460476548|FG005|Overall Study|Withdrawal by Subject|5|||
127960846|NCT04578535|460476543|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
127960847|NCT04578535|460476544|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
127960848|NCT04578535|460476545|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
127960849|NCT04578535|460476546|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
127960850|NCT04578535|460476547|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
127960851|NCT04578535|460476548|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
127960852|NCT01060072|460476549|FG000|Overall Study|Adverse Event|1|||
127960853|NCT01060072|460476550|FG001|Overall Study|Adverse Event|1|||
127960854|NCT01060072|460476549|FG000|Overall Study|Physician Decision|0|||
127960855|NCT01060072|460476550|FG001|Overall Study|Physician Decision|2|||
127960856|NCT01060072|460476549|FG000|Overall Study|Protocol Violation|0|||
127960857|NCT01060072|460476550|FG001|Overall Study|Protocol Violation|1|||
127960858|NCT01060072|460476549|FG000|Overall Study|Acute cholecystitis|1|||
127960859|NCT01060072|460476550|FG001|Overall Study|Acute cholecystitis|0|||
127960860|NCT01060072|460476549|FG000|Overall Study|Excluded Medications|0|||
127960861|NCT01060072|460476550|FG001|Overall Study|Excluded Medications|1|||
127960862|NCT00837148|460476551|FG000|Overall Study|Adverse Event|1|||
127960863|NCT00837148|460476551|FG000|Overall Study|Death|1|||
127960864|NCT00380874|460476552|FG000|Overall Study|Adverse Event|7|||
127960865|NCT00380874|460476553|FG001|Overall Study|Adverse Event|7|||
127960866|NCT00380874|460476552|FG000|Overall Study|Death|1|||
127960867|NCT00380874|460476553|FG001|Overall Study|Death|0|||
127960868|NCT00380874|460476552|FG000|Overall Study|Withdrawal by Subject|2|||
127960869|NCT00380874|460476553|FG001|Overall Study|Withdrawal by Subject|1|||
127960870|NCT00380874|460476552|FG000|Overall Study|Not related to study drug|3|||
127960871|NCT00380874|460476553|FG001|Overall Study|Not related to study drug|2|||
127960872|NCT03839628|460476554|FG000|Overall Study|Withdrawal by Subject|1|||
127960873|NCT01707290|460476555|FG000|Overall Study|Adverse event (AE)|1|||
127960874|NCT01707290|460476556|FG001|Overall Study|Adverse event (AE)|0|||
127960875|NCT01707290|460476555|FG000|Overall Study|Physician Decision|1|||
127960876|NCT01707290|460476556|FG001|Overall Study|Physician Decision|0|||
127960877|NCT01707290|460476555|FG000|Overall Study|Lost to Follow-up|3|||
127960878|NCT01707290|460476556|FG001|Overall Study|Lost to Follow-up|0|||
127960879|NCT01707290|460476555|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
127960880|NCT01707290|460476556|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
127960881|NCT01707290|460476555|FG000|Overall Study|Commercial drug available|60|||
127960882|NCT01707290|460476556|FG001|Overall Study|Commercial drug available|1|||
127960883|NCT01707290|460476555|FG000|Overall Study|Other unspecified|17|||
127960884|NCT01707290|460476556|FG001|Overall Study|Other unspecified|0|||
127960885|NCT01147068|460476559|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
127960886|NCT01147068|460476560|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
127960887|NCT01147068|460476561|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
127960888|NCT01147068|460476562|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
127960889|NCT01147068|460476563|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
127960890|NCT01147068|460476564|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
127960891|NCT01147068|460476565|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
127960892|NCT01147068|460476559|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
127960893|NCT01147068|460476560|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
127960894|NCT01147068|460476561|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
127960895|NCT01147068|460476562|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
127960896|NCT01147068|460476563|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
127960897|NCT01147068|460476564|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
127960898|NCT01147068|460476565|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
127960899|NCT01147068|460476559|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
127960900|NCT01147068|460476560|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
127960901|NCT01147068|460476561|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
127960902|NCT01147068|460476562|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
127960903|NCT01147068|460476563|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
127960904|NCT01147068|460476564|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
127960905|NCT01147068|460476565|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
127960906|NCT01147068|460476559|FG000|Subjects That Received 2nd Dose|Other|0|||
127960907|NCT01147068|460476560|FG001|Subjects That Received 2nd Dose|Other|3|||
127960908|NCT01147068|460476561|FG002|Subjects That Received 2nd Dose|Other|3|||
127960909|NCT01147068|460476562|FG003|Subjects That Received 2nd Dose|Other|0|||
127960910|NCT01147068|460476563|FG004|Subjects That Received 2nd Dose|Other|1|||
127960911|NCT01147068|460476564|FG005|Subjects That Received 2nd Dose|Other|0|||
127960912|NCT01147068|460476565|FG006|Subjects That Received 2nd Dose|Other|0|||
127960913|NCT01147068|460476559|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
127960914|NCT01147068|460476560|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
127960915|NCT01147068|460476561|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
127960916|NCT01147068|460476562|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
127960917|NCT01147068|460476563|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
127960918|NCT01147068|460476564|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
127960919|NCT01147068|460476565|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
127960920|NCT01147068|460476559|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
127960921|NCT01147068|460476560|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
127960922|NCT01147068|460476561|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
127960923|NCT01147068|460476562|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
127960924|NCT01147068|460476563|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
127960925|NCT01147068|460476564|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
127960926|NCT01147068|460476565|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
127960927|NCT01147068|460476559|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
127960928|NCT01147068|460476560|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
127960929|NCT01147068|460476561|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
127960930|NCT01147068|460476562|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
127960931|NCT01147068|460476563|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
127960932|NCT01147068|460476564|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
127960933|NCT01147068|460476565|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
127960934|NCT01964976|460476566|FG000|Overall Study|Protocol Violation|31|||
127960935|NCT01522456|460476567|FG000|Overall Study|Adverse Event|2|||
127960936|NCT01522456|460476567|FG000|Overall Study|Lost to Follow-up|2|||
127960937|NCT01522456|460476567|FG000|Overall Study|Withdrawal by Subject|2|||
127960938|NCT01522456|460476567|FG000|Overall Study|Pregnancy|1|||
127960939|NCT01522456|460476567|FG000|Overall Study|Tolerability Assessment|1|||
127960940|NCT01565889|460476571|FG000|Part A|Withdrawal by Subject|1|||
127960941|NCT01565889|460476572|FG001|Part A|Withdrawal by Subject|0|||
127960942|NCT01565889|460476573|FG002|Part A|Withdrawal by Subject|0|||
127960943|NCT01565889|460476574|FG003|Part A|Withdrawal by Subject|0|||
127960944|NCT01565889|460476575|FG004|Part A|Withdrawal by Subject|0|||
127960945|NCT01565889|460476576|FG005|Part A|Withdrawal by Subject|0|||
127960946|NCT01565889|460476571|FG000|Part B|Withdrawal by Subject|0|||
127960947|NCT01565889|460476572|FG001|Part B|Withdrawal by Subject|0|||
127960948|NCT01565889|460476573|FG002|Part B|Withdrawal by Subject|0|||
127960949|NCT01565889|460476574|FG003|Part B|Withdrawal by Subject|0|||
127960950|NCT01565889|460476575|FG004|Part B|Withdrawal by Subject|0|||
127960951|NCT01565889|460476576|FG005|Part B|Withdrawal by Subject|1|||
127960952|NCT01565889|460476571|FG000|Part B|Lack of Efficacy|0|||
127960953|NCT01565889|460476572|FG001|Part B|Lack of Efficacy|0|||
127960954|NCT01565889|460476573|FG002|Part B|Lack of Efficacy|0|||
127960955|NCT01565889|460476574|FG003|Part B|Lack of Efficacy|0|||
127960956|NCT01565889|460476575|FG004|Part B|Lack of Efficacy|0|||
127960957|NCT01565889|460476576|FG005|Part B|Lack of Efficacy|2|||
127960958|NCT01565889|460476571|FG000|Part B|Lost to Follow-up|0|||
127960959|NCT01565889|460476572|FG001|Part B|Lost to Follow-up|0|||
127960960|NCT01565889|460476573|FG002|Part B|Lost to Follow-up|0|||
127960961|NCT01565889|460476574|FG003|Part B|Lost to Follow-up|0|||
127960962|NCT01565889|460476575|FG004|Part B|Lost to Follow-up|0|||
127960963|NCT01565889|460476576|FG005|Part B|Lost to Follow-up|1|||
127960964|NCT01326845|460476578|FG000|Overall Study|Administrative Problems|5|||
127960965|NCT01326845|460476579|FG001|Overall Study|Administrative Problems|2|||
127960966|NCT01326845|460476578|FG000|Overall Study|Adverse Event|1|||
127960967|NCT01326845|460476579|FG001|Overall Study|Adverse Event|0|||
127960968|NCT01326845|460476578|FG000|Overall Study|Misisng|1|||
127960969|NCT01326845|460476579|FG001|Overall Study|Misisng|3|||
127960970|NCT03918629|460476580|FG000|Overall Study|Adverse Event|19|||
127960971|NCT03918629|460476581|FG001|Overall Study|Adverse Event|20|||
127960972|NCT03918629|460476580|FG000|Overall Study|Death|14|||
127960973|NCT03918629|460476581|FG001|Overall Study|Death|7|||
127960974|NCT03918629|460476580|FG000|Overall Study|Lost to Follow-up|36|||
127960975|NCT03918629|460476581|FG001|Overall Study|Lost to Follow-up|28|||
127960976|NCT03918629|460476580|FG000|Overall Study|Physician Decision|1|||
127960977|NCT03918629|460476581|FG001|Overall Study|Physician Decision|0|||
127960978|NCT03918629|460476580|FG000|Overall Study|Protocol Violation|7|||
127960979|NCT03918629|460476581|FG001|Overall Study|Protocol Violation|4|||
127960980|NCT03918629|460476580|FG000|Overall Study|Withdrawal by Subject|47|||
127960981|NCT03918629|460476581|FG001|Overall Study|Withdrawal by Subject|47|||
127960982|NCT03918629|460476580|FG000|Overall Study|Other|7|||
127960983|NCT03918629|460476581|FG001|Overall Study|Other|11|||
127960984|NCT03918629|460476580|FG000|Overall Study|Randomized but not vaccinated|2|||
127960985|NCT03918629|460476581|FG001|Overall Study|Randomized but not vaccinated|1|||
127960986|NCT00740636|460476586|FG000|Overall Study|Adverse Event|0|||
127960987|NCT00740636|460476587|FG001|Overall Study|Adverse Event|2|||
127960988|NCT00740636|460476586|FG000|Overall Study|Patient Ineligible|0|||
127960989|NCT00740636|460476587|FG001|Overall Study|Patient Ineligible|1|||
127960990|NCT00740636|460476586|FG000|Overall Study|Patient Not Treated|0|||
127960991|NCT00740636|460476587|FG001|Overall Study|Patient Not Treated|1|||
127960992|NCT00740636|460476586|FG000|Overall Study|Progressive Disease|1|||
127960993|NCT00740636|460476587|FG001|Overall Study|Progressive Disease|0|||
127960994|NCT00740636|460476586|FG000|Overall Study|Death|1|||
127960995|NCT00740636|460476587|FG001|Overall Study|Death|0|||
127960996|NCT02286713|460476588|FG000|One Week Follow-Up|Death|1|||
127960997|NCT02286713|460476589|FG001|One Week Follow-Up|Death|0|||
127960998|NCT02286713|460476588|FG000|One Week Follow-Up|Lost to Follow-up|17|||
127960999|NCT02286713|460476589|FG001|One Week Follow-Up|Lost to Follow-up|21|||
127961000|NCT02286713|460476588|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
127961001|NCT02286713|460476589|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
127961002|NCT02286713|460476588|FG000|Three Month Follow-Up|Death|1|||
127961003|NCT02286713|460476589|FG001|Three Month Follow-Up|Death|1|||
127961004|NCT02286713|460476588|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
127961005|NCT02286713|460476589|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
127961006|NCT02286713|460476588|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
127961007|NCT02286713|460476589|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
127961008|NCT02286713|460476588|FG000|Six Month Follow-Up|Death|2|||
127961009|NCT02286713|460476589|FG001|Six Month Follow-Up|Death|0|||
127961010|NCT02286713|460476588|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
127961011|NCT02286713|460476589|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
127961012|NCT03832686|460476590|FG000|Overall Study|Lost to Follow-up|6|||
127961013|NCT03832686|460476591|FG001|Overall Study|Lost to Follow-up|9|||
127961014|NCT03832686|460476590|FG000|Overall Study|Discontinued Intervention|5|||
127961015|NCT03832686|460476591|FG001|Overall Study|Discontinued Intervention|4|||
127961016|NCT02844543|460478744|FG000|Overall Study|Withdrawal by Subject|4|||
127961017|NCT02844543|460478744|FG000|Overall Study|Did not meet eligibility criteria|1|||
127961018|NCT04710576|460478750|FG000|Overall Study|Participants still in the study|73|||
127961019|NCT04710576|460478751|FG001|Overall Study|Participants still in the study|70|||
127961020|NCT04710576|460478752|FG002|Overall Study|Participants still in the study|60|||
127961021|NCT04710576|460478750|FG000|Overall Study|Death|2|||
127961022|NCT04710576|460478751|FG001|Overall Study|Death|7|||
127961023|NCT04710576|460478752|FG002|Overall Study|Death|12|||
127961024|NCT04710576|460478750|FG000|Overall Study|Withdrawal by Subject|4|||
127961025|NCT04710576|460478751|FG001|Overall Study|Withdrawal by Subject|3|||
127961026|NCT04710576|460478752|FG002|Overall Study|Withdrawal by Subject|7|||
127961027|NCT04710576|460478750|FG000|Overall Study|Sponsor decision|1|||
127961028|NCT04710576|460478751|FG001|Overall Study|Sponsor decision|0|||
127961029|NCT04710576|460478752|FG002|Overall Study|Sponsor decision|0|||
127961030|NCT04581824|460478753|FG000|Overall Study|Lost to Follow-up|1|||
127961031|NCT04581824|460478754|FG001|Overall Study|Lost to Follow-up|0|||
127961032|NCT04581824|460478753|FG000|Overall Study|Withdrawal by Subject|2|||
127961033|NCT04581824|460478754|FG001|Overall Study|Withdrawal by Subject|7|||
127961034|NCT04581824|460478753|FG000|Overall Study|Study terminated by sponsor|37|||
127961035|NCT04581824|460478754|FG001|Overall Study|Study terminated by sponsor|23|||
127961036|NCT04796909|460478755|FG000|Overall Study|Withdrawal by Subject|1|||
127961037|NCT04796909|460478756|FG001|Overall Study|Withdrawal by Subject|1|||
127961038|NCT03879135|460478757|FG000|Overall Study|Physician Decision|0|||
127961039|NCT03879135|460478758|FG001|Overall Study|Physician Decision|0|||
127961040|NCT03879135|460478759|FG002|Overall Study|Physician Decision|0|||
127961041|NCT03879135|460478760|FG003|Overall Study|Physician Decision|1|||
127961042|NCT03879135|460478761|FG004|Overall Study|Physician Decision|0|||
127961043|NCT03879135|460478762|FG005|Overall Study|Physician Decision|0|||
127961044|NCT03879135|460478757|FG000|Overall Study|Withdrawal by Subject|0|||
127961045|NCT03879135|460478758|FG001|Overall Study|Withdrawal by Subject|0|||
127961046|NCT03879135|460478759|FG002|Overall Study|Withdrawal by Subject|0|||
127961047|NCT03879135|460478760|FG003|Overall Study|Withdrawal by Subject|0|||
127961048|NCT03879135|460478761|FG004|Overall Study|Withdrawal by Subject|0|||
127961049|NCT03879135|460478762|FG005|Overall Study|Withdrawal by Subject|1|||
127961050|NCT03879135|460478757|FG000|Overall Study|Site Closed by Sponsor|0|||
127961051|NCT03879135|460478758|FG001|Overall Study|Site Closed by Sponsor|0|||
127961052|NCT03879135|460478759|FG002|Overall Study|Site Closed by Sponsor|0|||
127961053|NCT03879135|460478760|FG003|Overall Study|Site Closed by Sponsor|1|||
127961054|NCT03879135|460478761|FG004|Overall Study|Site Closed by Sponsor|1|||
127961055|NCT03879135|460478762|FG005|Overall Study|Site Closed by Sponsor|0|||
127961056|NCT04162847|460478763|FG000|Overall Study|Withdrawal by Subject|7|||
127961057|NCT04162847|460478764|FG001|Overall Study|Withdrawal by Subject|1|||
127961058|NCT00813150|460478765|FG000|Treatment Period|Adverse Event|16|||
127961059|NCT00813150|460478766|FG001|Treatment Period|Adverse Event|15|||
127961060|NCT00813150|460478765|FG000|Treatment Period|Death|2|||
127961061|NCT00813150|460478766|FG001|Treatment Period|Death|0|||
127961062|NCT00813150|460478765|FG000|Treatment Period|Progressive disease|1|||
127961063|NCT00813150|460478766|FG001|Treatment Period|Progressive disease|0|||
127961064|NCT00813150|460478765|FG000|Treatment Period|Complete response|0|||
127961065|NCT00813150|460478766|FG001|Treatment Period|Complete response|1|||
127961066|NCT00813150|460478765|FG000|Treatment Period|Stable disease|1|||
127961067|NCT00813150|460478766|FG001|Treatment Period|Stable disease|2|||
127961068|NCT00813150|460478765|FG000|Treatment Period|Protocol Violation|3|||
127961069|NCT00813150|460478766|FG001|Treatment Period|Protocol Violation|4|||
127961070|NCT00813150|460478765|FG000|Treatment Period|Withdrawal by Subject|5|||
127961071|NCT00813150|460478766|FG001|Treatment Period|Withdrawal by Subject|3|||
127961072|NCT00813150|460478765|FG000|Treatment Period|Non compliance|0|||
127961073|NCT00813150|460478766|FG001|Treatment Period|Non compliance|1|||
127961074|NCT00813150|460478765|FG000|Treatment Period|Reason not specified|3|||
127961075|NCT00813150|460478766|FG001|Treatment Period|Reason not specified|4|||
127961076|NCT00813150|460478765|FG000|Treatment Period|Data not available|1|||
127961077|NCT00813150|460478766|FG001|Treatment Period|Data not available|2|||
127961078|NCT00813150|460478765|FG000|Long Term Follow-up|Death|0|||
127961079|NCT00813150|460478766|FG001|Long Term Follow-up|Death|4|||
127961080|NCT00813150|460478765|FG000|Long Term Follow-up|Other|0|||
127961081|NCT00813150|460478766|FG001|Long Term Follow-up|Other|3|||
127961082|NCT00813150|460478765|FG000|Long Term Follow-up|Lost to Follow-up|2|||
127961083|NCT00813150|460478766|FG001|Long Term Follow-up|Lost to Follow-up|0|||
127961084|NCT00813150|460478765|FG000|Long Term Follow-up|Progression/Relapse|22|||
127961085|NCT00813150|460478766|FG001|Long Term Follow-up|Progression/Relapse|24|||
127961086|NCT02832687|460478767|FG000|Overall Study|Adverse Event|0|||
127961087|NCT02832687|460478768|FG001|Overall Study|Adverse Event|2|||
127961088|NCT00471822|460478769|FG000|Overall Study|Protocol Violation|2|||
127961089|NCT03664232|460478770|FG000|Overall Study|Withdrawal by Subject|0|||
127961090|NCT03664232|460478771|FG001|Overall Study|Withdrawal by Subject|1|||
127961091|NCT03664232|460478772|FG002|Overall Study|Withdrawal by Subject|0|||
127961092|NCT03664232|460478773|FG003|Overall Study|Withdrawal by Subject|1|||
127961093|NCT03664232|460478770|FG000|Overall Study|Adverse Event|0|||
127961094|NCT03664232|460478771|FG001|Overall Study|Adverse Event|0|||
127961095|NCT03664232|460478772|FG002|Overall Study|Adverse Event|1|||
127961096|NCT03664232|460478773|FG003|Overall Study|Adverse Event|0|||
127961097|NCT03664232|460478770|FG000|Overall Study|Other-Non-compliance with study drug|0|||
127961098|NCT03664232|460478771|FG001|Overall Study|Other-Non-compliance with study drug|1|||
127961099|NCT03664232|460478772|FG002|Overall Study|Other-Non-compliance with study drug|0|||
127961100|NCT03664232|460478773|FG003|Overall Study|Other-Non-compliance with study drug|2|||
127961101|NCT03664232|460478770|FG000|Overall Study|Other-Unspecified|0|||
127961102|NCT03664232|460478771|FG001|Overall Study|Other-Unspecified|3|||
127961103|NCT03664232|460478772|FG002|Overall Study|Other-Unspecified|0|||
127961104|NCT03664232|460478773|FG003|Overall Study|Other-Unspecified|1|||
127961105|NCT03664232|460478770|FG000|Overall Study|- Withdrawal by Parent/Guardian|0|||
127961106|NCT03664232|460478771|FG001|Overall Study|- Withdrawal by Parent/Guardian|0|||
127961107|NCT03664232|460478772|FG002|Overall Study|- Withdrawal by Parent/Guardian|0|||
127961108|NCT03664232|460478773|FG003|Overall Study|- Withdrawal by Parent/Guardian|1|||
127961109|NCT03334435|460478774|FG000|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|70|||
127961110|NCT03334435|460478775|FG001|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|32|||
127961111|NCT03334435|460478776|FG002|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|379|||
127961112|NCT03334435|460478777|FG003|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|519|||
127961113|NCT03334435|460478778|FG004|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|146|||
127961114|NCT03334435|460478779|FG005|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
127961115|NCT03334435|460478780|FG006|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
127961116|NCT03334435|460478781|FG007|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
127961117|NCT03334435|460478782|FG008|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
127961118|NCT03334435|460478783|FG009|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
127961119|NCT03334435|460478784|FG010|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
127961120|NCT03334435|460478785|FG011|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
127961121|NCT03334435|460478786|FG012|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
127961122|NCT03334435|460478787|FG013|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
127961123|NCT03334435|460478788|FG014|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
127961124|NCT03334435|460478774|FG000|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|3|||
127961125|NCT03334435|460478775|FG001|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|5|||
127961126|NCT03334435|460478776|FG002|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|76|||
127961127|NCT03334435|460478777|FG003|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|140|||
127961128|NCT03334435|460478778|FG004|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|61|||
127961129|NCT03334435|460478779|FG005|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
127961130|NCT03334435|460478780|FG006|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
127961131|NCT03334435|460478781|FG007|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
127961132|NCT03334435|460478782|FG008|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
127961133|NCT03334435|460478783|FG009|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
127961134|NCT03334435|460478784|FG010|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
127961135|NCT03334435|460478785|FG011|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
127961136|NCT03334435|460478786|FG012|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
127961137|NCT03334435|460478787|FG013|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
127961138|NCT03334435|460478788|FG014|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
127961139|NCT03334435|460478774|FG000|Treatment Period 1: Week 0 to Week 52|Adverse Event|2|||
127961140|NCT03334435|460478775|FG001|Treatment Period 1: Week 0 to Week 52|Adverse Event|1|||
127961141|NCT03334435|460478776|FG002|Treatment Period 1: Week 0 to Week 52|Adverse Event|9|||
127961142|NCT03334435|460478777|FG003|Treatment Period 1: Week 0 to Week 52|Adverse Event|23|||
127961143|NCT03334435|460478778|FG004|Treatment Period 1: Week 0 to Week 52|Adverse Event|13|||
127961144|NCT03334435|460478779|FG005|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
127961145|NCT03334435|460478780|FG006|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
127961146|NCT03334435|460478781|FG007|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
127961147|NCT03334435|460478782|FG008|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
127961148|NCT03334435|460478783|FG009|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
127961149|NCT03334435|460478784|FG010|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
127961150|NCT03334435|460478785|FG011|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
127961151|NCT03334435|460478786|FG012|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
127961152|NCT03334435|460478787|FG013|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
127961153|NCT03334435|460478788|FG014|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
127961154|NCT03334435|460478774|FG000|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|11|||
127961155|NCT03334435|460478775|FG001|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|4|||
127961156|NCT03334435|460478776|FG002|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|38|||
127961157|NCT03334435|460478777|FG003|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|42|||
127961158|NCT03334435|460478778|FG004|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|20|||
127961159|NCT03334435|460478779|FG005|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
127961160|NCT03334435|460478780|FG006|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
127961161|NCT03334435|460478781|FG007|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
127961162|NCT03334435|460478782|FG008|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
127961163|NCT03334435|460478783|FG009|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
127961164|NCT03334435|460478784|FG010|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
127961165|NCT03334435|460478785|FG011|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
127961166|NCT03334435|460478786|FG012|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
127961167|NCT03334435|460478787|FG013|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
127961168|NCT03334435|460478788|FG014|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
127961169|NCT03334435|460478774|FG000|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|3|||
127961170|NCT03334435|460478775|FG001|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
127961171|NCT03334435|460478776|FG002|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|2|||
127961172|NCT03334435|460478777|FG003|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
127961173|NCT03334435|460478778|FG004|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
127961174|NCT03334435|460478779|FG005|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
127961175|NCT03334435|460478780|FG006|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
127961176|NCT03334435|460478781|FG007|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
127961177|NCT03334435|460478782|FG008|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
127961178|NCT03334435|460478783|FG009|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
127961179|NCT03334435|460478784|FG010|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
127961180|NCT03334435|460478785|FG011|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
127961181|NCT03334435|460478786|FG012|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
127961182|NCT03334435|460478787|FG013|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
127961183|NCT03334435|460478788|FG014|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
127961184|NCT03334435|460478774|FG000|Treatment Period 1: Week 0 to Week 52|Death|0|||
127961185|NCT03334435|460478775|FG001|Treatment Period 1: Week 0 to Week 52|Death|0|||
127961186|NCT03334435|460478776|FG002|Treatment Period 1: Week 0 to Week 52|Death|0|||
127961187|NCT03334435|460478777|FG003|Treatment Period 1: Week 0 to Week 52|Death|1|||
127961188|NCT03334435|460478778|FG004|Treatment Period 1: Week 0 to Week 52|Death|0|||
127961189|NCT03334435|460478779|FG005|Treatment Period 1: Week 0 to Week 52|Death|0|||
127961190|NCT03334435|460478780|FG006|Treatment Period 1: Week 0 to Week 52|Death|0|||
127961191|NCT03334435|460478781|FG007|Treatment Period 1: Week 0 to Week 52|Death|0|||
127961192|NCT03334435|460478782|FG008|Treatment Period 1: Week 0 to Week 52|Death|0|||
127961193|NCT03334435|460478783|FG009|Treatment Period 1: Week 0 to Week 52|Death|0|||
127961194|NCT03334435|460478784|FG010|Treatment Period 1: Week 0 to Week 52|Death|0|||
127961195|NCT03334435|460478785|FG011|Treatment Period 1: Week 0 to Week 52|Death|0|||
127961196|NCT03334435|460478786|FG012|Treatment Period 1: Week 0 to Week 52|Death|0|||
127961197|NCT03334435|460478787|FG013|Treatment Period 1: Week 0 to Week 52|Death|0|||
127961198|NCT03334435|460478788|FG014|Treatment Period 1: Week 0 to Week 52|Death|0|||
127961199|NCT03334435|460478774|FG000|Treatment Period 1: Week 0 to Week 52|Other|0|||
127961200|NCT03334435|460478775|FG001|Treatment Period 1: Week 0 to Week 52|Other|1|||
127961201|NCT03334435|460478776|FG002|Treatment Period 1: Week 0 to Week 52|Other|3|||
127961202|NCT03334435|460478777|FG003|Treatment Period 1: Week 0 to Week 52|Other|2|||
127961203|NCT03334435|460478778|FG004|Treatment Period 1: Week 0 to Week 52|Other|1|||
127961204|NCT03334435|460478779|FG005|Treatment Period 1: Week 0 to Week 52|Other|0|||
127961205|NCT03334435|460478780|FG006|Treatment Period 1: Week 0 to Week 52|Other|0|||
127961206|NCT03334435|460478781|FG007|Treatment Period 1: Week 0 to Week 52|Other|0|||
127961207|NCT03334435|460478782|FG008|Treatment Period 1: Week 0 to Week 52|Other|0|||
127961208|NCT03334435|460478783|FG009|Treatment Period 1: Week 0 to Week 52|Other|0|||
127961209|NCT03334435|460478784|FG010|Treatment Period 1: Week 0 to Week 52|Other|0|||
127961210|NCT03334435|460478785|FG011|Treatment Period 1: Week 0 to Week 52|Other|0|||
127961211|NCT03334435|460478786|FG012|Treatment Period 1: Week 0 to Week 52|Other|0|||
127961212|NCT03334435|460478787|FG013|Treatment Period 1: Week 0 to Week 52|Other|0|||
127961213|NCT03334435|460478788|FG014|Treatment Period 1: Week 0 to Week 52|Other|0|||
127961214|NCT03334435|460478774|FG000|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
127961215|NCT03334435|460478775|FG001|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
127961216|NCT03334435|460478776|FG002|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
127961217|NCT03334435|460478777|FG003|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
127961218|NCT03334435|460478778|FG004|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
127961219|NCT03334435|460478779|FG005|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
127961220|NCT03334435|460478780|FG006|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|21|||
127961221|NCT03334435|460478781|FG007|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
127961222|NCT03334435|460478782|FG008|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|19|||
127961223|NCT03334435|460478783|FG009|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|15|||
127961224|NCT03334435|460478784|FG010|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
127961225|NCT03334435|460478785|FG011|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|16|||
127961226|NCT03334435|460478786|FG012|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|3|||
127961227|NCT03334435|460478787|FG013|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|66|||
127961228|NCT03334435|460478788|FG014|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|70|||
127961229|NCT03334435|460478774|FG000|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
127961230|NCT03334435|460478775|FG001|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
127961231|NCT03334435|460478776|FG002|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
127961232|NCT03334435|460478777|FG003|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
127961233|NCT03334435|460478778|FG004|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
127961234|NCT03334435|460478779|FG005|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|13|||
127961235|NCT03334435|460478780|FG006|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|10|||
127961236|NCT03334435|460478781|FG007|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|11|||
127961237|NCT03334435|460478782|FG008|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
127961238|NCT03334435|460478783|FG009|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|12|||
127961239|NCT03334435|460478784|FG010|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|8|||
127961240|NCT03334435|460478785|FG011|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
127961241|NCT03334435|460478786|FG012|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|2|||
127961242|NCT03334435|460478787|FG013|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|63|||
127961243|NCT03334435|460478788|FG014|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|72|||
127961244|NCT03334435|460478774|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
127961245|NCT03334435|460478775|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
127961246|NCT03334435|460478776|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
127961247|NCT03334435|460478777|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
127961248|NCT03334435|460478778|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
127961249|NCT03334435|460478779|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|23|||
127961250|NCT03334435|460478780|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|15|||
127961251|NCT03334435|460478781|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|20|||
127961252|NCT03334435|460478782|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|17|||
127961253|NCT03334435|460478783|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|10|||
127961254|NCT03334435|460478784|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|11|||
127961255|NCT03334435|460478785|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|8|||
127961256|NCT03334435|460478786|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
127961257|NCT03334435|460478787|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|41|||
127961258|NCT03334435|460478788|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|32|||
127961259|NCT03334435|460478774|FG000|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
127961260|NCT03334435|460478775|FG001|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
127961261|NCT03334435|460478776|FG002|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
127961262|NCT03334435|460478777|FG003|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
127961263|NCT03334435|460478778|FG004|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
127961264|NCT03334435|460478779|FG005|Treatment Period 2: Week 52 to Week 200|Adverse Event|6|||
127961265|NCT03334435|460478780|FG006|Treatment Period 2: Week 52 to Week 200|Adverse Event|1|||
127961266|NCT03334435|460478781|FG007|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
127961267|NCT03334435|460478782|FG008|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
127961268|NCT03334435|460478783|FG009|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
127961269|NCT03334435|460478784|FG010|Treatment Period 2: Week 52 to Week 200|Adverse Event|9|||
127961270|NCT03334435|460478785|FG011|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
127961271|NCT03334435|460478786|FG012|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
127961272|NCT03334435|460478787|FG013|Treatment Period 2: Week 52 to Week 200|Adverse Event|11|||
127961273|NCT03334435|460478788|FG014|Treatment Period 2: Week 52 to Week 200|Adverse Event|13|||
127961274|NCT03334435|460478774|FG000|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
127961275|NCT03334435|460478775|FG001|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
127961276|NCT03334435|460478776|FG002|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
127961277|NCT03334435|460478777|FG003|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
127961278|NCT03334435|460478778|FG004|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
127961279|NCT03334435|460478779|FG005|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
127961280|NCT03334435|460478780|FG006|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
127961281|NCT03334435|460478781|FG007|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
127961282|NCT03334435|460478782|FG008|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|3|||
127961283|NCT03334435|460478783|FG009|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
127961284|NCT03334435|460478784|FG010|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
127961285|NCT03334435|460478785|FG011|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
127961286|NCT03334435|460478786|FG012|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
127961287|NCT03334435|460478787|FG013|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
127961288|NCT03334435|460478788|FG014|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
127961289|NCT03334435|460478774|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
127961290|NCT03334435|460478775|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
127961291|NCT03334435|460478776|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
127961292|NCT03334435|460478777|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
127961293|NCT03334435|460478778|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
127961294|NCT03334435|460478779|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
127961295|NCT03334435|460478780|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
127961296|NCT03334435|460478781|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
127961297|NCT03334435|460478782|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
127961298|NCT03334435|460478783|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
127961299|NCT03334435|460478784|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
127961300|NCT03334435|460478785|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
127961301|NCT03334435|460478786|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
127961302|NCT03334435|460478787|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
127961303|NCT03334435|460478788|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
127961304|NCT03334435|460478774|FG000|Treatment Period 2: Week 52 to Week 200|Death|0|||
127961305|NCT03334435|460478775|FG001|Treatment Period 2: Week 52 to Week 200|Death|0|||
127961306|NCT03334435|460478776|FG002|Treatment Period 2: Week 52 to Week 200|Death|0|||
127961307|NCT03334435|460478777|FG003|Treatment Period 2: Week 52 to Week 200|Death|0|||
127961308|NCT03334435|460478778|FG004|Treatment Period 2: Week 52 to Week 200|Death|0|||
127961309|NCT03334435|460478779|FG005|Treatment Period 2: Week 52 to Week 200|Death|1|||
127961310|NCT03334435|460478780|FG006|Treatment Period 2: Week 52 to Week 200|Death|0|||
127961311|NCT03334435|460478781|FG007|Treatment Period 2: Week 52 to Week 200|Death|0|||
127961312|NCT03334435|460478782|FG008|Treatment Period 2: Week 52 to Week 200|Death|0|||
127961313|NCT03334435|460478783|FG009|Treatment Period 2: Week 52 to Week 200|Death|0|||
127961314|NCT03334435|460478784|FG010|Treatment Period 2: Week 52 to Week 200|Death|0|||
127961315|NCT03334435|460478785|FG011|Treatment Period 2: Week 52 to Week 200|Death|0|||
127961316|NCT03334435|460478786|FG012|Treatment Period 2: Week 52 to Week 200|Death|0|||
127961317|NCT03334435|460478787|FG013|Treatment Period 2: Week 52 to Week 200|Death|0|||
127961318|NCT03334435|460478788|FG014|Treatment Period 2: Week 52 to Week 200|Death|1|||
127961319|NCT03334435|460478774|FG000|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
127961320|NCT03334435|460478775|FG001|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
127961321|NCT03334435|460478776|FG002|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
127961322|NCT03334435|460478777|FG003|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
127961323|NCT03334435|460478778|FG004|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
127961324|NCT03334435|460478779|FG005|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
127961325|NCT03334435|460478780|FG006|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
127961326|NCT03334435|460478781|FG007|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
127961327|NCT03334435|460478782|FG008|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
127961328|NCT03334435|460478783|FG009|Treatment Period 2: Week 52 to Week 200|Physician is retiring|3|||
127961329|NCT03334435|460478784|FG010|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
127961330|NCT03334435|460478785|FG011|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
127961331|NCT03334435|460478786|FG012|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
127961332|NCT03334435|460478787|FG013|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
127961333|NCT03334435|460478788|FG014|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
127961334|NCT03334435|460478774|FG000|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
127961335|NCT03334435|460478775|FG001|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
127961336|NCT03334435|460478776|FG002|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
127961337|NCT03334435|460478777|FG003|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
127961338|NCT03334435|460478778|FG004|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
127961339|NCT03334435|460478779|FG005|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
127961340|NCT03334435|460478780|FG006|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
127961341|NCT03334435|460478781|FG007|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
127961342|NCT03334435|460478782|FG008|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
127961343|NCT03334435|460478783|FG009|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
127961344|NCT03334435|460478784|FG010|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
127961345|NCT03334435|460478785|FG011|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
127961346|NCT03334435|460478786|FG012|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
127961347|NCT03334435|460478787|FG013|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
127961348|NCT03334435|460478788|FG014|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
127961349|NCT03334435|460478774|FG000|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
127961350|NCT03334435|460478775|FG001|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
127961351|NCT03334435|460478776|FG002|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
127961352|NCT03334435|460478777|FG003|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
127961353|NCT03334435|460478778|FG004|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
127961354|NCT03334435|460478779|FG005|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
127961355|NCT03334435|460478780|FG006|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
127961356|NCT03334435|460478781|FG007|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
127961357|NCT03334435|460478782|FG008|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
127961358|NCT03334435|460478783|FG009|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
127961359|NCT03334435|460478784|FG010|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
127961360|NCT03334435|460478785|FG011|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
127961361|NCT03334435|460478786|FG012|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
127961362|NCT03334435|460478787|FG013|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
127961363|NCT03334435|460478788|FG014|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
127961364|NCT03334435|460478774|FG000|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
127961365|NCT03334435|460478775|FG001|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
127961366|NCT03334435|460478776|FG002|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
127961367|NCT03334435|460478777|FG003|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
127961368|NCT03334435|460478778|FG004|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
127961369|NCT03334435|460478779|FG005|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
127961370|NCT03334435|460478780|FG006|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
127961371|NCT03334435|460478781|FG007|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
127961372|NCT03334435|460478782|FG008|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
127961373|NCT03334435|460478783|FG009|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
127961374|NCT03334435|460478784|FG010|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
127961375|NCT03334435|460478785|FG011|Treatment Period 2: Week 52 to Week 200|Sponsor decision|3|||
127961376|NCT03334435|460478786|FG012|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
127961377|NCT03334435|460478787|FG013|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
127961378|NCT03334435|460478788|FG014|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
127961379|NCT03334435|460478774|FG000|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
127961380|NCT03334435|460478775|FG001|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
127961381|NCT03334435|460478776|FG002|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
127961382|NCT03334435|460478777|FG003|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
127961383|NCT03334435|460478778|FG004|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
127961384|NCT03334435|460478779|FG005|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
127961385|NCT03334435|460478780|FG006|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
127961386|NCT03334435|460478781|FG007|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
127961387|NCT03334435|460478782|FG008|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
127961388|NCT03334435|460478783|FG009|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
127961389|NCT03334435|460478784|FG010|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
127961390|NCT03334435|460478785|FG011|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
127961391|NCT03334435|460478786|FG012|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
127961392|NCT03334435|460478787|FG013|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
127961393|NCT03334435|460478788|FG014|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
127961394|NCT02383017|460478789|FG000|Overall Study|Injury Sustained Outside Study|1|||
127961395|NCT02383017|460478790|FG001|Overall Study|Injury Sustained Outside Study|0|||
127961396|NCT02383017|460478789|FG000|Overall Study|Compliance|3|||
127961397|NCT02383017|460478790|FG001|Overall Study|Compliance|2|||
127961398|NCT02383017|460478789|FG000|Overall Study|Found to be Hypogonadal|1|||
127961399|NCT02383017|460478790|FG001|Overall Study|Found to be Hypogonadal|0|||
127961400|NCT01068860|460478791|FG000|Overall Study|Withdrawal by Subject|0|||
127961401|NCT01068860|460478792|FG001|Overall Study|Withdrawal by Subject|0|||
127961402|NCT01068860|460478793|FG002|Overall Study|Withdrawal by Subject|0|||
127961403|NCT01068860|460478794|FG003|Overall Study|Withdrawal by Subject|0|||
127961404|NCT01068860|460478795|FG004|Overall Study|Withdrawal by Subject|0|||
127961405|NCT01068860|460478796|FG005|Overall Study|Withdrawal by Subject|2|||
127961406|NCT01068860|460478797|FG006|Overall Study|Withdrawal by Subject|0|||
127961407|NCT01068860|460478798|FG007|Overall Study|Withdrawal by Subject|0|||
127961408|NCT01068860|460478799|FG008|Overall Study|Withdrawal by Subject|0|||
127961409|NCT01068860|460478800|FG009|Overall Study|Withdrawal by Subject|3|||
127961410|NCT01068860|460478791|FG000|Overall Study|Administrative problems; misrandomized|0|||
127961411|NCT01068860|460478792|FG001|Overall Study|Administrative problems; misrandomized|0|||
127961412|NCT01068860|460478793|FG002|Overall Study|Administrative problems; misrandomized|0|||
127961413|NCT01068860|460478794|FG003|Overall Study|Administrative problems; misrandomized|1|||
127961414|NCT01068860|460478795|FG004|Overall Study|Administrative problems; misrandomized|0|||
127961415|NCT01068860|460478796|FG005|Overall Study|Administrative problems; misrandomized|0|||
127961416|NCT01068860|460478797|FG006|Overall Study|Administrative problems; misrandomized|0|||
127961417|NCT01068860|460478798|FG007|Overall Study|Administrative problems; misrandomized|0|||
127961418|NCT01068860|460478799|FG008|Overall Study|Administrative problems; misrandomized|0|||
127961419|NCT01068860|460478800|FG009|Overall Study|Administrative problems; misrandomized|1|||
127961420|NCT01068860|460478791|FG000|Overall Study|Lost to Follow-up|0|||
127961421|NCT01068860|460478792|FG001|Overall Study|Lost to Follow-up|1|||
127961422|NCT01068860|460478793|FG002|Overall Study|Lost to Follow-up|0|||
127961423|NCT01068860|460478794|FG003|Overall Study|Lost to Follow-up|0|||
127961424|NCT01068860|460478795|FG004|Overall Study|Lost to Follow-up|0|||
127961425|NCT01068860|460478796|FG005|Overall Study|Lost to Follow-up|0|||
127961426|NCT01068860|460478797|FG006|Overall Study|Lost to Follow-up|0|||
127961427|NCT01068860|460478798|FG007|Overall Study|Lost to Follow-up|0|||
127961428|NCT01068860|460478799|FG008|Overall Study|Lost to Follow-up|0|||
127961429|NCT01068860|460478800|FG009|Overall Study|Lost to Follow-up|0|||
127961430|NCT00460603|460478801|FG000|Phase 1|Death|1|||
127961431|NCT00460603|460478802|FG001|Phase 1|Death|0|||
127961432|NCT00460603|460478803|FG002|Phase 1|Death|0|||
127961433|NCT00460603|460478804|FG003|Phase 1|Death|2|||
127961434|NCT00460603|460478805|FG004|Phase 1|Death|0|||
127961435|NCT00460603|460478806|FG005|Phase 1|Death|0|||
127961436|NCT00460603|460478807|FG006|Phase 1|Death|0|||
127961437|NCT00460603|460478808|FG007|Phase 1|Death|0|||
127961438|NCT00460603|460478809|FG008|Phase 1|Death|1|||
127961439|NCT00460603|460478810|FG009|Phase 1|Death|0|||
127961440|NCT00460603|460478811|FG010|Phase 1|Death|0|||
127961441|NCT00460603|460478812|FG011|Phase 1|Death|0|||
127961442|NCT00460603|460478801|FG000|Phase 1|Adverse Event|3|||
127961443|NCT00460603|460478802|FG001|Phase 1|Adverse Event|1|||
127961444|NCT00460603|460478803|FG002|Phase 1|Adverse Event|1|||
127961445|NCT00460603|460478804|FG003|Phase 1|Adverse Event|2|||
127961446|NCT00460603|460478805|FG004|Phase 1|Adverse Event|0|||
127961447|NCT00460603|460478806|FG005|Phase 1|Adverse Event|0|||
127961448|NCT00460603|460478807|FG006|Phase 1|Adverse Event|3|||
127961449|NCT00460603|460478808|FG007|Phase 1|Adverse Event|0|||
127961450|NCT00460603|460478809|FG008|Phase 1|Adverse Event|4|||
127961451|NCT00460603|460478810|FG009|Phase 1|Adverse Event|0|||
127961452|NCT00460603|460478811|FG010|Phase 1|Adverse Event|0|||
127961453|NCT00460603|460478812|FG011|Phase 1|Adverse Event|0|||
127961454|NCT00460603|460478801|FG000|Phase 1|Lack of Efficacy|1|||
127961455|NCT00460603|460478802|FG001|Phase 1|Lack of Efficacy|0|||
127961456|NCT00460603|460478803|FG002|Phase 1|Lack of Efficacy|1|||
127961457|NCT00460603|460478804|FG003|Phase 1|Lack of Efficacy|2|||
127961458|NCT00460603|460478805|FG004|Phase 1|Lack of Efficacy|2|||
127961459|NCT00460603|460478806|FG005|Phase 1|Lack of Efficacy|2|||
127961460|NCT00460603|460478807|FG006|Phase 1|Lack of Efficacy|2|||
127961461|NCT00460603|460478808|FG007|Phase 1|Lack of Efficacy|2|||
127961462|NCT00460603|460478809|FG008|Phase 1|Lack of Efficacy|11|||
127961463|NCT00460603|460478810|FG009|Phase 1|Lack of Efficacy|0|||
127961464|NCT00460603|460478811|FG010|Phase 1|Lack of Efficacy|0|||
127961465|NCT00460603|460478812|FG011|Phase 1|Lack of Efficacy|0|||
127961466|NCT00460603|460478801|FG000|Phase 1|Withdrawal by Subject|1|||
127961467|NCT00460603|460478802|FG001|Phase 1|Withdrawal by Subject|2|||
127961468|NCT00460603|460478803|FG002|Phase 1|Withdrawal by Subject|1|||
127961469|NCT00460603|460478804|FG003|Phase 1|Withdrawal by Subject|1|||
127961470|NCT00460603|460478805|FG004|Phase 1|Withdrawal by Subject|3|||
127961471|NCT00460603|460478806|FG005|Phase 1|Withdrawal by Subject|0|||
127961472|NCT00460603|460478807|FG006|Phase 1|Withdrawal by Subject|1|||
127961473|NCT00460603|460478808|FG007|Phase 1|Withdrawal by Subject|0|||
127961474|NCT00460603|460478809|FG008|Phase 1|Withdrawal by Subject|2|||
127961475|NCT00460603|460478810|FG009|Phase 1|Withdrawal by Subject|0|||
127961476|NCT00460603|460478811|FG010|Phase 1|Withdrawal by Subject|0|||
127961477|NCT00460603|460478812|FG011|Phase 1|Withdrawal by Subject|0|||
127961478|NCT00460603|460478801|FG000|Phase 1|Other|0|||
127961479|NCT00460603|460478802|FG001|Phase 1|Other|3|||
127961480|NCT00460603|460478803|FG002|Phase 1|Other|1|||
127961481|NCT00460603|460478804|FG003|Phase 1|Other|1|||
127961482|NCT00460603|460478805|FG004|Phase 1|Other|1|||
127961483|NCT00460603|460478806|FG005|Phase 1|Other|2|||
127961484|NCT00460603|460478807|FG006|Phase 1|Other|0|||
127961485|NCT00460603|460478808|FG007|Phase 1|Other|1|||
127961486|NCT00460603|460478809|FG008|Phase 1|Other|0|||
127961487|NCT00460603|460478810|FG009|Phase 1|Other|0|||
127961488|NCT00460603|460478811|FG010|Phase 1|Other|0|||
127961489|NCT00460603|460478812|FG011|Phase 1|Other|0|||
127961490|NCT00460603|460478801|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
127961491|NCT00460603|460478802|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
127961492|NCT00460603|460478803|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
127961493|NCT00460603|460478804|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
127961494|NCT00460603|460478805|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
127961495|NCT00460603|460478806|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
127961496|NCT00460603|460478807|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
127961497|NCT00460603|460478808|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
127961498|NCT00460603|460478809|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
127961499|NCT00460603|460478810|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
127961500|NCT00460603|460478811|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
127961501|NCT00460603|460478812|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
127961502|NCT00460603|460478801|FG000|Phase 2|Adverse Event|0|||
127961503|NCT00460603|460478802|FG001|Phase 2|Adverse Event|0|||
127961504|NCT00460603|460478803|FG002|Phase 2|Adverse Event|0|||
127961505|NCT00460603|460478804|FG003|Phase 2|Adverse Event|0|||
127961506|NCT00460603|460478805|FG004|Phase 2|Adverse Event|0|||
127961507|NCT00460603|460478806|FG005|Phase 2|Adverse Event|0|||
127961508|NCT00460603|460478807|FG006|Phase 2|Adverse Event|0|||
127961509|NCT00460603|460478808|FG007|Phase 2|Adverse Event|0|||
127961510|NCT00460603|460478809|FG008|Phase 2|Adverse Event|0|||
127961511|NCT00460603|460478810|FG009|Phase 2|Adverse Event|12|||
127961512|NCT00460603|460478811|FG010|Phase 2|Adverse Event|9|||
127961513|NCT00460603|460478812|FG011|Phase 2|Adverse Event|10|||
127961514|NCT00460603|460478801|FG000|Phase 2|Death|0|||
127961515|NCT00460603|460478802|FG001|Phase 2|Death|0|||
127961516|NCT00460603|460478803|FG002|Phase 2|Death|0|||
127961517|NCT00460603|460478804|FG003|Phase 2|Death|0|||
127961518|NCT00460603|460478805|FG004|Phase 2|Death|0|||
127961519|NCT00460603|460478806|FG005|Phase 2|Death|0|||
127961520|NCT00460603|460478807|FG006|Phase 2|Death|0|||
127961521|NCT00460603|460478808|FG007|Phase 2|Death|0|||
127961522|NCT00460603|460478809|FG008|Phase 2|Death|0|||
127961523|NCT00460603|460478810|FG009|Phase 2|Death|4|||
127961524|NCT00460603|460478811|FG010|Phase 2|Death|2|||
127961525|NCT00460603|460478812|FG011|Phase 2|Death|2|||
127961526|NCT00460603|460478801|FG000|Phase 2|Protocol Violation|0|||
127961527|NCT00460603|460478802|FG001|Phase 2|Protocol Violation|0|||
127961528|NCT00460603|460478803|FG002|Phase 2|Protocol Violation|0|||
127961529|NCT00460603|460478804|FG003|Phase 2|Protocol Violation|0|||
127961530|NCT00460603|460478805|FG004|Phase 2|Protocol Violation|0|||
127961531|NCT00460603|460478806|FG005|Phase 2|Protocol Violation|0|||
127961532|NCT00460603|460478807|FG006|Phase 2|Protocol Violation|0|||
127961533|NCT00460603|460478808|FG007|Phase 2|Protocol Violation|0|||
127961534|NCT00460603|460478809|FG008|Phase 2|Protocol Violation|0|||
127961535|NCT00460603|460478810|FG009|Phase 2|Protocol Violation|1|||
127961536|NCT00460603|460478811|FG010|Phase 2|Protocol Violation|1|||
127961537|NCT00460603|460478812|FG011|Phase 2|Protocol Violation|0|||
127961538|NCT00460603|460478801|FG000|Phase 2|Lost to Follow-up|0|||
127961539|NCT00460603|460478802|FG001|Phase 2|Lost to Follow-up|0|||
127961540|NCT00460603|460478803|FG002|Phase 2|Lost to Follow-up|0|||
127961541|NCT00460603|460478804|FG003|Phase 2|Lost to Follow-up|0|||
127961542|NCT00460603|460478805|FG004|Phase 2|Lost to Follow-up|0|||
127961543|NCT00460603|460478806|FG005|Phase 2|Lost to Follow-up|0|||
127961544|NCT00460603|460478807|FG006|Phase 2|Lost to Follow-up|0|||
127961545|NCT00460603|460478808|FG007|Phase 2|Lost to Follow-up|0|||
127961546|NCT00460603|460478809|FG008|Phase 2|Lost to Follow-up|0|||
127961547|NCT00460603|460478810|FG009|Phase 2|Lost to Follow-up|1|||
127961548|NCT00460603|460478811|FG010|Phase 2|Lost to Follow-up|0|||
127961549|NCT00460603|460478812|FG011|Phase 2|Lost to Follow-up|0|||
127961550|NCT00460603|460478801|FG000|Phase 2|Other|0|||
127961551|NCT00460603|460478802|FG001|Phase 2|Other|0|||
127961552|NCT00460603|460478803|FG002|Phase 2|Other|0|||
127961553|NCT00460603|460478804|FG003|Phase 2|Other|0|||
127961554|NCT00460603|460478805|FG004|Phase 2|Other|0|||
127961555|NCT00460603|460478806|FG005|Phase 2|Other|0|||
127961556|NCT00460603|460478807|FG006|Phase 2|Other|0|||
127961557|NCT00460603|460478808|FG007|Phase 2|Other|0|||
127961558|NCT00460603|460478809|FG008|Phase 2|Other|0|||
127961559|NCT00460603|460478810|FG009|Phase 2|Other|6|||
127961560|NCT00460603|460478811|FG010|Phase 2|Other|16|||
127961561|NCT00460603|460478812|FG011|Phase 2|Other|7|||
127961562|NCT00460603|460478801|FG000|Phase 2|Objective Progression or Relapse|0|||
127961563|NCT00460603|460478802|FG001|Phase 2|Objective Progression or Relapse|0|||
127961564|NCT00460603|460478803|FG002|Phase 2|Objective Progression or Relapse|0|||
127961565|NCT00460603|460478804|FG003|Phase 2|Objective Progression or Relapse|0|||
127961566|NCT00460603|460478805|FG004|Phase 2|Objective Progression or Relapse|0|||
127961567|NCT00460603|460478806|FG005|Phase 2|Objective Progression or Relapse|0|||
127961568|NCT00460603|460478807|FG006|Phase 2|Objective Progression or Relapse|0|||
127961569|NCT00460603|460478808|FG007|Phase 2|Objective Progression or Relapse|0|||
127961570|NCT00460603|460478809|FG008|Phase 2|Objective Progression or Relapse|0|||
127961571|NCT00460603|460478810|FG009|Phase 2|Objective Progression or Relapse|9|||
127961572|NCT00460603|460478811|FG010|Phase 2|Objective Progression or Relapse|10|||
127961573|NCT00460603|460478812|FG011|Phase 2|Objective Progression or Relapse|17|||
127961574|NCT00460603|460478801|FG000|Phase 2|Global Deterioration of Health Status|0|||
127961575|NCT00460603|460478802|FG001|Phase 2|Global Deterioration of Health Status|0|||
127961576|NCT00460603|460478803|FG002|Phase 2|Global Deterioration of Health Status|0|||
127961577|NCT00460603|460478804|FG003|Phase 2|Global Deterioration of Health Status|0|||
127961578|NCT00460603|460478805|FG004|Phase 2|Global Deterioration of Health Status|0|||
127961579|NCT00460603|460478806|FG005|Phase 2|Global Deterioration of Health Status|0|||
127961580|NCT00460603|460478807|FG006|Phase 2|Global Deterioration of Health Status|0|||
127961581|NCT00460603|460478808|FG007|Phase 2|Global Deterioration of Health Status|0|||
127961582|NCT00460603|460478809|FG008|Phase 2|Global Deterioration of Health Status|0|||
127961583|NCT00460603|460478810|FG009|Phase 2|Global Deterioration of Health Status|0|||
127961584|NCT00460603|460478811|FG010|Phase 2|Global Deterioration of Health Status|1|||
127961585|NCT00460603|460478812|FG011|Phase 2|Global Deterioration of Health Status|0|||
127961586|NCT00460603|460478801|FG000|Phase 2|Withdrawal by Subject|0|||
127961587|NCT00460603|460478802|FG001|Phase 2|Withdrawal by Subject|0|||
127961588|NCT00460603|460478803|FG002|Phase 2|Withdrawal by Subject|0|||
127961589|NCT00460603|460478804|FG003|Phase 2|Withdrawal by Subject|0|||
127961590|NCT00460603|460478805|FG004|Phase 2|Withdrawal by Subject|0|||
127961591|NCT00460603|460478806|FG005|Phase 2|Withdrawal by Subject|0|||
127961592|NCT00460603|460478807|FG006|Phase 2|Withdrawal by Subject|0|||
127961593|NCT00460603|460478808|FG007|Phase 2|Withdrawal by Subject|0|||
127961594|NCT00460603|460478809|FG008|Phase 2|Withdrawal by Subject|0|||
127961595|NCT00460603|460478810|FG009|Phase 2|Withdrawal by Subject|5|||
127961596|NCT00460603|460478811|FG010|Phase 2|Withdrawal by Subject|4|||
127961597|NCT00460603|460478812|FG011|Phase 2|Withdrawal by Subject|5|||
127961598|NCT00460603|460478801|FG000|Phase 2|Randomized, but not treated|0|||
127961599|NCT00460603|460478802|FG001|Phase 2|Randomized, but not treated|0|||
127961600|NCT00460603|460478803|FG002|Phase 2|Randomized, but not treated|0|||
127961601|NCT00460603|460478804|FG003|Phase 2|Randomized, but not treated|0|||
127961602|NCT00460603|460478805|FG004|Phase 2|Randomized, but not treated|0|||
127961603|NCT00460603|460478806|FG005|Phase 2|Randomized, but not treated|0|||
127961604|NCT00460603|460478807|FG006|Phase 2|Randomized, but not treated|0|||
127961605|NCT00460603|460478808|FG007|Phase 2|Randomized, but not treated|0|||
127961606|NCT00460603|460478809|FG008|Phase 2|Randomized, but not treated|0|||
127961607|NCT00460603|460478810|FG009|Phase 2|Randomized, but not treated|3|||
127961608|NCT00460603|460478811|FG010|Phase 2|Randomized, but not treated|0|||
127961609|NCT00460603|460478812|FG011|Phase 2|Randomized, but not treated|0|||
127961610|NCT00513240|460478813|FG000|Overall Study|Did not have intended surgery|3|||
127961611|NCT00513240|460478814|FG001|Overall Study|Did not have intended surgery|0|||
127961612|NCT00513240|460478813|FG000|Overall Study|Death|3|||
127961613|NCT00513240|460478814|FG001|Overall Study|Death|3|||
127961614|NCT00513240|460478813|FG000|Overall Study|Withdrawal by Subject|7|||
127961615|NCT00513240|460478814|FG001|Overall Study|Withdrawal by Subject|4|||
127961616|NCT05263908|460478815|FG000|Overall Study|No informed consent for publication of study results|397|||
127961617|NCT05263908|460478815|FG000|Overall Study|CRF not collected|1|||
127961618|NCT00289848|460478817|FG000|Overall Study|Adverse Event|6|||
127961619|NCT00289848|460478818|FG001|Overall Study|Adverse Event|4|||
127961620|NCT00289848|460478817|FG000|Overall Study|Death|1|||
127961621|NCT00289848|460478818|FG001|Overall Study|Death|0|||
127961622|NCT00289848|460478817|FG000|Overall Study|Lack of Efficacy|20|||
127961623|NCT00289848|460478818|FG001|Overall Study|Lack of Efficacy|24|||
127961624|NCT00289848|460478817|FG000|Overall Study|Lost to Follow-up|3|||
127961625|NCT00289848|460478818|FG001|Overall Study|Lost to Follow-up|1|||
127961626|NCT00289848|460478817|FG000|Overall Study|Protocol Violation|5|||
127961627|NCT00289848|460478818|FG001|Overall Study|Protocol Violation|2|||
127961628|NCT00289848|460478817|FG000|Overall Study|Withdrawal by Subject|5|||
127961629|NCT00289848|460478818|FG001|Overall Study|Withdrawal by Subject|11|||
127961630|NCT00289848|460478817|FG000|Overall Study|Patient Moved|6|||
127961631|NCT00289848|460478818|FG001|Overall Study|Patient Moved|2|||
127961632|NCT00289848|460478817|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
127961633|NCT00289848|460478818|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
127961634|NCT03871543|460478821|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
127961635|NCT03871543|460478821|FG000|Period 1|Investigator Error|1|||
127961636|NCT03871543|460478821|FG000|Period 1|Protocol Violation|2|||
127961637|NCT03871543|460478821|FG000|Period 1|COVID-19 Related|1|||
127961638|NCT03871543|460478821|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
127961639|NCT03871543|460478821|FG000|Period 1|Withdrawal by Subject|10|||
127961640|NCT03871543|460478821|FG000|Period 2|Adverse Event|1|||
127961641|NCT03871543|460478821|FG000|Period 2|Withdrawal by Subject|1|||
127961642|NCT01930162|460478823|FG000|Overall Study|Abnormal test procedure result(s)|4|||
127961643|NCT01930162|460478823|FG000|Overall Study|Death|1|||
127961644|NCT00395629|460478827|FG000|Core Study|Adverse Event|0|||
127961645|NCT00395629|460478828|FG001|Core Study|Adverse Event|3|||
127961646|NCT00395629|460478829|FG002|Core Study|Adverse Event|4|||
127961647|NCT00395629|460478827|FG000|Core Study|Abnormal laboratory value(s)|0|||
127961648|NCT00395629|460478828|FG001|Core Study|Abnormal laboratory value(s)|0|||
127961649|NCT00395629|460478829|FG002|Core Study|Abnormal laboratory value(s)|1|||
127961650|NCT00395629|460478827|FG000|Core Study|Protocol Violation|1|||
127961651|NCT00395629|460478828|FG001|Core Study|Protocol Violation|0|||
127961652|NCT00395629|460478829|FG002|Core Study|Protocol Violation|0|||
127961653|NCT00395629|460478827|FG000|Core Study|Withdrawal by Subject|0|||
127961654|NCT00395629|460478828|FG001|Core Study|Withdrawal by Subject|1|||
127961655|NCT00395629|460478829|FG002|Core Study|Withdrawal by Subject|1|||
127961656|NCT00395629|460478827|FG000|Core Study|Lost to Follow-up|0|||
127961657|NCT00395629|460478828|FG001|Core Study|Lost to Follow-up|0|||
127961658|NCT00395629|460478829|FG002|Core Study|Lost to Follow-up|1|||
127961659|NCT00395629|460478827|FG000|Extension Study|Adverse Event|0|||
127961660|NCT00395629|460478828|FG001|Extension Study|Adverse Event|0|||
127961661|NCT00395629|460478829|FG002|Extension Study|Adverse Event|2|||
127961662|NCT00395629|460478827|FG000|Extension Study|Administrative problems|0|||
127961663|NCT00395629|460478828|FG001|Extension Study|Administrative problems|0|||
127961664|NCT00395629|460478829|FG002|Extension Study|Administrative problems|1|||
127961665|NCT03534687|460478830|FG000|Overall Study|Lost to Follow-up|7|||
127961666|NCT03534687|460478831|FG001|Overall Study|Lost to Follow-up|2|||
127961667|NCT02069015|460478833|FG000|Overall Study|Lost to Follow-up|39|||
127961668|NCT02069015|460478834|FG001|Overall Study|Lost to Follow-up|32|||
127961669|NCT02069015|460478833|FG000|Overall Study|Withdrawal by Subject|1|||
127961670|NCT02069015|460478834|FG001|Overall Study|Withdrawal by Subject|1|||
127961671|NCT00031590|460478835|FG000|Overall Study|Adverse Event|1|||
127961672|NCT00031590|460478835|FG000|Overall Study|Withdrawal by parents|2|||
127961673|NCT03051100|460478837|FG000|Overall Study|Withdrawal by Subject|1|||
127961674|NCT03051100|460478838|FG001|Overall Study|Withdrawal by Subject|0|||
127961675|NCT02059135|460478839|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
127961676|NCT02059135|460478840|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
127961677|NCT02059135|460478839|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
127961678|NCT02059135|460478840|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
127961679|NCT02059135|460478839|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
127961680|NCT02059135|460478840|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
127961681|NCT02059135|460478839|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
127961682|NCT02059135|460478840|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
127961683|NCT02059135|460478839|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
127961684|NCT02059135|460478840|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
127961685|NCT02059135|460478839|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
127961686|NCT02059135|460478840|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
127961687|NCT02059135|460478839|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
127961688|NCT02059135|460478840|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
127961689|NCT02059135|460478839|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
127961690|NCT02059135|460478840|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
127961691|NCT00658723|460478846|FG000|Overall Study|Lost to Follow-up|0|||
127961692|NCT00658723|460478847|FG001|Overall Study|Lost to Follow-up|2|||
127961693|NCT00658723|460478848|FG002|Overall Study|Lost to Follow-up|2|||
127961694|NCT00658723|460478846|FG000|Overall Study|Death|2|||
127961695|NCT00658723|460478847|FG001|Overall Study|Death|1|||
127961696|NCT00658723|460478848|FG002|Overall Study|Death|4|||
127961697|NCT00658723|460478846|FG000|Overall Study|Scheduling Issue|1|||
127961698|NCT00658723|460478847|FG001|Overall Study|Scheduling Issue|1|||
127961699|NCT00658723|460478848|FG002|Overall Study|Scheduling Issue|0|||
127961700|NCT00658723|460478846|FG000|Overall Study|Withdrawal by Subject|1|||
127961701|NCT00658723|460478847|FG001|Overall Study|Withdrawal by Subject|0|||
127961702|NCT00658723|460478848|FG002|Overall Study|Withdrawal by Subject|1|||
127961703|NCT02411656|460478849|FG000|Overall Study|Adverse Event|4|||
127961704|NCT02411656|460478849|FG000|Overall Study|Clinical Progression|33|||
127961705|NCT06481709|460478850|FG000|Overall Study|Withdrawal by Subject|0|||
127961706|NCT06481709|460478851|FG001|Overall Study|Withdrawal by Subject|0|||
127961707|NCT06481709|460478852|FG002|Overall Study|Withdrawal by Subject|2|||
127961708|NCT06481709|460478853|FG003|Overall Study|Withdrawal by Subject|0|||
127961709|NCT03305848|460478854|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
127961710|NCT03305848|460478854|FG000|Overall Study|Physician Decision|2|||
127961711|NCT00789854|460478857|FG000|Overall Study|Adverse Event|28|||
127961712|NCT00789854|460478858|FG001|Overall Study|Adverse Event|23|||
127961713|NCT00789854|460478859|FG002|Overall Study|Adverse Event|18|||
127961714|NCT00789854|460478857|FG000|Overall Study|Lost to Follow-up|1|||
127961715|NCT00789854|460478858|FG001|Overall Study|Lost to Follow-up|1|||
127961716|NCT00789854|460478859|FG002|Overall Study|Lost to Follow-up|4|||
127961717|NCT00789854|460478857|FG000|Overall Study|Withdrawal by Subject|9|||
127961718|NCT00789854|460478858|FG001|Overall Study|Withdrawal by Subject|6|||
127961719|NCT00789854|460478859|FG002|Overall Study|Withdrawal by Subject|17|||
127961720|NCT00789854|460478857|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
127961721|NCT00789854|460478858|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
127961722|NCT00789854|460478859|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
127961723|NCT00789854|460478857|FG000|Overall Study|Severe non-compliance to the protocol|3|||
127961724|NCT00789854|460478858|FG001|Overall Study|Severe non-compliance to the protocol|0|||
127961725|NCT00789854|460478859|FG002|Overall Study|Severe non-compliance to the protocol|0|||
127961726|NCT00789854|460478857|FG000|Overall Study|Safety reasons|0|||
127961727|NCT00789854|460478858|FG001|Overall Study|Safety reasons|0|||
127961728|NCT00789854|460478859|FG002|Overall Study|Safety reasons|2|||
127961729|NCT00789854|460478857|FG000|Overall Study|Other|6|||
127961730|NCT00789854|460478858|FG001|Overall Study|Other|0|||
127961731|NCT00789854|460478859|FG002|Overall Study|Other|5|||
127961732|NCT00923013|460478860|FG000|Overall Study|Refused further treatment|0|||
127961733|NCT00923013|460478861|FG001|Overall Study|Refused further treatment|1|||
127961734|NCT00923013|460478862|FG002|Overall Study|Refused further treatment|2|||
127961735|NCT00923013|460478863|FG003|Overall Study|Refused further treatment|0|||
127961736|NCT00923013|460478864|FG004|Overall Study|Refused further treatment|0|||
127961737|NCT00923013|460478865|FG005|Overall Study|Refused further treatment|0|||
127961738|NCT00923013|460478860|FG000|Overall Study|Switched to alternative treatment|0|||
127961739|NCT00923013|460478861|FG001|Overall Study|Switched to alternative treatment|1|||
127961740|NCT00923013|460478862|FG002|Overall Study|Switched to alternative treatment|0|||
127961741|NCT00923013|460478863|FG003|Overall Study|Switched to alternative treatment|0|||
127961742|NCT00923013|460478864|FG004|Overall Study|Switched to alternative treatment|0|||
127961743|NCT00923013|460478865|FG005|Overall Study|Switched to alternative treatment|0|||
127961744|NCT00923013|460478860|FG000|Overall Study|Death on study|2|||
127961745|NCT00923013|460478861|FG001|Overall Study|Death on study|2|||
127961746|NCT00923013|460478862|FG002|Overall Study|Death on study|0|||
127961747|NCT00923013|460478863|FG003|Overall Study|Death on study|1|||
127961748|NCT00923013|460478864|FG004|Overall Study|Death on study|0|||
127961749|NCT00923013|460478865|FG005|Overall Study|Death on study|0|||
127961750|NCT02301169|460478868|FG000|Overall Study|Adverse Event|1|||
127961751|NCT02301169|460478869|FG001|Overall Study|Adverse Event|0|||
127961752|NCT01198470|460478874|FG000|Overall Study|Adverse Event|2|||
127961753|NCT02949973|460478875|FG000|Overall Study|Physician Decision|1|||
127961754|NCT00586703|460478876|FG000|Overall Study|Death|12|||
127961755|NCT01422213|460478877|FG000|Overall Study|Adverse Event|8|||
127961756|NCT01422213|460478878|FG001|Overall Study|Adverse Event|7|||
127961757|NCT01422213|460478879|FG002|Overall Study|Adverse Event|11|||
127961758|NCT01422213|460478877|FG000|Overall Study|Lack of Efficacy|10|||
127961759|NCT01422213|460478878|FG001|Overall Study|Lack of Efficacy|2|||
127961760|NCT01422213|460478879|FG002|Overall Study|Lack of Efficacy|2|||
127961761|NCT01422213|460478877|FG000|Overall Study|Non-compliance with study drug|0|||
127961762|NCT01422213|460478878|FG001|Overall Study|Non-compliance with study drug|1|||
127961763|NCT01422213|460478879|FG002|Overall Study|Non-compliance with study drug|0|||
127961764|NCT01422213|460478877|FG000|Overall Study|Protocol Violation|0|||
127961765|NCT01422213|460478878|FG001|Overall Study|Protocol Violation|2|||
127961766|NCT01422213|460478879|FG002|Overall Study|Protocol Violation|4|||
127961767|NCT01422213|460478877|FG000|Overall Study|Withdrawal of Consent|7|||
127961768|NCT01422213|460478878|FG001|Overall Study|Withdrawal of Consent|3|||
127961769|NCT01422213|460478879|FG002|Overall Study|Withdrawal of Consent|5|||
127961770|NCT01422213|460478877|FG000|Overall Study|Lost to Follow-up|3|||
127961771|NCT01422213|460478878|FG001|Overall Study|Lost to Follow-up|3|||
127961772|NCT01422213|460478879|FG002|Overall Study|Lost to Follow-up|5|||
127961773|NCT01422213|460478877|FG000|Overall Study|Administrative or Other Reason(s)|5|||
127961774|NCT01422213|460478878|FG001|Overall Study|Administrative or Other Reason(s)|4|||
127961775|NCT01422213|460478879|FG002|Overall Study|Administrative or Other Reason(s)|2|||
127961776|NCT00765102|460478880|FG000|Overall Study|Progressive disease|18|||
127961777|NCT00765102|460478880|FG000|Overall Study|Adverse Event|6|||
127961778|NCT00765102|460478880|FG000|Overall Study|Physician Decision|4|||
127961779|NCT00765102|460478880|FG000|Overall Study|Withdrawal by Subject|2|||
127961780|NCT00765102|460478880|FG000|Overall Study|Protocol Violation|1|||
127961781|NCT02857816|460478881|FG000|Overall Study|Screen Failure|33|||
127961782|NCT02857816|460478881|FG000|Overall Study|Withdrawal by Subject|4|||
127961783|NCT02857816|460478881|FG000|Overall Study|Lost to Follow-up|1|||
127961784|NCT04129125|460478888|FG000|Overall Study|Participants did not meet eligibility criteria|65|||
127961785|NCT04129125|460478888|FG000|Overall Study|Study device was not used|3|||
127961786|NCT04484142|460478889|FG000|Overall Study|Adverse Event|13|||
127961787|NCT04484142|460478889|FG000|Overall Study|Progressive Disease|87|||
127961788|NCT04484142|460478889|FG000|Overall Study|Clinical Progression|10|||
127961789|NCT04484142|460478889|FG000|Overall Study|Withdrawal by Subject|6|||
127961790|NCT04484142|460478889|FG000|Overall Study|Physician Decision|1|||
127961791|NCT03181633|460478892|FG000|Overall Study|Withdrawal by Subject|1|||
127961792|NCT03181633|460478892|FG000|Overall Study|Missing follow-up visit|1|||
127961793|NCT05303194|460478893|FG000|Overall Study|Lost to Follow-up|1|||
127961794|NCT05303194|460478894|FG001|Overall Study|Lost to Follow-up|1|||
127961795|NCT05303194|460478893|FG000|Overall Study|Withdrawal by Subject|0|||
127961796|NCT05303194|460478894|FG001|Overall Study|Withdrawal by Subject|1|||
127961797|NCT04837196|460478904|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
127961798|NCT04837196|460478905|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|3|||
127961799|NCT04837196|460478906|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
127961800|NCT04837196|460478907|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
127961801|NCT04837196|460478908|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|4|||
127961802|NCT04837196|460478904|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
127961803|NCT04837196|460478905|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|4|||
127961804|NCT04837196|460478906|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|0|||
127961805|NCT04837196|460478907|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
127961806|NCT04837196|460478908|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
127961807|NCT04837196|460478904|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
127961808|NCT04837196|460478905|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|1|||
127961809|NCT04837196|460478906|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
127961810|NCT04837196|460478907|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
127961811|NCT04837196|460478908|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
127961812|NCT04837196|460478904|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
127961813|NCT04837196|460478905|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
127961814|NCT04837196|460478906|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|1|||
127961815|NCT04837196|460478907|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
127961816|NCT04837196|460478908|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
127961817|NCT04837196|460478904|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
127961818|NCT04837196|460478905|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
127961819|NCT04837196|460478906|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|1|||
127961820|NCT04837196|460478907|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
127961821|NCT04837196|460478908|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
127961822|NCT05271175|460478909|FG000|One Week Follow up|Lost to Follow-up|10|||
127961823|NCT05271175|460478910|FG001|One Week Follow up|Lost to Follow-up|7|||
127961824|NCT05271175|460478911|FG002|One Week Follow up|Lost to Follow-up|5|||
127961825|NCT05271175|460478909|FG000|One Month Follow up|Lost to Follow-up|12|||
127961826|NCT05271175|460478910|FG001|One Month Follow up|Lost to Follow-up|7|||
127961827|NCT05271175|460478911|FG002|One Month Follow up|Lost to Follow-up|9|||
127961828|NCT05271175|460478909|FG000|Six Months Follow up|Lost to Follow-up|8|||
127961829|NCT05271175|460478910|FG001|Six Months Follow up|Lost to Follow-up|2|||
127961830|NCT05271175|460478911|FG002|Six Months Follow up|Lost to Follow-up|2|||
127961831|NCT00991887|460478912|FG000|Overall Study|Lost to Follow-up|2|||
127961832|NCT00991887|460478913|FG001|Overall Study|Lost to Follow-up|1|||
127961833|NCT02723344|460478914|FG000|Overall Study|Lost to Follow-up|0|||
127961834|NCT02723344|460478915|FG001|Overall Study|Lost to Follow-up|4|||
127961835|NCT02964247|460478917|FG000|Overall Study|Lost to Follow-up|2|||
127961836|NCT02964247|460478918|FG001|Overall Study|Lost to Follow-up|0|||
127961837|NCT02964247|460478917|FG000|Overall Study|Withdrawal by Subject|1|||
127961838|NCT02964247|460478918|FG001|Overall Study|Withdrawal by Subject|2|||
127961839|NCT01709500|460478919|FG000|Overall Study|Randomized but not treated|0|||
127961840|NCT01709500|460478920|FG001|Overall Study|Randomized but not treated|1|||
127961841|NCT01709500|460478919|FG000|Overall Study|Adverse Event|5|||
127961842|NCT01709500|460478920|FG001|Overall Study|Adverse Event|1|||
127961843|NCT01709500|460478919|FG000|Overall Study|Poor compliance to protocol|2|||
127961844|NCT01709500|460478920|FG001|Overall Study|Poor compliance to protocol|1|||
127961845|NCT01709500|460478919|FG000|Overall Study|Other|3|||
127961846|NCT01709500|460478920|FG001|Overall Study|Other|1|||
127961847|NCT01709500|460478919|FG000|Overall Study|Related to IMP administration|1|||
127961848|NCT01709500|460478920|FG001|Overall Study|Related to IMP administration|0|||
127961849|NCT01709500|460478919|FG000|Overall Study|Treatment ongoing|156|||
127961850|NCT01709500|460478920|FG001|Overall Study|Treatment ongoing|78|||
127961851|NCT05207865|460480389|FG000|Open-Label Treatment Phase|Adverse Event|7|||
127961852|NCT05207865|460480389|FG000|Open-Label Treatment Phase|Lost to Follow-up|8|||
127961853|NCT05207865|460480389|FG000|Open-Label Treatment Phase|Non-compliance|3|||
127961854|NCT05207865|460480389|FG000|Open-Label Treatment Phase|Other|17|||
127961855|NCT05207865|460480389|FG000|Open-Label Treatment Phase|Physician Decision|2|||
127961856|NCT05207865|460480389|FG000|Open-Label Treatment Phase|Pregnancy|1|||
127961857|NCT05207865|460480389|FG000|Open-Label Treatment Phase|Protocol Violation|1|||
127961858|NCT05207865|460480389|FG000|Open-Label Treatment Phase|Protocol-specified withdrawal criterion met|14|||
127961859|NCT05207865|460480389|FG000|Open-Label Treatment Phase|Withdrawal by Subject|10|||
127961860|NCT05207865|460480389|FG000|Follow-up Phase|Lost to Follow-up|1|||
127961861|NCT05207865|460480389|FG000|Follow-up Phase|Non-compliance|1|||
127961862|NCT05207865|460480389|FG000|Follow-up Phase|Not reported|2|||
127961863|NCT05207865|460480389|FG000|Follow-up Phase|Not collected|11|||
127961864|NCT03593525|460480405|FG000|Overall Study|Withdrawal by Subject|1|||
127961865|NCT03593525|460480406|FG001|Overall Study|Withdrawal by Subject|0|||
127961866|NCT03593525|460480405|FG000|Overall Study|Lost to Follow-up|7|||
127961867|NCT03593525|460480406|FG001|Overall Study|Lost to Follow-up|5|||
127961868|NCT03103087|460480407|FG000|Overall Study|Did not receive any study drug|1|||
127961869|NCT03103087|460480408|FG001|Overall Study|Did not receive any study drug|0|||
127961870|NCT03103087|460480409|FG002|Overall Study|Did not receive any study drug|0|||
127961871|NCT03103087|460480407|FG000|Overall Study|Protocol Violation|1|||
127961872|NCT03103087|460480408|FG001|Overall Study|Protocol Violation|2|||
127961873|NCT03103087|460480409|FG002|Overall Study|Protocol Violation|1|||
127961874|NCT03103087|460480407|FG000|Overall Study|Lack of Efficacy|2|||
127961875|NCT03103087|460480408|FG001|Overall Study|Lack of Efficacy|1|||
127961876|NCT03103087|460480409|FG002|Overall Study|Lack of Efficacy|1|||
127961877|NCT03103087|460480407|FG000|Overall Study|Pregnancy|0|||
127961878|NCT03103087|460480408|FG001|Overall Study|Pregnancy|0|||
127961879|NCT03103087|460480409|FG002|Overall Study|Pregnancy|1|||
127961880|NCT03103087|460480407|FG000|Overall Study|Adverse Event|2|||
127961881|NCT03103087|460480408|FG001|Overall Study|Adverse Event|15|||
127961882|NCT03103087|460480409|FG002|Overall Study|Adverse Event|6|||
127961883|NCT03103087|460480407|FG000|Overall Study|Withdrawal by Subject|13|||
127961884|NCT03103087|460480408|FG001|Overall Study|Withdrawal by Subject|6|||
127961885|NCT03103087|460480409|FG002|Overall Study|Withdrawal by Subject|6|||
127961886|NCT03103087|460480407|FG000|Overall Study|Lost to Follow-up|4|||
127961887|NCT03103087|460480408|FG001|Overall Study|Lost to Follow-up|2|||
127961888|NCT03103087|460480409|FG002|Overall Study|Lost to Follow-up|7|||
127961889|NCT03103087|460480407|FG000|Overall Study|Other reason not reported|1|||
127961890|NCT03103087|460480408|FG001|Overall Study|Other reason not reported|3|||
127961891|NCT03103087|460480409|FG002|Overall Study|Other reason not reported|5|||
127961892|NCT00413699|460480410|FG000|Initial Period|Death|25|||
127961893|NCT00413699|460480411|FG001|Initial Period|Death|30|||
127961894|NCT00413699|460480412|FG002|Initial Period|Death|0|||
127961895|NCT00413699|460480410|FG000|Initial Period|Lack of Efficacy|59|||
127961896|NCT00413699|460480411|FG001|Initial Period|Lack of Efficacy|115|||
127961897|NCT00413699|460480412|FG002|Initial Period|Lack of Efficacy|0|||
127961898|NCT00413699|460480410|FG000|Initial Period|Lost to Follow-up|31|||
127961899|NCT00413699|460480411|FG001|Initial Period|Lost to Follow-up|101|||
127961900|NCT00413699|460480412|FG002|Initial Period|Lost to Follow-up|0|||
127961901|NCT00413699|460480410|FG000|Initial Period|Protocol Violation|38|||
127961902|NCT00413699|460480411|FG001|Initial Period|Protocol Violation|89|||
127961903|NCT00413699|460480412|FG002|Initial Period|Protocol Violation|0|||
127961904|NCT00413699|460480410|FG000|Initial Period|Pregnancy|10|||
127961905|NCT00413699|460480411|FG001|Initial Period|Pregnancy|8|||
127961906|NCT00413699|460480412|FG002|Initial Period|Pregnancy|0|||
127961907|NCT00413699|460480410|FG000|Initial Period|Did not meet entrance criteria|2|||
127961908|NCT00413699|460480411|FG001|Initial Period|Did not meet entrance criteria|2|||
127961909|NCT00413699|460480412|FG002|Initial Period|Did not meet entrance criteria|0|||
127961910|NCT00413699|460480410|FG000|Initial Period|Medication error without adverse event|0|||
127961911|NCT00413699|460480411|FG001|Initial Period|Medication error without adverse event|1|||
127961912|NCT00413699|460480412|FG002|Initial Period|Medication error without adverse event|0|||
127961913|NCT00413699|460480410|FG000|Initial Period|Study terminated by Sponsor|0|||
127961914|NCT00413699|460480411|FG001|Initial Period|Study terminated by Sponsor|1|||
127961915|NCT00413699|460480412|FG002|Initial Period|Study terminated by Sponsor|0|||
127961916|NCT00413699|460480410|FG000|Initial Period|Other|67|||
127961917|NCT00413699|460480411|FG001|Initial Period|Other|211|||
127961918|NCT00413699|460480412|FG002|Initial Period|Other|0|||
127961919|NCT00413699|460480410|FG000|Initial Period|Adverse event related to study drug|178|||
127961920|NCT00413699|460480411|FG001|Initial Period|Adverse event related to study drug|527|||
127961921|NCT00413699|460480412|FG002|Initial Period|Adverse event related to study drug|0|||
127961922|NCT00413699|460480410|FG000|Initial Period|Adverse event not related to study drug|113|||
127961923|NCT00413699|460480411|FG001|Initial Period|Adverse event not related to study drug|248|||
127961924|NCT00413699|460480412|FG002|Initial Period|Adverse event not related to study drug|0|||
127961925|NCT00413699|460480410|FG000|Initial Period|Missing end of study page|0|||
127961926|NCT00413699|460480411|FG001|Initial Period|Missing end of study page|4|||
127961927|NCT00413699|460480412|FG002|Initial Period|Missing end of study page|0|||
127961928|NCT00413699|460480410|FG000|Initial Period|No longer willing to participate|116|||
127961929|NCT00413699|460480411|FG001|Initial Period|No longer willing to participate|368|||
127961930|NCT00413699|460480412|FG002|Initial Period|No longer willing to participate|0|||
127961931|NCT00413699|460480410|FG000|Extension Period|No Longer Willing to Participate|0|||
127961932|NCT00413699|460480411|FG001|Extension Period|No Longer Willing to Participate|0|||
127961933|NCT00413699|460480412|FG002|Extension Period|No Longer Willing to Participate|2|||
127961934|NCT00413699|460480410|FG000|Extension Period|Protocol Violation|0|||
127961935|NCT00413699|460480411|FG001|Extension Period|Protocol Violation|0|||
127961936|NCT00413699|460480412|FG002|Extension Period|Protocol Violation|1|||
127961937|NCT00413699|460480410|FG000|Extension Period|Adverse Event|0|||
127961938|NCT00413699|460480411|FG001|Extension Period|Adverse Event|0|||
127961939|NCT00413699|460480412|FG002|Extension Period|Adverse Event|2|||
127961940|NCT00075816|460480413|FG000|Overall Study|Did not undergo transplantation|14|||
127961941|NCT00075816|460480414|FG001|Overall Study|Did not undergo transplantation|11|||
127961942|NCT04231825|460480415|FG000|Overall Study|Protocol Violation|3|||
127961943|NCT04231825|460480416|FG001|Overall Study|Protocol Violation|3|||
127961944|NCT04231825|460480415|FG000|Overall Study|Lost to Follow-up|0|||
127961945|NCT04231825|460480416|FG001|Overall Study|Lost to Follow-up|1|||
127961946|NCT02549859|460480419|FG000|Long-term 60 Hz DBS|Study Closed|1|||
127961947|NCT03922321|460480421|FG000|Overall Study|Participant Moved|1|||
127961948|NCT03922321|460480421|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
127961949|NCT04067050|460480429|FG000|One Month|Lost to Follow-up|4|||
127961950|NCT04067050|460480430|FG001|One Month|Lost to Follow-up|0|||
127961951|NCT04067050|460480429|FG000|Two Month|Lost to Follow-up|1|||
127961952|NCT04067050|460480430|FG001|Two Month|Lost to Follow-up|0|||
127961953|NCT04067050|460480429|FG000|Two Month|Adverse Event|1|||
127961954|NCT04067050|460480430|FG001|Two Month|Adverse Event|0|||
127961955|NCT01062425|460480435|FG000|Overall Study|Protocol Violation|3|||
127961956|NCT01062425|460480436|FG001|Overall Study|Protocol Violation|6|||
127961957|NCT02342678|460480437|FG000|Overall Study|Lost to Follow-up|0|||
127961958|NCT02342678|460480438|FG001|Overall Study|Lost to Follow-up|1|||
127961959|NCT02342678|460480437|FG000|Overall Study|Too busy to complete study|0|||
127961960|NCT02342678|460480438|FG001|Overall Study|Too busy to complete study|2|||
127961961|NCT02342678|460480437|FG000|Overall Study|Family illness/emergency|0|||
127961962|NCT02342678|460480438|FG001|Overall Study|Family illness/emergency|1|||
127961963|NCT02342678|460480437|FG000|Overall Study|Illness/medical reason|1|||
127961964|NCT02342678|460480438|FG001|Overall Study|Illness/medical reason|1|||
127961965|NCT02962648|460480440|FG000|Overall Study|Withdrawal by Subject|3|||
127961966|NCT02962648|460480440|FG000|Overall Study|Lost to Follow-up|3|||
127961967|NCT02962648|460480440|FG000|Overall Study|Physician Decision|1|||
127961968|NCT02962648|460480440|FG000|Overall Study|Subject had problems with transportation|2|||
127961969|NCT01597778|460480442|FG000|Overall Study|Death|7|||
127961970|NCT01597778|460480443|FG001|Overall Study|Death|10|||
127961971|NCT01597778|460480442|FG000|Overall Study|Withdrawal by Subject|3|||
127961972|NCT01597778|460480443|FG001|Overall Study|Withdrawal by Subject|4|||
127961973|NCT01597778|460480442|FG000|Overall Study|Adverse Event|1|||
127961974|NCT01597778|460480443|FG001|Overall Study|Adverse Event|1|||
127961975|NCT01597778|460480442|FG000|Overall Study|Protocol Violation|1|||
127961976|NCT01597778|460480443|FG001|Overall Study|Protocol Violation|11|||
127961977|NCT01597778|460480442|FG000|Overall Study|Transplanted off protocol|2|||
127961978|NCT01597778|460480443|FG001|Overall Study|Transplanted off protocol|3|||
127961979|NCT04383327|460480444|FG000|Overall Study|Lost to Follow-up|112|||
127961980|NCT04383327|460480445|FG001|Overall Study|Lost to Follow-up|14|||
127961981|NCT04383327|460480446|FG002|Overall Study|Lost to Follow-up|78|||
127961982|NCT04383327|460480447|FG003|Overall Study|Lost to Follow-up|13|||
127961983|NCT04383327|460480448|FG004|Overall Study|Lost to Follow-up|110|||
127961984|NCT04383327|460480449|FG005|Overall Study|Lost to Follow-up|13|||
127961985|NCT04383327|460480450|FG006|Overall Study|Lost to Follow-up|74|||
127961986|NCT04383327|460480451|FG007|Overall Study|Lost to Follow-up|13|||
127961987|NCT04383327|460480452|FG008|Overall Study|Lost to Follow-up|78|||
127961988|NCT04383327|460480453|FG009|Overall Study|Lost to Follow-up|10|||
127961989|NCT04383327|460480454|FG010|Overall Study|Lost to Follow-up|160|||
127961990|NCT04383327|460480455|FG011|Overall Study|Lost to Follow-up|13|||
127961991|NCT01289678|460480456|FG000|Overall Study|Physician Decision|6|||
127961992|NCT00468819|460480457|FG000|Overall Study|Withdrawal by Subject|4|||
127961993|NCT00468819|460480458|FG001|Overall Study|Withdrawal by Subject|0|||
127961994|NCT00468819|460480459|FG002|Overall Study|Withdrawal by Subject|1|||
127961995|NCT00468819|460480457|FG000|Overall Study|Lost to Follow-up|0|||
127961996|NCT00468819|460480458|FG001|Overall Study|Lost to Follow-up|0|||
127961997|NCT00468819|460480459|FG002|Overall Study|Lost to Follow-up|1|||
127961998|NCT00468819|460480457|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
127961999|NCT00468819|460480458|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
127962000|NCT00468819|460480459|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
127962001|NCT04030299|460480460|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
127962002|NCT04030299|460480460|FG000|Overall Study|Withdrawal by Subject|3|||
127962003|NCT04616612|460480461|FG000|Overall Study|Lost to Follow-up|6|||
127962004|NCT04616612|460480462|FG001|Overall Study|Lost to Follow-up|3|||
127962005|NCT04740918|460480463|FG000|Overall Study|Study Terminated by Sponsor|41|||
127962006|NCT04740918|460480464|FG001|Overall Study|Study Terminated by Sponsor|32|||
127962007|NCT04740918|460480463|FG000|Overall Study|Death|3|||
127962008|NCT04740918|460480464|FG001|Overall Study|Death|6|||
127962009|NCT04740918|460480463|FG000|Overall Study|Withdrawal by Subject|5|||
127962010|NCT04740918|460480464|FG001|Overall Study|Withdrawal by Subject|4|||
127962011|NCT04740918|460480463|FG000|Overall Study|Lost to Follow-up|1|||
127962012|NCT04740918|460480464|FG001|Overall Study|Lost to Follow-up|3|||
127962013|NCT04740918|460480463|FG000|Overall Study|Progressive disease|0|||
127962014|NCT04740918|460480464|FG001|Overall Study|Progressive disease|1|||
127962015|NCT02524847|460480465|FG000|Overall Study|Adverse Event|4|||
127962016|NCT02524847|460480465|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
127962017|NCT02524847|460480465|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
127962018|NCT02524847|460480465|FG000|Overall Study|Death|1|||
127962019|NCT02524847|460480465|FG000|Overall Study|Reason not Specified|1|||
127962020|NCT04352101|460480466|FG000|Overall Study|Physician Decision|2|||
127962021|NCT04352101|460480467|FG001|Overall Study|Physician Decision|1|||
127962022|NCT01288079|460480475|FG000|Overall Study|Withdrawal by Subject|2|||
127962023|NCT01288079|460480476|FG001|Overall Study|Withdrawal by Subject|4|||
127962024|NCT01288079|460480477|FG002|Overall Study|Withdrawal by Subject|1|||
127962025|NCT01288079|460480478|FG003|Overall Study|Withdrawal by Subject|0|||
127962026|NCT01288079|460480475|FG000|Overall Study|Adverse Event|2|||
127962027|NCT01288079|460480476|FG001|Overall Study|Adverse Event|1|||
127962028|NCT01288079|460480477|FG002|Overall Study|Adverse Event|2|||
127962029|NCT01288079|460480478|FG003|Overall Study|Adverse Event|3|||
127962030|NCT01288079|460480475|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
127962031|NCT01288079|460480476|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
127962032|NCT01288079|460480477|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
127962033|NCT01288079|460480478|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
127962034|NCT01288079|460480475|FG000|Overall Study|Condition under Investigation Worsened|0|||
127962035|NCT01288079|460480476|FG001|Overall Study|Condition under Investigation Worsened|0|||
127962036|NCT01288079|460480477|FG002|Overall Study|Condition under Investigation Worsened|0|||
127962037|NCT01288079|460480478|FG003|Overall Study|Condition under Investigation Worsened|1|||
127962038|NCT01288079|460480475|FG000|Overall Study|Lack of Efficacy|2|||
127962039|NCT01288079|460480476|FG001|Overall Study|Lack of Efficacy|2|||
127962040|NCT01288079|460480477|FG002|Overall Study|Lack of Efficacy|0|||
127962041|NCT01288079|460480478|FG003|Overall Study|Lack of Efficacy|2|||
127962042|NCT01288079|460480475|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
127962043|NCT01288079|460480476|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
127962044|NCT01288079|460480477|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
127962045|NCT01288079|460480478|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
127962046|NCT01288079|460480475|FG000|Overall Study|Lost to Follow-up|1|||
127962047|NCT01288079|460480476|FG001|Overall Study|Lost to Follow-up|1|||
127962048|NCT01288079|460480477|FG002|Overall Study|Lost to Follow-up|1|||
127962049|NCT01288079|460480478|FG003|Overall Study|Lost to Follow-up|0|||
127962050|NCT01288079|460480475|FG000|Overall Study|Other or Study Termination|11|||
127962051|NCT01288079|460480476|FG001|Overall Study|Other or Study Termination|15|||
127962052|NCT01288079|460480477|FG002|Overall Study|Other or Study Termination|14|||
127962053|NCT01288079|460480478|FG003|Overall Study|Other or Study Termination|8|||
127962054|NCT01530464|460480479|FG000|Washout (24h)|Withdrawal by Subject|1|||
127962055|NCT01530464|460480480|FG001|Washout (24h)|Withdrawal by Subject|0|||
127962056|NCT01530464|460480479|FG000|Washout (24h)|Withdrawal by Subject|0|||
127962057|NCT01530464|460480480|FG001|Washout (24h)|Withdrawal by Subject|1|||
127962058|NCT00908544|460480481|FG000|Overall Study|Withdrawal by Subject|2|||
127962059|NCT00908544|460480482|FG001|Overall Study|Withdrawal by Subject|4|||
127962060|NCT00908544|460480481|FG000|Overall Study|Lack of Efficacy|0|||
127962061|NCT00908544|460480482|FG001|Overall Study|Lack of Efficacy|1|||
127962062|NCT00908544|460480481|FG000|Overall Study|Pregnancy|1|||
127962063|NCT00908544|460480482|FG001|Overall Study|Pregnancy|0|||
127962064|NCT00908544|460480481|FG000|Overall Study|Relocation abroad|1|||
127962065|NCT00908544|460480482|FG001|Overall Study|Relocation abroad|1|||
127962066|NCT00908544|460480481|FG000|Overall Study|Unable to visit sutdy center|1|||
127962067|NCT00908544|460480482|FG001|Overall Study|Unable to visit sutdy center|0|||
127962068|NCT02387840|460480483|FG000|Overall Study|Death|0|||
127962069|NCT02387840|460480484|FG001|Overall Study|Death|0|||
127962070|NCT02387840|460480485|FG002|Overall Study|Death|0|||
127962071|NCT02387840|460480486|FG003|Overall Study|Death|0|||
127962072|NCT02387840|460480487|FG004|Overall Study|Death|0|||
127962073|NCT02387840|460480488|FG005|Overall Study|Death|1|||
127962074|NCT03170544|460480489|FG000|Part 1|Lost to Follow-up|1|||
127962075|NCT03170544|460480490|FG001|Part 1|Lost to Follow-up|0|||
127962076|NCT03170544|460480491|FG002|Part 1|Lost to Follow-up|0|||
127962077|NCT03170544|460480492|FG003|Part 1|Lost to Follow-up|0|||
127962078|NCT03170544|460480493|FG004|Part 1|Lost to Follow-up|0|||
127962079|NCT03170544|460480494|FG005|Part 1|Lost to Follow-up|0|||
127962080|NCT03170544|460480495|FG006|Part 1|Lost to Follow-up|0|||
127962081|NCT03170544|460480496|FG007|Part 1|Lost to Follow-up|0|||
127962082|NCT03170544|460480497|FG008|Part 1|Lost to Follow-up|0|||
127962083|NCT03170544|460480498|FG009|Part 1|Lost to Follow-up|0|||
127962084|NCT03170544|460480499|FG010|Part 1|Lost to Follow-up|0|||
127962085|NCT03170544|460480500|FG011|Part 1|Lost to Follow-up|0|||
127962086|NCT03170544|460480489|FG000|Part 1|Not treated|0|||
127962087|NCT03170544|460480490|FG001|Part 1|Not treated|0|||
127962088|NCT03170544|460480491|FG002|Part 1|Not treated|0|||
127962089|NCT03170544|460480492|FG003|Part 1|Not treated|1|||
127962090|NCT03170544|460480493|FG004|Part 1|Not treated|0|||
127962091|NCT03170544|460480494|FG005|Part 1|Not treated|0|||
127962092|NCT03170544|460480495|FG006|Part 1|Not treated|0|||
127962093|NCT03170544|460480496|FG007|Part 1|Not treated|0|||
127962094|NCT03170544|460480497|FG008|Part 1|Not treated|0|||
127962095|NCT03170544|460480498|FG009|Part 1|Not treated|0|||
127962096|NCT03170544|460480499|FG010|Part 1|Not treated|0|||
127962097|NCT03170544|460480500|FG011|Part 1|Not treated|0|||
127962098|NCT03539302|460480506|FG000|Overall Study|Spontaneous cardio version|0|||
127962099|NCT03539302|460480507|FG001|Overall Study|Spontaneous cardio version|0|||
127962100|NCT03539302|460480508|FG002|Overall Study|Spontaneous cardio version|0|||
127962101|NCT03539302|460480509|FG003|Overall Study|Spontaneous cardio version|0|||
127962102|NCT03539302|460480510|FG004|Overall Study|Spontaneous cardio version|0|||
127962103|NCT03539302|460480511|FG005|Overall Study|Spontaneous cardio version|1|||
127962104|NCT03539302|460480512|FG006|Overall Study|Spontaneous cardio version|1|||
127962105|NCT02107131|460480514|FG000|Overall Study|Lost to Follow-up|4|||
127962106|NCT02107131|460480515|FG001|Overall Study|Lost to Follow-up|4|||
127962107|NCT02107131|460480514|FG000|Overall Study|Physician Decision|1|||
127962108|NCT02107131|460480515|FG001|Overall Study|Physician Decision|0|||
127962109|NCT02107131|460480514|FG000|Overall Study|Withdrawal by Subject|2|||
127962110|NCT02107131|460480515|FG001|Overall Study|Withdrawal by Subject|0|||
127962111|NCT02107131|460480514|FG000|Overall Study|mental instability|1|||
127962112|NCT02107131|460480515|FG001|Overall Study|mental instability|0|||
127962113|NCT02107131|460480514|FG000|Overall Study|Death|0|||
127962114|NCT02107131|460480515|FG001|Overall Study|Death|1|||
127962115|NCT02107131|460480514|FG000|Overall Study|Protocol Violation|0|||
127962116|NCT02107131|460480515|FG001|Overall Study|Protocol Violation|4|||
127962117|NCT01609790|460480518|FG000|Overall Study|Protocol Violation|1|||
127962118|NCT01609790|460480519|FG001|Overall Study|Protocol Violation|7|||
127962119|NCT01609790|460480520|FG002|Overall Study|Protocol Violation|8|||
127962120|NCT00739882|460481807|FG000|Double-blind Period|Adverse Event|1|||
127962121|NCT00739882|460481808|FG001|Double-blind Period|Adverse Event|2|||
127962122|NCT00739882|460481807|FG000|Double-blind Period|Protocol Violation|1|||
127962123|NCT00739882|460481808|FG001|Double-blind Period|Protocol Violation|0|||
127962124|NCT00739882|460481807|FG000|Double-blind Period|Lack of Efficacy|1|||
127962125|NCT00739882|460481808|FG001|Double-blind Period|Lack of Efficacy|1|||
127962126|NCT00739882|460481807|FG000|Double-blind Period|Other|16|||
127962127|NCT00739882|460481808|FG001|Double-blind Period|Other|8|||
127962128|NCT00739882|460481807|FG000|Open-label Period|Adverse Event|1|||
127962129|NCT00739882|460481808|FG001|Open-label Period|Adverse Event|0|||
127962130|NCT00739882|460481807|FG000|Open-label Period|Other|9|||
127962131|NCT00739882|460481808|FG001|Open-label Period|Other|5|||
127962132|NCT05423093|460481811|FG000|Consented Participants - Baseline Comple|Lost to Follow-up|2|||
127962133|NCT05423093|460481811|FG000|Consented Participants - Baseline Comple|Withdrawal by Subject|2|||
127962134|NCT05423093|460481811|FG000|Attended Intervention Session|Lost to Follow-up|3|||
127962135|NCT05423093|460481811|FG000|Completed Post-intervention Measures|Lost to Follow-up|3|||
127962136|NCT05423093|460481811|FG000|6-month Post Intervention Data Collected|Lost to Follow-up|2|||
127962137|NCT05364931|460481812|FG000|Overall Study|Adverse Event|0|||
127962138|NCT05364931|460481813|FG001|Overall Study|Adverse Event|2|||
127962139|NCT05364931|460481814|FG002|Overall Study|Adverse Event|1|||
127962140|NCT05364931|460481815|FG003|Overall Study|Adverse Event|0|||
127962141|NCT05364931|460481812|FG000|Overall Study|Lost to Follow-up|1|||
127962142|NCT05364931|460481813|FG001|Overall Study|Lost to Follow-up|0|||
127962143|NCT05364931|460481814|FG002|Overall Study|Lost to Follow-up|0|||
127962144|NCT05364931|460481815|FG003|Overall Study|Lost to Follow-up|0|||
127962145|NCT05364931|460481812|FG000|Overall Study|Withdrawal by Subject|1|||
127962146|NCT05364931|460481813|FG001|Overall Study|Withdrawal by Subject|1|||
127962147|NCT05364931|460481814|FG002|Overall Study|Withdrawal by Subject|3|||
127962148|NCT05364931|460481815|FG003|Overall Study|Withdrawal by Subject|2|||
127962149|NCT05364931|460481812|FG000|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
127962150|NCT05364931|460481813|FG001|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|1|||
127962151|NCT05364931|460481814|FG002|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
127962152|NCT05364931|460481815|FG003|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
127962153|NCT05364931|460481812|FG000|Overall Study|Discontinued|1|||
127962154|NCT05364931|460481813|FG001|Overall Study|Discontinued|0|||
127962155|NCT05364931|460481814|FG002|Overall Study|Discontinued|0|||
127962156|NCT05364931|460481815|FG003|Overall Study|Discontinued|0|||
127962157|NCT03504397|460481823|FG000|Overall Study|Progressive Disease|151|||
127962158|NCT03504397|460481824|FG001|Overall Study|Progressive Disease|199|||
127962159|NCT03504397|460481823|FG000|Overall Study|Withdrawal by Subject|29|||
127962160|NCT03504397|460481824|FG001|Overall Study|Withdrawal by Subject|17|||
127962161|NCT03504397|460481823|FG000|Overall Study|Lost to Follow-up|1|||
127962162|NCT03504397|460481824|FG001|Overall Study|Lost to Follow-up|0|||
127962163|NCT03504397|460481823|FG000|Overall Study|Death|14|||
127962164|NCT03504397|460481824|FG001|Overall Study|Death|16|||
127962165|NCT03504397|460481823|FG000|Overall Study|Adverse Event|40|||
127962166|NCT03504397|460481824|FG001|Overall Study|Adverse Event|14|||
127962167|NCT03504397|460481823|FG000|Overall Study|miscellaneous|17|||
127962168|NCT03504397|460481824|FG001|Overall Study|miscellaneous|15|||
127962169|NCT03504397|460481823|FG000|Overall Study|Protocol deviation|1|||
127962170|NCT03504397|460481824|FG001|Overall Study|Protocol deviation|0|||
127962171|NCT03504397|460481823|FG000|Overall Study|Participants who did not take the study drug|4|||
127962172|NCT03504397|460481824|FG001|Overall Study|Participants who did not take the study drug|4|||
127962173|NCT01662635|460481825|FG000|Overall Study|scarce samples for evaluation|30|||
127962174|NCT02445248|460481826|FG000|Overall Study|Death|45|||
127962175|NCT02445248|460481827|FG001|Overall Study|Death|12|||
127962176|NCT02445248|460481826|FG000|Overall Study|Progressive disease|13|||
127962177|NCT02445248|460481827|FG001|Overall Study|Progressive disease|1|||
127962178|NCT02445248|460481826|FG000|Overall Study|Subject decision|8|||
127962179|NCT02445248|460481827|FG001|Overall Study|Subject decision|0|||
127962180|NCT02445248|460481826|FG000|Overall Study|Physician Decision|5|||
127962181|NCT02445248|460481827|FG001|Overall Study|Physician Decision|0|||
127962182|NCT02445248|460481826|FG000|Overall Study|Adverse Event|1|||
127962183|NCT02445248|460481827|FG001|Overall Study|Adverse Event|0|||
127962184|NCT02445248|460481826|FG000|Overall Study|Lost to Follow-up|1|||
127962185|NCT02445248|460481827|FG001|Overall Study|Lost to Follow-up|0|||
127962186|NCT02596971|460481828|FG000|Overall Study|Death|5|||
127962187|NCT02596971|460481829|FG001|Overall Study|Death|1|||
127962188|NCT02596971|460481830|FG002|Overall Study|Death|5|||
127962189|NCT02596971|460481828|FG000|Overall Study|Withdrawal by Subject|5|||
127962190|NCT02596971|460481829|FG001|Overall Study|Withdrawal by Subject|1|||
127962191|NCT02596971|460481830|FG002|Overall Study|Withdrawal by Subject|4|||
127962192|NCT00595920|460481831|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
127962193|NCT00351468|460481832|FG000|Overall Study|Adverse Event|42|||
127962194|NCT00351468|460481832|FG000|Overall Study|Withdrawal by Subject|39|||
127962195|NCT00351468|460481832|FG000|Overall Study|Various -follow up w clinical team|39|||
127962196|NCT00351468|460481832|FG000|Overall Study|Lack of Efficacy|32|||
127962197|NCT00351468|460481832|FG000|Overall Study|Non-compliance|8|||
127962198|NCT00351468|460481832|FG000|Overall Study|Lost to Follow-up|4|||
127962199|NCT00351468|460481832|FG000|Overall Study|Protocol Violation|3|||
127962200|NCT00611923|460481833|FG000|Overall Study|Withdrawal by Subject|2|||
127962201|NCT00611923|460481834|FG001|Overall Study|Withdrawal by Subject|2|||
127962202|NCT03588910|460481835|FG000|Overall Study|Withdrawal by Subject|1|||
127962203|NCT03588910|460481836|FG001|Overall Study|Withdrawal by Subject|0|||
127962204|NCT03588910|460481835|FG000|Overall Study|Allergy|2|||
127962205|NCT03588910|460481836|FG001|Overall Study|Allergy|0|||
127962206|NCT03588910|460481835|FG000|Overall Study|Protocol Violation|0|||
127962207|NCT03588910|460481836|FG001|Overall Study|Protocol Violation|3|||
127962208|NCT03588910|460481835|FG000|Overall Study|Did not complete Day 1 Survey|5|||
127962209|NCT03588910|460481836|FG001|Overall Study|Did not complete Day 1 Survey|10|||
127962210|NCT03588910|460481835|FG000|Overall Study|Did not complete Day 7 Survey|5|||
127962211|NCT03588910|460481836|FG001|Overall Study|Did not complete Day 7 Survey|2|||
127962212|NCT00838903|460481837|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
127962213|NCT00838903|460481838|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
127962214|NCT00838903|460481839|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
127962215|NCT00838903|460481840|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
127962216|NCT00838903|460481837|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
127962217|NCT00838903|460481838|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
127962218|NCT00838903|460481839|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
127962219|NCT00838903|460481840|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
127962220|NCT00838903|460481837|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
127962221|NCT00838903|460481838|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
127962222|NCT00838903|460481839|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
127962223|NCT00838903|460481840|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
127962224|NCT00838903|460481837|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
127962225|NCT00838903|460481838|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
127962226|NCT00838903|460481839|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
127962227|NCT00838903|460481840|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
127962228|NCT00838903|460481837|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
127962229|NCT00838903|460481838|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
127962230|NCT00838903|460481839|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
127962231|NCT00838903|460481840|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
127962232|NCT00838903|460481837|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
127962233|NCT00838903|460481838|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
127962234|NCT00838903|460481839|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
127962235|NCT00838903|460481840|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
127962236|NCT00838903|460481837|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
127962237|NCT00838903|460481838|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
127962238|NCT00838903|460481839|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
127962239|NCT00838903|460481840|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
127962240|NCT00838903|460481837|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
127962241|NCT00838903|460481838|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
127962242|NCT00838903|460481839|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
127962243|NCT00838903|460481840|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
127962244|NCT00838903|460481837|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
127962245|NCT00838903|460481838|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
127962246|NCT00838903|460481839|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
127962247|NCT00838903|460481840|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
127962248|NCT00838903|460481837|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
127962249|NCT00838903|460481838|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
127962250|NCT00838903|460481839|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
127962251|NCT00838903|460481840|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
127962252|NCT00838903|460481837|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
127962253|NCT00838903|460481838|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
127962254|NCT00838903|460481839|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
127962255|NCT00838903|460481840|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
127962256|NCT00838903|460481837|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
127962257|NCT00838903|460481838|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
127962258|NCT00838903|460481839|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
127962259|NCT00838903|460481840|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
127962260|NCT00838903|460481837|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
127962261|NCT00838903|460481838|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
127962262|NCT00838903|460481839|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
127962263|NCT00838903|460481840|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
127962264|NCT00838903|460481837|FG000|Treatment Period (156 Weeks)|Site closed|0|||
127962265|NCT00838903|460481838|FG001|Treatment Period (156 Weeks)|Site closed|0|||
127962266|NCT00838903|460481839|FG002|Treatment Period (156 Weeks)|Site closed|1|||
127962267|NCT00838903|460481840|FG003|Treatment Period (156 Weeks)|Site closed|0|||
127962268|NCT00838903|460481837|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
127962269|NCT00838903|460481838|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
127962270|NCT00838903|460481839|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
127962271|NCT00838903|460481840|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
127962272|NCT00838903|460481837|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
127962273|NCT00838903|460481838|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
127962274|NCT00838903|460481839|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
127962275|NCT00838903|460481840|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
127962276|NCT00838903|460481837|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
127962277|NCT00838903|460481838|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
127962278|NCT00838903|460481839|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
127962279|NCT00838903|460481840|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
127962280|NCT00838903|460481837|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
127962281|NCT00838903|460481838|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
127962282|NCT00838903|460481839|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
127962283|NCT00838903|460481840|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
127962284|NCT00838903|460481837|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
127962285|NCT00838903|460481838|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
127962286|NCT00838903|460481839|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
127962287|NCT00838903|460481840|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
127962288|NCT00838903|460481837|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
127962289|NCT00838903|460481838|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
127962290|NCT00838903|460481839|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
127962291|NCT00838903|460481840|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
127962292|NCT00838903|460481837|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
127962293|NCT00838903|460481838|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
127962294|NCT00838903|460481839|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
127962295|NCT00838903|460481840|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
127962296|NCT00838903|460481837|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
127962297|NCT00838903|460481838|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
127962298|NCT00838903|460481839|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
127962299|NCT00838903|460481840|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
127962300|NCT00838903|460481837|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
127962301|NCT00838903|460481838|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
127962302|NCT00838903|460481839|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
127962303|NCT00838903|460481840|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
127962304|NCT00838903|460481837|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
127962305|NCT00838903|460481838|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
127962306|NCT00838903|460481839|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
127962307|NCT00838903|460481840|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
127962308|NCT00838903|460481837|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
127962309|NCT00838903|460481838|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
127962310|NCT00838903|460481839|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
127962311|NCT00838903|460481840|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
127962312|NCT00838903|460481837|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
127962313|NCT00838903|460481838|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
127962314|NCT00838903|460481839|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
127962315|NCT00838903|460481840|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
127962316|NCT00838903|460481837|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
127962317|NCT00838903|460481838|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
127962318|NCT00838903|460481839|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
127962319|NCT00838903|460481840|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
127962320|NCT00838903|460481837|FG000|Follow-up Period (8 Weeks)|Missing|1|||
127962321|NCT00838903|460481838|FG001|Follow-up Period (8 Weeks)|Missing|2|||
127962322|NCT00838903|460481839|FG002|Follow-up Period (8 Weeks)|Missing|1|||
127962323|NCT00838903|460481840|FG003|Follow-up Period (8 Weeks)|Missing|1|||
127962324|NCT04565145|460481841|FG000|Overall Study|Withdrawal by Subject|1|||
127962325|NCT04565145|460481842|FG001|Overall Study|Withdrawal by Subject|1|||
127962326|NCT00683618|460481843|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
127962327|NCT00683618|460481844|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
127962328|NCT00683618|460481845|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
127962329|NCT00683618|460481843|FG000|Randomised Treatment Period|Protocol Violation|0|||
127962330|NCT00683618|460481844|FG001|Randomised Treatment Period|Protocol Violation|1|||
127962331|NCT00683618|460481845|FG002|Randomised Treatment Period|Protocol Violation|0|||
127962332|NCT00683618|460481843|FG000|Randomised Treatment Period|Adverse Event|2|||
127962333|NCT00683618|460481844|FG001|Randomised Treatment Period|Adverse Event|0|||
127962334|NCT00683618|460481845|FG002|Randomised Treatment Period|Adverse Event|2|||
127962335|NCT00683618|460481843|FG000|Randomised Treatment Period|Reason not provided|0|||
127962336|NCT00683618|460481844|FG001|Randomised Treatment Period|Reason not provided|0|||
127962337|NCT00683618|460481845|FG002|Randomised Treatment Period|Reason not provided|2|||
127962338|NCT00683618|460481843|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
127962339|NCT00683618|460481844|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
127962340|NCT00683618|460481845|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
127962341|NCT00683618|460481843|FG000|Extension Treatment Period|Adverse Event|1|||
127962342|NCT00683618|460481844|FG001|Extension Treatment Period|Adverse Event|0|||
127962343|NCT00683618|460481845|FG002|Extension Treatment Period|Adverse Event|0|||
127962344|NCT00683618|460481843|FG000|Extension Treatment Period|Protocol Violation|1|||
127962345|NCT00683618|460481844|FG001|Extension Treatment Period|Protocol Violation|0|||
127962346|NCT00683618|460481845|FG002|Extension Treatment Period|Protocol Violation|0|||
127962347|NCT04570670|460481846|FG000|Overall Study|Withdrawal by Subject|1|||
127962348|NCT04570670|460481847|FG001|Overall Study|Withdrawal by Subject|0|||
127962349|NCT03003962|460481848|FG000|Overall Study|Withdrawal by Subject|5|||
127962350|NCT03003962|460481849|FG001|Overall Study|Withdrawal by Subject|17|||
127962351|NCT03003962|460481848|FG000|Overall Study|Death|274|||
127962352|NCT03003962|460481849|FG001|Overall Study|Death|277|||
127962353|NCT03003962|460481848|FG000|Overall Study|Participants ongoing at DCO|55|||
127962354|NCT03003962|460481849|FG001|Overall Study|Participants ongoing at DCO|40|||
127962355|NCT03802825|460481850|FG000|Overall Study|Lost to follow-up for intervention|12|||
127962356|NCT03802825|460481851|FG001|Overall Study|Lost to follow-up for intervention|3|||
127962357|NCT03802825|460481850|FG000|Overall Study|Received only 1 component of intervention|0|||
127962358|NCT03802825|460481851|FG001|Overall Study|Received only 1 component of intervention|13|||
127962359|NCT03428152|460481853|FG000|Overall Study|Physician Decision|4|||
127962360|NCT03428152|460481854|FG001|Overall Study|Physician Decision|2|||
127962361|NCT03428152|460481853|FG000|Overall Study|Protocol Violation|3|||
127962362|NCT03428152|460481854|FG001|Overall Study|Protocol Violation|5|||
127962363|NCT03428152|460481853|FG000|Overall Study|Lack of Efficacy|0|||
127962364|NCT03428152|460481854|FG001|Overall Study|Lack of Efficacy|4|||
127962365|NCT02570308|460481855|FG000|Overall Study|Death|1|||
127962366|NCT02570308|460481856|FG001|Overall Study|Death|5|||
127962367|NCT02570308|460481857|FG002|Overall Study|Death|4|||
127962368|NCT02570308|460481858|FG003|Overall Study|Death|4|||
127962369|NCT02570308|460481859|FG004|Overall Study|Death|69|||
127962370|NCT02570308|460481855|FG000|Overall Study|Lost to Follow-up|0|||
127962371|NCT02570308|460481856|FG001|Overall Study|Lost to Follow-up|0|||
127962372|NCT02570308|460481857|FG002|Overall Study|Lost to Follow-up|0|||
127962373|NCT02570308|460481858|FG003|Overall Study|Lost to Follow-up|0|||
127962374|NCT02570308|460481859|FG004|Overall Study|Lost to Follow-up|2|||
127962375|NCT02570308|460481855|FG000|Overall Study|Withdrawal by Subject|0|||
127962376|NCT02570308|460481856|FG001|Overall Study|Withdrawal by Subject|0|||
127962377|NCT02570308|460481857|FG002|Overall Study|Withdrawal by Subject|0|||
127962378|NCT02570308|460481858|FG003|Overall Study|Withdrawal by Subject|0|||
127962379|NCT02570308|460481859|FG004|Overall Study|Withdrawal by Subject|1|||
127962380|NCT02570308|460481855|FG000|Overall Study|Other|0|||
127962381|NCT02570308|460481856|FG001|Overall Study|Other|0|||
127962382|NCT02570308|460481857|FG002|Overall Study|Other|0|||
127962383|NCT02570308|460481858|FG003|Overall Study|Other|0|||
127962384|NCT02570308|460481859|FG004|Overall Study|Other|2|||
127962385|NCT04242498|460481860|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
127962386|NCT04242498|460481861|FG001|Initial Treatment Period: Week 0-16|Adverse Event|1|||
127962387|NCT04242498|460481862|FG002|Initial Treatment Period: Week 0-16|Adverse Event|9|||
127962388|NCT04242498|460481863|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
127962389|NCT04242498|460481864|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
127962390|NCT04242498|460481865|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
127962391|NCT04242498|460481866|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
127962392|NCT04242498|460481860|FG000|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
127962393|NCT04242498|460481861|FG001|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
127962394|NCT04242498|460481862|FG002|Initial Treatment Period: Week 0-16|Lack of Efficacy|1|||
127962395|NCT04242498|460481863|FG003|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
127962396|NCT04242498|460481864|FG004|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
127962397|NCT04242498|460481865|FG005|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
127962398|NCT04242498|460481866|FG006|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
127962399|NCT04242498|460481860|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
127962400|NCT04242498|460481861|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
127962401|NCT04242498|460481862|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
127962402|NCT04242498|460481863|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
127962403|NCT04242498|460481864|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
127962404|NCT04242498|460481865|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
127962405|NCT04242498|460481866|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
127962406|NCT04242498|460481860|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
127962407|NCT04242498|460481861|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
127962408|NCT04242498|460481862|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
127962409|NCT04242498|460481863|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
127962410|NCT04242498|460481864|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
127962411|NCT04242498|460481865|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
127962412|NCT04242498|460481866|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
127962413|NCT04242498|460481860|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|2|||
127962414|NCT04242498|460481861|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|8|||
127962415|NCT04242498|460481862|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|12|||
127962416|NCT04242498|460481863|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
127962417|NCT04242498|460481864|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
127962418|NCT04242498|460481865|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
127962419|NCT04242498|460481866|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
127962420|NCT04242498|460481860|FG000|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
127962421|NCT04242498|460481861|FG001|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
127962422|NCT04242498|460481862|FG002|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|1|||
127962423|NCT04242498|460481863|FG003|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
127962424|NCT04242498|460481864|FG004|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
127962425|NCT04242498|460481865|FG005|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
127962426|NCT04242498|460481866|FG006|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
127962427|NCT04242498|460481860|FG000|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
127962428|NCT04242498|460481861|FG001|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
127962429|NCT04242498|460481862|FG002|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|1|||
127962430|NCT04242498|460481863|FG003|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
127962431|NCT04242498|460481864|FG004|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
127962432|NCT04242498|460481865|FG005|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
127962433|NCT04242498|460481866|FG006|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
127962434|NCT04242498|460481860|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
127962435|NCT04242498|460481861|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|2|||
127962436|NCT04242498|460481862|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
127962437|NCT04242498|460481863|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
127962438|NCT04242498|460481864|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
127962439|NCT04242498|460481865|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
127962440|NCT04242498|460481866|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
127962441|NCT04242498|460481860|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
127962442|NCT04242498|460481861|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
127962443|NCT04242498|460481862|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
127962444|NCT04242498|460481863|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
127962445|NCT04242498|460481864|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
127962446|NCT04242498|460481865|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
127962447|NCT04242498|460481866|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|4|||
127962448|NCT04242498|460481860|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
127962449|NCT04242498|460481861|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
127962450|NCT04242498|460481862|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
127962451|NCT04242498|460481863|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
127962452|NCT04242498|460481864|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|4|||
127962453|NCT04242498|460481865|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
127962454|NCT04242498|460481866|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
127962455|NCT04242498|460481860|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
127962456|NCT04242498|460481861|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
127962457|NCT04242498|460481862|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
127962458|NCT04242498|460481863|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
127962459|NCT04242498|460481864|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
127962460|NCT04242498|460481865|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
127962461|NCT04242498|460481866|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
127962462|NCT04242498|460481860|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
127962463|NCT04242498|460481861|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
127962464|NCT04242498|460481862|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
127962465|NCT04242498|460481863|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
127962466|NCT04242498|460481864|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
127962467|NCT04242498|460481865|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|1|||
127962468|NCT04242498|460481866|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
127962469|NCT04242498|460481860|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
127962470|NCT04242498|460481861|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
127962471|NCT04242498|460481862|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
127962472|NCT04242498|460481863|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|6|||
127962473|NCT04242498|460481864|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|9|||
127962474|NCT04242498|460481865|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|10|||
127962475|NCT04242498|460481866|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
127962476|NCT04242498|460481860|FG000|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
127962477|NCT04242498|460481861|FG001|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
127962478|NCT04242498|460481862|FG002|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
127962479|NCT04242498|460481863|FG003|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
127962480|NCT04242498|460481864|FG004|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|1|||
127962481|NCT04242498|460481865|FG005|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
127962482|NCT04242498|460481866|FG006|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
127962483|NCT04242498|460481860|FG000|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
127962484|NCT04242498|460481861|FG001|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
127962485|NCT04242498|460481862|FG002|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
127962486|NCT04242498|460481863|FG003|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
127962487|NCT04242498|460481864|FG004|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
127962488|NCT04242498|460481865|FG005|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|1|||
127962489|NCT04242498|460481866|FG006|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
127962490|NCT04242498|460481860|FG000|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
127962491|NCT04242498|460481861|FG001|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
127962492|NCT04242498|460481862|FG002|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
127962493|NCT04242498|460481863|FG003|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
127962494|NCT04242498|460481864|FG004|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
127962495|NCT04242498|460481865|FG005|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
127962496|NCT04242498|460481866|FG006|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
127962497|NCT01108718|460481867|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
127962498|NCT01108718|460481868|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
127962499|NCT03380429|460481869|FG000|Overall Study|Physician Decision|0|||
127962500|NCT03380429|460481870|FG001|Overall Study|Physician Decision|1|||
127962501|NCT03380429|460481871|FG002|Overall Study|Physician Decision|0|||
127962502|NCT03380429|460481872|FG003|Overall Study|Physician Decision|1|||
127962503|NCT03380429|460481873|FG004|Overall Study|Physician Decision|1|||
127962504|NCT03380429|460481869|FG000|Overall Study|Withdrawal by Subject|3|||
127962505|NCT03380429|460481870|FG001|Overall Study|Withdrawal by Subject|3|||
127962506|NCT03380429|460481871|FG002|Overall Study|Withdrawal by Subject|5|||
127962507|NCT03380429|460481872|FG003|Overall Study|Withdrawal by Subject|2|||
127962508|NCT03380429|460481873|FG004|Overall Study|Withdrawal by Subject|1|||
127962509|NCT03380429|460481869|FG000|Overall Study|Lost to Follow-up|0|||
127962510|NCT03380429|460481870|FG001|Overall Study|Lost to Follow-up|2|||
127962511|NCT03380429|460481871|FG002|Overall Study|Lost to Follow-up|4|||
127962512|NCT03380429|460481872|FG003|Overall Study|Lost to Follow-up|3|||
127962513|NCT03380429|460481873|FG004|Overall Study|Lost to Follow-up|1|||
127962514|NCT03380429|460481869|FG000|Overall Study|Protocol Violation|1|||
127962515|NCT03380429|460481870|FG001|Overall Study|Protocol Violation|0|||
127962516|NCT03380429|460481871|FG002|Overall Study|Protocol Violation|1|||
127962517|NCT03380429|460481872|FG003|Overall Study|Protocol Violation|0|||
127962518|NCT03380429|460481873|FG004|Overall Study|Protocol Violation|1|||
127962519|NCT03380429|460481869|FG000|Overall Study|Lack of Efficacy|0|||
127962520|NCT03380429|460481870|FG001|Overall Study|Lack of Efficacy|0|||
127962521|NCT03380429|460481871|FG002|Overall Study|Lack of Efficacy|0|||
127962522|NCT03380429|460481872|FG003|Overall Study|Lack of Efficacy|2|||
127962523|NCT03380429|460481873|FG004|Overall Study|Lack of Efficacy|1|||
127962524|NCT03380429|460481869|FG000|Overall Study|Adverse Event|1|||
127962525|NCT03380429|460481870|FG001|Overall Study|Adverse Event|1|||
127962526|NCT03380429|460481871|FG002|Overall Study|Adverse Event|1|||
127962527|NCT03380429|460481872|FG003|Overall Study|Adverse Event|2|||
127962528|NCT03380429|460481873|FG004|Overall Study|Adverse Event|0|||
127962529|NCT01827111|460481876|FG000|Overall Study|Disease Progression|1|||
127962530|NCT02169271|460481877|FG000|Overall Study|Protocol Violation|1|||
127962531|NCT02169271|460481878|FG001|Overall Study|Protocol Violation|2|||
127962532|NCT00226499|460481882|FG000|Overall Study|Adverse Event|10|||
127962533|NCT00226499|460481883|FG001|Overall Study|Adverse Event|6|||
127962534|NCT00226499|460481884|FG002|Overall Study|Adverse Event|3|||
127962535|NCT00226499|460481882|FG000|Overall Study|Others|1064|||
127962536|NCT00226499|460481883|FG001|Overall Study|Others|1066|||
127962537|NCT00226499|460481884|FG002|Overall Study|Others|356|||
127962538|NCT00946920|460481885|FG000|Overall Study|Withdrawal by Subject|28|||
127962539|NCT00946920|460481886|FG001|Overall Study|Withdrawal by Subject|15|||
127962540|NCT00946920|460481885|FG000|Overall Study|Lost to Follow-up|2|||
127962541|NCT00946920|460481886|FG001|Overall Study|Lost to Follow-up|2|||
127962542|NCT00946920|460481885|FG000|Overall Study|Physician Decision|5|||
127962543|NCT00946920|460481886|FG001|Overall Study|Physician Decision|2|||
127962544|NCT00946920|460481885|FG000|Overall Study|Adverse Event|41|||
127962545|NCT00946920|460481886|FG001|Overall Study|Adverse Event|14|||
127962546|NCT00946920|460481885|FG000|Overall Study|Protocol Violation|16|||
127962547|NCT00946920|460481886|FG001|Overall Study|Protocol Violation|8|||
127962548|NCT00946920|460481885|FG000|Overall Study|Miscellaneous reasons|18|||
127962549|NCT00946920|460481886|FG001|Overall Study|Miscellaneous reasons|3|||
127962550|NCT01597973|460481889|FG000|Overall Study|Found ineligible before study medication started|4|||
127962551|NCT01597973|460481890|FG001|Overall Study|Found ineligible before study medication started|2|||
127962552|NCT01597973|460481889|FG000|Overall Study|Eligible pathogen not confirmed|14|||
127962553|NCT01597973|460481890|FG001|Overall Study|Eligible pathogen not confirmed|15|||
127962554|NCT01597973|460481889|FG000|Overall Study|LAR not authorized to consent|0|||
127962555|NCT01597973|460481890|FG001|Overall Study|LAR not authorized to consent|1|||
127962556|NCT01597973|460481889|FG000|Overall Study|Ineligible due to early seizures|1|||
127962557|NCT01597973|460481890|FG001|Overall Study|Ineligible due to early seizures|0|||
127962558|NCT01597973|460481889|FG000|Overall Study|Ineligible due to non-target infection|1|||
127962559|NCT01597973|460481890|FG001|Overall Study|Ineligible due to non-target infection|1|||
127962560|NCT02174627|460481897|FG000|Overall Study|Missing|0|||
127962561|NCT02174627|460481898|FG001|Overall Study|Missing|1|||
127962562|NCT02174627|460481897|FG000|Overall Study|Incorrect enrolment before randomization|0|||
127962563|NCT02174627|460481898|FG001|Overall Study|Incorrect enrolment before randomization|1|||
127962564|NCT02174627|460481897|FG000|Overall Study|Participant decision|84|||
127962565|NCT02174627|460481898|FG001|Overall Study|Participant decision|128|||
127962566|NCT04564092|460481899|FG000|Overall Study|Withdrawal by Subject|1|||
127962567|NCT00071110|460481900|FG000|Overall Study|Protocol Violation|0|||
127962568|NCT00071110|460481901|FG001|Overall Study|Protocol Violation|4|||
127962569|NCT02259010|460481907|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
127962570|NCT02389829|460481910|FG000|Overall Study|Lost to Follow-up|0|||
127962571|NCT02389829|460481911|FG001|Overall Study|Lost to Follow-up|1|||
127962572|NCT02362360|460481912|FG000|Period 1|Lack of Efficacy|1|||
127962573|NCT02362360|460481913|FG001|Period 1|Lack of Efficacy|0|||
127962574|NCT02362360|460481912|FG000|Period 1|Withdrawal by Subject|2|||
127962575|NCT02362360|460481913|FG001|Period 1|Withdrawal by Subject|1|||
127962576|NCT03578367|460481916|FG000|Overall Study|Adverse Event|0|||
127962577|NCT03578367|460481917|FG001|Overall Study|Adverse Event|3|||
127962578|NCT03578367|460481918|FG002|Overall Study|Adverse Event|0|||
127962579|NCT03578367|460481919|FG003|Overall Study|Adverse Event|5|||
127962580|NCT03578367|460481916|FG000|Overall Study|Withdrawal by Subject|2|||
127962581|NCT03578367|460481917|FG001|Overall Study|Withdrawal by Subject|2|||
127962582|NCT03578367|460481918|FG002|Overall Study|Withdrawal by Subject|1|||
127962583|NCT03578367|460481919|FG003|Overall Study|Withdrawal by Subject|3|||
127962584|NCT03578367|460481916|FG000|Overall Study|Physician Decision|0|||
127962585|NCT03578367|460481917|FG001|Overall Study|Physician Decision|0|||
127962586|NCT03578367|460481918|FG002|Overall Study|Physician Decision|14|||
127962587|NCT03578367|460481919|FG003|Overall Study|Physician Decision|0|||
127962588|NCT03578367|460481916|FG000|Overall Study|Death|1|||
127962589|NCT03578367|460481917|FG001|Overall Study|Death|0|||
127962590|NCT03578367|460481918|FG002|Overall Study|Death|0|||
127962591|NCT03578367|460481919|FG003|Overall Study|Death|0|||
127962592|NCT03578367|460481916|FG000|Overall Study|Not treated|0|||
127962593|NCT03578367|460481917|FG001|Overall Study|Not treated|0|||
127962594|NCT03578367|460481918|FG002|Overall Study|Not treated|1|||
127962595|NCT03578367|460481919|FG003|Overall Study|Not treated|0|||
127962596|NCT02729025|460481920|FG000|Overall Study|Sponsor Decision|0|||
127962597|NCT02729025|460481921|FG001|Overall Study|Sponsor Decision|1|||
127962598|NCT05966584|460481927|FG000|Overall Study|Lost to Follow-up|1|||
127962599|NCT04242446|460483292|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
127962600|NCT04242446|460483293|FG001|Initial Treatment Period: Week 0-16|Adverse Event|5|||
127962601|NCT04242446|460483294|FG002|Initial Treatment Period: Week 0-16|Adverse Event|7|||
127962602|NCT04242446|460483295|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
127962603|NCT04242446|460483296|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
127962604|NCT04242446|460483297|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
127962605|NCT04242446|460483298|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
127962606|NCT04242446|460483292|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
127962607|NCT04242446|460483293|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
127962608|NCT04242446|460483294|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
127962609|NCT04242446|460483295|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
127962610|NCT04242446|460483296|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
127962611|NCT04242446|460483297|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
127962612|NCT04242446|460483298|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
127962613|NCT04242446|460483292|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
127962614|NCT04242446|460483293|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
127962615|NCT04242446|460483294|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|2|||
127962616|NCT04242446|460483295|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
127962617|NCT04242446|460483296|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
127962618|NCT04242446|460483297|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
127962619|NCT04242446|460483298|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
127962620|NCT04242446|460483292|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|4|||
127962621|NCT04242446|460483293|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|6|||
127962622|NCT04242446|460483294|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|14|||
127962623|NCT04242446|460483295|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
127962624|NCT04242446|460483296|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
127962625|NCT04242446|460483297|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
127962626|NCT04242446|460483298|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
127962627|NCT04242446|460483292|FG000|Initial Treatment Period: Week 0-16|Country Relocation|1|||
127962628|NCT04242446|460483293|FG001|Initial Treatment Period: Week 0-16|Country Relocation|0|||
127962629|NCT04242446|460483294|FG002|Initial Treatment Period: Week 0-16|Country Relocation|0|||
127962630|NCT04242446|460483295|FG003|Initial Treatment Period: Week 0-16|Country Relocation|0|||
127962631|NCT04242446|460483296|FG004|Initial Treatment Period: Week 0-16|Country Relocation|0|||
127962632|NCT04242446|460483297|FG005|Initial Treatment Period: Week 0-16|Country Relocation|0|||
127962633|NCT04242446|460483298|FG006|Initial Treatment Period: Week 0-16|Country Relocation|0|||
127962634|NCT04242446|460483292|FG000|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
127962635|NCT04242446|460483293|FG001|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
127962636|NCT04242446|460483294|FG002|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|1|||
127962637|NCT04242446|460483295|FG003|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
127962638|NCT04242446|460483296|FG004|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
127962639|NCT04242446|460483297|FG005|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
127962640|NCT04242446|460483298|FG006|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
127962641|NCT04242446|460483292|FG000|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
127962642|NCT04242446|460483293|FG001|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
127962643|NCT04242446|460483294|FG002|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|1|||
127962644|NCT04242446|460483295|FG003|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
127962645|NCT04242446|460483296|FG004|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
127962646|NCT04242446|460483297|FG005|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
127962647|NCT04242446|460483298|FG006|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
127962648|NCT04242446|460483292|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
127962649|NCT04242446|460483293|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
127962650|NCT04242446|460483294|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|3|||
127962651|NCT04242446|460483295|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
127962652|NCT04242446|460483296|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
127962653|NCT04242446|460483297|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
127962654|NCT04242446|460483298|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
127962655|NCT04242446|460483292|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
127962656|NCT04242446|460483293|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
127962657|NCT04242446|460483294|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
127962658|NCT04242446|460483295|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|9|||
127962659|NCT04242446|460483296|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
127962660|NCT04242446|460483297|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|5|||
127962661|NCT04242446|460483298|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
127962662|NCT04242446|460483292|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
127962663|NCT04242446|460483293|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
127962664|NCT04242446|460483294|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
127962665|NCT04242446|460483295|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|1|||
127962666|NCT04242446|460483296|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|7|||
127962667|NCT04242446|460483297|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
127962668|NCT04242446|460483298|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
127962669|NCT04242446|460483292|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
127962670|NCT04242446|460483293|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
127962671|NCT04242446|460483294|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
127962672|NCT04242446|460483295|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
127962673|NCT04242446|460483296|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
127962674|NCT04242446|460483297|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
127962675|NCT04242446|460483298|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
127962676|NCT04242446|460483292|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
127962677|NCT04242446|460483293|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
127962678|NCT04242446|460483294|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
127962679|NCT04242446|460483295|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
127962680|NCT04242446|460483296|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|5|||
127962681|NCT04242446|460483297|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
127962682|NCT04242446|460483298|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
127962683|NCT04242446|460483292|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
127962684|NCT04242446|460483293|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
127962685|NCT04242446|460483294|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
127962686|NCT04242446|460483295|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|7|||
127962687|NCT04242446|460483296|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|12|||
127962688|NCT04242446|460483297|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
127962689|NCT04242446|460483298|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|14|||
127962690|NCT04242446|460483292|FG000|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
127962691|NCT04242446|460483293|FG001|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
127962692|NCT04242446|460483294|FG002|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
127962693|NCT04242446|460483295|FG003|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|1|||
127962694|NCT04242446|460483296|FG004|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
127962695|NCT04242446|460483297|FG005|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
127962696|NCT04242446|460483298|FG006|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
127962697|NCT04242446|460483292|FG000|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
127962698|NCT04242446|460483293|FG001|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
127962699|NCT04242446|460483294|FG002|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
127962700|NCT04242446|460483295|FG003|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
127962701|NCT04242446|460483296|FG004|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|1|||
127962702|NCT04242446|460483297|FG005|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
127962703|NCT04242446|460483298|FG006|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
127962704|NCT04242446|460483292|FG000|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
127962705|NCT04242446|460483293|FG001|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
127962706|NCT04242446|460483294|FG002|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
127962707|NCT04242446|460483295|FG003|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
127962708|NCT04242446|460483296|FG004|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|1|||
127962709|NCT04242446|460483297|FG005|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
127962710|NCT04242446|460483298|FG006|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
127962711|NCT04242446|460483292|FG000|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
127962712|NCT04242446|460483293|FG001|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
127962713|NCT04242446|460483294|FG002|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
127962714|NCT04242446|460483295|FG003|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
127962715|NCT04242446|460483296|FG004|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|1|||
127962716|NCT04242446|460483297|FG005|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
127962717|NCT04242446|460483298|FG006|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
127962718|NCT04242446|460483292|FG000|Maintenance Treatment Period: Week 16-48|Relocation|0|||
127962719|NCT04242446|460483293|FG001|Maintenance Treatment Period: Week 16-48|Relocation|0|||
127962720|NCT04242446|460483294|FG002|Maintenance Treatment Period: Week 16-48|Relocation|0|||
127962721|NCT04242446|460483295|FG003|Maintenance Treatment Period: Week 16-48|Relocation|0|||
127962722|NCT04242446|460483296|FG004|Maintenance Treatment Period: Week 16-48|Relocation|1|||
127962723|NCT04242446|460483297|FG005|Maintenance Treatment Period: Week 16-48|Relocation|0|||
127962724|NCT04242446|460483298|FG006|Maintenance Treatment Period: Week 16-48|Relocation|0|||
127962725|NCT04242446|460483292|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
127962726|NCT04242446|460483293|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
127962727|NCT04242446|460483294|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
127962728|NCT04242446|460483295|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
127962729|NCT04242446|460483296|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|1|||
127962730|NCT04242446|460483297|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
127962731|NCT04242446|460483298|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
127962732|NCT04242446|460483292|FG000|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
127962733|NCT04242446|460483293|FG001|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
127962734|NCT04242446|460483294|FG002|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
127962735|NCT04242446|460483295|FG003|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
127962736|NCT04242446|460483296|FG004|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
127962737|NCT04242446|460483297|FG005|Maintenance Treatment Period: Week 16-48|Patient Move Away|1|||
127962738|NCT04242446|460483298|FG006|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
127962739|NCT04242446|460483292|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
127962740|NCT04242446|460483293|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
127962741|NCT04242446|460483294|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
127962742|NCT04242446|460483295|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
127962743|NCT04242446|460483296|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
127962744|NCT04242446|460483297|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|1|||
127962745|NCT04242446|460483298|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
127962746|NCT04242446|460483292|FG000|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
127962747|NCT04242446|460483293|FG001|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
127962748|NCT04242446|460483294|FG002|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
127962749|NCT04242446|460483295|FG003|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
127962750|NCT04242446|460483296|FG004|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
127962751|NCT04242446|460483297|FG005|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
127962752|NCT04242446|460483298|FG006|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|1|||
127962753|NCT04242446|460483292|FG000|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
127962754|NCT04242446|460483293|FG001|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
127962755|NCT04242446|460483294|FG002|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
127962756|NCT04242446|460483295|FG003|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
127962757|NCT04242446|460483296|FG004|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
127962758|NCT04242446|460483297|FG005|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
127962759|NCT04242446|460483298|FG006|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|1|||
127962760|NCT04242446|460483292|FG000|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
127962761|NCT04242446|460483293|FG001|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
127962762|NCT04242446|460483294|FG002|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
127962763|NCT04242446|460483295|FG003|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
127962764|NCT04242446|460483296|FG004|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
127962765|NCT04242446|460483297|FG005|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
127962766|NCT04242446|460483298|FG006|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|1|||
127962767|NCT00485732|460483302|FG000|Overall Study|Protocol Violation|1|||
127962768|NCT00485732|460483303|FG001|Overall Study|Protocol Violation|3|||
127962769|NCT00485732|460483302|FG000|Overall Study|Withdrawal by Subject|5|||
127962770|NCT00485732|460483303|FG001|Overall Study|Withdrawal by Subject|4|||
127962771|NCT00485732|460483302|FG000|Overall Study|Lost to Follow-up|2|||
127962772|NCT00485732|460483303|FG001|Overall Study|Lost to Follow-up|2|||
127962773|NCT00803790|460483304|FG000|Period 1|Adverse Event|0|||
127962774|NCT00803790|460483305|FG001|Period 1|Adverse Event|1|||
127962775|NCT00803790|460483306|FG002|Period 1|Adverse Event|0|||
127962776|NCT00803790|460483307|FG003|Period 1|Adverse Event|0|||
127962777|NCT00803790|460483304|FG000|Period 1|Lost to Follow-up|1|||
127962778|NCT00803790|460483305|FG001|Period 1|Lost to Follow-up|2|||
127962779|NCT00803790|460483306|FG002|Period 1|Lost to Follow-up|0|||
127962780|NCT00803790|460483307|FG003|Period 1|Lost to Follow-up|0|||
127962781|NCT00803790|460483304|FG000|Period 1|Withdrawal by Subject|8|||
127962782|NCT00803790|460483305|FG001|Period 1|Withdrawal by Subject|6|||
127962783|NCT00803790|460483306|FG002|Period 1|Withdrawal by Subject|0|||
127962784|NCT00803790|460483307|FG003|Period 1|Withdrawal by Subject|0|||
127962785|NCT00803790|460483304|FG000|Period 1|positive drug screen or personal reasons|0|||
127962786|NCT00803790|460483305|FG001|Period 1|positive drug screen or personal reasons|3|||
127962787|NCT00803790|460483306|FG002|Period 1|positive drug screen or personal reasons|0|||
127962788|NCT00803790|460483307|FG003|Period 1|positive drug screen or personal reasons|4|||
127962789|NCT00803790|460483304|FG000|Period 1|Protocol Violation|0|||
127962790|NCT00803790|460483305|FG001|Period 1|Protocol Violation|0|||
127962791|NCT00803790|460483306|FG002|Period 1|Protocol Violation|1|||
127962792|NCT00803790|460483307|FG003|Period 1|Protocol Violation|0|||
127962793|NCT00803790|460483304|FG000|Period 2|Adverse Event|0|||
127962794|NCT00803790|460483305|FG001|Period 2|Adverse Event|0|||
127962795|NCT00803790|460483306|FG002|Period 2|Adverse Event|1|||
127962796|NCT00803790|460483307|FG003|Period 2|Adverse Event|1|||
127962797|NCT00803790|460483304|FG000|Period 2|Withdrawal by Subject|1|||
127962798|NCT00803790|460483305|FG001|Period 2|Withdrawal by Subject|0|||
127962799|NCT00803790|460483306|FG002|Period 2|Withdrawal by Subject|0|||
127962800|NCT00803790|460483307|FG003|Period 2|Withdrawal by Subject|0|||
127962801|NCT00803790|460483304|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
127962802|NCT00803790|460483305|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
127962803|NCT00803790|460483306|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
127962804|NCT00803790|460483307|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
127962805|NCT03985800|460483308|FG000|Overall Study|Death|1|||
127962806|NCT03985800|460483309|FG001|Overall Study|Death|2|||
127962807|NCT03985800|460483308|FG000|Overall Study|Withdrawal by Subject|3|||
127962808|NCT03985800|460483309|FG001|Overall Study|Withdrawal by Subject|6|||
127962809|NCT03985800|460483308|FG000|Overall Study|Protocol Violation|2|||
127962810|NCT03985800|460483309|FG001|Overall Study|Protocol Violation|0|||
127962811|NCT04815083|460483310|FG000|Overall Study|Physician Decision|1|||
127962812|NCT04815083|460483310|FG000|Overall Study|Study pause|2|||
127962813|NCT04815083|460483310|FG000|Overall Study|Screening failure|4|||
127962814|NCT04281485|460483311|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
127962815|NCT04281485|460483312|FG001|Overall Study|No Longer Met Eligibility Criteria|2|||
127962816|NCT04281485|460483311|FG000|Overall Study|Ongoing (Safety data collection)|10|||
127962817|NCT04281485|460483312|FG001|Overall Study|Ongoing (Safety data collection)|5|||
127962818|NCT03096314|460483315|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
127962819|NCT03096314|460483316|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
127962820|NCT04335123|460483318|FG000|Overall Study|Withdrawal by Subject|2|||
127962821|NCT04335123|460483319|FG001|Overall Study|Withdrawal by Subject|0|||
127962822|NCT04335123|460483318|FG000|Overall Study|Physician Decision|2|||
127962823|NCT04335123|460483319|FG001|Overall Study|Physician Decision|0|||
127962824|NCT01293695|460483335|FG000|Overall Study|Withdrawal by Subject|7|||
127962825|NCT01293695|460483336|FG001|Overall Study|Withdrawal by Subject|1|||
127962826|NCT01293695|460483335|FG000|Overall Study|Lost to Follow-up|8|||
127962827|NCT01293695|460483336|FG001|Overall Study|Lost to Follow-up|6|||
127962828|NCT00957801|460483337|FG000|Overall Study|Withdrawal by Subject|0|||
127962829|NCT00957801|460483338|FG001|Overall Study|Withdrawal by Subject|0|||
127962830|NCT00957801|460483339|FG002|Overall Study|Withdrawal by Subject|0|||
127962831|NCT00957801|460483340|FG003|Overall Study|Withdrawal by Subject|1|||
127962832|NCT01283464|460483341|FG000|Overall Study|Lost to Follow-up|0|||
127962833|NCT01283464|460483342|FG001|Overall Study|Lost to Follow-up|1|||
127962834|NCT01283464|460483341|FG000|Overall Study|Withdrawal by Subject|1|||
127962835|NCT01283464|460483342|FG001|Overall Study|Withdrawal by Subject|0|||
127962836|NCT01283464|460483341|FG000|Overall Study|Physician Decision|1|||
127962837|NCT01283464|460483342|FG001|Overall Study|Physician Decision|0|||
127962838|NCT02626026|460483343|FG000|Overall Study|Randomized but Never Treated|0|||
127962839|NCT02626026|460483344|FG001|Overall Study|Randomized but Never Treated|0|||
127962840|NCT02626026|460483345|FG002|Overall Study|Randomized but Never Treated|0|||
127962841|NCT02626026|460483346|FG003|Overall Study|Randomized but Never Treated|0|||
127962842|NCT02626026|460483347|FG004|Overall Study|Randomized but Never Treated|1|||
127962843|NCT02626026|460483348|FG005|Overall Study|Randomized but Never Treated|0|||
127962844|NCT01778855|460483349|FG000|Overall Study|Death|0|||
127962845|NCT01778855|460483350|FG001|Overall Study|Death|1|||
127962846|NCT00191477|460483351|FG000|Overall Study|Tumor Recurrence|49|||
127962847|NCT00191477|460483352|FG001|Overall Study|Tumor Recurrence|48|||
127962848|NCT00191477|460483351|FG000|Overall Study|Death, Study Disease|1|||
127962849|NCT00191477|460483352|FG001|Overall Study|Death, Study Disease|1|||
127962850|NCT00191477|460483351|FG000|Overall Study|Death, Other Cause|3|||
127962851|NCT00191477|460483352|FG001|Overall Study|Death, Other Cause|6|||
127962852|NCT00191477|460483351|FG000|Overall Study|Lost to Follow-up|23|||
127962853|NCT00191477|460483352|FG001|Overall Study|Lost to Follow-up|21|||
127962854|NCT00191477|460483351|FG000|Overall Study|Protocol Violation|1|||
127962855|NCT00191477|460483352|FG001|Overall Study|Protocol Violation|1|||
127962856|NCT00191477|460483351|FG000|Overall Study|Treatment Change|2|||
127962857|NCT00191477|460483352|FG001|Overall Study|Treatment Change|0|||
127962858|NCT00191477|460483351|FG000|Overall Study|Withdrawal by Subject|2|||
127962859|NCT00191477|460483352|FG001|Overall Study|Withdrawal by Subject|0|||
127962860|NCT00191477|460483351|FG000|Overall Study|Other|2|||
127962861|NCT00191477|460483352|FG001|Overall Study|Other|0|||
127962862|NCT00191477|460483351|FG000|Overall Study|Not Eligible|41|||
127962863|NCT00191477|460483352|FG001|Overall Study|Not Eligible|38|||
127962864|NCT00191477|460483351|FG000|Overall Study|Pathological Specimen Lost|1|||
127962865|NCT00191477|460483352|FG001|Overall Study|Pathological Specimen Lost|0|||
127962866|NCT00191477|460483351|FG000|Overall Study|Discontinued Prior to Instillation|13|||
127962867|NCT00191477|460483352|FG001|Overall Study|Discontinued Prior to Instillation|14|||
127962868|NCT01286467|460483357|FG000|Overall Study|Death|1|||
127962869|NCT01286467|460483358|FG001|Overall Study|Death|1|||
127962870|NCT01286467|460483359|FG002|Overall Study|Death|1|||
127962871|NCT01286467|460483360|FG003|Overall Study|Death|0|||
127962872|NCT01286467|460483357|FG000|Overall Study|Lost to Follow-up|0|||
127962873|NCT01286467|460483358|FG001|Overall Study|Lost to Follow-up|0|||
127962874|NCT01286467|460483359|FG002|Overall Study|Lost to Follow-up|0|||
127962875|NCT01286467|460483360|FG003|Overall Study|Lost to Follow-up|1|||
127962876|NCT01286467|460483357|FG000|Overall Study|Withdrawal by Subject|0|||
127962877|NCT01286467|460483358|FG001|Overall Study|Withdrawal by Subject|0|||
127962878|NCT01286467|460483359|FG002|Overall Study|Withdrawal by Subject|1|||
127962879|NCT01286467|460483360|FG003|Overall Study|Withdrawal by Subject|0|||
127962880|NCT01286467|460483357|FG000|Overall Study|Physician Decision|0|||
127962881|NCT01286467|460483358|FG001|Overall Study|Physician Decision|0|||
127962882|NCT01286467|460483359|FG002|Overall Study|Physician Decision|0|||
127962883|NCT01286467|460483360|FG003|Overall Study|Physician Decision|1|||
127962884|NCT01286467|460483357|FG000|Overall Study|Disease progression|3|||
127962885|NCT01286467|460483358|FG001|Overall Study|Disease progression|2|||
127962886|NCT01286467|460483359|FG002|Overall Study|Disease progression|2|||
127962887|NCT01286467|460483360|FG003|Overall Study|Disease progression|3|||
127962888|NCT01286467|460483357|FG000|Overall Study|Adverse Event|0|||
127962889|NCT01286467|460483358|FG001|Overall Study|Adverse Event|1|||
127962890|NCT01286467|460483359|FG002|Overall Study|Adverse Event|2|||
127962891|NCT01286467|460483360|FG003|Overall Study|Adverse Event|3|||
127962892|NCT01286467|460483357|FG000|Overall Study|Study drug stop longer than 14 days|0|||
127962893|NCT01286467|460483358|FG001|Overall Study|Study drug stop longer than 14 days|0|||
127962894|NCT01286467|460483359|FG002|Overall Study|Study drug stop longer than 14 days|1|||
127962895|NCT01286467|460483360|FG003|Overall Study|Study drug stop longer than 14 days|0|||
127962896|NCT01058642|460483361|FG000|Treatment Period 1|Adverse Event|0|||
127962897|NCT01058642|460483362|FG001|Treatment Period 1|Adverse Event|1|||
127962898|NCT01058642|460483363|FG002|Treatment Period 1|Adverse Event|1|||
127962899|NCT01058642|460483364|FG003|Treatment Period 1|Adverse Event|0|||
127962900|NCT01058642|460483361|FG000|Treatment Period 1|Physician Decision|0|||
127962901|NCT01058642|460483362|FG001|Treatment Period 1|Physician Decision|0|||
127962902|NCT01058642|460483363|FG002|Treatment Period 1|Physician Decision|1|||
127962903|NCT01058642|460483364|FG003|Treatment Period 1|Physician Decision|0|||
127962904|NCT01058642|460483361|FG000|Treatment Period 1|Withdrawal by Subject|1|||
127962905|NCT01058642|460483362|FG001|Treatment Period 1|Withdrawal by Subject|0|||
127962906|NCT01058642|460483363|FG002|Treatment Period 1|Withdrawal by Subject|0|||
127962907|NCT01058642|460483364|FG003|Treatment Period 1|Withdrawal by Subject|0|||
127962908|NCT01058642|460483361|FG000|Treatment Period 1|Lack of Efficacy|0|||
127962909|NCT01058642|460483362|FG001|Treatment Period 1|Lack of Efficacy|0|||
127962910|NCT01058642|460483363|FG002|Treatment Period 1|Lack of Efficacy|0|||
127962911|NCT01058642|460483364|FG003|Treatment Period 1|Lack of Efficacy|1|||
127962912|NCT01058642|460483361|FG000|Treatment Period 1|Protocol Violation|0|||
127962913|NCT01058642|460483362|FG001|Treatment Period 1|Protocol Violation|0|||
127962914|NCT01058642|460483363|FG002|Treatment Period 1|Protocol Violation|0|||
127962915|NCT01058642|460483364|FG003|Treatment Period 1|Protocol Violation|1|||
127962916|NCT01058642|460483361|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
127962917|NCT01058642|460483362|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
127962918|NCT01058642|460483363|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
127962919|NCT01058642|460483364|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
127962920|NCT03876743|460483365|FG000|Overall Study|Lost to Follow-up|6|||
127962921|NCT03876743|460483366|FG001|Overall Study|Lost to Follow-up|4|||
127962922|NCT03876743|460483367|FG002|Overall Study|Lost to Follow-up|4|||
127962923|NCT03876743|460483368|FG003|Overall Study|Lost to Follow-up|7|||
127962924|NCT00092118|460483369|FG000|Overall Study|Adverse Event|35|||
127962925|NCT00092118|460483370|FG001|Overall Study|Adverse Event|32|||
127962926|NCT00092118|460483369|FG000|Overall Study|Lack of Efficacy|12|||
127962927|NCT00092118|460483370|FG001|Overall Study|Lack of Efficacy|14|||
127962928|NCT00092118|460483369|FG000|Overall Study|Lost to Follow-up|4|||
127962929|NCT00092118|460483370|FG001|Overall Study|Lost to Follow-up|3|||
127962930|NCT00092118|460483369|FG000|Overall Study|Protocol Violation|23|||
127962931|NCT00092118|460483370|FG001|Overall Study|Protocol Violation|25|||
127962932|NCT00092118|460483369|FG000|Overall Study|Withdrawal by Subject|4|||
127962933|NCT00092118|460483370|FG001|Overall Study|Withdrawal by Subject|10|||
127962934|NCT00092118|460483369|FG000|Overall Study|Other|6|||
127962935|NCT00092118|460483370|FG001|Overall Study|Other|5|||
127962936|NCT01139125|460483371|FG000|Overall Study|Withdrawal by Subject|1|||
127962937|NCT03751098|460483372|FG000|Overall Study|Withdrawal by Subject|0|||
127962938|NCT03751098|460483373|FG001|Overall Study|Withdrawal by Subject|1|||
127962939|NCT04426006|460483374|FG000|Inclusion|Protocol Violation|1|||
127962940|NCT04426006|460483374|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
127962941|NCT04426006|460483374|FG000|Inclusion|Blood sample at inclusion not done|1|||
127962942|NCT04426006|460483374|FG000|3 Months|Lost to Follow-up|17|||
127962943|NCT04426006|460483374|FG000|12 Months|Lost to Follow-up|38|||
127962944|NCT04760626|460483375|FG000|Overall Study|Withdrawal by Subject|24|||
127962945|NCT04760626|460483376|FG001|Overall Study|Withdrawal by Subject|20|||
127962946|NCT04760626|460483375|FG000|Overall Study|Lost to Follow-up|14|||
127962947|NCT04760626|460483376|FG001|Overall Study|Lost to Follow-up|19|||
127962948|NCT04760626|460483375|FG000|Overall Study|Physician Decision|3|||
127962949|NCT04760626|460483376|FG001|Overall Study|Physician Decision|5|||
127962950|NCT04760626|460483375|FG000|Overall Study|Death|3|||
127962951|NCT04760626|460483376|FG001|Overall Study|Death|6|||
127962952|NCT04760626|460483375|FG000|Overall Study|Site closure|1|||
127962953|NCT04760626|460483376|FG001|Overall Study|Site closure|0|||
127962954|NCT03762265|460483379|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
127962955|NCT03762265|460483380|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
127962956|NCT03762265|460483379|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
127962957|NCT03762265|460483380|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
127962958|NCT03762265|460483379|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
127962959|NCT03762265|460483380|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
127962960|NCT03762265|460483379|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
127962961|NCT03762265|460483380|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
127962962|NCT03762265|460483379|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
127962963|NCT03762265|460483380|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
127962964|NCT03762265|460483379|FG000|BT Period: Weeks 1 to 37|Other|0|||
127962965|NCT03762265|460483380|FG001|BT Period: Weeks 1 to 37|Other|1|||
127962966|NCT03762265|460483379|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
127962967|NCT03762265|460483380|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
127962968|NCT03762265|460483379|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
127962969|NCT03762265|460483380|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
127962970|NCT03762265|460483379|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
127962971|NCT03762265|460483380|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
127962972|NCT03762265|460483379|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
127962973|NCT03762265|460483380|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
127962974|NCT03762265|460483379|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
127962975|NCT03762265|460483380|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
127962976|NCT03762265|460483379|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
127962977|NCT03762265|460483380|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
127962978|NCT03762265|460483379|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
127962979|NCT03762265|460483380|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
127962980|NCT03762265|460483379|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
127962981|NCT03762265|460483380|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
127962982|NCT03762265|460483379|FG000|LTE Period: Weeks 61 to 109|Other|1|||
127962983|NCT03762265|460483380|FG001|LTE Period: Weeks 61 to 109|Other|0|||
127962984|NCT00806403|460483383|FG000|Overall Study|Death|4|||
127962985|NCT00806403|460483384|FG001|Overall Study|Death|3|||
127962986|NCT01882985|460483385|FG000|Overall Study|Lost to Follow-up|1|||
127962987|NCT01882985|460483385|FG000|Overall Study|Withdrawal by Subject|1|||
127962988|NCT02946463|460483386|FG000|Primary Evaluation Period|Physician Decision|0|||
127962989|NCT02946463|460483387|FG001|Primary Evaluation Period|Physician Decision|1|||
127962990|NCT02946463|460483388|FG002|Primary Evaluation Period|Physician Decision|0|||
127962991|NCT02946463|460483389|FG003|Primary Evaluation Period|Physician Decision|0|||
127962992|NCT02946463|460483386|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
127962993|NCT02946463|460483387|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
127962994|NCT02946463|460483388|FG002|Primary Evaluation Period|Withdrawal by Subject|0|||
127962995|NCT02946463|460483389|FG003|Primary Evaluation Period|Withdrawal by Subject|0|||
127962996|NCT02946463|460483386|FG000|Extension Period|Death|4|||
127962997|NCT02946463|460483387|FG001|Extension Period|Death|4|||
127962998|NCT02946463|460483388|FG002|Extension Period|Death|0|||
127962999|NCT02946463|460483389|FG003|Extension Period|Death|0|||
127963000|NCT02946463|460483386|FG000|Extension Period|Withdrawal by Subject|4|||
127963001|NCT02946463|460483387|FG001|Extension Period|Withdrawal by Subject|3|||
127963002|NCT02946463|460483388|FG002|Extension Period|Withdrawal by Subject|0|||
127963003|NCT02946463|460483389|FG003|Extension Period|Withdrawal by Subject|0|||
127963004|NCT02946463|460483386|FG000|Extension Period|Other than specified|2|||
127963005|NCT02946463|460483387|FG001|Extension Period|Other than specified|3|||
127963006|NCT02946463|460483388|FG002|Extension Period|Other than specified|2|||
127963007|NCT02946463|460483389|FG003|Extension Period|Other than specified|0|||
127963008|NCT02946463|460483386|FG000|Extension Period|Physician Decision|1|||
127963009|NCT02946463|460483387|FG001|Extension Period|Physician Decision|4|||
127963010|NCT02946463|460483388|FG002|Extension Period|Physician Decision|0|||
127963011|NCT02946463|460483389|FG003|Extension Period|Physician Decision|0|||
127963012|NCT02946463|460483386|FG000|Extension Period|Pregnancy|3|||
127963013|NCT02946463|460483387|FG001|Extension Period|Pregnancy|1|||
127963014|NCT02946463|460483388|FG002|Extension Period|Pregnancy|0|||
127963015|NCT02946463|460483389|FG003|Extension Period|Pregnancy|0|||
127963016|NCT02946463|460483386|FG000|Extension Period|Adverse Event|1|||
127963017|NCT02946463|460483387|FG001|Extension Period|Adverse Event|2|||
127963018|NCT02946463|460483388|FG002|Extension Period|Adverse Event|0|||
127963019|NCT02946463|460483389|FG003|Extension Period|Adverse Event|0|||
127963020|NCT02946463|460483386|FG000|Extension Period|Lost to Follow-up|1|||
127963021|NCT02946463|460483387|FG001|Extension Period|Lost to Follow-up|0|||
127963022|NCT02946463|460483388|FG002|Extension Period|Lost to Follow-up|0|||
127963023|NCT02946463|460483389|FG003|Extension Period|Lost to Follow-up|0|||
127963024|NCT01383174|460483390|FG000|3 Month Assessment|Death|0|||
127963025|NCT01383174|460483391|FG001|3 Month Assessment|Death|1|||
127963026|NCT01383174|460483390|FG000|3 Month Assessment|Lost to Follow-up|2|||
127963027|NCT01383174|460483391|FG001|3 Month Assessment|Lost to Follow-up|0|||
127963028|NCT01383174|460483390|FG000|3 Month Assessment|Refused to complete|4|||
127963029|NCT01383174|460483391|FG001|3 Month Assessment|Refused to complete|0|||
127963030|NCT01383174|460483390|FG000|6 Month Assessment|Lost to Follow-up|1|||
127963031|NCT01383174|460483391|FG001|6 Month Assessment|Lost to Follow-up|1|||
127963032|NCT01383174|460483390|FG000|6 Month Assessment|Refused to complete|4|||
127963033|NCT01383174|460483391|FG001|6 Month Assessment|Refused to complete|0|||
127963034|NCT01787292|460483392|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
127963035|NCT01787292|460483393|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
127963036|NCT01787292|460483392|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
127963037|NCT01787292|460483393|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
127963038|NCT01924689|460483394|FG000|Overall Study|Death|0|||
127963039|NCT01924689|460483395|FG001|Overall Study|Death|1|||
127963040|NCT01924689|460483396|FG002|Overall Study|Death|0|||
127963041|NCT01924689|460483397|FG003|Overall Study|Death|1|||
127963042|NCT01924689|460483398|FG004|Overall Study|Death|0|||
127963043|NCT01924689|460483399|FG005|Overall Study|Death|0|||
127963044|NCT01924689|460483394|FG000|Overall Study|Disease progression|0|||
127963045|NCT01924689|460483395|FG001|Overall Study|Disease progression|0|||
127963046|NCT01924689|460483396|FG002|Overall Study|Disease progression|2|||
127963047|NCT01924689|460483397|FG003|Overall Study|Disease progression|0|||
127963048|NCT01924689|460483398|FG004|Overall Study|Disease progression|3|||
127963049|NCT01924689|460483399|FG005|Overall Study|Disease progression|2|||
127963050|NCT01924689|460483394|FG000|Overall Study|New therapy or study|3|||
127963051|NCT01924689|460483395|FG001|Overall Study|New therapy or study|2|||
127963052|NCT01924689|460483396|FG002|Overall Study|New therapy or study|1|||
127963053|NCT01924689|460483397|FG003|Overall Study|New therapy or study|4|||
127963054|NCT01924689|460483398|FG004|Overall Study|New therapy or study|2|||
127963055|NCT01924689|460483399|FG005|Overall Study|New therapy or study|0|||
127963056|NCT01924689|460483394|FG000|Overall Study|Withdrawal of consent|0|||
127963057|NCT01924689|460483395|FG001|Overall Study|Withdrawal of consent|0|||
127963058|NCT01924689|460483396|FG002|Overall Study|Withdrawal of consent|1|||
127963059|NCT01924689|460483397|FG003|Overall Study|Withdrawal of consent|1|||
127963060|NCT01924689|460483398|FG004|Overall Study|Withdrawal of consent|0|||
127963061|NCT01924689|460483399|FG005|Overall Study|Withdrawal of consent|0|||
127963062|NCT01924689|460483394|FG000|Overall Study|Other|0|||
127963063|NCT01924689|460483395|FG001|Overall Study|Other|0|||
127963064|NCT01924689|460483396|FG002|Overall Study|Other|0|||
127963065|NCT01924689|460483397|FG003|Overall Study|Other|0|||
127963066|NCT01924689|460483398|FG004|Overall Study|Other|1|||
127963067|NCT01924689|460483399|FG005|Overall Study|Other|0|||
127963068|NCT03267212|460483400|FG000|First Intervention|Lost to Follow-up|0|||
127963069|NCT03267212|460483401|FG001|First Intervention|Lost to Follow-up|2|||
127963070|NCT03267212|460483400|FG000|First Intervention|Withdrawal by Subject|1|||
127963071|NCT03267212|460483401|FG001|First Intervention|Withdrawal by Subject|1|||
127963072|NCT03267212|460483400|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
127963073|NCT03267212|460483401|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
127963074|NCT05691712|460483403|FG000|Overall Study|Adverse Event|0|||
127963075|NCT05691712|460483404|FG001|Overall Study|Adverse Event|1|||
127963076|NCT05691712|460483405|FG002|Overall Study|Adverse Event|2|||
127963077|NCT05691712|460483406|FG003|Overall Study|Adverse Event|1|||
127963078|NCT05691712|460483403|FG000|Overall Study|Withdrawal by Subject|2|||
127963079|NCT05691712|460483404|FG001|Overall Study|Withdrawal by Subject|3|||
127963080|NCT05691712|460483405|FG002|Overall Study|Withdrawal by Subject|3|||
127963081|NCT05691712|460483406|FG003|Overall Study|Withdrawal by Subject|1|||
127963082|NCT05691712|460483403|FG000|Overall Study|Death|1|||
127963083|NCT05691712|460483404|FG001|Overall Study|Death|0|||
127963084|NCT05691712|460483405|FG002|Overall Study|Death|0|||
127963085|NCT05691712|460483406|FG003|Overall Study|Death|0|||
127963086|NCT05691712|460483403|FG000|Overall Study|Pregnancy|0|||
127963087|NCT05691712|460483404|FG001|Overall Study|Pregnancy|1|||
127963088|NCT05691712|460483405|FG002|Overall Study|Pregnancy|0|||
127963089|NCT05691712|460483406|FG003|Overall Study|Pregnancy|0|||
127963090|NCT05691712|460483403|FG000|Overall Study|Assigned Treatment by Mistake|1|||
127963091|NCT05691712|460483404|FG001|Overall Study|Assigned Treatment by Mistake|0|||
127963092|NCT05691712|460483405|FG002|Overall Study|Assigned Treatment by Mistake|0|||
127963093|NCT05691712|460483406|FG003|Overall Study|Assigned Treatment by Mistake|1|||
127963094|NCT02208362|460483407|FG000|Overall Study|Participant did not complete treatment|0|||
127963095|NCT02208362|460483408|FG001|Overall Study|Participant did not complete treatment|1|||
127963096|NCT02208362|460483409|FG002|Overall Study|Participant did not complete treatment|0|||
127963097|NCT02208362|460483410|FG003|Overall Study|Participant did not complete treatment|0|||
127963098|NCT02208362|460483411|FG004|Overall Study|Participant did not complete treatment|0|||
127963099|NCT02208362|460483412|FG005|Overall Study|Participant did not complete treatment|0|||
127963100|NCT02208362|460483413|FG006|Overall Study|Participant did not complete treatment|1|||
127963101|NCT02208362|460483414|FG007|Overall Study|Participant did not complete treatment|1|||
127963102|NCT02208362|460483415|FG008|Overall Study|Participant did not complete treatment|2|||
127963103|NCT02208362|460483416|FG009|Overall Study|Participant did not complete treatment|0|||
127963104|NCT02208362|460483417|FG010|Overall Study|Participant did not complete treatment|1|||
127963105|NCT02208362|460483418|FG011|Overall Study|Participant did not complete treatment|0|||
127963106|NCT02208362|460483407|FG000|Overall Study|Participant received disallowed treatment|0|||
127963107|NCT02208362|460483408|FG001|Overall Study|Participant received disallowed treatment|0|||
127963108|NCT02208362|460483409|FG002|Overall Study|Participant received disallowed treatment|0|||
127963109|NCT02208362|460483410|FG003|Overall Study|Participant received disallowed treatment|0|||
127963110|NCT02208362|460483411|FG004|Overall Study|Participant received disallowed treatment|0|||
127963111|NCT02208362|460483412|FG005|Overall Study|Participant received disallowed treatment|0|||
127963112|NCT02208362|460483413|FG006|Overall Study|Participant received disallowed treatment|0|||
127963113|NCT02208362|460483414|FG007|Overall Study|Participant received disallowed treatment|0|||
127963114|NCT02208362|460483415|FG008|Overall Study|Participant received disallowed treatment|1|||
127963115|NCT02208362|460483416|FG009|Overall Study|Participant received disallowed treatment|0|||
127963116|NCT02208362|460483417|FG010|Overall Study|Participant received disallowed treatment|0|||
127963117|NCT02208362|460483418|FG011|Overall Study|Participant received disallowed treatment|0|||
127963118|NCT04563754|460484885|FG000|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|11|||
127963119|NCT04563754|460484886|FG001|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|6|||
127963120|NCT04563754|460484887|FG002|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|0|||
127963121|NCT04563754|460484885|FG000|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
127963122|NCT04563754|460484886|FG001|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
127963123|NCT04563754|460484887|FG002|HRME Procedure|Optimization/validation of 3D imaging and HRME|18|||
127963124|NCT04563754|460484885|FG000|Follow up|Lost to Follow-up|61|||
127963125|NCT04563754|460484886|FG001|Follow up|Lost to Follow-up|23|||
127963126|NCT04563754|460484887|FG002|Follow up|Lost to Follow-up|5|||
127963127|NCT04563754|460484885|FG000|Follow up|Death|0|||
127963128|NCT04563754|460484886|FG001|Follow up|Death|2|||
127963129|NCT04563754|460484887|FG002|Follow up|Death|0|||
127963130|NCT04563754|460484885|FG000|Follow up|Ongoing|0|||
127963131|NCT04563754|460484886|FG001|Follow up|Ongoing|28|||
127963132|NCT04563754|460484887|FG002|Follow up|Ongoing|0|||
127963133|NCT04023396|460484888|FG000|Overall Study|Adverse Event|16|||
127963134|NCT04023396|460484888|FG000|Overall Study|Death|1|||
127963135|NCT04023396|460484888|FG000|Overall Study|Lost to Follow-up|1|||
127963136|NCT04023396|460484888|FG000|Overall Study|Withdrawal by Subject|14|||
127963137|NCT04023396|460484888|FG000|Overall Study|Pregnancy|4|||
127963138|NCT04023396|460484888|FG000|Overall Study|Lack of Efficacy|3|||
127963139|NCT04023396|460484888|FG000|Overall Study|Physician Decision|4|||
127963140|NCT04023396|460484888|FG000|Overall Study|Other reason (e.g., Ukraine Crisis)|10|||
127963141|NCT04075825|460484889|FG000|Overall Study|Withdrawal by Subject|6|||
127963142|NCT04075825|460484890|FG001|Overall Study|Withdrawal by Subject|8|||
127963143|NCT04075825|460484889|FG000|Overall Study|Physician Decision|3|||
127963144|NCT04075825|460484890|FG001|Overall Study|Physician Decision|1|||
127963145|NCT04075825|460484889|FG000|Overall Study|Lost to Follow-up|5|||
127963146|NCT04075825|460484890|FG001|Overall Study|Lost to Follow-up|1|||
127963147|NCT04075825|460484889|FG000|Overall Study|Participation in New Clinical Trial|1|||
127963148|NCT04075825|460484890|FG001|Overall Study|Participation in New Clinical Trial|1|||
127963149|NCT04075825|460484889|FG000|Overall Study|Reason Not Specified|2|||
127963150|NCT04075825|460484890|FG001|Overall Study|Reason Not Specified|2|||
127963151|NCT04021914|460484891|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
127963152|NCT03349060|460484892|FG000|Overall Study|Adverse Event|9|||
127963153|NCT03349060|460484893|FG001|Overall Study|Adverse Event|9|||
127963154|NCT03349060|460484894|FG002|Overall Study|Adverse Event|7|||
127963155|NCT03349060|460484892|FG000|Overall Study|Lack of Efficacy|1|||
127963156|NCT03349060|460484893|FG001|Overall Study|Lack of Efficacy|0|||
127963157|NCT03349060|460484894|FG002|Overall Study|Lack of Efficacy|2|||
127963158|NCT03349060|460484892|FG000|Overall Study|Lost to Follow-up|2|||
127963159|NCT03349060|460484893|FG001|Overall Study|Lost to Follow-up|1|||
127963160|NCT03349060|460484894|FG002|Overall Study|Lost to Follow-up|1|||
127963161|NCT03349060|460484892|FG000|Overall Study|Protocol Violation|2|||
127963162|NCT03349060|460484893|FG001|Overall Study|Protocol Violation|2|||
127963163|NCT03349060|460484894|FG002|Overall Study|Protocol Violation|1|||
127963164|NCT03349060|460484892|FG000|Overall Study|Withdrawal by Subject|5|||
127963165|NCT03349060|460484893|FG001|Overall Study|Withdrawal by Subject|3|||
127963166|NCT03349060|460484894|FG002|Overall Study|Withdrawal by Subject|4|||
127963167|NCT03349060|460484892|FG000|Overall Study|Medication error,no linked adverse event|0|||
127963168|NCT03349060|460484893|FG001|Overall Study|Medication error,no linked adverse event|0|||
127963169|NCT03349060|460484894|FG002|Overall Study|Medication error,no linked adverse event|1|||
127963170|NCT03349060|460484892|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
127963171|NCT03349060|460484893|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
127963172|NCT03349060|460484894|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
127963173|NCT03349060|460484892|FG000|Overall Study|Other|2|||
127963174|NCT03349060|460484893|FG001|Overall Study|Other|1|||
127963175|NCT03349060|460484894|FG002|Overall Study|Other|0|||
127963176|NCT02861586|460484895|FG000|Overall Study|Withdrawal by Subject|1|||
127963177|NCT02861586|460484896|FG001|Overall Study|Withdrawal by Subject|2|||
127963178|NCT02861586|460484897|FG002|Overall Study|Withdrawal by Subject|0|||
127963179|NCT02861586|460484898|FG003|Overall Study|Withdrawal by Subject|0|||
127963180|NCT02861586|460484899|FG004|Overall Study|Withdrawal by Subject|0|||
127963181|NCT02861586|460484900|FG005|Overall Study|Withdrawal by Subject|1|||
127963182|NCT02861586|460484901|FG006|Overall Study|Withdrawal by Subject|1|||
127963183|NCT02861586|460484902|FG007|Overall Study|Withdrawal by Subject|0|||
127963184|NCT02861586|460484895|FG000|Overall Study|Lost to Follow-up|3|||
127963185|NCT02861586|460484896|FG001|Overall Study|Lost to Follow-up|1|||
127963186|NCT02861586|460484897|FG002|Overall Study|Lost to Follow-up|1|||
127963187|NCT02861586|460484898|FG003|Overall Study|Lost to Follow-up|0|||
127963188|NCT02861586|460484899|FG004|Overall Study|Lost to Follow-up|0|||
127963189|NCT02861586|460484900|FG005|Overall Study|Lost to Follow-up|3|||
127963190|NCT02861586|460484901|FG006|Overall Study|Lost to Follow-up|0|||
127963191|NCT02861586|460484902|FG007|Overall Study|Lost to Follow-up|0|||
127963192|NCT02861586|460484895|FG000|Overall Study|Adverse Event|0|||
127963193|NCT02861586|460484896|FG001|Overall Study|Adverse Event|0|||
127963194|NCT02861586|460484897|FG002|Overall Study|Adverse Event|0|||
127963195|NCT02861586|460484898|FG003|Overall Study|Adverse Event|0|||
127963196|NCT02861586|460484899|FG004|Overall Study|Adverse Event|0|||
127963197|NCT02861586|460484900|FG005|Overall Study|Adverse Event|1|||
127963198|NCT02861586|460484901|FG006|Overall Study|Adverse Event|0|||
127963199|NCT02861586|460484902|FG007|Overall Study|Adverse Event|0|||
127963200|NCT00955409|460484903|FG000|Overall Study|Lack of Efficacy|1|||
127963201|NCT00955409|460484904|FG001|Overall Study|Lack of Efficacy|0|||
127963202|NCT00955409|460484905|FG002|Overall Study|Lack of Efficacy|0|||
127963203|NCT00955409|460484906|FG003|Overall Study|Lack of Efficacy|0|||
127963204|NCT00955409|460484907|FG004|Overall Study|Lack of Efficacy|0|||
127963205|NCT00955409|460484908|FG005|Overall Study|Lack of Efficacy|0|||
127963206|NCT00955409|460484909|FG006|Overall Study|Lack of Efficacy|0|||
127963207|NCT00955409|460484910|FG007|Overall Study|Lack of Efficacy|0|||
127963208|NCT00955409|460484911|FG008|Overall Study|Lack of Efficacy|0|||
127963209|NCT00955409|460484912|FG009|Overall Study|Lack of Efficacy|0|||
127963210|NCT00955409|460484903|FG000|Overall Study|Withdrawal by Subject|1|||
127963211|NCT00955409|460484904|FG001|Overall Study|Withdrawal by Subject|0|||
127963212|NCT00955409|460484905|FG002|Overall Study|Withdrawal by Subject|5|||
127963213|NCT00955409|460484906|FG003|Overall Study|Withdrawal by Subject|2|||
127963214|NCT00955409|460484907|FG004|Overall Study|Withdrawal by Subject|0|||
127963215|NCT00955409|460484908|FG005|Overall Study|Withdrawal by Subject|0|||
127963216|NCT00955409|460484909|FG006|Overall Study|Withdrawal by Subject|2|||
127963217|NCT00955409|460484910|FG007|Overall Study|Withdrawal by Subject|0|||
127963218|NCT00955409|460484911|FG008|Overall Study|Withdrawal by Subject|1|||
127963219|NCT00955409|460484912|FG009|Overall Study|Withdrawal by Subject|0|||
127963220|NCT00955409|460484903|FG000|Overall Study|Caregiver Request|2|||
127963221|NCT00955409|460484904|FG001|Overall Study|Caregiver Request|0|||
127963222|NCT00955409|460484905|FG002|Overall Study|Caregiver Request|6|||
127963223|NCT00955409|460484906|FG003|Overall Study|Caregiver Request|5|||
127963224|NCT00955409|460484907|FG004|Overall Study|Caregiver Request|0|||
127963225|NCT00955409|460484908|FG005|Overall Study|Caregiver Request|2|||
127963226|NCT00955409|460484909|FG006|Overall Study|Caregiver Request|3|||
127963227|NCT00955409|460484910|FG007|Overall Study|Caregiver Request|1|||
127963228|NCT00955409|460484911|FG008|Overall Study|Caregiver Request|3|||
127963229|NCT00955409|460484912|FG009|Overall Study|Caregiver Request|0|||
127963230|NCT00955409|460484903|FG000|Overall Study|Investigator Request|0|||
127963231|NCT00955409|460484904|FG001|Overall Study|Investigator Request|0|||
127963232|NCT00955409|460484905|FG002|Overall Study|Investigator Request|1|||
127963233|NCT00955409|460484906|FG003|Overall Study|Investigator Request|0|||
127963234|NCT00955409|460484907|FG004|Overall Study|Investigator Request|0|||
127963235|NCT00955409|460484908|FG005|Overall Study|Investigator Request|0|||
127963236|NCT00955409|460484909|FG006|Overall Study|Investigator Request|0|||
127963237|NCT00955409|460484910|FG007|Overall Study|Investigator Request|0|||
127963238|NCT00955409|460484911|FG008|Overall Study|Investigator Request|0|||
127963239|NCT00955409|460484912|FG009|Overall Study|Investigator Request|0|||
127963240|NCT00955409|460484903|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
127963241|NCT00955409|460484904|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
127963242|NCT00955409|460484905|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
127963243|NCT00955409|460484906|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
127963244|NCT00955409|460484907|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
127963245|NCT00955409|460484908|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
127963246|NCT00955409|460484909|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
127963247|NCT00955409|460484910|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
127963248|NCT00955409|460484911|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
127963249|NCT00955409|460484912|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
127963250|NCT00955409|460484903|FG000|Overall Study|Lost to Follow-up|0|||
127963251|NCT00955409|460484904|FG001|Overall Study|Lost to Follow-up|0|||
127963252|NCT00955409|460484905|FG002|Overall Study|Lost to Follow-up|1|||
127963253|NCT00955409|460484906|FG003|Overall Study|Lost to Follow-up|0|||
127963254|NCT00955409|460484907|FG004|Overall Study|Lost to Follow-up|0|||
127963255|NCT00955409|460484908|FG005|Overall Study|Lost to Follow-up|0|||
127963256|NCT00955409|460484909|FG006|Overall Study|Lost to Follow-up|1|||
127963257|NCT00955409|460484910|FG007|Overall Study|Lost to Follow-up|0|||
127963258|NCT00955409|460484911|FG008|Overall Study|Lost to Follow-up|0|||
127963259|NCT00955409|460484912|FG009|Overall Study|Lost to Follow-up|0|||
127963260|NCT00955409|460484903|FG000|Overall Study|Failed to Return|2|||
127963261|NCT00955409|460484904|FG001|Overall Study|Failed to Return|0|||
127963262|NCT00955409|460484905|FG002|Overall Study|Failed to Return|0|||
127963263|NCT00955409|460484906|FG003|Overall Study|Failed to Return|0|||
127963264|NCT00955409|460484907|FG004|Overall Study|Failed to Return|0|||
127963265|NCT00955409|460484908|FG005|Overall Study|Failed to Return|0|||
127963266|NCT00955409|460484909|FG006|Overall Study|Failed to Return|0|||
127963267|NCT00955409|460484910|FG007|Overall Study|Failed to Return|2|||
127963268|NCT00955409|460484911|FG008|Overall Study|Failed to Return|0|||
127963269|NCT00955409|460484912|FG009|Overall Study|Failed to Return|0|||
127963270|NCT00955409|460484903|FG000|Overall Study|Adverse Event (AE)|2|||
127963271|NCT00955409|460484904|FG001|Overall Study|Adverse Event (AE)|0|||
127963272|NCT00955409|460484905|FG002|Overall Study|Adverse Event (AE)|0|||
127963273|NCT00955409|460484906|FG003|Overall Study|Adverse Event (AE)|0|||
127963274|NCT00955409|460484907|FG004|Overall Study|Adverse Event (AE)|0|||
127963275|NCT00955409|460484908|FG005|Overall Study|Adverse Event (AE)|1|||
127963276|NCT00955409|460484909|FG006|Overall Study|Adverse Event (AE)|2|||
127963277|NCT00955409|460484910|FG007|Overall Study|Adverse Event (AE)|0|||
127963278|NCT00955409|460484911|FG008|Overall Study|Adverse Event (AE)|2|||
127963279|NCT00955409|460484912|FG009|Overall Study|Adverse Event (AE)|0|||
127963280|NCT00955409|460484903|FG000|Overall Study|Reason not Specified|2|||
127963281|NCT00955409|460484904|FG001|Overall Study|Reason not Specified|1|||
127963282|NCT00955409|460484905|FG002|Overall Study|Reason not Specified|13|||
127963283|NCT00955409|460484906|FG003|Overall Study|Reason not Specified|1|||
127963284|NCT00955409|460484907|FG004|Overall Study|Reason not Specified|2|||
127963285|NCT00955409|460484908|FG005|Overall Study|Reason not Specified|0|||
127963286|NCT00955409|460484909|FG006|Overall Study|Reason not Specified|16|||
127963287|NCT00955409|460484910|FG007|Overall Study|Reason not Specified|0|||
127963288|NCT00955409|460484911|FG008|Overall Study|Reason not Specified|8|||
127963289|NCT00955409|460484912|FG009|Overall Study|Reason not Specified|1|||
127963290|NCT01880554|460484913|FG000|Overall Study|Protocol Violation|14|||
127963291|NCT01880554|460484913|FG000|Overall Study|Simon's design requirements|2|||
127963292|NCT05161481|460484914|FG000|Overall Study|Withdrawal of consent|0|||
127963293|NCT05161481|460484915|FG001|Overall Study|Withdrawal of consent|1|||
127963294|NCT05161481|460484916|FG002|Overall Study|Withdrawal of consent|1|||
127963295|NCT05161481|460484914|FG000|Overall Study|Study terminated by sponsor|3|||
127963296|NCT05161481|460484915|FG001|Overall Study|Study terminated by sponsor|3|||
127963297|NCT05161481|460484916|FG002|Overall Study|Study terminated by sponsor|2|||
127963298|NCT05161481|460484914|FG000|Overall Study|Adverse Event|3|||
127963299|NCT05161481|460484915|FG001|Overall Study|Adverse Event|0|||
127963300|NCT05161481|460484916|FG002|Overall Study|Adverse Event|6|||
127963301|NCT05161481|460484914|FG000|Overall Study|Randomised in error and was not treated|1|||
127963302|NCT05161481|460484915|FG001|Overall Study|Randomised in error and was not treated|0|||
127963303|NCT05161481|460484916|FG002|Overall Study|Randomised in error and was not treated|0|||
127963304|NCT05161481|460484914|FG000|Overall Study|Subject decision|0|||
127963305|NCT05161481|460484915|FG001|Overall Study|Subject decision|0|||
127963306|NCT05161481|460484916|FG002|Overall Study|Subject decision|1|||
127963307|NCT04225715|460484917|FG000|Overall Study|Reason not Specified|1|||
127963308|NCT04225715|460484918|FG001|Overall Study|Reason not Specified|0|||
127963309|NCT04225715|460484919|FG002|Overall Study|Reason not Specified|0|||
127963310|NCT04225715|460484920|FG003|Overall Study|Reason not Specified|0|||
127963311|NCT04225715|460484921|FG004|Overall Study|Reason not Specified|0|||
127963312|NCT04225715|460484922|FG005|Overall Study|Reason not Specified|0|||
127963313|NCT04225715|460484923|FG006|Overall Study|Reason not Specified|0|||
127963314|NCT04225715|460484924|FG007|Overall Study|Reason not Specified|0|||
127963315|NCT04225715|460484925|FG008|Overall Study|Reason not Specified|0|||
127963316|NCT04225715|460484917|FG000|Overall Study|Protocol Violation|1|||
127963317|NCT04225715|460484918|FG001|Overall Study|Protocol Violation|0|||
127963318|NCT04225715|460484919|FG002|Overall Study|Protocol Violation|0|||
127963319|NCT04225715|460484920|FG003|Overall Study|Protocol Violation|0|||
127963320|NCT04225715|460484921|FG004|Overall Study|Protocol Violation|0|||
127963321|NCT04225715|460484922|FG005|Overall Study|Protocol Violation|9|||
127963322|NCT04225715|460484923|FG006|Overall Study|Protocol Violation|0|||
127963323|NCT04225715|460484924|FG007|Overall Study|Protocol Violation|0|||
127963324|NCT04225715|460484925|FG008|Overall Study|Protocol Violation|0|||
127963325|NCT04225715|460484917|FG000|Overall Study|Withdrawal by Subject|4|||
127963326|NCT04225715|460484918|FG001|Overall Study|Withdrawal by Subject|1|||
127963327|NCT04225715|460484919|FG002|Overall Study|Withdrawal by Subject|1|||
127963328|NCT04225715|460484920|FG003|Overall Study|Withdrawal by Subject|0|||
127963329|NCT04225715|460484921|FG004|Overall Study|Withdrawal by Subject|3|||
127963330|NCT04225715|460484922|FG005|Overall Study|Withdrawal by Subject|1|||
127963331|NCT04225715|460484923|FG006|Overall Study|Withdrawal by Subject|1|||
127963332|NCT04225715|460484924|FG007|Overall Study|Withdrawal by Subject|1|||
127963333|NCT04225715|460484925|FG008|Overall Study|Withdrawal by Subject|0|||
127963334|NCT04225715|460484917|FG000|Overall Study|Adverse Event|0|||
127963335|NCT04225715|460484918|FG001|Overall Study|Adverse Event|0|||
127963336|NCT04225715|460484919|FG002|Overall Study|Adverse Event|0|||
127963337|NCT04225715|460484920|FG003|Overall Study|Adverse Event|0|||
127963338|NCT04225715|460484921|FG004|Overall Study|Adverse Event|0|||
127963339|NCT04225715|460484922|FG005|Overall Study|Adverse Event|0|||
127963340|NCT04225715|460484923|FG006|Overall Study|Adverse Event|0|||
127963341|NCT04225715|460484924|FG007|Overall Study|Adverse Event|0|||
127963342|NCT04225715|460484925|FG008|Overall Study|Adverse Event|1|||
127963343|NCT04225715|460484917|FG000|Overall Study|Arm Terminated By Sponsor|0|||
127963344|NCT04225715|460484918|FG001|Overall Study|Arm Terminated By Sponsor|0|||
127963345|NCT04225715|460484919|FG002|Overall Study|Arm Terminated By Sponsor|0|||
127963346|NCT04225715|460484920|FG003|Overall Study|Arm Terminated By Sponsor|0|||
127963347|NCT04225715|460484921|FG004|Overall Study|Arm Terminated By Sponsor|0|||
127963348|NCT04225715|460484922|FG005|Overall Study|Arm Terminated By Sponsor|0|||
127963349|NCT04225715|460484923|FG006|Overall Study|Arm Terminated By Sponsor|0|||
127963350|NCT04225715|460484924|FG007|Overall Study|Arm Terminated By Sponsor|17|||
127963351|NCT04225715|460484925|FG008|Overall Study|Arm Terminated By Sponsor|18|||
127963352|NCT03318861|460484933|FG000|Overall Study|Death|2|||
127963353|NCT03318861|460484934|FG001|Overall Study|Death|3|||
127963354|NCT03318861|460484935|FG002|Overall Study|Death|3|||
127963355|NCT03318861|460484936|FG003|Overall Study|Death|2|||
127963356|NCT03318861|460484937|FG004|Overall Study|Death|2|||
127963357|NCT03318861|460484933|FG000|Overall Study|Enrolled But Never Treated|0|||
127963358|NCT03318861|460484934|FG001|Overall Study|Enrolled But Never Treated|1|||
127963359|NCT03318861|460484935|FG002|Overall Study|Enrolled But Never Treated|0|||
127963360|NCT03318861|460484936|FG003|Overall Study|Enrolled But Never Treated|1|||
127963361|NCT03318861|460484937|FG004|Overall Study|Enrolled But Never Treated|1|||
127963362|NCT03318861|460484933|FG000|Overall Study|Informed Consent Withdraw|0|||
127963363|NCT03318861|460484934|FG001|Overall Study|Informed Consent Withdraw|0|||
127963364|NCT03318861|460484935|FG002|Overall Study|Informed Consent Withdraw|0|||
127963365|NCT03318861|460484936|FG003|Overall Study|Informed Consent Withdraw|1|||
127963366|NCT03318861|460484937|FG004|Overall Study|Informed Consent Withdraw|0|||
127963367|NCT03318861|460484933|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
127963368|NCT03318861|460484934|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
127963369|NCT03318861|460484935|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
127963370|NCT03318861|460484936|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
127963371|NCT03318861|460484937|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
127963372|NCT00917852|460484938|FG000|Overall Study|Death|6|||
127963373|NCT00471081|460484939|FG000|Active Phase|Protocol Violation|1|||
127963374|NCT00471081|460484940|FG001|Active Phase|Protocol Violation|1|||
127963375|NCT00471081|460484939|FG000|Active Phase|Withdrawal by Subject|0|||
127963376|NCT00471081|460484940|FG001|Active Phase|Withdrawal by Subject|3|||
127963377|NCT00471081|460484939|FG000|Active Phase|Lost to Follow-up|0|||
127963378|NCT00471081|460484940|FG001|Active Phase|Lost to Follow-up|1|||
127963379|NCT00471081|460484939|FG000|Active Phase|Lost health plan/insurance|1|||
127963380|NCT00471081|460484940|FG001|Active Phase|Lost health plan/insurance|8|||
127963381|NCT00471081|460484939|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
127963382|NCT00471081|460484940|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
127963383|NCT00471081|460484939|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
127963384|NCT00471081|460484940|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
127963385|NCT00471081|460484939|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
127963386|NCT00471081|460484940|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
127963387|NCT02844933|460484941|FG000|Overall Study|Discontinued due to premature termination of study|3|||
127963388|NCT02844933|460484942|FG001|Overall Study|Discontinued due to premature termination of study|2|||
127963389|NCT03922308|460484943|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
127963390|NCT03922308|460484944|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
127963391|NCT03922308|460484945|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
127963392|NCT03922308|460484943|FG000|Overall Study|Lost to Follow-up|1|||
127963393|NCT03922308|460484944|FG001|Overall Study|Lost to Follow-up|0|||
127963394|NCT03922308|460484945|FG002|Overall Study|Lost to Follow-up|0|||
127963395|NCT03922308|460484943|FG000|Overall Study|Reason not Specified|0|||
127963396|NCT03922308|460484944|FG001|Overall Study|Reason not Specified|2|||
127963397|NCT03922308|460484945|FG002|Overall Study|Reason not Specified|1|||
127963398|NCT01256450|460484946|FG000|Open-label Titration|Adverse Event|39|||
127963399|NCT01256450|460484947|FG001|Open-label Titration|Adverse Event|0|||
127963400|NCT01256450|460484948|FG002|Open-label Titration|Adverse Event|0|||
127963401|NCT01256450|460484946|FG000|Open-label Titration|Lost to Follow-up|7|||
127963402|NCT01256450|460484947|FG001|Open-label Titration|Lost to Follow-up|0|||
127963403|NCT01256450|460484948|FG002|Open-label Titration|Lost to Follow-up|0|||
127963404|NCT01256450|460484946|FG000|Open-label Titration|Lack of analgesic effect|30|||
127963405|NCT01256450|460484947|FG001|Open-label Titration|Lack of analgesic effect|0|||
127963406|NCT01256450|460484948|FG002|Open-label Titration|Lack of analgesic effect|0|||
127963407|NCT01256450|460484946|FG000|Open-label Titration|Non-compliance|9|||
127963408|NCT01256450|460484947|FG001|Open-label Titration|Non-compliance|0|||
127963409|NCT01256450|460484948|FG002|Open-label Titration|Non-compliance|0|||
127963410|NCT01256450|460484946|FG000|Open-label Titration|Screen failure|1|||
127963411|NCT01256450|460484947|FG001|Open-label Titration|Screen failure|0|||
127963412|NCT01256450|460484948|FG002|Open-label Titration|Screen failure|0|||
127963413|NCT01256450|460484946|FG000|Open-label Titration|Other|13|||
127963414|NCT01256450|460484947|FG001|Open-label Titration|Other|0|||
127963415|NCT01256450|460484948|FG002|Open-label Titration|Other|0|||
127963416|NCT01256450|460484946|FG000|Double-blind Treatment|Adverse Event|0|||
127963417|NCT01256450|460484947|FG001|Double-blind Treatment|Adverse Event|8|||
127963418|NCT01256450|460484948|FG002|Double-blind Treatment|Adverse Event|6|||
127963419|NCT01256450|460484946|FG000|Double-blind Treatment|Lost to Follow-up|0|||
127963420|NCT01256450|460484947|FG001|Double-blind Treatment|Lost to Follow-up|1|||
127963421|NCT01256450|460484948|FG002|Double-blind Treatment|Lost to Follow-up|7|||
127963422|NCT01256450|460484946|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
127963423|NCT01256450|460484947|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
127963424|NCT01256450|460484948|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
127963425|NCT01256450|460484946|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
127963426|NCT01256450|460484947|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
127963427|NCT01256450|460484948|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
127963428|NCT01256450|460484946|FG000|Double-blind Treatment|Non-compliance|0|||
127963429|NCT01256450|460484947|FG001|Double-blind Treatment|Non-compliance|5|||
127963430|NCT01256450|460484948|FG002|Double-blind Treatment|Non-compliance|4|||
127963431|NCT01256450|460484946|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
127963432|NCT01256450|460484947|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
127963433|NCT01256450|460484948|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
127963434|NCT01256450|460484946|FG000|Double-blind Treatment|Other|0|||
127963435|NCT01256450|460484947|FG001|Double-blind Treatment|Other|9|||
127963436|NCT01256450|460484948|FG002|Double-blind Treatment|Other|12|||
127963437|NCT03376789|460484949|FG000|Overall Study|Withdrawal by Subject|3|||
127963438|NCT03376789|460484950|FG001|Overall Study|Withdrawal by Subject|5|||
127963439|NCT03376789|460484949|FG000|Overall Study|Protocol Violation|0|||
127963440|NCT03376789|460484950|FG001|Overall Study|Protocol Violation|1|||
127963441|NCT03376789|460484949|FG000|Overall Study|Adverse Event|0|||
127963442|NCT03376789|460484950|FG001|Overall Study|Adverse Event|1|||
127963443|NCT03376789|460484949|FG000|Overall Study|Lost to Follow-up|1|||
127963444|NCT03376789|460484950|FG001|Overall Study|Lost to Follow-up|1|||
127963445|NCT03376789|460484949|FG000|Overall Study|Per sponsor due to noncompliance|1|||
127963446|NCT03376789|460484950|FG001|Overall Study|Per sponsor due to noncompliance|0|||
127963447|NCT03376789|460484949|FG000|Overall Study|Subject off study medication|0|||
127963448|NCT03376789|460484950|FG001|Overall Study|Subject off study medication|1|||
127963449|NCT03889418|460484953|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
127963450|NCT03889418|460484954|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
127963451|NCT03889418|460484955|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
127963452|NCT03889418|460484956|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
127963453|NCT03889418|460484957|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
127963454|NCT03889418|460484958|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
127963455|NCT03889418|460484959|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
127963456|NCT03889418|460484960|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
127963457|NCT03889418|460484961|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
127963458|NCT03889418|460484962|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
127963459|NCT03889418|460484953|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
127963460|NCT03889418|460484954|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
127963461|NCT03889418|460484955|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
127963462|NCT03889418|460484956|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
127963463|NCT03889418|460484957|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
127963464|NCT03889418|460484958|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
127963465|NCT03889418|460484959|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
127963466|NCT03889418|460484960|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
127963467|NCT03889418|460484961|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
127963468|NCT03889418|460484962|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
127963469|NCT03889418|460484953|FG000|October-December 2019 (Month 7-9)|Death|0|||
127963470|NCT03889418|460484954|FG001|October-December 2019 (Month 7-9)|Death|0|||
127963471|NCT03889418|460484955|FG002|October-December 2019 (Month 7-9)|Death|0|||
127963472|NCT03889418|460484956|FG003|October-December 2019 (Month 7-9)|Death|0|||
127963473|NCT03889418|460484957|FG004|October-December 2019 (Month 7-9)|Death|0|||
127963474|NCT03889418|460484958|FG005|October-December 2019 (Month 7-9)|Death|0|||
127963475|NCT03889418|460484959|FG006|October-December 2019 (Month 7-9)|Death|0|||
127963476|NCT03889418|460484960|FG007|October-December 2019 (Month 7-9)|Death|0|||
127963477|NCT03889418|460484961|FG008|October-December 2019 (Month 7-9)|Death|1|||
127963478|NCT03889418|460484962|FG009|October-December 2019 (Month 7-9)|Death|0|||
127963479|NCT03889418|460484953|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
127963480|NCT03889418|460484954|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
127963481|NCT03889418|460484955|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
127963482|NCT03889418|460484956|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
127963483|NCT03889418|460484957|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
127963484|NCT03889418|460484958|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
127963485|NCT03889418|460484959|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
127963486|NCT03889418|460484960|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
127963487|NCT03889418|460484961|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
127963488|NCT03889418|460484962|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
127963489|NCT03889418|460484953|FG000|April - June 2020 (Month 13-15)|Death|0|||
127963490|NCT03889418|460484954|FG001|April - June 2020 (Month 13-15)|Death|1|||
127963491|NCT03889418|460484955|FG002|April - June 2020 (Month 13-15)|Death|0|||
127963492|NCT03889418|460484956|FG003|April - June 2020 (Month 13-15)|Death|0|||
127963493|NCT03889418|460484957|FG004|April - June 2020 (Month 13-15)|Death|0|||
127963494|NCT03889418|460484958|FG005|April - June 2020 (Month 13-15)|Death|0|||
127963495|NCT03889418|460484959|FG006|April - June 2020 (Month 13-15)|Death|0|||
127963496|NCT03889418|460484960|FG007|April - June 2020 (Month 13-15)|Death|0|||
127963497|NCT03889418|460484961|FG008|April - June 2020 (Month 13-15)|Death|0|||
127963498|NCT03889418|460484962|FG009|April - June 2020 (Month 13-15)|Death|0|||
127963499|NCT03889418|460484953|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
127963500|NCT03889418|460484954|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
127963501|NCT03889418|460484955|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
127963502|NCT03889418|460484956|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
127963503|NCT03889418|460484957|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
127963504|NCT03889418|460484958|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
127963505|NCT03889418|460484959|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
127963506|NCT03889418|460484960|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
127963507|NCT03889418|460484961|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
127963508|NCT03889418|460484962|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
127963509|NCT03889418|460484953|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
127963510|NCT03889418|460484954|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
127963511|NCT03889418|460484955|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
127963512|NCT03889418|460484956|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
127963513|NCT03889418|460484957|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
127963514|NCT03889418|460484958|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
127963515|NCT03889418|460484959|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
127963516|NCT03889418|460484960|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
127963517|NCT03889418|460484961|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
127963518|NCT03889418|460484962|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
127963519|NCT03889418|460484953|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
127963520|NCT03889418|460484954|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
127963521|NCT03889418|460484955|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
127963522|NCT03889418|460484956|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
127963523|NCT03889418|460484957|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
127963524|NCT03889418|460484958|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
127963525|NCT03889418|460484959|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
127963526|NCT03889418|460484960|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
127963527|NCT03889418|460484961|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
127963528|NCT03889418|460484962|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
127963529|NCT02172664|460484963|FG000|Overall Study|Lost to Follow-up|4|||
127963530|NCT02172664|460484964|FG001|Overall Study|Lost to Follow-up|4|||
127963531|NCT02172664|460484963|FG000|Overall Study|Death|1|||
127963532|NCT02172664|460484964|FG001|Overall Study|Death|1|||
127963533|NCT02172664|460484963|FG000|Overall Study|Moved out of area|1|||
127963534|NCT02172664|460484964|FG001|Overall Study|Moved out of area|1|||
127963535|NCT02022202|460484968|FG000|Overall Study|Withdrawal by Subject|2|||
127963536|NCT02022202|460484968|FG000|Overall Study|Disease Progression|3|||
127963537|NCT02022202|460484968|FG000|Overall Study|Desire go to immediately to surgery|3|||
127963538|NCT02166333|460484972|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
127963539|NCT02166333|460484973|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
127963540|NCT02166333|460484974|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
127963541|NCT02166333|460484975|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
127963542|NCT02166333|460484976|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
127963543|NCT02166333|460484977|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
127963544|NCT02166333|460484972|FG000|Stage 1|Death|4|||
127963545|NCT02166333|460484973|FG001|Stage 1|Death|0|||
127963546|NCT02166333|460484974|FG002|Stage 1|Death|2|||
127963547|NCT02166333|460484975|FG003|Stage 1|Death|0|||
127963548|NCT02166333|460484976|FG004|Stage 1|Death|3|||
127963549|NCT02166333|460484977|FG005|Stage 1|Death|2|||
127963550|NCT02166333|460484972|FG000|Stage 1|Lost to Follow-up|12|||
127963551|NCT02166333|460484973|FG001|Stage 1|Lost to Follow-up|0|||
127963552|NCT02166333|460484974|FG002|Stage 1|Lost to Follow-up|6|||
127963553|NCT02166333|460484975|FG003|Stage 1|Lost to Follow-up|0|||
127963554|NCT02166333|460484976|FG004|Stage 1|Lost to Follow-up|3|||
127963555|NCT02166333|460484977|FG005|Stage 1|Lost to Follow-up|3|||
127963556|NCT02166333|460484972|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
127963557|NCT02166333|460484973|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
127963558|NCT02166333|460484974|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
127963559|NCT02166333|460484975|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
127963560|NCT02166333|460484976|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
127963561|NCT02166333|460484977|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
127963562|NCT02166333|460484972|FG000|Stage 2|Death|4|||
127963563|NCT02166333|460484973|FG001|Stage 2|Death|2|||
127963564|NCT02166333|460484974|FG002|Stage 2|Death|1|||
127963565|NCT02166333|460484975|FG003|Stage 2|Death|0|||
127963566|NCT02166333|460484976|FG004|Stage 2|Death|0|||
127963567|NCT02166333|460484977|FG005|Stage 2|Death|1|||
127963568|NCT02166333|460484972|FG000|Stage 2|Lost to Follow-up|23|||
127963569|NCT02166333|460484973|FG001|Stage 2|Lost to Follow-up|4|||
127963570|NCT02166333|460484974|FG002|Stage 2|Lost to Follow-up|11|||
127963571|NCT02166333|460484975|FG003|Stage 2|Lost to Follow-up|9|||
127963572|NCT02166333|460484976|FG004|Stage 2|Lost to Follow-up|3|||
127963573|NCT02166333|460484977|FG005|Stage 2|Lost to Follow-up|6|||
127963574|NCT00503698|460484978|FG000|Overall Study|Protocol Violation|5|||
127963575|NCT00503698|460484979|FG001|Overall Study|Protocol Violation|6|||
127963576|NCT00503698|460484978|FG000|Overall Study|Adverse Event|52|||
127963577|NCT00503698|460484979|FG001|Overall Study|Adverse Event|41|||
127963578|NCT00503698|460484978|FG000|Overall Study|Death|1|||
127963579|NCT00503698|460484979|FG001|Overall Study|Death|0|||
127963580|NCT00503698|460484978|FG000|Overall Study|Lack of Efficacy|3|||
127963581|NCT00503698|460484979|FG001|Overall Study|Lack of Efficacy|4|||
127963582|NCT00503698|460484978|FG000|Overall Study|Trial terminated|216|||
127963583|NCT00503698|460484979|FG001|Overall Study|Trial terminated|253|||
127963584|NCT00503698|460484978|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
127963585|NCT00503698|460484979|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
127963586|NCT00503698|460484978|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
127963587|NCT00503698|460484979|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
127963588|NCT00503698|460484978|FG000|Overall Study|Any condition in exclusion criteria|4|||
127963589|NCT00503698|460484979|FG001|Overall Study|Any condition in exclusion criteria|6|||
127963590|NCT00503698|460484978|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
127963591|NCT00503698|460484979|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
127963592|NCT00503698|460484978|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
127963593|NCT00503698|460484979|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
127963594|NCT00503698|460484978|FG000|Overall Study|Critically ill|2|||
127963595|NCT00503698|460484979|FG001|Overall Study|Critically ill|0|||
127963596|NCT00503698|460484978|FG000|Overall Study|Unclassified|48|||
127963597|NCT00503698|460484979|FG001|Overall Study|Unclassified|32|||
127963598|NCT00503698|460484978|FG000|Overall Study|Not exposed to trial drug|11|||
127963599|NCT00503698|460484979|FG001|Overall Study|Not exposed to trial drug|6|||
127963600|NCT00682786|460484983|FG000|Overall Study|Withdrawal by Subject|2|||
127963601|NCT00682786|460484984|FG001|Overall Study|Withdrawal by Subject|2|||
127963602|NCT00682786|460484983|FG000|Overall Study|Did not receive irinotecan|0|||
127963603|NCT00682786|460484984|FG001|Overall Study|Did not receive irinotecan|1|||
127963604|NCT00359424|460484985|FG000|Overall Study|Death|99|||
127963605|NCT00359424|460484986|FG001|Overall Study|Death|58|||
127963606|NCT00359424|460484985|FG000|Overall Study|Lost to Follow-up|19|||
127963607|NCT00359424|460484986|FG001|Overall Study|Lost to Follow-up|7|||
127963608|NCT00359424|460484985|FG000|Overall Study|Withdrawal by Subject|10|||
127963609|NCT00359424|460484986|FG001|Overall Study|Withdrawal by Subject|2|||
127963610|NCT00359424|460484985|FG000|Overall Study|follow up not conducted|2|||
127963611|NCT00359424|460484986|FG001|Overall Study|follow up not conducted|0|||
127963612|NCT02462603|460484989|FG000|Overall Study|Investigator Decision|1|||
127963613|NCT02462603|460484989|FG000|Overall Study|Non-Compliance|1|||
127963614|NCT02462603|460484989|FG000|Overall Study|Withdrawal by Subject|2|||
127963615|NCT01591096|460484991|FG000|Overall Study|Adverse Event|1|||
127963616|NCT01831635|460484992|FG000|Overall Study|Withdrawal by Subject|0|||
127963617|NCT01831635|460484993|FG001|Overall Study|Withdrawal by Subject|2|||
127963618|NCT01831635|460484994|FG002|Overall Study|Withdrawal by Subject|0|||
127963619|NCT03830333|460484997|FG000|Overall Study|Death|0|||
127963620|NCT03830333|460484998|FG001|Overall Study|Death|1|||
127963621|NCT03830333|460484997|FG000|Overall Study|Withdrawal by Subject|5|||
127963622|NCT03830333|460484998|FG001|Overall Study|Withdrawal by Subject|1|||
127963623|NCT03830333|460484997|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
127963624|NCT03830333|460484998|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
127963625|NCT03805412|460484999|FG000|Overall Study|Lost to Follow-up|0|||
127963626|NCT03805412|460485000|FG001|Overall Study|Lost to Follow-up|1|||
127963627|NCT01546025|460485011|FG000|Overall Study|Lost to Follow-up|0|||
127963628|NCT01546025|460485012|FG001|Overall Study|Lost to Follow-up|1|||
127963629|NCT05514873|460485013|FG000|Main Treatment Period|Subject's lack of compliance with study procedures|1|||
127963630|NCT05514873|460485013|FG000|Main Treatment Period|Adverse Event|2|||
127963631|NCT05514873|460485013|FG000|Extension Treatment Period|Lost to Follow-up|3|||
127963632|NCT03525678|460485016|FG000|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|8|||
127963633|NCT03525678|460485017|FG001|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
127963634|NCT03525678|460485018|FG002|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
127963635|NCT03525678|460485019|FG003|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
127963636|NCT03525678|460485020|FG004|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
127963637|NCT03525678|460485016|FG000|Main Study (Day 1 to 186 Weeks)|Physician Decision|2|||
127963638|NCT03525678|460485017|FG001|Main Study (Day 1 to 186 Weeks)|Physician Decision|4|||
127963639|NCT03525678|460485018|FG002|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
127963640|NCT03525678|460485019|FG003|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
127963641|NCT03525678|460485020|FG004|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
127963642|NCT03525678|460485016|FG000|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
127963643|NCT03525678|460485017|FG001|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|1|||
127963644|NCT03525678|460485018|FG002|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
127963645|NCT03525678|460485019|FG003|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
127963646|NCT03525678|460485020|FG004|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
127963647|NCT03525678|460485016|FG000|Main Study (Day 1 to 186 Weeks)|Death|70|||
127963648|NCT03525678|460485017|FG001|Main Study (Day 1 to 186 Weeks)|Death|80|||
127963649|NCT03525678|460485018|FG002|Main Study (Day 1 to 186 Weeks)|Death|16|||
127963650|NCT03525678|460485019|FG003|Main Study (Day 1 to 186 Weeks)|Death|0|||
127963651|NCT03525678|460485020|FG004|Main Study (Day 1 to 186 Weeks)|Death|0|||
127963652|NCT03525678|460485016|FG000|Main Study (Day 1 to 186 Weeks)|other reasons|14|||
127963653|NCT03525678|460485017|FG001|Main Study (Day 1 to 186 Weeks)|other reasons|10|||
127963654|NCT03525678|460485018|FG002|Main Study (Day 1 to 186 Weeks)|other reasons|5|||
127963655|NCT03525678|460485019|FG003|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
127963656|NCT03525678|460485020|FG004|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
127963657|NCT03525678|460485016|FG000|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|1|||
127963658|NCT03525678|460485017|FG001|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|2|||
127963659|NCT03525678|460485018|FG002|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
127963660|NCT03525678|460485019|FG003|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
127963661|NCT03525678|460485020|FG004|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
127963662|NCT02747108|460485021|FG000|Overall Study|Death|2|||
127963663|NCT02747108|460485022|FG001|Overall Study|Death|2|||
127963664|NCT02747108|460485021|FG000|Overall Study|Withdrawal by Subject|1|||
127963665|NCT02747108|460485022|FG001|Overall Study|Withdrawal by Subject|0|||
127963666|NCT02747108|460485021|FG000|Overall Study|Protocol Violation|2|||
127963667|NCT02747108|460485022|FG001|Overall Study|Protocol Violation|0|||
127963668|NCT02393950|460486210|FG000|Overall Study|Adverse Event|1|||
127963669|NCT02393950|460486211|FG001|Overall Study|Adverse Event|0|||
127963670|NCT02393950|460486210|FG000|Overall Study|Withdrawal by Subject|0|||
127963671|NCT02393950|460486211|FG001|Overall Study|Withdrawal by Subject|1|||
127963672|NCT03971071|460486212|FG000|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
127963673|NCT03971071|460486213|FG001|Double-blind Treatment Period (DBTP)|Sponsor decision|1|||
127963674|NCT03971071|460486214|FG002|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
127963675|NCT03971071|460486215|FG003|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
127963676|NCT03971071|460486216|FG004|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
127963677|NCT03971071|460486212|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|7|||
127963678|NCT03971071|460486213|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|11|||
127963679|NCT03971071|460486214|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
127963680|NCT03971071|460486215|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
127963681|NCT03971071|460486216|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
127963682|NCT03971071|460486212|FG000|Double-blind Treatment Period (DBTP)|Other|2|||
127963683|NCT03971071|460486213|FG001|Double-blind Treatment Period (DBTP)|Other|2|||
127963684|NCT03971071|460486214|FG002|Double-blind Treatment Period (DBTP)|Other|0|||
127963685|NCT03971071|460486215|FG003|Double-blind Treatment Period (DBTP)|Other|0|||
127963686|NCT03971071|460486216|FG004|Double-blind Treatment Period (DBTP)|Other|0|||
127963687|NCT03971071|460486212|FG000|Open-label Treatment Period|Sponsor decision|0|||
127963688|NCT03971071|460486213|FG001|Open-label Treatment Period|Sponsor decision|0|||
127963689|NCT03971071|460486214|FG002|Open-label Treatment Period|Sponsor decision|0|||
127963690|NCT03971071|460486215|FG003|Open-label Treatment Period|Sponsor decision|0|||
127963691|NCT03971071|460486216|FG004|Open-label Treatment Period|Sponsor decision|1|||
127963692|NCT03971071|460486212|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
127963693|NCT03971071|460486213|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
127963694|NCT03971071|460486214|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
127963695|NCT03971071|460486215|FG003|Open-label Treatment Period|Withdrawal by Subject|10|||
127963696|NCT03971071|460486216|FG004|Open-label Treatment Period|Withdrawal by Subject|13|||
127963697|NCT03971071|460486212|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
127963698|NCT03971071|460486213|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
127963699|NCT03971071|460486214|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
127963700|NCT03971071|460486215|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
127963701|NCT03971071|460486216|FG004|Open-label Treatment Period|Lost to Follow-up|1|||
127963702|NCT04537078|460486217|FG000|Overall Study|Protocol Violation|3|||
127963703|NCT04537078|460486218|FG001|Overall Study|Protocol Violation|2|||
127963704|NCT04537078|460486217|FG000|Overall Study|Lost to Follow-up|1|||
127963705|NCT04537078|460486218|FG001|Overall Study|Lost to Follow-up|0|||
127963706|NCT04537078|460486217|FG000|Overall Study|Withdrawal by Subject|0|||
127963707|NCT04537078|460486218|FG001|Overall Study|Withdrawal by Subject|1|||
127963708|NCT01568892|460486220|FG000|Open-label Phase|Adverse Event|2|||
127963709|NCT01568892|460486221|FG001|Open-label Phase|Adverse Event|0|||
127963710|NCT01568892|460486220|FG000|Open-label Phase|Lack of Efficacy|4|||
127963711|NCT01568892|460486221|FG001|Open-label Phase|Lack of Efficacy|2|||
127963712|NCT01568892|460486220|FG000|Open-label Phase|Lost to Follow-up|0|||
127963713|NCT01568892|460486221|FG001|Open-label Phase|Lost to Follow-up|1|||
127963714|NCT01697748|460486228|FG000|Overall Study|ineligible skin incision|1|||
127963715|NCT01697748|460486229|FG001|Overall Study|ineligible skin incision|2|||
127963716|NCT01697748|460486228|FG000|Overall Study|ineligible uterine incision|4|||
127963717|NCT01697748|460486229|FG001|Overall Study|ineligible uterine incision|1|||
127963718|NCT01697748|460486228|FG000|Overall Study|Lost to Follow-up|53|||
127963719|NCT01697748|460486229|FG001|Overall Study|Lost to Follow-up|65|||
127963720|NCT01704495|460486233|FG000|Subjects Randomized|Other Reason|3|||
127963721|NCT01704495|460486234|FG001|Subjects Randomized|Other Reason|2|||
127963722|NCT01704495|460486235|FG002|Subjects Randomized|Other Reason|3|||
127963723|NCT01704495|460486236|FG003|Subjects Randomized|Other Reason|2|||
127963724|NCT01704495|460486233|FG000|Subjects Randomized|Discontinuation criteria met|4|||
127963725|NCT01704495|460486234|FG001|Subjects Randomized|Discontinuation criteria met|2|||
127963726|NCT01704495|460486235|FG002|Subjects Randomized|Discontinuation criteria met|2|||
127963727|NCT01704495|460486236|FG003|Subjects Randomized|Discontinuation criteria met|0|||
127963728|NCT01704495|460486233|FG000|Subjects Randomized|Adverse Event|8|||
127963729|NCT01704495|460486234|FG001|Subjects Randomized|Adverse Event|2|||
127963730|NCT01704495|460486235|FG002|Subjects Randomized|Adverse Event|0|||
127963731|NCT01704495|460486236|FG003|Subjects Randomized|Adverse Event|7|||
127963732|NCT01704495|460486233|FG000|Subjects Randomized|Withdrawal by Subject|5|||
127963733|NCT01704495|460486234|FG001|Subjects Randomized|Withdrawal by Subject|5|||
127963734|NCT01704495|460486235|FG002|Subjects Randomized|Withdrawal by Subject|5|||
127963735|NCT01704495|460486236|FG003|Subjects Randomized|Withdrawal by Subject|5|||
127963736|NCT01704495|460486233|FG000|Subjects Randomized|Protocol Violation|1|||
127963737|NCT01704495|460486234|FG001|Subjects Randomized|Protocol Violation|1|||
127963738|NCT01704495|460486235|FG002|Subjects Randomized|Protocol Violation|2|||
127963739|NCT01704495|460486236|FG003|Subjects Randomized|Protocol Violation|0|||
127963740|NCT01704495|460486233|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
127963741|NCT01704495|460486234|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
127963742|NCT01704495|460486235|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
127963743|NCT01704495|460486236|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
127963744|NCT01704495|460486233|FG000|Optional Safety Extension|Adverse Event|0|||
127963745|NCT01704495|460486234|FG001|Optional Safety Extension|Adverse Event|4|||
127963746|NCT01704495|460486235|FG002|Optional Safety Extension|Adverse Event|0|||
127963747|NCT01704495|460486236|FG003|Optional Safety Extension|Adverse Event|1|||
127963748|NCT01704495|460486233|FG000|Optional Safety Extension|Other reason|27|||
127963749|NCT01704495|460486234|FG001|Optional Safety Extension|Other reason|29|||
127963750|NCT01704495|460486235|FG002|Optional Safety Extension|Other reason|30|||
127963751|NCT01704495|460486236|FG003|Optional Safety Extension|Other reason|28|||
127963752|NCT01704495|460486233|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
127963753|NCT01704495|460486234|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
127963754|NCT01704495|460486235|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
127963755|NCT01704495|460486236|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
127963756|NCT03866512|460486237|FG000|Overall Study|Lost to Follow-up|1|||
127963757|NCT03866512|460486238|FG001|Overall Study|Lost to Follow-up|2|||
127963758|NCT03866512|460486239|FG002|Overall Study|Lost to Follow-up|1|||
127963759|NCT03866512|460486237|FG000|Overall Study|Cannulation issues|0|||
127963760|NCT03866512|460486238|FG001|Overall Study|Cannulation issues|1|||
127963761|NCT03866512|460486239|FG002|Overall Study|Cannulation issues|2|||
127963762|NCT00997373|460486244|FG000|Overall Study|Withdrawal by Subject|5|||
127963763|NCT00997373|460486245|FG001|Overall Study|Withdrawal by Subject|0|||
127963764|NCT00997373|460486244|FG000|Overall Study|wrong tumor type|4|||
127963765|NCT00997373|460486245|FG001|Overall Study|wrong tumor type|0|||
127963766|NCT00997373|460486244|FG000|Overall Study|could not have hysterectomy|6|||
127963767|NCT00997373|460486245|FG001|Overall Study|could not have hysterectomy|0|||
127963768|NCT04177095|460486254|FG000|Overall Study|Withdrawal by Subject|3|||
127963769|NCT04177095|460486254|FG000|Overall Study|Screen Failure|3|||
127963770|NCT04177095|460486254|FG000|Overall Study|Problems with the Trugraf assay|1|||
127963771|NCT00777296|460486255|FG000|Overall Study|Adverse Event|0|||
127963772|NCT00777296|460486256|FG001|Overall Study|Adverse Event|1|||
127963773|NCT00777296|460486257|FG002|Overall Study|Adverse Event|0|||
127963774|NCT00777296|460486258|FG003|Overall Study|Adverse Event|1|||
127963775|NCT00777296|460486255|FG000|Overall Study|Withdrawal by Subject|1|||
127963776|NCT00777296|460486256|FG001|Overall Study|Withdrawal by Subject|0|||
127963777|NCT00777296|460486257|FG002|Overall Study|Withdrawal by Subject|0|||
127963778|NCT00777296|460486258|FG003|Overall Study|Withdrawal by Subject|0|||
127963779|NCT00777296|460486255|FG000|Overall Study|CRF form not completed|0|||
127963780|NCT00777296|460486256|FG001|Overall Study|CRF form not completed|0|||
127963781|NCT00777296|460486257|FG002|Overall Study|CRF form not completed|2|||
127963782|NCT00777296|460486258|FG003|Overall Study|CRF form not completed|0|||
127963783|NCT01592786|460486262|FG000|Overall Study|Adverse Event|60|||
127963784|NCT01592786|460486262|FG000|Overall Study|Lack of Efficacy|19|||
127963785|NCT01592786|460486262|FG000|Overall Study|Protocol Violation|14|||
127963786|NCT01592786|460486262|FG000|Overall Study|Withdrawal by Subject|23|||
127963787|NCT01592786|460486262|FG000|Overall Study|Lost to Follow-up|19|||
127963788|NCT01592786|460486262|FG000|Overall Study|Other|3|||
127963789|NCT03210714|460486272|FG000|Overall Study|Adverse Event|6|||
127963790|NCT03210714|460486272|FG000|Overall Study|Physician Decision|1|||
127963791|NCT03210714|460486272|FG000|Overall Study|Progressive disease|11|||
127963792|NCT03210714|460486272|FG000|Overall Study|Refusal by patient/parent/guardian|2|||
127963793|NCT01909934|460486273|FG000|Overall Study|Withdrawal by Subject|3|||
127963794|NCT01909934|460486273|FG000|Overall Study|Lost to Follow-up|1|||
127963795|NCT01909934|460486273|FG000|Overall Study|Death|25|||
127963796|NCT01909934|460486273|FG000|Overall Study|Withdrawal of Informed Consent|1|||
127963797|NCT01909934|460486273|FG000|Overall Study|Reason Not Specified|1|||
127963798|NCT03810092|460486274|FG000|Overall Study|no ground support|17|||
127963799|NCT03810092|460486274|FG000|Overall Study|ADL not done at J0|16|||
127963800|NCT03810092|460486274|FG000|Overall Study|No hemoglobin measure at J5|27|||
127963801|NCT01139775|460486277|FG000|Overall Study|Adverse Event|0|||
127963802|NCT01139775|460486278|FG001|Overall Study|Adverse Event|6|||
127963803|NCT01139775|460486279|FG002|Overall Study|Adverse Event|2|||
127963804|NCT01139775|460486277|FG000|Overall Study|Protocol Violation|0|||
127963805|NCT01139775|460486278|FG001|Overall Study|Protocol Violation|5|||
127963806|NCT01139775|460486279|FG002|Overall Study|Protocol Violation|0|||
127963807|NCT01139775|460486277|FG000|Overall Study|Withdrawal by Subject|1|||
127963808|NCT01139775|460486278|FG001|Overall Study|Withdrawal by Subject|0|||
127963809|NCT01139775|460486279|FG002|Overall Study|Withdrawal by Subject|2|||
127963810|NCT01139775|460486277|FG000|Overall Study|Physician Decision|0|||
127963811|NCT01139775|460486278|FG001|Overall Study|Physician Decision|2|||
127963812|NCT01139775|460486279|FG002|Overall Study|Physician Decision|2|||
127963813|NCT01753310|460486282|FG000|Overall Study|Entered into open label extension study|25|||
127963814|NCT01753310|460486283|FG001|Overall Study|Entered into open label extension study|22|||
127963815|NCT01753310|460486282|FG000|Overall Study|Adverse Event|1|||
127963816|NCT01753310|460486283|FG001|Overall Study|Adverse Event|0|||
127963817|NCT01753310|460486282|FG000|Overall Study|Lost to Follow-up|2|||
127963818|NCT01753310|460486283|FG001|Overall Study|Lost to Follow-up|0|||
127963819|NCT01753310|460486282|FG000|Overall Study|Subject decision|2|||
127963820|NCT01753310|460486283|FG001|Overall Study|Subject decision|2|||
127963821|NCT01753310|460486282|FG000|Overall Study|Sponsor decision|1|||
127963822|NCT01753310|460486283|FG001|Overall Study|Sponsor decision|0|||
127963823|NCT01753310|460486282|FG000|Overall Study|Withdrawal by Subject|1|||
127963824|NCT01753310|460486283|FG001|Overall Study|Withdrawal by Subject|0|||
127963825|NCT03193853|460486284|FG000|Overall Study|Death|6|||
127963826|NCT05581641|460486288|FG000|Overall Study|Withdrawal by Subject|0|||
127963827|NCT05581641|460486289|FG001|Overall Study|Withdrawal by Subject|1|||
127963828|NCT05581641|460486290|FG002|Overall Study|Withdrawal by Subject|3|||
127963829|NCT05581641|460486291|FG003|Overall Study|Withdrawal by Subject|1|||
127963830|NCT05581641|460486288|FG000|Overall Study|Lost to Follow-up|0|||
127963831|NCT05581641|460486289|FG001|Overall Study|Lost to Follow-up|1|||
127963832|NCT05581641|460486290|FG002|Overall Study|Lost to Follow-up|0|||
127963833|NCT05581641|460486291|FG003|Overall Study|Lost to Follow-up|1|||
127963834|NCT05581641|460486288|FG000|Overall Study|Protocol Violation|1|||
127963835|NCT05581641|460486289|FG001|Overall Study|Protocol Violation|0|||
127963836|NCT05581641|460486290|FG002|Overall Study|Protocol Violation|0|||
127963837|NCT05581641|460486291|FG003|Overall Study|Protocol Violation|0|||
127963838|NCT05581641|460486288|FG000|Overall Study|Other|1|||
127963839|NCT05581641|460486289|FG001|Overall Study|Other|0|||
127963840|NCT05581641|460486290|FG002|Overall Study|Other|2|||
127963841|NCT05581641|460486291|FG003|Overall Study|Other|1|||
127963842|NCT01956773|460486296|FG000|Overall Study|Lost to Follow-up|628|||
127963843|NCT01956773|460486297|FG001|Overall Study|Lost to Follow-up|1|||
127963844|NCT00450437|460486302|FG000|Overall Study|Withdrawal by Subject|10|||
127963845|NCT00450437|460486303|FG001|Overall Study|Withdrawal by Subject|2|||
127963846|NCT00450437|460486304|FG002|Overall Study|Withdrawal by Subject|0|||
127963847|NCT00450437|460486305|FG003|Overall Study|Withdrawal by Subject|1|||
127963848|NCT00450437|460486302|FG000|Overall Study|Lost to Follow-up|31|||
127963849|NCT00450437|460486303|FG001|Overall Study|Lost to Follow-up|12|||
127963850|NCT00450437|460486304|FG002|Overall Study|Lost to Follow-up|19|||
127963851|NCT00450437|460486305|FG003|Overall Study|Lost to Follow-up|9|||
127963852|NCT00450437|460486302|FG000|Overall Study|Protocol Violation|0|||
127963853|NCT00450437|460486303|FG001|Overall Study|Protocol Violation|1|||
127963854|NCT00450437|460486304|FG002|Overall Study|Protocol Violation|0|||
127963855|NCT00450437|460486305|FG003|Overall Study|Protocol Violation|1|||
127963856|NCT00450437|460486302|FG000|Overall Study|Inappropriate enrollment|4|||
127963857|NCT00450437|460486303|FG001|Overall Study|Inappropriate enrollment|1|||
127963858|NCT00450437|460486304|FG002|Overall Study|Inappropriate enrollment|3|||
127963859|NCT00450437|460486305|FG003|Overall Study|Inappropriate enrollment|0|||
127963860|NCT00450437|460486302|FG000|Overall Study|Administrative reason|0|||
127963861|NCT00450437|460486303|FG001|Overall Study|Administrative reason|0|||
127963862|NCT00450437|460486304|FG002|Overall Study|Administrative reason|1|||
127963863|NCT00450437|460486305|FG003|Overall Study|Administrative reason|0|||
127963864|NCT00450437|460486302|FG000|Overall Study|Unable to Classify|1|||
127963865|NCT00450437|460486303|FG001|Overall Study|Unable to Classify|0|||
127963866|NCT00450437|460486304|FG002|Overall Study|Unable to Classify|1|||
127963867|NCT00450437|460486305|FG003|Overall Study|Unable to Classify|0|||
127963868|NCT02492867|460486306|FG000|Overall Study|Alternate therapy|1|||
127963869|NCT02492867|460486306|FG000|Overall Study|Withdrawal by Subject|2|||
127963870|NCT02492867|460486306|FG000|Overall Study|Disease progression after treatment started|1|||
127963871|NCT02492867|460486306|FG000|Overall Study|Death|1|||
127963872|NCT03296527|460486307|FG000|Overall Study|Adverse Event|15|||
127963873|NCT03296527|460486308|FG001|Overall Study|Adverse Event|33|||
127963874|NCT03296527|460486307|FG000|Overall Study|Protocol Deviation|4|||
127963875|NCT03296527|460486308|FG001|Overall Study|Protocol Deviation|0|||
127963876|NCT03296527|460486307|FG000|Overall Study|Participant withdrew consent|3|||
127963877|NCT03296527|460486308|FG001|Overall Study|Participant withdrew consent|1|||
127963878|NCT03296527|460486307|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
127963879|NCT03296527|460486308|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
127963880|NCT03296527|460486307|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
127963881|NCT03296527|460486308|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
127963882|NCT03296527|460486307|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
127963883|NCT03296527|460486308|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
127963884|NCT03296527|460486307|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
127963885|NCT03296527|460486308|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
127963886|NCT03296527|460486307|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
127963887|NCT03296527|460486308|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
127963888|NCT00122382|460486309|FG000|Double-Blind Study|Adverse Event|9|||
127963889|NCT00122382|460486310|FG001|Double-Blind Study|Adverse Event|11|||
127963890|NCT00122382|460486311|FG002|Double-Blind Study|Adverse Event|0|||
127963891|NCT00122382|460486309|FG000|Double-Blind Study|Death|2|||
127963892|NCT00122382|460486310|FG001|Double-Blind Study|Death|2|||
127963893|NCT00122382|460486311|FG002|Double-Blind Study|Death|0|||
127963894|NCT00122382|460486309|FG000|Double-Blind Study|Lack of Efficacy|0|||
127963895|NCT00122382|460486310|FG001|Double-Blind Study|Lack of Efficacy|8|||
127963896|NCT00122382|460486311|FG002|Double-Blind Study|Lack of Efficacy|0|||
127963897|NCT00122382|460486309|FG000|Double-Blind Study|Lost to Follow-up|2|||
127963898|NCT00122382|460486310|FG001|Double-Blind Study|Lost to Follow-up|1|||
127963899|NCT00122382|460486311|FG002|Double-Blind Study|Lost to Follow-up|0|||
127963900|NCT00122382|460486309|FG000|Double-Blind Study|Pregnancy|2|||
127963901|NCT00122382|460486310|FG001|Double-Blind Study|Pregnancy|0|||
127963902|NCT00122382|460486311|FG002|Double-Blind Study|Pregnancy|0|||
127963903|NCT00122382|460486309|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
127963904|NCT00122382|460486310|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
127963905|NCT00122382|460486311|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
127963906|NCT00122382|460486309|FG000|Double-Blind Study|Withdrawal of Consent|7|||
127963907|NCT00122382|460486310|FG001|Double-Blind Study|Withdrawal of Consent|3|||
127963908|NCT00122382|460486311|FG002|Double-Blind Study|Withdrawal of Consent|0|||
127963909|NCT00122382|460486309|FG000|Double-Blind Study|Protocol Violation|1|||
127963910|NCT00122382|460486310|FG001|Double-Blind Study|Protocol Violation|0|||
127963911|NCT00122382|460486311|FG002|Double-Blind Study|Protocol Violation|0|||
127963912|NCT00122382|460486309|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
127963913|NCT00122382|460486310|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
127963914|NCT00122382|460486311|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
127963915|NCT00122382|460486309|FG000|Double-Blind Study|Randomized but not treated|0|||
127963916|NCT00122382|460486310|FG001|Double-Blind Study|Randomized but not treated|2|||
127963917|NCT00122382|460486311|FG002|Double-Blind Study|Randomized but not treated|0|||
127963918|NCT00122382|460486309|FG000|Open-Label Study|Adverse Event|0|||
127963919|NCT00122382|460486310|FG001|Open-Label Study|Adverse Event|0|||
127963920|NCT00122382|460486311|FG002|Open-Label Study|Adverse Event|11|||
127963921|NCT00122382|460486309|FG000|Open-Label Study|Death|0|||
127963922|NCT00122382|460486310|FG001|Open-Label Study|Death|0|||
127963923|NCT00122382|460486311|FG002|Open-Label Study|Death|2|||
127963924|NCT00122382|460486309|FG000|Open-Label Study|Lack of Efficacy|0|||
127963925|NCT00122382|460486310|FG001|Open-Label Study|Lack of Efficacy|0|||
127963926|NCT00122382|460486311|FG002|Open-Label Study|Lack of Efficacy|3|||
127963927|NCT00122382|460486309|FG000|Open-Label Study|Lost to Follow-up|0|||
127963928|NCT00122382|460486310|FG001|Open-Label Study|Lost to Follow-up|0|||
127963929|NCT00122382|460486311|FG002|Open-Label Study|Lost to Follow-up|3|||
127963930|NCT00122382|460486309|FG000|Open-Label Study|Pregnancy|0|||
127963931|NCT00122382|460486310|FG001|Open-Label Study|Pregnancy|0|||
127963932|NCT00122382|460486311|FG002|Open-Label Study|Pregnancy|2|||
127963933|NCT00122382|460486309|FG000|Open-Label Study|Poor/Non-Compliance|0|||
127963934|NCT00122382|460486310|FG001|Open-Label Study|Poor/Non-Compliance|0|||
127963935|NCT00122382|460486311|FG002|Open-Label Study|Poor/Non-Compliance|1|||
127963936|NCT00122382|460486309|FG000|Open-Label Study|Withdrawal of Consent|0|||
127963937|NCT00122382|460486310|FG001|Open-Label Study|Withdrawal of Consent|0|||
127963938|NCT00122382|460486311|FG002|Open-Label Study|Withdrawal of Consent|4|||
127963939|NCT02040805|460486312|FG000|Overall Study|Lost to Follow-up|14|||
127963940|NCT02040805|460486313|FG001|Overall Study|Lost to Follow-up|9|||
127963941|NCT02040805|460486312|FG000|Overall Study|Withdrawal by Subject|28|||
127963942|NCT02040805|460486313|FG001|Overall Study|Withdrawal by Subject|41|||
127963943|NCT01213966|460486315|FG000|Overall Study|Protocol Violation|1|||
127963944|NCT01213966|460486316|FG001|Overall Study|Protocol Violation|0|||
127963945|NCT01213966|460486317|FG002|Overall Study|Protocol Violation|3|||
127963946|NCT01213966|460486318|FG003|Overall Study|Protocol Violation|1|||
127963947|NCT03591874|460486319|FG000|Overall Study|Adverse Event|4|||
127963948|NCT03591874|460486320|FG001|Overall Study|Adverse Event|0|||
127963949|NCT03591874|460486319|FG000|Overall Study|Withdrawal by Subject|2|||
127963950|NCT03591874|460486320|FG001|Overall Study|Withdrawal by Subject|1|||
127963951|NCT03591874|460486319|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
127963952|NCT03591874|460486320|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
127963953|NCT03591874|460486319|FG000|Overall Study|On Study at Time of Study Termination|12|||
127963954|NCT03591874|460486320|FG001|Overall Study|On Study at Time of Study Termination|6|||
127963955|NCT03644342|460486323|FG000|Overall Study|Adverse Event|2|||
127963956|NCT03644342|460486324|FG001|Overall Study|Adverse Event|0|||
127963957|NCT03644342|460486323|FG000|Overall Study|Protocol Violation|0|||
127963958|NCT03644342|460486324|FG001|Overall Study|Protocol Violation|1|||
127963959|NCT01445730|460486327|FG000|Overall Study|Adverse Event|1|||
127963960|NCT01445730|460486327|FG000|Overall Study|For the advice of a dentist|1|||
127963961|NCT01445730|460486327|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
127963962|NCT01167140|460486328|FG000|Overall Study|Withdrawal by Subject|1|||
127963963|NCT03896503|460487607|FG000|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
127963964|NCT03896503|460487608|FG001|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
127963965|NCT03896503|460487609|FG002|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
127963966|NCT03896503|460487610|FG003|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
127963967|NCT03896503|460487611|FG004|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
127963968|NCT03896503|460487612|FG005|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
127963969|NCT03896503|460487613|FG006|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
127963970|NCT03896503|460487614|FG007|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
127963971|NCT03896503|460487607|FG000|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
127963972|NCT03896503|460487608|FG001|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
127963973|NCT03896503|460487609|FG002|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
127963974|NCT03896503|460487610|FG003|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
127963975|NCT03896503|460487611|FG004|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
127963976|NCT03896503|460487612|FG005|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
127963977|NCT03896503|460487613|FG006|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
127963978|NCT03896503|460487614|FG007|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
127963979|NCT03896503|460487607|FG000|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
127963980|NCT03896503|460487608|FG001|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
127963981|NCT03896503|460487609|FG002|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
127963982|NCT03896503|460487610|FG003|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
127963983|NCT03896503|460487611|FG004|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
127963984|NCT03896503|460487612|FG005|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
127963985|NCT03896503|460487613|FG006|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
127963986|NCT03896503|460487614|FG007|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
127963987|NCT03896503|460487607|FG000|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
127963988|NCT03896503|460487608|FG001|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
127963989|NCT03896503|460487609|FG002|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
127963990|NCT03896503|460487610|FG003|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
127963991|NCT03896503|460487611|FG004|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
127963992|NCT03896503|460487612|FG005|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
127963993|NCT03896503|460487613|FG006|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
127963994|NCT03896503|460487614|FG007|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
127963995|NCT03896503|460487607|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
127963996|NCT03896503|460487608|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
127963997|NCT03896503|460487609|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|4|||
127963998|NCT03896503|460487610|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
127963999|NCT03896503|460487611|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
127964000|NCT03896503|460487612|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
127964001|NCT03896503|460487613|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|1|||
127964002|NCT03896503|460487614|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
127964003|NCT03896503|460487607|FG000|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
127964004|NCT03896503|460487608|FG001|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
127964005|NCT03896503|460487609|FG002|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
127964006|NCT03896503|460487610|FG003|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
127964007|NCT03896503|460487611|FG004|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
127964008|NCT03896503|460487612|FG005|Initial Subgroup and Arm Enrollment|Not treated; screen failure|3|||
127964009|NCT03896503|460487613|FG006|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
127964010|NCT03896503|460487614|FG007|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
127964011|NCT03896503|460487607|FG000|Initial Subgroup and Arm Enrollment|Refused further treatment|2|||
127964012|NCT03896503|460487608|FG001|Initial Subgroup and Arm Enrollment|Refused further treatment|1|||
127964013|NCT03896503|460487609|FG002|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
127964014|NCT03896503|460487610|FG003|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
127964015|NCT03896503|460487611|FG004|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
127964016|NCT03896503|460487612|FG005|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
127964017|NCT03896503|460487613|FG006|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
127964018|NCT03896503|460487614|FG007|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
127964019|NCT03896503|460487607|FG000|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
127964020|NCT03896503|460487608|FG001|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|1|||
127964021|NCT03896503|460487609|FG002|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
127964022|NCT03896503|460487610|FG003|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
127964023|NCT03896503|460487611|FG004|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
127964024|NCT03896503|460487612|FG005|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
127964025|NCT03896503|460487613|FG006|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
127964026|NCT03896503|460487614|FG007|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
127964027|NCT03896503|460487607|FG000|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
127964028|NCT03896503|460487608|FG001|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
127964029|NCT03896503|460487609|FG002|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
127964030|NCT03896503|460487610|FG003|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
127964031|NCT03896503|460487611|FG004|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|1|||
127964032|NCT03896503|460487612|FG005|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
127964033|NCT03896503|460487613|FG006|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
127964034|NCT03896503|460487614|FG007|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
127964035|NCT03896503|460487607|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
127964036|NCT03896503|460487608|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
127964037|NCT03896503|460487609|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
127964038|NCT03896503|460487610|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
127964039|NCT03896503|460487611|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
127964040|NCT03896503|460487612|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|2|||
127964041|NCT03896503|460487613|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
127964042|NCT03896503|460487614|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
127964043|NCT03896503|460487607|FG000|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
127964044|NCT03896503|460487608|FG001|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
127964045|NCT03896503|460487609|FG002|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
127964046|NCT03896503|460487610|FG003|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
127964047|NCT03896503|460487611|FG004|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
127964048|NCT03896503|460487612|FG005|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
127964049|NCT03896503|460487613|FG006|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
127964050|NCT03896503|460487614|FG007|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
127964051|NCT05734157|460487615|FG000|Overall Study|Death|3|||
127964052|NCT05734157|460487615|FG000|Overall Study|Withdrawal by Subject|2|||
127964053|NCT05734157|460487615|FG000|Overall Study|Lost to Follow-up|1|||
127964054|NCT05734157|460487615|FG000|Overall Study|Telephone call|3|||
127964055|NCT00210210|460487619|FG000|Overall Study|Withdrawal by Subject|3|||
127964056|NCT00210210|460487620|FG001|Overall Study|Withdrawal by Subject|2|||
127964057|NCT00210210|460487619|FG000|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|3|||
127964058|NCT00210210|460487620|FG001|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|9|||
127964059|NCT02275546|460487629|FG000|Treatment Period 2|Withdrawal by Subject|2|||
127964060|NCT02275546|460487630|FG001|Treatment Period 2|Withdrawal by Subject|1|||
127964061|NCT02275546|460487629|FG000|Treatment Period 2|Protocol Violation|0|||
127964062|NCT02275546|460487630|FG001|Treatment Period 2|Protocol Violation|1|||
127964063|NCT02955355|460487634|FG000|Overall Study|Adverse Event|4|||
127964064|NCT02955355|460487634|FG000|Overall Study|Death|1|||
127964065|NCT02955355|460487634|FG000|Overall Study|Physician Decision|21|||
127964066|NCT02955355|460487634|FG000|Overall Study|Site Terminated by Sponsor|35|||
127964067|NCT02955355|460487634|FG000|Overall Study|Withdrawal by Subject|19|||
127964068|NCT02955355|460487634|FG000|Overall Study|Reason Not Specified|5|||
127964069|NCT02612623|460487635|FG000|Overall Study|Withdrawal by Subject|0|||
127964070|NCT02612623|460487636|FG001|Overall Study|Withdrawal by Subject|1|||
127964071|NCT02612623|460487637|FG002|Overall Study|Withdrawal by Subject|0|||
127964072|NCT02612623|460487638|FG003|Overall Study|Withdrawal by Subject|0|||
127964073|NCT02612623|460487635|FG000|Overall Study|Adverse Event|1|||
127964074|NCT02612623|460487636|FG001|Overall Study|Adverse Event|0|||
127964075|NCT02612623|460487637|FG002|Overall Study|Adverse Event|1|||
127964076|NCT02612623|460487638|FG003|Overall Study|Adverse Event|0|||
127964077|NCT05177484|460487639|FG000|Overall Study|Withdrawn as not anaemic post operatively|1|||
127964078|NCT05177484|460487640|FG001|Overall Study|Withdrawn as not anaemic post operatively|0|||
127964079|NCT05177484|460487639|FG000|Overall Study|Inadvertently withdrawn|3|||
127964080|NCT05177484|460487640|FG001|Overall Study|Inadvertently withdrawn|1|||
127964081|NCT05177484|460487639|FG000|Overall Study|Withdrawn as not given standard care, given IV iron|0|||
127964082|NCT05177484|460487640|FG001|Overall Study|Withdrawn as not given standard care, given IV iron|1|||
127964083|NCT05486091|460487645|FG000|Overall Study|Withdrawal by Subject|1|||
127964084|NCT05486091|460487645|FG000|Overall Study|Lost to Follow-up|2|||
127964085|NCT03817853|460487649|FG000|Induction Phase|Adverse Event|5|||
127964086|NCT03817853|460487650|FG001|Induction Phase|Adverse Event|0|||
127964087|NCT03817853|460487651|FG002|Induction Phase|Adverse Event|0|||
127964088|NCT03817853|460487649|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
127964089|NCT03817853|460487650|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
127964090|NCT03817853|460487651|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
127964091|NCT03817853|460487649|FG000|Induction Phase|Physician Decision|2|||
127964092|NCT03817853|460487650|FG001|Induction Phase|Physician Decision|0|||
127964093|NCT03817853|460487651|FG002|Induction Phase|Physician Decision|0|||
127964094|NCT03817853|460487649|FG000|Induction Phase|Progressive Disease|6|||
127964095|NCT03817853|460487650|FG001|Induction Phase|Progressive Disease|0|||
127964096|NCT03817853|460487651|FG002|Induction Phase|Progressive Disease|0|||
127964097|NCT03817853|460487649|FG000|Induction Phase|Withdrawal by Subject|4|||
127964098|NCT03817853|460487650|FG001|Induction Phase|Withdrawal by Subject|0|||
127964099|NCT03817853|460487651|FG002|Induction Phase|Withdrawal by Subject|0|||
127964100|NCT03817853|460487649|FG000|Maintenance Phase|Adverse Event|0|||
127964101|NCT03817853|460487650|FG001|Maintenance Phase|Adverse Event|8|||
127964102|NCT03817853|460487651|FG002|Maintenance Phase|Adverse Event|0|||
127964103|NCT03817853|460487649|FG000|Maintenance Phase|Death|0|||
127964104|NCT03817853|460487650|FG001|Maintenance Phase|Death|5|||
127964105|NCT03817853|460487651|FG002|Maintenance Phase|Death|0|||
127964106|NCT03817853|460487649|FG000|Maintenance Phase|Progressive Disease|0|||
127964107|NCT03817853|460487650|FG001|Maintenance Phase|Progressive Disease|7|||
127964108|NCT03817853|460487651|FG002|Maintenance Phase|Progressive Disease|0|||
127964109|NCT03817853|460487649|FG000|Maintenance Phase|Withdrawal by Subject|0|||
127964110|NCT03817853|460487650|FG001|Maintenance Phase|Withdrawal by Subject|2|||
127964111|NCT03817853|460487651|FG002|Maintenance Phase|Withdrawal by Subject|0|||
127964112|NCT03817853|460487649|FG000|Maintenance Phase|Physician Decision|0|||
127964113|NCT03817853|460487650|FG001|Maintenance Phase|Physician Decision|1|||
127964114|NCT03817853|460487651|FG002|Maintenance Phase|Physician Decision|0|||
127964115|NCT03817853|460487649|FG000|Maintenance Phase|Various reasons|0|||
127964116|NCT03817853|460487650|FG001|Maintenance Phase|Various reasons|4|||
127964117|NCT03817853|460487651|FG002|Maintenance Phase|Various reasons|0|||
127964118|NCT03817853|460487649|FG000|Maintenance Phase|Protocol Deviation|0|||
127964119|NCT03817853|460487650|FG001|Maintenance Phase|Protocol Deviation|1|||
127964120|NCT03817853|460487651|FG002|Maintenance Phase|Protocol Deviation|0|||
127964121|NCT03817853|460487649|FG000|Follow-up Phase|Adverse Event|0|||
127964122|NCT03817853|460487650|FG001|Follow-up Phase|Adverse Event|0|||
127964123|NCT03817853|460487651|FG002|Follow-up Phase|Adverse Event|2|||
127964124|NCT03817853|460487649|FG000|Follow-up Phase|Death|0|||
127964125|NCT03817853|460487650|FG001|Follow-up Phase|Death|0|||
127964126|NCT03817853|460487651|FG002|Follow-up Phase|Death|1|||
127964127|NCT03817853|460487649|FG000|Follow-up Phase|Progressive Disease|0|||
127964128|NCT03817853|460487650|FG001|Follow-up Phase|Progressive Disease|0|||
127964129|NCT03817853|460487651|FG002|Follow-up Phase|Progressive Disease|3|||
127964130|NCT03817853|460487649|FG000|Follow-up Phase|Withdrawal by Subject|0|||
127964131|NCT03817853|460487650|FG001|Follow-up Phase|Withdrawal by Subject|0|||
127964132|NCT03817853|460487651|FG002|Follow-up Phase|Withdrawal by Subject|1|||
127964133|NCT00314340|460487652|FG000|Overall Study|lost interest|1|||
127964134|NCT01620138|460487655|FG000|Overall Study|Withdrawal by Subject|3|||
127964135|NCT01620138|460487656|FG001|Overall Study|Withdrawal by Subject|0|||
127964136|NCT01620138|460487655|FG000|Overall Study|Lack of Efficacy|1|||
127964137|NCT01620138|460487656|FG001|Overall Study|Lack of Efficacy|0|||
127964138|NCT01620138|460487655|FG000|Overall Study|Adverse Event|2|||
127964139|NCT01620138|460487656|FG001|Overall Study|Adverse Event|0|||
127964140|NCT03252535|460487657|FG000|Overall Study|Withdrawal by Subject|1|||
127964141|NCT03252535|460487658|FG001|Overall Study|Withdrawal by Subject|0|||
127964142|NCT03252535|460487659|FG002|Overall Study|Withdrawal by Subject|0|||
127964143|NCT03252535|460487657|FG000|Overall Study|Physician Decision|0|||
127964144|NCT03252535|460487658|FG001|Overall Study|Physician Decision|1|||
127964145|NCT03252535|460487659|FG002|Overall Study|Physician Decision|0|||
127964146|NCT03252535|460487657|FG000|Overall Study|Met discontinuation criteria|0|||
127964147|NCT03252535|460487658|FG001|Overall Study|Met discontinuation criteria|1|||
127964148|NCT03252535|460487659|FG002|Overall Study|Met discontinuation criteria|0|||
127964149|NCT05600283|460487660|FG000|Overall Study|Withdrawal by Subject|3|||
127964150|NCT05600283|460487661|FG001|Overall Study|Withdrawal by Subject|8|||
127964151|NCT05600283|460487660|FG000|Overall Study|invalid individual swab|1|||
127964152|NCT05600283|460487661|FG001|Overall Study|invalid individual swab|0|||
127964153|NCT05600283|460487660|FG000|Overall Study|missing clinician collection|3|||
127964154|NCT05600283|460487661|FG001|Overall Study|missing clinician collection|0|||
127964155|NCT05600283|460487660|FG000|Overall Study|screening failure|0|||
127964156|NCT05600283|460487661|FG001|Overall Study|screening failure|2|||
127964157|NCT03907488|460487662|FG000|Overall Study|Adverse Event|20|||
127964158|NCT03907488|460487663|FG001|Overall Study|Adverse Event|20|||
127964159|NCT03907488|460487662|FG000|Overall Study|Withdrawal by Subject|9|||
127964160|NCT03907488|460487663|FG001|Overall Study|Withdrawal by Subject|13|||
127964161|NCT03907488|460487662|FG000|Overall Study|Lack of Efficacy|0|||
127964162|NCT03907488|460487663|FG001|Overall Study|Lack of Efficacy|9|||
127964163|NCT03907488|460487662|FG000|Overall Study|Death|3|||
127964164|NCT03907488|460487663|FG001|Overall Study|Death|8|||
127964165|NCT03907488|460487662|FG000|Overall Study|not protocol specified|5|||
127964166|NCT03907488|460487663|FG001|Overall Study|not protocol specified|8|||
127964167|NCT03907488|460487662|FG000|Overall Study|Ineligible|9|||
127964168|NCT03907488|460487663|FG001|Overall Study|Ineligible|15|||
127964169|NCT02269098|460487664|FG000|Overall Study|Lost to Follow-up|14|||
127964170|NCT02269098|460487665|FG001|Overall Study|Lost to Follow-up|9|||
127964171|NCT03194542|460487668|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
127964172|NCT03194542|460487669|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
127964173|NCT03194542|460487670|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
127964174|NCT03194542|460487671|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
127964175|NCT03194542|460487668|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
127964176|NCT03194542|460487669|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
127964177|NCT03194542|460487670|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
127964178|NCT03194542|460487671|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
127964179|NCT03194542|460487668|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
127964180|NCT03194542|460487669|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
127964181|NCT03194542|460487670|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
127964182|NCT03194542|460487671|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
127964183|NCT03194542|460487668|FG000|Overall Study|Loss of Response|4|||
127964184|NCT03194542|460487669|FG001|Overall Study|Loss of Response|2|||
127964185|NCT03194542|460487670|FG002|Overall Study|Loss of Response|3|||
127964186|NCT03194542|460487671|FG003|Overall Study|Loss of Response|4|||
127964187|NCT03194542|460487668|FG000|Overall Study|Physician Decision|0|||
127964188|NCT03194542|460487669|FG001|Overall Study|Physician Decision|1|||
127964189|NCT03194542|460487670|FG002|Overall Study|Physician Decision|0|||
127964190|NCT03194542|460487671|FG003|Overall Study|Physician Decision|0|||
127964191|NCT03194542|460487668|FG000|Overall Study|Lack of Efficacy|2|||
127964192|NCT03194542|460487669|FG001|Overall Study|Lack of Efficacy|2|||
127964193|NCT03194542|460487670|FG002|Overall Study|Lack of Efficacy|2|||
127964194|NCT03194542|460487671|FG003|Overall Study|Lack of Efficacy|6|||
127964195|NCT03194542|460487668|FG000|Overall Study|Withdrawal by Subject|2|||
127964196|NCT03194542|460487669|FG001|Overall Study|Withdrawal by Subject|1|||
127964197|NCT03194542|460487670|FG002|Overall Study|Withdrawal by Subject|5|||
127964198|NCT03194542|460487671|FG003|Overall Study|Withdrawal by Subject|4|||
127964199|NCT03194542|460487668|FG000|Overall Study|Progressive Disease|1|||
127964200|NCT03194542|460487669|FG001|Overall Study|Progressive Disease|0|||
127964201|NCT03194542|460487670|FG002|Overall Study|Progressive Disease|1|||
127964202|NCT03194542|460487671|FG003|Overall Study|Progressive Disease|1|||
127964203|NCT03194542|460487668|FG000|Overall Study|Adverse Event|1|||
127964204|NCT03194542|460487669|FG001|Overall Study|Adverse Event|2|||
127964205|NCT03194542|460487670|FG002|Overall Study|Adverse Event|0|||
127964206|NCT03194542|460487671|FG003|Overall Study|Adverse Event|5|||
127964207|NCT03194542|460487668|FG000|Overall Study|Death|1|||
127964208|NCT03194542|460487669|FG001|Overall Study|Death|2|||
127964209|NCT03194542|460487670|FG002|Overall Study|Death|0|||
127964210|NCT03194542|460487671|FG003|Overall Study|Death|5|||
127964211|NCT03194542|460487668|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
127964212|NCT03194542|460487669|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
127964213|NCT03194542|460487670|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
127964214|NCT03194542|460487671|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
127964215|NCT04762160|460487672|FG000|Overall Study|Study terminated early due to business reasons|5|||
127964216|NCT03655405|460487675|FG000|Overall Study|Death after initial data collection|4|||
127964217|NCT03655405|460487676|FG001|Overall Study|Death after initial data collection|2|||
127964218|NCT03655405|460487675|FG000|Overall Study|Died before initial data collection|1|||
127964219|NCT03655405|460487676|FG001|Overall Study|Died before initial data collection|2|||
127964220|NCT03655405|460487675|FG000|Overall Study|Protocol Violation|0|||
127964221|NCT03655405|460487676|FG001|Overall Study|Protocol Violation|1|||
127964222|NCT01991743|460487678|FG000|Overall Study|external cephalic version not performed|0|||
127964223|NCT01991743|460487679|FG001|Overall Study|external cephalic version not performed|0|||
127964224|NCT01991743|460487680|FG002|Overall Study|external cephalic version not performed|1|||
127964225|NCT01991743|460487681|FG003|Overall Study|external cephalic version not performed|0|||
127964226|NCT02859337|460487683|FG000|Overall Study|Study drug not dosed (no dominant follicle)|2|||
127964227|NCT02859337|460487684|FG001|Overall Study|Study drug not dosed (no dominant follicle)|2|||
127964228|NCT02859337|460487685|FG002|Overall Study|Study drug not dosed (no dominant follicle)|0|||
127964229|NCT02859337|460487683|FG000|Overall Study|Withdrawal by Subject|3|||
127964230|NCT02859337|460487684|FG001|Overall Study|Withdrawal by Subject|1|||
127964231|NCT02859337|460487685|FG002|Overall Study|Withdrawal by Subject|0|||
127964232|NCT02859337|460487683|FG000|Overall Study|Lost to Follow-up|1|||
127964233|NCT02859337|460487684|FG001|Overall Study|Lost to Follow-up|0|||
127964234|NCT02859337|460487685|FG002|Overall Study|Lost to Follow-up|0|||
127964235|NCT04390113|460487692|FG000|Overall Study|Not Treated|0|||
127964236|NCT04390113|460487693|FG001|Overall Study|Not Treated|1|||
127964237|NCT04390113|460487692|FG000|Overall Study|Adverse Event|1|||
127964238|NCT04390113|460487693|FG001|Overall Study|Adverse Event|0|||
127964239|NCT04390113|460487692|FG000|Overall Study|Death|2|||
127964240|NCT04390113|460487693|FG001|Overall Study|Death|1|||
127964241|NCT04390113|460487692|FG000|Overall Study|Physician Decision|1|||
127964242|NCT04390113|460487693|FG001|Overall Study|Physician Decision|3|||
127964243|NCT04390113|460487692|FG000|Overall Study|Study Terminated by Sponsor|5|||
127964244|NCT04390113|460487693|FG001|Overall Study|Study Terminated by Sponsor|3|||
127964245|NCT04390113|460487692|FG000|Overall Study|Withdrawal by Subject|10|||
127964246|NCT04390113|460487693|FG001|Overall Study|Withdrawal by Subject|5|||
127964247|NCT04390113|460487692|FG000|Overall Study|Other|1|||
127964248|NCT04390113|460487693|FG001|Overall Study|Other|0|||
127964249|NCT04390113|460487692|FG000|Overall Study|Missing|0|||
127964250|NCT04390113|460487693|FG001|Overall Study|Missing|1|||
127964251|NCT01611883|460487694|FG000|Overall Study|Adverse Event|1|||
127964252|NCT01611883|460487695|FG001|Overall Study|Adverse Event|1|||
127964253|NCT00030901|460487696|FG000|Initial Registration|Ineligible|167|||
127964254|NCT00030901|460487697|FG001|Initial Registration|Ineligible|0|||
127964255|NCT00030901|460487698|FG002|Initial Registration|Ineligible|0|||
127964256|NCT00030901|460487696|FG000|Randomization|Adverse Event|0|||
127964257|NCT00030901|460487697|FG001|Randomization|Adverse Event|11|||
127964258|NCT00030901|460487698|FG002|Randomization|Adverse Event|7|||
127964259|NCT00030901|460487696|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
127964260|NCT00030901|460487697|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
127964261|NCT00030901|460487698|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
127964262|NCT00030901|460487696|FG000|Randomization|Progression/Relapse|0|||
127964263|NCT00030901|460487697|FG001|Randomization|Progression/Relapse|22|||
127964264|NCT00030901|460487698|FG002|Randomization|Progression/Relapse|21|||
127964265|NCT00030901|460487696|FG000|Randomization|Death|0|||
127964266|NCT00030901|460487697|FG001|Randomization|Death|1|||
127964267|NCT00030901|460487698|FG002|Randomization|Death|3|||
127964268|NCT00030901|460487696|FG000|Randomization|Other|0|||
127964269|NCT00030901|460487697|FG001|Randomization|Other|36|||
127964270|NCT00030901|460487698|FG002|Randomization|Other|33|||
127964271|NCT00030901|460487696|FG000|Randomization|Ineligible|0|||
127964272|NCT00030901|460487697|FG001|Randomization|Ineligible|15|||
127964273|NCT00030901|460487698|FG002|Randomization|Ineligible|14|||
127964274|NCT02576847|460487701|FG000|Overall Study|Adverse Event|27|||
127964275|NCT02576847|460487701|FG000|Overall Study|Lost to Follow-up|22|||
127964276|NCT02576847|460487701|FG000|Overall Study|Physician Decision|1|||
127964277|NCT02576847|460487701|FG000|Overall Study|Pregnancy|1|||
127964278|NCT02576847|460487701|FG000|Overall Study|Protocol Violation|3|||
127964279|NCT02576847|460487701|FG000|Overall Study|Withdrawal by Subject|78|||
127964280|NCT02576847|460487701|FG000|Overall Study|Other|5|||
127964281|NCT01806051|460487702|FG000|Overall Study|Withdrawal by Subject|6|||
127964282|NCT01205776|460487703|FG000|Overall Study|Lost to Follow-up|53|||
127964283|NCT01205776|460487704|FG001|Overall Study|Lost to Follow-up|61|||
127964284|NCT01205776|460487703|FG000|Overall Study|Withdrawal by Subject|11|||
127964285|NCT01205776|460487704|FG001|Overall Study|Withdrawal by Subject|34|||
127964286|NCT00734994|460487705|FG000|Overall Study|Withdrawal by Subject|1|||
127964287|NCT03817190|460487708|FG000|Overall Study|Early Termination|13|||
127964288|NCT03817190|460487709|FG001|Overall Study|Early Termination|20|||
127964289|NCT03817190|460487708|FG000|Overall Study|Adverse Event|10|||
127964290|NCT03817190|460487709|FG001|Overall Study|Adverse Event|17|||
127964291|NCT03817190|460487708|FG000|Overall Study|Withdrawal by Subject|12|||
127964292|NCT03817190|460487709|FG001|Overall Study|Withdrawal by Subject|8|||
127964293|NCT03817190|460487708|FG000|Overall Study|Lost to Follow-up|11|||
127964294|NCT03817190|460487709|FG001|Overall Study|Lost to Follow-up|7|||
127964295|NCT03817190|460487708|FG000|Overall Study|Lack of Efficacy|7|||
127964296|NCT03817190|460487709|FG001|Overall Study|Lack of Efficacy|5|||
127964297|NCT03817190|460487708|FG000|Overall Study|Investigator Decision|5|||
127964298|NCT03817190|460487709|FG001|Overall Study|Investigator Decision|1|||
127964299|NCT03817190|460487708|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
127964300|NCT03817190|460487709|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
127964301|NCT03817190|460487708|FG000|Overall Study|Lack of Contact|1|||
127964302|NCT03817190|460487709|FG001|Overall Study|Lack of Contact|0|||
127964303|NCT03817190|460487708|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
127964304|NCT03817190|460487709|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
127964305|NCT01622673|460487710|FG000|Treatment Period 1|Withdrawal by Subject|0|||
127964306|NCT01622673|460487711|FG001|Treatment Period 1|Withdrawal by Subject|0|||
127964307|NCT01622673|460487712|FG002|Treatment Period 1|Withdrawal by Subject|0|||
127964308|NCT01622673|460487713|FG003|Treatment Period 1|Withdrawal by Subject|1|||
127964309|NCT01622673|460487714|FG004|Treatment Period 1|Withdrawal by Subject|0|||
127964310|NCT01622673|460487715|FG005|Treatment Period 1|Withdrawal by Subject|0|||
127964311|NCT01622673|460487710|FG000|Treatment Period 1|Protocol Violation|0|||
127964312|NCT01622673|460487711|FG001|Treatment Period 1|Protocol Violation|1|||
127964313|NCT01622673|460487712|FG002|Treatment Period 1|Protocol Violation|0|||
127964314|NCT01622673|460487713|FG003|Treatment Period 1|Protocol Violation|0|||
127964315|NCT01622673|460487714|FG004|Treatment Period 1|Protocol Violation|0|||
127964316|NCT01622673|460487715|FG005|Treatment Period 1|Protocol Violation|0|||
127964317|NCT01622673|460487710|FG000|Treatment Period 2|Withdrawal by Subject|0|||
127964318|NCT01622673|460487711|FG001|Treatment Period 2|Withdrawal by Subject|0|||
127964319|NCT01622673|460487712|FG002|Treatment Period 2|Withdrawal by Subject|0|||
127964320|NCT01622673|460487713|FG003|Treatment Period 2|Withdrawal by Subject|1|||
127964321|NCT01622673|460487714|FG004|Treatment Period 2|Withdrawal by Subject|0|||
127964322|NCT01622673|460487715|FG005|Treatment Period 2|Withdrawal by Subject|0|||
127964323|NCT01622673|460487710|FG000|Treatment Period 3|Protocol Violation|0|||
127964324|NCT01622673|460487711|FG001|Treatment Period 3|Protocol Violation|1|||
127964325|NCT01622673|460487712|FG002|Treatment Period 3|Protocol Violation|0|||
127964326|NCT01622673|460487713|FG003|Treatment Period 3|Protocol Violation|0|||
127964327|NCT01622673|460487714|FG004|Treatment Period 3|Protocol Violation|0|||
127964328|NCT01622673|460487715|FG005|Treatment Period 3|Protocol Violation|0|||
127964329|NCT04146012|460487716|FG000|Overall Study|Study Terminated|30|||
127964330|NCT04146012|460487717|FG001|Overall Study|Study Terminated|15|||
127964331|NCT05142722|460488733|FG000|Overall Study|Lost to Follow-up|16|||
127964332|NCT05142722|460488734|FG001|Overall Study|Lost to Follow-up|38|||
127964333|NCT05142722|460488733|FG000|Overall Study|Withdrawal by Subject|20|||
127964334|NCT05142722|460488734|FG001|Overall Study|Withdrawal by Subject|27|||
127964335|NCT05142722|460488733|FG000|Overall Study|Death|11|||
127964336|NCT05142722|460488734|FG001|Overall Study|Death|17|||
127964337|NCT05142722|460488733|FG000|Overall Study|Physician Decision|0|||
127964338|NCT05142722|460488734|FG001|Overall Study|Physician Decision|1|||
127964339|NCT05142722|460488733|FG000|Overall Study|Participant Moved Away|0|||
127964340|NCT05142722|460488734|FG001|Overall Study|Participant Moved Away|2|||
127964341|NCT05142722|460488733|FG000|Overall Study|Adverse Event|2|||
127964342|NCT05142722|460488734|FG001|Overall Study|Adverse Event|1|||
127964343|NCT05731700|460488735|FG000|Overall Study|Death|1|||
127964344|NCT00437021|460488744|FG000|Overall Study|Adverse Event|0|||
127964345|NCT00437021|460488745|FG001|Overall Study|Adverse Event|0|||
127964346|NCT00437021|460488746|FG002|Overall Study|Adverse Event|0|||
127964347|NCT00437021|460488747|FG003|Overall Study|Adverse Event|0|||
127964348|NCT00437021|460488748|FG004|Overall Study|Adverse Event|0|||
127964349|NCT00437021|460488749|FG005|Overall Study|Adverse Event|0|||
127964350|NCT00437021|460488750|FG006|Overall Study|Adverse Event|1|||
127964351|NCT00437021|460488751|FG007|Overall Study|Adverse Event|0|||
127964352|NCT00437021|460488752|FG008|Overall Study|Adverse Event|0|||
127964353|NCT00437021|460488753|FG009|Overall Study|Adverse Event|0|||
127964354|NCT00437021|460488754|FG010|Overall Study|Adverse Event|0|||
127964355|NCT00437021|460488755|FG011|Overall Study|Adverse Event|0|||
127964356|NCT00437021|460488744|FG000|Overall Study|Lost to Follow-up|0|||
127964357|NCT00437021|460488745|FG001|Overall Study|Lost to Follow-up|3|||
127964358|NCT00437021|460488746|FG002|Overall Study|Lost to Follow-up|0|||
127964359|NCT00437021|460488747|FG003|Overall Study|Lost to Follow-up|0|||
127964360|NCT00437021|460488748|FG004|Overall Study|Lost to Follow-up|0|||
127964361|NCT00437021|460488749|FG005|Overall Study|Lost to Follow-up|2|||
127964362|NCT00437021|460488750|FG006|Overall Study|Lost to Follow-up|0|||
127964363|NCT00437021|460488751|FG007|Overall Study|Lost to Follow-up|1|||
127964364|NCT00437021|460488752|FG008|Overall Study|Lost to Follow-up|0|||
127964365|NCT00437021|460488753|FG009|Overall Study|Lost to Follow-up|0|||
127964366|NCT00437021|460488754|FG010|Overall Study|Lost to Follow-up|0|||
127964367|NCT00437021|460488755|FG011|Overall Study|Lost to Follow-up|0|||
127964368|NCT00437021|460488744|FG000|Overall Study|Withdrawal by Subject|2|||
127964369|NCT00437021|460488745|FG001|Overall Study|Withdrawal by Subject|1|||
127964370|NCT00437021|460488746|FG002|Overall Study|Withdrawal by Subject|0|||
127964371|NCT00437021|460488747|FG003|Overall Study|Withdrawal by Subject|0|||
127964372|NCT00437021|460488748|FG004|Overall Study|Withdrawal by Subject|0|||
127964373|NCT00437021|460488749|FG005|Overall Study|Withdrawal by Subject|0|||
127964374|NCT00437021|460488750|FG006|Overall Study|Withdrawal by Subject|0|||
127964375|NCT00437021|460488751|FG007|Overall Study|Withdrawal by Subject|0|||
127964376|NCT00437021|460488752|FG008|Overall Study|Withdrawal by Subject|0|||
127964377|NCT00437021|460488753|FG009|Overall Study|Withdrawal by Subject|0|||
127964378|NCT00437021|460488754|FG010|Overall Study|Withdrawal by Subject|0|||
127964379|NCT00437021|460488755|FG011|Overall Study|Withdrawal by Subject|0|||
127964380|NCT01467713|460488756|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
127964381|NCT01467713|460488757|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
127964382|NCT01467713|460488758|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
127964383|NCT01467713|460488759|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
127964384|NCT01467713|460488756|FG000|Overall Study|Major Protocol Deviation|2|||
127964385|NCT01467713|460488757|FG001|Overall Study|Major Protocol Deviation|4|||
127964386|NCT01467713|460488758|FG002|Overall Study|Major Protocol Deviation|4|||
127964387|NCT01467713|460488759|FG003|Overall Study|Major Protocol Deviation|1|||
127964388|NCT01467713|460488756|FG000|Overall Study|Lost to Follow-up|9|||
127964389|NCT01467713|460488757|FG001|Overall Study|Lost to Follow-up|12|||
127964390|NCT01467713|460488758|FG002|Overall Study|Lost to Follow-up|6|||
127964391|NCT01467713|460488759|FG003|Overall Study|Lost to Follow-up|9|||
127964392|NCT01467713|460488756|FG000|Overall Study|Voluntary Withdrawal|18|||
127964393|NCT01467713|460488757|FG001|Overall Study|Voluntary Withdrawal|14|||
127964394|NCT01467713|460488758|FG002|Overall Study|Voluntary Withdrawal|21|||
127964395|NCT01467713|460488759|FG003|Overall Study|Voluntary Withdrawal|20|||
127964396|NCT01467713|460488756|FG000|Overall Study|Study Termination|23|||
127964397|NCT01467713|460488757|FG001|Overall Study|Study Termination|33|||
127964398|NCT01467713|460488758|FG002|Overall Study|Study Termination|28|||
127964399|NCT01467713|460488759|FG003|Overall Study|Study Termination|29|||
127964400|NCT01467713|460488756|FG000|Overall Study|Pregnancy|0|||
127964401|NCT01467713|460488757|FG001|Overall Study|Pregnancy|1|||
127964402|NCT01467713|460488758|FG002|Overall Study|Pregnancy|1|||
127964403|NCT01467713|460488759|FG003|Overall Study|Pregnancy|3|||
127964404|NCT01467713|460488756|FG000|Overall Study|Relapse|35|||
127964405|NCT01467713|460488757|FG001|Overall Study|Relapse|25|||
127964406|NCT01467713|460488758|FG002|Overall Study|Relapse|28|||
127964407|NCT01467713|460488759|FG003|Overall Study|Relapse|35|||
127964408|NCT01467713|460488756|FG000|Overall Study|Reason not Specified|6|||
127964409|NCT01467713|460488757|FG001|Overall Study|Reason not Specified|11|||
127964410|NCT01467713|460488758|FG002|Overall Study|Reason not Specified|8|||
127964411|NCT01467713|460488759|FG003|Overall Study|Reason not Specified|7|||
127964412|NCT01100086|460488762|FG000|Period 1|Withdrawal by Subject|1|||
127964413|NCT01100086|460488763|FG001|Period 1|Withdrawal by Subject|0|||
127964414|NCT01611935|460488764|FG000|Overall Study|Family Declined Participation|1|||
127964415|NCT01611935|460488765|FG001|Overall Study|Family Declined Participation|0|||
127964416|NCT01209949|460488773|FG000|Overall Study|Lost to Follow-up|3|||
127964417|NCT00729612|460488774|FG000|Overall Study|Non evaluable for response|10|||
127964418|NCT02075203|460488778|FG000|Overall Study|Withdrawal by Subject|1|||
127964419|NCT02075203|460488779|FG001|Overall Study|Withdrawal by Subject|0|||
127964420|NCT02075203|460488780|FG002|Overall Study|Withdrawal by Subject|1|||
127964421|NCT02075203|460488778|FG000|Overall Study|Adverse Event|1|||
127964422|NCT02075203|460488779|FG001|Overall Study|Adverse Event|0|||
127964423|NCT02075203|460488780|FG002|Overall Study|Adverse Event|0|||
127964424|NCT02075203|460488778|FG000|Overall Study|participant refused to use contraception|1|||
127964425|NCT02075203|460488779|FG001|Overall Study|participant refused to use contraception|0|||
127964426|NCT02075203|460488780|FG002|Overall Study|participant refused to use contraception|0|||
127964427|NCT05344560|460488781|FG000|Period 1|Subject out of visit window|1|||
127964428|NCT05344560|460488782|FG001|Period 1|Subject out of visit window|1|||
127964429|NCT05344560|460488781|FG000|Period 2|Covid-19 Related|1|||
127964430|NCT05344560|460488782|FG001|Period 2|Covid-19 Related|0|||
127964431|NCT05344560|460488781|FG000|Period 2|Adverse Event|1|||
127964432|NCT05344560|460488782|FG001|Period 2|Adverse Event|0|||
127964433|NCT05344560|460488781|FG000|Period 2|Subject out of visit window|1|||
127964434|NCT05344560|460488782|FG001|Period 2|Subject out of visit window|1|||
127964435|NCT05344560|460488781|FG000|Period 3|Subject out of visit window|1|||
127964436|NCT05344560|460488782|FG001|Period 3|Subject out of visit window|0|||
127964437|NCT00360282|460488783|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
127964438|NCT00360282|460488784|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
127964439|NCT00360282|460488785|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
127964440|NCT00360282|460488786|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
127964441|NCT00360282|460488783|FG000|Second Intervention|Adverse Event|0|||
127964442|NCT00360282|460488784|FG001|Second Intervention|Adverse Event|1|||
127964443|NCT00360282|460488785|FG002|Second Intervention|Adverse Event|0|||
127964444|NCT00360282|460488786|FG003|Second Intervention|Adverse Event|0|||
127964445|NCT00449865|460488789|FG000|Overall Study|Withdrawal by Subject|110|||
127964446|NCT00449865|460488790|FG001|Overall Study|Withdrawal by Subject|110|||
127964447|NCT00449865|460488789|FG000|Overall Study|Lost to Follow-up|36|||
127964448|NCT00449865|460488790|FG001|Overall Study|Lost to Follow-up|37|||
127964449|NCT00449865|460488789|FG000|Overall Study|Physician Decision|13|||
127964450|NCT00449865|460488790|FG001|Overall Study|Physician Decision|12|||
127964451|NCT00449865|460488789|FG000|Overall Study|Death|31|||
127964452|NCT00449865|460488790|FG001|Overall Study|Death|40|||
127964453|NCT00449865|460488789|FG000|Overall Study|Protocol Violation|8|||
127964454|NCT00449865|460488790|FG001|Overall Study|Protocol Violation|7|||
127964455|NCT00449865|460488789|FG000|Overall Study|Study was stopped|324|||
127964456|NCT00449865|460488790|FG001|Overall Study|Study was stopped|328|||
127964457|NCT00444535|460488791|FG000|Overall Study|Withdrawal by Subject|5|||
127964458|NCT00444535|460488791|FG000|Overall Study|Physician Decision|5|||
127964459|NCT00444535|460488791|FG000|Overall Study|progressive disease|1|||
127964460|NCT00444535|460488791|FG000|Overall Study|Adverse Event|2|||
127964461|NCT00558467|460488795|FG000|Overall Study|Adverse Event|1|||
127964462|NCT00558467|460488796|FG001|Overall Study|Adverse Event|2|||
127964463|NCT00558467|460488795|FG000|Overall Study|Lack of Efficacy|0|||
127964464|NCT00558467|460488796|FG001|Overall Study|Lack of Efficacy|1|||
127964465|NCT00558467|460488795|FG000|Overall Study|Patient moving out of state|0|||
127964466|NCT00558467|460488796|FG001|Overall Study|Patient moving out of state|1|||
127964467|NCT02025725|460488799|FG000|Overall Study|Adverse Event|5|||
127964468|NCT02025725|460488800|FG001|Overall Study|Adverse Event|0|||
127964469|NCT02025725|460488799|FG000|Overall Study|Lost to Follow-up|2|||
127964470|NCT02025725|460488800|FG001|Overall Study|Lost to Follow-up|0|||
127964471|NCT02025725|460488799|FG000|Overall Study|Protocol Violation|1|||
127964472|NCT02025725|460488800|FG001|Overall Study|Protocol Violation|1|||
127964473|NCT02025725|460488799|FG000|Overall Study|Withdrawal by Subject|3|||
127964474|NCT02025725|460488800|FG001|Overall Study|Withdrawal by Subject|2|||
127964475|NCT02025725|460488799|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
127964476|NCT02025725|460488800|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
127964477|NCT02867592|460488801|FG000|Overall Study|Adverse Event|3|||
127964478|NCT02867592|460488802|FG001|Overall Study|Adverse Event|0|||
127964479|NCT02867592|460488803|FG002|Overall Study|Adverse Event|2|||
127964480|NCT02867592|460488804|FG003|Overall Study|Adverse Event|1|||
127964481|NCT02867592|460488805|FG004|Overall Study|Adverse Event|1|||
127964482|NCT02867592|460488806|FG005|Overall Study|Adverse Event|5|||
127964483|NCT02867592|460488801|FG000|Overall Study|Death|0|||
127964484|NCT02867592|460488802|FG001|Overall Study|Death|0|||
127964485|NCT02867592|460488803|FG002|Overall Study|Death|0|||
127964486|NCT02867592|460488804|FG003|Overall Study|Death|1|||
127964487|NCT02867592|460488805|FG004|Overall Study|Death|0|||
127964488|NCT02867592|460488806|FG005|Overall Study|Death|1|||
127964489|NCT02867592|460488801|FG000|Overall Study|Lack of Efficacy|8|||
127964490|NCT02867592|460488802|FG001|Overall Study|Lack of Efficacy|10|||
127964491|NCT02867592|460488803|FG002|Overall Study|Lack of Efficacy|8|||
127964492|NCT02867592|460488804|FG003|Overall Study|Lack of Efficacy|8|||
127964493|NCT02867592|460488805|FG004|Overall Study|Lack of Efficacy|12|||
127964494|NCT02867592|460488806|FG005|Overall Study|Lack of Efficacy|17|||
127964495|NCT02867592|460488801|FG000|Overall Study|Physician Decision|1|||
127964496|NCT02867592|460488802|FG001|Overall Study|Physician Decision|2|||
127964497|NCT02867592|460488803|FG002|Overall Study|Physician Decision|2|||
127964498|NCT02867592|460488804|FG003|Overall Study|Physician Decision|0|||
127964499|NCT02867592|460488805|FG004|Overall Study|Physician Decision|5|||
127964500|NCT02867592|460488806|FG005|Overall Study|Physician Decision|1|||
127964501|NCT02867592|460488801|FG000|Overall Study|Protocol Violation|0|||
127964502|NCT02867592|460488802|FG001|Overall Study|Protocol Violation|0|||
127964503|NCT02867592|460488803|FG002|Overall Study|Protocol Violation|0|||
127964504|NCT02867592|460488804|FG003|Overall Study|Protocol Violation|0|||
127964505|NCT02867592|460488805|FG004|Overall Study|Protocol Violation|1|||
127964506|NCT02867592|460488806|FG005|Overall Study|Protocol Violation|1|||
127964507|NCT02867592|460488801|FG000|Overall Study|Withdrawal by Subject|0|||
127964508|NCT02867592|460488802|FG001|Overall Study|Withdrawal by Subject|1|||
127964509|NCT02867592|460488803|FG002|Overall Study|Withdrawal by Subject|0|||
127964510|NCT02867592|460488804|FG003|Overall Study|Withdrawal by Subject|1|||
127964511|NCT02867592|460488805|FG004|Overall Study|Withdrawal by Subject|3|||
127964512|NCT02867592|460488806|FG005|Overall Study|Withdrawal by Subject|3|||
127964513|NCT02867592|460488801|FG000|Overall Study|Ineligible|1|||
127964514|NCT02867592|460488802|FG001|Overall Study|Ineligible|1|||
127964515|NCT02867592|460488803|FG002|Overall Study|Ineligible|0|||
127964516|NCT02867592|460488804|FG003|Overall Study|Ineligible|0|||
127964517|NCT02867592|460488805|FG004|Overall Study|Ineligible|2|||
127964518|NCT02867592|460488806|FG005|Overall Study|Ineligible|0|||
127964519|NCT02867592|460488801|FG000|Overall Study|No Treatment|1|||
127964520|NCT02867592|460488802|FG001|Overall Study|No Treatment|0|||
127964521|NCT02867592|460488803|FG002|Overall Study|No Treatment|0|||
127964522|NCT02867592|460488804|FG003|Overall Study|No Treatment|0|||
127964523|NCT02867592|460488805|FG004|Overall Study|No Treatment|0|||
127964524|NCT02867592|460488806|FG005|Overall Study|No Treatment|0|||
127964525|NCT02867592|460488801|FG000|Overall Study|Still on Therapy|0|||
127964526|NCT02867592|460488802|FG001|Overall Study|Still on Therapy|0|||
127964527|NCT02867592|460488803|FG002|Overall Study|Still on Therapy|0|||
127964528|NCT02867592|460488804|FG003|Overall Study|Still on Therapy|0|||
127964529|NCT02867592|460488805|FG004|Overall Study|Still on Therapy|1|||
127964530|NCT02867592|460488806|FG005|Overall Study|Still on Therapy|0|||
127964531|NCT02867592|460488801|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
127964532|NCT02867592|460488802|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
127964533|NCT02867592|460488803|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
127964534|NCT02867592|460488804|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
127964535|NCT02867592|460488805|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
127964536|NCT02867592|460488806|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
127964537|NCT02867592|460488801|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
127964538|NCT02867592|460488802|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
127964539|NCT02867592|460488803|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
127964540|NCT02867592|460488804|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
127964541|NCT02867592|460488805|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
127964542|NCT02867592|460488806|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
127964543|NCT00571727|460488815|FG000|Overall Study|Did not enter in this study|1|||
127964544|NCT00571727|460488815|FG000|Overall Study|Non-compliance|4|||
127964545|NCT00571727|460488815|FG000|Overall Study|Lost to Follow-up|30|||
127964546|NCT00571727|460488815|FG000|Overall Study|Poor growth|1|||
127964547|NCT00571727|460488815|FG000|Overall Study|Parent/patient decision|2|||
127964548|NCT00571727|460488815|FG000|Overall Study|Participant transferred to commercial drug|14|||
127964549|NCT00571727|460488815|FG000|Overall Study|Unable to provide study drug|6|||
127964550|NCT00571727|460488815|FG000|Overall Study|On-treatment at end of study|8|||
127964551|NCT05468164|460489816|FG000|Treatment Period 4|Adverse Event|0|||
127964552|NCT05468164|460489817|FG001|Treatment Period 4|Adverse Event|0|||
127964553|NCT05468164|460489818|FG002|Treatment Period 4|Adverse Event|0|||
127964554|NCT05468164|460489819|FG003|Treatment Period 4|Adverse Event|1|||
127964555|NCT05573464|460489820|FG000|12-week Treatment Period|Discontinued intervention - other reason|10|||
127964556|NCT05573464|460489821|FG001|12-week Treatment Period|Discontinued intervention - other reason|4|||
127964557|NCT05573464|460489820|FG000|12-week Treatment Period|Withdrawal by Subject|8|||
127964558|NCT05573464|460489821|FG001|12-week Treatment Period|Withdrawal by Subject|5|||
127964559|NCT05573464|460489820|FG000|12-week Treatment Period|Protocol Violation|3|||
127964560|NCT05573464|460489821|FG001|12-week Treatment Period|Protocol Violation|1|||
127964561|NCT05573464|460489820|FG000|12-week Treatment Period|Physician Decision|1|||
127964562|NCT05573464|460489821|FG001|12-week Treatment Period|Physician Decision|2|||
127964563|NCT05573464|460489820|FG000|12-week Treatment Period|Lost to Follow-up|2|||
127964564|NCT05573464|460489821|FG001|12-week Treatment Period|Lost to Follow-up|0|||
127964565|NCT05573464|460489820|FG000|12-week Treatment Period|Adverse Event|20|||
127964566|NCT05573464|460489821|FG001|12-week Treatment Period|Adverse Event|9|||
127964567|NCT05573464|460489820|FG000|12-week Treatment Period|Protocol-specified withdrawal criterion met|1|||
127964568|NCT05573464|460489821|FG001|12-week Treatment Period|Protocol-specified withdrawal criterion met|0|||
127964569|NCT05573464|460489820|FG000|12-week Treatment Period|Randomised, not treated|0|||
127964570|NCT05573464|460489821|FG001|12-week Treatment Period|Randomised, not treated|1|||
127964571|NCT05573464|460489820|FG000|52-week Treatment Period|Discontinued intervention - other reason|9|||
127964572|NCT05573464|460489821|FG001|52-week Treatment Period|Discontinued intervention - other reason|8|||
127964573|NCT05573464|460489820|FG000|52-week Treatment Period|Withdrawal by Subject|9|||
127964574|NCT05573464|460489821|FG001|52-week Treatment Period|Withdrawal by Subject|5|||
127964575|NCT05573464|460489820|FG000|52-week Treatment Period|Protocol Violation|1|||
127964576|NCT05573464|460489821|FG001|52-week Treatment Period|Protocol Violation|1|||
127964577|NCT05573464|460489820|FG000|52-week Treatment Period|Physician Decision|2|||
127964578|NCT05573464|460489821|FG001|52-week Treatment Period|Physician Decision|2|||
127964579|NCT05573464|460489820|FG000|52-week Treatment Period|Lost to Follow-up|1|||
127964580|NCT05573464|460489821|FG001|52-week Treatment Period|Lost to Follow-up|1|||
127964581|NCT05573464|460489820|FG000|52-week Treatment Period|Adverse Event|11|||
127964582|NCT05573464|460489821|FG001|52-week Treatment Period|Adverse Event|8|||
127964583|NCT05573464|460489820|FG000|52-week Treatment Period|Death|1|||
127964584|NCT05573464|460489821|FG001|52-week Treatment Period|Death|1|||
127964585|NCT04846569|460489822|FG000|Overall Study|Withdrawal by Subject|3|||
127964586|NCT04846569|460489823|FG001|Overall Study|Withdrawal by Subject|1|||
127964587|NCT00536939|460489828|FG000|Overall Study|Withdrawal by Subject|1|||
127964588|NCT00536939|460489829|FG001|Overall Study|Withdrawal by Subject|0|||
127964589|NCT00536939|460489828|FG000|Overall Study|Other Complicating Disease|1|||
127964590|NCT00536939|460489829|FG001|Overall Study|Other Complicating Disease|0|||
127964591|NCT02954601|460489830|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
127964592|NCT02954601|460489831|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
127964593|NCT02954601|460489832|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
127964594|NCT02954601|460489833|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
127964595|NCT00333983|460489837|FG000|Overall Study|Lost to Follow-up|2|||
127485462|NCT01240863|458741182|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
127485463|NCT01240863|458741183|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
127485464|NCT01240863|458741181|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
127485465|NCT01240863|458741182|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
127485466|NCT01240863|458741183|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
127485467|NCT01240863|458741181|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
127485468|NCT01240863|458741182|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
127485469|NCT01240863|458741183|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
127485470|NCT01240863|458741181|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
127485471|NCT01240863|458741182|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
127485472|NCT01240863|458741183|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
127485473|NCT01240863|458741181|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
127485474|NCT01240863|458741182|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
127485475|NCT01240863|458741183|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
127485476|NCT01240863|458741181|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
127485477|NCT01240863|458741182|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
127485478|NCT01240863|458741183|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
127485479|NCT01240863|458741181|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
127485480|NCT01240863|458741182|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
127485481|NCT01240863|458741183|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
127485482|NCT03783780|458741188|FG000|Overall Study|Withdrawn prior to completion|1|||
127485483|NCT03768427|458741189|FG000|Overall Study|Death|0|||
127485484|NCT03768427|458741190|FG001|Overall Study|Death|0|||
127485485|NCT03768427|458741191|FG002|Overall Study|Death|1|||
127485486|NCT03768427|458741192|FG003|Overall Study|Death|0|||
127485487|NCT03768427|458741189|FG000|Overall Study|Lost to Follow-up|2|||
127485488|NCT03768427|458741190|FG001|Overall Study|Lost to Follow-up|0|||
127485489|NCT03768427|458741191|FG002|Overall Study|Lost to Follow-up|0|||
127485490|NCT03768427|458741192|FG003|Overall Study|Lost to Follow-up|0|||
127485491|NCT03768427|458741189|FG000|Overall Study|Physician Decision|3|||
127485492|NCT03768427|458741190|FG001|Overall Study|Physician Decision|2|||
127485493|NCT03768427|458741191|FG002|Overall Study|Physician Decision|4|||
127485494|NCT03768427|458741192|FG003|Overall Study|Physician Decision|4|||
127485495|NCT03768427|458741189|FG000|Overall Study|Withdrawal by Subject|7|||
127964596|NCT00333983|460489838|FG001|Overall Study|Lost to Follow-up|1|||
127964597|NCT00333983|460489839|FG002|Overall Study|Lost to Follow-up|0|||
127964598|NCT00333983|460489837|FG000|Overall Study|Adverse Event|1|||
127964599|NCT00333983|460489838|FG001|Overall Study|Adverse Event|1|||
127964600|NCT00333983|460489839|FG002|Overall Study|Adverse Event|1|||
127964601|NCT00333983|460489837|FG000|Overall Study|Withdrawal by Subject|0|||
127964602|NCT00333983|460489838|FG001|Overall Study|Withdrawal by Subject|3|||
127964603|NCT00333983|460489839|FG002|Overall Study|Withdrawal by Subject|1|||
127964604|NCT04227197|460489840|FG000|Randomization|Protocol Violation|1|||
127964605|NCT04227197|460489841|FG001|Randomization|Protocol Violation|0|||
127964606|NCT04227197|460489840|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
127964607|NCT04227197|460489841|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
127964608|NCT04227197|460489840|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
127964609|NCT04227197|460489841|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
127964610|NCT04227197|460489840|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
127964611|NCT04227197|460489841|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
127964612|NCT04227197|460489840|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
127964613|NCT04227197|460489841|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
127964614|NCT04227197|460489840|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
127964615|NCT04227197|460489841|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
127964616|NCT04227197|460489840|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
127964617|NCT04227197|460489841|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
127964618|NCT00570141|460489842|FG000|Overall Study|Adverse Event|1|||
127964619|NCT00570141|460489842|FG000|Overall Study|Missed visits|1|||
127964620|NCT00570141|460489842|FG000|Overall Study|Lost to Follow-up|1|||
127964621|NCT03214224|460489854|FG000|Overall Study|Protocol Violation|1|||
127964622|NCT03214224|460489854|FG000|Overall Study|Withdrawal by Subject|2|||
127964623|NCT03214224|460489854|FG000|Overall Study|Practice controls or therapists|6|||
127964624|NCT02712320|460489855|FG000|Overall Study|Lost to Follow-up|1|||
127964625|NCT02712320|460489855|FG000|Overall Study|Withdrawal by Subject|1|||
127964626|NCT02712320|460489855|FG000|Overall Study|Transferred to another facility|1|||
127964627|NCT02712320|460489855|FG000|Overall Study|Treating with the prohibited medications|2|||
127964628|NCT00568451|460489858|FG000|Overall Study|Disease Progression|0|||
127964629|NCT00568451|460489859|FG001|Overall Study|Disease Progression|0|||
127964630|NCT00568451|460489860|FG002|Overall Study|Disease Progression|2|||
127964631|NCT00568451|460489861|FG003|Overall Study|Disease Progression|7|||
127964632|NCT05266053|460489862|FG000|Overall Study|Withdrawal by Subject|8|||
127964633|NCT05266053|460489863|FG001|Overall Study|Withdrawal by Subject|4|||
127964634|NCT01343043|460489866|FG000|Overall Study|Disease progression before treatment|1|||
127964635|NCT01343043|460489867|FG001|Overall Study|Disease progression before treatment|0|||
127964636|NCT01343043|460489868|FG002|Overall Study|Disease progression before treatment|0|||
127964637|NCT01343043|460489869|FG003|Overall Study|Disease progression before treatment|0|||
127964638|NCT01343043|460489866|FG000|Overall Study|Withdrawal by Subject|1|||
127964639|NCT01343043|460489867|FG001|Overall Study|Withdrawal by Subject|0|||
127964640|NCT01343043|460489868|FG002|Overall Study|Withdrawal by Subject|0|||
127964641|NCT01343043|460489869|FG003|Overall Study|Withdrawal by Subject|0|||
127964642|NCT01343043|460489866|FG000|Overall Study|Death|1|||
127964643|NCT01343043|460489867|FG001|Overall Study|Death|1|||
127964644|NCT01343043|460489868|FG002|Overall Study|Death|0|||
127964645|NCT01343043|460489869|FG003|Overall Study|Death|1|||
127964646|NCT02996968|460489870|FG000|Overall Study|Withdrawal by Subject|1|||
127964647|NCT02996968|460489871|FG001|Overall Study|Withdrawal by Subject|0|||
127964648|NCT03207815|460489874|FG000|Overall Study|Protocol Violation|3|||
127964649|NCT03207815|460489875|FG001|Overall Study|Protocol Violation|1|||
127964650|NCT03207815|460489874|FG000|Overall Study|Adverse Event|1|||
127964651|NCT03207815|460489875|FG001|Overall Study|Adverse Event|2|||
127964652|NCT03207815|460489874|FG000|Overall Study|Lost to Follow-up|1|||
127964653|NCT03207815|460489875|FG001|Overall Study|Lost to Follow-up|2|||
127964654|NCT03207815|460489874|FG000|Overall Study|Investigator's Discretion|1|||
127964655|NCT03207815|460489875|FG001|Overall Study|Investigator's Discretion|1|||
127964656|NCT03207815|460489874|FG000|Overall Study|Lack of Efficacy|0|||
127964657|NCT03207815|460489875|FG001|Overall Study|Lack of Efficacy|1|||
127964658|NCT03207815|460489874|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
127964659|NCT03207815|460489875|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
127964660|NCT03207815|460489874|FG000|Overall Study|Withdrew Consent|1|||
127964661|NCT03207815|460489875|FG001|Overall Study|Withdrew Consent|0|||
127964662|NCT00391768|460489876|FG000|Overall Study|Withdrawal by Subject|0|||
127964663|NCT00391768|460489877|FG001|Overall Study|Withdrawal by Subject|0|||
127964664|NCT00391768|460489878|FG002|Overall Study|Withdrawal by Subject|1|||
127964665|NCT00391768|460489879|FG003|Overall Study|Withdrawal by Subject|0|||
127964666|NCT00391768|460489880|FG004|Overall Study|Withdrawal by Subject|0|||
127964667|NCT00391768|460489881|FG005|Overall Study|Withdrawal by Subject|1|||
127964668|NCT00391768|460489882|FG006|Overall Study|Withdrawal by Subject|1|||
127964669|NCT00391768|460489876|FG000|Overall Study|Lost to Follow-up|0|||
127964670|NCT00391768|460489877|FG001|Overall Study|Lost to Follow-up|0|||
127964671|NCT00391768|460489878|FG002|Overall Study|Lost to Follow-up|0|||
127964672|NCT00391768|460489879|FG003|Overall Study|Lost to Follow-up|1|||
127964673|NCT00391768|460489880|FG004|Overall Study|Lost to Follow-up|2|||
127964674|NCT00391768|460489881|FG005|Overall Study|Lost to Follow-up|2|||
127964675|NCT00391768|460489882|FG006|Overall Study|Lost to Follow-up|3|||
127964676|NCT00406367|460489883|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
127964677|NCT00406367|460489884|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
127964678|NCT00406367|460489883|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
127964679|NCT00406367|460489884|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
127964680|NCT00406367|460489883|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
127964681|NCT00406367|460489884|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
127964682|NCT00406367|460489883|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
127964683|NCT00406367|460489884|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
127964684|NCT00406367|460489883|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
127964685|NCT00406367|460489884|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
127964686|NCT00406367|460489883|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
127964687|NCT00406367|460489884|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
127964688|NCT00406367|460489883|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
127964689|NCT00406367|460489884|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
127964690|NCT00406367|460489883|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
127964691|NCT00406367|460489884|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
127964692|NCT00406367|460489883|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
127964693|NCT00406367|460489884|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
127964694|NCT00406367|460489883|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
127964695|NCT00406367|460489884|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
127964696|NCT00406367|460489883|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
127964697|NCT00406367|460489884|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
127964698|NCT00406367|460489883|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
127964699|NCT00406367|460489884|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
127964700|NCT00171210|460489885|FG000|Overall Study|Adverse Event|16|||
127964701|NCT00171210|460489886|FG001|Overall Study|Adverse Event|27|||
127964702|NCT00171210|460489885|FG000|Overall Study|Abnormal laboratory value(s)|6|||
127964703|NCT00171210|460489886|FG001|Overall Study|Abnormal laboratory value(s)|3|||
127964704|NCT00171210|460489885|FG000|Overall Study|Abnormal test procedure result(s)|0|||
127964705|NCT00171210|460489886|FG001|Overall Study|Abnormal test procedure result(s)|1|||
127964706|NCT00171210|460489885|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
127964707|NCT00171210|460489886|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
127964708|NCT00171210|460489885|FG000|Overall Study|Protocol Violation|0|||
127964709|NCT00171210|460489886|FG001|Overall Study|Protocol Violation|2|||
127964710|NCT00171210|460489885|FG000|Overall Study|Withdrawal by Subject|32|||
127964711|NCT00171210|460489886|FG001|Overall Study|Withdrawal by Subject|30|||
127964712|NCT00171210|460489885|FG000|Overall Study|Lost to Follow-up|1|||
127964713|NCT00171210|460489886|FG001|Overall Study|Lost to Follow-up|0|||
127964714|NCT00171210|460489885|FG000|Overall Study|Administrative problems|1|||
127964715|NCT00171210|460489886|FG001|Overall Study|Administrative problems|1|||
127964716|NCT00171210|460489885|FG000|Overall Study|Death|2|||
127964717|NCT00171210|460489886|FG001|Overall Study|Death|3|||
127964718|NCT00171210|460489885|FG000|Overall Study|Stopped at end of core|0|||
127964719|NCT00171210|460489886|FG001|Overall Study|Stopped at end of core|32|||
127964720|NCT00171210|460489885|FG000|Overall Study|Stopped at end of extension 1|0|||
127964721|NCT00171210|460489886|FG001|Overall Study|Stopped at end of extension 1|1|||
127964722|NCT03187301|460489889|FG000|Titration Period|Adverse Event|0|||
127964723|NCT03187301|460489890|FG001|Titration Period|Adverse Event|0|||
127964724|NCT03187301|460489891|FG002|Titration Period|Adverse Event|0|||
127964725|NCT03187301|460489892|FG003|Titration Period|Adverse Event|0|||
127964726|NCT03187301|460489893|FG004|Titration Period|Adverse Event|0|||
127964727|NCT03187301|460489894|FG005|Titration Period|Adverse Event|0|||
127964728|NCT03187301|460489895|FG006|Titration Period|Adverse Event|5|||
127964729|NCT03187301|460489889|FG000|Titration Period|Withdrawal by Subject|0|||
127964730|NCT03187301|460489890|FG001|Titration Period|Withdrawal by Subject|0|||
127964731|NCT03187301|460489891|FG002|Titration Period|Withdrawal by Subject|0|||
127964732|NCT03187301|460489892|FG003|Titration Period|Withdrawal by Subject|0|||
127964733|NCT03187301|460489893|FG004|Titration Period|Withdrawal by Subject|0|||
127964734|NCT03187301|460489894|FG005|Titration Period|Withdrawal by Subject|0|||
127964735|NCT03187301|460489895|FG006|Titration Period|Withdrawal by Subject|1|||
127964736|NCT03187301|460489889|FG000|Titration Period|Exclusion Criteria Met|0|||
127964737|NCT03187301|460489890|FG001|Titration Period|Exclusion Criteria Met|0|||
127964738|NCT03187301|460489891|FG002|Titration Period|Exclusion Criteria Met|0|||
127964739|NCT03187301|460489892|FG003|Titration Period|Exclusion Criteria Met|0|||
127964740|NCT03187301|460489893|FG004|Titration Period|Exclusion Criteria Met|0|||
127964741|NCT03187301|460489894|FG005|Titration Period|Exclusion Criteria Met|0|||
127964742|NCT03187301|460489895|FG006|Titration Period|Exclusion Criteria Met|1|||
127964743|NCT03187301|460489889|FG000|Pre-Intervention|Withdrawal by Subject|1|||
127964744|NCT03187301|460489890|FG001|Pre-Intervention|Withdrawal by Subject|0|||
127964745|NCT03187301|460489891|FG002|Pre-Intervention|Withdrawal by Subject|0|||
127964746|NCT03187301|460489892|FG003|Pre-Intervention|Withdrawal by Subject|0|||
127964747|NCT03187301|460489893|FG004|Pre-Intervention|Withdrawal by Subject|0|||
127964748|NCT03187301|460489894|FG005|Pre-Intervention|Withdrawal by Subject|0|||
127964749|NCT03187301|460489895|FG006|Pre-Intervention|Withdrawal by Subject|0|||
127964750|NCT05005507|460489901|FG000|Overall Study|Premature termination of study|1|||
127964751|NCT02375971|460489906|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
127964752|NCT02375971|460489907|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
127964753|NCT02375971|460489908|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
127964754|NCT02375971|460489906|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
127964755|NCT02375971|460489907|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
127964756|NCT02375971|460489908|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
127964757|NCT02375971|460489906|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
127964758|NCT02375971|460489907|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
127964759|NCT02375971|460489908|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
127964760|NCT02375971|460489906|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
127964761|NCT02375971|460489907|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
127964762|NCT02375971|460489908|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
127964763|NCT02375971|460489906|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
127964764|NCT02375971|460489907|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
127964765|NCT02375971|460489908|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
127964766|NCT02375971|460489906|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
127964767|NCT02375971|460489907|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
127964768|NCT02375971|460489908|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
127964769|NCT02375971|460489906|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
127964770|NCT02375971|460489907|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
127964771|NCT02375971|460489908|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
127964772|NCT02375971|460489906|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
127964773|NCT02375971|460489907|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
127964774|NCT02375971|460489908|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
127964775|NCT02556775|460489909|FG000|Overall Study|Withdrawal by Subject|1|||
127964776|NCT02556775|460489910|FG001|Overall Study|Withdrawal by Subject|0|||
127964777|NCT02556775|460489911|FG002|Overall Study|Withdrawal by Subject|1|||
127964778|NCT02556775|460489912|FG003|Overall Study|Withdrawal by Subject|0|||
127964779|NCT02556775|460489909|FG000|Overall Study|Lost to Follow-up|1|||
127964780|NCT02556775|460489910|FG001|Overall Study|Lost to Follow-up|0|||
127964781|NCT02556775|460489911|FG002|Overall Study|Lost to Follow-up|0|||
127964782|NCT02556775|460489912|FG003|Overall Study|Lost to Follow-up|0|||
127964783|NCT01346059|460489913|FG000|Overall Study|Withdrawal by Subject|1|||
127964784|NCT01346059|460489914|FG001|Overall Study|Withdrawal by Subject|0|||
127964785|NCT05047211|460489919|FG000|Overall Study|Lost to Follow-up|8|||
127964786|NCT05047211|460489920|FG001|Overall Study|Lost to Follow-up|5|||
127964787|NCT00594165|460489921|FG000|Overall Study|Major protocol violation|1|||
127964788|NCT00594165|460489921|FG000|Overall Study|Lack of Efficacy|12|||
127964789|NCT00594165|460489921|FG000|Overall Study|Adverse Event|52|||
127964790|NCT00594165|460489921|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
127964791|NCT00594165|460489921|FG000|Overall Study|Subject withdrew consent|27|||
127964792|NCT00594165|460489921|FG000|Overall Study|Study ended per sponsor|102|||
127964793|NCT00594165|460489921|FG000|Overall Study|Lost to Follow-up|4|||
127964794|NCT00594165|460489921|FG000|Overall Study|Other: PI discretion|5|||
127964795|NCT00594165|460489921|FG000|Overall Study|Other: Subject moving|3|||
127964796|NCT00594165|460489921|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
127964797|NCT00594165|460489921|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
127964798|NCT00594165|460489921|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
127964799|NCT00594165|460489921|FG000|Overall Study|Other: Site terminated participation|2|||
127964800|NCT03581292|460489924|FG000|Overall Study|Physician Decision|9|||
127964801|NCT03581292|460489925|FG001|Overall Study|Physician Decision|5|||
127964802|NCT03581292|460489924|FG000|Overall Study|Withdrawal by Subject|3|||
127964803|NCT03581292|460489925|FG001|Overall Study|Withdrawal by Subject|0|||
127964804|NCT03581292|460489924|FG000|Overall Study|Withdrawal before Therapy Start|1|||
127964805|NCT03581292|460489925|FG001|Overall Study|Withdrawal before Therapy Start|0|||
127964806|NCT01735916|460491411|FG000|Overall Study|Subject not eligible to be randomized|11|||
127964807|NCT01735916|460491412|FG001|Overall Study|Subject not eligible to be randomized|0|||
127964808|NCT01735916|460491413|FG002|Overall Study|Subject not eligible to be randomized|0|||
127964809|NCT01735916|460491411|FG000|Overall Study|Early termination of study by sponsor|4|||
127964810|NCT01735916|460491412|FG001|Overall Study|Early termination of study by sponsor|19|||
127964811|NCT01735916|460491413|FG002|Overall Study|Early termination of study by sponsor|7|||
127964812|NCT01735916|460491411|FG000|Overall Study|Withdrawal by Subject|3|||
127964813|NCT01735916|460491412|FG001|Overall Study|Withdrawal by Subject|0|||
127964814|NCT01735916|460491413|FG002|Overall Study|Withdrawal by Subject|0|||
127964815|NCT00833105|460491414|FG000|Overall Study|Withdrawal by Subject|1|||
127964816|NCT00833105|460491414|FG000|Overall Study|Adverse Event|2|||
127964817|NCT00925704|460491422|FG000|First Intervention|Withdrew consent|0|||
127964818|NCT00925704|460491423|FG001|First Intervention|Withdrew consent|0|||
127964819|NCT00925704|460491424|FG002|First Intervention|Withdrew consent|0|||
127964820|NCT00925704|460491425|FG003|First Intervention|Withdrew consent|1|||
127964821|NCT00925704|460491426|FG004|First Intervention|Withdrew consent|1|||
127964822|NCT00925704|460491427|FG005|First Intervention|Withdrew consent|0|||
127964823|NCT00925704|460491422|FG000|Second Intervention|Withdrawal by Subject|1|||
127964824|NCT00925704|460491423|FG001|Second Intervention|Withdrawal by Subject|0|||
127964825|NCT00925704|460491424|FG002|Second Intervention|Withdrawal by Subject|0|||
127964826|NCT00925704|460491425|FG003|Second Intervention|Withdrawal by Subject|0|||
127964827|NCT00925704|460491426|FG004|Second Intervention|Withdrawal by Subject|1|||
127964828|NCT00925704|460491427|FG005|Second Intervention|Withdrawal by Subject|0|||
127964829|NCT00925704|460491422|FG000|Third Intervention|Withdrew consent|0|||
127964830|NCT00925704|460491423|FG001|Third Intervention|Withdrew consent|0|||
127964831|NCT00925704|460491424|FG002|Third Intervention|Withdrew consent|0|||
127964832|NCT00925704|460491425|FG003|Third Intervention|Withdrew consent|0|||
127964833|NCT00925704|460491426|FG004|Third Intervention|Withdrew consent|0|||
127964834|NCT00925704|460491427|FG005|Third Intervention|Withdrew consent|1|||
127964835|NCT02044302|460491431|FG000|Overall Study|study terminated|2|||
127964836|NCT02044302|460491432|FG001|Overall Study|study terminated|0|||
127964837|NCT01671007|460491433|FG000|Overall Study|Other reasons than listed|166|||
127964838|NCT01671007|460491434|FG001|Overall Study|Other reasons than listed|373|||
127964839|NCT01671007|460491435|FG002|Overall Study|Other reasons than listed|197|||
127964840|NCT01671007|460491436|FG003|Overall Study|Other reasons than listed|228|||
127964841|NCT01671007|460491437|FG004|Overall Study|Other reasons than listed|14|||
127964842|NCT01671007|460491438|FG005|Overall Study|Other reasons than listed|71|||
127964843|NCT01671007|460491439|FG006|Overall Study|Other reasons than listed|17|||
127964844|NCT01671007|460491440|FG007|Overall Study|Other reasons than listed|66|||
127964845|NCT01671007|460491441|FG008|Overall Study|Other reasons than listed|0|||
127964846|NCT01671007|460491433|FG000|Overall Study|Withdrawal by Subject|36|||
127964847|NCT01671007|460491434|FG001|Overall Study|Withdrawal by Subject|59|||
127964848|NCT01671007|460491435|FG002|Overall Study|Withdrawal by Subject|53|||
127964849|NCT01671007|460491436|FG003|Overall Study|Withdrawal by Subject|58|||
127964850|NCT01671007|460491437|FG004|Overall Study|Withdrawal by Subject|4|||
127964851|NCT01671007|460491438|FG005|Overall Study|Withdrawal by Subject|15|||
127964852|NCT01671007|460491439|FG006|Overall Study|Withdrawal by Subject|1|||
127964853|NCT01671007|460491440|FG007|Overall Study|Withdrawal by Subject|19|||
127964854|NCT01671007|460491441|FG008|Overall Study|Withdrawal by Subject|0|||
127964855|NCT01671007|460491433|FG000|Overall Study|Lost to Follow-up|93|||
127964856|NCT01671007|460491434|FG001|Overall Study|Lost to Follow-up|142|||
127964857|NCT01671007|460491435|FG002|Overall Study|Lost to Follow-up|91|||
127964858|NCT01671007|460491436|FG003|Overall Study|Lost to Follow-up|63|||
127964859|NCT01671007|460491437|FG004|Overall Study|Lost to Follow-up|7|||
127964860|NCT01671007|460491438|FG005|Overall Study|Lost to Follow-up|20|||
127964861|NCT01671007|460491439|FG006|Overall Study|Lost to Follow-up|2|||
127964862|NCT01671007|460491440|FG007|Overall Study|Lost to Follow-up|28|||
127964863|NCT01671007|460491441|FG008|Overall Study|Lost to Follow-up|0|||
127964864|NCT01671007|460491433|FG000|Overall Study|No end of study case report form|3|||
127964865|NCT01671007|460491434|FG001|Overall Study|No end of study case report form|1|||
127964866|NCT01671007|460491435|FG002|Overall Study|No end of study case report form|0|||
127964867|NCT01671007|460491436|FG003|Overall Study|No end of study case report form|2|||
127964868|NCT01671007|460491437|FG004|Overall Study|No end of study case report form|0|||
127964869|NCT01671007|460491438|FG005|Overall Study|No end of study case report form|0|||
127964870|NCT01671007|460491439|FG006|Overall Study|No end of study case report form|0|||
127964871|NCT01671007|460491440|FG007|Overall Study|No end of study case report form|0|||
127964872|NCT01671007|460491441|FG008|Overall Study|No end of study case report form|0|||
127964873|NCT01671007|460491433|FG000|Overall Study|Not eligible|23|||
127964874|NCT01671007|460491434|FG001|Overall Study|Not eligible|76|||
127964875|NCT01671007|460491435|FG002|Overall Study|Not eligible|25|||
127964876|NCT01671007|460491436|FG003|Overall Study|Not eligible|17|||
127964877|NCT01671007|460491437|FG004|Overall Study|Not eligible|0|||
127964878|NCT01671007|460491438|FG005|Overall Study|Not eligible|6|||
127964879|NCT01671007|460491439|FG006|Overall Study|Not eligible|1|||
127964880|NCT01671007|460491440|FG007|Overall Study|Not eligible|19|||
127964881|NCT01671007|460491441|FG008|Overall Study|Not eligible|0|||
127964882|NCT01812109|460491442|FG000|Overall Study|research personnel delay|16|||
127964883|NCT01812109|460491442|FG000|Overall Study|NIRS Unattainable|17|||
127964884|NCT04630002|460491444|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
127964885|NCT04630002|460491445|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
127964886|NCT04630002|460491446|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
127964887|NCT04630002|460491444|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
127964888|NCT04630002|460491445|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
127964889|NCT04630002|460491446|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
127964890|NCT04630002|460491444|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
127964891|NCT04630002|460491445|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
127964892|NCT04630002|460491446|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
127964893|NCT04630002|460491444|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
127964894|NCT04630002|460491445|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
127964895|NCT04630002|460491446|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
127964896|NCT04630002|460491444|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
127964897|NCT04630002|460491445|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
127964898|NCT04630002|460491446|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
127964899|NCT04630002|460491444|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
127964900|NCT04630002|460491445|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
127964901|NCT04630002|460491446|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
127964902|NCT04630002|460491444|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
127964903|NCT04630002|460491445|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
127964904|NCT04630002|460491446|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
127964905|NCT04630002|460491444|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
127964906|NCT04630002|460491445|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
127964907|NCT04630002|460491446|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
127964908|NCT04498182|460491447|FG000|Overall Study|Adverse Event|2|||
127964909|NCT04498182|460491448|FG001|Overall Study|Adverse Event|3|||
127964910|NCT04498182|460491449|FG002|Overall Study|Adverse Event|2|||
127964911|NCT04498182|460491447|FG000|Overall Study|Withdrawal of Consent|3|||
127964912|NCT04498182|460491448|FG001|Overall Study|Withdrawal of Consent|4|||
127964913|NCT04498182|460491449|FG002|Overall Study|Withdrawal of Consent|3|||
127964914|NCT04498182|460491447|FG000|Overall Study|Non-Compliant|1|||
127964915|NCT04498182|460491448|FG001|Overall Study|Non-Compliant|0|||
127964916|NCT04498182|460491449|FG002|Overall Study|Non-Compliant|1|||
127964917|NCT04498182|460491447|FG000|Overall Study|Lost to Follow-up|0|||
127964918|NCT04498182|460491448|FG001|Overall Study|Lost to Follow-up|0|||
127964919|NCT04498182|460491449|FG002|Overall Study|Lost to Follow-up|1|||
127964920|NCT04498182|460491447|FG000|Overall Study|Investigator Decision|0|||
127964921|NCT04498182|460491448|FG001|Overall Study|Investigator Decision|0|||
127964922|NCT04498182|460491449|FG002|Overall Study|Investigator Decision|1|||
127964923|NCT04498182|460491447|FG000|Overall Study|Protocol Violation|1|||
127964924|NCT04498182|460491448|FG001|Overall Study|Protocol Violation|0|||
127964925|NCT04498182|460491449|FG002|Overall Study|Protocol Violation|2|||
127964926|NCT02182843|460491450|FG000|Overall Study|Withdrawal by Subject|7|||
127964927|NCT02182843|460491450|FG000|Overall Study|Lost to Follow-up|2|||
127964928|NCT02182843|460491450|FG000|Overall Study|Adverse Event|1|||
127964929|NCT00832455|460491452|FG000|Overall Study|Adverse Event|13|||
127964930|NCT00832455|460491452|FG000|Overall Study|Lost to Follow-up|26|||
127964931|NCT00832455|460491452|FG000|Overall Study|Protocol Violation|4|||
127964932|NCT00832455|460491452|FG000|Overall Study|Withdrawal by Subject|17|||
127964933|NCT00832455|460491452|FG000|Overall Study|Screening Failure|2|||
127964934|NCT00832455|460491452|FG000|Overall Study|Stopped Medication|4|||
127964935|NCT00832455|460491452|FG000|Overall Study|Parent misunderstood study|1|||
127964936|NCT00832455|460491452|FG000|Overall Study|Parent dissatisfied|1|||
127964937|NCT00832455|460491452|FG000|Overall Study|No improvement|3|||
127964938|NCT00832455|460491452|FG000|Overall Study|Patient moved|1|||
127964939|NCT00561392|460491459|FG000|Overall Study|Adverse Event|38|||
127964940|NCT00561392|460491459|FG000|Overall Study|Lack of Efficacy|2|||
127964941|NCT00561392|460491459|FG000|Overall Study|Protocol Violation|1|||
127964942|NCT00561392|460491459|FG000|Overall Study|Withdrawal by Subject|8|||
127964943|NCT00561392|460491459|FG000|Overall Study|Administrative problems|4|||
127964944|NCT01741688|460491460|FG000|Overall Study|Lack of insurance coverage|2|||
127964945|NCT01741688|460491460|FG000|Overall Study|Withdrawal by Subject|1|||
127964946|NCT02198664|460491462|FG000|Overall Study|Adverse Event|2|||
127964947|NCT02198664|460491463|FG001|Overall Study|Adverse Event|0|||
127964948|NCT02198664|460491462|FG000|Overall Study|Withdrawal by Subject|11|||
127964949|NCT02198664|460491463|FG001|Overall Study|Withdrawal by Subject|8|||
127964950|NCT02198664|460491462|FG000|Overall Study|Failure to tolerate|2|||
127964951|NCT02198664|460491463|FG001|Overall Study|Failure to tolerate|0|||
127964952|NCT02198664|460491462|FG000|Overall Study|Not stated|1|||
127964953|NCT02198664|460491463|FG001|Overall Study|Not stated|0|||
127964954|NCT01262872|460491465|FG000|Step 2|Death|0|||
127964955|NCT01262872|460491466|FG001|Step 2|Death|0|||
127964956|NCT01262872|460491467|FG002|Step 2|Death|0|||
127964957|NCT01262872|460491468|FG003|Step 2|Death|1|||
127964958|NCT01262872|460491469|FG004|Step 2|Death|0|||
127964959|NCT01262872|460491470|FG005|Step 2|Death|2|||
127964960|NCT01262872|460491471|FG006|Step 2|Death|2|||
127964961|NCT01262872|460491472|FG007|Step 2|Death|1|||
127964962|NCT01262872|460491465|FG000|Step 2|Protocol Violation|0|||
127964963|NCT01262872|460491466|FG001|Step 2|Protocol Violation|0|||
127964964|NCT01262872|460491467|FG002|Step 2|Protocol Violation|1|||
127964965|NCT01262872|460491468|FG003|Step 2|Protocol Violation|0|||
127964966|NCT01262872|460491469|FG004|Step 2|Protocol Violation|0|||
127964967|NCT01262872|460491470|FG005|Step 2|Protocol Violation|0|||
127964968|NCT01262872|460491471|FG006|Step 2|Protocol Violation|3|||
127964969|NCT01262872|460491472|FG007|Step 2|Protocol Violation|1|||
127964970|NCT01262872|460491465|FG000|Step 2|Withdrawal by Subject|0|||
127964971|NCT01262872|460491466|FG001|Step 2|Withdrawal by Subject|0|||
127964972|NCT01262872|460491467|FG002|Step 2|Withdrawal by Subject|4|||
127964973|NCT01262872|460491468|FG003|Step 2|Withdrawal by Subject|6|||
127964974|NCT01262872|460491469|FG004|Step 2|Withdrawal by Subject|3|||
127964975|NCT01262872|460491470|FG005|Step 2|Withdrawal by Subject|1|||
127964976|NCT01262872|460491471|FG006|Step 2|Withdrawal by Subject|2|||
127964977|NCT01262872|460491472|FG007|Step 2|Withdrawal by Subject|1|||
127964978|NCT01262872|460491465|FG000|Step 2|Migrated/moved from study area|0|||
127964979|NCT01262872|460491466|FG001|Step 2|Migrated/moved from study area|0|||
127964980|NCT01262872|460491467|FG002|Step 2|Migrated/moved from study area|4|||
127964981|NCT01262872|460491468|FG003|Step 2|Migrated/moved from study area|3|||
127964982|NCT01262872|460491469|FG004|Step 2|Migrated/moved from study area|2|||
127964983|NCT01262872|460491470|FG005|Step 2|Migrated/moved from study area|6|||
127964984|NCT01262872|460491471|FG006|Step 2|Migrated/moved from study area|2|||
127964985|NCT01262872|460491472|FG007|Step 2|Migrated/moved from study area|3|||
127964986|NCT00365794|460491475|FG000|Overall Study|Withdrawal by Subject|2|||
127964987|NCT00745901|460491476|FG000|Overall Study|Adverse Event|3|||
127964988|NCT00745901|460491477|FG001|Overall Study|Adverse Event|4|||
127964989|NCT00745901|460491476|FG000|Overall Study|Protocol Violation|0|||
127964990|NCT00745901|460491477|FG001|Overall Study|Protocol Violation|1|||
127964991|NCT00745901|460491476|FG000|Overall Study|Withdrawal by Subject|1|||
127964992|NCT00745901|460491477|FG001|Overall Study|Withdrawal by Subject|0|||
127964993|NCT00745901|460491476|FG000|Overall Study|Lost to Follow-up|7|||
127964994|NCT00745901|460491477|FG001|Overall Study|Lost to Follow-up|4|||
127964995|NCT00745901|460491476|FG000|Overall Study|Pregnancy|2|||
127964996|NCT00745901|460491477|FG001|Overall Study|Pregnancy|4|||
127964997|NCT00745901|460491476|FG000|Overall Study|Lack of compliance|2|||
127964998|NCT00745901|460491477|FG001|Overall Study|Lack of compliance|2|||
127964999|NCT00745901|460491476|FG000|Overall Study|Patient's next menses did not start with|1|||
127965000|NCT00745901|460491477|FG001|Overall Study|Patient's next menses did not start with|0|||
127965001|NCT00745901|460491476|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
127965002|NCT00745901|460491477|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
127965003|NCT00745901|460491476|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
127965004|NCT00745901|460491477|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
127965005|NCT00745901|460491476|FG000|Overall Study|Patient didn't take any study medication|7|||
127965006|NCT00745901|460491477|FG001|Overall Study|Patient didn't take any study medication|3|||
127965007|NCT03859427|460491479|FG000|Overall Study|Withdrawal by Subject|4|||
127965008|NCT03859427|460491480|FG001|Overall Study|Withdrawal by Subject|7|||
127965009|NCT03859427|460491479|FG000|Overall Study|Decision by sponsor|0|||
127965010|NCT03859427|460491480|FG001|Overall Study|Decision by sponsor|3|||
127965011|NCT03859427|460491479|FG000|Overall Study|Lost to Follow-up|3|||
127965012|NCT03859427|460491480|FG001|Overall Study|Lost to Follow-up|2|||
127965013|NCT03859427|460491479|FG000|Overall Study|Death|22|||
127965014|NCT03859427|460491480|FG001|Overall Study|Death|25|||
127965015|NCT02503540|460491481|FG000|Overall Study|Death|2|||
127965016|NCT02503540|460491481|FG000|Overall Study|Withdrawal by Subject|1|||
127965017|NCT01662492|460491482|FG000|Overall Study|Other miscellaneous reasons.|1|||
127965018|NCT01662492|460491483|FG001|Overall Study|Other miscellaneous reasons.|0|||
127965019|NCT01662492|460491484|FG002|Overall Study|Other miscellaneous reasons.|1|||
127965020|NCT01662492|460491482|FG000|Overall Study|Withdrawal by Subject|0|||
127965021|NCT01662492|460491483|FG001|Overall Study|Withdrawal by Subject|0|||
127965022|NCT01662492|460491484|FG002|Overall Study|Withdrawal by Subject|1|||
127965023|NCT01662492|460491482|FG000|Overall Study|Protocol Violation|1|||
127965024|NCT01662492|460491483|FG001|Overall Study|Protocol Violation|0|||
127965025|NCT01662492|460491484|FG002|Overall Study|Protocol Violation|0|||
127965026|NCT01662492|460491482|FG000|Overall Study|Lost to Follow-up|0|||
127965027|NCT01662492|460491483|FG001|Overall Study|Lost to Follow-up|0|||
127965028|NCT01662492|460491484|FG002|Overall Study|Lost to Follow-up|2|||
127965029|NCT01662492|460491482|FG000|Overall Study|Lack of Efficacy|1|||
127965030|NCT01662492|460491483|FG001|Overall Study|Lack of Efficacy|1|||
127965031|NCT01662492|460491484|FG002|Overall Study|Lack of Efficacy|2|||
127965032|NCT01804946|460491487|FG000|Overall Study|Protocol Violation|1|||
127965033|NCT01804946|460491488|FG001|Overall Study|Protocol Violation|0|||
127965034|NCT01804946|460491487|FG000|Overall Study|Adverse Event|0|||
127965035|NCT01804946|460491488|FG001|Overall Study|Adverse Event|1|||
127965036|NCT01804946|460491487|FG000|Overall Study|Insufficient data available|0|||
127965037|NCT01804946|460491488|FG001|Overall Study|Insufficient data available|1|||
127965038|NCT01804946|460491487|FG000|Overall Study|Do not meet inclusion criteria|1|||
127965039|NCT01804946|460491488|FG001|Overall Study|Do not meet inclusion criteria|2|||
127965040|NCT00722137|460491489|FG000|Overall Study|Overt Disease Progression|5|||
127965041|NCT00722137|460491490|FG001|Overall Study|Overt Disease Progression|4|||
127965042|NCT00722137|460491489|FG000|Overall Study|Adverse Event|17|||
127965043|NCT00722137|460491490|FG001|Overall Study|Adverse Event|21|||
127965044|NCT00722137|460491489|FG000|Overall Study|Death|12|||
127965045|NCT00722137|460491490|FG001|Overall Study|Death|7|||
127965046|NCT00722137|460491489|FG000|Overall Study|Withdrawal by Subject|6|||
127965047|NCT00722137|460491490|FG001|Overall Study|Withdrawal by Subject|9|||
127965048|NCT00722137|460491489|FG000|Overall Study|Other Reason Unknown|3|||
127965049|NCT00722137|460491490|FG001|Overall Study|Other Reason Unknown|4|||
127965050|NCT00722137|460491489|FG000|Overall Study|Randomized But Not Treated|2|||
127965051|NCT00722137|460491490|FG001|Overall Study|Randomized But Not Treated|3|||
127965052|NCT00848718|460491491|FG000|Overall Study|Adverse Event|2|||
127965053|NCT00848718|460491492|FG001|Overall Study|Adverse Event|2|||
127965054|NCT00848718|460491493|FG002|Overall Study|Adverse Event|1|||
127965055|NCT00848718|460491494|FG003|Overall Study|Adverse Event|1|||
127965056|NCT00848718|460491495|FG004|Overall Study|Adverse Event|1|||
127965057|NCT00848718|460491496|FG005|Overall Study|Adverse Event|0|||
127965058|NCT00848718|460491497|FG006|Overall Study|Adverse Event|0|||
127965059|NCT00848718|460491498|FG007|Overall Study|Adverse Event|1|||
127965060|NCT00848718|460491499|FG008|Overall Study|Adverse Event|1|||
127965061|NCT00848718|460491500|FG009|Overall Study|Adverse Event|0|||
127965062|NCT00848718|460491501|FG010|Overall Study|Adverse Event|0|||
127965063|NCT00848718|460491502|FG011|Overall Study|Adverse Event|0|||
127965064|NCT00848718|460491503|FG012|Overall Study|Adverse Event|2|||
127965065|NCT00848718|460491491|FG000|Overall Study|Lack of Efficacy|0|||
127965066|NCT00848718|460491492|FG001|Overall Study|Lack of Efficacy|0|||
127965067|NCT00848718|460491493|FG002|Overall Study|Lack of Efficacy|1|||
127965068|NCT00848718|460491494|FG003|Overall Study|Lack of Efficacy|0|||
127965069|NCT00848718|460491495|FG004|Overall Study|Lack of Efficacy|0|||
127965070|NCT00848718|460491496|FG005|Overall Study|Lack of Efficacy|0|||
127965071|NCT00848718|460491497|FG006|Overall Study|Lack of Efficacy|1|||
127965072|NCT00848718|460491498|FG007|Overall Study|Lack of Efficacy|0|||
127965073|NCT00848718|460491499|FG008|Overall Study|Lack of Efficacy|0|||
127965074|NCT00848718|460491500|FG009|Overall Study|Lack of Efficacy|0|||
127965075|NCT00848718|460491501|FG010|Overall Study|Lack of Efficacy|0|||
127965076|NCT00848718|460491502|FG011|Overall Study|Lack of Efficacy|0|||
127965077|NCT00848718|460491503|FG012|Overall Study|Lack of Efficacy|0|||
127965078|NCT00848718|460491491|FG000|Overall Study|Physician Decision|0|||
127965079|NCT00848718|460491492|FG001|Overall Study|Physician Decision|1|||
127965080|NCT00848718|460491493|FG002|Overall Study|Physician Decision|0|||
127965081|NCT00848718|460491494|FG003|Overall Study|Physician Decision|0|||
127965082|NCT00848718|460491495|FG004|Overall Study|Physician Decision|1|||
127965083|NCT00848718|460491496|FG005|Overall Study|Physician Decision|1|||
127965084|NCT00848718|460491497|FG006|Overall Study|Physician Decision|0|||
127965085|NCT00848718|460491498|FG007|Overall Study|Physician Decision|0|||
127965086|NCT00848718|460491499|FG008|Overall Study|Physician Decision|1|||
127965087|NCT00848718|460491500|FG009|Overall Study|Physician Decision|2|||
127965088|NCT00848718|460491501|FG010|Overall Study|Physician Decision|0|||
127965089|NCT00848718|460491502|FG011|Overall Study|Physician Decision|0|||
127965090|NCT00848718|460491503|FG012|Overall Study|Physician Decision|1|||
127965091|NCT00848718|460491491|FG000|Overall Study|Progressive disease before treatment|1|||
127965092|NCT00848718|460491492|FG001|Overall Study|Progressive disease before treatment|5|||
127965093|NCT00848718|460491493|FG002|Overall Study|Progressive disease before treatment|1|||
127965094|NCT00848718|460491494|FG003|Overall Study|Progressive disease before treatment|3|||
127965095|NCT00848718|460491495|FG004|Overall Study|Progressive disease before treatment|4|||
127965096|NCT00848718|460491496|FG005|Overall Study|Progressive disease before treatment|4|||
127965097|NCT00848718|460491497|FG006|Overall Study|Progressive disease before treatment|2|||
127965098|NCT00848718|460491498|FG007|Overall Study|Progressive disease before treatment|1|||
127965099|NCT00848718|460491499|FG008|Overall Study|Progressive disease before treatment|2|||
127965100|NCT00848718|460491500|FG009|Overall Study|Progressive disease before treatment|7|||
127965101|NCT00848718|460491501|FG010|Overall Study|Progressive disease before treatment|3|||
127965102|NCT00848718|460491502|FG011|Overall Study|Progressive disease before treatment|6|||
127965103|NCT00848718|460491503|FG012|Overall Study|Progressive disease before treatment|2|||
127965104|NCT00848718|460491491|FG000|Overall Study|Protocol Violation|0|||
127965105|NCT00848718|460491492|FG001|Overall Study|Protocol Violation|1|||
127965106|NCT00848718|460491493|FG002|Overall Study|Protocol Violation|0|||
127965107|NCT00848718|460491494|FG003|Overall Study|Protocol Violation|0|||
127965108|NCT00848718|460491495|FG004|Overall Study|Protocol Violation|0|||
127965109|NCT00848718|460491496|FG005|Overall Study|Protocol Violation|0|||
127965110|NCT00848718|460491497|FG006|Overall Study|Protocol Violation|0|||
127965111|NCT00848718|460491498|FG007|Overall Study|Protocol Violation|1|||
127965112|NCT00848718|460491499|FG008|Overall Study|Protocol Violation|0|||
127965113|NCT00848718|460491500|FG009|Overall Study|Protocol Violation|0|||
127965114|NCT00848718|460491501|FG010|Overall Study|Protocol Violation|0|||
127965115|NCT00848718|460491502|FG011|Overall Study|Protocol Violation|0|||
127965116|NCT00848718|460491503|FG012|Overall Study|Protocol Violation|1|||
127965117|NCT00848718|460491491|FG000|Overall Study|Withdrawal by Subject|1|||
127965118|NCT00848718|460491492|FG001|Overall Study|Withdrawal by Subject|0|||
127965119|NCT00848718|460491493|FG002|Overall Study|Withdrawal by Subject|0|||
127965120|NCT00848718|460491494|FG003|Overall Study|Withdrawal by Subject|1|||
127965121|NCT00848718|460491495|FG004|Overall Study|Withdrawal by Subject|0|||
127965122|NCT00848718|460491496|FG005|Overall Study|Withdrawal by Subject|0|||
127965123|NCT00848718|460491497|FG006|Overall Study|Withdrawal by Subject|0|||
127965124|NCT00848718|460491498|FG007|Overall Study|Withdrawal by Subject|0|||
127965125|NCT00848718|460491499|FG008|Overall Study|Withdrawal by Subject|0|||
127965126|NCT00848718|460491500|FG009|Overall Study|Withdrawal by Subject|0|||
127965127|NCT00848718|460491501|FG010|Overall Study|Withdrawal by Subject|1|||
127965128|NCT00848718|460491502|FG011|Overall Study|Withdrawal by Subject|0|||
127965129|NCT00848718|460491503|FG012|Overall Study|Withdrawal by Subject|0|||
127965130|NCT00848718|460491491|FG000|Overall Study|Progressive disease during treatment|3|||
127965131|NCT00848718|460491492|FG001|Overall Study|Progressive disease during treatment|0|||
127965132|NCT00848718|460491493|FG002|Overall Study|Progressive disease during treatment|3|||
127965133|NCT00848718|460491494|FG003|Overall Study|Progressive disease during treatment|0|||
127965134|NCT00848718|460491495|FG004|Overall Study|Progressive disease during treatment|0|||
127965135|NCT00848718|460491496|FG005|Overall Study|Progressive disease during treatment|0|||
127965136|NCT00848718|460491497|FG006|Overall Study|Progressive disease during treatment|0|||
127965137|NCT00848718|460491498|FG007|Overall Study|Progressive disease during treatment|2|||
127965138|NCT00848718|460491499|FG008|Overall Study|Progressive disease during treatment|0|||
127965139|NCT00848718|460491500|FG009|Overall Study|Progressive disease during treatment|0|||
127965140|NCT00848718|460491501|FG010|Overall Study|Progressive disease during treatment|0|||
127965141|NCT00848718|460491502|FG011|Overall Study|Progressive disease during treatment|0|||
127965142|NCT00848718|460491503|FG012|Overall Study|Progressive disease during treatment|2|||
127965143|NCT02418182|460491507|FG000|Overall Study|Unable to re-consent|18|||
127965144|NCT02418182|460491508|FG001|Overall Study|Unable to re-consent|15|||
127965145|NCT02418182|460491507|FG000|Overall Study|Lost to Follow-up|0|||
127965146|NCT02418182|460491508|FG001|Overall Study|Lost to Follow-up|2|||
127965147|NCT02431676|460491511|FG000|Overall Study|no lab obtained|0|||
127965148|NCT02431676|460491512|FG001|Overall Study|no lab obtained|1|||
127965149|NCT02431676|460491513|FG002|Overall Study|no lab obtained|2|||
127965150|NCT01120184|460493562|FG000|Overall Study|Adverse Event|0|||
127965151|NCT01120184|460493563|FG001|Overall Study|Adverse Event|1|||
127965152|NCT01120184|460493564|FG002|Overall Study|Adverse Event|0|||
127965153|NCT01120184|460493562|FG000|Overall Study|Lost to Follow-up|13|||
127965154|NCT01120184|460493563|FG001|Overall Study|Lost to Follow-up|13|||
127965155|NCT01120184|460493564|FG002|Overall Study|Lost to Follow-up|11|||
127965156|NCT01120184|460493562|FG000|Overall Study|Physician Decision|9|||
127965157|NCT01120184|460493563|FG001|Overall Study|Physician Decision|1|||
127965158|NCT01120184|460493564|FG002|Overall Study|Physician Decision|3|||
127965159|NCT01120184|460493562|FG000|Overall Study|Reason not Specified|8|||
127965160|NCT01120184|460493563|FG001|Overall Study|Reason not Specified|3|||
127965161|NCT01120184|460493564|FG002|Overall Study|Reason not Specified|12|||
127965162|NCT01120184|460493562|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
127965163|NCT01120184|460493563|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
127965164|NCT01120184|460493564|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
127965165|NCT01120184|460493562|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
127965166|NCT01120184|460493563|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
127965167|NCT01120184|460493564|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
127965168|NCT01120184|460493562|FG000|Overall Study|Death|170|||
127965169|NCT01120184|460493563|FG001|Overall Study|Death|176|||
127965170|NCT01120184|460493564|FG002|Overall Study|Death|169|||
127965171|NCT04003636|460493565|FG000|Overall Study|Death|409|||
127965172|NCT04003636|460493566|FG001|Overall Study|Death|443|||
127965173|NCT04003636|460493565|FG000|Overall Study|Lost to Follow-up|0|||
127965174|NCT04003636|460493566|FG001|Overall Study|Lost to Follow-up|1|||
127965175|NCT04003636|460493565|FG000|Overall Study|Withdrawal by Subject|5|||
127965176|NCT04003636|460493566|FG001|Overall Study|Withdrawal by Subject|2|||
127965177|NCT04003636|460493565|FG000|Overall Study|Participant On-going|119|||
127965178|NCT04003636|460493566|FG001|Overall Study|Participant On-going|90|||
127965179|NCT00824772|460493567|FG000|Overall Study|Withdrawal by Subject|8|||
127965180|NCT03656068|460493568|FG000|Overall Study|Withdrawal by Subject|4|||
127965181|NCT03656068|460493568|FG000|Overall Study|Adverse Event|1|||
127965182|NCT03270657|460493569|FG000|Overall Study|Withdrawal by Subject|1|||
127965183|NCT00162981|460493570|FG000|Overall Study|Adverse Event|2|||
127965184|NCT00162981|460493571|FG001|Overall Study|Adverse Event|5|||
127965185|NCT00162981|460493570|FG000|Overall Study|Withdrawal by Subject|1|||
127965186|NCT00162981|460493571|FG001|Overall Study|Withdrawal by Subject|1|||
127965187|NCT00162981|460493570|FG000|Overall Study|Physician Decision|1|||
127965188|NCT00162981|460493571|FG001|Overall Study|Physician Decision|0|||
127965189|NCT00455403|460493578|FG000|Overall Study|Lost to Follow-up|2|||
127965190|NCT00455403|460493579|FG001|Overall Study|Lost to Follow-up|1|||
127965191|NCT00455403|460493578|FG000|Overall Study|Withdrawal by Subject|1|||
127965192|NCT00455403|460493579|FG001|Overall Study|Withdrawal by Subject|3|||
127965193|NCT00455403|460493578|FG000|Overall Study|Protocol Violation|0|||
127965194|NCT00455403|460493579|FG001|Overall Study|Protocol Violation|2|||
127965195|NCT00350207|460493580|FG000|Overall Study|Adverse Event|5|||
127965196|NCT00350207|460493581|FG001|Overall Study|Adverse Event|2|||
127965197|NCT00350207|460493582|FG002|Overall Study|Adverse Event|2|||
127965198|NCT00350207|460493580|FG000|Overall Study|Lack of Efficacy|1|||
127965199|NCT00350207|460493581|FG001|Overall Study|Lack of Efficacy|0|||
127965200|NCT00350207|460493582|FG002|Overall Study|Lack of Efficacy|2|||
127965201|NCT00350207|460493580|FG000|Overall Study|Lost to Follow-up|1|||
127965202|NCT00350207|460493581|FG001|Overall Study|Lost to Follow-up|0|||
127965203|NCT00350207|460493582|FG002|Overall Study|Lost to Follow-up|1|||
127965204|NCT00350207|460493580|FG000|Overall Study|Withdrawal by Subject|0|||
127965205|NCT00350207|460493581|FG001|Overall Study|Withdrawal by Subject|1|||
127965206|NCT00350207|460493582|FG002|Overall Study|Withdrawal by Subject|1|||
127965207|NCT00350207|460493580|FG000|Overall Study|Other|1|||
127965208|NCT00350207|460493581|FG001|Overall Study|Other|3|||
127965209|NCT00350207|460493582|FG002|Overall Study|Other|1|||
127965210|NCT00495391|460493583|FG000|Overall Study|Lack of Efficacy|34|||
127965211|NCT00495391|460493584|FG001|Overall Study|Lack of Efficacy|18|||
127965212|NCT00495391|460493583|FG000|Overall Study|Withdrawal by Subject|2|||
127965213|NCT00495391|460493584|FG001|Overall Study|Withdrawal by Subject|3|||
127965214|NCT04509076|460493593|FG000|Overall Study|Withdrawal by Subject|1|||
127965215|NCT04509076|460493594|FG001|Overall Study|Withdrawal by Subject|2|||
127965216|NCT04509076|460493593|FG000|Overall Study|Lost to Follow-up|1|||
127965217|NCT04509076|460493594|FG001|Overall Study|Lost to Follow-up|2|||
127965218|NCT00502242|460493599|FG000|Overall Study|Lack of Efficacy|1|||
127965219|NCT00502242|460493600|FG001|Overall Study|Lack of Efficacy|11|||
127965220|NCT00502242|460493599|FG000|Overall Study|Adverse Event|31|||
127965221|NCT00502242|460493600|FG001|Overall Study|Adverse Event|20|||
127965222|NCT00502242|460493599|FG000|Overall Study|Physician Decision|2|||
127965223|NCT00502242|460493600|FG001|Overall Study|Physician Decision|3|||
127965224|NCT00502242|460493599|FG000|Overall Study|Other - Unspecified|8|||
127965225|NCT00502242|460493600|FG001|Overall Study|Other - Unspecified|14|||
127965226|NCT00502242|460493599|FG000|Overall Study|Protocol Violation|3|||
127965227|NCT00502242|460493600|FG001|Overall Study|Protocol Violation|1|||
127965228|NCT00502242|460493599|FG000|Overall Study|Withdrawal by Subject|6|||
127965229|NCT00502242|460493600|FG001|Overall Study|Withdrawal by Subject|7|||
127965230|NCT03313180|460493601|FG000|Overall Study|Adverse Event|120|||
127965231|NCT03313180|460493601|FG000|Overall Study|Lost to Follow-up|3|||
127965232|NCT03313180|460493601|FG000|Overall Study|Withdrawal by Subject|39|||
127965233|NCT03313180|460493601|FG000|Overall Study|Other than listed above|15|||
127965234|NCT03313180|460493601|FG000|Overall Study|Covid-19 related|2|||
127965235|NCT01966120|460493602|FG000|Overall Study|Withdrawal by Subject|0|||
127965236|NCT01966120|460493603|FG001|Overall Study|Withdrawal by Subject|5|||
127965237|NCT01966120|460493602|FG000|Overall Study|Lost to Follow-up|1|||
127965238|NCT01966120|460493603|FG001|Overall Study|Lost to Follow-up|1|||
127965239|NCT00461630|460493604|FG000|Overall Study|Death|798|||
127965240|NCT00461630|460493605|FG001|Overall Study|Death|732|||
127965241|NCT00461630|460493604|FG000|Overall Study|Lost to Follow-up|108|||
127965242|NCT00461630|460493605|FG001|Overall Study|Lost to Follow-up|95|||
127965243|NCT00442897|460493607|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
127965244|NCT00442897|460493608|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
127965245|NCT00442897|460493607|FG000|Base Study (12 Week Follow-up)|Death|0|||
127965246|NCT00442897|460493608|FG001|Base Study (12 Week Follow-up)|Death|1|||
127965247|NCT00442897|460493607|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
127965248|NCT00442897|460493608|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
127965249|NCT00442897|460493607|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
127965250|NCT00442897|460493608|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
127965251|NCT00442897|460493607|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
127965252|NCT00442897|460493608|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
127965253|NCT00442897|460493607|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
127965254|NCT00442897|460493608|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
127965255|NCT00442897|460493607|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
127965256|NCT00442897|460493608|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
127965257|NCT00442897|460493607|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
127965258|NCT00442897|460493608|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
127965259|NCT00891020|460493613|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
127965260|NCT00891020|460493614|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
127965261|NCT00891020|460493615|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
127965262|NCT00891020|460493613|FG000|24 Week Treatment Period|Death|0|||
127965263|NCT00891020|460493614|FG001|24 Week Treatment Period|Death|2|||
127965264|NCT00891020|460493615|FG002|24 Week Treatment Period|Death|0|||
127965265|NCT00891020|460493613|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
127965266|NCT00891020|460493614|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
127965267|NCT00891020|460493615|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
127965268|NCT00891020|460493613|FG000|24 Week Treatment Period|Failure to return|4|||
127965269|NCT00891020|460493614|FG001|24 Week Treatment Period|Failure to return|5|||
127965270|NCT00891020|460493615|FG002|24 Week Treatment Period|Failure to return|5|||
127965271|NCT00891020|460493613|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
127965272|NCT00891020|460493614|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
127965273|NCT00891020|460493615|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
127965274|NCT00891020|460493613|FG000|24 Week Treatment Period|Other protocol violation|1|||
127965275|NCT00891020|460493614|FG001|24 Week Treatment Period|Other protocol violation|1|||
127965276|NCT00891020|460493615|FG002|24 Week Treatment Period|Other protocol violation|2|||
127965277|NCT00891020|460493613|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
127965278|NCT00891020|460493614|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
127965279|NCT00891020|460493615|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
127965280|NCT00891020|460493613|FG000|24 Week Treatment Period|Withdrew consent|6|||
127965281|NCT00891020|460493614|FG001|24 Week Treatment Period|Withdrew consent|3|||
127965282|NCT00891020|460493615|FG002|24 Week Treatment Period|Withdrew consent|15|||
127965283|NCT00891020|460493613|FG000|24 Week Treatment Period|Administrative/Other|5|||
127965284|NCT00891020|460493614|FG001|24 Week Treatment Period|Administrative/Other|6|||
127965285|NCT00891020|460493615|FG002|24 Week Treatment Period|Administrative/Other|1|||
127965286|NCT00891020|460493613|FG000|Long-term Extension Period|Adverse Event|1|||
127965287|NCT00891020|460493614|FG001|Long-term Extension Period|Adverse Event|11|||
127965288|NCT00891020|460493615|FG002|Long-term Extension Period|Adverse Event|10|||
127965289|NCT00891020|460493613|FG000|Long-term Extension Period|Death|0|||
127965290|NCT00891020|460493614|FG001|Long-term Extension Period|Death|0|||
127965291|NCT00891020|460493615|FG002|Long-term Extension Period|Death|1|||
127965292|NCT00891020|460493613|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
127965293|NCT00891020|460493614|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
127965294|NCT00891020|460493615|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
127965295|NCT00891020|460493613|FG000|Long-term Extension Period|Protocol Violation|0|||
127965296|NCT00891020|460493614|FG001|Long-term Extension Period|Protocol Violation|1|||
127965297|NCT00891020|460493615|FG002|Long-term Extension Period|Protocol Violation|1|||
127965298|NCT00891020|460493613|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
127965299|NCT00891020|460493614|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
127965300|NCT00891020|460493615|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
127965301|NCT00891020|460493613|FG000|Long-term Extension Period|Failure to return|0|||
127965302|NCT00891020|460493614|FG001|Long-term Extension Period|Failure to return|2|||
127965303|NCT00891020|460493615|FG002|Long-term Extension Period|Failure to return|3|||
127965304|NCT00891020|460493613|FG000|Long-term Extension Period|Administrative|1|||
127965305|NCT00891020|460493614|FG001|Long-term Extension Period|Administrative|2|||
127965306|NCT00891020|460493615|FG002|Long-term Extension Period|Administrative|2|||
127965307|NCT00320710|460493623|FG000|Overall Study|Disease progression|24|||
127965308|NCT00320710|460493624|FG001|Overall Study|Disease progression|19|||
127965309|NCT00320710|460493625|FG002|Overall Study|Disease progression|2|||
127965310|NCT00320710|460493623|FG000|Overall Study|Death|10|||
127965311|NCT00320710|460493624|FG001|Overall Study|Death|7|||
127965312|NCT00320710|460493625|FG002|Overall Study|Death|1|||
127965313|NCT00320710|460493623|FG000|Overall Study|Administrative problems|1|||
127965314|NCT00320710|460493624|FG001|Overall Study|Administrative problems|2|||
127965315|NCT00320710|460493625|FG002|Overall Study|Administrative problems|0|||
127965316|NCT00320710|460493623|FG000|Overall Study|Withdrawal by Subject|20|||
127965317|NCT00320710|460493624|FG001|Overall Study|Withdrawal by Subject|26|||
127965318|NCT00320710|460493625|FG002|Overall Study|Withdrawal by Subject|1|||
127965319|NCT00320710|460493623|FG000|Overall Study|Protocol Violation|6|||
127965320|NCT00320710|460493624|FG001|Overall Study|Protocol Violation|5|||
127965321|NCT00320710|460493625|FG002|Overall Study|Protocol Violation|0|||
127965322|NCT00320710|460493623|FG000|Overall Study|Abnormal test procedure result(s)|2|||
127965323|NCT00320710|460493624|FG001|Overall Study|Abnormal test procedure result(s)|0|||
127965324|NCT00320710|460493625|FG002|Overall Study|Abnormal test procedure result(s)|0|||
127965325|NCT00320710|460493623|FG000|Overall Study|Abnormal laboratory value(s)|12|||
127965326|NCT00320710|460493624|FG001|Overall Study|Abnormal laboratory value(s)|3|||
127965327|NCT00320710|460493625|FG002|Overall Study|Abnormal laboratory value(s)|0|||
127965328|NCT00320710|460493623|FG000|Overall Study|Adverse Event|18|||
127965329|NCT00320710|460493624|FG001|Overall Study|Adverse Event|14|||
127965330|NCT00320710|460493625|FG002|Overall Study|Adverse Event|1|||
127965331|NCT00320710|460493623|FG000|Overall Study|Lost to Follow-up|1|||
127965332|NCT00320710|460493624|FG001|Overall Study|Lost to Follow-up|0|||
127965333|NCT00320710|460493625|FG002|Overall Study|Lost to Follow-up|0|||
127965334|NCT03448419|460493626|FG000|Overall Study|Adverse Event|10|||
127965335|NCT03448419|460493627|FG001|Overall Study|Adverse Event|9|||
127965336|NCT03448419|460493626|FG000|Overall Study|Lost to Follow-up|0|||
127965337|NCT03448419|460493627|FG001|Overall Study|Lost to Follow-up|2|||
127965338|NCT03448419|460493626|FG000|Overall Study|Withdrawal by Subject|3|||
127965339|NCT03448419|460493627|FG001|Overall Study|Withdrawal by Subject|1|||
127965340|NCT03448419|460493626|FG000|Overall Study|Not treated|0|||
127965341|NCT03448419|460493627|FG001|Overall Study|Not treated|1|||
127965342|NCT03448419|460493626|FG000|Overall Study|Patient did not attend all visits|0|||
127965343|NCT03448419|460493627|FG001|Overall Study|Patient did not attend all visits|2|||
127965344|NCT03448419|460493626|FG000|Overall Study|Withdrawn by Sponsor|0|||
127965345|NCT03448419|460493627|FG001|Overall Study|Withdrawn by Sponsor|1|||
127965346|NCT02841995|460493628|FG000|Overall Study|Disease progression|5|||
127965347|NCT02841995|460493629|FG001|Overall Study|Disease progression|11|||
127965348|NCT02841995|460493630|FG002|Overall Study|Disease progression|8|||
127965349|NCT02841995|460493628|FG000|Overall Study|Withdrawal by Subject|2|||
127965350|NCT02841995|460493629|FG001|Overall Study|Withdrawal by Subject|4|||
127965351|NCT02841995|460493630|FG002|Overall Study|Withdrawal by Subject|4|||
127965352|NCT02841995|460493628|FG000|Overall Study|Adverse Event|2|||
127965353|NCT02841995|460493629|FG001|Overall Study|Adverse Event|0|||
127965354|NCT02841995|460493630|FG002|Overall Study|Adverse Event|1|||
127965355|NCT02841995|460493628|FG000|Overall Study|Investigator decision|2|||
127965356|NCT02841995|460493629|FG001|Overall Study|Investigator decision|0|||
127965357|NCT02841995|460493630|FG002|Overall Study|Investigator decision|1|||
127965358|NCT02841995|460493628|FG000|Overall Study|Death|0|||
127965359|NCT02841995|460493629|FG001|Overall Study|Death|0|||
127965360|NCT02841995|460493630|FG002|Overall Study|Death|2|||
127965361|NCT02841995|460493628|FG000|Overall Study|Noncompliance to protocol|1|||
127965362|NCT02841995|460493629|FG001|Overall Study|Noncompliance to protocol|0|||
127965363|NCT02841995|460493630|FG002|Overall Study|Noncompliance to protocol|0|||
127965364|NCT02841995|460493628|FG000|Overall Study|Sponsor decision|1|||
127965365|NCT02841995|460493629|FG001|Overall Study|Sponsor decision|0|||
127965366|NCT02841995|460493630|FG002|Overall Study|Sponsor decision|0|||
127965367|NCT02841995|460493628|FG000|Overall Study|Other|4|||
127965368|NCT02841995|460493629|FG001|Overall Study|Other|1|||
127965369|NCT02841995|460493630|FG002|Overall Study|Other|5|||
127965370|NCT01703260|460493631|FG000|Overall Study|Adverse Event|1|||
127965371|NCT01703260|460493632|FG001|Overall Study|Adverse Event|2|||
127965372|NCT01703260|460493633|FG002|Overall Study|Adverse Event|2|||
127965373|NCT01703260|460493631|FG000|Overall Study|Lost to Follow-up|1|||
127965374|NCT01703260|460493632|FG001|Overall Study|Lost to Follow-up|0|||
127965375|NCT01703260|460493633|FG002|Overall Study|Lost to Follow-up|0|||
127965376|NCT01703260|460493631|FG000|Overall Study|Withdrawal by Subject|0|||
127965377|NCT01703260|460493632|FG001|Overall Study|Withdrawal by Subject|0|||
127965378|NCT01703260|460493633|FG002|Overall Study|Withdrawal by Subject|1|||
127965379|NCT01703260|460493631|FG000|Overall Study|Study Termination|1|||
127965380|NCT01703260|460493632|FG001|Overall Study|Study Termination|2|||
127965381|NCT01703260|460493633|FG002|Overall Study|Study Termination|0|||
127965382|NCT04548193|460493636|FG000|Overall Study|Lost to Follow-up|0|||
127965383|NCT04548193|460493637|FG001|Overall Study|Lost to Follow-up|1|||
127965384|NCT04548193|460493636|FG000|Overall Study|Death|0|||
127965385|NCT04548193|460493637|FG001|Overall Study|Death|1|||
127965386|NCT04548193|460493636|FG000|Overall Study|Not eligible. Participant underwent cystectomy in August|1|||
127965387|NCT04548193|460493637|FG001|Overall Study|Not eligible. Participant underwent cystectomy in August|0|||
127965388|NCT04548193|460493636|FG000|Overall Study|Withdrawal by Subject|2|||
127965389|NCT04548193|460493637|FG001|Overall Study|Withdrawal by Subject|2|||
127965390|NCT00630825|460493638|FG000|Overall Study|Adverse Event|4|||
127965391|NCT00630825|460493639|FG001|Overall Study|Adverse Event|4|||
127965392|NCT00630825|460493640|FG002|Overall Study|Adverse Event|3|||
127965393|NCT00630825|460493641|FG003|Overall Study|Adverse Event|1|||
127965394|NCT00630825|460493638|FG000|Overall Study|Entry Criteria Not Met|1|||
127965395|NCT00630825|460493639|FG001|Overall Study|Entry Criteria Not Met|0|||
127965396|NCT00630825|460493640|FG002|Overall Study|Entry Criteria Not Met|2|||
127965397|NCT00630825|460493641|FG003|Overall Study|Entry Criteria Not Met|1|||
127965398|NCT00630825|460493638|FG000|Overall Study|Lost to Follow-up|1|||
127965399|NCT00630825|460493639|FG001|Overall Study|Lost to Follow-up|1|||
127965400|NCT00630825|460493640|FG002|Overall Study|Lost to Follow-up|1|||
127965401|NCT00630825|460493641|FG003|Overall Study|Lost to Follow-up|1|||
127965402|NCT00630825|460493638|FG000|Overall Study|Physician Decision|1|||
127965403|NCT00630825|460493639|FG001|Overall Study|Physician Decision|0|||
127965404|NCT00630825|460493640|FG002|Overall Study|Physician Decision|0|||
127965405|NCT00630825|460493641|FG003|Overall Study|Physician Decision|0|||
127965406|NCT00630825|460493638|FG000|Overall Study|Withdrawal by Subject|2|||
127965407|NCT00630825|460493639|FG001|Overall Study|Withdrawal by Subject|2|||
127965408|NCT00630825|460493640|FG002|Overall Study|Withdrawal by Subject|2|||
127965409|NCT00630825|460493641|FG003|Overall Study|Withdrawal by Subject|3|||
127965410|NCT02275819|460493642|FG000|Overall Study|Adverse Event|0|||
127965411|NCT02275819|460493643|FG001|Overall Study|Adverse Event|1|||
127965412|NCT02211209|460493645|FG000|Overall Study|Investigator judgment|0|||
127965413|NCT02211209|460493646|FG001|Overall Study|Investigator judgment|1|||
127965414|NCT02211209|460493645|FG000|Overall Study|Voluntary withdrawal|1|||
127965415|NCT02211209|460493646|FG001|Overall Study|Voluntary withdrawal|4|||
127965416|NCT02211209|460493645|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
127965417|NCT02211209|460493646|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
127965418|NCT02211209|460493645|FG000|Overall Study|Reason Not Specified|1|||
127965419|NCT02211209|460493646|FG001|Overall Study|Reason Not Specified|0|||
127965420|NCT02792062|460493649|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
127965421|NCT02792062|460493650|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
127965422|NCT02792062|460493651|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
127965423|NCT02792062|460493652|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
127965424|NCT02792062|460493653|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
127965425|NCT02792062|460493654|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
127965426|NCT03309943|460493657|FG000|Overall Study|Withdrawal by Subject|0|||
127965427|NCT03309943|460493658|FG001|Overall Study|Withdrawal by Subject|1|||
127965428|NCT03309943|460493657|FG000|Overall Study|Inappropriate behavior towards staff|0|||
127965429|NCT03309943|460493658|FG001|Overall Study|Inappropriate behavior towards staff|1|||
127965430|NCT00931255|460493659|FG000|Overall Study|Follow up biopsy not done|2|||
127965431|NCT00931255|460493660|FG001|Overall Study|Follow up biopsy not done|3|||
127965432|NCT01372995|460493661|FG000|Overall Study|Spouse withdrew participant from study|0|||
127965433|NCT01372995|460493662|FG001|Overall Study|Spouse withdrew participant from study|1|||
127965434|NCT01372995|460493663|FG002|Overall Study|Spouse withdrew participant from study|0|||
127965435|NCT01372995|460493661|FG000|Overall Study|Physician Decision|0|||
127965436|NCT01372995|460493662|FG001|Overall Study|Physician Decision|0|||
127965437|NCT01372995|460493663|FG002|Overall Study|Physician Decision|1|||
127965438|NCT03123393|460493669|FG000|Overall Study|Study Terminated by Sponsor|6|||
127965439|NCT03123393|460493670|FG001|Overall Study|Study Terminated by Sponsor|9|||
127965440|NCT03123393|460493669|FG000|Overall Study|Withdrawal by Subject|2|||
127965441|NCT03123393|460493670|FG001|Overall Study|Withdrawal by Subject|1|||
127965442|NCT03123393|460493669|FG000|Overall Study|Reason not Specified|13|||
127965443|NCT03123393|460493670|FG001|Overall Study|Reason not Specified|13|||
127965444|NCT00427648|460493671|FG000|Overall Study|Protocol Violation|1|||
127965445|NCT00427648|460493672|FG001|Overall Study|Protocol Violation|2|||
127965446|NCT00427648|460493671|FG000|Overall Study|Adverse Event|0|||
127965447|NCT00427648|460493672|FG001|Overall Study|Adverse Event|1|||
127965448|NCT00386360|460493673|FG000|Overall Study|Adverse Event|4|||
127965449|NCT00386360|460493674|FG001|Overall Study|Adverse Event|2|||
127965450|NCT00386360|460493673|FG000|Overall Study|Physician Decision|2|||
127965451|NCT00386360|460493674|FG001|Overall Study|Physician Decision|2|||
127965452|NCT00386360|460493673|FG000|Overall Study|Lost to Follow-up|0|||
127965453|NCT00386360|460493674|FG001|Overall Study|Lost to Follow-up|2|||
127965454|NCT00386360|460493673|FG000|Overall Study|Protocol Violation|0|||
127965455|NCT00386360|460493674|FG001|Overall Study|Protocol Violation|3|||
127965456|NCT00386360|460493673|FG000|Overall Study|Withdrawal by Subject|3|||
127965457|NCT00386360|460493674|FG001|Overall Study|Withdrawal by Subject|6|||
127965458|NCT00386360|460493673|FG000|Overall Study|Did not take any study medication|0|||
127965459|NCT00386360|460493674|FG001|Overall Study|Did not take any study medication|2|||
127965460|NCT01681212|460493675|FG000|Overall Study|No longer met study criteria|5|||
127965461|NCT01681212|460493675|FG000|Overall Study|Administrative reason by sponsor|1|||
127965462|NCT01575834|460493676|FG000|Overall Study|Withdrawal by Subject|352|||
127965463|NCT01575834|460493677|FG001|Overall Study|Withdrawal by Subject|390|||
127965464|NCT01575834|460493676|FG000|Overall Study|Death|81|||
127965465|NCT01575834|460493677|FG001|Overall Study|Death|74|||
127965466|NCT01575834|460493676|FG000|Overall Study|Other|70|||
127965467|NCT01575834|460493677|FG001|Overall Study|Other|70|||
127965468|NCT01575834|460493676|FG000|Overall Study|Adverse Event|63|||
127965469|NCT01575834|460493677|FG001|Overall Study|Adverse Event|61|||
127965470|NCT01575834|460493676|FG000|Overall Study|Lost to Follow-up|55|||
127965471|NCT01575834|460493677|FG001|Overall Study|Lost to Follow-up|68|||
127965472|NCT01575834|460493676|FG000|Overall Study|Noncompliance|52|||
127965473|NCT01575834|460493677|FG001|Overall Study|Noncompliance|27|||
127965474|NCT01575834|460493676|FG000|Overall Study|Administrative decision|15|||
127965475|NCT01575834|460493677|FG001|Overall Study|Administrative decision|33|||
127965476|NCT01575834|460493676|FG000|Overall Study|Ineligibility Determined|5|||
127965477|NCT01575834|460493677|FG001|Overall Study|Ineligibility Determined|8|||
127965478|NCT01575834|460493676|FG000|Overall Study|Protocol Deviation|4|||
127965479|NCT01575834|460493677|FG001|Overall Study|Protocol Deviation|3|||
127965480|NCT01575834|460493676|FG000|Overall Study|Requirement for Alternative Therapy|2|||
127965481|NCT01575834|460493677|FG001|Overall Study|Requirement for Alternative Therapy|4|||
127965482|NCT02220764|460493685|FG000|Overall Study|Lost to Follow-up|3|||
127965483|NCT02220764|460493686|FG001|Overall Study|Lost to Follow-up|1|||
127965484|NCT02220764|460493685|FG000|Overall Study|Death|1|||
127965485|NCT02220764|460493686|FG001|Overall Study|Death|0|||
127965486|NCT05000164|460493687|FG000|Overall Study|Adverse Event|1|||
127965487|NCT05000164|460493687|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
127965488|NCT05000164|460493687|FG000|Overall Study|Lens Discomfort|3|||
127965489|NCT05000164|460493687|FG000|Overall Study|Withdrew Consent during Study|2|||
127965490|NCT05000164|460493687|FG000|Overall Study|Subject Withdrawn by PI|2|||
127965491|NCT05000164|460493687|FG000|Overall Study|Other Fractured Test Article|1|||
127965492|NCT06509438|460493692|FG000|Overall Study|Adverse Event|1|||
127965493|NCT06509438|460493692|FG000|Overall Study|Lost to Follow-up|3|||
127965494|NCT03331796|460493693|FG000|Allocation and Primary Endpoint|Pandemic Disruption|0|||
127965495|NCT03331796|460493694|FG001|Allocation and Primary Endpoint|Pandemic Disruption|1|||
127965496|NCT03331796|460493695|FG002|Allocation and Primary Endpoint|Pandemic Disruption|1|||
127965497|NCT03331796|460493693|FG000|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
127965498|NCT03331796|460493694|FG001|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
127965499|NCT03331796|460493695|FG002|Allocation and Primary Endpoint|Withdrawal by Subject|1|||
127965500|NCT03331796|460493693|FG000|Extended Follow-up|Adverse Event|1|||
127965501|NCT03331796|460493694|FG001|Extended Follow-up|Adverse Event|0|||
127965502|NCT03331796|460493695|FG002|Extended Follow-up|Adverse Event|1|||
127965503|NCT03331796|460493693|FG000|Extended Follow-up|Lost to Follow-up|0|||
127965504|NCT03331796|460493694|FG001|Extended Follow-up|Lost to Follow-up|0|||
127965505|NCT03331796|460493695|FG002|Extended Follow-up|Lost to Follow-up|1|||
127965506|NCT03331796|460493693|FG000|Extended Follow-up|Withdrawal by Subject|1|||
127965507|NCT03331796|460493694|FG001|Extended Follow-up|Withdrawal by Subject|0|||
127965508|NCT03331796|460493695|FG002|Extended Follow-up|Withdrawal by Subject|0|||
127965509|NCT03331796|460493693|FG000|Extended Follow-up|Termination of Funding|0|||
127965510|NCT03331796|460493694|FG001|Extended Follow-up|Termination of Funding|1|||
127965511|NCT03331796|460493695|FG002|Extended Follow-up|Termination of Funding|0|||
127965512|NCT01753570|460493696|FG000|Overall Study|Adverse Event|1|||
127965513|NCT01753570|460493697|FG001|Overall Study|Adverse Event|0|||
127965514|NCT01753570|460493698|FG002|Overall Study|Adverse Event|1|||
127965515|NCT01753570|460493696|FG000|Overall Study|Physician Decision|0|||
127965516|NCT01753570|460493697|FG001|Overall Study|Physician Decision|1|||
127965517|NCT01753570|460493698|FG002|Overall Study|Physician Decision|0|||
127965518|NCT01753570|460493696|FG000|Overall Study|Withdrawal by Subject|1|||
127965519|NCT01753570|460493697|FG001|Overall Study|Withdrawal by Subject|4|||
127965520|NCT01753570|460493698|FG002|Overall Study|Withdrawal by Subject|0|||
127965521|NCT01000155|460493701|FG000|Overall Study|Withdrawal by Subject|1|||
127965522|NCT01000155|460493701|FG000|Overall Study|Adverse Event|1|||
127965523|NCT00720213|460493704|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
127965524|NCT00720213|460493705|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
127965525|NCT00720213|460493706|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
127965526|NCT01808066|460493709|FG000|Overall Study|Withdrawal by Subject|15|||
127965527|NCT01420068|460493710|FG000|Overall Study|Administrative problems|1|||
127965528|NCT01420068|460493711|FG001|Overall Study|Administrative problems|3|||
127965529|NCT01420068|460493710|FG000|Overall Study|Withdrawal by Subject|1|||
127965530|NCT01420068|460493711|FG001|Overall Study|Withdrawal by Subject|2|||
127965531|NCT00884117|460493714|FG000|Overall Study|Adverse Event|2|||
127965532|NCT00884117|460493714|FG000|Overall Study|Withdrawal by Subject|89|||
127965533|NCT00884117|460493714|FG000|Overall Study|Death|3|||
127965534|NCT00884117|460493714|FG000|Overall Study|Lost to Follow-up|143|||
127965535|NCT00884117|460493714|FG000|Overall Study|Other|12|||
127965536|NCT04830969|460493715|FG000|Overall Study|Withdrawal by Subject|6|||
127965537|NCT04830969|460493716|FG001|Overall Study|Withdrawal by Subject|2|||
127965538|NCT04830969|460493715|FG000|Overall Study|Protocol Violation|3|||
127965539|NCT04830969|460493716|FG001|Overall Study|Protocol Violation|9|||
127965540|NCT04830969|460493715|FG000|Overall Study|Lost to Follow-up|4|||
127965541|NCT04830969|460493716|FG001|Overall Study|Lost to Follow-up|4|||
127965542|NCT01786993|460493719|FG000|Overall Study|Death|6|||
127965543|NCT01786993|460493720|FG001|Overall Study|Death|7|||
127965544|NCT01786993|460493719|FG000|Overall Study|Withdrawal by Subject|3|||
127965545|NCT01786993|460493720|FG001|Overall Study|Withdrawal by Subject|2|||
127965546|NCT01786993|460493719|FG000|Overall Study|Lost to Follow-up|0|||
127965547|NCT01786993|460493720|FG001|Overall Study|Lost to Follow-up|1|||
127965548|NCT01786993|460493719|FG000|Overall Study|Subject Non-Compliance|1|||
127965549|NCT01786993|460493720|FG001|Overall Study|Subject Non-Compliance|0|||
127965550|NCT01786993|460493719|FG000|Overall Study|System Explant|1|||
127965551|NCT01786993|460493720|FG001|Overall Study|System Explant|0|||
127965552|NCT01786993|460493719|FG000|Overall Study|Hospice Admission|1|||
127965553|NCT01786993|460493720|FG001|Overall Study|Hospice Admission|0|||
127965554|NCT02712554|460493722|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
127965555|NCT02712554|460493723|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
127965556|NCT02712554|460493722|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
127965557|NCT02712554|460493723|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
127965558|NCT02712554|460493722|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
127965559|NCT02712554|460493723|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
127965560|NCT02712554|460493722|FG000|Part B: Qualification Phase|Adverse Event|0|||
127965561|NCT02712554|460493723|FG001|Part B: Qualification Phase|Adverse Event|1|||
127965562|NCT02712554|460493722|FG000|Part B: Treatment Phase|Adverse Event|0|||
127965563|NCT02712554|460493723|FG001|Part B: Treatment Phase|Adverse Event|1|||
127965564|NCT02712554|460493722|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
127965565|NCT02712554|460493723|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
127965566|NCT02712554|460493722|FG000|Part B: Treatment Phase|Other|0|||
127965567|NCT02712554|460493723|FG001|Part B: Treatment Phase|Other|1|||
127965568|NCT01129557|460493724|FG000|Overall Study|Adverse Event|1|||
127965569|NCT01129557|460493725|FG001|Overall Study|Adverse Event|2|||
127965570|NCT01129557|460493726|FG002|Overall Study|Adverse Event|2|||
127965571|NCT01129557|460493724|FG000|Overall Study|Novartis terminated study early|3|||
127965572|NCT01129557|460493725|FG001|Overall Study|Novartis terminated study early|3|||
127965573|NCT01129557|460493726|FG002|Overall Study|Novartis terminated study early|2|||
127965574|NCT00669669|460493727|FG000|Overall Study|To late to start treatment|1|||
127965575|NCT00570687|460495350|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
127965576|NCT00570687|460495351|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
127965577|NCT00570687|460495352|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
127965578|NCT00570687|460495353|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
127965579|NCT00570687|460495354|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
127965580|NCT00570687|460495355|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
127965581|NCT00570687|460495356|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
127965582|NCT00570687|460495357|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
127965583|NCT00570687|460495358|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
127965584|NCT00570687|460495359|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
127965585|NCT00570687|460495350|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
127965586|NCT00570687|460495351|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
127965587|NCT00570687|460495352|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
127965588|NCT00570687|460495353|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
127965589|NCT00570687|460495354|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
127965590|NCT00570687|460495355|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
127965591|NCT00570687|460495356|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
127965592|NCT00570687|460495357|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
127965593|NCT00570687|460495358|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
127965594|NCT00570687|460495359|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
127965595|NCT00570687|460495350|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
127965596|NCT00570687|460495351|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
127965597|NCT00570687|460495352|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
127965598|NCT00570687|460495353|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
127965599|NCT00570687|460495354|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
127965600|NCT00570687|460495355|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
127965601|NCT00570687|460495356|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
127965602|NCT00570687|460495357|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
127965603|NCT00570687|460495358|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
127965604|NCT00570687|460495359|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
127965605|NCT01102257|460495364|FG000|Overall Study|Adverse Event|1|||
127965606|NCT01102257|460495365|FG001|Overall Study|Adverse Event|0|||
127965607|NCT01102257|460495364|FG000|Overall Study|Adverse Event|1|||
127965608|NCT01102257|460495365|FG001|Overall Study|Adverse Event|0|||
127965609|NCT02525783|460495366|FG000|Overall Study|Lost to Follow-up|10|||
127965610|NCT03048747|460495367|FG000|Overall Study|Adverse Event|2|||
127965611|NCT03048747|460495367|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
127965612|NCT03048747|460495367|FG000|Overall Study|Physician Decision|1|||
127965613|NCT00866281|460495368|FG000|Overall Study|Adverse Event|1|||
127965614|NCT00866281|460495369|FG001|Overall Study|Adverse Event|0|||
127965615|NCT00866281|460495368|FG000|Overall Study|Withdrawal by participants|3|||
127965616|NCT00866281|460495369|FG001|Overall Study|Withdrawal by participants|0|||
127965617|NCT00866281|460495368|FG000|Overall Study|Disease progression|3|||
127965618|NCT00866281|460495369|FG001|Overall Study|Disease progression|11|||
127965619|NCT00866281|460495368|FG000|Overall Study|New cancer therapy|0|||
127965620|NCT00866281|460495369|FG001|Overall Study|New cancer therapy|4|||
127965621|NCT01894841|460495370|FG000|Overall Study|Withdrawal by Subject|9|||
127965622|NCT01894841|460495371|FG001|Overall Study|Withdrawal by Subject|4|||
127965623|NCT01894841|460495370|FG000|Overall Study|Withdrawn by investigator|2|||
127965624|NCT01894841|460495371|FG001|Overall Study|Withdrawn by investigator|2|||
127965625|NCT01894841|460495370|FG000|Overall Study|Lost to Follow-up|7|||
127965626|NCT01894841|460495371|FG001|Overall Study|Lost to Follow-up|3|||
127965627|NCT00529087|460495375|FG000|Overall Study|Adverse Event|10|||
127965628|NCT00529087|460495376|FG001|Overall Study|Adverse Event|13|||
127965629|NCT00529087|460495377|FG002|Overall Study|Adverse Event|4|||
127965630|NCT00529087|460495375|FG000|Overall Study|Lost to Follow-up|6|||
127965631|NCT00529087|460495376|FG001|Overall Study|Lost to Follow-up|4|||
127965632|NCT00529087|460495377|FG002|Overall Study|Lost to Follow-up|1|||
127965633|NCT00529087|460495375|FG000|Overall Study|Protocol Violation|8|||
127965634|NCT00529087|460495376|FG001|Overall Study|Protocol Violation|7|||
127965635|NCT00529087|460495377|FG002|Overall Study|Protocol Violation|6|||
127965636|NCT00529087|460495375|FG000|Overall Study|Withdrawal by Subject|3|||
127965637|NCT00529087|460495376|FG001|Overall Study|Withdrawal by Subject|3|||
127965638|NCT00529087|460495377|FG002|Overall Study|Withdrawal by Subject|3|||
127965639|NCT00529087|460495375|FG000|Overall Study|Protocol deviation|1|||
127965640|NCT00529087|460495376|FG001|Overall Study|Protocol deviation|1|||
127965641|NCT00529087|460495377|FG002|Overall Study|Protocol deviation|2|||
127965642|NCT00318474|460495378|FG000|Overall Study|Adverse Event|1|||
127965643|NCT00318474|460495379|FG001|Overall Study|Adverse Event|1|||
127965644|NCT00318474|460495378|FG000|Overall Study|Lost to Follow-up|0|||
127965645|NCT00318474|460495379|FG001|Overall Study|Lost to Follow-up|1|||
127965646|NCT00318474|460495378|FG000|Overall Study|Pregnancy|0|||
127965647|NCT00318474|460495379|FG001|Overall Study|Pregnancy|2|||
127965648|NCT00318474|460495378|FG000|Overall Study|Protocol Violation|1|||
127965649|NCT00318474|460495379|FG001|Overall Study|Protocol Violation|0|||
127965650|NCT00318474|460495378|FG000|Overall Study|Withdrawal by Subject|3|||
127965651|NCT00318474|460495379|FG001|Overall Study|Withdrawal by Subject|2|||
127965652|NCT00318474|460495378|FG000|Overall Study|Fall in GFR|3|||
127965653|NCT00318474|460495379|FG001|Overall Study|Fall in GFR|3|||
127965654|NCT00318474|460495378|FG000|Overall Study|Post-therapy hyperflycemia|0|||
127965655|NCT00318474|460495379|FG001|Overall Study|Post-therapy hyperflycemia|1|||
127965656|NCT00318474|460495378|FG000|Overall Study|Trial terminated|10|||
127965657|NCT00318474|460495379|FG001|Overall Study|Trial terminated|7|||
127965658|NCT05326529|460495389|FG000|Overall Study|Lack of Efficacy|0|||
127965659|NCT05326529|460495390|FG001|Overall Study|Lack of Efficacy|1|||
127965660|NCT05326529|460495391|FG002|Overall Study|Lack of Efficacy|0|||
127965661|NCT05326529|460495389|FG000|Overall Study|Physician Decision|0|||
127965662|NCT05326529|460495390|FG001|Overall Study|Physician Decision|0|||
127965663|NCT05326529|460495391|FG002|Overall Study|Physician Decision|2|||
127965664|NCT01379768|460495392|FG000|Overall Study|Adverse Event|1|||
127965665|NCT01379768|460495393|FG001|Overall Study|Adverse Event|1|||
127965666|NCT01379768|460495394|FG002|Overall Study|Adverse Event|0|||
127965667|NCT01379768|460495392|FG000|Overall Study|Lost to Follow-up|2|||
127965668|NCT01379768|460495393|FG001|Overall Study|Lost to Follow-up|0|||
127965669|NCT01379768|460495394|FG002|Overall Study|Lost to Follow-up|0|||
127965670|NCT00708552|460495395|FG000|Overall Study|Adverse Event|10|||
127965671|NCT00708552|460495396|FG001|Overall Study|Adverse Event|3|||
127965672|NCT00708552|460495397|FG002|Overall Study|Adverse Event|4|||
127965673|NCT00708552|460495398|FG003|Overall Study|Adverse Event|6|||
127965674|NCT00708552|460495395|FG000|Overall Study|Lack of Efficacy|0|||
127965675|NCT00708552|460495396|FG001|Overall Study|Lack of Efficacy|4|||
127965676|NCT00708552|460495397|FG002|Overall Study|Lack of Efficacy|1|||
127965677|NCT00708552|460495398|FG003|Overall Study|Lack of Efficacy|0|||
127965678|NCT00708552|460495395|FG000|Overall Study|Protocol Violation|0|||
127965679|NCT00708552|460495396|FG001|Overall Study|Protocol Violation|0|||
127965680|NCT00708552|460495397|FG002|Overall Study|Protocol Violation|2|||
127965681|NCT00708552|460495398|FG003|Overall Study|Protocol Violation|4|||
127965682|NCT00708552|460495395|FG000|Overall Study|Lost to Follow-up|4|||
127965683|NCT00708552|460495396|FG001|Overall Study|Lost to Follow-up|2|||
127965684|NCT00708552|460495397|FG002|Overall Study|Lost to Follow-up|0|||
127965685|NCT00708552|460495398|FG003|Overall Study|Lost to Follow-up|1|||
127965686|NCT00708552|460495395|FG000|Overall Study|Physician Decision|1|||
127965687|NCT00708552|460495396|FG001|Overall Study|Physician Decision|2|||
127965688|NCT00708552|460495397|FG002|Overall Study|Physician Decision|0|||
127965689|NCT00708552|460495398|FG003|Overall Study|Physician Decision|0|||
127965690|NCT00708552|460495395|FG000|Overall Study|Withdrawal by Subject|12|||
127965691|NCT00708552|460495396|FG001|Overall Study|Withdrawal by Subject|7|||
127965692|NCT00708552|460495397|FG002|Overall Study|Withdrawal by Subject|8|||
127965693|NCT00708552|460495398|FG003|Overall Study|Withdrawal by Subject|10|||
127965694|NCT02588612|460495401|FG000|Overall Study|Physician Decision|1|||
127965695|NCT02588612|460495401|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
127965696|NCT02588612|460495401|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
127965697|NCT02588612|460495401|FG000|Overall Study|Death prior to T-cell infusion|1|||
127965698|NCT02042014|460495402|FG000|Overall Study|Adverse Event|1|||
127965699|NCT02042014|460495402|FG000|Overall Study|Physician Decision|7|||
127965700|NCT00558701|460495406|FG000|Overall Study|Protocol Deviations|1|||
127965701|NCT00558701|460495407|FG001|Overall Study|Protocol Deviations|4|||
127965702|NCT00105079|460495408|FG000|Overall Study|Adverse Event|5|||
127965703|NCT00105079|460495409|FG001|Overall Study|Adverse Event|12|||
127965704|NCT00105079|460495408|FG000|Overall Study|Death|3|||
127965705|NCT00105079|460495409|FG001|Overall Study|Death|1|||
127965706|NCT00105079|460495408|FG000|Overall Study|Lost to Follow-up|12|||
127965707|NCT00105079|460495409|FG001|Overall Study|Lost to Follow-up|12|||
127965708|NCT00105079|460495408|FG000|Overall Study|Lack of Efficacy|9|||
127965709|NCT00105079|460495409|FG001|Overall Study|Lack of Efficacy|3|||
127965710|NCT00105079|460495408|FG000|Overall Study|Refused treatment|6|||
127965711|NCT00105079|460495409|FG001|Overall Study|Refused treatment|4|||
127965712|NCT00105079|460495408|FG000|Overall Study|Violation of selection criteria at entry|0|||
127965713|NCT00105079|460495409|FG001|Overall Study|Violation of selection criteria at entry|2|||
127965714|NCT00105079|460495408|FG000|Overall Study|Protocol Violation|1|||
127965715|NCT00105079|460495409|FG001|Overall Study|Protocol Violation|0|||
127965716|NCT00105079|460495408|FG000|Overall Study|Other|3|||
127965717|NCT00105079|460495409|FG001|Overall Study|Other|1|||
127965718|NCT01297517|460495410|FG000|Overall Study|Adverse Event|21|||
127965719|NCT01297517|460495411|FG001|Overall Study|Adverse Event|7|||
127965720|NCT01297517|460495412|FG002|Overall Study|Adverse Event|16|||
127965721|NCT01297517|460495410|FG000|Overall Study|Lost to Follow-up|1|||
127965722|NCT01297517|460495411|FG001|Overall Study|Lost to Follow-up|0|||
127965723|NCT01297517|460495412|FG002|Overall Study|Lost to Follow-up|1|||
127965724|NCT01297517|460495410|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
127965725|NCT01297517|460495411|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
127965726|NCT01297517|460495412|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
127965727|NCT01297517|460495410|FG000|Overall Study|Noncompliance|1|||
127965728|NCT01297517|460495411|FG001|Overall Study|Noncompliance|0|||
127965729|NCT01297517|460495412|FG002|Overall Study|Noncompliance|0|||
127965730|NCT01297517|460495410|FG000|Overall Study|Protocol Violation|1|||
127965731|NCT01297517|460495411|FG001|Overall Study|Protocol Violation|1|||
127965732|NCT01297517|460495412|FG002|Overall Study|Protocol Violation|1|||
127965733|NCT01297517|460495410|FG000|Overall Study|Inadequate Control of IOP|1|||
127965734|NCT01297517|460495411|FG001|Overall Study|Inadequate Control of IOP|1|||
127965735|NCT01297517|460495412|FG002|Overall Study|Inadequate Control of IOP|2|||
127965736|NCT02230904|460495417|FG000|Overall Study|Safety follow up could not take place|0|||
127965737|NCT02230904|460495418|FG001|Overall Study|Safety follow up could not take place|1|||
127965738|NCT01464424|460495419|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
127965739|NCT01464424|460495420|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
127965740|NCT01464333|460495424|FG000|Overall Study|Adverse Event|34|||
127965741|NCT01464333|460495424|FG000|Overall Study|Lack of Efficacy|72|||
127965742|NCT01464333|460495424|FG000|Overall Study|Withdrawal by Subject|11|||
127965743|NCT01464333|460495424|FG000|Overall Study|Other|4|||
127965744|NCT01464333|460495424|FG000|Overall Study|No Hospital Visit|42|||
127965745|NCT00789373|460495425|FG000|Induction|Adverse Event|64|||
127965746|NCT00789373|460495426|FG001|Induction|Adverse Event|0|||
127965747|NCT00789373|460495427|FG002|Induction|Adverse Event|0|||
127965748|NCT00789373|460495425|FG000|Induction|Death Due to study disease|24|||
127965749|NCT00789373|460495426|FG001|Induction|Death Due to study disease|0|||
127965750|NCT00789373|460495427|FG002|Induction|Death Due to study disease|0|||
127965751|NCT00789373|460495425|FG000|Induction|Death due to adverse event|19|||
127965752|NCT00789373|460495426|FG001|Induction|Death due to adverse event|0|||
127965753|NCT00789373|460495427|FG002|Induction|Death due to adverse event|0|||
127965754|NCT00789373|460495425|FG000|Induction|Death due to toxicity|11|||
127965755|NCT00789373|460495426|FG001|Induction|Death due to toxicity|0|||
127965756|NCT00789373|460495427|FG002|Induction|Death due to toxicity|0|||
127965757|NCT00789373|460495425|FG000|Induction|Death due to procedure|1|||
127965758|NCT00789373|460495426|FG001|Induction|Death due to procedure|0|||
127965759|NCT00789373|460495427|FG002|Induction|Death due to procedure|0|||
127965760|NCT00789373|460495425|FG000|Induction|Investigator decision|7|||
127965761|NCT00789373|460495426|FG001|Induction|Investigator decision|0|||
127965762|NCT00789373|460495427|FG002|Induction|Investigator decision|0|||
127965763|NCT00789373|460495425|FG000|Induction|Protocol entry criteria not met|9|||
127965764|NCT00789373|460495426|FG001|Induction|Protocol entry criteria not met|0|||
127965765|NCT00789373|460495427|FG002|Induction|Protocol entry criteria not met|0|||
127965766|NCT00789373|460495425|FG000|Induction|Lost to Follow-up|6|||
127965767|NCT00789373|460495426|FG001|Induction|Lost to Follow-up|0|||
127965768|NCT00789373|460495427|FG002|Induction|Lost to Follow-up|0|||
127965769|NCT00789373|460495425|FG000|Induction|Protocol Violation|1|||
127965770|NCT00789373|460495426|FG001|Induction|Protocol Violation|0|||
127965771|NCT00789373|460495427|FG002|Induction|Protocol Violation|0|||
127965772|NCT00789373|460495425|FG000|Induction|Progressive Disease|220|||
127965773|NCT00789373|460495426|FG001|Induction|Progressive Disease|0|||
127965774|NCT00789373|460495427|FG002|Induction|Progressive Disease|0|||
127965775|NCT00789373|460495425|FG000|Induction|Withdrawal by Subject|37|||
127965776|NCT00789373|460495426|FG001|Induction|Withdrawal by Subject|0|||
127965777|NCT00789373|460495427|FG002|Induction|Withdrawal by Subject|0|||
127965778|NCT00789373|460495425|FG000|Maintenance|Adverse Event|0|||
127965779|NCT00789373|460495426|FG001|Maintenance|Adverse Event|65|||
127965780|NCT00789373|460495427|FG002|Maintenance|Adverse Event|12|||
127965781|NCT00789373|460495425|FG000|Maintenance|Death due to study disease|0|||
127965782|NCT00789373|460495426|FG001|Maintenance|Death due to study disease|3|||
127965783|NCT00789373|460495427|FG002|Maintenance|Death due to study disease|1|||
127965784|NCT00789373|460495425|FG000|Maintenance|Death due to adverse event|0|||
127965785|NCT00789373|460495426|FG001|Maintenance|Death due to adverse event|4|||
127965786|NCT00789373|460495427|FG002|Maintenance|Death due to adverse event|1|||
127965787|NCT00789373|460495425|FG000|Maintenance|Death due to toxicity|0|||
127965788|NCT00789373|460495426|FG001|Maintenance|Death due to toxicity|1|||
127965789|NCT00789373|460495427|FG002|Maintenance|Death due to toxicity|2|||
127965790|NCT00789373|460495425|FG000|Maintenance|Investigator Decision|0|||
127965791|NCT00789373|460495426|FG001|Maintenance|Investigator Decision|4|||
127965792|NCT00789373|460495427|FG002|Maintenance|Investigator Decision|2|||
127965793|NCT00789373|460495425|FG000|Maintenance|Protocol entry criteria not met|0|||
127965794|NCT00789373|460495426|FG001|Maintenance|Protocol entry criteria not met|2|||
127965795|NCT00789373|460495427|FG002|Maintenance|Protocol entry criteria not met|0|||
127965796|NCT00789373|460495425|FG000|Maintenance|Lost to Follow-up|0|||
127965797|NCT00789373|460495426|FG001|Maintenance|Lost to Follow-up|2|||
127965798|NCT00789373|460495427|FG002|Maintenance|Lost to Follow-up|0|||
127965799|NCT00789373|460495425|FG000|Maintenance|Progressive Disease|0|||
127965800|NCT00789373|460495426|FG001|Maintenance|Progressive Disease|253|||
127965801|NCT00789373|460495427|FG002|Maintenance|Progressive Disease|152|||
127965802|NCT00789373|460495425|FG000|Maintenance|Withdrawal by Subject|0|||
127965803|NCT00789373|460495426|FG001|Maintenance|Withdrawal by Subject|21|||
127965804|NCT00789373|460495427|FG002|Maintenance|Withdrawal by Subject|8|||
127965805|NCT00789373|460495425|FG000|Maintenance|Sponsor Decision|0|||
127965806|NCT00789373|460495426|FG001|Maintenance|Sponsor Decision|0|||
127965807|NCT00789373|460495427|FG002|Maintenance|Sponsor Decision|2|||
127965808|NCT00789373|460495425|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
127965809|NCT00789373|460495426|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
127965810|NCT00789373|460495427|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
127965811|NCT02187198|460495430|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
127965812|NCT02187198|460495431|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
127965813|NCT02187198|460495430|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
127965814|NCT02187198|460495431|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
127965815|NCT03321968|460495432|FG000|Overall Study|Withdrawal by Subject|1|||
127965816|NCT03321968|460495433|FG001|Overall Study|Withdrawal by Subject|2|||
127965817|NCT03321968|460495434|FG002|Overall Study|Withdrawal by Subject|1|||
127965818|NCT03321968|460495432|FG000|Overall Study|Lost to Follow-up|2|||
127965819|NCT03321968|460495433|FG001|Overall Study|Lost to Follow-up|0|||
127965820|NCT03321968|460495434|FG002|Overall Study|Lost to Follow-up|1|||
127965821|NCT03321968|460495432|FG000|Overall Study|Other than specified|0|||
127965822|NCT03321968|460495433|FG001|Overall Study|Other than specified|0|||
127965823|NCT03321968|460495434|FG002|Overall Study|Other than specified|1|||
127965824|NCT01532518|460495435|FG000|Overall Study|Withdrawal by Subject|0|||
127965825|NCT01532518|460495436|FG001|Overall Study|Withdrawal by Subject|0|||
127965826|NCT01532518|460495437|FG002|Overall Study|Withdrawal by Subject|1|||
127965827|NCT02155283|460495441|FG000|Overall Study|Lost to Follow-up|3|||
127965828|NCT02155283|460495441|FG000|Overall Study|Withdrawal by Subject|1|||
127965829|NCT02155283|460495441|FG000|Overall Study|Protocol Violation|3|||
127965830|NCT02282813|460495445|FG000|Overall Study|Withdrawal by Subject|4|||
127965831|NCT02282813|460495446|FG001|Overall Study|Withdrawal by Subject|5|||
127965832|NCT02282813|460495447|FG002|Overall Study|Withdrawal by Subject|0|||
127965833|NCT02282813|460495445|FG000|Overall Study|Adverse Event|3|||
127965834|NCT02282813|460495446|FG001|Overall Study|Adverse Event|10|||
127965835|NCT02282813|460495447|FG002|Overall Study|Adverse Event|1|||
127965836|NCT02282813|460495445|FG000|Overall Study|Subject non-compliance|1|||
127965837|NCT02282813|460495446|FG001|Overall Study|Subject non-compliance|4|||
127965838|NCT02282813|460495447|FG002|Overall Study|Subject non-compliance|0|||
127965839|NCT02282813|460495445|FG000|Overall Study|Physician Decision|0|||
127965840|NCT02282813|460495446|FG001|Overall Study|Physician Decision|3|||
127965841|NCT02282813|460495447|FG002|Overall Study|Physician Decision|1|||
127965842|NCT02282813|460495445|FG000|Overall Study|Lost to Follow-up|2|||
127965843|NCT02282813|460495446|FG001|Overall Study|Lost to Follow-up|0|||
127965844|NCT02282813|460495447|FG002|Overall Study|Lost to Follow-up|1|||
127965845|NCT02282813|460495445|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
127965846|NCT02282813|460495446|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
127965847|NCT02282813|460495447|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
127965848|NCT02282813|460495445|FG000|Overall Study|Lack of Efficacy|1|||
127965849|NCT02282813|460495446|FG001|Overall Study|Lack of Efficacy|0|||
127965850|NCT02282813|460495447|FG002|Overall Study|Lack of Efficacy|0|||
127965851|NCT02282813|460495445|FG000|Overall Study|Administrative reasons|0|||
127965852|NCT02282813|460495446|FG001|Overall Study|Administrative reasons|1|||
127965853|NCT02282813|460495447|FG002|Overall Study|Administrative reasons|0|||
127965854|NCT00463047|460495448|FG000|Titration Period 1|Adverse Event|10|||
127965855|NCT00463047|460495449|FG001|Titration Period 1|Adverse Event|8|||
127965856|NCT00463047|460495448|FG000|Titration Period 1|Lack of Efficacy|10|||
127965857|NCT00463047|460495449|FG001|Titration Period 1|Lack of Efficacy|4|||
127965858|NCT00463047|460495448|FG000|Titration Period 1|Lost to Follow-up|2|||
127965859|NCT00463047|460495449|FG001|Titration Period 1|Lost to Follow-up|0|||
127965860|NCT00463047|460495448|FG000|Titration Period 1|Non-compliance with study medication|3|||
127965861|NCT00463047|460495449|FG001|Titration Period 1|Non-compliance with study medication|5|||
127965862|NCT00463047|460495448|FG000|Titration Period 1|Protocol Violation|5|||
127965863|NCT00463047|460495449|FG001|Titration Period 1|Protocol Violation|5|||
127965864|NCT00463047|460495448|FG000|Titration Period 1|Withdrawal by Subject|3|||
127965865|NCT00463047|460495449|FG001|Titration Period 1|Withdrawal by Subject|5|||
127965866|NCT00463047|460495448|FG000|Titration Period 1|Non-compliance procedures|4|||
127965867|NCT00463047|460495449|FG001|Titration Period 1|Non-compliance procedures|10|||
127965868|NCT00463047|460495448|FG000|Titration Period 1|Other|0|||
127965869|NCT00463047|460495449|FG001|Titration Period 1|Other|2|||
127965870|NCT00463047|460495448|FG000|Titration Period 2|Adverse Event|9|||
127965871|NCT00463047|460495449|FG001|Titration Period 2|Adverse Event|9|||
127965872|NCT00463047|460495448|FG000|Titration Period 2|Lack of Efficacy|6|||
127965873|NCT00463047|460495449|FG001|Titration Period 2|Lack of Efficacy|4|||
127965874|NCT00463047|460495448|FG000|Titration Period 2|Withdrawal by Subject|1|||
127965875|NCT00463047|460495449|FG001|Titration Period 2|Withdrawal by Subject|0|||
127965876|NCT00463047|460495448|FG000|Titration Period 2|Protocol Violation|2|||
127965877|NCT00463047|460495449|FG001|Titration Period 2|Protocol Violation|3|||
127965878|NCT00463047|460495448|FG000|Titration Period 2|Lost to Follow-up|1|||
127965879|NCT00463047|460495449|FG001|Titration Period 2|Lost to Follow-up|2|||
127965880|NCT00463047|460495448|FG000|Titration Period 2|Non-compliance study medication|4|||
127965881|NCT00463047|460495449|FG001|Titration Period 2|Non-compliance study medication|2|||
127965882|NCT00463047|460495448|FG000|Titration Period 2|Non-compliance procedures|4|||
127965883|NCT00463047|460495449|FG001|Titration Period 2|Non-compliance procedures|1|||
127965884|NCT00463047|460495448|FG000|Titration Period 2|Other|3|||
127965885|NCT00463047|460495449|FG001|Titration Period 2|Other|2|||
127965886|NCT00463047|460495448|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
127965887|NCT00463047|460495449|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
127965888|NCT00463047|460495448|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
127965889|NCT00463047|460495449|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
127965890|NCT00463047|460495448|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
127965891|NCT00463047|460495449|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
127965892|NCT00463047|460495448|FG000|Double-Blind Treatment Period 1|Other|1|||
127965893|NCT00463047|460495449|FG001|Double-Blind Treatment Period 1|Other|0|||
127965894|NCT00463047|460495448|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
127965895|NCT00463047|460495449|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
127965896|NCT00463047|460495448|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
127965897|NCT00463047|460495449|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
127965898|NCT00463047|460495448|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
127965899|NCT00463047|460495449|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
127965900|NCT03493854|460495457|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
127965901|NCT03493854|460495458|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
127965902|NCT03493854|460495457|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
127965903|NCT03493854|460495458|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
127965904|NCT03493854|460495457|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
127965905|NCT03493854|460495458|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
127965906|NCT03493854|460495457|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
127965907|NCT03493854|460495458|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
127965908|NCT03493854|460495457|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
127965909|NCT03493854|460495458|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
127965910|NCT03493854|460495457|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
127965911|NCT03493854|460495458|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
127965912|NCT03493854|460495457|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
127965913|NCT03493854|460495458|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
127965914|NCT03493854|460495457|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|12|||
127965915|NCT03493854|460495458|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|7|||
127965916|NCT03493854|460495457|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
127965917|NCT03493854|460495458|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|2|||
127965918|NCT03493854|460495457|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|4|||
127965919|NCT03493854|460495458|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
127965920|NCT03493854|460495457|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
127965921|NCT03493854|460495458|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
127965922|NCT03493854|460495457|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|7|||
127965923|NCT03493854|460495458|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|2|||
127965924|NCT03493854|460495457|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
127965925|NCT03493854|460495458|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
127965926|NCT03493854|460495457|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|3|||
127965927|NCT03493854|460495458|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|2|||
127965928|NCT03493854|460495457|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|4|||
127965929|NCT03493854|460495458|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|1|||
127965930|NCT03493854|460495457|FG000|Treatment-Free Follow-Up (up to 3 Years)|Death|10|||
127965931|NCT03493854|460495458|FG001|Treatment-Free Follow-Up (up to 3 Years)|Death|11|||
127965932|NCT03493854|460495457|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
127965933|NCT03493854|460495458|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
127965934|NCT03493854|460495457|FG000|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|4|||
127965935|NCT03493854|460495458|FG001|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|1|||
127965936|NCT00739661|460495459|FG000|Overall Study|Adverse Event|2|||
127965937|NCT00739661|460495460|FG001|Overall Study|Adverse Event|0|||
127965938|NCT00739661|460495459|FG000|Overall Study|Physician decision to withdraw patient|1|||
127965939|NCT00739661|460495460|FG001|Overall Study|Physician decision to withdraw patient|0|||
127965940|NCT00739661|460495459|FG000|Overall Study|Patient decision to withdraw|9|||
127965941|NCT00739661|460495460|FG001|Overall Study|Patient decision to withdraw|4|||
127965942|NCT00739661|460495459|FG000|Overall Study|Disease progression, radiographic|33|||
127965943|NCT00739661|460495460|FG001|Overall Study|Disease progression, radiographic|37|||
127965944|NCT00739661|460495459|FG000|Overall Study|Reason for discontinuation not available|1|||
127965945|NCT00739661|460495460|FG001|Overall Study|Reason for discontinuation not available|1|||
127965946|NCT05343364|460495462|FG000|Overall Study|Miscellaneous|0|||
127965947|NCT05343364|460495463|FG001|Overall Study|Miscellaneous|1|||
127965948|NCT02105987|460495464|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
127965949|NCT02105987|460495465|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
127965950|NCT02105987|460495466|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
127965951|NCT02105987|460495467|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
127965952|NCT02105987|460495468|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
127965953|NCT02105987|460495469|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
127965954|NCT02105987|460495464|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
127965955|NCT02105987|460495465|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
127965956|NCT02105987|460495466|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
127965957|NCT02105987|460495467|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
127965958|NCT02105987|460495468|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
127965959|NCT02105987|460495469|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
127965960|NCT02105987|460495464|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
127965961|NCT02105987|460495465|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
127965962|NCT02105987|460495466|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
127965963|NCT02105987|460495467|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
127965964|NCT02105987|460495468|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
127965965|NCT02105987|460495469|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
127965966|NCT02105987|460495464|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
127965967|NCT02105987|460495465|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
127965968|NCT02105987|460495466|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
127965969|NCT02105987|460495467|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
127965970|NCT02105987|460495468|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
127965971|NCT02105987|460495469|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
127965972|NCT02105987|460495464|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
127965973|NCT02105987|460495465|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
127965974|NCT02105987|460495466|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
127965975|NCT02105987|460495467|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
127965976|NCT02105987|460495468|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
127965977|NCT02105987|460495469|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
127965978|NCT02105987|460495464|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
127965979|NCT02105987|460495465|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
127965980|NCT02105987|460495466|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
127965981|NCT02105987|460495467|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
127965982|NCT02105987|460495468|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
127965983|NCT02105987|460495469|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
127965984|NCT02105987|460495464|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
127965985|NCT02105987|460495465|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
127965986|NCT02105987|460495466|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
127965987|NCT02105987|460495467|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
127965988|NCT02105987|460495468|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
127965989|NCT02105987|460495469|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
127965990|NCT02105987|460495464|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
127965991|NCT02105987|460495465|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
127965992|NCT02105987|460495466|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
127965993|NCT02105987|460495467|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
127965994|NCT02105987|460495468|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
127965995|NCT02105987|460495469|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
127965996|NCT02105987|460495464|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
127965997|NCT02105987|460495465|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
127965998|NCT02105987|460495466|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
127965999|NCT02105987|460495467|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
127966000|NCT02105987|460495468|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
127966001|NCT02105987|460495469|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
127966002|NCT02105987|460495464|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
127966003|NCT02105987|460495465|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
127966004|NCT02105987|460495466|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
127966005|NCT02105987|460495467|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
127966006|NCT02105987|460495468|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
127966007|NCT02105987|460495469|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
127966008|NCT02105987|460495464|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
127966009|NCT02105987|460495465|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
127966010|NCT02105987|460495466|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
127966011|NCT02105987|460495467|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
127966012|NCT02105987|460495468|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
127966013|NCT02105987|460495469|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
127966014|NCT02105987|460495464|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
127966015|NCT02105987|460495465|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
127966016|NCT02105987|460495466|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
127966017|NCT02105987|460495467|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
127966018|NCT02105987|460495468|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
127966019|NCT02105987|460495469|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
127966020|NCT02105987|460495464|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
127966021|NCT02105987|460495465|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
127966022|NCT02105987|460495466|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
127966023|NCT02105987|460495467|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
127966024|NCT02105987|460495468|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
127966025|NCT02105987|460495469|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
127966026|NCT02105987|460495464|FG000|Continuation Phase|Protocol Violation|0|||
127966027|NCT02105987|460495465|FG001|Continuation Phase|Protocol Violation|0|||
127966028|NCT02105987|460495466|FG002|Continuation Phase|Protocol Violation|0|||
127966029|NCT02105987|460495467|FG003|Continuation Phase|Protocol Violation|0|||
127966030|NCT02105987|460495468|FG004|Continuation Phase|Protocol Violation|1|||
127966031|NCT02105987|460495469|FG005|Continuation Phase|Protocol Violation|0|||
127966032|NCT01252095|460495471|FG000|Overall Study|Disease progression|1|||
127966033|NCT01252095|460495472|FG001|Overall Study|Disease progression|0|||
127966034|NCT02554682|460495473|FG000|Overall Study|Lost to Follow-up|11|||
127966035|NCT02554682|460495474|FG001|Overall Study|Lost to Follow-up|9|||
127966036|NCT02554682|460495475|FG002|Overall Study|Lost to Follow-up|4|||
127966037|NCT02554682|460495476|FG003|Overall Study|Lost to Follow-up|3|||
127966038|NCT02554682|460495477|FG004|Overall Study|Lost to Follow-up|2|||
127966039|NCT02554682|460495478|FG005|Overall Study|Lost to Follow-up|1|||
127966040|NCT02554682|460495479|FG006|Overall Study|Lost to Follow-up|6|||
127966041|NCT02554682|460495480|FG007|Overall Study|Lost to Follow-up|6|||
127966042|NCT02554682|460495481|FG008|Overall Study|Lost to Follow-up|2|||
127966043|NCT02554682|460495482|FG009|Overall Study|Lost to Follow-up|2|||
127966044|NCT02554682|460495473|FG000|Overall Study|Withdrawal by Subject|2|||
127966045|NCT02554682|460495474|FG001|Overall Study|Withdrawal by Subject|1|||
127966046|NCT02554682|460495475|FG002|Overall Study|Withdrawal by Subject|0|||
127966047|NCT02554682|460495476|FG003|Overall Study|Withdrawal by Subject|0|||
127966048|NCT02554682|460495477|FG004|Overall Study|Withdrawal by Subject|0|||
127966049|NCT02554682|460495478|FG005|Overall Study|Withdrawal by Subject|0|||
127966050|NCT02554682|460495479|FG006|Overall Study|Withdrawal by Subject|0|||
127966051|NCT02554682|460495480|FG007|Overall Study|Withdrawal by Subject|0|||
127966052|NCT02554682|460495481|FG008|Overall Study|Withdrawal by Subject|0|||
127966053|NCT02554682|460495482|FG009|Overall Study|Withdrawal by Subject|0|||
127966054|NCT02554682|460495473|FG000|Overall Study|Physician Decision|2|||
127966055|NCT02554682|460495474|FG001|Overall Study|Physician Decision|2|||
127966056|NCT02554682|460495475|FG002|Overall Study|Physician Decision|0|||
127966057|NCT02554682|460495476|FG003|Overall Study|Physician Decision|0|||
127966058|NCT02554682|460495477|FG004|Overall Study|Physician Decision|0|||
127966059|NCT02554682|460495478|FG005|Overall Study|Physician Decision|0|||
127966060|NCT02554682|460495479|FG006|Overall Study|Physician Decision|0|||
127966061|NCT02554682|460495480|FG007|Overall Study|Physician Decision|0|||
127966062|NCT02554682|460495481|FG008|Overall Study|Physician Decision|0|||
127966063|NCT02554682|460495482|FG009|Overall Study|Physician Decision|0|||
127966064|NCT01153815|460495486|FG000|Overall Study|Adverse Event|3|||
127966065|NCT01153815|460495487|FG001|Overall Study|Adverse Event|1|||
127966066|NCT01153815|460495486|FG000|Overall Study|Withdrawal by Subject|6|||
127966067|NCT01153815|460495487|FG001|Overall Study|Withdrawal by Subject|4|||
127966068|NCT01890122|460495488|FG000|Overall Study|Adverse Event|1|||
127966069|NCT01890122|460495489|FG001|Overall Study|Adverse Event|1|||
127966070|NCT01890122|460495490|FG002|Overall Study|Adverse Event|1|||
127966071|NCT01890122|460495491|FG003|Overall Study|Adverse Event|2|||
127966072|NCT01890122|460495488|FG000|Overall Study|Major Protocol Deviation|3|||
127966073|NCT01890122|460495489|FG001|Overall Study|Major Protocol Deviation|1|||
127966074|NCT01890122|460495490|FG002|Overall Study|Major Protocol Deviation|0|||
127966075|NCT01890122|460495491|FG003|Overall Study|Major Protocol Deviation|1|||
127966076|NCT01890122|460495488|FG000|Overall Study|Lost to Follow-up|0|||
127966077|NCT01890122|460495489|FG001|Overall Study|Lost to Follow-up|1|||
127966078|NCT01890122|460495490|FG002|Overall Study|Lost to Follow-up|2|||
127966079|NCT01890122|460495491|FG003|Overall Study|Lost to Follow-up|2|||
127966080|NCT01890122|460495488|FG000|Overall Study|Voluntary Withdrawal|8|||
127966081|NCT01890122|460495489|FG001|Overall Study|Voluntary Withdrawal|8|||
127966082|NCT01890122|460495490|FG002|Overall Study|Voluntary Withdrawal|2|||
127966083|NCT01890122|460495491|FG003|Overall Study|Voluntary Withdrawal|11|||
127966084|NCT01890122|460495488|FG000|Overall Study|Lack of Efficacy|14|||
127966085|NCT01890122|460495489|FG001|Overall Study|Lack of Efficacy|24|||
127966086|NCT01890122|460495490|FG002|Overall Study|Lack of Efficacy|7|||
127966087|NCT01890122|460495491|FG003|Overall Study|Lack of Efficacy|41|||
127966088|NCT01890122|460495488|FG000|Overall Study|Reason not Specified|0|||
127966089|NCT01890122|460495489|FG001|Overall Study|Reason not Specified|1|||
127966090|NCT01890122|460495490|FG002|Overall Study|Reason not Specified|1|||
127966091|NCT01890122|460495491|FG003|Overall Study|Reason not Specified|2|||
127966092|NCT01890122|460495488|FG000|Overall Study|Randomized but not Treated|1|||
127966093|NCT01890122|460495489|FG001|Overall Study|Randomized but not Treated|1|||
127966094|NCT01890122|460495490|FG002|Overall Study|Randomized but not Treated|0|||
127966095|NCT01890122|460495491|FG003|Overall Study|Randomized but not Treated|0|||
127966096|NCT02062450|460495494|FG000|Overall Study|No follow-up visit|124|||
127966097|NCT02907177|460495498|FG000|Overall Study|Death|0|||
127966098|NCT02907177|460495499|FG001|Overall Study|Death|1|||
127966099|NCT02907177|460495498|FG000|Overall Study|Physician Decision|3|||
127966100|NCT02907177|460495499|FG001|Overall Study|Physician Decision|3|||
127966101|NCT02907177|460495498|FG000|Overall Study|Withdrawal by Subject|15|||
127966102|NCT02907177|460495499|FG001|Overall Study|Withdrawal by Subject|7|||
127966103|NCT02907177|460495498|FG000|Overall Study|Sponsor's Decision|50|||
127966104|NCT02907177|460495499|FG001|Overall Study|Sponsor's Decision|57|||
127966105|NCT02505217|460495502|FG000|Overall Study|Withdrawal by Subject|1|||
127966106|NCT02505217|460495503|FG001|Overall Study|Withdrawal by Subject|2|||
127966107|NCT00153179|460495513|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
127966108|NCT00153179|460495514|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
127966109|NCT00153179|460495515|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
127966110|NCT00153179|460495516|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
127966111|NCT04495829|460495517|FG000|Overall Study|Lost to Follow-up|2|||
127966112|NCT04495829|460495517|FG000|Overall Study|Inclusion criterion not met|3|||
127966113|NCT01537042|460495522|FG000|Overall Study|Adverse Event|0|||
127966114|NCT01537042|460495523|FG001|Overall Study|Adverse Event|2|||
127966115|NCT01537042|460495522|FG000|Overall Study|Lack of Efficacy|0|||
127966116|NCT01537042|460495523|FG001|Overall Study|Lack of Efficacy|1|||
127966117|NCT01537042|460495522|FG000|Overall Study|Protocol Violation|0|||
127966118|NCT01537042|460495523|FG001|Overall Study|Protocol Violation|1|||
127966119|NCT01537042|460495522|FG000|Overall Study|Other|0|||
127966120|NCT01537042|460495523|FG001|Overall Study|Other|1|||
127966121|NCT00979654|460495524|FG000|Overall Study|Lost to Follow-up|1|||
127966122|NCT00979654|460495524|FG000|Overall Study|Withdrawal by Subject|22|||
127966123|NCT00979654|460495524|FG000|Overall Study|Death|1|||
127966124|NCT00979654|460495524|FG000|Overall Study|Lack of Efficacy|6|||
127966125|NCT00979654|460495524|FG000|Overall Study|Adverse Event|1|||
127966126|NCT00979654|460495524|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
127966127|NCT00979654|460495524|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
127966128|NCT00979654|460495524|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
127966129|NCT00979654|460495524|FG000|Overall Study|Serious Adverse Event|1|||
127966130|NCT00979654|460495524|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
127966131|NCT00457002|460497263|FG000|Overall Study|Death|40|||
127966132|NCT00457002|460497264|FG001|Overall Study|Death|47|||
127966133|NCT00457002|460497263|FG000|Overall Study|Adverse Event|284|||
127966134|NCT00457002|460497264|FG001|Overall Study|Adverse Event|260|||
127966135|NCT00457002|460497263|FG000|Overall Study|Withdrawal by Subject|299|||
127966136|NCT00457002|460497264|FG001|Overall Study|Withdrawal by Subject|271|||
127966137|NCT00457002|460497263|FG000|Overall Study|Lost to Follow-up|72|||
127966138|NCT00457002|460497264|FG001|Overall Study|Lost to Follow-up|71|||
127966139|NCT00457002|460497263|FG000|Overall Study|Poor/Non-compliance|46|||
127966140|NCT00457002|460497264|FG001|Overall Study|Poor/Non-compliance|33|||
127966141|NCT00457002|460497263|FG000|Overall Study|No longer met criteria|41|||
127966142|NCT00457002|460497264|FG001|Overall Study|No longer met criteria|37|||
127966143|NCT00457002|460497263|FG000|Overall Study|Administrative reason by Sponsor|1|||
127966144|NCT00457002|460497264|FG001|Overall Study|Administrative reason by Sponsor|0|||
127966145|NCT00457002|460497263|FG000|Overall Study|non-specified|29|||
127966146|NCT00457002|460497264|FG001|Overall Study|non-specified|38|||
127966147|NCT00457002|460497263|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
127966148|NCT00457002|460497264|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
127966149|NCT00454246|460497265|FG000|Overall Study|Adverse Event|2|||
127966150|NCT00454246|460497266|FG001|Overall Study|Adverse Event|2|||
127966151|NCT00454246|460497267|FG002|Overall Study|Adverse Event|0|||
127966152|NCT00454246|460497265|FG000|Overall Study|Violation of selection criteria at entry|6|||
127966153|NCT00454246|460497266|FG001|Overall Study|Violation of selection criteria at entry|0|||
127966154|NCT00454246|460497267|FG002|Overall Study|Violation of selection criteria at entry|0|||
127966155|NCT00454246|460497265|FG000|Overall Study|Protocol Violation|1|||
127966156|NCT00454246|460497266|FG001|Overall Study|Protocol Violation|0|||
127966157|NCT00454246|460497267|FG002|Overall Study|Protocol Violation|0|||
127966158|NCT00454246|460497265|FG000|Overall Study|Refused Treatment|1|||
127966159|NCT00454246|460497266|FG001|Overall Study|Refused Treatment|1|||
127966160|NCT00454246|460497267|FG002|Overall Study|Refused Treatment|0|||
127966161|NCT00454246|460497265|FG000|Overall Study|Failure to return|1|||
127966162|NCT00454246|460497266|FG001|Overall Study|Failure to return|0|||
127966163|NCT00454246|460497267|FG002|Overall Study|Failure to return|0|||
127966164|NCT00454246|460497265|FG000|Overall Study|Early termination of study|62|||
127966165|NCT00454246|460497266|FG001|Overall Study|Early termination of study|26|||
127966166|NCT00454246|460497267|FG002|Overall Study|Early termination of study|9|||
127966167|NCT02283268|460497268|FG000|Overall Study|Withdrawal by Subject|1|||
127966168|NCT01085630|460497280|FG000|Overall Study|Insufficient data|1|||
127966169|NCT01085630|460497281|FG001|Overall Study|Insufficient data|0|||
127966170|NCT01085630|460497280|FG000|Overall Study|Ineligible|3|||
127966171|NCT01085630|460497281|FG001|Overall Study|Ineligible|0|||
127966172|NCT01017874|460497282|FG000|Overall Study|Withdrawal by Subject|23|||
127966173|NCT01017874|460497283|FG001|Overall Study|Withdrawal by Subject|20|||
127966174|NCT01017874|460497282|FG000|Overall Study|Sponsor decision|3|||
127966175|NCT01017874|460497283|FG001|Overall Study|Sponsor decision|1|||
127966176|NCT01017874|460497282|FG000|Overall Study|Lost to Follow-up|3|||
127966177|NCT01017874|460497283|FG001|Overall Study|Lost to Follow-up|2|||
127966178|NCT01017874|460497282|FG000|Overall Study|Physician Decision|1|||
127966179|NCT01017874|460497283|FG001|Overall Study|Physician Decision|3|||
127966180|NCT01346696|460497284|FG000|Overall Study|Death|1|||
127966181|NCT00506415|460497295|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
127966182|NCT00506415|460497296|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
127966183|NCT00506415|460497297|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
127966184|NCT00506415|460497298|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
127966185|NCT00506415|460497295|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
127966186|NCT00506415|460497296|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
127966187|NCT00506415|460497297|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
127966188|NCT00506415|460497298|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
127966189|NCT00506415|460497295|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
127966190|NCT00506415|460497296|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
127966191|NCT00506415|460497297|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
127966192|NCT00506415|460497298|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
127966193|NCT00506415|460497295|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
127966194|NCT00506415|460497296|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
127966195|NCT00506415|460497297|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
127966196|NCT00506415|460497298|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
127966197|NCT00506415|460497295|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
127966198|NCT00506415|460497296|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
127966199|NCT00506415|460497297|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
127966200|NCT00506415|460497298|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
127966201|NCT00506415|460497295|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
127966202|NCT00506415|460497296|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
127966203|NCT00506415|460497297|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
127966204|NCT00506415|460497298|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
127966205|NCT00506415|460497295|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
127966206|NCT00506415|460497296|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
127966207|NCT00506415|460497297|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
127966208|NCT00506415|460497298|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
127966209|NCT00506415|460497295|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
127966210|NCT00506415|460497296|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
127966211|NCT00506415|460497297|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
127966212|NCT00506415|460497298|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
127966213|NCT00506415|460497295|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
127966214|NCT00506415|460497296|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
127966215|NCT00506415|460497297|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
127966216|NCT00506415|460497298|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
127966217|NCT00506415|460497295|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
127966218|NCT00506415|460497296|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
127966219|NCT00506415|460497297|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
127966220|NCT00506415|460497298|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
127966221|NCT00506415|460497295|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
127966222|NCT00506415|460497296|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
127966223|NCT00506415|460497297|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
127966224|NCT00506415|460497298|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
127966225|NCT00506415|460497295|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
127966226|NCT00506415|460497296|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
127966227|NCT00506415|460497297|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
127966228|NCT00506415|460497298|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
127966229|NCT00506415|460497295|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
127966230|NCT00506415|460497296|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
127966231|NCT00506415|460497297|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
127966232|NCT00506415|460497298|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
127966233|NCT00506415|460497295|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
127966234|NCT00506415|460497296|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
127966235|NCT00506415|460497297|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
127966236|NCT00506415|460497298|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
127966237|NCT00506415|460497295|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
127966238|NCT00506415|460497296|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
127966239|NCT00506415|460497297|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
127966240|NCT00506415|460497298|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
127966241|NCT00506415|460497295|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
127485496|NCT03768427|458741190|FG001|Overall Study|Withdrawal by Subject|2|||
127966242|NCT00506415|460497296|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
127966243|NCT00506415|460497297|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
127966244|NCT00506415|460497298|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
127966245|NCT00506415|460497295|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
127966246|NCT00506415|460497296|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
127966247|NCT00506415|460497297|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
127966248|NCT00506415|460497298|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
127966249|NCT00506415|460497295|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
127966250|NCT00506415|460497296|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
127966251|NCT00506415|460497297|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
127966252|NCT00506415|460497298|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
127966253|NCT00506415|460497295|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
127966254|NCT00506415|460497296|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
127966255|NCT00506415|460497297|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
127966256|NCT00506415|460497298|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
127966257|NCT00506415|460497295|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
127966258|NCT00506415|460497296|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
127966259|NCT00506415|460497297|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
127966260|NCT00506415|460497298|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
127966261|NCT00506415|460497295|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
127966262|NCT00506415|460497296|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
127966263|NCT00506415|460497297|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
127966264|NCT00506415|460497298|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
127966265|NCT00506415|460497295|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
127966266|NCT00506415|460497296|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
127966267|NCT00506415|460497297|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
127966268|NCT00506415|460497298|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
127966269|NCT00506415|460497295|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
127966270|NCT00506415|460497296|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
127966271|NCT00506415|460497297|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
127966272|NCT00506415|460497298|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
127966273|NCT00506415|460497295|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
127966274|NCT00506415|460497296|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
127966275|NCT00506415|460497297|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
127966276|NCT00506415|460497298|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
127966277|NCT04578457|460497299|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
127966278|NCT04578457|460497299|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
127966279|NCT04578457|460497299|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
127966280|NCT04578457|460497299|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
127966281|NCT03809663|460497307|FG000|Overall Study|Decision by sponsor|24|||
127966282|NCT03809663|460497308|FG001|Overall Study|Decision by sponsor|18|||
127966283|NCT03809663|460497309|FG002|Overall Study|Decision by sponsor|20|||
127966284|NCT03809663|460497310|FG003|Overall Study|Decision by sponsor|20|||
127966285|NCT03809663|460497311|FG004|Overall Study|Decision by sponsor|0|||
127966286|NCT03809663|460497312|FG005|Overall Study|Decision by sponsor|0|||
127966287|NCT03809663|460497307|FG000|Overall Study|Withdrawal by Subject|26|||
127966288|NCT03809663|460497308|FG001|Overall Study|Withdrawal by Subject|22|||
127966289|NCT03809663|460497309|FG002|Overall Study|Withdrawal by Subject|27|||
127966290|NCT03809663|460497310|FG003|Overall Study|Withdrawal by Subject|26|||
127966291|NCT03809663|460497311|FG004|Overall Study|Withdrawal by Subject|0|||
127966292|NCT03809663|460497312|FG005|Overall Study|Withdrawal by Subject|0|||
127966293|NCT03809663|460497307|FG000|Overall Study|Lost to Follow-up|1|||
127966294|NCT03809663|460497308|FG001|Overall Study|Lost to Follow-up|4|||
127966295|NCT03809663|460497309|FG002|Overall Study|Lost to Follow-up|1|||
127966296|NCT03809663|460497310|FG003|Overall Study|Lost to Follow-up|1|||
127966297|NCT03809663|460497311|FG004|Overall Study|Lost to Follow-up|0|||
127966298|NCT03809663|460497312|FG005|Overall Study|Lost to Follow-up|0|||
127966299|NCT01609296|460497321|FG000|Overall Study|Death|253|||
127966300|NCT01609296|460497321|FG000|Overall Study|Withdrawal by Subject|151|||
127966301|NCT01609296|460497321|FG000|Overall Study|Lost to Follow-up|21|||
127966302|NCT01609296|460497321|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
127966303|NCT01609296|460497321|FG000|Overall Study|missed visit but known to be alive|28|||
127966304|NCT00628212|460497322|FG000|Overall Study|Adverse Event|2|||
127966305|NCT00628212|460497323|FG001|Overall Study|Adverse Event|0|||
127966306|NCT00628212|460497324|FG002|Overall Study|Adverse Event|1|||
127966307|NCT00628212|460497325|FG003|Overall Study|Adverse Event|2|||
127966308|NCT00628212|460497322|FG000|Overall Study|Physician Decision|1|||
127966309|NCT00628212|460497323|FG001|Overall Study|Physician Decision|1|||
127966310|NCT00628212|460497324|FG002|Overall Study|Physician Decision|2|||
127966311|NCT00628212|460497325|FG003|Overall Study|Physician Decision|3|||
127966312|NCT00546377|460497326|FG000|Overall Study|Deemed ineligible|1|||
127966313|NCT00546377|460497326|FG000|Overall Study|Adverse Event|6|||
127966314|NCT03020992|460497327|FG000|Overall Study|Adverse Event|5|||
127966315|NCT03020992|460497327|FG000|Overall Study|Withdrawal by Subject|1|||
127966316|NCT01006122|460497328|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
127966317|NCT01006122|460497329|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
127966318|NCT01006122|460497328|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
127966319|NCT01006122|460497329|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
127966320|NCT01006122|460497328|FG000|First Double-blind Intervention Period|Pregnancy|0|||
127966321|NCT01006122|460497329|FG001|First Double-blind Intervention Period|Pregnancy|1|||
127966322|NCT01006122|460497328|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
127966323|NCT01006122|460497329|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
127966324|NCT01006122|460497328|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
127966325|NCT01006122|460497329|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
127966326|NCT01006122|460497328|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
127966327|NCT01006122|460497329|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
127966328|NCT01006122|460497328|FG000|First Double-blind Intervention Period|Other|3|||
127966329|NCT01006122|460497329|FG001|First Double-blind Intervention Period|Other|0|||
127966330|NCT01006122|460497328|FG000|First Double-blind Intervention Period|Adverse Event|0|||
127966331|NCT01006122|460497329|FG001|First Double-blind Intervention Period|Adverse Event|4|||
127966332|NCT01006122|460497328|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
127966333|NCT01006122|460497329|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
127966334|NCT01006122|460497328|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
127966335|NCT01006122|460497329|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
127966336|NCT01006122|460497328|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
127966337|NCT01006122|460497329|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
127966338|NCT01006122|460497328|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
127966339|NCT01006122|460497329|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
127966340|NCT01006122|460497328|FG000|Second Double-blind Intervention Period|Death|0|||
127966341|NCT01006122|460497329|FG001|Second Double-blind Intervention Period|Death|1|||
127966342|NCT00529308|460497332|FG000|Overall Study|Withdrawal by Subject|1|||
127966343|NCT00529308|460497333|FG001|Overall Study|Withdrawal by Subject|1|||
127966344|NCT01791894|460497340|FG000|Overall Study|Adverse Event|1|||
127966345|NCT02268916|460497345|FG000|Overall Study|Lost to Follow-up|1|||
127966346|NCT02268916|460497346|FG001|Overall Study|Lost to Follow-up|1|||
127966347|NCT02268916|460497345|FG000|Overall Study|Withdrawal by Subject|6|||
127966348|NCT02268916|460497346|FG001|Overall Study|Withdrawal by Subject|5|||
127966349|NCT02268916|460497345|FG000|Overall Study|Participant did not have diabetes|1|||
127966350|NCT02268916|460497346|FG001|Overall Study|Participant did not have diabetes|0|||
127966351|NCT02268916|460497345|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
127966352|NCT02268916|460497346|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
127966353|NCT02418949|460497347|FG000|Overall Study|Withdrawal by Subject|1|||
127966354|NCT02418949|460497348|FG001|Overall Study|Withdrawal by Subject|0|||
127966355|NCT02418949|460497349|FG002|Overall Study|Withdrawal by Subject|1|||
127966356|NCT02418949|460497350|FG003|Overall Study|Withdrawal by Subject|1|||
127966357|NCT02418949|460497347|FG000|Overall Study|Lost to Follow-up|1|||
127966358|NCT02418949|460497348|FG001|Overall Study|Lost to Follow-up|0|||
127966359|NCT02418949|460497349|FG002|Overall Study|Lost to Follow-up|1|||
127966360|NCT02418949|460497350|FG003|Overall Study|Lost to Follow-up|0|||
127966361|NCT02418949|460497347|FG000|Overall Study|Physician Decision|1|||
127966362|NCT02418949|460497348|FG001|Overall Study|Physician Decision|1|||
127966363|NCT02418949|460497349|FG002|Overall Study|Physician Decision|1|||
127966364|NCT02418949|460497350|FG003|Overall Study|Physician Decision|0|||
127966365|NCT03926117|460497351|FG000|Overall Study|Unclassified|1|||
127966366|NCT03926117|460497352|FG001|Overall Study|Unclassified|4|||
127966367|NCT03926117|460497353|FG002|Overall Study|Unclassified|1|||
127966368|NCT03926117|460497354|FG003|Overall Study|Unclassified|4|||
127966369|NCT03926117|460497351|FG000|Overall Study|Withdrawal by Subject|3|||
127966370|NCT03926117|460497352|FG001|Overall Study|Withdrawal by Subject|0|||
127966371|NCT03926117|460497353|FG002|Overall Study|Withdrawal by Subject|1|||
127966372|NCT03926117|460497354|FG003|Overall Study|Withdrawal by Subject|1|||
127966373|NCT03926117|460497351|FG000|Overall Study|Lost to Follow-up|0|||
127966374|NCT03926117|460497352|FG001|Overall Study|Lost to Follow-up|2|||
127966375|NCT03926117|460497353|FG002|Overall Study|Lost to Follow-up|1|||
127966376|NCT03926117|460497354|FG003|Overall Study|Lost to Follow-up|0|||
127966377|NCT03926117|460497351|FG000|Overall Study|Adverse Event|1|||
127966378|NCT03926117|460497352|FG001|Overall Study|Adverse Event|2|||
127966379|NCT03926117|460497353|FG002|Overall Study|Adverse Event|3|||
127966380|NCT03926117|460497354|FG003|Overall Study|Adverse Event|1|||
127966381|NCT03926117|460497351|FG000|Overall Study|Randomized but not treated|1|||
127966382|NCT03926117|460497352|FG001|Overall Study|Randomized but not treated|1|||
127966383|NCT03926117|460497353|FG002|Overall Study|Randomized but not treated|0|||
127966384|NCT03926117|460497354|FG003|Overall Study|Randomized but not treated|1|||
127966385|NCT04526288|460497358|FG000|Overall Study|Disease Progression|1|||
127966386|NCT04526288|460497359|FG001|Overall Study|Disease Progression|0|||
127966387|NCT02684097|460497362|FG000|Overall Study|Lack of Efficacy|13|||
127966388|NCT02684097|460497363|FG001|Overall Study|Lack of Efficacy|6|||
127966389|NCT00460811|460497364|FG000|Overall Study|Adverse Event|4|||
127966390|NCT00460811|460497365|FG001|Overall Study|Adverse Event|6|||
127966391|NCT00460811|460497366|FG002|Overall Study|Adverse Event|3|||
127966392|NCT00460811|460497367|FG003|Overall Study|Adverse Event|10|||
127966393|NCT00460811|460497368|FG004|Overall Study|Adverse Event|2|||
127966394|NCT00460811|460497364|FG000|Overall Study|Noncompliance|1|||
127966395|NCT00460811|460497365|FG001|Overall Study|Noncompliance|0|||
127966396|NCT00460811|460497366|FG002|Overall Study|Noncompliance|0|||
127966397|NCT00460811|460497367|FG003|Overall Study|Noncompliance|2|||
127966398|NCT00460811|460497368|FG004|Overall Study|Noncompliance|1|||
127966399|NCT00460811|460497364|FG000|Overall Study|Withdrawal by Subject|7|||
127966400|NCT00460811|460497365|FG001|Overall Study|Withdrawal by Subject|7|||
127966401|NCT00460811|460497366|FG002|Overall Study|Withdrawal by Subject|6|||
127966402|NCT00460811|460497367|FG003|Overall Study|Withdrawal by Subject|3|||
127966403|NCT00460811|460497368|FG004|Overall Study|Withdrawal by Subject|11|||
127966404|NCT00460811|460497364|FG000|Overall Study|Physician Decision|1|||
127966405|NCT00460811|460497365|FG001|Overall Study|Physician Decision|0|||
127966406|NCT00460811|460497366|FG002|Overall Study|Physician Decision|0|||
127966407|NCT00460811|460497367|FG003|Overall Study|Physician Decision|0|||
127966408|NCT00460811|460497368|FG004|Overall Study|Physician Decision|0|||
127966409|NCT00460811|460497364|FG000|Overall Study|Lost to Follow-up|3|||
127966410|NCT00460811|460497365|FG001|Overall Study|Lost to Follow-up|2|||
127966411|NCT00460811|460497366|FG002|Overall Study|Lost to Follow-up|5|||
127966412|NCT00460811|460497367|FG003|Overall Study|Lost to Follow-up|3|||
127966413|NCT00460811|460497368|FG004|Overall Study|Lost to Follow-up|6|||
127966414|NCT02748356|460497369|FG000|Overall Study|Withdrawal by Subject|1|||
127966415|NCT00996125|460497370|FG000|Overall Study|Adverse Event|0|||
127966416|NCT00996125|460497371|FG001|Overall Study|Adverse Event|2|||
127966417|NCT00996125|460497370|FG000|Overall Study|Lost to Follow-up|1|||
127966418|NCT00996125|460497371|FG001|Overall Study|Lost to Follow-up|6|||
127966419|NCT00996125|460497370|FG000|Overall Study|Withdrawal by Subject|4|||
127966420|NCT00996125|460497371|FG001|Overall Study|Withdrawal by Subject|3|||
127966421|NCT00237458|460497373|FG000|Overall Study|Lack of Efficacy|1|||
127966422|NCT00237458|460497373|FG000|Overall Study|Adverse Event|1|||
127966423|NCT00237458|460497373|FG000|Overall Study|Withdrawal by Subject|1|||
127966424|NCT00952068|460497374|FG000|Overall Study|Adverse Event|3|||
127966425|NCT00952068|460497374|FG000|Overall Study|Withdrawal by Subject|4|||
127966426|NCT04331067|460497375|FG000|Overall Study|Adverse Event|1|||
127966427|NCT04331067|460497376|FG001|Overall Study|Adverse Event|3|||
127966428|NCT04331067|460497377|FG002|Overall Study|Adverse Event|1|||
127966429|NCT04331067|460497375|FG000|Overall Study|Physician decision - patient not compliant with visits|1|||
127966430|NCT04331067|460497376|FG001|Overall Study|Physician decision - patient not compliant with visits|0|||
127966431|NCT04331067|460497377|FG002|Overall Study|Physician decision - patient not compliant with visits|0|||
127966432|NCT05870371|460497378|FG000|Overall Study|Nonadherence (missed appointmetns).|24|||
127966433|NCT05870371|460497379|FG001|Overall Study|Nonadherence (missed appointmetns).|24|||
127966434|NCT02203721|460497383|FG000|Overall Study|Lost to Follow-up|1|||
127966435|NCT02203721|460497384|FG001|Overall Study|Lost to Follow-up|0|||
127966436|NCT02203721|460497383|FG000|Overall Study|Death|0|||
127966437|NCT02203721|460497384|FG001|Overall Study|Death|2|||
127966438|NCT02203721|460497383|FG000|Overall Study|Illness|0|||
127966439|NCT02203721|460497384|FG001|Overall Study|Illness|1|||
127966440|NCT00708461|460497385|FG000|Overall Study|Lost to Follow-up|18|||
127966441|NCT00708461|460497386|FG001|Overall Study|Lost to Follow-up|11|||
127966442|NCT00708461|460497385|FG000|Overall Study|Withdrawal by Subject|8|||
127966443|NCT00708461|460497386|FG001|Overall Study|Withdrawal by Subject|9|||
127966444|NCT00708461|460497385|FG000|Overall Study|left workforce|115|||
127966445|NCT00708461|460497386|FG001|Overall Study|left workforce|180|||
127966446|NCT01796392|460497391|FG000|Overall Study|Withdrawal by Subject|2|||
127966447|NCT01796392|460497392|FG001|Overall Study|Withdrawal by Subject|0|||
127966448|NCT01796392|460497391|FG000|Overall Study|Death|5|||
127966449|NCT01796392|460497392|FG001|Overall Study|Death|1|||
127966450|NCT01796392|460497391|FG000|Overall Study|Excluded for medical reasons|1|||
127966451|NCT01796392|460497392|FG001|Overall Study|Excluded for medical reasons|2|||
127966452|NCT01796392|460497391|FG000|Overall Study|Lost to Follow-up|1|||
127966453|NCT01796392|460497392|FG001|Overall Study|Lost to Follow-up|0|||
127966454|NCT03517540|460497395|FG000|Overall Study|Protocol Violation|2|||
127966455|NCT03517540|460497396|FG001|Overall Study|Protocol Violation|0|||
127966456|NCT03517540|460497397|FG002|Overall Study|Protocol Violation|0|||
127966457|NCT03517540|460497398|FG003|Overall Study|Protocol Violation|1|||
127966458|NCT03517540|460497395|FG000|Overall Study|Adverse Event|9|||
127966459|NCT03517540|460497396|FG001|Overall Study|Adverse Event|3|||
127966460|NCT03517540|460497397|FG002|Overall Study|Adverse Event|8|||
127966461|NCT03517540|460497398|FG003|Overall Study|Adverse Event|1|||
127966462|NCT03517540|460497395|FG000|Overall Study|Withdrawal by Subject|3|||
127966463|NCT03517540|460497396|FG001|Overall Study|Withdrawal by Subject|4|||
127966464|NCT03517540|460497397|FG002|Overall Study|Withdrawal by Subject|1|||
127966465|NCT03517540|460497398|FG003|Overall Study|Withdrawal by Subject|3|||
127966466|NCT01779440|460497399|FG000|Overall Study|Withdrawal by Subject|3|||
127966467|NCT01779440|460497400|FG001|Overall Study|Withdrawal by Subject|5|||
127966468|NCT01205269|460497401|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
127966469|NCT01205269|460497402|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
127966470|NCT01205269|460497403|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
127966471|NCT01205269|460497404|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
127966472|NCT01205269|460497405|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
127966473|NCT01205269|460497406|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
127966474|NCT01408303|460497407|FG000|Overall Study|Adverse Event|3|||
127966475|NCT01408303|460497408|FG001|Overall Study|Adverse Event|7|||
127966476|NCT01408303|460497409|FG002|Overall Study|Adverse Event|2|||
127966477|NCT01408303|460497407|FG000|Overall Study|Lost to Follow-up|0|||
127966478|NCT01408303|460497408|FG001|Overall Study|Lost to Follow-up|1|||
127966479|NCT01408303|460497409|FG002|Overall Study|Lost to Follow-up|2|||
127966480|NCT01408303|460497407|FG000|Overall Study|Withdrawal by Subject|2|||
127966481|NCT01408303|460497408|FG001|Overall Study|Withdrawal by Subject|3|||
127966482|NCT01408303|460497409|FG002|Overall Study|Withdrawal by Subject|1|||
127966483|NCT01408303|460497407|FG000|Overall Study|Protocol Violation|0|||
127966484|NCT01408303|460497408|FG001|Overall Study|Protocol Violation|1|||
127966485|NCT01408303|460497409|FG002|Overall Study|Protocol Violation|0|||
127966486|NCT01408303|460497407|FG000|Overall Study|Noncompliance|1|||
127966487|NCT01408303|460497408|FG001|Overall Study|Noncompliance|0|||
127966488|NCT01408303|460497409|FG002|Overall Study|Noncompliance|1|||
127966489|NCT01207687|460497410|FG000|Overall Study|Adverse Event|1|||
127966490|NCT01207687|460497410|FG000|Overall Study|Withdrawal by Subject|1|||
127966491|NCT01486446|460497411|FG000|Overall Study|Adverse Event|1|||
127966492|NCT01486446|460497412|FG001|Overall Study|Adverse Event|0|||
127966493|NCT01801865|460497413|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
127966494|NCT01801865|460497413|FG000|Overall Study|Physician Decision|7|||
127966495|NCT00523848|460497414|FG000|Overall Study|Adverse Event|11|||
127966496|NCT00523848|460497414|FG000|Overall Study|Withdrawal by Subject|2|||
127966497|NCT00523848|460497414|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
127966498|NCT00523848|460497414|FG000|Overall Study|Disease Progression|5|||
127966499|NCT00523848|460497414|FG000|Overall Study|Other, unspecified|4|||
127966500|NCT01367886|460497417|FG000|Overall Study|Lost to Follow-up|4|||
127966501|NCT01367886|460497417|FG000|Overall Study|Lack of Efficacy|2|||
127966502|NCT01367886|460497417|FG000|Overall Study|Death|1|||
127966503|NCT00985504|460497418|FG000|Acute Treatment Period|Adverse Event|3|||
127966504|NCT00985504|460497419|FG001|Acute Treatment Period|Adverse Event|4|||
127966505|NCT00985504|460497418|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
127966506|NCT00985504|460497419|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
127966507|NCT00985504|460497418|FG000|Acute Treatment Period|Protocol Violation|2|||
127966508|NCT00985504|460497419|FG001|Acute Treatment Period|Protocol Violation|0|||
127966509|NCT00985504|460497418|FG000|Acute Treatment Period|Sponsor Decision|0|||
127966510|NCT00985504|460497419|FG001|Acute Treatment Period|Sponsor Decision|1|||
127966511|NCT00985504|460497418|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
127966512|NCT00985504|460497419|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
127966513|NCT00985504|460497418|FG000|Optimization Period|Adverse Event|7|||
127966514|NCT00985504|460497419|FG001|Optimization Period|Adverse Event|9|||
127966515|NCT00985504|460497418|FG000|Optimization Period|Death|0|||
127966516|NCT00985504|460497419|FG001|Optimization Period|Death|1|||
127966517|NCT00985504|460497418|FG000|Optimization Period|Lack of Efficacy|5|||
127966518|NCT00985504|460497419|FG001|Optimization Period|Lack of Efficacy|3|||
127966519|NCT00985504|460497418|FG000|Optimization Period|Lost to Follow-up|0|||
127966520|NCT00985504|460497419|FG001|Optimization Period|Lost to Follow-up|1|||
127966521|NCT00985504|460497418|FG000|Optimization Period|Physician Decision|1|||
127966522|NCT00985504|460497419|FG001|Optimization Period|Physician Decision|0|||
127966523|NCT00985504|460497418|FG000|Optimization Period|Protocol Violation|3|||
127966524|NCT00985504|460497419|FG001|Optimization Period|Protocol Violation|1|||
127966525|NCT00985504|460497418|FG000|Optimization Period|Withdrawal by Subject|10|||
127966526|NCT00985504|460497419|FG001|Optimization Period|Withdrawal by Subject|8|||
127966527|NCT03711786|460497424|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
127966528|NCT03711786|460497425|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
127966529|NCT03711786|460497424|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
127966530|NCT03711786|460497425|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
127966531|NCT03711786|460497424|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
127966532|NCT03711786|460497425|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
127966533|NCT03711786|460497424|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
127966534|NCT03711786|460497425|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
127966535|NCT03711786|460497424|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
127966536|NCT03711786|460497425|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
127966537|NCT03711786|460497424|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
127966538|NCT03711786|460497425|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
127966539|NCT03379727|460497429|FG000|Overall Study|Lack of Efficacy|73|||
127966540|NCT03379727|460497429|FG000|Overall Study|Adverse Event|32|||
127966541|NCT03379727|460497429|FG000|Overall Study|Death|18|||
127966542|NCT03379727|460497429|FG000|Overall Study|Patient/guardian decision|17|||
127966543|NCT03379727|460497429|FG000|Overall Study|Physician Decision|104|||
127966544|NCT03379727|460497429|FG000|Overall Study|Protocol Violation|4|||
127966545|NCT03379727|460497429|FG000|Overall Study|Lost to Follow-up|1|||
127966546|NCT04031846|460497430|FG000|Overall Study|Lost to Follow-up|4|||
127966547|NCT04031846|460497431|FG001|Overall Study|Lost to Follow-up|4|||
127966548|NCT04031846|460497430|FG000|Overall Study|Physician Decision|0|||
127966549|NCT04031846|460497431|FG001|Overall Study|Physician Decision|1|||
127966550|NCT04031846|460497430|FG000|Overall Study|Protocol Violation|1|||
127966551|NCT04031846|460497431|FG001|Overall Study|Protocol Violation|1|||
127966552|NCT04031846|460497430|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
127966553|NCT04031846|460497431|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
127966554|NCT06868654|460497432|FG000|Overall Study|Death|4|||
127966555|NCT06868654|460497433|FG001|Overall Study|Death|14|||
127966556|NCT06868654|460497432|FG000|Overall Study|Lost to Follow-up|0|||
127966557|NCT06868654|460497433|FG001|Overall Study|Lost to Follow-up|1|||
127966558|NCT06868654|460497432|FG000|Overall Study|Withdrawal by Subject|5|||
127966559|NCT06868654|460497433|FG001|Overall Study|Withdrawal by Subject|3|||
127966560|NCT06868654|460497432|FG000|Overall Study|Physician Decision|0|||
127966561|NCT06868654|460497433|FG001|Overall Study|Physician Decision|1|||
127966562|NCT06868654|460497432|FG000|Overall Study|Ongoing|23|||
127966563|NCT06868654|460497433|FG001|Overall Study|Ongoing|21|||
127966564|NCT01777282|460497440|FG000|Overall Study|Persistent Hyperglycemia|0|||
127966565|NCT01777282|460497441|FG001|Overall Study|Persistent Hyperglycemia|0|||
127966566|NCT01777282|460497442|FG002|Overall Study|Persistent Hyperglycemia|1|||
127966567|NCT01777282|460497443|FG003|Overall Study|Persistent Hyperglycemia|0|||
127966568|NCT01777282|460497444|FG004|Overall Study|Persistent Hyperglycemia|0|||
127966569|NCT01777282|460497440|FG000|Overall Study|New Antidiabetic Medication|0|||
127966570|NCT01777282|460497441|FG001|Overall Study|New Antidiabetic Medication|0|||
127966571|NCT01777282|460497442|FG002|Overall Study|New Antidiabetic Medication|1|||
127966572|NCT01777282|460497443|FG003|Overall Study|New Antidiabetic Medication|0|||
127966573|NCT01777282|460497444|FG004|Overall Study|New Antidiabetic Medication|0|||
127966574|NCT01777282|460497440|FG000|Overall Study|Adverse Event|4|||
127966575|NCT01777282|460497441|FG001|Overall Study|Adverse Event|4|||
127966576|NCT01777282|460497442|FG002|Overall Study|Adverse Event|2|||
127966577|NCT01777282|460497443|FG003|Overall Study|Adverse Event|1|||
127966578|NCT01777282|460497444|FG004|Overall Study|Adverse Event|3|||
127966579|NCT01777282|460497440|FG000|Overall Study|Withdrawal by Subject|4|||
127966580|NCT01777282|460497441|FG001|Overall Study|Withdrawal by Subject|0|||
127966581|NCT01777282|460497442|FG002|Overall Study|Withdrawal by Subject|0|||
127966582|NCT01777282|460497443|FG003|Overall Study|Withdrawal by Subject|1|||
127966583|NCT01777282|460497444|FG004|Overall Study|Withdrawal by Subject|2|||
127966584|NCT01777282|460497440|FG000|Overall Study|Protocol Violation|2|||
127966585|NCT01777282|460497441|FG001|Overall Study|Protocol Violation|0|||
127966586|NCT01777282|460497442|FG002|Overall Study|Protocol Violation|1|||
127966587|NCT01777282|460497443|FG003|Overall Study|Protocol Violation|0|||
127966588|NCT01777282|460497444|FG004|Overall Study|Protocol Violation|2|||
127966589|NCT01777282|460497440|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
127966590|NCT01777282|460497441|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
127966591|NCT01777282|460497442|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
127966592|NCT01777282|460497443|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
127966593|NCT01777282|460497444|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
127966594|NCT01131455|460497445|FG000|Overall Study|Death of PI|6|||
127966595|NCT01131455|460497446|FG001|Overall Study|Death of PI|4|||
127966596|NCT01131455|460497447|FG002|Overall Study|Death of PI|0|||
127966597|NCT00764660|460497448|FG000|Overall Study|Adverse Event|6|||
127966598|NCT00764660|460497449|FG001|Overall Study|Adverse Event|3|||
127966599|NCT00764660|460497448|FG000|Overall Study|Lost to Follow-up|3|||
127966600|NCT00764660|460497449|FG001|Overall Study|Lost to Follow-up|4|||
127966601|NCT00764660|460497448|FG000|Overall Study|Withdrawal by Subject|7|||
127966602|NCT00764660|460497449|FG001|Overall Study|Withdrawal by Subject|3|||
127966603|NCT00764660|460497448|FG000|Overall Study|Noncompliance With Protocol|5|||
127966604|NCT00764660|460497449|FG001|Overall Study|Noncompliance With Protocol|1|||
127966605|NCT00764660|460497448|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
127966606|NCT00764660|460497449|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
127966607|NCT03103152|460497450|FG000|Overall Study|Physician Decision|5|||
127966608|NCT03103152|460497451|FG001|Overall Study|Physician Decision|2|||
127966609|NCT03103152|460497452|FG002|Overall Study|Physician Decision|6|||
127966610|NCT03103152|460497453|FG003|Overall Study|Physician Decision|3|||
127966611|NCT03103152|460497454|FG004|Overall Study|Physician Decision|3|||
127966612|NCT03103152|460497455|FG005|Overall Study|Physician Decision|1|||
127966613|NCT03103152|460497450|FG000|Overall Study|Protocol Violation|2|||
127966614|NCT03103152|460497451|FG001|Overall Study|Protocol Violation|2|||
127966615|NCT03103152|460497452|FG002|Overall Study|Protocol Violation|1|||
127966616|NCT03103152|460497453|FG003|Overall Study|Protocol Violation|2|||
127966617|NCT03103152|460497454|FG004|Overall Study|Protocol Violation|1|||
127966618|NCT03103152|460497455|FG005|Overall Study|Protocol Violation|1|||
127966619|NCT03103152|460497450|FG000|Overall Study|Inter-current illness|0|||
127966620|NCT03103152|460497451|FG001|Overall Study|Inter-current illness|0|||
127966621|NCT03103152|460497452|FG002|Overall Study|Inter-current illness|1|||
127966622|NCT03103152|460497453|FG003|Overall Study|Inter-current illness|0|||
127966623|NCT03103152|460497454|FG004|Overall Study|Inter-current illness|0|||
127966624|NCT03103152|460497455|FG005|Overall Study|Inter-current illness|0|||
127966625|NCT03103152|460497450|FG000|Overall Study|Death|0|||
127966626|NCT03103152|460497451|FG001|Overall Study|Death|1|||
127966627|NCT03103152|460497452|FG002|Overall Study|Death|0|||
127966628|NCT03103152|460497453|FG003|Overall Study|Death|0|||
127966629|NCT03103152|460497454|FG004|Overall Study|Death|0|||
127966630|NCT03103152|460497455|FG005|Overall Study|Death|0|||
127966631|NCT03103152|460497450|FG000|Overall Study|Adverse Event|0|||
127966632|NCT03103152|460497451|FG001|Overall Study|Adverse Event|0|||
127966633|NCT03103152|460497452|FG002|Overall Study|Adverse Event|1|||
127966634|NCT03103152|460497453|FG003|Overall Study|Adverse Event|0|||
127966635|NCT03103152|460497454|FG004|Overall Study|Adverse Event|0|||
127966636|NCT03103152|460497455|FG005|Overall Study|Adverse Event|1|||
127966637|NCT03103152|460497450|FG000|Overall Study|Withdrawal by Subject|1|||
127966638|NCT03103152|460497451|FG001|Overall Study|Withdrawal by Subject|0|||
127966639|NCT03103152|460497452|FG002|Overall Study|Withdrawal by Subject|1|||
127966640|NCT03103152|460497453|FG003|Overall Study|Withdrawal by Subject|1|||
127966641|NCT03103152|460497454|FG004|Overall Study|Withdrawal by Subject|1|||
127966642|NCT03103152|460497455|FG005|Overall Study|Withdrawal by Subject|1|||
127966643|NCT03103152|460497450|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
127966644|NCT03103152|460497451|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
127966645|NCT03103152|460497452|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
127966646|NCT03103152|460497453|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
127966647|NCT03103152|460497454|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
127966648|NCT03103152|460497455|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
127966649|NCT03103152|460497450|FG000|Overall Study|Unacceptable side effects|0|||
127966650|NCT03103152|460497451|FG001|Overall Study|Unacceptable side effects|0|||
127966651|NCT03103152|460497452|FG002|Overall Study|Unacceptable side effects|0|||
127966652|NCT03103152|460497453|FG003|Overall Study|Unacceptable side effects|0|||
127966653|NCT03103152|460497454|FG004|Overall Study|Unacceptable side effects|0|||
127966654|NCT03103152|460497455|FG005|Overall Study|Unacceptable side effects|1|||
127966655|NCT03103152|460497450|FG000|Overall Study|Lost to Follow-up|0|||
127966656|NCT03103152|460497451|FG001|Overall Study|Lost to Follow-up|1|||
127966657|NCT03103152|460497452|FG002|Overall Study|Lost to Follow-up|0|||
127966658|NCT03103152|460497453|FG003|Overall Study|Lost to Follow-up|1|||
127966659|NCT03103152|460497454|FG004|Overall Study|Lost to Follow-up|0|||
127966660|NCT03103152|460497455|FG005|Overall Study|Lost to Follow-up|1|||
127966661|NCT03103152|460497450|FG000|Overall Study|Testicular pain|0|||
127966662|NCT03103152|460497451|FG001|Overall Study|Testicular pain|0|||
127966663|NCT03103152|460497452|FG002|Overall Study|Testicular pain|0|||
127966664|NCT03103152|460497453|FG003|Overall Study|Testicular pain|1|||
127966665|NCT03103152|460497454|FG004|Overall Study|Testicular pain|0|||
127966666|NCT03103152|460497455|FG005|Overall Study|Testicular pain|0|||
127966667|NCT01068678|460499003|FG000|Overall Study|Lack of Efficacy|3|||
127966668|NCT01068678|460499004|FG001|Overall Study|Lack of Efficacy|2|||
127966669|NCT01068678|460499003|FG000|Overall Study|Protocol Violation|5|||
127966670|NCT01068678|460499004|FG001|Overall Study|Protocol Violation|1|||
127966671|NCT01068678|460499003|FG000|Overall Study|Withdrawal criteria|12|||
127966672|NCT01068678|460499004|FG001|Overall Study|Withdrawal criteria|6|||
127966673|NCT01068678|460499003|FG000|Overall Study|Unclassified|18|||
127966674|NCT01068678|460499004|FG001|Overall Study|Unclassified|15|||
127966675|NCT03055338|460499007|FG000|Overall Study|Lost to Follow-up|9|||
127966676|NCT03055338|460499008|FG001|Overall Study|Lost to Follow-up|2|||
127966677|NCT03055338|460499009|FG002|Overall Study|Lost to Follow-up|3|||
127966678|NCT03055338|460499007|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
127966679|NCT03055338|460499008|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
127966680|NCT03055338|460499009|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
127966681|NCT03055338|460499007|FG000|Overall Study|Physician Decision|0|||
127966682|NCT03055338|460499008|FG001|Overall Study|Physician Decision|0|||
127966683|NCT03055338|460499009|FG002|Overall Study|Physician Decision|2|||
127966684|NCT03055338|460499007|FG000|Overall Study|Withdrawal by Subject|9|||
127966685|NCT03055338|460499008|FG001|Overall Study|Withdrawal by Subject|8|||
127966686|NCT03055338|460499009|FG002|Overall Study|Withdrawal by Subject|7|||
127966687|NCT00975611|460499010|FG000|Overall Study|Screen Fail|16|||
127966688|NCT00975611|460499010|FG000|Overall Study|Physician Decision|1|||
127966689|NCT03058705|460499011|FG000|Overall Study|Withdrawal by Subject|2|||
127966690|NCT03058705|460499011|FG000|Overall Study|Physician Decision|2|||
127966691|NCT01682226|460499012|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
127966692|NCT01682226|460499012|FG000|Overall Study|Participants did not receive treatment|2|||
127966693|NCT01682226|460499012|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
127966694|NCT02151851|460499013|FG000|Overall Study|Lack of Efficacy|67|||
127966695|NCT02151851|460499014|FG001|Overall Study|Lack of Efficacy|94|||
127966696|NCT02151851|460499013|FG000|Overall Study|Protocol Violation|0|||
127966697|NCT02151851|460499014|FG001|Overall Study|Protocol Violation|1|||
127966698|NCT02151851|460499013|FG000|Overall Study|Withdrawal by Subject|2|||
127966699|NCT02151851|460499014|FG001|Overall Study|Withdrawal by Subject|5|||
127966700|NCT02151851|460499013|FG000|Overall Study|Medical impairment|1|||
127966701|NCT02151851|460499014|FG001|Overall Study|Medical impairment|0|||
127966702|NCT02151851|460499013|FG000|Overall Study|Low compliance to study visits|0|||
127966703|NCT02151851|460499014|FG001|Overall Study|Low compliance to study visits|1|||
127966704|NCT02151851|460499013|FG000|Overall Study|Subject entered into study in error|0|||
127966705|NCT02151851|460499014|FG001|Overall Study|Subject entered into study in error|1|||
127966706|NCT02151851|460499013|FG000|Overall Study|Adverse Event|6|||
127966707|NCT02151851|460499014|FG001|Overall Study|Adverse Event|28|||
127966708|NCT02159053|460499015|FG000|Overall Study|Death|2|||
127966709|NCT02159053|460499016|FG001|Overall Study|Death|0|||
127966710|NCT02159053|460499017|FG002|Overall Study|Death|1|||
127966711|NCT02159053|460499015|FG000|Overall Study|Physician Decision|0|||
127966712|NCT02159053|460499016|FG001|Overall Study|Physician Decision|1|||
127966713|NCT02159053|460499017|FG002|Overall Study|Physician Decision|1|||
127966714|NCT02159053|460499015|FG000|Overall Study|Lack of Efficacy|3|||
127966715|NCT02159053|460499016|FG001|Overall Study|Lack of Efficacy|4|||
127966716|NCT02159053|460499017|FG002|Overall Study|Lack of Efficacy|7|||
127966717|NCT02159053|460499015|FG000|Overall Study|Adverse Event|7|||
127966718|NCT02159053|460499016|FG001|Overall Study|Adverse Event|6|||
127966719|NCT02159053|460499017|FG002|Overall Study|Adverse Event|5|||
127966720|NCT02159053|460499015|FG000|Overall Study|Participants/guardian decision|8|||
127966721|NCT02159053|460499016|FG001|Overall Study|Participants/guardian decision|10|||
127966722|NCT02159053|460499017|FG002|Overall Study|Participants/guardian decision|6|||
127966723|NCT01540487|460499022|FG000|Overall Study|Protocol Violation|1|||
127966724|NCT01540487|460499023|FG001|Overall Study|Protocol Violation|0|||
127966725|NCT03503370|460499026|FG000|Overall Study|Death|3|||
127966726|NCT03503370|460499027|FG001|Overall Study|Death|1|||
127966727|NCT00298272|460499032|FG000|Double-blind Phase|Adverse Event|2|||
127966728|NCT00298272|460499033|FG001|Double-blind Phase|Adverse Event|0|||
127966729|NCT00298272|460499032|FG000|Double-blind Phase|Failure to Return|2|||
127966730|NCT00298272|460499033|FG001|Double-blind Phase|Failure to Return|0|||
127966731|NCT00298272|460499032|FG000|Double-blind Phase|Protocol Violation|2|||
127966732|NCT00298272|460499033|FG001|Double-blind Phase|Protocol Violation|0|||
127966733|NCT00298272|460499032|FG000|Double-blind Phase|Withdrawal by Subject|2|||
127966734|NCT00298272|460499033|FG001|Double-blind Phase|Withdrawal by Subject|0|||
127966735|NCT00298272|460499032|FG000|Open Label Retreatment Phase|Adverse Event|1|||
127966736|NCT00298272|460499033|FG001|Open Label Retreatment Phase|Adverse Event|2|||
127966737|NCT00298272|460499032|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
127966738|NCT00298272|460499033|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
127966739|NCT00298272|460499032|FG000|Open Label Retreatment Phase|Failure to Return|1|||
127966740|NCT00298272|460499033|FG001|Open Label Retreatment Phase|Failure to Return|0|||
127966741|NCT00298272|460499032|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
127966742|NCT00298272|460499033|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
127966743|NCT00298272|460499032|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
127966744|NCT00298272|460499033|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
127966745|NCT00298272|460499032|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
127966746|NCT00298272|460499033|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
127966747|NCT00298272|460499032|FG000|Safety Follow-up Phase|Failure to Return|1|||
127966748|NCT00298272|460499033|FG001|Safety Follow-up Phase|Failure to Return|1|||
127966749|NCT00298272|460499032|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
127966750|NCT00298272|460499033|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
127966751|NCT00298272|460499032|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
127966752|NCT00298272|460499033|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
127966753|NCT04168112|460499034|FG000|Overall Study|Lost to Follow-up|1|||
127966754|NCT04168112|460499035|FG001|Overall Study|Lost to Follow-up|0|||
127966755|NCT04168112|460499034|FG000|Overall Study|Withdrawal by Subject|1|||
127966756|NCT04168112|460499035|FG001|Overall Study|Withdrawal by Subject|0|||
127966757|NCT01344824|460499038|FG000|Overall Study|Adverse Event|15|||
127966758|NCT01344824|460499038|FG000|Overall Study|Withdrawal by Subject|6|||
127966759|NCT01344824|460499038|FG000|Overall Study|Other complicating disease|1|||
127966760|NCT01344824|460499038|FG000|Overall Study|Progression|15|||
127966761|NCT01295671|460499040|FG000|Overall Study|Lost to Follow-up|4|||
127966762|NCT01295671|460499041|FG001|Overall Study|Lost to Follow-up|6|||
127966763|NCT01295671|460499042|FG002|Overall Study|Lost to Follow-up|3|||
127966764|NCT01295671|460499040|FG000|Overall Study|Withdrawal by Subject|3|||
127966765|NCT01295671|460499041|FG001|Overall Study|Withdrawal by Subject|1|||
127966766|NCT01295671|460499042|FG002|Overall Study|Withdrawal by Subject|0|||
127966767|NCT01436370|460499043|FG000|Overall Study|Lost to Follow-up|0|||
127966768|NCT01436370|460499044|FG001|Overall Study|Lost to Follow-up|0|||
127966769|NCT01436370|460499045|FG002|Overall Study|Lost to Follow-up|0|||
127966770|NCT01436370|460499046|FG003|Overall Study|Lost to Follow-up|0|||
127966771|NCT01436370|460499047|FG004|Overall Study|Lost to Follow-up|1|||
127966772|NCT01436370|460499048|FG005|Overall Study|Lost to Follow-up|0|||
127966773|NCT01436370|460499049|FG006|Overall Study|Lost to Follow-up|0|||
127966774|NCT01436370|460499050|FG007|Overall Study|Lost to Follow-up|0|||
127966775|NCT02395848|460499051|FG000|Overall Study|Lost to Follow-up|2|||
127966776|NCT01754129|460499052|FG000|Overall Study|Death|13|||
127966777|NCT01754129|460499052|FG000|Overall Study|Duodopa discontinuation|9|||
127966778|NCT01754129|460499052|FG000|Overall Study|Lost to Follow-up|7|||
127966779|NCT01754129|460499052|FG000|Overall Study|Withdrew consent|1|||
127966780|NCT01754129|460499052|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
127966781|NCT02126579|460499054|FG000|Overall Study|disease progression|0|||
127966782|NCT02126579|460499055|FG001|Overall Study|disease progression|0|||
127966783|NCT02126579|460499056|FG002|Overall Study|disease progression|0|||
127966784|NCT02126579|460499057|FG003|Overall Study|disease progression|1|||
127966785|NCT02126579|460499058|FG004|Overall Study|disease progression|0|||
127966786|NCT02126579|460499059|FG005|Overall Study|disease progression|0|||
127966787|NCT02126579|460499060|FG006|Overall Study|disease progression|1|||
127966788|NCT01780038|460499064|FG000|Overall Study|Lost to Follow-up|4|||
127966789|NCT01780038|460499065|FG001|Overall Study|Lost to Follow-up|1|||
127966790|NCT02609607|460499071|FG000|Overall Study|Lost to Follow-up|0|||
127966791|NCT02609607|460499072|FG001|Overall Study|Lost to Follow-up|1|||
127966792|NCT03168711|460499075|FG000|Overall Study|Adverse Event|2|||
127966793|NCT03168711|460499076|FG001|Overall Study|Adverse Event|0|||
127966794|NCT03168711|460499075|FG000|Overall Study|Withdrawal by Subject|0|||
127966795|NCT03168711|460499076|FG001|Overall Study|Withdrawal by Subject|1|||
127966796|NCT03168711|460499075|FG000|Overall Study|Death|0|||
127966797|NCT03168711|460499076|FG001|Overall Study|Death|1|||
127966798|NCT02877004|460499083|FG000|Overall Study|Pregnancy|0|||
127966799|NCT02877004|460499084|FG001|Overall Study|Pregnancy|0|||
127966800|NCT02877004|460499085|FG002|Overall Study|Pregnancy|1|||
127966801|NCT02633293|460499086|FG000|Overall Study|Death|56|||
127966802|NCT02633293|460499086|FG000|Overall Study|Progressive Disease|12|||
127966803|NCT02633293|460499086|FG000|Overall Study|Adverse Event|29|||
127966804|NCT02633293|460499086|FG000|Overall Study|Withdrawal by Subject|41|||
127966805|NCT02633293|460499086|FG000|Overall Study|Protocol Violation|1|||
127966806|NCT02633293|460499086|FG000|Overall Study|Lost to Follow-up|1|||
127966807|NCT02633293|460499086|FG000|Overall Study|Study Terminated by Sponsor|24|||
127966808|NCT02633293|460499086|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
127966809|NCT02633293|460499086|FG000|Overall Study|Lung Transplant|5|||
127966810|NCT02633293|460499086|FG000|Overall Study|Lack of Efficacy|2|||
127966811|NCT02633293|460499086|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
127966812|NCT00778817|460499087|FG000|Overall Study|Adverse Event|2|||
127966813|NCT00778817|460499087|FG000|Overall Study|Withdrawal by Subject|2|||
127966814|NCT02356588|460499088|FG000|Overall Study|Lack of Efficacy|4|||
127966815|NCT02356588|460499089|FG001|Overall Study|Lack of Efficacy|10|||
127966816|NCT02356588|460499088|FG000|Overall Study|Adverse Event|0|||
127966817|NCT02356588|460499089|FG001|Overall Study|Adverse Event|2|||
127966818|NCT02356588|460499088|FG000|Overall Study|Withdrawal by Subject|1|||
127966819|NCT02356588|460499089|FG001|Overall Study|Withdrawal by Subject|0|||
127966820|NCT02356588|460499088|FG000|Overall Study|Protocol Violation|0|||
127966821|NCT02356588|460499089|FG001|Overall Study|Protocol Violation|1|||
127966822|NCT01418378|460499090|FG000|Overall Study|Death|1|||
127966823|NCT01418378|460499091|FG001|Overall Study|Death|2|||
127966824|NCT01418378|460499090|FG000|Overall Study|Physician Decision|0|||
127966825|NCT01418378|460499091|FG001|Overall Study|Physician Decision|1|||
127966826|NCT01418378|460499090|FG000|Overall Study|ligament imbalance|0|||
127966827|NCT01418378|460499091|FG001|Overall Study|ligament imbalance|1|||
127966828|NCT01418378|460499090|FG000|Overall Study|developed chronic myopathy|0|||
127966829|NCT01418378|460499091|FG001|Overall Study|developed chronic myopathy|1|||
127966830|NCT03150719|460499094|FG000|Overall Study|Adverse Event|0|||
127966831|NCT03150719|460499095|FG001|Overall Study|Adverse Event|1|||
127966832|NCT03150719|460499094|FG000|Overall Study|Death|0|||
127966833|NCT03150719|460499095|FG001|Overall Study|Death|1|||
127966834|NCT03150719|460499094|FG000|Overall Study|Other|1|||
127966835|NCT03150719|460499095|FG001|Overall Study|Other|0|||
127966836|NCT01790984|460499096|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
127966837|NCT01790984|460499097|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
127966838|NCT01790984|460499098|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
127966839|NCT01790984|460499099|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
127966840|NCT01051791|460499108|FG000|Overall Study|Failed screening|3|||
127966841|NCT01051791|460499108|FG000|Overall Study|Withdrawal by Subject|1|||
127966842|NCT00288626|460499109|FG000|Overall Study|Death|3|||
127966843|NCT00288626|460499109|FG000|Overall Study|Withdrawal by Subject|4|||
127966844|NCT01081769|460499111|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
127966845|NCT01081769|460499112|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
127966846|NCT01081769|460499111|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
127966847|NCT01081769|460499112|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
127966848|NCT01081769|460499111|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
127966849|NCT01081769|460499112|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
127966850|NCT01081769|460499111|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
127966851|NCT01081769|460499112|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
127966852|NCT01081769|460499111|FG000|CORE Intent-To-Treat|Adverse Event|14|||
127966853|NCT01081769|460499112|FG001|CORE Intent-To-Treat|Adverse Event|11|||
127966854|NCT01081769|460499111|FG000|CORE Intent-To-Treat|Death|1|||
127966855|NCT01081769|460499112|FG001|CORE Intent-To-Treat|Death|1|||
127966856|NCT01081769|460499111|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
127966857|NCT01081769|460499112|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
127966858|NCT01081769|460499111|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
127966859|NCT01081769|460499112|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
127966860|NCT01081769|460499111|FG000|CORE Intent-To-Treat|Pregnancy|1|||
127966861|NCT01081769|460499112|FG001|CORE Intent-To-Treat|Pregnancy|0|||
127966862|NCT01081769|460499111|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
127966863|NCT01081769|460499112|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
127966864|NCT01081769|460499111|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
127966865|NCT01081769|460499112|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
127966866|NCT01081769|460499111|FG000|CORE Intent-To-Treat|Other|0|||
127966867|NCT01081769|460499112|FG001|CORE Intent-To-Treat|Other|1|||
127966868|NCT01081769|460499111|FG000|CORE Intent-To-Treat|Ineligibility|3|||
127966869|NCT01081769|460499112|FG001|CORE Intent-To-Treat|Ineligibility|4|||
127966870|NCT01081769|460499111|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
127966871|NCT01081769|460499112|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
127966872|NCT01081769|460499111|FG000|CORE Intent-To-Treat|Patient Moved|2|||
127966873|NCT01081769|460499112|FG001|CORE Intent-To-Treat|Patient Moved|2|||
127966874|NCT00507455|460499113|FG000|Overall Study|Adverse Event|3|||
127966875|NCT00507455|460499114|FG001|Overall Study|Adverse Event|3|||
127966876|NCT00507455|460499115|FG002|Overall Study|Adverse Event|6|||
127966877|NCT00507455|460499113|FG000|Overall Study|Withdrawal by Subject|2|||
127966878|NCT00507455|460499114|FG001|Overall Study|Withdrawal by Subject|1|||
127966879|NCT00507455|460499115|FG002|Overall Study|Withdrawal by Subject|2|||
127966880|NCT00507455|460499113|FG000|Overall Study|Protocol Violation|4|||
127966881|NCT00507455|460499114|FG001|Overall Study|Protocol Violation|1|||
127966882|NCT00507455|460499115|FG002|Overall Study|Protocol Violation|1|||
127966883|NCT00507455|460499113|FG000|Overall Study|Lost to Follow-up|2|||
127966884|NCT00507455|460499114|FG001|Overall Study|Lost to Follow-up|0|||
127966885|NCT00507455|460499115|FG002|Overall Study|Lost to Follow-up|2|||
127966886|NCT00507455|460499113|FG000|Overall Study|Lack of Efficacy|0|||
127966887|NCT00507455|460499114|FG001|Overall Study|Lack of Efficacy|1|||
127966888|NCT00507455|460499115|FG002|Overall Study|Lack of Efficacy|0|||
127966889|NCT00507455|460499113|FG000|Overall Study|Other - miscellaneous reason|1|||
127966890|NCT00507455|460499114|FG001|Overall Study|Other - miscellaneous reason|0|||
127966891|NCT00507455|460499115|FG002|Overall Study|Other - miscellaneous reason|1|||
127966892|NCT01964222|460499116|FG000|Overall Study|Lost to Follow-up|7|||
127966893|NCT01964222|460499117|FG001|Overall Study|Lost to Follow-up|5|||
127966894|NCT01964222|460499116|FG000|Overall Study|Withdrawal by Subject|6|||
127966895|NCT01964222|460499117|FG001|Overall Study|Withdrawal by Subject|6|||
127966896|NCT01964222|460499116|FG000|Overall Study|Screening Failure|2|||
127966897|NCT01964222|460499117|FG001|Overall Study|Screening Failure|0|||
127966898|NCT01737710|460499118|FG000|Overall Study|Lost to Follow-up|0|||
127966899|NCT01737710|460499119|FG001|Overall Study|Lost to Follow-up|2|||
127966900|NCT01737710|460499120|FG002|Overall Study|Lost to Follow-up|2|||
127966901|NCT01737710|460499121|FG003|Overall Study|Lost to Follow-up|0|||
127966902|NCT01737710|460499122|FG004|Overall Study|Lost to Follow-up|0|||
127966903|NCT01737710|460499118|FG000|Overall Study|Withdrawal by Subject|1|||
127966904|NCT01737710|460499119|FG001|Overall Study|Withdrawal by Subject|1|||
127966905|NCT01737710|460499120|FG002|Overall Study|Withdrawal by Subject|1|||
127966906|NCT01737710|460499121|FG003|Overall Study|Withdrawal by Subject|0|||
127966907|NCT01737710|460499122|FG004|Overall Study|Withdrawal by Subject|0|||
127966908|NCT01737710|460499118|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
127966909|NCT01737710|460499119|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
127966910|NCT01737710|460499120|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
127966911|NCT01737710|460499121|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
127966912|NCT01737710|460499122|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
127966913|NCT03363776|460499123|FG000|Overall Study|Progressive disease|2|||
127966914|NCT03363776|460499124|FG001|Overall Study|Progressive disease|3|||
127966915|NCT03363776|460499125|FG002|Overall Study|Progressive disease|1|||
127966916|NCT03363776|460499123|FG000|Overall Study|Study drug toxicity|0|||
127966917|NCT03363776|460499124|FG001|Overall Study|Study drug toxicity|0|||
127966918|NCT03363776|460499125|FG002|Overall Study|Study drug toxicity|1|||
127966919|NCT03363776|460499123|FG000|Overall Study|Death|1|||
127966920|NCT03363776|460499124|FG001|Overall Study|Death|0|||
127966921|NCT03363776|460499125|FG002|Overall Study|Death|0|||
127966922|NCT02861807|460499133|FG000|Overall Study|Lost to Follow-up|7|||
127966923|NCT02861807|460499134|FG001|Overall Study|Lost to Follow-up|6|||
127966924|NCT02861807|460499133|FG000|Overall Study|Withdrawal by Subject|5|||
127966925|NCT02861807|460499134|FG001|Overall Study|Withdrawal by Subject|8|||
127966926|NCT00410813|460499135|FG000|Overall Study|Adverse Event|6|||
127966927|NCT00410813|460499136|FG001|Overall Study|Adverse Event|11|||
127966928|NCT00410813|460499135|FG000|Overall Study|Progression|32|||
127966929|NCT00410813|460499136|FG001|Overall Study|Progression|21|||
127966930|NCT00410813|460499135|FG000|Overall Study|Not protocol specified|3|||
127966931|NCT00410813|460499136|FG001|Overall Study|Not protocol specified|4|||
127966932|NCT00410813|460499135|FG000|Overall Study|Ineligible|2|||
127966933|NCT00410813|460499136|FG001|Overall Study|Ineligible|4|||
127966934|NCT00410813|460499135|FG000|Overall Study|Death|0|||
127966935|NCT00410813|460499136|FG001|Overall Study|Death|2|||
127966936|NCT00812981|460499137|FG000|Overall Study|Other|0|||
127966937|NCT00812981|460499138|FG001|Overall Study|Other|1|||
127966938|NCT02199795|460499139|FG000|Overall Study|no longer met inclusion criteria|1|||
127966939|NCT02199795|460499140|FG001|Overall Study|no longer met inclusion criteria|0|||
127966940|NCT02199795|460499139|FG000|Overall Study|withdrew due to shoulder pain|1|||
127966941|NCT02199795|460499140|FG001|Overall Study|withdrew due to shoulder pain|0|||
127966942|NCT02677922|460499145|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
127966943|NCT02677922|460499146|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
127966944|NCT02677922|460499147|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
127966945|NCT02677922|460499148|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
127966946|NCT02677922|460499149|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
127966947|NCT02677922|460499150|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
127966948|NCT02677922|460499145|FG000|Treatment Period|Adverse Event|0|||
127966949|NCT02677922|460499146|FG001|Treatment Period|Adverse Event|0|||
127966950|NCT02677922|460499147|FG002|Treatment Period|Adverse Event|1|||
127966951|NCT02677922|460499148|FG003|Treatment Period|Adverse Event|3|||
127966952|NCT02677922|460499149|FG004|Treatment Period|Adverse Event|5|||
127966953|NCT02677922|460499150|FG005|Treatment Period|Adverse Event|2|||
127966954|NCT02677922|460499145|FG000|Treatment Period|Progressive Disease|1|||
127966955|NCT02677922|460499146|FG001|Treatment Period|Progressive Disease|1|||
127966956|NCT02677922|460499147|FG002|Treatment Period|Progressive Disease|0|||
127966957|NCT02677922|460499148|FG003|Treatment Period|Progressive Disease|0|||
127966958|NCT02677922|460499149|FG004|Treatment Period|Progressive Disease|8|||
127966959|NCT02677922|460499150|FG005|Treatment Period|Progressive Disease|7|||
127966960|NCT02677922|460499145|FG000|Treatment Period|Lack of Efficacy|0|||
127966961|NCT02677922|460499146|FG001|Treatment Period|Lack of Efficacy|0|||
127966962|NCT02677922|460499147|FG002|Treatment Period|Lack of Efficacy|0|||
127966963|NCT02677922|460499148|FG003|Treatment Period|Lack of Efficacy|1|||
127966964|NCT02677922|460499149|FG004|Treatment Period|Lack of Efficacy|1|||
127966965|NCT02677922|460499150|FG005|Treatment Period|Lack of Efficacy|6|||
127966966|NCT02677922|460499145|FG000|Treatment Period|Withdrawal by Subject|0|||
127966967|NCT02677922|460499146|FG001|Treatment Period|Withdrawal by Subject|0|||
127966968|NCT02677922|460499147|FG002|Treatment Period|Withdrawal by Subject|1|||
127966969|NCT02677922|460499148|FG003|Treatment Period|Withdrawal by Subject|3|||
127966970|NCT02677922|460499149|FG004|Treatment Period|Withdrawal by Subject|5|||
127966971|NCT02677922|460499150|FG005|Treatment Period|Withdrawal by Subject|5|||
127966972|NCT02677922|460499145|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
127966973|NCT02677922|460499146|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
127966974|NCT02677922|460499147|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
127966975|NCT02677922|460499148|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
127966976|NCT02677922|460499149|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
127966977|NCT02677922|460499150|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
127966978|NCT02677922|460499145|FG000|Treatment Period|Disease Relapse|0|||
127966979|NCT02677922|460499146|FG001|Treatment Period|Disease Relapse|0|||
127966980|NCT02677922|460499147|FG002|Treatment Period|Disease Relapse|0|||
127966981|NCT02677922|460499148|FG003|Treatment Period|Disease Relapse|3|||
127966982|NCT02677922|460499149|FG004|Treatment Period|Disease Relapse|6|||
127966983|NCT02677922|460499150|FG005|Treatment Period|Disease Relapse|1|||
127966984|NCT02677922|460499145|FG000|Treatment Period|Allogeneic HSCT|1|||
127966985|NCT02677922|460499146|FG001|Treatment Period|Allogeneic HSCT|0|||
127966986|NCT02677922|460499147|FG002|Treatment Period|Allogeneic HSCT|0|||
127966987|NCT02677922|460499148|FG003|Treatment Period|Allogeneic HSCT|1|||
127966988|NCT02677922|460499149|FG004|Treatment Period|Allogeneic HSCT|4|||
127966989|NCT02677922|460499150|FG005|Treatment Period|Allogeneic HSCT|1|||
127966990|NCT02677922|460499145|FG000|Treatment Period|Other Reasons|0|||
127966991|NCT02677922|460499146|FG001|Treatment Period|Other Reasons|0|||
127966992|NCT02677922|460499147|FG002|Treatment Period|Other Reasons|0|||
127966993|NCT02677922|460499148|FG003|Treatment Period|Other Reasons|1|||
127966994|NCT02677922|460499149|FG004|Treatment Period|Other Reasons|3|||
127966995|NCT02677922|460499150|FG005|Treatment Period|Other Reasons|5|||
127966996|NCT02677922|460499145|FG000|Treatment Period|Death|0|||
127966997|NCT02677922|460499146|FG001|Treatment Period|Death|0|||
127966998|NCT02677922|460499147|FG002|Treatment Period|Death|0|||
127966999|NCT02677922|460499148|FG003|Treatment Period|Death|0|||
127967000|NCT02677922|460499149|FG004|Treatment Period|Death|12|||
127967001|NCT02677922|460499150|FG005|Treatment Period|Death|1|||
127967002|NCT02677922|460499145|FG000|Treatment Period|Non-compliance with Study Drug|0|||
127967003|NCT02677922|460499146|FG001|Treatment Period|Non-compliance with Study Drug|0|||
127967004|NCT02677922|460499147|FG002|Treatment Period|Non-compliance with Study Drug|0|||
127967005|NCT02677922|460499148|FG003|Treatment Period|Non-compliance with Study Drug|0|||
127967006|NCT02677922|460499149|FG004|Treatment Period|Non-compliance with Study Drug|1|||
127967007|NCT02677922|460499150|FG005|Treatment Period|Non-compliance with Study Drug|0|||
127967008|NCT02677922|460499145|FG000|Treatment Period|Physician Decision|0|||
127967009|NCT02677922|460499146|FG001|Treatment Period|Physician Decision|0|||
127967010|NCT02677922|460499147|FG002|Treatment Period|Physician Decision|0|||
127967011|NCT02677922|460499148|FG003|Treatment Period|Physician Decision|0|||
127967012|NCT02677922|460499149|FG004|Treatment Period|Physician Decision|0|||
127967013|NCT02677922|460499150|FG005|Treatment Period|Physician Decision|1|||
127967014|NCT02677922|460499145|FG000|Treatment Period|Symptomatic Deterioration|0|||
127967015|NCT02677922|460499146|FG001|Treatment Period|Symptomatic Deterioration|0|||
127967016|NCT02677922|460499147|FG002|Treatment Period|Symptomatic Deterioration|0|||
127967017|NCT02677922|460499148|FG003|Treatment Period|Symptomatic Deterioration|0|||
127967018|NCT02677922|460499149|FG004|Treatment Period|Symptomatic Deterioration|1|||
127967019|NCT02677922|460499150|FG005|Treatment Period|Symptomatic Deterioration|0|||
127967020|NCT05310071|460499151|FG000|Overall Study|Death|0|||
127967021|NCT05310071|460499152|FG001|Overall Study|Death|3|||
127967022|NCT05310071|460499151|FG000|Overall Study|Adverse Event|4|||
127967023|NCT05310071|460499152|FG001|Overall Study|Adverse Event|31|||
127967024|NCT05310071|460499151|FG000|Overall Study|Lack of Efficacy - Based on Participant Perception|0|||
127967025|NCT05310071|460499152|FG001|Overall Study|Lack of Efficacy - Based on Participant Perception|2|||
127967026|NCT05310071|460499151|FG000|Overall Study|Protocol Deviation|2|||
127967027|NCT05310071|460499152|FG001|Overall Study|Protocol Deviation|0|||
127967028|NCT05310071|460499151|FG000|Overall Study|Randomized by Mistake|0|||
127967029|NCT05310071|460499152|FG001|Overall Study|Randomized by Mistake|1|||
127967030|NCT05310071|460499151|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
127967031|NCT05310071|460499152|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
127967032|NCT05310071|460499151|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
127967033|NCT05310071|460499152|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
127967034|NCT05310071|460499151|FG000|Overall Study|Site Terminated by Sponsor|0|||
127967035|NCT05310071|460499152|FG001|Overall Study|Site Terminated by Sponsor|2|||
127967036|NCT05310071|460499151|FG000|Overall Study|Study Terminated by Sponsor|282|||
127967037|NCT05310071|460499152|FG001|Overall Study|Study Terminated by Sponsor|559|||
127967038|NCT05310071|460499151|FG000|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|14|||
127967039|NCT05310071|460499152|FG001|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|17|||
127967040|NCT05310071|460499151|FG000|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|2|||
127967041|NCT05310071|460499152|FG001|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|6|||
127967042|NCT05310071|460499151|FG000|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|1|||
127967043|NCT05310071|460499152|FG001|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|3|||
127967044|NCT05310071|460499151|FG000|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|8|||
127967045|NCT05310071|460499152|FG001|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|17|||
127967046|NCT05310071|460499151|FG000|Overall Study|Withdrawal by Participant - Other|25|||
127967047|NCT05310071|460499152|FG001|Overall Study|Withdrawal by Participant - Other|30|||
127967048|NCT05310071|460499151|FG000|Overall Study|Lost to Follow-up|2|||
127967049|NCT05310071|460499152|FG001|Overall Study|Lost to Follow-up|4|||
127967050|NCT05310071|460499151|FG000|Overall Study|Reason Not Specified|1|||
127967051|NCT05310071|460499152|FG001|Overall Study|Reason Not Specified|3|||
127967052|NCT03515811|460499157|FG000|Overall Study|Lost to Follow-up|2|||
127967053|NCT03515811|460499158|FG001|Overall Study|Lost to Follow-up|1|||
127967054|NCT03515811|460499157|FG000|Overall Study|Protocol Violation|1|||
127967055|NCT03515811|460499158|FG001|Overall Study|Protocol Violation|1|||
127967056|NCT03515811|460499157|FG000|Overall Study|Death|1|||
127967057|NCT03515811|460499158|FG001|Overall Study|Death|1|||
127967058|NCT03515811|460499157|FG000|Overall Study|Withdrawal by Subject|0|||
127967059|NCT03515811|460499158|FG001|Overall Study|Withdrawal by Subject|2|||
127967060|NCT03515811|460499157|FG000|Overall Study|Technical Problems|1|||
127967061|NCT03515811|460499158|FG001|Overall Study|Technical Problems|0|||
127967062|NCT03515811|460499157|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
127967063|NCT03515811|460499158|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
127967064|NCT03515811|460499157|FG000|Overall Study|COVID-19|0|||
127967065|NCT03515811|460499158|FG001|Overall Study|COVID-19|1|||
127967066|NCT05107492|460499159|FG000|Overall Study|Lost to Follow-up|1|||
127967067|NCT05107492|460499160|FG001|Overall Study|Lost to Follow-up|0|||
127967068|NCT04339062|460499161|FG000|Overall Study|Death|0|||
127967069|NCT04339062|460499162|FG001|Overall Study|Death|1|||
127967070|NCT03668119|460500736|FG000|Pre-treatment|Disease Progression|1|||
127967071|NCT03668119|460500737|FG001|Pre-treatment|Disease Progression|0|||
127967072|NCT03668119|460500736|FG000|Treatment|Disease Progression|76|||
127967073|NCT03668119|460500737|FG001|Treatment|Disease Progression|57|||
127967074|NCT03668119|460500736|FG000|Treatment|Study drug toxicity|19|||
127967075|NCT03668119|460500737|FG001|Treatment|Study drug toxicity|1|||
127967076|NCT03668119|460500736|FG000|Treatment|Death|3|||
127967077|NCT03668119|460500737|FG001|Treatment|Death|0|||
127967078|NCT03668119|460500736|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
127967079|NCT03668119|460500737|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
127967080|NCT03668119|460500736|FG000|Treatment|Withdrawal by Subject|1|||
127967081|NCT03668119|460500737|FG001|Treatment|Withdrawal by Subject|1|||
127967082|NCT03668119|460500736|FG000|Treatment|Participant request to discontinue study treatment|3|||
127967083|NCT03668119|460500737|FG001|Treatment|Participant request to discontinue study treatment|1|||
127967084|NCT03668119|460500736|FG000|Treatment|Maximum Clinical Benefit|0|||
127967085|NCT03668119|460500737|FG001|Treatment|Maximum Clinical Benefit|1|||
127967086|NCT03668119|460500736|FG000|Treatment|Participants completed treatment|27|||
127967087|NCT03668119|460500737|FG001|Treatment|Participants completed treatment|11|||
127967088|NCT03668119|460500736|FG000|Treatment|Other reasons|2|||
127967089|NCT03668119|460500737|FG001|Treatment|Other reasons|1|||
127967090|NCT05336227|460500738|FG000|Overall Study|Adverse Event|1|||
127967091|NCT05336227|460500739|FG001|Overall Study|Adverse Event|0|||
127967092|NCT05336227|460500738|FG000|Overall Study|Lost to Follow-up|2|||
127967093|NCT05336227|460500739|FG001|Overall Study|Lost to Follow-up|0|||
127967094|NCT05336227|460500738|FG000|Overall Study|Withdrawal by Subject|1|||
127967095|NCT05336227|460500739|FG001|Overall Study|Withdrawal by Subject|0|||
127967096|NCT00347958|460500742|FG000|Overall Study|Adverse Event|1|||
127967097|NCT00347958|460500742|FG000|Overall Study|Protocol Violation|2|||
127967098|NCT00347958|460500742|FG000|Overall Study|Withdrawal by Subject|1|||
127967099|NCT00754234|460500743|FG000|Overall Study|Withdrawal by Subject|3|||
127967100|NCT00915018|460500744|FG000|Overall Study|Death|75|||
127967101|NCT00915018|460500745|FG001|Overall Study|Death|70|||
127967102|NCT00915018|460500744|FG000|Overall Study|Lost to Follow-up|10|||
127967103|NCT00915018|460500745|FG001|Overall Study|Lost to Follow-up|5|||
127967104|NCT00915018|460500744|FG000|Overall Study|Withdrawal by Subject|38|||
127967105|NCT00915018|460500745|FG001|Overall Study|Withdrawal by Subject|27|||
127967106|NCT00915018|460500744|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
127967107|NCT00915018|460500745|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
127967108|NCT00326716|460500746|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
127967109|NCT00326716|460500747|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
127967110|NCT00326716|460500748|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
127967111|NCT00326716|460500749|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
127967112|NCT00684411|460500750|FG000|Overall Study|New Primary Cancer|1|||
127967113|NCT00684411|460500750|FG000|Overall Study|Disease Progression|10|||
127967114|NCT00684411|460500750|FG000|Overall Study|Adverse Event|1|||
127967115|NCT05253573|460500751|FG000|Overall Study|Death|1|||
127967116|NCT05253573|460500752|FG001|Overall Study|Death|0|||
127967117|NCT02276560|460500754|FG000|Overall Study|Adverse Event|1|||
127967118|NCT02276560|460500755|FG001|Overall Study|Adverse Event|0|||
127967119|NCT02276560|460500756|FG002|Overall Study|Adverse Event|0|||
127967120|NCT02058537|460500757|FG000|Overall Study|Withdrawal by Subject|1|||
127967121|NCT01609010|460500758|FG000|Overall Study|Stable disease (SD)|22|||
127967122|NCT01609010|460500759|FG001|Overall Study|Stable disease (SD)|16|||
127967123|NCT01609010|460500758|FG000|Overall Study|Progressive disease (PD)|8|||
127967124|NCT01609010|460500759|FG001|Overall Study|Progressive disease (PD)|10|||
127967125|NCT01609010|460500758|FG000|Overall Study|Adverse Event|3|||
127967126|NCT01609010|460500759|FG001|Overall Study|Adverse Event|6|||
127967127|NCT01609010|460500758|FG000|Overall Study|Withdrawal by Subject|2|||
127967128|NCT01609010|460500759|FG001|Overall Study|Withdrawal by Subject|2|||
127967129|NCT01609010|460500758|FG000|Overall Study|Other|2|||
127967130|NCT01609010|460500759|FG001|Overall Study|Other|0|||
127967131|NCT01609010|460500758|FG000|Overall Study|Other malignancy|1|||
127967132|NCT01609010|460500759|FG001|Overall Study|Other malignancy|0|||
127967133|NCT01609010|460500758|FG000|Overall Study|Pathology review|2|||
127967134|NCT01609010|460500759|FG001|Overall Study|Pathology review|1|||
127967135|NCT01609010|460500758|FG000|Overall Study|Protocol Violation|1|||
127967136|NCT01609010|460500759|FG001|Overall Study|Protocol Violation|1|||
127967137|NCT01609010|460500758|FG000|Overall Study|New cancer|1|||
127967138|NCT01609010|460500759|FG001|Overall Study|New cancer|0|||
127967139|NCT01609010|460500758|FG000|Overall Study|Lost to Follow-up|1|||
127967140|NCT01609010|460500759|FG001|Overall Study|Lost to Follow-up|1|||
127967141|NCT00651261|460500760|FG000|Overall Study|Adverse Event|32|||
127967142|NCT00651261|460500761|FG001|Overall Study|Adverse Event|22|||
127967143|NCT00651261|460500760|FG000|Overall Study|Death|18|||
127967144|NCT00651261|460500761|FG001|Overall Study|Death|18|||
127967145|NCT00651261|460500760|FG000|Overall Study|Withdrawal by Subject|22|||
127967146|NCT00651261|460500761|FG001|Overall Study|Withdrawal by Subject|40|||
127967147|NCT00651261|460500760|FG000|Overall Study|Induction failure|24|||
127967148|NCT00651261|460500761|FG001|Overall Study|Induction failure|35|||
127967149|NCT00651261|460500760|FG000|Overall Study|Disease progression|58|||
127967150|NCT00651261|460500761|FG001|Overall Study|Disease progression|58|||
127967151|NCT00651261|460500760|FG000|Overall Study|Alternative therapy|109|||
127967152|NCT00651261|460500761|FG001|Overall Study|Alternative therapy|107|||
127967153|NCT00651261|460500760|FG000|Overall Study|Other disease or participant decisions|23|||
127967154|NCT00651261|460500761|FG001|Overall Study|Other disease or participant decisions|23|||
127967155|NCT00651261|460500760|FG000|Overall Study|Never treated|5|||
127967156|NCT00651261|460500761|FG001|Overall Study|Never treated|3|||
127967157|NCT00687271|460500762|FG000|Overall Study|Adverse Event|1|||
127967158|NCT00687271|460500763|FG001|Overall Study|Adverse Event|3|||
127967159|NCT00687271|460500764|FG002|Overall Study|Adverse Event|1|||
127967160|NCT00687271|460500765|FG003|Overall Study|Adverse Event|0|||
127967161|NCT00687271|460500762|FG000|Overall Study|Lost to Follow-up|0|||
127967162|NCT00687271|460500763|FG001|Overall Study|Lost to Follow-up|1|||
127967163|NCT00687271|460500764|FG002|Overall Study|Lost to Follow-up|0|||
127967164|NCT00687271|460500765|FG003|Overall Study|Lost to Follow-up|0|||
127967165|NCT00687271|460500762|FG000|Overall Study|Protocol Violation|2|||
127967166|NCT00687271|460500763|FG001|Overall Study|Protocol Violation|1|||
127967167|NCT00687271|460500764|FG002|Overall Study|Protocol Violation|1|||
127967168|NCT00687271|460500765|FG003|Overall Study|Protocol Violation|0|||
127967169|NCT00687271|460500762|FG000|Overall Study|Withdrawal by Subject|0|||
127967170|NCT00687271|460500763|FG001|Overall Study|Withdrawal by Subject|1|||
127967171|NCT00687271|460500764|FG002|Overall Study|Withdrawal by Subject|3|||
127967172|NCT00687271|460500765|FG003|Overall Study|Withdrawal by Subject|0|||
127967173|NCT05483686|460500767|FG000|Overall Study|Lost to Follow-up|5|||
127967174|NCT05483686|460500768|FG001|Overall Study|Lost to Follow-up|7|||
127967175|NCT03351608|460500772|FG000|Overall Study|Lost to Follow-up|0|||
127967176|NCT03351608|460500773|FG001|Overall Study|Lost to Follow-up|1|||
127967177|NCT03351608|460500774|FG002|Overall Study|Lost to Follow-up|1|||
127967178|NCT03351608|460500775|FG003|Overall Study|Lost to Follow-up|1|||
127967179|NCT03351608|460500776|FG004|Overall Study|Lost to Follow-up|1|||
127967180|NCT03351608|460500772|FG000|Overall Study|Physician Decision|1|||
127967181|NCT03351608|460500773|FG001|Overall Study|Physician Decision|0|||
127967182|NCT03351608|460500774|FG002|Overall Study|Physician Decision|0|||
127967183|NCT03351608|460500775|FG003|Overall Study|Physician Decision|2|||
127967184|NCT03351608|460500776|FG004|Overall Study|Physician Decision|1|||
127967185|NCT03351608|460500772|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
127967186|NCT03351608|460500773|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
127967187|NCT03351608|460500774|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
127967188|NCT03351608|460500775|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
127967189|NCT03351608|460500776|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
127967190|NCT03351608|460500772|FG000|Overall Study|Withdrawal by parent/guardian|0|||
127967191|NCT03351608|460500773|FG001|Overall Study|Withdrawal by parent/guardian|0|||
127967192|NCT03351608|460500774|FG002|Overall Study|Withdrawal by parent/guardian|1|||
127967193|NCT03351608|460500775|FG003|Overall Study|Withdrawal by parent/guardian|1|||
127967194|NCT03351608|460500776|FG004|Overall Study|Withdrawal by parent/guardian|0|||
127967195|NCT03351608|460500772|FG000|Overall Study|Other|0|||
127967196|NCT03351608|460500773|FG001|Overall Study|Other|1|||
127967197|NCT03351608|460500774|FG002|Overall Study|Other|1|||
127967198|NCT03351608|460500775|FG003|Overall Study|Other|3|||
127967199|NCT03351608|460500776|FG004|Overall Study|Other|0|||
127967200|NCT02727478|460500777|FG000|Overall Study|Withdrawal by Subject|8|||
127967201|NCT02727478|460500778|FG001|Overall Study|Withdrawal by Subject|10|||
127967202|NCT00808210|460500779|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
127967203|NCT00808210|460500780|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
127967204|NCT00808210|460500779|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
127967205|NCT00808210|460500780|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
127967206|NCT00808210|460500779|FG000|Double-Blind TX Period|Adverse Event|0|||
127967207|NCT00808210|460500780|FG001|Double-Blind TX Period|Adverse Event|1|||
127967208|NCT00808210|460500779|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
127967209|NCT00808210|460500780|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
127967210|NCT00808210|460500779|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
127967211|NCT00808210|460500780|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
127967212|NCT00808210|460500779|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
127967213|NCT00808210|460500780|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
127967214|NCT03877068|460500784|FG000|Overall Study|Physician Decision|9|||
127967215|NCT03877068|460500785|FG001|Overall Study|Physician Decision|3|||
127967216|NCT02019264|460500786|FG000|Overall Study|Not treated|6|||
127967217|NCT02019264|460500787|FG001|Overall Study|Not treated|4|||
127967218|NCT02019264|460500786|FG000|Overall Study|Lost to Follow-up|50|||
127967219|NCT02019264|460500787|FG001|Overall Study|Lost to Follow-up|47|||
127967220|NCT02019264|460500786|FG000|Overall Study|Withdrawal by Subject|142|||
127967221|NCT02019264|460500787|FG001|Overall Study|Withdrawal by Subject|117|||
127967222|NCT02019264|460500786|FG000|Overall Study|Administrative reason|36|||
127967223|NCT02019264|460500787|FG001|Overall Study|Administrative reason|28|||
127967224|NCT02019264|460500786|FG000|Overall Study|Missing|14|||
127967225|NCT02019264|460500787|FG001|Overall Study|Missing|11|||
127967226|NCT03850496|460500795|FG000|Overall Study|Withdrawal by Subject|1|||
127967227|NCT03850496|460500796|FG001|Overall Study|Withdrawal by Subject|0|||
127967228|NCT03850496|460500797|FG002|Overall Study|Withdrawal by Subject|0|||
127967229|NCT03850496|460500795|FG000|Overall Study|Lost to Follow-up|0|||
127967230|NCT03850496|460500796|FG001|Overall Study|Lost to Follow-up|1|||
127967231|NCT03850496|460500797|FG002|Overall Study|Lost to Follow-up|4|||
127967232|NCT01814696|460500798|FG000|Overall Study|Withdrawal by Subject|1|||
127967233|NCT01814696|460500799|FG001|Overall Study|Withdrawal by Subject|0|||
127967234|NCT01814696|460500798|FG000|Overall Study|Randomized to wrong group|1|||
127967235|NCT01814696|460500799|FG001|Overall Study|Randomized to wrong group|0|||
127967236|NCT00488644|460500809|FG000|Overall Study|Not Eligible|1|||
127967237|NCT00488644|460500809|FG000|Overall Study|Not Evaluable|1|||
127967238|NCT02977572|460500810|FG000|Overall Study|Exclusion criterion|2|||
127967239|NCT02977572|460500811|FG001|Overall Study|Exclusion criterion|2|||
127967240|NCT01197534|460500813|FG000|Overall Study|Not reported|16|||
127967241|NCT01197534|460500814|FG001|Overall Study|Not reported|10|||
127967242|NCT01197534|460500815|FG002|Overall Study|Not reported|16|||
127967243|NCT01197534|460500813|FG000|Overall Study|Enrolment in long term extension|57|||
127967244|NCT01197534|460500814|FG001|Overall Study|Enrolment in long term extension|66|||
127967245|NCT01197534|460500815|FG002|Overall Study|Enrolment in long term extension|119|||
127967246|NCT01197534|460500813|FG000|Overall Study|Severe non-compliance to protocol|3|||
127967247|NCT01197534|460500814|FG001|Overall Study|Severe non-compliance to protocol|4|||
127967248|NCT01197534|460500815|FG002|Overall Study|Severe non-compliance to protocol|1|||
127967249|NCT01197534|460500813|FG000|Overall Study|Lack of therapeutic response|9|||
127967250|NCT01197534|460500814|FG001|Overall Study|Lack of therapeutic response|4|||
127967251|NCT01197534|460500815|FG002|Overall Study|Lack of therapeutic response|9|||
127967252|NCT01197534|460500813|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
127967253|NCT01197534|460500814|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
127967254|NCT01197534|460500815|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
127967255|NCT01197534|460500813|FG000|Overall Study|Lost to Follow-up|1|||
127967256|NCT01197534|460500814|FG001|Overall Study|Lost to Follow-up|4|||
127967257|NCT01197534|460500815|FG002|Overall Study|Lost to Follow-up|2|||
127967258|NCT01197534|460500813|FG000|Overall Study|Adverse Event|35|||
127967259|NCT01197534|460500814|FG001|Overall Study|Adverse Event|36|||
127967260|NCT01197534|460500815|FG002|Overall Study|Adverse Event|24|||
127967261|NCT02589639|460500827|FG000|Overall Study|Lost to Follow-up|1|||
127967262|NCT02589639|460500828|FG001|Overall Study|Lost to Follow-up|0|||
127967263|NCT02589639|460500829|FG002|Overall Study|Lost to Follow-up|0|||
127967264|NCT02589639|460500827|FG000|Overall Study|Protocol Violation|1|||
127967265|NCT02589639|460500828|FG001|Overall Study|Protocol Violation|0|||
127967266|NCT02589639|460500829|FG002|Overall Study|Protocol Violation|0|||
127967267|NCT02589639|460500827|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
127967268|NCT02589639|460500828|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
127967269|NCT02589639|460500829|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
127967270|NCT02589639|460500827|FG000|Overall Study|Adverse Event|4|||
127967271|NCT02589639|460500828|FG001|Overall Study|Adverse Event|5|||
127967272|NCT02589639|460500829|FG002|Overall Study|Adverse Event|3|||
127967273|NCT02589639|460500827|FG000|Overall Study|Other reason than specified above|1|||
127967274|NCT02589639|460500828|FG001|Overall Study|Other reason than specified above|2|||
127967275|NCT02589639|460500829|FG002|Overall Study|Other reason than specified above|1|||
127967276|NCT02589639|460500827|FG000|Overall Study|Not Treated|0|||
127967277|NCT02589639|460500828|FG001|Overall Study|Not Treated|3|||
127967278|NCT02589639|460500829|FG002|Overall Study|Not Treated|0|||
127967279|NCT02593097|460500832|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
127967280|NCT02593097|460500833|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
127967281|NCT02593097|460500832|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
127967282|NCT02593097|460500833|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
127967283|NCT02593097|460500832|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
127967284|NCT02593097|460500833|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
127967285|NCT02593097|460500832|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
127967286|NCT02593097|460500833|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
127967287|NCT02593097|460500832|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
127967288|NCT02593097|460500833|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
127967289|NCT00703157|460500834|FG000|Overall Study|Lost to Follow-up|0|||
127967290|NCT00703157|460500835|FG001|Overall Study|Lost to Follow-up|1|||
127967291|NCT00703157|460500834|FG000|Overall Study|source data permanently lost/ other|4|||
127967292|NCT00703157|460500835|FG001|Overall Study|source data permanently lost/ other|1|||
127967293|NCT02522884|460500836|FG000|Overall Study|Withdrawal by Subject|6|||
127967294|NCT02522884|460500836|FG000|Overall Study|Death|3|||
127967295|NCT02522884|460500836|FG000|Overall Study|Missed 12-month Follow-up|9|||
127967296|NCT02630251|460500837|FG000|Overall Study|Physician Decision|0|||
127967297|NCT02630251|460500838|FG001|Overall Study|Physician Decision|0|||
127967298|NCT02630251|460500839|FG002|Overall Study|Physician Decision|1|||
127967299|NCT02630251|460500840|FG003|Overall Study|Physician Decision|0|||
127967300|NCT02968173|460500841|FG000|Overall Study|Withdrawal by Subject|1|||
127967301|NCT02670525|460500842|FG000|Overall Study|Death|94|||
127967302|NCT02670525|460500843|FG001|Overall Study|Death|14|||
127967303|NCT02670525|460500842|FG000|Overall Study|Lost to Follow-up|4|||
127967304|NCT02670525|460500843|FG001|Overall Study|Lost to Follow-up|1|||
127967305|NCT02670525|460500842|FG000|Overall Study|Subject withdrew consent|1|||
127967306|NCT02670525|460500843|FG001|Overall Study|Subject withdrew consent|0|||
127967307|NCT02670525|460500842|FG000|Overall Study|Unknown, data entry delayed|123|||
127967308|NCT02670525|460500843|FG001|Overall Study|Unknown, data entry delayed|78|||
127967309|NCT00591565|460500844|FG000|Overall Study|lost follow up, withdrawn|5|||
127967310|NCT03564119|460500848|FG000|Overall Study|Adverse Event|4|||
127967311|NCT03564119|460500849|FG001|Overall Study|Adverse Event|0|||
127967312|NCT03564119|460500848|FG000|Overall Study|Lost to Follow-up|1|||
127967313|NCT03564119|460500849|FG001|Overall Study|Lost to Follow-up|4|||
127967314|NCT03564119|460500848|FG000|Overall Study|Protocol Violation|1|||
127967315|NCT03564119|460500849|FG001|Overall Study|Protocol Violation|0|||
127967316|NCT03564119|460500848|FG000|Overall Study|Withdrawal by Subject|9|||
127967317|NCT03564119|460500849|FG001|Overall Study|Withdrawal by Subject|4|||
127967318|NCT03564119|460500848|FG000|Overall Study|Other Than Specified|0|||
127967319|NCT03564119|460500849|FG001|Overall Study|Other Than Specified|1|||
127967320|NCT00634036|460500850|FG000|Overall Study|Lost to Follow-up|1|||
127967321|NCT00634036|460500851|FG001|Overall Study|Lost to Follow-up|1|||
127967322|NCT00634036|460500850|FG000|Overall Study|Withdrawal by Subject|1|||
127967323|NCT00634036|460500851|FG001|Overall Study|Withdrawal by Subject|1|||
127967324|NCT03896022|460500857|FG000|Overall Study|Withdrawal by Subject|1|||
127967325|NCT03896022|460500858|FG001|Overall Study|Withdrawal by Subject|0|||
127967326|NCT03896022|460500859|FG002|Overall Study|Withdrawal by Subject|0|||
127967327|NCT03896022|460500857|FG000|Overall Study|Did not have procedure|3|||
127967328|NCT03896022|460500858|FG001|Overall Study|Did not have procedure|0|||
127967329|NCT03896022|460500859|FG002|Overall Study|Did not have procedure|0|||
127967330|NCT00314327|460500864|FG000|Overall Study|Withdrawal by Subject|1|||
127967331|NCT02741076|460500865|FG000|Overall Study|Adverse Event|0|||
127967332|NCT02741076|460500866|FG001|Overall Study|Adverse Event|1|||
127967333|NCT02741076|460500867|FG002|Overall Study|Adverse Event|1|||
127967334|NCT02741076|460500868|FG003|Overall Study|Adverse Event|0|||
127967335|NCT02741076|460500865|FG000|Overall Study|Lack of Efficacy|1|||
127967336|NCT02741076|460500866|FG001|Overall Study|Lack of Efficacy|0|||
127967337|NCT02741076|460500867|FG002|Overall Study|Lack of Efficacy|0|||
127967338|NCT02741076|460500868|FG003|Overall Study|Lack of Efficacy|0|||
127967339|NCT02741076|460500865|FG000|Overall Study|Withdrawal by Subject|0|||
127967340|NCT02741076|460500866|FG001|Overall Study|Withdrawal by Subject|1|||
127967341|NCT02741076|460500867|FG002|Overall Study|Withdrawal by Subject|0|||
127967342|NCT02741076|460500868|FG003|Overall Study|Withdrawal by Subject|0|||
127967343|NCT02741076|460500865|FG000|Overall Study|Sponsor Request|2|||
127967344|NCT02741076|460500866|FG001|Overall Study|Sponsor Request|3|||
127967345|NCT02741076|460500867|FG002|Overall Study|Sponsor Request|0|||
127967346|NCT02741076|460500868|FG003|Overall Study|Sponsor Request|1|||
127967347|NCT02741076|460500865|FG000|Overall Study|No additional information available|0|||
127967348|NCT02741076|460500866|FG001|Overall Study|No additional information available|0|||
127967349|NCT02741076|460500867|FG002|Overall Study|No additional information available|1|||
127967350|NCT02741076|460500868|FG003|Overall Study|No additional information available|1|||
127967351|NCT02965573|460500871|FG000|Overall Study|Lack of Efficacy|1|||
127967352|NCT02965573|460500872|FG001|Overall Study|Lack of Efficacy|0|||
127967353|NCT00987337|460500873|FG000|Overall Study|Adverse Event|10|||
127967354|NCT00987337|460500874|FG001|Overall Study|Adverse Event|9|||
127967355|NCT00987337|460500875|FG002|Overall Study|Adverse Event|8|||
127967356|NCT00987337|460500873|FG000|Overall Study|Insufficient Virologic Response|10|||
127967357|NCT00987337|460500874|FG001|Overall Study|Insufficient Virologic Response|7|||
127967358|NCT00987337|460500875|FG002|Overall Study|Insufficient Virologic Response|12|||
127967359|NCT00987337|460500873|FG000|Overall Study|Virologic Breakthrough|2|||
127967360|NCT00987337|460500874|FG001|Overall Study|Virologic Breakthrough|2|||
127967361|NCT00987337|460500875|FG002|Overall Study|Virologic Breakthrough|8|||
127967362|NCT00987337|460500873|FG000|Overall Study|Lost to Follow-up|10|||
127967363|NCT00987337|460500874|FG001|Overall Study|Lost to Follow-up|6|||
127967364|NCT00987337|460500875|FG002|Overall Study|Lost to Follow-up|2|||
127967365|NCT00987337|460500873|FG000|Overall Study|Withdrawal by Subject|6|||
127967366|NCT00987337|460500874|FG001|Overall Study|Withdrawal by Subject|9|||
127967367|NCT00987337|460500875|FG002|Overall Study|Withdrawal by Subject|9|||
127967368|NCT00987337|460500873|FG000|Overall Study|Other|0|||
127967369|NCT00987337|460500874|FG001|Overall Study|Other|2|||
127967370|NCT00987337|460500875|FG002|Overall Study|Other|5|||
127967371|NCT00987337|460500873|FG000|Overall Study|Protocol Violation|1|||
127967372|NCT00987337|460500874|FG001|Overall Study|Protocol Violation|0|||
127967373|NCT00987337|460500875|FG002|Overall Study|Protocol Violation|2|||
127967374|NCT00987337|460500873|FG000|Overall Study|Participant Relapsed|18|||
127967375|NCT00987337|460500874|FG001|Overall Study|Participant Relapsed|20|||
127967376|NCT00987337|460500875|FG002|Overall Study|Participant Relapsed|5|||
127967377|NCT00086619|460500877|FG000|Overall Study|Withdrawal by Subject|6|||
127967378|NCT00086619|460500878|FG001|Overall Study|Withdrawal by Subject|6|||
127967379|NCT00086619|460500877|FG000|Overall Study|Adverse Event|8|||
127967380|NCT00086619|460500878|FG001|Overall Study|Adverse Event|10|||
127967381|NCT00086619|460500877|FG000|Overall Study|Protocol Violation|1|||
127967382|NCT00086619|460500878|FG001|Overall Study|Protocol Violation|1|||
127967383|NCT00489918|460500879|FG000|Overall Study|Withdrawal by Subject|2|||
127967384|NCT00489918|460500880|FG001|Overall Study|Withdrawal by Subject|1|||
127967385|NCT00489918|460500881|FG002|Overall Study|Withdrawal by Subject|1|||
127967386|NCT00489918|460500882|FG003|Overall Study|Withdrawal by Subject|0|||
127967387|NCT00489918|460500883|FG004|Overall Study|Withdrawal by Subject|1|||
127967388|NCT00489918|460500879|FG000|Overall Study|Adverse Event|0|||
127967389|NCT00489918|460500880|FG001|Overall Study|Adverse Event|1|||
127967390|NCT00489918|460500881|FG002|Overall Study|Adverse Event|1|||
127967391|NCT00489918|460500882|FG003|Overall Study|Adverse Event|0|||
127967392|NCT00489918|460500883|FG004|Overall Study|Adverse Event|0|||
127967393|NCT00489918|460500879|FG000|Overall Study|Lost to Follow-up|0|||
127967394|NCT00489918|460500880|FG001|Overall Study|Lost to Follow-up|0|||
127967395|NCT00489918|460500881|FG002|Overall Study|Lost to Follow-up|1|||
127967396|NCT00489918|460500882|FG003|Overall Study|Lost to Follow-up|1|||
127967397|NCT00489918|460500883|FG004|Overall Study|Lost to Follow-up|0|||
127967398|NCT00489918|460500879|FG000|Overall Study|Physician Decision|0|||
127967399|NCT00489918|460500880|FG001|Overall Study|Physician Decision|0|||
127967400|NCT00489918|460500881|FG002|Overall Study|Physician Decision|1|||
127967401|NCT00489918|460500882|FG003|Overall Study|Physician Decision|0|||
127967402|NCT00489918|460500883|FG004|Overall Study|Physician Decision|0|||
127967403|NCT02748213|460500884|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
127967404|NCT02748213|460500885|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
127967405|NCT02748213|460500884|FG000|Overall Study|Abnormal Laboratory Test|1|||
127967406|NCT02748213|460500885|FG001|Overall Study|Abnormal Laboratory Test|0|||
127967407|NCT02748213|460500884|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
127967408|NCT02748213|460500885|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
127967409|NCT02748213|460500884|FG000|Overall Study|Death|5|||
127967410|NCT02748213|460500885|FG001|Overall Study|Death|3|||
127967411|NCT02748213|460500884|FG000|Overall Study|Insufficient Therapeutic Response|56|||
127967412|NCT02748213|460500885|FG001|Overall Study|Insufficient Therapeutic Response|57|||
127967413|NCT02748213|460500884|FG000|Overall Study|Violation of Selection Criteria|2|||
127967414|NCT02748213|460500885|FG001|Overall Study|Violation of Selection Criteria|0|||
127967415|NCT02748213|460500884|FG000|Overall Study|Protocol Violation|6|||
127967416|NCT02748213|460500885|FG001|Overall Study|Protocol Violation|4|||
127967417|NCT02748213|460500884|FG000|Overall Study|Refused Treatment*|6|||
127967418|NCT02748213|460500885|FG001|Overall Study|Refused Treatment*|6|||
127967419|NCT02748213|460500884|FG000|Overall Study|Failure to Return|1|||
127967420|NCT02748213|460500885|FG001|Overall Study|Failure to Return|0|||
127967421|NCT02748213|460500884|FG000|Overall Study|Other|30|||
127967422|NCT02748213|460500885|FG001|Overall Study|Other|29|||
127967423|NCT01209520|460500886|FG000|Overall Study|Withdrawal by Subject|3|||
127967424|NCT00961350|460500887|FG000|Overall Study|Adverse Event|18|||
127967425|NCT00961350|460500888|FG001|Overall Study|Adverse Event|33|||
127967426|NCT00961350|460500887|FG000|Overall Study|Withdrawal by Subject|10|||
127967427|NCT00961350|460500888|FG001|Overall Study|Withdrawal by Subject|10|||
127967428|NCT00961350|460500887|FG000|Overall Study|Lost to Follow-up|3|||
127967429|NCT00961350|460500888|FG001|Overall Study|Lost to Follow-up|3|||
127967430|NCT00961350|460500887|FG000|Overall Study|Misc|16|||
127967431|NCT00961350|460500888|FG001|Overall Study|Misc|21|||
127967432|NCT02134015|460500889|FG000|Overall Study|Protocol Violation|0|||
127967433|NCT02134015|460500890|FG001|Overall Study|Protocol Violation|1|||
127967434|NCT02134015|460500889|FG000|Overall Study|Death|2|||
127967435|NCT02134015|460500890|FG001|Overall Study|Death|1|||
127967436|NCT02134015|460500889|FG000|Overall Study|Reason not provided|1|||
127967437|NCT02134015|460500890|FG001|Overall Study|Reason not provided|2|||
127967438|NCT02134015|460500889|FG000|Overall Study|Clinical progression|14|||
127967439|NCT02134015|460500890|FG001|Overall Study|Clinical progression|7|||
127967440|NCT02134015|460500889|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
127967441|NCT02134015|460500890|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
127967442|NCT02134015|460500889|FG000|Overall Study|Study terminated by sponsor|2|||
127967443|NCT02134015|460500890|FG001|Overall Study|Study terminated by sponsor|3|||
127967444|NCT02134015|460500889|FG000|Overall Study|Adverse Event|9|||
127967445|NCT02134015|460500890|FG001|Overall Study|Adverse Event|10|||
127967446|NCT02134015|460500889|FG000|Overall Study|Withdrawal by Subject|3|||
127967447|NCT02134015|460500890|FG001|Overall Study|Withdrawal by Subject|7|||
127967448|NCT00617890|460502790|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
127967449|NCT00617890|460502791|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
127967450|NCT00617890|460502792|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
127967451|NCT00617890|460502793|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
127967452|NCT00617890|460502790|FG000|Overall Study|Lack of Efficacy|23|||
127967453|NCT00617890|460502791|FG001|Overall Study|Lack of Efficacy|26|||
127967454|NCT00617890|460502792|FG002|Overall Study|Lack of Efficacy|30|||
127967455|NCT00617890|460502793|FG003|Overall Study|Lack of Efficacy|97|||
127967456|NCT00617890|460502790|FG000|Overall Study|Lost to Follow-up|0|||
127967457|NCT00617890|460502791|FG001|Overall Study|Lost to Follow-up|0|||
127967458|NCT00617890|460502792|FG002|Overall Study|Lost to Follow-up|1|||
127967459|NCT00617890|460502793|FG003|Overall Study|Lost to Follow-up|2|||
127967460|NCT00617890|460502790|FG000|Overall Study|Withdrawal by Subject|4|||
127967461|NCT00617890|460502791|FG001|Overall Study|Withdrawal by Subject|1|||
127967462|NCT00617890|460502792|FG002|Overall Study|Withdrawal by Subject|0|||
127967463|NCT00617890|460502793|FG003|Overall Study|Withdrawal by Subject|2|||
127967464|NCT00617890|460502790|FG000|Overall Study|Protocol Violation|2|||
127967465|NCT00617890|460502791|FG001|Overall Study|Protocol Violation|1|||
127967466|NCT00617890|460502792|FG002|Overall Study|Protocol Violation|0|||
127967467|NCT00617890|460502793|FG003|Overall Study|Protocol Violation|0|||
127967468|NCT00617890|460502790|FG000|Overall Study|Adverse Event|1|||
127967469|NCT00617890|460502791|FG001|Overall Study|Adverse Event|0|||
127967470|NCT00617890|460502792|FG002|Overall Study|Adverse Event|3|||
127967471|NCT00617890|460502793|FG003|Overall Study|Adverse Event|8|||
127967472|NCT00617890|460502790|FG000|Overall Study|Not treated|1|||
127967473|NCT00617890|460502791|FG001|Overall Study|Not treated|0|||
127967474|NCT00617890|460502792|FG002|Overall Study|Not treated|1|||
127967475|NCT00617890|460502793|FG003|Overall Study|Not treated|1|||
127967476|NCT02640950|460502795|FG000|Overall Study|Adverse Event|1|||
127967477|NCT02640950|460502795|FG000|Overall Study|Withdrawal by Subject|1|||
127967478|NCT00154284|460502796|FG000|Overall Study|Adverse Event|6|||
127967479|NCT00154284|460502797|FG001|Overall Study|Adverse Event|9|||
127967480|NCT00154284|460502796|FG000|Overall Study|Abnormal laboratory value(s)|0|||
127967481|NCT00154284|460502797|FG001|Overall Study|Abnormal laboratory value(s)|1|||
127967482|NCT00154284|460502796|FG000|Overall Study|Lack of Efficacy|1|||
127967483|NCT00154284|460502797|FG001|Overall Study|Lack of Efficacy|2|||
127967484|NCT00154284|460502796|FG000|Overall Study|Protocol Violation|0|||
127967485|NCT00154284|460502797|FG001|Overall Study|Protocol Violation|1|||
127967486|NCT00566020|460502798|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
127967487|NCT00566020|460502799|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
127967488|NCT00566020|460502798|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
127967489|NCT00566020|460502799|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
127967490|NCT00566020|460502798|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
127967491|NCT00566020|460502799|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
127967492|NCT00566020|460502798|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
127967493|NCT00566020|460502799|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
127967494|NCT00566020|460502798|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
127967495|NCT00566020|460502799|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
127967496|NCT00566020|460502798|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
127967497|NCT00566020|460502799|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
127967498|NCT04134767|460502800|FG000|Overall Study|Death|0|||
127967499|NCT04134767|460502801|FG001|Overall Study|Death|1|||
127967500|NCT04134767|460502800|FG000|Overall Study|Removed for harassing staff|0|||
127967501|NCT04134767|460502801|FG001|Overall Study|Removed for harassing staff|1|||
127967502|NCT04134767|460502800|FG000|Overall Study|Lost to Follow-up|44|||
127967503|NCT04134767|460502801|FG001|Overall Study|Lost to Follow-up|40|||
127967504|NCT00300885|460502802|FG000|Treatment|Adverse Event|134|||
127967505|NCT00300885|460502803|FG001|Treatment|Adverse Event|82|||
127967506|NCT00300885|460502802|FG000|Treatment|Death|20|||
127967507|NCT00300885|460502803|FG001|Treatment|Death|7|||
127967508|NCT00300885|460502802|FG000|Treatment|Lack of Efficacy|1|||
127967509|NCT00300885|460502803|FG001|Treatment|Lack of Efficacy|1|||
127967510|NCT00300885|460502802|FG000|Treatment|Lost to Follow-up|3|||
127967511|NCT00300885|460502803|FG001|Treatment|Lost to Follow-up|2|||
127967512|NCT00300885|460502802|FG000|Treatment|Physician Decision|4|||
127967513|NCT00300885|460502803|FG001|Treatment|Physician Decision|5|||
127967514|NCT00300885|460502802|FG000|Treatment|Protocol Violation|11|||
127967515|NCT00300885|460502803|FG001|Treatment|Protocol Violation|11|||
127967516|NCT00300885|460502802|FG000|Treatment|Withdrawal by Subject|26|||
127967517|NCT00300885|460502803|FG001|Treatment|Withdrawal by Subject|23|||
127967518|NCT00300885|460502802|FG000|Treatment|Disease progression|171|||
127967519|NCT00300885|460502803|FG001|Treatment|Disease progression|238|||
127967520|NCT00300885|460502802|FG000|Treatment|Random code broken (subject died)|0|||
127967521|NCT00300885|460502803|FG001|Treatment|Random code broken (subject died)|1|||
127967522|NCT00300885|460502802|FG000|Treatment|Non-compliant with study medication|3|||
127967523|NCT00300885|460502803|FG001|Treatment|Non-compliant with study medication|4|||
127967524|NCT00300885|460502802|FG000|Follow-up|Death|141|||
127967525|NCT00300885|460502803|FG001|Follow-up|Death|163|||
127967526|NCT00300885|460502802|FG000|Follow-up|Lost to Follow-up|11|||
127967527|NCT00300885|460502803|FG001|Follow-up|Lost to Follow-up|7|||
127967528|NCT00300885|460502802|FG000|Follow-up|Withdrawal by Subject|26|||
127967529|NCT00300885|460502803|FG001|Follow-up|Withdrawal by Subject|25|||
127967530|NCT02366637|460502807|FG000|First Intervention Period|Adverse Event|0|||
127967531|NCT02366637|460502808|FG001|First Intervention Period|Adverse Event|1|||
127967532|NCT02366637|460502807|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
127967533|NCT02366637|460502808|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
127967534|NCT02366637|460502807|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
127967535|NCT02366637|460502808|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
127967536|NCT02309411|460502814|FG000|Overall Study|Physician Decision|1|||
127967537|NCT02309411|460502815|FG001|Overall Study|Physician Decision|0|||
127967538|NCT02309411|460502816|FG002|Overall Study|Physician Decision|0|||
127967539|NCT02309411|460502814|FG000|Overall Study|Withdrawal by Subject|1|||
127967540|NCT02309411|460502815|FG001|Overall Study|Withdrawal by Subject|1|||
127967541|NCT02309411|460502816|FG002|Overall Study|Withdrawal by Subject|0|||
127967542|NCT03656692|460502817|FG000|Overall Study|Worsening of disease activity|2|||
127967543|NCT03656692|460502817|FG000|Overall Study|Physician Decision|1|||
127967544|NCT01134107|460502818|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
127967545|NCT01134107|460502819|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
127967546|NCT01134107|460502818|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
127967547|NCT01134107|460502819|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
127967548|NCT01134107|460502818|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
127967549|NCT01134107|460502819|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
127967550|NCT01134107|460502818|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
127967551|NCT01134107|460502819|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
127967552|NCT01134107|460502818|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
127967553|NCT01134107|460502819|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
127967554|NCT01134107|460502818|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
127967555|NCT01134107|460502819|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
127967556|NCT01134107|460502818|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
127967557|NCT01134107|460502819|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
127967558|NCT01372618|460502830|FG000|Overall Study|PI Died. Study Terminated|9|||
127967559|NCT02801617|460502831|FG000|Overall Study|Protocol Violation|2|||
127967560|NCT02801617|460502832|FG001|Overall Study|Protocol Violation|6|||
127967561|NCT01954056|460502833|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
127967562|NCT01954056|460502834|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
127967563|NCT06110494|460502835|FG000|Overall Study|Protocol Violation|2|||
127967564|NCT06110494|460502836|FG001|Overall Study|Protocol Violation|0|||
127967565|NCT06110494|460502837|FG002|Overall Study|Protocol Violation|1|||
127967566|NCT06110494|460502835|FG000|Overall Study|Dixon's test for outlier analysis|1|||
127967567|NCT06110494|460502836|FG001|Overall Study|Dixon's test for outlier analysis|1|||
127967568|NCT06110494|460502837|FG002|Overall Study|Dixon's test for outlier analysis|0|||
127967569|NCT02914613|460502838|FG000|Overall Study|Withdrawal by Subject|1|||
127967570|NCT02914613|460502839|FG001|Overall Study|Withdrawal by Subject|2|||
127967571|NCT02914613|460502838|FG000|Overall Study|Adverse Event|1|||
127967572|NCT02914613|460502839|FG001|Overall Study|Adverse Event|0|||
127967573|NCT03777436|460502848|FG000|Placebo-controlled Phase|Adverse Event|8|||
127967574|NCT03777436|460502849|FG001|Placebo-controlled Phase|Adverse Event|10|||
127967575|NCT03777436|460502850|FG002|Placebo-controlled Phase|Adverse Event|0|||
127967576|NCT03777436|460502848|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
127967577|NCT03777436|460502849|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
127967578|NCT03777436|460502850|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
127967579|NCT03777436|460502848|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
127967580|NCT03777436|460502849|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
127967581|NCT03777436|460502850|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
127967582|NCT03777436|460502848|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
127967583|NCT03777436|460502849|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
127967584|NCT03777436|460502850|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
127967585|NCT03777436|460502848|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
127967586|NCT03777436|460502849|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
127967587|NCT03777436|460502850|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
127967588|NCT03777436|460502848|FG000|Placebo-controlled Phase|Physician Decision|0|||
127967589|NCT03777436|460502849|FG001|Placebo-controlled Phase|Physician Decision|1|||
127967590|NCT03777436|460502850|FG002|Placebo-controlled Phase|Physician Decision|0|||
127967591|NCT03777436|460502848|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
127967592|NCT03777436|460502849|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
127967593|NCT03777436|460502850|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
127967594|NCT03777436|460502848|FG000|Apremilast Extension Phase|Adverse Event|0|||
127967595|NCT03777436|460502849|FG001|Apremilast Extension Phase|Adverse Event|0|||
127967596|NCT03777436|460502850|FG002|Apremilast Extension Phase|Adverse Event|6|||
127967597|NCT03777436|460502848|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
127967598|NCT03777436|460502849|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
127967599|NCT03777436|460502850|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
127967600|NCT03777436|460502848|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
127967601|NCT03777436|460502849|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
127967602|NCT03777436|460502850|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
127967603|NCT03777436|460502848|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
127967604|NCT03777436|460502849|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
127967605|NCT03777436|460502850|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
127967606|NCT03777436|460502848|FG000|Apremilast Extension Phase|Miscellaneous|0|||
127967607|NCT03777436|460502849|FG001|Apremilast Extension Phase|Miscellaneous|0|||
127967608|NCT03777436|460502850|FG002|Apremilast Extension Phase|Miscellaneous|1|||
127967609|NCT00869999|460502856|FG000|Overall Study|Withdrawal by Subject|1|||
127967610|NCT00869999|460502856|FG000|Overall Study|removed prior to starting therapy|1|||
127967611|NCT04478695|460502857|FG000|Overall Study|Death|1|||
127967612|NCT04478695|460502858|FG001|Overall Study|Death|0|||
127485497|NCT03768427|458741191|FG002|Overall Study|Withdrawal by Subject|6|||
127967613|NCT00644917|460502859|FG000|Overall Study|Withdrawal by Subject|2|||
127967614|NCT00758485|460502860|FG000|Overall Study|Lost to Follow-up|0|||
127967615|NCT00758485|460502861|FG001|Overall Study|Lost to Follow-up|1|||
127967616|NCT00758485|460502860|FG000|Overall Study|Not Treated|1|||
127967617|NCT00758485|460502861|FG001|Overall Study|Not Treated|2|||
127967618|NCT02347774|460502862|FG000|Study Participation|Lost to Follow-up|3|||
127967619|NCT02347774|460502863|FG001|Study Participation|Lost to Follow-up|6|||
127967620|NCT02347774|460502864|FG002|Study Participation|Lost to Follow-up|2|||
127967621|NCT02347774|460502862|FG000|Study Participation|Withdrawal by Subject|8|||
127967622|NCT02347774|460502863|FG001|Study Participation|Withdrawal by Subject|9|||
127967623|NCT02347774|460502864|FG002|Study Participation|Withdrawal by Subject|15|||
127967624|NCT02347774|460502862|FG000|Study Participation|Adverse Event|1|||
127967625|NCT02347774|460502863|FG001|Study Participation|Adverse Event|4|||
127967626|NCT02347774|460502864|FG002|Study Participation|Adverse Event|6|||
127967627|NCT02347774|460502862|FG000|Study Participation|withdrew consent|1|||
127967628|NCT02347774|460502863|FG001|Study Participation|withdrew consent|1|||
127967629|NCT02347774|460502864|FG002|Study Participation|withdrew consent|1|||
127967630|NCT02347774|460502862|FG000|Study Participation|Met Prolonged QT criteria|1|||
127967631|NCT02347774|460502863|FG001|Study Participation|Met Prolonged QT criteria|0|||
127967632|NCT02347774|460502864|FG002|Study Participation|Met Prolonged QT criteria|0|||
127967633|NCT02347774|460502862|FG000|Study Participation|non-compliance with study drug|0|||
127967634|NCT02347774|460502863|FG001|Study Participation|non-compliance with study drug|1|||
127967635|NCT02347774|460502864|FG002|Study Participation|non-compliance with study drug|0|||
127967636|NCT02347774|460502862|FG000|Study Participation|incarceration|1|||
127967637|NCT02347774|460502863|FG001|Study Participation|incarceration|0|||
127967638|NCT02347774|460502864|FG002|Study Participation|incarceration|0|||
127967639|NCT02347774|460502862|FG000|Study Participation|randomized in error|0|||
127967640|NCT02347774|460502863|FG001|Study Participation|randomized in error|0|||
127967641|NCT02347774|460502864|FG002|Study Participation|randomized in error|1|||
127967642|NCT02347774|460502862|FG000|On Study Treatment|Adverse Event|9|||
127967643|NCT02347774|460502863|FG001|On Study Treatment|Adverse Event|15|||
127967644|NCT02347774|460502864|FG002|On Study Treatment|Adverse Event|19|||
127967645|NCT02347774|460502862|FG000|On Study Treatment|Lack of Efficacy|3|||
127967646|NCT02347774|460502863|FG001|On Study Treatment|Lack of Efficacy|0|||
127967647|NCT02347774|460502864|FG002|On Study Treatment|Lack of Efficacy|2|||
127967648|NCT02347774|460502862|FG000|On Study Treatment|non-complicance with study medication|0|||
127967649|NCT02347774|460502863|FG001|On Study Treatment|non-complicance with study medication|2|||
127967650|NCT02347774|460502864|FG002|On Study Treatment|non-complicance with study medication|0|||
127967651|NCT02347774|460502862|FG000|On Study Treatment|Protocol Violation|0|||
127967652|NCT02347774|460502863|FG001|On Study Treatment|Protocol Violation|0|||
127967653|NCT02347774|460502864|FG002|On Study Treatment|Protocol Violation|1|||
127967654|NCT02347774|460502862|FG000|On Study Treatment|withdrew consent|9|||
127967655|NCT02347774|460502863|FG001|On Study Treatment|withdrew consent|8|||
127967656|NCT02347774|460502864|FG002|On Study Treatment|withdrew consent|12|||
127967657|NCT02347774|460502862|FG000|On Study Treatment|Lost to Follow-up|2|||
127967658|NCT02347774|460502863|FG001|On Study Treatment|Lost to Follow-up|6|||
127967659|NCT02347774|460502864|FG002|On Study Treatment|Lost to Follow-up|1|||
127967660|NCT02347774|460502862|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
127967661|NCT02347774|460502863|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
127967662|NCT02347774|460502864|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
127967663|NCT02347774|460502862|FG000|On Study Treatment|ranomized in error|0|||
127967664|NCT02347774|460502863|FG001|On Study Treatment|ranomized in error|0|||
127967665|NCT02347774|460502864|FG002|On Study Treatment|ranomized in error|1|||
127967666|NCT00921557|460502865|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
127967667|NCT00921557|460502866|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
127967668|NCT00921557|460502867|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
127967669|NCT00921557|460502865|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
127967670|NCT00921557|460502866|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
127967671|NCT00921557|460502867|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
127967672|NCT00921557|460502865|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
127967673|NCT00921557|460502866|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
127967674|NCT00921557|460502867|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
127967675|NCT00921557|460502865|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
127967676|NCT00921557|460502866|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
127967677|NCT00921557|460502867|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
127967678|NCT00921557|460502865|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
127967679|NCT00921557|460502866|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
127967680|NCT00921557|460502867|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
127967681|NCT00656292|460502868|FG000|Overall Study|Withdrawal by Subject|2|||
127967682|NCT00656292|460502869|FG001|Overall Study|Withdrawal by Subject|3|||
127967683|NCT00656292|460502868|FG000|Overall Study|Screen failure|1|||
127967684|NCT00656292|460502869|FG001|Overall Study|Screen failure|2|||
127967685|NCT04112043|460502870|FG000|Overall Study|Withdrawal by Subject|1|||
127967686|NCT04112043|460502871|FG001|Overall Study|Withdrawal by Subject|1|||
127967687|NCT04112043|460502872|FG002|Overall Study|Withdrawal by Subject|1|||
127967688|NCT04112043|460502870|FG000|Overall Study|Taking NR supplement|1|||
127967689|NCT04112043|460502871|FG001|Overall Study|Taking NR supplement|0|||
127967690|NCT04112043|460502872|FG002|Overall Study|Taking NR supplement|0|||
127967691|NCT04112043|460502870|FG000|Overall Study|Adverse Event|0|||
127967692|NCT04112043|460502871|FG001|Overall Study|Adverse Event|1|||
127967693|NCT04112043|460502872|FG002|Overall Study|Adverse Event|0|||
127967694|NCT04157296|460502873|FG000|Overall Study|Withdrawal by Subject|0|||
127967695|NCT04157296|460502874|FG001|Overall Study|Withdrawal by Subject|1|||
127967696|NCT04157296|460502873|FG000|Overall Study|Did not obtain second fMRI.|0|||
127967697|NCT04157296|460502874|FG001|Overall Study|Did not obtain second fMRI.|1|||
127967698|NCT04157296|460502873|FG000|Overall Study|MRI failed/no second fMRI|0|||
127967699|NCT04157296|460502874|FG001|Overall Study|MRI failed/no second fMRI|1|||
127967700|NCT03674112|460502877|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
127967701|NCT03674112|460502878|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
127967702|NCT03674112|460502877|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
127967703|NCT03674112|460502878|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
127967704|NCT03674112|460502877|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
127967705|NCT03674112|460502878|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
127967706|NCT03674112|460502877|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
127967707|NCT03674112|460502878|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
127967708|NCT03674112|460502877|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
127967709|NCT03674112|460502878|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
127967710|NCT03674112|460502877|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
127967711|NCT03674112|460502878|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
127967712|NCT03674112|460502877|FG000|Follow-Up Period (≥3 Years)|Death|2|||
127967713|NCT03674112|460502878|FG001|Follow-Up Period (≥3 Years)|Death|0|||
127967714|NCT03674112|460502877|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
127967715|NCT03674112|460502878|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
127967716|NCT02097238|460502881|FG000|Overall Study|Death|1|||
127967717|NCT02097238|460502881|FG000|Overall Study|Physician Decision|1|||
127967718|NCT02097238|460502881|FG000|Overall Study|Progressive Disease|17|||
127967719|NCT01106911|460502883|FG000|Overall Study|Physician Decision|2|||
127967720|NCT01106911|460502883|FG000|Overall Study|deemed ineligible after screening|3|||
127967721|NCT00954941|460502891|FG000|Overall Study|Received treatment at home|1|||
127967722|NCT00954941|460502892|FG001|Overall Study|Received treatment at home|0|||
127967723|NCT00954941|460502891|FG000|Overall Study|Withdrawal by Subject|1|||
127967724|NCT00954941|460502892|FG001|Overall Study|Withdrawal by Subject|0|||
127967725|NCT00954941|460502891|FG000|Overall Study|Insurance Denial|2|||
127967726|NCT00954941|460502892|FG001|Overall Study|Insurance Denial|2|||
127967727|NCT00954941|460502891|FG000|Overall Study|Physician Decision|2|||
127967728|NCT00954941|460502892|FG001|Overall Study|Physician Decision|2|||
127967729|NCT00954941|460502891|FG000|Overall Study|Ineligible|2|||
127967730|NCT00954941|460502892|FG001|Overall Study|Ineligible|2|||
127967731|NCT00954941|460502891|FG000|Overall Study|Adverse Event|0|||
127967732|NCT00954941|460502892|FG001|Overall Study|Adverse Event|1|||
127967733|NCT00984542|460502904|FG000|Overall Study|disease progression|19|||
127967734|NCT00984542|460502904|FG000|Overall Study|toxicity|7|||
127967735|NCT00984542|460502904|FG000|Overall Study|Death|7|||
127967736|NCT00984542|460502904|FG000|Overall Study|complicating disease|3|||
127967737|NCT00984542|460502904|FG000|Overall Study|Withdrawal by Subject|3|||
127967738|NCT00984542|460502904|FG000|Overall Study|clinical deterioration|2|||
127967739|NCT01422889|460502905|FG000|Overall Study|No Data Entered for Study Stent|9|||
127967740|NCT02091089|460502907|FG000|Overall Study|Lost to Follow-up|2|||
127967741|NCT01580670|460502908|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
127967742|NCT01580670|460502908|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
127967743|NCT02097745|460502909|FG000|Overall Study|Adverse Event|25|||
127967744|NCT02097745|460502909|FG000|Overall Study|Death|16|||
127967745|NCT02097745|460502909|FG000|Overall Study|Failure to Return|14|||
127967746|NCT02097745|460502909|FG000|Overall Study|Administrative/Other|27|||
127967747|NCT02097745|460502909|FG000|Overall Study|Reason Not Specified|96|||
127967748|NCT00425750|460502910|FG000|Overall Study|Death|1|||
127967749|NCT00425750|460502910|FG000|Overall Study|Withdrawal by Subject|3|||
127967750|NCT00425750|460502910|FG000|Overall Study|Adverse Event|3|||
127967751|NCT00425750|460502910|FG000|Overall Study|Progression of disease|18|||
127967752|NCT01757184|460502911|FG000|Double-blind Period|Adverse Event|1|||
127967753|NCT01757184|460502912|FG001|Double-blind Period|Adverse Event|0|||
127967754|NCT01757184|460502913|FG002|Double-blind Period|Adverse Event|0|||
127967755|NCT01757184|460502914|FG003|Double-blind Period|Adverse Event|0|||
127967756|NCT01757184|460502911|FG000|Open-label Period|Lost to Follow-up|0|||
127967757|NCT01757184|460502912|FG001|Open-label Period|Lost to Follow-up|0|||
127967758|NCT01757184|460502913|FG002|Open-label Period|Lost to Follow-up|2|||
127967759|NCT01757184|460502914|FG003|Open-label Period|Lost to Follow-up|0|||
127967760|NCT01757184|460502911|FG000|Open-label Period|Withdrawal by Subject|0|||
127967761|NCT01757184|460502912|FG001|Open-label Period|Withdrawal by Subject|0|||
127967762|NCT01757184|460502913|FG002|Open-label Period|Withdrawal by Subject|1|||
127967763|NCT01757184|460502914|FG003|Open-label Period|Withdrawal by Subject|1|||
127967764|NCT01757184|460502911|FG000|Open-label Period|Discontinued by Sponsor|0|||
127967765|NCT01757184|460502912|FG001|Open-label Period|Discontinued by Sponsor|0|||
127967766|NCT01757184|460502913|FG002|Open-label Period|Discontinued by Sponsor|1|||
127967767|NCT01757184|460502914|FG003|Open-label Period|Discontinued by Sponsor|2|||
127967768|NCT01276756|460502915|FG000|Overall Study|Lost to Follow-up|2|||
127967769|NCT01276756|460502916|FG001|Overall Study|Lost to Follow-up|0|||
127967770|NCT01276756|460502915|FG000|Overall Study|Adverse Event|3|||
127967771|NCT01276756|460502916|FG001|Overall Study|Adverse Event|2|||
127967772|NCT01554527|460502924|FG000|Overall Study|Withdrawal by Subject|1|||
127967773|NCT01554527|460502925|FG001|Overall Study|Withdrawal by Subject|0|||
127967774|NCT01554527|460502926|FG002|Overall Study|Withdrawal by Subject|3|||
127967775|NCT01554527|460502924|FG000|Overall Study|Lost to Follow-up|0|||
127967776|NCT01554527|460502925|FG001|Overall Study|Lost to Follow-up|0|||
127967777|NCT01554527|460502926|FG002|Overall Study|Lost to Follow-up|4|||
127967778|NCT01554527|460502924|FG000|Overall Study|Physician Decision|0|||
127967779|NCT01554527|460502925|FG001|Overall Study|Physician Decision|0|||
127967780|NCT01554527|460502926|FG002|Overall Study|Physician Decision|1|||
127967781|NCT01052480|460502927|FG000|Overall Study|Lost to Follow-up|3|||
127967782|NCT01052480|460502928|FG001|Overall Study|Lost to Follow-up|3|||
127967783|NCT01052480|460502927|FG000|Overall Study|Protocol Violation|1|||
127967784|NCT01052480|460502928|FG001|Overall Study|Protocol Violation|0|||
127868689|NCT01072175|460137393|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
127868690|NCT01072175|460137394|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
127868691|NCT01072175|460137395|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
127868692|NCT01072175|460137383|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
127868693|NCT01072175|460137384|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
127868694|NCT01072175|460137385|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
127868695|NCT01072175|460137386|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
127868696|NCT01072175|460137387|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
127868697|NCT01072175|460137388|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
127868698|NCT01072175|460137389|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
127868699|NCT01072175|460137390|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
127868700|NCT01072175|460137391|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
127868701|NCT01072175|460137392|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
127967785|NCT01052480|460502927|FG000|Overall Study|Withdrawal by Subject|3|||
127967786|NCT01052480|460502928|FG001|Overall Study|Withdrawal by Subject|7|||
127967787|NCT01052480|460502927|FG000|Overall Study|Physician Decision|0|||
127967788|NCT01052480|460502928|FG001|Overall Study|Physician Decision|2|||
127967789|NCT01052480|460502927|FG000|Overall Study|Death|1|||
127967790|NCT01052480|460502928|FG001|Overall Study|Death|5|||
127967791|NCT00529373|460502929|FG000|Base Study|Adverse Event|525|||
127967792|NCT00529373|460502930|FG001|Base Study|Adverse Event|470|||
127967793|NCT00529373|460502929|FG000|Base Study|Lack of Efficacy|16|||
127967794|NCT00529373|460502930|FG001|Base Study|Lack of Efficacy|75|||
127967795|NCT00529373|460502929|FG000|Base Study|Lost to Follow-up|221|||
127868702|NCT01072175|460137393|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
127868703|NCT01072175|460137394|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
127868704|NCT01072175|460137395|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
127868705|NCT01072175|460137383|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
127868706|NCT01072175|460137384|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
127868707|NCT01072175|460137385|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
127868708|NCT01072175|460137386|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
127868709|NCT01072175|460137387|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
127868710|NCT01072175|460137388|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
127868711|NCT01072175|460137389|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
127868712|NCT01072175|460137390|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
127868713|NCT01072175|460137391|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
127967796|NCT00529373|460502930|FG001|Base Study|Lost to Follow-up|208|||
127967797|NCT00529373|460502929|FG000|Base Study|Other Protocol Specified Criteria|19|||
127967798|NCT00529373|460502930|FG001|Base Study|Other Protocol Specified Criteria|20|||
127967799|NCT00529373|460502929|FG000|Base Study|Physician Decision|60|||
127967800|NCT00529373|460502930|FG001|Base Study|Physician Decision|52|||
127967801|NCT00529373|460502929|FG000|Base Study|Protocol Violation|48|||
127967802|NCT00529373|460502930|FG001|Base Study|Protocol Violation|38|||
127967803|NCT00529373|460502929|FG000|Base Study|Withdrawal by Subject|1062|||
127967804|NCT00529373|460502930|FG001|Base Study|Withdrawal by Subject|967|||
127967805|NCT00529373|460502929|FG000|Base Study|Did not continue into Extension|1795|||
127967806|NCT00529373|460502930|FG001|Base Study|Did not continue into Extension|2238|||
127967807|NCT00529373|460502929|FG000|First Extension Study|Adverse Event|162|||
127868714|NCT01072175|460137392|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
127868715|NCT01072175|460137393|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
127868716|NCT01072175|460137394|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
127868717|NCT01072175|460137395|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
127868718|NCT01072175|460137383|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
127868719|NCT01072175|460137384|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
127868720|NCT01072175|460137385|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
127868721|NCT01072175|460137386|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
127868722|NCT01072175|460137387|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
127868723|NCT01072175|460137388|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
127868724|NCT01072175|460137389|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
127868725|NCT01072175|460137390|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
127868726|NCT01072175|460137391|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
127868727|NCT01072175|460137392|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
127868728|NCT01072175|460137393|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
127868729|NCT01072175|460137394|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
127868730|NCT01072175|460137395|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
127868731|NCT01072175|460137383|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
127868732|NCT01072175|460137384|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
127868733|NCT01072175|460137385|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
127868734|NCT01072175|460137386|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
127868735|NCT01072175|460137387|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
127868736|NCT01072175|460137388|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
127868737|NCT01072175|460137389|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
127868738|NCT01072175|460137390|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
127868739|NCT01072175|460137391|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
127868740|NCT01072175|460137392|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
127868741|NCT01072175|460137393|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
127868742|NCT01072175|460137394|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
127868743|NCT01072175|460137395|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
127868744|NCT01072175|460137383|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
127868745|NCT01072175|460137384|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
127868746|NCT01072175|460137385|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
127868747|NCT01072175|460137386|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
127868748|NCT01072175|460137387|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
127868749|NCT01072175|460137388|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
127967808|NCT00529373|460502930|FG001|First Extension Study|Adverse Event|142|||
127967809|NCT00529373|460502929|FG000|First Extension Study|Lack of Efficacy|65|||
127967810|NCT00529373|460502930|FG001|First Extension Study|Lack of Efficacy|427|||
127967811|NCT00529373|460502929|FG000|First Extension Study|Lost to Follow-up|41|||
127967812|NCT00529373|460502930|FG001|First Extension Study|Lost to Follow-up|37|||
127967813|NCT00529373|460502929|FG000|First Extension Study|Other|27|||
127967814|NCT00529373|460502930|FG001|First Extension Study|Other|47|||
127967815|NCT00529373|460502929|FG000|First Extension Study|Physician Decision|50|||
127967816|NCT00529373|460502930|FG001|First Extension Study|Physician Decision|45|||
127485498|NCT03768427|458741192|FG003|Overall Study|Withdrawal by Subject|7|||
127967817|NCT00529373|460502929|FG000|First Extension Study|Protocol Violation|16|||
127967818|NCT00529373|460502930|FG001|First Extension Study|Protocol Violation|13|||
127967819|NCT00529373|460502929|FG000|First Extension Study|Withdrawal by Subject|296|||
127967820|NCT00529373|460502930|FG001|First Extension Study|Withdrawal by Subject|287|||
127967821|NCT00529373|460502929|FG000|First Extension Study|Disposition record non-existing|0|||
127967822|NCT00529373|460502930|FG001|First Extension Study|Disposition record non-existing|1|||
127967823|NCT00529373|460502929|FG000|First Extension Study|Discontinued after 5 years completion|208|||
127967824|NCT00529373|460502930|FG001|First Extension Study|Discontinued after 5 years completion|346|||
127967825|NCT00529373|460502929|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
127967826|NCT00529373|460502930|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
127967827|NCT00529373|460502929|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
127967828|NCT00529373|460502930|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
127967829|NCT00529373|460502929|FG000|Second Extension Study|Adverse Event|101|||
127967830|NCT00529373|460502930|FG001|Second Extension Study|Adverse Event|51|||
127967831|NCT00529373|460502929|FG000|Second Extension Study|Lack of Efficacy|7|||
127967832|NCT00529373|460502930|FG001|Second Extension Study|Lack of Efficacy|15|||
127967833|NCT00529373|460502929|FG000|Second Extension Study|Lost to Follow-up|18|||
127967834|NCT00529373|460502930|FG001|Second Extension Study|Lost to Follow-up|12|||
127967835|NCT00529373|460502929|FG000|Second Extension Study|Other|7|||
127967836|NCT00529373|460502930|FG001|Second Extension Study|Other|12|||
127967837|NCT00529373|460502929|FG000|Second Extension Study|Physician Decision|63|||
127967838|NCT00529373|460502930|FG001|Second Extension Study|Physician Decision|26|||
127967839|NCT00529373|460502929|FG000|Second Extension Study|Protocol Violation|2|||
127967840|NCT00529373|460502930|FG001|Second Extension Study|Protocol Violation|1|||
127967841|NCT00529373|460502929|FG000|Second Extension Study|Withdrawal by Subject|97|||
127967842|NCT00529373|460502930|FG001|Second Extension Study|Withdrawal by Subject|75|||
127967843|NCT00529373|460502929|FG000|Second Extension Study|Status Missing|5|||
127967844|NCT00529373|460502930|FG001|Second Extension Study|Status Missing|5|||
127967845|NCT01863667|460502937|FG000|Overall Study|Adverse Event|1|||
127967846|NCT01863667|460502938|FG001|Overall Study|Adverse Event|0|||
127967847|NCT01863667|460502937|FG000|Overall Study|Study terminated by Sponsor|30|||
127967848|NCT01863667|460502938|FG001|Overall Study|Study terminated by Sponsor|30|||
127967849|NCT01863667|460502937|FG000|Overall Study|Withdrawal by Subject|2|||
127967850|NCT01863667|460502938|FG001|Overall Study|Withdrawal by Subject|2|||
127967851|NCT03627546|460502941|FG000|Overall Study|Deemed ineligible after ransdomization|1|||
127967852|NCT03627546|460502942|FG001|Overall Study|Deemed ineligible after ransdomization|0|||
127967853|NCT03627546|460502943|FG002|Overall Study|Deemed ineligible after ransdomization|0|||
127967854|NCT03627546|460502941|FG000|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
127967855|NCT03627546|460502942|FG001|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
127967856|NCT03627546|460502943|FG002|Overall Study|HCV RNA Negative (protocol pre-specified)|13|||
127967857|NCT00615550|460502944|FG000|Overall Study|Lost to Follow-up|6|||
127967858|NCT00615550|460502945|FG001|Overall Study|Lost to Follow-up|1|||
127967859|NCT00564850|460502946|FG000|Overall Study|Protocol Violation|2|||
127967860|NCT02640664|460502947|FG000|Epoch 1|Withdrawal of informed consent|1|||
127967861|NCT02640664|460502948|FG001|Epoch 1|Withdrawal of informed consent|0|||
127485499|NCT02629861|458741198|FG000|Overall Study|Adverse Event|7|||
127967862|NCT02640664|460502949|FG002|Epoch 1|Withdrawal of informed consent|0|||
127967863|NCT02640664|460502947|FG000|Epoch 1|Death|0|||
127967864|NCT02640664|460502948|FG001|Epoch 1|Death|0|||
127967865|NCT02640664|460502949|FG002|Epoch 1|Death|1|||
127967866|NCT02640664|460502947|FG000|Epoch 2|Withdrawal of informed consent|3|||
127485500|NCT02629861|458741199|FG001|Overall Study|Adverse Event|5|||
127485501|NCT02629861|458741200|FG002|Overall Study|Adverse Event|4|||
127967867|NCT02640664|460502948|FG001|Epoch 2|Withdrawal of informed consent|4|||
127967868|NCT02640664|460502949|FG002|Epoch 2|Withdrawal of informed consent|2|||
127967869|NCT02640664|460502947|FG000|Epoch 2|Subject/guardian decision|0|||
127967870|NCT02640664|460502948|FG001|Epoch 2|Subject/guardian decision|2|||
127967871|NCT02640664|460502949|FG002|Epoch 2|Subject/guardian decision|2|||
127967872|NCT02640664|460502947|FG000|Epoch 2|Lost to Follow-up|3|||
127967873|NCT02640664|460502948|FG001|Epoch 2|Lost to Follow-up|4|||
127967874|NCT02640664|460502949|FG002|Epoch 2|Lost to Follow-up|1|||
127967875|NCT02640664|460502947|FG000|Epoch 2|Death|0|||
127967876|NCT02640664|460502948|FG001|Epoch 2|Death|0|||
127967877|NCT02640664|460502949|FG002|Epoch 2|Death|1|||
127967878|NCT00315458|460502951|FG000|Overall Study|Administrative|0|||
127967879|NCT00315458|460502952|FG001|Overall Study|Administrative|3|||
127967880|NCT00315458|460502953|FG002|Overall Study|Administrative|8|||
127967881|NCT00315458|460502954|FG003|Overall Study|Administrative|21|||
127967882|NCT00315458|460502951|FG000|Overall Study|Adverse Event|2|||
127967883|NCT00315458|460502952|FG001|Overall Study|Adverse Event|4|||
127967884|NCT00315458|460502953|FG002|Overall Study|Adverse Event|23|||
127967885|NCT00315458|460502954|FG003|Overall Study|Adverse Event|3|||
127967886|NCT00315458|460502951|FG000|Overall Study|Lost to Follow-up|1|||
127967887|NCT00315458|460502952|FG001|Overall Study|Lost to Follow-up|2|||
127967888|NCT00315458|460502953|FG002|Overall Study|Lost to Follow-up|0|||
127967889|NCT00315458|460502954|FG003|Overall Study|Lost to Follow-up|2|||
127967890|NCT00315458|460502951|FG000|Overall Study|Withdrawal by Subject|0|||
127967891|NCT00315458|460502952|FG001|Overall Study|Withdrawal by Subject|3|||
127967892|NCT00315458|460502953|FG002|Overall Study|Withdrawal by Subject|0|||
127967893|NCT00315458|460502954|FG003|Overall Study|Withdrawal by Subject|2|||
127967894|NCT00315458|460502951|FG000|Overall Study|Lack of Efficacy|0|||
127967895|NCT00315458|460502952|FG001|Overall Study|Lack of Efficacy|0|||
127967896|NCT00315458|460502953|FG002|Overall Study|Lack of Efficacy|20|||
127967897|NCT00315458|460502954|FG003|Overall Study|Lack of Efficacy|1|||
127967898|NCT00315458|460502951|FG000|Overall Study|Did not qualify|0|||
127967899|NCT00315458|460502952|FG001|Overall Study|Did not qualify|0|||
127967900|NCT00315458|460502953|FG002|Overall Study|Did not qualify|1|||
127967901|NCT00315458|460502954|FG003|Overall Study|Did not qualify|0|||
127967902|NCT01500382|460502957|FG000|Washout Period|Study site went out of business|0|||
127967903|NCT01500382|460502958|FG001|Washout Period|Study site went out of business|0|||
127967904|NCT01500382|460502959|FG002|Washout Period|Study site went out of business|1|||
127967905|NCT01500382|460502960|FG003|Washout Period|Study site went out of business|0|||
127967906|NCT01870973|460502961|FG000|Overall Study|Lost to Follow-up|10|||
127967907|NCT01870973|460502962|FG001|Overall Study|Lost to Follow-up|3|||
127967908|NCT06098339|460504705|FG000|Period 1: First Intervention 28-32 Days|Lost to Follow-up|0|||
127967909|NCT06098339|460504706|FG001|Period 1: First Intervention 28-32 Days|Lost to Follow-up|1|||
127967910|NCT06098339|460504705|FG000|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
127967911|NCT06098339|460504706|FG001|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
127967912|NCT02582242|460504707|FG000|Overall Study|Adverse Event|4|||
127967913|NCT02582242|460504708|FG001|Overall Study|Adverse Event|3|||
127967914|NCT02582242|460504707|FG000|Overall Study|Protocol Violation|3|||
127967915|NCT02582242|460504708|FG001|Overall Study|Protocol Violation|1|||
127967916|NCT02582242|460504707|FG000|Overall Study|Lost to Follow-up|0|||
127967917|NCT02582242|460504708|FG001|Overall Study|Lost to Follow-up|1|||
127967918|NCT02582242|460504707|FG000|Overall Study|Withdrawal by Subject|11|||
127967919|NCT02582242|460504708|FG001|Overall Study|Withdrawal by Subject|11|||
127967920|NCT02582242|460504707|FG000|Overall Study|Unclassified|2|||
127967921|NCT02582242|460504708|FG001|Overall Study|Unclassified|1|||
127967922|NCT02101736|460504709|FG000|Overall Study|Protocol Violation|3|||
127967923|NCT02101736|460504710|FG001|Overall Study|Protocol Violation|0|||
127967924|NCT02101736|460504709|FG000|Overall Study|Withdrawal by Subject|1|||
127967925|NCT02101736|460504710|FG001|Overall Study|Withdrawal by Subject|1|||
127967926|NCT00459290|460504711|FG000|Overall Study|Adverse Event|3|||
127967927|NCT00459290|460504711|FG000|Overall Study|Ineligible|2|||
127967928|NCT02498444|460504712|FG000|Overall Study|Withdrawal by Subject|3|||
127967929|NCT02498444|460504713|FG001|Overall Study|Withdrawal by Subject|0|||
127967930|NCT02498444|460504712|FG000|Overall Study|Physician Decision|1|||
127967931|NCT02498444|460504713|FG001|Overall Study|Physician Decision|0|||
127967932|NCT02453334|460504714|FG000|Overall Study|Death|15|||
127967933|NCT02453334|460504715|FG001|Overall Study|Death|13|||
127967934|NCT02453334|460504714|FG000|Overall Study|Adverse Event|2|||
127967935|NCT02453334|460504715|FG001|Overall Study|Adverse Event|1|||
127967936|NCT02453334|460504714|FG000|Overall Study|Lost to Follow-up|5|||
127967937|NCT02453334|460504715|FG001|Overall Study|Lost to Follow-up|9|||
127967938|NCT02453334|460504714|FG000|Overall Study|Physician Decision|1|||
127967939|NCT02453334|460504715|FG001|Overall Study|Physician Decision|0|||
127967940|NCT02453334|460504714|FG000|Overall Study|Withdrawal by Subject|17|||
127967941|NCT02453334|460504715|FG001|Overall Study|Withdrawal by Subject|13|||
127967942|NCT02453334|460504714|FG000|Overall Study|Other reason|1|||
127967943|NCT02453334|460504715|FG001|Overall Study|Other reason|4|||
127967944|NCT00839800|460504716|FG000|Overall Study|Adverse Event|8|||
127967945|NCT00839800|460504717|FG001|Overall Study|Adverse Event|12|||
127967946|NCT00839800|460504716|FG000|Overall Study|Lost to Follow-up|31|||
127967947|NCT00839800|460504717|FG001|Overall Study|Lost to Follow-up|26|||
127967948|NCT00839800|460504716|FG000|Overall Study|Withdrawal by Subject|28|||
127967949|NCT00839800|460504717|FG001|Overall Study|Withdrawal by Subject|34|||
127967950|NCT00839800|460504716|FG000|Overall Study|Incorrect Enrolment|3|||
127967951|NCT00839800|460504717|FG001|Overall Study|Incorrect Enrolment|3|||
127967952|NCT00839800|460504716|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
127967953|NCT00839800|460504717|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
127967954|NCT00839800|460504716|FG000|Overall Study|Safety Reasons|2|||
127967955|NCT00839800|460504717|FG001|Overall Study|Safety Reasons|1|||
127967956|NCT00839800|460504716|FG000|Overall Study|Other|8|||
127967957|NCT00839800|460504717|FG001|Overall Study|Other|14|||
127967958|NCT00839800|460504716|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
127967959|NCT00839800|460504717|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
127967960|NCT03491462|460504730|FG000|Overall Study|Lost to Follow-up|2|||
127967961|NCT03491462|460504731|FG001|Overall Study|Lost to Follow-up|0|||
127967962|NCT03491462|460504730|FG000|Overall Study|Adverse Event|11|||
127967963|NCT03491462|460504731|FG001|Overall Study|Adverse Event|1|||
127967964|NCT03491462|460504730|FG000|Overall Study|Physician Decision|3|||
127967965|NCT03491462|460504731|FG001|Overall Study|Physician Decision|0|||
127967966|NCT03491462|460504730|FG000|Overall Study|Withdrawal by Subject|22|||
127967967|NCT03491462|460504731|FG001|Overall Study|Withdrawal by Subject|15|||
127967968|NCT04938180|460504732|FG000|Overall Study|Adverse Event|1|||
127967969|NCT01019694|460504733|FG000|Overall Study|Adverse Event|12|||
127967970|NCT01019694|460504734|FG001|Overall Study|Adverse Event|16|||
127967971|NCT01019694|460504735|FG002|Overall Study|Adverse Event|19|||
127967972|NCT01019694|460504733|FG000|Overall Study|Protocol Violation|2|||
127967973|NCT01019694|460504734|FG001|Overall Study|Protocol Violation|6|||
127967974|NCT01019694|460504735|FG002|Overall Study|Protocol Violation|4|||
127967975|NCT01019694|460504733|FG000|Overall Study|Lost to Follow-up|5|||
127967976|NCT01019694|460504734|FG001|Overall Study|Lost to Follow-up|3|||
127967977|NCT01019694|460504735|FG002|Overall Study|Lost to Follow-up|3|||
127967978|NCT01019694|460504733|FG000|Overall Study|Withdrawal by Subject|4|||
127967979|NCT01019694|460504734|FG001|Overall Study|Withdrawal by Subject|6|||
127967980|NCT01019694|460504735|FG002|Overall Study|Withdrawal by Subject|12|||
127967981|NCT01019694|460504733|FG000|Overall Study|Not treated|0|||
127967982|NCT01019694|460504734|FG001|Overall Study|Not treated|2|||
127967983|NCT01019694|460504735|FG002|Overall Study|Not treated|3|||
127967984|NCT01019694|460504733|FG000|Overall Study|Other reason (not specified)|1|||
127967985|NCT01019694|460504734|FG001|Overall Study|Other reason (not specified)|5|||
127967986|NCT01019694|460504735|FG002|Overall Study|Other reason (not specified)|6|||
127967987|NCT00026494|460504742|FG000|Overall Study|Withdrawal by Subject|1|||
127967988|NCT00026494|460504743|FG001|Overall Study|Withdrawal by Subject|0|||
127967989|NCT00026494|460504744|FG002|Overall Study|Withdrawal by Subject|1|||
127967990|NCT00026494|460504745|FG003|Overall Study|Withdrawal by Subject|0|||
127967991|NCT00026494|460504742|FG000|Overall Study|Patient non-compliance|1|||
127967992|NCT00026494|460504743|FG001|Overall Study|Patient non-compliance|0|||
127967993|NCT00026494|460504744|FG002|Overall Study|Patient non-compliance|0|||
127967994|NCT00026494|460504745|FG003|Overall Study|Patient non-compliance|0|||
127967995|NCT00026494|460504742|FG000|Overall Study|Patient not treated|0|||
127967996|NCT00026494|460504743|FG001|Overall Study|Patient not treated|0|||
127967997|NCT00026494|460504744|FG002|Overall Study|Patient not treated|2|||
127967998|NCT00026494|460504745|FG003|Overall Study|Patient not treated|0|||
127967999|NCT00026494|460504742|FG000|Overall Study|Clinical progression|0|||
127968000|NCT00026494|460504743|FG001|Overall Study|Clinical progression|0|||
127968001|NCT00026494|460504744|FG002|Overall Study|Clinical progression|3|||
127968002|NCT00026494|460504745|FG003|Overall Study|Clinical progression|0|||
127968003|NCT01684423|460504746|FG000|Overall Study|Withdrawal by Subject|0|||
127968004|NCT01684423|460504747|FG001|Overall Study|Withdrawal by Subject|0|||
127968005|NCT01684423|460504748|FG002|Overall Study|Withdrawal by Subject|1|||
127968006|NCT01684423|460504749|FG003|Overall Study|Withdrawal by Subject|0|||
127968007|NCT01684423|460504750|FG004|Overall Study|Withdrawal by Subject|0|||
127968008|NCT00441129|460504751|FG000|Overall Study|Withdrawal by Subject|6|||
127968009|NCT00441129|460504752|FG001|Overall Study|Withdrawal by Subject|14|||
127968010|NCT01455597|460504753|FG000|Overall Study|Adverse Event|7|||
127968011|NCT01455597|460504754|FG001|Overall Study|Adverse Event|0|||
127968012|NCT01455597|460504755|FG002|Overall Study|Adverse Event|5|||
127968013|NCT01455597|460504756|FG003|Overall Study|Adverse Event|1|||
127968014|NCT01455597|460504753|FG000|Overall Study|Lack of Efficacy|0|||
127968015|NCT01455597|460504754|FG001|Overall Study|Lack of Efficacy|1|||
127968016|NCT01455597|460504755|FG002|Overall Study|Lack of Efficacy|2|||
127968017|NCT01455597|460504756|FG003|Overall Study|Lack of Efficacy|0|||
127968018|NCT01455597|460504753|FG000|Overall Study|Lost to Follow-up|3|||
127968019|NCT01455597|460504754|FG001|Overall Study|Lost to Follow-up|0|||
127968020|NCT01455597|460504755|FG002|Overall Study|Lost to Follow-up|2|||
127968021|NCT01455597|460504756|FG003|Overall Study|Lost to Follow-up|1|||
127968022|NCT01455597|460504753|FG000|Overall Study|Withdrew Consent|6|||
127968023|NCT01455597|460504754|FG001|Overall Study|Withdrew Consent|5|||
127968024|NCT01455597|460504755|FG002|Overall Study|Withdrew Consent|8|||
127968025|NCT01455597|460504756|FG003|Overall Study|Withdrew Consent|5|||
127968026|NCT01455597|460504753|FG000|Overall Study|Reason not Specified|1|||
127968027|NCT01455597|460504754|FG001|Overall Study|Reason not Specified|2|||
127968028|NCT01455597|460504755|FG002|Overall Study|Reason not Specified|3|||
127968029|NCT01455597|460504756|FG003|Overall Study|Reason not Specified|3|||
127968030|NCT03412734|460504759|FG000|Overall Study|Incorrect labeling of samples|2|||
127968031|NCT03412734|460504760|FG001|Overall Study|Incorrect labeling of samples|0|||
127968032|NCT03412734|460504759|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
127968033|NCT03412734|460504760|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
127968034|NCT00423332|460504761|FG000|Overall Study|Adverse Event|6|||
127968035|NCT00423332|460504762|FG001|Overall Study|Adverse Event|2|||
127968036|NCT00423332|460504761|FG000|Overall Study|Withdrawal by Subject|1|||
127968037|NCT00423332|460504762|FG001|Overall Study|Withdrawal by Subject|0|||
127968038|NCT00423332|460504761|FG000|Overall Study|Condition under investigation worsened|1|||
127968039|NCT00423332|460504762|FG001|Overall Study|Condition under investigation worsened|1|||
127968040|NCT00423332|460504761|FG000|Overall Study|Progressive at Week 6|0|||
127968041|NCT00423332|460504762|FG001|Overall Study|Progressive at Week 6|1|||
127968042|NCT00423332|460504761|FG000|Overall Study|Unblinded before 12 weeks|1|||
127968043|NCT00423332|460504762|FG001|Overall Study|Unblinded before 12 weeks|3|||
127968044|NCT04747886|460504763|FG000|Overall Study|Withdrawal by Subject|1|||
127968045|NCT04747886|460504764|FG001|Overall Study|Withdrawal by Subject|4|||
127968046|NCT01136356|460504768|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
127968047|NCT01136356|460504769|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
127968048|NCT01136356|460504768|FG000|First 18-day Withdrawal|Physician Decision|1|||
127968049|NCT01136356|460504769|FG001|First 18-day Withdrawal|Physician Decision|0|||
127968050|NCT01136356|460504768|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
127968051|NCT01136356|460504769|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
127968052|NCT00402688|460504770|FG000|Overall Study|Adverse Event|12|||
127968053|NCT00402688|460504771|FG001|Overall Study|Adverse Event|9|||
127968054|NCT00402688|460504772|FG002|Overall Study|Adverse Event|3|||
127968055|NCT00402688|460504770|FG000|Overall Study|Withdrawal by Subject|3|||
127968056|NCT00402688|460504771|FG001|Overall Study|Withdrawal by Subject|1|||
127968057|NCT00402688|460504772|FG002|Overall Study|Withdrawal by Subject|1|||
127968058|NCT00402688|460504770|FG000|Overall Study|Physician Decision|0|||
127968059|NCT00402688|460504771|FG001|Overall Study|Physician Decision|0|||
127968060|NCT00402688|460504772|FG002|Overall Study|Physician Decision|1|||
127968061|NCT00402688|460504770|FG000|Overall Study|Lack of Efficacy|4|||
127968062|NCT00402688|460504771|FG001|Overall Study|Lack of Efficacy|4|||
127968063|NCT00402688|460504772|FG002|Overall Study|Lack of Efficacy|5|||
127968064|NCT00402688|460504770|FG000|Overall Study|Protocol Violation|1|||
127968065|NCT00402688|460504771|FG001|Overall Study|Protocol Violation|1|||
127968066|NCT00402688|460504772|FG002|Overall Study|Protocol Violation|1|||
127968067|NCT00402688|460504770|FG000|Overall Study|Lost to Follow-up|1|||
127968068|NCT00402688|460504771|FG001|Overall Study|Lost to Follow-up|0|||
127968069|NCT00402688|460504772|FG002|Overall Study|Lost to Follow-up|2|||
127968070|NCT00402688|460504770|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
127968071|NCT00402688|460504771|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
127968072|NCT00402688|460504772|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
127968073|NCT00402688|460504770|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
127968074|NCT00402688|460504771|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
127968075|NCT00402688|460504772|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
127968076|NCT00402688|460504770|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
127968077|NCT00402688|460504771|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
127968078|NCT00402688|460504772|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
127968079|NCT00927862|460504773|FG000|Overall Study|Missing data needed for endpt analyses|27|||
127968080|NCT00927862|460504774|FG001|Overall Study|Missing data needed for endpt analyses|45|||
127968081|NCT00820248|460504776|FG000|Overall Study|No treated|4|||
127968082|NCT00820248|460504777|FG001|Overall Study|No treated|1|||
127968083|NCT03259425|460504778|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
127968084|NCT02237196|460504779|FG000|Overall Study|Adverse Event|0|||
127968085|NCT02237196|460504780|FG001|Overall Study|Adverse Event|1|||
127968086|NCT02237196|460504781|FG002|Overall Study|Adverse Event|1|||
127968087|NCT02237196|460504782|FG003|Overall Study|Adverse Event|0|||
127968088|NCT02237196|460504779|FG000|Overall Study|Lost to Follow-up|4|||
127968089|NCT02237196|460504780|FG001|Overall Study|Lost to Follow-up|2|||
127968090|NCT02237196|460504781|FG002|Overall Study|Lost to Follow-up|4|||
127968091|NCT02237196|460504782|FG003|Overall Study|Lost to Follow-up|6|||
127968092|NCT02237196|460504779|FG000|Overall Study|Physician Decision|2|||
127968093|NCT02237196|460504780|FG001|Overall Study|Physician Decision|0|||
127968094|NCT02237196|460504781|FG002|Overall Study|Physician Decision|0|||
127968095|NCT02237196|460504782|FG003|Overall Study|Physician Decision|1|||
127968096|NCT02237196|460504779|FG000|Overall Study|Pregnancy|0|||
127968097|NCT02237196|460504780|FG001|Overall Study|Pregnancy|0|||
127968098|NCT02237196|460504781|FG002|Overall Study|Pregnancy|1|||
127968099|NCT02237196|460504782|FG003|Overall Study|Pregnancy|1|||
127968100|NCT02237196|460504779|FG000|Overall Study|Withdrawal by Subject|1|||
127968101|NCT02237196|460504780|FG001|Overall Study|Withdrawal by Subject|1|||
127968102|NCT02237196|460504781|FG002|Overall Study|Withdrawal by Subject|4|||
127968103|NCT02237196|460504782|FG003|Overall Study|Withdrawal by Subject|1|||
127968104|NCT02237196|460504779|FG000|Overall Study|Site Error|1|||
127968105|NCT02237196|460504780|FG001|Overall Study|Site Error|2|||
127968106|NCT02237196|460504781|FG002|Overall Study|Site Error|0|||
127968107|NCT02237196|460504782|FG003|Overall Study|Site Error|2|||
127968108|NCT01282372|460504792|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
127968109|NCT01282372|460504792|FG000|Overall Study|Lost to Follow-up|23|||
127968110|NCT01282372|460504792|FG000|Overall Study|Withdrawal by Subject|11|||
127968111|NCT01282372|460504792|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
127968112|NCT01282372|460504792|FG000|Overall Study|Death|1|||
127968113|NCT01282372|460504792|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
127968114|NCT01282372|460504792|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
127968115|NCT01282372|460504792|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
127968116|NCT01282372|460504792|FG000|Overall Study|Adverse Event|12|||
127968117|NCT01322490|460504793|FG000|Treatment Period|Adverse Event|12|||
127968118|NCT01322490|460504794|FG001|Treatment Period|Adverse Event|18|||
127968119|NCT01322490|460504795|FG002|Treatment Period|Adverse Event|15|||
127968120|NCT01322490|460504793|FG000|Treatment Period|Death|5|||
127968121|NCT01322490|460504794|FG001|Treatment Period|Death|7|||
127968122|NCT01322490|460504795|FG002|Treatment Period|Death|3|||
127968123|NCT01322490|460504793|FG000|Treatment Period|Lack of Efficacy|89|||
127968124|NCT01322490|460504794|FG001|Treatment Period|Lack of Efficacy|100|||
127968125|NCT01322490|460504795|FG002|Treatment Period|Lack of Efficacy|112|||
127968126|NCT01322490|460504793|FG000|Treatment Period|Physician Decision|0|||
127968127|NCT01322490|460504794|FG001|Treatment Period|Physician Decision|2|||
127968128|NCT01322490|460504795|FG002|Treatment Period|Physician Decision|1|||
127968129|NCT01322490|460504793|FG000|Treatment Period|Protocol Violation|7|||
127968130|NCT01322490|460504794|FG001|Treatment Period|Protocol Violation|5|||
127968131|NCT01322490|460504795|FG002|Treatment Period|Protocol Violation|4|||
127968132|NCT01322490|460504793|FG000|Treatment Period|Withdrawal by Subject|14|||
127968133|NCT01322490|460504794|FG001|Treatment Period|Withdrawal by Subject|16|||
127968134|NCT01322490|460504795|FG002|Treatment Period|Withdrawal by Subject|11|||
127968135|NCT01322490|460504793|FG000|Treatment Period|Non-compliance with study drug|0|||
127968136|NCT01322490|460504794|FG001|Treatment Period|Non-compliance with study drug|0|||
127968137|NCT01322490|460504795|FG002|Treatment Period|Non-compliance with study drug|1|||
127968138|NCT01322490|460504793|FG000|Treatment Period|Other per report|2|||
127968139|NCT01322490|460504794|FG001|Treatment Period|Other per report|2|||
127968140|NCT01322490|460504795|FG002|Treatment Period|Other per report|1|||
127968141|NCT01322490|460504793|FG000|Treatment Period|Randomized but Not Treated|3|||
127968142|NCT01322490|460504794|FG001|Treatment Period|Randomized but Not Treated|3|||
127968143|NCT01322490|460504795|FG002|Treatment Period|Randomized but Not Treated|5|||
127968144|NCT01322490|460504793|FG000|Long Term Follow-up Period|Death|235|||
127968145|NCT01322490|460504794|FG001|Long Term Follow-up Period|Death|239|||
127968146|NCT01322490|460504795|FG002|Long Term Follow-up Period|Death|236|||
127968147|NCT01322490|460504793|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
127968148|NCT01322490|460504794|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
127968149|NCT01322490|460504795|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
127968150|NCT01322490|460504793|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
127968151|NCT01322490|460504794|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
127968152|NCT01322490|460504795|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
127968153|NCT01322490|460504793|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
127968154|NCT01322490|460504794|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
127968155|NCT01322490|460504795|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
127968156|NCT01322490|460504793|FG000|Long Term Follow-up Period|Other per report|3|||
127968157|NCT01322490|460504794|FG001|Long Term Follow-up Period|Other per report|2|||
127968158|NCT01322490|460504795|FG002|Long Term Follow-up Period|Other per report|2|||
127968159|NCT01322490|460504793|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
127968160|NCT01322490|460504794|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
127968161|NCT01322490|460504795|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
127968162|NCT01431716|460504796|FG000|Overall Study|Withdrawal of consent|1|||
127968163|NCT05027451|460504797|FG000|Overall Study|Lost to Follow-up|1|||
127968164|NCT05027451|460504798|FG001|Overall Study|Lost to Follow-up|1|||
127968165|NCT02929589|460504833|FG000|Overall Study|Withdrawal by Subject|1|||
127968166|NCT02929589|460504834|FG001|Overall Study|Withdrawal by Subject|0|||
127968167|NCT02929589|460504835|FG002|Overall Study|Withdrawal by Subject|0|||
127968168|NCT02929589|460504836|FG003|Overall Study|Withdrawal by Subject|0|||
127968169|NCT02929589|460504833|FG000|Overall Study|Physician Decision|2|||
127968170|NCT02929589|460504834|FG001|Overall Study|Physician Decision|0|||
127968171|NCT02929589|460504835|FG002|Overall Study|Physician Decision|0|||
127968172|NCT02929589|460504836|FG003|Overall Study|Physician Decision|0|||
127968173|NCT02343939|460504837|FG000|Overall Study|Death|0|||
127968174|NCT02343939|460504838|FG001|Overall Study|Death|15|||
127968175|NCT02343939|460504839|FG002|Overall Study|Death|4|||
127968176|NCT02343939|460504840|FG003|Overall Study|Death|2|||
127968177|NCT02343939|460504841|FG004|Overall Study|Death|5|||
127968178|NCT02343939|460504842|FG005|Overall Study|Death|11|||
127968179|NCT02343939|460504843|FG006|Overall Study|Death|8|||
127968180|NCT02343939|460504844|FG007|Overall Study|Death|22|||
127968181|NCT02343939|460504845|FG008|Overall Study|Death|1|||
127968182|NCT02343939|460504837|FG000|Overall Study|Study terminated by sponsor|0|||
127968183|NCT02343939|460504838|FG001|Overall Study|Study terminated by sponsor|27|||
127968184|NCT02343939|460504839|FG002|Overall Study|Study terminated by sponsor|0|||
127968185|NCT02343939|460504840|FG003|Overall Study|Study terminated by sponsor|1|||
127968186|NCT02343939|460504841|FG004|Overall Study|Study terminated by sponsor|1|||
127968187|NCT02343939|460504842|FG005|Overall Study|Study terminated by sponsor|5|||
127968188|NCT02343939|460504843|FG006|Overall Study|Study terminated by sponsor|3|||
127968189|NCT02343939|460504844|FG007|Overall Study|Study terminated by sponsor|4|||
127968190|NCT02343939|460504845|FG008|Overall Study|Study terminated by sponsor|0|||
127968191|NCT02343939|460504837|FG000|Overall Study|Withdrew consent|3|||
127968192|NCT02343939|460504838|FG001|Overall Study|Withdrew consent|6|||
127968193|NCT02343939|460504839|FG002|Overall Study|Withdrew consent|1|||
127968194|NCT02343939|460504840|FG003|Overall Study|Withdrew consent|2|||
127968195|NCT02343939|460504841|FG004|Overall Study|Withdrew consent|2|||
127968196|NCT02343939|460504842|FG005|Overall Study|Withdrew consent|0|||
127968197|NCT02343939|460504843|FG006|Overall Study|Withdrew consent|0|||
127968198|NCT02343939|460504844|FG007|Overall Study|Withdrew consent|8|||
127968199|NCT02343939|460504845|FG008|Overall Study|Withdrew consent|6|||
127968200|NCT02343939|460504837|FG000|Overall Study|Treatment failure|0|||
127968201|NCT02343939|460504838|FG001|Overall Study|Treatment failure|0|||
127968202|NCT02343939|460504839|FG002|Overall Study|Treatment failure|0|||
127968203|NCT02343939|460504840|FG003|Overall Study|Treatment failure|0|||
127968204|NCT02343939|460504841|FG004|Overall Study|Treatment failure|0|||
127968205|NCT02343939|460504842|FG005|Overall Study|Treatment failure|0|||
127968206|NCT02343939|460504843|FG006|Overall Study|Treatment failure|2|||
127968207|NCT02343939|460504844|FG007|Overall Study|Treatment failure|1|||
127968208|NCT02343939|460504845|FG008|Overall Study|Treatment failure|0|||
127968209|NCT02343939|460504837|FG000|Overall Study|Investigator's discretion|0|||
127968210|NCT02343939|460504838|FG001|Overall Study|Investigator's discretion|0|||
127968211|NCT02343939|460504839|FG002|Overall Study|Investigator's discretion|0|||
127968212|NCT02343939|460504840|FG003|Overall Study|Investigator's discretion|1|||
127968213|NCT02343939|460504841|FG004|Overall Study|Investigator's discretion|0|||
127968214|NCT02343939|460504842|FG005|Overall Study|Investigator's discretion|0|||
127968215|NCT02343939|460504843|FG006|Overall Study|Investigator's discretion|1|||
127968216|NCT02343939|460504844|FG007|Overall Study|Investigator's discretion|0|||
127968217|NCT02343939|460504845|FG008|Overall Study|Investigator's discretion|0|||
127968218|NCT02343939|460504837|FG000|Overall Study|Adverse Event|0|||
127968219|NCT02343939|460504838|FG001|Overall Study|Adverse Event|0|||
127968220|NCT02343939|460504839|FG002|Overall Study|Adverse Event|0|||
127968221|NCT02343939|460504840|FG003|Overall Study|Adverse Event|0|||
127968222|NCT02343939|460504841|FG004|Overall Study|Adverse Event|0|||
127968223|NCT02343939|460504842|FG005|Overall Study|Adverse Event|1|||
127968224|NCT02343939|460504843|FG006|Overall Study|Adverse Event|0|||
127968225|NCT02343939|460504844|FG007|Overall Study|Adverse Event|0|||
127968226|NCT02343939|460504845|FG008|Overall Study|Adverse Event|0|||
127968227|NCT02343939|460504837|FG000|Overall Study|Never Treated With ENTO|0|||
127968228|NCT02343939|460504838|FG001|Overall Study|Never Treated With ENTO|0|||
127968229|NCT02343939|460504839|FG002|Overall Study|Never Treated With ENTO|0|||
127968230|NCT02343939|460504840|FG003|Overall Study|Never Treated With ENTO|0|||
127968231|NCT02343939|460504841|FG004|Overall Study|Never Treated With ENTO|0|||
127968232|NCT02343939|460504842|FG005|Overall Study|Never Treated With ENTO|0|||
127968233|NCT02343939|460504843|FG006|Overall Study|Never Treated With ENTO|1|||
127968234|NCT02343939|460504844|FG007|Overall Study|Never Treated With ENTO|2|||
127968235|NCT02343939|460504845|FG008|Overall Study|Never Treated With ENTO|0|||
127968236|NCT01303172|460504850|FG000|Overall Study|Physician Decision|9|||
127968237|NCT01303172|460504851|FG001|Overall Study|Physician Decision|6|||
127968238|NCT01303172|460504850|FG000|Overall Study|Adverse Event|5|||
127968239|NCT01303172|460504851|FG001|Overall Study|Adverse Event|2|||
127968240|NCT01303172|460504850|FG000|Overall Study|Withdrawal by Subject|4|||
127968241|NCT01303172|460504851|FG001|Overall Study|Withdrawal by Subject|2|||
127968242|NCT01303172|460504850|FG000|Overall Study|Death|20|||
127968243|NCT01303172|460504851|FG001|Overall Study|Death|7|||
127968244|NCT01303172|460504850|FG000|Overall Study|Lack of Efficacy|25|||
127968245|NCT01303172|460504851|FG001|Overall Study|Lack of Efficacy|17|||
127968246|NCT00462709|460504856|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
127968247|NCT00462709|460504856|FG000|Overall Study|Lost to Follow-up|10|||
127968248|NCT00462709|460504856|FG000|Overall Study|Withdrawal by Subject|8|||
127968249|NCT00462709|460504856|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
127968250|NCT00462709|460504856|FG000|Overall Study|Death|2|||
127968251|NCT00462709|460504856|FG000|Overall Study|Logistical reasons|2|||
127968252|NCT00462709|460504856|FG000|Overall Study|Physician Decision|1|||
127968253|NCT00462709|460504856|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
127968254|NCT04468347|460504857|FG000|Overall Study|Withdrawal by Subject|0|||
127968255|NCT04468347|460504858|FG001|Overall Study|Withdrawal by Subject|1|||
127968256|NCT04468347|460504859|FG002|Overall Study|Withdrawal by Subject|3|||
127968257|NCT04468347|460504860|FG003|Overall Study|Withdrawal by Subject|3|||
127968258|NCT04468347|460504857|FG000|Overall Study|Lost to Follow-up|0|||
127968259|NCT04468347|460504858|FG001|Overall Study|Lost to Follow-up|0|||
127968260|NCT04468347|460504859|FG002|Overall Study|Lost to Follow-up|1|||
127968261|NCT04468347|460504860|FG003|Overall Study|Lost to Follow-up|1|||
127968262|NCT04468347|460504857|FG000|Overall Study|Physician Decision|1|||
127968263|NCT04468347|460504858|FG001|Overall Study|Physician Decision|0|||
127968264|NCT04468347|460504859|FG002|Overall Study|Physician Decision|2|||
127968265|NCT04468347|460504860|FG003|Overall Study|Physician Decision|0|||
127968266|NCT04468347|460504857|FG000|Overall Study|Protocol Violation|1|||
127968267|NCT04468347|460504858|FG001|Overall Study|Protocol Violation|0|||
127968268|NCT04468347|460504859|FG002|Overall Study|Protocol Violation|0|||
127968269|NCT04468347|460504860|FG003|Overall Study|Protocol Violation|0|||
127968270|NCT00554515|460504861|FG000|Overall Study|Withdrawal by Subject|3|||
127968271|NCT00554515|460504861|FG000|Overall Study|Disease progression|52|||
127968272|NCT00554515|460504861|FG000|Overall Study|Physician Decision|18|||
127968273|NCT00554515|460504861|FG000|Overall Study|Withdrawal by Subject|11|||
127968274|NCT00554515|460504861|FG000|Overall Study|Adverse Event|9|||
127968275|NCT00554515|460504861|FG000|Overall Study|Death|2|||
127968276|NCT00554515|460504861|FG000|Overall Study|Achieved Stable Disease|7|||
127968277|NCT00554515|460504861|FG000|Overall Study|Other|1|||
127968278|NCT00554515|460504861|FG000|Overall Study|Misc|15|||
127968279|NCT00665431|460504864|FG000|Overall Study|Adverse Event|16|||
127968280|NCT00665431|460504865|FG001|Overall Study|Adverse Event|22|||
127968281|NCT00665431|460504866|FG002|Overall Study|Adverse Event|6|||
127968282|NCT00665431|460504864|FG000|Overall Study|Withdrawal by Subject|17|||
127968283|NCT00665431|460504865|FG001|Overall Study|Withdrawal by Subject|25|||
127968284|NCT00665431|460504866|FG002|Overall Study|Withdrawal by Subject|15|||
127968285|NCT00665431|460504864|FG000|Overall Study|Lost to Follow-up|3|||
127968286|NCT00665431|460504865|FG001|Overall Study|Lost to Follow-up|3|||
127968287|NCT00665431|460504866|FG002|Overall Study|Lost to Follow-up|1|||
127968288|NCT00665431|460504864|FG000|Overall Study|Other|4|||
127968289|NCT00665431|460504865|FG001|Overall Study|Other|7|||
127968290|NCT00665431|460504866|FG002|Overall Study|Other|2|||
127968291|NCT00757042|460504872|FG000|Overall Study|Lost to Follow-up|0|||
127968292|NCT00757042|460504873|FG001|Overall Study|Lost to Follow-up|0|||
127968293|NCT00757042|460504874|FG002|Overall Study|Lost to Follow-up|0|||
127968294|NCT00757042|460504875|FG003|Overall Study|Lost to Follow-up|0|||
127968295|NCT00757042|460504876|FG004|Overall Study|Lost to Follow-up|0|||
127968296|NCT00757042|460504877|FG005|Overall Study|Lost to Follow-up|0|||
127968297|NCT00757042|460504878|FG006|Overall Study|Lost to Follow-up|0|||
127968298|NCT00757042|460504879|FG007|Overall Study|Lost to Follow-up|0|||
127968299|NCT00757042|460504880|FG008|Overall Study|Lost to Follow-up|1|||
127968300|NCT00757042|460504881|FG009|Overall Study|Lost to Follow-up|0|||
127968301|NCT00757042|460504882|FG010|Overall Study|Lost to Follow-up|0|||
127968302|NCT00757042|460504872|FG000|Overall Study|Ineligibility Determined|0|||
127968303|NCT00757042|460504873|FG001|Overall Study|Ineligibility Determined|0|||
127968304|NCT00757042|460504874|FG002|Overall Study|Ineligibility Determined|0|||
127968305|NCT00757042|460504875|FG003|Overall Study|Ineligibility Determined|0|||
127968306|NCT00757042|460504876|FG004|Overall Study|Ineligibility Determined|0|||
127968307|NCT00757042|460504877|FG005|Overall Study|Ineligibility Determined|0|||
127968308|NCT00757042|460504878|FG006|Overall Study|Ineligibility Determined|0|||
127968309|NCT00757042|460504879|FG007|Overall Study|Ineligibility Determined|0|||
127968310|NCT00757042|460504880|FG008|Overall Study|Ineligibility Determined|0|||
127968311|NCT00757042|460504881|FG009|Overall Study|Ineligibility Determined|0|||
127968312|NCT00757042|460504882|FG010|Overall Study|Ineligibility Determined|1|||
127968313|NCT00757042|460504872|FG000|Overall Study|Withdrawal by Subject|0|||
127968314|NCT00757042|460504873|FG001|Overall Study|Withdrawal by Subject|0|||
127968315|NCT00757042|460504874|FG002|Overall Study|Withdrawal by Subject|0|||
127968316|NCT00757042|460504875|FG003|Overall Study|Withdrawal by Subject|0|||
127968317|NCT00757042|460504876|FG004|Overall Study|Withdrawal by Subject|0|||
127968318|NCT00757042|460504877|FG005|Overall Study|Withdrawal by Subject|0|||
127968319|NCT00757042|460504878|FG006|Overall Study|Withdrawal by Subject|0|||
127968320|NCT00757042|460504879|FG007|Overall Study|Withdrawal by Subject|0|||
127968321|NCT00757042|460504880|FG008|Overall Study|Withdrawal by Subject|0|||
127968322|NCT00757042|460504881|FG009|Overall Study|Withdrawal by Subject|1|||
127968323|NCT00757042|460504882|FG010|Overall Study|Withdrawal by Subject|0|||
127968324|NCT01266291|460504887|FG000|Overall Study|Adverse Event|1|||
127968325|NCT03291431|460504888|FG000|Overall Study|Protocol Violation|2|||
127968326|NCT03291431|460504889|FG001|Overall Study|Protocol Violation|1|||
127968327|NCT03291431|460504888|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
127968328|NCT03291431|460504889|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
127976444|NCT03535194|460536125|FG000|Induction Period|Withdrawal by Subject|3|||
127968329|NCT03291431|460504888|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
127968330|NCT03291431|460504889|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
127968331|NCT00550745|460504892|FG000|Overall Study|Death|20|||
127968332|NCT00550745|460504893|FG001|Overall Study|Death|16|||
127968333|NCT00550745|460504892|FG000|Overall Study|Lost to Follow-up|45|||
127968334|NCT00550745|460504893|FG001|Overall Study|Lost to Follow-up|30|||
127968335|NCT00550745|460504892|FG000|Overall Study|Physician Decision|0|||
127968336|NCT00550745|460504893|FG001|Overall Study|Physician Decision|2|||
127968337|NCT00550745|460504892|FG000|Overall Study|Protocol Violation|4|||
127968338|NCT00550745|460504893|FG001|Overall Study|Protocol Violation|2|||
127968339|NCT00550745|460504892|FG000|Overall Study|Withdrawal by Subject|17|||
127968340|NCT00550745|460504893|FG001|Overall Study|Withdrawal by Subject|10|||
127968341|NCT00550745|460504892|FG000|Overall Study|Screen failure|1|||
127968342|NCT00550745|460504893|FG001|Overall Study|Screen failure|0|||
127968343|NCT03850483|460504894|FG000|Treatment for Stage 1|Adverse Event|1|||
127968344|NCT03850483|460504895|FG001|Treatment for Stage 1|Adverse Event|1|||
127968345|NCT03850483|460504896|FG002|Treatment for Stage 1|Adverse Event|3|||
127968346|NCT03850483|460504897|FG003|Treatment for Stage 1|Adverse Event|0|||
127968347|NCT03850483|460504898|FG004|Treatment for Stage 1|Adverse Event|2|||
127968348|NCT03850483|460504899|FG005|Treatment for Stage 1|Adverse Event|0|||
127968349|NCT03850483|460504900|FG006|Treatment for Stage 1|Adverse Event|2|||
127968350|NCT03850483|460504901|FG007|Treatment for Stage 1|Adverse Event|2|||
127968351|NCT03850483|460504902|FG008|Treatment for Stage 1|Adverse Event|0|||
127968352|NCT03850483|460504903|FG009|Treatment for Stage 1|Adverse Event|0|||
127968353|NCT03850483|460504894|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
127968354|NCT03850483|460504895|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
127968355|NCT03850483|460504896|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
127968356|NCT03850483|460504897|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
127968357|NCT03850483|460504898|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
127968358|NCT03850483|460504899|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
127968359|NCT03850483|460504900|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
127968360|NCT03850483|460504901|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
127968361|NCT03850483|460504902|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
127968362|NCT03850483|460504903|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
127968363|NCT03850483|460504894|FG000|Treatment for Stage 1|Protocol Violation|1|||
127968364|NCT03850483|460504895|FG001|Treatment for Stage 1|Protocol Violation|0|||
127968365|NCT03850483|460504896|FG002|Treatment for Stage 1|Protocol Violation|0|||
127968366|NCT03850483|460504897|FG003|Treatment for Stage 1|Protocol Violation|0|||
127968367|NCT03850483|460504898|FG004|Treatment for Stage 1|Protocol Violation|0|||
127968368|NCT03850483|460504899|FG005|Treatment for Stage 1|Protocol Violation|0|||
127968369|NCT03850483|460504900|FG006|Treatment for Stage 1|Protocol Violation|1|||
127968370|NCT03850483|460504901|FG007|Treatment for Stage 1|Protocol Violation|0|||
127968371|NCT03850483|460504902|FG008|Treatment for Stage 1|Protocol Violation|0|||
127968372|NCT03850483|460504903|FG009|Treatment for Stage 1|Protocol Violation|0|||
127968373|NCT03850483|460504894|FG000|Treatment for Stage 1|Physician Decision|0|||
127968374|NCT03850483|460504895|FG001|Treatment for Stage 1|Physician Decision|0|||
127968375|NCT03850483|460504896|FG002|Treatment for Stage 1|Physician Decision|0|||
127968376|NCT03850483|460504897|FG003|Treatment for Stage 1|Physician Decision|0|||
127968377|NCT03850483|460504898|FG004|Treatment for Stage 1|Physician Decision|0|||
127968378|NCT03850483|460504899|FG005|Treatment for Stage 1|Physician Decision|1|||
127968379|NCT03850483|460504900|FG006|Treatment for Stage 1|Physician Decision|0|||
127968380|NCT03850483|460504901|FG007|Treatment for Stage 1|Physician Decision|0|||
127968381|NCT03850483|460504902|FG008|Treatment for Stage 1|Physician Decision|0|||
127968382|NCT03850483|460504903|FG009|Treatment for Stage 1|Physician Decision|0|||
127968383|NCT03850483|460504894|FG000|Treatment for Stage 1|Other|0|||
127968384|NCT03850483|460504895|FG001|Treatment for Stage 1|Other|0|||
127968385|NCT03850483|460504896|FG002|Treatment for Stage 1|Other|0|||
127968386|NCT03850483|460504897|FG003|Treatment for Stage 1|Other|0|||
127968387|NCT03850483|460504898|FG004|Treatment for Stage 1|Other|2|||
127968388|NCT03850483|460504899|FG005|Treatment for Stage 1|Other|1|||
127968389|NCT03850483|460504900|FG006|Treatment for Stage 1|Other|0|||
127968390|NCT03850483|460504901|FG007|Treatment for Stage 1|Other|0|||
127968391|NCT03850483|460504902|FG008|Treatment for Stage 1|Other|0|||
127968392|NCT03850483|460504903|FG009|Treatment for Stage 1|Other|0|||
127968393|NCT03850483|460504894|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
127968394|NCT03850483|460504895|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
127968395|NCT03850483|460504896|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
127968396|NCT03850483|460504897|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
127968397|NCT03850483|460504898|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
127968398|NCT03850483|460504899|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
127968399|NCT03850483|460504900|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
127968400|NCT03850483|460504901|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
127968401|NCT03850483|460504902|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
127968402|NCT03850483|460504903|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
127968403|NCT03850483|460504894|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
127968404|NCT03850483|460504895|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
127968405|NCT03850483|460504896|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
127968406|NCT03850483|460504897|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
127968407|NCT03850483|460504898|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
127968408|NCT03850483|460504899|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
127968409|NCT03850483|460504900|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
127968410|NCT03850483|460504901|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
127968411|NCT03850483|460504902|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
127968412|NCT03850483|460504903|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
127968413|NCT03850483|460504894|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
127968414|NCT03850483|460504895|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
127968415|NCT03850483|460504896|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
127968416|NCT03850483|460504897|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
127968417|NCT03850483|460504898|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
127968418|NCT03850483|460504899|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
127968419|NCT03850483|460504900|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
127968420|NCT03850483|460504901|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
127968421|NCT03850483|460504902|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
127968422|NCT03850483|460504903|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
127968423|NCT03850483|460504894|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
127968424|NCT03850483|460504895|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
127968425|NCT03850483|460504896|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
127968426|NCT03850483|460504897|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
127968427|NCT03850483|460504898|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
127968428|NCT03850483|460504899|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
127968429|NCT03850483|460504900|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
127968430|NCT03850483|460504901|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
127968431|NCT03850483|460504902|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
127968432|NCT03850483|460504903|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
127968433|NCT03850483|460504894|FG000|Treatment for Stage 1|Death|0|||
127968434|NCT03850483|460504895|FG001|Treatment for Stage 1|Death|0|||
127968435|NCT03850483|460504896|FG002|Treatment for Stage 1|Death|0|||
127968436|NCT03850483|460504897|FG003|Treatment for Stage 1|Death|0|||
127968437|NCT03850483|460504898|FG004|Treatment for Stage 1|Death|0|||
127968438|NCT03850483|460504899|FG005|Treatment for Stage 1|Death|1|||
127968439|NCT03850483|460504900|FG006|Treatment for Stage 1|Death|0|||
127968440|NCT03850483|460504901|FG007|Treatment for Stage 1|Death|0|||
127968441|NCT03850483|460504902|FG008|Treatment for Stage 1|Death|0|||
127968442|NCT03850483|460504903|FG009|Treatment for Stage 1|Death|0|||
127968443|NCT03850483|460504894|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
127968444|NCT03850483|460504895|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
127968445|NCT03850483|460504896|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
127968446|NCT03850483|460504897|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
127968447|NCT03850483|460504898|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
127968448|NCT03850483|460504899|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
127968449|NCT03850483|460504900|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
127968450|NCT03850483|460504901|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
127968451|NCT03850483|460504902|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
127968452|NCT03850483|460504903|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
127968453|NCT03850483|460504894|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
127968454|NCT03850483|460504895|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
127968455|NCT03850483|460504896|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
127968456|NCT03850483|460504897|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
127968457|NCT03850483|460504898|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
127968458|NCT03850483|460504899|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
127968459|NCT03850483|460504900|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
127968460|NCT03850483|460504901|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
127968461|NCT03850483|460504902|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
127968462|NCT03850483|460504903|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
127968463|NCT03850483|460504894|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
127968464|NCT03850483|460504895|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
127968465|NCT03850483|460504896|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
127968466|NCT03850483|460504897|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
127968467|NCT03850483|460504898|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
127968468|NCT03850483|460504899|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
127968469|NCT03850483|460504900|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
127968470|NCT03850483|460504901|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
127968471|NCT03850483|460504902|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
127968472|NCT03850483|460504903|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
127968473|NCT03850483|460504894|FG000|Follow-up for Stage 1|Physician Decision|0|||
127968474|NCT03850483|460504895|FG001|Follow-up for Stage 1|Physician Decision|0|||
127968475|NCT03850483|460504896|FG002|Follow-up for Stage 1|Physician Decision|0|||
127968476|NCT03850483|460504897|FG003|Follow-up for Stage 1|Physician Decision|0|||
127968477|NCT03850483|460504898|FG004|Follow-up for Stage 1|Physician Decision|1|||
127968478|NCT03850483|460504899|FG005|Follow-up for Stage 1|Physician Decision|0|||
127968479|NCT03850483|460504900|FG006|Follow-up for Stage 1|Physician Decision|1|||
127968480|NCT03850483|460504901|FG007|Follow-up for Stage 1|Physician Decision|0|||
127968481|NCT03850483|460504902|FG008|Follow-up for Stage 1|Physician Decision|0|||
127968482|NCT03850483|460504903|FG009|Follow-up for Stage 1|Physician Decision|0|||
127968483|NCT03850483|460504894|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
127968484|NCT03850483|460504895|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
127968485|NCT03850483|460504896|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
127968486|NCT03850483|460504897|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
127968487|NCT03850483|460504898|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
127968488|NCT03850483|460504899|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
127968489|NCT03850483|460504900|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
127968490|NCT03850483|460504901|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
127968491|NCT03850483|460504902|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
127968492|NCT03850483|460504903|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
127968493|NCT03850483|460504894|FG000|Follow-up for Stage 1|Adverse Event|0|||
127968494|NCT03850483|460504895|FG001|Follow-up for Stage 1|Adverse Event|0|||
127968495|NCT03850483|460504896|FG002|Follow-up for Stage 1|Adverse Event|1|||
127968496|NCT03850483|460504897|FG003|Follow-up for Stage 1|Adverse Event|0|||
127968497|NCT03850483|460504898|FG004|Follow-up for Stage 1|Adverse Event|0|||
127968498|NCT03850483|460504899|FG005|Follow-up for Stage 1|Adverse Event|1|||
127968499|NCT03850483|460504900|FG006|Follow-up for Stage 1|Adverse Event|0|||
127968500|NCT03850483|460504901|FG007|Follow-up for Stage 1|Adverse Event|0|||
127968501|NCT03850483|460504902|FG008|Follow-up for Stage 1|Adverse Event|0|||
127968502|NCT03850483|460504903|FG009|Follow-up for Stage 1|Adverse Event|0|||
127968503|NCT03850483|460504894|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
127968504|NCT03850483|460504895|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
127968505|NCT03850483|460504896|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
127968506|NCT03850483|460504897|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
127968507|NCT03850483|460504898|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
127968508|NCT03850483|460504899|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
127968509|NCT03850483|460504900|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
127968510|NCT03850483|460504901|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
127968511|NCT03850483|460504902|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
127968512|NCT03850483|460504903|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
127968513|NCT03850483|460504894|FG000|Follow-up for Stage 1|Other|0|||
127968514|NCT03850483|460504895|FG001|Follow-up for Stage 1|Other|2|||
127968515|NCT03850483|460504896|FG002|Follow-up for Stage 1|Other|0|||
127968516|NCT03850483|460504897|FG003|Follow-up for Stage 1|Other|2|||
127968517|NCT03850483|460504898|FG004|Follow-up for Stage 1|Other|0|||
127968518|NCT03850483|460504899|FG005|Follow-up for Stage 1|Other|1|||
127968519|NCT03850483|460504900|FG006|Follow-up for Stage 1|Other|0|||
127968520|NCT03850483|460504901|FG007|Follow-up for Stage 1|Other|0|||
127968521|NCT03850483|460504902|FG008|Follow-up for Stage 1|Other|0|||
127968522|NCT03850483|460504903|FG009|Follow-up for Stage 1|Other|0|||
127968523|NCT03850483|460504894|FG000|Treatment for Stage 2|Adverse Event|0|||
127968524|NCT03850483|460504895|FG001|Treatment for Stage 2|Adverse Event|0|||
127968525|NCT03850483|460504896|FG002|Treatment for Stage 2|Adverse Event|0|||
127968526|NCT03850483|460504897|FG003|Treatment for Stage 2|Adverse Event|0|||
127968527|NCT03850483|460504898|FG004|Treatment for Stage 2|Adverse Event|0|||
127968528|NCT03850483|460504899|FG005|Treatment for Stage 2|Adverse Event|0|||
127968529|NCT03850483|460504900|FG006|Treatment for Stage 2|Adverse Event|0|||
127968530|NCT03850483|460504901|FG007|Treatment for Stage 2|Adverse Event|0|||
127968531|NCT03850483|460504902|FG008|Treatment for Stage 2|Adverse Event|0|||
127968532|NCT03850483|460504903|FG009|Treatment for Stage 2|Adverse Event|1|||
127968533|NCT03850483|460504894|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
127968534|NCT03850483|460504895|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
127968535|NCT03850483|460504896|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
127968536|NCT03850483|460504897|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
127968537|NCT03850483|460504898|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
127968538|NCT03850483|460504899|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
127968539|NCT03850483|460504900|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
127968540|NCT03850483|460504901|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
127968541|NCT03850483|460504902|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
127968542|NCT03850483|460504903|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
127968543|NCT03850483|460504894|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
127968544|NCT03850483|460504895|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
127968545|NCT03850483|460504896|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
127968546|NCT03850483|460504897|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
127968547|NCT03850483|460504898|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
127968548|NCT03850483|460504899|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
127968549|NCT03850483|460504900|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
127968550|NCT03850483|460504901|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
127968551|NCT03850483|460504902|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
127968552|NCT03850483|460504903|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
127968553|NCT03850483|460504894|FG000|Treatment for Stage 2|Physician Decision|0|||
127968554|NCT03850483|460504895|FG001|Treatment for Stage 2|Physician Decision|0|||
127968555|NCT03850483|460504896|FG002|Treatment for Stage 2|Physician Decision|0|||
127968556|NCT03850483|460504897|FG003|Treatment for Stage 2|Physician Decision|0|||
127968557|NCT03850483|460504898|FG004|Treatment for Stage 2|Physician Decision|0|||
127968558|NCT03850483|460504899|FG005|Treatment for Stage 2|Physician Decision|0|||
127968559|NCT03850483|460504900|FG006|Treatment for Stage 2|Physician Decision|0|||
127968560|NCT03850483|460504901|FG007|Treatment for Stage 2|Physician Decision|0|||
127968561|NCT03850483|460504902|FG008|Treatment for Stage 2|Physician Decision|0|||
127968562|NCT03850483|460504903|FG009|Treatment for Stage 2|Physician Decision|1|||
127968563|NCT03850483|460504894|FG000|Treatment for Stage 2|Protocol Violation|0|||
127968564|NCT03850483|460504895|FG001|Treatment for Stage 2|Protocol Violation|0|||
127968565|NCT03850483|460504896|FG002|Treatment for Stage 2|Protocol Violation|0|||
127968566|NCT03850483|460504897|FG003|Treatment for Stage 2|Protocol Violation|0|||
127968567|NCT03850483|460504898|FG004|Treatment for Stage 2|Protocol Violation|0|||
127968568|NCT03850483|460504899|FG005|Treatment for Stage 2|Protocol Violation|0|||
127968569|NCT03850483|460504900|FG006|Treatment for Stage 2|Protocol Violation|0|||
127968570|NCT03850483|460504901|FG007|Treatment for Stage 2|Protocol Violation|0|||
127968571|NCT03850483|460504902|FG008|Treatment for Stage 2|Protocol Violation|1|||
127968572|NCT03850483|460504903|FG009|Treatment for Stage 2|Protocol Violation|0|||
127968573|NCT03850483|460504894|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
127968574|NCT03850483|460504895|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
127968575|NCT03850483|460504896|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
127968576|NCT03850483|460504897|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
127968577|NCT03850483|460504898|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
127968578|NCT03850483|460504899|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
127968579|NCT03850483|460504900|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
127968580|NCT03850483|460504901|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
127968581|NCT03850483|460504902|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
127968582|NCT03850483|460504903|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
127968583|NCT03850483|460504894|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
127968584|NCT03850483|460504895|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
127968585|NCT03850483|460504896|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
127968586|NCT03850483|460504897|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
127968587|NCT03850483|460504898|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
127968588|NCT03850483|460504899|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
127968589|NCT03850483|460504900|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
127968590|NCT03850483|460504901|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
127968591|NCT03850483|460504902|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
127968592|NCT03850483|460504903|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
127968593|NCT03850483|460504894|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
127968594|NCT03850483|460504895|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
127968595|NCT03850483|460504896|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
127968596|NCT03850483|460504897|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
127968597|NCT03850483|460504898|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
127968598|NCT03850483|460504899|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
127968599|NCT03850483|460504900|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
127968600|NCT03850483|460504901|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
127968601|NCT03850483|460504902|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
127968602|NCT03850483|460504903|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
127968603|NCT03850483|460504894|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
127968604|NCT03850483|460504895|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
127968605|NCT03850483|460504896|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
127968606|NCT03850483|460504897|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
127968607|NCT03850483|460504898|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
127968608|NCT03850483|460504899|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
127968609|NCT03850483|460504900|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
127968610|NCT03850483|460504901|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
127968611|NCT03850483|460504902|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
127968612|NCT03850483|460504903|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
127968613|NCT03850483|460504894|FG000|Follow-up For Stage 2|Other|0|||
127968614|NCT03850483|460504895|FG001|Follow-up For Stage 2|Other|0|||
127968615|NCT03850483|460504896|FG002|Follow-up For Stage 2|Other|0|||
127968616|NCT03850483|460504897|FG003|Follow-up For Stage 2|Other|0|||
127968617|NCT03850483|460504898|FG004|Follow-up For Stage 2|Other|0|||
127968618|NCT03850483|460504899|FG005|Follow-up For Stage 2|Other|0|||
127968619|NCT03850483|460504900|FG006|Follow-up For Stage 2|Other|0|||
127968620|NCT03850483|460504901|FG007|Follow-up For Stage 2|Other|0|||
127968621|NCT03850483|460504902|FG008|Follow-up For Stage 2|Other|0|||
127968622|NCT03850483|460504903|FG009|Follow-up For Stage 2|Other|1|||
127968623|NCT04432831|460506831|FG000|Overall Study|Withdrawal by Subject|24|||
127968624|NCT04432831|460506832|FG001|Overall Study|Withdrawal by Subject|28|||
127968625|NCT04432831|460506833|FG002|Overall Study|Withdrawal by Subject|21|||
127968626|NCT04432831|460506831|FG000|Overall Study|Death|23|||
127968627|NCT04432831|460506832|FG001|Overall Study|Death|23|||
127968628|NCT04432831|460506833|FG002|Overall Study|Death|17|||
127968629|NCT04432831|460506831|FG000|Overall Study|Lost to Follow-up|15|||
127968630|NCT04432831|460506832|FG001|Overall Study|Lost to Follow-up|15|||
127968631|NCT04432831|460506833|FG002|Overall Study|Lost to Follow-up|12|||
127968632|NCT04432831|460506831|FG000|Overall Study|Final End of Study Visit Not Completed|10|||
127968633|NCT04432831|460506832|FG001|Overall Study|Final End of Study Visit Not Completed|11|||
127968634|NCT04432831|460506833|FG002|Overall Study|Final End of Study Visit Not Completed|7|||
127968635|NCT04432831|460506831|FG000|Overall Study|Reason Not Specified|7|||
127968636|NCT04432831|460506832|FG001|Overall Study|Reason Not Specified|11|||
127968637|NCT04432831|460506833|FG002|Overall Study|Reason Not Specified|9|||
127968638|NCT04432831|460506831|FG000|Overall Study|Adverse Event|7|||
127968639|NCT04432831|460506832|FG001|Overall Study|Adverse Event|7|||
127968640|NCT04432831|460506833|FG002|Overall Study|Adverse Event|7|||
127968641|NCT04432831|460506831|FG000|Overall Study|Physician Decision|1|||
127968642|NCT04432831|460506832|FG001|Overall Study|Physician Decision|3|||
127968643|NCT04432831|460506833|FG002|Overall Study|Physician Decision|6|||
127968644|NCT04432831|460506831|FG000|Overall Study|Protocol Violation|1|||
127968645|NCT04432831|460506832|FG001|Overall Study|Protocol Violation|0|||
127968646|NCT04432831|460506833|FG002|Overall Study|Protocol Violation|2|||
127968647|NCT04432831|460506831|FG000|Overall Study|Pregnancy|0|||
127968648|NCT04432831|460506832|FG001|Overall Study|Pregnancy|1|||
127968649|NCT04432831|460506833|FG002|Overall Study|Pregnancy|0|||
127968650|NCT04432831|460506831|FG000|Overall Study|Lack of Efficacy|0|||
127968651|NCT04432831|460506832|FG001|Overall Study|Lack of Efficacy|0|||
127968652|NCT04432831|460506833|FG002|Overall Study|Lack of Efficacy|2|||
127968653|NCT00652626|460506836|FG000|Initial Treatment Phase|Adverse Event|0|||
127968654|NCT00652626|460506837|FG001|Initial Treatment Phase|Adverse Event|0|||
127968655|NCT00652626|460506838|FG002|Initial Treatment Phase|Adverse Event|0|||
127968656|NCT00652626|460506839|FG003|Initial Treatment Phase|Adverse Event|0|||
127968657|NCT00652626|460506840|FG004|Initial Treatment Phase|Adverse Event|1|||
127968658|NCT00652626|460506841|FG005|Initial Treatment Phase|Adverse Event|0|||
127968659|NCT00652626|460506842|FG006|Initial Treatment Phase|Adverse Event|0|||
127968660|NCT00652626|460506836|FG000|Initial Treatment Phase|Protocol Violation|0|||
127968661|NCT00652626|460506837|FG001|Initial Treatment Phase|Protocol Violation|0|||
127968662|NCT00652626|460506838|FG002|Initial Treatment Phase|Protocol Violation|0|||
127968663|NCT00652626|460506839|FG003|Initial Treatment Phase|Protocol Violation|1|||
127968664|NCT00652626|460506840|FG004|Initial Treatment Phase|Protocol Violation|0|||
127968665|NCT00652626|460506841|FG005|Initial Treatment Phase|Protocol Violation|0|||
127968666|NCT00652626|460506842|FG006|Initial Treatment Phase|Protocol Violation|0|||
127968667|NCT00652626|460506836|FG000|Initial Treatment Phase|Physician Decision|0|||
127968668|NCT00652626|460506837|FG001|Initial Treatment Phase|Physician Decision|0|||
127968669|NCT00652626|460506838|FG002|Initial Treatment Phase|Physician Decision|0|||
127968670|NCT00652626|460506839|FG003|Initial Treatment Phase|Physician Decision|0|||
127968671|NCT00652626|460506840|FG004|Initial Treatment Phase|Physician Decision|1|||
127968672|NCT00652626|460506841|FG005|Initial Treatment Phase|Physician Decision|0|||
127968673|NCT00652626|460506842|FG006|Initial Treatment Phase|Physician Decision|0|||
127968674|NCT00652626|460506836|FG000|Initial Treatment Phase|Sponsor Request|0|||
127968675|NCT00652626|460506837|FG001|Initial Treatment Phase|Sponsor Request|0|||
127968676|NCT00652626|460506838|FG002|Initial Treatment Phase|Sponsor Request|1|||
127968677|NCT00652626|460506839|FG003|Initial Treatment Phase|Sponsor Request|0|||
127968678|NCT00652626|460506840|FG004|Initial Treatment Phase|Sponsor Request|0|||
127968679|NCT00652626|460506841|FG005|Initial Treatment Phase|Sponsor Request|0|||
127968680|NCT00652626|460506842|FG006|Initial Treatment Phase|Sponsor Request|0|||
127968681|NCT00652626|460506836|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
127968682|NCT00652626|460506837|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
127968683|NCT00652626|460506838|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
127968684|NCT00652626|460506839|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
127968685|NCT00652626|460506840|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
127968686|NCT00652626|460506841|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
127968687|NCT00652626|460506842|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
127968688|NCT00652626|460506836|FG000|Extension Phase|Withdrawal by Subject|0|||
127968689|NCT00652626|460506837|FG001|Extension Phase|Withdrawal by Subject|0|||
127968690|NCT00652626|460506838|FG002|Extension Phase|Withdrawal by Subject|0|||
127968691|NCT00652626|460506839|FG003|Extension Phase|Withdrawal by Subject|0|||
127968692|NCT00652626|460506840|FG004|Extension Phase|Withdrawal by Subject|0|||
127968693|NCT00652626|460506841|FG005|Extension Phase|Withdrawal by Subject|2|||
127968694|NCT00652626|460506842|FG006|Extension Phase|Withdrawal by Subject|0|||
127968695|NCT00652626|460506836|FG000|Extension Phase|Adverse Event|0|||
127968696|NCT00652626|460506837|FG001|Extension Phase|Adverse Event|0|||
127968697|NCT00652626|460506838|FG002|Extension Phase|Adverse Event|0|||
127968698|NCT00652626|460506839|FG003|Extension Phase|Adverse Event|0|||
127968699|NCT00652626|460506840|FG004|Extension Phase|Adverse Event|0|||
127968700|NCT00652626|460506841|FG005|Extension Phase|Adverse Event|2|||
127968701|NCT00652626|460506842|FG006|Extension Phase|Adverse Event|1|||
127968702|NCT00652626|460506836|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
127968703|NCT00652626|460506837|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
127968704|NCT00652626|460506838|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
127968705|NCT00652626|460506839|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
127968706|NCT00652626|460506840|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
127968707|NCT00652626|460506841|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
127968708|NCT00652626|460506842|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
127968709|NCT00652626|460506836|FG000|Extension Phase|Physician Decision|0|||
127968710|NCT00652626|460506837|FG001|Extension Phase|Physician Decision|0|||
127968711|NCT00652626|460506838|FG002|Extension Phase|Physician Decision|0|||
127968712|NCT00652626|460506839|FG003|Extension Phase|Physician Decision|0|||
127968713|NCT00652626|460506840|FG004|Extension Phase|Physician Decision|0|||
127968714|NCT00652626|460506841|FG005|Extension Phase|Physician Decision|1|||
127968715|NCT00652626|460506842|FG006|Extension Phase|Physician Decision|1|||
127968716|NCT00652626|460506836|FG000|Extension Phase|Death|0|||
127968717|NCT00652626|460506837|FG001|Extension Phase|Death|0|||
127968718|NCT00652626|460506838|FG002|Extension Phase|Death|0|||
127968719|NCT00652626|460506839|FG003|Extension Phase|Death|0|||
127968720|NCT00652626|460506840|FG004|Extension Phase|Death|0|||
127968721|NCT00652626|460506841|FG005|Extension Phase|Death|1|||
127968722|NCT00652626|460506842|FG006|Extension Phase|Death|1|||
127968723|NCT01623310|460506843|FG000|Overall Study|Adverse Event|21|||
127968724|NCT01623310|460506843|FG000|Overall Study|Lost to Follow-up|18|||
127968725|NCT01623310|460506843|FG000|Overall Study|Lack of Efficacy|6|||
127968726|NCT01623310|460506843|FG000|Overall Study|Protocol Violation|6|||
127968727|NCT01623310|460506843|FG000|Overall Study|Withdrawal by Subject|25|||
127968728|NCT01623310|460506843|FG000|Overall Study|Became potentially child-bearing|1|||
127968729|NCT01623310|460506843|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
127968730|NCT01623310|460506843|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
127968731|NCT02898597|460506844|FG000|Overall Study|Protocol Violation|4|||
127968732|NCT02898597|460506845|FG001|Overall Study|Protocol Violation|2|||
127968733|NCT02898597|460506844|FG000|Overall Study|Lost to Follow-up|0|||
127968734|NCT02898597|460506845|FG001|Overall Study|Lost to Follow-up|9|||
127968735|NCT02898597|460506844|FG000|Overall Study|Death|0|||
127968736|NCT02898597|460506845|FG001|Overall Study|Death|1|||
127968737|NCT02530125|460506846|FG000|Completed Treatment|Early termination of study|1|||
127968738|NCT02530125|460506846|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
127968739|NCT00356603|460506847|FG000|Overall Study|Other|6|||
127968740|NCT00356603|460506848|FG001|Overall Study|Other|3|||
127968741|NCT00728468|460506850|FG000|Overall Study|Enrolled but not treated|1|||
127968742|NCT00728468|460506850|FG000|Overall Study|Death|1|||
127968743|NCT00728468|460506850|FG000|Overall Study|Protocol Violation|4|||
127968744|NCT00728468|460506850|FG000|Overall Study|Objective progression or relapse|9|||
127968745|NCT00728468|460506850|FG000|Overall Study|Study terminated by sponsor|1|||
127968746|NCT01568034|460506851|FG000|Overall Study|Withdrawal by Subject|1|||
127968747|NCT01568034|460506852|FG001|Overall Study|Withdrawal by Subject|0|||
127968748|NCT01568034|460506853|FG002|Overall Study|Withdrawal by Subject|0|||
127968749|NCT01568034|460506854|FG003|Overall Study|Withdrawal by Subject|0|||
127968750|NCT00932373|460506855|FG000|Overall Study|Progressive disease|3|||
127968751|NCT00932373|460506856|FG001|Overall Study|Progressive disease|1|||
127968752|NCT00932373|460506857|FG002|Overall Study|Progressive disease|0|||
127968753|NCT00932373|460506858|FG003|Overall Study|Progressive disease|0|||
127968754|NCT00932373|460506859|FG004|Overall Study|Progressive disease|10|||
127968755|NCT00932373|460506860|FG005|Overall Study|Progressive disease|1|||
127968756|NCT00932373|460506861|FG006|Overall Study|Progressive disease|0|||
127968757|NCT00932373|460506862|FG007|Overall Study|Progressive disease|2|||
127968758|NCT00932373|460506863|FG008|Overall Study|Progressive disease|1|||
127968759|NCT00932373|460506864|FG009|Overall Study|Progressive disease|9|||
127968760|NCT00932373|460506865|FG010|Overall Study|Progressive disease|2|||
127968761|NCT00932373|460506855|FG000|Overall Study|Adverse Event|0|||
127968762|NCT00932373|460506856|FG001|Overall Study|Adverse Event|0|||
127968763|NCT00932373|460506857|FG002|Overall Study|Adverse Event|0|||
127968764|NCT00932373|460506858|FG003|Overall Study|Adverse Event|0|||
127968765|NCT00932373|460506859|FG004|Overall Study|Adverse Event|2|||
127968766|NCT00932373|460506860|FG005|Overall Study|Adverse Event|1|||
127968767|NCT00932373|460506861|FG006|Overall Study|Adverse Event|0|||
127968768|NCT00932373|460506862|FG007|Overall Study|Adverse Event|1|||
127968769|NCT00932373|460506863|FG008|Overall Study|Adverse Event|0|||
127968770|NCT00932373|460506864|FG009|Overall Study|Adverse Event|2|||
127968771|NCT00932373|460506865|FG010|Overall Study|Adverse Event|1|||
127968772|NCT00932373|460506855|FG000|Overall Study|Physician Decision|0|||
127968773|NCT00932373|460506856|FG001|Overall Study|Physician Decision|0|||
127968774|NCT00932373|460506857|FG002|Overall Study|Physician Decision|1|||
127968775|NCT00932373|460506858|FG003|Overall Study|Physician Decision|0|||
127968776|NCT00932373|460506859|FG004|Overall Study|Physician Decision|2|||
127968777|NCT00932373|460506860|FG005|Overall Study|Physician Decision|0|||
127968778|NCT00932373|460506861|FG006|Overall Study|Physician Decision|0|||
127968779|NCT00932373|460506862|FG007|Overall Study|Physician Decision|0|||
127968780|NCT00932373|460506863|FG008|Overall Study|Physician Decision|0|||
127968781|NCT00932373|460506864|FG009|Overall Study|Physician Decision|1|||
127968782|NCT00932373|460506865|FG010|Overall Study|Physician Decision|0|||
127968783|NCT00932373|460506855|FG000|Overall Study|Dose limiting toxicity|0|||
127968784|NCT00932373|460506856|FG001|Overall Study|Dose limiting toxicity|0|||
127968785|NCT00932373|460506857|FG002|Overall Study|Dose limiting toxicity|0|||
127968786|NCT00932373|460506858|FG003|Overall Study|Dose limiting toxicity|0|||
127968787|NCT00932373|460506859|FG004|Overall Study|Dose limiting toxicity|0|||
127968788|NCT00932373|460506860|FG005|Overall Study|Dose limiting toxicity|1|||
127968789|NCT00932373|460506861|FG006|Overall Study|Dose limiting toxicity|0|||
127968790|NCT00932373|460506862|FG007|Overall Study|Dose limiting toxicity|0|||
127968791|NCT00932373|460506863|FG008|Overall Study|Dose limiting toxicity|0|||
127968792|NCT00932373|460506864|FG009|Overall Study|Dose limiting toxicity|0|||
127968793|NCT00932373|460506865|FG010|Overall Study|Dose limiting toxicity|0|||
127968794|NCT00932373|460506855|FG000|Overall Study|Withdrawal by Subject|0|||
127968795|NCT00932373|460506856|FG001|Overall Study|Withdrawal by Subject|0|||
127968796|NCT00932373|460506857|FG002|Overall Study|Withdrawal by Subject|0|||
127968797|NCT00932373|460506858|FG003|Overall Study|Withdrawal by Subject|0|||
127968798|NCT00932373|460506859|FG004|Overall Study|Withdrawal by Subject|0|||
127968799|NCT00932373|460506860|FG005|Overall Study|Withdrawal by Subject|0|||
127968800|NCT00932373|460506861|FG006|Overall Study|Withdrawal by Subject|0|||
127968801|NCT00932373|460506862|FG007|Overall Study|Withdrawal by Subject|0|||
127968802|NCT00932373|460506863|FG008|Overall Study|Withdrawal by Subject|1|||
127968803|NCT00932373|460506864|FG009|Overall Study|Withdrawal by Subject|0|||
127968804|NCT00932373|460506865|FG010|Overall Study|Withdrawal by Subject|0|||
127968805|NCT00932373|460506855|FG000|Overall Study|Clinical progression|0|||
127968806|NCT00932373|460506856|FG001|Overall Study|Clinical progression|0|||
127968807|NCT00932373|460506857|FG002|Overall Study|Clinical progression|0|||
127968808|NCT00932373|460506858|FG003|Overall Study|Clinical progression|0|||
127968809|NCT00932373|460506859|FG004|Overall Study|Clinical progression|0|||
127968810|NCT00932373|460506860|FG005|Overall Study|Clinical progression|0|||
127968811|NCT00932373|460506861|FG006|Overall Study|Clinical progression|1|||
127968812|NCT00932373|460506862|FG007|Overall Study|Clinical progression|0|||
127968813|NCT00932373|460506863|FG008|Overall Study|Clinical progression|0|||
127968814|NCT00932373|460506864|FG009|Overall Study|Clinical progression|0|||
127968815|NCT00932373|460506865|FG010|Overall Study|Clinical progression|0|||
127968816|NCT00932373|460506855|FG000|Overall Study|Lack of Efficacy|0|||
127968817|NCT00932373|460506856|FG001|Overall Study|Lack of Efficacy|0|||
127968818|NCT00932373|460506857|FG002|Overall Study|Lack of Efficacy|0|||
127968819|NCT00932373|460506858|FG003|Overall Study|Lack of Efficacy|0|||
127968820|NCT00932373|460506859|FG004|Overall Study|Lack of Efficacy|0|||
127968821|NCT00932373|460506860|FG005|Overall Study|Lack of Efficacy|0|||
127968822|NCT00932373|460506861|FG006|Overall Study|Lack of Efficacy|0|||
127968823|NCT00932373|460506862|FG007|Overall Study|Lack of Efficacy|0|||
127968824|NCT00932373|460506863|FG008|Overall Study|Lack of Efficacy|0|||
127968825|NCT00932373|460506864|FG009|Overall Study|Lack of Efficacy|1|||
127968826|NCT00932373|460506865|FG010|Overall Study|Lack of Efficacy|0|||
127968827|NCT01637922|460506866|FG000|Overall Study|Adverse Event|0|||
127968828|NCT01637922|460506867|FG001|Overall Study|Adverse Event|1|||
127968829|NCT01637922|460506866|FG000|Overall Study|Protocol Violation|0|||
127968830|NCT01637922|460506867|FG001|Overall Study|Protocol Violation|1|||
127968831|NCT01637922|460506866|FG000|Overall Study|Withdrawal by Subject|0|||
127968832|NCT01637922|460506867|FG001|Overall Study|Withdrawal by Subject|3|||
127968833|NCT01637922|460506866|FG000|Overall Study|Lost to Follow-up|2|||
127968834|NCT01637922|460506867|FG001|Overall Study|Lost to Follow-up|0|||
127968835|NCT00638404|460506868|FG000|Overall Study|Physician Decision|8|||
127968836|NCT00638404|460506869|FG001|Overall Study|Physician Decision|0|||
127968837|NCT02027545|460506870|FG000|Overall Study|Failed to sign HIPAA|0|||
127968838|NCT02027545|460506871|FG001|Overall Study|Failed to sign HIPAA|2|||
127968839|NCT02027545|460506870|FG000|Overall Study|Failed to attend study visit|2|||
127968840|NCT02027545|460506871|FG001|Overall Study|Failed to attend study visit|0|||
127968841|NCT02027545|460506870|FG000|Overall Study|Protocol Violation|1|||
127968842|NCT02027545|460506871|FG001|Overall Study|Protocol Violation|0|||
127968843|NCT02693106|460506874|FG000|Overall Study|No time|3|||
127968844|NCT02509507|460506875|FG000|Overall Study|Death|21|||
127968845|NCT02509507|460506876|FG001|Overall Study|Death|3|||
127968846|NCT02509507|460506877|FG002|Overall Study|Death|22|||
127968847|NCT02509507|460506878|FG003|Overall Study|Death|14|||
127968848|NCT02509507|460506879|FG004|Overall Study|Death|8|||
127968849|NCT02509507|460506880|FG005|Overall Study|Death|12|||
127968850|NCT02509507|460506881|FG006|Overall Study|Death|5|||
127968851|NCT02509507|460506882|FG007|Overall Study|Death|4|||
127968852|NCT02509507|460506883|FG008|Overall Study|Death|8|||
127968853|NCT02509507|460506875|FG000|Overall Study|Lost to Follow-up|0|||
127968854|NCT02509507|460506876|FG001|Overall Study|Lost to Follow-up|1|||
127968855|NCT02509507|460506877|FG002|Overall Study|Lost to Follow-up|0|||
127968856|NCT02509507|460506878|FG003|Overall Study|Lost to Follow-up|0|||
127968857|NCT02509507|460506879|FG004|Overall Study|Lost to Follow-up|0|||
127968858|NCT02509507|460506880|FG005|Overall Study|Lost to Follow-up|2|||
127968859|NCT02509507|460506881|FG006|Overall Study|Lost to Follow-up|0|||
127968860|NCT02509507|460506882|FG007|Overall Study|Lost to Follow-up|0|||
127968861|NCT02509507|460506883|FG008|Overall Study|Lost to Follow-up|0|||
127968862|NCT02509507|460506875|FG000|Overall Study|Withdrawal by Subject|2|||
127968863|NCT02509507|460506876|FG001|Overall Study|Withdrawal by Subject|0|||
127968864|NCT02509507|460506877|FG002|Overall Study|Withdrawal by Subject|1|||
127968865|NCT02509507|460506878|FG003|Overall Study|Withdrawal by Subject|4|||
127968866|NCT02509507|460506879|FG004|Overall Study|Withdrawal by Subject|1|||
127968867|NCT02509507|460506880|FG005|Overall Study|Withdrawal by Subject|3|||
127968868|NCT02509507|460506881|FG006|Overall Study|Withdrawal by Subject|4|||
127968869|NCT02509507|460506882|FG007|Overall Study|Withdrawal by Subject|0|||
127968870|NCT02509507|460506883|FG008|Overall Study|Withdrawal by Subject|1|||
127968871|NCT02510664|460506887|FG000|Overall Study|Transferred Care|9|||
127968872|NCT02510664|460506888|FG001|Overall Study|Transferred Care|9|||
127968873|NCT02510664|460506889|FG002|Overall Study|Transferred Care|0|||
127968874|NCT02510664|460506887|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
127968875|NCT02510664|460506888|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
127968876|NCT02510664|460506889|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
127968877|NCT02510664|460506887|FG000|Overall Study|Time Constraints|1|||
127968878|NCT02510664|460506888|FG001|Overall Study|Time Constraints|1|||
127968879|NCT02510664|460506889|FG002|Overall Study|Time Constraints|0|||
127968880|NCT04090060|460506892|FG000|Overall Study|Lost to Follow-up|76|||
127968881|NCT04090060|460506893|FG001|Overall Study|Lost to Follow-up|77|||
127968882|NCT03337113|460506900|FG000|Overall Study|Adverse Event|1|||
127968883|NCT03337113|460506901|FG001|Overall Study|Adverse Event|1|||
127968884|NCT03337113|460506902|FG002|Overall Study|Adverse Event|0|||
127968885|NCT03337113|460506903|FG003|Overall Study|Adverse Event|1|||
127968886|NCT03337113|460506900|FG000|Overall Study|Physician Decision|0|||
127968887|NCT03337113|460506901|FG001|Overall Study|Physician Decision|2|||
127968888|NCT03337113|460506902|FG002|Overall Study|Physician Decision|0|||
127968889|NCT03337113|460506903|FG003|Overall Study|Physician Decision|1|||
127968890|NCT03337113|460506900|FG000|Overall Study|Withdrawal by Subject|0|||
127968891|NCT03337113|460506901|FG001|Overall Study|Withdrawal by Subject|0|||
127968892|NCT03337113|460506902|FG002|Overall Study|Withdrawal by Subject|1|||
127968893|NCT03337113|460506903|FG003|Overall Study|Withdrawal by Subject|0|||
127968894|NCT01164579|460506904|FG000|Overall Study|Lack of Efficacy|0|||
127968895|NCT01164579|460506905|FG001|Overall Study|Lack of Efficacy|0|||
127968896|NCT01164579|460506906|FG002|Overall Study|Lack of Efficacy|6|||
127968897|NCT01164579|460506904|FG000|Overall Study|Lost to Follow-up|1|||
127968898|NCT01164579|460506905|FG001|Overall Study|Lost to Follow-up|1|||
127968899|NCT01164579|460506906|FG002|Overall Study|Lost to Follow-up|0|||
127968900|NCT01164579|460506904|FG000|Overall Study|Withdrawal by Subject|2|||
127968901|NCT01164579|460506905|FG001|Overall Study|Withdrawal by Subject|5|||
127968902|NCT01164579|460506906|FG002|Overall Study|Withdrawal by Subject|3|||
127968903|NCT01164579|460506904|FG000|Overall Study|Protocol Violation|0|||
127968904|NCT01164579|460506905|FG001|Overall Study|Protocol Violation|1|||
127968905|NCT01164579|460506906|FG002|Overall Study|Protocol Violation|2|||
127968906|NCT01164579|460506904|FG000|Overall Study|Adverse Event|4|||
127968907|NCT01164579|460506905|FG001|Overall Study|Adverse Event|2|||
127968908|NCT01164579|460506906|FG002|Overall Study|Adverse Event|5|||
127968909|NCT01164579|460506904|FG000|Overall Study|Reason not specified|1|||
127968910|NCT01164579|460506905|FG001|Overall Study|Reason not specified|0|||
127968911|NCT01164579|460506906|FG002|Overall Study|Reason not specified|0|||
127968912|NCT02176655|460506912|FG000|Overall Study|Subjects did not treat|6|||
127968913|NCT01464593|460506913|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
127968914|NCT02476578|460506920|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
127968915|NCT02476578|460506921|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
127968916|NCT02476578|460506920|FG000|Overall Study|Lost to Follow-up|6|||
127968917|NCT02476578|460506921|FG001|Overall Study|Lost to Follow-up|13|||
127968918|NCT00912743|460506924|FG000|Overall Study|Adverse Event|3|||
127968919|NCT00912743|460506925|FG001|Overall Study|Adverse Event|1|||
127968920|NCT00912743|460506924|FG000|Overall Study|Lack of Efficacy|9|||
127968921|NCT00912743|460506925|FG001|Overall Study|Lack of Efficacy|18|||
127968922|NCT00912743|460506924|FG000|Overall Study|Toxicity|0|||
127968923|NCT00912743|460506925|FG001|Overall Study|Toxicity|1|||
127968924|NCT00912743|460506924|FG000|Overall Study|End of treatment form was not collected|1|||
127968925|NCT00912743|460506925|FG001|Overall Study|End of treatment form was not collected|0|||
127968926|NCT00685399|460506936|FG000|Treatment Period 1|Withdrawal by Subject|2|||
127968927|NCT00685399|460506937|FG001|Treatment Period 1|Withdrawal by Subject|0|||
127968928|NCT00685399|460506938|FG002|Treatment Period 1|Withdrawal by Subject|0|||
127968929|NCT00685399|460506939|FG003|Treatment Period 1|Withdrawal by Subject|0|||
127968930|NCT00685399|460506940|FG004|Treatment Period 1|Withdrawal by Subject|0|||
127968931|NCT00685399|460506941|FG005|Treatment Period 1|Withdrawal by Subject|0|||
127968932|NCT00685399|460506942|FG006|Treatment Period 1|Withdrawal by Subject|0|||
127968933|NCT00685399|460506943|FG007|Treatment Period 1|Withdrawal by Subject|0|||
127968934|NCT00685399|460506936|FG000|Treatment Period 1|Protocol Violation|1|||
127968935|NCT00685399|460506937|FG001|Treatment Period 1|Protocol Violation|0|||
127968936|NCT00685399|460506938|FG002|Treatment Period 1|Protocol Violation|0|||
127968937|NCT00685399|460506939|FG003|Treatment Period 1|Protocol Violation|0|||
127968938|NCT00685399|460506940|FG004|Treatment Period 1|Protocol Violation|0|||
127968939|NCT00685399|460506941|FG005|Treatment Period 1|Protocol Violation|0|||
127968940|NCT00685399|460506942|FG006|Treatment Period 1|Protocol Violation|0|||
127968941|NCT00685399|460506943|FG007|Treatment Period 1|Protocol Violation|0|||
127968942|NCT00685399|460506936|FG000|Treatment Period 1|Administrative|2|||
127968943|NCT00685399|460506937|FG001|Treatment Period 1|Administrative|0|||
127968944|NCT00685399|460506938|FG002|Treatment Period 1|Administrative|0|||
127968945|NCT00685399|460506939|FG003|Treatment Period 1|Administrative|0|||
127968946|NCT00685399|460506940|FG004|Treatment Period 1|Administrative|0|||
127968947|NCT00685399|460506941|FG005|Treatment Period 1|Administrative|0|||
127968948|NCT00685399|460506942|FG006|Treatment Period 1|Administrative|0|||
127968949|NCT00685399|460506943|FG007|Treatment Period 1|Administrative|0|||
127968950|NCT00685399|460506936|FG000|Treatment Period 1|Lack of Efficacy|1|||
127968951|NCT00685399|460506937|FG001|Treatment Period 1|Lack of Efficacy|0|||
127968952|NCT00685399|460506938|FG002|Treatment Period 1|Lack of Efficacy|0|||
127968953|NCT00685399|460506939|FG003|Treatment Period 1|Lack of Efficacy|0|||
127968954|NCT00685399|460506940|FG004|Treatment Period 1|Lack of Efficacy|0|||
127968955|NCT00685399|460506941|FG005|Treatment Period 1|Lack of Efficacy|0|||
127968956|NCT00685399|460506942|FG006|Treatment Period 1|Lack of Efficacy|0|||
127968957|NCT00685399|460506943|FG007|Treatment Period 1|Lack of Efficacy|0|||
127968958|NCT00685399|460506936|FG000|Treatment Period 2|Administrative Problems|0|||
127968959|NCT00685399|460506937|FG001|Treatment Period 2|Administrative Problems|2|||
127968960|NCT00685399|460506938|FG002|Treatment Period 2|Administrative Problems|1|||
127968961|NCT00685399|460506939|FG003|Treatment Period 2|Administrative Problems|0|||
127968962|NCT00685399|460506940|FG004|Treatment Period 2|Administrative Problems|0|||
127968963|NCT00685399|460506941|FG005|Treatment Period 2|Administrative Problems|0|||
127968964|NCT00685399|460506942|FG006|Treatment Period 2|Administrative Problems|0|||
127968965|NCT00685399|460506943|FG007|Treatment Period 2|Administrative Problems|0|||
127968966|NCT00685399|460506936|FG000|Treatment Period 2|Withdrawal by Subject|0|||
127968967|NCT00685399|460506937|FG001|Treatment Period 2|Withdrawal by Subject|0|||
127968968|NCT00685399|460506938|FG002|Treatment Period 2|Withdrawal by Subject|0|||
127968969|NCT00685399|460506939|FG003|Treatment Period 2|Withdrawal by Subject|0|||
127968970|NCT00685399|460506940|FG004|Treatment Period 2|Withdrawal by Subject|0|||
127968971|NCT00685399|460506941|FG005|Treatment Period 2|Withdrawal by Subject|0|||
127968972|NCT00685399|460506942|FG006|Treatment Period 2|Withdrawal by Subject|0|||
127968973|NCT00685399|460506943|FG007|Treatment Period 2|Withdrawal by Subject|2|||
127968974|NCT00685399|460506936|FG000|Treatment Period 2|Adverse Event|0|||
127968975|NCT00685399|460506937|FG001|Treatment Period 2|Adverse Event|0|||
127968976|NCT00685399|460506938|FG002|Treatment Period 2|Adverse Event|0|||
127968977|NCT00685399|460506939|FG003|Treatment Period 2|Adverse Event|0|||
127968978|NCT00685399|460506940|FG004|Treatment Period 2|Adverse Event|0|||
127968979|NCT00685399|460506941|FG005|Treatment Period 2|Adverse Event|1|||
127968980|NCT00685399|460506942|FG006|Treatment Period 2|Adverse Event|0|||
127968981|NCT00685399|460506943|FG007|Treatment Period 2|Adverse Event|0|||
127968982|NCT00685399|460506936|FG000|Treatment Period 2|Lack of Efficacy|0|||
127968983|NCT00685399|460506937|FG001|Treatment Period 2|Lack of Efficacy|10|||
127968984|NCT00685399|460506938|FG002|Treatment Period 2|Lack of Efficacy|2|||
127968985|NCT00685399|460506939|FG003|Treatment Period 2|Lack of Efficacy|0|||
127968986|NCT00685399|460506940|FG004|Treatment Period 2|Lack of Efficacy|0|||
127968987|NCT00685399|460506941|FG005|Treatment Period 2|Lack of Efficacy|1|||
127968988|NCT00685399|460506942|FG006|Treatment Period 2|Lack of Efficacy|0|||
127968989|NCT00685399|460506943|FG007|Treatment Period 2|Lack of Efficacy|0|||
127968990|NCT00685399|460506936|FG000|Extension|Administrative Issues|0|||
127968991|NCT00685399|460506937|FG001|Extension|Administrative Issues|0|||
127968992|NCT00685399|460506938|FG002|Extension|Administrative Issues|0|||
127968993|NCT00685399|460506939|FG003|Extension|Administrative Issues|1|||
127968994|NCT00685399|460506940|FG004|Extension|Administrative Issues|0|||
127968995|NCT00685399|460506941|FG005|Extension|Administrative Issues|0|||
127968996|NCT00685399|460506942|FG006|Extension|Administrative Issues|0|||
127968997|NCT00685399|460506943|FG007|Extension|Administrative Issues|0|||
127968998|NCT00685399|460506936|FG000|Extension|Withdrawal by Subject|0|||
127968999|NCT00685399|460506937|FG001|Extension|Withdrawal by Subject|0|||
127969000|NCT00685399|460506938|FG002|Extension|Withdrawal by Subject|0|||
127969001|NCT00685399|460506939|FG003|Extension|Withdrawal by Subject|1|||
127969002|NCT00685399|460506940|FG004|Extension|Withdrawal by Subject|0|||
127969003|NCT00685399|460506941|FG005|Extension|Withdrawal by Subject|0|||
127969004|NCT00685399|460506942|FG006|Extension|Withdrawal by Subject|0|||
127969005|NCT00685399|460506943|FG007|Extension|Withdrawal by Subject|0|||
127969006|NCT00685399|460506936|FG000|Extension|Protocol Violation|0|||
127969007|NCT00685399|460506937|FG001|Extension|Protocol Violation|0|||
127969008|NCT00685399|460506938|FG002|Extension|Protocol Violation|0|||
127969009|NCT00685399|460506939|FG003|Extension|Protocol Violation|1|||
127969010|NCT00685399|460506940|FG004|Extension|Protocol Violation|0|||
127969011|NCT00685399|460506941|FG005|Extension|Protocol Violation|0|||
127969012|NCT00685399|460506942|FG006|Extension|Protocol Violation|0|||
127969013|NCT00685399|460506943|FG007|Extension|Protocol Violation|0|||
127969014|NCT00685399|460506936|FG000|Extension|Lack of Efficacy|0|||
127969015|NCT00685399|460506937|FG001|Extension|Lack of Efficacy|0|||
127969016|NCT00685399|460506938|FG002|Extension|Lack of Efficacy|0|||
127969017|NCT00685399|460506939|FG003|Extension|Lack of Efficacy|2|||
127969018|NCT00685399|460506940|FG004|Extension|Lack of Efficacy|0|||
127969019|NCT00685399|460506941|FG005|Extension|Lack of Efficacy|0|||
127969020|NCT00685399|460506942|FG006|Extension|Lack of Efficacy|0|||
127969021|NCT00685399|460506943|FG007|Extension|Lack of Efficacy|0|||
127969022|NCT00685399|460506936|FG000|Extension|Adverse Event|0|||
127969023|NCT00685399|460506937|FG001|Extension|Adverse Event|0|||
127969024|NCT00685399|460506938|FG002|Extension|Adverse Event|0|||
127969025|NCT00685399|460506939|FG003|Extension|Adverse Event|2|||
127969026|NCT00685399|460506940|FG004|Extension|Adverse Event|0|||
127969027|NCT00685399|460506941|FG005|Extension|Adverse Event|0|||
127969028|NCT00685399|460506942|FG006|Extension|Adverse Event|0|||
127969029|NCT00685399|460506943|FG007|Extension|Adverse Event|0|||
127969030|NCT01750697|460506944|FG000|Overall Study|Transferred Back to Local Hospital|1|||
127969031|NCT01750697|460506944|FG000|Overall Study|Physician and Family Decision|1|||
127969032|NCT01750697|460506944|FG000|Overall Study|Transferred to Adult Services|5|||
127969033|NCT01750697|460506944|FG000|Overall Study|Physician Decision|1|||
127969034|NCT01750697|460506944|FG000|Overall Study|Withdrawal by Subject|1|||
127969035|NCT00862823|460506949|FG000|First Intervention|Withdrawal by Subject|1|||
127969036|NCT00862823|460506950|FG001|First Intervention|Withdrawal by Subject|1|||
127969037|NCT01421225|460506953|FG000|Overall Study|Withdrawal by Subject|0|||
127969038|NCT01421225|460506954|FG001|Overall Study|Withdrawal by Subject|1|||
127969039|NCT02049814|460506957|FG000|Overall Study|Reason not Specified|4|||
127969040|NCT02049814|460506958|FG001|Overall Study|Reason not Specified|3|||
127969041|NCT02049814|460506957|FG000|Overall Study|Pregnancy|1|||
127969042|NCT02049814|460506958|FG001|Overall Study|Pregnancy|0|||
127969043|NCT02049814|460506957|FG000|Overall Study|Lost to Follow-up|2|||
127969044|NCT02049814|460506958|FG001|Overall Study|Lost to Follow-up|3|||
127969045|NCT02049814|460506957|FG000|Overall Study|Serious Protocol Violation|5|||
127969046|NCT02049814|460506958|FG001|Overall Study|Serious Protocol Violation|7|||
127969047|NCT02049814|460506957|FG000|Overall Study|Study Termination|0|||
127969048|NCT02049814|460506958|FG001|Overall Study|Study Termination|1|||
127969049|NCT02049814|460506957|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
127969050|NCT02049814|460506958|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
127969051|NCT02049814|460506957|FG000|Overall Study|Voluntary withdrawal|9|||
127969052|NCT02049814|460506958|FG001|Overall Study|Voluntary withdrawal|8|||
127969053|NCT02993250|460506960|FG000|Overall Study|Lost to Follow-up|0|||
127969054|NCT02993250|460506961|FG001|Overall Study|Lost to Follow-up|1|||
127969055|NCT02527434|460506962|FG000|Overall Study|Lost to Follow-up|2|||
127969056|NCT02527434|460506963|FG001|Overall Study|Lost to Follow-up|2|||
127969057|NCT02527434|460506964|FG002|Overall Study|Lost to Follow-up|0|||
127969058|NCT02527434|460506962|FG000|Overall Study|Death|19|||
127969059|NCT02527434|460506963|FG001|Overall Study|Death|6|||
127969060|NCT02527434|460506964|FG002|Overall Study|Death|17|||
127969061|NCT02527434|460506962|FG000|Overall Study|Withdrawal by Subject|5|||
127969062|NCT02527434|460506963|FG001|Overall Study|Withdrawal by Subject|3|||
127969063|NCT02527434|460506964|FG002|Overall Study|Withdrawal by Subject|3|||
127969064|NCT02527434|460506962|FG000|Overall Study|Reason Not Specified|1|||
127969065|NCT02527434|460506963|FG001|Overall Study|Reason Not Specified|0|||
127969066|NCT02527434|460506964|FG002|Overall Study|Reason Not Specified|0|||
127969067|NCT02527434|460506962|FG000|Overall Study|Site closure|1|||
127969068|NCT02527434|460506963|FG001|Overall Study|Site closure|0|||
127969069|NCT02527434|460506964|FG002|Overall Study|Site closure|0|||
127969070|NCT00568061|460506965|FG000|Overall Study|Inclusion / exclusion criteria|5|||
127969071|NCT00568061|460506966|FG001|Overall Study|Inclusion / exclusion criteria|1|||
127969072|NCT00568061|460506965|FG000|Overall Study|Adverse Event|0|||
127969073|NCT00568061|460506966|FG001|Overall Study|Adverse Event|1|||
127969074|NCT01896128|460506967|FG000|Overall Study|Withdrawal by Subject|3|||
127969075|NCT01896128|460506968|FG001|Overall Study|Withdrawal by Subject|3|||
127969076|NCT00356148|460506971|FG000|Overall Study|Reoperation within 30 days|2|||
127969077|NCT00356148|460506972|FG001|Overall Study|Reoperation within 30 days|1|||
127969078|NCT02484456|460506973|FG000|Washout Period|Withdrawal by Subject|0|||
127969079|NCT02484456|460506974|FG001|Washout Period|Withdrawal by Subject|1|||
127969080|NCT02484456|460506973|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
127969081|NCT02484456|460506974|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
127969082|NCT02484456|460506973|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
127969083|NCT02484456|460506974|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
127969084|NCT02484456|460506973|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
127969085|NCT02484456|460506974|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
127969086|NCT01996254|460506977|FG000|Overall Study|Change in Eligibility|0|||
127969087|NCT01996254|460506978|FG001|Overall Study|Change in Eligibility|2|||
127969088|NCT01996254|460506979|FG002|Overall Study|Change in Eligibility|0|||
127969089|NCT01996254|460506977|FG000|Overall Study|Withdrawal by Subject|0|||
127969090|NCT01996254|460506978|FG001|Overall Study|Withdrawal by Subject|3|||
127969091|NCT01996254|460506979|FG002|Overall Study|Withdrawal by Subject|4|||
127969092|NCT01996254|460506977|FG000|Overall Study|Lost to Follow-up|1|||
127969093|NCT01996254|460506978|FG001|Overall Study|Lost to Follow-up|0|||
127969094|NCT01996254|460506979|FG002|Overall Study|Lost to Follow-up|4|||
127969095|NCT03348930|460506980|FG000|Washout (1 Week)|Lost to Follow-up|1|||
127969096|NCT03348930|460506981|FG001|Washout (1 Week)|Lost to Follow-up|1|||
127969097|NCT02693002|460506984|FG000|Overall Study|Withdrawal by Subject|1|||
127969098|NCT02693002|460506985|FG001|Overall Study|Withdrawal by Subject|0|||
127969099|NCT00708214|460506986|FG000|Overall Study|Other Adverse Event|3|||
127969100|NCT00708214|460506987|FG001|Overall Study|Other Adverse Event|6|||
127969101|NCT00708214|460506988|FG002|Overall Study|Other Adverse Event|2|||
127969102|NCT00708214|460506986|FG000|Overall Study|Other|0|||
127969103|NCT00708214|460506987|FG001|Overall Study|Other|1|||
127969104|NCT00708214|460506988|FG002|Overall Study|Other|1|||
127969105|NCT00708214|460506986|FG000|Overall Study|Progressive Disease|4|||
127969106|NCT00708214|460506987|FG001|Overall Study|Progressive Disease|6|||
127969107|NCT00708214|460506988|FG002|Overall Study|Progressive Disease|5|||
127969108|NCT02411396|460506989|FG000|Overall Study|Lost to Follow-up|31|||
127969109|NCT02411396|460506989|FG000|Overall Study|Death|10|||
127969110|NCT02865499|460506990|FG000|Baseline|Adverse Event|1|||
127969111|NCT02865499|460506990|FG000|Baseline|Withdrawal by Subject|1|||
127969112|NCT01931995|460506991|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
127969113|NCT01931995|460506992|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
127969114|NCT01931995|460506991|FG000|First Intervention (1 Day)|Physician Decision|1|||
127969115|NCT01931995|460506992|FG001|First Intervention (1 Day)|Physician Decision|1|||
127969116|NCT01931995|460506991|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
127969117|NCT01931995|460506992|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
127969118|NCT00014495|460506993|FG000|Overall Study|Death|0|||
127969119|NCT00014495|460506994|FG001|Overall Study|Death|0|||
127969120|NCT00014495|460506995|FG002|Overall Study|Death|1|||
127969121|NCT00014495|460506996|FG003|Overall Study|Death|0|||
127969122|NCT00014495|460506993|FG000|Overall Study|Clinical deterioration|0|||
127969123|NCT00014495|460506994|FG001|Overall Study|Clinical deterioration|0|||
127969124|NCT00014495|460506995|FG002|Overall Study|Clinical deterioration|0|||
127969125|NCT00014495|460506996|FG003|Overall Study|Clinical deterioration|1|||
127969126|NCT04200651|460506997|FG000|Overall Study|Moved to another country during follow-up|2|||
127969127|NCT04200651|460506998|FG001|Overall Study|Moved to another country during follow-up|2|||
127969128|NCT04200651|460506997|FG000|Overall Study|Lost to Follow-up|1|||
127969129|NCT04200651|460506998|FG001|Overall Study|Lost to Follow-up|3|||
127969130|NCT03225105|460506999|FG000|Overall Study|Withdrawal by Subject|1|||
127969131|NCT03225105|460507000|FG001|Overall Study|Withdrawal by Subject|0|||
127969132|NCT03225105|460507001|FG002|Overall Study|Withdrawal by Subject|0|||
127969133|NCT03225105|460507002|FG003|Overall Study|Withdrawal by Subject|0|||
127969134|NCT03225105|460506999|FG000|Overall Study|Death|0|||
127969135|NCT03225105|460507000|FG001|Overall Study|Death|4|||
127969136|NCT03225105|460507001|FG002|Overall Study|Death|2|||
127969137|NCT03225105|460507002|FG003|Overall Study|Death|0|||
127969138|NCT03225105|460506999|FG000|Overall Study|Study termination per Sponsor Decision|2|||
127969139|NCT03225105|460507000|FG001|Overall Study|Study termination per Sponsor Decision|0|||
127969140|NCT03225105|460507001|FG002|Overall Study|Study termination per Sponsor Decision|3|||
127969141|NCT03225105|460507002|FG003|Overall Study|Study termination per Sponsor Decision|3|||
127969142|NCT03483961|460508707|FG000|Overall Study|Lost to Follow-up|7|||
127969143|NCT03483961|460508708|FG001|Overall Study|Lost to Follow-up|6|||
127969144|NCT03483961|460508709|FG002|Overall Study|Lost to Follow-up|6|||
127969145|NCT03483961|460508710|FG003|Overall Study|Lost to Follow-up|6|||
127969146|NCT03483961|460508711|FG004|Overall Study|Lost to Follow-up|6|||
127969147|NCT03483961|460508712|FG005|Overall Study|Lost to Follow-up|4|||
127969148|NCT03483961|460508713|FG006|Overall Study|Lost to Follow-up|4|||
127969149|NCT03483961|460508714|FG007|Overall Study|Lost to Follow-up|11|||
127969150|NCT03483961|460508715|FG008|Overall Study|Lost to Follow-up|1|||
127969151|NCT03483961|460508716|FG009|Overall Study|Lost to Follow-up|0|||
127969152|NCT03483961|460508707|FG000|Overall Study|Withdrawal by Subject|3|||
127969153|NCT03483961|460508708|FG001|Overall Study|Withdrawal by Subject|4|||
127969154|NCT03483961|460508709|FG002|Overall Study|Withdrawal by Subject|5|||
127969155|NCT03483961|460508710|FG003|Overall Study|Withdrawal by Subject|3|||
127969156|NCT03483961|460508711|FG004|Overall Study|Withdrawal by Subject|4|||
127969157|NCT03483961|460508712|FG005|Overall Study|Withdrawal by Subject|2|||
127969158|NCT03483961|460508713|FG006|Overall Study|Withdrawal by Subject|1|||
127969159|NCT03483961|460508714|FG007|Overall Study|Withdrawal by Subject|2|||
127969160|NCT03483961|460508715|FG008|Overall Study|Withdrawal by Subject|1|||
127969161|NCT03483961|460508716|FG009|Overall Study|Withdrawal by Subject|0|||
127969162|NCT03483961|460508707|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
127969163|NCT03483961|460508708|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
127969164|NCT03483961|460508709|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
127969165|NCT03483961|460508710|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
127969166|NCT03483961|460508711|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
127969167|NCT03483961|460508712|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
127969168|NCT03483961|460508713|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
127969169|NCT03483961|460508714|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
127969170|NCT03483961|460508715|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
127969171|NCT03483961|460508716|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
127969172|NCT03483961|460508707|FG000|Overall Study|Adverse Event|0|||
127969173|NCT03483961|460508708|FG001|Overall Study|Adverse Event|0|||
127969174|NCT03483961|460508709|FG002|Overall Study|Adverse Event|1|||
127969175|NCT03483961|460508710|FG003|Overall Study|Adverse Event|0|||
127969176|NCT03483961|460508711|FG004|Overall Study|Adverse Event|0|||
127969177|NCT03483961|460508712|FG005|Overall Study|Adverse Event|0|||
127969178|NCT03483961|460508713|FG006|Overall Study|Adverse Event|0|||
127969179|NCT03483961|460508714|FG007|Overall Study|Adverse Event|0|||
127969180|NCT03483961|460508715|FG008|Overall Study|Adverse Event|0|||
127969181|NCT03483961|460508716|FG009|Overall Study|Adverse Event|0|||
127969182|NCT01262287|460508717|FG000|Overall Study|Lost to Follow-up|2|||
127969183|NCT01262287|460508718|FG001|Overall Study|Lost to Follow-up|1|||
127969184|NCT02492984|460508719|FG000|Overall Study|Adverse Event|1|||
127969185|NCT02492984|460508720|FG001|Overall Study|Adverse Event|0|||
127969186|NCT02492984|460508719|FG000|Overall Study|Protocol Violation|1|||
127969187|NCT02492984|460508720|FG001|Overall Study|Protocol Violation|0|||
127969188|NCT02492984|460508719|FG000|Overall Study|Withdrawal by Subject|1|||
127969189|NCT02492984|460508720|FG001|Overall Study|Withdrawal by Subject|0|||
127969190|NCT00302328|460508729|FG000|Overall Study|Physician Decision|0|||
127969191|NCT00302328|460508730|FG001|Overall Study|Physician Decision|1|||
127969192|NCT00302328|460508731|FG002|Overall Study|Physician Decision|0|||
127969193|NCT01288937|460508734|FG000|Overall Study|Adverse Event|1|||
127969194|NCT01288937|460508735|FG001|Overall Study|Adverse Event|0|||
127969195|NCT02490371|460508736|FG000|Overall Study|Lost to Follow-up|1|||
127969196|NCT02490371|460508737|FG001|Overall Study|Lost to Follow-up|1|||
127969197|NCT03018080|460508740|FG000|Overall Study|Death|12|||
127969198|NCT03018080|460508741|FG001|Overall Study|Death|19|||
127969199|NCT00740792|460508742|FG000|Overall Study|Adverse Event|3|||
127969200|NCT00740792|460508743|FG001|Overall Study|Adverse Event|1|||
127969201|NCT00740792|460508744|FG002|Overall Study|Adverse Event|1|||
127969202|NCT00740792|460508745|FG003|Overall Study|Adverse Event|3|||
127969203|NCT00740792|460508742|FG000|Overall Study|Lack of Efficacy|1|||
127969204|NCT00740792|460508743|FG001|Overall Study|Lack of Efficacy|1|||
127969205|NCT00740792|460508744|FG002|Overall Study|Lack of Efficacy|0|||
127969206|NCT00740792|460508745|FG003|Overall Study|Lack of Efficacy|3|||
127969207|NCT00740792|460508742|FG000|Overall Study|Lost to Follow-up|2|||
127969208|NCT00740792|460508743|FG001|Overall Study|Lost to Follow-up|1|||
127969209|NCT00740792|460508744|FG002|Overall Study|Lost to Follow-up|0|||
127969210|NCT00740792|460508745|FG003|Overall Study|Lost to Follow-up|0|||
127969211|NCT00740792|460508742|FG000|Overall Study|Protocol Violation|0|||
127969212|NCT00740792|460508743|FG001|Overall Study|Protocol Violation|1|||
127969213|NCT00740792|460508744|FG002|Overall Study|Protocol Violation|0|||
127969214|NCT00740792|460508745|FG003|Overall Study|Protocol Violation|2|||
127969215|NCT00740792|460508742|FG000|Overall Study|Withdrawal by Subject|1|||
127969216|NCT00740792|460508743|FG001|Overall Study|Withdrawal by Subject|1|||
127969217|NCT00740792|460508744|FG002|Overall Study|Withdrawal by Subject|0|||
127969218|NCT00740792|460508745|FG003|Overall Study|Withdrawal by Subject|0|||
127969219|NCT00740792|460508742|FG000|Overall Study|administrative|3|||
127969220|NCT00740792|460508743|FG001|Overall Study|administrative|3|||
127969221|NCT00740792|460508744|FG002|Overall Study|administrative|8|||
127969222|NCT00740792|460508745|FG003|Overall Study|administrative|2|||
127969223|NCT00179660|460508747|FG000|Overall Study|Adverse Event|7|||
127969224|NCT00179660|460508747|FG000|Overall Study|Lack of therapeutic effect|28|||
127969225|NCT00179660|460508747|FG000|Overall Study|Withdrawal by Subject|2|||
127969226|NCT00179660|460508747|FG000|Overall Study|Lost to Follow-up|1|||
127969227|NCT00179660|460508747|FG000|Overall Study|Death|3|||
127969228|NCT00179660|460508747|FG000|Overall Study|Other - Unspecified|9|||
127969229|NCT00178685|460508750|FG000|Overall Study|Death|3|||
127969230|NCT00178685|460508751|FG001|Overall Study|Death|3|||
127969231|NCT00178685|460508752|FG002|Overall Study|Death|6|||
127969232|NCT00178685|460508750|FG000|Overall Study|Lost to Follow-up|100|||
127969233|NCT00178685|460508751|FG001|Overall Study|Lost to Follow-up|187|||
127969234|NCT00178685|460508752|FG002|Overall Study|Lost to Follow-up|183|||
127969235|NCT00178685|460508750|FG000|Overall Study|Withdrawal by Subject|8|||
127969236|NCT00178685|460508751|FG001|Overall Study|Withdrawal by Subject|14|||
127969237|NCT00178685|460508752|FG002|Overall Study|Withdrawal by Subject|7|||
127969238|NCT01562782|460508755|FG000|Overall Study|Withdrawal by Subject|3|||
127969239|NCT01562782|460508756|FG001|Overall Study|Withdrawal by Subject|3|||
127969240|NCT01562782|460508755|FG000|Overall Study|screen failure|1|||
127969241|NCT01562782|460508756|FG001|Overall Study|screen failure|2|||
127969242|NCT02714595|460508758|FG000|Overall Study|Lost to Follow-up|1|||
127969243|NCT02714595|460508759|FG001|Overall Study|Lost to Follow-up|0|||
127969244|NCT02714595|460508758|FG000|Overall Study|Withdrawal by Subject|1|||
127969245|NCT02714595|460508759|FG001|Overall Study|Withdrawal by Subject|2|||
127969246|NCT02714595|460508758|FG000|Overall Study|Lack of Efficacy|0|||
127969247|NCT02714595|460508759|FG001|Overall Study|Lack of Efficacy|1|||
127969248|NCT02714595|460508758|FG000|Overall Study|Death|30|||
127969249|NCT02714595|460508759|FG001|Overall Study|Death|9|||
127969250|NCT02714595|460508758|FG000|Overall Study|Other-Miscellaneous|0|||
127969251|NCT02714595|460508759|FG001|Overall Study|Other-Miscellaneous|1|||
127969252|NCT00713258|460508760|FG000|Overall Study|Adverse Event|2|||
127969253|NCT00713258|460508761|FG001|Overall Study|Adverse Event|4|||
127969254|NCT00713258|460508760|FG000|Overall Study|Non-Compliance|2|||
127969255|NCT00713258|460508761|FG001|Overall Study|Non-Compliance|1|||
127969256|NCT00713258|460508760|FG000|Overall Study|Other|1|||
127969257|NCT00713258|460508761|FG001|Overall Study|Other|1|||
127969258|NCT02064816|460508765|FG000|Overall Study|Adverse Event|3|||
127969259|NCT02064816|460508766|FG001|Overall Study|Adverse Event|2|||
127969260|NCT02064816|460508765|FG000|Overall Study|Withdrawal by Subject|2|||
127969261|NCT02064816|460508766|FG001|Overall Study|Withdrawal by Subject|1|||
127969262|NCT02064816|460508765|FG000|Overall Study|Lost to Follow-up|2|||
127969263|NCT02064816|460508766|FG001|Overall Study|Lost to Follow-up|1|||
127969264|NCT02064816|460508765|FG000|Overall Study|Therapeutic failure|0|||
127969265|NCT02064816|460508766|FG001|Overall Study|Therapeutic failure|1|||
127969266|NCT02064816|460508765|FG000|Overall Study|Other|1|||
127969267|NCT02064816|460508766|FG001|Overall Study|Other|3|||
127969268|NCT01732458|460508769|FG000|Overall Study|Lost to Follow-up|0|||
127969269|NCT01732458|460508770|FG001|Overall Study|Lost to Follow-up|2|||
127969270|NCT01732458|460508771|FG002|Overall Study|Lost to Follow-up|0|||
127969271|NCT01732458|460508772|FG003|Overall Study|Lost to Follow-up|0|||
127969272|NCT01732458|460508769|FG000|Overall Study|Non-Compliance With Study Drug|0|||
127969273|NCT01732458|460508770|FG001|Overall Study|Non-Compliance With Study Drug|0|||
127969274|NCT01732458|460508771|FG002|Overall Study|Non-Compliance With Study Drug|1|||
127969275|NCT01732458|460508772|FG003|Overall Study|Non-Compliance With Study Drug|0|||
127969276|NCT01732458|460508769|FG000|Overall Study|Physician Decision|1|||
127969277|NCT01732458|460508770|FG001|Overall Study|Physician Decision|2|||
127969278|NCT01732458|460508771|FG002|Overall Study|Physician Decision|2|||
127969279|NCT01732458|460508772|FG003|Overall Study|Physician Decision|0|||
127969280|NCT01732458|460508769|FG000|Overall Study|Protocol Violation|2|||
127969281|NCT01732458|460508770|FG001|Overall Study|Protocol Violation|0|||
127969282|NCT01732458|460508771|FG002|Overall Study|Protocol Violation|0|||
127969283|NCT01732458|460508772|FG003|Overall Study|Protocol Violation|2|||
127969284|NCT01732458|460508769|FG000|Overall Study|Screen Failure|0|||
127969285|NCT01732458|460508770|FG001|Overall Study|Screen Failure|1|||
127969286|NCT01732458|460508771|FG002|Overall Study|Screen Failure|0|||
127969287|NCT01732458|460508772|FG003|Overall Study|Screen Failure|0|||
127969288|NCT02887248|460508778|FG000|Overall Study|Withdrawal by Subject|1|||
127969289|NCT02887248|460508778|FG000|Overall Study|Adverse Event|1|||
127969290|NCT02887248|460508778|FG000|Overall Study|Progressive Disease|1|||
127969291|NCT03759587|460508779|FG000|Overall Study|Adverse Event|5|||
127969292|NCT03759587|460508779|FG000|Overall Study|Progressive Disease|10|||
127969293|NCT03759587|460508779|FG000|Overall Study|Site Terminated by Sponsor|3|||
127969294|NCT03759587|460508779|FG000|Overall Study|Withdrawal by Subject|1|||
127969295|NCT04615403|460508780|FG000|Overall Study|Death|1|||
127969296|NCT03170362|460508781|FG000|Overall Study|Death|2|||
127969297|NCT03170362|460508782|FG001|Overall Study|Death|2|||
127969298|NCT03170362|460508781|FG000|Overall Study|Withdrawal by Subject|23|||
127969299|NCT03170362|460508782|FG001|Overall Study|Withdrawal by Subject|22|||
127969300|NCT03170362|460508781|FG000|Overall Study|Lost to Follow-up|187|||
127969301|NCT03170362|460508782|FG001|Overall Study|Lost to Follow-up|167|||
127969302|NCT00454363|460508785|FG000|Overall Study|Adverse Event|1|||
127969303|NCT00454363|460508786|FG001|Overall Study|Adverse Event|2|||
127969304|NCT00454363|460508785|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
127969305|NCT00454363|460508786|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
127969306|NCT00570063|460508787|FG000|Overall Study|Adverse Event|4|||
127969307|NCT00570063|460508788|FG001|Overall Study|Adverse Event|1|||
127969308|NCT00570063|460508787|FG000|Overall Study|Lack of Efficacy|0|||
127969309|NCT00570063|460508788|FG001|Overall Study|Lack of Efficacy|1|||
127969310|NCT00570063|460508787|FG000|Overall Study|Withdrawal by Subject|4|||
127969311|NCT00570063|460508788|FG001|Overall Study|Withdrawal by Subject|3|||
127969312|NCT00570063|460508787|FG000|Overall Study|Sponsor's Decision|7|||
127969313|NCT00570063|460508788|FG001|Overall Study|Sponsor's Decision|3|||
127969314|NCT00697463|460508789|FG000|Overall Study|Withdrawal by Subject|1|||
127969315|NCT03307252|460508790|FG000|Part 2, Period 1|Treatment not received|0|||
127969316|NCT03307252|460508791|FG001|Part 2, Period 1|Treatment not received|0|||
127969317|NCT03307252|460508792|FG002|Part 2, Period 1|Treatment not received|0|||
127969318|NCT03307252|460508793|FG003|Part 2, Period 1|Treatment not received|0|||
127969319|NCT03307252|460508794|FG004|Part 2, Period 1|Treatment not received|0|||
127969320|NCT03307252|460508795|FG005|Part 2, Period 1|Treatment not received|1|||
127969321|NCT03307252|460508796|FG006|Part 2, Period 1|Treatment not received|0|||
127969322|NCT03307252|460508797|FG007|Part 2, Period 1|Treatment not received|0|||
127969323|NCT03307252|460508798|FG008|Part 2, Period 1|Treatment not received|0|||
127969324|NCT03307252|460508799|FG009|Part 2, Period 1|Treatment not received|0|||
127969325|NCT03307252|460508800|FG010|Part 2, Period 1|Treatment not received|0|||
127969326|NCT03307252|460508790|FG000|Part 2, Period 3|Other than listed|0|||
127969327|NCT03307252|460508791|FG001|Part 2, Period 3|Other than listed|0|||
127969328|NCT03307252|460508792|FG002|Part 2, Period 3|Other than listed|0|||
127969329|NCT03307252|460508793|FG003|Part 2, Period 3|Other than listed|0|||
127969330|NCT03307252|460508794|FG004|Part 2, Period 3|Other than listed|1|||
127969331|NCT03307252|460508795|FG005|Part 2, Period 3|Other than listed|0|||
127969332|NCT03307252|460508796|FG006|Part 2, Period 3|Other than listed|0|||
127969333|NCT03307252|460508797|FG007|Part 2, Period 3|Other than listed|0|||
127969334|NCT03307252|460508798|FG008|Part 2, Period 3|Other than listed|0|||
127969335|NCT03307252|460508799|FG009|Part 2, Period 3|Other than listed|0|||
127969336|NCT03307252|460508800|FG010|Part 2, Period 3|Other than listed|0|||
127969337|NCT03307252|460508790|FG000|Part 2, Period 4|Other than listed|0|||
127969338|NCT03307252|460508791|FG001|Part 2, Period 4|Other than listed|0|||
127969339|NCT03307252|460508792|FG002|Part 2, Period 4|Other than listed|0|||
127969340|NCT03307252|460508793|FG003|Part 2, Period 4|Other than listed|0|||
127969341|NCT03307252|460508794|FG004|Part 2, Period 4|Other than listed|0|||
127969342|NCT03307252|460508795|FG005|Part 2, Period 4|Other than listed|0|||
127969343|NCT03307252|460508796|FG006|Part 2, Period 4|Other than listed|1|||
127969344|NCT03307252|460508797|FG007|Part 2, Period 4|Other than listed|0|||
127969345|NCT03307252|460508798|FG008|Part 2, Period 4|Other than listed|0|||
127969346|NCT03307252|460508799|FG009|Part 2, Period 4|Other than listed|0|||
127969347|NCT03307252|460508800|FG010|Part 2, Period 4|Other than listed|0|||
127969348|NCT03307252|460508790|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
127969349|NCT03307252|460508791|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
127969350|NCT03307252|460508792|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
127969351|NCT03307252|460508793|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
127969352|NCT03307252|460508794|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
127969353|NCT03307252|460508795|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
127969354|NCT03307252|460508796|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
127969355|NCT03307252|460508797|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
127969356|NCT03307252|460508798|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
127969357|NCT03307252|460508799|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
127969358|NCT03307252|460508800|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
127969359|NCT03482453|460508801|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
127969360|NCT03482453|460508802|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
127969361|NCT03482453|460508803|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
127969362|NCT03482453|460508804|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
127969363|NCT03482453|460508805|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
127969364|NCT03482453|460508806|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
127969365|NCT03482453|460508807|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
127969366|NCT03482453|460508808|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
127969367|NCT03482453|460508809|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
127969368|NCT03482453|460508810|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
127969369|NCT03482453|460508811|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
127969370|NCT03482453|460508812|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
127969371|NCT02568189|460508813|FG000|Overall Study|Protocol Violation|0|||
127969372|NCT02568189|460508814|FG001|Overall Study|Protocol Violation|0|||
127969373|NCT02568189|460508815|FG002|Overall Study|Protocol Violation|19|||
127969374|NCT02568189|460508816|FG003|Overall Study|Protocol Violation|18|||
127969375|NCT02157376|460508817|FG000|Overall Study|Death|10|||
127969376|NCT02157376|460508818|FG001|Overall Study|Death|4|||
127969377|NCT02157376|460508817|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
127969378|NCT02157376|460508818|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
127969379|NCT02157376|460508817|FG000|Overall Study|Withdrawal by Subject|3|||
127969380|NCT02157376|460508818|FG001|Overall Study|Withdrawal by Subject|8|||
127969381|NCT02157376|460508817|FG000|Overall Study|Not treated|8|||
127969382|NCT02157376|460508818|FG001|Overall Study|Not treated|3|||
127969383|NCT02157376|460508817|FG000|Overall Study|Investigator's misjudgement|1|||
127969384|NCT02157376|460508818|FG001|Overall Study|Investigator's misjudgement|2|||
127969385|NCT01074268|460508821|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
127969386|NCT01074268|460508822|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
127969387|NCT01074268|460508821|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
127969388|NCT01074268|460508822|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
127969389|NCT01074268|460508821|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
127969390|NCT01074268|460508822|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
127969391|NCT01074268|460508821|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
127969392|NCT01074268|460508822|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
127969393|NCT01074268|460508821|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
127969394|NCT01074268|460508822|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
127969395|NCT01074268|460508821|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
127969396|NCT01074268|460508822|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
127969397|NCT01074268|460508821|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
127969398|NCT01074268|460508822|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
127969399|NCT01074268|460508821|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
127969400|NCT01074268|460508822|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
127969401|NCT01074268|460508821|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
127969402|NCT01074268|460508822|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
127969403|NCT01578239|460508823|FG000|Treatment Period|Progressive Disease|19|||
127969404|NCT01578239|460508824|FG001|Treatment Period|Progressive Disease|64|||
127969405|NCT01578239|460508823|FG000|Treatment Period|Physician Decision|17|||
127969406|NCT01578239|460508824|FG001|Treatment Period|Physician Decision|17|||
127969407|NCT01578239|460508823|FG000|Treatment Period|Adverse Event|13|||
127969408|NCT01578239|460508824|FG001|Treatment Period|Adverse Event|10|||
127969409|NCT01578239|460508823|FG000|Treatment Period|Non-compliance|2|||
127969410|NCT01578239|460508824|FG001|Treatment Period|Non-compliance|0|||
127969411|NCT01578239|460508823|FG000|Treatment Period|Withdrawal by Subject|10|||
127969412|NCT01578239|460508824|FG001|Treatment Period|Withdrawal by Subject|9|||
127969413|NCT01578239|460508823|FG000|Treatment Period|Other|6|||
127969414|NCT01578239|460508824|FG001|Treatment Period|Other|1|||
127969415|NCT01578239|460508823|FG000|Long-term Follow-Up Period|Death|69|||
127969416|NCT01578239|460508824|FG001|Long-term Follow-Up Period|Death|64|||
127969417|NCT01578239|460508823|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
127969418|NCT01578239|460508824|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
127969419|NCT01578239|460508823|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
127969420|NCT01578239|460508824|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
127969421|NCT01578239|460508823|FG000|Long-term Follow-Up Period|Other|2|||
127969422|NCT01578239|460508824|FG001|Long-term Follow-Up Period|Other|2|||
127969423|NCT02347813|460508830|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
127969424|NCT02347813|460508831|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
127969425|NCT02347813|460508830|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
127969426|NCT02347813|460508831|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
127969427|NCT02837731|460508834|FG000|Allocation|Admitted to General Floor|3|||
127969428|NCT02837731|460508835|FG001|Allocation|Admitted to General Floor|4|||
127969429|NCT02837731|460508834|FG000|Allocation|Immediate surgery/withdrew|2|||
127969430|NCT02837731|460508835|FG001|Allocation|Immediate surgery/withdrew|0|||
127969431|NCT02837731|460508834|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
127969432|NCT02837731|460508835|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
127969433|NCT02837731|460508834|FG000|Allocation|Withdrawal by Subject|2|||
127969434|NCT02837731|460508835|FG001|Allocation|Withdrawal by Subject|0|||
127969435|NCT02837731|460508834|FG000|Allocation|Device not available|1|||
127969436|NCT02837731|460508835|FG001|Allocation|Device not available|0|||
127969437|NCT02837731|460508834|FG000|Allocation|Protocol not implemented|7|||
127969438|NCT02837731|460508835|FG001|Allocation|Protocol not implemented|0|||
127969439|NCT02837731|460508834|FG000|Allocation|Moribund/Do not resuscitate|2|||
127969440|NCT02837731|460508835|FG001|Allocation|Moribund/Do not resuscitate|0|||
127969441|NCT02837731|460508834|FG000|Allocation|Did not meet sepsis criteria|1|||
127969442|NCT02837731|460508835|FG001|Allocation|Did not meet sepsis criteria|2|||
127969443|NCT02837731|460508834|FG000|Allocation|Known aortic abnormalities|0|||
127969444|NCT02837731|460508835|FG001|Allocation|Known aortic abnormalities|1|||
127969445|NCT01119859|460508836|FG000|Overall Study|Adverse Event|9|||
127969446|NCT01119859|460508837|FG001|Overall Study|Adverse Event|10|||
127969447|NCT01119859|460508836|FG000|Overall Study|Death|2|||
127969448|NCT01119859|460508837|FG001|Overall Study|Death|0|||
127969449|NCT01119859|460508836|FG000|Overall Study|Insufficient therapeutic response|7|||
127969450|NCT01119859|460508837|FG001|Overall Study|Insufficient therapeutic response|14|||
127969451|NCT01119859|460508836|FG000|Overall Study|Refused treatment|3|||
127969452|NCT01119859|460508837|FG001|Overall Study|Refused treatment|6|||
127969453|NCT01119859|460508836|FG000|Overall Study|Failure to return|3|||
127969454|NCT01119859|460508837|FG001|Overall Study|Failure to return|0|||
127969455|NCT00603473|460508838|FG000|Overall Study|Adverse Event|4|||
127969456|NCT00603473|460508838|FG000|Overall Study|Lack of Efficacy|4|||
127969457|NCT00603473|460508838|FG000|Overall Study|Protocol Violation|1|||
127969458|NCT02644668|460508839|FG000|Overall Study|Adverse Event|2|||
127969459|NCT02644668|460508840|FG001|Overall Study|Adverse Event|0|||
127969460|NCT02644668|460508841|FG002|Overall Study|Adverse Event|1|||
127969461|NCT02644668|460508839|FG000|Overall Study|Protocol Violation|0|||
127969462|NCT02644668|460508840|FG001|Overall Study|Protocol Violation|0|||
127969463|NCT02644668|460508841|FG002|Overall Study|Protocol Violation|1|||
127969464|NCT02644668|460508839|FG000|Overall Study|Withdrawal by Subject|0|||
127969465|NCT02644668|460508840|FG001|Overall Study|Withdrawal by Subject|0|||
127969466|NCT02644668|460508841|FG002|Overall Study|Withdrawal by Subject|1|||
127969467|NCT01134939|460508845|FG000|Overall Study|Adverse Event|9|||
127969468|NCT01134939|460508846|FG001|Overall Study|Adverse Event|3|||
127969469|NCT01134939|460508847|FG002|Overall Study|Adverse Event|4|||
127969470|NCT01134939|460508848|FG003|Overall Study|Adverse Event|5|||
127969471|NCT01134939|460508849|FG004|Overall Study|Adverse Event|5|||
127969472|NCT01134939|460508850|FG005|Overall Study|Adverse Event|5|||
127969473|NCT01134939|460508851|FG006|Overall Study|Adverse Event|1|||
127969474|NCT01134939|460508852|FG007|Overall Study|Adverse Event|0|||
127969475|NCT01134939|460508845|FG000|Overall Study|Lack of Efficacy|2|||
127969476|NCT01134939|460508846|FG001|Overall Study|Lack of Efficacy|5|||
127969477|NCT01134939|460508847|FG002|Overall Study|Lack of Efficacy|1|||
127969478|NCT01134939|460508848|FG003|Overall Study|Lack of Efficacy|0|||
127969479|NCT01134939|460508849|FG004|Overall Study|Lack of Efficacy|3|||
127969480|NCT01134939|460508850|FG005|Overall Study|Lack of Efficacy|0|||
127969481|NCT01134939|460508851|FG006|Overall Study|Lack of Efficacy|1|||
127969482|NCT01134939|460508852|FG007|Overall Study|Lack of Efficacy|0|||
127969483|NCT01134939|460508845|FG000|Overall Study|Lost to Follow-up|2|||
127969484|NCT01134939|460508846|FG001|Overall Study|Lost to Follow-up|3|||
127969485|NCT01134939|460508847|FG002|Overall Study|Lost to Follow-up|0|||
127969486|NCT01134939|460508848|FG003|Overall Study|Lost to Follow-up|1|||
127969487|NCT01134939|460508849|FG004|Overall Study|Lost to Follow-up|2|||
127969488|NCT01134939|460508850|FG005|Overall Study|Lost to Follow-up|1|||
127969489|NCT01134939|460508851|FG006|Overall Study|Lost to Follow-up|0|||
127969490|NCT01134939|460508852|FG007|Overall Study|Lost to Follow-up|0|||
127969491|NCT01134939|460508845|FG000|Overall Study|Death|0|||
127969492|NCT01134939|460508846|FG001|Overall Study|Death|1|||
127969493|NCT01134939|460508847|FG002|Overall Study|Death|0|||
127969494|NCT01134939|460508848|FG003|Overall Study|Death|0|||
127969495|NCT01134939|460508849|FG004|Overall Study|Death|0|||
127969496|NCT01134939|460508850|FG005|Overall Study|Death|0|||
127969497|NCT01134939|460508851|FG006|Overall Study|Death|0|||
127969498|NCT01134939|460508852|FG007|Overall Study|Death|0|||
127969499|NCT01134939|460508845|FG000|Overall Study|Termination page not available|4|||
127969500|NCT01134939|460508846|FG001|Overall Study|Termination page not available|6|||
127969501|NCT01134939|460508847|FG002|Overall Study|Termination page not available|5|||
127969502|NCT01134939|460508848|FG003|Overall Study|Termination page not available|8|||
127969503|NCT01134939|460508849|FG004|Overall Study|Termination page not available|0|||
127969504|NCT01134939|460508850|FG005|Overall Study|Termination page not available|3|||
127969505|NCT01134939|460508851|FG006|Overall Study|Termination page not available|7|||
127969506|NCT01134939|460508852|FG007|Overall Study|Termination page not available|0|||
127969507|NCT00733421|460508853|FG000|Overall Study|Withdrawal by Subject|1|||
127969508|NCT00733421|460508854|FG001|Overall Study|Withdrawal by Subject|1|||
127969509|NCT02547220|460508857|FG000|Overall Study|Withdrawal by Subject|1|||
127969510|NCT02547220|460508858|FG001|Overall Study|Withdrawal by Subject|0|||
127969511|NCT02547220|460508857|FG000|Overall Study|Study terminated by sponsor|18|||
127969512|NCT02547220|460508858|FG001|Overall Study|Study terminated by sponsor|20|||
127969513|NCT00550043|460508862|FG000|Overall Study|Adverse Event|0|||
127969514|NCT00550043|460508863|FG001|Overall Study|Adverse Event|0|||
127969515|NCT00550043|460508864|FG002|Overall Study|Adverse Event|0|||
127969516|NCT00550043|460508865|FG003|Overall Study|Adverse Event|1|||
127969517|NCT00550043|460508866|FG004|Overall Study|Adverse Event|1|||
127969518|NCT00550043|460508862|FG000|Overall Study|Subject Withdrew Consent|0|||
127969519|NCT00550043|460508863|FG001|Overall Study|Subject Withdrew Consent|2|||
127969520|NCT00550043|460508864|FG002|Overall Study|Subject Withdrew Consent|1|||
127969521|NCT00550043|460508865|FG003|Overall Study|Subject Withdrew Consent|0|||
127969522|NCT00550043|460508866|FG004|Overall Study|Subject Withdrew Consent|0|||
127969523|NCT00550043|460508862|FG000|Overall Study|Other Reasons- Unspecified|0|||
127969524|NCT00550043|460508863|FG001|Overall Study|Other Reasons- Unspecified|1|||
127969525|NCT00550043|460508864|FG002|Overall Study|Other Reasons- Unspecified|0|||
127969526|NCT00550043|460508865|FG003|Overall Study|Other Reasons- Unspecified|1|||
127969527|NCT00550043|460508866|FG004|Overall Study|Other Reasons- Unspecified|0|||
127969528|NCT02887183|460508868|FG000|Overall Study|Adverse Event|44|||
127969529|NCT02887183|460508868|FG000|Overall Study|Death|30|||
127969530|NCT02887183|460508868|FG000|Overall Study|Pregnancy|1|||
127969531|NCT02887183|460508868|FG000|Overall Study|Protocol Violation|6|||
127969532|NCT02887183|460508868|FG000|Overall Study|Technical Problems|2|||
127969533|NCT02887183|460508868|FG000|Overall Study|Lost to Follow-up|13|||
127969534|NCT02887183|460508868|FG000|Overall Study|Physician Decision|10|||
127969535|NCT02887183|460508868|FG000|Overall Study|Withdrawal by Subject|35|||
127969536|NCT01031680|460508869|FG000|Overall Study|Adverse Event|8|||
127969537|NCT01031680|460508870|FG001|Overall Study|Adverse Event|3|||
127969538|NCT01031680|460508869|FG000|Overall Study|Lost to Follow-up|2|||
127969539|NCT01031680|460508870|FG001|Overall Study|Lost to Follow-up|10|||
127969540|NCT01031680|460508869|FG000|Overall Study|Withdrawal by Subject|12|||
127969541|NCT01031680|460508870|FG001|Overall Study|Withdrawal by Subject|16|||
127969542|NCT01031680|460508869|FG000|Overall Study|Death|2|||
127969543|NCT01031680|460508870|FG001|Overall Study|Death|1|||
127969544|NCT01031680|460508869|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
127969545|NCT01031680|460508870|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
127969546|NCT01031680|460508869|FG000|Overall Study|Poor/Non-compliance|5|||
127969547|NCT01031680|460508870|FG001|Overall Study|Poor/Non-compliance|6|||
127969548|NCT01031680|460508869|FG000|Overall Study|Safety|1|||
127969549|NCT01031680|460508870|FG001|Overall Study|Safety|0|||
127969550|NCT01031680|460508869|FG000|Overall Study|Incorrect Enrolment|1|||
127969551|NCT01031680|460508870|FG001|Overall Study|Incorrect Enrolment|2|||
127969552|NCT01031680|460508869|FG000|Overall Study|Administrative Reason by Sponsor|0|||
127969553|NCT01031680|460508870|FG001|Overall Study|Administrative Reason by Sponsor|1|||
127969554|NCT01031680|460508869|FG000|Overall Study|Various|0|||
127969555|NCT01031680|460508870|FG001|Overall Study|Various|2|||
127969556|NCT02654977|460508875|FG000|Overall Study|Death|1|||
127969557|NCT02654977|460508875|FG000|Overall Study|Lost to Follow-up|1|||
127969558|NCT02654977|460508875|FG000|Overall Study|Adverse Event|1|||
127969559|NCT02654977|460508875|FG000|Overall Study|Withdrawal by Subject|1|||
127969560|NCT02654977|460508875|FG000|Overall Study|Lack of Efficacy|3|||
127969561|NCT01921101|460508876|FG000|Overall Study|Death|16|||
127969562|NCT01921101|460508877|FG001|Overall Study|Death|6|||
127969563|NCT01483027|460508878|FG000|Overall Study|Administrative Reasons|2|||
127969564|NCT01483027|460508879|FG001|Overall Study|Administrative Reasons|1|||
127969565|NCT01483027|460508878|FG000|Overall Study|Withdrawal by Subject|21|||
127969566|NCT01483027|460508879|FG001|Overall Study|Withdrawal by Subject|32|||
127969567|NCT01483027|460508878|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
127969568|NCT01483027|460508879|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
127969569|NCT01483027|460508878|FG000|Overall Study|Lost to Follow-up|1|||
127969570|NCT01483027|460508879|FG001|Overall Study|Lost to Follow-up|1|||
127969571|NCT01483027|460508878|FG000|Overall Study|Adverse Event|0|||
127969572|NCT01483027|460508879|FG001|Overall Study|Adverse Event|1|||
127969573|NCT01483027|460508878|FG000|Overall Study|Withdrawal by Subject|0|||
127969574|NCT01483027|460508879|FG001|Overall Study|Withdrawal by Subject|1|||
127969575|NCT03691207|460510347|FG000|Overall Study|Death|41|||
127969576|NCT03691207|460510348|FG001|Overall Study|Death|26|||
127969577|NCT03691207|460510347|FG000|Overall Study|Lost to Follow-up|1|||
127969578|NCT03691207|460510348|FG001|Overall Study|Lost to Follow-up|1|||
127969579|NCT03691207|460510347|FG000|Overall Study|Withdrawal by Subject|2|||
127969580|NCT03691207|460510348|FG001|Overall Study|Withdrawal by Subject|8|||
127969581|NCT03691207|460510347|FG000|Overall Study|Sponsor decision|1|||
127969582|NCT03691207|460510348|FG001|Overall Study|Sponsor decision|7|||
127969583|NCT00610155|460510351|FG000|Period 1|Withdrawal by Subject|0|||
127969584|NCT00610155|460510352|FG001|Period 1|Withdrawal by Subject|0|||
127969585|NCT00610155|460510353|FG002|Period 1|Withdrawal by Subject|1|||
127969586|NCT00610155|460510354|FG003|Period 1|Withdrawal by Subject|0|||
127969587|NCT00610155|460510355|FG004|Period 1|Withdrawal by Subject|0|||
127969588|NCT00610155|460510356|FG005|Period 1|Withdrawal by Subject|0|||
127969589|NCT00610155|460510351|FG000|Period 3|Adverse Event|1|||
127969590|NCT00610155|460510352|FG001|Period 3|Adverse Event|0|||
127969591|NCT00610155|460510353|FG002|Period 3|Adverse Event|0|||
127969592|NCT00610155|460510354|FG003|Period 3|Adverse Event|0|||
127969593|NCT00610155|460510355|FG004|Period 3|Adverse Event|0|||
127969594|NCT00610155|460510356|FG005|Period 3|Adverse Event|0|||
127969595|NCT01718535|460510357|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
127969596|NCT01718535|460510358|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
127969597|NCT01718535|460510359|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
127969598|NCT01718535|460510360|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
127969599|NCT01718535|460510361|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
127969600|NCT01718535|460510362|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
127969601|NCT01718535|460510363|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
127969602|NCT01718535|460510364|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
127969603|NCT01718535|460510365|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
127969604|NCT01718535|460510366|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
127969605|NCT01073605|460510370|FG000|Overall Study|Ongoing at Cutoff Date|1|||
127969606|NCT01073605|460510371|FG001|Overall Study|Ongoing at Cutoff Date|1|||
127969607|NCT01073605|460510372|FG002|Overall Study|Ongoing at Cutoff Date|0|||
127969608|NCT01073605|460510370|FG000|Overall Study|Adverse Event|2|||
127969609|NCT01073605|460510371|FG001|Overall Study|Adverse Event|1|||
127969610|NCT01073605|460510372|FG002|Overall Study|Adverse Event|0|||
127969611|NCT01073605|460510370|FG000|Overall Study|Lost to Follow-up|3|||
127969612|NCT01073605|460510371|FG001|Overall Study|Lost to Follow-up|4|||
127969613|NCT01073605|460510372|FG002|Overall Study|Lost to Follow-up|9|||
127969614|NCT01073605|460510370|FG000|Overall Study|Other|25|||
127969615|NCT01073605|460510371|FG001|Overall Study|Other|21|||
127969616|NCT01073605|460510372|FG002|Overall Study|Other|29|||
127969617|NCT01073605|460510370|FG000|Overall Study|Withdrawal by Subject|31|||
127969618|NCT01073605|460510371|FG001|Overall Study|Withdrawal by Subject|39|||
127969619|NCT01073605|460510372|FG002|Overall Study|Withdrawal by Subject|22|||
127969620|NCT01073605|460510370|FG000|Overall Study|Randomized But Not Treated|0|||
127969621|NCT01073605|460510371|FG001|Overall Study|Randomized But Not Treated|1|||
127969622|NCT01073605|460510372|FG002|Overall Study|Randomized But Not Treated|1|||
127969623|NCT02035202|460510373|FG000|Overall Study|Lost to Follow-up|8|||
127969624|NCT02035202|460510374|FG001|Overall Study|Lost to Follow-up|16|||
127969625|NCT02035202|460510375|FG002|Overall Study|Lost to Follow-up|2|||
127969626|NCT02875613|460510376|FG000|Overall Study|Withdrawal by Subject|1|||
127969627|NCT02875613|460510376|FG000|Overall Study|Screen Failure|1|||
127969628|NCT00267969|460510386|FG000|Controlled Period|Adverse Event|6|||
127969629|NCT00267969|460510387|FG001|Controlled Period|Adverse Event|0|||
127969630|NCT00267969|460510388|FG002|Controlled Period|Adverse Event|2|||
127969631|NCT00267969|460510389|FG003|Controlled Period|Adverse Event|0|||
127969632|NCT00267969|460510390|FG004|Controlled Period|Adverse Event|0|||
127969633|NCT00267969|460510391|FG005|Controlled Period|Adverse Event|0|||
127969634|NCT00267969|460510392|FG006|Controlled Period|Adverse Event|0|||
127969635|NCT00267969|460510386|FG000|Controlled Period|Lack of Efficacy|3|||
127969636|NCT00267969|460510387|FG001|Controlled Period|Lack of Efficacy|0|||
127969637|NCT00267969|460510388|FG002|Controlled Period|Lack of Efficacy|1|||
127969638|NCT00267969|460510389|FG003|Controlled Period|Lack of Efficacy|0|||
127969639|NCT00267969|460510390|FG004|Controlled Period|Lack of Efficacy|0|||
127969640|NCT00267969|460510391|FG005|Controlled Period|Lack of Efficacy|0|||
127969641|NCT00267969|460510392|FG006|Controlled Period|Lack of Efficacy|0|||
127969642|NCT00267969|460510386|FG000|Controlled Period|Lost to Follow-up|1|||
127969643|NCT00267969|460510387|FG001|Controlled Period|Lost to Follow-up|0|||
127969644|NCT00267969|460510388|FG002|Controlled Period|Lost to Follow-up|1|||
127969645|NCT00267969|460510389|FG003|Controlled Period|Lost to Follow-up|0|||
127969646|NCT00267969|460510390|FG004|Controlled Period|Lost to Follow-up|0|||
127969647|NCT00267969|460510391|FG005|Controlled Period|Lost to Follow-up|0|||
127969648|NCT00267969|460510392|FG006|Controlled Period|Lost to Follow-up|0|||
127969649|NCT00267969|460510386|FG000|Controlled Period|Randomized but not treated|0|||
127969650|NCT00267969|460510387|FG001|Controlled Period|Randomized but not treated|0|||
127969651|NCT00267969|460510388|FG002|Controlled Period|Randomized but not treated|1|||
127969652|NCT00267969|460510389|FG003|Controlled Period|Randomized but not treated|0|||
127969653|NCT00267969|460510390|FG004|Controlled Period|Randomized but not treated|0|||
127969654|NCT00267969|460510391|FG005|Controlled Period|Randomized but not treated|0|||
127969655|NCT00267969|460510392|FG006|Controlled Period|Randomized but not treated|0|||
127969656|NCT00267969|460510386|FG000|Controlled Period|Other|2|||
127969657|NCT00267969|460510387|FG001|Controlled Period|Other|1|||
127969658|NCT00267969|460510388|FG002|Controlled Period|Other|6|||
127969659|NCT00267969|460510389|FG003|Controlled Period|Other|0|||
127969660|NCT00267969|460510390|FG004|Controlled Period|Other|0|||
127969661|NCT00267969|460510391|FG005|Controlled Period|Other|0|||
127969662|NCT00267969|460510392|FG006|Controlled Period|Other|0|||
127969663|NCT00267969|460510386|FG000|After Controlled Period|Adverse Event|0|||
127969664|NCT00267969|460510387|FG001|After Controlled Period|Adverse Event|0|||
127969665|NCT00267969|460510388|FG002|After Controlled Period|Adverse Event|0|||
127969666|NCT00267969|460510389|FG003|After Controlled Period|Adverse Event|7|||
127969667|NCT00267969|460510390|FG004|After Controlled Period|Adverse Event|8|||
127969668|NCT00267969|460510391|FG005|After Controlled Period|Adverse Event|23|||
127969669|NCT00267969|460510392|FG006|After Controlled Period|Adverse Event|21|||
127969670|NCT00267969|460510386|FG000|After Controlled Period|Death|0|||
127969671|NCT00267969|460510387|FG001|After Controlled Period|Death|0|||
127969672|NCT00267969|460510388|FG002|After Controlled Period|Death|0|||
127969673|NCT00267969|460510389|FG003|After Controlled Period|Death|1|||
127969674|NCT00267969|460510390|FG004|After Controlled Period|Death|2|||
127969675|NCT00267969|460510391|FG005|After Controlled Period|Death|0|||
127969676|NCT00267969|460510392|FG006|After Controlled Period|Death|1|||
127969677|NCT00267969|460510386|FG000|After Controlled Period|Lack of Efficacy|0|||
127969678|NCT00267969|460510387|FG001|After Controlled Period|Lack of Efficacy|0|||
127969679|NCT00267969|460510388|FG002|After Controlled Period|Lack of Efficacy|0|||
127969680|NCT00267969|460510389|FG003|After Controlled Period|Lack of Efficacy|10|||
127969681|NCT00267969|460510390|FG004|After Controlled Period|Lack of Efficacy|6|||
127969682|NCT00267969|460510391|FG005|After Controlled Period|Lack of Efficacy|28|||
127969683|NCT00267969|460510392|FG006|After Controlled Period|Lack of Efficacy|15|||
127969684|NCT00267969|460510386|FG000|After Controlled Period|Lost to Follow-up|0|||
127969685|NCT00267969|460510387|FG001|After Controlled Period|Lost to Follow-up|0|||
127969686|NCT00267969|460510388|FG002|After Controlled Period|Lost to Follow-up|0|||
127969687|NCT00267969|460510389|FG003|After Controlled Period|Lost to Follow-up|5|||
127969688|NCT00267969|460510390|FG004|After Controlled Period|Lost to Follow-up|8|||
127969689|NCT00267969|460510391|FG005|After Controlled Period|Lost to Follow-up|9|||
127969690|NCT00267969|460510392|FG006|After Controlled Period|Lost to Follow-up|10|||
127969691|NCT00267969|460510386|FG000|After Controlled Period|Other|0|||
127969692|NCT00267969|460510387|FG001|After Controlled Period|Other|0|||
127969693|NCT00267969|460510388|FG002|After Controlled Period|Other|0|||
127969694|NCT00267969|460510389|FG003|After Controlled Period|Other|13|||
127969695|NCT00267969|460510390|FG004|After Controlled Period|Other|11|||
127969696|NCT00267969|460510391|FG005|After Controlled Period|Other|22|||
127969697|NCT00267969|460510392|FG006|After Controlled Period|Other|25|||
127969698|NCT02308540|460510397|FG000|Overall Study|Lost to Follow-up|0|||
127969699|NCT02308540|460510398|FG001|Overall Study|Lost to Follow-up|0|||
127969700|NCT02308540|460510399|FG002|Overall Study|Lost to Follow-up|0|||
127969701|NCT02308540|460510400|FG003|Overall Study|Lost to Follow-up|0|||
127969702|NCT02308540|460510401|FG004|Overall Study|Lost to Follow-up|0|||
127969703|NCT02308540|460510402|FG005|Overall Study|Lost to Follow-up|1|||
127969704|NCT00443079|460510403|FG000|Overall Study|Lost to Follow-up|0|||
127969705|NCT00443079|460510404|FG001|Overall Study|Lost to Follow-up|1|||
127969706|NCT02649439|460510405|FG000|Overall Study|Switched to alternative treatment|6|||
127969707|NCT02649439|460510406|FG001|Overall Study|Switched to alternative treatment|4|||
127969708|NCT02649439|460510405|FG000|Overall Study|Patient decision|1|||
127969709|NCT02649439|460510406|FG001|Overall Study|Patient decision|0|||
127969710|NCT02649439|460510405|FG000|Overall Study|Patient going out of country|1|||
127969711|NCT02649439|460510406|FG001|Overall Study|Patient going out of country|0|||
127969712|NCT02649439|460510405|FG000|Overall Study|To start finasteride|1|||
127969713|NCT02649439|460510406|FG001|Overall Study|To start finasteride|0|||
127969714|NCT02649439|460510405|FG000|Overall Study|Physician Decision|1|||
127969715|NCT02649439|460510406|FG001|Overall Study|Physician Decision|0|||
127969716|NCT02649439|460510405|FG000|Overall Study|Disease progression on study|12|||
127969717|NCT02649439|460510406|FG001|Overall Study|Disease progression on study|13|||
127969718|NCT02649439|460510405|FG000|Overall Study|Refused further treatment|1|||
127969719|NCT02649439|460510406|FG001|Overall Study|Refused further treatment|0|||
127969720|NCT02649439|460510405|FG000|Overall Study|Refused further follow up|2|||
127969721|NCT02649439|460510406|FG001|Overall Study|Refused further follow up|7|||
127969722|NCT02649439|460510405|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
127969723|NCT02649439|460510406|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
127969724|NCT02649439|460510405|FG000|Overall Study|No treatment, per protocol|1|||
127969725|NCT02649439|460510406|FG001|Overall Study|No treatment, per protocol|0|||
127969726|NCT02649439|460510405|FG000|Overall Study|PSA DT makes ineligible|0|||
127969727|NCT02649439|460510406|FG001|Overall Study|PSA DT makes ineligible|1|||
127969728|NCT02649439|460510405|FG000|Overall Study|Rising PSA No Mets|0|||
127969729|NCT02649439|460510406|FG001|Overall Study|Rising PSA No Mets|1|||
127969730|NCT02649439|460510405|FG000|Overall Study|Rising PSA|0|||
127969731|NCT02649439|460510406|FG001|Overall Study|Rising PSA|1|||
127969732|NCT02649439|460510405|FG000|Overall Study|Signed follow up protocol|0|||
127969733|NCT02649439|460510406|FG001|Overall Study|Signed follow up protocol|1|||
127969734|NCT01053663|460510409|FG000|Overall Study|Death|2|||
127969735|NCT01053663|460510409|FG000|Overall Study|Lost to Follow-up|1|||
127969736|NCT01053663|460510409|FG000|Overall Study|Poor IV Access|1|||
127969737|NCT01053663|460510409|FG000|Overall Study|Transferred to Another Hospital|1|||
127969738|NCT01053663|460510409|FG000|Overall Study|Negative Influenza Diagnosis|1|||
127969739|NCT03533114|460510410|FG000|Overall|Adverse Event|16|||
127969740|NCT03533114|460510411|FG001|Overall|Adverse Event|11|||
127969741|NCT03533114|460510410|FG000|Overall|Consent Withdrawal by Participant|7|||
127969742|NCT03533114|460510411|FG001|Overall|Consent Withdrawal by Participant|6|||
127969743|NCT03533114|460510410|FG000|Overall|Lack of Efficacy|5|||
127969744|NCT03533114|460510411|FG001|Overall|Lack of Efficacy|3|||
127969745|NCT03533114|460510410|FG000|Overall|Lost to Follow-up|1|||
127969746|NCT03533114|460510411|FG001|Overall|Lost to Follow-up|1|||
127969747|NCT03533114|460510410|FG000|Overall|Physician Decision|0|||
127969748|NCT03533114|460510411|FG001|Overall|Physician Decision|2|||
127969749|NCT03533114|460510410|FG000|Overall|Protocol deviation|1|||
127969750|NCT03533114|460510411|FG001|Overall|Protocol deviation|1|||
127969751|NCT03533114|460510410|FG000|Overall|Failure to meet randomization criteria|1|||
127969752|NCT03533114|460510411|FG001|Overall|Failure to meet randomization criteria|2|||
127969753|NCT03533114|460510410|FG000|Overall|Non-Compliance with study drug|0|||
127969754|NCT03533114|460510411|FG001|Overall|Non-Compliance with study drug|1|||
127969755|NCT03533114|460510410|FG000|Overall|Other|0|||
127969756|NCT03533114|460510411|FG001|Overall|Other|1|||
127969757|NCT03533114|460510410|FG000|Open Label Titration and Optimization|Adverse Event|11|||
127969758|NCT03533114|460510411|FG001|Open Label Titration and Optimization|Adverse Event|8|||
127969759|NCT03533114|460510410|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
127969760|NCT03533114|460510411|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
127969761|NCT03533114|460510410|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
127969762|NCT03533114|460510411|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
127969763|NCT03533114|460510410|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
127969764|NCT03533114|460510411|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
127969765|NCT03533114|460510410|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
127969766|NCT03533114|460510411|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
127969767|NCT03533114|460510410|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
127969768|NCT03533114|460510411|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
127969769|NCT03533114|460510410|FG000|Stable Dose|Adverse Event|0|||
127969770|NCT03533114|460510411|FG001|Stable Dose|Adverse Event|2|||
127969771|NCT03533114|460510410|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
127969772|NCT03533114|460510411|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
127969773|NCT03533114|460510410|FG000|Stable Dose|Lack of Efficacy|1|||
127969774|NCT03533114|460510411|FG001|Stable Dose|Lack of Efficacy|0|||
127969775|NCT03533114|460510410|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
127969776|NCT03533114|460510411|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
127969777|NCT03533114|460510410|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
127969778|NCT03533114|460510411|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
127969779|NCT03533114|460510410|FG000|Open-Label Safety Extension|Adverse Event|3|||
127969780|NCT03533114|460510411|FG001|Open-Label Safety Extension|Adverse Event|0|||
127969781|NCT03533114|460510410|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
127969782|NCT03533114|460510411|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
127969783|NCT03533114|460510410|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
127969784|NCT03533114|460510411|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
127969785|NCT03533114|460510410|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
127969786|NCT03533114|460510411|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
127969787|NCT03533114|460510410|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
127969788|NCT03533114|460510411|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
127969789|NCT01862250|460510412|FG000|Overall Study|Adverse Event|4|||
127969790|NCT02423343|460510413|FG000|Overall Study|Withdrawal by Subject|0|||
127969791|NCT02423343|460510414|FG001|Overall Study|Withdrawal by Subject|1|||
127969792|NCT02423343|460510415|FG002|Overall Study|Withdrawal by Subject|0|||
127969793|NCT02423343|460510416|FG003|Overall Study|Withdrawal by Subject|0|||
127969794|NCT02423343|460510417|FG004|Overall Study|Withdrawal by Subject|0|||
127969795|NCT02423343|460510418|FG005|Overall Study|Withdrawal by Subject|0|||
127969796|NCT02423343|460510413|FG000|Overall Study|Progressive Disease|0|||
127969797|NCT02423343|460510414|FG001|Overall Study|Progressive Disease|0|||
127969798|NCT02423343|460510415|FG002|Overall Study|Progressive Disease|0|||
127969799|NCT02423343|460510416|FG003|Overall Study|Progressive Disease|0|||
127969800|NCT02423343|460510417|FG004|Overall Study|Progressive Disease|2|||
127969801|NCT02423343|460510418|FG005|Overall Study|Progressive Disease|0|||
127969802|NCT02423343|460510413|FG000|Overall Study|Adverse Event|0|||
127969803|NCT02423343|460510414|FG001|Overall Study|Adverse Event|0|||
127969804|NCT02423343|460510415|FG002|Overall Study|Adverse Event|0|||
127969805|NCT02423343|460510416|FG003|Overall Study|Adverse Event|0|||
127969806|NCT02423343|460510417|FG004|Overall Study|Adverse Event|2|||
127969807|NCT02423343|460510418|FG005|Overall Study|Adverse Event|0|||
127969808|NCT02423343|460510413|FG000|Overall Study|Death|0|||
127969809|NCT02423343|460510414|FG001|Overall Study|Death|0|||
127969810|NCT02423343|460510415|FG002|Overall Study|Death|0|||
127969811|NCT02423343|460510416|FG003|Overall Study|Death|0|||
127969812|NCT02423343|460510417|FG004|Overall Study|Death|1|||
127969813|NCT02423343|460510418|FG005|Overall Study|Death|0|||
127969814|NCT02016105|460510419|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
127969815|NCT02016105|460510420|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
127969816|NCT02016105|460510421|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
127969817|NCT02016105|460510422|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
127969818|NCT02016105|460510423|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
127969819|NCT02016105|460510424|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
127969820|NCT02016105|460510419|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
127969821|NCT02016105|460510420|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
127969822|NCT02016105|460510421|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
127969823|NCT02016105|460510422|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
127969824|NCT02016105|460510423|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
127969825|NCT02016105|460510424|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
127969826|NCT02016105|460510419|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
127969827|NCT02016105|460510420|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
127969828|NCT02016105|460510421|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
127969829|NCT02016105|460510422|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
127969830|NCT02016105|460510423|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
127969831|NCT02016105|460510424|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
127969832|NCT02016105|460510419|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
127969833|NCT02016105|460510420|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
127969834|NCT02016105|460510421|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
127969835|NCT02016105|460510422|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
127969836|NCT02016105|460510423|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
127969837|NCT02016105|460510424|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
127969838|NCT02016105|460510419|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
127969839|NCT02016105|460510420|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
127969840|NCT02016105|460510421|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
127969841|NCT02016105|460510422|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
127969842|NCT02016105|460510423|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
127969843|NCT02016105|460510424|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
127969844|NCT02016105|460510419|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
127969845|NCT02016105|460510420|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
127969846|NCT02016105|460510421|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
127969847|NCT02016105|460510422|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
127969848|NCT02016105|460510423|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
127969849|NCT02016105|460510424|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
127969850|NCT02016105|460510419|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
127969851|NCT02016105|460510420|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
127969852|NCT02016105|460510421|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
127969853|NCT02016105|460510422|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
127969854|NCT02016105|460510423|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
127969855|NCT02016105|460510424|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
127969856|NCT02016105|460510419|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
127969857|NCT02016105|460510420|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
127969858|NCT02016105|460510421|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
127969859|NCT02016105|460510422|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
127969860|NCT02016105|460510423|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
127969861|NCT02016105|460510424|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
127969862|NCT02016105|460510419|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
127969863|NCT02016105|460510420|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
127969864|NCT02016105|460510421|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
127969865|NCT02016105|460510422|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
127969866|NCT02016105|460510423|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
127969867|NCT02016105|460510424|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
127969868|NCT02016105|460510419|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
127969869|NCT02016105|460510420|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
127969870|NCT02016105|460510421|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
127969871|NCT02016105|460510422|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
127969872|NCT02016105|460510423|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
127969873|NCT02016105|460510424|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
127969874|NCT02016105|460510419|FG000|TREATMENT PERIOD 2|Death|0|||
127969875|NCT02016105|460510420|FG001|TREATMENT PERIOD 2|Death|0|||
127969876|NCT02016105|460510421|FG002|TREATMENT PERIOD 2|Death|0|||
127969877|NCT02016105|460510422|FG003|TREATMENT PERIOD 2|Death|0|||
127969878|NCT02016105|460510423|FG004|TREATMENT PERIOD 2|Death|0|||
127969879|NCT02016105|460510424|FG005|TREATMENT PERIOD 2|Death|1|||
127969880|NCT02016105|460510419|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
127969881|NCT02016105|460510420|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
127969882|NCT02016105|460510421|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
127969883|NCT02016105|460510422|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
127969884|NCT02016105|460510423|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
127969885|NCT02016105|460510424|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
127969886|NCT02016105|460510419|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
127969887|NCT02016105|460510420|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
127969888|NCT02016105|460510421|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
127969889|NCT02016105|460510422|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
127969890|NCT02016105|460510423|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
127969891|NCT02016105|460510424|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
127969892|NCT02016105|460510419|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
127969893|NCT02016105|460510420|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
127969894|NCT02016105|460510421|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
127969895|NCT02016105|460510422|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
127969896|NCT02016105|460510423|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
127969897|NCT02016105|460510424|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
127969898|NCT02016105|460510419|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
127969899|NCT02016105|460510420|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
127969900|NCT02016105|460510421|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
127969901|NCT02016105|460510422|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
127969902|NCT02016105|460510423|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
127969903|NCT02016105|460510424|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
127969904|NCT02016105|460510419|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
127969905|NCT02016105|460510420|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
127969906|NCT02016105|460510421|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
127969907|NCT02016105|460510422|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
127969908|NCT02016105|460510423|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
127969909|NCT02016105|460510424|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
127969910|NCT02016105|460510419|FG000|EXTENSION PERIOD|Adverse Event|0|||
127969911|NCT02016105|460510420|FG001|EXTENSION PERIOD|Adverse Event|0|||
127969912|NCT02016105|460510421|FG002|EXTENSION PERIOD|Adverse Event|2|||
127969913|NCT02016105|460510422|FG003|EXTENSION PERIOD|Adverse Event|0|||
127969914|NCT02016105|460510423|FG004|EXTENSION PERIOD|Adverse Event|1|||
127969915|NCT02016105|460510424|FG005|EXTENSION PERIOD|Adverse Event|0|||
127969916|NCT02016105|460510419|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
127969917|NCT02016105|460510420|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
127969918|NCT02016105|460510421|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
127969919|NCT02016105|460510422|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
127969920|NCT02016105|460510423|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
127969921|NCT02016105|460510424|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
127969922|NCT02016105|460510419|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
127969923|NCT02016105|460510420|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
127969924|NCT02016105|460510421|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
127969925|NCT02016105|460510422|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
127969926|NCT02016105|460510423|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
127969927|NCT02016105|460510424|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
127969928|NCT02016105|460510419|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
127969929|NCT02016105|460510420|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
127969930|NCT02016105|460510421|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
127969931|NCT02016105|460510422|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
127969932|NCT02016105|460510423|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
127969933|NCT02016105|460510424|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
127969934|NCT00090493|460510425|FG000|Overall Study|Physician Decision|2|||
127969935|NCT02071706|460510426|FG000|Overall Study|Adverse Event|1|||
127969936|NCT02071706|460510426|FG000|Overall Study|Withdrawal by Subject|2|||
127969937|NCT01908829|460510432|FG000|Overall Study|Adverse Event|13|||
127969938|NCT01908829|460510433|FG001|Overall Study|Adverse Event|11|||
127969939|NCT01908829|460510434|FG002|Overall Study|Adverse Event|13|||
127969940|NCT01908829|460510432|FG000|Overall Study|Lost to Follow-up|4|||
127969941|NCT01908829|460510433|FG001|Overall Study|Lost to Follow-up|2|||
127969942|NCT01908829|460510434|FG002|Overall Study|Lost to Follow-up|1|||
127969943|NCT01908829|460510432|FG000|Overall Study|Randomized no double-blind drug received|1|||
127969944|NCT01908829|460510433|FG001|Overall Study|Randomized no double-blind drug received|0|||
127969945|NCT01908829|460510434|FG002|Overall Study|Randomized no double-blind drug received|1|||
127969946|NCT01908829|460510432|FG000|Overall Study|Discontinued (no EoT page)|2|||
127969947|NCT01908829|460510433|FG001|Overall Study|Discontinued (no EoT page)|0|||
127969948|NCT01908829|460510434|FG002|Overall Study|Discontinued (no EoT page)|0|||
127969949|NCT01908829|460510432|FG000|Overall Study|Miscellaneous|0|||
127969950|NCT01908829|460510433|FG001|Overall Study|Miscellaneous|2|||
127969951|NCT01908829|460510434|FG002|Overall Study|Miscellaneous|0|||
127969952|NCT01908829|460510432|FG000|Overall Study|Protocol Violation|2|||
127969953|NCT01908829|460510433|FG001|Overall Study|Protocol Violation|2|||
127969954|NCT01908829|460510434|FG002|Overall Study|Protocol Violation|0|||
127969955|NCT01908829|460510432|FG000|Overall Study|Lack of Efficacy|1|||
127969956|NCT01908829|460510433|FG001|Overall Study|Lack of Efficacy|3|||
127969957|NCT01908829|460510434|FG002|Overall Study|Lack of Efficacy|2|||
127969958|NCT01908829|460510432|FG000|Overall Study|Withdrawal by Subject|26|||
127969959|NCT01908829|460510433|FG001|Overall Study|Withdrawal by Subject|29|||
127969960|NCT01908829|460510434|FG002|Overall Study|Withdrawal by Subject|22|||
127969961|NCT02247440|460510435|FG000|Overall Study|Withdrawal by Subject|1|||
127969962|NCT02247440|460510435|FG000|Overall Study|Lack of Efficacy|3|||
127969963|NCT02792192|460510436|FG000|Overall Study|Death|1|||
127969964|NCT02792192|460510437|FG001|Overall Study|Death|0|||
127969965|NCT02792192|460510438|FG002|Overall Study|Death|0|||
127969966|NCT02792192|460510439|FG003|Overall Study|Death|0|||
127969967|NCT02792192|460510436|FG000|Overall Study|Informed Consent Withdrawn|4|||
127969968|NCT02792192|460510437|FG001|Overall Study|Informed Consent Withdrawn|0|||
127969969|NCT02792192|460510438|FG002|Overall Study|Informed Consent Withdrawn|0|||
127969970|NCT02792192|460510439|FG003|Overall Study|Informed Consent Withdrawn|0|||
127969971|NCT02792192|460510436|FG000|Overall Study|Physician Decision|1|||
127969972|NCT02792192|460510437|FG001|Overall Study|Physician Decision|0|||
127969973|NCT02792192|460510438|FG002|Overall Study|Physician Decision|0|||
127969974|NCT02792192|460510439|FG003|Overall Study|Physician Decision|0|||
127969975|NCT02792192|460510436|FG000|Overall Study|Progressive Disease|0|||
127969976|NCT02792192|460510437|FG001|Overall Study|Progressive Disease|1|||
127969977|NCT02792192|460510438|FG002|Overall Study|Progressive Disease|0|||
127969978|NCT02792192|460510439|FG003|Overall Study|Progressive Disease|0|||
127969979|NCT02792192|460510436|FG000|Overall Study|Study Terminated By Sponsor|6|||
127969980|NCT02792192|460510437|FG001|Overall Study|Study Terminated By Sponsor|10|||
127969981|NCT02792192|460510438|FG002|Overall Study|Study Terminated By Sponsor|0|||
127969982|NCT02792192|460510439|FG003|Overall Study|Study Terminated By Sponsor|0|||
127969983|NCT02320058|460510440|FG000|Overall Study|Death|25|||
127969984|NCT02320058|460510441|FG001|Overall Study|Death|10|||
127969985|NCT02320058|460510440|FG000|Overall Study|Lost to Follow-up|4|||
127969986|NCT02320058|460510441|FG001|Overall Study|Lost to Follow-up|0|||
127969987|NCT02320058|460510440|FG000|Overall Study|Other reasons|4|||
127969988|NCT02320058|460510441|FG001|Overall Study|Other reasons|1|||
127969989|NCT02320058|460510440|FG000|Overall Study|Withdrawal by Subject|8|||
127969990|NCT02320058|460510441|FG001|Overall Study|Withdrawal by Subject|2|||
127969991|NCT02320058|460510440|FG000|Overall Study|Not reported|1|||
127969992|NCT02320058|460510441|FG001|Overall Study|Not reported|0|||
127969993|NCT01339923|460510442|FG000|Overall Study|Adverse Event|1|||
127969994|NCT01339923|460510443|FG001|Overall Study|Adverse Event|1|||
127969995|NCT01339923|460510444|FG002|Overall Study|Adverse Event|1|||
127969996|NCT01339923|460510445|FG003|Overall Study|Adverse Event|0|||
127969997|NCT01339923|460510446|FG004|Overall Study|Adverse Event|0|||
127969998|NCT01339923|460510447|FG005|Overall Study|Adverse Event|0|||
127969999|NCT01339923|460510448|FG006|Overall Study|Adverse Event|1|||
127970000|NCT01339923|460510442|FG000|Overall Study|Inappropriate Enrollment|1|||
127970001|NCT01339923|460510443|FG001|Overall Study|Inappropriate Enrollment|0|||
127970002|NCT01339923|460510444|FG002|Overall Study|Inappropriate Enrollment|0|||
127970003|NCT01339923|460510445|FG003|Overall Study|Inappropriate Enrollment|0|||
127970004|NCT01339923|460510446|FG004|Overall Study|Inappropriate Enrollment|0|||
127970005|NCT01339923|460510447|FG005|Overall Study|Inappropriate Enrollment|1|||
127970006|NCT01339923|460510448|FG006|Overall Study|Inappropriate Enrollment|0|||
127970007|NCT01339923|460510442|FG000|Overall Study|Lost to Follow-up|4|||
127970008|NCT01339923|460510443|FG001|Overall Study|Lost to Follow-up|4|||
127970009|NCT01339923|460510444|FG002|Overall Study|Lost to Follow-up|0|||
127970010|NCT01339923|460510445|FG003|Overall Study|Lost to Follow-up|3|||
127970011|NCT01339923|460510446|FG004|Overall Study|Lost to Follow-up|1|||
127970012|NCT01339923|460510447|FG005|Overall Study|Lost to Follow-up|1|||
127970013|NCT01339923|460510448|FG006|Overall Study|Lost to Follow-up|5|||
127970014|NCT01339923|460510442|FG000|Overall Study|Protocol Violation|0|||
127970015|NCT01339923|460510443|FG001|Overall Study|Protocol Violation|0|||
127970016|NCT01339923|460510444|FG002|Overall Study|Protocol Violation|0|||
127970017|NCT01339923|460510445|FG003|Overall Study|Protocol Violation|0|||
127970018|NCT01339923|460510446|FG004|Overall Study|Protocol Violation|0|||
127970019|NCT01339923|460510447|FG005|Overall Study|Protocol Violation|3|||
127970020|NCT01339923|460510448|FG006|Overall Study|Protocol Violation|1|||
127970021|NCT01339923|460510442|FG000|Overall Study|Unable to Classify|1|||
127970022|NCT01339923|460510443|FG001|Overall Study|Unable to Classify|0|||
127970023|NCT01339923|460510444|FG002|Overall Study|Unable to Classify|1|||
127970024|NCT01339923|460510445|FG003|Overall Study|Unable to Classify|0|||
127970025|NCT01339923|460510446|FG004|Overall Study|Unable to Classify|0|||
127970026|NCT01339923|460510447|FG005|Overall Study|Unable to Classify|1|||
127970027|NCT01339923|460510448|FG006|Overall Study|Unable to Classify|5|||
127970028|NCT01339923|460510442|FG000|Overall Study|Withdrawal by Subject|7|||
127970029|NCT01339923|460510443|FG001|Overall Study|Withdrawal by Subject|11|||
127970030|NCT01339923|460510444|FG002|Overall Study|Withdrawal by Subject|6|||
127970031|NCT01339923|460510445|FG003|Overall Study|Withdrawal by Subject|1|||
127970032|NCT01339923|460510446|FG004|Overall Study|Withdrawal by Subject|4|||
127970033|NCT01339923|460510447|FG005|Overall Study|Withdrawal by Subject|3|||
127970034|NCT01339923|460510448|FG006|Overall Study|Withdrawal by Subject|2|||
127970035|NCT01860040|460510459|FG000|Overall Study|Withdrawal by Subject|1|||
127970036|NCT01860040|460510460|FG001|Overall Study|Withdrawal by Subject|0|||
127970037|NCT00403481|460510461|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
127970038|NCT00403481|460510461|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
127970039|NCT00403481|460510461|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
127970040|NCT00403481|460510461|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
127970041|NCT00403481|460510461|FG000|Olm 40 mg|Adverse Event|2|||
127970042|NCT00403481|460510461|FG000|Olm 40 mg|Protocol Violation|1|||
127970043|NCT00403481|460510461|FG000|Olm 40 mg|Withdrawal by Subject|1|||
127970044|NCT00403481|460510461|FG000|Olm 40 mg|Other|1|||
127970045|NCT00403481|460510461|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
127970046|NCT00403481|460510461|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
127970047|NCT00403481|460510461|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
127970048|NCT00403481|460510461|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
127970049|NCT00403481|460510461|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
127970050|NCT00403481|460510461|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
127970051|NCT02099110|460510470|FG000|Overall Study|Protocol Violation|2|||
127970052|NCT02099110|460510471|FG001|Overall Study|Protocol Violation|1|||
127970053|NCT02099110|460510472|FG002|Overall Study|Protocol Violation|0|||
127970054|NCT02099110|460510473|FG003|Overall Study|Protocol Violation|3|||
127970055|NCT02099110|460510474|FG004|Overall Study|Protocol Violation|1|||
127970056|NCT02099110|460510470|FG000|Overall Study|Participant moved|1|||
127970057|NCT02099110|460510471|FG001|Overall Study|Participant moved|1|||
127970058|NCT02099110|460510472|FG002|Overall Study|Participant moved|1|||
127970059|NCT02099110|460510473|FG003|Overall Study|Participant moved|0|||
127970060|NCT02099110|460510474|FG004|Overall Study|Participant moved|2|||
127970061|NCT02099110|460510470|FG000|Overall Study|Withdrawal by Subject|7|||
127970062|NCT02099110|460510471|FG001|Overall Study|Withdrawal by Subject|11|||
127970063|NCT02099110|460510472|FG002|Overall Study|Withdrawal by Subject|13|||
127970064|NCT02099110|460510473|FG003|Overall Study|Withdrawal by Subject|9|||
127970065|NCT02099110|460510474|FG004|Overall Study|Withdrawal by Subject|13|||
127970066|NCT02099110|460510470|FG000|Overall Study|Adverse Event|3|||
127970067|NCT02099110|460510471|FG001|Overall Study|Adverse Event|5|||
127970068|NCT02099110|460510472|FG002|Overall Study|Adverse Event|2|||
127970069|NCT02099110|460510473|FG003|Overall Study|Adverse Event|3|||
127970070|NCT02099110|460510474|FG004|Overall Study|Adverse Event|2|||
127970071|NCT02099110|460510470|FG000|Overall Study|Lost to Follow-up|6|||
127970072|NCT02099110|460510471|FG001|Overall Study|Lost to Follow-up|12|||
127970073|NCT02099110|460510472|FG002|Overall Study|Lost to Follow-up|11|||
127970074|NCT02099110|460510473|FG003|Overall Study|Lost to Follow-up|5|||
127970075|NCT02099110|460510474|FG004|Overall Study|Lost to Follow-up|6|||
127970076|NCT02099110|460510470|FG000|Overall Study|Death|0|||
127970077|NCT02099110|460510471|FG001|Overall Study|Death|1|||
127970078|NCT02099110|460510472|FG002|Overall Study|Death|0|||
127970079|NCT02099110|460510473|FG003|Overall Study|Death|0|||
127970080|NCT02099110|460510474|FG004|Overall Study|Death|0|||
127970081|NCT02099110|460510470|FG000|Overall Study|Screen failure|0|||
127970082|NCT02099110|460510471|FG001|Overall Study|Screen failure|0|||
127970083|NCT02099110|460510472|FG002|Overall Study|Screen failure|0|||
127970084|NCT02099110|460510473|FG003|Overall Study|Screen failure|0|||
127970085|NCT02099110|460510474|FG004|Overall Study|Screen failure|1|||
127970086|NCT02099110|460510470|FG000|Overall Study|Non-compliance with study drug|2|||
127970087|NCT02099110|460510471|FG001|Overall Study|Non-compliance with study drug|0|||
127970088|NCT02099110|460510472|FG002|Overall Study|Non-compliance with study drug|0|||
127970089|NCT02099110|460510473|FG003|Overall Study|Non-compliance with study drug|0|||
127970090|NCT02099110|460510474|FG004|Overall Study|Non-compliance with study drug|1|||
127970091|NCT02099110|460510470|FG000|Overall Study|Physician Decision|3|||
127970092|NCT02099110|460510471|FG001|Overall Study|Physician Decision|0|||
127970093|NCT02099110|460510472|FG002|Overall Study|Physician Decision|1|||
127970094|NCT02099110|460510473|FG003|Overall Study|Physician Decision|2|||
127970095|NCT02099110|460510474|FG004|Overall Study|Physician Decision|1|||
127970096|NCT00994461|460510478|FG000|Overall Study|Adverse Event|2|||
127970097|NCT00994461|460510479|FG001|Overall Study|Adverse Event|1|||
127970098|NCT00994461|460510480|FG002|Overall Study|Adverse Event|0|||
127970099|NCT03793842|460510485|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
127970100|NCT03793842|460510486|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
127970101|NCT03793842|460510485|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
127970102|NCT03793842|460510486|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
127970103|NCT00900159|460510487|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
127970104|NCT00900159|460510488|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
127970105|NCT01166438|460510489|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
127970106|NCT01166438|460510490|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
127970107|NCT01166438|460510489|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
127970108|NCT01166438|460510490|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
127970109|NCT01166438|460510489|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
127970110|NCT01166438|460510490|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
127970111|NCT01166438|460510489|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
127970112|NCT01166438|460510490|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
127970113|NCT01166438|460510489|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
127970114|NCT01166438|460510490|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
127970115|NCT01166438|460510489|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
127970116|NCT01166438|460510490|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
127970117|NCT01377922|460510497|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
127970118|NCT01377922|460510498|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
127970119|NCT03340454|460510500|FG000|Overall Study|Lost to Follow-up|0|||
127970120|NCT03340454|460510501|FG001|Overall Study|Lost to Follow-up|4|||
127970121|NCT03682848|460510502|FG000|Overall Study|Withdrawal by Subject|2|||
127970122|NCT03682848|460510502|FG000|Overall Study|Site closed|5|||
127970123|NCT03682848|460510502|FG000|Overall Study|Protocol Deviation|1|||
127970124|NCT03682848|460510502|FG000|Overall Study|Adverse Event|1|||
127970125|NCT01464164|460510503|FG000|Overall Study|Screen failure|0|||
127970126|NCT01464164|460510504|FG001|Overall Study|Screen failure|1|||
127970127|NCT01464164|460510505|FG002|Overall Study|Screen failure|2|||
127970128|NCT01464164|460510506|FG003|Overall Study|Screen failure|0|||
127970129|NCT01464164|460510507|FG004|Overall Study|Screen failure|0|||
127970130|NCT01464164|460510508|FG005|Overall Study|Screen failure|0|||
127970131|NCT01464164|460510509|FG006|Overall Study|Screen failure|0|||
127970132|NCT01464164|460510503|FG000|Overall Study|Physician Decision|0|||
127970133|NCT01464164|460510504|FG001|Overall Study|Physician Decision|1|||
127970134|NCT01464164|460510505|FG002|Overall Study|Physician Decision|0|||
127970135|NCT01464164|460510506|FG003|Overall Study|Physician Decision|0|||
127970136|NCT01464164|460510507|FG004|Overall Study|Physician Decision|0|||
127970137|NCT01464164|460510508|FG005|Overall Study|Physician Decision|0|||
127970138|NCT01464164|460510509|FG006|Overall Study|Physician Decision|2|||
127970139|NCT03478644|460510511|FG000|Phase 2|Withdrawal by Subject|2|||
127970140|NCT03478644|460510512|FG001|Phase 2|Withdrawal by Subject|1|||
127970141|NCT03478644|460510511|FG000|Phase 2|Lost to Follow-up|1|||
127970142|NCT03478644|460510512|FG001|Phase 2|Lost to Follow-up|0|||
127970143|NCT03300505|460512359|FG000|Overall Study|Death|0|||
127970144|NCT03300505|460512360|FG001|Overall Study|Death|1|||
127970145|NCT03300505|460512361|FG002|Overall Study|Death|0|||
127970146|NCT03300505|460512359|FG000|Overall Study|Withdrawal by Subject|0|||
127970147|NCT03300505|460512360|FG001|Overall Study|Withdrawal by Subject|1|||
127970148|NCT03300505|460512361|FG002|Overall Study|Withdrawal by Subject|1|||
127970149|NCT03300505|460512359|FG000|Overall Study|Sponsor Termination|0|||
127970150|NCT03300505|460512360|FG001|Overall Study|Sponsor Termination|1|||
127970151|NCT03300505|460512361|FG002|Overall Study|Sponsor Termination|0|||
127970152|NCT03300505|460512359|FG000|Overall Study|Adverse Event|0|||
127970153|NCT03300505|460512360|FG001|Overall Study|Adverse Event|0|||
127970154|NCT03300505|460512361|FG002|Overall Study|Adverse Event|2|||
127970155|NCT05119595|460512362|FG000|Overall Study|Death|1|||
127970156|NCT05119595|460512362|FG000|Overall Study|Lost to Follow-up|7|||
127970157|NCT00679029|460512363|FG000|Overall Study|Adverse Event|3|||
127970158|NCT00679029|460512363|FG000|Overall Study|Withdrawal by Subject|1|||
127970159|NCT00679029|460512363|FG000|Overall Study|Lost to Follow-up|1|||
127970160|NCT01108341|460512364|FG000|Overall Study|Death|2|||
127970161|NCT01108341|460512364|FG000|Overall Study|Withdrawal by Subject|1|||
127970162|NCT01108341|460512364|FG000|Overall Study|Lost to Follow-up|1|||
127970163|NCT01108341|460512364|FG000|Overall Study|Other|1|||
127970164|NCT04402138|460512365|FG000|Overall Study|Progressive Disease|2|||
127970165|NCT04402138|460512365|FG000|Overall Study|Adverse Event|1|||
127970166|NCT03056638|460512368|FG000|Overall Study|Death|1|||
127970167|NCT03056638|460512369|FG001|Overall Study|Death|0|||
127970168|NCT00468481|460512370|FG000|Overall Study|Adverse Event|13|||
127970169|NCT00468481|460512371|FG001|Overall Study|Adverse Event|3|||
127970170|NCT00468481|460512370|FG000|Overall Study|Lost to Follow-up|25|||
127970171|NCT00468481|460512371|FG001|Overall Study|Lost to Follow-up|8|||
127970172|NCT00468481|460512370|FG000|Overall Study|Pregnancy|2|||
127970173|NCT00468481|460512371|FG001|Overall Study|Pregnancy|0|||
127970174|NCT00468481|460512370|FG000|Overall Study|Protocol Violation|18|||
127970175|NCT00468481|460512371|FG001|Overall Study|Protocol Violation|8|||
127970176|NCT00468481|460512370|FG000|Overall Study|Withdrawal by Subject|12|||
127970177|NCT00468481|460512371|FG001|Overall Study|Withdrawal by Subject|3|||
127970178|NCT00468481|460512370|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
127970179|NCT00468481|460512371|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
127970180|NCT00468481|460512370|FG000|Overall Study|Prohibited Medication|1|||
127970181|NCT00468481|460512371|FG001|Overall Study|Prohibited Medication|1|||
127970182|NCT00468481|460512370|FG000|Overall Study|Egg Donor|1|||
127970183|NCT00468481|460512371|FG001|Overall Study|Egg Donor|0|||
127970184|NCT00468481|460512370|FG000|Overall Study|Moved out of area|4|||
127970185|NCT00468481|460512371|FG001|Overall Study|Moved out of area|1|||
127970186|NCT00468481|460512370|FG000|Overall Study|Non-Compliance|5|||
127970187|NCT00468481|460512371|FG001|Overall Study|Non-Compliance|0|||
127970188|NCT00468481|460512370|FG000|Overall Study|Other|6|||
127970189|NCT00468481|460512371|FG001|Overall Study|Other|0|||
127970190|NCT00734162|460512372|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
127970191|NCT00734162|460512373|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
127970192|NCT00734162|460512374|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
127970193|NCT00734162|460512375|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
127970194|NCT00734162|460512372|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
127970195|NCT00734162|460512373|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
127970196|NCT00734162|460512374|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
127970197|NCT00734162|460512375|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
127970198|NCT00734162|460512372|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
127970199|NCT00734162|460512373|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
127970200|NCT00734162|460512374|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
127970201|NCT00734162|460512375|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
127970202|NCT00734162|460512372|FG000|Open-Label Phase|Withdrew Consent|1|||
127970203|NCT00734162|460512373|FG001|Open-Label Phase|Withdrew Consent|0|||
127970204|NCT00734162|460512374|FG002|Open-Label Phase|Withdrew Consent|1|||
127970205|NCT00734162|460512375|FG003|Open-Label Phase|Withdrew Consent|1|||
127970206|NCT00734162|460512372|FG000|Open-Label Phase|Lost to Follow-up|1|||
127970207|NCT00734162|460512373|FG001|Open-Label Phase|Lost to Follow-up|2|||
127970208|NCT00734162|460512374|FG002|Open-Label Phase|Lost to Follow-up|0|||
127970209|NCT00734162|460512375|FG003|Open-Label Phase|Lost to Follow-up|1|||
127970210|NCT00734162|460512372|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
127970211|NCT00734162|460512373|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
127970212|NCT00734162|460512374|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
127970213|NCT00734162|460512375|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
127970214|NCT00596687|460512376|FG000|Overall Study|< 24 hours of insulin treatment|8|||
127970215|NCT00596687|460512377|FG001|Overall Study|< 24 hours of insulin treatment|6|||
127970216|NCT00596687|460512376|FG000|Overall Study|continuous insulin infusion during TPN|2|||
127970217|NCT00596687|460512377|FG001|Overall Study|continuous insulin infusion during TPN|1|||
127970218|NCT00596687|460512376|FG000|Overall Study|Withdrawal by Subject|3|||
127970219|NCT00596687|460512377|FG001|Overall Study|Withdrawal by Subject|1|||
127970220|NCT00596687|460512376|FG000|Overall Study|cancelled surgery|1|||
127970221|NCT00596687|460512377|FG001|Overall Study|cancelled surgery|1|||
127970222|NCT03831113|460512378|FG000|Overall Study|Withdrawal by Subject|0|||
127970223|NCT03831113|460512379|FG001|Overall Study|Withdrawal by Subject|2|||
127970224|NCT03831113|460512378|FG000|Overall Study|Protocol Violation|0|||
127970225|NCT03831113|460512379|FG001|Overall Study|Protocol Violation|9|||
127970226|NCT03508726|460512380|FG000|Overall Study|Withdrawal by Subject|0|||
127970227|NCT03508726|460512381|FG001|Overall Study|Withdrawal by Subject|1|||
127970228|NCT01515865|460512383|FG000|Part A (Open-label)|Other|3|||
127970229|NCT01515865|460512384|FG001|Part A (Open-label)|Other|0|||
127970230|NCT01515865|460512385|FG002|Part A (Open-label)|Other|0|||
127970231|NCT01515865|460512383|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
127970232|NCT01515865|460512384|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
127970233|NCT01515865|460512385|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
127970234|NCT01515865|460512383|FG000|Part B (Open-label)|Other|1|||
127970235|NCT01515865|460512384|FG001|Part B (Open-label)|Other|0|||
127970236|NCT01515865|460512385|FG002|Part B (Open-label)|Other|0|||
127970237|NCT03645395|460512388|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
127970238|NCT03645395|460512389|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
127970239|NCT03645395|460512390|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
127970240|NCT03645395|460512391|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
127970241|NCT03645395|460512388|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
127970242|NCT03645395|460512389|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
127970243|NCT03645395|460512390|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
127970244|NCT03645395|460512391|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
127970245|NCT03645395|460512388|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
127970246|NCT03645395|460512389|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
127970247|NCT03645395|460512390|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
127970248|NCT03645395|460512391|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
127970249|NCT03645395|460512388|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
127970250|NCT03645395|460512389|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
127970251|NCT03645395|460512390|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
127970252|NCT03645395|460512391|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
127970253|NCT04606394|460512392|FG000|Overall Study|Withdrawal by Subject|3|||
127970254|NCT04606394|460512392|FG000|Overall Study|Exclusion criteria screen failure|12|||
127970255|NCT03423173|460512393|FG000|Overall Study|Randomized but not vaccinated|1|||
127970256|NCT03423173|460512394|FG001|Overall Study|Randomized but not vaccinated|0|||
127970257|NCT03423173|460512395|FG002|Overall Study|Randomized but not vaccinated|2|||
127970258|NCT03423173|460512396|FG003|Overall Study|Randomized but not vaccinated|1|||
127970259|NCT03423173|460512393|FG000|Overall Study|Adverse Event|1|||
127970260|NCT03423173|460512394|FG001|Overall Study|Adverse Event|1|||
127970261|NCT03423173|460512395|FG002|Overall Study|Adverse Event|1|||
127970262|NCT03423173|460512396|FG003|Overall Study|Adverse Event|1|||
127970263|NCT03423173|460512393|FG000|Overall Study|Lost to Follow-up|10|||
127970264|NCT03423173|460512394|FG001|Overall Study|Lost to Follow-up|19|||
127970265|NCT03423173|460512395|FG002|Overall Study|Lost to Follow-up|17|||
127970266|NCT03423173|460512396|FG003|Overall Study|Lost to Follow-up|22|||
127970267|NCT03423173|460512393|FG000|Overall Study|Withdrawal of consent|4|||
127970268|NCT03423173|460512394|FG001|Overall Study|Withdrawal of consent|10|||
127970269|NCT03423173|460512395|FG002|Overall Study|Withdrawal of consent|4|||
127970270|NCT03423173|460512396|FG003|Overall Study|Withdrawal of consent|5|||
127970271|NCT03423173|460512393|FG000|Overall Study|Death|1|||
127970272|NCT03423173|460512394|FG001|Overall Study|Death|0|||
127970273|NCT03423173|460512395|FG002|Overall Study|Death|0|||
127970274|NCT03423173|460512396|FG003|Overall Study|Death|0|||
127970275|NCT03423173|460512393|FG000|Overall Study|Reason not Specified|2|||
127970276|NCT03423173|460512394|FG001|Overall Study|Reason not Specified|5|||
127970277|NCT03423173|460512395|FG002|Overall Study|Reason not Specified|3|||
127970278|NCT03423173|460512396|FG003|Overall Study|Reason not Specified|1|||
127970279|NCT00729157|460512401|FG000|Overall Study|Withdrawal by Subject|1|||
127970280|NCT00661609|460512402|FG000|Overall Study|Adverse Event|4|||
127970281|NCT00661609|460512402|FG000|Overall Study|Death|20|||
127970282|NCT00661609|460512402|FG000|Overall Study|Withdrawal by Subject|2|||
127970283|NCT00661609|460512402|FG000|Overall Study|PI Decision|1|||
127970284|NCT00661609|460512402|FG000|Overall Study|Survival follow up stage discontinued|11|||
127970285|NCT00661609|460512402|FG000|Overall Study|Disease progression|3|||
127970286|NCT01430403|460512403|FG000|Overall Study|Lost to Follow-up|5|||
127970287|NCT01430403|460512404|FG001|Overall Study|Lost to Follow-up|5|||
127970288|NCT01430403|460512405|FG002|Overall Study|Lost to Follow-up|3|||
127970289|NCT01430403|460512403|FG000|Overall Study|Physician Decision|1|||
127970290|NCT01430403|460512404|FG001|Overall Study|Physician Decision|0|||
127970291|NCT01430403|460512405|FG002|Overall Study|Physician Decision|0|||
127970292|NCT01430403|460512403|FG000|Overall Study|Protocol Violation|2|||
127970293|NCT01430403|460512404|FG001|Overall Study|Protocol Violation|3|||
127970294|NCT01430403|460512405|FG002|Overall Study|Protocol Violation|2|||
127970295|NCT01430403|460512403|FG000|Overall Study|Withdrawal by Subject|9|||
127970296|NCT01430403|460512404|FG001|Overall Study|Withdrawal by Subject|1|||
127970297|NCT01430403|460512405|FG002|Overall Study|Withdrawal by Subject|3|||
127970298|NCT04481789|460512406|FG000|Period 1|Withdrawal by Subject|1|||
127970299|NCT04481789|460512407|FG001|Period 1|Withdrawal by Subject|0|||
127970300|NCT04481789|460512408|FG002|Period 1|Withdrawal by Subject|0|||
127970301|NCT04481789|460512409|FG003|Period 1|Withdrawal by Subject|0|||
127970302|NCT04481789|460512410|FG004|Period 1|Withdrawal by Subject|0|||
127970303|NCT04481789|460512411|FG005|Period 1|Withdrawal by Subject|0|||
127970304|NCT02751450|460512412|FG000|Overall Study|Adverse Event|1|||
127970305|NCT02751450|460512413|FG001|Overall Study|Adverse Event|0|||
127970306|NCT01290679|460512414|FG000|Overall Study|Adverse Event|2|||
127970307|NCT01290679|460512415|FG001|Overall Study|Adverse Event|0|||
127970308|NCT01290679|460512414|FG000|Overall Study|Lost to Follow-up|8|||
127970309|NCT01290679|460512415|FG001|Overall Study|Lost to Follow-up|10|||
127970310|NCT01290679|460512414|FG000|Overall Study|Protocol Violation|0|||
127970311|NCT01290679|460512415|FG001|Overall Study|Protocol Violation|1|||
127970312|NCT01290679|460512414|FG000|Overall Study|Withdrawal by Subject|6|||
127970313|NCT01290679|460512415|FG001|Overall Study|Withdrawal by Subject|5|||
127970314|NCT01290679|460512414|FG000|Overall Study|Subject Entered Another Trial|0|||
127970315|NCT01290679|460512415|FG001|Overall Study|Subject Entered Another Trial|5|||
127970316|NCT00562302|460512416|FG000|Overall Study|Lost to Follow-up|3|||
127970317|NCT00562302|460512417|FG001|Overall Study|Lost to Follow-up|3|||
127970318|NCT00562302|460512416|FG000|Overall Study|Adverse Event|0|||
127970319|NCT00562302|460512417|FG001|Overall Study|Adverse Event|6|||
127970320|NCT00562302|460512416|FG000|Overall Study|Non-compliance|1|||
127970321|NCT00562302|460512417|FG001|Overall Study|Non-compliance|2|||
127970322|NCT00562302|460512416|FG000|Overall Study|Withdrawal by Subject|7|||
127970323|NCT00562302|460512417|FG001|Overall Study|Withdrawal by Subject|8|||
127970324|NCT00562302|460512416|FG000|Overall Study|Death|1|||
127970325|NCT00562302|460512417|FG001|Overall Study|Death|2|||
127970326|NCT00562302|460512416|FG000|Overall Study|Lung resection prior to study completion|7|||
127970327|NCT00562302|460512417|FG001|Overall Study|Lung resection prior to study completion|7|||
127970328|NCT00562302|460512416|FG000|Overall Study|Not stated|1|||
127970329|NCT00562302|460512417|FG001|Overall Study|Not stated|4|||
127970330|NCT01855243|460512418|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
127970331|NCT01855243|460512419|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
127970332|NCT01855243|460512420|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
127970333|NCT03124407|460512427|FG000|Overall Study|Lost to Follow-up|1|||
127970334|NCT03124407|460512428|FG001|Overall Study|Lost to Follow-up|0|||
127970335|NCT03124407|460512429|FG002|Overall Study|Lost to Follow-up|0|||
127970336|NCT03124407|460512430|FG003|Overall Study|Lost to Follow-up|0|||
127970337|NCT03124407|460512427|FG000|Overall Study|Adverse Event|0|||
127970338|NCT03124407|460512428|FG001|Overall Study|Adverse Event|0|||
127970339|NCT03124407|460512429|FG002|Overall Study|Adverse Event|1|||
127970340|NCT03124407|460512430|FG003|Overall Study|Adverse Event|0|||
127970341|NCT03315286|460512431|FG000|Overall Study|Lost to Follow-up|0|||
127970342|NCT03315286|460512432|FG001|Overall Study|Lost to Follow-up|3|||
127970343|NCT03315286|460512431|FG000|Overall Study|Withdrawal by Subject|1|||
127970344|NCT03315286|460512432|FG001|Overall Study|Withdrawal by Subject|0|||
127970345|NCT03315286|460512431|FG000|Overall Study|Protocol Violation|0|||
127970346|NCT03315286|460512432|FG001|Overall Study|Protocol Violation|1|||
127970347|NCT03075891|460512433|FG000|Overall Study|Withdrawal by Subject|3|||
127970348|NCT03075891|460512434|FG001|Overall Study|Withdrawal by Subject|6|||
127970349|NCT03075891|460512433|FG000|Overall Study|Lost to Follow-up|1|||
127970350|NCT03075891|460512434|FG001|Overall Study|Lost to Follow-up|0|||
127970351|NCT03075891|460512433|FG000|Overall Study|Pregnancy|3|||
127970352|NCT03075891|460512434|FG001|Overall Study|Pregnancy|1|||
127970353|NCT03075891|460512433|FG000|Overall Study|visits not performed (no time)|1|||
127970354|NCT03075891|460512434|FG001|Overall Study|visits not performed (no time)|0|||
127970355|NCT03075891|460512433|FG000|Overall Study|Drug abuse relapse issue|0|||
127970356|NCT03075891|460512434|FG001|Overall Study|Drug abuse relapse issue|1|||
127970357|NCT03075891|460512433|FG000|Overall Study|Participant requiring study withdrawal|0|||
127970358|NCT03075891|460512434|FG001|Overall Study|Participant requiring study withdrawal|1|||
127970359|NCT03075891|460512433|FG000|Overall Study|Adverse event, non-fatal|1|||
127970360|NCT03075891|460512434|FG001|Overall Study|Adverse event, non-fatal|4|||
127970361|NCT00828568|460512437|FG000|Randomized|Withdrawal by Subject|1|||
127970362|NCT00828568|460512438|FG001|Randomized|Withdrawal by Subject|0|||
127970363|NCT00828568|460512439|FG002|Randomized|Withdrawal by Subject|2|||
127970364|NCT00828568|460512437|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
127970365|NCT00828568|460512438|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
127970366|NCT00828568|460512439|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
127970367|NCT00828568|460512437|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
127970368|NCT00828568|460512438|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
127970369|NCT00828568|460512439|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
127970370|NCT00828568|460512437|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
127970371|NCT00828568|460512438|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
127970372|NCT00828568|460512439|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
127970373|NCT00828568|460512437|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
127970374|NCT00828568|460512438|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
127970375|NCT00828568|460512439|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
127970376|NCT02821754|460512440|FG000|Overall Study|Procedure not required prior to amendment change|13|||
127970377|NCT02821754|460512441|FG001|Overall Study|Procedure not required prior to amendment change|11|||
127970378|NCT02821754|460512442|FG002|Overall Study|Procedure not required prior to amendment change|0|||
127970379|NCT02821754|460512440|FG000|Overall Study|Participant's Clinical status|2|||
127970380|NCT02821754|460512441|FG001|Overall Study|Participant's Clinical status|0|||
127970381|NCT02821754|460512442|FG002|Overall Study|Participant's Clinical status|0|||
127970382|NCT02821754|460512440|FG000|Overall Study|Participant removed for noncompliance|1|||
127970383|NCT02821754|460512441|FG001|Overall Study|Participant removed for noncompliance|0|||
127970384|NCT02821754|460512442|FG002|Overall Study|Participant removed for noncompliance|0|||
127970385|NCT02821754|460512440|FG000|Overall Study|Drug not available.|0|||
127970386|NCT02821754|460512441|FG001|Overall Study|Drug not available.|0|||
127970387|NCT02821754|460512442|FG002|Overall Study|Drug not available.|1|||
127970388|NCT02821754|460512440|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
127970389|NCT02821754|460512441|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
127970390|NCT02821754|460512442|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
127970391|NCT00766636|460512444|FG000|Overall Study|Withdrawal by Subject|1|||
127970392|NCT00766636|460512445|FG001|Overall Study|Withdrawal by Subject|1|||
127970393|NCT00766636|460512444|FG000|Overall Study|Incomplete Treatment|0|||
127970394|NCT00766636|460512445|FG001|Overall Study|Incomplete Treatment|1|||
127970395|NCT00766636|460512444|FG000|Overall Study|Adverse Event|1|||
127970396|NCT00766636|460512445|FG001|Overall Study|Adverse Event|0|||
127970397|NCT00766636|460512444|FG000|Overall Study|Disease Progression|1|||
127970398|NCT00766636|460512445|FG001|Overall Study|Disease Progression|0|||
127970399|NCT02477332|460512446|FG000|Overall Study|Adverse Event|0|||
127970400|NCT02477332|460512447|FG001|Overall Study|Adverse Event|1|||
127970401|NCT02477332|460512448|FG002|Overall Study|Adverse Event|1|||
127970402|NCT02477332|460512449|FG003|Overall Study|Adverse Event|2|||
127970403|NCT02477332|460512450|FG004|Overall Study|Adverse Event|1|||
127970404|NCT02477332|460512451|FG005|Overall Study|Adverse Event|2|||
127970405|NCT02477332|460512446|FG000|Overall Study|Lack of Efficacy|1|||
127970406|NCT02477332|460512447|FG001|Overall Study|Lack of Efficacy|2|||
127970407|NCT02477332|460512448|FG002|Overall Study|Lack of Efficacy|1|||
127970408|NCT02477332|460512449|FG003|Overall Study|Lack of Efficacy|2|||
127970409|NCT02477332|460512450|FG004|Overall Study|Lack of Efficacy|1|||
127970410|NCT02477332|460512451|FG005|Overall Study|Lack of Efficacy|1|||
127970411|NCT02477332|460512446|FG000|Overall Study|Non-compliance with study treatment|0|||
127970412|NCT02477332|460512447|FG001|Overall Study|Non-compliance with study treatment|1|||
127970413|NCT02477332|460512448|FG002|Overall Study|Non-compliance with study treatment|2|||
127970414|NCT02477332|460512449|FG003|Overall Study|Non-compliance with study treatment|0|||
127970415|NCT02477332|460512450|FG004|Overall Study|Non-compliance with study treatment|0|||
127970416|NCT02477332|460512451|FG005|Overall Study|Non-compliance with study treatment|0|||
127970417|NCT02477332|460512446|FG000|Overall Study|Pregnancy|0|||
127970418|NCT02477332|460512447|FG001|Overall Study|Pregnancy|0|||
127970419|NCT02477332|460512448|FG002|Overall Study|Pregnancy|0|||
127970420|NCT02477332|460512449|FG003|Overall Study|Pregnancy|1|||
127970421|NCT02477332|460512450|FG004|Overall Study|Pregnancy|0|||
127970422|NCT02477332|460512451|FG005|Overall Study|Pregnancy|0|||
127970423|NCT02477332|460512446|FG000|Overall Study|Protocol Violation|2|||
127970424|NCT02477332|460512447|FG001|Overall Study|Protocol Violation|0|||
127970425|NCT02477332|460512448|FG002|Overall Study|Protocol Violation|3|||
127970426|NCT02477332|460512449|FG003|Overall Study|Protocol Violation|3|||
127970427|NCT02477332|460512450|FG004|Overall Study|Protocol Violation|1|||
127970428|NCT02477332|460512451|FG005|Overall Study|Protocol Violation|1|||
127970429|NCT02477332|460512446|FG000|Overall Study|Technical problems|0|||
127970430|NCT02477332|460512447|FG001|Overall Study|Technical problems|0|||
127970431|NCT02477332|460512448|FG002|Overall Study|Technical problems|1|||
127970432|NCT02477332|460512449|FG003|Overall Study|Technical problems|0|||
127970433|NCT02477332|460512450|FG004|Overall Study|Technical problems|0|||
127970434|NCT02477332|460512451|FG005|Overall Study|Technical problems|0|||
127970435|NCT02477332|460512446|FG000|Overall Study|Lost to Follow-up|0|||
127970436|NCT02477332|460512447|FG001|Overall Study|Lost to Follow-up|0|||
127970437|NCT02477332|460512448|FG002|Overall Study|Lost to Follow-up|2|||
127970438|NCT02477332|460512449|FG003|Overall Study|Lost to Follow-up|0|||
127970439|NCT02477332|460512450|FG004|Overall Study|Lost to Follow-up|0|||
127970440|NCT02477332|460512451|FG005|Overall Study|Lost to Follow-up|0|||
127970441|NCT02477332|460512446|FG000|Overall Study|Physician Decision|0|||
127970442|NCT02477332|460512447|FG001|Overall Study|Physician Decision|0|||
127970443|NCT02477332|460512448|FG002|Overall Study|Physician Decision|1|||
127970444|NCT02477332|460512449|FG003|Overall Study|Physician Decision|3|||
127970445|NCT02477332|460512450|FG004|Overall Study|Physician Decision|0|||
127970446|NCT02477332|460512451|FG005|Overall Study|Physician Decision|1|||
127970447|NCT02477332|460512446|FG000|Overall Study|Withdrawal by Subject|0|||
127970448|NCT02477332|460512447|FG001|Overall Study|Withdrawal by Subject|3|||
127970449|NCT02477332|460512448|FG002|Overall Study|Withdrawal by Subject|1|||
127970450|NCT02477332|460512449|FG003|Overall Study|Withdrawal by Subject|2|||
127970451|NCT02477332|460512450|FG004|Overall Study|Withdrawal by Subject|1|||
127970452|NCT02477332|460512451|FG005|Overall Study|Withdrawal by Subject|0|||
127970453|NCT04657198|460512452|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
127970454|NCT04657198|460512453|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
127970455|NCT04657198|460512454|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
127970456|NCT02549287|460512455|FG000|Overall Study|Lost to Follow-up|65|||
127970457|NCT02549287|460512456|FG001|Overall Study|Lost to Follow-up|26|||
127970458|NCT02549287|460512455|FG000|Overall Study|Withdrawal by Subject|15|||
127970459|NCT02549287|460512456|FG001|Overall Study|Withdrawal by Subject|6|||
127970460|NCT00427921|460512459|FG000|Overall Study|Adverse Event|26|||
127970461|NCT00427921|460512459|FG000|Overall Study|Withdrawal by Subject|4|||
127970462|NCT00427921|460512459|FG000|Overall Study|Lost to Follow-up|2|||
127970463|NCT00427921|460512459|FG000|Overall Study|Other reason not specified|10|||
127970464|NCT00427921|460512459|FG000|Overall Study|Adverse Event + Hospitalization|1|||
127970465|NCT00427921|460512459|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
127970466|NCT00427921|460512459|FG000|Overall Study|Adverse Event + No Response|1|||
127970467|NCT00427921|460512459|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
127970468|NCT00427921|460512459|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
127970469|NCT00427921|460512459|FG000|Overall Study|Adverse Event + Lost Response|1|||
127970470|NCT00427921|460512459|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
127970471|NCT00427921|460512459|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
127970472|NCT01075256|460512460|FG000|Overall Study|Withdrawal by Subject|1|||
127970473|NCT01075256|460512461|FG001|Overall Study|Withdrawal by Subject|0|||
127970474|NCT01075256|460512462|FG002|Overall Study|Withdrawal by Subject|0|||
127970475|NCT00765336|460512463|FG000|Overall Study|Protocol Violation|4|||
127970476|NCT00765336|460512464|FG001|Overall Study|Protocol Violation|2|||
127970477|NCT00765336|460512463|FG000|Overall Study|Withdrawal by Subject|6|||
127970478|NCT00765336|460512464|FG001|Overall Study|Withdrawal by Subject|4|||
127970479|NCT00765336|460512463|FG000|Overall Study|Lost to Follow-up|7|||
127970480|NCT00765336|460512464|FG001|Overall Study|Lost to Follow-up|9|||
127970481|NCT00765336|460512463|FG000|Overall Study|Adverse Event|2|||
127970482|NCT00765336|460512464|FG001|Overall Study|Adverse Event|1|||
127970483|NCT02858583|460512465|FG000|Overall Study|Declined consent|1|||
127970484|NCT02858583|460512466|FG001|Overall Study|Declined consent|1|||
127970485|NCT00347009|460512467|FG000|Overall Study|Death|1|||
127970486|NCT00347009|460512467|FG000|Overall Study|Adverse Event|6|||
127970487|NCT00347009|460512467|FG000|Overall Study|Withdrawal by Subject|3|||
127970488|NCT00347009|460512467|FG000|Overall Study|Physician Decision|5|||
127970489|NCT00347009|460512467|FG000|Overall Study|Lost to Follow-up|4|||
127970490|NCT00347009|460512467|FG000|Overall Study|Protocol Violation|2|||
127970491|NCT00347009|460512467|FG000|Overall Study|Adverse Laboratory Experience|1|||
127970492|NCT00347009|460512467|FG000|Overall Study|Insufficient Viral Suppression|3|||
127970493|NCT00347009|460512467|FG000|Overall Study|Increased ALT/HBV DNA|1|||
127970494|NCT00347009|460512467|FG000|Overall Study|Serious Adverse Event|1|||
127970495|NCT01972438|460512469|FG000|Baseline-Month 3 Crossover Period|Death|1|||
127970496|NCT01972438|460512470|FG001|Baseline-Month 3 Crossover Period|Death|0|||
127970497|NCT01972438|460512469|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
127970498|NCT01972438|460512470|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
127970499|NCT01972438|460512469|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
127970500|NCT01972438|460512470|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
127970501|NCT01972438|460512469|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
127970502|NCT01972438|460512470|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
127970503|NCT01972438|460512469|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
127970504|NCT01972438|460512470|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
127970505|NCT01972438|460512469|FG000|Months 6-12 Study Period|Death|1|||
127970506|NCT01972438|460512470|FG001|Months 6-12 Study Period|Death|0|||
127970507|NCT01972438|460512469|FG000|Months 6-12 Study Period|Early Study Closure|2|||
127970508|NCT01972438|460512470|FG001|Months 6-12 Study Period|Early Study Closure|2|||
127970509|NCT01972438|460512469|FG000|Post Month 12 Study Period|Early Study Closure|3|||
127970510|NCT01972438|460512470|FG001|Post Month 12 Study Period|Early Study Closure|4|||
127970511|NCT01029782|460512475|FG000|Overall Study|Lost to Follow-up|2|||
127970512|NCT01029782|460512476|FG001|Overall Study|Lost to Follow-up|2|||
127970513|NCT01029782|460512475|FG000|Overall Study|Diagnosis changed|1|||
127970514|NCT01029782|460512476|FG001|Overall Study|Diagnosis changed|1|||
127970515|NCT01029782|460512475|FG000|Overall Study|Adverse Event|0|||
127970516|NCT01029782|460512476|FG001|Overall Study|Adverse Event|1|||
127970517|NCT01029782|460512475|FG000|Overall Study|Physician Decision|0|||
127970518|NCT01029782|460512476|FG001|Overall Study|Physician Decision|1|||
127970519|NCT01029782|460512475|FG000|Overall Study|Protocol Violation|0|||
127970520|NCT01029782|460512476|FG001|Overall Study|Protocol Violation|2|||
127970521|NCT01029782|460512475|FG000|Overall Study|Withdrawal by Subject|0|||
127970522|NCT01029782|460512476|FG001|Overall Study|Withdrawal by Subject|1|||
127970523|NCT02195869|460512480|FG000|Overall Study|cGVHD Progression|5|||
127970524|NCT02195869|460512480|FG000|Overall Study|Malignancy Progression/relapse|2|||
127970525|NCT02195869|460512480|FG000|Overall Study|Adverse Event|15|||
127970526|NCT02195869|460512480|FG000|Overall Study|Withdrawal by Subject|7|||
127970527|NCT02195869|460512480|FG000|Overall Study|Physician Decision|4|||
127970528|NCT02195869|460512480|FG000|Overall Study|Study Terminated by Sponsor|7|||
127970529|NCT02195869|460512480|FG000|Overall Study|Noncompliance with study drug|2|||
127970530|NCT00789698|460512481|FG000|Overall Study|Lack of Efficacy|10|||
127970531|NCT00789698|460512482|FG001|Overall Study|Lack of Efficacy|4|||
127970532|NCT00789698|460512483|FG002|Overall Study|Lack of Efficacy|5|||
127970533|NCT00789698|460512484|FG003|Overall Study|Lack of Efficacy|18|||
127970534|NCT00789698|460512481|FG000|Overall Study|Adverse Event|5|||
127970535|NCT00789698|460512482|FG001|Overall Study|Adverse Event|5|||
127970536|NCT00789698|460512483|FG002|Overall Study|Adverse Event|3|||
127970537|NCT00789698|460512484|FG003|Overall Study|Adverse Event|4|||
127970538|NCT00789698|460512481|FG000|Overall Study|Lost to Follow-up|5|||
127970539|NCT00789698|460512482|FG001|Overall Study|Lost to Follow-up|5|||
127970540|NCT00789698|460512483|FG002|Overall Study|Lost to Follow-up|2|||
127970541|NCT00789698|460512484|FG003|Overall Study|Lost to Follow-up|9|||
127970542|NCT00789698|460512481|FG000|Overall Study|Protocol Violation|6|||
127970543|NCT00789698|460512482|FG001|Overall Study|Protocol Violation|1|||
127970544|NCT00789698|460512483|FG002|Overall Study|Protocol Violation|2|||
127970545|NCT00789698|460512484|FG003|Overall Study|Protocol Violation|1|||
127970546|NCT00789698|460512481|FG000|Overall Study|Withdrawal by Subject|14|||
127970547|NCT00789698|460512482|FG001|Overall Study|Withdrawal by Subject|15|||
127970548|NCT00789698|460512483|FG002|Overall Study|Withdrawal by Subject|12|||
127970549|NCT00789698|460512484|FG003|Overall Study|Withdrawal by Subject|19|||
127970550|NCT00789698|460512481|FG000|Overall Study|Administrative|0|||
127970551|NCT00789698|460512482|FG001|Overall Study|Administrative|3|||
127970552|NCT00789698|460512483|FG002|Overall Study|Administrative|3|||
127970553|NCT00789698|460512484|FG003|Overall Study|Administrative|1|||
127970554|NCT00596817|460512485|FG000|Open-label Period|Adverse Event|0|||
127970555|NCT00596817|460512486|FG001|Open-label Period|Adverse Event|49|||
127970556|NCT00596817|460512485|FG000|Open-label Period|Lack of Efficacy|0|||
127970557|NCT00596817|460512486|FG001|Open-label Period|Lack of Efficacy|33|||
127970558|NCT00596817|460512485|FG000|Open-label Period|Other Reasons|0|||
127970559|NCT00596817|460512486|FG001|Open-label Period|Other Reasons|65|||
127970560|NCT00596817|460512485|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
127970561|NCT00596817|460512486|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
127970562|NCT00596817|460512485|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
127970563|NCT00596817|460512486|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
127970564|NCT00596817|460512485|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
127970565|NCT00596817|460512486|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
127970566|NCT00596817|460512485|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
127970567|NCT00596817|460512486|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
127970568|NCT00596817|460512485|FG000|Double-blind Period|Adverse Event|5|||
127970569|NCT00596817|460512486|FG001|Double-blind Period|Adverse Event|16|||
127970570|NCT00596817|460512485|FG000|Double-blind Period|Lack of Efficacy|52|||
127970571|NCT00596817|460512486|FG001|Double-blind Period|Lack of Efficacy|28|||
127970572|NCT00596817|460512485|FG000|Double-blind Period|Non-compliance With Study Product|3|||
127970573|NCT00596817|460512486|FG001|Double-blind Period|Non-compliance With Study Product|4|||
127970574|NCT00596817|460512485|FG000|Double-blind Period|Protocol Violation|11|||
127970575|NCT00596817|460512486|FG001|Double-blind Period|Protocol Violation|8|||
127970576|NCT00596817|460512485|FG000|Double-blind Period|Withdrawal of Consent|7|||
127970577|NCT00596817|460512486|FG001|Double-blind Period|Withdrawal of Consent|3|||
127970578|NCT00596817|460512485|FG000|Double-blind Period|Lost to Follow-up|0|||
127970579|NCT00596817|460512486|FG001|Double-blind Period|Lost to Follow-up|2|||
127970580|NCT00596817|460512485|FG000|Double-blind Period|Other Reasons|10|||
127970581|NCT00596817|460512486|FG001|Double-blind Period|Other Reasons|18|||
127970582|NCT04390503|460513622|FG000|Overall Study|Physician Decision|2|||
127970583|NCT04390503|460513623|FG001|Overall Study|Physician Decision|1|||
127970584|NCT04390503|460513622|FG000|Overall Study|Adverse Event|1|||
127970585|NCT04390503|460513623|FG001|Overall Study|Adverse Event|0|||
127970586|NCT01068730|460513625|FG000|Period 3|Personal reason|1|||
127970587|NCT01068730|460513626|FG001|Period 3|Personal reason|0|||
127970588|NCT01068730|460513627|FG002|Period 3|Personal reason|0|||
127970589|NCT01068730|460513628|FG003|Period 3|Personal reason|0|||
127970590|NCT01068730|460513625|FG000|Period 4|Family emergency|0|||
127970591|NCT01068730|460513626|FG001|Period 4|Family emergency|1|||
127970592|NCT01068730|460513627|FG002|Period 4|Family emergency|0|||
127970593|NCT01068730|460513628|FG003|Period 4|Family emergency|0|||
127970594|NCT02448537|460513632|FG000|Overall Study|Withdrawal by Subject|1|||
127970595|NCT02448537|460513633|FG001|Overall Study|Withdrawal by Subject|1|||
127970596|NCT02448537|460513634|FG002|Overall Study|Withdrawal by Subject|1|||
127970597|NCT04696055|460513637|FG000|Overall Study|Adverse Event|10|||
127970598|NCT04696055|460513638|FG001|Overall Study|Adverse Event|2|||
127970599|NCT04696055|460513637|FG000|Overall Study|Death|4|||
127970600|NCT04696055|460513638|FG001|Overall Study|Death|0|||
127970601|NCT04696055|460513637|FG000|Overall Study|Other|7|||
127970602|NCT04696055|460513638|FG001|Overall Study|Other|2|||
127970603|NCT04696055|460513637|FG000|Overall Study|Physician Decision|3|||
127970604|NCT04696055|460513638|FG001|Overall Study|Physician Decision|0|||
127970605|NCT04696055|460513637|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
127970606|NCT04696055|460513638|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
127970607|NCT04696055|460513637|FG000|Overall Study|Progressive Disease - Radiological Progression|42|||
127970608|NCT04696055|460513638|FG001|Overall Study|Progressive Disease - Radiological Progression|20|||
127970609|NCT04696055|460513637|FG000|Overall Study|Subject Decision|1|||
127970610|NCT04696055|460513638|FG001|Overall Study|Subject Decision|2|||
127970611|NCT01920958|460513639|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
127970612|NCT01560234|460513640|FG000|Overall Study|Lost to Follow-up|3|||
127970613|NCT01560234|460513641|FG001|Overall Study|Lost to Follow-up|0|||
127970614|NCT01560234|460513642|FG002|Overall Study|Lost to Follow-up|1|||
127970615|NCT01560234|460513643|FG003|Overall Study|Lost to Follow-up|0|||
127970616|NCT01560234|460513644|FG004|Overall Study|Lost to Follow-up|0|||
127970617|NCT01560234|460513645|FG005|Overall Study|Lost to Follow-up|2|||
127970618|NCT01560234|460513646|FG006|Overall Study|Lost to Follow-up|0|||
127970619|NCT01560234|460513647|FG007|Overall Study|Lost to Follow-up|2|||
127970620|NCT01284348|460513648|FG000|Overall Study|Death|1|||
127970621|NCT01284348|460513649|FG001|Overall Study|Death|1|||
127970622|NCT01284348|460513648|FG000|Overall Study|Withdrew consent|0|||
127970623|NCT01284348|460513649|FG001|Overall Study|Withdrew consent|1|||
127970624|NCT01284348|460513648|FG000|Overall Study|Status not recorded|9|||
127970625|NCT01284348|460513649|FG001|Overall Study|Status not recorded|10|||
127970626|NCT00083759|460513651|FG000|Overall Study|Adverse Event|5|||
127970627|NCT00083759|460513652|FG001|Overall Study|Adverse Event|3|||
127970628|NCT00083759|460513651|FG000|Overall Study|Lost to Follow-up|1|||
127970629|NCT00083759|460513652|FG001|Overall Study|Lost to Follow-up|0|||
127970630|NCT00083759|460513651|FG000|Overall Study|Death|1|||
127970631|NCT00083759|460513652|FG001|Overall Study|Death|1|||
127970632|NCT00083759|460513651|FG000|Overall Study|Inadequate Therapeutic Response|32|||
127970633|NCT00083759|460513652|FG001|Overall Study|Inadequate Therapeutic Response|35|||
127970634|NCT00083759|460513651|FG000|Overall Study|Subject Withdrew Consent|2|||
127970635|NCT00083759|460513652|FG001|Overall Study|Subject Withdrew Consent|2|||
127970636|NCT00083759|460513651|FG000|Overall Study|Non-Compliance|1|||
127970637|NCT00083759|460513652|FG001|Overall Study|Non-Compliance|0|||
127970638|NCT00083759|460513651|FG000|Overall Study|Sponsor's Discretion|28|||
127970639|NCT00083759|460513652|FG001|Overall Study|Sponsor's Discretion|29|||
127970640|NCT00083759|460513651|FG000|Overall Study|Other|14|||
127970641|NCT00083759|460513652|FG001|Overall Study|Other|13|||
127970642|NCT01057810|460513658|FG000|Overall Study|Disease progression|156|||
127970643|NCT01057810|460513659|FG001|Overall Study|Disease progression|197|||
127970644|NCT01057810|460513658|FG000|Overall Study|Study drug toxicity|5|||
127970645|NCT01057810|460513659|FG001|Overall Study|Study drug toxicity|114|||
127970646|NCT01057810|460513658|FG000|Overall Study|Adverse event unrelated to study drug|13|||
127970647|NCT01057810|460513659|FG001|Overall Study|Adverse event unrelated to study drug|29|||
127970648|NCT01057810|460513658|FG000|Overall Study|Withdrawal by Subject|10|||
127970649|NCT01057810|460513659|FG001|Overall Study|Withdrawal by Subject|25|||
127970650|NCT01057810|460513658|FG000|Overall Study|Death|2|||
127970651|NCT01057810|460513659|FG001|Overall Study|Death|12|||
127970652|NCT01057810|460513658|FG000|Overall Study|Maximum clinical benefit|5|||
127970653|NCT01057810|460513659|FG001|Overall Study|Maximum clinical benefit|5|||
127970654|NCT01057810|460513658|FG000|Overall Study|Poor/non-compliance|0|||
127970655|NCT01057810|460513659|FG001|Overall Study|Poor/non-compliance|1|||
127970656|NCT01057810|460513658|FG000|Overall Study|No longer met study criteria|0|||
127970657|NCT01057810|460513659|FG001|Overall Study|No longer met study criteria|1|||
127970658|NCT01057810|460513658|FG000|Overall Study|Other|7|||
127970659|NCT01057810|460513659|FG001|Overall Study|Other|14|||
127970660|NCT02088905|460513660|FG000|Overall Study|Withdrawal by Subject|5|||
127970661|NCT02088905|460513661|FG001|Overall Study|Withdrawal by Subject|1|||
127970662|NCT00887315|460513662|FG000|Overall Study|Study termination|7|||
127970663|NCT00887315|460513663|FG001|Overall Study|Study termination|4|||
127970664|NCT00619892|460513664|FG000|Overall Study|Adverse Event|3|||
127970665|NCT00619892|460513665|FG001|Overall Study|Adverse Event|0|||
127970666|NCT00619892|460513664|FG000|Overall Study|Lost to Follow-up|0|||
127970667|NCT00619892|460513665|FG001|Overall Study|Lost to Follow-up|1|||
127970668|NCT00619892|460513664|FG000|Overall Study|Intercurrent illness|0|||
127970669|NCT00619892|460513665|FG001|Overall Study|Intercurrent illness|1|||
127970670|NCT00379080|460513666|FG000|Overall Study|Withdrawal by Subject|0|||
127970671|NCT00379080|460513667|FG001|Overall Study|Withdrawal by Subject|4|||
127970672|NCT00379080|460513668|FG002|Overall Study|Withdrawal by Subject|0|||
127970673|NCT00857896|460513674|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
127970674|NCT01091662|460513676|FG000|Overall Study|Adverse Event|1|||
127970675|NCT01091662|460513677|FG001|Overall Study|Adverse Event|9|||
127970676|NCT01091662|460513676|FG000|Overall Study|Physician Decision|1|||
127970677|NCT01091662|460513677|FG001|Overall Study|Physician Decision|1|||
127970678|NCT01091662|460513676|FG000|Overall Study|Withdrawal by Subject|7|||
127970679|NCT01091662|460513677|FG001|Overall Study|Withdrawal by Subject|6|||
127970680|NCT01091662|460513676|FG000|Overall Study|met exit criteria|7|||
127970681|NCT01091662|460513677|FG001|Overall Study|met exit criteria|13|||
127970682|NCT01091662|460513676|FG000|Overall Study|met exclusion criteria|1|||
127970683|NCT01091662|460513677|FG001|Overall Study|met exclusion criteria|0|||
127970684|NCT01091662|460513676|FG000|Overall Study|Lost to Follow-up|0|||
127970685|NCT01091662|460513677|FG001|Overall Study|Lost to Follow-up|1|||
127970686|NCT01091662|460513676|FG000|Overall Study|Pregnancy|0|||
127970687|NCT01091662|460513677|FG001|Overall Study|Pregnancy|1|||
127970688|NCT01091662|460513676|FG000|Overall Study|Protocol Violation|0|||
127970689|NCT01091662|460513677|FG001|Overall Study|Protocol Violation|2|||
127970690|NCT01091662|460513676|FG000|Overall Study|unable to swallow capsule|0|||
127970691|NCT01091662|460513677|FG001|Overall Study|unable to swallow capsule|1|||
127970692|NCT04109391|460513678|FG000|Overall Study|Adverse Event|2|||
127970693|NCT04109391|460513679|FG001|Overall Study|Adverse Event|2|||
127970694|NCT04109391|460513680|FG002|Overall Study|Adverse Event|0|||
127970695|NCT04109391|460513678|FG000|Overall Study|Withdrawal by Subject|2|||
127970696|NCT04109391|460513679|FG001|Overall Study|Withdrawal by Subject|0|||
127970697|NCT04109391|460513680|FG002|Overall Study|Withdrawal by Subject|0|||
127970698|NCT04109391|460513678|FG000|Overall Study|Pregnancy|1|||
127970699|NCT04109391|460513679|FG001|Overall Study|Pregnancy|0|||
127970700|NCT04109391|460513680|FG002|Overall Study|Pregnancy|0|||
127970701|NCT04109391|460513678|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
127970702|NCT04109391|460513679|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
127970703|NCT04109391|460513680|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
127970704|NCT04109391|460513678|FG000|Overall Study|Lost to Follow-up|0|||
127970705|NCT04109391|460513679|FG001|Overall Study|Lost to Follow-up|0|||
127970706|NCT04109391|460513680|FG002|Overall Study|Lost to Follow-up|1|||
127970707|NCT04109391|460513678|FG000|Overall Study|Lack of Efficacy|2|||
127970708|NCT04109391|460513679|FG001|Overall Study|Lack of Efficacy|2|||
127970709|NCT04109391|460513680|FG002|Overall Study|Lack of Efficacy|3|||
127970710|NCT01222520|460513681|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
127970711|NCT01222520|460513682|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
127970712|NCT01222520|460513681|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
127970713|NCT01222520|460513682|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
127970714|NCT01222520|460513681|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
127970715|NCT01222520|460513682|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
127970716|NCT01222520|460513681|FG000|Double-blind Period|Adverse Event|0|||
127970717|NCT01222520|460513682|FG001|Double-blind Period|Adverse Event|1|||
127970718|NCT01222520|460513681|FG000|Double-blind Period|Lack of Efficacy|0|||
127970719|NCT01222520|460513682|FG001|Double-blind Period|Lack of Efficacy|1|||
127970720|NCT01222520|460513681|FG000|Double-blind Period|Study medication stolen|1|||
127970721|NCT01222520|460513682|FG001|Double-blind Period|Study medication stolen|0|||
127970722|NCT02285166|460513683|FG000|Overall Study|Case Report Forms Uncollected|564|||
127970723|NCT02285166|460513683|FG000|Overall Study|Protocol Deviation|402|||
127970724|NCT01089608|460513686|FG000|Overall Study|Adverse Event|0|||
127970725|NCT01089608|460513687|FG001|Overall Study|Adverse Event|4|||
127970726|NCT01089608|460513686|FG000|Overall Study|Lost to Follow-up|0|||
127970727|NCT01089608|460513687|FG001|Overall Study|Lost to Follow-up|2|||
127970728|NCT00384839|460513690|FG000|Overall Study|Adverse Event|4|||
127970729|NCT00384839|460513690|FG000|Overall Study|Investigator Request|1|||
127970730|NCT00384839|460513690|FG000|Overall Study|Patient Request|1|||
127970731|NCT00384839|460513690|FG000|Overall Study|Ineligible|2|||
127970732|NCT00280397|460513691|FG000|Overall Study|Adverse Event|1|||
127970733|NCT02257489|460513694|FG000|Overall Study|Withdrawal by Subject|0|||
127970734|NCT02257489|460513695|FG001|Overall Study|Withdrawal by Subject|0|||
127970735|NCT02257489|460513696|FG002|Overall Study|Withdrawal by Subject|0|||
127970736|NCT02257489|460513697|FG003|Overall Study|Withdrawal by Subject|1|||
127970737|NCT02257489|460513698|FG004|Overall Study|Withdrawal by Subject|0|||
127970738|NCT02257489|460513699|FG005|Overall Study|Withdrawal by Subject|0|||
127970739|NCT02257489|460513700|FG006|Overall Study|Withdrawal by Subject|0|||
127970740|NCT02257489|460513701|FG007|Overall Study|Withdrawal by Subject|0|||
127970741|NCT02257489|460513702|FG008|Overall Study|Withdrawal by Subject|0|||
127970742|NCT00955955|460513703|FG000|Overall Study|Lost to Follow-up|2|||
127970743|NCT00955955|460513704|FG001|Overall Study|Lost to Follow-up|0|||
127970744|NCT00955955|460513705|FG002|Overall Study|Lost to Follow-up|0|||
127970745|NCT03852264|460513706|FG000|Third Research Visit|Lost to Follow-up|1|||
127970746|NCT03852264|460513707|FG001|Third Research Visit|Lost to Follow-up|0|||
127970747|NCT03169881|460513708|FG000|Overall Study|Incomplete Follow-up|10|||
127970748|NCT03169881|460513709|FG001|Overall Study|Incomplete Follow-up|15|||
127970749|NCT03169881|460513708|FG000|Overall Study|Lost to Follow-up|18|||
127970750|NCT03169881|460513709|FG001|Overall Study|Lost to Follow-up|20|||
127970751|NCT03169881|460513708|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
127970752|NCT03169881|460513709|FG001|Overall Study|Data withdrawn prior to hospital discharge|1|||
127970753|NCT01028014|460513711|FG000|Overall Study|Lost to Follow-up|1|||
127970754|NCT01028014|460513712|FG001|Overall Study|Lost to Follow-up|2|||
127970755|NCT01028014|460513713|FG002|Overall Study|Lost to Follow-up|0|||
127970756|NCT01028014|460513714|FG003|Overall Study|Lost to Follow-up|1|||
127970757|NCT01028014|460513715|FG004|Overall Study|Lost to Follow-up|1|||
127970758|NCT01028014|460513716|FG005|Overall Study|Lost to Follow-up|2|||
127970759|NCT02217410|460513718|FG000|Overall Study|Graft Loss|0|||
127970760|NCT02217410|460513719|FG001|Overall Study|Graft Loss|0|||
127970761|NCT02217410|460513720|FG002|Overall Study|Graft Loss|2|||
127970762|NCT02217410|460513718|FG000|Overall Study|Withdrawal by Subject|0|||
127970763|NCT02217410|460513719|FG001|Overall Study|Withdrawal by Subject|0|||
127970764|NCT02217410|460513720|FG002|Overall Study|Withdrawal by Subject|2|||
127970765|NCT02217410|460513718|FG000|Overall Study|Lost to Follow-up|0|||
127970766|NCT02217410|460513719|FG001|Overall Study|Lost to Follow-up|0|||
127970767|NCT02217410|460513720|FG002|Overall Study|Lost to Follow-up|1|||
127970768|NCT02217410|460513718|FG000|Overall Study|Lack of Efficacy|0|||
127970769|NCT02217410|460513719|FG001|Overall Study|Lack of Efficacy|1|||
127970770|NCT02217410|460513720|FG002|Overall Study|Lack of Efficacy|0|||
127970771|NCT02217410|460513718|FG000|Overall Study|Physician Decision|1|||
127970772|NCT02217410|460513719|FG001|Overall Study|Physician Decision|3|||
127970773|NCT02217410|460513720|FG002|Overall Study|Physician Decision|0|||
127970774|NCT00637000|460513722|FG000|Overall Study|Withdrawal by Subject|4|||
127970775|NCT00637000|460513723|FG001|Overall Study|Withdrawal by Subject|3|||
127970776|NCT00634803|460513728|FG000|Overall Study|Lost to Follow-up|6|||
127970777|NCT00634803|460513729|FG001|Overall Study|Lost to Follow-up|7|||
127970778|NCT00634803|460513730|FG002|Overall Study|Lost to Follow-up|7|||
127970779|NCT00396656|460513731|FG000|First Treatment Period|Withdrawal by Subject|0|||
127970780|NCT00396656|460513732|FG001|First Treatment Period|Withdrawal by Subject|2|||
127970781|NCT00396656|460513731|FG000|Second Treatment Period|Adverse Event|0|||
127970782|NCT00396656|460513732|FG001|Second Treatment Period|Adverse Event|1|||
127970783|NCT03474731|460513734|FG000|Overall Study|Withdrawal by Subject|36|||
127970784|NCT03474731|460513735|FG001|Overall Study|Withdrawal by Subject|29|||
127970785|NCT03474731|460513736|FG002|Overall Study|Withdrawal by Subject|11|||
127970786|NCT03474731|460513737|FG003|Overall Study|Withdrawal by Subject|27|||
127970787|NCT03474731|460513734|FG000|Overall Study|COVID|0|||
127970788|NCT03474731|460513735|FG001|Overall Study|COVID|23|||
127970789|NCT03474731|460513736|FG002|Overall Study|COVID|0|||
127970790|NCT03474731|460513737|FG003|Overall Study|COVID|0|||
127970791|NCT03474731|460513734|FG000|Overall Study|Participant moved from area|1|||
127970792|NCT03474731|460513735|FG001|Overall Study|Participant moved from area|0|||
127970793|NCT03474731|460513736|FG002|Overall Study|Participant moved from area|0|||
127970794|NCT03474731|460513737|FG003|Overall Study|Participant moved from area|0|||
127970795|NCT03474731|460513734|FG000|Overall Study|Lost to Follow-up|11|||
127970796|NCT03474731|460513735|FG001|Overall Study|Lost to Follow-up|3|||
127970797|NCT03474731|460513736|FG002|Overall Study|Lost to Follow-up|18|||
127970798|NCT03474731|460513737|FG003|Overall Study|Lost to Follow-up|17|||
127970799|NCT03474731|460513734|FG000|Overall Study|Death|0|||
127970800|NCT03474731|460513735|FG001|Overall Study|Death|1|||
127970801|NCT03474731|460513736|FG002|Overall Study|Death|0|||
127970802|NCT03474731|460513737|FG003|Overall Study|Death|0|||
127970803|NCT03474731|460513734|FG000|Overall Study|Participant Removed|0|||
127970804|NCT03474731|460513735|FG001|Overall Study|Participant Removed|0|||
127970805|NCT03474731|460513736|FG002|Overall Study|Participant Removed|0|||
127970806|NCT03474731|460513737|FG003|Overall Study|Participant Removed|1|||
127970807|NCT01218087|460513741|FG000|Overall Study|Death|2|||
127970808|NCT01218087|460513742|FG001|Overall Study|Death|1|||
127970809|NCT01218087|460513741|FG000|Overall Study|Withdrawal by Subject|5|||
127970810|NCT01218087|460513742|FG001|Overall Study|Withdrawal by Subject|0|||
127970811|NCT01218087|460513741|FG000|Overall Study|Transferred|8|||
127970812|NCT01218087|460513742|FG001|Overall Study|Transferred|5|||
127970813|NCT00552396|460513743|FG000|Overall Study|protocol withdrawal criteria|3|||
127970814|NCT00552396|460513744|FG001|Overall Study|protocol withdrawal criteria|3|||
127970815|NCT00552396|460513745|FG002|Overall Study|protocol withdrawal criteria|3|||
127970816|NCT00552396|460513746|FG003|Overall Study|protocol withdrawal criteria|6|||
127970817|NCT00552396|460513747|FG004|Overall Study|protocol withdrawal criteria|3|||
127970818|NCT00552396|460513748|FG005|Overall Study|protocol withdrawal criteria|3|||
127970819|NCT00552396|460513749|FG006|Overall Study|protocol withdrawal criteria|9|||
127970820|NCT04185220|460513750|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
127970821|NCT04185220|460513751|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
127970822|NCT04185220|460513750|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
127970823|NCT04185220|460513751|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
127970824|NCT01186692|460513754|FG000|Overall Study|Not Catheterized|11|||
127970825|NCT01186692|460513754|FG000|Overall Study|Futher testing contraindicated implant|19|||
127970826|NCT01186692|460513754|FG000|Overall Study|Adverse Event|2|||
127970827|NCT03232931|460514939|FG000|Overall Study|Physician Decision|1|||
127970828|NCT03232931|460514940|FG001|Overall Study|Physician Decision|1|||
127970829|NCT03232931|460514939|FG000|Overall Study|Withdrawal by Subject|6|||
127970830|NCT03232931|460514940|FG001|Overall Study|Withdrawal by Subject|0|||
127970831|NCT03232931|460514939|FG000|Overall Study|Discharged before completing study activities per protocol|4|||
127970832|NCT03232931|460514940|FG001|Overall Study|Discharged before completing study activities per protocol|2|||
127970833|NCT03232931|460514939|FG000|Overall Study|Parent did not record voice|1|||
127970834|NCT03232931|460514940|FG001|Overall Study|Parent did not record voice|2|||
127970835|NCT03232931|460514939|FG000|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|2|||
127970836|NCT03232931|460514940|FG001|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|1|||
127970837|NCT04925557|460514941|FG000|Overall Study|Study closed|5|||
127970838|NCT04925557|460514942|FG001|Overall Study|Study closed|3|||
127970839|NCT05488470|460514943|FG000|Overall Study|Physician Decision|2|||
127970840|NCT05488470|460514943|FG000|Overall Study|Withdrawal by Subject|1|||
127970841|NCT05488470|460514943|FG000|Overall Study|Death|1|||
127970842|NCT00068393|460514948|FG000|Overall Study|Adverse Event|2|||
127970843|NCT00068393|460514948|FG000|Overall Study|Death|3|||
127970844|NCT00068393|460514948|FG000|Overall Study|Withdrawal by Subject|3|||
127970845|NCT00068393|460514948|FG000|Overall Study|Alternative treatment|1|||
127970846|NCT00068393|460514948|FG000|Overall Study|Quality of life worsening|1|||
127970847|NCT04981470|460514952|FG000|Overall Study|Device failure in all 4 patients|4|||
127970848|NCT00593684|460514953|FG000|Overall Study|Death|2|||
127970849|NCT00593684|460514954|FG001|Overall Study|Death|1|||
127970850|NCT01736397|460514959|FG000|Overall Study|Lack of Efficacy|1|||
127970851|NCT01736397|460514960|FG001|Overall Study|Lack of Efficacy|11|||
127970852|NCT01736397|460514959|FG000|Overall Study|Withdrawal by Subject|6|||
127970853|NCT01736397|460514960|FG001|Overall Study|Withdrawal by Subject|5|||
127970854|NCT01736397|460514959|FG000|Overall Study|Lost to Follow-up|0|||
127970855|NCT01736397|460514960|FG001|Overall Study|Lost to Follow-up|1|||
127970856|NCT01736397|460514959|FG000|Overall Study|Adverse Event|6|||
127970857|NCT01736397|460514960|FG001|Overall Study|Adverse Event|3|||
127970858|NCT01736397|460514959|FG000|Overall Study|Not stated|1|||
127970859|NCT01736397|460514960|FG001|Overall Study|Not stated|4|||
127970860|NCT05088603|460514961|FG000|Overall Study|Protocol Violation|6|||
127970861|NCT05088603|460514962|FG001|Overall Study|Protocol Violation|1|||
127970862|NCT01841762|460514964|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
127970863|NCT01841762|460514964|FG000|Treatment Period|Adverse Event|16|||
127970864|NCT01841762|460514964|FG000|Treatment Period|Death|1|||
127970865|NCT01841762|460514964|FG000|Treatment Period|Withdrawal by Subject|7|||
127970866|NCT01841762|460514964|FG000|Treatment Period|Lost to Follow-up|1|||
127970867|NCT01841762|460514964|FG000|Treatment Period|Physician Decision|2|||
127970868|NCT01841762|460514964|FG000|Treatment Period|Other, including non-compliance|5|||
127970869|NCT01841762|460514964|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
127970870|NCT01841762|460514964|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
127970871|NCT01841762|460514964|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
127970872|NCT01841762|460514964|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
127970873|NCT00594100|460514969|FG000|Procedure|Technical Failure|9|||
127970874|NCT00594100|460514969|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
127970875|NCT00594100|460514969|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
127970876|NCT00594100|460514969|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
127970877|NCT01270464|460514970|FG000|Overall Study|Protocol Violation|4|||
127970878|NCT01270464|460514971|FG001|Overall Study|Protocol Violation|3|||
127970879|NCT01270464|460514972|FG002|Overall Study|Protocol Violation|2|||
127970880|NCT01270464|460514970|FG000|Overall Study|Lack of Efficacy|2|||
127970881|NCT01270464|460514971|FG001|Overall Study|Lack of Efficacy|3|||
127970882|NCT01270464|460514972|FG002|Overall Study|Lack of Efficacy|1|||
127970883|NCT01270464|460514970|FG000|Overall Study|Adverse Event|9|||
127970884|NCT01270464|460514971|FG001|Overall Study|Adverse Event|1|||
127970885|NCT01270464|460514972|FG002|Overall Study|Adverse Event|7|||
127970886|NCT01270464|460514970|FG000|Overall Study|Withdrawal by Subject|2|||
127970887|NCT01270464|460514971|FG001|Overall Study|Withdrawal by Subject|1|||
127970888|NCT01270464|460514972|FG002|Overall Study|Withdrawal by Subject|4|||
127970889|NCT01270464|460514970|FG000|Overall Study|Lost to Follow-up|2|||
127970890|NCT01270464|460514971|FG001|Overall Study|Lost to Follow-up|3|||
127970891|NCT01270464|460514972|FG002|Overall Study|Lost to Follow-up|1|||
127970892|NCT01270464|460514970|FG000|Overall Study|Other|1|||
127970893|NCT01270464|460514971|FG001|Overall Study|Other|1|||
127970894|NCT01270464|460514972|FG002|Overall Study|Other|3|||
127970895|NCT03981900|460514974|FG000|Overall Study|Participant decision - Without withdrawal of consent|17|||
127970896|NCT03981900|460514974|FG000|Overall Study|Adverse Event|5|||
127970897|NCT03981900|460514974|FG000|Overall Study|Protocol Violation|1|||
127970898|NCT03981900|460514974|FG000|Overall Study|Withdrawal by Subject|7|||
127970899|NCT03981900|460514974|FG000|Overall Study|Lost to Follow-up|46|||
127970900|NCT03981900|460514974|FG000|Overall Study|Decision of the researcher|3|||
127970901|NCT03981900|460514974|FG000|Overall Study|Death|3|||
127970902|NCT03981900|460514974|FG000|Overall Study|Other|5|||
127970903|NCT02162719|460514975|FG000|Overall Study|Death|41|||
127970904|NCT02162719|460514976|FG001|Overall Study|Death|46|||
127970905|NCT02162719|460514975|FG000|Overall Study|Lost to Follow-up|1|||
127970906|NCT02162719|460514976|FG001|Overall Study|Lost to Follow-up|3|||
127970907|NCT02162719|460514975|FG000|Overall Study|Disease Progression|2|||
127970908|NCT02162719|460514976|FG001|Overall Study|Disease Progression|1|||
127970909|NCT02162719|460514975|FG000|Overall Study|Withdrawal by Subject|8|||
127970910|NCT02162719|460514976|FG001|Overall Study|Withdrawal by Subject|2|||
127970911|NCT02162719|460514975|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
127970912|NCT02162719|460514976|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
127970913|NCT04725812|460514978|FG000|Overall Study|Withdrawal by Subject|1|||
127970914|NCT03969901|460514983|FG000|Overall Study|Withdrawal by parent/guardian|0|||
127970915|NCT03969901|460514984|FG001|Overall Study|Withdrawal by parent/guardian|0|||
127970916|NCT03969901|460514985|FG002|Overall Study|Withdrawal by parent/guardian|0|||
127970917|NCT03969901|460514986|FG003|Overall Study|Withdrawal by parent/guardian|0|||
127970918|NCT03969901|460514987|FG004|Overall Study|Withdrawal by parent/guardian|1|||
127970919|NCT03969901|460514988|FG005|Overall Study|Withdrawal by parent/guardian|0|||
127970920|NCT03969901|460514989|FG006|Overall Study|Withdrawal by parent/guardian|0|||
127970921|NCT03969901|460514990|FG007|Overall Study|Withdrawal by parent/guardian|1|||
127970922|NCT03969901|460514991|FG008|Overall Study|Withdrawal by parent/guardian|1|||
127970923|NCT03969901|460514992|FG009|Overall Study|Withdrawal by parent/guardian|0|||
127970924|NCT04411810|460514993|FG000|Overall Study|Screen failure|1|||
127970925|NCT04411810|460514993|FG000|Overall Study|Withdrawal by Subject|1|||
127970926|NCT02564900|460515002|FG000|Dose Escalation|Progressive disease per RECIST|2|||
127970927|NCT02564900|460515003|FG001|Dose Escalation|Progressive disease per RECIST|3|||
127970928|NCT02564900|460515004|FG002|Dose Escalation|Progressive disease per RECIST|3|||
127970929|NCT02564900|460515005|FG003|Dose Escalation|Progressive disease per RECIST|3|||
127970930|NCT02564900|460515006|FG004|Dose Escalation|Progressive disease per RECIST|3|||
127970931|NCT02564900|460515007|FG005|Dose Escalation|Progressive disease per RECIST|1|||
127970932|NCT02564900|460515008|FG006|Dose Escalation|Progressive disease per RECIST|0|||
127970933|NCT02564900|460515009|FG007|Dose Escalation|Progressive disease per RECIST|0|||
127970934|NCT02564900|460515010|FG008|Dose Escalation|Progressive disease per RECIST|0|||
127970935|NCT02564900|460515011|FG009|Dose Escalation|Progressive disease per RECIST|0|||
127970936|NCT02564900|460515012|FG010|Dose Escalation|Progressive disease per RECIST|0|||
127970937|NCT02564900|460515013|FG011|Dose Escalation|Progressive disease per RECIST|0|||
127970938|NCT02564900|460515014|FG012|Dose Escalation|Progressive disease per RECIST|0|||
127970939|NCT02564900|460515015|FG013|Dose Escalation|Progressive disease per RECIST|0|||
127970940|NCT02564900|460515016|FG014|Dose Escalation|Progressive disease per RECIST|0|||
127970941|NCT02564900|460515002|FG000|Dose Escalation|Ongoing|1|||
127970942|NCT02564900|460515003|FG001|Dose Escalation|Ongoing|0|||
127970943|NCT02564900|460515004|FG002|Dose Escalation|Ongoing|0|||
127970944|NCT02564900|460515005|FG003|Dose Escalation|Ongoing|2|||
127970945|NCT02564900|460515006|FG004|Dose Escalation|Ongoing|2|||
127970946|NCT02564900|460515007|FG005|Dose Escalation|Ongoing|2|||
127970947|NCT02564900|460515008|FG006|Dose Escalation|Ongoing|0|||
127970948|NCT02564900|460515009|FG007|Dose Escalation|Ongoing|0|||
127970949|NCT02564900|460515010|FG008|Dose Escalation|Ongoing|0|||
127970950|NCT02564900|460515011|FG009|Dose Escalation|Ongoing|0|||
127970951|NCT02564900|460515012|FG010|Dose Escalation|Ongoing|0|||
127970952|NCT02564900|460515013|FG011|Dose Escalation|Ongoing|0|||
127970953|NCT02564900|460515014|FG012|Dose Escalation|Ongoing|0|||
127970954|NCT02564900|460515015|FG013|Dose Escalation|Ongoing|0|||
127970955|NCT02564900|460515016|FG014|Dose Escalation|Ongoing|0|||
127970956|NCT02564900|460515002|FG000|Dose Escalation|Adverse Event|0|||
127970957|NCT02564900|460515003|FG001|Dose Escalation|Adverse Event|0|||
127970958|NCT02564900|460515004|FG002|Dose Escalation|Adverse Event|0|||
127970959|NCT02564900|460515005|FG003|Dose Escalation|Adverse Event|1|||
127970960|NCT02564900|460515006|FG004|Dose Escalation|Adverse Event|1|||
127970961|NCT02564900|460515007|FG005|Dose Escalation|Adverse Event|3|||
127970962|NCT02564900|460515008|FG006|Dose Escalation|Adverse Event|0|||
127970963|NCT02564900|460515009|FG007|Dose Escalation|Adverse Event|0|||
127970964|NCT02564900|460515010|FG008|Dose Escalation|Adverse Event|0|||
127970965|NCT02564900|460515011|FG009|Dose Escalation|Adverse Event|0|||
127970966|NCT02564900|460515012|FG010|Dose Escalation|Adverse Event|0|||
127970967|NCT02564900|460515013|FG011|Dose Escalation|Adverse Event|0|||
127970968|NCT02564900|460515014|FG012|Dose Escalation|Adverse Event|0|||
127970969|NCT02564900|460515015|FG013|Dose Escalation|Adverse Event|0|||
127970970|NCT02564900|460515016|FG014|Dose Escalation|Adverse Event|0|||
127970971|NCT02564900|460515002|FG000|Dose Expansion|Progressive disease per RECIST|0|||
127970972|NCT02564900|460515003|FG001|Dose Expansion|Progressive disease per RECIST|0|||
127970973|NCT02564900|460515004|FG002|Dose Expansion|Progressive disease per RECIST|0|||
127970974|NCT02564900|460515005|FG003|Dose Expansion|Progressive disease per RECIST|0|||
127970975|NCT02564900|460515006|FG004|Dose Expansion|Progressive disease per RECIST|0|||
127970976|NCT02564900|460515007|FG005|Dose Expansion|Progressive disease per RECIST|0|||
127970977|NCT02564900|460515008|FG006|Dose Expansion|Progressive disease per RECIST|19|||
127970978|NCT02564900|460515009|FG007|Dose Expansion|Progressive disease per RECIST|17|||
127970979|NCT02564900|460515010|FG008|Dose Expansion|Progressive disease per RECIST|8|||
127970980|NCT02564900|460515011|FG009|Dose Expansion|Progressive disease per RECIST|16|||
127970981|NCT02564900|460515012|FG010|Dose Expansion|Progressive disease per RECIST|13|||
127970982|NCT02564900|460515013|FG011|Dose Expansion|Progressive disease per RECIST|19|||
127970983|NCT02564900|460515014|FG012|Dose Expansion|Progressive disease per RECIST|10|||
127970984|NCT02564900|460515015|FG013|Dose Expansion|Progressive disease per RECIST|13|||
127970985|NCT02564900|460515016|FG014|Dose Expansion|Progressive disease per RECIST|11|||
127970986|NCT02564900|460515002|FG000|Dose Expansion|Clinical progression|0|||
127970987|NCT02564900|460515003|FG001|Dose Expansion|Clinical progression|0|||
127970988|NCT02564900|460515004|FG002|Dose Expansion|Clinical progression|0|||
127970989|NCT02564900|460515005|FG003|Dose Expansion|Clinical progression|0|||
127970990|NCT02564900|460515006|FG004|Dose Expansion|Clinical progression|0|||
127970991|NCT02564900|460515007|FG005|Dose Expansion|Clinical progression|0|||
127970992|NCT02564900|460515008|FG006|Dose Expansion|Clinical progression|5|||
127970993|NCT02564900|460515009|FG007|Dose Expansion|Clinical progression|12|||
127970994|NCT02564900|460515010|FG008|Dose Expansion|Clinical progression|0|||
127970995|NCT02564900|460515011|FG009|Dose Expansion|Clinical progression|3|||
127970996|NCT02564900|460515012|FG010|Dose Expansion|Clinical progression|2|||
127970997|NCT02564900|460515013|FG011|Dose Expansion|Clinical progression|0|||
127970998|NCT02564900|460515014|FG012|Dose Expansion|Clinical progression|1|||
127970999|NCT02564900|460515015|FG013|Dose Expansion|Clinical progression|3|||
127971000|NCT02564900|460515016|FG014|Dose Expansion|Clinical progression|1|||
127971001|NCT02564900|460515002|FG000|Dose Expansion|Adverse Event|0|||
127971002|NCT02564900|460515003|FG001|Dose Expansion|Adverse Event|0|||
127971003|NCT02564900|460515004|FG002|Dose Expansion|Adverse Event|0|||
127971004|NCT02564900|460515005|FG003|Dose Expansion|Adverse Event|0|||
127971005|NCT02564900|460515006|FG004|Dose Expansion|Adverse Event|0|||
127971006|NCT02564900|460515007|FG005|Dose Expansion|Adverse Event|0|||
127971007|NCT02564900|460515008|FG006|Dose Expansion|Adverse Event|9|||
127971008|NCT02564900|460515009|FG007|Dose Expansion|Adverse Event|22|||
127971009|NCT02564900|460515010|FG008|Dose Expansion|Adverse Event|0|||
127971010|NCT02564900|460515011|FG009|Dose Expansion|Adverse Event|11|||
127971011|NCT02564900|460515012|FG010|Dose Expansion|Adverse Event|0|||
127971012|NCT02564900|460515013|FG011|Dose Expansion|Adverse Event|5|||
127971013|NCT02564900|460515014|FG012|Dose Expansion|Adverse Event|2|||
127971014|NCT02564900|460515015|FG013|Dose Expansion|Adverse Event|2|||
127971015|NCT02564900|460515016|FG014|Dose Expansion|Adverse Event|1|||
127971016|NCT02564900|460515002|FG000|Dose Expansion|Ongoing|0|||
127971017|NCT02564900|460515003|FG001|Dose Expansion|Ongoing|0|||
127971018|NCT02564900|460515004|FG002|Dose Expansion|Ongoing|0|||
127971019|NCT02564900|460515005|FG003|Dose Expansion|Ongoing|0|||
127971020|NCT02564900|460515006|FG004|Dose Expansion|Ongoing|0|||
127971021|NCT02564900|460515007|FG005|Dose Expansion|Ongoing|0|||
127971022|NCT02564900|460515008|FG006|Dose Expansion|Ongoing|9|||
127971023|NCT02564900|460515009|FG007|Dose Expansion|Ongoing|10|||
127971024|NCT02564900|460515010|FG008|Dose Expansion|Ongoing|11|||
127971025|NCT02564900|460515011|FG009|Dose Expansion|Ongoing|3|||
127971026|NCT02564900|460515012|FG010|Dose Expansion|Ongoing|0|||
127971027|NCT02564900|460515013|FG011|Dose Expansion|Ongoing|0|||
127971028|NCT02564900|460515014|FG012|Dose Expansion|Ongoing|4|||
127971029|NCT02564900|460515015|FG013|Dose Expansion|Ongoing|0|||
127971030|NCT02564900|460515016|FG014|Dose Expansion|Ongoing|6|||
127971031|NCT02564900|460515002|FG000|Dose Expansion|Death|0|||
127971032|NCT02564900|460515003|FG001|Dose Expansion|Death|0|||
127971033|NCT02564900|460515004|FG002|Dose Expansion|Death|0|||
127971034|NCT02564900|460515005|FG003|Dose Expansion|Death|0|||
127971035|NCT02564900|460515006|FG004|Dose Expansion|Death|0|||
127971036|NCT02564900|460515007|FG005|Dose Expansion|Death|0|||
127971037|NCT02564900|460515008|FG006|Dose Expansion|Death|1|||
127971038|NCT02564900|460515009|FG007|Dose Expansion|Death|0|||
127971039|NCT02564900|460515010|FG008|Dose Expansion|Death|0|||
127971040|NCT02564900|460515011|FG009|Dose Expansion|Death|0|||
127971041|NCT02564900|460515012|FG010|Dose Expansion|Death|1|||
127971042|NCT02564900|460515013|FG011|Dose Expansion|Death|0|||
127971043|NCT02564900|460515014|FG012|Dose Expansion|Death|1|||
127971044|NCT02564900|460515015|FG013|Dose Expansion|Death|1|||
127971045|NCT02564900|460515016|FG014|Dose Expansion|Death|0|||
127971046|NCT02564900|460515002|FG000|Dose Expansion|Withdrawal by Subject|0|||
127971047|NCT02564900|460515003|FG001|Dose Expansion|Withdrawal by Subject|0|||
127971048|NCT02564900|460515004|FG002|Dose Expansion|Withdrawal by Subject|0|||
127971049|NCT02564900|460515005|FG003|Dose Expansion|Withdrawal by Subject|0|||
127971050|NCT02564900|460515006|FG004|Dose Expansion|Withdrawal by Subject|0|||
127971051|NCT02564900|460515007|FG005|Dose Expansion|Withdrawal by Subject|0|||
127971052|NCT02564900|460515008|FG006|Dose Expansion|Withdrawal by Subject|4|||
127971053|NCT02564900|460515009|FG007|Dose Expansion|Withdrawal by Subject|0|||
127971054|NCT02564900|460515010|FG008|Dose Expansion|Withdrawal by Subject|0|||
127971055|NCT02564900|460515011|FG009|Dose Expansion|Withdrawal by Subject|0|||
127971056|NCT02564900|460515012|FG010|Dose Expansion|Withdrawal by Subject|1|||
127971057|NCT02564900|460515013|FG011|Dose Expansion|Withdrawal by Subject|0|||
127971058|NCT02564900|460515014|FG012|Dose Expansion|Withdrawal by Subject|0|||
127971059|NCT02564900|460515015|FG013|Dose Expansion|Withdrawal by Subject|1|||
127971060|NCT02564900|460515016|FG014|Dose Expansion|Withdrawal by Subject|1|||
127971061|NCT02564900|460515002|FG000|Dose Expansion|Other|0|||
127971062|NCT02564900|460515003|FG001|Dose Expansion|Other|0|||
127971063|NCT02564900|460515004|FG002|Dose Expansion|Other|0|||
127971064|NCT02564900|460515005|FG003|Dose Expansion|Other|0|||
127971065|NCT02564900|460515006|FG004|Dose Expansion|Other|0|||
127971066|NCT02564900|460515007|FG005|Dose Expansion|Other|0|||
127971067|NCT02564900|460515008|FG006|Dose Expansion|Other|1|||
127971068|NCT02564900|460515009|FG007|Dose Expansion|Other|0|||
127971069|NCT02564900|460515010|FG008|Dose Expansion|Other|1|||
127971070|NCT02564900|460515011|FG009|Dose Expansion|Other|0|||
127971071|NCT02564900|460515012|FG010|Dose Expansion|Other|0|||
127971072|NCT02564900|460515013|FG011|Dose Expansion|Other|0|||
127971073|NCT02564900|460515014|FG012|Dose Expansion|Other|0|||
127971074|NCT02564900|460515015|FG013|Dose Expansion|Other|0|||
127971075|NCT02564900|460515016|FG014|Dose Expansion|Other|1|||
127971076|NCT02564900|460515002|FG000|Dose Expansion|Did not receive treatment|0|||
127971077|NCT02564900|460515003|FG001|Dose Expansion|Did not receive treatment|0|||
127971078|NCT02564900|460515004|FG002|Dose Expansion|Did not receive treatment|0|||
127971079|NCT02564900|460515005|FG003|Dose Expansion|Did not receive treatment|0|||
127971080|NCT02564900|460515006|FG004|Dose Expansion|Did not receive treatment|0|||
127971081|NCT02564900|460515007|FG005|Dose Expansion|Did not receive treatment|0|||
127971082|NCT02564900|460515008|FG006|Dose Expansion|Did not receive treatment|1|||
127971083|NCT02564900|460515009|FG007|Dose Expansion|Did not receive treatment|1|||
127971084|NCT02564900|460515010|FG008|Dose Expansion|Did not receive treatment|0|||
127971085|NCT02564900|460515011|FG009|Dose Expansion|Did not receive treatment|0|||
127971086|NCT02564900|460515012|FG010|Dose Expansion|Did not receive treatment|0|||
127971087|NCT02564900|460515013|FG011|Dose Expansion|Did not receive treatment|0|||
127971088|NCT02564900|460515014|FG012|Dose Expansion|Did not receive treatment|0|||
127971089|NCT02564900|460515015|FG013|Dose Expansion|Did not receive treatment|0|||
127971090|NCT02564900|460515016|FG014|Dose Expansion|Did not receive treatment|1|||
127971091|NCT01931475|460515020|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
127971092|NCT01931475|460515021|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
127971093|NCT01931475|460515020|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
127971094|NCT01931475|460515021|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
127971095|NCT01931475|460515020|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
127971096|NCT01931475|460515021|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
127971097|NCT01931475|460515020|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
127971098|NCT01931475|460515021|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
127971099|NCT01931475|460515020|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
127971100|NCT01931475|460515021|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
127971101|NCT01931475|460515020|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
127971102|NCT01931475|460515021|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
127971103|NCT01931475|460515020|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
127971104|NCT01931475|460515021|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
127971105|NCT01931475|460515020|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
127971106|NCT01931475|460515021|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
127971107|NCT01931475|460515020|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
127971108|NCT01931475|460515021|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
127971109|NCT01931475|460515020|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
127971110|NCT01931475|460515021|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
127971111|NCT01931475|460515020|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
127971112|NCT01931475|460515021|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
127971113|NCT02920008|460515030|FG000|Overall Study|Death|117|||
127971114|NCT02920008|460515031|FG001|Overall Study|Death|127|||
127971115|NCT02920008|460515030|FG000|Overall Study|Withdrawal by Subject|3|||
127971116|NCT02920008|460515031|FG001|Overall Study|Withdrawal by Subject|6|||
127971117|NCT02920008|460515030|FG000|Overall Study|Lost to Follow-up|0|||
127971118|NCT02920008|460515031|FG001|Overall Study|Lost to Follow-up|1|||
127971119|NCT02737930|460515032|FG000|Overall Study|Withdrawal by Subject|0|||
127971120|NCT02737930|460515033|FG001|Overall Study|Withdrawal by Subject|1|||
127971121|NCT01127451|460515043|FG000|Overall Study|Other|2|||
127971122|NCT01127451|460515044|FG001|Overall Study|Other|1|||
127971123|NCT01127451|460515043|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
127971124|NCT01127451|460515044|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
127971125|NCT01127451|460515043|FG000|Overall Study|Death|22|||
127971126|NCT01127451|460515044|FG001|Overall Study|Death|17|||
127971127|NCT01127451|460515043|FG000|Overall Study|Lost to Follow-up|3|||
127971128|NCT01127451|460515044|FG001|Overall Study|Lost to Follow-up|0|||
127971129|NCT01127451|460515043|FG000|Overall Study|Administrative Reason by Sponsor|2|||
127971130|NCT01127451|460515044|FG001|Overall Study|Administrative Reason by Sponsor|2|||
127971131|NCT00930774|460515045|FG000|Overall Study|Withdrawal by Subject|1|||
127971132|NCT00930774|460515046|FG001|Overall Study|Withdrawal by Subject|9|||
127971133|NCT00930774|460515047|FG002|Overall Study|Withdrawal by Subject|2|||
127971134|NCT00930774|460515048|FG003|Overall Study|Withdrawal by Subject|0|||
127971135|NCT03200704|460515049|FG000|Overall Study|Withdrawal by Subject|1|||
127971136|NCT00839527|460515050|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
127971137|NCT00839527|460515051|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
127971138|NCT00839527|460515052|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
127971139|NCT00839527|460515050|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
127971140|NCT00839527|460515051|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
127971141|NCT00839527|460515052|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
127971142|NCT00839527|460515050|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
127971143|NCT00839527|460515051|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
127971144|NCT00839527|460515052|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
127971145|NCT00839527|460515050|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
127971146|NCT00839527|460515051|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
127971147|NCT00839527|460515052|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
127971148|NCT00839527|460515050|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
127971149|NCT00839527|460515051|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
127971150|NCT00839527|460515052|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
127971151|NCT00839527|460515050|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
127971152|NCT00839527|460515051|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
127971153|NCT00839527|460515052|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
127971154|NCT00839527|460515050|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
127971155|NCT00839527|460515051|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
127971156|NCT00839527|460515052|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
127971157|NCT00839527|460515050|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
127971158|NCT00839527|460515051|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
127971159|NCT00839527|460515052|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
127971160|NCT00839527|460515050|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
127971161|NCT00839527|460515051|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
127971162|NCT00839527|460515052|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
127971163|NCT00839527|460515050|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
127971164|NCT00839527|460515051|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
127971165|NCT00839527|460515052|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
127971166|NCT00839527|460515050|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
127971167|NCT00839527|460515051|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
127971168|NCT00839527|460515052|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
127971169|NCT00839527|460515050|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
127971170|NCT00839527|460515051|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
127971171|NCT00839527|460515052|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
127971172|NCT00839527|460515050|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
127971173|NCT00839527|460515051|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
127971174|NCT00839527|460515052|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
127971175|NCT00839527|460515050|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
127971176|NCT00839527|460515051|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
127971177|NCT00839527|460515052|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
127971178|NCT00839527|460515050|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
127971179|NCT00839527|460515051|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
127971180|NCT00839527|460515052|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
127971181|NCT00839527|460515050|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
127971182|NCT00839527|460515051|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
127971183|NCT00839527|460515052|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
127971184|NCT00839527|460515050|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
127971185|NCT00839527|460515051|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
127971186|NCT00839527|460515052|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
127971187|NCT00839527|460515050|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
127971188|NCT00839527|460515051|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
127971189|NCT00839527|460515052|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
127971190|NCT00839527|460515050|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
127971191|NCT00839527|460515051|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
127971192|NCT00839527|460515052|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
127971193|NCT00839527|460515050|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
127971194|NCT00839527|460515051|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
127971195|NCT00839527|460515052|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
127971196|NCT00839527|460515050|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
127971197|NCT00839527|460515051|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
127971198|NCT00839527|460515052|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
127971199|NCT00839527|460515050|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
127971200|NCT00839527|460515051|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
127971201|NCT00839527|460515052|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
127971202|NCT00839527|460515050|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
127971203|NCT00839527|460515051|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
127971204|NCT00839527|460515052|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
127971205|NCT00839527|460515050|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
127971206|NCT00839527|460515051|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
127971207|NCT00839527|460515052|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
127971208|NCT01704651|460515053|FG000|Overall Study|Pre-op withdrawal by subject|1|||
127971209|NCT01704651|460515054|FG001|Overall Study|Pre-op withdrawal by subject|1|||
127971210|NCT01704651|460515053|FG000|Overall Study|Pre-op change in treatment plan|1|||
127971211|NCT01704651|460515054|FG001|Overall Study|Pre-op change in treatment plan|4|||
127971212|NCT01704651|460515053|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
127971213|NCT01704651|460515054|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
127971214|NCT01704651|460515053|FG000|Overall Study|Post-op did not have laparotomy|2|||
127971215|NCT01704651|460515054|FG001|Overall Study|Post-op did not have laparotomy|1|||
127971216|NCT00364923|460515057|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
127971217|NCT00364923|460515057|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
127971218|NCT00478777|460515060|FG000|Overall Study|Adverse Event|29|||
127971219|NCT00478777|460515060|FG000|Overall Study|Lack of Efficacy|23|||
127971220|NCT00478777|460515060|FG000|Overall Study|Withdrawal by Subject|4|||
127971221|NCT00478777|460515060|FG000|Overall Study|Death|3|||
127971222|NCT00478777|460515060|FG000|Overall Study|Protocol Violation|3|||
127971223|NCT00478777|460515060|FG000|Overall Study|Lost to Follow-up|3|||
127971224|NCT00478777|460515060|FG000|Overall Study|Physician Decision|1|||
127971225|NCT00478777|460515060|FG000|Overall Study|Intolerance of therapy|1|||
127971226|NCT00478777|460515060|FG000|Overall Study|Lack of compliance|1|||
127971227|NCT00478777|460515060|FG000|Overall Study|Lymphocytes infusion|1|||
127971228|NCT00478777|460515060|FG000|Overall Study|End of therapy|2|||
127971229|NCT00478777|460515060|FG000|Overall Study|Not treated with lenalidomide|6|||
127971230|NCT02553499|460515061|FG000|Overall Study|Adverse Event|0|||
127971231|NCT02553499|460515062|FG001|Overall Study|Adverse Event|0|||
127971232|NCT02553499|460515063|FG002|Overall Study|Adverse Event|0|||
127971233|NCT02553499|460515064|FG003|Overall Study|Adverse Event|0|||
127971234|NCT02553499|460515065|FG004|Overall Study|Adverse Event|0|||
127971235|NCT02553499|460515066|FG005|Overall Study|Adverse Event|0|||
127971236|NCT02553499|460515067|FG006|Overall Study|Adverse Event|1|||
127971237|NCT02553499|460515068|FG007|Overall Study|Adverse Event|1|||
127971238|NCT02553499|460515069|FG008|Overall Study|Adverse Event|0|||
127971239|NCT02553499|460515070|FG009|Overall Study|Adverse Event|0|||
127971240|NCT02553499|460515071|FG010|Overall Study|Adverse Event|0|||
127971241|NCT02553499|460515072|FG011|Overall Study|Adverse Event|0|||
127971242|NCT02553499|460515073|FG012|Overall Study|Adverse Event|0|||
127971243|NCT02553499|460515074|FG013|Overall Study|Adverse Event|1|||
127971244|NCT02553499|460515061|FG000|Overall Study|Death|0|||
127971245|NCT02553499|460515062|FG001|Overall Study|Death|1|||
127971246|NCT02553499|460515063|FG002|Overall Study|Death|1|||
127971247|NCT02553499|460515064|FG003|Overall Study|Death|0|||
127971248|NCT02553499|460515065|FG004|Overall Study|Death|1|||
127971249|NCT02553499|460515066|FG005|Overall Study|Death|2|||
127971250|NCT02553499|460515067|FG006|Overall Study|Death|0|||
127971251|NCT02553499|460515068|FG007|Overall Study|Death|0|||
127971252|NCT02553499|460515069|FG008|Overall Study|Death|0|||
127971253|NCT02553499|460515070|FG009|Overall Study|Death|0|||
127971254|NCT02553499|460515071|FG010|Overall Study|Death|1|||
127971255|NCT02553499|460515072|FG011|Overall Study|Death|0|||
127971256|NCT02553499|460515073|FG012|Overall Study|Death|0|||
127971257|NCT02553499|460515074|FG013|Overall Study|Death|0|||
127971258|NCT02553499|460515061|FG000|Overall Study|Lost to Follow-up|0|||
127971259|NCT02553499|460515062|FG001|Overall Study|Lost to Follow-up|0|||
127971260|NCT02553499|460515063|FG002|Overall Study|Lost to Follow-up|0|||
127971261|NCT02553499|460515064|FG003|Overall Study|Lost to Follow-up|0|||
127971262|NCT02553499|460515065|FG004|Overall Study|Lost to Follow-up|0|||
127971263|NCT02553499|460515066|FG005|Overall Study|Lost to Follow-up|0|||
127971264|NCT02553499|460515067|FG006|Overall Study|Lost to Follow-up|1|||
127971265|NCT02553499|460515068|FG007|Overall Study|Lost to Follow-up|0|||
127971266|NCT02553499|460515069|FG008|Overall Study|Lost to Follow-up|0|||
127971267|NCT02553499|460515070|FG009|Overall Study|Lost to Follow-up|0|||
127971268|NCT02553499|460515071|FG010|Overall Study|Lost to Follow-up|0|||
127971269|NCT02553499|460515072|FG011|Overall Study|Lost to Follow-up|0|||
127971270|NCT02553499|460515073|FG012|Overall Study|Lost to Follow-up|0|||
127971271|NCT02553499|460515074|FG013|Overall Study|Lost to Follow-up|0|||
127971272|NCT02553499|460515061|FG000|Overall Study|Physician Decision|0|||
127971273|NCT02553499|460515062|FG001|Overall Study|Physician Decision|1|||
127971274|NCT02553499|460515063|FG002|Overall Study|Physician Decision|1|||
127971275|NCT02553499|460515064|FG003|Overall Study|Physician Decision|0|||
127971276|NCT02553499|460515065|FG004|Overall Study|Physician Decision|1|||
127971277|NCT02553499|460515066|FG005|Overall Study|Physician Decision|0|||
127971278|NCT02553499|460515067|FG006|Overall Study|Physician Decision|0|||
127971279|NCT02553499|460515068|FG007|Overall Study|Physician Decision|1|||
127971280|NCT02553499|460515069|FG008|Overall Study|Physician Decision|1|||
127971281|NCT02553499|460515070|FG009|Overall Study|Physician Decision|2|||
127971282|NCT02553499|460515071|FG010|Overall Study|Physician Decision|1|||
127971283|NCT02553499|460515072|FG011|Overall Study|Physician Decision|3|||
127971284|NCT02553499|460515073|FG012|Overall Study|Physician Decision|1|||
127971285|NCT02553499|460515074|FG013|Overall Study|Physician Decision|0|||
127971286|NCT02553499|460515061|FG000|Overall Study|Progressive Disease|0|||
127971287|NCT02553499|460515062|FG001|Overall Study|Progressive Disease|0|||
127971288|NCT02553499|460515063|FG002|Overall Study|Progressive Disease|0|||
127971289|NCT02553499|460515064|FG003|Overall Study|Progressive Disease|2|||
127971290|NCT02553499|460515065|FG004|Overall Study|Progressive Disease|1|||
127971291|NCT02553499|460515066|FG005|Overall Study|Progressive Disease|1|||
127971292|NCT02553499|460515067|FG006|Overall Study|Progressive Disease|1|||
127971293|NCT02553499|460515068|FG007|Overall Study|Progressive Disease|0|||
127971294|NCT02553499|460515069|FG008|Overall Study|Progressive Disease|0|||
127971295|NCT02553499|460515070|FG009|Overall Study|Progressive Disease|1|||
127971296|NCT02553499|460515071|FG010|Overall Study|Progressive Disease|0|||
127971297|NCT02553499|460515072|FG011|Overall Study|Progressive Disease|0|||
127971298|NCT02553499|460515073|FG012|Overall Study|Progressive Disease|2|||
127971299|NCT02553499|460515074|FG013|Overall Study|Progressive Disease|1|||
127971300|NCT02553499|460515061|FG000|Overall Study|Study Terminated by Sponsor|0|||
127971301|NCT02553499|460515062|FG001|Overall Study|Study Terminated by Sponsor|0|||
127971302|NCT02553499|460515063|FG002|Overall Study|Study Terminated by Sponsor|0|||
127971303|NCT02553499|460515064|FG003|Overall Study|Study Terminated by Sponsor|0|||
127971304|NCT02553499|460515065|FG004|Overall Study|Study Terminated by Sponsor|0|||
127971305|NCT02553499|460515066|FG005|Overall Study|Study Terminated by Sponsor|0|||
127971306|NCT02553499|460515067|FG006|Overall Study|Study Terminated by Sponsor|0|||
127971307|NCT02553499|460515068|FG007|Overall Study|Study Terminated by Sponsor|0|||
127971308|NCT02553499|460515069|FG008|Overall Study|Study Terminated by Sponsor|1|||
127971309|NCT02553499|460515070|FG009|Overall Study|Study Terminated by Sponsor|0|||
127971310|NCT02553499|460515071|FG010|Overall Study|Study Terminated by Sponsor|0|||
127971311|NCT02553499|460515072|FG011|Overall Study|Study Terminated by Sponsor|0|||
127971312|NCT02553499|460515073|FG012|Overall Study|Study Terminated by Sponsor|0|||
127971313|NCT02553499|460515074|FG013|Overall Study|Study Terminated by Sponsor|0|||
127971314|NCT02553499|460515061|FG000|Overall Study|Withdrawal by Subject|2|||
127971315|NCT02553499|460515062|FG001|Overall Study|Withdrawal by Subject|0|||
127971316|NCT02553499|460515063|FG002|Overall Study|Withdrawal by Subject|0|||
127971317|NCT02553499|460515064|FG003|Overall Study|Withdrawal by Subject|0|||
127971318|NCT02553499|460515065|FG004|Overall Study|Withdrawal by Subject|0|||
127971319|NCT02553499|460515066|FG005|Overall Study|Withdrawal by Subject|0|||
127971320|NCT02553499|460515067|FG006|Overall Study|Withdrawal by Subject|0|||
127971321|NCT02553499|460515068|FG007|Overall Study|Withdrawal by Subject|1|||
127971322|NCT02553499|460515069|FG008|Overall Study|Withdrawal by Subject|1|||
127971323|NCT02553499|460515070|FG009|Overall Study|Withdrawal by Subject|0|||
127971324|NCT02553499|460515071|FG010|Overall Study|Withdrawal by Subject|1|||
127971325|NCT02553499|460515072|FG011|Overall Study|Withdrawal by Subject|0|||
127971326|NCT02553499|460515073|FG012|Overall Study|Withdrawal by Subject|0|||
127971327|NCT02553499|460515074|FG013|Overall Study|Withdrawal by Subject|0|||
127971328|NCT00078767|460516680|FG000|Overall Study|Withdrawal by Subject|1|||
127971329|NCT00078767|460516681|FG001|Overall Study|Withdrawal by Subject|1|||
127971330|NCT02282631|460516682|FG000|Overall Study|Lost to Follow-up|2|||
127971331|NCT02282631|460516683|FG001|Overall Study|Lost to Follow-up|0|||
127971332|NCT02589626|460516684|FG000|Overall Study|Other than the reason specified|1|||
127971333|NCT02589626|460516685|FG001|Overall Study|Other than the reason specified|0|||
127971334|NCT02589626|460516684|FG000|Overall Study|Withdrawal by Subject|1|||
127971335|NCT02589626|460516685|FG001|Overall Study|Withdrawal by Subject|1|||
127971336|NCT02589626|460516684|FG000|Overall Study|Adverse Event|1|||
127971337|NCT02589626|460516685|FG001|Overall Study|Adverse Event|1|||
127971338|NCT00892151|460516686|FG000|Overall Study|Protocol Violation|1|||
127971339|NCT04075682|460516689|FG000|Overall Study|Lost to Follow-up|5|||
127971340|NCT04075682|460516690|FG001|Overall Study|Lost to Follow-up|5|||
127971341|NCT04075682|460516691|FG002|Overall Study|Lost to Follow-up|2|||
127971342|NCT04075682|460516692|FG003|Overall Study|Lost to Follow-up|2|||
127971343|NCT04075682|460516689|FG000|Overall Study|Withdrawal by Subject|1|||
127971344|NCT04075682|460516690|FG001|Overall Study|Withdrawal by Subject|0|||
127971345|NCT04075682|460516691|FG002|Overall Study|Withdrawal by Subject|1|||
127971346|NCT04075682|460516692|FG003|Overall Study|Withdrawal by Subject|0|||
127971347|NCT04075682|460516689|FG000|Overall Study|Protocol Violation|0|||
127971348|NCT04075682|460516690|FG001|Overall Study|Protocol Violation|1|||
127971349|NCT04075682|460516691|FG002|Overall Study|Protocol Violation|1|||
127971350|NCT04075682|460516692|FG003|Overall Study|Protocol Violation|0|||
127971351|NCT04075682|460516689|FG000|Overall Study|Not literate enough to self-administer study surveys|1|||
127971352|NCT04075682|460516690|FG001|Overall Study|Not literate enough to self-administer study surveys|0|||
127971353|NCT04075682|460516691|FG002|Overall Study|Not literate enough to self-administer study surveys|0|||
127971354|NCT04075682|460516692|FG003|Overall Study|Not literate enough to self-administer study surveys|0|||
127971355|NCT04075682|460516689|FG000|Overall Study|Lost study phone the first day of study participation|0|||
127971356|NCT04075682|460516690|FG001|Overall Study|Lost study phone the first day of study participation|1|||
127971357|NCT04075682|460516691|FG002|Overall Study|Lost study phone the first day of study participation|0|||
127971358|NCT04075682|460516692|FG003|Overall Study|Lost study phone the first day of study participation|0|||
127971359|NCT04292912|460516693|FG000|Overall Study|Physician Decision|1|||
127971360|NCT04292912|460516693|FG000|Overall Study|Protocol Violation|6|||
127971361|NCT01680861|460516696|FG000|Early Post-transplant Period|Protocol Violation|1|||
127971362|NCT01680861|460516697|FG001|Early Post-transplant Period|Protocol Violation|1|||
127971363|NCT04791319|460516698|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
127971364|NCT04791319|460516699|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
127971365|NCT04791319|460516700|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
127971366|NCT04791319|460516701|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
127971367|NCT04791319|460516702|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
127971368|NCT04791319|460516703|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
127971369|NCT04791319|460516704|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
127971370|NCT04791319|460516705|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
127971371|NCT04791319|460516706|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
127971372|NCT04791319|460516707|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
127971373|NCT04791319|460516708|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
127971374|NCT04791319|460516698|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
127971375|NCT04791319|460516699|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
127971376|NCT04791319|460516700|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
127971377|NCT04791319|460516701|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
127971378|NCT04791319|460516702|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
127971379|NCT04791319|460516703|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
127971380|NCT04791319|460516704|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
127971381|NCT04791319|460516705|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
127971382|NCT04791319|460516706|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
127971383|NCT04791319|460516707|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
127971384|NCT04791319|460516708|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
127971385|NCT04791319|460516698|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
127971386|NCT04791319|460516699|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
127971387|NCT04791319|460516700|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
127971388|NCT04791319|460516701|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
127971389|NCT04791319|460516702|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
127971390|NCT04791319|460516703|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
127971391|NCT04791319|460516704|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
127971392|NCT04791319|460516705|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
127971393|NCT04791319|460516706|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
127971394|NCT04791319|460516707|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
127971395|NCT04791319|460516708|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
127971396|NCT04791319|460516698|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
127971397|NCT04791319|460516699|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
127971398|NCT04791319|460516700|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
127971399|NCT04791319|460516701|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
127971400|NCT04791319|460516702|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
127971401|NCT04791319|460516703|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
127971402|NCT04791319|460516704|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
127971403|NCT04791319|460516705|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
127971404|NCT04791319|460516706|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
127971405|NCT04791319|460516707|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
127971406|NCT04791319|460516708|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
127971407|NCT04791319|460516698|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
127971408|NCT04791319|460516699|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
127971409|NCT04791319|460516700|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
127971410|NCT04791319|460516701|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
127971411|NCT04791319|460516702|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
127971412|NCT04791319|460516703|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
127971413|NCT04791319|460516704|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
127971414|NCT04791319|460516705|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
127971415|NCT04791319|460516706|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
127971416|NCT04791319|460516707|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
127971417|NCT04791319|460516708|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
127971418|NCT04791319|460516698|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
127971419|NCT04791319|460516699|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
127971420|NCT04791319|460516700|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
127971421|NCT04791319|460516701|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
127971422|NCT04791319|460516702|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
127971423|NCT04791319|460516703|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
127971424|NCT04791319|460516704|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
127971425|NCT04791319|460516705|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
127971426|NCT04791319|460516706|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
127971427|NCT04791319|460516707|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
127971428|NCT04791319|460516708|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
127971429|NCT04791319|460516698|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
127971430|NCT04791319|460516699|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
127971431|NCT04791319|460516700|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
127971432|NCT04791319|460516701|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
127971433|NCT04791319|460516702|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
127971434|NCT04791319|460516703|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
127971435|NCT04791319|460516704|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
127971436|NCT04791319|460516705|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
127971437|NCT04791319|460516706|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
127971438|NCT04791319|460516707|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
127971439|NCT04791319|460516708|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
127971440|NCT04791319|460516698|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
127971441|NCT04791319|460516699|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
127971442|NCT04791319|460516700|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
127971443|NCT04791319|460516701|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
127971444|NCT04791319|460516702|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
127971445|NCT04791319|460516703|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
127971446|NCT04791319|460516704|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
127971447|NCT04791319|460516705|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
127971448|NCT04791319|460516706|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
127971449|NCT04791319|460516707|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
127971450|NCT04791319|460516708|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
127971451|NCT04791319|460516698|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
127971452|NCT04791319|460516699|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
127971453|NCT04791319|460516700|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
127971454|NCT04791319|460516701|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
127971455|NCT04791319|460516702|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
127971456|NCT04791319|460516703|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
127971457|NCT04791319|460516704|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
127971458|NCT04791319|460516705|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
127971459|NCT04791319|460516706|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
127971460|NCT04791319|460516707|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
127971461|NCT04791319|460516708|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
127971462|NCT04087720|460516715|FG000|Overall Study|Withdrawal by Subject|2|||
127971463|NCT04087720|460516715|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
127971464|NCT03706430|460516716|FG000|Overall Study|No A-Line placed|5|||
127971465|NCT03706430|460516716|FG000|Overall Study|Subject had gel nail polish|1|||
127971466|NCT03706430|460516716|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
127971467|NCT03706430|460516716|FG000|Overall Study|Cancelled Case|6|||
127971468|NCT03706430|460516716|FG000|Overall Study|Physician Decision|2|||
127971469|NCT00520533|460516717|FG000|Overall Study|Death|1|||
127971470|NCT00520533|460516717|FG000|Overall Study|Suspension of the study for safety reasons|1|||
127971471|NCT00520533|460516717|FG000|Overall Study|Withdrawal by Subject|1|||
127971472|NCT00520533|460516717|FG000|Overall Study|Physician Decision|1|||
127971473|NCT01726270|460516724|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
127971474|NCT01726270|460516724|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
127971475|NCT01726270|460516724|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
127971476|NCT01726270|460516724|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
127971477|NCT01726270|460516724|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
127971478|NCT01726270|460516724|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
127971479|NCT01323387|460516725|FG000|Overall Study|Withdrawal by Subject|41|||
127971480|NCT01323387|460516725|FG000|Overall Study|Radiographic Data Unavailable|1|||
127971481|NCT01323387|460516725|FG000|Overall Study|Revision|14|||
127971482|NCT01323387|460516725|FG000|Overall Study|Protocol Violation|12|||
127971483|NCT01323387|460516725|FG000|Overall Study|Randomized but Never Treated|16|||
127971484|NCT00582608|460516726|FG000|Overall Study|Not Treated|7|||
127971485|NCT00582608|460516726|FG000|Overall Study|Patient Ineligible|1|||
127971486|NCT00582608|460516726|FG000|Overall Study|Lack of accrual|4|||
127971487|NCT02073929|460516742|FG000|Overall Study|Lost to Follow-up|2|||
127971488|NCT02073929|460516743|FG001|Overall Study|Lost to Follow-up|1|||
127971489|NCT02073929|460516742|FG000|Overall Study|Adverse Event|2|||
127971490|NCT02073929|460516743|FG001|Overall Study|Adverse Event|1|||
127971491|NCT02073929|460516742|FG000|Overall Study|Withdrawal by Subject|0|||
127971492|NCT02073929|460516743|FG001|Overall Study|Withdrawal by Subject|1|||
127971493|NCT03319732|460516747|FG000|Overall Study|Adverse Event|40|||
127971494|NCT03319732|460516747|FG000|Overall Study|Withdrawal by Subject|50|||
127971495|NCT03319732|460516747|FG000|Overall Study|MS relapse|10|||
127971496|NCT03319732|460516747|FG000|Overall Study|reason not specified|5|||
127971497|NCT00767455|460516748|FG000|Overall Study|Investigator error|19|||
127971498|NCT00430573|460516749|FG000|Overall Study|Withdrawal by Subject|5|||
127971499|NCT04463251|460516752|FG000|Overall Study|Death|1|||
127971500|NCT04463251|460516753|FG001|Overall Study|Death|0|||
127971501|NCT04463251|460516754|FG002|Overall Study|Death|1|||
127971502|NCT04463251|460516752|FG000|Overall Study|Adverse Event|0|||
127971503|NCT04463251|460516753|FG001|Overall Study|Adverse Event|1|||
127971504|NCT04463251|460516754|FG002|Overall Study|Adverse Event|0|||
127971505|NCT04463251|460516752|FG000|Overall Study|Lost to Follow-up|0|||
127971506|NCT04463251|460516753|FG001|Overall Study|Lost to Follow-up|1|||
127971507|NCT04463251|460516754|FG002|Overall Study|Lost to Follow-up|0|||
127971508|NCT04463251|460516752|FG000|Overall Study|Withdrawal by Subject|0|||
127971509|NCT04463251|460516753|FG001|Overall Study|Withdrawal by Subject|2|||
127971510|NCT04463251|460516754|FG002|Overall Study|Withdrawal by Subject|2|||
127971511|NCT00072280|460516755|FG000|Treatment|Found ineligible|1|||
127971512|NCT00072280|460516756|FG001|Treatment|Found ineligible|2|||
127971513|NCT00072280|460516755|FG000|Follow-up|Early termination of study|2|||
127971514|NCT00072280|460516756|FG001|Follow-up|Early termination of study|2|||
127971515|NCT05020665|460516759|FG000|Overall Study|Study terminated by Sponsor|5|||
127971516|NCT05020665|460516760|FG001|Overall Study|Study terminated by Sponsor|4|||
127971517|NCT05020665|460516759|FG000|Overall Study|Death|2|||
127971518|NCT05020665|460516760|FG001|Overall Study|Death|1|||
127971519|NCT05020665|460516759|FG000|Overall Study|Physician Decision|0|||
127971520|NCT05020665|460516760|FG001|Overall Study|Physician Decision|1|||
127971521|NCT05020665|460516759|FG000|Overall Study|Withdrawal by Subject|0|||
127971522|NCT05020665|460516760|FG001|Overall Study|Withdrawal by Subject|1|||
127971523|NCT05020665|460516759|FG000|Overall Study|Reason not specified|1|||
127971524|NCT05020665|460516760|FG001|Overall Study|Reason not specified|0|||
127971525|NCT00022698|460516764|FG000|Overall Study|Adverse Event|5|||
127971526|NCT00022698|460516765|FG001|Overall Study|Adverse Event|9|||
127971527|NCT00022698|460516764|FG000|Overall Study|Death|0|||
127971528|NCT00022698|460516765|FG001|Overall Study|Death|2|||
127971529|NCT00022698|460516764|FG000|Overall Study|Failure to return|0|||
127971530|NCT00022698|460516765|FG001|Overall Study|Failure to return|1|||
127971531|NCT00022698|460516764|FG000|Overall Study|Refused treatment|0|||
127971532|NCT00022698|460516765|FG001|Overall Study|Refused treatment|2|||
127971533|NCT00022698|460516764|FG000|Overall Study|Insufficient therapeutic response|2|||
127971534|NCT00022698|460516765|FG001|Overall Study|Insufficient therapeutic response|14|||
127971535|NCT00022698|460516764|FG000|Overall Study|Administrative /other|1|||
127971536|NCT00022698|460516765|FG001|Overall Study|Administrative /other|7|||
127971537|NCT02504827|460516766|FG000|Overall Study|Could not produce sputum|1|||
127971538|NCT03386994|460516767|FG000|Overall Study|Lung transplant|1|||
127971539|NCT03386994|460516767|FG000|Overall Study|Adverse Event|14|||
127971540|NCT03386994|460516767|FG000|Overall Study|Lost to Follow-up|4|||
127971541|NCT03386994|460516767|FG000|Overall Study|Withdrawal by Subject|3|||
127971542|NCT03386994|460516767|FG000|Overall Study|Death|16|||
127971543|NCT01732640|460516774|FG000|Overall Study|Adverse Event|0|||
127971544|NCT01732640|460516775|FG001|Overall Study|Adverse Event|1|||
127971545|NCT01732640|460516774|FG000|Overall Study|Death|0|||
127971546|NCT01732640|460516775|FG001|Overall Study|Death|1|||
127971547|NCT00877487|460516778|FG000|Open-label Treatment Phase|Adverse Event|1|||
127971548|NCT00877487|460516779|FG001|Open-label Treatment Phase|Adverse Event|0|||
127971549|NCT00877487|460516778|FG000|Open-label Treatment Phase|Protocol Violation|3|||
127971550|NCT00877487|460516779|FG001|Open-label Treatment Phase|Protocol Violation|0|||
127971551|NCT00877487|460516778|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
127971552|NCT00877487|460516779|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
127971553|NCT00877487|460516778|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
127971554|NCT00877487|460516779|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
127971555|NCT00877487|460516778|FG000|Open-label Treatment Phase|Out of country for business|1|||
127971556|NCT00877487|460516779|FG001|Open-label Treatment Phase|Out of country for business|0|||
127971557|NCT00877487|460516778|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
127971558|NCT00877487|460516779|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
127971559|NCT00877487|460516778|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
127971560|NCT00877487|460516779|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
127971561|NCT00877487|460516778|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
127971562|NCT00877487|460516779|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
127971563|NCT00877487|460516778|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
127971564|NCT00877487|460516779|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
127971565|NCT03070002|460516780|FG000|Follow up for 2 Years|Death|1|||
127971566|NCT00712543|460516783|FG000|Day 8-14|Lost to Follow-up|0|||
127971567|NCT00712543|460516784|FG001|Day 8-14|Lost to Follow-up|2|||
127971568|NCT02702388|460516787|FG000|Overall Study|Disease Progression|18|||
127971569|NCT02702388|460516788|FG001|Overall Study|Disease Progression|25|||
127971570|NCT02702388|460516787|FG000|Overall Study|Withdrawal by Subject|9|||
127971571|NCT02702388|460516788|FG001|Overall Study|Withdrawal by Subject|7|||
127971572|NCT02702388|460516787|FG000|Overall Study|Adverse Event|11|||
127971573|NCT02702388|460516788|FG001|Overall Study|Adverse Event|15|||
127971574|NCT02702388|460516787|FG000|Overall Study|Other|2|||
127971575|NCT02702388|460516788|FG001|Overall Study|Other|4|||
127971576|NCT02729051|460516789|FG000|Overall Study|Adverse Event|21|||
127971577|NCT02729051|460516790|FG001|Overall Study|Adverse Event|11|||
127971578|NCT02729051|460516789|FG000|Overall Study|Lack of Efficacy|1|||
127971579|NCT02729051|460516790|FG001|Overall Study|Lack of Efficacy|1|||
127971580|NCT02729051|460516789|FG000|Overall Study|Lost to Follow-up|1|||
127971581|NCT02729051|460516790|FG001|Overall Study|Lost to Follow-up|2|||
127971582|NCT02729051|460516789|FG000|Overall Study|Physician Decision|1|||
127971583|NCT02729051|460516790|FG001|Overall Study|Physician Decision|1|||
127971584|NCT02729051|460516789|FG000|Overall Study|Withdrawal by Subject|6|||
127971585|NCT02729051|460516790|FG001|Overall Study|Withdrawal by Subject|17|||
127971586|NCT04740827|460516802|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
127971587|NCT04740827|460516803|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
127971588|NCT04740827|460516802|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
127971589|NCT04740827|460516803|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
127971590|NCT04740827|460516802|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
127971591|NCT04740827|460516803|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
127971592|NCT04740827|460516802|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
127971593|NCT04740827|460516803|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
127971594|NCT04740827|460516802|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
127971595|NCT04740827|460516803|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
127971596|NCT04740827|460516802|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
127971597|NCT04740827|460516803|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
127971598|NCT02147158|460516804|FG000|Treatment Course 1|Adverse Event|1|||
127971599|NCT02147158|460516805|FG001|Treatment Course 1|Adverse Event|4|||
127971600|NCT02147158|460516806|FG002|Treatment Course 1|Adverse Event|3|||
127971601|NCT02147158|460516807|FG003|Treatment Course 1|Adverse Event|4|||
127971602|NCT02147158|460516808|FG004|Treatment Course 1|Adverse Event|1|||
127971603|NCT02147158|460516809|FG005|Treatment Course 1|Adverse Event|2|||
127971604|NCT02147158|460516804|FG000|Treatment Course 1|Lost to Follow-up|2|||
127971605|NCT02147158|460516805|FG001|Treatment Course 1|Lost to Follow-up|4|||
127971606|NCT02147158|460516806|FG002|Treatment Course 1|Lost to Follow-up|3|||
127971607|NCT02147158|460516807|FG003|Treatment Course 1|Lost to Follow-up|3|||
127971608|NCT02147158|460516808|FG004|Treatment Course 1|Lost to Follow-up|2|||
127971609|NCT02147158|460516809|FG005|Treatment Course 1|Lost to Follow-up|4|||
127971610|NCT02147158|460516804|FG000|Treatment Course 1|Protocol Violation|0|||
127971611|NCT02147158|460516805|FG001|Treatment Course 1|Protocol Violation|0|||
127971612|NCT02147158|460516806|FG002|Treatment Course 1|Protocol Violation|1|||
127971613|NCT02147158|460516807|FG003|Treatment Course 1|Protocol Violation|1|||
127971614|NCT02147158|460516808|FG004|Treatment Course 1|Protocol Violation|0|||
127971615|NCT02147158|460516809|FG005|Treatment Course 1|Protocol Violation|0|||
127971616|NCT02147158|460516804|FG000|Treatment Course 1|Withdrawal of Consent|1|||
127971617|NCT02147158|460516805|FG001|Treatment Course 1|Withdrawal of Consent|1|||
127971618|NCT02147158|460516806|FG002|Treatment Course 1|Withdrawal of Consent|1|||
127971619|NCT02147158|460516807|FG003|Treatment Course 1|Withdrawal of Consent|5|||
127971620|NCT02147158|460516808|FG004|Treatment Course 1|Withdrawal of Consent|3|||
127971621|NCT02147158|460516809|FG005|Treatment Course 1|Withdrawal of Consent|2|||
127971622|NCT02147158|460516804|FG000|Off-Treatment Interval 1|Adverse Event|1|||
127971623|NCT02147158|460516805|FG001|Off-Treatment Interval 1|Adverse Event|0|||
127971624|NCT02147158|460516806|FG002|Off-Treatment Interval 1|Adverse Event|0|||
127971625|NCT02147158|460516807|FG003|Off-Treatment Interval 1|Adverse Event|1|||
127971626|NCT02147158|460516808|FG004|Off-Treatment Interval 1|Adverse Event|0|||
127971627|NCT02147158|460516809|FG005|Off-Treatment Interval 1|Adverse Event|0|||
127971628|NCT02147158|460516804|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
127971629|NCT02147158|460516805|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
127971630|NCT02147158|460516806|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
127971631|NCT02147158|460516807|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
127971632|NCT02147158|460516808|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
127971633|NCT02147158|460516809|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
127971634|NCT02147158|460516804|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
127971635|NCT02147158|460516805|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
127971636|NCT02147158|460516806|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
127971637|NCT02147158|460516807|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
127971638|NCT02147158|460516808|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
127971639|NCT02147158|460516809|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
127971640|NCT02147158|460516804|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
127971641|NCT02147158|460516805|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
127971642|NCT02147158|460516806|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
127971643|NCT02147158|460516807|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
127971644|NCT02147158|460516808|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
127971645|NCT02147158|460516809|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
127971646|NCT02147158|460516804|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
127971647|NCT02147158|460516805|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
127971648|NCT02147158|460516806|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
127971649|NCT02147158|460516807|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
127971650|NCT02147158|460516808|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
127971651|NCT02147158|460516809|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
127971652|NCT02147158|460516804|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
127971653|NCT02147158|460516805|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
127971654|NCT02147158|460516806|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
127971655|NCT02147158|460516807|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
127971656|NCT02147158|460516808|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
127971657|NCT02147158|460516809|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
127971658|NCT02147158|460516804|FG000|Treatment Course 2|Adverse Event|0|||
127971659|NCT02147158|460516805|FG001|Treatment Course 2|Adverse Event|4|||
127971660|NCT02147158|460516806|FG002|Treatment Course 2|Adverse Event|2|||
127971661|NCT02147158|460516807|FG003|Treatment Course 2|Adverse Event|1|||
127971662|NCT02147158|460516808|FG004|Treatment Course 2|Adverse Event|0|||
127971663|NCT02147158|460516809|FG005|Treatment Course 2|Adverse Event|1|||
127971664|NCT02147158|460516804|FG000|Treatment Course 2|Withdrawal of Consent|0|||
127971665|NCT02147158|460516805|FG001|Treatment Course 2|Withdrawal of Consent|1|||
127971666|NCT02147158|460516806|FG002|Treatment Course 2|Withdrawal of Consent|2|||
127971667|NCT02147158|460516807|FG003|Treatment Course 2|Withdrawal of Consent|3|||
127971668|NCT02147158|460516808|FG004|Treatment Course 2|Withdrawal of Consent|0|||
127971669|NCT02147158|460516809|FG005|Treatment Course 2|Withdrawal of Consent|0|||
127971670|NCT02147158|460516804|FG000|Treatment Course 2|Lost to Follow-up|1|||
127971671|NCT02147158|460516805|FG001|Treatment Course 2|Lost to Follow-up|0|||
127971672|NCT02147158|460516806|FG002|Treatment Course 2|Lost to Follow-up|1|||
127971673|NCT02147158|460516807|FG003|Treatment Course 2|Lost to Follow-up|1|||
127971674|NCT02147158|460516808|FG004|Treatment Course 2|Lost to Follow-up|0|||
127971675|NCT02147158|460516809|FG005|Treatment Course 2|Lost to Follow-up|1|||
127971676|NCT02147158|460516804|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
127971677|NCT02147158|460516805|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
127971678|NCT02147158|460516806|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
127971679|NCT02147158|460516807|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
127971680|NCT02147158|460516808|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
127971681|NCT02147158|460516809|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
127971682|NCT02147158|460516804|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
127971683|NCT02147158|460516805|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
127971684|NCT02147158|460516806|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
127971685|NCT02147158|460516807|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
127971686|NCT02147158|460516808|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
127971687|NCT02147158|460516809|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
127971688|NCT02147158|460516804|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
127971689|NCT02147158|460516805|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
127971690|NCT02147158|460516806|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
127971691|NCT02147158|460516807|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
127971692|NCT02147158|460516808|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
127971693|NCT02147158|460516809|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
127971694|NCT02147158|460516804|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
127971695|NCT02147158|460516805|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
127971696|NCT02147158|460516806|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
127971697|NCT02147158|460516807|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
127971698|NCT02147158|460516808|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
127971699|NCT02147158|460516809|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
127971700|NCT02147158|460516804|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
127971701|NCT02147158|460516805|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
127971702|NCT02147158|460516806|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
127971703|NCT02147158|460516807|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
127971704|NCT02147158|460516808|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
127971705|NCT02147158|460516809|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
127971706|NCT03425396|460516810|FG000|Overall Study|Lost to Follow-up|2|||
127971707|NCT03425396|460516811|FG001|Overall Study|Lost to Follow-up|5|||
127971708|NCT03425396|460516812|FG002|Overall Study|Lost to Follow-up|2|||
127971709|NCT03425396|460516813|FG003|Overall Study|Lost to Follow-up|0|||
127971710|NCT03425396|460516814|FG004|Overall Study|Lost to Follow-up|0|||
127971711|NCT03425396|460516810|FG000|Overall Study|Withdrawal by Subject|0|||
127971712|NCT03425396|460516811|FG001|Overall Study|Withdrawal by Subject|1|||
127971713|NCT03425396|460516812|FG002|Overall Study|Withdrawal by Subject|0|||
127971714|NCT03425396|460516813|FG003|Overall Study|Withdrawal by Subject|1|||
127971715|NCT03425396|460516814|FG004|Overall Study|Withdrawal by Subject|0|||
127971716|NCT03425396|460516810|FG000|Overall Study|Other|0|||
127971717|NCT03425396|460516811|FG001|Overall Study|Other|1|||
127971718|NCT03425396|460516812|FG002|Overall Study|Other|1|||
127971719|NCT03425396|460516813|FG003|Overall Study|Other|0|||
127971720|NCT03425396|460516814|FG004|Overall Study|Other|1|||
127971721|NCT01441765|460516815|FG000|Overall Study|Death|1|||
127971722|NCT01441765|460516816|FG001|Overall Study|Death|0|||
127971723|NCT04520997|460516820|FG000|Overall Study|Lost to Follow-up|1|||
127971724|NCT04520997|460516821|FG001|Overall Study|Lost to Follow-up|1|||
127971725|NCT04520997|460516820|FG000|Overall Study|Withdrawal by Subject|1|||
127971726|NCT04520997|460516821|FG001|Overall Study|Withdrawal by Subject|0|||
127971727|NCT04520997|460516820|FG000|Overall Study|Not Treated|0|||
127971728|NCT04520997|460516821|FG001|Overall Study|Not Treated|1|||
127971729|NCT02981082|460516822|FG000|Overall Study|Withdrawal by Subject|2|||
127971730|NCT02981082|460516823|FG001|Overall Study|Withdrawal by Subject|0|||
127971731|NCT02981082|460516822|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
127971732|NCT02981082|460516823|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
127971733|NCT02981082|460516822|FG000|Overall Study|Adverse Event|0|||
127971734|NCT02981082|460516823|FG001|Overall Study|Adverse Event|1|||
127971735|NCT03689374|460516824|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
127971736|NCT03689374|460516825|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
127971737|NCT03689374|460516826|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
127971738|NCT03689374|460516824|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
127971739|NCT03689374|460516825|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
127971740|NCT03689374|460516826|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
127971741|NCT03689374|460516824|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
127971742|NCT03689374|460516825|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
127971743|NCT03689374|460516826|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
127971744|NCT03689374|460516824|FG000|Treatment Period (Week 0 to 52)|Death|0|||
127971745|NCT03689374|460516825|FG001|Treatment Period (Week 0 to 52)|Death|11|||
127971746|NCT03689374|460516826|FG002|Treatment Period (Week 0 to 52)|Death|1|||
127971747|NCT05367973|460516827|FG000|Overall Study|Adverse Event|0|||
127971748|NCT05367973|460516828|FG001|Overall Study|Adverse Event|2|||
127971749|NCT02805660|460516829|FG000|Overall Study|Death|5|||
127971750|NCT02805660|460516830|FG001|Overall Study|Death|2|||
127971751|NCT02805660|460516831|FG002|Overall Study|Death|9|||
127971752|NCT02805660|460516832|FG003|Overall Study|Death|5|||
127971753|NCT02805660|460516833|FG004|Overall Study|Death|0|||
127971754|NCT02805660|460516834|FG005|Overall Study|Death|14|||
127971755|NCT02805660|460516835|FG006|Overall Study|Death|12|||
127971756|NCT02805660|460516829|FG000|Overall Study|Lost to Follow-up|0|||
127971757|NCT02805660|460516830|FG001|Overall Study|Lost to Follow-up|1|||
127971758|NCT02805660|460516831|FG002|Overall Study|Lost to Follow-up|1|||
127971759|NCT02805660|460516832|FG003|Overall Study|Lost to Follow-up|2|||
127971760|NCT02805660|460516833|FG004|Overall Study|Lost to Follow-up|0|||
127971761|NCT02805660|460516834|FG005|Overall Study|Lost to Follow-up|0|||
127971762|NCT02805660|460516835|FG006|Overall Study|Lost to Follow-up|0|||
127971763|NCT02805660|460516829|FG000|Overall Study|Withdrawal by Subject|0|||
127971764|NCT02805660|460516830|FG001|Overall Study|Withdrawal by Subject|0|||
127971765|NCT02805660|460516831|FG002|Overall Study|Withdrawal by Subject|0|||
127971766|NCT02805660|460516832|FG003|Overall Study|Withdrawal by Subject|3|||
127971767|NCT02805660|460516833|FG004|Overall Study|Withdrawal by Subject|1|||
127971768|NCT02805660|460516834|FG005|Overall Study|Withdrawal by Subject|0|||
127971769|NCT02805660|460516835|FG006|Overall Study|Withdrawal by Subject|2|||
127971770|NCT02805660|460516829|FG000|Overall Study|Study terminated by Sponsor|0|||
127971771|NCT02805660|460516830|FG001|Overall Study|Study terminated by Sponsor|0|||
127971772|NCT02805660|460516831|FG002|Overall Study|Study terminated by Sponsor|1|||
127971773|NCT02805660|460516832|FG003|Overall Study|Study terminated by Sponsor|4|||
127971774|NCT02805660|460516833|FG004|Overall Study|Study terminated by Sponsor|2|||
127971775|NCT02805660|460516834|FG005|Overall Study|Study terminated by Sponsor|3|||
127971776|NCT02805660|460516835|FG006|Overall Study|Study terminated by Sponsor|1|||
127971777|NCT02805660|460516829|FG000|Overall Study|Miscellaneous|0|||
127971778|NCT02805660|460516830|FG001|Overall Study|Miscellaneous|1|||
127971779|NCT02805660|460516831|FG002|Overall Study|Miscellaneous|0|||
127971780|NCT02805660|460516832|FG003|Overall Study|Miscellaneous|4|||
127971781|NCT02805660|460516833|FG004|Overall Study|Miscellaneous|0|||
127971782|NCT02805660|460516834|FG005|Overall Study|Miscellaneous|6|||
127971783|NCT02805660|460516835|FG006|Overall Study|Miscellaneous|4|||
127971784|NCT01314872|460516839|FG000|Treatment Period 1|Protocol Violation|2|||
127971785|NCT01314872|460516840|FG001|Treatment Period 1|Protocol Violation|1|||
127971786|NCT01314872|460516841|FG002|Treatment Period 1|Protocol Violation|1|||
127971787|NCT01314872|460516842|FG003|Treatment Period 1|Protocol Violation|0|||
127971788|NCT01314872|460516843|FG004|Treatment Period 1|Protocol Violation|1|||
127971789|NCT01314872|460516844|FG005|Treatment Period 1|Protocol Violation|0|||
127971790|NCT01314872|460516845|FG006|Treatment Period 1|Protocol Violation|0|||
127971791|NCT01314872|460516846|FG007|Treatment Period 1|Protocol Violation|0|||
127971792|NCT01314872|460516847|FG008|Treatment Period 1|Protocol Violation|0|||
127971793|NCT01314872|460516848|FG009|Treatment Period 1|Protocol Violation|1|||
127971794|NCT01314872|460516849|FG010|Treatment Period 1|Protocol Violation|1|||
127971795|NCT01314872|460516850|FG011|Treatment Period 1|Protocol Violation|0|||
127971796|NCT01314872|460516851|FG012|Treatment Period 1|Protocol Violation|0|||
127971797|NCT01314872|460516852|FG013|Treatment Period 1|Protocol Violation|0|||
127971798|NCT01314872|460516853|FG014|Treatment Period 1|Protocol Violation|0|||
127971799|NCT01314872|460516839|FG000|Treatment Period 1|Physician Decision|0|||
127971800|NCT01314872|460516840|FG001|Treatment Period 1|Physician Decision|1|||
127971801|NCT01314872|460516841|FG002|Treatment Period 1|Physician Decision|0|||
127971802|NCT01314872|460516842|FG003|Treatment Period 1|Physician Decision|1|||
127971803|NCT01314872|460516843|FG004|Treatment Period 1|Physician Decision|0|||
127971804|NCT01314872|460516844|FG005|Treatment Period 1|Physician Decision|0|||
127971805|NCT01314872|460516845|FG006|Treatment Period 1|Physician Decision|0|||
127971806|NCT01314872|460516846|FG007|Treatment Period 1|Physician Decision|0|||
127971807|NCT01314872|460516847|FG008|Treatment Period 1|Physician Decision|0|||
127971808|NCT01314872|460516848|FG009|Treatment Period 1|Physician Decision|1|||
127971809|NCT01314872|460516849|FG010|Treatment Period 1|Physician Decision|0|||
127971810|NCT01314872|460516850|FG011|Treatment Period 1|Physician Decision|0|||
127971811|NCT01314872|460516851|FG012|Treatment Period 1|Physician Decision|0|||
127971812|NCT01314872|460516852|FG013|Treatment Period 1|Physician Decision|0|||
127971813|NCT01314872|460516853|FG014|Treatment Period 1|Physician Decision|0|||
127971814|NCT01314872|460516839|FG000|Treatment Period 1|Lack of Efficacy|1|||
127971815|NCT01314872|460516840|FG001|Treatment Period 1|Lack of Efficacy|0|||
127971816|NCT01314872|460516841|FG002|Treatment Period 1|Lack of Efficacy|0|||
127971817|NCT01314872|460516842|FG003|Treatment Period 1|Lack of Efficacy|0|||
127971818|NCT01314872|460516843|FG004|Treatment Period 1|Lack of Efficacy|0|||
127971819|NCT01314872|460516844|FG005|Treatment Period 1|Lack of Efficacy|1|||
127971820|NCT01314872|460516845|FG006|Treatment Period 1|Lack of Efficacy|0|||
127971821|NCT01314872|460516846|FG007|Treatment Period 1|Lack of Efficacy|2|||
127971822|NCT01314872|460516847|FG008|Treatment Period 1|Lack of Efficacy|0|||
127971823|NCT01314872|460516848|FG009|Treatment Period 1|Lack of Efficacy|0|||
127971824|NCT01314872|460516849|FG010|Treatment Period 1|Lack of Efficacy|0|||
127971825|NCT01314872|460516850|FG011|Treatment Period 1|Lack of Efficacy|0|||
127971826|NCT01314872|460516851|FG012|Treatment Period 1|Lack of Efficacy|0|||
127971827|NCT01314872|460516852|FG013|Treatment Period 1|Lack of Efficacy|0|||
127971828|NCT01314872|460516853|FG014|Treatment Period 1|Lack of Efficacy|0|||
127971829|NCT01314872|460516839|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
127971830|NCT01314872|460516840|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
127971831|NCT01314872|460516841|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
127971832|NCT01314872|460516842|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
127971833|NCT01314872|460516843|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
127971834|NCT01314872|460516844|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
127971835|NCT01314872|460516845|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
127971836|NCT01314872|460516846|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
127971837|NCT01314872|460516847|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
127971838|NCT01314872|460516848|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
127971839|NCT01314872|460516849|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
127971840|NCT01314872|460516850|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
127971841|NCT01314872|460516851|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
127971842|NCT01314872|460516852|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
127971843|NCT01314872|460516853|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
127971844|NCT01314872|460516839|FG000|Treatment Period 1|Withdrawal by Subject|3|||
127971845|NCT01314872|460516840|FG001|Treatment Period 1|Withdrawal by Subject|1|||
127971846|NCT01314872|460516841|FG002|Treatment Period 1|Withdrawal by Subject|0|||
127971847|NCT01314872|460516842|FG003|Treatment Period 1|Withdrawal by Subject|2|||
127971848|NCT01314872|460516843|FG004|Treatment Period 1|Withdrawal by Subject|3|||
127971849|NCT01314872|460516844|FG005|Treatment Period 1|Withdrawal by Subject|1|||
127971850|NCT01314872|460516845|FG006|Treatment Period 1|Withdrawal by Subject|3|||
127971851|NCT01314872|460516846|FG007|Treatment Period 1|Withdrawal by Subject|2|||
127971852|NCT01314872|460516847|FG008|Treatment Period 1|Withdrawal by Subject|2|||
127971853|NCT01314872|460516848|FG009|Treatment Period 1|Withdrawal by Subject|2|||
127971854|NCT01314872|460516849|FG010|Treatment Period 1|Withdrawal by Subject|1|||
127971855|NCT01314872|460516850|FG011|Treatment Period 1|Withdrawal by Subject|0|||
127971856|NCT01314872|460516851|FG012|Treatment Period 1|Withdrawal by Subject|0|||
127971857|NCT01314872|460516852|FG013|Treatment Period 1|Withdrawal by Subject|0|||
127971858|NCT01314872|460516853|FG014|Treatment Period 1|Withdrawal by Subject|0|||
127971859|NCT01314872|460516839|FG000|Treatment Period 1|Lost to Follow-up|0|||
127971860|NCT01314872|460516840|FG001|Treatment Period 1|Lost to Follow-up|1|||
127971861|NCT01314872|460516841|FG002|Treatment Period 1|Lost to Follow-up|2|||
127971862|NCT01314872|460516842|FG003|Treatment Period 1|Lost to Follow-up|2|||
127971863|NCT01314872|460516843|FG004|Treatment Period 1|Lost to Follow-up|1|||
127971864|NCT01314872|460516844|FG005|Treatment Period 1|Lost to Follow-up|1|||
127971865|NCT01314872|460516845|FG006|Treatment Period 1|Lost to Follow-up|1|||
127971866|NCT01314872|460516846|FG007|Treatment Period 1|Lost to Follow-up|1|||
127971867|NCT01314872|460516847|FG008|Treatment Period 1|Lost to Follow-up|1|||
127971868|NCT01314872|460516848|FG009|Treatment Period 1|Lost to Follow-up|0|||
127971869|NCT01314872|460516849|FG010|Treatment Period 1|Lost to Follow-up|0|||
127971870|NCT01314872|460516850|FG011|Treatment Period 1|Lost to Follow-up|0|||
127971871|NCT01314872|460516851|FG012|Treatment Period 1|Lost to Follow-up|0|||
127971872|NCT01314872|460516852|FG013|Treatment Period 1|Lost to Follow-up|0|||
127971873|NCT01314872|460516853|FG014|Treatment Period 1|Lost to Follow-up|0|||
127971874|NCT01314872|460516839|FG000|Period 2|Protocol Violation|0|||
127971875|NCT01314872|460516840|FG001|Period 2|Protocol Violation|0|||
127971876|NCT01314872|460516841|FG002|Period 2|Protocol Violation|0|||
127971877|NCT01314872|460516842|FG003|Period 2|Protocol Violation|0|||
127971878|NCT01314872|460516843|FG004|Period 2|Protocol Violation|0|||
127971879|NCT01314872|460516844|FG005|Period 2|Protocol Violation|0|||
127971880|NCT01314872|460516845|FG006|Period 2|Protocol Violation|0|||
127971881|NCT01314872|460516846|FG007|Period 2|Protocol Violation|0|||
127971882|NCT01314872|460516847|FG008|Period 2|Protocol Violation|0|||
127971883|NCT01314872|460516848|FG009|Period 2|Protocol Violation|0|||
127971884|NCT01314872|460516849|FG010|Period 2|Protocol Violation|0|||
127971885|NCT01314872|460516850|FG011|Period 2|Protocol Violation|3|||
127971886|NCT01314872|460516851|FG012|Period 2|Protocol Violation|3|||
127971887|NCT01314872|460516852|FG013|Period 2|Protocol Violation|2|||
127971888|NCT01314872|460516853|FG014|Period 2|Protocol Violation|0|||
127971889|NCT01314872|460516839|FG000|Period 2|Non-compliance with study drug|0|||
127971890|NCT01314872|460516840|FG001|Period 2|Non-compliance with study drug|0|||
127971891|NCT01314872|460516841|FG002|Period 2|Non-compliance with study drug|0|||
127971892|NCT01314872|460516842|FG003|Period 2|Non-compliance with study drug|0|||
127971893|NCT01314872|460516843|FG004|Period 2|Non-compliance with study drug|0|||
127971894|NCT01314872|460516844|FG005|Period 2|Non-compliance with study drug|0|||
127971895|NCT01314872|460516845|FG006|Period 2|Non-compliance with study drug|0|||
127971896|NCT01314872|460516846|FG007|Period 2|Non-compliance with study drug|0|||
127971897|NCT01314872|460516847|FG008|Period 2|Non-compliance with study drug|0|||
127971898|NCT01314872|460516848|FG009|Period 2|Non-compliance with study drug|0|||
127971899|NCT01314872|460516849|FG010|Period 2|Non-compliance with study drug|0|||
127971900|NCT01314872|460516850|FG011|Period 2|Non-compliance with study drug|3|||
127971901|NCT01314872|460516851|FG012|Period 2|Non-compliance with study drug|3|||
127971902|NCT01314872|460516852|FG013|Period 2|Non-compliance with study drug|1|||
127971903|NCT01314872|460516853|FG014|Period 2|Non-compliance with study drug|2|||
127971904|NCT01314872|460516839|FG000|Period 2|Lack of Efficacy|0|||
127971905|NCT01314872|460516840|FG001|Period 2|Lack of Efficacy|0|||
127971906|NCT01314872|460516841|FG002|Period 2|Lack of Efficacy|0|||
127971907|NCT01314872|460516842|FG003|Period 2|Lack of Efficacy|0|||
127971908|NCT01314872|460516843|FG004|Period 2|Lack of Efficacy|0|||
127971909|NCT01314872|460516844|FG005|Period 2|Lack of Efficacy|0|||
127971910|NCT01314872|460516845|FG006|Period 2|Lack of Efficacy|0|||
127971911|NCT01314872|460516846|FG007|Period 2|Lack of Efficacy|0|||
127971912|NCT01314872|460516847|FG008|Period 2|Lack of Efficacy|0|||
127971913|NCT01314872|460516848|FG009|Period 2|Lack of Efficacy|0|||
127971914|NCT01314872|460516849|FG010|Period 2|Lack of Efficacy|0|||
127971915|NCT01314872|460516850|FG011|Period 2|Lack of Efficacy|7|||
127971916|NCT01314872|460516851|FG012|Period 2|Lack of Efficacy|12|||
127971917|NCT01314872|460516852|FG013|Period 2|Lack of Efficacy|9|||
127971918|NCT01314872|460516853|FG014|Period 2|Lack of Efficacy|2|||
127971919|NCT01314872|460516839|FG000|Period 2|Pregnancy|0|||
127971920|NCT01314872|460516840|FG001|Period 2|Pregnancy|0|||
127971921|NCT01314872|460516841|FG002|Period 2|Pregnancy|0|||
127971922|NCT01314872|460516842|FG003|Period 2|Pregnancy|0|||
127971923|NCT01314872|460516843|FG004|Period 2|Pregnancy|0|||
127971924|NCT01314872|460516844|FG005|Period 2|Pregnancy|0|||
127971925|NCT01314872|460516845|FG006|Period 2|Pregnancy|0|||
127971926|NCT01314872|460516846|FG007|Period 2|Pregnancy|0|||
127971927|NCT01314872|460516847|FG008|Period 2|Pregnancy|0|||
127971928|NCT01314872|460516848|FG009|Period 2|Pregnancy|0|||
127971929|NCT01314872|460516849|FG010|Period 2|Pregnancy|0|||
127971930|NCT01314872|460516850|FG011|Period 2|Pregnancy|0|||
127971931|NCT01314872|460516851|FG012|Period 2|Pregnancy|0|||
127971932|NCT01314872|460516852|FG013|Period 2|Pregnancy|0|||
127971933|NCT01314872|460516853|FG014|Period 2|Pregnancy|1|||
127971934|NCT01314872|460516839|FG000|Period 2|Study terminated by Sponsor|0|||
127971935|NCT01314872|460516840|FG001|Period 2|Study terminated by Sponsor|0|||
127971936|NCT01314872|460516841|FG002|Period 2|Study terminated by Sponsor|0|||
127971937|NCT01314872|460516842|FG003|Period 2|Study terminated by Sponsor|0|||
127971938|NCT01314872|460516843|FG004|Period 2|Study terminated by Sponsor|0|||
127971939|NCT01314872|460516844|FG005|Period 2|Study terminated by Sponsor|0|||
127971940|NCT01314872|460516845|FG006|Period 2|Study terminated by Sponsor|0|||
127971941|NCT01314872|460516846|FG007|Period 2|Study terminated by Sponsor|0|||
127971942|NCT01314872|460516847|FG008|Period 2|Study terminated by Sponsor|0|||
127971943|NCT01314872|460516848|FG009|Period 2|Study terminated by Sponsor|0|||
127971944|NCT01314872|460516849|FG010|Period 2|Study terminated by Sponsor|0|||
127971945|NCT01314872|460516850|FG011|Period 2|Study terminated by Sponsor|2|||
127971946|NCT01314872|460516851|FG012|Period 2|Study terminated by Sponsor|2|||
127971947|NCT01314872|460516852|FG013|Period 2|Study terminated by Sponsor|3|||
127971948|NCT01314872|460516853|FG014|Period 2|Study terminated by Sponsor|0|||
127971949|NCT01314872|460516839|FG000|Period 2|Adverse event, non-fatal|0|||
127971950|NCT01314872|460516840|FG001|Period 2|Adverse event, non-fatal|0|||
127971951|NCT01314872|460516841|FG002|Period 2|Adverse event, non-fatal|0|||
127971952|NCT01314872|460516842|FG003|Period 2|Adverse event, non-fatal|0|||
127971953|NCT01314872|460516843|FG004|Period 2|Adverse event, non-fatal|0|||
127971954|NCT01314872|460516844|FG005|Period 2|Adverse event, non-fatal|0|||
127971955|NCT01314872|460516845|FG006|Period 2|Adverse event, non-fatal|0|||
127971956|NCT01314872|460516846|FG007|Period 2|Adverse event, non-fatal|0|||
127971957|NCT01314872|460516847|FG008|Period 2|Adverse event, non-fatal|0|||
127971958|NCT01314872|460516848|FG009|Period 2|Adverse event, non-fatal|0|||
127971959|NCT01314872|460516849|FG010|Period 2|Adverse event, non-fatal|0|||
127971960|NCT01314872|460516850|FG011|Period 2|Adverse event, non-fatal|13|||
127971961|NCT01314872|460516851|FG012|Period 2|Adverse event, non-fatal|16|||
127971962|NCT01314872|460516852|FG013|Period 2|Adverse event, non-fatal|24|||
127971963|NCT01314872|460516853|FG014|Period 2|Adverse event, non-fatal|9|||
127971964|NCT01314872|460516839|FG000|Period 2|Withdrawal by Subject|0|||
127971965|NCT01314872|460516840|FG001|Period 2|Withdrawal by Subject|0|||
127971966|NCT01314872|460516841|FG002|Period 2|Withdrawal by Subject|0|||
127971967|NCT01314872|460516842|FG003|Period 2|Withdrawal by Subject|0|||
127971968|NCT01314872|460516843|FG004|Period 2|Withdrawal by Subject|0|||
127971969|NCT01314872|460516844|FG005|Period 2|Withdrawal by Subject|0|||
127971970|NCT01314872|460516845|FG006|Period 2|Withdrawal by Subject|0|||
127971971|NCT01314872|460516846|FG007|Period 2|Withdrawal by Subject|0|||
127971972|NCT01314872|460516847|FG008|Period 2|Withdrawal by Subject|0|||
127971973|NCT01314872|460516848|FG009|Period 2|Withdrawal by Subject|0|||
127971974|NCT01314872|460516849|FG010|Period 2|Withdrawal by Subject|0|||
127971975|NCT01314872|460516850|FG011|Period 2|Withdrawal by Subject|14|||
127971976|NCT01314872|460516851|FG012|Period 2|Withdrawal by Subject|17|||
127971977|NCT01314872|460516852|FG013|Period 2|Withdrawal by Subject|12|||
127971978|NCT01314872|460516853|FG014|Period 2|Withdrawal by Subject|4|||
127971979|NCT01314872|460516839|FG000|Period 2|Lost to Follow-up|0|||
127971980|NCT01314872|460516840|FG001|Period 2|Lost to Follow-up|0|||
127971981|NCT01314872|460516841|FG002|Period 2|Lost to Follow-up|0|||
127971982|NCT01314872|460516842|FG003|Period 2|Lost to Follow-up|0|||
127971983|NCT01314872|460516843|FG004|Period 2|Lost to Follow-up|0|||
127971984|NCT01314872|460516844|FG005|Period 2|Lost to Follow-up|0|||
127971985|NCT01314872|460516845|FG006|Period 2|Lost to Follow-up|0|||
127971986|NCT01314872|460516846|FG007|Period 2|Lost to Follow-up|0|||
127971987|NCT01314872|460516847|FG008|Period 2|Lost to Follow-up|0|||
127971988|NCT01314872|460516848|FG009|Period 2|Lost to Follow-up|0|||
127971989|NCT01314872|460516849|FG010|Period 2|Lost to Follow-up|0|||
127971990|NCT01314872|460516850|FG011|Period 2|Lost to Follow-up|6|||
127971991|NCT01314872|460516851|FG012|Period 2|Lost to Follow-up|7|||
127971992|NCT01314872|460516852|FG013|Period 2|Lost to Follow-up|2|||
127971993|NCT01314872|460516853|FG014|Period 2|Lost to Follow-up|6|||
127971994|NCT01435018|460518268|FG000|Overall Study|Death|37|||
127971995|NCT01435018|460518269|FG001|Overall Study|Death|18|||
127971996|NCT01435018|460518270|FG002|Overall Study|Death|25|||
127971997|NCT01435018|460518268|FG000|Overall Study|Site is closing|4|||
127971998|NCT01435018|460518269|FG001|Overall Study|Site is closing|9|||
127971999|NCT01435018|460518270|FG002|Overall Study|Site is closing|7|||
127972000|NCT01435018|460518268|FG000|Overall Study|Withdrew consent|0|||
127972001|NCT01435018|460518269|FG001|Overall Study|Withdrew consent|3|||
127972002|NCT01435018|460518270|FG002|Overall Study|Withdrew consent|1|||
127972003|NCT01435018|460518268|FG000|Overall Study|Not willing to adhere to requirements|0|||
127972004|NCT01435018|460518269|FG001|Overall Study|Not willing to adhere to requirements|2|||
127972005|NCT01435018|460518270|FG002|Overall Study|Not willing to adhere to requirements|3|||
127972006|NCT01435018|460518268|FG000|Overall Study|Not able to get to clinic|2|||
127972007|NCT01435018|460518269|FG001|Overall Study|Not able to get to clinic|0|||
127972008|NCT01435018|460518270|FG002|Overall Study|Not able to get to clinic|2|||
127972009|NCT01435018|460518268|FG000|Overall Study|Severe debilitation, unable to continue|0|||
127972010|NCT01435018|460518269|FG001|Overall Study|Severe debilitation, unable to continue|0|||
127972011|NCT01435018|460518270|FG002|Overall Study|Severe debilitation, unable to continue|1|||
127972012|NCT01435018|460518268|FG000|Overall Study|Unable to contact participant/parent|1|||
127972013|NCT01435018|460518269|FG001|Overall Study|Unable to contact participant/parent|1|||
127972014|NCT01435018|460518270|FG002|Overall Study|Unable to contact participant/parent|1|||
127972015|NCT01435018|460518268|FG000|Overall Study|Enrollment Violation|0|||
127972016|NCT01435018|460518269|FG001|Overall Study|Enrollment Violation|1|||
127972017|NCT01435018|460518270|FG002|Overall Study|Enrollment Violation|0|||
127972018|NCT01435018|460518268|FG000|Overall Study|Never started chemotherapy|3|||
127972019|NCT01435018|460518269|FG001|Overall Study|Never started chemotherapy|0|||
127972020|NCT01435018|460518270|FG002|Overall Study|Never started chemotherapy|1|||
127972021|NCT00769067|460518271|FG000|Overall Study|Death|89|||
127972022|NCT00769067|460518272|FG001|Overall Study|Death|86|||
127972023|NCT00769067|460518271|FG000|Overall Study|Lost to Follow-up|3|||
127972024|NCT00769067|460518272|FG001|Overall Study|Lost to Follow-up|1|||
127972025|NCT00769067|460518271|FG000|Overall Study|Study terminated by sponsor|1|||
127972026|NCT00769067|460518272|FG001|Overall Study|Study terminated by sponsor|3|||
127972027|NCT00769067|460518271|FG000|Overall Study|Other|1|||
127972028|NCT00769067|460518272|FG001|Overall Study|Other|3|||
127972029|NCT00769067|460518271|FG000|Overall Study|Withdrawal by Subject|0|||
127972030|NCT00769067|460518272|FG001|Overall Study|Withdrawal by Subject|1|||
127972031|NCT03806933|460518273|FG000|Main Period|Physician Decision|0|||
127972032|NCT03806933|460518274|FG001|Main Period|Physician Decision|0|||
127972033|NCT03806933|460518275|FG002|Main Period|Physician Decision|0|||
127972034|NCT03806933|460518276|FG003|Main Period|Physician Decision|1|||
127972035|NCT03806933|460518273|FG000|Main Period|Pregnancy|0|||
127972036|NCT03806933|460518274|FG001|Main Period|Pregnancy|0|||
127972037|NCT03806933|460518275|FG002|Main Period|Pregnancy|1|||
127972038|NCT03806933|460518276|FG003|Main Period|Pregnancy|0|||
127972039|NCT03806933|460518273|FG000|Main Period|Withdrawal by Subject|2|||
127972040|NCT03806933|460518274|FG001|Main Period|Withdrawal by Subject|1|||
127972041|NCT03806933|460518275|FG002|Main Period|Withdrawal by Subject|1|||
127972042|NCT03806933|460518276|FG003|Main Period|Withdrawal by Subject|2|||
127972043|NCT03806933|460518273|FG000|Main Period|Lost to Follow-up|2|||
127972044|NCT03806933|460518274|FG001|Main Period|Lost to Follow-up|2|||
127972045|NCT03806933|460518275|FG002|Main Period|Lost to Follow-up|0|||
127972046|NCT03806933|460518276|FG003|Main Period|Lost to Follow-up|0|||
127972047|NCT03806933|460518273|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
127972048|NCT03806933|460518274|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
127972049|NCT03806933|460518275|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
127972050|NCT03806933|460518276|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
127972051|NCT03625466|460518277|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
127972052|NCT03625466|460518278|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
127972053|NCT03625466|460518279|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
127972054|NCT03625466|460518277|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
127972055|NCT03625466|460518278|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
127972056|NCT03625466|460518279|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
127972057|NCT03625466|460518277|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
127972058|NCT03625466|460518278|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
127972059|NCT03625466|460518279|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
127972060|NCT00809471|460518282|FG000|Overall Study|Protocol non-compliance|15|||
127972061|NCT00809471|460518283|FG001|Overall Study|Protocol non-compliance|15|||
127972062|NCT00809471|460518284|FG002|Overall Study|Protocol non-compliance|6|||
127972063|NCT00809471|460518282|FG000|Overall Study|Lost to Follow-up|4|||
127972064|NCT00809471|460518283|FG001|Overall Study|Lost to Follow-up|2|||
127972065|NCT00809471|460518284|FG002|Overall Study|Lost to Follow-up|9|||
127972066|NCT00809471|460518282|FG000|Overall Study|Adverse Event|0|||
127972067|NCT00809471|460518283|FG001|Overall Study|Adverse Event|2|||
127972068|NCT00809471|460518284|FG002|Overall Study|Adverse Event|2|||
127972069|NCT00809471|460518282|FG000|Overall Study|Requirement for restricted medication|1|||
127972070|NCT00809471|460518283|FG001|Overall Study|Requirement for restricted medication|1|||
127972071|NCT00809471|460518284|FG002|Overall Study|Requirement for restricted medication|0|||
127972072|NCT00831311|460518285|FG000|Overall Study|Definitive Contraindication|3|||
127972073|NCT00831311|460518286|FG001|Overall Study|Definitive Contraindication|3|||
127972074|NCT00831311|460518285|FG000|Overall Study|Lost to Follow-up|3|||
127972075|NCT00831311|460518286|FG001|Overall Study|Lost to Follow-up|0|||
127972076|NCT00831311|460518285|FG000|Overall Study|Physician Decision|0|||
127972077|NCT00831311|460518286|FG001|Overall Study|Physician Decision|1|||
127972078|NCT00831311|460518285|FG000|Overall Study|Withdrawal by Subject|6|||
127972079|NCT00831311|460518286|FG001|Overall Study|Withdrawal by Subject|4|||
127972080|NCT01868438|460518287|FG000|First Intervention|Withdrawal by Subject|5|||
127972081|NCT01868438|460518288|FG001|First Intervention|Withdrawal by Subject|1|||
127972082|NCT01868438|460518287|FG000|First Intervention|Lost to Follow-up|2|||
127972083|NCT01868438|460518288|FG001|First Intervention|Lost to Follow-up|3|||
127972084|NCT01868438|460518287|FG000|First Intervention|Meeting the non-redosing criteria|0|||
127972085|NCT01868438|460518288|FG001|First Intervention|Meeting the non-redosing criteria|1|||
127972086|NCT01868438|460518287|FG000|Second Intervention|Adverse Event|3|||
127972087|NCT01868438|460518288|FG001|Second Intervention|Adverse Event|3|||
127972088|NCT03260244|460518289|FG000|Overall Study|Death|19|||
127972089|NCT03260244|460518289|FG000|Overall Study|Lost to Follow-up|60|||
127972090|NCT03260244|460518289|FG000|Overall Study|Withdrawal by Subject|48|||
127972091|NCT03260244|460518289|FG000|Overall Study|Procedure Not Performed|21|||
127972092|NCT03260244|460518289|FG000|Overall Study|Enrollment Criteria Not Met|31|||
127972093|NCT03260244|460518289|FG000|Overall Study|Procedure Not Performed Per Protocol|12|||
127972094|NCT03260244|460518289|FG000|Overall Study|Subject Noncompliance|6|||
127972095|NCT03260244|460518289|FG000|Overall Study|No inducible Arrhythmia|2|||
127972096|NCT03260244|460518289|FG000|Overall Study|Procedure Not Performed by Trained Physician on Study|2|||
127972097|NCT03260244|460518289|FG000|Overall Study|Screen Failure|2|||
127972098|NCT03260244|460518289|FG000|Overall Study|Treated Off Label|69|||
127972099|NCT03260244|460518289|FG000|Overall Study|No Radiofrequency Ablation|14|||
127972100|NCT03528369|460518292|FG000|Overall Study|Withdrawal by Subject|2|||
127972101|NCT03528369|460518293|FG001|Overall Study|Withdrawal by Subject|0|||
127972102|NCT03528369|460518294|FG002|Overall Study|Withdrawal by Subject|0|||
127972103|NCT03528369|460518292|FG000|Overall Study|Lost to Follow-up|1|||
127972104|NCT03528369|460518293|FG001|Overall Study|Lost to Follow-up|0|||
127972105|NCT03528369|460518294|FG002|Overall Study|Lost to Follow-up|0|||
127972106|NCT03528369|460518292|FG000|Overall Study|Adverse Event|0|||
127972107|NCT03528369|460518293|FG001|Overall Study|Adverse Event|1|||
127972108|NCT03528369|460518294|FG002|Overall Study|Adverse Event|0|||
127972109|NCT03555565|460518295|FG000|Overall Study|Case Report Forms Uncollected|2|||
127972110|NCT03555565|460518295|FG000|Overall Study|Protocol Deviation|13|||
127972111|NCT00394836|460518296|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
127972112|NCT00394836|460518297|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
127972113|NCT00394836|460518296|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
127972114|NCT00394836|460518297|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
127972115|NCT00394836|460518296|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
127972116|NCT00394836|460518297|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
127972117|NCT00394836|460518296|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
127972118|NCT00394836|460518297|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
127972119|NCT00394836|460518296|FG000|Teatment or Follow-up Phase|Death|0|||
127972120|NCT00394836|460518297|FG001|Teatment or Follow-up Phase|Death|1|||
127972121|NCT00394836|460518296|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
127972122|NCT00394836|460518297|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
127972123|NCT00394836|460518296|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
127972124|NCT00394836|460518297|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
127972125|NCT00394836|460518296|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
127972126|NCT00394836|460518297|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
127972127|NCT00394836|460518296|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
127972128|NCT00394836|460518297|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
127972129|NCT00394836|460518296|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
127972130|NCT00394836|460518297|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
127972131|NCT00394836|460518296|FG000|Teatment or Follow-up Phase|Non compliance|0|||
127972132|NCT00394836|460518297|FG001|Teatment or Follow-up Phase|Non compliance|1|||
127972133|NCT00394836|460518296|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
127972134|NCT00394836|460518297|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
127972135|NCT00394836|460518296|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
127972136|NCT00394836|460518297|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
127972137|NCT00394836|460518296|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
127972138|NCT00394836|460518297|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
127972139|NCT00394836|460518296|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
127972140|NCT00394836|460518297|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
127972141|NCT01289639|460518312|FG000|Overall Study|Lost to Follow-up|1|||
127972142|NCT01289639|460518313|FG001|Overall Study|Lost to Follow-up|0|||
127972143|NCT01289639|460518314|FG002|Overall Study|Lost to Follow-up|0|||
127972144|NCT02780713|460518315|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
127972145|NCT02780713|460518316|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
127972146|NCT02780713|460518317|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
127972147|NCT02780713|460518318|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
127972148|NCT02780713|460518319|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
127972149|NCT05338502|460518322|FG000|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
127972150|NCT05338502|460518323|FG001|Period 2 - Day 8 to Day 19|Withdrawal by Subject|2|||
127972151|NCT05338502|460518324|FG002|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
127972152|NCT05338502|460518322|FG000|Period 2 - Day 8 to Day 19|Adverse Event|0|||
127972153|NCT05338502|460518323|FG001|Period 2 - Day 8 to Day 19|Adverse Event|1|||
127972154|NCT05338502|460518324|FG002|Period 2 - Day 8 to Day 19|Adverse Event|0|||
127972155|NCT03575793|460518325|FG000|Overall Study|Withdrawal by Subject|0|||
127972156|NCT03575793|460518326|FG001|Overall Study|Withdrawal by Subject|1|||
127972157|NCT03575793|460518325|FG000|Overall Study|Never Treated|0|||
127972158|NCT03575793|460518326|FG001|Overall Study|Never Treated|2|||
127972159|NCT01250873|460518327|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
127972160|NCT01250873|460518327|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
127972161|NCT02278939|460518328|FG000|Overall Study|lack of time|1|||
127972162|NCT02278939|460518329|FG001|Overall Study|lack of time|0|||
127972163|NCT02278939|460518328|FG000|Overall Study|Lost to Follow-up|1|||
127972164|NCT02278939|460518329|FG001|Overall Study|Lost to Follow-up|1|||
127972165|NCT02278939|460518328|FG000|Overall Study|death in family|1|||
127972166|NCT02278939|460518329|FG001|Overall Study|death in family|0|||
127972167|NCT02278939|460518328|FG000|Overall Study|family emergency unable to commit|2|||
127972168|NCT02278939|460518329|FG001|Overall Study|family emergency unable to commit|0|||
127972169|NCT02111577|460518332|FG000|Overall Study|Protocol Violation|2|||
127972170|NCT02111577|460518333|FG001|Overall Study|Protocol Violation|0|||
127972171|NCT02111577|460518332|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
127972172|NCT02111577|460518333|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
127972173|NCT02111577|460518332|FG000|Overall Study|Failure to produce study treatment|6|||
127972174|NCT02111577|460518333|FG001|Overall Study|Failure to produce study treatment|0|||
127972175|NCT02111577|460518332|FG000|Overall Study|Death|518|||
127972176|NCT02111577|460518333|FG001|Overall Study|Death|254|||
127972177|NCT02111577|460518332|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
127972178|NCT02111577|460518333|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
127972179|NCT02111577|460518332|FG000|Overall Study|Adverse Event|1|||
127972180|NCT02111577|460518333|FG001|Overall Study|Adverse Event|1|||
127972181|NCT02111577|460518332|FG000|Overall Study|Withdrawal by Subject|51|||
127972182|NCT02111577|460518333|FG001|Overall Study|Withdrawal by Subject|23|||
127972183|NCT02111577|460518332|FG000|Overall Study|Disease progression|0|||
127972184|NCT02111577|460518333|FG001|Overall Study|Disease progression|1|||
127972185|NCT02111577|460518332|FG000|Overall Study|Lost to Follow-up|19|||
127972186|NCT02111577|460518333|FG001|Overall Study|Lost to Follow-up|10|||
127972187|NCT02042950|460518336|FG000|Overall Study|Progressive Disease|4|||
127972188|NCT01940887|460518339|FG000|Year 1|Protocol Violation|0|||
127972189|NCT01940887|460518340|FG001|Year 1|Protocol Violation|1|||
127972190|NCT01940887|460518339|FG000|Year 1|Physician Decision|7|||
127972191|NCT01940887|460518340|FG001|Year 1|Physician Decision|3|||
127972192|NCT01940887|460518339|FG000|Year 1|Death|5|||
127972193|NCT01940887|460518340|FG001|Year 1|Death|3|||
127972194|NCT01940887|460518339|FG000|Year 1|Adverse Event|7|||
127972195|NCT01940887|460518340|FG001|Year 1|Adverse Event|6|||
127972196|NCT01940887|460518339|FG000|Year 1|Withdrawal by Subject|18|||
127972197|NCT01940887|460518340|FG001|Year 1|Withdrawal by Subject|9|||
127972198|NCT01940887|460518339|FG000|Year 1|Lost to Follow-up|2|||
127972199|NCT01940887|460518340|FG001|Year 1|Lost to Follow-up|1|||
127972200|NCT01940887|460518339|FG000|Year 2|Physician Decision|8|||
127972201|NCT01940887|460518340|FG001|Year 2|Physician Decision|1|||
127972202|NCT01940887|460518339|FG000|Year 2|Death|0|||
127972203|NCT01940887|460518340|FG001|Year 2|Death|2|||
127972204|NCT01940887|460518339|FG000|Year 2|Sponsor Decision, early termination|192|||
127972205|NCT01940887|460518340|FG001|Year 2|Sponsor Decision, early termination|203|||
127972206|NCT01940887|460518339|FG000|Year 2|Adverse Event|8|||
127972207|NCT01940887|460518340|FG001|Year 2|Adverse Event|2|||
127972208|NCT01940887|460518339|FG000|Year 2|Withdrawal by Subject|8|||
127972209|NCT01940887|460518340|FG001|Year 2|Withdrawal by Subject|8|||
127972210|NCT01940887|460518339|FG000|Year 2|Lost to Follow-up|1|||
127972211|NCT01940887|460518340|FG001|Year 2|Lost to Follow-up|6|||
127972212|NCT02429778|460518342|FG000|Overall Study|Lost to Follow-up|2|||
127972213|NCT02429778|460518343|FG001|Overall Study|Lost to Follow-up|0|||
127972214|NCT02429778|460518342|FG000|Overall Study|Withdrawal by Subject|5|||
127972215|NCT02429778|460518343|FG001|Overall Study|Withdrawal by Subject|0|||
127972216|NCT03521115|460518345|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
127972217|NCT03521115|460518346|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
127972218|NCT03521115|460518345|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
127972219|NCT03521115|460518346|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
127972220|NCT02475265|460518347|FG000|Overall Study|Physician Decision|1|||
127972221|NCT02475265|460518347|FG000|Overall Study|Withdrawal by Subject|2|||
127972222|NCT01981954|460518354|FG000|Titration Period|Protocol Deviation|1|||
127972223|NCT01981954|460518354|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
127972224|NCT03655470|460518355|FG000|Overall Study|Lost to Follow-up|6|||
127972225|NCT03655470|460518356|FG001|Overall Study|Lost to Follow-up|7|||
127972226|NCT03063086|460518359|FG000|Overall Study|technical problems|1|||
127972227|NCT03063086|460518360|FG001|Overall Study|technical problems|0|||
127972228|NCT03063086|460518361|FG002|Overall Study|technical problems|0|||
127972229|NCT03063086|460518362|FG003|Overall Study|technical problems|0|||
127972230|NCT03063086|460518363|FG004|Overall Study|technical problems|0|||
127972231|NCT03063086|460518364|FG005|Overall Study|technical problems|0|||
127972232|NCT03063086|460518359|FG000|Overall Study|Adverse Event|1|||
127972233|NCT03063086|460518360|FG001|Overall Study|Adverse Event|1|||
127972234|NCT03063086|460518361|FG002|Overall Study|Adverse Event|1|||
127972235|NCT03063086|460518362|FG003|Overall Study|Adverse Event|1|||
127972236|NCT03063086|460518363|FG004|Overall Study|Adverse Event|0|||
127972237|NCT03063086|460518364|FG005|Overall Study|Adverse Event|0|||
127972238|NCT03063086|460518359|FG000|Overall Study|subject/guardian decision|1|||
127972239|NCT03063086|460518360|FG001|Overall Study|subject/guardian decision|0|||
127972240|NCT03063086|460518361|FG002|Overall Study|subject/guardian decision|0|||
127972241|NCT03063086|460518362|FG003|Overall Study|subject/guardian decision|0|||
127972242|NCT03063086|460518363|FG004|Overall Study|subject/guardian decision|0|||
127972243|NCT03063086|460518364|FG005|Overall Study|subject/guardian decision|0|||
127972244|NCT03063086|460518359|FG000|Overall Study|Non-compliance with study treatment|0|||
127972245|NCT03063086|460518360|FG001|Overall Study|Non-compliance with study treatment|0|||
127972246|NCT03063086|460518361|FG002|Overall Study|Non-compliance with study treatment|0|||
127972247|NCT03063086|460518362|FG003|Overall Study|Non-compliance with study treatment|1|||
127972248|NCT03063086|460518363|FG004|Overall Study|Non-compliance with study treatment|0|||
127972249|NCT03063086|460518364|FG005|Overall Study|Non-compliance with study treatment|1|||
127972250|NCT03063086|460518359|FG000|Overall Study|Physician Decision|0|||
127972251|NCT03063086|460518360|FG001|Overall Study|Physician Decision|0|||
127972252|NCT03063086|460518361|FG002|Overall Study|Physician Decision|0|||
127972253|NCT03063086|460518362|FG003|Overall Study|Physician Decision|1|||
127972254|NCT03063086|460518363|FG004|Overall Study|Physician Decision|0|||
127972255|NCT03063086|460518364|FG005|Overall Study|Physician Decision|0|||
127972256|NCT04590586|460518366|FG000|Overall Study|Death|7|||
127972257|NCT04590586|460518367|FG001|Overall Study|Death|1|||
127972258|NCT04590586|460518368|FG002|Overall Study|Death|37|||
127972259|NCT04590586|460518369|FG003|Overall Study|Death|34|||
127972260|NCT04590586|460518370|FG004|Overall Study|Death|19|||
127972261|NCT04590586|460518371|FG005|Overall Study|Death|3|||
127972262|NCT04590586|460518366|FG000|Overall Study|Lost to Follow-up|3|||
127972263|NCT04590586|460518367|FG001|Overall Study|Lost to Follow-up|0|||
127972264|NCT04590586|460518368|FG002|Overall Study|Lost to Follow-up|11|||
127972265|NCT04590586|460518369|FG003|Overall Study|Lost to Follow-up|11|||
127972266|NCT04590586|460518370|FG004|Overall Study|Lost to Follow-up|6|||
127972267|NCT04590586|460518371|FG005|Overall Study|Lost to Follow-up|0|||
127972268|NCT04590586|460518366|FG000|Overall Study|Withdrawal by Subject|0|||
127972269|NCT04590586|460518367|FG001|Overall Study|Withdrawal by Subject|0|||
127972270|NCT04590586|460518368|FG002|Overall Study|Withdrawal by Subject|6|||
127972271|NCT04590586|460518369|FG003|Overall Study|Withdrawal by Subject|0|||
127972272|NCT04590586|460518370|FG004|Overall Study|Withdrawal by Subject|3|||
127972273|NCT04590586|460518371|FG005|Overall Study|Withdrawal by Subject|0|||
127972274|NCT04590586|460518366|FG000|Overall Study|Other|3|||
127972275|NCT04590586|460518367|FG001|Overall Study|Other|0|||
127972276|NCT04590586|460518368|FG002|Overall Study|Other|1|||
127972277|NCT04590586|460518369|FG003|Overall Study|Other|1|||
127972278|NCT04590586|460518370|FG004|Overall Study|Other|2|||
127972279|NCT04590586|460518371|FG005|Overall Study|Other|1|||
127972280|NCT01893281|460518372|FG000|Overall Study|Adverse Event|1|||
127972281|NCT01893281|460518372|FG000|Overall Study|Protocol Violation|1|||
127972282|NCT01893281|460518372|FG000|Overall Study|Withdrawal by Subject|1|||
127972283|NCT02218736|460518373|FG000|Overall Study|Withdrawal by Subject|10|||
127972284|NCT02218736|460518374|FG001|Overall Study|Withdrawal by Subject|9|||
127972285|NCT02218736|460518373|FG000|Overall Study|Protocol Violation|2|||
127972286|NCT02218736|460518374|FG001|Overall Study|Protocol Violation|0|||
127972287|NCT05481125|460518377|FG000|Overall Study|Adverse Event|1|||
127972288|NCT05481125|460518378|FG001|Overall Study|Adverse Event|0|||
127972289|NCT05481125|460518377|FG000|Overall Study|Lost to Follow-up|0|||
127972290|NCT05481125|460518378|FG001|Overall Study|Lost to Follow-up|1|||
127972291|NCT05481125|460518377|FG000|Overall Study|Withdrawal by Subject|0|||
127972292|NCT05481125|460518378|FG001|Overall Study|Withdrawal by Subject|1|||
127972293|NCT02244463|460518379|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
127972294|NCT02244463|460518380|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
127972295|NCT02244463|460518381|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
127972296|NCT02244463|460518382|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
127972297|NCT02244463|460518383|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
127972298|NCT02244463|460518384|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
127972299|NCT02244463|460518379|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
127972300|NCT02244463|460518380|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
127972301|NCT02244463|460518381|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
127972302|NCT02244463|460518382|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
127972303|NCT02244463|460518383|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
127972304|NCT02244463|460518384|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
127972305|NCT02244463|460518379|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
127972306|NCT02244463|460518380|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
127972307|NCT02244463|460518381|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
127972308|NCT02244463|460518382|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
127972309|NCT02244463|460518383|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
127972310|NCT02244463|460518384|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
127972311|NCT02244463|460518379|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
127972312|NCT02244463|460518380|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
127972313|NCT02244463|460518381|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
127972314|NCT02244463|460518382|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
127972315|NCT02244463|460518383|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
127972316|NCT02244463|460518384|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
127972317|NCT02244463|460518379|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
127972318|NCT02244463|460518380|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
127972319|NCT02244463|460518381|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
127972320|NCT02244463|460518382|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
127972321|NCT02244463|460518383|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
127972322|NCT02244463|460518384|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
127972323|NCT02244463|460518379|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
127972324|NCT02244463|460518380|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
127972325|NCT02244463|460518381|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
127972326|NCT02244463|460518382|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
127972327|NCT02244463|460518383|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
127972328|NCT02244463|460518384|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
127972329|NCT02244463|460518379|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
127972330|NCT02244463|460518380|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
127972331|NCT02244463|460518381|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
127972332|NCT02244463|460518382|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
127972333|NCT02244463|460518383|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
127972334|NCT02244463|460518384|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
127972335|NCT02244463|460518379|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
127972336|NCT02244463|460518380|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
127972337|NCT02244463|460518381|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
127972338|NCT02244463|460518382|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
127972339|NCT02244463|460518383|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
127972340|NCT02244463|460518384|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
127972341|NCT02244463|460518379|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
127972342|NCT02244463|460518380|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
127972343|NCT02244463|460518381|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
127972344|NCT02244463|460518382|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
127972345|NCT02244463|460518383|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
127972346|NCT02244463|460518384|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
127972347|NCT02244463|460518379|FG000|Period 5: Phase II|Disease Progression|0|||
127972348|NCT02244463|460518380|FG001|Period 5: Phase II|Disease Progression|0|||
127972349|NCT02244463|460518381|FG002|Period 5: Phase II|Disease Progression|0|||
127972350|NCT02244463|460518382|FG003|Period 5: Phase II|Disease Progression|0|||
127972351|NCT02244463|460518383|FG004|Period 5: Phase II|Disease Progression|10|||
127972352|NCT02244463|460518384|FG005|Period 5: Phase II|Disease Progression|11|||
127972353|NCT02244463|460518379|FG000|Period 5: Phase II|Physician Decision|0|||
127972354|NCT02244463|460518380|FG001|Period 5: Phase II|Physician Decision|0|||
127972355|NCT02244463|460518381|FG002|Period 5: Phase II|Physician Decision|0|||
127972356|NCT02244463|460518382|FG003|Period 5: Phase II|Physician Decision|0|||
127972357|NCT02244463|460518383|FG004|Period 5: Phase II|Physician Decision|3|||
127972358|NCT02244463|460518384|FG005|Period 5: Phase II|Physician Decision|2|||
127972359|NCT02244463|460518379|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
127972360|NCT02244463|460518380|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
127972361|NCT02244463|460518381|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
127972362|NCT02244463|460518382|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
127972363|NCT02244463|460518383|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
127972364|NCT02244463|460518384|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
127972365|NCT02244463|460518379|FG000|Period 5: Phase II|Intercurrent Illness|0|||
127972366|NCT02244463|460518380|FG001|Period 5: Phase II|Intercurrent Illness|0|||
127972367|NCT02244463|460518381|FG002|Period 5: Phase II|Intercurrent Illness|0|||
127972368|NCT02244463|460518382|FG003|Period 5: Phase II|Intercurrent Illness|0|||
127972369|NCT02244463|460518383|FG004|Period 5: Phase II|Intercurrent Illness|2|||
127972370|NCT02244463|460518384|FG005|Period 5: Phase II|Intercurrent Illness|0|||
127972371|NCT02244463|460518379|FG000|Period 5: Phase II|Adverse Event|0|||
127972372|NCT02244463|460518380|FG001|Period 5: Phase II|Adverse Event|0|||
127972373|NCT02244463|460518381|FG002|Period 5: Phase II|Adverse Event|0|||
127972374|NCT02244463|460518382|FG003|Period 5: Phase II|Adverse Event|0|||
127972375|NCT02244463|460518383|FG004|Period 5: Phase II|Adverse Event|0|||
127972376|NCT02244463|460518384|FG005|Period 5: Phase II|Adverse Event|2|||
127972377|NCT02244463|460518379|FG000|Period 5: Phase II|Still On treatment|0|||
127972378|NCT02244463|460518380|FG001|Period 5: Phase II|Still On treatment|0|||
127972379|NCT02244463|460518381|FG002|Period 5: Phase II|Still On treatment|0|||
127972380|NCT02244463|460518382|FG003|Period 5: Phase II|Still On treatment|0|||
127972381|NCT02244463|460518383|FG004|Period 5: Phase II|Still On treatment|0|||
127972382|NCT02244463|460518384|FG005|Period 5: Phase II|Still On treatment|3|||
127972383|NCT01769508|460518385|FG000|Overall Study|Death|3|||
127972384|NCT01769508|460518385|FG000|Overall Study|Withdrawal by Subject|1|||
127972385|NCT01769508|460518385|FG000|Overall Study|Adverse Event|1|||
127972386|NCT01769508|460518385|FG000|Overall Study|Lost to Follow-up|1|||
127972387|NCT01598090|460518386|FG000|Treatment Period|Poor/non-compliance|0|||
127972388|NCT01598090|460518387|FG001|Treatment Period|Poor/non-compliance|2|||
127972389|NCT01598090|460518388|FG002|Treatment Period|Poor/non-compliance|0|||
127972390|NCT01598090|460518386|FG000|Treatment Period|No longer meet study criteria|0|||
127972391|NCT01598090|460518387|FG001|Treatment Period|No longer meet study criteria|1|||
127972392|NCT01598090|460518388|FG002|Treatment Period|No longer meet study criteria|0|||
127972393|NCT01598090|460518386|FG000|Treatment Period|Lack of Efficacy|5|||
127972394|NCT01598090|460518387|FG001|Treatment Period|Lack of Efficacy|14|||
127972395|NCT01598090|460518388|FG002|Treatment Period|Lack of Efficacy|6|||
127972396|NCT01598090|460518386|FG000|Treatment Period|Adverse Event|2|||
127972397|NCT01598090|460518387|FG001|Treatment Period|Adverse Event|33|||
127972398|NCT01598090|460518388|FG002|Treatment Period|Adverse Event|17|||
127972399|NCT01598090|460518386|FG000|Treatment Period|Other reasons|0|||
127972400|NCT01598090|460518387|FG001|Treatment Period|Other reasons|4|||
127972401|NCT01598090|460518388|FG002|Treatment Period|Other reasons|1|||
127972402|NCT01598090|460518386|FG000|Treatment Period|Withdrawal by Subject|3|||
127972403|NCT01598090|460518387|FG001|Treatment Period|Withdrawal by Subject|13|||
127972404|NCT01598090|460518388|FG002|Treatment Period|Withdrawal by Subject|10|||
127972405|NCT01598090|460518386|FG000|Treatment Period|Lost to Follow-up|1|||
127972406|NCT01598090|460518387|FG001|Treatment Period|Lost to Follow-up|5|||
127972407|NCT01598090|460518388|FG002|Treatment Period|Lost to Follow-up|1|||
127972408|NCT01598090|460518386|FG000|Follow-up Period|Death|0|||
127972409|NCT01598090|460518387|FG001|Follow-up Period|Death|1|||
127972410|NCT01598090|460518388|FG002|Follow-up Period|Death|0|||
127972411|NCT01598090|460518386|FG000|Follow-up Period|No longer required per protocol|1|||
127972412|NCT01598090|460518387|FG001|Follow-up Period|No longer required per protocol|3|||
127972413|NCT01598090|460518388|FG002|Follow-up Period|No longer required per protocol|2|||
127972414|NCT01598090|460518386|FG000|Follow-up Period|Not reported|0|||
127972415|NCT01598090|460518387|FG001|Follow-up Period|Not reported|10|||
127972416|NCT01598090|460518388|FG002|Follow-up Period|Not reported|4|||
127972417|NCT01598090|460518386|FG000|Follow-up Period|Withdrawal by Subject|0|||
127972418|NCT01598090|460518387|FG001|Follow-up Period|Withdrawal by Subject|3|||
127972419|NCT01598090|460518388|FG002|Follow-up Period|Withdrawal by Subject|2|||
127972420|NCT01598090|460518386|FG000|Follow-up Period|Other reasons|2|||
127972421|NCT01598090|460518387|FG001|Follow-up Period|Other reasons|8|||
127972422|NCT01598090|460518388|FG002|Follow-up Period|Other reasons|8|||
127972423|NCT01598090|460518386|FG000|Follow-up Period|Lost to Follow-up|2|||
127972424|NCT01598090|460518387|FG001|Follow-up Period|Lost to Follow-up|10|||
127972425|NCT01598090|460518388|FG002|Follow-up Period|Lost to Follow-up|12|||
127972426|NCT03615144|460518389|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
127972427|NCT03615144|460518390|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
127972428|NCT02587598|460518393|FG000|Overall Study|Death|4|||
127972429|NCT02587598|460518394|FG001|Overall Study|Death|8|||
127972430|NCT02587598|460518395|FG002|Overall Study|Death|4|||
127972431|NCT02587598|460518396|FG003|Overall Study|Death|16|||
127972432|NCT02587598|460518397|FG004|Overall Study|Death|9|||
127972433|NCT02587598|460518398|FG005|Overall Study|Death|4|||
127972434|NCT02587598|460518399|FG006|Overall Study|Death|6|||
127972435|NCT02587598|460518400|FG007|Overall Study|Death|7|||
127972436|NCT02587598|460518401|FG008|Overall Study|Death|9|||
127972437|NCT02587598|460518402|FG009|Overall Study|Death|1|||
127972438|NCT02587598|460518403|FG010|Overall Study|Death|3|||
127972439|NCT02587598|460518393|FG000|Overall Study|Study Terminated by the Sponsor|0|||
127972440|NCT02587598|460518394|FG001|Overall Study|Study Terminated by the Sponsor|1|||
127972441|NCT02587598|460518395|FG002|Overall Study|Study Terminated by the Sponsor|0|||
127972442|NCT02587598|460518396|FG003|Overall Study|Study Terminated by the Sponsor|3|||
127972443|NCT02587598|460518397|FG004|Overall Study|Study Terminated by the Sponsor|0|||
127972444|NCT02587598|460518398|FG005|Overall Study|Study Terminated by the Sponsor|1|||
127972445|NCT02587598|460518399|FG006|Overall Study|Study Terminated by the Sponsor|0|||
127972446|NCT02587598|460518400|FG007|Overall Study|Study Terminated by the Sponsor|0|||
127972447|NCT02587598|460518401|FG008|Overall Study|Study Terminated by the Sponsor|0|||
127972448|NCT02587598|460518402|FG009|Overall Study|Study Terminated by the Sponsor|1|||
127972449|NCT02587598|460518403|FG010|Overall Study|Study Terminated by the Sponsor|6|||
127972450|NCT02587598|460518393|FG000|Overall Study|Reason for study withdrawal not specified|0|||
127972451|NCT02587598|460518394|FG001|Overall Study|Reason for study withdrawal not specified|1|||
127972452|NCT02587598|460518395|FG002|Overall Study|Reason for study withdrawal not specified|0|||
127972453|NCT02587598|460518396|FG003|Overall Study|Reason for study withdrawal not specified|0|||
127972454|NCT02587598|460518397|FG004|Overall Study|Reason for study withdrawal not specified|0|||
127972455|NCT02587598|460518398|FG005|Overall Study|Reason for study withdrawal not specified|0|||
127972456|NCT02587598|460518399|FG006|Overall Study|Reason for study withdrawal not specified|0|||
127972457|NCT02587598|460518400|FG007|Overall Study|Reason for study withdrawal not specified|0|||
127972458|NCT02587598|460518401|FG008|Overall Study|Reason for study withdrawal not specified|0|||
127972459|NCT02587598|460518402|FG009|Overall Study|Reason for study withdrawal not specified|0|||
127972460|NCT02587598|460518403|FG010|Overall Study|Reason for study withdrawal not specified|0|||
127972461|NCT02587598|460518393|FG000|Overall Study|Withdrawal by Subject|0|||
127972462|NCT02587598|460518394|FG001|Overall Study|Withdrawal by Subject|1|||
127972463|NCT02587598|460518395|FG002|Overall Study|Withdrawal by Subject|0|||
127972464|NCT02587598|460518396|FG003|Overall Study|Withdrawal by Subject|2|||
127972465|NCT02587598|460518397|FG004|Overall Study|Withdrawal by Subject|3|||
127972466|NCT02587598|460518398|FG005|Overall Study|Withdrawal by Subject|1|||
127972467|NCT02587598|460518399|FG006|Overall Study|Withdrawal by Subject|0|||
127972468|NCT02587598|460518400|FG007|Overall Study|Withdrawal by Subject|0|||
127972469|NCT02587598|460518401|FG008|Overall Study|Withdrawal by Subject|0|||
127972470|NCT02587598|460518402|FG009|Overall Study|Withdrawal by Subject|1|||
127972471|NCT02587598|460518403|FG010|Overall Study|Withdrawal by Subject|2|||
127972472|NCT02587598|460518393|FG000|Overall Study|Physician Decision|0|||
127972473|NCT02587598|460518394|FG001|Overall Study|Physician Decision|0|||
127972474|NCT02587598|460518395|FG002|Overall Study|Physician Decision|0|||
127972475|NCT02587598|460518396|FG003|Overall Study|Physician Decision|0|||
127972476|NCT02587598|460518397|FG004|Overall Study|Physician Decision|0|||
127972477|NCT02587598|460518398|FG005|Overall Study|Physician Decision|0|||
127972478|NCT02587598|460518399|FG006|Overall Study|Physician Decision|0|||
127972479|NCT02587598|460518400|FG007|Overall Study|Physician Decision|0|||
127972480|NCT02587598|460518401|FG008|Overall Study|Physician Decision|0|||
127972481|NCT02587598|460518402|FG009|Overall Study|Physician Decision|0|||
127972482|NCT02587598|460518403|FG010|Overall Study|Physician Decision|3|||
127972483|NCT00355147|460518408|FG000|Overall Study|Lost to Follow-up|10|||
127972484|NCT00355147|460518409|FG001|Overall Study|Lost to Follow-up|8|||
127972485|NCT00355147|460518408|FG000|Overall Study|Withdrawal by Subject|8|||
127972486|NCT00355147|460518409|FG001|Overall Study|Withdrawal by Subject|12|||
127972487|NCT01672710|460518415|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
127972488|NCT01672710|460518416|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
127972489|NCT01672710|460518415|FG000|3 Month Follow up|Lost to Follow-up|2|||
127972490|NCT01672710|460518416|FG001|3 Month Follow up|Lost to Follow-up|3|||
127972491|NCT01672710|460518415|FG000|3 Month Follow up|follow up due after termination date|4|||
127972492|NCT01672710|460518416|FG001|3 Month Follow up|follow up due after termination date|1|||
127972493|NCT04999163|460518417|FG000|Overall Study|Surgery completed at hospital not participating in the study.|1|||
127972494|NCT04999163|460518418|FG001|Overall Study|Surgery completed at hospital not participating in the study.|0|||
127972495|NCT04999163|460518417|FG000|Overall Study|Study enrollment stopped prior to implant.|1|||
127972496|NCT04999163|460518418|FG001|Overall Study|Study enrollment stopped prior to implant.|0|||
127972497|NCT04999163|460518417|FG000|Overall Study|Withdrawal by Subject|1|||
127972498|NCT04999163|460518418|FG001|Overall Study|Withdrawal by Subject|0|||
127972499|NCT01190410|460520319|FG000|Overall Study|Adverse Event|0|||
127972500|NCT01190410|460520320|FG001|Overall Study|Adverse Event|3|||
127972501|NCT01190410|460520319|FG000|Overall Study|Lack of Efficacy|0|||
127972502|NCT01190410|460520320|FG001|Overall Study|Lack of Efficacy|2|||
127972503|NCT01190410|460520319|FG000|Overall Study|Withdrawal by Subject|0|||
127972504|NCT01190410|460520320|FG001|Overall Study|Withdrawal by Subject|2|||
127972505|NCT01190410|460520319|FG000|Overall Study|Administrative decision|1|||
127972506|NCT01190410|460520320|FG001|Overall Study|Administrative decision|0|||
127972507|NCT01190410|460520319|FG000|Overall Study|PI discretion|0|||
127972508|NCT01190410|460520320|FG001|Overall Study|PI discretion|2|||
127972509|NCT01399047|460520321|FG000|Overall Study|Withdrawal by Subject|0|||
127972510|NCT01399047|460520322|FG001|Overall Study|Withdrawal by Subject|1|||
127972511|NCT00504725|460520328|FG000|Overall Study|Protocol Violation|1|||
127972512|NCT00504725|460520329|FG001|Overall Study|Protocol Violation|0|||
127972513|NCT00956592|460520334|FG000|Overall Study|Protocol Violation|1|||
127972514|NCT00956592|460520335|FG001|Overall Study|Protocol Violation|3|||
127972515|NCT00160706|460520337|FG000|Overall Study|Adverse Event|53|||
127972516|NCT00160706|460520337|FG000|Overall Study|Adverse Event and Other Reason|105|||
127972517|NCT00160706|460520337|FG000|Overall Study|Protocol Violation|3|||
127972518|NCT00160706|460520337|FG000|Overall Study|Withdrawal by Subject|41|||
127972519|NCT00160706|460520337|FG000|Overall Study|Withdrawal by Subject and Other|12|||
127972520|NCT00160706|460520337|FG000|Overall Study|Physician Decision|10|||
127972521|NCT00160706|460520337|FG000|Overall Study|Physician Decision and Other|3|||
127972522|NCT00160706|460520337|FG000|Overall Study|Lost to Follow-up|4|||
127972523|NCT00160706|460520337|FG000|Overall Study|Lost to Follow-up and Other|1|||
127972524|NCT00160706|460520337|FG000|Overall Study|Lack of Efficacy|42|||
127972525|NCT00160706|460520337|FG000|Overall Study|Lack of Efficacy and Other|1|||
127972526|NCT00160706|460520337|FG000|Overall Study|Other Reason|11|||
127972527|NCT03214380|460520338|FG000|Lead-in|Adverse Event|3|||
127972528|NCT03214380|460520339|FG001|Lead-in|Adverse Event|0|||
127972529|NCT03214380|460520340|FG002|Lead-in|Adverse Event|0|||
127972530|NCT03214380|460520341|FG003|Lead-in|Adverse Event|1|||
127972531|NCT03214380|460520342|FG004|Lead-in|Adverse Event|0|||
127972532|NCT03214380|460520343|FG005|Lead-in|Adverse Event|0|||
127972533|NCT03214380|460520338|FG000|Lead-in|Lost to Follow-up|4|||
127972534|NCT03214380|460520339|FG001|Lead-in|Lost to Follow-up|0|||
127972535|NCT03214380|460520340|FG002|Lead-in|Lost to Follow-up|0|||
127972536|NCT03214380|460520341|FG003|Lead-in|Lost to Follow-up|1|||
127972537|NCT03214380|460520342|FG004|Lead-in|Lost to Follow-up|0|||
127972538|NCT03214380|460520343|FG005|Lead-in|Lost to Follow-up|0|||
127972539|NCT03214380|460520338|FG000|Lead-in|Eligibility Criteria|3|||
127972540|NCT03214380|460520339|FG001|Lead-in|Eligibility Criteria|0|||
127972541|NCT03214380|460520340|FG002|Lead-in|Eligibility Criteria|0|||
127972542|NCT03214380|460520341|FG003|Lead-in|Eligibility Criteria|0|||
127972543|NCT03214380|460520342|FG004|Lead-in|Eligibility Criteria|0|||
127972544|NCT03214380|460520343|FG005|Lead-in|Eligibility Criteria|0|||
127972545|NCT03214380|460520338|FG000|Lead-in|Physician Decision|6|||
127972546|NCT03214380|460520339|FG001|Lead-in|Physician Decision|0|||
127972547|NCT03214380|460520340|FG002|Lead-in|Physician Decision|0|||
127972548|NCT03214380|460520341|FG003|Lead-in|Physician Decision|0|||
127972549|NCT03214380|460520342|FG004|Lead-in|Physician Decision|0|||
127972550|NCT03214380|460520343|FG005|Lead-in|Physician Decision|0|||
127972551|NCT03214380|460520338|FG000|Lead-in|Protocol Deviation|7|||
127972552|NCT03214380|460520339|FG001|Lead-in|Protocol Deviation|0|||
127972553|NCT03214380|460520340|FG002|Lead-in|Protocol Deviation|0|||
127972554|NCT03214380|460520341|FG003|Lead-in|Protocol Deviation|3|||
127972555|NCT03214380|460520342|FG004|Lead-in|Protocol Deviation|0|||
127972556|NCT03214380|460520343|FG005|Lead-in|Protocol Deviation|0|||
127972557|NCT03214380|460520338|FG000|Lead-in|Withdrawal by Subject|41|||
127972558|NCT03214380|460520339|FG001|Lead-in|Withdrawal by Subject|0|||
127972559|NCT03214380|460520340|FG002|Lead-in|Withdrawal by Subject|0|||
127972560|NCT03214380|460520341|FG003|Lead-in|Withdrawal by Subject|14|||
127972561|NCT03214380|460520342|FG004|Lead-in|Withdrawal by Subject|0|||
127972562|NCT03214380|460520343|FG005|Lead-in|Withdrawal by Subject|0|||
127972563|NCT03214380|460520338|FG000|Lead-in|Family Emergency|1|||
127972564|NCT03214380|460520339|FG001|Lead-in|Family Emergency|0|||
127972565|NCT03214380|460520340|FG002|Lead-in|Family Emergency|0|||
127972566|NCT03214380|460520341|FG003|Lead-in|Family Emergency|0|||
127972567|NCT03214380|460520342|FG004|Lead-in|Family Emergency|0|||
127972568|NCT03214380|460520343|FG005|Lead-in|Family Emergency|0|||
127972569|NCT03214380|460520338|FG000|Lead-in|Natural Disaster|9|||
127972570|NCT03214380|460520339|FG001|Lead-in|Natural Disaster|0|||
127972571|NCT03214380|460520340|FG002|Lead-in|Natural Disaster|0|||
127972572|NCT03214380|460520341|FG003|Lead-in|Natural Disaster|0|||
127972573|NCT03214380|460520342|FG004|Lead-in|Natural Disaster|0|||
127972574|NCT03214380|460520343|FG005|Lead-in|Natural Disaster|0|||
127972575|NCT03214380|460520338|FG000|Lead-in|Non Compliance|1|||
127972576|NCT03214380|460520339|FG001|Lead-in|Non Compliance|0|||
127972577|NCT03214380|460520340|FG002|Lead-in|Non Compliance|0|||
127972578|NCT03214380|460520341|FG003|Lead-in|Non Compliance|0|||
127972579|NCT03214380|460520342|FG004|Lead-in|Non Compliance|0|||
127972580|NCT03214380|460520343|FG005|Lead-in|Non Compliance|0|||
127972581|NCT03214380|460520338|FG000|Lead-in|Participant Schedule|2|||
127972582|NCT03214380|460520339|FG001|Lead-in|Participant Schedule|0|||
127972583|NCT03214380|460520340|FG002|Lead-in|Participant Schedule|0|||
127972584|NCT03214380|460520341|FG003|Lead-in|Participant Schedule|0|||
127972585|NCT03214380|460520342|FG004|Lead-in|Participant Schedule|0|||
127972586|NCT03214380|460520343|FG005|Lead-in|Participant Schedule|0|||
127972587|NCT03214380|460520338|FG000|Treatment Period|Adverse Event|0|||
127972588|NCT03214380|460520339|FG001|Treatment Period|Adverse Event|1|||
127972589|NCT03214380|460520340|FG002|Treatment Period|Adverse Event|1|||
127972590|NCT03214380|460520341|FG003|Treatment Period|Adverse Event|0|||
127972591|NCT03214380|460520342|FG004|Treatment Period|Adverse Event|1|||
127972592|NCT03214380|460520343|FG005|Treatment Period|Adverse Event|0|||
127972593|NCT03214380|460520338|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
127972594|NCT03214380|460520339|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
127972595|NCT03214380|460520340|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
127972596|NCT03214380|460520341|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
127972597|NCT03214380|460520342|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
127972598|NCT03214380|460520343|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
127972599|NCT03214380|460520338|FG000|Treatment Period|Withdrawal by Subject|0|||
127972600|NCT03214380|460520339|FG001|Treatment Period|Withdrawal by Subject|10|||
127972601|NCT03214380|460520340|FG002|Treatment Period|Withdrawal by Subject|8|||
127972602|NCT03214380|460520341|FG003|Treatment Period|Withdrawal by Subject|0|||
127972603|NCT03214380|460520342|FG004|Treatment Period|Withdrawal by Subject|7|||
127972604|NCT03214380|460520343|FG005|Treatment Period|Withdrawal by Subject|11|||
127972605|NCT03214380|460520338|FG000|Treatment Period|Death|0|||
127972606|NCT03214380|460520339|FG001|Treatment Period|Death|1|||
127972607|NCT03214380|460520340|FG002|Treatment Period|Death|2|||
127972608|NCT03214380|460520341|FG003|Treatment Period|Death|0|||
127972609|NCT03214380|460520342|FG004|Treatment Period|Death|0|||
127972610|NCT03214380|460520343|FG005|Treatment Period|Death|0|||
127972611|NCT03214380|460520338|FG000|Treatment Period|Lost to Follow-up|0|||
127972612|NCT03214380|460520339|FG001|Treatment Period|Lost to Follow-up|6|||
127972613|NCT03214380|460520340|FG002|Treatment Period|Lost to Follow-up|3|||
127972614|NCT03214380|460520341|FG003|Treatment Period|Lost to Follow-up|0|||
127972615|NCT03214380|460520342|FG004|Treatment Period|Lost to Follow-up|0|||
127972616|NCT03214380|460520343|FG005|Treatment Period|Lost to Follow-up|0|||
127972617|NCT03214380|460520338|FG000|Treatment Period|Participant schedule|0|||
127972618|NCT03214380|460520339|FG001|Treatment Period|Participant schedule|0|||
127972619|NCT03214380|460520340|FG002|Treatment Period|Participant schedule|1|||
127972620|NCT03214380|460520341|FG003|Treatment Period|Participant schedule|0|||
127972621|NCT03214380|460520342|FG004|Treatment Period|Participant schedule|0|||
127972622|NCT03214380|460520343|FG005|Treatment Period|Participant schedule|0|||
127972623|NCT03214380|460520338|FG000|Treatment Period|Treatment Interruption|0|||
127972624|NCT03214380|460520339|FG001|Treatment Period|Treatment Interruption|0|||
127972625|NCT03214380|460520340|FG002|Treatment Period|Treatment Interruption|1|||
127972626|NCT03214380|460520341|FG003|Treatment Period|Treatment Interruption|0|||
127972627|NCT03214380|460520342|FG004|Treatment Period|Treatment Interruption|0|||
127972628|NCT03214380|460520343|FG005|Treatment Period|Treatment Interruption|0|||
127972629|NCT01163851|460520344|FG000|Overall Study|Site Closure|0|||
127972630|NCT01163851|460520345|FG001|Overall Study|Site Closure|1|||
127972631|NCT01163851|460520344|FG000|Overall Study|Enrolled but not treated|1|||
127972632|NCT01163851|460520345|FG001|Overall Study|Enrolled but not treated|0|||
127972633|NCT02028767|460520346|FG000|Treatment Period 2|Non compliant with protocol|1|||
127972634|NCT02028767|460520347|FG001|Treatment Period 2|Non compliant with protocol|0|||
127972635|NCT02028767|460520346|FG000|Treatment Period 2|Reason other than those specified above|1|||
127972636|NCT02028767|460520347|FG001|Treatment Period 2|Reason other than those specified above|0|||
127972637|NCT03192306|460520348|FG000|Overall Study|Did not treat cold sore during study|149|||
127972638|NCT03192306|460520349|FG001|Overall Study|Did not treat cold sore during study|143|||
127972639|NCT03192306|460520348|FG000|Overall Study|Withdrawal by Subject|1|||
127972640|NCT03192306|460520349|FG001|Overall Study|Withdrawal by Subject|1|||
127972641|NCT03192306|460520348|FG000|Overall Study|Lost to Follow-up|1|||
127972642|NCT03192306|460520349|FG001|Overall Study|Lost to Follow-up|0|||
127972643|NCT03192306|460520348|FG000|Overall Study|Protocol Violation|1|||
127972644|NCT03192306|460520349|FG001|Overall Study|Protocol Violation|1|||
127972645|NCT03436693|460520350|FG000|Overall Study|Adverse Event|22|||
127972646|NCT03436693|460520351|FG001|Overall Study|Adverse Event|10|||
127972647|NCT03436693|460520350|FG000|Overall Study|Physician Decision|3|||
127972648|NCT03436693|460520351|FG001|Overall Study|Physician Decision|3|||
127972649|NCT03436693|460520350|FG000|Overall Study|Withdrawal by Subject|4|||
127972650|NCT03436693|460520351|FG001|Overall Study|Withdrawal by Subject|13|||
127972651|NCT03436693|460520350|FG000|Overall Study|Progressive Disease|1|||
127972652|NCT03436693|460520351|FG001|Overall Study|Progressive Disease|1|||
127972653|NCT00654875|460520354|FG000|Overall Study|Adverse Event|5|||
127972654|NCT00654875|460520355|FG001|Overall Study|Adverse Event|5|||
127972655|NCT00654875|460520354|FG000|Overall Study|Withdrawal by Subject|4|||
127972656|NCT00654875|460520355|FG001|Overall Study|Withdrawal by Subject|4|||
127972657|NCT00654875|460520354|FG000|Overall Study|Protocol Violation|3|||
127972658|NCT00654875|460520355|FG001|Overall Study|Protocol Violation|3|||
127972659|NCT00654875|460520354|FG000|Overall Study|Lack of Efficacy|2|||
127972660|NCT00654875|460520355|FG001|Overall Study|Lack of Efficacy|2|||
127972661|NCT00654875|460520354|FG000|Overall Study|Lost to Follow-up|1|||
127972662|NCT00654875|460520355|FG001|Overall Study|Lost to Follow-up|3|||
127972663|NCT00654875|460520354|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
127972664|NCT00654875|460520355|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
127972665|NCT00654875|460520354|FG000|Overall Study|Administrative Problems|1|||
127972666|NCT00654875|460520355|FG001|Overall Study|Administrative Problems|0|||
127972667|NCT04967885|460520356|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
127972668|NCT04967885|460520357|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
127972669|NCT04967885|460520356|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
127972670|NCT04967885|460520357|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
127972671|NCT04967885|460520356|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
127972672|NCT04967885|460520357|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
127972673|NCT04967885|460520356|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
127972674|NCT04967885|460520357|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
127972675|NCT04967885|460520356|FG000|EMI-II Intervention|Lost to Follow-up|14|||
127972676|NCT04967885|460520357|FG001|EMI-II Intervention|Lost to Follow-up|10|||
127972677|NCT00886743|460520358|FG000|Overall Study|Adverse Event|3|||
127972678|NCT00886743|460520358|FG000|Overall Study|Other|1|||
127972679|NCT05217641|460520359|FG000|Overall Study|Lost to Follow-up|1|||
127972680|NCT05217641|460520360|FG001|Overall Study|Lost to Follow-up|1|||
127972681|NCT05217641|460520361|FG002|Overall Study|Lost to Follow-up|0|||
127972682|NCT05217641|460520362|FG003|Overall Study|Lost to Follow-up|1|||
127972683|NCT05217641|460520363|FG004|Overall Study|Lost to Follow-up|1|||
127972684|NCT05217641|460520364|FG005|Overall Study|Lost to Follow-up|0|||
127972685|NCT05217641|460520359|FG000|Overall Study|Withdrawal by Subject|0|||
127972686|NCT05217641|460520360|FG001|Overall Study|Withdrawal by Subject|0|||
127972687|NCT05217641|460520361|FG002|Overall Study|Withdrawal by Subject|0|||
127972688|NCT05217641|460520362|FG003|Overall Study|Withdrawal by Subject|3|||
127972689|NCT05217641|460520363|FG004|Overall Study|Withdrawal by Subject|1|||
127972690|NCT05217641|460520364|FG005|Overall Study|Withdrawal by Subject|0|||
127972691|NCT05217641|460520359|FG000|Overall Study|Other: participant did not specify reason|0|||
127972692|NCT05217641|460520360|FG001|Overall Study|Other: participant did not specify reason|0|||
127972693|NCT05217641|460520361|FG002|Overall Study|Other: participant did not specify reason|0|||
127972694|NCT05217641|460520362|FG003|Overall Study|Other: participant did not specify reason|0|||
127972695|NCT05217641|460520363|FG004|Overall Study|Other: participant did not specify reason|1|||
127972696|NCT05217641|460520364|FG005|Overall Study|Other: participant did not specify reason|0|||
127972697|NCT05217641|460520359|FG000|Overall Study|Extended Follow up|1|||
127972698|NCT05217641|460520360|FG001|Overall Study|Extended Follow up|1|||
127972699|NCT05217641|460520361|FG002|Overall Study|Extended Follow up|0|||
127972700|NCT05217641|460520362|FG003|Overall Study|Extended Follow up|0|||
127972701|NCT05217641|460520363|FG004|Overall Study|Extended Follow up|1|||
127972702|NCT05217641|460520364|FG005|Overall Study|Extended Follow up|0|||
127972703|NCT00626821|460520365|FG000|Overall Study|Adverse Event|44|||
127972704|NCT00626821|460520365|FG000|Overall Study|Protocol Violation|33|||
127972705|NCT00626821|460520365|FG000|Overall Study|Withdrawal by Subject|10|||
127972706|NCT00626821|460520365|FG000|Overall Study|Physician Decision|9|||
127972707|NCT00626821|460520365|FG000|Overall Study|Product dysfunction|21|||
127972708|NCT00626821|460520365|FG000|Overall Study|other/unknown reason|104|||
127972709|NCT02632409|460520366|FG000|Randomized|AE unrelated to study Drug|0|||
127972710|NCT02632409|460520367|FG001|Randomized|AE unrelated to study Drug|1|||
127972711|NCT02632409|460520366|FG000|Randomized|Participant withdrew consent|2|||
127972712|NCT02632409|460520367|FG001|Randomized|Participant withdrew consent|1|||
127972713|NCT02632409|460520366|FG000|Randomized|No Longer meets study criteria|5|||
127972714|NCT02632409|460520367|FG001|Randomized|No Longer meets study criteria|0|||
127972715|NCT02632409|460520366|FG000|Randomized|other reasons|1|||
127972716|NCT02632409|460520367|FG001|Randomized|other reasons|0|||
127972717|NCT02632409|460520366|FG000|Treatment Period|Ongoing Treatment|20|||
127972718|NCT02632409|460520367|FG001|Treatment Period|Ongoing Treatment|21|||
127972719|NCT02632409|460520366|FG000|Treatment Period|Disease Recurrence|147|||
127972720|NCT02632409|460520367|FG001|Treatment Period|Disease Recurrence|90|||
127972721|NCT02632409|460520366|FG000|Treatment Period|Study Drug Toxicity|8|||
127972722|NCT02632409|460520367|FG001|Treatment Period|Study Drug Toxicity|49|||
127972723|NCT02632409|460520366|FG000|Treatment Period|Death|1|||
127972724|NCT02632409|460520367|FG001|Treatment Period|Death|0|||
127972725|NCT02632409|460520366|FG000|Treatment Period|AE unrelated to study drug|15|||
127972726|NCT02632409|460520367|FG001|Treatment Period|AE unrelated to study drug|16|||
127972727|NCT02632409|460520366|FG000|Treatment Period|Request to discontinue treatment|4|||
127972728|NCT02632409|460520367|FG001|Treatment Period|Request to discontinue treatment|19|||
127972729|NCT02632409|460520366|FG000|Treatment Period|Participant withdrew consent|7|||
127972730|NCT02632409|460520367|FG001|Treatment Period|Participant withdrew consent|5|||
127972731|NCT02632409|460520366|FG000|Treatment Period|Lost to Follow-up|0|||
127972732|NCT02632409|460520367|FG001|Treatment Period|Lost to Follow-up|1|||
127972733|NCT02632409|460520366|FG000|Treatment Period|Maximum clinical benefit|1|||
127972734|NCT02632409|460520367|FG001|Treatment Period|Maximum clinical benefit|0|||
127972735|NCT02632409|460520366|FG000|Treatment Period|No longer meets study criteria|3|||
127972736|NCT02632409|460520367|FG001|Treatment Period|No longer meets study criteria|0|||
127972737|NCT02632409|460520366|FG000|Treatment Period|Administrative Reason by sponsor|0|||
127972738|NCT02632409|460520367|FG001|Treatment Period|Administrative Reason by sponsor|1|||
127972739|NCT02632409|460520366|FG000|Treatment Period|Other Reasons|10|||
127972740|NCT02632409|460520367|FG001|Treatment Period|Other Reasons|6|||
127972741|NCT04016779|460520368|FG000|Overall Study|Adverse Event|9|||
127972742|NCT04016779|460520369|FG001|Overall Study|Adverse Event|17|||
127972743|NCT04016779|460520368|FG000|Overall Study|Lack of Efficacy|4|||
127972744|NCT04016779|460520369|FG001|Overall Study|Lack of Efficacy|1|||
127972745|NCT04016779|460520368|FG000|Overall Study|Lost to Follow-up|5|||
127972746|NCT04016779|460520369|FG001|Overall Study|Lost to Follow-up|14|||
127972747|NCT04016779|460520368|FG000|Overall Study|Physician Decision|1|||
127972748|NCT04016779|460520369|FG001|Overall Study|Physician Decision|3|||
127972749|NCT04016779|460520368|FG000|Overall Study|Withdrawal by Subject|6|||
127972750|NCT04016779|460520369|FG001|Overall Study|Withdrawal by Subject|8|||
127972751|NCT04016779|460520368|FG000|Overall Study|Non-compliance with Study Drug|2|||
127972752|NCT04016779|460520369|FG001|Overall Study|Non-compliance with Study Drug|3|||
127972753|NCT04016779|460520368|FG000|Overall Study|Other, Multiple categories|17|||
127972754|NCT04016779|460520369|FG001|Overall Study|Other, Multiple categories|17|||
127972755|NCT02295020|460520373|FG000|Overall Study|Adverse Event|0|||
127972756|NCT02295020|460520374|FG001|Overall Study|Adverse Event|1|||
127972757|NCT02295020|460520373|FG000|Overall Study|Withdrawal by Subject|3|||
127972758|NCT02295020|460520374|FG001|Overall Study|Withdrawal by Subject|2|||
127972759|NCT02828124|460520375|FG000|Overall Study|Disease Progression|1|||
127972760|NCT02828124|460520376|FG001|Overall Study|Disease Progression|2|||
127972761|NCT02828124|460520377|FG002|Overall Study|Disease Progression|1|||
127972762|NCT02828124|460520378|FG003|Overall Study|Disease Progression|4|||
127972763|NCT02828124|460520375|FG000|Overall Study|AE Unrelated to Study Drug|0|||
127972764|NCT02828124|460520376|FG001|Overall Study|AE Unrelated to Study Drug|0|||
127972765|NCT02828124|460520377|FG002|Overall Study|AE Unrelated to Study Drug|0|||
127972766|NCT02828124|460520378|FG003|Overall Study|AE Unrelated to Study Drug|1|||
127972767|NCT02828124|460520375|FG000|Overall Study|Subject Withdrew Consent|0|||
127972768|NCT02828124|460520376|FG001|Overall Study|Subject Withdrew Consent|0|||
127972769|NCT02828124|460520377|FG002|Overall Study|Subject Withdrew Consent|0|||
127972770|NCT02828124|460520378|FG003|Overall Study|Subject Withdrew Consent|1|||
127972771|NCT00256854|460520379|FG000|Overall Study|Withdrawal by Subject|2|||
127972772|NCT00256854|460520380|FG001|Overall Study|Withdrawal by Subject|3|||
127972773|NCT00256854|460520381|FG002|Overall Study|Withdrawal by Subject|0|||
127972774|NCT00256854|460520382|FG003|Overall Study|Withdrawal by Subject|0|||
127972775|NCT00256854|460520383|FG004|Overall Study|Withdrawal by Subject|0|||
127972776|NCT00256854|460520384|FG005|Overall Study|Withdrawal by Subject|0|||
127972777|NCT00256854|460520379|FG000|Overall Study|Lack of Efficacy|1|||
127972778|NCT00256854|460520380|FG001|Overall Study|Lack of Efficacy|0|||
127972779|NCT00256854|460520381|FG002|Overall Study|Lack of Efficacy|0|||
127972780|NCT00256854|460520382|FG003|Overall Study|Lack of Efficacy|0|||
127972781|NCT00256854|460520383|FG004|Overall Study|Lack of Efficacy|0|||
127972782|NCT00256854|460520384|FG005|Overall Study|Lack of Efficacy|0|||
127972783|NCT00256854|460520379|FG000|Overall Study|Protocol Violation|0|||
127972784|NCT00256854|460520380|FG001|Overall Study|Protocol Violation|1|||
127972785|NCT00256854|460520381|FG002|Overall Study|Protocol Violation|1|||
127972786|NCT00256854|460520382|FG003|Overall Study|Protocol Violation|1|||
127972787|NCT00256854|460520383|FG004|Overall Study|Protocol Violation|0|||
127972788|NCT00256854|460520384|FG005|Overall Study|Protocol Violation|0|||
127972789|NCT00256854|460520379|FG000|Overall Study|Adverse Event|0|||
127972790|NCT00256854|460520380|FG001|Overall Study|Adverse Event|0|||
127972791|NCT00256854|460520381|FG002|Overall Study|Adverse Event|2|||
127972792|NCT00256854|460520382|FG003|Overall Study|Adverse Event|2|||
127972793|NCT00256854|460520383|FG004|Overall Study|Adverse Event|0|||
127972794|NCT00256854|460520384|FG005|Overall Study|Adverse Event|1|||
127972795|NCT00256854|460520379|FG000|Overall Study|Not compliant with the study drug|0|||
127972796|NCT00256854|460520380|FG001|Overall Study|Not compliant with the study drug|0|||
127972797|NCT00256854|460520381|FG002|Overall Study|Not compliant with the study drug|0|||
127972798|NCT00256854|460520382|FG003|Overall Study|Not compliant with the study drug|0|||
127972799|NCT00256854|460520383|FG004|Overall Study|Not compliant with the study drug|1|||
127972800|NCT00256854|460520384|FG005|Overall Study|Not compliant with the study drug|0|||
127972801|NCT02353442|460520385|FG000|Overall Study|Withdrawal by Subject|3|||
127972802|NCT02353442|460520386|FG001|Overall Study|Withdrawal by Subject|4|||
127972803|NCT06586788|460520388|FG000|Overall Study|Eye-tracking calibration / validation could not be completed with eight children|8|||
127972804|NCT03514485|460520389|FG000|Overall Study|Lost to Follow-up|5|||
127972805|NCT03514485|460520390|FG001|Overall Study|Lost to Follow-up|3|||
127972806|NCT03514485|460520391|FG002|Overall Study|Lost to Follow-up|2|||
127972807|NCT03514485|460520392|FG003|Overall Study|Lost to Follow-up|0|||
127972808|NCT03514485|460520393|FG004|Overall Study|Lost to Follow-up|1|||
127972809|NCT03514485|460520394|FG005|Overall Study|Lost to Follow-up|4|||
127972810|NCT03514485|460520389|FG000|Overall Study|Withdrawal by Subject|0|||
127972811|NCT03514485|460520390|FG001|Overall Study|Withdrawal by Subject|1|||
127972812|NCT03514485|460520391|FG002|Overall Study|Withdrawal by Subject|3|||
127972813|NCT03514485|460520392|FG003|Overall Study|Withdrawal by Subject|1|||
127972814|NCT03514485|460520393|FG004|Overall Study|Withdrawal by Subject|2|||
127972815|NCT03514485|460520394|FG005|Overall Study|Withdrawal by Subject|1|||
127972816|NCT00791661|460520395|FG000|7 Day Wash-out|Adverse Event|0|||
127972817|NCT00791661|460520396|FG001|7 Day Wash-out|Adverse Event|0|||
127972818|NCT00791661|460520397|FG002|7 Day Wash-out|Adverse Event|1|||
127972819|NCT00791661|460520395|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
127972820|NCT00791661|460520396|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
127972821|NCT00791661|460520397|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
127972822|NCT00679289|460520398|FG000|Overall Study|Progressive disease|4|||
127972823|NCT00679289|460520399|FG001|Overall Study|Progressive disease|5|||
127972824|NCT00679289|460520400|FG002|Overall Study|Progressive disease|18|||
127972825|NCT00679289|460520398|FG000|Overall Study|Withdrawal by Subject|0|||
127972826|NCT00679289|460520399|FG001|Overall Study|Withdrawal by Subject|1|||
127972827|NCT00679289|460520400|FG002|Overall Study|Withdrawal by Subject|1|||
127972828|NCT00679289|460520398|FG000|Overall Study|Adverse Event|0|||
127972829|NCT00679289|460520399|FG001|Overall Study|Adverse Event|0|||
127972830|NCT00679289|460520400|FG002|Overall Study|Adverse Event|3|||
127972831|NCT00679289|460520398|FG000|Overall Study|Physician Decision|1|||
127972832|NCT00679289|460520399|FG001|Overall Study|Physician Decision|0|||
127972833|NCT00679289|460520400|FG002|Overall Study|Physician Decision|1|||
127972834|NCT00937040|460520401|FG000|Overall Study|Adverse Event|5|||
127972835|NCT00937040|460520402|FG001|Overall Study|Adverse Event|8|||
127972836|NCT00937040|460520401|FG000|Overall Study|Lost to Follow-up|12|||
127972837|NCT00937040|460520402|FG001|Overall Study|Lost to Follow-up|12|||
127972838|NCT00937040|460520401|FG000|Overall Study|Protocol Violation|3|||
127972839|NCT00937040|460520402|FG001|Overall Study|Protocol Violation|0|||
127972840|NCT00937040|460520401|FG000|Overall Study|Withdrawal by Subject|13|||
127972841|NCT00937040|460520402|FG001|Overall Study|Withdrawal by Subject|7|||
127972842|NCT00937040|460520401|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
127972843|NCT00937040|460520402|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
127972844|NCT00937040|460520401|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
127972845|NCT00937040|460520402|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
127972846|NCT00638443|460520403|FG000|First Intervention|Adverse Event|2|||
127972847|NCT00638443|460520404|FG001|First Intervention|Adverse Event|1|||
127972848|NCT01355575|460520407|FG000|Overall Study|Withdrawal by Subject|2|||
127972849|NCT02294396|460520408|FG000|Overall Study|Adverse Event|26|||
127972850|NCT02294396|460520409|FG001|Overall Study|Adverse Event|25|||
127972851|NCT02294396|460520410|FG002|Overall Study|Adverse Event|21|||
127972852|NCT02294396|460520411|FG003|Overall Study|Adverse Event|24|||
127972853|NCT02294396|460520408|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
127972854|NCT02294396|460520409|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
127972855|NCT02294396|460520410|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
127972856|NCT02294396|460520411|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
127972857|NCT02294396|460520408|FG000|Overall Study|Withdrawal by Subject|8|||
127972858|NCT02294396|460520409|FG001|Overall Study|Withdrawal by Subject|6|||
127972859|NCT02294396|460520410|FG002|Overall Study|Withdrawal by Subject|6|||
127972860|NCT02294396|460520411|FG003|Overall Study|Withdrawal by Subject|8|||
127972861|NCT02294396|460520408|FG000|Overall Study|Lost to Follow-up|0|||
127972862|NCT02294396|460520409|FG001|Overall Study|Lost to Follow-up|0|||
127972863|NCT02294396|460520410|FG002|Overall Study|Lost to Follow-up|1|||
127972864|NCT02294396|460520411|FG003|Overall Study|Lost to Follow-up|1|||
127972865|NCT02294396|460520408|FG000|Overall Study|Protocol Deviation|3|||
127972866|NCT02294396|460520409|FG001|Overall Study|Protocol Deviation|2|||
127972867|NCT02294396|460520410|FG002|Overall Study|Protocol Deviation|2|||
127972868|NCT02294396|460520411|FG003|Overall Study|Protocol Deviation|1|||
127972869|NCT02294396|460520408|FG000|Overall Study|Miscellaneous|2|||
127972870|NCT02294396|460520409|FG001|Overall Study|Miscellaneous|0|||
127972871|NCT02294396|460520410|FG002|Overall Study|Miscellaneous|5|||
127972872|NCT02294396|460520411|FG003|Overall Study|Miscellaneous|2|||
127972873|NCT02120833|460520412|FG000|Overall Study|Adverse Event|1|||
127972874|NCT02120833|460520413|FG001|Overall Study|Adverse Event|0|||
127972875|NCT02120833|460520412|FG000|Overall Study|Withdrawal by Subject|2|||
127972876|NCT02120833|460520413|FG001|Overall Study|Withdrawal by Subject|0|||
127972877|NCT02120833|460520412|FG000|Overall Study|Lost to Follow-up|1|||
127972878|NCT02120833|460520413|FG001|Overall Study|Lost to Follow-up|1|||
127972879|NCT02438826|460520414|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
127972880|NCT02438826|460520415|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
127972881|NCT02438826|460520416|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
127972882|NCT02438826|460520417|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
127972883|NCT02438826|460520414|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
127972884|NCT02438826|460520415|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
127972885|NCT02438826|460520416|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
127972886|NCT02438826|460520417|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
127972887|NCT02438826|460520414|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
127972888|NCT02438826|460520415|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
127972889|NCT02438826|460520416|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
127972890|NCT02438826|460520417|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
127972891|NCT02438826|460520414|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
127972892|NCT02438826|460520415|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
127972893|NCT02438826|460520416|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
127972894|NCT02438826|460520417|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
127972895|NCT02438826|460520414|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
127972896|NCT02438826|460520415|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
127972897|NCT02438826|460520416|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
127972898|NCT02438826|460520417|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
127972899|NCT02438826|460520414|FG000|Open-Label Treatment Phase|Adverse Event|11|||
127972900|NCT02438826|460520415|FG001|Open-Label Treatment Phase|Adverse Event|6|||
127972901|NCT02438826|460520416|FG002|Open-Label Treatment Phase|Adverse Event|0|||
127972902|NCT02438826|460520417|FG003|Open-Label Treatment Phase|Adverse Event|0|||
127972903|NCT02438826|460520414|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
127972904|NCT02438826|460520415|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
127972905|NCT02438826|460520416|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
127972906|NCT02438826|460520417|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
127972907|NCT02438826|460520414|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
127972908|NCT02438826|460520415|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
127972909|NCT02438826|460520416|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
127972910|NCT02438826|460520417|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
127972911|NCT02438826|460520414|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
127972912|NCT02438826|460520415|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
127972913|NCT02438826|460520416|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
127972914|NCT02438826|460520417|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
127972915|NCT02438826|460520414|FG000|Post-Treatment Phase|Adverse Event|3|||
127972916|NCT02438826|460520415|FG001|Post-Treatment Phase|Adverse Event|0|||
127972917|NCT02438826|460520416|FG002|Post-Treatment Phase|Adverse Event|0|||
127972918|NCT02438826|460520417|FG003|Post-Treatment Phase|Adverse Event|0|||
127972919|NCT02438826|460520414|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
127972920|NCT02438826|460520415|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
127972921|NCT02438826|460520416|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
127972922|NCT02438826|460520417|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
127972923|NCT02438826|460520414|FG000|Post-Treatment Phase|Physician Decision|1|||
127972924|NCT02438826|460520415|FG001|Post-Treatment Phase|Physician Decision|0|||
127972925|NCT02438826|460520416|FG002|Post-Treatment Phase|Physician Decision|0|||
127972926|NCT02438826|460520417|FG003|Post-Treatment Phase|Physician Decision|0|||
127972927|NCT02438826|460520414|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
127972928|NCT02438826|460520415|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
127972929|NCT02438826|460520416|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
127972930|NCT02438826|460520417|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
127972931|NCT03502070|460520419|FG000|Overall Study|Withdrawal by Subject|1|||
127972932|NCT03502070|460520419|FG000|Overall Study|Screen Failure|1|||
127972933|NCT00595517|460520422|FG000|Overall Study|Adverse Event|6|||
127972934|NCT00595517|460520422|FG000|Overall Study|Withdrawal by Subject|4|||
127972935|NCT00595517|460520422|FG000|Overall Study|Protocol Violation|2|||
127972936|NCT00595517|460520422|FG000|Overall Study|Recurrence of ulcer|5|||
127972937|NCT00595517|460520422|FG000|Overall Study|usage of prohibited treatment|1|||
127972938|NCT00595517|460520422|FG000|Overall Study|No intention to attend regularly|1|||
127972939|NCT04105218|460520428|FG000|Overall Study|Withdrawal by Subject|3|||
127972940|NCT04105218|460520429|FG001|Overall Study|Withdrawal by Subject|2|||
127972941|NCT04105218|460520428|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
127972942|NCT04105218|460520429|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
127972943|NCT04105218|460520428|FG000|Overall Study|Failed screening tests|2|||
127972944|NCT04105218|460520429|FG001|Overall Study|Failed screening tests|1|||
127972945|NCT01167881|460520434|FG000|Overall Study|Adverse Event|47|||
127972946|NCT01167881|460520435|FG001|Overall Study|Adverse Event|51|||
127972947|NCT01167881|460520434|FG000|Overall Study|Lack of Efficacy|4|||
127972948|NCT01167881|460520435|FG001|Overall Study|Lack of Efficacy|7|||
127972949|NCT01167881|460520434|FG000|Overall Study|Non compliant with protocol|9|||
127972950|NCT01167881|460520435|FG001|Overall Study|Non compliant with protocol|18|||
127972951|NCT01167881|460520434|FG000|Overall Study|Lost to Follow-up|19|||
127972952|NCT01167881|460520435|FG001|Overall Study|Lost to Follow-up|20|||
127972953|NCT01167881|460520434|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
127972954|NCT01167881|460520435|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
127972955|NCT01167881|460520434|FG000|Overall Study|Not treated|4|||
127972956|NCT01167881|460520435|FG001|Overall Study|Not treated|0|||
127972957|NCT01167881|460520434|FG000|Overall Study|Other not defined above|31|||
127972958|NCT01167881|460520435|FG001|Overall Study|Other not defined above|55|||
127972959|NCT01435460|460520436|FG000|Overall Study|Adverse Event|2|||
127972960|NCT01435460|460520437|FG001|Overall Study|Adverse Event|1|||
127972961|NCT01435460|460520436|FG000|Overall Study|Lost to Follow-up|6|||
127972962|NCT01435460|460520437|FG001|Overall Study|Lost to Follow-up|1|||
127972963|NCT01435460|460520436|FG000|Overall Study|Withdrawal by Subject|1|||
127972964|NCT01435460|460520437|FG001|Overall Study|Withdrawal by Subject|3|||
127972965|NCT01435460|460520436|FG000|Overall Study|Protocol Violation|0|||
127972966|NCT01435460|460520437|FG001|Overall Study|Protocol Violation|1|||
127972967|NCT01435460|460520436|FG000|Overall Study|Did not meet eligibility criteria|2|||
127972968|NCT01435460|460520437|FG001|Overall Study|Did not meet eligibility criteria|0|||
127972969|NCT01706939|460520438|FG000|Pre Randomization|Screen Failure|1|||
127972970|NCT01706939|460520439|FG001|Pre Randomization|Screen Failure|0|||
127972971|NCT01706939|460520440|FG002|Pre Randomization|Screen Failure|0|||
127972972|NCT01706939|460520438|FG000|Pre Randomization|Ineligible for Randomization|1|||
127972973|NCT01706939|460520439|FG001|Pre Randomization|Ineligible for Randomization|0|||
127972974|NCT01706939|460520440|FG002|Pre Randomization|Ineligible for Randomization|0|||
127972975|NCT01706939|460520438|FG000|Pre Randomization|Withdrawal by Subject|1|||
127972976|NCT01706939|460520439|FG001|Pre Randomization|Withdrawal by Subject|0|||
127972977|NCT01706939|460520440|FG002|Pre Randomization|Withdrawal by Subject|0|||
127972978|NCT01706939|460520438|FG000|Randomization|Insufficient QoL survey compliance|0|||
127972979|NCT01706939|460520439|FG001|Randomization|Insufficient QoL survey compliance|1|||
127972980|NCT01706939|460520440|FG002|Randomization|Insufficient QoL survey compliance|1|||
127972981|NCT01706939|460520438|FG000|Randomization|Progression of disease|0|||
127972982|NCT01706939|460520439|FG001|Randomization|Progression of disease|2|||
127972983|NCT01706939|460520440|FG002|Randomization|Progression of disease|1|||
127972984|NCT01046903|460520442|FG000|Overall Study|Lost to Follow-up|16|||
127972985|NCT01046903|460520442|FG000|Overall Study|Adverse Event|4|||
127972986|NCT01046903|460520442|FG000|Overall Study|Withdrawal by Subject|3|||
127972987|NCT01046903|460520442|FG000|Overall Study|Other|5|||
127972988|NCT04152837|460520454|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
127972989|NCT04152837|460520454|FG000|Maintenance Period|Adverse Event|1|||
127972990|NCT04152837|460520454|FG000|Maintenance Period|Withdrawal by Subject|1|||
127972991|NCT04152837|460520454|FG000|Maintenance Period|Sponsor Termination of Study|2|||
127972992|NCT00101166|460520457|FG000|Overall Study|progressive disease|10|||
127972993|NCT00686829|460520458|FG000|Overall Study|Adverse Event|5|||
127972994|NCT00686829|460520458|FG000|Overall Study|Lack of Efficacy|6|||
127972995|NCT00686829|460520458|FG000|Overall Study|Lost to Follow-up|4|||
127972996|NCT00686829|460520458|FG000|Overall Study|Withdrawal by Subject|14|||
127972997|NCT00686829|460520458|FG000|Overall Study|Protocol Violation|3|||
127972998|NCT00686829|460520458|FG000|Overall Study|Sponsor discontinued VCV|47|||
127972999|NCT01217476|460520461|FG000|Overall Study|Adverse Event|6|||
127973000|NCT01217476|460520462|FG001|Overall Study|Adverse Event|1|||
127973001|NCT01217476|460520461|FG000|Overall Study|Physician Decision|0|||
127973002|NCT01217476|460520462|FG001|Overall Study|Physician Decision|1|||
127973003|NCT01217476|460520461|FG000|Overall Study|Withdrawal by Subject|3|||
127973004|NCT01217476|460520462|FG001|Overall Study|Withdrawal by Subject|3|||
127973005|NCT01217476|460520461|FG000|Overall Study|Surgery on the Target Limb|0|||
127973006|NCT01217476|460520462|FG001|Overall Study|Surgery on the Target Limb|2|||
127973007|NCT01217476|460520461|FG000|Overall Study|Protocol Deviation|1|||
127973008|NCT01217476|460520462|FG001|Overall Study|Protocol Deviation|0|||
127973009|NCT01217476|460520461|FG000|Overall Study|Other|2|||
127973010|NCT01217476|460520462|FG001|Overall Study|Other|0|||
127973011|NCT03033602|460520463|FG000|Overall Study|Withdrawal by Subject|11|||
127973012|NCT03033602|460520464|FG001|Overall Study|Withdrawal by Subject|21|||
127973013|NCT03033602|460520463|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
127973014|NCT03033602|460520464|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
127973015|NCT04445714|460520465|FG000|Overall Study|Discontinuation of the study|14|||
127973016|NCT04445714|460520465|FG000|Overall Study|High plasma glucose-fasting and HbA1c; investigator decision to withdraw participant|1|||
127973017|NCT04445714|460520465|FG000|Overall Study|Withdrawal of Informed Consent|8|||
127973018|NCT01684943|460520466|FG000|Overall Study|Inadequate Venous Access|3|||
127973019|NCT01684943|460520467|FG001|Overall Study|Inadequate Venous Access|0|||
127973020|NCT01684943|460520468|FG002|Overall Study|Inadequate Venous Access|0|||
127973021|NCT01684943|460520466|FG000|Overall Study|Principal Investigator Determination|1|||
127973022|NCT01684943|460520467|FG001|Overall Study|Principal Investigator Determination|0|||
127973023|NCT01684943|460520468|FG002|Overall Study|Principal Investigator Determination|0|||
127973024|NCT01684943|460520466|FG000|Overall Study|Excluded from Analysis|1|||
127973025|NCT01684943|460520467|FG001|Overall Study|Excluded from Analysis|1|||
127973026|NCT01684943|460520468|FG002|Overall Study|Excluded from Analysis|1|||
127973027|NCT01684943|460520466|FG000|Overall Study|Lost to Follow-up|3|||
127973028|NCT01684943|460520467|FG001|Overall Study|Lost to Follow-up|0|||
127973029|NCT01684943|460520468|FG002|Overall Study|Lost to Follow-up|0|||
127973030|NCT01684943|460520466|FG000|Overall Study|Planning Pregnancy|1|||
127973031|NCT01684943|460520467|FG001|Overall Study|Planning Pregnancy|0|||
127973032|NCT01684943|460520468|FG002|Overall Study|Planning Pregnancy|0|||
127973033|NCT03652636|460522473|FG000|Overall Study|Withdrawal by Subject|7|||
127973034|NCT01283334|460522477|FG000|Overall Study|Withdrawal by Subject|1|||
127973035|NCT01283334|460522477|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
127973036|NCT01283334|460522477|FG000|Overall Study|Adverse Event|4|||
127973037|NCT01283334|460522477|FG000|Overall Study|Physician Decision|1|||
127973038|NCT03467217|460522478|FG000|Overall Study|Trial stopped early|5|||
127973039|NCT03467217|460522479|FG001|Overall Study|Trial stopped early|2|||
127973040|NCT03467217|460522478|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
127973041|NCT03467217|460522479|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
127973042|NCT03467217|460522478|FG000|Overall Study|Lost to Follow-up|0|||
127973043|NCT03467217|460522479|FG001|Overall Study|Lost to Follow-up|2|||
127973044|NCT03233529|460522483|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
127973045|NCT03233529|460522483|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
127973046|NCT01177293|460522484|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
127973047|NCT01177293|460522485|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
127973048|NCT01905553|460522489|FG000|Period 2|Adverse Event|1|||
127973049|NCT01905553|460522490|FG001|Period 2|Adverse Event|0|||
127973050|NCT00076752|460522496|FG000|Overall Study|Death|2|||
127973051|NCT00076752|460522496|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
127973052|NCT03854370|460522497|FG000|Overall Study|samples not collected|1|||
127973053|NCT03854370|460522498|FG001|Overall Study|samples not collected|1|||
127973054|NCT03854370|460522499|FG002|Overall Study|samples not collected|1|||
127973055|NCT03854370|460522500|FG003|Overall Study|samples not collected|1|||
127973056|NCT00452673|460522501|FG000|Dose Escalation Period|Disease Progression|6|||
127973057|NCT00452673|460522502|FG001|Dose Escalation Period|Disease Progression|6|||
127973058|NCT00452673|460522503|FG002|Dose Escalation Period|Disease Progression|2|||
127973059|NCT00452673|460522504|FG003|Dose Escalation Period|Disease Progression|6|||
127973060|NCT00452673|460522505|FG004|Dose Escalation Period|Disease Progression|0|||
127973061|NCT00452673|460522501|FG000|Dose Escalation Period|study drug toxicity|1|||
127973062|NCT00452673|460522502|FG001|Dose Escalation Period|study drug toxicity|3|||
127973063|NCT00452673|460522503|FG002|Dose Escalation Period|study drug toxicity|3|||
127973064|NCT00452673|460522504|FG003|Dose Escalation Period|study drug toxicity|1|||
127973065|NCT00452673|460522505|FG004|Dose Escalation Period|study drug toxicity|0|||
127973066|NCT00452673|460522501|FG000|Dose Escalation Period|Other|0|||
127973067|NCT00452673|460522502|FG001|Dose Escalation Period|Other|0|||
127973068|NCT00452673|460522503|FG002|Dose Escalation Period|Other|1|||
127973069|NCT00452673|460522504|FG003|Dose Escalation Period|Other|0|||
127973070|NCT00452673|460522505|FG004|Dose Escalation Period|Other|0|||
127973071|NCT00452673|460522501|FG000|Dose Escalation Period|Adverse Event|0|||
127973072|NCT00452673|460522502|FG001|Dose Escalation Period|Adverse Event|0|||
127973073|NCT00452673|460522503|FG002|Dose Escalation Period|Adverse Event|0|||
127973074|NCT00452673|460522504|FG003|Dose Escalation Period|Adverse Event|1|||
127973075|NCT00452673|460522505|FG004|Dose Escalation Period|Adverse Event|0|||
127973076|NCT00452673|460522501|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
127973077|NCT00452673|460522502|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
127973078|NCT00452673|460522503|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
127973079|NCT00452673|460522504|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
127973080|NCT00452673|460522505|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
127973081|NCT00452673|460522501|FG000|Dose Expansion Period|Disease Progression|0|||
127973082|NCT00452673|460522502|FG001|Dose Expansion Period|Disease Progression|0|||
127973083|NCT00452673|460522503|FG002|Dose Expansion Period|Disease Progression|0|||
127973084|NCT00452673|460522504|FG003|Dose Expansion Period|Disease Progression|0|||
127973085|NCT00452673|460522505|FG004|Dose Expansion Period|Disease Progression|19|||
127973086|NCT00452673|460522501|FG000|Dose Expansion Period|Other|0|||
127973087|NCT00452673|460522502|FG001|Dose Expansion Period|Other|0|||
127973088|NCT00452673|460522503|FG002|Dose Expansion Period|Other|0|||
127973089|NCT00452673|460522504|FG003|Dose Expansion Period|Other|0|||
127973090|NCT00452673|460522505|FG004|Dose Expansion Period|Other|2|||
127973091|NCT02656290|460522506|FG000|Overall Study|Lost to Follow-up|1|||
127973092|NCT02656290|460522506|FG000|Overall Study|Reintervention|3|||
127973093|NCT01608087|460522509|FG000|Overall Study|Lost to Follow-up|0|||
127973094|NCT01608087|460522510|FG001|Overall Study|Lost to Follow-up|1|||
127973095|NCT01608087|460522511|FG002|Overall Study|Lost to Follow-up|0|||
127973096|NCT01608087|460522509|FG000|Overall Study|Other Reason|0|||
127973097|NCT01608087|460522510|FG001|Overall Study|Other Reason|1|||
127973098|NCT01608087|460522511|FG002|Overall Study|Other Reason|0|||
127973099|NCT00348595|460522512|FG000|Overall Study|Adverse Event|5|||
127973100|NCT00348595|460522513|FG001|Overall Study|Adverse Event|8|||
127973101|NCT01942486|460522516|FG000|Overall Study|Lost to Follow-up|27|||
127973102|NCT02048826|460522517|FG000|Overall Study|Withdrawal by Subject|1|||
127973103|NCT02048826|460522518|FG001|Overall Study|Withdrawal by Subject|0|||
127973104|NCT01011465|460522519|FG000|Overall Study|Withdrawal by Subject|2|||
127973105|NCT01011465|460522520|FG001|Overall Study|Withdrawal by Subject|1|||
127973106|NCT01011465|460522521|FG002|Overall Study|Withdrawal by Subject|0|||
127973107|NCT01011465|460522522|FG003|Overall Study|Withdrawal by Subject|0|||
127973108|NCT01011465|460522523|FG004|Overall Study|Withdrawal by Subject|1|||
127973109|NCT01011465|460522524|FG005|Overall Study|Withdrawal by Subject|0|||
127973110|NCT01011465|460522525|FG006|Overall Study|Withdrawal by Subject|1|||
127973111|NCT01011465|460522526|FG007|Overall Study|Withdrawal by Subject|0|||
127973112|NCT00723008|460522528|FG000|Enrollment|Lost to Follow-up|1|||
127973113|NCT00723008|460522529|FG001|Enrollment|Lost to Follow-up|0|||
127973114|NCT00723008|460522528|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
127973115|NCT00723008|460522529|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
127973116|NCT00723008|460522528|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
127973117|NCT00723008|460522529|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
127973118|NCT00723008|460522528|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
127973119|NCT00723008|460522529|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
127973120|NCT00723008|460522528|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
127973121|NCT00723008|460522529|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
127973122|NCT00723008|460522528|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
127973123|NCT00723008|460522529|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
127973124|NCT01014988|460522531|FG000|Overall Study|Adverse Event|20|||
127973125|NCT01014988|460522532|FG001|Overall Study|Adverse Event|0|||
127973126|NCT01014988|460522533|FG002|Overall Study|Adverse Event|1|||
127973127|NCT01014988|460522534|FG003|Overall Study|Adverse Event|0|||
127973128|NCT01014988|460522535|FG004|Overall Study|Adverse Event|1|||
127973129|NCT01014988|460522536|FG005|Overall Study|Adverse Event|3|||
127973130|NCT01014988|460522531|FG000|Overall Study|Lost to Follow-up|1|||
127973131|NCT01014988|460522532|FG001|Overall Study|Lost to Follow-up|0|||
127973132|NCT01014988|460522533|FG002|Overall Study|Lost to Follow-up|1|||
127973133|NCT01014988|460522534|FG003|Overall Study|Lost to Follow-up|0|||
127973134|NCT01014988|460522535|FG004|Overall Study|Lost to Follow-up|0|||
127973135|NCT01014988|460522536|FG005|Overall Study|Lost to Follow-up|0|||
127973136|NCT01014988|460522531|FG000|Overall Study|Physician Decision|1|||
127973137|NCT01014988|460522532|FG001|Overall Study|Physician Decision|0|||
127973138|NCT01014988|460522533|FG002|Overall Study|Physician Decision|0|||
127973139|NCT01014988|460522534|FG003|Overall Study|Physician Decision|0|||
127973140|NCT01014988|460522535|FG004|Overall Study|Physician Decision|0|||
127973141|NCT01014988|460522536|FG005|Overall Study|Physician Decision|0|||
127973142|NCT01014988|460522531|FG000|Overall Study|Withdrawal by Subject|1|||
127973143|NCT01014988|460522532|FG001|Overall Study|Withdrawal by Subject|0|||
127973144|NCT01014988|460522533|FG002|Overall Study|Withdrawal by Subject|0|||
127973145|NCT01014988|460522534|FG003|Overall Study|Withdrawal by Subject|0|||
127973146|NCT01014988|460522535|FG004|Overall Study|Withdrawal by Subject|0|||
127973147|NCT01014988|460522536|FG005|Overall Study|Withdrawal by Subject|0|||
127973148|NCT01683266|460522538|FG000|Overall Study|Adverse Event|5|||
127973149|NCT01683266|460522539|FG001|Overall Study|Adverse Event|4|||
127973150|NCT01683266|460522538|FG000|Overall Study|Lack of Efficacy|5|||
127973151|NCT01683266|460522539|FG001|Overall Study|Lack of Efficacy|2|||
127973152|NCT01683266|460522538|FG000|Overall Study|Protocol Violation|13|||
127973153|NCT01683266|460522539|FG001|Overall Study|Protocol Violation|6|||
127973154|NCT01683266|460522538|FG000|Overall Study|Personal Reason|17|||
127973155|NCT01683266|460522539|FG001|Overall Study|Personal Reason|25|||
127973156|NCT01683266|460522538|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
127973157|NCT01683266|460522539|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
127973158|NCT01683266|460522538|FG000|Overall Study|Lost to Follow-up|5|||
127973159|NCT01683266|460522539|FG001|Overall Study|Lost to Follow-up|0|||
127973160|NCT01683266|460522538|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
127973161|NCT01683266|460522539|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
127973162|NCT01683266|460522538|FG000|Overall Study|Nonserious Hypoglycemia|0|||
127973163|NCT01683266|460522539|FG001|Overall Study|Nonserious Hypoglycemia|3|||
127973164|NCT01683266|460522538|FG000|Overall Study|Perceived Lack of Efficacy|1|||
127973165|NCT01683266|460522539|FG001|Overall Study|Perceived Lack of Efficacy|1|||
127973166|NCT01683266|460522538|FG000|Overall Study|Possibly Hypoglycemia|1|||
127973167|NCT01683266|460522539|FG001|Overall Study|Possibly Hypoglycemia|0|||
127973168|NCT01683266|460522538|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
127973169|NCT01683266|460522539|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
127973170|NCT01867710|460522549|FG000|Overall Study|Death|25|||
127973171|NCT01867710|460522550|FG001|Overall Study|Death|15|||
127973172|NCT01867710|460522551|FG002|Overall Study|Death|27|||
127973173|NCT01867710|460522552|FG003|Overall Study|Death|20|||
127973174|NCT01867710|460522549|FG000|Overall Study|Lost to Follow-up|3|||
127973175|NCT01867710|460522550|FG001|Overall Study|Lost to Follow-up|4|||
127973176|NCT01867710|460522551|FG002|Overall Study|Lost to Follow-up|3|||
127973177|NCT01867710|460522552|FG003|Overall Study|Lost to Follow-up|2|||
127973178|NCT01867710|460522549|FG000|Overall Study|Withdrawal of consent|2|||
127973179|NCT01867710|460522550|FG001|Overall Study|Withdrawal of consent|5|||
127973180|NCT01867710|460522551|FG002|Overall Study|Withdrawal of consent|1|||
127973181|NCT01867710|460522552|FG003|Overall Study|Withdrawal of consent|2|||
127973182|NCT01867710|460522549|FG000|Overall Study|Study Terminated by Sponsor|9|||
127973183|NCT01867710|460522550|FG001|Overall Study|Study Terminated by Sponsor|13|||
127973184|NCT01867710|460522551|FG002|Overall Study|Study Terminated by Sponsor|8|||
127973185|NCT01867710|460522552|FG003|Overall Study|Study Terminated by Sponsor|16|||
127973186|NCT01867710|460522549|FG000|Overall Study|Biochemical progression|0|||
127973187|NCT01867710|460522550|FG001|Overall Study|Biochemical progression|1|||
127973188|NCT01867710|460522551|FG002|Overall Study|Biochemical progression|0|||
127973189|NCT01867710|460522552|FG003|Overall Study|Biochemical progression|0|||
127485502|NCT02629861|458741198|FG000|Overall Study|Withdrawal by Subject|5|||
127973190|NCT01867710|460522549|FG000|Overall Study|Clinical progression|0|||
127973191|NCT01867710|460522550|FG001|Overall Study|Clinical progression|0|||
127973192|NCT01867710|460522551|FG002|Overall Study|Clinical progression|1|||
127973193|NCT01867710|460522552|FG003|Overall Study|Clinical progression|0|||
127973194|NCT01867710|460522549|FG000|Overall Study|Disease progression|1|||
127973195|NCT01867710|460522550|FG001|Overall Study|Disease progression|0|||
127973196|NCT01867710|460522551|FG002|Overall Study|Disease progression|0|||
127973197|NCT01867710|460522552|FG003|Overall Study|Disease progression|0|||
127973198|NCT01867710|460522549|FG000|Overall Study|Patient decision|0|||
127973199|NCT01867710|460522550|FG001|Overall Study|Patient decision|0|||
127973200|NCT01867710|460522551|FG002|Overall Study|Patient decision|0|||
127973201|NCT01867710|460522552|FG003|Overall Study|Patient decision|1|||
127973202|NCT01867710|460522549|FG000|Overall Study|Patient to follow subsequent treatment|0|||
127973203|NCT01867710|460522550|FG001|Overall Study|Patient to follow subsequent treatment|1|||
127973204|NCT01867710|460522551|FG002|Overall Study|Patient to follow subsequent treatment|0|||
127973205|NCT01867710|460522552|FG003|Overall Study|Patient to follow subsequent treatment|0|||
127973206|NCT01867710|460522549|FG000|Overall Study|Progressive disease|1|||
127973207|NCT01867710|460522550|FG001|Overall Study|Progressive disease|0|||
127973208|NCT01867710|460522551|FG002|Overall Study|Progressive disease|0|||
127973209|NCT01867710|460522552|FG003|Overall Study|Progressive disease|0|||
127973210|NCT01867710|460522549|FG000|Overall Study|Protocol Violation|0|||
127973211|NCT01867710|460522550|FG001|Overall Study|Protocol Violation|0|||
127973212|NCT01867710|460522551|FG002|Overall Study|Protocol Violation|0|||
127973213|NCT01867710|460522552|FG003|Overall Study|Protocol Violation|1|||
127973214|NCT01867710|460522549|FG000|Overall Study|PSA-progression|0|||
127973215|NCT01867710|460522550|FG001|Overall Study|PSA-progression|1|||
127973216|NCT01867710|460522551|FG002|Overall Study|PSA-progression|0|||
127973217|NCT01867710|460522552|FG003|Overall Study|PSA-progression|0|||
127973218|NCT01867710|460522549|FG000|Overall Study|Study medication no longer effective|0|||
127973219|NCT01867710|460522550|FG001|Overall Study|Study medication no longer effective|1|||
127973220|NCT01867710|460522551|FG002|Overall Study|Study medication no longer effective|0|||
127973221|NCT01867710|460522552|FG003|Overall Study|Study medication no longer effective|0|||
127973222|NCT01062113|460522553|FG000|Overall Study|Adverse Event|1|||
127973223|NCT01062113|460522554|FG001|Overall Study|Adverse Event|0|||
127973224|NCT01062113|460522555|FG002|Overall Study|Adverse Event|0|||
127973225|NCT01062113|460522553|FG000|Overall Study|Lack of Efficacy|38|||
127973226|NCT01062113|460522554|FG001|Overall Study|Lack of Efficacy|22|||
127973227|NCT01062113|460522555|FG002|Overall Study|Lack of Efficacy|31|||
127973228|NCT01062113|460522553|FG000|Overall Study|Withdrawal by Subject|1|||
127973229|NCT01062113|460522554|FG001|Overall Study|Withdrawal by Subject|0|||
127973230|NCT01062113|460522555|FG002|Overall Study|Withdrawal by Subject|0|||
127973231|NCT01471340|460522556|FG000|Overall Study|Death|5|||
127973232|NCT01471340|460522557|FG001|Overall Study|Death|4|||
127973233|NCT01471340|460522556|FG000|Overall Study|Lost to Follow-up|0|||
127973234|NCT01471340|460522557|FG001|Overall Study|Lost to Follow-up|1|||
127973235|NCT01471340|460522556|FG000|Overall Study|Investigational site closure|0|||
127973236|NCT01471340|460522557|FG001|Overall Study|Investigational site closure|1|||
127973237|NCT01471340|460522556|FG000|Overall Study|Invalid informed consent|1|||
127973238|NCT01471340|460522557|FG001|Overall Study|Invalid informed consent|0|||
127973239|NCT00526669|460522560|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
127973240|NCT00526669|460522561|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
127973241|NCT00526669|460522560|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
127973242|NCT00526669|460522561|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
127973243|NCT00526669|460522560|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
127973244|NCT00526669|460522561|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
127973245|NCT00526669|460522560|FG000|Combined Treatment Phase|Death|0|||
127973246|NCT00526669|460522561|FG001|Combined Treatment Phase|Death|2|||
127973247|NCT03499899|460522563|FG000|Overall Study|Adverse Event|2|||
127973248|NCT03499899|460522564|FG001|Overall Study|Adverse Event|3|||
127973249|NCT03499899|460522565|FG002|Overall Study|Adverse Event|3|||
127973250|NCT03499899|460522563|FG000|Overall Study|Death|0|||
127973251|NCT03499899|460522564|FG001|Overall Study|Death|0|||
127973252|NCT03499899|460522565|FG002|Overall Study|Death|1|||
127973253|NCT03499899|460522563|FG000|Overall Study|Physician Decision|3|||
127973254|NCT03499899|460522564|FG001|Overall Study|Physician Decision|6|||
127973255|NCT03499899|460522565|FG002|Overall Study|Physician Decision|6|||
127973256|NCT03499899|460522563|FG000|Overall Study|Progressive disease|15|||
127973257|NCT03499899|460522564|FG001|Overall Study|Progressive disease|23|||
127973258|NCT03499899|460522565|FG002|Overall Study|Progressive disease|23|||
127973259|NCT03499899|460522563|FG000|Overall Study|Patient decision|0|||
127973260|NCT03499899|460522564|FG001|Overall Study|Patient decision|1|||
127973261|NCT03499899|460522565|FG002|Overall Study|Patient decision|1|||
127973262|NCT03499899|460522563|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
127973263|NCT03499899|460522564|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
127973264|NCT03499899|460522565|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
127973265|NCT01082211|460522567|FG000|Overall Study|Protocol Violation|4|||
127973266|NCT01082211|460522567|FG000|Overall Study|No protocol treatment received|3|||
127973267|NCT03702010|460522570|FG000|Follow-up (30days)|Lack of Efficacy|2|||
127973268|NCT03702010|460522571|FG001|Follow-up (30days)|Lack of Efficacy|2|||
127973269|NCT02394340|460522586|FG000|Overall Study|Failed drug screen test|1|||
127973270|NCT02394340|460522586|FG000|Overall Study|Adverse Event|1|||
127973271|NCT02004886|460522588|FG000|Overall Study|Adverse Event|0|||
127973272|NCT02004886|460522589|FG001|Overall Study|Adverse Event|1|||
127973273|NCT02004886|460522590|FG002|Overall Study|Adverse Event|0|||
127973274|NCT02004886|460522591|FG003|Overall Study|Adverse Event|0|||
127973275|NCT02004886|460522588|FG000|Overall Study|Unable to attend future visits|1|||
127973276|NCT02004886|460522589|FG001|Overall Study|Unable to attend future visits|0|||
127973277|NCT02004886|460522590|FG002|Overall Study|Unable to attend future visits|0|||
127973278|NCT02004886|460522591|FG003|Overall Study|Unable to attend future visits|0|||
127973279|NCT01876784|460522592|FG000|Randomized Treatment Period (40 Months)|Withdrawal by Subject|20|||
127973280|NCT01876784|460522593|FG001|Randomized Treatment Period (40 Months)|Withdrawal by Subject|4|||
127973281|NCT01876784|460522592|FG000|Randomized Treatment Period (40 Months)|Adverse Event|22|||
127973282|NCT01876784|460522593|FG001|Randomized Treatment Period (40 Months)|Adverse Event|5|||
127973283|NCT01876784|460522592|FG000|Randomized Treatment Period (40 Months)|Protocol Violation|1|||
127973284|NCT01876784|460522593|FG001|Randomized Treatment Period (40 Months)|Protocol Violation|0|||
127973285|NCT01876784|460522592|FG000|Randomized Treatment Period (40 Months)|Disease progression|43|||
127973286|NCT01876784|460522593|FG001|Randomized Treatment Period (40 Months)|Disease progression|81|||
127973287|NCT01876784|460522592|FG000|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
127973288|NCT01876784|460522593|FG001|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
127973289|NCT01876784|460522592|FG000|Randomized Treatment Period (40 Months)|Death|1|||
127973290|NCT01876784|460522593|FG001|Randomized Treatment Period (40 Months)|Death|0|||
127973291|NCT01876784|460522592|FG000|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|5|||
127973292|NCT01876784|460522593|FG001|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|2|||
127973293|NCT01876784|460522592|FG000|Randomized Treatment Period (40 Months)|Randomized but not treated|2|||
127973294|NCT01876784|460522593|FG001|Randomized Treatment Period (40 Months)|Randomized but not treated|1|||
127973295|NCT01876784|460522592|FG000|Randomized Treatment Period (40 Months)|Other than specified above|24|||
127973296|NCT01876784|460522593|FG001|Randomized Treatment Period (40 Months)|Other than specified above|25|||
127973297|NCT01876784|460522592|FG000|Open-label Period (31 Months)|Withdrawal by Subject|6|||
127973298|NCT01876784|460522593|FG001|Open-label Period (31 Months)|Withdrawal by Subject|8|||
127973299|NCT01876784|460522592|FG000|Open-label Period (31 Months)|Adverse Event|2|||
127973300|NCT01876784|460522593|FG001|Open-label Period (31 Months)|Adverse Event|6|||
127973301|NCT01876784|460522592|FG000|Open-label Period (31 Months)|Protocol Violation|0|||
127973302|NCT01876784|460522593|FG001|Open-label Period (31 Months)|Protocol Violation|1|||
127973303|NCT01876784|460522592|FG000|Open-label Period (31 Months)|Progressive disease|4|||
127973304|NCT01876784|460522593|FG001|Open-label Period (31 Months)|Progressive disease|35|||
127973305|NCT01876784|460522592|FG000|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|1|||
127973306|NCT01876784|460522593|FG001|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|5|||
127973307|NCT01876784|460522592|FG000|Open-label Period (31 Months)|Lost to Follow-up|1|||
127973308|NCT01876784|460522593|FG001|Open-label Period (31 Months)|Lost to Follow-up|0|||
127973309|NCT01876784|460522592|FG000|Open-label Period (31 Months)|Death|0|||
127973310|NCT01876784|460522593|FG001|Open-label Period (31 Months)|Death|1|||
127973311|NCT01876784|460522592|FG000|Open-label Period (31 Months)|Other than specified above|9|||
127973312|NCT01876784|460522593|FG001|Open-label Period (31 Months)|Other than specified above|18|||
127973313|NCT03605862|460522594|FG000|Overall Study|Withdrawal by Subject|12|||
127973314|NCT03605862|460522595|FG001|Overall Study|Withdrawal by Subject|9|||
127973315|NCT03605862|460522594|FG000|Overall Study|Adverse Event|2|||
127973316|NCT03605862|460522595|FG001|Overall Study|Adverse Event|1|||
127973317|NCT03605862|460522594|FG000|Overall Study|Physician Decision|3|||
127973318|NCT03605862|460522595|FG001|Overall Study|Physician Decision|1|||
127973319|NCT03605862|460522594|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
127973320|NCT03605862|460522595|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
127973321|NCT05239494|460522596|FG000|Overall Study|Lost to Follow-up|1|||
127973322|NCT03891862|460522597|FG000|Open-label Period|Adverse Event|2|||
127973323|NCT03891862|460522598|FG001|Open-label Period|Adverse Event|0|||
127973324|NCT03891862|460522599|FG002|Open-label Period|Adverse Event|0|||
127973325|NCT03891862|460522597|FG000|Open-label Period|Protocol Violation|5|||
127973326|NCT03891862|460522598|FG001|Open-label Period|Protocol Violation|0|||
127973327|NCT03891862|460522599|FG002|Open-label Period|Protocol Violation|0|||
127973328|NCT03891862|460522597|FG000|Open-label Period|Withdrawal by Subject|6|||
127973329|NCT03891862|460522598|FG001|Open-label Period|Withdrawal by Subject|0|||
127973330|NCT03891862|460522599|FG002|Open-label Period|Withdrawal by Subject|0|||
127973331|NCT03891862|460522597|FG000|Open-label Period|Death|1|||
127973332|NCT03891862|460522598|FG001|Open-label Period|Death|0|||
127973333|NCT03891862|460522599|FG002|Open-label Period|Death|0|||
127973334|NCT03891862|460522597|FG000|Open-label Period|Lost to Follow-up|2|||
127973335|NCT03891862|460522598|FG001|Open-label Period|Lost to Follow-up|0|||
127973336|NCT03891862|460522599|FG002|Open-label Period|Lost to Follow-up|0|||
127973337|NCT03891862|460522597|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
127973338|NCT03891862|460522598|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
127973339|NCT03891862|460522599|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
127973340|NCT03891862|460522597|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
127973341|NCT03891862|460522598|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
127973342|NCT03891862|460522599|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
127973343|NCT03891862|460522597|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
127973344|NCT03891862|460522598|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
127973345|NCT03891862|460522599|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
127973346|NCT03891862|460522597|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
127973347|NCT03891862|460522598|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
127973348|NCT03891862|460522599|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
127973349|NCT01194531|460522600|FG000|Overall Study|Withdrawal by Subject|1|||
127973350|NCT01194531|460522601|FG001|Overall Study|Withdrawal by Subject|0|||
127973351|NCT01194531|460522600|FG000|Overall Study|Protocol Violation|4|||
127973352|NCT01194531|460522601|FG001|Overall Study|Protocol Violation|1|||
127973353|NCT01194531|460522600|FG000|Overall Study|Physician Decision|0|||
127973354|NCT01194531|460522601|FG001|Overall Study|Physician Decision|2|||
127973355|NCT01053962|460522602|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
127973356|NCT01053962|460522603|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
127973357|NCT01053962|460522604|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
127973358|NCT01053962|460522605|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
127973359|NCT01053962|460522606|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
127973360|NCT01053962|460522602|FG000|Pretreatment Period|Venipuncture Failure|0|||
127868750|NCT01072175|460137389|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
127868751|NCT01072175|460137390|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
127868752|NCT01072175|460137391|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
127868753|NCT01072175|460137392|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
127868754|NCT01072175|460137393|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
127973361|NCT01053962|460522603|FG001|Pretreatment Period|Venipuncture Failure|0|||
127973362|NCT01053962|460522604|FG002|Pretreatment Period|Venipuncture Failure|1|||
127973363|NCT01053962|460522605|FG003|Pretreatment Period|Venipuncture Failure|0|||
127973364|NCT01053962|460522606|FG004|Pretreatment Period|Venipuncture Failure|0|||
127973365|NCT01053962|460522602|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
127973366|NCT01053962|460522603|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
127973367|NCT01053962|460522604|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
127973368|NCT01053962|460522605|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
127973369|NCT01053962|460522606|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
127973370|NCT01053962|460522602|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
127973371|NCT01053962|460522603|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
127973372|NCT01053962|460522604|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
127973373|NCT01053962|460522605|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
127973374|NCT01053962|460522606|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
127973375|NCT01053962|460522602|FG000|Treatment Period|Lack of Efficacy|0|||
127973376|NCT01053962|460522603|FG001|Treatment Period|Lack of Efficacy|0|||
127973377|NCT01053962|460522604|FG002|Treatment Period|Lack of Efficacy|0|||
127973378|NCT01053962|460522605|FG003|Treatment Period|Lack of Efficacy|0|||
127973379|NCT01053962|460522606|FG004|Treatment Period|Lack of Efficacy|1|||
127973380|NCT01053962|460522602|FG000|Treatment Period|Adverse Event|0|||
127973381|NCT01053962|460522603|FG001|Treatment Period|Adverse Event|0|||
127973382|NCT01053962|460522604|FG002|Treatment Period|Adverse Event|0|||
127973383|NCT01053962|460522605|FG003|Treatment Period|Adverse Event|0|||
127973384|NCT01053962|460522606|FG004|Treatment Period|Adverse Event|1|||
127973385|NCT01053962|460522602|FG000|Treatment Period|Withdrawal by Subject|0|||
127973386|NCT01053962|460522603|FG001|Treatment Period|Withdrawal by Subject|0|||
127973387|NCT01053962|460522604|FG002|Treatment Period|Withdrawal by Subject|0|||
127973388|NCT01053962|460522605|FG003|Treatment Period|Withdrawal by Subject|0|||
127973389|NCT01053962|460522606|FG004|Treatment Period|Withdrawal by Subject|1|||
127973390|NCT01053962|460522602|FG000|Treatment Period|Noncompliance with protocol|1|||
127973391|NCT01053962|460522603|FG001|Treatment Period|Noncompliance with protocol|0|||
127973392|NCT01053962|460522604|FG002|Treatment Period|Noncompliance with protocol|0|||
127973393|NCT01053962|460522605|FG003|Treatment Period|Noncompliance with protocol|0|||
127973394|NCT01053962|460522606|FG004|Treatment Period|Noncompliance with protocol|0|||
127973395|NCT01894100|460522608|FG000|Overall Study|Lost to Follow-up|0|||
127973396|NCT01894100|460522609|FG001|Overall Study|Lost to Follow-up|1|||
127973397|NCT01894100|460522608|FG000|Overall Study|Withdrawal by Subject|3|||
127973398|NCT01894100|460522609|FG001|Overall Study|Withdrawal by Subject|0|||
127973399|NCT01094301|460522610|FG000|Trial Stage|Withdrawal by Subject|1|||
127973400|NCT01094301|460522610|FG000|Implant Stage|Adverse Event|1|||
127973401|NCT01094301|460522610|FG000|Implant Stage|Protocol Violation|1|||
127973402|NCT01094301|460522610|FG000|Implant Stage|Withdrawal by Subject|2|||
127973403|NCT01094301|460522610|FG000|Implant Stage|No return of pain|4|||
127973404|NCT02235077|460522611|FG000|Overall Study|Death|5|||
127973405|NCT02235077|460522612|FG001|Overall Study|Death|7|||
127973406|NCT02235077|460522611|FG000|Overall Study|Lost to Follow-up|5|||
127973407|NCT02235077|460522612|FG001|Overall Study|Lost to Follow-up|6|||
127973408|NCT02235077|460522611|FG000|Overall Study|Withdrawal by Subject|8|||
127973409|NCT02235077|460522612|FG001|Overall Study|Withdrawal by Subject|5|||
127973410|NCT02235077|460522611|FG000|Overall Study|Physician Decision|0|||
127973411|NCT02235077|460522612|FG001|Overall Study|Physician Decision|1|||
127973412|NCT04013672|460522614|FG000|Overall Study|Withdrawal by Subject|3|||
127973413|NCT04013672|460522615|FG001|Overall Study|Withdrawal by Subject|0|||
127973414|NCT04013672|460522614|FG000|Overall Study|Death|1|||
127973415|NCT04013672|460522615|FG001|Overall Study|Death|0|||
127973416|NCT04013672|460522614|FG000|Overall Study|Physician Decision|5|||
127973417|NCT04013672|460522615|FG001|Overall Study|Physician Decision|0|||
127973418|NCT00586820|460522616|FG000|Overall Study|Unsuccessful PCI|1|||
127973419|NCT00586820|460522617|FG001|Overall Study|Unsuccessful PCI|0|||
127973420|NCT03887442|460522618|FG000|Overall Study|Adverse Event|1|||
127973421|NCT03887442|460522619|FG001|Overall Study|Adverse Event|0|||
127973422|NCT01868022|460522620|FG000|Overall Study|Withdrawal by Subject|0|||
127973423|NCT01868022|460522621|FG001|Overall Study|Withdrawal by Subject|0|||
127973424|NCT01868022|460522622|FG002|Overall Study|Withdrawal by Subject|1|||
127973425|NCT01868022|460522623|FG003|Overall Study|Withdrawal by Subject|1|||
127973426|NCT01868022|460522624|FG004|Overall Study|Withdrawal by Subject|0|||
127973427|NCT01868022|460522625|FG005|Overall Study|Withdrawal by Subject|0|||
127973428|NCT01868022|460522626|FG006|Overall Study|Withdrawal by Subject|0|||
127973429|NCT01868022|460522627|FG007|Overall Study|Withdrawal by Subject|1|||
127973430|NCT01868022|460522628|FG008|Overall Study|Withdrawal by Subject|0|||
127973431|NCT01868022|460522620|FG000|Overall Study|Adverse Event|0|||
127973432|NCT01868022|460522621|FG001|Overall Study|Adverse Event|0|||
127973433|NCT01868022|460522622|FG002|Overall Study|Adverse Event|0|||
127973434|NCT01868022|460522623|FG003|Overall Study|Adverse Event|0|||
127973435|NCT01868022|460522624|FG004|Overall Study|Adverse Event|2|||
127973436|NCT01868022|460522625|FG005|Overall Study|Adverse Event|0|||
127973437|NCT01868022|460522626|FG006|Overall Study|Adverse Event|0|||
127973438|NCT01868022|460522627|FG007|Overall Study|Adverse Event|2|||
127973439|NCT01868022|460522628|FG008|Overall Study|Adverse Event|2|||
127973440|NCT01868022|460522620|FG000|Overall Study|Physician Decision|0|||
127973441|NCT01868022|460522621|FG001|Overall Study|Physician Decision|0|||
127973442|NCT01868022|460522622|FG002|Overall Study|Physician Decision|0|||
127973443|NCT01868022|460522623|FG003|Overall Study|Physician Decision|0|||
127973444|NCT01868022|460522624|FG004|Overall Study|Physician Decision|0|||
127973445|NCT01868022|460522625|FG005|Overall Study|Physician Decision|1|||
127973446|NCT01868022|460522626|FG006|Overall Study|Physician Decision|0|||
127973447|NCT01868022|460522627|FG007|Overall Study|Physician Decision|2|||
127973448|NCT01868022|460522628|FG008|Overall Study|Physician Decision|0|||
127973449|NCT01868022|460522620|FG000|Overall Study|Study closed/terminated|0|||
127973450|NCT01868022|460522621|FG001|Overall Study|Study closed/terminated|0|||
127973451|NCT01868022|460522622|FG002|Overall Study|Study closed/terminated|0|||
127973452|NCT01868022|460522623|FG003|Overall Study|Study closed/terminated|0|||
127973453|NCT01868022|460522624|FG004|Overall Study|Study closed/terminated|0|||
127973454|NCT01868022|460522625|FG005|Overall Study|Study closed/terminated|0|||
127973455|NCT01868022|460522626|FG006|Overall Study|Study closed/terminated|0|||
127973456|NCT01868022|460522627|FG007|Overall Study|Study closed/terminated|1|||
127973457|NCT01868022|460522628|FG008|Overall Study|Study closed/terminated|0|||
127973458|NCT01868022|460522620|FG000|Overall Study|Ongoing|0|||
127973459|NCT01868022|460522621|FG001|Overall Study|Ongoing|0|||
127973460|NCT01868022|460522622|FG002|Overall Study|Ongoing|0|||
127973461|NCT01868022|460522623|FG003|Overall Study|Ongoing|0|||
127973462|NCT01868022|460522624|FG004|Overall Study|Ongoing|0|||
127973463|NCT01868022|460522625|FG005|Overall Study|Ongoing|0|||
127973464|NCT01868022|460522626|FG006|Overall Study|Ongoing|0|||
127973465|NCT01868022|460522627|FG007|Overall Study|Ongoing|3|||
127973466|NCT01868022|460522628|FG008|Overall Study|Ongoing|0|||
127973467|NCT01628198|460522629|FG000|Overall Study|Lost to Follow-up|7|||
127973468|NCT01628198|460522629|FG000|Overall Study|Withdrawal by Subject|10|||
127973469|NCT01628198|460522629|FG000|Overall Study|Screen failure|1|||
127973470|NCT02122887|460522630|FG000|Overall Study|Withdrawal by Subject|20|||
127973471|NCT02122887|460522631|FG001|Overall Study|Withdrawal by Subject|2|||
127973472|NCT00972816|460524737|FG000|Overall Study|Adverse Event|0|||
127973473|NCT00972816|460524738|FG001|Overall Study|Adverse Event|0|||
127973474|NCT00972816|460524739|FG002|Overall Study|Adverse Event|1|||
127973475|NCT00972816|460524740|FG003|Overall Study|Adverse Event|0|||
127973476|NCT00972816|460524741|FG004|Overall Study|Adverse Event|0|||
127973477|NCT00972816|460524742|FG005|Overall Study|Adverse Event|0|||
127973478|NCT00972816|460524743|FG006|Overall Study|Adverse Event|0|||
127973479|NCT00972816|460524744|FG007|Overall Study|Adverse Event|0|||
127973480|NCT00972816|460524737|FG000|Overall Study|Withdrawal by Subject|4|||
127973481|NCT00972816|460524738|FG001|Overall Study|Withdrawal by Subject|2|||
127973482|NCT00972816|460524739|FG002|Overall Study|Withdrawal by Subject|1|||
127973483|NCT00972816|460524740|FG003|Overall Study|Withdrawal by Subject|3|||
127973484|NCT00972816|460524741|FG004|Overall Study|Withdrawal by Subject|0|||
127973485|NCT00972816|460524742|FG005|Overall Study|Withdrawal by Subject|1|||
127973486|NCT00972816|460524743|FG006|Overall Study|Withdrawal by Subject|1|||
127973487|NCT00972816|460524744|FG007|Overall Study|Withdrawal by Subject|2|||
127973488|NCT00972816|460524737|FG000|Overall Study|Lost to Follow-up|11|||
127973489|NCT00972816|460524738|FG001|Overall Study|Lost to Follow-up|9|||
127973490|NCT00972816|460524739|FG002|Overall Study|Lost to Follow-up|7|||
127973491|NCT00972816|460524740|FG003|Overall Study|Lost to Follow-up|5|||
127973492|NCT00972816|460524741|FG004|Overall Study|Lost to Follow-up|11|||
127973493|NCT00972816|460524742|FG005|Overall Study|Lost to Follow-up|10|||
127973494|NCT00972816|460524743|FG006|Overall Study|Lost to Follow-up|7|||
127973495|NCT00972816|460524744|FG007|Overall Study|Lost to Follow-up|7|||
127973496|NCT00972816|460524737|FG000|Overall Study|Inappropriate enrolment|0|||
127973497|NCT00972816|460524738|FG001|Overall Study|Inappropriate enrolment|0|||
127973498|NCT00972816|460524739|FG002|Overall Study|Inappropriate enrolment|0|||
127973499|NCT00972816|460524740|FG003|Overall Study|Inappropriate enrolment|0|||
127973500|NCT00972816|460524741|FG004|Overall Study|Inappropriate enrolment|0|||
127973501|NCT00972816|460524742|FG005|Overall Study|Inappropriate enrolment|0|||
127973502|NCT00972816|460524743|FG006|Overall Study|Inappropriate enrolment|2|||
127973503|NCT00972816|460524744|FG007|Overall Study|Inappropriate enrolment|0|||
127973504|NCT00972816|460524737|FG000|Overall Study|Unable to classify|2|||
127973505|NCT00972816|460524738|FG001|Overall Study|Unable to classify|0|||
127973506|NCT00972816|460524739|FG002|Overall Study|Unable to classify|0|||
127973507|NCT00972816|460524740|FG003|Overall Study|Unable to classify|0|||
127973508|NCT00972816|460524741|FG004|Overall Study|Unable to classify|1|||
127973509|NCT00972816|460524742|FG005|Overall Study|Unable to classify|0|||
127973510|NCT00972816|460524743|FG006|Overall Study|Unable to classify|0|||
127973511|NCT00972816|460524744|FG007|Overall Study|Unable to classify|0|||
127973512|NCT01953601|460524747|FG000|Part 1 (Base Study)|Adverse Event|24|||
127973513|NCT01953601|460524748|FG001|Part 1 (Base Study)|Adverse Event|37|||
127973514|NCT01953601|460524749|FG002|Part 1 (Base Study)|Adverse Event|15|||
127973515|NCT01953601|460524747|FG000|Part 1 (Base Study)|Death|2|||
127973516|NCT01953601|460524748|FG001|Part 1 (Base Study)|Death|0|||
127973517|NCT01953601|460524749|FG002|Part 1 (Base Study)|Death|3|||
127973518|NCT01953601|460524747|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
127973519|NCT01953601|460524748|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
127973520|NCT01953601|460524749|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
127973521|NCT01953601|460524747|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
127973522|NCT01953601|460524748|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
127973523|NCT01953601|460524749|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
127973524|NCT01953601|460524747|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
127973525|NCT01953601|460524748|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
127973526|NCT01953601|460524749|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
127973527|NCT01953601|460524747|FG000|Part 1 (Base Study)|Physician Decision|3|||
127973528|NCT01953601|460524748|FG001|Part 1 (Base Study)|Physician Decision|7|||
127973529|NCT01953601|460524749|FG002|Part 1 (Base Study)|Physician Decision|4|||
127973530|NCT01953601|460524747|FG000|Part 1 (Base Study)|Screen failure|1|||
127973531|NCT01953601|460524748|FG001|Part 1 (Base Study)|Screen failure|0|||
127973532|NCT01953601|460524749|FG002|Part 1 (Base Study)|Screen failure|1|||
127973533|NCT01953601|460524747|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
127973534|NCT01953601|460524748|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
127973535|NCT01953601|460524749|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
127973536|NCT01953601|460524747|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
127973537|NCT01953601|460524748|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
127973538|NCT01953601|460524749|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
127973539|NCT01953601|460524747|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
127973540|NCT01953601|460524748|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
127973541|NCT01953601|460524749|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
127973542|NCT01953601|460524747|FG000|Part 1 (Base Study)|Subject moved|2|||
127973543|NCT01953601|460524748|FG001|Part 1 (Base Study)|Subject moved|2|||
127973544|NCT01953601|460524749|FG002|Part 1 (Base Study)|Subject moved|1|||
127973545|NCT01953601|460524747|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
127973546|NCT01953601|460524748|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
127973547|NCT01953601|460524749|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
127973548|NCT01953601|460524747|FG000|Part 2 (Extension Study)|Adverse Event|1|||
127973549|NCT01953601|460524748|FG001|Part 2 (Extension Study)|Adverse Event|1|||
127973550|NCT01953601|460524749|FG002|Part 2 (Extension Study)|Adverse Event|10|||
127973551|NCT01953601|460524747|FG000|Part 2 (Extension Study)|Death|0|||
127973552|NCT01953601|460524748|FG001|Part 2 (Extension Study)|Death|3|||
127973553|NCT01953601|460524749|FG002|Part 2 (Extension Study)|Death|0|||
127973554|NCT01953601|460524747|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
127973555|NCT01953601|460524748|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
127973556|NCT01953601|460524749|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
127973557|NCT01953601|460524747|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
127973558|NCT01953601|460524748|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
127973559|NCT01953601|460524749|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
127973560|NCT01953601|460524747|FG000|Part 2 (Extension Study)|Physician Decision|2|||
127973561|NCT01953601|460524748|FG001|Part 2 (Extension Study)|Physician Decision|0|||
127973562|NCT01953601|460524749|FG002|Part 2 (Extension Study)|Physician Decision|2|||
127973563|NCT01953601|460524747|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
127973564|NCT01953601|460524748|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
127973565|NCT01953601|460524749|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
127973566|NCT01953601|460524747|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
127973567|NCT01953601|460524748|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
127973568|NCT01953601|460524749|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
127973569|NCT01953601|460524747|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
127973570|NCT01953601|460524748|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
127973571|NCT01953601|460524749|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
127973572|NCT01953601|460524747|FG000|Part 2 (Extension Study)|Subject moved|0|||
127973573|NCT01953601|460524748|FG001|Part 2 (Extension Study)|Subject moved|0|||
127973574|NCT01953601|460524749|FG002|Part 2 (Extension Study)|Subject moved|1|||
127973575|NCT01953601|460524747|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
127973576|NCT01953601|460524748|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
127973577|NCT01953601|460524749|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
127973578|NCT03991299|460524757|FG000|Overall Study|Study closed, sponsor decision|3|||
127973579|NCT03991299|460524757|FG000|Overall Study|Withdrawal by Subject|1|||
127973580|NCT03728426|460524764|FG000|Overall Study|Death|3|||
127973581|NCT00231114|460524769|FG000|Randomized|Withdrawal by Subject|6|||
127973582|NCT00231114|460524770|FG001|Randomized|Withdrawal by Subject|3|||
127973583|NCT00231114|460524769|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
127973584|NCT00231114|460524770|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
127973585|NCT00231114|460524769|FG000|Post-Treatment Period|Lost to Follow-up|6|||
127973586|NCT00231114|460524770|FG001|Post-Treatment Period|Lost to Follow-up|1|||
127973587|NCT00231114|460524769|FG000|Post-Treatment Period|Physician Decision|1|||
127973588|NCT00231114|460524770|FG001|Post-Treatment Period|Physician Decision|0|||
127973589|NCT00231114|460524769|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
127973590|NCT00231114|460524770|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
127973591|NCT04470544|460524771|FG000|Overall Study|Withdrawal by Subject|4|||
127973592|NCT04470544|460524772|FG001|Overall Study|Withdrawal by Subject|6|||
127973593|NCT00712881|460524774|FG000|Overall Study|Adverse Event|3|||
127973594|NCT00712881|460524775|FG001|Overall Study|Adverse Event|3|||
127973595|NCT00712881|460524774|FG000|Overall Study|Withdrawal by Subject|1|||
127973596|NCT00712881|460524775|FG001|Overall Study|Withdrawal by Subject|1|||
127973597|NCT00712881|460524774|FG000|Overall Study|Disease Progression|2|||
127973598|NCT00712881|460524775|FG001|Overall Study|Disease Progression|1|||
127973599|NCT00712881|460524774|FG000|Overall Study|Lost to Follow-up|1|||
127973600|NCT00712881|460524775|FG001|Overall Study|Lost to Follow-up|1|||
127973601|NCT00712881|460524774|FG000|Overall Study|Non-Compliance To Study Procedures|1|||
127973602|NCT00712881|460524775|FG001|Overall Study|Non-Compliance To Study Procedures|0|||
127973603|NCT00712881|460524774|FG000|Overall Study|Protocol Violation|1|||
127973604|NCT00712881|460524775|FG001|Overall Study|Protocol Violation|1|||
127973605|NCT00712881|460524774|FG000|Overall Study|Randomized but not treated|1|||
127973606|NCT00712881|460524775|FG001|Overall Study|Randomized but not treated|0|||
127973607|NCT01194999|460524776|FG000|Overall Study|Lost to Follow-up|17|||
127973608|NCT05835011|460524777|FG000|Overall Study|Study Terminated by the Sponsor|1|||
127973609|NCT05835011|460524777|FG000|Overall Study|Enrolled but did not receive study treatment|1|||
127973610|NCT03557931|460524789|FG000|Overall Study|Adverse Event|4|||
127973611|NCT03557931|460524790|FG001|Overall Study|Adverse Event|6|||
127973612|NCT03557931|460524791|FG002|Overall Study|Adverse Event|1|||
127973613|NCT03557931|460524789|FG000|Overall Study|Lost to Follow-up|4|||
127973614|NCT03557931|460524790|FG001|Overall Study|Lost to Follow-up|4|||
127973615|NCT03557931|460524791|FG002|Overall Study|Lost to Follow-up|1|||
127973616|NCT03557931|460524789|FG000|Overall Study|Protocol Violation|1|||
127973617|NCT03557931|460524790|FG001|Overall Study|Protocol Violation|4|||
127973618|NCT03557931|460524791|FG002|Overall Study|Protocol Violation|1|||
127973619|NCT03557931|460524789|FG000|Overall Study|Withdrawal by Subject|14|||
127973620|NCT03557931|460524790|FG001|Overall Study|Withdrawal by Subject|0|||
127973621|NCT03557931|460524791|FG002|Overall Study|Withdrawal by Subject|7|||
127973622|NCT03557931|460524789|FG000|Overall Study|Miscellaneous|8|||
127973623|NCT03557931|460524790|FG001|Overall Study|Miscellaneous|5|||
127973624|NCT03557931|460524791|FG002|Overall Study|Miscellaneous|3|||
127973625|NCT02829723|460524794|FG000|Overall Study|Adverse Event|0|||
127973626|NCT02829723|460524795|FG001|Overall Study|Adverse Event|0|||
127973627|NCT02829723|460524796|FG002|Overall Study|Adverse Event|1|||
127973628|NCT02829723|460524797|FG003|Overall Study|Adverse Event|1|||
127973629|NCT02829723|460524798|FG004|Overall Study|Adverse Event|0|||
127973630|NCT02829723|460524799|FG005|Overall Study|Adverse Event|0|||
127973631|NCT02829723|460524800|FG006|Overall Study|Adverse Event|0|||
127973632|NCT02829723|460524801|FG007|Overall Study|Adverse Event|1|||
127973633|NCT02829723|460524802|FG008|Overall Study|Adverse Event|0|||
127973634|NCT02829723|460524803|FG009|Overall Study|Adverse Event|0|||
127973635|NCT02829723|460524804|FG010|Overall Study|Adverse Event|0|||
127973636|NCT02829723|460524805|FG011|Overall Study|Adverse Event|0|||
127973637|NCT02829723|460524806|FG012|Overall Study|Adverse Event|0|||
127973638|NCT02829723|460524807|FG013|Overall Study|Adverse Event|0|||
127973639|NCT02829723|460524808|FG014|Overall Study|Adverse Event|1|||
127973640|NCT02829723|460524809|FG015|Overall Study|Adverse Event|1|||
127973641|NCT02829723|460524810|FG016|Overall Study|Adverse Event|1|||
127973642|NCT02829723|460524811|FG017|Overall Study|Adverse Event|2|||
127973643|NCT02829723|460524812|FG018|Overall Study|Adverse Event|1|||
127973644|NCT02829723|460524813|FG019|Overall Study|Adverse Event|1|||
127973645|NCT02829723|460524814|FG020|Overall Study|Adverse Event|3|||
127973646|NCT02829723|460524815|FG021|Overall Study|Adverse Event|0|||
127973647|NCT02829723|460524816|FG022|Overall Study|Adverse Event|0|||
127973648|NCT02829723|460524817|FG023|Overall Study|Adverse Event|1|||
127973649|NCT02829723|460524818|FG024|Overall Study|Adverse Event|1|||
127973650|NCT02829723|460524819|FG025|Overall Study|Adverse Event|3|||
127973651|NCT02829723|460524820|FG026|Overall Study|Adverse Event|5|||
127973652|NCT02829723|460524794|FG000|Overall Study|Death|1|||
127973653|NCT02829723|460524795|FG001|Overall Study|Death|0|||
127973654|NCT02829723|460524796|FG002|Overall Study|Death|1|||
127973655|NCT02829723|460524797|FG003|Overall Study|Death|1|||
127973656|NCT02829723|460524798|FG004|Overall Study|Death|0|||
127973657|NCT02829723|460524799|FG005|Overall Study|Death|0|||
127973658|NCT02829723|460524800|FG006|Overall Study|Death|2|||
127973659|NCT02829723|460524801|FG007|Overall Study|Death|0|||
127973660|NCT02829723|460524802|FG008|Overall Study|Death|1|||
127973661|NCT02829723|460524803|FG009|Overall Study|Death|0|||
127973662|NCT02829723|460524804|FG010|Overall Study|Death|0|||
127973663|NCT02829723|460524805|FG011|Overall Study|Death|0|||
127973664|NCT02829723|460524806|FG012|Overall Study|Death|2|||
127973665|NCT02829723|460524807|FG013|Overall Study|Death|1|||
127973666|NCT02829723|460524808|FG014|Overall Study|Death|0|||
127973667|NCT02829723|460524809|FG015|Overall Study|Death|0|||
127973668|NCT02829723|460524810|FG016|Overall Study|Death|0|||
127973669|NCT02829723|460524811|FG017|Overall Study|Death|0|||
127973670|NCT02829723|460524812|FG018|Overall Study|Death|0|||
127973671|NCT02829723|460524813|FG019|Overall Study|Death|0|||
127973672|NCT02829723|460524814|FG020|Overall Study|Death|0|||
127973673|NCT02829723|460524815|FG021|Overall Study|Death|2|||
127973674|NCT02829723|460524816|FG022|Overall Study|Death|0|||
127973675|NCT02829723|460524817|FG023|Overall Study|Death|0|||
127973676|NCT02829723|460524818|FG024|Overall Study|Death|0|||
127973677|NCT02829723|460524819|FG025|Overall Study|Death|1|||
127973678|NCT02829723|460524820|FG026|Overall Study|Death|2|||
127973679|NCT02829723|460524794|FG000|Overall Study|Physician Decision|0|||
127973680|NCT02829723|460524795|FG001|Overall Study|Physician Decision|0|||
127973681|NCT02829723|460524796|FG002|Overall Study|Physician Decision|0|||
127973682|NCT02829723|460524797|FG003|Overall Study|Physician Decision|0|||
127973683|NCT02829723|460524798|FG004|Overall Study|Physician Decision|0|||
127973684|NCT02829723|460524799|FG005|Overall Study|Physician Decision|0|||
127973685|NCT02829723|460524800|FG006|Overall Study|Physician Decision|0|||
127973686|NCT02829723|460524801|FG007|Overall Study|Physician Decision|0|||
127973687|NCT02829723|460524802|FG008|Overall Study|Physician Decision|0|||
127973688|NCT02829723|460524803|FG009|Overall Study|Physician Decision|1|||
127973689|NCT02829723|460524804|FG010|Overall Study|Physician Decision|1|||
127973690|NCT02829723|460524805|FG011|Overall Study|Physician Decision|0|||
127973691|NCT02829723|460524806|FG012|Overall Study|Physician Decision|0|||
127973692|NCT02829723|460524807|FG013|Overall Study|Physician Decision|1|||
127973693|NCT02829723|460524808|FG014|Overall Study|Physician Decision|0|||
127973694|NCT02829723|460524809|FG015|Overall Study|Physician Decision|0|||
127973695|NCT02829723|460524810|FG016|Overall Study|Physician Decision|2|||
127973696|NCT02829723|460524811|FG017|Overall Study|Physician Decision|0|||
127973697|NCT02829723|460524812|FG018|Overall Study|Physician Decision|0|||
127973698|NCT02829723|460524813|FG019|Overall Study|Physician Decision|0|||
127973699|NCT02829723|460524814|FG020|Overall Study|Physician Decision|0|||
127973700|NCT02829723|460524815|FG021|Overall Study|Physician Decision|0|||
127973701|NCT02829723|460524816|FG022|Overall Study|Physician Decision|1|||
127973702|NCT02829723|460524817|FG023|Overall Study|Physician Decision|1|||
127973703|NCT02829723|460524818|FG024|Overall Study|Physician Decision|1|||
127973704|NCT02829723|460524819|FG025|Overall Study|Physician Decision|1|||
127973705|NCT02829723|460524820|FG026|Overall Study|Physician Decision|3|||
127973706|NCT02829723|460524794|FG000|Overall Study|Progressive disease|4|||
127973707|NCT02829723|460524795|FG001|Overall Study|Progressive disease|6|||
127973708|NCT02829723|460524796|FG002|Overall Study|Progressive disease|3|||
127973709|NCT02829723|460524797|FG003|Overall Study|Progressive disease|3|||
127973710|NCT02829723|460524798|FG004|Overall Study|Progressive disease|3|||
127973711|NCT02829723|460524799|FG005|Overall Study|Progressive disease|5|||
127973712|NCT02829723|460524800|FG006|Overall Study|Progressive disease|4|||
127973713|NCT02829723|460524801|FG007|Overall Study|Progressive disease|6|||
127973714|NCT02829723|460524802|FG008|Overall Study|Progressive disease|8|||
127973715|NCT02829723|460524803|FG009|Overall Study|Progressive disease|4|||
127973716|NCT02829723|460524804|FG010|Overall Study|Progressive disease|9|||
127973717|NCT02829723|460524805|FG011|Overall Study|Progressive disease|0|||
127973718|NCT02829723|460524806|FG012|Overall Study|Progressive disease|3|||
127973719|NCT02829723|460524807|FG013|Overall Study|Progressive disease|4|||
127973720|NCT02829723|460524808|FG014|Overall Study|Progressive disease|2|||
127973721|NCT02829723|460524809|FG015|Overall Study|Progressive disease|4|||
127973722|NCT02829723|460524810|FG016|Overall Study|Progressive disease|5|||
127973723|NCT02829723|460524811|FG017|Overall Study|Progressive disease|3|||
127973724|NCT02829723|460524812|FG018|Overall Study|Progressive disease|4|||
127973725|NCT02829723|460524813|FG019|Overall Study|Progressive disease|4|||
127973726|NCT02829723|460524814|FG020|Overall Study|Progressive disease|7|||
127973727|NCT02829723|460524815|FG021|Overall Study|Progressive disease|6|||
127973728|NCT02829723|460524816|FG022|Overall Study|Progressive disease|3|||
127973729|NCT02829723|460524817|FG023|Overall Study|Progressive disease|3|||
127973730|NCT02829723|460524818|FG024|Overall Study|Progressive disease|3|||
127973731|NCT02829723|460524819|FG025|Overall Study|Progressive disease|16|||
127973732|NCT02829723|460524820|FG026|Overall Study|Progressive disease|10|||
127973733|NCT02829723|460524794|FG000|Overall Study|Subject/guardian decision|0|||
127973734|NCT02829723|460524795|FG001|Overall Study|Subject/guardian decision|1|||
127973735|NCT02829723|460524796|FG002|Overall Study|Subject/guardian decision|0|||
127973736|NCT02829723|460524797|FG003|Overall Study|Subject/guardian decision|1|||
127973737|NCT02829723|460524798|FG004|Overall Study|Subject/guardian decision|0|||
127973738|NCT02829723|460524799|FG005|Overall Study|Subject/guardian decision|0|||
127973739|NCT02829723|460524800|FG006|Overall Study|Subject/guardian decision|0|||
127973740|NCT02829723|460524801|FG007|Overall Study|Subject/guardian decision|1|||
127973741|NCT02829723|460524802|FG008|Overall Study|Subject/guardian decision|0|||
127973742|NCT02829723|460524803|FG009|Overall Study|Subject/guardian decision|0|||
127973743|NCT02829723|460524804|FG010|Overall Study|Subject/guardian decision|0|||
127973744|NCT02829723|460524805|FG011|Overall Study|Subject/guardian decision|0|||
127973745|NCT02829723|460524806|FG012|Overall Study|Subject/guardian decision|0|||
127973746|NCT02829723|460524807|FG013|Overall Study|Subject/guardian decision|0|||
127973747|NCT02829723|460524808|FG014|Overall Study|Subject/guardian decision|1|||
127973748|NCT02829723|460524809|FG015|Overall Study|Subject/guardian decision|0|||
127973749|NCT02829723|460524810|FG016|Overall Study|Subject/guardian decision|1|||
127973750|NCT02829723|460524811|FG017|Overall Study|Subject/guardian decision|0|||
127973751|NCT02829723|460524812|FG018|Overall Study|Subject/guardian decision|1|||
127973752|NCT02829723|460524813|FG019|Overall Study|Subject/guardian decision|0|||
127973753|NCT02829723|460524814|FG020|Overall Study|Subject/guardian decision|1|||
127973754|NCT02829723|460524815|FG021|Overall Study|Subject/guardian decision|0|||
127973755|NCT02829723|460524816|FG022|Overall Study|Subject/guardian decision|0|||
127973756|NCT02829723|460524817|FG023|Overall Study|Subject/guardian decision|1|||
127973757|NCT02829723|460524818|FG024|Overall Study|Subject/guardian decision|0|||
127973758|NCT02829723|460524819|FG025|Overall Study|Subject/guardian decision|1|||
127973759|NCT02829723|460524820|FG026|Overall Study|Subject/guardian decision|1|||
127973760|NCT02829723|460524794|FG000|Overall Study|Study terminated by sponsor|0|||
127973761|NCT02829723|460524795|FG001|Overall Study|Study terminated by sponsor|0|||
127973762|NCT02829723|460524796|FG002|Overall Study|Study terminated by sponsor|0|||
127973763|NCT02829723|460524797|FG003|Overall Study|Study terminated by sponsor|0|||
127973764|NCT02829723|460524798|FG004|Overall Study|Study terminated by sponsor|0|||
127973765|NCT02829723|460524799|FG005|Overall Study|Study terminated by sponsor|0|||
127973766|NCT02829723|460524800|FG006|Overall Study|Study terminated by sponsor|0|||
127973767|NCT02829723|460524801|FG007|Overall Study|Study terminated by sponsor|0|||
127973768|NCT02829723|460524802|FG008|Overall Study|Study terminated by sponsor|0|||
127973769|NCT02829723|460524803|FG009|Overall Study|Study terminated by sponsor|0|||
127973770|NCT02829723|460524804|FG010|Overall Study|Study terminated by sponsor|0|||
127973771|NCT02829723|460524805|FG011|Overall Study|Study terminated by sponsor|0|||
127973772|NCT02829723|460524806|FG012|Overall Study|Study terminated by sponsor|0|||
127973773|NCT02829723|460524807|FG013|Overall Study|Study terminated by sponsor|0|||
127973774|NCT02829723|460524808|FG014|Overall Study|Study terminated by sponsor|0|||
127973775|NCT02829723|460524809|FG015|Overall Study|Study terminated by sponsor|0|||
127973776|NCT02829723|460524810|FG016|Overall Study|Study terminated by sponsor|0|||
127973777|NCT02829723|460524811|FG017|Overall Study|Study terminated by sponsor|0|||
127973778|NCT02829723|460524812|FG018|Overall Study|Study terminated by sponsor|0|||
127973779|NCT02829723|460524813|FG019|Overall Study|Study terminated by sponsor|0|||
127973780|NCT02829723|460524814|FG020|Overall Study|Study terminated by sponsor|0|||
127973781|NCT02829723|460524815|FG021|Overall Study|Study terminated by sponsor|1|||
127973782|NCT02829723|460524816|FG022|Overall Study|Study terminated by sponsor|0|||
127973783|NCT02829723|460524817|FG023|Overall Study|Study terminated by sponsor|0|||
127973784|NCT02829723|460524818|FG024|Overall Study|Study terminated by sponsor|0|||
127973785|NCT02829723|460524819|FG025|Overall Study|Study terminated by sponsor|0|||
127973786|NCT02829723|460524820|FG026|Overall Study|Study terminated by sponsor|0|||
127973787|NCT02989649|460524821|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
127973788|NCT02989649|460524821|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
127973789|NCT02989649|460524821|FG000|Overall Study|Lost For Observation During Study|3|||
127973790|NCT02989649|460524821|FG000|Overall Study|Reason Not Specified|13|||
127973791|NCT04603482|460524824|FG000|Overall Study|Lost to Follow-up|15|||
127973792|NCT04603482|460524825|FG001|Overall Study|Lost to Follow-up|15|||
127973793|NCT04603482|460524826|FG002|Overall Study|Lost to Follow-up|15|||
127973794|NCT01054196|460524827|FG000|Overall Study|Physician Decision|0|||
127973795|NCT01054196|460524828|FG001|Overall Study|Physician Decision|0|||
127973796|NCT01054196|460524829|FG002|Overall Study|Physician Decision|0|||
127973797|NCT01054196|460524830|FG003|Overall Study|Physician Decision|1|||
127973798|NCT01054196|460524831|FG004|Overall Study|Physician Decision|0|||
127973799|NCT01054196|460524832|FG005|Overall Study|Physician Decision|0|||
127973800|NCT01054196|460524833|FG006|Overall Study|Physician Decision|1|||
127973801|NCT00179673|460524834|FG000|Overall Study|Adverse Event|7|||
127973802|NCT00179673|460524834|FG000|Overall Study|Lack of Efficacy|15|||
127973803|NCT00179673|460524834|FG000|Overall Study|Withdrawal by Subject|3|||
127973804|NCT00179673|460524834|FG000|Overall Study|Death|4|||
127973805|NCT00179673|460524834|FG000|Overall Study|Other Observations and options|14|||
127973806|NCT00492648|460524835|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
127973807|NCT00492648|460524836|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
127973808|NCT00282113|460524837|FG000|Overall Study|Removed at parents request|1|||
127973809|NCT00282113|460524838|FG001|Overall Study|Removed at parents request|0|||
127973810|NCT00282113|460524839|FG002|Overall Study|Removed at parents request|0|||
127973811|NCT02949843|460524840|FG000|Overall Study|Withdrawal by Subject|0|||
127973812|NCT02949843|460524841|FG001|Overall Study|Withdrawal by Subject|1|||
127973813|NCT02949843|460524842|FG002|Overall Study|Withdrawal by Subject|1|||
127973814|NCT03852628|460524849|FG000|Overall Study|Lost to Follow-up|7|||
127973815|NCT03852628|460524850|FG001|Overall Study|Lost to Follow-up|6|||
127973816|NCT03852628|460524849|FG000|Overall Study|Lack of Efficacy|6|||
127973817|NCT03852628|460524850|FG001|Overall Study|Lack of Efficacy|6|||
127973818|NCT00556933|460524851|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
127973819|NCT00556933|460524852|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
127973820|NCT00556933|460524853|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
127973821|NCT00556933|460524854|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
127973822|NCT00556933|460524851|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
127973823|NCT00556933|460524852|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
127973824|NCT00556933|460524853|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
127973825|NCT00556933|460524854|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
127973826|NCT00556933|460524851|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
127973827|NCT00556933|460524852|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
127973828|NCT00556933|460524853|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
127973829|NCT00556933|460524854|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
127973830|NCT00556933|460524851|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
127973831|NCT00556933|460524852|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
127973832|NCT00556933|460524853|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
127973833|NCT00556933|460524854|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
127973834|NCT00556933|460524851|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
127973835|NCT00556933|460524852|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
127973836|NCT00556933|460524853|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
127973837|NCT00556933|460524854|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
127973838|NCT00556933|460524851|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
127973839|NCT00556933|460524852|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
127973840|NCT00556933|460524853|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
127973841|NCT00556933|460524854|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
127973842|NCT00556933|460524851|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
127973843|NCT00556933|460524852|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
127973844|NCT00556933|460524853|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
127973845|NCT00556933|460524854|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
127973846|NCT00556933|460524851|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
127973847|NCT00556933|460524852|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
127973848|NCT00556933|460524853|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
127973849|NCT00556933|460524854|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
127973850|NCT00556933|460524851|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
127973851|NCT00556933|460524852|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
127973852|NCT00556933|460524853|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
127973853|NCT00556933|460524854|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
127973854|NCT00556933|460524851|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
127973855|NCT00556933|460524852|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
127973856|NCT00556933|460524853|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
127973857|NCT00556933|460524854|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
127973858|NCT00556933|460524851|FG000|CNI Withdrawal vs. Minimization|Death|0|||
127973859|NCT00556933|460524852|FG001|CNI Withdrawal vs. Minimization|Death|0|||
127973860|NCT00556933|460524853|FG002|CNI Withdrawal vs. Minimization|Death|0|||
127973861|NCT00556933|460524854|FG003|CNI Withdrawal vs. Minimization|Death|1|||
127973862|NCT01668173|460524855|FG000|Overall Study|Adverse Event|3|||
127973863|NCT01668173|460524855|FG000|Overall Study|Trial suspension|4|||
127973864|NCT00746564|460524856|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
127973865|NCT01827267|460524860|FG000|Overall Study|Did not receive study drug|1|||
127973866|NCT01827267|460524861|FG001|Overall Study|Did not receive study drug|1|||
127973867|NCT01827267|460524860|FG000|Overall Study|Physician Decision|1|||
127973868|NCT01827267|460524861|FG001|Overall Study|Physician Decision|0|||
127973869|NCT01827267|460524860|FG000|Overall Study|Disease Progression|1|||
127973870|NCT01827267|460524861|FG001|Overall Study|Disease Progression|1|||
127973871|NCT01827267|460524860|FG000|Overall Study|Sponsor Discontinued Study|2|||
127973872|NCT01827267|460524861|FG001|Overall Study|Sponsor Discontinued Study|8|||
127973873|NCT01827267|460524860|FG000|Overall Study|Still on study|0|||
127973874|NCT01827267|460524861|FG001|Overall Study|Still on study|2|||
127973875|NCT00986921|460524874|FG000|Overall Study|Physician Decision|1|||
127973876|NCT00986921|460524875|FG001|Overall Study|Physician Decision|0|||
127973877|NCT00813813|460524876|FG000|Overall Study|Withdrawal by Subject|1|||
127973878|NCT00813813|460524877|FG001|Overall Study|Withdrawal by Subject|1|||
127973879|NCT00813813|460524876|FG000|Overall Study|Lost to Follow-up|2|||
127973880|NCT00813813|460524877|FG001|Overall Study|Lost to Follow-up|7|||
127973881|NCT00813813|460524876|FG000|Overall Study|Other|0|||
127973882|NCT00813813|460524877|FG001|Overall Study|Other|1|||
127973883|NCT00833482|460524878|FG000|Days 11-20|Adverse Event|0|||
127973884|NCT00833482|460524879|FG001|Days 11-20|Adverse Event|2|||
127973885|NCT00833482|460524880|FG002|Days 11-20|Adverse Event|0|||
127973886|NCT00833482|460524881|FG003|Days 11-20|Adverse Event|0|||
127973887|NCT00833482|460524882|FG004|Days 11-20|Adverse Event|0|||
127973888|NCT00833482|460524883|FG005|Days 11-20|Adverse Event|0|||
127973889|NCT00833482|460524878|FG000|Days 11-20|Withdrawal by Subject|0|||
127973890|NCT00833482|460524879|FG001|Days 11-20|Withdrawal by Subject|1|||
127973891|NCT00833482|460524880|FG002|Days 11-20|Withdrawal by Subject|0|||
127973892|NCT00833482|460524881|FG003|Days 11-20|Withdrawal by Subject|0|||
127973893|NCT00833482|460524882|FG004|Days 11-20|Withdrawal by Subject|0|||
127973894|NCT00833482|460524883|FG005|Days 11-20|Withdrawal by Subject|0|||
127973895|NCT00833482|460524878|FG000|Days 21-30|Adverse Event|0|||
127973896|NCT00833482|460524879|FG001|Days 21-30|Adverse Event|0|||
127973897|NCT00833482|460524880|FG002|Days 21-30|Adverse Event|1|||
127973898|NCT00833482|460524881|FG003|Days 21-30|Adverse Event|0|||
127973899|NCT00833482|460524882|FG004|Days 21-30|Adverse Event|0|||
127973900|NCT00833482|460524883|FG005|Days 21-30|Adverse Event|0|||
127973901|NCT00833482|460524878|FG000|Days 21-30|Withdrawal by Subject|0|||
127973902|NCT00833482|460524879|FG001|Days 21-30|Withdrawal by Subject|0|||
127973903|NCT00833482|460524880|FG002|Days 21-30|Withdrawal by Subject|0|||
127973904|NCT00833482|460524881|FG003|Days 21-30|Withdrawal by Subject|0|||
127973905|NCT00833482|460524882|FG004|Days 21-30|Withdrawal by Subject|1|||
127973906|NCT00833482|460524883|FG005|Days 21-30|Withdrawal by Subject|0|||
127973907|NCT02778074|460524884|FG000|Overall Study|Lost to Follow-up|7|||
127973908|NCT02778074|460524885|FG001|Overall Study|Lost to Follow-up|10|||
127973909|NCT03489707|460524886|FG000|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|13|||
127973910|NCT03489707|460524887|FG001|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|31|||
127973911|NCT03489707|460524886|FG000|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|42|||
127973912|NCT03489707|460524887|FG001|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|57|||
127973913|NCT01817582|460524888|FG000|Overall Study|Withdrawal by Subject|0|||
127973914|NCT01817582|460524889|FG001|Overall Study|Withdrawal by Subject|1|||
127973915|NCT01817582|460524890|FG002|Overall Study|Withdrawal by Subject|0|||
127973916|NCT01817582|460524888|FG000|Overall Study|Participant revealed masked treatment|1|||
127973917|NCT01817582|460524889|FG001|Overall Study|Participant revealed masked treatment|0|||
127973918|NCT01817582|460524890|FG002|Overall Study|Participant revealed masked treatment|0|||
127973919|NCT01817582|460524888|FG000|Overall Study|Randomized but exclusion criteria met|1|||
127973920|NCT01817582|460524889|FG001|Overall Study|Randomized but exclusion criteria met|0|||
127973921|NCT01817582|460524890|FG002|Overall Study|Randomized but exclusion criteria met|0|||
127973922|NCT03617770|460524893|FG000|Overall Study|Lost to Follow-up|1|||
127973923|NCT03617770|460524894|FG001|Overall Study|Lost to Follow-up|0|||
127973924|NCT03963232|460524895|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
127973925|NCT03963232|460524896|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
127973926|NCT03963232|460524895|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
127973927|NCT03963232|460524896|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
127973928|NCT03963232|460524895|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
127973929|NCT03963232|460524896|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
127973930|NCT03963232|460524895|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
127973931|NCT03963232|460524896|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
127973932|NCT03963232|460524895|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
127973933|NCT03963232|460524896|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
127973934|NCT03963232|460524895|FG000|Open-Label Treatment Phase|Adverse Event|1|||
127973935|NCT03963232|460524896|FG001|Open-Label Treatment Phase|Adverse Event|2|||
127973936|NCT03963232|460524895|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
127973937|NCT03963232|460524896|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
127973938|NCT03963232|460524895|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
127973939|NCT03963232|460524896|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
127973940|NCT03963232|460524895|FG000|Open-Label Treatment Phase|Pregnancy|1|||
127973941|NCT03963232|460524896|FG001|Open-Label Treatment Phase|Pregnancy|0|||
127973942|NCT03963232|460524895|FG000|Follow-up Phase|Withdrawal by Subject|7|||
127973943|NCT03963232|460524896|FG001|Follow-up Phase|Withdrawal by Subject|5|||
127973944|NCT03963232|460524895|FG000|Follow-up Phase|Protocol Violation|0|||
127973945|NCT03963232|460524896|FG001|Follow-up Phase|Protocol Violation|2|||
127973946|NCT03963232|460524895|FG000|Follow-up Phase|Adverse Event|0|||
127973947|NCT03963232|460524896|FG001|Follow-up Phase|Adverse Event|1|||
127973948|NCT03963232|460524895|FG000|Follow-up Phase|Lost to Follow-up|0|||
127973949|NCT03963232|460524896|FG001|Follow-up Phase|Lost to Follow-up|1|||
127973950|NCT00356135|460524897|FG000|Overall Study|Protocol Violation|1|||
127973951|NCT00356135|460524898|FG001|Overall Study|Protocol Violation|0|||
127973952|NCT00356135|460524899|FG002|Overall Study|Protocol Violation|0|||
127973953|NCT00356135|460524897|FG000|Overall Study|Adverse Event|1|||
127973954|NCT00356135|460524898|FG001|Overall Study|Adverse Event|0|||
127973955|NCT00356135|460524899|FG002|Overall Study|Adverse Event|0|||
127973956|NCT00356135|460524897|FG000|Overall Study|Lost to Follow-up|0|||
127973957|NCT00356135|460524898|FG001|Overall Study|Lost to Follow-up|0|||
127973958|NCT00356135|460524899|FG002|Overall Study|Lost to Follow-up|1|||
127973959|NCT00356135|460524897|FG000|Overall Study|Physician Decision|1|||
127973960|NCT00356135|460524898|FG001|Overall Study|Physician Decision|1|||
127973961|NCT00356135|460524899|FG002|Overall Study|Physician Decision|1|||
127973962|NCT00356135|460524897|FG000|Overall Study|Subject non-compliance|1|||
127973963|NCT00356135|460524898|FG001|Overall Study|Subject non-compliance|1|||
127973964|NCT00356135|460524899|FG002|Overall Study|Subject non-compliance|3|||
127973965|NCT03512210|460524901|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
127973966|NCT03512210|460524901|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
127973967|NCT03512210|460524901|FG000|Step 2:Post-MINMON|Death|2|||
127973968|NCT03512210|460524901|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
127973969|NCT03512210|460524901|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
127973970|NCT00378508|460527466|FG000|Overall Study|Withdrawal by Subject|1|||
127973971|NCT00378508|460527467|FG001|Overall Study|Withdrawal by Subject|3|||
127973972|NCT00378508|460527466|FG000|Overall Study|Lost to Follow-up|1|||
127973973|NCT00378508|460527467|FG001|Overall Study|Lost to Follow-up|0|||
127973974|NCT05318092|460527469|FG000|Overall Study|Lost to Follow-up|3|||
127973975|NCT05318092|460527469|FG000|Overall Study|Withdrawal by Subject|1|||
127973976|NCT03917472|460527470|FG000|Overall Study|Physician Decision|4|||
127973977|NCT03917472|460527471|FG001|Overall Study|Physician Decision|0|||
127973978|NCT03917472|460527470|FG000|Overall Study|Adverse Event|3|||
127973979|NCT03917472|460527471|FG001|Overall Study|Adverse Event|1|||
127973980|NCT03917472|460527470|FG000|Overall Study|Death|7|||
127973981|NCT03917472|460527471|FG001|Overall Study|Death|5|||
127973982|NCT03917472|460527470|FG000|Overall Study|Withdrawal by Subject|11|||
127973983|NCT03917472|460527471|FG001|Overall Study|Withdrawal by Subject|4|||
127973984|NCT03917472|460527470|FG000|Overall Study|Lost to Follow-up|10|||
127973985|NCT03917472|460527471|FG001|Overall Study|Lost to Follow-up|5|||
127973986|NCT04434469|460527472|FG000|Overall Study|Death|2|||
127973987|NCT04434469|460527473|FG001|Overall Study|Death|3|||
127973988|NCT04434469|460527474|FG002|Overall Study|Death|2|||
127973989|NCT04434469|460527475|FG003|Overall Study|Death|2|||
127973990|NCT04434469|460527476|FG004|Overall Study|Death|2|||
127973991|NCT04434469|460527477|FG005|Overall Study|Death|0|||
127973992|NCT04434469|460527472|FG000|Overall Study|Lost to Follow-up|0|||
127973993|NCT04434469|460527473|FG001|Overall Study|Lost to Follow-up|0|||
127973994|NCT04434469|460527474|FG002|Overall Study|Lost to Follow-up|0|||
127973995|NCT04434469|460527475|FG003|Overall Study|Lost to Follow-up|1|||
127973996|NCT04434469|460527476|FG004|Overall Study|Lost to Follow-up|1|||
127973997|NCT04434469|460527477|FG005|Overall Study|Lost to Follow-up|0|||
127973998|NCT04434469|460527472|FG000|Overall Study|Study terminated by sponsor|1|||
127973999|NCT04434469|460527473|FG001|Overall Study|Study terminated by sponsor|1|||
127974000|NCT04434469|460527474|FG002|Overall Study|Study terminated by sponsor|1|||
127974001|NCT04434469|460527475|FG003|Overall Study|Study terminated by sponsor|2|||
127974002|NCT04434469|460527476|FG004|Overall Study|Study terminated by sponsor|3|||
127974003|NCT04434469|460527477|FG005|Overall Study|Study terminated by sponsor|3|||
127974004|NCT04434469|460527472|FG000|Overall Study|Withdrawal by Subject|0|||
127974005|NCT04434469|460527473|FG001|Overall Study|Withdrawal by Subject|0|||
127974006|NCT04434469|460527474|FG002|Overall Study|Withdrawal by Subject|1|||
127974007|NCT04434469|460527475|FG003|Overall Study|Withdrawal by Subject|0|||
127974008|NCT04434469|460527476|FG004|Overall Study|Withdrawal by Subject|0|||
127974009|NCT04434469|460527477|FG005|Overall Study|Withdrawal by Subject|0|||
127974010|NCT01936181|460527492|FG000|Randomised, Double-blind|Adverse Event|27|||
127974011|NCT01936181|460527493|FG001|Randomised, Double-blind|Adverse Event|21|||
127974012|NCT01936181|460527494|FG002|Randomised, Double-blind|Adverse Event|0|||
127974013|NCT01936181|460527495|FG003|Randomised, Double-blind|Adverse Event|0|||
127974014|NCT01936181|460527492|FG000|Randomised, Double-blind|Protocol Violation|1|||
127974015|NCT01936181|460527493|FG001|Randomised, Double-blind|Protocol Violation|5|||
127974016|NCT01936181|460527494|FG002|Randomised, Double-blind|Protocol Violation|0|||
127974017|NCT01936181|460527495|FG003|Randomised, Double-blind|Protocol Violation|0|||
127974018|NCT01936181|460527492|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
127974019|NCT01936181|460527493|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
127974020|NCT01936181|460527494|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
127974021|NCT01936181|460527495|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
127974022|NCT01936181|460527492|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
127974023|NCT01936181|460527493|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
127974024|NCT01936181|460527494|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
127974025|NCT01936181|460527495|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
127974026|NCT01936181|460527492|FG000|Randomised, Double-blind|Pregnancy|0|||
127974027|NCT01936181|460527493|FG001|Randomised, Double-blind|Pregnancy|1|||
127974028|NCT01936181|460527494|FG002|Randomised, Double-blind|Pregnancy|0|||
127974029|NCT01936181|460527495|FG003|Randomised, Double-blind|Pregnancy|0|||
127974030|NCT01936181|460527492|FG000|Randomised, Double-blind|Physician Decision|4|||
127974031|NCT01936181|460527493|FG001|Randomised, Double-blind|Physician Decision|4|||
127974032|NCT01936181|460527494|FG002|Randomised, Double-blind|Physician Decision|0|||
127974033|NCT01936181|460527495|FG003|Randomised, Double-blind|Physician Decision|0|||
127974034|NCT01936181|460527492|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
127974035|NCT01936181|460527493|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
127974036|NCT01936181|460527494|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
127974037|NCT01936181|460527495|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
127974038|NCT01936181|460527492|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
127974039|NCT01936181|460527493|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
127974040|NCT01936181|460527494|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
127974041|NCT01936181|460527495|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
127974042|NCT01936181|460527492|FG000|Transition-extension|Adverse Event|3|||
127974043|NCT01936181|460527493|FG001|Transition-extension|Adverse Event|0|||
127974044|NCT01936181|460527494|FG002|Transition-extension|Adverse Event|3|||
127974045|NCT01936181|460527495|FG003|Transition-extension|Adverse Event|1|||
127974046|NCT01936181|460527492|FG000|Transition-extension|Lost to Follow-up|3|||
127974047|NCT01936181|460527493|FG001|Transition-extension|Lost to Follow-up|0|||
127974048|NCT01936181|460527494|FG002|Transition-extension|Lost to Follow-up|1|||
127974049|NCT01936181|460527495|FG003|Transition-extension|Lost to Follow-up|2|||
127974050|NCT01936181|460527492|FG000|Transition-extension|Physician Decision|2|||
127974051|NCT01936181|460527493|FG001|Transition-extension|Physician Decision|0|||
127974052|NCT01936181|460527494|FG002|Transition-extension|Physician Decision|0|||
127974053|NCT01936181|460527495|FG003|Transition-extension|Physician Decision|1|||
127974054|NCT01936181|460527492|FG000|Transition-extension|Withdrawal by Subject|7|||
127974055|NCT01936181|460527493|FG001|Transition-extension|Withdrawal by Subject|0|||
127974056|NCT01936181|460527494|FG002|Transition-extension|Withdrawal by Subject|2|||
127974057|NCT01936181|460527495|FG003|Transition-extension|Withdrawal by Subject|1|||
127974058|NCT00664859|460527496|FG000|Overall Study|Adverse Event|2|||
127974059|NCT00664859|460527497|FG001|Overall Study|Adverse Event|1|||
127974060|NCT00664859|460527498|FG002|Overall Study|Adverse Event|3|||
127974061|NCT00664859|460527496|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
127974062|NCT00664859|460527497|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
127974063|NCT00664859|460527498|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
127974064|NCT00664859|460527496|FG000|Overall Study|Noncompliance with protocol|1|||
127974065|NCT00664859|460527497|FG001|Overall Study|Noncompliance with protocol|0|||
127974066|NCT00664859|460527498|FG002|Overall Study|Noncompliance with protocol|4|||
127974067|NCT00664859|460527496|FG000|Overall Study|Laboratory abnormality|2|||
127974068|NCT00664859|460527497|FG001|Overall Study|Laboratory abnormality|1|||
127974069|NCT00664859|460527498|FG002|Overall Study|Laboratory abnormality|4|||
127974070|NCT00664859|460527496|FG000|Overall Study|Withdrawal by Subject|4|||
127974071|NCT00664859|460527497|FG001|Overall Study|Withdrawal by Subject|1|||
127974072|NCT00664859|460527498|FG002|Overall Study|Withdrawal by Subject|3|||
127974073|NCT00664859|460527496|FG000|Overall Study|Lost to Follow-up|2|||
127974074|NCT00664859|460527497|FG001|Overall Study|Lost to Follow-up|2|||
127974075|NCT00664859|460527498|FG002|Overall Study|Lost to Follow-up|1|||
127974076|NCT00664859|460527496|FG000|Overall Study|Other|0|||
127974077|NCT00664859|460527497|FG001|Overall Study|Other|1|||
127974078|NCT00664859|460527498|FG002|Overall Study|Other|2|||
127974079|NCT01943851|460527499|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
127974080|NCT01943851|460527500|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
127974081|NCT01943851|460527501|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
127974082|NCT01943851|460527502|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
127974083|NCT01943851|460527503|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
127974084|NCT01943851|460527504|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
127974085|NCT01943851|460527505|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
127974086|NCT01943851|460527506|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
127974087|NCT01943851|460527507|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
127974088|NCT01943851|460527508|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
127974089|NCT01943851|460527509|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
127974090|NCT01943851|460527510|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
127974091|NCT01943851|460527511|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
127974092|NCT01943851|460527512|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
127974093|NCT01943851|460527513|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
127974094|NCT01943851|460527514|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
127974095|NCT01943851|460527515|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
127974096|NCT01943851|460527516|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
127974097|NCT01943851|460527499|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
127974098|NCT01943851|460527500|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
127974099|NCT01943851|460527501|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
127974100|NCT01943851|460527502|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
127974101|NCT01943851|460527503|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
127974102|NCT01943851|460527504|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
127974103|NCT01943851|460527505|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
127974104|NCT01943851|460527506|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
127974105|NCT01943851|460527507|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
127974106|NCT01943851|460527508|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
127974107|NCT01943851|460527509|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
127974108|NCT01943851|460527510|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
127974109|NCT01943851|460527511|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
127974110|NCT01943851|460527512|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
127974111|NCT01943851|460527513|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
127974112|NCT01943851|460527514|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
127974113|NCT01943851|460527515|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
127974114|NCT01943851|460527516|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
127974115|NCT01943851|460527499|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
127974116|NCT01943851|460527500|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
127974117|NCT01943851|460527501|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
127974118|NCT01943851|460527502|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
127974119|NCT01943851|460527503|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
127974120|NCT01943851|460527504|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
127974121|NCT01943851|460527505|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
127974122|NCT01943851|460527506|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
127974123|NCT01943851|460527507|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
127974124|NCT01943851|460527508|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
127974125|NCT01943851|460527509|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
127974126|NCT01943851|460527510|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
127974127|NCT01943851|460527511|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
127974128|NCT01943851|460527512|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
127974129|NCT01943851|460527513|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
127974130|NCT01943851|460527514|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
127974131|NCT01943851|460527515|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
127974132|NCT01943851|460527516|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
127974133|NCT01943851|460527499|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
127974134|NCT01943851|460527500|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
127974135|NCT01943851|460527501|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
127974136|NCT01943851|460527502|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
127974137|NCT01943851|460527503|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
127974138|NCT01943851|460527504|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
127974139|NCT01943851|460527505|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
127974140|NCT01943851|460527506|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
127974141|NCT01943851|460527507|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
127974142|NCT01943851|460527508|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
127974143|NCT01943851|460527509|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
127974144|NCT01943851|460527510|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
127974145|NCT01943851|460527511|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
127974146|NCT01943851|460527512|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
127974147|NCT01943851|460527513|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
127974148|NCT01943851|460527514|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
127974149|NCT01943851|460527515|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
127974150|NCT01943851|460527516|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
127974151|NCT01943851|460527499|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
127974152|NCT01943851|460527500|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
127974153|NCT01943851|460527501|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
127974154|NCT01943851|460527502|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
127974155|NCT01943851|460527503|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
127974156|NCT01943851|460527504|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
127974157|NCT01943851|460527505|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
127974158|NCT01943851|460527506|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
127974159|NCT01943851|460527507|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
127974160|NCT01943851|460527508|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
127974161|NCT01943851|460527509|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
127974162|NCT01943851|460527510|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
127974163|NCT01943851|460527511|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
127974164|NCT01943851|460527512|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
127974165|NCT01943851|460527513|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
127974166|NCT01943851|460527514|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
127974167|NCT01943851|460527515|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
127974168|NCT01943851|460527516|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
127974169|NCT00900757|460527517|FG000|Overall Study|screen failure|19|||
127974170|NCT00748189|460527518|FG000|Overall Study|Death|99|||
127974171|NCT00748189|460527519|FG001|Overall Study|Death|84|||
127974172|NCT00748189|460527518|FG000|Overall Study|Withdrawal by Subject|23|||
127974173|NCT00748189|460527519|FG001|Overall Study|Withdrawal by Subject|29|||
127974174|NCT00748189|460527518|FG000|Overall Study|Physician Decision|16|||
127974175|NCT00748189|460527519|FG001|Overall Study|Physician Decision|5|||
127974176|NCT00748189|460527518|FG000|Overall Study|Lost to Follow-up|8|||
127974177|NCT00748189|460527519|FG001|Overall Study|Lost to Follow-up|15|||
127974178|NCT00748189|460527518|FG000|Overall Study|Study terminated by Sponsor|70|||
127974179|NCT00748189|460527519|FG001|Overall Study|Study terminated by Sponsor|79|||
127974180|NCT03320850|460527520|FG000|Overall Study|Lost to Follow-up|0|||
127974181|NCT03320850|460527521|FG001|Overall Study|Lost to Follow-up|0|||
127974182|NCT03320850|460527522|FG002|Overall Study|Lost to Follow-up|0|||
127974183|NCT03320850|460527523|FG003|Overall Study|Lost to Follow-up|0|||
127974184|NCT03320850|460527524|FG004|Overall Study|Lost to Follow-up|1|||
127974185|NCT03320850|460527525|FG005|Overall Study|Lost to Follow-up|2|||
127974186|NCT03320850|460527526|FG006|Overall Study|Lost to Follow-up|2|||
127974187|NCT03320850|460527527|FG007|Overall Study|Lost to Follow-up|0|||
127974188|NCT03320850|460527528|FG008|Overall Study|Lost to Follow-up|6|||
127974189|NCT03320850|460527529|FG009|Overall Study|Lost to Follow-up|4|||
127974190|NCT03320850|460527520|FG000|Overall Study|Withdrawal by Subject|0|||
127974191|NCT03320850|460527521|FG001|Overall Study|Withdrawal by Subject|0|||
127974192|NCT03320850|460527522|FG002|Overall Study|Withdrawal by Subject|0|||
127974193|NCT03320850|460527523|FG003|Overall Study|Withdrawal by Subject|0|||
127974194|NCT03320850|460527524|FG004|Overall Study|Withdrawal by Subject|1|||
127974195|NCT03320850|460527525|FG005|Overall Study|Withdrawal by Subject|2|||
127974196|NCT03320850|460527526|FG006|Overall Study|Withdrawal by Subject|4|||
127974197|NCT03320850|460527527|FG007|Overall Study|Withdrawal by Subject|5|||
127974198|NCT03320850|460527528|FG008|Overall Study|Withdrawal by Subject|2|||
127974199|NCT03320850|460527529|FG009|Overall Study|Withdrawal by Subject|1|||
127974200|NCT03320850|460527520|FG000|Overall Study|Lack of Efficacy|0|||
127974201|NCT03320850|460527521|FG001|Overall Study|Lack of Efficacy|0|||
127974202|NCT03320850|460527522|FG002|Overall Study|Lack of Efficacy|0|||
127974203|NCT03320850|460527523|FG003|Overall Study|Lack of Efficacy|1|||
127974204|NCT03320850|460527524|FG004|Overall Study|Lack of Efficacy|0|||
127974205|NCT03320850|460527525|FG005|Overall Study|Lack of Efficacy|1|||
127974206|NCT03320850|460527526|FG006|Overall Study|Lack of Efficacy|0|||
127974207|NCT03320850|460527527|FG007|Overall Study|Lack of Efficacy|2|||
127974208|NCT03320850|460527528|FG008|Overall Study|Lack of Efficacy|0|||
127974209|NCT03320850|460527529|FG009|Overall Study|Lack of Efficacy|3|||
127974210|NCT03320850|460527520|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
127974211|NCT03320850|460527521|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
127974212|NCT03320850|460527522|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
127974213|NCT03320850|460527523|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
127974214|NCT03320850|460527524|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
127974215|NCT03320850|460527525|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
127974216|NCT03320850|460527526|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
127974217|NCT03320850|460527527|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
127974218|NCT03320850|460527528|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
127974219|NCT03320850|460527529|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
127974220|NCT03320850|460527520|FG000|Overall Study|Adverse Event|0|||
127974221|NCT03320850|460527521|FG001|Overall Study|Adverse Event|0|||
127974222|NCT03320850|460527522|FG002|Overall Study|Adverse Event|0|||
127974223|NCT03320850|460527523|FG003|Overall Study|Adverse Event|0|||
127974224|NCT03320850|460527524|FG004|Overall Study|Adverse Event|0|||
127974225|NCT03320850|460527525|FG005|Overall Study|Adverse Event|2|||
127974226|NCT03320850|460527526|FG006|Overall Study|Adverse Event|1|||
127974227|NCT03320850|460527527|FG007|Overall Study|Adverse Event|0|||
127974228|NCT03320850|460527528|FG008|Overall Study|Adverse Event|2|||
127974229|NCT03320850|460527529|FG009|Overall Study|Adverse Event|0|||
127974230|NCT03320850|460527520|FG000|Overall Study|Reason Not Specified|0|||
127974231|NCT03320850|460527521|FG001|Overall Study|Reason Not Specified|0|||
127974232|NCT03320850|460527522|FG002|Overall Study|Reason Not Specified|0|||
127974233|NCT03320850|460527523|FG003|Overall Study|Reason Not Specified|0|||
127974234|NCT03320850|460527524|FG004|Overall Study|Reason Not Specified|0|||
127974235|NCT03320850|460527525|FG005|Overall Study|Reason Not Specified|1|||
127974236|NCT03320850|460527526|FG006|Overall Study|Reason Not Specified|0|||
127974237|NCT03320850|460527527|FG007|Overall Study|Reason Not Specified|0|||
127974238|NCT03320850|460527528|FG008|Overall Study|Reason Not Specified|0|||
127974239|NCT03320850|460527529|FG009|Overall Study|Reason Not Specified|1|||
127974240|NCT00546117|460527530|FG000|Overall Study|Withdrawal by Subject|3|||
127974241|NCT00546117|460527531|FG001|Overall Study|Withdrawal by Subject|0|||
127974242|NCT00546117|460527530|FG000|Overall Study|Inability to schedule follow-up visit|1|||
127974243|NCT00546117|460527531|FG001|Overall Study|Inability to schedule follow-up visit|0|||
127974244|NCT01424514|460527532|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
127974245|NCT01424514|460527533|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
127974246|NCT01424514|460527532|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
127974247|NCT01424514|460527533|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
127974248|NCT02653170|460527536|FG000|Overall Study|Withdrawal by Subject|3|||
127974249|NCT02653170|460527537|FG001|Overall Study|Withdrawal by Subject|8|||
127974250|NCT02653170|460527538|FG002|Overall Study|Withdrawal by Subject|3|||
127974251|NCT02653170|460527536|FG000|Overall Study|withdrawn by study team|2|||
127974252|NCT02653170|460527537|FG001|Overall Study|withdrawn by study team|4|||
127974253|NCT02653170|460527538|FG002|Overall Study|withdrawn by study team|5|||
127974254|NCT02653170|460527536|FG000|Overall Study|Lost to Follow-up|12|||
127974255|NCT02653170|460527537|FG001|Overall Study|Lost to Follow-up|4|||
127974256|NCT02653170|460527538|FG002|Overall Study|Lost to Follow-up|10|||
127974257|NCT04720911|460527551|FG000|Overall Study|Withdrawal by Subject|0|||
127974258|NCT04720911|460527552|FG001|Overall Study|Withdrawal by Subject|1|||
127974259|NCT04720911|460527553|FG002|Overall Study|Withdrawal by Subject|0|||
127974260|NCT00090220|460527554|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
127974261|NCT00090220|460527555|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
127974262|NCT00090220|460527556|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
127974263|NCT00090220|460527557|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
127974264|NCT00090220|460527558|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
127974265|NCT00090220|460527559|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
127974266|NCT00090220|460527554|FG000|Base Study Vaccination Period|Adverse Event|6|||
127974267|NCT00090220|460527555|FG001|Base Study Vaccination Period|Adverse Event|1|||
127974268|NCT00090220|460527556|FG002|Base Study Vaccination Period|Adverse Event|0|||
127974269|NCT00090220|460527557|FG003|Base Study Vaccination Period|Adverse Event|0|||
127974270|NCT00090220|460527558|FG004|Base Study Vaccination Period|Adverse Event|0|||
127974271|NCT00090220|460527559|FG005|Base Study Vaccination Period|Adverse Event|0|||
127974272|NCT00090220|460527554|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
127974273|NCT00090220|460527555|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
127974274|NCT00090220|460527556|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
127974275|NCT00090220|460527557|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
127974276|NCT00090220|460527558|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
127974277|NCT00090220|460527559|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
127974278|NCT00090220|460527554|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
127974279|NCT00090220|460527555|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
127974280|NCT00090220|460527556|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
127974281|NCT00090220|460527557|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
127974282|NCT00090220|460527558|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
127974283|NCT00090220|460527559|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
127974284|NCT00090220|460527554|FG000|Base Study Vaccination Period|Patient Moved|6|||
127974285|NCT00090220|460527555|FG001|Base Study Vaccination Period|Patient Moved|2|||
127974286|NCT00090220|460527556|FG002|Base Study Vaccination Period|Patient Moved|0|||
127974287|NCT00090220|460527557|FG003|Base Study Vaccination Period|Patient Moved|0|||
127974288|NCT00090220|460527558|FG004|Base Study Vaccination Period|Patient Moved|0|||
127974289|NCT00090220|460527559|FG005|Base Study Vaccination Period|Patient Moved|0|||
127974290|NCT00090220|460527554|FG000|Base Study Vaccination Period|Other|4|||
127974291|NCT00090220|460527555|FG001|Base Study Vaccination Period|Other|4|||
127974292|NCT00090220|460527556|FG002|Base Study Vaccination Period|Other|0|||
127974293|NCT00090220|460527557|FG003|Base Study Vaccination Period|Other|0|||
127974294|NCT00090220|460527558|FG004|Base Study Vaccination Period|Other|0|||
127974295|NCT00090220|460527559|FG005|Base Study Vaccination Period|Other|0|||
127974296|NCT00090220|460527554|FG000|Base Study Follow-up Period|Adverse Event|6|||
127974297|NCT00090220|460527555|FG001|Base Study Follow-up Period|Adverse Event|1|||
127974298|NCT00090220|460527556|FG002|Base Study Follow-up Period|Adverse Event|0|||
127974299|NCT00090220|460527557|FG003|Base Study Follow-up Period|Adverse Event|0|||
127974300|NCT00090220|460527558|FG004|Base Study Follow-up Period|Adverse Event|0|||
127974301|NCT00090220|460527559|FG005|Base Study Follow-up Period|Adverse Event|0|||
127974302|NCT00090220|460527554|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
127974303|NCT00090220|460527555|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
127974304|NCT00090220|460527556|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
127974305|NCT00090220|460527557|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
127974306|NCT00090220|460527558|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
127974307|NCT00090220|460527559|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
127974308|NCT00090220|460527554|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
127974309|NCT00090220|460527555|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
127974310|NCT00090220|460527556|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
127974311|NCT00090220|460527557|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
127974312|NCT00090220|460527558|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
127974313|NCT00090220|460527559|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
127974314|NCT00090220|460527554|FG000|Base Study Follow-up Period|Patient Moved|20|||
127974315|NCT00090220|460527555|FG001|Base Study Follow-up Period|Patient Moved|28|||
127974316|NCT00090220|460527556|FG002|Base Study Follow-up Period|Patient Moved|0|||
127974317|NCT00090220|460527557|FG003|Base Study Follow-up Period|Patient Moved|0|||
127974318|NCT00090220|460527558|FG004|Base Study Follow-up Period|Patient Moved|0|||
127974319|NCT00090220|460527559|FG005|Base Study Follow-up Period|Patient Moved|0|||
127974320|NCT00090220|460527554|FG000|Base Study Follow-up Period|Other|19|||
127974321|NCT00090220|460527555|FG001|Base Study Follow-up Period|Other|21|||
127974322|NCT00090220|460527556|FG002|Base Study Follow-up Period|Other|0|||
127974323|NCT00090220|460527557|FG003|Base Study Follow-up Period|Other|0|||
127974324|NCT00090220|460527558|FG004|Base Study Follow-up Period|Other|0|||
127974325|NCT00090220|460527559|FG005|Base Study Follow-up Period|Other|0|||
127974326|NCT00090220|460527554|FG000|Extension 1 (EXT1)|Adverse Event|0|||
127974327|NCT00090220|460527555|FG001|Extension 1 (EXT1)|Adverse Event|0|||
127974328|NCT00090220|460527556|FG002|Extension 1 (EXT1)|Adverse Event|4|||
127974329|NCT00090220|460527557|FG003|Extension 1 (EXT1)|Adverse Event|0|||
127974330|NCT00090220|460527558|FG004|Extension 1 (EXT1)|Adverse Event|0|||
127974331|NCT00090220|460527559|FG005|Extension 1 (EXT1)|Adverse Event|0|||
127974332|NCT00090220|460527554|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
127974333|NCT00090220|460527555|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
127974334|NCT00090220|460527556|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
127974335|NCT00090220|460527557|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
127974336|NCT00090220|460527558|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
127974337|NCT00090220|460527559|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
127974338|NCT00090220|460527554|FG000|Extension 1 (EXT1)|Moved|0|||
127974339|NCT00090220|460527555|FG001|Extension 1 (EXT1)|Moved|0|||
127974340|NCT00090220|460527556|FG002|Extension 1 (EXT1)|Moved|2|||
127974341|NCT00090220|460527557|FG003|Extension 1 (EXT1)|Moved|1|||
127974342|NCT00090220|460527558|FG004|Extension 1 (EXT1)|Moved|0|||
127974343|NCT00090220|460527559|FG005|Extension 1 (EXT1)|Moved|0|||
127974344|NCT00090220|460527554|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
127974345|NCT00090220|460527555|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
127974346|NCT00090220|460527556|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
127974347|NCT00090220|460527557|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
127974348|NCT00090220|460527558|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
127974349|NCT00090220|460527559|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
127974350|NCT00090220|460527554|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
127974351|NCT00090220|460527555|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
127974352|NCT00090220|460527556|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
127974353|NCT00090220|460527557|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
127974354|NCT00090220|460527558|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
127974355|NCT00090220|460527559|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
127974356|NCT00090220|460527554|FG000|Extension 1 (EXT1)|Other reason|0|||
127974357|NCT00090220|460527555|FG001|Extension 1 (EXT1)|Other reason|0|||
127974358|NCT00090220|460527556|FG002|Extension 1 (EXT1)|Other reason|2|||
127974359|NCT00090220|460527557|FG003|Extension 1 (EXT1)|Other reason|0|||
127974360|NCT00090220|460527558|FG004|Extension 1 (EXT1)|Other reason|0|||
127974361|NCT00090220|460527559|FG005|Extension 1 (EXT1)|Other reason|0|||
127974362|NCT00090220|460527554|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
127974363|NCT00090220|460527555|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
127974364|NCT00090220|460527556|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
127974365|NCT00090220|460527557|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
127974366|NCT00090220|460527558|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
127974367|NCT00090220|460527559|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
127974368|NCT00090220|460527554|FG000|Long-term Follow-up (EXT2)|Death|0|||
127974369|NCT00090220|460527555|FG001|Long-term Follow-up (EXT2)|Death|0|||
127974370|NCT00090220|460527556|FG002|Long-term Follow-up (EXT2)|Death|0|||
127974371|NCT00090220|460527557|FG003|Long-term Follow-up (EXT2)|Death|0|||
127974372|NCT00090220|460527558|FG004|Long-term Follow-up (EXT2)|Death|1|||
127974373|NCT00090220|460527559|FG005|Long-term Follow-up (EXT2)|Death|1|||
127974374|NCT00090220|460527554|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
127974375|NCT00090220|460527555|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
127974376|NCT00090220|460527556|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
127974377|NCT00090220|460527557|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
127974378|NCT00090220|460527558|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
127974379|NCT00090220|460527559|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
127974380|NCT00090220|460527554|FG000|Long-term Follow-up (EXT2)|Other|0|||
127974381|NCT00090220|460527555|FG001|Long-term Follow-up (EXT2)|Other|0|||
127974382|NCT00090220|460527556|FG002|Long-term Follow-up (EXT2)|Other|0|||
127974383|NCT00090220|460527557|FG003|Long-term Follow-up (EXT2)|Other|0|||
127974384|NCT00090220|460527558|FG004|Long-term Follow-up (EXT2)|Other|1|||
127974385|NCT00090220|460527559|FG005|Long-term Follow-up (EXT2)|Other|0|||
127974386|NCT00941863|460527560|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
127974387|NCT00941863|460527561|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
127974388|NCT00941863|460527562|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
127974389|NCT00941863|460527563|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
127974390|NCT00941863|460527564|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
127974391|NCT00941863|460527560|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
127974392|NCT00941863|460527561|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
127974393|NCT00941863|460527562|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
127974394|NCT00941863|460527563|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
127974395|NCT00941863|460527564|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
127974396|NCT00941863|460527560|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
127974397|NCT00941863|460527561|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
127974398|NCT00941863|460527562|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
127974399|NCT00941863|460527563|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
127974400|NCT00941863|460527564|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
127974401|NCT00941863|460527560|FG000|Until Primary Completion Date (PCD)|Death|0|||
127974402|NCT00941863|460527561|FG001|Until Primary Completion Date (PCD)|Death|0|||
127974403|NCT00941863|460527562|FG002|Until Primary Completion Date (PCD)|Death|1|||
127974404|NCT00941863|460527563|FG003|Until Primary Completion Date (PCD)|Death|2|||
127974405|NCT00941863|460527564|FG004|Until Primary Completion Date (PCD)|Death|7|||
127974406|NCT00941863|460527560|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
127974407|NCT00941863|460527561|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
127974408|NCT00941863|460527562|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
127974409|NCT00941863|460527563|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
127974410|NCT00941863|460527564|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
127974411|NCT00941863|460527560|FG000|Continued After PCD|Withdrawal by Subject|0|||
127974412|NCT00941863|460527561|FG001|Continued After PCD|Withdrawal by Subject|0|||
127974413|NCT00941863|460527562|FG002|Continued After PCD|Withdrawal by Subject|0|||
127974414|NCT00941863|460527563|FG003|Continued After PCD|Withdrawal by Subject|0|||
127974415|NCT00941863|460527564|FG004|Continued After PCD|Withdrawal by Subject|1|||
127974416|NCT00941863|460527560|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
127974417|NCT00941863|460527561|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
127974418|NCT00941863|460527562|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
127974419|NCT00941863|460527563|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
127974420|NCT00941863|460527564|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
127974421|NCT00537316|460527565|FG000|Part 1|Adverse Event|7|||
127974422|NCT00537316|460527566|FG001|Part 1|Adverse Event|11|||
127974423|NCT00537316|460527567|FG002|Part 1|Adverse Event|8|||
127974424|NCT00537316|460527568|FG003|Part 1|Adverse Event|0|||
127974425|NCT00537316|460527569|FG004|Part 1|Adverse Event|0|||
127974426|NCT00537316|460527570|FG005|Part 1|Adverse Event|0|||
127974427|NCT00537316|460527571|FG006|Part 1|Adverse Event|0|||
127974428|NCT00537316|460527565|FG000|Part 1|Protocol defined clinical event|1|||
127974429|NCT00537316|460527566|FG001|Part 1|Protocol defined clinical event|0|||
127974430|NCT00537316|460527567|FG002|Part 1|Protocol defined clinical event|0|||
127974431|NCT00537316|460527568|FG003|Part 1|Protocol defined clinical event|0|||
127974432|NCT00537316|460527569|FG004|Part 1|Protocol defined clinical event|0|||
127974433|NCT00537316|460527570|FG005|Part 1|Protocol defined clinical event|0|||
127974434|NCT00537316|460527571|FG006|Part 1|Protocol defined clinical event|0|||
127974435|NCT00537316|460527565|FG000|Part 1|Lost to Follow-up|1|||
127974436|NCT00537316|460527566|FG001|Part 1|Lost to Follow-up|0|||
127974437|NCT00537316|460527567|FG002|Part 1|Lost to Follow-up|0|||
127974438|NCT00537316|460527568|FG003|Part 1|Lost to Follow-up|0|||
127974439|NCT00537316|460527569|FG004|Part 1|Lost to Follow-up|0|||
127974440|NCT00537316|460527570|FG005|Part 1|Lost to Follow-up|0|||
127974441|NCT00537316|460527571|FG006|Part 1|Lost to Follow-up|0|||
127974442|NCT00537316|460527565|FG000|Part 1|Withdrawal by Subject|3|||
127974443|NCT00537316|460527566|FG001|Part 1|Withdrawal by Subject|8|||
127974444|NCT00537316|460527567|FG002|Part 1|Withdrawal by Subject|4|||
127974445|NCT00537316|460527568|FG003|Part 1|Withdrawal by Subject|0|||
127974446|NCT00537316|460527569|FG004|Part 1|Withdrawal by Subject|0|||
127974447|NCT00537316|460527570|FG005|Part 1|Withdrawal by Subject|0|||
127974448|NCT00537316|460527571|FG006|Part 1|Withdrawal by Subject|0|||
127974449|NCT00537316|460527565|FG000|Part 1|Protocol Violation|1|||
127974450|NCT00537316|460527566|FG001|Part 1|Protocol Violation|5|||
127974451|NCT00537316|460527567|FG002|Part 1|Protocol Violation|1|||
127974452|NCT00537316|460527568|FG003|Part 1|Protocol Violation|0|||
127974453|NCT00537316|460527569|FG004|Part 1|Protocol Violation|0|||
127974454|NCT00537316|460527570|FG005|Part 1|Protocol Violation|0|||
127974455|NCT00537316|460527571|FG006|Part 1|Protocol Violation|0|||
127974456|NCT00537316|460527565|FG000|Part 1|Did not meet protocol eligibility|1|||
127974457|NCT00537316|460527566|FG001|Part 1|Did not meet protocol eligibility|3|||
127974458|NCT00537316|460527567|FG002|Part 1|Did not meet protocol eligibility|2|||
127974459|NCT00537316|460527568|FG003|Part 1|Did not meet protocol eligibility|0|||
127974460|NCT00537316|460527569|FG004|Part 1|Did not meet protocol eligibility|0|||
127974461|NCT00537316|460527570|FG005|Part 1|Did not meet protocol eligibility|0|||
127974462|NCT00537316|460527571|FG006|Part 1|Did not meet protocol eligibility|0|||
127974463|NCT00537316|460527565|FG000|Part 1|Administrative|0|||
127974464|NCT00537316|460527566|FG001|Part 1|Administrative|0|||
127974465|NCT00537316|460527567|FG002|Part 1|Administrative|2|||
127974466|NCT00537316|460527568|FG003|Part 1|Administrative|0|||
127974467|NCT00537316|460527569|FG004|Part 1|Administrative|0|||
127974468|NCT00537316|460527570|FG005|Part 1|Administrative|0|||
127974469|NCT00537316|460527571|FG006|Part 1|Administrative|0|||
127974470|NCT00537316|460527565|FG000|Part 2|Never entered follow-up|0|||
127974471|NCT00537316|460527566|FG001|Part 2|Never entered follow-up|0|||
127974472|NCT00537316|460527567|FG002|Part 2|Never entered follow-up|0|||
127974473|NCT00537316|460527568|FG003|Part 2|Never entered follow-up|0|||
127974474|NCT00537316|460527569|FG004|Part 2|Never entered follow-up|0|||
127974475|NCT00537316|460527570|FG005|Part 2|Never entered follow-up|0|||
127974476|NCT00537316|460527571|FG006|Part 2|Never entered follow-up|1|||
127974477|NCT00537316|460527565|FG000|Part 2|Adverse Event|4|||
127974478|NCT00537316|460527566|FG001|Part 2|Adverse Event|0|||
127974479|NCT00537316|460527567|FG002|Part 2|Adverse Event|2|||
127974480|NCT00537316|460527568|FG003|Part 2|Adverse Event|0|||
127974481|NCT00537316|460527569|FG004|Part 2|Adverse Event|0|||
127974482|NCT00537316|460527570|FG005|Part 2|Adverse Event|0|||
127974483|NCT00537316|460527571|FG006|Part 2|Adverse Event|0|||
127974484|NCT00537316|460527565|FG000|Part 2|Lost to Follow-up|1|||
127974485|NCT00537316|460527566|FG001|Part 2|Lost to Follow-up|0|||
127974486|NCT00537316|460527567|FG002|Part 2|Lost to Follow-up|2|||
127974487|NCT00537316|460527568|FG003|Part 2|Lost to Follow-up|0|||
127974488|NCT00537316|460527569|FG004|Part 2|Lost to Follow-up|0|||
127974489|NCT00537316|460527570|FG005|Part 2|Lost to Follow-up|0|||
127974490|NCT00537316|460527571|FG006|Part 2|Lost to Follow-up|0|||
127974491|NCT00537316|460527565|FG000|Part 2|Withdrawal by Subject|5|||
127974492|NCT00537316|460527566|FG001|Part 2|Withdrawal by Subject|1|||
127974493|NCT00537316|460527567|FG002|Part 2|Withdrawal by Subject|4|||
127974494|NCT00537316|460527568|FG003|Part 2|Withdrawal by Subject|0|||
127974495|NCT00537316|460527569|FG004|Part 2|Withdrawal by Subject|0|||
127974496|NCT00537316|460527570|FG005|Part 2|Withdrawal by Subject|0|||
127974497|NCT00537316|460527571|FG006|Part 2|Withdrawal by Subject|0|||
127974498|NCT00537316|460527565|FG000|Part 2|Administrative|16|||
127974499|NCT00537316|460527566|FG001|Part 2|Administrative|8|||
127974500|NCT00537316|460527567|FG002|Part 2|Administrative|24|||
127974501|NCT00537316|460527568|FG003|Part 2|Administrative|3|||
127974502|NCT00537316|460527569|FG004|Part 2|Administrative|1|||
127974503|NCT00537316|460527570|FG005|Part 2|Administrative|4|||
127974504|NCT00537316|460527571|FG006|Part 2|Administrative|1|||
127974505|NCT05113979|460527572|FG000|Overall Study|Death|2|||
127974506|NCT05113979|460527572|FG000|Overall Study|Lost to Follow-up|1|||
127974507|NCT01609543|460527578|FG000|Overall Study|Disease Progression|28|||
127974508|NCT01609543|460527578|FG000|Overall Study|Adverse Event|5|||
127974509|NCT01609543|460527578|FG000|Overall Study|Withdrawal by Subject|1|||
127974510|NCT01609543|460527578|FG000|Overall Study|Protocol Violation|1|||
127974511|NCT01609543|460527578|FG000|Overall Study|Death|7|||
127974512|NCT03452488|460527579|FG000|Overall Study|Adverse Event|4|||
127974513|NCT03452488|460527580|FG001|Overall Study|Adverse Event|6|||
127974514|NCT03452488|460527581|FG002|Overall Study|Adverse Event|1|||
127974515|NCT03452488|460527579|FG000|Overall Study|Death|0|||
127974516|NCT03452488|460527580|FG001|Overall Study|Death|0|||
127974517|NCT03452488|460527581|FG002|Overall Study|Death|1|||
127974518|NCT03452488|460527579|FG000|Overall Study|Lost to Follow-up|1|||
127974519|NCT03452488|460527580|FG001|Overall Study|Lost to Follow-up|2|||
127974520|NCT03452488|460527581|FG002|Overall Study|Lost to Follow-up|0|||
127974521|NCT03452488|460527579|FG000|Overall Study|PI Decision|1|||
127974522|NCT03452488|460527580|FG001|Overall Study|PI Decision|0|||
127974523|NCT03452488|460527581|FG002|Overall Study|PI Decision|0|||
127974524|NCT03452488|460527579|FG000|Overall Study|Withdrew consent|4|||
127974525|NCT03452488|460527580|FG001|Overall Study|Withdrew consent|2|||
127974526|NCT03452488|460527581|FG002|Overall Study|Withdrew consent|2|||
127974527|NCT03452488|460527579|FG000|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
127974528|NCT03452488|460527580|FG001|Overall Study|Withdraw due to the COVID-19 outbreak|0|||
127974529|NCT03452488|460527581|FG002|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
127974530|NCT03452488|460527579|FG000|Overall Study|Other|0|||
127974531|NCT03452488|460527580|FG001|Overall Study|Other|2|||
127974532|NCT03452488|460527581|FG002|Overall Study|Other|2|||
127974533|NCT01137110|460527586|FG000|Overall Study|Protocol Violation|1|||
127974534|NCT01137110|460527587|FG001|Overall Study|Protocol Violation|0|||
127974535|NCT00330343|460527590|FG000|Overall Study|Lost to Follow-up|5|||
127974536|NCT00281632|460527591|FG000|Overall Study|Adverse Event|7|||
127974537|NCT00281632|460527591|FG000|Overall Study|Withdrawal by Subject|2|||
127974538|NCT00281632|460527591|FG000|Overall Study|Disease Progression|22|||
127974539|NCT00281632|460527591|FG000|Overall Study|Death|1|||
127974540|NCT00281632|460527591|FG000|Overall Study|Physician Decision|1|||
127974541|NCT00281632|460527591|FG000|Overall Study|Ongoing|3|||
127974542|NCT03990571|460527592|FG000|Overall Study|Withdrawal by Subject|1|||
127974543|NCT03990571|460527592|FG000|Overall Study|Insurance Issues|3|||
127974544|NCT03990571|460527592|FG000|Overall Study|Covid Restrictions|2|||
127974545|NCT00782184|460527599|FG000|Overall Study|Adverse Event|1|||
127974546|NCT00782184|460527600|FG001|Overall Study|Adverse Event|2|||
127974547|NCT00782184|460527599|FG000|Overall Study|Protocol Violation|0|||
127974548|NCT00782184|460527600|FG001|Overall Study|Protocol Violation|1|||
127974549|NCT00782184|460527599|FG000|Overall Study|Withdrawal by Subject|3|||
127974550|NCT00782184|460527600|FG001|Overall Study|Withdrawal by Subject|2|||
127974551|NCT03614078|460527601|FG000|Overall Study|Withdrawal by Subject|2|||
127974552|NCT03614078|460527602|FG001|Overall Study|Withdrawal by Subject|2|||
127974553|NCT03614078|460527603|FG002|Overall Study|Withdrawal by Subject|3|||
127974554|NCT03614078|460527601|FG000|Overall Study|Participant Did Not Return for Visit|0|||
127974555|NCT03614078|460527602|FG001|Overall Study|Participant Did Not Return for Visit|1|||
127974556|NCT03614078|460527603|FG002|Overall Study|Participant Did Not Return for Visit|0|||
127974557|NCT03614078|460527601|FG000|Overall Study|High Neutrophils|0|||
127974558|NCT03614078|460527602|FG001|Overall Study|High Neutrophils|0|||
127974559|NCT03614078|460527603|FG002|Overall Study|High Neutrophils|2|||
127974560|NCT03614078|460527601|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
127974561|NCT03614078|460527602|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
127974562|NCT03614078|460527603|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
127974563|NCT03614078|460527601|FG000|Overall Study|Exacerbation of Psoriasis|0|||
127974564|NCT03614078|460527602|FG001|Overall Study|Exacerbation of Psoriasis|1|||
127974565|NCT03614078|460527603|FG002|Overall Study|Exacerbation of Psoriasis|0|||
127974566|NCT03614078|460527601|FG000|Overall Study|Adverse Event|0|||
127974567|NCT03614078|460527602|FG001|Overall Study|Adverse Event|2|||
127974568|NCT03614078|460527603|FG002|Overall Study|Adverse Event|0|||
127974569|NCT03614078|460527601|FG000|Overall Study|Dizziness and Rash|0|||
127974570|NCT03614078|460527602|FG001|Overall Study|Dizziness and Rash|1|||
127974571|NCT03614078|460527603|FG002|Overall Study|Dizziness and Rash|0|||
127974572|NCT04143594|460527606|FG000|Overall Study|Withdrew consent|3|||
127974573|NCT04143594|460527607|FG001|Overall Study|Withdrew consent|10|||
127974574|NCT04143594|460527608|FG002|Overall Study|Withdrew consent|3|||
127974575|NCT04143594|460527609|FG003|Overall Study|Withdrew consent|1|||
127974576|NCT04143594|460527606|FG000|Overall Study|Lost to Follow-up|3|||
127974577|NCT04143594|460527607|FG001|Overall Study|Lost to Follow-up|5|||
127974578|NCT04143594|460527608|FG002|Overall Study|Lost to Follow-up|11|||
127974579|NCT04143594|460527609|FG003|Overall Study|Lost to Follow-up|0|||
127974580|NCT04143594|460527606|FG000|Overall Study|Investigator's discretion|2|||
127974581|NCT04143594|460527607|FG001|Overall Study|Investigator's discretion|2|||
127974582|NCT04143594|460527608|FG002|Overall Study|Investigator's discretion|0|||
127974583|NCT04143594|460527609|FG003|Overall Study|Investigator's discretion|0|||
127974584|NCT04143594|460527606|FG000|Overall Study|Randomized but never treated|0|||
127974585|NCT04143594|460527607|FG001|Overall Study|Randomized but never treated|0|||
127974586|NCT04143594|460527608|FG002|Overall Study|Randomized but never treated|0|||
127974587|NCT04143594|460527609|FG003|Overall Study|Randomized but never treated|1|||
127974588|NCT04143594|460527606|FG000|Overall Study|Death|1|||
127974589|NCT04143594|460527607|FG001|Overall Study|Death|0|||
127974590|NCT04143594|460527608|FG002|Overall Study|Death|1|||
127974591|NCT04143594|460527609|FG003|Overall Study|Death|0|||
127974592|NCT04143594|460527606|FG000|Overall Study|Adverse Event|1|||
127974593|NCT04143594|460527607|FG001|Overall Study|Adverse Event|0|||
127974594|NCT04143594|460527608|FG002|Overall Study|Adverse Event|0|||
127974595|NCT04143594|460527609|FG003|Overall Study|Adverse Event|0|||
127974596|NCT04143594|460527606|FG000|Overall Study|Pregnancy|0|||
127974597|NCT04143594|460527607|FG001|Overall Study|Pregnancy|0|||
127974598|NCT04143594|460527608|FG002|Overall Study|Pregnancy|1|||
127974599|NCT04143594|460527609|FG003|Overall Study|Pregnancy|0|||
127974600|NCT04143594|460527606|FG000|Overall Study|Lack of Efficacy|1|||
127974601|NCT04143594|460527607|FG001|Overall Study|Lack of Efficacy|1|||
127974602|NCT04143594|460527608|FG002|Overall Study|Lack of Efficacy|0|||
127974603|NCT04143594|460527609|FG003|Overall Study|Lack of Efficacy|0|||
127974604|NCT02107859|460527618|FG000|Overall Study|Withdrawal by Subject|14|||
127974605|NCT02107859|460527618|FG000|Overall Study|Adverse Event|3|||
127974606|NCT02107859|460527618|FG000|Overall Study|Study closure|41|||
127974607|NCT02107859|460527618|FG000|Overall Study|Other than specified|3|||
127974608|NCT00977314|460527619|FG000|Overall Study|Withdrawal by Subject|1|||
127974609|NCT00977314|460527620|FG001|Overall Study|Withdrawal by Subject|0|||
127974610|NCT00977314|460527619|FG000|Overall Study|Physician Decision|1|||
127974611|NCT00977314|460527620|FG001|Overall Study|Physician Decision|0|||
127974612|NCT01343277|460527624|FG000|Overall Study|Other|3|||
127974613|NCT01343277|460527625|FG001|Overall Study|Other|3|||
127974614|NCT01343277|460527624|FG000|Overall Study|Withdrawal by Subject|18|||
127974615|NCT01343277|460527625|FG001|Overall Study|Withdrawal by Subject|13|||
127974616|NCT01343277|460527624|FG000|Overall Study|Physician Decision|1|||
127974617|NCT01343277|460527625|FG001|Overall Study|Physician Decision|2|||
127974618|NCT01343277|460527624|FG000|Overall Study|Death|10|||
127974619|NCT01343277|460527625|FG001|Overall Study|Death|1|||
127974620|NCT01343277|460527624|FG000|Overall Study|Adverse Event|67|||
127974621|NCT01343277|460527625|FG001|Overall Study|Adverse Event|13|||
127974622|NCT01343277|460527624|FG000|Overall Study|Disease progression|270|||
127974623|NCT01343277|460527625|FG001|Overall Study|Disease progression|138|||
127974624|NCT01343277|460527624|FG000|Overall Study|Randomized not treated|6|||
127974625|NCT01343277|460527625|FG001|Overall Study|Randomized not treated|21|||
127974626|NCT01343277|460527624|FG000|Overall Study|Treatment ongoing|8|||
127974627|NCT01343277|460527625|FG001|Overall Study|Treatment ongoing|2|||
127974628|NCT01343277|460527624|FG000|Overall Study|Subsequent anticancer therapy|1|||
127974629|NCT01343277|460527625|FG001|Overall Study|Subsequent anticancer therapy|0|||
127974630|NCT00135512|460527628|FG000|Overall Study|Adverse Event|56|||
127974631|NCT00135512|460527628|FG000|Overall Study|Lack of Efficacy|25|||
127974632|NCT00135512|460527628|FG000|Overall Study|Other|42|||
127974633|NCT02964208|460527629|FG000|Overall Study|Death|103|||
127974634|NCT02964208|460527629|FG000|Overall Study|Withdrawal by Subject|6|||
127974635|NCT02964208|460527629|FG000|Overall Study|Lost to Follow-up|6|||
127974636|NCT02964208|460527629|FG000|Overall Study|Unsuccessful Procedure|5|||
127974637|NCT02964208|460527629|FG000|Overall Study|Device Explant|1|||
127974638|NCT02964208|460527629|FG000|Overall Study|Anatomical Heart Structure of the Patient; LAA Occluder Was Not Implanted; Heart Transplant|3|||
127974639|NCT01295827|460527641|FG000|Overall Study|Adverse Event|1|||
127974640|NCT01295827|460527642|FG001|Overall Study|Adverse Event|2|||
127974641|NCT01295827|460527643|FG002|Overall Study|Adverse Event|2|||
127974642|NCT01295827|460527644|FG003|Overall Study|Adverse Event|1|||
127974643|NCT01295827|460527645|FG004|Overall Study|Adverse Event|1|||
127974644|NCT01295827|460527646|FG005|Overall Study|Adverse Event|4|||
127974645|NCT01295827|460527647|FG006|Overall Study|Adverse Event|15|||
127974646|NCT01295827|460527648|FG007|Overall Study|Adverse Event|49|||
127974647|NCT01295827|460527649|FG008|Overall Study|Adverse Event|22|||
127974648|NCT01295827|460527650|FG009|Overall Study|Adverse Event|7|||
127974649|NCT01295827|460527651|FG010|Overall Study|Adverse Event|50|||
127974650|NCT01295827|460527652|FG011|Overall Study|Adverse Event|21|||
127974651|NCT01295827|460527653|FG012|Overall Study|Adverse Event|0|||
127974652|NCT01295827|460527654|FG013|Overall Study|Adverse Event|0|||
127974653|NCT01295827|460527655|FG014|Overall Study|Adverse Event|0|||
127974654|NCT01295827|460527641|FG000|Overall Study|Lost to Follow-up|0|||
127974655|NCT01295827|460527642|FG001|Overall Study|Lost to Follow-up|0|||
127974656|NCT01295827|460527643|FG002|Overall Study|Lost to Follow-up|3|||
127974657|NCT01295827|460527644|FG003|Overall Study|Lost to Follow-up|0|||
127974658|NCT01295827|460527645|FG004|Overall Study|Lost to Follow-up|1|||
127974659|NCT01295827|460527646|FG005|Overall Study|Lost to Follow-up|0|||
127974660|NCT01295827|460527647|FG006|Overall Study|Lost to Follow-up|4|||
127974661|NCT01295827|460527648|FG007|Overall Study|Lost to Follow-up|8|||
127974662|NCT01295827|460527649|FG008|Overall Study|Lost to Follow-up|7|||
127974663|NCT01295827|460527650|FG009|Overall Study|Lost to Follow-up|4|||
127974664|NCT01295827|460527651|FG010|Overall Study|Lost to Follow-up|7|||
127974665|NCT01295827|460527652|FG011|Overall Study|Lost to Follow-up|3|||
127974666|NCT01295827|460527653|FG012|Overall Study|Lost to Follow-up|0|||
127974667|NCT01295827|460527654|FG013|Overall Study|Lost to Follow-up|0|||
127974668|NCT01295827|460527655|FG014|Overall Study|Lost to Follow-up|0|||
127974669|NCT01295827|460527641|FG000|Overall Study|Not Reported|0|||
127974670|NCT01295827|460527642|FG001|Overall Study|Not Reported|0|||
127974671|NCT01295827|460527643|FG002|Overall Study|Not Reported|0|||
127974672|NCT01295827|460527644|FG003|Overall Study|Not Reported|1|||
127974673|NCT01295827|460527645|FG004|Overall Study|Not Reported|0|||
127974674|NCT01295827|460527646|FG005|Overall Study|Not Reported|0|||
127974675|NCT01295827|460527647|FG006|Overall Study|Not Reported|24|||
127974676|NCT01295827|460527648|FG007|Overall Study|Not Reported|58|||
127974677|NCT01295827|460527649|FG008|Overall Study|Not Reported|41|||
127974678|NCT01295827|460527650|FG009|Overall Study|Not Reported|2|||
127974679|NCT01295827|460527651|FG010|Overall Study|Not Reported|23|||
127974680|NCT01295827|460527652|FG011|Overall Study|Not Reported|13|||
127974681|NCT01295827|460527653|FG012|Overall Study|Not Reported|0|||
127974682|NCT01295827|460527654|FG013|Overall Study|Not Reported|0|||
127974683|NCT01295827|460527655|FG014|Overall Study|Not Reported|0|||
127974684|NCT01295827|460527641|FG000|Overall Study|Progressive Disease|2|||
127974685|NCT01295827|460527642|FG001|Overall Study|Progressive Disease|1|||
127974686|NCT01295827|460527643|FG002|Overall Study|Progressive Disease|5|||
127974687|NCT01295827|460527644|FG003|Overall Study|Progressive Disease|2|||
127974688|NCT01295827|460527645|FG004|Overall Study|Progressive Disease|0|||
127974689|NCT01295827|460527646|FG005|Overall Study|Progressive Disease|1|||
127974690|NCT01295827|460527647|FG006|Overall Study|Progressive Disease|87|||
127974691|NCT01295827|460527648|FG007|Overall Study|Progressive Disease|144|||
127974692|NCT01295827|460527649|FG008|Overall Study|Progressive Disease|85|||
127974693|NCT01295827|460527650|FG009|Overall Study|Progressive Disease|40|||
127974694|NCT01295827|460527651|FG010|Overall Study|Progressive Disease|175|||
127974695|NCT01295827|460527652|FG011|Overall Study|Progressive Disease|136|||
127974696|NCT01295827|460527653|FG012|Overall Study|Progressive Disease|0|||
127974697|NCT01295827|460527654|FG013|Overall Study|Progressive Disease|0|||
127974698|NCT01295827|460527655|FG014|Overall Study|Progressive Disease|0|||
127974699|NCT01295827|460527641|FG000|Overall Study|Screen Failure|0|||
127974700|NCT01295827|460527642|FG001|Overall Study|Screen Failure|0|||
127974701|NCT01295827|460527643|FG002|Overall Study|Screen Failure|0|||
127974702|NCT01295827|460527644|FG003|Overall Study|Screen Failure|0|||
127974703|NCT01295827|460527645|FG004|Overall Study|Screen Failure|0|||
127974704|NCT01295827|460527646|FG005|Overall Study|Screen Failure|0|||
127974705|NCT01295827|460527647|FG006|Overall Study|Screen Failure|2|||
127974706|NCT01295827|460527648|FG007|Overall Study|Screen Failure|2|||
127974707|NCT01295827|460527649|FG008|Overall Study|Screen Failure|2|||
127974708|NCT01295827|460527650|FG009|Overall Study|Screen Failure|0|||
127974709|NCT01295827|460527651|FG010|Overall Study|Screen Failure|1|||
127974710|NCT01295827|460527652|FG011|Overall Study|Screen Failure|0|||
127974711|NCT01295827|460527653|FG012|Overall Study|Screen Failure|0|||
127974712|NCT01295827|460527654|FG013|Overall Study|Screen Failure|0|||
127974713|NCT01295827|460527655|FG014|Overall Study|Screen Failure|0|||
127974714|NCT01295827|460527641|FG000|Overall Study|Withdrawal by Subject|1|||
127974715|NCT01295827|460527642|FG001|Overall Study|Withdrawal by Subject|0|||
127974716|NCT01295827|460527643|FG002|Overall Study|Withdrawal by Subject|2|||
127974717|NCT01295827|460527644|FG003|Overall Study|Withdrawal by Subject|0|||
127974718|NCT01295827|460527645|FG004|Overall Study|Withdrawal by Subject|0|||
127974719|NCT01295827|460527646|FG005|Overall Study|Withdrawal by Subject|1|||
127974720|NCT01295827|460527647|FG006|Overall Study|Withdrawal by Subject|13|||
127974721|NCT01295827|460527648|FG007|Overall Study|Withdrawal by Subject|35|||
127974722|NCT01295827|460527649|FG008|Overall Study|Withdrawal by Subject|11|||
127974723|NCT01295827|460527650|FG009|Overall Study|Withdrawal by Subject|2|||
127974724|NCT01295827|460527651|FG010|Overall Study|Withdrawal by Subject|18|||
127974725|NCT01295827|460527652|FG011|Overall Study|Withdrawal by Subject|13|||
127974726|NCT01295827|460527653|FG012|Overall Study|Withdrawal by Subject|0|||
127974727|NCT01295827|460527654|FG013|Overall Study|Withdrawal by Subject|0|||
127974728|NCT01295827|460527655|FG014|Overall Study|Withdrawal by Subject|0|||
127974729|NCT01295827|460527641|FG000|Overall Study|Other|0|||
127974730|NCT01295827|460527642|FG001|Overall Study|Other|0|||
127974731|NCT01295827|460527643|FG002|Overall Study|Other|0|||
127974732|NCT01295827|460527644|FG003|Overall Study|Other|0|||
127974733|NCT01295827|460527645|FG004|Overall Study|Other|0|||
127974734|NCT01295827|460527646|FG005|Overall Study|Other|0|||
127974735|NCT01295827|460527647|FG006|Overall Study|Other|1|||
127974736|NCT01295827|460527648|FG007|Overall Study|Other|1|||
127974737|NCT01295827|460527649|FG008|Overall Study|Other|1|||
127974738|NCT01295827|460527650|FG009|Overall Study|Other|0|||
127974739|NCT01295827|460527651|FG010|Overall Study|Other|2|||
127974740|NCT01295827|460527652|FG011|Overall Study|Other|0|||
127974741|NCT01295827|460527653|FG012|Overall Study|Other|0|||
127974742|NCT01295827|460527654|FG013|Overall Study|Other|0|||
127974743|NCT01295827|460527655|FG014|Overall Study|Other|0|||
127974744|NCT01743560|460527656|FG000|Overall Study|Disease progression|26|||
127974745|NCT01743560|460527656|FG000|Overall Study|Adverse Event|8|||
127974746|NCT01743560|460527656|FG000|Overall Study|Death|3|||
127974747|NCT01743560|460527656|FG000|Overall Study|Withdrawal by Subject|2|||
127974748|NCT01743560|460527656|FG000|Overall Study|Protocol Violation|1|||
127974749|NCT01743560|460527656|FG000|Overall Study|>1 dose of study drug|3|||
127974750|NCT03226769|460527657|FG000|Overall Study|Withdrawal by Subject|0|||
127974751|NCT03226769|460527658|FG001|Overall Study|Withdrawal by Subject|1|||
127974752|NCT02640677|460527659|FG000|Overall Study|Lost to Follow-up|1|||
127974753|NCT02640677|460527659|FG000|Overall Study|Withdrawal by Subject|1|||
127974754|NCT01516008|460527660|FG000|Overall Study|Adverse Event|0|||
127974755|NCT01516008|460527661|FG001|Overall Study|Adverse Event|2|||
127974756|NCT01516008|460527662|FG002|Overall Study|Adverse Event|7|||
127974757|NCT01516008|460527660|FG000|Overall Study|Lack of Efficacy|44|||
127974758|NCT01516008|460527661|FG001|Overall Study|Lack of Efficacy|14|||
127974759|NCT01516008|460527662|FG002|Overall Study|Lack of Efficacy|10|||
127974760|NCT01516008|460527660|FG000|Overall Study|Protocol Violation|1|||
127974761|NCT01516008|460527661|FG001|Overall Study|Protocol Violation|0|||
127974762|NCT01516008|460527662|FG002|Overall Study|Protocol Violation|0|||
127974763|NCT01516008|460527660|FG000|Overall Study|Reason not specified|0|||
127974764|NCT01516008|460527661|FG001|Overall Study|Reason not specified|0|||
127974765|NCT01516008|460527662|FG002|Overall Study|Reason not specified|1|||
127974766|NCT05270395|460527678|FG000|Overall Study|Lost to Follow-up|2|||
127974767|NCT05270395|460527679|FG001|Overall Study|Lost to Follow-up|2|||
127974768|NCT05270395|460527678|FG000|Overall Study|Death|1|||
127974769|NCT05270395|460527679|FG001|Overall Study|Death|2|||
127974770|NCT05270395|460527678|FG000|Overall Study|Study Team Withdrew|1|||
127974771|NCT05270395|460527679|FG001|Overall Study|Study Team Withdrew|0|||
127974772|NCT03725761|460527680|FG000|Overall Study|still on study|1|||
127974773|NCT00199797|460529545|FG000|Overall Study|Progressive Disease|1|||
127974774|NCT00199797|460529545|FG000|Overall Study|Adverse Event|1|||
127974775|NCT00199797|460529545|FG000|Overall Study|Physician Decision|1|||
127974776|NCT04250350|460529549|FG000|Overall Study|Withdrawal by Subject|13|||
127974777|NCT04250350|460529549|FG000|Overall Study|Lost to Follow-up|8|||
127974778|NCT04250350|460529549|FG000|Overall Study|Adverse Event|5|||
127974779|NCT04250350|460529549|FG000|Overall Study|Lack of Efficacy|4|||
127974780|NCT04250350|460529549|FG000|Overall Study|Physician Decision|1|||
127974781|NCT04250350|460529549|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
127974782|NCT02836236|460529557|FG000|Double-Blind Treatment Phase|Withdrew Consent|3|||
127974783|NCT02836236|460529558|FG001|Double-Blind Treatment Phase|Withdrew Consent|1|||
127974784|NCT02836236|460529559|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
127974785|NCT02836236|460529560|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
127974786|NCT02836236|460529557|FG000|Double-Blind Treatment Phase|Investigator's Discretion|2|||
127974787|NCT02836236|460529558|FG001|Double-Blind Treatment Phase|Investigator's Discretion|1|||
127974788|NCT02836236|460529559|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
127974789|NCT02836236|460529560|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
127974790|NCT02836236|460529557|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
127974791|NCT02836236|460529558|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
127974792|NCT02836236|460529559|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
127974793|NCT02836236|460529560|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
127974794|NCT02836236|460529557|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
127974795|NCT02836236|460529558|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
127974796|NCT02836236|460529559|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
127974797|NCT02836236|460529560|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
127974798|NCT02836236|460529557|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
127974799|NCT02836236|460529558|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
127974800|NCT02836236|460529559|FG002|Open-Label TAF Treatment Phase|Withdrew consent|3|||
127974801|NCT02836236|460529560|FG003|Open-Label TAF Treatment Phase|Withdrew consent|2|||
127974802|NCT02836236|460529557|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
127974803|NCT02836236|460529558|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
127974804|NCT02836236|460529559|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|2|||
127974805|NCT02836236|460529560|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
127974806|NCT02836236|460529557|FG000|Open-Label TAF Treatment Phase|Death|0|||
127974807|NCT02836236|460529558|FG001|Open-Label TAF Treatment Phase|Death|0|||
127974808|NCT02836236|460529559|FG002|Open-Label TAF Treatment Phase|Death|1|||
127974809|NCT02836236|460529560|FG003|Open-Label TAF Treatment Phase|Death|1|||
127974810|NCT02836236|460529557|FG000|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
127974811|NCT02836236|460529558|FG001|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
127974812|NCT02836236|460529559|FG002|Open-Label TAF Treatment Phase|Investigator's discretion|1|||
127974813|NCT02836236|460529560|FG003|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
127974814|NCT01806961|460529561|FG000|Overall Study|sponsor decision|16|||
127974815|NCT00784238|460529562|FG000|Overall Study|Adverse Event|14|||
127974816|NCT00784238|460529562|FG000|Overall Study|Death|2|||
127974817|NCT00784238|460529562|FG000|Overall Study|Lack of Efficacy|33|||
127974818|NCT00784238|460529562|FG000|Overall Study|Lost to Follow-up|29|||
127974819|NCT00784238|460529562|FG000|Overall Study|Pregnancy|1|||
127974820|NCT00784238|460529562|FG000|Overall Study|Withdrawal by Subject|26|||
127974821|NCT00784238|460529562|FG000|Overall Study|Other|14|||
127974822|NCT03693612|460529563|FG000|Overall Study|Lost to Follow-up|0|||
127974823|NCT03693612|460529564|FG001|Overall Study|Lost to Follow-up|0|||
127974824|NCT03693612|460529565|FG002|Overall Study|Lost to Follow-up|0|||
127974825|NCT03693612|460529566|FG003|Overall Study|Lost to Follow-up|0|||
127974826|NCT03693612|460529567|FG004|Overall Study|Lost to Follow-up|1|||
127974827|NCT03693612|460529568|FG005|Overall Study|Lost to Follow-up|0|||
127974828|NCT03693612|460529569|FG006|Overall Study|Lost to Follow-up|0|||
127974829|NCT03693612|460529563|FG000|Overall Study|Withdrawal by Subject|0|||
127974830|NCT03693612|460529564|FG001|Overall Study|Withdrawal by Subject|0|||
127974831|NCT03693612|460529565|FG002|Overall Study|Withdrawal by Subject|1|||
127974832|NCT03693612|460529566|FG003|Overall Study|Withdrawal by Subject|0|||
127974833|NCT03693612|460529567|FG004|Overall Study|Withdrawal by Subject|2|||
127974834|NCT03693612|460529568|FG005|Overall Study|Withdrawal by Subject|0|||
127974835|NCT03693612|460529569|FG006|Overall Study|Withdrawal by Subject|0|||
127974836|NCT03693612|460529563|FG000|Overall Study|Study Terminated by Sponsor|0|||
127974837|NCT03693612|460529564|FG001|Overall Study|Study Terminated by Sponsor|1|||
127974838|NCT03693612|460529565|FG002|Overall Study|Study Terminated by Sponsor|0|||
127974839|NCT03693612|460529566|FG003|Overall Study|Study Terminated by Sponsor|0|||
127974840|NCT03693612|460529567|FG004|Overall Study|Study Terminated by Sponsor|3|||
127974841|NCT03693612|460529568|FG005|Overall Study|Study Terminated by Sponsor|0|||
127974842|NCT03693612|460529569|FG006|Overall Study|Study Terminated by Sponsor|0|||
127974843|NCT01154296|460529573|FG000|Randomization and Intervention|Decided to decline|1|||
127974844|NCT01154296|460529574|FG001|Randomization and Intervention|Decided to decline|1|||
127974845|NCT01154296|460529573|FG000|Randomization and Intervention|Declined by staff|1|||
127974846|NCT01154296|460529574|FG001|Randomization and Intervention|Declined by staff|0|||
127974847|NCT01154296|460529573|FG000|Randomization and Intervention|Did not return|1|||
127974848|NCT01154296|460529574|FG001|Randomization and Intervention|Did not return|0|||
127974849|NCT01154296|460529573|FG000|Randomization and Intervention|Left before test|0|||
127974850|NCT01154296|460529574|FG001|Randomization and Intervention|Left before test|1|||
127974851|NCT01154296|460529573|FG000|Randomization and Intervention|Left clinic early|2|||
127974852|NCT01154296|460529574|FG001|Randomization and Intervention|Left clinic early|0|||
127974853|NCT01154296|460529573|FG000|6-month Follow-up|Lost contact|269|||
127974854|NCT01154296|460529574|FG001|6-month Follow-up|Lost contact|275|||
127974855|NCT01154296|460529573|FG000|6-month Follow-up|Incarcerated|37|||
127974856|NCT01154296|460529574|FG001|6-month Follow-up|Incarcerated|32|||
127974857|NCT01154296|460529573|FG000|6-month Follow-up|Withdrew consent|14|||
127974858|NCT01154296|460529574|FG001|6-month Follow-up|Withdrew consent|15|||
127974859|NCT01154296|460529573|FG000|6-month Follow-up|Death|3|||
127974860|NCT01154296|460529574|FG001|6-month Follow-up|Death|2|||
127974861|NCT01154296|460529573|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
127974862|NCT01154296|460529574|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
127974863|NCT02759055|460529575|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
127974864|NCT02759055|460529576|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
127974865|NCT03692325|460529587|FG000|Overall Study|Adverse Event|2|||
127974866|NCT03692325|460529587|FG000|Overall Study|Progression/Recurrence|2|||
127974867|NCT00970632|460529588|FG000|Overall Study|Adverse Event|2|||
127974868|NCT00970632|460529589|FG001|Overall Study|Adverse Event|2|||
127974869|NCT00970632|460529590|FG002|Overall Study|Adverse Event|1|||
127974870|NCT00970632|460529588|FG000|Overall Study|Lack of Efficacy|3|||
127974871|NCT00970632|460529589|FG001|Overall Study|Lack of Efficacy|0|||
127974872|NCT00970632|460529590|FG002|Overall Study|Lack of Efficacy|0|||
127974873|NCT00970632|460529588|FG000|Overall Study|Lost to Follow-up|3|||
127974874|NCT00970632|460529589|FG001|Overall Study|Lost to Follow-up|0|||
127974875|NCT00970632|460529590|FG002|Overall Study|Lost to Follow-up|2|||
127974876|NCT00970632|460529588|FG000|Overall Study|Protocol Violation|8|||
127974877|NCT00970632|460529589|FG001|Overall Study|Protocol Violation|5|||
127974878|NCT00970632|460529590|FG002|Overall Study|Protocol Violation|8|||
127974879|NCT00970632|460529588|FG000|Overall Study|Withdrawal by Subject|7|||
127974880|NCT00970632|460529589|FG001|Overall Study|Withdrawal by Subject|6|||
127974881|NCT00970632|460529590|FG002|Overall Study|Withdrawal by Subject|4|||
127974882|NCT00970632|460529588|FG000|Overall Study|Entry criteria not met|0|||
127974883|NCT00970632|460529589|FG001|Overall Study|Entry criteria not met|2|||
127974884|NCT00970632|460529590|FG002|Overall Study|Entry criteria not met|2|||
127974885|NCT00970632|460529588|FG000|Overall Study|Sponsor decision|1|||
127974886|NCT00970632|460529589|FG001|Overall Study|Sponsor decision|0|||
127974887|NCT00970632|460529590|FG002|Overall Study|Sponsor decision|1|||
127974888|NCT02817516|460529591|FG000|Overall Study|Other|0|||
127974889|NCT02817516|460529592|FG001|Overall Study|Other|0|||
127974890|NCT02817516|460529593|FG002|Overall Study|Other|1|||
127974891|NCT02817516|460529594|FG003|Overall Study|Other|0|||
127974892|NCT04304235|460529595|FG000|Overall Study|incomplete triage data|0|||
127974893|NCT04304235|460529596|FG001|Overall Study|incomplete triage data|69|||
127974894|NCT04304235|460529597|FG002|Overall Study|incomplete triage data|0|||
127974895|NCT04304235|460529598|FG003|Overall Study|incomplete triage data|0|||
127974896|NCT04304235|460529599|FG004|Overall Study|incomplete triage data|289|||
127974897|NCT04304235|460529600|FG005|Overall Study|incomplete triage data|123|||
127974898|NCT04304235|460529601|FG006|Overall Study|incomplete triage data|65|||
127974899|NCT04429555|460529602|FG000|Overall Study|Death|0|||
127974900|NCT04429555|460529603|FG001|Overall Study|Death|2|||
127974901|NCT04429555|460529602|FG000|Overall Study|Other|2|||
127974902|NCT04429555|460529603|FG001|Overall Study|Other|0|||
127974903|NCT00425061|460529604|FG000|Overall Study|Adverse Event|1|||
127974904|NCT00425061|460529605|FG001|Overall Study|Adverse Event|0|||
127974905|NCT00425061|460529606|FG002|Overall Study|Adverse Event|0|||
127974906|NCT00425061|460529607|FG003|Overall Study|Adverse Event|2|||
127974907|NCT00425061|460529608|FG004|Overall Study|Adverse Event|2|||
127974908|NCT00425061|460529609|FG005|Overall Study|Adverse Event|0|||
127974909|NCT00425061|460529610|FG006|Overall Study|Adverse Event|0|||
127974910|NCT00425061|460529604|FG000|Overall Study|Lost to Follow-up|0|||
127974911|NCT00425061|460529605|FG001|Overall Study|Lost to Follow-up|1|||
127974912|NCT00425061|460529606|FG002|Overall Study|Lost to Follow-up|0|||
127974913|NCT00425061|460529607|FG003|Overall Study|Lost to Follow-up|0|||
127974914|NCT00425061|460529608|FG004|Overall Study|Lost to Follow-up|0|||
127974915|NCT00425061|460529609|FG005|Overall Study|Lost to Follow-up|0|||
127974916|NCT00425061|460529610|FG006|Overall Study|Lost to Follow-up|0|||
127974917|NCT00425061|460529604|FG000|Overall Study|Protocol Violation|1|||
127974918|NCT00425061|460529605|FG001|Overall Study|Protocol Violation|0|||
127974919|NCT00425061|460529606|FG002|Overall Study|Protocol Violation|0|||
127974920|NCT00425061|460529607|FG003|Overall Study|Protocol Violation|0|||
127974921|NCT00425061|460529608|FG004|Overall Study|Protocol Violation|0|||
127974922|NCT00425061|460529609|FG005|Overall Study|Protocol Violation|0|||
127974923|NCT00425061|460529610|FG006|Overall Study|Protocol Violation|0|||
127974924|NCT00425061|460529604|FG000|Overall Study|Withdrawal by Subject|0|||
127974925|NCT00425061|460529605|FG001|Overall Study|Withdrawal by Subject|1|||
127974926|NCT00425061|460529606|FG002|Overall Study|Withdrawal by Subject|0|||
127974927|NCT00425061|460529607|FG003|Overall Study|Withdrawal by Subject|0|||
127974928|NCT00425061|460529608|FG004|Overall Study|Withdrawal by Subject|1|||
127974929|NCT00425061|460529609|FG005|Overall Study|Withdrawal by Subject|0|||
127974930|NCT00425061|460529610|FG006|Overall Study|Withdrawal by Subject|3|||
127974931|NCT00425061|460529604|FG000|Overall Study|Sponsor's request|0|||
127974932|NCT00425061|460529605|FG001|Overall Study|Sponsor's request|0|||
127974933|NCT00425061|460529606|FG002|Overall Study|Sponsor's request|0|||
127974934|NCT00425061|460529607|FG003|Overall Study|Sponsor's request|0|||
127974935|NCT00425061|460529608|FG004|Overall Study|Sponsor's request|19|||
127974936|NCT00425061|460529609|FG005|Overall Study|Sponsor's request|4|||
127974937|NCT00425061|460529610|FG006|Overall Study|Sponsor's request|15|||
127974938|NCT00425061|460529604|FG000|Overall Study|Physician Decision|0|||
127974939|NCT00425061|460529605|FG001|Overall Study|Physician Decision|0|||
127974940|NCT00425061|460529606|FG002|Overall Study|Physician Decision|0|||
127974941|NCT00425061|460529607|FG003|Overall Study|Physician Decision|0|||
127974942|NCT00425061|460529608|FG004|Overall Study|Physician Decision|1|||
127974943|NCT00425061|460529609|FG005|Overall Study|Physician Decision|0|||
127974944|NCT00425061|460529610|FG006|Overall Study|Physician Decision|0|||
127974945|NCT00425061|460529604|FG000|Overall Study|Other|0|||
127974946|NCT00425061|460529605|FG001|Overall Study|Other|0|||
127974947|NCT00425061|460529606|FG002|Overall Study|Other|0|||
127974948|NCT00425061|460529607|FG003|Overall Study|Other|0|||
127974949|NCT00425061|460529608|FG004|Overall Study|Other|3|||
127974950|NCT00425061|460529609|FG005|Overall Study|Other|0|||
127974951|NCT00425061|460529610|FG006|Overall Study|Other|1|||
127974952|NCT02137850|460529611|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|1|||
127974953|NCT02137850|460529612|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
127974954|NCT02137850|460529613|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
127974955|NCT02137850|460529611|FG000|Main Phase: Pre-Prophylaxis|Protocol Violation|1|||
127974956|NCT02137850|460529612|FG001|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
127974957|NCT02137850|460529613|FG002|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
127974958|NCT02137850|460529611|FG000|Main Phase: Pre-Prophylaxis|Adverse Event|3|||
127974959|NCT02137850|460529612|FG001|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
127974960|NCT02137850|460529613|FG002|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
127974961|NCT02137850|460529611|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|2|||
127974962|NCT02137850|460529612|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
127974963|NCT02137850|460529613|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
127974964|NCT02137850|460529611|FG000|Main Phase: Pre-Prophylaxis|Lack of Efficacy|1|||
127974965|NCT02137850|460529612|FG001|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
127974966|NCT02137850|460529613|FG002|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
127974967|NCT02137850|460529611|FG000|Main Phase: Pre-Prophylaxis|Other|3|||
127974968|NCT02137850|460529612|FG001|Main Phase: Pre-Prophylaxis|Other|0|||
127974969|NCT02137850|460529613|FG002|Main Phase: Pre-Prophylaxis|Other|0|||
127974970|NCT02137850|460529611|FG000|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
127974971|NCT02137850|460529612|FG001|Main Phase: Prophylaxis|Withdrawal by parent/guardian|2|||
127974972|NCT02137850|460529613|FG002|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
127974973|NCT02137850|460529611|FG000|Main Phase: Prophylaxis|Protocol Violation|0|||
127974974|NCT02137850|460529612|FG001|Main Phase: Prophylaxis|Protocol Violation|1|||
127974975|NCT02137850|460529613|FG002|Main Phase: Prophylaxis|Protocol Violation|0|||
127974976|NCT02137850|460529611|FG000|Main Phase: Prophylaxis|Adverse Event|0|||
127974977|NCT02137850|460529612|FG001|Main Phase: Prophylaxis|Adverse Event|4|||
127974978|NCT02137850|460529613|FG002|Main Phase: Prophylaxis|Adverse Event|0|||
127974979|NCT02137850|460529611|FG000|Main Phase: Prophylaxis|Lack of Efficacy|0|||
127974980|NCT02137850|460529612|FG001|Main Phase: Prophylaxis|Lack of Efficacy|1|||
127974981|NCT02137850|460529613|FG002|Main Phase: Prophylaxis|Lack of Efficacy|0|||
127974982|NCT02137850|460529611|FG000|Main Phase: Prophylaxis|Other|0|||
127974983|NCT02137850|460529612|FG001|Main Phase: Prophylaxis|Other|1|||
127974984|NCT02137850|460529613|FG002|Main Phase: Prophylaxis|Other|0|||
127974985|NCT02137850|460529611|FG000|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
127974986|NCT02137850|460529612|FG001|Main Phase: Prophylaxis|Switched to ITI without completing main phase|2|||
127974987|NCT02137850|460529613|FG002|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
127974988|NCT02137850|460529611|FG000|Main Phase: Prophylaxis|Early site closure|0|||
127974989|NCT02137850|460529612|FG001|Main Phase: Prophylaxis|Early site closure|2|||
127974990|NCT02137850|460529613|FG002|Main Phase: Prophylaxis|Early site closure|0|||
127974991|NCT02137850|460529611|FG000|Main Phase: Prophylaxis|Lost to Follow-up|0|||
127974992|NCT02137850|460529612|FG001|Main Phase: Prophylaxis|Lost to Follow-up|1|||
127974993|NCT02137850|460529613|FG002|Main Phase: Prophylaxis|Lost to Follow-up|0|||
127974994|NCT02137850|460529611|FG000|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
127974995|NCT02137850|460529612|FG001|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
127974996|NCT02137850|460529613|FG002|Immune Tolerance Induction|Withdrawal by parent/guardian|1|||
127974997|NCT02137850|460529611|FG000|Immune Tolerance Induction|Lack of Efficacy|0|||
127974998|NCT02137850|460529612|FG001|Immune Tolerance Induction|Lack of Efficacy|0|||
127974999|NCT02137850|460529613|FG002|Immune Tolerance Induction|Lack of Efficacy|1|||
127975000|NCT02137850|460529611|FG000|Immune Tolerance Induction|Undergone minor surgery|0|||
127975001|NCT02137850|460529612|FG001|Immune Tolerance Induction|Undergone minor surgery|0|||
127975002|NCT02137850|460529613|FG002|Immune Tolerance Induction|Undergone minor surgery|2|||
127975003|NCT02137850|460529611|FG000|Extension Phase: Prophylaxis|Adverse Event|0|||
127975004|NCT02137850|460529612|FG001|Extension Phase: Prophylaxis|Adverse Event|1|||
127975005|NCT02137850|460529613|FG002|Extension Phase: Prophylaxis|Adverse Event|0|||
127975006|NCT02137850|460529611|FG000|Extension Phase: Prophylaxis|Protocol Violation|0|||
127975007|NCT02137850|460529612|FG001|Extension Phase: Prophylaxis|Protocol Violation|1|||
127975008|NCT02137850|460529613|FG002|Extension Phase: Prophylaxis|Protocol Violation|0|||
127975009|NCT02137850|460529611|FG000|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
127975010|NCT02137850|460529612|FG001|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|1|||
127975011|NCT02137850|460529613|FG002|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
127975012|NCT02137850|460529611|FG000|Extension Phase: Prophylaxis|Other|0|||
127975013|NCT02137850|460529612|FG001|Extension Phase: Prophylaxis|Other|1|||
127975014|NCT02137850|460529613|FG002|Extension Phase: Prophylaxis|Other|0|||
127975015|NCT02137850|460529611|FG000|Extension Phase: Prophylaxis|Early site closure|0|||
127975016|NCT02137850|460529612|FG001|Extension Phase: Prophylaxis|Early site closure|2|||
127975017|NCT02137850|460529613|FG002|Extension Phase: Prophylaxis|Early site closure|0|||
127975018|NCT04533412|460529614|FG000|Overall Study|Withdrawal by Subject|1|||
127975019|NCT04533412|460529615|FG001|Overall Study|Withdrawal by Subject|1|||
127975020|NCT04533412|460529614|FG000|Overall Study|Lost to Follow-up|1|||
127975021|NCT04533412|460529615|FG001|Overall Study|Lost to Follow-up|4|||
127975022|NCT00968981|460529621|FG000|Overall Study|Adverse Event|2|||
127975023|NCT00968981|460529622|FG001|Overall Study|Adverse Event|0|||
127975024|NCT00968981|460529623|FG002|Overall Study|Adverse Event|0|||
127975025|NCT00968981|460529621|FG000|Overall Study|Disease Progression|14|||
127975026|NCT00968981|460529622|FG001|Overall Study|Disease Progression|16|||
127975027|NCT00968981|460529623|FG002|Overall Study|Disease Progression|13|||
127975028|NCT00968981|460529621|FG000|Overall Study|Lost to Follow-up|0|||
127975029|NCT00968981|460529622|FG001|Overall Study|Lost to Follow-up|0|||
127975030|NCT00968981|460529623|FG002|Overall Study|Lost to Follow-up|1|||
127975031|NCT00968981|460529621|FG000|Overall Study|Physician Decision|5|||
127975032|NCT00968981|460529622|FG001|Overall Study|Physician Decision|3|||
127975033|NCT00968981|460529623|FG002|Overall Study|Physician Decision|5|||
127975034|NCT00968981|460529621|FG000|Overall Study|Withdrawal by Subject|1|||
127975035|NCT00968981|460529622|FG001|Overall Study|Withdrawal by Subject|3|||
127975036|NCT00968981|460529623|FG002|Overall Study|Withdrawal by Subject|3|||
127975037|NCT01489254|460529626|FG000|Double-blind Part|Adverse Event|7|||
127975038|NCT01489254|460529627|FG001|Double-blind Part|Adverse Event|2|||
127975039|NCT01489254|460529628|FG002|Double-blind Part|Adverse Event|2|||
127975040|NCT01489254|460529629|FG003|Double-blind Part|Adverse Event|0|||
127975041|NCT01489254|460529626|FG000|Double-blind Part|Pregnancy|1|||
127975042|NCT01489254|460529627|FG001|Double-blind Part|Pregnancy|3|||
127975043|NCT01489254|460529628|FG002|Double-blind Part|Pregnancy|0|||
127975044|NCT01489254|460529629|FG003|Double-blind Part|Pregnancy|0|||
127975045|NCT01489254|460529626|FG000|Double-blind Part|Withdrawal by Subject|12|||
127975046|NCT01489254|460529627|FG001|Double-blind Part|Withdrawal by Subject|20|||
127975047|NCT01489254|460529628|FG002|Double-blind Part|Withdrawal by Subject|1|||
127975048|NCT01489254|460529629|FG003|Double-blind Part|Withdrawal by Subject|0|||
127975049|NCT01489254|460529626|FG000|Double-blind Part|Lost to Follow-up|1|||
127975050|NCT01489254|460529627|FG001|Double-blind Part|Lost to Follow-up|2|||
127975051|NCT01489254|460529628|FG002|Double-blind Part|Lost to Follow-up|0|||
127975052|NCT01489254|460529629|FG003|Double-blind Part|Lost to Follow-up|0|||
127975053|NCT01489254|460529626|FG000|Double-blind Part|Other reasons for not completing study|4|||
127975054|NCT01489254|460529627|FG001|Double-blind Part|Other reasons for not completing study|6|||
127975055|NCT01489254|460529628|FG002|Double-blind Part|Other reasons for not completing study|0|||
127975056|NCT01489254|460529629|FG003|Double-blind Part|Other reasons for not completing study|0|||
127975057|NCT01489254|460529626|FG000|Open-label Extension Part|Adverse Event|0|||
127975058|NCT01489254|460529627|FG001|Open-label Extension Part|Adverse Event|0|||
127975059|NCT01489254|460529628|FG002|Open-label Extension Part|Adverse Event|0|||
127975060|NCT01489254|460529629|FG003|Open-label Extension Part|Adverse Event|10|||
127975061|NCT01489254|460529626|FG000|Open-label Extension Part|Pregnancy|0|||
127975062|NCT01489254|460529627|FG001|Open-label Extension Part|Pregnancy|0|||
127975063|NCT01489254|460529628|FG002|Open-label Extension Part|Pregnancy|0|||
127975064|NCT01489254|460529629|FG003|Open-label Extension Part|Pregnancy|3|||
127975065|NCT01489254|460529626|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
127975066|NCT01489254|460529627|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
127975067|NCT01489254|460529628|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
127975068|NCT01489254|460529629|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
127975069|NCT01489254|460529626|FG000|Open-label Extension Part|Protocol Violation|0|||
127975070|NCT01489254|460529627|FG001|Open-label Extension Part|Protocol Violation|0|||
127975071|NCT01489254|460529628|FG002|Open-label Extension Part|Protocol Violation|0|||
127975072|NCT01489254|460529629|FG003|Open-label Extension Part|Protocol Violation|1|||
127975073|NCT01489254|460529626|FG000|Open-label Extension Part|Lost to Follow-up|0|||
127975074|NCT01489254|460529627|FG001|Open-label Extension Part|Lost to Follow-up|0|||
127975075|NCT01489254|460529628|FG002|Open-label Extension Part|Lost to Follow-up|0|||
127975076|NCT01489254|460529629|FG003|Open-label Extension Part|Lost to Follow-up|9|||
127975077|NCT01489254|460529626|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
127975078|NCT01489254|460529627|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
127975079|NCT01489254|460529628|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
127975080|NCT01489254|460529629|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
127975081|NCT00507819|460529630|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
127975082|NCT00507819|460529631|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
127975083|NCT01254318|460529634|FG000|Overall Study|Lost to Follow-up|5|||
127975084|NCT01254318|460529634|FG000|Overall Study|Death|47|||
127975085|NCT02691936|460529638|FG000|Overall Study|Withdrawal by Subject|2|||
127975086|NCT02691936|460529639|FG001|Overall Study|Withdrawal by Subject|5|||
127975087|NCT01878084|460529640|FG000|Overall Study|Physician Decision|2|||
127975088|NCT00749684|460529641|FG000|Overall Study|Death|1|||
127975089|NCT00749684|460529641|FG000|Overall Study|Adverse Event|27|||
127975090|NCT00749684|460529641|FG000|Overall Study|Participant's Wish|10|||
127975091|NCT00749684|460529641|FG000|Overall Study|Not Documented|1|||
127975092|NCT00749684|460529641|FG000|Overall Study|Progressive Desease|31|||
127975093|NCT00749684|460529641|FG000|Overall Study|Therapy according to protocol + AE|2|||
127975094|NCT00749684|460529641|FG000|Overall Study|AE+discontinuation on participants wish|1|||
127975095|NCT00749684|460529641|FG000|Overall Study|Missing|9|||
127975096|NCT02892422|460529643|FG000|Overall Study|Enrolled not treated|4|||
127975097|NCT02892422|460529643|FG000|Overall Study|Adverse Event|38|||
127975098|NCT02892422|460529643|FG000|Overall Study|Lack of Efficacy|32|||
127975099|NCT02892422|460529643|FG000|Overall Study|Non-compliance with study drug|11|||
127975100|NCT02892422|460529643|FG000|Overall Study|Protocol Violation|4|||
127975101|NCT02892422|460529643|FG000|Overall Study|Withdrawal by Subject|56|||
127975102|NCT02892422|460529643|FG000|Overall Study|Lost to Follow-up|5|||
127975103|NCT02892422|460529643|FG000|Overall Study|sponsor information 16159A results|21|||
127975104|NCT02892422|460529643|FG000|Overall Study|withdrawal of consent|13|||
127975105|NCT02892422|460529643|FG000|Overall Study|exclusion criteria met|3|||
127975106|NCT02892422|460529643|FG000|Overall Study|moving elsewhere|4|||
127975107|NCT02892422|460529643|FG000|Overall Study|non-compliance|10|||
127975108|NCT02892422|460529643|FG000|Overall Study|patient legally incapable|1|||
127975109|NCT02892422|460529643|FG000|Overall Study|patient decision|7|||
127975110|NCT02892422|460529643|FG000|Overall Study|Investigator decision|1|||
127975111|NCT01023256|460529644|FG000|Overall Study|Protocol Violation|2|||
127975112|NCT01023256|460529645|FG001|Overall Study|Protocol Violation|3|||
127975113|NCT01023256|460529646|FG002|Overall Study|Protocol Violation|0|||
127975114|NCT01023256|460529647|FG003|Overall Study|Protocol Violation|0|||
127975115|NCT01023256|460529644|FG000|Overall Study|Randomized but not treated|1|||
127975116|NCT01023256|460529645|FG001|Overall Study|Randomized but not treated|0|||
127975117|NCT01023256|460529646|FG002|Overall Study|Randomized but not treated|1|||
127975118|NCT01023256|460529647|FG003|Overall Study|Randomized but not treated|0|||
127975119|NCT01023256|460529644|FG000|Overall Study|Other|1|||
127975120|NCT01023256|460529645|FG001|Overall Study|Other|0|||
127975121|NCT01023256|460529646|FG002|Overall Study|Other|0|||
127975122|NCT01023256|460529647|FG003|Overall Study|Other|2|||
127975123|NCT01023256|460529644|FG000|Overall Study|Adverse Event|0|||
127975124|NCT01023256|460529645|FG001|Overall Study|Adverse Event|0|||
127975125|NCT01023256|460529646|FG002|Overall Study|Adverse Event|0|||
127975126|NCT01023256|460529647|FG003|Overall Study|Adverse Event|1|||
127975127|NCT01023256|460529644|FG000|Overall Study|Withdrawal by Subject|0|||
127975128|NCT01023256|460529645|FG001|Overall Study|Withdrawal by Subject|0|||
127975129|NCT01023256|460529646|FG002|Overall Study|Withdrawal by Subject|0|||
127975130|NCT01023256|460529647|FG003|Overall Study|Withdrawal by Subject|2|||
127975131|NCT03155178|460529648|FG000|Overall Study|Did not meet treatment day baseline|7|||
127975132|NCT03155178|460529649|FG001|Overall Study|Did not meet treatment day baseline|7|||
127975133|NCT03155178|460529650|FG002|Overall Study|Did not meet treatment day baseline|7|||
127975134|NCT03155178|460529651|FG003|Overall Study|Did not meet treatment day baseline|7|||
127975135|NCT03089697|460529652|FG000|Overall Study|Adverse Event|1|||
127975136|NCT03089697|460529653|FG001|Overall Study|Adverse Event|2|||
127975137|NCT03089697|460529652|FG000|Overall Study|Withdrawal by Subject|1|||
127975138|NCT03089697|460529653|FG001|Overall Study|Withdrawal by Subject|0|||
127975139|NCT00834639|460529654|FG000|Second Intervention|Physician Decision|0|||
127975140|NCT00834639|460529655|FG001|Second Intervention|Physician Decision|2|||
127975141|NCT03382834|460529658|FG000|Step 1|Lost to Follow-up|0|||
127975142|NCT03382834|460529659|FG001|Step 1|Lost to Follow-up|1|||
127975143|NCT03382834|460529658|FG000|Step 2|Death|1|||
127975144|NCT03382834|460529659|FG001|Step 2|Death|0|||
127975145|NCT03382834|460529658|FG000|Step 2|Lost to Follow-up|2|||
127975146|NCT03382834|460529659|FG001|Step 2|Lost to Follow-up|2|||
127975147|NCT03382834|460529658|FG000|Step 2|Site Terminated by Sponsor|1|||
127975148|NCT03382834|460529659|FG001|Step 2|Site Terminated by Sponsor|0|||
127975149|NCT02387957|460529660|FG000|Overall Study|The study was discontinued|21|||
127975150|NCT02387957|460529661|FG001|Overall Study|The study was discontinued|21|||
127975151|NCT02387957|460529662|FG002|Overall Study|The study was discontinued|20|||
127975152|NCT03613649|460529663|FG000|Second Treatment|Lost to Follow-up|0|||
127975153|NCT03613649|460529664|FG001|Second Treatment|Lost to Follow-up|0|||
127975154|NCT03613649|460529665|FG002|Second Treatment|Lost to Follow-up|1|||
127975155|NCT03613649|460529666|FG003|Second Treatment|Lost to Follow-up|0|||
127975156|NCT03613649|460529667|FG004|Second Treatment|Lost to Follow-up|0|||
127975157|NCT03613649|460529668|FG005|Second Treatment|Lost to Follow-up|0|||
127975158|NCT03613649|460529669|FG006|Second Treatment|Lost to Follow-up|0|||
127975159|NCT03613649|460529670|FG007|Second Treatment|Lost to Follow-up|0|||
127975160|NCT03613649|460529671|FG008|Second Treatment|Lost to Follow-up|0|||
127975161|NCT03613649|460529672|FG009|Second Treatment|Lost to Follow-up|0|||
127975162|NCT03613649|460529673|FG010|Second Treatment|Lost to Follow-up|0|||
127975163|NCT03613649|460529674|FG011|Second Treatment|Lost to Follow-up|0|||
127975164|NCT03613649|460529663|FG000|Second Treatment|Withdrawal by Subject|0|||
127975165|NCT03613649|460529664|FG001|Second Treatment|Withdrawal by Subject|0|||
127975166|NCT03613649|460529665|FG002|Second Treatment|Withdrawal by Subject|0|||
127975167|NCT03613649|460529666|FG003|Second Treatment|Withdrawal by Subject|0|||
127975168|NCT03613649|460529667|FG004|Second Treatment|Withdrawal by Subject|1|||
127975169|NCT03613649|460529668|FG005|Second Treatment|Withdrawal by Subject|0|||
127975170|NCT03613649|460529669|FG006|Second Treatment|Withdrawal by Subject|0|||
127975171|NCT03613649|460529670|FG007|Second Treatment|Withdrawal by Subject|0|||
127975172|NCT03613649|460529671|FG008|Second Treatment|Withdrawal by Subject|0|||
127975173|NCT03613649|460529672|FG009|Second Treatment|Withdrawal by Subject|0|||
127975174|NCT03613649|460529673|FG010|Second Treatment|Withdrawal by Subject|0|||
127975175|NCT03613649|460529674|FG011|Second Treatment|Withdrawal by Subject|0|||
127975176|NCT03613649|460529663|FG000|Third Treatment|Lost to Follow-up|0|||
127975177|NCT03613649|460529664|FG001|Third Treatment|Lost to Follow-up|0|||
127975178|NCT03613649|460529665|FG002|Third Treatment|Lost to Follow-up|0|||
127975179|NCT03613649|460529666|FG003|Third Treatment|Lost to Follow-up|0|||
127975180|NCT03613649|460529667|FG004|Third Treatment|Lost to Follow-up|1|||
127975181|NCT03613649|460529668|FG005|Third Treatment|Lost to Follow-up|0|||
127975182|NCT03613649|460529669|FG006|Third Treatment|Lost to Follow-up|0|||
127975183|NCT03613649|460529670|FG007|Third Treatment|Lost to Follow-up|0|||
127975184|NCT03613649|460529671|FG008|Third Treatment|Lost to Follow-up|0|||
127975185|NCT03613649|460529672|FG009|Third Treatment|Lost to Follow-up|0|||
127975186|NCT03613649|460529673|FG010|Third Treatment|Lost to Follow-up|0|||
127975187|NCT03613649|460529674|FG011|Third Treatment|Lost to Follow-up|1|||
127975188|NCT03613649|460529663|FG000|Third Treatment|Protocol Violation|0|||
127975189|NCT03613649|460529664|FG001|Third Treatment|Protocol Violation|0|||
127975190|NCT03613649|460529665|FG002|Third Treatment|Protocol Violation|0|||
127975191|NCT03613649|460529666|FG003|Third Treatment|Protocol Violation|0|||
127975192|NCT03613649|460529667|FG004|Third Treatment|Protocol Violation|0|||
127975193|NCT03613649|460529668|FG005|Third Treatment|Protocol Violation|0|||
127975194|NCT03613649|460529669|FG006|Third Treatment|Protocol Violation|1|||
127975195|NCT03613649|460529670|FG007|Third Treatment|Protocol Violation|0|||
127975196|NCT03613649|460529671|FG008|Third Treatment|Protocol Violation|0|||
127975197|NCT03613649|460529672|FG009|Third Treatment|Protocol Violation|0|||
127975198|NCT03613649|460529673|FG010|Third Treatment|Protocol Violation|0|||
127975199|NCT03613649|460529674|FG011|Third Treatment|Protocol Violation|1|||
127975200|NCT03613649|460529663|FG000|Fourth Treatment|Protocol Violation|1|||
127975201|NCT03613649|460529664|FG001|Fourth Treatment|Protocol Violation|0|||
127975202|NCT03613649|460529665|FG002|Fourth Treatment|Protocol Violation|0|||
127975203|NCT03613649|460529666|FG003|Fourth Treatment|Protocol Violation|0|||
127975204|NCT03613649|460529667|FG004|Fourth Treatment|Protocol Violation|1|||
127975205|NCT03613649|460529668|FG005|Fourth Treatment|Protocol Violation|0|||
127975206|NCT03613649|460529669|FG006|Fourth Treatment|Protocol Violation|0|||
127975207|NCT03613649|460529670|FG007|Fourth Treatment|Protocol Violation|0|||
127975208|NCT03613649|460529671|FG008|Fourth Treatment|Protocol Violation|0|||
127975209|NCT03613649|460529672|FG009|Fourth Treatment|Protocol Violation|0|||
127975210|NCT03613649|460529673|FG010|Fourth Treatment|Protocol Violation|0|||
127975211|NCT03613649|460529674|FG011|Fourth Treatment|Protocol Violation|0|||
127975212|NCT03613649|460529663|FG000|Fourth Treatment|Physician Decision|0|||
127975213|NCT03613649|460529664|FG001|Fourth Treatment|Physician Decision|0|||
127975214|NCT03613649|460529665|FG002|Fourth Treatment|Physician Decision|0|||
127975215|NCT03613649|460529666|FG003|Fourth Treatment|Physician Decision|0|||
127975216|NCT03613649|460529667|FG004|Fourth Treatment|Physician Decision|0|||
127975217|NCT03613649|460529668|FG005|Fourth Treatment|Physician Decision|0|||
127975218|NCT03613649|460529669|FG006|Fourth Treatment|Physician Decision|1|||
127975219|NCT03613649|460529670|FG007|Fourth Treatment|Physician Decision|0|||
127975220|NCT03613649|460529671|FG008|Fourth Treatment|Physician Decision|0|||
127975221|NCT03613649|460529672|FG009|Fourth Treatment|Physician Decision|0|||
127975222|NCT03613649|460529673|FG010|Fourth Treatment|Physician Decision|0|||
127975223|NCT03613649|460529674|FG011|Fourth Treatment|Physician Decision|0|||
127975224|NCT00675428|460529675|FG000|Overall Study|Disease Progression|2|||
127975225|NCT00675428|460529676|FG001|Overall Study|Disease Progression|2|||
127975226|NCT00675428|460529675|FG000|Overall Study|No Disease Response After Cycle 6|0|||
127975227|NCT00675428|460529676|FG001|Overall Study|No Disease Response After Cycle 6|1|||
127975228|NCT00675428|460529675|FG000|Overall Study|Physician Decision|1|||
127975229|NCT00675428|460529676|FG001|Overall Study|Physician Decision|0|||
127975230|NCT00319592|460529677|FG000|Overall Study|Protocol Violation|1|||
127975231|NCT00319592|460529678|FG001|Overall Study|Protocol Violation|0|||
127975232|NCT00319592|460529677|FG000|Overall Study|Physician Decision|0|||
127975233|NCT00319592|460529678|FG001|Overall Study|Physician Decision|1|||
127975234|NCT01500187|460529681|FG000|Overall Study|Lost to Follow-up|6|||
127975235|NCT01500187|460529682|FG001|Overall Study|Lost to Follow-up|0|||
127975236|NCT01992653|460529685|FG000|Overall Study|Death|0|||
127975237|NCT01992653|460529686|FG001|Overall Study|Death|0|||
127975238|NCT01992653|460529687|FG002|Overall Study|Death|1|||
127975239|NCT01992653|460529688|FG003|Overall Study|Death|0|||
127975240|NCT01992653|460529689|FG004|Overall Study|Death|1|||
127975241|NCT01992653|460529690|FG005|Overall Study|Death|0|||
127975242|NCT01992653|460529691|FG006|Overall Study|Death|4|||
127975243|NCT01992653|460529692|FG007|Overall Study|Death|2|||
127975244|NCT01992653|460529685|FG000|Overall Study|Lost to Follow-up|0|||
127975245|NCT01992653|460529686|FG001|Overall Study|Lost to Follow-up|0|||
127975246|NCT01992653|460529687|FG002|Overall Study|Lost to Follow-up|0|||
127975247|NCT01992653|460529688|FG003|Overall Study|Lost to Follow-up|0|||
127975248|NCT01992653|460529689|FG004|Overall Study|Lost to Follow-up|0|||
127975249|NCT01992653|460529690|FG005|Overall Study|Lost to Follow-up|0|||
127975250|NCT01992653|460529691|FG006|Overall Study|Lost to Follow-up|0|||
127975251|NCT01992653|460529692|FG007|Overall Study|Lost to Follow-up|1|||
127975252|NCT01992653|460529685|FG000|Overall Study|Study Completed|0|||
127975253|NCT01992653|460529686|FG001|Overall Study|Study Completed|0|||
127975254|NCT01992653|460529687|FG002|Overall Study|Study Completed|0|||
127975255|NCT01992653|460529688|FG003|Overall Study|Study Completed|0|||
127975256|NCT01992653|460529689|FG004|Overall Study|Study Completed|0|||
127975257|NCT01992653|460529690|FG005|Overall Study|Study Completed|0|||
127975258|NCT01992653|460529691|FG006|Overall Study|Study Completed|0|||
127975259|NCT01992653|460529692|FG007|Overall Study|Study Completed|1|||
127975260|NCT01992653|460529685|FG000|Overall Study|Disease Progression|0|||
127975261|NCT01992653|460529686|FG001|Overall Study|Disease Progression|0|||
127975262|NCT01992653|460529687|FG002|Overall Study|Disease Progression|0|||
127975263|NCT01992653|460529688|FG003|Overall Study|Disease Progression|0|||
127975264|NCT01992653|460529689|FG004|Overall Study|Disease Progression|0|||
127975265|NCT01992653|460529690|FG005|Overall Study|Disease Progression|0|||
127975266|NCT01992653|460529691|FG006|Overall Study|Disease Progression|4|||
127975267|NCT01992653|460529692|FG007|Overall Study|Disease Progression|0|||
127975268|NCT01582178|460529698|FG000|Overall Study|Physician Decision|6|||
127975269|NCT01582178|460529699|FG001|Overall Study|Physician Decision|5|||
127975270|NCT04439214|460529700|FG000|Overall Study|Adverse Event|13|||
127975271|NCT04439214|460529700|FG000|Overall Study|Disease progression|16|||
127975272|NCT04439214|460529700|FG000|Overall Study|Death|1|||
127975273|NCT04439214|460529700|FG000|Overall Study|Withdrawal by Subject|2|||
127975274|NCT04439214|460529700|FG000|Overall Study|Declining health|1|||
127975275|NCT04439214|460529700|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
127975276|NCT04439214|460529700|FG000|Overall Study|Ineligible|5|||
127975277|NCT04553471|460529701|FG000|Overall Study|Did not start treatment on protocol|3|||
127975278|NCT04553471|460529701|FG000|Overall Study|Death|1|||
127975279|NCT00940823|460529702|FG000|Overall Study|Death|8|||
127975280|NCT00940823|460529703|FG001|Overall Study|Death|12|||
127975281|NCT00940823|460529702|FG000|Overall Study|Lost to Follow-up|27|||
127975282|NCT00940823|460529703|FG001|Overall Study|Lost to Follow-up|20|||
127975283|NCT00784550|460531534|FG000|Overall Study|Adverse Event|12|||
127975284|NCT00784550|460531535|FG001|Overall Study|Adverse Event|10|||
127975285|NCT00784550|460531534|FG000|Overall Study|Lack of Efficacy|0|||
127975286|NCT00784550|460531535|FG001|Overall Study|Lack of Efficacy|1|||
127975287|NCT00784550|460531534|FG000|Overall Study|Protocol Violation|10|||
127975288|NCT00784550|460531535|FG001|Overall Study|Protocol Violation|10|||
127975289|NCT00784550|460531534|FG000|Overall Study|Lost to Follow-up|8|||
127975290|NCT00784550|460531535|FG001|Overall Study|Lost to Follow-up|5|||
127975291|NCT00784550|460531534|FG000|Overall Study|Physician Decision|2|||
127975292|NCT00784550|460531535|FG001|Overall Study|Physician Decision|3|||
127975293|NCT00784550|460531534|FG000|Overall Study|Withdrawal by Subject|4|||
127975294|NCT00784550|460531535|FG001|Overall Study|Withdrawal by Subject|13|||
127975295|NCT00688701|460531536|FG000|Overall Study|Adverse Event|1|||
127975296|NCT00688701|460531537|FG001|Overall Study|Adverse Event|0|||
127975297|NCT00688701|460531538|FG002|Overall Study|Adverse Event|5|||
127975298|NCT00688701|460531539|FG003|Overall Study|Adverse Event|3|||
127975299|NCT00688701|460531536|FG000|Overall Study|Lack of Efficacy|0|||
127975300|NCT00688701|460531537|FG001|Overall Study|Lack of Efficacy|1|||
127975301|NCT00688701|460531538|FG002|Overall Study|Lack of Efficacy|0|||
127975302|NCT00688701|460531539|FG003|Overall Study|Lack of Efficacy|0|||
127975303|NCT00688701|460531536|FG000|Overall Study|Withdrawal by Subject|3|||
127975304|NCT00688701|460531537|FG001|Overall Study|Withdrawal by Subject|3|||
127975305|NCT00688701|460531538|FG002|Overall Study|Withdrawal by Subject|4|||
127975306|NCT00688701|460531539|FG003|Overall Study|Withdrawal by Subject|8|||
127975307|NCT00688701|460531536|FG000|Overall Study|Poor compliance to protocol|0|||
127975308|NCT00688701|460531537|FG001|Overall Study|Poor compliance to protocol|1|||
127975309|NCT00688701|460531538|FG002|Overall Study|Poor compliance to protocol|1|||
127975310|NCT00688701|460531539|FG003|Overall Study|Poor compliance to protocol|0|||
127975311|NCT01106677|460531548|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
127975312|NCT01106677|460531549|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
127975313|NCT01106677|460531550|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
127975314|NCT01106677|460531551|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
127975315|NCT01106677|460531548|FG000|Core Period: Baseline to Week 26|Death|0|||
127975316|NCT01106677|460531549|FG001|Core Period: Baseline to Week 26|Death|0|||
127975317|NCT01106677|460531550|FG002|Core Period: Baseline to Week 26|Death|1|||
127975318|NCT01106677|460531551|FG003|Core Period: Baseline to Week 26|Death|0|||
127975319|NCT01106677|460531548|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
127975320|NCT01106677|460531549|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
127975321|NCT01106677|460531550|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
127975322|NCT01106677|460531551|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
127975323|NCT01106677|460531548|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
127975324|NCT01106677|460531549|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
127975325|NCT01106677|460531550|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
127975326|NCT01106677|460531551|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
127975327|NCT01106677|460531548|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
127975328|NCT01106677|460531549|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
127975329|NCT01106677|460531550|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
127975330|NCT01106677|460531551|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
127975331|NCT01106677|460531548|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
127975332|NCT01106677|460531549|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
127975333|NCT01106677|460531550|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
127975334|NCT01106677|460531551|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
127975335|NCT01106677|460531548|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
127975336|NCT01106677|460531549|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
127975337|NCT01106677|460531550|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
127975338|NCT01106677|460531551|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
127975339|NCT01106677|460531548|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
127975340|NCT01106677|460531549|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
127975341|NCT01106677|460531550|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
127975342|NCT01106677|460531551|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
127975343|NCT01106677|460531548|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
127975344|NCT01106677|460531549|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
127975345|NCT01106677|460531550|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
127975346|NCT01106677|460531551|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
127975347|NCT01106677|460531548|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
127975348|NCT01106677|460531549|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
127975349|NCT01106677|460531550|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
127975350|NCT01106677|460531551|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
127485503|NCT02629861|458741199|FG001|Overall Study|Withdrawal by Subject|8|||
127485504|NCT02629861|458741200|FG002|Overall Study|Withdrawal by Subject|13|||
127485505|NCT02629861|458741198|FG000|Overall Study|Protocol Violation|2|||
127485506|NCT02629861|458741199|FG001|Overall Study|Protocol Violation|3|||
127485507|NCT02629861|458741200|FG002|Overall Study|Protocol Violation|7|||
127485508|NCT02629861|458741198|FG000|Overall Study|Lost to Follow-up|12|||
127485509|NCT02629861|458741199|FG001|Overall Study|Lost to Follow-up|9|||
127485510|NCT02629861|458741200|FG002|Overall Study|Lost to Follow-up|4|||
127485511|NCT02629861|458741198|FG000|Overall Study|Other|1|||
127485512|NCT02629861|458741199|FG001|Overall Study|Other|1|||
127485513|NCT02629861|458741200|FG002|Overall Study|Other|0|||
127485514|NCT02629861|458741198|FG000|Overall Study|Pregnancy|2|||
127485515|NCT02629861|458741199|FG001|Overall Study|Pregnancy|1|||
127485516|NCT02629861|458741200|FG002|Overall Study|Pregnancy|0|||
127485517|NCT00907621|458741204|FG000|Overall Study|Lost to Follow-up|6|||
127485518|NCT00907621|458741205|FG001|Overall Study|Lost to Follow-up|3|||
127485519|NCT00907621|458741204|FG000|Overall Study|intercurrent febrile illness|1|||
127485520|NCT00907621|458741205|FG001|Overall Study|intercurrent febrile illness|1|||
127485521|NCT00902330|458741208|FG000|Overall Study|Too overwhelmed by treatment|2|||
127485522|NCT00902330|458741209|FG001|Overall Study|Too overwhelmed by treatment|5|||
127485523|NCT00902330|458741208|FG000|Overall Study|Adverse Event|1|||
127485524|NCT00902330|458741209|FG001|Overall Study|Adverse Event|0|||
127485525|NCT00902330|458741208|FG000|Overall Study|No post baseline data|1|||
127485526|NCT00902330|458741209|FG001|Overall Study|No post baseline data|0|||
127485527|NCT00165789|458741210|FG000|Overall Study|Adverse Event|0|||
127485528|NCT00165789|458741211|FG001|Overall Study|Adverse Event|3|||
127485529|NCT00165789|458741212|FG002|Overall Study|Adverse Event|0|||
127485530|NCT00165789|458741213|FG003|Overall Study|Adverse Event|12|||
127485531|NCT00165789|458741210|FG000|Overall Study|Withdrawal by Subject|0|||
127485532|NCT00165789|458741211|FG001|Overall Study|Withdrawal by Subject|1|||
127485533|NCT00165789|458741212|FG002|Overall Study|Withdrawal by Subject|1|||
127485534|NCT00165789|458741213|FG003|Overall Study|Withdrawal by Subject|2|||
127485535|NCT01816048|458741214|FG000|Overall Study|Adverse Event|1|||
127485536|NCT01816048|458741214|FG000|Overall Study|Death|1|||
127485537|NCT01816048|458741214|FG000|Overall Study|Withdrawal by Subject|1|||
127868755|NCT01072175|460137394|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
127868756|NCT01072175|460137395|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
127868757|NCT01072175|460137383|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
127868758|NCT01072175|460137384|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
127868759|NCT01072175|460137385|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
127868760|NCT01072175|460137386|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
127868761|NCT01072175|460137387|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
127868762|NCT01072175|460137388|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
127868763|NCT01072175|460137389|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
127868764|NCT01072175|460137390|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
127868765|NCT01072175|460137391|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
127868766|NCT01072175|460137392|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
127868767|NCT01072175|460137393|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
127868768|NCT01072175|460137394|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
127868769|NCT01072175|460137395|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
127868770|NCT01072175|460137383|FG000|Part D (HPMC Capsules)|Death|0|||
127868771|NCT01072175|460137384|FG001|Part D (HPMC Capsules)|Death|0|||
127868772|NCT01072175|460137385|FG002|Part D (HPMC Capsules)|Death|0|||
127868773|NCT01072175|460137386|FG003|Part D (HPMC Capsules)|Death|0|||
127868774|NCT01072175|460137387|FG004|Part D (HPMC Capsules)|Death|0|||
127868775|NCT01072175|460137388|FG005|Part D (HPMC Capsules)|Death|0|||
127868776|NCT01072175|460137389|FG006|Part D (HPMC Capsules)|Death|0|||
127868777|NCT01072175|460137390|FG007|Part D (HPMC Capsules)|Death|0|||
127868778|NCT01072175|460137391|FG008|Part D (HPMC Capsules)|Death|0|||
127868779|NCT01072175|460137392|FG009|Part D (HPMC Capsules)|Death|10|||
127868780|NCT01072175|460137393|FG010|Part D (HPMC Capsules)|Death|12|||
127868781|NCT01072175|460137394|FG011|Part D (HPMC Capsules)|Death|28|||
127868782|NCT01072175|460137395|FG012|Part D (HPMC Capsules)|Death|26|||
127868783|NCT01072175|460137383|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
127868784|NCT01072175|460137384|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
127868785|NCT01072175|460137385|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
127868786|NCT01072175|460137386|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
127868787|NCT01072175|460137387|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
127868788|NCT01072175|460137388|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
127868789|NCT01072175|460137389|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
127868790|NCT01072175|460137390|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
127868791|NCT01072175|460137391|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
127868792|NCT01072175|460137392|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
127868793|NCT01072175|460137393|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
127868794|NCT01072175|460137394|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
127868795|NCT01072175|460137395|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
127868796|NCT01072175|460137383|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
127868797|NCT01072175|460137384|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
127868798|NCT01072175|460137385|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
127868799|NCT01072175|460137386|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
127868800|NCT01072175|460137387|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
127868801|NCT01072175|460137388|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
127868802|NCT01072175|460137389|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
127868803|NCT01072175|460137390|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
127868804|NCT01072175|460137391|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
127868805|NCT01072175|460137392|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
127868806|NCT01072175|460137393|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
127975351|NCT01106677|460531548|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
127975352|NCT01106677|460531549|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
127975353|NCT01106677|460531550|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
127975354|NCT01106677|460531551|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
127975355|NCT01106677|460531548|FG000|Core Period: Baseline to Week 26|Other|8|||
127975356|NCT01106677|460531549|FG001|Core Period: Baseline to Week 26|Other|14|||
127975357|NCT01106677|460531550|FG002|Core Period: Baseline to Week 26|Other|8|||
127975358|NCT01106677|460531551|FG003|Core Period: Baseline to Week 26|Other|23|||
127975359|NCT01106677|460531548|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
127975360|NCT01106677|460531549|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
127975361|NCT01106677|460531550|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
127975362|NCT01106677|460531551|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
127975363|NCT01106677|460531548|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
127975364|NCT01106677|460531549|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
127975365|NCT01106677|460531550|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
127975366|NCT01106677|460531551|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
127975367|NCT01106677|460531548|FG000|Extension Period: Week 26 to Week 52|Death|0|||
127975368|NCT01106677|460531549|FG001|Extension Period: Week 26 to Week 52|Death|0|||
127975369|NCT01106677|460531550|FG002|Extension Period: Week 26 to Week 52|Death|0|||
127975370|NCT01106677|460531551|FG003|Extension Period: Week 26 to Week 52|Death|1|||
127975371|NCT01106677|460531548|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
127975372|NCT01106677|460531549|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
127975373|NCT01106677|460531550|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
127975374|NCT01106677|460531551|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
127975375|NCT01106677|460531548|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
127975376|NCT01106677|460531549|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
127975377|NCT01106677|460531550|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
127975378|NCT01106677|460531551|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
127975379|NCT01106677|460531548|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
127975380|NCT01106677|460531549|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
127975381|NCT01106677|460531550|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
127975382|NCT01106677|460531551|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
127975383|NCT01106677|460531548|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
127975384|NCT01106677|460531549|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
127975385|NCT01106677|460531550|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
127975386|NCT01106677|460531551|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
127975387|NCT01106677|460531548|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
127975388|NCT01106677|460531549|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
127975389|NCT01106677|460531550|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
127975390|NCT01106677|460531551|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
127975391|NCT01106677|460531548|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
127975392|NCT01106677|460531549|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
127975393|NCT01106677|460531550|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
127975394|NCT01106677|460531551|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
127975395|NCT01106677|460531548|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
127975396|NCT01106677|460531549|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
127975397|NCT01106677|460531550|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
127975398|NCT01106677|460531551|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
127975399|NCT01106677|460531548|FG000|Extension Period: Week 26 to Week 52|Other|6|||
127975400|NCT01106677|460531549|FG001|Extension Period: Week 26 to Week 52|Other|5|||
127975401|NCT01106677|460531550|FG002|Extension Period: Week 26 to Week 52|Other|8|||
127975402|NCT01106677|460531551|FG003|Extension Period: Week 26 to Week 52|Other|5|||
127975403|NCT03937908|460531552|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
127485538|NCT01816048|458741214|FG000|Overall Study|Disease Progression|3|||
127975404|NCT03937908|460531553|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
127975405|NCT03875092|460531554|FG000|Overall Study|Adverse Event|2|||
127975406|NCT03875092|460531555|FG001|Overall Study|Adverse Event|5|||
127975407|NCT03875092|460531554|FG000|Overall Study|Death|44|||
127975408|NCT03875092|460531555|FG001|Overall Study|Death|51|||
127975409|NCT03875092|460531554|FG000|Overall Study|Participation Was Terminated By Sponsor|19|||
127975410|NCT03875092|460531555|FG001|Overall Study|Participation Was Terminated By Sponsor|4|||
127975411|NCT03205761|460531556|FG000|Overall Study|Withdrawal by Subject|1|||
127975412|NCT03205761|460531556|FG000|Overall Study|Progressive Disease|10|||
127975413|NCT04420585|460531557|FG000|Overall Study|Adverse Event|1|||
127975414|NCT04420585|460531557|FG000|Overall Study|Never initiated medication|2|||
127975415|NCT02163226|460531558|FG000|Overall Study|Death|2|||
127975416|NCT02163226|460531559|FG001|Overall Study|Death|1|||
127975417|NCT02163226|460531558|FG000|Overall Study|Withdrawal by Subject|5|||
127975418|NCT02163226|460531559|FG001|Overall Study|Withdrawal by Subject|2|||
127975419|NCT02163226|460531558|FG000|Overall Study|Returned home, local radiotherapy|3|||
127975420|NCT02163226|460531559|FG001|Overall Study|Returned home, local radiotherapy|0|||
127975421|NCT02163226|460531558|FG000|Overall Study|Repeat imaging showed no disease|2|||
127975422|NCT02163226|460531559|FG001|Overall Study|Repeat imaging showed no disease|0|||
127975423|NCT02163226|460531558|FG000|Overall Study|Incomplete radiotherapy|3|||
127975424|NCT02163226|460531559|FG001|Overall Study|Incomplete radiotherapy|0|||
127975425|NCT02163226|460531558|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
127975426|NCT02163226|460531559|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
127975427|NCT02163226|460531558|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
127975428|NCT02163226|460531559|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
127975429|NCT02163226|460531558|FG000|Overall Study|ineligible|0|||
127975430|NCT02163226|460531559|FG001|Overall Study|ineligible|3|||
127975431|NCT04114357|460531560|FG000|Baseline-Randomization|Adverse Event|2|||
127975432|NCT04114357|460531561|FG001|Baseline-Randomization|Adverse Event|1|||
127975433|NCT04114357|460531560|FG000|Baseline-Randomization|Lost to Follow-up|1|||
127975434|NCT04114357|460531561|FG001|Baseline-Randomization|Lost to Follow-up|1|||
127975435|NCT04114357|460531560|FG000|Cross-over|Adverse Event|0|||
127975436|NCT04114357|460531561|FG001|Cross-over|Adverse Event|1|||
127975437|NCT00477750|460531562|FG000|Overall Study|Currently Receiving Treatment|11|||
127975438|NCT03558152|460531563|FG000|Overall Study|Adverse Event|0|||
127975439|NCT03558152|460531564|FG001|Overall Study|Adverse Event|0|||
127975440|NCT03558152|460531565|FG002|Overall Study|Adverse Event|1|||
127975441|NCT03558152|460531566|FG003|Overall Study|Adverse Event|1|||
127975442|NCT03558152|460531567|FG004|Overall Study|Adverse Event|2|||
127975443|NCT03558152|460531568|FG005|Overall Study|Adverse Event|1|||
127975444|NCT03558152|460531569|FG006|Overall Study|Adverse Event|1|||
127975445|NCT03558152|460531570|FG007|Overall Study|Adverse Event|0|||
127975446|NCT03558152|460531563|FG000|Overall Study|Death|0|||
127975447|NCT03558152|460531564|FG001|Overall Study|Death|0|||
127975448|NCT03558152|460531565|FG002|Overall Study|Death|0|||
127975449|NCT03558152|460531566|FG003|Overall Study|Death|0|||
127975450|NCT03558152|460531567|FG004|Overall Study|Death|1|||
127975451|NCT03558152|460531568|FG005|Overall Study|Death|0|||
127975452|NCT03558152|460531569|FG006|Overall Study|Death|0|||
127975453|NCT03558152|460531570|FG007|Overall Study|Death|0|||
127975454|NCT03558152|460531563|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
127975455|NCT03558152|460531564|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
127975456|NCT03558152|460531565|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
127975457|NCT03558152|460531566|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
127975458|NCT03558152|460531567|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
127975459|NCT03558152|460531568|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
127975460|NCT03558152|460531569|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
127975461|NCT03558152|460531570|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
127975462|NCT03558152|460531563|FG000|Overall Study|Miscalculation in mmcs|0|||
127975463|NCT03558152|460531564|FG001|Overall Study|Miscalculation in mmcs|0|||
127975464|NCT03558152|460531565|FG002|Overall Study|Miscalculation in mmcs|0|||
127975465|NCT03558152|460531566|FG003|Overall Study|Miscalculation in mmcs|0|||
127975466|NCT03558152|460531567|FG004|Overall Study|Miscalculation in mmcs|0|||
127975467|NCT03558152|460531568|FG005|Overall Study|Miscalculation in mmcs|0|||
127975468|NCT03558152|460531569|FG006|Overall Study|Miscalculation in mmcs|1|||
127975469|NCT03558152|460531570|FG007|Overall Study|Miscalculation in mmcs|0|||
127975470|NCT03558152|460531563|FG000|Overall Study|Mistake in calculation|0|||
127975471|NCT03558152|460531564|FG001|Overall Study|Mistake in calculation|0|||
127975472|NCT03558152|460531565|FG002|Overall Study|Mistake in calculation|0|||
127975473|NCT03558152|460531566|FG003|Overall Study|Mistake in calculation|1|||
127975474|NCT03558152|460531567|FG004|Overall Study|Mistake in calculation|0|||
127975475|NCT03558152|460531568|FG005|Overall Study|Mistake in calculation|0|||
127975476|NCT03558152|460531569|FG006|Overall Study|Mistake in calculation|0|||
127975477|NCT03558152|460531570|FG007|Overall Study|Mistake in calculation|0|||
127975478|NCT03558152|460531563|FG000|Overall Study|Mistake in evaluation of disease status|0|||
127975479|NCT03558152|460531564|FG001|Overall Study|Mistake in evaluation of disease status|0|||
127975480|NCT03558152|460531565|FG002|Overall Study|Mistake in evaluation of disease status|0|||
127975481|NCT03558152|460531566|FG003|Overall Study|Mistake in evaluation of disease status|0|||
127975482|NCT03558152|460531567|FG004|Overall Study|Mistake in evaluation of disease status|0|||
127975483|NCT03558152|460531568|FG005|Overall Study|Mistake in evaluation of disease status|0|||
127975484|NCT03558152|460531569|FG006|Overall Study|Mistake in evaluation of disease status|0|||
127975485|NCT03558152|460531570|FG007|Overall Study|Mistake in evaluation of disease status|1|||
127975486|NCT03558152|460531563|FG000|Overall Study|Physician Decision|0|||
127975487|NCT03558152|460531564|FG001|Overall Study|Physician Decision|0|||
127975488|NCT03558152|460531565|FG002|Overall Study|Physician Decision|0|||
127975489|NCT03558152|460531566|FG003|Overall Study|Physician Decision|0|||
127975490|NCT03558152|460531567|FG004|Overall Study|Physician Decision|0|||
127975491|NCT03558152|460531568|FG005|Overall Study|Physician Decision|0|||
127975492|NCT03558152|460531569|FG006|Overall Study|Physician Decision|1|||
127975493|NCT03558152|460531570|FG007|Overall Study|Physician Decision|0|||
127975494|NCT03558152|460531563|FG000|Overall Study|Withdrawal by Subject|2|||
127975495|NCT03558152|460531564|FG001|Overall Study|Withdrawal by Subject|3|||
127975496|NCT03558152|460531565|FG002|Overall Study|Withdrawal by Subject|2|||
127975497|NCT03558152|460531566|FG003|Overall Study|Withdrawal by Subject|1|||
127975498|NCT03558152|460531567|FG004|Overall Study|Withdrawal by Subject|1|||
127975499|NCT03558152|460531568|FG005|Overall Study|Withdrawal by Subject|1|||
127975500|NCT03558152|460531569|FG006|Overall Study|Withdrawal by Subject|3|||
127975501|NCT03558152|460531570|FG007|Overall Study|Withdrawal by Subject|2|||
127975502|NCT03558152|460531563|FG000|Overall Study|Lack of Efficacy|11|||
127975503|NCT03558152|460531564|FG001|Overall Study|Lack of Efficacy|11|||
127975504|NCT03558152|460531565|FG002|Overall Study|Lack of Efficacy|10|||
127975505|NCT03558152|460531566|FG003|Overall Study|Lack of Efficacy|11|||
127975506|NCT03558152|460531567|FG004|Overall Study|Lack of Efficacy|14|||
127975507|NCT03558152|460531568|FG005|Overall Study|Lack of Efficacy|12|||
127975508|NCT03558152|460531569|FG006|Overall Study|Lack of Efficacy|14|||
127975509|NCT03558152|460531570|FG007|Overall Study|Lack of Efficacy|13|||
127975510|NCT03558152|460531563|FG000|Overall Study|Protocol Violation|1|||
127975511|NCT03558152|460531564|FG001|Overall Study|Protocol Violation|1|||
127975512|NCT03558152|460531565|FG002|Overall Study|Protocol Violation|0|||
127975513|NCT03558152|460531566|FG003|Overall Study|Protocol Violation|1|||
127975514|NCT03558152|460531567|FG004|Overall Study|Protocol Violation|1|||
127975515|NCT03558152|460531568|FG005|Overall Study|Protocol Violation|0|||
127975516|NCT03558152|460531569|FG006|Overall Study|Protocol Violation|2|||
127975517|NCT03558152|460531570|FG007|Overall Study|Protocol Violation|0|||
127975518|NCT00601172|460531571|FG000|Overall Study|Adverse Event|43|||
127485539|NCT00656370|458741216|FG000|Overall Study|Screen Failures|7|||
127975519|NCT00601172|460531572|FG001|Overall Study|Adverse Event|32|||
127975520|NCT00601172|460531571|FG000|Overall Study|Lack of Efficacy|11|||
127975521|NCT00601172|460531572|FG001|Overall Study|Lack of Efficacy|12|||
127975522|NCT00601172|460531571|FG000|Overall Study|Protocol Violation|2|||
127975523|NCT00601172|460531572|FG001|Overall Study|Protocol Violation|5|||
127975524|NCT00601172|460531571|FG000|Overall Study|Lost to Follow-up|4|||
127975525|NCT00601172|460531572|FG001|Overall Study|Lost to Follow-up|3|||
127975526|NCT00601172|460531571|FG000|Overall Study|Physician Decision|27|||
127975527|NCT00601172|460531572|FG001|Overall Study|Physician Decision|28|||
127975528|NCT00601172|460531571|FG000|Overall Study|Withdrawal by Subject|35|||
127975529|NCT00601172|460531572|FG001|Overall Study|Withdrawal by Subject|27|||
127975530|NCT00601172|460531571|FG000|Overall Study|Did not meet continuation criteria|19|||
127975531|NCT00601172|460531572|FG001|Overall Study|Did not meet continuation criteria|20|||
127975532|NCT03030989|460531573|FG000|Overall Study|Fever|2|||
127975533|NCT03030989|460531574|FG001|Overall Study|Fever|2|||
127975534|NCT03030989|460531573|FG000|Overall Study|Rash|2|||
127975535|NCT03030989|460531574|FG001|Overall Study|Rash|1|||
127975536|NCT03030989|460531573|FG000|Overall Study|Fatigue/Overwhelmed|1|||
127975537|NCT03030989|460531574|FG001|Overall Study|Fatigue/Overwhelmed|5|||
127975538|NCT03030989|460531573|FG000|Overall Study|Positive Blood Cultures|2|||
127975539|NCT03030989|460531574|FG001|Overall Study|Positive Blood Cultures|1|||
127975540|NCT03030989|460531573|FG000|Overall Study|Line Removed|0|||
127975541|NCT03030989|460531574|FG001|Overall Study|Line Removed|2|||
127975542|NCT03030989|460531573|FG000|Overall Study|No longer interested|5|||
127975543|NCT03030989|460531574|FG001|Overall Study|No longer interested|3|||
127975544|NCT02706886|460531575|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
127975545|NCT02706886|460531576|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
127975546|NCT02706886|460531577|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
127975547|NCT02706886|460531578|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
127975548|NCT02706886|460531579|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
127975549|NCT02706886|460531580|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
127975550|NCT02706886|460531581|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
127975551|NCT02706886|460531582|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
127975552|NCT02706886|460531583|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
127975553|NCT01669174|460531590|FG000|Overall Study|Subject withdrew consent|2|||
127975554|NCT01669174|460531591|FG001|Overall Study|Subject withdrew consent|2|||
127975555|NCT01669174|460531590|FG000|Overall Study|Lost to Follow-up|1|||
127975556|NCT01669174|460531591|FG001|Overall Study|Lost to Follow-up|0|||
127975557|NCT01669174|460531590|FG000|Overall Study|Adverse Event|2|||
127975558|NCT01669174|460531591|FG001|Overall Study|Adverse Event|2|||
127975559|NCT01669174|460531590|FG000|Overall Study|Administrative problems|1|||
127975560|NCT01669174|460531591|FG001|Overall Study|Administrative problems|2|||
127975561|NCT04310397|460531594|FG000|Overall Study|Lack of Efficacy|3|||
127975562|NCT04310397|460531594|FG000|Overall Study|Withdrawal by Subject|1|||
127975563|NCT00723255|460531595|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
127975564|NCT00723255|460531595|FG000|Overall Study|Ineligible: Second primary|1|||
127975565|NCT00723255|460531595|FG000|Overall Study|Ineligible: Wrong Primary|2|||
127975566|NCT00614523|460531596|FG000|Overall Study|Adverse Event|4|||
127975567|NCT00614523|460531597|FG001|Overall Study|Adverse Event|20|||
127975568|NCT00614523|460531596|FG000|Overall Study|Death|5|||
127975569|NCT00614523|460531597|FG001|Overall Study|Death|8|||
127975570|NCT00614523|460531596|FG000|Overall Study|Lack of Efficacy|9|||
127975571|NCT00614523|460531597|FG001|Overall Study|Lack of Efficacy|11|||
127975572|NCT00614523|460531596|FG000|Overall Study|Lost to Follow-up|0|||
127975573|NCT00614523|460531597|FG001|Overall Study|Lost to Follow-up|1|||
127975574|NCT00614523|460531596|FG000|Overall Study|Protocol Violation|3|||
127975575|NCT00614523|460531597|FG001|Overall Study|Protocol Violation|2|||
127975576|NCT00614523|460531596|FG000|Overall Study|Withdrawal by Subject|12|||
127975577|NCT00614523|460531597|FG001|Overall Study|Withdrawal by Subject|22|||
127975578|NCT00614523|460531596|FG000|Overall Study|Other|6|||
127975579|NCT00614523|460531597|FG001|Overall Study|Other|11|||
127975580|NCT00614523|460531596|FG000|Overall Study|Ineligibility Determined|1|||
127975581|NCT00614523|460531597|FG001|Overall Study|Ineligibility Determined|2|||
127975582|NCT00614523|460531596|FG000|Overall Study|Disease Progression|0|||
127975583|NCT00614523|460531597|FG001|Overall Study|Disease Progression|8|||
127975584|NCT00614523|460531596|FG000|Overall Study|Administrative Decision|23|||
127975585|NCT00614523|460531597|FG001|Overall Study|Administrative Decision|46|||
127975586|NCT01300338|460531603|FG000|Overall Study|Lost to Follow-up|5|||
127975587|NCT01300338|460531604|FG001|Overall Study|Lost to Follow-up|0|||
127975588|NCT02461524|460531605|FG000|Overall Study|Death|16|||
127975589|NCT02461524|460531605|FG000|Overall Study|Withdrawal by Subject|4|||
127975590|NCT02461524|460531605|FG000|Overall Study|Device Explanted|5|||
127975591|NCT02461524|460531605|FG000|Overall Study|Missed Visit|6|||
127975592|NCT04481191|460531616|FG000|Overall Study|Withdrawn by parent/guardian|15|||
127975593|NCT04481191|460531617|FG001|Overall Study|Withdrawn by parent/guardian|10|||
127975594|NCT02487771|460531618|FG000|Overall Study|Lost to Follow-up|2|||
127975595|NCT02487771|460531619|FG001|Overall Study|Lost to Follow-up|3|||
127975596|NCT02487771|460531618|FG000|Overall Study|Moved out of area|5|||
127975597|NCT02487771|460531619|FG001|Overall Study|Moved out of area|6|||
127975598|NCT02487771|460531618|FG000|Overall Study|Withdrawal by Subject|3|||
127975599|NCT02487771|460531619|FG001|Overall Study|Withdrawal by Subject|5|||
127975600|NCT02002533|460531620|FG000|Overall Study|Withdrawal by Subject|6|||
127975601|NCT02002533|460531621|FG001|Overall Study|Withdrawal by Subject|13|||
127975602|NCT02002533|460531620|FG000|Overall Study|Protocol Violation|0|||
127975603|NCT02002533|460531621|FG001|Overall Study|Protocol Violation|1|||
127975604|NCT02002533|460531620|FG000|Overall Study|Adverse Event|0|||
127975605|NCT02002533|460531621|FG001|Overall Study|Adverse Event|3|||
127975606|NCT02002533|460531620|FG000|Overall Study|Lost to Follow-up|0|||
127975607|NCT02002533|460531621|FG001|Overall Study|Lost to Follow-up|1|||
127975608|NCT04984278|460531626|FG000|Period 1|Withdrawal by Subject|1|||
127975609|NCT04984278|460531627|FG001|Period 1|Withdrawal by Subject|0|||
127975610|NCT04984278|460531626|FG000|Period 1|Other|0|||
127975611|NCT04984278|460531627|FG001|Period 1|Other|1|||
127975612|NCT04984278|460531626|FG000|Period 2|Adverse Event|1|||
127975613|NCT04984278|460531627|FG001|Period 2|Adverse Event|0|||
127975614|NCT04984278|460531626|FG000|Period 2|Other|0|||
127975615|NCT04984278|460531627|FG001|Period 2|Other|1|||
127975616|NCT01482065|460531628|FG000|Overall Study|Withdrawal by Subject|0|||
127975617|NCT01482065|460531629|FG001|Overall Study|Withdrawal by Subject|1|||
127975618|NCT01895270|460531632|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
127975619|NCT01895270|460531633|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
127975620|NCT01895270|460531632|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
127975621|NCT01895270|460531633|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
127975622|NCT01895270|460531632|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
127975623|NCT01895270|460531633|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
127975624|NCT01895270|460531632|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
127975625|NCT01895270|460531633|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
127975626|NCT01895270|460531632|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
127975627|NCT01895270|460531633|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
127975628|NCT01895270|460531632|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
127975629|NCT01895270|460531633|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
127975630|NCT01895270|460531632|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
127975631|NCT01895270|460531633|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
127975632|NCT02651155|460531634|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
127975633|NCT02651155|460531635|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
127975634|NCT02651155|460531634|FG000|Overall Study|Voluntary Withdrawal|5|||
127975635|NCT02651155|460531635|FG001|Overall Study|Voluntary Withdrawal|0|||
127975636|NCT00976820|460531636|FG000|Overall Study|Lost to Follow-up|5|||
127975637|NCT00976820|460531637|FG001|Overall Study|Lost to Follow-up|16|||
127975638|NCT00976820|460531638|FG002|Overall Study|Lost to Follow-up|2|||
127975639|NCT00976820|460531639|FG003|Overall Study|Lost to Follow-up|3|||
127975640|NCT00976820|460531636|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
127975641|NCT00976820|460531637|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
127975642|NCT00976820|460531638|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
127975643|NCT00976820|460531639|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
127975644|NCT00976820|460531636|FG000|Overall Study|Withdrawal by Subject|2|||
127975645|NCT00976820|460531637|FG001|Overall Study|Withdrawal by Subject|4|||
127975646|NCT00976820|460531638|FG002|Overall Study|Withdrawal by Subject|1|||
127975647|NCT00976820|460531639|FG003|Overall Study|Withdrawal by Subject|4|||
127975648|NCT03261674|460531643|FG000|Overall Study|Lost to Follow-up|6|||
127975649|NCT03261674|460531644|FG001|Overall Study|Lost to Follow-up|7|||
127975650|NCT03261674|460531643|FG000|Overall Study|Protocol Violation|1|||
127975651|NCT03261674|460531644|FG001|Overall Study|Protocol Violation|4|||
127975652|NCT03261674|460531643|FG000|Overall Study|Withdrawal by Subject|1|||
127975653|NCT03261674|460531644|FG001|Overall Study|Withdrawal by Subject|4|||
127975654|NCT03261674|460531643|FG000|Overall Study|Physician Decision|1|||
127975655|NCT03261674|460531644|FG001|Overall Study|Physician Decision|0|||
127975656|NCT00623935|460531645|FG000|Overall Study|Death|1|||
127975657|NCT00623935|460531645|FG000|Overall Study|Patient Declined Transplant|1|||
127975658|NCT00747474|460531646|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
127975659|NCT00747474|460531647|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
127975660|NCT00747474|460531648|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
127975661|NCT00747474|460531649|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
127975662|NCT00747474|460531650|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
127975663|NCT00747474|460531651|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
127975664|NCT00747474|460531652|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
127975665|NCT00747474|460531653|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
127975666|NCT00747474|460531654|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
127975667|NCT00747474|460531655|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
127975668|NCT00747474|460531656|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
127975669|NCT00747474|460531657|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
127975670|NCT00890084|460531658|FG000|Overall Study|Adverse Event|16|||
127975671|NCT00890084|460531658|FG000|Overall Study|Lost to Follow-up|126|||
127975672|NCT01647516|460531659|FG000|Induction Period (IP)|Physician Decision|2|||
127975673|NCT01647516|460531660|FG001|Induction Period (IP)|Physician Decision|0|||
127975674|NCT01647516|460531661|FG002|Induction Period (IP)|Physician Decision|0|||
127975675|NCT01647516|460531662|FG003|Induction Period (IP)|Physician Decision|0|||
127975676|NCT01647516|460531663|FG004|Induction Period (IP)|Physician Decision|0|||
127975677|NCT01647516|460531664|FG005|Induction Period (IP)|Physician Decision|0|||
127975678|NCT01647516|460531659|FG000|Induction Period (IP)|Adverse Event|1|||
127975679|NCT01647516|460531660|FG001|Induction Period (IP)|Adverse Event|2|||
127975680|NCT01647516|460531661|FG002|Induction Period (IP)|Adverse Event|0|||
127975681|NCT01647516|460531662|FG003|Induction Period (IP)|Adverse Event|0|||
127975682|NCT01647516|460531663|FG004|Induction Period (IP)|Adverse Event|0|||
127975683|NCT01647516|460531664|FG005|Induction Period (IP)|Adverse Event|0|||
127975684|NCT01647516|460531659|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
127975685|NCT01647516|460531660|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
127975686|NCT01647516|460531661|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
127975687|NCT01647516|460531662|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
127975688|NCT01647516|460531663|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
127975689|NCT01647516|460531664|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
127975690|NCT01647516|460531659|FG000|Induction Period (IP)|Participant Choice|0|||
127975691|NCT01647516|460531660|FG001|Induction Period (IP)|Participant Choice|0|||
127975692|NCT01647516|460531661|FG002|Induction Period (IP)|Participant Choice|1|||
127975693|NCT01647516|460531662|FG003|Induction Period (IP)|Participant Choice|0|||
127975694|NCT01647516|460531663|FG004|Induction Period (IP)|Participant Choice|0|||
127975695|NCT01647516|460531664|FG005|Induction Period (IP)|Participant Choice|0|||
127975696|NCT01647516|460531659|FG000|Induction Period (IP)|Lack of Efficacy|1|||
127975697|NCT01647516|460531660|FG001|Induction Period (IP)|Lack of Efficacy|0|||
127975698|NCT01647516|460531661|FG002|Induction Period (IP)|Lack of Efficacy|0|||
127975699|NCT01647516|460531662|FG003|Induction Period (IP)|Lack of Efficacy|0|||
127975700|NCT01647516|460531663|FG004|Induction Period (IP)|Lack of Efficacy|0|||
127975701|NCT01647516|460531664|FG005|Induction Period (IP)|Lack of Efficacy|0|||
127975702|NCT01647516|460531659|FG000|Induction Period (IP)|No study drug received|1|||
127975703|NCT01647516|460531660|FG001|Induction Period (IP)|No study drug received|1|||
127975704|NCT01647516|460531661|FG002|Induction Period (IP)|No study drug received|0|||
127975705|NCT01647516|460531662|FG003|Induction Period (IP)|No study drug received|0|||
127975706|NCT01647516|460531663|FG004|Induction Period (IP)|No study drug received|0|||
127975707|NCT01647516|460531664|FG005|Induction Period (IP)|No study drug received|0|||
127975708|NCT01647516|460531659|FG000|Maintenance Period (MP)|Adverse Event|2|||
127975709|NCT01647516|460531660|FG001|Maintenance Period (MP)|Adverse Event|1|||
127975710|NCT01647516|460531661|FG002|Maintenance Period (MP)|Adverse Event|0|||
127975711|NCT01647516|460531662|FG003|Maintenance Period (MP)|Adverse Event|0|||
127975712|NCT01647516|460531663|FG004|Maintenance Period (MP)|Adverse Event|0|||
127975713|NCT01647516|460531664|FG005|Maintenance Period (MP)|Adverse Event|0|||
127975714|NCT01647516|460531659|FG000|Maintenance Period (MP)|Non-compliance|1|||
127975715|NCT01647516|460531660|FG001|Maintenance Period (MP)|Non-compliance|0|||
127975716|NCT01647516|460531661|FG002|Maintenance Period (MP)|Non-compliance|0|||
127975717|NCT01647516|460531662|FG003|Maintenance Period (MP)|Non-compliance|0|||
127975718|NCT01647516|460531663|FG004|Maintenance Period (MP)|Non-compliance|0|||
127975719|NCT01647516|460531664|FG005|Maintenance Period (MP)|Non-compliance|0|||
127975720|NCT01647516|460531659|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
127975721|NCT01647516|460531660|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
127975722|NCT01647516|460531661|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
127975723|NCT01647516|460531662|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
127975724|NCT01647516|460531663|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
127975725|NCT01647516|460531664|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
127975726|NCT01647516|460531659|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
127975727|NCT01647516|460531660|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
127975728|NCT01647516|460531661|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
127975729|NCT01647516|460531662|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
127975730|NCT01647516|460531663|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
127975731|NCT01647516|460531664|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
127975732|NCT01647516|460531659|FG000|Open-Label Period|Adverse Event|0|||
127975733|NCT01647516|460531660|FG001|Open-Label Period|Adverse Event|0|||
127975734|NCT01647516|460531661|FG002|Open-Label Period|Adverse Event|0|||
127975735|NCT01647516|460531662|FG003|Open-Label Period|Adverse Event|5|||
127975736|NCT01647516|460531663|FG004|Open-Label Period|Adverse Event|6|||
127975737|NCT01647516|460531664|FG005|Open-Label Period|Adverse Event|3|||
127975738|NCT01647516|460531659|FG000|Open-Label Period|Pregnancy|0|||
127975739|NCT01647516|460531660|FG001|Open-Label Period|Pregnancy|0|||
127975740|NCT01647516|460531661|FG002|Open-Label Period|Pregnancy|0|||
127975741|NCT01647516|460531662|FG003|Open-Label Period|Pregnancy|0|||
127975742|NCT01647516|460531663|FG004|Open-Label Period|Pregnancy|0|||
127975743|NCT01647516|460531664|FG005|Open-Label Period|Pregnancy|1|||
127975744|NCT01647516|460531659|FG000|Open-Label Period|Non-compliance|0|||
127975745|NCT01647516|460531660|FG001|Open-Label Period|Non-compliance|0|||
127975746|NCT01647516|460531661|FG002|Open-Label Period|Non-compliance|0|||
127975747|NCT01647516|460531662|FG003|Open-Label Period|Non-compliance|1|||
127975748|NCT01647516|460531663|FG004|Open-Label Period|Non-compliance|0|||
127975749|NCT01647516|460531664|FG005|Open-Label Period|Non-compliance|1|||
127975750|NCT01647516|460531659|FG000|Open-Label Period|Physician Decision|0|||
127975751|NCT01647516|460531660|FG001|Open-Label Period|Physician Decision|0|||
127975752|NCT01647516|460531661|FG002|Open-Label Period|Physician Decision|0|||
127975753|NCT01647516|460531662|FG003|Open-Label Period|Physician Decision|1|||
127975754|NCT01647516|460531663|FG004|Open-Label Period|Physician Decision|1|||
127975755|NCT01647516|460531664|FG005|Open-Label Period|Physician Decision|0|||
127975756|NCT01647516|460531659|FG000|Open-Label Period|Withdrawal by Subject|0|||
127975757|NCT01647516|460531660|FG001|Open-Label Period|Withdrawal by Subject|0|||
127975758|NCT01647516|460531661|FG002|Open-Label Period|Withdrawal by Subject|0|||
127975759|NCT01647516|460531662|FG003|Open-Label Period|Withdrawal by Subject|9|||
127975760|NCT01647516|460531663|FG004|Open-Label Period|Withdrawal by Subject|11|||
127975761|NCT01647516|460531664|FG005|Open-Label Period|Withdrawal by Subject|6|||
127975762|NCT01647516|460531659|FG000|Open-Label Period|Lost to Follow-up|0|||
127975763|NCT01647516|460531660|FG001|Open-Label Period|Lost to Follow-up|0|||
127975764|NCT01647516|460531661|FG002|Open-Label Period|Lost to Follow-up|0|||
127975765|NCT01647516|460531662|FG003|Open-Label Period|Lost to Follow-up|1|||
127975766|NCT01647516|460531663|FG004|Open-Label Period|Lost to Follow-up|0|||
127975767|NCT01647516|460531664|FG005|Open-Label Period|Lost to Follow-up|1|||
127975768|NCT01647516|460531659|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
127975769|NCT01647516|460531660|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
127975770|NCT01647516|460531661|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
127975771|NCT01647516|460531662|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
127975772|NCT01647516|460531663|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
127975773|NCT01647516|460531664|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
127975774|NCT01647516|460531659|FG000|Open-Label Period|Lack of Efficacy|0|||
127975775|NCT01647516|460531660|FG001|Open-Label Period|Lack of Efficacy|0|||
127975776|NCT01647516|460531661|FG002|Open-Label Period|Lack of Efficacy|0|||
127975777|NCT01647516|460531662|FG003|Open-Label Period|Lack of Efficacy|7|||
127975778|NCT01647516|460531663|FG004|Open-Label Period|Lack of Efficacy|9|||
127975779|NCT01647516|460531664|FG005|Open-Label Period|Lack of Efficacy|10|||
127975780|NCT01647516|460531659|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
127975781|NCT01647516|460531660|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
127975782|NCT01647516|460531661|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
127975783|NCT01647516|460531662|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
127975784|NCT01647516|460531663|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
127975785|NCT01647516|460531664|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
127975786|NCT01647516|460531659|FG000|Open-Label Period|No completion / discontinuation visit|0|||
127975787|NCT01647516|460531660|FG001|Open-Label Period|No completion / discontinuation visit|0|||
127975788|NCT01647516|460531661|FG002|Open-Label Period|No completion / discontinuation visit|0|||
127975789|NCT01647516|460531662|FG003|Open-Label Period|No completion / discontinuation visit|0|||
127975790|NCT01647516|460531663|FG004|Open-Label Period|No completion / discontinuation visit|2|||
127975791|NCT01647516|460531664|FG005|Open-Label Period|No completion / discontinuation visit|1|||
127975792|NCT03193801|460531667|FG000|Overall Study|Physician Decision|2|||
127975793|NCT03193801|460531667|FG000|Overall Study|Withdrawal by Subject|1|||
127975794|NCT04323306|460531668|FG000|Overall Study|Physician Decision|1|||
127975795|NCT04323306|460531669|FG001|Overall Study|Physician Decision|0|||
127975796|NCT04323306|460531670|FG002|Overall Study|Physician Decision|0|||
127975797|NCT04323306|460531671|FG003|Overall Study|Physician Decision|0|||
127975798|NCT04323306|460531672|FG004|Overall Study|Physician Decision|0|||
127975799|NCT04323306|460531673|FG005|Overall Study|Physician Decision|0|||
127975800|NCT04323306|460531674|FG006|Overall Study|Physician Decision|0|||
127975801|NCT04323306|460531675|FG007|Overall Study|Physician Decision|0|||
127975802|NCT04323306|460531676|FG008|Overall Study|Physician Decision|0|||
127975803|NCT04323306|460531668|FG000|Overall Study|Withdrawal by Subject|0|||
127975804|NCT04323306|460531669|FG001|Overall Study|Withdrawal by Subject|0|||
127975805|NCT04323306|460531670|FG002|Overall Study|Withdrawal by Subject|0|||
127975806|NCT04323306|460531671|FG003|Overall Study|Withdrawal by Subject|0|||
127975807|NCT04323306|460531672|FG004|Overall Study|Withdrawal by Subject|0|||
127975808|NCT04323306|460531673|FG005|Overall Study|Withdrawal by Subject|1|||
127975809|NCT04323306|460531674|FG006|Overall Study|Withdrawal by Subject|3|||
127975810|NCT04323306|460531675|FG007|Overall Study|Withdrawal by Subject|0|||
127975811|NCT04323306|460531676|FG008|Overall Study|Withdrawal by Subject|1|||
127975812|NCT05129137|460531677|FG000|Second Period|Adverse Event|1|||
127975813|NCT05129137|460531678|FG001|Second Period|Adverse Event|0|||
127975814|NCT05129137|460531679|FG002|Second Period|Adverse Event|0|||
127975815|NCT05129137|460531680|FG003|Second Period|Adverse Event|0|||
127975816|NCT05129137|460531677|FG000|Second Period|Protocol Violation|0|||
127975817|NCT05129137|460531678|FG001|Second Period|Protocol Violation|0|||
127975818|NCT05129137|460531679|FG002|Second Period|Protocol Violation|0|||
127975819|NCT05129137|460531680|FG003|Second Period|Protocol Violation|1|||
127975820|NCT05129137|460531677|FG000|Third Period|Protocol Violation|0|||
127975821|NCT05129137|460531678|FG001|Third Period|Protocol Violation|0|||
127975822|NCT05129137|460531679|FG002|Third Period|Protocol Violation|0|||
127975823|NCT05129137|460531680|FG003|Third Period|Protocol Violation|1|||
127975824|NCT05129137|460531677|FG000|Forth Period|Protocol Violation|0|||
127975825|NCT05129137|460531678|FG001|Forth Period|Protocol Violation|1|||
127975826|NCT05129137|460531679|FG002|Forth Period|Protocol Violation|0|||
127975827|NCT05129137|460531680|FG003|Forth Period|Protocol Violation|0|||
127975828|NCT05129137|460531677|FG000|Forth Period|Withdrawal by Subject|0|||
127975829|NCT05129137|460531678|FG001|Forth Period|Withdrawal by Subject|0|||
127975830|NCT05129137|460531679|FG002|Forth Period|Withdrawal by Subject|1|||
127975831|NCT05129137|460531680|FG003|Forth Period|Withdrawal by Subject|0|||
127975832|NCT01104246|460531681|FG000|Overall Study|Withdrawal by Subject|1|||
127975833|NCT01104246|460531681|FG000|Overall Study|did not meet inclusion criteria|4|||
127975834|NCT00750139|460531692|FG000|Overall Study|Adverse Event|1|||
127975835|NCT00750139|460531693|FG001|Overall Study|Adverse Event|2|||
127975836|NCT00750139|460531694|FG002|Overall Study|Adverse Event|0|||
127975837|NCT00750139|460531695|FG003|Overall Study|Adverse Event|1|||
127975838|NCT00750139|460531692|FG000|Overall Study|Lost to Follow-up|17|||
127975839|NCT00750139|460531693|FG001|Overall Study|Lost to Follow-up|12|||
127975840|NCT00750139|460531694|FG002|Overall Study|Lost to Follow-up|15|||
127975841|NCT00750139|460531695|FG003|Overall Study|Lost to Follow-up|6|||
127975842|NCT00750139|460531692|FG000|Overall Study|Withdrawal by Subject|3|||
127975843|NCT00750139|460531693|FG001|Overall Study|Withdrawal by Subject|2|||
127975844|NCT00750139|460531694|FG002|Overall Study|Withdrawal by Subject|6|||
127975845|NCT00750139|460531695|FG003|Overall Study|Withdrawal by Subject|2|||
127975846|NCT00750139|460531692|FG000|Overall Study|Physician Decision|1|||
127975847|NCT00750139|460531693|FG001|Overall Study|Physician Decision|1|||
127975848|NCT00750139|460531694|FG002|Overall Study|Physician Decision|0|||
127975849|NCT00750139|460531695|FG003|Overall Study|Physician Decision|0|||
127975850|NCT00750139|460531692|FG000|Overall Study|Non-compliance|1|||
127975851|NCT00750139|460531693|FG001|Overall Study|Non-compliance|0|||
127975852|NCT00750139|460531694|FG002|Overall Study|Non-compliance|1|||
127975853|NCT00750139|460531695|FG003|Overall Study|Non-compliance|3|||
127975854|NCT00750139|460531692|FG000|Overall Study|Termination by sponsor|4|||
127975855|NCT00750139|460531693|FG001|Overall Study|Termination by sponsor|0|||
127975856|NCT00750139|460531694|FG002|Overall Study|Termination by sponsor|0|||
127975857|NCT00750139|460531695|FG003|Overall Study|Termination by sponsor|1|||
127975858|NCT00750139|460531692|FG000|Overall Study|Non-specific|62|||
127975859|NCT00750139|460531693|FG001|Overall Study|Non-specific|42|||
127975860|NCT00750139|460531694|FG002|Overall Study|Non-specific|79|||
127975861|NCT00750139|460531695|FG003|Overall Study|Non-specific|33|||
127975862|NCT01758731|460531698|FG000|Overall Study|Physician Decision|1|||
127975863|NCT01397786|460533032|FG000|Phase A|Lost to Follow-up|0|||
127975864|NCT01397786|460533033|FG001|Phase A|Lost to Follow-up|0|||
127975865|NCT01397786|460533034|FG002|Phase A|Lost to Follow-up|6|||
127975866|NCT01397786|460533032|FG000|Phase A|Adverse Event|0|||
127975867|NCT01397786|460533033|FG001|Phase A|Adverse Event|0|||
127975868|NCT01397786|460533034|FG002|Phase A|Adverse Event|8|||
127975869|NCT01397786|460533032|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
127975870|NCT01397786|460533033|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
127975871|NCT01397786|460533034|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
127975872|NCT01397786|460533032|FG000|Phase A|Physician Decision|0|||
127975873|NCT01397786|460533033|FG001|Phase A|Physician Decision|0|||
127975874|NCT01397786|460533034|FG002|Phase A|Physician Decision|1|||
127975875|NCT01397786|460533032|FG000|Phase A|Withdrawal by Subject|0|||
127975876|NCT01397786|460533033|FG001|Phase A|Withdrawal by Subject|0|||
127975877|NCT01397786|460533034|FG002|Phase A|Withdrawal by Subject|5|||
127975878|NCT01397786|460533032|FG000|Phase A|Lack of Efficacy|0|||
127975879|NCT01397786|460533033|FG001|Phase A|Lack of Efficacy|0|||
127975880|NCT01397786|460533034|FG002|Phase A|Lack of Efficacy|1|||
127975881|NCT01397786|460533032|FG000|Phase B|Lost to Follow-up|22|||
127975882|NCT01397786|460533033|FG001|Phase B|Lost to Follow-up|12|||
127975883|NCT01397786|460533034|FG002|Phase B|Lost to Follow-up|22|||
127975884|NCT01397786|460533032|FG000|Phase B|Adverse Event|109|||
127975885|NCT01397786|460533033|FG001|Phase B|Adverse Event|23|||
127975886|NCT01397786|460533034|FG002|Phase B|Adverse Event|27|||
127975887|NCT01397786|460533032|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
127975888|NCT01397786|460533033|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
127975889|NCT01397786|460533034|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
127975890|NCT01397786|460533032|FG000|Phase B|Physician Decision|9|||
127975891|NCT01397786|460533033|FG001|Phase B|Physician Decision|1|||
127975892|NCT01397786|460533034|FG002|Phase B|Physician Decision|3|||
127975893|NCT01397786|460533032|FG000|Phase B|Withdrawal by Subject|102|||
127975894|NCT01397786|460533033|FG001|Phase B|Withdrawal by Subject|45|||
127975895|NCT01397786|460533034|FG002|Phase B|Withdrawal by Subject|30|||
127975896|NCT01397786|460533032|FG000|Phase B|Protocol Deviation|1|||
127975897|NCT01397786|460533033|FG001|Phase B|Protocol Deviation|2|||
127975898|NCT01397786|460533034|FG002|Phase B|Protocol Deviation|4|||
127975899|NCT01397786|460533032|FG000|Phase B|Lack of Efficacy|22|||
127975900|NCT01397786|460533033|FG001|Phase B|Lack of Efficacy|7|||
127975901|NCT01397786|460533034|FG002|Phase B|Lack of Efficacy|14|||
127975902|NCT02005692|460533038|FG000|Overall Study|Protocol Violation|1|||
127975903|NCT02005692|460533038|FG000|Overall Study|Withdrawal by Subject|1|||
127975904|NCT02005692|460533038|FG000|Overall Study|Discharged earlier than anticipated|5|||
127975905|NCT02091375|460533040|FG000|Overall Study|Adverse Event|8|||
127975906|NCT02091375|460533041|FG001|Overall Study|Adverse Event|1|||
127975907|NCT02091375|460533040|FG000|Overall Study|Lost to Follow-up|0|||
127975908|NCT02091375|460533041|FG001|Overall Study|Lost to Follow-up|1|||
127975909|NCT02091375|460533040|FG000|Overall Study|Withdrawal by Subject|0|||
127975910|NCT02091375|460533041|FG001|Overall Study|Withdrawal by Subject|1|||
127975911|NCT02091375|460533040|FG000|Overall Study|Withdrawn by the investigator|1|||
127975912|NCT02091375|460533041|FG001|Overall Study|Withdrawn by the investigator|0|||
127975913|NCT01741792|460533042|FG000|Overall Study|Death|6|||
127975914|NCT01741792|460533043|FG001|Overall Study|Death|1|||
127975915|NCT01741792|460533044|FG002|Overall Study|Death|12|||
127975916|NCT04507256|460533049|FG000|Overall Study|Withdrawal by Subject|1|||
127975917|NCT04507256|460533050|FG001|Overall Study|Withdrawal by Subject|0|||
127975918|NCT04507256|460533051|FG002|Overall Study|Withdrawal by Subject|0|||
127975919|NCT04507256|460533052|FG003|Overall Study|Withdrawal by Subject|1|||
127975920|NCT04507256|460533053|FG004|Overall Study|Withdrawal by Subject|0|||
127975921|NCT04507256|460533054|FG005|Overall Study|Withdrawal by Subject|0|||
127975922|NCT00631410|460533055|FG000|Overall Study|Adverse Event|1|||
127975923|NCT00631410|460533056|FG001|Overall Study|Adverse Event|3|||
127975924|NCT00631410|460533055|FG000|Overall Study|Objective Progression or Relapse|4|||
127975925|NCT00631410|460533056|FG001|Overall Study|Objective Progression or Relapse|3|||
127975926|NCT00631410|460533055|FG000|Overall Study|Surgery|1|||
127975927|NCT00631410|460533056|FG001|Overall Study|Surgery|0|||
127975928|NCT02980341|460533061|FG000|Dose Escalation|Progressive disease per RECIST v1.1|3|||
127975929|NCT02980341|460533062|FG001|Dose Escalation|Progressive disease per RECIST v1.1|3|||
127975930|NCT02980341|460533063|FG002|Dose Escalation|Progressive disease per RECIST v1.1|11|||
127975931|NCT02980341|460533064|FG003|Dose Escalation|Progressive disease per RECIST v1.1|10|||
127975932|NCT02980341|460533065|FG004|Dose Escalation|Progressive disease per RECIST v1.1|3|||
127975933|NCT02980341|460533066|FG005|Dose Escalation|Progressive disease per RECIST v1.1|0|||
127975934|NCT02980341|460533067|FG006|Dose Escalation|Progressive disease per RECIST v1.1|0|||
127975935|NCT02980341|460533068|FG007|Dose Escalation|Progressive disease per RECIST v1.1|0|||
127975936|NCT02980341|460533069|FG008|Dose Escalation|Progressive disease per RECIST v1.1|0|||
127975937|NCT02980341|460533070|FG009|Dose Escalation|Progressive disease per RECIST v1.1|0|||
127975938|NCT02980341|460533071|FG010|Dose Escalation|Progressive disease per RECIST v1.1|0|||
127975939|NCT02980341|460533061|FG000|Dose Escalation|Clinical progression|0|||
127975940|NCT02980341|460533062|FG001|Dose Escalation|Clinical progression|0|||
127975941|NCT02980341|460533063|FG002|Dose Escalation|Clinical progression|2|||
127975942|NCT02980341|460533064|FG003|Dose Escalation|Clinical progression|1|||
127975943|NCT02980341|460533065|FG004|Dose Escalation|Clinical progression|0|||
127975944|NCT02980341|460533066|FG005|Dose Escalation|Clinical progression|0|||
127975945|NCT02980341|460533067|FG006|Dose Escalation|Clinical progression|0|||
127975946|NCT02980341|460533068|FG007|Dose Escalation|Clinical progression|0|||
127975947|NCT02980341|460533069|FG008|Dose Escalation|Clinical progression|0|||
127975948|NCT02980341|460533070|FG009|Dose Escalation|Clinical progression|0|||
127975949|NCT02980341|460533071|FG010|Dose Escalation|Clinical progression|0|||
127975950|NCT02980341|460533061|FG000|Dose Escalation|Adverse Event|0|||
127975951|NCT02980341|460533062|FG001|Dose Escalation|Adverse Event|0|||
127975952|NCT02980341|460533063|FG002|Dose Escalation|Adverse Event|1|||
127975953|NCT02980341|460533064|FG003|Dose Escalation|Adverse Event|2|||
127975954|NCT02980341|460533065|FG004|Dose Escalation|Adverse Event|2|||
127975955|NCT02980341|460533066|FG005|Dose Escalation|Adverse Event|0|||
127975956|NCT02980341|460533067|FG006|Dose Escalation|Adverse Event|0|||
127975957|NCT02980341|460533068|FG007|Dose Escalation|Adverse Event|0|||
127975958|NCT02980341|460533069|FG008|Dose Escalation|Adverse Event|0|||
127975959|NCT02980341|460533070|FG009|Dose Escalation|Adverse Event|0|||
127975960|NCT02980341|460533071|FG010|Dose Escalation|Adverse Event|0|||
127975961|NCT02980341|460533061|FG000|Dose Escalation|Withdrawal by Subject|0|||
127975962|NCT02980341|460533062|FG001|Dose Escalation|Withdrawal by Subject|0|||
127975963|NCT02980341|460533063|FG002|Dose Escalation|Withdrawal by Subject|1|||
127975964|NCT02980341|460533064|FG003|Dose Escalation|Withdrawal by Subject|0|||
127975965|NCT02980341|460533065|FG004|Dose Escalation|Withdrawal by Subject|0|||
127975966|NCT02980341|460533066|FG005|Dose Escalation|Withdrawal by Subject|0|||
127975967|NCT02980341|460533067|FG006|Dose Escalation|Withdrawal by Subject|0|||
127975968|NCT02980341|460533068|FG007|Dose Escalation|Withdrawal by Subject|0|||
127975969|NCT02980341|460533069|FG008|Dose Escalation|Withdrawal by Subject|0|||
127975970|NCT02980341|460533070|FG009|Dose Escalation|Withdrawal by Subject|0|||
127975971|NCT02980341|460533071|FG010|Dose Escalation|Withdrawal by Subject|0|||
127975972|NCT02980341|460533061|FG000|Dose Escalation|Due to side effect management of chemotherapy|0|||
127975973|NCT02980341|460533062|FG001|Dose Escalation|Due to side effect management of chemotherapy|0|||
127975974|NCT02980341|460533063|FG002|Dose Escalation|Due to side effect management of chemotherapy|0|||
127975975|NCT02980341|460533064|FG003|Dose Escalation|Due to side effect management of chemotherapy|2|||
127975976|NCT02980341|460533065|FG004|Dose Escalation|Due to side effect management of chemotherapy|0|||
127975977|NCT02980341|460533066|FG005|Dose Escalation|Due to side effect management of chemotherapy|0|||
127975978|NCT02980341|460533067|FG006|Dose Escalation|Due to side effect management of chemotherapy|0|||
127975979|NCT02980341|460533068|FG007|Dose Escalation|Due to side effect management of chemotherapy|0|||
127975980|NCT02980341|460533069|FG008|Dose Escalation|Due to side effect management of chemotherapy|0|||
127975981|NCT02980341|460533070|FG009|Dose Escalation|Due to side effect management of chemotherapy|0|||
127975982|NCT02980341|460533071|FG010|Dose Escalation|Due to side effect management of chemotherapy|0|||
127975983|NCT02980341|460533061|FG000|Dose Escalation|Due to investigator's decision|0|||
127975984|NCT02980341|460533062|FG001|Dose Escalation|Due to investigator's decision|0|||
127975985|NCT02980341|460533063|FG002|Dose Escalation|Due to investigator's decision|0|||
127975986|NCT02980341|460533064|FG003|Dose Escalation|Due to investigator's decision|0|||
127975987|NCT02980341|460533065|FG004|Dose Escalation|Due to investigator's decision|1|||
127975988|NCT02980341|460533066|FG005|Dose Escalation|Due to investigator's decision|0|||
127975989|NCT02980341|460533067|FG006|Dose Escalation|Due to investigator's decision|0|||
127975990|NCT02980341|460533068|FG007|Dose Escalation|Due to investigator's decision|0|||
127975991|NCT02980341|460533069|FG008|Dose Escalation|Due to investigator's decision|0|||
127975992|NCT02980341|460533070|FG009|Dose Escalation|Due to investigator's decision|0|||
127975993|NCT02980341|460533071|FG010|Dose Escalation|Due to investigator's decision|0|||
127975994|NCT02980341|460533061|FG000|Dose Finding|Progressive disease per RECIST v1.1|0|||
127975995|NCT02980341|460533062|FG001|Dose Finding|Progressive disease per RECIST v1.1|0|||
127975996|NCT02980341|460533063|FG002|Dose Finding|Progressive disease per RECIST v1.1|0|||
127975997|NCT02980341|460533064|FG003|Dose Finding|Progressive disease per RECIST v1.1|0|||
127975998|NCT02980341|460533065|FG004|Dose Finding|Progressive disease per RECIST v1.1|0|||
127975999|NCT02980341|460533066|FG005|Dose Finding|Progressive disease per RECIST v1.1|8|||
127976000|NCT02980341|460533067|FG006|Dose Finding|Progressive disease per RECIST v1.1|11|||
127976001|NCT02980341|460533068|FG007|Dose Finding|Progressive disease per RECIST v1.1|0|||
127976002|NCT02980341|460533069|FG008|Dose Finding|Progressive disease per RECIST v1.1|0|||
127976003|NCT02980341|460533070|FG009|Dose Finding|Progressive disease per RECIST v1.1|0|||
127976004|NCT02980341|460533071|FG010|Dose Finding|Progressive disease per RECIST v1.1|0|||
127976005|NCT02980341|460533061|FG000|Dose Finding|Adverse Event|0|||
127976006|NCT02980341|460533062|FG001|Dose Finding|Adverse Event|0|||
127976007|NCT02980341|460533063|FG002|Dose Finding|Adverse Event|0|||
127976008|NCT02980341|460533064|FG003|Dose Finding|Adverse Event|0|||
127976009|NCT02980341|460533065|FG004|Dose Finding|Adverse Event|0|||
127976010|NCT02980341|460533066|FG005|Dose Finding|Adverse Event|3|||
127976011|NCT02980341|460533067|FG006|Dose Finding|Adverse Event|0|||
127976012|NCT02980341|460533068|FG007|Dose Finding|Adverse Event|0|||
127976013|NCT02980341|460533069|FG008|Dose Finding|Adverse Event|0|||
127976014|NCT02980341|460533070|FG009|Dose Finding|Adverse Event|0|||
127976015|NCT02980341|460533071|FG010|Dose Finding|Adverse Event|0|||
127976016|NCT02980341|460533061|FG000|Dose Finding|Withdrawal by Subject|0|||
127976017|NCT02980341|460533062|FG001|Dose Finding|Withdrawal by Subject|0|||
127976018|NCT02980341|460533063|FG002|Dose Finding|Withdrawal by Subject|0|||
127976019|NCT02980341|460533064|FG003|Dose Finding|Withdrawal by Subject|0|||
127976020|NCT02980341|460533065|FG004|Dose Finding|Withdrawal by Subject|0|||
127976021|NCT02980341|460533066|FG005|Dose Finding|Withdrawal by Subject|1|||
127976022|NCT02980341|460533067|FG006|Dose Finding|Withdrawal by Subject|1|||
127976023|NCT02980341|460533068|FG007|Dose Finding|Withdrawal by Subject|0|||
127976024|NCT02980341|460533069|FG008|Dose Finding|Withdrawal by Subject|0|||
127976025|NCT02980341|460533070|FG009|Dose Finding|Withdrawal by Subject|0|||
127976026|NCT02980341|460533071|FG010|Dose Finding|Withdrawal by Subject|0|||
127976027|NCT02980341|460533061|FG000|Dose Expansion|Progressive disease per RECIST v1.1|0|||
127976028|NCT02980341|460533062|FG001|Dose Expansion|Progressive disease per RECIST v1.1|0|||
127976029|NCT02980341|460533063|FG002|Dose Expansion|Progressive disease per RECIST v1.1|0|||
127976030|NCT02980341|460533064|FG003|Dose Expansion|Progressive disease per RECIST v1.1|0|||
127976031|NCT02980341|460533065|FG004|Dose Expansion|Progressive disease per RECIST v1.1|0|||
127976032|NCT02980341|460533066|FG005|Dose Expansion|Progressive disease per RECIST v1.1|0|||
127976033|NCT02980341|460533067|FG006|Dose Expansion|Progressive disease per RECIST v1.1|0|||
127976034|NCT02980341|460533068|FG007|Dose Expansion|Progressive disease per RECIST v1.1|23|||
127976035|NCT02980341|460533069|FG008|Dose Expansion|Progressive disease per RECIST v1.1|24|||
127976036|NCT02980341|460533070|FG009|Dose Expansion|Progressive disease per RECIST v1.1|17|||
127976037|NCT02980341|460533071|FG010|Dose Expansion|Progressive disease per RECIST v1.1|23|||
127976038|NCT02980341|460533061|FG000|Dose Expansion|Clinical progression|0|||
127976039|NCT02980341|460533062|FG001|Dose Expansion|Clinical progression|0|||
127976040|NCT02980341|460533063|FG002|Dose Expansion|Clinical progression|0|||
127976041|NCT02980341|460533064|FG003|Dose Expansion|Clinical progression|0|||
127976042|NCT02980341|460533065|FG004|Dose Expansion|Clinical progression|0|||
127976043|NCT02980341|460533066|FG005|Dose Expansion|Clinical progression|0|||
127976044|NCT02980341|460533067|FG006|Dose Expansion|Clinical progression|0|||
127976045|NCT02980341|460533068|FG007|Dose Expansion|Clinical progression|4|||
127976046|NCT02980341|460533069|FG008|Dose Expansion|Clinical progression|3|||
127976047|NCT02980341|460533070|FG009|Dose Expansion|Clinical progression|1|||
127976048|NCT02980341|460533071|FG010|Dose Expansion|Clinical progression|4|||
127976049|NCT02980341|460533061|FG000|Dose Expansion|Adverse Event|0|||
127976050|NCT02980341|460533062|FG001|Dose Expansion|Adverse Event|0|||
127976051|NCT02980341|460533063|FG002|Dose Expansion|Adverse Event|0|||
127976052|NCT02980341|460533064|FG003|Dose Expansion|Adverse Event|0|||
127976053|NCT02980341|460533065|FG004|Dose Expansion|Adverse Event|0|||
127976054|NCT02980341|460533066|FG005|Dose Expansion|Adverse Event|0|||
127976055|NCT02980341|460533067|FG006|Dose Expansion|Adverse Event|0|||
127976056|NCT02980341|460533068|FG007|Dose Expansion|Adverse Event|3|||
127976057|NCT02980341|460533069|FG008|Dose Expansion|Adverse Event|0|||
127976058|NCT02980341|460533070|FG009|Dose Expansion|Adverse Event|1|||
127976059|NCT02980341|460533071|FG010|Dose Expansion|Adverse Event|3|||
127976060|NCT02980341|460533061|FG000|Dose Expansion|Death|0|||
127976061|NCT02980341|460533062|FG001|Dose Expansion|Death|0|||
127976062|NCT02980341|460533063|FG002|Dose Expansion|Death|0|||
127976063|NCT02980341|460533064|FG003|Dose Expansion|Death|0|||
127976064|NCT02980341|460533065|FG004|Dose Expansion|Death|0|||
127976065|NCT02980341|460533066|FG005|Dose Expansion|Death|0|||
127976066|NCT02980341|460533067|FG006|Dose Expansion|Death|0|||
127976067|NCT02980341|460533068|FG007|Dose Expansion|Death|0|||
127976068|NCT02980341|460533069|FG008|Dose Expansion|Death|2|||
127976069|NCT02980341|460533070|FG009|Dose Expansion|Death|1|||
127976070|NCT02980341|460533071|FG010|Dose Expansion|Death|0|||
127976071|NCT02980341|460533061|FG000|Dose Expansion|Withdrawal by Subject|0|||
127976072|NCT02980341|460533062|FG001|Dose Expansion|Withdrawal by Subject|0|||
127976073|NCT02980341|460533063|FG002|Dose Expansion|Withdrawal by Subject|0|||
127976074|NCT02980341|460533064|FG003|Dose Expansion|Withdrawal by Subject|0|||
127976075|NCT02980341|460533065|FG004|Dose Expansion|Withdrawal by Subject|0|||
127976076|NCT02980341|460533066|FG005|Dose Expansion|Withdrawal by Subject|0|||
127976077|NCT02980341|460533067|FG006|Dose Expansion|Withdrawal by Subject|0|||
127976078|NCT02980341|460533068|FG007|Dose Expansion|Withdrawal by Subject|2|||
127976079|NCT02980341|460533069|FG008|Dose Expansion|Withdrawal by Subject|0|||
127976080|NCT02980341|460533070|FG009|Dose Expansion|Withdrawal by Subject|1|||
127976081|NCT02980341|460533071|FG010|Dose Expansion|Withdrawal by Subject|0|||
127976082|NCT02980341|460533061|FG000|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
127976083|NCT02980341|460533062|FG001|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
127976084|NCT02980341|460533063|FG002|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
127976085|NCT02980341|460533064|FG003|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
127976086|NCT02980341|460533065|FG004|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
127976087|NCT02980341|460533066|FG005|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
127976088|NCT02980341|460533067|FG006|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
127976089|NCT02980341|460533068|FG007|Dose Expansion|Due to investigator's decision considering patient's liver condition|1|||
127976090|NCT02980341|460533069|FG008|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
127976091|NCT02980341|460533070|FG009|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
127976092|NCT02980341|460533071|FG010|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
127976093|NCT02980341|460533061|FG000|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
127976094|NCT02980341|460533062|FG001|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
127976095|NCT02980341|460533063|FG002|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
127976096|NCT02980341|460533064|FG003|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
127976097|NCT02980341|460533065|FG004|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
127976098|NCT02980341|460533066|FG005|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
127976099|NCT02980341|460533067|FG006|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
127976100|NCT02980341|460533068|FG007|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
127976101|NCT02980341|460533069|FG008|Dose Expansion|Due to investigator's decision due to patient's general condition|1|||
127976102|NCT02980341|460533070|FG009|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
127976103|NCT02980341|460533071|FG010|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
127976104|NCT02980341|460533061|FG000|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
127976105|NCT02980341|460533062|FG001|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
127976106|NCT02980341|460533063|FG002|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
127976107|NCT02980341|460533064|FG003|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
127976108|NCT02980341|460533065|FG004|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
127976109|NCT02980341|460533066|FG005|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
127976110|NCT02980341|460533067|FG006|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
127976111|NCT02980341|460533068|FG007|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
127976112|NCT02980341|460533069|FG008|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|1|||
127976113|NCT02980341|460533070|FG009|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
127976114|NCT02980341|460533071|FG010|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
127976115|NCT02980341|460533061|FG000|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
127976116|NCT02980341|460533062|FG001|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
127976117|NCT02980341|460533063|FG002|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
127976118|NCT02980341|460533064|FG003|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
127976119|NCT02980341|460533065|FG004|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
127976120|NCT02980341|460533066|FG005|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
127976121|NCT02980341|460533067|FG006|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
127976122|NCT02980341|460533068|FG007|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
127976123|NCT02980341|460533069|FG008|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
127976124|NCT02980341|460533070|FG009|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
127976125|NCT02980341|460533071|FG010|Dose Expansion|Patient withdrew consent following 50 treatment cycles|1|||
127976126|NCT04964544|460533076|FG000|Overall Study|Screen failure or other uncategorised|10|||
127976127|NCT04964544|460533076|FG000|Overall Study|Physician Decision|4|||
127976128|NCT04964544|460533076|FG000|Overall Study|Lost to Follow-up|9|||
127976129|NCT04964544|460533076|FG000|Overall Study|Withdrawal by Subject|18|||
127976130|NCT04964544|460533076|FG000|Overall Study|Death|1|||
127976131|NCT01613222|460533077|FG000|Overall Study|Physician Decision|1|||
127976132|NCT01613222|460533077|FG000|Overall Study|Unable to place arterial line|1|||
127976133|NCT01613222|460533077|FG000|Overall Study|Reused disposable sensors|10|||
127976134|NCT03696108|460533078|FG000|Overall Study|Physician Decision|1|||
127976135|NCT03696108|460533079|FG001|Overall Study|Physician Decision|0|||
127976136|NCT03696108|460533078|FG000|Overall Study|Withdrawal by Subject|3|||
127976137|NCT03696108|460533079|FG001|Overall Study|Withdrawal by Subject|6|||
127976138|NCT01899742|460533083|FG000|Overall Study|Adverse Event|5|||
127976139|NCT01899742|460533084|FG001|Overall Study|Adverse Event|4|||
127976140|NCT01899742|460533083|FG000|Overall Study|Lack of Efficacy|1|||
127976141|NCT01899742|460533084|FG001|Overall Study|Lack of Efficacy|5|||
127976142|NCT01899742|460533083|FG000|Overall Study|Protocol Violation|2|||
127976143|NCT01899742|460533084|FG001|Overall Study|Protocol Violation|2|||
127976144|NCT01899742|460533083|FG000|Overall Study|Withdrawal by Subject|9|||
127976145|NCT01899742|460533084|FG001|Overall Study|Withdrawal by Subject|5|||
127976146|NCT02662764|460533085|FG000|Overall Study|Adverse Event|6|||
127976147|NCT02662764|460533085|FG000|Overall Study|Lack of Efficacy|8|||
127976148|NCT02662764|460533085|FG000|Overall Study|Protocol Violation|1|||
127976149|NCT02662764|460533085|FG000|Overall Study|Withdrawal by Subject|5|||
127976150|NCT02662764|460533085|FG000|Overall Study|Device failure|4|||
127976151|NCT02662764|460533085|FG000|Overall Study|Patient changed treatment|1|||
127976152|NCT02662764|460533085|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
127976153|NCT00089778|460533086|FG000|Overall Study|Protocol Violation|0|||
127976154|NCT00089778|460533087|FG001|Overall Study|Protocol Violation|0|||
127976155|NCT00089778|460533088|FG002|Overall Study|Protocol Violation|1|||
127976156|NCT01154088|460533091|FG000|Overall Study|Lost to Follow-up|4|||
127976157|NCT01154088|460533092|FG001|Overall Study|Lost to Follow-up|6|||
127976158|NCT01154088|460533093|FG002|Overall Study|Lost to Follow-up|7|||
127976159|NCT05178641|460533094|FG000|First 3 Weeks of Study (Week 1-3)|Protocol Violation|4|||
127976160|NCT05178641|460533095|FG001|First 3 Weeks of Study (Week 1-3)|Protocol Violation|1|||
127976161|NCT05178641|460533094|FG000|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|0|||
127976162|NCT05178641|460533095|FG001|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|1|||
127976163|NCT01869699|460533096|FG000|Overall Study|Withdrawal by Subject|1|||
127976164|NCT01869699|460533097|FG001|Overall Study|Withdrawal by Subject|0|||
127976165|NCT01475851|460533098|FG000|Overall Study|Protocol defined stopping criteria|1|||
127976166|NCT01475851|460533099|FG001|Overall Study|Protocol defined stopping criteria|0|||
127976167|NCT01867294|460533102|FG000|Overall Study|Withdrawal by Subject|1|||
127976168|NCT01867294|460533103|FG001|Overall Study|Withdrawal by Subject|1|||
127976169|NCT01867294|460533104|FG002|Overall Study|Withdrawal by Subject|0|||
127976170|NCT01867294|460533105|FG003|Overall Study|Withdrawal by Subject|0|||
127976171|NCT02447497|460533106|FG000|Overall Study|Did not meet treatment day baseline.|6|||
127976172|NCT02447497|460533107|FG001|Overall Study|Did not meet treatment day baseline.|5|||
127976173|NCT02447497|460533108|FG002|Overall Study|Did not meet treatment day baseline.|2|||
127976174|NCT02447497|460533109|FG003|Overall Study|Did not meet treatment day baseline.|2|||
127976175|NCT02447497|460533106|FG000|Overall Study|Dressing was compromised|0|||
127976176|NCT02447497|460533107|FG001|Overall Study|Dressing was compromised|1|||
127976177|NCT02447497|460533108|FG002|Overall Study|Dressing was compromised|0|||
127976178|NCT02447497|460533109|FG003|Overall Study|Dressing was compromised|0|||
127976179|NCT02017912|460533110|FG000|Overall Study|Withdrawal by Subject|2|||
127976180|NCT02017912|460533111|FG001|Overall Study|Withdrawal by Subject|1|||
127976181|NCT02017912|460533110|FG000|Overall Study|miscellaneous|1|||
127976182|NCT02017912|460533111|FG001|Overall Study|miscellaneous|1|||
127976183|NCT01322035|460533112|FG000|Overall Study|Lost to Follow-up|8|||
127976184|NCT01322035|460533113|FG001|Overall Study|Lost to Follow-up|3|||
127976185|NCT00732758|460533114|FG000|Overall Study|Lost to Follow-up|8|||
127976186|NCT00732758|460533115|FG001|Overall Study|Lost to Follow-up|16|||
127976187|NCT04240457|460533118|FG000|Overall Study|Lost to Follow-up|5|||
127976188|NCT04240457|460533119|FG001|Overall Study|Lost to Follow-up|1|||
127976189|NCT01508130|460533123|FG000|Overall Study|Adverse Event|81|||
127976190|NCT01508130|460533124|FG001|Overall Study|Adverse Event|28|||
127976191|NCT01508130|460533123|FG000|Overall Study|Death|3|||
127976192|NCT01508130|460533124|FG001|Overall Study|Death|1|||
127976193|NCT01508130|460533123|FG000|Overall Study|Protocol Violation|2|||
127976194|NCT01508130|460533124|FG001|Overall Study|Protocol Violation|0|||
127976195|NCT01508130|460533123|FG000|Overall Study|Lost to Follow-up|25|||
127976196|NCT01508130|460533124|FG001|Overall Study|Lost to Follow-up|2|||
127976197|NCT01508130|460533123|FG000|Overall Study|Withdrawal by Subject|3|||
127976198|NCT01508130|460533124|FG001|Overall Study|Withdrawal by Subject|3|||
127976199|NCT01508130|460533123|FG000|Overall Study|Subject's substantial non-compliance|25|||
127976200|NCT01508130|460533124|FG001|Overall Study|Subject's substantial non-compliance|9|||
127976201|NCT01508130|460533123|FG000|Overall Study|Insufficient therapeutic response|74|||
127976202|NCT01508130|460533124|FG001|Overall Study|Insufficient therapeutic response|23|||
127976203|NCT01508130|460533123|FG000|Overall Study|Administrative|14|||
127976204|NCT01508130|460533124|FG001|Overall Study|Administrative|3|||
127976205|NCT01680159|460533125|FG000|Screening Period|Not meet criteria for dose-up period|7|||
127976206|NCT01680159|460533125|FG000|Increased Dose Period|Adverse Event|6|||
127976207|NCT01680159|460533125|FG000|Increased Dose Period|Withdrawal by Subject|2|||
127976208|NCT01252563|460533131|FG000|Overall Study|Contract Deviation|41|||
127976209|NCT01252563|460533131|FG000|Overall Study|Centralized Registration Deviation|30|||
127976210|NCT01252563|460533131|FG000|Overall Study|Lost to Follow-up|161|||
127976211|NCT01252563|460533131|FG000|Overall Study|No visit after first day of treatment|194|||
127976212|NCT01252563|460533131|FG000|Overall Study|No drug administration|6|||
127976213|NCT03429244|460533132|FG000|Overall Study|Withdrawal by Subject|2|||
127976214|NCT03429244|460533133|FG001|Overall Study|Withdrawal by Subject|1|||
127976215|NCT03429244|460533134|FG002|Overall Study|Withdrawal by Subject|1|||
127976216|NCT00658775|460533135|FG000|Overall Study|Adverse Event|4|||
127976217|NCT00658775|460533136|FG001|Overall Study|Adverse Event|6|||
127976218|NCT00658775|460533135|FG000|Overall Study|Lost to Follow-up|17|||
127976219|NCT00658775|460533136|FG001|Overall Study|Lost to Follow-up|18|||
127976220|NCT00658775|460533135|FG000|Overall Study|Withdrawal by Subject|6|||
127976221|NCT00658775|460533136|FG001|Overall Study|Withdrawal by Subject|4|||
127976222|NCT00658775|460533135|FG000|Overall Study|Withdrawal of consent|8|||
127976223|NCT00658775|460533136|FG001|Overall Study|Withdrawal of consent|7|||
127976224|NCT00658775|460533135|FG000|Overall Study|Other|7|||
127976225|NCT00658775|460533136|FG001|Overall Study|Other|8|||
127976226|NCT00387010|460533137|FG000|Dose Titration Period|Adverse Event|12|||
127976227|NCT00387010|460533137|FG000|Dose Titration Period|Lack of Efficacy|5|||
127976228|NCT00387010|460533137|FG000|Dose Titration Period|Withdrawal by Subject|3|||
127976229|NCT00387010|460533137|FG000|Dose Titration Period|Protocol Violation|1|||
127976230|NCT00387010|460533137|FG000|Dose Titration Period|Lost to Follow-up|2|||
127976231|NCT00387010|460533137|FG000|Dose Titration Period|Noncompliance with study medication|8|||
127976232|NCT00387010|460533137|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
127976233|NCT00387010|460533137|FG000|Treatment Period|Adverse Event|4|||
127976234|NCT00387010|460533137|FG000|Treatment Period|Withdrawal by Subject|1|||
127976235|NCT00387010|460533137|FG000|Treatment Period|Noncompliance with study medication|2|||
127976236|NCT00387010|460533137|FG000|Treatment Period|Noncompliance with study procedures|3|||
127976237|NCT00387010|460533137|FG000|Treatment Period|Participant reported study drug stolen|1|||
127976238|NCT02841280|460533142|FG000|Overall Study|Adverse Event|2|||
127976239|NCT02841280|460533143|FG001|Overall Study|Adverse Event|1|||
127976240|NCT02841280|460533142|FG000|Overall Study|Death|1|||
127976241|NCT02841280|460533143|FG001|Overall Study|Death|0|||
127485540|NCT00656370|458741216|FG000|Overall Study|Alternates|3|||
127485541|NCT01816984|458741217|FG000|Overall Study|declining health status|1|||
127976242|NCT02841280|460533142|FG000|Overall Study|Lost to Follow-up|2|||
127976243|NCT02841280|460533143|FG001|Overall Study|Lost to Follow-up|2|||
127976244|NCT02841280|460533142|FG000|Overall Study|Withdrawal by Subject|7|||
127976245|NCT02841280|460533143|FG001|Overall Study|Withdrawal by Subject|3|||
127976246|NCT02841280|460533142|FG000|Overall Study|Stop Point: BP above threshold|2|||
127976247|NCT02841280|460533143|FG001|Overall Study|Stop Point: BP above threshold|0|||
127976248|NCT02727777|460533144|FG000|Overall Study|Screen Failure|2|||
127976249|NCT02727777|460533145|FG001|Overall Study|Screen Failure|0|||
127976250|NCT02727777|460533146|FG002|Overall Study|Screen Failure|0|||
127976251|NCT02727777|460533144|FG000|Overall Study|Progressive disease|2|||
127976252|NCT02727777|460533145|FG001|Overall Study|Progressive disease|0|||
127976253|NCT02727777|460533146|FG002|Overall Study|Progressive disease|0|||
127976254|NCT03005327|460533148|FG000|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
127976255|NCT03005327|460533149|FG001|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
127976256|NCT03005327|460533150|FG002|Initial Treatment Period (24 Weeks)|Adverse Event|1|||
127976257|NCT03005327|460533151|FG003|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
127976258|NCT03005327|460533148|FG000|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
127485542|NCT01342094|458741218|FG000|Overall Study|Adverse Event|5|||
127976259|NCT03005327|460533149|FG001|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
127976260|NCT03005327|460533150|FG002|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
127976261|NCT03005327|460533151|FG003|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
127976262|NCT00915876|460533152|FG000|Overall Study|Adverse Event|0|||
127976263|NCT00915876|460533153|FG001|Overall Study|Adverse Event|1|||
127976264|NCT02572076|460533155|FG000|Overall Study|Protocol Violation|1|||
127976265|NCT02496091|460533156|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
127976266|NCT02272842|460533157|FG000|Overall Study|Lost to Follow-up|8|||
127976267|NCT02272842|460533158|FG001|Overall Study|Lost to Follow-up|8|||
127976268|NCT02272842|460533157|FG000|Overall Study|Withdrawal by Subject|8|||
127976269|NCT02272842|460533158|FG001|Overall Study|Withdrawal by Subject|2|||
127976270|NCT05033262|460533161|FG000|Overall Study|Lost to Follow-up|1|||
127976271|NCT05033262|460533162|FG001|Overall Study|Lost to Follow-up|0|||
127976272|NCT05033262|460533163|FG002|Overall Study|Lost to Follow-up|0|||
127976273|NCT05033262|460533164|FG003|Overall Study|Lost to Follow-up|1|||
127484940|NCT03549338|458741069|FG000|Overall Study|Progressive Disease|1|||
127484941|NCT03549338|458741070|FG001|Overall Study|Progressive Disease|0|||
127484942|NCT03549338|458741071|FG002|Overall Study|Progressive Disease|0|||
127484943|NCT03549338|458741069|FG000|Overall Study|Clinical Progression|0|||
127484944|NCT03549338|458741070|FG001|Overall Study|Clinical Progression|1|||
127484945|NCT03549338|458741071|FG002|Overall Study|Clinical Progression|0|||
127484946|NCT00652743|458741072|FG000|Months 12-18|Lost to Follow-up|1|||
127484947|NCT00652743|458741073|FG001|Months 12-18|Lost to Follow-up|2|||
127484948|NCT00652743|458741074|FG002|Months 12-18|Lost to Follow-up|7|||
127484949|NCT00652743|458741072|FG000|Months 24-30|Other|5|||
127484950|NCT00652743|458741073|FG001|Months 24-30|Other|1|||
127484951|NCT00652743|458741074|FG002|Months 24-30|Other|11|||
127484952|NCT00652743|458741072|FG000|Months 36-42|Serious Adverse Events|0|||
127484953|NCT00652743|458741073|FG001|Months 36-42|Serious Adverse Events|1|||
127484954|NCT00652743|458741074|FG002|Months 36-42|Serious Adverse Events|1|||
127484955|NCT00652743|458741072|FG000|Months 36-42|Withdrawal by Subject|1|||
127484956|NCT00652743|458741073|FG001|Months 36-42|Withdrawal by Subject|1|||
127484957|NCT00652743|458741074|FG002|Months 36-42|Withdrawal by Subject|0|||
127484958|NCT00652743|458741072|FG000|Months 36-42|Lost to Follow-up|0|||
127484959|NCT00652743|458741073|FG001|Months 36-42|Lost to Follow-up|1|||
127484960|NCT00652743|458741074|FG002|Months 36-42|Lost to Follow-up|0|||
127484961|NCT00652743|458741072|FG000|Months 36-42|Migrated/moved from study area|1|||
127484962|NCT00652743|458741073|FG001|Months 36-42|Migrated/moved from study area|0|||
127484963|NCT00652743|458741074|FG002|Months 36-42|Migrated/moved from study area|0|||
127484964|NCT00652743|458741072|FG000|Months 36-42|Other|4|||
127484965|NCT00652743|458741073|FG001|Months 36-42|Other|2|||
127484966|NCT00652743|458741074|FG002|Months 36-42|Other|8|||
127484967|NCT00269113|458741075|FG000|Overall Study|Adverse Event|14|||
127484968|NCT00269113|458741076|FG001|Overall Study|Adverse Event|7|||
127484969|NCT00269113|458741075|FG000|Overall Study|Lack of Efficacy|35|||
127484970|NCT00269113|458741076|FG001|Overall Study|Lack of Efficacy|18|||
127484971|NCT00269113|458741075|FG000|Overall Study|Early Improvement|2|||
127484972|NCT00269113|458741076|FG001|Overall Study|Early Improvement|0|||
127484973|NCT00269113|458741075|FG000|Overall Study|Withdrawal by Subject|0|||
127484974|NCT00269113|458741076|FG001|Overall Study|Withdrawal by Subject|2|||
127484975|NCT00269113|458741075|FG000|Overall Study|Death|6|||
127484976|NCT00269113|458741076|FG001|Overall Study|Death|2|||
127484977|NCT00269113|458741075|FG000|Overall Study|Lost to Follow-up|2|||
127484978|NCT00269113|458741076|FG001|Overall Study|Lost to Follow-up|1|||
127484979|NCT00269113|458741075|FG000|Overall Study|Protocol Violation|15|||
127484980|NCT00269113|458741076|FG001|Overall Study|Protocol Violation|5|||
127484981|NCT00269113|458741075|FG000|Overall Study|Other|0|||
127484982|NCT00269113|458741076|FG001|Overall Study|Other|2|||
127484983|NCT00322049|458741077|FG000|Overall Study|Moved out of area|0|||
127484984|NCT00322049|458741078|FG001|Overall Study|Moved out of area|0|||
127484985|NCT00322049|458741079|FG002|Overall Study|Moved out of area|0|||
127484986|NCT00322049|458741080|FG003|Overall Study|Moved out of area|1|||
127484987|NCT00322049|458741077|FG000|Overall Study|Infected with Dengue during study|0|||
127484988|NCT00322049|458741078|FG001|Overall Study|Infected with Dengue during study|1|||
127485543|NCT01342094|458741219|FG001|Overall Study|Adverse Event|0|||
127484989|NCT00322049|458741079|FG002|Overall Study|Infected with Dengue during study|0|||
127484990|NCT00322049|458741080|FG003|Overall Study|Infected with Dengue during study|0|||
127484991|NCT00755807|458741081|FG000|Acute Phase|Adverse Event|16|||
127484992|NCT00755807|458741082|FG001|Acute Phase|Adverse Event|5|||
127484993|NCT00755807|458741081|FG000|Acute Phase|Protocol Violation|1|||
127484994|NCT00755807|458741082|FG001|Acute Phase|Protocol Violation|3|||
127976274|NCT01493284|460533167|FG000|Overall Study|Death|29|||
127484995|NCT00755807|458741081|FG000|Acute Phase|Withdrawal by Subject|1|||
127484996|NCT00755807|458741082|FG001|Acute Phase|Withdrawal by Subject|2|||
127484997|NCT00755807|458741081|FG000|Acute Phase|Lack of Efficacy|0|||
127484998|NCT00755807|458741082|FG001|Acute Phase|Lack of Efficacy|1|||
127484999|NCT00755807|458741081|FG000|Acute Phase|Physician Decision|0|||
127485000|NCT00755807|458741082|FG001|Acute Phase|Physician Decision|1|||
127485001|NCT00755807|458741081|FG000|Open-label Extension Phase|Adverse Event|7|||
127485002|NCT00755807|458741082|FG001|Open-label Extension Phase|Adverse Event|7|||
127485003|NCT00755807|458741081|FG000|Open-label Extension Phase|Protocol Violation|5|||
127485004|NCT00755807|458741082|FG001|Open-label Extension Phase|Protocol Violation|2|||
127485005|NCT00755807|458741081|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
127485006|NCT00755807|458741082|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
127485007|NCT00755807|458741081|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
127485008|NCT00755807|458741082|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
127485009|NCT00755807|458741081|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
127485010|NCT00755807|458741082|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
127485011|NCT00755807|458741081|FG000|Open-label Extension Phase|Sponsor Decision|0|||
127485012|NCT00755807|458741082|FG001|Open-label Extension Phase|Sponsor Decision|1|||
127485013|NCT05111145|458741089|FG000|Overall Study|Commercial drug is available for participant|76|||
127485014|NCT05111145|458741089|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
127485015|NCT02336815|458741090|FG000|Overall Study|Disease Progression|45|||
127485016|NCT02336815|458741091|FG001|Overall Study|Disease Progression|70|||
127485017|NCT02336815|458741090|FG000|Overall Study|Adverse Event|18|||
127485018|NCT02336815|458741091|FG001|Overall Study|Adverse Event|39|||
127485019|NCT02336815|458741090|FG000|Overall Study|Physician Decision|11|||
127485020|NCT02336815|458741091|FG001|Overall Study|Physician Decision|4|||
127485021|NCT02336815|458741090|FG000|Overall Study|Withdrawal by Subject|3|||
127485022|NCT02336815|458741091|FG001|Overall Study|Withdrawal by Subject|2|||
127485023|NCT02336815|458741090|FG000|Overall Study|Lost to Follow-up|1|||
127485024|NCT02336815|458741091|FG001|Overall Study|Lost to Follow-up|3|||
127485025|NCT02336815|458741090|FG000|Overall Study|Other|1|||
127485026|NCT02336815|458741091|FG001|Overall Study|Other|5|||
127485027|NCT00952705|458741092|FG000|Overall Study|Lost to Follow-up|24|||
127485028|NCT00952705|458741093|FG001|Overall Study|Lost to Follow-up|8|||
127485029|NCT00952705|458741094|FG002|Overall Study|Lost to Follow-up|9|||
127485030|NCT00952705|458741092|FG000|Overall Study|Withdrawal by Subject|2|||
127485031|NCT00952705|458741093|FG001|Overall Study|Withdrawal by Subject|1|||
127485032|NCT00952705|458741094|FG002|Overall Study|Withdrawal by Subject|1|||
127485033|NCT00952705|458741092|FG000|Overall Study|Death|2|||
127485034|NCT00952705|458741093|FG001|Overall Study|Death|0|||
127485035|NCT00952705|458741094|FG002|Overall Study|Death|0|||
127485036|NCT00952705|458741092|FG000|Overall Study|Incarcerated post dose|5|||
127485037|NCT00952705|458741093|FG001|Overall Study|Incarcerated post dose|0|||
127485038|NCT00952705|458741094|FG002|Overall Study|Incarcerated post dose|0|||
127485039|NCT00952705|458741092|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
127485040|NCT00952705|458741093|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
127485041|NCT00952705|458741094|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
127485042|NCT03759600|458741095|FG000|Overall Study|Adverse Event|2|||
127485043|NCT03759600|458741095|FG000|Overall Study|Progressive Disease|15|||
127485044|NCT03759600|458741095|FG000|Overall Study|Site Terminated by Sponsor|3|||
127485045|NCT05173974|458741096|FG000|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
127485046|NCT05173974|458741097|FG001|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
127485047|NCT05173974|458741098|FG002|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
127485048|NCT05173974|458741099|FG003|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|1|||
127485049|NCT05173974|458741096|FG000|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
127485050|NCT05173974|458741097|FG001|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|1|||
127485051|NCT05173974|458741098|FG002|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
127485052|NCT05173974|458741099|FG003|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
127485053|NCT03289143|458741101|FG000|Overall Study|Caregiver Unavailability|1|||
127485054|NCT03289143|458741102|FG001|Overall Study|Caregiver Unavailability|1|||
127485055|NCT03289143|458741103|FG002|Overall Study|Caregiver Unavailability|0|||
127485056|NCT03289143|458741104|FG003|Overall Study|Caregiver Unavailability|0|||
127485057|NCT03289143|458741101|FG000|Overall Study|Research Department Closure|0|||
127485058|NCT03289143|458741102|FG001|Overall Study|Research Department Closure|0|||
127485059|NCT03289143|458741103|FG002|Overall Study|Research Department Closure|1|||
127485060|NCT03289143|458741104|FG003|Overall Study|Research Department Closure|0|||
127485061|NCT03289143|458741101|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
127485062|NCT03289143|458741102|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
127485063|NCT03289143|458741103|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
127485064|NCT03289143|458741104|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
127485065|NCT03289143|458741101|FG000|Overall Study|Medical Monitor Decision|1|||
127485066|NCT03289143|458741102|FG001|Overall Study|Medical Monitor Decision|0|||
127485067|NCT03289143|458741103|FG002|Overall Study|Medical Monitor Decision|0|||
127485068|NCT03289143|458741104|FG003|Overall Study|Medical Monitor Decision|0|||
127485069|NCT03289143|458741101|FG000|Overall Study|Participant Non-Compliance|0|||
127485070|NCT03289143|458741102|FG001|Overall Study|Participant Non-Compliance|0|||
127485071|NCT03289143|458741103|FG002|Overall Study|Participant Non-Compliance|1|||
127485072|NCT03289143|458741104|FG003|Overall Study|Participant Non-Compliance|0|||
127485073|NCT03289143|458741101|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
127485074|NCT03289143|458741102|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
127485075|NCT03289143|458741103|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
127485076|NCT03289143|458741104|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
127485077|NCT03289143|458741101|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
127485078|NCT03289143|458741102|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
127485079|NCT03289143|458741103|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
127485080|NCT03289143|458741104|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
127485081|NCT03289143|458741101|FG000|Overall Study|Caregiver Passed Away|1|||
127485082|NCT03289143|458741102|FG001|Overall Study|Caregiver Passed Away|0|||
127485083|NCT03289143|458741103|FG002|Overall Study|Caregiver Passed Away|0|||
127485084|NCT03289143|458741104|FG003|Overall Study|Caregiver Passed Away|0|||
127485085|NCT03289143|458741101|FG000|Overall Study|Physician Decision|0|||
127485086|NCT03289143|458741102|FG001|Overall Study|Physician Decision|2|||
127485087|NCT03289143|458741103|FG002|Overall Study|Physician Decision|2|||
127485088|NCT03289143|458741104|FG003|Overall Study|Physician Decision|2|||
127485089|NCT03289143|458741101|FG000|Overall Study|Protocol Deviation|2|||
127485090|NCT03289143|458741102|FG001|Overall Study|Protocol Deviation|1|||
127485091|NCT03289143|458741103|FG002|Overall Study|Protocol Deviation|3|||
127485092|NCT03289143|458741104|FG003|Overall Study|Protocol Deviation|1|||
127485093|NCT03289143|458741101|FG000|Overall Study|Study Terminated By Sponsor|101|||
127485094|NCT03289143|458741102|FG001|Overall Study|Study Terminated By Sponsor|75|||
127485095|NCT03289143|458741103|FG002|Overall Study|Study Terminated By Sponsor|100|||
127485096|NCT03289143|458741104|FG003|Overall Study|Study Terminated By Sponsor|69|||
127485097|NCT03289143|458741101|FG000|Overall Study|Withdrawal by Subject|14|||
127485098|NCT03289143|458741102|FG001|Overall Study|Withdrawal by Subject|6|||
127485099|NCT03289143|458741103|FG002|Overall Study|Withdrawal by Subject|14|||
127485100|NCT03289143|458741104|FG003|Overall Study|Withdrawal by Subject|12|||
127485101|NCT03289143|458741101|FG000|Overall Study|Adverse Event|10|||
127485102|NCT03289143|458741102|FG001|Overall Study|Adverse Event|7|||
127485103|NCT03289143|458741103|FG002|Overall Study|Adverse Event|6|||
127485104|NCT03289143|458741104|FG003|Overall Study|Adverse Event|5|||
127485105|NCT03289143|458741101|FG000|Overall Study|Death|2|||
127485106|NCT03289143|458741102|FG001|Overall Study|Death|0|||
127485107|NCT03289143|458741103|FG002|Overall Study|Death|2|||
127485108|NCT03289143|458741104|FG003|Overall Study|Death|1|||
127485109|NCT03289143|458741101|FG000|Overall Study|Lost to Follow-up|2|||
127485110|NCT03289143|458741102|FG001|Overall Study|Lost to Follow-up|1|||
127485111|NCT03289143|458741103|FG002|Overall Study|Lost to Follow-up|1|||
127485112|NCT03289143|458741104|FG003|Overall Study|Lost to Follow-up|0|||
127485113|NCT03289143|458741101|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
127485114|NCT03289143|458741102|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
127485115|NCT03289143|458741103|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
127485116|NCT03289143|458741104|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
127485117|NCT03289143|458741101|FG000|Overall Study|Withdrawal by Caregiver|0|||
127485118|NCT03289143|458741102|FG001|Overall Study|Withdrawal by Caregiver|1|||
127485119|NCT03289143|458741103|FG002|Overall Study|Withdrawal by Caregiver|0|||
127485120|NCT03289143|458741104|FG003|Overall Study|Withdrawal by Caregiver|0|||
127485121|NCT03289143|458741101|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
127485122|NCT03289143|458741102|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
127485123|NCT03289143|458741103|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
127485124|NCT03289143|458741104|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
127485125|NCT03289143|458741101|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
127485126|NCT03289143|458741102|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
127485127|NCT03289143|458741103|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
127485128|NCT03289143|458741104|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
127485129|NCT00730756|458741105|FG000|Overall Study|Adverse Event|2|||
127485130|NCT00730756|458741106|FG001|Overall Study|Adverse Event|0|||
127485131|NCT00730756|458741105|FG000|Overall Study|Lack of Efficacy|1|||
127485132|NCT00730756|458741106|FG001|Overall Study|Lack of Efficacy|1|||
127485133|NCT00730756|458741105|FG000|Overall Study|Protocol Deviation|1|||
127485134|NCT00730756|458741106|FG001|Overall Study|Protocol Deviation|2|||
127485135|NCT00730756|458741105|FG000|Overall Study|Lost to Follow-up|0|||
127485136|NCT00730756|458741106|FG001|Overall Study|Lost to Follow-up|1|||
127485137|NCT00730756|458741105|FG000|Overall Study|Withdrew Consent|0|||
127485138|NCT00730756|458741106|FG001|Overall Study|Withdrew Consent|1|||
127485139|NCT00305877|458741107|FG000|Overall Study|Lack of Efficacy|6|||
127485140|NCT00305877|458741108|FG001|Overall Study|Lack of Efficacy|9|||
127485141|NCT00305877|458741107|FG000|Overall Study|Adverse Event|9|||
127485142|NCT00305877|458741108|FG001|Overall Study|Adverse Event|14|||
127485143|NCT00305877|458741107|FG000|Overall Study|Death|0|||
127485144|NCT00305877|458741108|FG001|Overall Study|Death|1|||
127485145|NCT00305877|458741107|FG000|Overall Study|Withdrawal by Subject|4|||
127485146|NCT00305877|458741108|FG001|Overall Study|Withdrawal by Subject|2|||
127485147|NCT00305877|458741107|FG000|Overall Study|Physician Decision|1|||
127485148|NCT00305877|458741108|FG001|Overall Study|Physician Decision|1|||
127485149|NCT00305877|458741107|FG000|Overall Study|Never start treatment|2|||
127485150|NCT00305877|458741108|FG001|Overall Study|Never start treatment|5|||
127485151|NCT00305877|458741107|FG000|Overall Study|Ineligible|2|||
127485152|NCT00305877|458741108|FG001|Overall Study|Ineligible|1|||
127485153|NCT00305877|458741107|FG000|Overall Study|Transportation issue with daily RT|0|||
127485154|NCT00305877|458741108|FG001|Overall Study|Transportation issue with daily RT|1|||
127485155|NCT01126190|458741111|FG000|Double-Blind Phase|Death|0|||
127485156|NCT01126190|458741112|FG001|Double-Blind Phase|Death|1|||
127485157|NCT01126190|458741113|FG002|Double-Blind Phase|Death|0|||
127485158|NCT01126190|458741111|FG000|Double-Blind Phase|Adverse Event|1|||
127485159|NCT01126190|458741112|FG001|Double-Blind Phase|Adverse Event|2|||
127485160|NCT01126190|458741113|FG002|Double-Blind Phase|Adverse Event|0|||
127485161|NCT01126190|458741111|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
127485162|NCT01126190|458741112|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
127485163|NCT01126190|458741113|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
127485164|NCT01126190|458741111|FG000|Double-Blind Phase|Request of Investigator|1|||
127485165|NCT01126190|458741112|FG001|Double-Blind Phase|Request of Investigator|0|||
127485166|NCT01126190|458741113|FG002|Double-Blind Phase|Request of Investigator|0|||
127485167|NCT01126190|458741111|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
127485168|NCT01126190|458741112|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
127485169|NCT01126190|458741113|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
127485170|NCT01126190|458741111|FG000|Double-Blind Phase|Non-compliance|1|||
127485171|NCT01126190|458741112|FG001|Double-Blind Phase|Non-compliance|0|||
127485172|NCT01126190|458741113|FG002|Double-Blind Phase|Non-compliance|0|||
127485173|NCT01126190|458741111|FG000|Double-Blind Phase|Lost to Follow-up|1|||
127485174|NCT01126190|458741112|FG001|Double-Blind Phase|Lost to Follow-up|3|||
127485175|NCT01126190|458741113|FG002|Double-Blind Phase|Lost to Follow-up|0|||
127485176|NCT01126190|458741111|FG000|Open-Label Phase|Death|0|||
127485177|NCT01126190|458741112|FG001|Open-Label Phase|Death|0|||
127485178|NCT01126190|458741113|FG002|Open-Label Phase|Death|1|||
127485179|NCT01126190|458741111|FG000|Open-Label Phase|Adverse Event|0|||
127485180|NCT01126190|458741112|FG001|Open-Label Phase|Adverse Event|0|||
127485181|NCT01126190|458741113|FG002|Open-Label Phase|Adverse Event|4|||
127485182|NCT01126190|458741111|FG000|Open-Label Phase|Withdrawal by Subject|0|||
127485183|NCT01126190|458741112|FG001|Open-Label Phase|Withdrawal by Subject|0|||
127485184|NCT01126190|458741113|FG002|Open-Label Phase|Withdrawal by Subject|6|||
127485185|NCT00524121|458741114|FG000|Overall Study|Disease progression|6|||
127485186|NCT00524121|458741114|FG000|Overall Study|Adverse Event|4|||
127485187|NCT00524121|458741114|FG000|Overall Study|Patient refused|2|||
127485188|NCT00524121|458741114|FG000|Overall Study|Other|1|||
127485189|NCT00524121|458741114|FG000|Overall Study|Death|1|||
127485190|NCT00524121|458741114|FG000|Overall Study|Not treated (became ineligible)|4|||
127485191|NCT00524121|458741114|FG000|Overall Study|Not treated (changed mind)|1|||
127485192|NCT01114737|458741115|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
127485193|NCT01114737|458741116|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
127485194|NCT01114737|458741115|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
127485195|NCT01114737|458741116|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
127485196|NCT01114737|458741115|FG000|Randomized Treatment Period|Pregnancy|1|||
127485197|NCT01114737|458741116|FG001|Randomized Treatment Period|Pregnancy|0|||
127485198|NCT01114737|458741115|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
127485199|NCT01114737|458741116|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
127485200|NCT01114737|458741115|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
127485201|NCT01114737|458741116|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
127485202|NCT01114737|458741115|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
127485203|NCT01114737|458741116|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
127485204|NCT01446874|458741117|FG000|Overall Study|Not eligible|1|||
127485205|NCT01446874|458741118|FG001|Overall Study|Not eligible|0|||
127485206|NCT01446874|458741119|FG002|Overall Study|Not eligible|0|||
127485207|NCT01446874|458741117|FG000|Overall Study|No surgery/No qualifying surgery|1|||
127485208|NCT01446874|458741118|FG001|Overall Study|No surgery/No qualifying surgery|0|||
127485209|NCT01446874|458741119|FG002|Overall Study|No surgery/No qualifying surgery|12|||
127485210|NCT01446874|458741117|FG000|Overall Study|Non-compliance|0|||
127485211|NCT01446874|458741118|FG001|Overall Study|Non-compliance|4|||
127485212|NCT01446874|458741119|FG002|Overall Study|Non-compliance|0|||
127485213|NCT01446874|458741117|FG000|Overall Study|Antibiotics for pre-op infection|0|||
127485214|NCT01446874|458741118|FG001|Overall Study|Antibiotics for pre-op infection|0|||
127485215|NCT01446874|458741119|FG002|Overall Study|Antibiotics for pre-op infection|2|||
127485216|NCT01446874|458741117|FG000|Overall Study|Withdrawal by Subject|0|||
127485217|NCT01446874|458741118|FG001|Overall Study|Withdrawal by Subject|0|||
127485218|NCT01446874|458741119|FG002|Overall Study|Withdrawal by Subject|4|||
127485219|NCT00457392|458741120|FG000|Overall Study|Objective Progression or Relapse|229|||
127485220|NCT00457392|458741121|FG001|Overall Study|Objective Progression or Relapse|296|||
127485221|NCT00457392|458741120|FG000|Overall Study|Death|106|||
127485222|NCT00457392|458741121|FG001|Overall Study|Death|106|||
127485223|NCT00457392|458741120|FG000|Overall Study|Adverse Event|84|||
127485224|NCT00457392|458741121|FG001|Overall Study|Adverse Event|41|||
127485225|NCT00457392|458741120|FG000|Overall Study|Global Deterioration of Health Status|22|||
127485226|NCT00457392|458741121|FG001|Overall Study|Global Deterioration of Health Status|8|||
127485227|NCT00457392|458741120|FG000|Overall Study|Withdrawal by Subject|14|||
127485228|NCT00457392|458741121|FG001|Overall Study|Withdrawal by Subject|8|||
127485229|NCT00457392|458741120|FG000|Overall Study|Lost to Follow-up|6|||
127976275|NCT01493284|460533167|FG000|Overall Study|Withdrawal by Subject|32|||
127976276|NCT00325156|460533170|FG000|Overall Study|Protocol Violation|8|||
127485230|NCT00457392|458741121|FG001|Overall Study|Lost to Follow-up|7|||
127485231|NCT00457392|458741120|FG000|Overall Study|Protocol Violation|4|||
127485232|NCT00457392|458741121|FG001|Overall Study|Protocol Violation|3|||
127485233|NCT00457392|458741120|FG000|Overall Study|Other|7|||
127485234|NCT00457392|458741121|FG001|Overall Study|Other|4|||
127485235|NCT00457392|458741120|FG000|Overall Study|Study Terminated by Sponsor|1|||
127485236|NCT00457392|458741121|FG001|Overall Study|Study Terminated by Sponsor|4|||
127485237|NCT00457392|458741120|FG000|Overall Study|Randomized, Not Treated|7|||
127485238|NCT00457392|458741121|FG001|Overall Study|Randomized, Not Treated|3|||
127485239|NCT05518461|458741124|FG000|Overall Study|Lost to Follow-up|25|||
127485240|NCT03179761|458741125|FG000|Overall Study|Death|2|||
127485241|NCT03179761|458741126|FG001|Overall Study|Death|5|||
127485242|NCT03179761|458741125|FG000|Overall Study|Lost to Follow-up|2|||
127485243|NCT03179761|458741126|FG001|Overall Study|Lost to Follow-up|2|||
127485244|NCT03179761|458741125|FG000|Overall Study|Protocol Violation|1|||
127485245|NCT03179761|458741126|FG001|Overall Study|Protocol Violation|0|||
127485246|NCT03179761|458741125|FG000|Overall Study|Withdrawal by Subject|1|||
127485247|NCT03179761|458741126|FG001|Overall Study|Withdrawal by Subject|4|||
127485248|NCT03179761|458741125|FG000|Overall Study|Investigator Request|0|||
127485249|NCT03179761|458741126|FG001|Overall Study|Investigator Request|2|||
127485250|NCT00448448|458741128|FG000|Overall Study|Withdrawal by Subject|13|||
127485251|NCT00448448|458741129|FG001|Overall Study|Withdrawal by Subject|2|||
127485252|NCT00448448|458741128|FG000|Overall Study|On protocol when study ended|83|||
127485253|NCT00448448|458741129|FG001|Overall Study|On protocol when study ended|36|||
127485254|NCT00448448|458741128|FG000|Overall Study|Lost to Follow-up|2|||
127485255|NCT00448448|458741129|FG001|Overall Study|Lost to Follow-up|1|||
127485256|NCT00448448|458741128|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
127485257|NCT00448448|458741129|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
127485258|NCT00448448|458741128|FG000|Overall Study|Signed consent lost|0|||
127485259|NCT00448448|458741129|FG001|Overall Study|Signed consent lost|1|||
127485260|NCT02284191|458741130|FG000|Overall Study|Withdrawal by Subject|1|||
127485261|NCT02284191|458741131|FG001|Overall Study|Withdrawal by Subject|3|||
127485262|NCT02284191|458741130|FG000|Overall Study|Lost to Follow-up|1|||
127485263|NCT02284191|458741131|FG001|Overall Study|Lost to Follow-up|0|||
127485264|NCT01188967|458741132|FG000|Overall Study|Withdrawal by Subject|1|||
127485265|NCT01188967|458741133|FG001|Overall Study|Withdrawal by Subject|1|||
127485266|NCT01188967|458741132|FG000|Overall Study|Physician Decision|1|||
127485267|NCT01188967|458741133|FG001|Overall Study|Physician Decision|1|||
127485268|NCT01188967|458741132|FG000|Overall Study|Lost to Follow-up|3|||
127485269|NCT01188967|458741133|FG001|Overall Study|Lost to Follow-up|2|||
127485270|NCT01832727|458741136|FG000|Overall Study|Adverse Event|4|||
127485271|NCT01832727|458741137|FG001|Overall Study|Adverse Event|6|||
127485272|NCT01832727|458741138|FG002|Overall Study|Adverse Event|1|||
127485273|NCT01832727|458741139|FG003|Overall Study|Adverse Event|0|||
127485274|NCT01832727|458741140|FG004|Overall Study|Adverse Event|1|||
127485275|NCT01832727|458741141|FG005|Overall Study|Adverse Event|1|||
127485276|NCT01832727|458741142|FG006|Overall Study|Adverse Event|2|||
127485277|NCT01832727|458741143|FG007|Overall Study|Adverse Event|1|||
127485278|NCT01832727|458741144|FG008|Overall Study|Adverse Event|9|||
127485279|NCT01832727|458741136|FG000|Overall Study|Disease progression|3|||
127485280|NCT01832727|458741137|FG001|Overall Study|Disease progression|0|||
127485281|NCT01832727|458741138|FG002|Overall Study|Disease progression|2|||
127485282|NCT01832727|458741139|FG003|Overall Study|Disease progression|1|||
127485283|NCT01832727|458741140|FG004|Overall Study|Disease progression|3|||
127485284|NCT01832727|458741141|FG005|Overall Study|Disease progression|3|||
127485285|NCT01832727|458741142|FG006|Overall Study|Disease progression|6|||
127485286|NCT01832727|458741143|FG007|Overall Study|Disease progression|2|||
127485287|NCT01832727|458741144|FG008|Overall Study|Disease progression|7|||
127485288|NCT01832727|458741136|FG000|Overall Study|Lost to Follow-up|0|||
127485289|NCT01832727|458741137|FG001|Overall Study|Lost to Follow-up|0|||
127485290|NCT01832727|458741138|FG002|Overall Study|Lost to Follow-up|0|||
127485291|NCT01832727|458741139|FG003|Overall Study|Lost to Follow-up|1|||
127485292|NCT01832727|458741140|FG004|Overall Study|Lost to Follow-up|0|||
127485293|NCT01832727|458741141|FG005|Overall Study|Lost to Follow-up|0|||
127485294|NCT01832727|458741142|FG006|Overall Study|Lost to Follow-up|0|||
127485295|NCT01832727|458741143|FG007|Overall Study|Lost to Follow-up|0|||
127485296|NCT01832727|458741144|FG008|Overall Study|Lost to Follow-up|0|||
127485297|NCT01832727|458741136|FG000|Overall Study|Physician Decision|1|||
127485298|NCT01832727|458741137|FG001|Overall Study|Physician Decision|0|||
127485299|NCT01832727|458741138|FG002|Overall Study|Physician Decision|0|||
127485300|NCT01832727|458741139|FG003|Overall Study|Physician Decision|1|||
127485301|NCT01832727|458741140|FG004|Overall Study|Physician Decision|0|||
127485302|NCT01832727|458741141|FG005|Overall Study|Physician Decision|1|||
127485303|NCT01832727|458741142|FG006|Overall Study|Physician Decision|0|||
127485304|NCT01832727|458741143|FG007|Overall Study|Physician Decision|0|||
127485305|NCT01832727|458741144|FG008|Overall Study|Physician Decision|0|||
127485306|NCT01832727|458741136|FG000|Overall Study|Withdrawal by Subject|1|||
127485307|NCT01832727|458741137|FG001|Overall Study|Withdrawal by Subject|1|||
127485308|NCT01832727|458741138|FG002|Overall Study|Withdrawal by Subject|0|||
127485309|NCT01832727|458741139|FG003|Overall Study|Withdrawal by Subject|1|||
127485310|NCT01832727|458741140|FG004|Overall Study|Withdrawal by Subject|0|||
127485311|NCT01832727|458741141|FG005|Overall Study|Withdrawal by Subject|1|||
127485312|NCT01832727|458741142|FG006|Overall Study|Withdrawal by Subject|0|||
127485313|NCT01832727|458741143|FG007|Overall Study|Withdrawal by Subject|2|||
127485314|NCT01832727|458741144|FG008|Overall Study|Withdrawal by Subject|1|||
127485315|NCT01832727|458741136|FG000|Overall Study|Study terminated by sponsor|0|||
127485316|NCT01832727|458741137|FG001|Overall Study|Study terminated by sponsor|0|||
127485317|NCT01832727|458741138|FG002|Overall Study|Study terminated by sponsor|0|||
127485318|NCT01832727|458741139|FG003|Overall Study|Study terminated by sponsor|0|||
127485319|NCT01832727|458741140|FG004|Overall Study|Study terminated by sponsor|0|||
127485320|NCT01832727|458741141|FG005|Overall Study|Study terminated by sponsor|0|||
127485321|NCT01832727|458741142|FG006|Overall Study|Study terminated by sponsor|0|||
127485322|NCT01832727|458741143|FG007|Overall Study|Study terminated by sponsor|1|||
127485323|NCT01832727|458741144|FG008|Overall Study|Study terminated by sponsor|1|||
127485324|NCT02216526|458741145|FG000|Overall Study|Adverse Event|1|||
127485325|NCT02216526|458741146|FG001|Overall Study|Adverse Event|1|||
127485326|NCT02216526|458741147|FG002|Overall Study|Adverse Event|0|||
127485327|NCT02216526|458741145|FG000|Overall Study|Death|0|||
127485328|NCT02216526|458741146|FG001|Overall Study|Death|1|||
127485329|NCT02216526|458741147|FG002|Overall Study|Death|3|||
127485330|NCT02216526|458741145|FG000|Overall Study|Protocol Violation|2|||
127485331|NCT02216526|458741146|FG001|Overall Study|Protocol Violation|0|||
127485332|NCT02216526|458741147|FG002|Overall Study|Protocol Violation|2|||
127485333|NCT02216526|458741145|FG000|Overall Study|Hospitalization|2|||
127485334|NCT02216526|458741146|FG001|Overall Study|Hospitalization|1|||
127485335|NCT02216526|458741147|FG002|Overall Study|Hospitalization|3|||
127485336|NCT04436744|458741151|FG000|Overall Study|Adverse Event|1|||
127485337|NCT04436744|458741152|FG001|Overall Study|Adverse Event|1|||
127485338|NCT04436744|458741151|FG000|Overall Study|Death|1|||
127485339|NCT04436744|458741152|FG001|Overall Study|Death|0|||
127485340|NCT04436744|458741151|FG000|Overall Study|Lost to Follow-up|0|||
127485341|NCT04436744|458741152|FG001|Overall Study|Lost to Follow-up|2|||
127485342|NCT04436744|458741151|FG000|Overall Study|Physician Decision|0|||
127485343|NCT04436744|458741152|FG001|Overall Study|Physician Decision|1|||
127485344|NCT04436744|458741151|FG000|Overall Study|Progressive Disease|0|||
127485345|NCT04436744|458741152|FG001|Overall Study|Progressive Disease|4|||
127485346|NCT04436744|458741151|FG000|Overall Study|Protocol Deviation|1|||
127485347|NCT04436744|458741152|FG001|Overall Study|Protocol Deviation|1|||
127485348|NCT04436744|458741151|FG000|Overall Study|Withdrawal by Subject|1|||
127485349|NCT04436744|458741152|FG001|Overall Study|Withdrawal by Subject|2|||
127485350|NCT01133847|458741156|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
127485351|NCT01133847|458741157|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
127485352|NCT01133847|458741158|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
127485353|NCT01133847|458741156|FG000|Follow-Up Phase|Lost to Follow-up|1|||
127485354|NCT01133847|458741157|FG001|Follow-Up Phase|Lost to Follow-up|3|||
127485355|NCT01133847|458741158|FG002|Follow-Up Phase|Lost to Follow-up|7|||
127485356|NCT01463033|458741159|FG000|Overall Study|Lost to Follow-up|4|||
127976277|NCT00325156|460533170|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
127485357|NCT01463033|458741160|FG001|Overall Study|Lost to Follow-up|4|||
127485358|NCT01463033|458741159|FG000|Overall Study|Death|3|||
127485359|NCT01463033|458741160|FG001|Overall Study|Death|2|||
127485360|NCT00967616|458741161|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
127485361|NCT00967616|458741162|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
127485362|NCT00967616|458741161|FG000|Overall Study|Death|0|||
127485363|NCT00967616|458741162|FG001|Overall Study|Death|3|||
127485364|NCT00967616|458741161|FG000|Overall Study|Withdrawal by Subject|8|||
127485365|NCT00967616|458741162|FG001|Overall Study|Withdrawal by Subject|4|||
127485366|NCT00967616|458741161|FG000|Overall Study|Progressive Disease|31|||
127485367|NCT00967616|458741162|FG001|Overall Study|Progressive Disease|18|||
127485368|NCT00967616|458741161|FG000|Overall Study|Other|8|||
127485369|NCT00967616|458741162|FG001|Overall Study|Other|8|||
127485370|NCT00967616|458741161|FG000|Overall Study|Protocol Violation|1|||
127485371|NCT00967616|458741162|FG001|Overall Study|Protocol Violation|0|||
127485372|NCT01368614|458741163|FG000|Screening Period|Screen Failure|58|||
127485373|NCT01368614|458741164|FG001|Screening Period|Screen Failure|0|||
127485374|NCT01368614|458741165|FG002|Screening Period|Screen Failure|0|||
127485375|NCT01368614|458741166|FG003|Screening Period|Screen Failure|0|||
127485376|NCT01368614|458741163|FG000|Study Period|Withdrawal by Subject|0|||
127485377|NCT01368614|458741164|FG001|Study Period|Withdrawal by Subject|1|||
127485378|NCT01368614|458741165|FG002|Study Period|Withdrawal by Subject|1|||
127485379|NCT01368614|458741166|FG003|Study Period|Withdrawal by Subject|3|||
127485380|NCT01368614|458741163|FG000|Study Period|Lost to Follow-up|0|||
127485381|NCT01368614|458741164|FG001|Study Period|Lost to Follow-up|0|||
127485382|NCT01368614|458741165|FG002|Study Period|Lost to Follow-up|1|||
127485383|NCT01368614|458741166|FG003|Study Period|Lost to Follow-up|0|||
127485384|NCT02951780|458741167|FG000|Period 1|Adverse Event|0|||
127485385|NCT02951780|458741168|FG001|Period 1|Adverse Event|0|||
127485386|NCT02951780|458741169|FG002|Period 1|Adverse Event|0|||
127485387|NCT02951780|458741170|FG003|Period 1|Adverse Event|1|||
127485388|NCT02951780|458741171|FG004|Period 1|Adverse Event|0|||
127485389|NCT02951780|458741172|FG005|Period 1|Adverse Event|0|||
127485390|NCT02951780|458741173|FG006|Period 1|Adverse Event|0|||
127485391|NCT02951780|458741174|FG007|Period 1|Adverse Event|0|||
127485392|NCT02951780|458741175|FG008|Period 1|Adverse Event|0|||
127485393|NCT02951780|458741167|FG000|Period 1|Scheduling Conflicts|0|||
127485394|NCT02951780|458741168|FG001|Period 1|Scheduling Conflicts|0|||
127485395|NCT02951780|458741169|FG002|Period 1|Scheduling Conflicts|0|||
127485396|NCT02951780|458741170|FG003|Period 1|Scheduling Conflicts|0|||
127485397|NCT02951780|458741171|FG004|Period 1|Scheduling Conflicts|0|||
127485398|NCT02951780|458741172|FG005|Period 1|Scheduling Conflicts|0|||
127485399|NCT02951780|458741173|FG006|Period 1|Scheduling Conflicts|0|||
127485400|NCT02951780|458741174|FG007|Period 1|Scheduling Conflicts|1|||
127485401|NCT02951780|458741175|FG008|Period 1|Scheduling Conflicts|0|||
127485402|NCT02951780|458741167|FG000|Period 2|Scheduling Conflicts|0|||
127485403|NCT02951780|458741168|FG001|Period 2|Scheduling Conflicts|0|||
127485404|NCT02951780|458741169|FG002|Period 2|Scheduling Conflicts|0|||
127485405|NCT02951780|458741170|FG003|Period 2|Scheduling Conflicts|0|||
127485406|NCT02951780|458741171|FG004|Period 2|Scheduling Conflicts|0|||
127485407|NCT02951780|458741172|FG005|Period 2|Scheduling Conflicts|0|||
127485408|NCT02951780|458741173|FG006|Period 2|Scheduling Conflicts|0|||
127485409|NCT02951780|458741174|FG007|Period 2|Scheduling Conflicts|1|||
127485410|NCT02951780|458741175|FG008|Period 2|Scheduling Conflicts|0|||
127485411|NCT01374425|458741176|FG000|Overall Study|Radiographic Disease Progression|86|||
127485412|NCT01374425|458741177|FG001|Overall Study|Radiographic Disease Progression|81|||
127485413|NCT01374425|458741176|FG000|Overall Study|Clinical Disease Progression|9|||
127485414|NCT01374425|458741177|FG001|Overall Study|Clinical Disease Progression|6|||
127485415|NCT01374425|458741176|FG000|Overall Study|Adverse Event|29|||
127485416|NCT01374425|458741177|FG001|Overall Study|Adverse Event|18|||
127485417|NCT01374425|458741176|FG000|Overall Study|Death (Progression of Disease)|1|||
127485418|NCT01374425|458741177|FG001|Overall Study|Death (Progression of Disease)|0|||
127485419|NCT01374425|458741176|FG000|Overall Study|Death (Adverse Event)|2|||
127485420|NCT01374425|458741177|FG001|Overall Study|Death (Adverse Event)|4|||
127485421|NCT01374425|458741176|FG000|Overall Study|Withdrawal by Subject|6|||
127485422|NCT01374425|458741177|FG001|Overall Study|Withdrawal by Subject|7|||
127485423|NCT01374425|458741176|FG000|Overall Study|Refused Treatment|10|||
127485424|NCT01374425|458741177|FG001|Overall Study|Refused Treatment|24|||
127485425|NCT01374425|458741176|FG000|Overall Study|Protocol Violation|2|||
127485426|NCT01374425|458741177|FG001|Overall Study|Protocol Violation|3|||
127485427|NCT01374425|458741176|FG000|Overall Study|Sponsor Decision|0|||
127485428|NCT01374425|458741177|FG001|Overall Study|Sponsor Decision|1|||
127485429|NCT01374425|458741176|FG000|Overall Study|Lost to Follow-up|2|||
127485430|NCT01374425|458741177|FG001|Overall Study|Lost to Follow-up|1|||
127485431|NCT01374425|458741176|FG000|Overall Study|Other|41|||
127485432|NCT01374425|458741177|FG001|Overall Study|Other|43|||
127485433|NCT02271529|458741180|FG000|Overall Study|Withdrawal by Subject|1|||
127485434|NCT01240863|458741181|FG000|Open-label Titration Period|Adverse Event|47|||
127485435|NCT01240863|458741182|FG001|Open-label Titration Period|Adverse Event|0|||
127485436|NCT01240863|458741183|FG002|Open-label Titration Period|Adverse Event|0|||
127485437|NCT01240863|458741181|FG000|Open-label Titration Period|Lack of Efficacy|19|||
127485438|NCT01240863|458741182|FG001|Open-label Titration Period|Lack of Efficacy|0|||
127485439|NCT01240863|458741183|FG002|Open-label Titration Period|Lack of Efficacy|0|||
127485440|NCT01240863|458741181|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
127485441|NCT01240863|458741182|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
127485442|NCT01240863|458741183|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
127485443|NCT01240863|458741181|FG000|Open-label Titration Period|Protocol Violation|7|||
127485444|NCT01240863|458741182|FG001|Open-label Titration Period|Protocol Violation|0|||
127485445|NCT01240863|458741183|FG002|Open-label Titration Period|Protocol Violation|0|||
127485544|NCT01342094|458741218|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
127485545|NCT01342094|458741219|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
127485546|NCT01342094|458741218|FG000|Overall Study|Withdrawal by Subject|0|||
127485547|NCT01342094|458741219|FG001|Overall Study|Withdrawal by Subject|2|||
127485548|NCT02121509|458741224|FG000|Washout Period (35 Days)|Adverse Event|1|||
127485549|NCT02121509|458741225|FG001|Washout Period (35 Days)|Adverse Event|1|||
127485550|NCT02121509|458741226|FG002|Washout Period (35 Days)|Adverse Event|0|||
127485551|NCT02121509|458741227|FG003|Washout Period (35 Days)|Adverse Event|0|||
127485552|NCT02121509|458741224|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
127485553|NCT02121509|458741225|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
127485554|NCT02121509|458741226|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
127485555|NCT02121509|458741227|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
127485556|NCT02121509|458741224|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
127485557|NCT02121509|458741225|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
127485558|NCT02121509|458741226|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
127485559|NCT02121509|458741227|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
127485560|NCT04021290|458741232|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
127485561|NCT04021290|458741233|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
127485562|NCT04021290|458741234|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
127485563|NCT04021290|458741232|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
127485564|NCT04021290|458741233|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
127485565|NCT04021290|458741234|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
127485566|NCT04021290|458741232|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
127485567|NCT04021290|458741233|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
127485568|NCT04021290|458741234|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
127485569|NCT04021290|458741232|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
127485570|NCT04021290|458741233|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
127485571|NCT04021290|458741234|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
127485572|NCT04021290|458741232|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
127485573|NCT04021290|458741233|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
127485574|NCT04021290|458741234|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
127485575|NCT04021290|458741232|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
127485576|NCT04021290|458741233|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
127485577|NCT04021290|458741234|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
127485578|NCT04021290|458741232|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
127485579|NCT04021290|458741233|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
127485580|NCT04021290|458741234|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
127485581|NCT04021290|458741232|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
127485582|NCT04021290|458741233|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
127485583|NCT04021290|458741234|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
127485584|NCT04021290|458741232|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
127485585|NCT04021290|458741233|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
127485586|NCT04021290|458741234|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
127485587|NCT04021290|458741232|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
127485588|NCT04021290|458741233|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
127485589|NCT04021290|458741234|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
127485590|NCT04021290|458741232|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
127485591|NCT04021290|458741233|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
127485592|NCT04021290|458741234|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
127485593|NCT04021290|458741232|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
127485594|NCT04021290|458741233|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
127485595|NCT04021290|458741234|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
127485596|NCT00636181|458741235|FG000|Overall Study|Withdrawal by Subject|8|||
127485597|NCT00636181|458741236|FG001|Overall Study|Withdrawal by Subject|6|||
127485598|NCT00636181|458741237|FG002|Overall Study|Withdrawal by Subject|10|||
127485599|NCT03069716|458741240|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
127485600|NCT03069716|458741241|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
127485601|NCT03069716|458741242|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
127485602|NCT03069716|458741240|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
127485603|NCT03069716|458741241|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
127485604|NCT03069716|458741242|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
127485605|NCT03069716|458741240|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
127485606|NCT03069716|458741241|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
127485607|NCT03069716|458741242|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
127485608|NCT03069716|458741240|FG000|Randomized Treatment|Withdrawal by Subject|0|||
127485609|NCT03069716|458741241|FG001|Randomized Treatment|Withdrawal by Subject|2|||
127485610|NCT03069716|458741242|FG002|Randomized Treatment|Withdrawal by Subject|0|||
127485611|NCT05076045|458741248|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
127485612|NCT05076045|458741249|FG001|Washout (1 Week)|Withdrawal by Subject|3|||
127485613|NCT03391882|458741250|FG000|Study Overall|Adverse Event|3|||
127485614|NCT03391882|458741251|FG001|Study Overall|Adverse Event|6|||
127485615|NCT03391882|458741252|FG002|Study Overall|Adverse Event|1|||
127485616|NCT03391882|458741253|FG003|Study Overall|Adverse Event|1|||
127485617|NCT03391882|458741254|FG004|Study Overall|Adverse Event|3|||
127485618|NCT03391882|458741255|FG005|Study Overall|Adverse Event|1|||
127485619|NCT03391882|458741250|FG000|Study Overall|Lack of Efficacy|13|||
127485620|NCT03391882|458741251|FG001|Study Overall|Lack of Efficacy|9|||
127485621|NCT03391882|458741252|FG002|Study Overall|Lack of Efficacy|0|||
127485622|NCT03391882|458741253|FG003|Study Overall|Lack of Efficacy|0|||
127485623|NCT03391882|458741254|FG004|Study Overall|Lack of Efficacy|0|||
127485624|NCT03391882|458741255|FG005|Study Overall|Lack of Efficacy|0|||
127485625|NCT03391882|458741250|FG000|Study Overall|Withdrawal by Subject|3|||
127485626|NCT03391882|458741251|FG001|Study Overall|Withdrawal by Subject|3|||
127485627|NCT03391882|458741252|FG002|Study Overall|Withdrawal by Subject|2|||
127485628|NCT03391882|458741253|FG003|Study Overall|Withdrawal by Subject|2|||
127485629|NCT03391882|458741254|FG004|Study Overall|Withdrawal by Subject|1|||
127485630|NCT03391882|458741255|FG005|Study Overall|Withdrawal by Subject|3|||
127485631|NCT03391882|458741250|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
127485632|NCT03391882|458741251|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
127485633|NCT03391882|458741252|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
127485634|NCT03391882|458741253|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
127485635|NCT03391882|458741254|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
127485636|NCT03391882|458741255|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
127485637|NCT03391882|458741250|FG000|Study Overall|Protocol Violation|1|||
127485638|NCT03391882|458741251|FG001|Study Overall|Protocol Violation|0|||
127485639|NCT03391882|458741252|FG002|Study Overall|Protocol Violation|0|||
127485640|NCT03391882|458741253|FG003|Study Overall|Protocol Violation|0|||
127485641|NCT03391882|458741254|FG004|Study Overall|Protocol Violation|0|||
127485642|NCT03391882|458741255|FG005|Study Overall|Protocol Violation|0|||
127485643|NCT03391882|458741250|FG000|Part A - Titration Phase|Adverse Event|3|||
127485644|NCT03391882|458741251|FG001|Part A - Titration Phase|Adverse Event|6|||
127485645|NCT03391882|458741252|FG002|Part A - Titration Phase|Adverse Event|0|||
127485646|NCT03391882|458741253|FG003|Part A - Titration Phase|Adverse Event|0|||
127485647|NCT03391882|458741254|FG004|Part A - Titration Phase|Adverse Event|0|||
127485648|NCT03391882|458741255|FG005|Part A - Titration Phase|Adverse Event|0|||
127485649|NCT03391882|458741250|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
127485650|NCT03391882|458741251|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
127485651|NCT03391882|458741252|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
127976458|NCT03535194|460536129|FG004|Maintenance Period|Lack of Efficacy|0|||
127976459|NCT03535194|460536125|FG000|Maintenance Period|Lost to Follow-up|4|||
127976460|NCT03535194|460536126|FG001|Maintenance Period|Lost to Follow-up|2|||
127976461|NCT03535194|460536127|FG002|Maintenance Period|Lost to Follow-up|1|||
127976462|NCT03535194|460536128|FG003|Maintenance Period|Lost to Follow-up|5|||
127976463|NCT03535194|460536129|FG004|Maintenance Period|Lost to Follow-up|2|||
127976464|NCT03535194|460536125|FG000|Maintenance Period|Other|1|||
127976465|NCT03535194|460536126|FG001|Maintenance Period|Other|2|||
127485652|NCT03391882|458741253|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
127485653|NCT03391882|458741254|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
127485654|NCT03391882|458741255|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
127485655|NCT03391882|458741250|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
127485656|NCT03391882|458741251|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
127485657|NCT03391882|458741252|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
127485658|NCT03391882|458741253|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
127485659|NCT03391882|458741254|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
127485660|NCT03391882|458741255|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
127976466|NCT03535194|460536127|FG002|Maintenance Period|Other|0|||
127976467|NCT03535194|460536128|FG003|Maintenance Period|Other|0|||
127976468|NCT03535194|460536129|FG004|Maintenance Period|Other|0|||
127976469|NCT03535194|460536125|FG000|Maintenance Period|Physician Decision|1|||
127485661|NCT03391882|458741250|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
127485662|NCT03391882|458741251|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
127485663|NCT03391882|458741252|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
127485664|NCT03391882|458741253|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
127485665|NCT03391882|458741254|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
127485666|NCT03391882|458741255|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
127485667|NCT03391882|458741250|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
127485668|NCT03391882|458741251|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
127485669|NCT03391882|458741252|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
127485670|NCT03391882|458741253|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
127485671|NCT03391882|458741254|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
127485672|NCT03391882|458741255|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
127485673|NCT03391882|458741250|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
127976470|NCT03535194|460536126|FG001|Maintenance Period|Physician Decision|2|||
127485674|NCT03391882|458741251|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
127485675|NCT03391882|458741252|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
127485676|NCT03391882|458741253|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
127485677|NCT03391882|458741254|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
127485678|NCT03391882|458741255|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
127485679|NCT03391882|458741250|FG000|Part B - Treatment Phase|Adverse Event|0|||
127485680|NCT03391882|458741251|FG001|Part B - Treatment Phase|Adverse Event|0|||
127485681|NCT03391882|458741252|FG002|Part B - Treatment Phase|Adverse Event|1|||
127485682|NCT03391882|458741253|FG003|Part B - Treatment Phase|Adverse Event|1|||
127485683|NCT03391882|458741254|FG004|Part B - Treatment Phase|Adverse Event|3|||
127485684|NCT03391882|458741255|FG005|Part B - Treatment Phase|Adverse Event|1|||
127485685|NCT03391882|458741250|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
127485686|NCT03391882|458741251|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
127485687|NCT03391882|458741252|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
127485688|NCT03391882|458741253|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
127485689|NCT03391882|458741254|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
127485690|NCT03391882|458741255|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
127485691|NCT03913130|458741256|FG000|Overall Study|Sponsor Decision|1|||
127485692|NCT01085214|458741259|FG000|Overall Study|Alternate treatment required|1|||
127485693|NCT01634152|458741273|FG000|Overall Study|Adverse Event|2|||
127485694|NCT01634152|458741274|FG001|Overall Study|Adverse Event|0|||
127485695|NCT01634152|458741275|FG002|Overall Study|Adverse Event|2|||
127485696|NCT01634152|458741273|FG000|Overall Study|Consent withdrawn not due to AE|1|||
127485697|NCT01634152|458741274|FG001|Overall Study|Consent withdrawn not due to AE|0|||
127485698|NCT01634152|458741275|FG002|Overall Study|Consent withdrawn not due to AE|1|||
127485699|NCT01634152|458741273|FG000|Overall Study|Not treated|0|||
127485700|NCT01634152|458741274|FG001|Overall Study|Not treated|1|||
127485701|NCT01634152|458741275|FG002|Overall Study|Not treated|0|||
127485702|NCT01634152|458741273|FG000|Overall Study|Other reason not defined above|1|||
127485703|NCT01634152|458741274|FG001|Overall Study|Other reason not defined above|0|||
127485704|NCT01634152|458741275|FG002|Overall Study|Other reason not defined above|1|||
127485705|NCT01152437|458741279|FG000|Overall Study|Other Adverse Event|8|||
127485706|NCT01152437|458741280|FG001|Overall Study|Other Adverse Event|1|||
127485707|NCT01152437|458741281|FG002|Overall Study|Other Adverse Event|7|||
127485708|NCT01152437|458741279|FG000|Overall Study|Not treated|0|||
127485709|NCT01152437|458741280|FG001|Overall Study|Not treated|1|||
127485710|NCT01152437|458741281|FG002|Overall Study|Not treated|2|||
127485711|NCT01152437|458741279|FG000|Overall Study|Progressive disease|27|||
127485712|NCT01152437|458741280|FG001|Overall Study|Progressive disease|13|||
127485713|NCT01152437|458741281|FG002|Overall Study|Progressive disease|32|||
127485714|NCT01152437|458741279|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
127485715|NCT01152437|458741280|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
127485716|NCT01152437|458741281|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
127485717|NCT01985022|458741282|FG000|Overall Study|Lost to Follow-up|0|||
127485718|NCT01985022|458741283|FG001|Overall Study|Lost to Follow-up|1|||
127485719|NCT01985022|458741282|FG000|Overall Study|Protocol Violation|0|||
127485720|NCT01985022|458741283|FG001|Overall Study|Protocol Violation|1|||
127485721|NCT01985022|458741282|FG000|Overall Study|Withdrawal by Subject|4|||
127485722|NCT01985022|458741283|FG001|Overall Study|Withdrawal by Subject|1|||
127485723|NCT00279214|458741284|FG000|Overall Study|Physician Decision|3|||
127485724|NCT00279214|458741285|FG001|Overall Study|Physician Decision|2|||
127485725|NCT01214837|458741286|FG000|Overall Study|Death|0|||
127485726|NCT01214837|458741287|FG001|Overall Study|Death|0|||
127485727|NCT01214837|458741288|FG002|Overall Study|Death|1|||
127485728|NCT01214837|458741286|FG000|Overall Study|Adverse Event|1|||
127485729|NCT01214837|458741287|FG001|Overall Study|Adverse Event|2|||
127485730|NCT01214837|458741288|FG002|Overall Study|Adverse Event|1|||
127485731|NCT01214837|458741286|FG000|Overall Study|Withdrawal by Subject|27|||
127485732|NCT01214837|458741287|FG001|Overall Study|Withdrawal by Subject|36|||
127485733|NCT01214837|458741288|FG002|Overall Study|Withdrawal by Subject|28|||
127485734|NCT01214837|458741286|FG000|Overall Study|Lost to Follow-up|20|||
127485735|NCT01214837|458741287|FG001|Overall Study|Lost to Follow-up|15|||
127485736|NCT01214837|458741288|FG002|Overall Study|Lost to Follow-up|21|||
127485737|NCT01214837|458741286|FG000|Overall Study|Inappropriate Enrolment|0|||
127485738|NCT01214837|458741287|FG001|Overall Study|Inappropriate Enrolment|1|||
127485739|NCT01214837|458741288|FG002|Overall Study|Inappropriate Enrolment|2|||
127485740|NCT01214837|458741286|FG000|Overall Study|Administrative Reason|2|||
127485741|NCT01214837|458741287|FG001|Overall Study|Administrative Reason|6|||
127485742|NCT01214837|458741288|FG002|Overall Study|Administrative Reason|4|||
127485743|NCT01214837|458741286|FG000|Overall Study|Protocol Violation|3|||
127485744|NCT01214837|458741287|FG001|Overall Study|Protocol Violation|1|||
127485745|NCT01214837|458741288|FG002|Overall Study|Protocol Violation|5|||
127485746|NCT01214837|458741286|FG000|Overall Study|Unable to Classify|1|||
127485747|NCT01214837|458741287|FG001|Overall Study|Unable to Classify|3|||
127485748|NCT01214837|458741288|FG002|Overall Study|Unable to Classify|0|||
127485749|NCT00457626|458741289|FG000|Overall Study|Adverse Event|3|||
127485750|NCT00457626|458741289|FG000|Overall Study|Administrative Problems|2|||
127485751|NCT00457626|458741289|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
127485752|NCT01944020|458743184|FG000|Overall Study|Withdrawal by Subject|5|||
127485753|NCT01944020|458743185|FG001|Overall Study|Withdrawal by Subject|0|||
127485754|NCT03257358|458743190|FG000|Overall Study|Adverse Event|25|||
127485755|NCT03257358|458743191|FG001|Overall Study|Adverse Event|12|||
127485756|NCT03257358|458743190|FG000|Overall Study|Lack of Efficacy|1|||
127485757|NCT03257358|458743191|FG001|Overall Study|Lack of Efficacy|1|||
127485758|NCT03257358|458743190|FG000|Overall Study|Lost to Follow-up|12|||
127485759|NCT03257358|458743191|FG001|Overall Study|Lost to Follow-up|4|||
127485760|NCT03257358|458743190|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
127485761|NCT03257358|458743191|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
127485762|NCT03257358|458743190|FG000|Overall Study|Physician Decision|2|||
127485763|NCT03257358|458743191|FG001|Overall Study|Physician Decision|2|||
127485764|NCT03257358|458743190|FG000|Overall Study|Protocol Violation|5|||
127485765|NCT03257358|458743191|FG001|Overall Study|Protocol Violation|3|||
127485766|NCT03257358|458743190|FG000|Overall Study|Technical problems|4|||
127485767|NCT03257358|458743191|FG001|Overall Study|Technical problems|1|||
127485768|NCT03257358|458743190|FG000|Overall Study|Withdrawal by Subject|8|||
127485769|NCT03257358|458743191|FG001|Overall Study|Withdrawal by Subject|3|||
127485770|NCT03257358|458743190|FG000|Overall Study|Withdrawal of informed consent|9|||
127485771|NCT03257358|458743191|FG001|Overall Study|Withdrawal of informed consent|5|||
127485772|NCT03257358|458743190|FG000|Overall Study|New therapy for study indication|1|||
127485773|NCT03257358|458743191|FG001|Overall Study|New therapy for study indication|0|||
127485774|NCT03257358|458743190|FG000|Overall Study|No longer requires treatment|0|||
127485775|NCT03257358|458743191|FG001|Overall Study|No longer requires treatment|1|||
127485776|NCT01135992|458743192|FG000|Overall Study|Adverse Event|1|||
127485777|NCT01135992|458743192|FG000|Overall Study|Lack of Efficacy|1|||
127485778|NCT01135992|458743192|FG000|Overall Study|Protocol Violation|2|||
127485779|NCT01135992|458743192|FG000|Overall Study|Withdrawal criteria|10|||
127485780|NCT01135992|458743192|FG000|Overall Study|Unclassified|7|||
127485781|NCT01977898|458743193|FG000|Overall Study|Non functioning catheter|1|||
127485782|NCT01977898|458743194|FG001|Overall Study|Non functioning catheter|1|||
127485783|NCT01466491|458743196|FG000|Overall Study|Protocol Violation|0|||
127485784|NCT01466491|458743197|FG001|Overall Study|Protocol Violation|3|||
127485785|NCT01466491|458743198|FG002|Overall Study|Protocol Violation|2|||
127485786|NCT01466491|458743199|FG003|Overall Study|Protocol Violation|0|||
127485787|NCT01466491|458743196|FG000|Overall Study|Missing Data|0|||
127485788|NCT01466491|458743197|FG001|Overall Study|Missing Data|0|||
127485789|NCT01466491|458743198|FG002|Overall Study|Missing Data|1|||
127485790|NCT01466491|458743199|FG003|Overall Study|Missing Data|0|||
127485791|NCT02727322|458743200|FG000|Overall Study|Withdrawal by Subject|1|||
127485792|NCT02727322|458743201|FG001|Overall Study|Withdrawal by Subject|1|||
127485793|NCT02727322|458743200|FG000|Overall Study|Protocol Violation|1|||
127485794|NCT02727322|458743201|FG001|Overall Study|Protocol Violation|0|||
127485795|NCT01123148|458743208|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
127485796|NCT01123148|458743208|FG000|Overall Study|Didn't meet milestone criteria|1|||
127485797|NCT00355030|458743209|FG000|Study Period 1 Treatment|Adverse Event|1|||
127485798|NCT00355030|458743210|FG001|Study Period 1 Treatment|Adverse Event|1|||
127485799|NCT00355030|458743209|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
127485800|NCT00355030|458743210|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
127485801|NCT00355030|458743209|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
127485802|NCT00355030|458743210|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
127485803|NCT00355030|458743209|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
127485804|NCT00355030|458743210|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
127485805|NCT00355030|458743209|FG000|Study Period 1 Treatment|Physician Decision|0|||
127485806|NCT00355030|458743210|FG001|Study Period 1 Treatment|Physician Decision|1|||
127485807|NCT00355030|458743209|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
127485808|NCT00355030|458743210|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
127485809|NCT00355030|458743209|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
127485810|NCT00355030|458743210|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
127485811|NCT00355030|458743209|FG000|Study Period 1 Treatment|Other|2|||
127976471|NCT03535194|460536127|FG002|Maintenance Period|Physician Decision|0|||
127485812|NCT00355030|458743210|FG001|Study Period 1 Treatment|Other|6|||
127485813|NCT00355030|458743209|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
127485814|NCT00355030|458743210|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
127485815|NCT00355030|458743209|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
127485816|NCT00355030|458743210|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
127976472|NCT03535194|460536128|FG003|Maintenance Period|Physician Decision|2|||
127485817|NCT01049373|458743211|FG000|Overall Study|Protocol Violation|9|||
127485818|NCT01049373|458743212|FG001|Overall Study|Protocol Violation|9|||
127485819|NCT01049373|458743211|FG000|Overall Study|Withdrawal by Subject|8|||
127976473|NCT03535194|460536129|FG004|Maintenance Period|Physician Decision|0|||
127485820|NCT01049373|458743212|FG001|Overall Study|Withdrawal by Subject|5|||
127485821|NCT01049373|458743211|FG000|Overall Study|Adverse Event|3|||
127485822|NCT01049373|458743212|FG001|Overall Study|Adverse Event|3|||
127485823|NCT01049373|458743211|FG000|Overall Study|Lost to Follow-up|9|||
127485824|NCT01049373|458743212|FG001|Overall Study|Lost to Follow-up|4|||
127485825|NCT01049373|458743211|FG000|Overall Study|no evaluable study values|9|||
127485826|NCT01049373|458743212|FG001|Overall Study|no evaluable study values|21|||
127485827|NCT01049373|458743211|FG000|Overall Study|Other|1|||
127485828|NCT01049373|458743212|FG001|Overall Study|Other|1|||
127485829|NCT01049373|458743211|FG000|Overall Study|Non-cooperation|0|||
127485830|NCT01049373|458743212|FG001|Overall Study|Non-cooperation|1|||
127485831|NCT00339040|458743213|FG000|Stage I|Not able to attend clinic|1|||
127485832|NCT00339040|458743214|FG001|Stage I|Not able to attend clinic|0|||
127485833|NCT00339040|458743213|FG000|Stage I|Protocol Violation|1|||
127485834|NCT00339040|458743214|FG001|Stage I|Protocol Violation|1|||
127485835|NCT00339040|458743213|FG000|Stage II|Lost to Follow-up|3|||
127485836|NCT00339040|458743214|FG001|Stage II|Lost to Follow-up|0|||
127485837|NCT00339040|458743213|FG000|Stage II|Withdrawal by Subject|1|||
127485838|NCT00339040|458743214|FG001|Stage II|Withdrawal by Subject|2|||
127485839|NCT00339040|458743213|FG000|Stage II|Protocol Violation|3|||
127485840|NCT00339040|458743214|FG001|Stage II|Protocol Violation|0|||
127485841|NCT00339040|458743213|FG000|Stage II|Not able to attend clinic|1|||
127485842|NCT00339040|458743214|FG001|Stage II|Not able to attend clinic|0|||
127485843|NCT00339040|458743213|FG000|Stage II|Site closing|2|||
127485844|NCT00339040|458743214|FG001|Stage II|Site closing|0|||
127485845|NCT00812955|458743219|FG000|Overall Study|Adverse Event|7|||
127485846|NCT00812955|458743220|FG001|Overall Study|Adverse Event|6|||
127485847|NCT00812955|458743221|FG002|Overall Study|Adverse Event|3|||
127485848|NCT00812955|458743222|FG003|Overall Study|Adverse Event|4|||
127485849|NCT00812955|458743219|FG000|Overall Study|Lost to Follow-up|2|||
127485850|NCT00812955|458743220|FG001|Overall Study|Lost to Follow-up|1|||
127485851|NCT00812955|458743221|FG002|Overall Study|Lost to Follow-up|1|||
127485852|NCT00812955|458743222|FG003|Overall Study|Lost to Follow-up|2|||
127485853|NCT00812955|458743219|FG000|Overall Study|Withdrawal by Subject|1|||
127485854|NCT00812955|458743220|FG001|Overall Study|Withdrawal by Subject|0|||
127485855|NCT00812955|458743221|FG002|Overall Study|Withdrawal by Subject|1|||
127485856|NCT00812955|458743222|FG003|Overall Study|Withdrawal by Subject|2|||
127485857|NCT00812955|458743219|FG000|Overall Study|randomized in error|0|||
127485858|NCT00812955|458743220|FG001|Overall Study|randomized in error|0|||
127485859|NCT00812955|458743221|FG002|Overall Study|randomized in error|1|||
127485860|NCT00812955|458743222|FG003|Overall Study|randomized in error|0|||
127485861|NCT02391311|458743223|FG000|Overall Study|Lost to Follow-up|2|||
127485862|NCT02391311|458743224|FG001|Overall Study|Lost to Follow-up|1|||
127485863|NCT02391311|458743223|FG000|Overall Study|deemed ineligible after baseline|1|||
127485864|NCT02391311|458743224|FG001|Overall Study|deemed ineligible after baseline|1|||
127485865|NCT01815424|458743227|FG000|Week 0 to 16|Adverse Event|1|||
127485866|NCT01815424|458743228|FG001|Week 0 to 16|Adverse Event|3|||
127485867|NCT01815424|458743229|FG002|Week 0 to 16|Adverse Event|3|||
127485868|NCT01815424|458743230|FG003|Week 0 to 16|Adverse Event|0|||
127485869|NCT01815424|458743231|FG004|Week 0 to 16|Adverse Event|0|||
127485870|NCT01815424|458743227|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
127485871|NCT01815424|458743228|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
127485872|NCT01815424|458743229|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
127485873|NCT01815424|458743230|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
127485874|NCT01815424|458743231|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
127485875|NCT01815424|458743227|FG000|Week 0 to 16|Lost to Follow-up|0|||
127485876|NCT01815424|458743228|FG001|Week 0 to 16|Lost to Follow-up|1|||
127485877|NCT01815424|458743229|FG002|Week 0 to 16|Lost to Follow-up|0|||
127485878|NCT01815424|458743230|FG003|Week 0 to 16|Lost to Follow-up|0|||
127485879|NCT01815424|458743231|FG004|Week 0 to 16|Lost to Follow-up|0|||
127485880|NCT01815424|458743227|FG000|Week 0 to 16|Withdrawal by Subject|0|||
127485881|NCT01815424|458743228|FG001|Week 0 to 16|Withdrawal by Subject|0|||
127485882|NCT01815424|458743229|FG002|Week 0 to 16|Withdrawal by Subject|1|||
127485883|NCT01815424|458743230|FG003|Week 0 to 16|Withdrawal by Subject|0|||
127485884|NCT01815424|458743231|FG004|Week 0 to 16|Withdrawal by Subject|0|||
127485885|NCT01815424|458743227|FG000|Week 0 to 16|Other|1|||
127485886|NCT01815424|458743228|FG001|Week 0 to 16|Other|0|||
127485887|NCT01815424|458743229|FG002|Week 0 to 16|Other|3|||
127485888|NCT01815424|458743230|FG003|Week 0 to 16|Other|0|||
127485889|NCT01815424|458743231|FG004|Week 0 to 16|Other|0|||
127485890|NCT01815424|458743227|FG000|Week 0 to 16|Protocol Violation|1|||
127485891|NCT01815424|458743228|FG001|Week 0 to 16|Protocol Violation|0|||
127485892|NCT01815424|458743229|FG002|Week 0 to 16|Protocol Violation|0|||
127485893|NCT01815424|458743230|FG003|Week 0 to 16|Protocol Violation|0|||
127485894|NCT01815424|458743231|FG004|Week 0 to 16|Protocol Violation|0|||
127485895|NCT01815424|458743227|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
127976474|NCT03535194|460536125|FG000|Maintenance Period|Pregnancy|0|||
127485896|NCT01815424|458743228|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
127485897|NCT01815424|458743229|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
127485898|NCT01815424|458743230|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
127485899|NCT01815424|458743231|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
127485900|NCT01815424|458743227|FG000|Week 16 to 52|Other|0|||
127485901|NCT01815424|458743228|FG001|Week 16 to 52|Other|1|||
127485902|NCT01815424|458743229|FG002|Week 16 to 52|Other|0|||
127485903|NCT01815424|458743230|FG003|Week 16 to 52|Other|0|||
127485904|NCT01815424|458743231|FG004|Week 16 to 52|Other|0|||
127485905|NCT01815424|458743227|FG000|Week 16 to 52|Adverse Event|0|||
127485906|NCT01815424|458743228|FG001|Week 16 to 52|Adverse Event|0|||
127485907|NCT01815424|458743229|FG002|Week 16 to 52|Adverse Event|0|||
127485908|NCT01815424|458743230|FG003|Week 16 to 52|Adverse Event|0|||
127485909|NCT01815424|458743231|FG004|Week 16 to 52|Adverse Event|1|||
127485910|NCT01815424|458743227|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
127485911|NCT01815424|458743228|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
127485912|NCT01815424|458743229|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
127485913|NCT01815424|458743230|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
127485914|NCT01815424|458743231|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
127485915|NCT01815424|458743227|FG000|Week 16 to 52|Lost to Follow-up|0|||
127485916|NCT01815424|458743228|FG001|Week 16 to 52|Lost to Follow-up|2|||
127485917|NCT01815424|458743229|FG002|Week 16 to 52|Lost to Follow-up|0|||
127485918|NCT01815424|458743230|FG003|Week 16 to 52|Lost to Follow-up|2|||
127485919|NCT01815424|458743231|FG004|Week 16 to 52|Lost to Follow-up|1|||
127485920|NCT01815424|458743227|FG000|Week 16 to 52|Withdrawal by Subject|1|||
127485921|NCT01815424|458743228|FG001|Week 16 to 52|Withdrawal by Subject|2|||
127485922|NCT01815424|458743229|FG002|Week 16 to 52|Withdrawal by Subject|0|||
127485923|NCT01815424|458743230|FG003|Week 16 to 52|Withdrawal by Subject|0|||
127485924|NCT01815424|458743231|FG004|Week 16 to 52|Withdrawal by Subject|0|||
127485925|NCT01309204|458743232|FG000|Overall Study|Adverse Event|48|||
127485926|NCT01309204|458743233|FG001|Overall Study|Adverse Event|58|||
127485927|NCT01309204|458743232|FG000|Overall Study|Lost to Follow-up|2|||
127485928|NCT01309204|458743233|FG001|Overall Study|Lost to Follow-up|2|||
127485929|NCT01309204|458743232|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
127485930|NCT01309204|458743233|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
127485931|NCT01309204|458743232|FG000|Overall Study|Inadequate control of IOP|4|||
127485932|NCT01309204|458743233|FG001|Overall Study|Inadequate control of IOP|4|||
127485933|NCT01309204|458743232|FG000|Overall Study|Other|4|||
127485934|NCT01309204|458743233|FG001|Overall Study|Other|1|||
127485935|NCT03046446|458743234|FG000|Overall Study|Lack of Efficacy|7|||
127485936|NCT03046446|458743234|FG000|Overall Study|Adverse Event|6|||
127485937|NCT03046446|458743234|FG000|Overall Study|Lost to Follow-up|3|||
127485938|NCT03046446|458743234|FG000|Overall Study|Withdrawal by Subject|14|||
127485939|NCT03046446|458743234|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
127485940|NCT03046446|458743234|FG000|Overall Study|Disease Progression (see caveats)|25|||
127485941|NCT03046446|458743234|FG000|Overall Study|Non OA related knee surgery|1|||
127485942|NCT00925002|458743235|FG000|Overall Study|Other|1|||
127485943|NCT00925002|458743236|FG001|Overall Study|Other|4|||
127485944|NCT00925002|458743237|FG002|Overall Study|Other|0|||
127485945|NCT00925002|458743235|FG000|Overall Study|Death|1|||
127485946|NCT00925002|458743236|FG001|Overall Study|Death|1|||
127485947|NCT00925002|458743237|FG002|Overall Study|Death|5|||
127485948|NCT00925002|458743235|FG000|Overall Study|Adverse Event|3|||
127485949|NCT00925002|458743236|FG001|Overall Study|Adverse Event|1|||
127485950|NCT00925002|458743237|FG002|Overall Study|Adverse Event|2|||
127485951|NCT00925002|458743235|FG000|Overall Study|Participant withdrew consent|1|||
127485952|NCT00925002|458743236|FG001|Overall Study|Participant withdrew consent|3|||
127485953|NCT00925002|458743237|FG002|Overall Study|Participant withdrew consent|3|||
127485954|NCT02808897|458743238|FG000|Overall Study|Lost to Follow-up|9|||
127485955|NCT02808897|458743239|FG001|Overall Study|Lost to Follow-up|11|||
127485956|NCT01496287|458743240|FG000|Overall Study|Lost to Follow-up|1|||
127485957|NCT01496287|458743240|FG000|Overall Study|Incomplete anesthesia|5|||
127485958|NCT00305448|458743241|FG000|Overall Study|Protocol Violation|0|||
127485959|NCT00305448|458743242|FG001|Overall Study|Protocol Violation|1|||
127485960|NCT00305448|458743243|FG002|Overall Study|Protocol Violation|0|||
127485961|NCT00305448|458743241|FG000|Overall Study|Withdrawal by Subject|2|||
127485962|NCT00305448|458743242|FG001|Overall Study|Withdrawal by Subject|0|||
127485963|NCT00305448|458743243|FG002|Overall Study|Withdrawal by Subject|1|||
127485964|NCT00305448|458743241|FG000|Overall Study|Adverse Event|1|||
127485965|NCT00305448|458743242|FG001|Overall Study|Adverse Event|0|||
127485966|NCT00305448|458743243|FG002|Overall Study|Adverse Event|1|||
127485967|NCT00305448|458743241|FG000|Overall Study|Disease Progression|27|||
127485968|NCT00305448|458743242|FG001|Overall Study|Disease Progression|31|||
127485969|NCT00305448|458743243|FG002|Overall Study|Disease Progression|28|||
127485970|NCT00305448|458743241|FG000|Overall Study|Subjective Disease Progression|1|||
127485971|NCT00305448|458743242|FG001|Overall Study|Subjective Disease Progression|2|||
127485972|NCT00305448|458743243|FG002|Overall Study|Subjective Disease Progression|2|||
127485973|NCT00305448|458743241|FG000|Overall Study|Tumor Marker Elevation|0|||
127485974|NCT00305448|458743242|FG001|Overall Study|Tumor Marker Elevation|0|||
127485975|NCT00305448|458743243|FG002|Overall Study|Tumor Marker Elevation|1|||
127485976|NCT00328172|458743244|FG000|Overall Study|Adverse Event|3|||
127485977|NCT00328172|458743245|FG001|Overall Study|Adverse Event|2|||
127485978|NCT00328172|458743246|FG002|Overall Study|Adverse Event|1|||
127485979|NCT00328172|458743247|FG003|Overall Study|Adverse Event|2|||
127485980|NCT00328172|458743248|FG004|Overall Study|Adverse Event|1|||
127976475|NCT03535194|460536126|FG001|Maintenance Period|Pregnancy|0|||
127976476|NCT03535194|460536127|FG002|Maintenance Period|Pregnancy|0|||
127976477|NCT03535194|460536128|FG003|Maintenance Period|Pregnancy|2|||
127976478|NCT03535194|460536129|FG004|Maintenance Period|Pregnancy|0|||
127976479|NCT03535194|460536125|FG000|Maintenance Period|Protocol Violation|0|||
127976480|NCT03535194|460536126|FG001|Maintenance Period|Protocol Violation|1|||
127976481|NCT03535194|460536127|FG002|Maintenance Period|Protocol Violation|0|||
127976482|NCT03535194|460536128|FG003|Maintenance Period|Protocol Violation|0|||
127976483|NCT03535194|460536129|FG004|Maintenance Period|Protocol Violation|0|||
127976484|NCT03535194|460536125|FG000|Maintenance Period|Withdrawal by Subject|7|||
127976485|NCT03535194|460536126|FG001|Maintenance Period|Withdrawal by Subject|2|||
127976486|NCT03535194|460536127|FG002|Maintenance Period|Withdrawal by Subject|1|||
127976487|NCT03535194|460536128|FG003|Maintenance Period|Withdrawal by Subject|8|||
127976488|NCT03535194|460536129|FG004|Maintenance Period|Withdrawal by Subject|0|||
127976489|NCT03535194|460536125|FG000|Post-Treatment Followup Period|Adverse Event|4|||
127976490|NCT03535194|460536126|FG001|Post-Treatment Followup Period|Adverse Event|5|||
127976491|NCT03535194|460536127|FG002|Post-Treatment Followup Period|Adverse Event|1|||
127976492|NCT03535194|460536128|FG003|Post-Treatment Followup Period|Adverse Event|8|||
127485981|NCT00328172|458743244|FG000|Overall Study|Protocol Violation|0|||
127485982|NCT00328172|458743245|FG001|Overall Study|Protocol Violation|1|||
127485983|NCT00328172|458743246|FG002|Overall Study|Protocol Violation|1|||
127485984|NCT00328172|458743247|FG003|Overall Study|Protocol Violation|0|||
127485985|NCT00328172|458743248|FG004|Overall Study|Protocol Violation|0|||
127485986|NCT00328172|458743244|FG000|Overall Study|Lost to Follow-up|1|||
127485987|NCT00328172|458743245|FG001|Overall Study|Lost to Follow-up|1|||
127485988|NCT00328172|458743246|FG002|Overall Study|Lost to Follow-up|2|||
127485989|NCT00328172|458743247|FG003|Overall Study|Lost to Follow-up|1|||
127485990|NCT00328172|458743248|FG004|Overall Study|Lost to Follow-up|1|||
127485991|NCT00328172|458743244|FG000|Overall Study|Withdrawal by Subject|1|||
127485992|NCT00328172|458743245|FG001|Overall Study|Withdrawal by Subject|1|||
127485993|NCT00328172|458743246|FG002|Overall Study|Withdrawal by Subject|1|||
127485994|NCT00328172|458743247|FG003|Overall Study|Withdrawal by Subject|6|||
127485995|NCT00328172|458743248|FG004|Overall Study|Withdrawal by Subject|0|||
127485996|NCT00328172|458743244|FG000|Overall Study|Lack of Efficacy|14|||
127485997|NCT00328172|458743245|FG001|Overall Study|Lack of Efficacy|9|||
127485998|NCT00328172|458743246|FG002|Overall Study|Lack of Efficacy|4|||
127485999|NCT00328172|458743247|FG003|Overall Study|Lack of Efficacy|4|||
127486000|NCT00328172|458743248|FG004|Overall Study|Lack of Efficacy|3|||
127486001|NCT00328172|458743244|FG000|Overall Study|Other reason (not specified)|3|||
127486002|NCT00328172|458743245|FG001|Overall Study|Other reason (not specified)|0|||
127486003|NCT00328172|458743246|FG002|Overall Study|Other reason (not specified)|1|||
127486004|NCT00328172|458743247|FG003|Overall Study|Other reason (not specified)|0|||
127486005|NCT00328172|458743248|FG004|Overall Study|Other reason (not specified)|0|||
127486006|NCT00558636|458743253|FG000|Treatment|Adverse Event|9|||
127486007|NCT00558636|458743254|FG001|Treatment|Adverse Event|2|||
127486008|NCT00558636|458743253|FG000|Treatment|Withdrawal by Subject|2|||
127486009|NCT00558636|458743254|FG001|Treatment|Withdrawal by Subject|0|||
127486010|NCT00558636|458743253|FG000|Treatment|Premature termination of the study|35|||
127486011|NCT00558636|458743254|FG001|Treatment|Premature termination of the study|37|||
127486012|NCT00558636|458743253|FG000|Treatment|Disease progression|1|||
127486013|NCT00558636|458743254|FG001|Treatment|Disease progression|5|||
127486014|NCT00558636|458743253|FG000|Follow-up|Premature termination of the study|12|||
127486015|NCT00558636|458743254|FG001|Follow-up|Premature termination of the study|7|||
127486016|NCT01990742|458743255|FG000|Overall Study|Withdrawal by facility|407|||
127486017|NCT01990742|458743256|FG001|Overall Study|Withdrawal by facility|1083|||
127486018|NCT01990742|458743255|FG000|Overall Study|Facility closed|0|||
127486019|NCT01990742|458743256|FG001|Overall Study|Facility closed|270|||
127486020|NCT03443687|458743257|FG000|Overall Study|Lost to Follow-up|3|||
127976493|NCT03535194|460536129|FG004|Post-Treatment Followup Period|Adverse Event|0|||
127486021|NCT03443687|458743258|FG001|Overall Study|Lost to Follow-up|5|||
127486022|NCT03443687|458743257|FG000|Overall Study|Withdrawal by Subject|1|||
127486023|NCT03443687|458743258|FG001|Overall Study|Withdrawal by Subject|0|||
127486024|NCT03443687|458743257|FG000|Overall Study|Discontinued intervention|1|||
127486025|NCT03443687|458743258|FG001|Overall Study|Discontinued intervention|1|||
127486026|NCT04108273|458743259|FG000|Overall Study|COVID Pandemic|1|||
127486027|NCT04108273|458743260|FG001|Overall Study|COVID Pandemic|0|||
127486028|NCT02897115|458743264|FG000|Overall Study|Early termination of study by sponsor|11|||
127486029|NCT02897115|458743265|FG001|Overall Study|Early termination of study by sponsor|8|||
127486030|NCT00487981|458743266|FG000|Overall Study|Hypothyroidism diagnosis|1|||
127486031|NCT02808429|458743271|FG000|Overall Study|Lost to Follow-up|1|||
127486032|NCT02808429|458743272|FG001|Overall Study|Lost to Follow-up|0|||
127976494|NCT03535194|460536125|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
127486033|NCT02808429|458743273|FG002|Overall Study|Lost to Follow-up|0|||
127486034|NCT02808429|458743271|FG000|Overall Study|Protocol Violation|0|||
127486035|NCT02808429|458743272|FG001|Overall Study|Protocol Violation|1|||
127486036|NCT02808429|458743273|FG002|Overall Study|Protocol Violation|0|||
127486037|NCT02808429|458743271|FG000|Overall Study|Premature study termination by sponsor|2|||
127486038|NCT02808429|458743272|FG001|Overall Study|Premature study termination by sponsor|0|||
127486039|NCT02808429|458743273|FG002|Overall Study|Premature study termination by sponsor|1|||
127486040|NCT02808429|458743271|FG000|Overall Study|Relocation|0|||
127486041|NCT02808429|458743272|FG001|Overall Study|Relocation|0|||
127486042|NCT02808429|458743273|FG002|Overall Study|Relocation|1|||
127486043|NCT00811954|458743279|FG000|Overall Study|Death|10|||
127486044|NCT00811954|458743280|FG001|Overall Study|Death|6|||
127486045|NCT00811954|458743281|FG002|Overall Study|Death|13|||
127486046|NCT00811954|458743279|FG000|Overall Study|Lost to Follow-up|29|||
127486047|NCT00811954|458743280|FG001|Overall Study|Lost to Follow-up|23|||
127486048|NCT00811954|458743281|FG002|Overall Study|Lost to Follow-up|34|||
127486049|NCT00811954|458743279|FG000|Overall Study|Not able to get to clinic|28|||
127486050|NCT00811954|458743280|FG001|Overall Study|Not able to get to clinic|35|||
127486051|NCT00811954|458743281|FG002|Overall Study|Not able to get to clinic|30|||
127486052|NCT00811954|458743279|FG000|Overall Study|Not willing to adhere to requirements|12|||
127486053|NCT00811954|458743280|FG001|Overall Study|Not willing to adhere to requirements|2|||
127486054|NCT00811954|458743281|FG002|Overall Study|Not willing to adhere to requirements|16|||
127486055|NCT00811954|458743279|FG000|Overall Study|Withdraw consent prior study completion|4|||
127486056|NCT00811954|458743280|FG001|Overall Study|Withdraw consent prior study completion|6|||
127486057|NCT00811954|458743281|FG002|Overall Study|Withdraw consent prior study completion|5|||
127486058|NCT00811954|458743279|FG000|Overall Study|Site Closure|4|||
127486059|NCT00811954|458743280|FG001|Overall Study|Site Closure|0|||
127486060|NCT00811954|458743281|FG002|Overall Study|Site Closure|1|||
127486061|NCT00811954|458743279|FG000|Overall Study|Severe Debilitation|2|||
127486062|NCT00811954|458743280|FG001|Overall Study|Severe Debilitation|0|||
127486063|NCT00811954|458743281|FG002|Overall Study|Severe Debilitation|1|||
127486064|NCT00811954|458743279|FG000|Overall Study|Complete Protocol: No follow-up|0|||
127486065|NCT00811954|458743280|FG001|Overall Study|Complete Protocol: No follow-up|0|||
127486066|NCT00811954|458743281|FG002|Overall Study|Complete Protocol: No follow-up|1|||
127486067|NCT01016067|458743282|FG000|Overall Study|Lost to Follow-up|1|||
127486068|NCT01016067|458743283|FG001|Overall Study|Lost to Follow-up|2|||
127486069|NCT01016067|458743282|FG000|Overall Study|Physician Decision|1|||
127486070|NCT01016067|458743283|FG001|Overall Study|Physician Decision|1|||
127486071|NCT01016067|458743282|FG000|Overall Study|Withdrew due to Relocation|0|||
127486072|NCT01016067|458743283|FG001|Overall Study|Withdrew due to Relocation|1|||
127486073|NCT01534481|458743290|FG000|Overall Study|Lost to Follow-up|29|||
127486074|NCT01534481|458743291|FG001|Overall Study|Lost to Follow-up|24|||
127486075|NCT01534481|458743290|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
127486076|NCT01534481|458743291|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
127486077|NCT01130337|458743292|FG000|Overall Study|Withdrawal by Subject|3|||
127486078|NCT01130337|458743292|FG000|Overall Study|Principal investigator decision|1|||
127486079|NCT01130337|458743292|FG000|Overall Study|Death|1|||
127486080|NCT01130337|458743292|FG000|Overall Study|Disease progression|1|||
127486081|NCT01130337|458743292|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
127486082|NCT01130337|458743292|FG000|Overall Study|Surgical resection (R2)|1|||
127486083|NCT05525910|458743293|FG000|Period 4|Per sponsor due to study timelines|0|||
127486084|NCT05525910|458743294|FG001|Period 4|Per sponsor due to study timelines|0|||
127486085|NCT05525910|458743295|FG002|Period 4|Per sponsor due to study timelines|1|||
127486086|NCT05525910|458743296|FG003|Period 4|Per sponsor due to study timelines|1|||
127486087|NCT05525910|458743297|FG004|Period 4|Per sponsor due to study timelines|1|||
127486088|NCT03886493|458743298|FG000|Overall Study|Adverse Event|1|||
127486089|NCT04828707|458743301|FG000|Overall Study|Lost to Follow-up|3|||
127486090|NCT04828707|458743302|FG001|Overall Study|Lost to Follow-up|2|||
127486091|NCT04828707|458743301|FG000|Overall Study|Withdrawal by Subject|2|||
127486092|NCT04828707|458743302|FG001|Overall Study|Withdrawal by Subject|1|||
127486093|NCT03139448|458743303|FG000|Overall Study|Lack of Efficacy|6|||
127486094|NCT03139448|458743304|FG001|Overall Study|Lack of Efficacy|7|||
127486095|NCT03139448|458743303|FG000|Overall Study|Location of procedure changed|2|||
127976495|NCT03535194|460536126|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
127976496|NCT03535194|460536127|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
127976497|NCT03535194|460536128|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
127486096|NCT03139448|458743304|FG001|Overall Study|Location of procedure changed|8|||
127976498|NCT03535194|460536129|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
127486097|NCT03139448|458743303|FG000|Overall Study|Withdrawal by Subject|3|||
127486098|NCT03139448|458743304|FG001|Overall Study|Withdrawal by Subject|6|||
127486099|NCT03139448|458743303|FG000|Overall Study|Screen fail|1|||
127486100|NCT03139448|458743304|FG001|Overall Study|Screen fail|3|||
127486101|NCT03139448|458743303|FG000|Overall Study|Physician Decision|0|||
127486102|NCT03139448|458743304|FG001|Overall Study|Physician Decision|2|||
127486103|NCT00523978|458743307|FG000|Overall Study|Withdrawal by Subject|3|||
127486104|NCT00523978|458743308|FG001|Overall Study|Withdrawal by Subject|7|||
127486105|NCT00523978|458743307|FG000|Overall Study|Screen Failures|5|||
127486106|NCT00523978|458743308|FG001|Overall Study|Screen Failures|1|||
127486107|NCT00523978|458743307|FG000|Overall Study|Death|1|||
127486108|NCT00523978|458743308|FG001|Overall Study|Death|0|||
127486109|NCT00696878|458743311|FG000|Overall Study|Adverse Event|8|||
127486110|NCT00696878|458743311|FG000|Overall Study|Withdrawal by Subject|87|||
127486111|NCT00696878|458743311|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
127486112|NCT00696878|458743311|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
127486113|NCT00696878|458743311|FG000|Overall Study|Trial stopped|32|||
127486114|NCT00696878|458743311|FG000|Overall Study|Other reason (not specified)|55|||
127486115|NCT02712788|458743312|FG000|Overall Study|Physician Decision|1|||
127486116|NCT02712788|458743313|FG001|Overall Study|Physician Decision|0|||
127486117|NCT02712788|458743312|FG000|Overall Study|Protocol Violation|1|||
127486118|NCT02712788|458743313|FG001|Overall Study|Protocol Violation|0|||
127486119|NCT00940602|458743314|FG000|Overall Study|Administrative problems|1|||
127486120|NCT00940602|458743315|FG001|Overall Study|Administrative problems|1|||
127486121|NCT00940602|458743314|FG000|Overall Study|Patient/guardian decision|13|||
127486122|NCT00940602|458743315|FG001|Overall Study|Patient/guardian decision|28|||
127486123|NCT00940602|458743314|FG000|Overall Study|Physician Decision|8|||
127486124|NCT00940602|458743315|FG001|Overall Study|Physician Decision|5|||
127486125|NCT00940602|458743314|FG000|Overall Study|Pregnancy|1|||
127486126|NCT00940602|458743315|FG001|Overall Study|Pregnancy|0|||
127486127|NCT00940602|458743314|FG000|Overall Study|Protocol Deviation (untreated)|1|||
127486128|NCT00940602|458743315|FG001|Overall Study|Protocol Deviation (untreated)|0|||
127486129|NCT00940602|458743314|FG000|Overall Study|Disease progression|8|||
127486130|NCT00940602|458743315|FG001|Overall Study|Disease progression|2|||
127486131|NCT00940602|458743314|FG000|Overall Study|Death|38|||
127486132|NCT00940602|458743315|FG001|Overall Study|Death|19|||
127486133|NCT00940602|458743314|FG000|Overall Study|Lost to Follow-up|3|||
127486134|NCT00940602|458743315|FG001|Overall Study|Lost to Follow-up|1|||
127486135|NCT00940602|458743314|FG000|Overall Study|Patient withdrew consent|26|||
127486136|NCT00940602|458743315|FG001|Overall Study|Patient withdrew consent|13|||
127486137|NCT00940602|458743314|FG000|Overall Study|Adverse Event|7|||
127486138|NCT00940602|458743315|FG001|Overall Study|Adverse Event|2|||
127486139|NCT00940602|458743314|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
127486140|NCT00940602|458743315|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
127486141|NCT01880957|458743316|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
127486142|NCT01880957|458743317|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
127486143|NCT01880957|458743316|FG000|Overall Study|Lost to Follow-up|11|||
127486144|NCT01880957|458743317|FG001|Overall Study|Lost to Follow-up|0|||
127486145|NCT01880957|458743316|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
127486146|NCT01880957|458743317|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
127486147|NCT00575666|458743320|FG000|Overall Study|Withdrawal by Subject|3|||
127486148|NCT00575666|458743321|FG001|Overall Study|Withdrawal by Subject|2|||
127486149|NCT00575666|458743320|FG000|Overall Study|Physician Decision|1|||
127486150|NCT00575666|458743321|FG001|Overall Study|Physician Decision|1|||
127486151|NCT00508482|458743322|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
127486152|NCT00508482|458743323|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
127486153|NCT00508482|458743324|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
127486154|NCT00508482|458743322|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
127486155|NCT00508482|458743323|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
127486156|NCT00508482|458743324|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
127486157|NCT00508482|458743322|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
127486158|NCT00508482|458743323|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
127486159|NCT00508482|458743324|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
127486160|NCT02359903|458743325|FG000|Overall Study|Adverse Event|0|||
127486161|NCT02359903|458743326|FG001|Overall Study|Adverse Event|2|||
127486162|NCT02289469|458743327|FG000|Overall Study|Unable to match a control|6|||
127486163|NCT02289469|458743328|FG001|Overall Study|Unable to match a control|0|||
127486164|NCT00546481|458743329|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
127486165|NCT00546481|458743330|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
127486166|NCT00546481|458743331|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
127976499|NCT03535194|460536125|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
127976500|NCT03535194|460536126|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
127976501|NCT03535194|460536127|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
127486167|NCT00546481|458743329|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
127486168|NCT00546481|458743330|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
127486169|NCT00546481|458743331|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
127486170|NCT00546481|458743329|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
127486171|NCT00546481|458743330|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
127486172|NCT00546481|458743331|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
127486173|NCT00546481|458743329|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
127976502|NCT03535194|460536128|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
127486174|NCT00546481|458743330|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
127486175|NCT00546481|458743331|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
127486176|NCT00546481|458743329|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
127486177|NCT00546481|458743330|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
127486178|NCT00546481|458743331|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
127486179|NCT00546481|458743329|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
127486180|NCT00546481|458743330|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
127486181|NCT00546481|458743331|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
127486182|NCT00546481|458743329|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
127486183|NCT00546481|458743330|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
127486184|NCT00546481|458743331|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
127486185|NCT00546481|458743329|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
127486186|NCT00546481|458743330|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
127486187|NCT00546481|458743331|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
127486188|NCT00546481|458743329|FG000|Maintenance Phase (CERA)|Other Reason|0|||
127486189|NCT00546481|458743330|FG001|Maintenance Phase (CERA)|Other Reason|0|||
127486190|NCT00546481|458743331|FG002|Maintenance Phase (CERA)|Other Reason|1|||
127486191|NCT02750930|458743335|FG000|Overall Study|Study closed/terminated|8|||
127486192|NCT00776789|458743337|FG000|Overall Study|Consent refusal|2|||
127486193|NCT00776789|458743338|FG001|Overall Study|Consent refusal|2|||
127486194|NCT00776789|458743337|FG000|Overall Study|Poor quality video|1|||
127486195|NCT00776789|458743338|FG001|Overall Study|Poor quality video|1|||
127486196|NCT04290624|458743343|FG000|Overall Study|Adverse Event|1|||
127486197|NCT04290624|458743344|FG001|Overall Study|Adverse Event|0|||
127486198|NCT01088906|458743348|FG000|Overall Study|Inclusion error|1|||
127486199|NCT01088906|458743348|FG000|Overall Study|Did not receive study treatment|3|||
127486200|NCT01088906|458743348|FG000|Overall Study|Missing data|1|||
127486201|NCT02805790|458744866|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
127486202|NCT02805790|458744867|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
127486203|NCT00800735|458744868|FG000|Overall Study|Administrative/Other|2|||
127486204|NCT00800735|458744868|FG000|Overall Study|Insufficient Therapeutic Response|2|||
127486205|NCT00800735|458744868|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
127486206|NCT00800735|458744868|FG000|Overall Study|Withdrew Consent|3|||
127486207|NCT04460183|458744869|FG000|Overall Study|Lost to Follow-up|3|||
127486208|NCT04460183|458744870|FG001|Overall Study|Lost to Follow-up|1|||
127486209|NCT04460183|458744869|FG000|Overall Study|Withdrawal by Subject|1|||
127486210|NCT04460183|458744870|FG001|Overall Study|Withdrawal by Subject|0|||
127486211|NCT00856323|458744871|FG000|Overall Study|Withdrawal by Subject|2|||
127486212|NCT01847092|458744872|FG000|Overall Study|Adverse Event|12|||
127486213|NCT01847092|458744873|FG001|Overall Study|Adverse Event|3|||
127486214|NCT01847092|458744872|FG000|Overall Study|Withdrawal by Subject|5|||
127486215|NCT01847092|458744873|FG001|Overall Study|Withdrawal by Subject|5|||
127486216|NCT01847092|458744872|FG000|Overall Study|Protocol Specified|8|||
127486217|NCT01847092|458744873|FG001|Overall Study|Protocol Specified|0|||
127486218|NCT01847092|458744872|FG000|Overall Study|Physician Decision|1|||
127486219|NCT01847092|458744873|FG001|Overall Study|Physician Decision|1|||
127486220|NCT01847092|458744872|FG000|Overall Study|Protocol Violation|0|||
127486221|NCT01847092|458744873|FG001|Overall Study|Protocol Violation|2|||
127486222|NCT00825994|458744874|FG000|Overall Study|Withdrawal by Subject|2|||
127486223|NCT00825994|458744874|FG000|Overall Study|Lost to Follow-up|1|||
127486224|NCT00825994|458744874|FG000|Overall Study|Protocol Violation|1|||
127486225|NCT00825994|458744874|FG000|Overall Study|Placebo Responder at V2|1|||
127486226|NCT00658541|458744876|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
127486227|NCT00658541|458744877|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
127486228|NCT00658541|458744876|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
127976503|NCT03535194|460536129|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
127976504|NCT03535194|460536125|FG000|Post-Treatment Followup Period|Other|1|||
127976505|NCT03535194|460536126|FG001|Post-Treatment Followup Period|Other|0|||
127976506|NCT03535194|460536127|FG002|Post-Treatment Followup Period|Other|0|||
127486229|NCT00658541|458744877|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
127486230|NCT01063348|458744878|FG000|Overall Study|Lost to Follow-up|3|||
127486231|NCT01063348|458744879|FG001|Overall Study|Lost to Follow-up|10|||
127486232|NCT01876381|458744880|FG000|Overall Study|Lack of Efficacy|5|||
127486233|NCT01876381|458744880|FG000|Overall Study|Physician Decision|1|||
127486234|NCT01876381|458744880|FG000|Overall Study|Withdrawal by Subject|1|||
127486235|NCT00461708|458744881|FG000|Overall Study|Adverse Event|17|||
127486236|NCT00461708|458744882|FG001|Overall Study|Adverse Event|7|||
127486237|NCT00461708|458744881|FG000|Overall Study|Lack of Efficacy|68|||
127486238|NCT00461708|458744882|FG001|Overall Study|Lack of Efficacy|20|||
127486239|NCT00461708|458744881|FG000|Overall Study|Physician Decision|10|||
127486240|NCT00461708|458744882|FG001|Overall Study|Physician Decision|4|||
127486241|NCT00461708|458744881|FG000|Overall Study|Withdrawal by Subject|8|||
127486242|NCT00461708|458744882|FG001|Overall Study|Withdrawal by Subject|2|||
127486243|NCT00461708|458744881|FG000|Overall Study|Other|4|||
127486244|NCT00461708|458744882|FG001|Overall Study|Other|4|||
127486245|NCT00461708|458744881|FG000|Overall Study|Death|8|||
127486246|NCT00461708|458744882|FG001|Overall Study|Death|1|||
127486247|NCT02394561|458744883|FG000|CORE Phase|Adverse Event|7|||
127486248|NCT02394561|458744884|FG001|CORE Phase|Adverse Event|9|||
127486249|NCT02394561|458744883|FG000|CORE Phase|Death|0|||
127486250|NCT02394561|458744884|FG001|CORE Phase|Death|1|||
127486251|NCT02394561|458744883|FG000|CORE Phase|Pregnancy|1|||
127486252|NCT02394561|458744884|FG001|CORE Phase|Pregnancy|0|||
127486253|NCT02394561|458744883|FG000|CORE Phase|Lost to Follow-up|1|||
127486254|NCT02394561|458744884|FG001|CORE Phase|Lost to Follow-up|0|||
127486255|NCT02394561|458744883|FG000|CORE Phase|Physician Decision|1|||
127486256|NCT02394561|458744884|FG001|CORE Phase|Physician Decision|1|||
127486257|NCT02394561|458744883|FG000|CORE Phase|Withdrawal by Subject|2|||
127486258|NCT02394561|458744884|FG001|CORE Phase|Withdrawal by Subject|2|||
127486259|NCT02394561|458744883|FG000|CORE Phase|Lack of Efficacy|1|||
127486260|NCT02394561|458744884|FG001|CORE Phase|Lack of Efficacy|6|||
127486261|NCT02394561|458744883|FG000|Extension Phase|Adverse Event|6|||
127486262|NCT02394561|458744884|FG001|Extension Phase|Adverse Event|1|||
127486263|NCT02394561|458744883|FG000|Extension Phase|Death|0|||
127486264|NCT02394561|458744884|FG001|Extension Phase|Death|1|||
127486265|NCT02394561|458744883|FG000|Extension Phase|Protocol Violation|1|||
127486266|NCT02394561|458744884|FG001|Extension Phase|Protocol Violation|0|||
127486267|NCT02394561|458744883|FG000|Extension Phase|Lost to Follow-up|1|||
127486268|NCT02394561|458744884|FG001|Extension Phase|Lost to Follow-up|0|||
127486269|NCT02394561|458744883|FG000|Extension Phase|Physician Decision|0|||
127486270|NCT02394561|458744884|FG001|Extension Phase|Physician Decision|2|||
127486271|NCT02394561|458744883|FG000|Extension Phase|Withdrawal by Subject|0|||
127486272|NCT02394561|458744884|FG001|Extension Phase|Withdrawal by Subject|5|||
127486273|NCT02394561|458744883|FG000|Extension Phase|Lack of Efficacy|3|||
127486274|NCT02394561|458744884|FG001|Extension Phase|Lack of Efficacy|3|||
127486275|NCT00501644|458744885|FG000|Overall Study|Adverse Event|4|||
127486276|NCT00501644|458744885|FG000|Overall Study|Withdrawal by Subject|1|||
127486277|NCT02750514|458744886|FG000|Track 1|Disease progression|20|||
127486278|NCT02750514|458744887|FG001|Track 1|Disease progression|1|||
127486279|NCT02750514|458744888|FG002|Track 1|Disease progression|0|||
127486280|NCT02750514|458744889|FG003|Track 1|Disease progression|1|||
127486281|NCT02750514|458744890|FG004|Track 1|Disease progression|0|||
127486282|NCT02750514|458744886|FG000|Track 1|Adverse event unrelated to study drug|1|||
127486283|NCT02750514|458744887|FG001|Track 1|Adverse event unrelated to study drug|0|||
127486284|NCT02750514|458744888|FG002|Track 1|Adverse event unrelated to study drug|0|||
127486285|NCT02750514|458744889|FG003|Track 1|Adverse event unrelated to study drug|0|||
127486286|NCT02750514|458744890|FG004|Track 1|Adverse event unrelated to study drug|0|||
127486287|NCT02750514|458744886|FG000|Track 1|Study drug toxicity|4|||
127486288|NCT02750514|458744887|FG001|Track 1|Study drug toxicity|1|||
127486289|NCT02750514|458744888|FG002|Track 1|Study drug toxicity|0|||
127486290|NCT02750514|458744889|FG003|Track 1|Study drug toxicity|1|||
127486291|NCT02750514|458744890|FG004|Track 1|Study drug toxicity|0|||
127486292|NCT02750514|458744886|FG000|Track 1|Participant request to discontinue|1|||
127486293|NCT02750514|458744887|FG001|Track 1|Participant request to discontinue|0|||
127486294|NCT02750514|458744888|FG002|Track 1|Participant request to discontinue|0|||
127976507|NCT03535194|460536128|FG003|Post-Treatment Followup Period|Other|5|||
127976508|NCT03535194|460536129|FG004|Post-Treatment Followup Period|Other|0|||
127976509|NCT03535194|460536125|FG000|Post-Treatment Followup Period|Physician Decision|0|||
127976510|NCT03535194|460536126|FG001|Post-Treatment Followup Period|Physician Decision|2|||
127976511|NCT03535194|460536127|FG002|Post-Treatment Followup Period|Physician Decision|1|||
127486295|NCT02750514|458744889|FG003|Track 1|Participant request to discontinue|0|||
127486296|NCT02750514|458744890|FG004|Track 1|Participant request to discontinue|0|||
127486297|NCT02750514|458744886|FG000|Track 1|Other reasons|1|||
127486298|NCT02750514|458744887|FG001|Track 1|Other reasons|0|||
127486299|NCT02750514|458744888|FG002|Track 1|Other reasons|0|||
127486300|NCT02750514|458744889|FG003|Track 1|Other reasons|0|||
127486301|NCT02750514|458744890|FG004|Track 1|Other reasons|0|||
127486302|NCT02750514|458744886|FG000|Track 2|Disease progression|4|||
127486303|NCT02750514|458744887|FG001|Track 2|Disease progression|5|||
127486304|NCT02750514|458744888|FG002|Track 2|Disease progression|2|||
127486305|NCT02750514|458744889|FG003|Track 2|Disease progression|5|||
127486306|NCT02750514|458744890|FG004|Track 2|Disease progression|0|||
127486307|NCT02750514|458744886|FG000|Track 2|Adverse event unrelated to study drug|1|||
127486308|NCT02750514|458744887|FG001|Track 2|Adverse event unrelated to study drug|0|||
127486309|NCT02750514|458744888|FG002|Track 2|Adverse event unrelated to study drug|0|||
127486310|NCT02750514|458744889|FG003|Track 2|Adverse event unrelated to study drug|0|||
127486311|NCT02750514|458744890|FG004|Track 2|Adverse event unrelated to study drug|0|||
127976512|NCT03535194|460536128|FG003|Post-Treatment Followup Period|Physician Decision|1|||
127486312|NCT02750514|458744886|FG000|Track 2|Study drug toxicity|1|||
127486313|NCT02750514|458744887|FG001|Track 2|Study drug toxicity|2|||
127486314|NCT02750514|458744888|FG002|Track 2|Study drug toxicity|0|||
127486315|NCT02750514|458744889|FG003|Track 2|Study drug toxicity|2|||
127486316|NCT02750514|458744890|FG004|Track 2|Study drug toxicity|0|||
127486317|NCT02750514|458744886|FG000|Track 2|Participant withdrew consent|0|||
127486318|NCT02750514|458744887|FG001|Track 2|Participant withdrew consent|1|||
127486319|NCT02750514|458744888|FG002|Track 2|Participant withdrew consent|0|||
127486320|NCT02750514|458744889|FG003|Track 2|Participant withdrew consent|0|||
127486321|NCT02750514|458744890|FG004|Track 2|Participant withdrew consent|0|||
127486322|NCT02750514|458744886|FG000|Track 3|Disease progression|0|||
127486323|NCT02750514|458744887|FG001|Track 3|Disease progression|24|||
127486324|NCT02750514|458744888|FG002|Track 3|Disease progression|13|||
127486325|NCT02750514|458744889|FG003|Track 3|Disease progression|14|||
127486326|NCT02750514|458744890|FG004|Track 3|Disease progression|0|||
127486327|NCT02750514|458744886|FG000|Track 3|Adverse event unrelated to study drug|0|||
127486328|NCT02750514|458744887|FG001|Track 3|Adverse event unrelated to study drug|1|||
127486329|NCT02750514|458744888|FG002|Track 3|Adverse event unrelated to study drug|1|||
127486330|NCT02750514|458744889|FG003|Track 3|Adverse event unrelated to study drug|1|||
127486331|NCT02750514|458744890|FG004|Track 3|Adverse event unrelated to study drug|0|||
127486332|NCT02750514|458744886|FG000|Track 3|Study drug toxicity|0|||
127486333|NCT02750514|458744887|FG001|Track 3|Study drug toxicity|3|||
127486334|NCT02750514|458744888|FG002|Track 3|Study drug toxicity|0|||
127486335|NCT02750514|458744889|FG003|Track 3|Study drug toxicity|1|||
127486336|NCT02750514|458744890|FG004|Track 3|Study drug toxicity|0|||
127486337|NCT02750514|458744886|FG000|Track 3|Participant request to discontinue|0|||
127486338|NCT02750514|458744887|FG001|Track 3|Participant request to discontinue|2|||
127486339|NCT02750514|458744888|FG002|Track 3|Participant request to discontinue|0|||
127486340|NCT02750514|458744889|FG003|Track 3|Participant request to discontinue|0|||
127486341|NCT02750514|458744890|FG004|Track 3|Participant request to discontinue|0|||
127486342|NCT02750514|458744886|FG000|Track 3|Participant withdrew consent|0|||
127486343|NCT02750514|458744887|FG001|Track 3|Participant withdrew consent|3|||
127486344|NCT02750514|458744888|FG002|Track 3|Participant withdrew consent|1|||
127486345|NCT02750514|458744889|FG003|Track 3|Participant withdrew consent|0|||
127486346|NCT02750514|458744890|FG004|Track 3|Participant withdrew consent|0|||
127486347|NCT02750514|458744886|FG000|Track 3|Other reasons|0|||
127486348|NCT02750514|458744887|FG001|Track 3|Other reasons|3|||
127486349|NCT02750514|458744888|FG002|Track 3|Other reasons|0|||
127486350|NCT02750514|458744889|FG003|Track 3|Other reasons|0|||
127486351|NCT02750514|458744890|FG004|Track 3|Other reasons|0|||
127486352|NCT02750514|458744886|FG000|Track 4|Study drug toxicity|0|||
127486353|NCT02750514|458744887|FG001|Track 4|Study drug toxicity|6|||
127486354|NCT02750514|458744888|FG002|Track 4|Study drug toxicity|0|||
127486355|NCT02750514|458744889|FG003|Track 4|Study drug toxicity|5|||
127486356|NCT02750514|458744890|FG004|Track 4|Study drug toxicity|0|||
127486357|NCT02750514|458744886|FG000|Track 4|Participant request to discontinue|0|||
127486358|NCT02750514|458744887|FG001|Track 4|Participant request to discontinue|1|||
127486359|NCT02750514|458744888|FG002|Track 4|Participant request to discontinue|0|||
127486360|NCT02750514|458744889|FG003|Track 4|Participant request to discontinue|1|||
127486361|NCT02750514|458744890|FG004|Track 4|Participant request to discontinue|0|||
127486362|NCT02750514|458744886|FG000|Track 4|Participant withdrew consent|0|||
127486363|NCT02750514|458744887|FG001|Track 4|Participant withdrew consent|1|||
127486364|NCT02750514|458744888|FG002|Track 4|Participant withdrew consent|0|||
127486365|NCT02750514|458744889|FG003|Track 4|Participant withdrew consent|0|||
127486366|NCT02750514|458744890|FG004|Track 4|Participant withdrew consent|0|||
127486367|NCT02750514|458744886|FG000|Track 4|Other reasons|0|||
127486368|NCT02750514|458744887|FG001|Track 4|Other reasons|5|||
127486369|NCT02750514|458744888|FG002|Track 4|Other reasons|0|||
127976513|NCT03535194|460536129|FG004|Post-Treatment Followup Period|Physician Decision|0|||
127976514|NCT03535194|460536125|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
127976515|NCT03535194|460536126|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
127976516|NCT03535194|460536127|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
127486370|NCT02750514|458744889|FG003|Track 4|Other reasons|3|||
127486371|NCT02750514|458744890|FG004|Track 4|Other reasons|0|||
127486372|NCT02750514|458744886|FG000|Track 4|Disease progression|0|||
127486373|NCT02750514|458744887|FG001|Track 4|Disease progression|33|||
127486374|NCT02750514|458744888|FG002|Track 4|Disease progression|0|||
127486375|NCT02750514|458744889|FG003|Track 4|Disease progression|32|||
127486376|NCT02750514|458744890|FG004|Track 4|Disease progression|0|||
127486377|NCT02750514|458744886|FG000|Track 4|Adverse event unrelated to study drug|0|||
127976517|NCT03535194|460536128|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
127976518|NCT03535194|460536129|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
127976519|NCT02091960|460536130|FG000|Overall Study|Death|7|||
127976520|NCT02091960|460536130|FG000|Overall Study|Withdrawal by Subject|1|||
127486378|NCT02750514|458744887|FG001|Track 4|Adverse event unrelated to study drug|5|||
127486379|NCT02750514|458744888|FG002|Track 4|Adverse event unrelated to study drug|0|||
127486380|NCT02750514|458744889|FG003|Track 4|Adverse event unrelated to study drug|0|||
127486381|NCT02750514|458744890|FG004|Track 4|Adverse event unrelated to study drug|0|||
127486382|NCT02750514|458744886|FG000|Track 4|Death|0|||
127486383|NCT02750514|458744887|FG001|Track 4|Death|0|||
127486384|NCT02750514|458744888|FG002|Track 4|Death|0|||
127486385|NCT02750514|458744889|FG003|Track 4|Death|1|||
127486386|NCT02750514|458744890|FG004|Track 4|Death|0|||
127486387|NCT02750514|458744886|FG000|Track 5|Disease progression|0|||
127486388|NCT02750514|458744887|FG001|Track 5|Disease progression|0|||
127486389|NCT02750514|458744888|FG002|Track 5|Disease progression|0|||
127976521|NCT02091960|460536130|FG000|Overall Study|Miscellaneous Reasons|37|||
127976522|NCT02682823|460536143|FG000|Overall Study|Withdrawal by Subject|0|||
127486390|NCT02750514|458744889|FG003|Track 5|Disease progression|0|||
127486391|NCT02750514|458744890|FG004|Track 5|Disease progression|34|||
127486392|NCT02750514|458744886|FG000|Track 5|Adverse event unrelated to study drug|0|||
127486393|NCT02750514|458744887|FG001|Track 5|Adverse event unrelated to study drug|0|||
127486394|NCT02750514|458744888|FG002|Track 5|Adverse event unrelated to study drug|0|||
127486395|NCT02750514|458744889|FG003|Track 5|Adverse event unrelated to study drug|0|||
127486396|NCT02750514|458744890|FG004|Track 5|Adverse event unrelated to study drug|2|||
127486397|NCT02750514|458744886|FG000|Track 5|Study drug toxicity|0|||
127486398|NCT02750514|458744887|FG001|Track 5|Study drug toxicity|0|||
127486399|NCT02750514|458744888|FG002|Track 5|Study drug toxicity|0|||
127486400|NCT02750514|458744889|FG003|Track 5|Study drug toxicity|0|||
127486401|NCT02750514|458744890|FG004|Track 5|Study drug toxicity|2|||
127486402|NCT02750514|458744886|FG000|Track 5|Participant request to discontinue|0|||
127486403|NCT02750514|458744887|FG001|Track 5|Participant request to discontinue|0|||
127486404|NCT02750514|458744888|FG002|Track 5|Participant request to discontinue|0|||
127486405|NCT02750514|458744889|FG003|Track 5|Participant request to discontinue|0|||
127486406|NCT02750514|458744890|FG004|Track 5|Participant request to discontinue|3|||
127486407|NCT02750514|458744886|FG000|Track 5|Other reasons|0|||
127486408|NCT02750514|458744887|FG001|Track 5|Other reasons|0|||
127486409|NCT02750514|458744888|FG002|Track 5|Other reasons|0|||
127486410|NCT02750514|458744889|FG003|Track 5|Other reasons|0|||
127486411|NCT02750514|458744890|FG004|Track 5|Other reasons|2|||
127486412|NCT02553629|458744891|FG000|Overall Study|Logistic reasons|3|||
127486413|NCT02553629|458744892|FG001|Overall Study|Logistic reasons|6|||
127486414|NCT01812057|458744893|FG000|Overall Study|Protocol Violation|1|||
127486415|NCT01812057|458744894|FG001|Overall Study|Protocol Violation|0|||
127486416|NCT01812057|458744893|FG000|Overall Study|Physician Decision|1|||
127486417|NCT01812057|458744894|FG001|Overall Study|Physician Decision|0|||
127486418|NCT01882465|458744895|FG000|Period 1|Lens Discomfort|0|||
127486419|NCT01882465|458744896|FG001|Period 1|Lens Discomfort|0|||
127486420|NCT01882465|458744897|FG002|Period 1|Lens Discomfort|0|||
127486421|NCT01882465|458744898|FG003|Period 1|Lens Discomfort|1|||
127486422|NCT01882465|458744899|FG004|Period 1|Lens Discomfort|0|||
127486423|NCT01882465|458744900|FG005|Period 1|Lens Discomfort|0|||
127486424|NCT01882465|458744901|FG006|Period 1|Lens Discomfort|0|||
127486425|NCT01882465|458744895|FG000|Period 1|Withdrawal by Subject|0|||
127486426|NCT01882465|458744896|FG001|Period 1|Withdrawal by Subject|0|||
127486427|NCT01882465|458744897|FG002|Period 1|Withdrawal by Subject|0|||
127486428|NCT01882465|458744898|FG003|Period 1|Withdrawal by Subject|0|||
127486429|NCT01882465|458744899|FG004|Period 1|Withdrawal by Subject|0|||
127486430|NCT01882465|458744900|FG005|Period 1|Withdrawal by Subject|0|||
127486431|NCT01882465|458744901|FG006|Period 1|Withdrawal by Subject|1|||
127486432|NCT01882465|458744895|FG000|Period 2|Protocol Violation|0|||
127486433|NCT01882465|458744896|FG001|Period 2|Protocol Violation|0|||
127486434|NCT01882465|458744897|FG002|Period 2|Protocol Violation|0|||
127486435|NCT01882465|458744898|FG003|Period 2|Protocol Violation|0|||
127486436|NCT01882465|458744899|FG004|Period 2|Protocol Violation|1|||
127486437|NCT01882465|458744900|FG005|Period 2|Protocol Violation|0|||
127486438|NCT01882465|458744901|FG006|Period 2|Protocol Violation|0|||
127486439|NCT02259114|458744906|FG000|Overall Study|Progressive Disease|14|||
127486440|NCT02259114|458744907|FG001|Overall Study|Progressive Disease|2|||
127486441|NCT02259114|458744908|FG002|Overall Study|Progressive Disease|10|||
127486442|NCT02259114|458744909|FG003|Overall Study|Progressive Disease|2|||
127486443|NCT02259114|458744910|FG004|Overall Study|Progressive Disease|5|||
127486444|NCT02259114|458744906|FG000|Overall Study|Adverse Event|2|||
127486445|NCT02259114|458744907|FG001|Overall Study|Adverse Event|1|||
127486446|NCT02259114|458744908|FG002|Overall Study|Adverse Event|0|||
127486447|NCT02259114|458744909|FG003|Overall Study|Adverse Event|0|||
127486448|NCT02259114|458744910|FG004|Overall Study|Adverse Event|1|||
127976523|NCT02682823|460536144|FG001|Overall Study|Withdrawal by Subject|0|||
127976524|NCT02682823|460536145|FG002|Overall Study|Withdrawal by Subject|1|||
127486449|NCT02259114|458744906|FG000|Overall Study|Death|3|||
127486450|NCT02259114|458744907|FG001|Overall Study|Death|0|||
127486451|NCT02259114|458744908|FG002|Overall Study|Death|1|||
127486452|NCT02259114|458744909|FG003|Overall Study|Death|0|||
127486453|NCT02259114|458744910|FG004|Overall Study|Death|0|||
127486454|NCT02259114|458744906|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
127486455|NCT02259114|458744907|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
127486456|NCT02259114|458744908|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
127976525|NCT02682823|460536146|FG003|Overall Study|Withdrawal by Subject|0|||
127486457|NCT02259114|458744909|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
127486458|NCT02259114|458744910|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
127486459|NCT02259114|458744906|FG000|Overall Study|Withdrawal by Subject|0|||
127486460|NCT02259114|458744907|FG001|Overall Study|Withdrawal by Subject|0|||
127486461|NCT02259114|458744908|FG002|Overall Study|Withdrawal by Subject|1|||
127486462|NCT02259114|458744909|FG003|Overall Study|Withdrawal by Subject|1|||
127486463|NCT02259114|458744910|FG004|Overall Study|Withdrawal by Subject|0|||
127486464|NCT02259114|458744906|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
127486465|NCT02259114|458744907|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
127486466|NCT02259114|458744908|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
127486467|NCT02259114|458744909|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
127486468|NCT02259114|458744910|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
127486469|NCT02259114|458744906|FG000|Overall Study|Not Treated|1|||
127486470|NCT02259114|458744907|FG001|Overall Study|Not Treated|0|||
127486471|NCT02259114|458744908|FG002|Overall Study|Not Treated|0|||
127486472|NCT02259114|458744909|FG003|Overall Study|Not Treated|0|||
127486473|NCT02259114|458744910|FG004|Overall Study|Not Treated|0|||
127486474|NCT03937479|458744911|FG000|Overall Study|Adverse Event|2|||
127486475|NCT03937479|458744912|FG001|Overall Study|Adverse Event|3|||
127486476|NCT03937479|458744913|FG002|Overall Study|Adverse Event|0|||
127486477|NCT03937479|458744914|FG003|Overall Study|Adverse Event|0|||
127486478|NCT03937479|458744915|FG004|Overall Study|Adverse Event|1|||
127486479|NCT03937479|458744911|FG000|Overall Study|Withdrawal by Subject|3|||
127486480|NCT03937479|458744912|FG001|Overall Study|Withdrawal by Subject|5|||
127486481|NCT03937479|458744913|FG002|Overall Study|Withdrawal by Subject|2|||
127486482|NCT03937479|458744914|FG003|Overall Study|Withdrawal by Subject|2|||
127486483|NCT03937479|458744915|FG004|Overall Study|Withdrawal by Subject|1|||
127486484|NCT03937479|458744911|FG000|Overall Study|Protocol Violation|5|||
127486485|NCT03937479|458744912|FG001|Overall Study|Protocol Violation|6|||
127486486|NCT03937479|458744913|FG002|Overall Study|Protocol Violation|4|||
127486487|NCT03937479|458744914|FG003|Overall Study|Protocol Violation|3|||
127486488|NCT03937479|458744915|FG004|Overall Study|Protocol Violation|2|||
127486489|NCT03937479|458744911|FG000|Overall Study|Lost to Follow-up|0|||
127486490|NCT03937479|458744912|FG001|Overall Study|Lost to Follow-up|1|||
127486491|NCT03937479|458744913|FG002|Overall Study|Lost to Follow-up|0|||
127486492|NCT03937479|458744914|FG003|Overall Study|Lost to Follow-up|1|||
127486493|NCT03937479|458744915|FG004|Overall Study|Lost to Follow-up|0|||
127486494|NCT03937479|458744911|FG000|Overall Study|Physician Decision|0|||
127486495|NCT03937479|458744912|FG001|Overall Study|Physician Decision|0|||
127486496|NCT03937479|458744913|FG002|Overall Study|Physician Decision|1|||
127486497|NCT03937479|458744914|FG003|Overall Study|Physician Decision|0|||
127486498|NCT03937479|458744915|FG004|Overall Study|Physician Decision|1|||
127486499|NCT01378117|458744918|FG000|Overall Study|withdrawal|2|||
127486500|NCT01378117|458744919|FG001|Overall Study|withdrawal|1|||
127486501|NCT01378117|458744920|FG002|Overall Study|withdrawal|2|||
127486502|NCT01378117|458744918|FG000|Overall Study|discharged before med given|2|||
127486503|NCT01378117|458744919|FG001|Overall Study|discharged before med given|0|||
127486504|NCT01378117|458744920|FG002|Overall Study|discharged before med given|1|||
127486505|NCT01854528|458744922|FG000|Overall Study|Adverse Event|0|||
127486506|NCT01854528|458744923|FG001|Overall Study|Adverse Event|4|||
127486507|NCT01854528|458744922|FG000|Overall Study|Withdrawal by Subject|0|||
127486508|NCT01854528|458744923|FG001|Overall Study|Withdrawal by Subject|2|||
127486509|NCT01854528|458744922|FG000|Overall Study|Virologic Failure|0|||
127486510|NCT01854528|458744923|FG001|Overall Study|Virologic Failure|9|||
127486511|NCT02961244|458744924|FG000|Overall Study|Protocol Violation|0|||
127486512|NCT02961244|458744925|FG001|Overall Study|Protocol Violation|1|||
127486513|NCT02961244|458744924|FG000|Overall Study|Withdrawal by Subject|1|||
127486514|NCT02961244|458744925|FG001|Overall Study|Withdrawal by Subject|2|||
127486515|NCT02961244|458744924|FG000|Overall Study|Surgery plan change after study approval|0|||
127486516|NCT02961244|458744925|FG001|Overall Study|Surgery plan change after study approval|2|||
127486517|NCT02961244|458744924|FG000|Overall Study|Lost to Follow-up|0|||
127486518|NCT02961244|458744925|FG001|Overall Study|Lost to Follow-up|2|||
127486519|NCT02961244|458744924|FG000|Overall Study|İnadequate data|0|||
127486520|NCT02961244|458744925|FG001|Overall Study|İnadequate data|2|||
127976526|NCT02682823|460536147|FG004|Overall Study|Withdrawal by Subject|1|||
127976527|NCT02682823|460536143|FG000|Overall Study|Protocol Deviation|0|||
127976528|NCT02682823|460536144|FG001|Overall Study|Protocol Deviation|1|||
127976529|NCT02682823|460536145|FG002|Overall Study|Protocol Deviation|0|||
127976530|NCT02682823|460536146|FG003|Overall Study|Protocol Deviation|0|||
127976531|NCT02682823|460536147|FG004|Overall Study|Protocol Deviation|0|||
127486521|NCT03789292|458744926|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
127486522|NCT03789292|458744927|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
127486523|NCT03789292|458744928|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
127486524|NCT03789292|458744926|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
127486525|NCT03789292|458744927|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
127486526|NCT03789292|458744928|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
127486527|NCT03789292|458744926|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
127486528|NCT03789292|458744927|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
127486529|NCT03789292|458744928|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
127486530|NCT03789292|458744926|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
127486531|NCT03789292|458744927|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
127486532|NCT03789292|458744928|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
127486533|NCT03789292|458744926|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
127486534|NCT03789292|458744927|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
127486535|NCT03789292|458744928|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
127486536|NCT03789292|458744926|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
127486537|NCT03789292|458744927|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
127486538|NCT03789292|458744928|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
127486539|NCT03789292|458744926|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
127486540|NCT03789292|458744927|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
127486541|NCT03789292|458744928|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
127486542|NCT03789292|458744926|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
127486543|NCT03789292|458744927|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
127486544|NCT03789292|458744928|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
127486545|NCT03789292|458744926|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
127486546|NCT03789292|458744927|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
127486547|NCT03789292|458744928|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
127486548|NCT03789292|458744926|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
127486549|NCT03789292|458744927|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
127486550|NCT03789292|458744928|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
127486551|NCT03789292|458744926|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
127486552|NCT03789292|458744927|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
127486553|NCT03789292|458744928|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
127486554|NCT03789292|458744926|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
127486555|NCT03789292|458744927|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
127486556|NCT03789292|458744928|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
127486557|NCT03789292|458744926|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
127486558|NCT03789292|458744927|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
127486559|NCT03789292|458744928|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
127486560|NCT01904721|458744930|FG000|Overall Study|Other Reasons|0|||
127486561|NCT01904721|458744931|FG001|Overall Study|Other Reasons|0|||
127486562|NCT01904721|458744932|FG002|Overall Study|Other Reasons|1|||
127486563|NCT01904721|458744933|FG003|Overall Study|Other Reasons|1|||
127486564|NCT01904721|458744934|FG004|Overall Study|Other Reasons|2|||
127486565|NCT01904721|458744935|FG005|Overall Study|Other Reasons|2|||
127486566|NCT01904721|458744936|FG006|Overall Study|Other Reasons|2|||
127486567|NCT01904721|458744930|FG000|Overall Study|Personal Reasons|0|||
127486568|NCT01904721|458744931|FG001|Overall Study|Personal Reasons|0|||
127486569|NCT01904721|458744932|FG002|Overall Study|Personal Reasons|0|||
127486570|NCT01904721|458744933|FG003|Overall Study|Personal Reasons|0|||
127486571|NCT01904721|458744934|FG004|Overall Study|Personal Reasons|2|||
127486572|NCT01904721|458744935|FG005|Overall Study|Personal Reasons|3|||
127486573|NCT01904721|458744936|FG006|Overall Study|Personal Reasons|3|||
127486574|NCT01904721|458744930|FG000|Overall Study|Lost to Follow-up|0|||
127486575|NCT01904721|458744931|FG001|Overall Study|Lost to Follow-up|0|||
127486576|NCT01904721|458744932|FG002|Overall Study|Lost to Follow-up|0|||
127486577|NCT01904721|458744933|FG003|Overall Study|Lost to Follow-up|0|||
127486578|NCT01904721|458744934|FG004|Overall Study|Lost to Follow-up|1|||
127486579|NCT01904721|458744935|FG005|Overall Study|Lost to Follow-up|3|||
127486580|NCT01904721|458744936|FG006|Overall Study|Lost to Follow-up|1|||
127486581|NCT01904721|458744930|FG000|Overall Study|Lack of Efficacy|0|||
127486582|NCT01904721|458744931|FG001|Overall Study|Lack of Efficacy|0|||
127486583|NCT01904721|458744932|FG002|Overall Study|Lack of Efficacy|0|||
127486584|NCT01904721|458744933|FG003|Overall Study|Lack of Efficacy|0|||
127486585|NCT01904721|458744934|FG004|Overall Study|Lack of Efficacy|0|||
127486586|NCT01904721|458744935|FG005|Overall Study|Lack of Efficacy|0|||
127486587|NCT01904721|458744936|FG006|Overall Study|Lack of Efficacy|1|||
127486588|NCT01904721|458744930|FG000|Overall Study|Adverse Event|0|||
127486589|NCT01904721|458744931|FG001|Overall Study|Adverse Event|0|||
127486590|NCT01904721|458744932|FG002|Overall Study|Adverse Event|0|||
127486591|NCT01904721|458744933|FG003|Overall Study|Adverse Event|0|||
127486592|NCT01904721|458744934|FG004|Overall Study|Adverse Event|3|||
127486593|NCT01904721|458744935|FG005|Overall Study|Adverse Event|1|||
127486594|NCT01904721|458744936|FG006|Overall Study|Adverse Event|0|||
127486595|NCT01957865|458744937|FG000|Overall Study|Found HIV negative|0|||
127486596|NCT01957865|458744938|FG001|Overall Study|Found HIV negative|0|||
127486597|NCT01957865|458744939|FG002|Overall Study|Found HIV negative|1|||
127486598|NCT01957865|458744937|FG000|Overall Study|Lost to Follow-up|0|||
127486599|NCT01957865|458744938|FG001|Overall Study|Lost to Follow-up|2|||
127486600|NCT01957865|458744939|FG002|Overall Study|Lost to Follow-up|2|||
127486601|NCT01082614|458744940|FG000|Overall Study|Adverse Event|1|||
127486602|NCT01082614|458744941|FG001|Overall Study|Adverse Event|4|||
127486603|NCT01082614|458744940|FG000|Overall Study|Equipment Malfunction|0|||
127486604|NCT01082614|458744941|FG001|Overall Study|Equipment Malfunction|1|||
127486605|NCT01082614|458744940|FG000|Overall Study|Physician Decision|2|||
127486606|NCT01082614|458744941|FG001|Overall Study|Physician Decision|0|||
127486607|NCT00811720|458744945|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
127486608|NCT00811720|458744946|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
127486609|NCT00811720|458744945|FG000|All Treated Patients|Adverse Event|20|||
127486610|NCT00811720|458744946|FG001|All Treated Patients|Adverse Event|62|||
127486611|NCT00811720|458744945|FG000|All Treated Patients|Lack of Efficacy|22|||
127486612|NCT00811720|458744946|FG001|All Treated Patients|Lack of Efficacy|18|||
127486613|NCT00811720|458744945|FG000|All Treated Patients|Non-compliance|0|||
127486614|NCT00811720|458744946|FG001|All Treated Patients|Non-compliance|14|||
127486615|NCT00811720|458744945|FG000|All Treated Patients|Protocol Violation|9|||
127486616|NCT00811720|458744946|FG001|All Treated Patients|Protocol Violation|16|||
127486617|NCT00811720|458744945|FG000|All Treated Patients|Withdrawal by Subject|28|||
127486618|NCT00811720|458744946|FG001|All Treated Patients|Withdrawal by Subject|34|||
127486619|NCT00811720|458744945|FG000|All Treated Patients|Lost to Follow-up|10|||
127486620|NCT00811720|458744946|FG001|All Treated Patients|Lost to Follow-up|16|||
127486621|NCT00811720|458744945|FG000|All Treated Patients|Other Reason|7|||
127486622|NCT00811720|458744946|FG001|All Treated Patients|Other Reason|4|||
127486623|NCT01077063|458744947|FG000|Overall Study|Adverse Event|3|||
127486624|NCT01077063|458744948|FG001|Overall Study|Adverse Event|0|||
127486625|NCT01077063|458744947|FG000|Overall Study|Death|1|||
127486626|NCT01077063|458744948|FG001|Overall Study|Death|1|||
127486627|NCT01077063|458744947|FG000|Overall Study|Withdrawal by Subject|0|||
127486628|NCT01077063|458744948|FG001|Overall Study|Withdrawal by Subject|2|||
127486629|NCT03894891|458744949|FG000|Overall Study|Withdrawal by Subject|1|||
127486630|NCT03894891|458744949|FG000|Overall Study|Completed protocol treatment per protocol|5|||
127486631|NCT00553631|458744953|FG000|Overall Study|Withdrawal by Subject|0|||
127486632|NCT00553631|458744954|FG001|Overall Study|Withdrawal by Subject|1|||
127486633|NCT00553631|458744953|FG000|Overall Study|Lost to Follow-up|1|||
127486634|NCT00553631|458744954|FG001|Overall Study|Lost to Follow-up|0|||
127486635|NCT02761642|458744955|FG000|Overall Study|Did not Receive Study Treatment|3|||
127486636|NCT02761642|458744955|FG000|Overall Study|Adverse Event|13|||
127486637|NCT02761642|458744955|FG000|Overall Study|Withdrawal by Subject|2|||
127486638|NCT02761642|458744955|FG000|Overall Study|Non-compliant|7|||
127486639|NCT02761642|458744955|FG000|Overall Study|Death|3|||
127486640|NCT02761642|458744955|FG000|Overall Study|Lack of Efficacy|20|||
127486641|NCT02761642|458744955|FG000|Overall Study|Physician Decision|1|||
127486642|NCT02761642|458744955|FG000|Overall Study|Reason Unspecified|21|||
127486643|NCT00950651|458744956|FG000|Overall Study|Adverse Event|17|||
127486644|NCT00950651|458744957|FG001|Overall Study|Adverse Event|20|||
127486645|NCT00950651|458744956|FG000|Overall Study|Death|1|||
127486646|NCT00950651|458744957|FG001|Overall Study|Death|0|||
127486647|NCT00950651|458744956|FG000|Overall Study|Lack of Efficacy|2|||
127486648|NCT00950651|458744957|FG001|Overall Study|Lack of Efficacy|2|||
127486649|NCT00950651|458744956|FG000|Overall Study|Protocol Violation|3|||
127486650|NCT00950651|458744957|FG001|Overall Study|Protocol Violation|4|||
127486651|NCT00950651|458744956|FG000|Overall Study|Withdrawal by Subject|8|||
127486652|NCT00950651|458744957|FG001|Overall Study|Withdrawal by Subject|9|||
127486653|NCT02756403|458744962|FG000|Overall Study|Unable to swallow medication|0|||
127486654|NCT02756403|458744963|FG001|Overall Study|Unable to swallow medication|1|||
127486655|NCT02756403|458744964|FG002|Overall Study|Unable to swallow medication|1|||
127486656|NCT02756403|458744965|FG003|Overall Study|Unable to swallow medication|1|||
127486657|NCT02756403|458744962|FG000|Overall Study|Did not complete Procedure|0|||
127486658|NCT02756403|458744963|FG001|Overall Study|Did not complete Procedure|1|||
127486659|NCT02756403|458744964|FG002|Overall Study|Did not complete Procedure|0|||
127486660|NCT02756403|458744965|FG003|Overall Study|Did not complete Procedure|0|||
127486661|NCT02756403|458744962|FG000|Overall Study|Changed Mind About Procedure|0|||
127486662|NCT02756403|458744963|FG001|Overall Study|Changed Mind About Procedure|0|||
127486663|NCT02756403|458744964|FG002|Overall Study|Changed Mind About Procedure|1|||
127486664|NCT02756403|458744965|FG003|Overall Study|Changed Mind About Procedure|0|||
127486665|NCT02756403|458744962|FG000|Overall Study|Protocol Violation|0|||
127486666|NCT02756403|458744963|FG001|Overall Study|Protocol Violation|1|||
127486667|NCT02756403|458744964|FG002|Overall Study|Protocol Violation|0|||
127486668|NCT02756403|458744965|FG003|Overall Study|Protocol Violation|1|||
127486669|NCT01644643|458744966|FG000|Overall Study|Death|1|||
127486670|NCT01644643|458744967|FG001|Overall Study|Death|0|||
127976532|NCT02682823|460536143|FG000|Overall Study|Adverse Event|0|||
127486671|NCT01644643|458744968|FG002|Overall Study|Death|3|||
127486672|NCT01644643|458744969|FG003|Overall Study|Death|3|||
127486673|NCT01644643|458744966|FG000|Overall Study|Lost to Follow-up|0|||
127486674|NCT01644643|458744967|FG001|Overall Study|Lost to Follow-up|0|||
127486675|NCT01644643|458744968|FG002|Overall Study|Lost to Follow-up|0|||
127486676|NCT01644643|458744969|FG003|Overall Study|Lost to Follow-up|4|||
127486677|NCT01644643|458744966|FG000|Overall Study|Withdrawal by Subject|1|||
127486678|NCT01644643|458744967|FG001|Overall Study|Withdrawal by Subject|0|||
127486679|NCT01644643|458744968|FG002|Overall Study|Withdrawal by Subject|2|||
127486680|NCT01644643|458744969|FG003|Overall Study|Withdrawal by Subject|1|||
127486681|NCT01644643|458744966|FG000|Overall Study|Other Eligibility criteria|0|||
127486682|NCT01644643|458744967|FG001|Overall Study|Other Eligibility criteria|0|||
127486683|NCT01644643|458744968|FG002|Overall Study|Other Eligibility criteria|0|||
127486684|NCT01644643|458744969|FG003|Overall Study|Other Eligibility criteria|2|||
127486685|NCT02850978|458744974|FG000|Overall Study|Uncollectable CRF|27|||
127486686|NCT02850978|458744974|FG000|Overall Study|No visit since the first visit|35|||
127486687|NCT02850978|458744974|FG000|Overall Study|Adverse Event|81|||
127486688|NCT02850978|458744974|FG000|Overall Study|Lack of Efficacy|40|||
127486689|NCT02850978|458744974|FG000|Overall Study|Improvement in condition|34|||
127486690|NCT02850978|458744974|FG000|Overall Study|Lost to Follow-up|121|||
127486691|NCT02850978|458744974|FG000|Overall Study|Reason not listed|88|||
127486692|NCT03188263|458744977|FG000|Overall Study|Withdrawal by Subject|3|||
127486693|NCT03188263|458744978|FG001|Overall Study|Withdrawal by Subject|0|||
127486694|NCT03188263|458744977|FG000|Overall Study|Physician Decision|1|||
127486695|NCT03188263|458744978|FG001|Overall Study|Physician Decision|0|||
127486696|NCT01030822|458744979|FG000|Overall Study|Moved/migrated from study area|6|||
127486697|NCT01030822|458744980|FG001|Overall Study|Moved/migrated from study area|7|||
127486698|NCT01030822|458744981|FG002|Overall Study|Moved/migrated from study area|3|||
127486699|NCT01030822|458744979|FG000|Overall Study|Withdrawal by Subject|16|||
127486700|NCT01030822|458744980|FG001|Overall Study|Withdrawal by Subject|13|||
127486701|NCT01030822|458744981|FG002|Overall Study|Withdrawal by Subject|16|||
127486702|NCT01030822|458744979|FG000|Overall Study|Lost to Follow-up|9|||
127486703|NCT01030822|458744980|FG001|Overall Study|Lost to Follow-up|4|||
127486704|NCT01030822|458744981|FG002|Overall Study|Lost to Follow-up|7|||
127486705|NCT00539240|458744982|FG000|Overall Study|Withdrawal by Subject|0|||
127486706|NCT00539240|458744983|FG001|Overall Study|Withdrawal by Subject|2|||
127486707|NCT00539240|458744984|FG002|Overall Study|Withdrawal by Subject|0|||
127486708|NCT00539240|458744982|FG000|Overall Study|Protocol Violation|1|||
127486709|NCT00539240|458744983|FG001|Overall Study|Protocol Violation|1|||
127486710|NCT00539240|458744984|FG002|Overall Study|Protocol Violation|4|||
127486711|NCT00539240|458744982|FG000|Overall Study|Lost to Follow-up|2|||
127486712|NCT00539240|458744983|FG001|Overall Study|Lost to Follow-up|3|||
127486713|NCT00539240|458744984|FG002|Overall Study|Lost to Follow-up|1|||
127486714|NCT00539240|458744982|FG000|Overall Study|Adverse Event|3|||
127486715|NCT00539240|458744983|FG001|Overall Study|Adverse Event|1|||
127486716|NCT00539240|458744984|FG002|Overall Study|Adverse Event|10|||
127486717|NCT01055613|458744985|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
127486718|NCT01055613|458744986|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
127486719|NCT01055613|458744985|FG000|Overall Study|Unacceptable lens fit|1|||
127486720|NCT01055613|458744986|FG001|Overall Study|Unacceptable lens fit|0|||
127486721|NCT01055613|458744985|FG000|Overall Study|Discomfort|2|||
127486722|NCT01055613|458744986|FG001|Overall Study|Discomfort|1|||
127486723|NCT01055613|458744985|FG000|Overall Study|Lost to Follow-up|1|||
127486724|NCT01055613|458744986|FG001|Overall Study|Lost to Follow-up|1|||
127486725|NCT01055613|458744985|FG000|Overall Study|Protocol Violation|1|||
127486726|NCT01055613|458744986|FG001|Overall Study|Protocol Violation|1|||
127486727|NCT01055613|458744985|FG000|Overall Study|Subject Disinterest|1|||
127486728|NCT01055613|458744986|FG001|Overall Study|Subject Disinterest|1|||
127486729|NCT02765399|458744987|FG000|Overall Study|Nausea|1|||
127486730|NCT02765399|458744988|FG001|Overall Study|Nausea|0|||
127486731|NCT01182298|458744995|FG000|Overall Study|Lack of Efficacy|4|||
127486732|NCT01182298|458744995|FG000|Overall Study|Withdrawal by Subject|2|||
127486733|NCT04540367|458745009|FG000|Overall Study|Withdrawal by Subject|0|||
127486734|NCT04540367|458745010|FG001|Overall Study|Withdrawal by Subject|0|||
127486735|NCT04540367|458745011|FG002|Overall Study|Withdrawal by Subject|0|||
127486736|NCT04540367|458745012|FG003|Overall Study|Withdrawal by Subject|2|||
127486737|NCT04540367|458745009|FG000|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
127486738|NCT04540367|458745010|FG001|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
127486739|NCT04540367|458745011|FG002|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|4|||
127486740|NCT04540367|458745012|FG003|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|1|||
127486741|NCT04540367|458745009|FG000|Overall Study|Adverse Event|0|||
127486742|NCT04540367|458745010|FG001|Overall Study|Adverse Event|0|||
127486743|NCT04540367|458745011|FG002|Overall Study|Adverse Event|1|||
127486744|NCT04540367|458745012|FG003|Overall Study|Adverse Event|1|||
127486745|NCT04422431|458745013|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
127486746|NCT04422431|458745013|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
127486747|NCT04422431|458745013|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
127486748|NCT04422431|458745013|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|1|||
127486749|NCT04422431|458745013|FG000|Extension Period (48 Weeks)|Lost to Follow-up|1|||
127486750|NCT04422431|458745013|FG000|Extension Period (48 Weeks)|Other than specified|2|||
127486751|NCT02317627|458745016|FG000|Overall Study|Withdrawal by Subject|0|||
127486752|NCT02317627|458745017|FG001|Overall Study|Withdrawal by Subject|1|||
127486753|NCT02317627|458745018|FG002|Overall Study|Withdrawal by Subject|1|||
127486754|NCT02317627|458745016|FG000|Overall Study|Lost to Follow-up|2|||
127486755|NCT02317627|458745017|FG001|Overall Study|Lost to Follow-up|0|||
127486756|NCT02317627|458745018|FG002|Overall Study|Lost to Follow-up|0|||
127486757|NCT02317627|458745016|FG000|Overall Study|Stopped by Investigator|0|||
127486758|NCT02317627|458745017|FG001|Overall Study|Stopped by Investigator|1|||
127486759|NCT02317627|458745018|FG002|Overall Study|Stopped by Investigator|0|||
127486760|NCT02317627|458745016|FG000|Overall Study|Adverse Event|0|||
127486761|NCT02317627|458745017|FG001|Overall Study|Adverse Event|2|||
127486762|NCT02317627|458745018|FG002|Overall Study|Adverse Event|3|||
127486763|NCT02317627|458745016|FG000|Overall Study|Non-compliance with study drug|0|||
127486764|NCT02317627|458745017|FG001|Overall Study|Non-compliance with study drug|1|||
127486765|NCT02317627|458745018|FG002|Overall Study|Non-compliance with study drug|0|||
127486766|NCT00027560|458745020|FG000|Overall Study|Withdrawal by Subject|1|||
127486767|NCT03384875|458745021|FG000|Overall Study|Death|1|||
127486768|NCT03384875|458745022|FG001|Overall Study|Death|1|||
127486769|NCT03384875|458745023|FG002|Overall Study|Death|0|||
127486770|NCT03384875|458745021|FG000|Overall Study|Reason not provided|1|||
127486771|NCT03384875|458745022|FG001|Overall Study|Reason not provided|0|||
127486772|NCT03384875|458745023|FG002|Overall Study|Reason not provided|0|||
127486773|NCT02735421|458746357|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
127486774|NCT02735421|458746357|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
127486775|NCT02735421|458746357|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
127486776|NCT02735421|458746357|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
127486777|NCT02735421|458746357|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
127486778|NCT02735421|458746357|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
127486779|NCT02735421|458746357|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
127486780|NCT05010070|458746358|FG000|Overall Study|Lost to Follow-up|1|||
127486781|NCT05010070|458746358|FG000|Overall Study|Withdrawal by Subject|1|||
127486782|NCT00939107|458746359|FG000|Overall Study|Lost to Follow-up|14|||
127486783|NCT00939107|458746360|FG001|Overall Study|Lost to Follow-up|12|||
127486784|NCT03247829|458746362|FG000|Overall Study|Death|3|||
127486785|NCT03247829|458746363|FG001|Overall Study|Death|4|||
127486786|NCT03247829|458746362|FG000|Overall Study|Enter Hospice Care|1|||
127486787|NCT03247829|458746363|FG001|Overall Study|Enter Hospice Care|0|||
127486788|NCT03247829|458746362|FG000|Overall Study|LVAD System Replaced / Exchange|1|||
127486789|NCT03247829|458746363|FG001|Overall Study|LVAD System Replaced / Exchange|0|||
127486790|NCT03247829|458746362|FG000|Overall Study|LVAD Explant|1|||
127486791|NCT03247829|458746363|FG001|Overall Study|LVAD Explant|1|||
127486792|NCT03247829|458746362|FG000|Overall Study|Transplant|1|||
127486793|NCT03247829|458746363|FG001|Overall Study|Transplant|1|||
127486794|NCT01783444|458746364|FG000|Treatment Phase|Adverse Event|9|||
127486795|NCT01783444|458746365|FG001|Treatment Phase|Adverse Event|20|||
127486796|NCT01783444|458746366|FG002|Treatment Phase|Adverse Event|19|||
127486797|NCT01783444|458746364|FG000|Treatment Phase|Disease Progression|76|||
127486798|NCT01783444|458746365|FG001|Treatment Phase|Disease Progression|66|||
127486799|NCT01783444|458746366|FG002|Treatment Phase|Disease Progression|64|||
127486800|NCT01783444|458746364|FG000|Treatment Phase|Death|2|||
127486801|NCT01783444|458746365|FG001|Treatment Phase|Death|2|||
127486802|NCT01783444|458746366|FG002|Treatment Phase|Death|2|||
127486803|NCT01783444|458746364|FG000|Treatment Phase|Protocol Violation|1|||
127486804|NCT01783444|458746365|FG001|Treatment Phase|Protocol Violation|1|||
127486805|NCT01783444|458746366|FG002|Treatment Phase|Protocol Violation|2|||
127486806|NCT01783444|458746364|FG000|Treatment Phase|Withdrawal by Subject|6|||
127486807|NCT01783444|458746365|FG001|Treatment Phase|Withdrawal by Subject|8|||
127486808|NCT01783444|458746366|FG002|Treatment Phase|Withdrawal by Subject|9|||
127486809|NCT01783444|458746364|FG000|Treatment Phase|Administrative problems|2|||
127486810|NCT01783444|458746365|FG001|Treatment Phase|Administrative problems|0|||
127486811|NCT01783444|458746366|FG002|Treatment Phase|Administrative problems|1|||
127486812|NCT01783444|458746364|FG000|Treatment Phase|Physician Decision|8|||
127486813|NCT01783444|458746365|FG001|Treatment Phase|Physician Decision|6|||
127486814|NCT01783444|458746366|FG002|Treatment Phase|Physician Decision|5|||
127486815|NCT01783444|458746364|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
127486816|NCT01783444|458746365|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
127486817|NCT01783444|458746366|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
127486818|NCT01783444|458746364|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
127486819|NCT01783444|458746365|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
127486820|NCT01783444|458746366|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
127486821|NCT01783444|458746364|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
127486822|NCT01783444|458746365|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
127486823|NCT01783444|458746366|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
127486824|NCT01783444|458746364|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
127486825|NCT01783444|458746365|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
127486826|NCT01783444|458746366|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
127869731|NCT02557308|460139634|FG000|Overall Study|Study Close|98|||
127869732|NCT02557308|460139635|FG001|Overall Study|Study Close|18|||
127869733|NCT02557308|460139636|FG002|Overall Study|Study Close|5|||
127486827|NCT01783444|458746364|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
127486828|NCT01783444|458746365|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
127486829|NCT01783444|458746366|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
127486830|NCT01783444|458746364|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
127486831|NCT01783444|458746365|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
127486832|NCT01783444|458746366|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
127486833|NCT01047007|458746372|FG000|Overall Study|Adverse Event|0|||
127486834|NCT01047007|458746373|FG001|Overall Study|Adverse Event|2|||
127486835|NCT01047007|458746374|FG002|Overall Study|Adverse Event|1|||
127486836|NCT01047007|458746375|FG003|Overall Study|Adverse Event|0|||
127486837|NCT01047007|458746372|FG000|Overall Study|Progressive Disease|2|||
127486838|NCT01047007|458746373|FG001|Overall Study|Progressive Disease|4|||
127486839|NCT01047007|458746374|FG002|Overall Study|Progressive Disease|1|||
127486840|NCT01047007|458746375|FG003|Overall Study|Progressive Disease|0|||
127486841|NCT01334554|458746376|FG000|Overall Study|Adverse Event|4|||
127486842|NCT01334554|458746377|FG001|Overall Study|Adverse Event|2|||
127486843|NCT02393859|458746378|FG000|Overall Study|Decision by Sponsor|2|||
127486844|NCT02393859|458746379|FG001|Overall Study|Decision by Sponsor|4|||
127486845|NCT02393859|458746378|FG000|Overall Study|Withdrawal by Subject|11|||
127486846|NCT02393859|458746379|FG001|Overall Study|Withdrawal by Subject|6|||
127486847|NCT02393859|458746378|FG000|Overall Study|Death|27|||
127486848|NCT02393859|458746379|FG001|Overall Study|Death|10|||
127486849|NCT02393859|458746378|FG000|Overall Study|Lost to Follow-up|1|||
127486850|NCT02393859|458746379|FG001|Overall Study|Lost to Follow-up|1|||
127486851|NCT00954447|458746380|FG000|Overall Study|Adverse Event|33|||
127486852|NCT00954447|458746381|FG001|Overall Study|Adverse Event|25|||
127486853|NCT00954447|458746380|FG000|Overall Study|Lack of Efficacy|17|||
127486854|NCT00954447|458746381|FG001|Overall Study|Lack of Efficacy|3|||
127486855|NCT00954447|458746380|FG000|Overall Study|Protocol Violation|5|||
127486856|NCT00954447|458746381|FG001|Overall Study|Protocol Violation|7|||
127486857|NCT00954447|458746380|FG000|Overall Study|Lost to Follow-up|8|||
127486858|NCT00954447|458746381|FG001|Overall Study|Lost to Follow-up|14|||
127486859|NCT00954447|458746380|FG000|Overall Study|Withdrawal by Subject|26|||
127486860|NCT00954447|458746381|FG001|Overall Study|Withdrawal by Subject|21|||
127486861|NCT00954447|458746380|FG000|Overall Study|Other|21|||
127486862|NCT00954447|458746381|FG001|Overall Study|Other|18|||
127486863|NCT04592341|458746382|FG000|Overall Study|Physician Decision|5|||
127486864|NCT04592341|458746382|FG000|Overall Study|Study Terminated by Sponsor|5|||
127486865|NCT04592341|458746382|FG000|Overall Study|Withdrawal by Subject|53|||
127486866|NCT04592341|458746382|FG000|Overall Study|Lost to Follow-up|3|||
127486867|NCT04592341|458746382|FG000|Overall Study|Death|1|||
127486868|NCT04592341|458746382|FG000|Overall Study|Adverse Event|5|||
127486869|NCT04592341|458746382|FG000|Overall Study|other|4|||
127486870|NCT00692003|458746383|FG000|Overall Study|Sponsor Decision|5|||
127486871|NCT00692003|458746384|FG001|Overall Study|Sponsor Decision|1|||
127486872|NCT01248793|458746385|FG000|Overall Study|Lost to Follow-up|0|||
127486873|NCT01248793|458746386|FG001|Overall Study|Lost to Follow-up|1|||
127486874|NCT01248793|458746385|FG000|Overall Study|Adverse Event|1|||
127486875|NCT01248793|458746386|FG001|Overall Study|Adverse Event|1|||
127486876|NCT01248793|458746385|FG000|Overall Study|Protocol Violation|0|||
127486877|NCT01248793|458746386|FG001|Overall Study|Protocol Violation|1|||
127486878|NCT01248793|458746385|FG000|Overall Study|Withdrawal by Subject|3|||
127486879|NCT01248793|458746386|FG001|Overall Study|Withdrawal by Subject|3|||
127486880|NCT01840943|458746387|FG000|Overall Study|Withdrawal by Subject|5|||
127486881|NCT01840943|458746388|FG001|Overall Study|Withdrawal by Subject|6|||
127486882|NCT01840943|458746387|FG000|Overall Study|Physician Decision|4|||
127486883|NCT01840943|458746388|FG001|Overall Study|Physician Decision|2|||
127976533|NCT02682823|460536144|FG001|Overall Study|Adverse Event|0|||
127976534|NCT02682823|460536145|FG002|Overall Study|Adverse Event|0|||
127486884|NCT01840943|458746387|FG000|Overall Study|Lost to Follow-up|4|||
127486885|NCT01840943|458746388|FG001|Overall Study|Lost to Follow-up|4|||
127486886|NCT02580877|458746391|FG000|Overall Study|Withdrawal by Subject|1|||
127486887|NCT02580877|458746392|FG001|Overall Study|Withdrawal by Subject|3|||
127976535|NCT02682823|460536146|FG003|Overall Study|Adverse Event|1|||
127976536|NCT02682823|460536147|FG004|Overall Study|Adverse Event|0|||
127486888|NCT02580877|458746391|FG000|Overall Study|Adverse Event|0|||
127486889|NCT02580877|458746392|FG001|Overall Study|Adverse Event|1|||
127486890|NCT02903823|458746393|FG000|Overall Study|Physician Decision|5|||
127486891|NCT02903823|458746393|FG000|Overall Study|Could not advance catheter|1|||
127486892|NCT02903823|458746393|FG000|Overall Study|Catheter dislodgement|1|||
127486893|NCT01747915|458746394|FG000|Overall Study|Other|1|||
127486894|NCT01747915|458746395|FG001|Overall Study|Other|1|||
127486895|NCT01747915|458746396|FG002|Overall Study|Other|1|||
127486896|NCT01747915|458746394|FG000|Overall Study|Adverse Event|8|||
127486897|NCT01747915|458746395|FG001|Overall Study|Adverse Event|5|||
127486898|NCT01747915|458746396|FG002|Overall Study|Adverse Event|2|||
127486899|NCT01747915|458746394|FG000|Overall Study|Death|0|||
127486900|NCT01747915|458746395|FG001|Overall Study|Death|0|||
127486901|NCT01747915|458746396|FG002|Overall Study|Death|1|||
127486902|NCT01747915|458746394|FG000|Overall Study|Lack of Efficacy|0|||
127486903|NCT01747915|458746395|FG001|Overall Study|Lack of Efficacy|1|||
127486904|NCT01747915|458746396|FG002|Overall Study|Lack of Efficacy|0|||
127486905|NCT01747915|458746394|FG000|Overall Study|Lost to Follow-up|1|||
127486906|NCT01747915|458746395|FG001|Overall Study|Lost to Follow-up|0|||
127486907|NCT01747915|458746396|FG002|Overall Study|Lost to Follow-up|0|||
127486908|NCT01747915|458746394|FG000|Overall Study|Withdrawal by Subject|4|||
127486909|NCT01747915|458746395|FG001|Overall Study|Withdrawal by Subject|4|||
127486910|NCT01747915|458746396|FG002|Overall Study|Withdrawal by Subject|1|||
127486911|NCT01747915|458746394|FG000|Overall Study|Protocol Violation|1|||
127486912|NCT01747915|458746395|FG001|Overall Study|Protocol Violation|0|||
127486913|NCT01747915|458746396|FG002|Overall Study|Protocol Violation|0|||
127486914|NCT01747915|458746394|FG000|Overall Study|Pregnancy|0|||
127486915|NCT01747915|458746395|FG001|Overall Study|Pregnancy|0|||
127486916|NCT01747915|458746396|FG002|Overall Study|Pregnancy|1|||
127486917|NCT03341637|458746397|FG000|Overall Study|Lost to Follow-up|1|||
127486918|NCT03341637|458746398|FG001|Overall Study|Lost to Follow-up|0|||
127486919|NCT03341637|458746397|FG000|Overall Study|Withdrawal by Subject|3|||
127486920|NCT03341637|458746398|FG001|Overall Study|Withdrawal by Subject|3|||
127486921|NCT03341637|458746397|FG000|Overall Study|Reason not Specified|1|||
127486922|NCT03341637|458746398|FG001|Overall Study|Reason not Specified|1|||
127486923|NCT00887159|458746405|FG000|Overall Study|Disease progression|6|||
127486924|NCT00887159|458746406|FG001|Overall Study|Disease progression|39|||
127486925|NCT00887159|458746407|FG002|Overall Study|Disease progression|33|||
127486926|NCT00887159|458746405|FG000|Overall Study|Adverse Event|3|||
127486927|NCT00887159|458746406|FG001|Overall Study|Adverse Event|4|||
127486928|NCT00887159|458746407|FG002|Overall Study|Adverse Event|17|||
127486929|NCT00887159|458746405|FG000|Overall Study|Death|2|||
127486930|NCT00887159|458746406|FG001|Overall Study|Death|2|||
127486931|NCT00887159|458746407|FG002|Overall Study|Death|0|||
127486932|NCT00887159|458746405|FG000|Overall Study|Withdrawal by Subject|4|||
127486933|NCT00887159|458746406|FG001|Overall Study|Withdrawal by Subject|4|||
127486934|NCT00887159|458746407|FG002|Overall Study|Withdrawal by Subject|2|||
127486935|NCT00887159|458746405|FG000|Overall Study|Alternative therapy|2|||
127486936|NCT00887159|458746406|FG001|Overall Study|Alternative therapy|0|||
127486937|NCT00887159|458746407|FG002|Overall Study|Alternative therapy|0|||
127486938|NCT00887159|458746405|FG000|Overall Study|Physician Decision|1|||
127486939|NCT00887159|458746406|FG001|Overall Study|Physician Decision|1|||
127486940|NCT00887159|458746407|FG002|Overall Study|Physician Decision|0|||
127486941|NCT00887159|458746405|FG000|Overall Study|Sympomatic deterioration|1|||
127486942|NCT00887159|458746406|FG001|Overall Study|Sympomatic deterioration|0|||
127486943|NCT00887159|458746407|FG002|Overall Study|Sympomatic deterioration|0|||
127486944|NCT00887159|458746405|FG000|Overall Study|Treatment delayed|1|||
127486945|NCT00887159|458746406|FG001|Overall Study|Treatment delayed|1|||
127486946|NCT00887159|458746407|FG002|Overall Study|Treatment delayed|0|||
127486947|NCT00887159|458746405|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
127486948|NCT00887159|458746406|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
127486949|NCT00887159|458746407|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
127486950|NCT00887159|458746405|FG000|Overall Study|Received more tx instead of observation|1|||
127486951|NCT00887159|458746406|FG001|Overall Study|Received more tx instead of observation|0|||
127486952|NCT00887159|458746407|FG002|Overall Study|Received more tx instead of observation|0|||
127486953|NCT00887159|458746405|FG000|Overall Study|Ineligible|5|||
127486954|NCT00887159|458746406|FG001|Overall Study|Ineligible|1|||
127486955|NCT00887159|458746407|FG002|Overall Study|Ineligible|0|||
127486956|NCT00887159|458746405|FG000|Overall Study|Never started assigned therapy|3|||
127486957|NCT00887159|458746406|FG001|Overall Study|Never started assigned therapy|3|||
127486958|NCT00887159|458746407|FG002|Overall Study|Never started assigned therapy|4|||
127486959|NCT01772550|458746411|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
127486960|NCT01772550|458746412|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
127486961|NCT01772550|458746413|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
127486962|NCT01772550|458746411|FG000|Overall Study|Adverse Event|0|||
127486963|NCT01772550|458746412|FG001|Overall Study|Adverse Event|0|||
127486964|NCT01772550|458746413|FG002|Overall Study|Adverse Event|1|||
127486965|NCT03374358|458746417|FG000|Overall Study|Withdrawal by Subject|0|||
127486966|NCT03374358|458746418|FG001|Overall Study|Withdrawal by Subject|2|||
127486967|NCT03183063|458746419|FG000|Overall Study|Withdrawal by Subject|2|||
127486968|NCT03183063|458746420|FG001|Overall Study|Withdrawal by Subject|0|||
127486969|NCT03183063|458746421|FG002|Overall Study|Withdrawal by Subject|0|||
127486970|NCT03183063|458746419|FG000|Overall Study|Physician Decision|3|||
127486971|NCT03183063|458746420|FG001|Overall Study|Physician Decision|4|||
127486972|NCT03183063|458746421|FG002|Overall Study|Physician Decision|4|||
127486973|NCT01127633|458746422|FG000|Overall Study|Adverse Event|74|||
127486974|NCT01127633|458746423|FG001|Overall Study|Adverse Event|73|||
127486975|NCT01127633|458746422|FG000|Overall Study|Death|40|||
127486976|NCT01127633|458746423|FG001|Overall Study|Death|43|||
127486977|NCT01127633|458746422|FG000|Overall Study|Lost to Follow-up|4|||
127486978|NCT01127633|458746423|FG001|Overall Study|Lost to Follow-up|0|||
127486979|NCT01127633|458746422|FG000|Overall Study|Parent/Caregiver Decision|246|||
127486980|NCT01127633|458746423|FG001|Overall Study|Parent/Caregiver Decision|228|||
127486981|NCT01127633|458746422|FG000|Overall Study|Physician Decision|60|||
127486982|NCT01127633|458746423|FG001|Overall Study|Physician Decision|45|||
127486983|NCT01127633|458746422|FG000|Overall Study|Withdrawal by Subject|57|||
127486984|NCT01127633|458746423|FG001|Overall Study|Withdrawal by Subject|72|||
127486985|NCT01127633|458746422|FG000|Overall Study|Sponsor Decision|163|||
127486986|NCT01127633|458746423|FG001|Overall Study|Sponsor Decision|195|||
127486987|NCT01127633|458746422|FG000|Overall Study|Protocol Violation|8|||
127486988|NCT01127633|458746423|FG001|Overall Study|Protocol Violation|16|||
127486989|NCT01127633|458746422|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
127486990|NCT01127633|458746423|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
127486991|NCT01127633|458746422|FG000|Overall Study|Not treated|1|||
127486992|NCT01127633|458746423|FG001|Overall Study|Not treated|0|||
127486993|NCT00688467|458746424|FG000|Treatment Period 1|Adverse Event|2|||
127486994|NCT00688467|458746425|FG001|Treatment Period 1|Adverse Event|1|||
127486995|NCT00688467|458746424|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
127486996|NCT00688467|458746425|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
127486997|NCT00688467|458746424|FG000|Treatment Period 2|Protocol Violation|0|||
127486998|NCT00688467|458746425|FG001|Treatment Period 2|Protocol Violation|1|||
127486999|NCT00688467|458746424|FG000|Treatment Period 2|Adverse Event|0|||
127487000|NCT00688467|458746425|FG001|Treatment Period 2|Adverse Event|1|||
127487001|NCT00690794|458746429|FG000|Overall Study|Adverse Event|12|||
127487002|NCT00690794|458746430|FG001|Overall Study|Adverse Event|10|||
127487003|NCT00690794|458746429|FG000|Overall Study|Lost to Follow-up|1|||
127487004|NCT00690794|458746430|FG001|Overall Study|Lost to Follow-up|4|||
127487005|NCT00690794|458746429|FG000|Overall Study|Withdrawal by Subject|0|||
127487006|NCT00690794|458746430|FG001|Overall Study|Withdrawal by Subject|9|||
127487007|NCT00690794|458746429|FG000|Overall Study|Protocol Violation|6|||
127487008|NCT00690794|458746430|FG001|Overall Study|Protocol Violation|7|||
127487009|NCT00690794|458746429|FG000|Overall Study|Noncompliance|1|||
127487010|NCT00690794|458746430|FG001|Overall Study|Noncompliance|2|||
127487011|NCT00690794|458746429|FG000|Overall Study|Other not specified|1|||
127487012|NCT00690794|458746430|FG001|Overall Study|Other not specified|3|||
127487013|NCT01823107|458746431|FG000|Overall Study|Withdrawal by Subject|1|||
127487014|NCT01343888|458746432|FG000|Overall Study|Adverse Event|12|||
127487015|NCT01343888|458746433|FG001|Overall Study|Adverse Event|22|||
127487016|NCT01343888|458746434|FG002|Overall Study|Adverse Event|5|||
127487017|NCT01343888|458746432|FG000|Overall Study|Lack of Efficacy|9|||
127487018|NCT01343888|458746433|FG001|Overall Study|Lack of Efficacy|9|||
127487019|NCT01343888|458746434|FG002|Overall Study|Lack of Efficacy|13|||
127487020|NCT01343888|458746432|FG000|Overall Study|Lost to Follow-up|0|||
127487021|NCT01343888|458746433|FG001|Overall Study|Lost to Follow-up|2|||
127487022|NCT01343888|458746434|FG002|Overall Study|Lost to Follow-up|1|||
127487023|NCT01343888|458746432|FG000|Overall Study|Protocol Violation|0|||
127487024|NCT01343888|458746433|FG001|Overall Study|Protocol Violation|2|||
127487025|NCT01343888|458746434|FG002|Overall Study|Protocol Violation|0|||
127487026|NCT01343888|458746432|FG000|Overall Study|Withdrawal by Subject|4|||
127487027|NCT01343888|458746433|FG001|Overall Study|Withdrawal by Subject|4|||
127487028|NCT01343888|458746434|FG002|Overall Study|Withdrawal by Subject|2|||
127487029|NCT01343888|458746432|FG000|Overall Study|other than stated above|0|||
127487030|NCT01343888|458746433|FG001|Overall Study|other than stated above|0|||
127487031|NCT01343888|458746434|FG002|Overall Study|other than stated above|1|||
127487032|NCT01331681|458746437|FG000|Overall Study|Adverse Event|10|||
127487033|NCT01331681|458746438|FG001|Overall Study|Adverse Event|13|||
127487034|NCT01331681|458746439|FG002|Overall Study|Adverse Event|10|||
127487035|NCT01331681|458746437|FG000|Overall Study|Death|6|||
127487036|NCT01331681|458746438|FG001|Overall Study|Death|6|||
127487037|NCT01331681|458746439|FG002|Overall Study|Death|2|||
127487038|NCT01331681|458746437|FG000|Overall Study|Lack of Efficacy|0|||
127487039|NCT01331681|458746438|FG001|Overall Study|Lack of Efficacy|1|||
127487040|NCT01331681|458746439|FG002|Overall Study|Lack of Efficacy|0|||
127487041|NCT01331681|458746437|FG000|Overall Study|Withdrawal by Subject|12|||
127976537|NCT01938430|460536148|FG000|Overall Study|Randomized but Not Treated|0|||
127976538|NCT01938430|460536149|FG001|Overall Study|Randomized but Not Treated|0|||
127487042|NCT01331681|458746438|FG001|Overall Study|Withdrawal by Subject|8|||
127487043|NCT01331681|458746439|FG002|Overall Study|Withdrawal by Subject|15|||
127487044|NCT01331681|458746437|FG000|Overall Study|Protocol Violation|1|||
127487045|NCT01331681|458746438|FG001|Overall Study|Protocol Violation|1|||
127976539|NCT01938430|460536150|FG002|Overall Study|Randomized but Not Treated|0|||
127487046|NCT01331681|458746439|FG002|Overall Study|Protocol Violation|0|||
127487047|NCT01331681|458746437|FG000|Overall Study|Lost to Follow-up|2|||
127487048|NCT01331681|458746438|FG001|Overall Study|Lost to Follow-up|4|||
127487049|NCT01331681|458746439|FG002|Overall Study|Lost to Follow-up|1|||
127487050|NCT01331681|458746437|FG000|Overall Study|Physician Decision|2|||
127976540|NCT01938430|460536151|FG003|Overall Study|Randomized but Not Treated|0|||
127487051|NCT01331681|458746438|FG001|Overall Study|Physician Decision|0|||
127487052|NCT01331681|458746439|FG002|Overall Study|Physician Decision|4|||
127487053|NCT01331681|458746437|FG000|Overall Study|Therapeutic procedure required|1|||
127487054|NCT01331681|458746438|FG001|Overall Study|Therapeutic procedure required|0|||
127487055|NCT01331681|458746439|FG002|Overall Study|Therapeutic procedure required|0|||
127487056|NCT01331681|458746437|FG000|Overall Study|Sponsor decision|1|||
127487057|NCT01331681|458746438|FG001|Overall Study|Sponsor decision|1|||
127487058|NCT01331681|458746439|FG002|Overall Study|Sponsor decision|0|||
127487059|NCT01331681|458746437|FG000|Overall Study|Switching to other therapy|0|||
127487060|NCT01331681|458746438|FG001|Overall Study|Switching to other therapy|0|||
127487061|NCT01331681|458746439|FG002|Overall Study|Switching to other therapy|1|||
127487062|NCT01331681|458746437|FG000|Overall Study|Not Received Study Treatment|0|||
127487063|NCT01331681|458746438|FG001|Overall Study|Not Received Study Treatment|0|||
127487064|NCT01331681|458746439|FG002|Overall Study|Not Received Study Treatment|2|||
127487065|NCT03326063|458746440|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
127487066|NCT03326063|458746441|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
127487067|NCT02803203|458746442|FG000|Overall Study|Adverse Event|4|||
127487068|NCT02803203|458746442|FG000|Overall Study|Death|4|||
127487069|NCT02803203|458746442|FG000|Overall Study|Progressive disease|29|||
127487070|NCT02803203|458746442|FG000|Overall Study|Withdrawal by Subject|8|||
127487071|NCT02803203|458746442|FG000|Overall Study|Complete resection of target disease|2|||
127487072|NCT02803203|458746442|FG000|Overall Study|Switched to commercial Osi|1|||
127487073|NCT02803203|458746442|FG000|Overall Study|Participant moved away|1|||
127487074|NCT04577781|458746443|FG000|Overall Study|Adverse Event|2|||
127487075|NCT04577781|458746444|FG001|Overall Study|Adverse Event|2|||
127487076|NCT04577781|458746443|FG000|Overall Study|Physician Decision|1|||
127487077|NCT04577781|458746444|FG001|Overall Study|Physician Decision|0|||
127487078|NCT00114127|458746445|FG000|Overall Study|Adverse Event|2|||
127487079|NCT00114127|458746446|FG001|Overall Study|Adverse Event|1|||
127487080|NCT00114127|458746445|FG000|Overall Study|Lost to Follow-up|1|||
127487081|NCT00114127|458746446|FG001|Overall Study|Lost to Follow-up|0|||
127487082|NCT00114127|458746445|FG000|Overall Study|Withdrawal by Subject|1|||
127487083|NCT00114127|458746446|FG001|Overall Study|Withdrawal by Subject|3|||
127487084|NCT00881894|458746447|FG000|Overall Study|Consent withdrawn|0|||
127487085|NCT00881894|458746448|FG001|Overall Study|Consent withdrawn|1|||
127487086|NCT00881894|458746447|FG000|Overall Study|Other reasons for premature termination|1|||
127487087|NCT00881894|458746448|FG001|Overall Study|Other reasons for premature termination|2|||
127487088|NCT00421148|458746449|FG000|Overall Study|Lost to Follow-up|0|||
127487089|NCT00421148|458746450|FG001|Overall Study|Lost to Follow-up|0|||
127487090|NCT00421148|458746451|FG002|Overall Study|Lost to Follow-up|0|||
127487091|NCT00421148|458746452|FG003|Overall Study|Lost to Follow-up|0|||
127487092|NCT00421148|458746453|FG004|Overall Study|Lost to Follow-up|0|||
127487093|NCT00421148|458746454|FG005|Overall Study|Lost to Follow-up|0|||
127487094|NCT00421148|458746455|FG006|Overall Study|Lost to Follow-up|0|||
127487095|NCT00421148|458746456|FG007|Overall Study|Lost to Follow-up|0|||
127487096|NCT00421148|458746457|FG008|Overall Study|Lost to Follow-up|0|||
127487097|NCT00421148|458746458|FG009|Overall Study|Lost to Follow-up|0|||
127487098|NCT00421148|458746459|FG010|Overall Study|Lost to Follow-up|0|||
127487099|NCT00421148|458746460|FG011|Overall Study|Lost to Follow-up|0|||
127487100|NCT00421148|458746461|FG012|Overall Study|Lost to Follow-up|0|||
127487101|NCT00421148|458746462|FG013|Overall Study|Lost to Follow-up|0|||
127487102|NCT00421148|458746463|FG014|Overall Study|Lost to Follow-up|0|||
127487103|NCT00421148|458746464|FG015|Overall Study|Lost to Follow-up|0|||
127487104|NCT00421148|458746465|FG016|Overall Study|Lost to Follow-up|0|||
127487105|NCT00421148|458746466|FG017|Overall Study|Lost to Follow-up|1|||
127487106|NCT00421148|458746467|FG018|Overall Study|Lost to Follow-up|0|||
127487107|NCT00421148|458746468|FG019|Overall Study|Lost to Follow-up|0|||
127487108|NCT00421148|458746449|FG000|Overall Study|Withdrawal by Subject|0|||
127487109|NCT00421148|458746450|FG001|Overall Study|Withdrawal by Subject|0|||
127487110|NCT00421148|458746451|FG002|Overall Study|Withdrawal by Subject|0|||
127487111|NCT00421148|458746452|FG003|Overall Study|Withdrawal by Subject|0|||
127487112|NCT00421148|458746453|FG004|Overall Study|Withdrawal by Subject|0|||
127487113|NCT00421148|458746454|FG005|Overall Study|Withdrawal by Subject|0|||
127487114|NCT00421148|458746455|FG006|Overall Study|Withdrawal by Subject|0|||
127487115|NCT00421148|458746456|FG007|Overall Study|Withdrawal by Subject|0|||
127487116|NCT00421148|458746457|FG008|Overall Study|Withdrawal by Subject|0|||
127487117|NCT00421148|458746458|FG009|Overall Study|Withdrawal by Subject|0|||
127487118|NCT00421148|458746459|FG010|Overall Study|Withdrawal by Subject|0|||
127487119|NCT00421148|458746460|FG011|Overall Study|Withdrawal by Subject|0|||
127976541|NCT01938430|460536152|FG004|Overall Study|Randomized but Not Treated|0|||
127976542|NCT01938430|460536153|FG005|Overall Study|Randomized but Not Treated|0|||
127487120|NCT00421148|458746461|FG012|Overall Study|Withdrawal by Subject|0|||
127487121|NCT00421148|458746462|FG013|Overall Study|Withdrawal by Subject|0|||
127976543|NCT01938430|460536154|FG006|Overall Study|Randomized but Not Treated|0|||
127487122|NCT00421148|458746463|FG014|Overall Study|Withdrawal by Subject|0|||
127487123|NCT00421148|458746464|FG015|Overall Study|Withdrawal by Subject|0|||
127487124|NCT00421148|458746465|FG016|Overall Study|Withdrawal by Subject|0|||
127487125|NCT00421148|458746466|FG017|Overall Study|Withdrawal by Subject|1|||
127487126|NCT00421148|458746467|FG018|Overall Study|Withdrawal by Subject|0|||
127487127|NCT00421148|458746468|FG019|Overall Study|Withdrawal by Subject|0|||
127487128|NCT00421148|458746449|FG000|Overall Study|Protocol Violation|0|||
127487129|NCT00421148|458746450|FG001|Overall Study|Protocol Violation|0|||
127487130|NCT00421148|458746451|FG002|Overall Study|Protocol Violation|0|||
127487131|NCT00421148|458746452|FG003|Overall Study|Protocol Violation|0|||
127487132|NCT00421148|458746453|FG004|Overall Study|Protocol Violation|0|||
127487133|NCT00421148|458746454|FG005|Overall Study|Protocol Violation|1|||
127487134|NCT00421148|458746455|FG006|Overall Study|Protocol Violation|0|||
127487135|NCT00421148|458746456|FG007|Overall Study|Protocol Violation|0|||
127487136|NCT00421148|458746457|FG008|Overall Study|Protocol Violation|0|||
127487137|NCT00421148|458746458|FG009|Overall Study|Protocol Violation|0|||
127487138|NCT00421148|458746459|FG010|Overall Study|Protocol Violation|0|||
127487139|NCT00421148|458746460|FG011|Overall Study|Protocol Violation|0|||
127487140|NCT00421148|458746461|FG012|Overall Study|Protocol Violation|0|||
127487141|NCT00421148|458746462|FG013|Overall Study|Protocol Violation|0|||
127487142|NCT00421148|458746463|FG014|Overall Study|Protocol Violation|0|||
127487143|NCT00421148|458746464|FG015|Overall Study|Protocol Violation|0|||
127487144|NCT00421148|458746465|FG016|Overall Study|Protocol Violation|0|||
127487145|NCT00421148|458746466|FG017|Overall Study|Protocol Violation|0|||
127487146|NCT00421148|458746467|FG018|Overall Study|Protocol Violation|1|||
127487147|NCT00421148|458746468|FG019|Overall Study|Protocol Violation|0|||
127487148|NCT00469833|458746469|FG000|Overall Study|No IV access|2|||
127487149|NCT01822665|458746472|FG000|Overall Study|Adverse Event|3|||
127487150|NCT01822665|458746472|FG000|Overall Study|Other Reason|5|||
127487151|NCT00959907|458746475|FG000|Overall Study|Protocol Violation|0|||
127487152|NCT00959907|458746476|FG001|Overall Study|Protocol Violation|1|||
127487153|NCT00959907|458746475|FG000|Overall Study|Adverse Event|1|||
127487154|NCT00959907|458746476|FG001|Overall Study|Adverse Event|0|||
127487155|NCT00959907|458746475|FG000|Overall Study|Withdrawal by Subject|2|||
127487156|NCT00959907|458746476|FG001|Overall Study|Withdrawal by Subject|0|||
127976544|NCT01938430|460536155|FG007|Overall Study|Randomized but Not Treated|0|||
127976545|NCT01938430|460536156|FG008|Overall Study|Randomized but Not Treated|0|||
127487157|NCT03958331|458746477|FG000|Overall Study|Withdrawal by Subject|3|||
127487158|NCT03958331|458746478|FG001|Overall Study|Withdrawal by Subject|1|||
127487159|NCT03958331|458746479|FG002|Overall Study|Withdrawal by Subject|5|||
127487160|NCT03958331|458746477|FG000|Overall Study|Weaned from medicine|2|||
127487161|NCT03958331|458746478|FG001|Overall Study|Weaned from medicine|0|||
127487162|NCT03958331|458746479|FG002|Overall Study|Weaned from medicine|0|||
127487163|NCT03958331|458746477|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
127487164|NCT03958331|458746478|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
127976546|NCT01938430|460536157|FG009|Overall Study|Randomized but Not Treated|0|||
127976547|NCT01938430|460536158|FG010|Overall Study|Randomized but Not Treated|1|||
127976548|NCT01938430|460536159|FG011|Overall Study|Randomized but Not Treated|0|||
127976549|NCT01938430|460536160|FG012|Overall Study|Randomized but Not Treated|0|||
127976550|NCT01938430|460536161|FG013|Overall Study|Randomized but Not Treated|1|||
127976551|NCT01938430|460536148|FG000|Overall Study|Adverse Event|0|||
127976552|NCT01938430|460536149|FG001|Overall Study|Adverse Event|0|||
127976553|NCT01938430|460536150|FG002|Overall Study|Adverse Event|0|||
127976554|NCT01938430|460536151|FG003|Overall Study|Adverse Event|0|||
127976555|NCT01938430|460536152|FG004|Overall Study|Adverse Event|0|||
127976556|NCT01938430|460536153|FG005|Overall Study|Adverse Event|0|||
127976557|NCT01938430|460536154|FG006|Overall Study|Adverse Event|1|||
127976558|NCT01938430|460536155|FG007|Overall Study|Adverse Event|0|||
127976559|NCT01938430|460536156|FG008|Overall Study|Adverse Event|0|||
127976560|NCT01938430|460536157|FG009|Overall Study|Adverse Event|0|||
127976561|NCT01938430|460536158|FG010|Overall Study|Adverse Event|0|||
127976562|NCT01938430|460536159|FG011|Overall Study|Adverse Event|0|||
127976563|NCT01938430|460536160|FG012|Overall Study|Adverse Event|0|||
127976564|NCT01938430|460536161|FG013|Overall Study|Adverse Event|0|||
127487165|NCT03958331|458746479|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
127487166|NCT01171677|458746481|FG000|Overall Study|Withdrawal by Subject|0|||
127487167|NCT01171677|458746482|FG001|Overall Study|Withdrawal by Subject|3|||
127487168|NCT01171677|458746481|FG000|Overall Study|Adverse Event|1|||
127487169|NCT01171677|458746482|FG001|Overall Study|Adverse Event|0|||
127487170|NCT01171677|458746481|FG000|Overall Study|completed <70% IntenSati classes|5|||
127976565|NCT01938430|460536148|FG000|Overall Study|Death|1|||
127487171|NCT01171677|458746482|FG001|Overall Study|completed <70% IntenSati classes|0|||
127487172|NCT01847443|458746483|FG000|Study Period 1|Withdrawal by Subject|0|||
127487173|NCT01847443|458746484|FG001|Study Period 1|Withdrawal by Subject|1|||
127976566|NCT01938430|460536149|FG001|Overall Study|Death|2|||
127487174|NCT01847443|458746485|FG002|Study Period 1|Withdrawal by Subject|0|||
127487175|NCT01847443|458746486|FG003|Study Period 1|Withdrawal by Subject|0|||
127487176|NCT01847443|458746483|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
127487177|NCT01847443|458746484|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
127487178|NCT01847443|458746485|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
127487179|NCT01847443|458746486|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
127976567|NCT01938430|460536150|FG002|Overall Study|Death|2|||
127976568|NCT01938430|460536151|FG003|Overall Study|Death|1|||
127487180|NCT01847443|458746483|FG000|Washout Period Before Study Period 2|Other reason|1|||
127487181|NCT01847443|458746484|FG001|Washout Period Before Study Period 2|Other reason|0|||
127487182|NCT01847443|458746485|FG002|Washout Period Before Study Period 2|Other reason|0|||
127487183|NCT01847443|458746486|FG003|Washout Period Before Study Period 2|Other reason|0|||
127487184|NCT01847443|458746483|FG000|Washout Period Before Study Period 3|Other reason|1|||
127487185|NCT01847443|458746484|FG001|Washout Period Before Study Period 3|Other reason|0|||
127487186|NCT01847443|458746485|FG002|Washout Period Before Study Period 3|Other reason|0|||
127487187|NCT01847443|458746486|FG003|Washout Period Before Study Period 3|Other reason|0|||
127487188|NCT01847443|458746483|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
127487189|NCT01847443|458746484|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
127487190|NCT01847443|458746485|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
127487191|NCT01847443|458746486|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
127487192|NCT01847443|458746483|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
127487193|NCT01847443|458746484|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
127487194|NCT01847443|458746485|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
127487195|NCT01847443|458746486|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
127487196|NCT03571971|458746487|FG000|Overall Study|Lost to Follow-up|2|||
127487197|NCT03571971|458746488|FG001|Overall Study|Lost to Follow-up|2|||
127487198|NCT03571971|458746487|FG000|Overall Study|Protocol Violation|2|||
127487199|NCT03571971|458746488|FG001|Overall Study|Protocol Violation|3|||
127487200|NCT03571971|458746487|FG000|Overall Study|Withdrawal by Subject|2|||
127487201|NCT03571971|458746488|FG001|Overall Study|Withdrawal by Subject|0|||
127487202|NCT03571971|458746487|FG000|Overall Study|Incomplete primary outcome data|2|||
127487203|NCT03571971|458746488|FG001|Overall Study|Incomplete primary outcome data|0|||
127487204|NCT04046939|458746500|FG000|Primary Assessment Period|Adverse Event|1|||
127487205|NCT04046939|458746501|FG001|Primary Assessment Period|Adverse Event|0|||
127487206|NCT04046939|458746502|FG002|Primary Assessment Period|Adverse Event|0|||
127487207|NCT04046939|458746503|FG003|Primary Assessment Period|Adverse Event|0|||
127487208|NCT04046939|458746500|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
127487209|NCT04046939|458746501|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
127487210|NCT04046939|458746502|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
127487211|NCT04046939|458746503|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
127487212|NCT04046939|458746500|FG000|Primary Assessment Period|Physician Decision|0|||
127487213|NCT04046939|458746501|FG001|Primary Assessment Period|Physician Decision|0|||
127487214|NCT04046939|458746502|FG002|Primary Assessment Period|Physician Decision|1|||
127487215|NCT04046939|458746503|FG003|Primary Assessment Period|Physician Decision|0|||
127487216|NCT04046939|458746500|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
127487217|NCT04046939|458746501|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
127487218|NCT04046939|458746502|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
127487219|NCT04046939|458746503|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
127487220|NCT00403130|458746504|FG000|2 Years From Start of Treatment|Not Eligible|3|||
127487221|NCT00403130|458746504|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
127487222|NCT00403130|458746504|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
127487223|NCT00403130|458746504|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
127487224|NCT00806260|458746505|FG000|Period 1 (1 Day)|Adverse Event|0|||
127487225|NCT00806260|458746506|FG001|Period 1 (1 Day)|Adverse Event|0|||
127487226|NCT00806260|458746507|FG002|Period 1 (1 Day)|Adverse Event|0|||
127487227|NCT00806260|458746508|FG003|Period 1 (1 Day)|Adverse Event|0|||
127487228|NCT00806260|458746509|FG004|Period 1 (1 Day)|Adverse Event|3|||
127487229|NCT00806260|458746510|FG005|Period 1 (1 Day)|Adverse Event|0|||
127487230|NCT00806260|458746505|FG000|Period 2|Adverse Event|0|||
127487231|NCT00806260|458746506|FG001|Period 2|Adverse Event|0|||
127487232|NCT00806260|458746507|FG002|Period 2|Adverse Event|0|||
127487233|NCT00806260|458746508|FG003|Period 2|Adverse Event|1|||
127487234|NCT00806260|458746509|FG004|Period 2|Adverse Event|0|||
127487235|NCT00806260|458746510|FG005|Period 2|Adverse Event|0|||
127487236|NCT00806260|458746505|FG000|Period 2|Protocol Violation|1|||
127487237|NCT00806260|458746506|FG001|Period 2|Protocol Violation|0|||
127487238|NCT00806260|458746507|FG002|Period 2|Protocol Violation|1|||
127487239|NCT00806260|458746508|FG003|Period 2|Protocol Violation|0|||
127487240|NCT00806260|458746509|FG004|Period 2|Protocol Violation|0|||
127487241|NCT00806260|458746510|FG005|Period 2|Protocol Violation|0|||
127487242|NCT00806260|458746505|FG000|Period 2|Need to take concomitant medication|1|||
127487243|NCT00806260|458746506|FG001|Period 2|Need to take concomitant medication|0|||
127487244|NCT00806260|458746507|FG002|Period 2|Need to take concomitant medication|0|||
127976569|NCT01938430|460536152|FG004|Overall Study|Death|0|||
127487245|NCT00806260|458746508|FG003|Period 2|Need to take concomitant medication|0|||
127487246|NCT00806260|458746509|FG004|Period 2|Need to take concomitant medication|0|||
127487247|NCT00806260|458746510|FG005|Period 2|Need to take concomitant medication|0|||
127487248|NCT00806260|458746505|FG000|Period 2|sponsor request|0|||
127487249|NCT00806260|458746506|FG001|Period 2|sponsor request|0|||
127487250|NCT00806260|458746507|FG002|Period 2|sponsor request|1|||
127487251|NCT00806260|458746508|FG003|Period 2|sponsor request|1|||
127487252|NCT00806260|458746509|FG004|Period 2|sponsor request|0|||
127487253|NCT00806260|458746510|FG005|Period 2|sponsor request|0|||
127487254|NCT00806260|458746505|FG000|Period 3|Protocol Violation|0|||
127487255|NCT00806260|458746506|FG001|Period 3|Protocol Violation|1|||
127487256|NCT00806260|458746507|FG002|Period 3|Protocol Violation|1|||
127487257|NCT00806260|458746508|FG003|Period 3|Protocol Violation|0|||
127487258|NCT00806260|458746509|FG004|Period 3|Protocol Violation|0|||
127487259|NCT00806260|458746510|FG005|Period 3|Protocol Violation|0|||
127487260|NCT00806260|458746505|FG000|Period 3|Pregnancy|1|||
127487261|NCT00806260|458746506|FG001|Period 3|Pregnancy|0|||
127487262|NCT00806260|458746507|FG002|Period 3|Pregnancy|0|||
127487263|NCT00806260|458746508|FG003|Period 3|Pregnancy|0|||
127487264|NCT00806260|458746509|FG004|Period 3|Pregnancy|0|||
127487265|NCT00806260|458746510|FG005|Period 3|Pregnancy|0|||
127487266|NCT03559270|458746511|FG000|Overall Study|Adverse Event|6|||
127487267|NCT03559270|458746512|FG001|Overall Study|Adverse Event|5|||
127487268|NCT03559270|458746513|FG002|Overall Study|Adverse Event|3|||
127487269|NCT03559270|458746514|FG003|Overall Study|Adverse Event|0|||
127487270|NCT03559270|458746511|FG000|Overall Study|Lack of Efficacy|34|||
127487271|NCT03559270|458746512|FG001|Overall Study|Lack of Efficacy|52|||
127487272|NCT03559270|458746513|FG002|Overall Study|Lack of Efficacy|37|||
127487273|NCT03559270|458746514|FG003|Overall Study|Lack of Efficacy|2|||
127487274|NCT03559270|458746511|FG000|Overall Study|Death|0|||
127487275|NCT03559270|458746512|FG001|Overall Study|Death|2|||
127487276|NCT03559270|458746513|FG002|Overall Study|Death|0|||
127487277|NCT03559270|458746514|FG003|Overall Study|Death|0|||
127487278|NCT03559270|458746511|FG000|Overall Study|Lost to Follow-up|16|||
127487279|NCT03559270|458746512|FG001|Overall Study|Lost to Follow-up|4|||
127487280|NCT03559270|458746513|FG002|Overall Study|Lost to Follow-up|12|||
127487281|NCT03559270|458746514|FG003|Overall Study|Lost to Follow-up|3|||
127487282|NCT03559270|458746511|FG000|Overall Study|Sponsor Decision|38|||
127487283|NCT03559270|458746512|FG001|Overall Study|Sponsor Decision|31|||
127487284|NCT03559270|458746513|FG002|Overall Study|Sponsor Decision|35|||
127487285|NCT03559270|458746514|FG003|Overall Study|Sponsor Decision|18|||
127487286|NCT03559270|458746511|FG000|Overall Study|Withdrawal by Subject|19|||
127487287|NCT03559270|458746512|FG001|Overall Study|Withdrawal by Subject|21|||
127487288|NCT03559270|458746513|FG002|Overall Study|Withdrawal by Subject|18|||
127487289|NCT03559270|458746514|FG003|Overall Study|Withdrawal by Subject|7|||
127487290|NCT03559270|458746511|FG000|Overall Study|Physician Decision|3|||
127487291|NCT03559270|458746512|FG001|Overall Study|Physician Decision|2|||
127487292|NCT03559270|458746513|FG002|Overall Study|Physician Decision|1|||
127487293|NCT03559270|458746514|FG003|Overall Study|Physician Decision|0|||
127487294|NCT03559270|458746511|FG000|Overall Study|Pregnancy|0|||
127487295|NCT03559270|458746512|FG001|Overall Study|Pregnancy|1|||
127487296|NCT03559270|458746513|FG002|Overall Study|Pregnancy|0|||
127487297|NCT03559270|458746514|FG003|Overall Study|Pregnancy|0|||
127487298|NCT03559270|458746511|FG000|Overall Study|Protocol Violation|1|||
127487299|NCT03559270|458746512|FG001|Overall Study|Protocol Violation|0|||
127487300|NCT03559270|458746513|FG002|Overall Study|Protocol Violation|2|||
127487301|NCT03559270|458746514|FG003|Overall Study|Protocol Violation|0|||
127487302|NCT00517699|458748229|FG000|Overall Study|Withdrawal by Subject|1|||
127487303|NCT00517699|458748229|FG000|Overall Study|Lack of Efficacy|1|||
127487304|NCT00517699|458748229|FG000|Overall Study|Administrative error|1|||
127487305|NCT00517699|458748229|FG000|Overall Study|Study terminated by Sponsor|2|||
127487306|NCT02332187|458748232|FG000|Overall Study|Withdrawal by Subject|2|||
127487307|NCT02332187|458748233|FG001|Overall Study|Withdrawal by Subject|2|||
127487308|NCT02332187|458748232|FG000|Overall Study|Adverse Event|0|||
127487309|NCT02332187|458748233|FG001|Overall Study|Adverse Event|1|||
127487310|NCT00980148|458748234|FG000|Overall Study|Discharged from facility|89|||
127976570|NCT01938430|460536153|FG005|Overall Study|Death|0|||
127976571|NCT01938430|460536154|FG006|Overall Study|Death|1|||
127976572|NCT01938430|460536155|FG007|Overall Study|Death|1|||
127976573|NCT01938430|460536156|FG008|Overall Study|Death|2|||
127487311|NCT00980148|458748235|FG001|Overall Study|Discharged from facility|96|||
127487312|NCT00980148|458748234|FG000|Overall Study|Received other antichlamydia treatment|20|||
127487313|NCT00980148|458748235|FG001|Overall Study|Received other antichlamydia treatment|14|||
127487314|NCT00980148|458748234|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
127487315|NCT00980148|458748235|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
127487316|NCT00980148|458748234|FG000|Overall Study|Various other reasons|8|||
127487317|NCT00980148|458748235|FG001|Overall Study|Various other reasons|9|||
127976574|NCT01938430|460536157|FG009|Overall Study|Death|3|||
127487318|NCT00551031|458748236|FG000|Overall Study|Adverse Event|0|||
127487319|NCT00551031|458748237|FG001|Overall Study|Adverse Event|1|||
127487320|NCT00551031|458748238|FG002|Overall Study|Adverse Event|0|||
127487321|NCT00551031|458748239|FG003|Overall Study|Adverse Event|0|||
127487322|NCT00551031|458748240|FG004|Overall Study|Adverse Event|0|||
127487323|NCT00551031|458748236|FG000|Overall Study|Protocol Violation|1|||
127487324|NCT00551031|458748237|FG001|Overall Study|Protocol Violation|1|||
127487325|NCT00551031|458748238|FG002|Overall Study|Protocol Violation|0|||
127487326|NCT00551031|458748239|FG003|Overall Study|Protocol Violation|0|||
127487327|NCT00551031|458748240|FG004|Overall Study|Protocol Violation|0|||
127976575|NCT01938430|460536158|FG010|Overall Study|Death|0|||
127487328|NCT00551031|458748236|FG000|Overall Study|Lost to Follow-up|0|||
127487329|NCT00551031|458748237|FG001|Overall Study|Lost to Follow-up|1|||
127487330|NCT00551031|458748238|FG002|Overall Study|Lost to Follow-up|0|||
127487331|NCT00551031|458748239|FG003|Overall Study|Lost to Follow-up|1|||
127487332|NCT00551031|458748240|FG004|Overall Study|Lost to Follow-up|1|||
127487333|NCT00551031|458748236|FG000|Overall Study|Withdrawal by Subject|0|||
127487334|NCT00551031|458748237|FG001|Overall Study|Withdrawal by Subject|4|||
127487335|NCT00551031|458748238|FG002|Overall Study|Withdrawal by Subject|1|||
127487336|NCT00551031|458748239|FG003|Overall Study|Withdrawal by Subject|2|||
127487337|NCT00551031|458748240|FG004|Overall Study|Withdrawal by Subject|0|||
127487338|NCT00551031|458748236|FG000|Overall Study|Serious Adverse Event|0|||
127487339|NCT00551031|458748237|FG001|Overall Study|Serious Adverse Event|2|||
127487340|NCT00551031|458748238|FG002|Overall Study|Serious Adverse Event|1|||
127487341|NCT00551031|458748239|FG003|Overall Study|Serious Adverse Event|0|||
127487342|NCT00551031|458748240|FG004|Overall Study|Serious Adverse Event|0|||
127487343|NCT00551031|458748236|FG000|Overall Study|Did not receive vaccine|1|||
127487344|NCT00551031|458748237|FG001|Overall Study|Did not receive vaccine|2|||
127487345|NCT00551031|458748238|FG002|Overall Study|Did not receive vaccine|0|||
127487346|NCT00551031|458748239|FG003|Overall Study|Did not receive vaccine|0|||
127487347|NCT00551031|458748240|FG004|Overall Study|Did not receive vaccine|0|||
127487348|NCT03500211|458748245|FG000|Overall Study|Withdrawal by Subject|1|||
127487349|NCT03500211|458748246|FG001|Overall Study|Withdrawal by Subject|1|||
127487350|NCT01119443|458748252|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
127487351|NCT01119443|458748253|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
127487352|NCT02078752|458748256|FG000|Overall Study|Death|0|||
127487353|NCT02078752|458748257|FG001|Overall Study|Death|3|||
127487354|NCT02078752|458748258|FG002|Overall Study|Death|0|||
127487355|NCT02078752|458748259|FG003|Overall Study|Death|0|||
127487356|NCT02078752|458748260|FG004|Overall Study|Death|0|||
127487357|NCT02078752|458748261|FG005|Overall Study|Death|1|||
127487358|NCT02078752|458748262|FG006|Overall Study|Death|0|||
127487359|NCT02078752|458748263|FG007|Overall Study|Death|1|||
127487360|NCT02078752|458748264|FG008|Overall Study|Death|0|||
127487361|NCT02078752|458748265|FG009|Overall Study|Death|4|||
127487362|NCT02078752|458748256|FG000|Overall Study|Lost to Follow-up|1|||
127487363|NCT02078752|458748257|FG001|Overall Study|Lost to Follow-up|0|||
127487364|NCT02078752|458748258|FG002|Overall Study|Lost to Follow-up|0|||
127487365|NCT02078752|458748259|FG003|Overall Study|Lost to Follow-up|1|||
127487366|NCT02078752|458748260|FG004|Overall Study|Lost to Follow-up|0|||
127487367|NCT02078752|458748261|FG005|Overall Study|Lost to Follow-up|0|||
127487368|NCT02078752|458748262|FG006|Overall Study|Lost to Follow-up|0|||
127487369|NCT02078752|458748263|FG007|Overall Study|Lost to Follow-up|0|||
127487370|NCT02078752|458748264|FG008|Overall Study|Lost to Follow-up|0|||
127487371|NCT02078752|458748265|FG009|Overall Study|Lost to Follow-up|0|||
127487372|NCT02078752|458748256|FG000|Overall Study|Withdrawal by Subject|1|||
127487373|NCT02078752|458748257|FG001|Overall Study|Withdrawal by Subject|1|||
127487374|NCT02078752|458748258|FG002|Overall Study|Withdrawal by Subject|1|||
127487375|NCT02078752|458748259|FG003|Overall Study|Withdrawal by Subject|1|||
127487376|NCT02078752|458748260|FG004|Overall Study|Withdrawal by Subject|0|||
127487377|NCT02078752|458748261|FG005|Overall Study|Withdrawal by Subject|3|||
127487378|NCT02078752|458748262|FG006|Overall Study|Withdrawal by Subject|2|||
127487379|NCT02078752|458748263|FG007|Overall Study|Withdrawal by Subject|1|||
127487380|NCT02078752|458748264|FG008|Overall Study|Withdrawal by Subject|0|||
127487381|NCT02078752|458748265|FG009|Overall Study|Withdrawal by Subject|1|||
127487382|NCT02078752|458748256|FG000|Overall Study|Other|0|||
127487383|NCT02078752|458748257|FG001|Overall Study|Other|3|||
127487384|NCT02078752|458748258|FG002|Overall Study|Other|0|||
127487385|NCT02078752|458748259|FG003|Overall Study|Other|0|||
127487386|NCT02078752|458748260|FG004|Overall Study|Other|1|||
127487387|NCT02078752|458748261|FG005|Overall Study|Other|0|||
127487388|NCT02078752|458748262|FG006|Overall Study|Other|0|||
127487389|NCT02078752|458748263|FG007|Overall Study|Other|1|||
127487390|NCT02078752|458748264|FG008|Overall Study|Other|0|||
127487391|NCT02078752|458748265|FG009|Overall Study|Other|0|||
127487392|NCT02078752|458748256|FG000|Overall Study|Study terminated by sponsor|0|||
127487393|NCT02078752|458748257|FG001|Overall Study|Study terminated by sponsor|0|||
127487394|NCT02078752|458748258|FG002|Overall Study|Study terminated by sponsor|0|||
127487395|NCT02078752|458748259|FG003|Overall Study|Study terminated by sponsor|0|||
127487396|NCT02078752|458748260|FG004|Overall Study|Study terminated by sponsor|0|||
127487397|NCT02078752|458748261|FG005|Overall Study|Study terminated by sponsor|0|||
127487398|NCT02078752|458748262|FG006|Overall Study|Study terminated by sponsor|0|||
127487399|NCT02078752|458748263|FG007|Overall Study|Study terminated by sponsor|0|||
127487400|NCT02078752|458748264|FG008|Overall Study|Study terminated by sponsor|0|||
127487401|NCT02078752|458748265|FG009|Overall Study|Study terminated by sponsor|5|||
127487402|NCT00775268|458748266|FG000|Baseline|Drug not synthesize dose|1|||
127487403|NCT00775268|458748267|FG001|Baseline|Drug not synthesize dose|0|||
127487404|NCT00775268|458748266|FG000|Baseline|Not treated-ineligible per CT|0|||
127487405|NCT00775268|458748267|FG001|Baseline|Not treated-ineligible per CT|1|||
127487406|NCT00775268|458748266|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
127487407|NCT00775268|458748267|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
127487408|NCT00775268|458748266|FG000|After Completion|Participant missed scan appointment|1|||
127487409|NCT00775268|458748267|FG001|After Completion|Participant missed scan appointment|0|||
127487410|NCT03604497|458748268|FG000|Overall Study|Protocol Violation|52|||
127487411|NCT01194245|458748270|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
127487412|NCT01194245|458748271|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
127487413|NCT01194245|458748272|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
127487414|NCT01194245|458748273|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
127487415|NCT01194245|458748274|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
127487416|NCT01194245|458748270|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
127487417|NCT01194245|458748271|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
127487418|NCT01194245|458748272|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
127487419|NCT01194245|458748273|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
127487420|NCT01194245|458748274|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
127487421|NCT01194245|458748270|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
127487422|NCT01194245|458748271|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
127487423|NCT01194245|458748272|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
127487424|NCT01194245|458748273|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
127487425|NCT01194245|458748274|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
127487426|NCT01194245|458748270|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
127487427|NCT01194245|458748271|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
127487428|NCT01194245|458748272|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
127487429|NCT01194245|458748273|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
127487430|NCT01194245|458748274|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
127487431|NCT01194245|458748270|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
127487432|NCT01194245|458748271|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
127487433|NCT01194245|458748272|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
127487434|NCT01194245|458748273|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
127487435|NCT01194245|458748274|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
127487436|NCT01194245|458748270|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
127487437|NCT01194245|458748271|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
127487438|NCT01194245|458748272|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
127487439|NCT01194245|458748273|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
127487440|NCT01194245|458748274|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
127487441|NCT00269087|458748275|FG000|Overall Study|Adverse Event|20|||
127487442|NCT00269087|458748275|FG000|Overall Study|Withdrawal by Subject|1|||
127487443|NCT00269087|458748275|FG000|Overall Study|Exacerbation of COPD|13|||
127487444|NCT00041470|458748286|FG000|Overall Study|Loss of Funding|38|||
127487445|NCT00332696|458748287|FG000|Overall Study|Death|24|||
127487446|NCT00332696|458748288|FG001|Overall Study|Death|14|||
127487447|NCT00332696|458748287|FG000|Overall Study|Insufficient therapeutic effect|4|||
127487448|NCT00332696|458748288|FG001|Overall Study|Insufficient therapeutic effect|11|||
127487449|NCT00332696|458748287|FG000|Overall Study|Adverse Event|1|||
127487450|NCT00332696|458748288|FG001|Overall Study|Adverse Event|2|||
127487451|NCT00332696|458748287|FG000|Overall Study|Condition does not justify treatment|0|||
127487452|NCT00332696|458748288|FG001|Overall Study|Condition does not justify treatment|2|||
127487453|NCT00332696|458748287|FG000|Overall Study|Lost to Follow-up|0|||
127487454|NCT00332696|458748288|FG001|Overall Study|Lost to Follow-up|1|||
127487455|NCT00332696|458748287|FG000|Overall Study|Withdrawal by Subject|1|||
127487456|NCT00332696|458748288|FG001|Overall Study|Withdrawal by Subject|0|||
127487457|NCT01193101|458748293|FG000|Overall Study|Adverse Event|0|||
127487458|NCT01193101|458748294|FG001|Overall Study|Adverse Event|1|||
127487459|NCT01193101|458748295|FG002|Overall Study|Adverse Event|1|||
127487460|NCT01193101|458748296|FG003|Overall Study|Adverse Event|3|||
127487461|NCT01193101|458748293|FG000|Overall Study|Lack of Efficacy|3|||
127487462|NCT01193101|458748294|FG001|Overall Study|Lack of Efficacy|1|||
127487463|NCT01193101|458748295|FG002|Overall Study|Lack of Efficacy|0|||
127487464|NCT01193101|458748296|FG003|Overall Study|Lack of Efficacy|8|||
127487465|NCT01193101|458748293|FG000|Overall Study|Withdrawal by Subject|2|||
127487466|NCT01193101|458748294|FG001|Overall Study|Withdrawal by Subject|4|||
127487467|NCT01193101|458748295|FG002|Overall Study|Withdrawal by Subject|1|||
127976576|NCT01938430|460536159|FG011|Overall Study|Death|0|||
127976577|NCT01938430|460536160|FG012|Overall Study|Death|0|||
127487468|NCT01193101|458748296|FG003|Overall Study|Withdrawal by Subject|1|||
127487469|NCT01193101|458748293|FG000|Overall Study|Administrative problems|0|||
127487470|NCT01193101|458748294|FG001|Overall Study|Administrative problems|0|||
127487471|NCT01193101|458748295|FG002|Overall Study|Administrative problems|1|||
127487472|NCT01193101|458748296|FG003|Overall Study|Administrative problems|0|||
127487473|NCT01193101|458748293|FG000|Overall Study|Abnormal test procedure results|0|||
127487474|NCT01193101|458748294|FG001|Overall Study|Abnormal test procedure results|1|||
127487475|NCT01193101|458748295|FG002|Overall Study|Abnormal test procedure results|0|||
127487476|NCT01193101|458748296|FG003|Overall Study|Abnormal test procedure results|0|||
127487477|NCT02347085|458748299|FG000|Overall Study|Adverse Event|2|||
127487478|NCT02347085|458748299|FG000|Overall Study|Lack of Efficacy|1|||
127487479|NCT02347085|458748299|FG000|Overall Study|Withdrawal by Subject|4|||
127487480|NCT02347085|458748299|FG000|Overall Study|Lost to Follow-up|1|||
127487481|NCT02347085|458748299|FG000|Overall Study|Protocol Criteria|2|||
127487482|NCT01824290|458748301|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
127487483|NCT01824290|458748302|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
127487484|NCT01824290|458748303|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
127487485|NCT01824290|458748304|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
127487486|NCT01824290|458748301|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
127487487|NCT01824290|458748302|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
127487488|NCT01824290|458748303|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
127487489|NCT01824290|458748304|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
127487490|NCT01824290|458748301|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
127487491|NCT01824290|458748302|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
127487492|NCT01824290|458748303|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
127487493|NCT01824290|458748304|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
127487494|NCT01824290|458748301|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
127487495|NCT01824290|458748302|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
127487496|NCT01824290|458748303|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
127487497|NCT01824290|458748304|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
127487498|NCT01824290|458748301|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
127487499|NCT01824290|458748302|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
127487500|NCT01824290|458748303|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
127487501|NCT01824290|458748304|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
127487502|NCT01824290|458748301|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
127487503|NCT01824290|458748302|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
127487504|NCT01824290|458748303|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
127487505|NCT01824290|458748304|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
127487506|NCT00800982|458748305|FG000|Overall Study|Lost to Follow-up|1|||
127487507|NCT00800982|458748306|FG001|Overall Study|Lost to Follow-up|2|||
127487508|NCT00800982|458748305|FG000|Overall Study|Withdrawal by Subject|0|||
127487509|NCT00800982|458748306|FG001|Overall Study|Withdrawal by Subject|1|||
127487510|NCT00800982|458748305|FG000|Overall Study|Patient moved out of state|1|||
127487511|NCT00800982|458748306|FG001|Overall Study|Patient moved out of state|0|||
127487512|NCT00527618|458748307|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
127487513|NCT00527618|458748308|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
127487514|NCT00527618|458748307|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
127487515|NCT00527618|458748308|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
127487516|NCT00527618|458748307|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
127487517|NCT00527618|458748308|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
127487518|NCT00527618|458748307|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
127487519|NCT00527618|458748308|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
127487520|NCT00527618|458748307|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
127487521|NCT00527618|458748308|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
127487522|NCT00527618|458748307|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
127487523|NCT00527618|458748308|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
127487524|NCT00648037|458748311|FG000|Overall Study|Not Treated|1|||
127487525|NCT00648037|458748311|FG000|Overall Study|Withdrawal by Subject|1|||
127487526|NCT00648037|458748311|FG000|Overall Study|Adverse Event|11|||
127487527|NCT00648037|458748311|FG000|Overall Study|Relapse|2|||
127487528|NCT00648037|458748311|FG000|Overall Study|Other|1|||
127487529|NCT00699413|458748323|FG000|Overall Study|Withdrawal by Subject|0|||
127487530|NCT00699413|458748324|FG001|Overall Study|Withdrawal by Subject|2|||
127487531|NCT00699413|458748323|FG000|Overall Study|Study terminated by sponsor|4|||
127487532|NCT00699413|458748324|FG001|Overall Study|Study terminated by sponsor|2|||
127487533|NCT01253369|458748326|FG000|Overall Study|Adverse Event|4|||
127487534|NCT01253369|458748326|FG000|Overall Study|Withdrawal by Subject|2|||
127487535|NCT01253369|458748326|FG000|Overall Study|Death|1|||
127487536|NCT01253369|458748326|FG000|Overall Study|Progressive disease|23|||
127487537|NCT01253369|458748326|FG000|Overall Study|Not Evaluable|3|||
127487538|NCT03289533|458748327|FG000|Overall Study|Death|12|||
127487539|NCT03289533|458748327|FG000|Overall Study|Terminated from study by sponsor|10|||
127487540|NCT00363311|458748328|FG000|Overall Study|Adverse Event|6|||
127487541|NCT00363311|458748329|FG001|Overall Study|Adverse Event|4|||
127487542|NCT00363311|458748328|FG000|Overall Study|Lost to Follow-up|3|||
127487543|NCT00363311|458748329|FG001|Overall Study|Lost to Follow-up|0|||
127487544|NCT00363311|458748328|FG000|Overall Study|Protocol Violation|1|||
127487545|NCT00363311|458748329|FG001|Overall Study|Protocol Violation|2|||
127487546|NCT00363311|458748328|FG000|Overall Study|Withdrawal by Subject|12|||
127487547|NCT00363311|458748329|FG001|Overall Study|Withdrawal by Subject|6|||
127487548|NCT00363311|458748328|FG000|Overall Study|Physician Decision|1|||
127487549|NCT00363311|458748329|FG001|Overall Study|Physician Decision|1|||
127487550|NCT00363311|458748328|FG000|Overall Study|Sponsor Terminated Study|2|||
127487551|NCT00363311|458748329|FG001|Overall Study|Sponsor Terminated Study|2|||
127487552|NCT00363311|458748328|FG000|Overall Study|Disease Progression|46|||
127487553|NCT00363311|458748329|FG001|Overall Study|Disease Progression|26|||
127487554|NCT00363311|458748328|FG000|Overall Study|Non-Compliance|1|||
127487555|NCT00363311|458748329|FG001|Overall Study|Non-Compliance|1|||
127487556|NCT00363311|458748328|FG000|Overall Study|Participant Refused Biopsy|1|||
127487557|NCT00363311|458748329|FG001|Overall Study|Participant Refused Biopsy|0|||
127487558|NCT00363311|458748328|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
127487559|NCT00363311|458748329|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
127487560|NCT00363311|458748328|FG000|Overall Study|Participant Opted for Treatment|1|||
127487561|NCT00363311|458748329|FG001|Overall Study|Participant Opted for Treatment|0|||
127487562|NCT00363311|458748328|FG000|Overall Study|Participant Moved to Another Country|1|||
127487563|NCT00363311|458748329|FG001|Overall Study|Participant Moved to Another Country|0|||
127487564|NCT00363311|458748328|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
127487565|NCT00363311|458748329|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
127487566|NCT00363311|458748328|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
127487567|NCT00363311|458748329|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
127487568|NCT00363311|458748328|FG000|Overall Study|Participant Moved to Louisiana|0|||
127487569|NCT00363311|458748329|FG001|Overall Study|Participant Moved to Louisiana|1|||
127487570|NCT00120627|458748332|FG000|Overall Study|Withdrawal by Subject|5|||
127487571|NCT00120627|458748333|FG001|Overall Study|Withdrawal by Subject|5|||
127487572|NCT01595529|458748334|FG000|Overall Study|Adverse Event|2|||
127487573|NCT01595529|458748335|FG001|Overall Study|Adverse Event|0|||
127487574|NCT01595529|458748334|FG000|Overall Study|Subject Non-Compliant|2|||
127487575|NCT01595529|458748335|FG001|Overall Study|Subject Non-Compliant|0|||
127487576|NCT01595529|458748334|FG000|Overall Study|Lost to Follow-up|8|||
127487577|NCT01595529|458748335|FG001|Overall Study|Lost to Follow-up|14|||
127487578|NCT01595529|458748334|FG000|Overall Study|Protocol Violation|1|||
127487579|NCT01595529|458748335|FG001|Overall Study|Protocol Violation|2|||
127487580|NCT01595529|458748334|FG000|Overall Study|Physician Decision|1|||
127487581|NCT01595529|458748335|FG001|Overall Study|Physician Decision|0|||
127487582|NCT01595529|458748334|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
127487583|NCT01595529|458748335|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
127487584|NCT01595529|458748334|FG000|Overall Study|Administrative Decision|1|||
127487585|NCT01595529|458748335|FG001|Overall Study|Administrative Decision|0|||
127487586|NCT01595529|458748334|FG000|Overall Study|Entry Failure/Screening Failure|6|||
127487587|NCT01595529|458748335|FG001|Overall Study|Entry Failure/Screening Failure|1|||
127487588|NCT01508910|458748336|FG000|Treatment|Death|2|||
127487589|NCT01508910|458748337|FG001|Treatment|Death|3|||
127487590|NCT01508910|458748338|FG002|Treatment|Death|2|||
127487591|NCT01508910|458748339|FG003|Treatment|Death|0|||
127487592|NCT01508910|458748336|FG000|Treatment|Lost to Follow-up|0|||
127487593|NCT01508910|458748337|FG001|Treatment|Lost to Follow-up|0|||
127487594|NCT01508910|458748338|FG002|Treatment|Lost to Follow-up|2|||
127487595|NCT01508910|458748339|FG003|Treatment|Lost to Follow-up|1|||
127487596|NCT01508910|458748336|FG000|Treatment|Withdrawal by Subject|0|||
127487597|NCT01508910|458748337|FG001|Treatment|Withdrawal by Subject|1|||
127487598|NCT01508910|458748338|FG002|Treatment|Withdrawal by Subject|6|||
127487599|NCT01508910|458748339|FG003|Treatment|Withdrawal by Subject|1|||
127487600|NCT01508910|458748336|FG000|Treatment|Sponsor Decision|0|||
127487601|NCT01508910|458748337|FG001|Treatment|Sponsor Decision|0|||
127487602|NCT01508910|458748338|FG002|Treatment|Sponsor Decision|0|||
127487603|NCT01508910|458748339|FG003|Treatment|Sponsor Decision|1|||
127487604|NCT04016714|458748340|FG000|Overall Study|Death|1|||
127976578|NCT01938430|460536161|FG013|Overall Study|Death|0|||
127976579|NCT01938430|460536148|FG000|Overall Study|Investigator's Discretion|0|||
127487605|NCT04016714|458748341|FG001|Overall Study|Death|0|||
127487606|NCT04016714|458748340|FG000|Overall Study|Lost to Follow-up|3|||
127487607|NCT04016714|458748341|FG001|Overall Study|Lost to Follow-up|1|||
127487608|NCT04016714|458748340|FG000|Overall Study|Physician Decision|3|||
127487609|NCT04016714|458748341|FG001|Overall Study|Physician Decision|3|||
127487610|NCT04016714|458748340|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
127487611|NCT04016714|458748341|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
127487612|NCT00730886|458748346|FG000|Overall Study|Lost to Follow-up|1|||
127487613|NCT00730886|458748347|FG001|Overall Study|Lost to Follow-up|0|||
127487614|NCT00730886|458748346|FG000|Overall Study|Physician Decision|1|||
127487615|NCT00730886|458748347|FG001|Overall Study|Physician Decision|0|||
127487616|NCT01991483|458748348|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
127487617|NCT01991483|458748349|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
127487618|NCT01991483|458748350|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
127487619|NCT01991483|458748351|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
127487620|NCT01991483|458748348|FG000|Dose Level 600 mg|Physician Decision|0|||
127487621|NCT01991483|458748349|FG001|Dose Level 600 mg|Physician Decision|0|||
127487622|NCT01991483|458748350|FG002|Dose Level 600 mg|Physician Decision|1|||
127487623|NCT01991483|458748351|FG003|Dose Level 600 mg|Physician Decision|0|||
127487624|NCT01991483|458748348|FG000|Dose Level 1000 mg|Protocol Violation|0|||
127487625|NCT01991483|458748349|FG001|Dose Level 1000 mg|Protocol Violation|0|||
127487626|NCT01991483|458748350|FG002|Dose Level 1000 mg|Protocol Violation|0|||
127487627|NCT01991483|458748351|FG003|Dose Level 1000 mg|Protocol Violation|1|||
127487628|NCT01932788|458748358|FG000|Overall Study|Protocol Violation|18|||
127487629|NCT01932788|458748359|FG001|Overall Study|Protocol Violation|0|||
127487630|NCT01932788|458748358|FG000|Overall Study|Lost to Follow-up|18|||
127487631|NCT01932788|458748359|FG001|Overall Study|Lost to Follow-up|46|||
127487632|NCT01932788|458748358|FG000|Overall Study|Lack of Efficacy|2|||
127487633|NCT01932788|458748359|FG001|Overall Study|Lack of Efficacy|0|||
127487634|NCT01932788|458748358|FG000|Overall Study|Withdrawal by Subject|0|||
127487635|NCT01932788|458748359|FG001|Overall Study|Withdrawal by Subject|5|||
127487636|NCT04819113|458748360|FG000|Overall Study|Withdrawal by parent/guardian|3|||
127487637|NCT04819113|458748360|FG000|Overall Study|Lost to Follow-up|1|||
127487638|NCT04819113|458748360|FG000|Overall Study|Withdrawn before vaccination|2|||
127487639|NCT04067492|458748361|FG000|Overall Study|Lost to Follow-up|0|||
127487640|NCT04067492|458748362|FG001|Overall Study|Lost to Follow-up|0|||
127487641|NCT04067492|458748363|FG002|Overall Study|Lost to Follow-up|0|||
127487642|NCT04067492|458748364|FG003|Overall Study|Lost to Follow-up|0|||
127487643|NCT04067492|458748365|FG004|Overall Study|Lost to Follow-up|0|||
127487644|NCT04067492|458748366|FG005|Overall Study|Lost to Follow-up|1|||
127487645|NCT04067492|458748361|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
127487646|NCT04067492|458748362|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
127487647|NCT04067492|458748363|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
127487648|NCT04067492|458748364|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
127487649|NCT04067492|458748365|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
127487650|NCT04067492|458748366|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
127487651|NCT04067492|458748361|FG000|Overall Study|COVID-19 epidemiological situation|0|||
127487652|NCT04067492|458748362|FG001|Overall Study|COVID-19 epidemiological situation|0|||
127487653|NCT04067492|458748363|FG002|Overall Study|COVID-19 epidemiological situation|0|||
127487654|NCT04067492|458748364|FG003|Overall Study|COVID-19 epidemiological situation|1|||
127487655|NCT04067492|458748365|FG004|Overall Study|COVID-19 epidemiological situation|0|||
127487656|NCT04067492|458748366|FG005|Overall Study|COVID-19 epidemiological situation|0|||
127487657|NCT00833027|458748367|FG000|Overall Study|Adverse Event|33|||
127487658|NCT00833027|458748367|FG000|Overall Study|Death|1|||
127487659|NCT00833027|458748367|FG000|Overall Study|Lack of Efficacy|12|||
127487660|NCT00833027|458748367|FG000|Overall Study|Lost to Follow-up|24|||
127487661|NCT00833027|458748367|FG000|Overall Study|Protocol Violation|115|||
127487662|NCT00833027|458748367|FG000|Overall Study|Withdrawal by Subject|16|||
127487663|NCT00833027|458748367|FG000|Overall Study|Missing|10|||
127487664|NCT02806414|458748374|FG000|Overall Study|Lost to Follow-up|2|||
127487665|NCT03092479|458748377|FG000|Overall Study|Lost to Follow-up|3|||
127487666|NCT03092479|458748378|FG001|Overall Study|Lost to Follow-up|2|||
127487667|NCT03092479|458748377|FG000|Overall Study|Withdrawal by Subject|4|||
127487668|NCT03092479|458748378|FG001|Overall Study|Withdrawal by Subject|0|||
127487669|NCT00543985|458748381|FG000|Overall Study|Withdrawal by Subject|4|||
127487670|NCT00237042|458748382|FG000|Treatment|Became ineligible post-randomization|0|||
127487671|NCT00237042|458748383|FG001|Treatment|Became ineligible post-randomization|1|||
127487672|NCT00237042|458748384|FG002|Treatment|Became ineligible post-randomization|16|||
127487673|NCT00237042|458748382|FG000|Treatment|Moved out of state|1|||
127487674|NCT00237042|458748383|FG001|Treatment|Moved out of state|1|||
127487675|NCT00237042|458748384|FG002|Treatment|Moved out of state|1|||
127487676|NCT00237042|458748382|FG000|Treatment|Completed no treatment|5|||
127487677|NCT00237042|458748383|FG001|Treatment|Completed no treatment|5|||
127487678|NCT00237042|458748384|FG002|Treatment|Completed no treatment|21|||
127487679|NCT00237042|458748382|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
127487680|NCT00237042|458748383|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
127487681|NCT00237042|458748384|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
127487682|NCT00237042|458748382|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
127487683|NCT00237042|458748383|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
127487684|NCT00237042|458748384|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
127487685|NCT01897532|458748385|FG000|Discontinuation From Treatment|Not Treated|7|||
127487686|NCT01897532|458748386|FG001|Discontinuation From Treatment|Not Treated|5|||
127487687|NCT01897532|458748385|FG000|Discontinuation From Treatment|Other reason than specified|196|||
127487688|NCT01897532|458748386|FG001|Discontinuation From Treatment|Other reason than specified|176|||
127487689|NCT01897532|458748385|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
127487690|NCT01897532|458748386|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
127487691|NCT01897532|458748385|FG000|Discontinuation From Treatment|Non compliance|24|||
127487692|NCT01897532|458748386|FG001|Discontinuation From Treatment|Non compliance|15|||
127487693|NCT01897532|458748385|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
127487694|NCT01897532|458748386|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
127487695|NCT01897532|458748385|FG000|Discontinuation From Trial|Not Treated|7|||
127487696|NCT01897532|458748386|FG001|Discontinuation From Trial|Not Treated|5|||
127487697|NCT01897532|458748385|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
127487698|NCT01897532|458748386|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
127487699|NCT03132467|458748387|FG000|Overall Study|Adverse Event|2|||
127487700|NCT03132467|458748387|FG000|Overall Study|Withdrawal by Subject|2|||
127487701|NCT00038948|458748388|FG000|Overall Study|Adverse Event|131|||
127487702|NCT00038948|458748389|FG001|Overall Study|Adverse Event|43|||
127487703|NCT00038948|458748388|FG000|Overall Study|Lost to Follow-up|4|||
127487704|NCT00038948|458748389|FG001|Overall Study|Lost to Follow-up|4|||
127487705|NCT00038948|458748388|FG000|Overall Study|Nonmedical event|5|||
127487706|NCT00038948|458748389|FG001|Overall Study|Nonmedical event|7|||
127487707|NCT00038948|458748388|FG000|Overall Study|Withdrawal by Subject|23|||
127487708|NCT00038948|458748389|FG001|Overall Study|Withdrawal by Subject|10|||
127487709|NCT00038948|458748388|FG000|Overall Study|Protocol Violation|3|||
127487710|NCT00038948|458748389|FG001|Overall Study|Protocol Violation|7|||
127487711|NCT00038948|458748388|FG000|Overall Study|Lack of Efficacy|3|||
127487712|NCT00038948|458748389|FG001|Overall Study|Lack of Efficacy|6|||
127487713|NCT05223673|458748392|FG000|Overall Study|Protocol Violation|1|||
127487714|NCT05223673|458748392|FG000|Overall Study|Study termination|6|||
127487715|NCT04472650|458750172|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
127487716|NCT04472650|458750173|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
127487717|NCT00937495|458750182|FG000|Overall Study|Protocol Violation|2|||
127487718|NCT00441272|458750183|FG000|Overall Study|Study terminated prior to enrollment|25|||
127487719|NCT00441272|458750184|FG001|Overall Study|Study terminated prior to enrollment|25|||
127487720|NCT01856322|458750185|FG000|Overall Study|off study due to lack of accrual|0|||
127487721|NCT01856322|458750186|FG001|Overall Study|off study due to lack of accrual|0|||
127487722|NCT01856322|458750187|FG002|Overall Study|off study due to lack of accrual|3|||
127487723|NCT00427011|458750188|FG000|Overall Study|Adverse Event|10|||
127487724|NCT00427011|458750188|FG000|Overall Study|Withdrawal by Subject|1|||
127487725|NCT00427011|458750188|FG000|Overall Study|Lack of Efficacy|2|||
127487726|NCT00427011|458750188|FG000|Overall Study|Other|12|||
127487727|NCT00288015|458750192|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
127487728|NCT00288015|458750192|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
127487729|NCT00288015|458750192|FG000|First Response Assessment|Withdrawal by Subject|1|||
127487730|NCT00288015|458750192|FG000|First Response Assessment|Death|1|||
127487731|NCT00288015|458750192|FG000|First Response Assessment|Physician Decision|2|||
127487732|NCT00288015|458750192|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
127487733|NCT00288015|458750192|FG000|Follow up for Survival x 2 Years|Death|13|||
127487734|NCT00288015|458750192|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
127487735|NCT00288015|458750192|FG000|Follow up for Survival x 2 Years|Other|9|||
127487736|NCT01333722|458750193|FG000|Overall Study|Lack of Efficacy|0|||
127487737|NCT01333722|458750194|FG001|Overall Study|Lack of Efficacy|2|||
127487738|NCT01333722|458750193|FG000|Overall Study|Withdrawal by Subject|0|||
127487739|NCT01333722|458750194|FG001|Overall Study|Withdrawal by Subject|1|||
127487740|NCT00443703|458750195|FG000|Overall Study|Never Treated|3|||
127487741|NCT00443703|458750196|FG001|Overall Study|Never Treated|1|||
127487742|NCT00443703|458750195|FG000|Overall Study|Adverse Event|7|||
127487743|NCT00443703|458750196|FG001|Overall Study|Adverse Event|3|||
127487744|NCT00443703|458750195|FG000|Overall Study|Lack of Efficacy|3|||
127487745|NCT00443703|458750196|FG001|Overall Study|Lack of Efficacy|1|||
127487746|NCT00443703|458750195|FG000|Overall Study|Lost to Follow-up|0|||
127487747|NCT00443703|458750196|FG001|Overall Study|Lost to Follow-up|4|||
127487748|NCT00443703|458750195|FG000|Overall Study|Physician Decision|4|||
127487749|NCT00443703|458750196|FG001|Overall Study|Physician Decision|2|||
127487750|NCT00443703|458750195|FG000|Overall Study|Protocol Violation|1|||
127487751|NCT00443703|458750196|FG001|Overall Study|Protocol Violation|1|||
127487752|NCT00443703|458750195|FG000|Overall Study|Withdrawal by Subject|9|||
127487753|NCT00443703|458750196|FG001|Overall Study|Withdrawal by Subject|6|||
127487754|NCT00443703|458750195|FG000|Overall Study|Progressive Disease|1|||
127487755|NCT00443703|458750196|FG001|Overall Study|Progressive Disease|0|||
127487756|NCT04776161|458750198|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
127487757|NCT04776161|458750199|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
127487758|NCT04776161|458750200|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
127487759|NCT04776161|458750198|FG000|Overall Study|Withdrawal by Subject|1|||
127487760|NCT04776161|458750199|FG001|Overall Study|Withdrawal by Subject|0|||
127976580|NCT01938430|460536149|FG001|Overall Study|Investigator's Discretion|0|||
127487761|NCT04776161|458750200|FG002|Overall Study|Withdrawal by Subject|1|||
127487762|NCT04776161|458750198|FG000|Overall Study|Adverse Event|0|||
127487763|NCT04776161|458750199|FG001|Overall Study|Adverse Event|1|||
127487764|NCT04776161|458750200|FG002|Overall Study|Adverse Event|1|||
127487765|NCT00661830|458750203|FG000|Overall Study|Death|37|||
127487766|NCT00661830|458750204|FG001|Overall Study|Death|33|||
127976581|NCT01938430|460536150|FG002|Overall Study|Investigator's Discretion|1|||
127487767|NCT00661830|458750203|FG000|Overall Study|Lost to Follow-up|1|||
127487768|NCT00661830|458750204|FG001|Overall Study|Lost to Follow-up|3|||
127487769|NCT00661830|458750203|FG000|Overall Study|Withdrawal by Subject|1|||
127487770|NCT00661830|458750204|FG001|Overall Study|Withdrawal by Subject|1|||
127487771|NCT00661830|458750203|FG000|Overall Study|Other reason|1|||
127487772|NCT00661830|458750204|FG001|Overall Study|Other reason|5|||
127487773|NCT00488514|458750205|FG000|Overall Study|Adverse Event|41|||
127487774|NCT00488514|458750205|FG000|Overall Study|Lost to Follow-up|44|||
127487775|NCT00488514|458750205|FG000|Overall Study|Protocol Violation|32|||
127487776|NCT00488514|458750205|FG000|Overall Study|Withdrawal by Subject|106|||
127487777|NCT00488514|458750205|FG000|Overall Study|Lack of Efficacy|28|||
127487778|NCT00488514|458750205|FG000|Overall Study|Did not meet criteria for treatment|30|||
127487779|NCT00488514|458750205|FG000|Overall Study|Postive drug screen|1|||
127487780|NCT00488514|458750205|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
127487781|NCT00488514|458750205|FG000|Overall Study|Investigator decision|1|||
127487782|NCT00488514|458750205|FG000|Overall Study|Participant had too few migraines|5|||
127487783|NCT00488514|458750205|FG000|Overall Study|Increase in number of migraines|2|||
127487784|NCT00488514|458750205|FG000|Overall Study|Increased use of concomitant medication|1|||
127487785|NCT01669902|458750206|FG000|Overall Study|Adverse Event|11|||
127487786|NCT01669902|458750206|FG000|Overall Study|Lack of Efficacy|10|||
127487787|NCT01669902|458750206|FG000|Overall Study|Other|8|||
127487788|NCT01535287|458750207|FG000|Overall Study|drug not prepared in time|5|||
127487789|NCT01535287|458750208|FG001|Overall Study|drug not prepared in time|6|||
127487790|NCT01475721|458750218|FG000|Overall Study|Death|3|||
127487791|NCT01475721|458750219|FG001|Overall Study|Death|6|||
127487792|NCT01475721|458750218|FG000|Overall Study|Withdrawal by Subject|8|||
127487793|NCT01475721|458750219|FG001|Overall Study|Withdrawal by Subject|8|||
127487794|NCT00803738|458750221|FG000|Overall Study|Adverse Event|3|||
127487795|NCT00803738|458750222|FG001|Overall Study|Adverse Event|5|||
127487796|NCT00803738|458750221|FG000|Overall Study|Lost to Follow-up|4|||
127487797|NCT00803738|458750222|FG001|Overall Study|Lost to Follow-up|4|||
127487798|NCT00803738|458750221|FG000|Overall Study|Protocol Violation|18|||
127487799|NCT00803738|458750222|FG001|Overall Study|Protocol Violation|10|||
127487800|NCT00803738|458750221|FG000|Overall Study|Withdrawal by Subject|1|||
127487801|NCT00803738|458750222|FG001|Overall Study|Withdrawal by Subject|4|||
127487802|NCT00803738|458750221|FG000|Overall Study|Lack of Efficacy|10|||
127487803|NCT00803738|458750222|FG001|Overall Study|Lack of Efficacy|16|||
127487804|NCT00803738|458750221|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
127487805|NCT00803738|458750222|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
127487806|NCT00803738|458750221|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
127487807|NCT00803738|458750222|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
127487808|NCT02364037|458750223|FG000|Overall Study|Withdrawal by Subject|7|||
127487809|NCT02364037|458750224|FG001|Overall Study|Withdrawal by Subject|4|||
127487810|NCT02364037|458750223|FG000|Overall Study|Lost to Follow-up|37|||
127487811|NCT02364037|458750224|FG001|Overall Study|Lost to Follow-up|49|||
127487812|NCT04567524|458750227|FG000|Overall Study|Adverse Event|1|||
127487813|NCT04567524|458750228|FG001|Overall Study|Adverse Event|1|||
127487814|NCT04567524|458750229|FG002|Overall Study|Adverse Event|0|||
127487815|NCT04567524|458750230|FG003|Overall Study|Adverse Event|0|||
127487816|NCT04567524|458750227|FG000|Overall Study|Withdrawal by Subject|2|||
127487817|NCT04567524|458750228|FG001|Overall Study|Withdrawal by Subject|0|||
127487818|NCT04567524|458750229|FG002|Overall Study|Withdrawal by Subject|0|||
127487819|NCT04567524|458750230|FG003|Overall Study|Withdrawal by Subject|1|||
127487820|NCT00616642|458750242|FG000|Overall Study|Withdrawal by Subject|0|||
127487821|NCT00616642|458750243|FG001|Overall Study|Withdrawal by Subject|1|||
127487822|NCT00589797|458750250|FG000|Overall Study|Death|1|||
127487823|NCT00589797|458750251|FG001|Overall Study|Death|0|||
127487824|NCT00589797|458750250|FG000|Overall Study|Lost to Follow-up|12|||
127487825|NCT00589797|458750251|FG001|Overall Study|Lost to Follow-up|9|||
127487826|NCT00589797|458750250|FG000|Overall Study|Physician Decision|8|||
127487827|NCT00589797|458750251|FG001|Overall Study|Physician Decision|3|||
127487828|NCT00589797|458750250|FG000|Overall Study|Withdrawal by Subject|6|||
127487829|NCT00589797|458750251|FG001|Overall Study|Withdrawal by Subject|5|||
127487830|NCT00589797|458750250|FG000|Overall Study|Non-Randomized Training Subjects|46|||
127487831|NCT00589797|458750251|FG001|Overall Study|Non-Randomized Training Subjects|6|||
127487832|NCT01881009|458750252|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
127487833|NCT01881009|458750253|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
127487834|NCT02141672|458750254|FG000|Overall Study|Adverse Event|0|||
127487835|NCT02141672|458750255|FG001|Overall Study|Adverse Event|1|||
127487836|NCT02141672|458750256|FG002|Overall Study|Adverse Event|0|||
127487837|NCT02141672|458750254|FG000|Overall Study|Death|10|||
127487838|NCT02141672|458750255|FG001|Overall Study|Death|2|||
127487839|NCT02141672|458750256|FG002|Overall Study|Death|1|||
127487840|NCT02141672|458750254|FG000|Overall Study|Lack of Efficacy|0|||
127976582|NCT01938430|460536151|FG003|Overall Study|Investigator's Discretion|0|||
127487841|NCT02141672|458750255|FG001|Overall Study|Lack of Efficacy|0|||
127487842|NCT02141672|458750256|FG002|Overall Study|Lack of Efficacy|2|||
127487843|NCT02141672|458750254|FG000|Overall Study|Lost to Follow-up|1|||
127487844|NCT02141672|458750255|FG001|Overall Study|Lost to Follow-up|1|||
127487845|NCT02141672|458750256|FG002|Overall Study|Lost to Follow-up|3|||
127487846|NCT02141672|458750254|FG000|Overall Study|Physician Decision|1|||
127487847|NCT02141672|458750255|FG001|Overall Study|Physician Decision|2|||
127487848|NCT02141672|458750256|FG002|Overall Study|Physician Decision|5|||
127487849|NCT02141672|458750254|FG000|Overall Study|Protocol Violation|0|||
127487850|NCT02141672|458750255|FG001|Overall Study|Protocol Violation|0|||
127487851|NCT02141672|458750256|FG002|Overall Study|Protocol Violation|1|||
127487852|NCT02141672|458750254|FG000|Overall Study|Withdrawal by Subject|3|||
127487853|NCT02141672|458750255|FG001|Overall Study|Withdrawal by Subject|2|||
127487854|NCT02141672|458750256|FG002|Overall Study|Withdrawal by Subject|5|||
127487855|NCT02141672|458750254|FG000|Overall Study|refused to follow-up|1|||
127487856|NCT02141672|458750255|FG001|Overall Study|refused to follow-up|0|||
127487857|NCT02141672|458750256|FG002|Overall Study|refused to follow-up|1|||
127487858|NCT02457247|458750257|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
127487859|NCT02457247|458750258|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
127487860|NCT02457247|458750259|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
127487861|NCT02457247|458750260|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
127487862|NCT02457247|458750257|FG000|Period 1|Significant Protocol Deviation|1|||
127487863|NCT02457247|458750258|FG001|Period 1|Significant Protocol Deviation|1|||
127487864|NCT02457247|458750259|FG002|Period 1|Significant Protocol Deviation|0|||
127487865|NCT02457247|458750260|FG003|Period 1|Significant Protocol Deviation|0|||
127487866|NCT02457247|458750257|FG000|Period 1|Voluntary Withdrawal|1|||
127487867|NCT02457247|458750258|FG001|Period 1|Voluntary Withdrawal|0|||
127487868|NCT02457247|458750259|FG002|Period 1|Voluntary Withdrawal|0|||
127487869|NCT02457247|458750260|FG003|Period 1|Voluntary Withdrawal|0|||
127487870|NCT02457247|458750257|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
127487871|NCT02457247|458750258|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
127487872|NCT02457247|458750259|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
127487873|NCT02457247|458750260|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
127487874|NCT02457247|458750257|FG000|Period 2|Significant Protocol Deviation|1|||
127487875|NCT02457247|458750258|FG001|Period 2|Significant Protocol Deviation|0|||
127487876|NCT02457247|458750259|FG002|Period 2|Significant Protocol Deviation|0|||
127487877|NCT02457247|458750260|FG003|Period 2|Significant Protocol Deviation|0|||
127487878|NCT02457247|458750257|FG000|Period 2|Lost to Follow-up|0|||
127487879|NCT02457247|458750258|FG001|Period 2|Lost to Follow-up|1|||
127487880|NCT02457247|458750259|FG002|Period 2|Lost to Follow-up|0|||
127487881|NCT02457247|458750260|FG003|Period 2|Lost to Follow-up|0|||
127487882|NCT02457247|458750257|FG000|Period 2|Voluntary Withdrawal|1|||
127487883|NCT02457247|458750258|FG001|Period 2|Voluntary Withdrawal|1|||
127487884|NCT02457247|458750259|FG002|Period 2|Voluntary Withdrawal|0|||
127487885|NCT02457247|458750260|FG003|Period 2|Voluntary Withdrawal|0|||
127487886|NCT01061385|458750261|FG000|Overall Study|Lost to Follow-up|1|||
127487887|NCT01061385|458750262|FG001|Overall Study|Lost to Follow-up|0|||
127487888|NCT01061385|458750261|FG000|Overall Study|subject decision not related to AE|0|||
127487889|NCT01061385|458750262|FG001|Overall Study|subject decision not related to AE|1|||
127487890|NCT00533429|458750263|FG000|Overall Study|Adverse Event|3|||
127487891|NCT00533429|458750264|FG001|Overall Study|Adverse Event|1|||
127487892|NCT00533429|458750263|FG000|Overall Study|Death|1|||
127487893|NCT00533429|458750264|FG001|Overall Study|Death|0|||
127487894|NCT00533429|458750263|FG000|Overall Study|Withdrawal by Subject|2|||
127487895|NCT00533429|458750264|FG001|Overall Study|Withdrawal by Subject|0|||
127487896|NCT00533429|458750263|FG000|Overall Study|Progressive Disease|12|||
127487897|NCT00533429|458750264|FG001|Overall Study|Progressive Disease|13|||
127487898|NCT00533429|458750263|FG000|Overall Study|Symptomatic deterioration|1|||
127487899|NCT00533429|458750264|FG001|Overall Study|Symptomatic deterioration|2|||
127487900|NCT01464879|458750265|FG000|Overall Study|Physician Decision|1|||
127487901|NCT01464879|458750265|FG000|Overall Study|Non-compliance|1|||
127487902|NCT02230189|458750272|FG000|Overall Study|Withdrawal by Subject|3|||
127487903|NCT02230189|458750273|FG001|Overall Study|Withdrawal by Subject|0|||
127487904|NCT02230189|458750274|FG002|Overall Study|Withdrawal by Subject|1|||
127487905|NCT02230189|458750272|FG000|Overall Study|Lost to Follow-up|1|||
127487906|NCT02230189|458750273|FG001|Overall Study|Lost to Follow-up|0|||
127487907|NCT02230189|458750274|FG002|Overall Study|Lost to Follow-up|0|||
127487908|NCT02230189|458750272|FG000|Overall Study|Physician Decision|1|||
127487909|NCT02230189|458750273|FG001|Overall Study|Physician Decision|0|||
127487910|NCT02230189|458750274|FG002|Overall Study|Physician Decision|0|||
127487911|NCT00244621|458750275|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
127487912|NCT00244621|458750276|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
127487913|NCT00244621|458750277|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
127487914|NCT00244621|458750275|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
127487915|NCT00244621|458750276|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
127487916|NCT00244621|458750277|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
127487917|NCT00244621|458750275|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
127487918|NCT00244621|458750276|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
127487919|NCT00244621|458750277|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
127487920|NCT00244621|458750275|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
127487921|NCT00244621|458750276|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
127487922|NCT00244621|458750277|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
127869734|NCT02557308|460139637|FG003|Overall Study|Study Close|3|||
127487923|NCT00244621|458750275|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
127487924|NCT00244621|458750276|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
127487925|NCT00244621|458750277|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
127487926|NCT00244621|458750275|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
127487927|NCT00244621|458750276|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
127487928|NCT00244621|458750277|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
127487929|NCT00244621|458750275|FG000|Open-label Treatment Period|Adverse Event|0|||
127487930|NCT00244621|458750276|FG001|Open-label Treatment Period|Adverse Event|0|||
127487931|NCT00244621|458750277|FG002|Open-label Treatment Period|Adverse Event|1|||
127487932|NCT00244621|458750275|FG000|Open-label Treatment Period|Moved abroad|0|||
127487933|NCT00244621|458750276|FG001|Open-label Treatment Period|Moved abroad|0|||
127487934|NCT00244621|458750277|FG002|Open-label Treatment Period|Moved abroad|1|||
127487935|NCT02834819|458750278|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
127487936|NCT02834819|458750279|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
127487937|NCT04389866|458750281|FG000|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
127487938|NCT04389866|458750282|FG001|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
127487939|NCT02967679|458750285|FG000|Overall Study|Adverse Event|1|||
127487940|NCT00600067|458750288|FG000|Overall Study|Adverse Event|0|||
127487941|NCT00600067|458750289|FG001|Overall Study|Adverse Event|1|||
127487942|NCT00600067|458750288|FG000|Overall Study|Lost to Follow-up|2|||
127487943|NCT00600067|458750289|FG001|Overall Study|Lost to Follow-up|3|||
127487944|NCT00600067|458750288|FG000|Overall Study|protocol non-compliance|0|||
127487945|NCT00600067|458750289|FG001|Overall Study|protocol non-compliance|3|||
127487946|NCT00600067|458750288|FG000|Overall Study|Lack of Efficacy|1|||
127487947|NCT00600067|458750289|FG001|Overall Study|Lack of Efficacy|0|||
127487948|NCT00003631|458750290|FG000|Overall Study|Patient not treated|1|||
127487949|NCT00003631|458750291|FG001|Overall Study|Patient not treated|0|||
127487950|NCT00003631|458750292|FG002|Overall Study|Patient not treated|1|||
127487951|NCT00003631|458750290|FG000|Overall Study|Protocol Violation|1|||
127487952|NCT00003631|458750291|FG001|Overall Study|Protocol Violation|0|||
127487953|NCT00003631|458750292|FG002|Overall Study|Protocol Violation|0|||
127487954|NCT00003631|458750290|FG000|Overall Study|Adverse Event|1|||
127487955|NCT00003631|458750291|FG001|Overall Study|Adverse Event|1|||
127487956|NCT00003631|458750292|FG002|Overall Study|Adverse Event|5|||
127487957|NCT00003631|458750290|FG000|Overall Study|Death|0|||
127487958|NCT00003631|458750291|FG001|Overall Study|Death|0|||
127487959|NCT00003631|458750292|FG002|Overall Study|Death|1|||
127487960|NCT00003631|458750290|FG000|Overall Study|Evaluable for toxicity only|0|||
127487961|NCT00003631|458750291|FG001|Overall Study|Evaluable for toxicity only|0|||
127487962|NCT00003631|458750292|FG002|Overall Study|Evaluable for toxicity only|2|||
127487963|NCT04339413|458750294|FG000|Overall Study|Reason Not Specified|2|||
127487964|NCT04339413|458750295|FG001|Overall Study|Reason Not Specified|7|||
127487965|NCT04339413|458750294|FG000|Overall Study|Study Terminated by Sponsor|30|||
127487966|NCT04339413|458750295|FG001|Overall Study|Study Terminated by Sponsor|33|||
127487967|NCT04339413|458750294|FG000|Overall Study|Progressive Disease|9|||
127487968|NCT04339413|458750295|FG001|Overall Study|Progressive Disease|6|||
127487969|NCT04339413|458750294|FG000|Overall Study|Withdrawal by Subject|9|||
127487970|NCT04339413|458750295|FG001|Overall Study|Withdrawal by Subject|10|||
127487971|NCT04339413|458750294|FG000|Overall Study|Physician Decision|3|||
127487972|NCT04339413|458750295|FG001|Overall Study|Physician Decision|1|||
127487973|NCT04339413|458750294|FG000|Overall Study|Death|2|||
127487974|NCT04339413|458750295|FG001|Overall Study|Death|0|||
127487975|NCT04339413|458750294|FG000|Overall Study|Adverse Event|3|||
127487976|NCT04339413|458750295|FG001|Overall Study|Adverse Event|0|||
127487977|NCT00251693|458750300|FG000|Overall Study|Adverse Event|17|||
127487978|NCT00251693|458750301|FG001|Overall Study|Adverse Event|9|||
127487979|NCT00251693|458750302|FG002|Overall Study|Adverse Event|9|||
127487980|NCT00251693|458750300|FG000|Overall Study|Protocol Violation|2|||
127487981|NCT00251693|458750301|FG001|Overall Study|Protocol Violation|0|||
127487982|NCT00251693|458750302|FG002|Overall Study|Protocol Violation|2|||
127487983|NCT00251693|458750300|FG000|Overall Study|Lost to Follow-up|12|||
127487984|NCT00251693|458750301|FG001|Overall Study|Lost to Follow-up|7|||
127487985|NCT00251693|458750302|FG002|Overall Study|Lost to Follow-up|8|||
127487986|NCT00251693|458750300|FG000|Overall Study|Withdrawal by Subject|11|||
127487987|NCT00251693|458750301|FG001|Overall Study|Withdrawal by Subject|17|||
127487988|NCT00251693|458750302|FG002|Overall Study|Withdrawal by Subject|14|||
127487989|NCT00251693|458750300|FG000|Overall Study|Lack of Efficacy|0|||
127487990|NCT00251693|458750301|FG001|Overall Study|Lack of Efficacy|1|||
127487991|NCT00251693|458750302|FG002|Overall Study|Lack of Efficacy|0|||
127487992|NCT00251693|458750300|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
127487993|NCT00251693|458750301|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
127487994|NCT00251693|458750302|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
127487995|NCT00251693|458750300|FG000|Overall Study|Noncompliant|0|||
127487996|NCT00251693|458750301|FG001|Overall Study|Noncompliant|0|||
127487997|NCT00251693|458750302|FG002|Overall Study|Noncompliant|2|||
127487998|NCT00251693|458750300|FG000|Overall Study|Possible Barrett's esophagus|3|||
127487999|NCT00251693|458750301|FG001|Overall Study|Possible Barrett's esophagus|5|||
127488000|NCT00251693|458750302|FG002|Overall Study|Possible Barrett's esophagus|2|||
127488001|NCT00251693|458750300|FG000|Overall Study|Subject request/subject unavailable|1|||
127488002|NCT00251693|458750301|FG001|Overall Study|Subject request/subject unavailable|2|||
127488003|NCT00251693|458750302|FG002|Overall Study|Subject request/subject unavailable|0|||
127488004|NCT00251693|458750300|FG000|Overall Study|Abnormal laboratory findings|0|||
127488005|NCT00251693|458750301|FG001|Overall Study|Abnormal laboratory findings|0|||
127488006|NCT00251693|458750302|FG002|Overall Study|Abnormal laboratory findings|1|||
127488007|NCT00401843|458750303|FG000|Overall Study|Achieved Complete Response|1|||
127488008|NCT00401843|458750304|FG001|Overall Study|Achieved Complete Response|5|||
127488009|NCT00401843|458750305|FG002|Overall Study|Achieved Complete Response|11|||
127488010|NCT00401843|458750303|FG000|Overall Study|Adverse Event|7|||
127488011|NCT00401843|458750304|FG001|Overall Study|Adverse Event|26|||
127488012|NCT00401843|458750305|FG002|Overall Study|Adverse Event|27|||
127488013|NCT00401843|458750303|FG000|Overall Study|Death|0|||
127488014|NCT00401843|458750304|FG001|Overall Study|Death|8|||
127488015|NCT00401843|458750305|FG002|Overall Study|Death|10|||
127488016|NCT00401843|458750303|FG000|Overall Study|Disease progression|10|||
127488017|NCT00401843|458750304|FG001|Overall Study|Disease progression|60|||
127488018|NCT00401843|458750305|FG002|Overall Study|Disease progression|49|||
127488019|NCT00401843|458750303|FG000|Overall Study|End of Study|1|||
127488020|NCT00401843|458750304|FG001|Overall Study|End of Study|1|||
127488021|NCT00401843|458750305|FG002|Overall Study|End of Study|2|||
127488022|NCT00401843|458750303|FG000|Overall Study|Lost to Follow-up|0|||
127488023|NCT00401843|458750304|FG001|Overall Study|Lost to Follow-up|0|||
127488024|NCT00401843|458750305|FG002|Overall Study|Lost to Follow-up|2|||
127488025|NCT00401843|458750303|FG000|Overall Study|Other Unspecified|0|||
127488026|NCT00401843|458750304|FG001|Overall Study|Other Unspecified|3|||
127488027|NCT00401843|458750305|FG002|Overall Study|Other Unspecified|5|||
127488028|NCT00401843|458750303|FG000|Overall Study|Physician Decision|0|||
127488029|NCT00401843|458750304|FG001|Overall Study|Physician Decision|16|||
127488030|NCT00401843|458750305|FG002|Overall Study|Physician Decision|10|||
127488031|NCT00401843|458750303|FG000|Overall Study|Protocol Violation|0|||
127488032|NCT00401843|458750304|FG001|Overall Study|Protocol Violation|0|||
127488033|NCT00401843|458750305|FG002|Overall Study|Protocol Violation|1|||
127488034|NCT00401843|458750303|FG000|Overall Study|Withdrawal by Subject|1|||
127488035|NCT00401843|458750304|FG001|Overall Study|Withdrawal by Subject|5|||
127488036|NCT00401843|458750305|FG002|Overall Study|Withdrawal by Subject|5|||
127488037|NCT00401843|458750303|FG000|Overall Study|Withdrawal of consent to study agent|1|||
127488038|NCT00401843|458750304|FG001|Overall Study|Withdrawal of consent to study agent|15|||
127488039|NCT00401843|458750305|FG002|Overall Study|Withdrawal of consent to study agent|17|||
127488040|NCT00401843|458750303|FG000|Overall Study|Randomized but not Treated|0|||
127488041|NCT00401843|458750304|FG001|Overall Study|Randomized but not Treated|2|||
127488042|NCT00401843|458750305|FG002|Overall Study|Randomized but not Treated|3|||
127488043|NCT00401843|458750303|FG000|Overall Study|Received incorrect treatment|0|||
127488044|NCT00401843|458750304|FG001|Overall Study|Received incorrect treatment|3|||
127488045|NCT00401843|458750305|FG002|Overall Study|Received incorrect treatment|0|||
127488046|NCT02103062|458750306|FG000|Overall Study|Adverse Event|1|||
127488047|NCT02103062|458750307|FG001|Overall Study|Adverse Event|2|||
127976583|NCT01938430|460536152|FG004|Overall Study|Investigator's Discretion|0|||
127976584|NCT01938430|460536153|FG005|Overall Study|Investigator's Discretion|0|||
127976585|NCT01938430|460536154|FG006|Overall Study|Investigator's Discretion|0|||
127976586|NCT01938430|460536155|FG007|Overall Study|Investigator's Discretion|0|||
127976587|NCT01938430|460536156|FG008|Overall Study|Investigator's Discretion|0|||
127976588|NCT01938430|460536157|FG009|Overall Study|Investigator's Discretion|0|||
127976589|NCT01938430|460536158|FG010|Overall Study|Investigator's Discretion|0|||
127976590|NCT01938430|460536159|FG011|Overall Study|Investigator's Discretion|0|||
127976591|NCT01938430|460536160|FG012|Overall Study|Investigator's Discretion|0|||
127976592|NCT01938430|460536161|FG013|Overall Study|Investigator's Discretion|0|||
127976593|NCT01938430|460536148|FG000|Overall Study|Lack of Efficacy|3|||
127976594|NCT01938430|460536149|FG001|Overall Study|Lack of Efficacy|1|||
127976595|NCT01938430|460536150|FG002|Overall Study|Lack of Efficacy|1|||
127488048|NCT02103062|458750306|FG000|Overall Study|Progressive Disease|17|||
127488049|NCT02103062|458750307|FG001|Overall Study|Progressive Disease|20|||
127488050|NCT02103062|458750306|FG000|Overall Study|Death|0|||
127488051|NCT02103062|458750307|FG001|Overall Study|Death|1|||
127488052|NCT02030821|458750309|FG000|Overall Study|Physician Decision|2|||
127488053|NCT02030821|458750310|FG001|Overall Study|Physician Decision|2|||
127488054|NCT02030821|458750311|FG002|Overall Study|Physician Decision|5|||
127488055|NCT02030821|458750312|FG003|Overall Study|Physician Decision|2|||
127488056|NCT03192137|458750313|FG000|Overall Study|Adverse Event|10|||
127488057|NCT03192137|458750314|FG001|Overall Study|Adverse Event|11|||
127488058|NCT03192137|458750313|FG000|Overall Study|Physician Decision|1|||
127488059|NCT03192137|458750314|FG001|Overall Study|Physician Decision|0|||
127488060|NCT03192137|458750313|FG000|Overall Study|Lack of Efficacy|20|||
127976596|NCT01938430|460536151|FG003|Overall Study|Lack of Efficacy|1|||
127488061|NCT03192137|458750314|FG001|Overall Study|Lack of Efficacy|37|||
127488062|NCT03192137|458750313|FG000|Overall Study|Withdrawal by Subject|3|||
127488063|NCT03192137|458750314|FG001|Overall Study|Withdrawal by Subject|3|||
127488064|NCT03192137|458750313|FG000|Overall Study|Protocol Violation|4|||
127488065|NCT03192137|458750314|FG001|Overall Study|Protocol Violation|3|||
127488066|NCT03192137|458750313|FG000|Overall Study|Surgery Cancelled|4|||
127488067|NCT03192137|458750314|FG001|Overall Study|Surgery Cancelled|1|||
127488068|NCT03192137|458750313|FG000|Overall Study|Other - Various Administrative Reasons|8|||
127488069|NCT03192137|458750314|FG001|Overall Study|Other - Various Administrative Reasons|3|||
127488070|NCT00657267|458750317|FG000|Overall Study|Progressive disease|45|||
127488071|NCT00657267|458750317|FG000|Overall Study|Adverse Event|9|||
127488072|NCT02737501|458750321|FG000|Randomized Phase|Died|41|||
127488073|NCT02737501|458750322|FG001|Randomized Phase|Died|29|||
127488074|NCT02737501|458750323|FG002|Randomized Phase|Died|0|||
127488075|NCT02737501|458750321|FG000|Randomized Phase|Withdrawal by Subject|16|||
127488076|NCT02737501|458750322|FG001|Randomized Phase|Withdrawal by Subject|6|||
127488077|NCT02737501|458750323|FG002|Randomized Phase|Withdrawal by Subject|0|||
127488078|NCT02737501|458750321|FG000|Randomized Phase|Lost to Follow-up|0|||
127488079|NCT02737501|458750322|FG001|Randomized Phase|Lost to Follow-up|1|||
127488080|NCT02737501|458750323|FG002|Randomized Phase|Lost to Follow-up|0|||
127488081|NCT02737501|458750321|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
127488082|NCT02737501|458750322|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
127488083|NCT02737501|458750323|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
127488084|NCT02737501|458750321|FG000|Randomized Phase|Reason not Specified|1|||
127488085|NCT02737501|458750322|FG001|Randomized Phase|Reason not Specified|1|||
127488086|NCT02737501|458750323|FG002|Randomized Phase|Reason not Specified|0|||
127488087|NCT02737501|458750321|FG000|Randomized Phase|Never Treated|1|||
127488088|NCT02737501|458750322|FG001|Randomized Phase|Never Treated|1|||
127488089|NCT02737501|458750323|FG002|Randomized Phase|Never Treated|0|||
127488090|NCT02737501|458750321|FG000|Crossover Phase|Died|0|||
127488091|NCT02737501|458750322|FG001|Crossover Phase|Died|0|||
127488092|NCT02737501|458750323|FG002|Crossover Phase|Died|22|||
127488093|NCT02737501|458750321|FG000|Crossover Phase|Withdrew Consent|0|||
127488094|NCT02737501|458750322|FG001|Crossover Phase|Withdrew Consent|0|||
127488095|NCT02737501|458750323|FG002|Crossover Phase|Withdrew Consent|9|||
127488096|NCT02737501|458750321|FG000|Crossover Phase|Physician Decision|0|||
127488097|NCT02737501|458750322|FG001|Crossover Phase|Physician Decision|0|||
127488098|NCT02737501|458750323|FG002|Crossover Phase|Physician Decision|1|||
127488099|NCT02737501|458750321|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
127488100|NCT02737501|458750322|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
127488101|NCT02737501|458750323|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
127488102|NCT01261975|458750324|FG000|Overall Study|Surgical complication|1|||
127488103|NCT00716274|458750325|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
127488104|NCT00716274|458750326|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
127488105|NCT00716274|458750327|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
127488106|NCT00716274|458750328|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
127488107|NCT00716274|458750329|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
127488108|NCT00716274|458750330|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
127488109|NCT00716274|458750325|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
127488110|NCT00716274|458750326|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
127488111|NCT00716274|458750327|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
127488112|NCT00716274|458750328|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
127488113|NCT00716274|458750329|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
127488114|NCT00716274|458750330|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
127488115|NCT00716274|458750325|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
127488116|NCT00716274|458750326|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
127488117|NCT00716274|458750327|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
127488118|NCT00716274|458750328|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
127488119|NCT00716274|458750329|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
127488120|NCT00716274|458750330|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
127488121|NCT00716274|458750325|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
127488122|NCT00716274|458750326|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
127488123|NCT00716274|458750327|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
127488124|NCT00716274|458750328|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
127488125|NCT00716274|458750329|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
127488126|NCT00716274|458750330|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
127488127|NCT00716274|458750325|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
127488128|NCT00716274|458750326|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
127488129|NCT00716274|458750327|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
127488130|NCT00716274|458750328|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
127488131|NCT00716274|458750329|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
127488132|NCT00716274|458750330|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
127488133|NCT00716274|458750325|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
127488134|NCT00716274|458750326|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
127488135|NCT00716274|458750327|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
127488136|NCT00716274|458750328|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
127488137|NCT00716274|458750329|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
127488138|NCT00716274|458750330|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
127488139|NCT00716274|458750325|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
127488140|NCT00716274|458750326|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
127488141|NCT00716274|458750327|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
127488142|NCT00716274|458750328|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
127488143|NCT00716274|458750329|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
127488144|NCT00716274|458750330|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
127488145|NCT00716274|458750325|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
127488146|NCT00716274|458750326|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
127488147|NCT00716274|458750327|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
127488148|NCT00716274|458750328|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
127488149|NCT00716274|458750329|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
127488150|NCT00716274|458750330|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
127488151|NCT00716274|458750325|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
127488152|NCT00716274|458750326|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
127488153|NCT00716274|458750327|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
127488154|NCT00716274|458750328|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
127488155|NCT00716274|458750329|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
127488156|NCT00716274|458750330|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
127488157|NCT00716274|458750325|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
127488158|NCT00716274|458750326|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
127488159|NCT00716274|458750327|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
127488160|NCT00716274|458750328|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
127488161|NCT00716274|458750329|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
127488162|NCT00716274|458750330|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
127488163|NCT00786422|458750333|FG000|Rivaroxaban Treatment|Death|2|||
127488164|NCT00786422|458750333|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
127488165|NCT00786422|458750333|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
127488166|NCT00786422|458750333|FG000|Rivaroxaban Treatment|Physician Decision|1|||
127488167|NCT00786422|458750333|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
127488168|NCT00786422|458750333|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
127488169|NCT00786422|458750333|FG000|Rivaroxaban Treatment|Adverse Event|2|||
127488170|NCT00786422|458750333|FG000|Follow-up Period|Death|1|||
127488171|NCT00786422|458750333|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
127488172|NCT02015039|458750336|FG000|Overall Study|Not eligible|0|||
127488173|NCT02015039|458750337|FG001|Overall Study|Not eligible|1|||
127488174|NCT04570384|458750338|FG000|Overall Study|Adverse Event|2|||
127488175|NCT04570384|458750339|FG001|Overall Study|Adverse Event|1|||
127488176|NCT04570384|458750338|FG000|Overall Study|Death|2|||
127488177|NCT04570384|458750339|FG001|Overall Study|Death|5|||
127488178|NCT04570384|458750338|FG000|Overall Study|Lost to Follow-up|1|||
127488179|NCT04570384|458750339|FG001|Overall Study|Lost to Follow-up|0|||
127488180|NCT04570384|458750338|FG000|Overall Study|Other|1|||
127488181|NCT04570384|458750339|FG001|Overall Study|Other|0|||
127488182|NCT04570384|458750338|FG000|Overall Study|Protocol Violation|0|||
127488183|NCT04570384|458750339|FG001|Overall Study|Protocol Violation|1|||
127488184|NCT04570384|458750338|FG000|Overall Study|Sponsor Decision|1|||
127488185|NCT04570384|458750339|FG001|Overall Study|Sponsor Decision|0|||
127488186|NCT04570384|458750338|FG000|Overall Study|Withdrawal by Subject|4|||
127488187|NCT04570384|458750339|FG001|Overall Study|Withdrawal by Subject|2|||
127488188|NCT01673126|458750340|FG000|Overall Study|change of diagnosis|4|||
127488189|NCT01673126|458750341|FG001|Overall Study|change of diagnosis|3|||
127488190|NCT02670473|458750348|FG000|Overall Study|Withdrawal by Subject|1|||
127488191|NCT01404234|458750349|FG000|Overall Study|Withdrawal by Subject|2|||
127488192|NCT00387088|458752055|FG000|Overall Study|Adverse Event|143|||
127488193|NCT00387088|458752056|FG001|Overall Study|Adverse Event|156|||
127488194|NCT00387088|458752055|FG000|Overall Study|Protocol Violation|47|||
127488195|NCT00387088|458752056|FG001|Overall Study|Protocol Violation|35|||
127488196|NCT00387088|458752055|FG000|Overall Study|Withdrawal by Subject|20|||
127488197|NCT00387088|458752056|FG001|Overall Study|Withdrawal by Subject|35|||
127488198|NCT00387088|458752055|FG000|Overall Study|Lack of Efficacy|28|||
127488199|NCT00387088|458752056|FG001|Overall Study|Lack of Efficacy|67|||
127488200|NCT00387088|458752055|FG000|Overall Study|Lost to Follow-up|22|||
127488201|NCT00387088|458752056|FG001|Overall Study|Lost to Follow-up|28|||
127488202|NCT00387088|458752055|FG000|Overall Study|Other|58|||
127488203|NCT00387088|458752056|FG001|Overall Study|Other|52|||
127488204|NCT02848092|458752059|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
127488205|NCT02848092|458752060|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
127488206|NCT02848092|458752059|FG000|1-month Post-training Follow-up|Adverse Event|2|||
127488207|NCT02848092|458752060|FG001|1-month Post-training Follow-up|Adverse Event|1|||
127488208|NCT02848092|458752059|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
127488209|NCT02848092|458752060|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
127488210|NCT02848092|458752059|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
127488211|NCT02848092|458752060|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
127488212|NCT02848092|458752059|FG000|1-month Post-training Follow-up|fatigue|0|||
127488213|NCT02848092|458752060|FG001|1-month Post-training Follow-up|fatigue|1|||
127488214|NCT02848092|458752059|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
127488215|NCT02848092|458752060|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
127488216|NCT02848092|458752059|FG000|6-month Post-training Follow-up|Adverse Event|1|||
127488217|NCT02848092|458752060|FG001|6-month Post-training Follow-up|Adverse Event|1|||
127488218|NCT02848092|458752059|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
127488219|NCT02848092|458752060|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
127488220|NCT02848092|458752059|FG000|6-month Post-training Follow-up|frustrated with task|1|||
127488221|NCT02848092|458752060|FG001|6-month Post-training Follow-up|frustrated with task|0|||
127488222|NCT02848092|458752059|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
127488223|NCT02848092|458752060|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
127488224|NCT02848092|458752059|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
127488225|NCT02848092|458752060|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
127488226|NCT01639469|458752062|FG000|Overall Study|Death|4|||
127488227|NCT01639469|458752063|FG001|Overall Study|Death|2|||
127488228|NCT01639469|458752062|FG000|Overall Study|Lost to Follow-up|1|||
127488229|NCT01639469|458752063|FG001|Overall Study|Lost to Follow-up|1|||
127488230|NCT00420381|458752064|FG000|Overall Study|Protocol Violation|1|||
127488231|NCT02329743|458752065|FG000|Overall Study|Adverse Event|1|||
127488232|NCT02329743|458752066|FG001|Overall Study|Adverse Event|1|||
127488233|NCT02329743|458752067|FG002|Overall Study|Adverse Event|3|||
127488234|NCT02329743|458752065|FG000|Overall Study|Lost to Follow-up|1|||
127488235|NCT02329743|458752066|FG001|Overall Study|Lost to Follow-up|0|||
127488236|NCT02329743|458752067|FG002|Overall Study|Lost to Follow-up|1|||
127488237|NCT02329743|458752065|FG000|Overall Study|Withdrawal by Subject|4|||
127488238|NCT02329743|458752066|FG001|Overall Study|Withdrawal by Subject|4|||
127488239|NCT02329743|458752067|FG002|Overall Study|Withdrawal by Subject|1|||
127488240|NCT02329743|458752065|FG000|Overall Study|Other|0|||
127488241|NCT02329743|458752066|FG001|Overall Study|Other|2|||
127488242|NCT02329743|458752067|FG002|Overall Study|Other|3|||
127488243|NCT03745768|458752070|FG000|Overall Study|discontinued study|2|||
127488244|NCT03745768|458752071|FG001|Overall Study|discontinued study|0|||
127488245|NCT01023217|458752077|FG000|Overall Study|Withdrawal by Subject|1|||
127488246|NCT01023217|458752078|FG001|Overall Study|Withdrawal by Subject|0|||
127488247|NCT01106157|458752079|FG000|Overall Study|Withdrawal by Subject|1|||
127488248|NCT01106157|458752080|FG001|Overall Study|Withdrawal by Subject|0|||
127488249|NCT01673646|458752084|FG000|Overall Study|Adverse Event|2|||
127488250|NCT01673646|458752085|FG001|Overall Study|Adverse Event|1|||
127488251|NCT01673646|458752086|FG002|Overall Study|Adverse Event|1|||
127488252|NCT01673646|458752084|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
127488253|NCT01673646|458752085|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
127488254|NCT01673646|458752086|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
127488255|NCT01673646|458752084|FG000|Overall Study|Condition no longer requires study drug|0|||
127488256|NCT01673646|458752085|FG001|Overall Study|Condition no longer requires study drug|1|||
127488257|NCT01673646|458752086|FG002|Overall Study|Condition no longer requires study drug|0|||
127488258|NCT01673646|458752084|FG000|Overall Study|Withdrawal by Subject|0|||
127488259|NCT01673646|458752085|FG001|Overall Study|Withdrawal by Subject|2|||
127488260|NCT01673646|458752086|FG002|Overall Study|Withdrawal by Subject|2|||
127488261|NCT01673646|458752084|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
127488262|NCT01673646|458752085|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
127488263|NCT01673646|458752086|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
127488264|NCT03064074|458752087|FG000|Overall Study|Physician Decision|0|||
127488265|NCT03064074|458752088|FG001|Overall Study|Physician Decision|0|||
127488266|NCT03064074|458752089|FG002|Overall Study|Physician Decision|0|||
127488267|NCT03064074|458752090|FG003|Overall Study|Physician Decision|1|||
127488268|NCT01118780|458752094|FG000|Overall Study|Adverse Event|15|||
127488269|NCT01118780|458752095|FG001|Overall Study|Adverse Event|15|||
127488270|NCT01118780|458752094|FG000|Overall Study|Death|1|||
127488271|NCT01118780|458752095|FG001|Overall Study|Death|0|||
127488272|NCT01118780|458752094|FG000|Overall Study|Lack of Efficacy|2|||
127488273|NCT01118780|458752095|FG001|Overall Study|Lack of Efficacy|6|||
127488274|NCT01118780|458752094|FG000|Overall Study|Physician Decision|2|||
127488275|NCT01118780|458752095|FG001|Overall Study|Physician Decision|0|||
127488276|NCT01118780|458752094|FG000|Overall Study|Protocol Violation|3|||
127488277|NCT01118780|458752095|FG001|Overall Study|Protocol Violation|6|||
127488278|NCT01118780|458752094|FG000|Overall Study|Withdrawal by Subject|13|||
127488279|NCT01118780|458752095|FG001|Overall Study|Withdrawal by Subject|8|||
127488280|NCT03962855|458752103|FG000|Overall Study|Death|0|||
127488281|NCT03962855|458752104|FG001|Overall Study|Death|1|||
127488282|NCT03962855|458752103|FG000|Overall Study|Lost to Follow-up|0|||
127488283|NCT03962855|458752104|FG001|Overall Study|Lost to Follow-up|1|||
127488284|NCT03962855|458752103|FG000|Overall Study|Adverse Event|0|||
127488285|NCT03962855|458752104|FG001|Overall Study|Adverse Event|1|||
127488286|NCT03962855|458752103|FG000|Overall Study|Physician Decision|0|||
127488287|NCT03962855|458752104|FG001|Overall Study|Physician Decision|2|||
127488288|NCT02651116|458752105|FG000|Overall Study|Adverse Event|0|||
127488289|NCT02651116|458752106|FG001|Overall Study|Adverse Event|1|||
127488290|NCT02651116|458752105|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
127488291|NCT02651116|458752106|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
127488292|NCT01492088|458752107|FG000|Overall Study|Withdrawal by Patient|0|||
127488293|NCT01492088|458752108|FG001|Overall Study|Withdrawal by Patient|2|||
127488294|NCT01492088|458752109|FG002|Overall Study|Withdrawal by Patient|0|||
127488295|NCT01492088|458752107|FG000|Overall Study|Death|1|||
127488296|NCT01492088|458752108|FG001|Overall Study|Death|6|||
127488297|NCT01492088|458752109|FG002|Overall Study|Death|2|||
127488298|NCT01492088|458752107|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
127488299|NCT01492088|458752108|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
127488300|NCT01492088|458752109|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
127488301|NCT01492088|458752107|FG000|Overall Study|Alive at Last Follow-up|0|||
127488302|NCT01492088|458752108|FG001|Overall Study|Alive at Last Follow-up|6|||
127488303|NCT01492088|458752109|FG002|Overall Study|Alive at Last Follow-up|11|||
127488304|NCT02379052|458752110|FG000|Overall Study|Protocol Violation|0|||
127488305|NCT02379052|458752111|FG001|Overall Study|Protocol Violation|1|||
127488306|NCT02379052|458752110|FG000|Overall Study|Adverse Event|0|||
127488307|NCT02379052|458752111|FG001|Overall Study|Adverse Event|1|||
127488308|NCT02379052|458752110|FG000|Overall Study|Physician Decision|1|||
127488309|NCT02379052|458752111|FG001|Overall Study|Physician Decision|1|||
127488310|NCT02379052|458752110|FG000|Overall Study|Withdrawal by Subject|2|||
127488311|NCT02379052|458752111|FG001|Overall Study|Withdrawal by Subject|0|||
127488312|NCT02379052|458752110|FG000|Overall Study|Lost to Follow-up|2|||
127488313|NCT02379052|458752111|FG001|Overall Study|Lost to Follow-up|1|||
127488314|NCT02379052|458752110|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
127488315|NCT02379052|458752111|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
127488316|NCT02379052|458752110|FG000|Overall Study|Subject was Incarcerated|0|||
127488317|NCT02379052|458752111|FG001|Overall Study|Subject was Incarcerated|1|||
127488318|NCT03824392|458752112|FG000|Overall Study|Adverse Event|1|||
127488319|NCT03824392|458752113|FG001|Overall Study|Adverse Event|0|||
127488320|NCT03824392|458752114|FG002|Overall Study|Adverse Event|0|||
127488321|NCT03824392|458752115|FG003|Overall Study|Adverse Event|0|||
127488322|NCT03824392|458752112|FG000|Overall Study|Investigator Decision|0|||
127488323|NCT03824392|458752113|FG001|Overall Study|Investigator Decision|1|||
127488324|NCT03824392|458752114|FG002|Overall Study|Investigator Decision|0|||
127488325|NCT03824392|458752115|FG003|Overall Study|Investigator Decision|0|||
127488326|NCT03824392|458752112|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
127488327|NCT03824392|458752113|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
127488328|NCT03824392|458752114|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
127488329|NCT03824392|458752115|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
127488330|NCT00127855|458752116|FG000|Primary Vaccination Course|Adverse Event|0|||
127488331|NCT00127855|458752117|FG001|Primary Vaccination Course|Adverse Event|0|||
127488332|NCT00127855|458752118|FG002|Primary Vaccination Course|Adverse Event|1|||
127488333|NCT00127855|458752119|FG003|Primary Vaccination Course|Adverse Event|0|||
127488334|NCT00127855|458752120|FG004|Primary Vaccination Course|Adverse Event|0|||
127488335|NCT00127855|458752116|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
127488336|NCT00127855|458752117|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
127488337|NCT00127855|458752118|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
127488338|NCT00127855|458752119|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
127488339|NCT00127855|458752120|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
127488340|NCT00127855|458752116|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
127488341|NCT00127855|458752117|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
127976597|NCT01938430|460536152|FG004|Overall Study|Lack of Efficacy|0|||
127976598|NCT01938430|460536153|FG005|Overall Study|Lack of Efficacy|0|||
127976599|NCT01938430|460536154|FG006|Overall Study|Lack of Efficacy|0|||
127976600|NCT01938430|460536155|FG007|Overall Study|Lack of Efficacy|0|||
127976601|NCT01938430|460536156|FG008|Overall Study|Lack of Efficacy|1|||
127976602|NCT01938430|460536157|FG009|Overall Study|Lack of Efficacy|0|||
127488342|NCT00127855|458752118|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
127488343|NCT00127855|458752119|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
127488344|NCT00127855|458752120|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
127488345|NCT00127855|458752116|FG000|Primary Vaccination Course|Other|0|||
127488346|NCT00127855|458752117|FG001|Primary Vaccination Course|Other|0|||
127488347|NCT00127855|458752118|FG002|Primary Vaccination Course|Other|0|||
127488348|NCT00127855|458752119|FG003|Primary Vaccination Course|Other|0|||
127488349|NCT00127855|458752120|FG004|Primary Vaccination Course|Other|1|||
127488350|NCT02343302|458752121|FG000|Overall Study|Physician Decision|1|||
127488351|NCT02343302|458752122|FG001|Overall Study|Physician Decision|1|||
127488352|NCT01887717|458752123|FG000|Overall Study|Withdrawal by Subject|1|||
127488353|NCT01887717|458752124|FG001|Overall Study|Withdrawal by Subject|7|||
127488354|NCT01887717|458752123|FG000|Overall Study|Physician Decision|0|||
127488355|NCT01887717|458752124|FG001|Overall Study|Physician Decision|2|||
127488356|NCT01887717|458752123|FG000|Overall Study|Administrative reasons|5|||
127488357|NCT01887717|458752124|FG001|Overall Study|Administrative reasons|2|||
127488358|NCT02655887|458752125|FG000|Overall Study|Lost to Follow-up|3|||
127488359|NCT02655887|458752125|FG000|Overall Study|Death|4|||
127488360|NCT02655887|458752125|FG000|Overall Study|Withdrawal by Subject|3|||
127488361|NCT02655887|458752125|FG000|Overall Study|Missed 12-month follow-up visit|4|||
127488362|NCT03637491|458752129|FG000|Overall Study|Death|9|||
127488363|NCT03637491|458752130|FG001|Overall Study|Death|9|||
127488364|NCT03637491|458752131|FG002|Overall Study|Death|5|||
127488365|NCT03637491|458752132|FG003|Overall Study|Death|3|||
127488366|NCT03637491|458752129|FG000|Overall Study|Lost to Follow-up|0|||
127488367|NCT03637491|458752130|FG001|Overall Study|Lost to Follow-up|1|||
127488368|NCT03637491|458752131|FG002|Overall Study|Lost to Follow-up|0|||
127488369|NCT03637491|458752132|FG003|Overall Study|Lost to Follow-up|1|||
127488370|NCT03637491|458752129|FG000|Overall Study|Study Terminated By Sponsor|0|||
127488371|NCT03637491|458752130|FG001|Overall Study|Study Terminated By Sponsor|2|||
127488372|NCT03637491|458752131|FG002|Overall Study|Study Terminated By Sponsor|1|||
127488373|NCT03637491|458752132|FG003|Overall Study|Study Terminated By Sponsor|0|||
127488374|NCT03637491|458752129|FG000|Overall Study|Withdrawal by Subject|1|||
127488375|NCT03637491|458752130|FG001|Overall Study|Withdrawal by Subject|0|||
127488376|NCT03637491|458752131|FG002|Overall Study|Withdrawal by Subject|1|||
127488377|NCT03637491|458752132|FG003|Overall Study|Withdrawal by Subject|2|||
127488378|NCT00532844|458752133|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
127488379|NCT00532844|458752134|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
127488380|NCT00532844|458752133|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
127488381|NCT00532844|458752134|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
127488382|NCT00532844|458752133|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
127488383|NCT00532844|458752134|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
127488384|NCT00532844|458752133|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
127488385|NCT00532844|458752134|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
127488386|NCT00532844|458752133|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
127488387|NCT00532844|458752134|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
127488388|NCT03465722|458752138|FG000|Overall Study|Withdrawal by Subject|21|||
127488389|NCT03465722|458752139|FG001|Overall Study|Withdrawal by Subject|14|||
127488390|NCT03465722|458752138|FG000|Overall Study|Death|89|||
127488391|NCT03465722|458752139|FG001|Overall Study|Death|87|||
127488392|NCT03465722|458752138|FG000|Overall Study|Lost to Follow-up|5|||
127488393|NCT03465722|458752139|FG001|Overall Study|Lost to Follow-up|3|||
127488394|NCT03465722|458752138|FG000|Overall Study|Administrative/Other|33|||
127488395|NCT03465722|458752139|FG001|Overall Study|Administrative/Other|32|||
127488396|NCT03465722|458752138|FG000|Overall Study|Not treated|1|||
127488397|NCT03465722|458752139|FG001|Overall Study|Not treated|2|||
127488398|NCT03465722|458752138|FG000|Overall Study|Sponsor decision|91|||
127488399|NCT03465722|458752139|FG001|Overall Study|Sponsor decision|98|||
127488400|NCT01490918|458752142|FG000|Overall Study|Lost to Follow-up|2|||
127488401|NCT01490918|458752143|FG001|Overall Study|Lost to Follow-up|1|||
127488402|NCT01490918|458752144|FG002|Overall Study|Lost to Follow-up|0|||
127488403|NCT01490918|458752142|FG000|Overall Study|Withdrawal by Subject|7|||
127488404|NCT01490918|458752143|FG001|Overall Study|Withdrawal by Subject|8|||
127488405|NCT01490918|458752144|FG002|Overall Study|Withdrawal by Subject|3|||
127488406|NCT01490918|458752142|FG000|Overall Study|Adverse Event|0|||
127488407|NCT01490918|458752143|FG001|Overall Study|Adverse Event|0|||
127488408|NCT01490918|458752144|FG002|Overall Study|Adverse Event|1|||
127488409|NCT01490918|458752142|FG000|Overall Study|other cause|4|||
127488410|NCT01490918|458752143|FG001|Overall Study|other cause|5|||
127488411|NCT01490918|458752144|FG002|Overall Study|other cause|8|||
127488412|NCT04940130|458752150|FG000|Overall Study|Travel|1|||
127488413|NCT04940130|458752151|FG001|Overall Study|Travel|0|||
127488414|NCT04940130|458752152|FG002|Overall Study|Travel|2|||
127488415|NCT04940130|458752150|FG000|Overall Study|Parent/Guardian withdrew consent|0|||
127488416|NCT04940130|458752151|FG001|Overall Study|Parent/Guardian withdrew consent|1|||
127488417|NCT04940130|458752152|FG002|Overall Study|Parent/Guardian withdrew consent|7|||
127488418|NCT04940130|458752150|FG000|Overall Study|Adverse Event|0|||
127488419|NCT04940130|458752151|FG001|Overall Study|Adverse Event|0|||
127488420|NCT04940130|458752152|FG002|Overall Study|Adverse Event|2|||
127488421|NCT04940130|458752150|FG000|Overall Study|Disease progression/treatment failure|0|||
127488422|NCT04940130|458752151|FG001|Overall Study|Disease progression/treatment failure|0|||
127488423|NCT04940130|458752152|FG002|Overall Study|Disease progression/treatment failure|1|||
127488424|NCT04940130|458752150|FG000|Overall Study|Participant refusal|0|||
127488425|NCT04940130|458752151|FG001|Overall Study|Participant refusal|0|||
127488426|NCT04940130|458752152|FG002|Overall Study|Participant refusal|1|||
127488427|NCT02240121|458752153|FG000|Overall Study|Protocol Violation|1|||
127488428|NCT02240121|458752154|FG001|Overall Study|Protocol Violation|2|||
127488429|NCT02240121|458752153|FG000|Overall Study|Physician Decision|0|||
127488430|NCT02240121|458752154|FG001|Overall Study|Physician Decision|1|||
127488431|NCT02240121|458752153|FG000|Overall Study|Change in protocol interpretation|1|||
127488432|NCT02240121|458752154|FG001|Overall Study|Change in protocol interpretation|0|||
127488433|NCT02240121|458752153|FG000|Overall Study|Lack of Efficacy|2|||
127488434|NCT02240121|458752154|FG001|Overall Study|Lack of Efficacy|3|||
127488435|NCT02240121|458752153|FG000|Overall Study|Site closed|1|||
127488436|NCT02240121|458752154|FG001|Overall Study|Site closed|1|||
127488437|NCT02240121|458752153|FG000|Overall Study|Pregnancy|1|||
127488438|NCT02240121|458752154|FG001|Overall Study|Pregnancy|0|||
127488439|NCT02240121|458752153|FG000|Overall Study|Adverse Event|2|||
127488440|NCT02240121|458752154|FG001|Overall Study|Adverse Event|4|||
127488441|NCT02240121|458752153|FG000|Overall Study|Withdrawal by Subject|6|||
127488442|NCT02240121|458752154|FG001|Overall Study|Withdrawal by Subject|2|||
127488443|NCT02240121|458752153|FG000|Overall Study|Lost to Follow-up|3|||
127488444|NCT02240121|458752154|FG001|Overall Study|Lost to Follow-up|4|||
127488445|NCT02240121|458752153|FG000|Overall Study|Other than specified|1|||
127488446|NCT02240121|458752154|FG001|Overall Study|Other than specified|3|||
127488447|NCT04419467|458752157|FG000|Overall Study|Not treated with IP|0|||
127488448|NCT04419467|458752158|FG001|Overall Study|Not treated with IP|0|||
127488449|NCT04419467|458752159|FG002|Overall Study|Not treated with IP|2|||
127488450|NCT04419467|458752157|FG000|Overall Study|Adverse Event|0|||
127488451|NCT04419467|458752158|FG001|Overall Study|Adverse Event|2|||
127488452|NCT04419467|458752159|FG002|Overall Study|Adverse Event|0|||
127488453|NCT04419467|458752157|FG000|Overall Study|Death|1|||
127488454|NCT04419467|458752158|FG001|Overall Study|Death|0|||
127488455|NCT04419467|458752159|FG002|Overall Study|Death|0|||
127488456|NCT04419467|458752157|FG000|Overall Study|Lost to Follow-up|0|||
127488457|NCT04419467|458752158|FG001|Overall Study|Lost to Follow-up|1|||
127488458|NCT04419467|458752159|FG002|Overall Study|Lost to Follow-up|2|||
127488459|NCT04419467|458752157|FG000|Overall Study|Withdrawal by Subject|0|||
127488460|NCT04419467|458752158|FG001|Overall Study|Withdrawal by Subject|0|||
127488461|NCT04419467|458752159|FG002|Overall Study|Withdrawal by Subject|4|||
127488462|NCT04419467|458752157|FG000|Overall Study|Pandemic related|0|||
127488463|NCT04419467|458752158|FG001|Overall Study|Pandemic related|0|||
127488464|NCT04419467|458752159|FG002|Overall Study|Pandemic related|1|||
127488465|NCT04419467|458752157|FG000|Overall Study|Reason not known|1|||
127488466|NCT04419467|458752158|FG001|Overall Study|Reason not known|0|||
127488467|NCT04419467|458752159|FG002|Overall Study|Reason not known|0|||
127488468|NCT01925768|458752160|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
127488469|NCT01925768|458752161|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
127488470|NCT01925768|458752160|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
127488471|NCT01925768|458752161|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
127488472|NCT01925768|458752160|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
127488473|NCT01925768|458752161|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
127488474|NCT01925768|458752160|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
127488475|NCT01925768|458752161|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
127488476|NCT01925768|458752160|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
127488477|NCT01925768|458752161|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
127488478|NCT01925768|458752160|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
127488479|NCT01925768|458752161|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
127488480|NCT01925768|458752160|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
127488481|NCT01925768|458752161|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
127488482|NCT01925768|458752160|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
127488483|NCT01925768|458752161|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
127488484|NCT01925768|458752160|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
127488485|NCT01925768|458752161|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
127488486|NCT01925768|458752160|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
127488487|NCT01925768|458752161|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
127488488|NCT01925768|458752160|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
127488489|NCT01925768|458752161|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
127488490|NCT02779777|458752166|FG000|Overall Study|Disease Progression|1|||
127488491|NCT02779777|458752167|FG001|Overall Study|Disease Progression|0|||
127488492|NCT02779777|458752168|FG002|Overall Study|Disease Progression|0|||
127488493|NCT02779777|458752166|FG000|Overall Study|Adverse Event|3|||
127488494|NCT02779777|458752167|FG001|Overall Study|Adverse Event|1|||
127488495|NCT02779777|458752168|FG002|Overall Study|Adverse Event|0|||
127488496|NCT02779777|458752166|FG000|Overall Study|Physician Decision|9|||
127488497|NCT02779777|458752167|FG001|Overall Study|Physician Decision|0|||
127488498|NCT02779777|458752168|FG002|Overall Study|Physician Decision|1|||
127488499|NCT02779777|458752166|FG000|Overall Study|Withdrawal by Subject|1|||
127488500|NCT02779777|458752167|FG001|Overall Study|Withdrawal by Subject|0|||
127488501|NCT02779777|458752168|FG002|Overall Study|Withdrawal by Subject|0|||
127488502|NCT04571060|458752169|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
127488503|NCT04571060|458752170|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
127488504|NCT04571060|458752169|FG000|Overall Study|Never treated migraine|47|||
127488505|NCT04571060|458752170|FG001|Overall Study|Never treated migraine|36|||
127488506|NCT04571060|458752169|FG000|Overall Study|Protocol Violation|4|||
127488507|NCT04571060|458752170|FG001|Overall Study|Protocol Violation|2|||
127488508|NCT04571060|458752169|FG000|Overall Study|Withdrawal by Subject|6|||
127488509|NCT04571060|458752170|FG001|Overall Study|Withdrawal by Subject|2|||
127488510|NCT04571060|458752169|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
127488511|NCT04571060|458752170|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
127488512|NCT00442416|458752171|FG000|Overall Study|Adverse Event|4|||
127488513|NCT00442416|458752172|FG001|Overall Study|Adverse Event|1|||
127488514|NCT00442416|458752171|FG000|Overall Study|Death|1|||
127488515|NCT00442416|458752172|FG001|Overall Study|Death|0|||
127488516|NCT00442416|458752171|FG000|Overall Study|Lack of Efficacy|2|||
127488517|NCT00442416|458752172|FG001|Overall Study|Lack of Efficacy|0|||
127488518|NCT00442416|458752171|FG000|Overall Study|Protocol Violation|2|||
127488519|NCT00442416|458752172|FG001|Overall Study|Protocol Violation|3|||
127488520|NCT00442416|458752171|FG000|Overall Study|Withdrew consent|1|||
127488521|NCT00442416|458752172|FG001|Overall Study|Withdrew consent|2|||
127488522|NCT00442416|458752171|FG000|Overall Study|Administrative/Other|27|||
127488523|NCT00442416|458752172|FG001|Overall Study|Administrative/Other|33|||
127488524|NCT00087698|458752178|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
127488525|NCT00087698|458752178|FG000|Overall Study|Death from Other Causes|3|||
127488526|NCT00087698|458752178|FG000|Overall Study|Adverse Event|4|||
127488527|NCT00087698|458752178|FG000|Overall Study|Withdrawal by Subject|4|||
127488528|NCT00087698|458752178|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
127488529|NCT00087698|458752178|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
127488530|NCT00087698|458752178|FG000|Overall Study|Clinical Relapse|1|||
127488531|NCT00087698|458752178|FG000|Overall Study|Death from Study Disease|2|||
127488532|NCT00087698|458752178|FG000|Overall Study|Death from Study Drug Toxicity|2|||
127488533|NCT00087698|458752178|FG000|Overall Study|Protocol Violation|1|||
127488534|NCT00142792|458752184|FG000|Overall Study|Death|0|||
127488535|NCT00142792|458752185|FG001|Overall Study|Death|0|||
127488536|NCT00142792|458752186|FG002|Overall Study|Death|1|||
127488537|NCT00142792|458752184|FG000|Overall Study|Withdrawal by Subject|3|||
127488538|NCT00142792|458752185|FG001|Overall Study|Withdrawal by Subject|2|||
127488539|NCT00142792|458752186|FG002|Overall Study|Withdrawal by Subject|3|||
127488540|NCT00142792|458752184|FG000|Overall Study|Lost to Follow-up|8|||
127488541|NCT00142792|458752185|FG001|Overall Study|Lost to Follow-up|11|||
127488542|NCT00142792|458752186|FG002|Overall Study|Lost to Follow-up|7|||
127488543|NCT00142792|458752184|FG000|Overall Study|No category|1|||
127488544|NCT00142792|458752185|FG001|Overall Study|No category|2|||
127488545|NCT00142792|458752186|FG002|Overall Study|No category|1|||
127488546|NCT01900665|458752198|FG000|Placebo Controlled Period|Death|9|||
127488547|NCT01900665|458752199|FG001|Placebo Controlled Period|Death|16|||
127488548|NCT01900665|458752198|FG000|Placebo Controlled Period|Adverse Event|48|||
127488549|NCT01900665|458752199|FG001|Placebo Controlled Period|Adverse Event|39|||
127488550|NCT01900665|458752198|FG000|Placebo Controlled Period|Protocol Violation|1|||
127488551|NCT01900665|458752199|FG001|Placebo Controlled Period|Protocol Violation|7|||
127488552|NCT01900665|458752198|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
127488553|NCT01900665|458752199|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
127488554|NCT01900665|458752198|FG000|Placebo Controlled Period|Physician Decision|11|||
127488555|NCT01900665|458752199|FG001|Placebo Controlled Period|Physician Decision|7|||
127488556|NCT01900665|458752198|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
127488557|NCT01900665|458752199|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
127488558|NCT01900665|458752198|FG000|Placebo Controlled Period|Caregiver Decision|33|||
127488559|NCT01900665|458752199|FG001|Placebo Controlled Period|Caregiver Decision|41|||
127488560|NCT01900665|458752198|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
127488561|NCT01900665|458752199|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
127488562|NCT01900665|458752198|FG000|Open Label Period|Adverse Event|16|||
127488563|NCT01900665|458752199|FG001|Open Label Period|Adverse Event|20|||
127488564|NCT01900665|458752198|FG000|Open Label Period|Death|5|||
127488565|NCT01900665|458752199|FG001|Open Label Period|Death|6|||
127488566|NCT01900665|458752198|FG000|Open Label Period|Lost to Follow-up|1|||
127488567|NCT01900665|458752199|FG001|Open Label Period|Lost to Follow-up|1|||
127488568|NCT01900665|458752198|FG000|Open Label Period|Parent/Caregiver Decision|33|||
127488569|NCT01900665|458752199|FG001|Open Label Period|Parent/Caregiver Decision|34|||
127488570|NCT01900665|458752198|FG000|Open Label Period|Physician Decision|4|||
127488571|NCT01900665|458752199|FG001|Open Label Period|Physician Decision|4|||
127488572|NCT01900665|458752198|FG000|Open Label Period|Protocol Violation|0|||
127488573|NCT01900665|458752199|FG001|Open Label Period|Protocol Violation|1|||
127488574|NCT01900665|458752198|FG000|Open Label Period|Sponsor Decision|802|||
127488575|NCT01900665|458752199|FG001|Open Label Period|Sponsor Decision|765|||
127488576|NCT01900665|458752198|FG000|Open Label Period|Withdrawal by Subject|20|||
127488577|NCT01900665|458752199|FG001|Open Label Period|Withdrawal by Subject|28|||
127488578|NCT03816176|458752200|FG000|Overall Study|Miscellaneous|5|||
127488579|NCT03816176|458752200|FG000|Overall Study|Lack of Efficacy|4|||
127488580|NCT03816176|458752200|FG000|Overall Study|Adverse Event|3|||
127488581|NCT00552071|458753219|FG000|Overall Study|Adverse Event|1|||
127488582|NCT00552071|458753220|FG001|Overall Study|Adverse Event|0|||
127488583|NCT00552071|458753219|FG000|Overall Study|Lack of Efficacy|1|||
127488584|NCT00552071|458753220|FG001|Overall Study|Lack of Efficacy|0|||
127488585|NCT00552071|458753219|FG000|Overall Study|Physician Decision|1|||
127488586|NCT00552071|458753220|FG001|Overall Study|Physician Decision|0|||
127488587|NCT00552071|458753219|FG000|Overall Study|Pregnancy|1|||
127488588|NCT00552071|458753220|FG001|Overall Study|Pregnancy|0|||
127488589|NCT00552071|458753219|FG000|Overall Study|Death|0|||
127488590|NCT00552071|458753220|FG001|Overall Study|Death|1|||
127488591|NCT00552071|458753219|FG000|Overall Study|Withdrawal by Subject|0|||
127488592|NCT00552071|458753220|FG001|Overall Study|Withdrawal by Subject|1|||
127488593|NCT01979614|458753221|FG000|Overall Study|Adverse Event|1|||
127488594|NCT01979614|458753222|FG001|Overall Study|Adverse Event|1|||
127488595|NCT00756275|458753223|FG000|Overall Study|Lost to Follow-up|25|||
127488596|NCT00756275|458753224|FG001|Overall Study|Lost to Follow-up|21|||
127488597|NCT00756275|458753223|FG000|Overall Study|Withdrawal by Subject|4|||
127488598|NCT00756275|458753224|FG001|Overall Study|Withdrawal by Subject|7|||
127488599|NCT00938912|458753225|FG000|Overall Study|Withdrawal by Subject|28|||
127488600|NCT00938912|458753225|FG000|Overall Study|Lost to Follow-up|4|||
127488601|NCT00938912|458753225|FG000|Overall Study|Lack of Efficacy|43|||
127488602|NCT00938912|458753225|FG000|Overall Study|Adverse event, non-fatal|24|||
127488603|NCT00938912|458753225|FG000|Overall Study|Adverse event, fatal|1|||
127488604|NCT00938912|458753225|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
127488605|NCT00938912|458753225|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
127488606|NCT00938912|458753225|FG000|Overall Study|Participant needed prohibit medication|1|||
127488607|NCT00938912|458753225|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
127488608|NCT00938912|458753225|FG000|Overall Study|Did not meet Eligibility criteria|1|||
127488609|NCT00938912|458753225|FG000|Overall Study|Participant relocated not related to AE|1|||
127488610|NCT00938912|458753225|FG000|Overall Study|Participant moved to another city|1|||
127488611|NCT00938912|458753225|FG000|Overall Study|Participant experienced break through seizures|1|||
127488612|NCT00938912|458753225|FG000|Overall Study|No longer wished to participate in the study|1|||
127488613|NCT00938912|458753225|FG000|Overall Study|Protocol Deviation|2|||
127488614|NCT00456755|458753228|FG000|Overall Study|Lost to Follow-up|2|||
127488615|NCT00456755|458753229|FG001|Overall Study|Lost to Follow-up|1|||
127488616|NCT06164691|458753230|FG000|Overall Study|Withdrawal by Subject|2|||
127488617|NCT06164691|458753231|FG001|Overall Study|Withdrawal by Subject|0|||
127488618|NCT06164691|458753232|FG002|Overall Study|Withdrawal by Subject|0|||
127488619|NCT02477527|458753235|FG000|Overall Study|Lost to Follow-up|2|||
127488620|NCT02477527|458753235|FG000|Overall Study|Withdrawal by Subject|1|||
127488621|NCT02477527|458753235|FG000|Overall Study|Screen Failure|3|||
127488622|NCT01428219|458753252|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
127488623|NCT00592631|458753253|FG000|Overall Study|Lost to Follow-up|0|||
127488624|NCT00592631|458753254|FG001|Overall Study|Lost to Follow-up|2|||
127488625|NCT02383862|458753257|FG000|3 Month Follow up|Lost to Follow-up|23|||
127488626|NCT02383862|458753258|FG001|3 Month Follow up|Lost to Follow-up|21|||
127488627|NCT01833494|458753259|FG000|Overall Study|Adverse Event|24|||
127488628|NCT01833494|458753259|FG000|Overall Study|Physician Decision|6|||
127488629|NCT01833494|458753259|FG000|Overall Study|Withdrawal by Subject|6|||
127976603|NCT01938430|460536158|FG010|Overall Study|Lack of Efficacy|2|||
127976604|NCT01938430|460536159|FG011|Overall Study|Lack of Efficacy|1|||
127976605|NCT01938430|460536160|FG012|Overall Study|Lack of Efficacy|0|||
127976606|NCT01938430|460536161|FG013|Overall Study|Lack of Efficacy|0|||
127976607|NCT01938430|460536148|FG000|Overall Study|Lost to Follow-up|0|||
127976608|NCT01938430|460536149|FG001|Overall Study|Lost to Follow-up|0|||
127976609|NCT01938430|460536150|FG002|Overall Study|Lost to Follow-up|1|||
127976610|NCT01938430|460536151|FG003|Overall Study|Lost to Follow-up|0|||
127976611|NCT01938430|460536152|FG004|Overall Study|Lost to Follow-up|0|||
127976612|NCT01938430|460536153|FG005|Overall Study|Lost to Follow-up|1|||
127976613|NCT01938430|460536154|FG006|Overall Study|Lost to Follow-up|0|||
127976614|NCT01938430|460536155|FG007|Overall Study|Lost to Follow-up|0|||
127976615|NCT01938430|460536156|FG008|Overall Study|Lost to Follow-up|0|||
127976616|NCT01938430|460536157|FG009|Overall Study|Lost to Follow-up|0|||
127976617|NCT01938430|460536158|FG010|Overall Study|Lost to Follow-up|0|||
127976618|NCT01938430|460536159|FG011|Overall Study|Lost to Follow-up|0|||
127976619|NCT01938430|460536160|FG012|Overall Study|Lost to Follow-up|0|||
127976620|NCT01938430|460536161|FG013|Overall Study|Lost to Follow-up|0|||
127976621|NCT01938430|460536148|FG000|Overall Study|Withdrew Consent|0|||
127488630|NCT01833494|458753259|FG000|Overall Study|Decrease in serum phosphorus|4|||
127488631|NCT01833494|458753259|FG000|Overall Study|Decrease in serum calcium|4|||
127488632|NCT01833494|458753259|FG000|Overall Study|Increase in serum ferritin|1|||
127488633|NCT01694433|458753260|FG000|Overall Study|Adverse Event|7|||
127976622|NCT01938430|460536149|FG001|Overall Study|Withdrew Consent|0|||
127976623|NCT01938430|460536150|FG002|Overall Study|Withdrew Consent|0|||
127488634|NCT01694433|458753261|FG001|Overall Study|Adverse Event|0|||
127488635|NCT01694433|458753260|FG000|Overall Study|Physician Decision|1|||
127976624|NCT01938430|460536151|FG003|Overall Study|Withdrew Consent|0|||
127976625|NCT01938430|460536152|FG004|Overall Study|Withdrew Consent|0|||
127976626|NCT01938430|460536153|FG005|Overall Study|Withdrew Consent|0|||
127488636|NCT01694433|458753261|FG001|Overall Study|Physician Decision|0|||
127488637|NCT01694433|458753260|FG000|Overall Study|Withdrawal by Subject|3|||
127488638|NCT01694433|458753261|FG001|Overall Study|Withdrawal by Subject|4|||
127488639|NCT00374595|458753264|FG000|Overall Study|Death|23|||
127488640|NCT00374595|458753264|FG000|Overall Study|Withdrawal by Subject|39|||
127488641|NCT00374595|458753264|FG000|Overall Study|Lost to Follow-up|3|||
127488642|NCT00374595|458753264|FG000|Overall Study|too much time commitment|1|||
127488643|NCT00374595|458753264|FG000|Overall Study|transfer care to other clinical site|1|||
127488644|NCT00374595|458753264|FG000|Overall Study|relocation|3|||
127488645|NCT00443118|458753266|FG000|Overall Study|unknown primary outcome|3|||
127488646|NCT00443118|458753267|FG001|Overall Study|unknown primary outcome|1|||
127488647|NCT00443118|458753268|FG002|Overall Study|unknown primary outcome|0|||
127488648|NCT00443118|458753266|FG000|Overall Study|Withdrawal by Subject|1|||
127488649|NCT00443118|458753267|FG001|Overall Study|Withdrawal by Subject|0|||
127488650|NCT00443118|458753268|FG002|Overall Study|Withdrawal by Subject|0|||
127488651|NCT01664247|458753270|FG000|Overall Study|Adverse Event|5|||
127488652|NCT01664247|458753271|FG001|Overall Study|Adverse Event|3|||
127488653|NCT01664247|458753270|FG000|Overall Study|Protocol Violation|3|||
127488654|NCT01664247|458753271|FG001|Overall Study|Protocol Violation|5|||
127488655|NCT01664247|458753270|FG000|Overall Study|Withdrawal Criteria|1|||
127488656|NCT01664247|458753271|FG001|Overall Study|Withdrawal Criteria|4|||
127488657|NCT01664247|458753270|FG000|Overall Study|Unclassified|5|||
127488658|NCT01664247|458753271|FG001|Overall Study|Unclassified|29|||
127488659|NCT00846846|458753277|FG000|Overall Study|Death|56|||
127488660|NCT00846846|458753277|FG000|Overall Study|Withdrawal by Subject|19|||
127488661|NCT01284959|458753278|FG000|Overall Study|Withdrawal by Subject|1|||
127488662|NCT01284959|458753279|FG001|Overall Study|Withdrawal by Subject|0|||
127488663|NCT01284959|458753280|FG002|Overall Study|Withdrawal by Subject|0|||
127488664|NCT01284959|458753278|FG000|Overall Study|Adverse Event|0|||
127488665|NCT01284959|458753279|FG001|Overall Study|Adverse Event|0|||
127488666|NCT01284959|458753280|FG002|Overall Study|Adverse Event|1|||
127488667|NCT00003869|458753282|FG000|Overall Study|Adverse Event|14|||
127488668|NCT00003869|458753283|FG001|Overall Study|Adverse Event|3|||
127488669|NCT00003869|458753282|FG000|Overall Study|Withdrawal by Subject|21|||
127488670|NCT00003869|458753283|FG001|Overall Study|Withdrawal by Subject|3|||
127488671|NCT00003869|458753282|FG000|Overall Study|Death|1|||
127488672|NCT00003869|458753283|FG001|Overall Study|Death|2|||
127488673|NCT00003869|458753282|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
127488674|NCT00003869|458753283|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
127488675|NCT03364231|458753284|FG000|Overall Study|Adverse Event|1|||
127488676|NCT03364231|458753285|FG001|Overall Study|Adverse Event|4|||
127488677|NCT03364231|458753284|FG000|Overall Study|Death|1|||
127488678|NCT03364231|458753285|FG001|Overall Study|Death|0|||
127488679|NCT03364231|458753284|FG000|Overall Study|Investigator Decision|2|||
127488680|NCT03364231|458753285|FG001|Overall Study|Investigator Decision|2|||
127488681|NCT03364231|458753284|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
127488682|NCT03364231|458753285|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
127488683|NCT03364231|458753284|FG000|Overall Study|Withdrawal of Subject Consent|1|||
127488684|NCT03364231|458753285|FG001|Overall Study|Withdrawal of Subject Consent|0|||
127488685|NCT03364231|458753284|FG000|Overall Study|Reason Not Specified|1|||
127488686|NCT03364231|458753285|FG001|Overall Study|Reason Not Specified|0|||
127488687|NCT03364231|458753284|FG000|Overall Study|Disease Progression|0|||
127488688|NCT03364231|458753285|FG001|Overall Study|Disease Progression|6|||
127488689|NCT04068922|458753286|FG000|Overall Study|Lost to Follow-up|5|||
127488690|NCT04068922|458753286|FG000|Overall Study|Withdrawal by Subject|7|||
127488691|NCT04068922|458753286|FG000|Overall Study|Adverse Event|1|||
127488692|NCT01070979|458753294|FG000|Overall Study|Adverse Event|2|||
127488693|NCT01070979|458753295|FG001|Overall Study|Adverse Event|3|||
127488694|NCT01070979|458753296|FG002|Overall Study|Adverse Event|3|||
127488695|NCT01070979|458753294|FG000|Overall Study|Lost to Follow-up|2|||
127488696|NCT01070979|458753295|FG001|Overall Study|Lost to Follow-up|1|||
127488697|NCT01070979|458753296|FG002|Overall Study|Lost to Follow-up|1|||
127488698|NCT01070979|458753294|FG000|Overall Study|Protocol Violation|0|||
127488699|NCT01070979|458753295|FG001|Overall Study|Protocol Violation|2|||
127488700|NCT01070979|458753296|FG002|Overall Study|Protocol Violation|6|||
127488701|NCT01070979|458753294|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
127488702|NCT01070979|458753295|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
127488703|NCT01070979|458753296|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
127488704|NCT01070979|458753294|FG000|Overall Study|Withdrawal by Subject|3|||
127488705|NCT01070979|458753295|FG001|Overall Study|Withdrawal by Subject|1|||
127488706|NCT01070979|458753296|FG002|Overall Study|Withdrawal by Subject|1|||
127488707|NCT01070979|458753294|FG000|Overall Study|No study drug taken|0|||
127488708|NCT01070979|458753295|FG001|Overall Study|No study drug taken|1|||
127488709|NCT01070979|458753296|FG002|Overall Study|No study drug taken|0|||
127488710|NCT03484429|458753298|FG000|Overall Study|Withdrawal by Subject|1|||
127488711|NCT03484429|458753299|FG001|Overall Study|Withdrawal by Subject|0|||
127488712|NCT03484429|458753298|FG000|Overall Study|Adverse Event|2|||
127488713|NCT03484429|458753299|FG001|Overall Study|Adverse Event|0|||
127488714|NCT00444106|458753302|FG000|Overall Study|Lost to Follow-up|2|||
127488715|NCT00444106|458753303|FG001|Overall Study|Lost to Follow-up|1|||
127488716|NCT00444106|458753304|FG002|Overall Study|Lost to Follow-up|0|||
127488717|NCT00444106|458753302|FG000|Overall Study|Abnormal Test Procedure Results|0|||
127488718|NCT00444106|458753303|FG001|Overall Study|Abnormal Test Procedure Results|0|||
127488719|NCT00444106|458753304|FG002|Overall Study|Abnormal Test Procedure Results|1|||
127488720|NCT04749914|458753305|FG000|Period 1|Adverse Event|1|||
127488721|NCT04749914|458753306|FG001|Period 1|Adverse Event|0|||
127488722|NCT04749914|458753307|FG002|Period 1|Adverse Event|0|||
127488723|NCT04749914|458753308|FG003|Period 1|Adverse Event|0|||
127488724|NCT04749914|458753305|FG000|Period 1|Withdrawal by Subject|1|||
127488725|NCT04749914|458753306|FG001|Period 1|Withdrawal by Subject|0|||
127488726|NCT04749914|458753307|FG002|Period 1|Withdrawal by Subject|1|||
127488727|NCT04749914|458753308|FG003|Period 1|Withdrawal by Subject|0|||
127488728|NCT01074931|458753311|FG000|Overall Study|Economic reasons|1|||
127488729|NCT01074931|458753311|FG000|Overall Study|Death|5|||
127488730|NCT00953706|458753312|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
127488731|NCT00953706|458753313|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
127488732|NCT00953706|458753314|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
127488733|NCT00953706|458753315|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
127488734|NCT00953706|458753312|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
127488735|NCT00953706|458753313|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
127488736|NCT00953706|458753314|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
127488737|NCT00953706|458753315|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
127488738|NCT00953706|458753312|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
127488739|NCT00953706|458753313|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
127488740|NCT00953706|458753314|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
127488741|NCT00953706|458753315|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
127488742|NCT00953706|458753312|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
127488743|NCT00953706|458753313|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
127488744|NCT00953706|458753314|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
127488745|NCT00953706|458753315|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
127488746|NCT00953706|458753312|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
127488747|NCT00953706|458753313|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
127488748|NCT00953706|458753314|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
127488749|NCT00953706|458753315|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
127488750|NCT00953706|458753312|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
127488751|NCT00953706|458753313|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
127488752|NCT00953706|458753314|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
127488753|NCT00953706|458753315|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
127488754|NCT00953706|458753312|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
127488755|NCT00953706|458753313|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
127488756|NCT00953706|458753314|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
127488757|NCT00953706|458753315|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
127488758|NCT00953706|458753312|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
127488759|NCT00953706|458753313|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
127488760|NCT00953706|458753314|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
127488761|NCT00953706|458753315|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
127488762|NCT00953706|458753312|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
127488763|NCT00953706|458753313|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
127488764|NCT00953706|458753314|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
127488765|NCT00953706|458753315|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
127488766|NCT00953706|458753312|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
127488767|NCT00953706|458753313|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
127488768|NCT00953706|458753314|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
127488769|NCT00953706|458753315|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
127976627|NCT01938430|460536154|FG006|Overall Study|Withdrew Consent|0|||
127976628|NCT01938430|460536155|FG007|Overall Study|Withdrew Consent|0|||
127976629|NCT01938430|460536156|FG008|Overall Study|Withdrew Consent|1|||
127488770|NCT00953706|458753312|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
127488771|NCT00953706|458753313|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
127488772|NCT00953706|458753314|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
127976630|NCT01938430|460536157|FG009|Overall Study|Withdrew Consent|0|||
127976631|NCT01938430|460536158|FG010|Overall Study|Withdrew Consent|0|||
127976632|NCT01938430|460536159|FG011|Overall Study|Withdrew Consent|0|||
127976633|NCT01938430|460536160|FG012|Overall Study|Withdrew Consent|0|||
127488773|NCT00953706|458753315|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
127488774|NCT05414175|458753316|FG000|Overall Study|Withdrawal by Subject|1|||
127488775|NCT05414175|458753316|FG000|Overall Study|Other Reasons|1|||
127488776|NCT02112656|458753319|FG000|Overall Study|Death|78|||
127488777|NCT02112656|458753320|FG001|Overall Study|Death|82|||
127488778|NCT02112656|458753319|FG000|Overall Study|Withdrawal by Subject|9|||
127488779|NCT02112656|458753320|FG001|Overall Study|Withdrawal by Subject|11|||
127488780|NCT02112656|458753319|FG000|Overall Study|Lost to Follow-up|2|||
127488781|NCT02112656|458753320|FG001|Overall Study|Lost to Follow-up|4|||
127488782|NCT02112656|458753319|FG000|Overall Study|Noncompliance|1|||
127488783|NCT02112656|458753320|FG001|Overall Study|Noncompliance|2|||
127488784|NCT03761056|458753321|FG000|Overall Study|Death|8|||
127488785|NCT03761056|458753321|FG000|Overall Study|Enrolled but never treated|2|||
127488786|NCT03761056|458753321|FG000|Overall Study|Withdrawal of consent from further follow-up|2|||
127488787|NCT03761056|458753321|FG000|Overall Study|Investigator decision|1|||
127488788|NCT04749745|458753322|FG000|Overall Study|Withdrawal by Subject|1|||
127488789|NCT04749745|458753323|FG001|Overall Study|Withdrawal by Subject|0|||
127488790|NCT03965403|458753330|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
127488791|NCT02479880|458754537|FG000|Overall Study|Study Terminated by Sponsor|13|||
127488792|NCT02479880|458754538|FG001|Overall Study|Study Terminated by Sponsor|12|||
127488793|NCT02479880|458754537|FG000|Overall Study|Pregnancy|0|||
127488794|NCT02479880|458754538|FG001|Overall Study|Pregnancy|1|||
127488795|NCT03432494|458754552|FG000|Overall Study|Death|1|||
127488796|NCT03432494|458754552|FG000|Overall Study|Noncompliance|1|||
127488797|NCT00856635|458754553|FG000|Overall Study|Lost to Follow-up|2|||
127488798|NCT00856635|458754554|FG001|Overall Study|Lost to Follow-up|5|||
127488799|NCT00856635|458754553|FG000|Overall Study|Pregnancy|1|||
127488800|NCT00856635|458754554|FG001|Overall Study|Pregnancy|0|||
127488801|NCT00856635|458754553|FG000|Overall Study|Withdrawal by Subject|3|||
127488802|NCT00856635|458754554|FG001|Overall Study|Withdrawal by Subject|1|||
127488803|NCT00856635|458754553|FG000|Overall Study|Serious Adverse Event|1|||
127488804|NCT00856635|458754554|FG001|Overall Study|Serious Adverse Event|0|||
127488805|NCT00856635|458754553|FG000|Overall Study|Other|1|||
127488806|NCT00856635|458754554|FG001|Overall Study|Other|0|||
127488807|NCT00856635|458754553|FG000|Overall Study|Discontinued at Randomization|2|||
127488808|NCT00856635|458754554|FG001|Overall Study|Discontinued at Randomization|2|||
127488809|NCT01244035|458754555|FG000|Part 1: Period 1|Adverse Event|0|||
127488810|NCT01244035|458754556|FG001|Part 1: Period 1|Adverse Event|0|||
127488811|NCT01244035|458754557|FG002|Part 1: Period 1|Adverse Event|0|||
127488812|NCT01244035|458754558|FG003|Part 1: Period 1|Adverse Event|0|||
127488813|NCT01244035|458754559|FG004|Part 1: Period 1|Adverse Event|0|||
127488814|NCT01244035|458754560|FG005|Part 1: Period 1|Adverse Event|1|||
127488815|NCT01244035|458754555|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
127488816|NCT01244035|458754556|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
127488817|NCT01244035|458754557|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
127488818|NCT01244035|458754558|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
127488819|NCT01244035|458754559|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
127488820|NCT01244035|458754560|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
127488821|NCT01244035|458754555|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
127488822|NCT01244035|458754556|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
127488823|NCT01244035|458754557|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
127488824|NCT01244035|458754558|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
127488825|NCT01244035|458754559|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
127488826|NCT01244035|458754560|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
127488827|NCT01244035|458754555|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
127488828|NCT01244035|458754556|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
127488829|NCT01244035|458754557|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
127488830|NCT01244035|458754558|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
127488831|NCT01244035|458754559|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
127488832|NCT01244035|458754560|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
127488833|NCT01244035|458754555|FG000|Part 1: Period 3|Adverse Event|0|||
127488834|NCT01244035|458754556|FG001|Part 1: Period 3|Adverse Event|0|||
127488835|NCT01244035|458754557|FG002|Part 1: Period 3|Adverse Event|0|||
127488836|NCT01244035|458754558|FG003|Part 1: Period 3|Adverse Event|0|||
127976634|NCT01938430|460536161|FG013|Overall Study|Withdrew Consent|0|||
127976635|NCT02738879|460536168|FG000|Overall Study|Adverse Event|1|||
127488837|NCT01244035|458754559|FG004|Part 1: Period 3|Adverse Event|0|||
127488838|NCT01244035|458754560|FG005|Part 1: Period 3|Adverse Event|1|||
127488839|NCT01244035|458754555|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
127488840|NCT01244035|458754556|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
127488841|NCT01244035|458754557|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
127488842|NCT01244035|458754558|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
127488843|NCT01244035|458754559|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
127488844|NCT01244035|458754560|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
127488845|NCT01244035|458754555|FG000|Part 1: Period 3|Protocol Deviation|0|||
127488846|NCT01244035|458754556|FG001|Part 1: Period 3|Protocol Deviation|1|||
127488847|NCT01244035|458754557|FG002|Part 1: Period 3|Protocol Deviation|0|||
127488848|NCT01244035|458754558|FG003|Part 1: Period 3|Protocol Deviation|0|||
127488849|NCT01244035|458754559|FG004|Part 1: Period 3|Protocol Deviation|0|||
127488850|NCT01244035|458754560|FG005|Part 1: Period 3|Protocol Deviation|0|||
127488851|NCT01696773|458754561|FG000|Days 15-27, Washout|Adverse Event|1|||
127488852|NCT01696773|458754562|FG001|Days 15-27, Washout|Adverse Event|0|||
127488853|NCT02370368|458754565|FG000|Overall Study|Adverse Event|1|||
127488854|NCT02370368|458754566|FG001|Overall Study|Adverse Event|2|||
127488855|NCT02370368|458754565|FG000|Overall Study|Withdrawal by Subject|5|||
127488856|NCT02370368|458754566|FG001|Overall Study|Withdrawal by Subject|4|||
127488857|NCT00347932|458754569|FG000|Overall Study|Adverse Event|4|||
127488858|NCT00347932|458754570|FG001|Overall Study|Adverse Event|5|||
127488859|NCT00347932|458754569|FG000|Overall Study|Lack of Efficacy|3|||
127488860|NCT00347932|458754570|FG001|Overall Study|Lack of Efficacy|14|||
127488861|NCT00347932|458754569|FG000|Overall Study|Lost to Follow-up|10|||
127488862|NCT00347932|458754570|FG001|Overall Study|Lost to Follow-up|9|||
127488863|NCT00347932|458754569|FG000|Overall Study|Withdrawal by Subject|10|||
127488864|NCT00347932|458754570|FG001|Overall Study|Withdrawal by Subject|16|||
127488865|NCT00347932|458754569|FG000|Overall Study|Did not meet inclusion criteria|4|||
127488866|NCT00347932|458754570|FG001|Overall Study|Did not meet inclusion criteria|8|||
127488867|NCT04512001|458754571|FG000|Week 0 to Week 24|Adverse Event|14|||
127488868|NCT04512001|458754572|FG001|Week 0 to Week 24|Adverse Event|10|||
127488869|NCT04512001|458754573|FG002|Week 0 to Week 24|Adverse Event|0|||
127488870|NCT04512001|458754574|FG003|Week 0 to Week 24|Adverse Event|0|||
127488871|NCT04512001|458754575|FG004|Week 0 to Week 24|Adverse Event|0|||
127488872|NCT04512001|458754571|FG000|Week 0 to Week 24|Death|0|||
127488873|NCT04512001|458754572|FG001|Week 0 to Week 24|Death|2|||
127488874|NCT04512001|458754573|FG002|Week 0 to Week 24|Death|0|||
127488875|NCT04512001|458754574|FG003|Week 0 to Week 24|Death|0|||
127488876|NCT04512001|458754575|FG004|Week 0 to Week 24|Death|0|||
127488877|NCT04512001|458754571|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
127488878|NCT04512001|458754572|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
127488879|NCT04512001|458754573|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
127488880|NCT04512001|458754574|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
127488881|NCT04512001|458754575|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
127488882|NCT04512001|458754571|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
127488883|NCT04512001|458754572|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
127488884|NCT04512001|458754573|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
127488885|NCT04512001|458754574|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
127488886|NCT04512001|458754575|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
127488887|NCT04512001|458754571|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
127488888|NCT04512001|458754572|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
127488889|NCT04512001|458754573|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
127488890|NCT04512001|458754574|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
127488891|NCT04512001|458754575|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
127488892|NCT04512001|458754571|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
127488893|NCT04512001|458754572|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
127488894|NCT04512001|458754573|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
127488895|NCT04512001|458754574|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
127488896|NCT04512001|458754575|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
127488897|NCT04512001|458754571|FG000|Week 24 to Week 63|Adverse Event|0|||
127488898|NCT04512001|458754572|FG001|Week 24 to Week 63|Adverse Event|0|||
127488899|NCT04512001|458754573|FG002|Week 24 to Week 63|Adverse Event|13|||
127488900|NCT04512001|458754574|FG003|Week 24 to Week 63|Adverse Event|8|||
127488901|NCT04512001|458754575|FG004|Week 24 to Week 63|Adverse Event|6|||
127488902|NCT04512001|458754571|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
127488903|NCT04512001|458754572|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
127488904|NCT04512001|458754573|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
127488905|NCT04512001|458754574|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
127488906|NCT04512001|458754575|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
127488907|NCT04512001|458754571|FG000|Week 24 to Week 63|Death|0|||
127488908|NCT04512001|458754572|FG001|Week 24 to Week 63|Death|0|||
127488909|NCT04512001|458754573|FG002|Week 24 to Week 63|Death|0|||
127488910|NCT04512001|458754574|FG003|Week 24 to Week 63|Death|1|||
127488911|NCT04512001|458754575|FG004|Week 24 to Week 63|Death|1|||
127488912|NCT04512001|458754571|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
127488913|NCT04512001|458754572|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
127488914|NCT04512001|458754573|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
127488915|NCT04512001|458754574|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
127488916|NCT04512001|458754575|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
127488917|NCT04512001|458754571|FG000|Week 24 to Week 63|Miscellaneous|0|||
127488918|NCT04512001|458754572|FG001|Week 24 to Week 63|Miscellaneous|0|||
127488919|NCT04512001|458754573|FG002|Week 24 to Week 63|Miscellaneous|3|||
127488920|NCT04512001|458754574|FG003|Week 24 to Week 63|Miscellaneous|2|||
127488921|NCT04512001|458754575|FG004|Week 24 to Week 63|Miscellaneous|1|||
127488922|NCT03389308|458754578|FG000|Overall Study|Withdrawal by Subject|5|||
127488923|NCT03389308|458754578|FG000|Overall Study|Lost to Follow-up|3|||
127488924|NCT03389308|458754578|FG000|Overall Study|Adverse Event|2|||
127488925|NCT03389308|458754578|FG000|Overall Study|Sponsor Request|2|||
127488926|NCT03198767|458754579|FG000|Overall Study|Protocol Violation|0|||
127488927|NCT03198767|458754580|FG001|Overall Study|Protocol Violation|0|||
127488928|NCT03198767|458754581|FG002|Overall Study|Protocol Violation|0|||
127488929|NCT03198767|458754582|FG003|Overall Study|Protocol Violation|6|||
127488930|NCT03198767|458754583|FG004|Overall Study|Protocol Violation|0|||
127488931|NCT03198767|458754584|FG005|Overall Study|Protocol Violation|0|||
127488932|NCT03198767|458754585|FG006|Overall Study|Protocol Violation|0|||
127488933|NCT00570323|458754586|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
127488934|NCT00570323|458754587|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
127488935|NCT00570323|458754586|FG000|Started Treatment After Randomization|Protocol Violation|1|||
127488936|NCT00570323|458754587|FG001|Started Treatment After Randomization|Protocol Violation|0|||
127488937|NCT00570323|458754586|FG000|Started Treatment After Randomization|Physician Decision|1|||
127488938|NCT00570323|458754587|FG001|Started Treatment After Randomization|Physician Decision|0|||
127488939|NCT00570323|458754586|FG000|Complete Study After Start|Lost to Follow-up|0|||
127488940|NCT00570323|458754587|FG001|Complete Study After Start|Lost to Follow-up|1|||
127488941|NCT00570323|458754586|FG000|Complete Study After Start|Withdrawal by Subject|2|||
127488942|NCT00570323|458754587|FG001|Complete Study After Start|Withdrawal by Subject|0|||
127488943|NCT00570323|458754586|FG000|Complete Study After Start|Physician Decision|1|||
127488944|NCT00570323|458754587|FG001|Complete Study After Start|Physician Decision|0|||
127488945|NCT04232943|458754588|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
127488946|NCT04232943|458754589|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
127488947|NCT04232943|458754590|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
127488948|NCT04232943|458754588|FG000|Overall Study|Withdrawal by Subject|1|||
127488949|NCT04232943|458754589|FG001|Overall Study|Withdrawal by Subject|1|||
127488950|NCT04232943|458754590|FG002|Overall Study|Withdrawal by Subject|0|||
127488951|NCT03896477|458754593|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
127488952|NCT03896477|458754594|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
127488953|NCT03896477|458754595|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
127488954|NCT03896477|458754593|FG000|Overall Study|Parent Requested Withdrawal|8|||
127488955|NCT03896477|458754594|FG001|Overall Study|Parent Requested Withdrawal|12|||
127488956|NCT03896477|458754595|FG002|Overall Study|Parent Requested Withdrawal|9|||
127488957|NCT03896477|458754593|FG000|Overall Study|Adverse Event|0|||
127488958|NCT03896477|458754594|FG001|Overall Study|Adverse Event|0|||
127488959|NCT03896477|458754595|FG002|Overall Study|Adverse Event|1|||
127488960|NCT03896477|458754593|FG000|Overall Study|Death|1|||
127488961|NCT03896477|458754594|FG001|Overall Study|Death|0|||
127488962|NCT03896477|458754595|FG002|Overall Study|Death|0|||
127488963|NCT03896477|458754593|FG000|Overall Study|Other|5|||
127488964|NCT03896477|458754594|FG001|Overall Study|Other|6|||
127488965|NCT03896477|458754595|FG002|Overall Study|Other|7|||
127488966|NCT03896477|458754593|FG000|Overall Study|Lost to Follow-up|2|||
127488967|NCT03896477|458754594|FG001|Overall Study|Lost to Follow-up|1|||
127488968|NCT03896477|458754595|FG002|Overall Study|Lost to Follow-up|1|||
127488969|NCT01791517|458754597|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
127488970|NCT01791517|458754598|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
127488971|NCT01791517|458754599|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
127488972|NCT01791517|458754600|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
127488973|NCT01791517|458754601|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
127488974|NCT01791517|458754602|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
127488975|NCT01791517|458754603|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
127488976|NCT01791517|458754604|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
127488977|NCT01791517|458754605|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
127488978|NCT01791517|458754606|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
127488979|NCT01791517|458754607|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
127488980|NCT01791517|458754608|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
127488981|NCT01791517|458754597|FG000|Phase I: Period 1|Adverse Event|0|||
127488982|NCT01791517|458754598|FG001|Phase I: Period 1|Adverse Event|0|||
127488983|NCT01791517|458754599|FG002|Phase I: Period 1|Adverse Event|1|||
127488984|NCT01791517|458754600|FG003|Phase I: Period 1|Adverse Event|1|||
127488985|NCT01791517|458754601|FG004|Phase I: Period 1|Adverse Event|0|||
127488986|NCT01791517|458754602|FG005|Phase I: Period 1|Adverse Event|0|||
127488987|NCT01791517|458754603|FG006|Phase I: Period 1|Adverse Event|0|||
127488988|NCT01791517|458754604|FG007|Phase I: Period 1|Adverse Event|0|||
127488989|NCT01791517|458754605|FG008|Phase I: Period 1|Adverse Event|0|||
127488990|NCT01791517|458754606|FG009|Phase I: Period 1|Adverse Event|0|||
127488991|NCT01791517|458754607|FG010|Phase I: Period 1|Adverse Event|0|||
127488992|NCT01791517|458754608|FG011|Phase I: Period 1|Adverse Event|0|||
127488993|NCT01791517|458754597|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
127488994|NCT01791517|458754598|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
127488995|NCT01791517|458754599|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
127488996|NCT01791517|458754600|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
127869735|NCT02557308|460139638|FG004|Overall Study|Study Close|1|||
127869736|NCT02557308|460139639|FG005|Overall Study|Study Close|0|||
127488997|NCT01791517|458754601|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
127488998|NCT01791517|458754602|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
127488999|NCT01791517|458754603|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
127489000|NCT01791517|458754604|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
127489001|NCT01791517|458754605|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
127489002|NCT01791517|458754606|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
127489003|NCT01791517|458754607|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
127489004|NCT01791517|458754608|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
127489005|NCT01791517|458754597|FG000|Phase I: Period 1|Protocol Violation|0|||
127489006|NCT01791517|458754598|FG001|Phase I: Period 1|Protocol Violation|1|||
127489007|NCT01791517|458754599|FG002|Phase I: Period 1|Protocol Violation|0|||
127489008|NCT01791517|458754600|FG003|Phase I: Period 1|Protocol Violation|0|||
127489009|NCT01791517|458754601|FG004|Phase I: Period 1|Protocol Violation|0|||
127489010|NCT01791517|458754602|FG005|Phase I: Period 1|Protocol Violation|0|||
127489011|NCT01791517|458754603|FG006|Phase I: Period 1|Protocol Violation|0|||
127489012|NCT01791517|458754604|FG007|Phase I: Period 1|Protocol Violation|0|||
127489013|NCT01791517|458754605|FG008|Phase I: Period 1|Protocol Violation|0|||
127489014|NCT01791517|458754606|FG009|Phase I: Period 1|Protocol Violation|0|||
127489015|NCT01791517|458754607|FG010|Phase I: Period 1|Protocol Violation|0|||
127489016|NCT01791517|458754608|FG011|Phase I: Period 1|Protocol Violation|0|||
127489017|NCT01791517|458754597|FG000|Phase I: Period 1|Lost to Follow-up|0|||
127489018|NCT01791517|458754598|FG001|Phase I: Period 1|Lost to Follow-up|0|||
127489019|NCT01791517|458754599|FG002|Phase I: Period 1|Lost to Follow-up|0|||
127489020|NCT01791517|458754600|FG003|Phase I: Period 1|Lost to Follow-up|1|||
127489021|NCT01791517|458754601|FG004|Phase I: Period 1|Lost to Follow-up|0|||
127489022|NCT01791517|458754602|FG005|Phase I: Period 1|Lost to Follow-up|0|||
127489023|NCT01791517|458754603|FG006|Phase I: Period 1|Lost to Follow-up|1|||
127489024|NCT01791517|458754604|FG007|Phase I: Period 1|Lost to Follow-up|0|||
127489025|NCT01791517|458754605|FG008|Phase I: Period 1|Lost to Follow-up|1|||
127489026|NCT01791517|458754606|FG009|Phase I: Period 1|Lost to Follow-up|1|||
127489027|NCT01791517|458754607|FG010|Phase I: Period 1|Lost to Follow-up|0|||
127489028|NCT01791517|458754608|FG011|Phase I: Period 1|Lost to Follow-up|0|||
127489029|NCT01791517|458754597|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
127489030|NCT01791517|458754598|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
127489031|NCT01791517|458754599|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
127489032|NCT01791517|458754600|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
127489033|NCT01791517|458754601|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
127489034|NCT01791517|458754602|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
127489035|NCT01791517|458754603|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
127489036|NCT01791517|458754604|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
127489037|NCT01791517|458754605|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
127489038|NCT01791517|458754606|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
127489039|NCT01791517|458754607|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
127489040|NCT01791517|458754608|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
127489041|NCT01791517|458754597|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
127489042|NCT01791517|458754598|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
127489043|NCT01791517|458754599|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
127489044|NCT01791517|458754600|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
127489045|NCT01791517|458754601|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
127489046|NCT01791517|458754602|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
127489047|NCT01791517|458754603|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
127489048|NCT01791517|458754604|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
127489049|NCT01791517|458754605|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
127489050|NCT01791517|458754606|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
127489051|NCT01791517|458754607|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
127489052|NCT01791517|458754608|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
127489053|NCT01791517|458754597|FG000|Phase I: Period 2|Protocol Violation|0|||
127489054|NCT01791517|458754598|FG001|Phase I: Period 2|Protocol Violation|0|||
127489055|NCT01791517|458754599|FG002|Phase I: Period 2|Protocol Violation|0|||
127489056|NCT01791517|458754600|FG003|Phase I: Period 2|Protocol Violation|1|||
127489057|NCT01791517|458754601|FG004|Phase I: Period 2|Protocol Violation|0|||
127489058|NCT01791517|458754602|FG005|Phase I: Period 2|Protocol Violation|0|||
127489059|NCT01791517|458754603|FG006|Phase I: Period 2|Protocol Violation|0|||
127489060|NCT01791517|458754604|FG007|Phase I: Period 2|Protocol Violation|0|||
127489061|NCT01791517|458754605|FG008|Phase I: Period 2|Protocol Violation|0|||
127489062|NCT01791517|458754606|FG009|Phase I: Period 2|Protocol Violation|0|||
127489063|NCT01791517|458754607|FG010|Phase I: Period 2|Protocol Violation|0|||
127489064|NCT01791517|458754608|FG011|Phase I: Period 2|Protocol Violation|0|||
127489065|NCT01791517|458754597|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
127489066|NCT01791517|458754598|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
127489067|NCT01791517|458754599|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
127489068|NCT01791517|458754600|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
127489069|NCT01791517|458754601|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
127489070|NCT01791517|458754602|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
127489071|NCT01791517|458754603|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
127489072|NCT01791517|458754604|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
127489073|NCT01791517|458754605|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
127489074|NCT01791517|458754606|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
127489075|NCT01791517|458754607|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
127489076|NCT01791517|458754608|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
127489077|NCT01791517|458754597|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
127489078|NCT01791517|458754598|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
127489079|NCT01791517|458754599|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
127489080|NCT01791517|458754600|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
127489081|NCT01791517|458754601|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
127489082|NCT01791517|458754602|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
127489083|NCT01791517|458754603|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
127489084|NCT01791517|458754604|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
127489085|NCT01791517|458754605|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
127489086|NCT01791517|458754606|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
127489087|NCT01791517|458754607|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
127489088|NCT01791517|458754608|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
127489089|NCT01791517|458754597|FG000|Phase I: Period 2|Lens Discomfort|0|||
127489090|NCT01791517|458754598|FG001|Phase I: Period 2|Lens Discomfort|0|||
127489091|NCT01791517|458754599|FG002|Phase I: Period 2|Lens Discomfort|0|||
127489092|NCT01791517|458754600|FG003|Phase I: Period 2|Lens Discomfort|0|||
127489093|NCT01791517|458754601|FG004|Phase I: Period 2|Lens Discomfort|0|||
127489094|NCT01791517|458754602|FG005|Phase I: Period 2|Lens Discomfort|1|||
127489095|NCT01791517|458754603|FG006|Phase I: Period 2|Lens Discomfort|0|||
127489096|NCT01791517|458754604|FG007|Phase I: Period 2|Lens Discomfort|0|||
127489097|NCT01791517|458754605|FG008|Phase I: Period 2|Lens Discomfort|0|||
127489098|NCT01791517|458754606|FG009|Phase I: Period 2|Lens Discomfort|0|||
127489099|NCT01791517|458754607|FG010|Phase I: Period 2|Lens Discomfort|0|||
127489100|NCT01791517|458754608|FG011|Phase I: Period 2|Lens Discomfort|0|||
127489101|NCT01791517|458754597|FG000|Phase I: Period 2|Lost to Follow-up|0|||
127489102|NCT01791517|458754598|FG001|Phase I: Period 2|Lost to Follow-up|3|||
127489103|NCT01791517|458754599|FG002|Phase I: Period 2|Lost to Follow-up|2|||
127489104|NCT01791517|458754600|FG003|Phase I: Period 2|Lost to Follow-up|0|||
127489105|NCT01791517|458754601|FG004|Phase I: Period 2|Lost to Follow-up|0|||
127489106|NCT01791517|458754602|FG005|Phase I: Period 2|Lost to Follow-up|0|||
127489107|NCT01791517|458754603|FG006|Phase I: Period 2|Lost to Follow-up|0|||
127489108|NCT01791517|458754604|FG007|Phase I: Period 2|Lost to Follow-up|0|||
127489109|NCT01791517|458754605|FG008|Phase I: Period 2|Lost to Follow-up|0|||
127489110|NCT01791517|458754606|FG009|Phase I: Period 2|Lost to Follow-up|0|||
127489111|NCT01791517|458754607|FG010|Phase I: Period 2|Lost to Follow-up|0|||
127489112|NCT01791517|458754608|FG011|Phase I: Period 2|Lost to Follow-up|0|||
127489113|NCT01791517|458754597|FG000|Phase I: Period 3|Lens Discomfort|0|||
127489114|NCT01791517|458754598|FG001|Phase I: Period 3|Lens Discomfort|0|||
127489115|NCT01791517|458754599|FG002|Phase I: Period 3|Lens Discomfort|0|||
127489116|NCT01791517|458754600|FG003|Phase I: Period 3|Lens Discomfort|0|||
127489117|NCT01791517|458754601|FG004|Phase I: Period 3|Lens Discomfort|0|||
127489118|NCT01791517|458754602|FG005|Phase I: Period 3|Lens Discomfort|0|||
127489119|NCT01791517|458754603|FG006|Phase I: Period 3|Lens Discomfort|0|||
127489120|NCT01791517|458754604|FG007|Phase I: Period 3|Lens Discomfort|0|||
127489121|NCT01791517|458754605|FG008|Phase I: Period 3|Lens Discomfort|0|||
127489122|NCT01791517|458754606|FG009|Phase I: Period 3|Lens Discomfort|0|||
127489123|NCT01791517|458754607|FG010|Phase I: Period 3|Lens Discomfort|0|||
127489124|NCT01791517|458754608|FG011|Phase I: Period 3|Lens Discomfort|1|||
127489125|NCT01791517|458754597|FG000|Phase I: Period 3|Lost to Follow-up|0|||
127489126|NCT01791517|458754598|FG001|Phase I: Period 3|Lost to Follow-up|1|||
127489127|NCT01791517|458754599|FG002|Phase I: Period 3|Lost to Follow-up|0|||
127489128|NCT01791517|458754600|FG003|Phase I: Period 3|Lost to Follow-up|0|||
127489129|NCT01791517|458754601|FG004|Phase I: Period 3|Lost to Follow-up|1|||
127489130|NCT01791517|458754602|FG005|Phase I: Period 3|Lost to Follow-up|0|||
127489131|NCT01791517|458754603|FG006|Phase I: Period 3|Lost to Follow-up|0|||
127489132|NCT01791517|458754604|FG007|Phase I: Period 3|Lost to Follow-up|0|||
127489133|NCT01791517|458754605|FG008|Phase I: Period 3|Lost to Follow-up|0|||
127489134|NCT01791517|458754606|FG009|Phase I: Period 3|Lost to Follow-up|0|||
127489135|NCT01791517|458754607|FG010|Phase I: Period 3|Lost to Follow-up|0|||
127489136|NCT01791517|458754608|FG011|Phase I: Period 3|Lost to Follow-up|0|||
127489137|NCT01791517|458754597|FG000|Phase I: Period 3|Adverse Event|0|||
127489138|NCT01791517|458754598|FG001|Phase I: Period 3|Adverse Event|0|||
127489139|NCT01791517|458754599|FG002|Phase I: Period 3|Adverse Event|0|||
127489140|NCT01791517|458754600|FG003|Phase I: Period 3|Adverse Event|1|||
127489141|NCT01791517|458754601|FG004|Phase I: Period 3|Adverse Event|0|||
127489142|NCT01791517|458754602|FG005|Phase I: Period 3|Adverse Event|0|||
127489143|NCT01791517|458754603|FG006|Phase I: Period 3|Adverse Event|0|||
127489144|NCT01791517|458754604|FG007|Phase I: Period 3|Adverse Event|0|||
127489145|NCT01791517|458754605|FG008|Phase I: Period 3|Adverse Event|0|||
127489146|NCT01791517|458754606|FG009|Phase I: Period 3|Adverse Event|0|||
127489147|NCT01791517|458754607|FG010|Phase I: Period 3|Adverse Event|0|||
127489148|NCT01791517|458754608|FG011|Phase I: Period 3|Adverse Event|0|||
127489149|NCT01791517|458754597|FG000|Phase II|Lost to Follow-up|1|||
127489150|NCT01791517|458754598|FG001|Phase II|Lost to Follow-up|0|||
127489151|NCT01791517|458754599|FG002|Phase II|Lost to Follow-up|1|||
127489152|NCT01791517|458754600|FG003|Phase II|Lost to Follow-up|0|||
127489153|NCT01791517|458754601|FG004|Phase II|Lost to Follow-up|1|||
127489154|NCT01791517|458754602|FG005|Phase II|Lost to Follow-up|2|||
127489155|NCT01791517|458754603|FG006|Phase II|Lost to Follow-up|0|||
127489156|NCT01791517|458754604|FG007|Phase II|Lost to Follow-up|1|||
127489157|NCT01791517|458754605|FG008|Phase II|Lost to Follow-up|1|||
127489158|NCT01791517|458754606|FG009|Phase II|Lost to Follow-up|1|||
127489159|NCT01791517|458754607|FG010|Phase II|Lost to Follow-up|0|||
127489160|NCT01791517|458754608|FG011|Phase II|Lost to Follow-up|0|||
127489161|NCT01791517|458754597|FG000|Phase II|Withdrawal by Subject|1|||
127489162|NCT01791517|458754598|FG001|Phase II|Withdrawal by Subject|0|||
127489163|NCT01791517|458754599|FG002|Phase II|Withdrawal by Subject|0|||
127489164|NCT01791517|458754600|FG003|Phase II|Withdrawal by Subject|0|||
127489165|NCT01791517|458754601|FG004|Phase II|Withdrawal by Subject|0|||
127489166|NCT01791517|458754602|FG005|Phase II|Withdrawal by Subject|2|||
127489167|NCT01791517|458754603|FG006|Phase II|Withdrawal by Subject|0|||
127489168|NCT01791517|458754604|FG007|Phase II|Withdrawal by Subject|1|||
127489169|NCT01791517|458754605|FG008|Phase II|Withdrawal by Subject|0|||
127489170|NCT01791517|458754606|FG009|Phase II|Withdrawal by Subject|0|||
127489171|NCT01791517|458754607|FG010|Phase II|Withdrawal by Subject|1|||
127489172|NCT01791517|458754608|FG011|Phase II|Withdrawal by Subject|0|||
127489173|NCT01791517|458754597|FG000|Phase II|Lack of Efficacy|0|||
127489174|NCT01791517|458754598|FG001|Phase II|Lack of Efficacy|0|||
127489175|NCT01791517|458754599|FG002|Phase II|Lack of Efficacy|0|||
127489176|NCT01791517|458754600|FG003|Phase II|Lack of Efficacy|0|||
127489177|NCT01791517|458754601|FG004|Phase II|Lack of Efficacy|1|||
127489178|NCT01791517|458754602|FG005|Phase II|Lack of Efficacy|0|||
127489179|NCT01791517|458754603|FG006|Phase II|Lack of Efficacy|0|||
127489180|NCT01791517|458754604|FG007|Phase II|Lack of Efficacy|0|||
127489181|NCT01791517|458754605|FG008|Phase II|Lack of Efficacy|0|||
127489182|NCT01791517|458754606|FG009|Phase II|Lack of Efficacy|0|||
127489183|NCT01791517|458754607|FG010|Phase II|Lack of Efficacy|0|||
127489184|NCT01791517|458754608|FG011|Phase II|Lack of Efficacy|0|||
127489185|NCT01791517|458754597|FG000|Phase II|Adverse Event|0|||
127489186|NCT01791517|458754598|FG001|Phase II|Adverse Event|0|||
127489187|NCT01791517|458754599|FG002|Phase II|Adverse Event|0|||
127489188|NCT01791517|458754600|FG003|Phase II|Adverse Event|0|||
127489189|NCT01791517|458754601|FG004|Phase II|Adverse Event|0|||
127489190|NCT01791517|458754602|FG005|Phase II|Adverse Event|0|||
127489191|NCT01791517|458754603|FG006|Phase II|Adverse Event|2|||
127489192|NCT01791517|458754604|FG007|Phase II|Adverse Event|1|||
127489193|NCT01791517|458754605|FG008|Phase II|Adverse Event|0|||
127489194|NCT01791517|458754606|FG009|Phase II|Adverse Event|1|||
127489195|NCT01791517|458754607|FG010|Phase II|Adverse Event|0|||
127489196|NCT01791517|458754608|FG011|Phase II|Adverse Event|0|||
127489197|NCT01791517|458754597|FG000|Phase II|Lens Handling Difficulties|0|||
127489198|NCT01791517|458754598|FG001|Phase II|Lens Handling Difficulties|0|||
127489199|NCT01791517|458754599|FG002|Phase II|Lens Handling Difficulties|0|||
127489200|NCT01791517|458754600|FG003|Phase II|Lens Handling Difficulties|0|||
127489201|NCT01791517|458754601|FG004|Phase II|Lens Handling Difficulties|0|||
127489202|NCT01791517|458754602|FG005|Phase II|Lens Handling Difficulties|0|||
127489203|NCT01791517|458754603|FG006|Phase II|Lens Handling Difficulties|0|||
127489204|NCT01791517|458754604|FG007|Phase II|Lens Handling Difficulties|0|||
127489205|NCT01791517|458754605|FG008|Phase II|Lens Handling Difficulties|1|||
127489206|NCT01791517|458754606|FG009|Phase II|Lens Handling Difficulties|0|||
127489207|NCT01791517|458754607|FG010|Phase II|Lens Handling Difficulties|0|||
127489208|NCT01791517|458754608|FG011|Phase II|Lens Handling Difficulties|0|||
127976636|NCT02738879|460536169|FG001|Overall Study|Adverse Event|1|||
127489209|NCT01791517|458754597|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
127489210|NCT01791517|458754598|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
127489211|NCT01791517|458754599|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
127489212|NCT01791517|458754600|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
127489213|NCT01791517|458754601|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
127489214|NCT01791517|458754602|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
127489215|NCT01791517|458754603|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
127489216|NCT01791517|458754604|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
127976637|NCT02738879|460536168|FG000|Overall Study|Death|0|||
127489217|NCT01791517|458754605|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
127489218|NCT01791517|458754606|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
127489219|NCT01791517|458754607|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
127489220|NCT01791517|458754608|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
127489221|NCT01791517|458754597|FG000|Phase II|Pre-Existing Ocular Issue|0|||
127489222|NCT01791517|458754598|FG001|Phase II|Pre-Existing Ocular Issue|0|||
127489223|NCT01791517|458754599|FG002|Phase II|Pre-Existing Ocular Issue|0|||
127489224|NCT01791517|458754600|FG003|Phase II|Pre-Existing Ocular Issue|0|||
127489225|NCT01791517|458754601|FG004|Phase II|Pre-Existing Ocular Issue|0|||
127976638|NCT02738879|460536169|FG001|Overall Study|Death|2|||
127489226|NCT01791517|458754602|FG005|Phase II|Pre-Existing Ocular Issue|0|||
127489227|NCT01791517|458754603|FG006|Phase II|Pre-Existing Ocular Issue|0|||
127489228|NCT01791517|458754604|FG007|Phase II|Pre-Existing Ocular Issue|0|||
127489229|NCT01791517|458754605|FG008|Phase II|Pre-Existing Ocular Issue|0|||
127489230|NCT01791517|458754606|FG009|Phase II|Pre-Existing Ocular Issue|0|||
127976639|NCT02738879|460536168|FG000|Overall Study|Lost to Follow-up|1|||
127976640|NCT02738879|460536169|FG001|Overall Study|Lost to Follow-up|5|||
127489231|NCT01791517|458754607|FG010|Phase II|Pre-Existing Ocular Issue|0|||
127489232|NCT01791517|458754608|FG011|Phase II|Pre-Existing Ocular Issue|1|||
127489233|NCT04011735|458754609|FG000|Overall Study|Withdrawal by Subject|1|||
127489234|NCT04011735|458754610|FG001|Overall Study|Withdrawal by Subject|0|||
127489235|NCT04011735|458754611|FG002|Overall Study|Withdrawal by Subject|1|||
127976641|NCT02738879|460536168|FG000|Overall Study|Protocol Violation|1|||
127976642|NCT02738879|460536169|FG001|Overall Study|Protocol Violation|3|||
127976643|NCT02738879|460536168|FG000|Overall Study|Physician Decision|3|||
127976644|NCT02738879|460536169|FG001|Overall Study|Physician Decision|4|||
127976645|NCT02738879|460536168|FG000|Overall Study|Pregnancy|0|||
127489236|NCT04011735|458754609|FG000|Overall Study|Met exclusion criteria after study entry|0|||
127489237|NCT04011735|458754610|FG001|Overall Study|Met exclusion criteria after study entry|1|||
127489238|NCT04011735|458754611|FG002|Overall Study|Met exclusion criteria after study entry|0|||
127489239|NCT02298868|458754612|FG000|Overall Study|Adverse Event|1|||
127489240|NCT02298868|458754612|FG000|Overall Study|Death|1|||
127489241|NCT02298868|458754612|FG000|Overall Study|Patient underwent transplant|1|||
127489242|NCT01000506|458754613|FG000|Overall Study|Adverse Event|6|||
127489243|NCT01000506|458754614|FG001|Overall Study|Adverse Event|5|||
127489244|NCT01000506|458754615|FG002|Overall Study|Adverse Event|8|||
127489245|NCT01000506|458754616|FG003|Overall Study|Adverse Event|9|||
127489246|NCT01000506|458754613|FG000|Overall Study|Lack of Efficacy|8|||
127489247|NCT01000506|458754614|FG001|Overall Study|Lack of Efficacy|6|||
127489248|NCT01000506|458754615|FG002|Overall Study|Lack of Efficacy|4|||
127489249|NCT01000506|458754616|FG003|Overall Study|Lack of Efficacy|4|||
127489250|NCT01000506|458754613|FG000|Overall Study|Protocol Violation|1|||
127489251|NCT01000506|458754614|FG001|Overall Study|Protocol Violation|1|||
127489252|NCT01000506|458754615|FG002|Overall Study|Protocol Violation|0|||
127489253|NCT01000506|458754616|FG003|Overall Study|Protocol Violation|0|||
127489254|NCT01000506|458754613|FG000|Overall Study|Lost to Follow-up|1|||
127489255|NCT01000506|458754614|FG001|Overall Study|Lost to Follow-up|1|||
127489256|NCT01000506|458754615|FG002|Overall Study|Lost to Follow-up|4|||
127489257|NCT01000506|458754616|FG003|Overall Study|Lost to Follow-up|0|||
127489258|NCT01000506|458754613|FG000|Overall Study|Physician Decision|1|||
127489259|NCT01000506|458754614|FG001|Overall Study|Physician Decision|3|||
127489260|NCT01000506|458754615|FG002|Overall Study|Physician Decision|3|||
127489261|NCT01000506|458754616|FG003|Overall Study|Physician Decision|3|||
127489262|NCT01000506|458754613|FG000|Overall Study|Withdrawal by Subject|11|||
127489263|NCT01000506|458754614|FG001|Overall Study|Withdrawal by Subject|8|||
127489264|NCT01000506|458754615|FG002|Overall Study|Withdrawal by Subject|2|||
127489265|NCT01000506|458754616|FG003|Overall Study|Withdrawal by Subject|7|||
127489266|NCT00739310|458754617|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
127489267|NCT00739310|458754617|FG000|Overall Study|Withdrawal by Subject|1|||
127489268|NCT00739310|458754617|FG000|Overall Study|Lost to Follow-up|2|||
127489269|NCT01071954|458754618|FG000|Overall Study|Noncompliance|4|||
127489270|NCT01071954|458754618|FG000|Overall Study|Adverse Event|1|||
127489271|NCT01071954|458754618|FG000|Overall Study|Withdrawal by Subject|11|||
127489272|NCT01071954|458754618|FG000|Overall Study|Requirement for Alternative Therapy|5|||
127489273|NCT01071954|458754618|FG000|Overall Study|Administrative Decision|5|||
127489274|NCT01071954|458754618|FG000|Overall Study|Protocol Specified Criteria|1|||
127489275|NCT00590967|458754619|FG000|Overall Study|Withdrawal by Subject|1|||
127489276|NCT00590967|458754620|FG001|Overall Study|Withdrawal by Subject|1|||
127489277|NCT00590967|458754619|FG000|Overall Study|Ineligible|1|||
127976646|NCT02738879|460536169|FG001|Overall Study|Pregnancy|1|||
127976647|NCT02738879|460536168|FG000|Overall Study|Screen Failure|1|||
127976648|NCT02738879|460536169|FG001|Overall Study|Screen Failure|2|||
127489278|NCT00590967|458754620|FG001|Overall Study|Ineligible|0|||
127489279|NCT00590967|458754619|FG000|Overall Study|Poor performance status|0|||
127489280|NCT00590967|458754620|FG001|Overall Study|Poor performance status|1|||
127489281|NCT00590967|458754619|FG000|Overall Study|Non-compliant|0|||
127489282|NCT00590967|458754620|FG001|Overall Study|Non-compliant|2|||
127489283|NCT00590967|458754619|FG000|Overall Study|Did not sign consent form|0|||
127489284|NCT00590967|458754620|FG001|Overall Study|Did not sign consent form|1|||
127489285|NCT00590967|458754619|FG000|Overall Study|Did not receive chemo per protocol|1|||
127489286|NCT00590967|458754620|FG001|Overall Study|Did not receive chemo per protocol|0|||
127489287|NCT01847755|458754621|FG000|Overall Study|Adverse Event|2|||
127489288|NCT01847755|458754621|FG000|Overall Study|Withdrawal by Subject|2|||
127489289|NCT01847755|458754621|FG000|Overall Study|Physician Decision|1|||
127976649|NCT02738879|460536168|FG000|Overall Study|Site Discontinued Study Participation|1|||
127489290|NCT00920556|458754622|FG000|Overall Study|Adverse Event|16|||
127489291|NCT00920556|458754622|FG000|Overall Study|Physician Decision|7|||
127489292|NCT00920556|458754622|FG000|Overall Study|Withdrawal by Subject|1|||
127489293|NCT00889707|458754625|FG000|Overall Study|Adverse Event|1|||
127489294|NCT00889707|458754626|FG001|Overall Study|Adverse Event|0|||
127489295|NCT00889707|458754625|FG000|Overall Study|Withdrawal by Subject|4|||
127489296|NCT00889707|458754626|FG001|Overall Study|Withdrawal by Subject|3|||
127489297|NCT00889707|458754625|FG000|Overall Study|Lost to Follow-up|0|||
127489298|NCT00889707|458754626|FG001|Overall Study|Lost to Follow-up|2|||
127489299|NCT00889707|458754625|FG000|Overall Study|Lack of Efficacy|2|||
127489300|NCT00889707|458754626|FG001|Overall Study|Lack of Efficacy|5|||
127489301|NCT02185534|458754627|FG000|First Period|Withdrawal by Subject|0|||
127489302|NCT02185534|458754628|FG001|First Period|Withdrawal by Subject|0|||
127489303|NCT02185534|458754629|FG002|First Period|Withdrawal by Subject|0|||
127489304|NCT02185534|458754630|FG003|First Period|Withdrawal by Subject|1|||
127489305|NCT02185534|458754631|FG004|First Period|Withdrawal by Subject|0|||
127489306|NCT02185534|458754632|FG005|First Period|Withdrawal by Subject|0|||
127489307|NCT02185534|458754627|FG000|First Washout Period|Withdrawal by Subject|1|||
127489308|NCT02185534|458754628|FG001|First Washout Period|Withdrawal by Subject|0|||
127489309|NCT02185534|458754629|FG002|First Washout Period|Withdrawal by Subject|0|||
127489310|NCT02185534|458754630|FG003|First Washout Period|Withdrawal by Subject|0|||
127489311|NCT02185534|458754631|FG004|First Washout Period|Withdrawal by Subject|1|||
127489312|NCT02185534|458754632|FG005|First Washout Period|Withdrawal by Subject|0|||
127489313|NCT02185534|458754627|FG000|First Washout Period|Protocol Violation|0|||
127489314|NCT02185534|458754628|FG001|First Washout Period|Protocol Violation|0|||
127489315|NCT02185534|458754629|FG002|First Washout Period|Protocol Violation|0|||
127489316|NCT02185534|458754630|FG003|First Washout Period|Protocol Violation|0|||
127489317|NCT02185534|458754631|FG004|First Washout Period|Protocol Violation|0|||
127489318|NCT02185534|458754632|FG005|First Washout Period|Protocol Violation|1|||
127489319|NCT02041299|458754636|FG000|Overall Study|Adverse Event|9|||
127489320|NCT02041299|458754637|FG001|Overall Study|Adverse Event|3|||
127489321|NCT02041299|458754636|FG000|Overall Study|Lost to Follow-up|4|||
127489322|NCT02041299|458754637|FG001|Overall Study|Lost to Follow-up|1|||
127489323|NCT02041299|458754636|FG000|Overall Study|Physician Decision|1|||
127489324|NCT02041299|458754637|FG001|Overall Study|Physician Decision|1|||
127489325|NCT02041299|458754636|FG000|Overall Study|Withdrawal by Subject|13|||
127489326|NCT02041299|458754637|FG001|Overall Study|Withdrawal by Subject|7|||
127489327|NCT02041299|458754636|FG000|Overall Study|Protocol Violation|11|||
127489328|NCT02041299|458754637|FG001|Overall Study|Protocol Violation|4|||
127489329|NCT02041299|458754636|FG000|Overall Study|Termination of the study|7|||
127489330|NCT02041299|458754637|FG001|Overall Study|Termination of the study|3|||
127489331|NCT02041299|458754636|FG000|Overall Study|Required bone marrow transplant|0|||
127489332|NCT02041299|458754637|FG001|Overall Study|Required bone marrow transplant|1|||
127489333|NCT02041299|458754636|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
127489334|NCT02041299|458754637|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
127489335|NCT02389465|458754638|FG000|Overall Study|Lost to Follow-up|1|||
127489336|NCT02389465|458754639|FG001|Overall Study|Lost to Follow-up|3|||
127489337|NCT02389465|458754640|FG002|Overall Study|Lost to Follow-up|3|||
127489338|NCT02389465|458754641|FG003|Overall Study|Lost to Follow-up|0|||
127489339|NCT02389465|458754638|FG000|Overall Study|Physician Decision|0|||
127489340|NCT02389465|458754639|FG001|Overall Study|Physician Decision|0|||
127489341|NCT02389465|458754640|FG002|Overall Study|Physician Decision|0|||
127489342|NCT02389465|458754641|FG003|Overall Study|Physician Decision|1|||
127489343|NCT02389465|458754638|FG000|Overall Study|Withdrawal by Subject|0|||
127489344|NCT02389465|458754639|FG001|Overall Study|Withdrawal by Subject|1|||
127489345|NCT02389465|458754640|FG002|Overall Study|Withdrawal by Subject|2|||
127489346|NCT02389465|458754641|FG003|Overall Study|Withdrawal by Subject|2|||
127489347|NCT04179305|458754649|FG000|Overall Study|Death|1|||
127489348|NCT04179305|458754650|FG001|Overall Study|Death|1|||
127489349|NCT04179305|458754651|FG002|Overall Study|Death|0|||
127489350|NCT04179305|458754652|FG003|Overall Study|Death|0|||
127489351|NCT04179305|458754649|FG000|Overall Study|Lost to Follow-up|1|||
127489352|NCT04179305|458754650|FG001|Overall Study|Lost to Follow-up|1|||
127489353|NCT04179305|458754651|FG002|Overall Study|Lost to Follow-up|0|||
127489354|NCT04179305|458754652|FG003|Overall Study|Lost to Follow-up|0|||
127489355|NCT04179305|458754649|FG000|Overall Study|Withdrawal by Subject|0|||
127489356|NCT04179305|458754650|FG001|Overall Study|Withdrawal by Subject|1|||
127489357|NCT04179305|458754651|FG002|Overall Study|Withdrawal by Subject|0|||
127489358|NCT04179305|458754652|FG003|Overall Study|Withdrawal by Subject|0|||
127489359|NCT04179305|458754649|FG000|Overall Study|Did not have scan|1|||
127489360|NCT04179305|458754650|FG001|Overall Study|Did not have scan|0|||
127489361|NCT04179305|458754651|FG002|Overall Study|Did not have scan|0|||
127489362|NCT04179305|458754652|FG003|Overall Study|Did not have scan|0|||
127489363|NCT04179305|458754649|FG000|Overall Study|In hospice care|3|||
127489364|NCT04179305|458754650|FG001|Overall Study|In hospice care|0|||
127489365|NCT04179305|458754651|FG002|Overall Study|In hospice care|0|||
127489366|NCT04179305|458754652|FG003|Overall Study|In hospice care|0|||
127489367|NCT00503425|458754655|FG000|Overall Study|Participant files lost|6|||
127489368|NCT00503425|458754655|FG000|Overall Study|Adverse Event|5|||
127489369|NCT00503425|458754655|FG000|Overall Study|Lack of Efficacy|25|||
127489370|NCT00503425|458754655|FG000|Overall Study|Withdrawal by Subject|8|||
127489371|NCT00503425|458754655|FG000|Overall Study|Lost to Follow-up|3|||
127489372|NCT00503425|458754655|FG000|Overall Study|Death|3|||
127489373|NCT00503425|458754655|FG000|Overall Study|Missing Data/Unknown|4|||
127489374|NCT00326599|458754656|FG000|Overall Study|Withdrawal by Subject|1|||
127489375|NCT00326599|458754657|FG001|Overall Study|Withdrawal by Subject|0|||
127489376|NCT00326599|458754658|FG002|Overall Study|Withdrawal by Subject|5|||
127489377|NCT00326599|458754659|FG003|Overall Study|Withdrawal by Subject|2|||
127489378|NCT00326599|458754656|FG000|Overall Study|Adverse Event|1|||
127489379|NCT00326599|458754657|FG001|Overall Study|Adverse Event|0|||
127489380|NCT00326599|458754658|FG002|Overall Study|Adverse Event|32|||
127489381|NCT00326599|458754659|FG003|Overall Study|Adverse Event|3|||
127489382|NCT00326599|458754656|FG000|Overall Study|Disease Progression|3|||
127489383|NCT00326599|458754657|FG001|Overall Study|Disease Progression|1|||
127489384|NCT00326599|458754658|FG002|Overall Study|Disease Progression|13|||
127489385|NCT00326599|458754659|FG003|Overall Study|Disease Progression|11|||
127489386|NCT00326599|458754656|FG000|Overall Study|Alternate Treatment|1|||
127489387|NCT00326599|458754657|FG001|Overall Study|Alternate Treatment|0|||
127489388|NCT00326599|458754658|FG002|Overall Study|Alternate Treatment|0|||
127489389|NCT00326599|458754659|FG003|Overall Study|Alternate Treatment|0|||
127489390|NCT00326599|458754656|FG000|Overall Study|Death|0|||
127489391|NCT00326599|458754657|FG001|Overall Study|Death|0|||
127489392|NCT00326599|458754658|FG002|Overall Study|Death|1|||
127489393|NCT00326599|458754659|FG003|Overall Study|Death|2|||
127489394|NCT00326599|458754656|FG000|Overall Study|Other Unspecified Reason|0|||
127489395|NCT00326599|458754657|FG001|Overall Study|Other Unspecified Reason|0|||
127489396|NCT00326599|458754658|FG002|Overall Study|Other Unspecified Reason|2|||
127489397|NCT00326599|458754659|FG003|Overall Study|Other Unspecified Reason|1|||
127489398|NCT03542266|458754660|FG000|Treatment Phase|Withdrawal by Subject|1|||
127489399|NCT03542266|458754660|FG000|Treatment Phase|Adverse Event|1|||
127489400|NCT03542266|458754660|FG000|Treatment Phase|PD|1|||
127489401|NCT00437268|458754661|FG000|Overall Study|Adverse Event|1|||
127489402|NCT00437268|458754662|FG001|Overall Study|Adverse Event|1|||
127489403|NCT00437268|458754661|FG000|Overall Study|Withdrawal by Subject|2|||
127489404|NCT00437268|458754662|FG001|Overall Study|Withdrawal by Subject|2|||
127489405|NCT00437268|458754661|FG000|Overall Study|Progressive disease|9|||
127489406|NCT00437268|458754662|FG001|Overall Study|Progressive disease|9|||
127489407|NCT00437268|458754661|FG000|Overall Study|Physician Decision|1|||
127489408|NCT00437268|458754662|FG001|Overall Study|Physician Decision|0|||
127489409|NCT00437268|458754661|FG000|Overall Study|Death|0|||
127489410|NCT00437268|458754662|FG001|Overall Study|Death|1|||
127489411|NCT00444925|458754663|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
127489412|NCT00444925|458754664|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
127489413|NCT00444925|458754665|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
127489414|NCT00444925|458754663|FG000|Double-blind Treatment Period|Death|2|||
127489415|NCT00444925|458754664|FG001|Double-blind Treatment Period|Death|0|||
127489416|NCT00444925|458754665|FG002|Double-blind Treatment Period|Death|0|||
127489417|NCT00444925|458754663|FG000|Double-blind Treatment Period|Adverse Event|6|||
127489418|NCT00444925|458754664|FG001|Double-blind Treatment Period|Adverse Event|28|||
127489419|NCT00444925|458754665|FG002|Double-blind Treatment Period|Adverse Event|44|||
127489420|NCT00444925|458754663|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
127489421|NCT00444925|458754664|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
127489422|NCT00444925|458754665|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
127489423|NCT00444925|458754663|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
127489424|NCT00444925|458754664|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
127489425|NCT00444925|458754665|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
127489426|NCT00444925|458754663|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
127976650|NCT02738879|460536169|FG001|Overall Study|Site Discontinued Study Participation|0|||
127489427|NCT00444925|458754664|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
127489428|NCT00444925|458754665|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
127489429|NCT00444925|458754663|FG000|Double-blind Treatment Period|Other|7|||
127489430|NCT00444925|458754664|FG001|Double-blind Treatment Period|Other|7|||
127489431|NCT00444925|458754665|FG002|Double-blind Treatment Period|Other|12|||
127489432|NCT00714948|458754672|FG000|Overall Study|Adverse Event|2|||
127489433|NCT03382912|458754673|FG000|Overall Study|Physician Decision|0|||
127489434|NCT03382912|458754674|FG001|Overall Study|Physician Decision|1|||
127489435|NCT03382912|458754673|FG000|Overall Study|Sponsor Decision|6|||
127976651|NCT02738879|460536168|FG000|Overall Study|Withdrawal by Subject|5|||
127489436|NCT03382912|458754674|FG001|Overall Study|Sponsor Decision|6|||
127489437|NCT03382912|458754673|FG000|Overall Study|Withdrawal by Subject|0|||
127489438|NCT03382912|458754674|FG001|Overall Study|Withdrawal by Subject|5|||
127489439|NCT05588440|458754675|FG000|Overall Study|Sponsor Decision|2|||
127489440|NCT05588440|458754676|FG001|Overall Study|Sponsor Decision|0|||
127976652|NCT02738879|460536169|FG001|Overall Study|Withdrawal by Subject|7|||
127489441|NCT05588440|458754677|FG002|Overall Study|Sponsor Decision|1|||
127976653|NCT01438294|460536170|FG000|Overall Study|Lost to Follow-up|3|||
127489442|NCT05588440|458754675|FG000|Overall Study|Death|1|||
127489443|NCT05588440|458754676|FG001|Overall Study|Death|1|||
127489444|NCT05588440|458754677|FG002|Overall Study|Death|1|||
127489445|NCT05588440|458754675|FG000|Overall Study|Screen Fail|0|||
127489446|NCT05588440|458754676|FG001|Overall Study|Screen Fail|1|||
127489447|NCT05588440|458754677|FG002|Overall Study|Screen Fail|1|||
127489448|NCT05588440|458754675|FG000|Overall Study|Withdrawal by Subject|0|||
127489449|NCT05588440|458754676|FG001|Overall Study|Withdrawal by Subject|0|||
127489450|NCT05588440|458754677|FG002|Overall Study|Withdrawal by Subject|1|||
127489451|NCT05653700|458754678|FG000|Overall Study|Non Responders|9|||
127489452|NCT05653700|458754679|FG001|Overall Study|Non Responders|0|||
127489453|NCT02573948|458754682|FG000|Longitudinal Cohort|Death|9|||
127489454|NCT02573948|458754682|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
127489455|NCT02573948|458754682|FG000|Longitudinal Cohort|Incarcerated|25|||
127489456|NCT00707993|458754685|FG000|Overall Study|Adverse Event|16|||
127489457|NCT00707993|458754686|FG001|Overall Study|Adverse Event|20|||
127489458|NCT00707993|458754685|FG000|Overall Study|Protocol Violation|4|||
127489459|NCT00707993|458754686|FG001|Overall Study|Protocol Violation|7|||
127489460|NCT00707993|458754685|FG000|Overall Study|Lost to Follow-up|0|||
127489461|NCT00707993|458754686|FG001|Overall Study|Lost to Follow-up|4|||
127489462|NCT00707993|458754685|FG000|Overall Study|Withdrawal by Subject|12|||
127489463|NCT00707993|458754686|FG001|Overall Study|Withdrawal by Subject|16|||
127489464|NCT00707993|458754685|FG000|Overall Study|Hyperglycemic Rescue|55|||
127489465|NCT00707993|458754686|FG001|Overall Study|Hyperglycemic Rescue|47|||
127489466|NCT00707993|458754685|FG000|Overall Study|Other|2|||
127489467|NCT00707993|458754686|FG001|Overall Study|Other|0|||
127489468|NCT01913327|458754687|FG000|Overall Study|Withdrawal by Subject|0|||
127489469|NCT01913327|458754688|FG001|Overall Study|Withdrawal by Subject|1|||
127489470|NCT02137070|458754695|FG000|Overall Study|Adverse Event|12|||
127489471|NCT02137070|458754696|FG001|Overall Study|Adverse Event|3|||
127489472|NCT02137070|458754695|FG000|Overall Study|Death|2|||
127489473|NCT02137070|458754696|FG001|Overall Study|Death|0|||
127489474|NCT02137070|458754695|FG000|Overall Study|Lost to Follow-up|24|||
127489475|NCT02137070|458754696|FG001|Overall Study|Lost to Follow-up|9|||
127489476|NCT02137070|458754695|FG000|Overall Study|Physician Decision|0|||
127489477|NCT02137070|458754696|FG001|Overall Study|Physician Decision|1|||
127489478|NCT02137070|458754695|FG000|Overall Study|Protocol Violation|18|||
127489479|NCT02137070|458754696|FG001|Overall Study|Protocol Violation|4|||
127489480|NCT02137070|458754695|FG000|Overall Study|Withdrawal by Subject|18|||
127489481|NCT02137070|458754696|FG001|Overall Study|Withdrawal by Subject|1|||
127489482|NCT00532129|458756648|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
127489483|NCT00532129|458756648|FG000|Treatment Period|Physician Decision|15|||
127489484|NCT00532129|458756648|FG000|Treatment Period|Disease progression|3|||
127489485|NCT00532129|458756648|FG000|Treatment Period|Protocol Violation|1|||
127489486|NCT00532129|458756648|FG000|Treatment Period|Other|5|||
127489487|NCT00532129|458756648|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
127489488|NCT00532129|458756648|FG000|Follow-up Period|Disease progression|57|||
127489489|NCT00532129|458756648|FG000|Follow-up Period|Lost to Follow-up|1|||
127489490|NCT00532129|458756648|FG000|Follow-up Period|Other|6|||
127489491|NCT00342628|458756649|FG000|Overall Study|Withdrawal by Subject|19|||
127489492|NCT00342628|458756650|FG001|Overall Study|Withdrawal by Subject|19|||
127489493|NCT00342628|458756651|FG002|Overall Study|Withdrawal by Subject|18|||
127489494|NCT00342628|458756649|FG000|Overall Study|Death|1|||
127489495|NCT00342628|458756650|FG001|Overall Study|Death|1|||
127489496|NCT00342628|458756651|FG002|Overall Study|Death|0|||
127489497|NCT00342628|458756649|FG000|Overall Study|moved residence|0|||
127489498|NCT00342628|458756650|FG001|Overall Study|moved residence|1|||
127489499|NCT00342628|458756651|FG002|Overall Study|moved residence|1|||
127489500|NCT03427814|458756652|FG000|Overall Study|Withdrawal by Subject|4|||
127489501|NCT03427814|458756653|FG001|Overall Study|Withdrawal by Subject|4|||
127489502|NCT03427814|458756652|FG000|Overall Study|Lost to Follow-up|0|||
127489503|NCT03427814|458756653|FG001|Overall Study|Lost to Follow-up|2|||
127489504|NCT03427814|458756652|FG000|Overall Study|Death|42|||
127489505|NCT03427814|458756653|FG001|Overall Study|Death|31|||
127489506|NCT03427814|458756652|FG000|Overall Study|Sponsor's Decision|1|||
127489507|NCT03427814|458756653|FG001|Overall Study|Sponsor's Decision|0|||
127489508|NCT03427814|458756652|FG000|Overall Study|Investigator's Decision|1|||
127489509|NCT03427814|458756653|FG001|Overall Study|Investigator's Decision|2|||
127489510|NCT03427814|458756652|FG000|Overall Study|Disease progression|1|||
127489511|NCT03427814|458756653|FG001|Overall Study|Disease progression|0|||
127489512|NCT03427814|458756652|FG000|Overall Study|Treatment Completed|0|||
127489513|NCT03427814|458756653|FG001|Overall Study|Treatment Completed|1|||
127489514|NCT03427814|458756652|FG000|Overall Study|Sponsor's Decision to End study|21|||
127489515|NCT03427814|458756653|FG001|Overall Study|Sponsor's Decision to End study|25|||
127489516|NCT03427814|458756652|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
127489517|NCT03427814|458756653|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
127489518|NCT03145064|458756654|FG000|Overall Study|Death|24|||
127489519|NCT03145064|458756654|FG000|Overall Study|Lost to Follow-up|3|||
127489520|NCT03145064|458756654|FG000|Overall Study|Withdrawal by Subject|6|||
127489521|NCT03145064|458756654|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
127489522|NCT03145064|458756654|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
127489523|NCT03846427|458756655|FG000|Overall Study|Death|13|||
127489524|NCT03846427|458756655|FG000|Overall Study|Withdrawal by Subject|3|||
127489525|NCT03846427|458756655|FG000|Overall Study|Physician Decision|1|||
127489526|NCT01693250|458756656|FG000|Overall Study|Lost to Follow-up|2|||
127489527|NCT01693250|458756657|FG001|Overall Study|Lost to Follow-up|2|||
127489528|NCT01396187|458756658|FG000|Overall Study|Adverse Event|0|||
127489529|NCT01396187|458756659|FG001|Overall Study|Adverse Event|1|||
127489530|NCT01396187|458756660|FG002|Overall Study|Adverse Event|0|||
127489531|NCT01396187|458756661|FG003|Overall Study|Adverse Event|0|||
127489532|NCT01396187|458756662|FG004|Overall Study|Adverse Event|0|||
127489533|NCT01396187|458756658|FG000|Overall Study|Withdrawal by Subject|0|||
127489534|NCT01396187|458756659|FG001|Overall Study|Withdrawal by Subject|1|||
127489535|NCT01396187|458756660|FG002|Overall Study|Withdrawal by Subject|1|||
127489536|NCT01396187|458756661|FG003|Overall Study|Withdrawal by Subject|0|||
127489537|NCT01396187|458756662|FG004|Overall Study|Withdrawal by Subject|0|||
127489538|NCT01396187|458756658|FG000|Overall Study|Other|1|||
127489539|NCT01396187|458756659|FG001|Overall Study|Other|1|||
127489540|NCT01396187|458756660|FG002|Overall Study|Other|0|||
127489541|NCT01396187|458756661|FG003|Overall Study|Other|0|||
127489542|NCT01396187|458756662|FG004|Overall Study|Other|1|||
127489543|NCT04971967|458756665|FG000|Overall Study|Lost to Follow-up|6|||
127489544|NCT04971967|458756666|FG001|Overall Study|Lost to Follow-up|7|||
127489545|NCT00682929|458756669|FG000|Overall Study|Adverse Event|4|||
127489546|NCT00682929|458756670|FG001|Overall Study|Adverse Event|1|||
127489547|NCT00682929|458756671|FG002|Overall Study|Adverse Event|1|||
127489548|NCT00682929|458756669|FG000|Overall Study|Withdrawal by Subject|1|||
127489549|NCT00682929|458756670|FG001|Overall Study|Withdrawal by Subject|2|||
127489550|NCT00682929|458756671|FG002|Overall Study|Withdrawal by Subject|1|||
127489551|NCT00682929|458756669|FG000|Overall Study|dosing compliance < 80%|0|||
127489552|NCT00682929|458756670|FG001|Overall Study|dosing compliance < 80%|2|||
127489553|NCT00682929|458756671|FG002|Overall Study|dosing compliance < 80%|0|||
127489554|NCT00682929|458756669|FG000|Overall Study|lag in DEA renewal|1|||
127489555|NCT00682929|458756670|FG001|Overall Study|lag in DEA renewal|0|||
127489556|NCT00682929|458756671|FG002|Overall Study|lag in DEA renewal|0|||
127489557|NCT01462929|458756672|FG000|Overall Study|Adverse Event|3|||
127489558|NCT01462929|458756673|FG001|Overall Study|Adverse Event|3|||
127489559|NCT01462929|458756674|FG002|Overall Study|Adverse Event|4|||
127489560|NCT01462929|458756672|FG000|Overall Study|Withdrawal by Subject|2|||
127489561|NCT01462929|458756673|FG001|Overall Study|Withdrawal by Subject|1|||
127489562|NCT01462929|458756674|FG002|Overall Study|Withdrawal by Subject|0|||
127489563|NCT01462929|458756672|FG000|Overall Study|Lack of Efficacy|0|||
127489564|NCT01462929|458756673|FG001|Overall Study|Lack of Efficacy|0|||
127489565|NCT01462929|458756674|FG002|Overall Study|Lack of Efficacy|1|||
127489566|NCT03333928|458756675|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
127489567|NCT03333928|458756676|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
127489568|NCT03333928|458756677|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
127489569|NCT03333928|458756675|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
127489570|NCT03333928|458756676|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
127489571|NCT03333928|458756677|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
127489572|NCT03333928|458756675|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
127489573|NCT03333928|458756676|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
127489574|NCT03333928|458756677|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
127489575|NCT03333928|458756675|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
127489576|NCT03333928|458756676|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
127489577|NCT03333928|458756677|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
127489578|NCT03333928|458756675|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
127489579|NCT03333928|458756676|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
127489580|NCT03333928|458756677|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
127489581|NCT03333928|458756675|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
127489582|NCT03333928|458756676|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
127489583|NCT03333928|458756677|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
127489584|NCT03333928|458756675|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
127489585|NCT03333928|458756676|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
127489586|NCT03333928|458756677|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
127489587|NCT03333928|458756675|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
127489588|NCT03333928|458756676|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
127489589|NCT03333928|458756677|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
127489590|NCT04072835|458756678|FG000|Overall Study|Overall trial ended|603|||
127489591|NCT04072835|458756678|FG000|Overall Study|Ablation|97|||
127489592|NCT04072835|458756678|FG000|Overall Study|Withdrawal of consent|66|||
127489593|NCT04072835|458756678|FG000|Overall Study|Physician Decision|50|||
127489594|NCT04072835|458756678|FG000|Overall Study|Lost to Follow-up|39|||
127489595|NCT04072835|458756678|FG000|Overall Study|Participant no longer meets the inclusion/exclusion criteria|38|||
127489596|NCT04072835|458756678|FG000|Overall Study|Participant wanted to try other therapy or treatment|34|||
127489597|NCT04072835|458756678|FG000|Overall Study|Adverse Event|25|||
127489598|NCT04072835|458756678|FG000|Overall Study|Participant non-compliance / Protocol violation(s)|25|||
127489599|NCT04072835|458756678|FG000|Overall Study|Death|11|||
127489600|NCT04072835|458756678|FG000|Overall Study|Participant felt the drug did not work|8|||
127489601|NCT04072835|458756678|FG000|Overall Study|Participant tolerability|5|||
127489602|NCT04072835|458756678|FG000|Overall Study|Missing|5|||
127489603|NCT04072835|458756678|FG000|Overall Study|Participant withdrawn due to COVID-19 situation|4|||
127489604|NCT04072835|458756678|FG000|Overall Study|Pregnancy|3|||
127489605|NCT04723355|458756679|FG000|Overall Study|Issues with leads off, substantial ECG signal artefacts, and ECG data upload errors|50|||
127489606|NCT04723355|458756679|FG000|Overall Study|Errors in the informed consent form|2|||
127489607|NCT00841776|458756682|FG000|Overall Study|Lack of Efficacy|0|||
127489608|NCT00841776|458756683|FG001|Overall Study|Lack of Efficacy|1|||
127489609|NCT00841776|458756682|FG000|Overall Study|Lost to Follow-up|2|||
127489610|NCT00841776|458756683|FG001|Overall Study|Lost to Follow-up|1|||
127489611|NCT00841776|458756682|FG000|Overall Study|Withdrawal by Subject|0|||
127489612|NCT00841776|458756683|FG001|Overall Study|Withdrawal by Subject|1|||
127489613|NCT01306643|458756684|FG000|Overall Study|Adverse Event|5|||
127489614|NCT01306643|458756684|FG000|Overall Study|Disease Progression|7|||
127489615|NCT01306643|458756684|FG000|Overall Study|Other: Change in Eligibility Status|1|||
127489616|NCT02071771|458756685|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
127489617|NCT02071771|458756686|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
127489618|NCT02071771|458756685|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
127489619|NCT02071771|458756686|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
127489620|NCT00355368|458756690|FG000|Overall Study|Protocol Violation|8|||
127489621|NCT00355368|458756691|FG001|Overall Study|Protocol Violation|7|||
127489622|NCT00355368|458756690|FG000|Overall Study|cardiac arrest prior to intubation|2|||
127489623|NCT00355368|458756691|FG001|Overall Study|cardiac arrest prior to intubation|2|||
127489624|NCT03688919|458756694|FG000|Overall Study|Lost to Follow-up|2|||
127489625|NCT03688919|458756695|FG001|Overall Study|Lost to Follow-up|1|||
127489626|NCT03688919|458756694|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
127489627|NCT03688919|458756695|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
127489628|NCT02776683|458756696|FG000|Pre-switch Period|Protocol Violation|1|||
127489629|NCT02776683|458756697|FG001|Pre-switch Period|Protocol Violation|0|||
127489630|NCT02776683|458756696|FG000|Pre-switch Period|Adverse Event|21|||
127489631|NCT02776683|458756697|FG001|Pre-switch Period|Adverse Event|0|||
127489632|NCT02776683|458756696|FG000|Pre-switch Period|Withdrawal by Subject|9|||
127489633|NCT02776683|458756697|FG001|Pre-switch Period|Withdrawal by Subject|0|||
127489634|NCT02776683|458756696|FG000|Pre-switch Period|Physician Decision|7|||
127489635|NCT02776683|458756697|FG001|Pre-switch Period|Physician Decision|0|||
127489636|NCT02776683|458756696|FG000|Pre-switch Period|Progressive disease|39|||
127489637|NCT02776683|458756697|FG001|Pre-switch Period|Progressive disease|0|||
127489638|NCT02776683|458756696|FG000|Pre-switch Period|Other than listed|3|||
127489639|NCT02776683|458756697|FG001|Pre-switch Period|Other than listed|0|||
127489640|NCT02776683|458756696|FG000|Post-switch Period|Adverse Event|0|||
127489641|NCT02776683|458756697|FG001|Post-switch Period|Adverse Event|3|||
127489642|NCT02776683|458756696|FG000|Post-switch Period|Withdrawal by Subject|0|||
127489643|NCT02776683|458756697|FG001|Post-switch Period|Withdrawal by Subject|2|||
127489644|NCT02776683|458756696|FG000|Post-switch Period|Physician Decision|0|||
127489645|NCT02776683|458756697|FG001|Post-switch Period|Physician Decision|3|||
127489646|NCT02776683|458756696|FG000|Post-switch Period|Progressive disease|0|||
127489647|NCT02776683|458756697|FG001|Post-switch Period|Progressive disease|20|||
127489648|NCT02776683|458756696|FG000|Post-switch Period|Other than listed|0|||
127489649|NCT02776683|458756697|FG001|Post-switch Period|Other than listed|15|||
127489650|NCT02639247|458756703|FG000|Overall Study|Lost to Follow-up|2|||
127489651|NCT02639247|458756704|FG001|Overall Study|Lost to Follow-up|1|||
127489652|NCT02639247|458756703|FG000|Overall Study|Death|2|||
127489653|NCT02639247|458756704|FG001|Overall Study|Death|0|||
127489654|NCT02639247|458756703|FG000|Overall Study|Withdrew Consent|0|||
127489655|NCT02639247|458756704|FG001|Overall Study|Withdrew Consent|1|||
127489656|NCT02639247|458756703|FG000|Overall Study|Protocol Violation|1|||
127489657|NCT02639247|458756704|FG001|Overall Study|Protocol Violation|0|||
127489658|NCT03462758|458756705|FG000|Overall Study|Chose no or other method of contraception|20|||
127489659|NCT03462758|458756706|FG001|Overall Study|Chose no or other method of contraception|23|||
127976654|NCT01438294|460536171|FG001|Overall Study|Lost to Follow-up|7|||
127489660|NCT03462758|458756705|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
127976655|NCT01346189|460536174|FG000|Overall Study|Withdrawal by Subject|7|||
127489661|NCT03462758|458756706|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
127489662|NCT03462758|458756705|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
127489663|NCT03462758|458756706|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
127489664|NCT03462758|458756705|FG000|Overall Study|Medical contraindication|2|||
127489665|NCT03462758|458756706|FG001|Overall Study|Medical contraindication|2|||
127489666|NCT03462758|458756705|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
127489667|NCT03462758|458756706|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
127489668|NCT02820844|458756707|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
127489669|NCT02820844|458756708|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
127489670|NCT02820844|458756709|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
127489671|NCT02820844|458756710|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
127489672|NCT02820844|458756711|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
127489673|NCT02820844|458756712|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
127489674|NCT02820844|458756707|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
127489675|NCT02820844|458756708|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
127489676|NCT02820844|458756709|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
127489677|NCT02820844|458756710|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
127489678|NCT02820844|458756711|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
127489679|NCT02820844|458756712|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
127489680|NCT02820844|458756707|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
127489681|NCT02820844|458756708|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
127489682|NCT02820844|458756709|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
127489683|NCT02820844|458756710|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
127489684|NCT02820844|458756711|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
127489685|NCT02820844|458756712|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
127489686|NCT02820844|458756707|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
127489687|NCT02820844|458756708|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
127489688|NCT02820844|458756709|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
127489689|NCT02820844|458756710|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
127489690|NCT02820844|458756711|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
127489691|NCT02820844|458756712|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
127489692|NCT02820844|458756707|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
127489693|NCT02820844|458756708|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
127489694|NCT02820844|458756709|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
127489695|NCT02820844|458756710|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
127489696|NCT02820844|458756711|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
127489697|NCT02820844|458756712|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
127489698|NCT02820844|458756707|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
127489699|NCT02820844|458756708|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
127489700|NCT02820844|458756709|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
127489701|NCT02820844|458756710|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
127489702|NCT02820844|458756711|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
127489703|NCT02820844|458756712|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
127489704|NCT02820844|458756707|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
127489705|NCT02820844|458756708|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
127489706|NCT02820844|458756709|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
127489707|NCT02820844|458756710|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
127489708|NCT02820844|458756711|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
127489709|NCT02820844|458756712|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
127489710|NCT02820844|458756707|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
127489711|NCT02820844|458756708|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
127489712|NCT02820844|458756709|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
127489713|NCT02820844|458756710|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
127489714|NCT02820844|458756711|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
127489715|NCT02820844|458756712|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
127489716|NCT02820844|458756707|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
127489717|NCT02820844|458756708|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
127489718|NCT02820844|458756709|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
127489719|NCT02820844|458756710|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
127489720|NCT02820844|458756711|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
127489721|NCT02820844|458756712|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
127489722|NCT02820844|458756707|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
127489723|NCT02820844|458756708|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
127489724|NCT02820844|458756709|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
127489725|NCT02820844|458756710|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
127489726|NCT02820844|458756711|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
127489727|NCT02820844|458756712|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
127976656|NCT01346189|460536175|FG001|Overall Study|Withdrawal by Subject|5|||
127489728|NCT02266147|458756714|FG000|PART 1: Dose Escalation|Physician Decision|0|||
127489729|NCT02266147|458756715|FG001|PART 1: Dose Escalation|Physician Decision|0|||
127489730|NCT02266147|458756716|FG002|PART 1: Dose Escalation|Physician Decision|1|||
127489731|NCT02266147|458756717|FG003|PART 1: Dose Escalation|Physician Decision|0|||
127489732|NCT02266147|458756714|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
127489733|NCT02266147|458756715|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
127489734|NCT02266147|458756716|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
127489735|NCT02266147|458756717|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
127489736|NCT02266147|458756714|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
127489737|NCT02266147|458756715|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
127489738|NCT02266147|458756716|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
127489739|NCT02266147|458756717|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
127489740|NCT02266147|458756714|FG000|PART 1: Dose Escalation|Other|1|||
127489741|NCT02266147|458756715|FG001|PART 1: Dose Escalation|Other|1|||
127489742|NCT02266147|458756716|FG002|PART 1: Dose Escalation|Other|0|||
127489743|NCT02266147|458756717|FG003|PART 1: Dose Escalation|Other|0|||
127489744|NCT02266147|458756714|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
127489745|NCT02266147|458756715|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
127489746|NCT02266147|458756716|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
127489747|NCT02266147|458756717|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
127489748|NCT02266147|458756714|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
127489749|NCT02266147|458756715|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
127489750|NCT02266147|458756716|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
127489751|NCT02266147|458756717|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
127489752|NCT00413660|458756720|FG000|Up To Week 12|Adverse Event|1|||
127489753|NCT00413660|458756721|FG001|Up To Week 12|Adverse Event|3|||
127489754|NCT00413660|458756722|FG002|Up To Week 12|Adverse Event|1|||
127489755|NCT00413660|458756723|FG003|Up To Week 12|Adverse Event|4|||
127489756|NCT00413660|458756724|FG004|Up To Week 12|Adverse Event|6|||
127489757|NCT00413660|458756725|FG005|Up To Week 12|Adverse Event|4|||
127489758|NCT00413660|458756726|FG006|Up To Week 12|Adverse Event|1|||
127489759|NCT00413660|458756727|FG007|Up To Week 12|Adverse Event|0|||
127489760|NCT00413660|458756728|FG008|Up To Week 12|Adverse Event|0|||
127489761|NCT00413660|458756729|FG009|Up To Week 12|Adverse Event|0|||
127489762|NCT00413660|458756730|FG010|Up To Week 12|Adverse Event|0|||
127489763|NCT00413660|458756720|FG000|Up To Week 12|Lack of Efficacy|2|||
127489764|NCT00413660|458756721|FG001|Up To Week 12|Lack of Efficacy|0|||
127489765|NCT00413660|458756722|FG002|Up To Week 12|Lack of Efficacy|0|||
127489766|NCT00413660|458756723|FG003|Up To Week 12|Lack of Efficacy|0|||
127489767|NCT00413660|458756724|FG004|Up To Week 12|Lack of Efficacy|0|||
127489768|NCT00413660|458756725|FG005|Up To Week 12|Lack of Efficacy|0|||
127489769|NCT00413660|458756726|FG006|Up To Week 12|Lack of Efficacy|5|||
127489770|NCT00413660|458756727|FG007|Up To Week 12|Lack of Efficacy|0|||
127489771|NCT00413660|458756728|FG008|Up To Week 12|Lack of Efficacy|0|||
127489772|NCT00413660|458756729|FG009|Up To Week 12|Lack of Efficacy|0|||
127489773|NCT00413660|458756730|FG010|Up To Week 12|Lack of Efficacy|0|||
127489774|NCT00413660|458756720|FG000|Up To Week 12|Lost to Follow-up|0|||
127489775|NCT00413660|458756721|FG001|Up To Week 12|Lost to Follow-up|1|||
127489776|NCT00413660|458756722|FG002|Up To Week 12|Lost to Follow-up|0|||
127489777|NCT00413660|458756723|FG003|Up To Week 12|Lost to Follow-up|0|||
127489778|NCT00413660|458756724|FG004|Up To Week 12|Lost to Follow-up|1|||
127489779|NCT00413660|458756725|FG005|Up To Week 12|Lost to Follow-up|0|||
127489780|NCT00413660|458756726|FG006|Up To Week 12|Lost to Follow-up|0|||
127489781|NCT00413660|458756727|FG007|Up To Week 12|Lost to Follow-up|0|||
127489782|NCT00413660|458756728|FG008|Up To Week 12|Lost to Follow-up|0|||
127489783|NCT00413660|458756729|FG009|Up To Week 12|Lost to Follow-up|0|||
127489784|NCT00413660|458756730|FG010|Up To Week 12|Lost to Follow-up|0|||
127489785|NCT00413660|458756720|FG000|Up To Week 12|Withdrawal by Subject|0|||
127489786|NCT00413660|458756721|FG001|Up To Week 12|Withdrawal by Subject|2|||
127489787|NCT00413660|458756722|FG002|Up To Week 12|Withdrawal by Subject|0|||
127489788|NCT00413660|458756723|FG003|Up To Week 12|Withdrawal by Subject|2|||
127489789|NCT00413660|458756724|FG004|Up To Week 12|Withdrawal by Subject|0|||
127489790|NCT00413660|458756725|FG005|Up To Week 12|Withdrawal by Subject|2|||
127489791|NCT00413660|458756726|FG006|Up To Week 12|Withdrawal by Subject|2|||
127489792|NCT00413660|458756727|FG007|Up To Week 12|Withdrawal by Subject|0|||
127489793|NCT00413660|458756728|FG008|Up To Week 12|Withdrawal by Subject|0|||
127489794|NCT00413660|458756729|FG009|Up To Week 12|Withdrawal by Subject|0|||
127489795|NCT00413660|458756730|FG010|Up To Week 12|Withdrawal by Subject|0|||
127489796|NCT00413660|458756720|FG000|Up To Week 12|Randomized, Not Treated|1|||
127489797|NCT00413660|458756721|FG001|Up To Week 12|Randomized, Not Treated|0|||
127489798|NCT00413660|458756722|FG002|Up To Week 12|Randomized, Not Treated|0|||
127489799|NCT00413660|458756723|FG003|Up To Week 12|Randomized, Not Treated|1|||
127489800|NCT00413660|458756724|FG004|Up To Week 12|Randomized, Not Treated|0|||
127489801|NCT00413660|458756725|FG005|Up To Week 12|Randomized, Not Treated|0|||
127489802|NCT00413660|458756726|FG006|Up To Week 12|Randomized, Not Treated|0|||
127489803|NCT00413660|458756727|FG007|Up To Week 12|Randomized, Not Treated|0|||
127489804|NCT00413660|458756728|FG008|Up To Week 12|Randomized, Not Treated|0|||
127489805|NCT00413660|458756729|FG009|Up To Week 12|Randomized, Not Treated|0|||
127489806|NCT00413660|458756730|FG010|Up To Week 12|Randomized, Not Treated|0|||
127489807|NCT00413660|458756720|FG000|Up To Week 12|Other|3|||
127489808|NCT00413660|458756721|FG001|Up To Week 12|Other|1|||
127489809|NCT00413660|458756722|FG002|Up To Week 12|Other|6|||
127489810|NCT00413660|458756723|FG003|Up To Week 12|Other|1|||
127489811|NCT00413660|458756724|FG004|Up To Week 12|Other|2|||
127489812|NCT00413660|458756725|FG005|Up To Week 12|Other|4|||
127489813|NCT00413660|458756726|FG006|Up To Week 12|Other|3|||
127489814|NCT00413660|458756727|FG007|Up To Week 12|Other|0|||
127489815|NCT00413660|458756728|FG008|Up To Week 12|Other|0|||
127489816|NCT00413660|458756729|FG009|Up To Week 12|Other|0|||
127489817|NCT00413660|458756730|FG010|Up To Week 12|Other|0|||
127489818|NCT00413660|458756720|FG000|Post Week 12|Adverse Event|2|||
127489819|NCT00413660|458756721|FG001|Post Week 12|Adverse Event|0|||
127489820|NCT00413660|458756722|FG002|Post Week 12|Adverse Event|2|||
127489821|NCT00413660|458756723|FG003|Post Week 12|Adverse Event|1|||
127489822|NCT00413660|458756724|FG004|Post Week 12|Adverse Event|4|||
127489823|NCT00413660|458756725|FG005|Post Week 12|Adverse Event|2|||
127489824|NCT00413660|458756726|FG006|Post Week 12|Adverse Event|2|||
127489825|NCT00413660|458756727|FG007|Post Week 12|Adverse Event|0|||
127489826|NCT00413660|458756728|FG008|Post Week 12|Adverse Event|0|||
127489827|NCT00413660|458756729|FG009|Post Week 12|Adverse Event|0|||
127489828|NCT00413660|458756730|FG010|Post Week 12|Adverse Event|0|||
127489829|NCT00413660|458756720|FG000|Post Week 12|Lack of Efficacy|0|||
127489830|NCT00413660|458756721|FG001|Post Week 12|Lack of Efficacy|0|||
127489831|NCT00413660|458756722|FG002|Post Week 12|Lack of Efficacy|1|||
127489832|NCT00413660|458756723|FG003|Post Week 12|Lack of Efficacy|0|||
127489833|NCT00413660|458756724|FG004|Post Week 12|Lack of Efficacy|0|||
127489834|NCT00413660|458756725|FG005|Post Week 12|Lack of Efficacy|0|||
127489835|NCT00413660|458756726|FG006|Post Week 12|Lack of Efficacy|0|||
127489836|NCT00413660|458756727|FG007|Post Week 12|Lack of Efficacy|0|||
127489837|NCT00413660|458756728|FG008|Post Week 12|Lack of Efficacy|0|||
127489838|NCT00413660|458756729|FG009|Post Week 12|Lack of Efficacy|1|||
127489839|NCT00413660|458756730|FG010|Post Week 12|Lack of Efficacy|0|||
127489840|NCT00413660|458756720|FG000|Post Week 12|Lost to Follow-up|0|||
127489841|NCT00413660|458756721|FG001|Post Week 12|Lost to Follow-up|1|||
127489842|NCT00413660|458756722|FG002|Post Week 12|Lost to Follow-up|1|||
127489843|NCT00413660|458756723|FG003|Post Week 12|Lost to Follow-up|0|||
127489844|NCT00413660|458756724|FG004|Post Week 12|Lost to Follow-up|0|||
127489845|NCT00413660|458756725|FG005|Post Week 12|Lost to Follow-up|0|||
127489846|NCT00413660|458756726|FG006|Post Week 12|Lost to Follow-up|0|||
127489847|NCT00413660|458756727|FG007|Post Week 12|Lost to Follow-up|0|||
127489848|NCT00413660|458756728|FG008|Post Week 12|Lost to Follow-up|0|||
127489849|NCT00413660|458756729|FG009|Post Week 12|Lost to Follow-up|0|||
127489850|NCT00413660|458756730|FG010|Post Week 12|Lost to Follow-up|0|||
127489851|NCT00413660|458756720|FG000|Post Week 12|Withdrawal by Subject|0|||
127489852|NCT00413660|458756721|FG001|Post Week 12|Withdrawal by Subject|1|||
127489853|NCT00413660|458756722|FG002|Post Week 12|Withdrawal by Subject|1|||
127489854|NCT00413660|458756723|FG003|Post Week 12|Withdrawal by Subject|0|||
127489855|NCT00413660|458756724|FG004|Post Week 12|Withdrawal by Subject|1|||
127489856|NCT00413660|458756725|FG005|Post Week 12|Withdrawal by Subject|0|||
127489857|NCT00413660|458756726|FG006|Post Week 12|Withdrawal by Subject|0|||
127489858|NCT00413660|458756727|FG007|Post Week 12|Withdrawal by Subject|0|||
127489859|NCT00413660|458756728|FG008|Post Week 12|Withdrawal by Subject|0|||
127489860|NCT00413660|458756729|FG009|Post Week 12|Withdrawal by Subject|0|||
127489861|NCT00413660|458756730|FG010|Post Week 12|Withdrawal by Subject|1|||
127976657|NCT01346189|460536176|FG002|Overall Study|Withdrawal by Subject|3|||
127976658|NCT01346189|460536177|FG003|Overall Study|Withdrawal by Subject|5|||
127489862|NCT00413660|458756720|FG000|Post Week 12|Other|1|||
127489863|NCT00413660|458756721|FG001|Post Week 12|Other|2|||
127489864|NCT00413660|458756722|FG002|Post Week 12|Other|3|||
127489865|NCT00413660|458756723|FG003|Post Week 12|Other|0|||
127976659|NCT01346189|460536174|FG000|Overall Study|Physician Decision|4|||
127489866|NCT00413660|458756724|FG004|Post Week 12|Other|1|||
127489867|NCT00413660|458756725|FG005|Post Week 12|Other|1|||
127489868|NCT00413660|458756726|FG006|Post Week 12|Other|1|||
127489869|NCT00413660|458756727|FG007|Post Week 12|Other|0|||
127489870|NCT00413660|458756728|FG008|Post Week 12|Other|0|||
127489871|NCT00413660|458756729|FG009|Post Week 12|Other|0|||
127489872|NCT00413660|458756730|FG010|Post Week 12|Other|0|||
127489873|NCT02831855|458756731|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
127489874|NCT02831855|458756732|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
127489875|NCT02831855|458756733|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
127489876|NCT02831855|458756731|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
127489877|NCT02831855|458756732|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
127489878|NCT02831855|458756733|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
127489879|NCT02831855|458756731|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
127489880|NCT02831855|458756732|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
127489881|NCT02831855|458756733|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
127489882|NCT02831855|458756731|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
127489883|NCT02831855|458756732|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
127489884|NCT02831855|458756733|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
127489885|NCT02831855|458756731|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
127489886|NCT02831855|458756732|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
127489887|NCT02831855|458756733|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
127489888|NCT02831855|458756731|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
127489889|NCT02831855|458756732|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
127489890|NCT02831855|458756733|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
127489891|NCT02831855|458756731|FG000|Open Label Phase (24 Weeks)|Other|4|||
127489892|NCT02831855|458756732|FG001|Open Label Phase (24 Weeks)|Other|0|||
127489893|NCT02831855|458756733|FG002|Open Label Phase (24 Weeks)|Other|0|||
127489894|NCT02831855|458756731|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
127489895|NCT02831855|458756732|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
127489896|NCT02831855|458756733|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
127489897|NCT02831855|458756731|FG000|Double Blind Phase (24 Weeks)|Death|0|||
127489898|NCT02831855|458756732|FG001|Double Blind Phase (24 Weeks)|Death|0|||
127489899|NCT02831855|458756733|FG002|Double Blind Phase (24 Weeks)|Death|2|||
127489900|NCT02831855|458756731|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
127489901|NCT02831855|458756732|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
127489902|NCT02831855|458756733|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
127489903|NCT02831855|458756731|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
127489904|NCT02831855|458756732|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
127489905|NCT02831855|458756733|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
127489906|NCT02831855|458756731|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
127489907|NCT02831855|458756732|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
127489908|NCT02831855|458756733|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
127489909|NCT02831855|458756731|FG000|Double Blind Phase (24 Weeks)|Other|0|||
127489910|NCT02831855|458756732|FG001|Double Blind Phase (24 Weeks)|Other|2|||
127489911|NCT02831855|458756733|FG002|Double Blind Phase (24 Weeks)|Other|5|||
127489912|NCT02831855|458756731|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
127489913|NCT02831855|458756732|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
127489914|NCT02831855|458756733|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
127489915|NCT02831855|458756731|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
127489916|NCT02831855|458756732|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
127489917|NCT02831855|458756733|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
127489918|NCT02831855|458756731|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
127489919|NCT02831855|458756732|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
127489920|NCT02831855|458756733|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
127489921|NCT01722994|458756734|FG000|Overall Study|Missing data|25|||
127489922|NCT01722994|458756735|FG001|Overall Study|Missing data|17|||
127489923|NCT01803880|458756739|FG000|Overall Study|Adverse Event|1|||
127489924|NCT01803880|458756740|FG001|Overall Study|Adverse Event|0|||
127489925|NCT01803880|458756741|FG002|Overall Study|Adverse Event|0|||
127489926|NCT01803880|458756739|FG000|Overall Study|Withdrawal by Subject|1|||
127489927|NCT01803880|458756740|FG001|Overall Study|Withdrawal by Subject|1|||
127489928|NCT01803880|458756741|FG002|Overall Study|Withdrawal by Subject|4|||
127489929|NCT01803880|458756739|FG000|Overall Study|Physician Decision|0|||
127489930|NCT01803880|458756740|FG001|Overall Study|Physician Decision|0|||
127489931|NCT01803880|458756741|FG002|Overall Study|Physician Decision|1|||
127489932|NCT01803880|458756739|FG000|Overall Study|Unable to return for follow-up visits|0|||
127489933|NCT01803880|458756740|FG001|Overall Study|Unable to return for follow-up visits|1|||
127489934|NCT01803880|458756741|FG002|Overall Study|Unable to return for follow-up visits|2|||
127489935|NCT01803880|458756739|FG000|Overall Study|Lost to Follow-up|1|||
127489936|NCT01803880|458756740|FG001|Overall Study|Lost to Follow-up|2|||
127489937|NCT01803880|458756741|FG002|Overall Study|Lost to Follow-up|3|||
127489938|NCT01803880|458756739|FG000|Overall Study|Protocol Violation|1|||
127489939|NCT01803880|458756740|FG001|Overall Study|Protocol Violation|0|||
127489940|NCT01803880|458756741|FG002|Overall Study|Protocol Violation|0|||
127489941|NCT01803880|458756739|FG000|Overall Study|Early study termination|0|||
127976660|NCT01346189|460536175|FG001|Overall Study|Physician Decision|0|||
127976661|NCT01346189|460536176|FG002|Overall Study|Physician Decision|0|||
127976662|NCT01346189|460536177|FG003|Overall Study|Physician Decision|0|||
127489942|NCT01803880|458756740|FG001|Overall Study|Early study termination|6|||
127489943|NCT01803880|458756741|FG002|Overall Study|Early study termination|5|||
127976663|NCT01346189|460536174|FG000|Overall Study|Moved|3|||
127976664|NCT01346189|460536175|FG001|Overall Study|Moved|0|||
127489944|NCT01803880|458756739|FG000|Overall Study|Incomplete data entry by sites|2|||
127489945|NCT01803880|458756740|FG001|Overall Study|Incomplete data entry by sites|0|||
127489946|NCT01803880|458756741|FG002|Overall Study|Incomplete data entry by sites|0|||
127489947|NCT02954887|458756742|FG000|Overall Study|Withdrawal by Subject|3|||
127489948|NCT02954887|458756742|FG000|Overall Study|Lack of Efficacy|3|||
127489949|NCT02954887|458756742|FG000|Overall Study|Other|1|||
127489950|NCT01299389|458756748|FG000|Double-blind|Adverse Event|45|||
127489951|NCT01299389|458756749|FG001|Double-blind|Adverse Event|27|||
127489952|NCT01299389|458756750|FG002|Double-blind|Adverse Event|0|||
127489953|NCT01299389|458756751|FG003|Double-blind|Adverse Event|0|||
127489954|NCT01299389|458756748|FG000|Double-blind|Lack of Efficacy|45|||
127489955|NCT01299389|458756749|FG001|Double-blind|Lack of Efficacy|21|||
127489956|NCT01299389|458756750|FG002|Double-blind|Lack of Efficacy|0|||
127489957|NCT01299389|458756751|FG003|Double-blind|Lack of Efficacy|0|||
127489958|NCT01299389|458756748|FG000|Double-blind|Lost to Follow-up|2|||
127489959|NCT01299389|458756749|FG001|Double-blind|Lost to Follow-up|1|||
127489960|NCT01299389|458756750|FG002|Double-blind|Lost to Follow-up|0|||
127489961|NCT01299389|458756751|FG003|Double-blind|Lost to Follow-up|0|||
127489962|NCT01299389|458756748|FG000|Double-blind|Withdrawal by Subject|16|||
127489963|NCT01299389|458756749|FG001|Double-blind|Withdrawal by Subject|13|||
127489964|NCT01299389|458756750|FG002|Double-blind|Withdrawal by Subject|0|||
127489965|NCT01299389|458756751|FG003|Double-blind|Withdrawal by Subject|0|||
127489966|NCT01299389|458756748|FG000|Double-blind|Other|1|||
127489967|NCT01299389|458756749|FG001|Double-blind|Other|1|||
127489968|NCT01299389|458756750|FG002|Double-blind|Other|0|||
127489969|NCT01299389|458756751|FG003|Double-blind|Other|0|||
127489970|NCT01299389|458756748|FG000|Double-blind|"fail to meet study population criteria"|0|||
127489971|NCT01299389|458756749|FG001|Double-blind|"fail to meet study population criteria"|1|||
127489972|NCT01299389|458756750|FG002|Double-blind|"fail to meet study population criteria"|0|||
127489973|NCT01299389|458756751|FG003|Double-blind|"fail to meet study population criteria"|0|||
127489974|NCT01299389|458756748|FG000|Post-observational|Other|0|||
127489975|NCT01299389|458756749|FG001|Post-observational|Other|0|||
127489976|NCT01299389|458756750|FG002|Post-observational|Other|12|||
127489977|NCT01299389|458756751|FG003|Post-observational|Other|6|||
127489978|NCT04245709|458756752|FG000|Overall Study|Adverse Event|13|||
127489979|NCT04245709|458756752|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
127489980|NCT01151020|458756753|FG000|Overall Study|Death|25|||
127489981|NCT01151020|458756753|FG000|Overall Study|Conversion to open repair|1|||
127489982|NCT01151020|458756753|FG000|Overall Study|Lost to Follow-up|4|||
127489983|NCT01151020|458756753|FG000|Overall Study|Withdrawal by Subject|22|||
127489984|NCT01151020|458756753|FG000|Overall Study|Patients did not receive the device|2|||
127489985|NCT01635998|458756754|FG000|Overall Study|Death|1|||
127489986|NCT01635998|458756755|FG001|Overall Study|Death|1|||
127489987|NCT01635998|458756754|FG000|Overall Study|Lost to Follow-up|2|||
127489988|NCT01635998|458756755|FG001|Overall Study|Lost to Follow-up|1|||
127489989|NCT01635998|458756754|FG000|Overall Study|Withdrawal by Subject|1|||
127489990|NCT01635998|458756755|FG001|Overall Study|Withdrawal by Subject|5|||
127489991|NCT01220401|458756756|FG000|Overall Study|Withdrawal by Subject|2|||
127489992|NCT01220401|458756756|FG000|Overall Study|Protocol Violation|1|||
127489993|NCT01162473|458756761|FG000|Overall Study|Adverse Event|2|||
127489994|NCT01162473|458756762|FG001|Overall Study|Adverse Event|1|||
127489995|NCT01162473|458756761|FG000|Overall Study|Withdrawal by Subject|0|||
127489996|NCT01162473|458756762|FG001|Overall Study|Withdrawal by Subject|4|||
127489997|NCT00943761|458756773|FG000|Overall Study|Lost to Follow-up|2|||
127489998|NCT00943761|458756774|FG001|Overall Study|Lost to Follow-up|0|||
127489999|NCT00943761|458756773|FG000|Overall Study|Withdrawal by Subject|2|||
127490000|NCT00943761|458756774|FG001|Overall Study|Withdrawal by Subject|1|||
127490001|NCT02268383|458756775|FG000|Overall Study|Death|12|||
127490002|NCT02268383|458756775|FG000|Overall Study|Lost to Follow-up|2|||
127490003|NCT02268383|458756775|FG000|Overall Study|Withdrawal by Subject|9|||
127490004|NCT02268383|458756775|FG000|Overall Study|Presence of ≥1% blasts in peripheral blood|1|||
127490005|NCT02268383|458756775|FG000|Overall Study|Protocol deviation|3|||
127490006|NCT02268383|458756775|FG000|Overall Study|Sponsor decision|22|||
127490007|NCT02268383|458756775|FG000|Overall Study|Not reported|12|||
127490008|NCT02708680|458756776|FG000|Overall Study|Withdrawal by Subject|4|||
127490009|NCT02708680|458756777|FG001|Overall Study|Withdrawal by Subject|12|||
127490010|NCT02708680|458756778|FG002|Overall Study|Withdrawal by Subject|12|||
127490011|NCT02708680|458756776|FG000|Overall Study|Death|4|||
127490012|NCT02708680|458756777|FG001|Overall Study|Death|19|||
127976665|NCT01346189|460536176|FG002|Overall Study|Moved|4|||
127490013|NCT02708680|458756778|FG002|Overall Study|Death|21|||
127976666|NCT01346189|460536177|FG003|Overall Study|Moved|0|||
127490014|NCT02708680|458756776|FG000|Overall Study|Lost to Follow-up|0|||
127490015|NCT02708680|458756777|FG001|Overall Study|Lost to Follow-up|3|||
127490016|NCT02708680|458756778|FG002|Overall Study|Lost to Follow-up|3|||
127490017|NCT02708680|458756776|FG000|Overall Study|Study Terminated By Sponsor|0|||
127490018|NCT02708680|458756777|FG001|Overall Study|Study Terminated By Sponsor|5|||
127490019|NCT02708680|458756778|FG002|Overall Study|Study Terminated By Sponsor|4|||
127490020|NCT02708680|458756776|FG000|Overall Study|Other than Specified|0|||
127490021|NCT02708680|458756777|FG001|Overall Study|Other than Specified|0|||
127490022|NCT02708680|458756778|FG002|Overall Study|Other than Specified|1|||
127490023|NCT02708680|458756776|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
127976667|NCT01346189|460536174|FG000|Overall Study|Other|2|||
127490024|NCT02708680|458756777|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
127490025|NCT02708680|458756778|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
127490026|NCT01342926|458756779|FG000|Overall Study|Adverse Event|5|||
127490027|NCT01342926|458756780|FG001|Overall Study|Adverse Event|8|||
127490028|NCT01342926|458756781|FG002|Overall Study|Adverse Event|10|||
127490029|NCT01342926|458756782|FG003|Overall Study|Adverse Event|7|||
127490030|NCT01342926|458756779|FG000|Overall Study|Lost to Follow-up|0|||
127490031|NCT01342926|458756780|FG001|Overall Study|Lost to Follow-up|1|||
127490032|NCT01342926|458756781|FG002|Overall Study|Lost to Follow-up|1|||
127490033|NCT01342926|458756782|FG003|Overall Study|Lost to Follow-up|0|||
127490034|NCT01342926|458756779|FG000|Overall Study|Investigator Discretion|2|||
127490035|NCT01342926|458756780|FG001|Overall Study|Investigator Discretion|2|||
127490036|NCT01342926|458756781|FG002|Overall Study|Investigator Discretion|0|||
127490037|NCT01342926|458756782|FG003|Overall Study|Investigator Discretion|0|||
127490038|NCT01342926|458756779|FG000|Overall Study|Withdrawal by Subject|2|||
127490039|NCT01342926|458756780|FG001|Overall Study|Withdrawal by Subject|4|||
127490040|NCT01342926|458756781|FG002|Overall Study|Withdrawal by Subject|3|||
127490041|NCT01342926|458756782|FG003|Overall Study|Withdrawal by Subject|5|||
127490042|NCT04162470|458756783|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
127490043|NCT01544348|458756790|FG000|Overall Study|Lost to Follow-up|1|||
127490044|NCT01544348|458756791|FG001|Overall Study|Lost to Follow-up|0|||
127490045|NCT01544348|458756792|FG002|Overall Study|Lost to Follow-up|0|||
127490046|NCT01544348|458756793|FG003|Overall Study|Lost to Follow-up|0|||
127490047|NCT01544348|458756794|FG004|Overall Study|Lost to Follow-up|0|||
127490048|NCT01544348|458756795|FG005|Overall Study|Lost to Follow-up|0|||
127490049|NCT01544348|458756796|FG006|Overall Study|Lost to Follow-up|1|||
127490050|NCT01544348|458756797|FG007|Overall Study|Lost to Follow-up|0|||
127490051|NCT01544348|458756790|FG000|Overall Study|Withdrawal by Subject|1|||
127490052|NCT01544348|458756791|FG001|Overall Study|Withdrawal by Subject|0|||
127490053|NCT01544348|458756792|FG002|Overall Study|Withdrawal by Subject|0|||
127490054|NCT01544348|458756793|FG003|Overall Study|Withdrawal by Subject|0|||
127490055|NCT01544348|458756794|FG004|Overall Study|Withdrawal by Subject|1|||
127490056|NCT01544348|458756795|FG005|Overall Study|Withdrawal by Subject|2|||
127490057|NCT01544348|458756796|FG006|Overall Study|Withdrawal by Subject|1|||
127490058|NCT01544348|458756797|FG007|Overall Study|Withdrawal by Subject|0|||
127490059|NCT01544348|458756790|FG000|Overall Study|Physician Decision|0|||
127490060|NCT01544348|458756791|FG001|Overall Study|Physician Decision|0|||
127490061|NCT01544348|458756792|FG002|Overall Study|Physician Decision|0|||
127490062|NCT01544348|458756793|FG003|Overall Study|Physician Decision|0|||
127490063|NCT01544348|458756794|FG004|Overall Study|Physician Decision|0|||
127490064|NCT01544348|458756795|FG005|Overall Study|Physician Decision|1|||
127490065|NCT01544348|458756796|FG006|Overall Study|Physician Decision|0|||
127490066|NCT01544348|458756797|FG007|Overall Study|Physician Decision|0|||
127490067|NCT01445847|458756798|FG000|Overall Study|Protocol Violation|13|||
127490068|NCT01445847|458756799|FG001|Overall Study|Protocol Violation|14|||
127490069|NCT01445847|458756798|FG000|Overall Study|Missed Data|1|||
127490070|NCT01445847|458756799|FG001|Overall Study|Missed Data|0|||
127490071|NCT04790279|458758979|FG000|Overall Study|Did not meet medication start criteria|27|||
127490072|NCT04790279|458758980|FG001|Overall Study|Did not meet medication start criteria|15|||
127490073|NCT04790279|458758979|FG000|Overall Study|Required long acting antihypertensive intrapartum|1|||
127490074|NCT04790279|458758980|FG001|Overall Study|Required long acting antihypertensive intrapartum|0|||
127490075|NCT04790279|458758979|FG000|Overall Study|Protocol Violation|8|||
127490076|NCT04790279|458758980|FG001|Overall Study|Protocol Violation|3|||
127490077|NCT04790279|458758979|FG000|Overall Study|Developed complication requiring alternative regimen|0|||
127490078|NCT04790279|458758980|FG001|Overall Study|Developed complication requiring alternative regimen|1|||
127490079|NCT00810277|458758993|FG000|Overall Study|Adverse Event|1|||
127490080|NCT00678288|458759000|FG000|Overall Study|Adverse Event|0|||
127490081|NCT00678288|458759001|FG001|Overall Study|Adverse Event|2|||
127490082|NCT00678288|458759000|FG000|Overall Study|Withdrawal by Subject|1|||
127490083|NCT00678288|458759001|FG001|Overall Study|Withdrawal by Subject|1|||
127490084|NCT00678288|458759000|FG000|Overall Study|Study terminated by the sponsor|2|||
127490085|NCT00678288|458759001|FG001|Overall Study|Study terminated by the sponsor|0|||
127490086|NCT00678288|458759000|FG000|Overall Study|Not compliant with study medication|0|||
127490087|NCT00678288|458759001|FG001|Overall Study|Not compliant with study medication|1|||
127490088|NCT00678288|458759000|FG000|Overall Study|Switch to commercial drug|0|||
127490089|NCT00678288|458759001|FG001|Overall Study|Switch to commercial drug|1|||
127490090|NCT00678288|458759000|FG000|Overall Study|Reason not reported|1|||
127490091|NCT00678288|458759001|FG001|Overall Study|Reason not reported|0|||
127490092|NCT00678288|458759000|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
127490093|NCT00678288|458759001|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
127490094|NCT02549989|458759002|FG000|Overall Study|Adverse Event|4|||
127490095|NCT02549989|458759002|FG000|Overall Study|Death|1|||
127490096|NCT02549989|458759002|FG000|Overall Study|Lack of Efficacy|19|||
127490097|NCT02549989|458759002|FG000|Overall Study|Withdrawal by Subject|3|||
127976668|NCT01346189|460536175|FG001|Overall Study|Other|4|||
127490098|NCT00972023|458759003|FG000|Overall Study|Withdrawal by Subject|1|||
127490099|NCT02628444|458759004|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
127490100|NCT02628444|458759005|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
127490101|NCT02628444|458759006|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
127490102|NCT02628444|458759007|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
127490103|NCT02628444|458759008|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
127490104|NCT02628444|458759009|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
127490105|NCT02628444|458759010|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
127490106|NCT02628444|458759011|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
127490107|NCT02628444|458759012|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
127490108|NCT02628444|458759004|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
127490109|NCT02628444|458759005|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
127490110|NCT02628444|458759006|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
127490111|NCT02628444|458759007|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
127490112|NCT02628444|458759008|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
127490113|NCT02628444|458759009|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
127490114|NCT02628444|458759010|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
127490115|NCT02628444|458759011|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
127490116|NCT02628444|458759012|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
127490117|NCT02628444|458759004|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
127490118|NCT02628444|458759005|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
127490119|NCT02628444|458759006|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
127490120|NCT02628444|458759007|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
127490121|NCT02628444|458759008|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
127490122|NCT02628444|458759009|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
127490123|NCT02628444|458759010|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
127490124|NCT02628444|458759011|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
127490125|NCT02628444|458759012|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
127490126|NCT02628444|458759004|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
127490127|NCT02628444|458759005|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
127490128|NCT02628444|458759006|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
127490129|NCT02628444|458759007|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
127490130|NCT02628444|458759008|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
127490131|NCT02628444|458759009|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
127490132|NCT02628444|458759010|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
127490133|NCT02628444|458759011|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
127490134|NCT02628444|458759012|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
127490135|NCT02628444|458759004|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
127490136|NCT02628444|458759005|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
127490137|NCT02628444|458759006|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
127490138|NCT02628444|458759007|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
127490139|NCT02628444|458759008|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
127490140|NCT02628444|458759009|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
127490141|NCT02628444|458759010|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
127490142|NCT02628444|458759011|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
127490143|NCT02628444|458759012|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
127490144|NCT02628444|458759004|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
127490145|NCT02628444|458759005|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
127490146|NCT02628444|458759006|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
127490147|NCT02628444|458759007|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
127490148|NCT02628444|458759008|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
127490149|NCT02628444|458759009|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
127490150|NCT02628444|458759010|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
127490151|NCT02628444|458759011|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
127490152|NCT02628444|458759012|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
127490153|NCT02628444|458759004|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
127490154|NCT02628444|458759005|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
127868947|NCT05602818|460137443|FG001|Qualification Phase (3 Days)|Adverse Event|0|||
127868948|NCT05602818|460137444|FG002|Qualification Phase (3 Days)|Adverse Event|0|||
127868949|NCT05602818|460137445|FG003|Qualification Phase (3 Days)|Adverse Event|0|||
127976669|NCT01346189|460536176|FG002|Overall Study|Other|7|||
127490155|NCT02628444|458759006|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
127490156|NCT02628444|458759007|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
127490157|NCT02628444|458759008|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
127490158|NCT02628444|458759009|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
127490159|NCT02628444|458759010|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
127490160|NCT02628444|458759011|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
127490161|NCT02628444|458759012|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
127490162|NCT02628444|458759004|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
127490163|NCT02628444|458759005|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
127490164|NCT02628444|458759006|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
127490165|NCT02628444|458759007|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
127490166|NCT02628444|458759008|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
127490167|NCT02628444|458759009|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
127490168|NCT02628444|458759010|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
127490169|NCT02628444|458759011|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
127490170|NCT02628444|458759012|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
127490171|NCT02628444|458759004|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
127490172|NCT02628444|458759005|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
127490173|NCT02628444|458759006|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
127490174|NCT02628444|458759007|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
127490175|NCT02628444|458759008|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
127490176|NCT02628444|458759009|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
127490177|NCT02628444|458759010|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
127490178|NCT02628444|458759011|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
127490179|NCT02628444|458759012|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
127490180|NCT02628444|458759004|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
127490181|NCT02628444|458759005|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
127490182|NCT02628444|458759006|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
127490183|NCT02628444|458759007|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
127490184|NCT02628444|458759008|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
127490185|NCT02628444|458759009|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
127490186|NCT02628444|458759010|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
127490187|NCT02628444|458759011|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
127490188|NCT02628444|458759012|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
127490189|NCT00784368|458759015|FG000|Overall Study|Physician Decision|0|||
127490190|NCT00784368|458759016|FG001|Overall Study|Physician Decision|0|||
127490191|NCT00784368|458759017|FG002|Overall Study|Physician Decision|6|||
127490192|NCT00784368|458759015|FG000|Overall Study|Lack of Efficacy|2|||
127490193|NCT00784368|458759016|FG001|Overall Study|Lack of Efficacy|0|||
127490194|NCT00784368|458759017|FG002|Overall Study|Lack of Efficacy|1|||
127490195|NCT00784368|458759015|FG000|Overall Study|Adverse Event|6|||
127490196|NCT00784368|458759016|FG001|Overall Study|Adverse Event|9|||
127490197|NCT00784368|458759017|FG002|Overall Study|Adverse Event|2|||
127490198|NCT00784368|458759015|FG000|Overall Study|Diagnosis of fever|0|||
127490199|NCT00784368|458759016|FG001|Overall Study|Diagnosis of fever|0|||
127490200|NCT00784368|458759017|FG002|Overall Study|Diagnosis of fever|1|||
127490201|NCT00784368|458759015|FG000|Overall Study|Worsening of complications|0|||
127490202|NCT00784368|458759016|FG001|Overall Study|Worsening of complications|0|||
127490203|NCT00784368|458759017|FG002|Overall Study|Worsening of complications|1|||
127490204|NCT00784368|458759015|FG000|Overall Study|Worsening of symptoms|0|||
127490205|NCT00784368|458759016|FG001|Overall Study|Worsening of symptoms|1|||
127490206|NCT00784368|458759017|FG002|Overall Study|Worsening of symptoms|0|||
127490207|NCT00784368|458759015|FG000|Overall Study|Withdrawal of informed consent|0|||
127490208|NCT00784368|458759016|FG001|Overall Study|Withdrawal of informed consent|1|||
127490209|NCT00784368|458759017|FG002|Overall Study|Withdrawal of informed consent|0|||
127490210|NCT02079909|458759018|FG000|Overall Study|Adverse Event|23|||
127490211|NCT02079909|458759019|FG001|Overall Study|Adverse Event|23|||
127490212|NCT02079909|458759020|FG002|Overall Study|Adverse Event|7|||
127490213|NCT02079909|458759018|FG000|Overall Study|Withdrawal by Subject|9|||
127490214|NCT02079909|458759019|FG001|Overall Study|Withdrawal by Subject|17|||
127490215|NCT02079909|458759020|FG002|Overall Study|Withdrawal by Subject|4|||
127490216|NCT02079909|458759018|FG000|Overall Study|Lost to Follow-up|2|||
127490217|NCT02079909|458759019|FG001|Overall Study|Lost to Follow-up|3|||
127490218|NCT02079909|458759020|FG002|Overall Study|Lost to Follow-up|1|||
127490219|NCT02079909|458759018|FG000|Overall Study|Death|2|||
127490220|NCT02079909|458759019|FG001|Overall Study|Death|2|||
127490221|NCT02079909|458759020|FG002|Overall Study|Death|0|||
127490222|NCT02079909|458759018|FG000|Overall Study|Lack of Efficacy|0|||
127490223|NCT02079909|458759019|FG001|Overall Study|Lack of Efficacy|0|||
127976670|NCT01346189|460536177|FG003|Overall Study|Other|3|||
127976671|NCT01346189|460536174|FG000|Overall Study|Death|0|||
127976672|NCT01346189|460536175|FG001|Overall Study|Death|3|||
127976673|NCT01346189|460536176|FG002|Overall Study|Death|0|||
127976674|NCT01346189|460536177|FG003|Overall Study|Death|0|||
127976675|NCT01346189|460536174|FG000|Overall Study|Non-health system primary care physician|0|||
127976676|NCT01346189|460536175|FG001|Overall Study|Non-health system primary care physician|5|||
127976677|NCT01346189|460536176|FG002|Overall Study|Non-health system primary care physician|0|||
127976678|NCT01346189|460536177|FG003|Overall Study|Non-health system primary care physician|0|||
127976679|NCT01346189|460536174|FG000|Overall Study|Travel|0|||
127976680|NCT01346189|460536175|FG001|Overall Study|Travel|0|||
127976681|NCT01346189|460536176|FG002|Overall Study|Travel|0|||
127976682|NCT01346189|460536177|FG003|Overall Study|Travel|3|||
127976683|NCT01730534|460536179|FG000|Overall Study|Withdrawal by Subject|97|||
127976684|NCT01730534|460536180|FG001|Overall Study|Withdrawal by Subject|127|||
127976685|NCT01730534|460536179|FG000|Overall Study|Lost to Follow-up|12|||
127976686|NCT01730534|460536180|FG001|Overall Study|Lost to Follow-up|18|||
127976687|NCT01895608|460536181|FG000|Overall Study|change in health status|0|||
127976688|NCT01895608|460536182|FG001|Overall Study|change in health status|1|||
127976689|NCT01895608|460536183|FG002|Overall Study|change in health status|1|||
127976690|NCT01895608|460536184|FG003|Overall Study|change in health status|0|||
127976691|NCT01895608|460536181|FG000|Overall Study|Withdrawal by Subject|0|||
127976692|NCT01895608|460536182|FG001|Overall Study|Withdrawal by Subject|0|||
127976693|NCT01895608|460536183|FG002|Overall Study|Withdrawal by Subject|2|||
127976694|NCT01895608|460536184|FG003|Overall Study|Withdrawal by Subject|0|||
127976695|NCT03505593|460536185|FG000|Overall Study|Withdrawal by Subject|1|||
127976696|NCT03505593|460536185|FG000|Overall Study|Died before procedure|1|||
127976697|NCT03505593|460536185|FG000|Overall Study|Anatomical abnormality|1|||
127976698|NCT03505593|460536185|FG000|Overall Study|Unable to pass through esophagus|1|||
127976699|NCT03505593|460536185|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
127976700|NCT02833844|460536186|FG000|Double-Blind Period|Withdrawal by Subject|2|||
127976701|NCT02833844|460536187|FG001|Double-Blind Period|Withdrawal by Subject|3|||
127976702|NCT02833844|460536186|FG000|Double-Blind Period|Protocol Violation|0|||
127976703|NCT02833844|460536187|FG001|Double-Blind Period|Protocol Violation|4|||
127976704|NCT02833844|460536186|FG000|Open-Label Period|Death|0|||
127976705|NCT02833844|460536187|FG001|Open-Label Period|Death|2|||
127976706|NCT02833844|460536186|FG000|Open-Label Period|Lost to Follow-up|1|||
127976707|NCT02833844|460536187|FG001|Open-Label Period|Lost to Follow-up|0|||
127976708|NCT02833844|460536186|FG000|Open-Label Period|Withdrawal by Subject|1|||
127976709|NCT02833844|460536187|FG001|Open-Label Period|Withdrawal by Subject|0|||
127976710|NCT02541669|460536190|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
127976711|NCT02541669|460536191|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
127976712|NCT02541669|460536192|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
127976713|NCT02541669|460536193|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
127976714|NCT02541669|460536194|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
127976715|NCT01084668|460536196|FG000|Overall Study|Lack of Efficacy|5|||
127976716|NCT01084668|460536196|FG000|Overall Study|Withdrawal by Subject|2|||
127976717|NCT01084668|460536196|FG000|Overall Study|Pregnancy|1|||
127976718|NCT01084668|460536196|FG000|Overall Study|Non-compliance|1|||
127976719|NCT02658734|460536199|FG000|Overall Study|Adverse Event|2|||
127976720|NCT02658734|460536199|FG000|Overall Study|Death|4|||
127976721|NCT02658734|460536199|FG000|Overall Study|Lost to Follow-up|7|||
127976722|NCT02658734|460536199|FG000|Overall Study|Withdrawal of Consent|16|||
127976723|NCT02658734|460536199|FG000|Overall Study|Disease Progression|28|||
127976724|NCT00459706|460536200|FG000|Overall Study|Adverse Event|19|||
127976725|NCT00459706|460536201|FG001|Overall Study|Adverse Event|13|||
127976726|NCT00459706|460536200|FG000|Overall Study|Withdrawal by Subject|1|||
127976727|NCT00459706|460536201|FG001|Overall Study|Withdrawal by Subject|6|||
127976728|NCT00459706|460536200|FG000|Overall Study|Physician Decision|2|||
127976729|NCT00459706|460536201|FG001|Overall Study|Physician Decision|0|||
127976730|NCT00459706|460536200|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
127976731|NCT00459706|460536201|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
127976732|NCT00459706|460536200|FG000|Overall Study|Protocol Violation|2|||
127976733|NCT00459706|460536201|FG001|Overall Study|Protocol Violation|1|||
127976734|NCT00459706|460536200|FG000|Overall Study|Failed to Return|1|||
127976735|NCT00459706|460536201|FG001|Overall Study|Failed to Return|0|||
127976736|NCT00459706|460536200|FG000|Overall Study|Other|0|||
127976737|NCT00459706|460536201|FG001|Overall Study|Other|1|||
127976738|NCT01880086|460536202|FG000|Overall Study|Lost to Follow-up|1|||
127976739|NCT01880086|460536203|FG001|Overall Study|Lost to Follow-up|1|||
127976740|NCT03843632|460536206|FG000|Overall Study|Withdrawal by Subject|1|||
127976741|NCT03843632|460536207|FG001|Overall Study|Withdrawal by Subject|0|||
127976742|NCT03843632|460536208|FG002|Overall Study|Withdrawal by Subject|0|||
127976743|NCT03843632|460536209|FG003|Overall Study|Withdrawal by Subject|0|||
127976744|NCT03403751|460536210|FG000|Overall Study|Death|5|||
127976745|NCT03403751|460536211|FG001|Overall Study|Death|6|||
127976746|NCT03403751|460536210|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
127490224|NCT02079909|458759020|FG002|Overall Study|Lack of Efficacy|1|||
127490225|NCT02079909|458759018|FG000|Overall Study|Protocol Violation|0|||
127490226|NCT02079909|458759019|FG001|Overall Study|Protocol Violation|1|||
127490227|NCT02079909|458759020|FG002|Overall Study|Protocol Violation|1|||
127490228|NCT02079909|458759018|FG000|Overall Study|Physician Decision|0|||
127490229|NCT02079909|458759019|FG001|Overall Study|Physician Decision|1|||
127490230|NCT02079909|458759020|FG002|Overall Study|Physician Decision|1|||
127490231|NCT02079909|458759018|FG000|Overall Study|Relocation etc.|2|||
127490232|NCT02079909|458759019|FG001|Overall Study|Relocation etc.|2|||
127490233|NCT02079909|458759020|FG002|Overall Study|Relocation etc.|3|||
127490234|NCT00720356|458759025|FG000|Registration to Study|Determined to have methylated MGMT|67|||
127490235|NCT00720356|458759025|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
127490236|NCT00720356|458759025|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
127490237|NCT00720356|458759025|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
127490238|NCT00720356|458759025|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
127490239|NCT00720356|458759025|FG000|Follow up Until Death|Withdrawal by Subject|1|||
127490240|NCT00720356|458759025|FG000|Follow up Until Death|Alive at last data collection|4|||
127490241|NCT02237001|458759028|FG000|Overall Study|Lost to Follow-up|2|||
127490242|NCT02237001|458759028|FG000|Overall Study|Withdrawal by Subject|1|||
127490243|NCT02237001|458759028|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
127490244|NCT02237001|458759028|FG000|Overall Study|Re-operation|4|||
127490245|NCT02237001|458759028|FG000|Overall Study|Incarceration|1|||
127490246|NCT01713582|458759029|FG000|Overall Study|Disease progression|3|||
127490247|NCT01713582|458759030|FG001|Overall Study|Disease progression|3|||
127490248|NCT01713582|458759031|FG002|Overall Study|Disease progression|3|||
127490249|NCT01713582|458759032|FG003|Overall Study|Disease progression|2|||
127490250|NCT01713582|458759033|FG004|Overall Study|Disease progression|3|||
127490251|NCT01713582|458759034|FG005|Overall Study|Disease progression|3|||
127490252|NCT01713582|458759035|FG006|Overall Study|Disease progression|3|||
127490253|NCT01713582|458759036|FG007|Overall Study|Disease progression|3|||
127490254|NCT01713582|458759037|FG008|Overall Study|Disease progression|3|||
127490255|NCT01713582|458759038|FG009|Overall Study|Disease progression|11|||
127490256|NCT01713582|458759039|FG010|Overall Study|Disease progression|10|||
127490257|NCT01713582|458759040|FG011|Overall Study|Disease progression|5|||
127490258|NCT01713582|458759041|FG012|Overall Study|Disease progression|3|||
127490259|NCT01713582|458759042|FG013|Overall Study|Disease progression|3|||
127490260|NCT01713582|458759043|FG014|Overall Study|Disease progression|6|||
127490261|NCT01713582|458759044|FG015|Overall Study|Disease progression|6|||
127490262|NCT01713582|458759045|FG016|Overall Study|Disease progression|5|||
127490263|NCT01713582|458759046|FG017|Overall Study|Disease progression|2|||
127490264|NCT01713582|458759047|FG018|Overall Study|Disease progression|3|||
127490265|NCT01713582|458759048|FG019|Overall Study|Disease progression|5|||
127490266|NCT01713582|458759049|FG020|Overall Study|Disease progression|15|||
127490267|NCT01713582|458759029|FG000|Overall Study|Death|0|||
127490268|NCT01713582|458759030|FG001|Overall Study|Death|0|||
127490269|NCT01713582|458759031|FG002|Overall Study|Death|0|||
127490270|NCT01713582|458759032|FG003|Overall Study|Death|1|||
127490271|NCT01713582|458759033|FG004|Overall Study|Death|1|||
127490272|NCT01713582|458759034|FG005|Overall Study|Death|3|||
127490273|NCT01713582|458759035|FG006|Overall Study|Death|3|||
127490274|NCT01713582|458759036|FG007|Overall Study|Death|2|||
127490275|NCT01713582|458759037|FG008|Overall Study|Death|3|||
127490276|NCT01713582|458759038|FG009|Overall Study|Death|4|||
127490277|NCT01713582|458759039|FG010|Overall Study|Death|3|||
127490278|NCT01713582|458759040|FG011|Overall Study|Death|0|||
127490279|NCT01713582|458759041|FG012|Overall Study|Death|0|||
127490280|NCT01713582|458759042|FG013|Overall Study|Death|0|||
127490281|NCT01713582|458759043|FG014|Overall Study|Death|0|||
127490282|NCT01713582|458759044|FG015|Overall Study|Death|0|||
127490283|NCT01713582|458759045|FG016|Overall Study|Death|0|||
127490284|NCT01713582|458759046|FG017|Overall Study|Death|0|||
127490285|NCT01713582|458759047|FG018|Overall Study|Death|0|||
127490286|NCT01713582|458759048|FG019|Overall Study|Death|0|||
127490287|NCT01713582|458759049|FG020|Overall Study|Death|0|||
127490288|NCT01713582|458759029|FG000|Overall Study|Adverse event-related|0|||
127490289|NCT01713582|458759030|FG001|Overall Study|Adverse event-related|0|||
127490290|NCT01713582|458759031|FG002|Overall Study|Adverse event-related|0|||
127490291|NCT01713582|458759032|FG003|Overall Study|Adverse event-related|0|||
127490292|NCT01713582|458759033|FG004|Overall Study|Adverse event-related|0|||
127490293|NCT01713582|458759034|FG005|Overall Study|Adverse event-related|0|||
127490294|NCT01713582|458759035|FG006|Overall Study|Adverse event-related|0|||
127490295|NCT01713582|458759036|FG007|Overall Study|Adverse event-related|0|||
127490296|NCT01713582|458759037|FG008|Overall Study|Adverse event-related|0|||
127490297|NCT01713582|458759038|FG009|Overall Study|Adverse event-related|1|||
127490298|NCT01713582|458759039|FG010|Overall Study|Adverse event-related|1|||
127490299|NCT01713582|458759040|FG011|Overall Study|Adverse event-related|0|||
127490300|NCT01713582|458759041|FG012|Overall Study|Adverse event-related|0|||
127490301|NCT01713582|458759042|FG013|Overall Study|Adverse event-related|0|||
127490302|NCT01713582|458759043|FG014|Overall Study|Adverse event-related|0|||
127490303|NCT01713582|458759044|FG015|Overall Study|Adverse event-related|0|||
127490304|NCT01713582|458759045|FG016|Overall Study|Adverse event-related|0|||
127490305|NCT01713582|458759046|FG017|Overall Study|Adverse event-related|0|||
127490306|NCT01713582|458759047|FG018|Overall Study|Adverse event-related|1|||
127490307|NCT01713582|458759048|FG019|Overall Study|Adverse event-related|0|||
127490308|NCT01713582|458759049|FG020|Overall Study|Adverse event-related|0|||
127490309|NCT01713582|458759029|FG000|Overall Study|Adverse event-unrelated|0|||
127490310|NCT01713582|458759030|FG001|Overall Study|Adverse event-unrelated|0|||
127490311|NCT01713582|458759031|FG002|Overall Study|Adverse event-unrelated|0|||
127490312|NCT01713582|458759032|FG003|Overall Study|Adverse event-unrelated|0|||
127490313|NCT01713582|458759033|FG004|Overall Study|Adverse event-unrelated|0|||
127490314|NCT01713582|458759034|FG005|Overall Study|Adverse event-unrelated|1|||
127490315|NCT01713582|458759035|FG006|Overall Study|Adverse event-unrelated|1|||
127490316|NCT01713582|458759036|FG007|Overall Study|Adverse event-unrelated|1|||
127490317|NCT01713582|458759037|FG008|Overall Study|Adverse event-unrelated|0|||
127490318|NCT01713582|458759038|FG009|Overall Study|Adverse event-unrelated|0|||
127490319|NCT01713582|458759039|FG010|Overall Study|Adverse event-unrelated|0|||
127490320|NCT01713582|458759040|FG011|Overall Study|Adverse event-unrelated|0|||
127490321|NCT01713582|458759041|FG012|Overall Study|Adverse event-unrelated|0|||
127490322|NCT01713582|458759042|FG013|Overall Study|Adverse event-unrelated|1|||
127490323|NCT01713582|458759043|FG014|Overall Study|Adverse event-unrelated|1|||
127490324|NCT01713582|458759044|FG015|Overall Study|Adverse event-unrelated|0|||
127490325|NCT01713582|458759045|FG016|Overall Study|Adverse event-unrelated|0|||
127490326|NCT01713582|458759046|FG017|Overall Study|Adverse event-unrelated|0|||
127490327|NCT01713582|458759047|FG018|Overall Study|Adverse event-unrelated|0|||
127490328|NCT01713582|458759048|FG019|Overall Study|Adverse event-unrelated|0|||
127490329|NCT01713582|458759049|FG020|Overall Study|Adverse event-unrelated|0|||
127490330|NCT01713582|458759029|FG000|Overall Study|Withdrawal of consent|0|||
127490331|NCT01713582|458759030|FG001|Overall Study|Withdrawal of consent|0|||
127490332|NCT01713582|458759031|FG002|Overall Study|Withdrawal of consent|1|||
127490333|NCT01713582|458759032|FG003|Overall Study|Withdrawal of consent|0|||
127490334|NCT01713582|458759033|FG004|Overall Study|Withdrawal of consent|0|||
127490335|NCT01713582|458759034|FG005|Overall Study|Withdrawal of consent|1|||
127490336|NCT01713582|458759035|FG006|Overall Study|Withdrawal of consent|0|||
127490337|NCT01713582|458759036|FG007|Overall Study|Withdrawal of consent|0|||
127490338|NCT01713582|458759037|FG008|Overall Study|Withdrawal of consent|0|||
127490339|NCT01713582|458759038|FG009|Overall Study|Withdrawal of consent|1|||
127490340|NCT01713582|458759039|FG010|Overall Study|Withdrawal of consent|0|||
127490341|NCT01713582|458759040|FG011|Overall Study|Withdrawal of consent|0|||
127490342|NCT01713582|458759041|FG012|Overall Study|Withdrawal of consent|0|||
127490343|NCT01713582|458759042|FG013|Overall Study|Withdrawal of consent|0|||
127490344|NCT01713582|458759043|FG014|Overall Study|Withdrawal of consent|0|||
127490345|NCT01713582|458759044|FG015|Overall Study|Withdrawal of consent|0|||
127490346|NCT01713582|458759045|FG016|Overall Study|Withdrawal of consent|0|||
127490347|NCT01713582|458759046|FG017|Overall Study|Withdrawal of consent|0|||
127490348|NCT01713582|458759047|FG018|Overall Study|Withdrawal of consent|1|||
127490349|NCT01713582|458759048|FG019|Overall Study|Withdrawal of consent|0|||
127490350|NCT01713582|458759049|FG020|Overall Study|Withdrawal of consent|0|||
127490351|NCT01713582|458759029|FG000|Overall Study|Lack of Efficacy|0|||
127490352|NCT01713582|458759030|FG001|Overall Study|Lack of Efficacy|0|||
127490353|NCT01713582|458759031|FG002|Overall Study|Lack of Efficacy|0|||
127490354|NCT01713582|458759032|FG003|Overall Study|Lack of Efficacy|0|||
127490355|NCT01713582|458759033|FG004|Overall Study|Lack of Efficacy|0|||
127490356|NCT01713582|458759034|FG005|Overall Study|Lack of Efficacy|0|||
127490357|NCT01713582|458759035|FG006|Overall Study|Lack of Efficacy|0|||
127490358|NCT01713582|458759036|FG007|Overall Study|Lack of Efficacy|0|||
127490359|NCT01713582|458759037|FG008|Overall Study|Lack of Efficacy|0|||
127490360|NCT01713582|458759038|FG009|Overall Study|Lack of Efficacy|1|||
127490361|NCT01713582|458759039|FG010|Overall Study|Lack of Efficacy|2|||
127490362|NCT01713582|458759040|FG011|Overall Study|Lack of Efficacy|0|||
127490363|NCT01713582|458759041|FG012|Overall Study|Lack of Efficacy|0|||
127490364|NCT01713582|458759042|FG013|Overall Study|Lack of Efficacy|0|||
127490365|NCT01713582|458759043|FG014|Overall Study|Lack of Efficacy|0|||
127490366|NCT01713582|458759044|FG015|Overall Study|Lack of Efficacy|0|||
127490367|NCT01713582|458759045|FG016|Overall Study|Lack of Efficacy|0|||
127490368|NCT01713582|458759046|FG017|Overall Study|Lack of Efficacy|0|||
127490369|NCT01713582|458759047|FG018|Overall Study|Lack of Efficacy|0|||
127490370|NCT01713582|458759048|FG019|Overall Study|Lack of Efficacy|0|||
127490371|NCT01713582|458759049|FG020|Overall Study|Lack of Efficacy|0|||
127490372|NCT01713582|458759029|FG000|Overall Study|Withdrawal by Subject|0|||
127490373|NCT01713582|458759030|FG001|Overall Study|Withdrawal by Subject|0|||
127490374|NCT01713582|458759031|FG002|Overall Study|Withdrawal by Subject|0|||
127490375|NCT01713582|458759032|FG003|Overall Study|Withdrawal by Subject|0|||
127490376|NCT01713582|458759033|FG004|Overall Study|Withdrawal by Subject|0|||
127490377|NCT01713582|458759034|FG005|Overall Study|Withdrawal by Subject|0|||
127490378|NCT01713582|458759035|FG006|Overall Study|Withdrawal by Subject|0|||
127490379|NCT01713582|458759036|FG007|Overall Study|Withdrawal by Subject|0|||
127490380|NCT01713582|458759037|FG008|Overall Study|Withdrawal by Subject|0|||
127490381|NCT01713582|458759038|FG009|Overall Study|Withdrawal by Subject|0|||
127490382|NCT01713582|458759039|FG010|Overall Study|Withdrawal by Subject|0|||
127490383|NCT01713582|458759040|FG011|Overall Study|Withdrawal by Subject|0|||
127490384|NCT01713582|458759041|FG012|Overall Study|Withdrawal by Subject|0|||
127490385|NCT01713582|458759042|FG013|Overall Study|Withdrawal by Subject|0|||
127490386|NCT01713582|458759043|FG014|Overall Study|Withdrawal by Subject|0|||
127490387|NCT01713582|458759044|FG015|Overall Study|Withdrawal by Subject|0|||
127490388|NCT01713582|458759045|FG016|Overall Study|Withdrawal by Subject|0|||
127490389|NCT01713582|458759046|FG017|Overall Study|Withdrawal by Subject|1|||
127490390|NCT01713582|458759047|FG018|Overall Study|Withdrawal by Subject|0|||
127490391|NCT01713582|458759048|FG019|Overall Study|Withdrawal by Subject|0|||
127490392|NCT01713582|458759049|FG020|Overall Study|Withdrawal by Subject|0|||
127490393|NCT01713582|458759029|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
127490394|NCT01713582|458759030|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
127490395|NCT01713582|458759031|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
127490396|NCT01713582|458759032|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
127490397|NCT01713582|458759033|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
127490398|NCT01713582|458759034|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
127490399|NCT01713582|458759035|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
127490400|NCT01713582|458759036|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
127490401|NCT01713582|458759037|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
127490402|NCT01713582|458759038|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
127490403|NCT01713582|458759039|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
127490404|NCT01713582|458759040|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
127490405|NCT01713582|458759041|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
127490406|NCT01713582|458759042|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
127490407|NCT01713582|458759043|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
127490408|NCT01713582|458759044|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
127490409|NCT01713582|458759045|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
127490410|NCT01713582|458759046|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
127490411|NCT01713582|458759047|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
127490412|NCT01713582|458759048|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
127490413|NCT01713582|458759049|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
127490414|NCT01713582|458759029|FG000|Overall Study|Disease progression and adverse event|0|||
127490415|NCT01713582|458759030|FG001|Overall Study|Disease progression and adverse event|0|||
127490416|NCT01713582|458759031|FG002|Overall Study|Disease progression and adverse event|0|||
127490417|NCT01713582|458759032|FG003|Overall Study|Disease progression and adverse event|0|||
127490418|NCT01713582|458759033|FG004|Overall Study|Disease progression and adverse event|0|||
127490419|NCT01713582|458759034|FG005|Overall Study|Disease progression and adverse event|0|||
127490420|NCT01713582|458759035|FG006|Overall Study|Disease progression and adverse event|0|||
127490421|NCT01713582|458759036|FG007|Overall Study|Disease progression and adverse event|0|||
127490422|NCT01713582|458759037|FG008|Overall Study|Disease progression and adverse event|0|||
127490423|NCT01713582|458759038|FG009|Overall Study|Disease progression and adverse event|0|||
127490424|NCT01713582|458759039|FG010|Overall Study|Disease progression and adverse event|0|||
127490425|NCT01713582|458759040|FG011|Overall Study|Disease progression and adverse event|0|||
127490426|NCT01713582|458759041|FG012|Overall Study|Disease progression and adverse event|0|||
127490427|NCT01713582|458759042|FG013|Overall Study|Disease progression and adverse event|0|||
127490428|NCT01713582|458759043|FG014|Overall Study|Disease progression and adverse event|0|||
127490429|NCT01713582|458759044|FG015|Overall Study|Disease progression and adverse event|0|||
127490430|NCT01713582|458759045|FG016|Overall Study|Disease progression and adverse event|1|||
127490431|NCT01713582|458759046|FG017|Overall Study|Disease progression and adverse event|0|||
127490432|NCT01713582|458759047|FG018|Overall Study|Disease progression and adverse event|0|||
127490433|NCT01713582|458759048|FG019|Overall Study|Disease progression and adverse event|0|||
127490434|NCT01713582|458759049|FG020|Overall Study|Disease progression and adverse event|0|||
127490435|NCT04551898|458759052|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
127976747|NCT03403751|460536211|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
127976748|NCT01820572|460536212|FG000|Randomization|Not Treated|2|||
127976749|NCT01820572|460536213|FG001|Randomization|Not Treated|1|||
127976750|NCT01820572|460536212|FG000|Treatment Period|Adverse Event|12|||
127976751|NCT01820572|460536213|FG001|Treatment Period|Adverse Event|7|||
127976752|NCT01820572|460536212|FG000|Treatment Period|Death|3|||
127976753|NCT01820572|460536213|FG001|Treatment Period|Death|3|||
127976754|NCT01820572|460536212|FG000|Treatment Period|Lack of Efficacy|1|||
127490436|NCT04551898|458759053|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
127490437|NCT04551898|458759054|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
127490438|NCT04551898|458759055|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
127976755|NCT01820572|460536213|FG001|Treatment Period|Lack of Efficacy|0|||
127976756|NCT01820572|460536212|FG000|Treatment Period|poor/non compliance|0|||
127490439|NCT04551898|458759052|FG000|Overall Study|Withdrawal by Subject|5|||
127490440|NCT04551898|458759053|FG001|Overall Study|Withdrawal by Subject|1|||
127490441|NCT04551898|458759054|FG002|Overall Study|Withdrawal by Subject|2|||
127490442|NCT04551898|458759055|FG003|Overall Study|Withdrawal by Subject|2|||
127490443|NCT04551898|458759052|FG000|Overall Study|Lost to Follow-up|2|||
127490444|NCT04551898|458759053|FG001|Overall Study|Lost to Follow-up|1|||
127490445|NCT04551898|458759054|FG002|Overall Study|Lost to Follow-up|2|||
127490446|NCT04551898|458759055|FG003|Overall Study|Lost to Follow-up|2|||
127490447|NCT04551898|458759052|FG000|Overall Study|Death|1|||
127490448|NCT04551898|458759053|FG001|Overall Study|Death|0|||
127490449|NCT04551898|458759054|FG002|Overall Study|Death|0|||
127490450|NCT04551898|458759055|FG003|Overall Study|Death|0|||
127490451|NCT04551898|458759052|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
127490452|NCT04551898|458759053|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
127490453|NCT04551898|458759054|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
127490454|NCT04551898|458759055|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
127490455|NCT00628446|458759058|FG000|Overall Study|Lost to Follow-up|3|||
127490456|NCT00628446|458759058|FG000|Overall Study|Withdrawal by Subject|1|||
127490457|NCT00628446|458759058|FG000|Overall Study|Protocol Violation|3|||
127490458|NCT02257242|458759059|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
127490459|NCT02257242|458759060|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
127490460|NCT02257242|458759061|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
127490461|NCT02257242|458759062|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
127490462|NCT02257242|458759063|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
127490463|NCT02257242|458759064|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
127490464|NCT02257242|458759065|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
127490465|NCT02257242|458759066|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
127490466|NCT02257242|458759067|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
127490467|NCT01650831|458759074|FG000|Overall Study|Screen failure|1|||
127490468|NCT01048242|458759077|FG000|Overall Study|See study flow chart|4|||
127490469|NCT01048242|458759078|FG001|Overall Study|See study flow chart|2|||
127490470|NCT02964273|458759079|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
127490471|NCT02964273|458759080|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
127490472|NCT02964273|458759081|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
127490473|NCT02964273|458759082|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
127490474|NCT02964273|458759079|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
127490475|NCT02964273|458759080|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
127490476|NCT02964273|458759081|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
127490477|NCT02964273|458759082|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
127490478|NCT02964273|458759079|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
127490479|NCT02964273|458759080|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
127490480|NCT02964273|458759081|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
127490481|NCT02964273|458759082|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
127490482|NCT02964273|458759079|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
127490483|NCT02964273|458759080|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
127490484|NCT02964273|458759081|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
127490485|NCT02964273|458759082|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
127490486|NCT02964273|458759079|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
127490487|NCT02964273|458759080|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
127490488|NCT02964273|458759081|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
127490489|NCT02964273|458759082|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
127490490|NCT02964273|458759079|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
127490491|NCT02964273|458759080|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
127490492|NCT02964273|458759081|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
127490493|NCT02964273|458759082|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
127490494|NCT01453036|458759084|FG000|Overall Study|Lost to Follow-up|26|||
127490495|NCT01453036|458759085|FG001|Overall Study|Lost to Follow-up|115|||
127490496|NCT01453036|458759086|FG002|Overall Study|Lost to Follow-up|31|||
127490497|NCT00559104|458759087|FG000|Overall Study|Lack of Efficacy|9|||
127490498|NCT00559104|458759088|FG001|Overall Study|Lack of Efficacy|0|||
127490499|NCT01336712|458759089|FG000|Overall Study|Death|2|||
127490500|NCT01336712|458759089|FG000|Overall Study|Lack of Efficacy|1|||
127976757|NCT01820572|460536213|FG001|Treatment Period|poor/non compliance|3|||
127976758|NCT01820572|460536212|FG000|Treatment Period|request to discontinue|6|||
127490501|NCT00620373|458759091|FG000|Overall Study|Unverified cancer status|33|||
127490502|NCT00399568|458759092|FG000|Overall Study|Adverse Event|1|||
127490503|NCT00399568|458759093|FG001|Overall Study|Adverse Event|2|||
127490504|NCT00399568|458759092|FG000|Overall Study|Withdrawal by Subject|7|||
127490505|NCT00399568|458759093|FG001|Overall Study|Withdrawal by Subject|3|||
127490506|NCT00399568|458759092|FG000|Overall Study|Protocol non-compliance|2|||
127490507|NCT00399568|458759093|FG001|Overall Study|Protocol non-compliance|2|||
127490508|NCT00399568|458759092|FG000|Overall Study|Lost to Follow-up|2|||
127490509|NCT00399568|458759093|FG001|Overall Study|Lost to Follow-up|2|||
127490510|NCT03073525|458759094|FG000|Overall Study|Withdrawal by Subject|0|||
127490511|NCT03073525|458759095|FG001|Overall Study|Withdrawal by Subject|0|||
127490512|NCT03073525|458759096|FG002|Overall Study|Withdrawal by Subject|3|||
127490513|NCT01273038|458759097|FG000|Second Intervention (14 Days)|Adverse Event|0|||
127490514|NCT01273038|458759098|FG001|Second Intervention (14 Days)|Adverse Event|1|||
127490515|NCT01273038|458759097|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
127490516|NCT01273038|458759098|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
127490517|NCT01976299|458759099|FG000|Overall Study|Withdrawal by Subject|3|||
127490518|NCT01976299|458759100|FG001|Overall Study|Withdrawal by Subject|1|||
127490519|NCT01976299|458759099|FG000|Overall Study|Death|4|||
127490520|NCT01976299|458759100|FG001|Overall Study|Death|2|||
127490521|NCT01976299|458759099|FG000|Overall Study|Lost to Follow-up|7|||
127490522|NCT01976299|458759100|FG001|Overall Study|Lost to Follow-up|1|||
127490523|NCT01976299|458759099|FG000|Overall Study|See clarification above in comments|9|||
127490524|NCT01976299|458759100|FG001|Overall Study|See clarification above in comments|2|||
127490525|NCT03692403|458759101|FG000|Overall Study|Withdrawal by Subject|1|||
127490526|NCT03692403|458759102|FG001|Overall Study|Withdrawal by Subject|0|||
127490527|NCT03692403|458759103|FG002|Overall Study|Withdrawal by Subject|1|||
127490528|NCT03692403|458759104|FG003|Overall Study|Withdrawal by Subject|0|||
127490529|NCT03692403|458759101|FG000|Overall Study|Adverse Event|0|||
127490530|NCT03692403|458759102|FG001|Overall Study|Adverse Event|0|||
127490531|NCT03692403|458759103|FG002|Overall Study|Adverse Event|0|||
127490532|NCT03692403|458759104|FG003|Overall Study|Adverse Event|1|||
127490533|NCT03692403|458759101|FG000|Overall Study|Pregnancy|0|||
127490534|NCT03692403|458759102|FG001|Overall Study|Pregnancy|1|||
127490535|NCT03692403|458759103|FG002|Overall Study|Pregnancy|0|||
127490536|NCT03692403|458759104|FG003|Overall Study|Pregnancy|0|||
127490537|NCT03692403|458759101|FG000|Overall Study|Other|0|||
127490538|NCT03692403|458759102|FG001|Overall Study|Other|0|||
127490539|NCT03692403|458759103|FG002|Overall Study|Other|1|||
127490540|NCT03692403|458759104|FG003|Overall Study|Other|0|||
127490541|NCT01349673|458759107|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
127490542|NCT01349673|458759107|FG000|Overall Study|No Longer Qualified For Study|1|||
127490543|NCT01349673|458759107|FG000|Overall Study|Site Closure|10|||
127490544|NCT01349673|458759107|FG000|Overall Study|Withdrawal by Subject|21|||
127490545|NCT01349673|458759107|FG000|Overall Study|Lost to Follow-up|6|||
127490546|NCT01349673|458759107|FG000|Overall Study|Adverse Event|17|||
127490547|NCT01349673|458759107|FG000|Overall Study|Study Terminated By Sponsor|50|||
127490548|NCT01349673|458759107|FG000|Overall Study|Lack of Efficacy|8|||
127490549|NCT00506779|458759108|FG000|Overall Study|Withdrawal by Subject|1|||
127490550|NCT00506779|458759109|FG001|Overall Study|Withdrawal by Subject|0|||
127490551|NCT00506779|458759110|FG002|Overall Study|Withdrawal by Subject|1|||
127490552|NCT00506779|458759111|FG003|Overall Study|Withdrawal by Subject|0|||
127490553|NCT00506779|458759108|FG000|Overall Study|Adverse Event|0|||
127490554|NCT00506779|458759109|FG001|Overall Study|Adverse Event|1|||
127490555|NCT00506779|458759110|FG002|Overall Study|Adverse Event|1|||
127490556|NCT00506779|458759111|FG003|Overall Study|Adverse Event|1|||
127490557|NCT01891396|458759112|FG000|Overall Study|Withdrawal by Subject|4|||
127490558|NCT01891396|458759113|FG001|Overall Study|Withdrawal by Subject|4|||
127490559|NCT01891396|458759114|FG002|Overall Study|Withdrawal by Subject|3|||
127490560|NCT01891396|458759112|FG000|Overall Study|Lost to Follow-up|0|||
127490561|NCT01891396|458759113|FG001|Overall Study|Lost to Follow-up|1|||
127490562|NCT01891396|458759114|FG002|Overall Study|Lost to Follow-up|0|||
127490563|NCT00540592|458759115|FG000|Overall Study|Adverse Event|0|||
127490564|NCT00540592|458759116|FG001|Overall Study|Adverse Event|1|||
127490565|NCT00540592|458759117|FG002|Overall Study|Adverse Event|0|||
127490566|NCT00540592|458759118|FG003|Overall Study|Adverse Event|0|||
127490567|NCT00540592|458759119|FG004|Overall Study|Adverse Event|1|||
127490568|NCT00540592|458759120|FG005|Overall Study|Adverse Event|0|||
127490569|NCT00540592|458759121|FG006|Overall Study|Adverse Event|0|||
127490570|NCT00540592|458759122|FG007|Overall Study|Adverse Event|1|||
127490571|NCT00540592|458759123|FG008|Overall Study|Adverse Event|1|||
127490572|NCT00540592|458759124|FG009|Overall Study|Adverse Event|2|||
127490573|NCT00540592|458759115|FG000|Overall Study|Lost to Follow-up|2|||
127490574|NCT00540592|458759116|FG001|Overall Study|Lost to Follow-up|0|||
127490575|NCT00540592|458759117|FG002|Overall Study|Lost to Follow-up|0|||
127490576|NCT00540592|458759118|FG003|Overall Study|Lost to Follow-up|0|||
127490577|NCT00540592|458759119|FG004|Overall Study|Lost to Follow-up|0|||
127490578|NCT00540592|458759120|FG005|Overall Study|Lost to Follow-up|0|||
127490579|NCT00540592|458759121|FG006|Overall Study|Lost to Follow-up|0|||
127490580|NCT00540592|458759122|FG007|Overall Study|Lost to Follow-up|0|||
127490581|NCT00540592|458759123|FG008|Overall Study|Lost to Follow-up|0|||
127490582|NCT00540592|458759124|FG009|Overall Study|Lost to Follow-up|0|||
127490583|NCT00540592|458759115|FG000|Overall Study|Withdrawal by Subject|0|||
127490584|NCT00540592|458759116|FG001|Overall Study|Withdrawal by Subject|0|||
127490585|NCT00540592|458759117|FG002|Overall Study|Withdrawal by Subject|1|||
127490586|NCT00540592|458759118|FG003|Overall Study|Withdrawal by Subject|1|||
127490587|NCT00540592|458759119|FG004|Overall Study|Withdrawal by Subject|0|||
127490588|NCT00540592|458759120|FG005|Overall Study|Withdrawal by Subject|0|||
127490589|NCT00540592|458759121|FG006|Overall Study|Withdrawal by Subject|0|||
127490590|NCT00540592|458759122|FG007|Overall Study|Withdrawal by Subject|0|||
127490591|NCT00540592|458759123|FG008|Overall Study|Withdrawal by Subject|0|||
127490592|NCT00540592|458759124|FG009|Overall Study|Withdrawal by Subject|0|||
127490593|NCT01456130|458759125|FG000|Overall Study|Adverse Event|4|||
127490594|NCT01456130|458759125|FG000|Overall Study|Voluntary Withdrawal|1|||
127490595|NCT01456130|458759125|FG000|Overall Study|Lack of Efficacy|4|||
127490596|NCT01456130|458759125|FG000|Overall Study|Other|1|||
127490597|NCT00400517|458759126|FG000|Overall Study|Withdrawal by Subject|1|||
127490598|NCT00400517|458759126|FG000|Overall Study|Physician Decision|1|||
127490599|NCT05384834|458759132|FG000|Overall Study|Lost to Follow-up|43|||
127490600|NCT05384834|458759132|FG000|Overall Study|Withdrawal by Subject|5|||
127490601|NCT01459666|458759135|FG000|Overall Study|PI left institution|5|||
127490602|NCT01459666|458759136|FG001|Overall Study|PI left institution|4|||
127490603|NCT01152788|458759137|FG000|Overall Study|Withdrawal by Subject|0|||
127490604|NCT01152788|458759138|FG001|Overall Study|Withdrawal by Subject|3|||
127490605|NCT01152788|458759137|FG000|Overall Study|No treatment|0|||
127490606|NCT01152788|458759138|FG001|Overall Study|No treatment|1|||
127490607|NCT01881789|458759139|FG000|Overall Study|Withdrawal by Subject|0|||
127490608|NCT01881789|458759140|FG001|Overall Study|Withdrawal by Subject|2|||
127490609|NCT01881789|458759141|FG002|Overall Study|Withdrawal by Subject|1|||
127490610|NCT01881789|458759142|FG003|Overall Study|Withdrawal by Subject|0|||
127490611|NCT01881789|458759143|FG004|Overall Study|Withdrawal by Subject|1|||
127490612|NCT01881789|458759144|FG005|Overall Study|Withdrawal by Subject|1|||
127490613|NCT01881789|458759139|FG000|Overall Study|Study Terminated by Sponsor|0|||
127490614|NCT01881789|458759140|FG001|Overall Study|Study Terminated by Sponsor|0|||
127490615|NCT01881789|458759141|FG002|Overall Study|Study Terminated by Sponsor|0|||
127490616|NCT01881789|458759142|FG003|Overall Study|Study Terminated by Sponsor|0|||
127490617|NCT01881789|458759143|FG004|Overall Study|Study Terminated by Sponsor|0|||
127490618|NCT01881789|458759144|FG005|Overall Study|Study Terminated by Sponsor|1|||
127490619|NCT01881789|458759139|FG000|Overall Study|Other|3|||
127490620|NCT01881789|458759140|FG001|Overall Study|Other|5|||
127490621|NCT01881789|458759141|FG002|Overall Study|Other|2|||
127490622|NCT01881789|458759142|FG003|Overall Study|Other|3|||
127490623|NCT01881789|458759143|FG004|Overall Study|Other|1|||
127490624|NCT01881789|458759144|FG005|Overall Study|Other|1|||
127490625|NCT01282866|458759146|FG000|Overall Study|Adverse Event|1|||
127490626|NCT02948582|458759147|FG000|Washout Period 1|Adverse Event|0|||
127490627|NCT02948582|458759148|FG001|Washout Period 1|Adverse Event|2|||
127490628|NCT02948582|458759149|FG002|Washout Period 1|Adverse Event|0|||
127490629|NCT02948582|458759150|FG003|Washout Period 1|Adverse Event|0|||
127490630|NCT02948582|458759151|FG004|Washout Period 1|Adverse Event|0|||
127490631|NCT02948582|458759152|FG005|Washout Period 1|Adverse Event|0|||
127490632|NCT02948582|458759147|FG000|Washout Period 1|Protocol Violation|0|||
127490633|NCT02948582|458759148|FG001|Washout Period 1|Protocol Violation|0|||
127490634|NCT02948582|458759149|FG002|Washout Period 1|Protocol Violation|0|||
127490635|NCT02948582|458759150|FG003|Washout Period 1|Protocol Violation|0|||
127490636|NCT02948582|458759151|FG004|Washout Period 1|Protocol Violation|0|||
127490637|NCT02948582|458759152|FG005|Washout Period 1|Protocol Violation|1|||
127490638|NCT02948582|458759147|FG000|Washout Period 2|Adverse Event|0|||
127976759|NCT01820572|460536213|FG001|Treatment Period|request to discontinue|11|||
127490639|NCT02948582|458759148|FG001|Washout Period 2|Adverse Event|1|||
127490640|NCT02948582|458759149|FG002|Washout Period 2|Adverse Event|0|||
127490641|NCT02948582|458759150|FG003|Washout Period 2|Adverse Event|0|||
127490642|NCT02948582|458759151|FG004|Washout Period 2|Adverse Event|0|||
127490643|NCT02948582|458759152|FG005|Washout Period 2|Adverse Event|0|||
127490644|NCT02948582|458759147|FG000|Washout Period 2|personal reasons|0|||
127490645|NCT02948582|458759148|FG001|Washout Period 2|personal reasons|0|||
127490646|NCT02948582|458759149|FG002|Washout Period 2|personal reasons|0|||
127490647|NCT02948582|458759150|FG003|Washout Period 2|personal reasons|1|||
127490648|NCT02948582|458759151|FG004|Washout Period 2|personal reasons|0|||
127976760|NCT01820572|460536212|FG000|Treatment Period|No longer meets study criteria|3|||
127490649|NCT02948582|458759152|FG005|Washout Period 2|personal reasons|0|||
127490650|NCT02948582|458759147|FG000|Washout Period 4|Adverse Event|1|||
127490651|NCT02948582|458759148|FG001|Washout Period 4|Adverse Event|0|||
127490652|NCT02948582|458759149|FG002|Washout Period 4|Adverse Event|1|||
127490653|NCT02948582|458759150|FG003|Washout Period 4|Adverse Event|0|||
127490654|NCT02948582|458759151|FG004|Washout Period 4|Adverse Event|0|||
127490655|NCT02948582|458759152|FG005|Washout Period 4|Adverse Event|0|||
127490656|NCT01964378|458759155|FG000|Overall Study|Disc. due to death before first dosing|0|||
127490657|NCT01964378|458759156|FG001|Overall Study|Disc. due to death before first dosing|1|||
127490658|NCT01964378|458759155|FG000|Overall Study|Disc. due to AE before first dosing|1|||
127490659|NCT01964378|458759156|FG001|Overall Study|Disc. due to AE before first dosing|0|||
127490660|NCT01964378|458759155|FG000|Overall Study|Death|3|||
127490661|NCT01964378|458759156|FG001|Overall Study|Death|2|||
127490662|NCT01964378|458759155|FG000|Overall Study|Adverse Event|12|||
127490663|NCT01964378|458759156|FG001|Overall Study|Adverse Event|5|||
127490664|NCT01964378|458759155|FG000|Overall Study|Lack of Efficacy|0|||
127490665|NCT01964378|458759156|FG001|Overall Study|Lack of Efficacy|1|||
127490666|NCT01964378|458759155|FG000|Overall Study|Protocol Violation|0|||
127490667|NCT01964378|458759156|FG001|Overall Study|Protocol Violation|1|||
127490668|NCT01964378|458759155|FG000|Overall Study|Lost to Follow-up|0|||
127490669|NCT01964378|458759156|FG001|Overall Study|Lost to Follow-up|1|||
127490670|NCT01964378|458759155|FG000|Overall Study|Withdrawal by Subject|7|||
127490671|NCT01964378|458759156|FG001|Overall Study|Withdrawal by Subject|5|||
127490672|NCT01964378|458759155|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
127490673|NCT01964378|458759156|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
127490674|NCT01964378|458759155|FG000|Overall Study|Other|1|||
127490675|NCT01964378|458759156|FG001|Overall Study|Other|2|||
127490676|NCT01392573|458759157|FG000|Overall Study|Adverse Event|1|||
127490677|NCT01392573|458759158|FG001|Overall Study|Adverse Event|3|||
127490678|NCT01392573|458759157|FG000|Overall Study|Lack of Efficacy|1|||
127490679|NCT01392573|458759158|FG001|Overall Study|Lack of Efficacy|2|||
127490680|NCT01392573|458759157|FG000|Overall Study|Protocol Violation|0|||
127490681|NCT01392573|458759158|FG001|Overall Study|Protocol Violation|2|||
127490682|NCT01392573|458759157|FG000|Overall Study|Withdrawal Criteria|13|||
127490683|NCT01392573|458759158|FG001|Overall Study|Withdrawal Criteria|15|||
127490684|NCT01392573|458759157|FG000|Overall Study|Site closure|8|||
127490685|NCT01392573|458759158|FG001|Overall Study|Site closure|7|||
127490686|NCT01392573|458759157|FG000|Overall Study|Unclassified|9|||
127490687|NCT01392573|458759158|FG001|Overall Study|Unclassified|6|||
127490688|NCT03008070|458759159|FG000|Overall Study|Adverse Event|3|||
127490689|NCT03008070|458759160|FG001|Overall Study|Adverse Event|3|||
127490690|NCT03008070|458759161|FG002|Overall Study|Adverse Event|3|||
127490691|NCT03008070|458759159|FG000|Overall Study|Lost to Follow-up|1|||
127490692|NCT03008070|458759160|FG001|Overall Study|Lost to Follow-up|1|||
127490693|NCT03008070|458759161|FG002|Overall Study|Lost to Follow-up|0|||
127490694|NCT03008070|458759159|FG000|Overall Study|Non compliance|0|||
127490695|NCT03008070|458759160|FG001|Overall Study|Non compliance|1|||
127490696|NCT03008070|458759161|FG002|Overall Study|Non compliance|1|||
127490697|NCT03008070|458759159|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
127490698|NCT03008070|458759160|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
127490699|NCT03008070|458759161|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
127490700|NCT03008070|458759159|FG000|Overall Study|Withdrawal by Subject|2|||
127490701|NCT03008070|458759160|FG001|Overall Study|Withdrawal by Subject|0|||
127490702|NCT03008070|458759161|FG002|Overall Study|Withdrawal by Subject|1|||
127490703|NCT03008070|458759159|FG000|Overall Study|Use of prohibited drug|0|||
127490704|NCT03008070|458759160|FG001|Overall Study|Use of prohibited drug|0|||
127490705|NCT03008070|458759161|FG002|Overall Study|Use of prohibited drug|2|||
127490706|NCT04409834|458759164|FG000|Overall Study|Death|55|||
127490707|NCT04409834|458759165|FG001|Overall Study|Death|62|||
127490708|NCT01365455|458759166|FG000|Induction Period|Adverse Event|5|||
127490709|NCT01365455|458759167|FG001|Induction Period|Adverse Event|3|||
127490710|NCT01365455|458759168|FG002|Induction Period|Adverse Event|4|||
127490711|NCT01365455|458759169|FG003|Induction Period|Adverse Event|0|||
127490712|NCT01365455|458759170|FG004|Induction Period|Adverse Event|0|||
127490713|NCT01365455|458759166|FG000|Induction Period|Lack of Efficacy|1|||
127490714|NCT01365455|458759167|FG001|Induction Period|Lack of Efficacy|1|||
127490715|NCT01365455|458759168|FG002|Induction Period|Lack of Efficacy|0|||
127976761|NCT01820572|460536213|FG001|Treatment Period|No longer meets study criteria|10|||
127976762|NCT01820572|460536212|FG000|Treatment Period|withdrew consent|1|||
127490716|NCT01365455|458759169|FG003|Induction Period|Lack of Efficacy|0|||
127490717|NCT01365455|458759170|FG004|Induction Period|Lack of Efficacy|0|||
127490718|NCT01365455|458759166|FG000|Induction Period|Pregnancy|0|||
127490719|NCT01365455|458759167|FG001|Induction Period|Pregnancy|1|||
127490720|NCT01365455|458759168|FG002|Induction Period|Pregnancy|0|||
127976763|NCT01820572|460536213|FG001|Treatment Period|withdrew consent|2|||
127976764|NCT05036668|460536217|FG000|Overall Study|lost to follow Up|0|||
127490721|NCT01365455|458759169|FG003|Induction Period|Pregnancy|0|||
127490722|NCT01365455|458759170|FG004|Induction Period|Pregnancy|0|||
127490723|NCT01365455|458759166|FG000|Induction Period|Protocol deviation|0|||
127490724|NCT01365455|458759167|FG001|Induction Period|Protocol deviation|1|||
127490725|NCT01365455|458759168|FG002|Induction Period|Protocol deviation|1|||
127490726|NCT01365455|458759169|FG003|Induction Period|Protocol deviation|0|||
127490727|NCT01365455|458759170|FG004|Induction Period|Protocol deviation|0|||
127490728|NCT01365455|458759166|FG000|Induction Period|Subject/guardian decision|9|||
127490729|NCT01365455|458759167|FG001|Induction Period|Subject/guardian decision|1|||
127976765|NCT05036668|460536218|FG001|Overall Study|lost to follow Up|0|||
127490730|NCT01365455|458759168|FG002|Induction Period|Subject/guardian decision|8|||
127490731|NCT01365455|458759169|FG003|Induction Period|Subject/guardian decision|0|||
127490732|NCT01365455|458759170|FG004|Induction Period|Subject/guardian decision|0|||
127490733|NCT01365455|458759166|FG000|Induction Period|Lost to Follow-up|0|||
127490734|NCT01365455|458759167|FG001|Induction Period|Lost to Follow-up|0|||
127490735|NCT01365455|458759168|FG002|Induction Period|Lost to Follow-up|3|||
127490736|NCT01365455|458759169|FG003|Induction Period|Lost to Follow-up|0|||
127490737|NCT01365455|458759170|FG004|Induction Period|Lost to Follow-up|0|||
127490738|NCT01365455|458759166|FG000|Maintenance Period|Adverse Event|12|||
127490739|NCT01365455|458759167|FG001|Maintenance Period|Adverse Event|5|||
127490740|NCT01365455|458759168|FG002|Maintenance Period|Adverse Event|1|||
127490741|NCT01365455|458759169|FG003|Maintenance Period|Adverse Event|2|||
127490742|NCT01365455|458759170|FG004|Maintenance Period|Adverse Event|4|||
127490743|NCT01365455|458759166|FG000|Maintenance Period|Lack of Efficacy|10|||
127490744|NCT01365455|458759167|FG001|Maintenance Period|Lack of Efficacy|2|||
127490745|NCT01365455|458759168|FG002|Maintenance Period|Lack of Efficacy|0|||
127490746|NCT01365455|458759169|FG003|Maintenance Period|Lack of Efficacy|2|||
127490747|NCT01365455|458759170|FG004|Maintenance Period|Lack of Efficacy|2|||
127490748|NCT01365455|458759166|FG000|Maintenance Period|Lost to Follow-up|2|||
127490749|NCT01365455|458759167|FG001|Maintenance Period|Lost to Follow-up|4|||
127490750|NCT01365455|458759168|FG002|Maintenance Period|Lost to Follow-up|0|||
127490751|NCT01365455|458759169|FG003|Maintenance Period|Lost to Follow-up|0|||
127490752|NCT01365455|458759170|FG004|Maintenance Period|Lost to Follow-up|3|||
127490753|NCT01365455|458759166|FG000|Maintenance Period|Non-compliance with study treatment|0|||
127490754|NCT01365455|458759167|FG001|Maintenance Period|Non-compliance with study treatment|0|||
127490755|NCT01365455|458759168|FG002|Maintenance Period|Non-compliance with study treatment|0|||
127490756|NCT01365455|458759169|FG003|Maintenance Period|Non-compliance with study treatment|1|||
127490757|NCT01365455|458759170|FG004|Maintenance Period|Non-compliance with study treatment|0|||
127490758|NCT01365455|458759166|FG000|Maintenance Period|Physician Decision|0|||
127490759|NCT01365455|458759167|FG001|Maintenance Period|Physician Decision|1|||
127490760|NCT01365455|458759168|FG002|Maintenance Period|Physician Decision|0|||
127490761|NCT01365455|458759169|FG003|Maintenance Period|Physician Decision|0|||
127490762|NCT01365455|458759170|FG004|Maintenance Period|Physician Decision|1|||
127490763|NCT01365455|458759166|FG000|Maintenance Period|Pregnancy|0|||
127490764|NCT01365455|458759167|FG001|Maintenance Period|Pregnancy|4|||
127490765|NCT01365455|458759168|FG002|Maintenance Period|Pregnancy|0|||
127490766|NCT01365455|458759169|FG003|Maintenance Period|Pregnancy|0|||
127490767|NCT01365455|458759170|FG004|Maintenance Period|Pregnancy|2|||
127490768|NCT01365455|458759166|FG000|Maintenance Period|Protocol deviation|1|||
127490769|NCT01365455|458759167|FG001|Maintenance Period|Protocol deviation|1|||
127490770|NCT01365455|458759168|FG002|Maintenance Period|Protocol deviation|0|||
127490771|NCT01365455|458759169|FG003|Maintenance Period|Protocol deviation|0|||
127490772|NCT01365455|458759170|FG004|Maintenance Period|Protocol deviation|0|||
127490773|NCT01365455|458759166|FG000|Maintenance Period|Subject/guardian decision|4|||
127490774|NCT01365455|458759167|FG001|Maintenance Period|Subject/guardian decision|6|||
127490775|NCT01365455|458759168|FG002|Maintenance Period|Subject/guardian decision|2|||
127490776|NCT01365455|458759169|FG003|Maintenance Period|Subject/guardian decision|4|||
127490777|NCT01365455|458759170|FG004|Maintenance Period|Subject/guardian decision|1|||
127490778|NCT00928187|458759171|FG000|Overall Study|Death|1|||
127490779|NCT00928187|458759172|FG001|Overall Study|Death|2|||
127490780|NCT00928187|458759173|FG002|Overall Study|Death|3|||
127490781|NCT00928187|458759171|FG000|Overall Study|Lost to Follow-up|1|||
127490782|NCT00928187|458759172|FG001|Overall Study|Lost to Follow-up|2|||
127490783|NCT00928187|458759173|FG002|Overall Study|Lost to Follow-up|1|||
127490784|NCT00928187|458759171|FG000|Overall Study|Withdrawal by Subject|0|||
127490785|NCT00928187|458759172|FG001|Overall Study|Withdrawal by Subject|1|||
127490786|NCT00928187|458759173|FG002|Overall Study|Withdrawal by Subject|1|||
127976766|NCT05036668|460536219|FG002|Overall Study|lost to follow Up|1|||
127976767|NCT01931956|460536222|FG000|Overall Study|Death|42|||
127976768|NCT01931956|460536223|FG001|Overall Study|Death|7|||
127490787|NCT00928187|458759171|FG000|Overall Study|Protocol Violation|0|||
127490788|NCT00928187|458759172|FG001|Overall Study|Protocol Violation|1|||
127490789|NCT00928187|458759173|FG002|Overall Study|Protocol Violation|0|||
127490790|NCT01898286|458760646|FG000|Overall Study|Withdrawal by Subject|1|||
127490791|NCT01898286|458760646|FG000|Overall Study|Protocol Violation|1|||
127490792|NCT01898286|458760646|FG000|Overall Study|Lost to Follow-up|1|||
127490793|NCT01766037|458760647|FG000|Overall Study|Adverse Event|1|||
127490794|NCT01766037|458760648|FG001|Overall Study|Adverse Event|0|||
127490795|NCT01766037|458760647|FG000|Overall Study|Lack of Efficacy|1|||
127490796|NCT01766037|458760648|FG001|Overall Study|Lack of Efficacy|0|||
127490797|NCT01766037|458760647|FG000|Overall Study|Lost to Follow-up|0|||
127490798|NCT01766037|458760648|FG001|Overall Study|Lost to Follow-up|10|||
127490799|NCT01766037|458760647|FG000|Overall Study|Physician Decision|0|||
127490800|NCT01766037|458760648|FG001|Overall Study|Physician Decision|1|||
127490801|NCT01766037|458760647|FG000|Overall Study|Withdrawal by Subject|18|||
127490802|NCT01766037|458760648|FG001|Overall Study|Withdrawal by Subject|16|||
127976769|NCT01931956|460536224|FG002|Overall Study|Death|379|||
127490803|NCT01766037|458760647|FG000|Overall Study|Moved from area|5|||
127490804|NCT01766037|458760648|FG001|Overall Study|Moved from area|0|||
127490805|NCT01766037|458760647|FG000|Overall Study|medical - unrelated|1|||
127490806|NCT01766037|458760648|FG001|Overall Study|medical - unrelated|2|||
127490807|NCT01766037|458760647|FG000|Overall Study|nausea / discomfort|3|||
127490808|NCT01766037|458760648|FG001|Overall Study|nausea / discomfort|0|||
127490809|NCT02413996|458760649|FG000|Overall Study|not comfortable with the intervention|9|||
127490810|NCT02413996|458760650|FG001|Overall Study|not comfortable with the intervention|2|||
127490811|NCT03810014|458760651|FG000|Overall Study|Pregnancy|2|||
127490812|NCT03810014|458760652|FG001|Overall Study|Pregnancy|2|||
127490813|NCT03810014|458760653|FG002|Overall Study|Pregnancy|0|||
127490814|NCT03810014|458760654|FG003|Overall Study|Pregnancy|2|||
127490815|NCT03606486|458760655|FG000|Overall Study|Unable to collect sample|5|||
127490816|NCT01853462|458760668|FG000|Overall Study|Withdrawal by Subject|1|||
127490817|NCT01853462|458760669|FG001|Overall Study|Withdrawal by Subject|1|||
127490818|NCT02148263|458760670|FG000|Overall Study|Withdrawal by Subject|3|||
127490819|NCT02148263|458760671|FG001|Overall Study|Withdrawal by Subject|2|||
127490820|NCT03386435|458760672|FG000|Overall Study|Protocol Violation|5|||
127490821|NCT03386435|458760673|FG001|Overall Study|Protocol Violation|7|||
127490822|NCT00625586|458760674|FG000|Overall Study|Adverse Event|1|||
127490823|NCT00625586|458760674|FG000|Overall Study|Progressive disease|1|||
127490824|NCT00124072|458760677|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
127490825|NCT00124072|458760678|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
127490826|NCT00124072|458760679|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
127490827|NCT00124072|458760680|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
127490828|NCT00124072|458760677|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
127490829|NCT00124072|458760678|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
127490830|NCT00124072|458760679|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
127490831|NCT00124072|458760680|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
127490832|NCT00124072|458760677|FG000|Overall Study|Death|499|||
127490833|NCT00124072|458760678|FG001|Overall Study|Death|484|||
127490834|NCT00124072|458760679|FG002|Overall Study|Death|471|||
127490835|NCT00124072|458760680|FG003|Overall Study|Death|480|||
127490836|NCT02534883|458760681|FG000|Overall Study|Early Termination|8|||
127490837|NCT02534883|458760682|FG001|Overall Study|Early Termination|3|||
127490838|NCT00886769|458760683|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
127490839|NCT00886769|458760684|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
127490840|NCT00778336|458760685|FG000|Index Procedure-Discharge|Death|6|||
127490841|NCT00778336|458760686|FG001|Index Procedure-Discharge|Death|3|||
127490842|NCT00778336|458760687|FG002|Index Procedure-Discharge|Death|2|||
127490843|NCT00778336|458760688|FG003|Index Procedure-Discharge|Death|0|||
127490844|NCT00778336|458760685|FG000|3 Month Follow Up|Lost to Follow-up|15|||
127490845|NCT00778336|458760686|FG001|3 Month Follow Up|Lost to Follow-up|20|||
127490846|NCT00778336|458760687|FG002|3 Month Follow Up|Lost to Follow-up|3|||
127490847|NCT00778336|458760688|FG003|3 Month Follow Up|Lost to Follow-up|0|||
127490848|NCT00778336|458760685|FG000|3 Month Follow Up|Death|8|||
127490849|NCT00778336|458760686|FG001|3 Month Follow Up|Death|3|||
127490850|NCT00778336|458760687|FG002|3 Month Follow Up|Death|2|||
127490851|NCT00778336|458760688|FG003|3 Month Follow Up|Death|0|||
127490852|NCT00414076|458760691|FG000|Overall Study|Progression|1|||
127490853|NCT00414076|458760692|FG001|Overall Study|Progression|2|||
127490854|NCT00414076|458760691|FG000|Overall Study|Withdrawal by Subject|1|||
127490855|NCT00414076|458760692|FG001|Overall Study|Withdrawal by Subject|3|||
127490856|NCT00414076|458760691|FG000|Overall Study|Adverse Event|1|||
127490857|NCT00414076|458760692|FG001|Overall Study|Adverse Event|0|||
127490858|NCT00049257|458760693|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
127490859|NCT00049257|458760693|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
127490860|NCT00049257|458760693|FG000|Carboplatin, Paclitaxel|Death|2|||
127490861|NCT00049257|458760693|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
127490862|NCT04721158|458760694|FG000|Overall Study|Lost to Follow-up|4|||
127490863|NCT04721158|458760694|FG000|Overall Study|Device did not connect|1|||
127490864|NCT02012218|458760695|FG000|Overall Study|Withdrawal by Subject|1|||
127490865|NCT02012218|458760696|FG001|Overall Study|Withdrawal by Subject|0|||
127490866|NCT02012218|458760697|FG002|Overall Study|Withdrawal by Subject|1|||
127490867|NCT02012218|458760698|FG003|Overall Study|Withdrawal by Subject|1|||
127490868|NCT02012218|458760699|FG004|Overall Study|Withdrawal by Subject|1|||
127490869|NCT02012218|458760695|FG000|Overall Study|Adverse Event|1|||
127490870|NCT02012218|458760696|FG001|Overall Study|Adverse Event|0|||
127490871|NCT02012218|458760697|FG002|Overall Study|Adverse Event|0|||
127490872|NCT02012218|458760698|FG003|Overall Study|Adverse Event|1|||
127490873|NCT02012218|458760699|FG004|Overall Study|Adverse Event|0|||
127490874|NCT02012218|458760695|FG000|Overall Study|Lost to Follow-up|0|||
127490875|NCT02012218|458760696|FG001|Overall Study|Lost to Follow-up|1|||
127490876|NCT02012218|458760697|FG002|Overall Study|Lost to Follow-up|1|||
127490877|NCT02012218|458760698|FG003|Overall Study|Lost to Follow-up|0|||
127490878|NCT02012218|458760699|FG004|Overall Study|Lost to Follow-up|0|||
127490879|NCT02012218|458760695|FG000|Overall Study|Protocol Specified|1|||
127490880|NCT02012218|458760696|FG001|Overall Study|Protocol Specified|0|||
127490881|NCT02012218|458760697|FG002|Overall Study|Protocol Specified|0|||
127490882|NCT02012218|458760698|FG003|Overall Study|Protocol Specified|0|||
127490883|NCT02012218|458760699|FG004|Overall Study|Protocol Specified|0|||
127490884|NCT02012218|458760695|FG000|Overall Study|Protocol Deviation|1|||
127490885|NCT02012218|458760696|FG001|Overall Study|Protocol Deviation|0|||
127490886|NCT02012218|458760697|FG002|Overall Study|Protocol Deviation|0|||
127490887|NCT02012218|458760698|FG003|Overall Study|Protocol Deviation|0|||
127490888|NCT02012218|458760699|FG004|Overall Study|Protocol Deviation|0|||
127490889|NCT04872569|458760705|FG000|Overall Study|Withdrawal by Subject|2|||
127490890|NCT04466384|458760706|FG000|First Phase|Protocol Violation|1|||
127490891|NCT04466384|458760707|FG001|First Phase|Protocol Violation|0|||
127490892|NCT04466384|458760706|FG000|First Phase|Missing data|1|||
127490893|NCT04466384|458760707|FG001|First Phase|Missing data|0|||
127490894|NCT04466384|458760706|FG000|Cross Over Phase|Physician Decision|1|||
127490895|NCT04466384|458760707|FG001|Cross Over Phase|Physician Decision|0|||
127490896|NCT04466384|458760706|FG000|Cross Over Phase|Withdrawal by Subject|0|||
127490897|NCT04466384|458760707|FG001|Cross Over Phase|Withdrawal by Subject|1|||
127490898|NCT03666988|458760708|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
127490899|NCT03666988|458760709|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
127490900|NCT03666988|458760710|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
127490901|NCT03666988|458760711|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
127490902|NCT03666988|458760712|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
127490903|NCT03666988|458760713|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
127490904|NCT03666988|458760708|FG000|Part 1 (Up to 28 Months)|Other|0|||
127490905|NCT03666988|458760709|FG001|Part 1 (Up to 28 Months)|Other|1|||
127490906|NCT03666988|458760710|FG002|Part 1 (Up to 28 Months)|Other|1|||
127490907|NCT03666988|458760711|FG003|Part 1 (Up to 28 Months)|Other|0|||
127490908|NCT03666988|458760712|FG004|Part 1 (Up to 28 Months)|Other|0|||
127490909|NCT03666988|458760713|FG005|Part 1 (Up to 28 Months)|Other|0|||
127490910|NCT03666988|458760708|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
127490911|NCT03666988|458760709|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
127490912|NCT03666988|458760710|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
127490913|NCT03666988|458760711|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
127490914|NCT03666988|458760712|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
127490915|NCT03666988|458760713|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
127490916|NCT03666988|458760708|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
127490917|NCT03666988|458760709|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
127490918|NCT03666988|458760710|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
127490919|NCT03666988|458760711|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
127490920|NCT03666988|458760712|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
127490921|NCT03666988|458760713|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
127976770|NCT01931956|460536225|FG003|Overall Study|Death|96|||
127976771|NCT01931956|460536222|FG000|Overall Study|Withdrawal by Subject|5|||
127976772|NCT01931956|460536223|FG001|Overall Study|Withdrawal by Subject|0|||
127976773|NCT01931956|460536224|FG002|Overall Study|Withdrawal by Subject|70|||
127976774|NCT01931956|460536225|FG003|Overall Study|Withdrawal by Subject|30|||
127976775|NCT01931956|460536222|FG000|Overall Study|Lost to Follow-up|2|||
127976776|NCT01931956|460536223|FG001|Overall Study|Lost to Follow-up|0|||
127976777|NCT01931956|460536224|FG002|Overall Study|Lost to Follow-up|11|||
127976778|NCT01931956|460536225|FG003|Overall Study|Lost to Follow-up|7|||
127976779|NCT01931956|460536222|FG000|Overall Study|Expected|2|||
127976780|NCT01931956|460536223|FG001|Overall Study|Expected|0|||
127976781|NCT01931956|460536224|FG002|Overall Study|Expected|6|||
127976782|NCT01931956|460536225|FG003|Overall Study|Expected|0|||
127976783|NCT01931956|460536222|FG000|Overall Study|Not due|0|||
127976784|NCT01931956|460536223|FG001|Overall Study|Not due|0|||
127976785|NCT01931956|460536224|FG002|Overall Study|Not due|21|||
127976786|NCT01931956|460536225|FG003|Overall Study|Not due|0|||
127976787|NCT02847494|460536226|FG000|Overall Study|Lost to Follow-up|8|||
127976788|NCT02847494|460536227|FG001|Overall Study|Lost to Follow-up|5|||
127976789|NCT01901653|460536228|FG000|Overall Study|Death|2|||
127490922|NCT03666988|458760708|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
127490923|NCT03666988|458760709|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
127490924|NCT03666988|458760710|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
127490925|NCT03666988|458760711|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
127490926|NCT03666988|458760712|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
127490927|NCT03666988|458760713|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
127490928|NCT03554018|458760716|FG000|Overall Study|Lost to Follow-up|3|||
127490929|NCT03554018|458760717|FG001|Overall Study|Lost to Follow-up|7|||
127490930|NCT02891226|458760720|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
127490931|NCT02891226|458760721|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
127490932|NCT02891226|458760722|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
127976790|NCT01901653|460536229|FG001|Overall Study|Death|1|||
127976791|NCT01901653|460536230|FG002|Overall Study|Death|8|||
127976792|NCT01901653|460536231|FG003|Overall Study|Death|3|||
127976793|NCT01901653|460536232|FG004|Overall Study|Death|2|||
127976794|NCT01901653|460536233|FG005|Overall Study|Death|2|||
127976795|NCT01901653|460536234|FG006|Overall Study|Death|6|||
127490933|NCT02891226|458760723|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
127490934|NCT02891226|458760724|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
127490935|NCT02891226|458760725|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
127490936|NCT02891226|458760726|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
127490937|NCT02891226|458760727|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
127490938|NCT02891226|458760728|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
127490939|NCT02891226|458760729|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
127490940|NCT02891226|458760730|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
127490941|NCT02891226|458760731|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
127490942|NCT02891226|458760732|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
127490943|NCT02891226|458760733|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
127490944|NCT02891226|458760734|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
127490945|NCT02891226|458760735|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
127490946|NCT02891226|458760720|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
127490947|NCT02891226|458760721|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
127490948|NCT02891226|458760722|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
127490949|NCT02891226|458760723|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
127490950|NCT02891226|458760724|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
127490951|NCT02891226|458760725|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
127490952|NCT02891226|458760726|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
127490953|NCT02891226|458760727|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
127490954|NCT02891226|458760728|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
127490955|NCT02891226|458760729|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
127490956|NCT02891226|458760730|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
127490957|NCT02891226|458760731|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
127490958|NCT02891226|458760732|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
127490959|NCT02891226|458760733|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
127490960|NCT02891226|458760734|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
127490961|NCT02891226|458760735|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
127490962|NCT02891226|458760720|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
127490963|NCT02891226|458760721|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
127490964|NCT02891226|458760722|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
127490965|NCT02891226|458760723|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
127490966|NCT02891226|458760724|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
127490967|NCT02891226|458760725|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
127490968|NCT02891226|458760726|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
127490969|NCT02891226|458760727|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
127490970|NCT02891226|458760728|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
127490971|NCT02891226|458760729|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
127490972|NCT02891226|458760730|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
127490973|NCT02891226|458760731|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
127490974|NCT02891226|458760732|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
127490975|NCT02891226|458760733|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
127490976|NCT02891226|458760734|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
127490977|NCT02891226|458760735|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
127490978|NCT02891226|458760720|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
127490979|NCT02891226|458760721|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
127490980|NCT02891226|458760722|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
127490981|NCT02891226|458760723|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
127490982|NCT02891226|458760724|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
127490983|NCT02891226|458760725|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
127490984|NCT02891226|458760726|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
127490985|NCT02891226|458760727|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
127490986|NCT02891226|458760728|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
127490987|NCT02891226|458760729|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
127490988|NCT02891226|458760730|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
127490989|NCT02891226|458760731|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
127490990|NCT02891226|458760732|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
127490991|NCT02891226|458760733|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
127490992|NCT02891226|458760734|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
127490993|NCT02891226|458760735|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
127490994|NCT02891226|458760720|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
127490995|NCT02891226|458760721|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
127490996|NCT02891226|458760722|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
127490997|NCT02891226|458760723|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
127490998|NCT02891226|458760724|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
127490999|NCT02891226|458760725|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
127491000|NCT02891226|458760726|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
127491001|NCT02891226|458760727|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
127491002|NCT02891226|458760728|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
127491003|NCT02891226|458760729|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
127491004|NCT02891226|458760730|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
127491005|NCT02891226|458760731|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
127491006|NCT02891226|458760732|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
127491007|NCT02891226|458760733|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
127491008|NCT02891226|458760734|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
127491009|NCT02891226|458760735|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
127491010|NCT02891226|458760720|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
127491011|NCT02891226|458760721|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
127976796|NCT01901653|460536235|FG007|Overall Study|Death|9|||
127976797|NCT01901653|460536236|FG008|Overall Study|Death|1|||
127976798|NCT01901653|460536237|FG009|Overall Study|Death|16|||
127976799|NCT01901653|460536238|FG010|Overall Study|Death|2|||
127976800|NCT01901653|460536239|FG011|Overall Study|Death|15|||
127976801|NCT01901653|460536240|FG012|Overall Study|Death|4|||
127976802|NCT01901653|460536228|FG000|Overall Study|Lost to Follow-up|1|||
127976803|NCT01901653|460536229|FG001|Overall Study|Lost to Follow-up|0|||
127491012|NCT02891226|458760722|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
127491013|NCT02891226|458760723|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
127491014|NCT02891226|458760724|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
127491015|NCT02891226|458760725|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
127491016|NCT02891226|458760726|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
127491017|NCT02891226|458760727|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
127491018|NCT02891226|458760728|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
127491019|NCT02891226|458760729|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
127491020|NCT02891226|458760730|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
127491021|NCT02891226|458760731|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
127491022|NCT02891226|458760732|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
127491023|NCT02891226|458760733|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
127976804|NCT01901653|460536230|FG002|Overall Study|Lost to Follow-up|2|||
127976805|NCT01901653|460536231|FG003|Overall Study|Lost to Follow-up|0|||
127491024|NCT02891226|458760734|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
127491025|NCT02891226|458760735|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
127491026|NCT02891226|458760720|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
127491027|NCT02891226|458760721|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
127491028|NCT02891226|458760722|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
127491029|NCT02891226|458760723|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
127491030|NCT02891226|458760724|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
127491031|NCT02891226|458760725|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
127491032|NCT02891226|458760726|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
127491033|NCT02891226|458760727|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
127491034|NCT02891226|458760728|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
127491035|NCT02891226|458760729|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
127491036|NCT02891226|458760730|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
127491037|NCT02891226|458760731|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
127491038|NCT02891226|458760732|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
127491039|NCT02891226|458760733|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
127491040|NCT02891226|458760734|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
127491041|NCT02891226|458760735|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
127491042|NCT02891226|458760720|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
127491043|NCT02891226|458760721|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
127491044|NCT02891226|458760722|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
127491045|NCT02891226|458760723|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
127491046|NCT02891226|458760724|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
127491047|NCT02891226|458760725|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
127491048|NCT02891226|458760726|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
127491049|NCT02891226|458760727|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
127491050|NCT02891226|458760728|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
127491051|NCT02891226|458760729|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
127491052|NCT02891226|458760730|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
127491053|NCT02891226|458760731|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
127491054|NCT02891226|458760732|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
127491055|NCT02891226|458760733|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
127491056|NCT02891226|458760734|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
127491057|NCT02891226|458760735|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
127491058|NCT02891226|458760720|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
127491059|NCT02891226|458760721|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
127491060|NCT02891226|458760722|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
127491061|NCT02891226|458760723|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
127491062|NCT02891226|458760724|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
127491063|NCT02891226|458760725|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
127491064|NCT02891226|458760726|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
127491065|NCT02891226|458760727|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
127491066|NCT02891226|458760728|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
127976806|NCT01901653|460536232|FG004|Overall Study|Lost to Follow-up|0|||
127976807|NCT01901653|460536233|FG005|Overall Study|Lost to Follow-up|1|||
127976808|NCT01901653|460536234|FG006|Overall Study|Lost to Follow-up|0|||
127491067|NCT02891226|458760729|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
127491068|NCT02891226|458760730|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
127491069|NCT02891226|458760731|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
127491070|NCT02891226|458760732|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
127491071|NCT02891226|458760733|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
127491072|NCT02891226|458760734|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
127491073|NCT02891226|458760735|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
127491074|NCT02891226|458760720|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
127491075|NCT02891226|458760721|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
127491076|NCT02891226|458760722|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
127491077|NCT02891226|458760723|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
127491078|NCT02891226|458760724|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
127491079|NCT02891226|458760725|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
127491080|NCT02891226|458760726|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
127491081|NCT02891226|458760727|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
127491082|NCT02891226|458760728|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
127491083|NCT02891226|458760729|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
127491084|NCT02891226|458760730|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
127491085|NCT02891226|458760731|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
127491086|NCT02891226|458760732|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
127491087|NCT02891226|458760733|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
127491088|NCT02891226|458760734|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
127491089|NCT02891226|458760735|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
127491090|NCT02891226|458760720|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
127491091|NCT02891226|458760721|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
127491092|NCT02891226|458760722|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
127491093|NCT02891226|458760723|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
127491094|NCT02891226|458760724|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
127491095|NCT02891226|458760725|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
127491096|NCT02891226|458760726|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
127491097|NCT02891226|458760727|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
127491098|NCT02891226|458760728|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
127491099|NCT02891226|458760729|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
127491100|NCT02891226|458760730|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
127491101|NCT02891226|458760731|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
127491102|NCT02891226|458760732|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
127491103|NCT02891226|458760733|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
127491104|NCT02891226|458760734|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
127491105|NCT02891226|458760735|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
127491106|NCT02891226|458760720|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
127491107|NCT02891226|458760721|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
127491108|NCT02891226|458760722|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
127491109|NCT02891226|458760723|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
127491110|NCT02891226|458760724|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
127491111|NCT02891226|458760725|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
127491112|NCT02891226|458760726|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
127491113|NCT02891226|458760727|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
127491114|NCT02891226|458760728|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
127491115|NCT02891226|458760729|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
127491116|NCT02891226|458760730|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
127491117|NCT02891226|458760731|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
127491118|NCT02891226|458760732|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
127491119|NCT02891226|458760733|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
127491120|NCT02891226|458760734|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
127491121|NCT02891226|458760735|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
127491122|NCT02891226|458760720|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
127491123|NCT02891226|458760721|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
127491124|NCT02891226|458760722|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
127491125|NCT02891226|458760723|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
127491126|NCT02891226|458760724|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
127491127|NCT02891226|458760725|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
127491128|NCT02891226|458760726|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
127491129|NCT02891226|458760727|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
127491130|NCT02891226|458760728|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
127491131|NCT02891226|458760729|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
127491132|NCT02891226|458760730|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
127491133|NCT02891226|458760731|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
127491134|NCT02891226|458760732|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
127491135|NCT02891226|458760733|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
127491136|NCT02891226|458760734|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
127491137|NCT02891226|458760735|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
127491138|NCT02891226|458760720|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
127491139|NCT02891226|458760721|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
127491140|NCT02891226|458760722|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
127491141|NCT02891226|458760723|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
127491142|NCT02891226|458760724|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
127491143|NCT02891226|458760725|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
127491144|NCT02891226|458760726|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
127491145|NCT02891226|458760727|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
127491146|NCT02891226|458760728|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
127491147|NCT02891226|458760729|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
127491148|NCT02891226|458760730|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
127491149|NCT02891226|458760731|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
127491150|NCT02891226|458760732|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
127491151|NCT02891226|458760733|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
127491152|NCT02891226|458760734|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
127491153|NCT02891226|458760735|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
127491154|NCT02891226|458760720|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
127491155|NCT02891226|458760721|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
127491156|NCT02891226|458760722|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
127491157|NCT02891226|458760723|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
127491158|NCT02891226|458760724|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
127491159|NCT02891226|458760725|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
127491160|NCT02891226|458760726|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
127491161|NCT02891226|458760727|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
127491162|NCT02891226|458760728|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
127491163|NCT02891226|458760729|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
127491164|NCT02891226|458760730|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
127491165|NCT02891226|458760731|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
127491166|NCT02891226|458760732|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
127491167|NCT02891226|458760733|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
127491168|NCT02891226|458760734|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
127491169|NCT02891226|458760735|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
127491170|NCT02891226|458760720|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
127491171|NCT02891226|458760721|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
127491172|NCT02891226|458760722|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
127491173|NCT02891226|458760723|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
127491174|NCT02891226|458760724|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
127491175|NCT02891226|458760725|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
127491176|NCT02891226|458760726|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
127491177|NCT02891226|458760727|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
127491178|NCT02891226|458760728|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
127491179|NCT02891226|458760729|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
127491180|NCT02891226|458760730|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
127491181|NCT02891226|458760731|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
127491182|NCT02891226|458760732|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
127491183|NCT02891226|458760733|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
127491184|NCT02891226|458760734|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
127491185|NCT02891226|458760735|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
127491186|NCT02891226|458760720|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
127491187|NCT02891226|458760721|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
127491188|NCT02891226|458760722|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
127491189|NCT02891226|458760723|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
127491190|NCT02891226|458760724|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
127976809|NCT01901653|460536235|FG007|Overall Study|Lost to Follow-up|1|||
127491191|NCT02891226|458760725|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
127976810|NCT01901653|460536236|FG008|Overall Study|Lost to Follow-up|0|||
127491192|NCT02891226|458760726|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
127491193|NCT02891226|458760727|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
127491194|NCT02891226|458760728|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
127491195|NCT02891226|458760729|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
127491196|NCT02891226|458760730|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
127491197|NCT02891226|458760731|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
127491198|NCT02891226|458760732|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
127491199|NCT02891226|458760733|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
127491200|NCT02891226|458760734|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
127491201|NCT02891226|458760735|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
127491202|NCT02891226|458760720|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
127491203|NCT02891226|458760721|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
127491204|NCT02891226|458760722|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
127491205|NCT02891226|458760723|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
127491206|NCT02891226|458760724|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
127491207|NCT02891226|458760725|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
127491208|NCT02891226|458760726|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
127491209|NCT02891226|458760727|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
127491210|NCT02891226|458760728|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
127491211|NCT02891226|458760729|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
127491212|NCT02891226|458760730|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
127491213|NCT02891226|458760731|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
127491214|NCT02891226|458760732|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
127491215|NCT02891226|458760733|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
127491216|NCT02891226|458760734|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
127491217|NCT02891226|458760735|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
127491218|NCT02891226|458760720|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
127491219|NCT02891226|458760721|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
127491220|NCT02891226|458760722|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
127491221|NCT02891226|458760723|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
127491222|NCT02891226|458760724|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
127491223|NCT02891226|458760725|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
127491224|NCT02891226|458760726|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
127491225|NCT02891226|458760727|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
127491226|NCT02891226|458760728|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
127491227|NCT02891226|458760729|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
127491228|NCT02891226|458760730|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
127491229|NCT02891226|458760731|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
127491230|NCT02891226|458760732|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
127491231|NCT02891226|458760733|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
127491232|NCT02891226|458760734|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
127491233|NCT02891226|458760735|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
127491234|NCT02891226|458760720|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
127491235|NCT02891226|458760721|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
127491236|NCT02891226|458760722|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
127491237|NCT02891226|458760723|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
127491238|NCT02891226|458760724|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
127491239|NCT02891226|458760725|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
127491240|NCT02891226|458760726|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
127491241|NCT02891226|458760727|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
127491242|NCT02891226|458760728|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
127491243|NCT02891226|458760729|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
127491244|NCT02891226|458760730|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
127491245|NCT02891226|458760731|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
127491246|NCT02891226|458760732|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
127491247|NCT02891226|458760733|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
127491248|NCT02891226|458760734|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
127491249|NCT02891226|458760735|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
127491250|NCT02891226|458760720|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
127491251|NCT02891226|458760721|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
127976811|NCT01901653|460536237|FG009|Overall Study|Lost to Follow-up|0|||
127491252|NCT02891226|458760722|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
127976812|NCT01901653|460536238|FG010|Overall Study|Lost to Follow-up|0|||
127976813|NCT01901653|460536239|FG011|Overall Study|Lost to Follow-up|0|||
127976814|NCT01901653|460536240|FG012|Overall Study|Lost to Follow-up|0|||
127976815|NCT01901653|460536228|FG000|Overall Study|Withdrawal by Subject|0|||
127976816|NCT01901653|460536229|FG001|Overall Study|Withdrawal by Subject|0|||
127976817|NCT01901653|460536230|FG002|Overall Study|Withdrawal by Subject|0|||
127976818|NCT01901653|460536231|FG003|Overall Study|Withdrawal by Subject|0|||
127976819|NCT01901653|460536232|FG004|Overall Study|Withdrawal by Subject|0|||
127976820|NCT01901653|460536233|FG005|Overall Study|Withdrawal by Subject|0|||
127491253|NCT02891226|458760723|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
127491254|NCT02891226|458760724|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
127491255|NCT02891226|458760725|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
127491256|NCT02891226|458760726|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
127491257|NCT02891226|458760727|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
127491258|NCT02891226|458760728|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
127491259|NCT02891226|458760729|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
127491260|NCT02891226|458760730|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
127491261|NCT02891226|458760731|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
127491262|NCT02891226|458760732|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
127491263|NCT02891226|458760733|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
127491264|NCT02891226|458760734|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
127491265|NCT02891226|458760735|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
127491266|NCT02891226|458760720|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
127491267|NCT02891226|458760721|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
127491268|NCT02891226|458760722|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
127491269|NCT02891226|458760723|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
127491270|NCT02891226|458760724|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
127491271|NCT02891226|458760725|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
127491272|NCT02891226|458760726|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
127491273|NCT02891226|458760727|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
127491274|NCT02891226|458760728|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
127491275|NCT02891226|458760729|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
127491276|NCT02891226|458760730|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
127491277|NCT02891226|458760731|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
127491278|NCT02891226|458760732|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
127491279|NCT02891226|458760733|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
127491280|NCT02891226|458760734|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
127491281|NCT02891226|458760735|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
127491282|NCT02891226|458760720|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
127491283|NCT02891226|458760721|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
127491284|NCT02891226|458760722|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
127491285|NCT02891226|458760723|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
127491286|NCT02891226|458760724|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
127491287|NCT02891226|458760725|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
127491288|NCT02891226|458760726|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
127491289|NCT02891226|458760727|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
127491290|NCT02891226|458760728|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
127491291|NCT02891226|458760729|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
127491292|NCT02891226|458760730|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
127491293|NCT02891226|458760731|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
127491294|NCT02891226|458760732|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
127491295|NCT02891226|458760733|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
127491296|NCT02891226|458760734|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
127491297|NCT02891226|458760735|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
127491298|NCT02891226|458760720|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
127491299|NCT02891226|458760721|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
127491300|NCT02891226|458760722|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
127491301|NCT02891226|458760723|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
127491302|NCT02891226|458760724|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
127491303|NCT02891226|458760725|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
127491304|NCT02891226|458760726|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
127491305|NCT02891226|458760727|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
127491306|NCT02891226|458760728|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
127491307|NCT02891226|458760729|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
127491308|NCT02891226|458760730|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
127491309|NCT02891226|458760731|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
127491310|NCT02891226|458760732|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
127491311|NCT02891226|458760733|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
127491312|NCT02891226|458760734|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
127491313|NCT02891226|458760735|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
127491314|NCT02891226|458760720|FG000|Follow-up Period|Withdrawal by Subject|0|||
127491315|NCT02891226|458760721|FG001|Follow-up Period|Withdrawal by Subject|0|||
127491316|NCT02891226|458760722|FG002|Follow-up Period|Withdrawal by Subject|0|||
127491317|NCT02891226|458760723|FG003|Follow-up Period|Withdrawal by Subject|0|||
127491318|NCT02891226|458760724|FG004|Follow-up Period|Withdrawal by Subject|0|||
127491319|NCT02891226|458760725|FG005|Follow-up Period|Withdrawal by Subject|0|||
127491320|NCT02891226|458760726|FG006|Follow-up Period|Withdrawal by Subject|0|||
127491321|NCT02891226|458760727|FG007|Follow-up Period|Withdrawal by Subject|0|||
127491322|NCT02891226|458760728|FG008|Follow-up Period|Withdrawal by Subject|0|||
127491323|NCT02891226|458760729|FG009|Follow-up Period|Withdrawal by Subject|0|||
127491324|NCT02891226|458760730|FG010|Follow-up Period|Withdrawal by Subject|0|||
127491325|NCT02891226|458760731|FG011|Follow-up Period|Withdrawal by Subject|1|||
127491326|NCT02891226|458760732|FG012|Follow-up Period|Withdrawal by Subject|0|||
127491327|NCT02891226|458760733|FG013|Follow-up Period|Withdrawal by Subject|0|||
127491328|NCT02891226|458760734|FG014|Follow-up Period|Withdrawal by Subject|1|||
127491329|NCT02891226|458760735|FG015|Follow-up Period|Withdrawal by Subject|1|||
127491330|NCT01928433|458760736|FG000|Overall Study|Adverse Event|5|||
127491331|NCT01928433|458760737|FG001|Overall Study|Adverse Event|2|||
127491332|NCT01928433|458760738|FG002|Overall Study|Adverse Event|5|||
127491333|NCT01928433|458760736|FG000|Overall Study|Protocol Violation|0|||
127491334|NCT01928433|458760737|FG001|Overall Study|Protocol Violation|0|||
127491335|NCT01928433|458760738|FG002|Overall Study|Protocol Violation|2|||
127491336|NCT01928433|458760736|FG000|Overall Study|Lack of Efficacy|5|||
127491337|NCT01928433|458760737|FG001|Overall Study|Lack of Efficacy|4|||
127491338|NCT01928433|458760738|FG002|Overall Study|Lack of Efficacy|4|||
127491339|NCT01928433|458760736|FG000|Overall Study|Withdrawal by Subject|0|||
127491340|NCT01928433|458760737|FG001|Overall Study|Withdrawal by Subject|4|||
127491341|NCT01928433|458760738|FG002|Overall Study|Withdrawal by Subject|0|||
127491342|NCT01928433|458760736|FG000|Overall Study|Negative screening urine culture|7|||
127491343|NCT01928433|458760737|FG001|Overall Study|Negative screening urine culture|6|||
127491344|NCT01928433|458760738|FG002|Overall Study|Negative screening urine culture|10|||
127491345|NCT01928433|458760736|FG000|Overall Study|Lost to Follow-up|0|||
127491346|NCT01928433|458760737|FG001|Overall Study|Lost to Follow-up|2|||
127491347|NCT01928433|458760738|FG002|Overall Study|Lost to Follow-up|3|||
127491348|NCT01928433|458760736|FG000|Overall Study|Other reasons|3|||
127491349|NCT01928433|458760737|FG001|Overall Study|Other reasons|3|||
127491350|NCT01928433|458760738|FG002|Overall Study|Other reasons|4|||
127491351|NCT00145626|458760739|FG000|Overall Study|Did not have NK infusions|2|||
127491352|NCT00145626|458760739|FG000|Overall Study|Turned 2 years old before treatment|1|||
127491353|NCT00145626|458760739|FG000|Overall Study|Death|1|||
127491354|NCT00145626|458760739|FG000|Overall Study|Withdrawal by Subject|1|||
127491355|NCT00436436|458760740|FG000|Overall Study|Progression|4|||
127491356|NCT00436436|458760740|FG000|Overall Study|Adverse Event|2|||
127491357|NCT00436436|458760740|FG000|Overall Study|Death|6|||
127491358|NCT03654274|458760745|FG000|Overall Study|Adverse Event|19|||
127491359|NCT03654274|458760746|FG001|Overall Study|Adverse Event|23|||
127491360|NCT03654274|458760747|FG002|Overall Study|Adverse Event|24|||
127491361|NCT03654274|458760745|FG000|Overall Study|Protocol Deviation|0|||
127491362|NCT03654274|458760746|FG001|Overall Study|Protocol Deviation|2|||
127491363|NCT03654274|458760747|FG002|Overall Study|Protocol Deviation|0|||
127491364|NCT03654274|458760745|FG000|Overall Study|Lost to Follow-up|8|||
127491365|NCT03654274|458760746|FG001|Overall Study|Lost to Follow-up|6|||
127491366|NCT03654274|458760747|FG002|Overall Study|Lost to Follow-up|5|||
127491367|NCT03654274|458760745|FG000|Overall Study|Withdrawal by Subject|46|||
127491368|NCT03654274|458760746|FG001|Overall Study|Withdrawal by Subject|25|||
127491369|NCT03654274|458760747|FG002|Overall Study|Withdrawal by Subject|33|||
127491370|NCT03654274|458760745|FG000|Overall Study|Lack of Efficacy|4|||
127491371|NCT03654274|458760746|FG001|Overall Study|Lack of Efficacy|5|||
127491372|NCT03654274|458760747|FG002|Overall Study|Lack of Efficacy|7|||
127491373|NCT03654274|458760745|FG000|Overall Study|Pregnancy|2|||
127491374|NCT03654274|458760746|FG001|Overall Study|Pregnancy|2|||
127491375|NCT03654274|458760747|FG002|Overall Study|Pregnancy|1|||
127491376|NCT03654274|458760745|FG000|Overall Study|Other|27|||
127491377|NCT03654274|458760746|FG001|Overall Study|Other|29|||
127491378|NCT03654274|458760747|FG002|Overall Study|Other|32|||
127491379|NCT03654274|458760745|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
127491380|NCT03654274|458760746|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
127491381|NCT03654274|458760747|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
127491382|NCT01102491|458760750|FG000|Overall Study|Protocol Violation|11|||
127491383|NCT01102491|458760751|FG001|Overall Study|Protocol Violation|12|||
127491384|NCT05005273|458760752|FG000|Overall Study|Study Terminated|1|||
127491385|NCT05005273|458760753|FG001|Overall Study|Study Terminated|0|||
127491386|NCT02151786|458760754|FG000|Overall Study|Unavailability of Case Report Form|26|||
127869737|NCT02557308|460139640|FG006|Overall Study|Study Close|123|||
127976821|NCT01901653|460536234|FG006|Overall Study|Withdrawal by Subject|1|||
127491387|NCT02151786|458760754|FG000|Overall Study|Outside the Contract Period|1|||
127491388|NCT02151786|458760754|FG000|Overall Study|Randomized, not Treated|1|||
127491389|NCT02151786|458760754|FG000|Overall Study|Unavailability of Information|8|||
127491390|NCT03533660|458760755|FG000|Overall Study|Withdrawal by Subject|2|||
127491391|NCT03533660|458760756|FG001|Overall Study|Withdrawal by Subject|2|||
127491392|NCT03533660|458760755|FG000|Overall Study|Death|2|||
127491393|NCT03533660|458760756|FG001|Overall Study|Death|4|||
127491394|NCT03533660|458760755|FG000|Overall Study|Adverse Event|0|||
127491395|NCT03533660|458760756|FG001|Overall Study|Adverse Event|2|||
127491396|NCT00996658|458760757|FG000|Overall Study|Adverse Event|2|||
127491397|NCT00996658|458760758|FG001|Overall Study|Adverse Event|5|||
127491398|NCT00996658|458760757|FG000|Overall Study|Protocol Violation|0|||
127491399|NCT00996658|458760758|FG001|Overall Study|Protocol Violation|1|||
127491400|NCT00996658|458760757|FG000|Overall Study|Lost to Follow-up|2|||
127491401|NCT00996658|458760758|FG001|Overall Study|Lost to Follow-up|5|||
127491402|NCT00996658|458760757|FG000|Overall Study|Non-compliance issues|3|||
127491403|NCT00996658|458760758|FG001|Overall Study|Non-compliance issues|3|||
127491404|NCT00996658|458760757|FG000|Overall Study|Other|9|||
127491405|NCT00996658|458760758|FG001|Overall Study|Other|7|||
127491406|NCT02685826|458760767|FG000|Overall Study|Adverse Event|2|||
127491407|NCT02685826|458760768|FG001|Overall Study|Adverse Event|0|||
127491408|NCT02685826|458760769|FG002|Overall Study|Adverse Event|1|||
127491409|NCT02685826|458760767|FG000|Overall Study|Progressive Disease|2|||
127491410|NCT02685826|458760768|FG001|Overall Study|Progressive Disease|1|||
127491411|NCT02685826|458760769|FG002|Overall Study|Progressive Disease|0|||
127491412|NCT02685826|458760767|FG000|Overall Study|Withdrawal by Subject|2|||
127491413|NCT02685826|458760768|FG001|Overall Study|Withdrawal by Subject|0|||
127491414|NCT02685826|458760769|FG002|Overall Study|Withdrawal by Subject|0|||
127491415|NCT02685826|458760767|FG000|Overall Study|Full Clinical Hold by FDA|19|||
127491416|NCT02685826|458760768|FG001|Overall Study|Full Clinical Hold by FDA|9|||
127491417|NCT02685826|458760769|FG002|Overall Study|Full Clinical Hold by FDA|20|||
127491418|NCT03154476|458760770|FG000|Overall Study|Lost to Follow-up|4|||
127491419|NCT03154476|458760771|FG001|Overall Study|Lost to Follow-up|4|||
127491420|NCT00200967|458760772|FG000|First Treatment Period|Withdrawal by Subject|5|||
127491421|NCT00200967|458760773|FG001|First Treatment Period|Withdrawal by Subject|1|||
127491422|NCT00200967|458760772|FG000|First Treatment Period|Pregnancy|1|||
127491423|NCT00200967|458760773|FG001|First Treatment Period|Pregnancy|0|||
127491424|NCT00200967|458760772|FG000|Wash-out Period|Lost to Follow-up|0|||
127491425|NCT00200967|458760773|FG001|Wash-out Period|Lost to Follow-up|1|||
127491426|NCT00200967|458760772|FG000|Second Treatment Period|Withdrawal by Subject|1|||
127491427|NCT00200967|458760773|FG001|Second Treatment Period|Withdrawal by Subject|2|||
127491428|NCT00200967|458760772|FG000|Run-out Period|Lost to Follow-up|1|||
127491429|NCT00200967|458760773|FG001|Run-out Period|Lost to Follow-up|0|||
127491430|NCT01444430|458760776|FG000|Overall Study|Withdrawal by Subject|53|||
127491431|NCT01444430|458760777|FG001|Overall Study|Withdrawal by Subject|72|||
127491432|NCT01444430|458760776|FG000|Overall Study|Death|6|||
127491433|NCT01444430|458760777|FG001|Overall Study|Death|8|||
127491434|NCT01444430|458760776|FG000|Overall Study|Lost to Follow-up|2|||
127491435|NCT01444430|458760777|FG001|Overall Study|Lost to Follow-up|0|||
127491436|NCT01444430|458760776|FG000|Overall Study|CRF termination module not completed.|0|||
127491437|NCT01444430|458760777|FG001|Overall Study|CRF termination module not completed.|1|||
127491438|NCT02297815|458761872|FG000|Overall Study|Lost to Follow-up|236|||
127491439|NCT02297815|458761873|FG001|Overall Study|Lost to Follow-up|140|||
127491440|NCT00662831|458761874|FG000|Overall Study|Death|4|||
127491441|NCT00662831|458761875|FG001|Overall Study|Death|1|||
127491442|NCT00662831|458761874|FG000|Overall Study|Lack of Efficacy|6|||
127491443|NCT00662831|458761875|FG001|Overall Study|Lack of Efficacy|6|||
127491444|NCT00662831|458761874|FG000|Overall Study|Lost to Follow-up|1|||
127491445|NCT00662831|458761875|FG001|Overall Study|Lost to Follow-up|0|||
127491446|NCT00662831|458761874|FG000|Overall Study|Withdrawal by Subject|2|||
127491447|NCT00662831|458761875|FG001|Overall Study|Withdrawal by Subject|1|||
127491448|NCT00662831|458761874|FG000|Overall Study|Other|62|||
127491449|NCT00662831|458761875|FG001|Overall Study|Other|31|||
127491450|NCT00662831|458761874|FG000|Overall Study|Protocol Violation|8|||
127491451|NCT00662831|458761875|FG001|Overall Study|Protocol Violation|4|||
127491452|NCT00662831|458761874|FG000|Overall Study|Adverse Event|23|||
127491453|NCT00662831|458761875|FG001|Overall Study|Adverse Event|16|||
127491454|NCT04245449|458761877|FG000|Overall Study|COVID shutdown|7|||
127491455|NCT02197572|458761882|FG000|Overall Study|Progressive Disease|28|||
127491456|NCT02197572|458761882|FG000|Overall Study|Withdrawal by Subject|9|||
127491457|NCT02197572|458761882|FG000|Overall Study|Adverse Event|3|||
127491458|NCT02197572|458761882|FG000|Overall Study|Reason Not Specified|4|||
127491459|NCT01147393|458761883|FG000|Dose Level 1|Dose limiting Toxicity|2|||
127491460|NCT01147393|458761883|FG000|Dose Level -1|Dose Limited Toxicity|1|||
127491461|NCT01408277|458761887|FG000|Overall Study|Adverse Event|3|||
127491462|NCT01408277|458761888|FG001|Overall Study|Adverse Event|4|||
127491463|NCT01408277|458761887|FG000|Overall Study|Lost to Follow-up|1|||
127491464|NCT01408277|458761888|FG001|Overall Study|Lost to Follow-up|0|||
127491465|NCT01408277|458761887|FG000|Overall Study|Withdrawal by Subject|2|||
127491466|NCT01408277|458761888|FG001|Overall Study|Withdrawal by Subject|0|||
127491467|NCT01408277|458761887|FG000|Overall Study|Protocol Violation|2|||
127491468|NCT01408277|458761888|FG001|Overall Study|Protocol Violation|0|||
127491469|NCT04263766|458761891|FG000|Overall Study|Withdrawal by Subject|6|||
127491470|NCT04263766|458761892|FG001|Overall Study|Withdrawal by Subject|4|||
127491471|NCT04263766|458761891|FG000|Overall Study|Lack of Efficacy|1|||
127491472|NCT04263766|458761892|FG001|Overall Study|Lack of Efficacy|3|||
127491473|NCT00573391|458761894|FG000|Overall Study|study stopped|2|||
127491474|NCT00573391|458761895|FG001|Overall Study|study stopped|2|||
127491475|NCT00573391|458761894|FG000|Overall Study|Death|1|||
127491476|NCT00573391|458761895|FG001|Overall Study|Death|0|||
127491477|NCT03369665|458761896|FG000|Overall Study|Adverse Event|3|||
127491478|NCT03369665|458761896|FG000|Overall Study|Lost to Follow-up|7|||
127491479|NCT03369665|458761896|FG000|Overall Study|Withdrawal by Subject|15|||
127491480|NCT03369665|458761896|FG000|Overall Study|Progression Disease|2|||
127491481|NCT03369665|458761896|FG000|Overall Study|Not classified|3|||
127491482|NCT02553928|458761897|FG000|Overall Study|Adverse Event|2|||
127491483|NCT02553928|458761898|FG001|Overall Study|Adverse Event|1|||
127491484|NCT02553928|458761897|FG000|Overall Study|Lost to Follow-up|0|||
127491485|NCT02553928|458761898|FG001|Overall Study|Lost to Follow-up|1|||
127491486|NCT02553928|458761897|FG000|Overall Study|Administrative reason(s)|0|||
127491487|NCT02553928|458761898|FG001|Overall Study|Administrative reason(s)|1|||
127491488|NCT03230318|458761899|FG000|Overall Study|Radiographic disease progression|72|||
127491489|NCT03230318|458761900|FG001|Overall Study|Radiographic disease progression|19|||
127491490|NCT03230318|458761899|FG000|Overall Study|Clinical progression|17|||
127491491|NCT03230318|458761900|FG001|Overall Study|Clinical progression|7|||
127491492|NCT03230318|458761899|FG000|Overall Study|Adverse Event|5|||
127491493|NCT03230318|458761900|FG001|Overall Study|Adverse Event|3|||
127491494|NCT03230318|458761899|FG000|Overall Study|Physician Decision|2|||
127491495|NCT03230318|458761900|FG001|Overall Study|Physician Decision|3|||
127491496|NCT03230318|458761899|FG000|Overall Study|Death|3|||
127491497|NCT03230318|458761900|FG001|Overall Study|Death|2|||
127491498|NCT03230318|458761899|FG000|Overall Study|Lost to Follow-up|1|||
127491499|NCT03230318|458761900|FG001|Overall Study|Lost to Follow-up|0|||
127491500|NCT03230318|458761899|FG000|Overall Study|Withdrawal by Subject|1|||
127491501|NCT03230318|458761900|FG001|Overall Study|Withdrawal by Subject|3|||
127491502|NCT03230318|458761899|FG000|Overall Study|Other|3|||
127491503|NCT03230318|458761900|FG001|Overall Study|Other|7|||
127491504|NCT02688192|458761903|FG000|Overall Study|Lost to Follow-up|11|||
127491505|NCT02688192|458761904|FG001|Overall Study|Lost to Follow-up|5|||
127491506|NCT02688192|458761903|FG000|Overall Study|Physician Decision|1|||
127491507|NCT02688192|458761904|FG001|Overall Study|Physician Decision|0|||
127491508|NCT00075764|458761905|FG000|Overall Study|Adverse Event|5|||
127491509|NCT00075764|458761906|FG001|Overall Study|Adverse Event|12|||
127491510|NCT00075764|458761905|FG000|Overall Study|Death|4|||
127491511|NCT00075764|458761906|FG001|Overall Study|Death|8|||
127491512|NCT00075764|458761905|FG000|Overall Study|Withdrawal by Subject|28|||
127491513|NCT00075764|458761906|FG001|Overall Study|Withdrawal by Subject|18|||
127491514|NCT00075764|458761905|FG000|Overall Study|Progression|269|||
127491515|NCT00075764|458761906|FG001|Overall Study|Progression|274|||
127491516|NCT00075764|458761905|FG000|Overall Study|Still on treatment|8|||
127491517|NCT00075764|458761906|FG001|Overall Study|Still on treatment|15|||
127491518|NCT00075764|458761905|FG000|Overall Study|Delinquent|4|||
127491519|NCT00075764|458761906|FG001|Overall Study|Delinquent|2|||
127491520|NCT00075764|458761905|FG000|Overall Study|Not protocol specified|27|||
127491521|NCT00075764|458761906|FG001|Overall Study|Not protocol specified|19|||
127491522|NCT00075764|458761905|FG000|Overall Study|Under review|0|||
127491523|NCT00075764|458761906|FG001|Overall Study|Under review|1|||
127491524|NCT02010593|458761907|FG000|Overall Study|Lost to Follow-up|1|||
127491525|NCT02010593|458761908|FG001|Overall Study|Lost to Follow-up|0|||
127491526|NCT02010593|458761907|FG000|Overall Study|Physician Decision|1|||
127491527|NCT02010593|458761908|FG001|Overall Study|Physician Decision|0|||
127491528|NCT02010593|458761907|FG000|Overall Study|Unable to adhere to visit schedule|0|||
127491529|NCT02010593|458761908|FG001|Overall Study|Unable to adhere to visit schedule|2|||
127491530|NCT01773967|458761909|FG000|Overall Study|Lost to Follow-up|15|||
127491531|NCT01773967|458761910|FG001|Overall Study|Lost to Follow-up|13|||
127491532|NCT01135459|458761911|FG000|Overall Study|Adverse Event|8|||
127491533|NCT01135459|458761912|FG001|Overall Study|Adverse Event|10|||
127491534|NCT01135459|458761911|FG000|Overall Study|Lack of Efficacy|3|||
127491535|NCT01135459|458761912|FG001|Overall Study|Lack of Efficacy|1|||
127491536|NCT01135459|458761911|FG000|Overall Study|Withdrawal by Subject|2|||
127491537|NCT01135459|458761912|FG001|Overall Study|Withdrawal by Subject|3|||
127491538|NCT01135459|458761911|FG000|Overall Study|Protocol Violation|5|||
127491539|NCT01135459|458761912|FG001|Overall Study|Protocol Violation|3|||
127491540|NCT01135459|458761911|FG000|Overall Study|Lost to Follow-up|2|||
127491541|NCT01135459|458761912|FG001|Overall Study|Lost to Follow-up|1|||
127491542|NCT01135459|458761911|FG000|Overall Study|Non-compliance to study procedures|0|||
127491543|NCT01135459|458761912|FG001|Overall Study|Non-compliance to study procedures|1|||
127491544|NCT01135459|458761911|FG000|Overall Study|Other than specified|1|||
127491545|NCT01135459|458761912|FG001|Overall Study|Other than specified|1|||
127491546|NCT01194219|458761913|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
127491547|NCT01194219|458761914|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
127491548|NCT01194219|458761915|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
127491549|NCT01194219|458761916|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
127491550|NCT01194219|458761917|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
127491551|NCT01194219|458761918|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
127491552|NCT01194219|458761919|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
127491553|NCT01194219|458761920|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
127491554|NCT01194219|458761921|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
127491555|NCT01194219|458761922|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
127491556|NCT01194219|458761913|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
127491557|NCT01194219|458761914|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
127491558|NCT01194219|458761915|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
127491559|NCT01194219|458761916|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
127491560|NCT01194219|458761917|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
127491561|NCT01194219|458761918|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
127491562|NCT01194219|458761919|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
127491563|NCT01194219|458761920|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
127491564|NCT01194219|458761921|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
127491565|NCT01194219|458761922|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
127491566|NCT01194219|458761913|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
127491567|NCT01194219|458761914|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
127491568|NCT01194219|458761915|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
127491569|NCT01194219|458761916|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
127491570|NCT01194219|458761917|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
127491571|NCT01194219|458761918|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
127491572|NCT01194219|458761919|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
127491573|NCT01194219|458761920|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
127491574|NCT01194219|458761921|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
127491575|NCT01194219|458761922|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
127491576|NCT01194219|458761913|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
127491577|NCT01194219|458761914|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
127491578|NCT01194219|458761915|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
127491579|NCT01194219|458761916|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
127491580|NCT01194219|458761917|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
127491581|NCT01194219|458761918|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
127491582|NCT01194219|458761919|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
127491583|NCT01194219|458761920|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
127491584|NCT01194219|458761921|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
127491585|NCT01194219|458761922|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
127491586|NCT01194219|458761913|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
127491587|NCT01194219|458761914|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
127491588|NCT01194219|458761915|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
127491589|NCT01194219|458761916|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
127491590|NCT01194219|458761917|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
127491591|NCT01194219|458761918|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
127491592|NCT01194219|458761919|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
127491593|NCT01194219|458761920|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
127491594|NCT01194219|458761921|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
127491595|NCT01194219|458761922|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
127491596|NCT01194219|458761913|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
127491597|NCT01194219|458761914|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
127491598|NCT01194219|458761915|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
127491599|NCT01194219|458761916|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
127491600|NCT01194219|458761917|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
127491601|NCT01194219|458761918|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
127491602|NCT01194219|458761919|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
127491603|NCT01194219|458761920|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
127491604|NCT01194219|458761921|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
127491605|NCT01194219|458761922|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
127491606|NCT01194219|458761913|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
127491607|NCT01194219|458761914|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
127491608|NCT01194219|458761915|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
127491609|NCT01194219|458761916|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
127491610|NCT01194219|458761917|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
127491611|NCT01194219|458761918|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
127491612|NCT01194219|458761919|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
127491613|NCT01194219|458761920|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
127491614|NCT01194219|458761921|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
127491615|NCT01194219|458761922|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
127491616|NCT01194219|458761913|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
127491617|NCT01194219|458761914|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
127491618|NCT01194219|458761915|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
127491619|NCT01194219|458761916|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
127491620|NCT01194219|458761917|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
127491621|NCT01194219|458761918|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
127491622|NCT01194219|458761919|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
127491623|NCT01194219|458761920|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
127491624|NCT01194219|458761921|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
127491625|NCT01194219|458761922|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
127491626|NCT01194219|458761913|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
127491627|NCT01194219|458761914|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
127491628|NCT01194219|458761915|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
127491629|NCT01194219|458761916|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
127491630|NCT01194219|458761917|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
127491631|NCT01194219|458761918|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
127491632|NCT01194219|458761919|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
127491633|NCT01194219|458761920|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
127491634|NCT01194219|458761921|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
127491635|NCT01194219|458761922|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
127491636|NCT01194219|458761913|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
127491637|NCT01194219|458761914|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
127976822|NCT01901653|460536235|FG007|Overall Study|Withdrawal by Subject|0|||
127976823|NCT01901653|460536236|FG008|Overall Study|Withdrawal by Subject|0|||
127976824|NCT01901653|460536237|FG009|Overall Study|Withdrawal by Subject|0|||
127976825|NCT01901653|460536238|FG010|Overall Study|Withdrawal by Subject|0|||
127976826|NCT01901653|460536239|FG011|Overall Study|Withdrawal by Subject|0|||
127976827|NCT01901653|460536240|FG012|Overall Study|Withdrawal by Subject|0|||
127976828|NCT01901653|460536228|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
127976829|NCT01901653|460536229|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
127976830|NCT01901653|460536230|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
127976831|NCT01901653|460536231|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
127976832|NCT01901653|460536232|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
127976833|NCT01901653|460536233|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
127976834|NCT01901653|460536234|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
127976835|NCT01901653|460536235|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
127976836|NCT01901653|460536236|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
127976837|NCT01901653|460536237|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
127976838|NCT01901653|460536238|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
127976839|NCT01901653|460536239|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
127976840|NCT01901653|460536240|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
127976841|NCT02091986|460536241|FG000|Overall Study|7 rand in error 1 patient decision|2|||
127976842|NCT02091986|460536242|FG001|Overall Study|7 rand in error 1 patient decision|3|||
127976843|NCT02091986|460536243|FG002|Overall Study|7 rand in error 1 patient decision|3|||
127976844|NCT02091986|460536241|FG000|Overall Study|Lost to Follow-up|1|||
127976845|NCT02091986|460536242|FG001|Overall Study|Lost to Follow-up|0|||
127976846|NCT02091986|460536243|FG002|Overall Study|Lost to Follow-up|0|||
127976847|NCT02091986|460536241|FG000|Overall Study|Withdrawal by Subject|4|||
127976848|NCT02091986|460536242|FG001|Overall Study|Withdrawal by Subject|8|||
127976849|NCT02091986|460536243|FG002|Overall Study|Withdrawal by Subject|3|||
127976850|NCT02091986|460536241|FG000|Overall Study|Adverse Event|0|||
127976851|NCT02091986|460536242|FG001|Overall Study|Adverse Event|0|||
127976852|NCT02091986|460536243|FG002|Overall Study|Adverse Event|2|||
127976853|NCT02537431|460536247|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
127976854|NCT01738503|460536248|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
127976855|NCT01738503|460536249|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
127976856|NCT01738503|460536250|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
127976857|NCT01738503|460536251|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
127976858|NCT01738503|460536252|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
127976859|NCT01738503|460536253|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
127491638|NCT01194219|458761915|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
127491639|NCT01194219|458761916|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
127976860|NCT01738503|460536254|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
127976861|NCT01738503|460536248|FG000|Treatment Period|Adverse Event|0|||
127976862|NCT01738503|460536249|FG001|Treatment Period|Adverse Event|1|||
127976863|NCT01738503|460536250|FG002|Treatment Period|Adverse Event|0|||
127976864|NCT01738503|460536251|FG003|Treatment Period|Adverse Event|1|||
127491640|NCT01194219|458761917|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
127491641|NCT01194219|458761918|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
127491642|NCT01194219|458761919|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
127491643|NCT01194219|458761920|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
127491644|NCT01194219|458761921|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
127491645|NCT01194219|458761922|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
127491646|NCT01194219|458761913|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
127491647|NCT01194219|458761914|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
127491648|NCT01194219|458761915|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
127491649|NCT01194219|458761916|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
127491650|NCT01194219|458761917|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
127491651|NCT01194219|458761918|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
127491652|NCT01194219|458761919|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
127491653|NCT01194219|458761920|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
127491654|NCT01194219|458761921|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
127491655|NCT01194219|458761922|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
127491656|NCT01194219|458761913|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
127491657|NCT01194219|458761914|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
127491658|NCT01194219|458761915|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
127491659|NCT01194219|458761916|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
127491660|NCT01194219|458761917|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
127491661|NCT01194219|458761918|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
127491662|NCT01194219|458761919|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
127491663|NCT01194219|458761920|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
127491664|NCT01194219|458761921|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
127491665|NCT01194219|458761922|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
127491666|NCT01194219|458761913|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
127491667|NCT01194219|458761914|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
127491668|NCT01194219|458761915|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
127491669|NCT01194219|458761916|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
127491670|NCT01194219|458761917|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
127491671|NCT01194219|458761918|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
127491672|NCT01194219|458761919|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
127491673|NCT01194219|458761920|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
127491674|NCT01194219|458761921|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
127491675|NCT01194219|458761922|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
127491676|NCT01194219|458761913|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
127491677|NCT01194219|458761914|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
127491678|NCT01194219|458761915|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
127491679|NCT01194219|458761916|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
127491680|NCT01194219|458761917|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
127491681|NCT01194219|458761918|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
127491682|NCT01194219|458761919|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
127491683|NCT01194219|458761920|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
127491684|NCT01194219|458761921|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
127491685|NCT01194219|458761922|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
127491686|NCT01194219|458761913|FG000|Maintenance Phase Weeks16-32|Other|0|||
127491687|NCT01194219|458761914|FG001|Maintenance Phase Weeks16-32|Other|0|||
127491688|NCT01194219|458761915|FG002|Maintenance Phase Weeks16-32|Other|2|||
127491689|NCT01194219|458761916|FG003|Maintenance Phase Weeks16-32|Other|1|||
127491690|NCT01194219|458761917|FG004|Maintenance Phase Weeks16-32|Other|0|||
127491691|NCT01194219|458761918|FG005|Maintenance Phase Weeks16-32|Other|0|||
127491692|NCT01194219|458761919|FG006|Maintenance Phase Weeks16-32|Other|0|||
127491693|NCT01194219|458761920|FG007|Maintenance Phase Weeks16-32|Other|0|||
127491694|NCT01194219|458761921|FG008|Maintenance Phase Weeks16-32|Other|0|||
127491695|NCT01194219|458761922|FG009|Maintenance Phase Weeks16-32|Other|0|||
127491696|NCT01194219|458761913|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
127491697|NCT01194219|458761914|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
127491698|NCT01194219|458761915|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
127491699|NCT01194219|458761916|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
127491700|NCT01194219|458761917|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
127491701|NCT01194219|458761918|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
127491702|NCT01194219|458761919|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
127491703|NCT01194219|458761920|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
127491704|NCT01194219|458761921|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
127491705|NCT01194219|458761922|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
127491706|NCT01194219|458761913|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
127491707|NCT01194219|458761914|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
127491708|NCT01194219|458761915|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
127491709|NCT01194219|458761916|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
127491710|NCT01194219|458761917|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
127491711|NCT01194219|458761918|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
127491712|NCT01194219|458761919|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
127491713|NCT01194219|458761920|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
127491714|NCT01194219|458761921|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
127491715|NCT01194219|458761922|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
127491716|NCT01194219|458761913|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
127491717|NCT01194219|458761914|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
127491718|NCT01194219|458761915|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
127491719|NCT01194219|458761916|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
127491720|NCT01194219|458761917|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
127491721|NCT01194219|458761918|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
127491722|NCT01194219|458761919|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
127491723|NCT01194219|458761920|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
127491724|NCT01194219|458761921|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
127491725|NCT01194219|458761922|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
127491726|NCT01194219|458761913|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
127491727|NCT01194219|458761914|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
127491728|NCT01194219|458761915|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
127491729|NCT01194219|458761916|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
127491730|NCT01194219|458761917|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
127491731|NCT01194219|458761918|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
127491732|NCT01194219|458761919|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
127491733|NCT01194219|458761920|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
127491734|NCT01194219|458761921|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
127491735|NCT01194219|458761922|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
127491736|NCT01194219|458761913|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
127491737|NCT01194219|458761914|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
127491738|NCT01194219|458761915|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
127491739|NCT01194219|458761916|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
127491740|NCT01194219|458761917|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
127491741|NCT01194219|458761918|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
127491742|NCT01194219|458761919|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
127491743|NCT01194219|458761920|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
127491744|NCT01194219|458761921|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
127491745|NCT01194219|458761922|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
127491746|NCT01194219|458761913|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
127491747|NCT01194219|458761914|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
127491748|NCT01194219|458761915|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
127491749|NCT01194219|458761916|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
127491750|NCT01194219|458761917|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
127491751|NCT01194219|458761918|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
127491752|NCT01194219|458761919|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
127491753|NCT01194219|458761920|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
127491754|NCT01194219|458761921|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
127491755|NCT01194219|458761922|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
127491756|NCT01194219|458761913|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
127491757|NCT01194219|458761914|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
127491758|NCT01194219|458761915|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
127491759|NCT01194219|458761916|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
127491760|NCT01194219|458761917|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
127491761|NCT01194219|458761918|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
127491762|NCT01194219|458761919|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
127491763|NCT01194219|458761920|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
127491764|NCT01194219|458761921|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
127491765|NCT01194219|458761922|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
127491766|NCT01194219|458761913|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
127491767|NCT01194219|458761914|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
127491768|NCT01194219|458761915|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
127491769|NCT01194219|458761916|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
127491770|NCT01194219|458761917|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
127491771|NCT01194219|458761918|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
127491772|NCT01194219|458761919|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
127491773|NCT01194219|458761920|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
127491774|NCT01194219|458761921|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
127491775|NCT01194219|458761922|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
127491776|NCT01194219|458761913|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
127491777|NCT01194219|458761914|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
127491778|NCT01194219|458761915|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
127491779|NCT01194219|458761916|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
127491780|NCT01194219|458761917|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
127491781|NCT01194219|458761918|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
127491782|NCT01194219|458761919|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
127491783|NCT01194219|458761920|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
127491784|NCT01194219|458761921|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
127491785|NCT01194219|458761922|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
127491786|NCT01194219|458761913|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
127491787|NCT01194219|458761914|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
127491788|NCT01194219|458761915|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
127491789|NCT01194219|458761916|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
127491790|NCT01194219|458761917|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
127491791|NCT01194219|458761918|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
127491792|NCT01194219|458761919|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
127491793|NCT01194219|458761920|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
127976865|NCT01738503|460536252|FG004|Treatment Period|Adverse Event|2|||
127976866|NCT01738503|460536253|FG005|Treatment Period|Adverse Event|2|||
127976867|NCT01738503|460536254|FG006|Treatment Period|Adverse Event|2|||
127976868|NCT01738503|460536248|FG000|Treatment Period|Lost to Follow-up|0|||
127976869|NCT01738503|460536249|FG001|Treatment Period|Lost to Follow-up|0|||
127976870|NCT01738503|460536250|FG002|Treatment Period|Lost to Follow-up|3|||
127976871|NCT01738503|460536251|FG003|Treatment Period|Lost to Follow-up|4|||
127976872|NCT01738503|460536252|FG004|Treatment Period|Lost to Follow-up|1|||
127976873|NCT01738503|460536253|FG005|Treatment Period|Lost to Follow-up|1|||
127976874|NCT01738503|460536254|FG006|Treatment Period|Lost to Follow-up|5|||
127976875|NCT01738503|460536248|FG000|Treatment Period|Withdrawal by Subject|0|||
127976876|NCT01738503|460536249|FG001|Treatment Period|Withdrawal by Subject|1|||
127976877|NCT01738503|460536250|FG002|Treatment Period|Withdrawal by Subject|0|||
127976878|NCT01738503|460536251|FG003|Treatment Period|Withdrawal by Subject|1|||
127976879|NCT01738503|460536252|FG004|Treatment Period|Withdrawal by Subject|1|||
127976880|NCT01738503|460536253|FG005|Treatment Period|Withdrawal by Subject|1|||
127976881|NCT01738503|460536254|FG006|Treatment Period|Withdrawal by Subject|1|||
127976882|NCT01738503|460536248|FG000|Treatment Period|Protocol Violation|0|||
127976883|NCT01738503|460536249|FG001|Treatment Period|Protocol Violation|3|||
127976884|NCT01738503|460536250|FG002|Treatment Period|Protocol Violation|1|||
127976885|NCT01738503|460536251|FG003|Treatment Period|Protocol Violation|0|||
127976886|NCT01738503|460536252|FG004|Treatment Period|Protocol Violation|4|||
127976887|NCT01738503|460536253|FG005|Treatment Period|Protocol Violation|2|||
127976888|NCT01738503|460536254|FG006|Treatment Period|Protocol Violation|0|||
127976889|NCT01738503|460536248|FG000|Treatment Period|Other|0|||
127976890|NCT01738503|460536249|FG001|Treatment Period|Other|0|||
127976891|NCT01738503|460536250|FG002|Treatment Period|Other|1|||
127976892|NCT01738503|460536251|FG003|Treatment Period|Other|0|||
127976893|NCT01738503|460536252|FG004|Treatment Period|Other|0|||
127976894|NCT01738503|460536253|FG005|Treatment Period|Other|0|||
127976895|NCT01738503|460536254|FG006|Treatment Period|Other|0|||
127976896|NCT01738503|460536248|FG000|PET Imaging Sub-study|Adverse Event|0|||
127976897|NCT01738503|460536249|FG001|PET Imaging Sub-study|Adverse Event|0|||
127976898|NCT01738503|460536250|FG002|PET Imaging Sub-study|Adverse Event|0|||
127976899|NCT01738503|460536251|FG003|PET Imaging Sub-study|Adverse Event|0|||
127976900|NCT01738503|460536252|FG004|PET Imaging Sub-study|Adverse Event|0|||
127976901|NCT01738503|460536253|FG005|PET Imaging Sub-study|Adverse Event|1|||
127976902|NCT01738503|460536254|FG006|PET Imaging Sub-study|Adverse Event|0|||
127976903|NCT01738503|460536248|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
127491794|NCT01194219|458761921|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
127976904|NCT01738503|460536249|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
127976905|NCT01738503|460536250|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
127976906|NCT01738503|460536251|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
127976907|NCT01738503|460536252|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
127976908|NCT01738503|460536253|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
127491795|NCT01194219|458761922|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
127976909|NCT01738503|460536254|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
127976910|NCT00794040|460536255|FG000|Overall Study|Withdrawal by Subject|3|||
127491796|NCT01194219|458761913|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
127491797|NCT01194219|458761914|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
127491798|NCT01194219|458761915|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
127491799|NCT01194219|458761916|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
127491800|NCT01194219|458761917|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
127491801|NCT01194219|458761918|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
127491802|NCT01194219|458761919|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
127491803|NCT01194219|458761920|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
127491804|NCT01194219|458761921|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
127491805|NCT01194219|458761922|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
127491806|NCT01194219|458761913|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
127491807|NCT01194219|458761914|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
127491808|NCT01194219|458761915|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
127491809|NCT01194219|458761916|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
127491810|NCT01194219|458761917|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
127491811|NCT01194219|458761918|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
127491812|NCT01194219|458761919|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
127491813|NCT01194219|458761920|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
127491814|NCT01194219|458761921|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
127491815|NCT01194219|458761922|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
127491816|NCT01194219|458761913|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
127491817|NCT01194219|458761914|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
127491818|NCT01194219|458761915|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
127491819|NCT01194219|458761916|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
127491820|NCT01194219|458761917|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
127491821|NCT01194219|458761918|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
127869738|NCT02557308|460139641|FG007|Overall Study|Study Close|5|||
127869739|NCT02557308|460139634|FG000|Overall Study|Except for study close|5|||
127869740|NCT02557308|460139635|FG001|Overall Study|Except for study close|0|||
127869741|NCT02557308|460139636|FG002|Overall Study|Except for study close|0|||
127869742|NCT02557308|460139637|FG003|Overall Study|Except for study close|0|||
127869743|NCT02557308|460139638|FG004|Overall Study|Except for study close|3|||
127869744|NCT02557308|460139639|FG005|Overall Study|Except for study close|0|||
127869745|NCT02557308|460139640|FG006|Overall Study|Except for study close|6|||
127869746|NCT02557308|460139641|FG007|Overall Study|Except for study close|10|||
127869747|NCT00368069|460139644|FG000|Overall Study|Adverse Event|5|||
127869748|NCT00368069|460139645|FG001|Overall Study|Adverse Event|2|||
127869749|NCT00368069|460139644|FG000|Overall Study|Lack of Efficacy|0|||
127869750|NCT00368069|460139645|FG001|Overall Study|Lack of Efficacy|1|||
127869751|NCT00368069|460139644|FG000|Overall Study|Lost to Follow-up|1|||
127869752|NCT00368069|460139645|FG001|Overall Study|Lost to Follow-up|0|||
127869753|NCT00368069|460139644|FG000|Overall Study|Protocol Violation|0|||
127869754|NCT00368069|460139645|FG001|Overall Study|Protocol Violation|2|||
127869755|NCT00368069|460139644|FG000|Overall Study|Withdrawal of Consent|2|||
127869756|NCT00368069|460139645|FG001|Overall Study|Withdrawal of Consent|1|||
127869757|NCT00368069|460139644|FG000|Overall Study|no blood sampling possible|0|||
127869758|NCT00368069|460139645|FG001|Overall Study|no blood sampling possible|1|||
127869759|NCT03907072|460139649|FG000|Overall Study|Study Terminated by Sponsor|2|||
127869760|NCT03907072|460139650|FG001|Overall Study|Study Terminated by Sponsor|2|||
127869761|NCT03907072|460139651|FG002|Overall Study|Study Terminated by Sponsor|2|||
127869762|NCT01430559|460139655|FG000|Overall Study|Adverse Event|7|||
127869763|NCT01430559|460139656|FG001|Overall Study|Adverse Event|3|||
127869764|NCT01430559|460139655|FG000|Overall Study|Entry criteria not met|1|||
127869765|NCT01430559|460139656|FG001|Overall Study|Entry criteria not met|1|||
127869766|NCT01430559|460139655|FG000|Overall Study|Lost to Follow-up|1|||
127869767|NCT01430559|460139656|FG001|Overall Study|Lost to Follow-up|0|||
127869768|NCT01430559|460139655|FG000|Overall Study|Medication error|1|||
127869769|NCT01430559|460139656|FG001|Overall Study|Medication error|0|||
127869770|NCT01430559|460139655|FG000|Overall Study|Withdrawal by Subject|3|||
127869771|NCT01430559|460139656|FG001|Overall Study|Withdrawal by Subject|2|||
127869772|NCT01430559|460139655|FG000|Overall Study|Protocol Violation|1|||
127869773|NCT01430559|460139656|FG001|Overall Study|Protocol Violation|0|||
127869774|NCT01430559|460139655|FG000|Overall Study|Other|3|||
127869775|NCT01430559|460139656|FG001|Overall Study|Other|3|||
127869776|NCT01430559|460139655|FG000|Overall Study|Randomized, Not Treated|3|||
127869777|NCT01430559|460139656|FG001|Overall Study|Randomized, Not Treated|3|||
127869778|NCT01177943|460139657|FG000|First Intervention|Withdrawal by Subject|2|||
127869779|NCT01177943|460139658|FG001|First Intervention|Withdrawal by Subject|0|||
127869780|NCT00808665|460139659|FG000|Overall Study|Withdrawal by Subject|1|||
127869781|NCT00808665|460139660|FG001|Overall Study|Withdrawal by Subject|0|||
127869782|NCT00808665|460139659|FG000|Overall Study|only required minimally invasive surgery|1|||
127869783|NCT00808665|460139660|FG001|Overall Study|only required minimally invasive surgery|0|||
127869784|NCT00808665|460139659|FG000|Overall Study|surgery cancelled|1|||
127869785|NCT00808665|460139660|FG001|Overall Study|surgery cancelled|0|||
127491822|NCT01194219|458761919|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
127491823|NCT01194219|458761920|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
127976911|NCT00794040|460536256|FG001|Overall Study|Withdrawal by Subject|4|||
127976912|NCT00794040|460536255|FG000|Overall Study|Physician Decision|0|||
127976913|NCT00794040|460536256|FG001|Overall Study|Physician Decision|1|||
127976914|NCT01340027|460536257|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
127491824|NCT01194219|458761921|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
127491825|NCT01194219|458761922|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
127491826|NCT01194219|458761913|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
127491827|NCT01194219|458761914|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
127491828|NCT01194219|458761915|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
127491829|NCT01194219|458761916|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
127491830|NCT01194219|458761917|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
127491831|NCT01194219|458761918|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
127491832|NCT01194219|458761919|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
127491833|NCT01194219|458761920|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
127491834|NCT01194219|458761921|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
127491835|NCT01194219|458761922|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
127491836|NCT01194219|458761913|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
127491837|NCT01194219|458761914|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
127491838|NCT01194219|458761915|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
127491839|NCT01194219|458761916|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
127491840|NCT01194219|458761917|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
127491841|NCT01194219|458761918|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
127491842|NCT01194219|458761919|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
127491843|NCT01194219|458761920|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
127491844|NCT01194219|458761921|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
127491845|NCT01194219|458761922|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
127491846|NCT00292045|458761925|FG000|Core Study (Through Week 13)|Adverse Event|1|||
127491847|NCT00292045|458761925|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
127491848|NCT04474197|458761926|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
127491849|NCT04474197|458761927|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
127491850|NCT04474197|458761928|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
127491851|NCT04474197|458761929|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
127491852|NCT01672879|458761931|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
127491853|NCT01672879|458761932|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
127491854|NCT01672879|458761933|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
127491855|NCT01672879|458761931|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
127491856|NCT01672879|458761932|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
127491857|NCT01672879|458761933|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
127491858|NCT01672879|458761931|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
127491859|NCT01672879|458761932|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
127491860|NCT01672879|458761933|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
127491861|NCT01672879|458761931|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
127491862|NCT01672879|458761932|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
127491863|NCT01672879|458761933|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
127491864|NCT01672879|458761931|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
127491865|NCT01672879|458761932|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
127491866|NCT01672879|458761933|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
127491867|NCT01672879|458761931|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
127491868|NCT01672879|458761932|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
127491869|NCT01672879|458761933|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
127491870|NCT01672879|458761931|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
127491871|NCT01672879|458761932|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
127491872|NCT01672879|458761933|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
127491873|NCT01672879|458761931|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
127491874|NCT01672879|458761932|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
127491875|NCT01672879|458761933|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
127491876|NCT01672879|458761931|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
127491877|NCT01672879|458761932|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
127491878|NCT01672879|458761933|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
127491879|NCT01672879|458761931|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
127491880|NCT01672879|458761932|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
127491881|NCT01672879|458761933|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
127491882|NCT01672879|458761931|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
127976915|NCT01340027|460536258|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
127976916|NCT01340027|460536259|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
127491883|NCT01672879|458761932|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
127491884|NCT01672879|458761933|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
127491885|NCT01672879|458761931|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
127491886|NCT01672879|458761932|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
127491887|NCT01672879|458761933|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
127491888|NCT01672879|458761931|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
127491889|NCT01672879|458761932|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
127491890|NCT01672879|458761933|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
127491891|NCT01871545|458761934|FG000|Overall Study|Death|2|||
127491892|NCT01871545|458761935|FG001|Overall Study|Death|0|||
127491893|NCT01871545|458761934|FG000|Overall Study|Lack of Efficacy|11|||
127491894|NCT01871545|458761935|FG001|Overall Study|Lack of Efficacy|2|||
127491895|NCT01871545|458761934|FG000|Overall Study|Physician Decision|4|||
127491896|NCT01871545|458761935|FG001|Overall Study|Physician Decision|0|||
127491897|NCT01871545|458761934|FG000|Overall Study|Withdrawal by Subject|0|||
127491898|NCT01871545|458761935|FG001|Overall Study|Withdrawal by Subject|1|||
127491899|NCT04834726|458761938|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
127491900|NCT04834726|458761939|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
127491901|NCT04834726|458761940|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
127491902|NCT04834726|458761941|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
127491903|NCT04834726|458761942|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
127491904|NCT04834726|458761943|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
127491905|NCT04834726|458761944|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
127491906|NCT04834726|458761945|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
127491907|NCT04834726|458761946|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
127491908|NCT01737762|458761956|FG000|Overall Study|Adverse Event|2|||
127491909|NCT01737762|458761957|FG001|Overall Study|Adverse Event|2|||
127491910|NCT01737762|458761956|FG000|Overall Study|Lost to Follow-up|1|||
127491911|NCT01737762|458761957|FG001|Overall Study|Lost to Follow-up|0|||
127491912|NCT01737762|458761956|FG000|Overall Study|Withdrawal by Subject|2|||
127491913|NCT01737762|458761957|FG001|Overall Study|Withdrawal by Subject|2|||
127491914|NCT01737762|458761956|FG000|Overall Study|Progressive disease|1|||
127491915|NCT01737762|458761957|FG001|Overall Study|Progressive disease|2|||
127491916|NCT01737762|458761956|FG000|Overall Study|Physician Decision|1|||
127491917|NCT01737762|458761957|FG001|Overall Study|Physician Decision|1|||
127491918|NCT01737762|458761956|FG000|Overall Study|Moved from area|2|||
127491919|NCT01737762|458761957|FG001|Overall Study|Moved from area|1|||
127491920|NCT01737762|458761956|FG000|Overall Study|Trial termination|11|||
127491921|NCT01737762|458761957|FG001|Overall Study|Trial termination|9|||
127491922|NCT03083665|458761958|FG000|Double-Blind Period|Adverse Event|5|||
127491923|NCT03083665|458761959|FG001|Double-Blind Period|Adverse Event|4|||
127491924|NCT03083665|458761960|FG002|Double-Blind Period|Adverse Event|5|||
127491925|NCT03083665|458761961|FG003|Double-Blind Period|Adverse Event|0|||
127491926|NCT03083665|458761962|FG004|Double-Blind Period|Adverse Event|0|||
127491927|NCT03083665|458761963|FG005|Double-Blind Period|Adverse Event|0|||
127491928|NCT03083665|458761958|FG000|Double-Blind Period|Lack of Efficacy|0|||
127491929|NCT03083665|458761959|FG001|Double-Blind Period|Lack of Efficacy|0|||
127491930|NCT03083665|458761960|FG002|Double-Blind Period|Lack of Efficacy|1|||
127491931|NCT03083665|458761961|FG003|Double-Blind Period|Lack of Efficacy|0|||
127491932|NCT03083665|458761962|FG004|Double-Blind Period|Lack of Efficacy|0|||
127491933|NCT03083665|458761963|FG005|Double-Blind Period|Lack of Efficacy|0|||
127491934|NCT03083665|458761958|FG000|Double-Blind Period|Protocol Violation|1|||
127491935|NCT03083665|458761959|FG001|Double-Blind Period|Protocol Violation|0|||
127491936|NCT03083665|458761960|FG002|Double-Blind Period|Protocol Violation|1|||
127491937|NCT03083665|458761961|FG003|Double-Blind Period|Protocol Violation|0|||
127491938|NCT03083665|458761962|FG004|Double-Blind Period|Protocol Violation|0|||
127491939|NCT03083665|458761963|FG005|Double-Blind Period|Protocol Violation|0|||
127491940|NCT03083665|458761958|FG000|Double-Blind Period|Lost to Follow-up|1|||
127491941|NCT03083665|458761959|FG001|Double-Blind Period|Lost to Follow-up|0|||
127491942|NCT03083665|458761960|FG002|Double-Blind Period|Lost to Follow-up|1|||
127491943|NCT03083665|458761961|FG003|Double-Blind Period|Lost to Follow-up|0|||
127491944|NCT03083665|458761962|FG004|Double-Blind Period|Lost to Follow-up|0|||
127491945|NCT03083665|458761963|FG005|Double-Blind Period|Lost to Follow-up|0|||
127491946|NCT03083665|458761958|FG000|Double-Blind Period|Withdrawal by Subject|3|||
127491947|NCT03083665|458761959|FG001|Double-Blind Period|Withdrawal by Subject|0|||
127491948|NCT03083665|458761960|FG002|Double-Blind Period|Withdrawal by Subject|0|||
127491949|NCT03083665|458761961|FG003|Double-Blind Period|Withdrawal by Subject|0|||
127491950|NCT03083665|458761962|FG004|Double-Blind Period|Withdrawal by Subject|0|||
127491951|NCT03083665|458761963|FG005|Double-Blind Period|Withdrawal by Subject|0|||
127491952|NCT03083665|458761958|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
127491953|NCT03083665|458761959|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
127491954|NCT03083665|458761960|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
127491955|NCT03083665|458761961|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
127491956|NCT03083665|458761962|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
127491957|NCT03083665|458761963|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
127491958|NCT03083665|458761958|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
127491959|NCT03083665|458761959|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
127491960|NCT03083665|458761960|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
127491961|NCT03083665|458761961|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
127491962|NCT03083665|458761962|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
127491963|NCT03083665|458761963|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
127491964|NCT03083665|458761958|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
127491965|NCT03083665|458761959|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
127491966|NCT03083665|458761960|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
127491967|NCT03083665|458761961|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
127491968|NCT03083665|458761962|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
127491969|NCT03083665|458761963|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
127491970|NCT03083665|458761958|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
127491971|NCT03083665|458761959|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
127491972|NCT03083665|458761960|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
127491973|NCT03083665|458761961|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
127491974|NCT03083665|458761962|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
127491975|NCT03083665|458761963|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
127491976|NCT03083665|458761958|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
127491977|NCT03083665|458761959|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
127491978|NCT03083665|458761960|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
127491979|NCT03083665|458761961|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
127491980|NCT03083665|458761962|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
127491981|NCT03083665|458761963|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
127491982|NCT03083665|458761958|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
127491983|NCT03083665|458761959|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
127491984|NCT03083665|458761960|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
127491985|NCT03083665|458761961|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
127491986|NCT03083665|458761962|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
127491987|NCT03083665|458761963|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
127491988|NCT03083665|458761958|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
127491989|NCT03083665|458761959|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
127491990|NCT03083665|458761960|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
127491991|NCT03083665|458761961|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
127491992|NCT03083665|458761962|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
127491993|NCT03083665|458761963|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
127491994|NCT03083665|458761958|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
127491995|NCT03083665|458761959|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
127491996|NCT03083665|458761960|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
127491997|NCT03083665|458761961|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
127491998|NCT03083665|458761962|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
127491999|NCT03083665|458761963|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
127492000|NCT03083665|458761958|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
127492001|NCT03083665|458761959|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
127492002|NCT03083665|458761960|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
127492003|NCT03083665|458761961|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
127492004|NCT03083665|458761962|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
127492005|NCT03083665|458761963|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
127492006|NCT01467466|458761964|FG000|Overall Study|Withdrawal by Subject|15|||
127492007|NCT01467466|458761965|FG001|Overall Study|Withdrawal by Subject|18|||
127492008|NCT01467466|458761966|FG002|Overall Study|Withdrawal by Subject|13|||
127492009|NCT01467466|458761967|FG003|Overall Study|Withdrawal by Subject|11|||
127492010|NCT01467466|458761964|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
127492011|NCT01467466|458761965|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
127492012|NCT01467466|458761966|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
127492013|NCT01467466|458761967|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
127492014|NCT01467466|458761964|FG000|Overall Study|Procedure Cancelled|46|||
127492015|NCT01467466|458761965|FG001|Overall Study|Procedure Cancelled|45|||
127492016|NCT01467466|458761966|FG002|Overall Study|Procedure Cancelled|25|||
127492017|NCT01467466|458761967|FG003|Overall Study|Procedure Cancelled|29|||
127492018|NCT01467466|458761964|FG000|Overall Study|No Endpoint Blood Draw|38|||
127492019|NCT01467466|458761965|FG001|Overall Study|No Endpoint Blood Draw|32|||
127492020|NCT01467466|458761966|FG002|Overall Study|No Endpoint Blood Draw|51|||
127492021|NCT01467466|458761967|FG003|Overall Study|No Endpoint Blood Draw|43|||
127492022|NCT01144416|458761972|FG000|Intervention Period|Adverse Event|5|||
127492023|NCT01144416|458761973|FG001|Intervention Period|Adverse Event|6|||
127492024|NCT01144416|458761972|FG000|Intervention Period|Insufficient ovarian response|11|||
127492025|NCT01144416|458761973|FG001|Intervention Period|Insufficient ovarian response|17|||
127492026|NCT01144416|458761972|FG000|Intervention Period|Risk of OHSS|0|||
127492027|NCT01144416|458761973|FG001|Intervention Period|Risk of OHSS|1|||
127492028|NCT01144416|458761972|FG000|Intervention Period|Too high ovarian response|4|||
127492029|NCT01144416|458761973|FG001|Intervention Period|Too high ovarian response|2|||
127492030|NCT01144416|458761972|FG000|Intervention Period|No/too few/bad oocytes|7|||
127492031|NCT01144416|458761973|FG001|Intervention Period|No/too few/bad oocytes|5|||
127492032|NCT01144416|458761972|FG000|Intervention Period|No or abnormal fertilization|25|||
127492033|NCT01144416|458761973|FG001|Intervention Period|No or abnormal fertilization|10|||
127492034|NCT01144416|458761972|FG000|Intervention Period|No/too few/bad quality embryos|3|||
127492035|NCT01144416|458761973|FG001|Intervention Period|No/too few/bad quality embryos|3|||
127492036|NCT01144416|458761972|FG000|Intervention Period|Other|7|||
127492037|NCT01144416|458761973|FG001|Intervention Period|Other|5|||
127492038|NCT03328832|458761974|FG000|Overall Study|Lost to Follow-up|0|||
127492039|NCT03328832|458761975|FG001|Overall Study|Lost to Follow-up|1|||
127492040|NCT00132301|458761976|FG000|Overall Study|Death|7|||
127492041|NCT00132301|458761977|FG001|Overall Study|Death|6|||
127492042|NCT00132301|458761976|FG000|Overall Study|Withdrawal by Subject|5|||
127492043|NCT00132301|458761977|FG001|Overall Study|Withdrawal by Subject|2|||
127492044|NCT00132301|458761976|FG000|Overall Study|Physician Decision|1|||
127492045|NCT00132301|458761977|FG001|Overall Study|Physician Decision|1|||
127492046|NCT00132301|458761976|FG000|Overall Study|Lost to Follow-up|5|||
127492047|NCT00132301|458761977|FG001|Overall Study|Lost to Follow-up|3|||
127492048|NCT00132301|458761976|FG000|Overall Study|Other|1|||
127492049|NCT00132301|458761977|FG001|Overall Study|Other|1|||
127492050|NCT00132301|458761976|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
127492051|NCT00132301|458761977|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
127492052|NCT02720523|458761978|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
127492053|NCT02720523|458761979|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
127492054|NCT02720523|458761980|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
127492055|NCT02720523|458761981|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
127492056|NCT02720523|458761982|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
127492057|NCT02720523|458761983|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
127492058|NCT02720523|458761984|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
127492059|NCT02720523|458761978|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
127492060|NCT02720523|458761979|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
127492061|NCT02720523|458761980|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
127492062|NCT02720523|458761981|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
127492063|NCT02720523|458761982|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
127492064|NCT02720523|458761983|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
127492065|NCT02720523|458761984|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
127492066|NCT02720523|458761978|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
127492067|NCT02720523|458761979|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
127492068|NCT02720523|458761980|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
127492069|NCT02720523|458761981|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
127492070|NCT02720523|458761982|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
127492071|NCT02720523|458761983|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
127492072|NCT02720523|458761984|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
127492073|NCT02720523|458761978|FG000|Period 1: Placebo-controlled Period|Other|0|||
127492074|NCT02720523|458761979|FG001|Period 1: Placebo-controlled Period|Other|0|||
127492075|NCT02720523|458761980|FG002|Period 1: Placebo-controlled Period|Other|1|||
127492076|NCT02720523|458761981|FG003|Period 1: Placebo-controlled Period|Other|1|||
127492077|NCT02720523|458761982|FG004|Period 1: Placebo-controlled Period|Other|0|||
127492078|NCT02720523|458761983|FG005|Period 1: Placebo-controlled Period|Other|0|||
127492079|NCT02720523|458761984|FG006|Period 1: Placebo-controlled Period|Other|0|||
127492080|NCT02720523|458761978|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
127492081|NCT02720523|458761979|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
127492082|NCT02720523|458761980|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
127492083|NCT02720523|458761981|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
127492084|NCT02720523|458761982|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
127492085|NCT02720523|458761983|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
127492086|NCT02720523|458761984|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
127492087|NCT02720523|458761978|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
127492088|NCT02720523|458761979|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
127492089|NCT02720523|458761980|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
127492090|NCT02720523|458761981|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
127492091|NCT02720523|458761982|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
127492092|NCT02720523|458761983|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
127492093|NCT02720523|458761984|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
127492094|NCT02720523|458761978|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
127492095|NCT02720523|458761979|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
127492096|NCT02720523|458761980|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
127492097|NCT02720523|458761981|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
127492098|NCT02720523|458761982|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
127492099|NCT02720523|458761983|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
127492100|NCT02720523|458761984|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
127492101|NCT02720523|458761978|FG000|Period 2: Long-term Extension Period|Other|0|||
127492102|NCT02720523|458761979|FG001|Period 2: Long-term Extension Period|Other|0|||
127492103|NCT02720523|458761980|FG002|Period 2: Long-term Extension Period|Other|0|||
127492104|NCT02720523|458761981|FG003|Period 2: Long-term Extension Period|Other|0|||
127492105|NCT02720523|458761982|FG004|Period 2: Long-term Extension Period|Other|2|||
127492106|NCT02720523|458761983|FG005|Period 2: Long-term Extension Period|Other|0|||
127492107|NCT02720523|458761984|FG006|Period 2: Long-term Extension Period|Other|3|||
127492108|NCT02382991|458761992|FG000|Overall Study|Adverse Event|1|||
127492109|NCT02382991|458761993|FG001|Overall Study|Adverse Event|2|||
127492110|NCT02382991|458761992|FG000|Overall Study|Lost to Follow-up|1|||
127492111|NCT02382991|458761993|FG001|Overall Study|Lost to Follow-up|0|||
127492112|NCT02382991|458761992|FG000|Overall Study|Withdrawal by Subject|0|||
127492113|NCT02382991|458761993|FG001|Overall Study|Withdrawal by Subject|1|||
127492114|NCT01445613|458761994|FG000|30-day Follow-up|Withdrawal by Subject|6|||
127492115|NCT01445613|458761994|FG000|30-day Follow-up|Physician Decision|3|||
127492116|NCT01445613|458761994|FG000|30-day Follow-up|Missed visit|23|||
127492117|NCT01445613|458761994|FG000|30-day Follow-up|Death|3|||
127492118|NCT01445613|458761994|FG000|1-year Follow-up|Withdrawal by Subject|12|||
127492119|NCT01445613|458761994|FG000|1-year Follow-up|Missed visit|29|||
127492120|NCT01445613|458761994|FG000|1-year Follow-up|Lost to Follow-up|2|||
127492121|NCT01445613|458761994|FG000|1-year Follow-up|Death|30|||
127492122|NCT01445613|458761994|FG000|1-year Follow-up|Physician Decision|2|||
127492123|NCT01445613|458761994|FG000|1-year Follow-up|Received a non-study stent|2|||
127492124|NCT03929913|458761997|FG000|Overall Study|Death|4|||
127492125|NCT03929913|458761997|FG000|Overall Study|Lost to Follow-up|1|||
127492126|NCT03929913|458761997|FG000|Overall Study|Failed Procedure|2|||
127492127|NCT01154452|458761998|FG000|Phase Ib|Not Treated|1|||
127492128|NCT01154452|458761999|FG001|Phase Ib|Not Treated|0|||
127492129|NCT01154452|458762000|FG002|Phase Ib|Not Treated|0|||
127492130|NCT01154452|458762001|FG003|Phase Ib|Not Treated|0|||
127492131|NCT01154452|458761998|FG000|Phase Ib|Adverse Event|2|||
127492132|NCT01154452|458761999|FG001|Phase Ib|Adverse Event|1|||
127492133|NCT01154452|458762000|FG002|Phase Ib|Adverse Event|0|||
127492134|NCT01154452|458762001|FG003|Phase Ib|Adverse Event|0|||
127492135|NCT01154452|458761998|FG000|Phase II|Withdrawal by Subject|0|||
127492136|NCT01154452|458761999|FG001|Phase II|Withdrawal by Subject|0|||
127492137|NCT01154452|458762000|FG002|Phase II|Withdrawal by Subject|1|||
127492138|NCT01154452|458762001|FG003|Phase II|Withdrawal by Subject|2|||
127492139|NCT01154452|458761998|FG000|Phase II|Adverse Event|0|||
127492140|NCT01154452|458761999|FG001|Phase II|Adverse Event|0|||
127492141|NCT01154452|458762000|FG002|Phase II|Adverse Event|4|||
127492142|NCT01154452|458762001|FG003|Phase II|Adverse Event|4|||
127492143|NCT03381287|458762002|FG000|Overall Study|Withdrawal by Subject|0|||
127492144|NCT03381287|458762003|FG001|Overall Study|Withdrawal by Subject|1|||
127492145|NCT03381287|458762004|FG002|Overall Study|Withdrawal by Subject|0|||
127492146|NCT03381287|458762005|FG003|Overall Study|Withdrawal by Subject|0|||
127492147|NCT03381287|458762002|FG000|Overall Study|Adverse Event|0|||
127492148|NCT03381287|458762003|FG001|Overall Study|Adverse Event|0|||
127492149|NCT03381287|458762004|FG002|Overall Study|Adverse Event|0|||
127492150|NCT03381287|458762005|FG003|Overall Study|Adverse Event|1|||
127492151|NCT03381287|458762002|FG000|Overall Study|Physician Decision|0|||
127492152|NCT03381287|458762003|FG001|Overall Study|Physician Decision|0|||
127492153|NCT03381287|458762004|FG002|Overall Study|Physician Decision|0|||
127492154|NCT03381287|458762005|FG003|Overall Study|Physician Decision|1|||
127492155|NCT01265992|458762008|FG000|Overall Study|Lost to Follow-up|1|||
127492156|NCT01265992|458762008|FG000|Overall Study|Withdrawal by Subject|1|||
127492157|NCT01265992|458762008|FG000|Overall Study|Adverse Event|1|||
127492158|NCT01265992|458762008|FG000|Overall Study|Administrative reasons|2|||
127492159|NCT01265992|458762008|FG000|Overall Study|Stopped treatment|3|||
127492160|NCT01265992|458762008|FG000|Overall Study|Did not receive treatment|1|||
127492161|NCT01837680|458762009|FG000|Overall Study|Lost to Follow-up|2|||
127492162|NCT01837680|458762010|FG001|Overall Study|Lost to Follow-up|2|||
127492163|NCT01837680|458762009|FG000|Overall Study|lack of insurance|0|||
127492164|NCT01837680|458762010|FG001|Overall Study|lack of insurance|2|||
127492165|NCT01837680|458762009|FG000|Overall Study|allergic reaction|6|||
127492166|NCT01837680|458762010|FG001|Overall Study|allergic reaction|0|||
127492167|NCT01837680|458762009|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
127492168|NCT01837680|458762010|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
127492169|NCT01061723|458763611|FG000|Overall Study|Adverse Event|0|||
127492170|NCT01061723|458763612|FG001|Overall Study|Adverse Event|2|||
127492171|NCT01061723|458763613|FG002|Overall Study|Adverse Event|5|||
127492172|NCT01061723|458763614|FG003|Overall Study|Adverse Event|5|||
127492173|NCT01061723|458763615|FG004|Overall Study|Adverse Event|2|||
127492174|NCT01061723|458763616|FG005|Overall Study|Adverse Event|6|||
127492175|NCT01061723|458763611|FG000|Overall Study|Lack of Efficacy|2|||
127492176|NCT01061723|458763612|FG001|Overall Study|Lack of Efficacy|3|||
127492177|NCT01061723|458763613|FG002|Overall Study|Lack of Efficacy|4|||
127492178|NCT01061723|458763614|FG003|Overall Study|Lack of Efficacy|2|||
127492179|NCT01061723|458763615|FG004|Overall Study|Lack of Efficacy|1|||
127492180|NCT01061723|458763616|FG005|Overall Study|Lack of Efficacy|1|||
127492181|NCT01061723|458763611|FG000|Overall Study|Randomized but not treated|0|||
127492182|NCT01061723|458763612|FG001|Overall Study|Randomized but not treated|0|||
127492183|NCT01061723|458763613|FG002|Overall Study|Randomized but not treated|0|||
127492184|NCT01061723|458763614|FG003|Overall Study|Randomized but not treated|0|||
127492185|NCT01061723|458763615|FG004|Overall Study|Randomized but not treated|0|||
127492186|NCT01061723|458763616|FG005|Overall Study|Randomized but not treated|1|||
127492187|NCT01061723|458763611|FG000|Overall Study|Other than specified above|2|||
127492188|NCT01061723|458763612|FG001|Overall Study|Other than specified above|1|||
127492189|NCT01061723|458763613|FG002|Overall Study|Other than specified above|1|||
127492190|NCT01061723|458763614|FG003|Overall Study|Other than specified above|1|||
127492191|NCT01061723|458763615|FG004|Overall Study|Other than specified above|0|||
127492192|NCT01061723|458763616|FG005|Overall Study|Other than specified above|1|||
127492193|NCT00566982|458763617|FG000|Overall Study|Adverse Event|6|||
127492194|NCT00566982|458763618|FG001|Overall Study|Adverse Event|48|||
127492195|NCT00566982|458763617|FG000|Overall Study|Withdrawal by Subject|1|||
127492196|NCT00566982|458763618|FG001|Overall Study|Withdrawal by Subject|14|||
127492197|NCT00566982|458763617|FG000|Overall Study|Protocol Violation|1|||
127492198|NCT00566982|458763618|FG001|Overall Study|Protocol Violation|4|||
127492199|NCT00566982|458763617|FG000|Overall Study|Lost to Follow-up|0|||
127492200|NCT00566982|458763618|FG001|Overall Study|Lost to Follow-up|1|||
127492201|NCT00566982|458763617|FG000|Overall Study|Other-family problems & doctor's request|0|||
127492202|NCT00566982|458763618|FG001|Overall Study|Other-family problems & doctor's request|2|||
127492203|NCT02840253|458763622|FG000|Overall Study|Unsuccessful block|4|||
127492204|NCT00473889|458763623|FG000|Overall Study|Did not receive study medication|1|||
127492205|NCT00473889|458763624|FG001|Overall Study|Did not receive study medication|4|||
127492206|NCT00473889|458763623|FG000|Overall Study|Adverse Event|30|||
127492207|NCT00473889|458763624|FG001|Overall Study|Adverse Event|17|||
127492208|NCT00473889|458763623|FG000|Overall Study|Protocol Violation|4|||
127492209|NCT00473889|458763624|FG001|Overall Study|Protocol Violation|2|||
127492210|NCT00473889|458763623|FG000|Overall Study|Lack of Efficacy|28|||
127492211|NCT00473889|458763624|FG001|Overall Study|Lack of Efficacy|29|||
127492212|NCT00473889|458763623|FG000|Overall Study|Lost to Follow-up|2|||
127492213|NCT00473889|458763624|FG001|Overall Study|Lost to Follow-up|1|||
127492214|NCT00473889|458763623|FG000|Overall Study|Physician Decision|10|||
127492215|NCT00473889|458763624|FG001|Overall Study|Physician Decision|5|||
127492216|NCT00473889|458763623|FG000|Overall Study|Trial Terminated|3|||
127492217|NCT00473889|458763624|FG001|Overall Study|Trial Terminated|6|||
127492218|NCT00473889|458763623|FG000|Overall Study|Withdrawal by Subject|5|||
127492219|NCT00473889|458763624|FG001|Overall Study|Withdrawal by Subject|0|||
127492220|NCT03783962|458763625|FG000|Overall Study|Lost to Follow-up|3|||
127492221|NCT03783962|458763626|FG001|Overall Study|Lost to Follow-up|6|||
127492222|NCT03783962|458763625|FG000|Overall Study|Protocol Violation|0|||
127492223|NCT03783962|458763626|FG001|Overall Study|Protocol Violation|1|||
127976917|NCT01340027|460536260|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
127976918|NCT01340027|460536261|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
127976919|NCT01340027|460536262|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
127976920|NCT01340027|460536263|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
127976921|NCT01340027|460536264|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
127976922|NCT01340027|460536265|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
127976923|NCT01340027|460536266|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
127492224|NCT03458325|458763627|FG000|Overall Study|Withdrawal by Subject|1|||
127492225|NCT03801928|458763632|FG000|Overall Study|Adverse Event|1|||
127492226|NCT03801928|458763633|FG001|Overall Study|Adverse Event|0|||
127492227|NCT03801928|458763634|FG002|Overall Study|Adverse Event|1|||
127976924|NCT01340027|460536267|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
127976925|NCT01340027|460536268|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
127492228|NCT03801928|458763635|FG003|Overall Study|Adverse Event|2|||
127492229|NCT03801928|458763636|FG004|Overall Study|Adverse Event|0|||
127492230|NCT03801928|458763637|FG005|Overall Study|Adverse Event|2|||
127492231|NCT03801928|458763632|FG000|Overall Study|Lack of Efficacy|0|||
127492232|NCT03801928|458763633|FG001|Overall Study|Lack of Efficacy|0|||
127492233|NCT03801928|458763634|FG002|Overall Study|Lack of Efficacy|1|||
127492234|NCT03801928|458763635|FG003|Overall Study|Lack of Efficacy|0|||
127492235|NCT03801928|458763636|FG004|Overall Study|Lack of Efficacy|0|||
127492236|NCT03801928|458763637|FG005|Overall Study|Lack of Efficacy|0|||
127492237|NCT03801928|458763632|FG000|Overall Study|Lost to Follow-up|5|||
127492238|NCT03801928|458763633|FG001|Overall Study|Lost to Follow-up|1|||
127492239|NCT03801928|458763634|FG002|Overall Study|Lost to Follow-up|1|||
127492240|NCT03801928|458763635|FG003|Overall Study|Lost to Follow-up|4|||
127492241|NCT03801928|458763636|FG004|Overall Study|Lost to Follow-up|4|||
127492242|NCT03801928|458763637|FG005|Overall Study|Lost to Follow-up|2|||
127492243|NCT03801928|458763632|FG000|Overall Study|Withdrawal by Subject|0|||
127492244|NCT03801928|458763633|FG001|Overall Study|Withdrawal by Subject|0|||
127492245|NCT03801928|458763634|FG002|Overall Study|Withdrawal by Subject|2|||
127492246|NCT03801928|458763635|FG003|Overall Study|Withdrawal by Subject|1|||
127492247|NCT03801928|458763636|FG004|Overall Study|Withdrawal by Subject|0|||
127492248|NCT03801928|458763637|FG005|Overall Study|Withdrawal by Subject|0|||
127492249|NCT03801928|458763632|FG000|Overall Study|Other|0|||
127492250|NCT03801928|458763633|FG001|Overall Study|Other|2|||
127492251|NCT03801928|458763634|FG002|Overall Study|Other|0|||
127492252|NCT03801928|458763635|FG003|Overall Study|Other|1|||
127492253|NCT03801928|458763636|FG004|Overall Study|Other|0|||
127492254|NCT03801928|458763637|FG005|Overall Study|Other|1|||
127492255|NCT01724216|458763642|FG000|Overall Study|Scan was not completed|1|||
127492256|NCT00175916|458763643|FG000|Overall Study|Death|19|||
127492257|NCT00175916|458763643|FG000|Overall Study|Adverse Event|81|||
127492258|NCT00175916|458763643|FG000|Overall Study|Lack of Efficacy|354|||
127492259|NCT00175916|458763643|FG000|Overall Study|Lost to Follow-up|17|||
127492260|NCT00175916|458763643|FG000|Overall Study|Subject Choice|98|||
127492261|NCT00175916|458763643|FG000|Overall Study|Lack of compliance|8|||
127492262|NCT00175916|458763643|FG000|Overall Study|Patient cannot record seizures|1|||
127492263|NCT00175916|458763643|FG000|Overall Study|Sponsor decision|17|||
127492264|NCT00175916|458763643|FG000|Overall Study|Vigabatrin intake|1|||
127492265|NCT00175916|458763643|FG000|Overall Study|Suicidal behaviour|1|||
127492266|NCT00175916|458763643|FG000|Overall Study|Withdrawal by Subject|1|||
127492267|NCT00175916|458763643|FG000|Overall Study|Seizure - free|4|||
127492268|NCT00175916|458763643|FG000|Overall Study|Administrative reason|1|||
127492269|NCT00175916|458763643|FG000|Overall Study|Pregnancy|1|||
127492270|NCT00175916|458763643|FG000|Overall Study|Patient's request|2|||
127492271|NCT00175916|458763643|FG000|Overall Study|Treating physiciant's choice|1|||
127492272|NCT00175916|458763643|FG000|Overall Study|Moved overseas|1|||
127492273|NCT00175916|458763643|FG000|Overall Study|Loss of job and economic burden|1|||
127492274|NCT00175916|458763643|FG000|Overall Study|Site was closed|9|||
127492275|NCT00175916|458763643|FG000|Overall Study|Patient went to prison|1|||
127492276|NCT03650413|458763644|FG000|Overall Study|Adverse Event|1|||
127492277|NCT03650413|458763644|FG000|Overall Study|Lack of Efficacy|17|||
127492278|NCT03650413|458763644|FG000|Overall Study|Other|9|||
127492279|NCT03650413|458763644|FG000|Overall Study|Physician Decision|2|||
127492280|NCT03650413|458763644|FG000|Overall Study|Study Terminated By Sponsor|16|||
127492281|NCT03650413|458763644|FG000|Overall Study|Withdrawal by Subject|16|||
127492282|NCT00564733|458763645|FG000|Overall Study|Withdrawal by Subject|4|||
127492283|NCT00564733|458763645|FG000|Overall Study|Ineligible|5|||
127492284|NCT01014767|458763646|FG000|Overall Study|PI left institution, data unavailable|12|||
127492285|NCT01014767|458763647|FG001|Overall Study|PI left institution, data unavailable|1|||
127492286|NCT01014767|458763648|FG002|Overall Study|PI left institution, data unavailable|4|||
127492287|NCT01014767|458763649|FG003|Overall Study|PI left institution, data unavailable|1|||
127492288|NCT03654040|458763650|FG000|Overall Study|Death|1|||
127492289|NCT03654040|458763651|FG001|Overall Study|Death|0|||
127492290|NCT03654040|458763650|FG000|Overall Study|Withdrawal by Subject|1|||
127492291|NCT03654040|458763651|FG001|Overall Study|Withdrawal by Subject|0|||
127492292|NCT03654040|458763650|FG000|Overall Study|Study terminated by sponsor|8|||
127492293|NCT03654040|458763651|FG001|Overall Study|Study terminated by sponsor|2|||
127492294|NCT03654040|458763650|FG000|Overall Study|Failure to initiate study therapy|2|||
127492295|NCT03654040|458763651|FG001|Overall Study|Failure to initiate study therapy|0|||
127492296|NCT03654040|458763650|FG000|Overall Study|Transplanted at another center|2|||
127492297|NCT03654040|458763651|FG001|Overall Study|Transplanted at another center|0|||
127492298|NCT03654040|458763650|FG000|Overall Study|Failure to meet eligibility criteria|14|||
127492299|NCT03654040|458763651|FG001|Overall Study|Failure to meet eligibility criteria|2|||
127492300|NCT03654040|458763650|FG000|Overall Study|No longer transplant candidate|1|||
127492301|NCT03654040|458763651|FG001|Overall Study|No longer transplant candidate|0|||
127492302|NCT03654040|458763650|FG000|Overall Study|Manufacturing unable to accept specimens|1|||
127492303|NCT03654040|458763651|FG001|Overall Study|Manufacturing unable to accept specimens|0|||
127492304|NCT03654040|458763650|FG000|Overall Study|Recipient ineligible|0|||
127492305|NCT03654040|458763651|FG001|Overall Study|Recipient ineligible|2|||
127492306|NCT03654040|458763650|FG000|Overall Study|Received deceased liver|0|||
127492307|NCT03654040|458763651|FG001|Overall Study|Received deceased liver|1|||
127492308|NCT01484496|458763657|FG000|Period 1|Protocol Violation|3|||
127492309|NCT01484496|458763658|FG001|Period 1|Protocol Violation|4|||
127492310|NCT01484496|458763659|FG002|Period 1|Protocol Violation|0|||
127492311|NCT01484496|458763660|FG003|Period 1|Protocol Violation|0|||
127492312|NCT01484496|458763657|FG000|Period 1|Physician Decision|5|||
127492313|NCT01484496|458763658|FG001|Period 1|Physician Decision|1|||
127492314|NCT01484496|458763659|FG002|Period 1|Physician Decision|0|||
127492315|NCT01484496|458763660|FG003|Period 1|Physician Decision|0|||
127492316|NCT01484496|458763657|FG000|Period 1|Lack of Efficacy|10|||
127492317|NCT01484496|458763658|FG001|Period 1|Lack of Efficacy|15|||
127492318|NCT01484496|458763659|FG002|Period 1|Lack of Efficacy|0|||
127492319|NCT01484496|458763660|FG003|Period 1|Lack of Efficacy|0|||
127492320|NCT01484496|458763657|FG000|Period 1|Adverse Event|25|||
127492321|NCT01484496|458763658|FG001|Period 1|Adverse Event|40|||
127492322|NCT01484496|458763659|FG002|Period 1|Adverse Event|0|||
127492323|NCT01484496|458763660|FG003|Period 1|Adverse Event|0|||
127492324|NCT01484496|458763657|FG000|Period 1|Withdrawal by Subject|15|||
127492325|NCT01484496|458763658|FG001|Period 1|Withdrawal by Subject|12|||
127492326|NCT01484496|458763659|FG002|Period 1|Withdrawal by Subject|0|||
127492327|NCT01484496|458763660|FG003|Period 1|Withdrawal by Subject|0|||
127492328|NCT01484496|458763657|FG000|Period 1|Lost to Follow-up|2|||
127492329|NCT01484496|458763658|FG001|Period 1|Lost to Follow-up|6|||
127492330|NCT01484496|458763659|FG002|Period 1|Lost to Follow-up|0|||
127492331|NCT01484496|458763660|FG003|Period 1|Lost to Follow-up|0|||
127492332|NCT01484496|458763657|FG000|Period 1|Positive Pregnancy|1|||
127492333|NCT01484496|458763658|FG001|Period 1|Positive Pregnancy|6|||
127492334|NCT01484496|458763659|FG002|Period 1|Positive Pregnancy|0|||
127492335|NCT01484496|458763660|FG003|Period 1|Positive Pregnancy|0|||
127492336|NCT01484496|458763657|FG000|Period 1|Treatment Failure|3|||
127492337|NCT01484496|458763658|FG001|Period 1|Treatment Failure|6|||
127492338|NCT01484496|458763659|FG002|Period 1|Treatment Failure|0|||
127492339|NCT01484496|458763660|FG003|Period 1|Treatment Failure|0|||
127492340|NCT01484496|458763657|FG000|Period 1|Lack of Compliance|2|||
127492341|NCT01484496|458763658|FG001|Period 1|Lack of Compliance|1|||
127492342|NCT01484496|458763659|FG002|Period 1|Lack of Compliance|0|||
127492343|NCT01484496|458763660|FG003|Period 1|Lack of Compliance|0|||
127492344|NCT01484496|458763657|FG000|Period 1|Unable to Visit Site|0|||
127492345|NCT01484496|458763658|FG001|Period 1|Unable to Visit Site|2|||
127492346|NCT01484496|458763659|FG002|Period 1|Unable to Visit Site|0|||
127492347|NCT01484496|458763660|FG003|Period 1|Unable to Visit Site|0|||
127492348|NCT01484496|458763657|FG000|Period 2|Lack of Efficacy|0|||
127492349|NCT01484496|458763658|FG001|Period 2|Lack of Efficacy|0|||
127492350|NCT01484496|458763659|FG002|Period 2|Lack of Efficacy|1|||
127492351|NCT01484496|458763660|FG003|Period 2|Lack of Efficacy|3|||
127492352|NCT01484496|458763657|FG000|Period 2|Adverse Event|0|||
127492353|NCT01484496|458763658|FG001|Period 2|Adverse Event|0|||
127492354|NCT01484496|458763659|FG002|Period 2|Adverse Event|5|||
127492355|NCT01484496|458763660|FG003|Period 2|Adverse Event|13|||
127492356|NCT01484496|458763657|FG000|Period 2|Other|0|||
127492357|NCT01484496|458763658|FG001|Period 2|Other|0|||
127492358|NCT01484496|458763659|FG002|Period 2|Other|9|||
127492359|NCT01484496|458763660|FG003|Period 2|Other|6|||
127492360|NCT01645735|458763661|FG000|Overall Study|Physician Decision|2|||
127492361|NCT01645735|458763662|FG001|Overall Study|Physician Decision|0|||
127492362|NCT01645735|458763661|FG000|Overall Study|Withdrawal by Subject|1|||
127492363|NCT01645735|458763662|FG001|Overall Study|Withdrawal by Subject|0|||
127492364|NCT01645735|458763661|FG000|Overall Study|Protocol Violation|1|||
127492365|NCT01645735|458763662|FG001|Overall Study|Protocol Violation|0|||
127492366|NCT01645735|458763661|FG000|Overall Study|Adverse Event|0|||
127492367|NCT01645735|458763662|FG001|Overall Study|Adverse Event|1|||
127492368|NCT00310375|458763665|FG000|Primary Reporting Phase|Adverse Event|28|||
127492369|NCT00310375|458763666|FG001|Primary Reporting Phase|Adverse Event|22|||
127492370|NCT00310375|458763667|FG002|Primary Reporting Phase|Adverse Event|0|||
127492371|NCT00310375|458763665|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
127492372|NCT00310375|458763666|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
127492373|NCT00310375|458763667|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
127492374|NCT00310375|458763665|FG000|Primary Reporting Phase|Pregnancy|2|||
127492375|NCT00310375|458763666|FG001|Primary Reporting Phase|Pregnancy|2|||
127492376|NCT00310375|458763667|FG002|Primary Reporting Phase|Pregnancy|0|||
127492377|NCT00310375|458763665|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
127492378|NCT00310375|458763666|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
127492379|NCT00310375|458763667|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
127492380|NCT00310375|458763665|FG000|Primary Reporting Phase|Protocol Violation|8|||
127492381|NCT00310375|458763666|FG001|Primary Reporting Phase|Protocol Violation|5|||
127492382|NCT00310375|458763667|FG002|Primary Reporting Phase|Protocol Violation|0|||
127976926|NCT01340027|460536257|FG000|Overall Study|Adverse Event|0|||
127492383|NCT00310375|458763665|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
127492384|NCT00310375|458763666|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
127492385|NCT00310375|458763667|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
127492386|NCT00310375|458763665|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
127492387|NCT00310375|458763666|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
127492388|NCT00310375|458763667|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
127492389|NCT00310375|458763665|FG000|Primary Reporting Phase|Physician Decision|5|||
127492390|NCT00310375|458763666|FG001|Primary Reporting Phase|Physician Decision|3|||
127492391|NCT00310375|458763667|FG002|Primary Reporting Phase|Physician Decision|0|||
127492392|NCT00310375|458763665|FG000|Primary Reporting Phase|Request of the sponsor|2|||
127492393|NCT00310375|458763666|FG001|Primary Reporting Phase|Request of the sponsor|2|||
127492394|NCT00310375|458763667|FG002|Primary Reporting Phase|Request of the sponsor|0|||
127492395|NCT00310375|458763665|FG000|Primary Reporting Phase|Failed to return|1|||
127492396|NCT00310375|458763666|FG001|Primary Reporting Phase|Failed to return|3|||
127492397|NCT00310375|458763667|FG002|Primary Reporting Phase|Failed to return|0|||
127492398|NCT00310375|458763665|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
127492399|NCT00310375|458763666|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
127492400|NCT00310375|458763667|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
127492401|NCT00310375|458763665|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
127492402|NCT00310375|458763666|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
127492403|NCT00310375|458763667|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
127492404|NCT00310375|458763665|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
127492405|NCT00310375|458763666|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
127492406|NCT00310375|458763667|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
127492407|NCT00310375|458763665|FG000|Primary Reporting Phase|Site closure|3|||
127492408|NCT00310375|458763666|FG001|Primary Reporting Phase|Site closure|0|||
127492409|NCT00310375|458763667|FG002|Primary Reporting Phase|Site closure|0|||
127492410|NCT00310375|458763665|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
127492411|NCT00310375|458763666|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
127492412|NCT00310375|458763667|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
127492413|NCT00310375|458763665|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
127492414|NCT00310375|458763666|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
127492415|NCT00310375|458763667|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
127492416|NCT00310375|458763665|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
127492417|NCT00310375|458763666|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
127492418|NCT00310375|458763667|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
127492419|NCT00310375|458763665|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
127492420|NCT00310375|458763666|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
127492421|NCT00310375|458763667|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
127492422|NCT00131352|458763668|FG000|Initial Treatment Period|Adverse Event|1|||
127492423|NCT00131352|458763669|FG001|Initial Treatment Period|Adverse Event|3|||
127492424|NCT00131352|458763668|FG000|Initial Treatment Period|Non-compliant|1|||
127492425|NCT00131352|458763669|FG001|Initial Treatment Period|Non-compliant|2|||
127492426|NCT00131352|458763668|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
127492427|NCT00131352|458763669|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
127492428|NCT00131352|458763668|FG000|Initial Treatment Period|Lack of Efficacy|6|||
127492429|NCT00131352|458763669|FG001|Initial Treatment Period|Lack of Efficacy|4|||
127492430|NCT00131352|458763668|FG000|Initial Treatment Period|Other|0|||
127492431|NCT00131352|458763669|FG001|Initial Treatment Period|Other|2|||
127492432|NCT00131352|458763668|FG000|Repeat Treatment Period|Adverse Event|1|||
127492433|NCT00131352|458763669|FG001|Repeat Treatment Period|Adverse Event|0|||
127492434|NCT00131352|458763668|FG000|Repeat Treatment Period|Other|1|||
127492435|NCT00131352|458763669|FG001|Repeat Treatment Period|Other|0|||
127492436|NCT01206140|458763674|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
127492437|NCT01206140|458763675|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
127492438|NCT02817594|458763676|FG000|Overall Study|Withdrawal by Subject|1|||
127492439|NCT02817594|458763676|FG000|Overall Study|Other|1|||
127492440|NCT02817594|458763676|FG000|Overall Study|Did Not Receive Treatment|1|||
127492441|NCT00211172|458763677|FG000|Overall Study|Died or lost health plan eligibility|39|||
127492442|NCT00211172|458763678|FG001|Overall Study|Died or lost health plan eligibility|32|||
127492443|NCT00770562|458763682|FG000|Overall Study|Did not take treatment|1|||
127492444|NCT00770562|458763683|FG001|Overall Study|Did not take treatment|1|||
127492445|NCT01643408|458763684|FG000|Overall Study|Adverse Event|12|||
127492446|NCT01643408|458763684|FG000|Overall Study|Other|2|||
127492447|NCT01057693|458763685|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
127492448|NCT01057693|458763686|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
127492449|NCT01057693|458763687|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
127492450|NCT01057693|458763685|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
127492451|NCT01057693|458763686|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
127492452|NCT01057693|458763687|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
127492453|NCT01057693|458763685|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
127492454|NCT01057693|458763686|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
127492455|NCT01057693|458763687|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
127492456|NCT01057693|458763685|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
127492457|NCT01057693|458763686|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
127492458|NCT01057693|458763687|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
127492459|NCT01057693|458763685|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
127492460|NCT01057693|458763686|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
127492461|NCT01057693|458763687|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
127492462|NCT01057693|458763685|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
127492463|NCT01057693|458763686|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
127492464|NCT01057693|458763687|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
127492465|NCT01057693|458763685|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
127492466|NCT01057693|458763686|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
127492467|NCT01057693|458763687|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
127492468|NCT01057693|458763685|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
127492469|NCT01057693|458763686|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
127492470|NCT01057693|458763687|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
127492471|NCT01057693|458763685|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
127492472|NCT01057693|458763686|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
127492473|NCT01057693|458763687|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
127492474|NCT01057693|458763685|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
127492475|NCT01057693|458763686|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
127492476|NCT01057693|458763687|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
127492477|NCT01057693|458763685|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
127492478|NCT01057693|458763686|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
127492479|NCT01057693|458763687|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
127492480|NCT01057693|458763685|FG000|Between Single-Blind and Double-Blind|Other|6|||
127492481|NCT01057693|458763686|FG001|Between Single-Blind and Double-Blind|Other|0|||
127492482|NCT01057693|458763687|FG002|Between Single-Blind and Double-Blind|Other|0|||
127492483|NCT01057693|458763685|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
127492484|NCT01057693|458763686|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
127492485|NCT01057693|458763687|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
127492486|NCT01057693|458763685|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
127492487|NCT01057693|458763686|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
127492488|NCT01057693|458763687|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
127492489|NCT01057693|458763685|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
127492490|NCT01057693|458763686|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
127492491|NCT01057693|458763687|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
127492492|NCT01057693|458763685|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
127492493|NCT01057693|458763686|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
127492494|NCT01057693|458763687|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
127492495|NCT01057693|458763685|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
127492496|NCT01057693|458763686|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
127492497|NCT01057693|458763687|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
127492498|NCT01057693|458763685|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
127492499|NCT01057693|458763686|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
127492500|NCT01057693|458763687|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
127492501|NCT01057693|458763685|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
127492502|NCT01057693|458763686|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
127492503|NCT01057693|458763687|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
127492504|NCT04860869|458763690|FG000|Overall Study|Withdrawal by Subject|1|||
127492505|NCT04860869|458763691|FG001|Overall Study|Withdrawal by Subject|0|||
127492506|NCT03951766|458763692|FG000|Treatment Phase|Lost to Follow-up|1|||
127492507|NCT03951766|458763692|FG000|Follow-up Phase|Lost to Follow-up|10|||
127492508|NCT00363142|458763693|FG000|Overall Study|Adverse Event|2|||
127492509|NCT00363142|458763694|FG001|Overall Study|Adverse Event|0|||
127492510|NCT00363142|458763693|FG000|Overall Study|Lack of Efficacy|0|||
127492511|NCT00363142|458763694|FG001|Overall Study|Lack of Efficacy|1|||
127492512|NCT00363142|458763693|FG000|Overall Study|Lost to Follow-up|1|||
127492513|NCT00363142|458763694|FG001|Overall Study|Lost to Follow-up|0|||
127492514|NCT00363142|458763693|FG000|Overall Study|Non-compliance|1|||
127492515|NCT00363142|458763694|FG001|Overall Study|Non-compliance|1|||
127492516|NCT00363142|458763693|FG000|Overall Study|Withdrawal by Subject|3|||
127492517|NCT00363142|458763694|FG001|Overall Study|Withdrawal by Subject|1|||
127492518|NCT01541865|458763695|FG000|Overall Study|Lost to Follow-up|11|||
127492519|NCT01541865|458763695|FG000|Overall Study|Withdrawal by Subject|9|||
127492520|NCT01541865|458763695|FG000|Overall Study|Adverse Event|1|||
127492521|NCT01541865|458763695|FG000|Overall Study|Protocol Violation|1|||
127492522|NCT00049322|458763696|FG000|Overall Study|disease burden|0|||
127492523|NCT00049322|458763697|FG001|Overall Study|disease burden|3|||
127492524|NCT00049322|458763696|FG000|Overall Study|Adverse Event|1|||
127492525|NCT00049322|458763697|FG001|Overall Study|Adverse Event|0|||
127492526|NCT00049322|458763696|FG000|Overall Study|refused angio|0|||
127492527|NCT00049322|458763697|FG001|Overall Study|refused angio|3|||
127492528|NCT01926444|458763699|FG000|Overall Study|Colonoscopy not performed|0|||
127976927|NCT01340027|460536258|FG001|Overall Study|Adverse Event|1|||
127492529|NCT01926444|458763700|FG001|Overall Study|Colonoscopy not performed|0|||
127492530|NCT01926444|458763701|FG002|Overall Study|Colonoscopy not performed|4|||
127492531|NCT01926444|458763702|FG003|Overall Study|Colonoscopy not performed|2|||
127492532|NCT03943290|458763703|FG000|Overall Study|Sponsor Terminated Study|6|||
127492533|NCT03943290|458763704|FG001|Overall Study|Sponsor Terminated Study|1|||
127492534|NCT03943290|458763705|FG002|Overall Study|Sponsor Terminated Study|11|||
127492535|NCT03943290|458763706|FG003|Overall Study|Sponsor Terminated Study|6|||
127492536|NCT03943290|458763707|FG004|Overall Study|Sponsor Terminated Study|7|||
127492537|NCT03943290|458763708|FG005|Overall Study|Sponsor Terminated Study|6|||
127492538|NCT03943290|458763709|FG006|Overall Study|Sponsor Terminated Study|6|||
127492539|NCT03943290|458763710|FG007|Overall Study|Sponsor Terminated Study|7|||
127492540|NCT03943290|458763711|FG008|Overall Study|Sponsor Terminated Study|8|||
127492541|NCT03943290|458763703|FG000|Overall Study|Lost to Follow-up|1|||
127492542|NCT03943290|458763704|FG001|Overall Study|Lost to Follow-up|0|||
127492543|NCT03943290|458763705|FG002|Overall Study|Lost to Follow-up|1|||
127492544|NCT03943290|458763706|FG003|Overall Study|Lost to Follow-up|0|||
127492545|NCT03943290|458763707|FG004|Overall Study|Lost to Follow-up|0|||
127492546|NCT03943290|458763708|FG005|Overall Study|Lost to Follow-up|0|||
127492547|NCT03943290|458763709|FG006|Overall Study|Lost to Follow-up|0|||
127492548|NCT03943290|458763710|FG007|Overall Study|Lost to Follow-up|1|||
127492549|NCT03943290|458763711|FG008|Overall Study|Lost to Follow-up|0|||
127492550|NCT03943290|458763703|FG000|Overall Study|Withdrawal by Subject|0|||
127492551|NCT03943290|458763704|FG001|Overall Study|Withdrawal by Subject|0|||
127492552|NCT03943290|458763705|FG002|Overall Study|Withdrawal by Subject|1|||
127492553|NCT03943290|458763706|FG003|Overall Study|Withdrawal by Subject|0|||
127492554|NCT03943290|458763707|FG004|Overall Study|Withdrawal by Subject|0|||
127492555|NCT03943290|458763708|FG005|Overall Study|Withdrawal by Subject|0|||
127492556|NCT03943290|458763709|FG006|Overall Study|Withdrawal by Subject|0|||
127492557|NCT03943290|458763710|FG007|Overall Study|Withdrawal by Subject|0|||
127492558|NCT03943290|458763711|FG008|Overall Study|Withdrawal by Subject|0|||
127492559|NCT00295646|458763712|FG000|Overall Study|Protocol Violation|18|||
127492560|NCT00295646|458763713|FG001|Overall Study|Protocol Violation|20|||
127492561|NCT00295646|458763714|FG002|Overall Study|Protocol Violation|20|||
127492562|NCT00295646|458763715|FG003|Overall Study|Protocol Violation|18|||
127492563|NCT00295646|458763712|FG000|Overall Study|Withdrawal by Subject|8|||
127492564|NCT00295646|458763713|FG001|Overall Study|Withdrawal by Subject|9|||
127492565|NCT00295646|458763714|FG002|Overall Study|Withdrawal by Subject|11|||
127492566|NCT00295646|458763715|FG003|Overall Study|Withdrawal by Subject|14|||
127492567|NCT00295646|458763712|FG000|Overall Study|Lost to Follow-up|0|||
127492568|NCT00295646|458763713|FG001|Overall Study|Lost to Follow-up|5|||
127492569|NCT00295646|458763714|FG002|Overall Study|Lost to Follow-up|1|||
127492570|NCT00295646|458763715|FG003|Overall Study|Lost to Follow-up|5|||
127492571|NCT00295646|458763712|FG000|Overall Study|Death|9|||
127492572|NCT00295646|458763713|FG001|Overall Study|Death|7|||
127492573|NCT00295646|458763714|FG002|Overall Study|Death|18|||
127492574|NCT00295646|458763715|FG003|Overall Study|Death|8|||
127492575|NCT02441101|458763722|FG000|Overall Study|Withdrawal by Subject|1|||
127492576|NCT02441101|458763723|FG001|Overall Study|Withdrawal by Subject|0|||
127492577|NCT02441101|458763722|FG000|Overall Study|Lost to Follow-up|1|||
127492578|NCT02441101|458763723|FG001|Overall Study|Lost to Follow-up|0|||
127492579|NCT02441101|458763722|FG000|Overall Study|PI relocated and study terminated|1|||
127492580|NCT02441101|458763723|FG001|Overall Study|PI relocated and study terminated|0|||
127492581|NCT00955474|458763724|FG000|Overall Study|Physician Decision|7|||
127492582|NCT00955474|458763725|FG001|Overall Study|Physician Decision|5|||
127492583|NCT02528942|458763726|FG000|Overall Study|Did not meet imaging criteria|9|||
127492584|NCT02528942|458763726|FG000|Overall Study|Lost to Follow-up|25|||
127492585|NCT00881530|458763727|FG000|Overall Study|Adverse Event|5|||
127492586|NCT00881530|458763728|FG001|Overall Study|Adverse Event|1|||
127492587|NCT00881530|458763729|FG002|Overall Study|Adverse Event|1|||
127492588|NCT00881530|458763730|FG003|Overall Study|Adverse Event|4|||
127492589|NCT00881530|458763731|FG004|Overall Study|Adverse Event|10|||
127492590|NCT00881530|458763732|FG005|Overall Study|Adverse Event|2|||
127492591|NCT00881530|458763727|FG000|Overall Study|Lack of Efficacy|1|||
127492592|NCT00881530|458763728|FG001|Overall Study|Lack of Efficacy|0|||
127492593|NCT00881530|458763729|FG002|Overall Study|Lack of Efficacy|0|||
127492594|NCT00881530|458763730|FG003|Overall Study|Lack of Efficacy|0|||
127492595|NCT00881530|458763731|FG004|Overall Study|Lack of Efficacy|1|||
127492596|NCT00881530|458763732|FG005|Overall Study|Lack of Efficacy|1|||
127492597|NCT00881530|458763727|FG000|Overall Study|Not compliant with the protocol|0|||
127492598|NCT00881530|458763728|FG001|Overall Study|Not compliant with the protocol|0|||
127492599|NCT00881530|458763729|FG002|Overall Study|Not compliant with the protocol|0|||
127492600|NCT00881530|458763730|FG003|Overall Study|Not compliant with the protocol|0|||
127492601|NCT00881530|458763731|FG004|Overall Study|Not compliant with the protocol|2|||
127492602|NCT00881530|458763732|FG005|Overall Study|Not compliant with the protocol|0|||
127492603|NCT00881530|458763727|FG000|Overall Study|Lost to Follow-up|0|||
127492604|NCT00881530|458763728|FG001|Overall Study|Lost to Follow-up|1|||
127492605|NCT00881530|458763729|FG002|Overall Study|Lost to Follow-up|1|||
127492606|NCT00881530|458763730|FG003|Overall Study|Lost to Follow-up|3|||
127492607|NCT00881530|458763731|FG004|Overall Study|Lost to Follow-up|1|||
127492608|NCT00881530|458763732|FG005|Overall Study|Lost to Follow-up|0|||
127492609|NCT00881530|458763727|FG000|Overall Study|Refused to continue medication|7|||
127492610|NCT00881530|458763728|FG001|Overall Study|Refused to continue medication|2|||
127492611|NCT00881530|458763729|FG002|Overall Study|Refused to continue medication|1|||
127492612|NCT00881530|458763730|FG003|Overall Study|Refused to continue medication|2|||
127492613|NCT00881530|458763731|FG004|Overall Study|Refused to continue medication|0|||
127492614|NCT00881530|458763732|FG005|Overall Study|Refused to continue medication|0|||
127492615|NCT00881530|458763727|FG000|Overall Study|Other reason not defined above|1|||
127492616|NCT00881530|458763728|FG001|Overall Study|Other reason not defined above|1|||
127492617|NCT00881530|458763729|FG002|Overall Study|Other reason not defined above|2|||
127492618|NCT00881530|458763730|FG003|Overall Study|Other reason not defined above|0|||
127492619|NCT00881530|458763731|FG004|Overall Study|Other reason not defined above|0|||
127492620|NCT00881530|458763732|FG005|Overall Study|Other reason not defined above|2|||
127492621|NCT02131662|458763737|FG000|Overall Study|Protocol Violation|1|||
127492622|NCT02131662|458763738|FG001|Overall Study|Protocol Violation|0|||
127492623|NCT02131662|458763739|FG002|Overall Study|Protocol Violation|0|||
127492624|NCT02131662|458763740|FG003|Overall Study|Protocol Violation|0|||
127492625|NCT02131662|458763741|FG004|Overall Study|Protocol Violation|0|||
127492626|NCT02131662|458763737|FG000|Overall Study|Other|2|||
127492627|NCT02131662|458763738|FG001|Overall Study|Other|4|||
127492628|NCT02131662|458763739|FG002|Overall Study|Other|3|||
127492629|NCT02131662|458763740|FG003|Overall Study|Other|3|||
127492630|NCT02131662|458763741|FG004|Overall Study|Other|4|||
127492631|NCT02131662|458763737|FG000|Overall Study|Adverse Event|0|||
127492632|NCT02131662|458763738|FG001|Overall Study|Adverse Event|1|||
127492633|NCT02131662|458763739|FG002|Overall Study|Adverse Event|1|||
127492634|NCT02131662|458763740|FG003|Overall Study|Adverse Event|1|||
127492635|NCT02131662|458763741|FG004|Overall Study|Adverse Event|3|||
127492636|NCT02131662|458763737|FG000|Overall Study|Pregnancy|0|||
127492637|NCT02131662|458763738|FG001|Overall Study|Pregnancy|1|||
127492638|NCT02131662|458763739|FG002|Overall Study|Pregnancy|0|||
127492639|NCT02131662|458763740|FG003|Overall Study|Pregnancy|1|||
127492640|NCT02131662|458763741|FG004|Overall Study|Pregnancy|0|||
127492641|NCT02131662|458763737|FG000|Overall Study|Wish for pregnancy|0|||
127492642|NCT02131662|458763738|FG001|Overall Study|Wish for pregnancy|0|||
127492643|NCT02131662|458763739|FG002|Overall Study|Wish for pregnancy|0|||
127492644|NCT02131662|458763740|FG003|Overall Study|Wish for pregnancy|0|||
127492645|NCT02131662|458763741|FG004|Overall Study|Wish for pregnancy|1|||
127492646|NCT02131662|458763737|FG000|Overall Study|Lack of Efficacy|1|||
127492647|NCT02131662|458763738|FG001|Overall Study|Lack of Efficacy|0|||
127492648|NCT02131662|458763739|FG002|Overall Study|Lack of Efficacy|0|||
127492649|NCT02131662|458763740|FG003|Overall Study|Lack of Efficacy|0|||
127492650|NCT02131662|458763741|FG004|Overall Study|Lack of Efficacy|1|||
127492651|NCT02131662|458763737|FG000|Overall Study|Withdrawal by Subject|1|||
127492652|NCT02131662|458763738|FG001|Overall Study|Withdrawal by Subject|5|||
127492653|NCT02131662|458763739|FG002|Overall Study|Withdrawal by Subject|1|||
127492654|NCT02131662|458763740|FG003|Overall Study|Withdrawal by Subject|5|||
127492655|NCT02131662|458763741|FG004|Overall Study|Withdrawal by Subject|6|||
127492656|NCT02131662|458763737|FG000|Overall Study|Lost to Follow-up|1|||
127492657|NCT02131662|458763738|FG001|Overall Study|Lost to Follow-up|3|||
127492658|NCT02131662|458763739|FG002|Overall Study|Lost to Follow-up|0|||
127492659|NCT02131662|458763740|FG003|Overall Study|Lost to Follow-up|9|||
127492660|NCT02131662|458763741|FG004|Overall Study|Lost to Follow-up|0|||
127492661|NCT02131662|458763737|FG000|Overall Study|Not treated|2|||
127492662|NCT02131662|458763738|FG001|Overall Study|Not treated|0|||
127492663|NCT02131662|458763739|FG002|Overall Study|Not treated|2|||
127492664|NCT02131662|458763740|FG003|Overall Study|Not treated|2|||
127976928|NCT01340027|460536259|FG002|Overall Study|Adverse Event|2|||
127976929|NCT01340027|460536260|FG003|Overall Study|Adverse Event|0|||
127976930|NCT01340027|460536261|FG004|Overall Study|Adverse Event|1|||
127976931|NCT01340027|460536262|FG005|Overall Study|Adverse Event|2|||
127492665|NCT02131662|458763741|FG004|Overall Study|Not treated|3|||
127492666|NCT01402869|458763742|FG000|Overall Study|Required Tooth Extraction|0|||
127976932|NCT01340027|460536263|FG006|Overall Study|Adverse Event|2|||
127492667|NCT01402869|458763743|FG001|Overall Study|Required Tooth Extraction|0|||
127492668|NCT01402869|458763744|FG002|Overall Study|Required Tooth Extraction|1|||
127492669|NCT01740687|458763745|FG000|Overall Study|Lost to Follow-up|11|||
127492670|NCT01740687|458763745|FG000|Overall Study|Withdrawal by Subject|2|||
127492671|NCT01740687|458763745|FG000|Overall Study|other reason|22|||
127492672|NCT01740687|458763745|FG000|Overall Study|treatment not received|2|||
127492673|NCT00104728|458763747|FG000|Overall Study|screen failures|19|||
127492674|NCT01963767|458763748|FG000|Overall Study|Withdrawal by Subject|4|||
127492675|NCT01963767|458763749|FG001|Overall Study|Withdrawal by Subject|2|||
127492676|NCT01963767|458763748|FG000|Overall Study|Adverse Event|2|||
127492677|NCT01963767|458763749|FG001|Overall Study|Adverse Event|0|||
127492678|NCT03960684|458763750|FG000|Overall Study|Did not proceed to surgery with MSS|1|||
127492679|NCT03941483|458763754|FG000|Overall Study|Miscellaneous|2|||
127976933|NCT01340027|460536264|FG007|Overall Study|Adverse Event|1|||
127492680|NCT03941483|458763755|FG001|Overall Study|Miscellaneous|3|||
127492681|NCT03941483|458763756|FG002|Overall Study|Miscellaneous|0|||
127492682|NCT03941483|458763754|FG000|Overall Study|Study Terminated by Sponsor|1|||
127492683|NCT03941483|458763755|FG001|Overall Study|Study Terminated by Sponsor|0|||
127492684|NCT03941483|458763756|FG002|Overall Study|Study Terminated by Sponsor|0|||
127492685|NCT03941483|458763754|FG000|Overall Study|Withdrawal by Subject|1|||
127492686|NCT03941483|458763755|FG001|Overall Study|Withdrawal by Subject|4|||
127492687|NCT03941483|458763756|FG002|Overall Study|Withdrawal by Subject|1|||
127492688|NCT03941483|458763754|FG000|Overall Study|Lost to Follow-up|2|||
127492689|NCT03941483|458763755|FG001|Overall Study|Lost to Follow-up|1|||
127492690|NCT03941483|458763756|FG002|Overall Study|Lost to Follow-up|8|||
127492691|NCT03941483|458763754|FG000|Overall Study|Death|3|||
127492692|NCT03941483|458763755|FG001|Overall Study|Death|2|||
127492693|NCT03941483|458763756|FG002|Overall Study|Death|6|||
127492694|NCT01082081|458763757|FG000|Overall Study|Lost to Follow-up|0|||
127492695|NCT01082081|458763758|FG001|Overall Study|Lost to Follow-up|0|||
127492696|NCT01082081|458763759|FG002|Overall Study|Lost to Follow-up|1|||
127492697|NCT01082081|458763757|FG000|Overall Study|Withdrawal by Subject|0|||
127492698|NCT01082081|458763758|FG001|Overall Study|Withdrawal by Subject|0|||
127492699|NCT01082081|458763759|FG002|Overall Study|Withdrawal by Subject|1|||
127492700|NCT01082081|458763757|FG000|Overall Study|Other Reason|0|||
127492701|NCT01082081|458763758|FG001|Overall Study|Other Reason|1|||
127492702|NCT01082081|458763759|FG002|Overall Study|Other Reason|0|||
127492703|NCT00670930|458763762|FG000|Overall Study|Adminstrative Problem|0|||
127492704|NCT00670930|458763763|FG001|Overall Study|Adminstrative Problem|1|||
127492705|NCT00670930|458763762|FG000|Overall Study|Lost to Follow-up|1|||
127492706|NCT00670930|458763763|FG001|Overall Study|Lost to Follow-up|0|||
127492707|NCT03493451|458765086|FG000|Overall Study|Death|11|||
127492708|NCT03493451|458765087|FG001|Overall Study|Death|26|||
127492709|NCT03493451|458765088|FG002|Overall Study|Death|3|||
127492710|NCT03493451|458765086|FG000|Overall Study|Lost to Follow-up|1|||
127492711|NCT03493451|458765087|FG001|Overall Study|Lost to Follow-up|4|||
127492712|NCT03493451|458765088|FG002|Overall Study|Lost to Follow-up|1|||
127492713|NCT03493451|458765086|FG000|Overall Study|Withdrawal by Subject|1|||
127492714|NCT03493451|458765087|FG001|Overall Study|Withdrawal by Subject|1|||
127492715|NCT03493451|458765088|FG002|Overall Study|Withdrawal by Subject|2|||
127492716|NCT03493451|458765086|FG000|Overall Study|Progressive Disease|1|||
127492717|NCT03493451|458765087|FG001|Overall Study|Progressive Disease|0|||
127492718|NCT03493451|458765088|FG002|Overall Study|Progressive Disease|0|||
127492719|NCT03493451|458765086|FG000|Overall Study|Transferred to long term extension study|8|||
127492720|NCT03493451|458765087|FG001|Overall Study|Transferred to long term extension study|13|||
127492721|NCT03493451|458765088|FG002|Overall Study|Transferred to long term extension study|5|||
127976934|NCT01340027|460536265|FG008|Overall Study|Adverse Event|4|||
127976935|NCT01340027|460536266|FG009|Overall Study|Adverse Event|1|||
127976936|NCT01340027|460536267|FG010|Overall Study|Adverse Event|1|||
127976937|NCT01340027|460536268|FG011|Overall Study|Adverse Event|3|||
127976938|NCT01340027|460536257|FG000|Overall Study|Lack of Efficacy|0|||
127976939|NCT01340027|460536258|FG001|Overall Study|Lack of Efficacy|0|||
127976940|NCT01340027|460536259|FG002|Overall Study|Lack of Efficacy|0|||
127976941|NCT01340027|460536260|FG003|Overall Study|Lack of Efficacy|0|||
127976942|NCT01340027|460536261|FG004|Overall Study|Lack of Efficacy|0|||
127976943|NCT01340027|460536262|FG005|Overall Study|Lack of Efficacy|0|||
127976944|NCT01340027|460536263|FG006|Overall Study|Lack of Efficacy|1|||
127976945|NCT01340027|460536264|FG007|Overall Study|Lack of Efficacy|1|||
127976946|NCT01340027|460536265|FG008|Overall Study|Lack of Efficacy|1|||
127976947|NCT01340027|460536266|FG009|Overall Study|Lack of Efficacy|0|||
127976948|NCT01340027|460536267|FG010|Overall Study|Lack of Efficacy|0|||
127976949|NCT01340027|460536268|FG011|Overall Study|Lack of Efficacy|0|||
127976950|NCT01340027|460536257|FG000|Overall Study|Lost to Follow-up|0|||
127976951|NCT01340027|460536258|FG001|Overall Study|Lost to Follow-up|1|||
127976952|NCT01340027|460536259|FG002|Overall Study|Lost to Follow-up|0|||
127976953|NCT01340027|460536260|FG003|Overall Study|Lost to Follow-up|0|||
127976954|NCT01340027|460536261|FG004|Overall Study|Lost to Follow-up|0|||
127976955|NCT01340027|460536262|FG005|Overall Study|Lost to Follow-up|0|||
127492722|NCT01238991|458765089|FG000|Overall Study|Adverse Event|1|||
127492723|NCT01238991|458765090|FG001|Overall Study|Adverse Event|0|||
127492724|NCT01238991|458765091|FG002|Overall Study|Adverse Event|3|||
127492725|NCT01238991|458765092|FG003|Overall Study|Adverse Event|1|||
127492726|NCT01238991|458765093|FG004|Overall Study|Adverse Event|1|||
127492727|NCT01238991|458765094|FG005|Overall Study|Adverse Event|0|||
127492728|NCT01238991|458765095|FG006|Overall Study|Adverse Event|1|||
127492729|NCT01238991|458765096|FG007|Overall Study|Adverse Event|1|||
127492730|NCT01238991|458765097|FG008|Overall Study|Adverse Event|0|||
127492731|NCT01238991|458765098|FG009|Overall Study|Adverse Event|0|||
127492732|NCT01238991|458765089|FG000|Overall Study|Death|0|||
127492733|NCT01238991|458765090|FG001|Overall Study|Death|0|||
127492734|NCT01238991|458765091|FG002|Overall Study|Death|0|||
127976956|NCT01340027|460536263|FG006|Overall Study|Lost to Follow-up|1|||
127976957|NCT01340027|460536264|FG007|Overall Study|Lost to Follow-up|0|||
127976958|NCT01340027|460536265|FG008|Overall Study|Lost to Follow-up|0|||
127492735|NCT01238991|458765092|FG003|Overall Study|Death|1|||
127492736|NCT01238991|458765093|FG004|Overall Study|Death|0|||
127492737|NCT01238991|458765094|FG005|Overall Study|Death|0|||
127492738|NCT01238991|458765095|FG006|Overall Study|Death|0|||
127492739|NCT01238991|458765096|FG007|Overall Study|Death|0|||
127492740|NCT01238991|458765097|FG008|Overall Study|Death|0|||
127492741|NCT01238991|458765098|FG009|Overall Study|Death|0|||
127492742|NCT01238991|458765089|FG000|Overall Study|Lack of Efficacy|0|||
127492743|NCT01238991|458765090|FG001|Overall Study|Lack of Efficacy|0|||
127492744|NCT01238991|458765091|FG002|Overall Study|Lack of Efficacy|1|||
127492745|NCT01238991|458765092|FG003|Overall Study|Lack of Efficacy|0|||
127492746|NCT01238991|458765093|FG004|Overall Study|Lack of Efficacy|0|||
127492747|NCT01238991|458765094|FG005|Overall Study|Lack of Efficacy|0|||
127492748|NCT01238991|458765095|FG006|Overall Study|Lack of Efficacy|0|||
127492749|NCT01238991|458765096|FG007|Overall Study|Lack of Efficacy|0|||
127492750|NCT01238991|458765097|FG008|Overall Study|Lack of Efficacy|1|||
127492751|NCT01238991|458765098|FG009|Overall Study|Lack of Efficacy|0|||
127492752|NCT01238991|458765089|FG000|Overall Study|Withdrawal by Subject|0|||
127492753|NCT01238991|458765090|FG001|Overall Study|Withdrawal by Subject|0|||
127492754|NCT01238991|458765091|FG002|Overall Study|Withdrawal by Subject|1|||
127492755|NCT01238991|458765092|FG003|Overall Study|Withdrawal by Subject|0|||
127492756|NCT01238991|458765093|FG004|Overall Study|Withdrawal by Subject|0|||
127492757|NCT01238991|458765094|FG005|Overall Study|Withdrawal by Subject|0|||
127492758|NCT01238991|458765095|FG006|Overall Study|Withdrawal by Subject|0|||
127492759|NCT01238991|458765096|FG007|Overall Study|Withdrawal by Subject|0|||
127492760|NCT01238991|458765097|FG008|Overall Study|Withdrawal by Subject|0|||
127492761|NCT01238991|458765098|FG009|Overall Study|Withdrawal by Subject|0|||
127492762|NCT01238991|458765089|FG000|Overall Study|Study Terminated by Sponsor|0|||
127492763|NCT01238991|458765090|FG001|Overall Study|Study Terminated by Sponsor|0|||
127492764|NCT01238991|458765091|FG002|Overall Study|Study Terminated by Sponsor|0|||
127492765|NCT01238991|458765092|FG003|Overall Study|Study Terminated by Sponsor|0|||
127492766|NCT01238991|458765093|FG004|Overall Study|Study Terminated by Sponsor|1|||
127492767|NCT01238991|458765094|FG005|Overall Study|Study Terminated by Sponsor|0|||
127492768|NCT01238991|458765095|FG006|Overall Study|Study Terminated by Sponsor|7|||
127492769|NCT01238991|458765096|FG007|Overall Study|Study Terminated by Sponsor|4|||
127492770|NCT01238991|458765097|FG008|Overall Study|Study Terminated by Sponsor|2|||
127492771|NCT01238991|458765098|FG009|Overall Study|Study Terminated by Sponsor|2|||
127492772|NCT01238991|458765089|FG000|Overall Study|Caregiver's request|0|||
127492773|NCT01238991|458765090|FG001|Overall Study|Caregiver's request|0|||
127492774|NCT01238991|458765091|FG002|Overall Study|Caregiver's request|0|||
127492775|NCT01238991|458765092|FG003|Overall Study|Caregiver's request|0|||
127492776|NCT01238991|458765093|FG004|Overall Study|Caregiver's request|0|||
127492777|NCT01238991|458765094|FG005|Overall Study|Caregiver's request|0|||
127492778|NCT01238991|458765095|FG006|Overall Study|Caregiver's request|0|||
127492779|NCT01238991|458765096|FG007|Overall Study|Caregiver's request|0|||
127492780|NCT01238991|458765097|FG008|Overall Study|Caregiver's request|1|||
127492781|NCT01238991|458765098|FG009|Overall Study|Caregiver's request|0|||
127492782|NCT01238991|458765089|FG000|Overall Study|Admission to a nursing home|1|||
127492783|NCT01238991|458765090|FG001|Overall Study|Admission to a nursing home|0|||
127492784|NCT01238991|458765091|FG002|Overall Study|Admission to a nursing home|1|||
127492785|NCT01238991|458765092|FG003|Overall Study|Admission to a nursing home|0|||
127492786|NCT01238991|458765093|FG004|Overall Study|Admission to a nursing home|0|||
127492787|NCT01238991|458765094|FG005|Overall Study|Admission to a nursing home|0|||
127492788|NCT01238991|458765095|FG006|Overall Study|Admission to a nursing home|0|||
127492789|NCT01238991|458765096|FG007|Overall Study|Admission to a nursing home|0|||
127492790|NCT01238991|458765097|FG008|Overall Study|Admission to a nursing home|0|||
127492791|NCT01238991|458765098|FG009|Overall Study|Admission to a nursing home|0|||
127492792|NCT03370419|458765099|FG000|Overall Study|Lost to Follow-up|16|||
127492793|NCT00600106|458765109|FG000|Overall Study|Withdrawal by Subject|1|||
127492794|NCT00600106|458765110|FG001|Overall Study|Withdrawal by Subject|1|||
127492795|NCT01897727|458765113|FG000|Overall Study|Exclusion: central sleep apnea|0|||
127492796|NCT01897727|458765114|FG001|Overall Study|Exclusion: central sleep apnea|1|||
127492797|NCT03015363|458765115|FG000|Overall Study|Physician Decision|14|||
127492798|NCT03015363|458765115|FG000|Overall Study|Withdrawal by Subject|3|||
127492799|NCT00078806|458765116|FG000|Part 1A|Adverse Event|2|||
127492800|NCT00078806|458765117|FG001|Part 1A|Adverse Event|0|||
127492801|NCT00078806|458765118|FG002|Part 1A|Adverse Event|0|||
127492802|NCT00078806|458765119|FG003|Part 1A|Adverse Event|0|||
127492803|NCT00078806|458765116|FG000|Part 1A|Lack of Efficacy|7|||
127492804|NCT00078806|458765117|FG001|Part 1A|Lack of Efficacy|0|||
127492805|NCT00078806|458765118|FG002|Part 1A|Lack of Efficacy|0|||
127492806|NCT00078806|458765119|FG003|Part 1A|Lack of Efficacy|0|||
127492807|NCT00078806|458765116|FG000|Part 1A|Other|1|||
127492808|NCT00078806|458765117|FG001|Part 1A|Other|0|||
127492809|NCT00078806|458765118|FG002|Part 1A|Other|0|||
127492810|NCT00078806|458765119|FG003|Part 1A|Other|0|||
127492811|NCT00078806|458765116|FG000|Part 1B|Adverse Event|1|||
127492812|NCT00078806|458765117|FG001|Part 1B|Adverse Event|0|||
127492813|NCT00078806|458765118|FG002|Part 1B|Adverse Event|0|||
127492814|NCT00078806|458765119|FG003|Part 1B|Adverse Event|0|||
127492815|NCT00078806|458765116|FG000|Part 1B|Lack of Efficacy|7|||
127492816|NCT00078806|458765117|FG001|Part 1B|Lack of Efficacy|0|||
127492817|NCT00078806|458765118|FG002|Part 1B|Lack of Efficacy|0|||
127492818|NCT00078806|458765119|FG003|Part 1B|Lack of Efficacy|0|||
127492819|NCT00078806|458765116|FG000|Part 2|Adverse Event|0|||
127492820|NCT00078806|458765117|FG001|Part 2|Adverse Event|1|||
127492821|NCT00078806|458765118|FG002|Part 2|Adverse Event|0|||
127492822|NCT00078806|458765119|FG003|Part 2|Adverse Event|0|||
127492823|NCT01734785|458765122|FG000|Open-Label Period|Adverse Event|0|||
127492824|NCT01734785|458765123|FG001|Open-Label Period|Adverse Event|0|||
127492825|NCT01734785|458765124|FG002|Open-Label Period|Adverse Event|0|||
127492826|NCT01734785|458765125|FG003|Open-Label Period|Adverse Event|9|||
127492827|NCT01734785|458765122|FG000|Open-Label Period|Lack of Efficacy|0|||
127492828|NCT01734785|458765123|FG001|Open-Label Period|Lack of Efficacy|0|||
127492829|NCT01734785|458765124|FG002|Open-Label Period|Lack of Efficacy|0|||
127492830|NCT01734785|458765125|FG003|Open-Label Period|Lack of Efficacy|1|||
127492831|NCT01734785|458765122|FG000|Open-Label Period|Protocol Violation|0|||
127492832|NCT01734785|458765123|FG001|Open-Label Period|Protocol Violation|0|||
127492833|NCT01734785|458765124|FG002|Open-Label Period|Protocol Violation|0|||
127492834|NCT01734785|458765125|FG003|Open-Label Period|Protocol Violation|13|||
127492835|NCT01734785|458765122|FG000|Open-Label Period|Lost to Follow-up|0|||
127492836|NCT01734785|458765123|FG001|Open-Label Period|Lost to Follow-up|0|||
127492837|NCT01734785|458765124|FG002|Open-Label Period|Lost to Follow-up|0|||
127492838|NCT01734785|458765125|FG003|Open-Label Period|Lost to Follow-up|14|||
127492839|NCT01734785|458765122|FG000|Open-Label Period|Withdrawal by Subject|0|||
127492840|NCT01734785|458765123|FG001|Open-Label Period|Withdrawal by Subject|0|||
127492841|NCT01734785|458765124|FG002|Open-Label Period|Withdrawal by Subject|0|||
127492842|NCT01734785|458765125|FG003|Open-Label Period|Withdrawal by Subject|12|||
127492843|NCT01734785|458765122|FG000|Open-Label Period|Other Reasons|0|||
127492844|NCT01734785|458765123|FG001|Open-Label Period|Other Reasons|0|||
127492845|NCT01734785|458765124|FG002|Open-Label Period|Other Reasons|0|||
127492846|NCT01734785|458765125|FG003|Open-Label Period|Other Reasons|224|||
127492847|NCT01734785|458765122|FG000|Double-Blind Period|Adverse Event|0|||
127492848|NCT01734785|458765123|FG001|Double-Blind Period|Adverse Event|3|||
127492849|NCT01734785|458765124|FG002|Double-Blind Period|Adverse Event|2|||
127492850|NCT01734785|458765125|FG003|Double-Blind Period|Adverse Event|0|||
127492851|NCT01734785|458765122|FG000|Double-Blind Period|Lack of Efficacy|0|||
127492852|NCT01734785|458765123|FG001|Double-Blind Period|Lack of Efficacy|1|||
127492853|NCT01734785|458765124|FG002|Double-Blind Period|Lack of Efficacy|0|||
127492854|NCT01734785|458765125|FG003|Double-Blind Period|Lack of Efficacy|0|||
127492855|NCT01734785|458765122|FG000|Double-Blind Period|Protocol Violation|0|||
127492856|NCT01734785|458765123|FG001|Double-Blind Period|Protocol Violation|1|||
127492857|NCT01734785|458765124|FG002|Double-Blind Period|Protocol Violation|1|||
127492858|NCT01734785|458765125|FG003|Double-Blind Period|Protocol Violation|0|||
127492859|NCT01734785|458765122|FG000|Double-Blind Period|Lost to Follow-up|2|||
127492860|NCT01734785|458765123|FG001|Double-Blind Period|Lost to Follow-up|4|||
127492861|NCT01734785|458765124|FG002|Double-Blind Period|Lost to Follow-up|2|||
127492862|NCT01734785|458765125|FG003|Double-Blind Period|Lost to Follow-up|0|||
127492863|NCT01734785|458765122|FG000|Double-Blind Period|Withdrawal by Subject|2|||
127492864|NCT01734785|458765123|FG001|Double-Blind Period|Withdrawal by Subject|0|||
127492865|NCT01734785|458765124|FG002|Double-Blind Period|Withdrawal by Subject|0|||
127492866|NCT01734785|458765125|FG003|Double-Blind Period|Withdrawal by Subject|0|||
127492867|NCT01734785|458765122|FG000|Double-Blind Period|Not treated|1|||
127492868|NCT01734785|458765123|FG001|Double-Blind Period|Not treated|0|||
127492869|NCT01734785|458765124|FG002|Double-Blind Period|Not treated|0|||
127492870|NCT01734785|458765125|FG003|Double-Blind Period|Not treated|0|||
127492871|NCT02013778|458765128|FG000|Overall Study|Death|4|||
127492872|NCT02013778|458765128|FG000|Overall Study|Withdrawal by Subject|1|||
127492873|NCT02013778|458765128|FG000|Overall Study|Physician Decision|1|||
127492874|NCT02013778|458765128|FG000|Overall Study|Adverse Event|1|||
127492875|NCT00293813|458765129|FG000|Overall Study|Physician Decision|0|||
127492876|NCT00293813|458765130|FG001|Overall Study|Physician Decision|1|||
127492877|NCT00293813|458765131|FG002|Overall Study|Physician Decision|0|||
127976959|NCT01340027|460536266|FG009|Overall Study|Lost to Follow-up|1|||
127492878|NCT00293813|458765129|FG000|Overall Study|Adverse Event|3|||
127492879|NCT00293813|458765130|FG001|Overall Study|Adverse Event|1|||
127492880|NCT00293813|458765131|FG002|Overall Study|Adverse Event|1|||
127492881|NCT00293813|458765129|FG000|Overall Study|Withdrawal by Subject|7|||
127492882|NCT00293813|458765130|FG001|Overall Study|Withdrawal by Subject|4|||
127492883|NCT00293813|458765131|FG002|Overall Study|Withdrawal by Subject|4|||
127492884|NCT00293813|458765129|FG000|Overall Study|Lost to Follow-up|3|||
127492885|NCT00293813|458765130|FG001|Overall Study|Lost to Follow-up|2|||
127492886|NCT00293813|458765131|FG002|Overall Study|Lost to Follow-up|3|||
127492887|NCT00293813|458765129|FG000|Overall Study|Noncompliance|0|||
127492888|NCT00293813|458765130|FG001|Overall Study|Noncompliance|1|||
127492889|NCT00293813|458765131|FG002|Overall Study|Noncompliance|0|||
127492890|NCT01521923|458765134|FG000|Overall Study|AE, serious fatal|1|||
127492891|NCT01521923|458765135|FG001|Overall Study|AE, serious fatal|0|||
127492892|NCT01521923|458765136|FG002|Overall Study|AE, serious fatal|0|||
127492893|NCT01521923|458765137|FG003|Overall Study|AE, serious fatal|0|||
127492894|NCT01521923|458765134|FG000|Overall Study|SAE, non-fatal|0|||
127492895|NCT01521923|458765135|FG001|Overall Study|SAE, non-fatal|2|||
127492896|NCT01521923|458765136|FG002|Overall Study|SAE, non-fatal|2|||
127492897|NCT01521923|458765137|FG003|Overall Study|SAE, non-fatal|0|||
127492898|NCT01521923|458765134|FG000|Overall Study|AE, non-serious, non-fatal|1|||
127492899|NCT01521923|458765135|FG001|Overall Study|AE, non-serious, non-fatal|3|||
127492900|NCT01521923|458765136|FG002|Overall Study|AE, non-serious, non-fatal|6|||
127492901|NCT01521923|458765137|FG003|Overall Study|AE, non-serious, non-fatal|2|||
127492902|NCT01521923|458765134|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
127492903|NCT01521923|458765135|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
127976960|NCT01340027|460536267|FG010|Overall Study|Lost to Follow-up|0|||
127976961|NCT01340027|460536268|FG011|Overall Study|Lost to Follow-up|0|||
127976962|NCT01340027|460536257|FG000|Overall Study|Protocol Violation|1|||
127976963|NCT01340027|460536258|FG001|Overall Study|Protocol Violation|2|||
127976964|NCT01340027|460536259|FG002|Overall Study|Protocol Violation|0|||
127976965|NCT01340027|460536260|FG003|Overall Study|Protocol Violation|0|||
127976966|NCT01340027|460536261|FG004|Overall Study|Protocol Violation|6|||
127976967|NCT01340027|460536262|FG005|Overall Study|Protocol Violation|0|||
127976968|NCT01340027|460536263|FG006|Overall Study|Protocol Violation|0|||
127976969|NCT01340027|460536264|FG007|Overall Study|Protocol Violation|1|||
127976970|NCT01340027|460536265|FG008|Overall Study|Protocol Violation|2|||
127976971|NCT01340027|460536266|FG009|Overall Study|Protocol Violation|2|||
127976972|NCT01340027|460536267|FG010|Overall Study|Protocol Violation|0|||
127976973|NCT01340027|460536268|FG011|Overall Study|Protocol Violation|0|||
127976974|NCT01340027|460536257|FG000|Overall Study|Withdrawal by Subject|4|||
127976975|NCT01340027|460536258|FG001|Overall Study|Withdrawal by Subject|3|||
127976976|NCT01340027|460536259|FG002|Overall Study|Withdrawal by Subject|1|||
127976977|NCT01340027|460536260|FG003|Overall Study|Withdrawal by Subject|3|||
127976978|NCT01340027|460536261|FG004|Overall Study|Withdrawal by Subject|3|||
127976979|NCT01340027|460536262|FG005|Overall Study|Withdrawal by Subject|2|||
127976980|NCT01340027|460536263|FG006|Overall Study|Withdrawal by Subject|3|||
127976981|NCT01340027|460536264|FG007|Overall Study|Withdrawal by Subject|4|||
127976982|NCT01340027|460536265|FG008|Overall Study|Withdrawal by Subject|1|||
127976983|NCT01340027|460536266|FG009|Overall Study|Withdrawal by Subject|2|||
127976984|NCT01340027|460536267|FG010|Overall Study|Withdrawal by Subject|0|||
127976985|NCT01340027|460536268|FG011|Overall Study|Withdrawal by Subject|1|||
127976986|NCT01340027|460536257|FG000|Overall Study|Miscellaneous|0|||
127976987|NCT01340027|460536258|FG001|Overall Study|Miscellaneous|0|||
127976988|NCT01340027|460536259|FG002|Overall Study|Miscellaneous|0|||
127976989|NCT01340027|460536260|FG003|Overall Study|Miscellaneous|1|||
127976990|NCT01340027|460536261|FG004|Overall Study|Miscellaneous|0|||
127976991|NCT01340027|460536262|FG005|Overall Study|Miscellaneous|0|||
127976992|NCT01340027|460536263|FG006|Overall Study|Miscellaneous|0|||
127976993|NCT01340027|460536264|FG007|Overall Study|Miscellaneous|0|||
127976994|NCT01340027|460536265|FG008|Overall Study|Miscellaneous|0|||
127976995|NCT01340027|460536266|FG009|Overall Study|Miscellaneous|0|||
127976996|NCT01340027|460536267|FG010|Overall Study|Miscellaneous|1|||
127976997|NCT01340027|460536268|FG011|Overall Study|Miscellaneous|0|||
127976998|NCT04687072|460536269|FG000|Overall Study|Adverse Event|2|||
127976999|NCT04687072|460536270|FG001|Overall Study|Adverse Event|0|||
127977000|NCT04687072|460536269|FG000|Overall Study|Death|1|||
127977001|NCT04687072|460536270|FG001|Overall Study|Death|0|||
127977002|NCT04687072|460536269|FG000|Overall Study|Lack of Efficacy|2|||
127977003|NCT04687072|460536270|FG001|Overall Study|Lack of Efficacy|1|||
127977004|NCT04687072|460536269|FG000|Overall Study|Physician Decision|1|||
127977005|NCT04687072|460536270|FG001|Overall Study|Physician Decision|0|||
127977006|NCT04687072|460536269|FG000|Overall Study|Pregnancy|1|||
127977007|NCT04687072|460536270|FG001|Overall Study|Pregnancy|0|||
127977008|NCT04687072|460536269|FG000|Overall Study|Requires Prohibited Medication|2|||
127977009|NCT04687072|460536270|FG001|Overall Study|Requires Prohibited Medication|0|||
127977010|NCT04687072|460536269|FG000|Overall Study|Withdrawal of Consent|11|||
127977011|NCT04687072|460536270|FG001|Overall Study|Withdrawal of Consent|6|||
127977012|NCT04687072|460536269|FG000|Overall Study|Miscellaneous|4|||
127977013|NCT04687072|460536270|FG001|Overall Study|Miscellaneous|1|||
127492904|NCT01521923|458765136|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
127492905|NCT01521923|458765137|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
127977014|NCT02396420|460536276|FG000|Overall Study|Death|1|||
127977015|NCT01273623|460536277|FG000|Overall Study|did not meet IVUS criteria|29|||
127977016|NCT00519428|460536278|FG000|Overall Study|Adverse Event|5|||
127977017|NCT00519428|460536279|FG001|Overall Study|Adverse Event|2|||
127977018|NCT00519428|460536280|FG002|Overall Study|Adverse Event|10|||
127977019|NCT00519428|460536278|FG000|Overall Study|Lost to Follow-up|7|||
127977020|NCT00519428|460536279|FG001|Overall Study|Lost to Follow-up|7|||
127492906|NCT01521923|458765134|FG000|Overall Study|Lack of Efficacy|1|||
127492907|NCT01521923|458765135|FG001|Overall Study|Lack of Efficacy|1|||
127492908|NCT01521923|458765136|FG002|Overall Study|Lack of Efficacy|0|||
127977021|NCT00519428|460536280|FG002|Overall Study|Lost to Follow-up|6|||
127977022|NCT00519428|460536278|FG000|Overall Study|Withdrawal by Subject|8|||
127492909|NCT01521923|458765137|FG003|Overall Study|Lack of Efficacy|0|||
127492910|NCT01521923|458765134|FG000|Overall Study|Protocol Violation|0|||
127492911|NCT01521923|458765135|FG001|Overall Study|Protocol Violation|0|||
127492912|NCT01521923|458765136|FG002|Overall Study|Protocol Violation|1|||
127492913|NCT01521923|458765137|FG003|Overall Study|Protocol Violation|0|||
127492914|NCT01521923|458765134|FG000|Overall Study|Lost to Follow-up|1|||
127492915|NCT01521923|458765135|FG001|Overall Study|Lost to Follow-up|0|||
127492916|NCT01521923|458765136|FG002|Overall Study|Lost to Follow-up|2|||
127492917|NCT01521923|458765137|FG003|Overall Study|Lost to Follow-up|1|||
127492918|NCT01521923|458765134|FG000|Overall Study|Withdrawal by Subject|1|||
127492919|NCT01521923|458765135|FG001|Overall Study|Withdrawal by Subject|1|||
127492920|NCT01521923|458765136|FG002|Overall Study|Withdrawal by Subject|1|||
127492921|NCT01521923|458765137|FG003|Overall Study|Withdrawal by Subject|2|||
127492922|NCT01521923|458765134|FG000|Overall Study|Other|2|||
127492923|NCT01521923|458765135|FG001|Overall Study|Other|1|||
127492924|NCT01521923|458765136|FG002|Overall Study|Other|3|||
127492925|NCT01521923|458765137|FG003|Overall Study|Other|6|||
127492926|NCT01521923|458765134|FG000|Overall Study|AE, captured in Period 1|0|||
127492927|NCT01521923|458765135|FG001|Overall Study|AE, captured in Period 1|1|||
127492928|NCT01521923|458765136|FG002|Overall Study|AE, captured in Period 1|0|||
127492929|NCT01521923|458765137|FG003|Overall Study|AE, captured in Period 1|1|||
127492930|NCT01465386|458765141|FG000|Overall Study|Lack of Efficacy|3|||
127492931|NCT01465386|458765141|FG000|Overall Study|Adverse Event|1|||
127492932|NCT00460655|458765142|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
127492933|NCT00460655|458765143|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
127492934|NCT00460655|458765144|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
127492935|NCT00460655|458765145|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
127492936|NCT00460655|458765142|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
127492937|NCT00460655|458765143|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
127492938|NCT00460655|458765144|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
127492939|NCT00460655|458765145|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
127492940|NCT00460655|458765142|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
127492941|NCT00460655|458765143|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
127492942|NCT00460655|458765144|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
127492943|NCT00460655|458765145|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
127492944|NCT00460655|458765142|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
127492945|NCT00460655|458765143|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
127492946|NCT00460655|458765144|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
127492947|NCT00460655|458765145|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
127492948|NCT00460655|458765142|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
127492949|NCT00460655|458765143|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
127492950|NCT00460655|458765144|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
127492951|NCT00460655|458765145|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
127492952|NCT00460655|458765142|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
127492953|NCT00460655|458765143|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
127492954|NCT00460655|458765144|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
127492955|NCT00460655|458765145|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
127492956|NCT02236572|458765148|FG000|Overall Study|Withdrawal by Subject|1|||
127492957|NCT02236572|458765148|FG000|Overall Study|Protocol Violation|1|||
127492958|NCT02236572|458765148|FG000|Overall Study|Lost to Follow-up|1|||
127492959|NCT02443337|458765149|FG000|Overall Study|Adverse Event|0|||
127492960|NCT02443337|458765150|FG001|Overall Study|Adverse Event|1|||
127492961|NCT02443337|458765149|FG000|Overall Study|Clinical Progressive Disease|3|||
127492962|NCT02443337|458765150|FG001|Overall Study|Clinical Progressive Disease|0|||
127492963|NCT02443337|458765149|FG000|Overall Study|Withdrawal by Subject|2|||
127492964|NCT02443337|458765150|FG001|Overall Study|Withdrawal by Subject|1|||
127492965|NCT00709319|458765151|FG000|Overall Study|Death|4|||
127492966|NCT00709319|458765151|FG000|Overall Study|Withdrawal by Subject|2|||
127492967|NCT00579553|458765152|FG000|Overall Study|Lost to Follow-up|16|||
127492968|NCT00579553|458765153|FG001|Overall Study|Lost to Follow-up|13|||
127977023|NCT00519428|460536279|FG001|Overall Study|Withdrawal by Subject|3|||
127492969|NCT00635349|458765154|FG000|Overall Study|Other|8|||
127492970|NCT00635349|458765155|FG001|Overall Study|Other|6|||
127492971|NCT00635349|458765154|FG000|Overall Study|Protocol Violation|18|||
127492972|NCT00635349|458765155|FG001|Overall Study|Protocol Violation|22|||
127492973|NCT00635349|458765154|FG000|Overall Study|Withdrawal by Subject|3|||
127492974|NCT00635349|458765155|FG001|Overall Study|Withdrawal by Subject|8|||
127492975|NCT00635349|458765154|FG000|Overall Study|Lost to Follow-up|4|||
127492976|NCT00635349|458765155|FG001|Overall Study|Lost to Follow-up|3|||
127492977|NCT00635349|458765154|FG000|Overall Study|Adverse Event|11|||
127492978|NCT00635349|458765155|FG001|Overall Study|Adverse Event|9|||
127492979|NCT03072043|458765165|FG000|Overall Study|Death|0|||
127492980|NCT03072043|458765166|FG001|Overall Study|Death|0|||
127492981|NCT03072043|458765167|FG002|Overall Study|Death|3|||
127492982|NCT03072043|458765165|FG000|Overall Study|Adverse Event|0|||
127492983|NCT03072043|458765166|FG001|Overall Study|Adverse Event|0|||
127492984|NCT03072043|458765167|FG002|Overall Study|Adverse Event|2|||
127492985|NCT03072043|458765165|FG000|Overall Study|Withdrawal by Subject|0|||
127492986|NCT03072043|458765166|FG001|Overall Study|Withdrawal by Subject|0|||
127492987|NCT03072043|458765167|FG002|Overall Study|Withdrawal by Subject|4|||
127492988|NCT01340664|458765168|FG000|Overall Study|Adverse Event|0|||
127492989|NCT01340664|458765169|FG001|Overall Study|Adverse Event|1|||
127492990|NCT01340664|458765170|FG002|Overall Study|Adverse Event|7|||
127492991|NCT01340664|458765168|FG000|Overall Study|Lost to Follow-up|2|||
127492992|NCT01340664|458765169|FG001|Overall Study|Lost to Follow-up|0|||
127492993|NCT01340664|458765170|FG002|Overall Study|Lost to Follow-up|2|||
127492994|NCT01340664|458765168|FG000|Overall Study|Withdrawal by Subject|2|||
127492995|NCT01340664|458765169|FG001|Overall Study|Withdrawal by Subject|4|||
127492996|NCT01340664|458765170|FG002|Overall Study|Withdrawal by Subject|0|||
127492997|NCT01340664|458765168|FG000|Overall Study|Glycemic withdrawal criteria|2|||
127492998|NCT01340664|458765169|FG001|Overall Study|Glycemic withdrawal criteria|0|||
127492999|NCT01340664|458765170|FG002|Overall Study|Glycemic withdrawal criteria|0|||
127493000|NCT01340664|458765168|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
127493001|NCT01340664|458765169|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
127493002|NCT01340664|458765170|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
127493003|NCT01340664|458765168|FG000|Overall Study|Other|1|||
127493004|NCT01340664|458765169|FG001|Overall Study|Other|2|||
127493005|NCT01340664|458765170|FG002|Overall Study|Other|2|||
127493006|NCT02997865|458765174|FG000|Overall Study|Death|2|||
127493007|NCT02997865|458765175|FG001|Overall Study|Death|1|||
127493008|NCT02997865|458765174|FG000|Overall Study|Lost to Follow-up|6|||
127493009|NCT02997865|458765175|FG001|Overall Study|Lost to Follow-up|3|||
127493010|NCT02997865|458765174|FG000|Overall Study|Withdrawal by Subject|5|||
127493011|NCT02997865|458765175|FG001|Overall Study|Withdrawal by Subject|0|||
127493012|NCT01509846|458765176|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
127493013|NCT01509846|458765177|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
127493014|NCT01509846|458765178|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
127493015|NCT01509846|458765179|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
127493016|NCT01509846|458765180|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
127493017|NCT01509846|458765176|FG000|Received Vaccination 2|Illness|0|||
127493018|NCT01509846|458765177|FG001|Received Vaccination 2|Illness|0|||
127493019|NCT01509846|458765178|FG002|Received Vaccination 2|Illness|0|||
127493020|NCT01509846|458765179|FG003|Received Vaccination 2|Illness|0|||
127493021|NCT01509846|458765180|FG004|Received Vaccination 2|Illness|1|||
127493022|NCT01509846|458765176|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
127493023|NCT01509846|458765177|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
127493024|NCT01509846|458765178|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
127493025|NCT01509846|458765179|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
127493026|NCT01509846|458765180|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
127493027|NCT01509846|458765176|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
127493028|NCT01509846|458765177|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
127493029|NCT01509846|458765178|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
127493030|NCT01509846|458765179|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
127493031|NCT01509846|458765180|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
127493032|NCT01509846|458765176|FG000|Received Vaccination 3|Pregnancy|0|||
127493033|NCT01509846|458765177|FG001|Received Vaccination 3|Pregnancy|0|||
127493034|NCT01509846|458765178|FG002|Received Vaccination 3|Pregnancy|0|||
127493035|NCT01509846|458765179|FG003|Received Vaccination 3|Pregnancy|1|||
127493036|NCT01509846|458765180|FG004|Received Vaccination 3|Pregnancy|0|||
127493037|NCT01509846|458765176|FG000|Received Vaccination 3|Lost to Follow-up|0|||
127493038|NCT01509846|458765177|FG001|Received Vaccination 3|Lost to Follow-up|0|||
127493039|NCT01509846|458765178|FG002|Received Vaccination 3|Lost to Follow-up|1|||
127493040|NCT01509846|458765179|FG003|Received Vaccination 3|Lost to Follow-up|0|||
127493041|NCT01509846|458765180|FG004|Received Vaccination 3|Lost to Follow-up|0|||
127493042|NCT01637584|458765181|FG000|Overall Study|Withdrawal by Subject|1|||
127493043|NCT01637584|458765182|FG001|Overall Study|Withdrawal by Subject|3|||
127493044|NCT02484443|458765184|FG000|Overall Study|Lack of Efficacy|28|||
127493045|NCT02484443|458765184|FG000|Overall Study|Physician Decision|2|||
127977024|NCT00519428|460536280|FG002|Overall Study|Withdrawal by Subject|7|||
127977025|NCT00519428|460536278|FG000|Overall Study|unstated|1|||
127493046|NCT02484443|458765184|FG000|Overall Study|Ineligible|2|||
127493047|NCT02969915|458765185|FG000|Overall Study|Death|104|||
127493048|NCT02969915|458765186|FG001|Overall Study|Death|125|||
127493049|NCT02969915|458765185|FG000|Overall Study|Lost to Follow-up|108|||
127493050|NCT02969915|458765186|FG001|Overall Study|Lost to Follow-up|112|||
127493051|NCT02969915|458765185|FG000|Overall Study|Censored due to COVID-19|481|||
127493052|NCT02969915|458765186|FG001|Overall Study|Censored due to COVID-19|471|||
127493053|NCT03799952|458765187|FG000|Overall Study|Program was too easy, discontinued|1|||
127977026|NCT00519428|460536279|FG001|Overall Study|unstated|3|||
127493054|NCT03799952|458765188|FG001|Overall Study|Program was too easy, discontinued|0|||
127493055|NCT03799952|458765187|FG000|Overall Study|Lost to Follow-up|0|||
127493056|NCT03799952|458765188|FG001|Overall Study|Lost to Follow-up|2|||
127493057|NCT01393899|458765191|FG000|Overall Study|Study terminated by sponsor|1|||
127493058|NCT01393899|458765192|FG001|Overall Study|Study terminated by sponsor|0|||
127493059|NCT01393899|458765193|FG002|Overall Study|Study terminated by sponsor|1|||
127493060|NCT01393899|458765191|FG000|Overall Study|Other|1|||
127493061|NCT01393899|458765192|FG001|Overall Study|Other|0|||
127493062|NCT01393899|458765193|FG002|Overall Study|Other|0|||
127493063|NCT01393899|458765191|FG000|Overall Study|Withdrawal by Subject|2|||
127493064|NCT01393899|458765192|FG001|Overall Study|Withdrawal by Subject|2|||
127493065|NCT01393899|458765193|FG002|Overall Study|Withdrawal by Subject|1|||
127493066|NCT01393899|458765191|FG000|Overall Study|Lost to Follow-up|0|||
127493067|NCT01393899|458765192|FG001|Overall Study|Lost to Follow-up|0|||
127493068|NCT01393899|458765193|FG002|Overall Study|Lost to Follow-up|1|||
127493069|NCT01393899|458765191|FG000|Overall Study|Does not meet entrance criteria|1|||
127493070|NCT01393899|458765192|FG001|Overall Study|Does not meet entrance criteria|0|||
127493071|NCT01393899|458765193|FG002|Overall Study|Does not meet entrance criteria|1|||
127493072|NCT01393899|458765191|FG000|Overall Study|Lack of Efficacy|26|||
127493073|NCT01393899|458765192|FG001|Overall Study|Lack of Efficacy|21|||
127493074|NCT01393899|458765193|FG002|Overall Study|Lack of Efficacy|16|||
127493075|NCT01393899|458765191|FG000|Overall Study|Adverse Event|1|||
127493076|NCT01393899|458765192|FG001|Overall Study|Adverse Event|5|||
127493077|NCT01393899|458765193|FG002|Overall Study|Adverse Event|3|||
127493078|NCT02503085|458765194|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
127493079|NCT02503085|458765195|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
127493080|NCT02503085|458765196|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
127493081|NCT02503085|458765197|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
127493082|NCT02595866|458765198|FG000|Overall Study|Adverse Event|2|||
127493083|NCT02595866|458765199|FG001|Overall Study|Adverse Event|5|||
127493084|NCT02595866|458765198|FG000|Overall Study|Complicating Disease/Intercurrent Illness|1|||
127493085|NCT02595866|458765199|FG001|Overall Study|Complicating Disease/Intercurrent Illness|1|||
127493086|NCT02595866|458765198|FG000|Overall Study|Death|0|||
127493087|NCT02595866|458765199|FG001|Overall Study|Death|1|||
127493088|NCT02595866|458765198|FG000|Overall Study|Incarceration|1|||
127493089|NCT02595866|458765199|FG001|Overall Study|Incarceration|0|||
127493090|NCT02595866|458765198|FG000|Overall Study|Lack of Efficacy|17|||
127493091|NCT02595866|458765199|FG001|Overall Study|Lack of Efficacy|7|||
127493092|NCT02595866|458765198|FG000|Overall Study|Physician Decision|4|||
127493093|NCT02595866|458765199|FG001|Overall Study|Physician Decision|3|||
127493094|NCT02595866|458765198|FG000|Overall Study|Switched to Alternative Treatment|1|||
127493095|NCT02595866|458765199|FG001|Overall Study|Switched to Alternative Treatment|0|||
127493096|NCT02595866|458765198|FG000|Overall Study|Study Terminated|0|||
127493097|NCT02595866|458765199|FG001|Overall Study|Study Terminated|4|||
127493098|NCT02595866|458765198|FG000|Overall Study|Withdrawal by Subject|6|||
127493099|NCT02595866|458765199|FG001|Overall Study|Withdrawal by Subject|1|||
127493100|NCT02520388|458765200|FG000|Overall Study|Physician Decision|1|||
127493101|NCT02520388|458765201|FG001|Overall Study|Physician Decision|0|||
127493102|NCT02520388|458765200|FG000|Overall Study|Subject or parent/guardian request|0|||
127493103|NCT02520388|458765201|FG001|Overall Study|Subject or parent/guardian request|6|||
127493104|NCT02520388|458765200|FG000|Overall Study|Adverse Event|1|||
127493105|NCT02520388|458765201|FG001|Overall Study|Adverse Event|4|||
127493106|NCT02520388|458765200|FG000|Overall Study|Lost to Follow-up|3|||
127493107|NCT02520388|458765201|FG001|Overall Study|Lost to Follow-up|2|||
127493108|NCT02520388|458765200|FG000|Overall Study|Other (reason not defined)|4|||
127493109|NCT02520388|458765201|FG001|Overall Study|Other (reason not defined)|4|||
127493110|NCT01232127|458765202|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
127493111|NCT01232127|458765203|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
127493112|NCT01232127|458765204|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
127493113|NCT03035864|458765210|FG000|Treatment Period|Adverse Event|1|||
127977027|NCT00519428|460536280|FG002|Overall Study|unstated|2|||
127977028|NCT04064411|460536281|FG000|Overall Study|Adverse Event|29|||
127977029|NCT04064411|460536282|FG001|Overall Study|Adverse Event|19|||
127977030|NCT04064411|460536281|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
127493114|NCT03035864|458765211|FG001|Treatment Period|Adverse Event|0|||
127493115|NCT03035864|458765210|FG000|Treatment Period|Other|3|||
127493116|NCT03035864|458765211|FG001|Treatment Period|Other|1|||
127493117|NCT03035864|458765210|FG000|Follow-up Period|Adverse Event|1|||
127493118|NCT03035864|458765211|FG001|Follow-up Period|Adverse Event|0|||
127493119|NCT03035864|458765210|FG000|Follow-up Period|Lost to Follow-up|6|||
127493120|NCT03035864|458765211|FG001|Follow-up Period|Lost to Follow-up|2|||
127493121|NCT03035864|458765210|FG000|Follow-up Period|Physician Decision|1|||
127493122|NCT03035864|458765211|FG001|Follow-up Period|Physician Decision|0|||
127493123|NCT03035864|458765210|FG000|Follow-up Period|Other|3|||
127493124|NCT03035864|458765211|FG001|Follow-up Period|Other|2|||
127493125|NCT02375373|458765212|FG000|Overall Study|Withdrawal by Subject|11|||
127493126|NCT01890265|458765213|FG000|Overall Study|Other (Unspecified reason)|0|||
127493127|NCT01890265|458765214|FG001|Overall Study|Other (Unspecified reason)|1|||
127493128|NCT01890265|458765215|FG002|Overall Study|Other (Unspecified reason)|0|||
127493129|NCT01890265|458765216|FG003|Overall Study|Other (Unspecified reason)|0|||
127493130|NCT01890265|458765217|FG004|Overall Study|Other (Unspecified reason)|0|||
127493131|NCT01890265|458765218|FG005|Overall Study|Other (Unspecified reason)|0|||
127493132|NCT01890265|458765213|FG000|Overall Study|Progressive disease|6|||
127493133|NCT01890265|458765214|FG001|Overall Study|Progressive disease|6|||
127493134|NCT01890265|458765215|FG002|Overall Study|Progressive disease|0|||
127493135|NCT01890265|458765216|FG003|Overall Study|Progressive disease|0|||
127493136|NCT01890265|458765217|FG004|Overall Study|Progressive disease|0|||
127493137|NCT01890265|458765218|FG005|Overall Study|Progressive disease|0|||
127493138|NCT01890265|458765213|FG000|Overall Study|Adverse Event|2|||
127493139|NCT01890265|458765214|FG001|Overall Study|Adverse Event|1|||
127493140|NCT01890265|458765215|FG002|Overall Study|Adverse Event|0|||
127493141|NCT01890265|458765216|FG003|Overall Study|Adverse Event|0|||
127493142|NCT01890265|458765217|FG004|Overall Study|Adverse Event|0|||
127493143|NCT01890265|458765218|FG005|Overall Study|Adverse Event|0|||
127493144|NCT01890265|458765213|FG000|Overall Study|Death|2|||
127493145|NCT01890265|458765214|FG001|Overall Study|Death|3|||
127493146|NCT01890265|458765215|FG002|Overall Study|Death|1|||
127493147|NCT01890265|458765216|FG003|Overall Study|Death|0|||
127493148|NCT01890265|458765217|FG004|Overall Study|Death|0|||
127493149|NCT01890265|458765218|FG005|Overall Study|Death|0|||
127493150|NCT01890265|458765213|FG000|Overall Study|Withdrawal by Subject|0|||
127493151|NCT01890265|458765214|FG001|Overall Study|Withdrawal by Subject|2|||
127493152|NCT01890265|458765215|FG002|Overall Study|Withdrawal by Subject|3|||
127493153|NCT01890265|458765216|FG003|Overall Study|Withdrawal by Subject|0|||
127493154|NCT01890265|458765217|FG004|Overall Study|Withdrawal by Subject|2|||
127493155|NCT01890265|458765218|FG005|Overall Study|Withdrawal by Subject|0|||
127493156|NCT00809926|458765219|FG000|Overall Study|Adverse Event|18|||
127493157|NCT00809926|458765220|FG001|Overall Study|Adverse Event|10|||
127493158|NCT00809926|458765219|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
127493159|NCT00809926|458765220|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
127493160|NCT00809926|458765219|FG000|Overall Study|Patient withdrew consent|8|||
127493161|NCT00809926|458765220|FG001|Overall Study|Patient withdrew consent|6|||
127493162|NCT00809926|458765219|FG000|Overall Study|Lost to Follow-up|2|||
127493163|NCT00809926|458765220|FG001|Overall Study|Lost to Follow-up|1|||
127493164|NCT00809926|458765219|FG000|Overall Study|Administrative Problems|0|||
127493165|NCT00809926|458765220|FG001|Overall Study|Administrative Problems|1|||
127493166|NCT00809926|458765219|FG000|Overall Study|Protocol deviation|0|||
127493167|NCT00809926|458765220|FG001|Overall Study|Protocol deviation|2|||
127493168|NCT00642707|458765225|FG000|Overall Study|Adverse Event|0|||
127493169|NCT00642707|458765226|FG001|Overall Study|Adverse Event|0|||
127493170|NCT00642707|458765227|FG002|Overall Study|Adverse Event|0|||
127493171|NCT00642707|458765228|FG003|Overall Study|Adverse Event|2|||
127493172|NCT00642707|458765225|FG000|Overall Study|Withdrawal by Subject|1|||
127493173|NCT00642707|458765226|FG001|Overall Study|Withdrawal by Subject|0|||
127493174|NCT00642707|458765227|FG002|Overall Study|Withdrawal by Subject|0|||
127493175|NCT00642707|458765228|FG003|Overall Study|Withdrawal by Subject|0|||
127493176|NCT00130039|458765229|FG000|Overall Study|Withdrawal by Subject|15|||
127493177|NCT00130039|458765230|FG001|Overall Study|Withdrawal by Subject|11|||
127493178|NCT00130039|458765229|FG000|Overall Study|Lost to Follow-up|3|||
127493179|NCT00130039|458765230|FG001|Overall Study|Lost to Follow-up|1|||
127493180|NCT00130039|458765229|FG000|Overall Study|Adverse Event|4|||
127493181|NCT00130039|458765230|FG001|Overall Study|Adverse Event|2|||
127493182|NCT00130039|458765229|FG000|Overall Study|Physician Decision|3|||
127493183|NCT00130039|458765230|FG001|Overall Study|Physician Decision|0|||
127493184|NCT00130039|458765229|FG000|Overall Study|clinical events without follow up MRI|5|||
127493185|NCT00130039|458765230|FG001|Overall Study|clinical events without follow up MRI|4|||
127493186|NCT00100802|458765234|FG000|Overall Study|Adverse Event|9|||
127493187|NCT00100802|458765234|FG000|Overall Study|Death|1|||
127493188|NCT00100802|458765234|FG000|Overall Study|Lack of Efficacy|47|||
127493189|NCT00100802|458765234|FG000|Overall Study|Physician Decision|5|||
127493190|NCT00100802|458765234|FG000|Overall Study|Protocol Violation|1|||
127493191|NCT00100802|458765234|FG000|Overall Study|Withdrawal by Subject|5|||
127493192|NCT00100802|458765234|FG000|Overall Study|Ineligible|12|||
127493193|NCT02709720|458765235|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
127493194|NCT02709720|458765235|FG000|Overall Study|Protocol Violation|1|||
127493195|NCT02709720|458765235|FG000|Overall Study|Not take study medication|1|||
127493196|NCT00326001|458765237|FG000|Overall Study|Adverse Event|4|||
127493197|NCT00326001|458765238|FG001|Overall Study|Adverse Event|5|||
127493198|NCT00326001|458765237|FG000|Overall Study|Physician Decision|3|||
127493199|NCT00326001|458765238|FG001|Overall Study|Physician Decision|3|||
127493200|NCT00617084|458766649|FG000|Overall Study|Withdrawal by Subject|5|||
127493201|NCT00617084|458766650|FG001|Overall Study|Withdrawal by Subject|7|||
127493202|NCT00617084|458766649|FG000|Overall Study|Missed 12 Months visit|16|||
127493203|NCT00617084|458766650|FG001|Overall Study|Missed 12 Months visit|19|||
127493204|NCT01279044|458766651|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
127493205|NCT01279044|458766652|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
127493206|NCT01279044|458766653|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
127493207|NCT01279044|458766651|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
127493208|NCT01279044|458766652|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
127493209|NCT01279044|458766653|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
127493210|NCT01279044|458766651|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
127493211|NCT01279044|458766652|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
127977031|NCT04064411|460536282|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
127977032|NCT04064411|460536281|FG000|Overall Study|Protocol Deviation|0|||
127977033|NCT04064411|460536282|FG001|Overall Study|Protocol Deviation|2|||
127977034|NCT04064411|460536281|FG000|Overall Study|Withdrawal by Subject|25|||
127977035|NCT04064411|460536282|FG001|Overall Study|Withdrawal by Subject|29|||
127977036|NCT04064411|460536281|FG000|Overall Study|Lost to Follow-up|5|||
127977037|NCT04064411|460536282|FG001|Overall Study|Lost to Follow-up|2|||
127977038|NCT04064411|460536281|FG000|Overall Study|Other than Specified|4|||
127977039|NCT04064411|460536282|FG001|Overall Study|Other than Specified|1|||
127977040|NCT04064411|460536281|FG000|Overall Study|Death|1|||
127977041|NCT04064411|460536282|FG001|Overall Study|Death|0|||
127977042|NCT00533702|460536285|FG000|Overall Study|Withdrawal by Subject|3|||
127977043|NCT00533702|460536286|FG001|Overall Study|Withdrawal by Subject|1|||
127977044|NCT00533702|460536285|FG000|Overall Study|Found ineligible after randomization|2|||
127977045|NCT00533702|460536286|FG001|Overall Study|Found ineligible after randomization|1|||
127977046|NCT03053063|460536289|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
127977047|NCT03053063|460536290|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
127977048|NCT03053063|460536291|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
127977049|NCT03053063|460536292|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
127977050|NCT03053063|460536289|FG000|Randomized Phase|Withdrew consent|8|||
127977051|NCT03053063|460536290|FG001|Randomized Phase|Withdrew consent|11|||
127977052|NCT03053063|460536291|FG002|Randomized Phase|Withdrew consent|5|||
127977053|NCT03053063|460536292|FG003|Randomized Phase|Withdrew consent|0|||
127977054|NCT03053063|460536289|FG000|Randomized Phase|Investigator's Discretion|8|||
127977055|NCT03053063|460536290|FG001|Randomized Phase|Investigator's Discretion|6|||
127977056|NCT03053063|460536291|FG002|Randomized Phase|Investigator's Discretion|2|||
127977057|NCT03053063|460536292|FG003|Randomized Phase|Investigator's Discretion|0|||
127977058|NCT03053063|460536289|FG000|Randomized Phase|Lost to Follow-up|3|||
127977059|NCT03053063|460536290|FG001|Randomized Phase|Lost to Follow-up|5|||
127977060|NCT03053063|460536291|FG002|Randomized Phase|Lost to Follow-up|1|||
127977061|NCT03053063|460536292|FG003|Randomized Phase|Lost to Follow-up|0|||
127977062|NCT03053063|460536289|FG000|Randomized Phase|Adverse Event|0|||
127977063|NCT03053063|460536290|FG001|Randomized Phase|Adverse Event|1|||
127977064|NCT03053063|460536291|FG002|Randomized Phase|Adverse Event|0|||
127977065|NCT03053063|460536292|FG003|Randomized Phase|Adverse Event|0|||
127977066|NCT03053063|460536289|FG000|Randomized Phase|Randomized but Never Treated|1|||
127977067|NCT03053063|460536290|FG001|Randomized Phase|Randomized but Never Treated|3|||
127977068|NCT03053063|460536291|FG002|Randomized Phase|Randomized but Never Treated|2|||
127977069|NCT03053063|460536292|FG003|Randomized Phase|Randomized but Never Treated|0|||
127977070|NCT03053063|460536289|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
127977071|NCT03053063|460536290|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
127977072|NCT03053063|460536291|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
127977073|NCT03053063|460536292|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
127977074|NCT03053063|460536289|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
127977075|NCT03053063|460536290|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
127977076|NCT03053063|460536291|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
127977077|NCT03053063|460536292|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
127977078|NCT03053063|460536289|FG000|Open-Label Phase|Death|0|||
127977079|NCT03053063|460536290|FG001|Open-Label Phase|Death|0|||
127977080|NCT03053063|460536291|FG002|Open-Label Phase|Death|0|||
127493212|NCT01279044|458766653|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
127493213|NCT01582009|458766654|FG000|Overall Study|Withdrawal by Subject|1|||
127493214|NCT01582009|458766654|FG000|Overall Study|Physician Decision|1|||
127493215|NCT01947283|458766658|FG000|Overall Study|Death|1|||
127493216|NCT01947283|458766659|FG001|Overall Study|Death|1|||
127493217|NCT01947283|458766660|FG002|Overall Study|Death|1|||
127493218|NCT01947283|458766661|FG003|Overall Study|Death|0|||
127977081|NCT03053063|460536292|FG003|Open-Label Phase|Death|2|||
127977082|NCT03053063|460536289|FG000|Open-Label Phase|Investigator's discretion|0|||
127977083|NCT03053063|460536290|FG001|Open-Label Phase|Investigator's discretion|0|||
127977084|NCT03053063|460536291|FG002|Open-Label Phase|Investigator's discretion|0|||
127977085|NCT03053063|460536292|FG003|Open-Label Phase|Investigator's discretion|2|||
127977086|NCT01970475|460536294|FG000|Overall Study|Withdrawal by Subject|11|||
127977087|NCT01970475|460536295|FG001|Overall Study|Withdrawal by Subject|6|||
127977088|NCT01970475|460536294|FG000|Overall Study|Adverse Event|7|||
127977089|NCT01970475|460536295|FG001|Overall Study|Adverse Event|3|||
127977090|NCT01970475|460536294|FG000|Overall Study|Lost to Follow-up|2|||
127977091|NCT01970475|460536295|FG001|Overall Study|Lost to Follow-up|2|||
127977092|NCT01970475|460536294|FG000|Overall Study|Protocol Violation|1|||
127493219|NCT01947283|458766662|FG004|Overall Study|Death|0|||
127493220|NCT01947283|458766663|FG005|Overall Study|Death|0|||
127493221|NCT01947283|458766664|FG006|Overall Study|Death|0|||
127493222|NCT01947283|458766658|FG000|Overall Study|Lost to Follow-up|4|||
127493223|NCT01947283|458766659|FG001|Overall Study|Lost to Follow-up|6|||
127493224|NCT01947283|458766660|FG002|Overall Study|Lost to Follow-up|5|||
127493225|NCT01947283|458766661|FG003|Overall Study|Lost to Follow-up|5|||
127493226|NCT01947283|458766662|FG004|Overall Study|Lost to Follow-up|0|||
127493227|NCT01947283|458766663|FG005|Overall Study|Lost to Follow-up|2|||
127493228|NCT01947283|458766664|FG006|Overall Study|Lost to Follow-up|5|||
127493229|NCT01947283|458766658|FG000|Overall Study|Withdrawal by Subject|10|||
127493230|NCT01947283|458766659|FG001|Overall Study|Withdrawal by Subject|8|||
127493231|NCT01947283|458766660|FG002|Overall Study|Withdrawal by Subject|4|||
127493232|NCT01947283|458766661|FG003|Overall Study|Withdrawal by Subject|1|||
127493233|NCT01947283|458766662|FG004|Overall Study|Withdrawal by Subject|0|||
127493234|NCT01947283|458766663|FG005|Overall Study|Withdrawal by Subject|0|||
127493235|NCT01947283|458766664|FG006|Overall Study|Withdrawal by Subject|2|||
127493236|NCT01947283|458766658|FG000|Overall Study|No Clinical Recording|12|||
127493237|NCT01947283|458766659|FG001|Overall Study|No Clinical Recording|6|||
127493238|NCT01947283|458766660|FG002|Overall Study|No Clinical Recording|8|||
127493239|NCT01947283|458766661|FG003|Overall Study|No Clinical Recording|10|||
127493240|NCT01947283|458766662|FG004|Overall Study|No Clinical Recording|0|||
127493241|NCT01947283|458766663|FG005|Overall Study|No Clinical Recording|0|||
127493242|NCT01947283|458766664|FG006|Overall Study|No Clinical Recording|0|||
127977093|NCT01970475|460536295|FG001|Overall Study|Protocol Violation|0|||
127977094|NCT00381238|460538187|FG000|Overall Study|Adverse Event|3|||
127977095|NCT00381238|460538187|FG000|Overall Study|Protocol Violation|1|||
127977096|NCT00381238|460538187|FG000|Overall Study|Withdrawal by Subject|4|||
127977097|NCT00381238|460538187|FG000|Overall Study|Lack of Efficacy|2|||
127977098|NCT00381238|460538187|FG000|Overall Study|Withdrew by physician|1|||
127977099|NCT00381238|460538187|FG000|Overall Study|Disease progression|1|||
127977100|NCT02086448|460538193|FG000|Overall Study|Withdrawal by Subject|1|||
127977101|NCT02086448|460538194|FG001|Overall Study|Withdrawal by Subject|0|||
127977102|NCT02086448|460538195|FG002|Overall Study|Withdrawal by Subject|0|||
127977103|NCT02086448|460538196|FG003|Overall Study|Withdrawal by Subject|2|||
127977104|NCT00843037|460538197|FG000|Overall Study|Lost to Follow-up|1|||
127977105|NCT01871402|460538200|FG000|Overall Study|Lost to Follow-up|1|||
127977106|NCT01871402|460538201|FG001|Overall Study|Lost to Follow-up|0|||
127977107|NCT01871402|460538200|FG000|Overall Study|Withdrawal by Subject|0|||
127977108|NCT01871402|460538201|FG001|Overall Study|Withdrawal by Subject|2|||
127977109|NCT01871402|460538200|FG000|Overall Study|Non-compliance|0|||
127977110|NCT01871402|460538201|FG001|Overall Study|Non-compliance|1|||
127977111|NCT04594941|460538202|FG000|Overall Study|Other|0|||
127977112|NCT04594941|460538203|FG001|Overall Study|Other|3|||
127977113|NCT04594941|460538204|FG002|Overall Study|Other|1|||
127977114|NCT04594941|460538205|FG003|Overall Study|Other|0|||
127977115|NCT02424630|460538206|FG000|Overall Study|No rotator cuff tear|1|||
127977116|NCT02424630|460538207|FG001|Overall Study|No rotator cuff tear|2|||
127977117|NCT02424630|460538206|FG000|Overall Study|Open procedure|0|||
127977118|NCT02424630|460538207|FG001|Overall Study|Open procedure|1|||
127977119|NCT02703272|460538208|FG000|Overall Study|Death|4|||
127977120|NCT02703272|460538209|FG001|Overall Study|Death|9|||
127977121|NCT02703272|460538210|FG002|Overall Study|Death|19|||
127977122|NCT02703272|460538211|FG003|Overall Study|Death|10|||
127977123|NCT02703272|460538208|FG000|Overall Study|Withdrawal by Subject|0|||
127977124|NCT02703272|460538209|FG001|Overall Study|Withdrawal by Subject|0|||
127493243|NCT01947283|458766658|FG000|Overall Study|Non-coding Clinical Recording language|0|||
127493244|NCT01947283|458766659|FG001|Overall Study|Non-coding Clinical Recording language|0|||
127493245|NCT01947283|458766660|FG002|Overall Study|Non-coding Clinical Recording language|0|||
127493246|NCT01947283|458766661|FG003|Overall Study|Non-coding Clinical Recording language|1|||
127493247|NCT01947283|458766662|FG004|Overall Study|Non-coding Clinical Recording language|0|||
127493248|NCT01947283|458766663|FG005|Overall Study|Non-coding Clinical Recording language|0|||
127493249|NCT01947283|458766664|FG006|Overall Study|Non-coding Clinical Recording language|0|||
127493250|NCT01947283|458766658|FG000|Overall Study|Missing Follow-up Assessment|2|||
127493251|NCT01947283|458766659|FG001|Overall Study|Missing Follow-up Assessment|2|||
127493252|NCT01947283|458766660|FG002|Overall Study|Missing Follow-up Assessment|3|||
127977125|NCT02703272|460538210|FG002|Overall Study|Withdrawal by Subject|4|||
127977126|NCT02703272|460538211|FG003|Overall Study|Withdrawal by Subject|2|||
127977127|NCT02703272|460538208|FG000|Overall Study|Study Terminated by Sponsor|6|||
127977128|NCT02703272|460538209|FG001|Overall Study|Study Terminated by Sponsor|1|||
127493253|NCT01947283|458766661|FG003|Overall Study|Missing Follow-up Assessment|0|||
127493254|NCT01947283|458766662|FG004|Overall Study|Missing Follow-up Assessment|0|||
127977129|NCT02703272|460538210|FG002|Overall Study|Study Terminated by Sponsor|12|||
127977130|NCT02703272|460538211|FG003|Overall Study|Study Terminated by Sponsor|4|||
127977131|NCT02703272|460538208|FG000|Overall Study|Other|1|||
127977132|NCT02703272|460538209|FG001|Overall Study|Other|0|||
127977133|NCT02703272|460538210|FG002|Overall Study|Other|0|||
127977134|NCT02703272|460538211|FG003|Overall Study|Other|0|||
127493255|NCT01947283|458766663|FG005|Overall Study|Missing Follow-up Assessment|2|||
127493256|NCT01947283|458766664|FG006|Overall Study|Missing Follow-up Assessment|0|||
127493257|NCT01947283|458766658|FG000|Overall Study|No patients were enrolled in study|0|||
127493258|NCT01947283|458766659|FG001|Overall Study|No patients were enrolled in study|0|||
127493259|NCT01947283|458766660|FG002|Overall Study|No patients were enrolled in study|0|||
127493260|NCT01947283|458766661|FG003|Overall Study|No patients were enrolled in study|0|||
127493261|NCT01947283|458766662|FG004|Overall Study|No patients were enrolled in study|0|||
127493262|NCT01947283|458766663|FG005|Overall Study|No patients were enrolled in study|3|||
127493263|NCT01947283|458766664|FG006|Overall Study|No patients were enrolled in study|1|||
127493264|NCT00833469|458766665|FG000|Overall Study|Withdrawal by Subject|1|||
127493265|NCT00833469|458766665|FG000|Overall Study|Lost to Follow-up|1|||
127493266|NCT01665911|458766666|FG000|Overall Study|Protocol Violation|4|||
127493267|NCT01665911|458766666|FG000|Overall Study|Withdrawal by Subject|1|||
127493268|NCT01665911|458766666|FG000|Overall Study|Adverse Event|1|||
127493269|NCT03592771|458766667|FG000|Overall Study|Adverse Event|2|||
127493270|NCT03592771|458766668|FG001|Overall Study|Adverse Event|0|||
127493271|NCT03592771|458766669|FG002|Overall Study|Adverse Event|1|||
127493272|NCT03592771|458766667|FG000|Overall Study|Death|0|||
127493273|NCT03592771|458766668|FG001|Overall Study|Death|1|||
127493274|NCT03592771|458766669|FG002|Overall Study|Death|1|||
127493275|NCT03592771|458766667|FG000|Overall Study|Lost to Follow-up|5|||
127493276|NCT03592771|458766668|FG001|Overall Study|Lost to Follow-up|11|||
127493277|NCT03592771|458766669|FG002|Overall Study|Lost to Follow-up|15|||
127493278|NCT03592771|458766667|FG000|Overall Study|Withdrawal by Subject|0|||
127493279|NCT03592771|458766668|FG001|Overall Study|Withdrawal by Subject|2|||
127493280|NCT03592771|458766669|FG002|Overall Study|Withdrawal by Subject|0|||
127493281|NCT00735553|458766670|FG000|Overall Study|Study prematurely terminated|77|||
127493282|NCT04830215|458766671|FG000|Overall Study|Adverse Event|6|||
127493283|NCT04830215|458766671|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
127493284|NCT04830215|458766671|FG000|Overall Study|Withdrawal by Subject|3|||
127977135|NCT02637895|460538212|FG000|Overall Study|Lost to Follow-up|4|||
127977136|NCT02637895|460538213|FG001|Overall Study|Lost to Follow-up|0|||
127977137|NCT02637895|460538212|FG000|Overall Study|Protocol Violation|0|||
127977138|NCT02637895|460538213|FG001|Overall Study|Protocol Violation|1|||
127977139|NCT02637895|460538212|FG000|Overall Study|Lack of Efficacy|1|||
127977140|NCT02637895|460538213|FG001|Overall Study|Lack of Efficacy|0|||
127977141|NCT02637895|460538212|FG000|Overall Study|Withdrawal by Subject|1|||
127977142|NCT02637895|460538213|FG001|Overall Study|Withdrawal by Subject|1|||
127977143|NCT02637895|460538212|FG000|Overall Study|Abnormal baseline lab|0|||
127977144|NCT02637895|460538213|FG001|Overall Study|Abnormal baseline lab|1|||
127977145|NCT05896527|460538214|FG000|Overall Study|Withdrawal by Subject|11|||
127977146|NCT05896527|460538215|FG001|Overall Study|Withdrawal by Subject|10|||
127977147|NCT05896527|460538216|FG002|Overall Study|Withdrawal by Subject|4|||
127977148|NCT05896527|460538217|FG003|Overall Study|Withdrawal by Subject|3|||
127977149|NCT05896527|460538218|FG004|Overall Study|Withdrawal by Subject|2|||
127977150|NCT05896527|460538214|FG000|Overall Study|Lost to Follow-up|0|||
127977151|NCT05896527|460538215|FG001|Overall Study|Lost to Follow-up|2|||
127977152|NCT05896527|460538216|FG002|Overall Study|Lost to Follow-up|2|||
127977153|NCT05896527|460538217|FG003|Overall Study|Lost to Follow-up|2|||
127977154|NCT05896527|460538218|FG004|Overall Study|Lost to Follow-up|1|||
127977155|NCT05896527|460538214|FG000|Overall Study|Significant protocol noncompliance|0|||
127977156|NCT05896527|460538215|FG001|Overall Study|Significant protocol noncompliance|1|||
127977157|NCT05896527|460538216|FG002|Overall Study|Significant protocol noncompliance|0|||
127977158|NCT05896527|460538217|FG003|Overall Study|Significant protocol noncompliance|0|||
127977159|NCT05896527|460538218|FG004|Overall Study|Significant protocol noncompliance|0|||
127977160|NCT05896527|460538214|FG000|Overall Study|Eligibility criteria not met|1|||
127977161|NCT05896527|460538215|FG001|Overall Study|Eligibility criteria not met|0|||
127977162|NCT05896527|460538216|FG002|Overall Study|Eligibility criteria not met|0|||
127977163|NCT05896527|460538217|FG003|Overall Study|Eligibility criteria not met|0|||
127977164|NCT05896527|460538218|FG004|Overall Study|Eligibility criteria not met|0|||
127977165|NCT05896527|460538214|FG000|Overall Study|Sponsor's decision|0|||
127977166|NCT05896527|460538215|FG001|Overall Study|Sponsor's decision|0|||
127977167|NCT05896527|460538216|FG002|Overall Study|Sponsor's decision|0|||
127493285|NCT04830215|458766671|FG000|Overall Study|Protocol Deviation|1|||
127977168|NCT05896527|460538217|FG003|Overall Study|Sponsor's decision|1|||
127493286|NCT01775553|458766675|FG000|Overall Study|Adverse Event|1|||
127493287|NCT01775553|458766675|FG000|Overall Study|Disease Progression|12|||
127493288|NCT00988052|458766676|FG000|Overall Study|Missing|1|||
127493289|NCT00988052|458766677|FG001|Overall Study|Missing|0|||
127493290|NCT00988052|458766676|FG000|Overall Study|Teva requested subject withdrawal|3|||
127493291|NCT00988052|458766677|FG001|Overall Study|Teva requested subject withdrawal|1|||
127493292|NCT00988052|458766676|FG000|Overall Study|Death|1|||
127977169|NCT05896527|460538218|FG004|Overall Study|Sponsor's decision|0|||
127977170|NCT05896527|460538214|FG000|Overall Study|Investigator's decision|0|||
127977171|NCT05896527|460538215|FG001|Overall Study|Investigator's decision|1|||
127977172|NCT05896527|460538216|FG002|Overall Study|Investigator's decision|0|||
127493293|NCT00988052|458766677|FG001|Overall Study|Death|3|||
127493294|NCT00988052|458766676|FG000|Overall Study|Protocol Violation|6|||
127493295|NCT00988052|458766677|FG001|Overall Study|Protocol Violation|5|||
127493296|NCT00988052|458766676|FG000|Overall Study|Pregnancy|6|||
127493297|NCT00988052|458766677|FG001|Overall Study|Pregnancy|6|||
127493298|NCT00988052|458766676|FG000|Overall Study|Lack of Efficacy|8|||
127493299|NCT00988052|458766677|FG001|Overall Study|Lack of Efficacy|7|||
127493300|NCT00988052|458766676|FG000|Overall Study|Lost to Follow-up|6|||
127493301|NCT00988052|458766677|FG001|Overall Study|Lost to Follow-up|11|||
127493302|NCT00988052|458766676|FG000|Overall Study|Physician Decision|27|||
127493303|NCT00988052|458766677|FG001|Overall Study|Physician Decision|28|||
127493304|NCT00988052|458766676|FG000|Overall Study|Adverse Event|35|||
127493305|NCT00988052|458766677|FG001|Overall Study|Adverse Event|28|||
127493306|NCT00988052|458766676|FG000|Overall Study|Withdrawal by Subject|90|||
127493307|NCT00988052|458766677|FG001|Overall Study|Withdrawal by Subject|91|||
127493308|NCT00988052|458766676|FG000|Overall Study|Study terminated by sponsor|240|||
127493309|NCT00988052|458766677|FG001|Overall Study|Study terminated by sponsor|236|||
127493310|NCT01523743|458766678|FG000|Period 1|Adverse Event|1|||
127493311|NCT01523743|458766679|FG001|Period 1|Adverse Event|0|||
127493312|NCT01523743|458766678|FG000|Period 1|Withdrawal by Subject|6|||
127493313|NCT01523743|458766679|FG001|Period 1|Withdrawal by Subject|2|||
127493314|NCT01523743|458766678|FG000|Period 1|Lost to Follow-up|1|||
127493315|NCT01523743|458766679|FG001|Period 1|Lost to Follow-up|0|||
127493316|NCT01523743|458766678|FG000|Period 1|Lack of Efficacy|1|||
127493317|NCT01523743|458766679|FG001|Period 1|Lack of Efficacy|0|||
127493318|NCT01523743|458766678|FG000|Period 1|Felt unable to empty bladder|1|||
127493319|NCT01523743|458766679|FG001|Period 1|Felt unable to empty bladder|0|||
127493320|NCT01523743|458766678|FG000|Period 2|Withdrawal by Subject|0|||
127493321|NCT01523743|458766679|FG001|Period 2|Withdrawal by Subject|2|||
127493322|NCT01523743|458766678|FG000|Period 2|Adverse Event|1|||
127493323|NCT01523743|458766679|FG001|Period 2|Adverse Event|0|||
127493324|NCT03782064|458766680|FG000|Overall Study|Lack of Efficacy|2|||
127493325|NCT03782064|458766680|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
127493326|NCT02446769|458766681|FG000|Screening Period|Screen Failure|11|||
127493327|NCT02446769|458766682|FG001|Screening Period|Screen Failure|0|||
127493328|NCT02446769|458766683|FG002|Screening Period|Screen Failure|0|||
127493329|NCT02446769|458766681|FG000|Study Period|Randomized in Error|0|||
127493330|NCT02446769|458766682|FG001|Study Period|Randomized in Error|2|||
127493331|NCT02446769|458766683|FG002|Study Period|Randomized in Error|0|||
127493332|NCT00703963|458766684|FG000|Overall Study|Withdrawal by Subject|7|||
127493333|NCT00703963|458766685|FG001|Overall Study|Withdrawal by Subject|13|||
127493334|NCT00703963|458766684|FG000|Overall Study|Physician Decision|0|||
127493335|NCT00703963|458766685|FG001|Overall Study|Physician Decision|1|||
127493336|NCT00645840|458766686|FG000|Overall Study|Protocol Violation|3|||
127493337|NCT00402324|458766687|FG000|Overall Study|Lost to Follow-up|11|||
127493338|NCT00402324|458766688|FG001|Overall Study|Lost to Follow-up|11|||
127493339|NCT00402324|458766687|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
127493340|NCT00402324|458766688|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
127493341|NCT00402324|458766687|FG000|Overall Study|Protocol Violation|8|||
127493342|NCT00402324|458766688|FG001|Overall Study|Protocol Violation|7|||
127493343|NCT00402324|458766687|FG000|Overall Study|Withdrawal by Subject|5|||
127493344|NCT00402324|458766688|FG001|Overall Study|Withdrawal by Subject|2|||
127493345|NCT00402324|458766687|FG000|Overall Study|Physician Decision|2|||
127493346|NCT00402324|458766688|FG001|Overall Study|Physician Decision|4|||
127493347|NCT00402324|458766687|FG000|Overall Study|Sponsor Decision|4|||
127493348|NCT00402324|458766688|FG001|Overall Study|Sponsor Decision|5|||
127493349|NCT00402324|458766687|FG000|Overall Study|Lack of Efficacy|1|||
127493350|NCT00402324|458766688|FG001|Overall Study|Lack of Efficacy|4|||
127493351|NCT00402324|458766687|FG000|Overall Study|Adverse Event|6|||
127493352|NCT00402324|458766688|FG001|Overall Study|Adverse Event|4|||
127493353|NCT00402324|458766687|FG000|Overall Study|Death|1|||
127493354|NCT00402324|458766688|FG001|Overall Study|Death|0|||
127493355|NCT03994211|458766689|FG000|Core Phase|Adverse Event|0|||
127977173|NCT05896527|460538217|FG003|Overall Study|Investigator's decision|0|||
127977174|NCT05896527|460538218|FG004|Overall Study|Investigator's decision|0|||
127977175|NCT05896527|460538214|FG000|Overall Study|Pregnancy of his partner|0|||
127977176|NCT05896527|460538215|FG001|Overall Study|Pregnancy of his partner|0|||
127977177|NCT05896527|460538216|FG002|Overall Study|Pregnancy of his partner|0|||
127977178|NCT05896527|460538217|FG003|Overall Study|Pregnancy of his partner|1|||
127977179|NCT05896527|460538218|FG004|Overall Study|Pregnancy of his partner|0|||
127977180|NCT03085238|460538219|FG000|Overall Study|Adverse Event|2|||
127493356|NCT03994211|458766690|FG001|Core Phase|Adverse Event|1|||
127493357|NCT03994211|458766691|FG002|Core Phase|Adverse Event|0|||
127493358|NCT03994211|458766689|FG000|Extension Phase|Adverse Event|0|||
127493359|NCT03994211|458766690|FG001|Extension Phase|Adverse Event|0|||
127493360|NCT03994211|458766691|FG002|Extension Phase|Adverse Event|1|||
127493361|NCT03994211|458766689|FG000|Extension Phase|Physician Decision|0|||
127493362|NCT03994211|458766690|FG001|Extension Phase|Physician Decision|0|||
127493363|NCT03994211|458766691|FG002|Extension Phase|Physician Decision|1|||
127493364|NCT03994211|458766689|FG000|Extension Phase|Progressive Disease|0|||
127493365|NCT03994211|458766690|FG001|Extension Phase|Progressive Disease|0|||
127493366|NCT03994211|458766691|FG002|Extension Phase|Progressive Disease|20|||
127493367|NCT03994211|458766689|FG000|Extension Phase|Withdrawal by Subject|0|||
127493368|NCT03994211|458766690|FG001|Extension Phase|Withdrawal by Subject|0|||
127493369|NCT03994211|458766691|FG002|Extension Phase|Withdrawal by Subject|2|||
127493370|NCT02625220|458766692|FG000|Overall Study|Adverse Event|2|||
127493371|NCT02625220|458766692|FG000|Overall Study|Lost to Follow-up|2|||
127493372|NCT02625220|458766692|FG000|Overall Study|Protocol Violation|1|||
127493373|NCT02625220|458766692|FG000|Overall Study|Study discontinued at site|2|||
127493374|NCT01140867|458766693|FG000|Overall Study|Adverse Event|22|||
127493375|NCT01140867|458766693|FG000|Overall Study|Lack of Efficacy|3|||
127493376|NCT01140867|458766693|FG000|Overall Study|Lost to Follow-up|2|||
127493377|NCT01140867|458766693|FG000|Overall Study|Withdrawal by Subject|1|||
127493378|NCT01140867|458766693|FG000|Overall Study|Protocol Violation|1|||
127493379|NCT01140867|458766693|FG000|Overall Study|Uncooperative patient|2|||
127493380|NCT01140867|458766693|FG000|Overall Study|Medication Noncompliance|2|||
127493381|NCT00271856|458766699|FG000|Overall Study|Withdrawal by Subject|1|||
127493382|NCT00271856|458766700|FG001|Overall Study|Withdrawal by Subject|7|||
127493383|NCT00271856|458766699|FG000|Overall Study|Lost to Follow-up|10|||
127493384|NCT00271856|458766700|FG001|Overall Study|Lost to Follow-up|11|||
127493385|NCT04599803|458766701|FG000|Overall Study|Withdrawal by Subject|5|||
127493386|NCT04599803|458766701|FG000|Overall Study|Lost to Follow-up|26|||
127493387|NCT02366923|458766702|FG000|Overall Study|Withdrawal by Subject|1|||
127493388|NCT02366923|458766702|FG000|Overall Study|Positive Slit Lamp Findings|2|||
127493389|NCT02366923|458766702|FG000|Overall Study|High Astigmatism|3|||
127493390|NCT04677543|458766703|FG000|Overall Study|Withdrawal by Subject|4|||
127493391|NCT04677543|458766704|FG001|Overall Study|Withdrawal by Subject|1|||
127493392|NCT04677543|458766703|FG000|Overall Study|Physician Decision|0|||
127493393|NCT04677543|458766704|FG001|Overall Study|Physician Decision|1|||
127493394|NCT04677543|458766703|FG000|Overall Study|Adverse Event|0|||
127493395|NCT04677543|458766704|FG001|Overall Study|Adverse Event|1|||
127493396|NCT00995436|458766709|FG000|Overall Study|Withdrawal by Subject|2|||
127493397|NCT00995436|458766710|FG001|Overall Study|Withdrawal by Subject|5|||
127493398|NCT00995436|458766711|FG002|Overall Study|Withdrawal by Subject|0|||
127493399|NCT00771927|458766713|FG000|Overall Study|Adverse Event|100|||
127493400|NCT00771927|458766714|FG001|Overall Study|Adverse Event|105|||
127493401|NCT00771927|458766713|FG000|Overall Study|Lack of Efficacy|70|||
127493402|NCT00771927|458766714|FG001|Overall Study|Lack of Efficacy|42|||
127493403|NCT00771927|458766713|FG000|Overall Study|Lost to Follow-up|46|||
127493404|NCT00771927|458766714|FG001|Overall Study|Lost to Follow-up|46|||
127493405|NCT00771927|458766713|FG000|Overall Study|Withdrawal by Subject|16|||
127493406|NCT00771927|458766714|FG001|Overall Study|Withdrawal by Subject|17|||
127493407|NCT00771927|458766713|FG000|Overall Study|Other reason|23|||
127493408|NCT00771927|458766714|FG001|Overall Study|Other reason|27|||
127493409|NCT03711370|458766715|FG000|Overall Study|Lost to Follow-up|16|||
127493410|NCT03711370|458766716|FG001|Overall Study|Lost to Follow-up|10|||
127493411|NCT03711370|458766715|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
127493412|NCT03711370|458766716|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
127493413|NCT00407602|458766717|FG000|Overall Study|Death - unrelated to device|1|||
127493414|NCT00407602|458766717|FG000|Overall Study|Device explanted|5|||
127493415|NCT00407602|458766717|FG000|Overall Study|Withdrawal by Subject|1|||
127493416|NCT02063984|458766718|FG000|Overall Study|Lost to Follow-up|6|||
127493417|NCT02063984|458766719|FG001|Overall Study|Lost to Follow-up|5|||
127493418|NCT00577707|458766725|FG000|Overall Study|Withdrawal by Subject|3|||
127493419|NCT03299244|458766726|FG000|Overall Study|Withdrawal by Subject|34|||
127493420|NCT03299244|458766727|FG001|Overall Study|Withdrawal by Subject|29|||
127493421|NCT03299244|458766726|FG000|Overall Study|Decision by Sponsor|4|||
127977181|NCT03085238|460538219|FG000|Overall Study|Death|2|||
127977182|NCT03781583|460538220|FG000|Overall Study|Technical issue prevents the device from starting properly|1|||
127977183|NCT03781583|460538221|FG001|Overall Study|Technical issue prevents the device from starting properly|0|||
127493422|NCT03299244|458766727|FG001|Overall Study|Decision by Sponsor|5|||
127493423|NCT03299244|458766726|FG000|Overall Study|Death|9|||
127493424|NCT03299244|458766727|FG001|Overall Study|Death|4|||
127493425|NCT00431444|458766728|FG000|Overall Study|Protocol Violation|1|||
127977184|NCT03781583|460538222|FG002|Overall Study|Technical issue prevents the device from starting properly|0|||
127977185|NCT03781583|460538223|FG003|Overall Study|Technical issue prevents the device from starting properly|0|||
127493426|NCT00431444|458766729|FG001|Overall Study|Protocol Violation|4|||
127493427|NCT00431444|458766728|FG000|Overall Study|Adverse Event|2|||
127493428|NCT00431444|458766729|FG001|Overall Study|Adverse Event|1|||
127493429|NCT00431444|458766728|FG000|Overall Study|Withdrawal by Subject|1|||
127493430|NCT00431444|458766729|FG001|Overall Study|Withdrawal by Subject|1|||
127493431|NCT00431444|458766728|FG000|Overall Study|Lost to Follow-up|1|||
127493432|NCT00431444|458766729|FG001|Overall Study|Lost to Follow-up|0|||
127493433|NCT00431444|458766728|FG000|Overall Study|Administrative Problems|0|||
127493434|NCT00431444|458766729|FG001|Overall Study|Administrative Problems|1|||
127493435|NCT01603043|458766730|FG000|Overall Study|Study Futility|7|||
127493436|NCT01603043|458766731|FG001|Overall Study|Study Futility|3|||
127493437|NCT02712996|458766758|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
127493438|NCT02712996|458766759|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
127493439|NCT01016132|458766760|FG000|Overall Study|Discomfort|1|||
127493440|NCT01451749|458766763|FG000|Overall Study|Protocol Violation|14|||
127493441|NCT01451749|458766764|FG001|Overall Study|Protocol Violation|7|||
127493442|NCT01451749|458766763|FG000|Overall Study|Lost to Follow-up|15|||
127493443|NCT01451749|458766764|FG001|Overall Study|Lost to Follow-up|5|||
127493444|NCT01451749|458766763|FG000|Overall Study|Meet the exclusion criteria,and|1|||
127493445|NCT01451749|458766764|FG001|Overall Study|Meet the exclusion criteria,and|1|||
127493446|NCT01451749|458766763|FG000|Overall Study|Adverse Event|2|||
127493447|NCT01451749|458766764|FG001|Overall Study|Adverse Event|0|||
127493448|NCT01451749|458766763|FG000|Overall Study|Withdrawal by Subject|0|||
127493449|NCT01451749|458766764|FG001|Overall Study|Withdrawal by Subject|1|||
127493450|NCT01198574|458766800|FG000|Overall Study|Resigned from schools|4|||
127493451|NCT01198574|458766801|FG001|Overall Study|Resigned from schools|1|||
127493452|NCT01198574|458766802|FG002|Overall Study|Resigned from schools|1|||
127493453|NCT01198574|458766803|FG003|Overall Study|Resigned from schools|4|||
127493454|NCT00556439|458766805|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
127493455|NCT00556439|458766806|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
127493456|NCT00556439|458766807|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
127493457|NCT00556439|458766808|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
127493458|NCT00556439|458766805|FG000|Study Entry to Week 12|Physician Decision|1|||
127493459|NCT00556439|458766806|FG001|Study Entry to Week 12|Physician Decision|0|||
127493460|NCT00556439|458766807|FG002|Study Entry to Week 12|Physician Decision|0|||
127493461|NCT00556439|458766808|FG003|Study Entry to Week 12|Physician Decision|0|||
127977186|NCT03781583|460538220|FG000|Overall Study|Technology did not work for that person in that environment|1|||
127977187|NCT03781583|460538221|FG001|Overall Study|Technology did not work for that person in that environment|0|||
127977188|NCT03781583|460538222|FG002|Overall Study|Technology did not work for that person in that environment|0|||
127977189|NCT03781583|460538223|FG003|Overall Study|Technology did not work for that person in that environment|0|||
127977190|NCT03781583|460538220|FG000|Overall Study|Participant was not sufficiently visually impaired|0|||
127977191|NCT03781583|460538221|FG001|Overall Study|Participant was not sufficiently visually impaired|1|||
127977192|NCT03781583|460538222|FG002|Overall Study|Participant was not sufficiently visually impaired|0|||
127977193|NCT03781583|460538223|FG003|Overall Study|Participant was not sufficiently visually impaired|0|||
127977194|NCT03781583|460538220|FG000|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
127977195|NCT03781583|460538221|FG001|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|1|||
127977196|NCT03781583|460538222|FG002|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
127977197|NCT03781583|460538223|FG003|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
127977198|NCT02222545|460538224|FG000|Overall Study|Adverse Event|1|||
127977199|NCT02222545|460538225|FG001|Overall Study|Adverse Event|0|||
127977200|NCT02222545|460538226|FG002|Overall Study|Adverse Event|2|||
127977201|NCT02222545|460538224|FG000|Overall Study|Death|0|||
127977202|NCT02222545|460538225|FG001|Overall Study|Death|0|||
127977203|NCT02222545|460538226|FG002|Overall Study|Death|9|||
127977204|NCT02222545|460538224|FG000|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
127977205|NCT02222545|460538225|FG001|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
127977206|NCT02222545|460538226|FG002|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|10|||
127977207|NCT02222545|460538224|FG000|Overall Study|Withdrawal by Subject|0|||
127977208|NCT02222545|460538225|FG001|Overall Study|Withdrawal by Subject|0|||
127977209|NCT02222545|460538226|FG002|Overall Study|Withdrawal by Subject|3|||
127977210|NCT02222545|460538224|FG000|Overall Study|Proceeded to compassionate use of OMS721|0|||
127977211|NCT02222545|460538225|FG001|Overall Study|Proceeded to compassionate use of OMS721|0|||
127977212|NCT02222545|460538226|FG002|Overall Study|Proceeded to compassionate use of OMS721|1|||
127977213|NCT00761280|460538227|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
127977214|NCT00761280|460538228|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
127977215|NCT00761280|460538227|FG000|Randomization to First Dose|Sponsor decision|1|||
127977216|NCT00761280|460538228|FG001|Randomization to First Dose|Sponsor decision|0|||
127977217|NCT00761280|460538227|FG000|Randomization to First Dose|Other|1|||
127977218|NCT00761280|460538228|FG001|Randomization to First Dose|Other|0|||
127977219|NCT00761280|460538227|FG000|First Dose to End of Study|End of trial|5|||
127493462|NCT00556439|458766805|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
127493463|NCT00556439|458766806|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
127493464|NCT00556439|458766807|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
127493465|NCT00556439|458766808|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
127493466|NCT00556439|458766805|FG000|Study Entry to Week 12|Recurrent infection|1|||
127493467|NCT00556439|458766806|FG001|Study Entry to Week 12|Recurrent infection|0|||
127493468|NCT00556439|458766807|FG002|Study Entry to Week 12|Recurrent infection|0|||
127493469|NCT00556439|458766808|FG003|Study Entry to Week 12|Recurrent infection|0|||
127493470|NCT00556439|458766805|FG000|Study Entry to Week 12|Malignancy|0|||
127493471|NCT00556439|458766806|FG001|Study Entry to Week 12|Malignancy|0|||
127493472|NCT00556439|458766807|FG002|Study Entry to Week 12|Malignancy|1|||
127493473|NCT00556439|458766808|FG003|Study Entry to Week 12|Malignancy|0|||
127493474|NCT00556439|458766805|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
127493475|NCT00556439|458766806|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
127493476|NCT00556439|458766807|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
127493477|NCT00556439|458766808|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
127493478|NCT00556439|458766805|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
127493479|NCT00556439|458766806|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
127493480|NCT00556439|458766807|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
127493481|NCT00556439|458766808|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
127493482|NCT00556439|458766805|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
127493483|NCT00556439|458766806|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
127493484|NCT00556439|458766807|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
127493485|NCT00556439|458766808|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
127493486|NCT00556439|458766805|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
127493487|NCT00556439|458766806|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
127493488|NCT00556439|458766807|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
127493489|NCT00556439|458766808|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
127493490|NCT02100423|458766809|FG000|Overall Study|Death|1|||
127493491|NCT02100423|458766809|FG000|Overall Study|Withdrawal by Subject|3|||
127493492|NCT02100423|458766809|FG000|Overall Study|Adverse Event|1|||
127493493|NCT02100423|458766809|FG000|Overall Study|Physician Decision|1|||
127493494|NCT00325130|458766810|FG000|Overall Study|Lost to Follow-up|6|||
127493495|NCT00325130|458766811|FG001|Overall Study|Lost to Follow-up|14|||
127493496|NCT00325130|458766810|FG000|Overall Study|Withdrawal by Subject|12|||
127493497|NCT00325130|458766811|FG001|Overall Study|Withdrawal by Subject|14|||
127493498|NCT00325130|458766810|FG000|Overall Study|Protocol Deviation|0|||
127493499|NCT00325130|458766811|FG001|Overall Study|Protocol Deviation|1|||
127493500|NCT00325130|458766810|FG000|Overall Study|Moved|0|||
127493501|NCT00325130|458766811|FG001|Overall Study|Moved|1|||
127493502|NCT00325130|458766810|FG000|Overall Study|Patient Discontinued for Other|1|||
127493503|NCT00325130|458766811|FG001|Overall Study|Patient Discontinued for Other|0|||
127493504|NCT02454530|458766812|FG000|Overall Study|Other|8|||
127493505|NCT02454530|458766813|FG001|Overall Study|Other|13|||
127493506|NCT02454530|458766812|FG000|Overall Study|Missing information|56|||
127493507|NCT02454530|458766813|FG001|Overall Study|Missing information|69|||
127493508|NCT02454530|458766812|FG000|Overall Study|Death|2|||
127493509|NCT02454530|458766813|FG001|Overall Study|Death|41|||
127493510|NCT02454530|458766812|FG000|Overall Study|Lost to Follow-up|4|||
127493511|NCT02454530|458766813|FG001|Overall Study|Lost to Follow-up|4|||
127493512|NCT03265145|458766814|FG000|Overall Study|Protocol Violation|2|||
127493513|NCT03265145|458766815|FG001|Overall Study|Protocol Violation|0|||
127493514|NCT03265145|458766814|FG000|Overall Study|Adverse Event|1|||
127493515|NCT03265145|458766815|FG001|Overall Study|Adverse Event|0|||
127493516|NCT03265145|458766814|FG000|Overall Study|Withdrawal by Subject|23|||
127493517|NCT03265145|458766815|FG001|Overall Study|Withdrawal by Subject|19|||
127493518|NCT03265145|458766814|FG000|Overall Study|Death|12|||
127493519|NCT03265145|458766815|FG001|Overall Study|Death|12|||
127493520|NCT03265145|458766814|FG000|Overall Study|Lost to Follow-up|13|||
127493521|NCT03265145|458766815|FG001|Overall Study|Lost to Follow-up|9|||
127493522|NCT03265145|458766814|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
127493523|NCT03265145|458766815|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
127493524|NCT03265145|458766814|FG000|Overall Study|Switched back to previous medication|1|||
127493525|NCT03265145|458766815|FG001|Overall Study|Switched back to previous medication|0|||
127493526|NCT03265145|458766814|FG000|Overall Study|Did not want to take medication|1|||
127493527|NCT03265145|458766815|FG001|Overall Study|Did not want to take medication|0|||
127493528|NCT03265145|458766814|FG000|Overall Study|Subject could not afford medication|0|||
127493529|NCT03265145|458766815|FG001|Overall Study|Subject could not afford medication|1|||
127493530|NCT03265145|458766814|FG000|Overall Study|Site closed|2|||
127493531|NCT03265145|458766815|FG001|Overall Study|Site closed|3|||
127493532|NCT03265145|458766814|FG000|Overall Study|Incorrectly randomized|16|||
127493533|NCT03265145|458766815|FG001|Overall Study|Incorrectly randomized|6|||
127493534|NCT03265145|458766814|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
127493535|NCT03265145|458766815|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
127493536|NCT03265145|458766814|FG000|Overall Study|Physician Decision|0|||
127493537|NCT03265145|458766815|FG001|Overall Study|Physician Decision|3|||
127493538|NCT03265145|458766814|FG000|Overall Study|Subject transferred to another facility|0|||
127493539|NCT03265145|458766815|FG001|Overall Study|Subject transferred to another facility|1|||
127493540|NCT02949024|458766818|FG000|Overall Study|Withdrawal by Subject|0|||
127493541|NCT02949024|458766819|FG001|Overall Study|Withdrawal by Subject|1|||
127493542|NCT01042158|458766820|FG000|Overall Study|Physician Decision|1|||
127977220|NCT00761280|460538228|FG001|First Dose to End of Study|End of trial|5|||
127493543|NCT03159468|458766821|FG000|Overall Study|Withdrawal by Subject|0|||
127493544|NCT03159468|458766822|FG001|Overall Study|Withdrawal by Subject|0|||
127493545|NCT03159468|458766823|FG002|Overall Study|Withdrawal by Subject|3|||
127493546|NCT03159468|458766824|FG003|Overall Study|Withdrawal by Subject|0|||
127493547|NCT03159468|458766825|FG004|Overall Study|Withdrawal by Subject|0|||
127493548|NCT03159468|458766826|FG005|Overall Study|Withdrawal by Subject|0|||
127493549|NCT03640325|458768686|FG000|Overall Study|Withdrawal by Subject|4|||
127493550|NCT03640325|458768687|FG001|Overall Study|Withdrawal by Subject|1|||
127493551|NCT03640325|458768688|FG002|Overall Study|Withdrawal by Subject|0|||
127493552|NCT03640325|458768686|FG000|Overall Study|Lost to Follow-up|4|||
127493553|NCT03640325|458768687|FG001|Overall Study|Lost to Follow-up|5|||
127493554|NCT03640325|458768688|FG002|Overall Study|Lost to Follow-up|21|||
127493555|NCT03640325|458768686|FG000|Overall Study|Death|5|||
127493556|NCT03640325|458768687|FG001|Overall Study|Death|5|||
127493557|NCT03640325|458768688|FG002|Overall Study|Death|0|||
127493558|NCT01133756|458768692|FG000|Overall Study|Adverse Event|1|||
127493559|NCT01133756|458768693|FG001|Overall Study|Adverse Event|2|||
127493560|NCT01133756|458768694|FG002|Overall Study|Adverse Event|1|||
127493561|NCT01133756|458768692|FG000|Overall Study|Investigator Decision|1|||
127493562|NCT01133756|458768693|FG001|Overall Study|Investigator Decision|0|||
127493563|NCT01133756|458768694|FG002|Overall Study|Investigator Decision|0|||
127493564|NCT01133756|458768692|FG000|Overall Study|Withdrawal by Subject|0|||
127493565|NCT01133756|458768693|FG001|Overall Study|Withdrawal by Subject|1|||
127493566|NCT01133756|458768694|FG002|Overall Study|Withdrawal by Subject|0|||
127493567|NCT01133756|458768692|FG000|Overall Study|Progression of Disease|0|||
127493568|NCT01133756|458768693|FG001|Overall Study|Progression of Disease|0|||
127493569|NCT01133756|458768694|FG002|Overall Study|Progression of Disease|1|||
127493570|NCT01566149|458768695|FG000|Overall Study|Adverse Event|0|||
127493571|NCT01566149|458768696|FG001|Overall Study|Adverse Event|1|||
127493572|NCT01566149|458768695|FG000|Overall Study|Non-compliance with study medication|2|||
127493573|NCT01566149|458768696|FG001|Overall Study|Non-compliance with study medication|0|||
127493574|NCT01566149|458768695|FG000|Overall Study|Protocol Violation|0|||
127493575|NCT01566149|458768696|FG001|Overall Study|Protocol Violation|1|||
127493576|NCT01566149|458768695|FG000|Overall Study|Withdrawal by Subject|1|||
127493577|NCT01566149|458768696|FG001|Overall Study|Withdrawal by Subject|0|||
127493578|NCT03276728|458768700|FG000|Overall Study|Lost to Follow-up|0|||
127493579|NCT03276728|458768701|FG001|Overall Study|Lost to Follow-up|0|||
127493580|NCT03276728|458768702|FG002|Overall Study|Lost to Follow-up|2|||
127493581|NCT03276728|458768703|FG003|Overall Study|Lost to Follow-up|2|||
127493582|NCT03276728|458768704|FG004|Overall Study|Lost to Follow-up|0|||
127493583|NCT03276728|458768705|FG005|Overall Study|Lost to Follow-up|0|||
127493584|NCT03276728|458768706|FG006|Overall Study|Lost to Follow-up|0|||
127493585|NCT03276728|458768707|FG007|Overall Study|Lost to Follow-up|0|||
127493586|NCT03276728|458768700|FG000|Overall Study|Withdrawal by Subject|0|||
127493587|NCT03276728|458768701|FG001|Overall Study|Withdrawal by Subject|0|||
127493588|NCT03276728|458768702|FG002|Overall Study|Withdrawal by Subject|0|||
127493589|NCT03276728|458768703|FG003|Overall Study|Withdrawal by Subject|3|||
127493590|NCT03276728|458768704|FG004|Overall Study|Withdrawal by Subject|0|||
127493591|NCT03276728|458768705|FG005|Overall Study|Withdrawal by Subject|0|||
127493592|NCT03276728|458768706|FG006|Overall Study|Withdrawal by Subject|0|||
127493593|NCT03276728|458768707|FG007|Overall Study|Withdrawal by Subject|0|||
127493594|NCT03276728|458768700|FG000|Overall Study|Decision by sponsor|0|||
127493595|NCT03276728|458768701|FG001|Overall Study|Decision by sponsor|0|||
127493596|NCT03276728|458768702|FG002|Overall Study|Decision by sponsor|0|||
127493597|NCT03276728|458768703|FG003|Overall Study|Decision by sponsor|0|||
127493598|NCT03276728|458768704|FG004|Overall Study|Decision by sponsor|1|||
127493599|NCT03276728|458768705|FG005|Overall Study|Decision by sponsor|0|||
127493600|NCT03276728|458768706|FG006|Overall Study|Decision by sponsor|2|||
127493601|NCT03276728|458768707|FG007|Overall Study|Decision by sponsor|1|||
127493602|NCT03941873|458768714|FG000|Overall Study|Death|0|||
127493603|NCT03941873|458768715|FG001|Overall Study|Death|12|||
127493604|NCT03941873|458768716|FG002|Overall Study|Death|2|||
127493605|NCT03941873|458768717|FG003|Overall Study|Death|53|||
127493606|NCT03941873|458768714|FG000|Overall Study|Withdrawal by Subject|1|||
127493607|NCT03941873|458768715|FG001|Overall Study|Withdrawal by Subject|1|||
127493608|NCT03941873|458768716|FG002|Overall Study|Withdrawal by Subject|0|||
127493609|NCT03941873|458768717|FG003|Overall Study|Withdrawal by Subject|5|||
127493610|NCT03941873|458768714|FG000|Overall Study|Lost to Follow-up|1|||
127493611|NCT03941873|458768715|FG001|Overall Study|Lost to Follow-up|2|||
127493612|NCT03941873|458768716|FG002|Overall Study|Lost to Follow-up|0|||
127493613|NCT03941873|458768717|FG003|Overall Study|Lost to Follow-up|0|||
127493614|NCT03941873|458768714|FG000|Overall Study|Sponsor Decision|0|||
127493615|NCT03941873|458768715|FG001|Overall Study|Sponsor Decision|6|||
127493616|NCT03941873|458768716|FG002|Overall Study|Sponsor Decision|0|||
127493617|NCT03941873|458768717|FG003|Overall Study|Sponsor Decision|15|||
127493618|NCT02982772|458768720|FG000|Intervention|Lost to Follow-up|19|||
127493619|NCT02982772|458768721|FG001|Intervention|Lost to Follow-up|13|||
127493620|NCT02982772|458768720|FG000|1M Follow-Up|Lost to Follow-up|21|||
127493621|NCT02982772|458768721|FG001|1M Follow-Up|Lost to Follow-up|18|||
127493622|NCT02982772|458768720|FG000|3M Follow-Up|Lost to Follow-up|17|||
127493623|NCT02982772|458768721|FG001|3M Follow-Up|Lost to Follow-up|11|||
127493624|NCT02982772|458768720|FG000|6M Follow-Up|Lost to Follow-up|11|||
127493625|NCT02982772|458768721|FG001|6M Follow-Up|Lost to Follow-up|9|||
127493626|NCT02982772|458768720|FG000|12M Follow-Up|Lost to Follow-up|11|||
127493627|NCT02982772|458768721|FG001|12M Follow-Up|Lost to Follow-up|5|||
127493628|NCT01234480|458768722|FG000|Overall Study|Pregnancy|88|||
127493629|NCT01234480|458768722|FG000|Overall Study|>36/Normal History|50|||
127493630|NCT01234480|458768722|FG000|Overall Study|Age|3|||
127493631|NCT01234480|458768722|FG000|Overall Study|HPV Vaccine History|28|||
127493632|NCT01234480|458768722|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
127493633|NCT01234480|458768722|FG000|Overall Study|Hysterectomy|2|||
127493634|NCT01234480|458768722|FG000|Overall Study|Hysterectomy post enrollment|1|||
127493635|NCT01234480|458768722|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
127493636|NCT01234480|458768722|FG000|Overall Study|Informed Consent Form Violation|30|||
127493637|NCT01234480|458768722|FG000|Overall Study|Incorrect Visit|3|||
127493638|NCT01234480|458768722|FG000|Overall Study|No Florida Lab License|20|||
127493639|NCT01234480|458768722|FG000|Overall Study|Out of Window|42|||
127493640|NCT01234480|458768722|FG000|Overall Study|Sample Processing/Storage|92|||
127493641|NCT01234480|458768722|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
127493642|NCT01234480|458768722|FG000|Overall Study|Site/Subject non-compliance|44|||
127493643|NCT01234480|458768722|FG000|Overall Study|Missing Sample|9|||
127493644|NCT02974140|458768723|FG000|Overall Study|Adverse Event|2|||
127493645|NCT02974140|458768723|FG000|Overall Study|Lost to Follow-up|1|||
127493646|NCT02974140|458768723|FG000|Overall Study|Study Terminated by Sponsor|36|||
127493647|NCT02222688|458768728|FG000|Overall Study|Withdrawal by Subject|0|||
127493648|NCT02222688|458768729|FG001|Overall Study|Withdrawal by Subject|0|||
127493649|NCT02222688|458768730|FG002|Overall Study|Withdrawal by Subject|0|||
127493650|NCT02222688|458768731|FG003|Overall Study|Withdrawal by Subject|2|||
127493651|NCT02222688|458768732|FG004|Overall Study|Withdrawal by Subject|1|||
127493652|NCT02222688|458768733|FG005|Overall Study|Withdrawal by Subject|0|||
127493653|NCT02222688|458768734|FG006|Overall Study|Withdrawal by Subject|1|||
127493654|NCT02222688|458768728|FG000|Overall Study|Disease progression|1|||
127493655|NCT02222688|458768729|FG001|Overall Study|Disease progression|0|||
127493656|NCT02222688|458768730|FG002|Overall Study|Disease progression|0|||
127493657|NCT02222688|458768731|FG003|Overall Study|Disease progression|0|||
127493658|NCT02222688|458768732|FG004|Overall Study|Disease progression|0|||
127493659|NCT02222688|458768733|FG005|Overall Study|Disease progression|0|||
127493660|NCT02222688|458768734|FG006|Overall Study|Disease progression|0|||
127493661|NCT02522429|458768743|FG000|Overall Study|Lost to Follow-up|8|||
127493662|NCT02522429|458768743|FG000|Overall Study|Adverse Event|2|||
127493663|NCT02522429|458768743|FG000|Overall Study|Death|1|||
127493664|NCT02522429|458768743|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
127493665|NCT00500357|458768747|FG000|Overall Study|Death|1|||
127493666|NCT00161616|458768748|FG000|Overall Study|Withdrawal by Subject|6|||
127493667|NCT00161616|458768749|FG001|Overall Study|Withdrawal by Subject|5|||
127493668|NCT00161616|458768748|FG000|Overall Study|Physician Decision|1|||
127493669|NCT00161616|458768749|FG001|Overall Study|Physician Decision|0|||
127493670|NCT00161616|458768748|FG000|Overall Study|Death|1|||
127493671|NCT00161616|458768749|FG001|Overall Study|Death|1|||
127493672|NCT00161616|458768748|FG000|Overall Study|Lost to Follow-up|17|||
127493673|NCT00161616|458768749|FG001|Overall Study|Lost to Follow-up|13|||
127493674|NCT00161616|458768748|FG000|Overall Study|Protocol deviation|1|||
127493675|NCT00161616|458768749|FG001|Overall Study|Protocol deviation|0|||
127493676|NCT00854724|458768750|FG000|First Intervention|Withdrawal by Subject|1|||
127493677|NCT00854724|458768751|FG001|First Intervention|Withdrawal by Subject|1|||
127493678|NCT00854724|458768750|FG000|Washout|Protocol Violation|1|||
127493679|NCT00854724|458768751|FG001|Washout|Protocol Violation|0|||
127493680|NCT00854724|458768750|FG000|Washout|Withdrawal by Subject|0|||
127493681|NCT00854724|458768751|FG001|Washout|Withdrawal by Subject|1|||
127493682|NCT00854724|458768750|FG000|Second Intervention|Protocol Violation|1|||
127977221|NCT00761280|460538227|FG000|First Dose to End of Study|Progressive disease|5|||
127493683|NCT00854724|458768751|FG001|Second Intervention|Protocol Violation|0|||
127493684|NCT00854724|458768750|FG000|Second Intervention|Physician Decision|0|||
127493685|NCT00854724|458768751|FG001|Second Intervention|Physician Decision|1|||
127977222|NCT00761280|460538228|FG001|First Dose to End of Study|Progressive disease|3|||
127977223|NCT00761280|460538227|FG000|First Dose to End of Study|Sponsor decision|1|||
127977224|NCT00761280|460538228|FG001|First Dose to End of Study|Sponsor decision|2|||
127977225|NCT00761280|460538227|FG000|First Dose to End of Study|Death|1|||
127977226|NCT00761280|460538228|FG001|First Dose to End of Study|Death|0|||
127493686|NCT00861757|458768753|FG000|Overall Study|Adverse Event|1|||
127493687|NCT00861757|458768754|FG001|Overall Study|Adverse Event|5|||
127493688|NCT00861757|458768755|FG002|Overall Study|Adverse Event|7|||
127493689|NCT00861757|458768756|FG003|Overall Study|Adverse Event|2|||
127493690|NCT00861757|458768753|FG000|Overall Study|Entry Criteria Not Met|1|||
127493691|NCT00861757|458768754|FG001|Overall Study|Entry Criteria Not Met|2|||
127493692|NCT00861757|458768755|FG002|Overall Study|Entry Criteria Not Met|1|||
127493693|NCT00861757|458768756|FG003|Overall Study|Entry Criteria Not Met|1|||
127493694|NCT00861757|458768753|FG000|Overall Study|Lack of Efficacy|3|||
127493695|NCT00861757|458768754|FG001|Overall Study|Lack of Efficacy|1|||
127493696|NCT00861757|458768755|FG002|Overall Study|Lack of Efficacy|0|||
127493697|NCT00861757|458768756|FG003|Overall Study|Lack of Efficacy|1|||
127493698|NCT00861757|458768753|FG000|Overall Study|Lost to Follow-up|1|||
127493699|NCT00861757|458768754|FG001|Overall Study|Lost to Follow-up|0|||
127493700|NCT00861757|458768755|FG002|Overall Study|Lost to Follow-up|1|||
127493701|NCT00861757|458768756|FG003|Overall Study|Lost to Follow-up|1|||
127493702|NCT00861757|458768753|FG000|Overall Study|Physician Decision|0|||
127493703|NCT00861757|458768754|FG001|Overall Study|Physician Decision|0|||
127493704|NCT00861757|458768755|FG002|Overall Study|Physician Decision|0|||
127493705|NCT00861757|458768756|FG003|Overall Study|Physician Decision|1|||
127493706|NCT00861757|458768753|FG000|Overall Study|Protocol Violation|2|||
127493707|NCT00861757|458768754|FG001|Overall Study|Protocol Violation|2|||
127493708|NCT00861757|458768755|FG002|Overall Study|Protocol Violation|4|||
127493709|NCT00861757|458768756|FG003|Overall Study|Protocol Violation|1|||
127493710|NCT00861757|458768753|FG000|Overall Study|Withdrawal by Subject|1|||
127493711|NCT00861757|458768754|FG001|Overall Study|Withdrawal by Subject|5|||
127493712|NCT00861757|458768755|FG002|Overall Study|Withdrawal by Subject|5|||
127493713|NCT00861757|458768756|FG003|Overall Study|Withdrawal by Subject|2|||
127493714|NCT03308968|458768757|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
127493715|NCT03308968|458768758|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
127493716|NCT03308968|458768759|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
127493717|NCT03308968|458768757|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
127493718|NCT03308968|458768758|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
127493719|NCT03308968|458768759|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
127493720|NCT03308968|458768757|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
127493721|NCT03308968|458768758|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
127493722|NCT03308968|458768759|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
127493723|NCT03308968|458768757|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
127493724|NCT03308968|458768758|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
127493725|NCT03308968|458768759|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
127493726|NCT03308968|458768757|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
127493727|NCT03308968|458768758|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
127493728|NCT03308968|458768759|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
127493729|NCT03308968|458768757|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
127493730|NCT03308968|458768758|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
127493731|NCT03308968|458768759|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
127493732|NCT03308968|458768757|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
127493733|NCT03308968|458768758|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
127493734|NCT03308968|458768759|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
127493735|NCT03308968|458768757|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
127493736|NCT03308968|458768758|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
127493737|NCT03308968|458768759|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
127493738|NCT03308968|458768757|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
127493739|NCT03308968|458768758|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
127493740|NCT03308968|458768759|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
127493741|NCT03308968|458768757|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
127493742|NCT03308968|458768758|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
127493743|NCT03308968|458768759|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
127493744|NCT03308968|458768757|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
127493745|NCT03308968|458768758|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
127493746|NCT03308968|458768759|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
127493747|NCT03308968|458768757|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
127493748|NCT03308968|458768758|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
127493749|NCT03308968|458768759|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
127493750|NCT03308968|458768757|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
127493751|NCT03308968|458768758|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
127493752|NCT03308968|458768759|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
127493753|NCT03308968|458768757|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
127493754|NCT03308968|458768758|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
127493755|NCT03308968|458768759|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
127493756|NCT01961297|458768760|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
127493757|NCT01961297|458768761|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
127493758|NCT02141633|458768762|FG000|Overall Study|Physician Decision|1|||
127493759|NCT02141633|458768763|FG001|Overall Study|Physician Decision|0|||
127493760|NCT02482298|458768764|FG000|Overall Study|Withdrawal by Subject|2|||
127493761|NCT02482298|458768765|FG001|Overall Study|Withdrawal by Subject|1|||
127493762|NCT02482298|458768766|FG002|Overall Study|Withdrawal by Subject|2|||
127493763|NCT02482298|458768764|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
127493764|NCT02482298|458768765|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
127493765|NCT02482298|458768766|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
127493766|NCT02482298|458768764|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
127493767|NCT02482298|458768765|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
127493768|NCT02482298|458768766|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
127493769|NCT02482298|458768764|FG000|Overall Study|Lost to Follow-up|0|||
127493770|NCT02482298|458768765|FG001|Overall Study|Lost to Follow-up|1|||
127493771|NCT02482298|458768766|FG002|Overall Study|Lost to Follow-up|0|||
127493772|NCT02140970|458768774|FG000|Overall Study|Lost to Follow-up|1|||
127493773|NCT02140970|458768775|FG001|Overall Study|Lost to Follow-up|2|||
127493774|NCT02140970|458768774|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
127493775|NCT02140970|458768775|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
127493776|NCT02140970|458768774|FG000|Overall Study|Did not meet inclusion criteria|0|||
127493777|NCT02140970|458768775|FG001|Overall Study|Did not meet inclusion criteria|1|||
127493778|NCT02705105|458768776|FG000|Treatment|Objective Disease Progression|1|||
127493779|NCT02705105|458768777|FG001|Treatment|Objective Disease Progression|50|||
127493780|NCT02705105|458768776|FG000|Treatment|Withdrawal by Subject|3|||
127493781|NCT02705105|458768777|FG001|Treatment|Withdrawal by Subject|5|||
127493782|NCT02705105|458768776|FG000|Treatment|Adverse Event|0|||
127493783|NCT02705105|458768777|FG001|Treatment|Adverse Event|17|||
127493784|NCT02705105|458768776|FG000|Treatment|Clinical Disease Progression|0|||
127493785|NCT02705105|458768777|FG001|Treatment|Clinical Disease Progression|32|||
127493786|NCT02705105|458768776|FG000|Treatment|Physician Decision|0|||
127493787|NCT02705105|458768777|FG001|Treatment|Physician Decision|3|||
127493788|NCT02705105|458768776|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
127493789|NCT02705105|458768777|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
127493790|NCT02705105|458768776|FG000|Follow-Up|Death|3|||
127493791|NCT02705105|458768777|FG001|Follow-Up|Death|68|||
127493792|NCT02705105|458768776|FG000|Follow-Up|Withdrawal by Subject|1|||
127493793|NCT02705105|458768777|FG001|Follow-Up|Withdrawal by Subject|14|||
127493794|NCT02705105|458768776|FG000|Follow-Up|Study Terminated|0|||
127493795|NCT02705105|458768777|FG001|Follow-Up|Study Terminated|26|||
127493796|NCT02705105|458768776|FG000|Follow-Up|Discontinued per Amendment 3|0|||
127493797|NCT02705105|458768777|FG001|Follow-Up|Discontinued per Amendment 3|2|||
127493798|NCT01709110|458768780|FG000|Overall Study|Adverse Event|56|||
127493799|NCT01709110|458768781|FG001|Overall Study|Adverse Event|48|||
127493800|NCT01709110|458768780|FG000|Overall Study|Death|14|||
127493801|NCT01709110|458768781|FG001|Overall Study|Death|6|||
127493802|NCT01709110|458768780|FG000|Overall Study|Lost to Follow-up|7|||
127493803|NCT01709110|458768781|FG001|Overall Study|Lost to Follow-up|5|||
127493804|NCT01709110|458768780|FG000|Overall Study|Protocol Violation|4|||
127493805|NCT01709110|458768781|FG001|Overall Study|Protocol Violation|6|||
127493806|NCT01709110|458768780|FG000|Overall Study|Withdrawal by Subject|96|||
127493807|NCT01709110|458768781|FG001|Overall Study|Withdrawal by Subject|89|||
127493808|NCT01709110|458768780|FG000|Overall Study|Physician Decision|4|||
127493809|NCT01709110|458768781|FG001|Overall Study|Physician Decision|10|||
127493810|NCT01709110|458768780|FG000|Overall Study|Sponsor Decision|2|||
127493811|NCT01709110|458768781|FG001|Overall Study|Sponsor Decision|2|||
127493812|NCT01709110|458768780|FG000|Overall Study|Lack of Efficacy|1|||
127493813|NCT01709110|458768781|FG001|Overall Study|Lack of Efficacy|1|||
127493814|NCT01709110|458768780|FG000|Overall Study|Caregiver Decision|1|||
127493815|NCT01709110|458768781|FG001|Overall Study|Caregiver Decision|1|||
127493816|NCT03332173|458768782|FG000|Overall Study|Death|7|||
127493817|NCT03332173|458768782|FG000|Overall Study|Withdrawal by Subject|6|||
127493818|NCT03332173|458768782|FG000|Overall Study|Lost to Follow-up|2|||
127493819|NCT03332173|458768782|FG000|Overall Study|Transferred to long-term extension study|29|||
127493820|NCT02168101|458768783|FG000|Overall Study|Death|2|||
127493821|NCT02168101|458768784|FG001|Overall Study|Death|2|||
127493822|NCT02168101|458768785|FG002|Overall Study|Death|1|||
127977227|NCT00761280|460538227|FG000|First Dose to End of Study|Lost to Follow-up|0|||
127977228|NCT00761280|460538228|FG001|First Dose to End of Study|Lost to Follow-up|1|||
127977229|NCT03875482|460538229|FG000|Overall Study|Adverse Event|0|||
127977230|NCT03875482|460538230|FG001|Overall Study|Adverse Event|1|||
127977231|NCT03875482|460538229|FG000|Overall Study|Withdrew consent|5|||
127977232|NCT03875482|460538230|FG001|Overall Study|Withdrew consent|6|||
127977233|NCT03875482|460538229|FG000|Overall Study|Lost to Follow-up|8|||
127977234|NCT03875482|460538230|FG001|Overall Study|Lost to Follow-up|2|||
127977235|NCT03875482|460538229|FG000|Overall Study|Lack of Efficacy|0|||
127493823|NCT00910910|458768786|FG000|Overall Study|Adverse Event|63|||
127493824|NCT00910910|458768787|FG001|Overall Study|Adverse Event|35|||
127493825|NCT00910910|458768786|FG000|Overall Study|PD without histologic change|27|||
127493826|NCT00910910|458768787|FG001|Overall Study|PD without histologic change|23|||
127493827|NCT00910910|458768786|FG000|Overall Study|PD with histologic change|0|||
127493828|NCT00910910|458768787|FG001|Overall Study|PD with histologic change|2|||
127977236|NCT03875482|460538230|FG001|Overall Study|Lack of Efficacy|11|||
127977237|NCT02045862|460538232|FG000|Overall Study|Death|0|||
127493829|NCT00910910|458768786|FG000|Overall Study|Withdrawal by Subject|7|||
127493830|NCT00910910|458768787|FG001|Overall Study|Withdrawal by Subject|5|||
127977238|NCT02045862|460538233|FG001|Overall Study|Death|0|||
127977239|NCT02045862|460538234|FG002|Overall Study|Death|1|||
127977240|NCT02045862|460538232|FG000|Overall Study|Miscellaneous|5|||
127977241|NCT02045862|460538233|FG001|Overall Study|Miscellaneous|0|||
127977242|NCT02045862|460538234|FG002|Overall Study|Miscellaneous|8|||
127977243|NCT02045862|460538232|FG000|Overall Study|Withdrawal by Patient|18|||
127977244|NCT02045862|460538233|FG001|Overall Study|Withdrawal by Patient|27|||
127977245|NCT02045862|460538234|FG002|Overall Study|Withdrawal by Patient|57|||
127977246|NCT02045862|460538232|FG000|Overall Study|Protocol Violation|0|||
127977247|NCT02045862|460538233|FG001|Overall Study|Protocol Violation|0|||
127977248|NCT02045862|460538234|FG002|Overall Study|Protocol Violation|6|||
127977249|NCT02045862|460538232|FG000|Overall Study|Lack of Efficacy|8|||
127977250|NCT02045862|460538233|FG001|Overall Study|Lack of Efficacy|4|||
127977251|NCT02045862|460538234|FG002|Overall Study|Lack of Efficacy|13|||
127977252|NCT02045862|460538232|FG000|Overall Study|Randomized but not Received Study Drug|0|||
127977253|NCT02045862|460538233|FG001|Overall Study|Randomized but not Received Study Drug|2|||
127977254|NCT02045862|460538234|FG002|Overall Study|Randomized but not Received Study Drug|8|||
127977255|NCT02045862|460538232|FG000|Overall Study|Adverse Event|7|||
127977256|NCT02045862|460538233|FG001|Overall Study|Adverse Event|5|||
127977257|NCT02045862|460538234|FG002|Overall Study|Adverse Event|27|||
127977258|NCT02045862|460538232|FG000|Overall Study|Lost to Follow-up|1|||
127977259|NCT02045862|460538233|FG001|Overall Study|Lost to Follow-up|2|||
127977260|NCT02045862|460538234|FG002|Overall Study|Lost to Follow-up|6|||
127977261|NCT03164564|460538235|FG000|Overall Study|Death|3|||
127977262|NCT03164564|460538236|FG001|Overall Study|Death|0|||
127977263|NCT03164564|460538235|FG000|Overall Study|Withdrawal by Subject|20|||
127977264|NCT03164564|460538236|FG001|Overall Study|Withdrawal by Subject|15|||
127977265|NCT03164564|460538235|FG000|Overall Study|Lost to Follow-up|2|||
127977266|NCT03164564|460538236|FG001|Overall Study|Lost to Follow-up|0|||
127977267|NCT03164564|460538235|FG000|Overall Study|Physician Decision|0|||
127977268|NCT03164564|460538236|FG001|Overall Study|Physician Decision|1|||
127977269|NCT03164564|460538235|FG000|Overall Study|Adverse Event|0|||
127977270|NCT03164564|460538236|FG001|Overall Study|Adverse Event|1|||
127977271|NCT03164564|460538235|FG000|Overall Study|Ongoing|1586|||
127977272|NCT03164564|460538236|FG001|Overall Study|Ongoing|1586|||
127977273|NCT02691013|460538237|FG000|Overall Study|Withdrawal by Subject|3|||
127977274|NCT02691013|460538238|FG001|Overall Study|Withdrawal by Subject|0|||
127977275|NCT02111785|460538242|FG000|Overall Study|Death|0|||
127977276|NCT02111785|460538243|FG001|Overall Study|Death|1|||
127977277|NCT02111785|460538244|FG002|Overall Study|Death|0|||
127977278|NCT02111785|460538245|FG003|Overall Study|Death|0|||
127977279|NCT01075646|460538248|FG000|Overall Study|Lost to Follow-up|4|||
127977280|NCT01075646|460538249|FG001|Overall Study|Lost to Follow-up|3|||
127977281|NCT01075646|460538250|FG002|Overall Study|Lost to Follow-up|1|||
127977282|NCT01075646|460538251|FG003|Overall Study|Lost to Follow-up|2|||
127977283|NCT01676896|460538255|FG000|Overall Study|Withdrawal by Subject|12|||
127493831|NCT00910910|458768786|FG000|Overall Study|Lost to Follow-up|2|||
127493832|NCT00910910|458768787|FG001|Overall Study|Lost to Follow-up|2|||
127493833|NCT00910910|458768786|FG000|Overall Study|Death|9|||
127493834|NCT00910910|458768787|FG001|Overall Study|Death|3|||
127493835|NCT00910910|458768786|FG000|Overall Study|Protocol Violation|2|||
127493836|NCT00910910|458768787|FG001|Overall Study|Protocol Violation|2|||
127493837|NCT00910910|458768786|FG000|Overall Study|Completed 13 cycles of treatment|0|||
127493838|NCT00910910|458768787|FG001|Overall Study|Completed 13 cycles of treatment|118|||
127493839|NCT00910910|458768786|FG000|Overall Study|Other|114|||
127493840|NCT00910910|458768787|FG001|Overall Study|Other|32|||
127493841|NCT00910910|458768786|FG000|Overall Study|Untreated before cycle 1|1|||
127493842|NCT00910910|458768787|FG001|Overall Study|Untreated before cycle 1|2|||
127493843|NCT01973231|458768788|FG000|Overall Study|Protocol Violation|1|||
127493844|NCT01973231|458768789|FG001|Overall Study|Protocol Violation|1|||
127493845|NCT01973231|458768788|FG000|Overall Study|Lost to Follow-up|1|||
127493846|NCT01973231|458768789|FG001|Overall Study|Lost to Follow-up|1|||
127493847|NCT01973231|458768788|FG000|Overall Study|unclassified|2|||
127493848|NCT01973231|458768789|FG001|Overall Study|unclassified|1|||
127493849|NCT01973231|458768788|FG000|Overall Study|Withdrawal by Subject|7|||
127493850|NCT01973231|458768789|FG001|Overall Study|Withdrawal by Subject|9|||
127493851|NCT03726658|458768794|FG000|Overall Study|Lost to Follow-up|0|||
127493852|NCT03726658|458768795|FG001|Overall Study|Lost to Follow-up|0|||
127493853|NCT03726658|458768796|FG002|Overall Study|Lost to Follow-up|2|||
127493854|NCT03726658|458768797|FG003|Overall Study|Lost to Follow-up|0|||
127493855|NCT03726658|458768798|FG004|Overall Study|Lost to Follow-up|0|||
127493856|NCT03726658|458768799|FG005|Overall Study|Lost to Follow-up|1|||
127493857|NCT03726658|458768800|FG006|Overall Study|Lost to Follow-up|1|||
127493858|NCT03726658|458768794|FG000|Overall Study|Withdrawal by Subject|1|||
127493859|NCT03726658|458768795|FG001|Overall Study|Withdrawal by Subject|0|||
127493860|NCT03726658|458768796|FG002|Overall Study|Withdrawal by Subject|0|||
127493861|NCT03726658|458768797|FG003|Overall Study|Withdrawal by Subject|0|||
127493862|NCT03726658|458768798|FG004|Overall Study|Withdrawal by Subject|6|||
127493863|NCT03726658|458768799|FG005|Overall Study|Withdrawal by Subject|4|||
127493864|NCT03726658|458768800|FG006|Overall Study|Withdrawal by Subject|2|||
127493865|NCT03726658|458768794|FG000|Overall Study|Pregnancy|0|||
127493866|NCT03726658|458768795|FG001|Overall Study|Pregnancy|0|||
127493867|NCT03726658|458768796|FG002|Overall Study|Pregnancy|0|||
127493868|NCT03726658|458768797|FG003|Overall Study|Pregnancy|0|||
127493869|NCT03726658|458768798|FG004|Overall Study|Pregnancy|0|||
127493870|NCT03726658|458768799|FG005|Overall Study|Pregnancy|0|||
127493871|NCT03726658|458768800|FG006|Overall Study|Pregnancy|1|||
127493872|NCT03726658|458768794|FG000|Overall Study|Not Reported|0|||
127493873|NCT03726658|458768795|FG001|Overall Study|Not Reported|0|||
127493874|NCT03726658|458768796|FG002|Overall Study|Not Reported|0|||
127493875|NCT03726658|458768797|FG003|Overall Study|Not Reported|0|||
127493876|NCT03726658|458768798|FG004|Overall Study|Not Reported|0|||
127493877|NCT03726658|458768799|FG005|Overall Study|Not Reported|0|||
127493878|NCT03726658|458768800|FG006|Overall Study|Not Reported|1|||
127493879|NCT00090779|458768801|FG000|Step 1|Withdrawal by Subject|4|||
127493880|NCT00090779|458768802|FG001|Step 1|Withdrawal by Subject|2|||
127493881|NCT00090779|458768801|FG000|Step 1|Lost to Follow-up|3|||
127493882|NCT00090779|458768802|FG001|Step 1|Lost to Follow-up|2|||
127493883|NCT00090779|458768801|FG000|Step 1|Death|0|||
127493884|NCT00090779|458768802|FG001|Step 1|Death|2|||
127493885|NCT00090779|458768801|FG000|Step 1|Physician Decision|1|||
127493886|NCT00090779|458768802|FG001|Step 1|Physician Decision|0|||
127493887|NCT00090779|458768801|FG000|Step 1|Pregnancy|1|||
127493888|NCT00090779|458768802|FG001|Step 1|Pregnancy|0|||
127493889|NCT00090779|458768801|FG000|Step 1|Non-compliance to study requirements|0|||
127493890|NCT00090779|458768802|FG001|Step 1|Non-compliance to study requirements|1|||
127493891|NCT00090779|458768801|FG000|Step 1|Subject relocated|2|||
127493892|NCT00090779|458768802|FG001|Step 1|Subject relocated|8|||
127493893|NCT00090779|458768801|FG000|Step 2|Off study per study closure|6|||
127493894|NCT00090779|458768802|FG001|Step 2|Off study per study closure|16|||
127493895|NCT00090779|458768801|FG000|Step 2|Subject relocated|0|||
127493896|NCT00090779|458768802|FG001|Step 2|Subject relocated|1|||
127493897|NCT00090779|458768801|FG000|Step 2|Non-compliance to study requirements|0|||
127493898|NCT00090779|458768802|FG001|Step 2|Non-compliance to study requirements|1|||
127493899|NCT00090779|458768801|FG000|Step 3|Initiation of ART and off extended study|3|||
127493900|NCT00090779|458768802|FG001|Step 3|Initiation of ART and off extended study|2|||
127493901|NCT00090779|458768801|FG000|Step 3|Off extended study due to study closure|4|||
127493902|NCT00090779|458768802|FG001|Step 3|Off extended study due to study closure|3|||
127493903|NCT01318135|458768803|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
127493904|NCT01318135|458768804|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
127493905|NCT01318135|458768805|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
127493906|NCT01318135|458768806|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
127493907|NCT01318135|458768807|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
127493908|NCT01318135|458768808|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
127493909|NCT01318135|458768809|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
127493910|NCT01318135|458768810|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
127493911|NCT01318135|458768803|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
127493912|NCT01318135|458768804|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
127493913|NCT01318135|458768805|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
127493914|NCT01318135|458768806|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
127493915|NCT01318135|458768807|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
127493916|NCT01318135|458768808|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
127493917|NCT01318135|458768809|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
127493918|NCT01318135|458768810|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
127493919|NCT01318135|458768803|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
127493920|NCT01318135|458768804|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
127493921|NCT01318135|458768805|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
127493922|NCT01318135|458768806|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
127493923|NCT01318135|458768807|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
127493924|NCT01318135|458768808|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
127493925|NCT01318135|458768809|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
127493926|NCT01318135|458768810|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
127493927|NCT01318135|458768803|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
127493928|NCT01318135|458768804|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
127493929|NCT01318135|458768805|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
127493930|NCT01318135|458768806|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
127493931|NCT01318135|458768807|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
127493932|NCT01318135|458768808|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
127493933|NCT01318135|458768809|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
127493934|NCT01318135|458768810|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
127493935|NCT01318135|458768803|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
127493936|NCT01318135|458768804|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
127493937|NCT01318135|458768805|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
127493938|NCT01318135|458768806|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
127493939|NCT01318135|458768807|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
127493940|NCT01318135|458768808|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
127493941|NCT01318135|458768809|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
127493942|NCT01318135|458768810|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
127493943|NCT01318135|458768803|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
127493944|NCT01318135|458768804|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
127493945|NCT01318135|458768805|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
127493946|NCT01318135|458768806|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
127493947|NCT01318135|458768807|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
127493948|NCT01318135|458768808|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
127493949|NCT01318135|458768809|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
127493950|NCT01318135|458768810|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
127493951|NCT01318135|458768803|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
127493952|NCT01318135|458768804|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
127493953|NCT01318135|458768805|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
127493954|NCT01318135|458768806|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
127493955|NCT01318135|458768807|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
127493956|NCT01318135|458768808|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
127493957|NCT01318135|458768809|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
127493958|NCT01318135|458768810|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
127493959|NCT02569476|458768815|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
127493960|NCT02569476|458768815|FG000|Overall Study|Death|33|||
127493961|NCT02569476|458768815|FG000|Overall Study|Withdrawal by Subject|9|||
127493962|NCT02569476|458768815|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
127493963|NCT02569476|458768815|FG000|Overall Study|Palliative care|1|||
127493964|NCT02569476|458768815|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
127493965|NCT02569476|458768815|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
127493966|NCT02923531|458768818|FG000|Overall Study|Adverse Event|4|||
127493967|NCT02923531|458768818|FG000|Overall Study|Clinical Deterioration|1|||
127493968|NCT02923531|458768818|FG000|Overall Study|Disease Progression|3|||
127493969|NCT02923531|458768818|FG000|Overall Study|Study Termination|1|||
127493970|NCT00997984|458768819|FG000|Overall Study|Adverse Event|1|||
127493971|NCT00997984|458768820|FG001|Overall Study|Adverse Event|8|||
127493972|NCT00997984|458768821|FG002|Overall Study|Adverse Event|8|||
127493973|NCT00997984|458768819|FG000|Overall Study|Protocol Violation|1|||
127493974|NCT00997984|458768820|FG001|Overall Study|Protocol Violation|3|||
127493975|NCT00997984|458768821|FG002|Overall Study|Protocol Violation|0|||
127493976|NCT00997984|458768819|FG000|Overall Study|Withdrawal by Subject|6|||
127493977|NCT00997984|458768820|FG001|Overall Study|Withdrawal by Subject|9|||
127493978|NCT00997984|458768821|FG002|Overall Study|Withdrawal by Subject|5|||
127493979|NCT00997984|458768819|FG000|Overall Study|Lost to Follow-up|8|||
127493980|NCT00997984|458768820|FG001|Overall Study|Lost to Follow-up|5|||
127493981|NCT00997984|458768821|FG002|Overall Study|Lost to Follow-up|4|||
127493982|NCT00997984|458768819|FG000|Overall Study|Lack of Efficacy|20|||
127493983|NCT00997984|458768820|FG001|Overall Study|Lack of Efficacy|6|||
127493984|NCT00997984|458768821|FG002|Overall Study|Lack of Efficacy|3|||
127493985|NCT00997984|458768819|FG000|Overall Study|Met exclusion criteria|1|||
127493986|NCT00997984|458768820|FG001|Overall Study|Met exclusion criteria|0|||
127493987|NCT00997984|458768821|FG002|Overall Study|Met exclusion criteria|0|||
127493988|NCT00997984|458768819|FG000|Overall Study|non-compliance|0|||
127493989|NCT00997984|458768820|FG001|Overall Study|non-compliance|2|||
127493990|NCT00997984|458768821|FG002|Overall Study|non-compliance|3|||
127493991|NCT00997984|458768819|FG000|Overall Study|Wrong medication dispensed|0|||
127493992|NCT00997984|458768820|FG001|Overall Study|Wrong medication dispensed|1|||
127493993|NCT00997984|458768821|FG002|Overall Study|Wrong medication dispensed|0|||
127977284|NCT01676896|460538256|FG001|Overall Study|Withdrawal by Subject|7|||
127977285|NCT01676896|460538257|FG002|Overall Study|Withdrawal by Subject|19|||
127977286|NCT02256982|460538258|FG000|Overall Study|Disease Progression|0|||
127977287|NCT02256982|460538259|FG001|Overall Study|Disease Progression|1|||
127977288|NCT01044290|460538262|FG000|Follow-up 1|Death|3|||
127977289|NCT01044290|460538263|FG001|Follow-up 1|Death|3|||
127493994|NCT00997984|458768819|FG000|Overall Study|Suicidal ideation|0|||
127493995|NCT00997984|458768820|FG001|Overall Study|Suicidal ideation|0|||
127493996|NCT00997984|458768821|FG002|Overall Study|Suicidal ideation|1|||
127493997|NCT00997984|458768819|FG000|Overall Study|Work schedule|0|||
127493998|NCT00997984|458768820|FG001|Overall Study|Work schedule|0|||
127493999|NCT00997984|458768821|FG002|Overall Study|Work schedule|2|||
127494000|NCT01119066|458768823|FG000|Overall Study|Withdrawal by Subject|4|||
127494001|NCT01119066|458768824|FG001|Overall Study|Withdrawal by Subject|6|||
127494002|NCT01119066|458768825|FG002|Overall Study|Withdrawal by Subject|0|||
127494003|NCT01119066|458768826|FG003|Overall Study|Withdrawal by Subject|0|||
127494004|NCT01119066|458768823|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
127977290|NCT01044290|460538264|FG002|Follow-up 1|Death|1|||
127494005|NCT01119066|458768824|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
127494006|NCT01119066|458768825|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
127494007|NCT01119066|458768826|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
127494008|NCT01119066|458768823|FG000|Overall Study|Relapse identified before transplant|1|||
127494009|NCT01119066|458768824|FG001|Overall Study|Relapse identified before transplant|0|||
127494010|NCT01119066|458768825|FG002|Overall Study|Relapse identified before transplant|0|||
127494011|NCT01119066|458768826|FG003|Overall Study|Relapse identified before transplant|0|||
127494012|NCT01119066|458768823|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
127494013|NCT01119066|458768824|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
127494014|NCT01119066|458768825|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
127494015|NCT01119066|458768826|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
127494016|NCT01119066|458768823|FG000|Overall Study|Relapse identified before transplant|0|||
127494017|NCT01119066|458768824|FG001|Overall Study|Relapse identified before transplant|4|||
127494018|NCT01119066|458768825|FG002|Overall Study|Relapse identified before transplant|0|||
127494019|NCT01119066|458768826|FG003|Overall Study|Relapse identified before transplant|0|||
127494020|NCT03902392|458768827|FG000|Overall Study|Lost to Follow-up|7|||
127494021|NCT03902392|458768828|FG001|Overall Study|Lost to Follow-up|7|||
127494022|NCT01437111|458768829|FG000|Overall Study|Adverse Event|2|||
127494023|NCT01437111|458768829|FG000|Overall Study|Withdrawal by Subject|4|||
127494024|NCT01437111|458768829|FG000|Overall Study|Not reported|5|||
127494025|NCT01437111|458768829|FG000|Overall Study|Physician Decision|1|||
127494026|NCT01437111|458768829|FG000|Overall Study|Lost to Follow-up|5|||
127494027|NCT01437111|458768829|FG000|Overall Study|Protocol Violation|1|||
127494028|NCT02517398|458768830|FG000|Overall Study|Death|2|||
127494029|NCT02517398|458768831|FG001|Overall Study|Death|3|||
127494030|NCT02517398|458768832|FG002|Overall Study|Death|4|||
127494031|NCT02517398|458768833|FG003|Overall Study|Death|2|||
127494032|NCT02517398|458768834|FG004|Overall Study|Death|3|||
127494033|NCT02517398|458768835|FG005|Overall Study|Death|8|||
127494034|NCT02517398|458768836|FG006|Overall Study|Death|3|||
127494035|NCT02517398|458768837|FG007|Overall Study|Death|2|||
127494036|NCT02517398|458768838|FG008|Overall Study|Death|6|||
127494037|NCT02517398|458768839|FG009|Overall Study|Death|24|||
127494038|NCT02517398|458768840|FG010|Overall Study|Death|53|||
127494039|NCT02517398|458768841|FG011|Overall Study|Death|25|||
127494040|NCT02517398|458768842|FG012|Overall Study|Death|73|||
127494041|NCT02517398|458768843|FG013|Overall Study|Death|29|||
127494042|NCT02517398|458768844|FG014|Overall Study|Death|26|||
127494043|NCT02517398|458768845|FG015|Overall Study|Death|23|||
127494044|NCT02517398|458768846|FG016|Overall Study|Death|26|||
127494045|NCT02517398|458768847|FG017|Overall Study|Death|25|||
127494046|NCT02517398|458768848|FG018|Overall Study|Death|22|||
127494047|NCT02517398|458768849|FG019|Overall Study|Death|7|||
127494048|NCT02517398|458768850|FG020|Overall Study|Death|26|||
127494049|NCT02517398|458768851|FG021|Overall Study|Death|30|||
127494050|NCT02517398|458768852|FG022|Overall Study|Death|20|||
127494051|NCT02517398|458768830|FG000|Overall Study|Other|0|||
127494052|NCT02517398|458768831|FG001|Overall Study|Other|0|||
127494053|NCT02517398|458768832|FG002|Overall Study|Other|0|||
127494054|NCT02517398|458768833|FG003|Overall Study|Other|1|||
127494055|NCT02517398|458768834|FG004|Overall Study|Other|0|||
127494056|NCT02517398|458768835|FG005|Overall Study|Other|0|||
127494057|NCT02517398|458768836|FG006|Overall Study|Other|0|||
127494058|NCT02517398|458768837|FG007|Overall Study|Other|0|||
127494059|NCT02517398|458768838|FG008|Overall Study|Other|0|||
127494060|NCT02517398|458768839|FG009|Overall Study|Other|1|||
127494061|NCT02517398|458768840|FG010|Overall Study|Other|0|||
127494062|NCT02517398|458768841|FG011|Overall Study|Other|0|||
127494063|NCT02517398|458768842|FG012|Overall Study|Other|0|||
127977291|NCT01044290|460538262|FG000|Follow-up 1|Withdrawal by Subject|2|||
127977292|NCT01044290|460538263|FG001|Follow-up 1|Withdrawal by Subject|2|||
127977293|NCT01044290|460538264|FG002|Follow-up 1|Withdrawal by Subject|0|||
127977294|NCT01044290|460538262|FG000|Follow-Up 2|Death|0|||
127494064|NCT02517398|458768843|FG013|Overall Study|Other|1|||
127494065|NCT02517398|458768844|FG014|Overall Study|Other|0|||
127494066|NCT02517398|458768845|FG015|Overall Study|Other|1|||
127494067|NCT02517398|458768846|FG016|Overall Study|Other|1|||
127977295|NCT01044290|460538263|FG001|Follow-Up 2|Death|1|||
127494068|NCT02517398|458768847|FG017|Overall Study|Other|0|||
127494069|NCT02517398|458768848|FG018|Overall Study|Other|0|||
127494070|NCT02517398|458768849|FG019|Overall Study|Other|1|||
127494071|NCT02517398|458768850|FG020|Overall Study|Other|0|||
127494072|NCT02517398|458768851|FG021|Overall Study|Other|0|||
127494073|NCT02517398|458768852|FG022|Overall Study|Other|0|||
127494074|NCT02517398|458768830|FG000|Overall Study|Lost to Follow-up|0|||
127494075|NCT02517398|458768831|FG001|Overall Study|Lost to Follow-up|0|||
127494076|NCT02517398|458768832|FG002|Overall Study|Lost to Follow-up|0|||
127494077|NCT02517398|458768833|FG003|Overall Study|Lost to Follow-up|0|||
127494078|NCT02517398|458768834|FG004|Overall Study|Lost to Follow-up|0|||
127494079|NCT02517398|458768835|FG005|Overall Study|Lost to Follow-up|0|||
127494080|NCT02517398|458768836|FG006|Overall Study|Lost to Follow-up|0|||
127494081|NCT02517398|458768837|FG007|Overall Study|Lost to Follow-up|0|||
127494082|NCT02517398|458768838|FG008|Overall Study|Lost to Follow-up|0|||
127494083|NCT02517398|458768839|FG009|Overall Study|Lost to Follow-up|1|||
127494084|NCT02517398|458768840|FG010|Overall Study|Lost to Follow-up|0|||
127494085|NCT02517398|458768841|FG011|Overall Study|Lost to Follow-up|2|||
127494086|NCT02517398|458768842|FG012|Overall Study|Lost to Follow-up|2|||
127494087|NCT02517398|458768843|FG013|Overall Study|Lost to Follow-up|0|||
127494088|NCT02517398|458768844|FG014|Overall Study|Lost to Follow-up|1|||
127494089|NCT02517398|458768845|FG015|Overall Study|Lost to Follow-up|1|||
127977296|NCT01044290|460538264|FG002|Follow-Up 2|Death|1|||
127977297|NCT01044290|460538262|FG000|Follow-Up 2|Withdrawal by Subject|0|||
127977298|NCT01044290|460538263|FG001|Follow-Up 2|Withdrawal by Subject|1|||
127977299|NCT01044290|460538264|FG002|Follow-Up 2|Withdrawal by Subject|1|||
127977300|NCT00759785|460538269|FG000|Overall Study|Participant sample not evaluable|11|||
127977301|NCT00759785|460538270|FG001|Overall Study|Participant sample not evaluable|2|||
127977302|NCT00759785|460538269|FG000|Overall Study|Participant sample lost|0|||
127977303|NCT00759785|460538270|FG001|Overall Study|Participant sample lost|1|||
127977304|NCT00759785|460538269|FG000|Overall Study|Protocol Violation|1|||
127977305|NCT00759785|460538270|FG001|Overall Study|Protocol Violation|0|||
127977306|NCT00759785|460538269|FG000|Overall Study|Physician Decision|0|||
127977307|NCT00759785|460538270|FG001|Overall Study|Physician Decision|1|||
127977308|NCT00759785|460538269|FG000|Overall Study|Withdrawal by Subject|0|||
127977309|NCT00759785|460538270|FG001|Overall Study|Withdrawal by Subject|1|||
127977310|NCT01967706|460538274|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
127977311|NCT01967706|460538275|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
127977312|NCT01967706|460538276|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
127977313|NCT01967706|460538277|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
127977314|NCT02777970|460538278|FG000|Overall Study|Lost to Follow-up|0|||
127977315|NCT02777970|460538279|FG001|Overall Study|Lost to Follow-up|1|||
127977316|NCT02777970|460538280|FG002|Overall Study|Lost to Follow-up|0|||
127977317|NCT02777970|460538278|FG000|Overall Study|Protocol Violation|1|||
127977318|NCT02777970|460538279|FG001|Overall Study|Protocol Violation|0|||
127977319|NCT02777970|460538280|FG002|Overall Study|Protocol Violation|0|||
127977320|NCT02347891|460538281|FG000|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|2|||
127977321|NCT02347891|460538282|FG001|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|1|||
127977322|NCT02347891|460538281|FG000|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
127977323|NCT02347891|460538282|FG001|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
127977324|NCT01083186|460538286|FG000|Overall Study|Lost to Follow-up|48|||
127977325|NCT01083186|460538286|FG000|Overall Study|Consent Withdrawal|7|||
127977326|NCT01083186|460538286|FG000|Overall Study|Death|3|||
127977327|NCT01083186|460538286|FG000|Overall Study|Adverse Event|3|||
127977328|NCT01083186|460538286|FG000|Overall Study|Lack of Efficacy|2|||
127977329|NCT01083186|460538286|FG000|Overall Study|Hemodialysis Initiation|28|||
127977330|NCT01083186|460538286|FG000|Overall Study|Administrative Reasons|2|||
127977331|NCT01083186|460538286|FG000|Overall Study|Non-compliance to Study Treatment|1|||
127977332|NCT00655733|460538292|FG000|Overall Study|Lost to Follow-up|2|||
127977333|NCT00655733|460538293|FG001|Overall Study|Lost to Follow-up|2|||
127977334|NCT00655733|460538292|FG000|Overall Study|Adverse Event|2|||
127977335|NCT00655733|460538293|FG001|Overall Study|Adverse Event|2|||
127977336|NCT00655733|460538292|FG000|Overall Study|Withdrawal by Subject|3|||
127977337|NCT00655733|460538293|FG001|Overall Study|Withdrawal by Subject|3|||
127977338|NCT00655733|460538292|FG000|Overall Study|Physician Decision|0|||
127977339|NCT00655733|460538293|FG001|Overall Study|Physician Decision|1|||
127977340|NCT02122770|460538294|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
127977341|NCT02122770|460538295|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
127977342|NCT02122770|460538296|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
127977343|NCT02122770|460538297|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
127977344|NCT02122770|460538298|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
127977345|NCT02122770|460538299|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
127977346|NCT02122770|460538294|FG000|Part A: Drug-drug Interaction 2|Other|0|||
127977347|NCT02122770|460538295|FG001|Part A: Drug-drug Interaction 2|Other|0|||
127977348|NCT02122770|460538296|FG002|Part A: Drug-drug Interaction 2|Other|1|||
127494090|NCT02517398|458768846|FG016|Overall Study|Lost to Follow-up|0|||
127977349|NCT02122770|460538297|FG003|Part A: Drug-drug Interaction 2|Other|0|||
127977350|NCT02122770|460538298|FG004|Part A: Drug-drug Interaction 2|Other|0|||
127977351|NCT02122770|460538299|FG005|Part A: Drug-drug Interaction 2|Other|0|||
127977352|NCT02122770|460538294|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
127977353|NCT02122770|460538295|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
127977354|NCT02122770|460538296|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
127977355|NCT02122770|460538297|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
127977356|NCT02122770|460538298|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
127494091|NCT02517398|458768847|FG017|Overall Study|Lost to Follow-up|3|||
127977357|NCT02122770|460538299|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
127494092|NCT02517398|458768848|FG018|Overall Study|Lost to Follow-up|1|||
127494093|NCT02517398|458768849|FG019|Overall Study|Lost to Follow-up|0|||
127494094|NCT02517398|458768850|FG020|Overall Study|Lost to Follow-up|1|||
127494095|NCT02517398|458768851|FG021|Overall Study|Lost to Follow-up|0|||
127494096|NCT02517398|458768852|FG022|Overall Study|Lost to Follow-up|2|||
127494097|NCT02517398|458768830|FG000|Overall Study|Withdrew Consent|0|||
127494098|NCT02517398|458768831|FG001|Overall Study|Withdrew Consent|0|||
127494099|NCT02517398|458768832|FG002|Overall Study|Withdrew Consent|0|||
127494100|NCT02517398|458768833|FG003|Overall Study|Withdrew Consent|0|||
127494101|NCT02517398|458768834|FG004|Overall Study|Withdrew Consent|0|||
127494102|NCT02517398|458768835|FG005|Overall Study|Withdrew Consent|0|||
127494103|NCT02517398|458768836|FG006|Overall Study|Withdrew Consent|1|||
127494104|NCT02517398|458768837|FG007|Overall Study|Withdrew Consent|0|||
127494105|NCT02517398|458768838|FG008|Overall Study|Withdrew Consent|0|||
127494106|NCT02517398|458768839|FG009|Overall Study|Withdrew Consent|2|||
127494107|NCT02517398|458768840|FG010|Overall Study|Withdrew Consent|7|||
127494108|NCT02517398|458768841|FG011|Overall Study|Withdrew Consent|1|||
127494109|NCT02517398|458768842|FG012|Overall Study|Withdrew Consent|5|||
127494110|NCT02517398|458768843|FG013|Overall Study|Withdrew Consent|4|||
127494111|NCT02517398|458768844|FG014|Overall Study|Withdrew Consent|2|||
127494112|NCT02517398|458768845|FG015|Overall Study|Withdrew Consent|5|||
127494113|NCT02517398|458768846|FG016|Overall Study|Withdrew Consent|4|||
127494114|NCT02517398|458768847|FG017|Overall Study|Withdrew Consent|2|||
127494115|NCT02517398|458768848|FG018|Overall Study|Withdrew Consent|3|||
127494116|NCT02517398|458768849|FG019|Overall Study|Withdrew Consent|2|||
127494117|NCT02517398|458768850|FG020|Overall Study|Withdrew Consent|9|||
127494118|NCT02517398|458768851|FG021|Overall Study|Withdrew Consent|3|||
127494119|NCT02517398|458768852|FG022|Overall Study|Withdrew Consent|1|||
127494120|NCT02195700|458768855|FG000|Overall Study|Protocol Violation|0|||
127494121|NCT02195700|458768856|FG001|Overall Study|Protocol Violation|2|||
127494122|NCT02195700|458768855|FG000|Overall Study|Noncompliance|1|||
127494123|NCT02195700|458768856|FG001|Overall Study|Noncompliance|0|||
127494124|NCT02195700|458768855|FG000|Overall Study|Adverse Event|1|||
127494125|NCT02195700|458768856|FG001|Overall Study|Adverse Event|2|||
127494126|NCT02195700|458768855|FG000|Overall Study|Withdrawal by Subject|3|||
127494127|NCT02195700|458768856|FG001|Overall Study|Withdrawal by Subject|2|||
127494128|NCT02195700|458768855|FG000|Overall Study|Lost to Follow-up|1|||
127494129|NCT02195700|458768856|FG001|Overall Study|Lost to Follow-up|1|||
127494130|NCT02931838|458768857|FG000|Overall Study|Reason not provided by investigator|1|||
127494131|NCT02931838|458768858|FG001|Overall Study|Reason not provided by investigator|0|||
127494132|NCT02931838|458768859|FG002|Overall Study|Reason not provided by investigator|1|||
127494133|NCT02931838|458768860|FG003|Overall Study|Reason not provided by investigator|0|||
127494134|NCT02931838|458768861|FG004|Overall Study|Reason not provided by investigator|0|||
127494135|NCT02931838|458768862|FG005|Overall Study|Reason not provided by investigator|0|||
127494136|NCT02931838|458768857|FG000|Overall Study|Poor/non-compliance|0|||
127494137|NCT02931838|458768858|FG001|Overall Study|Poor/non-compliance|0|||
127494138|NCT02931838|458768859|FG002|Overall Study|Poor/non-compliance|1|||
127494139|NCT02931838|458768860|FG003|Overall Study|Poor/non-compliance|0|||
127494140|NCT02931838|458768861|FG004|Overall Study|Poor/non-compliance|0|||
127494141|NCT02931838|458768862|FG005|Overall Study|Poor/non-compliance|0|||
127494142|NCT02931838|458768857|FG000|Overall Study|Lack of Efficacy|5|||
127494143|NCT02931838|458768858|FG001|Overall Study|Lack of Efficacy|4|||
127494144|NCT02931838|458768859|FG002|Overall Study|Lack of Efficacy|0|||
127494145|NCT02931838|458768860|FG003|Overall Study|Lack of Efficacy|0|||
127494146|NCT02931838|458768861|FG004|Overall Study|Lack of Efficacy|0|||
127494147|NCT02931838|458768862|FG005|Overall Study|Lack of Efficacy|1|||
127494148|NCT02931838|458768857|FG000|Overall Study|Lost to Follow-up|1|||
127494149|NCT02931838|458768858|FG001|Overall Study|Lost to Follow-up|0|||
127494150|NCT02931838|458768859|FG002|Overall Study|Lost to Follow-up|1|||
127494151|NCT02931838|458768860|FG003|Overall Study|Lost to Follow-up|1|||
127494152|NCT02931838|458768861|FG004|Overall Study|Lost to Follow-up|2|||
127494153|NCT02931838|458768862|FG005|Overall Study|Lost to Follow-up|0|||
127494154|NCT02931838|458768857|FG000|Overall Study|Subject request to discontinue treatment|4|||
127977358|NCT02122770|460538294|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
127977359|NCT02122770|460538295|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
127494155|NCT02931838|458768858|FG001|Overall Study|Subject request to discontinue treatment|3|||
127494156|NCT02931838|458768859|FG002|Overall Study|Subject request to discontinue treatment|3|||
127494157|NCT02931838|458768860|FG003|Overall Study|Subject request to discontinue treatment|0|||
127494158|NCT02931838|458768861|FG004|Overall Study|Subject request to discontinue treatment|1|||
127494159|NCT02931838|458768862|FG005|Overall Study|Subject request to discontinue treatment|0|||
127494160|NCT02931838|458768857|FG000|Overall Study|Withdrawal by Subject|1|||
127494161|NCT02931838|458768858|FG001|Overall Study|Withdrawal by Subject|2|||
127494162|NCT02931838|458768859|FG002|Overall Study|Withdrawal by Subject|0|||
127494163|NCT02931838|458768860|FG003|Overall Study|Withdrawal by Subject|1|||
127494164|NCT02931838|458768861|FG004|Overall Study|Withdrawal by Subject|0|||
127494165|NCT02931838|458768862|FG005|Overall Study|Withdrawal by Subject|0|||
127494166|NCT02931838|458768857|FG000|Overall Study|Adverse Event|2|||
127494167|NCT02931838|458768858|FG001|Overall Study|Adverse Event|1|||
127494168|NCT02931838|458768859|FG002|Overall Study|Adverse Event|2|||
127494169|NCT02931838|458768860|FG003|Overall Study|Adverse Event|1|||
127494170|NCT02931838|458768861|FG004|Overall Study|Adverse Event|3|||
127494171|NCT02931838|458768862|FG005|Overall Study|Adverse Event|1|||
127494172|NCT02701764|458768863|FG000|Overall Study|Lost to Follow-up|0|||
127494173|NCT02701764|458768864|FG001|Overall Study|Lost to Follow-up|1|||
127494174|NCT01027650|458768865|FG000|Overall Study|Personal Reasons|0|||
127494175|NCT01027650|458768866|FG001|Overall Study|Personal Reasons|0|||
127494176|NCT01027650|458768867|FG002|Overall Study|Personal Reasons|0|||
127494177|NCT01027650|458768868|FG003|Overall Study|Personal Reasons|0|||
127494178|NCT01027650|458768869|FG004|Overall Study|Personal Reasons|2|||
127494179|NCT01027650|458768870|FG005|Overall Study|Personal Reasons|1|||
127494180|NCT01027650|458768871|FG006|Overall Study|Personal Reasons|0|||
127494181|NCT01027650|458768872|FG007|Overall Study|Personal Reasons|0|||
127494182|NCT01027650|458768865|FG000|Overall Study|Lost to Follow-up|0|||
127494183|NCT01027650|458768866|FG001|Overall Study|Lost to Follow-up|0|||
127494184|NCT01027650|458768867|FG002|Overall Study|Lost to Follow-up|0|||
127494185|NCT01027650|458768868|FG003|Overall Study|Lost to Follow-up|0|||
127494186|NCT01027650|458768869|FG004|Overall Study|Lost to Follow-up|0|||
127494187|NCT01027650|458768870|FG005|Overall Study|Lost to Follow-up|0|||
127494188|NCT01027650|458768871|FG006|Overall Study|Lost to Follow-up|1|||
127494189|NCT01027650|458768872|FG007|Overall Study|Lost to Follow-up|0|||
127494190|NCT01027650|458768865|FG000|Overall Study|Lack of Efficacy|0|||
127494191|NCT01027650|458768866|FG001|Overall Study|Lack of Efficacy|0|||
127494192|NCT01027650|458768867|FG002|Overall Study|Lack of Efficacy|0|||
127494193|NCT01027650|458768868|FG003|Overall Study|Lack of Efficacy|0|||
127494194|NCT01027650|458768869|FG004|Overall Study|Lack of Efficacy|0|||
127494195|NCT01027650|458768870|FG005|Overall Study|Lack of Efficacy|1|||
127494196|NCT01027650|458768871|FG006|Overall Study|Lack of Efficacy|0|||
127494197|NCT01027650|458768872|FG007|Overall Study|Lack of Efficacy|0|||
127494198|NCT03110029|458768873|FG000|Overall Study|Withdrawal by Subject|1|||
127494199|NCT03110029|458768874|FG001|Overall Study|Withdrawal by Subject|1|||
127494200|NCT00912782|458768876|FG000|Overall Study|Death|2|||
127494201|NCT00912782|458768877|FG001|Overall Study|Death|1|||
127494202|NCT00912782|458768876|FG000|Overall Study|Lost to Follow-up|0|||
127494203|NCT00912782|458768877|FG001|Overall Study|Lost to Follow-up|1|||
127494204|NCT00912782|458768876|FG000|Overall Study|Did not receive vascular access type|1|||
127494205|NCT00912782|458768877|FG001|Overall Study|Did not receive vascular access type|2|||
127494206|NCT00912782|458768876|FG000|Overall Study|Relocated before study completion|0|||
127494207|NCT00912782|458768877|FG001|Overall Study|Relocated before study completion|1|||
127494208|NCT02524145|458768878|FG000|Overall Study|Withdrawal by Subject|2|||
127494209|NCT02524145|458768879|FG001|Overall Study|Withdrawal by Subject|2|||
127494210|NCT02524145|458768880|FG002|Overall Study|Withdrawal by Subject|3|||
127494211|NCT00283803|458770567|FG000|Overall Study|Physician Decision|9|||
127494212|NCT00283803|458770567|FG000|Overall Study|Withdrawal by Subject|4|||
127494213|NCT01127607|458770568|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
127494214|NCT01127607|458770569|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
127494215|NCT01127607|458770568|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
127494216|NCT01127607|458770569|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
127494217|NCT02220855|458770570|FG000|Overall Study|Adverse Event|8|||
127494218|NCT02220855|458770570|FG000|Overall Study|Disease Progression|5|||
127494219|NCT02220855|458770570|FG000|Overall Study|Withdrawal by Subject|1|||
127494220|NCT03280303|458770571|FG000|Overall Study|Death|505|||
127494221|NCT03280303|458770571|FG000|Overall Study|Study terminated by sponsor|383|||
127494222|NCT03280303|458770571|FG000|Overall Study|Other|148|||
127494223|NCT03280303|458770571|FG000|Overall Study|No longer willing to participate in study|101|||
127494224|NCT03280303|458770571|FG000|Overall Study|Lost to follow up|39|||
127494225|NCT03280303|458770571|FG000|Overall Study|Adverse Event|20|||
127494226|NCT03419897|458770572|FG000|Overall Study|Death|180|||
127494227|NCT03419897|458770572|FG000|Overall Study|Lost to Follow-up|1|||
127494228|NCT03419897|458770572|FG000|Overall Study|Withdrawal by Subject|6|||
127494229|NCT03419897|458770572|FG000|Overall Study|Sponsor Decision|61|||
127494230|NCT03419897|458770572|FG000|Overall Study|Physician Decision|1|||
127494231|NCT00958360|458770584|FG000|Overall Study|Withdrawal by Subject|3|||
127494232|NCT00958360|458770585|FG001|Overall Study|Withdrawal by Subject|1|||
127494233|NCT00958360|458770584|FG000|Overall Study|Death|6|||
127494234|NCT00958360|458770585|FG001|Overall Study|Death|7|||
127494235|NCT00958360|458770584|FG000|Overall Study|Physician Decision|2|||
127494236|NCT00958360|458770585|FG001|Overall Study|Physician Decision|1|||
127494237|NCT00958360|458770584|FG000|Overall Study|Lost to Follow-up|0|||
127494238|NCT00958360|458770585|FG001|Overall Study|Lost to Follow-up|1|||
127494239|NCT02719691|458770586|FG000|Overall Study|Physician Decision|0|||
127494240|NCT02719691|458770587|FG001|Overall Study|Physician Decision|0|||
127494241|NCT02719691|458770588|FG002|Overall Study|Physician Decision|1|||
127494242|NCT02719691|458770589|FG003|Overall Study|Physician Decision|0|||
127494243|NCT02719691|458770590|FG004|Overall Study|Physician Decision|0|||
127494244|NCT02719691|458770591|FG005|Overall Study|Physician Decision|0|||
127494245|NCT02719691|458770592|FG006|Overall Study|Physician Decision|0|||
127494246|NCT02719691|458770586|FG000|Overall Study|Withdrawal by Subject|0|||
127494247|NCT02719691|458770587|FG001|Overall Study|Withdrawal by Subject|0|||
127494248|NCT02719691|458770588|FG002|Overall Study|Withdrawal by Subject|0|||
127494249|NCT02719691|458770589|FG003|Overall Study|Withdrawal by Subject|0|||
127494250|NCT02719691|458770590|FG004|Overall Study|Withdrawal by Subject|0|||
127494251|NCT02719691|458770591|FG005|Overall Study|Withdrawal by Subject|1|||
127494252|NCT02719691|458770592|FG006|Overall Study|Withdrawal by Subject|0|||
127494253|NCT00336284|458770593|FG000|Overall Study|Death|52|||
127494254|NCT00336284|458770594|FG001|Overall Study|Death|26|||
127494255|NCT00336284|458770593|FG000|Overall Study|Lost to Follow-up|82|||
127494256|NCT00336284|458770594|FG001|Overall Study|Lost to Follow-up|61|||
127494257|NCT00336284|458770593|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
127494258|NCT00336284|458770594|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
127494259|NCT01188551|458770604|FG000|Overall Study|Pharmacy issues|1|||
127494260|NCT01188551|458770605|FG001|Overall Study|Pharmacy issues|0|||
127494261|NCT01188551|458770606|FG002|Overall Study|Pharmacy issues|0|||
127494262|NCT01188551|458770607|FG003|Overall Study|Pharmacy issues|0|||
127494263|NCT03782259|458770610|FG000|Overall Study|Lost to Follow-up|1|||
127494264|NCT03782259|458770611|FG001|Overall Study|Lost to Follow-up|1|||
127494265|NCT03782259|458770610|FG000|Overall Study|Moved out of state|0|||
127494266|NCT03782259|458770611|FG001|Overall Study|Moved out of state|2|||
127494267|NCT03782259|458770610|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
127494268|NCT03782259|458770611|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
127494269|NCT03782259|458770610|FG000|Overall Study|Subject discontinued intervention|1|||
127494270|NCT03782259|458770611|FG001|Overall Study|Subject discontinued intervention|0|||
127494271|NCT00603941|458770615|FG000|Overall Study|Disease progression|6|||
127494272|NCT00603941|458770616|FG001|Overall Study|Disease progression|7|||
127494273|NCT00603941|458770617|FG002|Overall Study|Disease progression|1|||
127494274|NCT00603941|458770615|FG000|Overall Study|Adverse Event|1|||
127494275|NCT00603941|458770616|FG001|Overall Study|Adverse Event|0|||
127494276|NCT00603941|458770617|FG002|Overall Study|Adverse Event|1|||
127494277|NCT00603941|458770615|FG000|Overall Study|Physician Decision|0|||
127494278|NCT00603941|458770616|FG001|Overall Study|Physician Decision|1|||
127494279|NCT00603941|458770617|FG002|Overall Study|Physician Decision|0|||
127494280|NCT00603941|458770615|FG000|Overall Study|Withdrawal by Subject|0|||
127494281|NCT00603941|458770616|FG001|Overall Study|Withdrawal by Subject|2|||
127494282|NCT00603941|458770617|FG002|Overall Study|Withdrawal by Subject|0|||
127494283|NCT05069597|458770618|FG000|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
127494284|NCT05069597|458770619|FG001|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
127494285|NCT04556591|458770624|FG000|Overall Study|Lost to Follow-up|1|||
127494286|NCT04556591|458770625|FG001|Overall Study|Lost to Follow-up|0|||
127494287|NCT04556591|458770624|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
127494288|NCT04556591|458770625|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
127494289|NCT05507567|458770626|FG000|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
127494290|NCT05507567|458770627|FG001|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
127494291|NCT05507567|458770628|FG002|Randomised and Received Challenge Virus|Lost to Follow-up|1|||
127494292|NCT05507567|458770626|FG000|Randomised and Received Challenge Virus|Physician Decision|1|||
127494293|NCT05507567|458770627|FG001|Randomised and Received Challenge Virus|Physician Decision|0|||
127494294|NCT05507567|458770628|FG002|Randomised and Received Challenge Virus|Physician Decision|0|||
127494295|NCT05507567|458770626|FG000|Randomised and Received Challenge Virus|Did not complete quarantine|1|||
127494296|NCT05507567|458770627|FG001|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
127494297|NCT05507567|458770628|FG002|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
127494298|NCT05507567|458770626|FG000|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
127494299|NCT05507567|458770627|FG001|From Challenge Virus to End of Study|Withdrawal by Subject|2|||
127494300|NCT05507567|458770628|FG002|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
127494301|NCT01485796|458770629|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
127494302|NCT01485796|458770629|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
127494303|NCT01485796|458770629|FG000|Period 2: Epoch 2|Adverse Event|3|||
127494304|NCT01485796|458770629|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
127494305|NCT01485796|458770629|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
127494306|NCT01485796|458770629|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
127494307|NCT01485796|458770629|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
127494308|NCT01485796|458770629|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
127494309|NCT00606411|458770637|FG000|Overall Study|Adverse Event|1|||
127494310|NCT00606411|458770638|FG001|Overall Study|Adverse Event|2|||
127494311|NCT00606411|458770637|FG000|Overall Study|Lack of Adherence|1|||
127494312|NCT00606411|458770638|FG001|Overall Study|Lack of Adherence|1|||
127494313|NCT00606411|458770637|FG000|Overall Study|Lack of Efficacy|1|||
127494314|NCT00606411|458770638|FG001|Overall Study|Lack of Efficacy|1|||
127494315|NCT00606411|458770637|FG000|Overall Study|Withdrawal by Subject|2|||
127494316|NCT00606411|458770638|FG001|Overall Study|Withdrawal by Subject|0|||
127494317|NCT00606411|458770637|FG000|Overall Study|Lost to Follow-up|1|||
127494318|NCT00606411|458770638|FG001|Overall Study|Lost to Follow-up|2|||
127494319|NCT00606411|458770637|FG000|Overall Study|Move out of state|0|||
127494320|NCT00606411|458770638|FG001|Overall Study|Move out of state|1|||
127494321|NCT02526212|458770639|FG000|Overall Study|Incarceration|1|||
127494322|NCT02526212|458770640|FG001|Overall Study|Incarceration|0|||
127494323|NCT02526212|458770639|FG000|Overall Study|Lost to Follow-up|1|||
127494324|NCT02526212|458770640|FG001|Overall Study|Lost to Follow-up|0|||
127494325|NCT02526212|458770639|FG000|Overall Study|Death|0|||
127494326|NCT02526212|458770640|FG001|Overall Study|Death|1|||
127494327|NCT01390298|458770641|FG000|Overall Study|Death|1|||
127494328|NCT01390298|458770641|FG000|Overall Study|long term ICU admission|1|||
127494329|NCT01390298|458770641|FG000|Overall Study|Withdrawal by Subject|14|||
127494330|NCT01390298|458770641|FG000|Overall Study|Lost to Follow-up|7|||
127494331|NCT01390298|458770641|FG000|Overall Study|Surgery cancelled|1|||
127494332|NCT00040742|458770648|FG000|Overall Study|Death|0|||
127494333|NCT00040742|458770649|FG001|Overall Study|Death|0|||
127494334|NCT00040742|458770650|FG002|Overall Study|Death|1|||
127494335|NCT00040742|458770651|FG003|Overall Study|Death|0|||
127494336|NCT00040742|458770648|FG000|Overall Study|Adverse Event|15|||
127494337|NCT00040742|458770649|FG001|Overall Study|Adverse Event|16|||
127494338|NCT00040742|458770650|FG002|Overall Study|Adverse Event|21|||
127494339|NCT00040742|458770651|FG003|Overall Study|Adverse Event|9|||
127494340|NCT00040742|458770648|FG000|Overall Study|Withdrawal by Subject|7|||
127494341|NCT00040742|458770649|FG001|Overall Study|Withdrawal by Subject|15|||
127494342|NCT00040742|458770650|FG002|Overall Study|Withdrawal by Subject|10|||
127494343|NCT00040742|458770651|FG003|Overall Study|Withdrawal by Subject|13|||
127494344|NCT00040742|458770648|FG000|Overall Study|Chemotoxicity|4|||
127494345|NCT00040742|458770649|FG001|Overall Study|Chemotoxicity|3|||
127494346|NCT00040742|458770650|FG002|Overall Study|Chemotoxicity|5|||
127494347|NCT00040742|458770651|FG003|Overall Study|Chemotoxicity|2|||
127494348|NCT00040742|458770648|FG000|Overall Study|Incomplete Forms|6|||
127494349|NCT00040742|458770649|FG001|Overall Study|Incomplete Forms|10|||
127494350|NCT00040742|458770650|FG002|Overall Study|Incomplete Forms|4|||
127494351|NCT00040742|458770651|FG003|Overall Study|Incomplete Forms|5|||
127494352|NCT00040742|458770648|FG000|Overall Study|Other medical|7|||
127494353|NCT00040742|458770649|FG001|Overall Study|Other medical|5|||
127494354|NCT00040742|458770650|FG002|Overall Study|Other medical|5|||
127494355|NCT00040742|458770651|FG003|Overall Study|Other medical|5|||
127494356|NCT03520920|458770654|FG000|Overall Study|Death|13|||
127494357|NCT03520920|458770655|FG001|Overall Study|Death|1|||
127494358|NCT03520920|458770656|FG002|Overall Study|Death|0|||
127494359|NCT03520920|458770654|FG000|Overall Study|Withdrawal by Subject|2|||
127494360|NCT03520920|458770655|FG001|Overall Study|Withdrawal by Subject|1|||
127494361|NCT03520920|458770656|FG002|Overall Study|Withdrawal by Subject|0|||
127494362|NCT03520920|458770654|FG000|Overall Study|Study Terminated by the Sponsor|5|||
127494363|NCT03520920|458770655|FG001|Overall Study|Study Terminated by the Sponsor|14|||
127494364|NCT03520920|458770656|FG002|Overall Study|Study Terminated by the Sponsor|5|||
127494365|NCT00405392|458770657|FG000|Overall Study|Adverse Event|15|||
127494366|NCT00405392|458770658|FG001|Overall Study|Adverse Event|14|||
127494367|NCT00405392|458770657|FG000|Overall Study|Did not meet Eligibility criteria|7|||
127494368|NCT00405392|458770658|FG001|Overall Study|Did not meet Eligibility criteria|2|||
127494369|NCT00405392|458770657|FG000|Overall Study|Withdrawal by Subject|4|||
127494370|NCT00405392|458770658|FG001|Overall Study|Withdrawal by Subject|3|||
127494371|NCT00405392|458770657|FG000|Overall Study|Lost to Follow-up|1|||
127494372|NCT00405392|458770658|FG001|Overall Study|Lost to Follow-up|2|||
127494373|NCT00405392|458770657|FG000|Overall Study|Data missing|2|||
127494374|NCT00405392|458770658|FG001|Overall Study|Data missing|0|||
127494375|NCT00405392|458770657|FG000|Overall Study|Non-compliance|0|||
127494376|NCT00405392|458770658|FG001|Overall Study|Non-compliance|1|||
127977360|NCT02122770|460538296|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
127494377|NCT00405392|458770657|FG000|Overall Study|Other|1|||
127494378|NCT00405392|458770658|FG001|Overall Study|Other|5|||
127494379|NCT00412958|458770659|FG000|Overall Study|Withdrawal by Subject|3|||
127494380|NCT00412958|458770660|FG001|Overall Study|Withdrawal by Subject|0|||
127494381|NCT00412958|458770661|FG002|Overall Study|Withdrawal by Subject|0|||
127494382|NCT00412958|458770662|FG003|Overall Study|Withdrawal by Subject|1|||
127494383|NCT00412958|458770659|FG000|Overall Study|Adverse Event|0|||
127494384|NCT00412958|458770660|FG001|Overall Study|Adverse Event|1|||
127977361|NCT02122770|460538297|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
127977362|NCT02122770|460538298|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
127494385|NCT00412958|458770661|FG002|Overall Study|Adverse Event|0|||
127494386|NCT00412958|458770662|FG003|Overall Study|Adverse Event|0|||
127494387|NCT00412958|458770659|FG000|Overall Study|Lost to Follow-up|0|||
127494388|NCT00412958|458770660|FG001|Overall Study|Lost to Follow-up|1|||
127494389|NCT00412958|458770661|FG002|Overall Study|Lost to Follow-up|0|||
127494390|NCT00412958|458770662|FG003|Overall Study|Lost to Follow-up|0|||
127494391|NCT00412958|458770659|FG000|Overall Study|Death|0|||
127494392|NCT00412958|458770660|FG001|Overall Study|Death|1|||
127494393|NCT00412958|458770661|FG002|Overall Study|Death|0|||
127494394|NCT00412958|458770662|FG003|Overall Study|Death|0|||
127494395|NCT00412958|458770659|FG000|Overall Study|Transport issue|0|||
127494396|NCT00412958|458770660|FG001|Overall Study|Transport issue|1|||
127494397|NCT00412958|458770661|FG002|Overall Study|Transport issue|0|||
127494398|NCT00412958|458770662|FG003|Overall Study|Transport issue|0|||
127494399|NCT01434654|458770676|FG000|Overall Study|Withdrawal by Subject|1|||
127494400|NCT01434654|458770677|FG001|Overall Study|Withdrawal by Subject|0|||
127494401|NCT01434654|458770676|FG000|Overall Study|Lost to Follow-up|1|||
127494402|NCT01434654|458770677|FG001|Overall Study|Lost to Follow-up|0|||
127494403|NCT01277822|458770682|FG000|Overall Study|Adverse Event|2|||
127494404|NCT01277822|458770683|FG001|Overall Study|Adverse Event|1|||
127494405|NCT01277822|458770682|FG000|Overall Study|Withdrawal by Subject|6|||
127494406|NCT01277822|458770683|FG001|Overall Study|Withdrawal by Subject|7|||
127494407|NCT01277822|458770682|FG000|Overall Study|Physician Decision|1|||
127494408|NCT01277822|458770683|FG001|Overall Study|Physician Decision|1|||
127494409|NCT01277822|458770682|FG000|Overall Study|Protocol Violation|1|||
127494410|NCT01277822|458770683|FG001|Overall Study|Protocol Violation|0|||
127494411|NCT01277822|458770682|FG000|Overall Study|Lost to Follow-up|2|||
127494412|NCT01277822|458770683|FG001|Overall Study|Lost to Follow-up|1|||
127494413|NCT01277822|458770682|FG000|Overall Study|Contraindicated medication used|2|||
127494414|NCT01277822|458770683|FG001|Overall Study|Contraindicated medication used|1|||
127494415|NCT01277822|458770682|FG000|Overall Study|Participant moved|1|||
127494416|NCT01277822|458770683|FG001|Overall Study|Participant moved|0|||
127494417|NCT03012828|458770684|FG000|Overall Study|Lost to Follow-up|1|||
127494418|NCT03012828|458770685|FG001|Overall Study|Lost to Follow-up|0|||
127494419|NCT03012828|458770686|FG002|Overall Study|Lost to Follow-up|1|||
127494420|NCT03012828|458770687|FG003|Overall Study|Lost to Follow-up|0|||
127494421|NCT03012828|458770688|FG004|Overall Study|Lost to Follow-up|1|||
127494422|NCT03012828|458770689|FG005|Overall Study|Lost to Follow-up|0|||
127494423|NCT03012828|458770684|FG000|Overall Study|Withdrawal by Subject|0|||
127494424|NCT03012828|458770685|FG001|Overall Study|Withdrawal by Subject|0|||
127494425|NCT03012828|458770686|FG002|Overall Study|Withdrawal by Subject|1|||
127494426|NCT03012828|458770687|FG003|Overall Study|Withdrawal by Subject|0|||
127494427|NCT03012828|458770688|FG004|Overall Study|Withdrawal by Subject|0|||
127494428|NCT03012828|458770689|FG005|Overall Study|Withdrawal by Subject|1|||
127494429|NCT03012828|458770684|FG000|Overall Study|Non-compliance with protocol|0|||
127494430|NCT03012828|458770685|FG001|Overall Study|Non-compliance with protocol|0|||
127494431|NCT03012828|458770686|FG002|Overall Study|Non-compliance with protocol|0|||
127494432|NCT03012828|458770687|FG003|Overall Study|Non-compliance with protocol|0|||
127494433|NCT03012828|458770688|FG004|Overall Study|Non-compliance with protocol|1|||
127494434|NCT03012828|458770689|FG005|Overall Study|Non-compliance with protocol|0|||
127494435|NCT03012828|458770684|FG000|Overall Study|Delay to last visit would delay DBL|0|||
127494436|NCT03012828|458770685|FG001|Overall Study|Delay to last visit would delay DBL|0|||
127494437|NCT03012828|458770686|FG002|Overall Study|Delay to last visit would delay DBL|0|||
127494438|NCT03012828|458770687|FG003|Overall Study|Delay to last visit would delay DBL|0|||
127494439|NCT03012828|458770688|FG004|Overall Study|Delay to last visit would delay DBL|0|||
127494440|NCT03012828|458770689|FG005|Overall Study|Delay to last visit would delay DBL|1|||
127494441|NCT04396795|458770694|FG000|Month 1|Lost to Follow-up|2|||
127494442|NCT04396795|458770695|FG001|Month 1|Lost to Follow-up|3|||
127494443|NCT04396795|458770694|FG000|Month 3|Lost to Follow-up|1|||
127494444|NCT04396795|458770695|FG001|Month 3|Lost to Follow-up|3|||
127494445|NCT04396795|458770694|FG000|Month 6|Lost to Follow-up|3|||
127494446|NCT04396795|458770695|FG001|Month 6|Lost to Follow-up|3|||
127494447|NCT00244725|458770699|FG000|Overall Study|Lost to Follow-up|3|||
127494448|NCT00244725|458770700|FG001|Overall Study|Lost to Follow-up|4|||
127494449|NCT00244725|458770701|FG002|Overall Study|Lost to Follow-up|9|||
127494450|NCT00244725|458770702|FG003|Overall Study|Lost to Follow-up|2|||
127494451|NCT00244725|458770699|FG000|Overall Study|Withdrawal by Subject|9|||
127494452|NCT00244725|458770700|FG001|Overall Study|Withdrawal by Subject|7|||
127494453|NCT00244725|458770701|FG002|Overall Study|Withdrawal by Subject|7|||
127494454|NCT00244725|458770702|FG003|Overall Study|Withdrawal by Subject|8|||
127494455|NCT00244725|458770699|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
127494456|NCT00244725|458770700|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
127494457|NCT00244725|458770701|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
127494458|NCT00244725|458770702|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
127494459|NCT00244725|458770699|FG000|Overall Study|Physician Decision|3|||
127494460|NCT00244725|458770700|FG001|Overall Study|Physician Decision|0|||
127494461|NCT00244725|458770701|FG002|Overall Study|Physician Decision|1|||
127494462|NCT00244725|458770702|FG003|Overall Study|Physician Decision|2|||
127494463|NCT00244725|458770699|FG000|Overall Study|Adverse Events|3|||
127494464|NCT00244725|458770700|FG001|Overall Study|Adverse Events|1|||
127494465|NCT00244725|458770701|FG002|Overall Study|Adverse Events|4|||
127494466|NCT00244725|458770702|FG003|Overall Study|Adverse Events|4|||
127494467|NCT00244725|458770699|FG000|Overall Study|Withdrwal by participant|1|||
127494468|NCT00244725|458770700|FG001|Overall Study|Withdrwal by participant|0|||
127494469|NCT00244725|458770701|FG002|Overall Study|Withdrwal by participant|0|||
127494470|NCT00244725|458770702|FG003|Overall Study|Withdrwal by participant|1|||
127494471|NCT00244725|458770699|FG000|Overall Study|Liver function test abnormality|2|||
127494472|NCT00244725|458770700|FG001|Overall Study|Liver function test abnormality|0|||
127494473|NCT00244725|458770701|FG002|Overall Study|Liver function test abnormality|0|||
127494474|NCT00244725|458770702|FG003|Overall Study|Liver function test abnormality|1|||
127494475|NCT00244725|458770699|FG000|Overall Study|Sponsor withdrew the participant|1|||
127494476|NCT00244725|458770700|FG001|Overall Study|Sponsor withdrew the participant|0|||
127494477|NCT00244725|458770701|FG002|Overall Study|Sponsor withdrew the participant|0|||
127494478|NCT00244725|458770702|FG003|Overall Study|Sponsor withdrew the participant|1|||
127494479|NCT00244725|458770699|FG000|Overall Study|Mediciation Error|0|||
127494480|NCT00244725|458770700|FG001|Overall Study|Mediciation Error|1|||
127494481|NCT00244725|458770701|FG002|Overall Study|Mediciation Error|0|||
127494482|NCT00244725|458770702|FG003|Overall Study|Mediciation Error|0|||
127494483|NCT00244725|458770699|FG000|Overall Study|Rehab Refused to allow participantion|0|||
127494484|NCT00244725|458770700|FG001|Overall Study|Rehab Refused to allow participantion|1|||
127494485|NCT00244725|458770701|FG002|Overall Study|Rehab Refused to allow participantion|0|||
127494486|NCT00244725|458770702|FG003|Overall Study|Rehab Refused to allow participantion|0|||
127494487|NCT00244725|458770699|FG000|Overall Study|Headache|0|||
127494488|NCT00244725|458770700|FG001|Overall Study|Headache|1|||
127494489|NCT00244725|458770701|FG002|Overall Study|Headache|0|||
127494490|NCT00244725|458770702|FG003|Overall Study|Headache|0|||
127494491|NCT00244725|458770699|FG000|Overall Study|Received prohibited medication|0|||
127494492|NCT00244725|458770700|FG001|Overall Study|Received prohibited medication|1|||
127494493|NCT00244725|458770701|FG002|Overall Study|Received prohibited medication|0|||
127494494|NCT00244725|458770702|FG003|Overall Study|Received prohibited medication|1|||
127494495|NCT00244725|458770699|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
127494496|NCT00244725|458770700|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
127494497|NCT00244725|458770701|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
127494498|NCT00244725|458770702|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
127494499|NCT00244725|458770699|FG000|Overall Study|Administrative reason|0|||
127494500|NCT00244725|458770700|FG001|Overall Study|Administrative reason|0|||
127494501|NCT00244725|458770701|FG002|Overall Study|Administrative reason|1|||
127494502|NCT00244725|458770702|FG003|Overall Study|Administrative reason|0|||
127494503|NCT00244725|458770699|FG000|Overall Study|Vomit|0|||
127494504|NCT00244725|458770700|FG001|Overall Study|Vomit|0|||
127494505|NCT00244725|458770701|FG002|Overall Study|Vomit|1|||
127494506|NCT00244725|458770702|FG003|Overall Study|Vomit|0|||
127494507|NCT00244725|458770699|FG000|Overall Study|Failed to follow-up|0|||
127494508|NCT00244725|458770700|FG001|Overall Study|Failed to follow-up|0|||
127494509|NCT00244725|458770701|FG002|Overall Study|Failed to follow-up|1|||
127494510|NCT00244725|458770702|FG003|Overall Study|Failed to follow-up|1|||
127494511|NCT03472495|458770703|FG000|Overall Study|Treatment no longer indicated|1|||
127494512|NCT03472495|458770704|FG001|Overall Study|Treatment no longer indicated|2|||
127494513|NCT03472495|458770703|FG000|Overall Study|Physician Decision|0|||
127494514|NCT03472495|458770704|FG001|Overall Study|Physician Decision|2|||
127494515|NCT01107392|458770705|FG000|Overall Study|Adverse Event|2|||
127494516|NCT01107392|458770706|FG001|Overall Study|Adverse Event|0|||
127494517|NCT01107392|458770705|FG000|Overall Study|Personal Reasons|2|||
127494518|NCT01107392|458770706|FG001|Overall Study|Personal Reasons|3|||
127494519|NCT01107392|458770705|FG000|Overall Study|Administrative decision|1|||
127494520|NCT01107392|458770706|FG001|Overall Study|Administrative decision|0|||
127494521|NCT02998671|458770710|FG000|Period 1|Study Terminated By Sponsor|2|||
127494522|NCT02998671|458770711|FG001|Period 1|Study Terminated By Sponsor|1|||
127494523|NCT02998671|458770712|FG002|Period 1|Study Terminated By Sponsor|0|||
127494524|NCT02998671|458770713|FG003|Period 1|Study Terminated By Sponsor|0|||
127494525|NCT02998671|458770714|FG004|Period 1|Study Terminated By Sponsor|1|||
127494526|NCT02998671|458770710|FG000|Period 1|Withdrawal by Subject|1|||
127494527|NCT02998671|458770711|FG001|Period 1|Withdrawal by Subject|2|||
127494528|NCT02998671|458770712|FG002|Period 1|Withdrawal by Subject|0|||
127494529|NCT02998671|458770713|FG003|Period 1|Withdrawal by Subject|0|||
127494530|NCT02998671|458770714|FG004|Period 1|Withdrawal by Subject|2|||
127494531|NCT02998671|458770710|FG000|Period 1|Pregnancy|1|||
127494532|NCT02998671|458770711|FG001|Period 1|Pregnancy|0|||
127494533|NCT02998671|458770712|FG002|Period 1|Pregnancy|0|||
127494534|NCT02998671|458770713|FG003|Period 1|Pregnancy|0|||
127494535|NCT02998671|458770714|FG004|Period 1|Pregnancy|0|||
127494536|NCT02998671|458770710|FG000|Period 1|Adverse Event|0|||
127494537|NCT02998671|458770711|FG001|Period 1|Adverse Event|0|||
127494538|NCT02998671|458770712|FG002|Period 1|Adverse Event|0|||
127494539|NCT02998671|458770713|FG003|Period 1|Adverse Event|0|||
127977363|NCT02122770|460538299|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
127977364|NCT02122770|460538294|FG000|Part B: Standard of Care|Adverse Event|0|||
127977365|NCT02122770|460538295|FG001|Part B: Standard of Care|Adverse Event|0|||
127494540|NCT02998671|458770714|FG004|Period 1|Adverse Event|1|||
127494541|NCT02998671|458770710|FG000|Period 2|Adverse Event|0|||
127977366|NCT02122770|460538296|FG002|Part B: Standard of Care|Adverse Event|0|||
127977367|NCT02122770|460538297|FG003|Part B: Standard of Care|Adverse Event|0|||
127494542|NCT02998671|458770711|FG001|Period 2|Adverse Event|1|||
127494543|NCT02998671|458770712|FG002|Period 2|Adverse Event|0|||
127494544|NCT02998671|458770713|FG003|Period 2|Adverse Event|0|||
127494545|NCT02998671|458770714|FG004|Period 2|Adverse Event|0|||
127977368|NCT02122770|460538298|FG004|Part B: Standard of Care|Adverse Event|4|||
127494546|NCT02998671|458770710|FG000|Period 2|Study Terminated By Sponsor|3|||
127494547|NCT02998671|458770711|FG001|Period 2|Study Terminated By Sponsor|5|||
127494548|NCT02998671|458770712|FG002|Period 2|Study Terminated By Sponsor|1|||
127494549|NCT02998671|458770713|FG003|Period 2|Study Terminated By Sponsor|3|||
127494550|NCT02998671|458770714|FG004|Period 2|Study Terminated By Sponsor|0|||
127494551|NCT02998671|458770710|FG000|Period 2|Withdrawal by Subject|0|||
127494552|NCT02998671|458770711|FG001|Period 2|Withdrawal by Subject|1|||
127494553|NCT02998671|458770712|FG002|Period 2|Withdrawal by Subject|0|||
127494554|NCT02998671|458770713|FG003|Period 2|Withdrawal by Subject|0|||
127494555|NCT02998671|458770714|FG004|Period 2|Withdrawal by Subject|0|||
127494556|NCT02998671|458770710|FG000|Period 2|Lost to Follow-up|0|||
127494557|NCT02998671|458770711|FG001|Period 2|Lost to Follow-up|0|||
127494558|NCT02998671|458770712|FG002|Period 2|Lost to Follow-up|0|||
127494559|NCT02998671|458770713|FG003|Period 2|Lost to Follow-up|1|||
127494560|NCT02998671|458770714|FG004|Period 2|Lost to Follow-up|0|||
127494561|NCT02038946|458770716|FG000|Overall Study|Death|5|||
127494562|NCT02038946|458770716|FG000|Overall Study|Withdrawal by Subject|3|||
127494563|NCT02038946|458770716|FG000|Overall Study|Lost to Follow-up|2|||
127494564|NCT02038946|458770716|FG000|Overall Study|Other reasons|2|||
127494565|NCT02131311|458770717|FG000|Overall Study|Adverse Event|2|||
127494566|NCT02131311|458770717|FG000|Overall Study|Protocol Violation|1|||
127494567|NCT02131311|458770717|FG000|Overall Study|Lost to Follow-up|1|||
127494568|NCT02623205|458770719|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
127494569|NCT02623205|458770720|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
127494570|NCT03162796|458770721|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
127494571|NCT03162796|458770722|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
127494572|NCT03162796|458770723|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
127494573|NCT03162796|458770721|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
127494574|NCT03162796|458770722|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
127494575|NCT03162796|458770723|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
127494576|NCT03162796|458770721|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
127494577|NCT03162796|458770722|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
127494578|NCT03162796|458770723|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
127494579|NCT03162796|458770721|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
127494580|NCT03162796|458770722|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
127494581|NCT03162796|458770723|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
127494582|NCT03162796|458770721|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
127494583|NCT03162796|458770722|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
127494584|NCT03162796|458770723|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
127494585|NCT03162796|458770721|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
127494586|NCT03162796|458770722|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
127494587|NCT03162796|458770723|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
127494588|NCT03162796|458770721|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
127494589|NCT03162796|458770722|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
127494590|NCT03162796|458770723|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
127494591|NCT03162796|458770721|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
127494592|NCT03162796|458770722|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
127494593|NCT03162796|458770723|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
127494594|NCT03162796|458770721|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
127494595|NCT03162796|458770722|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
127494596|NCT03162796|458770723|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
127494597|NCT03162796|458770721|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
127494598|NCT03162796|458770722|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
127494599|NCT03162796|458770723|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
127494600|NCT03162796|458770721|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
127494601|NCT03162796|458770722|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
127494602|NCT03162796|458770723|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
127494603|NCT02342288|458770724|FG000|Overall Study|no protocol anesthesiologist available|3|||
127494604|NCT02342288|458770725|FG001|Overall Study|no protocol anesthesiologist available|2|||
127494605|NCT02342288|458770724|FG000|Overall Study|anesthesia leak in system|1|||
127494606|NCT02342288|458770725|FG001|Overall Study|anesthesia leak in system|0|||
127494607|NCT02342288|458770724|FG000|Overall Study|Withdrawal by Subject|1|||
127494608|NCT02342288|458770725|FG001|Overall Study|Withdrawal by Subject|0|||
127494609|NCT02342288|458770724|FG000|Overall Study|coordinator contaminated with blood|0|||
127494610|NCT02342288|458770725|FG001|Overall Study|coordinator contaminated with blood|1|||
127494611|NCT02342288|458770724|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
127494612|NCT02342288|458770725|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
127494613|NCT02342288|458770724|FG000|Overall Study|coordinator not available|0|||
127494614|NCT02342288|458770725|FG001|Overall Study|coordinator not available|2|||
127494615|NCT03082677|458770726|FG000|Overall Study|Not Treated|2|||
127494616|NCT01916824|458770733|FG000|Overall Study|Lost to Follow-up|3|||
127494617|NCT01916824|458770734|FG001|Overall Study|Lost to Follow-up|6|||
127494618|NCT01916824|458770733|FG000|Overall Study|Physician Decision|2|||
127494619|NCT01916824|458770734|FG001|Overall Study|Physician Decision|0|||
127494620|NCT01916824|458770733|FG000|Overall Study|Withdrawal by Subject|2|||
127494621|NCT01916824|458770734|FG001|Overall Study|Withdrawal by Subject|3|||
127494622|NCT02467192|458770738|FG000|Overall Study|Death|1|||
127494623|NCT02467192|458770738|FG000|Overall Study|revealed to have pneumonia before|2|||
127494624|NCT00005947|458770742|FG000|Overall Study|Death|54|||
127494625|NCT00005947|458770743|FG001|Overall Study|Death|40|||
127494626|NCT00005947|458770742|FG000|Overall Study|Patient Refused to Continue|2|||
127494627|NCT00005947|458770743|FG001|Overall Study|Patient Refused to Continue|1|||
127494628|NCT00005947|458770742|FG000|Overall Study|Site Closure|1|||
127494629|NCT00005947|458770743|FG001|Overall Study|Site Closure|0|||
127494630|NCT05823974|458773023|FG000|Overall Study|Lost to Follow-up|0|||
127494631|NCT05823974|458773024|FG001|Overall Study|Lost to Follow-up|3|||
127494632|NCT05823974|458773025|FG002|Overall Study|Lost to Follow-up|1|||
127494633|NCT05823974|458773026|FG003|Overall Study|Lost to Follow-up|0|||
127494634|NCT05823974|458773027|FG004|Overall Study|Lost to Follow-up|1|||
127494635|NCT05823974|458773028|FG005|Overall Study|Lost to Follow-up|0|||
127494636|NCT05823974|458773029|FG006|Overall Study|Lost to Follow-up|1|||
127494637|NCT05823974|458773030|FG007|Overall Study|Lost to Follow-up|0|||
127494638|NCT05823974|458773031|FG008|Overall Study|Lost to Follow-up|0|||
127494639|NCT05823974|458773032|FG009|Overall Study|Lost to Follow-up|1|||
127494640|NCT05823974|458773033|FG010|Overall Study|Lost to Follow-up|1|||
127494641|NCT05823974|458773034|FG011|Overall Study|Lost to Follow-up|0|||
127494642|NCT05823974|458773035|FG012|Overall Study|Lost to Follow-up|1|||
127494643|NCT05823974|458773036|FG013|Overall Study|Lost to Follow-up|2|||
127494644|NCT05823974|458773037|FG014|Overall Study|Lost to Follow-up|1|||
127494645|NCT05823974|458773038|FG015|Overall Study|Lost to Follow-up|1|||
127494646|NCT05823974|458773039|FG016|Overall Study|Lost to Follow-up|1|||
127494647|NCT05823974|458773040|FG017|Overall Study|Lost to Follow-up|0|||
127494648|NCT05823974|458773041|FG018|Overall Study|Lost to Follow-up|0|||
127494649|NCT05823974|458773042|FG019|Overall Study|Lost to Follow-up|2|||
127494650|NCT05823974|458773043|FG020|Overall Study|Lost to Follow-up|0|||
127494651|NCT05823974|458773023|FG000|Overall Study|Physician Decision|0|||
127494652|NCT05823974|458773024|FG001|Overall Study|Physician Decision|0|||
127494653|NCT05823974|458773025|FG002|Overall Study|Physician Decision|0|||
127494654|NCT05823974|458773026|FG003|Overall Study|Physician Decision|0|||
127494655|NCT05823974|458773027|FG004|Overall Study|Physician Decision|0|||
127494656|NCT05823974|458773028|FG005|Overall Study|Physician Decision|0|||
127494657|NCT05823974|458773029|FG006|Overall Study|Physician Decision|0|||
127494658|NCT05823974|458773030|FG007|Overall Study|Physician Decision|0|||
127494659|NCT05823974|458773031|FG008|Overall Study|Physician Decision|0|||
127494660|NCT05823974|458773032|FG009|Overall Study|Physician Decision|0|||
127494661|NCT05823974|458773033|FG010|Overall Study|Physician Decision|0|||
127494662|NCT05823974|458773034|FG011|Overall Study|Physician Decision|0|||
127494663|NCT05823974|458773035|FG012|Overall Study|Physician Decision|0|||
127494664|NCT05823974|458773036|FG013|Overall Study|Physician Decision|0|||
127494665|NCT05823974|458773037|FG014|Overall Study|Physician Decision|0|||
127494666|NCT05823974|458773038|FG015|Overall Study|Physician Decision|1|||
127494667|NCT05823974|458773039|FG016|Overall Study|Physician Decision|0|||
127494668|NCT05823974|458773040|FG017|Overall Study|Physician Decision|1|||
127494669|NCT05823974|458773041|FG018|Overall Study|Physician Decision|1|||
127494670|NCT05823974|458773042|FG019|Overall Study|Physician Decision|0|||
127494671|NCT05823974|458773043|FG020|Overall Study|Physician Decision|0|||
127494672|NCT05823974|458773023|FG000|Overall Study|Withdrawal by Subject|1|||
127494673|NCT05823974|458773024|FG001|Overall Study|Withdrawal by Subject|1|||
127494674|NCT05823974|458773025|FG002|Overall Study|Withdrawal by Subject|2|||
127494675|NCT05823974|458773026|FG003|Overall Study|Withdrawal by Subject|0|||
127494676|NCT05823974|458773027|FG004|Overall Study|Withdrawal by Subject|2|||
127494677|NCT05823974|458773028|FG005|Overall Study|Withdrawal by Subject|3|||
127494678|NCT05823974|458773029|FG006|Overall Study|Withdrawal by Subject|1|||
127494679|NCT05823974|458773030|FG007|Overall Study|Withdrawal by Subject|1|||
127494680|NCT05823974|458773031|FG008|Overall Study|Withdrawal by Subject|2|||
127494681|NCT05823974|458773032|FG009|Overall Study|Withdrawal by Subject|1|||
127977369|NCT02122770|460538299|FG005|Part B: Standard of Care|Adverse Event|1|||
127977370|NCT02122770|460538294|FG000|Part B: Standard of Care|Other|0|||
127977371|NCT02122770|460538295|FG001|Part B: Standard of Care|Other|0|||
127977372|NCT02122770|460538296|FG002|Part B: Standard of Care|Other|0|||
127977373|NCT02122770|460538297|FG003|Part B: Standard of Care|Other|0|||
127977374|NCT02122770|460538298|FG004|Part B: Standard of Care|Other|0|||
127494682|NCT05823974|458773033|FG010|Overall Study|Withdrawal by Subject|1|||
127494683|NCT05823974|458773034|FG011|Overall Study|Withdrawal by Subject|0|||
127494684|NCT05823974|458773035|FG012|Overall Study|Withdrawal by Subject|0|||
127494685|NCT05823974|458773036|FG013|Overall Study|Withdrawal by Subject|1|||
127494686|NCT05823974|458773037|FG014|Overall Study|Withdrawal by Subject|1|||
127494687|NCT05823974|458773038|FG015|Overall Study|Withdrawal by Subject|3|||
127494688|NCT05823974|458773039|FG016|Overall Study|Withdrawal by Subject|0|||
127977375|NCT02122770|460538299|FG005|Part B: Standard of Care|Other|2|||
127494689|NCT05823974|458773040|FG017|Overall Study|Withdrawal by Subject|2|||
127494690|NCT05823974|458773041|FG018|Overall Study|Withdrawal by Subject|2|||
127494691|NCT05823974|458773042|FG019|Overall Study|Withdrawal by Subject|0|||
127494692|NCT05823974|458773043|FG020|Overall Study|Withdrawal by Subject|1|||
127494693|NCT05823974|458773023|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127494694|NCT05823974|458773024|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127494695|NCT05823974|458773025|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
127494696|NCT05823974|458773026|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127494697|NCT05823974|458773027|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127494698|NCT05823974|458773028|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127494699|NCT05823974|458773029|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127494700|NCT05823974|458773030|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127494701|NCT05823974|458773031|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127494702|NCT05823974|458773032|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127494703|NCT05823974|458773033|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127494704|NCT05823974|458773034|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127494705|NCT05823974|458773035|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127494706|NCT05823974|458773036|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127494707|NCT05823974|458773037|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
127494708|NCT05823974|458773038|FG015|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127494709|NCT05823974|458773039|FG016|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127494710|NCT05823974|458773040|FG017|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127494711|NCT05823974|458773041|FG018|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127494712|NCT05823974|458773042|FG019|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127494713|NCT05823974|458773043|FG020|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
127494714|NCT05823974|458773023|FG000|Overall Study|Other|0|||
127494715|NCT05823974|458773024|FG001|Overall Study|Other|1|||
127494716|NCT05823974|458773025|FG002|Overall Study|Other|1|||
127494717|NCT05823974|458773026|FG003|Overall Study|Other|1|||
127494718|NCT05823974|458773027|FG004|Overall Study|Other|0|||
127494719|NCT05823974|458773028|FG005|Overall Study|Other|1|||
127494720|NCT05823974|458773029|FG006|Overall Study|Other|1|||
127494721|NCT05823974|458773030|FG007|Overall Study|Other|1|||
127494722|NCT05823974|458773031|FG008|Overall Study|Other|1|||
127494723|NCT05823974|458773032|FG009|Overall Study|Other|0|||
127494724|NCT05823974|458773033|FG010|Overall Study|Other|0|||
127494725|NCT05823974|458773034|FG011|Overall Study|Other|0|||
127494726|NCT05823974|458773035|FG012|Overall Study|Other|2|||
127494727|NCT05823974|458773036|FG013|Overall Study|Other|1|||
127494728|NCT05823974|458773037|FG014|Overall Study|Other|0|||
127494729|NCT05823974|458773038|FG015|Overall Study|Other|1|||
127494730|NCT05823974|458773039|FG016|Overall Study|Other|0|||
127494731|NCT05823974|458773040|FG017|Overall Study|Other|0|||
127494732|NCT05823974|458773041|FG018|Overall Study|Other|0|||
127494733|NCT05823974|458773042|FG019|Overall Study|Other|0|||
127494734|NCT05823974|458773043|FG020|Overall Study|Other|0|||
127494735|NCT00316706|458773044|FG000|Overall Study|Lost to Follow-up|38|||
127494736|NCT00316706|458773045|FG001|Overall Study|Lost to Follow-up|48|||
127494737|NCT03107052|458773050|FG000|Overall Study|Adverse Event|6|||
127494738|NCT03107052|458773051|FG001|Overall Study|Adverse Event|1|||
127494739|NCT03107052|458773052|FG002|Overall Study|Adverse Event|2|||
127494740|NCT03107052|458773050|FG000|Overall Study|Withdrawal by Subject|9|||
127494741|NCT03107052|458773051|FG001|Overall Study|Withdrawal by Subject|5|||
127494742|NCT03107052|458773052|FG002|Overall Study|Withdrawal by Subject|8|||
127494743|NCT03107052|458773050|FG000|Overall Study|Protocol Violation|6|||
127494744|NCT03107052|458773051|FG001|Overall Study|Protocol Violation|0|||
127494745|NCT03107052|458773052|FG002|Overall Study|Protocol Violation|3|||
127494746|NCT03107052|458773050|FG000|Overall Study|Lost to Follow-up|4|||
127494747|NCT03107052|458773051|FG001|Overall Study|Lost to Follow-up|0|||
127494748|NCT03107052|458773052|FG002|Overall Study|Lost to Follow-up|1|||
127494749|NCT03107052|458773050|FG000|Overall Study|Lack of Efficacy|23|||
127494750|NCT03107052|458773051|FG001|Overall Study|Lack of Efficacy|7|||
127494751|NCT03107052|458773052|FG002|Overall Study|Lack of Efficacy|4|||
127494752|NCT03107052|458773050|FG000|Overall Study|Other than specified|4|||
127494753|NCT03107052|458773051|FG001|Overall Study|Other than specified|2|||
127977376|NCT02122770|460538294|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
127494754|NCT03107052|458773052|FG002|Overall Study|Other than specified|0|||
127494755|NCT03107052|458773050|FG000|Overall Study|Study terminated due to futility|67|||
127494756|NCT03107052|458773051|FG001|Overall Study|Study terminated due to futility|31|||
127977377|NCT02122770|460538295|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
127494757|NCT03107052|458773052|FG002|Overall Study|Study terminated due to futility|23|||
127494758|NCT00391053|458773053|FG000|Overall Study|Serious Adverse Events|1|||
127494759|NCT00391053|458773054|FG001|Overall Study|Serious Adverse Events|0|||
127494760|NCT00391053|458773055|FG002|Overall Study|Serious Adverse Events|1|||
127494761|NCT00391053|458773056|FG003|Overall Study|Serious Adverse Events|4|||
127494762|NCT00391053|458773053|FG000|Overall Study|Protocol Violation|2|||
127494763|NCT00391053|458773054|FG001|Overall Study|Protocol Violation|0|||
127494764|NCT00391053|458773055|FG002|Overall Study|Protocol Violation|0|||
127494765|NCT00391053|458773056|FG003|Overall Study|Protocol Violation|0|||
127494766|NCT00391053|458773053|FG000|Overall Study|Lost to Follow-up|1|||
127494767|NCT00391053|458773054|FG001|Overall Study|Lost to Follow-up|0|||
127494768|NCT00391053|458773055|FG002|Overall Study|Lost to Follow-up|0|||
127494769|NCT00391053|458773056|FG003|Overall Study|Lost to Follow-up|5|||
127494770|NCT00391053|458773053|FG000|Overall Study|Withdrawal by Subject|5|||
127494771|NCT00391053|458773054|FG001|Overall Study|Withdrawal by Subject|1|||
127494772|NCT00391053|458773055|FG002|Overall Study|Withdrawal by Subject|1|||
127494773|NCT00391053|458773056|FG003|Overall Study|Withdrawal by Subject|1|||
127494774|NCT05002985|458773057|FG000|Overall Study|Withdrawal by Subject|1|||
127494775|NCT01642901|458773058|FG000|12-month Follow-up|Withdrawal by Subject|1|||
127494776|NCT01642901|458773059|FG001|12-month Follow-up|Withdrawal by Subject|0|||
127494777|NCT02943070|458773061|FG000|Overall Study|Physician Decision|1|||
127494778|NCT02943070|458773061|FG000|Overall Study|Adverse Event|2|||
127494779|NCT02943070|458773061|FG000|Overall Study|Death|2|||
127494780|NCT02943070|458773061|FG000|Overall Study|Withdrawal by Subject|3|||
127494781|NCT02943070|458773061|FG000|Overall Study|Lost to Follow-up|4|||
127494782|NCT02943070|458773061|FG000|Overall Study|Retreatment or TURP|13|||
127494783|NCT02943070|458773061|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
127494784|NCT04123093|458773062|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
127494785|NCT04123093|458773063|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
127494786|NCT04123093|458773062|FG000|Phase 2|Physician Decision|0|||
127494787|NCT04123093|458773063|FG001|Phase 2|Physician Decision|1|||
127494788|NCT04123093|458773062|FG000|Phase 2|Withdrawal by Subject|0|||
127494789|NCT04123093|458773063|FG001|Phase 2|Withdrawal by Subject|1|||
127494790|NCT04551963|458773064|FG000|Overall Study|Physician Decision|1|||
127494791|NCT04551963|458773065|FG001|Overall Study|Physician Decision|1|||
127494792|NCT04551963|458773064|FG000|Overall Study|Death|1|||
127494793|NCT04551963|458773065|FG001|Overall Study|Death|0|||
127494794|NCT03379259|458773066|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
127494795|NCT03379259|458773067|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
127494796|NCT03379259|458773068|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
127494797|NCT03379259|458773069|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
127494798|NCT03379259|458773070|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
127494799|NCT03379259|458773071|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
127494800|NCT03379259|458773066|FG000|Overall Study|Death|0|||
127494801|NCT03379259|458773067|FG001|Overall Study|Death|1|||
127494802|NCT03379259|458773068|FG002|Overall Study|Death|2|||
127494803|NCT03379259|458773069|FG003|Overall Study|Death|1|||
127494804|NCT03379259|458773070|FG004|Overall Study|Death|4|||
127494805|NCT03379259|458773071|FG005|Overall Study|Death|2|||
127494806|NCT03379259|458773066|FG000|Overall Study|Withdrawal by Subject|0|||
127494807|NCT03379259|458773067|FG001|Overall Study|Withdrawal by Subject|0|||
127494808|NCT03379259|458773068|FG002|Overall Study|Withdrawal by Subject|1|||
127494809|NCT03379259|458773069|FG003|Overall Study|Withdrawal by Subject|0|||
127494810|NCT03379259|458773070|FG004|Overall Study|Withdrawal by Subject|2|||
127494811|NCT03379259|458773071|FG005|Overall Study|Withdrawal by Subject|0|||
127494812|NCT03379259|458773066|FG000|Overall Study|Study terminated by sponsor|0|||
127494813|NCT03379259|458773067|FG001|Overall Study|Study terminated by sponsor|0|||
127494814|NCT03379259|458773068|FG002|Overall Study|Study terminated by sponsor|0|||
127494815|NCT03379259|458773069|FG003|Overall Study|Study terminated by sponsor|1|||
127494816|NCT03379259|458773070|FG004|Overall Study|Study terminated by sponsor|1|||
127494817|NCT03379259|458773071|FG005|Overall Study|Study terminated by sponsor|4|||
127494818|NCT03379259|458773066|FG000|Overall Study|Disease progression|0|||
127494819|NCT03379259|458773067|FG001|Overall Study|Disease progression|0|||
127494820|NCT03379259|458773068|FG002|Overall Study|Disease progression|0|||
127494821|NCT03379259|458773069|FG003|Overall Study|Disease progression|1|||
127494822|NCT03379259|458773070|FG004|Overall Study|Disease progression|0|||
127494823|NCT03379259|458773071|FG005|Overall Study|Disease progression|1|||
127494824|NCT03379259|458773066|FG000|Overall Study|Lost to Follow-up|0|||
127494825|NCT03379259|458773067|FG001|Overall Study|Lost to Follow-up|0|||
127494826|NCT03379259|458773068|FG002|Overall Study|Lost to Follow-up|0|||
127494827|NCT03379259|458773069|FG003|Overall Study|Lost to Follow-up|0|||
127494828|NCT03379259|458773070|FG004|Overall Study|Lost to Follow-up|1|||
127494829|NCT03379259|458773071|FG005|Overall Study|Lost to Follow-up|0|||
127494830|NCT03379259|458773066|FG000|Overall Study|Deteriorating condition|0|||
127494831|NCT03379259|458773067|FG001|Overall Study|Deteriorating condition|0|||
127494832|NCT03379259|458773068|FG002|Overall Study|Deteriorating condition|0|||
127494833|NCT03379259|458773069|FG003|Overall Study|Deteriorating condition|0|||
127494834|NCT03379259|458773070|FG004|Overall Study|Deteriorating condition|1|||
127494835|NCT03379259|458773071|FG005|Overall Study|Deteriorating condition|0|||
127494836|NCT00700622|458773073|FG000|Overall Study|Adverse Event|4|||
127494837|NCT00700622|458773074|FG001|Overall Study|Adverse Event|0|||
127494838|NCT00700622|458773073|FG000|Overall Study|Lost to Follow-up|0|||
127494839|NCT00700622|458773074|FG001|Overall Study|Lost to Follow-up|1|||
127494840|NCT00700622|458773073|FG000|Overall Study|Physician Decision|2|||
127494841|NCT00700622|458773074|FG001|Overall Study|Physician Decision|1|||
127494842|NCT00700622|458773073|FG000|Overall Study|Protocol Violation|0|||
127494843|NCT00700622|458773074|FG001|Overall Study|Protocol Violation|1|||
127494844|NCT00700622|458773073|FG000|Overall Study|Withdrawal by Subject|4|||
127494845|NCT00700622|458773074|FG001|Overall Study|Withdrawal by Subject|1|||
127494846|NCT00700622|458773073|FG000|Overall Study|Other|3|||
127494847|NCT00700622|458773074|FG001|Overall Study|Other|1|||
127494848|NCT00375427|458773075|FG000|Overall Study|Adverse Event|21|||
127494849|NCT00375427|458773076|FG001|Overall Study|Adverse Event|27|||
127494850|NCT00375427|458773075|FG000|Overall Study|Abnormal test procedure result(s)|0|||
127494851|NCT00375427|458773076|FG001|Overall Study|Abnormal test procedure result(s)|1|||
127494852|NCT00375427|458773075|FG000|Overall Study|Abnormal laboratory value(s)|1|||
127494853|NCT00375427|458773076|FG001|Overall Study|Abnormal laboratory value(s)|2|||
127494854|NCT00375427|458773075|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
127494855|NCT00375427|458773076|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
127494856|NCT00375427|458773075|FG000|Overall Study|Patient no longer requires study drug|3|||
127494857|NCT00375427|458773076|FG001|Overall Study|Patient no longer requires study drug|7|||
127494858|NCT00375427|458773075|FG000|Overall Study|Protocol Violation|10|||
127494859|NCT00375427|458773076|FG001|Overall Study|Protocol Violation|8|||
127494860|NCT00375427|458773075|FG000|Overall Study|Withdrawal by Subject|9|||
127494861|NCT00375427|458773076|FG001|Overall Study|Withdrawal by Subject|13|||
127494862|NCT00375427|458773075|FG000|Overall Study|Lost to Follow-up|1|||
127494863|NCT00375427|458773076|FG001|Overall Study|Lost to Follow-up|1|||
127494864|NCT00375427|458773075|FG000|Overall Study|Administrative reasons|0|||
127494865|NCT00375427|458773076|FG001|Overall Study|Administrative reasons|1|||
127494866|NCT00375427|458773075|FG000|Overall Study|Death|11|||
127494867|NCT00375427|458773076|FG001|Overall Study|Death|10|||
127494868|NCT01703091|458773080|FG000|Overall Study|Adverse Event|5|||
127494869|NCT01703091|458773081|FG001|Overall Study|Adverse Event|3|||
127494870|NCT01703091|458773080|FG000|Overall Study|Physician Decision|2|||
127494871|NCT01703091|458773081|FG001|Overall Study|Physician Decision|1|||
127494872|NCT01703091|458773080|FG000|Overall Study|Withdrawal by Subject|1|||
127494873|NCT01703091|458773081|FG001|Overall Study|Withdrawal by Subject|0|||
127494874|NCT01703091|458773080|FG000|Overall Study|Sponsor Decision|1|||
127494875|NCT01703091|458773081|FG001|Overall Study|Sponsor Decision|0|||
127494876|NCT00803361|458773082|FG000|Overall Study|Adverse Event|13|||
127494877|NCT00803361|458773083|FG001|Overall Study|Adverse Event|3|||
127494878|NCT00803361|458773082|FG000|Overall Study|Lack of Efficacy|4|||
127494879|NCT00803361|458773083|FG001|Overall Study|Lack of Efficacy|13|||
127494880|NCT00803361|458773082|FG000|Overall Study|Lost to Follow-up|1|||
127494881|NCT00803361|458773083|FG001|Overall Study|Lost to Follow-up|2|||
127494882|NCT00803361|458773082|FG000|Overall Study|Physician Decision|1|||
127494883|NCT00803361|458773083|FG001|Overall Study|Physician Decision|0|||
127494884|NCT00803361|458773082|FG000|Overall Study|Protocol Violation|2|||
127494885|NCT00803361|458773083|FG001|Overall Study|Protocol Violation|4|||
127494886|NCT00803361|458773082|FG000|Overall Study|Withdrawal by Subject|5|||
127494887|NCT00803361|458773083|FG001|Overall Study|Withdrawal by Subject|6|||
127494888|NCT02819297|458773084|FG000|Overall Study|Withdrawal by Subject|25|||
127494889|NCT02819297|458773085|FG001|Overall Study|Withdrawal by Subject|13|||
127494890|NCT02819297|458773084|FG000|Overall Study|Lost to Follow-up|12|||
127494891|NCT02819297|458773085|FG001|Overall Study|Lost to Follow-up|14|||
127494892|NCT02819297|458773084|FG000|Overall Study|Adverse Event|12|||
127494893|NCT02819297|458773085|FG001|Overall Study|Adverse Event|10|||
127494894|NCT02819297|458773084|FG000|Overall Study|Physician Decision|5|||
127494895|NCT02819297|458773085|FG001|Overall Study|Physician Decision|5|||
127494896|NCT02819297|458773084|FG000|Overall Study|Lack of Efficacy|5|||
127494897|NCT02819297|458773085|FG001|Overall Study|Lack of Efficacy|8|||
127494898|NCT02819297|458773084|FG000|Overall Study|Protocol Violation|1|||
127494899|NCT02819297|458773085|FG001|Overall Study|Protocol Violation|2|||
127494900|NCT02858440|458773086|FG000|Overall Study|Lost to Follow-up|3|||
127494901|NCT02858440|458773086|FG000|Overall Study|Protocol Violation|2|||
127494902|NCT02858440|458773086|FG000|Overall Study|Consent withdrawal|3|||
127494903|NCT02858440|458773086|FG000|Overall Study|Migrated/moved from study area|4|||
127494904|NCT01670279|458773087|FG000|Overall Study|Adverse Event|0|||
127494905|NCT01670279|458773088|FG001|Overall Study|Adverse Event|1|||
127494906|NCT01670279|458773089|FG002|Overall Study|Adverse Event|0|||
127494907|NCT01670279|458773090|FG003|Overall Study|Adverse Event|0|||
127494908|NCT01670279|458773087|FG000|Overall Study|Physician Decision|0|||
127494909|NCT01670279|458773088|FG001|Overall Study|Physician Decision|1|||
127494910|NCT01670279|458773089|FG002|Overall Study|Physician Decision|0|||
127977378|NCT02122770|460538296|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
127494911|NCT01670279|458773090|FG003|Overall Study|Physician Decision|0|||
127494912|NCT01670279|458773087|FG000|Overall Study|Participant met withdrawal criteria|0|||
127494913|NCT01670279|458773088|FG001|Overall Study|Participant met withdrawal criteria|0|||
127494914|NCT01670279|458773089|FG002|Overall Study|Participant met withdrawal criteria|0|||
127494915|NCT01670279|458773090|FG003|Overall Study|Participant met withdrawal criteria|1|||
127494916|NCT01901614|458773091|FG000|Overall Study|Adverse Event|0|||
127494917|NCT01901614|458773092|FG001|Overall Study|Adverse Event|1|||
127494918|NCT01901614|458773091|FG000|Overall Study|Lost to Follow-up|1|||
127494919|NCT01901614|458773092|FG001|Overall Study|Lost to Follow-up|0|||
127494920|NCT01901614|458773091|FG000|Overall Study|Screen Fail|1|||
127494921|NCT01901614|458773092|FG001|Overall Study|Screen Fail|0|||
127494922|NCT01823198|458773094|FG000|Overall Study|Physician Decision|0|||
127494923|NCT01823198|458773095|FG001|Overall Study|Physician Decision|1|||
127494924|NCT01823198|458773096|FG002|Overall Study|Physician Decision|0|||
127494925|NCT01823198|458773097|FG003|Overall Study|Physician Decision|0|||
127494926|NCT01823198|458773098|FG004|Overall Study|Physician Decision|0|||
127494927|NCT01823198|458773099|FG005|Overall Study|Physician Decision|3|||
127494928|NCT01823198|458773100|FG006|Overall Study|Physician Decision|3|||
127494929|NCT01262638|458773101|FG000|Overall Study|Adverse Event|3|||
127494930|NCT01262638|458773102|FG001|Overall Study|Adverse Event|4|||
127494931|NCT01262638|458773103|FG002|Overall Study|Adverse Event|3|||
127494932|NCT01262638|458773104|FG003|Overall Study|Adverse Event|4|||
127494933|NCT01262638|458773101|FG000|Overall Study|Protocol Violation|1|||
127494934|NCT01262638|458773102|FG001|Overall Study|Protocol Violation|0|||
127494935|NCT01262638|458773103|FG002|Overall Study|Protocol Violation|0|||
127494936|NCT01262638|458773104|FG003|Overall Study|Protocol Violation|1|||
127494937|NCT01262638|458773101|FG000|Overall Study|Withdrawal by Subject|2|||
127494938|NCT01262638|458773102|FG001|Overall Study|Withdrawal by Subject|1|||
127494939|NCT01262638|458773103|FG002|Overall Study|Withdrawal by Subject|0|||
127494940|NCT01262638|458773104|FG003|Overall Study|Withdrawal by Subject|1|||
127494941|NCT01262638|458773101|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
127494942|NCT01262638|458773102|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
127494943|NCT01262638|458773103|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
127494944|NCT01262638|458773104|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
127494945|NCT01262638|458773101|FG000|Overall Study|Lost to Follow-up|1|||
127494946|NCT01262638|458773102|FG001|Overall Study|Lost to Follow-up|1|||
127494947|NCT01262638|458773103|FG002|Overall Study|Lost to Follow-up|1|||
127494948|NCT01262638|458773104|FG003|Overall Study|Lost to Follow-up|1|||
127494949|NCT01262638|458773101|FG000|Overall Study|Participant Went Out of Town|0|||
127494950|NCT01262638|458773102|FG001|Overall Study|Participant Went Out of Town|0|||
127494951|NCT01262638|458773103|FG002|Overall Study|Participant Went Out of Town|1|||
127494952|NCT01262638|458773104|FG003|Overall Study|Participant Went Out of Town|0|||
127494953|NCT02243371|458773109|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
127494954|NCT02243371|458773110|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
127494955|NCT02243371|458773109|FG000|Overall Study|Death (unrelated)|2|||
127494956|NCT02243371|458773110|FG001|Overall Study|Death (unrelated)|4|||
127494957|NCT02243371|458773109|FG000|Overall Study|Adverse Event (unrelated)|0|||
127494958|NCT02243371|458773110|FG001|Overall Study|Adverse Event (unrelated)|1|||
127494959|NCT02243371|458773109|FG000|Overall Study|Lack of Clinical Benefit|0|||
127494960|NCT02243371|458773110|FG001|Overall Study|Lack of Clinical Benefit|1|||
127494961|NCT02243371|458773109|FG000|Overall Study|Withdrawal by Subject|0|||
127494962|NCT02243371|458773110|FG001|Overall Study|Withdrawal by Subject|2|||
127494963|NCT01369199|458773111|FG000|Overall Study|Withdrawal by Subject|1|||
127494964|NCT01369199|458773111|FG000|Overall Study|Lost to Follow-up|2|||
127494965|NCT01071252|458773112|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
127494966|NCT01071252|458773113|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
127494967|NCT01071252|458773114|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
127494968|NCT01071252|458773115|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
127494969|NCT01071252|458773116|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
127494970|NCT01071252|458773112|FG000|Overall Study|Withdrawal by Subject|8|||
127494971|NCT01071252|458773113|FG001|Overall Study|Withdrawal by Subject|2|||
127494972|NCT01071252|458773114|FG002|Overall Study|Withdrawal by Subject|1|||
127494973|NCT01071252|458773115|FG003|Overall Study|Withdrawal by Subject|2|||
127494974|NCT01071252|458773116|FG004|Overall Study|Withdrawal by Subject|3|||
127494975|NCT01071252|458773112|FG000|Overall Study|administrative problems|1|||
127494976|NCT01071252|458773113|FG001|Overall Study|administrative problems|1|||
127494977|NCT01071252|458773114|FG002|Overall Study|administrative problems|0|||
127494978|NCT01071252|458773115|FG003|Overall Study|administrative problems|2|||
127494979|NCT01071252|458773116|FG004|Overall Study|administrative problems|1|||
127494980|NCT01071252|458773112|FG000|Overall Study|Lost to Follow-up|1|||
127494981|NCT01071252|458773113|FG001|Overall Study|Lost to Follow-up|0|||
127494982|NCT01071252|458773114|FG002|Overall Study|Lost to Follow-up|1|||
127494983|NCT01071252|458773115|FG003|Overall Study|Lost to Follow-up|2|||
127494984|NCT01071252|458773116|FG004|Overall Study|Lost to Follow-up|0|||
127494985|NCT01071252|458773112|FG000|Overall Study|Adverse Event|1|||
127494986|NCT01071252|458773113|FG001|Overall Study|Adverse Event|1|||
127494987|NCT01071252|458773114|FG002|Overall Study|Adverse Event|0|||
127494988|NCT01071252|458773115|FG003|Overall Study|Adverse Event|1|||
127494989|NCT01071252|458773116|FG004|Overall Study|Adverse Event|0|||
127494990|NCT01071252|458773112|FG000|Overall Study|Death|0|||
127494991|NCT01071252|458773113|FG001|Overall Study|Death|0|||
127494992|NCT01071252|458773114|FG002|Overall Study|Death|0|||
127494993|NCT01071252|458773115|FG003|Overall Study|Death|0|||
127494994|NCT01071252|458773116|FG004|Overall Study|Death|1|||
127494995|NCT03928418|458773117|FG000|Overall Study|Lost to Follow-up|5|||
127494996|NCT03928418|458773118|FG001|Overall Study|Lost to Follow-up|3|||
127494997|NCT03928418|458773119|FG002|Overall Study|Lost to Follow-up|5|||
127494998|NCT03928418|458773117|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
127494999|NCT03928418|458773118|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
127495000|NCT03928418|458773119|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
127495001|NCT00470262|458773120|FG000|Overall Study|Withdrawal by Subject|2|||
127495002|NCT00470262|458773121|FG001|Overall Study|Withdrawal by Subject|0|||
127495003|NCT03900728|458773122|FG000|Overall Study|No text responses|0|||
127495004|NCT03900728|458773123|FG001|Overall Study|No text responses|0|||
127495005|NCT03900728|458773124|FG002|Overall Study|No text responses|4|||
127495006|NCT00763256|458773125|FG000|Overall Study|Didn't return for appointments|7|||
127977379|NCT02122770|460538297|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
127977380|NCT02122770|460538298|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
127977381|NCT02122770|460538299|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
127977382|NCT02122770|460538294|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
127977383|NCT02122770|460538295|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
127495007|NCT00763256|458773126|FG001|Overall Study|Didn't return for appointments|10|||
127495008|NCT02544750|458773127|FG000|Overall Study|Physician Decision|3|||
127495009|NCT02544750|458773128|FG001|Overall Study|Physician Decision|1|||
127495010|NCT02544750|458773127|FG000|Overall Study|Other reasons|69|||
127495011|NCT02544750|458773128|FG001|Overall Study|Other reasons|39|||
127495012|NCT02544750|458773127|FG000|Overall Study|Met withdrawal criteria|2|||
127495013|NCT02544750|458773128|FG001|Overall Study|Met withdrawal criteria|2|||
127495014|NCT02544750|458773127|FG000|Overall Study|Transition To Commercial Product|1|||
127495015|NCT02544750|458773128|FG001|Overall Study|Transition To Commercial Product|0|||
127495016|NCT02544750|458773127|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
127495017|NCT02544750|458773128|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
127495018|NCT02544750|458773127|FG000|Overall Study|Adverse Event|8|||
127495019|NCT02544750|458773128|FG001|Overall Study|Adverse Event|10|||
127495020|NCT02544750|458773127|FG000|Overall Study|Withdrawal by Subject|10|||
127495021|NCT02544750|458773128|FG001|Overall Study|Withdrawal by Subject|4|||
127495022|NCT02544750|458773127|FG000|Overall Study|Lost to Follow-up|1|||
127495023|NCT02544750|458773128|FG001|Overall Study|Lost to Follow-up|0|||
127495024|NCT03248167|458773131|FG000|Overall Study|Withdrawal by Subject|2|||
127495025|NCT03248167|458773132|FG001|Overall Study|Withdrawal by Subject|2|||
127495026|NCT03248167|458773131|FG000|Overall Study|Physician Decision|0|||
127495027|NCT03248167|458773132|FG001|Overall Study|Physician Decision|1|||
127495028|NCT03248167|458773131|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
127495029|NCT03248167|458773132|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
127495030|NCT03248167|458773131|FG000|Overall Study|Lost to Follow-up|1|||
127495031|NCT03248167|458773132|FG001|Overall Study|Lost to Follow-up|0|||
127495032|NCT02122146|458773133|FG000|Part 1: Dose Escalation|Death|0|||
127495033|NCT02122146|458773134|FG001|Part 1: Dose Escalation|Death|1|||
127495034|NCT02122146|458773135|FG002|Part 1: Dose Escalation|Death|1|||
127495035|NCT02122146|458773136|FG003|Part 1: Dose Escalation|Death|0|||
127495036|NCT02122146|458773137|FG004|Part 1: Dose Escalation|Death|0|||
127495037|NCT02122146|458773138|FG005|Part 1: Dose Escalation|Death|0|||
127495038|NCT02122146|458773139|FG006|Part 1: Dose Escalation|Death|0|||
127495039|NCT02122146|458773140|FG007|Part 1: Dose Escalation|Death|0|||
127495040|NCT02122146|458773133|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
127495041|NCT02122146|458773134|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
127495042|NCT02122146|458773135|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
127495043|NCT02122146|458773136|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
127495044|NCT02122146|458773137|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
127495045|NCT02122146|458773138|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
127495046|NCT02122146|458773139|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
127495047|NCT02122146|458773140|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
127495048|NCT02122146|458773133|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
127495049|NCT02122146|458773134|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
127495050|NCT02122146|458773135|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
127495051|NCT02122146|458773136|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
127495052|NCT02122146|458773137|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
127495053|NCT02122146|458773138|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
127495054|NCT02122146|458773139|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
127495055|NCT02122146|458773140|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
127495056|NCT02122146|458773133|FG000|Part 1: Dose Escalation|Other|1|||
127495057|NCT02122146|458773134|FG001|Part 1: Dose Escalation|Other|0|||
127495058|NCT02122146|458773135|FG002|Part 1: Dose Escalation|Other|0|||
127495059|NCT02122146|458773136|FG003|Part 1: Dose Escalation|Other|0|||
127495060|NCT02122146|458773137|FG004|Part 1: Dose Escalation|Other|0|||
127495061|NCT02122146|458773138|FG005|Part 1: Dose Escalation|Other|1|||
127495062|NCT02122146|458773139|FG006|Part 1: Dose Escalation|Other|1|||
127495063|NCT02122146|458773140|FG007|Part 1: Dose Escalation|Other|2|||
127495064|NCT02473471|458773141|FG000|Overall Study|poor oral hygiene|2|||
127495065|NCT02473471|458773141|FG000|Overall Study|Lost to Follow-up|1|||
127495066|NCT00255723|458773145|FG000|Overall Study|Adverse Event|1|||
127495067|NCT00255723|458773146|FG001|Overall Study|Adverse Event|1|||
127495068|NCT00255723|458773145|FG000|Overall Study|Death|0|||
127495069|NCT00255723|458773146|FG001|Overall Study|Death|1|||
127495070|NCT00255723|458773145|FG000|Overall Study|Response Data Not Available|1|||
127495071|NCT00255723|458773146|FG001|Overall Study|Response Data Not Available|0|||
127495072|NCT01169701|458773151|FG000|Overall Study|Lost to Follow-up|1|||
127495073|NCT01169701|458773152|FG001|Overall Study|Lost to Follow-up|1|||
127495074|NCT01169701|458773151|FG000|Overall Study|Withdrawal by Subject|1|||
127495075|NCT01169701|458773152|FG001|Overall Study|Withdrawal by Subject|3|||
127495076|NCT01169701|458773151|FG000|Overall Study|Adverse Event|1|||
127495077|NCT01169701|458773152|FG001|Overall Study|Adverse Event|2|||
127495078|NCT01169701|458773151|FG000|Overall Study|Exclusion criteria|2|||
127495079|NCT01169701|458773152|FG001|Overall Study|Exclusion criteria|0|||
127495080|NCT01169701|458773151|FG000|Overall Study|Death|0|||
127495081|NCT01169701|458773152|FG001|Overall Study|Death|1|||
127495082|NCT01169701|458773151|FG000|Overall Study|Administrative problems|0|||
127495083|NCT01169701|458773152|FG001|Overall Study|Administrative problems|1|||
127495084|NCT01169701|458773151|FG000|Overall Study|Serious adverse event|0|||
127495085|NCT01169701|458773152|FG001|Overall Study|Serious adverse event|1|||
127495086|NCT01169701|458773151|FG000|Overall Study|Sponsor decision|0|||
127495087|NCT01169701|458773152|FG001|Overall Study|Sponsor decision|1|||
127495088|NCT00553436|458773153|FG000|Overall Study|Conversion to another procedure|1|||
127495089|NCT02455336|458773154|FG000|Overall Study|Withdrawal by Subject|0|||
127495090|NCT02455336|458773155|FG001|Overall Study|Withdrawal by Subject|2|||
127495091|NCT02455336|458773154|FG000|Overall Study|Adverse Event|3|||
127495092|NCT02455336|458773155|FG001|Overall Study|Adverse Event|0|||
127495093|NCT02455336|458773154|FG000|Overall Study|Non-responder to treatment|2|||
127495094|NCT02455336|458773155|FG001|Overall Study|Non-responder to treatment|0|||
127495095|NCT01814046|458773157|FG000|Drug Administration|Death due to complications of RSV|1|||
127495096|NCT01814046|458773158|FG001|Drug Administration|Death due to complications of RSV|0|||
127495097|NCT01814046|458773159|FG002|Drug Administration|Death due to complications of RSV|0|||
127495098|NCT03146663|458773162|FG000|Overall Study|Did not receive study treatment|1|||
127495099|NCT03146663|458773163|FG001|Overall Study|Did not receive study treatment|1|||
127495100|NCT03089047|458773164|FG000|Overall Study|Lost to Follow-up|1|||
127495101|NCT03089047|458773165|FG001|Overall Study|Lost to Follow-up|0|||
127495102|NCT03599518|458773166|FG000|Overall Study|Clinical progression|0|||
127495103|NCT03599518|458773167|FG001|Overall Study|Clinical progression|0|||
127495104|NCT03599518|458773168|FG002|Overall Study|Clinical progression|0|||
127495105|NCT03599518|458773169|FG003|Overall Study|Clinical progression|0|||
127495106|NCT03599518|458773170|FG004|Overall Study|Clinical progression|1|||
127495107|NCT03599518|458773166|FG000|Overall Study|Adverse Event|0|||
127495108|NCT03599518|458773167|FG001|Overall Study|Adverse Event|0|||
127495109|NCT03599518|458773168|FG002|Overall Study|Adverse Event|0|||
127495110|NCT03599518|458773169|FG003|Overall Study|Adverse Event|0|||
127495111|NCT03599518|458773170|FG004|Overall Study|Adverse Event|1|||
127495112|NCT03599518|458773166|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
127495113|NCT03599518|458773167|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
127495114|NCT03599518|458773168|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
127495115|NCT03599518|458773169|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
127495116|NCT03599518|458773170|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
127495117|NCT03599518|458773166|FG000|Overall Study|Participant withdrawal from study treatment|0|||
127495118|NCT03599518|458773167|FG001|Overall Study|Participant withdrawal from study treatment|0|||
127495119|NCT03599518|458773168|FG002|Overall Study|Participant withdrawal from study treatment|1|||
127495120|NCT03599518|458773169|FG003|Overall Study|Participant withdrawal from study treatment|0|||
127495121|NCT03599518|458773170|FG004|Overall Study|Participant withdrawal from study treatment|0|||
127495122|NCT00429182|458773176|FG000|Overall Study|Not evaluable, Disease Progression|2|||
127495123|NCT00429182|458773176|FG000|Overall Study|Not eligible|5|||
127495124|NCT02311881|458773191|FG000|Overall Study|Did not meet the study criteria|2|||
127495125|NCT02311881|458773192|FG001|Overall Study|Did not meet the study criteria|2|||
127495126|NCT02311881|458773193|FG002|Overall Study|Did not meet the study criteria|0|||
127977384|NCT02122770|460538296|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
127977385|NCT02122770|460538297|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
127495127|NCT02311881|458773191|FG000|Overall Study|Adverse Event|7|||
127977386|NCT02122770|460538298|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
127495128|NCT02311881|458773192|FG001|Overall Study|Adverse Event|15|||
127495129|NCT02311881|458773193|FG002|Overall Study|Adverse Event|8|||
127495130|NCT02311881|458773191|FG000|Overall Study|Lost to Follow-up|3|||
127495131|NCT02311881|458773192|FG001|Overall Study|Lost to Follow-up|3|||
127495132|NCT02311881|458773193|FG002|Overall Study|Lost to Follow-up|2|||
127495133|NCT02311881|458773191|FG000|Overall Study|Protocol Violation|1|||
127495134|NCT02311881|458773192|FG001|Overall Study|Protocol Violation|2|||
127495135|NCT02311881|458773193|FG002|Overall Study|Protocol Violation|3|||
127495136|NCT02311881|458773191|FG000|Overall Study|Withdrawal of consent|14|||
127495137|NCT02311881|458773192|FG001|Overall Study|Withdrawal of consent|16|||
127495138|NCT02311881|458773193|FG002|Overall Study|Withdrawal of consent|17|||
127495139|NCT02311881|458773191|FG000|Overall Study|Other|0|||
127495140|NCT02311881|458773192|FG001|Overall Study|Other|0|||
127495141|NCT02311881|458773193|FG002|Overall Study|Other|1|||
127495142|NCT02311881|458773191|FG000|Overall Study|Lack of Efficacy|1|||
127495143|NCT02311881|458773192|FG001|Overall Study|Lack of Efficacy|2|||
127495144|NCT02311881|458773193|FG002|Overall Study|Lack of Efficacy|0|||
127495145|NCT02311881|458773191|FG000|Overall Study|Subject has border line pregnancy test|1|||
127495146|NCT02311881|458773192|FG001|Overall Study|Subject has border line pregnancy test|0|||
127495147|NCT02311881|458773193|FG002|Overall Study|Subject has border line pregnancy test|0|||
127495148|NCT02311881|458773191|FG000|Overall Study|Withdrawal by Subject|3|||
127495149|NCT02311881|458773192|FG001|Overall Study|Withdrawal by Subject|1|||
127495150|NCT02311881|458773193|FG002|Overall Study|Withdrawal by Subject|4|||
127495151|NCT02311881|458773191|FG000|Overall Study|Sponsor Decision|1|||
127495152|NCT02311881|458773192|FG001|Overall Study|Sponsor Decision|1|||
127495153|NCT02311881|458773193|FG002|Overall Study|Sponsor Decision|1|||
127495154|NCT02311881|458773191|FG000|Overall Study|Protocol Deviation|1|||
127495155|NCT02311881|458773192|FG001|Overall Study|Protocol Deviation|0|||
127495156|NCT02311881|458773193|FG002|Overall Study|Protocol Deviation|0|||
127495157|NCT02311881|458773191|FG000|Overall Study|Non-Compliance|1|||
127495158|NCT02311881|458773192|FG001|Overall Study|Non-Compliance|0|||
127495159|NCT02311881|458773193|FG002|Overall Study|Non-Compliance|2|||
127495160|NCT02311881|458773191|FG000|Overall Study|Physician Decision|0|||
127495161|NCT02311881|458773192|FG001|Overall Study|Physician Decision|0|||
127495162|NCT02311881|458773193|FG002|Overall Study|Physician Decision|1|||
127495163|NCT02311881|458773191|FG000|Overall Study|Medical Monitor Discretion|0|||
127495164|NCT02311881|458773192|FG001|Overall Study|Medical Monitor Discretion|0|||
127495165|NCT02311881|458773193|FG002|Overall Study|Medical Monitor Discretion|1|||
127495166|NCT02311881|458773191|FG000|Overall Study|Participant taking another medication|0|||
127495167|NCT02311881|458773192|FG001|Overall Study|Participant taking another medication|0|||
127495168|NCT02311881|458773193|FG002|Overall Study|Participant taking another medication|1|||
127495169|NCT02311881|458773191|FG000|Overall Study|Serious Adverse Event|0|||
127495170|NCT02311881|458773192|FG001|Overall Study|Serious Adverse Event|1|||
127495171|NCT02311881|458773193|FG002|Overall Study|Serious Adverse Event|0|||
127495172|NCT00819156|458773194|FG000|Overall Study|Adverse Event|1|||
127495173|NCT00819156|458773195|FG001|Overall Study|Adverse Event|4|||
127495174|NCT00819156|458773196|FG002|Overall Study|Adverse Event|2|||
127495175|NCT00819156|458773197|FG003|Overall Study|Adverse Event|1|||
127495176|NCT00819156|458773198|FG004|Overall Study|Adverse Event|2|||
127495177|NCT00819156|458773199|FG005|Overall Study|Adverse Event|3|||
127495178|NCT00819156|458773194|FG000|Overall Study|Withdrawal by Subject|0|||
127495179|NCT00819156|458773195|FG001|Overall Study|Withdrawal by Subject|3|||
127495180|NCT00819156|458773196|FG002|Overall Study|Withdrawal by Subject|2|||
127495181|NCT00819156|458773197|FG003|Overall Study|Withdrawal by Subject|0|||
127495182|NCT00819156|458773198|FG004|Overall Study|Withdrawal by Subject|1|||
127495183|NCT00819156|458773199|FG005|Overall Study|Withdrawal by Subject|0|||
127495184|NCT00819156|458773194|FG000|Overall Study|Protocol Violation|1|||
127495185|NCT00819156|458773195|FG001|Overall Study|Protocol Violation|0|||
127495186|NCT00819156|458773196|FG002|Overall Study|Protocol Violation|1|||
127495187|NCT00819156|458773197|FG003|Overall Study|Protocol Violation|0|||
127495188|NCT00819156|458773198|FG004|Overall Study|Protocol Violation|0|||
127495189|NCT00819156|458773199|FG005|Overall Study|Protocol Violation|1|||
127495190|NCT00819156|458773194|FG000|Overall Study|Lost to Follow-up|0|||
127495191|NCT00819156|458773195|FG001|Overall Study|Lost to Follow-up|1|||
127495192|NCT00819156|458773196|FG002|Overall Study|Lost to Follow-up|0|||
127495193|NCT00819156|458773197|FG003|Overall Study|Lost to Follow-up|0|||
127495194|NCT00819156|458773198|FG004|Overall Study|Lost to Follow-up|0|||
127495195|NCT00819156|458773199|FG005|Overall Study|Lost to Follow-up|2|||
127495196|NCT00819156|458773194|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
127495197|NCT00819156|458773195|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
127495198|NCT00819156|458773196|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
127495199|NCT00819156|458773197|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
127977387|NCT02122770|460538299|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
127495200|NCT00819156|458773198|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
127495201|NCT00819156|458773199|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
127495202|NCT00819156|458773194|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
127495203|NCT00819156|458773195|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
127495204|NCT00819156|458773196|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
127495205|NCT00819156|458773197|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
127495206|NCT00819156|458773198|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
127495207|NCT00819156|458773199|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
127495208|NCT00819156|458773194|FG000|Overall Study|Prostate-specific antigen progression|0|||
127495209|NCT00819156|458773195|FG001|Overall Study|Prostate-specific antigen progression|0|||
127495210|NCT00819156|458773196|FG002|Overall Study|Prostate-specific antigen progression|0|||
127495211|NCT00819156|458773197|FG003|Overall Study|Prostate-specific antigen progression|0|||
127495212|NCT00819156|458773198|FG004|Overall Study|Prostate-specific antigen progression|1|||
127495213|NCT00819156|458773199|FG005|Overall Study|Prostate-specific antigen progression|0|||
127495214|NCT00790582|458773200|FG000|Overall Study|Death|14|||
127495215|NCT00790582|458773201|FG001|Overall Study|Death|32|||
127495216|NCT00790582|458773200|FG000|Overall Study|Physician Decision|7|||
127495217|NCT00790582|458773201|FG001|Overall Study|Physician Decision|1|||
127495218|NCT00790582|458773200|FG000|Overall Study|Lost to Follow-up|3|||
127495219|NCT00790582|458773201|FG001|Overall Study|Lost to Follow-up|3|||
127495220|NCT00790582|458773200|FG000|Overall Study|Withdrawal by Subject|7|||
127495221|NCT00790582|458773201|FG001|Overall Study|Withdrawal by Subject|51|||
127495222|NCT01575808|458773204|FG000|Overall Study|Death|2|||
127495223|NCT01575808|458773205|FG001|Overall Study|Death|0|||
127495224|NCT01575808|458773204|FG000|Overall Study|Withdrawal by Subject|1|||
127495225|NCT01575808|458773205|FG001|Overall Study|Withdrawal by Subject|0|||
127495226|NCT02263326|458774957|FG000|Overall Study|Lost to Follow-up|1|||
127495227|NCT02263326|458774958|FG001|Overall Study|Lost to Follow-up|1|||
127495228|NCT01893411|458774959|FG000|Overall Study|Protocol Violation|1|||
127495229|NCT01893411|458774960|FG001|Overall Study|Protocol Violation|0|||
127495230|NCT01893411|458774961|FG002|Overall Study|Protocol Violation|0|||
127495231|NCT01893411|458774959|FG000|Overall Study|Physician Decision|1|||
127495232|NCT01893411|458774960|FG001|Overall Study|Physician Decision|1|||
127495233|NCT01893411|458774961|FG002|Overall Study|Physician Decision|2|||
127495234|NCT01893411|458774959|FG000|Overall Study|Lack of Efficacy|2|||
127495235|NCT01893411|458774960|FG001|Overall Study|Lack of Efficacy|1|||
127495236|NCT01893411|458774961|FG002|Overall Study|Lack of Efficacy|0|||
127495237|NCT01893411|458774959|FG000|Overall Study|Other|3|||
127495238|NCT01893411|458774960|FG001|Overall Study|Other|1|||
127495239|NCT01893411|458774961|FG002|Overall Study|Other|3|||
127495240|NCT01893411|458774959|FG000|Overall Study|Adverse Event|1|||
127495241|NCT01893411|458774960|FG001|Overall Study|Adverse Event|0|||
127495242|NCT01893411|458774961|FG002|Overall Study|Adverse Event|0|||
127495243|NCT01893411|458774959|FG000|Overall Study|Withdrawal by Subject|7|||
127495244|NCT01893411|458774960|FG001|Overall Study|Withdrawal by Subject|4|||
127495245|NCT01893411|458774961|FG002|Overall Study|Withdrawal by Subject|3|||
127495246|NCT01893411|458774959|FG000|Overall Study|Lost to Follow-up|2|||
127495247|NCT01893411|458774960|FG001|Overall Study|Lost to Follow-up|0|||
127495248|NCT01893411|458774961|FG002|Overall Study|Lost to Follow-up|1|||
127495249|NCT02397915|458774962|FG000|Period 1|Protocol Violation|0|||
127495250|NCT02397915|458774963|FG001|Period 1|Protocol Violation|1|||
127495251|NCT02397915|458774964|FG002|Period 1|Protocol Violation|0|||
127495252|NCT02397915|458774965|FG003|Period 1|Protocol Violation|0|||
127495253|NCT02397915|458774962|FG000|Period 1|Physician Decision|1|||
127495254|NCT02397915|458774963|FG001|Period 1|Physician Decision|0|||
127495255|NCT02397915|458774964|FG002|Period 1|Physician Decision|0|||
127495256|NCT02397915|458774965|FG003|Period 1|Physician Decision|0|||
127495257|NCT03292874|458774966|FG000|Overall Study|Due to pandemic|5|||
127495258|NCT00933608|458774967|FG000|Overall Study|Adverse Event|4|||
127495259|NCT00933608|458774968|FG001|Overall Study|Adverse Event|2|||
127495260|NCT00933608|458774967|FG000|Overall Study|Physician Decision|1|||
127495261|NCT00933608|458774968|FG001|Overall Study|Physician Decision|0|||
127495262|NCT03053440|458774973|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
127495263|NCT03053440|458774974|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
127495264|NCT03053440|458774973|FG000|Overall Study|Death|18|||
127495265|NCT03053440|458774974|FG001|Overall Study|Death|14|||
127495266|NCT03053440|458774973|FG000|Overall Study|Withdrawal by Subject|9|||
127495267|NCT03053440|458774974|FG001|Overall Study|Withdrawal by Subject|8|||
127495268|NCT03053440|458774973|FG000|Overall Study|Lost to Follow-up|1|||
127495269|NCT03053440|458774974|FG001|Overall Study|Lost to Follow-up|0|||
127495270|NCT03053440|458774973|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
127495271|NCT03053440|458774974|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
127495272|NCT03053440|458774973|FG000|Overall Study|Physician Decision|2|||
127495273|NCT03053440|458774974|FG001|Overall Study|Physician Decision|1|||
127495274|NCT03053440|458774973|FG000|Overall Study|Participant Randomized but died before dosing|1|||
127495275|NCT03053440|458774974|FG001|Overall Study|Participant Randomized but died before dosing|0|||
127495276|NCT04908384|458774975|FG000|Overall Study|Lost to Follow-up|4|||
127495277|NCT04908384|458774976|FG001|Overall Study|Lost to Follow-up|4|||
127495278|NCT04908384|458774977|FG002|Overall Study|Lost to Follow-up|0|||
127495279|NCT04908384|458774978|FG003|Overall Study|Lost to Follow-up|0|||
127495280|NCT00430989|458774979|FG000|Overall Study|Lost to Follow-up|2|||
127495281|NCT00430989|458774980|FG001|Overall Study|Lost to Follow-up|3|||
127495282|NCT00430989|458774979|FG000|Overall Study|Withdrawal by Subject|15|||
127495283|NCT00430989|458774980|FG001|Overall Study|Withdrawal by Subject|14|||
127495284|NCT00430989|458774979|FG000|Overall Study|Protocol Violation|30|||
127495285|NCT00430989|458774980|FG001|Overall Study|Protocol Violation|37|||
127495286|NCT00430989|458774979|FG000|Overall Study|Not eligible|13|||
127495287|NCT00430989|458774980|FG001|Overall Study|Not eligible|6|||
127495288|NCT01701362|458774981|FG000|Overall Study|Adverse events not related to study drug|1|||
127495289|NCT01701362|458774982|FG001|Overall Study|Adverse events not related to study drug|6|||
127495290|NCT01701362|458774981|FG000|Overall Study|Adverse events related to study drug|12|||
127495291|NCT01701362|458774982|FG001|Overall Study|Adverse events related to study drug|10|||
127495292|NCT01701362|458774981|FG000|Overall Study|Protocol Violation|5|||
127495293|NCT01701362|458774982|FG001|Overall Study|Protocol Violation|3|||
127495294|NCT01701362|458774981|FG000|Overall Study|No longer willing to participate|8|||
127495295|NCT01701362|458774982|FG001|Overall Study|No longer willing to participate|14|||
127495296|NCT01701362|458774981|FG000|Overall Study|Lost to Follow-up|6|||
127495297|NCT01701362|458774982|FG001|Overall Study|Lost to Follow-up|9|||
127495298|NCT01701362|458774981|FG000|Overall Study|Insufficient clinical response|6|||
127495299|NCT01701362|458774982|FG001|Overall Study|Insufficient clinical response|6|||
127495300|NCT01701362|458774981|FG000|Overall Study|Death|0|||
127495301|NCT01701362|458774982|FG001|Overall Study|Death|1|||
127495302|NCT01701362|458774981|FG000|Overall Study|Randomized but not treated|1|||
127495303|NCT01701362|458774982|FG001|Overall Study|Randomized but not treated|2|||
127495304|NCT01701362|458774981|FG000|Overall Study|Reasons other than those mentioned above|3|||
127495305|NCT01701362|458774982|FG001|Overall Study|Reasons other than those mentioned above|5|||
127495306|NCT00485758|458774988|FG000|Overall Study|Adverse Event|102|||
127495307|NCT00485758|458774989|FG001|Overall Study|Adverse Event|31|||
127495308|NCT00485758|458774988|FG000|Overall Study|Death|0|||
127495309|NCT00485758|458774989|FG001|Overall Study|Death|1|||
127495310|NCT00485758|458774988|FG000|Overall Study|Lost to Follow-up|5|||
127495311|NCT00485758|458774989|FG001|Overall Study|Lost to Follow-up|1|||
127495312|NCT00485758|458774988|FG000|Overall Study|Physician Decision|3|||
127495313|NCT00485758|458774989|FG001|Overall Study|Physician Decision|3|||
127495314|NCT00485758|458774988|FG000|Overall Study|Protocol Violation|11|||
127495315|NCT00485758|458774989|FG001|Overall Study|Protocol Violation|2|||
127495316|NCT00485758|458774988|FG000|Overall Study|Withdrawal by Subject|32|||
127495317|NCT00485758|458774989|FG001|Overall Study|Withdrawal by Subject|27|||
127495318|NCT00485758|458774988|FG000|Overall Study|Study Terminated by Sponsor|3|||
127495319|NCT00485758|458774989|FG001|Overall Study|Study Terminated by Sponsor|0|||
127495320|NCT00654745|458774990|FG000|Overall Study|Adverse Event|12|||
127495321|NCT00654745|458774990|FG000|Overall Study|Lost to Follow-up|7|||
127495322|NCT00654745|458774990|FG000|Overall Study|Protocol Violation|11|||
127495323|NCT00654745|458774990|FG000|Overall Study|Withdrawal by Subject|10|||
127495324|NCT00654745|458774990|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
127495325|NCT00466947|458774991|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
127495326|NCT00466947|458774992|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
127495327|NCT00466947|458774991|FG000|Study End Analysis Period|Adverse Event|35|||
127495328|NCT00466947|458774992|FG001|Study End Analysis Period|Adverse Event|43|||
127495329|NCT00466947|458774991|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
127495330|NCT00466947|458774992|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
127495331|NCT00466947|458774991|FG000|Study End Analysis Period|Physician Decision|29|||
127495332|NCT00466947|458774992|FG001|Study End Analysis Period|Physician Decision|29|||
127495333|NCT00466947|458774991|FG000|Study End Analysis Period|Protocol Violation|9|||
127495334|NCT00466947|458774992|FG001|Study End Analysis Period|Protocol Violation|17|||
127495335|NCT00466947|458774991|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
127495336|NCT00466947|458774992|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
127495337|NCT00466947|458774991|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
127495338|NCT00466947|458774992|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
127495339|NCT00466947|458774991|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
127495340|NCT00466947|458774992|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
127495341|NCT00466947|458774991|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
127495342|NCT00466947|458774992|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
127495343|NCT00383331|458774993|FG000|Overall Study|Protocol Violation|0|||
127495344|NCT00383331|458774994|FG001|Overall Study|Protocol Violation|1|||
127495345|NCT03850093|458774995|FG000|Overall Study|Withdrawal by Subject|1|||
127495346|NCT03850093|458774996|FG001|Overall Study|Withdrawal by Subject|0|||
127495347|NCT03850093|458774997|FG002|Overall Study|Withdrawal by Subject|2|||
127495348|NCT03226249|458775002|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
127977388|NCT02122770|460538294|FG000|Part B: Standard of Care|Progressive Disease|0|||
127977389|NCT02122770|460538295|FG001|Part B: Standard of Care|Progressive Disease|0|||
127977390|NCT02122770|460538296|FG002|Part B: Standard of Care|Progressive Disease|0|||
127977391|NCT02122770|460538297|FG003|Part B: Standard of Care|Progressive Disease|0|||
127495349|NCT03226249|458775002|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
127495350|NCT03226249|458775002|FG000|Survival Follow-up|Patients still in follow-up.|30|||
127495351|NCT01532921|458775003|FG000|Overall Study|Death|3|||
127495352|NCT01532921|458775003|FG000|Overall Study|Withdrawal by Subject|2|||
127495353|NCT01532921|458775003|FG000|Overall Study|Lost to Follow-up|3|||
127495354|NCT01532921|458775003|FG000|Overall Study|Physician Decision|7|||
127495355|NCT01532921|458775003|FG000|Overall Study|Device was explanted during procedure|1|||
127495356|NCT00070109|458775004|FG000|Overall Study|Death|1|||
127495357|NCT00070109|458775005|FG001|Overall Study|Death|1|||
127495358|NCT00070109|458775006|FG002|Overall Study|Death|0|||
127495359|NCT00070109|458775007|FG003|Overall Study|Death|0|||
127495360|NCT00070109|458775008|FG004|Overall Study|Death|1|||
127495361|NCT00070109|458775004|FG000|Overall Study|Lack of Efficacy|6|||
127495362|NCT00070109|458775005|FG001|Overall Study|Lack of Efficacy|4|||
127495363|NCT00070109|458775006|FG002|Overall Study|Lack of Efficacy|5|||
127495364|NCT00070109|458775007|FG003|Overall Study|Lack of Efficacy|15|||
127495365|NCT00070109|458775008|FG004|Overall Study|Lack of Efficacy|5|||
127495366|NCT00070109|458775004|FG000|Overall Study|Physician Decision|1|||
127495367|NCT00070109|458775005|FG001|Overall Study|Physician Decision|0|||
127495368|NCT00070109|458775006|FG002|Overall Study|Physician Decision|0|||
127495369|NCT00070109|458775007|FG003|Overall Study|Physician Decision|0|||
127495370|NCT00070109|458775008|FG004|Overall Study|Physician Decision|0|||
127495371|NCT00070109|458775004|FG000|Overall Study|Withdrawal by Subject|0|||
127495372|NCT00070109|458775005|FG001|Overall Study|Withdrawal by Subject|1|||
127495373|NCT00070109|458775006|FG002|Overall Study|Withdrawal by Subject|1|||
127495374|NCT00070109|458775007|FG003|Overall Study|Withdrawal by Subject|0|||
127495375|NCT00070109|458775008|FG004|Overall Study|Withdrawal by Subject|0|||
127495376|NCT00070109|458775004|FG000|Overall Study|Adverse Event|0|||
127495377|NCT00070109|458775005|FG001|Overall Study|Adverse Event|0|||
127495378|NCT00070109|458775006|FG002|Overall Study|Adverse Event|2|||
127495379|NCT00070109|458775007|FG003|Overall Study|Adverse Event|4|||
127495380|NCT00070109|458775008|FG004|Overall Study|Adverse Event|2|||
127495381|NCT00070109|458775004|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
127495382|NCT00070109|458775005|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
127495383|NCT00070109|458775006|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
127495384|NCT00070109|458775007|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
127495385|NCT00070109|458775008|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
127495386|NCT00624468|458775011|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
127495387|NCT00624468|458775012|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
127495388|NCT00624468|458775013|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
127495389|NCT00624468|458775014|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
127495390|NCT00624468|458775011|FG000|Double-blind Period|Withdrew Prematurely|1|||
127495391|NCT00624468|458775012|FG001|Double-blind Period|Withdrew Prematurely|1|||
127495392|NCT00624468|458775013|FG002|Double-blind Period|Withdrew Prematurely|0|||
127495393|NCT00624468|458775014|FG003|Double-blind Period|Withdrew Prematurely|0|||
127495394|NCT00624468|458775011|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
127495395|NCT00624468|458775012|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
127495396|NCT00624468|458775013|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
127495397|NCT00624468|458775014|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
127495398|NCT00624468|458775011|FG000|Safety Follow-up (SFU) Period|Other|0|||
127495399|NCT00624468|458775012|FG001|Safety Follow-up (SFU) Period|Other|0|||
127495400|NCT00624468|458775013|FG002|Safety Follow-up (SFU) Period|Other|1|||
127495401|NCT00624468|458775014|FG003|Safety Follow-up (SFU) Period|Other|1|||
127495402|NCT02550288|458775017|FG000|Overall Study|Adverse Event|0|||
127495403|NCT02550288|458775018|FG001|Overall Study|Adverse Event|1|||
127495404|NCT02550288|458775019|FG002|Overall Study|Adverse Event|0|||
127495405|NCT02550288|458775020|FG003|Overall Study|Adverse Event|0|||
127495406|NCT02550288|458775021|FG004|Overall Study|Adverse Event|0|||
127495407|NCT02550288|458775017|FG000|Overall Study|Physician Decision|0|||
127495408|NCT02550288|458775018|FG001|Overall Study|Physician Decision|0|||
127495409|NCT02550288|458775019|FG002|Overall Study|Physician Decision|0|||
127495410|NCT02550288|458775020|FG003|Overall Study|Physician Decision|1|||
127495411|NCT02550288|458775021|FG004|Overall Study|Physician Decision|0|||
127495412|NCT02550288|458775017|FG000|Overall Study|Protocol Violation|2|||
127495413|NCT02550288|458775018|FG001|Overall Study|Protocol Violation|2|||
127495414|NCT02550288|458775019|FG002|Overall Study|Protocol Violation|1|||
127977392|NCT02122770|460538298|FG004|Part B: Standard of Care|Progressive Disease|10|||
127977393|NCT02122770|460538299|FG005|Part B: Standard of Care|Progressive Disease|8|||
127977394|NCT00727844|460538301|FG000|Initial Randomization|Physician Decision|2|||
127977395|NCT00727844|460538302|FG001|Initial Randomization|Physician Decision|0|||
127977396|NCT00727844|460538303|FG002|Initial Randomization|Physician Decision|0|||
127977397|NCT00727844|460538304|FG003|Initial Randomization|Physician Decision|0|||
127977398|NCT00373958|460538305|FG000|Infant Series|Withdrawal by Subject|13|||
127495415|NCT02550288|458775020|FG003|Overall Study|Protocol Violation|0|||
127495416|NCT02550288|458775021|FG004|Overall Study|Protocol Violation|3|||
127495417|NCT02550288|458775017|FG000|Overall Study|Participant moved|0|||
127495418|NCT02550288|458775018|FG001|Overall Study|Participant moved|0|||
127495419|NCT02550288|458775019|FG002|Overall Study|Participant moved|0|||
127495420|NCT02550288|458775020|FG003|Overall Study|Participant moved|1|||
127495421|NCT02550288|458775021|FG004|Overall Study|Participant moved|0|||
127495422|NCT02550288|458775017|FG000|Overall Study|Withdrawal by Subject|0|||
127495423|NCT02550288|458775018|FG001|Overall Study|Withdrawal by Subject|0|||
127495424|NCT02550288|458775019|FG002|Overall Study|Withdrawal by Subject|0|||
127495425|NCT02550288|458775020|FG003|Overall Study|Withdrawal by Subject|1|||
127495426|NCT02550288|458775021|FG004|Overall Study|Withdrawal by Subject|0|||
127495427|NCT04482439|458775023|FG000|Overall Study|Lost to Follow-up|1|||
127495428|NCT04482439|458775023|FG000|Overall Study|Unrelated illness|1|||
127495429|NCT02318368|458775024|FG000|Overall Study|Withdrawal by Subject|2|||
127495430|NCT02318368|458775025|FG001|Overall Study|Withdrawal by Subject|0|||
127495431|NCT02318368|458775024|FG000|Overall Study|Study terminated by the sponsor|5|||
127495432|NCT02318368|458775025|FG001|Overall Study|Study terminated by the sponsor|2|||
127495433|NCT02318368|458775024|FG000|Overall Study|Death|0|||
127495434|NCT02318368|458775025|FG001|Overall Study|Death|1|||
127495435|NCT02201329|458775026|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
127495436|NCT02201329|458775026|FG000|Overall Study|Withdrawal by Subject|2|||
127495437|NCT03629223|458775027|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
127495438|NCT03629223|458775028|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
127495439|NCT03629223|458775029|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
127495440|NCT03629223|458775030|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
127495441|NCT03629223|458775031|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
127495442|NCT03629223|458775032|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
127495443|NCT03629223|458775027|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
127495444|NCT03629223|458775028|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
127495445|NCT03629223|458775029|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
127495446|NCT03629223|458775030|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
127495447|NCT03629223|458775031|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
127495448|NCT03629223|458775032|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
127495449|NCT03629223|458775027|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
127495450|NCT03629223|458775028|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
127495451|NCT03629223|458775029|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
127495452|NCT03629223|458775030|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
127495453|NCT03629223|458775031|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
127495454|NCT03629223|458775032|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
127495455|NCT03629223|458775027|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
127495456|NCT03629223|458775028|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
127495457|NCT03629223|458775029|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
127495458|NCT03629223|458775030|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
127495459|NCT03629223|458775031|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
127495460|NCT03629223|458775032|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
127495461|NCT03629223|458775027|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
127495462|NCT03629223|458775028|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
127495463|NCT03629223|458775029|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
127495464|NCT03629223|458775030|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
127495465|NCT03629223|458775031|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
127495466|NCT03629223|458775032|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
127495467|NCT01534351|458775033|FG000|Overall Study|Study Terminated Early|1|||
127495468|NCT01534351|458775034|FG001|Overall Study|Study Terminated Early|0|||
127495469|NCT01534351|458775035|FG002|Overall Study|Study Terminated Early|0|||
127495470|NCT02702609|458775036|FG000|Overall Study|Lost to Follow-up|8|||
127495471|NCT02702609|458775037|FG001|Overall Study|Lost to Follow-up|4|||
127495472|NCT02702609|458775036|FG000|Overall Study|Physician Decision|1|||
127495473|NCT02702609|458775037|FG001|Overall Study|Physician Decision|0|||
127495474|NCT02674464|458775038|FG000|Overall Study|Death|10|||
127495475|NCT02674464|458775039|FG001|Overall Study|Death|21|||
127495476|NCT02674464|458775038|FG000|Overall Study|Withdrawal by Subject|24|||
127495477|NCT02674464|458775039|FG001|Overall Study|Withdrawal by Subject|44|||
127495478|NCT02674464|458775038|FG000|Overall Study|Lost to Follow-up|97|||
127495479|NCT02674464|458775039|FG001|Overall Study|Lost to Follow-up|92|||
127495480|NCT02674464|458775038|FG000|Overall Study|Outside survey window|6|||
127495481|NCT02674464|458775039|FG001|Overall Study|Outside survey window|3|||
127495482|NCT00783835|458775040|FG000|Overall Study|Adverse Event|3|||
127495483|NCT00783835|458775040|FG000|Overall Study|Medical Criteria|1|||
127977399|NCT00373958|460538306|FG001|Infant Series|Withdrawal by Subject|15|||
127977400|NCT00373958|460538305|FG000|Infant Series|Failed to return|8|||
127977401|NCT00373958|460538306|FG001|Infant Series|Failed to return|13|||
127977402|NCT00373958|460538305|FG000|Infant Series|Lost to Follow-up|6|||
127495484|NCT00783835|458775040|FG000|Overall Study|Withdrawal by Subject|2|||
127495485|NCT00783835|458775040|FG000|Overall Study|Lost to Follow-up|1|||
127495486|NCT00783835|458775040|FG000|Overall Study|Participant not Adherent|3|||
127495487|NCT01945996|458775041|FG000|Overall Study|Lost to Follow-up|3|||
127495488|NCT01945996|458775042|FG001|Overall Study|Lost to Follow-up|5|||
127495489|NCT04660552|458775043|FG000|Overall Study|Withdrawal by Subject|3|||
127495490|NCT04660552|458775044|FG001|Overall Study|Withdrawal by Subject|1|||
127495491|NCT03835481|458775052|FG000|Double-blind Period|Other not stated below|0|||
127495492|NCT03835481|458775053|FG001|Double-blind Period|Other not stated below|0|||
127495493|NCT03835481|458775054|FG002|Double-blind Period|Other not stated below|0|||
127495494|NCT03835481|458775055|FG003|Double-blind Period|Other not stated below|1|||
127495495|NCT03835481|458775056|FG004|Double-blind Period|Other not stated below|1|||
127495496|NCT03835481|458775052|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
127495497|NCT03835481|458775053|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
127495498|NCT03835481|458775054|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
127495499|NCT03835481|458775055|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
127495500|NCT03835481|458775056|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
127495501|NCT03835481|458775052|FG000|Double-blind Period|Withdrawal by Subject|0|||
127495502|NCT03835481|458775053|FG001|Double-blind Period|Withdrawal by Subject|0|||
127495503|NCT03835481|458775054|FG002|Double-blind Period|Withdrawal by Subject|1|||
127495504|NCT03835481|458775055|FG003|Double-blind Period|Withdrawal by Subject|0|||
127495505|NCT03835481|458775056|FG004|Double-blind Period|Withdrawal by Subject|5|||
127495506|NCT03835481|458775052|FG000|Double-blind Period|Lost to Follow-up|0|||
127495507|NCT03835481|458775053|FG001|Double-blind Period|Lost to Follow-up|0|||
127495508|NCT03835481|458775054|FG002|Double-blind Period|Lost to Follow-up|0|||
127495509|NCT03835481|458775055|FG003|Double-blind Period|Lost to Follow-up|1|||
127495510|NCT03835481|458775056|FG004|Double-blind Period|Lost to Follow-up|0|||
127495511|NCT03835481|458775052|FG000|Double-blind Period|Protocol Violation|0|||
127495512|NCT03835481|458775053|FG001|Double-blind Period|Protocol Violation|2|||
127495513|NCT03835481|458775054|FG002|Double-blind Period|Protocol Violation|0|||
127495514|NCT03835481|458775055|FG003|Double-blind Period|Protocol Violation|1|||
127495515|NCT03835481|458775056|FG004|Double-blind Period|Protocol Violation|0|||
127495516|NCT03835481|458775052|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
127495517|NCT03835481|458775053|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
127495518|NCT03835481|458775054|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
127495519|NCT03835481|458775055|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
127495520|NCT03835481|458775056|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
127495521|NCT03835481|458775052|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
127495522|NCT03835481|458775053|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
127495523|NCT03835481|458775054|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
127495524|NCT03835481|458775055|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
127495525|NCT03835481|458775056|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
127495526|NCT03835481|458775052|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
127495527|NCT03835481|458775053|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
127495528|NCT03835481|458775054|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
127495529|NCT03835481|458775055|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
127495530|NCT03835481|458775056|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
127495531|NCT03835481|458775052|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
127495532|NCT03835481|458775053|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
127495533|NCT03835481|458775054|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
127495534|NCT03835481|458775055|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
127495535|NCT03835481|458775056|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
127495536|NCT03835481|458775052|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
127495537|NCT03835481|458775053|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
127495538|NCT03835481|458775054|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
127495539|NCT03835481|458775055|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
127495540|NCT03835481|458775056|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
127495541|NCT03835481|458775052|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
127495542|NCT03835481|458775053|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
127495543|NCT03835481|458775054|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
127495544|NCT03835481|458775055|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
127495545|NCT03835481|458775056|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
127495546|NCT02725476|458775058|FG000|Overall Study|Physician Decision|2|||
127495547|NCT02725476|458775059|FG001|Overall Study|Physician Decision|0|||
127495548|NCT02725476|458775058|FG000|Overall Study|Adverse Event|1|||
127495549|NCT02725476|458775059|FG001|Overall Study|Adverse Event|1|||
127495550|NCT00191945|458775060|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
127495551|NCT00191945|458775061|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
127495552|NCT00191945|458775060|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
127495553|NCT00191945|458775061|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
127495554|NCT00191945|458775060|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
127977403|NCT00373958|460538306|FG001|Infant Series|Lost to Follow-up|5|||
127977404|NCT00373958|460538305|FG000|Infant Series|Protocol Violation|3|||
127977405|NCT00373958|460538306|FG001|Infant Series|Protocol Violation|7|||
127977406|NCT00373958|460538305|FG000|Infant Series|Lost Kaiser coverage|4|||
127977407|NCT00373958|460538306|FG001|Infant Series|Lost Kaiser coverage|0|||
127977408|NCT00373958|460538305|FG000|Infant Series|Child relocated|1|||
127495555|NCT00191945|458775061|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
127495556|NCT00191945|458775060|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
127495557|NCT00191945|458775061|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
127495558|NCT04188834|458775072|FG000|Overall Study|Participants did not complete enough proportion of experiment(s) to be included in analysis|4|||
127495559|NCT01030952|458775073|FG000|Overall Study|Protocol Violation|0|||
127495560|NCT01030952|458775074|FG001|Overall Study|Protocol Violation|1|||
127495561|NCT01030952|458775073|FG000|Overall Study|Informed consent withdrawal|1|||
127495562|NCT01030952|458775074|FG001|Overall Study|Informed consent withdrawal|0|||
127495563|NCT01030952|458775073|FG000|Overall Study|Lost to Follow-up|0|||
127495564|NCT01030952|458775074|FG001|Overall Study|Lost to Follow-up|1|||
127495565|NCT01030952|458775073|FG000|Overall Study|Unexplained|1|||
127495566|NCT01030952|458775074|FG001|Overall Study|Unexplained|1|||
127495567|NCT00391430|458775075|FG000|Overall Study|Withdrawal by Subject|3|||
127495568|NCT00391430|458775076|FG001|Overall Study|Withdrawal by Subject|0|||
127495569|NCT00391430|458775077|FG002|Overall Study|Withdrawal by Subject|12|||
127495570|NCT00958347|458775081|FG000|Overall Study|Death|43|||
127495571|NCT00958347|458775081|FG000|Overall Study|Withdrawal by Subject|23|||
127495572|NCT00958347|458775081|FG000|Overall Study|Lost to Follow-up|15|||
127495573|NCT00958347|458775081|FG000|Overall Study|revision/removal|10|||
127495574|NCT00958347|458775081|FG000|Overall Study|study termination|135|||
127495575|NCT02470585|458775086|FG000|Overall Study|Death|224|||
127495576|NCT02470585|458775087|FG001|Overall Study|Death|227|||
127495577|NCT02470585|458775088|FG002|Overall Study|Death|199|||
127495578|NCT02470585|458775086|FG000|Overall Study|Withdrew consent|21|||
127495579|NCT02470585|458775087|FG001|Overall Study|Withdrew consent|22|||
127495580|NCT02470585|458775088|FG002|Overall Study|Withdrew consent|31|||
127495581|NCT02470585|458775086|FG000|Overall Study|Lost to Follow-up|8|||
127495582|NCT02470585|458775087|FG001|Overall Study|Lost to Follow-up|15|||
127495583|NCT02470585|458775088|FG002|Overall Study|Lost to Follow-up|13|||
127495584|NCT02470585|458775086|FG000|Overall Study|Sponsor discontinued study|117|||
127495585|NCT02470585|458775087|FG001|Overall Study|Sponsor discontinued study|110|||
127495586|NCT02470585|458775088|FG002|Overall Study|Sponsor discontinued study|122|||
127495587|NCT02470585|458775086|FG000|Overall Study|Other, not specified|5|||
127495588|NCT02470585|458775087|FG001|Overall Study|Other, not specified|7|||
127495589|NCT02470585|458775088|FG002|Overall Study|Other, not specified|14|||
127495590|NCT02470585|458775086|FG000|Overall Study|Missing due to site non-compliance|0|||
127495591|NCT02470585|458775087|FG001|Overall Study|Missing due to site non-compliance|2|||
127495592|NCT02470585|458775088|FG002|Overall Study|Missing due to site non-compliance|3|||
127495593|NCT03497039|458775089|FG000|Overall Study|Withdrawal by Subject|1|||
127495594|NCT03497039|458775090|FG001|Overall Study|Withdrawal by Subject|0|||
127495595|NCT03497039|458775089|FG000|Overall Study|Protocol Violation|0|||
127495596|NCT03497039|458775090|FG001|Overall Study|Protocol Violation|1|||
127495597|NCT02146131|458775091|FG000|Overall Study|Physician Decision|61|||
127495598|NCT02146131|458775092|FG001|Overall Study|Physician Decision|56|||
127495599|NCT00465972|458775095|FG000|Overall Study|Withdrawal by Subject|2|||
127495600|NCT00465972|458775096|FG001|Overall Study|Withdrawal by Subject|1|||
127495601|NCT00861692|458775097|FG000|Overall Study|Death|6|||
127495602|NCT03292640|458775098|FG000|Overall Study|Withdrawal by Subject|17|||
127495603|NCT03292640|458775099|FG001|Overall Study|Withdrawal by Subject|16|||
127495604|NCT03292640|458775098|FG000|Overall Study|Adverse Event|20|||
127495605|NCT03292640|458775099|FG001|Overall Study|Adverse Event|2|||
127495606|NCT03292640|458775098|FG000|Overall Study|Lost to Follow-up|24|||
127495607|NCT03292640|458775099|FG001|Overall Study|Lost to Follow-up|24|||
127495608|NCT02218697|458775100|FG000|Overall Study|Adverse Event|0|||
127495609|NCT02218697|458775101|FG001|Overall Study|Adverse Event|2|||
127495610|NCT02218697|458775100|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
127495611|NCT02218697|458775101|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
127495612|NCT02218697|458775100|FG000|Overall Study|Withdrawal by Subject|2|||
127495613|NCT02218697|458775101|FG001|Overall Study|Withdrawal by Subject|3|||
127495614|NCT04380753|458775102|FG000|Overall Study|Participants continuing study|4|||
127495615|NCT04380753|458775102|FG000|Overall Study|Death|2|||
127495616|NCT03306433|458775105|FG000|Overall Study|Lost to Follow-up|3|||
127495617|NCT03306433|458775105|FG000|Overall Study|Patient did not have teeth extracted|1|||
127495618|NCT03306433|458775105|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
127495619|NCT00803595|458775106|FG000|Overall Study|Adverse Event|3|||
127495620|NCT00803595|458775107|FG001|Overall Study|Adverse Event|4|||
127495621|NCT00803595|458775108|FG002|Overall Study|Adverse Event|1|||
127495622|NCT00803595|458775106|FG000|Overall Study|Protocol Violation|7|||
127495623|NCT00803595|458775107|FG001|Overall Study|Protocol Violation|2|||
127495624|NCT00803595|458775108|FG002|Overall Study|Protocol Violation|12|||
127495625|NCT00803595|458775106|FG000|Overall Study|Withdrawal by Subject|5|||
127495626|NCT00803595|458775107|FG001|Overall Study|Withdrawal by Subject|2|||
127495627|NCT00803595|458775108|FG002|Overall Study|Withdrawal by Subject|3|||
127495628|NCT00294671|458776848|FG000|Overall Study|Lack of Efficacy|11|||
127495629|NCT00294671|458776849|FG001|Overall Study|Lack of Efficacy|23|||
127495630|NCT00294671|458776848|FG000|Overall Study|Liver transplant|7|||
127495631|NCT00294671|458776849|FG001|Overall Study|Liver transplant|9|||
127495632|NCT00294671|458776848|FG000|Overall Study|Drug related adverse event (AE)|4|||
127495633|NCT00294671|458776849|FG001|Overall Study|Drug related adverse event (AE)|2|||
127495634|NCT00294671|458776848|FG000|Overall Study|Non-drug related AE|3|||
127495635|NCT00294671|458776849|FG001|Overall Study|Non-drug related AE|2|||
127495636|NCT00294671|458776848|FG000|Overall Study|Lost to Follow-up|1|||
127495637|NCT00294671|458776849|FG001|Overall Study|Lost to Follow-up|3|||
127495638|NCT00294671|458776848|FG000|Overall Study|Non-compliance|1|||
127495639|NCT00294671|458776849|FG001|Overall Study|Non-compliance|0|||
127495640|NCT00294671|458776848|FG000|Overall Study|Death|0|||
127495641|NCT00294671|458776849|FG001|Overall Study|Death|1|||
127495642|NCT02403817|458776853|FG000|Overall Study|Withdrawal by Subject|5|||
127495643|NCT02403817|458776854|FG001|Overall Study|Withdrawal by Subject|0|||
127495644|NCT00570778|458776855|FG000|Overall Study|Protocol deviation|2|||
127495645|NCT00570778|458776856|FG001|Overall Study|Protocol deviation|1|||
127495646|NCT00570778|458776857|FG002|Overall Study|Protocol deviation|2|||
127495647|NCT00570778|458776858|FG003|Overall Study|Protocol deviation|2|||
127495648|NCT00570778|458776855|FG000|Overall Study|Adverse Event|0|||
127495649|NCT00570778|458776856|FG001|Overall Study|Adverse Event|1|||
127495650|NCT00570778|458776857|FG002|Overall Study|Adverse Event|4|||
127495651|NCT00570778|458776858|FG003|Overall Study|Adverse Event|1|||
127495652|NCT00570778|458776855|FG000|Overall Study|Subject withdrew consent|0|||
127495653|NCT00570778|458776856|FG001|Overall Study|Subject withdrew consent|1|||
127495654|NCT00570778|458776857|FG002|Overall Study|Subject withdrew consent|0|||
127495655|NCT00570778|458776858|FG003|Overall Study|Subject withdrew consent|1|||
127495656|NCT00570778|458776855|FG000|Overall Study|Abnormal test procedure|1|||
127495657|NCT00570778|458776856|FG001|Overall Study|Abnormal test procedure|0|||
127495658|NCT00570778|458776857|FG002|Overall Study|Abnormal test procedure|0|||
127495659|NCT00570778|458776858|FG003|Overall Study|Abnormal test procedure|0|||
127495660|NCT00570778|458776855|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
127495661|NCT00570778|458776856|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
127495662|NCT00570778|458776857|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
127495663|NCT00570778|458776858|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
127495664|NCT00570778|458776855|FG000|Overall Study|Lost to Follow-up|0|||
127495665|NCT00570778|458776856|FG001|Overall Study|Lost to Follow-up|0|||
127495666|NCT00570778|458776857|FG002|Overall Study|Lost to Follow-up|1|||
127495667|NCT00570778|458776858|FG003|Overall Study|Lost to Follow-up|0|||
127495668|NCT00570778|458776855|FG000|Overall Study|Subject no longer requires study drug|0|||
127495669|NCT00570778|458776856|FG001|Overall Study|Subject no longer requires study drug|1|||
127495670|NCT00570778|458776857|FG002|Overall Study|Subject no longer requires study drug|0|||
127495671|NCT00570778|458776858|FG003|Overall Study|Subject no longer requires study drug|0|||
127495672|NCT02120781|458776863|FG000|Overall Study|Physician Decision|2|||
127495673|NCT02120781|458776864|FG001|Overall Study|Physician Decision|0|||
127495674|NCT02120781|458776863|FG000|Overall Study|Completion not documented|2|||
127495675|NCT02120781|458776864|FG001|Overall Study|Completion not documented|1|||
127495676|NCT00984165|458776867|FG000|Overall Study|Death on study|2|||
127495677|NCT00984165|458776868|FG001|Overall Study|Death on study|0|||
127495678|NCT00984165|458776869|FG002|Overall Study|Death on study|0|||
127495679|NCT00984165|458776870|FG003|Overall Study|Death on study|0|||
127495680|NCT00984165|458776867|FG000|Overall Study|Disease progression on study|5|||
127495681|NCT00984165|458776868|FG001|Overall Study|Disease progression on study|1|||
127495682|NCT00984165|458776869|FG002|Overall Study|Disease progression on study|0|||
127495683|NCT00984165|458776870|FG003|Overall Study|Disease progression on study|0|||
127495684|NCT00984165|458776867|FG000|Overall Study|Death of recipient|0|||
127495685|NCT00984165|458776868|FG001|Overall Study|Death of recipient|0|||
127495686|NCT00984165|458776869|FG002|Overall Study|Death of recipient|0|||
127495687|NCT00984165|458776870|FG003|Overall Study|Death of recipient|1|||
127495688|NCT00984165|458776867|FG000|Overall Study|New protocol|0|||
127495689|NCT00984165|458776868|FG001|Overall Study|New protocol|0|||
127495690|NCT00984165|458776869|FG002|Overall Study|New protocol|0|||
127495691|NCT00984165|458776870|FG003|Overall Study|New protocol|1|||
127495692|NCT00984165|458776867|FG000|Overall Study|P+/donor pair removed from protocol|0|||
127495693|NCT00984165|458776868|FG001|Overall Study|P+/donor pair removed from protocol|0|||
127495694|NCT00984165|458776869|FG002|Overall Study|P+/donor pair removed from protocol|0|||
127495695|NCT00984165|458776870|FG003|Overall Study|P+/donor pair removed from protocol|1|||
127495696|NCT00984165|458776867|FG000|Overall Study|removed with a pair recipient|0|||
127495697|NCT00984165|458776868|FG001|Overall Study|removed with a pair recipient|0|||
127495698|NCT00984165|458776869|FG002|Overall Study|removed with a pair recipient|0|||
127495699|NCT00984165|458776870|FG003|Overall Study|removed with a pair recipient|1|||
127495700|NCT01995526|458776871|FG000|Overall Study|Physician Decision|1|||
127495701|NCT02229825|458776877|FG000|Overall Study|Personal Reasons|0|||
127495702|NCT02229825|458776878|FG001|Overall Study|Personal Reasons|1|||
127495703|NCT02229825|458776877|FG000|Overall Study|Refused continuing medication|7|||
127495704|NCT02229825|458776878|FG001|Overall Study|Refused continuing medication|6|||
127495705|NCT02229825|458776877|FG000|Overall Study|Lost to Follow-up|1|||
127495706|NCT02229825|458776878|FG001|Overall Study|Lost to Follow-up|2|||
127495707|NCT02229825|458776877|FG000|Overall Study|Protocol Violation|1|||
127495708|NCT02229825|458776878|FG001|Overall Study|Protocol Violation|1|||
127495709|NCT02229825|458776877|FG000|Overall Study|Lack of Efficacy|4|||
127495710|NCT02229825|458776878|FG001|Overall Study|Lack of Efficacy|10|||
127495711|NCT02229825|458776877|FG000|Overall Study|Adverse Event|11|||
127495712|NCT02229825|458776878|FG001|Overall Study|Adverse Event|9|||
127495713|NCT02229825|458776877|FG000|Overall Study|Not treated|0|||
127495714|NCT02229825|458776878|FG001|Overall Study|Not treated|1|||
127495715|NCT00104416|458776879|FG000|Double-Blind Phase|Adverse Event|2|||
127495716|NCT00104416|458776880|FG001|Double-Blind Phase|Adverse Event|1|||
127495717|NCT00104416|458776881|FG002|Double-Blind Phase|Adverse Event|0|||
127495718|NCT00104416|458776882|FG003|Double-Blind Phase|Adverse Event|0|||
127495719|NCT00104416|458776883|FG004|Double-Blind Phase|Adverse Event|0|||
127495720|NCT00104416|458776879|FG000|Double-Blind Phase|Lost to Follow-up|0|||
127495721|NCT00104416|458776880|FG001|Double-Blind Phase|Lost to Follow-up|1|||
127495722|NCT00104416|458776881|FG002|Double-Blind Phase|Lost to Follow-up|0|||
127495723|NCT00104416|458776882|FG003|Double-Blind Phase|Lost to Follow-up|0|||
127495724|NCT00104416|458776883|FG004|Double-Blind Phase|Lost to Follow-up|0|||
127495725|NCT00104416|458776879|FG000|Double-Blind Phase|Protocol Violation|0|||
127495726|NCT00104416|458776880|FG001|Double-Blind Phase|Protocol Violation|1|||
127495727|NCT00104416|458776881|FG002|Double-Blind Phase|Protocol Violation|0|||
127495728|NCT00104416|458776882|FG003|Double-Blind Phase|Protocol Violation|0|||
127495729|NCT00104416|458776883|FG004|Double-Blind Phase|Protocol Violation|0|||
127495730|NCT00104416|458776879|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
127495731|NCT00104416|458776880|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
127495732|NCT00104416|458776881|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
127495733|NCT00104416|458776882|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
127495734|NCT00104416|458776883|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
127495735|NCT00104416|458776879|FG000|Double-Blind Phase|Pregnancy|1|||
127495736|NCT00104416|458776880|FG001|Double-Blind Phase|Pregnancy|0|||
127495737|NCT00104416|458776881|FG002|Double-Blind Phase|Pregnancy|0|||
127495738|NCT00104416|458776882|FG003|Double-Blind Phase|Pregnancy|0|||
127495739|NCT00104416|458776883|FG004|Double-Blind Phase|Pregnancy|0|||
127495740|NCT00104416|458776879|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
127495741|NCT00104416|458776880|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
127495742|NCT00104416|458776881|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
127495743|NCT00104416|458776882|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
127495744|NCT00104416|458776883|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
127495745|NCT00104416|458776879|FG000|Continuation Phase|Adverse Event|0|||
127495746|NCT00104416|458776880|FG001|Continuation Phase|Adverse Event|0|||
127495747|NCT00104416|458776881|FG002|Continuation Phase|Adverse Event|2|||
127495748|NCT00104416|458776882|FG003|Continuation Phase|Adverse Event|0|||
127495749|NCT00104416|458776883|FG004|Continuation Phase|Adverse Event|2|||
127495750|NCT00104416|458776879|FG000|Continuation Phase|Lost to Follow-up|0|||
127495751|NCT00104416|458776880|FG001|Continuation Phase|Lost to Follow-up|0|||
127495752|NCT00104416|458776881|FG002|Continuation Phase|Lost to Follow-up|1|||
127495753|NCT00104416|458776882|FG003|Continuation Phase|Lost to Follow-up|0|||
127495754|NCT00104416|458776883|FG004|Continuation Phase|Lost to Follow-up|1|||
127495755|NCT00104416|458776879|FG000|Continuation Phase|Withdrawal by Subject|0|||
127495756|NCT00104416|458776880|FG001|Continuation Phase|Withdrawal by Subject|0|||
127495757|NCT00104416|458776881|FG002|Continuation Phase|Withdrawal by Subject|2|||
127495758|NCT00104416|458776882|FG003|Continuation Phase|Withdrawal by Subject|1|||
127495759|NCT00104416|458776883|FG004|Continuation Phase|Withdrawal by Subject|1|||
127495760|NCT00104416|458776879|FG000|Continuation Phase|Pregnancy|0|||
127495761|NCT00104416|458776880|FG001|Continuation Phase|Pregnancy|0|||
127495762|NCT00104416|458776881|FG002|Continuation Phase|Pregnancy|1|||
127495763|NCT00104416|458776882|FG003|Continuation Phase|Pregnancy|1|||
127495764|NCT00104416|458776883|FG004|Continuation Phase|Pregnancy|0|||
127495765|NCT00104416|458776879|FG000|Continuation Phase|Non-compliance|0|||
127495766|NCT00104416|458776880|FG001|Continuation Phase|Non-compliance|0|||
127495767|NCT00104416|458776881|FG002|Continuation Phase|Non-compliance|0|||
127495768|NCT00104416|458776882|FG003|Continuation Phase|Non-compliance|0|||
127495769|NCT00104416|458776883|FG004|Continuation Phase|Non-compliance|1|||
127495770|NCT01309997|458776884|FG000|Overall Study|Adverse Event|1|||
127495771|NCT01309997|458776885|FG001|Overall Study|Adverse Event|0|||
127495772|NCT01309997|458776884|FG000|Overall Study|Death|1|||
127495773|NCT01309997|458776885|FG001|Overall Study|Death|3|||
127495774|NCT01309997|458776884|FG000|Overall Study|Lack of Efficacy|2|||
127495775|NCT01309997|458776885|FG001|Overall Study|Lack of Efficacy|2|||
127495776|NCT01309997|458776884|FG000|Overall Study|Withdrawal by Subject|1|||
127495777|NCT01309997|458776885|FG001|Overall Study|Withdrawal by Subject|1|||
127495778|NCT03462641|458776888|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
127495779|NCT03462641|458776889|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
127495780|NCT03462641|458776888|FG000|Visit 2|Withdrawal by Subject|0|||
127495781|NCT03462641|458776889|FG001|Visit 2|Withdrawal by Subject|1|||
127495782|NCT02096952|458776893|FG000|Overall Study|Adverse Event|1|||
127495783|NCT00372619|458776894|FG000|Overall Study|Ineligible|0|||
127495784|NCT00372619|458776895|FG001|Overall Study|Ineligible|0|||
127495785|NCT00372619|458776896|FG002|Overall Study|Ineligible|0|||
127495786|NCT00372619|458776897|FG003|Overall Study|Ineligible|0|||
127495787|NCT00372619|458776898|FG004|Overall Study|Ineligible|0|||
127495788|NCT00372619|458776899|FG005|Overall Study|Ineligible|2|||
127495789|NCT00372619|458776900|FG006|Overall Study|Ineligible|0|||
127495790|NCT00372619|458776894|FG000|Overall Study|Inevaluable|0|||
127495791|NCT00372619|458776895|FG001|Overall Study|Inevaluable|0|||
127495792|NCT00372619|458776896|FG002|Overall Study|Inevaluable|0|||
127495793|NCT00372619|458776897|FG003|Overall Study|Inevaluable|0|||
127495794|NCT00372619|458776898|FG004|Overall Study|Inevaluable|0|||
127495795|NCT00372619|458776899|FG005|Overall Study|Inevaluable|1|||
127495796|NCT00372619|458776900|FG006|Overall Study|Inevaluable|0|||
127495797|NCT00066222|458776901|FG000|Overall Study|No protocol treatment received|1|||
127495798|NCT02684617|458776902|FG000|Overall Study|Adverse Event|1|||
127495799|NCT02684617|458776903|FG001|Overall Study|Adverse Event|0|||
127495800|NCT02684617|458776904|FG002|Overall Study|Adverse Event|1|||
127495801|NCT02684617|458776902|FG000|Overall Study|Death|8|||
127495802|NCT02684617|458776903|FG001|Overall Study|Death|16|||
127495803|NCT02684617|458776904|FG002|Overall Study|Death|28|||
127495804|NCT02684617|458776902|FG000|Overall Study|Withdrawal by Subject|2|||
127495805|NCT02684617|458776903|FG001|Overall Study|Withdrawal by Subject|0|||
127495806|NCT02684617|458776904|FG002|Overall Study|Withdrawal by Subject|4|||
127495807|NCT02684617|458776902|FG000|Overall Study|Screen Failure|1|||
127495808|NCT02684617|458776903|FG001|Overall Study|Screen Failure|0|||
127495809|NCT02684617|458776904|FG002|Overall Study|Screen Failure|2|||
127495810|NCT02684617|458776902|FG000|Overall Study|Study Terminated by Sponsor|6|||
127495811|NCT02684617|458776903|FG001|Overall Study|Study Terminated by Sponsor|1|||
127495812|NCT02684617|458776904|FG002|Overall Study|Study Terminated by Sponsor|5|||
127495813|NCT01524224|458776919|FG000|Overall Study|Progressive Disease|1|||
127495814|NCT01524224|458776920|FG001|Overall Study|Progressive Disease|0|||
127495815|NCT01524224|458776921|FG002|Overall Study|Progressive Disease|2|||
127495816|NCT01524224|458776922|FG003|Overall Study|Progressive Disease|1|||
127495817|NCT01524224|458776923|FG004|Overall Study|Progressive Disease|2|||
127495818|NCT01524224|458776924|FG005|Overall Study|Progressive Disease|1|||
127495819|NCT01524224|458776925|FG006|Overall Study|Progressive Disease|1|||
127495820|NCT01524224|458776926|FG007|Overall Study|Progressive Disease|5|||
127495821|NCT01524224|458776919|FG000|Overall Study|Withdrawal by Subject|2|||
127495822|NCT01524224|458776920|FG001|Overall Study|Withdrawal by Subject|0|||
127495823|NCT01524224|458776921|FG002|Overall Study|Withdrawal by Subject|0|||
127495824|NCT01524224|458776922|FG003|Overall Study|Withdrawal by Subject|0|||
127495825|NCT01524224|458776923|FG004|Overall Study|Withdrawal by Subject|0|||
127495826|NCT01524224|458776924|FG005|Overall Study|Withdrawal by Subject|0|||
127495827|NCT01524224|458776925|FG006|Overall Study|Withdrawal by Subject|2|||
127495828|NCT01524224|458776926|FG007|Overall Study|Withdrawal by Subject|0|||
127495829|NCT01524224|458776919|FG000|Overall Study|Adverse Event|0|||
127495830|NCT01524224|458776920|FG001|Overall Study|Adverse Event|1|||
127495831|NCT01524224|458776921|FG002|Overall Study|Adverse Event|0|||
127495832|NCT01524224|458776922|FG003|Overall Study|Adverse Event|0|||
127495833|NCT01524224|458776923|FG004|Overall Study|Adverse Event|0|||
127495834|NCT01524224|458776924|FG005|Overall Study|Adverse Event|1|||
127495835|NCT01524224|458776925|FG006|Overall Study|Adverse Event|0|||
127495836|NCT01524224|458776926|FG007|Overall Study|Adverse Event|0|||
127495837|NCT01524224|458776919|FG000|Overall Study|Physician Decision|0|||
127495838|NCT01524224|458776920|FG001|Overall Study|Physician Decision|0|||
127495839|NCT01524224|458776921|FG002|Overall Study|Physician Decision|0|||
127495840|NCT01524224|458776922|FG003|Overall Study|Physician Decision|1|||
127495841|NCT01524224|458776923|FG004|Overall Study|Physician Decision|1|||
127495842|NCT01524224|458776924|FG005|Overall Study|Physician Decision|0|||
127495843|NCT01524224|458776925|FG006|Overall Study|Physician Decision|0|||
127495844|NCT01524224|458776926|FG007|Overall Study|Physician Decision|1|||
127495845|NCT01524224|458776919|FG000|Overall Study|Sponsor Decision|0|||
127495846|NCT01524224|458776920|FG001|Overall Study|Sponsor Decision|0|||
127495847|NCT01524224|458776921|FG002|Overall Study|Sponsor Decision|0|||
127495848|NCT01524224|458776922|FG003|Overall Study|Sponsor Decision|0|||
127495849|NCT01524224|458776923|FG004|Overall Study|Sponsor Decision|1|||
127495850|NCT01524224|458776924|FG005|Overall Study|Sponsor Decision|0|||
127495851|NCT01524224|458776925|FG006|Overall Study|Sponsor Decision|0|||
127495852|NCT01524224|458776926|FG007|Overall Study|Sponsor Decision|0|||
127495853|NCT01066104|458776933|FG000|Overall Study|Adverse Event|1|||
127495854|NCT01066104|458776934|FG001|Overall Study|Adverse Event|1|||
127495855|NCT01066104|458776933|FG000|Overall Study|Protocol Violation|1|||
127495856|NCT01066104|458776934|FG001|Overall Study|Protocol Violation|0|||
127495857|NCT02091362|458776937|FG000|Period 1|Protocol Violation|1|||
127495858|NCT02091362|458776938|FG001|Period 1|Protocol Violation|0|||
127495859|NCT02091362|458776937|FG000|Period 1|Withdrawal by Subject|2|||
127495860|NCT02091362|458776938|FG001|Period 1|Withdrawal by Subject|3|||
127495861|NCT02091362|458776937|FG000|Period 1|Lost to Follow-up|0|||
127495862|NCT02091362|458776938|FG001|Period 1|Lost to Follow-up|1|||
127495863|NCT02091362|458776937|FG000|Period 1|Adverse Event|2|||
127495864|NCT02091362|458776938|FG001|Period 1|Adverse Event|0|||
127495865|NCT02091362|458776937|FG000|Wash-out|Lost to Follow-up|1|||
127495866|NCT02091362|458776938|FG001|Wash-out|Lost to Follow-up|1|||
127495867|NCT02091362|458776937|FG000|Wash-out|Withdrawal by Subject|0|||
127495868|NCT02091362|458776938|FG001|Wash-out|Withdrawal by Subject|2|||
127495869|NCT02091362|458776937|FG000|Period 2|Adverse Event|1|||
127495870|NCT02091362|458776938|FG001|Period 2|Adverse Event|0|||
127495871|NCT02091362|458776937|FG000|Period 2|Lost to Follow-up|0|||
127495872|NCT02091362|458776938|FG001|Period 2|Lost to Follow-up|1|||
127495873|NCT02091362|458776937|FG000|Period 2|Withdrawal by Subject|1|||
127495874|NCT02091362|458776938|FG001|Period 2|Withdrawal by Subject|1|||
127495875|NCT00690430|458776939|FG000|Core Phase|Abnormal Laboratory value|0|||
127495876|NCT00690430|458776940|FG001|Core Phase|Abnormal Laboratory value|1|||
127495877|NCT00690430|458776941|FG002|Core Phase|Abnormal Laboratory value|0|||
127495878|NCT00690430|458776939|FG000|Core Phase|Adverse Event|5|||
127495879|NCT00690430|458776940|FG001|Core Phase|Adverse Event|1|||
127495880|NCT00690430|458776941|FG002|Core Phase|Adverse Event|0|||
127495881|NCT00690430|458776939|FG000|Core Phase|Death|0|||
127495882|NCT00690430|458776940|FG001|Core Phase|Death|2|||
127495883|NCT00690430|458776941|FG002|Core Phase|Death|0|||
127495884|NCT00690430|458776939|FG000|Core Phase|Protocol Violation|1|||
127495885|NCT00690430|458776940|FG001|Core Phase|Protocol Violation|0|||
127495886|NCT00690430|458776941|FG002|Core Phase|Protocol Violation|0|||
127495887|NCT00690430|458776939|FG000|Core Phase|Withdrawal by Subject|3|||
127495888|NCT00690430|458776940|FG001|Core Phase|Withdrawal by Subject|3|||
127495889|NCT00690430|458776941|FG002|Core Phase|Withdrawal by Subject|0|||
127495890|NCT00690430|458776939|FG000|Core Phase|Subject no longer requires study drug|1|||
127495891|NCT00690430|458776940|FG001|Core Phase|Subject no longer requires study drug|0|||
127495892|NCT00690430|458776941|FG002|Core Phase|Subject no longer requires study drug|0|||
127495893|NCT00690430|458776939|FG000|Core Phase|Lack of Efficacy|8|||
127495894|NCT00690430|458776940|FG001|Core Phase|Lack of Efficacy|10|||
127495895|NCT00690430|458776941|FG002|Core Phase|Lack of Efficacy|0|||
127495896|NCT00690430|458776939|FG000|Core Phase|Administrative Problems|0|||
127495897|NCT00690430|458776940|FG001|Core Phase|Administrative Problems|1|||
127495898|NCT00690430|458776941|FG002|Core Phase|Administrative Problems|0|||
127495899|NCT00690430|458776939|FG000|Core Phase|Early Termination|0|||
127495900|NCT00690430|458776940|FG001|Core Phase|Early Termination|5|||
127495901|NCT00690430|458776941|FG002|Core Phase|Early Termination|0|||
127495902|NCT00690430|458776939|FG000|Extension Phase|Lack of Efficacy|3|||
127495903|NCT00690430|458776940|FG001|Extension Phase|Lack of Efficacy|1|||
127495904|NCT00690430|458776941|FG002|Extension Phase|Lack of Efficacy|4|||
127495905|NCT00690430|458776939|FG000|Extension Phase|Abnormal Lab Values|1|||
127495906|NCT00690430|458776940|FG001|Extension Phase|Abnormal Lab Values|0|||
127495907|NCT00690430|458776941|FG002|Extension Phase|Abnormal Lab Values|0|||
127495908|NCT00690430|458776939|FG000|Extension Phase|Abnormal test procedure results|1|||
127495909|NCT00690430|458776940|FG001|Extension Phase|Abnormal test procedure results|0|||
127495910|NCT00690430|458776941|FG002|Extension Phase|Abnormal test procedure results|0|||
127495911|NCT00690430|458776939|FG000|Extension Phase|Administrative Problems|0|||
127495912|NCT00690430|458776940|FG001|Extension Phase|Administrative Problems|1|||
127495913|NCT00690430|458776941|FG002|Extension Phase|Administrative Problems|1|||
127495914|NCT00690430|458776939|FG000|Extension Phase|Adverse Event|2|||
127495915|NCT00690430|458776940|FG001|Extension Phase|Adverse Event|1|||
127495916|NCT00690430|458776941|FG002|Extension Phase|Adverse Event|2|||
127495917|NCT00690430|458776939|FG000|Extension Phase|Death|1|||
127495918|NCT00690430|458776940|FG001|Extension Phase|Death|1|||
127495919|NCT00690430|458776941|FG002|Extension Phase|Death|1|||
127495920|NCT00690430|458776939|FG000|Extension Phase|Withdrawal by Subject|0|||
127495921|NCT00690430|458776940|FG001|Extension Phase|Withdrawal by Subject|0|||
127495922|NCT00690430|458776941|FG002|Extension Phase|Withdrawal by Subject|2|||
127495923|NCT00690430|458776939|FG000|Extension Phase|Early Termination|10|||
127495924|NCT00690430|458776940|FG001|Extension Phase|Early Termination|1|||
127495925|NCT00690430|458776941|FG002|Extension Phase|Early Termination|3|||
127495926|NCT02125838|458776950|FG000|Overall Study|Lost to Follow-up|4|||
127495927|NCT02125838|458776951|FG001|Overall Study|Lost to Follow-up|4|||
127495928|NCT00787839|458776952|FG000|Overall Study|Failure to have the OGTT was most common|404|||
127495929|NCT01970241|458776955|FG000|Overall Study|Withdrawal by Subject|2|||
127495930|NCT01970241|458776956|FG001|Overall Study|Withdrawal by Subject|0|||
127495931|NCT01970241|458776955|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
127495932|NCT01970241|458776956|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
127977409|NCT00373958|460538306|FG001|Infant Series|Child relocated|0|||
127977410|NCT00373958|460538305|FG000|Infant Series|Consent was not received|1|||
127977411|NCT00373958|460538306|FG001|Infant Series|Consent was not received|0|||
127977412|NCT00373958|460538305|FG000|Infant Series|Adverse Event|3|||
127495933|NCT00564902|458776964|FG000|Overall Study|Withdrawal by Subject|0|||
127495934|NCT00564902|458776965|FG001|Overall Study|Withdrawal by Subject|3|||
127495935|NCT00564902|458776966|FG002|Overall Study|Withdrawal by Subject|4|||
127495936|NCT00564902|458776964|FG000|Overall Study|Death|1|||
127495937|NCT00564902|458776965|FG001|Overall Study|Death|1|||
127495938|NCT00564902|458776966|FG002|Overall Study|Death|0|||
127495939|NCT03583359|458776969|FG000|Overall Study|Withdrawal by Subject|15|||
127495940|NCT03583359|458776970|FG001|Overall Study|Withdrawal by Subject|6|||
127495941|NCT03583359|458776969|FG000|Overall Study|Lost to Follow-up|12|||
127495942|NCT03583359|458776970|FG001|Overall Study|Lost to Follow-up|3|||
127495943|NCT03583359|458776969|FG000|Overall Study|Adverse Event|0|||
127495944|NCT03583359|458776970|FG001|Overall Study|Adverse Event|1|||
127495945|NCT03583359|458776969|FG000|Overall Study|Protocol Violation|0|||
127495946|NCT03583359|458776970|FG001|Overall Study|Protocol Violation|1|||
127495947|NCT03583359|458776969|FG000|Overall Study|Other|2|||
127495948|NCT03583359|458776970|FG001|Overall Study|Other|1|||
127495949|NCT00375505|458776971|FG000|Overall Study|Adverse Event|1|||
127495950|NCT00375505|458776972|FG001|Overall Study|Adverse Event|2|||
127977413|NCT00373958|460538306|FG001|Infant Series|Adverse Event|1|||
127977414|NCT00373958|460538305|FG000|Infant Series|Physician Decision|1|||
127977415|NCT00373958|460538306|FG001|Infant Series|Physician Decision|1|||
127977416|NCT00373958|460538305|FG000|Toddler Dose|Lost to Follow-up|5|||
127977417|NCT00373958|460538306|FG001|Toddler Dose|Lost to Follow-up|8|||
127977418|NCT00373958|460538305|FG000|Toddler Dose|Withdrawal by Subject|2|||
127977419|NCT00373958|460538306|FG001|Toddler Dose|Withdrawal by Subject|2|||
127977420|NCT00373958|460538305|FG000|Toddler Dose|Failed to return|1|||
127977421|NCT00373958|460538306|FG001|Toddler Dose|Failed to return|2|||
127977422|NCT00373958|460538305|FG000|Toddler Dose|Protocol Violation|0|||
127977423|NCT00373958|460538306|FG001|Toddler Dose|Protocol Violation|1|||
127977424|NCT00373958|460538305|FG000|Toddler Dose|Withdrawn after infant series|22|||
127977425|NCT00373958|460538306|FG001|Toddler Dose|Withdrawn after infant series|25|||
127977426|NCT00520481|460538317|FG000|Overall Study|Adverse Event|4|||
127977427|NCT00520481|460538318|FG001|Overall Study|Adverse Event|1|||
127977428|NCT00520481|460538317|FG000|Overall Study|Withdrawal by Subject|3|||
127977429|NCT00520481|460538318|FG001|Overall Study|Withdrawal by Subject|0|||
127977430|NCT00957268|460538323|FG000|Overall Study|Voluntary Withdrawal|0|||
127977431|NCT00957268|460538324|FG001|Overall Study|Voluntary Withdrawal|0|||
127977432|NCT00957268|460538325|FG002|Overall Study|Voluntary Withdrawal|1|||
127977433|NCT00957268|460538326|FG003|Overall Study|Voluntary Withdrawal|0|||
127977434|NCT00957268|460538327|FG004|Overall Study|Voluntary Withdrawal|0|||
127977435|NCT03626363|460538328|FG000|Overall Study|Protocol Violation|4|||
127977436|NCT03626363|460538329|FG001|Overall Study|Protocol Violation|0|||
127977437|NCT03626363|460538328|FG000|Overall Study|Lost to Follow-up|5|||
127977438|NCT03626363|460538329|FG001|Overall Study|Lost to Follow-up|7|||
127977439|NCT02600845|460538335|FG000|Overall Study|Reason Not Specified|3|||
127977440|NCT02600845|460538335|FG000|Overall Study|Non-compliance with Study Procedures|10|||
127977441|NCT02600845|460538335|FG000|Overall Study|Consent Withdrawal|5|||
127977442|NCT04413552|460538336|FG000|Overall Study|Adverse Event|0|||
127977443|NCT04413552|460538337|FG001|Overall Study|Adverse Event|0|||
127977444|NCT04413552|460538338|FG002|Overall Study|Adverse Event|0|||
127977445|NCT04413552|460538339|FG003|Overall Study|Adverse Event|0|||
127977446|NCT04413552|460538340|FG004|Overall Study|Adverse Event|0|||
127977447|NCT04413552|460538341|FG005|Overall Study|Adverse Event|0|||
127977448|NCT04413552|460538342|FG006|Overall Study|Adverse Event|1|||
127977449|NCT04413552|460538343|FG007|Overall Study|Adverse Event|0|||
127977450|NCT04413552|460538344|FG008|Overall Study|Adverse Event|0|||
127977451|NCT04413552|460538345|FG009|Overall Study|Adverse Event|0|||
127977452|NCT04852679|460538346|FG000|Main Intervention Period|Withdrawal by Subject|3|||
127977453|NCT04852679|460538346|FG000|Main Intervention Period|Adverse Event|1|||
127977454|NCT04852679|460538346|FG000|Main Intervention Period|Progressive Disease|16|||
127977455|NCT04852679|460538346|FG000|Main Intervention Period|Refused study visit|1|||
127977456|NCT04852679|460538346|FG000|Independent Injection Period|Missed study visit|1|||
127977457|NCT01294696|460538347|FG000|Overall Study|Screening failures|7|||
127977458|NCT01294696|460538347|FG000|Overall Study|Protocol Violation|8|||
127977459|NCT01294696|460538347|FG000|Overall Study|Missing BPI Response|7|||
127977460|NCT01294696|460538347|FG000|Overall Study|Site closure|52|||
127977461|NCT06366087|460540295|FG000|Overall Study|Withdrawal by Subject|0|||
127977462|NCT06366087|460540296|FG001|Overall Study|Withdrawal by Subject|1|||
127977463|NCT00860249|460540298|FG000|Overall Study|trial was terminated prior to completion|21|||
127977464|NCT00860249|460540299|FG001|Overall Study|trial was terminated prior to completion|18|||
127495951|NCT01831466|458776973|FG000|Overall Study|Protocol Violation|1|||
127495952|NCT01831466|458776974|FG001|Overall Study|Protocol Violation|1|||
127495953|NCT01831466|458776975|FG002|Overall Study|Protocol Violation|2|||
127495954|NCT01831466|458776976|FG003|Overall Study|Protocol Violation|0|||
127495955|NCT01831466|458776977|FG004|Overall Study|Protocol Violation|0|||
127495956|NCT01831466|458776978|FG005|Overall Study|Protocol Violation|1|||
127495957|NCT01831466|458776979|FG006|Overall Study|Protocol Violation|0|||
127495958|NCT01831466|458776980|FG007|Overall Study|Protocol Violation|0|||
127495959|NCT01831466|458776981|FG008|Overall Study|Protocol Violation|0|||
127495960|NCT01831466|458776982|FG009|Overall Study|Protocol Violation|0|||
127977465|NCT00860249|460540300|FG002|Overall Study|trial was terminated prior to completion|21|||
127977466|NCT00174967|460540301|FG000|Overall Study|Adverse Event|1|||
127977467|NCT00174967|460540302|FG001|Overall Study|Adverse Event|2|||
127977468|NCT00174967|460540303|FG002|Overall Study|Adverse Event|2|||
127977469|NCT00174967|460540304|FG003|Overall Study|Adverse Event|1|||
127977470|NCT00174967|460540301|FG000|Overall Study|Gout Flare|0|||
127977471|NCT00174967|460540302|FG001|Overall Study|Gout Flare|0|||
127977472|NCT00174967|460540303|FG002|Overall Study|Gout Flare|0|||
127977473|NCT00174967|460540304|FG003|Overall Study|Gout Flare|1|||
127977474|NCT00174967|460540301|FG000|Overall Study|Other|0|||
127977475|NCT00174967|460540302|FG001|Overall Study|Other|1|||
127495961|NCT01831466|458776983|FG010|Overall Study|Protocol Violation|0|||
127495962|NCT01831466|458776984|FG011|Overall Study|Protocol Violation|0|||
127495963|NCT01831466|458776973|FG000|Overall Study|Other|2|||
127495964|NCT01831466|458776974|FG001|Overall Study|Other|3|||
127495965|NCT01831466|458776975|FG002|Overall Study|Other|2|||
127495966|NCT01831466|458776976|FG003|Overall Study|Other|2|||
127495967|NCT01831466|458776977|FG004|Overall Study|Other|2|||
127495968|NCT01831466|458776978|FG005|Overall Study|Other|1|||
127495969|NCT01831466|458776979|FG006|Overall Study|Other|0|||
127495970|NCT01831466|458776980|FG007|Overall Study|Other|0|||
127495971|NCT01831466|458776981|FG008|Overall Study|Other|0|||
127495972|NCT01831466|458776982|FG009|Overall Study|Other|0|||
127495973|NCT01831466|458776983|FG010|Overall Study|Other|0|||
127495974|NCT01831466|458776984|FG011|Overall Study|Other|0|||
127495975|NCT01831466|458776973|FG000|Overall Study|Non-compliance with study treatment|2|||
127495976|NCT01831466|458776974|FG001|Overall Study|Non-compliance with study treatment|1|||
127495977|NCT01831466|458776975|FG002|Overall Study|Non-compliance with study treatment|1|||
127495978|NCT01831466|458776976|FG003|Overall Study|Non-compliance with study treatment|0|||
127495979|NCT01831466|458776977|FG004|Overall Study|Non-compliance with study treatment|0|||
127495980|NCT01831466|458776978|FG005|Overall Study|Non-compliance with study treatment|1|||
127495981|NCT01831466|458776979|FG006|Overall Study|Non-compliance with study treatment|0|||
127495982|NCT01831466|458776980|FG007|Overall Study|Non-compliance with study treatment|0|||
127495983|NCT01831466|458776981|FG008|Overall Study|Non-compliance with study treatment|0|||
127495984|NCT01831466|458776982|FG009|Overall Study|Non-compliance with study treatment|0|||
127495985|NCT01831466|458776983|FG010|Overall Study|Non-compliance with study treatment|0|||
127495986|NCT01831466|458776984|FG011|Overall Study|Non-compliance with study treatment|0|||
127495987|NCT01831466|458776973|FG000|Overall Study|Death|0|||
127495988|NCT01831466|458776974|FG001|Overall Study|Death|1|||
127495989|NCT01831466|458776975|FG002|Overall Study|Death|0|||
127495990|NCT01831466|458776976|FG003|Overall Study|Death|0|||
127495991|NCT01831466|458776977|FG004|Overall Study|Death|0|||
127495992|NCT01831466|458776978|FG005|Overall Study|Death|0|||
127495993|NCT01831466|458776979|FG006|Overall Study|Death|0|||
127495994|NCT01831466|458776980|FG007|Overall Study|Death|0|||
127495995|NCT01831466|458776981|FG008|Overall Study|Death|0|||
127495996|NCT01831466|458776982|FG009|Overall Study|Death|0|||
127495997|NCT01831466|458776983|FG010|Overall Study|Death|0|||
127495998|NCT01831466|458776984|FG011|Overall Study|Death|0|||
127495999|NCT01831466|458776973|FG000|Overall Study|Withdrawal by Subject|6|||
127496000|NCT01831466|458776974|FG001|Overall Study|Withdrawal by Subject|3|||
127496001|NCT01831466|458776975|FG002|Overall Study|Withdrawal by Subject|3|||
127496002|NCT01831466|458776976|FG003|Overall Study|Withdrawal by Subject|3|||
127496003|NCT01831466|458776977|FG004|Overall Study|Withdrawal by Subject|3|||
127496004|NCT01831466|458776978|FG005|Overall Study|Withdrawal by Subject|5|||
127496005|NCT01831466|458776979|FG006|Overall Study|Withdrawal by Subject|0|||
127496006|NCT01831466|458776980|FG007|Overall Study|Withdrawal by Subject|0|||
127496007|NCT01831466|458776981|FG008|Overall Study|Withdrawal by Subject|0|||
127496008|NCT01831466|458776982|FG009|Overall Study|Withdrawal by Subject|1|||
127496009|NCT01831466|458776983|FG010|Overall Study|Withdrawal by Subject|0|||
127496010|NCT01831466|458776984|FG011|Overall Study|Withdrawal by Subject|1|||
127496011|NCT01831466|458776973|FG000|Overall Study|Lost to Follow-up|0|||
127496012|NCT01831466|458776974|FG001|Overall Study|Lost to Follow-up|1|||
127496013|NCT01831466|458776975|FG002|Overall Study|Lost to Follow-up|4|||
127496014|NCT01831466|458776976|FG003|Overall Study|Lost to Follow-up|2|||
127496015|NCT01831466|458776977|FG004|Overall Study|Lost to Follow-up|0|||
127496016|NCT01831466|458776978|FG005|Overall Study|Lost to Follow-up|3|||
127496017|NCT01831466|458776979|FG006|Overall Study|Lost to Follow-up|0|||
127496018|NCT01831466|458776980|FG007|Overall Study|Lost to Follow-up|0|||
127496019|NCT01831466|458776981|FG008|Overall Study|Lost to Follow-up|0|||
127496020|NCT01831466|458776982|FG009|Overall Study|Lost to Follow-up|1|||
127496021|NCT01831466|458776983|FG010|Overall Study|Lost to Follow-up|0|||
127496022|NCT01831466|458776984|FG011|Overall Study|Lost to Follow-up|1|||
127977476|NCT00174967|460540303|FG002|Overall Study|Other|0|||
127496023|NCT01831466|458776973|FG000|Overall Study|Lack of Efficacy|5|||
127496024|NCT01831466|458776974|FG001|Overall Study|Lack of Efficacy|8|||
127496025|NCT01831466|458776975|FG002|Overall Study|Lack of Efficacy|7|||
127496026|NCT01831466|458776976|FG003|Overall Study|Lack of Efficacy|6|||
127496027|NCT01831466|458776977|FG004|Overall Study|Lack of Efficacy|9|||
127496028|NCT01831466|458776978|FG005|Overall Study|Lack of Efficacy|8|||
127496029|NCT01831466|458776979|FG006|Overall Study|Lack of Efficacy|1|||
127496030|NCT01831466|458776980|FG007|Overall Study|Lack of Efficacy|1|||
127496031|NCT01831466|458776981|FG008|Overall Study|Lack of Efficacy|2|||
127496032|NCT01831466|458776982|FG009|Overall Study|Lack of Efficacy|2|||
127496033|NCT01831466|458776983|FG010|Overall Study|Lack of Efficacy|2|||
127496034|NCT01831466|458776984|FG011|Overall Study|Lack of Efficacy|0|||
127496035|NCT01831466|458776973|FG000|Overall Study|Adverse Event|0|||
127496036|NCT01831466|458776974|FG001|Overall Study|Adverse Event|0|||
127496037|NCT01831466|458776975|FG002|Overall Study|Adverse Event|4|||
127496038|NCT01831466|458776976|FG003|Overall Study|Adverse Event|6|||
127496039|NCT01831466|458776977|FG004|Overall Study|Adverse Event|3|||
127496040|NCT01831466|458776978|FG005|Overall Study|Adverse Event|7|||
127496041|NCT01831466|458776979|FG006|Overall Study|Adverse Event|0|||
127496042|NCT01831466|458776980|FG007|Overall Study|Adverse Event|1|||
127496043|NCT01831466|458776981|FG008|Overall Study|Adverse Event|1|||
127496044|NCT01831466|458776982|FG009|Overall Study|Adverse Event|1|||
127496045|NCT01831466|458776983|FG010|Overall Study|Adverse Event|0|||
127496046|NCT01831466|458776984|FG011|Overall Study|Adverse Event|2|||
127496047|NCT02567799|458776985|FG000|Concurrent Chemoradiotherapy|Death|1|||
127496048|NCT02567799|458776986|FG001|Concurrent Chemoradiotherapy|Death|0|||
127496049|NCT02567799|458776987|FG002|Concurrent Chemoradiotherapy|Death|0|||
127496050|NCT02567799|458776985|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
127496051|NCT02567799|458776986|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
127496052|NCT02567799|458776987|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
127496053|NCT02567799|458776985|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
127496054|NCT02567799|458776986|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
127496055|NCT02567799|458776987|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
127496056|NCT02567799|458776985|FG000|Follow-up|Death|1|||
127496057|NCT02567799|458776986|FG001|Follow-up|Death|0|||
127496058|NCT02567799|458776987|FG002|Follow-up|Death|1|||
127496059|NCT02567799|458776985|FG000|Follow-up|Progressive Disease|1|||
127496060|NCT02567799|458776986|FG001|Follow-up|Progressive Disease|1|||
127496061|NCT02567799|458776987|FG002|Follow-up|Progressive Disease|3|||
127496062|NCT00349349|458776989|FG000|Overall Study|Adverse Event|5|||
127496063|NCT00349349|458776990|FG001|Overall Study|Adverse Event|6|||
127496064|NCT00349349|458776991|FG002|Overall Study|Adverse Event|2|||
127496065|NCT00349349|458776989|FG000|Overall Study|Withdrawal by Subject|5|||
127496066|NCT00349349|458776990|FG001|Overall Study|Withdrawal by Subject|2|||
127496067|NCT00349349|458776991|FG002|Overall Study|Withdrawal by Subject|1|||
127496068|NCT00349349|458776989|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
127496069|NCT00349349|458776990|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
127496070|NCT00349349|458776991|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
127496071|NCT00349349|458776989|FG000|Overall Study|Death|13|||
127496072|NCT00349349|458776990|FG001|Overall Study|Death|10|||
127496073|NCT00349349|458776991|FG002|Overall Study|Death|1|||
127496074|NCT00349349|458776989|FG000|Overall Study|Other Treatment Selected|2|||
127496075|NCT00349349|458776990|FG001|Overall Study|Other Treatment Selected|0|||
127496076|NCT00349349|458776991|FG002|Overall Study|Other Treatment Selected|0|||
127496077|NCT00349349|458776989|FG000|Overall Study|Participant Reduced General Condition|0|||
127496078|NCT00349349|458776990|FG001|Overall Study|Participant Reduced General Condition|1|||
127496079|NCT00349349|458776991|FG002|Overall Study|Participant Reduced General Condition|0|||
127496080|NCT00349349|458776989|FG000|Overall Study|Physician Decision|1|||
127496081|NCT00349349|458776990|FG001|Overall Study|Physician Decision|2|||
127496082|NCT00349349|458776991|FG002|Overall Study|Physician Decision|1|||
127496083|NCT00349349|458776989|FG000|Overall Study|No Response|0|||
127496084|NCT00349349|458776990|FG001|Overall Study|No Response|3|||
127496085|NCT00349349|458776991|FG002|Overall Study|No Response|0|||
127496086|NCT00349349|458776989|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
127496087|NCT00349349|458776990|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
127496088|NCT00349349|458776991|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
127496089|NCT05111002|458776996|FG000|Primary Outcome|Negative Confirmatory Aptima MG Test|1|||
127496090|NCT05111002|458776997|FG001|Primary Outcome|Negative Confirmatory Aptima MG Test|0|||
127496091|NCT05111002|458776996|FG000|Secondary Outcome|Lost to Follow-up|1|||
127496092|NCT05111002|458776997|FG001|Secondary Outcome|Lost to Follow-up|0|||
127496093|NCT04776720|458777000|FG000|Overall Study|COVID Related|4|||
127496094|NCT04776720|458777001|FG001|Overall Study|COVID Related|2|||
127496095|NCT04776720|458777000|FG000|Overall Study|Adverse Event|2|||
127496096|NCT04776720|458777001|FG001|Overall Study|Adverse Event|0|||
127496097|NCT04776720|458777000|FG000|Overall Study|Serious Adverse Event|0|||
127496098|NCT04776720|458777001|FG001|Overall Study|Serious Adverse Event|1|||
127496099|NCT04776720|458777000|FG000|Overall Study|Too Busy|3|||
127496100|NCT04776720|458777001|FG001|Overall Study|Too Busy|1|||
127496101|NCT04776720|458777000|FG000|Overall Study|Lost to Follow-up|1|||
127496102|NCT04776720|458777001|FG001|Overall Study|Lost to Follow-up|2|||
127496103|NCT04776720|458777000|FG000|Overall Study|Family|2|||
127496104|NCT04776720|458777001|FG001|Overall Study|Family|2|||
127496105|NCT04776720|458777000|FG000|Overall Study|No remote technology access|0|||
127496106|NCT04776720|458777001|FG001|Overall Study|No remote technology access|1|||
127496107|NCT04776720|458777000|FG000|Overall Study|Withdrawal by Subject|1|||
127496108|NCT04776720|458777001|FG001|Overall Study|Withdrawal by Subject|0|||
127496109|NCT04776720|458777000|FG000|Overall Study|Cannot tolerate intervention|1|||
127496110|NCT04776720|458777001|FG001|Overall Study|Cannot tolerate intervention|0|||
127496111|NCT04776720|458777000|FG000|Overall Study|Incomplete outcome data|6|||
127496112|NCT04776720|458777001|FG001|Overall Study|Incomplete outcome data|1|||
127496113|NCT05356910|458777002|FG000|Overall Study|Lost to Follow-up|10|||
127496114|NCT05356910|458777003|FG001|Overall Study|Lost to Follow-up|19|||
127496115|NCT05356910|458777004|FG002|Overall Study|Lost to Follow-up|0|||
127496116|NCT05356910|458777005|FG003|Overall Study|Lost to Follow-up|0|||
127496117|NCT05356910|458777002|FG000|Overall Study|Withdrawal by Subject|4|||
127496118|NCT05356910|458777003|FG001|Overall Study|Withdrawal by Subject|2|||
127496119|NCT05356910|458777004|FG002|Overall Study|Withdrawal by Subject|0|||
127496120|NCT05356910|458777005|FG003|Overall Study|Withdrawal by Subject|0|||
127496121|NCT00972517|458777006|FG000|Overall Study|Adverse Event|0|||
127496122|NCT00972517|458777007|FG001|Overall Study|Adverse Event|0|||
127496123|NCT00972517|458777008|FG002|Overall Study|Adverse Event|0|||
127496124|NCT00972517|458777009|FG003|Overall Study|Adverse Event|1|||
127496125|NCT00972517|458777010|FG004|Overall Study|Adverse Event|0|||
127496126|NCT00972517|458777011|FG005|Overall Study|Adverse Event|0|||
127496127|NCT00972517|458777006|FG000|Overall Study|Withdrawal by Subject|0|||
127496128|NCT00972517|458777007|FG001|Overall Study|Withdrawal by Subject|1|||
127496129|NCT00972517|458777008|FG002|Overall Study|Withdrawal by Subject|0|||
127496130|NCT00972517|458777009|FG003|Overall Study|Withdrawal by Subject|2|||
127496131|NCT00972517|458777010|FG004|Overall Study|Withdrawal by Subject|1|||
127496132|NCT00972517|458777011|FG005|Overall Study|Withdrawal by Subject|0|||
127496133|NCT00984594|458777012|FG000|Overall Study|Lost to Follow-up|1|||
127496134|NCT00984594|458777013|FG001|Overall Study|Lost to Follow-up|0|||
127496135|NCT00984594|458777012|FG000|Overall Study|Withdrawal by Subject|0|||
127496136|NCT00984594|458777013|FG001|Overall Study|Withdrawal by Subject|1|||
127496137|NCT00851890|458777014|FG000|Overall Study|Lost to Follow-up|0|||
127496138|NCT00851890|458777015|FG001|Overall Study|Lost to Follow-up|1|||
127496139|NCT00851890|458777016|FG002|Overall Study|Lost to Follow-up|0|||
127496140|NCT00851890|458777017|FG003|Overall Study|Lost to Follow-up|1|||
127496141|NCT03135431|458777018|FG000|Overall Study|Study Surgeon not available|2|||
127496142|NCT03135431|458777019|FG001|Overall Study|Study Surgeon not available|0|||
127496143|NCT03122145|458777020|FG000|Overall Study|Concurrent respiratory disease|3|||
127496144|NCT03122145|458777021|FG001|Overall Study|Concurrent respiratory disease|0|||
127496145|NCT01597908|458777022|FG000|Randomized Phase|Death|217|||
127496146|NCT01597908|458777023|FG001|Randomized Phase|Death|238|||
127496147|NCT01597908|458777024|FG002|Randomized Phase|Death|0|||
127496148|NCT01597908|458777022|FG000|Randomized Phase|Sponsor Decision|93|||
127496149|NCT01597908|458777023|FG001|Randomized Phase|Sponsor Decision|39|||
127496150|NCT01597908|458777024|FG002|Randomized Phase|Sponsor Decision|0|||
127496151|NCT01597908|458777022|FG000|Randomized Phase|Lost to Follow-up|9|||
127496152|NCT01597908|458777023|FG001|Randomized Phase|Lost to Follow-up|16|||
127496153|NCT01597908|458777024|FG002|Randomized Phase|Lost to Follow-up|0|||
127496154|NCT01597908|458777022|FG000|Randomized Phase|Physician Decision|6|||
127496155|NCT01597908|458777023|FG001|Randomized Phase|Physician Decision|3|||
127496156|NCT01597908|458777024|FG002|Randomized Phase|Physician Decision|0|||
127496157|NCT01597908|458777022|FG000|Randomized Phase|Withdrawal by Subject|26|||
127496158|NCT01597908|458777023|FG001|Randomized Phase|Withdrawal by Subject|22|||
127496159|NCT01597908|458777024|FG002|Randomized Phase|Withdrawal by Subject|0|||
127496160|NCT01597908|458777022|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
127496161|NCT01597908|458777023|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
127496162|NCT01597908|458777024|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
127496163|NCT01597908|458777022|FG000|Crossover Phase|Death|0|||
127496164|NCT01597908|458777023|FG001|Crossover Phase|Death|0|||
127496165|NCT01597908|458777024|FG002|Crossover Phase|Death|11|||
127496166|NCT01597908|458777022|FG000|Crossover Phase|Withdrawal by Subject|0|||
127496167|NCT01597908|458777023|FG001|Crossover Phase|Withdrawal by Subject|0|||
127496168|NCT01597908|458777024|FG002|Crossover Phase|Withdrawal by Subject|3|||
127496169|NCT01597908|458777022|FG000|Crossover Phase|Sponsor Decision|0|||
127496170|NCT01597908|458777023|FG001|Crossover Phase|Sponsor Decision|0|||
127496171|NCT01597908|458777024|FG002|Crossover Phase|Sponsor Decision|20|||
127496172|NCT00837161|458777025|FG000|Overall Study|refused hysterectomy|2|||
127496173|NCT01659996|458777028|FG000|Overall Study|Protocol Violation|3|||
127496174|NCT01659996|458777029|FG001|Overall Study|Protocol Violation|3|||
127496175|NCT01659996|458777030|FG002|Overall Study|Protocol Violation|3|||
127496176|NCT01659996|458777028|FG000|Overall Study|Lost to Follow-up|1|||
127496177|NCT01659996|458777029|FG001|Overall Study|Lost to Follow-up|3|||
127496178|NCT01659996|458777030|FG002|Overall Study|Lost to Follow-up|2|||
127496179|NCT01659996|458777028|FG000|Overall Study|Adverse Event|0|||
127496180|NCT01659996|458777029|FG001|Overall Study|Adverse Event|0|||
127496181|NCT01659996|458777030|FG002|Overall Study|Adverse Event|1|||
127496182|NCT01659996|458777028|FG000|Overall Study|Withdrawal by Subject|4|||
127496183|NCT01659996|458777029|FG001|Overall Study|Withdrawal by Subject|1|||
127496184|NCT01659996|458777030|FG002|Overall Study|Withdrawal by Subject|5|||
127496185|NCT02709577|458777031|FG000|Overall Study|non-accommodating anatomy|0|||
127496186|NCT02709577|458777032|FG001|Overall Study|non-accommodating anatomy|1|||
127496187|NCT02709577|458777033|FG002|Overall Study|non-accommodating anatomy|0|||
127496188|NCT02709577|458777034|FG003|Overall Study|non-accommodating anatomy|0|||
127496189|NCT02709577|458777031|FG000|Overall Study|procedural complication|0|||
127496190|NCT02709577|458777032|FG001|Overall Study|procedural complication|1|||
127496191|NCT02709577|458777033|FG002|Overall Study|procedural complication|0|||
127496192|NCT02709577|458777034|FG003|Overall Study|procedural complication|0|||
127496193|NCT02709577|458777031|FG000|Overall Study|Withdrawal by Subject|2|||
127496194|NCT02709577|458777032|FG001|Overall Study|Withdrawal by Subject|3|||
127496195|NCT02709577|458777033|FG002|Overall Study|Withdrawal by Subject|2|||
127977477|NCT00174967|460540304|FG003|Overall Study|Other|0|||
127496196|NCT02709577|458777034|FG003|Overall Study|Withdrawal by Subject|0|||
127496197|NCT00375674|458777035|FG000|Overall Study|Other|26|||
127496198|NCT00375674|458777036|FG001|Overall Study|Other|18|||
127496199|NCT00375674|458777035|FG000|Overall Study|Death|67|||
127496200|NCT00375674|458777036|FG001|Overall Study|Death|76|||
127496201|NCT00375674|458777035|FG000|Overall Study|Participants refused further follow-up|31|||
127496202|NCT00375674|458777036|FG001|Overall Study|Participants refused further follow-up|30|||
127496203|NCT00375674|458777035|FG000|Overall Study|Lost to Follow-up|17|||
127496204|NCT00375674|458777036|FG001|Overall Study|Lost to Follow-up|15|||
127496205|NCT00375674|458777035|FG000|Overall Study|Enrolled but not treated|3|||
127496206|NCT00375674|458777036|FG001|Overall Study|Enrolled but not treated|2|||
127496207|NCT03744910|458779214|FG000|Overall Study|Withdrew Consent|1|||
127496208|NCT03744910|458779215|FG001|Overall Study|Withdrew Consent|8|||
127496209|NCT03744910|458779214|FG000|Overall Study|Physician Decision|5|||
127496210|NCT03744910|458779215|FG001|Overall Study|Physician Decision|4|||
127496211|NCT03744910|458779214|FG000|Overall Study|Sponsor Decision (due to study termination)|68|||
127496212|NCT03744910|458779215|FG001|Overall Study|Sponsor Decision (due to study termination)|71|||
127977478|NCT02031640|460540305|FG000|Screening Period|Adverse Event|1|||
127977479|NCT02031640|460540306|FG001|Screening Period|Adverse Event|0|||
127977480|NCT02031640|460540307|FG002|Screening Period|Adverse Event|0|||
127977481|NCT02031640|460540308|FG003|Screening Period|Adverse Event|0|||
127977482|NCT02031640|460540309|FG004|Screening Period|Adverse Event|0|||
127977483|NCT02031640|460540310|FG005|Screening Period|Adverse Event|0|||
127977484|NCT02031640|460540305|FG000|Screening Period|Withdrawal by Subject|29|||
127977485|NCT02031640|460540306|FG001|Screening Period|Withdrawal by Subject|0|||
127977486|NCT02031640|460540307|FG002|Screening Period|Withdrawal by Subject|0|||
127977487|NCT02031640|460540308|FG003|Screening Period|Withdrawal by Subject|0|||
127977488|NCT02031640|460540309|FG004|Screening Period|Withdrawal by Subject|0|||
127977489|NCT02031640|460540310|FG005|Screening Period|Withdrawal by Subject|0|||
127977490|NCT02031640|460540305|FG000|Screening Period|Inclusion criteria not met|312|||
127977491|NCT02031640|460540306|FG001|Screening Period|Inclusion criteria not met|0|||
127977492|NCT02031640|460540307|FG002|Screening Period|Inclusion criteria not met|0|||
127977493|NCT02031640|460540308|FG003|Screening Period|Inclusion criteria not met|0|||
127977494|NCT02031640|460540309|FG004|Screening Period|Inclusion criteria not met|0|||
127977495|NCT02031640|460540310|FG005|Screening Period|Inclusion criteria not met|0|||
127977496|NCT02031640|460540305|FG000|Screening Period|Exclusion criteria met|30|||
127977497|NCT02031640|460540306|FG001|Screening Period|Exclusion criteria met|0|||
127977498|NCT02031640|460540307|FG002|Screening Period|Exclusion criteria met|0|||
127977499|NCT02031640|460540308|FG003|Screening Period|Exclusion criteria met|0|||
127977500|NCT02031640|460540309|FG004|Screening Period|Exclusion criteria met|0|||
127977501|NCT02031640|460540310|FG005|Screening Period|Exclusion criteria met|0|||
127977502|NCT02031640|460540305|FG000|Screening Period|Lost to Follow-up|14|||
127977503|NCT02031640|460540306|FG001|Screening Period|Lost to Follow-up|0|||
127977504|NCT02031640|460540307|FG002|Screening Period|Lost to Follow-up|0|||
127977505|NCT02031640|460540308|FG003|Screening Period|Lost to Follow-up|0|||
127977506|NCT02031640|460540309|FG004|Screening Period|Lost to Follow-up|0|||
127977507|NCT02031640|460540310|FG005|Screening Period|Lost to Follow-up|0|||
127977508|NCT02031640|460540305|FG000|Screening Period|Enrollment closed|26|||
127977509|NCT02031640|460540306|FG001|Screening Period|Enrollment closed|0|||
127977510|NCT02031640|460540307|FG002|Screening Period|Enrollment closed|0|||
127977511|NCT02031640|460540308|FG003|Screening Period|Enrollment closed|0|||
127977512|NCT02031640|460540309|FG004|Screening Period|Enrollment closed|0|||
127977513|NCT02031640|460540310|FG005|Screening Period|Enrollment closed|0|||
127977514|NCT02031640|460540305|FG000|Run-In Period|Adverse Event|4|||
127977515|NCT02031640|460540306|FG001|Run-In Period|Adverse Event|0|||
127977516|NCT02031640|460540307|FG002|Run-In Period|Adverse Event|0|||
127977517|NCT02031640|460540308|FG003|Run-In Period|Adverse Event|0|||
127977518|NCT02031640|460540309|FG004|Run-In Period|Adverse Event|0|||
127977519|NCT02031640|460540310|FG005|Run-In Period|Adverse Event|0|||
127977520|NCT02031640|460540305|FG000|Run-In Period|Withdrawal by Subject|17|||
127977521|NCT02031640|460540306|FG001|Run-In Period|Withdrawal by Subject|0|||
127496213|NCT03744910|458779214|FG000|Overall Study|Lost to Follow-up|0|||
127496214|NCT03744910|458779215|FG001|Overall Study|Lost to Follow-up|1|||
127496215|NCT03744910|458779214|FG000|Overall Study|Other-unspecified|4|||
127496216|NCT03744910|458779215|FG001|Overall Study|Other-unspecified|1|||
127496217|NCT00064259|458779216|FG000|Overall Study|Adverse Event|1|||
127496218|NCT00064259|458779217|FG001|Overall Study|Adverse Event|0|||
127496219|NCT00064259|458779218|FG002|Overall Study|Adverse Event|0|||
127496220|NCT00064259|458779219|FG003|Overall Study|Adverse Event|1|||
127977522|NCT02031640|460540307|FG002|Run-In Period|Withdrawal by Subject|0|||
127977523|NCT02031640|460540308|FG003|Run-In Period|Withdrawal by Subject|0|||
127977524|NCT02031640|460540309|FG004|Run-In Period|Withdrawal by Subject|0|||
127977525|NCT02031640|460540310|FG005|Run-In Period|Withdrawal by Subject|0|||
127977526|NCT02031640|460540305|FG000|Run-In Period|Inclusion criteria not met|38|||
127977527|NCT02031640|460540306|FG001|Run-In Period|Inclusion criteria not met|0|||
127977528|NCT02031640|460540307|FG002|Run-In Period|Inclusion criteria not met|0|||
127977529|NCT02031640|460540308|FG003|Run-In Period|Inclusion criteria not met|0|||
127496221|NCT01132651|458779222|FG000|Overall Study|Lost to Follow-up|1|||
127496222|NCT01132651|458779223|FG001|Overall Study|Lost to Follow-up|1|||
127496223|NCT00948857|458779224|FG000|Overall Study|Lost to Follow-up|1|||
127496224|NCT00948857|458779225|FG001|Overall Study|Lost to Follow-up|0|||
127496225|NCT03430843|458779228|FG000|Overall Study|Death|233|||
127496226|NCT03430843|458779229|FG001|Overall Study|Death|233|||
127496227|NCT03430843|458779228|FG000|Overall Study|Sponsor Decision|17|||
127496228|NCT03430843|458779229|FG001|Overall Study|Sponsor Decision|6|||
127496229|NCT03430843|458779228|FG000|Overall Study|Withdrawal by Subject|5|||
127496230|NCT03430843|458779229|FG001|Overall Study|Withdrawal by Subject|14|||
127496231|NCT03430843|458779228|FG000|Overall Study|Lost to Follow-up|1|||
127496232|NCT03430843|458779229|FG001|Overall Study|Lost to Follow-up|3|||
127496233|NCT01905943|458779236|FG000|Overall Study|Withdrawal of consent|90|||
127496234|NCT01905943|458779236|FG000|Overall Study|Lost to Follow-up|16|||
127496235|NCT01905943|458779236|FG000|Overall Study|Investigator discretion|7|||
127496236|NCT01905943|458779236|FG000|Overall Study|Death|186|||
127496237|NCT01905943|458779236|FG000|Overall Study|Adverse Event|3|||
127496238|NCT01905943|458779236|FG000|Overall Study|Other|12|||
127496239|NCT02574078|458779237|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
127496240|NCT02574078|458779238|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
127496241|NCT02574078|458779239|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
127496242|NCT02574078|458779240|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
127496243|NCT02574078|458779241|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
127496244|NCT02574078|458779242|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
127496245|NCT02574078|458779243|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
127496246|NCT02574078|458779244|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
127496247|NCT02574078|458779245|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
127496248|NCT02574078|458779246|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
127496249|NCT02574078|458779247|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
127496250|NCT02574078|458779248|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
127496251|NCT02574078|458779249|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
127496252|NCT02574078|458779237|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
127496253|NCT02574078|458779238|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
127496254|NCT02574078|458779239|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
127496255|NCT02574078|458779240|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
127496256|NCT02574078|458779241|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
127496257|NCT02574078|458779242|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
127496258|NCT02574078|458779243|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
127496259|NCT02574078|458779244|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
127496260|NCT02574078|458779245|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
127496261|NCT02574078|458779246|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
127496262|NCT02574078|458779247|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
127496263|NCT02574078|458779248|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
127496264|NCT02574078|458779249|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
127496265|NCT02574078|458779237|FG000|Pre-Treatment Period|Other reasons|0|||
127496266|NCT02574078|458779238|FG001|Pre-Treatment Period|Other reasons|0|||
127496267|NCT02574078|458779239|FG002|Pre-Treatment Period|Other reasons|0|||
127496268|NCT02574078|458779240|FG003|Pre-Treatment Period|Other reasons|0|||
127496269|NCT02574078|458779241|FG004|Pre-Treatment Period|Other reasons|0|||
127496270|NCT02574078|458779242|FG005|Pre-Treatment Period|Other reasons|0|||
127496271|NCT02574078|458779243|FG006|Pre-Treatment Period|Other reasons|2|||
127496272|NCT02574078|458779244|FG007|Pre-Treatment Period|Other reasons|0|||
127496273|NCT02574078|458779245|FG008|Pre-Treatment Period|Other reasons|0|||
127496274|NCT02574078|458779246|FG009|Pre-Treatment Period|Other reasons|0|||
127496275|NCT02574078|458779247|FG010|Pre-Treatment Period|Other reasons|2|||
127496276|NCT02574078|458779248|FG011|Pre-Treatment Period|Other reasons|0|||
127496277|NCT02574078|458779249|FG012|Pre-Treatment Period|Other reasons|0|||
127496278|NCT02574078|458779237|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
127496279|NCT02574078|458779238|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
127496280|NCT02574078|458779239|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
127496281|NCT02574078|458779240|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
127496282|NCT02574078|458779241|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
127496283|NCT02574078|458779242|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
127496284|NCT02574078|458779243|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
127496285|NCT02574078|458779244|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
127496286|NCT02574078|458779245|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
127496287|NCT02574078|458779246|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
127496288|NCT02574078|458779247|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
127496289|NCT02574078|458779248|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
127496290|NCT02574078|458779249|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
127496291|NCT02574078|458779237|FG000|Treatment Period|Disease progression|6|||
127496292|NCT02574078|458779238|FG001|Treatment Period|Disease progression|4|||
127496293|NCT02574078|458779239|FG002|Treatment Period|Disease progression|7|||
127496294|NCT02574078|458779240|FG003|Treatment Period|Disease progression|18|||
127496295|NCT02574078|458779241|FG004|Treatment Period|Disease progression|16|||
127496296|NCT02574078|458779242|FG005|Treatment Period|Disease progression|26|||
127496297|NCT02574078|458779243|FG006|Treatment Period|Disease progression|5|||
127496298|NCT02574078|458779244|FG007|Treatment Period|Disease progression|9|||
127496299|NCT02574078|458779245|FG008|Treatment Period|Disease progression|8|||
127496300|NCT02574078|458779246|FG009|Treatment Period|Disease progression|5|||
127496301|NCT02574078|458779247|FG010|Treatment Period|Disease progression|20|||
127496302|NCT02574078|458779248|FG011|Treatment Period|Disease progression|29|||
127496303|NCT02574078|458779249|FG012|Treatment Period|Disease progression|2|||
127496304|NCT02574078|458779237|FG000|Treatment Period|Study drug toxicity|1|||
127496305|NCT02574078|458779238|FG001|Treatment Period|Study drug toxicity|1|||
127496306|NCT02574078|458779239|FG002|Treatment Period|Study drug toxicity|0|||
127496307|NCT02574078|458779240|FG003|Treatment Period|Study drug toxicity|5|||
127496308|NCT02574078|458779241|FG004|Treatment Period|Study drug toxicity|3|||
127496309|NCT02574078|458779242|FG005|Treatment Period|Study drug toxicity|1|||
127496310|NCT02574078|458779243|FG006|Treatment Period|Study drug toxicity|2|||
127496311|NCT02574078|458779244|FG007|Treatment Period|Study drug toxicity|0|||
127496312|NCT02574078|458779245|FG008|Treatment Period|Study drug toxicity|2|||
127496313|NCT02574078|458779246|FG009|Treatment Period|Study drug toxicity|1|||
127496314|NCT02574078|458779247|FG010|Treatment Period|Study drug toxicity|16|||
127496315|NCT02574078|458779248|FG011|Treatment Period|Study drug toxicity|2|||
127496316|NCT02574078|458779249|FG012|Treatment Period|Study drug toxicity|4|||
127496317|NCT02574078|458779237|FG000|Treatment Period|Death|2|||
127496318|NCT02574078|458779238|FG001|Treatment Period|Death|0|||
127496319|NCT02574078|458779239|FG002|Treatment Period|Death|0|||
127496320|NCT02574078|458779240|FG003|Treatment Period|Death|0|||
127496321|NCT02574078|458779241|FG004|Treatment Period|Death|1|||
127496322|NCT02574078|458779242|FG005|Treatment Period|Death|1|||
127496323|NCT02574078|458779243|FG006|Treatment Period|Death|1|||
127496324|NCT02574078|458779244|FG007|Treatment Period|Death|1|||
127496325|NCT02574078|458779245|FG008|Treatment Period|Death|7|||
127977530|NCT02031640|460540309|FG004|Run-In Period|Inclusion criteria not met|0|||
127977531|NCT02031640|460540310|FG005|Run-In Period|Inclusion criteria not met|0|||
127977532|NCT02031640|460540305|FG000|Run-In Period|Exclusion criteria met|8|||
127977533|NCT02031640|460540306|FG001|Run-In Period|Exclusion criteria met|0|||
127977534|NCT02031640|460540307|FG002|Run-In Period|Exclusion criteria met|0|||
127977535|NCT02031640|460540308|FG003|Run-In Period|Exclusion criteria met|0|||
127977536|NCT02031640|460540309|FG004|Run-In Period|Exclusion criteria met|0|||
127977537|NCT02031640|460540310|FG005|Run-In Period|Exclusion criteria met|0|||
127977538|NCT02031640|460540305|FG000|Run-In Period|Randomization criteria not met|85|||
127977539|NCT02031640|460540306|FG001|Run-In Period|Randomization criteria not met|0|||
127977540|NCT02031640|460540307|FG002|Run-In Period|Randomization criteria not met|0|||
127977541|NCT02031640|460540308|FG003|Run-In Period|Randomization criteria not met|0|||
127977542|NCT02031640|460540309|FG004|Run-In Period|Randomization criteria not met|0|||
127977543|NCT02031640|460540310|FG005|Run-In Period|Randomization criteria not met|0|||
127977544|NCT02031640|460540305|FG000|Run-In Period|Various administrative reasons|17|||
127977545|NCT02031640|460540306|FG001|Run-In Period|Various administrative reasons|0|||
127977546|NCT02031640|460540307|FG002|Run-In Period|Various administrative reasons|0|||
127977547|NCT02031640|460540308|FG003|Run-In Period|Various administrative reasons|0|||
127977548|NCT02031640|460540309|FG004|Run-In Period|Various administrative reasons|0|||
127977549|NCT02031640|460540310|FG005|Run-In Period|Various administrative reasons|0|||
127977550|NCT02031640|460540305|FG000|Double-blind Treatment Period|Protocol deviation|0|||
127977551|NCT02031640|460540306|FG001|Double-blind Treatment Period|Protocol deviation|2|||
127977552|NCT02031640|460540307|FG002|Double-blind Treatment Period|Protocol deviation|0|||
127977553|NCT02031640|460540308|FG003|Double-blind Treatment Period|Protocol deviation|1|||
127977554|NCT02031640|460540309|FG004|Double-blind Treatment Period|Protocol deviation|3|||
127977555|NCT02031640|460540310|FG005|Double-blind Treatment Period|Protocol deviation|1|||
127977556|NCT02031640|460540305|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
127977557|NCT02031640|460540306|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
127496326|NCT02574078|458779246|FG009|Treatment Period|Death|1|||
127496327|NCT02574078|458779247|FG010|Treatment Period|Death|0|||
127496328|NCT02574078|458779248|FG011|Treatment Period|Death|2|||
127496329|NCT02574078|458779249|FG012|Treatment Period|Death|1|||
127496330|NCT02574078|458779237|FG000|Treatment Period|Adverse event unrelated to drug|0|||
127496331|NCT02574078|458779238|FG001|Treatment Period|Adverse event unrelated to drug|0|||
127496332|NCT02574078|458779239|FG002|Treatment Period|Adverse event unrelated to drug|1|||
127496333|NCT02574078|458779240|FG003|Treatment Period|Adverse event unrelated to drug|0|||
127496334|NCT02574078|458779241|FG004|Treatment Period|Adverse event unrelated to drug|2|||
127496335|NCT02574078|458779242|FG005|Treatment Period|Adverse event unrelated to drug|3|||
127496336|NCT02574078|458779243|FG006|Treatment Period|Adverse event unrelated to drug|0|||
127496337|NCT02574078|458779244|FG007|Treatment Period|Adverse event unrelated to drug|0|||
127496338|NCT02574078|458779245|FG008|Treatment Period|Adverse event unrelated to drug|1|||
127977558|NCT02031640|460540307|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
127977559|NCT02031640|460540308|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
127496339|NCT02574078|458779246|FG009|Treatment Period|Adverse event unrelated to drug|2|||
127496340|NCT02574078|458779247|FG010|Treatment Period|Adverse event unrelated to drug|4|||
127496341|NCT02574078|458779248|FG011|Treatment Period|Adverse event unrelated to drug|1|||
127496342|NCT02574078|458779249|FG012|Treatment Period|Adverse event unrelated to drug|0|||
127496343|NCT02574078|458779237|FG000|Treatment Period|Administrative reason by Sponsor|0|||
127496344|NCT02574078|458779238|FG001|Treatment Period|Administrative reason by Sponsor|1|||
127496345|NCT02574078|458779239|FG002|Treatment Period|Administrative reason by Sponsor|0|||
127496346|NCT02574078|458779240|FG003|Treatment Period|Administrative reason by Sponsor|0|||
127496347|NCT02574078|458779241|FG004|Treatment Period|Administrative reason by Sponsor|0|||
127496348|NCT02574078|458779242|FG005|Treatment Period|Administrative reason by Sponsor|0|||
127496349|NCT02574078|458779243|FG006|Treatment Period|Administrative reason by Sponsor|1|||
127496350|NCT02574078|458779244|FG007|Treatment Period|Administrative reason by Sponsor|0|||
127496351|NCT02574078|458779245|FG008|Treatment Period|Administrative reason by Sponsor|0|||
127496352|NCT02574078|458779246|FG009|Treatment Period|Administrative reason by Sponsor|0|||
127496353|NCT02574078|458779247|FG010|Treatment Period|Administrative reason by Sponsor|0|||
127496354|NCT02574078|458779248|FG011|Treatment Period|Administrative reason by Sponsor|0|||
127496355|NCT02574078|458779249|FG012|Treatment Period|Administrative reason by Sponsor|3|||
127496356|NCT02574078|458779237|FG000|Treatment Period|Other reasons|1|||
127496357|NCT02574078|458779238|FG001|Treatment Period|Other reasons|0|||
127496358|NCT02574078|458779239|FG002|Treatment Period|Other reasons|1|||
127496359|NCT02574078|458779240|FG003|Treatment Period|Other reasons|3|||
127496360|NCT02574078|458779241|FG004|Treatment Period|Other reasons|3|||
127496361|NCT02574078|458779242|FG005|Treatment Period|Other reasons|1|||
127496362|NCT02574078|458779243|FG006|Treatment Period|Other reasons|2|||
127496363|NCT02574078|458779244|FG007|Treatment Period|Other reasons|1|||
127496364|NCT02574078|458779245|FG008|Treatment Period|Other reasons|3|||
127496365|NCT02574078|458779246|FG009|Treatment Period|Other reasons|1|||
127496366|NCT02574078|458779247|FG010|Treatment Period|Other reasons|1|||
127496367|NCT02574078|458779248|FG011|Treatment Period|Other reasons|3|||
127496368|NCT02574078|458779249|FG012|Treatment Period|Other reasons|1|||
127496369|NCT02574078|458779237|FG000|Treatment Period|Participant request to stop drug|0|||
127496370|NCT02574078|458779238|FG001|Treatment Period|Participant request to stop drug|0|||
127496371|NCT02574078|458779239|FG002|Treatment Period|Participant request to stop drug|0|||
127496372|NCT02574078|458779240|FG003|Treatment Period|Participant request to stop drug|2|||
127496373|NCT02574078|458779241|FG004|Treatment Period|Participant request to stop drug|4|||
127496374|NCT02574078|458779242|FG005|Treatment Period|Participant request to stop drug|0|||
127496375|NCT02574078|458779243|FG006|Treatment Period|Participant request to stop drug|1|||
127496376|NCT02574078|458779244|FG007|Treatment Period|Participant request to stop drug|0|||
127496377|NCT02574078|458779245|FG008|Treatment Period|Participant request to stop drug|3|||
127496378|NCT02574078|458779246|FG009|Treatment Period|Participant request to stop drug|2|||
127496379|NCT02574078|458779247|FG010|Treatment Period|Participant request to stop drug|2|||
127496380|NCT02574078|458779248|FG011|Treatment Period|Participant request to stop drug|4|||
127496381|NCT02574078|458779249|FG012|Treatment Period|Participant request to stop drug|1|||
127496382|NCT02574078|458779237|FG000|Treatment Period|Participant withdrew consent|0|||
127496383|NCT02574078|458779238|FG001|Treatment Period|Participant withdrew consent|0|||
127496384|NCT02574078|458779239|FG002|Treatment Period|Participant withdrew consent|0|||
127496385|NCT02574078|458779240|FG003|Treatment Period|Participant withdrew consent|0|||
127496386|NCT02574078|458779241|FG004|Treatment Period|Participant withdrew consent|1|||
127496387|NCT02574078|458779242|FG005|Treatment Period|Participant withdrew consent|1|||
127496388|NCT02574078|458779243|FG006|Treatment Period|Participant withdrew consent|0|||
127496389|NCT02574078|458779244|FG007|Treatment Period|Participant withdrew consent|1|||
127496390|NCT02574078|458779245|FG008|Treatment Period|Participant withdrew consent|0|||
127496391|NCT02574078|458779246|FG009|Treatment Period|Participant withdrew consent|2|||
127496392|NCT02574078|458779247|FG010|Treatment Period|Participant withdrew consent|1|||
127496393|NCT02574078|458779248|FG011|Treatment Period|Participant withdrew consent|4|||
127496394|NCT02574078|458779249|FG012|Treatment Period|Participant withdrew consent|1|||
127496395|NCT02574078|458779237|FG000|Treatment Period|Participant no longer meets criteria|0|||
127496396|NCT02574078|458779238|FG001|Treatment Period|Participant no longer meets criteria|0|||
127496397|NCT02574078|458779239|FG002|Treatment Period|Participant no longer meets criteria|0|||
127496398|NCT02574078|458779240|FG003|Treatment Period|Participant no longer meets criteria|0|||
127977560|NCT02031640|460540309|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
127977561|NCT02031640|460540310|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
127496399|NCT02574078|458779241|FG004|Treatment Period|Participant no longer meets criteria|1|||
127496400|NCT02574078|458779242|FG005|Treatment Period|Participant no longer meets criteria|0|||
127496401|NCT02574078|458779243|FG006|Treatment Period|Participant no longer meets criteria|0|||
127496402|NCT02574078|458779244|FG007|Treatment Period|Participant no longer meets criteria|0|||
127496403|NCT02574078|458779245|FG008|Treatment Period|Participant no longer meets criteria|0|||
127496404|NCT02574078|458779246|FG009|Treatment Period|Participant no longer meets criteria|1|||
127496405|NCT02574078|458779247|FG010|Treatment Period|Participant no longer meets criteria|1|||
127496406|NCT02574078|458779248|FG011|Treatment Period|Participant no longer meets criteria|1|||
127496407|NCT02574078|458779249|FG012|Treatment Period|Participant no longer meets criteria|0|||
127496408|NCT02574078|458779237|FG000|Treatment Period|Lost to Follow-up|0|||
127496409|NCT02574078|458779238|FG001|Treatment Period|Lost to Follow-up|0|||
127496410|NCT02574078|458779239|FG002|Treatment Period|Lost to Follow-up|0|||
127496411|NCT02574078|458779240|FG003|Treatment Period|Lost to Follow-up|0|||
127496412|NCT02574078|458779241|FG004|Treatment Period|Lost to Follow-up|0|||
127496413|NCT02574078|458779242|FG005|Treatment Period|Lost to Follow-up|0|||
127496414|NCT02574078|458779243|FG006|Treatment Period|Lost to Follow-up|0|||
127496415|NCT02574078|458779244|FG007|Treatment Period|Lost to Follow-up|0|||
127496416|NCT02574078|458779245|FG008|Treatment Period|Lost to Follow-up|0|||
127496417|NCT02574078|458779246|FG009|Treatment Period|Lost to Follow-up|1|||
127496418|NCT02574078|458779247|FG010|Treatment Period|Lost to Follow-up|0|||
127496419|NCT02574078|458779248|FG011|Treatment Period|Lost to Follow-up|1|||
127496420|NCT02574078|458779249|FG012|Treatment Period|Lost to Follow-up|0|||
127496421|NCT02574078|458779237|FG000|Treatment Period|Maximum clinical benefit|0|||
127496422|NCT02574078|458779238|FG001|Treatment Period|Maximum clinical benefit|0|||
127496423|NCT02574078|458779239|FG002|Treatment Period|Maximum clinical benefit|0|||
127496424|NCT02574078|458779240|FG003|Treatment Period|Maximum clinical benefit|0|||
127496425|NCT02574078|458779241|FG004|Treatment Period|Maximum clinical benefit|0|||
127496426|NCT02574078|458779242|FG005|Treatment Period|Maximum clinical benefit|0|||
127496427|NCT02574078|458779243|FG006|Treatment Period|Maximum clinical benefit|0|||
127496428|NCT02574078|458779244|FG007|Treatment Period|Maximum clinical benefit|0|||
127496429|NCT02574078|458779245|FG008|Treatment Period|Maximum clinical benefit|0|||
127496430|NCT02574078|458779246|FG009|Treatment Period|Maximum clinical benefit|1|||
127496431|NCT02574078|458779247|FG010|Treatment Period|Maximum clinical benefit|0|||
127496432|NCT02574078|458779248|FG011|Treatment Period|Maximum clinical benefit|0|||
127496433|NCT02574078|458779249|FG012|Treatment Period|Maximum clinical benefit|0|||
127496434|NCT03037476|458779255|FG000|Overall Study|Lost to Follow-up|63|||
127496435|NCT03037476|458779256|FG001|Overall Study|Lost to Follow-up|46|||
127496436|NCT01498692|458779259|FG000|Overall Study|Death|4|||
127496437|NCT01498692|458779259|FG000|Overall Study|Withdrawal by Subject|1|||
127496438|NCT01498692|458779259|FG000|Overall Study|Missed 12-month visit|3|||
127496439|NCT03050450|458779260|FG000|Overall Study|Physician Decision|1|||
127496440|NCT03050450|458779261|FG001|Overall Study|Physician Decision|0|||
127496441|NCT03050450|458779262|FG002|Overall Study|Physician Decision|0|||
127496442|NCT03050450|458779263|FG003|Overall Study|Physician Decision|0|||
127496443|NCT03050450|458779264|FG004|Overall Study|Physician Decision|0|||
127496444|NCT00590122|458779265|FG000|Overall Study|swallowed oral dissolving dose|1|||
127496445|NCT00590122|458779266|FG001|Overall Study|swallowed oral dissolving dose|0|||
127496446|NCT00711594|458779267|FG000|Overall Study|Progressive disease|2|||
127496447|NCT00711594|458779268|FG001|Overall Study|Progressive disease|2|||
127496448|NCT00711594|458779269|FG002|Overall Study|Progressive disease|6|||
127496449|NCT00711594|458779270|FG003|Overall Study|Progressive disease|44|||
127496450|NCT00711594|458779267|FG000|Overall Study|Other Adverse Event|1|||
127496451|NCT00711594|458779268|FG001|Overall Study|Other Adverse Event|0|||
127496452|NCT00711594|458779269|FG002|Overall Study|Other Adverse Event|0|||
127496453|NCT00711594|458779270|FG003|Overall Study|Other Adverse Event|16|||
127496454|NCT00711594|458779267|FG000|Overall Study|Withdrawal by Subject|0|||
127496455|NCT00711594|458779268|FG001|Overall Study|Withdrawal by Subject|1|||
127496456|NCT00711594|458779269|FG002|Overall Study|Withdrawal by Subject|0|||
127496457|NCT00711594|458779270|FG003|Overall Study|Withdrawal by Subject|2|||
127496458|NCT00443872|458779271|FG000|Overall Study|Protocol Violation|7|||
127496459|NCT00443872|458779271|FG000|Overall Study|Lost to Follow-up|2|||
127496460|NCT00443872|458779271|FG000|Overall Study|Adverse Event|8|||
127496461|NCT00135330|458779272|FG000|Overall Study|Adverse Event|2|||
127496462|NCT00135330|458779273|FG001|Overall Study|Adverse Event|5|||
127496463|NCT00135330|458779274|FG002|Overall Study|Adverse Event|1|||
127496464|NCT00135330|458779272|FG000|Overall Study|Lost to Follow-up|0|||
127496465|NCT00135330|458779273|FG001|Overall Study|Lost to Follow-up|2|||
127496466|NCT00135330|458779274|FG002|Overall Study|Lost to Follow-up|3|||
127496467|NCT00135330|458779272|FG000|Overall Study|Physician Decision|1|||
127496468|NCT00135330|458779273|FG001|Overall Study|Physician Decision|1|||
127496469|NCT00135330|458779274|FG002|Overall Study|Physician Decision|0|||
127496470|NCT00135330|458779272|FG000|Overall Study|Protocol Violation|4|||
127496471|NCT00135330|458779273|FG001|Overall Study|Protocol Violation|3|||
127496472|NCT00135330|458779274|FG002|Overall Study|Protocol Violation|3|||
127496473|NCT00135330|458779272|FG000|Overall Study|Patient Decision|5|||
127496474|NCT00135330|458779273|FG001|Overall Study|Patient Decision|1|||
127496475|NCT00135330|458779274|FG002|Overall Study|Patient Decision|4|||
127496476|NCT00135330|458779272|FG000|Overall Study|Sponsor Decision|0|||
127496477|NCT00135330|458779273|FG001|Overall Study|Sponsor Decision|1|||
127496478|NCT00135330|458779274|FG002|Overall Study|Sponsor Decision|0|||
127496479|NCT00615719|458779279|FG000|Overall Study|Physician Decision|5|||
127496480|NCT03748706|458779280|FG000|Overall Study|Lost to Follow-up|1|||
127496481|NCT03517371|458779281|FG000|Overall Study|Adverse Event|8|||
127496482|NCT03517371|458779282|FG001|Overall Study|Adverse Event|9|||
127496483|NCT03517371|458779281|FG000|Overall Study|Lost to Follow-up|1|||
127496484|NCT03517371|458779282|FG001|Overall Study|Lost to Follow-up|2|||
127496485|NCT03517371|458779281|FG000|Overall Study|Withdrawal by Subject|4|||
127496486|NCT03517371|458779282|FG001|Overall Study|Withdrawal by Subject|4|||
127496487|NCT03517371|458779281|FG000|Overall Study|Not idiopathic Parkinson's disease|0|||
127496488|NCT03517371|458779282|FG001|Overall Study|Not idiopathic Parkinson's disease|3|||
127496489|NCT03517371|458779281|FG000|Overall Study|COVID restrictions|2|||
127496490|NCT03517371|458779282|FG001|Overall Study|COVID restrictions|0|||
127496491|NCT03517371|458779281|FG000|Overall Study|Receiving DBS Surgery|0|||
127496492|NCT03517371|458779282|FG001|Overall Study|Receiving DBS Surgery|1|||
127496493|NCT05420961|458779283|FG000|Overall Study|Withdrawal by Subject|2|||
127496494|NCT05420961|458779284|FG001|Overall Study|Withdrawal by Subject|1|||
127496495|NCT05420961|458779285|FG002|Overall Study|Withdrawal by Subject|1|||
127496496|NCT05420961|458779286|FG003|Overall Study|Withdrawal by Subject|0|||
127496497|NCT05420961|458779287|FG004|Overall Study|Withdrawal by Subject|0|||
127496498|NCT05420961|458779283|FG000|Overall Study|Lost to Follow-up|0|||
127496499|NCT05420961|458779284|FG001|Overall Study|Lost to Follow-up|0|||
127496500|NCT05420961|458779285|FG002|Overall Study|Lost to Follow-up|1|||
127496501|NCT05420961|458779286|FG003|Overall Study|Lost to Follow-up|0|||
127496502|NCT05420961|458779287|FG004|Overall Study|Lost to Follow-up|0|||
127496503|NCT05420961|458779283|FG000|Overall Study|Randomized by mistake without study treatment|0|||
127496504|NCT05420961|458779284|FG001|Overall Study|Randomized by mistake without study treatment|0|||
127496505|NCT05420961|458779285|FG002|Overall Study|Randomized by mistake without study treatment|1|||
127496506|NCT05420961|458779286|FG003|Overall Study|Randomized by mistake without study treatment|0|||
127496507|NCT05420961|458779287|FG004|Overall Study|Randomized by mistake without study treatment|1|||
127496508|NCT04283656|458779288|FG000|Overall Study|Adverse Event|1|||
127496509|NCT04283656|458779289|FG001|Overall Study|Adverse Event|0|||
127496510|NCT04283656|458779288|FG000|Overall Study|Lost to Follow-up|0|||
127496511|NCT04283656|458779289|FG001|Overall Study|Lost to Follow-up|1|||
127496512|NCT00935493|458779290|FG000|Overall Study|Lost to Follow-up|1|||
127496513|NCT00935493|458779291|FG001|Overall Study|Lost to Follow-up|1|||
127496514|NCT00935493|458779292|FG002|Overall Study|Lost to Follow-up|1|||
127496515|NCT00935493|458779290|FG000|Overall Study|Treatment Discontinued|0|||
127496516|NCT00935493|458779291|FG001|Overall Study|Treatment Discontinued|1|||
127496517|NCT00935493|458779292|FG002|Overall Study|Treatment Discontinued|0|||
127496518|NCT01555073|458779293|FG000|Overall Study|Lost to Follow-up|1|||
127496519|NCT01555073|458779294|FG001|Overall Study|Lost to Follow-up|2|||
127496520|NCT01555073|458779295|FG002|Overall Study|Lost to Follow-up|0|||
127496521|NCT01555073|458779296|FG003|Overall Study|Lost to Follow-up|5|||
127496522|NCT02565147|458779299|FG000|Overall Study|Withdrawal by Subject|5|||
127496523|NCT02565147|458779300|FG001|Overall Study|Withdrawal by Subject|1|||
127496524|NCT02565147|458779299|FG000|Overall Study|Lost to Follow-up|0|||
127496525|NCT02565147|458779300|FG001|Overall Study|Lost to Follow-up|1|||
127496526|NCT02565147|458779299|FG000|Overall Study|Death|1|||
127496527|NCT02565147|458779300|FG001|Overall Study|Death|1|||
127496528|NCT00335738|458779301|FG000|Overall Study|Physician Decision|6|||
127496529|NCT00335738|458779302|FG001|Overall Study|Physician Decision|0|||
127496530|NCT00335738|458779301|FG000|Overall Study|Withdrawal by Subject|2|||
127496531|NCT00335738|458779302|FG001|Overall Study|Withdrawal by Subject|0|||
127496532|NCT00335738|458779301|FG000|Overall Study|Ineligible|3|||
127496533|NCT00335738|458779302|FG001|Overall Study|Ineligible|4|||
127496534|NCT00992056|458779309|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
127496535|NCT00992056|458779310|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
127496536|NCT00992056|458779309|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
127496537|NCT00992056|458779310|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
127496538|NCT01001767|458779311|FG000|Overall Study|no baseline study performed|1|||
127496539|NCT01001767|458779312|FG001|Overall Study|no baseline study performed|0|||
127496540|NCT01001767|458779311|FG000|Overall Study|Protocol Violation|1|||
127496541|NCT01001767|458779312|FG001|Overall Study|Protocol Violation|0|||
127496542|NCT01001767|458779311|FG000|Overall Study|Lost to Follow-up|1|||
127496543|NCT01001767|458779312|FG001|Overall Study|Lost to Follow-up|0|||
127496544|NCT01001767|458779311|FG000|Overall Study|Physician Decision|1|||
127496545|NCT01001767|458779312|FG001|Overall Study|Physician Decision|0|||
127496546|NCT01667133|458779314|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
127496547|NCT01667133|458779315|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
127496548|NCT01667133|458779316|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
127496549|NCT01667133|458779317|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
127496550|NCT01667133|458779318|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
127496551|NCT01667133|458779319|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
127496552|NCT01667133|458779320|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
127496553|NCT01667133|458779321|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
127496554|NCT01667133|458779322|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
127496555|NCT01667133|458779323|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
127496556|NCT01667133|458779324|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
127496557|NCT01667133|458779325|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
127496558|NCT01667133|458779314|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
127496559|NCT01667133|458779315|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
127496560|NCT01667133|458779316|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
127496561|NCT01667133|458779317|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
127496562|NCT01667133|458779318|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
127496563|NCT01667133|458779319|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
127496564|NCT01667133|458779320|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
127496565|NCT01667133|458779321|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
127496566|NCT01667133|458779322|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
127496567|NCT01667133|458779323|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
127496568|NCT01667133|458779324|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
127496569|NCT01667133|458779325|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
127496570|NCT01667133|458779314|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
127496571|NCT01667133|458779315|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
127496572|NCT01667133|458779316|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
127496573|NCT01667133|458779317|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
127496574|NCT01667133|458779318|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
127496575|NCT01667133|458779319|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
127496576|NCT01667133|458779320|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
127496577|NCT01667133|458779321|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
127496578|NCT01667133|458779322|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
127496579|NCT01667133|458779323|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
127496580|NCT01667133|458779324|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
127496581|NCT01667133|458779325|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
127496582|NCT01667133|458779314|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
127496583|NCT01667133|458779315|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
127496584|NCT01667133|458779316|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
127496585|NCT01667133|458779317|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
127496586|NCT01667133|458779318|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
127496587|NCT01667133|458779319|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
127496588|NCT01667133|458779320|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
127496589|NCT01667133|458779321|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
127496590|NCT01667133|458779322|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
127496591|NCT01667133|458779323|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
127496592|NCT01667133|458779324|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
127496593|NCT01667133|458779325|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
127496594|NCT01667133|458779314|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
127496595|NCT01667133|458779315|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
127496596|NCT01667133|458779316|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
127496597|NCT01667133|458779317|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
127496598|NCT01667133|458779318|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
127496599|NCT01667133|458779319|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
127496600|NCT01667133|458779320|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
127496601|NCT01667133|458779321|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
127496602|NCT01667133|458779322|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
127496603|NCT01667133|458779323|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
127496604|NCT01667133|458779324|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
127496605|NCT01667133|458779325|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
127496606|NCT01667133|458779314|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
127496607|NCT01667133|458779315|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
127496608|NCT01667133|458779316|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
127496609|NCT01667133|458779317|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
127496610|NCT01667133|458779318|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
127496611|NCT01667133|458779319|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
127496612|NCT01667133|458779320|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
127496613|NCT01667133|458779321|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
127496614|NCT01667133|458779322|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
127496615|NCT01667133|458779323|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
127496616|NCT01667133|458779324|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
127496617|NCT01667133|458779325|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
127496618|NCT01667133|458779314|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
127496619|NCT01667133|458779315|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
127496620|NCT01667133|458779316|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
127496621|NCT01667133|458779317|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
127496622|NCT01667133|458779318|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
127977562|NCT02031640|460540305|FG000|Double-blind Treatment Period|Non-compliance|0|||
127977563|NCT02031640|460540306|FG001|Double-blind Treatment Period|Non-compliance|1|||
127977564|NCT02031640|460540307|FG002|Double-blind Treatment Period|Non-compliance|0|||
127977565|NCT02031640|460540308|FG003|Double-blind Treatment Period|Non-compliance|1|||
127496623|NCT01667133|458779319|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
127977566|NCT02031640|460540309|FG004|Double-blind Treatment Period|Non-compliance|1|||
127496624|NCT01667133|458779320|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
127496625|NCT01667133|458779321|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
127496626|NCT01667133|458779322|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
127496627|NCT01667133|458779323|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
127977567|NCT02031640|460540310|FG005|Double-blind Treatment Period|Non-compliance|0|||
127496628|NCT01667133|458779324|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
127496629|NCT01667133|458779325|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
127496630|NCT01667133|458779314|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
127496631|NCT01667133|458779315|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
127496632|NCT01667133|458779316|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
127496633|NCT01667133|458779317|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
127496634|NCT01667133|458779318|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
127496635|NCT01667133|458779319|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
127496636|NCT01667133|458779320|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
127496637|NCT01667133|458779321|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
127496638|NCT01667133|458779322|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
127496639|NCT01667133|458779323|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
127496640|NCT01667133|458779324|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
127496641|NCT01667133|458779325|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
127496642|NCT01667133|458779314|FG000|Phase 2: Dose-expansion|Death|0|||
127496643|NCT01667133|458779315|FG001|Phase 2: Dose-expansion|Death|0|||
127496644|NCT01667133|458779316|FG002|Phase 2: Dose-expansion|Death|0|||
127496645|NCT01667133|458779317|FG003|Phase 2: Dose-expansion|Death|0|||
127496646|NCT01667133|458779318|FG004|Phase 2: Dose-expansion|Death|0|||
127496647|NCT01667133|458779319|FG005|Phase 2: Dose-expansion|Death|0|||
127496648|NCT01667133|458779320|FG006|Phase 2: Dose-expansion|Death|0|||
127496649|NCT01667133|458779321|FG007|Phase 2: Dose-expansion|Death|0|||
127496650|NCT01667133|458779322|FG008|Phase 2: Dose-expansion|Death|0|||
127496651|NCT01667133|458779323|FG009|Phase 2: Dose-expansion|Death|1|||
127496652|NCT01667133|458779324|FG010|Phase 2: Dose-expansion|Death|0|||
127496653|NCT01667133|458779325|FG011|Phase 2: Dose-expansion|Death|0|||
127496654|NCT01667133|458779314|FG000|Phase 2: Dose-expansion|Other|0|||
127496655|NCT01667133|458779315|FG001|Phase 2: Dose-expansion|Other|0|||
127496656|NCT01667133|458779316|FG002|Phase 2: Dose-expansion|Other|0|||
127496657|NCT01667133|458779317|FG003|Phase 2: Dose-expansion|Other|0|||
127496658|NCT01667133|458779318|FG004|Phase 2: Dose-expansion|Other|0|||
127496659|NCT01667133|458779319|FG005|Phase 2: Dose-expansion|Other|0|||
127496660|NCT01667133|458779320|FG006|Phase 2: Dose-expansion|Other|0|||
127496661|NCT01667133|458779321|FG007|Phase 2: Dose-expansion|Other|0|||
127496662|NCT01667133|458779322|FG008|Phase 2: Dose-expansion|Other|0|||
127496663|NCT01667133|458779323|FG009|Phase 2: Dose-expansion|Other|0|||
127496664|NCT01667133|458779324|FG010|Phase 2: Dose-expansion|Other|0|||
127496665|NCT01667133|458779325|FG011|Phase 2: Dose-expansion|Other|1|||
127496666|NCT00289289|458779329|FG000|Overall Study|Withdrawal by Subject|5|||
127496667|NCT00289289|458779330|FG001|Overall Study|Withdrawal by Subject|3|||
127496668|NCT00289289|458779331|FG002|Overall Study|Withdrawal by Subject|15|||
127496669|NCT00289289|458779329|FG000|Overall Study|Lost to Follow-up|1|||
127496670|NCT00289289|458779330|FG001|Overall Study|Lost to Follow-up|0|||
127496671|NCT00289289|458779331|FG002|Overall Study|Lost to Follow-up|1|||
127496672|NCT00289289|458779329|FG000|Overall Study|Death|4|||
127496673|NCT00289289|458779330|FG001|Overall Study|Death|2|||
127496674|NCT00289289|458779331|FG002|Overall Study|Death|5|||
127496675|NCT00289289|458779329|FG000|Overall Study|No implant attempted|0|||
127496676|NCT00289289|458779330|FG001|Overall Study|No implant attempted|0|||
127496677|NCT00289289|458779331|FG002|Overall Study|No implant attempted|1|||
127496678|NCT00289289|458779329|FG000|Overall Study|Physician Decision|1|||
127496679|NCT00289289|458779330|FG001|Overall Study|Physician Decision|0|||
127496680|NCT00289289|458779331|FG002|Overall Study|Physician Decision|6|||
127496681|NCT00289289|458779329|FG000|Overall Study|Non-study device implanted|2|||
127496682|NCT00289289|458779330|FG001|Overall Study|Non-study device implanted|1|||
127496683|NCT00289289|458779331|FG002|Overall Study|Non-study device implanted|3|||
127496684|NCT00289289|458779329|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
127496685|NCT00289289|458779330|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
127496686|NCT00289289|458779331|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
127496687|NCT00289289|458779329|FG000|Overall Study|Other Exit Reason|6|||
127496688|NCT00289289|458779330|FG001|Overall Study|Other Exit Reason|4|||
127496689|NCT00289289|458779331|FG002|Overall Study|Other Exit Reason|12|||
127496690|NCT03028129|458779337|FG000|Overall Study|Adverse Event|13|||
127496691|NCT03028129|458779338|FG001|Overall Study|Adverse Event|2|||
127496692|NCT03028129|458779337|FG000|Overall Study|Lost to Follow-up|50|||
127496693|NCT03028129|458779338|FG001|Overall Study|Lost to Follow-up|38|||
127496694|NCT03028129|458779337|FG000|Overall Study|Physician Decision|0|||
127496695|NCT03028129|458779338|FG001|Overall Study|Physician Decision|1|||
127496696|NCT03028129|458779337|FG000|Overall Study|Protocol Violation|1|||
127496697|NCT03028129|458779338|FG001|Overall Study|Protocol Violation|1|||
127496698|NCT03028129|458779337|FG000|Overall Study|Withdrawal by Subject|62|||
127496699|NCT03028129|458779338|FG001|Overall Study|Withdrawal by Subject|45|||
127496700|NCT01696981|458779340|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
127496701|NCT01696981|458779341|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
127496702|NCT01696981|458779340|FG000|Overall Study|Died Before Randomization|3|||
127496703|NCT01696981|458779341|FG001|Overall Study|Died Before Randomization|8|||
127977568|NCT02031640|460540305|FG000|Double-blind Treatment Period|Adverse Event|0|||
127496704|NCT01696981|458779340|FG000|Overall Study|Died Before ASU (Control)|278|||
127496705|NCT01696981|458779341|FG001|Overall Study|Died Before ASU (Control)|0|||
127496706|NCT01696981|458779340|FG000|Overall Study|Refused ASU (Control)|920|||
127496707|NCT01696981|458779341|FG001|Overall Study|Refused ASU (Control)|0|||
127496708|NCT01696981|458779340|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
127496709|NCT01696981|458779341|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
127496710|NCT01854775|458779342|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
127496711|NCT01854775|458779343|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
127496712|NCT01854775|458779344|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0|||
127496713|NCT01854775|458779342|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
127496714|NCT01854775|458779343|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
127496715|NCT01854775|458779344|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
127496716|NCT01854775|458779342|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
127496717|NCT01854775|458779343|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
127496718|NCT01854775|458779344|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9|||
127496719|NCT01854775|458779342|FG000|Extension Phase|Pregnancy|3|||
127496720|NCT01854775|458779343|FG001|Extension Phase|Pregnancy|0|||
127496721|NCT01854775|458779344|FG002|Extension Phase|Pregnancy|0|||
127496722|NCT01854775|458779342|FG000|Extension Phase|Investigator's Discretion|1|||
127496723|NCT01854775|458779343|FG001|Extension Phase|Investigator's Discretion|0|||
127496724|NCT01854775|458779344|FG002|Extension Phase|Investigator's Discretion|0|||
127496725|NCT01854775|458779342|FG000|Extension Phase|Non-Compliance with Study Drug|1|||
127496726|NCT01854775|458779343|FG001|Extension Phase|Non-Compliance with Study Drug|0|||
127496727|NCT01854775|458779344|FG002|Extension Phase|Non-Compliance with Study Drug|0|||
127496728|NCT01854775|458779342|FG000|Extension Phase|Lost to Follow-up|2|||
127496729|NCT01854775|458779343|FG001|Extension Phase|Lost to Follow-up|0|||
127496730|NCT01854775|458779344|FG002|Extension Phase|Lost to Follow-up|0|||
127496731|NCT01854775|458779342|FG000|Extension Phase|Still on Study|32|||
127496732|NCT01854775|458779343|FG001|Extension Phase|Still on Study|47|||
127496733|NCT01854775|458779344|FG002|Extension Phase|Still on Study|18|||
127496734|NCT00281099|458779348|FG000|Overall Study|Death|46|||
127496735|NCT00281099|458779349|FG001|Overall Study|Death|57|||
127496736|NCT00281099|458779348|FG000|Overall Study|Lost to Follow-up|10|||
127496737|NCT00281099|458779349|FG001|Overall Study|Lost to Follow-up|19|||
127496738|NCT00281099|458779348|FG000|Overall Study|Withdrawal by Subject|65|||
127496739|NCT00281099|458779349|FG001|Overall Study|Withdrawal by Subject|70|||
127496740|NCT00281099|458779348|FG000|Overall Study|Physician Decision|79|||
127496741|NCT00281099|458779349|FG001|Overall Study|Physician Decision|72|||
127496742|NCT00281099|458779348|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
127496743|NCT00281099|458779349|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
127496744|NCT01059864|458779356|FG000|Open-Label Run-In Phase|Adverse Event|7|||
127496745|NCT01059864|458779357|FG001|Open-Label Run-In Phase|Adverse Event|0|||
127496746|NCT01059864|458779358|FG002|Open-Label Run-In Phase|Adverse Event|0|||
127496747|NCT01059864|458779356|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
127496748|NCT01059864|458779357|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
127496749|NCT01059864|458779358|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
127496750|NCT01059864|458779356|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
127496751|NCT01059864|458779357|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
127496752|NCT01059864|458779358|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
127496753|NCT01059864|458779356|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
127496754|NCT01059864|458779357|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
127496755|NCT01059864|458779358|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
127496756|NCT01059864|458779356|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
127496757|NCT01059864|458779357|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
127496758|NCT01059864|458779358|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
127496759|NCT01059864|458779356|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
127977569|NCT02031640|460540306|FG001|Double-blind Treatment Period|Adverse Event|0|||
127496760|NCT01059864|458779357|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
127496761|NCT01059864|458779358|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
127496762|NCT00451958|458779359|FG000|CS21A (NCT00451958)|Adverse Event|21|||
127496763|NCT00451958|458779360|FG001|CS21A (NCT00451958)|Adverse Event|34|||
127496764|NCT00451958|458779361|FG002|CS21A (NCT00451958)|Adverse Event|14|||
127496765|NCT00451958|458779362|FG003|CS21A (NCT00451958)|Adverse Event|17|||
127496766|NCT00451958|458779363|FG004|CS21A (NCT00451958)|Adverse Event|0|||
127496767|NCT00451958|458779359|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
127496768|NCT00451958|458779360|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
127496769|NCT00451958|458779361|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
127496770|NCT00451958|458779362|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
127496771|NCT00451958|458779363|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
127496772|NCT00451958|458779359|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
127496773|NCT00451958|458779360|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
127496774|NCT00451958|458779361|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
127496775|NCT00451958|458779362|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
127496776|NCT00451958|458779363|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
127496777|NCT00451958|458779359|FG000|CS21A (NCT00451958)|Physician Decision|2|||
127496778|NCT00451958|458779360|FG001|CS21A (NCT00451958)|Physician Decision|4|||
127496779|NCT00451958|458779361|FG002|CS21A (NCT00451958)|Physician Decision|4|||
127496780|NCT00451958|458779362|FG003|CS21A (NCT00451958)|Physician Decision|4|||
127977570|NCT02031640|460540307|FG002|Double-blind Treatment Period|Adverse Event|0|||
127977571|NCT02031640|460540308|FG003|Double-blind Treatment Period|Adverse Event|2|||
127977572|NCT02031640|460540309|FG004|Double-blind Treatment Period|Adverse Event|0|||
127977573|NCT02031640|460540310|FG005|Double-blind Treatment Period|Adverse Event|0|||
127977574|NCT02031640|460540305|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
127977575|NCT02031640|460540306|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
127977576|NCT02031640|460540307|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
127977577|NCT02031640|460540308|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
127977578|NCT02031640|460540309|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
127977579|NCT02031640|460540310|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
127977580|NCT02031640|460540305|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
127977581|NCT02031640|460540306|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
127977582|NCT02031640|460540307|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
127977583|NCT02031640|460540308|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
127977584|NCT02031640|460540309|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
127977585|NCT02031640|460540310|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
127977586|NCT01279070|460540315|FG000|Overall Study|Withdrawal by Subject|2|||
127977587|NCT01279070|460540316|FG001|Overall Study|Withdrawal by Subject|3|||
127977588|NCT01279070|460540315|FG000|Overall Study|Acute exacerbation|3|||
127977589|NCT01279070|460540316|FG001|Overall Study|Acute exacerbation|1|||
127977590|NCT05139303|460540317|FG000|Overall Study|Lost to Follow-up|3|||
127977591|NCT05139303|460540318|FG001|Overall Study|Lost to Follow-up|0|||
127977592|NCT05139303|460540317|FG000|Overall Study|Adverse Event|1|||
127977593|NCT05139303|460540318|FG001|Overall Study|Adverse Event|0|||
127977594|NCT02822573|460540319|FG000|Overall Study|Lost to Follow-up|5|||
127977595|NCT02822573|460540320|FG001|Overall Study|Lost to Follow-up|3|||
127977596|NCT02822573|460540319|FG000|Overall Study|Physician Decision|1|||
127977597|NCT02822573|460540320|FG001|Overall Study|Physician Decision|1|||
127977598|NCT02822573|460540319|FG000|Overall Study|Withdrawal by Subject|9|||
127977599|NCT02822573|460540320|FG001|Overall Study|Withdrawal by Subject|5|||
127977600|NCT02822573|460540319|FG000|Overall Study|Protocol Violation|6|||
127977601|NCT02822573|460540320|FG001|Overall Study|Protocol Violation|4|||
127977602|NCT02822573|460540319|FG000|Overall Study|Too sick or ill|2|||
127977603|NCT02822573|460540320|FG001|Overall Study|Too sick or ill|1|||
127977604|NCT02822573|460540319|FG000|Overall Study|Disease Progression|1|||
127977605|NCT02822573|460540320|FG001|Overall Study|Disease Progression|1|||
127977606|NCT02822573|460540319|FG000|Overall Study|No reason given|6|||
127977607|NCT02822573|460540320|FG001|Overall Study|No reason given|4|||
127977608|NCT02275780|460540321|FG000|Base Study: 96 Weeks|Adverse Event|6|||
127977609|NCT02275780|460540322|FG001|Base Study: 96 Weeks|Adverse Event|14|||
127977610|NCT02275780|460540321|FG000|Base Study: 96 Weeks|Death|3|||
127977611|NCT02275780|460540322|FG001|Base Study: 96 Weeks|Death|1|||
127977612|NCT02275780|460540321|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
127977613|NCT02275780|460540322|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
127977614|NCT02275780|460540321|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
127977615|NCT02275780|460540322|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
127977616|NCT02275780|460540321|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
127977617|NCT02275780|460540322|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
127977618|NCT02275780|460540321|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
127977619|NCT02275780|460540322|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
127977620|NCT02275780|460540321|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
127977621|NCT02275780|460540322|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
127977622|NCT02275780|460540321|FG000|Base Study: 96 Weeks|Physician Decision|2|||
127977623|NCT02275780|460540322|FG001|Base Study: 96 Weeks|Physician Decision|4|||
127977624|NCT02275780|460540321|FG000|Base Study: 96 Weeks|Pregnancy|2|||
127977625|NCT02275780|460540322|FG001|Base Study: 96 Weeks|Pregnancy|1|||
127977626|NCT02275780|460540321|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
127977627|NCT02275780|460540322|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
127977628|NCT02275780|460540321|FG000|Study Extension 1: Week 96 to Week 192|Adverse Event|6|||
127977629|NCT02275780|460540322|FG001|Study Extension 1: Week 96 to Week 192|Adverse Event|1|||
127496781|NCT00451958|458779363|FG004|CS21A (NCT00451958)|Physician Decision|0|||
127977630|NCT02275780|460540321|FG000|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|2|||
127977631|NCT02275780|460540322|FG001|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|0|||
127977632|NCT02275780|460540321|FG000|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|8|||
127977633|NCT02275780|460540322|FG001|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|11|||
127977634|NCT02275780|460540321|FG000|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|8|||
127977635|NCT02275780|460540322|FG001|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|7|||
127977636|NCT02275780|460540321|FG000|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|1|||
127496782|NCT00451958|458779359|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
127496783|NCT00451958|458779360|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
127496784|NCT00451958|458779361|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
127496785|NCT00451958|458779362|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
127496786|NCT00451958|458779363|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
127496787|NCT00451958|458779359|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
127496788|NCT00451958|458779360|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
127496789|NCT00451958|458779361|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
127496790|NCT00451958|458779362|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
127496791|NCT00451958|458779363|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
127496792|NCT06899737|458779371|FG000|Overall Study|Lost to Follow-up|19|||
127496793|NCT06899737|458779372|FG001|Overall Study|Lost to Follow-up|7|||
127496794|NCT03281629|458779374|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
127496795|NCT03281629|458779375|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
127496796|NCT03281629|458779374|FG000|Overall Study|Death|0|||
127496797|NCT03281629|458779375|FG001|Overall Study|Death|1|||
127496798|NCT03281629|458779374|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
127496799|NCT03281629|458779375|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
127496800|NCT02175277|458779377|FG000|Overall Study|Protocol-specified Criteria|1|||
127496801|NCT00301262|458781393|FG000|Double Blind Phase (DB)|Adverse Event|1|||
127496802|NCT00301262|458781394|FG001|Double Blind Phase (DB)|Adverse Event|0|||
127496803|NCT00301262|458781393|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
127496804|NCT00301262|458781394|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
127496805|NCT00301262|458781393|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
127496806|NCT00301262|458781394|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
127496807|NCT00301262|458781393|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
127496808|NCT00301262|458781394|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
127496809|NCT00301262|458781393|FG000|Double Blind Phase (DB)|Other|1|||
127496810|NCT00301262|458781394|FG001|Double Blind Phase (DB)|Other|4|||
127496811|NCT00301262|458781393|FG000|Open Label Phase (OL)|Adverse Event|1|||
127496812|NCT00301262|458781394|FG001|Open Label Phase (OL)|Adverse Event|0|||
127496813|NCT00301262|458781393|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
127496814|NCT00301262|458781394|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
127496815|NCT00301262|458781393|FG000|Open Label Phase (OL)|Other|2|||
127496816|NCT00301262|458781394|FG001|Open Label Phase (OL)|Other|0|||
127496817|NCT00368745|458781395|FG000|Double-blind Treatment Period|Adverse Event|6|||
127496818|NCT00368745|458781396|FG001|Double-blind Treatment Period|Adverse Event|6|||
127496819|NCT00368745|458781395|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
127496820|NCT00368745|458781396|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
127496821|NCT00368745|458781395|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
127496822|NCT00368745|458781396|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
127496823|NCT00368745|458781395|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
127496824|NCT00368745|458781396|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
127496825|NCT00368745|458781395|FG000|Double-blind Treatment Period|Other|7|||
127496826|NCT00368745|458781396|FG001|Double-blind Treatment Period|Other|6|||
127496827|NCT01208324|458781402|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
127496828|NCT01208324|458781403|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
127496829|NCT01208324|458781404|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
127496830|NCT01208324|458781405|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
127496831|NCT02707965|458781406|FG000|Overall Study|Withdrawal by Subject|0|||
127496832|NCT02707965|458781407|FG001|Overall Study|Withdrawal by Subject|0|||
127496833|NCT02707965|458781408|FG002|Overall Study|Withdrawal by Subject|1|||
127496834|NCT02707965|458781409|FG003|Overall Study|Withdrawal by Subject|0|||
127496835|NCT02707965|458781410|FG004|Overall Study|Withdrawal by Subject|0|||
127496836|NCT02707965|458781411|FG005|Overall Study|Withdrawal by Subject|0|||
127496837|NCT02707965|458781412|FG006|Overall Study|Withdrawal by Subject|0|||
127496838|NCT02707965|458781413|FG007|Overall Study|Withdrawal by Subject|2|||
127496839|NCT02707965|458781414|FG008|Overall Study|Withdrawal by Subject|0|||
127496840|NCT02707965|458781415|FG009|Overall Study|Withdrawal by Subject|0|||
127496841|NCT02707965|458781416|FG010|Overall Study|Withdrawal by Subject|0|||
127496842|NCT02707965|458781417|FG011|Overall Study|Withdrawal by Subject|0|||
127496843|NCT02707965|458781418|FG012|Overall Study|Withdrawal by Subject|0|||
127496844|NCT02707965|458781419|FG013|Overall Study|Withdrawal by Subject|0|||
127496845|NCT02707965|458781420|FG014|Overall Study|Withdrawal by Subject|0|||
127496846|NCT02707965|458781421|FG015|Overall Study|Withdrawal by Subject|0|||
127496847|NCT02707965|458781406|FG000|Overall Study|PI decisions|0|||
127496848|NCT02707965|458781407|FG001|Overall Study|PI decisions|0|||
127977637|NCT02275780|460540322|FG001|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|2|||
127977638|NCT02275780|460540321|FG000|Study Extension 1: Week 96 to Week 192|Physician Decision|3|||
127496849|NCT02707965|458781408|FG002|Overall Study|PI decisions|0|||
127496850|NCT02707965|458781409|FG003|Overall Study|PI decisions|0|||
127496851|NCT02707965|458781410|FG004|Overall Study|PI decisions|0|||
127496852|NCT02707965|458781411|FG005|Overall Study|PI decisions|0|||
127496853|NCT02707965|458781412|FG006|Overall Study|PI decisions|0|||
127496854|NCT02707965|458781413|FG007|Overall Study|PI decisions|0|||
127496855|NCT02707965|458781414|FG008|Overall Study|PI decisions|0|||
127496856|NCT02707965|458781415|FG009|Overall Study|PI decisions|0|||
127496857|NCT02707965|458781416|FG010|Overall Study|PI decisions|0|||
127496858|NCT02707965|458781417|FG011|Overall Study|PI decisions|0|||
127496859|NCT02707965|458781418|FG012|Overall Study|PI decisions|0|||
127496860|NCT02707965|458781419|FG013|Overall Study|PI decisions|0|||
127496861|NCT02707965|458781420|FG014|Overall Study|PI decisions|2|||
127496862|NCT02707965|458781421|FG015|Overall Study|PI decisions|0|||
127496863|NCT02707965|458781406|FG000|Overall Study|Protocol deviation|1|||
127496864|NCT02707965|458781407|FG001|Overall Study|Protocol deviation|1|||
127496865|NCT02707965|458781408|FG002|Overall Study|Protocol deviation|0|||
127496866|NCT02707965|458781409|FG003|Overall Study|Protocol deviation|0|||
127496867|NCT02707965|458781410|FG004|Overall Study|Protocol deviation|0|||
127496868|NCT02707965|458781411|FG005|Overall Study|Protocol deviation|0|||
127496869|NCT02707965|458781412|FG006|Overall Study|Protocol deviation|0|||
127496870|NCT02707965|458781413|FG007|Overall Study|Protocol deviation|1|||
127496871|NCT02707965|458781414|FG008|Overall Study|Protocol deviation|0|||
127496872|NCT02707965|458781415|FG009|Overall Study|Protocol deviation|0|||
127496873|NCT02707965|458781416|FG010|Overall Study|Protocol deviation|0|||
127496874|NCT02707965|458781417|FG011|Overall Study|Protocol deviation|0|||
127496875|NCT02707965|458781418|FG012|Overall Study|Protocol deviation|0|||
127496876|NCT02707965|458781419|FG013|Overall Study|Protocol deviation|0|||
127496877|NCT02707965|458781420|FG014|Overall Study|Protocol deviation|0|||
127496878|NCT02707965|458781421|FG015|Overall Study|Protocol deviation|0|||
127496879|NCT00249808|458781422|FG000|Overall Study|Other|27|||
127496880|NCT00249808|458781422|FG000|Overall Study|Protocol Violation|3|||
127496881|NCT00249808|458781422|FG000|Overall Study|Lost to Follow-up|8|||
127496882|NCT00249808|458781422|FG000|Overall Study|Adverse Event|81|||
127496883|NCT00249808|458781422|FG000|Overall Study|Lack of Efficacy|52|||
127496884|NCT00249808|458781422|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
127496885|NCT02789345|458781423|FG000|Overall Study|Adverse Event|0|||
127496886|NCT02789345|458781424|FG001|Overall Study|Adverse Event|0|||
127496887|NCT02789345|458781425|FG002|Overall Study|Adverse Event|1|||
127496888|NCT02789345|458781423|FG000|Overall Study|Death|0|||
127496889|NCT02789345|458781424|FG001|Overall Study|Death|0|||
127496890|NCT02789345|458781425|FG002|Overall Study|Death|1|||
127496891|NCT02789345|458781423|FG000|Overall Study|Physician Decision|2|||
127496892|NCT02789345|458781424|FG001|Overall Study|Physician Decision|0|||
127496893|NCT02789345|458781425|FG002|Overall Study|Physician Decision|1|||
127496894|NCT02789345|458781423|FG000|Overall Study|Progressive Disease|1|||
127496895|NCT02789345|458781424|FG001|Overall Study|Progressive Disease|3|||
127496896|NCT02789345|458781425|FG002|Overall Study|Progressive Disease|14|||
127496897|NCT00748618|458781427|FG000|Overall Study|Adverse Event|1|||
127496898|NCT00748618|458781428|FG001|Overall Study|Adverse Event|0|||
127496899|NCT02854436|458781429|FG000|Overall Study|Adverse Event|1|||
127496900|NCT02854436|458781429|FG000|Overall Study|Death|208|||
127496901|NCT02854436|458781429|FG000|Overall Study|Lost to Follow-up|5|||
127496902|NCT02854436|458781429|FG000|Overall Study|Withdrawal by Subject|24|||
127496903|NCT02854436|458781429|FG000|Overall Study|Other|45|||
127496904|NCT02854436|458781429|FG000|Overall Study|Physician Decision|6|||
127496905|NCT01977729|458781430|FG000|Overall Study|Study terminated|1|||
127496906|NCT01268046|458781431|FG000|Overall Study|Withdrawal by Subject|1|||
127496907|NCT01268046|458781432|FG001|Overall Study|Withdrawal by Subject|0|||
127496908|NCT01268046|458781433|FG002|Overall Study|Withdrawal by Subject|0|||
127496909|NCT01268046|458781434|FG003|Overall Study|Withdrawal by Subject|1|||
127496910|NCT01268046|458781431|FG000|Overall Study|Lost to Follow-up|0|||
127496911|NCT01268046|458781432|FG001|Overall Study|Lost to Follow-up|0|||
127496912|NCT01268046|458781433|FG002|Overall Study|Lost to Follow-up|1|||
127496913|NCT01268046|458781434|FG003|Overall Study|Lost to Follow-up|0|||
127496914|NCT00282087|458781435|FG000|Overall Study|Death|1|||
127496915|NCT01804049|458781438|FG000|Overall Study|Adverse Event|2|||
127496916|NCT01804049|458781439|FG001|Overall Study|Adverse Event|10|||
127496917|NCT01804049|458781438|FG000|Overall Study|Lost to Follow-up|2|||
127496918|NCT01804049|458781439|FG001|Overall Study|Lost to Follow-up|1|||
127496919|NCT01804049|458781438|FG000|Overall Study|Decreased interest/personal|4|||
127496920|NCT01804049|458781439|FG001|Overall Study|Decreased interest/personal|5|||
127496921|NCT01804049|458781438|FG000|Overall Study|Other health concerns|2|||
127496922|NCT01804049|458781439|FG001|Overall Study|Other health concerns|7|||
127496923|NCT01804049|458781438|FG000|Overall Study|Moved out of area|0|||
127496924|NCT01804049|458781439|FG001|Overall Study|Moved out of area|7|||
127496925|NCT01804049|458781438|FG000|Overall Study|other MD recommended|1|||
127496926|NCT01804049|458781439|FG001|Overall Study|other MD recommended|1|||
127496927|NCT01804049|458781438|FG000|Overall Study|Enrollment in dual studies|0|||
127496928|NCT01804049|458781439|FG001|Overall Study|Enrollment in dual studies|1|||
127496929|NCT01147250|458781444|FG000|Overall Study|Lost to Follow-up|14|||
127496930|NCT01147250|458781445|FG001|Overall Study|Lost to Follow-up|11|||
127496931|NCT01147250|458781444|FG000|Overall Study|Withdrawal by Subject|83|||
127496932|NCT01147250|458781445|FG001|Overall Study|Withdrawal by Subject|88|||
127496933|NCT01147250|458781444|FG000|Overall Study|Site termination by sponsor|13|||
127496934|NCT01147250|458781445|FG001|Overall Study|Site termination by sponsor|5|||
127496935|NCT01147250|458781444|FG000|Overall Study|Other than specified|0|||
127496936|NCT01147250|458781445|FG001|Overall Study|Other than specified|1|||
127496937|NCT00338286|458781449|FG000|Overall Study|Withdrawal by Subject|50|||
127496938|NCT00338286|458781450|FG001|Overall Study|Withdrawal by Subject|54|||
127496939|NCT00338286|458781449|FG000|Overall Study|Lost to Follow-up|80|||
127496940|NCT00338286|458781450|FG001|Overall Study|Lost to Follow-up|66|||
127496941|NCT00338286|458781449|FG000|Overall Study|Other|103|||
127496942|NCT00338286|458781450|FG001|Overall Study|Other|93|||
127496943|NCT00022763|458781454|FG000|Overall Study|Adverse Event|1|||
127496944|NCT00022763|458781455|FG001|Overall Study|Adverse Event|2|||
127496945|NCT00022763|458781454|FG000|Overall Study|Injection Site Reactions|0|||
127496946|NCT00022763|458781455|FG001|Overall Study|Injection Site Reactions|2|||
127496947|NCT00022763|458781454|FG000|Overall Study|Death|0|||
127496948|NCT00022763|458781455|FG001|Overall Study|Death|1|||
127496949|NCT00022763|458781454|FG000|Overall Study|Lost to Follow-up|0|||
127496950|NCT00022763|458781455|FG001|Overall Study|Lost to Follow-up|3|||
127496951|NCT00022763|458781454|FG000|Overall Study|Withdrawal by Subject|4|||
127496952|NCT00022763|458781455|FG001|Overall Study|Withdrawal by Subject|7|||
127496953|NCT00022763|458781454|FG000|Overall Study|Insufficient Therapy|1|||
127496954|NCT00022763|458781455|FG001|Overall Study|Insufficient Therapy|0|||
127496955|NCT00022763|458781454|FG000|Overall Study|Admin|3|||
127496956|NCT00022763|458781455|FG001|Overall Study|Admin|2|||
127496957|NCT00716482|458781456|FG000|Overall Study|Lost to Follow-up|6|||
127496958|NCT00716482|458781456|FG000|Overall Study|Inadequate acquisition or analysis|50|||
127496959|NCT00716482|458781456|FG000|Overall Study|no pathology obtained|10|||
127496960|NCT00716482|458781456|FG000|Overall Study|technical/machine error|28|||
127496961|NCT00716482|458781456|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
127496962|NCT03248531|458781457|FG000|Overall Study|Adverse Event|0|||
127496963|NCT03248531|458781458|FG001|Overall Study|Adverse Event|0|||
127496964|NCT03248531|458781459|FG002|Overall Study|Adverse Event|1|||
127496965|NCT03248531|458781457|FG000|Overall Study|Lost to Follow-up|1|||
127496966|NCT03248531|458781458|FG001|Overall Study|Lost to Follow-up|0|||
127496967|NCT03248531|458781459|FG002|Overall Study|Lost to Follow-up|5|||
127496968|NCT03248531|458781457|FG000|Overall Study|Withdrawal by Subject|3|||
127496969|NCT03248531|458781458|FG001|Overall Study|Withdrawal by Subject|3|||
127496970|NCT03248531|458781459|FG002|Overall Study|Withdrawal by Subject|2|||
127496971|NCT03248531|458781457|FG000|Overall Study|Sponsor Request|0|||
127496972|NCT03248531|458781458|FG001|Overall Study|Sponsor Request|2|||
127496973|NCT03248531|458781459|FG002|Overall Study|Sponsor Request|0|||
127496974|NCT04075513|458781460|FG000|Overall Study|Withdrawal by Subject|2|||
127496975|NCT04075513|458781461|FG001|Overall Study|Withdrawal by Subject|2|||
127496976|NCT04075513|458781460|FG000|Overall Study|Lack of Efficacy|1|||
127496977|NCT04075513|458781461|FG001|Overall Study|Lack of Efficacy|0|||
127496978|NCT04075513|458781460|FG000|Overall Study|Lost to Follow-up|4|||
127496979|NCT04075513|458781461|FG001|Overall Study|Lost to Follow-up|2|||
127496980|NCT04075513|458781460|FG000|Overall Study|Switch to insulin pump|1|||
127496981|NCT04075513|458781461|FG001|Overall Study|Switch to insulin pump|0|||
127496982|NCT01035463|458781462|FG000|Overall Study|Adverse Event|0|||
127496983|NCT01035463|458781463|FG001|Overall Study|Adverse Event|0|||
127496984|NCT01035463|458781464|FG002|Overall Study|Adverse Event|4|||
127496985|NCT01035463|458781465|FG003|Overall Study|Adverse Event|1|||
127496986|NCT01035463|458781466|FG004|Overall Study|Adverse Event|5|||
127496987|NCT01035463|458781467|FG005|Overall Study|Adverse Event|7|||
127496988|NCT01035463|458781462|FG000|Overall Study|Withdrawal by Subject|0|||
127496989|NCT01035463|458781463|FG001|Overall Study|Withdrawal by Subject|2|||
127496990|NCT01035463|458781464|FG002|Overall Study|Withdrawal by Subject|1|||
127496991|NCT01035463|458781465|FG003|Overall Study|Withdrawal by Subject|0|||
127496992|NCT01035463|458781466|FG004|Overall Study|Withdrawal by Subject|1|||
127977639|NCT02275780|460540322|FG001|Study Extension 1: Week 96 to Week 192|Physician Decision|7|||
127977640|NCT02275780|460540321|FG000|Study Extension 1: Week 96 to Week 192|Pregnancy|2|||
127977641|NCT02275780|460540322|FG001|Study Extension 1: Week 96 to Week 192|Pregnancy|1|||
127977642|NCT02275780|460540321|FG000|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|19|||
127977643|NCT02275780|460540322|FG001|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|14|||
127496993|NCT01035463|458781467|FG005|Overall Study|Withdrawal by Subject|4|||
127496994|NCT01035463|458781462|FG000|Overall Study|Disease progression|0|||
127496995|NCT01035463|458781463|FG001|Overall Study|Disease progression|0|||
127496996|NCT01035463|458781464|FG002|Overall Study|Disease progression|0|||
127496997|NCT01035463|458781465|FG003|Overall Study|Disease progression|0|||
127496998|NCT01035463|458781466|FG004|Overall Study|Disease progression|0|||
127496999|NCT01035463|458781467|FG005|Overall Study|Disease progression|3|||
127497000|NCT01035463|458781462|FG000|Overall Study|Other Malignancy|0|||
127497001|NCT01035463|458781463|FG001|Overall Study|Other Malignancy|0|||
127497002|NCT01035463|458781464|FG002|Overall Study|Other Malignancy|0|||
127497003|NCT01035463|458781465|FG003|Overall Study|Other Malignancy|0|||
127497004|NCT01035463|458781466|FG004|Overall Study|Other Malignancy|0|||
127497005|NCT01035463|458781467|FG005|Overall Study|Other Malignancy|2|||
127497006|NCT01035463|458781462|FG000|Overall Study|Other|0|||
127497007|NCT01035463|458781463|FG001|Overall Study|Other|0|||
127497008|NCT01035463|458781464|FG002|Overall Study|Other|0|||
127497009|NCT01035463|458781465|FG003|Overall Study|Other|1|||
127497010|NCT01035463|458781466|FG004|Overall Study|Other|0|||
127497011|NCT01035463|458781467|FG005|Overall Study|Other|2|||
127497012|NCT01092780|458781468|FG000|Washout Period 1|Adverse Event|0|||
127497013|NCT01092780|458781469|FG001|Washout Period 1|Adverse Event|1|||
127497014|NCT01092780|458781470|FG002|Washout Period 1|Adverse Event|0|||
127497015|NCT01092780|458781471|FG003|Washout Period 1|Adverse Event|0|||
127497016|NCT01092780|458781468|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
127497017|NCT01092780|458781469|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
127497018|NCT01092780|458781470|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
127497019|NCT01092780|458781471|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
127497020|NCT01092780|458781468|FG000|Washout Period 2|Adverse Event|0|||
127497021|NCT01092780|458781469|FG001|Washout Period 2|Adverse Event|1|||
127497022|NCT01092780|458781470|FG002|Washout Period 2|Adverse Event|1|||
127497023|NCT01092780|458781471|FG003|Washout Period 2|Adverse Event|0|||
127497024|NCT04153981|458781483|FG000|Overall Study|Death|1|||
127497025|NCT04153981|458781483|FG000|Overall Study|Withdrawal by Subject|24|||
127497026|NCT04153981|458781483|FG000|Overall Study|Lost to Follow-up|1|||
127497027|NCT04153981|458781483|FG000|Overall Study|Physician Decision|1|||
127497028|NCT04153981|458781483|FG000|Overall Study|Due to Unavailable Glucometer|1|||
127497029|NCT04153981|458781483|FG000|Overall Study|Covid 19|52|||
127497030|NCT04153981|458781483|FG000|Overall Study|Participant Dropped Out as Required Laboratory Test was Not Performed|5|||
127497031|NCT04153981|458781483|FG000|Overall Study|Due to Low Fasting Blood Sugar Levels|1|||
127497032|NCT01355679|458781484|FG000|Overall Study|benign tumor types found at biopsy|2|||
127497033|NCT03490292|458781485|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Death|0|||
127497034|NCT03490292|458781486|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Death|1|||
127497035|NCT03490292|458781485|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|0|||
127497036|NCT03490292|458781486|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|2|||
127497037|NCT03490292|458781485|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|0|||
127497038|NCT03490292|458781486|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|2|||
127497039|NCT03490292|458781485|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|0|||
127497040|NCT03490292|458781486|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|2|||
127497041|NCT03490292|458781485|FG000|1 Year Follow Up Post Last Dose|Death|1|||
127497042|NCT03490292|458781486|FG001|1 Year Follow Up Post Last Dose|Death|1|||
127497043|NCT00904670|458781487|FG000|Open Label Phase|Withdrawal by Subject|2|||
127497044|NCT00904670|458781488|FG001|Open Label Phase|Withdrawal by Subject|0|||
127497045|NCT00904670|458781487|FG000|Open Label Phase|Adverse Event|2|||
127497046|NCT00904670|458781488|FG001|Open Label Phase|Adverse Event|0|||
127497047|NCT00904670|458781487|FG000|Open Label Phase|Lack of Efficacy|1|||
127497048|NCT00904670|458781488|FG001|Open Label Phase|Lack of Efficacy|0|||
127497049|NCT00904670|458781487|FG000|Open Label Phase|Lost to Follow-up|1|||
127497050|NCT00904670|458781488|FG001|Open Label Phase|Lost to Follow-up|0|||
127497051|NCT00286091|458781489|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
127497052|NCT00286091|458781490|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
127497053|NCT00286091|458781489|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
127497054|NCT00286091|458781490|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
127497055|NCT00286091|458781489|FG000|Double-blind Treatment Phase|Death|58|||
127497056|NCT00286091|458781490|FG001|Double-blind Treatment Phase|Death|65|||
127497057|NCT00286091|458781489|FG000|Double-blind Treatment Phase|Adverse Event|28|||
127497058|NCT00286091|458781490|FG001|Double-blind Treatment Phase|Adverse Event|40|||
127497059|NCT00286091|458781489|FG000|Double-blind Treatment Phase|Disease Progression|22|||
127497060|NCT00286091|458781490|FG001|Double-blind Treatment Phase|Disease Progression|35|||
127497061|NCT00286091|458781489|FG000|Double-blind Treatment Phase|Other|25|||
127497062|NCT00286091|458781490|FG001|Double-blind Treatment Phase|Other|33|||
127497063|NCT00286091|458781489|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
127497064|NCT00286091|458781490|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
127497065|NCT00286091|458781489|FG000|Double-blind Treatment Phase|Noncompliance|8|||
127497066|NCT00286091|458781490|FG001|Double-blind Treatment Phase|Noncompliance|8|||
127497067|NCT00286091|458781489|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
127497068|NCT00286091|458781490|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
127497069|NCT00286091|458781489|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
127497070|NCT00286091|458781490|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
127497071|NCT00286091|458781489|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
127497072|NCT00286091|458781490|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
127497073|NCT00286091|458781489|FG000|Open-label Treatment Phase|Physician Decision|24|||
127497074|NCT00286091|458781490|FG001|Open-label Treatment Phase|Physician Decision|21|||
127497075|NCT00286091|458781489|FG000|Open-label Treatment Phase|Adverse Event|5|||
127497076|NCT00286091|458781490|FG001|Open-label Treatment Phase|Adverse Event|16|||
127497077|NCT00286091|458781489|FG000|Open-label Treatment Phase|Other|11|||
127497078|NCT00286091|458781490|FG001|Open-label Treatment Phase|Other|11|||
127977644|NCT02275780|460540321|FG000|Study Extension 2: Week 192 to Week 288|Adverse Event|0|||
127497079|NCT00286091|458781489|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
127497080|NCT00286091|458781490|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
127497081|NCT00286091|458781489|FG000|Open-label Treatment Phase|Death|10|||
127497082|NCT00286091|458781490|FG001|Open-label Treatment Phase|Death|7|||
127497083|NCT00286091|458781489|FG000|Open-label Treatment Phase|Disease Progression|9|||
127497084|NCT00286091|458781490|FG001|Open-label Treatment Phase|Disease Progression|3|||
127497085|NCT00286091|458781489|FG000|Open-label Treatment Phase|Noncompliance|3|||
127497086|NCT00286091|458781490|FG001|Open-label Treatment Phase|Noncompliance|1|||
127497087|NCT00286091|458781489|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
127497088|NCT00286091|458781490|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
127497089|NCT00286091|458781489|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
127497090|NCT00286091|458781490|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
127497091|NCT00286091|458781489|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
127497092|NCT00286091|458781490|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
127497093|NCT03423238|458781491|FG000|Overall Study|Lost to Follow-up|1|||
127497094|NCT03423238|458781492|FG001|Overall Study|Lost to Follow-up|0|||
127497095|NCT03423238|458781491|FG000|Overall Study|Withdrawal by Subject|1|||
127497096|NCT03423238|458781492|FG001|Overall Study|Withdrawal by Subject|0|||
127497097|NCT02036580|458781493|FG000|Overall Study|Withdrawal by Subject|0|||
127497098|NCT02036580|458781494|FG001|Overall Study|Withdrawal by Subject|1|||
127497099|NCT02036580|458781495|FG002|Overall Study|Withdrawal by Subject|0|||
127497100|NCT02036580|458781493|FG000|Overall Study|Adverse Event|1|||
127497101|NCT02036580|458781494|FG001|Overall Study|Adverse Event|0|||
127497102|NCT02036580|458781495|FG002|Overall Study|Adverse Event|0|||
127497103|NCT02584452|458781498|FG000|Overall Study|Physician Decision|1|||
127497104|NCT02584452|458781499|FG001|Overall Study|Physician Decision|1|||
127497105|NCT02584452|458781498|FG000|Overall Study|Lost to Follow-up|1|||
127497106|NCT02584452|458781499|FG001|Overall Study|Lost to Follow-up|1|||
127497107|NCT01479764|458781500|FG000|Randomized|Adverse Event|1|||
127497108|NCT01479764|458781501|FG001|Randomized|Adverse Event|1|||
127497109|NCT01479764|458781500|FG000|Randomized|Withdrawal by Subject|1|||
127497110|NCT01479764|458781501|FG001|Randomized|Withdrawal by Subject|0|||
127497111|NCT01479764|458781500|FG000|Treated|Lost to Follow-up|0|||
127497112|NCT01479764|458781501|FG001|Treated|Lost to Follow-up|2|||
127497113|NCT00902850|458781503|FG000|Overall Study|Physician Decision|2|||
127497114|NCT00902850|458781504|FG001|Overall Study|Physician Decision|2|||
127497115|NCT00260832|458781505|FG000|Overall Study|Adverse Event|26|||
127497116|NCT00260832|458781506|FG001|Overall Study|Adverse Event|19|||
127497117|NCT00260832|458781505|FG000|Overall Study|Progression|116|||
127497118|NCT00260832|458781506|FG001|Overall Study|Progression|96|||
127497119|NCT00260832|458781505|FG000|Overall Study|Withdrawal by Subject|15|||
127497120|NCT00260832|458781506|FG001|Overall Study|Withdrawal by Subject|17|||
127497121|NCT00260832|458781505|FG000|Overall Study|Physician Decision|15|||
127497122|NCT00260832|458781506|FG001|Overall Study|Physician Decision|9|||
127497123|NCT00260832|458781505|FG000|Overall Study|Death|43|||
127497124|NCT00260832|458781506|FG001|Overall Study|Death|62|||
127497125|NCT00260832|458781505|FG000|Overall Study|Other|10|||
127497126|NCT00260832|458781506|FG001|Overall Study|Other|7|||
127497127|NCT00260832|458781505|FG000|Overall Study|Protocol Violation|3|||
127497128|NCT00260832|458781506|FG001|Overall Study|Protocol Violation|1|||
127497129|NCT03745638|458781507|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
127497130|NCT03745638|458781508|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
127497131|NCT03745638|458781509|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
127497132|NCT03745638|458781510|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
127497133|NCT03745638|458781511|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
127497134|NCT03745638|458781512|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
127497135|NCT03745638|458781513|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
127497136|NCT03745638|458781507|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
127497137|NCT03745638|458781508|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
127497138|NCT03745638|458781509|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
127497139|NCT03745638|458781510|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
127497140|NCT03745638|458781511|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
127497141|NCT03745638|458781512|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
127497142|NCT03745638|458781513|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
127497143|NCT03745638|458781507|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
127497144|NCT03745638|458781508|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
127497145|NCT03745638|458781509|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
127497146|NCT03745638|458781510|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
127497147|NCT03745638|458781511|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
127497148|NCT03745638|458781512|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
127497149|NCT03745638|458781513|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
127497150|NCT03745638|458781507|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
127497151|NCT03745638|458781508|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
127497152|NCT03745638|458781509|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
127497153|NCT03745638|458781510|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
127497154|NCT03745638|458781511|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
127497155|NCT03745638|458781512|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
127497156|NCT03745638|458781513|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
127497157|NCT03745638|458781507|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
127497158|NCT03745638|458781508|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
127497159|NCT03745638|458781509|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
127497160|NCT03745638|458781510|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
127497161|NCT03745638|458781511|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
127497162|NCT03745638|458781512|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
127497163|NCT03745638|458781513|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
127497164|NCT03745638|458781507|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
127497165|NCT03745638|458781508|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
127497166|NCT03745638|458781509|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
127497167|NCT03745638|458781510|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
127497168|NCT03745638|458781511|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
127497169|NCT03745638|458781512|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
127497170|NCT03745638|458781513|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
127497171|NCT03745638|458781507|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
127497172|NCT03745638|458781508|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
127497173|NCT03745638|458781509|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
127497174|NCT03745638|458781510|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
127497175|NCT03745638|458781511|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
127497176|NCT03745638|458781512|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
127497177|NCT03745638|458781513|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
127497178|NCT03745638|458781507|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
127497179|NCT03745638|458781508|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
127497180|NCT03745638|458781509|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
127497181|NCT03745638|458781510|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
127497182|NCT03745638|458781511|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
127497183|NCT03745638|458781512|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
127497184|NCT03745638|458781513|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
127497185|NCT03745638|458781507|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
127497186|NCT03745638|458781508|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
127497187|NCT03745638|458781509|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
127497188|NCT03745638|458781510|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
127497189|NCT03745638|458781511|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
127497190|NCT03745638|458781512|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
127497191|NCT03745638|458781513|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
127497192|NCT03745638|458781507|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
127497193|NCT03745638|458781508|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
127497194|NCT03745638|458781509|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
127497195|NCT03745638|458781510|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
127497196|NCT03745638|458781511|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
127497197|NCT03745638|458781512|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
127497198|NCT03745638|458781513|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
127497199|NCT03745638|458781507|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
127497200|NCT03745638|458781508|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
127497201|NCT03745638|458781509|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
127497202|NCT03745638|458781510|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
127497203|NCT03745638|458781511|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
127497204|NCT03745638|458781512|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
127497205|NCT03745638|458781513|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
127497206|NCT03745638|458781507|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
127497207|NCT03745638|458781508|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
127497208|NCT03745638|458781509|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
127497209|NCT03745638|458781510|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
127977645|NCT02275780|460540322|FG001|Study Extension 2: Week 192 to Week 288|Adverse Event|1|||
127977646|NCT02275780|460540321|FG000|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|38|||
127497210|NCT03745638|458781511|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
127497211|NCT03745638|458781512|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
127977647|NCT02275780|460540322|FG001|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|29|||
127497212|NCT03745638|458781513|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
127497213|NCT03745638|458781507|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
127497214|NCT03745638|458781508|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
127497215|NCT03745638|458781509|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
127497216|NCT03745638|458781510|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
127497217|NCT03745638|458781511|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
127497218|NCT03745638|458781512|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
127497219|NCT03745638|458781513|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
127497220|NCT03745638|458781507|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
127497221|NCT03745638|458781508|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
127497222|NCT03745638|458781509|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
127497223|NCT03745638|458781510|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
127497224|NCT03745638|458781511|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
127497225|NCT03745638|458781512|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
127497226|NCT03745638|458781513|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
127497227|NCT03745638|458781507|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
127497228|NCT03745638|458781508|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
127497229|NCT03745638|458781509|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
127497230|NCT03745638|458781510|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
127497231|NCT03745638|458781511|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
127497232|NCT03745638|458781512|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
127497233|NCT03745638|458781513|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
127497234|NCT04470050|458781516|FG000|Double-blind Treatment Phase|Adverse Event|0|||
127497235|NCT04470050|458781517|FG001|Double-blind Treatment Phase|Adverse Event|0|||
127497236|NCT04470050|458781518|FG002|Double-blind Treatment Phase|Adverse Event|0|||
127497237|NCT04470050|458781519|FG003|Double-blind Treatment Phase|Adverse Event|1|||
127497238|NCT04470050|458781520|FG004|Double-blind Treatment Phase|Adverse Event|0|||
127497239|NCT04470050|458781521|FG005|Double-blind Treatment Phase|Adverse Event|0|||
127497240|NCT04470050|458781522|FG006|Double-blind Treatment Phase|Adverse Event|0|||
127497241|NCT04470050|458781516|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
127497242|NCT04470050|458781517|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
127497243|NCT04470050|458781518|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
127497244|NCT04470050|458781519|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
127497245|NCT04470050|458781520|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
127497246|NCT04470050|458781521|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
127497247|NCT04470050|458781522|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
127497248|NCT04470050|458781516|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
127497249|NCT04470050|458781517|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
127497250|NCT04470050|458781518|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
127497251|NCT04470050|458781519|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
127497252|NCT04470050|458781520|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
127497253|NCT04470050|458781521|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
127497254|NCT04470050|458781522|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
127497255|NCT03098433|458781523|FG000|Overall Study|Withdrawal by Subject|10|||
127497256|NCT01104545|458781524|FG000|Overall Study|Adverse Event|0|||
127497257|NCT01104545|458781525|FG001|Overall Study|Adverse Event|1|||
127497258|NCT01104545|458781526|FG002|Overall Study|Adverse Event|2|||
127497259|NCT03585764|458781529|FG000|Overall Study|Death|3|||
127497260|NCT03585764|458781530|FG001|Overall Study|Death|2|||
127497261|NCT03585764|458781531|FG002|Overall Study|Death|3|||
127497262|NCT03585764|458781532|FG003|Overall Study|Death|0|||
127497263|NCT03585764|458781529|FG000|Overall Study|Lost to Follow-up|0|||
127497264|NCT03585764|458781530|FG001|Overall Study|Lost to Follow-up|1|||
127497265|NCT03585764|458781531|FG002|Overall Study|Lost to Follow-up|0|||
127497266|NCT03585764|458781532|FG003|Overall Study|Lost to Follow-up|0|||
127497267|NCT03585764|458781529|FG000|Overall Study|Physician Decision|0|||
127497268|NCT03585764|458781530|FG001|Overall Study|Physician Decision|0|||
127497269|NCT03585764|458781531|FG002|Overall Study|Physician Decision|2|||
127497270|NCT03585764|458781532|FG003|Overall Study|Physician Decision|0|||
127497271|NCT03604172|458781533|FG000|Overall Study|Lost to Follow-up|1|||
127497272|NCT03604172|458781534|FG001|Overall Study|Lost to Follow-up|2|||
127977648|NCT02275780|460540321|FG000|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|2|||
127497273|NCT02676895|458781535|FG000|Overall Study|Administrative reason|1|||
127497274|NCT02676895|458781536|FG001|Overall Study|Administrative reason|0|||
127497275|NCT02676895|458781537|FG002|Overall Study|Administrative reason|0|||
127497276|NCT02676895|458781535|FG000|Overall Study|Protocol Violation|1|||
127977649|NCT02275780|460540322|FG001|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|3|||
127497277|NCT02676895|458781536|FG001|Overall Study|Protocol Violation|0|||
127497278|NCT02676895|458781537|FG002|Overall Study|Protocol Violation|0|||
127977650|NCT02275780|460540321|FG000|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|0|||
127497279|NCT02676895|458781535|FG000|Overall Study|Adverse Event|0|||
127497280|NCT02676895|458781536|FG001|Overall Study|Adverse Event|3|||
127497281|NCT02676895|458781537|FG002|Overall Study|Adverse Event|1|||
127497282|NCT02676895|458781535|FG000|Overall Study|Lost to Follow-up|0|||
127497283|NCT02676895|458781536|FG001|Overall Study|Lost to Follow-up|0|||
127497284|NCT02676895|458781537|FG002|Overall Study|Lost to Follow-up|1|||
127497285|NCT02676895|458781535|FG000|Overall Study|Withdrawal by Subject|0|||
127497286|NCT02676895|458781536|FG001|Overall Study|Withdrawal by Subject|0|||
127497287|NCT02676895|458781537|FG002|Overall Study|Withdrawal by Subject|1|||
127497288|NCT00976716|458781543|FG000|Overall Study|Adverse Event|1|||
127497289|NCT04222699|458781544|FG000|Overall Study|Lost to Follow-up|2|||
127497290|NCT00923351|458781545|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
127497291|NCT00923351|458781546|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
127497292|NCT00923351|458781547|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
127497293|NCT01536561|458781552|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
127497294|NCT01536561|458781552|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
127497295|NCT01536561|458781552|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
127497296|NCT01536561|458781552|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
127497297|NCT01536561|458781552|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
127497298|NCT01536561|458781552|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
127497299|NCT02993822|458781554|FG000|Overall Study|Lack of Efficacy|1|||
127497300|NCT02993822|458781555|FG001|Overall Study|Lack of Efficacy|1|||
127497301|NCT02993822|458781556|FG002|Overall Study|Lack of Efficacy|0|||
127497302|NCT02993822|458781557|FG003|Overall Study|Lack of Efficacy|0|||
127497303|NCT02993822|458781554|FG000|Overall Study|Protocol Violation|1|||
127497304|NCT02993822|458781555|FG001|Overall Study|Protocol Violation|0|||
127497305|NCT02993822|458781556|FG002|Overall Study|Protocol Violation|0|||
127497306|NCT02993822|458781557|FG003|Overall Study|Protocol Violation|0|||
127497307|NCT02993822|458781554|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
127497308|NCT02993822|458781555|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
127497309|NCT02993822|458781556|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
127497310|NCT02993822|458781557|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
127497311|NCT02993822|458781554|FG000|Overall Study|Adverse Event|3|||
127497312|NCT02993822|458781555|FG001|Overall Study|Adverse Event|1|||
127497313|NCT02993822|458781556|FG002|Overall Study|Adverse Event|7|||
127497314|NCT02993822|458781557|FG003|Overall Study|Adverse Event|0|||
127497315|NCT02993822|458781554|FG000|Overall Study|Withdrawal by Subject|4|||
127497316|NCT02993822|458781555|FG001|Overall Study|Withdrawal by Subject|2|||
127497317|NCT02993822|458781556|FG002|Overall Study|Withdrawal by Subject|2|||
127497318|NCT02993822|458781557|FG003|Overall Study|Withdrawal by Subject|3|||
127497319|NCT02993822|458781554|FG000|Overall Study|Lost to Follow-up|1|||
127497320|NCT02993822|458781555|FG001|Overall Study|Lost to Follow-up|0|||
127497321|NCT02993822|458781556|FG002|Overall Study|Lost to Follow-up|1|||
127497322|NCT02993822|458781557|FG003|Overall Study|Lost to Follow-up|0|||
127497323|NCT01221753|458781558|FG000|Overall Study|Adverse Event|1|||
127497324|NCT04552288|458781562|FG000|Overall Study|Death|3|||
127497325|NCT04552288|458781562|FG000|Overall Study|Lost to Follow-up|6|||
127497326|NCT04552288|458781562|FG000|Overall Study|Physician Decision|3|||
127497327|NCT04552288|458781562|FG000|Overall Study|Protocol Violation|9|||
127497328|NCT04552288|458781562|FG000|Overall Study|Withdrawal by Subject|6|||
127497329|NCT04552288|458781562|FG000|Overall Study|Disease progression, Complicated disease, Ineligible|10|||
127497330|NCT05285644|458781563|FG000|Overall Study|Adverse Event|3|||
127497331|NCT05285644|458781564|FG001|Overall Study|Adverse Event|3|||
127497332|NCT05285644|458781563|FG000|Overall Study|Withdrawal of Consent|2|||
127497333|NCT05285644|458781564|FG001|Overall Study|Withdrawal of Consent|5|||
127497334|NCT05285644|458781563|FG000|Overall Study|Noncompliance|0|||
127497335|NCT05285644|458781564|FG001|Overall Study|Noncompliance|4|||
127497336|NCT05285644|458781563|FG000|Overall Study|Lost to Follow-up|4|||
127497337|NCT05285644|458781564|FG001|Overall Study|Lost to Follow-up|6|||
127497338|NCT05285644|458781563|FG000|Overall Study|Disallowed Concurrent Medication|1|||
127497339|NCT05285644|458781564|FG001|Overall Study|Disallowed Concurrent Medication|1|||
127497340|NCT05285644|458781563|FG000|Overall Study|Investigator Decision|2|||
127497341|NCT05285644|458781564|FG001|Overall Study|Investigator Decision|0|||
127497342|NCT05285644|458781563|FG000|Overall Study|Protocol Deviation|1|||
127497343|NCT05285644|458781564|FG001|Overall Study|Protocol Deviation|0|||
127497344|NCT05285644|458781563|FG000|Overall Study|As specified in the Clinical Study Report|7|||
127497345|NCT05285644|458781564|FG001|Overall Study|As specified in the Clinical Study Report|3|||
127497346|NCT04532294|458781565|FG000|Overall Study|Withdrawal by Subject|0|||
127497347|NCT04532294|458781566|FG001|Overall Study|Withdrawal by Subject|0|||
127497348|NCT04532294|458781567|FG002|Overall Study|Withdrawal by Subject|1|||
127497349|NCT04532294|458781565|FG000|Overall Study|Participants Not Dosed|0|||
127497350|NCT04532294|458781566|FG001|Overall Study|Participants Not Dosed|0|||
127497351|NCT04532294|458781567|FG002|Overall Study|Participants Not Dosed|2|||
127497352|NCT04295759|458781568|FG000|Overall Study|Lack of Efficacy|9|||
127497353|NCT04295759|458781568|FG000|Overall Study|Death|1|||
127497354|NCT04295759|458781568|FG000|Overall Study|Withdrawal by Subject|2|||
127977651|NCT02275780|460540322|FG001|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|1|||
127977652|NCT02275780|460540321|FG000|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|2|||
127977653|NCT02275780|460540322|FG001|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|0|||
127977654|NCT02275780|460540321|FG000|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
127977655|NCT02275780|460540322|FG001|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
127977656|NCT02275780|460540321|FG000|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|4|||
127977657|NCT02275780|460540322|FG001|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|3|||
127977658|NCT02275780|460540321|FG000|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
127977659|NCT02275780|460540322|FG001|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
127977660|NCT02275780|460540321|FG000|Study Extension 3: Week 288 to Week 384|Death|0|||
127977661|NCT02275780|460540322|FG001|Study Extension 3: Week 288 to Week 384|Death|1|||
127977662|NCT02275780|460540321|FG000|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|1|||
127977663|NCT02275780|460540322|FG001|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|3|||
127977664|NCT02275780|460540321|FG000|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
127977665|NCT02275780|460540322|FG001|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
127977666|NCT02275780|460540321|FG000|Study Extension 3: Week 288 to Week 384|Physician Decision|1|||
127977667|NCT02275780|460540322|FG001|Study Extension 3: Week 288 to Week 384|Physician Decision|0|||
127977668|NCT02275780|460540321|FG000|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|5|||
127977669|NCT02275780|460540322|FG001|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|2|||
127977670|NCT02855359|460540325|FG000|Overall Study|Death|2|||
127977671|NCT02855359|460540326|FG001|Overall Study|Death|2|||
127977672|NCT02855359|460540327|FG002|Overall Study|Death|0|||
127977673|NCT02855359|460540328|FG003|Overall Study|Death|0|||
127977674|NCT02855359|460540325|FG000|Overall Study|Study Termination by Sponsor|9|||
127977675|NCT02855359|460540326|FG001|Overall Study|Study Termination by Sponsor|11|||
127977676|NCT02855359|460540327|FG002|Overall Study|Study Termination by Sponsor|0|||
127977677|NCT02855359|460540328|FG003|Overall Study|Study Termination by Sponsor|0|||
127977678|NCT00738881|460540329|FG000|Overall Study|Withdrawal by Subject|0|||
127977679|NCT00738881|460540330|FG001|Overall Study|Withdrawal by Subject|2|||
127977680|NCT00348790|460540331|FG000|Completed Treatment|Withdrawal by Subject|4|||
127977681|NCT00348790|460540331|FG000|Completed Treatment|Disease progression|14|||
127977682|NCT00348790|460540331|FG000|Completed Treatment|Adverse Event|4|||
127977683|NCT00348790|460540331|FG000|Completed Treatment|Required surgery|2|||
127977684|NCT00348790|460540331|FG000|Completed Treatment|Unable to travel to study site|1|||
127977685|NCT04712019|460540334|FG000|Overall Study|Withdrawal by Subject|2|||
127977686|NCT04712019|460540335|FG001|Overall Study|Withdrawal by Subject|2|||
127977687|NCT04712019|460540334|FG000|Overall Study|Protocol required withdrawal - crossover treatment|1|||
127977688|NCT04712019|460540335|FG001|Overall Study|Protocol required withdrawal - crossover treatment|1|||
127977689|NCT01646021|460540336|FG000|Overall Study|Death|77|||
127977690|NCT01646021|460540337|FG001|Overall Study|Death|83|||
127977691|NCT01646021|460540336|FG000|Overall Study|Study Terminated by Sponsor|50|||
127977692|NCT01646021|460540337|FG001|Overall Study|Study Terminated by Sponsor|41|||
127977693|NCT01646021|460540336|FG000|Overall Study|Lost to Follow-up|2|||
127977694|NCT01646021|460540337|FG001|Overall Study|Lost to Follow-up|2|||
127977695|NCT01646021|460540336|FG000|Overall Study|Withdrawal by Subject|10|||
127977696|NCT01646021|460540337|FG001|Overall Study|Withdrawal by Subject|15|||
127977697|NCT04521621|460540338|FG000|Overall Study|Death|17|||
127977698|NCT04521621|460540339|FG001|Overall Study|Death|8|||
127977699|NCT04521621|460540340|FG002|Overall Study|Death|8|||
127977700|NCT04521621|460540341|FG003|Overall Study|Death|5|||
127977701|NCT04521621|460540342|FG004|Overall Study|Death|2|||
127977702|NCT04521621|460540343|FG005|Overall Study|Death|7|||
127977703|NCT04521621|460540344|FG006|Overall Study|Death|0|||
127977704|NCT04521621|460540345|FG007|Overall Study|Death|0|||
127977705|NCT04521621|460540338|FG000|Overall Study|Study Terminated by Sponsor|4|||
127977706|NCT04521621|460540339|FG001|Overall Study|Study Terminated by Sponsor|6|||
127977707|NCT04521621|460540340|FG002|Overall Study|Study Terminated by Sponsor|8|||
127977708|NCT04521621|460540341|FG003|Overall Study|Study Terminated by Sponsor|0|||
127977709|NCT04521621|460540342|FG004|Overall Study|Study Terminated by Sponsor|1|||
127977710|NCT04521621|460540343|FG005|Overall Study|Study Terminated by Sponsor|7|||
127977711|NCT04521621|460540344|FG006|Overall Study|Study Terminated by Sponsor|0|||
127977712|NCT04521621|460540345|FG007|Overall Study|Study Terminated by Sponsor|0|||
127977713|NCT04521621|460540338|FG000|Overall Study|Withdrawal by Subject|0|||
127977714|NCT04521621|460540339|FG001|Overall Study|Withdrawal by Subject|0|||
127497355|NCT04295759|458781568|FG000|Overall Study|Deemed ineligible|1|||
127977715|NCT04521621|460540340|FG002|Overall Study|Withdrawal by Subject|1|||
127977716|NCT04521621|460540341|FG003|Overall Study|Withdrawal by Subject|1|||
127977717|NCT04521621|460540342|FG004|Overall Study|Withdrawal by Subject|0|||
127977718|NCT04521621|460540343|FG005|Overall Study|Withdrawal by Subject|0|||
127977719|NCT04521621|460540344|FG006|Overall Study|Withdrawal by Subject|0|||
127977720|NCT04521621|460540345|FG007|Overall Study|Withdrawal by Subject|0|||
127977721|NCT04521621|460540338|FG000|Overall Study|Allocated in error without study intervention|1|||
127497356|NCT02798315|458781569|FG000|Overall Study|Failure to return|1|||
127497357|NCT03335150|458781571|FG000|Overall Study|Withdrawal by Subject|10|||
127497358|NCT03335150|458781572|FG001|Overall Study|Withdrawal by Subject|4|||
127497359|NCT03335150|458781571|FG000|Overall Study|Adverse Event|0|||
127497360|NCT03335150|458781572|FG001|Overall Study|Adverse Event|1|||
127497361|NCT02097719|458781573|FG000|Overall Study|Subject Withdrew Consent|1|||
127497362|NCT02097719|458781574|FG001|Overall Study|Subject Withdrew Consent|0|||
127497363|NCT02097719|458781573|FG000|Overall Study|Lost to Follow-up|0|||
127497364|NCT02097719|458781574|FG001|Overall Study|Lost to Follow-up|1|||
127497365|NCT02097719|458781573|FG000|Overall Study|Adverse Event|2|||
127497366|NCT02097719|458781574|FG001|Overall Study|Adverse Event|0|||
127497367|NCT04601532|458781575|FG000|Overall Study|Lost to Follow-up|1|||
127497368|NCT04601532|458781576|FG001|Overall Study|Lost to Follow-up|2|||
127497369|NCT04601532|458781575|FG000|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|1|||
127497370|NCT04601532|458781576|FG001|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|0|||
127497371|NCT03108521|458781577|FG000|Overall Study|Lost to Follow-up|3|||
127977722|NCT04521621|460540339|FG001|Overall Study|Allocated in error without study intervention|0|||
127977723|NCT04521621|460540340|FG002|Overall Study|Allocated in error without study intervention|0|||
127977724|NCT04521621|460540341|FG003|Overall Study|Allocated in error without study intervention|0|||
127977725|NCT04521621|460540342|FG004|Overall Study|Allocated in error without study intervention|0|||
127977726|NCT04521621|460540343|FG005|Overall Study|Allocated in error without study intervention|0|||
127977727|NCT04521621|460540344|FG006|Overall Study|Allocated in error without study intervention|0|||
127977728|NCT04521621|460540345|FG007|Overall Study|Allocated in error without study intervention|0|||
127977729|NCT01282164|460540346|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
127977730|NCT01282164|460540347|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
127977731|NCT05845567|460540359|FG000|Overall Study|Withdrawal by Subject|1|||
127977732|NCT00725608|460540360|FG000|Overall Study|Lost to Follow-up|60|||
127977733|NCT00725608|460540360|FG000|Overall Study|Adverse Event|14|||
127977734|NCT00725608|460540360|FG000|Overall Study|Individual reasons|86|||
127977735|NCT00725608|460540360|FG000|Overall Study|Other|7|||
127977736|NCT03409107|460540361|FG000|Overall Study|Withdrawal by Subject|4|||
127977737|NCT03409107|460540362|FG001|Overall Study|Withdrawal by Subject|2|||
127977738|NCT03409107|460540361|FG000|Overall Study|Physician Decision|1|||
127977739|NCT03409107|460540362|FG001|Overall Study|Physician Decision|0|||
127977740|NCT03409107|460540361|FG000|Overall Study|Lost to Follow-up|7|||
127977741|NCT03409107|460540362|FG001|Overall Study|Lost to Follow-up|2|||
127977742|NCT03409107|460540361|FG000|Overall Study|Adverse Event|5|||
127977743|NCT03409107|460540362|FG001|Overall Study|Adverse Event|3|||
127977744|NCT03419598|460540371|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
127977745|NCT02474589|460540372|FG000|Overall Study|Adverse Event|6|||
127977746|NCT02474589|460540373|FG001|Overall Study|Adverse Event|2|||
127977747|NCT02474589|460540372|FG000|Overall Study|Lost to Follow-up|6|||
127977748|NCT02474589|460540373|FG001|Overall Study|Lost to Follow-up|1|||
127977749|NCT02474589|460540372|FG000|Overall Study|Protocol Violation|4|||
127977750|NCT02474589|460540373|FG001|Overall Study|Protocol Violation|1|||
127977751|NCT02474589|460540372|FG000|Overall Study|Withdrawal by Subject|4|||
127977752|NCT02474589|460540373|FG001|Overall Study|Withdrawal by Subject|0|||
127977753|NCT02474589|460540372|FG000|Overall Study|Inability to complete study procedures|5|||
127977754|NCT02474589|460540373|FG001|Overall Study|Inability to complete study procedures|1|||
127977755|NCT01740128|460540374|FG000|Overall Study|Pregnancy|0|||
127977756|NCT01740128|460540375|FG001|Overall Study|Pregnancy|1|||
127977757|NCT01740128|460540374|FG000|Overall Study|Protocol Violation|1|||
127977758|NCT01740128|460540375|FG001|Overall Study|Protocol Violation|2|||
127977759|NCT01740128|460540374|FG000|Overall Study|Lost to Follow-up|2|||
127977760|NCT01740128|460540375|FG001|Overall Study|Lost to Follow-up|2|||
127977761|NCT01740128|460540374|FG000|Overall Study|Withdrawal by Subject|1|||
127977762|NCT01740128|460540375|FG001|Overall Study|Withdrawal by Subject|0|||
127977763|NCT01740128|460540374|FG000|Overall Study|Insufficient protocol compliance|2|||
127977764|NCT01740128|460540375|FG001|Overall Study|Insufficient protocol compliance|2|||
127977765|NCT00189306|460540378|FG000|Treatment Period|Withdrawal by Subject|2|||
127977766|NCT00189306|460540378|FG000|Treatment Period|Adverse Event|2|||
127497372|NCT03108521|458781578|FG001|Overall Study|Lost to Follow-up|0|||
127497373|NCT03108521|458781577|FG000|Overall Study|Lack of Efficacy|2|||
127497374|NCT03108521|458781578|FG001|Overall Study|Lack of Efficacy|0|||
127497375|NCT03108521|458781577|FG000|Overall Study|Physician Decision|4|||
127977767|NCT00189306|460540378|FG000|Treatment Period|Protocol Violation|1|||
127977768|NCT00189306|460540378|FG000|Posttreatment Period|Death|1|||
127977769|NCT00189306|460540378|FG000|Posttreatment Period|Withdrawal by Subject|2|||
127977770|NCT00189306|460540378|FG000|Posttreatment Period|Noncompliance|1|||
127977771|NCT00189306|460540378|FG000|Posttreatment Period|Target lesion excised|1|||
127977772|NCT00189306|460540378|FG000|Posttreatment Period|Protocol Violation|1|||
127977773|NCT00189306|460540378|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
127977774|NCT00189306|460540378|FG000|Posttreatment Period|Local skin reaction/sign|1|||
127977775|NCT00189306|460540378|FG000|Long-Term Follow-up|Adverse Event|2|||
127977776|NCT00189306|460540378|FG000|Long-Term Follow-up|Death|4|||
127497376|NCT03108521|458781578|FG001|Overall Study|Physician Decision|0|||
127497377|NCT03108521|458781577|FG000|Overall Study|Adverse Event|3|||
127497378|NCT03108521|458781578|FG001|Overall Study|Adverse Event|0|||
127497379|NCT02744612|458783633|FG000|Overall Study|Withdrawal by Subject|0|||
127497380|NCT02744612|458783634|FG001|Overall Study|Withdrawal by Subject|2|||
127497381|NCT02712983|458783636|FG000|Treatment Phase|Adverse Event|3|||
127497382|NCT02712983|458783637|FG001|Treatment Phase|Adverse Event|1|||
127497383|NCT02712983|458783638|FG002|Treatment Phase|Adverse Event|1|||
127497384|NCT02712983|458783639|FG003|Treatment Phase|Adverse Event|4|||
127497385|NCT02712983|458783640|FG004|Treatment Phase|Adverse Event|3|||
127497386|NCT02712983|458783641|FG005|Treatment Phase|Adverse Event|0|||
127497387|NCT02712983|458783642|FG006|Treatment Phase|Adverse Event|6|||
127497388|NCT02712983|458783643|FG007|Treatment Phase|Adverse Event|6|||
127497389|NCT02712983|458783644|FG008|Treatment Phase|Adverse Event|1|||
127497390|NCT02712983|458783636|FG000|Treatment Phase|Protocol Deviation|0|||
127497391|NCT02712983|458783637|FG001|Treatment Phase|Protocol Deviation|0|||
127497392|NCT02712983|458783638|FG002|Treatment Phase|Protocol Deviation|0|||
127497393|NCT02712983|458783639|FG003|Treatment Phase|Protocol Deviation|2|||
127497394|NCT02712983|458783640|FG004|Treatment Phase|Protocol Deviation|0|||
127497395|NCT02712983|458783641|FG005|Treatment Phase|Protocol Deviation|0|||
127497396|NCT02712983|458783642|FG006|Treatment Phase|Protocol Deviation|1|||
127497397|NCT02712983|458783643|FG007|Treatment Phase|Protocol Deviation|0|||
127497398|NCT02712983|458783644|FG008|Treatment Phase|Protocol Deviation|0|||
127497399|NCT02712983|458783636|FG000|Treatment Phase|Technical Problems|0|||
127497400|NCT02712983|458783637|FG001|Treatment Phase|Technical Problems|0|||
127497401|NCT02712983|458783638|FG002|Treatment Phase|Technical Problems|0|||
127497402|NCT02712983|458783639|FG003|Treatment Phase|Technical Problems|0|||
127497403|NCT02712983|458783640|FG004|Treatment Phase|Technical Problems|0|||
127497404|NCT02712983|458783641|FG005|Treatment Phase|Technical Problems|0|||
127497405|NCT02712983|458783642|FG006|Treatment Phase|Technical Problems|1|||
127497406|NCT02712983|458783643|FG007|Treatment Phase|Technical Problems|0|||
127497407|NCT02712983|458783644|FG008|Treatment Phase|Technical Problems|0|||
127497408|NCT02712983|458783636|FG000|Treatment Phase|Physician Decision|0|||
127497409|NCT02712983|458783637|FG001|Treatment Phase|Physician Decision|0|||
127497410|NCT02712983|458783638|FG002|Treatment Phase|Physician Decision|0|||
127497411|NCT02712983|458783639|FG003|Treatment Phase|Physician Decision|0|||
127497412|NCT02712983|458783640|FG004|Treatment Phase|Physician Decision|0|||
127497413|NCT02712983|458783641|FG005|Treatment Phase|Physician Decision|0|||
127497414|NCT02712983|458783642|FG006|Treatment Phase|Physician Decision|0|||
127497415|NCT02712983|458783643|FG007|Treatment Phase|Physician Decision|1|||
127497416|NCT02712983|458783644|FG008|Treatment Phase|Physician Decision|1|||
127497417|NCT02712983|458783636|FG000|Treatment Phase|Subject Decision|2|||
127497418|NCT02712983|458783637|FG001|Treatment Phase|Subject Decision|0|||
127497419|NCT02712983|458783638|FG002|Treatment Phase|Subject Decision|0|||
127497420|NCT02712983|458783639|FG003|Treatment Phase|Subject Decision|2|||
127497421|NCT02712983|458783640|FG004|Treatment Phase|Subject Decision|1|||
127497422|NCT02712983|458783641|FG005|Treatment Phase|Subject Decision|0|||
127497423|NCT02712983|458783642|FG006|Treatment Phase|Subject Decision|1|||
127497424|NCT02712983|458783643|FG007|Treatment Phase|Subject Decision|2|||
127497425|NCT02712983|458783644|FG008|Treatment Phase|Subject Decision|0|||
127497426|NCT02712983|458783636|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
127497427|NCT02712983|458783637|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
127497428|NCT02712983|458783638|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
127497429|NCT02712983|458783639|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
127497430|NCT02712983|458783640|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
127497431|NCT02712983|458783641|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
127497432|NCT02712983|458783642|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
127497433|NCT02712983|458783643|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
127497434|NCT02712983|458783644|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
127497435|NCT02712983|458783636|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
127497436|NCT02712983|458783637|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
127497437|NCT02712983|458783638|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
127497438|NCT02712983|458783639|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
127497439|NCT02712983|458783640|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
127497440|NCT02712983|458783641|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
127497441|NCT02712983|458783642|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
127497442|NCT02712983|458783643|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
127497443|NCT02712983|458783644|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
127497444|NCT02712983|458783636|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
127497445|NCT02712983|458783637|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
127497446|NCT02712983|458783638|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
127497447|NCT02712983|458783639|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
127497448|NCT02712983|458783640|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
127497449|NCT02712983|458783641|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
127497450|NCT02712983|458783642|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
127497451|NCT02712983|458783643|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
127497452|NCT02712983|458783644|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
127497453|NCT01945216|458783645|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
127497454|NCT01945216|458783645|FG000|Overall Study|Protocol Violation|42|||
127497455|NCT01945216|458783645|FG000|Overall Study|CRF not assured by investigators|5|||
127497456|NCT05360966|458783649|FG000|Overall Study|Adverse Event|5|||
127497457|NCT05360966|458783650|FG001|Overall Study|Adverse Event|5|||
127497458|NCT05360966|458783649|FG000|Overall Study|Withdrawal of Consent|5|||
127497459|NCT05360966|458783650|FG001|Overall Study|Withdrawal of Consent|3|||
127497460|NCT05360966|458783649|FG000|Overall Study|Noncompliance|2|||
127497461|NCT05360966|458783650|FG001|Overall Study|Noncompliance|1|||
127497462|NCT05360966|458783649|FG000|Overall Study|Lost to Follow-up|2|||
127497463|NCT05360966|458783650|FG001|Overall Study|Lost to Follow-up|3|||
127497464|NCT05360966|458783649|FG000|Overall Study|Protocol Deviation|2|||
127497465|NCT05360966|458783650|FG001|Overall Study|Protocol Deviation|1|||
127497466|NCT05360966|458783649|FG000|Overall Study|As specified in the Clinical Study Report|1|||
127497467|NCT05360966|458783650|FG001|Overall Study|As specified in the Clinical Study Report|3|||
127497468|NCT05396014|458783651|FG000|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|18|||
127497469|NCT05396014|458783652|FG001|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
127497470|NCT05396014|458783653|FG002|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
127497471|NCT05396014|458783654|FG003|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
127497472|NCT05396014|458783655|FG004|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
127497473|NCT05396014|458783656|FG005|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
127497474|NCT05396014|458783657|FG006|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
127497475|NCT05396014|458783658|FG007|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
127497476|NCT05396014|458783659|FG008|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
127497477|NCT05396014|458783660|FG009|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
127497478|NCT05396014|458783661|FG010|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
127497479|NCT05396014|458783662|FG011|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
127497480|NCT05396014|458783663|FG012|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
127497481|NCT05396014|458783664|FG013|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|13|||
127497482|NCT05396014|458783665|FG014|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
127497483|NCT05396014|458783666|FG015|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
127497484|NCT05396014|458783667|FG016|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
127497485|NCT05396014|458783668|FG017|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
127497486|NCT05396014|458783669|FG018|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
127497487|NCT05396014|458783670|FG019|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
127497488|NCT05396014|458783671|FG020|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
127497489|NCT05396014|458783672|FG021|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
127497490|NCT05396014|458783673|FG022|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
127497491|NCT05396014|458783674|FG023|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
127497492|NCT05396014|458783675|FG024|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
127497493|NCT05396014|458783676|FG025|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
127497494|NCT05396014|458783677|FG026|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
127497495|NCT05396014|458783678|FG027|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
127497496|NCT05396014|458783679|FG028|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
127497497|NCT05396014|458783680|FG029|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
127497498|NCT05396014|458783681|FG030|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
127497499|NCT05396014|458783682|FG031|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
127497500|NCT05396014|458783683|FG032|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
127497501|NCT05396014|458783684|FG033|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
127497502|NCT05396014|458783685|FG034|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
127497503|NCT05396014|458783686|FG035|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
127497504|NCT05396014|458783687|FG036|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
127497505|NCT05396014|458783688|FG037|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
127497506|NCT05396014|458783689|FG038|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
127497507|NCT05396014|458783690|FG039|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
127497508|NCT05396014|458783691|FG040|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
127497509|NCT05396014|458783692|FG041|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
127497510|NCT05396014|458783693|FG042|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
127497511|NCT05396014|458783651|FG000|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|15|||
127497512|NCT05396014|458783652|FG001|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
127497513|NCT05396014|458783653|FG002|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
127497514|NCT05396014|458783654|FG003|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
127497515|NCT05396014|458783655|FG004|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
127497516|NCT05396014|458783656|FG005|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
127497517|NCT05396014|458783657|FG006|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
127497518|NCT05396014|458783658|FG007|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
127497519|NCT05396014|458783659|FG008|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
127497520|NCT05396014|458783660|FG009|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
127497521|NCT05396014|458783661|FG010|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
127497522|NCT05396014|458783662|FG011|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
127497523|NCT05396014|458783663|FG012|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
127497524|NCT05396014|458783664|FG013|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
127497525|NCT05396014|458783665|FG014|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
127497526|NCT05396014|458783666|FG015|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
127497527|NCT05396014|458783667|FG016|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
127497528|NCT05396014|458783668|FG017|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
127497529|NCT05396014|458783669|FG018|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
127497530|NCT05396014|458783670|FG019|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
127497531|NCT05396014|458783671|FG020|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
127497532|NCT05396014|458783672|FG021|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
127497533|NCT05396014|458783673|FG022|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
127497534|NCT05396014|458783674|FG023|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
127497535|NCT05396014|458783675|FG024|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
127497536|NCT05396014|458783676|FG025|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
127497537|NCT05396014|458783677|FG026|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
127497538|NCT05396014|458783678|FG027|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
127497539|NCT05396014|458783679|FG028|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
127497540|NCT05396014|458783680|FG029|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
127497541|NCT05396014|458783681|FG030|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
127497542|NCT05396014|458783682|FG031|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
127497543|NCT05396014|458783683|FG032|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
127497544|NCT05396014|458783684|FG033|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
127497545|NCT05396014|458783685|FG034|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
127497546|NCT05396014|458783686|FG035|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
127497547|NCT05396014|458783687|FG036|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
127497548|NCT05396014|458783688|FG037|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
127497549|NCT05396014|458783689|FG038|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
127497550|NCT05396014|458783690|FG039|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|14|||
127497551|NCT05396014|458783691|FG040|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
127497552|NCT05396014|458783692|FG041|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
127497553|NCT05396014|458783693|FG042|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
127497554|NCT05396014|458783651|FG000|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
127497555|NCT05396014|458783652|FG001|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
127497556|NCT05396014|458783653|FG002|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
127497557|NCT05396014|458783654|FG003|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
127497558|NCT05396014|458783655|FG004|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
127497559|NCT05396014|458783656|FG005|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
127497560|NCT05396014|458783657|FG006|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
127497561|NCT05396014|458783658|FG007|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
127497562|NCT05396014|458783659|FG008|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
127497563|NCT05396014|458783660|FG009|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
127497564|NCT05396014|458783661|FG010|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
127497565|NCT05396014|458783662|FG011|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
127497566|NCT05396014|458783663|FG012|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
127497567|NCT05396014|458783664|FG013|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
127497568|NCT05396014|458783665|FG014|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
127497569|NCT05396014|458783666|FG015|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
127497570|NCT05396014|458783667|FG016|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
127497571|NCT05396014|458783668|FG017|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
127497572|NCT05396014|458783669|FG018|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
127497573|NCT05396014|458783670|FG019|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
127497574|NCT05396014|458783671|FG020|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
127497575|NCT05396014|458783672|FG021|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
127497576|NCT05396014|458783673|FG022|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
127497577|NCT05396014|458783674|FG023|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
127497578|NCT05396014|458783675|FG024|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
127497579|NCT05396014|458783676|FG025|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
127497580|NCT05396014|458783677|FG026|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
127497581|NCT05396014|458783678|FG027|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
127497582|NCT05396014|458783679|FG028|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
127497583|NCT05396014|458783680|FG029|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
127497584|NCT05396014|458783681|FG030|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
127497585|NCT05396014|458783682|FG031|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
127497586|NCT05396014|458783683|FG032|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
127497587|NCT05396014|458783684|FG033|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
127497588|NCT05396014|458783685|FG034|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
127497589|NCT05396014|458783686|FG035|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
127497590|NCT05396014|458783687|FG036|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
127497591|NCT05396014|458783688|FG037|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
127497592|NCT05396014|458783689|FG038|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
127497593|NCT05396014|458783690|FG039|Stage 1 Intervention (Weeks 0-12)|Adverse Event|1|||
127497594|NCT05396014|458783691|FG040|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
127497595|NCT05396014|458783692|FG041|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
127497596|NCT05396014|458783693|FG042|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
127497597|NCT05396014|458783651|FG000|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
127497598|NCT05396014|458783652|FG001|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
127497599|NCT05396014|458783653|FG002|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
127497600|NCT05396014|458783654|FG003|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
127497601|NCT05396014|458783655|FG004|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
127497602|NCT05396014|458783656|FG005|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
127497603|NCT05396014|458783657|FG006|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
127497604|NCT05396014|458783658|FG007|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
127497605|NCT05396014|458783659|FG008|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
127497606|NCT05396014|458783660|FG009|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
127497607|NCT05396014|458783661|FG010|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
127497608|NCT05396014|458783662|FG011|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
127497609|NCT05396014|458783663|FG012|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
127497610|NCT05396014|458783664|FG013|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
127497611|NCT05396014|458783665|FG014|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
127497612|NCT05396014|458783666|FG015|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
127497613|NCT05396014|458783667|FG016|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
127497614|NCT05396014|458783668|FG017|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
127497615|NCT05396014|458783669|FG018|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
127497616|NCT05396014|458783670|FG019|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
127497617|NCT05396014|458783671|FG020|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
127497618|NCT05396014|458783672|FG021|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
127497619|NCT05396014|458783673|FG022|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
127497620|NCT05396014|458783674|FG023|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
127497621|NCT05396014|458783675|FG024|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
127497622|NCT05396014|458783676|FG025|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
127497623|NCT05396014|458783677|FG026|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
127497624|NCT05396014|458783678|FG027|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
127497625|NCT05396014|458783679|FG028|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
127497626|NCT05396014|458783680|FG029|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
127497627|NCT05396014|458783681|FG030|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
127497628|NCT05396014|458783682|FG031|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
127497629|NCT05396014|458783683|FG032|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
127497630|NCT05396014|458783684|FG033|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
127497631|NCT05396014|458783685|FG034|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
127497632|NCT05396014|458783686|FG035|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
127497633|NCT05396014|458783687|FG036|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
127497634|NCT05396014|458783688|FG037|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
127497635|NCT05396014|458783689|FG038|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
127497636|NCT05396014|458783690|FG039|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
127497637|NCT05396014|458783691|FG040|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
127497638|NCT05396014|458783692|FG041|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
127497639|NCT05396014|458783693|FG042|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
127497640|NCT05396014|458783651|FG000|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
127497641|NCT05396014|458783652|FG001|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
127497642|NCT05396014|458783653|FG002|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
127497643|NCT05396014|458783654|FG003|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
127497644|NCT05396014|458783655|FG004|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
127497645|NCT05396014|458783656|FG005|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
127497646|NCT05396014|458783657|FG006|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
127497647|NCT05396014|458783658|FG007|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
127497648|NCT05396014|458783659|FG008|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
127497649|NCT05396014|458783660|FG009|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
127497650|NCT05396014|458783661|FG010|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
127497651|NCT05396014|458783662|FG011|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
127497652|NCT05396014|458783663|FG012|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
127497653|NCT05396014|458783664|FG013|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
127497654|NCT05396014|458783665|FG014|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
127497655|NCT05396014|458783666|FG015|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
127497656|NCT05396014|458783667|FG016|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
127497657|NCT05396014|458783668|FG017|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
127497658|NCT05396014|458783669|FG018|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
127497659|NCT05396014|458783670|FG019|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
127497660|NCT05396014|458783671|FG020|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
127497661|NCT05396014|458783672|FG021|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
127497662|NCT05396014|458783673|FG022|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
127497663|NCT05396014|458783674|FG023|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
127497664|NCT05396014|458783675|FG024|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
127497665|NCT05396014|458783676|FG025|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
127497666|NCT05396014|458783677|FG026|Stage 1 Intervention (Weeks 0-12)|Physician Decision|1|||
127497667|NCT05396014|458783678|FG027|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
127497668|NCT05396014|458783679|FG028|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
127497669|NCT05396014|458783680|FG029|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
127497670|NCT05396014|458783681|FG030|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
127497671|NCT05396014|458783682|FG031|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
127497672|NCT05396014|458783683|FG032|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
127497673|NCT05396014|458783684|FG033|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
127497674|NCT05396014|458783685|FG034|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
127497675|NCT05396014|458783686|FG035|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
127497676|NCT05396014|458783687|FG036|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
127497677|NCT05396014|458783688|FG037|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
127497678|NCT05396014|458783689|FG038|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
127497679|NCT05396014|458783690|FG039|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
127497680|NCT05396014|458783691|FG040|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
127497681|NCT05396014|458783692|FG041|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
127497682|NCT05396014|458783693|FG042|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
127497683|NCT05396014|458783651|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
127497684|NCT05396014|458783652|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
127497685|NCT05396014|458783653|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
127497686|NCT05396014|458783654|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
127497687|NCT05396014|458783655|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
127497688|NCT05396014|458783656|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
127497689|NCT05396014|458783657|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
127497690|NCT05396014|458783658|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
127497691|NCT05396014|458783659|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
127497692|NCT05396014|458783660|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
127497693|NCT05396014|458783661|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
127497694|NCT05396014|458783662|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
127497695|NCT05396014|458783663|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
127497696|NCT05396014|458783664|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|1|||
127497697|NCT05396014|458783665|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
127497698|NCT05396014|458783666|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
127497699|NCT05396014|458783667|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
127497700|NCT05396014|458783668|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
127497701|NCT05396014|458783669|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
127497702|NCT05396014|458783670|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
127497703|NCT05396014|458783671|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
127497704|NCT05396014|458783672|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
127497705|NCT05396014|458783673|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
127497706|NCT05396014|458783674|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
127497707|NCT05396014|458783675|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
127497708|NCT05396014|458783676|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
127497709|NCT05396014|458783677|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
127497710|NCT05396014|458783678|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
127497711|NCT05396014|458783679|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
127497712|NCT05396014|458783680|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
127497713|NCT05396014|458783681|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
127497714|NCT05396014|458783682|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
127497715|NCT05396014|458783683|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
127497716|NCT05396014|458783684|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
127497717|NCT05396014|458783685|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
127497718|NCT05396014|458783686|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
127497719|NCT05396014|458783687|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
127497720|NCT05396014|458783688|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
127497721|NCT05396014|458783689|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
127497722|NCT05396014|458783690|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
127497723|NCT05396014|458783691|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
127497724|NCT05396014|458783692|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
127497725|NCT05396014|458783693|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
127497726|NCT05396014|458783651|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
127497727|NCT05396014|458783652|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
127497728|NCT05396014|458783653|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
127497729|NCT05396014|458783654|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
127497730|NCT05396014|458783655|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
127497731|NCT05396014|458783656|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
127497732|NCT05396014|458783657|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
127497733|NCT05396014|458783658|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
127497734|NCT05396014|458783659|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
127497735|NCT05396014|458783660|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
127497736|NCT05396014|458783661|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
127497737|NCT05396014|458783662|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
127497738|NCT05396014|458783663|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
127497739|NCT05396014|458783664|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
127497740|NCT05396014|458783665|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
127497741|NCT05396014|458783666|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
127497742|NCT05396014|458783667|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
127497743|NCT05396014|458783668|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
127497744|NCT05396014|458783669|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
127497745|NCT05396014|458783670|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
127497746|NCT05396014|458783671|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
127497747|NCT05396014|458783672|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
127497748|NCT05396014|458783673|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
127497749|NCT05396014|458783674|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
127497750|NCT05396014|458783675|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
127497751|NCT05396014|458783676|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
127497752|NCT05396014|458783677|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
127497753|NCT05396014|458783678|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
127497754|NCT05396014|458783679|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
127497755|NCT05396014|458783680|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
127497756|NCT05396014|458783681|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
127497757|NCT05396014|458783682|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
127497758|NCT05396014|458783683|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
127497759|NCT05396014|458783684|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
127497760|NCT05396014|458783685|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
127497761|NCT05396014|458783686|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
127497762|NCT05396014|458783687|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
127497763|NCT05396014|458783688|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
127497764|NCT05396014|458783689|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
127497765|NCT05396014|458783690|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|2|||
127497766|NCT05396014|458783691|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
127497767|NCT05396014|458783692|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
127497768|NCT05396014|458783693|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
127497769|NCT05396014|458783651|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
127497770|NCT05396014|458783652|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
127497771|NCT05396014|458783653|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
127497772|NCT05396014|458783654|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
127497773|NCT05396014|458783655|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
127497774|NCT05396014|458783656|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
127497775|NCT05396014|458783657|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
127497776|NCT05396014|458783658|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
127497777|NCT05396014|458783659|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
127497778|NCT05396014|458783660|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
127497779|NCT05396014|458783661|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
127497780|NCT05396014|458783662|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
127497781|NCT05396014|458783663|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
127497782|NCT05396014|458783664|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
127497783|NCT05396014|458783665|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
127497784|NCT05396014|458783666|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
127497785|NCT05396014|458783667|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
127497786|NCT05396014|458783668|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
127497787|NCT05396014|458783669|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
127497788|NCT05396014|458783670|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
127497789|NCT05396014|458783671|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
127497790|NCT05396014|458783672|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
127497791|NCT05396014|458783673|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
127497792|NCT05396014|458783674|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
127497793|NCT05396014|458783675|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
127497794|NCT05396014|458783676|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
127497795|NCT05396014|458783677|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
127497796|NCT05396014|458783678|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
127497797|NCT05396014|458783679|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
127497798|NCT05396014|458783680|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
127497799|NCT05396014|458783681|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
127497800|NCT05396014|458783682|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
127497801|NCT05396014|458783683|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
127497802|NCT05396014|458783684|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
127497803|NCT05396014|458783685|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
127497804|NCT05396014|458783686|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
127497805|NCT05396014|458783687|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
127497806|NCT05396014|458783688|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
127497807|NCT05396014|458783689|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
127497808|NCT05396014|458783690|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
127497809|NCT05396014|458783691|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
127497810|NCT05396014|458783692|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
127497811|NCT05396014|458783693|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
127497812|NCT05396014|458783651|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
127497813|NCT05396014|458783652|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
127497814|NCT05396014|458783653|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
127497815|NCT05396014|458783654|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
127497816|NCT05396014|458783655|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
127497817|NCT05396014|458783656|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
127497818|NCT05396014|458783657|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
127497819|NCT05396014|458783658|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
127497820|NCT05396014|458783659|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
127497821|NCT05396014|458783660|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
127497822|NCT05396014|458783661|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
127497823|NCT05396014|458783662|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
127497824|NCT05396014|458783663|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
127497825|NCT05396014|458783664|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|1|||
127497826|NCT05396014|458783665|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
127497827|NCT05396014|458783666|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
127497828|NCT05396014|458783667|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
127497829|NCT05396014|458783668|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
127497830|NCT05396014|458783669|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
127977777|NCT00189306|460540378|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
127977778|NCT00189306|460540378|FG000|Long-Term Follow-up|Intercurrent disease|2|||
127977779|NCT00189306|460540378|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
127977780|NCT00189306|460540378|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
127977781|NCT03640481|460540379|FG000|Overall Study|Death|14|||
127977782|NCT03640481|460540380|FG001|Overall Study|Death|14|||
127977783|NCT03640481|460540381|FG002|Overall Study|Death|0|||
127977784|NCT03640481|460540382|FG003|Overall Study|Death|0|||
127977785|NCT03640481|460540379|FG000|Overall Study|Lost to Follow-up|2|||
127977786|NCT03640481|460540380|FG001|Overall Study|Lost to Follow-up|0|||
127977787|NCT03640481|460540381|FG002|Overall Study|Lost to Follow-up|0|||
127977788|NCT03640481|460540382|FG003|Overall Study|Lost to Follow-up|0|||
127977789|NCT03640481|460540379|FG000|Overall Study|Site terminated by sponsor|1|||
127497831|NCT05396014|458783670|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
127497832|NCT05396014|458783671|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
127497833|NCT05396014|458783672|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
127497834|NCT05396014|458783673|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
127497835|NCT05396014|458783674|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
127497836|NCT05396014|458783675|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
127497837|NCT05396014|458783676|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
127497838|NCT05396014|458783677|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
127497839|NCT05396014|458783678|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
127497840|NCT05396014|458783679|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
127497841|NCT05396014|458783680|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
127497842|NCT05396014|458783681|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
127497843|NCT05396014|458783682|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
127497844|NCT05396014|458783683|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
127497845|NCT05396014|458783684|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
127497846|NCT05396014|458783685|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
127497847|NCT05396014|458783686|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
127497848|NCT05396014|458783687|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
127497849|NCT05396014|458783688|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
127497850|NCT05396014|458783689|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
127497851|NCT05396014|458783690|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
127497852|NCT05396014|458783691|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
127497853|NCT05396014|458783692|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
127497854|NCT05396014|458783693|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
127497855|NCT05396014|458783651|FG000|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
127497856|NCT05396014|458783652|FG001|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
127497857|NCT05396014|458783653|FG002|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
127497858|NCT05396014|458783654|FG003|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
127497859|NCT05396014|458783655|FG004|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
127497860|NCT05396014|458783656|FG005|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
127497861|NCT05396014|458783657|FG006|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
127497862|NCT05396014|458783658|FG007|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
127497863|NCT05396014|458783659|FG008|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
127497864|NCT05396014|458783660|FG009|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
127497865|NCT05396014|458783661|FG010|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
127497866|NCT05396014|458783662|FG011|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
127497867|NCT05396014|458783663|FG012|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
127497868|NCT05396014|458783664|FG013|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
127497869|NCT05396014|458783665|FG014|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
127497870|NCT05396014|458783666|FG015|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
127497871|NCT05396014|458783667|FG016|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
127497872|NCT05396014|458783668|FG017|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
127497873|NCT05396014|458783669|FG018|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
127497874|NCT05396014|458783670|FG019|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
127497875|NCT05396014|458783671|FG020|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
127497876|NCT05396014|458783672|FG021|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
127497877|NCT05396014|458783673|FG022|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
127497878|NCT05396014|458783674|FG023|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
127497879|NCT05396014|458783675|FG024|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
127497880|NCT05396014|458783676|FG025|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
127497881|NCT05396014|458783677|FG026|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
127497882|NCT05396014|458783678|FG027|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
127497883|NCT05396014|458783679|FG028|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
127497884|NCT05396014|458783680|FG029|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
127497885|NCT05396014|458783681|FG030|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
127497886|NCT05396014|458783682|FG031|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
127497887|NCT05396014|458783683|FG032|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
127497888|NCT05396014|458783684|FG033|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
127497889|NCT05396014|458783685|FG034|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
127497890|NCT05396014|458783686|FG035|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
127497891|NCT05396014|458783687|FG036|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
127497892|NCT05396014|458783688|FG037|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
127497893|NCT05396014|458783689|FG038|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
127497894|NCT05396014|458783690|FG039|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
127497895|NCT05396014|458783691|FG040|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|3|||
127497896|NCT05396014|458783692|FG041|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
127497897|NCT05396014|458783693|FG042|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
127497898|NCT05396014|458783651|FG000|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
127497899|NCT05396014|458783652|FG001|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
127497900|NCT05396014|458783653|FG002|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
127497901|NCT05396014|458783654|FG003|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
127497902|NCT05396014|458783655|FG004|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
127497903|NCT05396014|458783656|FG005|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
127497904|NCT05396014|458783657|FG006|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
127497905|NCT05396014|458783658|FG007|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
127497906|NCT05396014|458783659|FG008|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
127497907|NCT05396014|458783660|FG009|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
127497908|NCT05396014|458783661|FG010|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
127497909|NCT05396014|458783662|FG011|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
127497910|NCT05396014|458783663|FG012|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
127497911|NCT05396014|458783664|FG013|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
127497912|NCT05396014|458783665|FG014|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
127497913|NCT05396014|458783666|FG015|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
127497914|NCT05396014|458783667|FG016|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
127497915|NCT05396014|458783668|FG017|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
127497916|NCT05396014|458783669|FG018|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
127497917|NCT05396014|458783670|FG019|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
127497918|NCT05396014|458783671|FG020|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
127497919|NCT05396014|458783672|FG021|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
127497920|NCT05396014|458783673|FG022|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
127497921|NCT05396014|458783674|FG023|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
127497922|NCT05396014|458783675|FG024|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
127497923|NCT05396014|458783676|FG025|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
127497924|NCT05396014|458783677|FG026|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
127497925|NCT05396014|458783678|FG027|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
127497926|NCT05396014|458783679|FG028|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
127497927|NCT05396014|458783680|FG029|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
127497928|NCT05396014|458783681|FG030|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
127497929|NCT05396014|458783682|FG031|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
127497930|NCT05396014|458783683|FG032|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
127497931|NCT05396014|458783684|FG033|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
127497932|NCT05396014|458783685|FG034|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
127497933|NCT05396014|458783686|FG035|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
127497934|NCT05396014|458783687|FG036|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
127497935|NCT05396014|458783688|FG037|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
127497936|NCT05396014|458783689|FG038|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
127497937|NCT05396014|458783690|FG039|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
127497938|NCT05396014|458783691|FG040|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
127497939|NCT05396014|458783692|FG041|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|3|||
127497940|NCT05396014|458783693|FG042|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
127497941|NCT05396014|458783651|FG000|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
127497942|NCT05396014|458783652|FG001|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
127497943|NCT05396014|458783653|FG002|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
127497944|NCT05396014|458783654|FG003|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
127497945|NCT05396014|458783655|FG004|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
127497946|NCT05396014|458783656|FG005|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
127497947|NCT05396014|458783657|FG006|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
127497948|NCT05396014|458783658|FG007|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
127497949|NCT05396014|458783659|FG008|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
127497950|NCT05396014|458783660|FG009|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
127497951|NCT05396014|458783661|FG010|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
127497952|NCT05396014|458783662|FG011|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
127497953|NCT05396014|458783663|FG012|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
127497954|NCT05396014|458783664|FG013|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
127497955|NCT05396014|458783665|FG014|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
127497956|NCT05396014|458783666|FG015|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
127497957|NCT05396014|458783667|FG016|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
127497958|NCT05396014|458783668|FG017|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
127497959|NCT05396014|458783669|FG018|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
127497960|NCT05396014|458783670|FG019|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
127497961|NCT05396014|458783671|FG020|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
127497962|NCT05396014|458783672|FG021|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
127497963|NCT05396014|458783673|FG022|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
127497964|NCT05396014|458783674|FG023|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
127497965|NCT05396014|458783675|FG024|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
127497966|NCT05396014|458783676|FG025|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
127497967|NCT05396014|458783677|FG026|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
127497968|NCT05396014|458783678|FG027|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
127497969|NCT05396014|458783679|FG028|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
127497970|NCT05396014|458783680|FG029|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
127497971|NCT05396014|458783681|FG030|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
127497972|NCT05396014|458783682|FG031|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
127497973|NCT05396014|458783683|FG032|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
127497974|NCT05396014|458783684|FG033|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
127497975|NCT05396014|458783685|FG034|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
127497976|NCT05396014|458783686|FG035|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
127497977|NCT05396014|458783687|FG036|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
127497978|NCT05396014|458783688|FG037|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
127497979|NCT05396014|458783689|FG038|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
127497980|NCT05396014|458783690|FG039|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
127497981|NCT05396014|458783691|FG040|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
127497982|NCT05396014|458783692|FG041|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
127497983|NCT05396014|458783693|FG042|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
127497984|NCT05396014|458783651|FG000|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
127497985|NCT05396014|458783652|FG001|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
127497986|NCT05396014|458783653|FG002|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
127497987|NCT05396014|458783654|FG003|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
127497988|NCT05396014|458783655|FG004|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
127497989|NCT05396014|458783656|FG005|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
127497990|NCT05396014|458783657|FG006|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
127497991|NCT05396014|458783658|FG007|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
127497992|NCT05396014|458783659|FG008|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
127497993|NCT05396014|458783660|FG009|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
127497994|NCT05396014|458783661|FG010|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
127497995|NCT05396014|458783662|FG011|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
127497996|NCT05396014|458783663|FG012|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
127497997|NCT05396014|458783664|FG013|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
127497998|NCT05396014|458783665|FG014|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
127497999|NCT05396014|458783666|FG015|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
127498000|NCT05396014|458783667|FG016|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
127498001|NCT05396014|458783668|FG017|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
127498002|NCT05396014|458783669|FG018|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
127498003|NCT05396014|458783670|FG019|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
127498004|NCT05396014|458783671|FG020|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
127498005|NCT05396014|458783672|FG021|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
127498006|NCT05396014|458783673|FG022|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
127498007|NCT05396014|458783674|FG023|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
127498008|NCT05396014|458783675|FG024|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
127498009|NCT05396014|458783676|FG025|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
127498010|NCT05396014|458783677|FG026|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|1|||
127498011|NCT05396014|458783678|FG027|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
127498012|NCT05396014|458783679|FG028|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
127498013|NCT05396014|458783680|FG029|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
127498014|NCT05396014|458783681|FG030|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
127498015|NCT05396014|458783682|FG031|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
127498016|NCT05396014|458783683|FG032|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
127498017|NCT05396014|458783684|FG033|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
127498018|NCT05396014|458783685|FG034|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
127498019|NCT05396014|458783686|FG035|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
127498020|NCT05396014|458783687|FG036|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
127498021|NCT05396014|458783688|FG037|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
127498022|NCT05396014|458783689|FG038|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
127498023|NCT05396014|458783690|FG039|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
127498024|NCT05396014|458783691|FG040|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
127498025|NCT05396014|458783692|FG041|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
127498026|NCT05396014|458783693|FG042|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
127498027|NCT03062280|458783694|FG000|Overall Study|Adverse Event|1|||
127498028|NCT03062280|458783694|FG000|Overall Study|Death|1|||
127498029|NCT03062280|458783694|FG000|Overall Study|Fertility Treatment|2|||
127498030|NCT03062280|458783694|FG000|Overall Study|Physician Decision|2|||
127498031|NCT03062280|458783694|FG000|Overall Study|Pregnancy|5|||
127498032|NCT03062280|458783694|FG000|Overall Study|Withdrawal by Subject|11|||
127498033|NCT04299308|458783696|FG000|Overall Study|Withdrawal by Subject|1|||
127498034|NCT04299308|458783697|FG001|Overall Study|Withdrawal by Subject|0|||
127498035|NCT04299308|458783696|FG000|Overall Study|issue with PET image (1)|1|||
127498036|NCT04299308|458783697|FG001|Overall Study|issue with PET image (1)|0|||
127498037|NCT05258890|458783698|FG000|Overall Study|Patient withdrawal|6|||
127498038|NCT05258890|458783699|FG001|Overall Study|Patient withdrawal|7|||
127498039|NCT05258890|458783698|FG000|Overall Study|Patient lost to follow-up|10|||
127498040|NCT05258890|458783699|FG001|Overall Study|Patient lost to follow-up|3|||
127498041|NCT05258890|458783698|FG000|Overall Study|Social network member withdrawal|1|||
127498042|NCT05258890|458783699|FG001|Overall Study|Social network member withdrawal|0|||
127498043|NCT05258890|458783698|FG000|Overall Study|Social network member lost to follow-up|5|||
127498044|NCT05258890|458783699|FG001|Overall Study|Social network member lost to follow-up|0|||
127498045|NCT04493424|458783700|FG000|Overall Study|Termination of the trial by the sponsor|89|||
127498046|NCT04493424|458783700|FG000|Overall Study|Withdrawal by Subject|9|||
127498047|NCT04493424|458783700|FG000|Overall Study|Lost to Follow-up|2|||
127498048|NCT04493424|458783700|FG000|Overall Study|Lack of Efficacy|3|||
127498049|NCT04493424|458783700|FG000|Overall Study|Adverse Event|5|||
127498050|NCT05924165|458783703|FG000|Overall Study|Physician Decision|2|||
127498051|NCT05924165|458783704|FG001|Overall Study|Physician Decision|3|||
127498052|NCT05959447|458783705|FG000|Part 1 (Up to Day 21)|Adverse Event|1|||
127498053|NCT05959447|458783706|FG001|Part 1 (Up to Day 21)|Adverse Event|0|||
127498054|NCT05959447|458783705|FG000|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|9|||
127498055|NCT05959447|458783706|FG001|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|0|||
127498056|NCT05959447|458783705|FG000|Part 2 (Up to Day 22)|Adverse Event|0|||
127498057|NCT05959447|458783706|FG001|Part 2 (Up to Day 22)|Adverse Event|2|||
127498058|NCT05959447|458783705|FG000|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
127498059|NCT05959447|458783706|FG001|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
127498060|NCT01436656|458783707|FG000|Dose Escalation|Death|1|||
127498061|NCT01436656|458783708|FG001|Dose Escalation|Death|3|||
127498062|NCT01436656|458783709|FG002|Dose Escalation|Death|1|||
127498063|NCT01436656|458783710|FG003|Dose Escalation|Death|0|||
127498064|NCT01436656|458783711|FG004|Dose Escalation|Death|2|||
127498065|NCT01436656|458783712|FG005|Dose Escalation|Death|1|||
127498066|NCT01436656|458783713|FG006|Dose Escalation|Death|1|||
127498067|NCT01436656|458783714|FG007|Dose Escalation|Death|1|||
127498068|NCT01436656|458783715|FG008|Dose Escalation|Death|1|||
127498069|NCT01436656|458783716|FG009|Dose Escalation|Death|0|||
127498070|NCT01436656|458783717|FG010|Dose Escalation|Death|0|||
127498071|NCT01436656|458783718|FG011|Dose Escalation|Death|0|||
127498072|NCT01436656|458783719|FG012|Dose Escalation|Death|0|||
127498073|NCT01436656|458783720|FG013|Dose Escalation|Death|0|||
127498074|NCT01436656|458783721|FG014|Dose Escalation|Death|0|||
127498075|NCT01436656|458783722|FG015|Dose Escalation|Death|0|||
127498076|NCT01436656|458783723|FG016|Dose Escalation|Death|0|||
127498077|NCT01436656|458783724|FG017|Dose Escalation|Death|0|||
127498078|NCT01436656|458783707|FG000|Dose Escalation|Protocol Violation|0|||
127498079|NCT01436656|458783708|FG001|Dose Escalation|Protocol Violation|0|||
127498080|NCT01436656|458783709|FG002|Dose Escalation|Protocol Violation|0|||
127498081|NCT01436656|458783710|FG003|Dose Escalation|Protocol Violation|0|||
127498082|NCT01436656|458783711|FG004|Dose Escalation|Protocol Violation|0|||
127498083|NCT01436656|458783712|FG005|Dose Escalation|Protocol Violation|1|||
127498084|NCT01436656|458783713|FG006|Dose Escalation|Protocol Violation|0|||
127498085|NCT01436656|458783714|FG007|Dose Escalation|Protocol Violation|0|||
127498086|NCT01436656|458783715|FG008|Dose Escalation|Protocol Violation|0|||
127498087|NCT01436656|458783716|FG009|Dose Escalation|Protocol Violation|0|||
127498088|NCT01436656|458783717|FG010|Dose Escalation|Protocol Violation|0|||
127498089|NCT01436656|458783718|FG011|Dose Escalation|Protocol Violation|0|||
127498090|NCT01436656|458783719|FG012|Dose Escalation|Protocol Violation|0|||
127498091|NCT01436656|458783720|FG013|Dose Escalation|Protocol Violation|0|||
127498092|NCT01436656|458783721|FG014|Dose Escalation|Protocol Violation|0|||
127498093|NCT01436656|458783722|FG015|Dose Escalation|Protocol Violation|0|||
127498094|NCT01436656|458783723|FG016|Dose Escalation|Protocol Violation|0|||
127498095|NCT01436656|458783724|FG017|Dose Escalation|Protocol Violation|0|||
127498096|NCT01436656|458783707|FG000|Dose Escalation|Withdrawal by Subject|0|||
127498097|NCT01436656|458783708|FG001|Dose Escalation|Withdrawal by Subject|0|||
127498098|NCT01436656|458783709|FG002|Dose Escalation|Withdrawal by Subject|0|||
127498099|NCT01436656|458783710|FG003|Dose Escalation|Withdrawal by Subject|0|||
127498100|NCT01436656|458783711|FG004|Dose Escalation|Withdrawal by Subject|1|||
127498101|NCT01436656|458783712|FG005|Dose Escalation|Withdrawal by Subject|0|||
127498102|NCT01436656|458783713|FG006|Dose Escalation|Withdrawal by Subject|0|||
127498103|NCT01436656|458783714|FG007|Dose Escalation|Withdrawal by Subject|2|||
127498104|NCT01436656|458783715|FG008|Dose Escalation|Withdrawal by Subject|0|||
127498105|NCT01436656|458783716|FG009|Dose Escalation|Withdrawal by Subject|1|||
127498106|NCT01436656|458783717|FG010|Dose Escalation|Withdrawal by Subject|1|||
127498107|NCT01436656|458783718|FG011|Dose Escalation|Withdrawal by Subject|0|||
127498108|NCT01436656|458783719|FG012|Dose Escalation|Withdrawal by Subject|0|||
127498109|NCT01436656|458783720|FG013|Dose Escalation|Withdrawal by Subject|0|||
127498110|NCT01436656|458783721|FG014|Dose Escalation|Withdrawal by Subject|0|||
127498111|NCT01436656|458783722|FG015|Dose Escalation|Withdrawal by Subject|0|||
127498112|NCT01436656|458783723|FG016|Dose Escalation|Withdrawal by Subject|0|||
127498113|NCT01436656|458783724|FG017|Dose Escalation|Withdrawal by Subject|0|||
127498114|NCT01436656|458783707|FG000|Dose Escalation|Administrative problems|0|||
127498115|NCT01436656|458783708|FG001|Dose Escalation|Administrative problems|1|||
127498116|NCT01436656|458783709|FG002|Dose Escalation|Administrative problems|0|||
127498117|NCT01436656|458783710|FG003|Dose Escalation|Administrative problems|0|||
127498118|NCT01436656|458783711|FG004|Dose Escalation|Administrative problems|0|||
127498119|NCT01436656|458783712|FG005|Dose Escalation|Administrative problems|0|||
127498120|NCT01436656|458783713|FG006|Dose Escalation|Administrative problems|0|||
127498121|NCT01436656|458783714|FG007|Dose Escalation|Administrative problems|0|||
127498122|NCT01436656|458783715|FG008|Dose Escalation|Administrative problems|0|||
127498123|NCT01436656|458783716|FG009|Dose Escalation|Administrative problems|0|||
127498124|NCT01436656|458783717|FG010|Dose Escalation|Administrative problems|0|||
127498125|NCT01436656|458783718|FG011|Dose Escalation|Administrative problems|0|||
127498126|NCT01436656|458783719|FG012|Dose Escalation|Administrative problems|0|||
127498127|NCT01436656|458783720|FG013|Dose Escalation|Administrative problems|0|||
127498128|NCT01436656|458783721|FG014|Dose Escalation|Administrative problems|0|||
127498129|NCT01436656|458783722|FG015|Dose Escalation|Administrative problems|0|||
127498130|NCT01436656|458783723|FG016|Dose Escalation|Administrative problems|0|||
127498131|NCT01436656|458783724|FG017|Dose Escalation|Administrative problems|0|||
127498132|NCT01436656|458783707|FG000|Dose Escalation|Lost to Follow-up|1|||
127498133|NCT01436656|458783708|FG001|Dose Escalation|Lost to Follow-up|0|||
127498134|NCT01436656|458783709|FG002|Dose Escalation|Lost to Follow-up|0|||
127498135|NCT01436656|458783710|FG003|Dose Escalation|Lost to Follow-up|0|||
127498136|NCT01436656|458783711|FG004|Dose Escalation|Lost to Follow-up|1|||
127498137|NCT01436656|458783712|FG005|Dose Escalation|Lost to Follow-up|0|||
127498138|NCT01436656|458783713|FG006|Dose Escalation|Lost to Follow-up|0|||
127498139|NCT01436656|458783714|FG007|Dose Escalation|Lost to Follow-up|0|||
127498140|NCT01436656|458783715|FG008|Dose Escalation|Lost to Follow-up|0|||
127498141|NCT01436656|458783716|FG009|Dose Escalation|Lost to Follow-up|0|||
127498142|NCT01436656|458783717|FG010|Dose Escalation|Lost to Follow-up|0|||
127498143|NCT01436656|458783718|FG011|Dose Escalation|Lost to Follow-up|0|||
127498144|NCT01436656|458783719|FG012|Dose Escalation|Lost to Follow-up|0|||
127498145|NCT01436656|458783720|FG013|Dose Escalation|Lost to Follow-up|0|||
127498146|NCT01436656|458783721|FG014|Dose Escalation|Lost to Follow-up|0|||
127498147|NCT01436656|458783722|FG015|Dose Escalation|Lost to Follow-up|0|||
127498148|NCT01436656|458783723|FG016|Dose Escalation|Lost to Follow-up|0|||
127498149|NCT01436656|458783724|FG017|Dose Escalation|Lost to Follow-up|0|||
127498150|NCT01436656|458783707|FG000|Dose Escalation|New anti-cancer therapy|1|||
127498151|NCT01436656|458783708|FG001|Dose Escalation|New anti-cancer therapy|0|||
127498152|NCT01436656|458783709|FG002|Dose Escalation|New anti-cancer therapy|0|||
127498153|NCT01436656|458783710|FG003|Dose Escalation|New anti-cancer therapy|0|||
127498154|NCT01436656|458783711|FG004|Dose Escalation|New anti-cancer therapy|0|||
127498155|NCT01436656|458783712|FG005|Dose Escalation|New anti-cancer therapy|0|||
127498156|NCT01436656|458783713|FG006|Dose Escalation|New anti-cancer therapy|0|||
127498157|NCT01436656|458783714|FG007|Dose Escalation|New anti-cancer therapy|0|||
127498158|NCT01436656|458783715|FG008|Dose Escalation|New anti-cancer therapy|1|||
127498159|NCT01436656|458783716|FG009|Dose Escalation|New anti-cancer therapy|1|||
127498160|NCT01436656|458783717|FG010|Dose Escalation|New anti-cancer therapy|0|||
127498161|NCT01436656|458783718|FG011|Dose Escalation|New anti-cancer therapy|0|||
127498162|NCT01436656|458783719|FG012|Dose Escalation|New anti-cancer therapy|0|||
127498163|NCT01436656|458783720|FG013|Dose Escalation|New anti-cancer therapy|0|||
127498164|NCT01436656|458783721|FG014|Dose Escalation|New anti-cancer therapy|0|||
127498165|NCT01436656|458783722|FG015|Dose Escalation|New anti-cancer therapy|0|||
127498166|NCT01436656|458783723|FG016|Dose Escalation|New anti-cancer therapy|0|||
127498167|NCT01436656|458783724|FG017|Dose Escalation|New anti-cancer therapy|0|||
127498168|NCT01436656|458783707|FG000|Dose Expansion|Adverse Event|0|||
127498169|NCT01436656|458783708|FG001|Dose Expansion|Adverse Event|0|||
127498170|NCT01436656|458783709|FG002|Dose Expansion|Adverse Event|0|||
127498171|NCT01436656|458783710|FG003|Dose Expansion|Adverse Event|0|||
127498172|NCT01436656|458783711|FG004|Dose Expansion|Adverse Event|0|||
127498173|NCT01436656|458783712|FG005|Dose Expansion|Adverse Event|0|||
127498174|NCT01436656|458783713|FG006|Dose Expansion|Adverse Event|0|||
127498175|NCT01436656|458783714|FG007|Dose Expansion|Adverse Event|0|||
127498176|NCT01436656|458783715|FG008|Dose Expansion|Adverse Event|0|||
127498177|NCT01436656|458783716|FG009|Dose Expansion|Adverse Event|0|||
127498178|NCT01436656|458783717|FG010|Dose Expansion|Adverse Event|0|||
127498179|NCT01436656|458783718|FG011|Dose Expansion|Adverse Event|1|||
127498180|NCT01436656|458783719|FG012|Dose Expansion|Adverse Event|0|||
127498181|NCT01436656|458783720|FG013|Dose Expansion|Adverse Event|0|||
127498182|NCT01436656|458783721|FG014|Dose Expansion|Adverse Event|0|||
127498183|NCT01436656|458783722|FG015|Dose Expansion|Adverse Event|0|||
127498184|NCT01436656|458783723|FG016|Dose Expansion|Adverse Event|0|||
127498185|NCT01436656|458783724|FG017|Dose Expansion|Adverse Event|0|||
127498186|NCT01436656|458783707|FG000|Dose Expansion|Withdrawal by Subject|0|||
127498187|NCT01436656|458783708|FG001|Dose Expansion|Withdrawal by Subject|0|||
127498188|NCT01436656|458783709|FG002|Dose Expansion|Withdrawal by Subject|0|||
127498189|NCT01436656|458783710|FG003|Dose Expansion|Withdrawal by Subject|0|||
127498190|NCT01436656|458783711|FG004|Dose Expansion|Withdrawal by Subject|0|||
127498191|NCT01436656|458783712|FG005|Dose Expansion|Withdrawal by Subject|0|||
127498192|NCT01436656|458783713|FG006|Dose Expansion|Withdrawal by Subject|0|||
127498193|NCT01436656|458783714|FG007|Dose Expansion|Withdrawal by Subject|0|||
127498194|NCT01436656|458783715|FG008|Dose Expansion|Withdrawal by Subject|0|||
127498195|NCT01436656|458783716|FG009|Dose Expansion|Withdrawal by Subject|0|||
127498196|NCT01436656|458783717|FG010|Dose Expansion|Withdrawal by Subject|0|||
127498197|NCT01436656|458783718|FG011|Dose Expansion|Withdrawal by Subject|1|||
127498198|NCT01436656|458783719|FG012|Dose Expansion|Withdrawal by Subject|3|||
127498199|NCT01436656|458783720|FG013|Dose Expansion|Withdrawal by Subject|1|||
127498200|NCT01436656|458783721|FG014|Dose Expansion|Withdrawal by Subject|2|||
127498201|NCT01436656|458783722|FG015|Dose Expansion|Withdrawal by Subject|0|||
127498202|NCT01436656|458783723|FG016|Dose Expansion|Withdrawal by Subject|1|||
127498203|NCT01436656|458783724|FG017|Dose Expansion|Withdrawal by Subject|1|||
127498204|NCT01436656|458783707|FG000|Dose Expansion|Death|0|||
127498205|NCT01436656|458783708|FG001|Dose Expansion|Death|0|||
127498206|NCT01436656|458783709|FG002|Dose Expansion|Death|0|||
127498207|NCT01436656|458783710|FG003|Dose Expansion|Death|0|||
127498208|NCT01436656|458783711|FG004|Dose Expansion|Death|0|||
127498209|NCT01436656|458783712|FG005|Dose Expansion|Death|0|||
127498210|NCT01436656|458783713|FG006|Dose Expansion|Death|0|||
127498211|NCT01436656|458783714|FG007|Dose Expansion|Death|0|||
127498212|NCT01436656|458783715|FG008|Dose Expansion|Death|0|||
127498213|NCT01436656|458783716|FG009|Dose Expansion|Death|0|||
127498214|NCT01436656|458783717|FG010|Dose Expansion|Death|0|||
127498215|NCT01436656|458783718|FG011|Dose Expansion|Death|0|||
127498216|NCT01436656|458783719|FG012|Dose Expansion|Death|1|||
127498217|NCT01436656|458783720|FG013|Dose Expansion|Death|0|||
127498218|NCT01436656|458783721|FG014|Dose Expansion|Death|3|||
127498219|NCT01436656|458783722|FG015|Dose Expansion|Death|0|||
127498220|NCT01436656|458783723|FG016|Dose Expansion|Death|3|||
127498221|NCT01436656|458783724|FG017|Dose Expansion|Death|3|||
127498222|NCT01436656|458783707|FG000|Dose Expansion|Lost to Follow-up|0|||
127498223|NCT01436656|458783708|FG001|Dose Expansion|Lost to Follow-up|0|||
127498224|NCT01436656|458783709|FG002|Dose Expansion|Lost to Follow-up|0|||
127498225|NCT01436656|458783710|FG003|Dose Expansion|Lost to Follow-up|0|||
127498226|NCT01436656|458783711|FG004|Dose Expansion|Lost to Follow-up|0|||
127498227|NCT01436656|458783712|FG005|Dose Expansion|Lost to Follow-up|0|||
127498228|NCT01436656|458783713|FG006|Dose Expansion|Lost to Follow-up|0|||
127498229|NCT01436656|458783714|FG007|Dose Expansion|Lost to Follow-up|0|||
127498230|NCT01436656|458783715|FG008|Dose Expansion|Lost to Follow-up|0|||
127498231|NCT01436656|458783716|FG009|Dose Expansion|Lost to Follow-up|0|||
127498232|NCT01436656|458783717|FG010|Dose Expansion|Lost to Follow-up|0|||
127498233|NCT01436656|458783718|FG011|Dose Expansion|Lost to Follow-up|0|||
127498234|NCT01436656|458783719|FG012|Dose Expansion|Lost to Follow-up|0|||
127498235|NCT01436656|458783720|FG013|Dose Expansion|Lost to Follow-up|0|||
127498236|NCT01436656|458783721|FG014|Dose Expansion|Lost to Follow-up|0|||
127498237|NCT01436656|458783722|FG015|Dose Expansion|Lost to Follow-up|0|||
127498238|NCT01436656|458783723|FG016|Dose Expansion|Lost to Follow-up|0|||
127498239|NCT01436656|458783724|FG017|Dose Expansion|Lost to Follow-up|3|||
127498240|NCT01436656|458783707|FG000|Dose Expansion|Disease progression|0|||
127498241|NCT01436656|458783708|FG001|Dose Expansion|Disease progression|0|||
127498242|NCT01436656|458783709|FG002|Dose Expansion|Disease progression|0|||
127498243|NCT01436656|458783710|FG003|Dose Expansion|Disease progression|0|||
127498244|NCT01436656|458783711|FG004|Dose Expansion|Disease progression|0|||
127498245|NCT01436656|458783712|FG005|Dose Expansion|Disease progression|0|||
127498246|NCT01436656|458783713|FG006|Dose Expansion|Disease progression|0|||
127977790|NCT03640481|460540380|FG001|Overall Study|Site terminated by sponsor|3|||
127977791|NCT03640481|460540381|FG002|Overall Study|Site terminated by sponsor|0|||
127498247|NCT01436656|458783714|FG007|Dose Expansion|Disease progression|0|||
127498248|NCT01436656|458783715|FG008|Dose Expansion|Disease progression|0|||
127498249|NCT01436656|458783716|FG009|Dose Expansion|Disease progression|0|||
127498250|NCT01436656|458783717|FG010|Dose Expansion|Disease progression|0|||
127498251|NCT01436656|458783718|FG011|Dose Expansion|Disease progression|3|||
127498252|NCT01436656|458783719|FG012|Dose Expansion|Disease progression|1|||
127498253|NCT01436656|458783720|FG013|Dose Expansion|Disease progression|0|||
127498254|NCT01436656|458783721|FG014|Dose Expansion|Disease progression|1|||
127498255|NCT01436656|458783722|FG015|Dose Expansion|Disease progression|0|||
127498256|NCT01436656|458783723|FG016|Dose Expansion|Disease progression|0|||
127498257|NCT01436656|458783724|FG017|Dose Expansion|Disease progression|1|||
127498258|NCT01436656|458783707|FG000|Dose Expansion|New cancer therapy|0|||
127498259|NCT01436656|458783708|FG001|Dose Expansion|New cancer therapy|0|||
127498260|NCT01436656|458783709|FG002|Dose Expansion|New cancer therapy|0|||
127498261|NCT01436656|458783710|FG003|Dose Expansion|New cancer therapy|0|||
127498262|NCT01436656|458783711|FG004|Dose Expansion|New cancer therapy|0|||
127498263|NCT01436656|458783712|FG005|Dose Expansion|New cancer therapy|0|||
127498264|NCT01436656|458783713|FG006|Dose Expansion|New cancer therapy|0|||
127498265|NCT01436656|458783714|FG007|Dose Expansion|New cancer therapy|0|||
127498266|NCT01436656|458783715|FG008|Dose Expansion|New cancer therapy|0|||
127498267|NCT01436656|458783716|FG009|Dose Expansion|New cancer therapy|0|||
127498268|NCT01436656|458783717|FG010|Dose Expansion|New cancer therapy|0|||
127498269|NCT01436656|458783718|FG011|Dose Expansion|New cancer therapy|1|||
127498270|NCT01436656|458783719|FG012|Dose Expansion|New cancer therapy|1|||
127498271|NCT01436656|458783720|FG013|Dose Expansion|New cancer therapy|0|||
127498272|NCT01436656|458783721|FG014|Dose Expansion|New cancer therapy|2|||
127498273|NCT01436656|458783722|FG015|Dose Expansion|New cancer therapy|0|||
127498274|NCT01436656|458783723|FG016|Dose Expansion|New cancer therapy|0|||
127498275|NCT01436656|458783724|FG017|Dose Expansion|New cancer therapy|0|||
127498276|NCT04729972|458783725|FG000|Overall Study|Adverse Event|1|||
127498277|NCT00576628|458783727|FG000|Overall Study|Adverse Event|11|||
127498278|NCT00576628|458783727|FG000|Overall Study|Death|2|||
127498279|NCT00576628|458783727|FG000|Overall Study|Failure to return|1|||
127498280|NCT00576628|458783727|FG000|Overall Study|Refused Treatment|8|||
127498281|NCT00576628|458783727|FG000|Overall Study|Pregnancy|1|||
127498282|NCT00576628|458783727|FG000|Overall Study|RBC transfusion|1|||
127498283|NCT00576628|458783727|FG000|Overall Study|Progression of Kidney Disease|1|||
127498284|NCT00576628|458783727|FG000|Overall Study|Progression of Renal Failure|1|||
127498285|NCT00576628|458783727|FG000|Overall Study|The patient move into other town|1|||
127498286|NCT00576628|458783727|FG000|Overall Study|Transplantation|1|||
127498287|NCT00576628|458783727|FG000|Overall Study|Dialysis|15|||
127498288|NCT03206970|458783728|FG000|Overall Study|Death|21|||
127498289|NCT03206970|458783728|FG000|Overall Study|Withdrawal by Subject|13|||
127498290|NCT03206970|458783728|FG000|Overall Study|Lost to Follow-up|3|||
127498291|NCT03206970|458783728|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
127498292|NCT02516982|458783731|FG000|Overall Study|Called in to antenatal appointment|32|||
127498293|NCT02516982|458783732|FG001|Overall Study|Called in to antenatal appointment|35|||
127498294|NCT02516982|458783733|FG002|Overall Study|Called in to antenatal appointment|0|||
127498295|NCT02516982|458783734|FG003|Overall Study|Called in to antenatal appointment|0|||
127498296|NCT02516982|458783731|FG000|Overall Study|Withdrawal by Subject|0|||
127498297|NCT02516982|458783732|FG001|Overall Study|Withdrawal by Subject|0|||
127498298|NCT02516982|458783733|FG002|Overall Study|Withdrawal by Subject|1|||
127498299|NCT02516982|458783734|FG003|Overall Study|Withdrawal by Subject|2|||
127498300|NCT02516982|458783731|FG000|Overall Study|Protocol Violation|0|||
127498301|NCT02516982|458783732|FG001|Overall Study|Protocol Violation|0|||
127498302|NCT02516982|458783733|FG002|Overall Study|Protocol Violation|1|||
127498303|NCT02516982|458783734|FG003|Overall Study|Protocol Violation|1|||
127498304|NCT02516982|458783731|FG000|Overall Study|Did not install the app|0|||
127498305|NCT02516982|458783732|FG001|Overall Study|Did not install the app|0|||
127498306|NCT02516982|458783733|FG002|Overall Study|Did not install the app|46|||
127498307|NCT02516982|458783734|FG003|Overall Study|Did not install the app|47|||
127498308|NCT00962741|458783736|FG000|Overall Study|Failed to return|3|||
127498309|NCT00962741|458783736|FG000|Overall Study|Lost to Follow-up|2|||
127498310|NCT00962741|458783736|FG000|Overall Study|Withdrawal by Subject|1|||
127498311|NCT00962741|458783736|FG000|Overall Study|Lack of Efficacy|1|||
127498312|NCT00962741|458783736|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
127498313|NCT01814878|458783739|FG000|Overall Study|Adverse Event|16|||
127498314|NCT01814878|458783740|FG001|Overall Study|Adverse Event|5|||
127498315|NCT01814878|458783739|FG000|Overall Study|Withdrawal by Subject|20|||
127498316|NCT01814878|458783740|FG001|Overall Study|Withdrawal by Subject|16|||
127498317|NCT01814878|458783739|FG000|Overall Study|Protocol Violation|5|||
127498318|NCT01814878|458783740|FG001|Overall Study|Protocol Violation|5|||
127498319|NCT01814878|458783739|FG000|Overall Study|Physician Decision|3|||
127498320|NCT01814878|458783740|FG001|Overall Study|Physician Decision|1|||
127498321|NCT01814878|458783739|FG000|Overall Study|Screening failure (drop-out)|0|||
127498322|NCT01814878|458783740|FG001|Overall Study|Screening failure (drop-out)|3|||
127498323|NCT01814878|458783739|FG000|Overall Study|Other|2|||
127498324|NCT01814878|458783740|FG001|Overall Study|Other|0|||
127498325|NCT03645421|458783741|FG000|Overall Study|Adverse Event|0|||
127498326|NCT03645421|458783742|FG001|Overall Study|Adverse Event|0|||
127498327|NCT03645421|458783743|FG002|Overall Study|Adverse Event|4|||
127498328|NCT03645421|458783744|FG003|Overall Study|Adverse Event|1|||
127498329|NCT03645421|458783741|FG000|Overall Study|Withdrawal by patient|0|||
127977792|NCT03640481|460540382|FG003|Overall Study|Site terminated by sponsor|0|||
127498330|NCT03645421|458783742|FG001|Overall Study|Withdrawal by patient|0|||
127498331|NCT03645421|458783743|FG002|Overall Study|Withdrawal by patient|0|||
127498332|NCT03645421|458783744|FG003|Overall Study|Withdrawal by patient|3|||
127498333|NCT03645421|458783741|FG000|Overall Study|Study specific withdrawal criteria|0|||
127498334|NCT03645421|458783742|FG001|Overall Study|Study specific withdrawal criteria|0|||
127498335|NCT03645421|458783743|FG002|Overall Study|Study specific withdrawal criteria|1|||
127498336|NCT03645421|458783744|FG003|Overall Study|Study specific withdrawal criteria|0|||
127498337|NCT02253433|458783748|FG000|Overall Study|Unable to Contact|9|||
127977793|NCT03640481|460540379|FG000|Overall Study|Study terminated by sponsor|29|||
127498338|NCT02253433|458783749|FG001|Overall Study|Unable to Contact|16|||
127498339|NCT02253433|458783748|FG000|Overall Study|Death|1|||
127498340|NCT02253433|458783749|FG001|Overall Study|Death|1|||
127498341|NCT02253433|458783748|FG000|Overall Study|No Longer Interested|3|||
127498342|NCT02253433|458783749|FG001|Overall Study|No Longer Interested|15|||
127498343|NCT02253433|458783748|FG000|Overall Study|Out of Study Area|2|||
127498344|NCT02253433|458783749|FG001|Overall Study|Out of Study Area|7|||
127498345|NCT02253433|458783748|FG000|Overall Study|Uncomfortable with home visitors|0|||
127498346|NCT02253433|458783749|FG001|Overall Study|Uncomfortable with home visitors|3|||
127498347|NCT02253433|458783748|FG000|Overall Study|Unstable Housing/Homeless|0|||
127498348|NCT02253433|458783749|FG001|Overall Study|Unstable Housing/Homeless|7|||
127498349|NCT02253433|458783748|FG000|Overall Study|Too Busy|0|||
127498350|NCT02253433|458783749|FG001|Overall Study|Too Busy|4|||
127498351|NCT02253433|458783748|FG000|Overall Study|Medical or Other Concerns|1|||
127498352|NCT02253433|458783749|FG001|Overall Study|Medical or Other Concerns|2|||
127498353|NCT02836717|458783755|FG000|Test Phase|Lack of Efficacy|14|||
127498354|NCT02836717|458783756|FG001|Test Phase|Lack of Efficacy|8|||
127498355|NCT02836717|458783757|FG002|Test Phase|Lack of Efficacy|0|||
127498356|NCT02836717|458783755|FG000|Study Phase|Adverse Event|2|||
127498357|NCT02836717|458783756|FG001|Study Phase|Adverse Event|0|||
127498358|NCT02836717|458783757|FG002|Study Phase|Adverse Event|0|||
127498359|NCT02836717|458783755|FG000|Study Phase|Lack of Efficacy|8|||
127498360|NCT02836717|458783756|FG001|Study Phase|Lack of Efficacy|6|||
127498361|NCT02836717|458783757|FG002|Study Phase|Lack of Efficacy|1|||
127498362|NCT02836717|458783755|FG000|Study Phase|Withdrawal by Subject|1|||
127498363|NCT02836717|458783756|FG001|Study Phase|Withdrawal by Subject|0|||
127498364|NCT02836717|458783757|FG002|Study Phase|Withdrawal by Subject|0|||
127498365|NCT02836717|458783755|FG000|Study Phase|Death|1|||
127498366|NCT02836717|458783756|FG001|Study Phase|Death|0|||
127498367|NCT02836717|458783757|FG002|Study Phase|Death|0|||
127498368|NCT02836717|458783755|FG000|Study Phase|abdominal surgeries|2|||
127498369|NCT02836717|458783756|FG001|Study Phase|abdominal surgeries|1|||
127498370|NCT02836717|458783757|FG002|Study Phase|abdominal surgeries|0|||
127498371|NCT00224120|458783758|FG000|Overall Study|Adverse Event|10|||
127498372|NCT00224120|458783759|FG001|Overall Study|Adverse Event|4|||
127498373|NCT00224120|458783758|FG000|Overall Study|Protocol Violation|1|||
127498374|NCT00224120|458783759|FG001|Overall Study|Protocol Violation|0|||
127498375|NCT00224120|458783758|FG000|Overall Study|Withdrawal by Subject|5|||
127498376|NCT00224120|458783759|FG001|Overall Study|Withdrawal by Subject|10|||
127498377|NCT00224120|458783758|FG000|Overall Study|Lack of Efficacy|0|||
127498378|NCT00224120|458783759|FG001|Overall Study|Lack of Efficacy|2|||
127498379|NCT00224120|458783758|FG000|Overall Study|Lost to Follow-up|2|||
127498380|NCT00224120|458783759|FG001|Overall Study|Lost to Follow-up|3|||
127498381|NCT00224120|458783758|FG000|Overall Study|Other|4|||
127498382|NCT00224120|458783759|FG001|Overall Study|Other|5|||
127498383|NCT00438360|458783760|FG000|Overall Study|Adverse Event|6|||
127498384|NCT00438360|458783761|FG001|Overall Study|Adverse Event|1|||
127498385|NCT00438360|458783760|FG000|Overall Study|Lack of Efficacy|42|||
127498386|NCT00438360|458783761|FG001|Overall Study|Lack of Efficacy|27|||
127498387|NCT00438360|458783760|FG000|Overall Study|Other|24|||
127498388|NCT00438360|458783761|FG001|Overall Study|Other|15|||
127498389|NCT03985943|458783762|FG000|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
127498390|NCT03985943|458783763|FG001|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|2|||
127498391|NCT03985943|458783764|FG002|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
127498392|NCT03985943|458783765|FG003|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
127498393|NCT03985943|458783766|FG004|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
127498394|NCT03985943|458783767|FG005|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
127498395|NCT03985943|458783762|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|2|||
127498396|NCT03985943|458783763|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|5|||
127498397|NCT03985943|458783764|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
127498398|NCT03985943|458783765|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
127498399|NCT03985943|458783766|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
127498400|NCT03985943|458783767|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
127498401|NCT03985943|458783762|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
127498402|NCT03985943|458783763|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
127498403|NCT03985943|458783764|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
127498404|NCT03985943|458783765|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
127498405|NCT03985943|458783766|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
127498406|NCT03985943|458783767|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
127498407|NCT03985943|458783762|FG000|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|11|||
127498408|NCT03985943|458783763|FG001|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|25|||
127498409|NCT03985943|458783764|FG002|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
127498410|NCT03985943|458783765|FG003|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
127498411|NCT03985943|458783766|FG004|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
127498412|NCT03985943|458783767|FG005|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
127498413|NCT03985943|458783762|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
127498414|NCT03985943|458783763|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|10|||
127498415|NCT03985943|458783764|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
127498416|NCT03985943|458783765|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
127498417|NCT03985943|458783766|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
127498418|NCT03985943|458783767|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
127498419|NCT03985943|458783762|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|3|||
127498420|NCT03985943|458783763|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|4|||
127498421|NCT03985943|458783764|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
127498422|NCT03985943|458783765|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
127498423|NCT03985943|458783766|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
127498424|NCT03985943|458783767|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
127498425|NCT03985943|458783762|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
127498426|NCT03985943|458783763|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|1|||
127498427|NCT03985943|458783764|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
127498428|NCT03985943|458783765|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
127498429|NCT03985943|458783766|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
127498430|NCT03985943|458783767|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
127498431|NCT03985943|458783762|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
127498432|NCT03985943|458783763|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|4|||
127498433|NCT03985943|458783764|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
127498434|NCT03985943|458783765|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
127498435|NCT03985943|458783766|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
127498436|NCT03985943|458783767|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
127498437|NCT03985943|458783762|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
127498438|NCT03985943|458783763|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
127498439|NCT03985943|458783764|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
127498440|NCT03985943|458783765|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
127498441|NCT03985943|458783766|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|12|||
127498442|NCT03985943|458783767|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
127498443|NCT03985943|458783762|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
127498444|NCT03985943|458783763|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
127498445|NCT03985943|458783764|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
127498446|NCT03985943|458783765|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
127498447|NCT03985943|458783766|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
127498448|NCT03985943|458783767|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
127498449|NCT03985943|458783762|FG000|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
127498450|NCT03985943|458783763|FG001|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
127498451|NCT03985943|458783764|FG002|Maintenance Period (Week 16-Week 48)|Subjects request|6|||
127498452|NCT03985943|458783765|FG003|Maintenance Period (Week 16-Week 48)|Subjects request|4|||
127498453|NCT03985943|458783766|FG004|Maintenance Period (Week 16-Week 48)|Subjects request|5|||
127498454|NCT03985943|458783767|FG005|Maintenance Period (Week 16-Week 48)|Subjects request|9|||
127498455|NCT03985943|458783762|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
127498456|NCT03985943|458783763|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
127498457|NCT03985943|458783764|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
127498458|NCT03985943|458783765|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
127498459|NCT03985943|458783766|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
127498460|NCT03985943|458783767|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
127498461|NCT03985943|458783762|FG000|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
127498462|NCT03985943|458783763|FG001|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
127498463|NCT03985943|458783764|FG002|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
127498464|NCT03985943|458783765|FG003|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
127498465|NCT03985943|458783766|FG004|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
127498466|NCT03985943|458783767|FG005|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
127498467|NCT03985943|458783762|FG000|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
127498468|NCT03985943|458783763|FG001|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
127498469|NCT03985943|458783764|FG002|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
127977794|NCT03640481|460540380|FG001|Overall Study|Study terminated by sponsor|42|||
127977795|NCT03640481|460540381|FG002|Overall Study|Study terminated by sponsor|1|||
127977796|NCT03640481|460540382|FG003|Overall Study|Study terminated by sponsor|0|||
127977797|NCT03640481|460540379|FG000|Overall Study|Withdrawal by Subject|5|||
127977798|NCT03640481|460540380|FG001|Overall Study|Withdrawal by Subject|4|||
127977799|NCT03640481|460540381|FG002|Overall Study|Withdrawal by Subject|0|||
127977800|NCT03640481|460540382|FG003|Overall Study|Withdrawal by Subject|1|||
127498470|NCT03985943|458783765|FG003|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
127498471|NCT03985943|458783766|FG004|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
127498472|NCT03985943|458783767|FG005|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
127498473|NCT03985943|458783762|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
127498474|NCT03985943|458783763|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
127498475|NCT03985943|458783764|FG002|Maintenance Period (Week 16-Week 48)|Other|0|||
127498476|NCT03985943|458783765|FG003|Maintenance Period (Week 16-Week 48)|Other|0|||
127498477|NCT03985943|458783766|FG004|Maintenance Period (Week 16-Week 48)|Other|1|||
127498478|NCT03985943|458783767|FG005|Maintenance Period (Week 16-Week 48)|Other|1|||
127498479|NCT00964002|458783770|FG000|Overall Study|Protocol Violation|8|||
127498480|NCT02936869|458783779|FG000|Overall Study|Lost to Follow-up|1|||
127498481|NCT02936869|458783780|FG001|Overall Study|Lost to Follow-up|3|||
127498482|NCT02936869|458783779|FG000|Overall Study|Death|0|||
127498483|NCT02936869|458783780|FG001|Overall Study|Death|1|||
127498484|NCT02936869|458783779|FG000|Overall Study|Legal Case|0|||
127498485|NCT02936869|458783780|FG001|Overall Study|Legal Case|1|||
127498486|NCT02936869|458783779|FG000|Overall Study|Protocol Violation|1|||
127498487|NCT02936869|458783780|FG001|Overall Study|Protocol Violation|0|||
127498488|NCT04004221|458783781|FG000|Overall Study|Death|89|||
127498489|NCT04004221|458783781|FG000|Overall Study|Withdrawal by Subject|5|||
127498490|NCT04004221|458783781|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
127498491|NCT04004221|458783781|FG000|Overall Study|Sponsor Decision|9|||
127498492|NCT04004221|458783781|FG000|Overall Study|Participant refused to enter LTE|1|||
127498493|NCT00506454|458783782|FG000|Overall Study|Withdrawal by Subject|1|||
127498494|NCT00506454|458783783|FG001|Overall Study|Withdrawal by Subject|1|||
127498495|NCT00851552|458783784|FG000|Overall Study|Death|2|||
127498496|NCT00851552|458783784|FG000|Overall Study|Adverse Event|1|||
127498497|NCT00851552|458783784|FG000|Overall Study|Disease Progression|4|||
127498498|NCT02689206|458783785|FG000|Overall Study|Adverse Event|0|||
127498499|NCT02689206|458783786|FG001|Overall Study|Adverse Event|0|||
127498500|NCT02689206|458783787|FG002|Overall Study|Adverse Event|1|||
127498501|NCT02689206|458783788|FG003|Overall Study|Adverse Event|0|||
127498502|NCT02689206|458783789|FG004|Overall Study|Adverse Event|2|||
127498503|NCT02689206|458783785|FG000|Overall Study|Protocol Violation|1|||
127498504|NCT02689206|458783786|FG001|Overall Study|Protocol Violation|0|||
127498505|NCT02689206|458783787|FG002|Overall Study|Protocol Violation|0|||
127498506|NCT02689206|458783788|FG003|Overall Study|Protocol Violation|1|||
127498507|NCT02689206|458783789|FG004|Overall Study|Protocol Violation|2|||
127498508|NCT02689206|458783785|FG000|Overall Study|Other: Reached stopping criteria|0|||
127498509|NCT02689206|458783786|FG001|Overall Study|Other: Reached stopping criteria|1|||
127498510|NCT02689206|458783787|FG002|Overall Study|Other: Reached stopping criteria|2|||
127498511|NCT02689206|458783788|FG003|Overall Study|Other: Reached stopping criteria|3|||
127498512|NCT02689206|458783789|FG004|Overall Study|Other: Reached stopping criteria|4|||
127498513|NCT02689206|458783785|FG000|Overall Study|Physician Decision|1|||
127498514|NCT02689206|458783786|FG001|Overall Study|Physician Decision|0|||
127498515|NCT02689206|458783787|FG002|Overall Study|Physician Decision|0|||
127498516|NCT02689206|458783788|FG003|Overall Study|Physician Decision|0|||
127498517|NCT02689206|458783789|FG004|Overall Study|Physician Decision|0|||
127498518|NCT02689206|458783785|FG000|Overall Study|Withdrawal by Subject|1|||
127498519|NCT02689206|458783786|FG001|Overall Study|Withdrawal by Subject|0|||
127498520|NCT02689206|458783787|FG002|Overall Study|Withdrawal by Subject|1|||
127498521|NCT02689206|458783788|FG003|Overall Study|Withdrawal by Subject|0|||
127498522|NCT02689206|458783789|FG004|Overall Study|Withdrawal by Subject|0|||
127498523|NCT01558596|458783792|FG000|Overall Study|Withdrawal by Subject|1|||
127498524|NCT01558596|458783793|FG001|Overall Study|Withdrawal by Subject|0|||
127977801|NCT03640481|460540379|FG000|Overall Study|Other|26|||
127977802|NCT03640481|460540380|FG001|Overall Study|Other|12|||
127977803|NCT03640481|460540381|FG002|Overall Study|Other|1|||
127977804|NCT03640481|460540382|FG003|Overall Study|Other|0|||
127977805|NCT03640481|460540379|FG000|Overall Study|Randomized, but not treated|1|||
127977806|NCT03640481|460540380|FG001|Overall Study|Randomized, but not treated|3|||
127977807|NCT03640481|460540381|FG002|Overall Study|Randomized, but not treated|0|||
127977808|NCT03640481|460540382|FG003|Overall Study|Randomized, but not treated|0|||
127498525|NCT01558596|458783792|FG000|Overall Study|surgery elsewhere or cancelled|1|||
127498526|NCT01558596|458783793|FG001|Overall Study|surgery elsewhere or cancelled|1|||
127498527|NCT01558596|458783792|FG000|Overall Study|Protocol Violation|1|||
127498528|NCT01558596|458783793|FG001|Overall Study|Protocol Violation|0|||
127498529|NCT03640507|458783795|FG000|Overall Study|Withdrawal by Subject|0|||
127498530|NCT03640507|458783796|FG001|Overall Study|Withdrawal by Subject|0|||
127498531|NCT03640507|458783797|FG002|Overall Study|Withdrawal by Subject|1|||
127498532|NCT01939977|458783798|FG000|Overall Study|Adverse Event|4|||
127498533|NCT01939977|458783799|FG001|Overall Study|Adverse Event|3|||
127498534|NCT01939977|458783798|FG000|Overall Study|Lack of Efficacy|3|||
127498535|NCT01939977|458783799|FG001|Overall Study|Lack of Efficacy|0|||
127498536|NCT01939977|458783798|FG000|Overall Study|Physician Decision|1|||
127977809|NCT00535847|460540383|FG000|Overall Study|Adverse Event|5|||
127977810|NCT00535847|460540384|FG001|Overall Study|Adverse Event|3|||
127498537|NCT01939977|458783799|FG001|Overall Study|Physician Decision|1|||
127498538|NCT01939977|458783798|FG000|Overall Study|Withdrawal by Subject|0|||
127498539|NCT01939977|458783799|FG001|Overall Study|Withdrawal by Subject|2|||
127498540|NCT01939977|458783798|FG000|Overall Study|Did not meet inclusion criteria|1|||
127498541|NCT01939977|458783799|FG001|Overall Study|Did not meet inclusion criteria|0|||
127498542|NCT01939977|458783798|FG000|Overall Study|Did not receive study medication|0|||
127498543|NCT01939977|458783799|FG001|Overall Study|Did not receive study medication|1|||
127498544|NCT01262560|458783803|FG000|Overall Study|Protocol Violation|0|||
127498545|NCT01262560|458783804|FG001|Overall Study|Protocol Violation|1|||
127498546|NCT01262560|458783805|FG002|Overall Study|Protocol Violation|2|||
127498547|NCT03213938|458783806|FG000|Overall Study|Lost to Follow-up|4|||
127498548|NCT03213938|458783807|FG001|Overall Study|Lost to Follow-up|3|||
127498549|NCT03213938|458783806|FG000|Overall Study|Lack of Efficacy|1|||
127498550|NCT03213938|458783807|FG001|Overall Study|Lack of Efficacy|0|||
127498551|NCT03213938|458783806|FG000|Overall Study|Decline to participate|5|||
127498552|NCT03213938|458783807|FG001|Overall Study|Decline to participate|4|||
127498553|NCT03213938|458783806|FG000|Overall Study|Without reason|4|||
127498554|NCT03213938|458783807|FG001|Overall Study|Without reason|5|||
127498555|NCT04238481|458783808|FG000|Overall Study|Miscellaneous|0|||
127498556|NCT04238481|458783809|FG001|Overall Study|Miscellaneous|1|||
127498557|NCT04238481|458783810|FG002|Overall Study|Miscellaneous|0|||
127498558|NCT04238481|458783811|FG003|Overall Study|Miscellaneous|0|||
127498559|NCT00673231|458783812|FG000|Overall Study|Withdrawal by Subject|14|||
127498560|NCT00673231|458783813|FG001|Overall Study|Withdrawal by Subject|10|||
127498561|NCT00673231|458783814|FG002|Overall Study|Withdrawal by Subject|8|||
127498562|NCT00673231|458783815|FG003|Overall Study|Withdrawal by Subject|6|||
127498563|NCT00673231|458783812|FG000|Overall Study|Adverse Event|6|||
127498564|NCT00673231|458783813|FG001|Overall Study|Adverse Event|5|||
127498565|NCT00673231|458783814|FG002|Overall Study|Adverse Event|9|||
127498566|NCT00673231|458783815|FG003|Overall Study|Adverse Event|6|||
127498567|NCT00673231|458783812|FG000|Overall Study|Lost to Follow-up|1|||
127498568|NCT00673231|458783813|FG001|Overall Study|Lost to Follow-up|2|||
127498569|NCT00673231|458783814|FG002|Overall Study|Lost to Follow-up|1|||
127498570|NCT00673231|458783815|FG003|Overall Study|Lost to Follow-up|2|||
127498571|NCT00673231|458783812|FG000|Overall Study|Death|0|||
127498572|NCT00673231|458783813|FG001|Overall Study|Death|0|||
127498573|NCT00673231|458783814|FG002|Overall Study|Death|1|||
127498574|NCT00673231|458783815|FG003|Overall Study|Death|0|||
127498575|NCT00673231|458783812|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
127498576|NCT00673231|458783813|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
127498577|NCT00673231|458783814|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
127498578|NCT00673231|458783815|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
127498579|NCT03028415|458783816|FG000|Overall Study|Lost to Follow-up|6|||
127498580|NCT03028415|458783817|FG001|Overall Study|Lost to Follow-up|3|||
127498581|NCT03028415|458783816|FG000|Overall Study|Withdrawal by Subject|1|||
127498582|NCT03028415|458783817|FG001|Overall Study|Withdrawal by Subject|0|||
127498583|NCT03028415|458783816|FG000|Overall Study|Discontinued due to COVID-19|1|||
127498584|NCT03028415|458783817|FG001|Overall Study|Discontinued due to COVID-19|0|||
127498585|NCT02907216|458783818|FG000|Overall Study|No benefit to be obtained by continuing|0|||
127498586|NCT02907216|458783819|FG001|Overall Study|No benefit to be obtained by continuing|1|||
127498587|NCT02907216|458783818|FG000|Overall Study|Withdrawal by Subject|1|||
127498588|NCT02907216|458783819|FG001|Overall Study|Withdrawal by Subject|0|||
127498589|NCT02095873|458783821|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
127498590|NCT02095873|458783822|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
127498591|NCT02095873|458783821|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
127498592|NCT02095873|458783822|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
127498593|NCT02095873|458783821|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
127498594|NCT02095873|458783822|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
127498595|NCT00792740|458783825|FG000|Overall Study|Disease Worsening|3|||
127977811|NCT00535847|460540385|FG002|Overall Study|Adverse Event|2|||
127977812|NCT00535847|460540383|FG000|Overall Study|Non compliance|1|||
127498596|NCT00792740|458783826|FG001|Overall Study|Disease Worsening|2|||
127498597|NCT00792740|458783825|FG000|Overall Study|Personal Reason|1|||
127498598|NCT00792740|458783826|FG001|Overall Study|Personal Reason|0|||
127498599|NCT00792740|458783825|FG000|Overall Study|Adverse Event|1|||
127498600|NCT00792740|458783826|FG001|Overall Study|Adverse Event|3|||
127498601|NCT00792740|458783825|FG000|Overall Study|Patient's withdrawal of consent|0|||
127498602|NCT00792740|458783826|FG001|Overall Study|Patient's withdrawal of consent|1|||
127498603|NCT00792740|458783825|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
127498604|NCT00792740|458783826|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
127498605|NCT00792740|458783825|FG000|Overall Study|Other reasons|0|||
127498606|NCT00792740|458783826|FG001|Overall Study|Other reasons|1|||
127498607|NCT01063062|458783827|FG000|Overall Study|Patient withdrew consent|0|||
127498608|NCT01063062|458783828|FG001|Overall Study|Patient withdrew consent|1|||
127498609|NCT01063062|458783827|FG000|Overall Study|Adverse Event|2|||
127498610|NCT01063062|458783828|FG001|Overall Study|Adverse Event|4|||
127498611|NCT01063062|458783827|FG000|Overall Study|Protocol Violation|5|||
127498612|NCT01063062|458783828|FG001|Overall Study|Protocol Violation|4|||
127498613|NCT01063062|458783827|FG000|Overall Study|Investigator's request|1|||
127498614|NCT01063062|458783828|FG001|Overall Study|Investigator's request|0|||
127498615|NCT01063062|458783827|FG000|Overall Study|Lost to Follow-up|0|||
127498616|NCT01063062|458783828|FG001|Overall Study|Lost to Follow-up|2|||
127498617|NCT01063062|458783827|FG000|Overall Study|Miscellaneous reason|0|||
127498618|NCT01063062|458783828|FG001|Overall Study|Miscellaneous reason|1|||
127498619|NCT02485639|458783833|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
127498620|NCT02485639|458783833|FG000|Overall Study|Early termination|4|||
127498621|NCT02485639|458783833|FG000|Overall Study|Withdrawal by Subject|4|||
127498622|NCT02015481|458783834|FG000|Overall Study|Death|1|||
127498623|NCT02597452|458783835|FG000|Overall Study|testing incomplete|30|||
127498624|NCT02566785|458783842|FG000|Overall Study|Lost to Follow-up|0|||
127498625|NCT02566785|458783843|FG001|Overall Study|Lost to Follow-up|2|||
127498626|NCT02566785|458783842|FG000|Overall Study|Worsening condition|1|||
127498627|NCT02566785|458783843|FG001|Overall Study|Worsening condition|1|||
127498628|NCT04621240|458783844|FG000|Overall Study|Withdrawal by Subject|36|||
127498629|NCT02147197|458783845|FG000|Overall Study|Adverse Event|1|||
127498630|NCT02147197|458783846|FG001|Overall Study|Adverse Event|0|||
127498631|NCT02147197|458783847|FG002|Overall Study|Adverse Event|0|||
127498632|NCT02147197|458783845|FG000|Overall Study|Withdrawal of Consent|4|||
127498633|NCT02147197|458783846|FG001|Overall Study|Withdrawal of Consent|3|||
127498634|NCT02147197|458783847|FG002|Overall Study|Withdrawal of Consent|2|||
127498635|NCT02147197|458783845|FG000|Overall Study|Lost to Follow-up|2|||
127498636|NCT02147197|458783846|FG001|Overall Study|Lost to Follow-up|3|||
127498637|NCT02147197|458783847|FG002|Overall Study|Lost to Follow-up|1|||
127498638|NCT02147197|458783845|FG000|Overall Study|Protocol Violation|1|||
127498639|NCT02147197|458783846|FG001|Overall Study|Protocol Violation|0|||
127498640|NCT02147197|458783847|FG002|Overall Study|Protocol Violation|3|||
127498641|NCT02147197|458783845|FG000|Overall Study|Other Miscellaneous Reasons|1|||
127498642|NCT02147197|458783846|FG001|Overall Study|Other Miscellaneous Reasons|0|||
127498643|NCT02147197|458783847|FG002|Overall Study|Other Miscellaneous Reasons|3|||
127498644|NCT03522246|458785645|FG000|Overall Study|Ongoing in Long-Term Follow-up (Alive)|184|||
127498645|NCT03522246|458785646|FG001|Overall Study|Ongoing in Long-Term Follow-up (Alive)|194|||
127498646|NCT03522246|458785647|FG002|Overall Study|Ongoing in Long-Term Follow-up (Alive)|46|||
127498647|NCT03522246|458785648|FG003|Overall Study|Ongoing in Long-Term Follow-up (Alive)|45|||
127498648|NCT03522246|458785649|FG004|Overall Study|Ongoing in Long-Term Follow-up (Alive)|0|||
127498649|NCT04683029|458785650|FG000|Main Study: Week 0-Week 60|Withdrawal by Subject|1|||
127498650|NCT04683029|458785651|FG001|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
127498651|NCT04683029|458785652|FG002|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
127498652|NCT04683029|458785653|FG003|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
127498653|NCT04683029|458785650|FG000|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
127498654|NCT04683029|458785651|FG001|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
127498655|NCT04683029|458785652|FG002|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
127498656|NCT04683029|458785653|FG003|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|2|||
127498657|NCT04683029|458785650|FG000|Long-term Extension(LTE):Week52-Week 112|Death|0|||
127498658|NCT04683029|458785651|FG001|Long-term Extension(LTE):Week52-Week 112|Death|0|||
127498659|NCT04683029|458785652|FG002|Long-term Extension(LTE):Week52-Week 112|Death|1|||
127498660|NCT04683029|458785653|FG003|Long-term Extension(LTE):Week52-Week 112|Death|0|||
127498661|NCT00814580|458785654|FG000|Overall Study|Adverse Event|6|||
127498662|NCT00814580|458785655|FG001|Overall Study|Adverse Event|15|||
127498663|NCT00814580|458785654|FG000|Overall Study|Lack of Efficacy|18|||
127498664|NCT00814580|458785655|FG001|Overall Study|Lack of Efficacy|25|||
127498665|NCT00814580|458785654|FG000|Overall Study|Protocol Violation|2|||
127498666|NCT00814580|458785655|FG001|Overall Study|Protocol Violation|0|||
127498667|NCT00814580|458785654|FG000|Overall Study|Withdrawal by Subject|2|||
127498668|NCT00814580|458785655|FG001|Overall Study|Withdrawal by Subject|2|||
127498669|NCT00814580|458785654|FG000|Overall Study|Other|1|||
127498670|NCT00814580|458785655|FG001|Overall Study|Other|3|||
127498671|NCT00814580|458785654|FG000|Overall Study|Did Not Take Drug|2|||
127498672|NCT00814580|458785655|FG001|Overall Study|Did Not Take Drug|2|||
127498673|NCT02482428|458785656|FG000|Overall Study|Lost to Follow-up|4|||
127498674|NCT02482428|458785657|FG001|Overall Study|Lost to Follow-up|9|||
127498675|NCT02482428|458785658|FG002|Overall Study|Lost to Follow-up|1|||
127498676|NCT02482428|458785659|FG003|Overall Study|Lost to Follow-up|2|||
127498677|NCT02482428|458785660|FG004|Overall Study|Lost to Follow-up|4|||
127498678|NCT02482428|458785656|FG000|Overall Study|Physician Decision|0|||
127498679|NCT02482428|458785657|FG001|Overall Study|Physician Decision|0|||
127498680|NCT02482428|458785658|FG002|Overall Study|Physician Decision|0|||
127498681|NCT02482428|458785659|FG003|Overall Study|Physician Decision|0|||
127498682|NCT02482428|458785660|FG004|Overall Study|Physician Decision|1|||
127498683|NCT02482428|458785656|FG000|Overall Study|protocol deviation|1|||
127498684|NCT02482428|458785657|FG001|Overall Study|protocol deviation|1|||
127498685|NCT02482428|458785658|FG002|Overall Study|protocol deviation|0|||
127498686|NCT02482428|458785659|FG003|Overall Study|protocol deviation|0|||
127498687|NCT02482428|458785660|FG004|Overall Study|protocol deviation|0|||
127498688|NCT02482428|458785656|FG000|Overall Study|subject/guardian decision|4|||
127498689|NCT02482428|458785657|FG001|Overall Study|subject/guardian decision|2|||
127498690|NCT02482428|458785658|FG002|Overall Study|subject/guardian decision|0|||
127498691|NCT02482428|458785659|FG003|Overall Study|subject/guardian decision|0|||
127498692|NCT02482428|458785660|FG004|Overall Study|subject/guardian decision|2|||
127498693|NCT00516893|458785661|FG000|Overall Study|Lost to Follow-up|4|||
127498694|NCT00516893|458785661|FG000|Overall Study|Adverse Event|3|||
127498695|NCT00516893|458785661|FG000|Overall Study|Withdrawal by Subject|2|||
127498696|NCT00516893|458785661|FG000|Overall Study|Noncompliance|2|||
127498697|NCT00516893|458785661|FG000|Overall Study|Death|1|||
127498698|NCT00516893|458785661|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
127498699|NCT00516893|458785661|FG000|Overall Study|Relocated|1|||
127498700|NCT00516893|458785661|FG000|Overall Study|Pregnancy|1|||
127498701|NCT00516893|458785661|FG000|Overall Study|Received Medication From Another Study|1|||
127498702|NCT05935878|458785667|FG000|Overall Study|Death|1|||
127498703|NCT05935878|458785668|FG001|Overall Study|Death|2|||
127498704|NCT05935878|458785667|FG000|Overall Study|Withdrawal by Subject|5|||
127498705|NCT05935878|458785668|FG001|Overall Study|Withdrawal by Subject|5|||
127498706|NCT05935878|458785667|FG000|Overall Study|Revision of implant|1|||
127498707|NCT05935878|458785668|FG001|Overall Study|Revision of implant|1|||
127498708|NCT05935878|458785667|FG000|Overall Study|Mobile bearing dislocation|0|||
127498709|NCT05935878|458785668|FG001|Overall Study|Mobile bearing dislocation|1|||
127498710|NCT04308239|458785671|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
127498711|NCT04308239|458785672|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
127498712|NCT04308239|458785671|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
127498713|NCT04308239|458785672|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
127498714|NCT04308239|458785671|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
127498715|NCT04308239|458785672|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
127498716|NCT04308239|458785671|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
127498717|NCT04308239|458785672|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
127498718|NCT00459875|458785675|FG000|Overall Study|Ineligible participant|1|||
127498719|NCT00459875|458785675|FG000|Overall Study|Adverse Event|2|||
127498720|NCT01406938|458785678|FG000|Induction Period|Subject/guardian decision|6|||
127498721|NCT01406938|458785679|FG001|Induction Period|Subject/guardian decision|8|||
127498722|NCT01406938|458785680|FG002|Induction Period|Subject/guardian decision|0|||
127498723|NCT01406938|458785681|FG003|Induction Period|Subject/guardian decision|0|||
127498724|NCT01406938|458785682|FG004|Induction Period|Subject/guardian decision|0|||
127498725|NCT01406938|458785683|FG005|Induction Period|Subject/guardian decision|0|||
127498726|NCT01406938|458785678|FG000|Induction Period|Protocol deviation|1|||
127498727|NCT01406938|458785679|FG001|Induction Period|Protocol deviation|0|||
127498728|NCT01406938|458785680|FG002|Induction Period|Protocol deviation|0|||
127498729|NCT01406938|458785681|FG003|Induction Period|Protocol deviation|0|||
127498730|NCT01406938|458785682|FG004|Induction Period|Protocol deviation|0|||
127498731|NCT01406938|458785683|FG005|Induction Period|Protocol deviation|0|||
127498732|NCT01406938|458785678|FG000|Induction Period|Adverse Event|8|||
127498733|NCT01406938|458785679|FG001|Induction Period|Adverse Event|9|||
127498734|NCT01406938|458785680|FG002|Induction Period|Adverse Event|0|||
127498735|NCT01406938|458785681|FG003|Induction Period|Adverse Event|0|||
127498736|NCT01406938|458785682|FG004|Induction Period|Adverse Event|0|||
127498737|NCT01406938|458785683|FG005|Induction Period|Adverse Event|0|||
127498738|NCT01406938|458785678|FG000|Induction Period|Lack of Efficacy|1|||
127498739|NCT01406938|458785679|FG001|Induction Period|Lack of Efficacy|0|||
127498740|NCT01406938|458785680|FG002|Induction Period|Lack of Efficacy|0|||
127498741|NCT01406938|458785681|FG003|Induction Period|Lack of Efficacy|0|||
127498742|NCT01406938|458785682|FG004|Induction Period|Lack of Efficacy|0|||
127498743|NCT01406938|458785683|FG005|Induction Period|Lack of Efficacy|0|||
127498744|NCT01406938|458785678|FG000|Induction Period|Lost to Follow-up|2|||
127498745|NCT01406938|458785679|FG001|Induction Period|Lost to Follow-up|3|||
127498746|NCT01406938|458785680|FG002|Induction Period|Lost to Follow-up|0|||
127498747|NCT01406938|458785681|FG003|Induction Period|Lost to Follow-up|0|||
127498748|NCT01406938|458785682|FG004|Induction Period|Lost to Follow-up|0|||
127498749|NCT01406938|458785683|FG005|Induction Period|Lost to Follow-up|0|||
127498750|NCT01406938|458785678|FG000|Maintenance Period|Adverse Event|0|||
127498751|NCT01406938|458785679|FG001|Maintenance Period|Adverse Event|0|||
127498752|NCT01406938|458785680|FG002|Maintenance Period|Adverse Event|2|||
127498753|NCT01406938|458785681|FG003|Maintenance Period|Adverse Event|8|||
127498754|NCT01406938|458785682|FG004|Maintenance Period|Adverse Event|4|||
127498755|NCT01406938|458785683|FG005|Maintenance Period|Adverse Event|2|||
127498756|NCT01406938|458785678|FG000|Maintenance Period|Death|0|||
127498757|NCT01406938|458785679|FG001|Maintenance Period|Death|0|||
127498758|NCT01406938|458785680|FG002|Maintenance Period|Death|0|||
127498759|NCT01406938|458785681|FG003|Maintenance Period|Death|0|||
127498760|NCT01406938|458785682|FG004|Maintenance Period|Death|1|||
127498761|NCT01406938|458785683|FG005|Maintenance Period|Death|0|||
127498762|NCT01406938|458785678|FG000|Maintenance Period|Subject/guardian decision|0|||
127498763|NCT01406938|458785679|FG001|Maintenance Period|Subject/guardian decision|0|||
127498764|NCT01406938|458785680|FG002|Maintenance Period|Subject/guardian decision|11|||
127498765|NCT01406938|458785681|FG003|Maintenance Period|Subject/guardian decision|7|||
127498766|NCT01406938|458785682|FG004|Maintenance Period|Subject/guardian decision|10|||
127498767|NCT01406938|458785683|FG005|Maintenance Period|Subject/guardian decision|7|||
127498768|NCT01406938|458785678|FG000|Maintenance Period|Protocol Violation|0|||
127498769|NCT01406938|458785679|FG001|Maintenance Period|Protocol Violation|0|||
127498770|NCT01406938|458785680|FG002|Maintenance Period|Protocol Violation|2|||
127498771|NCT01406938|458785681|FG003|Maintenance Period|Protocol Violation|2|||
127498772|NCT01406938|458785682|FG004|Maintenance Period|Protocol Violation|2|||
127498773|NCT01406938|458785683|FG005|Maintenance Period|Protocol Violation|2|||
127498774|NCT01406938|458785678|FG000|Maintenance Period|Pregnancy|0|||
127498775|NCT01406938|458785679|FG001|Maintenance Period|Pregnancy|0|||
127498776|NCT01406938|458785680|FG002|Maintenance Period|Pregnancy|0|||
127498777|NCT01406938|458785681|FG003|Maintenance Period|Pregnancy|0|||
127977813|NCT00535847|460540384|FG001|Overall Study|Non compliance|1|||
127977814|NCT00535847|460540385|FG002|Overall Study|Non compliance|0|||
127977815|NCT00535847|460540383|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
127977816|NCT00535847|460540384|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
127977817|NCT00535847|460540385|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
127977818|NCT04569968|460540386|FG000|Overall Study|Lost to Follow-up|2|||
127977819|NCT04569968|460540387|FG001|Overall Study|Lost to Follow-up|5|||
127977820|NCT04569968|460540386|FG000|Overall Study|Story of head and/or neck surgery|2|||
127977821|NCT04569968|460540387|FG001|Overall Study|Story of head and/or neck surgery|2|||
127977822|NCT04569968|460540386|FG000|Overall Study|Time of stroke onset|8|||
127977823|NCT04569968|460540387|FG001|Overall Study|Time of stroke onset|7|||
127977824|NCT04569968|460540386|FG000|Overall Study|Type of strokr|12|||
127977825|NCT04569968|460540387|FG001|Overall Study|Type of strokr|8|||
127977826|NCT04569968|460540386|FG000|Overall Study|Cooperation|8|||
127977827|NCT04569968|460540387|FG001|Overall Study|Cooperation|8|||
127977828|NCT04569968|460540386|FG000|Overall Study|Age interval|17|||
127977829|NCT04569968|460540387|FG001|Overall Study|Age interval|6|||
127977830|NCT04569968|460540386|FG000|Overall Study|Denial of participation to the study|0|||
127977831|NCT04569968|460540387|FG001|Overall Study|Denial of participation to the study|3|||
127977832|NCT04569968|460540386|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
127977833|NCT04569968|460540387|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
127498778|NCT01406938|458785682|FG004|Maintenance Period|Pregnancy|1|||
127498779|NCT01406938|458785683|FG005|Maintenance Period|Pregnancy|0|||
127498780|NCT01406938|458785678|FG000|Maintenance Period|Lost to Follow-up|0|||
127498781|NCT01406938|458785679|FG001|Maintenance Period|Lost to Follow-up|0|||
127498782|NCT01406938|458785680|FG002|Maintenance Period|Lost to Follow-up|0|||
127498783|NCT01406938|458785681|FG003|Maintenance Period|Lost to Follow-up|0|||
127498784|NCT01406938|458785682|FG004|Maintenance Period|Lost to Follow-up|4|||
127498785|NCT01406938|458785683|FG005|Maintenance Period|Lost to Follow-up|0|||
127498786|NCT01406938|458785678|FG000|Maintenance Period|Lack of Efficacy|0|||
127498787|NCT01406938|458785679|FG001|Maintenance Period|Lack of Efficacy|0|||
127498788|NCT01406938|458785680|FG002|Maintenance Period|Lack of Efficacy|2|||
127498789|NCT01406938|458785681|FG003|Maintenance Period|Lack of Efficacy|1|||
127498790|NCT01406938|458785682|FG004|Maintenance Period|Lack of Efficacy|3|||
127498791|NCT01406938|458785683|FG005|Maintenance Period|Lack of Efficacy|5|||
127498792|NCT01406938|458785678|FG000|Follow up|Lack of Efficacy|3|||
127498793|NCT01406938|458785679|FG001|Follow up|Lack of Efficacy|2|||
127498794|NCT01406938|458785680|FG002|Follow up|Lack of Efficacy|1|||
127498795|NCT01406938|458785681|FG003|Follow up|Lack of Efficacy|0|||
127498796|NCT01406938|458785682|FG004|Follow up|Lack of Efficacy|0|||
127498797|NCT01406938|458785683|FG005|Follow up|Lack of Efficacy|0|||
127498798|NCT01406938|458785678|FG000|Follow up|Patient/guardian decision|4|||
127498799|NCT01406938|458785679|FG001|Follow up|Patient/guardian decision|2|||
127498800|NCT01406938|458785680|FG002|Follow up|Patient/guardian decision|4|||
127498801|NCT01406938|458785681|FG003|Follow up|Patient/guardian decision|2|||
127498802|NCT01406938|458785682|FG004|Follow up|Patient/guardian decision|4|||
127498803|NCT01406938|458785683|FG005|Follow up|Patient/guardian decision|1|||
127498804|NCT01406938|458785678|FG000|Follow up|Protocol Violation|0|||
127498805|NCT01406938|458785679|FG001|Follow up|Protocol Violation|0|||
127498806|NCT01406938|458785680|FG002|Follow up|Protocol Violation|1|||
127498807|NCT01406938|458785681|FG003|Follow up|Protocol Violation|0|||
127498808|NCT01406938|458785682|FG004|Follow up|Protocol Violation|0|||
127977834|NCT04569968|460540386|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
127498809|NCT01406938|458785683|FG005|Follow up|Protocol Violation|0|||
127498810|NCT01406938|458785678|FG000|Follow up|Physician Decision|0|||
127977835|NCT04569968|460540387|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
127977836|NCT04569968|460540386|FG000|Overall Study|Quarantine|1|||
127977837|NCT04569968|460540387|FG001|Overall Study|Quarantine|0|||
127498811|NCT01406938|458785679|FG001|Follow up|Physician Decision|0|||
127498812|NCT01406938|458785680|FG002|Follow up|Physician Decision|2|||
127498813|NCT01406938|458785681|FG003|Follow up|Physician Decision|0|||
127498814|NCT01406938|458785682|FG004|Follow up|Physician Decision|3|||
127498815|NCT01406938|458785683|FG005|Follow up|Physician Decision|1|||
127498816|NCT01406938|458785678|FG000|Follow up|Lost to Follow-up|1|||
127498817|NCT01406938|458785679|FG001|Follow up|Lost to Follow-up|1|||
127498818|NCT01406938|458785680|FG002|Follow up|Lost to Follow-up|0|||
127498819|NCT01406938|458785681|FG003|Follow up|Lost to Follow-up|1|||
127498820|NCT01406938|458785682|FG004|Follow up|Lost to Follow-up|2|||
127498821|NCT01406938|458785683|FG005|Follow up|Lost to Follow-up|1|||
127498822|NCT04560816|458785688|FG000|Overall Study|Withdrawal by Subject|1|||
127498823|NCT04560816|458785689|FG001|Overall Study|Withdrawal by Subject|1|||
127498824|NCT04560816|458785690|FG002|Overall Study|Withdrawal by Subject|1|||
127498825|NCT04560816|458785691|FG003|Overall Study|Withdrawal by Subject|0|||
127498826|NCT04560816|458785692|FG004|Overall Study|Withdrawal by Subject|3|||
127498827|NCT04560816|458785693|FG005|Overall Study|Withdrawal by Subject|0|||
127498828|NCT04560816|458785688|FG000|Overall Study|Lost to Follow-up|1|||
127498829|NCT04560816|458785689|FG001|Overall Study|Lost to Follow-up|0|||
127498830|NCT04560816|458785690|FG002|Overall Study|Lost to Follow-up|0|||
127498831|NCT04560816|458785691|FG003|Overall Study|Lost to Follow-up|0|||
127498832|NCT04560816|458785692|FG004|Overall Study|Lost to Follow-up|0|||
127498833|NCT04560816|458785693|FG005|Overall Study|Lost to Follow-up|0|||
127498834|NCT04560816|458785688|FG000|Overall Study|Protocol Violation|1|||
127498835|NCT04560816|458785689|FG001|Overall Study|Protocol Violation|0|||
127498836|NCT04560816|458785690|FG002|Overall Study|Protocol Violation|0|||
127498837|NCT04560816|458785691|FG003|Overall Study|Protocol Violation|0|||
127498838|NCT04560816|458785692|FG004|Overall Study|Protocol Violation|0|||
127498839|NCT04560816|458785693|FG005|Overall Study|Protocol Violation|0|||
127498840|NCT02277691|458785694|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
127498841|NCT02277691|458785694|FG000|Overall Study|Voluntary Withdrawal|7|||
127498842|NCT02277691|458785694|FG000|Overall Study|Lack of Efficacy|5|||
127498843|NCT02277691|458785694|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
127498844|NCT03818607|458785695|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
127498845|NCT03818607|458785696|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
127498846|NCT03818607|458785695|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
127498847|NCT03818607|458785696|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
127498848|NCT03818607|458785695|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
127498849|NCT03818607|458785696|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
127498850|NCT05059301|458785698|FG000|Overall Study|Adverse Event|0|||
127498851|NCT05059301|458785699|FG001|Overall Study|Adverse Event|2|||
127498852|NCT05059301|458785700|FG002|Overall Study|Adverse Event|2|||
127498853|NCT05059301|458785698|FG000|Overall Study|Lost to Follow-up|2|||
127498854|NCT05059301|458785699|FG001|Overall Study|Lost to Follow-up|3|||
127498855|NCT05059301|458785700|FG002|Overall Study|Lost to Follow-up|3|||
127498856|NCT01164891|458785701|FG000|Overall Study|Disease Progression|5|||
127498857|NCT01164891|458785701|FG000|Overall Study|Adverse Event|1|||
127498858|NCT00441142|458785702|FG000|Overall Study|Adverse Event|2|||
127498859|NCT00441142|458785703|FG001|Overall Study|Adverse Event|3|||
127498860|NCT00441142|458785704|FG002|Overall Study|Adverse Event|3|||
127498861|NCT00441142|458785705|FG003|Overall Study|Adverse Event|22|||
127498862|NCT00441142|458785702|FG000|Overall Study|Lack of Efficacy|3|||
127498863|NCT00441142|458785703|FG001|Overall Study|Lack of Efficacy|3|||
127498864|NCT00441142|458785704|FG002|Overall Study|Lack of Efficacy|17|||
127498865|NCT00441142|458785705|FG003|Overall Study|Lack of Efficacy|32|||
127498866|NCT00441142|458785702|FG000|Overall Study|Withdrawal by Subject|0|||
127498867|NCT00441142|458785703|FG001|Overall Study|Withdrawal by Subject|0|||
127498868|NCT00441142|458785704|FG002|Overall Study|Withdrawal by Subject|2|||
127498869|NCT00441142|458785705|FG003|Overall Study|Withdrawal by Subject|10|||
127498870|NCT00441142|458785702|FG000|Overall Study|Patient still receiving active study tx|1|||
127498871|NCT00441142|458785703|FG001|Overall Study|Patient still receiving active study tx|0|||
127498872|NCT00441142|458785704|FG002|Overall Study|Patient still receiving active study tx|0|||
127977838|NCT04569968|460540386|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
127977839|NCT04569968|460540387|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
127977840|NCT04569968|460540386|FG000|Overall Study|Repetitive stroke|8|||
127977841|NCT04569968|460540387|FG001|Overall Study|Repetitive stroke|0|||
127977842|NCT04569968|460540386|FG000|Overall Study|Insufficient mastication|1|||
127977843|NCT04569968|460540387|FG001|Overall Study|Insufficient mastication|0|||
127977844|NCT04569968|460540386|FG000|Overall Study|Infection|1|||
127977845|NCT04569968|460540387|FG001|Overall Study|Infection|0|||
127498873|NCT00441142|458785705|FG003|Overall Study|Patient still receiving active study tx|2|||
127498874|NCT00441142|458785702|FG000|Overall Study|Physician Decision|0|||
127977846|NCT01552915|460540388|FG000|Overall Study|Adverse Event|3|||
127498875|NCT00441142|458785703|FG001|Overall Study|Physician Decision|1|||
127498876|NCT00441142|458785704|FG002|Overall Study|Physician Decision|0|||
127498877|NCT00441142|458785705|FG003|Overall Study|Physician Decision|1|||
127498878|NCT00441142|458785702|FG000|Overall Study|Death|0|||
127498879|NCT00441142|458785703|FG001|Overall Study|Death|0|||
127498880|NCT00441142|458785704|FG002|Overall Study|Death|0|||
127977847|NCT01552915|460540389|FG001|Overall Study|Adverse Event|14|||
127498881|NCT00441142|458785705|FG003|Overall Study|Death|1|||
127498882|NCT04952597|458785706|FG000|Overall Study|Death|12|||
127498883|NCT04952597|458785707|FG001|Overall Study|Death|13|||
127498884|NCT04952597|458785708|FG002|Overall Study|Death|14|||
127498885|NCT04952597|458785706|FG000|Overall Study|Withdrawal by Subject|1|||
127498886|NCT04952597|458785707|FG001|Overall Study|Withdrawal by Subject|0|||
127498887|NCT04952597|458785708|FG002|Overall Study|Withdrawal by Subject|3|||
127498888|NCT04952597|458785706|FG000|Overall Study|Lost to Follow-up|0|||
127498889|NCT04952597|458785707|FG001|Overall Study|Lost to Follow-up|1|||
127498890|NCT04952597|458785708|FG002|Overall Study|Lost to Follow-up|1|||
127498891|NCT05730335|458785709|FG000|Overall Study|Lost to Follow-up|8|||
127498892|NCT05730335|458785709|FG000|Overall Study|Withdrawal by Subject|6|||
127498893|NCT03249909|458785714|FG000|Overall Study|Withdrawal by Subject|3|||
127498894|NCT03249909|458785715|FG001|Overall Study|Withdrawal by Subject|0|||
127498895|NCT03249909|458785716|FG002|Overall Study|Withdrawal by Subject|0|||
127498896|NCT03249909|458785714|FG000|Overall Study|Adverse Event|3|||
127498897|NCT03249909|458785715|FG001|Overall Study|Adverse Event|0|||
127498898|NCT03249909|458785716|FG002|Overall Study|Adverse Event|0|||
127498899|NCT03249909|458785714|FG000|Overall Study|Lost to Follow-up|0|||
127498900|NCT03249909|458785715|FG001|Overall Study|Lost to Follow-up|1|||
127498901|NCT03249909|458785716|FG002|Overall Study|Lost to Follow-up|0|||
127498902|NCT05286658|458785720|FG000|Overall Study|Head circumference too large for MEG scanner (exclusion criterion for the study).|1|||
127498903|NCT05286658|458785720|FG000|Overall Study|Participant did not show SIS (the dependent measure), thus the hypothesis could not be assessed|1|||
127498904|NCT05411822|458785721|FG000|Overall Study|Withdrawal by Subject|2|||
127498905|NCT05411822|458785722|FG001|Overall Study|Withdrawal by Subject|1|||
127498906|NCT01864148|458785724|FG000|Overall Study|Other|2|||
127498907|NCT01864148|458785725|FG001|Overall Study|Other|1|||
127498908|NCT01864148|458785726|FG002|Overall Study|Other|1|||
127498909|NCT01864148|458785727|FG003|Overall Study|Other|3|||
127498910|NCT01864148|458785728|FG004|Overall Study|Other|1|||
127498911|NCT01864148|458785724|FG000|Overall Study|Death|0|||
127498912|NCT01864148|458785725|FG001|Overall Study|Death|0|||
127498913|NCT01864148|458785726|FG002|Overall Study|Death|0|||
127498914|NCT01864148|458785727|FG003|Overall Study|Death|1|||
127498915|NCT01864148|458785728|FG004|Overall Study|Death|0|||
127498916|NCT01864148|458785724|FG000|Overall Study|Investigator Decision|5|||
127498917|NCT01864148|458785725|FG001|Overall Study|Investigator Decision|0|||
127498918|NCT01864148|458785726|FG002|Overall Study|Investigator Decision|0|||
127498919|NCT01864148|458785727|FG003|Overall Study|Investigator Decision|4|||
127498920|NCT01864148|458785728|FG004|Overall Study|Investigator Decision|6|||
127498921|NCT01864148|458785724|FG000|Overall Study|Withdrawal by Subject|9|||
127498922|NCT01864148|458785725|FG001|Overall Study|Withdrawal by Subject|2|||
127498923|NCT01864148|458785726|FG002|Overall Study|Withdrawal by Subject|6|||
127498924|NCT01864148|458785727|FG003|Overall Study|Withdrawal by Subject|8|||
127498925|NCT01864148|458785728|FG004|Overall Study|Withdrawal by Subject|8|||
127498926|NCT01864148|458785724|FG000|Overall Study|Lost to Follow-up|0|||
127498927|NCT01864148|458785725|FG001|Overall Study|Lost to Follow-up|0|||
127498928|NCT01864148|458785726|FG002|Overall Study|Lost to Follow-up|0|||
127498929|NCT01864148|458785727|FG003|Overall Study|Lost to Follow-up|2|||
127498930|NCT01864148|458785728|FG004|Overall Study|Lost to Follow-up|1|||
127498931|NCT01864148|458785724|FG000|Overall Study|Adverse Event|4|||
127498932|NCT01864148|458785725|FG001|Overall Study|Adverse Event|2|||
127498933|NCT01864148|458785726|FG002|Overall Study|Adverse Event|4|||
127498934|NCT01864148|458785727|FG003|Overall Study|Adverse Event|7|||
127498935|NCT01864148|458785728|FG004|Overall Study|Adverse Event|7|||
127498936|NCT01864148|458785724|FG000|Overall Study|Not Dosed|0|||
127498937|NCT01864148|458785725|FG001|Overall Study|Not Dosed|0|||
127498938|NCT01864148|458785726|FG002|Overall Study|Not Dosed|0|||
127498939|NCT01864148|458785727|FG003|Overall Study|Not Dosed|1|||
127498940|NCT01864148|458785728|FG004|Overall Study|Not Dosed|0|||
127498941|NCT02027311|458785729|FG000|Overall Study|Protocol Violation|3|||
127498942|NCT02027311|458785730|FG001|Overall Study|Protocol Violation|2|||
127498943|NCT02466425|458785733|FG000|Overall Study|Adverse Event|3|||
127498944|NCT02466425|458785734|FG001|Overall Study|Adverse Event|11|||
127498945|NCT02466425|458785733|FG000|Overall Study|Lack of Efficacy|4|||
127498946|NCT02466425|458785734|FG001|Overall Study|Lack of Efficacy|1|||
127498947|NCT02466425|458785733|FG000|Overall Study|Lost to Follow-up|3|||
127498948|NCT02466425|458785734|FG001|Overall Study|Lost to Follow-up|0|||
127498949|NCT02466425|458785733|FG000|Overall Study|Protocol Violation|1|||
127498950|NCT02466425|458785734|FG001|Overall Study|Protocol Violation|0|||
127498951|NCT02466425|458785733|FG000|Overall Study|Withdrawal by Subject|0|||
127498952|NCT02466425|458785734|FG001|Overall Study|Withdrawal by Subject|1|||
127498953|NCT02466425|458785733|FG000|Overall Study|Other|1|||
127498954|NCT02466425|458785734|FG001|Overall Study|Other|3|||
127498955|NCT02466425|458785733|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
127498956|NCT02466425|458785734|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
127498957|NCT01721486|458785739|FG000|Overall Study|Protocol Violation|1|||
127498958|NCT01721486|458785740|FG001|Overall Study|Protocol Violation|0|||
127498959|NCT01721486|458785739|FG000|Overall Study|Physician Decision|0|||
127498960|NCT01721486|458785740|FG001|Overall Study|Physician Decision|1|||
127498961|NCT00582712|458785741|FG000|Overall Study|Adverse Event|1|||
127498962|NCT00582712|458785741|FG000|Overall Study|Lack of Efficacy|1|||
127498963|NCT00582712|458785741|FG000|Overall Study|Withdrawal by Subject|1|||
127498964|NCT00582712|458785741|FG000|Overall Study|Complicating disease requiring treatment|1|||
127498965|NCT05141175|458785742|FG000|Overall Study|Withdrawal by Subject|1|||
127498966|NCT01901289|458785744|FG000|Overall Study|Death|32|||
127498967|NCT01901289|458785744|FG000|Overall Study|Lost to Follow-up|16|||
127498968|NCT01901289|458785744|FG000|Overall Study|Withdrawal by Subject|35|||
127498969|NCT01901289|458785744|FG000|Overall Study|Other type of endpoint met|2|||
127498970|NCT01813058|458785745|FG000|Overall Study|Withdrawal by Subject|5|||
127498971|NCT01813058|458785746|FG001|Overall Study|Withdrawal by Subject|4|||
127498972|NCT01270880|458785748|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
127498973|NCT00182078|458785749|FG000|Overall Study|Withdrawal by Subject|1|||
127498974|NCT00182078|458785750|FG001|Overall Study|Withdrawal by Subject|0|||
127498975|NCT01606176|458785752|FG000|Overall Study|Adverse Event|2|||
127498976|NCT01606176|458785753|FG001|Overall Study|Adverse Event|3|||
127498977|NCT01606176|458785752|FG000|Overall Study|Disease progression|1|||
127498978|NCT01606176|458785753|FG001|Overall Study|Disease progression|0|||
127498979|NCT01606176|458785752|FG000|Overall Study|Withdrawal by Subject|1|||
127498980|NCT01606176|458785753|FG001|Overall Study|Withdrawal by Subject|0|||
127498981|NCT01076205|458785754|FG000|Overall Study|Adverse Drug Reaction|299|||
127498982|NCT01076205|458785754|FG000|Overall Study|Lack of Effectiveness|1423|||
127498983|NCT01076205|458785754|FG000|Overall Study|Other Reason|1075|||
127498984|NCT01076205|458785754|FG000|Overall Study|Unknown Reason|71|||
127498985|NCT01076205|458785754|FG000|Overall Study|Lost to Follow-up|3151|||
127498986|NCT01832493|458785755|FG000|Overall Study|Physician Decision|2|||
127498987|NCT01832493|458785755|FG000|Overall Study|Protocol Violation|4|||
127498988|NCT01832493|458785755|FG000|Overall Study|Unable to place LV lead|2|||
127498989|NCT01814397|458785756|FG000|Overall Study|Adverse Event|7|||
127498990|NCT01814397|458785756|FG000|Overall Study|Withdrawal by Subject|7|||
127498991|NCT01732510|458785757|FG000|Overall Study|Adverse Event|0|||
127498992|NCT01732510|458785758|FG001|Overall Study|Adverse Event|1|||
127498993|NCT01732510|458785759|FG002|Overall Study|Adverse Event|1|||
127498994|NCT01732510|458785760|FG003|Overall Study|Adverse Event|0|||
127498995|NCT01732510|458785761|FG004|Overall Study|Adverse Event|0|||
127498996|NCT01732510|458785762|FG005|Overall Study|Adverse Event|0|||
127498997|NCT01732510|458785763|FG006|Overall Study|Adverse Event|1|||
127498998|NCT01732510|458785757|FG000|Overall Study|Protocol Violation|0|||
127498999|NCT01732510|458785758|FG001|Overall Study|Protocol Violation|0|||
127499000|NCT01732510|458785759|FG002|Overall Study|Protocol Violation|0|||
127499001|NCT01732510|458785760|FG003|Overall Study|Protocol Violation|1|||
127499002|NCT01732510|458785761|FG004|Overall Study|Protocol Violation|0|||
127499003|NCT01732510|458785762|FG005|Overall Study|Protocol Violation|0|||
127499004|NCT01732510|458785763|FG006|Overall Study|Protocol Violation|0|||
127499005|NCT01732510|458785757|FG000|Overall Study|Withdrawal by Subject|1|||
127499006|NCT01732510|458785758|FG001|Overall Study|Withdrawal by Subject|3|||
127499007|NCT01732510|458785759|FG002|Overall Study|Withdrawal by Subject|2|||
127499008|NCT01732510|458785760|FG003|Overall Study|Withdrawal by Subject|1|||
127499009|NCT01732510|458785761|FG004|Overall Study|Withdrawal by Subject|5|||
127499010|NCT01732510|458785762|FG005|Overall Study|Withdrawal by Subject|0|||
127499011|NCT01732510|458785763|FG006|Overall Study|Withdrawal by Subject|1|||
127499012|NCT01732510|458785757|FG000|Overall Study|Lost to Follow-up|0|||
127499013|NCT01732510|458785758|FG001|Overall Study|Lost to Follow-up|0|||
127499014|NCT01732510|458785759|FG002|Overall Study|Lost to Follow-up|1|||
127499015|NCT01732510|458785760|FG003|Overall Study|Lost to Follow-up|1|||
127499016|NCT01732510|458785761|FG004|Overall Study|Lost to Follow-up|0|||
127499017|NCT01732510|458785762|FG005|Overall Study|Lost to Follow-up|1|||
127499018|NCT01732510|458785763|FG006|Overall Study|Lost to Follow-up|0|||
127499019|NCT01732510|458785757|FG000|Overall Study|Physician Decision|0|||
127499020|NCT01732510|458785758|FG001|Overall Study|Physician Decision|1|||
127499021|NCT01732510|458785759|FG002|Overall Study|Physician Decision|0|||
127499022|NCT01732510|458785760|FG003|Overall Study|Physician Decision|0|||
127499023|NCT01732510|458785761|FG004|Overall Study|Physician Decision|0|||
127499024|NCT01732510|458785762|FG005|Overall Study|Physician Decision|0|||
127499025|NCT01732510|458785763|FG006|Overall Study|Physician Decision|0|||
127499026|NCT01732510|458785757|FG000|Overall Study|Pregnancy|0|||
127499027|NCT01732510|458785758|FG001|Overall Study|Pregnancy|0|||
127499028|NCT01732510|458785759|FG002|Overall Study|Pregnancy|0|||
127499029|NCT01732510|458785760|FG003|Overall Study|Pregnancy|1|||
127499030|NCT01732510|458785761|FG004|Overall Study|Pregnancy|0|||
127499031|NCT01732510|458785762|FG005|Overall Study|Pregnancy|0|||
127499032|NCT01732510|458785763|FG006|Overall Study|Pregnancy|0|||
127499033|NCT01732510|458785757|FG000|Overall Study|Study Terminated By Sponsor|0|||
127499034|NCT01732510|458785758|FG001|Overall Study|Study Terminated By Sponsor|0|||
127499035|NCT01732510|458785759|FG002|Overall Study|Study Terminated By Sponsor|0|||
127499036|NCT01732510|458785760|FG003|Overall Study|Study Terminated By Sponsor|1|||
127499037|NCT01732510|458785761|FG004|Overall Study|Study Terminated By Sponsor|0|||
127499038|NCT01732510|458785762|FG005|Overall Study|Study Terminated By Sponsor|12|||
127499039|NCT01732510|458785763|FG006|Overall Study|Study Terminated By Sponsor|6|||
127499040|NCT00313144|458785764|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
127499041|NCT00313144|458785764|FG000|Overall Study|Death|7|||
127499042|NCT00313144|458785764|FG000|Overall Study|Lost to Follow-up|5|||
127499043|NCT00313144|458785764|FG000|Overall Study|Withdrawal by Subject|4|||
127499044|NCT00313144|458785764|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
127499045|NCT00313144|458785764|FG000|Overall Study|Physician Decision|4|||
127499046|NCT00313144|458785764|FG000|Overall Study|Adverse event - transient|5|||
127499047|NCT00313144|458785764|FG000|Overall Study|Liver transplant|1|||
127499048|NCT00313144|458785764|FG000|Overall Study|Insurance (homecare provider) change|1|||
127499049|NCT00313144|458785764|FG000|Overall Study|Change to different product|1|||
127499050|NCT00313144|458785764|FG000|Overall Study|Due to termination of the study|66|||
127499051|NCT02952313|458785777|FG000|Primary Endpoint|Lost to Follow-up|4|||
127499052|NCT02952313|458785777|FG000|Primary Endpoint|Withdrawal by Subject|1|||
127499053|NCT02952313|458785777|FG000|Primary Endpoint|Lack of Efficacy|1|||
127499054|NCT02952313|458785777|FG000|Primary Endpoint|Missed visit|1|||
127499055|NCT02952313|458785777|FG000|Long-term Follow-up|Lost to Follow-up|12|||
127499056|NCT02952313|458785777|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
127499057|NCT02952313|458785777|FG000|Long-term Follow-up|Lack of Efficacy|6|||
127499058|NCT02952313|458785777|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
127499059|NCT02952313|458785777|FG000|Long-term Follow-up|Physician Decision|1|||
127499060|NCT02952313|458785777|FG000|Long-term Follow-up|Death|1|||
127499061|NCT03594747|458785778|FG000|Overall Study|Death|78|||
127499062|NCT03594747|458785779|FG001|Overall Study|Death|86|||
127499063|NCT03594747|458785780|FG002|Overall Study|Death|87|||
127499064|NCT03594747|458785778|FG000|Overall Study|Withdrawal by Subject|5|||
127499065|NCT03594747|458785779|FG001|Overall Study|Withdrawal by Subject|2|||
127499066|NCT03594747|458785780|FG002|Overall Study|Withdrawal by Subject|11|||
127499067|NCT03594747|458785778|FG000|Overall Study|Lost to Follow-up|4|||
127499068|NCT03594747|458785779|FG001|Overall Study|Lost to Follow-up|1|||
127499069|NCT03594747|458785780|FG002|Overall Study|Lost to Follow-up|1|||
127499070|NCT03594747|458785778|FG000|Overall Study|Physician Decision|0|||
127499071|NCT03594747|458785779|FG001|Overall Study|Physician Decision|1|||
127499072|NCT03594747|458785780|FG002|Overall Study|Physician Decision|0|||
127499073|NCT03594747|458785778|FG000|Overall Study|Sponsor decision|23|||
127499074|NCT03594747|458785779|FG001|Overall Study|Sponsor decision|17|||
127499075|NCT03594747|458785780|FG002|Overall Study|Sponsor decision|16|||
127499076|NCT03594747|458785778|FG000|Overall Study|Did not meet inclusion criteria|0|||
127499077|NCT03594747|458785779|FG001|Overall Study|Did not meet inclusion criteria|0|||
127499078|NCT03594747|458785780|FG002|Overall Study|Did not meet inclusion criteria|1|||
127499079|NCT03594747|458785778|FG000|Overall Study|Transfer to long term extension study|10|||
127499080|NCT03594747|458785779|FG001|Overall Study|Transfer to long term extension study|12|||
127499081|NCT03594747|458785780|FG002|Overall Study|Transfer to long term extension study|5|||
127499082|NCT00703846|458785789|FG000|Overall Study|Adverse Event|8|||
127499083|NCT00703846|458785789|FG000|Overall Study|Lost to Follow-up|55|||
127499084|NCT00703846|458785789|FG000|Overall Study|Lack of Efficacy|15|||
127499085|NCT00703846|458785789|FG000|Overall Study|Noncompliance with Study Treatment|2|||
127499086|NCT00703846|458785789|FG000|Overall Study|Withdrawal by Subject|40|||
127499087|NCT00703846|458785789|FG000|Overall Study|Death|1|||
127499088|NCT00703846|458785789|FG000|Overall Study|Other|14|||
127499089|NCT00703846|458785789|FG000|Overall Study|Did Not Receive Study Drug|2|||
127499090|NCT03206918|458785792|FG000|Overall Study|Death|11|||
127499091|NCT03206918|458785792|FG000|Overall Study|Withdrawal by Subject|5|||
127499092|NCT03206918|458785792|FG000|Overall Study|Study terminated by sponsor|12|||
127499093|NCT03206918|458785792|FG000|Overall Study|Lost to Follow-up|3|||
127499094|NCT03206918|458785792|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
127499095|NCT03823287|458785793|FG000|Overall Study|Withdrawal by Subject|25|||
127499096|NCT03823287|458785794|FG001|Overall Study|Withdrawal by Subject|17|||
127499097|NCT03823287|458785793|FG000|Overall Study|Death|13|||
127499098|NCT03823287|458785794|FG001|Overall Study|Death|7|||
127499099|NCT03823287|458785793|FG000|Overall Study|Lost to Follow-up|7|||
127499100|NCT03823287|458785794|FG001|Overall Study|Lost to Follow-up|8|||
127499101|NCT03823287|458785793|FG000|Overall Study|Adverse Event|6|||
127499102|NCT03823287|458785794|FG001|Overall Study|Adverse Event|8|||
127499103|NCT03823287|458785793|FG000|Overall Study|Physician Decision|5|||
127499104|NCT03823287|458785794|FG001|Overall Study|Physician Decision|2|||
127499105|NCT03823287|458785793|FG000|Overall Study|Lack of Efficacy|2|||
127499106|NCT03823287|458785794|FG001|Overall Study|Lack of Efficacy|0|||
127499107|NCT03823287|458785793|FG000|Overall Study|Other|2|||
127499108|NCT03823287|458785794|FG001|Overall Study|Other|4|||
127499109|NCT01170273|458785796|FG000|Overall Study|Lost to Follow-up|6|||
127499110|NCT01170273|458785797|FG001|Overall Study|Lost to Follow-up|8|||
127499111|NCT01170273|458785796|FG000|Overall Study|Protocol Violation|1|||
127499112|NCT01170273|458785797|FG001|Overall Study|Protocol Violation|0|||
127499113|NCT01170273|458785796|FG000|Overall Study|Death|1|||
127499114|NCT01170273|458785797|FG001|Overall Study|Death|0|||
127499115|NCT01170273|458785796|FG000|Overall Study|Adverse Event|0|||
127499116|NCT01170273|458785797|FG001|Overall Study|Adverse Event|1|||
127499117|NCT00334737|458785798|FG000|Hospital Phase|Death|1|||
127499118|NCT00334737|458785799|FG001|Hospital Phase|Death|2|||
127499119|NCT00334737|458785800|FG002|Hospital Phase|Death|3|||
127499120|NCT00334737|458785798|FG000|Hospital Phase|Withdrawal by Subject|0|||
127499121|NCT00334737|458785799|FG001|Hospital Phase|Withdrawal by Subject|0|||
127499122|NCT00334737|458785800|FG002|Hospital Phase|Withdrawal by Subject|1|||
127499123|NCT00334737|458785798|FG000|Hospital Phase|Did not receive study drug|1|||
127499124|NCT00334737|458785799|FG001|Hospital Phase|Did not receive study drug|0|||
127499125|NCT00334737|458785800|FG002|Hospital Phase|Did not receive study drug|0|||
127499126|NCT00334737|458785798|FG000|Follow up Phase|Lost to Follow-up|5|||
127499127|NCT00334737|458785799|FG001|Follow up Phase|Lost to Follow-up|3|||
127499128|NCT00334737|458785800|FG002|Follow up Phase|Lost to Follow-up|6|||
127499129|NCT00583752|458785801|FG000|Overall Study|Lost to Follow-up|5|||
127499130|NCT00583752|458785802|FG001|Overall Study|Lost to Follow-up|5|||
127499131|NCT02316353|458785803|FG000|Overall Study|Pregnancy|1|||
127499132|NCT02316353|458785804|FG001|Overall Study|Pregnancy|3|||
127499133|NCT02316353|458785803|FG000|Overall Study|Adverse Event|1|||
127499134|NCT02316353|458785804|FG001|Overall Study|Adverse Event|3|||
127499135|NCT02316353|458785803|FG000|Overall Study|Withdrawal by Subject|6|||
127499136|NCT02316353|458785804|FG001|Overall Study|Withdrawal by Subject|2|||
127499137|NCT02954406|458787100|FG000|Overall Study|Adverse Event|0|||
127499138|NCT02954406|458787101|FG001|Overall Study|Adverse Event|1|||
127499139|NCT02954406|458787102|FG002|Overall Study|Adverse Event|0|||
127499140|NCT02954406|458787103|FG003|Overall Study|Adverse Event|0|||
127499141|NCT02954406|458787104|FG004|Overall Study|Adverse Event|1|||
127499142|NCT02954406|458787105|FG005|Overall Study|Adverse Event|0|||
127499143|NCT02954406|458787106|FG006|Overall Study|Adverse Event|0|||
127499144|NCT02954406|458787107|FG007|Overall Study|Adverse Event|0|||
127499145|NCT02954406|458787108|FG008|Overall Study|Adverse Event|1|||
127499146|NCT02954406|458787109|FG009|Overall Study|Adverse Event|1|||
127499147|NCT02954406|458787110|FG010|Overall Study|Adverse Event|0|||
127499148|NCT02954406|458787100|FG000|Overall Study|Progressive Disease|3|||
127499149|NCT02954406|458787101|FG001|Overall Study|Progressive Disease|4|||
127499150|NCT02954406|458787102|FG002|Overall Study|Progressive Disease|3|||
127499151|NCT02954406|458787103|FG003|Overall Study|Progressive Disease|4|||
127499152|NCT02954406|458787104|FG004|Overall Study|Progressive Disease|3|||
127499153|NCT02954406|458787105|FG005|Overall Study|Progressive Disease|3|||
127499154|NCT02954406|458787106|FG006|Overall Study|Progressive Disease|2|||
127499155|NCT02954406|458787107|FG007|Overall Study|Progressive Disease|2|||
127499156|NCT02954406|458787108|FG008|Overall Study|Progressive Disease|1|||
127499157|NCT02954406|458787109|FG009|Overall Study|Progressive Disease|1|||
127499158|NCT02954406|458787110|FG010|Overall Study|Progressive Disease|0|||
127499159|NCT02954406|458787100|FG000|Overall Study|Symptomatic Deterioration|0|||
127499160|NCT02954406|458787101|FG001|Overall Study|Symptomatic Deterioration|1|||
127499161|NCT02954406|458787102|FG002|Overall Study|Symptomatic Deterioration|0|||
127499162|NCT02954406|458787103|FG003|Overall Study|Symptomatic Deterioration|0|||
127499163|NCT02954406|458787104|FG004|Overall Study|Symptomatic Deterioration|0|||
127499164|NCT02954406|458787105|FG005|Overall Study|Symptomatic Deterioration|0|||
127499165|NCT02954406|458787106|FG006|Overall Study|Symptomatic Deterioration|0|||
127499166|NCT02954406|458787107|FG007|Overall Study|Symptomatic Deterioration|0|||
127499167|NCT02954406|458787108|FG008|Overall Study|Symptomatic Deterioration|0|||
127499168|NCT02954406|458787109|FG009|Overall Study|Symptomatic Deterioration|0|||
127499169|NCT02954406|458787110|FG010|Overall Study|Symptomatic Deterioration|0|||
127499170|NCT02954406|458787100|FG000|Overall Study|Death|0|||
127499171|NCT02954406|458787101|FG001|Overall Study|Death|0|||
127499172|NCT02954406|458787102|FG002|Overall Study|Death|0|||
127499173|NCT02954406|458787103|FG003|Overall Study|Death|0|||
127499174|NCT02954406|458787104|FG004|Overall Study|Death|1|||
127499175|NCT02954406|458787105|FG005|Overall Study|Death|0|||
127499176|NCT02954406|458787106|FG006|Overall Study|Death|0|||
127977848|NCT01552915|460540390|FG002|Overall Study|Adverse Event|3|||
127977849|NCT01552915|460540388|FG000|Overall Study|Lost to Follow-up|4|||
127499177|NCT02954406|458787107|FG007|Overall Study|Death|0|||
127977850|NCT01552915|460540389|FG001|Overall Study|Lost to Follow-up|6|||
127499178|NCT02954406|458787108|FG008|Overall Study|Death|1|||
127499179|NCT02954406|458787109|FG009|Overall Study|Death|1|||
127499180|NCT02954406|458787110|FG010|Overall Study|Death|0|||
127499181|NCT02954406|458787100|FG000|Overall Study|Reason Not Specified|0|||
127499182|NCT02954406|458787101|FG001|Overall Study|Reason Not Specified|0|||
127499183|NCT02954406|458787102|FG002|Overall Study|Reason Not Specified|3|||
127499184|NCT02954406|458787103|FG003|Overall Study|Reason Not Specified|2|||
127499185|NCT02954406|458787104|FG004|Overall Study|Reason Not Specified|2|||
127499186|NCT02954406|458787105|FG005|Overall Study|Reason Not Specified|0|||
127499187|NCT02954406|458787106|FG006|Overall Study|Reason Not Specified|1|||
127499188|NCT02954406|458787107|FG007|Overall Study|Reason Not Specified|0|||
127499189|NCT02954406|458787108|FG008|Overall Study|Reason Not Specified|1|||
127499190|NCT02954406|458787109|FG009|Overall Study|Reason Not Specified|0|||
127499191|NCT02954406|458787110|FG010|Overall Study|Reason Not Specified|0|||
127499192|NCT00782171|458787111|FG000|Overall Study|Lost to Follow-up|2|||
127977851|NCT01552915|460540390|FG002|Overall Study|Lost to Follow-up|5|||
127499193|NCT00782171|458787112|FG001|Overall Study|Lost to Follow-up|2|||
127499194|NCT00782171|458787111|FG000|Overall Study|Withdrawal by Subject|2|||
127499195|NCT00782171|458787112|FG001|Overall Study|Withdrawal by Subject|1|||
127499196|NCT00782171|458787111|FG000|Overall Study|complications|3|||
127499197|NCT00782171|458787112|FG001|Overall Study|complications|1|||
127499198|NCT00782171|458787111|FG000|Overall Study|others|7|||
127499199|NCT00782171|458787112|FG001|Overall Study|others|9|||
127499200|NCT00782171|458787111|FG000|Overall Study|not eligible|8|||
127499201|NCT00782171|458787112|FG001|Overall Study|not eligible|6|||
127499202|NCT04075292|458787118|FG000|Overall Study|Withdrawal by Subject|1|||
127499203|NCT04075292|458787119|FG001|Overall Study|Withdrawal by Subject|9|||
127499204|NCT04075292|458787118|FG000|Overall Study|Death|2|||
127499205|NCT04075292|458787119|FG001|Overall Study|Death|5|||
127499206|NCT04075292|458787118|FG000|Overall Study|Remained on study at time of DCO|74|||
127499207|NCT04075292|458787119|FG001|Overall Study|Remained on study at time of DCO|64|||
127499208|NCT01443364|458787120|FG000|Overall Study|Lack of Efficacy|14|||
127499209|NCT01443364|458787120|FG000|Overall Study|Lost to Follow-up|3|||
127499210|NCT01443364|458787120|FG000|Overall Study|Withdrawal by Subject|5|||
127499211|NCT01443364|458787120|FG000|Overall Study|Other Reason|4|||
127499212|NCT01443364|458787120|FG000|Overall Study|SAE, non-fatal|6|||
127499213|NCT01443364|458787120|FG000|Overall Study|AE, non-serious non-fatal|8|||
127499214|NCT01443364|458787120|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
127499215|NCT00559845|458787121|FG000|Overall Study|Withdrew Consent|1|||
127499216|NCT00559845|458787121|FG000|Overall Study|Disease Progression|1|||
127499217|NCT00559845|458787121|FG000|Overall Study|Adverse Event|3|||
127499218|NCT00559845|458787121|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
127499219|NCT00559845|458787121|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
127499220|NCT00878254|458787122|FG000|Overall Study|Physician Decision|1|||
127499221|NCT00878254|458787122|FG000|Overall Study|Death|1|||
127499222|NCT00878254|458787122|FG000|Overall Study|Withdrawal by Subject|1|||
127499223|NCT03367403|458787123|FG000|Overall Study|Adverse Event|20|||
127499224|NCT03367403|458787124|FG001|Overall Study|Adverse Event|6|||
127499225|NCT03367403|458787125|FG002|Overall Study|Adverse Event|2|||
127499226|NCT03367403|458787123|FG000|Overall Study|Withdrawal by Subject|12|||
127499227|NCT03367403|458787124|FG001|Overall Study|Withdrawal by Subject|13|||
127499228|NCT03367403|458787125|FG002|Overall Study|Withdrawal by Subject|1|||
127499229|NCT03367403|458787123|FG000|Overall Study|Death|1|||
127499230|NCT03367403|458787124|FG001|Overall Study|Death|2|||
127499231|NCT03367403|458787125|FG002|Overall Study|Death|0|||
127499232|NCT03367403|458787123|FG000|Overall Study|Physician Decision|0|||
127499233|NCT03367403|458787124|FG001|Overall Study|Physician Decision|1|||
127499234|NCT03367403|458787125|FG002|Overall Study|Physician Decision|0|||
127499235|NCT03367403|458787123|FG000|Overall Study|Protocol Violation|1|||
127499236|NCT03367403|458787124|FG001|Overall Study|Protocol Violation|1|||
127499237|NCT03367403|458787125|FG002|Overall Study|Protocol Violation|0|||
127499238|NCT03367403|458787123|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
127499239|NCT03367403|458787124|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
127499240|NCT03367403|458787125|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
127499241|NCT03367403|458787123|FG000|Overall Study|COVID-19|3|||
127499242|NCT03367403|458787124|FG001|Overall Study|COVID-19|6|||
127499243|NCT03367403|458787125|FG002|Overall Study|COVID-19|0|||
127499244|NCT03367403|458787123|FG000|Overall Study|Abuse of Alcohol Intake|0|||
127499245|NCT03367403|458787124|FG001|Overall Study|Abuse of Alcohol Intake|1|||
127499246|NCT03367403|458787125|FG002|Overall Study|Abuse of Alcohol Intake|0|||
127499247|NCT03367403|458787123|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
127499248|NCT03367403|458787124|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
127499249|NCT03367403|458787125|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
127499250|NCT00194077|458787126|FG000|Overall Study|Lack of Efficacy|22|||
127499251|NCT00194077|458787127|FG001|Overall Study|Lack of Efficacy|29|||
127499252|NCT00194077|458787126|FG000|Overall Study|Study nonadherence|1|||
127499253|NCT00194077|458787127|FG001|Overall Study|Study nonadherence|0|||
127499254|NCT00194077|458787126|FG000|Overall Study|Withdrawal by Subject|1|||
127499255|NCT00194077|458787127|FG001|Overall Study|Withdrawal by Subject|1|||
127499256|NCT03470194|458787130|FG000|Overall Study|Lost to Follow-up|11|||
127499257|NCT03470194|458787131|FG001|Overall Study|Lost to Follow-up|17|||
127499258|NCT03286543|458787132|FG000|Consented|Screen failure before randomization|2|||
127499259|NCT03286543|458787133|FG001|Consented|Screen failure before randomization|0|||
127499260|NCT03286543|458787134|FG002|Consented|Screen failure before randomization|0|||
127499261|NCT03286543|458787132|FG000|Consented|Screen failure before enrollment|4|||
127499262|NCT03286543|458787133|FG001|Consented|Screen failure before enrollment|0|||
127499263|NCT03286543|458787134|FG002|Consented|Screen failure before enrollment|0|||
127499264|NCT03286543|458787132|FG000|Consented|TKA cancelled after enrollment|1|||
127499265|NCT03286543|458787133|FG001|Consented|TKA cancelled after enrollment|0|||
127499266|NCT03286543|458787134|FG002|Consented|TKA cancelled after enrollment|0|||
127499267|NCT03286543|458787132|FG000|Consented|Withdrawn from study|12|||
127499268|NCT03286543|458787133|FG001|Consented|Withdrawn from study|0|||
127499269|NCT03286543|458787134|FG002|Consented|Withdrawn from study|0|||
127499270|NCT03286543|458787132|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
127499271|NCT03286543|458787133|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
127499272|NCT03286543|458787134|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
127499273|NCT03286543|458787132|FG000|Study Enrollment|Withdrawn from study|0|||
127499274|NCT03286543|458787133|FG001|Study Enrollment|Withdrawn from study|6|||
127499275|NCT03286543|458787134|FG002|Study Enrollment|Withdrawn from study|6|||
127499276|NCT01822899|458787135|FG000|Overall Study|Adverse Event|6|||
127499277|NCT01822899|458787136|FG001|Overall Study|Adverse Event|5|||
127499278|NCT01822899|458787135|FG000|Overall Study|Lack of Efficacy|6|||
127499279|NCT01822899|458787136|FG001|Overall Study|Lack of Efficacy|3|||
127499280|NCT01822899|458787135|FG000|Overall Study|Protocol Violation|6|||
127499281|NCT01822899|458787136|FG001|Overall Study|Protocol Violation|3|||
127499282|NCT01822899|458787135|FG000|Overall Study|Lost to Follow-up|1|||
127499283|NCT01822899|458787136|FG001|Overall Study|Lost to Follow-up|0|||
127499284|NCT01822899|458787135|FG000|Overall Study|Withdrawal by Subject|5|||
127499285|NCT01822899|458787136|FG001|Overall Study|Withdrawal by Subject|7|||
127499286|NCT05332392|458787137|FG000|Overall Study|Did not meet inclusion criteria|25|||
127499287|NCT05332392|458787137|FG000|Overall Study|Principal Investigator's decision|17|||
127499288|NCT05332392|458787137|FG000|Overall Study|Adverse Event|1|||
127499289|NCT05332392|458787137|FG000|Overall Study|Subject's decision|1|||
127499290|NCT00759876|458787141|FG000|Overall Study|Sponsor terminated study early|36|||
127499291|NCT03636893|458787142|FG000|Overall Study|Death|0|||
127499292|NCT03636893|458787143|FG001|Overall Study|Death|1|||
127499293|NCT03636893|458787142|FG000|Overall Study|Protocol Violation|0|||
127499294|NCT03636893|458787143|FG001|Overall Study|Protocol Violation|3|||
127499295|NCT03636893|458787142|FG000|Overall Study|Withdrawal by Subject|1|||
127499296|NCT03636893|458787143|FG001|Overall Study|Withdrawal by Subject|2|||
127499297|NCT03636893|458787142|FG000|Overall Study|Refusal to surgery|4|||
127499298|NCT03636893|458787143|FG001|Overall Study|Refusal to surgery|3|||
127499299|NCT03636893|458787142|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
127499300|NCT03636893|458787143|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
127499301|NCT03636893|458787142|FG000|Overall Study|Adverse Event|1|||
127499302|NCT03636893|458787143|FG001|Overall Study|Adverse Event|1|||
127499303|NCT00758069|458787144|FG000|Overall Study|Lack of Efficacy|0|||
127499304|NCT00758069|458787145|FG001|Overall Study|Lack of Efficacy|0|||
127499305|NCT00758069|458787146|FG002|Overall Study|Lack of Efficacy|1|||
127499306|NCT00758069|458787144|FG000|Overall Study|Incorrect Study Drug|1|||
127499307|NCT00758069|458787145|FG001|Overall Study|Incorrect Study Drug|0|||
127499308|NCT00758069|458787146|FG002|Overall Study|Incorrect Study Drug|0|||
127499309|NCT00588237|458787148|FG000|Overall Study|Evaluable for toxicity only|3|||
127499310|NCT00588237|458787148|FG000|Overall Study|Patien not treated|1|||
127499311|NCT01265563|458787152|FG000|Overall Study|Withdrawal by Subject|0|||
127499312|NCT01265563|458787153|FG001|Overall Study|Withdrawal by Subject|1|||
127499313|NCT01265563|458787154|FG002|Overall Study|Withdrawal by Subject|1|||
127499314|NCT01265563|458787155|FG003|Overall Study|Withdrawal by Subject|0|||
127499315|NCT01265563|458787156|FG004|Overall Study|Withdrawal by Subject|2|||
127499316|NCT04908865|458787161|FG000|Overall Study|Adverse Event|2|||
127499317|NCT04908865|458787161|FG000|Overall Study|Lack of Efficacy|5|||
127499318|NCT04908865|458787161|FG000|Overall Study|Lost to Follow-up|1|||
127499319|NCT02141399|458787162|FG000|Overall Study|Adverse Event|158|||
127499320|NCT02141399|458787162|FG000|Overall Study|Lack of Efficacy|62|||
127499321|NCT02141399|458787162|FG000|Overall Study|Lost to Follow-up|151|||
127499322|NCT02141399|458787162|FG000|Overall Study|Non-compliance with study drug|18|||
127499323|NCT02141399|458787162|FG000|Overall Study|Other|45|||
127499324|NCT02141399|458787162|FG000|Overall Study|Physician Decision|17|||
127499325|NCT02141399|458787162|FG000|Overall Study|Pregnancy|3|||
127499326|NCT02141399|458787162|FG000|Overall Study|Protocol Violation|38|||
127499327|NCT02141399|458787162|FG000|Overall Study|Withdrawal by Subject|238|||
127499328|NCT02141399|458787162|FG000|Overall Study|Failure to meet eligibility criteria|14|||
127499329|NCT01296711|458787165|FG000|Overall Study|Adverse Event|3|||
127499330|NCT01296711|458787166|FG001|Overall Study|Adverse Event|1|||
127499331|NCT01296711|458787167|FG002|Overall Study|Adverse Event|4|||
127499332|NCT01296711|458787168|FG003|Overall Study|Adverse Event|3|||
127499333|NCT01296711|458787169|FG004|Overall Study|Adverse Event|1|||
127499334|NCT01296711|458787170|FG005|Overall Study|Adverse Event|6|||
127499335|NCT01296711|458787171|FG006|Overall Study|Adverse Event|11|||
127499336|NCT01296711|458787172|FG007|Overall Study|Adverse Event|3|||
127499337|NCT01296711|458787165|FG000|Overall Study|Lack of Efficacy|1|||
127499338|NCT01296711|458787166|FG001|Overall Study|Lack of Efficacy|4|||
127499339|NCT01296711|458787167|FG002|Overall Study|Lack of Efficacy|1|||
127499340|NCT01296711|458787168|FG003|Overall Study|Lack of Efficacy|1|||
127499341|NCT01296711|458787169|FG004|Overall Study|Lack of Efficacy|1|||
127499342|NCT01296711|458787170|FG005|Overall Study|Lack of Efficacy|0|||
127499343|NCT01296711|458787171|FG006|Overall Study|Lack of Efficacy|2|||
127499344|NCT01296711|458787172|FG007|Overall Study|Lack of Efficacy|3|||
127499345|NCT01296711|458787165|FG000|Overall Study|Lost to Follow-up|0|||
127499346|NCT01296711|458787166|FG001|Overall Study|Lost to Follow-up|0|||
127499347|NCT01296711|458787167|FG002|Overall Study|Lost to Follow-up|1|||
127499348|NCT01296711|458787168|FG003|Overall Study|Lost to Follow-up|1|||
127499349|NCT01296711|458787169|FG004|Overall Study|Lost to Follow-up|2|||
127499350|NCT01296711|458787170|FG005|Overall Study|Lost to Follow-up|0|||
127499351|NCT01296711|458787171|FG006|Overall Study|Lost to Follow-up|4|||
127499352|NCT01296711|458787172|FG007|Overall Study|Lost to Follow-up|2|||
127499353|NCT01296711|458787165|FG000|Overall Study|Protocol Violation|0|||
127499354|NCT01296711|458787166|FG001|Overall Study|Protocol Violation|0|||
127499355|NCT01296711|458787167|FG002|Overall Study|Protocol Violation|0|||
127499356|NCT01296711|458787168|FG003|Overall Study|Protocol Violation|1|||
127499357|NCT01296711|458787169|FG004|Overall Study|Protocol Violation|1|||
127499358|NCT01296711|458787170|FG005|Overall Study|Protocol Violation|0|||
127499359|NCT01296711|458787171|FG006|Overall Study|Protocol Violation|0|||
127499360|NCT01296711|458787172|FG007|Overall Study|Protocol Violation|0|||
127499361|NCT01296711|458787165|FG000|Overall Study|Withdrawal by Subject|4|||
127499362|NCT01296711|458787166|FG001|Overall Study|Withdrawal by Subject|2|||
127499363|NCT01296711|458787167|FG002|Overall Study|Withdrawal by Subject|2|||
127499364|NCT01296711|458787168|FG003|Overall Study|Withdrawal by Subject|1|||
127499365|NCT01296711|458787169|FG004|Overall Study|Withdrawal by Subject|1|||
127499366|NCT01296711|458787170|FG005|Overall Study|Withdrawal by Subject|1|||
127499367|NCT01296711|458787171|FG006|Overall Study|Withdrawal by Subject|2|||
127499368|NCT01296711|458787172|FG007|Overall Study|Withdrawal by Subject|1|||
127499369|NCT01296711|458787165|FG000|Overall Study|Study termination|8|||
127499370|NCT01296711|458787166|FG001|Overall Study|Study termination|1|||
127499371|NCT01296711|458787167|FG002|Overall Study|Study termination|5|||
127499372|NCT01296711|458787168|FG003|Overall Study|Study termination|4|||
127499373|NCT01296711|458787169|FG004|Overall Study|Study termination|4|||
127499374|NCT01296711|458787170|FG005|Overall Study|Study termination|4|||
127499375|NCT01296711|458787171|FG006|Overall Study|Study termination|8|||
127499376|NCT01296711|458787172|FG007|Overall Study|Study termination|10|||
127499377|NCT01296711|458787165|FG000|Overall Study|Continued elevated liver enzymes|0|||
127499378|NCT01296711|458787166|FG001|Overall Study|Continued elevated liver enzymes|0|||
127499379|NCT01296711|458787167|FG002|Overall Study|Continued elevated liver enzymes|0|||
127499380|NCT01296711|458787168|FG003|Overall Study|Continued elevated liver enzymes|1|||
127499381|NCT01296711|458787169|FG004|Overall Study|Continued elevated liver enzymes|0|||
127499382|NCT01296711|458787170|FG005|Overall Study|Continued elevated liver enzymes|0|||
127499383|NCT01296711|458787171|FG006|Overall Study|Continued elevated liver enzymes|0|||
127499384|NCT01296711|458787172|FG007|Overall Study|Continued elevated liver enzymes|0|||
127499385|NCT01296711|458787165|FG000|Overall Study|Methotrexate discontinued|0|||
127499386|NCT01296711|458787166|FG001|Overall Study|Methotrexate discontinued|0|||
127499387|NCT01296711|458787167|FG002|Overall Study|Methotrexate discontinued|0|||
127499388|NCT01296711|458787168|FG003|Overall Study|Methotrexate discontinued|1|||
127499389|NCT01296711|458787169|FG004|Overall Study|Methotrexate discontinued|0|||
127499390|NCT01296711|458787170|FG005|Overall Study|Methotrexate discontinued|0|||
127499391|NCT01296711|458787171|FG006|Overall Study|Methotrexate discontinued|0|||
127499392|NCT01296711|458787172|FG007|Overall Study|Methotrexate discontinued|0|||
127499393|NCT01296711|458787165|FG000|Overall Study|Investigator discretion|0|||
127499394|NCT01296711|458787166|FG001|Overall Study|Investigator discretion|0|||
127499395|NCT01296711|458787167|FG002|Overall Study|Investigator discretion|0|||
127499396|NCT01296711|458787168|FG003|Overall Study|Investigator discretion|0|||
127499397|NCT01296711|458787169|FG004|Overall Study|Investigator discretion|0|||
127499398|NCT01296711|458787170|FG005|Overall Study|Investigator discretion|0|||
127499399|NCT01296711|458787171|FG006|Overall Study|Investigator discretion|1|||
127499400|NCT01296711|458787172|FG007|Overall Study|Investigator discretion|0|||
127499401|NCT01296711|458787165|FG000|Overall Study|Other|0|||
127499402|NCT01296711|458787166|FG001|Overall Study|Other|0|||
127499403|NCT01296711|458787167|FG002|Overall Study|Other|0|||
127499404|NCT01296711|458787168|FG003|Overall Study|Other|0|||
127499405|NCT01296711|458787169|FG004|Overall Study|Other|0|||
127499406|NCT01296711|458787170|FG005|Overall Study|Other|0|||
127499407|NCT01296711|458787171|FG006|Overall Study|Other|1|||
127499408|NCT01296711|458787172|FG007|Overall Study|Other|0|||
127499409|NCT01296711|458787165|FG000|Overall Study|Required restricted steroid injections|0|||
127499410|NCT01296711|458787166|FG001|Overall Study|Required restricted steroid injections|0|||
127499411|NCT01296711|458787167|FG002|Overall Study|Required restricted steroid injections|0|||
127499412|NCT01296711|458787168|FG003|Overall Study|Required restricted steroid injections|0|||
127499413|NCT01296711|458787169|FG004|Overall Study|Required restricted steroid injections|0|||
127499414|NCT01296711|458787170|FG005|Overall Study|Required restricted steroid injections|0|||
127499415|NCT01296711|458787171|FG006|Overall Study|Required restricted steroid injections|1|||
127499416|NCT01296711|458787172|FG007|Overall Study|Required restricted steroid injections|0|||
127499417|NCT01296711|458787165|FG000|Overall Study|Ongoing missed appointments|0|||
127499418|NCT01296711|458787166|FG001|Overall Study|Ongoing missed appointments|0|||
127499419|NCT01296711|458787167|FG002|Overall Study|Ongoing missed appointments|0|||
127499420|NCT01296711|458787168|FG003|Overall Study|Ongoing missed appointments|0|||
127499421|NCT01296711|458787169|FG004|Overall Study|Ongoing missed appointments|0|||
127499422|NCT01296711|458787170|FG005|Overall Study|Ongoing missed appointments|0|||
127499423|NCT01296711|458787171|FG006|Overall Study|Ongoing missed appointments|1|||
127499424|NCT01296711|458787172|FG007|Overall Study|Ongoing missed appointments|0|||
127499425|NCT01296711|458787165|FG000|Overall Study|Failure to comply with visits|0|||
127499426|NCT01296711|458787166|FG001|Overall Study|Failure to comply with visits|0|||
127499427|NCT01296711|458787167|FG002|Overall Study|Failure to comply with visits|0|||
127499428|NCT01296711|458787168|FG003|Overall Study|Failure to comply with visits|0|||
127499429|NCT01296711|458787169|FG004|Overall Study|Failure to comply with visits|0|||
127499430|NCT01296711|458787170|FG005|Overall Study|Failure to comply with visits|0|||
127499431|NCT01296711|458787171|FG006|Overall Study|Failure to comply with visits|0|||
127499432|NCT01296711|458787172|FG007|Overall Study|Failure to comply with visits|1|||
127499433|NCT01296711|458787165|FG000|Overall Study|Patient decision due to transport|0|||
127499434|NCT01296711|458787166|FG001|Overall Study|Patient decision due to transport|0|||
127499435|NCT01296711|458787167|FG002|Overall Study|Patient decision due to transport|0|||
127499436|NCT01296711|458787168|FG003|Overall Study|Patient decision due to transport|0|||
127499437|NCT01296711|458787169|FG004|Overall Study|Patient decision due to transport|0|||
127499438|NCT01296711|458787170|FG005|Overall Study|Patient decision due to transport|0|||
127499439|NCT01296711|458787171|FG006|Overall Study|Patient decision due to transport|0|||
127499440|NCT01296711|458787172|FG007|Overall Study|Patient decision due to transport|1|||
127499441|NCT00606034|458787175|FG000|Overall Study|incarceration|1|||
127499442|NCT01126268|458787176|FG000|Overall Study|Adverse Event|1|||
127499443|NCT02120300|458787179|FG000|Overall Study|Enrolled but Never Treated|2|||
127499444|NCT02120300|458787180|FG001|Overall Study|Enrolled but Never Treated|0|||
127499445|NCT02120300|458787181|FG002|Overall Study|Enrolled but Never Treated|0|||
127499446|NCT02120300|458787182|FG003|Overall Study|Enrolled but Never Treated|0|||
127499447|NCT02120300|458787179|FG000|Overall Study|Lack of Efficacy|0|||
127499448|NCT02120300|458787180|FG001|Overall Study|Lack of Efficacy|0|||
127499449|NCT02120300|458787181|FG002|Overall Study|Lack of Efficacy|0|||
127499450|NCT02120300|458787182|FG003|Overall Study|Lack of Efficacy|1|||
127499451|NCT02120300|458787179|FG000|Overall Study|Lost to Follow-up|1|||
127499452|NCT02120300|458787180|FG001|Overall Study|Lost to Follow-up|0|||
127499453|NCT02120300|458787181|FG002|Overall Study|Lost to Follow-up|0|||
127499454|NCT02120300|458787182|FG003|Overall Study|Lost to Follow-up|0|||
127499455|NCT02443116|458787185|FG000|Part 1|Adverse Event|2|||
127499456|NCT02443116|458787186|FG001|Part 1|Adverse Event|3|||
127499457|NCT02443116|458787187|FG002|Part 1|Adverse Event|0|||
127499458|NCT02443116|458787188|FG003|Part 1|Adverse Event|0|||
127499459|NCT02443116|458787189|FG004|Part 1|Adverse Event|0|||
127499460|NCT02443116|458787190|FG005|Part 1|Adverse Event|0|||
127499461|NCT02443116|458787191|FG006|Part 1|Adverse Event|0|||
127499462|NCT02443116|458787192|FG007|Part 1|Adverse Event|0|||
127499463|NCT02443116|458787193|FG008|Part 1|Adverse Event|0|||
127499464|NCT02443116|458787185|FG000|Part 1|Withdrew informed consent|0|||
127499465|NCT02443116|458787186|FG001|Part 1|Withdrew informed consent|1|||
127499466|NCT02443116|458787187|FG002|Part 1|Withdrew informed consent|0|||
127499467|NCT02443116|458787188|FG003|Part 1|Withdrew informed consent|0|||
127499468|NCT02443116|458787189|FG004|Part 1|Withdrew informed consent|0|||
127499469|NCT02443116|458787190|FG005|Part 1|Withdrew informed consent|0|||
127499470|NCT02443116|458787191|FG006|Part 1|Withdrew informed consent|0|||
127499471|NCT02443116|458787192|FG007|Part 1|Withdrew informed consent|0|||
127499472|NCT02443116|458787193|FG008|Part 1|Withdrew informed consent|0|||
127499473|NCT02443116|458787185|FG000|Part 1|Lost to Follow-up|0|||
127499474|NCT02443116|458787186|FG001|Part 1|Lost to Follow-up|0|||
127499475|NCT02443116|458787187|FG002|Part 1|Lost to Follow-up|2|||
127499476|NCT02443116|458787188|FG003|Part 1|Lost to Follow-up|0|||
127499477|NCT02443116|458787189|FG004|Part 1|Lost to Follow-up|0|||
127499478|NCT02443116|458787190|FG005|Part 1|Lost to Follow-up|0|||
127499479|NCT02443116|458787191|FG006|Part 1|Lost to Follow-up|0|||
127499480|NCT02443116|458787192|FG007|Part 1|Lost to Follow-up|0|||
127499481|NCT02443116|458787193|FG008|Part 1|Lost to Follow-up|0|||
127499482|NCT02443116|458787185|FG000|Part 1|Participant moved out of state|0|||
127499483|NCT02443116|458787186|FG001|Part 1|Participant moved out of state|0|||
127499484|NCT02443116|458787187|FG002|Part 1|Participant moved out of state|1|||
127977852|NCT01552915|460540388|FG000|Overall Study|Withdrawal by Subject|6|||
127499485|NCT02443116|458787188|FG003|Part 1|Participant moved out of state|0|||
127499486|NCT02443116|458787189|FG004|Part 1|Participant moved out of state|0|||
127499487|NCT02443116|458787190|FG005|Part 1|Participant moved out of state|0|||
127499488|NCT02443116|458787191|FG006|Part 1|Participant moved out of state|0|||
127499489|NCT02443116|458787192|FG007|Part 1|Participant moved out of state|0|||
127499490|NCT02443116|458787193|FG008|Part 1|Participant moved out of state|0|||
127499491|NCT02443116|458787185|FG000|Part 1|Participant enrolled in another clinical trial|0|||
127499492|NCT02443116|458787186|FG001|Part 1|Participant enrolled in another clinical trial|0|||
127499493|NCT02443116|458787187|FG002|Part 1|Participant enrolled in another clinical trial|1|||
127499494|NCT02443116|458787188|FG003|Part 1|Participant enrolled in another clinical trial|0|||
127499495|NCT02443116|458787189|FG004|Part 1|Participant enrolled in another clinical trial|0|||
127499496|NCT02443116|458787190|FG005|Part 1|Participant enrolled in another clinical trial|0|||
127499497|NCT02443116|458787191|FG006|Part 1|Participant enrolled in another clinical trial|0|||
127977853|NCT01552915|460540389|FG001|Overall Study|Withdrawal by Subject|4|||
127499498|NCT02443116|458787192|FG007|Part 1|Participant enrolled in another clinical trial|0|||
127499499|NCT02443116|458787193|FG008|Part 1|Participant enrolled in another clinical trial|0|||
127499500|NCT02443116|458787185|FG000|Part 2|Adverse Event|0|||
127499501|NCT02443116|458787186|FG001|Part 2|Adverse Event|0|||
127499502|NCT02443116|458787187|FG002|Part 2|Adverse Event|0|||
127499503|NCT02443116|458787188|FG003|Part 2|Adverse Event|0|||
127499504|NCT02443116|458787189|FG004|Part 2|Adverse Event|1|||
127499505|NCT02443116|458787190|FG005|Part 2|Adverse Event|1|||
127499506|NCT02443116|458787191|FG006|Part 2|Adverse Event|2|||
127499507|NCT02443116|458787192|FG007|Part 2|Adverse Event|0|||
127499508|NCT02443116|458787193|FG008|Part 2|Adverse Event|0|||
127499509|NCT02443116|458787185|FG000|Part 2|Withdrew informed consent|0|||
127499510|NCT02443116|458787186|FG001|Part 2|Withdrew informed consent|0|||
127499511|NCT02443116|458787187|FG002|Part 2|Withdrew informed consent|0|||
127499512|NCT02443116|458787188|FG003|Part 2|Withdrew informed consent|0|||
127499513|NCT02443116|458787189|FG004|Part 2|Withdrew informed consent|0|||
127499514|NCT02443116|458787190|FG005|Part 2|Withdrew informed consent|1|||
127499515|NCT02443116|458787191|FG006|Part 2|Withdrew informed consent|1|||
127499516|NCT02443116|458787192|FG007|Part 2|Withdrew informed consent|0|||
127499517|NCT02443116|458787193|FG008|Part 2|Withdrew informed consent|0|||
127499518|NCT02443116|458787185|FG000|Part 2|Inability to comply with protocol|0|||
127499519|NCT02443116|458787186|FG001|Part 2|Inability to comply with protocol|0|||
127499520|NCT02443116|458787187|FG002|Part 2|Inability to comply with protocol|0|||
127499521|NCT02443116|458787188|FG003|Part 2|Inability to comply with protocol|1|||
127499522|NCT02443116|458787189|FG004|Part 2|Inability to comply with protocol|0|||
127499523|NCT02443116|458787190|FG005|Part 2|Inability to comply with protocol|0|||
127499524|NCT02443116|458787191|FG006|Part 2|Inability to comply with protocol|0|||
127499525|NCT02443116|458787192|FG007|Part 2|Inability to comply with protocol|0|||
127499526|NCT02443116|458787193|FG008|Part 2|Inability to comply with protocol|0|||
127499527|NCT02443116|458787185|FG000|Part 2|Lost to Follow-up|0|||
127499528|NCT02443116|458787186|FG001|Part 2|Lost to Follow-up|0|||
127499529|NCT02443116|458787187|FG002|Part 2|Lost to Follow-up|0|||
127499530|NCT02443116|458787188|FG003|Part 2|Lost to Follow-up|1|||
127499531|NCT02443116|458787189|FG004|Part 2|Lost to Follow-up|0|||
127499532|NCT02443116|458787190|FG005|Part 2|Lost to Follow-up|0|||
127499533|NCT02443116|458787191|FG006|Part 2|Lost to Follow-up|0|||
127499534|NCT02443116|458787192|FG007|Part 2|Lost to Follow-up|0|||
127499535|NCT02443116|458787193|FG008|Part 2|Lost to Follow-up|0|||
127499536|NCT02443116|458787185|FG000|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
127499537|NCT02443116|458787186|FG001|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
127499538|NCT02443116|458787187|FG002|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
127499539|NCT02443116|458787188|FG003|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
127499540|NCT02443116|458787189|FG004|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
127499541|NCT02443116|458787190|FG005|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|1|||
127499542|NCT02443116|458787191|FG006|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
127499543|NCT02443116|458787192|FG007|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
127499544|NCT02443116|458787193|FG008|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
127499545|NCT02443116|458787185|FG000|Part 3|Adverse Event|0|||
127499546|NCT02443116|458787186|FG001|Part 3|Adverse Event|0|||
127499547|NCT02443116|458787187|FG002|Part 3|Adverse Event|0|||
127499548|NCT02443116|458787188|FG003|Part 3|Adverse Event|0|||
127499549|NCT02443116|458787189|FG004|Part 3|Adverse Event|0|||
127499550|NCT02443116|458787190|FG005|Part 3|Adverse Event|0|||
127499551|NCT02443116|458787191|FG006|Part 3|Adverse Event|0|||
127499552|NCT02443116|458787192|FG007|Part 3|Adverse Event|0|||
127499553|NCT02443116|458787193|FG008|Part 3|Adverse Event|1|||
127499554|NCT02443116|458787185|FG000|Part 3|Withdrew informed consent|0|||
127499555|NCT02443116|458787186|FG001|Part 3|Withdrew informed consent|0|||
127499556|NCT02443116|458787187|FG002|Part 3|Withdrew informed consent|0|||
127499557|NCT02443116|458787188|FG003|Part 3|Withdrew informed consent|0|||
127499558|NCT02443116|458787189|FG004|Part 3|Withdrew informed consent|0|||
127499559|NCT02443116|458787190|FG005|Part 3|Withdrew informed consent|0|||
127499560|NCT02443116|458787191|FG006|Part 3|Withdrew informed consent|0|||
127499561|NCT02443116|458787192|FG007|Part 3|Withdrew informed consent|3|||
127499562|NCT02443116|458787193|FG008|Part 3|Withdrew informed consent|2|||
127499563|NCT02443116|458787185|FG000|Part 3|Lost to Follow-up|0|||
127499564|NCT02443116|458787186|FG001|Part 3|Lost to Follow-up|0|||
127499565|NCT02443116|458787187|FG002|Part 3|Lost to Follow-up|0|||
127499566|NCT02443116|458787188|FG003|Part 3|Lost to Follow-up|0|||
127499567|NCT02443116|458787189|FG004|Part 3|Lost to Follow-up|0|||
127499568|NCT02443116|458787190|FG005|Part 3|Lost to Follow-up|0|||
127499569|NCT02443116|458787191|FG006|Part 3|Lost to Follow-up|0|||
127499570|NCT02443116|458787192|FG007|Part 3|Lost to Follow-up|1|||
127499571|NCT02443116|458787193|FG008|Part 3|Lost to Follow-up|2|||
127499572|NCT01932372|458787194|FG000|Overall Study|Not meeting eligibility criteria|33|||
127499573|NCT01932372|458787195|FG001|Overall Study|Not meeting eligibility criteria|179|||
127499574|NCT01917929|458787196|FG000|Overall Study|Death|8|||
127499575|NCT01917929|458787196|FG000|Overall Study|Lost to Follow-up|19|||
127499576|NCT01917929|458787196|FG000|Overall Study|Withdrawal by Subject|33|||
127499577|NCT01917929|458787196|FG000|Overall Study|Adverse Event|6|||
127499578|NCT01917929|458787196|FG000|Overall Study|Investigative Site Terminated|35|||
127499579|NCT01917929|458787196|FG000|Overall Study|Censored because study device not implanted|6|||
127499580|NCT01917929|458787196|FG000|Overall Study|Censored because surgery not performed|3|||
127499581|NCT01917929|458787196|FG000|Overall Study|Censored because of inclusion exclusion violation|3|||
127499582|NCT01917929|458787196|FG000|Overall Study|Sponsor terminated study|175|||
127499583|NCT02241733|458787197|FG000|Overall Study|Lost to Follow-up|9|||
127499584|NCT02241733|458787198|FG001|Overall Study|Lost to Follow-up|4|||
127499585|NCT02241733|458787197|FG000|Overall Study|Physician Decision|6|||
127499586|NCT02241733|458787198|FG001|Overall Study|Physician Decision|2|||
127499587|NCT02241733|458787197|FG000|Overall Study|Withdrawal by Subject|0|||
127499588|NCT02241733|458787198|FG001|Overall Study|Withdrawal by Subject|2|||
127499589|NCT02241733|458787197|FG000|Overall Study|Death|0|||
127499590|NCT02241733|458787198|FG001|Overall Study|Death|2|||
127499591|NCT04576455|458787202|FG000|Overall Study|Ongoing in the Study|48|||
127499592|NCT04576455|458787203|FG001|Overall Study|Ongoing in the Study|58|||
127499593|NCT04576455|458787202|FG000|Overall Study|Death|83|||
127499594|NCT04576455|458787203|FG001|Overall Study|Death|77|||
127499595|NCT04576455|458787202|FG000|Overall Study|Lost to Follow-up|4|||
127499596|NCT04576455|458787203|FG001|Overall Study|Lost to Follow-up|5|||
127499597|NCT04576455|458787202|FG000|Overall Study|Withdrawal by Subject|16|||
127499598|NCT04576455|458787203|FG001|Overall Study|Withdrawal by Subject|12|||
127499599|NCT02059499|458787204|FG000|Upto Week 20|Lost to Follow-up|2|||
127499600|NCT02059499|458787205|FG001|Upto Week 20|Lost to Follow-up|6|||
127499601|NCT02059499|458787206|FG002|Upto Week 20|Lost to Follow-up|0|||
127499602|NCT02059499|458787204|FG000|Upto Week 20|Treatment completed per protocol criteria|0|||
127499603|NCT02059499|458787205|FG001|Upto Week 20|Treatment completed per protocol criteria|2|||
127499604|NCT02059499|458787206|FG002|Upto Week 20|Treatment completed per protocol criteria|0|||
127499605|NCT02059499|458787204|FG000|Upto Week 20|Withdrawal by Subject|1|||
127499606|NCT02059499|458787205|FG001|Upto Week 20|Withdrawal by Subject|1|||
127499607|NCT02059499|458787206|FG002|Upto Week 20|Withdrawal by Subject|0|||
127499608|NCT02059499|458787204|FG000|Upto Week 20|No treatment per protocol criteria|0|||
127499609|NCT02059499|458787205|FG001|Upto Week 20|No treatment per protocol criteria|0|||
127499610|NCT02059499|458787206|FG002|Upto Week 20|No treatment per protocol criteria|5|||
127499611|NCT02059499|458787204|FG000|Post-week 20|Treatment not as per protocol criteria|3|||
127499612|NCT02059499|458787205|FG001|Post-week 20|Treatment not as per protocol criteria|4|||
127499613|NCT02059499|458787206|FG002|Post-week 20|Treatment not as per protocol criteria|9|||
127499614|NCT02059499|458787204|FG000|Post-week 20|Lost to Follow-up|0|||
127499615|NCT02059499|458787205|FG001|Post-week 20|Lost to Follow-up|2|||
127499616|NCT02059499|458787206|FG002|Post-week 20|Lost to Follow-up|0|||
127499617|NCT02059499|458787204|FG000|Post-week 20|Withdrawal by Subject|0|||
127499618|NCT02059499|458787205|FG001|Post-week 20|Withdrawal by Subject|1|||
127499619|NCT02059499|458787206|FG002|Post-week 20|Withdrawal by Subject|0|||
127499620|NCT02059499|458787204|FG000|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
127499621|NCT02059499|458787205|FG001|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|3|||
127499622|NCT02059499|458787206|FG002|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
127499623|NCT01673854|458787207|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
127499624|NCT01673854|458787207|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
127499625|NCT01673854|458787207|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
127499626|NCT01673854|458787207|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
127499627|NCT01673854|458787207|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
127499628|NCT01673854|458787207|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
127499629|NCT01673854|458787207|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
127499630|NCT01673854|458787207|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
127499631|NCT01673854|458787207|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
127499632|NCT01673854|458787207|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
127499633|NCT01673854|458787207|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
127499634|NCT01673854|458787207|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
127499635|NCT01700959|458787209|FG000|Overall Study|Adverse Event|0|||
127499636|NCT01700959|458787210|FG001|Overall Study|Adverse Event|1|||
127499637|NCT01700959|458787211|FG002|Overall Study|Adverse Event|1|||
127499638|NCT01700959|458787212|FG003|Overall Study|Adverse Event|2|||
127499639|NCT01700959|458787213|FG004|Overall Study|Adverse Event|0|||
127499640|NCT01700959|458787214|FG005|Overall Study|Adverse Event|2|||
127977854|NCT01552915|460540390|FG002|Overall Study|Withdrawal by Subject|5|||
127499641|NCT01700959|458787209|FG000|Overall Study|Withdrawal by Subject|15|||
127977855|NCT01552915|460540388|FG000|Overall Study|Protocol Violation|0|||
127499642|NCT01700959|458787210|FG001|Overall Study|Withdrawal by Subject|9|||
127499643|NCT01700959|458787211|FG002|Overall Study|Withdrawal by Subject|12|||
127499644|NCT01700959|458787212|FG003|Overall Study|Withdrawal by Subject|11|||
127977856|NCT01552915|460540389|FG001|Overall Study|Protocol Violation|4|||
127499645|NCT01700959|458787213|FG004|Overall Study|Withdrawal by Subject|8|||
127499646|NCT01700959|458787214|FG005|Overall Study|Withdrawal by Subject|12|||
127499647|NCT01700959|458787209|FG000|Overall Study|Ineligible|2|||
127499648|NCT01700959|458787210|FG001|Overall Study|Ineligible|1|||
127499649|NCT01700959|458787211|FG002|Overall Study|Ineligible|2|||
127499650|NCT01700959|458787212|FG003|Overall Study|Ineligible|0|||
127499651|NCT01700959|458787213|FG004|Overall Study|Ineligible|0|||
127499652|NCT01700959|458787214|FG005|Overall Study|Ineligible|1|||
127499653|NCT01700959|458787209|FG000|Overall Study|Noncompliant|9|||
127499654|NCT01700959|458787210|FG001|Overall Study|Noncompliant|9|||
127499655|NCT01700959|458787211|FG002|Overall Study|Noncompliant|17|||
127499656|NCT01700959|458787212|FG003|Overall Study|Noncompliant|18|||
127499657|NCT01700959|458787213|FG004|Overall Study|Noncompliant|15|||
127499658|NCT01700959|458787214|FG005|Overall Study|Noncompliant|9|||
127499659|NCT01700959|458787209|FG000|Overall Study|Side effects|1|||
127499660|NCT01700959|458787210|FG001|Overall Study|Side effects|4|||
127499661|NCT01700959|458787211|FG002|Overall Study|Side effects|8|||
127499662|NCT01700959|458787212|FG003|Overall Study|Side effects|4|||
127499663|NCT01700959|458787213|FG004|Overall Study|Side effects|4|||
127499664|NCT01700959|458787214|FG005|Overall Study|Side effects|1|||
127499665|NCT00830375|458787215|FG000|Overall Study|Lost to Follow-up|1|||
127499666|NCT02582814|458788963|FG000|Overall Study|Study-specific withdrawal criteria|1|||
127499667|NCT02582814|458788964|FG001|Overall Study|Study-specific withdrawal criteria|0|||
127499668|NCT02582814|458788963|FG000|Overall Study|Withdrawal by Subject|4|||
127499669|NCT02582814|458788964|FG001|Overall Study|Withdrawal by Subject|3|||
127499670|NCT02582814|458788963|FG000|Overall Study|Adverse Event|4|||
127499671|NCT02582814|458788964|FG001|Overall Study|Adverse Event|4|||
127499672|NCT03530995|458788965|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
127499673|NCT03530995|458788966|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
127499674|NCT03530995|458788965|FG000|Part 1 Period 3|Protocol Violation|1|||
127499675|NCT03530995|458788966|FG001|Part 1 Period 3|Protocol Violation|0|||
127499676|NCT03530995|458788965|FG000|Part 1 Period 4|Physician Decision|1|||
127499677|NCT03530995|458788966|FG001|Part 1 Period 4|Physician Decision|0|||
127499678|NCT03530995|458788965|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
127499679|NCT03530995|458788966|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
127499680|NCT01986231|458788970|FG000|Overall Study|Adverse Event|1|||
127499681|NCT00623233|458788971|FG000|Overall Study|Adverse Event|10|||
127499682|NCT00623233|458788971|FG000|Overall Study|Physician Decision|10|||
127499683|NCT00623233|458788971|FG000|Overall Study|Lost to Follow-up|1|||
127499684|NCT00623233|458788971|FG000|Overall Study|Withdrawal by Subject|3|||
127499685|NCT01751906|458788972|FG000|Overall Study|Lost to Follow-up|151|||
127499686|NCT01751906|458788973|FG001|Overall Study|Lost to Follow-up|68|||
127499687|NCT01751906|458788972|FG000|Overall Study|Withdrawal by Subject|22|||
127499688|NCT01751906|458788973|FG001|Overall Study|Withdrawal by Subject|18|||
127499689|NCT01751906|458788972|FG000|Overall Study|Physician Decision|5|||
127499690|NCT01751906|458788973|FG001|Overall Study|Physician Decision|2|||
127499691|NCT01751906|458788972|FG000|Overall Study|Death|84|||
127499692|NCT01751906|458788973|FG001|Overall Study|Death|43|||
127499693|NCT01751906|458788972|FG000|Overall Study|Denied on premises for follow-up by law|1|||
127499694|NCT01751906|458788973|FG001|Overall Study|Denied on premises for follow-up by law|0|||
127499695|NCT01110330|458788974|FG000|Overall Study|Adverse Event|0|||
127499696|NCT01110330|458788975|FG001|Overall Study|Adverse Event|4|||
127499697|NCT01110330|458788976|FG002|Overall Study|Adverse Event|3|||
127499698|NCT01110330|458788974|FG000|Overall Study|Lack of Efficacy|3|||
127499699|NCT01110330|458788975|FG001|Overall Study|Lack of Efficacy|1|||
127499700|NCT01110330|458788976|FG002|Overall Study|Lack of Efficacy|1|||
127499701|NCT01110330|458788974|FG000|Overall Study|Lost to Follow-up|9|||
127499702|NCT01110330|458788975|FG001|Overall Study|Lost to Follow-up|10|||
127499703|NCT01110330|458788976|FG002|Overall Study|Lost to Follow-up|15|||
127499704|NCT01110330|458788974|FG000|Overall Study|Physician Decision|0|||
127499705|NCT01110330|458788975|FG001|Overall Study|Physician Decision|1|||
127499706|NCT01110330|458788976|FG002|Overall Study|Physician Decision|0|||
127499707|NCT01110330|458788974|FG000|Overall Study|Protocol Violation|2|||
127977857|NCT01552915|460540390|FG002|Overall Study|Protocol Violation|4|||
127499708|NCT01110330|458788975|FG001|Overall Study|Protocol Violation|0|||
127499709|NCT01110330|458788976|FG002|Overall Study|Protocol Violation|4|||
127499710|NCT01110330|458788974|FG000|Overall Study|Withdrawal by Subject|0|||
127499711|NCT01110330|458788975|FG001|Overall Study|Withdrawal by Subject|6|||
127499712|NCT01110330|458788976|FG002|Overall Study|Withdrawal by Subject|2|||
127499713|NCT01110330|458788974|FG000|Overall Study|Other|1|||
127499714|NCT01110330|458788975|FG001|Overall Study|Other|1|||
127499715|NCT01110330|458788976|FG002|Overall Study|Other|1|||
127499716|NCT02557100|458788977|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
127499717|NCT02557100|458788978|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
127499718|NCT02557100|458788979|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
127499719|NCT02557100|458788977|FG000|Single Blind Treatment Period|Death|0|||
127499720|NCT02557100|458788978|FG001|Single Blind Treatment Period|Death|1|||
127977858|NCT01552915|460540388|FG000|Overall Study|Lack of Efficacy|8|||
127499721|NCT02557100|458788979|FG002|Single Blind Treatment Period|Death|0|||
127499722|NCT02557100|458788977|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
127499723|NCT02557100|458788978|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
127499724|NCT02557100|458788979|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
127499725|NCT02557100|458788977|FG000|Single Blind Treatment Period|Adverse Event|0|||
127499726|NCT02557100|458788978|FG001|Single Blind Treatment Period|Adverse Event|1|||
127499727|NCT02557100|458788979|FG002|Single Blind Treatment Period|Adverse Event|0|||
127499728|NCT02557100|458788977|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
127499729|NCT02557100|458788978|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
127499730|NCT02557100|458788979|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
127499731|NCT02557100|458788977|FG000|Cumulative Abatacept Period|Other Reasons|0|||
127499732|NCT02557100|458788978|FG001|Cumulative Abatacept Period|Other Reasons|0|||
127499733|NCT02557100|458788979|FG002|Cumulative Abatacept Period|Other Reasons|1|||
127499734|NCT02557100|458788977|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
127499735|NCT02557100|458788978|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
127499736|NCT02557100|458788979|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
127499737|NCT02557100|458788977|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
127499738|NCT02557100|458788978|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
127499739|NCT02557100|458788979|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
127499740|NCT02150057|458788987|FG000|Overall Study|Lost to Follow-up|6|||
127499741|NCT02150057|458788988|FG001|Overall Study|Lost to Follow-up|4|||
127499742|NCT00489424|458788989|FG000|Overall Study|Adverse Event|3|||
127499743|NCT00489424|458788990|FG001|Overall Study|Adverse Event|3|||
127499744|NCT00489424|458788991|FG002|Overall Study|Adverse Event|4|||
127499745|NCT00489424|458788989|FG000|Overall Study|Lack of Efficacy|1|||
127499746|NCT00489424|458788990|FG001|Overall Study|Lack of Efficacy|0|||
127499747|NCT00489424|458788991|FG002|Overall Study|Lack of Efficacy|0|||
127499748|NCT00489424|458788989|FG000|Overall Study|Administrative problems|0|||
127499749|NCT00489424|458788990|FG001|Overall Study|Administrative problems|2|||
127499750|NCT00489424|458788991|FG002|Overall Study|Administrative problems|1|||
127499751|NCT00394251|458788992|FG000|Overall Study|Adverse Event|7|||
127499752|NCT00394251|458788993|FG001|Overall Study|Adverse Event|5|||
127499753|NCT00394251|458788992|FG000|Overall Study|Unacceptable Toxicity|20|||
127499754|NCT00394251|458788993|FG001|Overall Study|Unacceptable Toxicity|18|||
127499755|NCT00394251|458788992|FG000|Overall Study|Physician Decision|1|||
127499756|NCT00394251|458788993|FG001|Overall Study|Physician Decision|1|||
127499757|NCT00394251|458788992|FG000|Overall Study|Protocol Violation|0|||
127499758|NCT00394251|458788993|FG001|Overall Study|Protocol Violation|1|||
127499759|NCT00394251|458788992|FG000|Overall Study|Withdrawal by Subject|7|||
127499760|NCT00394251|458788993|FG001|Overall Study|Withdrawal by Subject|11|||
127499761|NCT00394251|458788992|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
127499762|NCT00394251|458788993|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
127499763|NCT01558115|458788994|FG000|Overall Study|Withdrawal by Subject|3|||
127499764|NCT01558115|458788994|FG000|Overall Study|Study closed due to poor enrollment|4|||
127499765|NCT01696994|458788995|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
127499766|NCT01696994|458788996|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
127499767|NCT01696994|458788995|FG000|Overall Study|Died Before Randomization|1|||
127499768|NCT01696994|458788996|FG001|Overall Study|Died Before Randomization|2|||
127499769|NCT01696994|458788995|FG000|Overall Study|Died Before ASU (Control)|73|||
127499770|NCT01696994|458788996|FG001|Overall Study|Died Before ASU (Control)|0|||
127499771|NCT01696994|458788995|FG000|Overall Study|No Ovaries at Baseline|4807|||
127499772|NCT01696994|458788996|FG001|Overall Study|No Ovaries at Baseline|4851|||
127499773|NCT01696994|458788995|FG000|Overall Study|Refused ASU (Control)|311|||
127499774|NCT01696994|458788996|FG001|Overall Study|Refused ASU (Control)|0|||
127499775|NCT01696994|458788995|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
127499776|NCT01696994|458788996|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
127499777|NCT04644276|458788997|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
127499778|NCT04644276|458788998|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
127499779|NCT04644276|458788999|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
127499780|NCT00705250|458789000|FG000|Overall Study|Withdrawal by Subject|1|||
127499781|NCT00705250|458789000|FG000|Overall Study|Patient died in car accident|1|||
127499782|NCT01576146|458789001|FG000|Extension Period 1|Adverse Event|2|||
127499783|NCT01576146|458789001|FG000|Extension Period 1|Death|2|||
127499784|NCT01576146|458789001|FG000|Extension Period 1|Physician Decision|2|||
127499785|NCT01576146|458789001|FG000|Extension Period 1|Withdrawal by Subject|1|||
127499786|NCT01576146|458789001|FG000|Extension Period 1|Lost to Follow-up|1|||
127499787|NCT01576146|458789001|FG000|Extension Period 1|Parathyroidectomy|1|||
127499788|NCT01576146|458789001|FG000|Extension Period 1|Renal Transplant|1|||
127499789|NCT01576146|458789001|FG000|Extension Period 2|Sponsor Decision|13|||
127499790|NCT01576146|458789001|FG000|Extension Period 2|Death|1|||
127499791|NCT01576146|458789001|FG000|Extension Period 2|Adverse Event|1|||
127499792|NCT01576146|458789001|FG000|Extension Period 2|Renal Transplant|1|||
127499793|NCT01576146|458789001|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
127499794|NCT01951586|458789008|FG000|Overall Study|Death|61|||
127499795|NCT01951586|458789009|FG001|Overall Study|Death|120|||
127499796|NCT01951586|458789008|FG000|Overall Study|Withdrawal by Subject|8|||
127499797|NCT01951586|458789009|FG001|Overall Study|Withdrawal by Subject|17|||
127499798|NCT01951586|458789008|FG000|Overall Study|Lost to Follow-up|0|||
127499799|NCT01951586|458789009|FG001|Overall Study|Lost to Follow-up|1|||
127499800|NCT01951586|458789008|FG000|Overall Study|Sponsor Decision|9|||
127499801|NCT01951586|458789009|FG001|Overall Study|Sponsor Decision|10|||
127499802|NCT01667224|458789014|FG000|Overall Study|Withdrawal by Subject|3|||
127499803|NCT01667224|458789015|FG001|Overall Study|Withdrawal by Subject|1|||
127499804|NCT01667224|458789014|FG000|Overall Study|Protocol Violation|1|||
127499805|NCT01667224|458789015|FG001|Overall Study|Protocol Violation|1|||
127868950|NCT05602818|460137446|FG004|Qualification Phase (3 Days)|Adverse Event|0|||
127868951|NCT05602818|460137447|FG005|Qualification Phase (3 Days)|Adverse Event|0|||
127868952|NCT05602818|460137448|FG006|Qualification Phase (3 Days)|Adverse Event|0|||
127868953|NCT05602818|460137449|FG007|Qualification Phase (3 Days)|Adverse Event|0|||
127499810|NCT02314156|458789019|FG000|Overall Study|Adverse Event|1|||
127499811|NCT02314156|458789020|FG001|Overall Study|Adverse Event|0|||
127499812|NCT02314156|458789019|FG000|Overall Study|Withdrawal by Subject|1|||
127499813|NCT02314156|458789020|FG001|Overall Study|Withdrawal by Subject|0|||
127499814|NCT02752633|458789021|FG000|Overall Study|Withdrawal by Subject|1|||
127499815|NCT02846389|458789022|FG000|Overall Study|Withdrawal by Subject|1|||
127499816|NCT02846389|458789023|FG001|Overall Study|Withdrawal by Subject|1|||
127499817|NCT04026009|458789026|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
127499818|NCT04026009|458789027|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
127499819|NCT04026009|458789028|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
127499820|NCT04026009|458789029|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
127499821|NCT04026009|458789030|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
127499822|NCT04026009|458789026|FG000|Overall Study|Consent withdrawal, not due to adverse event|0|||
127499823|NCT04026009|458789027|FG001|Overall Study|Consent withdrawal, not due to adverse event|0|||
127499824|NCT04026009|458789028|FG002|Overall Study|Consent withdrawal, not due to adverse event|0|||
127499825|NCT04026009|458789029|FG003|Overall Study|Consent withdrawal, not due to adverse event|0|||
127499826|NCT04026009|458789030|FG004|Overall Study|Consent withdrawal, not due to adverse event|1|||
127499827|NCT01988662|458789031|FG000|Overall Study|Subject/guardian decision|1|||
127499828|NCT01988662|458789032|FG001|Overall Study|Subject/guardian decision|1|||
127499829|NCT01988662|458789031|FG000|Overall Study|Adverse Event|3|||
127499830|NCT01988662|458789032|FG001|Overall Study|Adverse Event|1|||
127499831|NCT00842153|458789036|FG000|Overall Study|Adverse Event|0|||
127499832|NCT00842153|458789037|FG001|Overall Study|Adverse Event|1|||
127499833|NCT00842153|458789036|FG000|Overall Study|Lost to Follow-up|1|||
127499834|NCT00842153|458789037|FG001|Overall Study|Lost to Follow-up|2|||
127499835|NCT00002540|458789038|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
127499836|NCT00002540|458789039|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
127499837|NCT00002540|458789038|FG000|Overall Study|Died Before Randomization|2|||
127499838|NCT00002540|458789039|FG001|Overall Study|Died Before Randomization|6|||
127499839|NCT00002540|458789038|FG000|Overall Study|Died Before ASU (Control)|202|||
127499840|NCT00002540|458789039|FG001|Overall Study|Died Before ASU (Control)|0|||
127499841|NCT00002540|458789038|FG000|Overall Study|Refused ASU (Control)|597|||
127499842|NCT00002540|458789039|FG001|Overall Study|Refused ASU (Control)|0|||
127499843|NCT00002540|458789038|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
127499844|NCT00002540|458789039|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
127499845|NCT05312697|458789040|FG000|Overall Study|Sponsor Terminated Trial|2|||
127499846|NCT04445519|458789041|FG000|Overall Study|Due to adaptive design|3|||
127499847|NCT04445519|458789042|FG001|Overall Study|Due to adaptive design|0|||
127499848|NCT04445519|458789043|FG002|Overall Study|Due to adaptive design|0|||
127499849|NCT04445519|458789041|FG000|Overall Study|Lost to Follow-up|0|||
127499850|NCT04445519|458789042|FG001|Overall Study|Lost to Follow-up|1|||
127499851|NCT04445519|458789043|FG002|Overall Study|Lost to Follow-up|4|||
127499852|NCT04445519|458789041|FG000|Overall Study|Sponsor or IRB Decision|0|||
127499853|NCT04445519|458789042|FG001|Overall Study|Sponsor or IRB Decision|1|||
127499854|NCT04445519|458789043|FG002|Overall Study|Sponsor or IRB Decision|2|||
127499855|NCT04445519|458789041|FG000|Overall Study|Withdrawal by Subject|0|||
127499856|NCT04445519|458789042|FG001|Overall Study|Withdrawal by Subject|3|||
127499857|NCT04445519|458789043|FG002|Overall Study|Withdrawal by Subject|3|||
127499858|NCT04445519|458789041|FG000|Overall Study|Adverse Event|0|||
127499859|NCT04445519|458789042|FG001|Overall Study|Adverse Event|8|||
127499860|NCT04445519|458789043|FG002|Overall Study|Adverse Event|6|||
127499861|NCT04445519|458789041|FG000|Overall Study|Other Reason|0|||
127499862|NCT04445519|458789042|FG001|Overall Study|Other Reason|1|||
127499863|NCT04445519|458789043|FG002|Overall Study|Other Reason|1|||
127499864|NCT04445519|458789041|FG000|Overall Study|Protocol Violation|0|||
127499865|NCT04445519|458789042|FG001|Overall Study|Protocol Violation|0|||
127499866|NCT04445519|458789043|FG002|Overall Study|Protocol Violation|1|||
127499867|NCT01345929|458789044|FG000|Overall Study|Withdrawal by Subject|9|||
127868954|NCT05602818|460137450|FG008|Qualification Phase (3 Days)|Adverse Event|0|||
127499868|NCT01345929|458789045|FG001|Overall Study|Withdrawal by Subject|8|||
127499869|NCT01345929|458789044|FG000|Overall Study|Lost to Follow-up|9|||
127499870|NCT01345929|458789045|FG001|Overall Study|Lost to Follow-up|9|||
127499871|NCT01345929|458789044|FG000|Overall Study|Adverse Event|0|||
127499872|NCT01345929|458789045|FG001|Overall Study|Adverse Event|1|||
127499873|NCT01345929|458789044|FG000|Overall Study|Didn't meet eligibility criteria|2|||
127499874|NCT01345929|458789045|FG001|Overall Study|Didn't meet eligibility criteria|0|||
127499875|NCT01345929|458789044|FG000|Overall Study|40,000 CFU/ML|1|||
127499876|NCT01345929|458789045|FG001|Overall Study|40,000 CFU/ML|0|||
127499877|NCT01345929|458789044|FG000|Overall Study|Patient withdrawal|0|||
127499878|NCT01345929|458789045|FG001|Overall Study|Patient withdrawal|1|||
127499879|NCT02151903|458789046|FG000|Overall Study|Withdrawal by Subject|1|||
127499880|NCT02151903|458789047|FG001|Overall Study|Withdrawal by Subject|0|||
127499881|NCT02151903|458789046|FG000|Overall Study|Progressive disease|2|||
127499882|NCT02151903|458789047|FG001|Overall Study|Progressive disease|1|||
127499883|NCT01500252|458789053|FG000|Overall Study|Death|4|||
127499884|NCT01500252|458789054|FG001|Overall Study|Death|2|||
127499885|NCT01500252|458789053|FG000|Overall Study|Lost to Follow-up|5|||
127499886|NCT01500252|458789054|FG001|Overall Study|Lost to Follow-up|4|||
127499887|NCT05319600|458789056|FG000|Overall Study|Withdrawal by Subject|1|||
127499888|NCT05319600|458789057|FG001|Overall Study|Withdrawal by Subject|0|||
127499889|NCT05319600|458789056|FG000|Overall Study|Lost to Follow-up|0|||
127499890|NCT05319600|458789057|FG001|Overall Study|Lost to Follow-up|4|||
127499891|NCT03768089|458789061|FG000|Part A|Lost to Follow-up|0|||
127499892|NCT03768089|458789062|FG001|Part A|Lost to Follow-up|0|||
127499893|NCT03768089|458789063|FG002|Part A|Lost to Follow-up|0|||
127499894|NCT03768089|458789064|FG003|Part A|Lost to Follow-up|0|||
127499895|NCT03768089|458789065|FG004|Part A|Lost to Follow-up|1|||
127499896|NCT03768089|458789066|FG005|Part A|Lost to Follow-up|0|||
127499897|NCT03768089|458789067|FG006|Part A|Lost to Follow-up|0|||
127499898|NCT03768089|458789068|FG007|Part A|Lost to Follow-up|0|||
127499899|NCT03768089|458789069|FG008|Part A|Lost to Follow-up|0|||
127499900|NCT03768089|458789070|FG009|Part A|Lost to Follow-up|0|||
127499901|NCT03768089|458789071|FG010|Part A|Lost to Follow-up|0|||
127499902|NCT03768089|458789072|FG011|Part A|Lost to Follow-up|0|||
127499903|NCT03768089|458789073|FG012|Part A|Lost to Follow-up|0|||
127499904|NCT03768089|458789074|FG013|Part A|Lost to Follow-up|0|||
127499905|NCT03768089|458789075|FG014|Part A|Lost to Follow-up|0|||
127499906|NCT03768089|458789076|FG015|Part A|Lost to Follow-up|0|||
127499907|NCT03768089|458789077|FG016|Part A|Lost to Follow-up|0|||
127499908|NCT03768089|458789078|FG017|Part A|Lost to Follow-up|0|||
127499909|NCT03768089|458789061|FG000|Part C|Randomized, Never Dosed|0|||
127499910|NCT03768089|458789062|FG001|Part C|Randomized, Never Dosed|0|||
127499911|NCT03768089|458789063|FG002|Part C|Randomized, Never Dosed|0|||
127499912|NCT03768089|458789064|FG003|Part C|Randomized, Never Dosed|0|||
127499913|NCT03768089|458789065|FG004|Part C|Randomized, Never Dosed|0|||
127499914|NCT03768089|458789066|FG005|Part C|Randomized, Never Dosed|0|||
127499915|NCT03768089|458789067|FG006|Part C|Randomized, Never Dosed|0|||
127499916|NCT03768089|458789068|FG007|Part C|Randomized, Never Dosed|0|||
127499917|NCT03768089|458789069|FG008|Part C|Randomized, Never Dosed|0|||
127499918|NCT03768089|458789070|FG009|Part C|Randomized, Never Dosed|0|||
127499919|NCT03768089|458789071|FG010|Part C|Randomized, Never Dosed|0|||
127499920|NCT03768089|458789072|FG011|Part C|Randomized, Never Dosed|0|||
127499921|NCT03768089|458789073|FG012|Part C|Randomized, Never Dosed|0|||
127499922|NCT03768089|458789074|FG013|Part C|Randomized, Never Dosed|0|||
127499923|NCT03768089|458789075|FG014|Part C|Randomized, Never Dosed|1|||
127499924|NCT03768089|458789076|FG015|Part C|Randomized, Never Dosed|0|||
127499925|NCT03768089|458789077|FG016|Part C|Randomized, Never Dosed|0|||
127499926|NCT03768089|458789078|FG017|Part C|Randomized, Never Dosed|0|||
127499927|NCT00177294|458789081|FG000|Overall Study|Withdrawal by Subject|7|||
127499928|NCT00177294|458789082|FG001|Overall Study|Withdrawal by Subject|5|||
127499929|NCT00395486|458789086|FG000|Overall Study|Adverse Event|1|||
127499930|NCT00395486|458789087|FG001|Overall Study|Adverse Event|2|||
127499931|NCT00395486|458789086|FG000|Overall Study|Withdrawal by Subject|5|||
127499932|NCT00395486|458789087|FG001|Overall Study|Withdrawal by Subject|2|||
127499933|NCT00395486|458789086|FG000|Overall Study|Lost to Follow-up|0|||
127499934|NCT00395486|458789087|FG001|Overall Study|Lost to Follow-up|1|||
127499935|NCT00361231|458789092|FG000|Overall Study|Physician Decision|3|||
127499936|NCT00361231|458789092|FG000|Overall Study|Symptomatic deterioration|5|||
127499937|NCT00361231|458789092|FG000|Overall Study|Radiographic disease progression|16|||
127499938|NCT00361231|458789092|FG000|Overall Study|Withdrawal by Subject|4|||
127499939|NCT00361231|458789092|FG000|Overall Study|Adverse Event|6|||
127499940|NCT04731298|458789095|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
127499941|NCT04731298|458789096|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
127499942|NCT03989349|458789105|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|3|||
127499943|NCT03989349|458789106|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
127499944|NCT03989349|458789107|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
127499945|NCT03989349|458789108|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
127499946|NCT03989349|458789109|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
127499947|NCT03989349|458789110|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
127499948|NCT03989349|458789105|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|17|||
127499949|NCT03989349|458789106|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|4|||
127499950|NCT03989349|458789107|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
127499951|NCT03989349|458789108|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
127499952|NCT03989349|458789109|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
127499953|NCT03989349|458789110|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
127499954|NCT03989349|458789105|FG000|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|24|||
127499955|NCT03989349|458789106|FG001|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|15|||
127499956|NCT03989349|458789107|FG002|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
127499957|NCT03989349|458789108|FG003|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
127499958|NCT03989349|458789109|FG004|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
127499959|NCT03989349|458789110|FG005|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
127499960|NCT03989349|458789105|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
127499961|NCT03989349|458789106|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
127499962|NCT03989349|458789107|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
127499963|NCT03989349|458789108|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
127499964|NCT03989349|458789109|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
127499965|NCT03989349|458789110|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
127499966|NCT03989349|458789105|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|3|||
127499967|NCT03989349|458789106|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|2|||
127499968|NCT03989349|458789107|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
127499969|NCT03989349|458789108|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
127499970|NCT03989349|458789109|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
127499971|NCT03989349|458789110|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
127499972|NCT03989349|458789105|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|1|||
127499973|NCT03989349|458789106|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
127499974|NCT03989349|458789107|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
127499975|NCT03989349|458789108|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
127499976|NCT03989349|458789109|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
127499977|NCT03989349|458789110|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
127499978|NCT03989349|458789105|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|3|||
127499979|NCT03989349|458789106|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|2|||
127499980|NCT03989349|458789107|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
127499981|NCT03989349|458789108|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
127499982|NCT03989349|458789109|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
127499983|NCT03989349|458789110|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
127499984|NCT03989349|458789105|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
127499985|NCT03989349|458789106|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
127499986|NCT03989349|458789107|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
127499987|NCT03989349|458789108|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
127499988|NCT03989349|458789109|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
127499989|NCT03989349|458789110|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
127499990|NCT03989349|458789105|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
127499991|NCT03989349|458789106|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
127499992|NCT03989349|458789107|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
127499993|NCT03989349|458789108|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
127499994|NCT03989349|458789109|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
127499995|NCT03989349|458789110|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
127499996|NCT03989349|458789105|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
127499997|NCT03989349|458789106|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
127499998|NCT03989349|458789107|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|2|||
127499999|NCT03989349|458789108|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|3|||
127500000|NCT03989349|458789109|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|1|||
127500001|NCT03989349|458789110|FG005|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
127500002|NCT03989349|458789105|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
127500003|NCT03989349|458789106|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
127500004|NCT03989349|458789107|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
127500005|NCT03989349|458789108|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
127977859|NCT01552915|460540389|FG001|Overall Study|Lack of Efficacy|1|||
127977860|NCT01552915|460540390|FG002|Overall Study|Lack of Efficacy|4|||
127977861|NCT01552915|460540388|FG000|Overall Study|Other|2|||
127977862|NCT01552915|460540389|FG001|Overall Study|Other|0|||
127977863|NCT01552915|460540390|FG002|Overall Study|Other|6|||
127500006|NCT03989349|458789109|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|3|||
127500007|NCT03989349|458789110|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
127500008|NCT03989349|458789105|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
127500009|NCT03989349|458789106|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
127500010|NCT03989349|458789107|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
127500011|NCT03989349|458789108|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
127500012|NCT03989349|458789109|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
127500013|NCT03989349|458789110|FG005|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
127500014|NCT03989349|458789105|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
127500015|NCT03989349|458789106|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
127500016|NCT03989349|458789107|FG002|Maintenance Period (Week 16-Week 48)|Other|4|||
127500017|NCT03989349|458789108|FG003|Maintenance Period (Week 16-Week 48)|Other|2|||
127500018|NCT03989349|458789109|FG004|Maintenance Period (Week 16-Week 48)|Other|2|||
127500019|NCT03989349|458789110|FG005|Maintenance Period (Week 16-Week 48)|Other|0|||
127500020|NCT03989349|458789105|FG000|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
127500021|NCT03989349|458789106|FG001|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
127500022|NCT03989349|458789107|FG002|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
127500023|NCT03989349|458789108|FG003|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
127500024|NCT03989349|458789109|FG004|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
127500025|NCT03989349|458789110|FG005|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
127500026|NCT01352221|458789111|FG000|Double-blind Phase|Adverse Event|6|||
127500027|NCT01352221|458789112|FG001|Double-blind Phase|Adverse Event|4|||
127500028|NCT01352221|458789113|FG002|Double-blind Phase|Adverse Event|0|||
127500029|NCT01352221|458789114|FG003|Double-blind Phase|Adverse Event|0|||
127500030|NCT01352221|458789111|FG000|Double-blind Phase|Withdrawal by Subject|3|||
127500031|NCT01352221|458789112|FG001|Double-blind Phase|Withdrawal by Subject|5|||
127500032|NCT01352221|458789113|FG002|Double-blind Phase|Withdrawal by Subject|0|||
127500033|NCT01352221|458789114|FG003|Double-blind Phase|Withdrawal by Subject|0|||
127500034|NCT01352221|458789111|FG000|Double-blind Phase|Lost to Follow-up|0|||
127500035|NCT01352221|458789112|FG001|Double-blind Phase|Lost to Follow-up|1|||
127500036|NCT01352221|458789113|FG002|Double-blind Phase|Lost to Follow-up|0|||
127500037|NCT01352221|458789114|FG003|Double-blind Phase|Lost to Follow-up|0|||
127500038|NCT01352221|458789111|FG000|Double-blind Phase|Protocol Violation|0|||
127500039|NCT01352221|458789112|FG001|Double-blind Phase|Protocol Violation|1|||
127500040|NCT01352221|458789113|FG002|Double-blind Phase|Protocol Violation|0|||
127500041|NCT01352221|458789114|FG003|Double-blind Phase|Protocol Violation|0|||
127500042|NCT01352221|458789111|FG000|Open-label Phase|Physician Decision|0|||
127500043|NCT01352221|458789112|FG001|Open-label Phase|Physician Decision|0|||
127500044|NCT01352221|458789113|FG002|Open-label Phase|Physician Decision|2|||
127500045|NCT01352221|458789114|FG003|Open-label Phase|Physician Decision|1|||
127500046|NCT01352221|458789111|FG000|Open-label Phase|Pregnancy|0|||
127500047|NCT01352221|458789112|FG001|Open-label Phase|Pregnancy|0|||
127500048|NCT01352221|458789113|FG002|Open-label Phase|Pregnancy|1|||
127500049|NCT01352221|458789114|FG003|Open-label Phase|Pregnancy|0|||
127500050|NCT01352221|458789111|FG000|Open-label Phase|Adverse Event|0|||
127500051|NCT01352221|458789112|FG001|Open-label Phase|Adverse Event|0|||
127500052|NCT01352221|458789113|FG002|Open-label Phase|Adverse Event|8|||
127500053|NCT01352221|458789114|FG003|Open-label Phase|Adverse Event|4|||
127500054|NCT01352221|458789111|FG000|Open-label Phase|Withdrawal by Subject|0|||
127500055|NCT01352221|458789112|FG001|Open-label Phase|Withdrawal by Subject|0|||
127500056|NCT01352221|458789113|FG002|Open-label Phase|Withdrawal by Subject|1|||
127500057|NCT01352221|458789114|FG003|Open-label Phase|Withdrawal by Subject|6|||
127500058|NCT01352221|458789111|FG000|Open-label Phase|Worsening of IBD|0|||
127500059|NCT01352221|458789112|FG001|Open-label Phase|Worsening of IBD|0|||
127500060|NCT01352221|458789113|FG002|Open-label Phase|Worsening of IBD|1|||
127500061|NCT01352221|458789114|FG003|Open-label Phase|Worsening of IBD|0|||
127500062|NCT02016716|458789115|FG000|Overall Study|Withdrawal by Subject|5|||
127500063|NCT02016716|458789116|FG001|Overall Study|Withdrawal by Subject|5|||
127500064|NCT02016716|458789117|FG002|Overall Study|Withdrawal by Subject|5|||
127500065|NCT02016716|458789115|FG000|Overall Study|Protocol-specified Criteria|0|||
127500066|NCT02016716|458789116|FG001|Overall Study|Protocol-specified Criteria|1|||
127500067|NCT02016716|458789117|FG002|Overall Study|Protocol-specified Criteria|0|||
127500068|NCT02016716|458789115|FG000|Overall Study|Lost to Follow-up|1|||
127500069|NCT02016716|458789116|FG001|Overall Study|Lost to Follow-up|2|||
127500070|NCT02016716|458789117|FG002|Overall Study|Lost to Follow-up|1|||
127500071|NCT02248649|458789118|FG000|Overall Study|Death|7|||
127500072|NCT02248649|458789119|FG001|Overall Study|Death|11|||
127500073|NCT02248649|458789118|FG000|Overall Study|Lost to Follow-up|14|||
127500074|NCT02248649|458789119|FG001|Overall Study|Lost to Follow-up|10|||
127500075|NCT01439971|458789120|FG000|Overall Study|Required number in cohort dosed|0|||
127500076|NCT01439971|458789121|FG001|Overall Study|Required number in cohort dosed|1|||
127500077|NCT01439971|458789122|FG002|Overall Study|Required number in cohort dosed|2|||
127500078|NCT01439971|458789123|FG003|Overall Study|Required number in cohort dosed|0|||
127500079|NCT01439971|458789124|FG004|Overall Study|Required number in cohort dosed|1|||
127500080|NCT02628600|458789128|FG000|Overall Study|Death|2|||
127500081|NCT02628600|458789129|FG001|Overall Study|Death|1|||
127500082|NCT02628600|458789128|FG000|Overall Study|Adverse Event|3|||
127500083|NCT02628600|458789129|FG001|Overall Study|Adverse Event|20|||
127500084|NCT02628600|458789128|FG000|Overall Study|Protocol Violation|0|||
127500085|NCT02628600|458789129|FG001|Overall Study|Protocol Violation|1|||
127500086|NCT02628600|458789128|FG000|Overall Study|Lack of Efficacy|2|||
127500087|NCT02628600|458789129|FG001|Overall Study|Lack of Efficacy|0|||
127500088|NCT02628600|458789128|FG000|Overall Study|Withdrawal by Subject|13|||
127500089|NCT02628600|458789129|FG001|Overall Study|Withdrawal by Subject|8|||
127500090|NCT02628600|458789128|FG000|Overall Study|Lost to Follow-up|1|||
127500091|NCT02628600|458789129|FG001|Overall Study|Lost to Follow-up|0|||
127500092|NCT02628600|458789128|FG000|Overall Study|Physician Decision|2|||
127500093|NCT02628600|458789129|FG001|Overall Study|Physician Decision|2|||
127500094|NCT02628600|458789128|FG000|Overall Study|Other not specified|1|||
127500095|NCT02628600|458789129|FG001|Overall Study|Other not specified|0|||
127500096|NCT00875485|458792140|FG000|Challenge Dose Epoch|Pregnancy|1|||
127500097|NCT00875485|458792141|FG001|Challenge Dose Epoch|Pregnancy|0|||
127500098|NCT01271010|458792142|FG000|Overall Study|Reason not specified|11|||
127500099|NCT01271010|458792142|FG000|Overall Study|Start of new CLL therapy|1|||
127500100|NCT01271010|458792142|FG000|Overall Study|Protocol Violation|1|||
127500101|NCT01271010|458792142|FG000|Overall Study|Death|2|||
127500102|NCT01271010|458792142|FG000|Overall Study|Progression and relapse of disease|1|||
127500103|NCT01271010|458792142|FG000|Overall Study|Withdrawal by Subject|18|||
127500104|NCT01271010|458792142|FG000|Overall Study|Disease progression|27|||
127500105|NCT01631747|458792143|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
127500106|NCT01631747|458792144|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
127500107|NCT01631747|458792143|FG000|Live Birth|Pregnancy Termination|1|||
127500108|NCT01631747|458792144|FG001|Live Birth|Pregnancy Termination|0|||
127500109|NCT01631747|458792143|FG000|Live Birth|MIscarriage|2|||
127500110|NCT01631747|458792144|FG001|Live Birth|MIscarriage|0|||
127500111|NCT01631747|458792143|FG000|Live Birth|Stillbirth|1|||
127500112|NCT01631747|458792144|FG001|Live Birth|Stillbirth|1|||
127500113|NCT01631747|458792143|FG000|One Year Infant Outcomes|Patient Refused|13|||
127500114|NCT01631747|458792144|FG001|One Year Infant Outcomes|Patient Refused|9|||
127500115|NCT02908685|458792145|FG000|Part 1 OLE|Withdrawal by Subject|0|||
127500116|NCT02908685|458792146|FG001|Part 1 OLE|Withdrawal by Subject|0|||
127500117|NCT02908685|458792147|FG002|Part 1 OLE|Withdrawal by Subject|0|||
127500118|NCT02908685|458792148|FG003|Part 1 OLE|Withdrawal by Subject|0|||
127500119|NCT02908685|458792149|FG004|Part 1 OLE|Withdrawal by Subject|0|||
127500120|NCT02908685|458792150|FG005|Part 1 OLE|Withdrawal by Subject|0|||
127500121|NCT02908685|458792151|FG006|Part 1 OLE|Withdrawal by Subject|0|||
127500122|NCT02908685|458792152|FG007|Part 1 OLE|Withdrawal by Subject|0|||
127500123|NCT02908685|458792153|FG008|Part 1 OLE|Withdrawal by Subject|0|||
127500124|NCT02908685|458792154|FG009|Part 1 OLE|Withdrawal by Subject|0|||
127500125|NCT02908685|458792155|FG010|Part 1 OLE|Withdrawal by Subject|2|||
127500126|NCT02908685|458792156|FG011|Part 1 OLE|Withdrawal by Subject|1|||
127500127|NCT02908685|458792157|FG012|Part 1 OLE|Withdrawal by Subject|0|||
127500128|NCT02908685|458792158|FG013|Part 1 OLE|Withdrawal by Subject|0|||
127500129|NCT02908685|458792145|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
127500130|NCT02908685|458792146|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
127500131|NCT02908685|458792147|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
127500132|NCT02908685|458792148|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
127500133|NCT02908685|458792149|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
127500134|NCT02908685|458792150|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
127500135|NCT02908685|458792151|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
127500136|NCT02908685|458792152|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
127500137|NCT02908685|458792153|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
127500138|NCT02908685|458792154|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
127500139|NCT02908685|458792155|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
127500140|NCT02908685|458792156|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
127500141|NCT02908685|458792157|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|2|||
127500142|NCT02908685|458792158|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|1|||
127500143|NCT02908685|458792145|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
127500144|NCT02908685|458792146|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
127500145|NCT02908685|458792147|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
127500146|NCT02908685|458792148|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
127500147|NCT02908685|458792149|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
127500148|NCT02908685|458792150|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
127500149|NCT02908685|458792151|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
127500150|NCT02908685|458792152|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
127500151|NCT02908685|458792153|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
127500152|NCT02908685|458792154|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
127500153|NCT02908685|458792155|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
127500154|NCT02908685|458792156|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
127500155|NCT02908685|458792157|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|1|||
127500156|NCT02908685|458792158|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
127500157|NCT02908685|458792145|FG000|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
127500158|NCT02908685|458792146|FG001|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
127500159|NCT02908685|458792147|FG002|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
127500160|NCT02908685|458792148|FG003|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
127500161|NCT02908685|458792149|FG004|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
127500162|NCT02908685|458792150|FG005|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
127500163|NCT02908685|458792151|FG006|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
127500164|NCT02908685|458792152|FG007|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
127500165|NCT02908685|458792153|FG008|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
127500166|NCT02908685|458792154|FG009|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
127500167|NCT02908685|458792155|FG010|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
127500168|NCT02908685|458792156|FG011|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
127500169|NCT02908685|458792157|FG012|Part 2 OLT: Month 12-24|Withdrawal by Subject|1|||
127500170|NCT02908685|458792158|FG013|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
127500171|NCT02908685|458792145|FG000|Part 2 OLE: > Month 24|Death|0|||
127500172|NCT02908685|458792146|FG001|Part 2 OLE: > Month 24|Death|0|||
127500173|NCT02908685|458792147|FG002|Part 2 OLE: > Month 24|Death|0|||
127500174|NCT02908685|458792148|FG003|Part 2 OLE: > Month 24|Death|0|||
127500175|NCT02908685|458792149|FG004|Part 2 OLE: > Month 24|Death|0|||
127500176|NCT02908685|458792150|FG005|Part 2 OLE: > Month 24|Death|0|||
127500177|NCT02908685|458792151|FG006|Part 2 OLE: > Month 24|Death|0|||
127500178|NCT02908685|458792152|FG007|Part 2 OLE: > Month 24|Death|0|||
127500179|NCT02908685|458792153|FG008|Part 2 OLE: > Month 24|Death|0|||
127500180|NCT02908685|458792154|FG009|Part 2 OLE: > Month 24|Death|0|||
127500181|NCT02908685|458792155|FG010|Part 2 OLE: > Month 24|Death|0|||
127500182|NCT02908685|458792156|FG011|Part 2 OLE: > Month 24|Death|0|||
127500183|NCT02908685|458792157|FG012|Part 2 OLE: > Month 24|Death|1|||
127500184|NCT02908685|458792158|FG013|Part 2 OLE: > Month 24|Death|0|||
127500185|NCT02908685|458792145|FG000|Part 2 OLE: > Month 24|Reason not specified|0|||
127500186|NCT02908685|458792146|FG001|Part 2 OLE: > Month 24|Reason not specified|0|||
127500187|NCT02908685|458792147|FG002|Part 2 OLE: > Month 24|Reason not specified|0|||
127500188|NCT02908685|458792148|FG003|Part 2 OLE: > Month 24|Reason not specified|0|||
127500189|NCT02908685|458792149|FG004|Part 2 OLE: > Month 24|Reason not specified|0|||
127500190|NCT02908685|458792150|FG005|Part 2 OLE: > Month 24|Reason not specified|0|||
127500191|NCT02908685|458792151|FG006|Part 2 OLE: > Month 24|Reason not specified|0|||
127500192|NCT02908685|458792152|FG007|Part 2 OLE: > Month 24|Reason not specified|0|||
127500193|NCT02908685|458792153|FG008|Part 2 OLE: > Month 24|Reason not specified|0|||
127500194|NCT02908685|458792154|FG009|Part 2 OLE: > Month 24|Reason not specified|0|||
127500195|NCT02908685|458792155|FG010|Part 2 OLE: > Month 24|Reason not specified|0|||
127500196|NCT02908685|458792156|FG011|Part 2 OLE: > Month 24|Reason not specified|0|||
127500197|NCT02908685|458792157|FG012|Part 2 OLE: > Month 24|Reason not specified|2|||
127500198|NCT02908685|458792158|FG013|Part 2 OLE: > Month 24|Reason not specified|1|||
127500199|NCT02908685|458792145|FG000|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
127500200|NCT02908685|458792146|FG001|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
127500201|NCT02908685|458792147|FG002|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
127500202|NCT02908685|458792148|FG003|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
127500203|NCT02908685|458792149|FG004|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
127500204|NCT02908685|458792150|FG005|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
127500205|NCT02908685|458792151|FG006|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
127500206|NCT02908685|458792152|FG007|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
127500207|NCT02908685|458792153|FG008|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
127500208|NCT02908685|458792154|FG009|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
127500209|NCT02908685|458792155|FG010|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
127500210|NCT02908685|458792156|FG011|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
127500211|NCT02908685|458792157|FG012|Part 2 OLE: > Month 24|Withdrawal by Subject|10|||
127500212|NCT02908685|458792158|FG013|Part 2 OLE: > Month 24|Withdrawal by Subject|5|||
127500213|NCT02370537|458792161|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
127500214|NCT02370537|458792162|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
127500215|NCT02370537|458792163|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
127500216|NCT02370537|458792161|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
127500217|NCT02370537|458792162|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
127500218|NCT02370537|458792163|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
127500219|NCT02370537|458792161|FG000|Part B|Not randomised to receive treatment|1|||
127500220|NCT02370537|458792162|FG001|Part B|Not randomised to receive treatment|2|||
127500221|NCT02370537|458792163|FG002|Part B|Not randomised to receive treatment|259|||
127500222|NCT02370537|458792161|FG000|Part B|Withdrawal by Subject|0|||
127500223|NCT02370537|458792162|FG001|Part B|Withdrawal by Subject|1|||
127500224|NCT02370537|458792163|FG002|Part B|Withdrawal by Subject|0|||
127500225|NCT01691014|458792164|FG000|Overall Study|Premature Termination|1|||
127500226|NCT01691014|458792165|FG001|Overall Study|Premature Termination|6|||
127500227|NCT01691014|458792166|FG002|Overall Study|Premature Termination|0|||
127500228|NCT01691014|458792167|FG003|Overall Study|Premature Termination|3|||
127500229|NCT01691014|458792164|FG000|Overall Study|Other|0|||
127500230|NCT01691014|458792165|FG001|Overall Study|Other|0|||
127500231|NCT01691014|458792166|FG002|Overall Study|Other|2|||
127500232|NCT01691014|458792167|FG003|Overall Study|Other|0|||
127500233|NCT01691014|458792164|FG000|Overall Study|Withdrawal by Subject|0|||
127500234|NCT01691014|458792165|FG001|Overall Study|Withdrawal by Subject|1|||
127500235|NCT01691014|458792166|FG002|Overall Study|Withdrawal by Subject|1|||
127500236|NCT01691014|458792167|FG003|Overall Study|Withdrawal by Subject|1|||
127500237|NCT01691014|458792164|FG000|Overall Study|Adverse Event|0|||
127500238|NCT01691014|458792165|FG001|Overall Study|Adverse Event|5|||
127500239|NCT01691014|458792166|FG002|Overall Study|Adverse Event|1|||
127500240|NCT01691014|458792167|FG003|Overall Study|Adverse Event|1|||
127500241|NCT01691014|458792164|FG000|Overall Study|Lack of Efficacy|2|||
127500242|NCT01691014|458792165|FG001|Overall Study|Lack of Efficacy|3|||
127500243|NCT01691014|458792166|FG002|Overall Study|Lack of Efficacy|7|||
127500244|NCT01691014|458792167|FG003|Overall Study|Lack of Efficacy|0|||
127500245|NCT03100539|458792170|FG000|Overall Study|Lost to Follow-up|60|||
127500246|NCT03100539|458792171|FG001|Overall Study|Lost to Follow-up|54|||
127500247|NCT03100539|458792172|FG002|Overall Study|Lost to Follow-up|17|||
127500248|NCT03100539|458792170|FG000|Overall Study|Uncollected|8|||
127500249|NCT03100539|458792171|FG001|Overall Study|Uncollected|8|||
127500250|NCT03100539|458792172|FG002|Overall Study|Uncollected|0|||
127500251|NCT03100539|458792170|FG000|Overall Study|Ally Health|0|||
127500252|NCT03100539|458792171|FG001|Overall Study|Ally Health|0|||
127500253|NCT03100539|458792172|FG002|Overall Study|Ally Health|3|||
127500254|NCT03100539|458792170|FG000|Overall Study|Disinterest|0|||
127500255|NCT03100539|458792171|FG001|Overall Study|Disinterest|0|||
127500256|NCT03100539|458792172|FG002|Overall Study|Disinterest|22|||
127500257|NCT03100539|458792170|FG000|Overall Study|Veteran Health|0|||
127500258|NCT03100539|458792171|FG001|Overall Study|Veteran Health|0|||
127500259|NCT03100539|458792172|FG002|Overall Study|Veteran Health|8|||
127500260|NCT03100539|458792170|FG000|Overall Study|Moved|0|||
127500261|NCT03100539|458792171|FG001|Overall Study|Moved|0|||
127500262|NCT03100539|458792172|FG002|Overall Study|Moved|1|||
127500263|NCT03100539|458792170|FG000|Overall Study|Scheduling Conflicts|0|||
127500264|NCT03100539|458792171|FG001|Overall Study|Scheduling Conflicts|0|||
127500265|NCT03100539|458792172|FG002|Overall Study|Scheduling Conflicts|12|||
127500266|NCT00809835|458792173|FG000|Overall Study|Lost to Follow-up|7|||
127500267|NCT00809835|458792174|FG001|Overall Study|Lost to Follow-up|6|||
127500268|NCT00809835|458792175|FG002|Overall Study|Lost to Follow-up|10|||
127500269|NCT00809835|458792176|FG003|Overall Study|Lost to Follow-up|2|||
127500270|NCT00809835|458792173|FG000|Overall Study|Withdrawal by Subject|1|||
127500271|NCT00809835|458792174|FG001|Overall Study|Withdrawal by Subject|1|||
127500272|NCT00809835|458792175|FG002|Overall Study|Withdrawal by Subject|1|||
127500273|NCT00809835|458792176|FG003|Overall Study|Withdrawal by Subject|0|||
127500274|NCT05659719|458792177|FG000|Overall Study|At sponsor's request|0|||
127500275|NCT05659719|458792178|FG001|Overall Study|At sponsor's request|0|||
127500276|NCT05659719|458792179|FG002|Overall Study|At sponsor's request|0|||
127500277|NCT05659719|458792180|FG003|Overall Study|At sponsor's request|95|||
127500278|NCT05659719|458792177|FG000|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
127500279|NCT05659719|458792178|FG001|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
127500280|NCT05659719|458792179|FG002|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
127500281|NCT05659719|458792180|FG003|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|1|||
127500282|NCT05659719|458792177|FG000|Overall Study|Inclusion/Exclusion criteria|0|||
127500283|NCT05659719|458792178|FG001|Overall Study|Inclusion/Exclusion criteria|0|||
127500284|NCT05659719|458792179|FG002|Overall Study|Inclusion/Exclusion criteria|0|||
127500285|NCT05659719|458792180|FG003|Overall Study|Inclusion/Exclusion criteria|5|||
127500286|NCT05659719|458792177|FG000|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
127500287|NCT05659719|458792178|FG001|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
127500288|NCT05659719|458792179|FG002|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
127500289|NCT05659719|458792180|FG003|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|27|||
127500290|NCT05659719|458792177|FG000|Overall Study|Lost to Follow-up|0|||
127977864|NCT02370667|460540391|FG000|Overall Study|Lost to Follow-up|0|||
127500291|NCT05659719|458792178|FG001|Overall Study|Lost to Follow-up|0|||
127977865|NCT02370667|460540392|FG001|Overall Study|Lost to Follow-up|1|||
127977866|NCT02370667|460540393|FG002|Overall Study|Lost to Follow-up|0|||
127977867|NCT02457832|460540396|FG000|Training|Lost to Follow-up|10|||
127977868|NCT02457832|460540397|FG001|Training|Lost to Follow-up|6|||
127977869|NCT02457832|460540398|FG002|Training|Lost to Follow-up|3|||
127977870|NCT02457832|460540396|FG000|One Month Washout|Lost to Follow-up|0|||
127977871|NCT02457832|460540397|FG001|One Month Washout|Lost to Follow-up|1|||
127977872|NCT02457832|460540398|FG002|One Month Washout|Lost to Follow-up|1|||
127977873|NCT00423189|460540399|FG000|Overall Study|Death|0|||
127977874|NCT00423189|460540400|FG001|Overall Study|Death|1|||
127977875|NCT00423189|460540401|FG002|Overall Study|Death|0|||
127977876|NCT01459718|460540402|FG000|Overall Study|Physician Decision|1|||
127977877|NCT01459718|460540402|FG000|Overall Study|Lost to Follow-up|1|||
127977878|NCT01459718|460540402|FG000|Overall Study|Adverse Event|1|||
127977879|NCT01258075|460540403|FG000|Overall Study|Adverse Event|8|||
127977880|NCT01258075|460540404|FG001|Overall Study|Adverse Event|3|||
127977881|NCT01258075|460540403|FG000|Overall Study|Lost to Follow-up|11|||
127977882|NCT01258075|460540404|FG001|Overall Study|Lost to Follow-up|6|||
127977883|NCT01258075|460540403|FG000|Overall Study|Withdrawal by Subject|10|||
127977884|NCT01258075|460540404|FG001|Overall Study|Withdrawal by Subject|7|||
127977885|NCT01258075|460540403|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
127977886|NCT01258075|460540404|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
127977887|NCT01258075|460540403|FG000|Overall Study|Other|12|||
127977888|NCT01258075|460540404|FG001|Overall Study|Other|5|||
127977889|NCT01618019|460540410|FG000|Overall Study|Withdrawal by Subject|14|||
127977890|NCT01618019|460540411|FG001|Overall Study|Withdrawal by Subject|14|||
127977891|NCT02783729|460540412|FG000|Overall Study|Lack of Efficacy|1|||
127977892|NCT02783729|460540413|FG001|Overall Study|Lack of Efficacy|0|||
127977893|NCT02783729|460540414|FG002|Overall Study|Lack of Efficacy|0|||
127977894|NCT02783729|460540415|FG003|Overall Study|Lack of Efficacy|0|||
127977895|NCT02783729|460540412|FG000|Overall Study|Adverse Event|2|||
127977896|NCT02783729|460540413|FG001|Overall Study|Adverse Event|6|||
127977897|NCT02783729|460540414|FG002|Overall Study|Adverse Event|2|||
127977898|NCT02783729|460540415|FG003|Overall Study|Adverse Event|3|||
127977899|NCT02783729|460540412|FG000|Overall Study|Other|1|||
127977900|NCT02783729|460540413|FG001|Overall Study|Other|6|||
127977901|NCT02783729|460540414|FG002|Overall Study|Other|2|||
127977902|NCT02783729|460540415|FG003|Overall Study|Other|3|||
127977903|NCT02783729|460540412|FG000|Overall Study|Withdrawal by Subject|2|||
127977904|NCT02783729|460540413|FG001|Overall Study|Withdrawal by Subject|3|||
127977905|NCT02783729|460540414|FG002|Overall Study|Withdrawal by Subject|1|||
127977906|NCT02783729|460540415|FG003|Overall Study|Withdrawal by Subject|2|||
127977907|NCT02783729|460540412|FG000|Overall Study|Participant's choice|2|||
127977908|NCT02783729|460540413|FG001|Overall Study|Participant's choice|1|||
127977909|NCT02783729|460540414|FG002|Overall Study|Participant's choice|2|||
127977910|NCT02783729|460540415|FG003|Overall Study|Participant's choice|1|||
127977911|NCT02783729|460540412|FG000|Overall Study|Lost to Follow-up|2|||
127977912|NCT02783729|460540413|FG001|Overall Study|Lost to Follow-up|1|||
127977913|NCT02783729|460540414|FG002|Overall Study|Lost to Follow-up|1|||
127977914|NCT02783729|460540415|FG003|Overall Study|Lost to Follow-up|0|||
127977915|NCT02693171|460540416|FG000|Overall Study|Adverse Event|1|||
127977916|NCT02693171|460540416|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
127977917|NCT01866657|460540422|FG000|Overall Study|Surgery canceled|2|||
127977918|NCT01866657|460540423|FG001|Overall Study|Surgery canceled|0|||
127977919|NCT02288091|460540428|FG000|Overall Study|Lost to Follow-up|1|||
127977920|NCT02288091|460540428|FG000|Overall Study|Screen fail|7|||
127977921|NCT03973918|460540430|FG000|Overall Study|Adverse Event|0|||
127977922|NCT03973918|460540431|FG001|Overall Study|Adverse Event|0|||
127977923|NCT03973918|460540432|FG002|Overall Study|Adverse Event|0|||
127977924|NCT03973918|460540433|FG003|Overall Study|Adverse Event|1|||
127977925|NCT03973918|460540430|FG000|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
127977926|NCT03973918|460540431|FG001|Overall Study|pt had to stop treatment on this study but continued treatment off this study|1|||
127977927|NCT03973918|460540432|FG002|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
127977928|NCT03973918|460540433|FG003|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
127977929|NCT04351373|460540434|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
127977930|NCT02880865|460540441|FG000|Overall Study|Adverse Event|1|||
127977931|NCT02880865|460540442|FG001|Overall Study|Adverse Event|0|||
127977932|NCT02880865|460540441|FG000|Overall Study|Withdrawal by Subject|0|||
127977933|NCT02880865|460540442|FG001|Overall Study|Withdrawal by Subject|2|||
127977934|NCT02880865|460540441|FG000|Overall Study|Physician Decision|0|||
127977935|NCT02880865|460540442|FG001|Overall Study|Physician Decision|1|||
127977936|NCT01446237|460540445|FG000|Overall Study|Adverse Event|1|||
127977937|NCT01446237|460540445|FG000|Overall Study|Lost to Follow-up|2|||
127977938|NCT01446237|460540445|FG000|Overall Study|Withdrawal by Subject|7|||
127977939|NCT01190267|460540448|FG000|Overall Study|Adverse Event|10|||
127977940|NCT01190267|460540449|FG001|Overall Study|Adverse Event|0|||
127977941|NCT01190267|460540448|FG000|Overall Study|Treatment Failure|8|||
127500292|NCT05659719|458792179|FG002|Overall Study|Lost to Follow-up|0|||
127977942|NCT01190267|460540449|FG001|Overall Study|Treatment Failure|2|||
127977943|NCT01190267|460540448|FG000|Overall Study|Lost to Follow-up|2|||
127977944|NCT01190267|460540449|FG001|Overall Study|Lost to Follow-up|0|||
127977945|NCT01190267|460540448|FG000|Overall Study|Withdrawal by Subject|13|||
127977946|NCT01190267|460540449|FG001|Overall Study|Withdrawal by Subject|1|||
127977947|NCT01190267|460540448|FG000|Overall Study|Protocol Violation|8|||
127977948|NCT01190267|460540449|FG001|Overall Study|Protocol Violation|1|||
127977949|NCT00742508|460540452|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
127977950|NCT00742508|460540453|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
127977951|NCT00742508|460540452|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
127977952|NCT00742508|460540453|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
127977953|NCT00742508|460540452|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
127977954|NCT00742508|460540453|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
127977955|NCT00742508|460540452|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
127977956|NCT00742508|460540453|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
127977957|NCT00742508|460540452|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
127977958|NCT00742508|460540453|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
127977959|NCT04017832|460540454|FG000|Overall Study|Withdrawal by Subject|13|||
127977960|NCT04017832|460540455|FG001|Overall Study|Withdrawal by Subject|12|||
127977961|NCT04017832|460540456|FG002|Overall Study|Withdrawal by Subject|21|||
127977962|NCT04017832|460540457|FG003|Overall Study|Withdrawal by Subject|7|||
127977963|NCT04017832|460540454|FG000|Overall Study|Lost to Follow-up|0|||
127977964|NCT04017832|460540455|FG001|Overall Study|Lost to Follow-up|3|||
127977965|NCT04017832|460540456|FG002|Overall Study|Lost to Follow-up|3|||
127977966|NCT04017832|460540457|FG003|Overall Study|Lost to Follow-up|1|||
127977967|NCT04017832|460540454|FG000|Overall Study|Physician Decision|1|||
127977968|NCT04017832|460540455|FG001|Overall Study|Physician Decision|1|||
127977969|NCT04017832|460540456|FG002|Overall Study|Physician Decision|1|||
127977970|NCT04017832|460540457|FG003|Overall Study|Physician Decision|1|||
127977971|NCT04017832|460540454|FG000|Overall Study|Death|2|||
127977972|NCT04017832|460540455|FG001|Overall Study|Death|2|||
127977973|NCT04017832|460540456|FG002|Overall Study|Death|1|||
127977974|NCT04017832|460540457|FG003|Overall Study|Death|0|||
127977975|NCT02100670|460540462|FG000|Overall Study|Adverse Event|10|||
127977976|NCT02100670|460540463|FG001|Overall Study|Adverse Event|3|||
127977977|NCT02100670|460540464|FG002|Overall Study|Adverse Event|3|||
127977978|NCT02100670|460540465|FG003|Overall Study|Adverse Event|0|||
127977979|NCT02100670|460540462|FG000|Overall Study|Lost to Follow-up|1|||
127500293|NCT05659719|458792180|FG003|Overall Study|Lost to Follow-up|2|||
127500294|NCT05659719|458792177|FG000|Overall Study|Moved to another observational study|0|||
127500295|NCT05659719|458792178|FG001|Overall Study|Moved to another observational study|0|||
127500296|NCT05659719|458792179|FG002|Overall Study|Moved to another observational study|0|||
127500297|NCT05659719|458792180|FG003|Overall Study|Moved to another observational study|1|||
127500298|NCT05659719|458792177|FG000|Overall Study|The child was enrolled in an interventional study|0|||
127500299|NCT05659719|458792178|FG001|Overall Study|The child was enrolled in an interventional study|0|||
127500300|NCT05659719|458792179|FG002|Overall Study|The child was enrolled in an interventional study|0|||
127500301|NCT05659719|458792180|FG003|Overall Study|The child was enrolled in an interventional study|55|||
127500302|NCT05659719|458792177|FG000|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
127500303|NCT05659719|458792178|FG001|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
127500304|NCT05659719|458792179|FG002|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
127500305|NCT05659719|458792180|FG003|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|1|||
127500306|NCT05659719|458792177|FG000|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
127500307|NCT05659719|458792178|FG001|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
127500308|NCT05659719|458792179|FG002|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
127500309|NCT05659719|458792180|FG003|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|2|||
127500310|NCT01681186|458792181|FG000|Washout Period From Second Intervention|Adverse Event|0|||
127500311|NCT01681186|458792182|FG001|Washout Period From Second Intervention|Adverse Event|0|||
127500312|NCT01681186|458792183|FG002|Washout Period From Second Intervention|Adverse Event|0|||
127500313|NCT01681186|458792184|FG003|Washout Period From Second Intervention|Adverse Event|0|||
127500314|NCT01681186|458792185|FG004|Washout Period From Second Intervention|Adverse Event|0|||
127500315|NCT01681186|458792186|FG005|Washout Period From Second Intervention|Adverse Event|0|||
127500316|NCT01681186|458792187|FG006|Washout Period From Second Intervention|Adverse Event|1|||
127500317|NCT01681186|458792188|FG007|Washout Period From Second Intervention|Adverse Event|0|||
127977980|NCT02100670|460540463|FG001|Overall Study|Lost to Follow-up|0|||
127977981|NCT02100670|460540464|FG002|Overall Study|Lost to Follow-up|0|||
127977982|NCT02100670|460540465|FG003|Overall Study|Lost to Follow-up|0|||
127977983|NCT02100670|460540462|FG000|Overall Study|Protocol Violation|0|||
127977984|NCT02100670|460540463|FG001|Overall Study|Protocol Violation|1|||
127977985|NCT02100670|460540464|FG002|Overall Study|Protocol Violation|0|||
127977986|NCT02100670|460540465|FG003|Overall Study|Protocol Violation|1|||
127977987|NCT02100670|460540462|FG000|Overall Study|Withdrawal of Consent|0|||
127977988|NCT02100670|460540463|FG001|Overall Study|Withdrawal of Consent|1|||
127500318|NCT01681186|458792181|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
127500319|NCT01681186|458792182|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
127500320|NCT01681186|458792183|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
127500321|NCT01681186|458792184|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
127500322|NCT01681186|458792185|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
127500323|NCT01681186|458792186|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
127500324|NCT01681186|458792187|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
127500325|NCT01681186|458792188|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
127500326|NCT01681186|458792181|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
127500327|NCT01681186|458792182|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
127500328|NCT01681186|458792183|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
127500329|NCT01681186|458792184|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
127500330|NCT01681186|458792185|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
127500331|NCT01681186|458792186|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
127500332|NCT01681186|458792187|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
127500333|NCT01681186|458792188|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
127500334|NCT01681186|458792181|FG000|Fourth Intervention|Protocol Violation|0|||
127500335|NCT01681186|458792182|FG001|Fourth Intervention|Protocol Violation|0|||
127500336|NCT01681186|458792183|FG002|Fourth Intervention|Protocol Violation|0|||
127500337|NCT01681186|458792184|FG003|Fourth Intervention|Protocol Violation|0|||
127500338|NCT01681186|458792185|FG004|Fourth Intervention|Protocol Violation|0|||
127500339|NCT01681186|458792186|FG005|Fourth Intervention|Protocol Violation|0|||
127500340|NCT01681186|458792187|FG006|Fourth Intervention|Protocol Violation|0|||
127500341|NCT01681186|458792188|FG007|Fourth Intervention|Protocol Violation|1|||
127500342|NCT05160415|458792189|FG000|Overall Study|Withdrawal by Subject|3|||
127500343|NCT04848220|458792190|FG000|Overall Study|Unable to proceed to study procedure|0|||
127500344|NCT04848220|458792191|FG001|Overall Study|Unable to proceed to study procedure|1|||
127500345|NCT04848220|458792192|FG002|Overall Study|Unable to proceed to study procedure|0|||
127500346|NCT04848220|458792190|FG000|Overall Study|Fractional flow not significant|0|||
127500347|NCT04848220|458792191|FG001|Overall Study|Fractional flow not significant|1|||
127500348|NCT04848220|458792192|FG002|Overall Study|Fractional flow not significant|0|||
127500349|NCT02923830|458792193|FG000|Overall Study|Physician Decision|13|||
127500350|NCT02923830|458792194|FG001|Overall Study|Physician Decision|15|||
127500351|NCT00510718|458792195|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
127500352|NCT00510718|458792196|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
127500353|NCT00510718|458792195|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
127500354|NCT00510718|458792196|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
127500355|NCT00510718|458792195|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
127500356|NCT00510718|458792196|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
127500357|NCT00510718|458792195|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
127500358|NCT00510718|458792196|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
127500359|NCT00510718|458792195|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
127500360|NCT00510718|458792196|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
127500361|NCT00510718|458792195|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
127500362|NCT00510718|458792196|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
127500363|NCT05791565|458792197|FG000|Washout Period (Minimum 72 Hours)|Adverse Event|1|||
127500364|NCT05791565|458792198|FG001|Washout Period (Minimum 72 Hours)|Adverse Event|0|||
127500365|NCT02388165|458792199|FG000|Overall Study|Study terminated by sponsor|5|||
127500366|NCT02388165|458792200|FG001|Overall Study|Study terminated by sponsor|5|||
127500367|NCT02388165|458792199|FG000|Overall Study|Other|11|||
127500368|NCT02388165|458792200|FG001|Overall Study|Other|13|||
127500369|NCT02388165|458792199|FG000|Overall Study|No longer meet eligibility criteria|40|||
127500370|NCT02388165|458792200|FG001|Overall Study|No longer meet eligibility criteria|43|||
127500371|NCT02388165|458792199|FG000|Overall Study|Withdrawal of consent|31|||
127500372|NCT02388165|458792200|FG001|Overall Study|Withdrawal of consent|32|||
127500373|NCT02388165|458792199|FG000|Overall Study|Lost to Follow-up|19|||
127500374|NCT02388165|458792200|FG001|Overall Study|Lost to Follow-up|20|||
127500375|NCT02388165|458792199|FG000|Overall Study|Death|13|||
127500376|NCT02388165|458792200|FG001|Overall Study|Death|10|||
127500377|NCT02388165|458792199|FG000|Overall Study|Adverse Event|3|||
127500378|NCT02388165|458792200|FG001|Overall Study|Adverse Event|5|||
127500379|NCT02388165|458792199|FG000|Overall Study|Did not meet entrance criteria|5|||
127500380|NCT02388165|458792200|FG001|Overall Study|Did not meet entrance criteria|2|||
127500381|NCT00316225|458792207|FG000|Overall Study|Adverse Event|2|||
127500382|NCT00316225|458792207|FG000|Overall Study|Physician Decision|3|||
127500383|NCT00316225|458792207|FG000|Overall Study|Progressive Disease|15|||
127977989|NCT02100670|460540464|FG002|Overall Study|Withdrawal of Consent|1|||
127500384|NCT00316225|458792207|FG000|Overall Study|Withdrawal by Subject|3|||
127977990|NCT02100670|460540465|FG003|Overall Study|Withdrawal of Consent|0|||
127977991|NCT02100670|460540462|FG000|Overall Study|No swelling no pain|1|||
127977992|NCT02100670|460540463|FG001|Overall Study|No swelling no pain|0|||
127500385|NCT00316225|458792207|FG000|Overall Study|Death|2|||
127500386|NCT01811485|458792208|FG000|Overall Study|Adverse Event|1|||
127500387|NCT01811485|458792209|FG001|Overall Study|Adverse Event|3|||
127500388|NCT01811485|458792210|FG002|Overall Study|Adverse Event|2|||
127500389|NCT01811485|458792208|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
127500390|NCT01811485|458792209|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
127500391|NCT01811485|458792210|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
127500392|NCT01811485|458792208|FG000|Overall Study|Administrative problems|1|||
127500393|NCT01811485|458792209|FG001|Overall Study|Administrative problems|0|||
127500394|NCT01811485|458792210|FG002|Overall Study|Administrative problems|0|||
127500395|NCT01811485|458792208|FG000|Overall Study|Protocol Deviation|0|||
127500396|NCT01811485|458792209|FG001|Overall Study|Protocol Deviation|1|||
127500397|NCT01811485|458792210|FG002|Overall Study|Protocol Deviation|0|||
127500398|NCT01545934|458792211|FG000|Overall Study|Withdrawal by Subject|4|||
127500399|NCT01545934|458792212|FG001|Overall Study|Withdrawal by Subject|3|||
127500400|NCT01545934|458792211|FG000|Overall Study|Lost to Follow-up|1|||
127500401|NCT01545934|458792212|FG001|Overall Study|Lost to Follow-up|0|||
127500402|NCT03654404|458792213|FG000|Overall Study|Death|1|||
127500403|NCT03654404|458792213|FG000|Overall Study|Lost to Follow-up|2|||
127500404|NCT03654404|458792213|FG000|Overall Study|Withdrawal by Subject|5|||
127500405|NCT02003638|458792216|FG000|Overall Study|Withdrawal by Subject|1|||
127500406|NCT02003638|458792217|FG001|Overall Study|Withdrawal by Subject|0|||
127500407|NCT03215758|458792218|FG000|Overall Study|Technical Problems|1|||
127500408|NCT03215758|458792219|FG001|Overall Study|Technical Problems|0|||
127500409|NCT03215758|458792218|FG000|Overall Study|Protocol deviation|0|||
127500410|NCT03215758|458792219|FG001|Overall Study|Protocol deviation|1|||
127500411|NCT03215758|458792218|FG000|Overall Study|Physician Decision|0|||
127500412|NCT03215758|458792219|FG001|Overall Study|Physician Decision|1|||
127500413|NCT03215758|458792218|FG000|Overall Study|Death|0|||
127500414|NCT03215758|458792219|FG001|Overall Study|Death|1|||
127500415|NCT03215758|458792218|FG000|Overall Study|Adverse Event|1|||
127500416|NCT03215758|458792219|FG001|Overall Study|Adverse Event|2|||
127500417|NCT03215758|458792218|FG000|Overall Study|Subject/Guardian Decision|3|||
127500418|NCT03215758|458792219|FG001|Overall Study|Subject/Guardian Decision|3|||
127500419|NCT00713349|458792225|FG000|Overall Study|Protocol Violation|1|||
127500420|NCT03764631|458792226|FG000|Overall Study|Personal Reasons|3|||
127500421|NCT03764631|458792227|FG001|Overall Study|Personal Reasons|2|||
127500422|NCT03764631|458792226|FG000|Overall Study|Switching Therapy|3|||
127500423|NCT03764631|458792227|FG001|Overall Study|Switching Therapy|3|||
127500424|NCT03764631|458792226|FG000|Overall Study|Adverse Event|0|||
127500425|NCT03764631|458792227|FG001|Overall Study|Adverse Event|1|||
127500426|NCT03764631|458792226|FG000|Overall Study|Lost to Follow-up|33|||
127500427|NCT03764631|458792227|FG001|Overall Study|Lost to Follow-up|41|||
127500428|NCT03764631|458792226|FG000|Overall Study|No data as study site was closed|2|||
127500429|NCT03764631|458792227|FG001|Overall Study|No data as study site was closed|6|||
127500430|NCT01200407|458792228|FG000|Overall Study|Lost to Follow-up|56|||
127500431|NCT01200407|458792228|FG000|Overall Study|Adverse Event|3|||
127500432|NCT01200407|458792228|FG000|Overall Study|Withdrawal by Subject|4|||
127500433|NCT01200407|458792228|FG000|Overall Study|Other|19|||
127500434|NCT03299881|458792229|FG000|Overall Study|Study Termination|17|||
127500435|NCT03299881|458792230|FG001|Overall Study|Study Termination|13|||
127500436|NCT06004895|458792233|FG000|Overall Study|Development of a stye in the upper left eyelid detected at the second visit|1|||
127500437|NCT06004895|458792233|FG000|Overall Study|Prescribed with corticosteroid eyedrops by their eye care clinician following the baseline visit|1|||
127500438|NCT00433966|458792235|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
127500439|NCT00433966|458792236|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
127500440|NCT00433966|458792237|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
127500441|NCT00433966|458792238|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
127500442|NCT00433966|458792235|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
127500443|NCT00433966|458792236|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
127500444|NCT00433966|458792237|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
127500445|NCT00433966|458792238|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
127977993|NCT02100670|460540464|FG002|Overall Study|No swelling no pain|0|||
127977994|NCT02100670|460540465|FG003|Overall Study|No swelling no pain|0|||
127500446|NCT00433966|458792235|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
127500447|NCT00433966|458792236|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
127500448|NCT00433966|458792237|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
127500449|NCT00433966|458792238|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
127500450|NCT00433966|458792235|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
127500451|NCT00433966|458792236|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
127500452|NCT00433966|458792237|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
127500453|NCT00433966|458792238|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
127500454|NCT00433966|458792235|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
127500455|NCT00433966|458792236|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
127500456|NCT00433966|458792237|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
127500457|NCT00433966|458792238|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
127500458|NCT00853242|458792240|FG000|Overall Study|Adverse Event|0|||
127500459|NCT00853242|458792241|FG001|Overall Study|Adverse Event|1|||
127500460|NCT00853242|458792242|FG002|Overall Study|Adverse Event|1|||
127500461|NCT00853242|458792243|FG003|Overall Study|Adverse Event|0|||
127500462|NCT00853242|458792244|FG004|Overall Study|Adverse Event|3|||
127500463|NCT00853242|458792245|FG005|Overall Study|Adverse Event|1|||
127500464|NCT00853242|458792246|FG006|Overall Study|Adverse Event|1|||
127500465|NCT00853242|458792240|FG000|Overall Study|Noncompliant|0|||
127500466|NCT00853242|458792241|FG001|Overall Study|Noncompliant|0|||
127500467|NCT00853242|458792242|FG002|Overall Study|Noncompliant|0|||
127500468|NCT00853242|458792243|FG003|Overall Study|Noncompliant|0|||
127500469|NCT00853242|458792244|FG004|Overall Study|Noncompliant|1|||
127500470|NCT00853242|458792245|FG005|Overall Study|Noncompliant|0|||
127500471|NCT00853242|458792246|FG006|Overall Study|Noncompliant|0|||
127500472|NCT00853242|458792240|FG000|Overall Study|Withdrawal by Subject|1|||
127500473|NCT00853242|458792241|FG001|Overall Study|Withdrawal by Subject|2|||
127500474|NCT00853242|458792242|FG002|Overall Study|Withdrawal by Subject|0|||
127500475|NCT00853242|458792243|FG003|Overall Study|Withdrawal by Subject|4|||
127500476|NCT00853242|458792244|FG004|Overall Study|Withdrawal by Subject|0|||
127500477|NCT00853242|458792245|FG005|Overall Study|Withdrawal by Subject|0|||
127500478|NCT00853242|458792246|FG006|Overall Study|Withdrawal by Subject|2|||
127500479|NCT00853242|458792240|FG000|Overall Study|Other|2|||
127500480|NCT00853242|458792241|FG001|Overall Study|Other|0|||
127500481|NCT00853242|458792242|FG002|Overall Study|Other|2|||
127500482|NCT00853242|458792243|FG003|Overall Study|Other|0|||
127500483|NCT00853242|458792244|FG004|Overall Study|Other|0|||
127500484|NCT00853242|458792245|FG005|Overall Study|Other|1|||
127500485|NCT00853242|458792246|FG006|Overall Study|Other|2|||
127500486|NCT03497975|458792247|FG000|Overall Study|Withdrew Consent|34|||
127500487|NCT03497975|458792248|FG001|Overall Study|Withdrew Consent|35|||
127500488|NCT03497975|458792247|FG000|Overall Study|Lost to Follow-up|7|||
127500489|NCT03497975|458792248|FG001|Overall Study|Lost to Follow-up|7|||
127500490|NCT03497975|458792247|FG000|Overall Study|Physician Decision|4|||
127500491|NCT03497975|458792248|FG001|Overall Study|Physician Decision|5|||
127500492|NCT03497975|458792247|FG000|Overall Study|Discontinued|42|||
127500493|NCT03497975|458792248|FG001|Overall Study|Discontinued|39|||
127500494|NCT03497975|458792247|FG000|Overall Study|Reason Not Specified|15|||
127500495|NCT03497975|458792248|FG001|Overall Study|Reason Not Specified|14|||
127500496|NCT01257230|458792249|FG000|Overall Study|Not Treated|0|||
127500497|NCT01257230|458792250|FG001|Overall Study|Not Treated|0|||
127500498|NCT01257230|458792251|FG002|Overall Study|Not Treated|1|||
127500499|NCT01257230|458792249|FG000|Overall Study|Adverse Event|2|||
127500500|NCT01257230|458792250|FG001|Overall Study|Adverse Event|0|||
127500501|NCT01257230|458792251|FG002|Overall Study|Adverse Event|0|||
127500502|NCT01257230|458792249|FG000|Overall Study|Lack of Efficacy|0|||
127500503|NCT01257230|458792250|FG001|Overall Study|Lack of Efficacy|1|||
127500504|NCT01257230|458792251|FG002|Overall Study|Lack of Efficacy|0|||
127500505|NCT01257230|458792249|FG000|Overall Study|Protocol Violation|3|||
127500506|NCT01257230|458792250|FG001|Overall Study|Protocol Violation|0|||
127500507|NCT01257230|458792251|FG002|Overall Study|Protocol Violation|1|||
127500508|NCT01257230|458792249|FG000|Overall Study|Withdrawal by Subject|0|||
127500509|NCT01257230|458792250|FG001|Overall Study|Withdrawal by Subject|4|||
127500510|NCT01257230|458792251|FG002|Overall Study|Withdrawal by Subject|1|||
127500511|NCT01257230|458792249|FG000|Overall Study|Other reason not defined above|1|||
127500512|NCT01257230|458792250|FG001|Overall Study|Other reason not defined above|5|||
127500513|NCT01257230|458792251|FG002|Overall Study|Other reason not defined above|3|||
127500514|NCT01205061|458792254|FG000|Overall Study|Adverse Event|4|||
127500515|NCT01205061|458792254|FG000|Overall Study|Withdrawal by Subject|11|||
127500516|NCT01205061|458792254|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
127500517|NCT01205061|458792254|FG000|Overall Study|Lost to Follow-up|9|||
127500518|NCT01205061|458792254|FG000|Overall Study|Other|1|||
127977995|NCT02100670|460540462|FG000|Overall Study|Poor Efficacy|0|||
127977996|NCT02100670|460540463|FG001|Overall Study|Poor Efficacy|1|||
127977997|NCT02100670|460540464|FG002|Overall Study|Poor Efficacy|0|||
127500519|NCT00765037|458792255|FG000|Overall Study|Lost to Follow-up|5|||
127500520|NCT00765037|458792255|FG000|Overall Study|Adverse Event|1|||
127500521|NCT03070171|458792260|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
127500522|NCT03070171|458792261|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
127500523|NCT03070171|458792260|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
127500524|NCT03070171|458792261|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
127500525|NCT01471028|458792265|FG000|VTI-208|Adverse Event|39|||
127500526|NCT01471028|458792266|FG001|VTI-208|Adverse Event|41|||
127500527|NCT01471028|458792265|FG000|VTI-208|Withdrawal by Subject|0|||
127500528|NCT01471028|458792266|FG001|VTI-208|Withdrawal by Subject|2|||
127500529|NCT01471028|458792265|FG000|VTI-208|Lost to Follow-up|1|||
127500530|NCT01471028|458792266|FG001|VTI-208|Lost to Follow-up|1|||
127500531|NCT01471028|458792265|FG000|VTI-208E|Death|7|||
127500532|NCT01471028|458792266|FG001|VTI-208E|Death|10|||
127500533|NCT01471028|458792265|FG000|VTI-208E|Withdrawal by Subject|1|||
127500534|NCT01471028|458792266|FG001|VTI-208E|Withdrawal by Subject|0|||
127500535|NCT01471028|458792265|FG000|VTI-208E|Lost to Follow-up|0|||
127500536|NCT01471028|458792266|FG001|VTI-208E|Lost to Follow-up|2|||
127500537|NCT00610857|458792268|FG000|Overall Study|Not evaluable for response|2|||
127500538|NCT04826094|458792269|FG000|Overall Study|Lost to Follow-up|2|||
127500539|NCT04826094|458792270|FG001|Overall Study|Lost to Follow-up|1|||
127500540|NCT04826094|458792271|FG002|Overall Study|Lost to Follow-up|0|||
127500541|NCT04826094|458792272|FG003|Overall Study|Lost to Follow-up|0|||
127500542|NCT04826094|458792273|FG004|Overall Study|Lost to Follow-up|1|||
127500543|NCT04826094|458792274|FG005|Overall Study|Lost to Follow-up|3|||
127500544|NCT04826094|458792275|FG006|Overall Study|Lost to Follow-up|1|||
127500545|NCT04826094|458792276|FG007|Overall Study|Lost to Follow-up|1|||
127500546|NCT04826094|458792269|FG000|Overall Study|Participant withdrew consent|1|||
127500547|NCT04826094|458792270|FG001|Overall Study|Participant withdrew consent|0|||
127500548|NCT04826094|458792271|FG002|Overall Study|Participant withdrew consent|0|||
127500549|NCT04826094|458792272|FG003|Overall Study|Participant withdrew consent|1|||
127500550|NCT04826094|458792273|FG004|Overall Study|Participant withdrew consent|1|||
127500551|NCT04826094|458792274|FG005|Overall Study|Participant withdrew consent|1|||
127500552|NCT04826094|458792275|FG006|Overall Study|Participant withdrew consent|0|||
127500553|NCT04826094|458792276|FG007|Overall Study|Participant withdrew consent|1|||
127500554|NCT04826094|458792269|FG000|Overall Study|Non-adherence (protocol deviation)|0|||
127500555|NCT04826094|458792270|FG001|Overall Study|Non-adherence (protocol deviation)|0|||
127500556|NCT04826094|458792271|FG002|Overall Study|Non-adherence (protocol deviation)|0|||
127500557|NCT04826094|458792272|FG003|Overall Study|Non-adherence (protocol deviation)|0|||
127500558|NCT04826094|458792273|FG004|Overall Study|Non-adherence (protocol deviation)|0|||
127500559|NCT04826094|458792274|FG005|Overall Study|Non-adherence (protocol deviation)|0|||
127500560|NCT04826094|458792275|FG006|Overall Study|Non-adherence (protocol deviation)|1|||
127500561|NCT04826094|458792276|FG007|Overall Study|Non-adherence (protocol deviation)|0|||
127500562|NCT04826094|458792269|FG000|Overall Study|Withdrawn by Investigator|0|||
127500563|NCT04826094|458792270|FG001|Overall Study|Withdrawn by Investigator|0|||
127500564|NCT04826094|458792271|FG002|Overall Study|Withdrawn by Investigator|0|||
127500565|NCT04826094|458792272|FG003|Overall Study|Withdrawn by Investigator|0|||
127500566|NCT04826094|458792273|FG004|Overall Study|Withdrawn by Investigator|0|||
127500567|NCT04826094|458792274|FG005|Overall Study|Withdrawn by Investigator|1|||
127500568|NCT04826094|458792275|FG006|Overall Study|Withdrawn by Investigator|0|||
127500569|NCT04826094|458792276|FG007|Overall Study|Withdrawn by Investigator|1|||
127500570|NCT04826094|458792269|FG000|Overall Study|Other: Moved from area|1|||
127500571|NCT04826094|458792270|FG001|Overall Study|Other: Moved from area|1|||
127500572|NCT04826094|458792271|FG002|Overall Study|Other: Moved from area|1|||
127500573|NCT04826094|458792272|FG003|Overall Study|Other: Moved from area|0|||
127500574|NCT04826094|458792273|FG004|Overall Study|Other: Moved from area|0|||
127500575|NCT04826094|458792274|FG005|Overall Study|Other: Moved from area|0|||
127500576|NCT04826094|458792275|FG006|Overall Study|Other: Moved from area|0|||
127500577|NCT04826094|458792276|FG007|Overall Study|Other: Moved from area|0|||
127500578|NCT04826094|458792269|FG000|Overall Study|Other: Declined|0|||
127500579|NCT04826094|458792270|FG001|Overall Study|Other: Declined|0|||
127500580|NCT04826094|458792271|FG002|Overall Study|Other: Declined|0|||
127500581|NCT04826094|458792272|FG003|Overall Study|Other: Declined|0|||
127500582|NCT04826094|458792273|FG004|Overall Study|Other: Declined|1|||
127500583|NCT04826094|458792274|FG005|Overall Study|Other: Declined|0|||
127500584|NCT04826094|458792275|FG006|Overall Study|Other: Declined|0|||
127500585|NCT04826094|458792276|FG007|Overall Study|Other: Declined|0|||
127500586|NCT04826094|458792269|FG000|Overall Study|Other: Vaccine not administered|0|||
127500587|NCT04826094|458792270|FG001|Overall Study|Other: Vaccine not administered|0|||
127500588|NCT04826094|458792271|FG002|Overall Study|Other: Vaccine not administered|1|||
127500589|NCT04826094|458792272|FG003|Overall Study|Other: Vaccine not administered|0|||
127500590|NCT04826094|458792273|FG004|Overall Study|Other: Vaccine not administered|0|||
127500591|NCT04826094|458792274|FG005|Overall Study|Other: Vaccine not administered|1|||
127500592|NCT04826094|458792275|FG006|Overall Study|Other: Vaccine not administered|1|||
127500593|NCT04826094|458792276|FG007|Overall Study|Other: Vaccine not administered|3|||
127500594|NCT00700882|458792277|FG000|Overall Study|Never received treatment|6|||
127500595|NCT00700882|458792277|FG000|Overall Study|Ineligible|2|||
127500596|NCT00700882|458792277|FG000|Overall Study|No KIT mutation|51|||
127500597|NCT04154293|458792281|FG000|Overall Study|Withdrawal by Subject|2|||
127500598|NCT04154293|458792282|FG001|Overall Study|Withdrawal by Subject|3|||
127500599|NCT04154293|458792283|FG002|Overall Study|Withdrawal by Subject|1|||
127500600|NCT04154293|458792281|FG000|Overall Study|Physician Decision|0|||
127500601|NCT04154293|458792282|FG001|Overall Study|Physician Decision|0|||
127500602|NCT04154293|458792283|FG002|Overall Study|Physician Decision|1|||
127500603|NCT01208961|458792284|FG000|High-Fat Period III|Protocol Violation|1|||
127500604|NCT01208961|458792285|FG001|High-Fat Period III|Protocol Violation|0|||
127500605|NCT03403361|458792286|FG000|Overall Study|Not imaged due to issues during the pandemic|16|||
127500606|NCT02152371|458792288|FG000|Overall Study|Adverse Event|6|||
127500607|NCT02152371|458792289|FG001|Overall Study|Adverse Event|2|||
127500608|NCT02152371|458792288|FG000|Overall Study|Withdrawal by Subject|3|||
127500609|NCT02152371|458792289|FG001|Overall Study|Withdrawal by Subject|7|||
127500610|NCT02152371|458792288|FG000|Overall Study|Protocol Violation|2|||
127500611|NCT02152371|458792289|FG001|Overall Study|Protocol Violation|3|||
127500612|NCT02152371|458792288|FG000|Overall Study|Lost to Follow-up|1|||
127500613|NCT02152371|458792289|FG001|Overall Study|Lost to Follow-up|0|||
127500614|NCT02152371|458792288|FG000|Overall Study|Lack of Efficacy|0|||
127500615|NCT02152371|458792289|FG001|Overall Study|Lack of Efficacy|1|||
127500616|NCT02152371|458792288|FG000|Overall Study|Physician Decision|0|||
127500617|NCT02152371|458792289|FG001|Overall Study|Physician Decision|2|||
127500618|NCT02152371|458792288|FG000|Overall Study|Reason Not Given|0|||
127500619|NCT02152371|458792289|FG001|Overall Study|Reason Not Given|1|||
127500620|NCT06359028|458792294|FG000|Overall Study|Adverse Event|1|||
127500621|NCT06359028|458792295|FG001|Overall Study|Adverse Event|0|||
127500622|NCT06359028|458792294|FG000|Overall Study|Withdrawal by Subject|1|||
127500623|NCT06359028|458792295|FG001|Overall Study|Withdrawal by Subject|0|||
127500624|NCT04382586|458792296|FG000|Overall Study|Death|3|||
127500625|NCT04382586|458792297|FG001|Overall Study|Death|4|||
127500626|NCT04382586|458792296|FG000|Overall Study|Lost to Follow-up|11|||
127500627|NCT04382586|458792297|FG001|Overall Study|Lost to Follow-up|8|||
127500628|NCT04382586|458792296|FG000|Overall Study|Withdrawal by Subject|3|||
127500629|NCT04382586|458792297|FG001|Overall Study|Withdrawal by Subject|1|||
127500630|NCT04382586|458792296|FG000|Overall Study|Physician Decision|0|||
127500631|NCT04382586|458792297|FG001|Overall Study|Physician Decision|3|||
127500632|NCT01866111|458792301|FG000|Double-blind Period of Study YKP3089C017|Adverse Event|5|||
127500633|NCT01866111|458792302|FG001|Double-blind Period of Study YKP3089C017|Adverse Event|12|||
127500634|NCT01866111|458792303|FG002|Double-blind Period of Study YKP3089C017|Adverse Event|15|||
127500635|NCT01866111|458792304|FG003|Double-blind Period of Study YKP3089C017|Adverse Event|23|||
127500636|NCT01866111|458792301|FG000|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|5|||
127500637|NCT01866111|458792302|FG001|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|0|||
127500638|NCT01866111|458792303|FG002|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|4|||
127500639|NCT01866111|458792304|FG003|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|3|||
127500640|NCT01866111|458792301|FG000|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
127500641|NCT01866111|458792302|FG001|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
127500642|NCT01866111|458792303|FG002|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
127500643|NCT01866111|458792304|FG003|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
127500644|NCT01866111|458792301|FG000|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
127500645|NCT01866111|458792302|FG001|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
127500646|NCT01866111|458792303|FG002|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
127500647|NCT01866111|458792304|FG003|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
127500648|NCT01866111|458792301|FG000|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
127500649|NCT01866111|458792302|FG001|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
127500650|NCT01866111|458792303|FG002|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
127500651|NCT01866111|458792304|FG003|Double-blind Period of Study YKP3089C017|Lost to Follow-up|1|||
127500652|NCT01866111|458792301|FG000|Double-blind Period of Study YKP3089C017|Pregnancy|1|||
127500653|NCT01866111|458792302|FG001|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
127500654|NCT01866111|458792303|FG002|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
127500655|NCT01866111|458792304|FG003|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
127500656|NCT01866111|458792301|FG000|Double-blind Period of Study YKP3089C017|Reason Unknown|3|||
127500657|NCT01866111|458792302|FG001|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
127500658|NCT01866111|458792303|FG002|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
127500659|NCT01866111|458792304|FG003|Double-blind Period of Study YKP3089C017|Reason Unknown|1|||
127500660|NCT01866111|458792301|FG000|Open-label Extension Study YKP3089C017|Adverse Event|9|||
127500661|NCT01866111|458792302|FG001|Open-label Extension Study YKP3089C017|Adverse Event|6|||
127500662|NCT01866111|458792303|FG002|Open-label Extension Study YKP3089C017|Adverse Event|6|||
127500663|NCT01866111|458792304|FG003|Open-label Extension Study YKP3089C017|Adverse Event|7|||
127500664|NCT01866111|458792301|FG000|Open-label Extension Study YKP3089C017|Withdrawal by Subject|16|||
127500665|NCT01866111|458792302|FG001|Open-label Extension Study YKP3089C017|Withdrawal by Subject|7|||
127500666|NCT01866111|458792303|FG002|Open-label Extension Study YKP3089C017|Withdrawal by Subject|9|||
127500667|NCT01866111|458792304|FG003|Open-label Extension Study YKP3089C017|Withdrawal by Subject|3|||
127500668|NCT01866111|458792301|FG000|Open-label Extension Study YKP3089C017|Protocol Violation|1|||
127500669|NCT01866111|458792302|FG001|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
127500670|NCT01866111|458792303|FG002|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
127500671|NCT01866111|458792304|FG003|Open-label Extension Study YKP3089C017|Protocol Violation|2|||
127500672|NCT01866111|458792301|FG000|Open-label Extension Study YKP3089C017|Lost to Follow-up|2|||
127500673|NCT01866111|458792302|FG001|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
127500674|NCT01866111|458792303|FG002|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
127500675|NCT01866111|458792304|FG003|Open-label Extension Study YKP3089C017|Lost to Follow-up|3|||
127977998|NCT02100670|460540465|FG003|Overall Study|Poor Efficacy|0|||
127500676|NCT01866111|458792301|FG000|Open-label Extension Study YKP3089C017|Death|1|||
127500677|NCT01866111|458792302|FG001|Open-label Extension Study YKP3089C017|Death|1|||
127500678|NCT01866111|458792303|FG002|Open-label Extension Study YKP3089C017|Death|3|||
127500679|NCT01866111|458792304|FG003|Open-label Extension Study YKP3089C017|Death|2|||
127500680|NCT01866111|458792301|FG000|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|30|||
127500681|NCT01866111|458792302|FG001|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|39|||
127500682|NCT01866111|458792303|FG002|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|28|||
127500683|NCT01866111|458792304|FG003|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|32|||
127500684|NCT01866111|458792301|FG000|Open-label Extension Study YKP3089C017|Lack of Efficacy|13|||
127500685|NCT01866111|458792302|FG001|Open-label Extension Study YKP3089C017|Lack of Efficacy|17|||
127500686|NCT01866111|458792303|FG002|Open-label Extension Study YKP3089C017|Lack of Efficacy|23|||
127500687|NCT01866111|458792304|FG003|Open-label Extension Study YKP3089C017|Lack of Efficacy|14|||
127500688|NCT01866111|458792301|FG000|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
127500689|NCT01866111|458792302|FG001|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
127500690|NCT01866111|458792303|FG002|Open-label Extension Study YKP3089C017|Reason Unknown|1|||
127500691|NCT01866111|458792304|FG003|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
127500692|NCT01802580|458792305|FG000|Overall Study|Physician Decision|1|||
127500693|NCT01802580|458792306|FG001|Overall Study|Physician Decision|0|||
127500694|NCT01802580|458792305|FG000|Overall Study|Protocol Violation|2|||
127500695|NCT01802580|458792306|FG001|Overall Study|Protocol Violation|0|||
127500696|NCT01802580|458792305|FG000|Overall Study|Withdrawal by Subject|5|||
127500697|NCT01802580|458792306|FG001|Overall Study|Withdrawal by Subject|6|||
127500698|NCT01802580|458792305|FG000|Overall Study|Other|1|||
127500699|NCT01802580|458792306|FG001|Overall Study|Other|3|||
127500700|NCT01802580|458792305|FG000|Overall Study|Lack of Efficacy|0|||
127500701|NCT01802580|458792306|FG001|Overall Study|Lack of Efficacy|2|||
127500702|NCT01221623|458792308|FG000|Overall Study|Withdrawal by Subject|19|||
127500703|NCT01221623|458792309|FG001|Overall Study|Withdrawal by Subject|8|||
127500704|NCT01221623|458792308|FG000|Overall Study|Lost to Follow-up|7|||
127500705|NCT01221623|458792309|FG001|Overall Study|Lost to Follow-up|1|||
127500706|NCT01221623|458792308|FG000|Overall Study|Adverse Event|6|||
127500707|NCT01221623|458792309|FG001|Overall Study|Adverse Event|3|||
127500708|NCT01221623|458792308|FG000|Overall Study|Death|1|||
127500709|NCT01221623|458792309|FG001|Overall Study|Death|0|||
127500710|NCT01221623|458792308|FG000|Overall Study|Other|5|||
127500711|NCT01221623|458792309|FG001|Overall Study|Other|2|||
127500712|NCT03479541|458792310|FG000|Early and Late Physical Therapy|Lost to Follow-up|2|||
127500713|NCT03479541|458792311|FG001|Early and Late Physical Therapy|Lost to Follow-up|18|||
127500714|NCT03479541|458792312|FG002|Early and Late Physical Therapy|Lost to Follow-up|0|||
127500715|NCT03479541|458792313|FG003|Early and Late Physical Therapy|Lost to Follow-up|0|||
127500716|NCT03479541|458792310|FG000|Early and Late Physical Therapy|Withdrawal by Subject|15|||
127500717|NCT03479541|458792311|FG001|Early and Late Physical Therapy|Withdrawal by Subject|32|||
127500718|NCT03479541|458792312|FG002|Early and Late Physical Therapy|Withdrawal by Subject|0|||
127500719|NCT03479541|458792313|FG003|Early and Late Physical Therapy|Withdrawal by Subject|0|||
127500720|NCT03479541|458792310|FG000|Early and Late Physical Therapy|Early Termination - PI Decision|2|||
127500721|NCT03479541|458792311|FG001|Early and Late Physical Therapy|Early Termination - PI Decision|8|||
127500722|NCT03479541|458792312|FG002|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
127500723|NCT03479541|458792313|FG003|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
127500724|NCT03479541|458792310|FG000|Home Monitoring|Lost to Follow-up|0|||
127500725|NCT03479541|458792311|FG001|Home Monitoring|Lost to Follow-up|0|||
127500726|NCT03479541|458792312|FG002|Home Monitoring|Lost to Follow-up|8|||
127500727|NCT03479541|458792313|FG003|Home Monitoring|Lost to Follow-up|12|||
127500728|NCT03479541|458792310|FG000|Home Monitoring|Withdrawal by Subject|0|||
127500729|NCT03479541|458792311|FG001|Home Monitoring|Withdrawal by Subject|0|||
127500730|NCT03479541|458792312|FG002|Home Monitoring|Withdrawal by Subject|17|||
127500731|NCT03479541|458792313|FG003|Home Monitoring|Withdrawal by Subject|30|||
127500732|NCT03479541|458792310|FG000|Home Monitoring|Early Termination - PI Decision|0|||
127500733|NCT03479541|458792311|FG001|Home Monitoring|Early Termination - PI Decision|0|||
127500734|NCT03479541|458792312|FG002|Home Monitoring|Early Termination - PI Decision|4|||
127500735|NCT03479541|458792313|FG003|Home Monitoring|Early Termination - PI Decision|6|||
127977999|NCT02100670|460540462|FG000|Overall Study|Physician Decision|0|||
127500736|NCT00661726|458792314|FG000|Overall Study|Adverse Event|1|||
127978000|NCT02100670|460540463|FG001|Overall Study|Physician Decision|1|||
127500737|NCT00107900|458792317|FG000|Overall Study|Adverse Event|3|||
127500738|NCT00107900|458792318|FG001|Overall Study|Adverse Event|2|||
127500739|NCT00107900|458792319|FG002|Overall Study|Adverse Event|10|||
127500740|NCT00107900|458792320|FG003|Overall Study|Adverse Event|3|||
127500741|NCT00107900|458792321|FG004|Overall Study|Adverse Event|5|||
127500742|NCT00107900|458792322|FG005|Overall Study|Adverse Event|3|||
127500743|NCT00107900|458792317|FG000|Overall Study|Death|0|||
127500744|NCT00107900|458792318|FG001|Overall Study|Death|0|||
127500745|NCT00107900|458792319|FG002|Overall Study|Death|0|||
127500746|NCT00107900|458792320|FG003|Overall Study|Death|0|||
127500747|NCT00107900|458792321|FG004|Overall Study|Death|1|||
127500748|NCT00107900|458792322|FG005|Overall Study|Death|0|||
127500749|NCT00107900|458792317|FG000|Overall Study|Lost to Follow-up|4|||
127500750|NCT00107900|458792318|FG001|Overall Study|Lost to Follow-up|1|||
127500751|NCT00107900|458792319|FG002|Overall Study|Lost to Follow-up|3|||
127500752|NCT00107900|458792320|FG003|Overall Study|Lost to Follow-up|2|||
127500753|NCT00107900|458792321|FG004|Overall Study|Lost to Follow-up|5|||
127500754|NCT00107900|458792322|FG005|Overall Study|Lost to Follow-up|5|||
127500755|NCT00107900|458792317|FG000|Overall Study|Protocol Violation|1|||
127500756|NCT00107900|458792318|FG001|Overall Study|Protocol Violation|0|||
127500757|NCT00107900|458792319|FG002|Overall Study|Protocol Violation|5|||
127500758|NCT00107900|458792320|FG003|Overall Study|Protocol Violation|5|||
127500759|NCT00107900|458792321|FG004|Overall Study|Protocol Violation|7|||
127500760|NCT00107900|458792322|FG005|Overall Study|Protocol Violation|0|||
127500761|NCT00107900|458792317|FG000|Overall Study|Withdrawal by Subject|1|||
127500762|NCT00107900|458792318|FG001|Overall Study|Withdrawal by Subject|0|||
127500763|NCT00107900|458792319|FG002|Overall Study|Withdrawal by Subject|5|||
127500764|NCT00107900|458792320|FG003|Overall Study|Withdrawal by Subject|0|||
127500765|NCT00107900|458792321|FG004|Overall Study|Withdrawal by Subject|1|||
127500766|NCT00107900|458792322|FG005|Overall Study|Withdrawal by Subject|1|||
127500767|NCT00107900|458792317|FG000|Overall Study|Administrative Reasons|1|||
127500768|NCT00107900|458792318|FG001|Overall Study|Administrative Reasons|0|||
127500769|NCT00107900|458792319|FG002|Overall Study|Administrative Reasons|2|||
127500770|NCT00107900|458792320|FG003|Overall Study|Administrative Reasons|2|||
127500771|NCT00107900|458792321|FG004|Overall Study|Administrative Reasons|2|||
127500772|NCT00107900|458792322|FG005|Overall Study|Administrative Reasons|0|||
127500773|NCT02461290|458792323|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
127500774|NCT02461290|458792323|FG000|Overall Study|Lost to Follow-up|3|||
127500775|NCT00526656|458792324|FG000|Overall Study|Death|1|||
127500776|NCT00526656|458792324|FG000|Overall Study|Refused surgery|1|||
127500777|NCT02109432|458794019|FG000|Overall Study|Withdrawal by Subject|1|||
127500778|NCT05897242|458794020|FG000|Overall Study|Lost to Follow-up|6|||
127500779|NCT05897242|458794021|FG001|Overall Study|Lost to Follow-up|1|||
127500780|NCT05897242|458794020|FG000|Overall Study|Incomplete|1|||
127500781|NCT05897242|458794021|FG001|Overall Study|Incomplete|0|||
127500782|NCT05897242|458794020|FG000|Overall Study|Withdrawal by Subject|1|||
127500783|NCT05897242|458794021|FG001|Overall Study|Withdrawal by Subject|0|||
127500784|NCT02920528|458794022|FG000|Overall Study|Incomplete Data|1|||
127500785|NCT02920528|458794023|FG001|Overall Study|Incomplete Data|1|||
127500786|NCT02920528|458794024|FG002|Overall Study|Incomplete Data|1|||
127500787|NCT02920528|458794022|FG000|Overall Study|Adverse Event|0|||
127500788|NCT02920528|458794023|FG001|Overall Study|Adverse Event|0|||
127500789|NCT02920528|458794024|FG002|Overall Study|Adverse Event|3|||
127500790|NCT02920528|458794022|FG000|Overall Study|Did not meet inclusion criteria|2|||
127500791|NCT02920528|458794023|FG001|Overall Study|Did not meet inclusion criteria|0|||
127500792|NCT02920528|458794024|FG002|Overall Study|Did not meet inclusion criteria|1|||
127500793|NCT00066703|458794025|FG000|Overall Study|Adverse Event|80|||
127500794|NCT00066703|458794026|FG001|Overall Study|Adverse Event|111|||
127500795|NCT00066703|458794025|FG000|Overall Study|Death|3|||
127500796|NCT00066703|458794026|FG001|Overall Study|Death|0|||
127500797|NCT00066703|458794025|FG000|Overall Study|Lack of Efficacy|114|||
127500798|NCT00066703|458794026|FG001|Overall Study|Lack of Efficacy|69|||
127500799|NCT00066703|458794025|FG000|Overall Study|Lost to Follow-up|31|||
127500800|NCT00066703|458794026|FG001|Overall Study|Lost to Follow-up|28|||
127500801|NCT00066703|458794025|FG000|Overall Study|Withdrawal by Subject|38|||
127500802|NCT00066703|458794026|FG001|Overall Study|Withdrawal by Subject|63|||
127500803|NCT00066703|458794025|FG000|Overall Study|Treatment ongoing|346|||
127500804|NCT00066703|458794026|FG001|Overall Study|Treatment ongoing|311|||
127500805|NCT01696968|458794027|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
127500806|NCT01696968|458794028|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
127500807|NCT01696968|458794027|FG000|Overall Study|Died Before Randomization|3|||
127500808|NCT01696968|458794028|FG001|Overall Study|Died Before Randomization|8|||
127500809|NCT01696968|458794027|FG000|Overall Study|Died Before ASU (Control)|278|||
127500810|NCT01696968|458794028|FG001|Overall Study|Died Before ASU (Control)|0|||
127500811|NCT01696968|458794027|FG000|Overall Study|Refused ASU (Control)|920|||
127500812|NCT01696968|458794028|FG001|Overall Study|Refused ASU (Control)|0|||
127500813|NCT01696968|458794027|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
127500814|NCT01696968|458794028|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
127500815|NCT00880269|458794052|FG000|Overall Study|Protocol Violation|1|||
127500816|NCT00880269|458794053|FG001|Overall Study|Protocol Violation|0|||
127500817|NCT00880269|458794052|FG000|Overall Study|Disease Progression|13|||
127500818|NCT00880269|458794053|FG001|Overall Study|Disease Progression|11|||
127500819|NCT00880269|458794052|FG000|Overall Study|New Cancer Therapy|1|||
127500820|NCT00880269|458794053|FG001|Overall Study|New Cancer Therapy|0|||
127500821|NCT00880269|458794052|FG000|Overall Study|Death|4|||
127500822|NCT00880269|458794053|FG001|Overall Study|Death|2|||
127500823|NCT00880269|458794052|FG000|Overall Study|Lost to Follow-up|0|||
127500824|NCT00880269|458794053|FG001|Overall Study|Lost to Follow-up|1|||
127500825|NCT00880269|458794052|FG000|Overall Study|Withdrawal by Subject|3|||
127500826|NCT00880269|458794053|FG001|Overall Study|Withdrawal by Subject|4|||
127500827|NCT00880269|458794052|FG000|Overall Study|Adverse Event|10|||
127500828|NCT00880269|458794053|FG001|Overall Study|Adverse Event|9|||
127500829|NCT04115748|458794054|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
127500830|NCT04115748|458794055|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
127500831|NCT04115748|458794056|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
127500832|NCT04115748|458794057|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
127500833|NCT04115748|458794058|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
127500834|NCT04115748|458794059|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
127500835|NCT04115748|458794060|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
127500836|NCT04115748|458794061|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
127500837|NCT04115748|458794062|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
127500838|NCT04115748|458794063|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
127500839|NCT04115748|458794054|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
127500840|NCT04115748|458794055|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
127500841|NCT04115748|458794056|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
127500842|NCT04115748|458794057|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
127500843|NCT04115748|458794058|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
127500844|NCT04115748|458794059|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
127500845|NCT04115748|458794060|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
127500846|NCT04115748|458794061|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
127500847|NCT04115748|458794062|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
127500848|NCT04115748|458794063|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
127500849|NCT04115748|458794054|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
127500850|NCT04115748|458794055|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
127500851|NCT04115748|458794056|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
127500852|NCT04115748|458794057|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
127500853|NCT04115748|458794058|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
127500854|NCT04115748|458794059|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
127500855|NCT04115748|458794060|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
127500856|NCT04115748|458794061|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
127500857|NCT04115748|458794062|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
127500858|NCT04115748|458794063|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
127500859|NCT04115748|458794054|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
127500860|NCT04115748|458794055|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
127500861|NCT04115748|458794056|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
127500862|NCT04115748|458794057|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
127500863|NCT04115748|458794058|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
127500864|NCT04115748|458794059|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
127500865|NCT04115748|458794060|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
127500866|NCT04115748|458794061|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
127500867|NCT04115748|458794062|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
127500868|NCT04115748|458794063|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
127500869|NCT01549886|458794064|FG000|Overall Study|Sponsor's decision|2|||
127500870|NCT01549886|458794065|FG001|Overall Study|Sponsor's decision|3|||
127500871|NCT00967694|458794066|FG000|Overall Study|Withdrawal by Subject|6|||
127500872|NCT02570152|458794067|FG000|Overall Study|Protocol Violation|2|||
127500873|NCT02570152|458794067|FG000|Overall Study|Migrated/moved from study area|13|||
127500874|NCT02957747|458794068|FG000|Overall Study|Withdrawal by Subject|0|||
127500875|NCT02957747|458794069|FG001|Overall Study|Withdrawal by Subject|3|||
127500876|NCT02957747|458794068|FG000|Overall Study|Lost to Follow-up|10|||
127500877|NCT02957747|458794069|FG001|Overall Study|Lost to Follow-up|5|||
127500878|NCT00923975|458794070|FG000|Overall Study|Did not meet inclusion criteria|1|||
127500879|NCT00632827|458794071|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
127500880|NCT00632827|458794071|FG000|Overall Study|Death|2|||
127500881|NCT00632827|458794071|FG000|Overall Study|Adverse Event|5|||
127500882|NCT00632827|458794071|FG000|Overall Study|Lost to Follow-up|1|||
127500883|NCT01177553|458794072|FG000|Overall Study|babies not yet 6 months of age|1|||
127500884|NCT01177553|458794073|FG001|Overall Study|babies not yet 6 months of age|0|||
127500885|NCT01626118|458794076|FG000|Overall Study|Lack of Efficacy|1|||
127500886|NCT01626118|458794077|FG001|Overall Study|Lack of Efficacy|0|||
127500887|NCT01626118|458794078|FG002|Overall Study|Lack of Efficacy|1|||
127500888|NCT01626118|458794079|FG003|Overall Study|Lack of Efficacy|3|||
127978001|NCT02100670|460540464|FG002|Overall Study|Physician Decision|0|||
127978002|NCT02100670|460540465|FG003|Overall Study|Physician Decision|0|||
127978003|NCT02100670|460540462|FG000|Overall Study|Withdrawal by Subject|1|||
127500889|NCT01626118|458794076|FG000|Overall Study|Lost to Follow-up|1|||
127500890|NCT01626118|458794077|FG001|Overall Study|Lost to Follow-up|0|||
127500891|NCT01626118|458794078|FG002|Overall Study|Lost to Follow-up|0|||
127978004|NCT02100670|460540463|FG001|Overall Study|Withdrawal by Subject|0|||
127978005|NCT02100670|460540464|FG002|Overall Study|Withdrawal by Subject|0|||
127500892|NCT01626118|458794079|FG003|Overall Study|Lost to Follow-up|0|||
127500893|NCT01626118|458794076|FG000|Overall Study|Adverse Event|0|||
127500894|NCT01626118|458794077|FG001|Overall Study|Adverse Event|1|||
127500895|NCT01626118|458794078|FG002|Overall Study|Adverse Event|1|||
127500896|NCT01626118|458794079|FG003|Overall Study|Adverse Event|0|||
127500897|NCT01626118|458794076|FG000|Overall Study|Investigator Decision|0|||
127500898|NCT01626118|458794077|FG001|Overall Study|Investigator Decision|1|||
127500899|NCT01626118|458794078|FG002|Overall Study|Investigator Decision|0|||
127500900|NCT01626118|458794079|FG003|Overall Study|Investigator Decision|0|||
127500901|NCT03931382|458794080|FG000|Overall Study|Equipment malfunction|2|||
127500902|NCT03931382|458794081|FG001|Overall Study|Equipment malfunction|0|||
127500903|NCT03931382|458794082|FG002|Overall Study|Equipment malfunction|2|||
127500904|NCT03931382|458794080|FG000|Overall Study|Withdrawal by Subject|0|||
127500905|NCT03931382|458794081|FG001|Overall Study|Withdrawal by Subject|1|||
127500906|NCT03931382|458794082|FG002|Overall Study|Withdrawal by Subject|0|||
127500907|NCT00778375|458794088|FG000|Overall Study|Ineligible|3|||
127500908|NCT04590404|458794091|FG000|Overall Study|Death|16|||
127500909|NCT04590404|458794092|FG001|Overall Study|Death|17|||
127500910|NCT04590404|458794091|FG000|Overall Study|Withdrawal by Subject|7|||
127500911|NCT04590404|458794092|FG001|Overall Study|Withdrawal by Subject|2|||
127500912|NCT04154605|458794094|FG000|Overall Study|Procedure Canceled|1|||
127500913|NCT04154605|458794095|FG001|Overall Study|Procedure Canceled|1|||
127500914|NCT04154605|458794094|FG000|Overall Study|Missed follow up|1|||
127500915|NCT04154605|458794095|FG001|Overall Study|Missed follow up|1|||
127500916|NCT04154605|458794094|FG000|Overall Study|Withdrawal by Subject|1|||
127500917|NCT04154605|458794095|FG001|Overall Study|Withdrawal by Subject|0|||
127500918|NCT01581021|458794096|FG000|Overall Study|Lost to Follow-up|4|||
127500919|NCT01581021|458794097|FG001|Overall Study|Lost to Follow-up|6|||
127500920|NCT01581021|458794096|FG000|Overall Study|More than 2 hooks in thoracic|3|||
127500921|NCT01581021|458794097|FG001|Overall Study|More than 2 hooks in thoracic|0|||
127500922|NCT01581021|458794096|FG000|Overall Study|Neuromuscular|2|||
127500923|NCT01581021|458794097|FG001|Overall Study|Neuromuscular|1|||
127500924|NCT01581021|458794096|FG000|Overall Study|Not Randomized|1|||
127500925|NCT01581021|458794097|FG001|Overall Study|Not Randomized|2|||
127500926|NCT01581021|458794096|FG000|Overall Study|Lenke 6 Classification|0|||
127500927|NCT01581021|458794097|FG001|Overall Study|Lenke 6 Classification|1|||
127500928|NCT01581021|458794096|FG000|Overall Study|Lack of Efficacy|0|||
127500929|NCT01581021|458794097|FG001|Overall Study|Lack of Efficacy|1|||
127500930|NCT00675441|458794098|FG000|Overall Study|Withdrawal by Subject|2|||
127500931|NCT00675441|458794098|FG000|Overall Study|Death|1|||
127500932|NCT00054327|458794101|FG000|Overall Study|Engraftment failure|1|||
127500933|NCT00054327|458794102|FG001|Overall Study|Engraftment failure|0|||
127500934|NCT00054327|458794103|FG002|Overall Study|Engraftment failure|0|||
127500935|NCT00054327|458794104|FG003|Overall Study|Engraftment failure|0|||
127500936|NCT00054327|458794105|FG004|Overall Study|Engraftment failure|0|||
127500937|NCT00054327|458794106|FG005|Overall Study|Engraftment failure|0|||
127500938|NCT00344318|458794110|FG000|Overall Study|Adverse Event|0|||
127500939|NCT00344318|458794111|FG001|Overall Study|Adverse Event|3|||
127500940|NCT00344318|458794112|FG002|Overall Study|Adverse Event|0|||
127500941|NCT00344318|458794113|FG003|Overall Study|Adverse Event|1|||
127500942|NCT00344318|458794110|FG000|Overall Study|Withdrawal by Subject|2|||
127500943|NCT00344318|458794111|FG001|Overall Study|Withdrawal by Subject|2|||
127500944|NCT00344318|458794112|FG002|Overall Study|Withdrawal by Subject|0|||
127500945|NCT00344318|458794113|FG003|Overall Study|Withdrawal by Subject|2|||
127500946|NCT00344318|458794110|FG000|Overall Study|Lost to Follow-up|2|||
127500947|NCT00344318|458794111|FG001|Overall Study|Lost to Follow-up|0|||
127500948|NCT00344318|458794112|FG002|Overall Study|Lost to Follow-up|1|||
127500949|NCT00344318|458794113|FG003|Overall Study|Lost to Follow-up|0|||
127500950|NCT01923363|458794116|FG000|Overall Study|Protocol Violation|1|||
127500951|NCT00656058|458794121|FG000|Overall Study|Withdrawal by Subject|2|||
127500952|NCT00656058|458794121|FG000|Overall Study|Withdrawal by Subject|4|||
127978006|NCT02100670|460540465|FG003|Overall Study|Withdrawal by Subject|0|||
127978007|NCT03634033|460542383|FG000|Overall Study|Did not have a post-assessment|384|||
127978008|NCT03634033|460542384|FG001|Overall Study|Did not have a post-assessment|291|||
127500953|NCT03515551|458794122|FG000|Overall Study|Death|4|||
127500954|NCT03515551|458794123|FG001|Overall Study|Death|1|||
127500955|NCT03515551|458794124|FG002|Overall Study|Death|2|||
127500956|NCT03515551|458794125|FG003|Overall Study|Death|2|||
127500957|NCT03515551|458794126|FG004|Overall Study|Death|2|||
127500958|NCT03515551|458794127|FG005|Overall Study|Death|4|||
127500959|NCT03515551|458794128|FG006|Overall Study|Death|1|||
127500960|NCT03515551|458794122|FG000|Overall Study|Lost to Follow-up|0|||
127500961|NCT03515551|458794123|FG001|Overall Study|Lost to Follow-up|0|||
127500962|NCT03515551|458794124|FG002|Overall Study|Lost to Follow-up|1|||
127500963|NCT03515551|458794125|FG003|Overall Study|Lost to Follow-up|0|||
127500964|NCT03515551|458794126|FG004|Overall Study|Lost to Follow-up|0|||
127500965|NCT03515551|458794127|FG005|Overall Study|Lost to Follow-up|0|||
127500966|NCT03515551|458794128|FG006|Overall Study|Lost to Follow-up|0|||
127500967|NCT03515551|458794122|FG000|Overall Study|Withdrawal by Subject|0|||
127500968|NCT03515551|458794123|FG001|Overall Study|Withdrawal by Subject|1|||
127500969|NCT03515551|458794124|FG002|Overall Study|Withdrawal by Subject|0|||
127500970|NCT03515551|458794125|FG003|Overall Study|Withdrawal by Subject|0|||
127500971|NCT03515551|458794126|FG004|Overall Study|Withdrawal by Subject|0|||
127500972|NCT03515551|458794127|FG005|Overall Study|Withdrawal by Subject|0|||
127500973|NCT03515551|458794128|FG006|Overall Study|Withdrawal by Subject|1|||
127500974|NCT03515551|458794122|FG000|Overall Study|Study ended by sponsor|0|||
127500975|NCT03515551|458794123|FG001|Overall Study|Study ended by sponsor|0|||
127500976|NCT03515551|458794124|FG002|Overall Study|Study ended by sponsor|2|||
127500977|NCT03515551|458794125|FG003|Overall Study|Study ended by sponsor|1|||
127500978|NCT03515551|458794126|FG004|Overall Study|Study ended by sponsor|3|||
127500979|NCT03515551|458794127|FG005|Overall Study|Study ended by sponsor|0|||
127500980|NCT03515551|458794128|FG006|Overall Study|Study ended by sponsor|3|||
127500981|NCT03515551|458794122|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
127500982|NCT03515551|458794123|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
127500983|NCT03515551|458794124|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
127500984|NCT03515551|458794125|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
127500985|NCT03515551|458794126|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
127500986|NCT03515551|458794127|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
127500987|NCT03515551|458794128|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
127500988|NCT00920387|458794129|FG000|Stage 1|Adverse Event|1|||
127500989|NCT00920387|458794130|FG001|Stage 1|Adverse Event|0|||
127500990|NCT00920387|458794131|FG002|Stage 1|Adverse Event|0|||
127500991|NCT02265536|458794132|FG000|Overall Study|Adverse Event|1|||
127500992|NCT02265536|458794133|FG001|Overall Study|Adverse Event|0|||
127500993|NCT02265536|458794134|FG002|Overall Study|Adverse Event|0|||
127500994|NCT02265536|458794135|FG003|Overall Study|Adverse Event|0|||
127500995|NCT02265536|458794136|FG004|Overall Study|Adverse Event|1|||
127500996|NCT02265536|458794137|FG005|Overall Study|Adverse Event|0|||
127500997|NCT02265536|458794132|FG000|Overall Study|Physician Decision|0|||
127500998|NCT02265536|458794133|FG001|Overall Study|Physician Decision|0|||
127500999|NCT02265536|458794134|FG002|Overall Study|Physician Decision|0|||
127501000|NCT02265536|458794135|FG003|Overall Study|Physician Decision|0|||
127501001|NCT02265536|458794136|FG004|Overall Study|Physician Decision|2|||
127501002|NCT02265536|458794137|FG005|Overall Study|Physician Decision|0|||
127501003|NCT02265536|458794132|FG000|Overall Study|Withdrawal by Subject|0|||
127501004|NCT02265536|458794133|FG001|Overall Study|Withdrawal by Subject|3|||
127501005|NCT02265536|458794134|FG002|Overall Study|Withdrawal by Subject|0|||
127501006|NCT02265536|458794135|FG003|Overall Study|Withdrawal by Subject|0|||
127501007|NCT02265536|458794136|FG004|Overall Study|Withdrawal by Subject|0|||
127501008|NCT02265536|458794137|FG005|Overall Study|Withdrawal by Subject|0|||
127501009|NCT05596734|458794138|FG000|Substudy A|Withdrawal by Subject|1|||
127501010|NCT05596734|458794139|FG001|Substudy A|Withdrawal by Subject|0|||
127501011|NCT05596734|458794140|FG002|Substudy A|Withdrawal by Subject|0|||
127501012|NCT05596734|458794141|FG003|Substudy A|Withdrawal by Subject|0|||
127501013|NCT05596734|458794142|FG004|Substudy A|Withdrawal by Subject|0|||
127501014|NCT05596734|458794143|FG005|Substudy A|Withdrawal by Subject|0|||
127501015|NCT05596734|458794144|FG006|Substudy A|Withdrawal by Subject|1|||
127501016|NCT05596734|458794145|FG007|Substudy A|Withdrawal by Subject|0|||
127501017|NCT05596734|458794146|FG008|Substudy A|Withdrawal by Subject|0|||
127501018|NCT05596734|458794147|FG009|Substudy A|Withdrawal by Subject|0|||
127501019|NCT05596734|458794148|FG010|Substudy A|Withdrawal by Subject|0|||
127501020|NCT05596734|458794149|FG011|Substudy A|Withdrawal by Subject|0|||
127501021|NCT05596734|458794150|FG012|Substudy A|Withdrawal by Subject|0|||
127501022|NCT05596734|458794151|FG013|Substudy A|Withdrawal by Subject|0|||
127501023|NCT05596734|458794152|FG014|Substudy A|Withdrawal by Subject|0|||
127501024|NCT05596734|458794153|FG015|Substudy A|Withdrawal by Subject|0|||
127501025|NCT05596734|458794154|FG016|Substudy A|Withdrawal by Subject|0|||
127501026|NCT05596734|458794155|FG017|Substudy A|Withdrawal by Subject|0|||
127501027|NCT05596734|458794156|FG018|Substudy A|Withdrawal by Subject|0|||
127501028|NCT05596734|458794157|FG019|Substudy A|Withdrawal by Subject|0|||
127501029|NCT05596734|458794158|FG020|Substudy A|Withdrawal by Subject|0|||
127501030|NCT05596734|458794159|FG021|Substudy A|Withdrawal by Subject|0|||
127501031|NCT05596734|458794160|FG022|Substudy A|Withdrawal by Subject|0|||
127501032|NCT05596734|458794161|FG023|Substudy A|Withdrawal by Subject|0|||
127501033|NCT05596734|458794138|FG000|Substudy A|Lost to Follow-up|1|||
127501034|NCT05596734|458794139|FG001|Substudy A|Lost to Follow-up|0|||
127501035|NCT05596734|458794140|FG002|Substudy A|Lost to Follow-up|1|||
127501036|NCT05596734|458794141|FG003|Substudy A|Lost to Follow-up|0|||
127501037|NCT05596734|458794142|FG004|Substudy A|Lost to Follow-up|0|||
127501038|NCT05596734|458794143|FG005|Substudy A|Lost to Follow-up|0|||
127501039|NCT05596734|458794144|FG006|Substudy A|Lost to Follow-up|0|||
127501040|NCT05596734|458794145|FG007|Substudy A|Lost to Follow-up|0|||
127501041|NCT05596734|458794146|FG008|Substudy A|Lost to Follow-up|0|||
127501042|NCT05596734|458794147|FG009|Substudy A|Lost to Follow-up|0|||
127501043|NCT05596734|458794148|FG010|Substudy A|Lost to Follow-up|0|||
127501044|NCT05596734|458794149|FG011|Substudy A|Lost to Follow-up|0|||
127501045|NCT05596734|458794150|FG012|Substudy A|Lost to Follow-up|0|||
127501046|NCT05596734|458794151|FG013|Substudy A|Lost to Follow-up|0|||
127501047|NCT05596734|458794152|FG014|Substudy A|Lost to Follow-up|0|||
127501048|NCT05596734|458794153|FG015|Substudy A|Lost to Follow-up|0|||
127501049|NCT05596734|458794154|FG016|Substudy A|Lost to Follow-up|0|||
127501050|NCT05596734|458794155|FG017|Substudy A|Lost to Follow-up|0|||
127501051|NCT05596734|458794156|FG018|Substudy A|Lost to Follow-up|0|||
127501052|NCT05596734|458794157|FG019|Substudy A|Lost to Follow-up|0|||
127501053|NCT05596734|458794158|FG020|Substudy A|Lost to Follow-up|0|||
127501054|NCT05596734|458794159|FG021|Substudy A|Lost to Follow-up|0|||
127501055|NCT05596734|458794160|FG022|Substudy A|Lost to Follow-up|0|||
127501056|NCT05596734|458794161|FG023|Substudy A|Lost to Follow-up|0|||
127501057|NCT05596734|458794138|FG000|Substudy B|Withdrawal by Subject|0|||
127501058|NCT05596734|458794139|FG001|Substudy B|Withdrawal by Subject|0|||
127501059|NCT05596734|458794140|FG002|Substudy B|Withdrawal by Subject|0|||
127501060|NCT05596734|458794141|FG003|Substudy B|Withdrawal by Subject|0|||
127501061|NCT05596734|458794142|FG004|Substudy B|Withdrawal by Subject|0|||
127501062|NCT05596734|458794143|FG005|Substudy B|Withdrawal by Subject|0|||
127501063|NCT05596734|458794144|FG006|Substudy B|Withdrawal by Subject|0|||
127501064|NCT05596734|458794145|FG007|Substudy B|Withdrawal by Subject|0|||
127501065|NCT05596734|458794146|FG008|Substudy B|Withdrawal by Subject|0|||
127501066|NCT05596734|458794147|FG009|Substudy B|Withdrawal by Subject|0|||
127501067|NCT05596734|458794148|FG010|Substudy B|Withdrawal by Subject|0|||
127501068|NCT05596734|458794149|FG011|Substudy B|Withdrawal by Subject|0|||
127501069|NCT05596734|458794150|FG012|Substudy B|Withdrawal by Subject|1|||
127501070|NCT05596734|458794151|FG013|Substudy B|Withdrawal by Subject|0|||
127501071|NCT05596734|458794152|FG014|Substudy B|Withdrawal by Subject|1|||
127501072|NCT05596734|458794153|FG015|Substudy B|Withdrawal by Subject|2|||
127501073|NCT05596734|458794154|FG016|Substudy B|Withdrawal by Subject|2|||
127501074|NCT05596734|458794155|FG017|Substudy B|Withdrawal by Subject|1|||
127501075|NCT05596734|458794156|FG018|Substudy B|Withdrawal by Subject|2|||
127501076|NCT05596734|458794157|FG019|Substudy B|Withdrawal by Subject|0|||
127501077|NCT05596734|458794158|FG020|Substudy B|Withdrawal by Subject|0|||
127501078|NCT05596734|458794159|FG021|Substudy B|Withdrawal by Subject|0|||
127501079|NCT05596734|458794160|FG022|Substudy B|Withdrawal by Subject|0|||
127501080|NCT05596734|458794161|FG023|Substudy B|Withdrawal by Subject|1|||
127501081|NCT05596734|458794138|FG000|Substudy B|Physician Decision|0|||
127501082|NCT05596734|458794139|FG001|Substudy B|Physician Decision|0|||
127501083|NCT05596734|458794140|FG002|Substudy B|Physician Decision|0|||
127501084|NCT05596734|458794141|FG003|Substudy B|Physician Decision|0|||
127501085|NCT05596734|458794142|FG004|Substudy B|Physician Decision|0|||
127501086|NCT05596734|458794143|FG005|Substudy B|Physician Decision|0|||
127501087|NCT05596734|458794144|FG006|Substudy B|Physician Decision|0|||
127501088|NCT05596734|458794145|FG007|Substudy B|Physician Decision|0|||
127501089|NCT05596734|458794146|FG008|Substudy B|Physician Decision|0|||
127501090|NCT05596734|458794147|FG009|Substudy B|Physician Decision|0|||
127501091|NCT05596734|458794148|FG010|Substudy B|Physician Decision|0|||
127501092|NCT05596734|458794149|FG011|Substudy B|Physician Decision|0|||
127501093|NCT05596734|458794150|FG012|Substudy B|Physician Decision|0|||
127501094|NCT05596734|458794151|FG013|Substudy B|Physician Decision|0|||
127501095|NCT05596734|458794152|FG014|Substudy B|Physician Decision|0|||
127501096|NCT05596734|458794153|FG015|Substudy B|Physician Decision|1|||
127501097|NCT05596734|458794154|FG016|Substudy B|Physician Decision|0|||
127501098|NCT05596734|458794155|FG017|Substudy B|Physician Decision|0|||
127501099|NCT05596734|458794156|FG018|Substudy B|Physician Decision|0|||
127501100|NCT05596734|458794157|FG019|Substudy B|Physician Decision|0|||
127501101|NCT05596734|458794158|FG020|Substudy B|Physician Decision|0|||
127501102|NCT05596734|458794159|FG021|Substudy B|Physician Decision|0|||
127501103|NCT05596734|458794160|FG022|Substudy B|Physician Decision|0|||
127501104|NCT05596734|458794161|FG023|Substudy B|Physician Decision|0|||
127501105|NCT05596734|458794138|FG000|Substudy B|Lost to Follow-up|0|||
127501106|NCT05596734|458794139|FG001|Substudy B|Lost to Follow-up|0|||
127501107|NCT05596734|458794140|FG002|Substudy B|Lost to Follow-up|0|||
127501108|NCT05596734|458794141|FG003|Substudy B|Lost to Follow-up|0|||
127501109|NCT05596734|458794142|FG004|Substudy B|Lost to Follow-up|0|||
127501110|NCT05596734|458794143|FG005|Substudy B|Lost to Follow-up|0|||
127501111|NCT05596734|458794144|FG006|Substudy B|Lost to Follow-up|0|||
127501112|NCT05596734|458794145|FG007|Substudy B|Lost to Follow-up|0|||
127501113|NCT05596734|458794146|FG008|Substudy B|Lost to Follow-up|0|||
127501114|NCT05596734|458794147|FG009|Substudy B|Lost to Follow-up|0|||
127501115|NCT05596734|458794148|FG010|Substudy B|Lost to Follow-up|0|||
127501116|NCT05596734|458794149|FG011|Substudy B|Lost to Follow-up|0|||
127501117|NCT05596734|458794150|FG012|Substudy B|Lost to Follow-up|1|||
127501118|NCT05596734|458794151|FG013|Substudy B|Lost to Follow-up|0|||
127501119|NCT05596734|458794152|FG014|Substudy B|Lost to Follow-up|1|||
127501120|NCT05596734|458794153|FG015|Substudy B|Lost to Follow-up|1|||
127501121|NCT05596734|458794154|FG016|Substudy B|Lost to Follow-up|0|||
127501122|NCT05596734|458794155|FG017|Substudy B|Lost to Follow-up|0|||
127501123|NCT05596734|458794156|FG018|Substudy B|Lost to Follow-up|0|||
127501124|NCT05596734|458794157|FG019|Substudy B|Lost to Follow-up|0|||
127501125|NCT05596734|458794158|FG020|Substudy B|Lost to Follow-up|0|||
127501126|NCT05596734|458794159|FG021|Substudy B|Lost to Follow-up|0|||
127501127|NCT05596734|458794160|FG022|Substudy B|Lost to Follow-up|0|||
127501128|NCT05596734|458794161|FG023|Substudy B|Lost to Follow-up|0|||
127501129|NCT04113018|458794162|FG000|Overall Study|Death|2|||
127501130|NCT04113018|458794162|FG000|Overall Study|Lost to Follow-up|1|||
127501131|NCT04113018|458794162|FG000|Overall Study|Still On Study (on study treatment)|24|||
127501132|NCT04113018|458794162|FG000|Overall Study|Still On Study (in follow up)|12|||
127501133|NCT05005013|458794163|FG000|Overall Study|Withdrawal by Subject|5|||
127501134|NCT05005013|458794164|FG001|Overall Study|Withdrawal by Subject|1|||
127501135|NCT05005013|458794163|FG000|Overall Study|Lost to Follow-up|3|||
127501136|NCT05005013|458794164|FG001|Overall Study|Lost to Follow-up|1|||
127501137|NCT05005013|458794163|FG000|Overall Study|Ineligibility|1|||
127501138|NCT05005013|458794164|FG001|Overall Study|Ineligibility|1|||
127501139|NCT06099223|458794165|FG000|Overall Study|Preoperative surveys missed|0|||
127501140|NCT06099223|458794166|FG001|Overall Study|Preoperative surveys missed|1|||
127501141|NCT00079391|458794167|FG000|Overall Study|Withdrawal by Subject|1|||
127501142|NCT02791516|458794170|FG000|Overall Study|Withdrawal by Subject|1|||
127501143|NCT02791516|458794171|FG001|Overall Study|Withdrawal by Subject|1|||
127501144|NCT00211757|458794176|FG000|Overall Study|Withdrawal by Subject|1|||
127501145|NCT00211757|458794177|FG001|Overall Study|Withdrawal by Subject|1|||
127501146|NCT00211757|458794176|FG000|Overall Study|Lack of Efficacy|0|||
127501147|NCT00211757|458794177|FG001|Overall Study|Lack of Efficacy|1|||
127501148|NCT02644096|458794178|FG000|Overall Study|Withdrawal by Subject|28|||
127501149|NCT02644096|458794179|FG001|Overall Study|Withdrawal by Subject|25|||
127501150|NCT04091581|458794180|FG000|Overall Study|Lost to Follow-up|0|||
127501151|NCT04091581|458794181|FG001|Overall Study|Lost to Follow-up|1|||
127501152|NCT01456195|458796021|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
127501153|NCT01456195|458796022|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
127501154|NCT01456195|458796023|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
127501155|NCT01456195|458796021|FG000|Overall Study|Lost to Follow-up|3|||
127501156|NCT01456195|458796022|FG001|Overall Study|Lost to Follow-up|1|||
127501157|NCT01456195|458796023|FG002|Overall Study|Lost to Follow-up|3|||
127501158|NCT01456195|458796021|FG000|Overall Study|Voluntary Withdrawal|5|||
127501159|NCT01456195|458796022|FG001|Overall Study|Voluntary Withdrawal|3|||
127501160|NCT01456195|458796023|FG002|Overall Study|Voluntary Withdrawal|7|||
127501161|NCT01456195|458796021|FG000|Overall Study|Lack of Efficacy|0|||
127501162|NCT01456195|458796022|FG001|Overall Study|Lack of Efficacy|1|||
127501163|NCT01456195|458796023|FG002|Overall Study|Lack of Efficacy|0|||
127501164|NCT01456195|458796021|FG000|Overall Study|Other Reasons|2|||
127501165|NCT01456195|458796022|FG001|Overall Study|Other Reasons|1|||
127501166|NCT01456195|458796023|FG002|Overall Study|Other Reasons|3|||
127501167|NCT02547038|458796024|FG000|Overall Study|Lost to Follow-up|3|||
127501168|NCT02547038|458796025|FG001|Overall Study|Lost to Follow-up|2|||
127501169|NCT01340625|458796026|FG000|First Intervention|Adverse Event|1|||
127501170|NCT01340625|458796027|FG001|First Intervention|Adverse Event|0|||
127501171|NCT01340625|458796026|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
127501172|NCT01340625|458796027|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
127501173|NCT00734604|458796034|FG000|Overall Study|Adverse Event|0|||
127501174|NCT00734604|458796035|FG001|Overall Study|Adverse Event|2|||
127501175|NCT00734604|458796036|FG002|Overall Study|Adverse Event|0|||
127501176|NCT00734604|458796037|FG003|Overall Study|Adverse Event|2|||
127501177|NCT00734604|458796038|FG004|Overall Study|Adverse Event|1|||
127501178|NCT00734604|458796039|FG005|Overall Study|Adverse Event|1|||
127501179|NCT00734604|458796034|FG000|Overall Study|Serious Adverse Event|1|||
127501180|NCT00734604|458796035|FG001|Overall Study|Serious Adverse Event|0|||
127501181|NCT00734604|458796036|FG002|Overall Study|Serious Adverse Event|1|||
127501182|NCT00734604|458796037|FG003|Overall Study|Serious Adverse Event|2|||
127501183|NCT00734604|458796038|FG004|Overall Study|Serious Adverse Event|0|||
127501184|NCT00734604|458796039|FG005|Overall Study|Serious Adverse Event|1|||
127501185|NCT00734604|458796034|FG000|Overall Study|Lost to Follow-up|1|||
127501186|NCT00734604|458796035|FG001|Overall Study|Lost to Follow-up|2|||
127501187|NCT00734604|458796036|FG002|Overall Study|Lost to Follow-up|2|||
127501188|NCT00734604|458796037|FG003|Overall Study|Lost to Follow-up|4|||
127501189|NCT00734604|458796038|FG004|Overall Study|Lost to Follow-up|2|||
127501190|NCT00734604|458796039|FG005|Overall Study|Lost to Follow-up|3|||
127501191|NCT00734604|458796034|FG000|Overall Study|Physician Decision|0|||
127501192|NCT00734604|458796035|FG001|Overall Study|Physician Decision|1|||
127501193|NCT00734604|458796036|FG002|Overall Study|Physician Decision|1|||
127501194|NCT00734604|458796037|FG003|Overall Study|Physician Decision|0|||
127501195|NCT00734604|458796038|FG004|Overall Study|Physician Decision|0|||
127501196|NCT00734604|458796039|FG005|Overall Study|Physician Decision|0|||
127501197|NCT00734604|458796034|FG000|Overall Study|Protocol Violation|0|||
127501198|NCT00734604|458796035|FG001|Overall Study|Protocol Violation|2|||
127501199|NCT00734604|458796036|FG002|Overall Study|Protocol Violation|0|||
127501200|NCT00734604|458796037|FG003|Overall Study|Protocol Violation|0|||
127501201|NCT00734604|458796038|FG004|Overall Study|Protocol Violation|1|||
127501202|NCT00734604|458796039|FG005|Overall Study|Protocol Violation|0|||
127501203|NCT00734604|458796034|FG000|Overall Study|Sponsor Decision|1|||
127501204|NCT00734604|458796035|FG001|Overall Study|Sponsor Decision|2|||
127501205|NCT00734604|458796036|FG002|Overall Study|Sponsor Decision|1|||
127501206|NCT00734604|458796037|FG003|Overall Study|Sponsor Decision|0|||
127501207|NCT00734604|458796038|FG004|Overall Study|Sponsor Decision|2|||
127501208|NCT00734604|458796039|FG005|Overall Study|Sponsor Decision|0|||
127501209|NCT00734604|458796034|FG000|Overall Study|Withdrawal by Subject|0|||
127501210|NCT00734604|458796035|FG001|Overall Study|Withdrawal by Subject|2|||
127501211|NCT00734604|458796036|FG002|Overall Study|Withdrawal by Subject|0|||
127501212|NCT00734604|458796037|FG003|Overall Study|Withdrawal by Subject|1|||
127501213|NCT00734604|458796038|FG004|Overall Study|Withdrawal by Subject|2|||
127501214|NCT00734604|458796039|FG005|Overall Study|Withdrawal by Subject|1|||
127501215|NCT00734604|458796034|FG000|Overall Study|Lack of Efficacy|0|||
127501216|NCT00734604|458796035|FG001|Overall Study|Lack of Efficacy|1|||
127501217|NCT00734604|458796036|FG002|Overall Study|Lack of Efficacy|1|||
127501218|NCT00734604|458796037|FG003|Overall Study|Lack of Efficacy|0|||
127501219|NCT00734604|458796038|FG004|Overall Study|Lack of Efficacy|0|||
127501220|NCT00734604|458796039|FG005|Overall Study|Lack of Efficacy|0|||
127501221|NCT02589665|458796040|FG000|Induction Period|Did not receive drug|0|||
127501222|NCT02589665|458796041|FG001|Induction Period|Did not receive drug|0|||
127501223|NCT02589665|458796042|FG002|Induction Period|Did not receive drug|0|||
127501224|NCT02589665|458796043|FG003|Induction Period|Did not receive drug|1|||
127501225|NCT02589665|458796044|FG004|Induction Period|Did not receive drug|0|||
127501226|NCT02589665|458796045|FG005|Induction Period|Did not receive drug|0|||
127501227|NCT02589665|458796046|FG006|Induction Period|Did not receive drug|0|||
127501228|NCT02589665|458796047|FG007|Induction Period|Did not receive drug|0|||
127501229|NCT02589665|458796048|FG008|Induction Period|Did not receive drug|0|||
127501230|NCT02589665|458796049|FG009|Induction Period|Did not receive drug|0|||
127501231|NCT02589665|458796040|FG000|Induction Period|Adverse Event|3|||
127501232|NCT02589665|458796041|FG001|Induction Period|Adverse Event|0|||
127501233|NCT02589665|458796042|FG002|Induction Period|Adverse Event|2|||
127501234|NCT02589665|458796043|FG003|Induction Period|Adverse Event|2|||
127501235|NCT02589665|458796044|FG004|Induction Period|Adverse Event|0|||
127501236|NCT02589665|458796045|FG005|Induction Period|Adverse Event|0|||
127501237|NCT02589665|458796046|FG006|Induction Period|Adverse Event|0|||
127501238|NCT02589665|458796047|FG007|Induction Period|Adverse Event|0|||
127501239|NCT02589665|458796048|FG008|Induction Period|Adverse Event|0|||
127501240|NCT02589665|458796049|FG009|Induction Period|Adverse Event|0|||
127501241|NCT02589665|458796040|FG000|Induction Period|Withdrawal by Subject|0|||
127501242|NCT02589665|458796041|FG001|Induction Period|Withdrawal by Subject|1|||
127501243|NCT02589665|458796042|FG002|Induction Period|Withdrawal by Subject|0|||
127501244|NCT02589665|458796043|FG003|Induction Period|Withdrawal by Subject|1|||
127501245|NCT02589665|458796044|FG004|Induction Period|Withdrawal by Subject|0|||
127501246|NCT02589665|458796045|FG005|Induction Period|Withdrawal by Subject|0|||
127501247|NCT02589665|458796046|FG006|Induction Period|Withdrawal by Subject|0|||
127501248|NCT02589665|458796047|FG007|Induction Period|Withdrawal by Subject|0|||
127501249|NCT02589665|458796048|FG008|Induction Period|Withdrawal by Subject|0|||
127501250|NCT02589665|458796049|FG009|Induction Period|Withdrawal by Subject|0|||
127501251|NCT02589665|458796040|FG000|Induction Period|Protocol Violation|0|||
127501252|NCT02589665|458796041|FG001|Induction Period|Protocol Violation|1|||
127501253|NCT02589665|458796042|FG002|Induction Period|Protocol Violation|0|||
127501254|NCT02589665|458796043|FG003|Induction Period|Protocol Violation|0|||
127501255|NCT02589665|458796044|FG004|Induction Period|Protocol Violation|0|||
127501256|NCT02589665|458796045|FG005|Induction Period|Protocol Violation|0|||
127501257|NCT02589665|458796046|FG006|Induction Period|Protocol Violation|0|||
127501258|NCT02589665|458796047|FG007|Induction Period|Protocol Violation|0|||
127501259|NCT02589665|458796048|FG008|Induction Period|Protocol Violation|0|||
127501260|NCT02589665|458796049|FG009|Induction Period|Protocol Violation|0|||
127501261|NCT02589665|458796040|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
127501262|NCT02589665|458796041|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
127501263|NCT02589665|458796042|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
127501264|NCT02589665|458796043|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
127501265|NCT02589665|458796044|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
127501266|NCT02589665|458796045|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
127501267|NCT02589665|458796046|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
127501268|NCT02589665|458796047|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
127501269|NCT02589665|458796048|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
127501270|NCT02589665|458796049|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
127501271|NCT02589665|458796040|FG000|Maintenance Period|Withdrawal by Subject|0|||
127501272|NCT02589665|458796041|FG001|Maintenance Period|Withdrawal by Subject|0|||
127501273|NCT02589665|458796042|FG002|Maintenance Period|Withdrawal by Subject|0|||
127501274|NCT02589665|458796043|FG003|Maintenance Period|Withdrawal by Subject|0|||
127501275|NCT02589665|458796044|FG004|Maintenance Period|Withdrawal by Subject|4|||
127501276|NCT02589665|458796045|FG005|Maintenance Period|Withdrawal by Subject|2|||
127501277|NCT02589665|458796046|FG006|Maintenance Period|Withdrawal by Subject|4|||
127501278|NCT02589665|458796047|FG007|Maintenance Period|Withdrawal by Subject|0|||
127501279|NCT02589665|458796048|FG008|Maintenance Period|Withdrawal by Subject|0|||
127501280|NCT02589665|458796049|FG009|Maintenance Period|Withdrawal by Subject|0|||
127501281|NCT02589665|458796040|FG000|Maintenance Period|Lack of Efficacy|0|||
127501282|NCT02589665|458796041|FG001|Maintenance Period|Lack of Efficacy|0|||
127501283|NCT02589665|458796042|FG002|Maintenance Period|Lack of Efficacy|0|||
127501284|NCT02589665|458796043|FG003|Maintenance Period|Lack of Efficacy|0|||
127501285|NCT02589665|458796044|FG004|Maintenance Period|Lack of Efficacy|2|||
127501286|NCT02589665|458796045|FG005|Maintenance Period|Lack of Efficacy|1|||
127501287|NCT02589665|458796046|FG006|Maintenance Period|Lack of Efficacy|0|||
127501288|NCT02589665|458796047|FG007|Maintenance Period|Lack of Efficacy|0|||
127501289|NCT02589665|458796048|FG008|Maintenance Period|Lack of Efficacy|0|||
127501290|NCT02589665|458796049|FG009|Maintenance Period|Lack of Efficacy|0|||
127501291|NCT02589665|458796040|FG000|Maintenance Period|Adverse Event|0|||
127501292|NCT02589665|458796041|FG001|Maintenance Period|Adverse Event|0|||
127501293|NCT02589665|458796042|FG002|Maintenance Period|Adverse Event|0|||
127501294|NCT02589665|458796043|FG003|Maintenance Period|Adverse Event|0|||
127501295|NCT02589665|458796044|FG004|Maintenance Period|Adverse Event|0|||
127501296|NCT02589665|458796045|FG005|Maintenance Period|Adverse Event|0|||
127501297|NCT02589665|458796046|FG006|Maintenance Period|Adverse Event|2|||
127501298|NCT02589665|458796047|FG007|Maintenance Period|Adverse Event|0|||
127501299|NCT02589665|458796048|FG008|Maintenance Period|Adverse Event|0|||
127501300|NCT02589665|458796049|FG009|Maintenance Period|Adverse Event|0|||
127501301|NCT02589665|458796040|FG000|Maintenance Period|Lost to Follow-up|0|||
127501302|NCT02589665|458796041|FG001|Maintenance Period|Lost to Follow-up|0|||
127501303|NCT02589665|458796042|FG002|Maintenance Period|Lost to Follow-up|0|||
127501304|NCT02589665|458796043|FG003|Maintenance Period|Lost to Follow-up|0|||
127501305|NCT02589665|458796044|FG004|Maintenance Period|Lost to Follow-up|0|||
127501306|NCT02589665|458796045|FG005|Maintenance Period|Lost to Follow-up|1|||
127501307|NCT02589665|458796046|FG006|Maintenance Period|Lost to Follow-up|0|||
127501308|NCT02589665|458796047|FG007|Maintenance Period|Lost to Follow-up|0|||
127501309|NCT02589665|458796048|FG008|Maintenance Period|Lost to Follow-up|0|||
127501310|NCT02589665|458796049|FG009|Maintenance Period|Lost to Follow-up|0|||
127501311|NCT02589665|458796040|FG000|Maintenance Period|Physician Decision|0|||
127501312|NCT02589665|458796041|FG001|Maintenance Period|Physician Decision|0|||
127501313|NCT02589665|458796042|FG002|Maintenance Period|Physician Decision|0|||
127501314|NCT02589665|458796043|FG003|Maintenance Period|Physician Decision|0|||
127501315|NCT02589665|458796044|FG004|Maintenance Period|Physician Decision|0|||
127501316|NCT02589665|458796045|FG005|Maintenance Period|Physician Decision|1|||
127501317|NCT02589665|458796046|FG006|Maintenance Period|Physician Decision|0|||
127501318|NCT02589665|458796047|FG007|Maintenance Period|Physician Decision|0|||
127501319|NCT02589665|458796048|FG008|Maintenance Period|Physician Decision|0|||
127501320|NCT02589665|458796049|FG009|Maintenance Period|Physician Decision|0|||
127501321|NCT02589665|458796040|FG000|Maintenance Period|Reason Not Collected|0|||
127501322|NCT02589665|458796041|FG001|Maintenance Period|Reason Not Collected|0|||
127501323|NCT02589665|458796042|FG002|Maintenance Period|Reason Not Collected|0|||
127501324|NCT02589665|458796043|FG003|Maintenance Period|Reason Not Collected|0|||
127501325|NCT02589665|458796044|FG004|Maintenance Period|Reason Not Collected|0|||
127501326|NCT02589665|458796045|FG005|Maintenance Period|Reason Not Collected|1|||
127501327|NCT02589665|458796046|FG006|Maintenance Period|Reason Not Collected|1|||
127501328|NCT02589665|458796047|FG007|Maintenance Period|Reason Not Collected|0|||
127501329|NCT02589665|458796048|FG008|Maintenance Period|Reason Not Collected|0|||
127501330|NCT02589665|458796049|FG009|Maintenance Period|Reason Not Collected|0|||
127501331|NCT02589665|458796040|FG000|Induction Extension Period|Adverse Event|0|||
127501332|NCT02589665|458796041|FG001|Induction Extension Period|Adverse Event|0|||
127501333|NCT02589665|458796042|FG002|Induction Extension Period|Adverse Event|0|||
127501334|NCT02589665|458796043|FG003|Induction Extension Period|Adverse Event|0|||
127501335|NCT02589665|458796044|FG004|Induction Extension Period|Adverse Event|0|||
127501336|NCT02589665|458796045|FG005|Induction Extension Period|Adverse Event|0|||
127501337|NCT02589665|458796046|FG006|Induction Extension Period|Adverse Event|0|||
127501338|NCT02589665|458796047|FG007|Induction Extension Period|Adverse Event|0|||
127501339|NCT02589665|458796048|FG008|Induction Extension Period|Adverse Event|4|||
127501340|NCT02589665|458796049|FG009|Induction Extension Period|Adverse Event|0|||
127501341|NCT02589665|458796040|FG000|Induction Extension Period|Lack of Efficacy|0|||
127501342|NCT02589665|458796041|FG001|Induction Extension Period|Lack of Efficacy|0|||
127501343|NCT02589665|458796042|FG002|Induction Extension Period|Lack of Efficacy|0|||
127501344|NCT02589665|458796043|FG003|Induction Extension Period|Lack of Efficacy|0|||
127501345|NCT02589665|458796044|FG004|Induction Extension Period|Lack of Efficacy|0|||
127501346|NCT02589665|458796045|FG005|Induction Extension Period|Lack of Efficacy|0|||
127501347|NCT02589665|458796046|FG006|Induction Extension Period|Lack of Efficacy|0|||
127978009|NCT03634033|460542385|FG002|Overall Study|Did not have a post-assessment|114|||
127501348|NCT02589665|458796047|FG007|Induction Extension Period|Lack of Efficacy|0|||
127501349|NCT02589665|458796048|FG008|Induction Extension Period|Lack of Efficacy|3|||
127501350|NCT02589665|458796049|FG009|Induction Extension Period|Lack of Efficacy|0|||
127501351|NCT02589665|458796040|FG000|Induction Extension Period|Withdrawal by Subject|0|||
127501352|NCT02589665|458796041|FG001|Induction Extension Period|Withdrawal by Subject|0|||
127501353|NCT02589665|458796042|FG002|Induction Extension Period|Withdrawal by Subject|0|||
127501354|NCT02589665|458796043|FG003|Induction Extension Period|Withdrawal by Subject|0|||
127501355|NCT02589665|458796044|FG004|Induction Extension Period|Withdrawal by Subject|0|||
127501356|NCT02589665|458796045|FG005|Induction Extension Period|Withdrawal by Subject|0|||
127501357|NCT02589665|458796046|FG006|Induction Extension Period|Withdrawal by Subject|0|||
127501358|NCT02589665|458796047|FG007|Induction Extension Period|Withdrawal by Subject|2|||
127501359|NCT02589665|458796048|FG008|Induction Extension Period|Withdrawal by Subject|3|||
127501360|NCT02589665|458796049|FG009|Induction Extension Period|Withdrawal by Subject|0|||
127501361|NCT02589665|458796040|FG000|Induction Extension Period|Physician Decision|0|||
127501362|NCT02589665|458796041|FG001|Induction Extension Period|Physician Decision|0|||
127501363|NCT02589665|458796042|FG002|Induction Extension Period|Physician Decision|0|||
127501364|NCT02589665|458796043|FG003|Induction Extension Period|Physician Decision|0|||
127501365|NCT02589665|458796044|FG004|Induction Extension Period|Physician Decision|0|||
127501366|NCT02589665|458796045|FG005|Induction Extension Period|Physician Decision|0|||
127501367|NCT02589665|458796046|FG006|Induction Extension Period|Physician Decision|0|||
127501368|NCT02589665|458796047|FG007|Induction Extension Period|Physician Decision|0|||
127501369|NCT02589665|458796048|FG008|Induction Extension Period|Physician Decision|1|||
127501370|NCT02589665|458796049|FG009|Induction Extension Period|Physician Decision|0|||
127501371|NCT02589665|458796040|FG000|Induction Extension Period|Reason Not Collected|0|||
127501372|NCT02589665|458796041|FG001|Induction Extension Period|Reason Not Collected|0|||
127501373|NCT02589665|458796042|FG002|Induction Extension Period|Reason Not Collected|0|||
127501374|NCT02589665|458796043|FG003|Induction Extension Period|Reason Not Collected|0|||
127501375|NCT02589665|458796044|FG004|Induction Extension Period|Reason Not Collected|0|||
127501376|NCT02589665|458796045|FG005|Induction Extension Period|Reason Not Collected|0|||
127501377|NCT02589665|458796046|FG006|Induction Extension Period|Reason Not Collected|0|||
127501378|NCT02589665|458796047|FG007|Induction Extension Period|Reason Not Collected|0|||
127501379|NCT02589665|458796048|FG008|Induction Extension Period|Reason Not Collected|1|||
127501380|NCT02589665|458796049|FG009|Induction Extension Period|Reason Not Collected|0|||
127501381|NCT02589665|458796040|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
127501382|NCT02589665|458796041|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
127501383|NCT02589665|458796042|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
127501384|NCT02589665|458796043|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
127501385|NCT02589665|458796044|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
127501386|NCT02589665|458796045|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
127501387|NCT02589665|458796046|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
127501388|NCT02589665|458796047|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
127501389|NCT02589665|458796048|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
127501390|NCT02589665|458796049|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
127501391|NCT02589665|458796040|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
127501392|NCT02589665|458796041|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
127501393|NCT02589665|458796042|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
127501394|NCT02589665|458796043|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
127501395|NCT02589665|458796044|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
127501396|NCT02589665|458796045|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
127501397|NCT02589665|458796046|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
127501398|NCT02589665|458796047|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
127501399|NCT02589665|458796048|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
127501400|NCT02589665|458796049|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
127501401|NCT02589665|458796040|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
127501402|NCT02589665|458796041|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
127501403|NCT02589665|458796042|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
127501404|NCT02589665|458796043|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
127501405|NCT02589665|458796044|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
127501406|NCT02589665|458796045|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
127501407|NCT02589665|458796046|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
127501408|NCT02589665|458796047|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
127501409|NCT02589665|458796048|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
127501410|NCT02589665|458796049|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
127501411|NCT02589665|458796040|FG000|Maintenance Extension Period|Adverse Event|0|||
127501412|NCT02589665|458796041|FG001|Maintenance Extension Period|Adverse Event|0|||
127501413|NCT02589665|458796042|FG002|Maintenance Extension Period|Adverse Event|0|||
127501414|NCT02589665|458796043|FG003|Maintenance Extension Period|Adverse Event|0|||
127501415|NCT02589665|458796044|FG004|Maintenance Extension Period|Adverse Event|0|||
127501416|NCT02589665|458796045|FG005|Maintenance Extension Period|Adverse Event|0|||
127501417|NCT02589665|458796046|FG006|Maintenance Extension Period|Adverse Event|0|||
127501418|NCT02589665|458796047|FG007|Maintenance Extension Period|Adverse Event|0|||
127501419|NCT02589665|458796048|FG008|Maintenance Extension Period|Adverse Event|0|||
127501420|NCT02589665|458796049|FG009|Maintenance Extension Period|Adverse Event|2|||
127501421|NCT02589665|458796040|FG000|Maintenance Extension Period|Non-responder|0|||
127501422|NCT02589665|458796041|FG001|Maintenance Extension Period|Non-responder|0|||
127501423|NCT02589665|458796042|FG002|Maintenance Extension Period|Non-responder|0|||
127501424|NCT02589665|458796043|FG003|Maintenance Extension Period|Non-responder|0|||
127501425|NCT02589665|458796044|FG004|Maintenance Extension Period|Non-responder|0|||
127501426|NCT02589665|458796045|FG005|Maintenance Extension Period|Non-responder|0|||
127501427|NCT02589665|458796046|FG006|Maintenance Extension Period|Non-responder|0|||
127501428|NCT02589665|458796047|FG007|Maintenance Extension Period|Non-responder|0|||
127501429|NCT02589665|458796048|FG008|Maintenance Extension Period|Non-responder|0|||
127501430|NCT02589665|458796049|FG009|Maintenance Extension Period|Non-responder|1|||
127501431|NCT00978380|458796050|FG000|Overall Study|Protocol Violation|2|||
127501432|NCT00978380|458796050|FG000|Overall Study|Withdrawal criteria|9|||
127501433|NCT00978380|458796050|FG000|Overall Study|Unclassified|8|||
127501434|NCT00327015|458796051|FG000|Overall Study|Lack of Efficacy|18|||
127501435|NCT00327015|458796052|FG001|Overall Study|Lack of Efficacy|18|||
127501436|NCT00327015|458796053|FG002|Overall Study|Lack of Efficacy|35|||
127501437|NCT00327015|458796054|FG003|Overall Study|Lack of Efficacy|29|||
127501438|NCT00327015|458796051|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
127501439|NCT00327015|458796052|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
127501440|NCT00327015|458796053|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
127501441|NCT00327015|458796054|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
127501442|NCT00327015|458796051|FG000|Overall Study|Lost to Follow-up|22|||
127501443|NCT00327015|458796052|FG001|Overall Study|Lost to Follow-up|23|||
127501444|NCT00327015|458796053|FG002|Overall Study|Lost to Follow-up|29|||
127501445|NCT00327015|458796054|FG003|Overall Study|Lost to Follow-up|22|||
127501446|NCT00327015|458796051|FG000|Overall Study|Adverse Event|14|||
127501447|NCT00327015|458796052|FG001|Overall Study|Adverse Event|10|||
127501448|NCT00327015|458796053|FG002|Overall Study|Adverse Event|14|||
127501449|NCT00327015|458796054|FG003|Overall Study|Adverse Event|14|||
127501450|NCT00327015|458796051|FG000|Overall Study|Subject no longer meets study criteria|4|||
127501451|NCT00327015|458796052|FG001|Overall Study|Subject no longer meets study criteria|2|||
127501452|NCT00327015|458796053|FG002|Overall Study|Subject no longer meets study criteria|8|||
127501453|NCT00327015|458796054|FG003|Overall Study|Subject no longer meets study criteria|7|||
127501454|NCT00327015|458796051|FG000|Overall Study|Poor/Noncompliance|11|||
127501455|NCT00327015|458796052|FG001|Overall Study|Poor/Noncompliance|8|||
127501456|NCT00327015|458796053|FG002|Overall Study|Poor/Noncompliance|4|||
127501457|NCT00327015|458796054|FG003|Overall Study|Poor/Noncompliance|5|||
127501458|NCT00327015|458796051|FG000|Overall Study|Physician Decision|0|||
127501459|NCT00327015|458796052|FG001|Overall Study|Physician Decision|1|||
127501460|NCT00327015|458796053|FG002|Overall Study|Physician Decision|3|||
127501461|NCT00327015|458796054|FG003|Overall Study|Physician Decision|2|||
127501462|NCT00327015|458796051|FG000|Overall Study|Death|1|||
127501463|NCT00327015|458796052|FG001|Overall Study|Death|2|||
127501464|NCT00327015|458796053|FG002|Overall Study|Death|2|||
127501465|NCT00327015|458796054|FG003|Overall Study|Death|3|||
127501466|NCT00327015|458796051|FG000|Overall Study|Pregnancy|0|||
127501467|NCT00327015|458796052|FG001|Overall Study|Pregnancy|2|||
127501468|NCT00327015|458796053|FG002|Overall Study|Pregnancy|1|||
127501469|NCT00327015|458796054|FG003|Overall Study|Pregnancy|1|||
127501470|NCT00327015|458796051|FG000|Overall Study|Administrative Reason by Sponsor|1|||
127501471|NCT00327015|458796052|FG001|Overall Study|Administrative Reason by Sponsor|2|||
127978010|NCT03634033|460542386|FG003|Overall Study|Did not have a post-assessment|161|||
127978011|NCT03634033|460542387|FG004|Overall Study|Did not have a post-assessment|5|||
127978012|NCT03634033|460542388|FG005|Overall Study|Did not have a post-assessment|0|||
127978013|NCT03634033|460542389|FG006|Overall Study|Did not have a post-assessment|0|||
127978014|NCT03634033|460542383|FG000|Overall Study|Death|0|||
127978015|NCT03634033|460542384|FG001|Overall Study|Death|0|||
127978016|NCT03634033|460542385|FG002|Overall Study|Death|0|||
127978017|NCT03634033|460542386|FG003|Overall Study|Death|0|||
127978018|NCT03634033|460542387|FG004|Overall Study|Death|0|||
127978019|NCT03634033|460542388|FG005|Overall Study|Death|7|||
127978020|NCT03634033|460542389|FG006|Overall Study|Death|7|||
127978021|NCT03634033|460542383|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
127978022|NCT03634033|460542384|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
127978023|NCT03634033|460542385|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
127978024|NCT03634033|460542386|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
127978025|NCT03634033|460542387|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
127978026|NCT03634033|460542388|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
127501472|NCT00327015|458796053|FG002|Overall Study|Administrative Reason by Sponsor|2|||
127501473|NCT00327015|458796054|FG003|Overall Study|Administrative Reason by Sponsor|1|||
127501474|NCT01519791|458796055|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
127978027|NCT03634033|460542389|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
127978028|NCT03634033|460542383|FG000|Overall Study|Lost to Follow-up|0|||
127978029|NCT03634033|460542384|FG001|Overall Study|Lost to Follow-up|0|||
127978030|NCT03634033|460542385|FG002|Overall Study|Lost to Follow-up|0|||
127501475|NCT01519791|458796056|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
127978031|NCT03634033|460542386|FG003|Overall Study|Lost to Follow-up|0|||
127978032|NCT03634033|460542387|FG004|Overall Study|Lost to Follow-up|0|||
127978033|NCT03634033|460542388|FG005|Overall Study|Lost to Follow-up|1|||
127978034|NCT03634033|460542389|FG006|Overall Study|Lost to Follow-up|2|||
127978035|NCT03634033|460542383|FG000|Overall Study|Withdrawal by Subject|0|||
127978036|NCT03634033|460542384|FG001|Overall Study|Withdrawal by Subject|0|||
127978037|NCT03634033|460542385|FG002|Overall Study|Withdrawal by Subject|0|||
127978038|NCT03634033|460542386|FG003|Overall Study|Withdrawal by Subject|0|||
127978039|NCT03634033|460542387|FG004|Overall Study|Withdrawal by Subject|0|||
127978040|NCT03634033|460542388|FG005|Overall Study|Withdrawal by Subject|0|||
127978041|NCT03634033|460542389|FG006|Overall Study|Withdrawal by Subject|1|||
127978042|NCT01944670|460542392|FG000|Overall Study|Lost to Follow-up|2|||
127978043|NCT00743288|460542393|FG000|Overall Study|Adverse Event|1|||
127978044|NCT00743288|460542394|FG001|Overall Study|Adverse Event|1|||
127978045|NCT00743288|460542395|FG002|Overall Study|Adverse Event|2|||
127978046|NCT00743288|460542396|FG003|Overall Study|Adverse Event|2|||
127978047|NCT00743288|460542397|FG004|Overall Study|Adverse Event|1|||
127978048|NCT00743288|460542398|FG005|Overall Study|Adverse Event|1|||
127978049|NCT00743288|460542399|FG006|Overall Study|Adverse Event|2|||
127978050|NCT00743288|460542393|FG000|Overall Study|Withdrawal by Subject|0|||
127978051|NCT00743288|460542394|FG001|Overall Study|Withdrawal by Subject|0|||
127978052|NCT00743288|460542395|FG002|Overall Study|Withdrawal by Subject|1|||
127978053|NCT00743288|460542396|FG003|Overall Study|Withdrawal by Subject|0|||
127978054|NCT00743288|460542397|FG004|Overall Study|Withdrawal by Subject|0|||
127978055|NCT00743288|460542398|FG005|Overall Study|Withdrawal by Subject|1|||
127978056|NCT00743288|460542399|FG006|Overall Study|Withdrawal by Subject|1|||
127978057|NCT00743288|460542393|FG000|Overall Study|Progressive disease (PD)|2|||
127978058|NCT00743288|460542394|FG001|Overall Study|Progressive disease (PD)|0|||
127978059|NCT00743288|460542395|FG002|Overall Study|Progressive disease (PD)|1|||
127978060|NCT00743288|460542396|FG003|Overall Study|Progressive disease (PD)|4|||
127978061|NCT00743288|460542397|FG004|Overall Study|Progressive disease (PD)|5|||
127978062|NCT00743288|460542398|FG005|Overall Study|Progressive disease (PD)|3|||
127978063|NCT00743288|460542399|FG006|Overall Study|Progressive disease (PD)|6|||
127978064|NCT00743288|460542393|FG000|Overall Study|Worsening of condition (Not PD)|0|||
127978065|NCT00743288|460542394|FG001|Overall Study|Worsening of condition (Not PD)|2|||
127978066|NCT00743288|460542395|FG002|Overall Study|Worsening of condition (Not PD)|1|||
127978067|NCT00743288|460542396|FG003|Overall Study|Worsening of condition (Not PD)|1|||
127978068|NCT00743288|460542397|FG004|Overall Study|Worsening of condition (Not PD)|0|||
127978069|NCT00743288|460542398|FG005|Overall Study|Worsening of condition (Not PD)|0|||
127978070|NCT00743288|460542399|FG006|Overall Study|Worsening of condition (Not PD)|0|||
127978071|NCT04338269|460542400|FG000|Overall Study|Death|86|||
127978072|NCT04338269|460542401|FG001|Overall Study|Death|89|||
127978073|NCT04338269|460542400|FG000|Overall Study|Lost to Follow-up|1|||
127978074|NCT04338269|460542401|FG001|Overall Study|Lost to Follow-up|2|||
127978075|NCT04338269|460542400|FG000|Overall Study|Physician Decision|1|||
127978076|NCT04338269|460542401|FG001|Overall Study|Physician Decision|0|||
127978077|NCT04338269|460542400|FG000|Overall Study|Withdrawal by Subject|14|||
127978078|NCT04338269|460542401|FG001|Overall Study|Withdrawal by Subject|11|||
127978079|NCT02730377|460542403|FG000|Overall Study|Other|5|||
127978080|NCT02730377|460542404|FG001|Overall Study|Other|4|||
127978081|NCT02730377|460542403|FG000|Overall Study|Death|1|||
127978082|NCT02730377|460542404|FG001|Overall Study|Death|8|||
127978083|NCT02730377|460542403|FG000|Overall Study|Inadequate glycaemic control|368|||
127978084|NCT02730377|460542404|FG001|Overall Study|Inadequate glycaemic control|473|||
127978085|NCT02730377|460542403|FG000|Overall Study|Adverse Event|79|||
127978086|NCT02730377|460542404|FG001|Overall Study|Adverse Event|41|||
127978087|NCT02730377|460542403|FG000|Overall Study|Protocol Violation|23|||
127978088|NCT02730377|460542404|FG001|Overall Study|Protocol Violation|30|||
127978089|NCT02730377|460542403|FG000|Overall Study|Lack of Efficacy|4|||
127978090|NCT02730377|460542404|FG001|Overall Study|Lack of Efficacy|13|||
127978091|NCT02730377|460542403|FG000|Overall Study|Pregnancy|0|||
127978092|NCT02730377|460542404|FG001|Overall Study|Pregnancy|1|||
127978093|NCT02730377|460542403|FG000|Overall Study|Withdrawal by Subject|45|||
127978094|NCT02730377|460542404|FG001|Overall Study|Withdrawal by Subject|42|||
127978095|NCT02730377|460542403|FG000|Overall Study|Lost to Follow-up|25|||
127978096|NCT02730377|460542404|FG001|Overall Study|Lost to Follow-up|21|||
127978097|NCT01054300|460542421|FG000|Period 1|Adverse Event|1|||
127978098|NCT01054300|460542422|FG001|Period 1|Adverse Event|0|||
127978099|NCT01054300|460542423|FG002|Period 1|Adverse Event|0|||
127978100|NCT01054300|460542424|FG003|Period 1|Adverse Event|0|||
127978101|NCT01054300|460542421|FG000|Period 2|Withdrawal by Subject|0|||
127978102|NCT01054300|460542422|FG001|Period 2|Withdrawal by Subject|0|||
127978103|NCT01054300|460542423|FG002|Period 2|Withdrawal by Subject|1|||
127978104|NCT01054300|460542424|FG003|Period 2|Withdrawal by Subject|0|||
127978105|NCT00308087|460542425|FG000|Overall Study|Progressive Disease|19|||
127978106|NCT00308087|460542426|FG001|Overall Study|Progressive Disease|21|||
127978107|NCT00308087|460542425|FG000|Overall Study|Study Closure|11|||
127978108|NCT00308087|460542426|FG001|Overall Study|Study Closure|12|||
127978109|NCT00308087|460542425|FG000|Overall Study|Withdrawal by Subject|2|||
127978110|NCT00308087|460542426|FG001|Overall Study|Withdrawal by Subject|1|||
127978111|NCT00308087|460542425|FG000|Overall Study|Other|4|||
127978112|NCT00308087|460542426|FG001|Overall Study|Other|3|||
127978113|NCT00177307|460542427|FG000|Overall Study|Withdrawal by Subject|1|||
127978114|NCT02677038|460542431|FG000|Overall Study|Physician Decision|1|||
127978115|NCT02677038|460542431|FG000|Overall Study|Withdrawal by Subject|1|||
127978116|NCT03671564|460542432|FG000|Overall Study|Progressive Disease|3|||
127978117|NCT03671564|460542433|FG001|Overall Study|Progressive Disease|5|||
127978118|NCT03671564|460542434|FG002|Overall Study|Progressive Disease|3|||
127978119|NCT03671564|460542432|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
127978120|NCT03671564|460542433|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
127978121|NCT03671564|460542434|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
127978122|NCT03671564|460542432|FG000|Overall Study|Withdrawal by Subject|1|||
127978123|NCT03671564|460542433|FG001|Overall Study|Withdrawal by Subject|1|||
127978124|NCT03671564|460542434|FG002|Overall Study|Withdrawal by Subject|0|||
127978125|NCT05007041|460542435|FG000|Overall Study|Missing Diary Entries|0|||
127978126|NCT05007041|460542436|FG001|Overall Study|Missing Diary Entries|1|||
127978127|NCT01546168|460542439|FG000|Overall Study|Lost to Follow-up|1|||
127501476|NCT01519791|458796055|FG000|Overall Study|Protocol Violation|6|||
127501477|NCT01519791|458796056|FG001|Overall Study|Protocol Violation|19|||
127501478|NCT01519791|458796055|FG000|Overall Study|Other Reason|87|||
127501479|NCT01519791|458796056|FG001|Overall Study|Other Reason|222|||
127501480|NCT01519791|458796055|FG000|Overall Study|subjects randomized in error|2|||
127501481|NCT01519791|458796056|FG001|Overall Study|subjects randomized in error|0|||
127501482|NCT01519791|458796055|FG000|Overall Study|Lack of Efficacy|16|||
127501483|NCT01519791|458796056|FG001|Overall Study|Lack of Efficacy|20|||
127501484|NCT01519791|458796055|FG000|Overall Study|SAE, non-fatal|6|||
127501485|NCT01519791|458796056|FG001|Overall Study|SAE, non-fatal|22|||
127501486|NCT01519791|458796055|FG000|Overall Study|AE, serious fatal|0|||
127501487|NCT01519791|458796056|FG001|Overall Study|AE, serious fatal|1|||
127501488|NCT01519791|458796055|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
127501489|NCT01519791|458796056|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
127501490|NCT01519791|458796055|FG000|Overall Study|AE, non-serious non-fatal|12|||
127501491|NCT01519791|458796056|FG001|Overall Study|AE, non-serious non-fatal|31|||
127501492|NCT01519791|458796055|FG000|Overall Study|Withdrawal by Subject|15|||
127501493|NCT01519791|458796056|FG001|Overall Study|Withdrawal by Subject|37|||
127501494|NCT01519791|458796055|FG000|Overall Study|Lost to Follow-up|6|||
127501495|NCT01519791|458796056|FG001|Overall Study|Lost to Follow-up|14|||
127501496|NCT00837265|458796057|FG000|Pilot Phase|Withdrawal by Subject|0|||
127501497|NCT00837265|458796058|FG001|Pilot Phase|Withdrawal by Subject|2|||
127501498|NCT00837265|458796059|FG002|Pilot Phase|Withdrawal by Subject|3|||
127501499|NCT00837265|458796060|FG003|Pilot Phase|Withdrawal by Subject|2|||
127501500|NCT00837265|458796061|FG004|Pilot Phase|Withdrawal by Subject|0|||
127501501|NCT00837265|458796062|FG005|Pilot Phase|Withdrawal by Subject|0|||
127501502|NCT00837265|458796063|FG006|Pilot Phase|Withdrawal by Subject|0|||
127501503|NCT00837265|458796057|FG000|Pilot Phase|Decision of the investigator|2|||
127501504|NCT00837265|458796058|FG001|Pilot Phase|Decision of the investigator|1|||
127501505|NCT00837265|458796059|FG002|Pilot Phase|Decision of the investigator|0|||
127501506|NCT00837265|458796060|FG003|Pilot Phase|Decision of the investigator|0|||
127501507|NCT00837265|458796061|FG004|Pilot Phase|Decision of the investigator|0|||
127501508|NCT00837265|458796062|FG005|Pilot Phase|Decision of the investigator|0|||
127501509|NCT00837265|458796063|FG006|Pilot Phase|Decision of the investigator|0|||
127501510|NCT00837265|458796057|FG000|Pilot Phase|Adverse Event|1|||
127501511|NCT00837265|458796058|FG001|Pilot Phase|Adverse Event|0|||
127501512|NCT00837265|458796059|FG002|Pilot Phase|Adverse Event|0|||
127501513|NCT00837265|458796060|FG003|Pilot Phase|Adverse Event|0|||
127501514|NCT00837265|458796061|FG004|Pilot Phase|Adverse Event|0|||
127501515|NCT00837265|458796062|FG005|Pilot Phase|Adverse Event|0|||
127501516|NCT00837265|458796063|FG006|Pilot Phase|Adverse Event|0|||
127978128|NCT01546168|460542440|FG001|Overall Study|Lost to Follow-up|0|||
127978129|NCT01546168|460542439|FG000|Overall Study|Withdrawal by Subject|1|||
127978130|NCT01546168|460542440|FG001|Overall Study|Withdrawal by Subject|0|||
127978131|NCT01546168|460542439|FG000|Overall Study|ineligible after signing consent|2|||
127978132|NCT01546168|460542440|FG001|Overall Study|ineligible after signing consent|0|||
127978133|NCT02850016|460542441|FG000|Overall Study|Withdrawal by Subject|1|||
127501517|NCT00837265|458796057|FG000|Pilot Phase|Disease progression|0|||
127501518|NCT00837265|458796058|FG001|Pilot Phase|Disease progression|0|||
127501519|NCT00837265|458796059|FG002|Pilot Phase|Disease progression|0|||
127501520|NCT00837265|458796060|FG003|Pilot Phase|Disease progression|1|||
127501521|NCT00837265|458796061|FG004|Pilot Phase|Disease progression|0|||
127501522|NCT00837265|458796062|FG005|Pilot Phase|Disease progression|0|||
127501523|NCT00837265|458796063|FG006|Pilot Phase|Disease progression|0|||
127501524|NCT00837265|458796057|FG000|Pilot Phase|Participant left the city|0|||
127501525|NCT00837265|458796058|FG001|Pilot Phase|Participant left the city|0|||
127501526|NCT00837265|458796059|FG002|Pilot Phase|Participant left the city|0|||
127501527|NCT00837265|458796060|FG003|Pilot Phase|Participant left the city|1|||
127501528|NCT00837265|458796061|FG004|Pilot Phase|Participant left the city|0|||
127501529|NCT00837265|458796062|FG005|Pilot Phase|Participant left the city|0|||
127501530|NCT00837265|458796063|FG006|Pilot Phase|Participant left the city|0|||
127501531|NCT00837265|458796057|FG000|Main Phase|Withdrawal by Subject|0|||
127501532|NCT00837265|458796058|FG001|Main Phase|Withdrawal by Subject|0|||
127501533|NCT00837265|458796059|FG002|Main Phase|Withdrawal by Subject|0|||
127501534|NCT00837265|458796060|FG003|Main Phase|Withdrawal by Subject|0|||
127501535|NCT00837265|458796061|FG004|Main Phase|Withdrawal by Subject|4|||
127501536|NCT00837265|458796062|FG005|Main Phase|Withdrawal by Subject|2|||
127501537|NCT00837265|458796063|FG006|Main Phase|Withdrawal by Subject|1|||
127501538|NCT00837265|458796057|FG000|Main Phase|Decision of the investigator|0|||
127501539|NCT00837265|458796058|FG001|Main Phase|Decision of the investigator|0|||
127501540|NCT00837265|458796059|FG002|Main Phase|Decision of the investigator|0|||
127501541|NCT00837265|458796060|FG003|Main Phase|Decision of the investigator|0|||
127501542|NCT00837265|458796061|FG004|Main Phase|Decision of the investigator|0|||
127501543|NCT00837265|458796062|FG005|Main Phase|Decision of the investigator|2|||
127501544|NCT00837265|458796063|FG006|Main Phase|Decision of the investigator|1|||
127501545|NCT00837265|458796057|FG000|Main Phase|Adverse Event|0|||
127501546|NCT00837265|458796058|FG001|Main Phase|Adverse Event|0|||
127501547|NCT00837265|458796059|FG002|Main Phase|Adverse Event|0|||
127501548|NCT00837265|458796060|FG003|Main Phase|Adverse Event|0|||
127501549|NCT00837265|458796061|FG004|Main Phase|Adverse Event|0|||
127501550|NCT00837265|458796062|FG005|Main Phase|Adverse Event|1|||
127501551|NCT00837265|458796063|FG006|Main Phase|Adverse Event|0|||
127501552|NCT00837265|458796057|FG000|Main Phase|Death|0|||
127501553|NCT00837265|458796058|FG001|Main Phase|Death|0|||
127501554|NCT00837265|458796059|FG002|Main Phase|Death|0|||
127501555|NCT00837265|458796060|FG003|Main Phase|Death|0|||
127501556|NCT00837265|458796061|FG004|Main Phase|Death|2|||
127501557|NCT00837265|458796062|FG005|Main Phase|Death|0|||
127501558|NCT00837265|458796063|FG006|Main Phase|Death|1|||
127501559|NCT00837265|458796057|FG000|Main Phase|Lost to Follow-up|0|||
127501560|NCT00837265|458796058|FG001|Main Phase|Lost to Follow-up|0|||
127501561|NCT00837265|458796059|FG002|Main Phase|Lost to Follow-up|0|||
127501562|NCT00837265|458796060|FG003|Main Phase|Lost to Follow-up|0|||
127501563|NCT00837265|458796061|FG004|Main Phase|Lost to Follow-up|1|||
127501564|NCT00837265|458796062|FG005|Main Phase|Lost to Follow-up|0|||
127501565|NCT00837265|458796063|FG006|Main Phase|Lost to Follow-up|0|||
127501566|NCT00837265|458796057|FG000|Main Phase|Principal investigator resignation|0|||
127501567|NCT00837265|458796058|FG001|Main Phase|Principal investigator resignation|0|||
127501568|NCT00837265|458796059|FG002|Main Phase|Principal investigator resignation|0|||
127501569|NCT00837265|458796060|FG003|Main Phase|Principal investigator resignation|0|||
127501570|NCT00837265|458796061|FG004|Main Phase|Principal investigator resignation|2|||
127501571|NCT00837265|458796062|FG005|Main Phase|Principal investigator resignation|0|||
127501572|NCT00837265|458796063|FG006|Main Phase|Principal investigator resignation|0|||
127501573|NCT00837265|458796057|FG000|Main Phase|Participant's personal reason|0|||
127501574|NCT00837265|458796058|FG001|Main Phase|Participant's personal reason|0|||
127501575|NCT00837265|458796059|FG002|Main Phase|Participant's personal reason|0|||
127501576|NCT00837265|458796060|FG003|Main Phase|Participant's personal reason|0|||
127501577|NCT00837265|458796061|FG004|Main Phase|Participant's personal reason|1|||
127501578|NCT00837265|458796062|FG005|Main Phase|Participant's personal reason|0|||
127501579|NCT00837265|458796063|FG006|Main Phase|Participant's personal reason|0|||
127501580|NCT01289353|458796064|FG000|Overall Study|Lost to Follow-up|2|||
127501581|NCT00473668|458796065|FG000|Overall Study|Withdrawal by Subject|0|||
127501582|NCT00473668|458796066|FG001|Overall Study|Withdrawal by Subject|2|||
127501583|NCT00473668|458796067|FG002|Overall Study|Withdrawal by Subject|0|||
127501584|NCT00473668|458796065|FG000|Overall Study|Migrated/moved from study area|3|||
127501585|NCT00473668|458796066|FG001|Overall Study|Migrated/moved from study area|2|||
127501586|NCT00473668|458796067|FG002|Overall Study|Migrated/moved from study area|0|||
127501587|NCT00473668|458796065|FG000|Overall Study|Lost to Follow-up|0|||
127501588|NCT00473668|458796066|FG001|Overall Study|Lost to Follow-up|4|||
127501589|NCT00473668|458796067|FG002|Overall Study|Lost to Follow-up|6|||
127978134|NCT02850016|460542442|FG001|Overall Study|Withdrawal by Subject|2|||
127501590|NCT00473668|458796065|FG000|Overall Study|Other|2|||
127501591|NCT00473668|458796066|FG001|Overall Study|Other|3|||
127501592|NCT00473668|458796067|FG002|Overall Study|Other|4|||
127501593|NCT02226562|458796068|FG000|Overall Study|Lost to Follow-up|0|||
127501594|NCT02226562|458796069|FG001|Overall Study|Lost to Follow-up|1|||
127501595|NCT01474772|458796071|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
127501596|NCT01474772|458796072|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
127501597|NCT01474772|458796071|FG000|Period 1|AE not Related to Study Drug|1|||
127501598|NCT01474772|458796072|FG001|Period 1|AE not Related to Study Drug|0|||
127501599|NCT01474772|458796071|FG000|Period 1|Withdrawal by Subject|3|||
127501600|NCT01474772|458796072|FG001|Period 1|Withdrawal by Subject|1|||
127501601|NCT01474772|458796071|FG000|Period 1|Lost to Follow-up|1|||
127501602|NCT01474772|458796072|FG001|Period 1|Lost to Follow-up|0|||
127501603|NCT01474772|458796071|FG000|Period 1|Reason not Specified|1|||
127501604|NCT01474772|458796072|FG001|Period 1|Reason not Specified|1|||
127501605|NCT01474772|458796071|FG000|Washout|AE not Related to Study Drug|2|||
127501606|NCT01474772|458796072|FG001|Washout|AE not Related to Study Drug|0|||
127501607|NCT01474772|458796071|FG000|Washout|Withdrawal by Subject|1|||
127501608|NCT01474772|458796072|FG001|Washout|Withdrawal by Subject|0|||
127501609|NCT01474772|458796071|FG000|Washout|Lost to Follow-up|0|||
127501610|NCT01474772|458796072|FG001|Washout|Lost to Follow-up|1|||
127501611|NCT01474772|458796071|FG000|Washout|Reason not Specified|0|||
127501612|NCT01474772|458796072|FG001|Washout|Reason not Specified|1|||
127501613|NCT01474772|458796071|FG000|Period 2|Death|0|||
127501614|NCT01474772|458796072|FG001|Period 2|Death|1|||
127501615|NCT01474772|458796071|FG000|Period 2|AE Related to Study Drug|0|||
127501616|NCT01474772|458796072|FG001|Period 2|AE Related to Study Drug|1|||
127501617|NCT01474772|458796071|FG000|Period 2|AE not Related to Study Drug|4|||
127501618|NCT01474772|458796072|FG001|Period 2|AE not Related to Study Drug|1|||
127501619|NCT01474772|458796071|FG000|Period 2|Lack of Efficacy|1|||
127501620|NCT01474772|458796072|FG001|Period 2|Lack of Efficacy|0|||
127501621|NCT01474772|458796071|FG000|Period 2|Withdrawal by Subject|3|||
127501622|NCT01474772|458796072|FG001|Period 2|Withdrawal by Subject|4|||
127501623|NCT01474772|458796071|FG000|Period 2|Lost to Follow-up|1|||
127501624|NCT01474772|458796072|FG001|Period 2|Lost to Follow-up|1|||
127501625|NCT01474772|458796071|FG000|Period 2|Reason not Specified|0|||
127501626|NCT01474772|458796072|FG001|Period 2|Reason not Specified|2|||
127501627|NCT01474772|458796071|FG000|Follow-up|AE not Related to Study Drug|0|||
127501628|NCT01474772|458796072|FG001|Follow-up|AE not Related to Study Drug|1|||
127501629|NCT00223808|458796073|FG000|Overall Study|<5 hrs therapy before discharge|3|||
127501630|NCT00223808|458796074|FG001|Overall Study|<5 hrs therapy before discharge|5|||
127501631|NCT00223808|458796075|FG002|Overall Study|<5 hrs therapy before discharge|5|||
127501632|NCT03195660|458796076|FG000|Overall Study|The study was terminated|2|||
127501633|NCT05260073|458796078|FG000|Overall Study|Physician Decision|1|||
127501634|NCT05260073|458796078|FG000|Overall Study|Withdrawal by Subject|6|||
127501635|NCT05260073|458796078|FG000|Overall Study|Lost to Follow-up|14|||
127501636|NCT03458910|458796079|FG000|Overall Study|Withdrawal by Subject|7|||
127501637|NCT03458910|458796080|FG001|Overall Study|Withdrawal by Subject|8|||
127501638|NCT03458910|458796081|FG002|Overall Study|Withdrawal by Subject|6|||
127501639|NCT03458910|458796082|FG003|Overall Study|Withdrawal by Subject|4|||
127501640|NCT03458910|458796079|FG000|Overall Study|Study halted due to risk of catching COVID-19|0|||
127501641|NCT03458910|458796080|FG001|Overall Study|Study halted due to risk of catching COVID-19|0|||
127501642|NCT03458910|458796081|FG002|Overall Study|Study halted due to risk of catching COVID-19|3|||
127501643|NCT03458910|458796082|FG003|Overall Study|Study halted due to risk of catching COVID-19|3|||
127501644|NCT04484649|458796083|FG000|Overall Study|Lost to Follow-up|2|||
127501645|NCT04484649|458796084|FG001|Overall Study|Lost to Follow-up|1|||
127501646|NCT04484649|458796083|FG000|Overall Study|Did not submit actigraphy post interc\vention|6|||
127501647|NCT04484649|458796084|FG001|Overall Study|Did not submit actigraphy post interc\vention|4|||
127501648|NCT01450696|458796087|FG000|Overall Study|Never Treated|1|||
127501649|NCT01450696|458796088|FG001|Overall Study|Never Treated|1|||
127501650|NCT01450696|458796087|FG000|Overall Study|Death|77|||
127501651|NCT01450696|458796088|FG001|Overall Study|Death|84|||
127501652|NCT01450696|458796087|FG000|Overall Study|Lost to Follow-up|3|||
127501653|NCT01450696|458796088|FG001|Overall Study|Lost to Follow-up|3|||
127501654|NCT01450696|458796087|FG000|Overall Study|Non-Compliance|1|||
127501655|NCT01450696|458796088|FG001|Overall Study|Non-Compliance|0|||
127501656|NCT01450696|458796087|FG000|Overall Study|Withdrawal by Subject|13|||
127501657|NCT01450696|458796088|FG001|Overall Study|Withdrawal by Subject|2|||
127501658|NCT01450696|458796087|FG000|Overall Study|Study Terminated by Sponsor|53|||
127501659|NCT01450696|458796088|FG001|Overall Study|Study Terminated by Sponsor|58|||
127501660|NCT01843673|458796091|FG000|Overall Study|Lack of Efficacy|2|||
127501661|NCT01843673|458796091|FG000|Overall Study|Withdrawal by Subject|4|||
127501662|NCT02321319|458796092|FG000|Overall Study|Product discontinued|5|||
127501663|NCT00152477|458796093|FG000|Chemotherapy Period|Adverse Event|9|||
127501664|NCT00152477|458796094|FG001|Chemotherapy Period|Adverse Event|4|||
127501665|NCT00152477|458796095|FG002|Chemotherapy Period|Adverse Event|5|||
127501666|NCT00152477|458796093|FG000|Chemotherapy Period|Death|1|||
127501667|NCT00152477|458796094|FG001|Chemotherapy Period|Death|3|||
127978135|NCT02954653|460542443|FG000|Overall Study|Death|3|||
127978136|NCT02954653|460542444|FG001|Overall Study|Death|1|||
127501668|NCT00152477|458796095|FG002|Chemotherapy Period|Death|3|||
127501669|NCT00152477|458796093|FG000|Chemotherapy Period|Lack of Efficacy|4|||
127501670|NCT00152477|458796094|FG001|Chemotherapy Period|Lack of Efficacy|5|||
127501671|NCT00152477|458796095|FG002|Chemotherapy Period|Lack of Efficacy|6|||
127501672|NCT00152477|458796093|FG000|Chemotherapy Period|Lost to Follow-up|1|||
127501673|NCT00152477|458796094|FG001|Chemotherapy Period|Lost to Follow-up|0|||
127501674|NCT00152477|458796095|FG002|Chemotherapy Period|Lost to Follow-up|1|||
127501675|NCT00152477|458796093|FG000|Chemotherapy Period|Protocol Violation|1|||
127501676|NCT00152477|458796094|FG001|Chemotherapy Period|Protocol Violation|1|||
127501677|NCT00152477|458796095|FG002|Chemotherapy Period|Protocol Violation|0|||
127501678|NCT00152477|458796093|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
127501679|NCT00152477|458796094|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
127501680|NCT00152477|458796095|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
127501681|NCT00152477|458796093|FG000|Chemotherapy Period|Progression of Disease|6|||
127501682|NCT00152477|458796094|FG001|Chemotherapy Period|Progression of Disease|8|||
127978137|NCT02954653|460542445|FG002|Overall Study|Death|0|||
127501683|NCT00152477|458796095|FG002|Chemotherapy Period|Progression of Disease|4|||
127501684|NCT00152477|458796093|FG000|Chemotherapy Period|Investigator decision|0|||
127501685|NCT00152477|458796094|FG001|Chemotherapy Period|Investigator decision|0|||
127501686|NCT00152477|458796095|FG002|Chemotherapy Period|Investigator decision|1|||
127501687|NCT00152477|458796093|FG000|Chemotherapy Period|Patient condition worsened|1|||
127501688|NCT00152477|458796094|FG001|Chemotherapy Period|Patient condition worsened|0|||
127501689|NCT00152477|458796095|FG002|Chemotherapy Period|Patient condition worsened|0|||
127501690|NCT00152477|458796093|FG000|Monotherapy Period|Adverse Event|1|||
127501691|NCT00152477|458796094|FG001|Monotherapy Period|Adverse Event|0|||
127501692|NCT00152477|458796095|FG002|Monotherapy Period|Adverse Event|5|||
127501693|NCT00152477|458796093|FG000|Monotherapy Period|Death|2|||
127501694|NCT00152477|458796094|FG001|Monotherapy Period|Death|0|||
127501695|NCT00152477|458796095|FG002|Monotherapy Period|Death|1|||
127501696|NCT00152477|458796093|FG000|Monotherapy Period|Lack of Efficacy|7|||
127501697|NCT00152477|458796094|FG001|Monotherapy Period|Lack of Efficacy|16|||
127501698|NCT00152477|458796095|FG002|Monotherapy Period|Lack of Efficacy|10|||
127501699|NCT00152477|458796093|FG000|Monotherapy Period|Protocol Violation|0|||
127501700|NCT00152477|458796094|FG001|Monotherapy Period|Protocol Violation|1|||
127501701|NCT00152477|458796095|FG002|Monotherapy Period|Protocol Violation|0|||
127501702|NCT00152477|458796093|FG000|Monotherapy Period|Withdrawal by Subject|0|||
127501703|NCT00152477|458796094|FG001|Monotherapy Period|Withdrawal by Subject|0|||
127501704|NCT00152477|458796095|FG002|Monotherapy Period|Withdrawal by Subject|4|||
127501705|NCT00152477|458796093|FG000|Monotherapy Period|Progression of Disease|5|||
127501706|NCT00152477|458796094|FG001|Monotherapy Period|Progression of Disease|11|||
127501707|NCT00152477|458796095|FG002|Monotherapy Period|Progression of Disease|12|||
127501708|NCT00152477|458796093|FG000|Monotherapy Period|Patient decision|0|||
127501709|NCT00152477|458796094|FG001|Monotherapy Period|Patient decision|1|||
127501710|NCT00152477|458796095|FG002|Monotherapy Period|Patient decision|1|||
127501711|NCT00152477|458796093|FG000|Monotherapy Period|Study personel decision|0|||
127501712|NCT00152477|458796094|FG001|Monotherapy Period|Study personel decision|0|||
127501713|NCT00152477|458796095|FG002|Monotherapy Period|Study personel decision|1|||
127501714|NCT02249091|458796096|FG000|Overall Study|Lack of Efficacy|8|||
127501715|NCT02249091|458796097|FG001|Overall Study|Lack of Efficacy|3|||
127501716|NCT02249091|458796096|FG000|Overall Study|Physician Decision|4|||
127501717|NCT02249091|458796097|FG001|Overall Study|Physician Decision|1|||
127501718|NCT02249091|458796096|FG000|Overall Study|Withdrawal by Subject|2|||
127501719|NCT02249091|458796097|FG001|Overall Study|Withdrawal by Subject|2|||
127501720|NCT02249091|458796096|FG000|Overall Study|Death|3|||
127501721|NCT02249091|458796097|FG001|Overall Study|Death|4|||
127501722|NCT02249091|458796096|FG000|Overall Study|Adverse Event|1|||
127501723|NCT02249091|458796097|FG001|Overall Study|Adverse Event|0|||
127501724|NCT02249091|458796096|FG000|Overall Study|Stable disease with following SCT|0|||
127501725|NCT02249091|458796097|FG001|Overall Study|Stable disease with following SCT|1|||
127501726|NCT02249091|458796096|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
127501727|NCT02249091|458796097|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
127501728|NCT02249091|458796096|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
127501729|NCT02249091|458796097|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
127501730|NCT02249091|458796096|FG000|Overall Study|Refractory AML|1|||
127501731|NCT02249091|458796097|FG001|Overall Study|Refractory AML|1|||
127501732|NCT01328535|458796101|FG000|Overall Study|Ineligible|1|||
127501733|NCT01005316|458796102|FG000|Overall Study|Adverse Event|0|||
127501734|NCT01005316|458796103|FG001|Overall Study|Adverse Event|0|||
127501735|NCT01005316|458796104|FG002|Overall Study|Adverse Event|0|||
127501736|NCT01005316|458796105|FG003|Overall Study|Adverse Event|1|||
127501737|NCT01005316|458796102|FG000|Overall Study|Death|20|||
127501738|NCT01005316|458796103|FG001|Overall Study|Death|5|||
127501739|NCT01005316|458796104|FG002|Overall Study|Death|1|||
127501740|NCT01005316|458796105|FG003|Overall Study|Death|15|||
127501741|NCT01005316|458796102|FG000|Overall Study|Study Termination|5|||
127501742|NCT01005316|458796103|FG001|Overall Study|Study Termination|63|||
127501743|NCT01005316|458796104|FG002|Overall Study|Study Termination|9|||
127501744|NCT01005316|458796105|FG003|Overall Study|Study Termination|85|||
127501745|NCT01005316|458796102|FG000|Overall Study|Lost to Follow-up|1|||
127978138|NCT02954653|460542446|FG003|Overall Study|Death|0|||
127501746|NCT01005316|458796103|FG001|Overall Study|Lost to Follow-up|3|||
127501747|NCT01005316|458796104|FG002|Overall Study|Lost to Follow-up|0|||
127501748|NCT01005316|458796105|FG003|Overall Study|Lost to Follow-up|2|||
127501749|NCT01005316|458796102|FG000|Overall Study|Physician Decision|6|||
127501750|NCT01005316|458796103|FG001|Overall Study|Physician Decision|0|||
127501751|NCT01005316|458796104|FG002|Overall Study|Physician Decision|0|||
127501752|NCT01005316|458796105|FG003|Overall Study|Physician Decision|0|||
127501753|NCT01005316|458796102|FG000|Overall Study|Sponsor Decision|6|||
127501754|NCT01005316|458796103|FG001|Overall Study|Sponsor Decision|3|||
127501755|NCT01005316|458796104|FG002|Overall Study|Sponsor Decision|0|||
127501756|NCT01005316|458796105|FG003|Overall Study|Sponsor Decision|0|||
127501757|NCT01005316|458796102|FG000|Overall Study|Withdrawal by Subject|1|||
127501758|NCT01005316|458796103|FG001|Overall Study|Withdrawal by Subject|1|||
127978139|NCT02954653|460542447|FG004|Overall Study|Death|0|||
127501759|NCT01005316|458796104|FG002|Overall Study|Withdrawal by Subject|0|||
127501760|NCT01005316|458796105|FG003|Overall Study|Withdrawal by Subject|2|||
127501761|NCT01005316|458796102|FG000|Overall Study|Consented to Another Study|2|||
127501762|NCT01005316|458796103|FG001|Overall Study|Consented to Another Study|0|||
127501763|NCT01005316|458796104|FG002|Overall Study|Consented to Another Study|0|||
127501764|NCT01005316|458796105|FG003|Overall Study|Consented to Another Study|0|||
127501765|NCT01005316|458796102|FG000|Overall Study|Delisted|8|||
127501766|NCT01005316|458796103|FG001|Overall Study|Delisted|0|||
127501767|NCT01005316|458796104|FG002|Overall Study|Delisted|0|||
127501768|NCT01005316|458796105|FG003|Overall Study|Delisted|0|||
127501769|NCT01005316|458796102|FG000|Overall Study|Transferred Care|1|||
127501770|NCT01005316|458796103|FG001|Overall Study|Transferred Care|0|||
127501771|NCT01005316|458796104|FG002|Overall Study|Transferred Care|1|||
127501772|NCT01005316|458796105|FG003|Overall Study|Transferred Care|3|||
127501773|NCT01005316|458796102|FG000|Overall Study|Retransplanted|0|||
127501774|NCT01005316|458796103|FG001|Overall Study|Retransplanted|1|||
127501775|NCT01005316|458796104|FG002|Overall Study|Retransplanted|0|||
127501776|NCT01005316|458796105|FG003|Overall Study|Retransplanted|0|||
127501777|NCT00960011|458796106|FG000|Overall Study|Death|5|||
127501778|NCT00960011|458796107|FG001|Overall Study|Death|0|||
127501779|NCT00960011|458796106|FG000|Overall Study|Lost to Follow-up|6|||
127501780|NCT00960011|458796107|FG001|Overall Study|Lost to Follow-up|2|||
127501781|NCT04417218|458796108|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
127501782|NCT04417218|458796109|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
127501783|NCT00873041|458796112|FG000|Core Study|Adverse Event|2|||
127501784|NCT00873041|458796113|FG001|Core Study|Adverse Event|3|||
127501785|NCT00873041|458796114|FG002|Core Study|Adverse Event|1|||
127501786|NCT00873041|458796112|FG000|Core Study|Withdrawal by Subject|1|||
127501787|NCT00873041|458796113|FG001|Core Study|Withdrawal by Subject|2|||
127501788|NCT00873041|458796114|FG002|Core Study|Withdrawal by Subject|2|||
127501789|NCT00873041|458796112|FG000|Core Study|Lost to Follow-up|3|||
127501790|NCT00873041|458796113|FG001|Core Study|Lost to Follow-up|1|||
127501791|NCT00873041|458796114|FG002|Core Study|Lost to Follow-up|0|||
127501792|NCT00873041|458796112|FG000|Core Study|Abnormal laboratory value|0|||
127501793|NCT00873041|458796113|FG001|Core Study|Abnormal laboratory value|0|||
127501794|NCT00873041|458796114|FG002|Core Study|Abnormal laboratory value|1|||
127501795|NCT00873041|458796112|FG000|Core Study|Protocol deviation|1|||
127501796|NCT00873041|458796113|FG001|Core Study|Protocol deviation|0|||
127501797|NCT00873041|458796114|FG002|Core Study|Protocol deviation|1|||
127501798|NCT00873041|458796112|FG000|Extension Study|Adverse Event|1|||
127501799|NCT00873041|458796113|FG001|Extension Study|Adverse Event|0|||
127501800|NCT00873041|458796114|FG002|Extension Study|Adverse Event|1|||
127501801|NCT00873041|458796112|FG000|Extension Study|Administrative reasons|0|||
127501802|NCT00873041|458796113|FG001|Extension Study|Administrative reasons|0|||
127501803|NCT00873041|458796114|FG002|Extension Study|Administrative reasons|1|||
127501804|NCT01734395|458796117|FG000|Overall Study|Other|65|||
127501805|NCT01734395|458796117|FG000|Overall Study|Lost to Follow-up|287|||
127501806|NCT01734395|458796117|FG000|Overall Study|Lack of Efficacy|5|||
127501807|NCT01734395|458796117|FG000|Overall Study|Adverse Event|40|||
127501808|NCT01734395|458796117|FG000|Overall Study|Withdrawal by Subject|10|||
127501809|NCT01734395|458796117|FG000|Overall Study|Missing the reasons for not completed|3|||
127501810|NCT01032291|458796118|FG000|Safety Lead-in|Adverse Event|1|||
127501811|NCT01032291|458796119|FG001|Safety Lead-in|Adverse Event|0|||
127501812|NCT01032291|458796120|FG002|Safety Lead-in|Adverse Event|0|||
127501813|NCT01032291|458796118|FG000|Safety Lead-in|Death|1|||
127501814|NCT01032291|458796119|FG001|Safety Lead-in|Death|0|||
127501815|NCT01032291|458796120|FG002|Safety Lead-in|Death|0|||
127501816|NCT01032291|458796118|FG000|Proof of Concept|Adverse Event|0|||
127501817|NCT01032291|458796119|FG001|Proof of Concept|Adverse Event|5|||
127501818|NCT01032291|458796120|FG002|Proof of Concept|Adverse Event|1|||
127501819|NCT01032291|458796118|FG000|Proof of Concept|Death|0|||
127501820|NCT01032291|458796119|FG001|Proof of Concept|Death|1|||
127501821|NCT01032291|458796120|FG002|Proof of Concept|Death|2|||
127501822|NCT01032291|458796118|FG000|Proof of Concept|Lack of Efficacy|0|||
127501823|NCT01032291|458796119|FG001|Proof of Concept|Lack of Efficacy|1|||
127501824|NCT01032291|458796120|FG002|Proof of Concept|Lack of Efficacy|0|||
127501825|NCT01032291|458796118|FG000|Proof of Concept|Never Received Study Drug|0|||
127501826|NCT01032291|458796119|FG001|Proof of Concept|Never Received Study Drug|1|||
127978140|NCT02954653|460542448|FG005|Overall Study|Death|0|||
127978141|NCT02954653|460542449|FG006|Overall Study|Death|0|||
127501827|NCT01032291|458796120|FG002|Proof of Concept|Never Received Study Drug|0|||
127501828|NCT00313313|458796121|FG000|Overall Study|Lack of Efficacy|14|||
127501829|NCT00313313|458796122|FG001|Overall Study|Lack of Efficacy|9|||
127501830|NCT00313313|458796123|FG002|Overall Study|Lack of Efficacy|20|||
127501831|NCT00313313|458796121|FG000|Overall Study|Withdrawal of consent by subject|18|||
127501832|NCT00313313|458796122|FG001|Overall Study|Withdrawal of consent by subject|17|||
127501833|NCT00313313|458796123|FG002|Overall Study|Withdrawal of consent by subject|31|||
127501834|NCT00313313|458796121|FG000|Overall Study|Lost to Follow-up|10|||
127501835|NCT00313313|458796122|FG001|Overall Study|Lost to Follow-up|7|||
127501836|NCT00313313|458796123|FG002|Overall Study|Lost to Follow-up|9|||
127501837|NCT00313313|458796121|FG000|Overall Study|Adverse Event|15|||
127501838|NCT00313313|458796122|FG001|Overall Study|Adverse Event|16|||
127501839|NCT00313313|458796123|FG002|Overall Study|Adverse Event|12|||
127501840|NCT00313313|458796121|FG000|Overall Study|Physician Decision|2|||
127501841|NCT00313313|458796122|FG001|Overall Study|Physician Decision|6|||
127501842|NCT00313313|458796123|FG002|Overall Study|Physician Decision|4|||
127501843|NCT00313313|458796121|FG000|Overall Study|Poor/Noncompliance|3|||
127501844|NCT00313313|458796122|FG001|Overall Study|Poor/Noncompliance|6|||
127501845|NCT00313313|458796123|FG002|Overall Study|Poor/Noncompliance|2|||
127501846|NCT00313313|458796121|FG000|Overall Study|Pregnancy|1|||
127501847|NCT00313313|458796122|FG001|Overall Study|Pregnancy|2|||
127501848|NCT00313313|458796123|FG002|Overall Study|Pregnancy|0|||
127501849|NCT00313313|458796121|FG000|Overall Study|Death|0|||
127501850|NCT00313313|458796122|FG001|Overall Study|Death|0|||
127501851|NCT00313313|458796123|FG002|Overall Study|Death|2|||
127501852|NCT00313313|458796121|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
127501853|NCT00313313|458796122|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
127501854|NCT00313313|458796123|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
127501855|NCT00758264|458796126|FG000|Active Phase|Withdrawal by Subject|0|||
127501856|NCT00758264|458796127|FG001|Active Phase|Withdrawal by Subject|0|||
127501857|NCT00758264|458796128|FG002|Active Phase|Withdrawal by Subject|1|||
127501858|NCT00758264|458796126|FG000|Active Phase|Lost to Follow-up|1|||
127501859|NCT00758264|458796127|FG001|Active Phase|Lost to Follow-up|0|||
127501860|NCT00758264|458796128|FG002|Active Phase|Lost to Follow-up|0|||
127501861|NCT00758264|458796126|FG000|Active Phase|Other|0|||
127501862|NCT00758264|458796127|FG001|Active Phase|Other|0|||
127501863|NCT00758264|458796128|FG002|Active Phase|Other|4|||
127501864|NCT03425006|458796129|FG000|Overall Study|Withdrawal by Subject|1|||
127501865|NCT03425006|458796129|FG000|Overall Study|Physician Decision|1|||
127501866|NCT03425006|458796129|FG000|Overall Study|Death|1|||
127501867|NCT00695955|458796136|FG000|Cohort 1|Adverse Event|26|||
127501868|NCT00695955|458796136|FG000|Cohort 1|Protocol Violation|2|||
127501869|NCT00695955|458796136|FG000|Cohort 1|Lost to Follow-up|30|||
127501870|NCT00695955|458796136|FG000|Cohort 1|Withdrawal by Subject|25|||
127978142|NCT02954653|460542450|FG007|Overall Study|Death|0|||
127978143|NCT02954653|460542451|FG008|Overall Study|Death|0|||
127978144|NCT02954653|460542443|FG000|Overall Study|Randomized but did not receive treatment|1|||
127978145|NCT02954653|460542444|FG001|Overall Study|Randomized but did not receive treatment|0|||
127978146|NCT02954653|460542445|FG002|Overall Study|Randomized but did not receive treatment|0|||
127978147|NCT02954653|460542446|FG003|Overall Study|Randomized but did not receive treatment|0|||
127978148|NCT02954653|460542447|FG004|Overall Study|Randomized but did not receive treatment|0|||
127978149|NCT02954653|460542448|FG005|Overall Study|Randomized but did not receive treatment|0|||
127978150|NCT02954653|460542449|FG006|Overall Study|Randomized but did not receive treatment|0|||
127978151|NCT02954653|460542450|FG007|Overall Study|Randomized but did not receive treatment|0|||
127978152|NCT02954653|460542451|FG008|Overall Study|Randomized but did not receive treatment|0|||
127978153|NCT02954653|460542443|FG000|Overall Study|Started another anti-cancer therapy|0|||
127978154|NCT02954653|460542444|FG001|Overall Study|Started another anti-cancer therapy|1|||
127978155|NCT02954653|460542445|FG002|Overall Study|Started another anti-cancer therapy|0|||
127501871|NCT00695955|458796136|FG000|Cohort 1|Lack of Efficacy|3|||
127501872|NCT00695955|458796136|FG000|Cohort 1|Other|16|||
127501873|NCT00695955|458796136|FG000|Cohort 2|Adverse Event|24|||
127501874|NCT00695955|458796136|FG000|Cohort 2|Protocol Violation|5|||
127501875|NCT00695955|458796136|FG000|Cohort 2|Lost to Follow-up|38|||
127501876|NCT00695955|458796136|FG000|Cohort 2|Withdrawal by Subject|28|||
127978156|NCT02954653|460542446|FG003|Overall Study|Started another anti-cancer therapy|0|||
127501877|NCT00695955|458796136|FG000|Cohort 2|Lack of Efficacy|4|||
127501878|NCT00695955|458796136|FG000|Cohort 2|Other|5|||
127501879|NCT00888329|458796137|FG000|Overall Study|Physician Decision|6|||
127501880|NCT00888329|458796138|FG001|Overall Study|Physician Decision|9|||
127501881|NCT00939029|458796139|FG000|Overall Study|Withdrawal by Subject|3|||
127501882|NCT00939029|458796140|FG001|Overall Study|Withdrawal by Subject|7|||
127978157|NCT02954653|460542447|FG004|Overall Study|Started another anti-cancer therapy|0|||
127978158|NCT02954653|460542448|FG005|Overall Study|Started another anti-cancer therapy|0|||
127978159|NCT02954653|460542449|FG006|Overall Study|Started another anti-cancer therapy|0|||
127978160|NCT02954653|460542450|FG007|Overall Study|Started another anti-cancer therapy|0|||
127978161|NCT02954653|460542451|FG008|Overall Study|Started another anti-cancer therapy|0|||
127978162|NCT02954653|460542443|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
127501883|NCT00939029|458796139|FG000|Overall Study|Lost to Follow-up|3|||
127501884|NCT00939029|458796140|FG001|Overall Study|Lost to Follow-up|4|||
127978163|NCT02954653|460542444|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
127501885|NCT00939029|458796139|FG000|Overall Study|Adverse Event|0|||
127501886|NCT00939029|458796140|FG001|Overall Study|Adverse Event|1|||
127501887|NCT06003777|458796141|FG000|Period 1|Adverse Event|0|||
127501888|NCT06003777|458796142|FG001|Period 1|Adverse Event|0|||
127501889|NCT06003777|458796143|FG002|Period 1|Adverse Event|1|||
127501890|NCT06003777|458796144|FG003|Period 1|Adverse Event|0|||
127501891|NCT06003777|458796145|FG004|Period 1|Adverse Event|0|||
127501892|NCT06003777|458796146|FG005|Period 1|Adverse Event|0|||
127501893|NCT06003777|458796147|FG006|Period 1|Adverse Event|0|||
127501894|NCT06003777|458796148|FG007|Period 1|Adverse Event|0|||
127501895|NCT06003777|458796149|FG008|Period 1|Adverse Event|0|||
127501896|NCT06003777|458796150|FG009|Period 1|Adverse Event|0|||
127501897|NCT06003777|458796151|FG010|Period 1|Adverse Event|0|||
127501898|NCT06003777|458796152|FG011|Period 1|Adverse Event|0|||
127501899|NCT06003777|458796141|FG000|Period 1|Withdrawal by Subject|0|||
127501900|NCT06003777|458796142|FG001|Period 1|Withdrawal by Subject|0|||
127501901|NCT06003777|458796143|FG002|Period 1|Withdrawal by Subject|0|||
127501902|NCT06003777|458796144|FG003|Period 1|Withdrawal by Subject|0|||
127501903|NCT06003777|458796145|FG004|Period 1|Withdrawal by Subject|1|||
127501904|NCT06003777|458796146|FG005|Period 1|Withdrawal by Subject|0|||
127501905|NCT06003777|458796147|FG006|Period 1|Withdrawal by Subject|0|||
127501906|NCT06003777|458796148|FG007|Period 1|Withdrawal by Subject|0|||
127501907|NCT06003777|458796149|FG008|Period 1|Withdrawal by Subject|0|||
127501908|NCT06003777|458796150|FG009|Period 1|Withdrawal by Subject|0|||
127501909|NCT06003777|458796151|FG010|Period 1|Withdrawal by Subject|0|||
127501910|NCT06003777|458796152|FG011|Period 1|Withdrawal by Subject|0|||
127501911|NCT06003777|458796141|FG000|Period 2|Withdrawal by Subject|0|||
127501912|NCT06003777|458796142|FG001|Period 2|Withdrawal by Subject|0|||
127501913|NCT06003777|458796143|FG002|Period 2|Withdrawal by Subject|0|||
127501914|NCT06003777|458796144|FG003|Period 2|Withdrawal by Subject|0|||
127501915|NCT06003777|458796145|FG004|Period 2|Withdrawal by Subject|0|||
127501916|NCT06003777|458796146|FG005|Period 2|Withdrawal by Subject|0|||
127501917|NCT06003777|458796147|FG006|Period 2|Withdrawal by Subject|0|||
127501918|NCT06003777|458796148|FG007|Period 2|Withdrawal by Subject|0|||
127501919|NCT06003777|458796149|FG008|Period 2|Withdrawal by Subject|1|||
127501920|NCT06003777|458796150|FG009|Period 2|Withdrawal by Subject|0|||
127501921|NCT06003777|458796151|FG010|Period 2|Withdrawal by Subject|0|||
127501922|NCT06003777|458796152|FG011|Period 2|Withdrawal by Subject|0|||
127501923|NCT06003777|458796141|FG000|Period 3|Adverse Event|0|||
127501924|NCT06003777|458796142|FG001|Period 3|Adverse Event|0|||
127501925|NCT06003777|458796143|FG002|Period 3|Adverse Event|0|||
127501926|NCT06003777|458796144|FG003|Period 3|Adverse Event|0|||
127501927|NCT06003777|458796145|FG004|Period 3|Adverse Event|0|||
127501928|NCT06003777|458796146|FG005|Period 3|Adverse Event|0|||
127501929|NCT06003777|458796147|FG006|Period 3|Adverse Event|1|||
127501930|NCT06003777|458796148|FG007|Period 3|Adverse Event|0|||
127501931|NCT06003777|458796149|FG008|Period 3|Adverse Event|0|||
127501932|NCT06003777|458796150|FG009|Period 3|Adverse Event|0|||
127501933|NCT06003777|458796151|FG010|Period 3|Adverse Event|0|||
127501934|NCT06003777|458796152|FG011|Period 3|Adverse Event|0|||
127501935|NCT06003777|458796141|FG000|Period 4|No longer met eligibility criteria|0|||
127501936|NCT06003777|458796142|FG001|Period 4|No longer met eligibility criteria|0|||
127501937|NCT06003777|458796143|FG002|Period 4|No longer met eligibility criteria|1|||
127501938|NCT06003777|458796144|FG003|Period 4|No longer met eligibility criteria|0|||
127501939|NCT06003777|458796145|FG004|Period 4|No longer met eligibility criteria|0|||
127501940|NCT06003777|458796146|FG005|Period 4|No longer met eligibility criteria|0|||
127501941|NCT06003777|458796147|FG006|Period 4|No longer met eligibility criteria|0|||
127501942|NCT06003777|458796148|FG007|Period 4|No longer met eligibility criteria|0|||
127501943|NCT06003777|458796149|FG008|Period 4|No longer met eligibility criteria|0|||
127501944|NCT06003777|458796150|FG009|Period 4|No longer met eligibility criteria|0|||
127501945|NCT06003777|458796151|FG010|Period 4|No longer met eligibility criteria|0|||
127501946|NCT06003777|458796152|FG011|Period 4|No longer met eligibility criteria|0|||
127501947|NCT06003777|458796141|FG000|Period 4|Withdrawal by Subject|0|||
127501948|NCT06003777|458796142|FG001|Period 4|Withdrawal by Subject|1|||
127501949|NCT06003777|458796143|FG002|Period 4|Withdrawal by Subject|0|||
127501950|NCT06003777|458796144|FG003|Period 4|Withdrawal by Subject|0|||
127501951|NCT06003777|458796145|FG004|Period 4|Withdrawal by Subject|0|||
127501952|NCT06003777|458796146|FG005|Period 4|Withdrawal by Subject|0|||
127501953|NCT06003777|458796147|FG006|Period 4|Withdrawal by Subject|0|||
127978164|NCT02954653|460542445|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
127501954|NCT06003777|458796148|FG007|Period 4|Withdrawal by Subject|0|||
127501955|NCT06003777|458796149|FG008|Period 4|Withdrawal by Subject|0|||
127501956|NCT06003777|458796150|FG009|Period 4|Withdrawal by Subject|0|||
127501957|NCT06003777|458796151|FG010|Period 4|Withdrawal by Subject|0|||
127501958|NCT06003777|458796152|FG011|Period 4|Withdrawal by Subject|0|||
127501959|NCT01106651|458796153|FG000|Overall Study|Adverse Event|17|||
127501960|NCT01106651|458796154|FG001|Overall Study|Adverse Event|9|||
127501961|NCT01106651|458796155|FG002|Overall Study|Adverse Event|23|||
127501962|NCT01106651|458796153|FG000|Overall Study|Lost to Follow-up|8|||
127501963|NCT01106651|458796154|FG001|Overall Study|Lost to Follow-up|2|||
127501964|NCT01106651|458796155|FG002|Overall Study|Lost to Follow-up|6|||
127501965|NCT01106651|458796153|FG000|Overall Study|Physician Decision|4|||
127501966|NCT01106651|458796154|FG001|Overall Study|Physician Decision|3|||
127501967|NCT01106651|458796155|FG002|Overall Study|Physician Decision|1|||
127501968|NCT01106651|458796153|FG000|Overall Study|Protocol Violation|1|||
127501969|NCT01106651|458796154|FG001|Overall Study|Protocol Violation|2|||
127501970|NCT01106651|458796155|FG002|Overall Study|Protocol Violation|1|||
127501971|NCT01106651|458796153|FG000|Overall Study|Withdrawal by Subject|14|||
127501972|NCT01106651|458796154|FG001|Overall Study|Withdrawal by Subject|7|||
127501973|NCT01106651|458796155|FG002|Overall Study|Withdrawal by Subject|4|||
127501974|NCT01106651|458796153|FG000|Overall Study|Noncompliance with study drug|1|||
127501975|NCT01106651|458796154|FG001|Overall Study|Noncompliance with study drug|0|||
127501976|NCT01106651|458796155|FG002|Overall Study|Noncompliance with study drug|2|||
127501977|NCT01106651|458796153|FG000|Overall Study|Other|34|||
127501978|NCT01106651|458796154|FG001|Overall Study|Other|31|||
127501979|NCT01106651|458796155|FG002|Overall Study|Other|21|||
127501980|NCT01106651|458796153|FG000|Overall Study|Death|0|||
127501981|NCT01106651|458796154|FG001|Overall Study|Death|3|||
127501982|NCT01106651|458796155|FG002|Overall Study|Death|0|||
127501983|NCT00613327|458796159|FG000|Overall Study|Adverse Event|38|||
127501984|NCT00613327|458796159|FG000|Overall Study|Lost to Follow-up|8|||
127501985|NCT00613327|458796159|FG000|Overall Study|Withdrawal by Subject|6|||
127501986|NCT00613327|458796159|FG000|Overall Study|Protocol Violation|2|||
127501987|NCT00613327|458796159|FG000|Overall Study|Other|47|||
127501988|NCT03832322|458796162|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
127501989|NCT03832322|458796163|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
127501990|NCT00290771|458796166|FG000|Overall Study|Disease progression|95|||
127501991|NCT00290771|458796167|FG001|Overall Study|Disease progression|73|||
127501992|NCT00290771|458796166|FG000|Overall Study|Death|11|||
127501993|NCT00290771|458796167|FG001|Overall Study|Death|10|||
127501994|NCT00290771|458796166|FG000|Overall Study|Adverse Event|12|||
127501995|NCT00290771|458796167|FG001|Overall Study|Adverse Event|6|||
127501996|NCT00290771|458796166|FG000|Overall Study|Withdrawal by Subject|5|||
127501997|NCT00290771|458796167|FG001|Overall Study|Withdrawal by Subject|6|||
127501998|NCT00290771|458796166|FG000|Overall Study|Administrative problems|2|||
127501999|NCT00290771|458796167|FG001|Overall Study|Administrative problems|1|||
127502000|NCT00290771|458796166|FG000|Overall Study|Protocol Violation|2|||
127502001|NCT00290771|458796167|FG001|Overall Study|Protocol Violation|0|||
127502002|NCT00290771|458796166|FG000|Overall Study|Lost to Follow-up|0|||
127502003|NCT00290771|458796167|FG001|Overall Study|Lost to Follow-up|1|||
127502004|NCT00244933|458796170|FG000|Overall Study|Not response evaluable|2|||
127502005|NCT02487654|458796173|FG000|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|0|||
127502006|NCT02487654|458796174|FG001|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|4|||
127502007|NCT02487654|458796173|FG000|Overall Study|Withdrawal by Subject|3|||
127502008|NCT02487654|458796174|FG001|Overall Study|Withdrawal by Subject|7|||
127502009|NCT02247011|458796175|FG000|Overall Study|Poor quality of radiological results|125|||
127502010|NCT03718884|458796176|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
127502011|NCT03718884|458796177|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
127502012|NCT03718884|458796176|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
127502013|NCT03718884|458796177|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
127502014|NCT04700540|458796178|FG000|Overall Study|Withdrawal by Subject|12|||
127502015|NCT04700540|458796179|FG001|Overall Study|Withdrawal by Subject|8|||
127502016|NCT04700540|458796178|FG000|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|28|||
127502017|NCT04700540|458796179|FG001|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|0|||
127502018|NCT03724981|458798062|FG000|First Device|Protocol Violation|1|||
127502019|NCT03724981|458798063|FG001|First Device|Protocol Violation|1|||
127502020|NCT00197145|458798064|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
127502021|NCT00197145|458798065|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
127502022|NCT00197145|458798064|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
127502023|NCT00197145|458798065|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
127502024|NCT00197145|458798064|FG000|Period 1: Randomized Treatment Phase|Other|2|||
127502025|NCT00197145|458798065|FG001|Period 1: Randomized Treatment Phase|Other|2|||
127502026|NCT00197145|458798064|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
127502027|NCT00197145|458798065|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
127502028|NCT00197145|458798064|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
127502029|NCT00197145|458798065|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
127502030|NCT00197145|458798064|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
127502031|NCT00197145|458798065|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
127502032|NCT00197145|458798064|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
127502033|NCT00197145|458798065|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
127502034|NCT00197145|458798064|FG000|Period 2 : Open Label Phase|Other|1|||
127502035|NCT00197145|458798065|FG001|Period 2 : Open Label Phase|Other|0|||
127502036|NCT03372551|458798067|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
127502037|NCT03372551|458798068|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
127978165|NCT02954653|460542446|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
127502038|NCT04439539|458798074|FG000|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|1|||
127502039|NCT04439539|458798075|FG001|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|0|||
127502040|NCT04439539|458798076|FG002|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|2|||
127502041|NCT04439539|458798074|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
127502042|NCT04439539|458798075|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Other|1|||
127502043|NCT04439539|458798076|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
127502044|NCT04439539|458798074|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
127502045|NCT04439539|458798075|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|1|||
127502046|NCT04439539|458798076|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
127502047|NCT02578680|458798077|FG000|Overall Study|Death|329|||
127502048|NCT02578680|458798078|FG001|Overall Study|Death|181|||
127502049|NCT02578680|458798077|FG000|Overall Study|Lost to Follow-up|3|||
127502050|NCT02578680|458798078|FG001|Overall Study|Lost to Follow-up|1|||
127502051|NCT02578680|458798077|FG000|Overall Study|Physician Decision|0|||
127502052|NCT02578680|458798078|FG001|Overall Study|Physician Decision|1|||
127502053|NCT02578680|458798077|FG000|Overall Study|Protocol Violation|1|||
127502054|NCT02578680|458798078|FG001|Overall Study|Protocol Violation|1|||
127502055|NCT02578680|458798077|FG000|Overall Study|Sponsor Decision|64|||
127502056|NCT02578680|458798078|FG001|Overall Study|Sponsor Decision|13|||
127502057|NCT02578680|458798077|FG000|Overall Study|Withdrawal by Subject|13|||
127502058|NCT02578680|458798078|FG001|Overall Study|Withdrawal by Subject|9|||
127502059|NCT03596047|458798079|FG000|Overall Study|Withdrawal by Subject|7|||
127502060|NCT03596047|458798080|FG001|Overall Study|Withdrawal by Subject|4|||
127502061|NCT03596047|458798079|FG000|Overall Study|Lost to Follow-up|0|||
127502062|NCT03596047|458798080|FG001|Overall Study|Lost to Follow-up|2|||
127502063|NCT03727646|458798081|FG000|Overall Study|Adverse Event|1|||
127502064|NCT03727646|458798082|FG001|Overall Study|Adverse Event|0|||
127502065|NCT02290691|458798085|FG000|Overall Study|Noncompliance|0|||
127502066|NCT02290691|458798086|FG001|Overall Study|Noncompliance|1|||
127502067|NCT02290691|458798085|FG000|Overall Study|Withdrawal by Subject|1|||
127502068|NCT02290691|458798086|FG001|Overall Study|Withdrawal by Subject|1|||
127502069|NCT02290691|458798085|FG000|Overall Study|Lost to Follow-up|7|||
127502070|NCT02290691|458798086|FG001|Overall Study|Lost to Follow-up|7|||
127502071|NCT01681069|458798099|FG000|Overall Study|Withdrawal by Subject|4|||
127502072|NCT01681069|458798100|FG001|Overall Study|Withdrawal by Subject|5|||
127502073|NCT01681069|458798099|FG000|Overall Study|Protocol Violation|1|||
127502074|NCT01681069|458798100|FG001|Overall Study|Protocol Violation|1|||
127502075|NCT01681069|458798099|FG000|Overall Study|Adverse Event|0|||
127502076|NCT01681069|458798100|FG001|Overall Study|Adverse Event|1|||
127502077|NCT03831191|458798103|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
127502078|NCT03831191|458798104|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
127502079|NCT03831191|458798105|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
127502080|NCT03831191|458798106|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
127502081|NCT03831191|458798107|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
127502082|NCT03831191|458798108|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
127502083|NCT03831191|458798109|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
127502084|NCT03831191|458798110|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
127502085|NCT03831191|458798111|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
127502086|NCT03831191|458798112|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
127502087|NCT03831191|458798113|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
127502088|NCT03831191|458798114|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
127502089|NCT03831191|458798115|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
127502090|NCT03831191|458798116|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
127502091|NCT03831191|458798117|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
127502092|NCT03831191|458798103|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
127502093|NCT03831191|458798104|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
127502094|NCT03831191|458798105|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
127502095|NCT03831191|458798106|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
127502096|NCT03831191|458798107|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
127502097|NCT03831191|458798108|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
127502098|NCT03831191|458798109|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
127502099|NCT03831191|458798110|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
127502100|NCT03831191|458798111|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
127502101|NCT03831191|458798112|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
127502102|NCT03831191|458798113|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
127502103|NCT03831191|458798114|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
127502104|NCT03831191|458798115|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
127502105|NCT03831191|458798116|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
127502106|NCT03831191|458798117|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
127502107|NCT03831191|458798103|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
127502108|NCT03831191|458798104|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
127502109|NCT03831191|458798105|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
127502110|NCT03831191|458798106|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
127502111|NCT03831191|458798107|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
127502112|NCT03831191|458798108|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
127502113|NCT03831191|458798109|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
127502114|NCT03831191|458798110|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
127502115|NCT03831191|458798111|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
127502116|NCT03831191|458798112|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
127502117|NCT03831191|458798113|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
127502118|NCT03831191|458798114|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
127502119|NCT03831191|458798115|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
127502120|NCT03831191|458798116|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
127502121|NCT03831191|458798117|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
127502122|NCT03831191|458798103|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
127502123|NCT03831191|458798104|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
127502124|NCT03831191|458798105|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
127502125|NCT03831191|458798106|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
127502126|NCT03831191|458798107|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
127502127|NCT03831191|458798108|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
127502128|NCT03831191|458798109|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
127502129|NCT03831191|458798110|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
127502130|NCT03831191|458798111|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
127502131|NCT03831191|458798112|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
127502132|NCT03831191|458798113|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
127502133|NCT03831191|458798114|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
127502134|NCT03831191|458798115|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
127502135|NCT03831191|458798116|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
127502136|NCT03831191|458798117|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
127502137|NCT03831191|458798103|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
127502138|NCT03831191|458798104|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
127502139|NCT03831191|458798105|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
127502140|NCT03831191|458798106|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
127502141|NCT03831191|458798107|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
127502142|NCT03831191|458798108|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
127502143|NCT03831191|458798109|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
127502144|NCT03831191|458798110|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
127502145|NCT03831191|458798111|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
127502146|NCT03831191|458798112|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
127502147|NCT03831191|458798113|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
127502148|NCT03831191|458798114|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
127502149|NCT03831191|458798115|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
127502150|NCT03831191|458798116|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
127502151|NCT03831191|458798117|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
127502152|NCT03831191|458798103|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
127502153|NCT03831191|458798104|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
127502154|NCT03831191|458798105|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
127502155|NCT03831191|458798106|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
127502156|NCT03831191|458798107|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
127502157|NCT03831191|458798108|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
127502158|NCT03831191|458798109|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
127502159|NCT03831191|458798110|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
127502160|NCT03831191|458798111|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
127502161|NCT03831191|458798112|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
127502162|NCT03831191|458798113|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
127502163|NCT03831191|458798114|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
127502164|NCT03831191|458798115|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
127502165|NCT03831191|458798116|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
127502166|NCT03831191|458798117|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
127502167|NCT03831191|458798103|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
127502168|NCT03831191|458798104|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
127502169|NCT03831191|458798105|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
127502170|NCT03831191|458798106|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
127502171|NCT03831191|458798107|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
127502172|NCT03831191|458798108|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
127502173|NCT03831191|458798109|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
127502174|NCT03831191|458798110|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
127502175|NCT03831191|458798111|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
127502176|NCT03831191|458798112|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
127502177|NCT03831191|458798113|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
127502178|NCT03831191|458798114|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
127502179|NCT03831191|458798115|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
127502180|NCT03831191|458798116|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
127502181|NCT03831191|458798117|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
127502182|NCT03831191|458798103|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
127502183|NCT03831191|458798104|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
127502184|NCT03831191|458798105|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
127502185|NCT03831191|458798106|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
127502186|NCT03831191|458798107|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
127502187|NCT03831191|458798108|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
127502188|NCT03831191|458798109|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
127502189|NCT03831191|458798110|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
127502190|NCT03831191|458798111|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
127502191|NCT03831191|458798112|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
127502192|NCT03831191|458798113|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
127502193|NCT03831191|458798114|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
127502194|NCT03831191|458798115|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
127502195|NCT03831191|458798116|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
127502196|NCT03831191|458798117|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
127502197|NCT03831191|458798103|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
127502198|NCT03831191|458798104|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
127502199|NCT03831191|458798105|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
127502200|NCT03831191|458798106|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
127502201|NCT03831191|458798107|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
127502202|NCT03831191|458798108|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
127502203|NCT03831191|458798109|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
127502204|NCT03831191|458798110|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
127502205|NCT03831191|458798111|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
127502206|NCT03831191|458798112|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
127502207|NCT03831191|458798113|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
127502208|NCT03831191|458798114|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
127502209|NCT03831191|458798115|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
127502210|NCT03831191|458798116|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
127502211|NCT03831191|458798117|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
127502212|NCT03831191|458798103|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
127502213|NCT03831191|458798104|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
127502214|NCT03831191|458798105|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
127502215|NCT03831191|458798106|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
127502216|NCT03831191|458798107|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
127502217|NCT03831191|458798108|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
127502218|NCT03831191|458798109|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
127502219|NCT03831191|458798110|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
127502220|NCT03831191|458798111|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
127502221|NCT03831191|458798112|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
127502222|NCT03831191|458798113|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
127502223|NCT03831191|458798114|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
127502224|NCT03831191|458798115|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
127502225|NCT03831191|458798116|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
127502226|NCT03831191|458798117|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
127502227|NCT02300558|458798118|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
127502228|NCT02300558|458798118|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
127502229|NCT02300558|458798118|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
127502230|NCT02300558|458798118|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
127502231|NCT01054560|458798121|FG000|Overall Study|Death|10|||
127502232|NCT01054560|458798122|FG001|Overall Study|Death|21|||
127502233|NCT01054560|458798121|FG000|Overall Study|Lost to Follow-up|2|||
127502234|NCT01054560|458798122|FG001|Overall Study|Lost to Follow-up|5|||
127502235|NCT01054560|458798121|FG000|Overall Study|Withdrawal by Subject|0|||
127502236|NCT01054560|458798122|FG001|Overall Study|Withdrawal by Subject|2|||
127502237|NCT01054560|458798121|FG000|Overall Study|Physician Decision|1|||
127502238|NCT01054560|458798122|FG001|Overall Study|Physician Decision|0|||
127502239|NCT01421303|458798123|FG000|Overall Study|Lost to Follow-up|13|||
127502240|NCT01421303|458798123|FG000|Overall Study|Non compliance with study procedure|1|||
127502241|NCT01421303|458798123|FG000|Overall Study|Other|7|||
127502242|NCT01421303|458798123|FG000|Overall Study|Withdrawal by Subject|1|||
127502243|NCT00712725|458798125|FG000|Overall Study|Adverse Event|1|||
127502244|NCT00712725|458798126|FG001|Overall Study|Adverse Event|0|||
127502245|NCT00712725|458798127|FG002|Overall Study|Adverse Event|0|||
127502246|NCT00712725|458798128|FG003|Overall Study|Adverse Event|1|||
127502247|NCT00712725|458798129|FG004|Overall Study|Adverse Event|0|||
127502248|NCT00712725|458798130|FG005|Overall Study|Adverse Event|0|||
127502249|NCT00712725|458798131|FG006|Overall Study|Adverse Event|0|||
127502250|NCT00712725|458798132|FG007|Overall Study|Adverse Event|0|||
127502251|NCT00712725|458798125|FG000|Overall Study|Lost to Follow-up|3|||
127502252|NCT00712725|458798126|FG001|Overall Study|Lost to Follow-up|2|||
127502253|NCT00712725|458798127|FG002|Overall Study|Lost to Follow-up|1|||
127502254|NCT00712725|458798128|FG003|Overall Study|Lost to Follow-up|1|||
127502255|NCT00712725|458798129|FG004|Overall Study|Lost to Follow-up|2|||
127502256|NCT00712725|458798130|FG005|Overall Study|Lost to Follow-up|2|||
127502257|NCT00712725|458798131|FG006|Overall Study|Lost to Follow-up|3|||
127502258|NCT00712725|458798132|FG007|Overall Study|Lost to Follow-up|1|||
127502259|NCT00712725|458798125|FG000|Overall Study|Physician Decision|2|||
127502260|NCT00712725|458798126|FG001|Overall Study|Physician Decision|0|||
127502261|NCT00712725|458798127|FG002|Overall Study|Physician Decision|0|||
127502262|NCT00712725|458798128|FG003|Overall Study|Physician Decision|0|||
127502263|NCT00712725|458798129|FG004|Overall Study|Physician Decision|1|||
127502264|NCT00712725|458798130|FG005|Overall Study|Physician Decision|0|||
127502265|NCT00712725|458798131|FG006|Overall Study|Physician Decision|2|||
127502266|NCT00712725|458798132|FG007|Overall Study|Physician Decision|0|||
127502267|NCT00712725|458798125|FG000|Overall Study|Pregnancy|0|||
127502268|NCT00712725|458798126|FG001|Overall Study|Pregnancy|1|||
127502269|NCT00712725|458798127|FG002|Overall Study|Pregnancy|0|||
127502270|NCT00712725|458798128|FG003|Overall Study|Pregnancy|0|||
127502271|NCT00712725|458798129|FG004|Overall Study|Pregnancy|1|||
127502272|NCT00712725|458798130|FG005|Overall Study|Pregnancy|0|||
127502273|NCT00712725|458798131|FG006|Overall Study|Pregnancy|2|||
127502274|NCT00712725|458798132|FG007|Overall Study|Pregnancy|0|||
127502275|NCT00712725|458798125|FG000|Overall Study|Protocol Violation|2|||
127502276|NCT00712725|458798126|FG001|Overall Study|Protocol Violation|0|||
127502277|NCT00712725|458798127|FG002|Overall Study|Protocol Violation|1|||
127502278|NCT00712725|458798128|FG003|Overall Study|Protocol Violation|3|||
127502279|NCT00712725|458798129|FG004|Overall Study|Protocol Violation|2|||
127502280|NCT00712725|458798130|FG005|Overall Study|Protocol Violation|0|||
127502281|NCT00712725|458798131|FG006|Overall Study|Protocol Violation|1|||
127502282|NCT00712725|458798132|FG007|Overall Study|Protocol Violation|1|||
127502283|NCT00712725|458798125|FG000|Overall Study|Withdrawal by Subject|2|||
127502284|NCT00712725|458798126|FG001|Overall Study|Withdrawal by Subject|1|||
127502285|NCT00712725|458798127|FG002|Overall Study|Withdrawal by Subject|1|||
127502286|NCT00712725|458798128|FG003|Overall Study|Withdrawal by Subject|2|||
127502287|NCT00712725|458798129|FG004|Overall Study|Withdrawal by Subject|1|||
127502288|NCT00712725|458798130|FG005|Overall Study|Withdrawal by Subject|1|||
127502289|NCT00712725|458798131|FG006|Overall Study|Withdrawal by Subject|1|||
127502290|NCT00712725|458798132|FG007|Overall Study|Withdrawal by Subject|2|||
127502291|NCT00712725|458798125|FG000|Overall Study|Lack of Qualifying Event|16|||
127502292|NCT00712725|458798126|FG001|Overall Study|Lack of Qualifying Event|2|||
127502293|NCT00712725|458798127|FG002|Overall Study|Lack of Qualifying Event|6|||
127502294|NCT00712725|458798128|FG003|Overall Study|Lack of Qualifying Event|8|||
127502295|NCT00712725|458798129|FG004|Overall Study|Lack of Qualifying Event|11|||
127502296|NCT00712725|458798130|FG005|Overall Study|Lack of Qualifying Event|13|||
127502297|NCT00712725|458798131|FG006|Overall Study|Lack of Qualifying Event|11|||
127502298|NCT00712725|458798132|FG007|Overall Study|Lack of Qualifying Event|6|||
127502299|NCT00712725|458798125|FG000|Overall Study|Protocol Specified Criteria|3|||
127502300|NCT00712725|458798126|FG001|Overall Study|Protocol Specified Criteria|0|||
127502301|NCT00712725|458798127|FG002|Overall Study|Protocol Specified Criteria|1|||
127502302|NCT00712725|458798128|FG003|Overall Study|Protocol Specified Criteria|2|||
127502303|NCT00712725|458798129|FG004|Overall Study|Protocol Specified Criteria|1|||
127502304|NCT00712725|458798130|FG005|Overall Study|Protocol Specified Criteria|0|||
127502305|NCT00712725|458798131|FG006|Overall Study|Protocol Specified Criteria|2|||
127502306|NCT00712725|458798132|FG007|Overall Study|Protocol Specified Criteria|1|||
127502307|NCT03466099|458798133|FG000|Overall Study|Adverse Event|1|||
127502308|NCT03466099|458798134|FG001|Overall Study|Adverse Event|1|||
127502309|NCT03466099|458798135|FG002|Overall Study|Adverse Event|1|||
127502310|NCT03466099|458798133|FG000|Overall Study|Withdrawal by Subject|2|||
127502311|NCT03466099|458798134|FG001|Overall Study|Withdrawal by Subject|3|||
127502312|NCT03466099|458798135|FG002|Overall Study|Withdrawal by Subject|1|||
127502313|NCT03466099|458798133|FG000|Overall Study|Use of rescue medication|8|||
127502314|NCT03466099|458798134|FG001|Overall Study|Use of rescue medication|9|||
127502315|NCT03466099|458798135|FG002|Overall Study|Use of rescue medication|13|||
127502316|NCT03466099|458798133|FG000|Overall Study|Rescued without meeting criteria|4|||
127502317|NCT03466099|458798134|FG001|Overall Study|Rescued without meeting criteria|1|||
127502318|NCT03466099|458798135|FG002|Overall Study|Rescued without meeting criteria|1|||
127502319|NCT03466099|458798133|FG000|Overall Study|Subject compliance|2|||
127502320|NCT03466099|458798134|FG001|Overall Study|Subject compliance|0|||
127502321|NCT03466099|458798135|FG002|Overall Study|Subject compliance|0|||
127502322|NCT03466099|458798133|FG000|Overall Study|Worsening disease|0|||
127502323|NCT03466099|458798134|FG001|Overall Study|Worsening disease|0|||
127502324|NCT03466099|458798135|FG002|Overall Study|Worsening disease|1|||
127502325|NCT00616018|458798138|FG000|Overall Study|Protocol Violation|3|||
127502326|NCT00404755|458798140|FG000|Phase I (Bupropion)|Adverse Event|3|||
127502327|NCT00404755|458798140|FG000|Phase I (Bupropion)|Other|1|||
127502328|NCT00404755|458798140|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
127502329|NCT00350870|458798141|FG000|Overall Study|Withdrawal by Subject|21|||
127502330|NCT00350870|458798142|FG001|Overall Study|Withdrawal by Subject|17|||
127502331|NCT00350870|458798143|FG002|Overall Study|Withdrawal by Subject|15|||
127502332|NCT00350870|458798144|FG003|Overall Study|Withdrawal by Subject|14|||
127502333|NCT00350870|458798141|FG000|Overall Study|Physician Decision|1|||
127502334|NCT00350870|458798142|FG001|Overall Study|Physician Decision|0|||
127502335|NCT00350870|458798143|FG002|Overall Study|Physician Decision|1|||
127502336|NCT00350870|458798144|FG003|Overall Study|Physician Decision|1|||
127502337|NCT03194568|458798145|FG000|Overall Study|Withdrawn due to need for re-operation related to an anticipated device SAE|4|||
127502338|NCT05248997|458798146|FG000|Overall Study|Lost to Follow-up|1|||
127502339|NCT05248997|458798147|FG001|Overall Study|Lost to Follow-up|1|||
127502340|NCT05248997|458798146|FG000|Overall Study|Randomized but not treated|32|||
127502341|NCT05248997|458798147|FG001|Overall Study|Randomized but not treated|25|||
127502342|NCT01453205|458798148|FG000|Overall Study|Lost to Follow-up|3|||
127502343|NCT01453205|458798149|FG001|Overall Study|Lost to Follow-up|0|||
127502344|NCT01453205|458798150|FG002|Overall Study|Lost to Follow-up|1|||
127502345|NCT01453205|458798148|FG000|Overall Study|Withdrawal by Subject|8|||
127502346|NCT01453205|458798149|FG001|Overall Study|Withdrawal by Subject|3|||
127502347|NCT01453205|458798150|FG002|Overall Study|Withdrawal by Subject|0|||
127502348|NCT01453205|458798148|FG000|Overall Study|Death|24|||
127502349|NCT01453205|458798149|FG001|Overall Study|Death|22|||
127502350|NCT01453205|458798150|FG002|Overall Study|Death|18|||
127502351|NCT01453205|458798148|FG000|Overall Study|Other|45|||
127502352|NCT01453205|458798149|FG001|Overall Study|Other|27|||
127502353|NCT01453205|458798150|FG002|Overall Study|Other|35|||
127502354|NCT02602275|458798155|FG000|Day 1|Physician Decision|0|||
127502355|NCT02602275|458798156|FG001|Day 1|Physician Decision|1|||
127502356|NCT04262882|458798157|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
127502357|NCT04262882|458798158|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
127502358|NCT04262882|458798157|FG000|Overall Study|Lost to Follow-up|1|||
127502359|NCT04262882|458798158|FG001|Overall Study|Lost to Follow-up|0|||
127502360|NCT03268954|458798163|FG000|Overall Study|Ongoing|23|||
127502361|NCT03268954|458798164|FG001|Overall Study|Ongoing|31|||
127502362|NCT03268954|458798163|FG000|Overall Study|Adverse Event|53|||
127502363|NCT03268954|458798164|FG001|Overall Study|Adverse Event|62|||
127502364|NCT03268954|458798163|FG000|Overall Study|Withdrawal by Subject|25|||
127502365|NCT03268954|458798164|FG001|Overall Study|Withdrawal by Subject|16|||
127502366|NCT03268954|458798163|FG000|Overall Study|Progressive Disease|61|||
127502367|NCT03268954|458798164|FG001|Overall Study|Progressive Disease|48|||
127502368|NCT03268954|458798163|FG000|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|25|||
127502369|NCT03268954|458798164|FG001|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|30|||
127502370|NCT03268954|458798163|FG000|Overall Study|Reason not Specified|40|||
127502371|NCT03268954|458798164|FG001|Overall Study|Reason not Specified|40|||
127502372|NCT03802630|458798167|FG000|Overall Study|Study terminated by sponsor|130|||
127502373|NCT03802630|458798168|FG001|Overall Study|Study terminated by sponsor|134|||
127502374|NCT03802630|458798167|FG000|Overall Study|Subject decision|16|||
127502375|NCT03802630|458798168|FG001|Overall Study|Subject decision|9|||
127502376|NCT03802630|458798167|FG000|Overall Study|Adverse Event|3|||
127502377|NCT03802630|458798168|FG001|Overall Study|Adverse Event|1|||
127502378|NCT03802630|458798167|FG000|Overall Study|Lost to Follow-up|2|||
127502379|NCT03802630|458798168|FG001|Overall Study|Lost to Follow-up|2|||
127502380|NCT03802630|458798167|FG000|Overall Study|Physician Decision|2|||
127502381|NCT03802630|458798168|FG001|Overall Study|Physician Decision|0|||
127502382|NCT03802630|458798167|FG000|Overall Study|Death|0|||
127502383|NCT03802630|458798168|FG001|Overall Study|Death|2|||
127502384|NCT01108731|458798169|FG000|Overall Study|Withdrawal by Subject|1|||
127502385|NCT01108731|458798170|FG001|Overall Study|Withdrawal by Subject|1|||
127502386|NCT01108731|458798169|FG000|Overall Study|Adverse Event|3|||
127502387|NCT01108731|458798170|FG001|Overall Study|Adverse Event|3|||
127502388|NCT00157196|458798171|FG000|Overall Study|Ongoing at data cut-off|9|||
127502389|NCT04210245|458798172|FG000|Overall Study|Adverse Event|0|||
127502390|NCT04210245|458798173|FG001|Overall Study|Adverse Event|3|||
127502391|NCT04210245|458798174|FG002|Overall Study|Adverse Event|6|||
127502392|NCT04210245|458798175|FG003|Overall Study|Adverse Event|0|||
127502393|NCT04210245|458798172|FG000|Overall Study|Withdrawal by Subject|0|||
127502394|NCT04210245|458798173|FG001|Overall Study|Withdrawal by Subject|1|||
127502395|NCT04210245|458798174|FG002|Overall Study|Withdrawal by Subject|4|||
127502396|NCT04210245|458798175|FG003|Overall Study|Withdrawal by Subject|4|||
127502397|NCT04210245|458798172|FG000|Overall Study|Lost to Follow-up|0|||
127502398|NCT04210245|458798173|FG001|Overall Study|Lost to Follow-up|1|||
127502399|NCT04210245|458798174|FG002|Overall Study|Lost to Follow-up|1|||
127502400|NCT04210245|458798175|FG003|Overall Study|Lost to Follow-up|1|||
127502401|NCT04210245|458798172|FG000|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
127502402|NCT04210245|458798173|FG001|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
127502403|NCT04210245|458798174|FG002|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
127502404|NCT04210245|458798175|FG003|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|2|||
127502405|NCT01892722|458798176|FG000|Overall Study|Protocol deviation|0|||
127502406|NCT01892722|458798177|FG001|Overall Study|Protocol deviation|1|||
127502407|NCT01892722|458798176|FG000|Overall Study|Administrative problems|0|||
127502408|NCT01892722|458798177|FG001|Overall Study|Administrative problems|1|||
127502409|NCT01892722|458798176|FG000|Overall Study|Patient/guardian decision|0|||
127502410|NCT01892722|458798177|FG001|Overall Study|Patient/guardian decision|2|||
127502411|NCT01892722|458798176|FG000|Overall Study|Physician Decision|1|||
127502412|NCT01892722|458798177|FG001|Overall Study|Physician Decision|2|||
127502413|NCT01892722|458798176|FG000|Overall Study|Adverse Event|3|||
127502414|NCT01892722|458798177|FG001|Overall Study|Adverse Event|2|||
127502415|NCT01892722|458798176|FG000|Overall Study|Lack of Efficacy|0|||
127502416|NCT01892722|458798177|FG001|Overall Study|Lack of Efficacy|7|||
127502417|NCT01892722|458798176|FG000|Overall Study|Withdrawal by Subject|3|||
127502418|NCT01892722|458798177|FG001|Overall Study|Withdrawal by Subject|5|||
127502419|NCT01252186|458798178|FG000|Overall Study|Adverse Event|9|||
127502420|NCT01252186|458798179|FG001|Overall Study|Adverse Event|6|||
127502421|NCT01252186|458798180|FG002|Overall Study|Adverse Event|8|||
127502422|NCT01252186|458798178|FG000|Overall Study|Withdrawal by Subject|2|||
127502423|NCT01252186|458798179|FG001|Overall Study|Withdrawal by Subject|5|||
127502424|NCT01252186|458798180|FG002|Overall Study|Withdrawal by Subject|2|||
127502425|NCT01252186|458798178|FG000|Overall Study|Physician Decision|0|||
127502426|NCT01252186|458798179|FG001|Overall Study|Physician Decision|0|||
127502427|NCT01252186|458798180|FG002|Overall Study|Physician Decision|1|||
127502428|NCT01252186|458798178|FG000|Overall Study|Non-compliance|0|||
127502429|NCT01252186|458798179|FG001|Overall Study|Non-compliance|3|||
127502430|NCT01252186|458798180|FG002|Overall Study|Non-compliance|4|||
127502431|NCT01252186|458798178|FG000|Overall Study|Protocol Violation|0|||
127502432|NCT01252186|458798179|FG001|Overall Study|Protocol Violation|0|||
127502433|NCT01252186|458798180|FG002|Overall Study|Protocol Violation|1|||
127502434|NCT01252186|458798178|FG000|Overall Study|Pregnancy|2|||
127502435|NCT01252186|458798179|FG001|Overall Study|Pregnancy|2|||
127502436|NCT01252186|458798180|FG002|Overall Study|Pregnancy|0|||
127502437|NCT01252186|458798178|FG000|Overall Study|Sponsor Request|2|||
127502438|NCT01252186|458798179|FG001|Overall Study|Sponsor Request|1|||
127502439|NCT01252186|458798180|FG002|Overall Study|Sponsor Request|0|||
127502440|NCT01252186|458798178|FG000|Overall Study|Lost to Follow-up|10|||
127502441|NCT01252186|458798179|FG001|Overall Study|Lost to Follow-up|10|||
127502442|NCT01252186|458798180|FG002|Overall Study|Lost to Follow-up|11|||
127502443|NCT01252186|458798178|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
127502444|NCT01252186|458798179|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
127502445|NCT01252186|458798180|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
127502446|NCT02524275|458798181|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
127502447|NCT04283994|458798188|FG000|Overall Study|Death|11|||
127502448|NCT04283994|458798189|FG001|Overall Study|Death|20|||
127502449|NCT04283994|458798190|FG002|Overall Study|Death|11|||
127502450|NCT04283994|458798191|FG003|Overall Study|Death|0|||
127502451|NCT04283994|458798192|FG004|Overall Study|Death|0|||
127502452|NCT04283994|458798193|FG005|Overall Study|Death|0|||
127502453|NCT04283994|458798194|FG006|Overall Study|Death|0|||
127502454|NCT04283994|458798188|FG000|Overall Study|Withdrawal by Subject|16|||
127502455|NCT04283994|458798189|FG001|Overall Study|Withdrawal by Subject|4|||
127502456|NCT04283994|458798190|FG002|Overall Study|Withdrawal by Subject|6|||
127502457|NCT04283994|458798191|FG003|Overall Study|Withdrawal by Subject|1|||
127502458|NCT04283994|458798192|FG004|Overall Study|Withdrawal by Subject|0|||
127502459|NCT04283994|458798193|FG005|Overall Study|Withdrawal by Subject|1|||
127502460|NCT04283994|458798194|FG006|Overall Study|Withdrawal by Subject|0|||
127502461|NCT03763656|458798195|FG000|Overall Study|Physician Decision|1|||
127502462|NCT03763656|458798195|FG000|Overall Study|Protocol Violation|1|||
127502463|NCT03763656|458798195|FG000|Overall Study|Withdrawal by Subject|7|||
127502464|NCT00487942|458798196|FG000|Overall Study|Adverse Event|1|||
127502465|NCT00487942|458798197|FG001|Overall Study|Adverse Event|1|||
127502466|NCT00487942|458798198|FG002|Overall Study|Adverse Event|1|||
127502467|NCT00487942|458798199|FG003|Overall Study|Adverse Event|1|||
127502468|NCT00487942|458798196|FG000|Overall Study|Lost to Follow-up|1|||
127502469|NCT00487942|458798197|FG001|Overall Study|Lost to Follow-up|0|||
127502470|NCT00487942|458798198|FG002|Overall Study|Lost to Follow-up|0|||
127502471|NCT00487942|458798199|FG003|Overall Study|Lost to Follow-up|1|||
127502472|NCT00487942|458798196|FG000|Overall Study|Protocol Violation|1|||
127502473|NCT00487942|458798197|FG001|Overall Study|Protocol Violation|1|||
127502474|NCT00487942|458798198|FG002|Overall Study|Protocol Violation|0|||
127502475|NCT00487942|458798199|FG003|Overall Study|Protocol Violation|0|||
127502476|NCT00487942|458798196|FG000|Overall Study|Withdrawal by Subject|0|||
127502477|NCT00487942|458798197|FG001|Overall Study|Withdrawal by Subject|1|||
127502478|NCT00487942|458798198|FG002|Overall Study|Withdrawal by Subject|2|||
127502479|NCT00487942|458798199|FG003|Overall Study|Withdrawal by Subject|0|||
127502480|NCT00322452|458798200|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
127502481|NCT00322452|458798201|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
127502482|NCT00322452|458798200|FG000|Overall Study|Lost to Follow-up|5|||
127502483|NCT00322452|458798201|FG001|Overall Study|Lost to Follow-up|2|||
127502484|NCT00322452|458798200|FG000|Overall Study|Withdrawal by Subject|19|||
127502485|NCT00322452|458798201|FG001|Overall Study|Withdrawal by Subject|46|||
127502486|NCT00322452|458798200|FG000|Overall Study|Death|223|||
127502487|NCT00322452|458798201|FG001|Overall Study|Death|227|||
127502488|NCT01380535|458799403|FG000|Overall Study|Adverse Event|3|||
127502489|NCT01380535|458799404|FG001|Overall Study|Adverse Event|3|||
127502490|NCT01380535|458799403|FG000|Overall Study|Death|3|||
127502491|NCT01380535|458799404|FG001|Overall Study|Death|0|||
127502492|NCT01380535|458799403|FG000|Overall Study|Study site closed|0|||
127502493|NCT01380535|458799404|FG001|Overall Study|Study site closed|5|||
127502494|NCT01380535|458799403|FG000|Overall Study|Withdrawal by Subject|1|||
127502495|NCT01380535|458799404|FG001|Overall Study|Withdrawal by Subject|2|||
127502496|NCT01380535|458799403|FG000|Overall Study|Protocol Violation|0|||
127502497|NCT01380535|458799404|FG001|Overall Study|Protocol Violation|2|||
127502498|NCT01380535|458799403|FG000|Overall Study|Lack of Efficacy|0|||
127502499|NCT01380535|458799404|FG001|Overall Study|Lack of Efficacy|3|||
127502500|NCT03895086|458799410|FG000|Overall Study|Early termination study|1|||
127502501|NCT03895086|458799411|FG001|Overall Study|Early termination study|0|||
127502502|NCT00420004|458799415|FG000|Overall Study|Adverse Event|4|||
127502503|NCT00420004|458799416|FG001|Overall Study|Adverse Event|1|||
127502504|NCT00420004|458799417|FG002|Overall Study|Adverse Event|1|||
127502505|NCT00420004|458799415|FG000|Overall Study|Lack of Efficacy|5|||
127502506|NCT00420004|458799416|FG001|Overall Study|Lack of Efficacy|4|||
127502507|NCT00420004|458799417|FG002|Overall Study|Lack of Efficacy|1|||
127502508|NCT00420004|458799415|FG000|Overall Study|Lost to Follow-up|31|||
127502509|NCT00420004|458799416|FG001|Overall Study|Lost to Follow-up|12|||
127502510|NCT00420004|458799417|FG002|Overall Study|Lost to Follow-up|10|||
127502511|NCT00420004|458799415|FG000|Overall Study|Entry Criteria Not Met|0|||
127502512|NCT00420004|458799416|FG001|Overall Study|Entry Criteria Not Met|1|||
127502513|NCT00420004|458799417|FG002|Overall Study|Entry Criteria Not Met|0|||
127502514|NCT00420004|458799415|FG000|Overall Study|Physician Decision|14|||
127502515|NCT00420004|458799416|FG001|Overall Study|Physician Decision|4|||
127502516|NCT00420004|458799417|FG002|Overall Study|Physician Decision|2|||
127502517|NCT00420004|458799415|FG000|Overall Study|Protocol Violation|5|||
127502518|NCT00420004|458799416|FG001|Overall Study|Protocol Violation|4|||
127502519|NCT00420004|458799417|FG002|Overall Study|Protocol Violation|3|||
127502520|NCT00420004|458799415|FG000|Overall Study|Withdrawal by Subject|67|||
127502521|NCT00420004|458799416|FG001|Overall Study|Withdrawal by Subject|42|||
127502522|NCT00420004|458799417|FG002|Overall Study|Withdrawal by Subject|14|||
127502523|NCT00420004|458799415|FG000|Overall Study|Sponsor Decision|3|||
127502524|NCT00420004|458799416|FG001|Overall Study|Sponsor Decision|3|||
127502525|NCT00420004|458799417|FG002|Overall Study|Sponsor Decision|1|||
127502526|NCT00591149|458799419|FG000|Overall Study|Adverse Event|4|||
127502527|NCT00591149|458799419|FG000|Overall Study|Withdrawal by Subject|1|||
127502528|NCT00470093|458799420|FG000|Overall Study|Adverse Event|2|||
127502529|NCT00664560|458799421|FG000|Overall Study|Adverse Event|19|||
127502530|NCT00664560|458799422|FG001|Overall Study|Adverse Event|16|||
127502531|NCT00664560|458799423|FG002|Overall Study|Adverse Event|7|||
127502532|NCT00664560|458799421|FG000|Overall Study|Withdrawal by Subject|9|||
127502533|NCT00664560|458799422|FG001|Overall Study|Withdrawal by Subject|13|||
127502534|NCT00664560|458799423|FG002|Overall Study|Withdrawal by Subject|7|||
127502535|NCT00664560|458799421|FG000|Overall Study|Lost to Follow-up|0|||
127502536|NCT00664560|458799422|FG001|Overall Study|Lost to Follow-up|2|||
127502537|NCT00664560|458799423|FG002|Overall Study|Lost to Follow-up|0|||
127502538|NCT00664560|458799421|FG000|Overall Study|Other|11|||
127502539|NCT00664560|458799422|FG001|Overall Study|Other|4|||
127502540|NCT00664560|458799423|FG002|Overall Study|Other|5|||
127502541|NCT02456636|458799424|FG000|Overall Study|Death|0|||
127502542|NCT02456636|458799425|FG001|Overall Study|Death|3|||
127502543|NCT02456636|458799426|FG002|Overall Study|Death|0|||
127502544|NCT02456636|458799424|FG000|Overall Study|Pregnancy|1|||
127502545|NCT02456636|458799425|FG001|Overall Study|Pregnancy|3|||
127502546|NCT02456636|458799426|FG002|Overall Study|Pregnancy|5|||
127502547|NCT02456636|458799424|FG000|Overall Study|Physician Decision|4|||
127502548|NCT02456636|458799425|FG001|Overall Study|Physician Decision|5|||
127502549|NCT02456636|458799426|FG002|Overall Study|Physician Decision|4|||
127502550|NCT02456636|458799424|FG000|Overall Study|Withdrawal by Subject|13|||
127502551|NCT02456636|458799425|FG001|Overall Study|Withdrawal by Subject|14|||
127502552|NCT02456636|458799426|FG002|Overall Study|Withdrawal by Subject|16|||
127502553|NCT02456636|458799424|FG000|Overall Study|Lost to Follow-up|50|||
127502554|NCT02456636|458799425|FG001|Overall Study|Lost to Follow-up|44|||
127978166|NCT02954653|460542447|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
127502555|NCT02456636|458799426|FG002|Overall Study|Lost to Follow-up|50|||
127502556|NCT03350035|458799427|FG000|Overall Study|Lack of Efficacy|2|||
127502557|NCT03350035|458799428|FG001|Overall Study|Lack of Efficacy|0|||
127502558|NCT03350035|458799429|FG002|Overall Study|Lack of Efficacy|0|||
127502559|NCT03350035|458799427|FG000|Overall Study|Subject discharged to hospice|0|||
127502560|NCT03350035|458799428|FG001|Overall Study|Subject discharged to hospice|0|||
127502561|NCT03350035|458799429|FG002|Overall Study|Subject discharged to hospice|1|||
127502562|NCT02379221|458799430|FG000|Overall Study|Lost to Follow-up|1|||
127502563|NCT01610557|458799431|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
127502564|NCT01610557|458799432|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
127502565|NCT01610557|458799433|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
127502566|NCT01610557|458799434|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
127502567|NCT01610557|458799435|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
127502568|NCT01610557|458799431|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
127502569|NCT01610557|458799432|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
127502570|NCT01610557|458799433|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
127502571|NCT01610557|458799434|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
127502572|NCT01610557|458799435|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
127502573|NCT00365105|458799438|FG000|Overall Study|Protocol Violation|5|||
127502574|NCT00365105|458799439|FG001|Overall Study|Protocol Violation|8|||
127502575|NCT00608023|458799440|FG000|Overall Study|Withdrawal by Subject|8|||
127502576|NCT00608023|458799441|FG001|Overall Study|Withdrawal by Subject|10|||
127502577|NCT00608023|458799442|FG002|Overall Study|Withdrawal by Subject|7|||
127502578|NCT00608023|458799440|FG000|Overall Study|Adverse Event|1|||
127502579|NCT00608023|458799441|FG001|Overall Study|Adverse Event|4|||
127502580|NCT00608023|458799442|FG002|Overall Study|Adverse Event|5|||
127502581|NCT00608023|458799440|FG000|Overall Study|Lost to Follow-up|2|||
127502582|NCT00608023|458799441|FG001|Overall Study|Lost to Follow-up|2|||
127502583|NCT00608023|458799442|FG002|Overall Study|Lost to Follow-up|1|||
127502584|NCT00608023|458799440|FG000|Overall Study|Protocol Violation|1|||
127502585|NCT00608023|458799441|FG001|Overall Study|Protocol Violation|3|||
127502586|NCT00608023|458799442|FG002|Overall Study|Protocol Violation|1|||
127502587|NCT00608023|458799440|FG000|Overall Study|Unknown reason|0|||
127502588|NCT00608023|458799441|FG001|Overall Study|Unknown reason|3|||
127502589|NCT00608023|458799442|FG002|Overall Study|Unknown reason|0|||
127502590|NCT06422364|458799443|FG000|Overall Study|Withdrawn due to study closure|0|||
127502591|NCT06422364|458799444|FG001|Overall Study|Withdrawn due to study closure|2|||
127502592|NCT01463696|458799446|FG000|Overall Study|Adverse Event|0|||
127502593|NCT01463696|458799447|FG001|Overall Study|Adverse Event|1|||
127502594|NCT01463696|458799448|FG002|Overall Study|Adverse Event|0|||
127502595|NCT01463696|458799449|FG003|Overall Study|Adverse Event|2|||
127502596|NCT01463696|458799450|FG004|Overall Study|Adverse Event|0|||
127502597|NCT01463696|458799451|FG005|Overall Study|Adverse Event|1|||
127502598|NCT01463696|458799452|FG006|Overall Study|Adverse Event|3|||
127502599|NCT01463696|458799453|FG007|Overall Study|Adverse Event|2|||
127502600|NCT01463696|458799446|FG000|Overall Study|Lost to Follow-up|0|||
127502601|NCT01463696|458799447|FG001|Overall Study|Lost to Follow-up|0|||
127502602|NCT01463696|458799448|FG002|Overall Study|Lost to Follow-up|1|||
127502603|NCT01463696|458799449|FG003|Overall Study|Lost to Follow-up|0|||
127502604|NCT01463696|458799450|FG004|Overall Study|Lost to Follow-up|0|||
127502605|NCT01463696|458799451|FG005|Overall Study|Lost to Follow-up|0|||
127502606|NCT01463696|458799452|FG006|Overall Study|Lost to Follow-up|0|||
127502607|NCT01463696|458799453|FG007|Overall Study|Lost to Follow-up|0|||
127502608|NCT01463696|458799446|FG000|Overall Study|Progressive Disease|0|||
127502609|NCT01463696|458799447|FG001|Overall Study|Progressive Disease|1|||
127502610|NCT01463696|458799448|FG002|Overall Study|Progressive Disease|0|||
127502611|NCT01463696|458799449|FG003|Overall Study|Progressive Disease|1|||
127502612|NCT01463696|458799450|FG004|Overall Study|Progressive Disease|0|||
127502613|NCT01463696|458799451|FG005|Overall Study|Progressive Disease|1|||
127502614|NCT01463696|458799452|FG006|Overall Study|Progressive Disease|4|||
127502615|NCT01463696|458799453|FG007|Overall Study|Progressive Disease|2|||
127502616|NCT01463696|458799446|FG000|Overall Study|Withdrawal by Subject|0|||
127502617|NCT01463696|458799447|FG001|Overall Study|Withdrawal by Subject|0|||
127502618|NCT01463696|458799448|FG002|Overall Study|Withdrawal by Subject|0|||
127502619|NCT01463696|458799449|FG003|Overall Study|Withdrawal by Subject|1|||
127502620|NCT01463696|458799450|FG004|Overall Study|Withdrawal by Subject|1|||
127502621|NCT01463696|458799451|FG005|Overall Study|Withdrawal by Subject|1|||
127502622|NCT01463696|458799452|FG006|Overall Study|Withdrawal by Subject|2|||
127502623|NCT01463696|458799453|FG007|Overall Study|Withdrawal by Subject|0|||
127502624|NCT01463696|458799446|FG000|Overall Study|Not Treated|0|||
127502625|NCT01463696|458799447|FG001|Overall Study|Not Treated|0|||
127502626|NCT01463696|458799448|FG002|Overall Study|Not Treated|0|||
127502627|NCT01463696|458799449|FG003|Overall Study|Not Treated|0|||
127502628|NCT01463696|458799450|FG004|Overall Study|Not Treated|0|||
127502629|NCT01463696|458799451|FG005|Overall Study|Not Treated|0|||
127502630|NCT01463696|458799452|FG006|Overall Study|Not Treated|1|||
127502631|NCT01463696|458799453|FG007|Overall Study|Not Treated|0|||
127502632|NCT03883165|458799454|FG000|Overall Study|Withdrawal by Subject|4|||
127502633|NCT03883165|458799455|FG001|Overall Study|Withdrawal by Subject|3|||
127502634|NCT00245050|458799459|FG000|Overall Study|Adverse Event|3|||
127502635|NCT00245050|458799460|FG001|Overall Study|Adverse Event|2|||
127502636|NCT00425698|458799461|FG000|Overall Study|Adverse Event|3|||
127502637|NCT00425698|458799462|FG001|Overall Study|Adverse Event|1|||
127502638|NCT00425698|458799461|FG000|Overall Study|Withdrawal by Subject|0|||
127502639|NCT00425698|458799462|FG001|Overall Study|Withdrawal by Subject|1|||
127502640|NCT03275246|458799469|FG000|Overall Study|Protocol Violation|5|||
127502641|NCT03275246|458799469|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
127502642|NCT03905265|458799470|FG000|Overall Study|Withdrawal by Subject|1|||
127502643|NCT03905265|458799471|FG001|Overall Study|Withdrawal by Subject|1|||
127502644|NCT03905265|458799472|FG002|Overall Study|Withdrawal by Subject|0|||
127502645|NCT03905265|458799473|FG003|Overall Study|Withdrawal by Subject|0|||
127978167|NCT02954653|460542448|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
127502646|NCT02516098|458799474|FG000|Period 1|Protocol Violation|1|||
127502647|NCT02516098|458799475|FG001|Period 1|Protocol Violation|0|||
127502648|NCT02516098|458799474|FG000|Washout After Period 1|Adverse Event|0|||
127502649|NCT02516098|458799475|FG001|Washout After Period 1|Adverse Event|1|||
127502650|NCT02516098|458799474|FG000|Period 2|Withdrawal by Subject|0|||
127502651|NCT02516098|458799475|FG001|Period 2|Withdrawal by Subject|1|||
127502652|NCT01973387|458799476|FG000|Overall Study|Adverse Event|14|||
127502653|NCT01973387|458799477|FG001|Overall Study|Adverse Event|4|||
127978168|NCT02954653|460542449|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
127978169|NCT02954653|460542450|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
127978170|NCT02954653|460542451|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
127978171|NCT01500213|460542462|FG000|Overall Study|Adverse Event|35|||
127978172|NCT01500213|460542463|FG001|Overall Study|Adverse Event|35|||
127978173|NCT01500213|460542462|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
127978174|NCT01500213|460542463|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
127978175|NCT01500213|460542462|FG000|Overall Study|Withdrawal by Subject|28|||
127978176|NCT01500213|460542463|FG001|Overall Study|Withdrawal by Subject|37|||
127978177|NCT01500213|460542462|FG000|Overall Study|Death|7|||
127978178|NCT01500213|460542463|FG001|Overall Study|Death|3|||
127978179|NCT01500213|460542462|FG000|Overall Study|Disease Progression|13|||
127978180|NCT01500213|460542463|FG001|Overall Study|Disease Progression|21|||
127978181|NCT01500213|460542462|FG000|Overall Study|Protocol Violation|19|||
127978182|NCT01500213|460542463|FG001|Overall Study|Protocol Violation|19|||
127978183|NCT01500213|460542462|FG000|Overall Study|Physician Decision|12|||
127978184|NCT01500213|460542463|FG001|Overall Study|Physician Decision|10|||
127978185|NCT01500213|460542462|FG000|Overall Study|Lack of Efficacy|9|||
127978186|NCT01500213|460542463|FG001|Overall Study|Lack of Efficacy|7|||
127978187|NCT01500213|460542462|FG000|Overall Study|Lost to Follow-up|3|||
127978188|NCT01500213|460542463|FG001|Overall Study|Lost to Follow-up|6|||
127978189|NCT01500213|460542462|FG000|Overall Study|Other Reasons|7|||
127978190|NCT01500213|460542463|FG001|Overall Study|Other Reasons|5|||
127978191|NCT00976209|460542464|FG000|Treatment Period 1|Protocol Violation|1|||
127978192|NCT00976209|460542465|FG001|Treatment Period 1|Protocol Violation|0|||
127978193|NCT00976209|460542464|FG000|Treatment Period 1|Lost to Follow-up|2|||
127978194|NCT00976209|460542465|FG001|Treatment Period 1|Lost to Follow-up|0|||
127978195|NCT00976209|460542464|FG000|Treatment Period 1|Other|0|||
127978196|NCT00976209|460542465|FG001|Treatment Period 1|Other|1|||
127978197|NCT00976209|460542464|FG000|Wash-out Period|Adverse Event|1|||
127978198|NCT00976209|460542465|FG001|Wash-out Period|Adverse Event|2|||
127978199|NCT00976209|460542464|FG000|Wash-out Period|Lost to Follow-up|1|||
127978200|NCT00976209|460542465|FG001|Wash-out Period|Lost to Follow-up|0|||
127978201|NCT00976209|460542464|FG000|Wash-out Period|Protocol Violation|1|||
127978202|NCT00976209|460542465|FG001|Wash-out Period|Protocol Violation|0|||
127978203|NCT00976209|460542464|FG000|Wash-out Period|Other|1|||
127978204|NCT00976209|460542465|FG001|Wash-out Period|Other|0|||
127978205|NCT00976209|460542464|FG000|Treatment Period 2|Withdrawal by Subject|0|||
127978206|NCT00976209|460542465|FG001|Treatment Period 2|Withdrawal by Subject|1|||
127978207|NCT00976209|460542464|FG000|Treatment Period 2|Lost to Follow-up|0|||
127978208|NCT00976209|460542465|FG001|Treatment Period 2|Lost to Follow-up|1|||
127978209|NCT03197870|460542466|FG000|Overall Study|Adverse Event|9|||
127978210|NCT03197870|460542467|FG001|Overall Study|Adverse Event|4|||
127978211|NCT03197870|460542468|FG002|Overall Study|Adverse Event|6|||
127978212|NCT03197870|460542466|FG000|Overall Study|Withdrawal by Subject|2|||
127978213|NCT03197870|460542467|FG001|Overall Study|Withdrawal by Subject|3|||
127978214|NCT03197870|460542468|FG002|Overall Study|Withdrawal by Subject|0|||
127978215|NCT03197870|460542466|FG000|Overall Study|Lost to Follow-up|2|||
127978216|NCT03197870|460542467|FG001|Overall Study|Lost to Follow-up|2|||
127978217|NCT03197870|460542468|FG002|Overall Study|Lost to Follow-up|0|||
127978218|NCT03197870|460542466|FG000|Overall Study|data not available|1|||
127978219|NCT03197870|460542467|FG001|Overall Study|data not available|1|||
127978220|NCT03197870|460542468|FG002|Overall Study|data not available|0|||
127978221|NCT01542034|460542470|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
127978222|NCT01542034|460542471|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
127978223|NCT01542034|460542470|FG000|Overall Study|Administrative decision|0|||
127978224|NCT01542034|460542471|FG001|Overall Study|Administrative decision|3|||
127978225|NCT01542034|460542470|FG000|Overall Study|Subject Noncompliance|1|||
127978226|NCT01542034|460542471|FG001|Overall Study|Subject Noncompliance|0|||
127978227|NCT01542034|460542470|FG000|Overall Study|Adverse Event|2|||
127978228|NCT01542034|460542471|FG001|Overall Study|Adverse Event|2|||
127978229|NCT01542034|460542470|FG000|Overall Study|Lost to Follow-up|7|||
127978230|NCT01542034|460542471|FG001|Overall Study|Lost to Follow-up|6|||
127978231|NCT02612610|460542472|FG000|Overall Study|Withdrawal by Subject|1|||
127978232|NCT02612610|460542473|FG001|Overall Study|Withdrawal by Subject|1|||
127502654|NCT01973387|458799476|FG000|Overall Study|Withdrawal by Subject|7|||
127502655|NCT01973387|458799477|FG001|Overall Study|Withdrawal by Subject|4|||
127978233|NCT02612610|460542474|FG002|Overall Study|Withdrawal by Subject|0|||
127502656|NCT01973387|458799476|FG000|Overall Study|Study terminated by sponsor|63|||
127978234|NCT02612610|460542475|FG003|Overall Study|Withdrawal by Subject|2|||
127502657|NCT01973387|458799477|FG001|Overall Study|Study terminated by sponsor|0|||
127502658|NCT01973387|458799476|FG000|Overall Study|Progressive disease or relapse|16|||
127502659|NCT01973387|458799477|FG001|Overall Study|Progressive disease or relapse|5|||
127502660|NCT01973387|458799476|FG000|Overall Study|Death|4|||
127502661|NCT01973387|458799477|FG001|Overall Study|Death|3|||
127502662|NCT01973387|458799476|FG000|Overall Study|Randomized, not treated|2|||
127502663|NCT01973387|458799477|FG001|Overall Study|Randomized, not treated|2|||
127502664|NCT01562314|458799481|FG000|Overall Study|Adverse Event|10|||
127502665|NCT01562314|458799482|FG001|Overall Study|Adverse Event|5|||
127502666|NCT01562314|458799481|FG000|Overall Study|Met Withdrawal Criteria|3|||
127502667|NCT01562314|458799482|FG001|Overall Study|Met Withdrawal Criteria|2|||
127502668|NCT01562314|458799481|FG000|Overall Study|Withdrawal by Subject|0|||
127502669|NCT01562314|458799482|FG001|Overall Study|Withdrawal by Subject|1|||
127502670|NCT02256384|458799493|FG000|Overall Study|Withdrawal by Subject|12|||
127502671|NCT02256384|458799493|FG000|Overall Study|Equipment not capturing data|2|||
127502672|NCT03888235|458799495|FG000|Overall Study|Lost to Follow-up|1|||
127502673|NCT03888235|458799496|FG001|Overall Study|Lost to Follow-up|1|||
127502674|NCT03888235|458799497|FG002|Overall Study|Lost to Follow-up|0|||
127502675|NCT02135029|458799500|FG000|Overall Study|Adverse Event|2|||
127502676|NCT02135029|458799501|FG001|Overall Study|Adverse Event|2|||
127502677|NCT02135029|458799502|FG002|Overall Study|Adverse Event|2|||
127502678|NCT02135029|458799500|FG000|Overall Study|Lost to Follow-up|0|||
127502679|NCT02135029|458799501|FG001|Overall Study|Lost to Follow-up|1|||
127502680|NCT02135029|458799502|FG002|Overall Study|Lost to Follow-up|0|||
127502681|NCT02135029|458799500|FG000|Overall Study|Withdrawal by Subject|2|||
127502682|NCT02135029|458799501|FG001|Overall Study|Withdrawal by Subject|0|||
127502683|NCT02135029|458799502|FG002|Overall Study|Withdrawal by Subject|1|||
127502684|NCT02135029|458799500|FG000|Overall Study|Other|0|||
127502685|NCT02135029|458799501|FG001|Overall Study|Other|1|||
127502686|NCT02135029|458799502|FG002|Overall Study|Other|0|||
127502687|NCT02135029|458799500|FG000|Overall Study|Death|0|||
127502688|NCT02135029|458799501|FG001|Overall Study|Death|1|||
127502689|NCT02135029|458799502|FG002|Overall Study|Death|0|||
127502690|NCT03525600|458799503|FG000|Overall Study|Adverse Event|9|||
127502691|NCT03525600|458799504|FG001|Overall Study|Adverse Event|6|||
127502692|NCT03525600|458799505|FG002|Overall Study|Adverse Event|5|||
127502693|NCT03525600|458799506|FG003|Overall Study|Adverse Event|3|||
127502694|NCT03525600|458799503|FG000|Overall Study|Lost to Follow-up|2|||
127502695|NCT03525600|458799504|FG001|Overall Study|Lost to Follow-up|4|||
127502696|NCT03525600|458799505|FG002|Overall Study|Lost to Follow-up|4|||
127502697|NCT03525600|458799506|FG003|Overall Study|Lost to Follow-up|0|||
127502698|NCT03525600|458799503|FG000|Overall Study|Physician Decision|1|||
127502699|NCT03525600|458799504|FG001|Overall Study|Physician Decision|0|||
127502700|NCT03525600|458799505|FG002|Overall Study|Physician Decision|2|||
127502701|NCT03525600|458799506|FG003|Overall Study|Physician Decision|0|||
127502702|NCT03525600|458799503|FG000|Overall Study|Consent withdrawal|36|||
127502703|NCT03525600|458799504|FG001|Overall Study|Consent withdrawal|20|||
127502704|NCT03525600|458799505|FG002|Overall Study|Consent withdrawal|6|||
127502705|NCT03525600|458799506|FG003|Overall Study|Consent withdrawal|13|||
127502706|NCT03525600|458799503|FG000|Overall Study|Death|7|||
127502707|NCT03525600|458799504|FG001|Overall Study|Death|6|||
127502708|NCT03525600|458799505|FG002|Overall Study|Death|4|||
127502709|NCT03525600|458799506|FG003|Overall Study|Death|3|||
127502710|NCT03525600|458799503|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
127502711|NCT03525600|458799504|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
127502712|NCT03525600|458799505|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
127502713|NCT03525600|458799506|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
127502714|NCT03525600|458799503|FG000|Overall Study|Other|0|||
127502715|NCT03525600|458799504|FG001|Overall Study|Other|1|||
127502716|NCT03525600|458799505|FG002|Overall Study|Other|0|||
127502717|NCT03525600|458799506|FG003|Overall Study|Other|0|||
127502718|NCT03703817|458799516|FG000|Overall Study|Not meeting eligibility criteria|7|||
127502719|NCT03703817|458799517|FG001|Overall Study|Not meeting eligibility criteria|4|||
127502720|NCT00349921|458799518|FG000|First Spinal Injection|Physician Decision|1|||
127502721|NCT00349921|458799519|FG001|First Spinal Injection|Physician Decision|0|||
127502722|NCT00349921|458799520|FG002|First Spinal Injection|Physician Decision|0|||
127502723|NCT00349921|458799521|FG003|First Spinal Injection|Physician Decision|0|||
127502724|NCT00349921|458799518|FG000|First Spinal Injection|Adverse Event|0|||
127502725|NCT00349921|458799519|FG001|First Spinal Injection|Adverse Event|0|||
127502726|NCT00349921|458799520|FG002|First Spinal Injection|Adverse Event|1|||
127502727|NCT00349921|458799521|FG003|First Spinal Injection|Adverse Event|0|||
127502728|NCT01301066|458799522|FG000|Overall Study|Lost to Follow-up|5|||
127502729|NCT01301066|458799523|FG001|Overall Study|Lost to Follow-up|11|||
127502730|NCT01301066|458799522|FG000|Overall Study|Protocol Violation|8|||
127502731|NCT01301066|458799523|FG001|Overall Study|Protocol Violation|7|||
127502732|NCT01301066|458799522|FG000|Overall Study|Withdrawal by Subject|4|||
127502733|NCT01301066|458799523|FG001|Overall Study|Withdrawal by Subject|9|||
127502734|NCT01301066|458799522|FG000|Overall Study|Adverse Event|6|||
127502735|NCT01301066|458799523|FG001|Overall Study|Adverse Event|6|||
127502736|NCT01301066|458799522|FG000|Overall Study|Sponsor Decision|2|||
127502737|NCT01301066|458799523|FG001|Overall Study|Sponsor Decision|1|||
127502738|NCT01301066|458799522|FG000|Overall Study|Physician Decision|0|||
127502739|NCT01301066|458799523|FG001|Overall Study|Physician Decision|1|||
127502740|NCT01301066|458799522|FG000|Overall Study|Other|2|||
127502741|NCT01301066|458799523|FG001|Overall Study|Other|0|||
127502742|NCT00778258|458799524|FG000|Overall Study|Adverse Event|1|||
127502743|NCT00778258|458799525|FG001|Overall Study|Adverse Event|0|||
127502744|NCT00778258|458799526|FG002|Overall Study|Adverse Event|0|||
127502745|NCT00778258|458799527|FG003|Overall Study|Adverse Event|0|||
127502746|NCT00778258|458799528|FG004|Overall Study|Adverse Event|0|||
127502747|NCT00778258|458799529|FG005|Overall Study|Adverse Event|1|||
127502748|NCT00778258|458799530|FG006|Overall Study|Adverse Event|0|||
127502749|NCT00778258|458799531|FG007|Overall Study|Adverse Event|0|||
127502750|NCT00778258|458799532|FG008|Overall Study|Adverse Event|0|||
127502751|NCT00778258|458799524|FG000|Overall Study|Lost to Follow-up|0|||
127502752|NCT00778258|458799525|FG001|Overall Study|Lost to Follow-up|0|||
127502753|NCT00778258|458799526|FG002|Overall Study|Lost to Follow-up|2|||
127502754|NCT00778258|458799527|FG003|Overall Study|Lost to Follow-up|0|||
127502755|NCT00778258|458799528|FG004|Overall Study|Lost to Follow-up|0|||
127502756|NCT00778258|458799529|FG005|Overall Study|Lost to Follow-up|3|||
127502757|NCT00778258|458799530|FG006|Overall Study|Lost to Follow-up|2|||
127502758|NCT00778258|458799531|FG007|Overall Study|Lost to Follow-up|2|||
127502759|NCT00778258|458799532|FG008|Overall Study|Lost to Follow-up|0|||
127502760|NCT00778258|458799524|FG000|Overall Study|Withdrawal by Subject|6|||
127502761|NCT00778258|458799525|FG001|Overall Study|Withdrawal by Subject|2|||
127502762|NCT00778258|458799526|FG002|Overall Study|Withdrawal by Subject|8|||
127502763|NCT00778258|458799527|FG003|Overall Study|Withdrawal by Subject|2|||
127502764|NCT00778258|458799528|FG004|Overall Study|Withdrawal by Subject|0|||
127502765|NCT00778258|458799529|FG005|Overall Study|Withdrawal by Subject|6|||
127502766|NCT00778258|458799530|FG006|Overall Study|Withdrawal by Subject|12|||
127502767|NCT00778258|458799531|FG007|Overall Study|Withdrawal by Subject|12|||
127502768|NCT00778258|458799532|FG008|Overall Study|Withdrawal by Subject|4|||
127502769|NCT00778258|458799524|FG000|Overall Study|New Contraindication|0|||
127502770|NCT00778258|458799525|FG001|Overall Study|New Contraindication|0|||
127502771|NCT00778258|458799526|FG002|Overall Study|New Contraindication|0|||
127502772|NCT00778258|458799527|FG003|Overall Study|New Contraindication|0|||
127502773|NCT00778258|458799528|FG004|Overall Study|New Contraindication|0|||
127502774|NCT00778258|458799529|FG005|Overall Study|New Contraindication|0|||
127502775|NCT00778258|458799530|FG006|Overall Study|New Contraindication|0|||
127502776|NCT00778258|458799531|FG007|Overall Study|New Contraindication|1|||
127502777|NCT00778258|458799532|FG008|Overall Study|New Contraindication|0|||
127502778|NCT00778258|458799524|FG000|Overall Study|Non-compliance|0|||
127502779|NCT00778258|458799525|FG001|Overall Study|Non-compliance|0|||
127502780|NCT00778258|458799526|FG002|Overall Study|Non-compliance|0|||
127502781|NCT00778258|458799527|FG003|Overall Study|Non-compliance|1|||
127502782|NCT00778258|458799528|FG004|Overall Study|Non-compliance|0|||
127502783|NCT00778258|458799529|FG005|Overall Study|Non-compliance|0|||
127502784|NCT00778258|458799530|FG006|Overall Study|Non-compliance|0|||
127502785|NCT00778258|458799531|FG007|Overall Study|Non-compliance|0|||
127502786|NCT00778258|458799532|FG008|Overall Study|Non-compliance|0|||
127502787|NCT00778258|458799524|FG000|Overall Study|Other|0|||
127502788|NCT00778258|458799525|FG001|Overall Study|Other|0|||
127502789|NCT00778258|458799526|FG002|Overall Study|Other|0|||
127502790|NCT00778258|458799527|FG003|Overall Study|Other|0|||
127502791|NCT00778258|458799528|FG004|Overall Study|Other|0|||
127502792|NCT00778258|458799529|FG005|Overall Study|Other|0|||
127502793|NCT00778258|458799530|FG006|Overall Study|Other|1|||
127502794|NCT00778258|458799531|FG007|Overall Study|Other|0|||
127502795|NCT00778258|458799532|FG008|Overall Study|Other|0|||
127502796|NCT00780143|458799541|FG000|Overall Study|Progressive disease|1|||
127502797|NCT00780143|458799541|FG000|Overall Study|Toxicity|1|||
127502798|NCT00780143|458799541|FG000|Overall Study|Adverse Event|1|||
127502799|NCT00082368|458799544|FG000|Overall Study|Not treated-pt had poor IV access|1|||
127502800|NCT03319953|458799547|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
127502801|NCT03319953|458799548|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
127502802|NCT03319953|458799549|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
127502803|NCT03319953|458799550|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
127502804|NCT03319953|458799547|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
127502805|NCT03319953|458799548|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
127502806|NCT03319953|458799549|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
127502807|NCT03319953|458799550|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
127502808|NCT01795495|458799551|FG000|Overall Study|Protocol Violation|1|||
127502809|NCT01795495|458799552|FG001|Overall Study|Protocol Violation|0|||
127502810|NCT01795495|458799553|FG002|Overall Study|Protocol Violation|1|||
127502811|NCT01795495|458799551|FG000|Overall Study|Physician Decision|0|||
127502812|NCT01795495|458799552|FG001|Overall Study|Physician Decision|0|||
127502813|NCT01795495|458799553|FG002|Overall Study|Physician Decision|1|||
127502814|NCT01331837|458799554|FG000|Overall Study|Death|30|||
127502815|NCT01331837|458799555|FG001|Overall Study|Death|34|||
127502816|NCT01331837|458799554|FG000|Overall Study|Lost to Follow-up|3|||
127502817|NCT01331837|458799555|FG001|Overall Study|Lost to Follow-up|1|||
127502818|NCT01331837|458799554|FG000|Overall Study|Info not recorded|10|||
127502819|NCT01331837|458799555|FG001|Overall Study|Info not recorded|16|||
127502820|NCT01331837|458799554|FG000|Overall Study|Withdrawal by Subject|13|||
127502821|NCT01331837|458799555|FG001|Overall Study|Withdrawal by Subject|16|||
127502822|NCT00790868|458801557|FG000|Overall Study|Withdrawal by Subject|4|||
127502823|NCT00790868|458801558|FG001|Overall Study|Withdrawal by Subject|5|||
127502824|NCT00790868|458801557|FG000|Overall Study|Lost to Follow-up|2|||
127502825|NCT00790868|458801558|FG001|Overall Study|Lost to Follow-up|12|||
127502826|NCT03285958|458801566|FG000|Overall Study|Lost to Follow-up|1|||
127502827|NCT03285958|458801567|FG001|Overall Study|Lost to Follow-up|1|||
127502828|NCT03285958|458801566|FG000|Overall Study|Withdrawal by Subject|1|||
127502829|NCT03285958|458801567|FG001|Overall Study|Withdrawal by Subject|0|||
127502830|NCT03285958|458801566|FG000|Overall Study|Not able to attend required orientation|3|||
127502831|NCT03285958|458801567|FG001|Overall Study|Not able to attend required orientation|0|||
127502832|NCT03116828|458801568|FG000|Overall Study|Adverse Event|1|||
127502833|NCT03116828|458801569|FG001|Overall Study|Adverse Event|10|||
127502834|NCT03116828|458801568|FG000|Overall Study|Withdrawal by Subject|4|||
127502835|NCT03116828|458801569|FG001|Overall Study|Withdrawal by Subject|8|||
127502836|NCT03116828|458801568|FG000|Overall Study|OTHER|3|||
127502837|NCT03116828|458801569|FG001|Overall Study|OTHER|3|||
127502838|NCT00882583|458801570|FG000|Overall Study|Physician Decision|1|||
127502839|NCT00882583|458801571|FG001|Overall Study|Physician Decision|0|||
127502840|NCT00882583|458801570|FG000|Overall Study|Adverse Event|0|||
127502841|NCT00882583|458801571|FG001|Overall Study|Adverse Event|1|||
127502842|NCT04753658|458801573|FG000|Overall Study|Progressive disease|7|||
127502843|NCT04753658|458801573|FG000|Overall Study|Other|7|||
127502844|NCT04753658|458801573|FG000|Overall Study|Adverse Event|1|||
127502845|NCT00306293|458801574|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
127502846|NCT00306293|458801575|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
127502847|NCT00306293|458801574|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
127502848|NCT00306293|458801575|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
127502849|NCT00306293|458801574|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
127502850|NCT00306293|458801575|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
127502851|NCT00306293|458801574|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
127502852|NCT00306293|458801575|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
127502853|NCT00306293|458801574|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
127502854|NCT00306293|458801575|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
127502855|NCT00306293|458801574|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
127502856|NCT00306293|458801575|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
127502857|NCT00306293|458801574|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
127502858|NCT00306293|458801575|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
127502859|NCT00306293|458801574|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
127502860|NCT00306293|458801575|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
127502861|NCT05243745|458801576|FG000|Overall Study|Withdrawal by Subject|0|||
127502862|NCT05243745|458801577|FG001|Overall Study|Withdrawal by Subject|0|||
127502863|NCT05243745|458801578|FG002|Overall Study|Withdrawal by Subject|0|||
127502864|NCT05243745|458801579|FG003|Overall Study|Withdrawal by Subject|1|||
127502865|NCT05243745|458801576|FG000|Overall Study|Unable to Attend Visit 6|0|||
127502866|NCT05243745|458801577|FG001|Overall Study|Unable to Attend Visit 6|0|||
127502867|NCT05243745|458801578|FG002|Overall Study|Unable to Attend Visit 6|1|||
127502868|NCT05243745|458801579|FG003|Overall Study|Unable to Attend Visit 6|0|||
127502869|NCT00176488|458801592|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
127502870|NCT01044745|458801593|FG000|Overall Study|Ineiligible|2|||
127502871|NCT00733291|458801597|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
127502872|NCT00733291|458801598|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
127502873|NCT00733291|458801599|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
127502874|NCT00733291|458801600|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
127502875|NCT02759107|458801603|FG000|Overall Study|Adverse Event|0|||
127502876|NCT02759107|458801604|FG001|Overall Study|Adverse Event|0|||
127502877|NCT02759107|458801605|FG002|Overall Study|Adverse Event|0|||
127502878|NCT02759107|458801606|FG003|Overall Study|Adverse Event|0|||
127502879|NCT02759107|458801607|FG004|Overall Study|Adverse Event|0|||
127502880|NCT02759107|458801608|FG005|Overall Study|Adverse Event|0|||
127502881|NCT02759107|458801609|FG006|Overall Study|Adverse Event|0|||
127502882|NCT02759107|458801610|FG007|Overall Study|Adverse Event|0|||
127502883|NCT02759107|458801611|FG008|Overall Study|Adverse Event|0|||
127502884|NCT02759107|458801612|FG009|Overall Study|Adverse Event|0|||
127502885|NCT02759107|458801613|FG010|Overall Study|Adverse Event|0|||
127502886|NCT02759107|458801614|FG011|Overall Study|Adverse Event|0|||
127502887|NCT02759107|458801615|FG012|Overall Study|Adverse Event|2|||
127502888|NCT02759107|458801616|FG013|Overall Study|Adverse Event|0|||
127502889|NCT02759107|458801617|FG014|Overall Study|Adverse Event|0|||
127502890|NCT02759107|458801618|FG015|Overall Study|Adverse Event|1|||
127502891|NCT02759107|458801619|FG016|Overall Study|Adverse Event|0|||
127502892|NCT02759107|458801620|FG017|Overall Study|Adverse Event|2|||
127502893|NCT02759107|458801603|FG000|Overall Study|Scheduling Conflict|0|||
127502894|NCT02759107|458801604|FG001|Overall Study|Scheduling Conflict|0|||
127502895|NCT02759107|458801605|FG002|Overall Study|Scheduling Conflict|0|||
127502896|NCT02759107|458801606|FG003|Overall Study|Scheduling Conflict|0|||
127502897|NCT02759107|458801607|FG004|Overall Study|Scheduling Conflict|0|||
127502898|NCT02759107|458801608|FG005|Overall Study|Scheduling Conflict|0|||
127502899|NCT02759107|458801609|FG006|Overall Study|Scheduling Conflict|0|||
127502900|NCT02759107|458801610|FG007|Overall Study|Scheduling Conflict|0|||
127502901|NCT02759107|458801611|FG008|Overall Study|Scheduling Conflict|0|||
127502902|NCT02759107|458801612|FG009|Overall Study|Scheduling Conflict|1|||
127502903|NCT02759107|458801613|FG010|Overall Study|Scheduling Conflict|0|||
127502904|NCT02759107|458801614|FG011|Overall Study|Scheduling Conflict|0|||
127502905|NCT02759107|458801615|FG012|Overall Study|Scheduling Conflict|0|||
127502906|NCT02759107|458801616|FG013|Overall Study|Scheduling Conflict|0|||
127502907|NCT02759107|458801617|FG014|Overall Study|Scheduling Conflict|0|||
127502908|NCT02759107|458801618|FG015|Overall Study|Scheduling Conflict|0|||
127502909|NCT02759107|458801619|FG016|Overall Study|Scheduling Conflict|0|||
127502910|NCT02759107|458801620|FG017|Overall Study|Scheduling Conflict|0|||
127502911|NCT01089413|458801626|FG000|Overall Study|Lost to Follow-up|1|||
127502912|NCT01089413|458801626|FG000|Overall Study|Progressive Disease|93|||
127502913|NCT01089413|458801626|FG000|Overall Study|Participant Withdrew Consent|1|||
127502914|NCT01089413|458801626|FG000|Overall Study|Unacceptable Toxicity|12|||
127502915|NCT01089413|458801626|FG000|Overall Study|Death|10|||
127502916|NCT01089413|458801626|FG000|Overall Study|Metastasectomy|13|||
127502917|NCT01089413|458801626|FG000|Overall Study|Other|71|||
127502918|NCT02513485|458801627|FG000|Overall Study|Adverse Event|1|||
127502919|NCT02513485|458801628|FG001|Overall Study|Adverse Event|0|||
127502920|NCT02526524|458801635|FG000|Overall Study|Withdrawal by Subject|3|||
127502921|NCT02526524|458801636|FG001|Overall Study|Withdrawal by Subject|3|||
127502922|NCT02526524|458801637|FG002|Overall Study|Withdrawal by Subject|6|||
127502923|NCT02526524|458801638|FG003|Overall Study|Withdrawal by Subject|1|||
127502924|NCT02526524|458801639|FG004|Overall Study|Withdrawal by Subject|9|||
127502925|NCT02526524|458801640|FG005|Overall Study|Withdrawal by Subject|5|||
127502926|NCT02526524|458801635|FG000|Overall Study|Adverse Event|3|||
127502927|NCT02526524|458801636|FG001|Overall Study|Adverse Event|2|||
127502928|NCT02526524|458801637|FG002|Overall Study|Adverse Event|4|||
127502929|NCT02526524|458801638|FG003|Overall Study|Adverse Event|2|||
127502930|NCT02526524|458801639|FG004|Overall Study|Adverse Event|6|||
127502931|NCT02526524|458801640|FG005|Overall Study|Adverse Event|8|||
127502932|NCT02526524|458801635|FG000|Overall Study|Lost to Follow-up|2|||
127502933|NCT02526524|458801636|FG001|Overall Study|Lost to Follow-up|3|||
127502934|NCT02526524|458801637|FG002|Overall Study|Lost to Follow-up|8|||
127502935|NCT02526524|458801638|FG003|Overall Study|Lost to Follow-up|1|||
127502936|NCT02526524|458801639|FG004|Overall Study|Lost to Follow-up|2|||
127502937|NCT02526524|458801640|FG005|Overall Study|Lost to Follow-up|5|||
127502938|NCT02526524|458801635|FG000|Overall Study|Protocol Violation|3|||
127502939|NCT02526524|458801636|FG001|Overall Study|Protocol Violation|1|||
127502940|NCT02526524|458801637|FG002|Overall Study|Protocol Violation|5|||
127502941|NCT02526524|458801638|FG003|Overall Study|Protocol Violation|3|||
127502942|NCT02526524|458801639|FG004|Overall Study|Protocol Violation|4|||
127502943|NCT02526524|458801640|FG005|Overall Study|Protocol Violation|3|||
127502944|NCT02526524|458801635|FG000|Overall Study|Loss of Glucose Control|0|||
127502945|NCT02526524|458801636|FG001|Overall Study|Loss of Glucose Control|0|||
127502946|NCT02526524|458801637|FG002|Overall Study|Loss of Glucose Control|3|||
127502947|NCT02526524|458801638|FG003|Overall Study|Loss of Glucose Control|0|||
127502948|NCT02526524|458801639|FG004|Overall Study|Loss of Glucose Control|2|||
127502949|NCT02526524|458801640|FG005|Overall Study|Loss of Glucose Control|0|||
127502950|NCT02526524|458801635|FG000|Overall Study|Physician Decision|0|||
127502951|NCT02526524|458801636|FG001|Overall Study|Physician Decision|0|||
127502952|NCT02526524|458801637|FG002|Overall Study|Physician Decision|0|||
127502953|NCT02526524|458801638|FG003|Overall Study|Physician Decision|0|||
127502954|NCT02526524|458801639|FG004|Overall Study|Physician Decision|1|||
127978235|NCT02612610|460542472|FG000|Overall Study|Adverse Event|2|||
127502955|NCT02526524|458801640|FG005|Overall Study|Physician Decision|0|||
127502956|NCT02526524|458801635|FG000|Overall Study|Sponsor Decision|1|||
127978236|NCT02612610|460542473|FG001|Overall Study|Adverse Event|2|||
127502957|NCT02526524|458801636|FG001|Overall Study|Sponsor Decision|0|||
127502958|NCT02526524|458801637|FG002|Overall Study|Sponsor Decision|0|||
127502959|NCT02526524|458801638|FG003|Overall Study|Sponsor Decision|0|||
127502960|NCT02526524|458801639|FG004|Overall Study|Sponsor Decision|0|||
127502961|NCT02526524|458801640|FG005|Overall Study|Sponsor Decision|0|||
127502962|NCT00519376|458801643|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
127502963|NCT00519376|458801644|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
127502964|NCT00519376|458801645|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
127502965|NCT00519376|458801646|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
127502966|NCT00519376|458801647|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
127502967|NCT00519376|458801648|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
127502968|NCT00519376|458801649|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
127502969|NCT00519376|458801650|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
127502970|NCT00519376|458801651|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
127502971|NCT00519376|458801652|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
127502972|NCT00519376|458801653|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
127502973|NCT00519376|458801654|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
127502974|NCT00519376|458801655|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
127502975|NCT00519376|458801656|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
127502976|NCT00519376|458801657|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
127502977|NCT00519376|458801658|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
127502978|NCT00519376|458801643|FG000|Treatment Period 4|Lost to Follow-up|0|||
127502979|NCT00519376|458801644|FG001|Treatment Period 4|Lost to Follow-up|0|||
127502980|NCT00519376|458801645|FG002|Treatment Period 4|Lost to Follow-up|1|||
127502981|NCT00519376|458801646|FG003|Treatment Period 4|Lost to Follow-up|0|||
127502982|NCT00519376|458801647|FG004|Treatment Period 4|Lost to Follow-up|0|||
127502983|NCT00519376|458801648|FG005|Treatment Period 4|Lost to Follow-up|0|||
127502984|NCT00519376|458801649|FG006|Treatment Period 4|Lost to Follow-up|0|||
127502985|NCT00519376|458801650|FG007|Treatment Period 4|Lost to Follow-up|0|||
127502986|NCT00519376|458801651|FG008|Treatment Period 4|Lost to Follow-up|0|||
127502987|NCT00519376|458801652|FG009|Treatment Period 4|Lost to Follow-up|0|||
127502988|NCT00519376|458801653|FG010|Treatment Period 4|Lost to Follow-up|0|||
127502989|NCT00519376|458801654|FG011|Treatment Period 4|Lost to Follow-up|0|||
127502990|NCT00519376|458801655|FG012|Treatment Period 4|Lost to Follow-up|0|||
127502991|NCT00519376|458801656|FG013|Treatment Period 4|Lost to Follow-up|0|||
127502992|NCT00519376|458801657|FG014|Treatment Period 4|Lost to Follow-up|0|||
127502993|NCT00519376|458801658|FG015|Treatment Period 4|Lost to Follow-up|0|||
127502994|NCT02039219|458801659|FG000|Treatment|Withdrawal by Subject|1|||
127502995|NCT02039219|458801660|FG001|Treatment|Withdrawal by Subject|0|||
127502996|NCT02039219|458801659|FG000|Treatment|Adverse Event|0|||
127502997|NCT02039219|458801660|FG001|Treatment|Adverse Event|1|||
127502998|NCT02039219|458801659|FG000|Treatment|Physician Decision|1|||
127502999|NCT02039219|458801660|FG001|Treatment|Physician Decision|0|||
127503000|NCT02039219|458801659|FG000|Treatment|Lost to Follow-up|0|||
127503001|NCT02039219|458801660|FG001|Treatment|Lost to Follow-up|1|||
127503002|NCT02039219|458801659|FG000|Treatment|Protocol Violation|1|||
127503003|NCT02039219|458801660|FG001|Treatment|Protocol Violation|0|||
127503004|NCT02039219|458801659|FG000|Treatment|Death|1|||
127503005|NCT02039219|458801660|FG001|Treatment|Death|0|||
127503006|NCT02039219|458801659|FG000|Follow up|Adverse Event|0|||
127503007|NCT02039219|458801660|FG001|Follow up|Adverse Event|1|||
127503008|NCT02974855|458801661|FG000|Overall Study|Adverse Event|0|||
127503009|NCT02974855|458801662|FG001|Overall Study|Adverse Event|1|||
127503010|NCT02974855|458801663|FG002|Overall Study|Adverse Event|0|||
127503011|NCT02974855|458801664|FG003|Overall Study|Adverse Event|1|||
127503012|NCT03576066|458801665|FG000|Overall Study|Noncompliance with study drug|0|||
127503013|NCT03576066|458801666|FG001|Overall Study|Noncompliance with study drug|1|||
127503014|NCT00129701|458801667|FG000|Overall Study|Withdrawal by Subject|33|||
127503015|NCT00006164|458801668|FG000|Overall Study|Withdrew or lost to follow-up|70|||
127503016|NCT00006164|458801669|FG001|Overall Study|Withdrew or lost to follow-up|81|||
127503017|NCT02750345|458801670|FG000|Intervention 1|Adverse Event|0|||
127503018|NCT02750345|458801671|FG001|Intervention 1|Adverse Event|0|||
127503019|NCT02750345|458801672|FG002|Intervention 1|Adverse Event|0|||
127503020|NCT02750345|458801673|FG003|Intervention 1|Adverse Event|0|||
127503021|NCT02750345|458801674|FG004|Intervention 1|Adverse Event|1|||
127503022|NCT02750345|458801675|FG005|Intervention 1|Adverse Event|0|||
127503023|NCT00633074|458801676|FG000|Overall Study|Adverse Event|1|||
127503024|NCT00633074|458801677|FG001|Overall Study|Adverse Event|0|||
127503025|NCT02650128|458801678|FG000|Overall Study|Death|2|||
127503026|NCT01801436|458801702|FG000|Overall Study|Withdrawal by Subject|3|||
127503027|NCT01801436|458801702|FG000|Overall Study|Adverse Event|2|||
127503028|NCT01801436|458801702|FG000|Overall Study|Progressive disease|4|||
127503029|NCT02447250|458801703|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
127503030|NCT02447250|458801703|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
127503031|NCT02447250|458801703|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
127503032|NCT01885208|458801706|FG000|Overall Study|Unclassified|32|||
127503033|NCT01885208|458801707|FG001|Overall Study|Unclassified|38|||
127503034|NCT03224507|458801710|FG000|Overall Study|Death|3|||
127503035|NCT03224507|458801711|FG001|Overall Study|Death|0|||
127503036|NCT03224507|458801710|FG000|Overall Study|Lack of Efficacy|6|||
127503037|NCT03224507|458801711|FG001|Overall Study|Lack of Efficacy|0|||
127503038|NCT03224507|458801710|FG000|Overall Study|Withdrawal by Subject|6|||
127503039|NCT03224507|458801711|FG001|Overall Study|Withdrawal by Subject|0|||
127503040|NCT01126437|458801716|FG000|Overall Study|Not treated|11|||
127503041|NCT01126437|458801717|FG001|Overall Study|Not treated|18|||
127503042|NCT01126437|458801718|FG002|Overall Study|Not treated|19|||
127503043|NCT01126437|458801716|FG000|Overall Study|Sites with data irregularities/fraud|6|||
127503044|NCT01126437|458801717|FG001|Overall Study|Sites with data irregularities/fraud|6|||
127503045|NCT01126437|458801718|FG002|Overall Study|Sites with data irregularities/fraud|7|||
127503046|NCT01126437|458801716|FG000|Overall Study|Adverse Event|602|||
127503047|NCT01126437|458801717|FG001|Overall Study|Adverse Event|606|||
127503048|NCT01126437|458801718|FG002|Overall Study|Adverse Event|635|||
127503049|NCT01126437|458801716|FG000|Overall Study|Lack of Efficacy|65|||
127503050|NCT01126437|458801717|FG001|Overall Study|Lack of Efficacy|60|||
127503051|NCT01126437|458801718|FG002|Overall Study|Lack of Efficacy|59|||
127503052|NCT01126437|458801716|FG000|Overall Study|Protocol Violation|64|||
127503053|NCT01126437|458801717|FG001|Overall Study|Protocol Violation|66|||
127503054|NCT01126437|458801718|FG002|Overall Study|Protocol Violation|41|||
127503055|NCT01126437|458801716|FG000|Overall Study|Lost to Follow-up|52|||
127503056|NCT01126437|458801717|FG001|Overall Study|Lost to Follow-up|63|||
127503057|NCT01126437|458801718|FG002|Overall Study|Lost to Follow-up|55|||
127503058|NCT01126437|458801716|FG000|Overall Study|Withdrawal by Subject|331|||
127503059|NCT01126437|458801717|FG001|Overall Study|Withdrawal by Subject|335|||
127503060|NCT01126437|458801718|FG002|Overall Study|Withdrawal by Subject|319|||
127503061|NCT01126437|458801716|FG000|Overall Study|Other reason not specified|210|||
127503062|NCT01126437|458801717|FG001|Overall Study|Other reason not specified|176|||
127503063|NCT01126437|458801718|FG002|Overall Study|Other reason not specified|178|||
127503064|NCT01846663|458801729|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
127503065|NCT01846663|458801730|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
127503066|NCT01846663|458801729|FG000|Overall Study|Withdrawal by Subject|1|||
127503067|NCT01846663|458801730|FG001|Overall Study|Withdrawal by Subject|0|||
127503068|NCT01846663|458801729|FG000|Overall Study|Adverse Event|1|||
127503069|NCT01846663|458801730|FG001|Overall Study|Adverse Event|2|||
127503070|NCT02851797|458801736|FG000|Overall Study|Withdrawal by Subject|4|||
127503071|NCT02851797|458801737|FG001|Overall Study|Withdrawal by Subject|2|||
127503072|NCT02851797|458801736|FG000|Overall Study|Adverse Event|3|||
127503073|NCT02851797|458801737|FG001|Overall Study|Adverse Event|0|||
127503074|NCT03655054|458801738|FG000|Overall Study|Lost to Follow-up|1|||
127503075|NCT00813865|458801739|FG000|Overall Study|Failure to Respond|3|||
127503076|NCT00813865|458801739|FG000|Overall Study|Lost to Follow-up|3|||
127503077|NCT00813865|458801739|FG000|Overall Study|Withdrawal by Subject|1|||
127503078|NCT04295681|458801740|FG000|Overall Study|Eligibility error|1|||
127503079|NCT04295681|458801741|FG001|Overall Study|Eligibility error|3|||
127503080|NCT03255967|458801752|FG000|Overall Study|Adverse Event|26|||
127503081|NCT03255967|458801753|FG001|Overall Study|Adverse Event|30|||
127503082|NCT03255967|458801752|FG000|Overall Study|Withdrawal by Subject|6|||
127503083|NCT03255967|458801753|FG001|Overall Study|Withdrawal by Subject|6|||
127503084|NCT03255967|458801752|FG000|Overall Study|Schedule conflict|6|||
127503085|NCT03255967|458801753|FG001|Overall Study|Schedule conflict|4|||
127503086|NCT03255967|458801752|FG000|Overall Study|POA did not sign consent form|2|||
127503087|NCT03255967|458801753|FG001|Overall Study|POA did not sign consent form|0|||
127503088|NCT01202188|458801754|FG000|Overall Study|Protocol deviation|14|||
127503089|NCT01202188|458801755|FG001|Overall Study|Protocol deviation|8|||
127503090|NCT01202188|458801756|FG002|Overall Study|Protocol deviation|12|||
127503091|NCT01202188|458801757|FG003|Overall Study|Protocol deviation|10|||
127503092|NCT01202188|458801758|FG004|Overall Study|Protocol deviation|11|||
127503093|NCT01202188|458801754|FG000|Overall Study|Subject withdrew consent|12|||
127503094|NCT01202188|458801755|FG001|Overall Study|Subject withdrew consent|13|||
127503095|NCT01202188|458801756|FG002|Overall Study|Subject withdrew consent|22|||
127503096|NCT01202188|458801757|FG003|Overall Study|Subject withdrew consent|11|||
127503097|NCT01202188|458801758|FG004|Overall Study|Subject withdrew consent|13|||
127503098|NCT01202188|458801754|FG000|Overall Study|Adverse Event|5|||
127503099|NCT01202188|458801755|FG001|Overall Study|Adverse Event|23|||
127503100|NCT01202188|458801756|FG002|Overall Study|Adverse Event|13|||
127503101|NCT01202188|458801757|FG003|Overall Study|Adverse Event|10|||
127503102|NCT01202188|458801758|FG004|Overall Study|Adverse Event|10|||
127503103|NCT01202188|458801754|FG000|Overall Study|Administrative problems|3|||
127503104|NCT01202188|458801755|FG001|Overall Study|Administrative problems|2|||
127503105|NCT01202188|458801756|FG002|Overall Study|Administrative problems|1|||
127503106|NCT01202188|458801757|FG003|Overall Study|Administrative problems|1|||
127503107|NCT01202188|458801758|FG004|Overall Study|Administrative problems|2|||
127978237|NCT02612610|460542474|FG002|Overall Study|Adverse Event|3|||
127503108|NCT01202188|458801754|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
127503109|NCT01202188|458801755|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
127503110|NCT01202188|458801756|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
127978238|NCT02612610|460542475|FG003|Overall Study|Adverse Event|10|||
127503111|NCT01202188|458801757|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
127503112|NCT01202188|458801758|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
127503113|NCT01202188|458801754|FG000|Overall Study|Lost to Follow-up|1|||
127503114|NCT01202188|458801755|FG001|Overall Study|Lost to Follow-up|1|||
127503115|NCT01202188|458801756|FG002|Overall Study|Lost to Follow-up|0|||
127503116|NCT01202188|458801757|FG003|Overall Study|Lost to Follow-up|4|||
127503117|NCT01202188|458801758|FG004|Overall Study|Lost to Follow-up|1|||
127503118|NCT01202188|458801754|FG000|Overall Study|Death|1|||
127503119|NCT01202188|458801755|FG001|Overall Study|Death|1|||
127503120|NCT01202188|458801756|FG002|Overall Study|Death|1|||
127503121|NCT01202188|458801757|FG003|Overall Study|Death|1|||
127503122|NCT01202188|458801758|FG004|Overall Study|Death|0|||
127503123|NCT01202188|458801754|FG000|Overall Study|Abnormal test procedure result (s)|0|||
127503124|NCT01202188|458801755|FG001|Overall Study|Abnormal test procedure result (s)|0|||
127503125|NCT01202188|458801756|FG002|Overall Study|Abnormal test procedure result (s)|2|||
127503126|NCT01202188|458801757|FG003|Overall Study|Abnormal test procedure result (s)|0|||
127503127|NCT01202188|458801758|FG004|Overall Study|Abnormal test procedure result (s)|0|||
127503128|NCT02438384|458801760|FG000|Overall Study|Lost to Follow-up|8|||
127503129|NCT02438384|458801761|FG001|Overall Study|Lost to Follow-up|6|||
127503130|NCT02438384|458801762|FG002|Overall Study|Lost to Follow-up|4|||
127503131|NCT03315793|458801763|FG000|Overall Study|Adverse Event|4|||
127503132|NCT03315793|458801764|FG001|Overall Study|Adverse Event|2|||
127503133|NCT03315793|458801763|FG000|Overall Study|Protocol Deviation|1|||
127503134|NCT03315793|458801764|FG001|Overall Study|Protocol Deviation|0|||
127503135|NCT03315793|458801763|FG000|Overall Study|Difficult for regular visit|0|||
127503136|NCT03315793|458801764|FG001|Overall Study|Difficult for regular visit|1|||
127503137|NCT02640625|458803979|FG000|Overall Study|Adverse Event|1|||
127503138|NCT00511433|458803980|FG000|Overall Study|Adverse Event|5|||
127503139|NCT00511433|458803981|FG001|Overall Study|Adverse Event|0|||
127503140|NCT00511433|458803980|FG000|Overall Study|Other Reason|1|||
127503141|NCT00511433|458803981|FG001|Overall Study|Other Reason|1|||
127503142|NCT01740089|458803982|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
127503143|NCT01740089|458803983|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
127503144|NCT01740089|458803984|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
127503145|NCT01740089|458803982|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
127503146|NCT01740089|458803983|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
127503147|NCT01740089|458803984|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
127503148|NCT01740089|458803982|FG000|After 12 Weeks|Lack of Efficacy|3|||
127503149|NCT01740089|458803983|FG001|After 12 Weeks|Lack of Efficacy|1|||
127503150|NCT01740089|458803984|FG002|After 12 Weeks|Lack of Efficacy|4|||
127503151|NCT01740089|458803982|FG000|After 12 Weeks|Adverse Event|2|||
127503152|NCT01740089|458803983|FG001|After 12 Weeks|Adverse Event|0|||
127503153|NCT01740089|458803984|FG002|After 12 Weeks|Adverse Event|5|||
127503154|NCT01740089|458803982|FG000|After 12 Weeks|Protocol Violation|1|||
127503155|NCT01740089|458803983|FG001|After 12 Weeks|Protocol Violation|1|||
127503156|NCT01740089|458803984|FG002|After 12 Weeks|Protocol Violation|1|||
127503157|NCT01740089|458803982|FG000|After 12 Weeks|Withdrawal by Subject|1|||
127503158|NCT01740089|458803983|FG001|After 12 Weeks|Withdrawal by Subject|1|||
127503159|NCT01740089|458803984|FG002|After 12 Weeks|Withdrawal by Subject|1|||
127503160|NCT01579565|458803987|FG000|Randomized|Adverse Event|1|||
127503161|NCT01579565|458803988|FG001|Randomized|Adverse Event|3|||
127503162|NCT01579565|458803987|FG000|Randomized|Withdrawal by Subject|3|||
127503163|NCT01579565|458803988|FG001|Randomized|Withdrawal by Subject|0|||
127503164|NCT01579565|458803987|FG000|Randomized|inadequate preoperative pupil dilation|0|||
127503165|NCT01579565|458803988|FG001|Randomized|inadequate preoperative pupil dilation|1|||
127503166|NCT01579565|458803987|FG000|Randomized|prohibited preoperative eating|1|||
127503167|NCT01579565|458803988|FG001|Randomized|prohibited preoperative eating|0|||
127503168|NCT01579565|458803987|FG000|Randomized|prohibited preoperative medication|0|||
127503169|NCT01579565|458803988|FG001|Randomized|prohibited preoperative medication|1|||
127503170|NCT01579565|458803987|FG000|Treated|Physician Decision|0|||
127503171|NCT01579565|458803988|FG001|Treated|Physician Decision|1|||
127503172|NCT01579565|458803987|FG000|Treated|Lost to Follow-up|2|||
127503173|NCT01579565|458803988|FG001|Treated|Lost to Follow-up|1|||
127978239|NCT02612610|460542472|FG000|Overall Study|Lost to Follow-up|0|||
127978240|NCT02612610|460542473|FG001|Overall Study|Lost to Follow-up|1|||
127978241|NCT02612610|460542474|FG002|Overall Study|Lost to Follow-up|0|||
127978242|NCT02612610|460542475|FG003|Overall Study|Lost to Follow-up|0|||
127978243|NCT02612610|460542472|FG000|Overall Study|Protocol Violation|0|||
127978244|NCT02612610|460542473|FG001|Overall Study|Protocol Violation|1|||
127978245|NCT02612610|460542474|FG002|Overall Study|Protocol Violation|1|||
127978246|NCT02612610|460542475|FG003|Overall Study|Protocol Violation|0|||
127978247|NCT02612610|460542472|FG000|Overall Study|Lack of Efficacy|1|||
127978248|NCT02612610|460542473|FG001|Overall Study|Lack of Efficacy|2|||
127978249|NCT02612610|460542474|FG002|Overall Study|Lack of Efficacy|0|||
127978250|NCT02612610|460542475|FG003|Overall Study|Lack of Efficacy|1|||
127503174|NCT01579565|458803987|FG000|Treated|declined to return for final visit|0|||
127503175|NCT01579565|458803988|FG001|Treated|declined to return for final visit|1|||
127503176|NCT02013206|458803989|FG000|Overall Study|Progressive disease (PD)|14|||
127503177|NCT02013206|458803990|FG001|Overall Study|Progressive disease (PD)|17|||
127503178|NCT02013206|458803989|FG000|Overall Study|Symptomatic deterioration|3|||
127978251|NCT02612610|460542472|FG000|Overall Study|Physician Decision|0|||
127503179|NCT02013206|458803990|FG001|Overall Study|Symptomatic deterioration|1|||
127503180|NCT02013206|458803989|FG000|Overall Study|Adverse Event|1|||
127503181|NCT02013206|458803990|FG001|Overall Study|Adverse Event|0|||
127503182|NCT02013206|458803989|FG000|Overall Study|Patient refusal|2|||
127978252|NCT02612610|460542473|FG001|Overall Study|Physician Decision|1|||
127503183|NCT02013206|458803990|FG001|Overall Study|Patient refusal|0|||
127503184|NCT02013206|458803989|FG000|Overall Study|Patient non-compliance|1|||
127503185|NCT02013206|458803990|FG001|Overall Study|Patient non-compliance|0|||
127503186|NCT02013206|458803989|FG000|Overall Study|Death|1|||
127503187|NCT02013206|458803990|FG001|Overall Study|Death|2|||
127503188|NCT02013206|458803989|FG000|Overall Study|Other reasons off treatment|5|||
127503189|NCT02013206|458803990|FG001|Overall Study|Other reasons off treatment|2|||
127503190|NCT02867813|458803991|FG000|Overall Study|Withdrawal by Subject|57|||
127503191|NCT02867813|458803992|FG001|Overall Study|Withdrawal by Subject|56|||
127503192|NCT02867813|458803991|FG000|Overall Study|Decision by Sponsor|7|||
127503193|NCT02867813|458803992|FG001|Overall Study|Decision by Sponsor|7|||
127503194|NCT02867813|458803991|FG000|Overall Study|Lost to Follow-up|91|||
127503195|NCT02867813|458803992|FG001|Overall Study|Lost to Follow-up|78|||
127503196|NCT02867813|458803991|FG000|Overall Study|Missing|2|||
127503197|NCT02867813|458803992|FG001|Overall Study|Missing|1|||
127503198|NCT02867813|458803991|FG000|Overall Study|Death|294|||
127503199|NCT02867813|458803992|FG001|Overall Study|Death|268|||
127503200|NCT02791191|458803993|FG000|Overall Study|Adverse Event|2|||
127503201|NCT02791191|458803994|FG001|Overall Study|Adverse Event|4|||
127503202|NCT02791191|458803995|FG002|Overall Study|Adverse Event|5|||
127503203|NCT02791191|458803993|FG000|Overall Study|Lack of Efficacy|0|||
127503204|NCT02791191|458803994|FG001|Overall Study|Lack of Efficacy|1|||
127503205|NCT02791191|458803995|FG002|Overall Study|Lack of Efficacy|0|||
127503206|NCT02791191|458803993|FG000|Overall Study|Study Drug Non-Compliance|0|||
127503207|NCT02791191|458803994|FG001|Overall Study|Study Drug Non-Compliance|2|||
127503208|NCT02791191|458803995|FG002|Overall Study|Study Drug Non-Compliance|0|||
127503209|NCT02791191|458803993|FG000|Overall Study|Site Closed by Sponsor|1|||
127503210|NCT02791191|458803994|FG001|Overall Study|Site Closed by Sponsor|1|||
127503211|NCT02791191|458803995|FG002|Overall Study|Site Closed by Sponsor|3|||
127503212|NCT02791191|458803993|FG000|Overall Study|Progressive Disease|1|||
127503213|NCT02791191|458803994|FG001|Overall Study|Progressive Disease|0|||
127503214|NCT02791191|458803995|FG002|Overall Study|Progressive Disease|0|||
127503215|NCT02791191|458803993|FG000|Overall Study|Study Terminated by Sponsor|29|||
127503216|NCT02791191|458803994|FG001|Overall Study|Study Terminated by Sponsor|101|||
127503217|NCT02791191|458803995|FG002|Overall Study|Study Terminated by Sponsor|109|||
127503218|NCT02791191|458803993|FG000|Overall Study|Withdrawal by Subject|3|||
127503219|NCT02791191|458803994|FG001|Overall Study|Withdrawal by Subject|1|||
127503220|NCT02791191|458803995|FG002|Overall Study|Withdrawal by Subject|3|||
127503221|NCT02791191|458803993|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
127503222|NCT02791191|458803994|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
127503223|NCT02791191|458803995|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
127503224|NCT01952665|458803998|FG000|Overall Study|Physician Decision|3|||
127503225|NCT01952665|458803999|FG001|Overall Study|Physician Decision|2|||
127503226|NCT01952665|458803998|FG000|Overall Study|Lost to Follow-up|1|||
127503227|NCT01952665|458803999|FG001|Overall Study|Lost to Follow-up|2|||
127503228|NCT01952665|458803998|FG000|Overall Study|Adverse Event|2|||
127503229|NCT01952665|458803999|FG001|Overall Study|Adverse Event|1|||
127503230|NCT01952665|458803998|FG000|Overall Study|Protocol Violation|0|||
127503231|NCT01952665|458803999|FG001|Overall Study|Protocol Violation|1|||
127503232|NCT01537081|458804001|FG000|Overall Study|Adverse Event|5|||
127503233|NCT01537081|458804002|FG001|Overall Study|Adverse Event|2|||
127503234|NCT01537081|458804003|FG002|Overall Study|Adverse Event|2|||
127503235|NCT01537081|458804001|FG000|Overall Study|Lack of Efficacy|2|||
127503236|NCT01537081|458804002|FG001|Overall Study|Lack of Efficacy|1|||
127503237|NCT01537081|458804003|FG002|Overall Study|Lack of Efficacy|0|||
127503238|NCT01537081|458804001|FG000|Overall Study|Lost to Follow-up|17|||
127503239|NCT01537081|458804002|FG001|Overall Study|Lost to Follow-up|15|||
127503240|NCT01537081|458804003|FG002|Overall Study|Lost to Follow-up|9|||
127503241|NCT01537081|458804001|FG000|Overall Study|Protocol Violation|3|||
127503242|NCT01537081|458804002|FG001|Overall Study|Protocol Violation|2|||
127503243|NCT01537081|458804003|FG002|Overall Study|Protocol Violation|2|||
127503244|NCT01537081|458804001|FG000|Overall Study|Withdrawal by Subject|6|||
127503245|NCT01537081|458804002|FG001|Overall Study|Withdrawal by Subject|11|||
127503246|NCT01537081|458804003|FG002|Overall Study|Withdrawal by Subject|3|||
127503247|NCT01537081|458804001|FG000|Overall Study|Physician Decision|5|||
127503248|NCT01537081|458804002|FG001|Overall Study|Physician Decision|6|||
127503249|NCT01537081|458804003|FG002|Overall Study|Physician Decision|0|||
127503250|NCT01537081|458804001|FG000|Overall Study|Sponsor decision|0|||
127503251|NCT01537081|458804002|FG001|Overall Study|Sponsor decision|1|||
127503252|NCT01537081|458804003|FG002|Overall Study|Sponsor decision|0|||
127503253|NCT01537081|458804001|FG000|Overall Study|Assigned but never dosed|1|||
127503254|NCT01537081|458804002|FG001|Overall Study|Assigned but never dosed|0|||
127503255|NCT01537081|458804003|FG002|Overall Study|Assigned but never dosed|0|||
127503256|NCT01463111|458804006|FG000|Overall Study|Withdrawal by Subject|2|||
127503257|NCT01463111|458804006|FG000|Overall Study|Lost to Follow-up|5|||
127503258|NCT01463111|458804006|FG000|Overall Study|Physician Decision|2|||
127503259|NCT02596958|458804017|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
127503260|NCT02596958|458804017|FG000|Overall Study|Cancer Progression|441|||
127503261|NCT02596958|458804017|FG000|Overall Study|Death From Cancer|112|||
127503262|NCT02596958|458804017|FG000|Overall Study|Death From Other Cause|33|||
127503263|NCT02596958|458804017|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
127503264|NCT02596958|458804017|FG000|Overall Study|Administrative Reasons/Other|231|||
127503265|NCT02596958|458804017|FG000|Overall Study|Lost to Follow-up|33|||
127503266|NCT02596958|458804017|FG000|Overall Study|Missing|32|||
127503267|NCT02596958|458804017|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
127503268|NCT01559259|458804018|FG000|Overall Study|Withdrawal by Subject|0|||
127503269|NCT01559259|458804019|FG001|Overall Study|Withdrawal by Subject|0|||
127503270|NCT01559259|458804020|FG002|Overall Study|Withdrawal by Subject|0|||
127503271|NCT01559259|458804021|FG003|Overall Study|Withdrawal by Subject|1|||
127503272|NCT01559259|458804022|FG004|Overall Study|Withdrawal by Subject|0|||
127503273|NCT01559259|458804018|FG000|Overall Study|Adverse Event|0|||
127503274|NCT01559259|458804019|FG001|Overall Study|Adverse Event|1|||
127503275|NCT01559259|458804020|FG002|Overall Study|Adverse Event|1|||
127503276|NCT01559259|458804021|FG003|Overall Study|Adverse Event|0|||
127503277|NCT01559259|458804022|FG004|Overall Study|Adverse Event|0|||
127503278|NCT00185380|458804023|FG000|Overall Study|Adverse Event|41|||
127503279|NCT00185380|458804024|FG001|Overall Study|Adverse Event|43|||
127503280|NCT00185380|458804025|FG002|Overall Study|Adverse Event|48|||
127503281|NCT00185380|458804023|FG000|Overall Study|Lost to Follow-up|0|||
127503282|NCT00185380|458804024|FG001|Overall Study|Lost to Follow-up|4|||
127503283|NCT00185380|458804025|FG002|Overall Study|Lost to Follow-up|3|||
127503284|NCT00185380|458804023|FG000|Overall Study|Pregnancy|1|||
127503285|NCT00185380|458804024|FG001|Overall Study|Pregnancy|4|||
127503286|NCT00185380|458804025|FG002|Overall Study|Pregnancy|0|||
127503287|NCT00185380|458804023|FG000|Overall Study|Protocol Violation|2|||
127503288|NCT00185380|458804024|FG001|Overall Study|Protocol Violation|2|||
127503289|NCT00185380|458804025|FG002|Overall Study|Protocol Violation|1|||
127503290|NCT00185380|458804023|FG000|Overall Study|Withdrawal by Subject|1|||
127503291|NCT00185380|458804024|FG001|Overall Study|Withdrawal by Subject|2|||
127503292|NCT00185380|458804025|FG002|Overall Study|Withdrawal by Subject|0|||
127503293|NCT00185380|458804023|FG000|Overall Study|Failed insertion|1|||
127503294|NCT00185380|458804024|FG001|Overall Study|Failed insertion|1|||
127503295|NCT00185380|458804025|FG002|Overall Study|Failed insertion|2|||
127503296|NCT00185380|458804023|FG000|Overall Study|Planned pregnancy|9|||
127503297|NCT00185380|458804024|FG001|Overall Study|Planned pregnancy|12|||
127503298|NCT00185380|458804025|FG002|Overall Study|Planned pregnancy|12|||
127503299|NCT00185380|458804023|FG000|Overall Study|No need for contraception|3|||
127503300|NCT00185380|458804024|FG001|Overall Study|No need for contraception|3|||
127503301|NCT00185380|458804025|FG002|Overall Study|No need for contraception|3|||
127503302|NCT00185380|458804023|FG000|Overall Study|Could not attend visits|2|||
127503303|NCT00185380|458804024|FG001|Overall Study|Could not attend visits|0|||
127503304|NCT00185380|458804025|FG002|Overall Study|Could not attend visits|4|||
127503305|NCT00185380|458804023|FG000|Overall Study|personal reason|6|||
127503306|NCT00185380|458804024|FG001|Overall Study|personal reason|1|||
127503307|NCT00185380|458804025|FG002|Overall Study|personal reason|1|||
127503308|NCT00218634|458804026|FG000|Overall Study|Lost to Follow-up|8|||
127503309|NCT00218634|458804027|FG001|Overall Study|Lost to Follow-up|15|||
127503310|NCT02199314|458804028|FG000|Overall Study|Withdrawal by Subject|6|||
127503311|NCT02199314|458804028|FG000|Overall Study|Physician Decision|10|||
127503312|NCT03842969|458804029|FG000|Overall Study|Participant declined follow-up visit|0|||
127503313|NCT03842969|458804030|FG001|Overall Study|Participant declined follow-up visit|1|||
127503314|NCT03842969|458804031|FG002|Overall Study|Participant declined follow-up visit|0|||
127503315|NCT03842969|458804029|FG000|Overall Study|Sponsor's decision|12|||
127503316|NCT03842969|458804030|FG001|Overall Study|Sponsor's decision|99|||
127503317|NCT03842969|458804031|FG002|Overall Study|Sponsor's decision|61|||
127503318|NCT03842969|458804029|FG000|Overall Study|Pregnancy|0|||
127503319|NCT03842969|458804030|FG001|Overall Study|Pregnancy|0|||
127503320|NCT03842969|458804031|FG002|Overall Study|Pregnancy|1|||
127503321|NCT03842969|458804029|FG000|Overall Study|Death|1|||
127503322|NCT03842969|458804030|FG001|Overall Study|Death|0|||
127503323|NCT03842969|458804031|FG002|Overall Study|Death|1|||
127978253|NCT02612610|460542474|FG002|Overall Study|Physician Decision|0|||
127503324|NCT03842969|458804029|FG000|Overall Study|Withdrawal by Subject|3|||
127503325|NCT03842969|458804030|FG001|Overall Study|Withdrawal by Subject|30|||
127503326|NCT03842969|458804031|FG002|Overall Study|Withdrawal by Subject|18|||
127503327|NCT03842969|458804029|FG000|Overall Study|Protocol Violation|1|||
127503328|NCT03842969|458804030|FG001|Overall Study|Protocol Violation|1|||
127503329|NCT03842969|458804031|FG002|Overall Study|Protocol Violation|0|||
127503330|NCT03842969|458804029|FG000|Overall Study|Physician Decision|0|||
127503331|NCT03842969|458804030|FG001|Overall Study|Physician Decision|3|||
127503332|NCT03842969|458804031|FG002|Overall Study|Physician Decision|0|||
127503333|NCT03842969|458804029|FG000|Overall Study|Lost to Follow-up|0|||
127503334|NCT03842969|458804030|FG001|Overall Study|Lost to Follow-up|2|||
127503335|NCT03842969|458804031|FG002|Overall Study|Lost to Follow-up|0|||
127503336|NCT03842969|458804029|FG000|Overall Study|Adverse Event|0|||
127978254|NCT02612610|460542475|FG003|Overall Study|Physician Decision|0|||
127503337|NCT03842969|458804030|FG001|Overall Study|Adverse Event|2|||
127503338|NCT03842969|458804031|FG002|Overall Study|Adverse Event|0|||
127503339|NCT01159171|458804034|FG000|Overall Study|Adverse Event|11|||
127503340|NCT01159171|458804034|FG000|Overall Study|Progression of Disease|28|||
127503341|NCT01159171|458804034|FG000|Overall Study|Protocol Violation|1|||
127503342|NCT01159171|458804034|FG000|Overall Study|Need for Surgery|5|||
127503343|NCT01159171|458804034|FG000|Overall Study|Medical Decision|4|||
127503344|NCT01159171|458804034|FG000|Overall Study|Death|1|||
127503345|NCT01461928|458804035|FG000|Induction (up to 8 Months)|Adverse Event|76|||
127503346|NCT01461928|458804036|FG001|Induction (up to 8 Months)|Adverse Event|0|||
127503347|NCT01461928|458804037|FG002|Induction (up to 8 Months)|Adverse Event|0|||
127503348|NCT01461928|458804035|FG000|Induction (up to 8 Months)|Death|3|||
127503349|NCT01461928|458804036|FG001|Induction (up to 8 Months)|Death|0|||
127503350|NCT01461928|458804037|FG002|Induction (up to 8 Months)|Death|0|||
127503351|NCT01461928|458804035|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
127503352|NCT01461928|458804036|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
127503353|NCT01461928|458804037|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
127503354|NCT01461928|458804035|FG000|Induction (up to 8 Months)|Physician Decision|9|||
127503355|NCT01461928|458804036|FG001|Induction (up to 8 Months)|Physician Decision|0|||
127503356|NCT01461928|458804037|FG002|Induction (up to 8 Months)|Physician Decision|0|||
127503357|NCT01461928|458804035|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
127503358|NCT01461928|458804036|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
127503359|NCT01461928|458804037|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
127503360|NCT01461928|458804035|FG000|Induction (up to 8 Months)|Disease progression|45|||
127503361|NCT01461928|458804036|FG001|Induction (up to 8 Months)|Disease progression|0|||
127503362|NCT01461928|458804037|FG002|Induction (up to 8 Months)|Disease progression|0|||
127503363|NCT01461928|458804035|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
127503364|NCT01461928|458804036|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
127503365|NCT01461928|458804037|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
127503366|NCT01461928|458804035|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
127503367|NCT01461928|458804036|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
127503368|NCT01461928|458804037|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
127503369|NCT01461928|458804035|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
127503370|NCT01461928|458804036|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
127503371|NCT01461928|458804037|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
127503372|NCT01461928|458804035|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
127503373|NCT01461928|458804036|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
127503374|NCT01461928|458804037|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
127503375|NCT01461928|458804035|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
127503376|NCT01461928|458804036|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
127503377|NCT01461928|458804037|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
127503378|NCT01461928|458804035|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
127503379|NCT01461928|458804036|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
127503380|NCT01461928|458804037|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
127503381|NCT01461928|458804035|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
127503382|NCT01461928|458804036|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
127503383|NCT01461928|458804037|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
127503384|NCT01461928|458804035|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
127503385|NCT01461928|458804036|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
127503386|NCT01461928|458804037|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
127503387|NCT01461928|458804035|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
127503388|NCT01461928|458804036|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
127503389|NCT01461928|458804037|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
127503390|NCT01461928|458804035|FG000|Induction (up to 8 Months)|Promotor request|1|||
127503391|NCT01461928|458804036|FG001|Induction (up to 8 Months)|Promotor request|0|||
127503392|NCT01461928|458804037|FG002|Induction (up to 8 Months)|Promotor request|0|||
127503393|NCT01461928|458804035|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
127503394|NCT01461928|458804036|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
127503395|NCT01461928|458804037|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
127503396|NCT01461928|458804035|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
127503397|NCT01461928|458804036|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
127503398|NCT01461928|458804037|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
127503399|NCT01461928|458804035|FG000|Maintenance I (24 Months)|Death|3|||
127503400|NCT01461928|458804036|FG001|Maintenance I (24 Months)|Death|0|||
127503401|NCT01461928|458804037|FG002|Maintenance I (24 Months)|Death|0|||
127503402|NCT01461928|458804035|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
127503403|NCT01461928|458804036|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
127503404|NCT01461928|458804037|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
127503405|NCT01461928|458804035|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
127503406|NCT01461928|458804036|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
127978255|NCT02612610|460542472|FG000|Overall Study|Noncompliance|1|||
127978256|NCT02612610|460542473|FG001|Overall Study|Noncompliance|0|||
127503407|NCT01461928|458804037|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
127503408|NCT01461928|458804035|FG000|Maintenance I (24 Months)|Diseases progression|91|||
127503409|NCT01461928|458804036|FG001|Maintenance I (24 Months)|Diseases progression|0|||
127503410|NCT01461928|458804037|FG002|Maintenance I (24 Months)|Diseases progression|0|||
127503411|NCT01461928|458804035|FG000|Maintenance I (24 Months)|Adverse Event|70|||
127503412|NCT01461928|458804036|FG001|Maintenance I (24 Months)|Adverse Event|0|||
127503413|NCT01461928|458804037|FG002|Maintenance I (24 Months)|Adverse Event|0|||
127503414|NCT01461928|458804035|FG000|Maintenance I (24 Months)|Physician Decision|9|||
127503415|NCT01461928|458804036|FG001|Maintenance I (24 Months)|Physician Decision|0|||
127503416|NCT01461928|458804037|FG002|Maintenance I (24 Months)|Physician Decision|0|||
127503417|NCT01461928|458804035|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
127503418|NCT01461928|458804036|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
127503419|NCT01461928|458804037|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
127503420|NCT01461928|458804035|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
127503421|NCT01461928|458804036|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
127503422|NCT01461928|458804037|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
127503423|NCT01461928|458804035|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
127503424|NCT01461928|458804036|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
127503425|NCT01461928|458804037|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
127503426|NCT01461928|458804035|FG000|Maintenance I (24 Months)|Not compliant|1|||
127503427|NCT01461928|458804036|FG001|Maintenance I (24 Months)|Not compliant|0|||
127503428|NCT01461928|458804037|FG002|Maintenance I (24 Months)|Not compliant|0|||
127503429|NCT01461928|458804035|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
127503430|NCT01461928|458804036|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
127503431|NCT01461928|458804037|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
127503432|NCT01461928|458804035|FG000|Maintenance II (15 Months)|Adverse Event|0|||
127503433|NCT01461928|458804036|FG001|Maintenance II (15 Months)|Adverse Event|2|||
127503434|NCT01461928|458804037|FG002|Maintenance II (15 Months)|Adverse Event|0|||
127503435|NCT01461928|458804035|FG000|Maintenance II (15 Months)|Death|0|||
127503436|NCT01461928|458804036|FG001|Maintenance II (15 Months)|Death|10|||
127503437|NCT01461928|458804037|FG002|Maintenance II (15 Months)|Death|8|||
127503438|NCT01461928|458804035|FG000|Maintenance II (15 Months)|Physician Decision|0|||
127503439|NCT01461928|458804036|FG001|Maintenance II (15 Months)|Physician Decision|0|||
127503440|NCT01461928|458804037|FG002|Maintenance II (15 Months)|Physician Decision|4|||
127503441|NCT01461928|458804035|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
127503442|NCT01461928|458804036|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
127503443|NCT01461928|458804037|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
127503444|NCT01461928|458804035|FG000|Maintenance II (15 Months)|Moved to another town|0|||
127503445|NCT01461928|458804036|FG001|Maintenance II (15 Months)|Moved to another town|1|||
127503446|NCT01461928|458804037|FG002|Maintenance II (15 Months)|Moved to another town|0|||
127503447|NCT01461928|458804035|FG000|Maintenance II (15 Months)|Disease progression|0|||
127503448|NCT01461928|458804036|FG001|Maintenance II (15 Months)|Disease progression|0|||
127503449|NCT01461928|458804037|FG002|Maintenance II (15 Months)|Disease progression|3|||
127503450|NCT01461928|458804035|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
127503451|NCT01461928|458804036|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
127503452|NCT01461928|458804037|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
127503453|NCT01461928|458804035|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
127503454|NCT01461928|458804036|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
127503455|NCT01461928|458804037|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
127503456|NCT01461928|458804035|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
127503457|NCT01461928|458804036|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
127503458|NCT01461928|458804037|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
127503459|NCT01461928|458804035|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
127503460|NCT01461928|458804036|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
127503461|NCT01461928|458804037|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
127503462|NCT01461928|458804035|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
127503463|NCT01461928|458804036|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
127503464|NCT01461928|458804037|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
127503465|NCT01892436|458804038|FG000|Overall Study|Withdrawal by Subject|8|||
127503466|NCT01892436|458804039|FG001|Overall Study|Withdrawal by Subject|15|||
127503467|NCT01892436|458804040|FG002|Overall Study|Withdrawal by Subject|4|||
127503468|NCT01892436|458804041|FG003|Overall Study|Withdrawal by Subject|4|||
127503469|NCT01892436|458804038|FG000|Overall Study|Death|1|||
127503470|NCT01892436|458804039|FG001|Overall Study|Death|1|||
127503471|NCT01892436|458804040|FG002|Overall Study|Death|0|||
127978257|NCT02612610|460542474|FG002|Overall Study|Noncompliance|0|||
127503472|NCT01892436|458804041|FG003|Overall Study|Death|0|||
127503473|NCT01892436|458804038|FG000|Overall Study|Physician Decision|2|||
127978258|NCT02612610|460542475|FG003|Overall Study|Noncompliance|0|||
127978259|NCT02612610|460542472|FG000|Overall Study|Cough Improvement|0|||
127978260|NCT02612610|460542473|FG001|Overall Study|Cough Improvement|0|||
127978261|NCT02612610|460542474|FG002|Overall Study|Cough Improvement|1|||
127978262|NCT02612610|460542475|FG003|Overall Study|Cough Improvement|0|||
127978263|NCT01801280|460542476|FG000|Period 1|Withdrawal by Subject|0|||
127503474|NCT01892436|458804039|FG001|Overall Study|Physician Decision|1|||
127503475|NCT01892436|458804040|FG002|Overall Study|Physician Decision|0|||
127503476|NCT01892436|458804041|FG003|Overall Study|Physician Decision|1|||
127503477|NCT01892436|458804038|FG000|Overall Study|Pregnancy|0|||
127503478|NCT01892436|458804039|FG001|Overall Study|Pregnancy|2|||
127503479|NCT01892436|458804040|FG002|Overall Study|Pregnancy|1|||
127503480|NCT01892436|458804041|FG003|Overall Study|Pregnancy|0|||
127503481|NCT01892436|458804038|FG000|Overall Study|Technical problems|2|||
127503482|NCT01892436|458804039|FG001|Overall Study|Technical problems|1|||
127503483|NCT01892436|458804040|FG002|Overall Study|Technical problems|1|||
127503484|NCT01892436|458804041|FG003|Overall Study|Technical problems|1|||
127503485|NCT01892436|458804038|FG000|Overall Study|Lack of Efficacy|1|||
127503486|NCT01892436|458804039|FG001|Overall Study|Lack of Efficacy|2|||
127503487|NCT01892436|458804040|FG002|Overall Study|Lack of Efficacy|2|||
127503488|NCT01892436|458804041|FG003|Overall Study|Lack of Efficacy|2|||
127503489|NCT01892436|458804038|FG000|Overall Study|Lost to Follow-up|1|||
127503490|NCT01892436|458804039|FG001|Overall Study|Lost to Follow-up|1|||
127503491|NCT01892436|458804040|FG002|Overall Study|Lost to Follow-up|1|||
127503492|NCT01892436|458804041|FG003|Overall Study|Lost to Follow-up|3|||
127503493|NCT01892436|458804038|FG000|Overall Study|non-compliance with treatment|1|||
127503494|NCT01892436|458804039|FG001|Overall Study|non-compliance with treatment|0|||
127503495|NCT01892436|458804040|FG002|Overall Study|non-compliance with treatment|0|||
127503496|NCT01892436|458804041|FG003|Overall Study|non-compliance with treatment|0|||
127503497|NCT01892436|458804038|FG000|Overall Study|Adverse Event|7|||
127503498|NCT01892436|458804039|FG001|Overall Study|Adverse Event|6|||
127503499|NCT01892436|458804040|FG002|Overall Study|Adverse Event|2|||
127503500|NCT01892436|458804041|FG003|Overall Study|Adverse Event|3|||
127503501|NCT02242435|458804050|FG000|Overall Study|Lost to Follow-up|3|||
127503502|NCT02242435|458804051|FG001|Overall Study|Lost to Follow-up|4|||
127503503|NCT02242435|458804050|FG000|Overall Study|Adverse Event|3|||
127503504|NCT02242435|458804051|FG001|Overall Study|Adverse Event|2|||
127503505|NCT02242435|458804050|FG000|Overall Study|Withdrawal by Subject|13|||
127503506|NCT02242435|458804051|FG001|Overall Study|Withdrawal by Subject|8|||
127503507|NCT02242435|458804050|FG000|Overall Study|Death|0|||
127503508|NCT02242435|458804051|FG001|Overall Study|Death|1|||
127503509|NCT02242435|458804050|FG000|Overall Study|Protocol Violation|1|||
127503510|NCT02242435|458804051|FG001|Overall Study|Protocol Violation|0|||
127503511|NCT02242435|458804050|FG000|Overall Study|Physician Decision|0|||
127503512|NCT02242435|458804051|FG001|Overall Study|Physician Decision|1|||
127503513|NCT05312632|458804056|FG000|Overall Study|Adverse Event|12|||
127503514|NCT05312632|458804056|FG000|Overall Study|Withdrawal by Subject|10|||
127503515|NCT05312632|458804056|FG000|Overall Study|Lack of Efficacy|4|||
127503516|NCT05312632|458804056|FG000|Overall Study|Non-compliance with study procedures|9|||
127503517|NCT05312632|458804056|FG000|Overall Study|Other|4|||
127503518|NCT02019108|458804057|FG000|Overall Study|Lost to Follow-up|5|||
127503519|NCT02019108|458804058|FG001|Overall Study|Lost to Follow-up|7|||
127503520|NCT04569136|458804064|FG000|Overall Study|Lost to Follow-up|2|||
127503521|NCT04569136|458804065|FG001|Overall Study|Lost to Follow-up|0|||
127503522|NCT04569136|458804066|FG002|Overall Study|Lost to Follow-up|1|||
127503523|NCT01466660|458804071|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
127503524|NCT01466660|458804072|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
127503525|NCT01466660|458804071|FG000|Overall Study|Worsening of underlying cancer disease|5|||
127503526|NCT01466660|458804072|FG001|Overall Study|Worsening of underlying cancer disease|2|||
127503527|NCT01466660|458804071|FG000|Overall Study|Other adverse event|19|||
127503528|NCT01466660|458804072|FG001|Overall Study|Other adverse event|18|||
127503529|NCT01466660|458804071|FG000|Overall Study|Protocol Violation|2|||
127503530|NCT01466660|458804072|FG001|Overall Study|Protocol Violation|1|||
127503531|NCT01466660|458804071|FG000|Overall Study|Refused continuation of trial medication|4|||
127503532|NCT01466660|458804072|FG001|Overall Study|Refused continuation of trial medication|3|||
127503533|NCT01466660|458804071|FG000|Overall Study|Other reason not defined above|10|||
127503534|NCT01466660|458804072|FG001|Overall Study|Other reason not defined above|8|||
127503535|NCT00191724|458804073|FG000|Overall Study|Adverse Event|0|||
127503536|NCT00191724|458804074|FG001|Overall Study|Adverse Event|0|||
127503537|NCT00191724|458804075|FG002|Overall Study|Adverse Event|1|||
127503538|NCT00191724|458804076|FG003|Overall Study|Adverse Event|0|||
127503539|NCT00191724|458804077|FG004|Overall Study|Adverse Event|0|||
127978264|NCT01801280|460542477|FG001|Period 1|Withdrawal by Subject|1|||
127978265|NCT01801280|460542478|FG002|Period 1|Withdrawal by Subject|0|||
127503540|NCT00191724|458804073|FG000|Overall Study|Lost to Follow-up|1|||
127503541|NCT00191724|458804074|FG001|Overall Study|Lost to Follow-up|1|||
127503542|NCT00191724|458804075|FG002|Overall Study|Lost to Follow-up|0|||
127503543|NCT00191724|458804076|FG003|Overall Study|Lost to Follow-up|2|||
127503544|NCT00191724|458804077|FG004|Overall Study|Lost to Follow-up|3|||
127503545|NCT00191724|458804073|FG000|Overall Study|Withdrawal by Subject|0|||
127503546|NCT00191724|458804074|FG001|Overall Study|Withdrawal by Subject|0|||
127503547|NCT00191724|458804075|FG002|Overall Study|Withdrawal by Subject|0|||
127503548|NCT00191724|458804076|FG003|Overall Study|Withdrawal by Subject|1|||
127503549|NCT00191724|458804077|FG004|Overall Study|Withdrawal by Subject|0|||
127503550|NCT02301546|458804078|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
127503551|NCT02301546|458804079|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
127503552|NCT02301546|458804078|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
127503553|NCT02301546|458804079|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
127503554|NCT02301546|458804078|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
127503555|NCT02301546|458804079|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
127503556|NCT02301546|458804078|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
127503557|NCT02301546|458804079|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
127503558|NCT02301546|458804078|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
127503559|NCT02301546|458804079|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
127503560|NCT02301546|458804078|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
127503561|NCT02301546|458804079|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
127503562|NCT02301546|458804078|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
127503563|NCT02301546|458804079|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
127503564|NCT01498575|458804083|FG000|Overall Sample|Withdrawal by Subject|60|||
127503565|NCT01498575|458804084|FG001|Overall Sample|Withdrawal by Subject|14|||
127503566|NCT01498575|458804083|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
127503567|NCT01498575|458804084|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
127503568|NCT01498575|458804083|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
127503569|NCT01498575|458804084|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
127503570|NCT01972308|458804086|FG000|Overall Study|Withdrawal by Subject|0|||
127503571|NCT01972308|458804087|FG001|Overall Study|Withdrawal by Subject|1|||
127503572|NCT01972308|458804086|FG000|Overall Study|Lost to Follow-up|4|||
127503573|NCT01972308|458804087|FG001|Overall Study|Lost to Follow-up|6|||
127503574|NCT01972308|458804086|FG000|Overall Study|Death|4|||
127503575|NCT01972308|458804087|FG001|Overall Study|Death|1|||
127503576|NCT00543803|458804088|FG000|Overall Study|Adverse Event|14|||
127503577|NCT00543803|458804088|FG000|Overall Study|Lack of Efficacy|22|||
127503578|NCT00543803|458804088|FG000|Overall Study|Lost to Follow-up|20|||
127503579|NCT00543803|458804088|FG000|Overall Study|Other|86|||
127503580|NCT02186652|458804100|FG000|Overall Study|Lost to Follow-up|2|||
127503581|NCT02186652|458804101|FG001|Overall Study|Lost to Follow-up|0|||
127503582|NCT00744978|458804102|FG000|Period 1|Lost to Follow-up|1|||
127503583|NCT00744978|458804103|FG001|Period 1|Lost to Follow-up|0|||
127503584|NCT00744978|458804102|FG000|Period 1|Withdrawal by Subject|0|||
127503585|NCT00744978|458804103|FG001|Period 1|Withdrawal by Subject|2|||
127503586|NCT00744978|458804102|FG000|Period 1|Other|0|||
127503587|NCT00744978|458804103|FG001|Period 1|Other|2|||
127503588|NCT00744978|458804102|FG000|Period 1|Adverse Event|4|||
127503589|NCT00744978|458804103|FG001|Period 1|Adverse Event|0|||
127503590|NCT00744978|458804102|FG000|Period 1|Randomized but not Treated|1|||
127503591|NCT00744978|458804103|FG001|Period 1|Randomized but not Treated|1|||
127503592|NCT00744978|458804102|FG000|Period 2|Adverse Event|0|||
127503593|NCT00744978|458804103|FG001|Period 2|Adverse Event|1|||
127503594|NCT00515294|458804107|FG000|Overall Study|Lost to Follow-up|3|||
127503595|NCT00515294|458804108|FG001|Overall Study|Lost to Follow-up|2|||
127503596|NCT00515294|458804109|FG002|Overall Study|Lost to Follow-up|3|||
127503597|NCT00515294|458804110|FG003|Overall Study|Lost to Follow-up|1|||
127503598|NCT00515294|458804107|FG000|Overall Study|Driver simulator problems|1|||
127503599|NCT00515294|458804108|FG001|Overall Study|Driver simulator problems|1|||
127503600|NCT00515294|458804109|FG002|Overall Study|Driver simulator problems|1|||
127503601|NCT00515294|458804110|FG003|Overall Study|Driver simulator problems|3|||
127503602|NCT00515294|458804107|FG000|Overall Study|Caffeine amount inaccurate|5|||
127503603|NCT00515294|458804108|FG001|Overall Study|Caffeine amount inaccurate|0|||
127503604|NCT00515294|458804109|FG002|Overall Study|Caffeine amount inaccurate|7|||
127503605|NCT00515294|458804110|FG003|Overall Study|Caffeine amount inaccurate|0|||
127503606|NCT04659174|458804117|FG000|Overall Study|Sponsor decision to discontinue study|0|||
127503607|NCT04659174|458804118|FG001|Overall Study|Sponsor decision to discontinue study|2|||
127503608|NCT04659174|458804117|FG000|Overall Study|Lost to Follow-up|9|||
127503609|NCT04659174|458804118|FG001|Overall Study|Lost to Follow-up|11|||
127503610|NCT04659174|458804117|FG000|Overall Study|Adverse Event|8|||
127978266|NCT01801280|460542479|FG003|Period 1|Withdrawal by Subject|0|||
127503611|NCT04659174|458804118|FG001|Overall Study|Adverse Event|5|||
127503612|NCT04659174|458804117|FG000|Overall Study|Withdrawal by Subject|17|||
127503613|NCT04659174|458804118|FG001|Overall Study|Withdrawal by Subject|33|||
127503614|NCT04659174|458804117|FG000|Overall Study|Progressive disease|0|||
127503615|NCT04659174|458804118|FG001|Overall Study|Progressive disease|2|||
127503616|NCT04659174|458804117|FG000|Overall Study|Other reasons|0|||
127503617|NCT04659174|458804118|FG001|Overall Study|Other reasons|2|||
127503618|NCT04659174|458804117|FG000|Overall Study|Participant fails to adhere to the protocol requirements|14|||
127978267|NCT01801280|460542476|FG000|Period 2|Withdrawal by Subject|1|||
127503619|NCT04659174|458804118|FG001|Overall Study|Participant fails to adhere to the protocol requirements|9|||
127503620|NCT04659174|458804117|FG000|Overall Study|Alcohol or illegal drug use|0|||
127503621|NCT04659174|458804118|FG001|Overall Study|Alcohol or illegal drug use|3|||
127503622|NCT04659174|458804117|FG000|Overall Study|Violation of entry criteria|1|||
127503623|NCT04659174|458804118|FG001|Overall Study|Violation of entry criteria|0|||
127503624|NCT04659174|458804117|FG000|Overall Study|Death|0|||
127503625|NCT04659174|458804118|FG001|Overall Study|Death|1|||
127503626|NCT05129449|458804121|FG000|Overall Study|Protocol Violation|1|||
127503627|NCT01818258|458804127|FG000|Overall Study|Death|3|||
127503628|NCT01818258|458804128|FG001|Overall Study|Death|0|||
127503629|NCT01818258|458804127|FG000|Overall Study|Withdrawal by Subject|0|||
127503630|NCT01818258|458804128|FG001|Overall Study|Withdrawal by Subject|1|||
127503631|NCT01818258|458804127|FG000|Overall Study|Lost to Follow-up|0|||
127503632|NCT01818258|458804128|FG001|Overall Study|Lost to Follow-up|1|||
127503633|NCT01818258|458804127|FG000|Overall Study|Unable to Travel to Clinic|0|||
127503634|NCT01818258|458804128|FG001|Overall Study|Unable to Travel to Clinic|1|||
127503635|NCT02099344|458804129|FG000|Overall Study|Physician Decision|1|||
127503636|NCT02099344|458804130|FG001|Overall Study|Physician Decision|0|||
127503637|NCT01639339|458804133|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
127503638|NCT01639339|458804134|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
127503639|NCT01639339|458804133|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
127503640|NCT01639339|458804134|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
127503641|NCT01639339|458804133|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
127503642|NCT01639339|458804134|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
127503643|NCT01639339|458804133|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
127503644|NCT01639339|458804134|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
127503645|NCT01639339|458804133|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
127503646|NCT01639339|458804134|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
127503647|NCT01639339|458804133|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
127503648|NCT01639339|458804134|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
127503649|NCT01639339|458804133|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
127503650|NCT01639339|458804134|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
127503651|NCT01639339|458804133|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
127503652|NCT01639339|458804134|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
127503653|NCT01639339|458804133|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
127503654|NCT01639339|458804134|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
127503655|NCT01639339|458804133|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
127503656|NCT01639339|458804134|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
127503657|NCT02839720|458804135|FG000|Overall Study|Adverse Event|2|||
127503658|NCT02839720|458804135|FG000|Overall Study|Non-compliance|2|||
127503659|NCT02839720|458804135|FG000|Overall Study|Intercurrent Illness|1|||
127503660|NCT02839720|458804135|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
127503661|NCT02649218|458804136|FG000|Overall Study|Adverse Event|8|||
127503662|NCT02649218|458804136|FG000|Overall Study|Lack of Efficacy|8|||
127503663|NCT02649218|458804136|FG000|Overall Study|Pregnancy|3|||
127503664|NCT02649218|458804136|FG000|Overall Study|Protocol Violation|3|||
127503665|NCT02649218|458804136|FG000|Overall Study|Physician Decision|1|||
127503666|NCT02649218|458804136|FG000|Overall Study|Withdrawal by Subject|2|||
127503667|NCT00503581|458804137|FG000|Overall Study|Study closed|3|||
127503668|NCT00503581|458804138|FG001|Overall Study|Study closed|4|||
127503669|NCT00503581|458804139|FG002|Overall Study|Study closed|2|||
127503670|NCT04730635|458804145|FG000|Overall Study|Lost to Follow-up|1|||
127503671|NCT04730635|458804146|FG001|Overall Study|Lost to Follow-up|0|||
127503672|NCT04730635|458804145|FG000|Overall Study|Withdrawal by Subject|0|||
127503673|NCT04730635|458804146|FG001|Overall Study|Withdrawal by Subject|1|||
127503674|NCT04934800|458804147|FG000|Overall Study|Other|1|||
127978268|NCT01801280|460542477|FG001|Period 2|Withdrawal by Subject|0|||
127503675|NCT04934800|458804147|FG000|Overall Study|Withdrawal by Subject|5|||
127503676|NCT04934800|458804147|FG000|Overall Study|Lack of Efficacy|1|||
127503677|NCT04934800|458804147|FG000|Overall Study|Adverse Event|9|||
127503678|NCT04934800|458804147|FG000|Overall Study|Lost to Follow-up|5|||
127503679|NCT04934800|458804147|FG000|Overall Study|Enrolled but not treated|1|||
127503680|NCT00516906|458804148|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
127503681|NCT00516906|458804149|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
127868955|NCT05602818|460137451|FG009|Qualification Phase (3 Days)|Adverse Event|0|||
127503683|NCT02438683|458804156|FG000|Overall Study|Adverse Event|1|||
127503684|NCT02438683|458804157|FG001|Overall Study|Adverse Event|0|||
127868956|NCT05602818|460137452|FG010|Qualification Phase (3 Days)|Adverse Event|0|||
127868957|NCT05602818|460137453|FG011|Qualification Phase (3 Days)|Adverse Event|0|||
127868958|NCT05602818|460137442|FG000|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
127868959|NCT05602818|460137443|FG001|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
127868960|NCT05602818|460137444|FG002|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
127868961|NCT05602818|460137445|FG003|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
127503685|NCT02438683|458804158|FG002|Overall Study|Adverse Event|0|||
127503686|NCT02438683|458804159|FG003|Overall Study|Adverse Event|0|||
127503687|NCT02438683|458804160|FG004|Overall Study|Adverse Event|0|||
127503688|NCT02438683|458804161|FG005|Overall Study|Adverse Event|0|||
127503689|NCT04669262|458804167|FG000|Overall Study|Withdrawal by Subject|0|||
127503690|NCT04669262|458804168|FG001|Overall Study|Withdrawal by Subject|0|||
127503691|NCT04669262|458804169|FG002|Overall Study|Withdrawal by Subject|0|||
127503692|NCT04669262|458804170|FG003|Overall Study|Withdrawal by Subject|1|||
127503693|NCT04669262|458804167|FG000|Overall Study|Randomized but Not Treated|0|||
127503694|NCT04669262|458804168|FG001|Overall Study|Randomized but Not Treated|1|||
127503695|NCT04669262|458804169|FG002|Overall Study|Randomized but Not Treated|0|||
127503696|NCT04669262|458804170|FG003|Overall Study|Randomized but Not Treated|0|||
127503697|NCT01638013|458804171|FG000|Overall Study|Adverse Event|36|||
127503698|NCT01638013|458804172|FG001|Overall Study|Adverse Event|29|||
127503699|NCT01638013|458804173|FG002|Overall Study|Adverse Event|48|||
127503700|NCT01638013|458804171|FG000|Overall Study|Lack of Efficacy|39|||
127503701|NCT01638013|458804172|FG001|Overall Study|Lack of Efficacy|11|||
127503702|NCT01638013|458804173|FG002|Overall Study|Lack of Efficacy|14|||
127503703|NCT01638013|458804171|FG000|Overall Study|Protocol Violation|10|||
127503704|NCT01638013|458804172|FG001|Overall Study|Protocol Violation|7|||
127503705|NCT01638013|458804173|FG002|Overall Study|Protocol Violation|11|||
127503706|NCT01638013|458804171|FG000|Overall Study|Met discontinuation criteria|4|||
127503707|NCT01638013|458804172|FG001|Overall Study|Met discontinuation criteria|0|||
127503708|NCT01638013|458804173|FG002|Overall Study|Met discontinuation criteria|7|||
127503709|NCT01638013|458804171|FG000|Overall Study|Subject Lost to Follow up|1|||
127503710|NCT01638013|458804172|FG001|Overall Study|Subject Lost to Follow up|0|||
127503711|NCT01638013|458804173|FG002|Overall Study|Subject Lost to Follow up|1|||
127503712|NCT01638013|458804171|FG000|Overall Study|Miscellaneous|25|||
127503713|NCT01638013|458804172|FG001|Overall Study|Miscellaneous|19|||
127503714|NCT01638013|458804173|FG002|Overall Study|Miscellaneous|23|||
127503715|NCT01638013|458804171|FG000|Overall Study|Withdrawal of Consent|16|||
127503716|NCT01638013|458804172|FG001|Overall Study|Withdrawal of Consent|12|||
127503717|NCT01638013|458804173|FG002|Overall Study|Withdrawal of Consent|16|||
127503718|NCT01638013|458804171|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
127503719|NCT01638013|458804172|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
127503720|NCT01638013|458804173|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
127503721|NCT05463744|458804174|FG000|Treatment Period|Withdrawal by Subject|19|||
127503722|NCT05463744|458804175|FG001|Treatment Period|Withdrawal by Subject|16|||
127503723|NCT05463744|458804174|FG000|Treatment Period|Adverse Event|4|||
127503724|NCT05463744|458804175|FG001|Treatment Period|Adverse Event|4|||
127503725|NCT05463744|458804174|FG000|Treatment Period|Pregnancy|0|||
127503726|NCT05463744|458804175|FG001|Treatment Period|Pregnancy|3|||
127503727|NCT05463744|458804174|FG000|Treatment Period|Lost to Follow-up|1|||
127503728|NCT05463744|458804175|FG001|Treatment Period|Lost to Follow-up|3|||
127503729|NCT05463744|458804174|FG000|Treatment Period|Inadvertent enrollment|2|||
127503730|NCT05463744|458804175|FG001|Treatment Period|Inadvertent enrollment|1|||
127503731|NCT05463744|458804174|FG000|Treatment Period|Death|0|||
127503732|NCT05463744|458804175|FG001|Treatment Period|Death|1|||
127503733|NCT05463744|458804174|FG000|Treatment Period|Non-compliance with Study Drug|1|||
127503734|NCT05463744|458804175|FG001|Treatment Period|Non-compliance with Study Drug|0|||
127503735|NCT05463744|458804174|FG000|Treatment Period|Subject Terminated by Sponsor|0|||
127503736|NCT05463744|458804175|FG001|Treatment Period|Subject Terminated by Sponsor|1|||
127503737|NCT05463744|458804174|FG000|Treatment Period|Physician Decision|0|||
127503738|NCT05463744|458804175|FG001|Treatment Period|Physician Decision|1|||
127503739|NCT05463744|458804174|FG000|Follow-Up Period|Withdrawal by Subject|3|||
127503740|NCT05463744|458804175|FG001|Follow-Up Period|Withdrawal by Subject|1|||
127503741|NCT05463744|458804174|FG000|Follow-Up Period|Lost to Follow-up|1|||
127503742|NCT05463744|458804175|FG001|Follow-Up Period|Lost to Follow-up|1|||
127503743|NCT01448824|458806048|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
127503744|NCT01448824|458806049|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
127503745|NCT01448824|458806050|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
127503746|NCT01448824|458806051|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
127503747|NCT01448824|458806052|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
127503748|NCT01448824|458806053|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
127503749|NCT01448824|458806054|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
127503750|NCT01448824|458806055|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
127503751|NCT01448824|458806048|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
127503752|NCT01448824|458806049|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
127503753|NCT01448824|458806050|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
127503754|NCT01448824|458806051|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
127503755|NCT01448824|458806052|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
127503756|NCT01448824|458806053|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
127503757|NCT01448824|458806054|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
127503758|NCT01448824|458806055|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
127503759|NCT01448824|458806048|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
127503760|NCT01448824|458806049|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
127503761|NCT01448824|458806050|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
127503762|NCT01448824|458806051|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
127503763|NCT01448824|458806052|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
127503764|NCT01448824|458806053|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
127503765|NCT01448824|458806054|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
127503766|NCT01448824|458806055|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
127503767|NCT01448824|458806048|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
127503768|NCT01448824|458806049|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
127503769|NCT01448824|458806050|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
127503770|NCT01448824|458806051|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
127503771|NCT01448824|458806052|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
127503772|NCT01448824|458806053|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
127503773|NCT01448824|458806054|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
127503774|NCT01448824|458806055|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
127503775|NCT01448824|458806048|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
127503776|NCT01448824|458806049|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
127503777|NCT01448824|458806050|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
127503778|NCT01448824|458806051|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
127503779|NCT01448824|458806052|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
127503780|NCT01448824|458806053|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
127503781|NCT01448824|458806054|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
127503782|NCT01448824|458806055|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
127503783|NCT01448824|458806048|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
127503784|NCT01448824|458806049|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
127503785|NCT01448824|458806050|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
127503786|NCT01448824|458806051|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
127503787|NCT01448824|458806052|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
127503788|NCT01448824|458806053|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
127503789|NCT01448824|458806054|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
127503790|NCT01448824|458806055|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
127503791|NCT01448824|458806048|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
127503792|NCT01448824|458806049|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
127503793|NCT01448824|458806050|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
127503794|NCT01448824|458806051|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
127503795|NCT01448824|458806052|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
127503796|NCT01448824|458806053|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
127503797|NCT01448824|458806054|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
127503798|NCT01448824|458806055|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
127503799|NCT01448824|458806048|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
127503800|NCT01448824|458806049|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
127503801|NCT01448824|458806050|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
127503802|NCT01448824|458806051|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
127503803|NCT01448824|458806052|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
127503804|NCT01448824|458806053|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
127503805|NCT01448824|458806054|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
127503806|NCT01448824|458806055|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
127503807|NCT01995669|458806056|FG000|Overall Study|Progression|2|||
127503808|NCT01995669|458806057|FG001|Overall Study|Progression|1|||
127503809|NCT01995669|458806058|FG002|Overall Study|Progression|1|||
127503810|NCT01995669|458806059|FG003|Overall Study|Progression|13|||
127503811|NCT01995669|458806056|FG000|Overall Study|Adverse Event|0|||
127503812|NCT01995669|458806057|FG001|Overall Study|Adverse Event|0|||
127503813|NCT01995669|458806058|FG002|Overall Study|Adverse Event|0|||
127503814|NCT01995669|458806059|FG003|Overall Study|Adverse Event|3|||
127503815|NCT01995669|458806056|FG000|Overall Study|Death|0|||
127503816|NCT01995669|458806057|FG001|Overall Study|Death|0|||
127503817|NCT01995669|458806058|FG002|Overall Study|Death|0|||
127503818|NCT01995669|458806059|FG003|Overall Study|Death|6|||
127503819|NCT01995669|458806056|FG000|Overall Study|Withdrawal by Subject|0|||
127503820|NCT01995669|458806057|FG001|Overall Study|Withdrawal by Subject|0|||
127503821|NCT01995669|458806058|FG002|Overall Study|Withdrawal by Subject|0|||
127503822|NCT01995669|458806059|FG003|Overall Study|Withdrawal by Subject|6|||
127503823|NCT01995669|458806056|FG000|Overall Study|Insurance Expired|0|||
127503824|NCT01995669|458806057|FG001|Overall Study|Insurance Expired|0|||
127503825|NCT01995669|458806058|FG002|Overall Study|Insurance Expired|0|||
127503826|NCT01995669|458806059|FG003|Overall Study|Insurance Expired|1|||
127503827|NCT05425732|458806060|FG000|Overall Study|Death|4|||
127503828|NCT05425732|458806061|FG001|Overall Study|Death|2|||
127503829|NCT05425732|458806062|FG002|Overall Study|Death|0|||
127503830|NCT05425732|458806063|FG003|Overall Study|Death|0|||
127503831|NCT05425732|458806060|FG000|Overall Study|Lost to Follow-up|10|||
127503832|NCT05425732|458806061|FG001|Overall Study|Lost to Follow-up|15|||
127503833|NCT05425732|458806062|FG002|Overall Study|Lost to Follow-up|5|||
127503834|NCT05425732|458806063|FG003|Overall Study|Lost to Follow-up|3|||
127503835|NCT05425732|458806060|FG000|Overall Study|Physician Decision|0|||
127503836|NCT05425732|458806061|FG001|Overall Study|Physician Decision|2|||
127503837|NCT05425732|458806062|FG002|Overall Study|Physician Decision|0|||
127503838|NCT05425732|458806063|FG003|Overall Study|Physician Decision|0|||
127503839|NCT05425732|458806060|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
127503840|NCT05425732|458806061|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
127503841|NCT05425732|458806062|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
127503842|NCT05425732|458806063|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
127503843|NCT05425732|458806060|FG000|Overall Study|Withdrawal by Subject|4|||
127503844|NCT05425732|458806061|FG001|Overall Study|Withdrawal by Subject|8|||
127503845|NCT05425732|458806062|FG002|Overall Study|Withdrawal by Subject|1|||
127503846|NCT05425732|458806063|FG003|Overall Study|Withdrawal by Subject|1|||
127503847|NCT05425732|458806060|FG000|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|2|||
127503848|NCT05425732|458806061|FG001|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
127503849|NCT05425732|458806062|FG002|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
127503850|NCT05425732|458806063|FG003|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
127503851|NCT02998203|458806065|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
127503852|NCT02998203|458806066|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
127503853|NCT02998203|458806065|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
127503854|NCT02998203|458806066|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
127503855|NCT04187144|458806067|FG000|Overall Study|Lost to Follow-up|12|||
127503856|NCT04187144|458806068|FG001|Overall Study|Lost to Follow-up|11|||
127503857|NCT04187144|458806067|FG000|Overall Study|Withdrawal by Subject|20|||
127503858|NCT04187144|458806068|FG001|Overall Study|Withdrawal by Subject|18|||
127503859|NCT04187144|458806067|FG000|Overall Study|Adverse Event|19|||
127503860|NCT04187144|458806068|FG001|Overall Study|Adverse Event|4|||
127503861|NCT04187144|458806067|FG000|Overall Study|Physician Decision|5|||
127503862|NCT04187144|458806068|FG001|Overall Study|Physician Decision|3|||
127503863|NCT04187144|458806067|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
127503864|NCT04187144|458806068|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
127503865|NCT04187144|458806067|FG000|Overall Study|Protocol Deviation|1|||
127503866|NCT04187144|458806068|FG001|Overall Study|Protocol Deviation|4|||
127503867|NCT02650804|458806069|FG000|Overall Study|Adverse Event|3|||
127503868|NCT02650804|458806070|FG001|Overall Study|Adverse Event|2|||
127503869|NCT02650804|458806069|FG000|Overall Study|Death|1|||
127503870|NCT02650804|458806070|FG001|Overall Study|Death|2|||
127503871|NCT02650804|458806069|FG000|Overall Study|Progressive Disease|7|||
127503872|NCT02650804|458806070|FG001|Overall Study|Progressive Disease|10|||
127503873|NCT02650804|458806069|FG000|Overall Study|Physician Decision|0|||
127503874|NCT02650804|458806070|FG001|Overall Study|Physician Decision|2|||
127503875|NCT02650804|458806069|FG000|Overall Study|Withdrawal by Subject|1|||
127503876|NCT02650804|458806070|FG001|Overall Study|Withdrawal by Subject|4|||
127503877|NCT02650804|458806069|FG000|Overall Study|Symptomatic deterioration|5|||
127503878|NCT02650804|458806070|FG001|Overall Study|Symptomatic deterioration|7|||
127503879|NCT02650804|458806069|FG000|Overall Study|Protocol Violation|0|||
127503880|NCT02650804|458806070|FG001|Overall Study|Protocol Violation|1|||
127503881|NCT04085458|458806071|FG000|Overall Study|Other|1|||
127503882|NCT04085458|458806071|FG000|Overall Study|Withdrawal by Subject|2|||
127503883|NCT04085458|458806071|FG000|Overall Study|Adverse Event|2|||
127503884|NCT03632993|458806072|FG000|Overall Study|Withdrawal by Subject|1|||
127503885|NCT03632993|458806073|FG001|Overall Study|Withdrawal by Subject|0|||
127503886|NCT03632993|458806074|FG002|Overall Study|Withdrawal by Subject|0|||
127503887|NCT03632993|458806075|FG003|Overall Study|Withdrawal by Subject|0|||
127503888|NCT03632993|458806076|FG004|Overall Study|Withdrawal by Subject|0|||
127503889|NCT03632993|458806077|FG005|Overall Study|Withdrawal by Subject|0|||
127503890|NCT03632993|458806078|FG006|Overall Study|Withdrawal by Subject|0|||
127503891|NCT03632993|458806079|FG007|Overall Study|Withdrawal by Subject|0|||
127503892|NCT03632993|458806080|FG008|Overall Study|Withdrawal by Subject|0|||
127503893|NCT03632993|458806081|FG009|Overall Study|Withdrawal by Subject|1|||
127503894|NCT03632993|458806072|FG000|Overall Study|Protocol Non-compliance|0|||
127503895|NCT03632993|458806073|FG001|Overall Study|Protocol Non-compliance|1|||
127503896|NCT03632993|458806074|FG002|Overall Study|Protocol Non-compliance|0|||
127503897|NCT03632993|458806075|FG003|Overall Study|Protocol Non-compliance|0|||
127503898|NCT03632993|458806076|FG004|Overall Study|Protocol Non-compliance|0|||
127503899|NCT03632993|458806077|FG005|Overall Study|Protocol Non-compliance|0|||
127503900|NCT03632993|458806078|FG006|Overall Study|Protocol Non-compliance|0|||
127503901|NCT03632993|458806079|FG007|Overall Study|Protocol Non-compliance|0|||
127503902|NCT03632993|458806080|FG008|Overall Study|Protocol Non-compliance|0|||
127503903|NCT03632993|458806081|FG009|Overall Study|Protocol Non-compliance|0|||
127503904|NCT03632993|458806072|FG000|Overall Study|Lost to Follow-up|0|||
127503905|NCT03632993|458806073|FG001|Overall Study|Lost to Follow-up|0|||
127503906|NCT03632993|458806074|FG002|Overall Study|Lost to Follow-up|0|||
127503907|NCT03632993|458806075|FG003|Overall Study|Lost to Follow-up|0|||
127503908|NCT03632993|458806076|FG004|Overall Study|Lost to Follow-up|0|||
127503909|NCT03632993|458806077|FG005|Overall Study|Lost to Follow-up|1|||
127503910|NCT03632993|458806078|FG006|Overall Study|Lost to Follow-up|0|||
127503911|NCT03632993|458806079|FG007|Overall Study|Lost to Follow-up|1|||
127503912|NCT03632993|458806080|FG008|Overall Study|Lost to Follow-up|0|||
127503913|NCT03632993|458806081|FG009|Overall Study|Lost to Follow-up|0|||
127503914|NCT03632993|458806072|FG000|Overall Study|Adverse Event|0|||
127503915|NCT03632993|458806073|FG001|Overall Study|Adverse Event|0|||
127503916|NCT03632993|458806074|FG002|Overall Study|Adverse Event|0|||
127503917|NCT03632993|458806075|FG003|Overall Study|Adverse Event|0|||
127503918|NCT03632993|458806076|FG004|Overall Study|Adverse Event|0|||
127503919|NCT03632993|458806077|FG005|Overall Study|Adverse Event|1|||
127503920|NCT03632993|458806078|FG006|Overall Study|Adverse Event|0|||
127503921|NCT03632993|458806079|FG007|Overall Study|Adverse Event|1|||
127503922|NCT03632993|458806080|FG008|Overall Study|Adverse Event|0|||
127503923|NCT03632993|458806081|FG009|Overall Study|Adverse Event|0|||
127503924|NCT02743949|458806082|FG000|Overall Study|Adverse Event|0|||
127503925|NCT02743949|458806083|FG001|Overall Study|Adverse Event|0|||
127503926|NCT02743949|458806084|FG002|Overall Study|Adverse Event|2|||
127503927|NCT02743949|458806082|FG000|Overall Study|Significant Protocol Deviation|2|||
127503928|NCT02743949|458806083|FG001|Overall Study|Significant Protocol Deviation|0|||
127503929|NCT02743949|458806084|FG002|Overall Study|Significant Protocol Deviation|1|||
127503930|NCT02743949|458806082|FG000|Overall Study|Voluntary Withdrawal|2|||
127503931|NCT02743949|458806083|FG001|Overall Study|Voluntary Withdrawal|1|||
127503932|NCT02743949|458806084|FG002|Overall Study|Voluntary Withdrawal|0|||
127503933|NCT03389555|458806085|FG000|Overall Study|Protocol Violation|1|||
127503934|NCT03389555|458806086|FG001|Overall Study|Protocol Violation|3|||
127503935|NCT03389555|458806085|FG000|Overall Study|Death|1|||
127503936|NCT03389555|458806086|FG001|Overall Study|Death|0|||
127503937|NCT00920218|458806087|FG000|Overall Study|Serious Adverse Event|2|||
127503938|NCT00920218|458806088|FG001|Overall Study|Serious Adverse Event|0|||
127503939|NCT00920218|458806089|FG002|Overall Study|Serious Adverse Event|2|||
127503940|NCT00920218|458806090|FG003|Overall Study|Serious Adverse Event|1|||
127503941|NCT00920218|458806087|FG000|Overall Study|Withdrawal by Subject|0|||
127503942|NCT00920218|458806088|FG001|Overall Study|Withdrawal by Subject|3|||
127503943|NCT00920218|458806089|FG002|Overall Study|Withdrawal by Subject|2|||
127503944|NCT00920218|458806090|FG003|Overall Study|Withdrawal by Subject|0|||
127503945|NCT00920218|458806087|FG000|Overall Study|Migrated/moved from study area|0|||
127503946|NCT00920218|458806088|FG001|Overall Study|Migrated/moved from study area|0|||
127503947|NCT00920218|458806089|FG002|Overall Study|Migrated/moved from study area|1|||
127503948|NCT00920218|458806090|FG003|Overall Study|Migrated/moved from study area|0|||
127503949|NCT00920218|458806087|FG000|Overall Study|Lost to Follow-up|0|||
127503950|NCT00920218|458806088|FG001|Overall Study|Lost to Follow-up|1|||
127503951|NCT00920218|458806089|FG002|Overall Study|Lost to Follow-up|0|||
127503952|NCT00920218|458806090|FG003|Overall Study|Lost to Follow-up|3|||
127503953|NCT00920218|458806087|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
127503954|NCT00920218|458806088|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
127503955|NCT00920218|458806089|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
127503956|NCT00920218|458806090|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
127503957|NCT00920218|458806087|FG000|Overall Study|Other|0|||
127503958|NCT00920218|458806088|FG001|Overall Study|Other|0|||
127503959|NCT00920218|458806089|FG002|Overall Study|Other|1|||
127503960|NCT00920218|458806090|FG003|Overall Study|Other|0|||
127503961|NCT01007435|458806091|FG000|Overall Study|Adverse Event|16|||
127503962|NCT01007435|458806092|FG001|Overall Study|Adverse Event|25|||
127503963|NCT01007435|458806093|FG002|Overall Study|Adverse Event|47|||
127503964|NCT01007435|458806094|FG003|Overall Study|Adverse Event|31|||
127503965|NCT01007435|458806091|FG000|Overall Study|Death|2|||
127503966|NCT01007435|458806092|FG001|Overall Study|Death|4|||
127503967|NCT01007435|458806093|FG002|Overall Study|Death|2|||
127978269|NCT01801280|460542478|FG002|Period 2|Withdrawal by Subject|0|||
127978270|NCT01801280|460542479|FG003|Period 2|Withdrawal by Subject|0|||
127503968|NCT01007435|458806094|FG003|Overall Study|Death|1|||
127503969|NCT01007435|458806091|FG000|Overall Study|Insufficient Therapeutic Response|21|||
127503970|NCT01007435|458806092|FG001|Overall Study|Insufficient Therapeutic Response|7|||
127503971|NCT01007435|458806093|FG002|Overall Study|Insufficient Therapeutic Response|2|||
127503972|NCT01007435|458806094|FG003|Overall Study|Insufficient Therapeutic Response|9|||
127503973|NCT01007435|458806091|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
127503974|NCT01007435|458806092|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
127503975|NCT01007435|458806093|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
127503976|NCT01007435|458806094|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
127503977|NCT01007435|458806091|FG000|Overall Study|Other Protocol Violation|2|||
127503978|NCT01007435|458806092|FG001|Overall Study|Other Protocol Violation|0|||
127503979|NCT01007435|458806093|FG002|Overall Study|Other Protocol Violation|1|||
127503980|NCT01007435|458806094|FG003|Overall Study|Other Protocol Violation|0|||
127503981|NCT01007435|458806091|FG000|Overall Study|Refused Treatment|13|||
127503982|NCT01007435|458806092|FG001|Overall Study|Refused Treatment|13|||
127503983|NCT01007435|458806093|FG002|Overall Study|Refused Treatment|5|||
127503984|NCT01007435|458806094|FG003|Overall Study|Refused Treatment|8|||
127503985|NCT01007435|458806091|FG000|Overall Study|Failure to Return|5|||
127503986|NCT01007435|458806092|FG001|Overall Study|Failure to Return|4|||
127503987|NCT01007435|458806093|FG002|Overall Study|Failure to Return|3|||
127503988|NCT01007435|458806094|FG003|Overall Study|Failure to Return|6|||
127503989|NCT01007435|458806091|FG000|Overall Study|Reason not Specified|1|||
127503990|NCT01007435|458806092|FG001|Overall Study|Reason not Specified|1|||
127503991|NCT01007435|458806093|FG002|Overall Study|Reason not Specified|2|||
127503992|NCT01007435|458806094|FG003|Overall Study|Reason not Specified|1|||
127503993|NCT01345591|458806097|FG000|Overall Study|Lost to Follow-up|1|||
127503994|NCT00847665|458806104|FG000|Overall Study|Withdrawal by Subject|1|||
127503995|NCT00847665|458806105|FG001|Overall Study|Withdrawal by Subject|0|||
127503996|NCT00624585|458806106|FG000|Overall Study|Death|3|||
127503997|NCT00624585|458806106|FG000|Overall Study|Disease Progression|6|||
127503998|NCT00624585|458806106|FG000|Overall Study|Adverse Event|3|||
127503999|NCT00676520|458806108|FG000|Overall Study|Withdrawal by Subject|163|||
127504000|NCT00676520|458806108|FG000|Overall Study|Lost to Follow-up|162|||
127504001|NCT00676520|458806108|FG000|Overall Study|Death|159|||
127504002|NCT00676520|458806108|FG000|Overall Study|Physician Decision|20|||
127504003|NCT00676520|458806108|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
127504004|NCT00676520|458806108|FG000|Overall Study|Other Reason|18|||
127504005|NCT01425359|458806109|FG000|Overall Study|Randomized but Not Treated|2|||
127504006|NCT01425359|458806110|FG001|Overall Study|Randomized but Not Treated|3|||
127504007|NCT01425359|458806109|FG000|Overall Study|Adverse Event|9|||
127504008|NCT01425359|458806110|FG001|Overall Study|Adverse Event|8|||
127504009|NCT01425359|458806109|FG000|Overall Study|Revascularization|0|||
127504010|NCT01425359|458806110|FG001|Overall Study|Revascularization|1|||
127504011|NCT01425359|458806109|FG000|Overall Study|Death|0|||
127504012|NCT01425359|458806110|FG001|Overall Study|Death|1|||
127504013|NCT01425359|458806109|FG000|Overall Study|Unsatisfactory Response|1|||
127504014|NCT01425359|458806110|FG001|Overall Study|Unsatisfactory Response|0|||
127504015|NCT01425359|458806109|FG000|Overall Study|Protocol Violation|1|||
127504016|NCT01425359|458806110|FG001|Overall Study|Protocol Violation|2|||
127504017|NCT01425359|458806109|FG000|Overall Study|Subject Withdrew Consent|1|||
127504018|NCT01425359|458806110|FG001|Overall Study|Subject Withdrew Consent|2|||
127978271|NCT01801280|460542476|FG000|Period 4|Protocol Violation|0|||
127978272|NCT01801280|460542477|FG001|Period 4|Protocol Violation|0|||
127978273|NCT01801280|460542478|FG002|Period 4|Protocol Violation|1|||
127978274|NCT01801280|460542479|FG003|Period 4|Protocol Violation|0|||
127978275|NCT00176644|460542480|FG000|Overall Study|Withdrawal by Subject|1|||
127978276|NCT04021121|460542485|FG000|Overall Study|Death|3|||
127978277|NCT04021121|460542486|FG001|Overall Study|Death|3|||
127978278|NCT04021121|460542487|FG002|Overall Study|Death|5|||
127978279|NCT04021121|460542488|FG003|Overall Study|Death|4|||
127978280|NCT00978250|460542490|FG000|Overall Study|Late determination of ineligibility|0|||
127978281|NCT00978250|460542491|FG001|Overall Study|Late determination of ineligibility|1|||
127978282|NCT00978250|460542492|FG002|Overall Study|Late determination of ineligibility|0|||
127978283|NCT00978250|460542493|FG003|Overall Study|Late determination of ineligibility|1|||
127978284|NCT05174949|460542501|FG000|Overall Study|Physician Decision|1|||
127978285|NCT05174949|460542502|FG001|Overall Study|Physician Decision|2|||
127978286|NCT05174949|460542503|FG002|Overall Study|Physician Decision|0|||
127978287|NCT05174949|460542504|FG003|Overall Study|Physician Decision|1|||
127978288|NCT05174949|460542505|FG004|Overall Study|Physician Decision|0|||
127978289|NCT05174949|460542506|FG005|Overall Study|Physician Decision|0|||
127978290|NCT05174949|460542501|FG000|Overall Study|Withdrawal by Subject|0|||
127978291|NCT05174949|460542502|FG001|Overall Study|Withdrawal by Subject|1|||
127978292|NCT05174949|460542503|FG002|Overall Study|Withdrawal by Subject|0|||
127978293|NCT05174949|460542504|FG003|Overall Study|Withdrawal by Subject|0|||
127978294|NCT05174949|460542505|FG004|Overall Study|Withdrawal by Subject|0|||
127978295|NCT05174949|460542506|FG005|Overall Study|Withdrawal by Subject|0|||
127978296|NCT05174949|460542501|FG000|Overall Study|Lost to Follow-up|0|||
127978297|NCT05174949|460542502|FG001|Overall Study|Lost to Follow-up|0|||
127978298|NCT05174949|460542503|FG002|Overall Study|Lost to Follow-up|0|||
127978299|NCT05174949|460542504|FG003|Overall Study|Lost to Follow-up|1|||
127978300|NCT05174949|460542505|FG004|Overall Study|Lost to Follow-up|0|||
127978301|NCT05174949|460542506|FG005|Overall Study|Lost to Follow-up|0|||
127978302|NCT02951533|460542507|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
127978303|NCT02951533|460542508|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
127504019|NCT01425359|458806109|FG000|Overall Study|Investigator's Discretion|2|||
127504020|NCT01425359|458806110|FG001|Overall Study|Investigator's Discretion|0|||
127504021|NCT01425359|458806109|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
127504022|NCT01425359|458806110|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
127504023|NCT03172325|458806111|FG000|Overall Study|Adverse Event|2|||
127504024|NCT03172325|458806112|FG001|Overall Study|Adverse Event|3|||
127504025|NCT03172325|458806111|FG000|Overall Study|Positive PPD|1|||
127504026|NCT03172325|458806112|FG001|Overall Study|Positive PPD|0|||
127504027|NCT03172325|458806111|FG000|Overall Study|Poor Compliance|1|||
127504028|NCT03172325|458806112|FG001|Overall Study|Poor Compliance|1|||
127504029|NCT03305419|458806128|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
127504030|NCT03305419|458806129|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
127504031|NCT03305419|458806130|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
127504032|NCT03305419|458806131|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
127504033|NCT03305419|458806132|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
127504034|NCT03305419|458806133|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
127504035|NCT03305419|458806134|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
127504036|NCT03305419|458806135|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
127504037|NCT03305419|458806128|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
127504038|NCT03305419|458806129|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
127504039|NCT03305419|458806130|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
127504040|NCT03305419|458806131|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
127504041|NCT03305419|458806132|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
127504042|NCT03305419|458806133|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
127504043|NCT03305419|458806134|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
127504044|NCT03305419|458806135|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
127504045|NCT03305419|458806128|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
127504046|NCT03305419|458806129|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
127504047|NCT03305419|458806130|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
127504048|NCT03305419|458806131|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
127504049|NCT03305419|458806132|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
127504050|NCT03305419|458806133|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
127504051|NCT03305419|458806134|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
127504052|NCT03305419|458806135|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
127504053|NCT03305419|458806128|FG000|Part B (14 Days)|Adverse Event|0|||
127504054|NCT03305419|458806129|FG001|Part B (14 Days)|Adverse Event|0|||
127504055|NCT03305419|458806130|FG002|Part B (14 Days)|Adverse Event|0|||
127504056|NCT03305419|458806131|FG003|Part B (14 Days)|Adverse Event|0|||
127504057|NCT03305419|458806132|FG004|Part B (14 Days)|Adverse Event|1|||
127504058|NCT03305419|458806133|FG005|Part B (14 Days)|Adverse Event|2|||
127504059|NCT03305419|458806134|FG006|Part B (14 Days)|Adverse Event|4|||
127504060|NCT03305419|458806135|FG007|Part B (14 Days)|Adverse Event|0|||
127504061|NCT03305419|458806128|FG000|Part B (14 Days)|Physician Decision|0|||
127504062|NCT03305419|458806129|FG001|Part B (14 Days)|Physician Decision|0|||
127504063|NCT03305419|458806130|FG002|Part B (14 Days)|Physician Decision|0|||
127504064|NCT03305419|458806131|FG003|Part B (14 Days)|Physician Decision|0|||
127504065|NCT03305419|458806132|FG004|Part B (14 Days)|Physician Decision|2|||
127504066|NCT03305419|458806133|FG005|Part B (14 Days)|Physician Decision|8|||
127504067|NCT03305419|458806134|FG006|Part B (14 Days)|Physician Decision|1|||
127504068|NCT03305419|458806135|FG007|Part B (14 Days)|Physician Decision|0|||
127504069|NCT00075946|458806136|FG000|Overall Study|Path ineligible: undetermined histology|0|||
127504070|NCT00075946|458806137|FG001|Overall Study|Path ineligible: undetermined histology|0|||
127504071|NCT00075946|458806138|FG002|Overall Study|Path ineligible: undetermined histology|0|||
127504072|NCT00075946|458806139|FG003|Overall Study|Path ineligible: undetermined histology|0|||
127504073|NCT00075946|458806140|FG004|Overall Study|Path ineligible: undetermined histology|6|||
127504074|NCT00075946|458806136|FG000|Overall Study|Did not achieve response after induction|0|||
127504075|NCT00075946|458806137|FG001|Overall Study|Did not achieve response after induction|0|||
127504076|NCT00075946|458806138|FG002|Overall Study|Did not achieve response after induction|0|||
127504077|NCT00075946|458806139|FG003|Overall Study|Did not achieve response after induction|0|||
127504078|NCT00075946|458806140|FG004|Overall Study|Did not achieve response after induction|182|||
127504079|NCT00075946|458806136|FG000|Overall Study|Incorrectly randomized (no response)|5|||
127504080|NCT00075946|458806137|FG001|Overall Study|Incorrectly randomized (no response)|5|||
127504081|NCT00075946|458806138|FG002|Overall Study|Incorrectly randomized (no response)|5|||
127504082|NCT00075946|458806139|FG003|Overall Study|Incorrectly randomized (no response)|1|||
127504083|NCT00075946|458806140|FG004|Overall Study|Incorrectly randomized (no response)|0|||
127504084|NCT00075946|458806136|FG000|Overall Study|Adverse Event|2|||
127504085|NCT00075946|458806137|FG001|Overall Study|Adverse Event|10|||
127504086|NCT00075946|458806138|FG002|Overall Study|Adverse Event|0|||
127504087|NCT00075946|458806139|FG003|Overall Study|Adverse Event|2|||
127504088|NCT00075946|458806140|FG004|Overall Study|Adverse Event|0|||
127504089|NCT00075946|458806136|FG000|Overall Study|Death|0|||
127504090|NCT00075946|458806137|FG001|Overall Study|Death|1|||
127504091|NCT00075946|458806138|FG002|Overall Study|Death|0|||
127504092|NCT00075946|458806139|FG003|Overall Study|Death|0|||
127504093|NCT00075946|458806140|FG004|Overall Study|Death|0|||
127504094|NCT00075946|458806136|FG000|Overall Study|Withdrawal by Subject|23|||
127504095|NCT00075946|458806137|FG001|Overall Study|Withdrawal by Subject|58|||
127504096|NCT00075946|458806138|FG002|Overall Study|Withdrawal by Subject|4|||
127504097|NCT00075946|458806139|FG003|Overall Study|Withdrawal by Subject|9|||
127504098|NCT00075946|458806140|FG004|Overall Study|Withdrawal by Subject|0|||
127504099|NCT00075946|458806136|FG000|Overall Study|Alternative therapy|16|||
127504100|NCT00075946|458806137|FG001|Overall Study|Alternative therapy|2|||
127504101|NCT00075946|458806138|FG002|Overall Study|Alternative therapy|5|||
127504102|NCT00075946|458806139|FG003|Overall Study|Alternative therapy|0|||
127504103|NCT00075946|458806140|FG004|Overall Study|Alternative therapy|0|||
127504104|NCT00075946|458806136|FG000|Overall Study|Other complicating disease|7|||
127504105|NCT00075946|458806137|FG001|Overall Study|Other complicating disease|13|||
127504106|NCT00075946|458806138|FG002|Overall Study|Other complicating disease|1|||
127504107|NCT00075946|458806139|FG003|Overall Study|Other complicating disease|4|||
127504108|NCT00075946|458806140|FG004|Overall Study|Other complicating disease|0|||
127504109|NCT00075946|458806136|FG000|Overall Study|No response to retreatment|23|||
127504110|NCT00075946|458806137|FG001|Overall Study|No response to retreatment|0|||
127504111|NCT00075946|458806138|FG002|Overall Study|No response to retreatment|2|||
127504112|NCT00075946|458806139|FG003|Overall Study|No response to retreatment|0|||
127504113|NCT00075946|458806140|FG004|Overall Study|No response to retreatment|0|||
127504114|NCT00075946|458806136|FG000|Overall Study|Time to progression less than 6 months|15|||
127504115|NCT00075946|458806137|FG001|Overall Study|Time to progression less than 6 months|30|||
127504116|NCT00075946|458806138|FG002|Overall Study|Time to progression less than 6 months|8|||
127504117|NCT00075946|458806139|FG003|Overall Study|Time to progression less than 6 months|3|||
127504118|NCT00075946|458806140|FG004|Overall Study|Time to progression less than 6 months|0|||
127504119|NCT00075946|458806136|FG000|Overall Study|Other|57|||
127504120|NCT00075946|458806137|FG001|Overall Study|Other|32|||
127504121|NCT00075946|458806138|FG002|Overall Study|Other|3|||
127504122|NCT00075946|458806139|FG003|Overall Study|Other|11|||
127504123|NCT00075946|458806140|FG004|Overall Study|Other|0|||
127504124|NCT00889603|458806143|FG000|Overall Study|Adverse Event|7|||
127504125|NCT00889603|458806143|FG000|Overall Study|Death|3|||
127504126|NCT00889603|458806143|FG000|Overall Study|Lost to Follow-up|19|||
127504127|NCT00889603|458806143|FG000|Overall Study|No longer willing to participant in stud|4|||
127504128|NCT00889603|458806143|FG000|Overall Study|Other|4|||
127504129|NCT01229254|458806144|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
127504130|NCT01229254|458806145|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
127504131|NCT01229254|458806146|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
127504132|NCT01229254|458806144|FG000|Overall Study|Adverse Event|4|||
127504133|NCT01229254|458806145|FG001|Overall Study|Adverse Event|5|||
127504134|NCT01229254|458806146|FG002|Overall Study|Adverse Event|3|||
127504135|NCT01229254|458806144|FG000|Overall Study|Lost to Follow-up|3|||
127504136|NCT01229254|458806145|FG001|Overall Study|Lost to Follow-up|0|||
127504137|NCT01229254|458806146|FG002|Overall Study|Lost to Follow-up|1|||
127504138|NCT01229254|458806144|FG000|Overall Study|Physician Decision|0|||
127504139|NCT01229254|458806145|FG001|Overall Study|Physician Decision|3|||
127504140|NCT01229254|458806146|FG002|Overall Study|Physician Decision|0|||
127504141|NCT01229254|458806144|FG000|Overall Study|Protocol Violation|4|||
127504142|NCT01229254|458806145|FG001|Overall Study|Protocol Violation|6|||
127504143|NCT01229254|458806146|FG002|Overall Study|Protocol Violation|5|||
127504144|NCT01229254|458806144|FG000|Overall Study|Withdrawal by Subject|1|||
127504145|NCT01229254|458806145|FG001|Overall Study|Withdrawal by Subject|0|||
127504146|NCT01229254|458806146|FG002|Overall Study|Withdrawal by Subject|1|||
127504147|NCT01229254|458806144|FG000|Overall Study|Non-compliance with Study Drug|0|||
127504148|NCT01229254|458806145|FG001|Overall Study|Non-compliance with Study Drug|1|||
127504149|NCT01229254|458806146|FG002|Overall Study|Non-compliance with Study Drug|1|||
127504150|NCT02231892|458806147|FG000|Overall Study|Lost to Follow-up|1|||
127504151|NCT02231892|458806148|FG001|Overall Study|Lost to Follow-up|0|||
127504152|NCT02231892|458806149|FG002|Overall Study|Lost to Follow-up|3|||
127504153|NCT02231892|458806147|FG000|Overall Study|Withdrawal by Subject|4|||
127504154|NCT02231892|458806148|FG001|Overall Study|Withdrawal by Subject|3|||
127504155|NCT02231892|458806149|FG002|Overall Study|Withdrawal by Subject|15|||
127504156|NCT02231892|458806147|FG000|Overall Study|Physician Decision|0|||
127504157|NCT02231892|458806148|FG001|Overall Study|Physician Decision|2|||
127504158|NCT02231892|458806149|FG002|Overall Study|Physician Decision|4|||
127504159|NCT02231892|458806147|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
127504160|NCT02231892|458806148|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
127504161|NCT02231892|458806149|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
127504162|NCT02231892|458806147|FG000|Overall Study|Participant motor threshold was >83%|0|||
127504163|NCT02231892|458806148|FG001|Overall Study|Participant motor threshold was >83%|0|||
127504164|NCT02231892|458806149|FG002|Overall Study|Participant motor threshold was >83%|9|||
127504165|NCT02231892|458806147|FG000|Overall Study|Could not find motor threshold|2|||
127504166|NCT02231892|458806148|FG001|Overall Study|Could not find motor threshold|0|||
127504167|NCT02231892|458806149|FG002|Overall Study|Could not find motor threshold|1|||
127504168|NCT02231892|458806147|FG000|Overall Study|Could not find reliable motor hotspot|0|||
127504169|NCT02231892|458806148|FG001|Overall Study|Could not find reliable motor hotspot|0|||
127504170|NCT02231892|458806149|FG002|Overall Study|Could not find reliable motor hotspot|1|||
127504171|NCT02680041|458806151|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
127504172|NCT02680041|458806151|FG000|Overall Study|Lost to Follow-up|2|||
127504173|NCT03022097|458806157|FG000|Overall Study|Adverse Event|3|||
127504174|NCT03022097|458806158|FG001|Overall Study|Adverse Event|4|||
127504175|NCT03022097|458806159|FG002|Overall Study|Adverse Event|1|||
127504176|NCT03022097|458806160|FG003|Overall Study|Adverse Event|3|||
127504177|NCT03022097|458806157|FG000|Overall Study|Progressive Disease|2|||
127504178|NCT03022097|458806158|FG001|Overall Study|Progressive Disease|0|||
127504179|NCT03022097|458806159|FG002|Overall Study|Progressive Disease|5|||
127504180|NCT03022097|458806160|FG003|Overall Study|Progressive Disease|2|||
127504181|NCT03022097|458806157|FG000|Overall Study|Lack of Efficacy|0|||
127504182|NCT03022097|458806158|FG001|Overall Study|Lack of Efficacy|0|||
127504183|NCT03022097|458806159|FG002|Overall Study|Lack of Efficacy|3|||
127504184|NCT03022097|458806160|FG003|Overall Study|Lack of Efficacy|3|||
127504185|NCT03022097|458806157|FG000|Overall Study|Protocol Violation|1|||
127504186|NCT03022097|458806158|FG001|Overall Study|Protocol Violation|0|||
127504187|NCT03022097|458806159|FG002|Overall Study|Protocol Violation|1|||
127504188|NCT03022097|458806160|FG003|Overall Study|Protocol Violation|0|||
127504189|NCT03022097|458806157|FG000|Overall Study|Withdrawal by Subject|11|||
127504190|NCT03022097|458806158|FG001|Overall Study|Withdrawal by Subject|13|||
127504191|NCT03022097|458806159|FG002|Overall Study|Withdrawal by Subject|15|||
127504192|NCT03022097|458806160|FG003|Overall Study|Withdrawal by Subject|21|||
127504193|NCT03022097|458806157|FG000|Overall Study|Lost to Follow-up|0|||
127504194|NCT03022097|458806158|FG001|Overall Study|Lost to Follow-up|0|||
127504195|NCT03022097|458806159|FG002|Overall Study|Lost to Follow-up|1|||
127504196|NCT03022097|458806160|FG003|Overall Study|Lost to Follow-up|1|||
127504197|NCT03022097|458806157|FG000|Overall Study|Other|4|||
127504198|NCT03022097|458806158|FG001|Overall Study|Other|1|||
127504199|NCT03022097|458806159|FG002|Overall Study|Other|6|||
127504200|NCT03022097|458806160|FG003|Overall Study|Other|4|||
127504201|NCT03022097|458806157|FG000|Overall Study|Due to COVID-19 pandemic|0|||
127504202|NCT03022097|458806158|FG001|Overall Study|Due to COVID-19 pandemic|1|||
127504203|NCT03022097|458806159|FG002|Overall Study|Due to COVID-19 pandemic|0|||
127504204|NCT03022097|458806160|FG003|Overall Study|Due to COVID-19 pandemic|0|||
127504205|NCT01451931|458806163|FG000|Overall Study|Lost to Follow-up|17|||
127504206|NCT01451931|458806164|FG001|Overall Study|Lost to Follow-up|36|||
127504207|NCT01451931|458806165|FG002|Overall Study|Lost to Follow-up|21|||
127504208|NCT01451931|458806163|FG000|Overall Study|Withdrawal by Subject|16|||
127504209|NCT01451931|458806164|FG001|Overall Study|Withdrawal by Subject|22|||
127504210|NCT01451931|458806165|FG002|Overall Study|Withdrawal by Subject|22|||
127504211|NCT01349322|458806166|FG000|Overall Study|Protocol Violation|45|||
127504212|NCT01349322|458806167|FG001|Overall Study|Protocol Violation|47|||
127504213|NCT04470908|458806172|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
127504214|NCT04376684|458806173|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
127504215|NCT04376684|458806174|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
127504216|NCT04376684|458806175|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
127504217|NCT04376684|458806176|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
127504218|NCT04376684|458806173|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
127504219|NCT04376684|458806174|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
127504220|NCT04376684|458806175|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
127504221|NCT04376684|458806176|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
127504222|NCT04376684|458806173|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
127504223|NCT04376684|458806174|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
127504224|NCT04376684|458806175|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
127504225|NCT04376684|458806176|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
127504226|NCT04376684|458806173|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
127504227|NCT04376684|458806174|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
127504228|NCT04376684|458806175|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
127504229|NCT04376684|458806176|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
127504230|NCT04376684|458806173|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
127504231|NCT04376684|458806174|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
127504232|NCT04376684|458806175|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
127504233|NCT04376684|458806176|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
127504234|NCT04376684|458806173|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
127504235|NCT04376684|458806174|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
127504236|NCT04376684|458806175|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
127504237|NCT04376684|458806176|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
127504238|NCT04376684|458806173|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
127504239|NCT04376684|458806174|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
127504240|NCT04376684|458806175|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
127504241|NCT04376684|458806176|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
127504242|NCT06107803|458806178|FG000|Overall Study|Adverse Event|1|||
127504243|NCT06107803|458806178|FG000|Overall Study|Withdrawal by Subject|2|||
127504244|NCT06107803|458806178|FG000|Overall Study|Protocol Violation|1|||
127504245|NCT02378298|458806180|FG000|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
127504246|NCT02378298|458806181|FG001|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|2|||
127504247|NCT02378298|458806182|FG002|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
127504248|NCT02378298|458806180|FG000|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
127504249|NCT02378298|458806181|FG001|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
127504250|NCT02378298|458806182|FG002|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|1|||
127504251|NCT02378298|458806180|FG000|Surveillance (19-68 Weeks)|Death|1|||
127504252|NCT02378298|458806181|FG001|Surveillance (19-68 Weeks)|Death|0|||
127504253|NCT02378298|458806182|FG002|Surveillance (19-68 Weeks)|Death|0|||
127504254|NCT01974206|458806183|FG000|Overall Study|Did Not Take Study Drug|0|||
127504255|NCT01974206|458806184|FG001|Overall Study|Did Not Take Study Drug|1|||
127504256|NCT01974206|458806183|FG000|Overall Study|Physician Decision|1|||
127504257|NCT01974206|458806184|FG001|Overall Study|Physician Decision|0|||
127504258|NCT01974206|458806183|FG000|Overall Study|Withdrawal by Subject|3|||
127504259|NCT01974206|458806184|FG001|Overall Study|Withdrawal by Subject|0|||
127504260|NCT01974206|458806183|FG000|Overall Study|Lost to Follow-up|1|||
127504261|NCT01974206|458806184|FG001|Overall Study|Lost to Follow-up|0|||
127504262|NCT01974206|458806183|FG000|Overall Study|Death|1|||
127504263|NCT01974206|458806184|FG001|Overall Study|Death|0|||
127504264|NCT02118766|458806189|FG000|Overall Study|Adverse Event|7|||
127504265|NCT02118766|458806190|FG001|Overall Study|Adverse Event|2|||
127504266|NCT02118766|458806189|FG000|Overall Study|Withdrawal by Subject|3|||
127504267|NCT02118766|458806190|FG001|Overall Study|Withdrawal by Subject|6|||
127504268|NCT02118766|458806189|FG000|Overall Study|Lost to Follow-up|5|||
127504269|NCT02118766|458806190|FG001|Overall Study|Lost to Follow-up|4|||
127504270|NCT02118766|458806189|FG000|Overall Study|Withdrawal by parent/guardian|12|||
127504271|NCT02118766|458806190|FG001|Overall Study|Withdrawal by parent/guardian|18|||
127504272|NCT02118766|458806189|FG000|Overall Study|Other|3|||
127504273|NCT02118766|458806190|FG001|Overall Study|Other|1|||
127504274|NCT03219034|458806191|FG000|Overall Study|Lost to Follow-up|9|||
127504275|NCT03219034|458806192|FG001|Overall Study|Lost to Follow-up|13|||
127504276|NCT03219034|458806191|FG000|Overall Study|Additional dental work needed|1|||
127504277|NCT03219034|458806192|FG001|Overall Study|Additional dental work needed|0|||
127504278|NCT03219034|458806191|FG000|Overall Study|UPPP Surgery|1|||
127504279|NCT03219034|458806192|FG001|Overall Study|UPPP Surgery|0|||
127504280|NCT03219034|458806191|FG000|Overall Study|Dental sensitivity|0|||
127504281|NCT03219034|458806192|FG001|Overall Study|Dental sensitivity|1|||
127504282|NCT03219034|458806191|FG000|Overall Study|Death in family|0|||
127504283|NCT03219034|458806192|FG001|Overall Study|Death in family|1|||
127504284|NCT02136680|458806198|FG000|Overall Study|No Longer Interested|1|||
127504285|NCT02136680|458806199|FG001|Overall Study|No Longer Interested|1|||
127504286|NCT02136680|458806198|FG000|Overall Study|No longer receiving care at clinic|3|||
127504287|NCT02136680|458806199|FG001|Overall Study|No longer receiving care at clinic|5|||
127504288|NCT02136680|458806198|FG000|Overall Study|Moved away|5|||
127504289|NCT02136680|458806199|FG001|Overall Study|Moved away|4|||
127504290|NCT02136680|458806198|FG000|Overall Study|Unable to schedule|17|||
127504291|NCT02136680|458806199|FG001|Overall Study|Unable to schedule|16|||
127504292|NCT02136680|458806198|FG000|Overall Study|Study ended before interview due|6|||
127504293|NCT02136680|458806199|FG001|Overall Study|Study ended before interview due|3|||
127504294|NCT03559517|458806202|FG000|Overall Study|Withdrawal by Subject|1|||
127504295|NCT03559517|458806203|FG001|Overall Study|Withdrawal by Subject|0|||
127504296|NCT03559517|458806204|FG002|Overall Study|Withdrawal by Subject|0|||
127504297|NCT01846299|458806205|FG000|Overall Study|Physician Decision|4|||
127504298|NCT01846299|458806206|FG001|Overall Study|Physician Decision|2|||
127504299|NCT01846299|458806205|FG000|Overall Study|Protocol deviation|1|||
127504300|NCT01846299|458806206|FG001|Overall Study|Protocol deviation|0|||
127504301|NCT01846299|458806205|FG000|Overall Study|Death|1|||
127504302|NCT01846299|458806206|FG001|Overall Study|Death|2|||
127504303|NCT01846299|458806205|FG000|Overall Study|Lost to Follow-up|3|||
127504304|NCT01846299|458806206|FG001|Overall Study|Lost to Follow-up|0|||
127504305|NCT01846299|458806205|FG000|Overall Study|Withdrawal by Subject|1|||
127504306|NCT01846299|458806206|FG001|Overall Study|Withdrawal by Subject|6|||
127504307|NCT01846299|458806205|FG000|Overall Study|Adverse Event|2|||
127504308|NCT01846299|458806206|FG001|Overall Study|Adverse Event|0|||
127504309|NCT01457014|458806208|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
127504310|NCT01457014|458806209|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
127504311|NCT01457014|458806210|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
127504312|NCT01457014|458806211|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
127504313|NCT01457014|458806208|FG000|First Night|Withdrawal by Subject|3|||
127504314|NCT01457014|458806209|FG001|First Night|Withdrawal by Subject|0|||
127504315|NCT01457014|458806210|FG002|First Night|Withdrawal by Subject|0|||
127504316|NCT01457014|458806211|FG003|First Night|Withdrawal by Subject|0|||
127504317|NCT01357161|458806212|FG000|Part 1 (Open Label Run-in)|Death|5|||
127504318|NCT01357161|458806213|FG001|Part 1 (Open Label Run-in)|Death|0|||
127504319|NCT01357161|458806214|FG002|Part 1 (Open Label Run-in)|Death|0|||
127504320|NCT01357161|458806212|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
127504321|NCT01357161|458806213|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
127504322|NCT01357161|458806214|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
127504323|NCT01357161|458806212|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
127504324|NCT01357161|458806213|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
127504325|NCT01357161|458806214|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
127504326|NCT01357161|458806212|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
127504327|NCT01357161|458806213|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
127504328|NCT01357161|458806214|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
127504329|NCT01357161|458806212|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
127504330|NCT01357161|458806213|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
127504331|NCT01357161|458806214|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
127504332|NCT01357161|458806212|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
127504333|NCT01357161|458806213|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
127504334|NCT01357161|458806214|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
127504335|NCT01357161|458806212|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
127504336|NCT01357161|458806213|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
127504337|NCT01357161|458806214|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
127504338|NCT01357161|458806212|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
127504339|NCT01357161|458806213|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
127504340|NCT01357161|458806214|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
127504341|NCT01357161|458806212|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
127504342|NCT01357161|458806213|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
127504343|NCT01357161|458806214|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
127504344|NCT01357161|458806212|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
127504345|NCT01357161|458806213|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
127504346|NCT01357161|458806214|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
127504347|NCT01357161|458806212|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
127504348|NCT01357161|458806213|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
127504349|NCT01357161|458806214|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
127504350|NCT02825420|458806216|FG000|Overall Study|Death|30|||
127504351|NCT02825420|458806217|FG001|Overall Study|Death|12|||
127504352|NCT02825420|458806216|FG000|Overall Study|Progressive disease|6|||
127504353|NCT02825420|458806217|FG001|Overall Study|Progressive disease|1|||
127504354|NCT02825420|458806216|FG000|Overall Study|Lost to Follow-up|2|||
127504355|NCT02825420|458806217|FG001|Overall Study|Lost to Follow-up|2|||
127504356|NCT02825420|458806216|FG000|Overall Study|Withdrawal by Subject|1|||
127504357|NCT02825420|458806217|FG001|Overall Study|Withdrawal by Subject|1|||
127504358|NCT02825420|458806216|FG000|Overall Study|Protocol amendment not signed|1|||
127504359|NCT02825420|458806217|FG001|Overall Study|Protocol amendment not signed|1|||
127504360|NCT02825420|458806216|FG000|Overall Study|Physician Decision|1|||
127504361|NCT02825420|458806217|FG001|Overall Study|Physician Decision|0|||
127504362|NCT02825420|458806216|FG000|Overall Study|Did not receive PLD|2|||
127504363|NCT02825420|458806217|FG001|Overall Study|Did not receive PLD|0|||
127504364|NCT04027049|458806218|FG000|Overall Study|Withdrawn by family|1|||
127504365|NCT04027049|458806219|FG001|Overall Study|Withdrawn by family|0|||
127504366|NCT04027049|458806218|FG000|Overall Study|Participant safety|1|||
127504367|NCT04027049|458806219|FG001|Overall Study|Participant safety|0|||
127504368|NCT01328041|458807956|FG000|Overall Study|Adverse Event|7|||
127504369|NCT01328041|458807956|FG000|Overall Study|Lack of Efficacy|27|||
127504370|NCT01328041|458807956|FG000|Overall Study|Protocol Violation|7|||
127504371|NCT01328041|458807956|FG000|Overall Study|Lost to Follow-up|7|||
127504372|NCT01328041|458807956|FG000|Overall Study|Physician Decision|2|||
127504373|NCT01328041|458807956|FG000|Overall Study|Withdrawal by Subject|7|||
127504374|NCT02688088|458807960|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
127504375|NCT02688088|458807961|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
127504376|NCT02688088|458807962|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
127504377|NCT02688088|458807963|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
127504378|NCT02688088|458807964|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
127504379|NCT02688088|458807960|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
127504380|NCT02688088|458807961|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
127504381|NCT02688088|458807962|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
127504382|NCT02688088|458807963|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
127504383|NCT02688088|458807964|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
127504384|NCT02688088|458807960|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
127504385|NCT02688088|458807961|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
127504386|NCT02688088|458807962|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
127504387|NCT02688088|458807963|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
127504388|NCT02688088|458807964|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
127504389|NCT02688088|458807960|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
127504390|NCT02688088|458807961|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
127504391|NCT02688088|458807962|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
127504392|NCT02688088|458807963|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
127504393|NCT02688088|458807964|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
127504394|NCT02688088|458807960|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
127504395|NCT02688088|458807961|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
127504396|NCT02688088|458807962|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
127504397|NCT02688088|458807963|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
127504398|NCT02688088|458807964|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
127504399|NCT02688088|458807960|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
127504400|NCT02688088|458807961|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
127504401|NCT02688088|458807962|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
127504402|NCT02688088|458807963|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
127504403|NCT02688088|458807964|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
127504404|NCT02688088|458807960|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
127504405|NCT02688088|458807961|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
127504406|NCT02688088|458807962|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
127504407|NCT02688088|458807963|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
127504408|NCT02688088|458807964|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
127504409|NCT02688088|458807960|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
127504410|NCT02688088|458807961|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
127504411|NCT02688088|458807962|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
127504412|NCT02688088|458807963|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
127504413|NCT02688088|458807964|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
127504414|NCT02688088|458807960|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
127504415|NCT02688088|458807961|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
127504416|NCT02688088|458807962|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
127504417|NCT02688088|458807963|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
127504418|NCT02688088|458807964|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
127504419|NCT04021524|458807967|FG000|Overall Study|Change in surgical intervention|0|||
127504420|NCT04021524|458807968|FG001|Overall Study|Change in surgical intervention|1|||
127504421|NCT05275010|458807969|FG000|Overall Study|Reason Not Specified|4|||
127504422|NCT05275010|458807970|FG001|Overall Study|Reason Not Specified|1|||
127504423|NCT05275010|458807969|FG000|Overall Study|Withdrawal by Subject|1|||
127504424|NCT05275010|458807970|FG001|Overall Study|Withdrawal by Subject|0|||
127504425|NCT05275010|458807969|FG000|Overall Study|Lost to Follow-up|0|||
127504426|NCT05275010|458807970|FG001|Overall Study|Lost to Follow-up|1|||
127504427|NCT00730041|458807971|FG000|Overall Study|Lost to Follow-up|0|||
127504428|NCT00730041|458807972|FG001|Overall Study|Lost to Follow-up|2|||
127504429|NCT05526781|458807973|FG000|Overall Study|Lost to Follow-up|1|||
127504430|NCT01921218|458807974|FG000|Overall Study|Death|2|||
127504431|NCT01921218|458807975|FG001|Overall Study|Death|1|||
127504432|NCT01921218|458807974|FG000|Overall Study|Withdrawal by Subject|0|||
127504433|NCT01921218|458807975|FG001|Overall Study|Withdrawal by Subject|2|||
127504434|NCT01921218|458807974|FG000|Overall Study|Kidney transplant|1|||
127504435|NCT01921218|458807975|FG001|Overall Study|Kidney transplant|1|||
127504436|NCT02449889|458807976|FG000|Overall Study|Adverse Event|1|||
127504437|NCT02449889|458807977|FG001|Overall Study|Adverse Event|2|||
127504438|NCT02449889|458807978|FG002|Overall Study|Adverse Event|0|||
127504439|NCT02449889|458807976|FG000|Overall Study|Protocol Violation|0|||
127504440|NCT02449889|458807977|FG001|Overall Study|Protocol Violation|4|||
127504441|NCT02449889|458807978|FG002|Overall Study|Protocol Violation|1|||
127504442|NCT03327220|458807979|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
127504443|NCT03327220|458807980|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
127504444|NCT03327220|458807979|FG000|Overall Study|Investigator Decision|2|||
127504445|NCT03327220|458807980|FG001|Overall Study|Investigator Decision|0|||
127504446|NCT03327220|458807979|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
127504447|NCT03327220|458807980|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
127504448|NCT03327220|458807979|FG000|Overall Study|Fungal infection|1|||
127504449|NCT03327220|458807980|FG001|Overall Study|Fungal infection|0|||
127978304|NCT02951533|460542509|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
127978305|NCT02951533|460542507|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
127978306|NCT02951533|460542508|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
127978307|NCT02951533|460542509|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
127978308|NCT02951533|460542507|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
127978309|NCT02951533|460542508|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
127978310|NCT02951533|460542509|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
127504450|NCT03327220|458807979|FG000|Overall Study|Discharged to Rehabilitation|0|||
127504451|NCT03327220|458807980|FG001|Overall Study|Discharged to Rehabilitation|1|||
127978311|NCT02951533|460542507|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
127504452|NCT03327220|458807979|FG000|Overall Study|Missing|1|||
127504453|NCT03327220|458807980|FG001|Overall Study|Missing|0|||
127504454|NCT00368836|458807983|FG000|Phase II|Screen Failure|1|||
127504455|NCT00368836|458807983|FG000|Phase II|Withdrawal by Subject|1|||
127504456|NCT00368836|458807983|FG000|Phase II|unable to collect blood and/or breath|17|||
127504457|NCT00368836|458807983|FG000|Phase II|Protocol Violation|2|||
127504458|NCT00090142|458807984|FG000|Treatment Period I|Lost to Follow-up|1|||
127504459|NCT00090142|458807985|FG001|Treatment Period I|Lost to Follow-up|2|||
127504460|NCT00090142|458807984|FG000|Treatment Period I|Protocol Violation|2|||
127504461|NCT00090142|458807985|FG001|Treatment Period I|Protocol Violation|0|||
127504462|NCT00090142|458807984|FG000|Treatment Period I|Withdrawal by Subject|2|||
127504463|NCT00090142|458807985|FG001|Treatment Period I|Withdrawal by Subject|0|||
127504464|NCT00090142|458807984|FG000|Treatment Period I|Other|0|||
127504465|NCT00090142|458807985|FG001|Treatment Period I|Other|1|||
127504466|NCT00090142|458807984|FG000|Treatment Period II|Other|1|||
127504467|NCT00090142|458807985|FG001|Treatment Period II|Other|0|||
127504468|NCT02442310|458807986|FG000|Overall Study|Adverse Event|2|||
127504469|NCT02442310|458807986|FG000|Overall Study|Withdrawal by Subject|1|||
127504470|NCT00688324|458807987|FG000|Overall Study|Withdrawal by Subject|2|||
127504471|NCT00688324|458807987|FG000|Overall Study|Physician Decision|5|||
127504472|NCT00688324|458807987|FG000|Overall Study|Lost to Follow-up|1|||
127504473|NCT03176472|458807988|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
127504474|NCT03176472|458807989|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
127504475|NCT03176472|458807988|FG000|Double Blind Treatment Period|Adverse Event|0|||
127504476|NCT03176472|458807989|FG001|Double Blind Treatment Period|Adverse Event|5|||
127504477|NCT03176472|458807988|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
127504478|NCT03176472|458807989|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
127504479|NCT03176472|458807988|FG000|Double Blind Treatment Period|Physician Decision|0|||
127504480|NCT03176472|458807989|FG001|Double Blind Treatment Period|Physician Decision|1|||
127504481|NCT03176472|458807988|FG000|Double Blind Treatment Period|Protocol Violation|1|||
127504482|NCT03176472|458807989|FG001|Double Blind Treatment Period|Protocol Violation|0|||
127504483|NCT03176472|458807988|FG000|Double Blind Treatment Period|Not Provided|1|||
127504484|NCT03176472|458807989|FG001|Double Blind Treatment Period|Not Provided|0|||
127504485|NCT03176472|458807988|FG000|Open Label Extension|Withdrawal by Subject|3|||
127504486|NCT03176472|458807989|FG001|Open Label Extension|Withdrawal by Subject|4|||
127504487|NCT03176472|458807988|FG000|Open Label Extension|Adverse Event|2|||
127504488|NCT03176472|458807989|FG001|Open Label Extension|Adverse Event|4|||
127504489|NCT03176472|458807988|FG000|Open Label Extension|Lost to Follow-up|1|||
127504490|NCT03176472|458807989|FG001|Open Label Extension|Lost to Follow-up|2|||
127504491|NCT03176472|458807988|FG000|Open Label Extension|Protocol Violation|0|||
127504492|NCT03176472|458807989|FG001|Open Label Extension|Protocol Violation|1|||
127504493|NCT03176472|458807988|FG000|Open Label Extension|Not Provided|2|||
127504494|NCT03176472|458807989|FG001|Open Label Extension|Not Provided|1|||
127504495|NCT03077438|458807990|FG000|Overall Study|Protocol Violation|3|||
127504496|NCT03077438|458807991|FG001|Overall Study|Protocol Violation|5|||
127504497|NCT03077438|458807990|FG000|Overall Study|Withdrawal by Subject|3|||
127504498|NCT03077438|458807991|FG001|Overall Study|Withdrawal by Subject|6|||
127504499|NCT03077438|458807990|FG000|Overall Study|Lost to Follow-up|6|||
127504500|NCT03077438|458807991|FG001|Overall Study|Lost to Follow-up|3|||
127504501|NCT01190475|458807992|FG000|Overall Study|Withdrawal by Subject|0|||
127504502|NCT01190475|458807993|FG001|Overall Study|Withdrawal by Subject|0|||
127504503|NCT01190475|458807994|FG002|Overall Study|Withdrawal by Subject|1|||
127504504|NCT04154345|458807997|FG000|Overall Study|Covid-19 pandemic|4|||
127504505|NCT03622112|458807999|FG000|Overall Study|Withdrawal by Subject|6|||
127504506|NCT03622112|458808000|FG001|Overall Study|Withdrawal by Subject|2|||
127504507|NCT03622112|458808001|FG002|Overall Study|Withdrawal by Subject|4|||
127504508|NCT03622112|458808002|FG003|Overall Study|Withdrawal by Subject|2|||
127504509|NCT03622112|458808003|FG004|Overall Study|Withdrawal by Subject|1|||
127504510|NCT03622112|458808004|FG005|Overall Study|Withdrawal by Subject|2|||
127504511|NCT03622112|458808005|FG006|Overall Study|Withdrawal by Subject|2|||
127504512|NCT03622112|458807999|FG000|Overall Study|Death|0|||
127504513|NCT03622112|458808000|FG001|Overall Study|Death|0|||
127504514|NCT03622112|458808001|FG002|Overall Study|Death|0|||
127504515|NCT03622112|458808002|FG003|Overall Study|Death|1|||
127504516|NCT03622112|458808003|FG004|Overall Study|Death|0|||
127504517|NCT03622112|458808004|FG005|Overall Study|Death|0|||
127504518|NCT03622112|458808005|FG006|Overall Study|Death|0|||
127504519|NCT03622112|458807999|FG000|Overall Study|Lost to Follow-up|1|||
127504520|NCT03622112|458808000|FG001|Overall Study|Lost to Follow-up|1|||
127504521|NCT03622112|458808001|FG002|Overall Study|Lost to Follow-up|0|||
127504522|NCT03622112|458808002|FG003|Overall Study|Lost to Follow-up|0|||
127504523|NCT03622112|458808003|FG004|Overall Study|Lost to Follow-up|0|||
127504524|NCT03622112|458808004|FG005|Overall Study|Lost to Follow-up|0|||
127504525|NCT03622112|458808005|FG006|Overall Study|Lost to Follow-up|0|||
127504526|NCT03622112|458807999|FG000|Overall Study|Study-specific withdrawal criteria|10|||
127504527|NCT03622112|458808000|FG001|Overall Study|Study-specific withdrawal criteria|8|||
127504528|NCT03622112|458808001|FG002|Overall Study|Study-specific withdrawal criteria|7|||
127504529|NCT03622112|458808002|FG003|Overall Study|Study-specific withdrawal criteria|6|||
127504530|NCT03622112|458808003|FG004|Overall Study|Study-specific withdrawal criteria|4|||
127504531|NCT03622112|458808004|FG005|Overall Study|Study-specific withdrawal criteria|18|||
127504532|NCT03622112|458808005|FG006|Overall Study|Study-specific withdrawal criteria|4|||
127504533|NCT03622112|458807999|FG000|Overall Study|Protocol Violation|2|||
127504534|NCT03622112|458808000|FG001|Overall Study|Protocol Violation|0|||
127504535|NCT03622112|458808001|FG002|Overall Study|Protocol Violation|1|||
127504536|NCT03622112|458808002|FG003|Overall Study|Protocol Violation|1|||
127504537|NCT03622112|458808003|FG004|Overall Study|Protocol Violation|0|||
127504538|NCT03622112|458808004|FG005|Overall Study|Protocol Violation|0|||
127504539|NCT03622112|458808005|FG006|Overall Study|Protocol Violation|0|||
127504540|NCT03622112|458807999|FG000|Overall Study|Adverse Event|6|||
127504541|NCT03622112|458808000|FG001|Overall Study|Adverse Event|8|||
127504542|NCT03622112|458808001|FG002|Overall Study|Adverse Event|4|||
127504543|NCT03622112|458808002|FG003|Overall Study|Adverse Event|11|||
127504544|NCT03622112|458808003|FG004|Overall Study|Adverse Event|4|||
127504545|NCT03622112|458808004|FG005|Overall Study|Adverse Event|20|||
127504546|NCT03622112|458808005|FG006|Overall Study|Adverse Event|2|||
127504547|NCT03622112|458807999|FG000|Overall Study|Reason not specified|0|||
127504548|NCT03622112|458808000|FG001|Overall Study|Reason not specified|1|||
127504549|NCT03622112|458808001|FG002|Overall Study|Reason not specified|0|||
127504550|NCT03622112|458808002|FG003|Overall Study|Reason not specified|1|||
127504551|NCT03622112|458808003|FG004|Overall Study|Reason not specified|1|||
127504552|NCT03622112|458808004|FG005|Overall Study|Reason not specified|2|||
127504553|NCT03622112|458808005|FG006|Overall Study|Reason not specified|1|||
127504554|NCT01694121|458808007|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
127504555|NCT01694121|458808008|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
127504556|NCT00521599|458808009|FG000|Overall Study|Adverse Event|5|||
127504557|NCT00521599|458808010|FG001|Overall Study|Adverse Event|7|||
127504558|NCT00521599|458808011|FG002|Overall Study|Adverse Event|6|||
127504559|NCT00521599|458808009|FG000|Overall Study|Treatment Failure|8|||
127504560|NCT00521599|458808010|FG001|Overall Study|Treatment Failure|9|||
127504561|NCT00521599|458808011|FG002|Overall Study|Treatment Failure|22|||
127504562|NCT00521599|458808009|FG000|Overall Study|Lost to Follow-up|2|||
127504563|NCT00521599|458808010|FG001|Overall Study|Lost to Follow-up|1|||
127504564|NCT00521599|458808011|FG002|Overall Study|Lost to Follow-up|2|||
127504565|NCT00521599|458808009|FG000|Overall Study|Withdrawal by Subject|3|||
127504566|NCT00521599|458808010|FG001|Overall Study|Withdrawal by Subject|5|||
127504567|NCT00521599|458808011|FG002|Overall Study|Withdrawal by Subject|1|||
127504568|NCT00521599|458808009|FG000|Overall Study|Withdrawal by subject treatment related|3|||
127504569|NCT00521599|458808010|FG001|Overall Study|Withdrawal by subject treatment related|1|||
127504570|NCT00521599|458808011|FG002|Overall Study|Withdrawal by subject treatment related|2|||
127504571|NCT00521599|458808009|FG000|Overall Study|Protocol Violation|2|||
127504572|NCT00521599|458808010|FG001|Overall Study|Protocol Violation|4|||
127504573|NCT00521599|458808011|FG002|Overall Study|Protocol Violation|2|||
127978312|NCT02951533|460542508|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
127978313|NCT02951533|460542509|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
127978314|NCT02951533|460542507|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
127978315|NCT02951533|460542508|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
127978316|NCT02951533|460542509|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
127978317|NCT02951533|460542507|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
127978318|NCT02951533|460542508|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
127978319|NCT02951533|460542509|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
127978320|NCT02951533|460542507|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
127978321|NCT02951533|460542508|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
127978322|NCT02951533|460542509|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
127978323|NCT02951533|460542507|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
127978324|NCT02951533|460542508|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
127978325|NCT02951533|460542509|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
127978326|NCT02951533|460542507|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
127978327|NCT02951533|460542508|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
127978328|NCT02951533|460542509|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
127504574|NCT00521599|458808009|FG000|Overall Study|Did not meet protocol eligibility|2|||
127504575|NCT00521599|458808010|FG001|Overall Study|Did not meet protocol eligibility|2|||
127504576|NCT00521599|458808011|FG002|Overall Study|Did not meet protocol eligibility|1|||
127504577|NCT03773133|458808012|FG000|Overall Study|Screen Failure|8|||
127504578|NCT00866047|458808013|FG000|Treatment Period|Progressive disease|13|||
127504579|NCT00866047|458808013|FG000|Treatment Period|Adverse Event|16|||
127504580|NCT00866047|458808013|FG000|Treatment Period|Physician Decision|14|||
127504581|NCT00866047|458808013|FG000|Treatment Period|Withdrawal by Subject|5|||
127978329|NCT02951533|460542507|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
127978330|NCT02951533|460542508|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
127978331|NCT02951533|460542509|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
127504582|NCT00866047|458808013|FG000|Follow-up Period|Lost to Follow-up|5|||
127504583|NCT02928029|458808014|FG000|Overall Study|Withdrawal by Subject|0|||
127504584|NCT02928029|458808015|FG001|Overall Study|Withdrawal by Subject|1|||
127504585|NCT02928029|458808014|FG000|Overall Study|Radiological progression|1|||
127504586|NCT02928029|458808015|FG001|Overall Study|Radiological progression|0|||
127504587|NCT02928029|458808014|FG000|Overall Study|Clinical progression|1|||
127504588|NCT02928029|458808015|FG001|Overall Study|Clinical progression|2|||
127504589|NCT02928029|458808014|FG000|Overall Study|AE not related to clinical progression|1|||
127504590|NCT02928029|458808015|FG001|Overall Study|AE not related to clinical progression|1|||
127504591|NCT01610713|458808016|FG000|Overall Study|Adverse Event|3|||
127504592|NCT01610713|458808017|FG001|Overall Study|Adverse Event|0|||
127504593|NCT01610713|458808016|FG000|Overall Study|Lack of Efficacy|1|||
127504594|NCT01610713|458808017|FG001|Overall Study|Lack of Efficacy|0|||
127504595|NCT01610713|458808016|FG000|Overall Study|low mood and poor motivation|1|||
127504596|NCT01610713|458808017|FG001|Overall Study|low mood and poor motivation|0|||
127504597|NCT01610713|458808016|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
127504598|NCT01610713|458808017|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
127504599|NCT01610713|458808016|FG000|Overall Study|Lost to Follow-up|0|||
127504600|NCT01610713|458808017|FG001|Overall Study|Lost to Follow-up|1|||
127504601|NCT02778555|458808019|FG000|Overall Study|Withdrawal by Subject|55|||
127504602|NCT02778555|458808020|FG001|Overall Study|Withdrawal by Subject|32|||
127504603|NCT02778555|458808021|FG002|Overall Study|Withdrawal by Subject|107|||
127504604|NCT03943550|458808024|FG000|Overall Study|Adverse Event|0|||
127504605|NCT03943550|458808025|FG001|Overall Study|Adverse Event|0|||
127504606|NCT03943550|458808026|FG002|Overall Study|Adverse Event|1|||
127504607|NCT03943550|458808024|FG000|Overall Study|Lost to Follow-up|0|||
127504608|NCT03943550|458808025|FG001|Overall Study|Lost to Follow-up|0|||
127504609|NCT03943550|458808026|FG002|Overall Study|Lost to Follow-up|1|||
127504610|NCT03943550|458808024|FG000|Overall Study|Progressive Disease|0|||
127504611|NCT03943550|458808025|FG001|Overall Study|Progressive Disease|0|||
127978332|NCT02951533|460542507|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
127978333|NCT02951533|460542508|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
127978334|NCT02951533|460542509|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
127978335|NCT02029989|460542510|FG000|Overall Study|Withdrawal by Subject|1|||
127978336|NCT02029989|460542511|FG001|Overall Study|Withdrawal by Subject|0|||
127978337|NCT02029989|460542510|FG000|Overall Study|Withdrawal: Fear of needles|1|||
127978338|NCT02029989|460542511|FG001|Overall Study|Withdrawal: Fear of needles|0|||
127978339|NCT02029989|460542510|FG000|Overall Study|Change of location|2|||
127978340|NCT02029989|460542511|FG001|Overall Study|Change of location|3|||
127978341|NCT02029989|460542510|FG000|Overall Study|Physician Decision|2|||
127978342|NCT02029989|460542511|FG001|Overall Study|Physician Decision|0|||
127978343|NCT02029989|460542510|FG000|Overall Study|Lost to Follow-up|9|||
127978344|NCT02029989|460542511|FG001|Overall Study|Lost to Follow-up|7|||
127978345|NCT02029989|460542510|FG000|Overall Study|Death|0|||
127978346|NCT02029989|460542511|FG001|Overall Study|Death|1|||
127978347|NCT02029989|460542510|FG000|Overall Study|Protocol Violation|1|||
127978348|NCT02029989|460542511|FG001|Overall Study|Protocol Violation|0|||
127978349|NCT03099694|460542526|FG000|Overall Study|Withdrawal by Subject|11|||
127978350|NCT03099694|460542527|FG001|Overall Study|Withdrawal by Subject|13|||
127978351|NCT03099694|460542526|FG000|Overall Study|Lost to Follow-up|9|||
127978352|NCT03099694|460542527|FG001|Overall Study|Lost to Follow-up|5|||
127978353|NCT00471718|460542528|FG000|Overall Study|Adverse Event|3|||
127978354|NCT00471718|460542528|FG000|Overall Study|other complicating disease|1|||
127978355|NCT00471718|460542528|FG000|Overall Study|disease progression|22|||
127978356|NCT00471718|460542528|FG000|Overall Study|Withdrawal by Subject|1|||
127978357|NCT04696354|460542531|FG000|Overall Study|Study termination|6|||
127978358|NCT04696354|460542532|FG001|Overall Study|Study termination|6|||
127978359|NCT00965341|460542533|FG000|Overall Study|Withdrew consent|1|||
127978360|NCT00965341|460542534|FG001|Overall Study|Withdrew consent|5|||
127978361|NCT00965341|460542533|FG000|Overall Study|Lost to Follow-up|1|||
127978362|NCT00965341|460542534|FG001|Overall Study|Lost to Follow-up|0|||
127978363|NCT00965341|460542533|FG000|Overall Study|Transportation issues|4|||
127504612|NCT03943550|458808026|FG002|Overall Study|Progressive Disease|2|||
127504613|NCT03943550|458808024|FG000|Overall Study|Participant Moved Out of the Country|0|||
127504614|NCT03943550|458808025|FG001|Overall Study|Participant Moved Out of the Country|1|||
127504615|NCT03943550|458808026|FG002|Overall Study|Participant Moved Out of the Country|0|||
127504616|NCT03359785|458808027|FG000|Overall Study|Protocol Violation|0|||
127504617|NCT03359785|458808028|FG001|Overall Study|Protocol Violation|1|||
127504618|NCT03359785|458808029|FG002|Overall Study|Protocol Violation|0|||
127978364|NCT00965341|460542534|FG001|Overall Study|Transportation issues|3|||
127978365|NCT00960986|460542540|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
127978366|NCT00960986|460542541|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
127978367|NCT00960986|460542542|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
127978368|NCT00960986|460542543|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
127978369|NCT00960986|460542540|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
127978370|NCT00960986|460542541|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
127978371|NCT00960986|460542542|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
127978372|NCT00960986|460542543|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
127978373|NCT00960986|460542540|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
127978374|NCT00960986|460542541|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
127978375|NCT00960986|460542542|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
127978376|NCT00960986|460542543|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
127978377|NCT00960986|460542540|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
127978378|NCT00960986|460542541|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
127978379|NCT00960986|460542542|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
127978380|NCT00960986|460542543|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
127978381|NCT00960986|460542540|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
127978382|NCT00960986|460542541|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
127978383|NCT00960986|460542542|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
127978384|NCT00960986|460542543|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
127978385|NCT00960986|460542540|FG000|Period 3 (7-week Therapy Period)|Death|0|||
127978386|NCT00960986|460542541|FG001|Period 3 (7-week Therapy Period)|Death|0|||
127978387|NCT00960986|460542542|FG002|Period 3 (7-week Therapy Period)|Death|1|||
127978388|NCT00960986|460542543|FG003|Period 3 (7-week Therapy Period)|Death|0|||
127978389|NCT00960986|460542540|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
127978390|NCT00960986|460542541|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
127978391|NCT00960986|460542542|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
127978392|NCT00960986|460542543|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
127978393|NCT00960986|460542540|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
127978394|NCT00960986|460542541|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
127978395|NCT00960986|460542542|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
127978396|NCT00960986|460542543|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
127978397|NCT00960986|460542540|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
127978398|NCT00960986|460542541|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
127978399|NCT00960986|460542542|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
127978400|NCT00960986|460542543|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
127978401|NCT00960986|460542540|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
127978402|NCT00960986|460542541|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
127978403|NCT00960986|460542542|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
127978404|NCT00960986|460542543|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
127978405|NCT01077739|460542544|FG000|Overall Study|Premature withdrawal|1|||
127978406|NCT01077739|460542545|FG001|Overall Study|Premature withdrawal|3|||
127978407|NCT01077739|460542544|FG000|Overall Study|Withdrawal by Subject|1|||
127978408|NCT01077739|460542545|FG001|Overall Study|Withdrawal by Subject|0|||
127978409|NCT01077739|460542544|FG000|Overall Study|Death|0|||
127978410|NCT01077739|460542545|FG001|Overall Study|Death|3|||
127978411|NCT01077739|460542544|FG000|Overall Study|Unacceptable toxicity|1|||
127978412|NCT01077739|460542545|FG001|Overall Study|Unacceptable toxicity|2|||
127978413|NCT01077739|460542544|FG000|Overall Study|Other|2|||
127978414|NCT01077739|460542545|FG001|Overall Study|Other|2|||
127978415|NCT04464720|460542546|FG000|Pre-Intervention|Intervention (hood retrofit) beyond the scope available in the study, so participation ended.|1|||
127978416|NCT00954512|460542553|FG000|Overall Study|Withdrawal by Subject|0|||
127978417|NCT00954512|460542554|FG001|Overall Study|Withdrawal by Subject|0|||
127978418|NCT00954512|460542555|FG002|Overall Study|Withdrawal by Subject|0|||
127978419|NCT00954512|460542556|FG003|Overall Study|Withdrawal by Subject|0|||
127978420|NCT00954512|460542557|FG004|Overall Study|Withdrawal by Subject|0|||
127978421|NCT00954512|460542558|FG005|Overall Study|Withdrawal by Subject|1|||
127978422|NCT00954512|460542553|FG000|Overall Study|Adverse Event|0|||
127978423|NCT00954512|460542554|FG001|Overall Study|Adverse Event|0|||
127978424|NCT00954512|460542555|FG002|Overall Study|Adverse Event|0|||
127978425|NCT00954512|460542556|FG003|Overall Study|Adverse Event|0|||
127978426|NCT00954512|460542557|FG004|Overall Study|Adverse Event|1|||
127978427|NCT00954512|460542558|FG005|Overall Study|Adverse Event|2|||
127978428|NCT00954512|460542553|FG000|Overall Study|Physician Decision|0|||
127978429|NCT00954512|460542554|FG001|Overall Study|Physician Decision|1|||
127978430|NCT00954512|460542555|FG002|Overall Study|Physician Decision|0|||
127978431|NCT00954512|460542556|FG003|Overall Study|Physician Decision|1|||
127978432|NCT00954512|460542557|FG004|Overall Study|Physician Decision|0|||
127978433|NCT00954512|460542558|FG005|Overall Study|Physician Decision|0|||
127978434|NCT00954512|460542553|FG000|Overall Study|Symptomatic Deterioration|0|||
127978435|NCT00954512|460542554|FG001|Overall Study|Symptomatic Deterioration|1|||
127978436|NCT00954512|460542555|FG002|Overall Study|Symptomatic Deterioration|0|||
127978437|NCT00954512|460542556|FG003|Overall Study|Symptomatic Deterioration|0|||
127978438|NCT00954512|460542557|FG004|Overall Study|Symptomatic Deterioration|2|||
127978439|NCT00954512|460542558|FG005|Overall Study|Symptomatic Deterioration|0|||
127978440|NCT00954512|460542553|FG000|Overall Study|Progression of Disease|2|||
127978441|NCT00954512|460542554|FG001|Overall Study|Progression of Disease|1|||
127978442|NCT00954512|460542555|FG002|Overall Study|Progression of Disease|0|||
127978443|NCT00954512|460542556|FG003|Overall Study|Progression of Disease|1|||
127978444|NCT00954512|460542557|FG004|Overall Study|Progression of Disease|1|||
127978445|NCT00954512|460542558|FG005|Overall Study|Progression of Disease|1|||
127978446|NCT01794793|460542559|FG000|Treatment Period|Withdrawal by Subject|24|||
127978447|NCT01794793|460542559|FG000|Treatment Period|Lack of Efficacy|22|||
127978448|NCT01794793|460542559|FG000|Treatment Period|Adverse Event|17|||
127978449|NCT01794793|460542559|FG000|Treatment Period|Physician Decision|14|||
127978450|NCT01794793|460542559|FG000|Treatment Period|Lost to Follow-up|7|||
127978451|NCT01794793|460542559|FG000|Treatment Period|Death|6|||
127978452|NCT01794793|460542559|FG000|Treatment Period|Protocol Violation|5|||
127978453|NCT01794793|460542559|FG000|Treatment Period|administrative problem|3|||
127978454|NCT01794793|460542559|FG000|Post-treatment Follow-up|Lack of Efficacy|14|||
127978455|NCT01794793|460542559|FG000|Post-treatment Follow-up|Adverse Event|8|||
127978456|NCT01794793|460542559|FG000|Post-treatment Follow-up|Withdrawal by Subject|6|||
127978457|NCT01794793|460542559|FG000|Post-treatment Follow-up|administrative problem|5|||
127978458|NCT01794793|460542559|FG000|Post-treatment Follow-up|Lost to Follow-up|3|||
127978459|NCT01794793|460542559|FG000|Post-treatment Follow-up|Protocol Violation|3|||
127978460|NCT03495154|460542560|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
127978461|NCT03495154|460542560|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
127978462|NCT03495154|460542560|FG000|Overall Study|Screen Failures During Surgery|6|||
127978463|NCT03495154|460542560|FG000|Overall Study|Death|2|||
127978464|NCT03495154|460542560|FG000|Overall Study|Lost to Follow-up|16|||
127978465|NCT03495154|460542560|FG000|Overall Study|Withdrawal by Subject|2|||
127978466|NCT03495154|460542560|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
127978467|NCT05685732|460542561|FG000|Overall Study|Withdrawal by Subject|2|||
127978468|NCT05685732|460542562|FG001|Overall Study|Withdrawal by Subject|0|||
127978469|NCT05685732|460542563|FG002|Overall Study|Withdrawal by Subject|2|||
127978470|NCT05685732|460542564|FG003|Overall Study|Withdrawal by Subject|3|||
127978471|NCT05685732|460542561|FG000|Overall Study|Protocol Violation|1|||
127978472|NCT05685732|460542562|FG001|Overall Study|Protocol Violation|2|||
127978473|NCT05685732|460542563|FG002|Overall Study|Protocol Violation|4|||
127978474|NCT05685732|460542564|FG003|Overall Study|Protocol Violation|1|||
127978475|NCT05685732|460542561|FG000|Overall Study|Lost to Follow-up|5|||
127978476|NCT05685732|460542562|FG001|Overall Study|Lost to Follow-up|1|||
127978477|NCT05685732|460542563|FG002|Overall Study|Lost to Follow-up|3|||
127978478|NCT05685732|460542564|FG003|Overall Study|Lost to Follow-up|1|||
127978479|NCT05685732|460542561|FG000|Overall Study|Adverse Event|2|||
127978480|NCT05685732|460542562|FG001|Overall Study|Adverse Event|1|||
127978481|NCT05685732|460542563|FG002|Overall Study|Adverse Event|0|||
127978482|NCT05685732|460542564|FG003|Overall Study|Adverse Event|0|||
127978483|NCT05685732|460542561|FG000|Overall Study|Physician Decision|1|||
127978484|NCT05685732|460542562|FG001|Overall Study|Physician Decision|0|||
127978485|NCT05685732|460542563|FG002|Overall Study|Physician Decision|0|||
127978486|NCT05685732|460542564|FG003|Overall Study|Physician Decision|0|||
127978487|NCT02640404|460542565|FG000|Overall Study|Protocol Violation|1|||
127978488|NCT02640404|460542566|FG001|Overall Study|Protocol Violation|0|||
127978489|NCT02640404|460542565|FG000|Overall Study|Withdrawal by Subject|1|||
127978490|NCT02640404|460542566|FG001|Overall Study|Withdrawal by Subject|0|||
127978491|NCT05397171|460542567|FG000|Overall Study|Death|2|||
127504619|NCT03359785|458808030|FG003|Overall Study|Protocol Violation|0|||
127504620|NCT03359785|458808027|FG000|Overall Study|Early study termination due to study pause|0|||
127504621|NCT03359785|458808028|FG001|Overall Study|Early study termination due to study pause|0|||
127504622|NCT03359785|458808029|FG002|Overall Study|Early study termination due to study pause|2|||
127504623|NCT03359785|458808030|FG003|Overall Study|Early study termination due to study pause|0|||
127504624|NCT03359785|458808027|FG000|Overall Study|Withdrawal by Subject|2|||
127504625|NCT03359785|458808028|FG001|Overall Study|Withdrawal by Subject|2|||
127504626|NCT03359785|458808029|FG002|Overall Study|Withdrawal by Subject|0|||
127978492|NCT05397171|460542568|FG001|Overall Study|Death|3|||
127978493|NCT05397171|460542569|FG002|Overall Study|Death|3|||
127978494|NCT05397171|460542567|FG000|Overall Study|Study Terminated By Sponsor|1|||
127978495|NCT05397171|460542568|FG001|Overall Study|Study Terminated By Sponsor|2|||
127978496|NCT05397171|460542569|FG002|Overall Study|Study Terminated By Sponsor|3|||
127978497|NCT05397171|460542567|FG000|Overall Study|Withdrawal by Subject|0|||
127978498|NCT05397171|460542568|FG001|Overall Study|Withdrawal by Subject|1|||
127504627|NCT03359785|458808030|FG003|Overall Study|Withdrawal by Subject|0|||
127978499|NCT05397171|460542569|FG002|Overall Study|Withdrawal by Subject|1|||
127504628|NCT01895543|458808031|FG000|Overall Study|Withdrawal by Subject|43|||
127504629|NCT01895543|458808031|FG000|Overall Study|Lost to Follow-up|25|||
127504630|NCT01895543|458808031|FG000|Overall Study|Adverse Event|28|||
127504631|NCT01895543|458808031|FG000|Overall Study|Subject's substantial non-compliance|6|||
127504632|NCT01895543|458808031|FG000|Overall Study|Protocol Violation|1|||
127504633|NCT01895543|458808031|FG000|Overall Study|Physician Decision|2|||
127504634|NCT01895543|458808031|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
127504635|NCT03650803|458808035|FG000|Overall Study|Lost to Follow-up|6|||
127504636|NCT02901054|458808039|FG000|Overall Study|Physician Decision|1|||
127504637|NCT02901054|458808039|FG000|Overall Study|Withdrawal by Subject|3|||
127504638|NCT01534260|458808040|FG000|Overall Study|Adverse Event|1|||
127504639|NCT01534260|458808041|FG001|Overall Study|Adverse Event|8|||
127504640|NCT01534260|458808040|FG000|Overall Study|Death|2|||
127504641|NCT01534260|458808041|FG001|Overall Study|Death|0|||
127504642|NCT01534260|458808040|FG000|Overall Study|Lack of Efficacy|1|||
127504643|NCT01534260|458808041|FG001|Overall Study|Lack of Efficacy|1|||
127504644|NCT01534260|458808040|FG000|Overall Study|Withdrawal by Subject|1|||
127504645|NCT01534260|458808041|FG001|Overall Study|Withdrawal by Subject|3|||
127504646|NCT01534260|458808040|FG000|Overall Study|Disease Progression|8|||
127504647|NCT01534260|458808041|FG001|Overall Study|Disease Progression|6|||
127504648|NCT01534260|458808040|FG000|Overall Study|Physician Decision|3|||
127504649|NCT01534260|458808041|FG001|Overall Study|Physician Decision|1|||
127504650|NCT01534260|458808040|FG000|Overall Study|No treatment, per protocol|0|||
127504651|NCT01534260|458808041|FG001|Overall Study|No treatment, per protocol|1|||
127504652|NCT05145322|458808044|FG000|Overall Study|Lost to Follow-up|4|||
127504653|NCT05145322|458808045|FG001|Overall Study|Lost to Follow-up|5|||
127504654|NCT05593913|458808046|FG000|Overall Study|Insufficient image quality|39|||
127504655|NCT02979093|458808049|FG000|First Scan Session|Scanning data problems|1|||
127504656|NCT02979093|458808050|FG001|First Scan Session|Scanning data problems|2|||
127504657|NCT02979093|458808051|FG002|First Scan Session|Scanning data problems|2|||
127504658|NCT02979093|458808052|FG003|First Scan Session|Scanning data problems|0|||
127504659|NCT02979093|458808049|FG000|Second Scan Session|Scanning data problems|3|||
127504660|NCT02979093|458808050|FG001|Second Scan Session|Scanning data problems|0|||
127504661|NCT02979093|458808051|FG002|Second Scan Session|Scanning data problems|1|||
127504662|NCT02979093|458808052|FG003|Second Scan Session|Scanning data problems|3|||
127504663|NCT03099174|458808053|FG000|Overall Study|Withdrawal by Subject|0|||
127504664|NCT03099174|458808054|FG001|Overall Study|Withdrawal by Subject|0|||
127504665|NCT03099174|458808055|FG002|Overall Study|Withdrawal by Subject|1|||
127504666|NCT03099174|458808056|FG003|Overall Study|Withdrawal by Subject|0|||
127504667|NCT03099174|458808057|FG004|Overall Study|Withdrawal by Subject|2|||
127504668|NCT03099174|458808058|FG005|Overall Study|Withdrawal by Subject|2|||
127504669|NCT03099174|458808059|FG006|Overall Study|Withdrawal by Subject|1|||
127504670|NCT03099174|458808060|FG007|Overall Study|Withdrawal by Subject|4|||
127504671|NCT03099174|458808053|FG000|Overall Study|Adverse Event|0|||
127504672|NCT03099174|458808054|FG001|Overall Study|Adverse Event|1|||
127504673|NCT03099174|458808055|FG002|Overall Study|Adverse Event|1|||
127504674|NCT03099174|458808056|FG003|Overall Study|Adverse Event|2|||
127504675|NCT03099174|458808057|FG004|Overall Study|Adverse Event|5|||
127504676|NCT03099174|458808058|FG005|Overall Study|Adverse Event|3|||
127504677|NCT03099174|458808059|FG006|Overall Study|Adverse Event|6|||
127504678|NCT03099174|458808060|FG007|Overall Study|Adverse Event|4|||
127504679|NCT03099174|458808053|FG000|Overall Study|Other than listed|6|||
127504680|NCT03099174|458808054|FG001|Overall Study|Other than listed|6|||
127504681|NCT03099174|458808055|FG002|Overall Study|Other than listed|5|||
127504682|NCT03099174|458808056|FG003|Overall Study|Other than listed|6|||
127504683|NCT03099174|458808057|FG004|Overall Study|Other than listed|19|||
127504684|NCT03099174|458808058|FG005|Overall Study|Other than listed|10|||
127504685|NCT03099174|458808059|FG006|Overall Study|Other than listed|26|||
127504686|NCT03099174|458808060|FG007|Overall Study|Other than listed|23|||
127504687|NCT04173260|458808061|FG000|Overall Study|Early termination|4|||
127504688|NCT01096368|458808062|FG000|Overall Study|Death|0|||
127504689|NCT01096368|458808063|FG001|Overall Study|Death|1|||
127504690|NCT01096368|458808064|FG002|Overall Study|Death|0|||
127504691|NCT01096368|458808065|FG003|Overall Study|Death|0|||
127504692|NCT01096368|458808066|FG004|Overall Study|Death|0|||
127504693|NCT01096368|458808062|FG000|Overall Study|Physician Decision|0|||
127504694|NCT01096368|458808063|FG001|Overall Study|Physician Decision|13|||
127504695|NCT01096368|458808064|FG002|Overall Study|Physician Decision|2|||
127504696|NCT01096368|458808065|FG003|Overall Study|Physician Decision|4|||
127504697|NCT01096368|458808066|FG004|Overall Study|Physician Decision|6|||
127504698|NCT01096368|458808062|FG000|Overall Study|Withdrawal by Subject|0|||
127504699|NCT01096368|458808063|FG001|Overall Study|Withdrawal by Subject|52|||
127504700|NCT01096368|458808064|FG002|Overall Study|Withdrawal by Subject|0|||
127504701|NCT01096368|458808065|FG003|Overall Study|Withdrawal by Subject|10|||
127504702|NCT01096368|458808066|FG004|Overall Study|Withdrawal by Subject|14|||
127504703|NCT01096368|458808062|FG000|Overall Study|Ineligible|0|||
127504704|NCT01096368|458808063|FG001|Overall Study|Ineligible|3|||
127504705|NCT01096368|458808064|FG002|Overall Study|Ineligible|2|||
127504706|NCT01096368|458808065|FG003|Overall Study|Ineligible|0|||
127504707|NCT01096368|458808066|FG004|Overall Study|Ineligible|25|||
127504708|NCT01096368|458808062|FG000|Overall Study|Did not start treatment|0|||
127504709|NCT01096368|458808063|FG001|Overall Study|Did not start treatment|4|||
127504710|NCT01096368|458808064|FG002|Overall Study|Did not start treatment|4|||
127504711|NCT01096368|458808065|FG003|Overall Study|Did not start treatment|0|||
127504712|NCT01096368|458808066|FG004|Overall Study|Did not start treatment|0|||
127504713|NCT01096368|458808062|FG000|Overall Study|Progressive disease|0|||
127504714|NCT01096368|458808063|FG001|Overall Study|Progressive disease|6|||
127504715|NCT01096368|458808064|FG002|Overall Study|Progressive disease|0|||
127504716|NCT01096368|458808065|FG003|Overall Study|Progressive disease|10|||
127504717|NCT01096368|458808066|FG004|Overall Study|Progressive disease|3|||
127504718|NCT01096368|458808062|FG000|Overall Study|Other|0|||
127504719|NCT01096368|458808063|FG001|Overall Study|Other|0|||
127504720|NCT01096368|458808064|FG002|Overall Study|Other|1|||
127504721|NCT01096368|458808065|FG003|Overall Study|Other|0|||
127504722|NCT01096368|458808066|FG004|Overall Study|Other|0|||
127504723|NCT01096368|458808062|FG000|Overall Study|Treated with institutional review|0|||
127504724|NCT01096368|458808063|FG001|Overall Study|Treated with institutional review|0|||
127504725|NCT01096368|458808064|FG002|Overall Study|Treated with institutional review|0|||
127504726|NCT01096368|458808065|FG003|Overall Study|Treated with institutional review|0|||
127504727|NCT01096368|458808066|FG004|Overall Study|Treated with institutional review|1|||
127504728|NCT03070223|458808067|FG000|Overall Study|Lost to Follow-up|34|||
127504729|NCT03070223|458808068|FG001|Overall Study|Lost to Follow-up|27|||
127504730|NCT03070223|458808067|FG000|Overall Study|Withdrawal by Subject|12|||
127504731|NCT03070223|458808068|FG001|Overall Study|Withdrawal by Subject|22|||
127504732|NCT03070223|458808067|FG000|Overall Study|Protocol Violation|0|||
127504733|NCT03070223|458808068|FG001|Overall Study|Protocol Violation|1|||
127504734|NCT02308163|458808069|FG000|Overall Study|Not fulfill eligible criteria|1|||
127504735|NCT02308163|458808070|FG001|Overall Study|Not fulfill eligible criteria|2|||
127504736|NCT02308163|458808071|FG002|Overall Study|Not fulfill eligible criteria|0|||
127504737|NCT02308163|458808072|FG003|Overall Study|Not fulfill eligible criteria|1|||
127504738|NCT02308163|458808073|FG004|Overall Study|Not fulfill eligible criteria|1|||
127504739|NCT02308163|458808069|FG000|Overall Study|Adverse Event|9|||
127504740|NCT02308163|458808070|FG001|Overall Study|Adverse Event|5|||
127504741|NCT02308163|458808071|FG002|Overall Study|Adverse Event|2|||
127504742|NCT02308163|458808072|FG003|Overall Study|Adverse Event|2|||
127504743|NCT02308163|458808073|FG004|Overall Study|Adverse Event|11|||
127504744|NCT02308163|458808069|FG000|Overall Study|Lack of Efficacy|11|||
127504745|NCT02308163|458808070|FG001|Overall Study|Lack of Efficacy|3|||
127504746|NCT02308163|458808071|FG002|Overall Study|Lack of Efficacy|8|||
127504747|NCT02308163|458808072|FG003|Overall Study|Lack of Efficacy|4|||
127504748|NCT02308163|458808073|FG004|Overall Study|Lack of Efficacy|6|||
127504749|NCT02308163|458808069|FG000|Overall Study|Withdrawal of consent|2|||
127504750|NCT02308163|458808070|FG001|Overall Study|Withdrawal of consent|3|||
127504751|NCT02308163|458808071|FG002|Overall Study|Withdrawal of consent|0|||
127504752|NCT02308163|458808072|FG003|Overall Study|Withdrawal of consent|2|||
127504753|NCT02308163|458808073|FG004|Overall Study|Withdrawal of consent|6|||
127504754|NCT02308163|458808069|FG000|Overall Study|Protocol Violation|3|||
127504755|NCT02308163|458808070|FG001|Overall Study|Protocol Violation|3|||
127504756|NCT02308163|458808071|FG002|Overall Study|Protocol Violation|3|||
127504757|NCT02308163|458808072|FG003|Overall Study|Protocol Violation|2|||
127504758|NCT02308163|458808073|FG004|Overall Study|Protocol Violation|5|||
127504759|NCT02308163|458808069|FG000|Overall Study|Lab data met discontinuation criteria|3|||
127504760|NCT02308163|458808070|FG001|Overall Study|Lab data met discontinuation criteria|0|||
127504761|NCT02308163|458808071|FG002|Overall Study|Lab data met discontinuation criteria|0|||
127978516|NCT02234596|460542572|FG000|Overall Study|Participant not treated|2|||
127978517|NCT05903924|460544068|FG000|Overall Study|Lost to Follow-up|1|||
127978518|NCT05903924|460544069|FG001|Overall Study|Lost to Follow-up|0|||
127978519|NCT05903924|460544070|FG002|Overall Study|Lost to Follow-up|0|||
127978520|NCT04166591|460544074|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
127978521|NCT04166591|460544075|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
127978522|NCT04166591|460544076|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
127504762|NCT02308163|458808072|FG003|Overall Study|Lab data met discontinuation criteria|2|||
127504763|NCT02308163|458808073|FG004|Overall Study|Lab data met discontinuation criteria|0|||
127504764|NCT02308163|458808069|FG000|Overall Study|Miscellaneous|2|||
127504765|NCT02308163|458808070|FG001|Overall Study|Miscellaneous|2|||
127504766|NCT02308163|458808071|FG002|Overall Study|Miscellaneous|1|||
127504767|NCT02308163|458808072|FG003|Overall Study|Miscellaneous|0|||
127504768|NCT02308163|458808073|FG004|Overall Study|Miscellaneous|5|||
127504769|NCT03941964|458808078|FG000|Overall Study|Adverse Event|1|||
127504770|NCT03941964|458808079|FG001|Overall Study|Adverse Event|8|||
127504771|NCT03941964|458808078|FG000|Overall Study|Progressive disease|7|||
127504772|NCT03941964|458808079|FG001|Overall Study|Progressive disease|3|||
127504773|NCT03941964|458808078|FG000|Overall Study|Lack of Efficacy|0|||
127504774|NCT03941964|458808079|FG001|Overall Study|Lack of Efficacy|1|||
127504775|NCT03941964|458808078|FG000|Overall Study|Death|3|||
127504776|NCT03941964|458808079|FG001|Overall Study|Death|1|||
127504777|NCT03941964|458808078|FG000|Overall Study|Withdrew consent|1|||
127504778|NCT03941964|458808079|FG001|Overall Study|Withdrew consent|3|||
127504779|NCT03941964|458808078|FG000|Overall Study|Physician Decision|9|||
127504780|NCT03941964|458808079|FG001|Overall Study|Physician Decision|2|||
127504781|NCT03941964|458808078|FG000|Overall Study|Other, not specified|2|||
127504782|NCT03941964|458808079|FG001|Overall Study|Other, not specified|1|||
127504783|NCT02684058|458808080|FG000|Treatment Period|Progressive disease|4|||
127504784|NCT02684058|458808081|FG001|Treatment Period|Progressive disease|10|||
127504785|NCT02684058|458808082|FG002|Treatment Period|Progressive disease|19|||
127504786|NCT02684058|458808080|FG000|Treatment Period|Adverse Event|3|||
127504787|NCT02684058|458808081|FG001|Treatment Period|Adverse Event|8|||
127504788|NCT02684058|458808082|FG002|Treatment Period|Adverse Event|1|||
127504789|NCT02684058|458808080|FG000|Treatment Period|Physician Decision|5|||
127504790|NCT02684058|458808081|FG001|Treatment Period|Physician Decision|1|||
127978523|NCT04166591|460544077|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
127978524|NCT04166591|460544074|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
127978525|NCT04166591|460544075|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
127978526|NCT04166591|460544076|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
127978527|NCT04166591|460544077|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
127978528|NCT02203851|460544080|FG000|Overall Study|Lost to Follow-up|4|||
127978529|NCT02203851|460544080|FG000|Overall Study|Withdrawal by Subject|6|||
127978530|NCT02203851|460544080|FG000|Overall Study|Other|1|||
127978531|NCT04045132|460544083|FG000|Overall Study|Lost to Follow-up|3|||
127978532|NCT04045132|460544084|FG001|Overall Study|Lost to Follow-up|6|||
127978533|NCT01632150|460544086|FG000|Overall Study|Disease progression|27|||
127978534|NCT01632150|460544086|FG000|Overall Study|Study drug toxicity|1|||
127978535|NCT01632150|460544086|FG000|Overall Study|Unrelated adverse event|7|||
127978536|NCT01632150|460544086|FG000|Overall Study|Withdrawal by Subject|2|||
127978537|NCT01632150|460544086|FG000|Overall Study|Patient underwent autologous transplant|1|||
127978538|NCT01632150|460544086|FG000|Overall Study|Moved to compassionate program|2|||
127978539|NCT02143791|460544087|FG000|Enrolled|Withdrawal by Subject|4|||
127978540|NCT02143791|460544087|FG000|Trial Stimulation|Lack of Efficacy|21|||
127978541|NCT02143791|460544087|FG000|Burst Stimulation Only (3 Months)|Withdrawal by Subject|4|||
127978542|NCT02143791|460544087|FG000|Burst Stimulation Only (3 Months)|Missing Data|4|||
127978543|NCT02143791|460544087|FG000|Any Programming (3-6 Months)|Withdrawal by Subject|3|||
127978544|NCT02143791|460544087|FG000|Any Programming (3-6 Months)|Missing Data|1|||
127978545|NCT02143791|460544087|FG000|Any Program (6-12 Months)|Withdrawal by Subject|2|||
127978546|NCT00401544|460544088|FG000|Overall Study|Adverse Event|5|||
127978547|NCT00401544|460544089|FG001|Overall Study|Adverse Event|1|||
127978548|NCT00401544|460544090|FG002|Overall Study|Adverse Event|1|||
127978549|NCT00401544|460544091|FG003|Overall Study|Adverse Event|1|||
127978550|NCT00401544|460544088|FG000|Overall Study|Death|3|||
127978551|NCT00401544|460544089|FG001|Overall Study|Death|6|||
127978552|NCT00401544|460544090|FG002|Overall Study|Death|2|||
127978553|NCT00401544|460544091|FG003|Overall Study|Death|5|||
127978554|NCT00401544|460544088|FG000|Overall Study|Lost to Follow-up|2|||
127978555|NCT00401544|460544089|FG001|Overall Study|Lost to Follow-up|0|||
127978556|NCT00401544|460544090|FG002|Overall Study|Lost to Follow-up|1|||
127978557|NCT00401544|460544091|FG003|Overall Study|Lost to Follow-up|1|||
127978558|NCT00401544|460544088|FG000|Overall Study|Withdrawal by Subject|7|||
127978559|NCT00401544|460544089|FG001|Overall Study|Withdrawal by Subject|6|||
127978560|NCT00401544|460544090|FG002|Overall Study|Withdrawal by Subject|6|||
127978561|NCT00401544|460544091|FG003|Overall Study|Withdrawal by Subject|5|||
127978562|NCT00401544|460544088|FG000|Overall Study|Physician Decision|1|||
127978563|NCT00401544|460544089|FG001|Overall Study|Physician Decision|3|||
127978564|NCT00401544|460544090|FG002|Overall Study|Physician Decision|0|||
127978565|NCT00401544|460544091|FG003|Overall Study|Physician Decision|0|||
127978566|NCT00401544|460544088|FG000|Overall Study|Ineligibility determined|0|||
127978567|NCT00401544|460544089|FG001|Overall Study|Ineligibility determined|1|||
127978568|NCT00401544|460544090|FG002|Overall Study|Ineligibility determined|0|||
127978569|NCT00401544|460544091|FG003|Overall Study|Ineligibility determined|2|||
127978570|NCT00401544|460544088|FG000|Overall Study|Disease progression|0|||
127978571|NCT00401544|460544089|FG001|Overall Study|Disease progression|1|||
127978572|NCT00401544|460544090|FG002|Overall Study|Disease progression|0|||
127978573|NCT00401544|460544091|FG003|Overall Study|Disease progression|0|||
127978574|NCT00401544|460544088|FG000|Overall Study|Other|0|||
127978575|NCT00401544|460544089|FG001|Overall Study|Other|0|||
127978576|NCT00401544|460544090|FG002|Overall Study|Other|2|||
127504791|NCT02684058|458808082|FG002|Treatment Period|Physician Decision|2|||
127504792|NCT02684058|458808080|FG000|Treatment Period|New therapy for study indication|1|||
127504793|NCT02684058|458808081|FG001|Treatment Period|New therapy for study indication|0|||
127504794|NCT02684058|458808082|FG002|Treatment Period|New therapy for study indication|0|||
127504795|NCT02684058|458808080|FG000|Treatment Period|Protocol deviation|0|||
127504796|NCT02684058|458808081|FG001|Treatment Period|Protocol deviation|1|||
127504797|NCT02684058|458808082|FG002|Treatment Period|Protocol deviation|0|||
127504798|NCT02684058|458808080|FG000|Treatment Period|Subject/guardian decision|4|||
127504799|NCT02684058|458808081|FG001|Treatment Period|Subject/guardian decision|3|||
127504800|NCT02684058|458808082|FG002|Treatment Period|Subject/guardian decision|0|||
127504801|NCT02684058|458808080|FG000|Treatment Period|Death|0|||
127504802|NCT02684058|458808081|FG001|Treatment Period|Death|0|||
127504803|NCT02684058|458808082|FG002|Treatment Period|Death|2|||
127504804|NCT02684058|458808080|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
127504805|NCT02684058|458808081|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
127504806|NCT02684058|458808082|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
127504807|NCT02684058|458808080|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
127504808|NCT02684058|458808081|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
127504809|NCT02684058|458808082|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
127504810|NCT02684058|458808080|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
127504811|NCT02684058|458808081|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
127504812|NCT02684058|458808082|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
127504813|NCT02684058|458808080|FG000|Post-treatment Efficacy Follow-up|Death|0|||
127504814|NCT02684058|458808081|FG001|Post-treatment Efficacy Follow-up|Death|0|||
127504815|NCT02684058|458808082|FG002|Post-treatment Efficacy Follow-up|Death|3|||
127504816|NCT02684058|458808080|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
127504817|NCT02684058|458808081|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
127504818|NCT02684058|458808082|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
127504819|NCT02684058|458808080|FG000|Post-treatment Survival Follow-up|Death|0|||
127504820|NCT02684058|458808081|FG001|Post-treatment Survival Follow-up|Death|0|||
127504821|NCT02684058|458808082|FG002|Post-treatment Survival Follow-up|Death|7|||
127504822|NCT02684058|458808080|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
127504823|NCT02684058|458808081|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
127504824|NCT02684058|458808082|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
127504825|NCT02684058|458808080|FG000|Crossover Treatment Period|Progressive disease|0|||
127504826|NCT02684058|458808081|FG001|Crossover Treatment Period|Progressive disease|1|||
127504827|NCT02684058|458808082|FG002|Crossover Treatment Period|Progressive disease|0|||
127504828|NCT05151445|458808086|FG000|Overall Study|Withdrawal by Subject|3|||
127504829|NCT01330628|458808088|FG000|Overall Study|Death|2|||
127504830|NCT01330628|458808089|FG001|Overall Study|Death|3|||
127504831|NCT01330628|458808088|FG000|Overall Study|Lost to Follow-up|5|||
127504832|NCT01330628|458808089|FG001|Overall Study|Lost to Follow-up|6|||
127504833|NCT01330628|458808088|FG000|Overall Study|Adverse Event|44|||
127504834|NCT01330628|458808089|FG001|Overall Study|Adverse Event|25|||
127504835|NCT01330628|458808088|FG000|Overall Study|Withdrawn|18|||
127504836|NCT01330628|458808089|FG001|Overall Study|Withdrawn|6|||
127504837|NCT01330628|458808088|FG000|Overall Study|Didn't receive study treatment|1|||
127504838|NCT01330628|458808089|FG001|Overall Study|Didn't receive study treatment|0|||
127504839|NCT05599451|458809625|FG000|Overall Study|Not randomized|11|||
127504840|NCT05599451|458809626|FG001|Overall Study|Not randomized|0|||
127504841|NCT05599451|458809627|FG002|Overall Study|Not randomized|0|||
127504842|NCT05599451|458809628|FG003|Overall Study|Not randomized|0|||
127978577|NCT00401544|460544091|FG003|Overall Study|Other|2|||
127978578|NCT04186806|460544103|FG000|Period 1: 7 Days|Adverse Event|1|||
127978579|NCT04186806|460544104|FG001|Period 1: 7 Days|Adverse Event|0|||
127978580|NCT04739722|460544109|FG000|Overall Study|Lost to Follow-up|5301|||
127978581|NCT04739722|460544109|FG000|Overall Study|Withdrawal by Subject|42|||
127978582|NCT04739722|460544109|FG000|Overall Study|Non Average-risk|1157|||
127978583|NCT01185509|460544113|FG000|Overall Study|Progression/Relapse|9|||
127978584|NCT01185509|460544114|FG001|Overall Study|Progression/Relapse|15|||
127978585|NCT01185509|460544113|FG000|Overall Study|Physician Decision|2|||
127978586|NCT01185509|460544114|FG001|Overall Study|Physician Decision|2|||
127978587|NCT01185509|460544113|FG000|Overall Study|Withdrawal by Subject|0|||
127978588|NCT01185509|460544114|FG001|Overall Study|Withdrawal by Subject|1|||
127978589|NCT01185509|460544113|FG000|Overall Study|Death|0|||
127978590|NCT01185509|460544114|FG001|Overall Study|Death|1|||
127978591|NCT01185509|460544113|FG000|Overall Study|Intercurrent Illness|0|||
127978592|NCT01185509|460544114|FG001|Overall Study|Intercurrent Illness|1|||
127978593|NCT03687372|460544115|FG000|Overall Study|Lost to Follow-up|12|||
127978594|NCT03687372|460544116|FG001|Overall Study|Lost to Follow-up|21|||
127504843|NCT05599451|458809629|FG004|Overall Study|Not randomized|0|||
127504844|NCT05599451|458809625|FG000|Overall Study|Physician Decision|0|||
127504845|NCT05599451|458809626|FG001|Overall Study|Physician Decision|0|||
127504846|NCT05599451|458809627|FG002|Overall Study|Physician Decision|0|||
127504847|NCT05599451|458809628|FG003|Overall Study|Physician Decision|1|||
127978595|NCT03687372|460544115|FG000|Overall Study|Withdrawal by Subject|4|||
127504848|NCT05599451|458809629|FG004|Overall Study|Physician Decision|0|||
127504849|NCT00496483|458809630|FG000|Overall Study|Not dosed|9|||
127978596|NCT03687372|460544116|FG001|Overall Study|Withdrawal by Subject|17|||
127504850|NCT00496483|458809630|FG000|Overall Study|Adverse Event|2|||
127504851|NCT00496483|458809630|FG000|Overall Study|Lack of Efficacy|1|||
127504852|NCT01730339|458809633|FG000|Overall Study|Withdrawal by Subject|3|||
127504853|NCT01730339|458809634|FG001|Overall Study|Withdrawal by Subject|2|||
127504854|NCT01730339|458809633|FG000|Overall Study|Lost to Follow-up|1|||
127504855|NCT01730339|458809634|FG001|Overall Study|Lost to Follow-up|1|||
127504856|NCT01730339|458809633|FG000|Overall Study|Un-specified|1|||
127504857|NCT01730339|458809634|FG001|Overall Study|Un-specified|0|||
127504858|NCT03095027|458809635|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
127504859|NCT03095027|458809636|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
127504860|NCT04143217|458809637|FG000|Overall Study|Withdrawal by Subject|42|||
127504861|NCT04143217|458809637|FG000|Overall Study|Adverse Event|29|||
127504862|NCT04143217|458809637|FG000|Overall Study|Lost to Follow-up|29|||
127504863|NCT04143217|458809637|FG000|Overall Study|Lack of Efficacy|15|||
127504864|NCT04143217|458809637|FG000|Overall Study|Physician Decision|1|||
127504865|NCT04143217|458809637|FG000|Overall Study|Non-Compliance With Study Drug|6|||
127504866|NCT04143217|458809637|FG000|Overall Study|Other, Multiple Categories|11|||
127504867|NCT01962987|458809640|FG000|Overall Study|Adverse Event|4|||
127504868|NCT01962987|458809641|FG001|Overall Study|Adverse Event|4|||
127504869|NCT01962987|458809642|FG002|Overall Study|Adverse Event|0|||
127504870|NCT01962987|458809640|FG000|Overall Study|Lost to Follow-up|0|||
127504871|NCT01962987|458809641|FG001|Overall Study|Lost to Follow-up|0|||
127504872|NCT01962987|458809642|FG002|Overall Study|Lost to Follow-up|1|||
127504873|NCT01962987|458809640|FG000|Overall Study|Non compliance with dosing requirements|4|||
127504874|NCT01962987|458809641|FG001|Overall Study|Non compliance with dosing requirements|2|||
127504875|NCT01962987|458809642|FG002|Overall Study|Non compliance with dosing requirements|0|||
127504876|NCT01962987|458809640|FG000|Overall Study|Miscellaneous|1|||
127504877|NCT01962987|458809641|FG001|Overall Study|Miscellaneous|9|||
127504878|NCT01962987|458809642|FG002|Overall Study|Miscellaneous|2|||
127504879|NCT01962987|458809640|FG000|Overall Study|Restricted medication|5|||
127504880|NCT01962987|458809641|FG001|Overall Study|Restricted medication|1|||
127504881|NCT01962987|458809642|FG002|Overall Study|Restricted medication|1|||
127504882|NCT01962987|458809640|FG000|Overall Study|Serious Adverse Event|1|||
127504883|NCT01962987|458809641|FG001|Overall Study|Serious Adverse Event|0|||
127504884|NCT01962987|458809642|FG002|Overall Study|Serious Adverse Event|0|||
127504885|NCT01962987|458809640|FG000|Overall Study|Withdrawal by Subject|11|||
127504886|NCT01962987|458809641|FG001|Overall Study|Withdrawal by Subject|10|||
127504887|NCT01962987|458809642|FG002|Overall Study|Withdrawal by Subject|6|||
127504888|NCT01962987|458809640|FG000|Overall Study|Randomized in Error|4|||
127504889|NCT01962987|458809641|FG001|Overall Study|Randomized in Error|2|||
127504890|NCT01962987|458809642|FG002|Overall Study|Randomized in Error|2|||
127504891|NCT02264665|458809643|FG000|Overall Study|Other|0|||
127504892|NCT02264665|458809644|FG001|Overall Study|Other|0|||
127504893|NCT02264665|458809645|FG002|Overall Study|Other|3|||
127504894|NCT02264665|458809646|FG003|Overall Study|Other|0|||
127504895|NCT02264665|458809647|FG004|Overall Study|Other|0|||
127504896|NCT02264665|458809648|FG005|Overall Study|Other|0|||
127504897|NCT02264665|458809649|FG006|Overall Study|Other|0|||
127504898|NCT02264665|458809643|FG000|Overall Study|Death|9|||
127504899|NCT02264665|458809644|FG001|Overall Study|Death|8|||
127504900|NCT02264665|458809645|FG002|Overall Study|Death|13|||
127504901|NCT02264665|458809646|FG003|Overall Study|Death|5|||
127504902|NCT02264665|458809647|FG004|Overall Study|Death|0|||
127504903|NCT02264665|458809648|FG005|Overall Study|Death|0|||
127504904|NCT02264665|458809649|FG006|Overall Study|Death|1|||
127504905|NCT02264665|458809643|FG000|Overall Study|Lost to Follow-up|1|||
127504906|NCT02264665|458809644|FG001|Overall Study|Lost to Follow-up|0|||
127504907|NCT02264665|458809645|FG002|Overall Study|Lost to Follow-up|2|||
127504908|NCT02264665|458809646|FG003|Overall Study|Lost to Follow-up|1|||
127504909|NCT02264665|458809647|FG004|Overall Study|Lost to Follow-up|0|||
127504910|NCT02264665|458809648|FG005|Overall Study|Lost to Follow-up|0|||
127504911|NCT02264665|458809649|FG006|Overall Study|Lost to Follow-up|0|||
127504912|NCT02264665|458809643|FG000|Overall Study|Participant decision|0|||
127978597|NCT03687372|460544115|FG000|Overall Study|Investigator Decision|1|||
127978598|NCT03687372|460544116|FG001|Overall Study|Investigator Decision|1|||
127504913|NCT02264665|458809644|FG001|Overall Study|Participant decision|0|||
127504914|NCT02264665|458809645|FG002|Overall Study|Participant decision|0|||
127504915|NCT02264665|458809646|FG003|Overall Study|Participant decision|1|||
127504916|NCT02264665|458809647|FG004|Overall Study|Participant decision|0|||
127504917|NCT02264665|458809648|FG005|Overall Study|Participant decision|0|||
127504918|NCT02264665|458809649|FG006|Overall Study|Participant decision|0|||
127978599|NCT00878969|460544119|FG000|Overall Study|Physician Decision|5|||
127504919|NCT02264665|458809643|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
127504920|NCT02264665|458809644|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
127504921|NCT02264665|458809645|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
127504922|NCT02264665|458809646|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
127504923|NCT02264665|458809647|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
127978600|NCT00878969|460544120|FG001|Overall Study|Physician Decision|3|||
127504924|NCT02264665|458809648|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
127504925|NCT02264665|458809649|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
127504926|NCT02264665|458809643|FG000|Overall Study|Data Missing|0|||
127504927|NCT02264665|458809644|FG001|Overall Study|Data Missing|0|||
127504928|NCT02264665|458809645|FG002|Overall Study|Data Missing|1|||
127504929|NCT02264665|458809646|FG003|Overall Study|Data Missing|0|||
127504930|NCT02264665|458809647|FG004|Overall Study|Data Missing|0|||
127504931|NCT02264665|458809648|FG005|Overall Study|Data Missing|0|||
127504932|NCT02264665|458809649|FG006|Overall Study|Data Missing|0|||
127504933|NCT00789581|458809653|FG000|AC Therapy|Adverse Event|2|||
127504934|NCT00789581|458809654|FG001|AC Therapy|Adverse Event|3|||
127504935|NCT00789581|458809653|FG000|AC Therapy|Withdrawal by Subject|4|||
127504936|NCT00789581|458809654|FG001|AC Therapy|Withdrawal by Subject|7|||
127504937|NCT00789581|458809653|FG000|AC Therapy|Disease recurrence|3|||
127504938|NCT00789581|458809654|FG001|AC Therapy|Disease recurrence|1|||
127504939|NCT00789581|458809653|FG000|AC Therapy|Intercurrent Illness|1|||
127504940|NCT00789581|458809654|FG001|AC Therapy|Intercurrent Illness|0|||
127504941|NCT00789581|458809653|FG000|AC Therapy|Never Treated|1|||
127504942|NCT00789581|458809654|FG001|AC Therapy|Never Treated|4|||
127504943|NCT00789581|458809653|FG000|AC Therapy|Other|0|||
127504944|NCT00789581|458809654|FG001|AC Therapy|Other|2|||
127504945|NCT00789581|458809653|FG000|Adjuvant Therapy|Never treated|2|||
127504946|NCT00789581|458809654|FG001|Adjuvant Therapy|Never treated|2|||
127504947|NCT00789581|458809653|FG000|Adjuvant Therapy|Adverse Event|20|||
127504948|NCT00789581|458809654|FG001|Adjuvant Therapy|Adverse Event|44|||
127504949|NCT00789581|458809653|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
127504950|NCT00789581|458809654|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
127504951|NCT00789581|458809653|FG000|Adjuvant Therapy|Disease recurrence|2|||
127504952|NCT00789581|458809654|FG001|Adjuvant Therapy|Disease recurrence|1|||
127504953|NCT00789581|458809653|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
127504954|NCT00789581|458809654|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
127504955|NCT00789581|458809653|FG000|Adjuvant Therapy|Protocol Violation|1|||
127504956|NCT00789581|458809654|FG001|Adjuvant Therapy|Protocol Violation|1|||
127504957|NCT00789581|458809653|FG000|Adjuvant Therapy|Other|0|||
127504958|NCT00789581|458809654|FG001|Adjuvant Therapy|Other|1|||
127504959|NCT00539513|458809657|FG000|Overall Study|Withdrawal by Subject|2|||
127504960|NCT00539513|458809658|FG001|Overall Study|Withdrawal by Subject|1|||
127504961|NCT00539513|458809657|FG000|Overall Study|Lost to Follow-up|0|||
127504962|NCT00539513|458809658|FG001|Overall Study|Lost to Follow-up|1|||
127504963|NCT00908115|458809659|FG000|Overall Study|Other|14|||
127504964|NCT00347438|458809663|FG000|Overall Study|Withdrawal by Subject|1|||
127504965|NCT00347438|458809663|FG000|Overall Study|Physician Decision|1|||
127504966|NCT00523705|458809664|FG000|Overall Study|No time for study.|0|||
127504967|NCT00523705|458809665|FG001|Overall Study|No time for study.|1|||
127504968|NCT01082874|458809666|FG000|Overall Study|Lost to Follow-up|10|||
127504969|NCT01082874|458809667|FG001|Overall Study|Lost to Follow-up|10|||
127504970|NCT01082874|458809668|FG002|Overall Study|Lost to Follow-up|6|||
127504971|NCT01082874|458809669|FG003|Overall Study|Lost to Follow-up|10|||
127504972|NCT01082874|458809666|FG000|Overall Study|Withdrawal by Subject|1|||
127504973|NCT01082874|458809667|FG001|Overall Study|Withdrawal by Subject|2|||
127504974|NCT01082874|458809668|FG002|Overall Study|Withdrawal by Subject|5|||
127504975|NCT01082874|458809669|FG003|Overall Study|Withdrawal by Subject|3|||
127504976|NCT00006046|458809671|FG000|Overall Study|Adverse Event|3|||
127504977|NCT00006046|458809672|FG001|Overall Study|Adverse Event|0|||
127504978|NCT00006046|458809673|FG002|Overall Study|Adverse Event|0|||
127504979|NCT00006046|458809674|FG003|Overall Study|Adverse Event|0|||
127504980|NCT00006046|458809675|FG004|Overall Study|Adverse Event|0|||
127504981|NCT00006046|458809671|FG000|Overall Study|Disease Progression|2|||
127504982|NCT00006046|458809672|FG001|Overall Study|Disease Progression|0|||
127504983|NCT00006046|458809673|FG002|Overall Study|Disease Progression|0|||
127504984|NCT00006046|458809674|FG003|Overall Study|Disease Progression|0|||
127504985|NCT00006046|458809675|FG004|Overall Study|Disease Progression|0|||
127504986|NCT00596154|458809676|FG000|Overall Study|Not Evaluable|2|||
127504987|NCT00642369|458809677|FG000|Overall Study|Adverse Event|2|||
127504988|NCT00642369|458809678|FG001|Overall Study|Adverse Event|3|||
127504989|NCT00642369|458809677|FG000|Overall Study|Withdrawal by Subject|1|||
127504990|NCT00642369|458809678|FG001|Overall Study|Withdrawal by Subject|0|||
127504991|NCT00642369|458809677|FG000|Overall Study|misdiagnosis|0|||
127504992|NCT00642369|458809678|FG001|Overall Study|misdiagnosis|1|||
127504993|NCT00642369|458809677|FG000|Overall Study|Lack of Efficacy|2|||
127504994|NCT00642369|458809678|FG001|Overall Study|Lack of Efficacy|2|||
127504995|NCT00585546|458809685|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
127504996|NCT00585546|458809685|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
127504997|NCT00113399|458809694|FG000|Overall Study|Death|1|||
127504998|NCT00113399|458809695|FG001|Overall Study|Death|1|||
127504999|NCT00113399|458809694|FG000|Overall Study|Withdrawal by Subject|1|||
127505000|NCT00113399|458809695|FG001|Overall Study|Withdrawal by Subject|2|||
127505001|NCT00113399|458809694|FG000|Overall Study|Complete Response|0|||
127505002|NCT00113399|458809695|FG001|Overall Study|Complete Response|1|||
127505003|NCT00113399|458809694|FG000|Overall Study|Other|0|||
127505004|NCT00113399|458809695|FG001|Overall Study|Other|1|||
127505005|NCT01535599|458809696|FG000|Overall Study|Adverse Event|6|||
127505006|NCT01535599|458809697|FG001|Overall Study|Adverse Event|15|||
127505007|NCT01535599|458809696|FG000|Overall Study|Lost to Follow-up|3|||
127505008|NCT01535599|458809697|FG001|Overall Study|Lost to Follow-up|4|||
127505009|NCT01535599|458809696|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
127505010|NCT01535599|458809697|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
127505011|NCT01535599|458809696|FG000|Overall Study|Treatment Failure|33|||
127505012|NCT01535599|458809697|FG001|Overall Study|Treatment Failure|66|||
127505013|NCT01535599|458809696|FG000|Overall Study|BL Culture + for Group A Strep|0|||
127505014|NCT01535599|458809697|FG001|Overall Study|BL Culture + for Group A Strep|1|||
127505015|NCT01535599|458809696|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
127505016|NCT01535599|458809697|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
127505017|NCT01535599|458809696|FG000|Overall Study|Randomized in Error|2|||
127505018|NCT01535599|458809697|FG001|Overall Study|Randomized in Error|4|||
127505019|NCT01535599|458809696|FG000|Overall Study|Did not use product|1|||
127505020|NCT01535599|458809697|FG001|Overall Study|Did not use product|0|||
127505021|NCT01535599|458809696|FG000|Overall Study|Other|1|||
127505022|NCT01535599|458809697|FG001|Overall Study|Other|0|||
127505023|NCT01535599|458809696|FG000|Overall Study|Stopped medication|0|||
127505024|NCT01535599|458809697|FG001|Overall Study|Stopped medication|1|||
127505025|NCT01535599|458809696|FG000|Overall Study|Noncompliance|0|||
127505026|NCT01535599|458809697|FG001|Overall Study|Noncompliance|1|||
127505027|NCT01165320|458809698|FG000|Overall Study|Clinical adverse experience|2|||
127505028|NCT01165320|458809699|FG001|Overall Study|Clinical adverse experience|1|||
127505029|NCT01165320|458809700|FG002|Overall Study|Clinical adverse experience|0|||
127505030|NCT01165320|458809698|FG000|Overall Study|Laboratory adverse experience|1|||
127505031|NCT01165320|458809699|FG001|Overall Study|Laboratory adverse experience|0|||
127505032|NCT01165320|458809700|FG002|Overall Study|Laboratory adverse experience|0|||
127505033|NCT01165320|458809698|FG000|Overall Study|Lack of Efficacy|0|||
127505034|NCT01165320|458809699|FG001|Overall Study|Lack of Efficacy|2|||
127505035|NCT01165320|458809700|FG002|Overall Study|Lack of Efficacy|0|||
127505036|NCT01165320|458809698|FG000|Overall Study|Reason unknown|0|||
127505037|NCT01165320|458809699|FG001|Overall Study|Reason unknown|1|||
127505038|NCT01165320|458809700|FG002|Overall Study|Reason unknown|0|||
127505039|NCT00385944|458809701|FG000|1st Maintenance Dose Period|Physician Decision|1|||
127505040|NCT00385944|458809702|FG001|1st Maintenance Dose Period|Physician Decision|0|||
127505041|NCT00385944|458809703|FG002|1st Maintenance Dose Period|Physician Decision|0|||
127505042|NCT00385944|458809701|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
127505043|NCT00385944|458809702|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
127505044|NCT00385944|458809703|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
127505045|NCT00385944|458809701|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
127505046|NCT00385944|458809702|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
127505047|NCT00385944|458809703|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
127505048|NCT00385944|458809701|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
127505049|NCT00385944|458809702|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
127505050|NCT00385944|458809703|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
127505051|NCT00590824|458809707|FG000|Overall Study|Disease could not be resected|0|||
127505052|NCT00590824|458809708|FG001|Overall Study|Disease could not be resected|2|||
127505053|NCT00590824|458809709|FG002|Overall Study|Disease could not be resected|1|||
127505054|NCT00590824|458809710|FG003|Overall Study|Disease could not be resected|0|||
127505055|NCT00590824|458809707|FG000|Overall Study|Adverse Event|0|||
127505056|NCT00590824|458809708|FG001|Overall Study|Adverse Event|0|||
127505057|NCT00590824|458809709|FG002|Overall Study|Adverse Event|0|||
127505058|NCT00590824|458809710|FG003|Overall Study|Adverse Event|1|||
127505059|NCT00791479|458809716|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
127505060|NCT00791479|458809717|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
127505061|NCT00791479|458809718|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
127505062|NCT00791479|458809719|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
127505063|NCT00791479|458809720|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
127505064|NCT00791479|458809721|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
127505065|NCT00791479|458809716|FG000|Overall Study|Adverse Event|0|||
127505066|NCT00791479|458809717|FG001|Overall Study|Adverse Event|1|||
127505067|NCT00791479|458809718|FG002|Overall Study|Adverse Event|0|||
127505068|NCT00791479|458809719|FG003|Overall Study|Adverse Event|2|||
127505069|NCT00791479|458809720|FG004|Overall Study|Adverse Event|0|||
127505070|NCT00791479|458809721|FG005|Overall Study|Adverse Event|1|||
127505071|NCT00791479|458809716|FG000|Overall Study|Lost to Follow-up|0|||
127505072|NCT00791479|458809717|FG001|Overall Study|Lost to Follow-up|1|||
127505073|NCT00791479|458809718|FG002|Overall Study|Lost to Follow-up|0|||
127505074|NCT00791479|458809719|FG003|Overall Study|Lost to Follow-up|0|||
127505075|NCT00791479|458809720|FG004|Overall Study|Lost to Follow-up|0|||
127505076|NCT00791479|458809721|FG005|Overall Study|Lost to Follow-up|1|||
127505077|NCT00791479|458809716|FG000|Overall Study|Protocol Violation|2|||
127505078|NCT00791479|458809717|FG001|Overall Study|Protocol Violation|1|||
127505079|NCT00791479|458809718|FG002|Overall Study|Protocol Violation|0|||
127505080|NCT00791479|458809719|FG003|Overall Study|Protocol Violation|1|||
127505081|NCT00791479|458809720|FG004|Overall Study|Protocol Violation|0|||
127505082|NCT00791479|458809721|FG005|Overall Study|Protocol Violation|0|||
127505083|NCT00791479|458809716|FG000|Overall Study|Withdrawal by Subject|0|||
127505084|NCT00791479|458809717|FG001|Overall Study|Withdrawal by Subject|0|||
127505085|NCT00791479|458809718|FG002|Overall Study|Withdrawal by Subject|0|||
127505086|NCT00791479|458809719|FG003|Overall Study|Withdrawal by Subject|1|||
127505087|NCT00791479|458809720|FG004|Overall Study|Withdrawal by Subject|0|||
127505088|NCT00791479|458809721|FG005|Overall Study|Withdrawal by Subject|1|||
127505089|NCT01778049|458809722|FG000|Open Label Treatment Period|Adverse Event|5|||
127505090|NCT01778049|458809723|FG001|Open Label Treatment Period|Adverse Event|15|||
127505091|NCT01778049|458809724|FG002|Open Label Treatment Period|Adverse Event|0|||
127505092|NCT01778049|458809725|FG003|Open Label Treatment Period|Adverse Event|0|||
127505093|NCT01778049|458809726|FG004|Open Label Treatment Period|Adverse Event|0|||
127505094|NCT01778049|458809727|FG005|Open Label Treatment Period|Adverse Event|0|||
127505095|NCT01778049|458809722|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
127505096|NCT01778049|458809723|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
127505097|NCT01778049|458809724|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
127505098|NCT01778049|458809725|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
127505099|NCT01778049|458809726|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
127505100|NCT01778049|458809727|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
127505101|NCT01778049|458809722|FG000|Open Label Treatment Period|Protocol Violation|5|||
127505102|NCT01778049|458809723|FG001|Open Label Treatment Period|Protocol Violation|5|||
127505103|NCT01778049|458809724|FG002|Open Label Treatment Period|Protocol Violation|0|||
127505104|NCT01778049|458809725|FG003|Open Label Treatment Period|Protocol Violation|0|||
127505105|NCT01778049|458809726|FG004|Open Label Treatment Period|Protocol Violation|0|||
127505106|NCT01778049|458809727|FG005|Open Label Treatment Period|Protocol Violation|0|||
127505107|NCT01778049|458809722|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
127505108|NCT01778049|458809723|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
127505109|NCT01778049|458809724|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
127505110|NCT01778049|458809725|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
127505111|NCT01778049|458809726|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
127505112|NCT01778049|458809727|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
127505113|NCT01778049|458809722|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
127505114|NCT01778049|458809723|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
127505115|NCT01778049|458809724|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
127505116|NCT01778049|458809725|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
127505117|NCT01778049|458809726|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
127505118|NCT01778049|458809727|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
127505119|NCT01778049|458809722|FG000|Open Label Treatment Period|Not treated|2|||
127505120|NCT01778049|458809723|FG001|Open Label Treatment Period|Not treated|1|||
127505121|NCT01778049|458809724|FG002|Open Label Treatment Period|Not treated|0|||
127505122|NCT01778049|458809725|FG003|Open Label Treatment Period|Not treated|0|||
127505123|NCT01778049|458809726|FG004|Open Label Treatment Period|Not treated|0|||
127505124|NCT01778049|458809727|FG005|Open Label Treatment Period|Not treated|0|||
127505125|NCT01778049|458809722|FG000|Open Label Treatment Period|Other reason not defined above|77|||
127505126|NCT01778049|458809723|FG001|Open Label Treatment Period|Other reason not defined above|94|||
127505127|NCT01778049|458809724|FG002|Open Label Treatment Period|Other reason not defined above|0|||
127505128|NCT01778049|458809725|FG003|Open Label Treatment Period|Other reason not defined above|0|||
127505129|NCT01778049|458809726|FG004|Open Label Treatment Period|Other reason not defined above|0|||
127505130|NCT01778049|458809727|FG005|Open Label Treatment Period|Other reason not defined above|0|||
127505131|NCT01778049|458809722|FG000|Double Blind Treatment Period|Adverse Event|0|||
127505132|NCT01778049|458809723|FG001|Double Blind Treatment Period|Adverse Event|0|||
127505133|NCT01778049|458809724|FG002|Double Blind Treatment Period|Adverse Event|4|||
127505134|NCT01778049|458809725|FG003|Double Blind Treatment Period|Adverse Event|5|||
127505135|NCT01778049|458809726|FG004|Double Blind Treatment Period|Adverse Event|3|||
127505136|NCT01778049|458809727|FG005|Double Blind Treatment Period|Adverse Event|2|||
127505137|NCT01778049|458809722|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
127505138|NCT01778049|458809723|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
127505139|NCT01778049|458809724|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
127505140|NCT01778049|458809725|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
127505141|NCT01778049|458809726|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
127505142|NCT01778049|458809727|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
127505143|NCT01778049|458809722|FG000|Double Blind Treatment Period|Protocol Violation|0|||
127505144|NCT01778049|458809723|FG001|Double Blind Treatment Period|Protocol Violation|0|||
127505145|NCT01778049|458809724|FG002|Double Blind Treatment Period|Protocol Violation|2|||
127505146|NCT01778049|458809725|FG003|Double Blind Treatment Period|Protocol Violation|0|||
127505147|NCT01778049|458809726|FG004|Double Blind Treatment Period|Protocol Violation|0|||
127505148|NCT01778049|458809727|FG005|Double Blind Treatment Period|Protocol Violation|0|||
127505149|NCT01778049|458809722|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
127505150|NCT01778049|458809723|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
127505151|NCT01778049|458809724|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
127505152|NCT01778049|458809725|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
127505153|NCT01778049|458809726|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
127505154|NCT01778049|458809727|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
127505155|NCT01778049|458809722|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
127505156|NCT01778049|458809723|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
127505157|NCT01778049|458809724|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
127505158|NCT01778049|458809725|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
127505159|NCT01778049|458809726|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
127505160|NCT01778049|458809727|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
127505161|NCT01778049|458809722|FG000|Double Blind Treatment Period|Not treated|0|||
127505162|NCT01778049|458809723|FG001|Double Blind Treatment Period|Not treated|0|||
127505163|NCT01778049|458809724|FG002|Double Blind Treatment Period|Not treated|0|||
127505164|NCT01778049|458809725|FG003|Double Blind Treatment Period|Not treated|2|||
127505165|NCT01778049|458809726|FG004|Double Blind Treatment Period|Not treated|2|||
127505166|NCT01778049|458809727|FG005|Double Blind Treatment Period|Not treated|0|||
127505167|NCT01778049|458809722|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
127505168|NCT01778049|458809723|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
127505169|NCT01778049|458809724|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
127505170|NCT01778049|458809725|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
127505171|NCT01778049|458809726|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
127505172|NCT01778049|458809727|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
127505173|NCT03770728|458809728|FG000|Overall Study|Adverse Event|1|||
127505174|NCT03770728|458809729|FG001|Overall Study|Adverse Event|0|||
127505175|NCT03770728|458809730|FG002|Overall Study|Adverse Event|1|||
127505176|NCT03770728|458809731|FG003|Overall Study|Adverse Event|0|||
127505177|NCT03770728|458809728|FG000|Overall Study|Poor compliance to protocol|0|||
127505178|NCT03770728|458809729|FG001|Overall Study|Poor compliance to protocol|0|||
127505179|NCT03770728|458809730|FG002|Overall Study|Poor compliance to protocol|1|||
127505180|NCT03770728|458809731|FG003|Overall Study|Poor compliance to protocol|0|||
127505181|NCT03770728|458809728|FG000|Overall Study|Withdrawal by Subject|13|||
127505182|NCT03770728|458809729|FG001|Overall Study|Withdrawal by Subject|8|||
127505183|NCT03770728|458809730|FG002|Overall Study|Withdrawal by Subject|9|||
127505184|NCT03770728|458809731|FG003|Overall Study|Withdrawal by Subject|13|||
127505185|NCT03770728|458809728|FG000|Overall Study|Other than specified|24|||
127505186|NCT03770728|458809729|FG001|Overall Study|Other than specified|23|||
127505187|NCT03770728|458809730|FG002|Overall Study|Other than specified|21|||
127505188|NCT03770728|458809731|FG003|Overall Study|Other than specified|22|||
127505189|NCT00503776|458809732|FG000|Overall Study|Withdrawal by Subject|1|||
127505190|NCT00503776|458809733|FG001|Overall Study|Withdrawal by Subject|0|||
127505191|NCT00503776|458809734|FG002|Overall Study|Withdrawal by Subject|1|||
127505192|NCT00503776|458809735|FG003|Overall Study|Withdrawal by Subject|1|||
127505193|NCT00503776|458809732|FG000|Overall Study|Physician Decision|0|||
127505194|NCT00503776|458809733|FG001|Overall Study|Physician Decision|0|||
127505195|NCT00503776|458809734|FG002|Overall Study|Physician Decision|1|||
127505196|NCT00503776|458809735|FG003|Overall Study|Physician Decision|1|||
127505197|NCT02379988|458809736|FG000|Overall Study|Not eligible|1|||
127505198|NCT00107315|458809737|FG000|Overall Study|Disease Progression|9|||
127505199|NCT00107315|458809737|FG000|Overall Study|Adverse Event|4|||
127505200|NCT00107315|458809737|FG000|Overall Study|Withdrawal by Subject|2|||
127505201|NCT02509039|458809740|FG000|Overall Study|Adverse Event|0|||
127505202|NCT02509039|458809741|FG001|Overall Study|Adverse Event|1|||
127505203|NCT02509039|458809742|FG002|Overall Study|Adverse Event|1|||
127505204|NCT02509039|458809743|FG003|Overall Study|Adverse Event|1|||
127505205|NCT02509039|458809740|FG000|Overall Study|Withdrawal by Subject|0|||
127505206|NCT02509039|458809741|FG001|Overall Study|Withdrawal by Subject|0|||
127505207|NCT02509039|458809742|FG002|Overall Study|Withdrawal by Subject|1|||
127505208|NCT02509039|458809743|FG003|Overall Study|Withdrawal by Subject|0|||
127505209|NCT02509039|458809740|FG000|Overall Study|Progressive disease|2|||
127505210|NCT02509039|458809741|FG001|Overall Study|Progressive disease|2|||
127505211|NCT02509039|458809742|FG002|Overall Study|Progressive disease|1|||
127505212|NCT02509039|458809743|FG003|Overall Study|Progressive disease|5|||
127505213|NCT02509039|458809740|FG000|Overall Study|Study terminated by Sponsor|1|||
127505214|NCT02509039|458809741|FG001|Overall Study|Study terminated by Sponsor|0|||
127505215|NCT02509039|458809742|FG002|Overall Study|Study terminated by Sponsor|0|||
127505216|NCT02509039|458809743|FG003|Overall Study|Study terminated by Sponsor|0|||
127505217|NCT05427539|458809746|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
127505218|NCT05427539|458809747|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
127505219|NCT05427539|458809746|FG000|Period 1|Withdrawal by Subject|1|||
127505220|NCT05427539|458809747|FG001|Period 1|Withdrawal by Subject|0|||
127505221|NCT00543296|458809750|FG000|Overall Study|Physician Decision|7|||
127505222|NCT00934947|458809751|FG000|Overall Study|Adverse Event|0|||
127505223|NCT00934947|458809752|FG001|Overall Study|Adverse Event|2|||
127505224|NCT03276026|458809755|FG000|Overall Study|Protocol Violation|1|||
127505225|NCT03276026|458809756|FG001|Overall Study|Protocol Violation|0|||
127505226|NCT04049266|458809757|FG000|Overall Study|Adverse Event|16|||
127505227|NCT04049266|458809758|FG001|Overall Study|Adverse Event|9|||
127505228|NCT04049266|458809757|FG000|Overall Study|Non-compliance with study drug|0|||
127505229|NCT04049266|458809758|FG001|Overall Study|Non-compliance with study drug|3|||
127505230|NCT04049266|458809757|FG000|Overall Study|Withdrawal by Subject|6|||
127505231|NCT04049266|458809758|FG001|Overall Study|Withdrawal by Subject|10|||
127505232|NCT04049266|458809757|FG000|Overall Study|Lost to Follow-up|2|||
127505233|NCT04049266|458809758|FG001|Overall Study|Lost to Follow-up|2|||
127505234|NCT04049266|458809757|FG000|Overall Study|Progressive disease|11|||
127505235|NCT04049266|458809758|FG001|Overall Study|Progressive disease|2|||
127505236|NCT04049266|458809757|FG000|Overall Study|Physician Decision|1|||
127505237|NCT04049266|458809758|FG001|Overall Study|Physician Decision|0|||
127505238|NCT04049266|458809757|FG000|Overall Study|Patient moved out of state|1|||
127505239|NCT04049266|458809758|FG001|Overall Study|Patient moved out of state|0|||
127505240|NCT01703208|458809759|FG000|Overall Study|Death|61|||
127505241|NCT01703208|458809760|FG001|Overall Study|Death|48|||
127505242|NCT01703208|458809759|FG000|Overall Study|Lack of Efficacy|1|||
127505243|NCT01703208|458809760|FG001|Overall Study|Lack of Efficacy|2|||
127505244|NCT01703208|458809759|FG000|Overall Study|Lost to Follow-up|68|||
127505245|NCT01703208|458809760|FG001|Overall Study|Lost to Follow-up|62|||
127505246|NCT01703208|458809759|FG000|Overall Study|Non-Compliance with Study Drug|1|||
127505247|NCT01703208|458809760|FG001|Overall Study|Non-Compliance with Study Drug|0|||
127505248|NCT01703208|458809759|FG000|Overall Study|Excluded Medication|1|||
127505249|NCT01703208|458809760|FG001|Overall Study|Excluded Medication|2|||
127505250|NCT01703208|458809759|FG000|Overall Study|Site Discontinued Study Participation|23|||
127505251|NCT01703208|458809760|FG001|Overall Study|Site Discontinued Study Participation|27|||
127505252|NCT01703208|458809759|FG000|Overall Study|Physician Decision|11|||
127505253|NCT01703208|458809760|FG001|Overall Study|Physician Decision|13|||
127505254|NCT01703208|458809759|FG000|Overall Study|Progressive disease|2|||
127505255|NCT01703208|458809760|FG001|Overall Study|Progressive disease|2|||
127505256|NCT01703208|458809759|FG000|Overall Study|Protocol Violation|1|||
127505257|NCT01703208|458809760|FG001|Overall Study|Protocol Violation|1|||
127505258|NCT01703208|458809759|FG000|Overall Study|Study Terminated by Sponsor|1710|||
127505259|NCT01703208|458809760|FG001|Overall Study|Study Terminated by Sponsor|1716|||
127505260|NCT01703208|458809759|FG000|Overall Study|Withdrawal by Subject|205|||
127505261|NCT01703208|458809760|FG001|Overall Study|Withdrawal by Subject|209|||
127505262|NCT01703208|458809759|FG000|Overall Study|Adverse Event|14|||
127505263|NCT01703208|458809760|FG001|Overall Study|Adverse Event|19|||
127505264|NCT01703208|458809759|FG000|Overall Study|Technical Problems|0|||
127505265|NCT01703208|458809760|FG001|Overall Study|Technical Problems|1|||
127505266|NCT01703208|458809759|FG000|Overall Study|Protocol Deviation|2|||
127505267|NCT01703208|458809760|FG001|Overall Study|Protocol Deviation|0|||
127505268|NCT02298179|458809764|FG000|Overall Study|Lost to Follow-up|0|||
127505269|NCT02298179|458809765|FG001|Overall Study|Lost to Follow-up|0|||
127505270|NCT02298179|458809766|FG002|Overall Study|Lost to Follow-up|1|||
127505271|NCT02298179|458809767|FG003|Overall Study|Lost to Follow-up|0|||
127505272|NCT02298179|458809768|FG004|Overall Study|Lost to Follow-up|0|||
127505273|NCT02298179|458809769|FG005|Overall Study|Lost to Follow-up|0|||
127505274|NCT02298179|458809770|FG006|Overall Study|Lost to Follow-up|0|||
127505275|NCT02298179|458809771|FG007|Overall Study|Lost to Follow-up|1|||
127505276|NCT02298179|458809772|FG008|Overall Study|Lost to Follow-up|0|||
127505277|NCT02298179|458809773|FG009|Overall Study|Lost to Follow-up|0|||
127505278|NCT02298179|458809774|FG010|Overall Study|Lost to Follow-up|0|||
127505279|NCT02298179|458809775|FG011|Overall Study|Lost to Follow-up|0|||
127505280|NCT00350272|458809776|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
127505281|NCT00350272|458809777|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
127505282|NCT00350272|458809776|FG000|Blinded 12-Week Treatment|Death|1|||
127505283|NCT00350272|458809777|FG001|Blinded 12-Week Treatment|Death|0|||
127978601|NCT00878969|460544121|FG002|Overall Study|Physician Decision|2|||
127505284|NCT00350272|458809776|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
127505285|NCT00350272|458809777|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
127505286|NCT00350272|458809776|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
127505287|NCT00350272|458809777|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
127505288|NCT00350272|458809776|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
127505289|NCT00350272|458809777|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
127978602|NCT00878969|460544119|FG000|Overall Study|Withdrawal by Subject|1|||
127505290|NCT00350272|458809776|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
127505291|NCT00350272|458809777|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
127505292|NCT00350272|458809776|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
127505293|NCT00350272|458809777|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
127505294|NCT00350272|458809776|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
127505295|NCT00350272|458809777|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
127505296|NCT00350272|458809776|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
127505297|NCT00350272|458809777|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
127505298|NCT00350272|458809776|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
127505299|NCT00350272|458809777|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
127505300|NCT00350272|458809776|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
127505301|NCT00350272|458809777|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
127505302|NCT00433160|458809784|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
127505303|NCT00433160|458809785|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
127505304|NCT00433160|458809784|FG000|52-Week Double-Blind (DB) Period|Death|0|||
127505305|NCT00433160|458809785|FG001|52-Week Double-Blind (DB) Period|Death|0|||
127505306|NCT00433160|458809784|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
127505307|NCT00433160|458809785|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
127505308|NCT00433160|458809784|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
127505309|NCT00433160|458809785|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
127505310|NCT00433160|458809784|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
127505311|NCT00433160|458809785|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
127505312|NCT00433160|458809784|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
127505313|NCT00433160|458809785|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
127505314|NCT00433160|458809784|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
127505315|NCT00433160|458809785|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
127505316|NCT00433160|458809784|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
127505317|NCT00433160|458809785|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
127505318|NCT00433160|458809784|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
127505319|NCT00433160|458809785|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
127505320|NCT00433160|458809784|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
127505321|NCT00433160|458809785|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
127505322|NCT00433160|458809784|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
127505323|NCT00433160|458809785|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
127505324|NCT00433160|458809784|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
127505325|NCT00433160|458809785|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
127505326|NCT00433160|458809784|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
127505327|NCT00433160|458809785|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
127505328|NCT00433160|458809784|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
127505329|NCT00433160|458809785|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
127505330|NCT00433160|458809784|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
127505331|NCT00433160|458809785|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
127505332|NCT00433160|458809784|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
127505333|NCT00433160|458809785|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
127505334|NCT03222973|458809792|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
127505335|NCT03222973|458809793|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
127505336|NCT03222973|458809794|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
127505337|NCT03222973|458809795|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
127505338|NCT03222973|458809792|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
127505339|NCT03222973|458809793|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
127505340|NCT03222973|458809794|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
127505341|NCT03222973|458809795|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
127505342|NCT03222973|458809792|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
127505343|NCT03222973|458809793|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
127505344|NCT03222973|458809794|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
127505345|NCT03222973|458809795|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
127505346|NCT03222973|458809792|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
127505347|NCT03222973|458809793|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
127505348|NCT03222973|458809794|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
127505349|NCT03222973|458809795|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
127505350|NCT03222973|458809792|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
127505351|NCT03222973|458809793|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
127505352|NCT03222973|458809794|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
127505353|NCT03222973|458809795|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
127505354|NCT03222973|458809792|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
127505355|NCT03222973|458809793|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
127505356|NCT03222973|458809794|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
127505357|NCT03222973|458809795|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
127505358|NCT03222973|458809792|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
127505359|NCT03222973|458809793|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
127978603|NCT00878969|460544120|FG001|Overall Study|Withdrawal by Subject|6|||
127505360|NCT03222973|458809794|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
127505361|NCT03222973|458809795|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
127505362|NCT03222973|458809792|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
127505363|NCT03222973|458809793|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
127505364|NCT03222973|458809794|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
127505365|NCT03222973|458809795|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
127978604|NCT00878969|460544121|FG002|Overall Study|Withdrawal by Subject|3|||
127978605|NCT00878969|460544119|FG000|Overall Study|kidney transplant|2|||
127505366|NCT03222973|458809792|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
127505367|NCT03222973|458809793|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
127505368|NCT03222973|458809794|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
127505369|NCT03222973|458809795|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
127505370|NCT03222973|458809792|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
127505371|NCT03222973|458809793|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
127505372|NCT03222973|458809794|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
127505373|NCT03222973|458809795|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
127505374|NCT03222973|458809792|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
127505375|NCT03222973|458809793|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
127505376|NCT03222973|458809794|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
127505377|NCT03222973|458809795|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
127505378|NCT03222973|458809792|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
127505379|NCT03222973|458809793|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
127505380|NCT03222973|458809794|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
127505381|NCT03222973|458809795|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
127505382|NCT02080481|458809796|FG000|Overall Study|Never received a block.|1|||
127505383|NCT02080481|458809797|FG001|Overall Study|Never received a block.|0|||
127505384|NCT02226198|458811242|FG000|Lead-in Phase|Protocol Violation|1|||
127505385|NCT02226198|458811243|FG001|Lead-in Phase|Protocol Violation|0|||
127505386|NCT02226198|458811244|FG002|Lead-in Phase|Protocol Violation|0|||
127505387|NCT02226198|458811242|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
127505388|NCT02226198|458811243|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
127505389|NCT02226198|458811244|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
127505390|NCT01440517|458811246|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
127505391|NCT01288612|458811248|FG000|Overall Study|Unable to contact|11|||
127505392|NCT01288612|458811249|FG001|Overall Study|Unable to contact|16|||
127505393|NCT01288612|458811250|FG002|Overall Study|Unable to contact|20|||
127505394|NCT01288612|458811248|FG000|Overall Study|Declined|78|||
127505395|NCT01288612|458811249|FG001|Overall Study|Declined|63|||
127505396|NCT01288612|458811250|FG002|Overall Study|Declined|62|||
127505397|NCT01288612|458811248|FG000|Overall Study|Unable to intubate|0|||
127505398|NCT01288612|458811249|FG001|Overall Study|Unable to intubate|3|||
127505399|NCT01288612|458811250|FG002|Overall Study|Unable to intubate|0|||
127505400|NCT00871923|458811251|FG000|Overall Study|Death|1|||
127505401|NCT00871923|458811251|FG000|Overall Study|Withdrawal by Subject|1|||
127505402|NCT02723006|458811256|FG000|Overall Study|Withdrawal by Subject|0|||
127505403|NCT02723006|458811257|FG001|Overall Study|Withdrawal by Subject|1|||
127505404|NCT02723006|458811258|FG002|Overall Study|Withdrawal by Subject|1|||
127505405|NCT02723006|458811256|FG000|Overall Study|Study Terminated by Sponsor|1|||
127505406|NCT02723006|458811257|FG001|Overall Study|Study Terminated by Sponsor|6|||
127505407|NCT02723006|458811258|FG002|Overall Study|Study Terminated by Sponsor|6|||
127505408|NCT04258995|458811259|FG000|Overall Study|Lost to Follow-up|1|||
127505409|NCT04258995|458811260|FG001|Overall Study|Lost to Follow-up|1|||
127505410|NCT00983515|458811263|FG000|Ritonavir Alone|liver panel out of range|6|||
127505411|NCT00983515|458811263|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
127505412|NCT01145352|458811264|FG000|Overall Study|Found to have been registered twice|6|||
127505413|NCT01145352|458811264|FG000|Overall Study|Treated before marketing approval|4|||
127505414|NCT01145352|458811264|FG000|Overall Study|Syringe formulation was used|1|||
127505415|NCT01468207|458811265|FG000|Treatment Period 1|Adverse Event|1|||
127505416|NCT01468207|458811266|FG001|Treatment Period 1|Adverse Event|0|||
127505417|NCT01468207|458811267|FG002|Treatment Period 1|Adverse Event|0|||
127505418|NCT01468207|458811268|FG003|Treatment Period 1|Adverse Event|0|||
127505419|NCT01468207|458811269|FG004|Treatment Period 1|Adverse Event|0|||
127505420|NCT01468207|458811270|FG005|Treatment Period 1|Adverse Event|0|||
127505421|NCT01468207|458811265|FG000|Treatment Period 1|Protocol Violation|1|||
127505422|NCT01468207|458811266|FG001|Treatment Period 1|Protocol Violation|1|||
127505423|NCT01468207|458811267|FG002|Treatment Period 1|Protocol Violation|0|||
127505424|NCT01468207|458811268|FG003|Treatment Period 1|Protocol Violation|0|||
127505425|NCT01468207|458811269|FG004|Treatment Period 1|Protocol Violation|0|||
127505426|NCT01468207|458811270|FG005|Treatment Period 1|Protocol Violation|0|||
127505427|NCT01468207|458811265|FG000|Treatment Period 1|Withdrawal by Subject|5|||
127505428|NCT01468207|458811266|FG001|Treatment Period 1|Withdrawal by Subject|4|||
127505429|NCT01468207|458811267|FG002|Treatment Period 1|Withdrawal by Subject|0|||
127505430|NCT01468207|458811268|FG003|Treatment Period 1|Withdrawal by Subject|0|||
127505431|NCT01468207|458811269|FG004|Treatment Period 1|Withdrawal by Subject|0|||
127505432|NCT01468207|458811270|FG005|Treatment Period 1|Withdrawal by Subject|0|||
127505433|NCT01468207|458811265|FG000|Treatment Period 1|Lost to Follow-up|2|||
127505434|NCT01468207|458811266|FG001|Treatment Period 1|Lost to Follow-up|1|||
127505435|NCT01468207|458811267|FG002|Treatment Period 1|Lost to Follow-up|0|||
127505436|NCT01468207|458811268|FG003|Treatment Period 1|Lost to Follow-up|0|||
127505437|NCT01468207|458811269|FG004|Treatment Period 1|Lost to Follow-up|0|||
127505438|NCT01468207|458811270|FG005|Treatment Period 1|Lost to Follow-up|0|||
127505439|NCT01468207|458811265|FG000|Treatment Period 1|Other|0|||
127505440|NCT01468207|458811266|FG001|Treatment Period 1|Other|2|||
127505441|NCT01468207|458811267|FG002|Treatment Period 1|Other|0|||
127505442|NCT01468207|458811268|FG003|Treatment Period 1|Other|0|||
127505443|NCT01468207|458811269|FG004|Treatment Period 1|Other|0|||
127505444|NCT01468207|458811270|FG005|Treatment Period 1|Other|0|||
127505445|NCT01468207|458811265|FG000|Treatment Period 2|Adverse Event|0|||
127505446|NCT01468207|458811266|FG001|Treatment Period 2|Adverse Event|0|||
127505447|NCT01468207|458811267|FG002|Treatment Period 2|Adverse Event|6|||
127505448|NCT01468207|458811268|FG003|Treatment Period 2|Adverse Event|1|||
127505449|NCT01468207|458811269|FG004|Treatment Period 2|Adverse Event|2|||
127505450|NCT01468207|458811270|FG005|Treatment Period 2|Adverse Event|1|||
127505451|NCT01468207|458811265|FG000|Treatment Period 2|Lack of Efficacy|0|||
127978606|NCT00878969|460544120|FG001|Overall Study|kidney transplant|3|||
127978607|NCT00878969|460544121|FG002|Overall Study|kidney transplant|2|||
127505452|NCT01468207|458811266|FG001|Treatment Period 2|Lack of Efficacy|0|||
127505453|NCT01468207|458811267|FG002|Treatment Period 2|Lack of Efficacy|1|||
127505454|NCT01468207|458811268|FG003|Treatment Period 2|Lack of Efficacy|1|||
127505455|NCT01468207|458811269|FG004|Treatment Period 2|Lack of Efficacy|0|||
127505456|NCT01468207|458811270|FG005|Treatment Period 2|Lack of Efficacy|2|||
127505457|NCT01468207|458811265|FG000|Treatment Period 2|Withdrawal by Subject|0|||
127505458|NCT01468207|458811266|FG001|Treatment Period 2|Withdrawal by Subject|0|||
127505459|NCT01468207|458811267|FG002|Treatment Period 2|Withdrawal by Subject|5|||
127505460|NCT01468207|458811268|FG003|Treatment Period 2|Withdrawal by Subject|0|||
127505461|NCT01468207|458811269|FG004|Treatment Period 2|Withdrawal by Subject|0|||
127505462|NCT01468207|458811270|FG005|Treatment Period 2|Withdrawal by Subject|2|||
127505463|NCT01468207|458811265|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
127505464|NCT01468207|458811266|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
127505465|NCT01468207|458811267|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
127505466|NCT01468207|458811268|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
127505467|NCT01468207|458811269|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
127505468|NCT01468207|458811270|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
127505469|NCT01468207|458811265|FG000|Treatment Period 2|Lost to Follow-up|0|||
127505470|NCT01468207|458811266|FG001|Treatment Period 2|Lost to Follow-up|0|||
127505471|NCT01468207|458811267|FG002|Treatment Period 2|Lost to Follow-up|5|||
127505472|NCT01468207|458811268|FG003|Treatment Period 2|Lost to Follow-up|1|||
127505473|NCT01468207|458811269|FG004|Treatment Period 2|Lost to Follow-up|0|||
127505474|NCT01468207|458811270|FG005|Treatment Period 2|Lost to Follow-up|0|||
127505475|NCT01468207|458811265|FG000|Treatment Period 2|Other|0|||
127505476|NCT01468207|458811266|FG001|Treatment Period 2|Other|0|||
127505477|NCT01468207|458811267|FG002|Treatment Period 2|Other|5|||
127505478|NCT01468207|458811268|FG003|Treatment Period 2|Other|1|||
127505479|NCT01468207|458811269|FG004|Treatment Period 2|Other|1|||
127505480|NCT01468207|458811270|FG005|Treatment Period 2|Other|2|||
127505481|NCT00316693|458811271|FG000|Overall Study|Adverse Event|6|||
127505482|NCT00316693|458811272|FG001|Overall Study|Adverse Event|1|||
127505483|NCT00316693|458811271|FG000|Overall Study|Protocol Violation|1|||
127505484|NCT00316693|458811272|FG001|Overall Study|Protocol Violation|0|||
127505485|NCT00316693|458811271|FG000|Overall Study|Withdrawal by Subject|6|||
127505486|NCT00316693|458811272|FG001|Overall Study|Withdrawal by Subject|6|||
127505487|NCT00316693|458811271|FG000|Overall Study|Lost to Follow-up|26|||
127505488|NCT00316693|458811272|FG001|Overall Study|Lost to Follow-up|34|||
127505489|NCT00316693|458811271|FG000|Overall Study|Other|38|||
127505490|NCT00316693|458811272|FG001|Overall Study|Other|44|||
127505491|NCT01967823|458811273|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
127505492|NCT03002818|458811276|FG000|Overall Study|Decision of the investigator|1|||
127505493|NCT00711113|458811280|FG000|Overall Study|Lost to Follow-up|9|||
127505494|NCT00711113|458811280|FG000|Overall Study|Implant lost|2|||
127505495|NCT01257568|458811287|FG000|Overall Study|Lost to Follow-up|2|||
127505496|NCT01257568|458811287|FG000|Overall Study|Withdrawal by Subject|6|||
127505497|NCT01257568|458811287|FG000|Overall Study|Terminated|1|||
127505498|NCT01257568|458811287|FG000|Overall Study|Component Revision|24|||
127505499|NCT03392883|458811288|FG000|Overall Study|Lost to Follow-up|122|||
127505500|NCT03392883|458811289|FG001|Overall Study|Lost to Follow-up|13|||
127505501|NCT03392883|458811290|FG002|Overall Study|Lost to Follow-up|9|||
127505502|NCT03392883|458811288|FG000|Overall Study|Death|4|||
127505503|NCT03392883|458811289|FG001|Overall Study|Death|0|||
127505504|NCT03392883|458811290|FG002|Overall Study|Death|0|||
127505505|NCT03392883|458811288|FG000|Overall Study|Lack of Efficacy|29|||
127505506|NCT03392883|458811289|FG001|Overall Study|Lack of Efficacy|0|||
127505507|NCT03392883|458811290|FG002|Overall Study|Lack of Efficacy|0|||
127505508|NCT03392883|458811288|FG000|Overall Study|Withdrawal by Subject|180|||
127505509|NCT03392883|458811289|FG001|Overall Study|Withdrawal by Subject|0|||
127505510|NCT03392883|458811290|FG002|Overall Study|Withdrawal by Subject|0|||
127505511|NCT03392883|458811288|FG000|Overall Study|Adverse Event|1|||
127505512|NCT03392883|458811289|FG001|Overall Study|Adverse Event|0|||
127505513|NCT03392883|458811290|FG002|Overall Study|Adverse Event|0|||
127505514|NCT01728077|458811291|FG000|Overall Study|Lack of Efficacy|3|||
127505515|NCT01728077|458811292|FG001|Overall Study|Lack of Efficacy|1|||
127505516|NCT01728077|458811291|FG000|Overall Study|Lost to Follow-up|1|||
127505517|NCT01728077|458811292|FG001|Overall Study|Lost to Follow-up|0|||
127505518|NCT01728077|458811291|FG000|Overall Study|Subject choice|2|||
127505519|NCT01728077|458811292|FG001|Overall Study|Subject choice|3|||
127505520|NCT01728077|458811291|FG000|Overall Study|Death|0|||
127505521|NCT01728077|458811292|FG001|Overall Study|Death|1|||
127505522|NCT01728077|458811291|FG000|Overall Study|Patient moving|1|||
127505523|NCT01728077|458811292|FG001|Overall Study|Patient moving|0|||
127505524|NCT01728077|458811291|FG000|Overall Study|Non compliance|1|||
127505525|NCT01728077|458811292|FG001|Overall Study|Non compliance|0|||
127505526|NCT00322023|458811293|FG000|Overall Study|various|0|||
127505527|NCT00322023|458811294|FG001|Overall Study|various|2|||
127505528|NCT00322023|458811295|FG002|Overall Study|various|6|||
127505529|NCT00693017|458811296|FG000|Overall Study|Sponsor Decision|2|||
127505530|NCT00693017|458811297|FG001|Overall Study|Sponsor Decision|1|||
127505531|NCT00693017|458811296|FG000|Overall Study|Death|0|||
127505532|NCT00693017|458811297|FG001|Overall Study|Death|1|||
127505533|NCT01779856|458811302|FG000|Overall Study|Withdrawal by Subject|15|||
127505534|NCT01779856|458811302|FG000|Overall Study|Death|3|||
127505535|NCT01779856|458811302|FG000|Overall Study|Physician Decision|1|||
127505536|NCT01779856|458811302|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
127505537|NCT01779856|458811302|FG000|Overall Study|Delays in scheduling implant|1|||
127505538|NCT01779856|458811302|FG000|Overall Study|Subject ineligible for Implant|2|||
127505539|NCT04043234|458811303|FG000|Overall Study|Lost to Follow-up|1|||
127505540|NCT04043234|458811303|FG000|Overall Study|Withdrawal by Subject|1|||
127505541|NCT01155466|458811304|FG000|Overall Study|Adverse Event|13|||
127505542|NCT01155466|458811305|FG001|Overall Study|Adverse Event|15|||
127505543|NCT01155466|458811306|FG002|Overall Study|Adverse Event|6|||
127505544|NCT01155466|458811307|FG003|Overall Study|Adverse Event|17|||
127505545|NCT01155466|458811308|FG004|Overall Study|Adverse Event|18|||
127505546|NCT01155466|458811304|FG000|Overall Study|Lost to Follow-up|0|||
127505547|NCT01155466|458811305|FG001|Overall Study|Lost to Follow-up|0|||
127505548|NCT01155466|458811306|FG002|Overall Study|Lost to Follow-up|0|||
127505549|NCT01155466|458811307|FG003|Overall Study|Lost to Follow-up|0|||
127505550|NCT01155466|458811308|FG004|Overall Study|Lost to Follow-up|2|||
127505551|NCT01155466|458811304|FG000|Overall Study|Withdrawal by Subject|7|||
127505552|NCT01155466|458811305|FG001|Overall Study|Withdrawal by Subject|5|||
127505553|NCT01155466|458811306|FG002|Overall Study|Withdrawal by Subject|9|||
127505554|NCT01155466|458811307|FG003|Overall Study|Withdrawal by Subject|4|||
127505555|NCT01155466|458811308|FG004|Overall Study|Withdrawal by Subject|4|||
127505556|NCT01155466|458811304|FG000|Overall Study|Protocol Violation|0|||
127505557|NCT01155466|458811305|FG001|Overall Study|Protocol Violation|0|||
127505558|NCT01155466|458811306|FG002|Overall Study|Protocol Violation|2|||
127505559|NCT01155466|458811307|FG003|Overall Study|Protocol Violation|0|||
127505560|NCT01155466|458811308|FG004|Overall Study|Protocol Violation|1|||
127505561|NCT01155466|458811304|FG000|Overall Study|Administrative|0|||
127505562|NCT01155466|458811305|FG001|Overall Study|Administrative|3|||
127505563|NCT01155466|458811306|FG002|Overall Study|Administrative|0|||
127505564|NCT01155466|458811307|FG003|Overall Study|Administrative|0|||
127505565|NCT01155466|458811308|FG004|Overall Study|Administrative|0|||
127505566|NCT01155466|458811304|FG000|Overall Study|Randomized not treated|2|||
127505567|NCT01155466|458811305|FG001|Overall Study|Randomized not treated|2|||
127505568|NCT01155466|458811306|FG002|Overall Study|Randomized not treated|3|||
127505569|NCT01155466|458811307|FG003|Overall Study|Randomized not treated|0|||
127505570|NCT01155466|458811308|FG004|Overall Study|Randomized not treated|2|||
127505571|NCT02210689|458811309|FG000|Overall Study|Withdrawal by Subject|7|||
127505572|NCT02210689|458811310|FG001|Overall Study|Withdrawal by Subject|4|||
127505573|NCT02210689|458811311|FG002|Overall Study|Withdrawal by Subject|2|||
127505574|NCT02210689|458811309|FG000|Overall Study|Adverse Event|0|||
127505575|NCT02210689|458811310|FG001|Overall Study|Adverse Event|1|||
127505576|NCT02210689|458811311|FG002|Overall Study|Adverse Event|0|||
127505577|NCT02210689|458811309|FG000|Overall Study|Protocol Violation|1|||
127505578|NCT02210689|458811310|FG001|Overall Study|Protocol Violation|0|||
127505579|NCT02210689|458811311|FG002|Overall Study|Protocol Violation|0|||
127505580|NCT02210689|458811309|FG000|Overall Study|Lost to Follow-up|11|||
127505581|NCT02210689|458811310|FG001|Overall Study|Lost to Follow-up|9|||
127505582|NCT02210689|458811311|FG002|Overall Study|Lost to Follow-up|5|||
127505583|NCT02210689|458811309|FG000|Overall Study|Pregnancy|0|||
127505584|NCT02210689|458811310|FG001|Overall Study|Pregnancy|1|||
127505585|NCT02210689|458811311|FG002|Overall Study|Pregnancy|0|||
127505586|NCT02210689|458811309|FG000|Overall Study|Lack of Efficacy|0|||
127505587|NCT02210689|458811310|FG001|Overall Study|Lack of Efficacy|1|||
127505588|NCT02210689|458811311|FG002|Overall Study|Lack of Efficacy|5|||
127505589|NCT02210689|458811309|FG000|Overall Study|Prohibited medication|2|||
127505590|NCT02210689|458811310|FG001|Overall Study|Prohibited medication|8|||
127505591|NCT02210689|458811311|FG002|Overall Study|Prohibited medication|1|||
127505592|NCT02210689|458811309|FG000|Overall Study|Negative Nugent score at baseline|6|||
127505593|NCT02210689|458811310|FG001|Overall Study|Negative Nugent score at baseline|2|||
127505594|NCT02210689|458811311|FG002|Overall Study|Negative Nugent score at baseline|2|||
127505595|NCT02210689|458811309|FG000|Overall Study|Other|25|||
127505596|NCT02210689|458811310|FG001|Overall Study|Other|21|||
127505597|NCT02210689|458811311|FG002|Overall Study|Other|8|||
127505598|NCT00223977|458811315|FG000|Overall Study|Adverse Event|7|||
127505599|NCT00223977|458811316|FG001|Overall Study|Adverse Event|10|||
127505600|NCT00223977|458811317|FG002|Overall Study|Adverse Event|0|||
127505601|NCT00223977|458811315|FG000|Overall Study|Protocol Violation|0|||
127505602|NCT00223977|458811316|FG001|Overall Study|Protocol Violation|0|||
127505603|NCT00223977|458811317|FG002|Overall Study|Protocol Violation|1|||
127505604|NCT00223977|458811315|FG000|Overall Study|Withdrawal by Subject|1|||
127505605|NCT00223977|458811316|FG001|Overall Study|Withdrawal by Subject|1|||
127505606|NCT00223977|458811317|FG002|Overall Study|Withdrawal by Subject|2|||
127505607|NCT00223977|458811315|FG000|Overall Study|Other|1|||
127505608|NCT00223977|458811316|FG001|Overall Study|Other|0|||
127505609|NCT00223977|458811317|FG002|Overall Study|Other|0|||
127505610|NCT03136497|458811318|FG000|Overall Study|Screen Failure|1|||
127505611|NCT03136497|458811319|FG001|Overall Study|Screen Failure|0|||
127505612|NCT03136497|458811320|FG002|Overall Study|Screen Failure|0|||
127505613|NCT00557310|458811323|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
127505614|NCT00557310|458811323|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
127505615|NCT00557310|458811323|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
127978608|NCT00878969|460544119|FG000|Overall Study|Adverse Event|3|||
127978609|NCT00878969|460544120|FG001|Overall Study|Adverse Event|1|||
127978610|NCT00878969|460544121|FG002|Overall Study|Adverse Event|2|||
127978611|NCT00878969|460544119|FG000|Overall Study|Lost to Follow-up|2|||
127978612|NCT00878969|460544120|FG001|Overall Study|Lost to Follow-up|1|||
127978613|NCT00878969|460544121|FG002|Overall Study|Lost to Follow-up|0|||
127978614|NCT00878969|460544119|FG000|Overall Study|Protocol Violation|2|||
127978615|NCT00878969|460544120|FG001|Overall Study|Protocol Violation|0|||
127978616|NCT00878969|460544121|FG002|Overall Study|Protocol Violation|0|||
127978617|NCT00878969|460544119|FG000|Overall Study|Death|0|||
127978618|NCT00878969|460544120|FG001|Overall Study|Death|0|||
127978619|NCT00878969|460544121|FG002|Overall Study|Death|2|||
127978620|NCT00878969|460544119|FG000|Overall Study|Pregnancy|0|||
127978621|NCT00878969|460544120|FG001|Overall Study|Pregnancy|1|||
127978622|NCT00878969|460544121|FG002|Overall Study|Pregnancy|0|||
127978623|NCT02083185|460544122|FG000|Overall Study|Lost to Follow-up|0|||
127978624|NCT02083185|460544123|FG001|Overall Study|Lost to Follow-up|3|||
127978625|NCT02083185|460544124|FG002|Overall Study|Lost to Follow-up|0|||
127978626|NCT02083185|460544122|FG000|Overall Study|Withdrawal by Subject|9|||
127978627|NCT02083185|460544123|FG001|Overall Study|Withdrawal by Subject|15|||
127978628|NCT02083185|460544124|FG002|Overall Study|Withdrawal by Subject|1|||
127978629|NCT02083185|460544122|FG000|Overall Study|Death|2|||
127978630|NCT02083185|460544123|FG001|Overall Study|Death|2|||
127978631|NCT02083185|460544124|FG002|Overall Study|Death|1|||
127978632|NCT02083185|460544122|FG000|Overall Study|Reason not Specified|9|||
127978633|NCT02083185|460544123|FG001|Overall Study|Reason not Specified|6|||
127978634|NCT02083185|460544124|FG002|Overall Study|Reason not Specified|5|||
127978635|NCT02083185|460544122|FG000|Overall Study|Study Terminated by Sponsor|0|||
127978636|NCT02083185|460544123|FG001|Overall Study|Study Terminated by Sponsor|1|||
127978637|NCT02083185|460544124|FG002|Overall Study|Study Terminated by Sponsor|0|||
127978638|NCT02083185|460544122|FG000|Overall Study|Did not Receive Study Drug|0|||
127978639|NCT02083185|460544123|FG001|Overall Study|Did not Receive Study Drug|2|||
127978640|NCT02083185|460544124|FG002|Overall Study|Did not Receive Study Drug|0|||
127978641|NCT00380081|460544125|FG000|Overall Study|Withdrawal by Subject|0|||
127978642|NCT00380081|460544126|FG001|Overall Study|Withdrawal by Subject|0|||
127978643|NCT00380081|460544127|FG002|Overall Study|Withdrawal by Subject|0|||
127978644|NCT00380081|460544128|FG003|Overall Study|Withdrawal by Subject|0|||
127978645|NCT00380081|460544129|FG004|Overall Study|Withdrawal by Subject|1|||
127978646|NCT00380081|460544130|FG005|Overall Study|Withdrawal by Subject|0|||
127978647|NCT00380081|460544125|FG000|Overall Study|Family Emergency|0|||
127978648|NCT00380081|460544126|FG001|Overall Study|Family Emergency|0|||
127978649|NCT00380081|460544127|FG002|Overall Study|Family Emergency|0|||
127978650|NCT00380081|460544128|FG003|Overall Study|Family Emergency|0|||
127978651|NCT00380081|460544129|FG004|Overall Study|Family Emergency|0|||
127978652|NCT00380081|460544130|FG005|Overall Study|Family Emergency|1|||
127978653|NCT03054064|460544131|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
127978654|NCT03054064|460544131|FG000|Overall Study|Investigator Decision|2|||
127978655|NCT03054064|460544131|FG000|Overall Study|Bladder Issue|1|||
127978656|NCT03054064|460544131|FG000|Overall Study|High Blood Pressure|1|||
127978657|NCT03054064|460544131|FG000|Overall Study|Change in Status|1|||
127978658|NCT03787303|460544132|FG000|Overall Study|Death|1|||
127978659|NCT03787303|460544132|FG000|Overall Study|Premature Termination of Study|1|||
127978660|NCT01384019|460544133|FG000|Overall Study|Withdrawal by Subject|3|||
127978661|NCT01384019|460544134|FG001|Overall Study|Withdrawal by Subject|0|||
127978662|NCT01384019|460544133|FG000|Overall Study|Death|1|||
127978663|NCT01384019|460544134|FG001|Overall Study|Death|0|||
127978664|NCT01384019|460544133|FG000|Overall Study|MRI refusal|6|||
127978665|NCT01384019|460544134|FG001|Overall Study|MRI refusal|6|||
127505616|NCT00557310|458811323|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
127978666|NCT04489381|460544139|FG000|Overall Study|Lost to Follow-up|2|||
127978667|NCT04489381|460544140|FG001|Overall Study|Lost to Follow-up|3|||
127505617|NCT00557310|458811323|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
127505618|NCT00557310|458811323|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
127505619|NCT00367744|458811328|FG000|Overall Study|Lost to Follow-up|4|||
127505620|NCT00367744|458811329|FG001|Overall Study|Lost to Follow-up|5|||
127505621|NCT01271712|458811333|FG000|Double Blind Treatment|Death|2|||
127505622|NCT01271712|458811334|FG001|Double Blind Treatment|Death|0|||
127505623|NCT01271712|458811333|FG000|Double Blind Treatment|Lack of Efficacy|1|||
127505624|NCT01271712|458811334|FG001|Double Blind Treatment|Lack of Efficacy|0|||
127505625|NCT01271712|458811333|FG000|Double Blind Treatment|Adverse Event|9|||
127505626|NCT01271712|458811334|FG001|Double Blind Treatment|Adverse Event|4|||
127505627|NCT01271712|458811333|FG000|Double Blind Treatment|Progressive disease|23|||
127505628|NCT01271712|458811334|FG001|Double Blind Treatment|Progressive disease|3|||
127505629|NCT01271712|458811333|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
127505630|NCT01271712|458811334|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
127505631|NCT01271712|458811333|FG000|Double Blind Treatment|Non compliance with study drug|2|||
127505632|NCT01271712|458811334|FG001|Double Blind Treatment|Non compliance with study drug|0|||
127505633|NCT01271712|458811333|FG000|Double Blind Treatment|receive no study drug|1|||
127505634|NCT01271712|458811334|FG001|Double Blind Treatment|receive no study drug|0|||
127505635|NCT01271712|458811333|FG000|Open Label Treatment|Death|6|||
127505636|NCT01271712|458811334|FG001|Open Label Treatment|Death|5|||
127505637|NCT01271712|458811333|FG000|Open Label Treatment|Withdrawal by Subject|6|||
127505638|NCT01271712|458811334|FG001|Open Label Treatment|Withdrawal by Subject|11|||
127505639|NCT01271712|458811333|FG000|Open Label Treatment|Physician Decision|2|||
127505640|NCT01271712|458811334|FG001|Open Label Treatment|Physician Decision|0|||
127505641|NCT01271712|458811333|FG000|Open Label Treatment|Adverse Event|14|||
127505642|NCT01271712|458811334|FG001|Open Label Treatment|Adverse Event|8|||
127505643|NCT01271712|458811333|FG000|Open Label Treatment|Progressive disease|59|||
127505644|NCT01271712|458811334|FG001|Open Label Treatment|Progressive disease|32|||
127505645|NCT01271712|458811333|FG000|Open Label Treatment|transferred to rollover study|1|||
127505646|NCT01271712|458811334|FG001|Open Label Treatment|transferred to rollover study|0|||
127505647|NCT01271712|458811333|FG000|Open Label Treatment|Non-compliance with study drug|1|||
127505648|NCT01271712|458811334|FG001|Open Label Treatment|Non-compliance with study drug|0|||
127505649|NCT01271712|458811333|FG000|Open Label Treatment|Protocol Violation|0|||
127505650|NCT01271712|458811334|FG001|Open Label Treatment|Protocol Violation|1|||
127505651|NCT01271712|458811333|FG000|Open Label Treatment|Switching to other therapy|2|||
127505652|NCT01271712|458811334|FG001|Open Label Treatment|Switching to other therapy|1|||
127505653|NCT01271712|458811333|FG000|Safety Follow-up|Death|11|||
127505654|NCT01271712|458811334|FG001|Safety Follow-up|Death|7|||
127505655|NCT01271712|458811333|FG000|Safety Follow-up|Withdrawal by Subject|4|||
127505656|NCT01271712|458811334|FG001|Safety Follow-up|Withdrawal by Subject|2|||
127505657|NCT01271712|458811333|FG000|Safety Follow-up|Protocol Violation|1|||
127505658|NCT01271712|458811334|FG001|Safety Follow-up|Protocol Violation|1|||
127505659|NCT01271712|458811333|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
127505660|NCT01271712|458811334|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
127505661|NCT01271712|458811333|FG000|Safety Follow-up|No follow-up|1|||
127505662|NCT01271712|458811334|FG001|Safety Follow-up|No follow-up|1|||
127505663|NCT01271712|458811333|FG000|Safety Follow-up|Progressive disease|1|||
127505664|NCT01271712|458811334|FG001|Safety Follow-up|Progressive disease|0|||
127505665|NCT01271712|458811333|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
127505666|NCT01271712|458811334|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
127505667|NCT00096226|458811337|FG000|Overall Study|Ineligible|2|||
127505668|NCT00096226|458811337|FG000|Overall Study|Protocol treatment not started|1|||
127505669|NCT01666119|458811338|FG000|Overall Study|Adverse Event|6|||
127505670|NCT01666119|458811338|FG000|Overall Study|Withdrawal by Subject|16|||
127505671|NCT01666119|458811338|FG000|Overall Study|Lost to Follow-up|7|||
127505672|NCT01666119|458811338|FG000|Overall Study|non compliance with study medication, pa|18|||
127505673|NCT01666119|458811338|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
127505674|NCT05479097|458811344|FG000|Overall Study|Withdrawal by Subject|2|||
127505675|NCT04003207|458811351|FG000|Overall Study|Protocol Violation|1|||
127505676|NCT03894969|458811352|FG000|Overall Study|Adverse Event|0|||
127505677|NCT03894969|458811353|FG001|Overall Study|Adverse Event|2|||
127505678|NCT03894969|458811354|FG002|Overall Study|Adverse Event|0|||
127505679|NCT03894969|458811355|FG003|Overall Study|Adverse Event|1|||
127505680|NCT03894969|458811356|FG004|Overall Study|Adverse Event|2|||
127505681|NCT03894969|458811352|FG000|Overall Study|Lost to Follow-up|3|||
127505682|NCT03894969|458811353|FG001|Overall Study|Lost to Follow-up|1|||
127505683|NCT03894969|458811354|FG002|Overall Study|Lost to Follow-up|1|||
127505684|NCT03894969|458811355|FG003|Overall Study|Lost to Follow-up|0|||
127505685|NCT03894969|458811356|FG004|Overall Study|Lost to Follow-up|0|||
127505686|NCT03894969|458811352|FG000|Overall Study|Withdrawal by Subject|2|||
127505687|NCT03894969|458811353|FG001|Overall Study|Withdrawal by Subject|1|||
127505688|NCT03894969|458811354|FG002|Overall Study|Withdrawal by Subject|3|||
127505689|NCT03894969|458811355|FG003|Overall Study|Withdrawal by Subject|4|||
127505690|NCT03894969|458811356|FG004|Overall Study|Withdrawal by Subject|8|||
127505691|NCT03894969|458811352|FG000|Overall Study|Other|0|||
127505692|NCT03894969|458811353|FG001|Overall Study|Other|0|||
127505693|NCT03894969|458811354|FG002|Overall Study|Other|0|||
127505694|NCT03894969|458811355|FG003|Overall Study|Other|0|||
127505695|NCT03894969|458811356|FG004|Overall Study|Other|3|||
127978668|NCT04489381|460544139|FG000|Overall Study|Withdrawal by Subject|1|||
127978669|NCT04489381|460544140|FG001|Overall Study|Withdrawal by Subject|0|||
127978670|NCT00525902|460544141|FG000|Overall Study|Lack of Efficacy|1|||
127978671|NCT00985959|460544142|FG000|Overall Study|Adverse Event|0|||
127978672|NCT00985959|460544143|FG001|Overall Study|Adverse Event|0|||
127978673|NCT00985959|460544144|FG002|Overall Study|Adverse Event|19|||
127978674|NCT00985959|460544142|FG000|Overall Study|Withdrawal by Subject|0|||
127978675|NCT00985959|460544143|FG001|Overall Study|Withdrawal by Subject|0|||
127978676|NCT00985959|460544144|FG002|Overall Study|Withdrawal by Subject|8|||
127978677|NCT00985959|460544142|FG000|Overall Study|Progressive disease|1|||
127978678|NCT00985959|460544143|FG001|Overall Study|Progressive disease|2|||
127978679|NCT00985959|460544144|FG002|Overall Study|Progressive disease|8|||
127978680|NCT00985959|460544142|FG000|Overall Study|Unrecovered toxicity|0|||
127978681|NCT00985959|460544143|FG001|Overall Study|Unrecovered toxicity|0|||
127978682|NCT00985959|460544144|FG002|Overall Study|Unrecovered toxicity|7|||
127978683|NCT00985959|460544142|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
127978684|NCT00985959|460544143|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
127978685|NCT00985959|460544144|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
127978686|NCT00985959|460544142|FG000|Overall Study|Complete response observed over 2 cycles|0|||
127978687|NCT00985959|460544143|FG001|Overall Study|Complete response observed over 2 cycles|1|||
127978688|NCT00985959|460544144|FG002|Overall Study|Complete response observed over 2 cycles|4|||
127978689|NCT00985959|460544142|FG000|Overall Study|Other|0|||
127978690|NCT00985959|460544143|FG001|Overall Study|Other|0|||
127978691|NCT00985959|460544144|FG002|Overall Study|Other|11|||
127978692|NCT02858180|460544149|FG000|Overall Study|Lost to Follow-up|0|||
127978693|NCT02858180|460544150|FG001|Overall Study|Lost to Follow-up|2|||
127978694|NCT00526331|460544151|FG000|Overall Study|Sponsor Termination|55|||
127978695|NCT00574249|460544153|FG000|Overall Study|Adverse Event|6|||
127978696|NCT00574249|460544154|FG001|Overall Study|Adverse Event|18|||
127978697|NCT00574249|460544153|FG000|Overall Study|Lack of Efficacy|5|||
127978698|NCT00574249|460544154|FG001|Overall Study|Lack of Efficacy|3|||
127978699|NCT00574249|460544153|FG000|Overall Study|Lost to Follow-up|4|||
127978700|NCT00574249|460544154|FG001|Overall Study|Lost to Follow-up|3|||
127978701|NCT00574249|460544153|FG000|Overall Study|Protocol Violation|5|||
127978702|NCT00574249|460544154|FG001|Overall Study|Protocol Violation|2|||
127978703|NCT00574249|460544153|FG000|Overall Study|History of carcinoma|1|||
127978704|NCT00574249|460544154|FG001|Overall Study|History of carcinoma|0|||
127978705|NCT00574249|460544153|FG000|Overall Study|Withdrawal by Subject|3|||
127978706|NCT00574249|460544154|FG001|Overall Study|Withdrawal by Subject|0|||
127978707|NCT00574249|460544153|FG000|Overall Study|Physician Decision|1|||
127978708|NCT00574249|460544154|FG001|Overall Study|Physician Decision|0|||
127978709|NCT00574249|460544153|FG000|Overall Study|Pregnancy|1|||
127978710|NCT00574249|460544154|FG001|Overall Study|Pregnancy|0|||
127978711|NCT00574249|460544153|FG000|Overall Study|Excluded by company|0|||
127978712|NCT00574249|460544154|FG001|Overall Study|Excluded by company|1|||
127978713|NCT00574249|460544153|FG000|Overall Study|PPD test taken twice|0|||
127978714|NCT00574249|460544154|FG001|Overall Study|PPD test taken twice|1|||
127978715|NCT01123941|460544156|FG000|Overall Study|Lost to Follow-up|2|||
127978716|NCT01123941|460544157|FG001|Overall Study|Lost to Follow-up|1|||
127978717|NCT04601103|460544158|FG000|Overall Study|Needed crown & cleaning|0|||
127978718|NCT04601103|460544159|FG001|Overall Study|Needed crown & cleaning|0|||
127978719|NCT04601103|460544160|FG002|Overall Study|Needed crown & cleaning|1|||
127978720|NCT04601103|460544158|FG000|Overall Study|study was terminated|18|||
127978721|NCT04601103|460544159|FG001|Overall Study|study was terminated|18|||
127978722|NCT04601103|460544160|FG002|Overall Study|study was terminated|16|||
127978723|NCT06011161|460544161|FG000|Overall Study|Withdrawal by Subject|2|||
127978724|NCT06011161|460544161|FG000|Overall Study|Lost to Follow-up|5|||
127978725|NCT00381043|460544162|FG000|Overall Study|Lost to Follow-up|8|||
127978726|NCT00381043|460544163|FG001|Overall Study|Lost to Follow-up|6|||
127978727|NCT00381043|460544162|FG000|Overall Study|Withdrawal by Subject|3|||
127978728|NCT00381043|460544163|FG001|Overall Study|Withdrawal by Subject|1|||
127978729|NCT00381043|460544162|FG000|Overall Study|wanted more care|0|||
127505696|NCT03894969|458811352|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
127978730|NCT00381043|460544163|FG001|Overall Study|wanted more care|1|||
127978731|NCT00381043|460544162|FG000|Overall Study|incarcerated|1|||
127978732|NCT00381043|460544163|FG001|Overall Study|incarcerated|0|||
127978733|NCT03045276|460544166|FG000|Intervention Phase|Withdrawal by Subject|7|||
127978734|NCT03045276|460544167|FG001|Intervention Phase|Withdrawal by Subject|2|||
127978735|NCT03045276|460544168|FG002|Intervention Phase|Withdrawal by Subject|3|||
127978736|NCT03045276|460544169|FG003|Intervention Phase|Withdrawal by Subject|7|||
127978737|NCT03045276|460544166|FG000|Intervention Phase|Developed exclusionary criteria|3|||
127978738|NCT03045276|460544167|FG001|Intervention Phase|Developed exclusionary criteria|3|||
127978739|NCT03045276|460544168|FG002|Intervention Phase|Developed exclusionary criteria|0|||
127505697|NCT03894969|458811353|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
127505698|NCT03894969|458811354|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
127505699|NCT03894969|458811355|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
127505700|NCT03894969|458811356|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
127505701|NCT03894969|458811352|FG000|Overall Study|Solicited Adverse Event|0|||
127505702|NCT03894969|458811353|FG001|Overall Study|Solicited Adverse Event|1|||
127505703|NCT03894969|458811354|FG002|Overall Study|Solicited Adverse Event|0|||
127505704|NCT03894969|458811355|FG003|Overall Study|Solicited Adverse Event|0|||
127505705|NCT03894969|458811356|FG004|Overall Study|Solicited Adverse Event|0|||
127505706|NCT00468676|458811358|FG000|Overall Study|Lost to Follow-up|14|||
127505707|NCT00468676|458811359|FG001|Overall Study|Lost to Follow-up|11|||
127505708|NCT00468676|458811358|FG000|Overall Study|Death|2|||
127505709|NCT00468676|458811359|FG001|Overall Study|Death|1|||
127505710|NCT00118846|458811367|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
127505711|NCT00118846|458811368|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
127505712|NCT00118846|458811367|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
127505713|NCT00118846|458811368|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
127505714|NCT00118846|458811367|FG000|Overall Study|Physician Decision|1|||
127505715|NCT00118846|458811368|FG001|Overall Study|Physician Decision|0|||
127505716|NCT00118846|458811367|FG000|Overall Study|Medical condition|2|||
127505717|NCT00118846|458811368|FG001|Overall Study|Medical condition|2|||
127505718|NCT00118846|458811367|FG000|Overall Study|Lost to Follow-up|0|||
127505719|NCT00118846|458811368|FG001|Overall Study|Lost to Follow-up|2|||
127505720|NCT00118846|458811367|FG000|Overall Study|Personal reason|4|||
127505721|NCT00118846|458811368|FG001|Overall Study|Personal reason|5|||
127505722|NCT00443053|458811369|FG000|Overall Study|Adverse Event|2|||
127505723|NCT00443053|458811370|FG001|Overall Study|Adverse Event|1|||
127505724|NCT00443053|458811369|FG000|Overall Study|Withdrawal by Subject|9|||
127505725|NCT00443053|458811370|FG001|Overall Study|Withdrawal by Subject|18|||
127505726|NCT00443053|458811369|FG000|Overall Study|Lost to Follow-up|4|||
127505727|NCT00443053|458811370|FG001|Overall Study|Lost to Follow-up|5|||
127505728|NCT00443053|458811369|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
127505729|NCT00443053|458811370|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
127505730|NCT00443053|458811369|FG000|Overall Study|Noncompliance|2|||
127505731|NCT00443053|458811370|FG001|Overall Study|Noncompliance|1|||
127505732|NCT00443053|458811369|FG000|Overall Study|Other|3|||
127505733|NCT00443053|458811370|FG001|Overall Study|Other|4|||
127505734|NCT00443053|458811369|FG000|Overall Study|Physician Decision|0|||
127505735|NCT00443053|458811370|FG001|Overall Study|Physician Decision|4|||
127505736|NCT01327053|458811371|FG000|Overall Study|Adverse Event|23|||
127505737|NCT01327053|458811372|FG001|Overall Study|Adverse Event|57|||
127505738|NCT01327053|458811371|FG000|Overall Study|Patient/guardian decision|11|||
127505739|NCT01327053|458811372|FG001|Overall Study|Patient/guardian decision|35|||
127505740|NCT01327053|458811371|FG000|Overall Study|Physician Decision|10|||
127505741|NCT01327053|458811372|FG001|Overall Study|Physician Decision|14|||
127505742|NCT01327053|458811371|FG000|Overall Study|Death|1|||
127505743|NCT01327053|458811372|FG001|Overall Study|Death|5|||
127505744|NCT01327053|458811371|FG000|Overall Study|Lost to Follow-up|2|||
127505745|NCT01327053|458811372|FG001|Overall Study|Lost to Follow-up|4|||
127505746|NCT01327053|458811371|FG000|Overall Study|Non-compliance with study treatment|0|||
127505747|NCT01327053|458811372|FG001|Overall Study|Non-compliance with study treatment|5|||
127505748|NCT01327053|458811371|FG000|Overall Study|Study terminated by Sponsor|1|||
127505749|NCT01327053|458811372|FG001|Overall Study|Study terminated by Sponsor|3|||
127505750|NCT01327053|458811371|FG000|Overall Study|Progressive disease|31|||
127505751|NCT01327053|458811372|FG001|Overall Study|Progressive disease|26|||
127505752|NCT01327053|458811371|FG000|Overall Study|Protocol Violation|0|||
127505753|NCT01327053|458811372|FG001|Overall Study|Protocol Violation|1|||
127505754|NCT01327053|458811371|FG000|Overall Study|Untreated|0|||
127505755|NCT01327053|458811372|FG001|Overall Study|Untreated|1|||
127505756|NCT01574157|458811373|FG000|Overall Study|Withdrawal by Subject|4|||
127505757|NCT01574157|458811374|FG001|Overall Study|Withdrawal by Subject|5|||
127505758|NCT01574157|458811373|FG000|Overall Study|Lost to Follow-up|0|||
127505759|NCT01574157|458811374|FG001|Overall Study|Lost to Follow-up|3|||
127505760|NCT00721578|458811375|FG000|Overall Study|Death|1|||
127505761|NCT00721578|458811376|FG001|Overall Study|Death|1|||
127505762|NCT00721578|458811375|FG000|Overall Study|Withdrawal by Subject|1|||
127505763|NCT00721578|458811376|FG001|Overall Study|Withdrawal by Subject|1|||
127505764|NCT02910401|458811380|FG000|Overall Study|Study closure Study closure|0|||
127505765|NCT02910401|458811381|FG001|Overall Study|Study closure Study closure|0|||
127978740|NCT03045276|460544169|FG003|Intervention Phase|Developed exclusionary criteria|0|||
127505766|NCT02910401|458811382|FG002|Overall Study|Study closure Study closure|2|||
127505767|NCT02910401|458811380|FG000|Overall Study|Physician Decision|1|||
127505768|NCT02910401|458811381|FG001|Overall Study|Physician Decision|0|||
127505769|NCT02910401|458811382|FG002|Overall Study|Physician Decision|0|||
127505770|NCT03300024|458811383|FG000|Overall Study|Physician Decision|4|||
127505771|NCT03300024|458811384|FG001|Overall Study|Physician Decision|6|||
127505772|NCT00570037|458811385|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
127505773|NCT00570037|458811386|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
127505774|NCT01263015|458813659|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
127505775|NCT01263015|458813660|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
127505776|NCT01263015|458813659|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
127505777|NCT01263015|458813660|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
127505778|NCT01263015|458813659|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
127505779|NCT01263015|458813660|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
127505780|NCT01263015|458813659|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
127505781|NCT01263015|458813660|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
127505782|NCT01263015|458813659|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
127505783|NCT01263015|458813660|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
127505784|NCT01263015|458813659|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
127505785|NCT01263015|458813660|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
127505786|NCT01263015|458813659|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
127505787|NCT01263015|458813660|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
127505788|NCT01263015|458813659|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
127505789|NCT01263015|458813660|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
127505790|NCT01263015|458813659|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
127505791|NCT01263015|458813660|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
127505792|NCT01263015|458813659|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
127505793|NCT01263015|458813660|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
127505794|NCT01263015|458813659|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
127505795|NCT01263015|458813660|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
127505796|NCT01263015|458813659|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
127505797|NCT01263015|458813660|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
127505798|NCT00132691|458813678|FG000|Overall Study|Lost to Follow-up|5|||
127505799|NCT00132691|458813679|FG001|Overall Study|Lost to Follow-up|8|||
127505800|NCT00132691|458813678|FG000|Overall Study|Missed 2-year visit|4|||
127505801|NCT00132691|458813679|FG001|Overall Study|Missed 2-year visit|4|||
127505802|NCT00132691|458813678|FG000|Overall Study|Death|2|||
127505803|NCT00132691|458813679|FG001|Overall Study|Death|0|||
127505804|NCT01739933|458813680|FG000|Overall Study|Death|89|||
127505805|NCT01739933|458813681|FG001|Overall Study|Death|86|||
127505806|NCT01739933|458813680|FG000|Overall Study|Withdrawal by Subject|10|||
127505807|NCT01739933|458813681|FG001|Overall Study|Withdrawal by Subject|8|||
127505808|NCT01739933|458813680|FG000|Overall Study|Lost to Follow-up|3|||
127505809|NCT01739933|458813681|FG001|Overall Study|Lost to Follow-up|10|||
127505810|NCT01739933|458813680|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
127505811|NCT01739933|458813681|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
127505812|NCT04098367|458813682|FG000|Overall Study|Adverse Event|0|||
127505813|NCT04098367|458813683|FG001|Overall Study|Adverse Event|0|||
127505814|NCT04098367|458813684|FG002|Overall Study|Adverse Event|1|||
127505815|NCT04098367|458813682|FG000|Overall Study|Lost to Follow-up|1|||
127505816|NCT04098367|458813683|FG001|Overall Study|Lost to Follow-up|5|||
127505817|NCT04098367|458813684|FG002|Overall Study|Lost to Follow-up|2|||
127505818|NCT04098367|458813682|FG000|Overall Study|Withdrawal by Subject|0|||
127505819|NCT04098367|458813683|FG001|Overall Study|Withdrawal by Subject|0|||
127505820|NCT04098367|458813684|FG002|Overall Study|Withdrawal by Subject|1|||
127505821|NCT04098367|458813682|FG000|Overall Study|Sick . Could not attend visit|1|||
127505822|NCT04098367|458813683|FG001|Overall Study|Sick . Could not attend visit|0|||
127505823|NCT04098367|458813684|FG002|Overall Study|Sick . Could not attend visit|0|||
127978741|NCT03045276|460544166|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
127978742|NCT03045276|460544167|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
127978743|NCT03045276|460544168|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
127978744|NCT03045276|460544169|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
127978745|NCT03045276|460544166|FG000|Follow-Up Phase|Lost to Follow-up|0|||
127978746|NCT03045276|460544167|FG001|Follow-Up Phase|Lost to Follow-up|1|||
127978747|NCT03045276|460544168|FG002|Follow-Up Phase|Lost to Follow-up|0|||
127978748|NCT03045276|460544169|FG003|Follow-Up Phase|Lost to Follow-up|1|||
127978749|NCT03045276|460544166|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
127505824|NCT01231321|458813690|FG000|Overall Study|Adverse Event|3|||
127505825|NCT01231321|458813690|FG000|Overall Study|Lack of Efficacy|2|||
127505826|NCT00354107|458813698|FG000|Overall Study|Adverse Event|2|||
127505827|NCT00354107|458813698|FG000|Overall Study|Physician Decision|2|||
127505828|NCT00354107|458813698|FG000|Overall Study|Withdrawal by Subject|1|||
127505829|NCT03575065|458813701|FG000|Overall Study|Death|31|||
127505830|NCT03575065|458813702|FG001|Overall Study|Death|12|||
127505831|NCT03575065|458813701|FG000|Overall Study|Sponsor's Decision|28|||
127505832|NCT03575065|458813702|FG001|Overall Study|Sponsor's Decision|13|||
127978750|NCT03045276|460544167|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
127978751|NCT03045276|460544168|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
127978752|NCT03045276|460544169|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
127505833|NCT03575065|458813701|FG000|Overall Study|Withdrawal by Subject|2|||
127505834|NCT03575065|458813702|FG001|Overall Study|Withdrawal by Subject|1|||
127505835|NCT03575065|458813701|FG000|Overall Study|Lost to Follow-up|1|||
127505836|NCT03575065|458813702|FG001|Overall Study|Lost to Follow-up|0|||
127505837|NCT01685801|458813703|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
127505838|NCT01685801|458813704|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
127505839|NCT01685801|458813705|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
127505840|NCT01685801|458813706|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
127505841|NCT01685801|458813703|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
127505842|NCT01685801|458813704|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
127505843|NCT01685801|458813705|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
127505844|NCT01685801|458813706|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
127505845|NCT00396136|458813707|FG000|Overall Study|Death|43|||
127505846|NCT00396136|458813707|FG000|Overall Study|Withdrawal by Subject|59|||
127505847|NCT00396136|458813707|FG000|Overall Study|Lost to Follow-up|15|||
127505848|NCT00396136|458813707|FG000|Overall Study|Study device explanted|8|||
127505849|NCT04686084|458813708|FG000|Overall Study|Lost to Follow-up|1|||
127505850|NCT03350256|458813709|FG000|Overall Study|Inclusion/exclusion violation|4|||
127505851|NCT03350256|458813709|FG000|Overall Study|Recommended for other therapies|2|||
127505852|NCT03350256|458813709|FG000|Overall Study|Protocol Violation|3|||
127505853|NCT03350256|458813709|FG000|Overall Study|Non compliance|2|||
127505854|NCT03350256|458813709|FG000|Overall Study|Denial by insurance|1|||
127505855|NCT03350256|458813709|FG000|Overall Study|Adverse Event|2|||
127505856|NCT03350256|458813709|FG000|Overall Study|Trial failure|12|||
127505857|NCT03350256|458813709|FG000|Overall Study|Did not proceed to permanent implant|3|||
127505858|NCT03350256|458813709|FG000|Overall Study|Withdrawal by Subject|3|||
127505859|NCT03350256|458813709|FG000|Overall Study|Subject moving out of state|1|||
127505860|NCT03350256|458813709|FG000|Overall Study|Lost to Follow-up|1|||
127505861|NCT03350256|458813709|FG000|Overall Study|Lack of Efficacy|2|||
127505862|NCT03960580|458813710|FG000|Overall Study|Adverse Event|2|||
127505863|NCT03960580|458813711|FG001|Overall Study|Adverse Event|1|||
127505864|NCT03960580|458813712|FG002|Overall Study|Adverse Event|1|||
127505865|NCT03960580|458813710|FG000|Overall Study|Lost to Follow-up|1|||
127505866|NCT03960580|458813711|FG001|Overall Study|Lost to Follow-up|0|||
127505867|NCT03960580|458813712|FG002|Overall Study|Lost to Follow-up|0|||
127505868|NCT03960580|458813710|FG000|Overall Study|Lack of Efficacy|2|||
127505869|NCT03960580|458813711|FG001|Overall Study|Lack of Efficacy|1|||
127505870|NCT03960580|458813712|FG002|Overall Study|Lack of Efficacy|0|||
127505871|NCT03960580|458813710|FG000|Overall Study|Protocol Violation|0|||
127505872|NCT03960580|458813711|FG001|Overall Study|Protocol Violation|0|||
127505873|NCT03960580|458813712|FG002|Overall Study|Protocol Violation|1|||
127505874|NCT03960580|458813710|FG000|Overall Study|Withdrawal by Subject|1|||
127505875|NCT03960580|458813711|FG001|Overall Study|Withdrawal by Subject|1|||
127505876|NCT03960580|458813712|FG002|Overall Study|Withdrawal by Subject|1|||
127505877|NCT03960580|458813710|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
127505878|NCT03960580|458813711|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
127505879|NCT03960580|458813712|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
127505880|NCT03447314|458813720|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
127505881|NCT03447314|458813721|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
127505882|NCT03447314|458813722|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
127505883|NCT03447314|458813723|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
127505884|NCT03447314|458813724|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
127505885|NCT03447314|458813725|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
127505886|NCT03447314|458813726|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
127505887|NCT03447314|458813727|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
127505888|NCT03447314|458813728|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
127505889|NCT03447314|458813729|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
127505890|NCT03447314|458813730|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
127505891|NCT03447314|458813731|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
127978753|NCT04713592|460544172|FG000|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
127978754|NCT04713592|460544173|FG001|Double-blind Period (Baseline - Week 16)|Adverse Event|1|||
127978755|NCT04713592|460544174|FG002|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
127978756|NCT04713592|460544175|FG003|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
127505892|NCT03447314|458813732|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
127505893|NCT03447314|458813733|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
127505894|NCT03447314|458813734|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
127505895|NCT03447314|458813735|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
127505896|NCT03447314|458813736|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
127505897|NCT03447314|458813737|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
127505898|NCT03447314|458813720|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
127505899|NCT03447314|458813721|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
127505900|NCT03447314|458813722|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
127505901|NCT03447314|458813723|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
127978757|NCT04713592|460544172|FG000|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|6|||
127505902|NCT03447314|458813724|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
127505903|NCT03447314|458813725|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
127505904|NCT03447314|458813726|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
127505905|NCT03447314|458813727|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
127505906|NCT03447314|458813728|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
127505907|NCT03447314|458813729|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
127505908|NCT03447314|458813730|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
127505909|NCT03447314|458813731|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
127505910|NCT03447314|458813732|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
127505911|NCT03447314|458813733|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
127505912|NCT03447314|458813734|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
127505913|NCT03447314|458813735|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
127505914|NCT03447314|458813736|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
127505915|NCT03447314|458813737|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
127505916|NCT03447314|458813720|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
127505917|NCT03447314|458813721|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
127505918|NCT03447314|458813722|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
127505919|NCT03447314|458813723|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
127505920|NCT03447314|458813724|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
127505921|NCT03447314|458813725|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
127505922|NCT03447314|458813726|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
127505923|NCT03447314|458813727|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
127505924|NCT03447314|458813728|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
127505925|NCT03447314|458813729|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
127505926|NCT03447314|458813730|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
127505927|NCT03447314|458813731|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
127505928|NCT03447314|458813732|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
127505929|NCT03447314|458813733|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
127505930|NCT03447314|458813734|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
127505931|NCT03447314|458813735|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
127505932|NCT03447314|458813736|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
127505933|NCT03447314|458813737|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
127505934|NCT03447314|458813720|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
127505935|NCT03447314|458813721|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
127505936|NCT03447314|458813722|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
127505937|NCT03447314|458813723|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
127505938|NCT03447314|458813724|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
127505939|NCT03447314|458813725|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
127505940|NCT03447314|458813726|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
127505941|NCT03447314|458813727|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
127505942|NCT03447314|458813728|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
127505943|NCT03447314|458813729|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
127505944|NCT03447314|458813730|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
127505945|NCT03447314|458813731|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
127505946|NCT03447314|458813732|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
127505947|NCT03447314|458813733|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
127505948|NCT03447314|458813734|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
127505949|NCT03447314|458813735|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
127505950|NCT03447314|458813736|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
127505951|NCT03447314|458813737|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
127505952|NCT03447314|458813720|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
127505953|NCT03447314|458813721|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
127505954|NCT03447314|458813722|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
127505955|NCT03447314|458813723|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
127505956|NCT03447314|458813724|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
127505957|NCT03447314|458813725|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
127505958|NCT03447314|458813726|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
127505959|NCT03447314|458813727|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
127505960|NCT03447314|458813728|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
127978758|NCT04713592|460544173|FG001|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|2|||
127505961|NCT03447314|458813729|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
127505962|NCT03447314|458813730|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
127505963|NCT03447314|458813731|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
127505964|NCT03447314|458813732|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
127505965|NCT03447314|458813733|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
127505966|NCT03447314|458813734|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
127505967|NCT03447314|458813735|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
127505968|NCT03447314|458813736|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
127505969|NCT03447314|458813737|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
127505970|NCT03447314|458813720|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
127505971|NCT03447314|458813721|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
127505972|NCT03447314|458813722|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
127505973|NCT03447314|458813723|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
127505974|NCT03447314|458813724|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
127505975|NCT03447314|458813725|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
127505976|NCT03447314|458813726|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
127505977|NCT03447314|458813727|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
127505978|NCT03447314|458813728|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
127505979|NCT03447314|458813729|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
127505980|NCT03447314|458813730|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
127505981|NCT03447314|458813731|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
127505982|NCT03447314|458813732|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
127505983|NCT03447314|458813733|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
127505984|NCT03447314|458813734|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
127505985|NCT03447314|458813735|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
127505986|NCT03447314|458813736|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
127505987|NCT03447314|458813737|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
127505988|NCT02359045|458813738|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
127505989|NCT02359045|458813739|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
127505990|NCT02359045|458813738|FG000|Overall Study|Lost to Follow-up|1|||
127505991|NCT02359045|458813739|FG001|Overall Study|Lost to Follow-up|1|||
127505992|NCT02359045|458813738|FG000|Overall Study|Adverse Event|0|||
127505993|NCT02359045|458813739|FG001|Overall Study|Adverse Event|1|||
127505994|NCT04600076|458813742|FG000|Overall Study|Lost to Follow-up|3|||
127505995|NCT00541866|458813743|FG000|Overall Study|Adverse Event|3|||
127505996|NCT00541866|458813744|FG001|Overall Study|Adverse Event|0|||
127505997|NCT00541866|458813745|FG002|Overall Study|Adverse Event|0|||
127505998|NCT00541866|458813746|FG003|Overall Study|Adverse Event|0|||
127505999|NCT00541866|458813747|FG004|Overall Study|Adverse Event|0|||
127506000|NCT00541866|458813743|FG000|Overall Study|Death|1|||
127506001|NCT00541866|458813744|FG001|Overall Study|Death|0|||
127506002|NCT00541866|458813745|FG002|Overall Study|Death|0|||
127506003|NCT00541866|458813746|FG003|Overall Study|Death|0|||
127506004|NCT00541866|458813747|FG004|Overall Study|Death|0|||
127506005|NCT00541866|458813743|FG000|Overall Study|Lack of Efficacy|19|||
127506006|NCT00541866|458813744|FG001|Overall Study|Lack of Efficacy|15|||
127506007|NCT00541866|458813745|FG002|Overall Study|Lack of Efficacy|10|||
127506008|NCT00541866|458813746|FG003|Overall Study|Lack of Efficacy|12|||
127506009|NCT00541866|458813747|FG004|Overall Study|Lack of Efficacy|14|||
127506010|NCT00541866|458813743|FG000|Overall Study|Not Reported or Other|11|||
127506011|NCT00541866|458813744|FG001|Overall Study|Not Reported or Other|3|||
127506012|NCT00541866|458813745|FG002|Overall Study|Not Reported or Other|3|||
127506013|NCT00541866|458813746|FG003|Overall Study|Not Reported or Other|3|||
127506014|NCT00541866|458813747|FG004|Overall Study|Not Reported or Other|1|||
127506015|NCT00541866|458813743|FG000|Overall Study|Physician Decision|0|||
127506016|NCT00541866|458813744|FG001|Overall Study|Physician Decision|0|||
127506017|NCT00541866|458813745|FG002|Overall Study|Physician Decision|2|||
127506018|NCT00541866|458813746|FG003|Overall Study|Physician Decision|1|||
127506019|NCT00541866|458813747|FG004|Overall Study|Physician Decision|0|||
127978759|NCT04713592|460544174|FG002|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
127506020|NCT00957944|458813748|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
127506021|NCT00957944|458813749|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
127506022|NCT00522418|458813750|FG000|Overall Study|Local IRB Consent Violation|5|||
127506023|NCT00522418|458813751|FG001|Overall Study|Local IRB Consent Violation|5|||
127506024|NCT00522418|458813750|FG000|Overall Study|Early Study Termination|46|||
127978760|NCT04713592|460544175|FG003|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
127978761|NCT04713592|460544172|FG000|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
127506025|NCT00522418|458813751|FG001|Overall Study|Early Study Termination|47|||
127506026|NCT00522418|458813750|FG000|Overall Study|Noncompliance|2|||
127506027|NCT00522418|458813751|FG001|Overall Study|Noncompliance|2|||
127506028|NCT00522418|458813750|FG000|Overall Study|Reason Not Specified|3|||
127506029|NCT00522418|458813751|FG001|Overall Study|Reason Not Specified|1|||
127506030|NCT00522418|458813750|FG000|Overall Study|Consent Withdraw|1|||
127506031|NCT00522418|458813751|FG001|Overall Study|Consent Withdraw|2|||
127506032|NCT00522418|458813750|FG000|Overall Study|Lack of Efficacy|0|||
127506033|NCT00522418|458813751|FG001|Overall Study|Lack of Efficacy|1|||
127506034|NCT00578877|458813752|FG000|Overall Study|Lost to Follow-up|8|||
127506035|NCT00578877|458813753|FG001|Overall Study|Lost to Follow-up|10|||
127506036|NCT00578877|458813752|FG000|Overall Study|early discontinue|61|||
127506037|NCT00578877|458813753|FG001|Overall Study|early discontinue|101|||
127506038|NCT00578877|458813752|FG000|Overall Study|did not provide follow-up data|12|||
127506039|NCT00578877|458813753|FG001|Overall Study|did not provide follow-up data|17|||
127506040|NCT01944098|458813756|FG000|Overall Study|Physician Decision|1|||
127506041|NCT01944098|458813757|FG001|Overall Study|Physician Decision|0|||
127506042|NCT00737568|458813760|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
127506043|NCT00737568|458813761|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
127506044|NCT00737568|458813760|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
127506045|NCT00737568|458813761|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
127506046|NCT00737568|458813760|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
127506047|NCT00737568|458813761|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
127506048|NCT00737568|458813760|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
127506049|NCT00737568|458813761|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
127506050|NCT00737568|458813760|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
127506051|NCT00737568|458813761|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
127506052|NCT00737568|458813760|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
127506053|NCT00737568|458813761|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
127506054|NCT00737568|458813760|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
127506055|NCT00737568|458813761|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
127506056|NCT00737568|458813760|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
127506057|NCT00737568|458813761|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
127506058|NCT00737568|458813760|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
127506059|NCT00737568|458813761|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
127506060|NCT00855933|458813762|FG000|Overall Study|Withdrawal by Subject|0|||
127506061|NCT00855933|458813763|FG001|Overall Study|Withdrawal by Subject|1|||
127506062|NCT00951080|458813764|FG000|Overall Study|Adverse Event|3|||
127506063|NCT00951080|458813765|FG001|Overall Study|Adverse Event|3|||
127506064|NCT00951080|458813764|FG000|Overall Study|Lost to Follow-up|0|||
127506065|NCT00951080|458813765|FG001|Overall Study|Lost to Follow-up|1|||
127506066|NCT00951080|458813764|FG000|Overall Study|Physician Decision|4|||
127506067|NCT00951080|458813765|FG001|Overall Study|Physician Decision|1|||
127506068|NCT00951080|458813764|FG000|Overall Study|Other|19|||
127506069|NCT00951080|458813765|FG001|Overall Study|Other|22|||
127506070|NCT01960998|458813766|FG000|Overall Study|Lost to Follow-up|3|||
127506071|NCT01960998|458813767|FG001|Overall Study|Lost to Follow-up|7|||
127506072|NCT01960998|458813766|FG000|Overall Study|Death|0|||
127506073|NCT01960998|458813767|FG001|Overall Study|Death|1|||
127506074|NCT01960998|458813766|FG000|Overall Study|Withdrawal by Subject|8|||
127506075|NCT01960998|458813767|FG001|Overall Study|Withdrawal by Subject|2|||
127506076|NCT01960998|458813766|FG000|Overall Study|lost computer access|0|||
127506077|NCT01960998|458813767|FG001|Overall Study|lost computer access|1|||
127506078|NCT00759356|458813768|FG000|Overall Study|Adverse Event|0|||
127506079|NCT00759356|458813769|FG001|Overall Study|Adverse Event|1|||
127506080|NCT00759356|458813768|FG000|Overall Study|Withdrawal by Subject|0|||
127506081|NCT00759356|458813769|FG001|Overall Study|Withdrawal by Subject|2|||
127506082|NCT00759356|458813768|FG000|Overall Study|Subject was unable to return|1|||
127978762|NCT04713592|460544173|FG001|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
127978763|NCT04713592|460544174|FG002|Open-label Period (Week 16 - Week 52)|Adverse Event|1|||
127978764|NCT04713592|460544175|FG003|Open-label Period (Week 16 - Week 52)|Adverse Event|2|||
127978765|NCT04713592|460544172|FG000|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
127978766|NCT04713592|460544173|FG001|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
127978767|NCT04713592|460544174|FG002|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|3|||
127978768|NCT04713592|460544175|FG003|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|5|||
127978769|NCT04713592|460544172|FG000|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
127978770|NCT04713592|460544173|FG001|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
127978771|NCT04713592|460544174|FG002|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
127506083|NCT00759356|458813769|FG001|Overall Study|Subject was unable to return|0|||
127506084|NCT01713283|458813773|FG000|Overall Study|Lack of Efficacy|10|||
127506085|NCT01713283|458813774|FG001|Overall Study|Lack of Efficacy|2|||
127506086|NCT01713283|458813773|FG000|Overall Study|Lost to Follow-up|1|||
127506087|NCT01713283|458813774|FG001|Overall Study|Lost to Follow-up|1|||
127506088|NCT01904149|458813780|FG000|Overall Study|Adverse Event|3|||
127506089|NCT01904149|458813781|FG001|Overall Study|Adverse Event|4|||
127506090|NCT01904149|458813782|FG002|Overall Study|Adverse Event|0|||
127506091|NCT01904149|458813783|FG003|Overall Study|Adverse Event|1|||
127506092|NCT01904149|458813784|FG004|Overall Study|Adverse Event|1|||
127506093|NCT01904149|458813785|FG005|Overall Study|Adverse Event|2|||
127506094|NCT01904149|458813780|FG000|Overall Study|Lack of Efficacy|0|||
127506095|NCT01904149|458813781|FG001|Overall Study|Lack of Efficacy|3|||
127506096|NCT01904149|458813782|FG002|Overall Study|Lack of Efficacy|1|||
127506097|NCT01904149|458813783|FG003|Overall Study|Lack of Efficacy|3|||
127506098|NCT01904149|458813784|FG004|Overall Study|Lack of Efficacy|3|||
127506099|NCT01904149|458813785|FG005|Overall Study|Lack of Efficacy|1|||
127506100|NCT01904149|458813780|FG000|Overall Study|Withdrawal by Subject|1|||
127506101|NCT01904149|458813781|FG001|Overall Study|Withdrawal by Subject|3|||
127506102|NCT01904149|458813782|FG002|Overall Study|Withdrawal by Subject|1|||
127506103|NCT01904149|458813783|FG003|Overall Study|Withdrawal by Subject|0|||
127506104|NCT01904149|458813784|FG004|Overall Study|Withdrawal by Subject|1|||
127506105|NCT01904149|458813785|FG005|Overall Study|Withdrawal by Subject|0|||
127506106|NCT01904149|458813780|FG000|Overall Study|Protocol Violation|0|||
127506107|NCT01904149|458813781|FG001|Overall Study|Protocol Violation|1|||
127506108|NCT01904149|458813782|FG002|Overall Study|Protocol Violation|0|||
127506109|NCT01904149|458813783|FG003|Overall Study|Protocol Violation|0|||
127506110|NCT01904149|458813784|FG004|Overall Study|Protocol Violation|0|||
127506111|NCT01904149|458813785|FG005|Overall Study|Protocol Violation|0|||
127506112|NCT01904149|458813780|FG000|Overall Study|non compliance with study drug|1|||
127506113|NCT01904149|458813781|FG001|Overall Study|non compliance with study drug|0|||
127506114|NCT01904149|458813782|FG002|Overall Study|non compliance with study drug|0|||
127506115|NCT01904149|458813783|FG003|Overall Study|non compliance with study drug|0|||
127506116|NCT01904149|458813784|FG004|Overall Study|non compliance with study drug|0|||
127506117|NCT01904149|458813785|FG005|Overall Study|non compliance with study drug|0|||
127506118|NCT00812006|458813786|FG000|Overall Study|Lost to Follow-up|0|||
127506119|NCT00812006|458813787|FG001|Overall Study|Lost to Follow-up|0|||
127506120|NCT00812006|458813788|FG002|Overall Study|Lost to Follow-up|2|||
127506121|NCT00812006|458813786|FG000|Overall Study|Physician Decision|0|||
127506122|NCT00812006|458813787|FG001|Overall Study|Physician Decision|0|||
127506123|NCT00812006|458813788|FG002|Overall Study|Physician Decision|1|||
127506124|NCT00812006|458813786|FG000|Overall Study|Withdrawal by Subject|2|||
127506125|NCT00812006|458813787|FG001|Overall Study|Withdrawal by Subject|1|||
127506126|NCT00812006|458813788|FG002|Overall Study|Withdrawal by Subject|1|||
127506127|NCT00812006|458813786|FG000|Overall Study|Lack of Qualifying Event|4|||
127506128|NCT00812006|458813787|FG001|Overall Study|Lack of Qualifying Event|2|||
127506129|NCT00812006|458813788|FG002|Overall Study|Lack of Qualifying Event|2|||
127506130|NCT00235391|458813789|FG000|Overall Study|Adverse Event|4|||
127506131|NCT00235391|458813790|FG001|Overall Study|Adverse Event|5|||
127506132|NCT00235391|458813791|FG002|Overall Study|Adverse Event|10|||
127506133|NCT00235391|458813792|FG003|Overall Study|Adverse Event|72|||
127506134|NCT00235391|458813793|FG004|Overall Study|Adverse Event|5|||
127506135|NCT00235391|458813794|FG005|Overall Study|Adverse Event|2|||
127506136|NCT00235391|458813789|FG000|Overall Study|Abnormal laboratory value(s)|3|||
127506137|NCT00235391|458813790|FG001|Overall Study|Abnormal laboratory value(s)|5|||
127506138|NCT00235391|458813791|FG002|Overall Study|Abnormal laboratory value(s)|4|||
127506139|NCT00235391|458813792|FG003|Overall Study|Abnormal laboratory value(s)|27|||
127506140|NCT00235391|458813793|FG004|Overall Study|Abnormal laboratory value(s)|1|||
127506141|NCT00235391|458813794|FG005|Overall Study|Abnormal laboratory value(s)|2|||
127506142|NCT00235391|458813789|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
127506143|NCT00235391|458813790|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
127506144|NCT00235391|458813791|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
127506145|NCT00235391|458813792|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
127506146|NCT00235391|458813793|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
127506147|NCT00235391|458813794|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
127506148|NCT00235391|458813789|FG000|Overall Study|Condition no longer requires treatment|3|||
127506149|NCT00235391|458813790|FG001|Overall Study|Condition no longer requires treatment|0|||
127506150|NCT00235391|458813791|FG002|Overall Study|Condition no longer requires treatment|0|||
127506151|NCT00235391|458813792|FG003|Overall Study|Condition no longer requires treatment|11|||
127506152|NCT00235391|458813793|FG004|Overall Study|Condition no longer requires treatment|1|||
127506153|NCT00235391|458813794|FG005|Overall Study|Condition no longer requires treatment|0|||
127506154|NCT00235391|458813789|FG000|Overall Study|Protocol deviation|0|||
127506155|NCT00235391|458813790|FG001|Overall Study|Protocol deviation|0|||
127506156|NCT00235391|458813791|FG002|Overall Study|Protocol deviation|1|||
127506157|NCT00235391|458813792|FG003|Overall Study|Protocol deviation|11|||
127506158|NCT00235391|458813793|FG004|Overall Study|Protocol deviation|0|||
127506159|NCT00235391|458813794|FG005|Overall Study|Protocol deviation|0|||
127506160|NCT00235391|458813789|FG000|Overall Study|Withdrawal by Subject|2|||
127506161|NCT00235391|458813790|FG001|Overall Study|Withdrawal by Subject|3|||
127506162|NCT00235391|458813791|FG002|Overall Study|Withdrawal by Subject|3|||
127506163|NCT00235391|458813792|FG003|Overall Study|Withdrawal by Subject|61|||
127506164|NCT00235391|458813793|FG004|Overall Study|Withdrawal by Subject|5|||
127506165|NCT00235391|458813794|FG005|Overall Study|Withdrawal by Subject|0|||
127506166|NCT00235391|458813789|FG000|Overall Study|Lost to Follow-up|0|||
127506167|NCT00235391|458813790|FG001|Overall Study|Lost to Follow-up|3|||
127506168|NCT00235391|458813791|FG002|Overall Study|Lost to Follow-up|3|||
127506169|NCT00235391|458813792|FG003|Overall Study|Lost to Follow-up|16|||
127506170|NCT00235391|458813793|FG004|Overall Study|Lost to Follow-up|0|||
127506171|NCT00235391|458813794|FG005|Overall Study|Lost to Follow-up|0|||
127506172|NCT00235391|458813789|FG000|Overall Study|Administrative problems|0|||
127506173|NCT00235391|458813790|FG001|Overall Study|Administrative problems|0|||
127506174|NCT00235391|458813791|FG002|Overall Study|Administrative problems|0|||
127506175|NCT00235391|458813792|FG003|Overall Study|Administrative problems|1|||
127506176|NCT00235391|458813793|FG004|Overall Study|Administrative problems|0|||
127506177|NCT00235391|458813794|FG005|Overall Study|Administrative problems|0|||
127506178|NCT00235391|458813789|FG000|Overall Study|Death|0|||
127506179|NCT00235391|458813790|FG001|Overall Study|Death|0|||
127506180|NCT00235391|458813791|FG002|Overall Study|Death|1|||
127506181|NCT00235391|458813792|FG003|Overall Study|Death|4|||
127506182|NCT00235391|458813793|FG004|Overall Study|Death|0|||
127506183|NCT00235391|458813794|FG005|Overall Study|Death|0|||
127506184|NCT01939002|458813797|FG000|Overall Study|Adverse Event|13|||
127506185|NCT01939002|458813798|FG001|Overall Study|Adverse Event|13|||
127506186|NCT01939002|458813797|FG000|Overall Study|Withdrawal by Subject|5|||
127506187|NCT01939002|458813798|FG001|Overall Study|Withdrawal by Subject|3|||
127506188|NCT01939002|458813797|FG000|Overall Study|Other|1|||
127506189|NCT01939002|458813798|FG001|Overall Study|Other|2|||
127506190|NCT00098748|458813802|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
127506191|NCT00098748|458813803|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
127506192|NCT00098748|458813804|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
127506193|NCT00098748|458813802|FG000|Received Study Treatment|Death|2|||
127506194|NCT00098748|458813803|FG001|Received Study Treatment|Death|1|||
127506195|NCT00098748|458813804|FG002|Received Study Treatment|Death|2|||
127506196|NCT00098748|458813802|FG000|Received Study Treatment|Adverse Event|1|||
127506197|NCT00098748|458813803|FG001|Received Study Treatment|Adverse Event|2|||
127506198|NCT00098748|458813804|FG002|Received Study Treatment|Adverse Event|5|||
127506199|NCT00098748|458813802|FG000|Received Study Treatment|Lack of Efficacy|40|||
127506200|NCT00098748|458813803|FG001|Received Study Treatment|Lack of Efficacy|27|||
127506201|NCT00098748|458813804|FG002|Received Study Treatment|Lack of Efficacy|27|||
127506202|NCT00098748|458813802|FG000|Received Study Treatment|Other|2|||
127506203|NCT00098748|458813803|FG001|Received Study Treatment|Other|2|||
127506204|NCT00098748|458813804|FG002|Received Study Treatment|Other|6|||
127506205|NCT00098748|458813802|FG000|Received Study Treatment|Subject defaulted|3|||
127506206|NCT00098748|458813803|FG001|Received Study Treatment|Subject defaulted|4|||
127506207|NCT00098748|458813804|FG002|Received Study Treatment|Subject defaulted|4|||
127506208|NCT00098748|458813802|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
127506209|NCT00098748|458813803|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
127506210|NCT00098748|458813804|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
127506211|NCT00098748|458813802|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
127506212|NCT00098748|458813803|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
127506213|NCT00098748|458813804|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
127506214|NCT00098748|458813802|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
127506215|NCT00098748|458813803|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
127506216|NCT00098748|458813804|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
127506217|NCT00098748|458813802|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
127506218|NCT00098748|458813803|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
127506219|NCT00098748|458813804|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
127506220|NCT00098748|458813802|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
127506221|NCT00098748|458813803|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
127506222|NCT00098748|458813804|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
127506223|NCT03372460|458813805|FG000|Overall Study|Discontinued due to stimulation site discomfort|0|||
127506224|NCT03372460|458813806|FG001|Overall Study|Discontinued due to stimulation site discomfort|1|||
127506225|NCT02499900|458813807|FG000|Core Study Period|Other|1|||
127506226|NCT02499900|458813808|FG001|Core Study Period|Other|4|||
127506227|NCT02499900|458813807|FG000|Core Study Period|Lost to Follow-up|1|||
127506228|NCT02499900|458813808|FG001|Core Study Period|Lost to Follow-up|2|||
127506229|NCT02499900|458813807|FG000|Core Study Period|Per sponsor request|0|||
127506230|NCT02499900|458813808|FG001|Core Study Period|Per sponsor request|1|||
127506231|NCT02499900|458813807|FG000|Core Study Period|Pregnancy|1|||
127506232|NCT02499900|458813808|FG001|Core Study Period|Pregnancy|0|||
127506233|NCT02499900|458813807|FG000|Core Study Period|Protocol Violation|3|||
127506234|NCT02499900|458813808|FG001|Core Study Period|Protocol Violation|0|||
127506235|NCT02499900|458813807|FG000|Core Study Period|Withdrawal by Subject|11|||
127506236|NCT02499900|458813808|FG001|Core Study Period|Withdrawal by Subject|10|||
127506237|NCT02499900|458813807|FG000|Core Study Period|Adverse Event|18|||
127506238|NCT02499900|458813808|FG001|Core Study Period|Adverse Event|14|||
127506239|NCT02499900|458813807|FG000|Core Study Period|Death|0|||
127506240|NCT02499900|458813808|FG001|Core Study Period|Death|1|||
127506241|NCT02499900|458813807|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
127506242|NCT02499900|458813808|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
127506243|NCT02499900|458813807|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
127506244|NCT02499900|458813808|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
127506245|NCT02499900|458813807|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
127506246|NCT02499900|458813808|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
127506247|NCT02499900|458813807|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
127506248|NCT02499900|458813808|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
127506249|NCT02499900|458813807|FG000|Extension Study Period|Adverse Event|2|||
127506250|NCT02499900|458813808|FG001|Extension Study Period|Adverse Event|4|||
127506251|NCT02499900|458813807|FG000|Extension Study Period|Withdrawal by Subject|5|||
127506252|NCT02499900|458813808|FG001|Extension Study Period|Withdrawal by Subject|2|||
127506253|NCT02499900|458813807|FG000|Extension Study Period|Physician Decision|2|||
127506254|NCT02499900|458813808|FG001|Extension Study Period|Physician Decision|5|||
127506255|NCT02499900|458813807|FG000|Extension Study Period|Pregnancy|1|||
127506256|NCT02499900|458813808|FG001|Extension Study Period|Pregnancy|2|||
127506257|NCT02499900|458813807|FG000|Extension Study Period|Lost to Follow-up|2|||
127506258|NCT02499900|458813808|FG001|Extension Study Period|Lost to Follow-up|5|||
127506259|NCT02499900|458813807|FG000|Extension Study Period|Other|0|||
127506260|NCT02499900|458813808|FG001|Extension Study Period|Other|2|||
127506261|NCT02439450|458813812|FG000|Overall Study|Adverse Event|4|||
127506262|NCT02439450|458813813|FG001|Overall Study|Adverse Event|1|||
127506263|NCT02439450|458813814|FG002|Overall Study|Adverse Event|0|||
127506264|NCT02439450|458813815|FG003|Overall Study|Adverse Event|0|||
127506265|NCT02439450|458813812|FG000|Overall Study|Withdrawal by Subject|1|||
127506266|NCT02439450|458813813|FG001|Overall Study|Withdrawal by Subject|2|||
127506267|NCT02439450|458813814|FG002|Overall Study|Withdrawal by Subject|0|||
127506268|NCT02439450|458813815|FG003|Overall Study|Withdrawal by Subject|0|||
127506269|NCT02439450|458813812|FG000|Overall Study|Death|3|||
127506270|NCT02439450|458813813|FG001|Overall Study|Death|0|||
127506271|NCT02439450|458813814|FG002|Overall Study|Death|0|||
127506272|NCT02439450|458813815|FG003|Overall Study|Death|1|||
127506273|NCT02439450|458813812|FG000|Overall Study|Progressive Disease|18|||
127506274|NCT02439450|458813813|FG001|Overall Study|Progressive Disease|41|||
127506275|NCT02439450|458813814|FG002|Overall Study|Progressive Disease|2|||
127506276|NCT02439450|458813815|FG003|Overall Study|Progressive Disease|3|||
127506277|NCT01170065|458813820|FG000|Overall Study|Adverse Event|17|||
127506278|NCT01170065|458813821|FG001|Overall Study|Adverse Event|50|||
127506279|NCT01170065|458813822|FG002|Overall Study|Adverse Event|10|||
127506280|NCT01170065|458813820|FG000|Overall Study|Lost to Follow-up|1|||
127506281|NCT01170065|458813821|FG001|Overall Study|Lost to Follow-up|4|||
127506282|NCT01170065|458813822|FG002|Overall Study|Lost to Follow-up|1|||
127506283|NCT01170065|458813820|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
127506284|NCT01170065|458813821|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
127506285|NCT01170065|458813822|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
127506286|NCT01170065|458813820|FG000|Overall Study|Reason other than specified|3|||
127506287|NCT01170065|458813821|FG001|Overall Study|Reason other than specified|8|||
127506288|NCT01170065|458813822|FG002|Overall Study|Reason other than specified|3|||
127506289|NCT01170065|458813820|FG000|Overall Study|Ongoing after planned observation time|5|||
127506290|NCT01170065|458813821|FG001|Overall Study|Ongoing after planned observation time|26|||
127506291|NCT01170065|458813822|FG002|Overall Study|Ongoing after planned observation time|10|||
127506292|NCT01081301|458813823|FG000|Overall Study|Bereaved|3|||
127506293|NCT01081301|458813823|FG000|Overall Study|Too busy|5|||
127506294|NCT01081301|458813823|FG000|Overall Study|Patient too ill|2|||
127506295|NCT01081301|458813823|FG000|Overall Study|Lost to Follow-up|4|||
127506296|NCT03551665|458813826|FG000|Overall Study|Lost to Follow-up|11|||
127506297|NCT03551665|458813827|FG001|Overall Study|Lost to Follow-up|2|||
127506298|NCT00840060|458815847|FG000|Overall Study|Withdrawal by Subject|1|||
127506299|NCT00840060|458815848|FG001|Overall Study|Withdrawal by Subject|0|||
127506300|NCT00840060|458815847|FG000|Overall Study|Change in emotional/behavioral status|0|||
127506301|NCT00840060|458815848|FG001|Overall Study|Change in emotional/behavioral status|1|||
127506302|NCT00303446|458815850|FG000|Overall Study|Withdrawal by Subject|2|||
127506303|NCT00303446|458815851|FG001|Overall Study|Withdrawal by Subject|2|||
127506304|NCT00303446|458815850|FG000|Overall Study|Death|0|||
127506305|NCT00303446|458815851|FG001|Overall Study|Death|1|||
127506306|NCT00303446|458815850|FG000|Overall Study|Physician Decision|0|||
127506307|NCT00303446|458815851|FG001|Overall Study|Physician Decision|1|||
127506308|NCT00428220|458815852|FG000|Overall Study|Participant died|8|||
127506309|NCT00428220|458815852|FG000|Overall Study|Global deterioration of health status|7|||
127506310|NCT00428220|458815852|FG000|Overall Study|Lost to Follow-up|4|||
127506311|NCT00428220|458815852|FG000|Overall Study|Objective progression or relapse|123|||
127506312|NCT00428220|458815852|FG000|Overall Study|Participant refused continued treatment|7|||
127506313|NCT00428220|458815852|FG000|Overall Study|Adverse Event|51|||
127506314|NCT00428220|458815852|FG000|Overall Study|Other|23|||
127506315|NCT00642174|458815853|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
127506316|NCT00642174|458815854|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
127506317|NCT00896363|458815855|FG000|Overall Study|Adverse Event|3|||
127506318|NCT00896363|458815856|FG001|Overall Study|Adverse Event|4|||
127506319|NCT00896363|458815857|FG002|Overall Study|Adverse Event|2|||
127506320|NCT00896363|458815855|FG000|Overall Study|Lack of Efficacy|0|||
127506321|NCT00896363|458815856|FG001|Overall Study|Lack of Efficacy|2|||
127506322|NCT00896363|458815857|FG002|Overall Study|Lack of Efficacy|1|||
127506323|NCT00896363|458815855|FG000|Overall Study|Withdrawal by Subject|3|||
127506324|NCT00896363|458815856|FG001|Overall Study|Withdrawal by Subject|5|||
127506325|NCT00896363|458815857|FG002|Overall Study|Withdrawal by Subject|5|||
127506326|NCT02982018|458815862|FG000|Overall Study|Incorrect Lens Dispensed|1|||
127506327|NCT02982018|458815863|FG001|Overall Study|Incorrect Lens Dispensed|0|||
127506328|NCT02982018|458815862|FG000|Overall Study|Protocol Violation|1|||
127506329|NCT02982018|458815863|FG001|Overall Study|Protocol Violation|1|||
127506330|NCT02982018|458815862|FG000|Overall Study|Adverse Event|1|||
127506331|NCT02982018|458815863|FG001|Overall Study|Adverse Event|1|||
127506332|NCT02982018|458815862|FG000|Overall Study|Lens Discomfort|2|||
127506333|NCT02982018|458815863|FG001|Overall Study|Lens Discomfort|0|||
127506334|NCT02982018|458815862|FG000|Overall Study|Withdrawal by Subject|0|||
127506335|NCT02982018|458815863|FG001|Overall Study|Withdrawal by Subject|1|||
127506336|NCT03283098|458815865|FG000|Overall Study|Withdrawal by Subject|0|||
127506337|NCT03283098|458815866|FG001|Overall Study|Withdrawal by Subject|1|||
127506338|NCT01606787|458815868|FG000|Overall Study|Withdrawal by Subject|4|||
127506339|NCT01606787|458815869|FG001|Overall Study|Withdrawal by Subject|5|||
127506340|NCT01606787|458815868|FG000|Overall Study|Surgery canceled|0|||
127506341|NCT01606787|458815869|FG001|Overall Study|Surgery canceled|2|||
127506342|NCT00413894|458815870|FG000|Overall Study|Withdrawal by Subject|10|||
127506343|NCT00413894|458815870|FG000|Overall Study|Administrative Reasons|1|||
127506344|NCT00413894|458815870|FG000|Overall Study|Hb <10 grams/deciliter|12|||
127506345|NCT00413894|458815870|FG000|Overall Study|Adverse Event|28|||
127506346|NCT00413894|458815870|FG000|Overall Study|Protocol Violation|11|||
127506347|NCT00413894|458815870|FG000|Overall Study|Other|18|||
127506348|NCT04225676|458815871|FG000|Overall Study|Physician Decision|1|||
127506349|NCT04225676|458815871|FG000|Overall Study|Lack of Efficacy|1|||
127506350|NCT04225676|458815871|FG000|Overall Study|Study terminated by sponsor|3|||
127506351|NCT03245736|458815872|FG000|Overall Study|Adverse Event|1|||
127506352|NCT03245736|458815872|FG000|Overall Study|Progressive Disease|4|||
127506353|NCT01942161|458815873|FG000|Overall Study|Adverse Event|1|||
127506354|NCT01942161|458815874|FG001|Overall Study|Adverse Event|2|||
127506355|NCT01942161|458815875|FG002|Overall Study|Adverse Event|5|||
127506356|NCT01942161|458815873|FG000|Overall Study|Physician Decision|3|||
127506357|NCT01942161|458815874|FG001|Overall Study|Physician Decision|1|||
127506358|NCT01942161|458815875|FG002|Overall Study|Physician Decision|0|||
127506359|NCT01942161|458815873|FG000|Overall Study|Protocol Violation|1|||
127506360|NCT01942161|458815874|FG001|Overall Study|Protocol Violation|0|||
127506361|NCT01942161|458815875|FG002|Overall Study|Protocol Violation|0|||
127506362|NCT01942161|458815873|FG000|Overall Study|Withdrawal by Subject|3|||
127506363|NCT01942161|458815874|FG001|Overall Study|Withdrawal by Subject|3|||
127506364|NCT01942161|458815875|FG002|Overall Study|Withdrawal by Subject|1|||
127506365|NCT05289271|458815878|FG000|Overall Study|Mistakenly allocated, untreated|1|||
127506366|NCT05289271|458815879|FG001|Overall Study|Mistakenly allocated, untreated|0|||
127506367|NCT02251717|458815882|FG000|Overall Study|Adverse Event|0|||
127506368|NCT02251717|458815883|FG001|Overall Study|Adverse Event|1|||
127506369|NCT02251717|458815882|FG000|Overall Study|Withdrew Consent|1|||
127506370|NCT02251717|458815883|FG001|Overall Study|Withdrew Consent|0|||
127506371|NCT03356977|458815884|FG000|Overall Study|Lost to Follow-up|3|||
127506372|NCT03356977|458815884|FG000|Overall Study|Withdrawal by parent/guardian|2|||
127506373|NCT00445939|458815888|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
127506374|NCT00445939|458815889|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
127506375|NCT00445939|458815890|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
127506376|NCT00445939|458815891|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
127506377|NCT00445939|458815888|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
127506378|NCT00445939|458815889|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
127506379|NCT00445939|458815890|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
127506380|NCT00445939|458815891|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
127506381|NCT00798317|458815893|FG000|Overall Study|Physician Decision|0|||
127506382|NCT00798317|458815894|FG001|Overall Study|Physician Decision|1|||
127506383|NCT00798317|458815893|FG000|Overall Study|Withdrawal by Subject|5|||
127506384|NCT00798317|458815894|FG001|Overall Study|Withdrawal by Subject|4|||
127506385|NCT00798317|458815893|FG000|Overall Study|Lost to Follow-up|2|||
127506386|NCT00798317|458815894|FG001|Overall Study|Lost to Follow-up|2|||
127506387|NCT00798317|458815893|FG000|Overall Study|Adverse Event|2|||
127506388|NCT00798317|458815894|FG001|Overall Study|Adverse Event|0|||
127978772|NCT04713592|460544175|FG003|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
127506389|NCT00798317|458815893|FG000|Overall Study|Death|1|||
127506390|NCT00798317|458815894|FG001|Overall Study|Death|0|||
127506391|NCT00378599|458815898|FG000|Overall Study|Adverse Event|38|||
127506392|NCT00378599|458815898|FG000|Overall Study|Protocol Violation|2|||
127506393|NCT00378599|458815898|FG000|Overall Study|Treatment failure|7|||
127506394|NCT00378599|458815898|FG000|Overall Study|Withdrawal by Subject|5|||
127506395|NCT00416715|458815899|FG000|Overall Study|Not evaluable for joint aches|7|||
127506396|NCT00416715|458815899|FG000|Overall Study|Vitamin D levels not evaluable|8|||
127506397|NCT00489736|458815903|FG000|Overall Study|Lack of Efficacy|53|||
127506398|NCT00489736|458815904|FG001|Overall Study|Lack of Efficacy|14|||
127506399|NCT00489736|458815903|FG000|Overall Study|Adverse Event|32|||
127506400|NCT00489736|458815904|FG001|Overall Study|Adverse Event|45|||
127506401|NCT00489736|458815903|FG000|Overall Study|Poor compliance|6|||
127506402|NCT00489736|458815904|FG001|Overall Study|Poor compliance|2|||
127506403|NCT00489736|458815903|FG000|Overall Study|Not coded/ Not pre-specified|5|||
127506404|NCT00489736|458815904|FG001|Overall Study|Not coded/ Not pre-specified|8|||
127506405|NCT03812185|458815905|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
127506406|NCT02576535|458815920|FG000|Overall Study|Withdrawal by Subject|2|||
127506407|NCT03334851|458815922|FG000|Overall Study|Other|0|||
127506408|NCT03334851|458815923|FG001|Overall Study|Other|0|||
127506409|NCT03334851|458815924|FG002|Overall Study|Other|0|||
127506410|NCT03334851|458815925|FG003|Overall Study|Other|0|||
127506411|NCT03334851|458815926|FG004|Overall Study|Other|0|||
127506412|NCT03334851|458815927|FG005|Overall Study|Other|0|||
127506413|NCT03334851|458815928|FG006|Overall Study|Other|0|||
127506414|NCT03334851|458815929|FG007|Overall Study|Other|1|||
127506415|NCT03334851|458815930|FG008|Overall Study|Other|0|||
127506416|NCT03334851|458815931|FG009|Overall Study|Other|0|||
127506417|NCT03334851|458815932|FG010|Overall Study|Other|0|||
127506418|NCT03334851|458815933|FG011|Overall Study|Other|0|||
127506419|NCT03334851|458815934|FG012|Overall Study|Other|0|||
127506420|NCT03334851|458815922|FG000|Overall Study|Adverse Event|0|||
127506421|NCT03334851|458815923|FG001|Overall Study|Adverse Event|0|||
127506422|NCT03334851|458815924|FG002|Overall Study|Adverse Event|0|||
127506423|NCT03334851|458815925|FG003|Overall Study|Adverse Event|0|||
127506424|NCT03334851|458815926|FG004|Overall Study|Adverse Event|0|||
127506425|NCT03334851|458815927|FG005|Overall Study|Adverse Event|0|||
127506426|NCT03334851|458815928|FG006|Overall Study|Adverse Event|0|||
127506427|NCT03334851|458815929|FG007|Overall Study|Adverse Event|1|||
127506428|NCT03334851|458815930|FG008|Overall Study|Adverse Event|0|||
127506429|NCT03334851|458815931|FG009|Overall Study|Adverse Event|0|||
127506430|NCT03334851|458815932|FG010|Overall Study|Adverse Event|0|||
127506431|NCT03334851|458815933|FG011|Overall Study|Adverse Event|0|||
127506432|NCT03334851|458815934|FG012|Overall Study|Adverse Event|0|||
127506433|NCT03334851|458815922|FG000|Overall Study|Withdrawal by Subject|0|||
127506434|NCT03334851|458815923|FG001|Overall Study|Withdrawal by Subject|0|||
127506435|NCT03334851|458815924|FG002|Overall Study|Withdrawal by Subject|0|||
127506436|NCT03334851|458815925|FG003|Overall Study|Withdrawal by Subject|0|||
127506437|NCT03334851|458815926|FG004|Overall Study|Withdrawal by Subject|0|||
127978773|NCT04713592|460544172|FG000|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
127978774|NCT04713592|460544173|FG001|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
127978775|NCT04713592|460544174|FG002|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
127978776|NCT04713592|460544175|FG003|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
127978777|NCT04713592|460544172|FG000|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
127978778|NCT04713592|460544173|FG001|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
127978779|NCT04713592|460544174|FG002|Open-label Period (Week 16 - Week 52)|Other, not specified|16|||
127978780|NCT04713592|460544175|FG003|Open-label Period (Week 16 - Week 52)|Other, not specified|14|||
127978781|NCT03782298|460544185|FG000|Overall Study|Protocol Deviation|4|||
127978782|NCT01382225|460544186|FG000|Overall Study|Adverse Event|3|||
127978783|NCT01382225|460544187|FG001|Overall Study|Adverse Event|2|||
127506438|NCT03334851|458815927|FG005|Overall Study|Withdrawal by Subject|0|||
127506439|NCT03334851|458815928|FG006|Overall Study|Withdrawal by Subject|0|||
127506440|NCT03334851|458815929|FG007|Overall Study|Withdrawal by Subject|0|||
127506441|NCT03334851|458815930|FG008|Overall Study|Withdrawal by Subject|0|||
127506442|NCT03334851|458815931|FG009|Overall Study|Withdrawal by Subject|0|||
127506443|NCT03334851|458815932|FG010|Overall Study|Withdrawal by Subject|1|||
127506444|NCT03334851|458815933|FG011|Overall Study|Withdrawal by Subject|0|||
127506445|NCT03334851|458815934|FG012|Overall Study|Withdrawal by Subject|1|||
127506446|NCT03334851|458815922|FG000|Overall Study|Lost to Follow-up|0|||
127506447|NCT03334851|458815923|FG001|Overall Study|Lost to Follow-up|0|||
127506448|NCT03334851|458815924|FG002|Overall Study|Lost to Follow-up|0|||
127506449|NCT03334851|458815925|FG003|Overall Study|Lost to Follow-up|0|||
127506450|NCT03334851|458815926|FG004|Overall Study|Lost to Follow-up|0|||
127506451|NCT03334851|458815927|FG005|Overall Study|Lost to Follow-up|0|||
127506452|NCT03334851|458815928|FG006|Overall Study|Lost to Follow-up|0|||
127506453|NCT03334851|458815929|FG007|Overall Study|Lost to Follow-up|0|||
127506454|NCT03334851|458815930|FG008|Overall Study|Lost to Follow-up|0|||
127506455|NCT03334851|458815931|FG009|Overall Study|Lost to Follow-up|0|||
127978784|NCT01382225|460544186|FG000|Overall Study|Protocol Violation|2|||
127978785|NCT01382225|460544187|FG001|Overall Study|Protocol Violation|1|||
127978786|NCT01382225|460544186|FG000|Overall Study|Subject Withdrew Consent|5|||
127978787|NCT01382225|460544187|FG001|Overall Study|Subject Withdrew Consent|2|||
127978788|NCT01382225|460544186|FG000|Overall Study|Other|4|||
127978789|NCT01382225|460544187|FG001|Overall Study|Other|2|||
127978790|NCT02294175|460544193|FG000|Overall Study|Withdrawal by Subject|1|||
127978791|NCT02294175|460544194|FG001|Overall Study|Withdrawal by Subject|2|||
127978792|NCT02294175|460544193|FG000|Overall Study|pt taking excluded medication|3|||
127978793|NCT02294175|460544194|FG001|Overall Study|pt taking excluded medication|1|||
127978794|NCT02294175|460544193|FG000|Overall Study|Protocol Violation|1|||
127978795|NCT02294175|460544194|FG001|Overall Study|Protocol Violation|0|||
127978796|NCT02294175|460544193|FG000|Overall Study|Lost to Follow-up|0|||
127506456|NCT03334851|458815932|FG010|Overall Study|Lost to Follow-up|2|||
127506457|NCT03334851|458815933|FG011|Overall Study|Lost to Follow-up|1|||
127506458|NCT03334851|458815934|FG012|Overall Study|Lost to Follow-up|0|||
127506459|NCT03920293|458815935|FG000|Randomized-Controlled Period|Withdrawal by Subject|2|||
127506460|NCT03920293|458815936|FG001|Randomized-Controlled Period|Withdrawal by Subject|1|||
127506461|NCT03920293|458815935|FG000|Randomized-Controlled Period|Physician Decision|1|||
127506462|NCT03920293|458815936|FG001|Randomized-Controlled Period|Physician Decision|2|||
127506463|NCT03920293|458815935|FG000|Randomized-Controlled Period|Adverse Event|0|||
127506464|NCT03920293|458815936|FG001|Randomized-Controlled Period|Adverse Event|2|||
127506465|NCT03920293|458815935|FG000|Randomized-Controlled Period|Sponsor Decision|0|||
127506466|NCT03920293|458815936|FG001|Randomized-Controlled Period|Sponsor Decision|1|||
127506467|NCT03920293|458815935|FG000|Randomized-Controlled Period|Death|2|||
127506468|NCT03920293|458815936|FG001|Randomized-Controlled Period|Death|0|||
127506469|NCT03920293|458815935|FG000|Randomized-Controlled Period|Protocol Violation|1|||
127506470|NCT03920293|458815936|FG001|Randomized-Controlled Period|Protocol Violation|0|||
127506471|NCT03920293|458815935|FG000|Randomized-Controlled Period|Noncompliance|1|||
127506472|NCT03920293|458815936|FG001|Randomized-Controlled Period|Noncompliance|0|||
127506473|NCT03920293|458815935|FG000|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|3|||
127506474|NCT03920293|458815936|FG001|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|5|||
127506475|NCT03920293|458815935|FG000|Open- Label Extension Period|Death|3|||
127506476|NCT03920293|458815936|FG001|Open- Label Extension Period|Death|3|||
127506477|NCT03920293|458815935|FG000|Open- Label Extension Period|Physician Decision|5|||
127506478|NCT03920293|458815936|FG001|Open- Label Extension Period|Physician Decision|3|||
127506479|NCT03920293|458815935|FG000|Open- Label Extension Period|Withdrawal by Subject|7|||
127506480|NCT03920293|458815936|FG001|Open- Label Extension Period|Withdrawal by Subject|9|||
127506481|NCT01691885|458815938|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
127506482|NCT01691885|458815939|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
127506483|NCT01691885|458815938|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
127506484|NCT01691885|458815939|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
127506485|NCT03555981|458815940|FG000|Overall Study|Lost to Follow-up|0|||
127506486|NCT03555981|458815941|FG001|Overall Study|Lost to Follow-up|2|||
127506487|NCT03272828|458815944|FG000|Overall Study|Lost to Follow-up|7|||
127506488|NCT03272828|458815945|FG001|Overall Study|Lost to Follow-up|7|||
127506489|NCT03272828|458815944|FG000|Overall Study|Withdrawal by Subject|2|||
127506490|NCT03272828|458815945|FG001|Overall Study|Withdrawal by Subject|0|||
127506491|NCT03272828|458815944|FG000|Overall Study|Deceased|1|||
127506492|NCT03272828|458815945|FG001|Overall Study|Deceased|1|||
127506493|NCT03272828|458815944|FG000|Overall Study|Failed implant|1|||
127506494|NCT03272828|458815945|FG001|Overall Study|Failed implant|2|||
127506495|NCT02323126|458815953|FG000|Overall Study|Patient / guardian decision|0|||
127506496|NCT02323126|458815954|FG001|Overall Study|Patient / guardian decision|1|||
127506497|NCT02323126|458815955|FG002|Overall Study|Patient / guardian decision|2|||
127506498|NCT02323126|458815953|FG000|Overall Study|Progressive disease|14|||
127506499|NCT02323126|458815954|FG001|Overall Study|Progressive disease|8|||
127506500|NCT02323126|458815955|FG002|Overall Study|Progressive disease|14|||
127506501|NCT02323126|458815953|FG000|Overall Study|Physician Decision|0|||
127506502|NCT02323126|458815954|FG001|Overall Study|Physician Decision|1|||
127506503|NCT02323126|458815955|FG002|Overall Study|Physician Decision|3|||
127506504|NCT02323126|458815953|FG000|Overall Study|Death|1|||
127506505|NCT02323126|458815954|FG001|Overall Study|Death|1|||
127506506|NCT02323126|458815955|FG002|Overall Study|Death|4|||
127506507|NCT02323126|458815953|FG000|Overall Study|Adverse Event|3|||
127506508|NCT02323126|458815954|FG001|Overall Study|Adverse Event|5|||
127506509|NCT02323126|458815955|FG002|Overall Study|Adverse Event|7|||
127978797|NCT02294175|460544194|FG001|Overall Study|Lost to Follow-up|1|||
127978798|NCT02294175|460544193|FG000|Overall Study|wound healed|0|||
127978799|NCT02294175|460544194|FG001|Overall Study|wound healed|2|||
127978800|NCT02548351|460544195|FG000|Overall Study|Withdrawal by Subject|149|||
127506510|NCT02891681|458815967|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
127506511|NCT02891681|458815968|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
127506512|NCT02891681|458815969|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
127506513|NCT02891681|458815967|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
127506514|NCT02891681|458815968|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
127506515|NCT02891681|458815969|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
127506516|NCT02891681|458815967|FG000|Overall Study|Taken off study after first imaging appointment|1|||
127506517|NCT02891681|458815968|FG001|Overall Study|Taken off study after first imaging appointment|0|||
127506518|NCT02891681|458815969|FG002|Overall Study|Taken off study after first imaging appointment|0|||
127506519|NCT03664674|458815971|FG000|Overall Study|Adverse Event|1|||
127506520|NCT03664674|458815972|FG001|Overall Study|Adverse Event|1|||
127506521|NCT03664674|458815971|FG000|Overall Study|Physician Decision|0|||
127506522|NCT03664674|458815972|FG001|Overall Study|Physician Decision|1|||
127506523|NCT03664674|458815971|FG000|Overall Study|Withdrawal by Subject|2|||
127506524|NCT03664674|458815972|FG001|Overall Study|Withdrawal by Subject|0|||
127506525|NCT02174523|458815974|FG000|Overall Study|Withdrawal by Subject|1|||
127506526|NCT02174523|458815975|FG001|Overall Study|Withdrawal by Subject|0|||
127506527|NCT00856206|458815976|FG000|Overall Study|Protocol Violation|6|||
127506528|NCT00856206|458815977|FG001|Overall Study|Protocol Violation|18|||
127506529|NCT00856206|458815976|FG000|Overall Study|Adverse Event|10|||
127506530|NCT00856206|458815977|FG001|Overall Study|Adverse Event|46|||
127506531|NCT00856206|458815976|FG000|Overall Study|Lack of Efficacy|1|||
127506532|NCT00856206|458815977|FG001|Overall Study|Lack of Efficacy|2|||
127506533|NCT00856206|458815976|FG000|Overall Study|Withdrawal by Subject|15|||
127506534|NCT00856206|458815977|FG001|Overall Study|Withdrawal by Subject|36|||
127506535|NCT00856206|458815976|FG000|Overall Study|Lost to Follow-up|13|||
127506536|NCT00856206|458815977|FG001|Overall Study|Lost to Follow-up|39|||
127506537|NCT00856206|458815976|FG000|Overall Study|Death|2|||
127506538|NCT00856206|458815977|FG001|Overall Study|Death|2|||
127506539|NCT00856206|458815976|FG000|Overall Study|Decision by the Sponsor|4|||
127506540|NCT00856206|458815977|FG001|Overall Study|Decision by the Sponsor|8|||
127506541|NCT00856206|458815976|FG000|Overall Study|Other than specified above|3|||
127506542|NCT00856206|458815977|FG001|Overall Study|Other than specified above|10|||
127506543|NCT04584346|458815978|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
127506544|NCT04584346|458815979|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
127506545|NCT02780856|458815984|FG000|Overall Study|Lost to Follow-up|1|||
127506546|NCT01482169|458815991|FG000|Overall Study|Physician Decision|2|||
127506547|NCT00457821|458815992|FG000|Part 2|Withdrawal by Subject|0|||
127506548|NCT00457821|458815993|FG001|Part 2|Withdrawal by Subject|0|||
127506549|NCT00457821|458815994|FG002|Part 2|Withdrawal by Subject|0|||
127506550|NCT00457821|458815995|FG003|Part 2|Withdrawal by Subject|0|||
127506551|NCT00457821|458815996|FG004|Part 2|Withdrawal by Subject|0|||
127506552|NCT00457821|458815997|FG005|Part 2|Withdrawal by Subject|0|||
127506553|NCT00457821|458815998|FG006|Part 2|Withdrawal by Subject|0|||
127506554|NCT00457821|458815999|FG007|Part 2|Withdrawal by Subject|1|||
127506555|NCT02437409|458816004|FG000|Overall Study|Withdrawal by Subject|3|||
127506556|NCT02437409|458816004|FG000|Overall Study|Screening failure|12|||
127506557|NCT01632241|458816005|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
127506558|NCT01632241|458816006|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
127506559|NCT01632241|458816005|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
127506560|NCT01632241|458816006|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
127506561|NCT01632241|458816005|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
127506562|NCT01632241|458816006|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
127506563|NCT01632241|458816005|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
127506564|NCT01632241|458816006|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
127506565|NCT01632241|458816005|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
127506566|NCT01632241|458816006|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
127506567|NCT01632241|458816005|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
127506568|NCT01632241|458816006|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
127506569|NCT01632241|458816005|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
127506570|NCT01632241|458816006|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
127506571|NCT01632241|458816005|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
127506572|NCT01632241|458816006|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
127506573|NCT01632241|458816005|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
127506574|NCT01632241|458816006|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
127506575|NCT01632241|458816005|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
127506576|NCT01632241|458816006|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
127506577|NCT01632241|458816005|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
127506578|NCT01632241|458816006|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
127506579|NCT01632241|458816005|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
127506580|NCT01632241|458816006|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
127506581|NCT01632241|458816005|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
127506582|NCT01632241|458816006|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
127506583|NCT01632241|458816005|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
127506584|NCT01632241|458816006|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
127506585|NCT05032690|458816015|FG000|Period 1|Adverse Event|0|||
127506586|NCT05032690|458816016|FG001|Period 1|Adverse Event|1|||
127506587|NCT05032690|458816017|FG002|Period 1|Adverse Event|0|||
127506588|NCT05032690|458816018|FG003|Period 1|Adverse Event|0|||
127506589|NCT05032690|458816015|FG000|Period 1|Withdrawal by Subject|1|||
127506590|NCT05032690|458816016|FG001|Period 1|Withdrawal by Subject|0|||
127506591|NCT05032690|458816017|FG002|Period 1|Withdrawal by Subject|0|||
127506592|NCT05032690|458816018|FG003|Period 1|Withdrawal by Subject|0|||
127506593|NCT05032690|458816015|FG000|Period 1|No longer meets eligibility criteria|0|||
127506594|NCT05032690|458816016|FG001|Period 1|No longer meets eligibility criteria|1|||
127506595|NCT05032690|458816017|FG002|Period 1|No longer meets eligibility criteria|0|||
127506596|NCT05032690|458816018|FG003|Period 1|No longer meets eligibility criteria|0|||
127506597|NCT05032690|458816015|FG000|Period 2|Adverse Event|1|||
127506598|NCT05032690|458816016|FG001|Period 2|Adverse Event|0|||
127506599|NCT05032690|458816017|FG002|Period 2|Adverse Event|0|||
127506600|NCT05032690|458816018|FG003|Period 2|Adverse Event|0|||
127506601|NCT05032690|458816015|FG000|Period 2|Withdrawal by Subject|0|||
127506602|NCT05032690|458816016|FG001|Period 2|Withdrawal by Subject|1|||
127506603|NCT05032690|458816017|FG002|Period 2|Withdrawal by Subject|0|||
127506604|NCT05032690|458816018|FG003|Period 2|Withdrawal by Subject|0|||
127506605|NCT05032690|458816015|FG000|Period 2|No longer meets eligibility criteria|0|||
127506606|NCT05032690|458816016|FG001|Period 2|No longer meets eligibility criteria|1|||
127506607|NCT05032690|458816017|FG002|Period 2|No longer meets eligibility criteria|0|||
127506608|NCT05032690|458816018|FG003|Period 2|No longer meets eligibility criteria|0|||
127506609|NCT05032690|458816015|FG000|Period 3|Adverse Event|0|||
127506610|NCT05032690|458816016|FG001|Period 3|Adverse Event|1|||
127506611|NCT05032690|458816017|FG002|Period 3|Adverse Event|0|||
127506612|NCT05032690|458816018|FG003|Period 3|Adverse Event|0|||
127506613|NCT02403635|458816019|FG000|Overall Study|Not eligible|9|||
127506614|NCT00835640|458816020|FG000|Second Intervention|Protocol Violation|1|||
127506615|NCT00835640|458816021|FG001|Second Intervention|Protocol Violation|0|||
127506616|NCT00068250|458816022|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
127506617|NCT00068250|458816023|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
127506618|NCT00068250|458816024|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
127506619|NCT00068250|458816025|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
127506620|NCT03349645|458816026|FG000|Overall Study|Sponsor Terminated Study|75|||
127506621|NCT03349645|458816026|FG000|Overall Study|Withdrawal by Subject|4|||
127506622|NCT03349645|458816026|FG000|Overall Study|Protocol Violation|1|||
127506623|NCT03349645|458816026|FG000|Overall Study|Other|2|||
127506624|NCT00580034|458816027|FG000|Overall Study|Toxicity|10|||
127506625|NCT00580034|458816028|FG001|Overall Study|Toxicity|0|||
127506626|NCT00549900|458817464|FG000|Overall Study|Adverse Event|1|||
127506627|NCT02545517|458817467|FG000|Overall Study|Death|2|||
127506628|NCT02545517|458817468|FG001|Overall Study|Death|2|||
127506629|NCT02545517|458817469|FG002|Overall Study|Death|1|||
127506630|NCT02545517|458817467|FG000|Overall Study|Lost to Follow-up|14|||
127506631|NCT02545517|458817468|FG001|Overall Study|Lost to Follow-up|13|||
127506632|NCT02545517|458817469|FG002|Overall Study|Lost to Follow-up|17|||
127506633|NCT02545517|458817467|FG000|Overall Study|Protocol Violation|0|||
127506634|NCT02545517|458817468|FG001|Overall Study|Protocol Violation|1|||
127506635|NCT02545517|458817469|FG002|Overall Study|Protocol Violation|1|||
127506636|NCT02545517|458817467|FG000|Overall Study|Withdrawal by Subject|5|||
127506637|NCT02545517|458817468|FG001|Overall Study|Withdrawal by Subject|8|||
127506638|NCT02545517|458817469|FG002|Overall Study|Withdrawal by Subject|9|||
127506639|NCT02545517|458817467|FG000|Overall Study|Administrative reason|5|||
127506640|NCT02545517|458817468|FG001|Overall Study|Administrative reason|6|||
127506641|NCT02545517|458817469|FG002|Overall Study|Administrative reason|10|||
127506642|NCT02545517|458817467|FG000|Overall Study|Other|2|||
127506643|NCT02545517|458817468|FG001|Overall Study|Other|4|||
127506644|NCT02545517|458817469|FG002|Overall Study|Other|3|||
127506645|NCT01529515|458817470|FG000|TRANSITION PHASE|Adverse Event|16|||
127506646|NCT01529515|458817471|FG001|TRANSITION PHASE|Adverse Event|0|||
127506647|NCT01529515|458817472|FG002|TRANSITION PHASE|Adverse Event|0|||
127506648|NCT01529515|458817473|FG003|TRANSITION PHASE|Adverse Event|0|||
127506649|NCT01529515|458817470|FG000|TRANSITION PHASE|Death|1|||
127506650|NCT01529515|458817471|FG001|TRANSITION PHASE|Death|0|||
127978801|NCT02548351|460544196|FG001|Overall Study|Withdrawal by Subject|154|||
127506651|NCT01529515|458817472|FG002|TRANSITION PHASE|Death|0|||
127506652|NCT01529515|458817473|FG003|TRANSITION PHASE|Death|0|||
127506653|NCT01529515|458817470|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
127506654|NCT01529515|458817471|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
127506655|NCT01529515|458817472|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
127506656|NCT01529515|458817473|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
127506657|NCT01529515|458817470|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
127978802|NCT02548351|460544197|FG002|Overall Study|Withdrawal by Subject|152|||
127978803|NCT02548351|460544195|FG000|Overall Study|Death|11|||
127506658|NCT01529515|458817471|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
127506659|NCT01529515|458817472|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
127506660|NCT01529515|458817473|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
127506661|NCT01529515|458817470|FG000|TRANSITION PHASE|Protocol Violation|4|||
127506662|NCT01529515|458817471|FG001|TRANSITION PHASE|Protocol Violation|0|||
127506663|NCT01529515|458817472|FG002|TRANSITION PHASE|Protocol Violation|0|||
127506664|NCT01529515|458817473|FG003|TRANSITION PHASE|Protocol Violation|0|||
127506665|NCT01529515|458817470|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
127506666|NCT01529515|458817471|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
127506667|NCT01529515|458817472|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
127506668|NCT01529515|458817473|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
127506669|NCT01529515|458817470|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
127506670|NCT01529515|458817471|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
127506671|NCT01529515|458817472|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
127506672|NCT01529515|458817473|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
127506673|NCT01529515|458817470|FG000|TRANSITION PHASE|Other|9|||
127506674|NCT01529515|458817471|FG001|TRANSITION PHASE|Other|0|||
127506675|NCT01529515|458817472|FG002|TRANSITION PHASE|Other|0|||
127506676|NCT01529515|458817473|FG003|TRANSITION PHASE|Other|0|||
127506677|NCT01529515|458817470|FG000|MAINTENANCE PHASE|Adverse Event|0|||
127506678|NCT01529515|458817471|FG001|MAINTENANCE PHASE|Adverse Event|10|||
127506679|NCT01529515|458817472|FG002|MAINTENANCE PHASE|Adverse Event|0|||
127506680|NCT01529515|458817473|FG003|MAINTENANCE PHASE|Adverse Event|0|||
127506681|NCT01529515|458817470|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
127506682|NCT01529515|458817471|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
127506683|NCT01529515|458817472|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
127506684|NCT01529515|458817473|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
127506685|NCT01529515|458817470|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
127506686|NCT01529515|458817471|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
127506687|NCT01529515|458817472|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
127506688|NCT01529515|458817473|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
127506689|NCT01529515|458817470|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
127506690|NCT01529515|458817471|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
127506691|NCT01529515|458817472|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
127506692|NCT01529515|458817473|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
127506693|NCT01529515|458817470|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
127506694|NCT01529515|458817471|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
127506695|NCT01529515|458817472|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
127506696|NCT01529515|458817473|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
127506697|NCT01529515|458817470|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
127506698|NCT01529515|458817471|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
127506699|NCT01529515|458817472|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
127506700|NCT01529515|458817473|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
127506701|NCT01529515|458817470|FG000|MAINTENANCE PHASE|Other|0|||
127506702|NCT01529515|458817471|FG001|MAINTENANCE PHASE|Other|10|||
127506703|NCT01529515|458817472|FG002|MAINTENANCE PHASE|Other|0|||
127506704|NCT01529515|458817473|FG003|MAINTENANCE PHASE|Other|0|||
127506705|NCT01529515|458817470|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
127506706|NCT01529515|458817471|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
127506707|NCT01529515|458817472|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
127506708|NCT01529515|458817473|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
127506709|NCT01529515|458817470|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
127506710|NCT01529515|458817471|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
127506711|NCT01529515|458817472|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
127506712|NCT01529515|458817473|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
127506713|NCT01529515|458817470|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
127506714|NCT01529515|458817471|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
127506715|NCT01529515|458817472|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
127506716|NCT01529515|458817473|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
127506717|NCT01529515|458817470|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
127506718|NCT01529515|458817471|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
127506719|NCT01529515|458817472|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
127506720|NCT01529515|458817473|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
127506721|NCT01529515|458817470|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
127506722|NCT01529515|458817471|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
127506723|NCT01529515|458817472|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
127506724|NCT01529515|458817473|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
127506725|NCT01529515|458817470|FG000|DOUBLE BLIND PHASE|Other|0|||
127506726|NCT01529515|458817471|FG001|DOUBLE BLIND PHASE|Other|0|||
127978804|NCT02548351|460544196|FG001|Overall Study|Death|15|||
127978805|NCT02548351|460544197|FG002|Overall Study|Death|12|||
127506727|NCT01529515|458817472|FG002|DOUBLE BLIND PHASE|Other|9|||
127506728|NCT01529515|458817473|FG003|DOUBLE BLIND PHASE|Other|2|||
127506729|NCT01069861|458817476|FG000|Overall Study|Death|1|||
127978806|NCT02548351|460544195|FG000|Overall Study|Adverse Event|22|||
127978807|NCT02548351|460544196|FG001|Overall Study|Adverse Event|56|||
127506730|NCT01069861|458817476|FG000|Overall Study|Adverse Event|1|||
127506731|NCT01069861|458817476|FG000|Overall Study|Did not meet entrance criteria|1|||
127506732|NCT04035564|458817477|FG000|Overall Study|Protocol Violation|1|||
127506733|NCT04035564|458817478|FG001|Overall Study|Protocol Violation|2|||
127506734|NCT04035564|458817477|FG000|Overall Study|No laboratory available|2|||
127506735|NCT04035564|458817478|FG001|Overall Study|No laboratory available|2|||
127978808|NCT02548351|460544197|FG002|Overall Study|Adverse Event|36|||
127506736|NCT04035564|458817477|FG000|Overall Study|Guardian declined consent|1|||
127506737|NCT04035564|458817478|FG001|Overall Study|Guardian declined consent|2|||
127506738|NCT00996281|458817480|FG000|Overall Study|Adverse Event|75|||
127506739|NCT00996281|458817481|FG001|Overall Study|Adverse Event|37|||
127506740|NCT00996281|458817480|FG000|Overall Study|Major Protocol Deviation|6|||
127506741|NCT00996281|458817481|FG001|Overall Study|Major Protocol Deviation|7|||
127506742|NCT00996281|458817480|FG000|Overall Study|Lost to Follow-up|14|||
127506743|NCT00996281|458817481|FG001|Overall Study|Lost to Follow-up|16|||
127506744|NCT00996281|458817480|FG000|Overall Study|Withdrawal by Subject|31|||
127506745|NCT00996281|458817481|FG001|Overall Study|Withdrawal by Subject|20|||
127506746|NCT00996281|458817480|FG000|Overall Study|Lack of Efficacy|0|||
127506747|NCT00996281|458817481|FG001|Overall Study|Lack of Efficacy|2|||
127506748|NCT00996281|458817480|FG000|Overall Study|Other|5|||
127506749|NCT00996281|458817481|FG001|Overall Study|Other|7|||
127506750|NCT02754141|458817482|FG000|Overall Study|Disease progression|11|||
127506751|NCT02754141|458817483|FG001|Overall Study|Disease progression|7|||
127506752|NCT02754141|458817484|FG002|Overall Study|Disease progression|8|||
127506753|NCT02754141|458817485|FG003|Overall Study|Disease progression|5|||
127506754|NCT02754141|458817486|FG004|Overall Study|Disease progression|7|||
127506755|NCT02754141|458817487|FG005|Overall Study|Disease progression|7|||
127506756|NCT02754141|458817488|FG006|Overall Study|Disease progression|7|||
127506757|NCT02754141|458817489|FG007|Overall Study|Disease progression|6|||
127506758|NCT02754141|458817490|FG008|Overall Study|Disease progression|11|||
127506759|NCT02754141|458817491|FG009|Overall Study|Disease progression|16|||
127506760|NCT02754141|458817492|FG010|Overall Study|Disease progression|18|||
127506761|NCT02754141|458817493|FG011|Overall Study|Disease progression|13|||
127506762|NCT02754141|458817494|FG012|Overall Study|Disease progression|10|||
127506763|NCT02754141|458817495|FG013|Overall Study|Disease progression|12|||
127506764|NCT02754141|458817496|FG014|Overall Study|Disease progression|12|||
127506765|NCT02754141|458817497|FG015|Overall Study|Disease progression|14|||
127506766|NCT02754141|458817498|FG016|Overall Study|Disease progression|0|||
127506767|NCT02754141|458817499|FG017|Overall Study|Disease progression|1|||
127506768|NCT02754141|458817482|FG000|Overall Study|Study drug toxicity|1|||
127506769|NCT02754141|458817483|FG001|Overall Study|Study drug toxicity|1|||
127506770|NCT02754141|458817484|FG002|Overall Study|Study drug toxicity|0|||
127506771|NCT02754141|458817485|FG003|Overall Study|Study drug toxicity|0|||
127506772|NCT02754141|458817486|FG004|Overall Study|Study drug toxicity|0|||
127506773|NCT02754141|458817487|FG005|Overall Study|Study drug toxicity|0|||
127506774|NCT02754141|458817488|FG006|Overall Study|Study drug toxicity|0|||
127506775|NCT02754141|458817489|FG007|Overall Study|Study drug toxicity|0|||
127506776|NCT02754141|458817490|FG008|Overall Study|Study drug toxicity|0|||
127506777|NCT02754141|458817491|FG009|Overall Study|Study drug toxicity|0|||
127506778|NCT02754141|458817492|FG010|Overall Study|Study drug toxicity|2|||
127506779|NCT02754141|458817493|FG011|Overall Study|Study drug toxicity|1|||
127506780|NCT02754141|458817494|FG012|Overall Study|Study drug toxicity|1|||
127506781|NCT02754141|458817495|FG013|Overall Study|Study drug toxicity|0|||
127506782|NCT02754141|458817496|FG014|Overall Study|Study drug toxicity|0|||
127506783|NCT02754141|458817497|FG015|Overall Study|Study drug toxicity|0|||
127506784|NCT02754141|458817498|FG016|Overall Study|Study drug toxicity|0|||
127506785|NCT02754141|458817499|FG017|Overall Study|Study drug toxicity|0|||
127506786|NCT02754141|458817482|FG000|Overall Study|AE unrelated to study drug|1|||
127506787|NCT02754141|458817483|FG001|Overall Study|AE unrelated to study drug|1|||
127506788|NCT02754141|458817484|FG002|Overall Study|AE unrelated to study drug|0|||
127506789|NCT02754141|458817485|FG003|Overall Study|AE unrelated to study drug|1|||
127506790|NCT02754141|458817486|FG004|Overall Study|AE unrelated to study drug|3|||
127506791|NCT02754141|458817487|FG005|Overall Study|AE unrelated to study drug|2|||
127506792|NCT02754141|458817488|FG006|Overall Study|AE unrelated to study drug|1|||
127506793|NCT02754141|458817489|FG007|Overall Study|AE unrelated to study drug|0|||
127506794|NCT02754141|458817490|FG008|Overall Study|AE unrelated to study drug|0|||
127506795|NCT02754141|458817491|FG009|Overall Study|AE unrelated to study drug|0|||
127506796|NCT02754141|458817492|FG010|Overall Study|AE unrelated to study drug|0|||
127506797|NCT02754141|458817493|FG011|Overall Study|AE unrelated to study drug|0|||
127506798|NCT02754141|458817494|FG012|Overall Study|AE unrelated to study drug|0|||
127506799|NCT02754141|458817495|FG013|Overall Study|AE unrelated to study drug|0|||
127506800|NCT02754141|458817496|FG014|Overall Study|AE unrelated to study drug|0|||
127978809|NCT02548351|460544195|FG000|Overall Study|Study Terminated by Sponsor|549|||
127978810|NCT02548351|460544196|FG001|Overall Study|Study Terminated by Sponsor|509|||
127506801|NCT02754141|458817497|FG015|Overall Study|AE unrelated to study drug|0|||
127506802|NCT02754141|458817498|FG016|Overall Study|AE unrelated to study drug|0|||
127978811|NCT02548351|460544197|FG002|Overall Study|Study Terminated by Sponsor|528|||
127978812|NCT02548351|460544195|FG000|Overall Study|Site Closure|14|||
127506803|NCT02754141|458817499|FG017|Overall Study|AE unrelated to study drug|0|||
127506804|NCT02754141|458817482|FG000|Overall Study|Request to discontinue|0|||
127506805|NCT02754141|458817483|FG001|Overall Study|Request to discontinue|0|||
127506806|NCT02754141|458817484|FG002|Overall Study|Request to discontinue|0|||
127506807|NCT02754141|458817485|FG003|Overall Study|Request to discontinue|0|||
127506808|NCT02754141|458817486|FG004|Overall Study|Request to discontinue|0|||
127978813|NCT02548351|460544196|FG001|Overall Study|Site Closure|5|||
127506809|NCT02754141|458817487|FG005|Overall Study|Request to discontinue|0|||
127506810|NCT02754141|458817488|FG006|Overall Study|Request to discontinue|0|||
127506811|NCT02754141|458817489|FG007|Overall Study|Request to discontinue|0|||
127506812|NCT02754141|458817490|FG008|Overall Study|Request to discontinue|1|||
127506813|NCT02754141|458817491|FG009|Overall Study|Request to discontinue|0|||
127506814|NCT02754141|458817492|FG010|Overall Study|Request to discontinue|0|||
127506815|NCT02754141|458817493|FG011|Overall Study|Request to discontinue|0|||
127506816|NCT02754141|458817494|FG012|Overall Study|Request to discontinue|0|||
127506817|NCT02754141|458817495|FG013|Overall Study|Request to discontinue|1|||
127506818|NCT02754141|458817496|FG014|Overall Study|Request to discontinue|1|||
127506819|NCT02754141|458817497|FG015|Overall Study|Request to discontinue|0|||
127506820|NCT02754141|458817498|FG016|Overall Study|Request to discontinue|0|||
127506821|NCT02754141|458817499|FG017|Overall Study|Request to discontinue|0|||
127506822|NCT02754141|458817482|FG000|Overall Study|Withdrew consent|0|||
127506823|NCT02754141|458817483|FG001|Overall Study|Withdrew consent|0|||
127506824|NCT02754141|458817484|FG002|Overall Study|Withdrew consent|0|||
127506825|NCT02754141|458817485|FG003|Overall Study|Withdrew consent|0|||
127506826|NCT02754141|458817486|FG004|Overall Study|Withdrew consent|0|||
127506827|NCT02754141|458817487|FG005|Overall Study|Withdrew consent|0|||
127506828|NCT02754141|458817488|FG006|Overall Study|Withdrew consent|0|||
127506829|NCT02754141|458817489|FG007|Overall Study|Withdrew consent|0|||
127506830|NCT02754141|458817490|FG008|Overall Study|Withdrew consent|0|||
127506831|NCT02754141|458817491|FG009|Overall Study|Withdrew consent|1|||
127506832|NCT02754141|458817492|FG010|Overall Study|Withdrew consent|0|||
127506833|NCT02754141|458817493|FG011|Overall Study|Withdrew consent|0|||
127506834|NCT02754141|458817494|FG012|Overall Study|Withdrew consent|0|||
127506835|NCT02754141|458817495|FG013|Overall Study|Withdrew consent|0|||
127506836|NCT02754141|458817496|FG014|Overall Study|Withdrew consent|0|||
127506837|NCT02754141|458817497|FG015|Overall Study|Withdrew consent|0|||
127506838|NCT02754141|458817498|FG016|Overall Study|Withdrew consent|0|||
127506839|NCT02754141|458817499|FG017|Overall Study|Withdrew consent|0|||
127506840|NCT02754141|458817482|FG000|Overall Study|Maximum clinical benefit|0|||
127506841|NCT02754141|458817483|FG001|Overall Study|Maximum clinical benefit|0|||
127506842|NCT02754141|458817484|FG002|Overall Study|Maximum clinical benefit|0|||
127506843|NCT02754141|458817485|FG003|Overall Study|Maximum clinical benefit|1|||
127506844|NCT02754141|458817486|FG004|Overall Study|Maximum clinical benefit|0|||
127506845|NCT02754141|458817487|FG005|Overall Study|Maximum clinical benefit|0|||
127506846|NCT02754141|458817488|FG006|Overall Study|Maximum clinical benefit|0|||
127506847|NCT02754141|458817489|FG007|Overall Study|Maximum clinical benefit|0|||
127506848|NCT02754141|458817490|FG008|Overall Study|Maximum clinical benefit|0|||
127506849|NCT02754141|458817491|FG009|Overall Study|Maximum clinical benefit|0|||
127506850|NCT02754141|458817492|FG010|Overall Study|Maximum clinical benefit|0|||
127506851|NCT02754141|458817493|FG011|Overall Study|Maximum clinical benefit|0|||
127506852|NCT02754141|458817494|FG012|Overall Study|Maximum clinical benefit|0|||
127506853|NCT02754141|458817495|FG013|Overall Study|Maximum clinical benefit|0|||
127506854|NCT02754141|458817496|FG014|Overall Study|Maximum clinical benefit|0|||
127506855|NCT02754141|458817497|FG015|Overall Study|Maximum clinical benefit|0|||
127506856|NCT02754141|458817498|FG016|Overall Study|Maximum clinical benefit|0|||
127506857|NCT02754141|458817499|FG017|Overall Study|Maximum clinical benefit|0|||
127506858|NCT02754141|458817482|FG000|Overall Study|No longer meets study criteria|0|||
127506859|NCT02754141|458817483|FG001|Overall Study|No longer meets study criteria|0|||
127506860|NCT02754141|458817484|FG002|Overall Study|No longer meets study criteria|0|||
127506861|NCT02754141|458817485|FG003|Overall Study|No longer meets study criteria|1|||
127506862|NCT02754141|458817486|FG004|Overall Study|No longer meets study criteria|0|||
127506863|NCT02754141|458817487|FG005|Overall Study|No longer meets study criteria|0|||
127506864|NCT02754141|458817488|FG006|Overall Study|No longer meets study criteria|0|||
127506865|NCT02754141|458817489|FG007|Overall Study|No longer meets study criteria|0|||
127506866|NCT02754141|458817490|FG008|Overall Study|No longer meets study criteria|0|||
127506867|NCT02754141|458817491|FG009|Overall Study|No longer meets study criteria|0|||
127506868|NCT02754141|458817492|FG010|Overall Study|No longer meets study criteria|0|||
127506869|NCT02754141|458817493|FG011|Overall Study|No longer meets study criteria|0|||
127506870|NCT02754141|458817494|FG012|Overall Study|No longer meets study criteria|0|||
127506871|NCT02754141|458817495|FG013|Overall Study|No longer meets study criteria|0|||
127506872|NCT02754141|458817496|FG014|Overall Study|No longer meets study criteria|0|||
127506873|NCT02754141|458817497|FG015|Overall Study|No longer meets study criteria|0|||
127506874|NCT02754141|458817498|FG016|Overall Study|No longer meets study criteria|0|||
127506875|NCT02754141|458817499|FG017|Overall Study|No longer meets study criteria|0|||
127506876|NCT02754141|458817482|FG000|Overall Study|Other reasons|0|||
127506877|NCT02754141|458817483|FG001|Overall Study|Other reasons|0|||
127506878|NCT02754141|458817484|FG002|Overall Study|Other reasons|0|||
127506879|NCT02754141|458817485|FG003|Overall Study|Other reasons|0|||
127506880|NCT02754141|458817486|FG004|Overall Study|Other reasons|0|||
127506881|NCT02754141|458817487|FG005|Overall Study|Other reasons|0|||
127506882|NCT02754141|458817488|FG006|Overall Study|Other reasons|0|||
127506883|NCT02754141|458817489|FG007|Overall Study|Other reasons|1|||
127506884|NCT02754141|458817490|FG008|Overall Study|Other reasons|0|||
127506885|NCT02754141|458817491|FG009|Overall Study|Other reasons|0|||
127506886|NCT02754141|458817492|FG010|Overall Study|Other reasons|0|||
127506887|NCT02754141|458817493|FG011|Overall Study|Other reasons|0|||
127506888|NCT02754141|458817494|FG012|Overall Study|Other reasons|2|||
127506889|NCT02754141|458817495|FG013|Overall Study|Other reasons|0|||
127506890|NCT02754141|458817496|FG014|Overall Study|Other reasons|0|||
127506891|NCT02754141|458817497|FG015|Overall Study|Other reasons|0|||
127506892|NCT02754141|458817498|FG016|Overall Study|Other reasons|0|||
127506893|NCT02754141|458817499|FG017|Overall Study|Other reasons|0|||
127506894|NCT02754141|458817482|FG000|Overall Study|Completed treatment as per protocol|0|||
127506895|NCT02754141|458817483|FG001|Overall Study|Completed treatment as per protocol|1|||
127506896|NCT02754141|458817484|FG002|Overall Study|Completed treatment as per protocol|0|||
127506897|NCT02754141|458817485|FG003|Overall Study|Completed treatment as per protocol|0|||
127506898|NCT02754141|458817486|FG004|Overall Study|Completed treatment as per protocol|0|||
127506899|NCT02754141|458817487|FG005|Overall Study|Completed treatment as per protocol|0|||
127506900|NCT02754141|458817488|FG006|Overall Study|Completed treatment as per protocol|0|||
127506901|NCT02754141|458817489|FG007|Overall Study|Completed treatment as per protocol|0|||
127506902|NCT02754141|458817490|FG008|Overall Study|Completed treatment as per protocol|0|||
127506903|NCT02754141|458817491|FG009|Overall Study|Completed treatment as per protocol|0|||
127506904|NCT02754141|458817492|FG010|Overall Study|Completed treatment as per protocol|0|||
127506905|NCT02754141|458817493|FG011|Overall Study|Completed treatment as per protocol|0|||
127506906|NCT02754141|458817494|FG012|Overall Study|Completed treatment as per protocol|1|||
127506907|NCT02754141|458817495|FG013|Overall Study|Completed treatment as per protocol|0|||
127506908|NCT02754141|458817496|FG014|Overall Study|Completed treatment as per protocol|0|||
127506909|NCT02754141|458817497|FG015|Overall Study|Completed treatment as per protocol|0|||
127506910|NCT02754141|458817498|FG016|Overall Study|Completed treatment as per protocol|0|||
127506911|NCT02754141|458817499|FG017|Overall Study|Completed treatment as per protocol|0|||
127506912|NCT02754141|458817482|FG000|Overall Study|Not completing monotherapy|0|||
127506913|NCT02754141|458817483|FG001|Overall Study|Not completing monotherapy|0|||
127506914|NCT02754141|458817484|FG002|Overall Study|Not completing monotherapy|0|||
127506915|NCT02754141|458817485|FG003|Overall Study|Not completing monotherapy|0|||
127506916|NCT02754141|458817486|FG004|Overall Study|Not completing monotherapy|0|||
127506917|NCT02754141|458817487|FG005|Overall Study|Not completing monotherapy|0|||
127506918|NCT02754141|458817488|FG006|Overall Study|Not completing monotherapy|0|||
127506919|NCT02754141|458817489|FG007|Overall Study|Not completing monotherapy|0|||
127506920|NCT02754141|458817490|FG008|Overall Study|Not completing monotherapy|0|||
127506921|NCT02754141|458817491|FG009|Overall Study|Not completing monotherapy|0|||
127506922|NCT02754141|458817492|FG010|Overall Study|Not completing monotherapy|0|||
127506923|NCT02754141|458817493|FG011|Overall Study|Not completing monotherapy|0|||
127506924|NCT02754141|458817494|FG012|Overall Study|Not completing monotherapy|0|||
127506925|NCT02754141|458817495|FG013|Overall Study|Not completing monotherapy|1|||
127506926|NCT02754141|458817496|FG014|Overall Study|Not completing monotherapy|0|||
127506927|NCT02754141|458817497|FG015|Overall Study|Not completing monotherapy|0|||
127506928|NCT02754141|458817498|FG016|Overall Study|Not completing monotherapy|0|||
127506929|NCT02754141|458817499|FG017|Overall Study|Not completing monotherapy|0|||
127506930|NCT03361189|458817500|FG000|Overall Study|Received heart transplant|1|||
127506931|NCT03361189|458817501|FG001|Overall Study|Received heart transplant|0|||
127506932|NCT03361189|458817500|FG000|Overall Study|Pacemake replacement|0|||
127506933|NCT03361189|458817501|FG001|Overall Study|Pacemake replacement|1|||
127506934|NCT03505788|458817502|FG000|Overall Study|Lost to Follow-up|2|||
127506935|NCT03505788|458817503|FG001|Overall Study|Lost to Follow-up|1|||
127506936|NCT03505788|458817502|FG000|Overall Study|Withdrawal by Subject|1|||
127506937|NCT03505788|458817503|FG001|Overall Study|Withdrawal by Subject|3|||
127506938|NCT03505788|458817502|FG000|Overall Study|Physician Decision|0|||
127506939|NCT03505788|458817503|FG001|Overall Study|Physician Decision|1|||
127506940|NCT03344549|458817504|FG000|Overall Study|Withdrawal by Subject|3|||
127506941|NCT03344549|458817505|FG001|Overall Study|Withdrawal by Subject|2|||
127506942|NCT03344549|458817504|FG000|Overall Study|Dialysis|2|||
127506943|NCT03344549|458817505|FG001|Overall Study|Dialysis|0|||
127506944|NCT03344549|458817504|FG000|Overall Study|Cancer|1|||
127506945|NCT03344549|458817505|FG001|Overall Study|Cancer|0|||
127506946|NCT03344549|458817504|FG000|Overall Study|Lack of electronic device|1|||
127506947|NCT03344549|458817505|FG001|Overall Study|Lack of electronic device|0|||
127506948|NCT03344549|458817504|FG000|Overall Study|Transportation difficulty|0|||
127506949|NCT03344549|458817505|FG001|Overall Study|Transportation difficulty|13|||
127506950|NCT03333252|458817506|FG000|Overall Study|Adverse Event|10|||
127506951|NCT03333252|458817507|FG001|Overall Study|Adverse Event|6|||
127506952|NCT03333252|458817508|FG002|Overall Study|Adverse Event|5|||
127506953|NCT03333252|458817509|FG003|Overall Study|Adverse Event|2|||
127506954|NCT03333252|458817506|FG000|Overall Study|Death|1|||
127506955|NCT03333252|458817507|FG001|Overall Study|Death|3|||
127506956|NCT03333252|458817508|FG002|Overall Study|Death|0|||
127506957|NCT03333252|458817509|FG003|Overall Study|Death|0|||
127506958|NCT03333252|458817506|FG000|Overall Study|Lack of Efficacy|8|||
127506959|NCT03333252|458817507|FG001|Overall Study|Lack of Efficacy|4|||
127506960|NCT03333252|458817508|FG002|Overall Study|Lack of Efficacy|0|||
127506961|NCT03333252|458817509|FG003|Overall Study|Lack of Efficacy|7|||
127506962|NCT03333252|458817506|FG000|Overall Study|Lost to Follow-up|0|||
127506963|NCT03333252|458817507|FG001|Overall Study|Lost to Follow-up|5|||
127506964|NCT03333252|458817508|FG002|Overall Study|Lost to Follow-up|9|||
127506965|NCT03333252|458817509|FG003|Overall Study|Lost to Follow-up|3|||
127506966|NCT03333252|458817506|FG000|Overall Study|Withdrawal by Subject|14|||
127506967|NCT03333252|458817507|FG001|Overall Study|Withdrawal by Subject|24|||
127506968|NCT03333252|458817508|FG002|Overall Study|Withdrawal by Subject|11|||
127506969|NCT03333252|458817509|FG003|Overall Study|Withdrawal by Subject|17|||
127506970|NCT00666588|458817513|FG000|Overall Study|ineligible|2|||
127506971|NCT00666588|458817514|FG001|Overall Study|ineligible|0|||
127506972|NCT00666588|458817515|FG002|Overall Study|ineligible|0|||
127506973|NCT00666588|458817516|FG003|Overall Study|ineligible|2|||
127506974|NCT00666588|458817513|FG000|Overall Study|inevaluable|2|||
127506975|NCT00666588|458817514|FG001|Overall Study|inevaluable|0|||
127506976|NCT00666588|458817515|FG002|Overall Study|inevaluable|0|||
127506977|NCT00666588|458817516|FG003|Overall Study|inevaluable|0|||
127506978|NCT01007123|458817521|FG000|Overall Study|Adverse Event|3|||
127506979|NCT01007123|458817522|FG001|Overall Study|Adverse Event|4|||
127506980|NCT01007123|458817523|FG002|Overall Study|Adverse Event|7|||
127506981|NCT01007123|458817524|FG003|Overall Study|Adverse Event|1|||
127506982|NCT01007123|458817521|FG000|Overall Study|Lack of Efficacy|1|||
127506983|NCT01007123|458817522|FG001|Overall Study|Lack of Efficacy|0|||
127506984|NCT01007123|458817523|FG002|Overall Study|Lack of Efficacy|1|||
127506985|NCT01007123|458817524|FG003|Overall Study|Lack of Efficacy|4|||
127506986|NCT01007123|458817521|FG000|Overall Study|Protocol Violation|1|||
127506987|NCT01007123|458817522|FG001|Overall Study|Protocol Violation|1|||
127506988|NCT01007123|458817523|FG002|Overall Study|Protocol Violation|2|||
127506989|NCT01007123|458817524|FG003|Overall Study|Protocol Violation|1|||
127506990|NCT01007123|458817521|FG000|Overall Study|Withdrawal by Subject|1|||
127506991|NCT01007123|458817522|FG001|Overall Study|Withdrawal by Subject|0|||
127506992|NCT01007123|458817523|FG002|Overall Study|Withdrawal by Subject|1|||
127506993|NCT01007123|458817524|FG003|Overall Study|Withdrawal by Subject|0|||
127506994|NCT01007123|458817521|FG000|Overall Study|Lost to Follow-up|0|||
127506995|NCT01007123|458817522|FG001|Overall Study|Lost to Follow-up|1|||
127506996|NCT01007123|458817523|FG002|Overall Study|Lost to Follow-up|0|||
127506997|NCT01007123|458817524|FG003|Overall Study|Lost to Follow-up|0|||
127506998|NCT02075047|458817525|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
127506999|NCT02075047|458817526|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
127507000|NCT02075047|458817525|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
127507001|NCT02075047|458817526|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
127507002|NCT02075047|458817525|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
127507003|NCT02075047|458817526|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
127507004|NCT02075047|458817525|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
127507005|NCT02075047|458817526|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
127507006|NCT02075047|458817525|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
127507007|NCT02075047|458817526|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
127507008|NCT02075047|458817525|FG000|Treatment Phase (4 Weeks)|Other|1|||
127507009|NCT02075047|458817526|FG001|Treatment Phase (4 Weeks)|Other|1|||
127507010|NCT02075047|458817525|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
127507011|NCT02075047|458817526|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
127507012|NCT02075047|458817525|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
127507013|NCT02075047|458817526|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
127507014|NCT02075047|458817525|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
127507015|NCT02075047|458817526|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
127507016|NCT02075047|458817525|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
127507017|NCT02075047|458817526|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
127507018|NCT02075047|458817525|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
127507019|NCT02075047|458817526|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
127507020|NCT02075047|458817525|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
127507021|NCT02075047|458817526|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
127507022|NCT02075047|458817525|FG000|Follow up Phase (5 Weeks)|Other|1|||
127507023|NCT02075047|458817526|FG001|Follow up Phase (5 Weeks)|Other|2|||
127507024|NCT02075047|458817525|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
127507025|NCT02075047|458817526|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
127507026|NCT00149994|458817529|FG000|Overall Study|Administrative problems:|1|||
127507027|NCT00149994|458817530|FG001|Overall Study|Administrative problems:|0|||
127507028|NCT00149994|458817529|FG000|Overall Study|Protocol Violation|0|||
127507029|NCT00149994|458817530|FG001|Overall Study|Protocol Violation|1|||
127507030|NCT02324205|458817533|FG000|Overall Study|Withdrawal by Subject|37|||
127507031|NCT04195438|458817536|FG000|Overall Study|Withdrawal by Subject|1|||
127507032|NCT01774097|458817537|FG000|Overall Study|Withdrawal by Subject|1|||
127507033|NCT01774097|458817538|FG001|Overall Study|Withdrawal by Subject|1|||
127507034|NCT01774097|458817537|FG000|Overall Study|Adverse Event|1|||
127507035|NCT01774097|458817538|FG001|Overall Study|Adverse Event|1|||
127507036|NCT01920568|458817539|FG000|Overall Study|Adverse Event|27|||
127507037|NCT01920568|458817540|FG001|Overall Study|Adverse Event|8|||
127507038|NCT01920568|458817539|FG000|Overall Study|Protocol Violation|5|||
127507039|NCT01920568|458817540|FG001|Overall Study|Protocol Violation|3|||
127507040|NCT01920568|458817539|FG000|Overall Study|Lost to Follow-up|2|||
127507041|NCT01920568|458817540|FG001|Overall Study|Lost to Follow-up|2|||
127507042|NCT01920568|458817539|FG000|Overall Study|Physician Decision|13|||
127507043|NCT01920568|458817540|FG001|Overall Study|Physician Decision|4|||
127507044|NCT01920568|458817539|FG000|Overall Study|Withdrawal by Subject|79|||
127507045|NCT01920568|458817540|FG001|Overall Study|Withdrawal by Subject|55|||
127507046|NCT01920568|458817539|FG000|Overall Study|Death due to disease progression|25|||
127507047|NCT01920568|458817540|FG001|Overall Study|Death due to disease progression|12|||
127507048|NCT00794365|458817544|FG000|Overall Study|Lost to Follow-up|38|||
127507049|NCT00794365|458817544|FG000|Overall Study|Other|17|||
127507050|NCT00794365|458817544|FG000|Overall Study|Poor Compliance|11|||
127507051|NCT00794365|458817544|FG000|Overall Study|Adverse Event|10|||
127507052|NCT00794365|458817544|FG000|Overall Study|Lack of Efficacy|3|||
127507053|NCT04422561|458817545|FG000|Overall Study|Lost to Follow-up|25|||
127507054|NCT04422561|458817546|FG001|Overall Study|Lost to Follow-up|11|||
127507055|NCT03640052|458817547|FG000|Overall Study|Lost to Follow-up|0|||
127507056|NCT03640052|458817548|FG001|Overall Study|Lost to Follow-up|1|||
127507057|NCT03640052|458817549|FG002|Overall Study|Lost to Follow-up|0|||
127507058|NCT03640052|458817550|FG003|Overall Study|Lost to Follow-up|0|||
127507059|NCT03640052|458817551|FG004|Overall Study|Lost to Follow-up|0|||
127507060|NCT04239222|458817554|FG000|Baseline|Withdrawal by Subject|0|||
127507061|NCT04239222|458817555|FG001|Baseline|Withdrawal by Subject|0|||
127507062|NCT04239222|458817556|FG002|Baseline|Withdrawal by Subject|1|||
127507063|NCT04239222|458817557|FG003|Baseline|Withdrawal by Subject|1|||
127507064|NCT04239222|458817554|FG000|First Foot Assignment|Withdrawal by Subject|0|||
127507065|NCT04239222|458817555|FG001|First Foot Assignment|Withdrawal by Subject|0|||
127507066|NCT04239222|458817556|FG002|First Foot Assignment|Withdrawal by Subject|1|||
127507067|NCT04239222|458817557|FG003|First Foot Assignment|Withdrawal by Subject|0|||
127507068|NCT04239222|458817554|FG000|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
127507069|NCT04239222|458817555|FG001|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
127507070|NCT04239222|458817556|FG002|Crossover to Alternate Foot Assignment|Protocol Violation|1|||
127507071|NCT04239222|458817557|FG003|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
127507072|NCT00230282|458817562|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
127507073|NCT00230282|458817562|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
127507074|NCT00230282|458817562|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
127507075|NCT00230282|458817562|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
127507076|NCT03006458|458817565|FG000|First Intervention|Unsatisfied Vision|0|||
127507077|NCT03006458|458817566|FG001|First Intervention|Unsatisfied Vision|3|||
127507078|NCT01468233|458817568|FG000|Treatment Period 1|Adverse Event|5|||
127507079|NCT01468233|458817569|FG001|Treatment Period 1|Adverse Event|3|||
127507080|NCT01468233|458817570|FG002|Treatment Period 1|Adverse Event|0|||
127507081|NCT01468233|458817571|FG003|Treatment Period 1|Adverse Event|0|||
127507082|NCT01468233|458817572|FG004|Treatment Period 1|Adverse Event|0|||
127507083|NCT01468233|458817573|FG005|Treatment Period 1|Adverse Event|0|||
127507084|NCT01468233|458817568|FG000|Treatment Period 1|Withdrawal by Subject|3|||
127507085|NCT01468233|458817569|FG001|Treatment Period 1|Withdrawal by Subject|4|||
127507086|NCT01468233|458817570|FG002|Treatment Period 1|Withdrawal by Subject|0|||
127507087|NCT01468233|458817571|FG003|Treatment Period 1|Withdrawal by Subject|0|||
127507088|NCT01468233|458817572|FG004|Treatment Period 1|Withdrawal by Subject|0|||
127507089|NCT01468233|458817573|FG005|Treatment Period 1|Withdrawal by Subject|0|||
127507090|NCT01468233|458817568|FG000|Treatment Period 1|Lost to Follow-up|3|||
127507091|NCT01468233|458817569|FG001|Treatment Period 1|Lost to Follow-up|0|||
127507092|NCT01468233|458817570|FG002|Treatment Period 1|Lost to Follow-up|0|||
127507093|NCT01468233|458817571|FG003|Treatment Period 1|Lost to Follow-up|0|||
127507094|NCT01468233|458817572|FG004|Treatment Period 1|Lost to Follow-up|0|||
127507095|NCT01468233|458817573|FG005|Treatment Period 1|Lost to Follow-up|0|||
127507096|NCT01468233|458817568|FG000|Treatment Period 1|Other|1|||
127507097|NCT01468233|458817569|FG001|Treatment Period 1|Other|1|||
127507098|NCT01468233|458817570|FG002|Treatment Period 1|Other|0|||
127507099|NCT01468233|458817571|FG003|Treatment Period 1|Other|0|||
127507100|NCT01468233|458817572|FG004|Treatment Period 1|Other|0|||
127507101|NCT01468233|458817573|FG005|Treatment Period 1|Other|0|||
127507102|NCT01468233|458817568|FG000|Treatment Period 2|Adverse Event|0|||
127507103|NCT01468233|458817569|FG001|Treatment Period 2|Adverse Event|0|||
127507104|NCT01468233|458817570|FG002|Treatment Period 2|Adverse Event|3|||
127507105|NCT01468233|458817571|FG003|Treatment Period 2|Adverse Event|0|||
127507106|NCT01468233|458817572|FG004|Treatment Period 2|Adverse Event|2|||
127507107|NCT01468233|458817573|FG005|Treatment Period 2|Adverse Event|1|||
127507108|NCT01468233|458817568|FG000|Treatment Period 2|Lack of Efficacy|0|||
127978814|NCT02548351|460544197|FG002|Overall Study|Site Closure|7|||
127978815|NCT02548351|460544195|FG000|Overall Study|Non-compliance with Study Drug|4|||
127507109|NCT01468233|458817569|FG001|Treatment Period 2|Lack of Efficacy|0|||
127507110|NCT01468233|458817570|FG002|Treatment Period 2|Lack of Efficacy|9|||
127507111|NCT01468233|458817571|FG003|Treatment Period 2|Lack of Efficacy|2|||
127507112|NCT01468233|458817572|FG004|Treatment Period 2|Lack of Efficacy|0|||
127507113|NCT01468233|458817573|FG005|Treatment Period 2|Lack of Efficacy|1|||
127507114|NCT01468233|458817568|FG000|Treatment Period 2|Withdrawal by Subject|0|||
127507115|NCT01468233|458817569|FG001|Treatment Period 2|Withdrawal by Subject|0|||
127507116|NCT01468233|458817570|FG002|Treatment Period 2|Withdrawal by Subject|9|||
127507117|NCT01468233|458817571|FG003|Treatment Period 2|Withdrawal by Subject|1|||
127507118|NCT01468233|458817572|FG004|Treatment Period 2|Withdrawal by Subject|1|||
127507119|NCT01468233|458817573|FG005|Treatment Period 2|Withdrawal by Subject|1|||
127507120|NCT01468233|458817568|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
127507121|NCT01468233|458817569|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
127507122|NCT01468233|458817570|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
127507123|NCT01468233|458817571|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
127507124|NCT01468233|458817572|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
127507125|NCT01468233|458817573|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
127507126|NCT01468233|458817568|FG000|Treatment Period 2|Lost to Follow-up|0|||
127507127|NCT01468233|458817569|FG001|Treatment Period 2|Lost to Follow-up|0|||
127507128|NCT01468233|458817570|FG002|Treatment Period 2|Lost to Follow-up|3|||
127507129|NCT01468233|458817571|FG003|Treatment Period 2|Lost to Follow-up|0|||
127507130|NCT01468233|458817572|FG004|Treatment Period 2|Lost to Follow-up|2|||
127507131|NCT01468233|458817573|FG005|Treatment Period 2|Lost to Follow-up|0|||
127507132|NCT01468233|458817568|FG000|Treatment Period 2|Other|0|||
127507133|NCT01468233|458817569|FG001|Treatment Period 2|Other|0|||
127507134|NCT01468233|458817570|FG002|Treatment Period 2|Other|3|||
127507135|NCT01468233|458817571|FG003|Treatment Period 2|Other|0|||
127507136|NCT01468233|458817572|FG004|Treatment Period 2|Other|1|||
127507137|NCT01468233|458817573|FG005|Treatment Period 2|Other|0|||
127507138|NCT00790647|458817581|FG000|Overall Study|Adverse Event|1|||
127507139|NCT04926831|458817583|FG000|Overall Study|Withdrawal by Subject|2|||
127507140|NCT04926831|458817583|FG000|Overall Study|Adverse Event|2|||
127507141|NCT02701777|458817584|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
127507142|NCT02701777|458817585|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
127507143|NCT02701777|458817586|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
127507144|NCT02701777|458817587|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
127507145|NCT02701777|458817584|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
127507146|NCT02701777|458817585|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
127507147|NCT02701777|458817586|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
127507148|NCT02701777|458817587|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
127507149|NCT01133626|458817589|FG000|Overall Study|Adverse Event|0|||
127507150|NCT01133626|458817590|FG001|Overall Study|Adverse Event|1|||
127507151|NCT01133626|458817591|FG002|Overall Study|Adverse Event|0|||
127507152|NCT01133626|458817589|FG000|Overall Study|Withdrawal by Subject|1|||
127507153|NCT01133626|458817590|FG001|Overall Study|Withdrawal by Subject|2|||
127507154|NCT01133626|458817591|FG002|Overall Study|Withdrawal by Subject|2|||
127507155|NCT01133626|458817589|FG000|Overall Study|Other|0|||
127507156|NCT01133626|458817590|FG001|Overall Study|Other|2|||
127507157|NCT01133626|458817591|FG002|Overall Study|Other|0|||
127507158|NCT02851407|458817592|FG000|Overall Study|Withdrawal by parent/guardian|2|||
127507159|NCT02851407|458817593|FG001|Overall Study|Withdrawal by parent/guardian|7|||
127507160|NCT02851407|458817592|FG000|Overall Study|Protocol deviation|0|||
127507161|NCT02851407|458817593|FG001|Overall Study|Protocol deviation|1|||
127507162|NCT02851407|458817592|FG000|Overall Study|Transferred to another hospital to continue|1|||
127507163|NCT02851407|458817593|FG001|Overall Study|Transferred to another hospital to continue|0|||
127507164|NCT02851407|458817592|FG000|Overall Study|Other Death|30|||
127507165|NCT02851407|458817593|FG001|Overall Study|Other Death|20|||
127507166|NCT02851407|458817592|FG000|Overall Study|Adverse event, serious fatal|6|||
127507167|NCT02851407|458817593|FG001|Overall Study|Adverse event, serious fatal|8|||
127507168|NCT02851407|458817592|FG000|Overall Study|Consent withdrawn by participant|5|||
127507169|NCT02851407|458817593|FG001|Overall Study|Consent withdrawn by participant|3|||
127507170|NCT02851407|458817592|FG000|Overall Study|Screen failure|2|||
127507171|NCT02851407|458817593|FG001|Overall Study|Screen failure|1|||
127507172|NCT02851407|458817592|FG000|Overall Study|Disease relapse|9|||
127507173|NCT02851407|458817593|FG001|Overall Study|Disease relapse|6|||
127507174|NCT02851407|458817592|FG000|Overall Study|Physician Decision|7|||
127507175|NCT02851407|458817593|FG001|Overall Study|Physician Decision|6|||
127507176|NCT02851407|458817592|FG000|Overall Study|Transferred to hospital closer to home|0|||
127507177|NCT02851407|458817593|FG001|Overall Study|Transferred to hospital closer to home|1|||
127507178|NCT02851407|458817592|FG000|Overall Study|Enrolled in an investigational study|0|||
127507179|NCT02851407|458817593|FG001|Overall Study|Enrolled in an investigational study|1|||
127507180|NCT02851407|458817592|FG000|Overall Study|Early recovery|1|||
127507181|NCT02851407|458817593|FG001|Overall Study|Early recovery|0|||
127507182|NCT02851407|458817592|FG000|Overall Study|Adverse event, non-fatal|7|||
127507183|NCT02851407|458817593|FG001|Overall Study|Adverse event, non-fatal|5|||
127507184|NCT02851407|458817592|FG000|Overall Study|Lost to Follow-up|0|||
127507185|NCT02851407|458817593|FG001|Overall Study|Lost to Follow-up|2|||
127507186|NCT00075725|458817594|FG000|Overall Study|Adverse Event|6|||
127507187|NCT00075725|458817595|FG001|Overall Study|Adverse Event|6|||
127507188|NCT00075725|458817596|FG002|Overall Study|Adverse Event|20|||
127507189|NCT00075725|458817597|FG003|Overall Study|Adverse Event|8|||
127507190|NCT00075725|458817598|FG004|Overall Study|Adverse Event|4|||
127507191|NCT00075725|458817599|FG005|Overall Study|Adverse Event|38|||
127507192|NCT00075725|458817600|FG006|Overall Study|Adverse Event|3|||
127507193|NCT00075725|458817601|FG007|Overall Study|Adverse Event|51|||
127507194|NCT00075725|458817602|FG008|Overall Study|Adverse Event|15|||
127507195|NCT00075725|458817603|FG009|Overall Study|Adverse Event|4|||
127507196|NCT00075725|458817604|FG010|Overall Study|Adverse Event|2|||
127507197|NCT00075725|458817605|FG011|Overall Study|Adverse Event|2|||
127507198|NCT00075725|458817594|FG000|Overall Study|Death|3|||
127507199|NCT00075725|458817595|FG001|Overall Study|Death|5|||
127507200|NCT00075725|458817596|FG002|Overall Study|Death|10|||
127507201|NCT00075725|458817597|FG003|Overall Study|Death|2|||
127507202|NCT00075725|458817598|FG004|Overall Study|Death|3|||
127507203|NCT00075725|458817599|FG005|Overall Study|Death|25|||
127507204|NCT00075725|458817600|FG006|Overall Study|Death|4|||
127507205|NCT00075725|458817601|FG007|Overall Study|Death|22|||
127507206|NCT00075725|458817602|FG008|Overall Study|Death|14|||
127507207|NCT00075725|458817603|FG009|Overall Study|Death|4|||
127507208|NCT00075725|458817604|FG010|Overall Study|Death|3|||
127507209|NCT00075725|458817605|FG011|Overall Study|Death|0|||
127507210|NCT00075725|458817594|FG000|Overall Study|Lost to Follow-up|1|||
127507211|NCT00075725|458817595|FG001|Overall Study|Lost to Follow-up|1|||
127507212|NCT00075725|458817596|FG002|Overall Study|Lost to Follow-up|4|||
127507213|NCT00075725|458817597|FG003|Overall Study|Lost to Follow-up|1|||
127507214|NCT00075725|458817598|FG004|Overall Study|Lost to Follow-up|0|||
127507215|NCT00075725|458817599|FG005|Overall Study|Lost to Follow-up|13|||
127507216|NCT00075725|458817600|FG006|Overall Study|Lost to Follow-up|2|||
127507217|NCT00075725|458817601|FG007|Overall Study|Lost to Follow-up|4|||
127507218|NCT00075725|458817602|FG008|Overall Study|Lost to Follow-up|1|||
127507219|NCT00075725|458817603|FG009|Overall Study|Lost to Follow-up|0|||
127507220|NCT00075725|458817604|FG010|Overall Study|Lost to Follow-up|0|||
127507221|NCT00075725|458817605|FG011|Overall Study|Lost to Follow-up|0|||
127507222|NCT00075725|458817594|FG000|Overall Study|Physician Decision|2|||
127507223|NCT00075725|458817595|FG001|Overall Study|Physician Decision|6|||
127507224|NCT00075725|458817596|FG002|Overall Study|Physician Decision|5|||
127507225|NCT00075725|458817597|FG003|Overall Study|Physician Decision|8|||
127507226|NCT00075725|458817598|FG004|Overall Study|Physician Decision|4|||
127507227|NCT00075725|458817599|FG005|Overall Study|Physician Decision|19|||
127507228|NCT00075725|458817600|FG006|Overall Study|Physician Decision|3|||
127507229|NCT00075725|458817601|FG007|Overall Study|Physician Decision|17|||
127507230|NCT00075725|458817602|FG008|Overall Study|Physician Decision|5|||
127507231|NCT00075725|458817603|FG009|Overall Study|Physician Decision|0|||
127507232|NCT00075725|458817604|FG010|Overall Study|Physician Decision|1|||
127507233|NCT00075725|458817605|FG011|Overall Study|Physician Decision|0|||
127507234|NCT00075725|458817594|FG000|Overall Study|Pregnancy|0|||
127507235|NCT00075725|458817595|FG001|Overall Study|Pregnancy|0|||
127507236|NCT00075725|458817596|FG002|Overall Study|Pregnancy|0|||
127507237|NCT00075725|458817597|FG003|Overall Study|Pregnancy|0|||
127507238|NCT00075725|458817598|FG004|Overall Study|Pregnancy|0|||
127507239|NCT00075725|458817599|FG005|Overall Study|Pregnancy|1|||
127507240|NCT00075725|458817600|FG006|Overall Study|Pregnancy|0|||
127507241|NCT00075725|458817601|FG007|Overall Study|Pregnancy|1|||
127507242|NCT00075725|458817602|FG008|Overall Study|Pregnancy|0|||
127507243|NCT00075725|458817603|FG009|Overall Study|Pregnancy|0|||
127507244|NCT00075725|458817604|FG010|Overall Study|Pregnancy|0|||
127507245|NCT00075725|458817605|FG011|Overall Study|Pregnancy|0|||
127507246|NCT00075725|458817594|FG000|Overall Study|Protocol Violation|1|||
127507247|NCT00075725|458817595|FG001|Overall Study|Protocol Violation|1|||
127507248|NCT00075725|458817596|FG002|Overall Study|Protocol Violation|0|||
127507249|NCT00075725|458817597|FG003|Overall Study|Protocol Violation|3|||
127507250|NCT00075725|458817598|FG004|Overall Study|Protocol Violation|3|||
127507251|NCT00075725|458817599|FG005|Overall Study|Protocol Violation|2|||
127507252|NCT00075725|458817600|FG006|Overall Study|Protocol Violation|1|||
127507253|NCT00075725|458817601|FG007|Overall Study|Protocol Violation|2|||
127507254|NCT00075725|458817602|FG008|Overall Study|Protocol Violation|3|||
127507255|NCT00075725|458817603|FG009|Overall Study|Protocol Violation|0|||
127507256|NCT00075725|458817604|FG010|Overall Study|Protocol Violation|0|||
127507257|NCT00075725|458817605|FG011|Overall Study|Protocol Violation|1|||
127507258|NCT00075725|458817594|FG000|Overall Study|Withdrawal by Subject|12|||
127507259|NCT00075725|458817595|FG001|Overall Study|Withdrawal by Subject|3|||
127507260|NCT00075725|458817596|FG002|Overall Study|Withdrawal by Subject|6|||
127507261|NCT00075725|458817597|FG003|Overall Study|Withdrawal by Subject|10|||
127507262|NCT00075725|458817598|FG004|Overall Study|Withdrawal by Subject|6|||
127507263|NCT00075725|458817599|FG005|Overall Study|Withdrawal by Subject|27|||
127507264|NCT00075725|458817600|FG006|Overall Study|Withdrawal by Subject|7|||
127507265|NCT00075725|458817601|FG007|Overall Study|Withdrawal by Subject|31|||
127507266|NCT00075725|458817602|FG008|Overall Study|Withdrawal by Subject|10|||
127507267|NCT00075725|458817603|FG009|Overall Study|Withdrawal by Subject|2|||
127507268|NCT00075725|458817604|FG010|Overall Study|Withdrawal by Subject|0|||
127507269|NCT00075725|458817605|FG011|Overall Study|Withdrawal by Subject|0|||
127507270|NCT00075725|458817594|FG000|Overall Study|Disease Progression, all other reasons|17|||
127507271|NCT00075725|458817595|FG001|Overall Study|Disease Progression, all other reasons|5|||
127507272|NCT00075725|458817596|FG002|Overall Study|Disease Progression, all other reasons|33|||
127507273|NCT00075725|458817597|FG003|Overall Study|Disease Progression, all other reasons|6|||
127507274|NCT00075725|458817598|FG004|Overall Study|Disease Progression, all other reasons|21|||
127507275|NCT00075725|458817599|FG005|Overall Study|Disease Progression, all other reasons|59|||
127507276|NCT00075725|458817600|FG006|Overall Study|Disease Progression, all other reasons|20|||
127507277|NCT00075725|458817601|FG007|Overall Study|Disease Progression, all other reasons|46|||
127507278|NCT00075725|458817602|FG008|Overall Study|Disease Progression, all other reasons|21|||
127507279|NCT00075725|458817603|FG009|Overall Study|Disease Progression, all other reasons|4|||
127507280|NCT00075725|458817604|FG010|Overall Study|Disease Progression, all other reasons|0|||
127507281|NCT00075725|458817605|FG011|Overall Study|Disease Progression, all other reasons|5|||
127507282|NCT00075725|458817594|FG000|Overall Study|Patient off treatment|0|||
127507283|NCT00075725|458817595|FG001|Overall Study|Patient off treatment|0|||
127507284|NCT00075725|458817596|FG002|Overall Study|Patient off treatment|1|||
127507285|NCT00075725|458817597|FG003|Overall Study|Patient off treatment|2|||
127507286|NCT00075725|458817598|FG004|Overall Study|Patient off treatment|1|||
127507287|NCT00075725|458817599|FG005|Overall Study|Patient off treatment|0|||
127507288|NCT00075725|458817600|FG006|Overall Study|Patient off treatment|0|||
127507289|NCT00075725|458817601|FG007|Overall Study|Patient off treatment|2|||
127507290|NCT00075725|458817602|FG008|Overall Study|Patient off treatment|1|||
127507291|NCT00075725|458817603|FG009|Overall Study|Patient off treatment|0|||
127507292|NCT00075725|458817604|FG010|Overall Study|Patient off treatment|0|||
127507293|NCT00075725|458817605|FG011|Overall Study|Patient off treatment|0|||
127507294|NCT00075725|458817594|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
127507295|NCT00075725|458817595|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
127507296|NCT00075725|458817596|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
127507297|NCT00075725|458817597|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
127507298|NCT00075725|458817598|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
127507299|NCT00075725|458817599|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
127507300|NCT00075725|458817600|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
127507301|NCT00075725|458817601|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
127507302|NCT00075725|458817602|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
127507303|NCT00075725|458817603|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
127507304|NCT00075725|458817604|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
127507305|NCT00075725|458817605|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
127507306|NCT00075725|458817594|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
127507307|NCT00075725|458817595|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
127507308|NCT00075725|458817596|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
127507309|NCT00075725|458817597|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
127507310|NCT00075725|458817598|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
127507311|NCT00075725|458817599|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
127507312|NCT00075725|458817600|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
127507313|NCT00075725|458817601|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
127507314|NCT00075725|458817602|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
127507315|NCT00075725|458817603|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
127507316|NCT00075725|458817604|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
127507317|NCT00075725|458817605|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
127507318|NCT00075725|458817594|FG000|Overall Study|Pt non compliant with therapy|2|||
127507319|NCT00075725|458817595|FG001|Overall Study|Pt non compliant with therapy|1|||
127507320|NCT00075725|458817596|FG002|Overall Study|Pt non compliant with therapy|1|||
127507321|NCT00075725|458817597|FG003|Overall Study|Pt non compliant with therapy|0|||
127507322|NCT00075725|458817598|FG004|Overall Study|Pt non compliant with therapy|2|||
127507323|NCT00075725|458817599|FG005|Overall Study|Pt non compliant with therapy|14|||
127507324|NCT00075725|458817600|FG006|Overall Study|Pt non compliant with therapy|2|||
127507325|NCT00075725|458817601|FG007|Overall Study|Pt non compliant with therapy|5|||
127507326|NCT00075725|458817602|FG008|Overall Study|Pt non compliant with therapy|3|||
127507327|NCT00075725|458817603|FG009|Overall Study|Pt non compliant with therapy|0|||
127507328|NCT00075725|458817604|FG010|Overall Study|Pt non compliant with therapy|0|||
127507329|NCT00075725|458817605|FG011|Overall Study|Pt non compliant with therapy|0|||
127507330|NCT00075725|458817594|FG000|Overall Study|Pt age out of range for treatment|0|||
127507331|NCT00075725|458817595|FG001|Overall Study|Pt age out of range for treatment|1|||
127507332|NCT00075725|458817596|FG002|Overall Study|Pt age out of range for treatment|0|||
127507333|NCT00075725|458817597|FG003|Overall Study|Pt age out of range for treatment|0|||
127507334|NCT00075725|458817598|FG004|Overall Study|Pt age out of range for treatment|0|||
127507335|NCT00075725|458817599|FG005|Overall Study|Pt age out of range for treatment|1|||
127507336|NCT00075725|458817600|FG006|Overall Study|Pt age out of range for treatment|0|||
127507337|NCT00075725|458817601|FG007|Overall Study|Pt age out of range for treatment|1|||
127978816|NCT02548351|460544196|FG001|Overall Study|Non-compliance with Study Drug|2|||
127507338|NCT00075725|458817602|FG008|Overall Study|Pt age out of range for treatment|0|||
127507339|NCT00075725|458817603|FG009|Overall Study|Pt age out of range for treatment|0|||
127507340|NCT00075725|458817604|FG010|Overall Study|Pt age out of range for treatment|0|||
127507341|NCT00075725|458817605|FG011|Overall Study|Pt age out of range for treatment|0|||
127507342|NCT00075725|458817594|FG000|Overall Study|Insurance issues|0|||
127507343|NCT00075725|458817595|FG001|Overall Study|Insurance issues|1|||
127507344|NCT00075725|458817596|FG002|Overall Study|Insurance issues|0|||
127507345|NCT00075725|458817597|FG003|Overall Study|Insurance issues|1|||
127507346|NCT00075725|458817598|FG004|Overall Study|Insurance issues|1|||
127507347|NCT00075725|458817599|FG005|Overall Study|Insurance issues|1|||
127507348|NCT00075725|458817600|FG006|Overall Study|Insurance issues|0|||
127507349|NCT00075725|458817601|FG007|Overall Study|Insurance issues|1|||
127507350|NCT00075725|458817602|FG008|Overall Study|Insurance issues|0|||
127507351|NCT00075725|458817603|FG009|Overall Study|Insurance issues|0|||
127507352|NCT00075725|458817604|FG010|Overall Study|Insurance issues|0|||
127507353|NCT00075725|458817605|FG011|Overall Study|Insurance issues|0|||
127507354|NCT00075725|458817594|FG000|Overall Study|MRD positive after extended ind|0|||
127507355|NCT00075725|458817595|FG001|Overall Study|MRD positive after extended ind|1|||
127507356|NCT00075725|458817596|FG002|Overall Study|MRD positive after extended ind|1|||
127507357|NCT00075725|458817597|FG003|Overall Study|MRD positive after extended ind|0|||
127507358|NCT00075725|458817598|FG004|Overall Study|MRD positive after extended ind|1|||
127507359|NCT00075725|458817599|FG005|Overall Study|MRD positive after extended ind|2|||
127507360|NCT00075725|458817600|FG006|Overall Study|MRD positive after extended ind|0|||
127507361|NCT00075725|458817601|FG007|Overall Study|MRD positive after extended ind|1|||
127507362|NCT00075725|458817602|FG008|Overall Study|MRD positive after extended ind|0|||
127507363|NCT00075725|458817603|FG009|Overall Study|MRD positive after extended ind|0|||
127507364|NCT00075725|458817604|FG010|Overall Study|MRD positive after extended ind|0|||
127507365|NCT00075725|458817605|FG011|Overall Study|MRD positive after extended ind|0|||
127507366|NCT00075725|458817594|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
127507367|NCT00075725|458817595|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
127507368|NCT00075725|458817596|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
127507369|NCT00075725|458817597|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
127507370|NCT00075725|458817598|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
127507371|NCT00075725|458817599|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
127507372|NCT00075725|458817600|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
127507373|NCT00075725|458817601|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
127507374|NCT00075725|458817602|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
127507375|NCT00075725|458817603|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
127507376|NCT00075725|458817604|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
127507377|NCT00075725|458817605|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
127507378|NCT00075725|458817594|FG000|Overall Study|Inevaluable|1|||
127507379|NCT00075725|458817595|FG001|Overall Study|Inevaluable|1|||
127507380|NCT00075725|458817596|FG002|Overall Study|Inevaluable|4|||
127507381|NCT00075725|458817597|FG003|Overall Study|Inevaluable|2|||
127507382|NCT00075725|458817598|FG004|Overall Study|Inevaluable|2|||
127507383|NCT00075725|458817599|FG005|Overall Study|Inevaluable|9|||
127507384|NCT00075725|458817600|FG006|Overall Study|Inevaluable|1|||
127507385|NCT00075725|458817601|FG007|Overall Study|Inevaluable|11|||
127507386|NCT00075725|458817602|FG008|Overall Study|Inevaluable|2|||
127507387|NCT00075725|458817603|FG009|Overall Study|Inevaluable|0|||
127507388|NCT00075725|458817604|FG010|Overall Study|Inevaluable|1|||
127507389|NCT00075725|458817605|FG011|Overall Study|Inevaluable|0|||
127507390|NCT00075725|458817594|FG000|Overall Study|Other|4|||
127507391|NCT00075725|458817595|FG001|Overall Study|Other|2|||
127507392|NCT00075725|458817596|FG002|Overall Study|Other|1|||
127507393|NCT00075725|458817597|FG003|Overall Study|Other|1|||
127507394|NCT00075725|458817598|FG004|Overall Study|Other|1|||
127507395|NCT00075725|458817599|FG005|Overall Study|Other|4|||
127507396|NCT00075725|458817600|FG006|Overall Study|Other|2|||
127507397|NCT00075725|458817601|FG007|Overall Study|Other|9|||
127507398|NCT00075725|458817602|FG008|Overall Study|Other|2|||
127507399|NCT00075725|458817603|FG009|Overall Study|Other|1|||
127507400|NCT00075725|458817604|FG010|Overall Study|Other|0|||
127507401|NCT00075725|458817605|FG011|Overall Study|Other|3|||
127507402|NCT00075725|458817594|FG000|Overall Study|Pt trying to find a BM donor|0|||
127507403|NCT00075725|458817595|FG001|Overall Study|Pt trying to find a BM donor|1|||
127507404|NCT00075725|458817596|FG002|Overall Study|Pt trying to find a BM donor|0|||
127507405|NCT00075725|458817597|FG003|Overall Study|Pt trying to find a BM donor|0|||
127507406|NCT00075725|458817598|FG004|Overall Study|Pt trying to find a BM donor|0|||
127507407|NCT00075725|458817599|FG005|Overall Study|Pt trying to find a BM donor|0|||
127507408|NCT00075725|458817600|FG006|Overall Study|Pt trying to find a BM donor|0|||
127978817|NCT02548351|460544197|FG002|Overall Study|Non-compliance with Study Drug|0|||
127507409|NCT00075725|458817601|FG007|Overall Study|Pt trying to find a BM donor|0|||
127507410|NCT00075725|458817602|FG008|Overall Study|Pt trying to find a BM donor|0|||
127507411|NCT00075725|458817603|FG009|Overall Study|Pt trying to find a BM donor|0|||
127507412|NCT00075725|458817604|FG010|Overall Study|Pt trying to find a BM donor|0|||
127507413|NCT00075725|458817605|FG011|Overall Study|Pt trying to find a BM donor|0|||
127507414|NCT00075725|458817594|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
127507415|NCT00075725|458817595|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
127507416|NCT00075725|458817596|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
127507417|NCT00075725|458817597|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
127507418|NCT00075725|458817598|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
127507419|NCT00075725|458817599|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
127507420|NCT00075725|458817600|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
127507421|NCT00075725|458817601|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
127507422|NCT00075725|458817602|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
127507423|NCT00075725|458817603|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
127507424|NCT00075725|458817604|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
127507425|NCT00075725|458817605|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
127507426|NCT00075725|458817594|FG000|Overall Study|Unsuccessful institutional transfer|0|||
127507427|NCT00075725|458817595|FG001|Overall Study|Unsuccessful institutional transfer|0|||
127507428|NCT00075725|458817596|FG002|Overall Study|Unsuccessful institutional transfer|2|||
127507429|NCT00075725|458817597|FG003|Overall Study|Unsuccessful institutional transfer|0|||
127507430|NCT00075725|458817598|FG004|Overall Study|Unsuccessful institutional transfer|0|||
127507431|NCT00075725|458817599|FG005|Overall Study|Unsuccessful institutional transfer|0|||
127507432|NCT00075725|458817600|FG006|Overall Study|Unsuccessful institutional transfer|0|||
127507433|NCT00075725|458817601|FG007|Overall Study|Unsuccessful institutional transfer|0|||
127507434|NCT00075725|458817602|FG008|Overall Study|Unsuccessful institutional transfer|0|||
127507435|NCT00075725|458817603|FG009|Overall Study|Unsuccessful institutional transfer|1|||
127507436|NCT00075725|458817604|FG010|Overall Study|Unsuccessful institutional transfer|0|||
127507437|NCT00075725|458817605|FG011|Overall Study|Unsuccessful institutional transfer|0|||
127507438|NCT00075725|458817594|FG000|Overall Study|specimen(s) not submitted|0|||
127507439|NCT00075725|458817595|FG001|Overall Study|specimen(s) not submitted|0|||
127507440|NCT00075725|458817596|FG002|Overall Study|specimen(s) not submitted|2|||
127507441|NCT00075725|458817597|FG003|Overall Study|specimen(s) not submitted|0|||
127507442|NCT00075725|458817598|FG004|Overall Study|specimen(s) not submitted|0|||
127507443|NCT00075725|458817599|FG005|Overall Study|specimen(s) not submitted|0|||
127507444|NCT00075725|458817600|FG006|Overall Study|specimen(s) not submitted|0|||
127507445|NCT00075725|458817601|FG007|Overall Study|specimen(s) not submitted|0|||
127507446|NCT00075725|458817602|FG008|Overall Study|specimen(s) not submitted|0|||
127507447|NCT00075725|458817603|FG009|Overall Study|specimen(s) not submitted|0|||
127507448|NCT00075725|458817604|FG010|Overall Study|specimen(s) not submitted|0|||
127507449|NCT00075725|458817605|FG011|Overall Study|specimen(s) not submitted|0|||
127507450|NCT00075725|458817594|FG000|Overall Study|Pt went to transplant|0|||
127507451|NCT00075725|458817595|FG001|Overall Study|Pt went to transplant|0|||
127507452|NCT00075725|458817596|FG002|Overall Study|Pt went to transplant|0|||
127507453|NCT00075725|458817597|FG003|Overall Study|Pt went to transplant|1|||
127507454|NCT00075725|458817598|FG004|Overall Study|Pt went to transplant|0|||
127507455|NCT00075725|458817599|FG005|Overall Study|Pt went to transplant|1|||
127507456|NCT00075725|458817600|FG006|Overall Study|Pt went to transplant|0|||
127507457|NCT00075725|458817601|FG007|Overall Study|Pt went to transplant|0|||
127507458|NCT00075725|458817602|FG008|Overall Study|Pt went to transplant|0|||
127507459|NCT00075725|458817603|FG009|Overall Study|Pt went to transplant|0|||
127507460|NCT00075725|458817604|FG010|Overall Study|Pt went to transplant|0|||
127507461|NCT00075725|458817605|FG011|Overall Study|Pt went to transplant|0|||
127507462|NCT00075725|458817594|FG000|Overall Study|Pt received additional steroids|0|||
127507463|NCT00075725|458817595|FG001|Overall Study|Pt received additional steroids|0|||
127507464|NCT00075725|458817596|FG002|Overall Study|Pt received additional steroids|0|||
127507465|NCT00075725|458817597|FG003|Overall Study|Pt received additional steroids|1|||
127507466|NCT00075725|458817598|FG004|Overall Study|Pt received additional steroids|0|||
127507467|NCT00075725|458817599|FG005|Overall Study|Pt received additional steroids|0|||
127507468|NCT00075725|458817600|FG006|Overall Study|Pt received additional steroids|0|||
127507469|NCT00075725|458817601|FG007|Overall Study|Pt received additional steroids|0|||
127507470|NCT00075725|458817602|FG008|Overall Study|Pt received additional steroids|0|||
127507471|NCT00075725|458817603|FG009|Overall Study|Pt received additional steroids|0|||
127507472|NCT00075725|458817604|FG010|Overall Study|Pt received additional steroids|0|||
127507473|NCT00075725|458817605|FG011|Overall Study|Pt received additional steroids|0|||
127507474|NCT00075725|458817594|FG000|Overall Study|Pt relocated|0|||
127507475|NCT00075725|458817595|FG001|Overall Study|Pt relocated|0|||
127507476|NCT00075725|458817596|FG002|Overall Study|Pt relocated|0|||
127507477|NCT00075725|458817597|FG003|Overall Study|Pt relocated|2|||
127507478|NCT00075725|458817598|FG004|Overall Study|Pt relocated|0|||
127507479|NCT00075725|458817599|FG005|Overall Study|Pt relocated|1|||
127507480|NCT00075725|458817600|FG006|Overall Study|Pt relocated|1|||
127978818|NCT02548351|460544195|FG000|Overall Study|Protocol Violation|2|||
127978819|NCT02548351|460544196|FG001|Overall Study|Protocol Violation|1|||
127978820|NCT02548351|460544197|FG002|Overall Study|Protocol Violation|2|||
127507481|NCT00075725|458817601|FG007|Overall Study|Pt relocated|2|||
127507482|NCT00075725|458817602|FG008|Overall Study|Pt relocated|1|||
127978821|NCT02548351|460544195|FG000|Overall Study|Physician Decision|11|||
127507483|NCT00075725|458817603|FG009|Overall Study|Pt relocated|0|||
127507484|NCT00075725|458817604|FG010|Overall Study|Pt relocated|0|||
127507485|NCT00075725|458817605|FG011|Overall Study|Pt relocated|0|||
127507486|NCT00075725|458817594|FG000|Overall Study|Institution Terminated|0|||
127507487|NCT00075725|458817595|FG001|Overall Study|Institution Terminated|0|||
127507488|NCT00075725|458817596|FG002|Overall Study|Institution Terminated|0|||
127507489|NCT00075725|458817597|FG003|Overall Study|Institution Terminated|0|||
127507490|NCT00075725|458817598|FG004|Overall Study|Institution Terminated|1|||
127507491|NCT00075725|458817599|FG005|Overall Study|Institution Terminated|0|||
127507492|NCT00075725|458817600|FG006|Overall Study|Institution Terminated|0|||
127507493|NCT00075725|458817601|FG007|Overall Study|Institution Terminated|3|||
127507494|NCT00075725|458817602|FG008|Overall Study|Institution Terminated|0|||
127507495|NCT00075725|458817603|FG009|Overall Study|Institution Terminated|0|||
127507496|NCT00075725|458817604|FG010|Overall Study|Institution Terminated|0|||
127507497|NCT00075725|458817605|FG011|Overall Study|Institution Terminated|0|||
127507498|NCT00075725|458817594|FG000|Overall Study|Study Closure|1|||
127507499|NCT00075725|458817595|FG001|Overall Study|Study Closure|0|||
127507500|NCT00075725|458817596|FG002|Overall Study|Study Closure|0|||
127507501|NCT00075725|458817597|FG003|Overall Study|Study Closure|0|||
127507502|NCT00075725|458817598|FG004|Overall Study|Study Closure|1|||
127507503|NCT00075725|458817599|FG005|Overall Study|Study Closure|3|||
127507504|NCT00075725|458817600|FG006|Overall Study|Study Closure|0|||
127507505|NCT00075725|458817601|FG007|Overall Study|Study Closure|1|||
127507506|NCT00075725|458817602|FG008|Overall Study|Study Closure|0|||
127507507|NCT00075725|458817603|FG009|Overall Study|Study Closure|0|||
127507508|NCT00075725|458817604|FG010|Overall Study|Study Closure|0|||
127507509|NCT00075725|458817605|FG011|Overall Study|Study Closure|0|||
127507510|NCT00075725|458817594|FG000|Overall Study|Other complications|0|||
127507511|NCT00075725|458817595|FG001|Overall Study|Other complications|0|||
127507512|NCT00075725|458817596|FG002|Overall Study|Other complications|0|||
127507513|NCT00075725|458817597|FG003|Overall Study|Other complications|0|||
127507514|NCT00075725|458817598|FG004|Overall Study|Other complications|0|||
127507515|NCT00075725|458817599|FG005|Overall Study|Other complications|1|||
127507516|NCT00075725|458817600|FG006|Overall Study|Other complications|0|||
127507517|NCT00075725|458817601|FG007|Overall Study|Other complications|0|||
127507518|NCT00075725|458817602|FG008|Overall Study|Other complications|0|||
127507519|NCT00075725|458817603|FG009|Overall Study|Other complications|0|||
127507520|NCT00075725|458817604|FG010|Overall Study|Other complications|0|||
127507521|NCT00075725|458817605|FG011|Overall Study|Other complications|0|||
127507522|NCT00075725|458817594|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
127507523|NCT00075725|458817595|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
127507524|NCT00075725|458817596|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
127507525|NCT00075725|458817597|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
127507526|NCT00075725|458817598|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
127507527|NCT00075725|458817599|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
127507528|NCT00075725|458817600|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
127507529|NCT00075725|458817601|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
127507530|NCT00075725|458817602|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
127507531|NCT00075725|458817603|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
127507532|NCT00075725|458817604|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
127507533|NCT00075725|458817605|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
127507534|NCT00075725|458817594|FG000|Overall Study|Pt incarcerated|0|||
127507535|NCT00075725|458817595|FG001|Overall Study|Pt incarcerated|0|||
127507536|NCT00075725|458817596|FG002|Overall Study|Pt incarcerated|0|||
127507537|NCT00075725|458817597|FG003|Overall Study|Pt incarcerated|0|||
127507538|NCT00075725|458817598|FG004|Overall Study|Pt incarcerated|0|||
127507539|NCT00075725|458817599|FG005|Overall Study|Pt incarcerated|0|||
127507540|NCT00075725|458817600|FG006|Overall Study|Pt incarcerated|0|||
127507541|NCT00075725|458817601|FG007|Overall Study|Pt incarcerated|1|||
127507542|NCT00075725|458817602|FG008|Overall Study|Pt incarcerated|0|||
127507543|NCT00075725|458817603|FG009|Overall Study|Pt incarcerated|0|||
127507544|NCT00075725|458817604|FG010|Overall Study|Pt incarcerated|0|||
127507545|NCT00075725|458817605|FG011|Overall Study|Pt incarcerated|0|||
127507546|NCT01514240|458819528|FG000|Overall Study|Adverse Event|4|||
127507547|NCT01514240|458819529|FG001|Overall Study|Adverse Event|4|||
127507548|NCT01514240|458819528|FG000|Overall Study|Subject Decision|2|||
127507549|NCT01514240|458819529|FG001|Overall Study|Subject Decision|7|||
127507550|NCT01103063|458819531|FG000|Overall Study|Adverse Event|3|||
127507551|NCT01103063|458819532|FG001|Overall Study|Adverse Event|1|||
127507552|NCT01103063|458819531|FG000|Overall Study|Lost to Follow-up|68|||
127507553|NCT01103063|458819532|FG001|Overall Study|Lost to Follow-up|51|||
127507554|NCT01103063|458819531|FG000|Overall Study|Withdrawal by Subject|60|||
127507555|NCT01103063|458819532|FG001|Overall Study|Withdrawal by Subject|15|||
127507556|NCT01103063|458819531|FG000|Overall Study|Other|16|||
127507557|NCT01103063|458819532|FG001|Overall Study|Other|11|||
127507558|NCT01103063|458819531|FG000|Overall Study|Protocol Violation|1|||
127507559|NCT01103063|458819532|FG001|Overall Study|Protocol Violation|0|||
127507560|NCT01103063|458819531|FG000|Overall Study|Study terminated by Sponsor|326|||
127507561|NCT01103063|458819532|FG001|Overall Study|Study terminated by Sponsor|342|||
127507562|NCT01103063|458819531|FG000|Overall Study|Death|3|||
127507563|NCT01103063|458819532|FG001|Overall Study|Death|1|||
127507564|NCT01187446|458819535|FG000|Overall Study|Patient started non-protocol therapy|0|||
127507565|NCT01187446|458819536|FG001|Overall Study|Patient started non-protocol therapy|1|||
127507566|NCT00613925|458819537|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
127507567|NCT00613925|458819538|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
127507568|NCT00252694|458819541|FG000|Overall Study|Withdrawal by Subject|83|||
127507569|NCT00252694|458819542|FG001|Overall Study|Withdrawal by Subject|91|||
127507570|NCT00252694|458819541|FG000|Overall Study|Death|36|||
127507571|NCT00252694|458819542|FG001|Overall Study|Death|34|||
127507572|NCT00252694|458819541|FG000|Overall Study|Mostly Lost to Follow Up|8|||
127507573|NCT00252694|458819542|FG001|Overall Study|Mostly Lost to Follow Up|13|||
127507574|NCT00252694|458819541|FG000|Overall Study|Patient Moving|17|||
127507575|NCT00252694|458819542|FG001|Overall Study|Patient Moving|16|||
127507576|NCT01342965|458819543|FG000|Overall Study|Death|58|||
127507577|NCT01342965|458819544|FG001|Overall Study|Death|57|||
127507578|NCT01342965|458819543|FG000|Overall Study|Lost to Follow-up|5|||
127507579|NCT01342965|458819544|FG001|Overall Study|Lost to Follow-up|3|||
127507580|NCT01342965|458819543|FG000|Overall Study|Other Reasons- Unspecified|44|||
127507581|NCT01342965|458819544|FG001|Overall Study|Other Reasons- Unspecified|38|||
127507582|NCT01342965|458819543|FG000|Overall Study|Withdrawal by Subject|2|||
127507583|NCT01342965|458819544|FG001|Overall Study|Withdrawal by Subject|9|||
127507584|NCT03538444|458819555|FG000|Overall Study|opioid withdrawal|1|||
127507585|NCT03538444|458819556|FG001|Overall Study|opioid withdrawal|0|||
127507586|NCT03549871|458819561|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
127507587|NCT03549871|458819562|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
127507588|NCT03549871|458819561|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
127507589|NCT03549871|458819562|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
127507590|NCT03549871|458819561|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
127507591|NCT03549871|458819562|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
127507592|NCT03549871|458819561|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
127507593|NCT03549871|458819562|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
127507594|NCT03549871|458819561|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
127507595|NCT03549871|458819562|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
127507596|NCT03549871|458819561|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
127507597|NCT03549871|458819562|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
127507598|NCT03549871|458819561|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
127507599|NCT03549871|458819562|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
127507600|NCT03549871|458819561|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
127507601|NCT03549871|458819562|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
127507602|NCT03549871|458819561|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
127507603|NCT03549871|458819562|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
127507604|NCT03549871|458819561|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
127507605|NCT03549871|458819562|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
127507606|NCT03549871|458819561|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
127507607|NCT03549871|458819562|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
127507608|NCT03298984|458819565|FG000|Overall Study|Physician Decision|1|||
127507609|NCT03298984|458819566|FG001|Overall Study|Physician Decision|0|||
127507610|NCT03298984|458819567|FG002|Overall Study|Physician Decision|0|||
127507611|NCT03298984|458819568|FG003|Overall Study|Physician Decision|6|||
127507612|NCT03298984|458819565|FG000|Overall Study|Lack of Efficacy|0|||
127507613|NCT03298984|458819566|FG001|Overall Study|Lack of Efficacy|1|||
127507614|NCT03298984|458819567|FG002|Overall Study|Lack of Efficacy|1|||
127507615|NCT03298984|458819568|FG003|Overall Study|Lack of Efficacy|4|||
127507616|NCT03298984|458819565|FG000|Overall Study|Relapsed disease (following remission)|0|||
127507617|NCT03298984|458819566|FG001|Overall Study|Relapsed disease (following remission)|0|||
127507618|NCT03298984|458819567|FG002|Overall Study|Relapsed disease (following remission)|1|||
127507619|NCT03298984|458819568|FG003|Overall Study|Relapsed disease (following remission)|1|||
127507620|NCT03298984|458819565|FG000|Overall Study|Adverse Event|0|||
127507621|NCT03298984|458819566|FG001|Overall Study|Adverse Event|0|||
127507622|NCT03298984|458819567|FG002|Overall Study|Adverse Event|0|||
127507623|NCT03298984|458819568|FG003|Overall Study|Adverse Event|1|||
127507624|NCT03298984|458819565|FG000|Overall Study|Death|0|||
127507625|NCT03298984|458819566|FG001|Overall Study|Death|0|||
127507626|NCT03298984|458819567|FG002|Overall Study|Death|0|||
127507627|NCT03298984|458819568|FG003|Overall Study|Death|2|||
127507628|NCT03298984|458819565|FG000|Overall Study|Insurance Company Decision|0|||
127507629|NCT03298984|458819566|FG001|Overall Study|Insurance Company Decision|0|||
127507630|NCT03298984|458819567|FG002|Overall Study|Insurance Company Decision|0|||
127507631|NCT03298984|458819568|FG003|Overall Study|Insurance Company Decision|1|||
127507632|NCT00294645|458819569|FG000|Overall Study|Death|10|||
127507633|NCT00294645|458819570|FG001|Overall Study|Death|18|||
127507634|NCT00294645|458819569|FG000|Overall Study|Lost to Follow-up|1|||
127507635|NCT00294645|458819570|FG001|Overall Study|Lost to Follow-up|10|||
127507636|NCT00294645|458819569|FG000|Overall Study|Withdrawal by Subject|18|||
127507637|NCT00294645|458819570|FG001|Overall Study|Withdrawal by Subject|34|||
127507638|NCT00294645|458819569|FG000|Overall Study|Physician Decision|15|||
127507639|NCT00294645|458819570|FG001|Overall Study|Physician Decision|20|||
127507640|NCT00294645|458819569|FG000|Overall Study|Other|4|||
127507641|NCT00294645|458819570|FG001|Overall Study|Other|10|||
127507642|NCT02229214|458819579|FG000|Overall Study|Adverse Event|2|||
127507643|NCT02229214|458819580|FG001|Overall Study|Adverse Event|0|||
127507644|NCT02229214|458819579|FG000|Overall Study|Withdrawal by Subject|4|||
127507645|NCT02229214|458819580|FG001|Overall Study|Withdrawal by Subject|0|||
127507646|NCT03305081|458819589|FG000|Overall Study|Lost to Follow-up|10|||
127507647|NCT03305081|458819590|FG001|Overall Study|Lost to Follow-up|15|||
127507648|NCT00871117|458819591|FG000|Overall Study|Lost to Follow-up|5|||
127507649|NCT00871117|458819592|FG001|Overall Study|Lost to Follow-up|6|||
127507650|NCT00871117|458819591|FG000|Overall Study|Other|0|||
127507651|NCT00871117|458819592|FG001|Overall Study|Other|4|||
127507652|NCT03385265|458819596|FG000|Overall Study|Withdrawal by Subject|5|||
127507653|NCT03385265|458819597|FG001|Overall Study|Withdrawal by Subject|2|||
127507654|NCT03385265|458819598|FG002|Overall Study|Withdrawal by Subject|5|||
127507655|NCT03385265|458819599|FG003|Overall Study|Withdrawal by Subject|2|||
127507656|NCT01560637|458819600|FG000|Overall Study|Adverse Event|63|||
127507657|NCT01560637|458819600|FG000|Overall Study|Death|69|||
127507658|NCT01560637|458819600|FG000|Overall Study|Lost to Follow-up|8|||
127507659|NCT01560637|458819600|FG000|Overall Study|Protocol Violation|8|||
127507660|NCT01560637|458819600|FG000|Overall Study|Withdrawal by Subject|24|||
127507661|NCT01560637|458819600|FG000|Overall Study|Progressive Disease|20|||
127507662|NCT01560637|458819600|FG000|Overall Study|Other Reason Not Specified|6|||
127507663|NCT02323204|458819601|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
127507664|NCT02323204|458819602|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
127507665|NCT02323204|458819603|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
127507666|NCT02323204|458819604|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
127507667|NCT02323204|458819601|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
127507668|NCT02323204|458819602|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
127507669|NCT02323204|458819603|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
127507670|NCT02323204|458819604|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
127507671|NCT02323204|458819601|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
127507672|NCT02323204|458819602|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
127507673|NCT02323204|458819603|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
127507674|NCT02323204|458819604|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
127507675|NCT02323204|458819601|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
127507676|NCT02323204|458819602|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
127507677|NCT02323204|458819603|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
127507678|NCT02323204|458819604|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
127507679|NCT02323204|458819601|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
127507680|NCT02323204|458819602|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
127507681|NCT02323204|458819603|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
127507682|NCT02323204|458819604|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
127507683|NCT02323204|458819601|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
127507684|NCT02323204|458819602|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
127507685|NCT02323204|458819603|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
127507686|NCT02323204|458819604|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
127507687|NCT02323204|458819601|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
127507688|NCT02323204|458819602|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
127507689|NCT02323204|458819603|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
127507690|NCT02323204|458819604|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
127507691|NCT02323204|458819601|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
127507692|NCT02323204|458819602|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
127978822|NCT02548351|460544196|FG001|Overall Study|Physician Decision|18|||
127978823|NCT02548351|460544197|FG002|Overall Study|Physician Decision|11|||
127978824|NCT02548351|460544195|FG000|Overall Study|Lost to Follow-up|43|||
127507693|NCT02323204|458819603|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
127507694|NCT02323204|458819604|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
127507695|NCT02323204|458819601|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
127978825|NCT02548351|460544196|FG001|Overall Study|Lost to Follow-up|50|||
127978826|NCT02548351|460544197|FG002|Overall Study|Lost to Follow-up|57|||
127978827|NCT02548351|460544195|FG000|Overall Study|Other|19|||
127978828|NCT02548351|460544196|FG001|Overall Study|Other|16|||
127978829|NCT02548351|460544197|FG002|Overall Study|Other|20|||
127507696|NCT02323204|458819602|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
127507697|NCT02323204|458819603|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
127507698|NCT02323204|458819604|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
127507699|NCT01852825|458819605|FG000|Overall Study|Withdrawal by Subject|2|||
127507700|NCT01852825|458819606|FG001|Overall Study|Withdrawal by Subject|0|||
127507701|NCT01852825|458819607|FG002|Overall Study|Withdrawal by Subject|0|||
127507702|NCT00724854|458819609|FG000|Overall Study|Lack of Efficacy|187|||
127507703|NCT00724854|458819610|FG001|Overall Study|Lack of Efficacy|13|||
127507704|NCT00724854|458819609|FG000|Overall Study|Lost to Follow-up|87|||
127507705|NCT00724854|458819610|FG001|Overall Study|Lost to Follow-up|10|||
127507706|NCT00724854|458819609|FG000|Overall Study|Adverse Event|62|||
127507707|NCT00724854|458819610|FG001|Overall Study|Adverse Event|4|||
127507708|NCT00724854|458819609|FG000|Overall Study|Other|42|||
127507709|NCT00724854|458819610|FG001|Overall Study|Other|3|||
127507710|NCT00724854|458819609|FG000|Overall Study|Death|11|||
127507711|NCT00724854|458819610|FG001|Overall Study|Death|0|||
127507712|NCT00724854|458819609|FG000|Overall Study|Change of treatment|7|||
127507713|NCT00724854|458819610|FG001|Overall Study|Change of treatment|0|||
127507714|NCT00724854|458819609|FG000|Overall Study|Withdrawal by Subject|5|||
127507715|NCT00724854|458819610|FG001|Overall Study|Withdrawal by Subject|0|||
127507716|NCT00724854|458819609|FG000|Overall Study|Adverse event + lack of efficacy|2|||
127507717|NCT00724854|458819610|FG001|Overall Study|Adverse event + lack of efficacy|1|||
127507718|NCT01095653|458819611|FG000|Overall Study|Lack of Efficacy|3|||
127507719|NCT01095653|458819612|FG001|Overall Study|Lack of Efficacy|0|||
127507720|NCT01095653|458819613|FG002|Overall Study|Lack of Efficacy|0|||
127507721|NCT01095653|458819611|FG000|Overall Study|Adverse Event|1|||
127507722|NCT01095653|458819612|FG001|Overall Study|Adverse Event|4|||
127507723|NCT01095653|458819613|FG002|Overall Study|Adverse Event|4|||
127507724|NCT01095653|458819611|FG000|Overall Study|Lost to Follow-up|1|||
127507725|NCT01095653|458819612|FG001|Overall Study|Lost to Follow-up|0|||
127507726|NCT01095653|458819613|FG002|Overall Study|Lost to Follow-up|4|||
127507727|NCT01095653|458819611|FG000|Overall Study|Withdrawal by Subject|4|||
127507728|NCT01095653|458819612|FG001|Overall Study|Withdrawal by Subject|5|||
127507729|NCT01095653|458819613|FG002|Overall Study|Withdrawal by Subject|3|||
127507730|NCT01095653|458819611|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
127507731|NCT01095653|458819612|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
127507732|NCT01095653|458819613|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
127507733|NCT02692040|458819614|FG000|Overall Study|Protocol Violation|0|||
127507734|NCT02692040|458819615|FG001|Overall Study|Protocol Violation|0|||
127507735|NCT02692040|458819616|FG002|Overall Study|Protocol Violation|0|||
127507736|NCT02692040|458819617|FG003|Overall Study|Protocol Violation|0|||
127507737|NCT02692040|458819618|FG004|Overall Study|Protocol Violation|0|||
127507738|NCT02692040|458819619|FG005|Overall Study|Protocol Violation|0|||
127507739|NCT02692040|458819620|FG006|Overall Study|Protocol Violation|0|||
127507740|NCT02692040|458819621|FG007|Overall Study|Protocol Violation|0|||
127507741|NCT02692040|458819622|FG008|Overall Study|Protocol Violation|0|||
127507742|NCT02692040|458819623|FG009|Overall Study|Protocol Violation|0|||
127507743|NCT02692040|458819624|FG010|Overall Study|Protocol Violation|0|||
127507744|NCT02692040|458819625|FG011|Overall Study|Protocol Violation|0|||
127507745|NCT02692040|458819626|FG012|Overall Study|Protocol Violation|1|||
127507746|NCT02692040|458819627|FG013|Overall Study|Protocol Violation|0|||
127507747|NCT02692040|458819628|FG014|Overall Study|Protocol Violation|0|||
127507748|NCT02692040|458819629|FG015|Overall Study|Protocol Violation|0|||
127507749|NCT02692040|458819630|FG016|Overall Study|Protocol Violation|0|||
127507750|NCT02692040|458819614|FG000|Overall Study|Adverse Event|0|||
127507751|NCT02692040|458819615|FG001|Overall Study|Adverse Event|0|||
127507752|NCT02692040|458819616|FG002|Overall Study|Adverse Event|0|||
127507753|NCT02692040|458819617|FG003|Overall Study|Adverse Event|0|||
127507754|NCT02692040|458819618|FG004|Overall Study|Adverse Event|0|||
127507755|NCT02692040|458819619|FG005|Overall Study|Adverse Event|0|||
127507756|NCT02692040|458819620|FG006|Overall Study|Adverse Event|0|||
127507757|NCT02692040|458819621|FG007|Overall Study|Adverse Event|0|||
127507758|NCT02692040|458819622|FG008|Overall Study|Adverse Event|0|||
127507759|NCT02692040|458819623|FG009|Overall Study|Adverse Event|0|||
127507760|NCT02692040|458819624|FG010|Overall Study|Adverse Event|0|||
127507761|NCT02692040|458819625|FG011|Overall Study|Adverse Event|0|||
127507762|NCT02692040|458819626|FG012|Overall Study|Adverse Event|0|||
127507763|NCT02692040|458819627|FG013|Overall Study|Adverse Event|3|||
127507764|NCT02692040|458819628|FG014|Overall Study|Adverse Event|1|||
127507765|NCT02692040|458819629|FG015|Overall Study|Adverse Event|1|||
127507766|NCT02692040|458819630|FG016|Overall Study|Adverse Event|0|||
127507767|NCT00171925|458819631|FG000|Overall Study|Adverse Event|10|||
127507768|NCT00171925|458819632|FG001|Overall Study|Adverse Event|6|||
127507769|NCT00171925|458819631|FG000|Overall Study|Protocol Violation|1|||
127507770|NCT00171925|458819632|FG001|Overall Study|Protocol Violation|1|||
127978830|NCT02548351|460544195|FG000|Overall Study|Missing|1|||
127507771|NCT00171925|458819631|FG000|Overall Study|Withdrawal by Subject|6|||
127507772|NCT00171925|458819632|FG001|Overall Study|Withdrawal by Subject|9|||
127507773|NCT00171925|458819631|FG000|Overall Study|Lost to Follow-up|2|||
127507774|NCT00171925|458819632|FG001|Overall Study|Lost to Follow-up|2|||
127507775|NCT00171925|458819631|FG000|Overall Study|Administrative problems|10|||
127507776|NCT00171925|458819632|FG001|Overall Study|Administrative problems|11|||
127507777|NCT00171925|458819631|FG000|Overall Study|Death|1|||
127507778|NCT00171925|458819632|FG001|Overall Study|Death|2|||
127507779|NCT02752958|458819633|FG000|Overall Study|Adverse Event|3|||
127507780|NCT02752958|458819633|FG000|Overall Study|Lost to Follow-up|1|||
127507781|NCT02752958|458819633|FG000|Overall Study|Protocol Violation|1|||
127507782|NCT02752958|458819633|FG000|Overall Study|Withdrawal by Subject|2|||
127507783|NCT02752958|458819633|FG000|Overall Study|Other (Reason not specified)|2|||
127507784|NCT00853125|458819634|FG000|Overall Study|Study participant's donor was CMV +|1|||
127507785|NCT03023826|458819640|FG000|Period 1|Withdrawal by Subject|0|||
127507786|NCT03023826|458819641|FG001|Period 1|Withdrawal by Subject|0|||
127507787|NCT03023826|458819642|FG002|Period 1|Withdrawal by Subject|0|||
127507788|NCT03023826|458819643|FG003|Period 1|Withdrawal by Subject|0|||
127507789|NCT03023826|458819644|FG004|Period 1|Withdrawal by Subject|1|||
127507790|NCT03023826|458819645|FG005|Period 1|Withdrawal by Subject|0|||
127507791|NCT03746600|458819646|FG000|Overall Study|Withdrawal by Subject|3|||
127507792|NCT03746600|458819647|FG001|Overall Study|Withdrawal by Subject|3|||
127507793|NCT03746600|458819646|FG000|Overall Study|dismissed from study|1|||
127507794|NCT03746600|458819647|FG001|Overall Study|dismissed from study|0|||
127507795|NCT03746600|458819646|FG000|Overall Study|Lost to Follow-up|1|||
127507796|NCT03746600|458819647|FG001|Overall Study|Lost to Follow-up|0|||
127507797|NCT00977938|458819648|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
127507798|NCT00977938|458819649|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
127507799|NCT00977938|458819650|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
127507800|NCT00977938|458819651|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
127507801|NCT00977938|458819648|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
127507802|NCT00977938|458819649|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
127507803|NCT00977938|458819650|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
127507804|NCT00977938|458819651|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
127507805|NCT00977938|458819648|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
127507806|NCT00977938|458819649|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
127507807|NCT00977938|458819650|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
127507808|NCT00977938|458819651|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
127507809|NCT00977938|458819648|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
127507810|NCT00977938|458819649|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
127507811|NCT00977938|458819650|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
127507812|NCT00977938|458819651|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
127507813|NCT00977938|458819648|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
127507814|NCT00977938|458819649|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
127507815|NCT00977938|458819650|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
127507816|NCT00977938|458819651|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
127507817|NCT00977938|458819648|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
127507818|NCT00977938|458819649|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
127507819|NCT00977938|458819650|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
127507820|NCT00977938|458819651|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
127507821|NCT02142283|458819656|FG000|Overall Study|Death|20|||
127507822|NCT02142283|458819657|FG001|Overall Study|Death|18|||
127507823|NCT02142283|458819656|FG000|Overall Study|Withdrawal by Subject|1|||
127507824|NCT02142283|458819657|FG001|Overall Study|Withdrawal by Subject|3|||
127507825|NCT02460783|458819658|FG000|Overall Study|Withdrawal by Subject|1|||
127507826|NCT02460783|458819659|FG001|Overall Study|Withdrawal by Subject|3|||
127507827|NCT02460783|458819658|FG000|Overall Study|Lost to Follow-up|1|||
127507828|NCT02460783|458819659|FG001|Overall Study|Lost to Follow-up|1|||
127507829|NCT01646645|458819660|FG000|Overall Study|No Treated|1|||
127507830|NCT01646645|458819660|FG000|Overall Study|Inevaluable Donor|29|||
127507831|NCT00884039|458819669|FG000|Overall Study|Withdrawal by Subject|0|||
127507832|NCT00884039|458819670|FG001|Overall Study|Withdrawal by Subject|1|||
127507833|NCT00884039|458819669|FG000|Overall Study|Lack of Efficacy|2|||
127507834|NCT00884039|458819670|FG001|Overall Study|Lack of Efficacy|0|||
127507835|NCT00717522|458819671|FG000|Overall Study|Disease Progression|5|||
127507836|NCT00717522|458819671|FG000|Overall Study|Adverse Event|1|||
127507837|NCT00717522|458819671|FG000|Overall Study|Death|1|||
127507838|NCT02182440|458819672|FG000|Overall Study|Adverse Event|0|||
127507839|NCT02182440|458819673|FG001|Overall Study|Adverse Event|1|||
127507840|NCT02182440|458819674|FG002|Overall Study|Adverse Event|0|||
127507841|NCT02182440|458819675|FG003|Overall Study|Adverse Event|0|||
127507842|NCT02182440|458819672|FG000|Overall Study|Death|31|||
127507843|NCT02182440|458819673|FG001|Overall Study|Death|8|||
127507844|NCT02182440|458819674|FG002|Overall Study|Death|5|||
127978831|NCT02548351|460544196|FG001|Overall Study|Missing|1|||
127507845|NCT02182440|458819675|FG003|Overall Study|Death|16|||
127507846|NCT02182440|458819672|FG000|Overall Study|Protocol Violation|0|||
127507847|NCT02182440|458819673|FG001|Overall Study|Protocol Violation|1|||
127507848|NCT02182440|458819674|FG002|Overall Study|Protocol Violation|0|||
127507849|NCT02182440|458819675|FG003|Overall Study|Protocol Violation|0|||
127507850|NCT02182440|458819672|FG000|Overall Study|Physician Decision|1|||
127507851|NCT02182440|458819673|FG001|Overall Study|Physician Decision|0|||
127507852|NCT02182440|458819674|FG002|Overall Study|Physician Decision|0|||
127507853|NCT02182440|458819675|FG003|Overall Study|Physician Decision|0|||
127507854|NCT02182440|458819672|FG000|Overall Study|Withdrawal by Subject|1|||
127507855|NCT02182440|458819673|FG001|Overall Study|Withdrawal by Subject|1|||
127507856|NCT02182440|458819674|FG002|Overall Study|Withdrawal by Subject|3|||
127507857|NCT02182440|458819675|FG003|Overall Study|Withdrawal by Subject|4|||
127507858|NCT02182440|458819672|FG000|Overall Study|different, e.g adm other hospital|12|||
127507859|NCT02182440|458819673|FG001|Overall Study|different, e.g adm other hospital|3|||
127507860|NCT02182440|458819674|FG002|Overall Study|different, e.g adm other hospital|3|||
127507861|NCT02182440|458819675|FG003|Overall Study|different, e.g adm other hospital|10|||
127507862|NCT00072293|458819676|FG000|Overall Study|Lost to Follow-up|1|||
127507863|NCT00072293|458819677|FG001|Overall Study|Lost to Follow-up|1|||
127507864|NCT00072293|458819676|FG000|Overall Study|Withdrawal by Subject|0|||
127507865|NCT00072293|458819677|FG001|Overall Study|Withdrawal by Subject|1|||
127507866|NCT01166958|458819678|FG000|Overall Study|Withdrawal by Subject|1|||
127507867|NCT01166958|458819679|FG001|Overall Study|Withdrawal by Subject|0|||
127507868|NCT02981407|458819684|FG000|Overall Study|Withdrawal by Subject|2|||
127507869|NCT02981407|458819685|FG001|Overall Study|Withdrawal by Subject|0|||
127507870|NCT00355342|458819688|FG000|Overall Study|Adverse Event|13|||
127507871|NCT00355342|458819689|FG001|Overall Study|Adverse Event|15|||
127507872|NCT00355342|458819688|FG000|Overall Study|Lost to Follow-up|4|||
127507873|NCT00355342|458819689|FG001|Overall Study|Lost to Follow-up|2|||
127507874|NCT00355342|458819688|FG000|Overall Study|Withdrawal by Subject|14|||
127507875|NCT00355342|458819689|FG001|Overall Study|Withdrawal by Subject|11|||
127507876|NCT00355342|458819688|FG000|Overall Study|Sponsor terminated study|2|||
127507877|NCT00355342|458819689|FG001|Overall Study|Sponsor terminated study|2|||
127507878|NCT00355342|458819688|FG000|Overall Study|Overcompliant-PI discretion|1|||
127507879|NCT00355342|458819689|FG001|Overall Study|Overcompliant-PI discretion|0|||
127507880|NCT00355342|458819688|FG000|Overall Study|Use of prohibited medication|1|||
127507881|NCT00355342|458819689|FG001|Overall Study|Use of prohibited medication|0|||
127507882|NCT00355342|458819688|FG000|Overall Study|COPD exacerbation|1|||
127507883|NCT00355342|458819689|FG001|Overall Study|COPD exacerbation|1|||
127507884|NCT00355342|458819688|FG000|Overall Study|Dispensed wrong study drug kit|1|||
127507885|NCT00355342|458819689|FG001|Overall Study|Dispensed wrong study drug kit|0|||
127507886|NCT00355342|458819688|FG000|Overall Study|Non-compliance with Dexa scans|1|||
127507887|NCT00355342|458819689|FG001|Overall Study|Non-compliance with Dexa scans|0|||
127507888|NCT00355342|458819688|FG000|Overall Study|Withdrawal by participant and physician|1|||
127507889|NCT00355342|458819689|FG001|Overall Study|Withdrawal by participant and physician|0|||
127507890|NCT00355342|458819688|FG000|Overall Study|Participant relocated|0|||
127507891|NCT00355342|458819689|FG001|Overall Study|Participant relocated|1|||
127507892|NCT00355342|458819688|FG000|Overall Study|Participant discontinued study drug|0|||
127507893|NCT00355342|458819689|FG001|Overall Study|Participant discontinued study drug|1|||
127507894|NCT00355342|458819688|FG000|Overall Study|Study management|0|||
127507895|NCT00355342|458819689|FG001|Overall Study|Study management|1|||
127507896|NCT00355342|458819688|FG000|Overall Study|Protocol Violation|0|||
127507897|NCT00355342|458819689|FG001|Overall Study|Protocol Violation|1|||
127507898|NCT00355342|458819688|FG000|Overall Study|Use of protocol excluded medication|0|||
127507899|NCT00355342|458819689|FG001|Overall Study|Use of protocol excluded medication|1|||
127507900|NCT01444027|458819690|FG000|Overall Study|Withdrawal by Subject|4|||
127507901|NCT01444027|458819691|FG001|Overall Study|Withdrawal by Subject|10|||
127507902|NCT01444027|458819692|FG002|Overall Study|Withdrawal by Subject|24|||
127507903|NCT01444027|458819690|FG000|Overall Study|Lost to Follow-up|26|||
127507904|NCT01444027|458819691|FG001|Overall Study|Lost to Follow-up|20|||
127507905|NCT01444027|458819692|FG002|Overall Study|Lost to Follow-up|14|||
127507906|NCT01416441|458819694|FG000|Overall Study|Lost to Follow-up|5|||
127507907|NCT01416441|458819694|FG000|Overall Study|Adverse Event|6|||
127507908|NCT01416441|458819694|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
127507909|NCT01416441|458819694|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
127507910|NCT01416441|458819694|FG000|Overall Study|Investigator Withdrew Subject|2|||
127507911|NCT01416441|458819694|FG000|Overall Study|Subject Withdrew Consent|12|||
127507912|NCT01416441|458819694|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
127507913|NCT02653495|458819699|FG000|Overall Study|Lost to Follow-up|2|||
127507914|NCT02653495|458819700|FG001|Overall Study|Lost to Follow-up|0|||
127507915|NCT02653495|458819699|FG000|Overall Study|Screening Failure|10|||
127507916|NCT02653495|458819700|FG001|Overall Study|Screening Failure|0|||
127507917|NCT00953680|458819701|FG000|Period 1|Withdrawal by Subject|0|||
127507918|NCT00953680|458819702|FG001|Period 1|Withdrawal by Subject|1|||
127507919|NCT01360398|458819703|FG000|Overall Study|Withdrawal by Subject|14|||
127507920|NCT01360398|458819703|FG000|Overall Study|Other|7|||
127507921|NCT01360398|458819703|FG000|Overall Study|Migrated/moved from study area|1|||
127507922|NCT00737711|458819704|FG000|Overall Study|Adverse Event|2|||
127507923|NCT00737711|458819704|FG000|Overall Study|Death|8|||
127507924|NCT00737711|458819704|FG000|Overall Study|Failure to return|4|||
127507925|NCT00737711|458819704|FG000|Overall Study|Protocol Violation|1|||
127507926|NCT00737711|458819704|FG000|Overall Study|Withdrawal by Subject|5|||
127507927|NCT00737711|458819704|FG000|Overall Study|Blood transfusion|6|||
127507928|NCT00737711|458819704|FG000|Overall Study|Other|5|||
127507929|NCT00624780|458819708|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
127507930|NCT00624780|458819709|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
127507931|NCT00624780|458819710|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
127507932|NCT00624780|458819711|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
127507933|NCT00624780|458819712|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
127507934|NCT00624780|458819713|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
127507935|NCT00624780|458819708|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
127507936|NCT00624780|458819709|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
127507937|NCT00624780|458819710|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
127507938|NCT00624780|458819711|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
127507939|NCT00624780|458819712|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
127978832|NCT02548351|460544197|FG002|Overall Study|Missing|0|||
127978833|NCT00125242|460544201|FG000|Overall Study|did not qualify|7|||
127978834|NCT00125242|460544202|FG001|Overall Study|did not qualify|2|||
127978835|NCT01664949|460544205|FG000|Overall Study|Adverse Event|11|||
127978836|NCT01664949|460544206|FG001|Overall Study|Adverse Event|12|||
127978837|NCT01664949|460544205|FG000|Overall Study|Lack of Efficacy|1|||
127978838|NCT01664949|460544206|FG001|Overall Study|Lack of Efficacy|1|||
127978839|NCT01664949|460544205|FG000|Overall Study|Lost to Follow-up|1|||
127507940|NCT00624780|458819713|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
127507941|NCT00624780|458819708|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
127507942|NCT00624780|458819709|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
127507943|NCT00624780|458819710|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
127507944|NCT00624780|458819711|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
127507945|NCT00624780|458819712|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
127507946|NCT00624780|458819713|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
127507947|NCT00624780|458819708|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
127507948|NCT00624780|458819709|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
127507949|NCT00624780|458819710|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
127507950|NCT00624780|458819711|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
127507951|NCT00624780|458819712|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
127507952|NCT00624780|458819713|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
127507953|NCT00624780|458819708|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
127507954|NCT00624780|458819709|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
127507955|NCT00624780|458819710|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
127507956|NCT00624780|458819711|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
127507957|NCT00624780|458819712|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
127507958|NCT00624780|458819713|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
127507959|NCT00624780|458819708|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
127507960|NCT00624780|458819709|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
127507961|NCT00624780|458819710|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
127507962|NCT00624780|458819711|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
127507963|NCT00624780|458819712|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
127507964|NCT00624780|458819713|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
127507965|NCT00624780|458819708|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
127507966|NCT00624780|458819709|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
127507967|NCT00624780|458819710|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
127507968|NCT00624780|458819711|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
127507969|NCT00624780|458819712|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
127507970|NCT00624780|458819713|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
127507971|NCT00624780|458819708|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
127507972|NCT00624780|458819709|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
127507973|NCT00624780|458819710|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
127507974|NCT00624780|458819711|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
127507975|NCT00624780|458819712|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
127507976|NCT00624780|458819713|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
127507977|NCT00624780|458819708|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
127507978|NCT00624780|458819709|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
127507979|NCT00624780|458819710|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
127507980|NCT00624780|458819711|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
127978840|NCT01664949|460544206|FG001|Overall Study|Lost to Follow-up|2|||
127978841|NCT01664949|460544205|FG000|Overall Study|Personal Reasons|3|||
127978842|NCT01664949|460544206|FG001|Overall Study|Personal Reasons|4|||
127978843|NCT01664949|460544205|FG000|Overall Study|Protocol Violation|5|||
127507981|NCT00624780|458819712|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
127507982|NCT00624780|458819713|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
127507983|NCT00624780|458819708|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
127507984|NCT00624780|458819709|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
127507985|NCT00624780|458819710|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
127507986|NCT00624780|458819711|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
127507987|NCT00624780|458819712|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
127507988|NCT00624780|458819713|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
127507989|NCT00624780|458819708|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
127507990|NCT00624780|458819709|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
127507991|NCT00624780|458819710|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
127507992|NCT00624780|458819711|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
127507993|NCT00624780|458819712|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
127507994|NCT00624780|458819713|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
127507995|NCT00624780|458819708|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
127507996|NCT00624780|458819709|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
127507997|NCT00624780|458819710|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
127507998|NCT00624780|458819711|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
127507999|NCT00624780|458819712|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
127508000|NCT00624780|458819713|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
127508001|NCT00624780|458819708|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
127508002|NCT00624780|458819709|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
127508003|NCT00624780|458819710|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
127508004|NCT00624780|458819711|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
127508005|NCT00624780|458819712|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
127508006|NCT00624780|458819713|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
127508007|NCT00624780|458819708|FG000|Follow-up (Week 26)|Death|0|||
127508008|NCT00624780|458819709|FG001|Follow-up (Week 26)|Death|0|||
127508009|NCT00624780|458819710|FG002|Follow-up (Week 26)|Death|1|||
127508010|NCT00624780|458819711|FG003|Follow-up (Week 26)|Death|0|||
127508011|NCT00624780|458819712|FG004|Follow-up (Week 26)|Death|0|||
127508012|NCT00624780|458819713|FG005|Follow-up (Week 26)|Death|0|||
127508013|NCT00624780|458819708|FG000|Follow-up (Week 26)|Adverse Event|0|||
127508014|NCT00624780|458819709|FG001|Follow-up (Week 26)|Adverse Event|0|||
127508015|NCT00624780|458819710|FG002|Follow-up (Week 26)|Adverse Event|0|||
127508016|NCT00624780|458819711|FG003|Follow-up (Week 26)|Adverse Event|0|||
127508017|NCT00624780|458819712|FG004|Follow-up (Week 26)|Adverse Event|1|||
127508018|NCT00624780|458819713|FG005|Follow-up (Week 26)|Adverse Event|0|||
127508019|NCT00624780|458819708|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
127508020|NCT00624780|458819709|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
127508021|NCT00624780|458819710|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
127508022|NCT00624780|458819711|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
127508023|NCT00624780|458819712|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
127508024|NCT00624780|458819713|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
127508025|NCT00624780|458819708|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
127508026|NCT00624780|458819709|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
127508027|NCT00624780|458819710|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
127508028|NCT00624780|458819711|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
127508029|NCT00624780|458819712|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
127508030|NCT00624780|458819713|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
127508031|NCT00624780|458819708|FG000|Follow-up (Week 26)|Other|1|||
127508032|NCT00624780|458819709|FG001|Follow-up (Week 26)|Other|1|||
127508033|NCT00624780|458819710|FG002|Follow-up (Week 26)|Other|0|||
127508034|NCT00624780|458819711|FG003|Follow-up (Week 26)|Other|0|||
127508035|NCT00624780|458819712|FG004|Follow-up (Week 26)|Other|0|||
127508036|NCT00624780|458819713|FG005|Follow-up (Week 26)|Other|0|||
127508037|NCT00937404|458822225|FG000|Overall Study|Protocol Violation|1|||
127508038|NCT00937404|458822225|FG000|Overall Study|Withdrawal by Subject|1|||
127508039|NCT04644237|458822228|FG000|Overall Study|Death|3|||
127508040|NCT04644237|458822229|FG001|Overall Study|Death|2|||
127508041|NCT04644237|458822228|FG000|Overall Study|Adverse Event|15|||
127508042|NCT04644237|458822229|FG001|Overall Study|Adverse Event|12|||
127508043|NCT04644237|458822228|FG000|Overall Study|Progressive Disease|47|||
127508044|NCT04644237|458822229|FG001|Overall Study|Progressive Disease|19|||
127508045|NCT04644237|458822228|FG000|Overall Study|Clinical Progression|4|||
127508046|NCT04644237|458822229|FG001|Overall Study|Clinical Progression|1|||
127508047|NCT04644237|458822228|FG000|Overall Study|Withdrawal by Subject|1|||
127508048|NCT04644237|458822229|FG001|Overall Study|Withdrawal by Subject|2|||
127508049|NCT04644237|458822228|FG000|Overall Study|Physician Decision|3|||
127508050|NCT04644237|458822229|FG001|Overall Study|Physician Decision|0|||
127508051|NCT04644237|458822228|FG000|Overall Study|Other|1|||
127508052|NCT04644237|458822229|FG001|Overall Study|Other|0|||
127508053|NCT04644237|458822228|FG000|Overall Study|Randomized but not Treated|1|||
127508054|NCT04644237|458822229|FG001|Overall Study|Randomized but not Treated|0|||
127508055|NCT00090233|458822230|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
127508056|NCT00090233|458822231|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
127508057|NCT00090233|458822230|FG000|Overall Study|Adverse Event|214|||
127508058|NCT00090233|458822231|FG001|Overall Study|Adverse Event|198|||
127508059|NCT00090233|458822230|FG000|Overall Study|Lost to Follow-up|68|||
127508060|NCT00090233|458822231|FG001|Overall Study|Lost to Follow-up|95|||
127508061|NCT00090233|458822230|FG000|Overall Study|Protocol Violation|960|||
127508062|NCT00090233|458822231|FG001|Overall Study|Protocol Violation|1022|||
127508063|NCT00090233|458822230|FG000|Overall Study|Withdrawal by Subject|182|||
127508064|NCT00090233|458822231|FG001|Overall Study|Withdrawal by Subject|211|||
127508065|NCT00090233|458822230|FG000|Overall Study|Moved|203|||
127508066|NCT00090233|458822231|FG001|Overall Study|Moved|189|||
127508067|NCT00090233|458822230|FG000|Overall Study|Other|1211|||
127508068|NCT00090233|458822231|FG001|Overall Study|Other|1160|||
127508069|NCT00090233|458822230|FG000|Overall Study|Data not available at data cut-off point|1552|||
127508070|NCT00090233|458822231|FG001|Overall Study|Data not available at data cut-off point|1563|||
127508071|NCT04863248|458822232|FG000|Overall Study|Sponsor Terminated|4|||
127508072|NCT04863248|458822233|FG001|Overall Study|Sponsor Terminated|1|||
127508073|NCT04863248|458822232|FG000|Overall Study|Death|0|||
127508074|NCT04863248|458822233|FG001|Overall Study|Death|1|||
127508075|NCT04863248|458822232|FG000|Overall Study|Withdrawal by Subject|0|||
127508076|NCT04863248|458822233|FG001|Overall Study|Withdrawal by Subject|1|||
127508077|NCT01779869|458822234|FG000|Overall Study|Physician Decision|2|||
127508078|NCT01691105|458822236|FG000|1 Month Follow-up|Lost to Follow-up|41|||
127508079|NCT01691105|458822237|FG001|1 Month Follow-up|Lost to Follow-up|38|||
127508080|NCT01691105|458822236|FG000|1 Month Follow-up|Death|2|||
127508081|NCT01691105|458822237|FG001|1 Month Follow-up|Death|3|||
127508082|NCT01691105|458822236|FG000|6 Month Follow-up|Lost to Follow-up|39|||
127508083|NCT01691105|458822237|FG001|6 Month Follow-up|Lost to Follow-up|58|||
127508084|NCT01691105|458822236|FG000|6 Month Follow-up|Death|13|||
127508085|NCT01691105|458822237|FG001|6 Month Follow-up|Death|13|||
127508086|NCT01691105|458822236|FG000|12 Month Follow-up|Lost to Follow-up|50|||
127508087|NCT01691105|458822237|FG001|12 Month Follow-up|Lost to Follow-up|71|||
127508088|NCT01691105|458822236|FG000|12 Month Follow-up|Death|22|||
127508089|NCT01691105|458822237|FG001|12 Month Follow-up|Death|30|||
127508090|NCT01691105|458822236|FG000|12 Month Biochemical Verification|Death|22|||
127508091|NCT01691105|458822237|FG001|12 Month Biochemical Verification|Death|30|||
127508092|NCT01691105|458822236|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
127508093|NCT01691105|458822237|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
127508094|NCT01691105|458822236|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
127508095|NCT01691105|458822237|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
127508096|NCT02233738|458822238|FG000|Overall Study|Lost to Follow-up|5|||
127508097|NCT02233738|458822239|FG001|Overall Study|Lost to Follow-up|12|||
127508098|NCT02233738|458822238|FG000|Overall Study|Death|0|||
127508099|NCT02233738|458822239|FG001|Overall Study|Death|1|||
127508100|NCT02233738|458822238|FG000|Overall Study|Withdrawal by Subject|0|||
127508101|NCT02233738|458822239|FG001|Overall Study|Withdrawal by Subject|1|||
127508102|NCT02233738|458822238|FG000|Overall Study|Did not return after Baseline|3|||
127508103|NCT02233738|458822239|FG001|Overall Study|Did not return after Baseline|2|||
127508104|NCT00096174|458822240|FG000|Overall Study|Lack of Efficacy|9|||
127508105|NCT00096174|458822240|FG000|Overall Study|Adverse Event|15|||
127508106|NCT00096174|458822240|FG000|Overall Study|Death|6|||
127508107|NCT00096174|458822240|FG000|Overall Study|Withdrawal by Subject|15|||
127508108|NCT00096174|458822240|FG000|Overall Study|Not started protocol therapy|3|||
127508109|NCT00096174|458822240|FG000|Overall Study|Ineligible|6|||
127508110|NCT00096174|458822240|FG000|Overall Study|other reason|8|||
127508111|NCT00027378|458822244|FG000|Overall Study|Physician Decision|0|||
127508112|NCT00027378|458822245|FG001|Overall Study|Physician Decision|3|||
127508113|NCT05605691|458822246|FG000|Overall Study|Lost to Follow-up|1|||
127508114|NCT03199053|458822249|FG000|ST Period|Withdrawal by Subject|2|||
127508115|NCT03199053|458822250|FG001|ST Period|Withdrawal by Subject|4|||
127508116|NCT03199053|458822251|FG002|ST Period|Withdrawal by Subject|6|||
127508117|NCT03199053|458822249|FG000|ST Period|Withdrawal by parent/guardian|1|||
127508118|NCT03199053|458822250|FG001|ST Period|Withdrawal by parent/guardian|1|||
127508119|NCT03199053|458822251|FG002|ST Period|Withdrawal by parent/guardian|1|||
127508120|NCT03199053|458822249|FG000|ST Period|Lost to Follow-up|2|||
127508121|NCT03199053|458822250|FG001|ST Period|Lost to Follow-up|0|||
127508122|NCT03199053|458822251|FG002|ST Period|Lost to Follow-up|1|||
127508123|NCT03199053|458822249|FG000|LT Period|Withdrawal by Subject|1|||
127508124|NCT03199053|458822250|FG001|LT Period|Withdrawal by Subject|3|||
127508125|NCT03199053|458822251|FG002|LT Period|Withdrawal by Subject|3|||
127508126|NCT03199053|458822249|FG000|LT Period|Withdrawal by parent/guardian|0|||
127508127|NCT03199053|458822250|FG001|LT Period|Withdrawal by parent/guardian|0|||
127508128|NCT03199053|458822251|FG002|LT Period|Withdrawal by parent/guardian|1|||
127508129|NCT03199053|458822249|FG000|LT Period|Lost to Follow-up|0|||
127508130|NCT03199053|458822250|FG001|LT Period|Lost to Follow-up|1|||
127508131|NCT03199053|458822251|FG002|LT Period|Lost to Follow-up|1|||
127508132|NCT03199053|458822249|FG000|LT Period|Miscellaneous|0|||
127508133|NCT03199053|458822250|FG001|LT Period|Miscellaneous|0|||
127508134|NCT03199053|458822251|FG002|LT Period|Miscellaneous|2|||
127508135|NCT03199053|458822249|FG000|Non-treatment Follow-up Period|Withdrawal by Subject|2|||
127508136|NCT03199053|458822250|FG001|Non-treatment Follow-up Period|Withdrawal by Subject|1|||
127508137|NCT03199053|458822251|FG002|Non-treatment Follow-up Period|Withdrawal by Subject|0|||
127508138|NCT03199053|458822249|FG000|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
127508139|NCT03199053|458822250|FG001|Non-treatment Follow-up Period|Withdrawal by parent/guardian|3|||
127508140|NCT03199053|458822251|FG002|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
127508141|NCT03199053|458822249|FG000|Non-treatment Follow-up Period|Lost to Follow-up|3|||
127508142|NCT03199053|458822250|FG001|Non-treatment Follow-up Period|Lost to Follow-up|4|||
127508143|NCT03199053|458822251|FG002|Non-treatment Follow-up Period|Lost to Follow-up|5|||
127508144|NCT03199053|458822249|FG000|Non-treatment Follow-up Period|Miscellaneous|0|||
127508145|NCT03199053|458822250|FG001|Non-treatment Follow-up Period|Miscellaneous|1|||
127508146|NCT03199053|458822251|FG002|Non-treatment Follow-up Period|Miscellaneous|0|||
127508147|NCT01824823|458822254|FG000|Overall Study|Lack of Efficacy|1|||
127508148|NCT01824823|458822255|FG001|Overall Study|Lack of Efficacy|1|||
127508149|NCT01824823|458822254|FG000|Overall Study|Off-treatment reason not submitted|1|||
127508150|NCT01824823|458822255|FG001|Overall Study|Off-treatment reason not submitted|0|||
127508151|NCT03263923|458822256|FG000|Overall Study|Withdrawal by Subject|10|||
127508152|NCT03263923|458822257|FG001|Overall Study|Withdrawal by Subject|8|||
127508153|NCT03263923|458822256|FG000|Overall Study|Lost to Follow-up|15|||
127508154|NCT03263923|458822257|FG001|Overall Study|Lost to Follow-up|13|||
127508155|NCT02098369|458822258|FG000|Overall Study|Withdrawal by Subject|1|||
127508156|NCT02098369|458822259|FG001|Overall Study|Withdrawal by Subject|5|||
127508157|NCT02098369|458822260|FG002|Overall Study|Withdrawal by Subject|0|||
127508158|NCT02098369|458822258|FG000|Overall Study|Lost to Follow-up|5|||
127508159|NCT02098369|458822259|FG001|Overall Study|Lost to Follow-up|1|||
127508160|NCT02098369|458822260|FG002|Overall Study|Lost to Follow-up|3|||
127508161|NCT02098369|458822258|FG000|Overall Study|Death|1|||
127508162|NCT02098369|458822259|FG001|Overall Study|Death|1|||
127508163|NCT02098369|458822260|FG002|Overall Study|Death|1|||
127508164|NCT02098369|458822258|FG000|Overall Study|Other|0|||
127508165|NCT02098369|458822259|FG001|Overall Study|Other|2|||
127508166|NCT02098369|458822260|FG002|Overall Study|Other|1|||
127508167|NCT03362931|458822261|FG000|Overall Study|Adverse Event|1|||
127508168|NCT03362931|458822261|FG000|Overall Study|Death|2|||
127508169|NCT02927925|458822268|FG000|Overall Study|Death|16|||
127508170|NCT02927925|458822268|FG000|Overall Study|Physician Decision|1|||
127508171|NCT02927925|458822268|FG000|Overall Study|Withdrawal by Subject|11|||
127508172|NCT02927925|458822268|FG000|Overall Study|Other|3|||
127508173|NCT02927925|458822268|FG000|Overall Study|Disease progression at clinical cutoff|1|||
127508174|NCT00969761|458822269|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
127508175|NCT00969761|458822270|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
127508176|NCT00969761|458822271|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
127508177|NCT00969761|458822272|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
127508178|NCT00969761|458822273|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
127508179|NCT00969761|458822274|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
127508180|NCT00969761|458822275|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
127508181|NCT00969761|458822276|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
127508182|NCT00969761|458822277|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
127508183|NCT00969761|458822278|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
127508184|NCT00969761|458822279|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
127508185|NCT00969761|458822280|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
127508186|NCT00969761|458822269|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
127508187|NCT00969761|458822270|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
127508188|NCT00969761|458822271|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
127508189|NCT00969761|458822272|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
127508190|NCT00969761|458822273|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
127508191|NCT00969761|458822274|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
127508192|NCT00969761|458822275|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
127508193|NCT00969761|458822276|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
127508194|NCT00969761|458822277|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
127508195|NCT00969761|458822278|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
127508196|NCT00969761|458822279|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
127508197|NCT00969761|458822280|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
127508198|NCT00969761|458822269|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
127508199|NCT00969761|458822270|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
127508200|NCT00969761|458822271|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
127508201|NCT00969761|458822272|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
127508202|NCT00969761|458822273|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
127508203|NCT00969761|458822274|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
127508204|NCT00969761|458822275|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
127508205|NCT00969761|458822276|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
127508206|NCT00969761|458822277|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
127508207|NCT00969761|458822278|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
127508208|NCT00969761|458822279|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
127508209|NCT00969761|458822280|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
127508210|NCT00969761|458822269|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
127508211|NCT00969761|458822270|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
127508212|NCT00969761|458822271|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
127508213|NCT00969761|458822272|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
127508214|NCT00969761|458822273|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
127508215|NCT00969761|458822274|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
127508216|NCT00969761|458822275|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
127508217|NCT00969761|458822276|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
127508218|NCT00969761|458822277|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
127508219|NCT00969761|458822278|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
127508220|NCT00969761|458822279|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
127508221|NCT00969761|458822280|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
127508222|NCT00969761|458822269|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
127508223|NCT00969761|458822270|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
127508224|NCT00969761|458822271|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
127508225|NCT00969761|458822272|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
127508226|NCT00969761|458822273|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
127508227|NCT00969761|458822274|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
127508228|NCT00969761|458822275|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
127508229|NCT00969761|458822276|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
127508230|NCT00969761|458822277|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
127508231|NCT00969761|458822278|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
127508232|NCT00969761|458822279|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
127508233|NCT00969761|458822280|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
127508234|NCT00969761|458822269|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
127508235|NCT00969761|458822270|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
127508236|NCT00969761|458822271|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
127508237|NCT00969761|458822272|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
127508238|NCT00969761|458822273|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
127508239|NCT00969761|458822274|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
127508240|NCT00969761|458822275|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
127508241|NCT00969761|458822276|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
127508242|NCT00969761|458822277|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
127508243|NCT00969761|458822278|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
127508244|NCT00969761|458822279|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
127508245|NCT00969761|458822280|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
127508246|NCT00246025|458822281|FG000|Overall Study|Adverse Event|7|||
127508247|NCT00246025|458822282|FG001|Overall Study|Adverse Event|9|||
127508248|NCT00246025|458822283|FG002|Overall Study|Adverse Event|9|||
127508249|NCT00246025|458822284|FG003|Overall Study|Adverse Event|10|||
127508250|NCT00246025|458822281|FG000|Overall Study|Withdrawal by Subject|3|||
127508251|NCT00246025|458822282|FG001|Overall Study|Withdrawal by Subject|0|||
127508252|NCT00246025|458822283|FG002|Overall Study|Withdrawal by Subject|1|||
127508253|NCT00246025|458822284|FG003|Overall Study|Withdrawal by Subject|2|||
127508254|NCT00246025|458822281|FG000|Overall Study|unsuitable medical history was found|0|||
127508255|NCT00246025|458822282|FG001|Overall Study|unsuitable medical history was found|0|||
127508256|NCT00246025|458822283|FG002|Overall Study|unsuitable medical history was found|0|||
127508257|NCT00246025|458822284|FG003|Overall Study|unsuitable medical history was found|1|||
127508258|NCT01774253|458822287|FG000|Overall Study|Lack of Efficacy|4|||
127508259|NCT01774253|458822287|FG000|Overall Study|Physician Decision|2|||
127508260|NCT01774253|458822287|FG000|Overall Study|Withdrawal by Subject|2|||
127508261|NCT01774253|458822287|FG000|Overall Study|Death|1|||
127508262|NCT00772369|458822288|FG000|Overall Study|Did not return record release form|1|||
127508263|NCT00554619|458822289|FG000|Overall Study|Adverse Event|1|||
127508264|NCT00554619|458822289|FG000|Overall Study|Physician Decision|1|||
127508265|NCT00554619|458822289|FG000|Overall Study|Liver Function Test Abnormality|1|||
127508266|NCT01571284|458822293|FG000|Overall Study|Participant's decision|84|||
127508267|NCT01571284|458822293|FG000|Overall Study|Lost to Follow-up|3|||
127508268|NCT01571284|458822293|FG000|Overall Study|Enrolled but not treated|2|||
127508269|NCT01571284|458822293|FG000|Overall Study|Other than specified above|80|||
127508270|NCT02240368|458822294|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
127508271|NCT02240368|458822295|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
127508272|NCT02240368|458822296|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
127508273|NCT02240368|458822294|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
127508274|NCT02240368|458822295|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
127508275|NCT02240368|458822296|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
127508276|NCT03352557|458822297|FG000|PC Period: Day 1 to Week 78|Death|1|||
127508277|NCT03352557|458822298|FG001|PC Period: Day 1 to Week 78|Death|1|||
127508278|NCT03352557|458822299|FG002|PC Period: Day 1 to Week 78|Death|0|||
127508279|NCT03352557|458822300|FG003|PC Period: Day 1 to Week 78|Death|0|||
127508280|NCT03352557|458822301|FG004|PC Period: Day 1 to Week 78|Death|1|||
127508281|NCT03352557|458822302|FG005|PC Period: Day 1 to Week 78|Death|0|||
127508282|NCT03352557|458822303|FG006|PC Period: Day 1 to Week 78|Death|0|||
127508283|NCT03352557|458822304|FG007|PC Period: Day 1 to Week 78|Death|0|||
127508284|NCT03352557|458822305|FG008|PC Period: Day 1 to Week 78|Death|0|||
127508285|NCT03352557|458822306|FG009|PC Period: Day 1 to Week 78|Death|0|||
127508286|NCT03352557|458822297|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
127508287|NCT03352557|458822298|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
127508288|NCT03352557|458822299|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
127508289|NCT03352557|458822300|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
127508290|NCT03352557|458822301|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
127508291|NCT03352557|458822302|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
127508292|NCT03352557|458822303|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
127508293|NCT03352557|458822304|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
127508294|NCT03352557|458822305|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
127508295|NCT03352557|458822306|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
127508296|NCT03352557|458822297|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
127508297|NCT03352557|458822298|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
127508298|NCT03352557|458822299|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
127508299|NCT03352557|458822300|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
127508300|NCT03352557|458822301|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
127508301|NCT03352557|458822302|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
127508302|NCT03352557|458822303|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
127508303|NCT03352557|458822304|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
127508304|NCT03352557|458822305|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
127508305|NCT03352557|458822306|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
127508306|NCT03352557|458822297|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
127508307|NCT03352557|458822298|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
127508308|NCT03352557|458822299|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
127508309|NCT03352557|458822300|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
127508310|NCT03352557|458822301|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
127508311|NCT03352557|458822302|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
127508312|NCT03352557|458822303|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
127508313|NCT03352557|458822304|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
127508314|NCT03352557|458822305|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
127508315|NCT03352557|458822306|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
127508316|NCT03352557|458822297|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
127508317|NCT03352557|458822298|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
127508318|NCT03352557|458822299|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
127508319|NCT03352557|458822300|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
127508320|NCT03352557|458822301|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
127508321|NCT03352557|458822302|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
127508322|NCT03352557|458822303|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
127508323|NCT03352557|458822304|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
127508324|NCT03352557|458822305|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
127508325|NCT03352557|458822306|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
127508326|NCT03352557|458822297|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
127508327|NCT03352557|458822298|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
127508328|NCT03352557|458822299|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
127508329|NCT03352557|458822300|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
127508330|NCT03352557|458822301|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
127508331|NCT03352557|458822302|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
127508332|NCT03352557|458822303|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
127508333|NCT03352557|458822304|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
127508334|NCT03352557|458822305|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
127508335|NCT03352557|458822306|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
127508336|NCT03352557|458822297|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
127508337|NCT03352557|458822298|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
127508338|NCT03352557|458822299|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
127508339|NCT03352557|458822300|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
127508340|NCT03352557|458822301|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
127508341|NCT03352557|458822302|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
127508342|NCT03352557|458822303|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
127508343|NCT03352557|458822304|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
127508344|NCT03352557|458822305|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
127508345|NCT03352557|458822306|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
127508346|NCT03352557|458822297|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
127508347|NCT03352557|458822298|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
127508348|NCT03352557|458822299|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
127508349|NCT03352557|458822300|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
127508350|NCT03352557|458822301|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
127508351|NCT03352557|458822302|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
127508352|NCT03352557|458822303|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
127508353|NCT03352557|458822304|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
127508354|NCT03352557|458822305|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
127508355|NCT03352557|458822306|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
127508356|NCT03352557|458822297|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
127508357|NCT03352557|458822298|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
127508358|NCT03352557|458822299|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
127508359|NCT03352557|458822300|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
127508360|NCT03352557|458822301|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
127508361|NCT03352557|458822302|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
127508362|NCT03352557|458822303|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
127508363|NCT03352557|458822304|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
127508364|NCT03352557|458822305|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
127508365|NCT03352557|458822306|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
127508366|NCT03352557|458822297|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
127508367|NCT03352557|458822298|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
127508368|NCT03352557|458822299|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
127508369|NCT03352557|458822300|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
127508370|NCT03352557|458822301|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
127508371|NCT03352557|458822302|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
127508372|NCT03352557|458822303|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
127508373|NCT03352557|458822304|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
127508374|NCT03352557|458822305|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
127508375|NCT03352557|458822306|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
127508376|NCT03352557|458822297|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
127508377|NCT03352557|458822298|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
127508378|NCT03352557|458822299|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
127508379|NCT03352557|458822300|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
127508380|NCT03352557|458822301|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
127508381|NCT03352557|458822302|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
127508382|NCT03352557|458822303|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
127508383|NCT03352557|458822304|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
127508384|NCT03352557|458822305|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
127508385|NCT03352557|458822306|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
127508386|NCT03352557|458822297|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
127508387|NCT03352557|458822298|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
127508388|NCT03352557|458822299|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
127508389|NCT03352557|458822300|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
127508390|NCT03352557|458822301|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
127508391|NCT03352557|458822302|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
127508392|NCT03352557|458822303|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
127508393|NCT03352557|458822304|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
127508394|NCT03352557|458822305|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
127508395|NCT03352557|458822306|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
127508396|NCT03352557|458822297|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
127508397|NCT03352557|458822298|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
127508398|NCT03352557|458822299|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
127508399|NCT03352557|458822300|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
127508400|NCT03352557|458822301|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
127508401|NCT03352557|458822302|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
127508402|NCT03352557|458822303|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
127508403|NCT03352557|458822304|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
127508404|NCT03352557|458822305|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
127508405|NCT03352557|458822306|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
127508406|NCT03352557|458822297|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
127508407|NCT03352557|458822298|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
127508408|NCT03352557|458822299|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
127508409|NCT03352557|458822300|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
127508410|NCT03352557|458822301|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
127508411|NCT03352557|458822302|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
127508412|NCT03352557|458822303|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
127508413|NCT03352557|458822304|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
127508414|NCT03352557|458822305|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
127508415|NCT03352557|458822306|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
127508416|NCT03352557|458822297|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
127508417|NCT03352557|458822298|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
127508418|NCT03352557|458822299|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
127508419|NCT03352557|458822300|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
127508420|NCT03352557|458822301|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
127508421|NCT03352557|458822302|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
127508422|NCT03352557|458822303|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
127508423|NCT03352557|458822304|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
127508424|NCT03352557|458822305|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
127508425|NCT03352557|458822306|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
127508426|NCT03352557|458822297|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
127508427|NCT03352557|458822298|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
127508428|NCT03352557|458822299|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
127508429|NCT03352557|458822300|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
127508430|NCT03352557|458822301|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
127508431|NCT03352557|458822302|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
127508432|NCT03352557|458822303|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
127508433|NCT03352557|458822304|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
127508434|NCT03352557|458822305|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
127508435|NCT03352557|458822306|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
127508436|NCT03352557|458822297|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
127508437|NCT03352557|458822298|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
127508438|NCT03352557|458822299|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
127508439|NCT03352557|458822300|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
127508440|NCT03352557|458822301|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
127508441|NCT03352557|458822302|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
127508442|NCT03352557|458822303|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
127508443|NCT03352557|458822304|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
127508444|NCT03352557|458822305|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
127508445|NCT03352557|458822306|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
127508446|NCT03352557|458822297|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
127508447|NCT03352557|458822298|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
127508448|NCT03352557|458822299|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
127508449|NCT03352557|458822300|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
127508450|NCT03352557|458822301|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
127508451|NCT03352557|458822302|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
127508452|NCT03352557|458822303|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
127508453|NCT03352557|458822304|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
127508454|NCT03352557|458822305|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
127508455|NCT03352557|458822306|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
127508456|NCT03352557|458822297|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
127508457|NCT03352557|458822298|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
127508458|NCT03352557|458822299|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
127508459|NCT03352557|458822300|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
127508460|NCT03352557|458822301|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
127508461|NCT03352557|458822302|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
127508462|NCT03352557|458822303|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
127508463|NCT03352557|458822304|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
127508464|NCT03352557|458822305|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
127508465|NCT03352557|458822306|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
127508466|NCT03352557|458822297|FG000|PC Period: Day 1 to Week 78|Other|5|||
127508467|NCT03352557|458822298|FG001|PC Period: Day 1 to Week 78|Other|1|||
127508468|NCT03352557|458822299|FG002|PC Period: Day 1 to Week 78|Other|0|||
127508469|NCT03352557|458822300|FG003|PC Period: Day 1 to Week 78|Other|3|||
127508470|NCT03352557|458822301|FG004|PC Period: Day 1 to Week 78|Other|0|||
127508471|NCT03352557|458822302|FG005|PC Period: Day 1 to Week 78|Other|0|||
127508472|NCT03352557|458822303|FG006|PC Period: Day 1 to Week 78|Other|0|||
127508473|NCT03352557|458822304|FG007|PC Period: Day 1 to Week 78|Other|0|||
127508474|NCT03352557|458822305|FG008|PC Period: Day 1 to Week 78|Other|0|||
127508475|NCT03352557|458822306|FG009|PC Period: Day 1 to Week 78|Other|0|||
127508476|NCT03352557|458822297|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
127508477|NCT03352557|458822298|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
127508478|NCT03352557|458822299|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
127508479|NCT03352557|458822300|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
127508480|NCT03352557|458822301|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
127508481|NCT03352557|458822302|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
127508482|NCT03352557|458822303|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
127508483|NCT03352557|458822304|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
127508484|NCT03352557|458822305|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
127508485|NCT03352557|458822306|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
127508486|NCT03352557|458822297|FG000|LTE Period: Week 80 to Week 173|Death|0|||
127508487|NCT03352557|458822298|FG001|LTE Period: Week 80 to Week 173|Death|0|||
127508488|NCT03352557|458822299|FG002|LTE Period: Week 80 to Week 173|Death|0|||
127508489|NCT03352557|458822300|FG003|LTE Period: Week 80 to Week 173|Death|0|||
127508490|NCT03352557|458822301|FG004|LTE Period: Week 80 to Week 173|Death|0|||
127508491|NCT03352557|458822302|FG005|LTE Period: Week 80 to Week 173|Death|1|||
127508492|NCT03352557|458822303|FG006|LTE Period: Week 80 to Week 173|Death|0|||
127508493|NCT03352557|458822304|FG007|LTE Period: Week 80 to Week 173|Death|1|||
127508494|NCT03352557|458822305|FG008|LTE Period: Week 80 to Week 173|Death|1|||
127508495|NCT03352557|458822306|FG009|LTE Period: Week 80 to Week 173|Death|1|||
127508496|NCT03352557|458822297|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
127508497|NCT03352557|458822298|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
127508498|NCT03352557|458822299|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
127508499|NCT03352557|458822300|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
127508500|NCT03352557|458822301|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
127508501|NCT03352557|458822302|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
127508502|NCT03352557|458822303|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
127508503|NCT03352557|458822304|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
127508504|NCT03352557|458822305|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
127508505|NCT03352557|458822306|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
127508506|NCT03352557|458822297|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
127508507|NCT03352557|458822298|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
127508508|NCT03352557|458822299|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
127508509|NCT03352557|458822300|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
127508510|NCT03352557|458822301|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
127508511|NCT03352557|458822302|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
127508512|NCT03352557|458822303|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
127508513|NCT03352557|458822304|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
127508514|NCT03352557|458822305|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
127508515|NCT03352557|458822306|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
127508516|NCT03352557|458822297|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
127508517|NCT03352557|458822298|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
127508518|NCT03352557|458822299|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
127508519|NCT03352557|458822300|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
127508520|NCT03352557|458822301|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
127508521|NCT03352557|458822302|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
127508522|NCT03352557|458822303|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
127508523|NCT03352557|458822304|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
127508524|NCT03352557|458822305|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
127508525|NCT03352557|458822306|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
127508526|NCT03352557|458822297|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
127508527|NCT03352557|458822298|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
127508528|NCT03352557|458822299|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
127508529|NCT03352557|458822300|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
127508530|NCT03352557|458822301|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
127508531|NCT03352557|458822302|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
127508532|NCT03352557|458822303|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
127508533|NCT03352557|458822304|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
127508534|NCT03352557|458822305|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
127508535|NCT03352557|458822306|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
127508536|NCT03352557|458822297|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
127508537|NCT03352557|458822298|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
127508538|NCT03352557|458822299|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
127508539|NCT03352557|458822300|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
127508540|NCT03352557|458822301|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
127508541|NCT03352557|458822302|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
127508542|NCT03352557|458822303|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
127978844|NCT01664949|460544206|FG001|Overall Study|Protocol Violation|5|||
127978845|NCT01664949|460544205|FG000|Overall Study|Other Miscellaneous Reasons|3|||
127978846|NCT01664949|460544206|FG001|Overall Study|Other Miscellaneous Reasons|1|||
127978847|NCT03003494|460544208|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
127978848|NCT05238025|460544209|FG000|Overall Study|Adverse Event|2|||
127978849|NCT05238025|460544210|FG001|Overall Study|Adverse Event|2|||
127508543|NCT03352557|458822304|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
127508544|NCT03352557|458822305|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
127508545|NCT03352557|458822306|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
127508546|NCT03352557|458822297|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
127508547|NCT03352557|458822298|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
127508548|NCT03352557|458822299|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
127508549|NCT03352557|458822300|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
127508550|NCT03352557|458822301|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
127508551|NCT03352557|458822302|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
127508552|NCT03352557|458822303|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
127508553|NCT03352557|458822304|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
127508554|NCT03352557|458822305|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
127508555|NCT03352557|458822306|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
127508556|NCT03352557|458822297|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
127508557|NCT03352557|458822298|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
127508558|NCT03352557|458822299|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
127508559|NCT03352557|458822300|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
127508560|NCT03352557|458822301|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
127508561|NCT03352557|458822302|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
127508562|NCT03352557|458822303|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
127508563|NCT03352557|458822304|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
127508564|NCT03352557|458822305|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
127508565|NCT03352557|458822306|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
127508566|NCT03352557|458822297|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
127508567|NCT03352557|458822298|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
127508568|NCT03352557|458822299|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
127508569|NCT03352557|458822300|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
127508570|NCT03352557|458822301|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
127508571|NCT03352557|458822302|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
127508572|NCT03352557|458822303|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
127508573|NCT03352557|458822304|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
127508574|NCT03352557|458822305|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
127508575|NCT03352557|458822306|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
127508576|NCT03352557|458822297|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
127508577|NCT03352557|458822298|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
127508578|NCT03352557|458822299|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
127508579|NCT03352557|458822300|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
127508580|NCT03352557|458822301|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
127508581|NCT03352557|458822302|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
127508582|NCT03352557|458822303|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
127508583|NCT03352557|458822304|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
127508584|NCT03352557|458822305|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
127508585|NCT03352557|458822306|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
127508586|NCT03352557|458822297|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
127508587|NCT03352557|458822298|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
127508588|NCT03352557|458822299|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
127508589|NCT03352557|458822300|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
127508590|NCT03352557|458822301|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
127508591|NCT03352557|458822302|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
127508592|NCT03352557|458822303|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
127508593|NCT03352557|458822304|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
127508594|NCT03352557|458822305|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
127508595|NCT03352557|458822306|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
127508596|NCT03352557|458822297|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
127508597|NCT03352557|458822298|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
127508598|NCT03352557|458822299|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
127508599|NCT03352557|458822300|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
127508600|NCT03352557|458822301|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
127508601|NCT03352557|458822302|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
127508602|NCT03352557|458822303|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
127508603|NCT03352557|458822304|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
127508604|NCT03352557|458822305|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
127508605|NCT03352557|458822306|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
127508606|NCT03352557|458822297|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
127508607|NCT03352557|458822298|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
127508608|NCT03352557|458822299|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
127508609|NCT03352557|458822300|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
127508610|NCT03352557|458822301|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
127508611|NCT03352557|458822302|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
127508612|NCT03352557|458822303|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
127508613|NCT03352557|458822304|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
127508614|NCT03352557|458822305|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
127508615|NCT03352557|458822306|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
127508616|NCT03352557|458822297|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
127508617|NCT03352557|458822298|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
127508618|NCT03352557|458822299|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
127508619|NCT03352557|458822300|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
127508620|NCT03352557|458822301|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
127508621|NCT03352557|458822302|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
127508622|NCT03352557|458822303|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
127508623|NCT03352557|458822304|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
127508624|NCT03352557|458822305|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
127508625|NCT03352557|458822306|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
127508626|NCT03352557|458822297|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
127508627|NCT03352557|458822298|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
127508628|NCT03352557|458822299|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
127508629|NCT03352557|458822300|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
127508630|NCT03352557|458822301|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
127508631|NCT03352557|458822302|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
127508632|NCT03352557|458822303|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
127508633|NCT03352557|458822304|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
127508634|NCT03352557|458822305|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
127508635|NCT03352557|458822306|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
127508636|NCT03352557|458822297|FG000|LTE Period: Week 80 to Week 173|Other|0|||
127508637|NCT03352557|458822298|FG001|LTE Period: Week 80 to Week 173|Other|0|||
127508638|NCT03352557|458822299|FG002|LTE Period: Week 80 to Week 173|Other|0|||
127508639|NCT03352557|458822300|FG003|LTE Period: Week 80 to Week 173|Other|0|||
127508640|NCT03352557|458822301|FG004|LTE Period: Week 80 to Week 173|Other|0|||
127508641|NCT03352557|458822302|FG005|LTE Period: Week 80 to Week 173|Other|0|||
127508642|NCT03352557|458822303|FG006|LTE Period: Week 80 to Week 173|Other|0|||
127508643|NCT03352557|458822304|FG007|LTE Period: Week 80 to Week 173|Other|1|||
127508644|NCT03352557|458822305|FG008|LTE Period: Week 80 to Week 173|Other|0|||
127508645|NCT03352557|458822306|FG009|LTE Period: Week 80 to Week 173|Other|0|||
127508646|NCT04065074|458822311|FG000|Overall Study|Adverse Event|1|||
127508647|NCT04065074|458822311|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
127508648|NCT00916058|458822312|FG000|Phase 1|Screen Failure|0|||
127508649|NCT00916058|458822313|FG001|Phase 1|Screen Failure|0|||
127508650|NCT00916058|458822314|FG002|Phase 1|Screen Failure|0|||
127508651|NCT00916058|458822315|FG003|Phase 1|Screen Failure|0|||
127508652|NCT00916058|458822316|FG004|Phase 1|Screen Failure|0|||
127508653|NCT00916058|458822317|FG005|Phase 1|Screen Failure|1|||
127508654|NCT00916058|458822318|FG006|Phase 1|Screen Failure|0|||
127508655|NCT00916058|458822312|FG000|Phase 2|Screen Failure|0|||
127508656|NCT00916058|458822313|FG001|Phase 2|Screen Failure|0|||
127508657|NCT00916058|458822314|FG002|Phase 2|Screen Failure|0|||
127508658|NCT00916058|458822315|FG003|Phase 2|Screen Failure|0|||
127508659|NCT00916058|458822316|FG004|Phase 2|Screen Failure|0|||
127508660|NCT00916058|458822317|FG005|Phase 2|Screen Failure|0|||
127508661|NCT00916058|458822318|FG006|Phase 2|Screen Failure|3|||
127508662|NCT02437305|458822319|FG000|Overall Study|Lost to Follow-up|18|||
127508663|NCT02437305|458822320|FG001|Overall Study|Lost to Follow-up|12|||
127508664|NCT01071200|458822337|FG000|Overall Study|Lack of ovarian response|1|||
127508665|NCT01071200|458822338|FG001|Overall Study|Lack of ovarian response|1|||
127508666|NCT01071200|458822337|FG000|Overall Study|No fertilization|4|||
127508667|NCT01071200|458822338|FG001|Overall Study|No fertilization|0|||
127508668|NCT01071200|458822337|FG000|Overall Study|No oocytes retrieved|1|||
127508669|NCT01071200|458822338|FG001|Overall Study|No oocytes retrieved|1|||
127508670|NCT01071200|458822337|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
127508671|NCT01071200|458822338|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
127508672|NCT01071200|458822337|FG000|Overall Study|No viable embryos|0|||
127508673|NCT01071200|458822338|FG001|Overall Study|No viable embryos|1|||
127508674|NCT00413920|458822339|FG000|Overall Study|Adverse Event|9|||
127508675|NCT00413920|458822340|FG001|Overall Study|Adverse Event|11|||
127508676|NCT00413920|458822339|FG000|Overall Study|Lack of Efficacy|11|||
127508677|NCT00413920|458822340|FG001|Overall Study|Lack of Efficacy|9|||
127508678|NCT00413920|458822339|FG000|Overall Study|Death|3|||
127508679|NCT00413920|458822340|FG001|Overall Study|Death|5|||
127508680|NCT00413920|458822339|FG000|Overall Study|Graft Loss|5|||
127508681|NCT00413920|458822340|FG001|Overall Study|Graft Loss|3|||
127508682|NCT03730961|458822341|FG000|Overall Study|Adverse Event|0|||
127508683|NCT03730961|458822342|FG001|Overall Study|Adverse Event|1|||
127508684|NCT04465877|458822345|FG000|Overall Study|Noncompliant with study requirements|0|||
127508685|NCT04465877|458822346|FG001|Overall Study|Noncompliant with study requirements|0|||
127508686|NCT04465877|458822347|FG002|Overall Study|Noncompliant with study requirements|1|||
127508687|NCT04465877|458822348|FG003|Overall Study|Noncompliant with study requirements|0|||
127508688|NCT03762616|458822349|FG000|Overall Study|Protocol Violation|2|||
127508689|NCT03576755|458822355|FG000|Overall Study|Withdrawal by Subject|1|||
127508690|NCT03576755|458822356|FG001|Overall Study|Withdrawal by Subject|0|||
127508691|NCT03576755|458822357|FG002|Overall Study|Withdrawal by Subject|0|||
127508692|NCT03576755|458822358|FG003|Overall Study|Withdrawal by Subject|0|||
127508693|NCT04962230|458822359|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
127508694|NCT04962230|458822359|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
127508695|NCT03831880|458822362|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
127508696|NCT03831880|458822363|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
127508697|NCT03831880|458822362|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
127508698|NCT03831880|458822363|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
127508699|NCT03958656|458822364|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
127508700|NCT03958656|458822365|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
127508701|NCT03958656|458822366|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
127508702|NCT03958656|458822367|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
127508703|NCT03958656|458822364|FG000|Overall Study|No longer meets eligibility criteria|0|||
127508704|NCT03958656|458822365|FG001|Overall Study|No longer meets eligibility criteria|0|||
127508705|NCT03958656|458822366|FG002|Overall Study|No longer meets eligibility criteria|1|||
127508706|NCT03958656|458822367|FG003|Overall Study|No longer meets eligibility criteria|0|||
127508707|NCT03958656|458822364|FG000|Overall Study|Started anti-cancer treatment|0|||
127508708|NCT03958656|458822365|FG001|Overall Study|Started anti-cancer treatment|0|||
127508709|NCT03958656|458822366|FG002|Overall Study|Started anti-cancer treatment|1|||
127508710|NCT03958656|458822367|FG003|Overall Study|Started anti-cancer treatment|0|||
127508711|NCT01767493|458822368|FG000|Overall Study|screen failures|3|||
127508712|NCT03444766|458822369|FG000|Overall Study|Other Reasons|2|||
127508713|NCT03444766|458822369|FG000|Overall Study|Participant Withdrew Consent|5|||
127508714|NCT03444766|458822369|FG000|Overall Study|Lost to Follow-up|2|||
127508715|NCT03444766|458822369|FG000|Overall Study|Death|2|||
127508716|NCT03444766|458822369|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
127508717|NCT03444766|458822369|FG000|Overall Study|Disease Progression|49|||
127508718|NCT03158012|458822370|FG000|Overall Study|Withdrawal by Subject|0|||
127508719|NCT03158012|458822371|FG001|Overall Study|Withdrawal by Subject|1|||
127508720|NCT04346108|458822372|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
127508721|NCT04346108|458822373|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|1|||
127508722|NCT04346108|458822374|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
127508723|NCT04346108|458822372|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
127508724|NCT04346108|458822373|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|1|||
127508725|NCT04346108|458822374|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
127508726|NCT02788201|458822375|FG000|Overall Study|Death|1|||
127508727|NCT02788201|458822376|FG001|Overall Study|Death|1|||
127508728|NCT02788201|458822377|FG002|Overall Study|Death|1|||
127508729|NCT02788201|458822378|FG003|Overall Study|Death|1|||
127508730|NCT02788201|458822379|FG004|Overall Study|Death|0|||
127508731|NCT02788201|458822380|FG005|Overall Study|Death|1|||
127508732|NCT02788201|458822375|FG000|Overall Study|Ineligible|0|||
127508733|NCT02788201|458822376|FG001|Overall Study|Ineligible|0|||
127508734|NCT02788201|458822377|FG002|Overall Study|Ineligible|0|||
127508735|NCT02788201|458822378|FG003|Overall Study|Ineligible|0|||
127508736|NCT02788201|458822379|FG004|Overall Study|Ineligible|0|||
127508737|NCT02788201|458822380|FG005|Overall Study|Ineligible|1|||
127508738|NCT02788201|458822375|FG000|Overall Study|Withdrawal by Subject|0|||
127508739|NCT02788201|458822376|FG001|Overall Study|Withdrawal by Subject|0|||
127508740|NCT02788201|458822377|FG002|Overall Study|Withdrawal by Subject|0|||
127508741|NCT02788201|458822378|FG003|Overall Study|Withdrawal by Subject|0|||
127508742|NCT02788201|458822379|FG004|Overall Study|Withdrawal by Subject|0|||
127508743|NCT02788201|458822380|FG005|Overall Study|Withdrawal by Subject|1|||
127508744|NCT02374814|458822388|FG000|Overall Study|Lost to Follow-up|1|||
127508745|NCT02374814|458822389|FG001|Overall Study|Lost to Follow-up|1|||
127508746|NCT02374814|458822390|FG002|Overall Study|Lost to Follow-up|0|||
127508747|NCT02374814|458822391|FG003|Overall Study|Lost to Follow-up|1|||
127508748|NCT02374814|458822392|FG004|Overall Study|Lost to Follow-up|0|||
127508749|NCT02374814|458822393|FG005|Overall Study|Lost to Follow-up|0|||
127508750|NCT02374814|458822388|FG000|Overall Study|Withdrawal by Subject|0|||
127508751|NCT02374814|458822389|FG001|Overall Study|Withdrawal by Subject|0|||
127508752|NCT02374814|458822390|FG002|Overall Study|Withdrawal by Subject|1|||
127508753|NCT02374814|458822391|FG003|Overall Study|Withdrawal by Subject|1|||
127508754|NCT02374814|458822392|FG004|Overall Study|Withdrawal by Subject|0|||
127508755|NCT02374814|458822393|FG005|Overall Study|Withdrawal by Subject|0|||
127508756|NCT04209114|458822396|FG000|Pre-Treatment Phase|Completed without radical cystectomy|0|||
127508757|NCT04209114|458822397|FG001|Pre-Treatment Phase|Completed without radical cystectomy|0|||
127508758|NCT04209114|458822398|FG002|Pre-Treatment Phase|Completed without radical cystectomy|5|||
127508759|NCT04209114|458822396|FG000|Pre-Treatment Phase|Other reasons|0|||
127508760|NCT04209114|458822397|FG001|Pre-Treatment Phase|Other reasons|0|||
127508761|NCT04209114|458822398|FG002|Pre-Treatment Phase|Other reasons|1|||
127508762|NCT04209114|458822396|FG000|Pre-Treatment Phase|Death|0|||
127508763|NCT04209114|458822397|FG001|Pre-Treatment Phase|Death|0|||
127508764|NCT04209114|458822398|FG002|Pre-Treatment Phase|Death|1|||
127508765|NCT04209114|458822396|FG000|Pre-Treatment Phase|Participant withdrew consent|0|||
127508766|NCT04209114|458822397|FG001|Pre-Treatment Phase|Participant withdrew consent|0|||
127508767|NCT04209114|458822398|FG002|Pre-Treatment Phase|Participant withdrew consent|1|||
127508768|NCT04209114|458822396|FG000|Treatment Phase|Other reasons|5|||
127508769|NCT04209114|458822397|FG001|Treatment Phase|Other reasons|3|||
127508770|NCT04209114|458822398|FG002|Treatment Phase|Other reasons|0|||
127508771|NCT04209114|458822396|FG000|Treatment Phase|Lost to Follow-up|1|||
127508772|NCT04209114|458822397|FG001|Treatment Phase|Lost to Follow-up|0|||
127508773|NCT04209114|458822398|FG002|Treatment Phase|Lost to Follow-up|0|||
127508774|NCT04209114|458822396|FG000|Treatment Phase|Participant withdrew consent|1|||
127508775|NCT04209114|458822397|FG001|Treatment Phase|Participant withdrew consent|0|||
127508776|NCT04209114|458822398|FG002|Treatment Phase|Participant withdrew consent|0|||
127508777|NCT04209114|458822396|FG000|Treatment Phase|Adverse event unrelated to study drug|1|||
127508778|NCT04209114|458822397|FG001|Treatment Phase|Adverse event unrelated to study drug|5|||
127508779|NCT04209114|458822398|FG002|Treatment Phase|Adverse event unrelated to study drug|0|||
127508780|NCT04209114|458822396|FG000|Treatment Phase|Death|4|||
127508781|NCT04209114|458822397|FG001|Treatment Phase|Death|1|||
127508782|NCT04209114|458822398|FG002|Treatment Phase|Death|0|||
127508783|NCT04209114|458822396|FG000|Treatment Phase|Study drug toxicity|4|||
127508784|NCT04209114|458822397|FG001|Treatment Phase|Study drug toxicity|6|||
127508785|NCT04209114|458822398|FG002|Treatment Phase|Study drug toxicity|0|||
127508786|NCT04209114|458822396|FG000|Treatment Phase|Disease progression|6|||
127508787|NCT04209114|458822397|FG001|Treatment Phase|Disease progression|9|||
127508788|NCT04209114|458822398|FG002|Treatment Phase|Disease progression|0|||
127508789|NCT00624819|458822401|FG000|Follow-up Period: Year 4|Parents decision|0|||
127508790|NCT00624819|458822402|FG001|Follow-up Period: Year 4|Parents decision|0|||
127508791|NCT00624819|458822403|FG002|Follow-up Period: Year 4|Parents decision|1|||
127508792|NCT00624819|458822404|FG003|Follow-up Period: Year 4|Parents decision|0|||
127508793|NCT00624819|458822401|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
127508794|NCT00624819|458822402|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
127508795|NCT00624819|458822403|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
127508796|NCT00624819|458822404|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
127508797|NCT02826421|458822409|FG000|Overall Study|Adverse Event|1|||
127508798|NCT02826421|458822410|FG001|Overall Study|Adverse Event|0|||
127508799|NCT02826421|458822411|FG002|Overall Study|Adverse Event|0|||
127508800|NCT02826421|458822412|FG003|Overall Study|Adverse Event|1|||
127508801|NCT02826421|458822409|FG000|Overall Study|Withdrawal by Subject|1|||
127508802|NCT02826421|458822410|FG001|Overall Study|Withdrawal by Subject|3|||
127508803|NCT02826421|458822411|FG002|Overall Study|Withdrawal by Subject|1|||
127508804|NCT02826421|458822412|FG003|Overall Study|Withdrawal by Subject|1|||
127508805|NCT02826421|458822409|FG000|Overall Study|Reason not given|1|||
127508806|NCT02826421|458822410|FG001|Overall Study|Reason not given|0|||
127508807|NCT02826421|458822411|FG002|Overall Study|Reason not given|1|||
127508808|NCT02826421|458822412|FG003|Overall Study|Reason not given|0|||
127508809|NCT02210221|458822417|FG000|Overall Study|Lack of Efficacy|7|||
127508810|NCT02210221|458822417|FG000|Overall Study|Withdrawal by Subject|43|||
127508811|NCT02141490|458822418|FG000|Overall Study|Screening failures|4|||
127508812|NCT02141490|458822419|FG001|Overall Study|Screening failures|0|||
127508813|NCT02141490|458822420|FG002|Overall Study|Screening failures|0|||
127508814|NCT00405964|458822421|FG000|Overall Study|Treatment Failure|17|||
127508815|NCT00405964|458822422|FG001|Overall Study|Treatment Failure|45|||
127508816|NCT00405964|458822421|FG000|Overall Study|Adverse Event|7|||
127508817|NCT00405964|458822422|FG001|Overall Study|Adverse Event|16|||
127508818|NCT00405964|458822421|FG000|Overall Study|Lost to Follow-up|5|||
127508819|NCT00405964|458822422|FG001|Overall Study|Lost to Follow-up|5|||
127508820|NCT00405964|458822421|FG000|Overall Study|Withdrawal by Subject|19|||
127508821|NCT00405964|458822422|FG001|Overall Study|Withdrawal by Subject|23|||
127508822|NCT00405964|458822421|FG000|Overall Study|Protocol Violation|11|||
127508823|NCT00405964|458822422|FG001|Overall Study|Protocol Violation|6|||
127868962|NCT05602818|460137446|FG004|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
127868963|NCT05602818|460137447|FG005|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
127868964|NCT05602818|460137448|FG006|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
127868965|NCT05602818|460137449|FG007|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
127868966|NCT05602818|460137450|FG008|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
127868967|NCT05602818|460137451|FG009|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
127868968|NCT05602818|460137452|FG010|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
127868969|NCT05602818|460137453|FG011|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
127868970|NCT05602818|460137442|FG000|Qualification Phase (3 Days)|Withdrawal by Subject|2|||
127868971|NCT05602818|460137443|FG001|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
127868972|NCT05602818|460137444|FG002|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
127868973|NCT05602818|460137445|FG003|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
127868974|NCT05602818|460137446|FG004|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
127868975|NCT05602818|460137447|FG005|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
127868976|NCT05602818|460137448|FG006|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
127868977|NCT05602818|460137449|FG007|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
127868978|NCT05602818|460137450|FG008|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
127868979|NCT05602818|460137451|FG009|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
127868980|NCT05602818|460137452|FG010|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
127868981|NCT05602818|460137453|FG011|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
127978850|NCT05238025|460544209|FG000|Overall Study|Lost to Follow-up|334|||
127978851|NCT05238025|460544210|FG001|Overall Study|Lost to Follow-up|339|||
127978852|NCT05238025|460544209|FG000|Overall Study|Withdrawal by Subject|203|||
127978853|NCT05238025|460544210|FG001|Overall Study|Withdrawal by Subject|222|||
127868982|NCT05602818|460137442|FG000|Qualification Phase (3 Days)|Other|1|||
127868983|NCT05602818|460137443|FG001|Qualification Phase (3 Days)|Other|0|||
127868984|NCT05602818|460137444|FG002|Qualification Phase (3 Days)|Other|0|||
127978854|NCT05238025|460544209|FG000|Overall Study|Physician Decision|20|||
127868985|NCT05602818|460137445|FG003|Qualification Phase (3 Days)|Other|0|||
127868986|NCT05602818|460137446|FG004|Qualification Phase (3 Days)|Other|0|||
127508824|NCT00823212|458825046|FG000|Overall Study|Death|8|||
127508825|NCT00823212|458825047|FG001|Overall Study|Death|10|||
127508826|NCT00823212|458825046|FG000|Overall Study|Withdrawal by Subject|6|||
127508827|NCT00823212|458825047|FG001|Overall Study|Withdrawal by Subject|1|||
127508828|NCT00823212|458825046|FG000|Overall Study|Incarcerated|0|||
127508829|NCT00823212|458825047|FG001|Overall Study|Incarcerated|1|||
127508830|NCT00823212|458825046|FG000|Overall Study|Missed 12-month visit|21|||
127508831|NCT00823212|458825047|FG001|Overall Study|Missed 12-month visit|21|||
127508832|NCT00496197|458825048|FG000|Overall Study|Discontinued study due to death|43|||
127508833|NCT00496197|458825048|FG000|Overall Study|Adverse Event|13|||
127508834|NCT00496197|458825048|FG000|Overall Study|Does not meet entrance criteria|5|||
127508835|NCT00496197|458825048|FG000|Overall Study|Insufficient clinical response|3|||
127508836|NCT00496197|458825048|FG000|Overall Study|Insufficient bacteriological response|10|||
127508837|NCT00496197|458825048|FG000|Overall Study|Lost to Follow-up|11|||
127508838|NCT00496197|458825048|FG000|Overall Study|Withdrawal by Subject|11|||
127508839|NCT00496197|458825048|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
127508840|NCT00496197|458825048|FG000|Overall Study|Other|14|||
127508841|NCT00496197|458825048|FG000|Overall Study|Protocol Violation|8|||
127508842|NCT01344538|458825049|FG000|Overall Study|Adverse Event|1|||
127508843|NCT01344538|458825050|FG001|Overall Study|Adverse Event|1|||
127508844|NCT01344538|458825049|FG000|Overall Study|Lost to Follow-up|1|||
127508845|NCT01344538|458825050|FG001|Overall Study|Lost to Follow-up|0|||
127508846|NCT01655381|458825051|FG000|Overall Study|Investigator Decision|1|||
127508847|NCT01655381|458825051|FG000|Overall Study|Moved to Another City|1|||
127508848|NCT01655381|458825051|FG000|Overall Study|Insufficient Treatment Response|1|||
127508849|NCT02781792|458825059|FG000|Overall Study|Adverse Event|1|||
127508850|NCT02781792|458825060|FG001|Overall Study|Adverse Event|2|||
127508851|NCT02781792|458825059|FG000|Overall Study|Withdrawal by Subject|3|||
127508852|NCT02781792|458825060|FG001|Overall Study|Withdrawal by Subject|1|||
127508853|NCT02781792|458825059|FG000|Overall Study|Lack of Efficacy|1|||
127508854|NCT02781792|458825060|FG001|Overall Study|Lack of Efficacy|1|||
127508855|NCT02781792|458825059|FG000|Overall Study|Hospice|0|||
127508856|NCT02781792|458825060|FG001|Overall Study|Hospice|1|||
127508857|NCT01703117|458825061|FG000|Overall Study|Adverse Event|4|||
127508858|NCT01703117|458825062|FG001|Overall Study|Adverse Event|3|||
127508859|NCT01703117|458825061|FG000|Overall Study|Withdrawal by Subject|0|||
127508860|NCT01703117|458825062|FG001|Overall Study|Withdrawal by Subject|1|||
127508861|NCT00683917|458825064|FG000|Overall Study|Study prematurely terminated|10|||
127508862|NCT01170598|458825068|FG000|Overall Study|Withdrawal by Subject|1|||
127508863|NCT01170598|458825068|FG000|Overall Study|Death|3|||
127508864|NCT01170598|458825068|FG000|Overall Study|Lost to Follow-up|1|||
127508865|NCT01170598|458825068|FG000|Overall Study|Refused|1|||
127508866|NCT02119156|458825069|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
127508867|NCT02119156|458825070|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
127508868|NCT02119156|458825071|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
127508869|NCT02119156|458825069|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
127508870|NCT02119156|458825070|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
127508871|NCT02119156|458825071|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
127508872|NCT02119156|458825069|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
127508873|NCT02119156|458825070|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
127508874|NCT02119156|458825071|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
127508875|NCT02119156|458825069|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
127508876|NCT02119156|458825070|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
127508877|NCT02119156|458825071|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
127508878|NCT02119156|458825069|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
127508879|NCT02119156|458825070|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
127508880|NCT02119156|458825071|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
127508881|NCT02685748|458825072|FG000|Overall Study|Withdrawal by Subject|3|||
127508882|NCT02685748|458825073|FG001|Overall Study|Withdrawal by Subject|2|||
127508883|NCT04126564|458825074|FG000|Overall Study|Withdrawal by Subject|0|||
127508884|NCT04126564|458825075|FG001|Overall Study|Withdrawal by Subject|2|||
127508885|NCT04126564|458825074|FG000|Overall Study|Lost to Follow-up|0|||
127508886|NCT04126564|458825075|FG001|Overall Study|Lost to Follow-up|1|||
127508887|NCT03500172|458825079|FG000|Period 1: Baseline Randomization|Death|0|||
127508888|NCT03500172|458825080|FG001|Period 1: Baseline Randomization|Death|0|||
127508889|NCT03500172|458825081|FG002|Period 1: Baseline Randomization|Death|0|||
127508890|NCT03500172|458825082|FG003|Period 1: Baseline Randomization|Death|0|||
127508891|NCT03500172|458825083|FG004|Period 1: Baseline Randomization|Death|0|||
127508892|NCT03500172|458825084|FG005|Period 1: Baseline Randomization|Death|0|||
127508893|NCT03500172|458825085|FG006|Period 1: Baseline Randomization|Death|0|||
127508894|NCT03500172|458825086|FG007|Period 1: Baseline Randomization|Death|0|||
127508895|NCT03500172|458825087|FG008|Period 1: Baseline Randomization|Death|0|||
127508896|NCT03500172|458825088|FG009|Period 1: Baseline Randomization|Death|2|||
127508897|NCT03500172|458825089|FG010|Period 1: Baseline Randomization|Death|0|||
127508898|NCT03500172|458825079|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
127508899|NCT03500172|458825080|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
127508900|NCT03500172|458825081|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
127508901|NCT03500172|458825082|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
127508902|NCT03500172|458825083|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
127508903|NCT03500172|458825084|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
127508904|NCT03500172|458825085|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
127508905|NCT03500172|458825086|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
127508906|NCT03500172|458825087|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
127508907|NCT03500172|458825088|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
127508908|NCT03500172|458825089|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
127508909|NCT03500172|458825079|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
127508910|NCT03500172|458825080|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
127508911|NCT03500172|458825081|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
127508912|NCT03500172|458825082|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
127508913|NCT03500172|458825083|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
127508914|NCT03500172|458825084|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
127508915|NCT03500172|458825085|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
127508916|NCT03500172|458825086|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
127508917|NCT03500172|458825087|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
127508918|NCT03500172|458825088|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
127508919|NCT03500172|458825089|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
127508920|NCT03500172|458825079|FG000|Period 2: Re-Randomization|Death|0|||
127508921|NCT03500172|458825080|FG001|Period 2: Re-Randomization|Death|0|||
127508922|NCT03500172|458825081|FG002|Period 2: Re-Randomization|Death|0|||
127508923|NCT03500172|458825082|FG003|Period 2: Re-Randomization|Death|4|||
127508924|NCT03500172|458825083|FG004|Period 2: Re-Randomization|Death|2|||
127508925|NCT03500172|458825084|FG005|Period 2: Re-Randomization|Death|0|||
127508926|NCT03500172|458825085|FG006|Period 2: Re-Randomization|Death|5|||
127508927|NCT03500172|458825086|FG007|Period 2: Re-Randomization|Death|2|||
127508928|NCT03500172|458825087|FG008|Period 2: Re-Randomization|Death|0|||
127508929|NCT03500172|458825088|FG009|Period 2: Re-Randomization|Death|0|||
127508930|NCT03500172|458825089|FG010|Period 2: Re-Randomization|Death|0|||
127508931|NCT02536300|458825090|FG000|Overall Study|Investigator's Discretion|17|||
127508932|NCT02536300|458825091|FG001|Overall Study|Investigator's Discretion|11|||
127508933|NCT02536300|458825092|FG002|Overall Study|Investigator's Discretion|2|||
127508934|NCT02536300|458825090|FG000|Overall Study|Progressive Disease|11|||
127508935|NCT02536300|458825091|FG001|Overall Study|Progressive Disease|7|||
127508936|NCT02536300|458825092|FG002|Overall Study|Progressive Disease|6|||
127508937|NCT02536300|458825090|FG000|Overall Study|Study Terminated by Sponsor|6|||
127508938|NCT02536300|458825091|FG001|Overall Study|Study Terminated by Sponsor|4|||
127508939|NCT02536300|458825092|FG002|Overall Study|Study Terminated by Sponsor|7|||
127508940|NCT02536300|458825090|FG000|Overall Study|Death|7|||
127508941|NCT02536300|458825091|FG001|Overall Study|Death|0|||
127508942|NCT02536300|458825092|FG002|Overall Study|Death|5|||
127508943|NCT02536300|458825090|FG000|Overall Study|Withdrew Consent|4|||
127508944|NCT02536300|458825091|FG001|Overall Study|Withdrew Consent|2|||
127508945|NCT02536300|458825092|FG002|Overall Study|Withdrew Consent|0|||
127508946|NCT02536300|458825090|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
127508947|NCT02536300|458825091|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
127508948|NCT02536300|458825092|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
127508949|NCT02536300|458825090|FG000|Overall Study|Enrolled but Never Treated|0|||
127508950|NCT02536300|458825091|FG001|Overall Study|Enrolled but Never Treated|0|||
127508951|NCT02536300|458825092|FG002|Overall Study|Enrolled but Never Treated|1|||
127508952|NCT02536300|458825090|FG000|Overall Study|Non-compliance With Study Drug|1|||
127508953|NCT02536300|458825091|FG001|Overall Study|Non-compliance With Study Drug|0|||
127508954|NCT02536300|458825092|FG002|Overall Study|Non-compliance With Study Drug|0|||
127508955|NCT02536300|458825090|FG000|Overall Study|Protocol Violation|0|||
127508956|NCT02536300|458825091|FG001|Overall Study|Protocol Violation|1|||
127508957|NCT02536300|458825092|FG002|Overall Study|Protocol Violation|0|||
127508958|NCT00445848|458825096|FG000|Overall Study|Adverse Event|14|||
127508959|NCT00445848|458825096|FG000|Overall Study|Withdrawal by Subject|4|||
127508960|NCT00445848|458825096|FG000|Overall Study|Progression|62|||
127508961|NCT00445848|458825096|FG000|Overall Study|Other-Not protocol specified|5|||
127508962|NCT04706273|458825097|FG000|Overall Study|Withdrawal by Subject|27|||
127978855|NCT05238025|460544210|FG001|Overall Study|Physician Decision|8|||
127508963|NCT04706273|458825097|FG000|Overall Study|Physician Decision|1|||
127508964|NCT04706273|458825097|FG000|Overall Study|Lost to Follow-up|42|||
127508965|NCT04706273|458825097|FG000|Overall Study|Death|85|||
127508966|NCT04706273|458825097|FG000|Overall Study|Amputation that removes study device|2|||
127508967|NCT04706273|458825097|FG000|Overall Study|Surgical bypass|3|||
127508968|NCT04706273|458825097|FG000|Overall Study|Changing hospital|23|||
127508969|NCT04706273|458825097|FG000|Overall Study|Unable to attend hospital|2|||
127508970|NCT01080768|458825103|FG000|Overall Study|Protocol Deviation|2|||
127508971|NCT01080768|458825104|FG001|Overall Study|Protocol Deviation|1|||
127508972|NCT01643850|458825109|FG000|Overall Study|Withdrawal by Subject|0|||
127508973|NCT01643850|458825110|FG001|Overall Study|Withdrawal by Subject|0|||
127508974|NCT01643850|458825111|FG002|Overall Study|Withdrawal by Subject|0|||
127508975|NCT01643850|458825112|FG003|Overall Study|Withdrawal by Subject|0|||
127508976|NCT01643850|458825113|FG004|Overall Study|Withdrawal by Subject|1|||
127508977|NCT01643850|458825114|FG005|Overall Study|Withdrawal by Subject|0|||
127508978|NCT01643850|458825115|FG006|Overall Study|Withdrawal by Subject|0|||
127508979|NCT01643850|458825116|FG007|Overall Study|Withdrawal by Subject|0|||
127508980|NCT01643850|458825117|FG008|Overall Study|Withdrawal by Subject|0|||
127508981|NCT01643850|458825109|FG000|Overall Study|Lost to Follow-up|0|||
127508982|NCT01643850|458825110|FG001|Overall Study|Lost to Follow-up|0|||
127508983|NCT01643850|458825111|FG002|Overall Study|Lost to Follow-up|0|||
127508984|NCT01643850|458825112|FG003|Overall Study|Lost to Follow-up|0|||
127508985|NCT01643850|458825113|FG004|Overall Study|Lost to Follow-up|0|||
127508986|NCT01643850|458825114|FG005|Overall Study|Lost to Follow-up|0|||
127508987|NCT01643850|458825115|FG006|Overall Study|Lost to Follow-up|1|||
127508988|NCT01643850|458825116|FG007|Overall Study|Lost to Follow-up|0|||
127508989|NCT01643850|458825117|FG008|Overall Study|Lost to Follow-up|1|||
127508990|NCT01643850|458825109|FG000|Overall Study|Adverse Event|0|||
127508991|NCT01643850|458825110|FG001|Overall Study|Adverse Event|0|||
127508992|NCT01643850|458825111|FG002|Overall Study|Adverse Event|0|||
127508993|NCT01643850|458825112|FG003|Overall Study|Adverse Event|0|||
127508994|NCT01643850|458825113|FG004|Overall Study|Adverse Event|1|||
127508995|NCT01643850|458825114|FG005|Overall Study|Adverse Event|0|||
127508996|NCT01643850|458825115|FG006|Overall Study|Adverse Event|0|||
127508997|NCT01643850|458825116|FG007|Overall Study|Adverse Event|0|||
127508998|NCT01643850|458825117|FG008|Overall Study|Adverse Event|0|||
127508999|NCT01643850|458825109|FG000|Overall Study|Administrative Problems|0|||
127509000|NCT01643850|458825110|FG001|Overall Study|Administrative Problems|0|||
127509001|NCT01643850|458825111|FG002|Overall Study|Administrative Problems|1|||
127509002|NCT01643850|458825112|FG003|Overall Study|Administrative Problems|0|||
127509003|NCT01643850|458825113|FG004|Overall Study|Administrative Problems|1|||
127509004|NCT01643850|458825114|FG005|Overall Study|Administrative Problems|0|||
127509005|NCT01643850|458825115|FG006|Overall Study|Administrative Problems|0|||
127509006|NCT01643850|458825116|FG007|Overall Study|Administrative Problems|0|||
127509007|NCT01643850|458825117|FG008|Overall Study|Administrative Problems|0|||
127509008|NCT03054350|458825120|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
127509009|NCT03054350|458825121|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
127509010|NCT03054350|458825122|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
127509011|NCT03054350|458825123|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
127509012|NCT03054350|458825124|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
127509013|NCT03054350|458825125|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
127509014|NCT03054350|458825120|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
127509015|NCT03054350|458825121|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
127509016|NCT03054350|458825122|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
127509017|NCT03054350|458825123|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
127509018|NCT03054350|458825124|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
127509019|NCT03054350|458825125|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
127509020|NCT03054350|458825120|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
127509021|NCT03054350|458825121|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
127509022|NCT03054350|458825122|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
127509023|NCT03054350|458825123|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
127509024|NCT03054350|458825124|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
127509025|NCT03054350|458825125|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
127509026|NCT03054350|458825120|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
127509027|NCT03054350|458825121|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
127509028|NCT03054350|458825122|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
127509029|NCT03054350|458825123|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
127509030|NCT03054350|458825124|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
127509031|NCT03054350|458825125|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
127509032|NCT00931723|458825126|FG000|Overall Study|Withdrawal by Subject|11|||
127509033|NCT00931723|458825127|FG001|Overall Study|Withdrawal by Subject|13|||
127509034|NCT00931723|458825126|FG000|Overall Study|Adverse Event|6|||
127509035|NCT00931723|458825127|FG001|Overall Study|Adverse Event|13|||
127509036|NCT00931723|458825126|FG000|Overall Study|Lithium found in blood|0|||
127509037|NCT00931723|458825127|FG001|Overall Study|Lithium found in blood|1|||
127509038|NCT00931723|458825126|FG000|Overall Study|Condition under investigation worsened|1|||
127509039|NCT00931723|458825127|FG001|Overall Study|Condition under investigation worsened|2|||
127509040|NCT00931723|458825126|FG000|Overall Study|Lost to Follow-up|1|||
127509041|NCT00931723|458825127|FG001|Overall Study|Lost to Follow-up|2|||
127509042|NCT00931723|458825126|FG000|Overall Study|Study-specific discontinuation criteria|1|||
127509043|NCT00931723|458825127|FG001|Overall Study|Study-specific discontinuation criteria|1|||
127509044|NCT00931723|458825126|FG000|Overall Study|Severe non-compliance to protocol|2|||
127509045|NCT00931723|458825127|FG001|Overall Study|Severe non-compliance to protocol|0|||
127509046|NCT00931723|458825126|FG000|Overall Study|Safety reasons|0|||
127509047|NCT00931723|458825127|FG001|Overall Study|Safety reasons|1|||
127509048|NCT00931723|458825126|FG000|Overall Study|Took prohibited concomitant medication|0|||
127509049|NCT00931723|458825127|FG001|Overall Study|Took prohibited concomitant medication|1|||
127509050|NCT00931723|458825126|FG000|Overall Study|Lack or insufficient theraputic response|2|||
127509051|NCT00931723|458825127|FG001|Overall Study|Lack or insufficient theraputic response|5|||
127509052|NCT00931723|458825126|FG000|Overall Study|Sponsor decision|1|||
127509053|NCT00931723|458825127|FG001|Overall Study|Sponsor decision|0|||
127509054|NCT00931723|458825126|FG000|Overall Study|Late hospital discharge|1|||
127509055|NCT00931723|458825127|FG001|Overall Study|Late hospital discharge|0|||
127509056|NCT01133405|458825129|FG000|Period 1|Withdrawal by Subject|0|||
127509057|NCT01133405|458825130|FG001|Period 1|Withdrawal by Subject|1|||
127509058|NCT01133405|458825131|FG002|Period 1|Withdrawal by Subject|0|||
127509059|NCT01133405|458825132|FG003|Period 1|Withdrawal by Subject|1|||
127509060|NCT01133405|458825133|FG004|Period 1|Withdrawal by Subject|0|||
127509061|NCT01133405|458825134|FG005|Period 1|Withdrawal by Subject|1|||
127509062|NCT01133405|458825135|FG006|Period 1|Withdrawal by Subject|0|||
127509063|NCT01133405|458825136|FG007|Period 1|Withdrawal by Subject|0|||
127509064|NCT01133405|458825137|FG008|Period 1|Withdrawal by Subject|0|||
127509065|NCT01133405|458825138|FG009|Period 1|Withdrawal by Subject|0|||
127509066|NCT01133405|458825129|FG000|Period 1|Physician Decision|0|||
127509067|NCT01133405|458825130|FG001|Period 1|Physician Decision|0|||
127509068|NCT01133405|458825131|FG002|Period 1|Physician Decision|0|||
127509069|NCT01133405|458825132|FG003|Period 1|Physician Decision|1|||
127509070|NCT01133405|458825133|FG004|Period 1|Physician Decision|0|||
127509071|NCT01133405|458825134|FG005|Period 1|Physician Decision|0|||
127509072|NCT01133405|458825135|FG006|Period 1|Physician Decision|0|||
127509073|NCT01133405|458825136|FG007|Period 1|Physician Decision|0|||
127509074|NCT01133405|458825137|FG008|Period 1|Physician Decision|0|||
127509075|NCT01133405|458825138|FG009|Period 1|Physician Decision|0|||
127509076|NCT01133405|458825129|FG000|Period 1|Discontinued after randomization|1|||
127509077|NCT01133405|458825130|FG001|Period 1|Discontinued after randomization|0|||
127509078|NCT01133405|458825131|FG002|Period 1|Discontinued after randomization|0|||
127509079|NCT01133405|458825132|FG003|Period 1|Discontinued after randomization|0|||
127509080|NCT01133405|458825133|FG004|Period 1|Discontinued after randomization|0|||
127509081|NCT01133405|458825134|FG005|Period 1|Discontinued after randomization|0|||
127509082|NCT01133405|458825135|FG006|Period 1|Discontinued after randomization|1|||
127509083|NCT01133405|458825136|FG007|Period 1|Discontinued after randomization|0|||
127509084|NCT01133405|458825137|FG008|Period 1|Discontinued after randomization|0|||
127509085|NCT01133405|458825138|FG009|Period 1|Discontinued after randomization|0|||
127509086|NCT01133405|458825129|FG000|Period 1|Received drug only in period 2|0|||
127509087|NCT01133405|458825130|FG001|Period 1|Received drug only in period 2|1|||
127509088|NCT01133405|458825131|FG002|Period 1|Received drug only in period 2|0|||
127509089|NCT01133405|458825132|FG003|Period 1|Received drug only in period 2|2|||
127509090|NCT01133405|458825133|FG004|Period 1|Received drug only in period 2|0|||
127509091|NCT01133405|458825134|FG005|Period 1|Received drug only in period 2|1|||
127509092|NCT01133405|458825135|FG006|Period 1|Received drug only in period 2|0|||
127509093|NCT01133405|458825136|FG007|Period 1|Received drug only in period 2|0|||
127509094|NCT01133405|458825137|FG008|Period 1|Received drug only in period 2|0|||
127509095|NCT01133405|458825138|FG009|Period 1|Received drug only in period 2|0|||
127509096|NCT01133405|458825129|FG000|Period 1|Received drug only in period 3|0|||
127509097|NCT01133405|458825130|FG001|Period 1|Received drug only in period 3|1|||
127978856|NCT05238025|460544209|FG000|Overall Study|Protocol Violation|6|||
127978857|NCT05238025|460544210|FG001|Overall Study|Protocol Violation|2|||
127978858|NCT05238025|460544209|FG000|Overall Study|Death|38|||
127978859|NCT05238025|460544210|FG001|Overall Study|Death|32|||
127978860|NCT05238025|460544209|FG000|Overall Study|Study terminated by Sponsor|6358|||
127978861|NCT05238025|460544210|FG001|Overall Study|Study terminated by Sponsor|6358|||
127509098|NCT01133405|458825131|FG002|Period 1|Received drug only in period 3|1|||
127509099|NCT01133405|458825132|FG003|Period 1|Received drug only in period 3|0|||
127509100|NCT01133405|458825133|FG004|Period 1|Received drug only in period 3|0|||
127509101|NCT01133405|458825134|FG005|Period 1|Received drug only in period 3|0|||
127509102|NCT01133405|458825135|FG006|Period 1|Received drug only in period 3|0|||
127509103|NCT01133405|458825136|FG007|Period 1|Received drug only in period 3|0|||
127509104|NCT01133405|458825137|FG008|Period 1|Received drug only in period 3|0|||
127509105|NCT01133405|458825138|FG009|Period 1|Received drug only in period 3|0|||
127509106|NCT01133405|458825129|FG000|Period 2|Adverse Event|0|||
127509107|NCT01133405|458825130|FG001|Period 2|Adverse Event|0|||
127509108|NCT01133405|458825131|FG002|Period 2|Adverse Event|1|||
127509109|NCT01133405|458825132|FG003|Period 2|Adverse Event|0|||
127509110|NCT01133405|458825133|FG004|Period 2|Adverse Event|0|||
127509111|NCT01133405|458825134|FG005|Period 2|Adverse Event|0|||
127509112|NCT01133405|458825135|FG006|Period 2|Adverse Event|0|||
127509113|NCT01133405|458825136|FG007|Period 2|Adverse Event|0|||
127509114|NCT01133405|458825137|FG008|Period 2|Adverse Event|0|||
127509115|NCT01133405|458825138|FG009|Period 2|Adverse Event|0|||
127509116|NCT01133405|458825129|FG000|Period 2|Withdrawal by Subject|0|||
127509117|NCT01133405|458825130|FG001|Period 2|Withdrawal by Subject|0|||
127509118|NCT01133405|458825131|FG002|Period 2|Withdrawal by Subject|0|||
127978862|NCT05238025|460544209|FG000|Overall Study|Other Reason|669|||
127978863|NCT05238025|460544210|FG001|Overall Study|Other Reason|690|||
127978864|NCT03814720|460544212|FG000|Overall Study|Lost to Follow-up|0|||
127978865|NCT03814720|460544213|FG001|Overall Study|Lost to Follow-up|1|||
127978866|NCT03814720|460544214|FG002|Overall Study|Lost to Follow-up|0|||
127978867|NCT03814720|460544215|FG003|Overall Study|Lost to Follow-up|0|||
127978868|NCT03814720|460544216|FG004|Overall Study|Lost to Follow-up|0|||
127978869|NCT03197324|460544217|FG000|Overall Study|Adverse Event|0|||
127978870|NCT03197324|460544218|FG001|Overall Study|Adverse Event|1|||
127978871|NCT00877071|460544219|FG000|Overall Study|disease progression|2|||
127978872|NCT01984892|460544220|FG000|Overall Study|Progressive disease|7|||
127978873|NCT05723328|460544222|FG000|Overall Study|Investigator's Decision|5|||
127978874|NCT05723328|460544223|FG001|Overall Study|Investigator's Decision|2|||
127978875|NCT04161079|460545615|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
127978876|NCT00623597|460545616|FG000|Overall Study|Failed to return|1|||
127978877|NCT00623597|460545617|FG001|Overall Study|Failed to return|0|||
127978878|NCT02515994|460545618|FG000|Overall Study|Protocol Violation|3|||
127978879|NCT02515994|460545619|FG001|Overall Study|Protocol Violation|5|||
127978880|NCT02515994|460545618|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
127978881|NCT02515994|460545619|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
127978882|NCT02515994|460545618|FG000|Overall Study|Adverse Event|3|||
127978883|NCT02515994|460545619|FG001|Overall Study|Adverse Event|1|||
127978884|NCT02515994|460545618|FG000|Overall Study|Withdrawal by Subject|2|||
127978885|NCT02515994|460545619|FG001|Overall Study|Withdrawal by Subject|0|||
127978886|NCT02339155|460545625|FG000|Overall Study|Adverse Event|0|||
127978887|NCT02339155|460545626|FG001|Overall Study|Adverse Event|6|||
127978888|NCT02339155|460545625|FG000|Overall Study|Death|1|||
127978889|NCT02339155|460545626|FG001|Overall Study|Death|1|||
127978890|NCT02339155|460545625|FG000|Overall Study|Lost to Follow-up|8|||
127978891|NCT02339155|460545626|FG001|Overall Study|Lost to Follow-up|9|||
127978892|NCT02339155|460545625|FG000|Overall Study|Physician Decision|2|||
127978893|NCT02339155|460545626|FG001|Overall Study|Physician Decision|1|||
127978894|NCT02339155|460545625|FG000|Overall Study|Withdrawal by Subject|4|||
127978895|NCT02339155|460545626|FG001|Overall Study|Withdrawal by Subject|4|||
127978896|NCT01214252|460545629|FG000|Overall Study|Not eligible per protocol|82|||
127978897|NCT04327661|460545633|FG000|Overall Study|Withdrawal by Subject|1|||
127978898|NCT04327661|460545634|FG001|Overall Study|Withdrawal by Subject|0|||
127978899|NCT04327661|460545635|FG002|Overall Study|Withdrawal by Subject|0|||
127978900|NCT02659514|460545636|FG000|Overall Study|Adverse Event|3|||
127978901|NCT02659514|460545637|FG001|Overall Study|Adverse Event|12|||
127978902|NCT02659514|460545636|FG000|Overall Study|Disease Progression|23|||
127978903|NCT02659514|460545637|FG001|Overall Study|Disease Progression|13|||
127978904|NCT02659514|460545636|FG000|Overall Study|Withdrawal by Subject|0|||
127978905|NCT02659514|460545637|FG001|Overall Study|Withdrawal by Subject|4|||
127978906|NCT02659514|460545636|FG000|Overall Study|Lost to Follow-up|0|||
127978907|NCT02659514|460545637|FG001|Overall Study|Lost to Follow-up|1|||
127978908|NCT02659514|460545636|FG000|Overall Study|Death|6|||
127978909|NCT02659514|460545637|FG001|Overall Study|Death|1|||
127978910|NCT02659514|460545636|FG000|Overall Study|Reason Unspecified|0|||
127978911|NCT02659514|460545637|FG001|Overall Study|Reason Unspecified|3|||
127978912|NCT00108485|460545642|FG000|Overall Study|Withdrawal by Subject|3|||
127978913|NCT00108485|460545643|FG001|Overall Study|Withdrawal by Subject|0|||
127978914|NCT00108485|460545642|FG000|Overall Study|Lost to Follow-up|0|||
127978915|NCT00108485|460545643|FG001|Overall Study|Lost to Follow-up|2|||
127978916|NCT01701193|460545644|FG000|Overall Study|Withdrawal by Subject|2|||
127978917|NCT01701193|460545645|FG001|Overall Study|Withdrawal by Subject|2|||
127978918|NCT01701193|460545646|FG002|Overall Study|Withdrawal by Subject|1|||
127978919|NCT01701193|460545647|FG003|Overall Study|Withdrawal by Subject|2|||
127978920|NCT01701193|460545644|FG000|Overall Study|Adverse Event|1|||
127978921|NCT01701193|460545645|FG001|Overall Study|Adverse Event|0|||
127978922|NCT01701193|460545646|FG002|Overall Study|Adverse Event|0|||
127978923|NCT01701193|460545647|FG003|Overall Study|Adverse Event|0|||
127978924|NCT02062944|460545648|FG000|Overall Study|Lost to Follow-up|1|||
127978925|NCT02062944|460545648|FG000|Overall Study|New hemotological disorder identified|1|||
127978926|NCT02062944|460545648|FG000|Overall Study|Uncontrolled Hypertension|1|||
127978927|NCT02062944|460545648|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
127978928|NCT00278148|460545649|FG000|Phase II - Expansion Phase|Disease progression|0|||
127978929|NCT00278148|460545650|FG001|Phase II - Expansion Phase|Disease progression|0|||
127509119|NCT01133405|458825132|FG003|Period 2|Withdrawal by Subject|1|||
127978930|NCT00278148|460545651|FG002|Phase II - Expansion Phase|Disease progression|4|||
127978931|NCT00278148|460545649|FG000|Phase II - Expansion Phase|Adverse Event|0|||
127509120|NCT01133405|458825133|FG004|Period 2|Withdrawal by Subject|0|||
127509121|NCT01133405|458825134|FG005|Period 2|Withdrawal by Subject|1|||
127509122|NCT01133405|458825135|FG006|Period 2|Withdrawal by Subject|0|||
127509123|NCT01133405|458825136|FG007|Period 2|Withdrawal by Subject|0|||
127509124|NCT01133405|458825137|FG008|Period 2|Withdrawal by Subject|0|||
127509125|NCT01133405|458825138|FG009|Period 2|Withdrawal by Subject|0|||
127509126|NCT01133405|458825129|FG000|Period 2|Entry Criteria Not Met|0|||
127509127|NCT01133405|458825130|FG001|Period 2|Entry Criteria Not Met|1|||
127509128|NCT01133405|458825131|FG002|Period 2|Entry Criteria Not Met|0|||
127509129|NCT01133405|458825132|FG003|Period 2|Entry Criteria Not Met|0|||
127509130|NCT01133405|458825133|FG004|Period 2|Entry Criteria Not Met|0|||
127509131|NCT01133405|458825134|FG005|Period 2|Entry Criteria Not Met|0|||
127509132|NCT01133405|458825135|FG006|Period 2|Entry Criteria Not Met|0|||
127509133|NCT01133405|458825136|FG007|Period 2|Entry Criteria Not Met|0|||
127509134|NCT01133405|458825137|FG008|Period 2|Entry Criteria Not Met|0|||
127509135|NCT01133405|458825138|FG009|Period 2|Entry Criteria Not Met|0|||
127509136|NCT01133405|458825129|FG000|Period 2|Physician Decision|0|||
127509137|NCT01133405|458825130|FG001|Period 2|Physician Decision|0|||
127509138|NCT01133405|458825131|FG002|Period 2|Physician Decision|0|||
127509139|NCT01133405|458825132|FG003|Period 2|Physician Decision|0|||
127509140|NCT01133405|458825133|FG004|Period 2|Physician Decision|0|||
127509141|NCT01133405|458825134|FG005|Period 2|Physician Decision|1|||
127509142|NCT01133405|458825135|FG006|Period 2|Physician Decision|0|||
127509143|NCT01133405|458825136|FG007|Period 2|Physician Decision|0|||
127509144|NCT01133405|458825137|FG008|Period 2|Physician Decision|0|||
127509145|NCT01133405|458825138|FG009|Period 2|Physician Decision|0|||
127509146|NCT01238835|458825139|FG000|Overall Study|Death|124|||
127509147|NCT01238835|458825139|FG000|Overall Study|Withdrawal by Subject|9|||
127509148|NCT01238835|458825139|FG000|Overall Study|Lost to Follow-up|1|||
127509149|NCT01238835|458825139|FG000|Overall Study|Site early discontinuation|2|||
127509150|NCT00907803|458825140|FG000|Overall Study|Withdrawal of consent - long commute|1|||
127509151|NCT00907803|458825141|FG001|Overall Study|Withdrawal of consent - long commute|0|||
127509152|NCT00907803|458825142|FG002|Overall Study|Withdrawal of consent - long commute|0|||
127509153|NCT00907803|458825140|FG000|Overall Study|Adverse Event|2|||
127509154|NCT00907803|458825141|FG001|Overall Study|Adverse Event|0|||
127509155|NCT00907803|458825142|FG002|Overall Study|Adverse Event|0|||
127509156|NCT00907803|458825140|FG000|Overall Study|Withdrawal by Subject|0|||
127509157|NCT00907803|458825141|FG001|Overall Study|Withdrawal by Subject|1|||
127509158|NCT00907803|458825142|FG002|Overall Study|Withdrawal by Subject|0|||
127509159|NCT00907803|458825140|FG000|Overall Study|Lost to Follow-up|0|||
127509160|NCT00907803|458825141|FG001|Overall Study|Lost to Follow-up|1|||
127509161|NCT00907803|458825142|FG002|Overall Study|Lost to Follow-up|0|||
127509162|NCT00907803|458825140|FG000|Overall Study|Protocol Violation|0|||
127509163|NCT00907803|458825141|FG001|Overall Study|Protocol Violation|1|||
127509164|NCT00907803|458825142|FG002|Overall Study|Protocol Violation|0|||
127509165|NCT03510468|458825143|FG000|Overall Study|Lost to Follow-up|1|||
127509166|NCT03510468|458825143|FG000|Overall Study|Adverse Event|5|||
127509167|NCT03510468|458825143|FG000|Overall Study|Physician Decision|1|||
127509168|NCT03510468|458825143|FG000|Overall Study|non-compliant with treatment|2|||
127509169|NCT03510468|458825143|FG000|Overall Study|Missed visit|1|||
127509170|NCT04612842|458825144|FG000|Overall Study|Lost to Follow-up|20|||
127509171|NCT04612842|458825145|FG001|Overall Study|Lost to Follow-up|11|||
127509172|NCT04612842|458825144|FG000|Overall Study|Withdrawal by Subject|26|||
127509173|NCT04612842|458825145|FG001|Overall Study|Withdrawal by Subject|15|||
127509174|NCT04612842|458825144|FG000|Overall Study|Death|2|||
127509175|NCT04612842|458825145|FG001|Overall Study|Death|2|||
127509176|NCT02419131|458825146|FG000|Consent and Randomization|Did not receive treatment after randomization|10|||
127509177|NCT02419131|458825147|FG001|Consent and Randomization|Did not receive treatment after randomization|16|||
127509178|NCT02419131|458825148|FG002|Consent and Randomization|Did not receive treatment after randomization|7|||
127509179|NCT02419131|458825146|FG000|Randomization and Treatment|Withdrawn or lost to follow-up|22|||
127509180|NCT02419131|458825147|FG001|Randomization and Treatment|Withdrawn or lost to follow-up|25|||
127509181|NCT02419131|458825148|FG002|Randomization and Treatment|Withdrawn or lost to follow-up|9|||
127509182|NCT05426031|458825149|FG000|Overall Study|Circulatory Arrest|3|||
127509183|NCT05426031|458825150|FG001|Overall Study|Circulatory Arrest|2|||
127509184|NCT04677660|458825151|FG000|Overall Study|Lost to Follow-up|0|||
127509185|NCT04677660|458825152|FG001|Overall Study|Lost to Follow-up|2|||
127978932|NCT00278148|460545650|FG001|Phase II - Expansion Phase|Adverse Event|0|||
127509186|NCT04677660|458825151|FG000|Overall Study|Withdrawal by Subject|0|||
127509187|NCT04677660|458825152|FG001|Overall Study|Withdrawal by Subject|1|||
127509188|NCT04677660|458825151|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
127509189|NCT04677660|458825152|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
127509190|NCT00089986|458825153|FG000|Overall Study|Adverse Event|6|||
127509191|NCT00089986|458825154|FG001|Overall Study|Adverse Event|9|||
127509192|NCT00089986|458825155|FG002|Overall Study|Adverse Event|6|||
127509193|NCT00089986|458825153|FG000|Overall Study|Lost to Follow-up|3|||
127509194|NCT00089986|458825154|FG001|Overall Study|Lost to Follow-up|1|||
127509195|NCT00089986|458825155|FG002|Overall Study|Lost to Follow-up|1|||
127509196|NCT00089986|458825153|FG000|Overall Study|Protocol Violation|0|||
127509197|NCT00089986|458825154|FG001|Overall Study|Protocol Violation|1|||
127509198|NCT00089986|458825155|FG002|Overall Study|Protocol Violation|0|||
127509199|NCT00089986|458825153|FG000|Overall Study|Patient transferred to another hospital|2|||
127509200|NCT00089986|458825154|FG001|Overall Study|Patient transferred to another hospital|1|||
127509201|NCT00089986|458825155|FG002|Overall Study|Patient transferred to another hospital|0|||
127509202|NCT00089986|458825153|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
127509203|NCT00089986|458825154|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
127509204|NCT00089986|458825155|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
127509205|NCT00089986|458825153|FG000|Overall Study|Hemohlobin stopping rule|0|||
127509206|NCT00089986|458825154|FG001|Overall Study|Hemohlobin stopping rule|1|||
127509207|NCT00089986|458825155|FG002|Overall Study|Hemohlobin stopping rule|0|||
127509208|NCT00089986|458825153|FG000|Overall Study|Investigator decision to withdrew|0|||
127509209|NCT00089986|458825154|FG001|Overall Study|Investigator decision to withdrew|1|||
127509210|NCT00089986|458825155|FG002|Overall Study|Investigator decision to withdrew|0|||
127509211|NCT00089986|458825153|FG000|Overall Study|Enrollment in another study|0|||
127509212|NCT00089986|458825154|FG001|Overall Study|Enrollment in another study|1|||
127509213|NCT00089986|458825155|FG002|Overall Study|Enrollment in another study|0|||
127509214|NCT00089986|458825153|FG000|Overall Study|Family decision|0|||
127509215|NCT00089986|458825154|FG001|Overall Study|Family decision|1|||
127509216|NCT00089986|458825155|FG002|Overall Study|Family decision|0|||
127509217|NCT00089986|458825153|FG000|Overall Study|Do not resuscitate (DNR)|0|||
127509218|NCT00089986|458825154|FG001|Overall Study|Do not resuscitate (DNR)|0|||
127509219|NCT00089986|458825155|FG002|Overall Study|Do not resuscitate (DNR)|1|||
127509220|NCT00089986|458825153|FG000|Overall Study|Withdrawal by Subject|3|||
127509221|NCT00089986|458825154|FG001|Overall Study|Withdrawal by Subject|6|||
127509222|NCT00089986|458825155|FG002|Overall Study|Withdrawal by Subject|2|||
127509223|NCT02334683|458825162|FG000|First 12 Week Period|Lost to Follow-up|1|||
127509224|NCT02334683|458825163|FG001|First 12 Week Period|Lost to Follow-up|0|||
127509225|NCT02334683|458825162|FG000|Second 12 Week Period|Adverse Event|0|||
127509226|NCT02334683|458825163|FG001|Second 12 Week Period|Adverse Event|1|||
127509227|NCT01218100|458825164|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
127509228|NCT01218100|458825165|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
127509229|NCT01218100|458825166|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
127509230|NCT01218100|458825167|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
127509231|NCT01218100|458825164|FG000|Overall Study|Adverse Event|4|||
127509232|NCT01218100|458825165|FG001|Overall Study|Adverse Event|6|||
127509233|NCT01218100|458825166|FG002|Overall Study|Adverse Event|6|||
127509234|NCT01218100|458825167|FG003|Overall Study|Adverse Event|7|||
127509235|NCT01218100|458825164|FG000|Overall Study|Lack of Efficacy|9|||
127509236|NCT01218100|458825165|FG001|Overall Study|Lack of Efficacy|6|||
127509237|NCT01218100|458825166|FG002|Overall Study|Lack of Efficacy|5|||
127509238|NCT01218100|458825167|FG003|Overall Study|Lack of Efficacy|12|||
127509239|NCT01218100|458825164|FG000|Overall Study|Protocol Violation|0|||
127509240|NCT01218100|458825165|FG001|Overall Study|Protocol Violation|0|||
127509241|NCT01218100|458825166|FG002|Overall Study|Protocol Violation|1|||
127509242|NCT01218100|458825167|FG003|Overall Study|Protocol Violation|1|||
127509243|NCT01218100|458825164|FG000|Overall Study|Withdrawal by Subject|5|||
127509244|NCT01218100|458825165|FG001|Overall Study|Withdrawal by Subject|2|||
127509245|NCT01218100|458825166|FG002|Overall Study|Withdrawal by Subject|6|||
127509246|NCT01218100|458825167|FG003|Overall Study|Withdrawal by Subject|7|||
127509247|NCT01218100|458825164|FG000|Overall Study|Lost to Follow-up|3|||
127509248|NCT01218100|458825165|FG001|Overall Study|Lost to Follow-up|8|||
127509249|NCT01218100|458825166|FG002|Overall Study|Lost to Follow-up|2|||
127509250|NCT01218100|458825167|FG003|Overall Study|Lost to Follow-up|1|||
127509251|NCT01218100|458825164|FG000|Overall Study|Other Reason|2|||
127509252|NCT01218100|458825165|FG001|Overall Study|Other Reason|2|||
127509253|NCT01218100|458825166|FG002|Overall Study|Other Reason|6|||
127509254|NCT01218100|458825167|FG003|Overall Study|Other Reason|4|||
127978933|NCT00278148|460545651|FG002|Phase II - Expansion Phase|Adverse Event|2|||
127978934|NCT01088243|460545653|FG000|Overall Study|Adverse Event|1|||
127509255|NCT02434354|458825174|FG000|Overall Study|screen fail|3|||
127509256|NCT01185964|458825178|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
127509257|NCT01185964|458825179|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
127509258|NCT01185964|458825180|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
127509259|NCT01185964|458825181|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
127509260|NCT01185964|458825178|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
127509261|NCT01185964|458825179|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
127509262|NCT01185964|458825180|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
127509263|NCT01185964|458825181|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
127509264|NCT01185964|458825178|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
127509265|NCT01185964|458825179|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
127509266|NCT01185964|458825180|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
127509267|NCT01185964|458825181|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
127509268|NCT01185964|458825178|FG000|Phase 1b and Phase 2|Adverse Event|1|||
127509269|NCT01185964|458825179|FG001|Phase 1b and Phase 2|Adverse Event|0|||
127509270|NCT01185964|458825180|FG002|Phase 1b and Phase 2|Adverse Event|2|||
127509271|NCT01185964|458825181|FG003|Phase 1b and Phase 2|Adverse Event|0|||
127509272|NCT01185964|458825178|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
127509273|NCT01185964|458825179|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
127509274|NCT01185964|458825180|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
127509275|NCT01185964|458825181|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
127509276|NCT01185964|458825178|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
127509277|NCT01185964|458825179|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
127509278|NCT01185964|458825180|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
127509279|NCT01185964|458825181|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
127509280|NCT01185964|458825178|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
127509281|NCT01185964|458825179|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
127509282|NCT01185964|458825180|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
127509283|NCT01185964|458825181|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
127509284|NCT01185964|458825178|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
127509285|NCT01185964|458825179|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
127509286|NCT01185964|458825180|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
127509287|NCT01185964|458825181|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
127509288|NCT01920893|458825182|FG000|Overall Study|Adverse Event|5|||
127509289|NCT01920893|458825183|FG001|Overall Study|Adverse Event|2|||
127509290|NCT01920893|458825182|FG000|Overall Study|Lack of Efficacy|2|||
127509291|NCT01920893|458825183|FG001|Overall Study|Lack of Efficacy|0|||
127509292|NCT03440918|458825187|FG000|Overall Study|Protocol Violation|0|||
127509293|NCT03440918|458825188|FG001|Overall Study|Protocol Violation|16|||
127509294|NCT01396265|458825200|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
127509295|NCT01598753|458825203|FG000|Overall Study|Adverse Event|1|||
127509296|NCT01598753|458825204|FG001|Overall Study|Adverse Event|9|||
127509297|NCT01598753|458825205|FG002|Overall Study|Adverse Event|1|||
127509298|NCT01598753|458825206|FG003|Overall Study|Adverse Event|7|||
127509299|NCT01598753|458825203|FG000|Overall Study|Lost to Follow-up|4|||
127509300|NCT01598753|458825204|FG001|Overall Study|Lost to Follow-up|3|||
127509301|NCT01598753|458825205|FG002|Overall Study|Lost to Follow-up|7|||
127509302|NCT01598753|458825206|FG003|Overall Study|Lost to Follow-up|5|||
127509303|NCT01598753|458825203|FG000|Overall Study|Physician Decision|0|||
127509304|NCT01598753|458825204|FG001|Overall Study|Physician Decision|1|||
127509305|NCT01598753|458825205|FG002|Overall Study|Physician Decision|0|||
127509306|NCT01598753|458825206|FG003|Overall Study|Physician Decision|2|||
127509307|NCT01598753|458825203|FG000|Overall Study|Withdrawal by Subject|7|||
127509308|NCT01598753|458825204|FG001|Overall Study|Withdrawal by Subject|2|||
127509309|NCT01598753|458825205|FG002|Overall Study|Withdrawal by Subject|0|||
127509310|NCT01598753|458825206|FG003|Overall Study|Withdrawal by Subject|1|||
127509311|NCT02275117|458825207|FG000|Overall Study|Adverse Event|0|||
127509312|NCT02275117|458825208|FG001|Overall Study|Adverse Event|0|||
127509313|NCT02275117|458825209|FG002|Overall Study|Adverse Event|0|||
127509314|NCT02275117|458825210|FG003|Overall Study|Adverse Event|0|||
127509315|NCT02275117|458825211|FG004|Overall Study|Adverse Event|1|||
127509316|NCT02275117|458825207|FG000|Overall Study|Lack of Efficacy|6|||
127509317|NCT02275117|458825208|FG001|Overall Study|Lack of Efficacy|7|||
127509318|NCT02275117|458825209|FG002|Overall Study|Lack of Efficacy|5|||
127509319|NCT02275117|458825210|FG003|Overall Study|Lack of Efficacy|2|||
127509320|NCT02275117|458825211|FG004|Overall Study|Lack of Efficacy|10|||
127509321|NCT02275117|458825207|FG000|Overall Study|Lost to Follow-up|11|||
127509322|NCT02275117|458825208|FG001|Overall Study|Lost to Follow-up|16|||
127509323|NCT02275117|458825209|FG002|Overall Study|Lost to Follow-up|15|||
127509324|NCT02275117|458825210|FG003|Overall Study|Lost to Follow-up|16|||
127509325|NCT02275117|458825211|FG004|Overall Study|Lost to Follow-up|8|||
127509326|NCT02275117|458825207|FG000|Overall Study|Physician Decision|0|||
127509327|NCT02275117|458825208|FG001|Overall Study|Physician Decision|1|||
127509328|NCT02275117|458825209|FG002|Overall Study|Physician Decision|1|||
127509329|NCT02275117|458825210|FG003|Overall Study|Physician Decision|0|||
127509330|NCT02275117|458825211|FG004|Overall Study|Physician Decision|1|||
127509331|NCT02275117|458825207|FG000|Overall Study|Protocol Violation|1|||
127509332|NCT02275117|458825208|FG001|Overall Study|Protocol Violation|0|||
127509333|NCT02275117|458825209|FG002|Overall Study|Protocol Violation|1|||
127509334|NCT02275117|458825210|FG003|Overall Study|Protocol Violation|1|||
127509335|NCT02275117|458825211|FG004|Overall Study|Protocol Violation|0|||
127509336|NCT02275117|458825207|FG000|Overall Study|Withdrawal by Subject|6|||
127509337|NCT02275117|458825208|FG001|Overall Study|Withdrawal by Subject|4|||
127509338|NCT02275117|458825209|FG002|Overall Study|Withdrawal by Subject|7|||
127509339|NCT02275117|458825210|FG003|Overall Study|Withdrawal by Subject|3|||
127509340|NCT02275117|458825211|FG004|Overall Study|Withdrawal by Subject|3|||
127509341|NCT02275117|458825207|FG000|Overall Study|Terminated by Sponsor|4|||
127509342|NCT02275117|458825208|FG001|Overall Study|Terminated by Sponsor|4|||
127509343|NCT02275117|458825209|FG002|Overall Study|Terminated by Sponsor|4|||
127509344|NCT02275117|458825210|FG003|Overall Study|Terminated by Sponsor|6|||
127509345|NCT02275117|458825211|FG004|Overall Study|Terminated by Sponsor|4|||
127509346|NCT02275117|458825207|FG000|Overall Study|Worsening of Study Indication|0|||
127509347|NCT02275117|458825208|FG001|Overall Study|Worsening of Study Indication|1|||
127509348|NCT02275117|458825209|FG002|Overall Study|Worsening of Study Indication|2|||
127509349|NCT02275117|458825210|FG003|Overall Study|Worsening of Study Indication|0|||
127509350|NCT02275117|458825211|FG004|Overall Study|Worsening of Study Indication|0|||
127509351|NCT02275117|458825207|FG000|Overall Study|Study Burden|5|||
127509352|NCT02275117|458825208|FG001|Overall Study|Study Burden|4|||
127509353|NCT02275117|458825209|FG002|Overall Study|Study Burden|7|||
127509354|NCT02275117|458825210|FG003|Overall Study|Study Burden|5|||
127509355|NCT02275117|458825211|FG004|Overall Study|Study Burden|7|||
127509356|NCT02275117|458825207|FG000|Overall Study|Other|1|||
127509357|NCT02275117|458825208|FG001|Overall Study|Other|0|||
127509358|NCT02275117|458825209|FG002|Overall Study|Other|0|||
127509359|NCT02275117|458825210|FG003|Overall Study|Other|0|||
127509360|NCT02275117|458825211|FG004|Overall Study|Other|2|||
127509361|NCT02446418|458825212|FG000|Overall Study|Adverse Event|4|||
127509362|NCT02446418|458825213|FG001|Overall Study|Adverse Event|8|||
127509363|NCT02446418|458825212|FG000|Overall Study|Physician Decision|5|||
127509364|NCT02446418|458825213|FG001|Overall Study|Physician Decision|1|||
127509365|NCT02446418|458825212|FG000|Overall Study|Withdrawal by Subject|3|||
127509366|NCT02446418|458825213|FG001|Overall Study|Withdrawal by Subject|3|||
127509367|NCT02446418|458825212|FG000|Overall Study|Lost to Follow-up|2|||
127509368|NCT02446418|458825213|FG001|Overall Study|Lost to Follow-up|2|||
127509369|NCT02446418|458825212|FG000|Overall Study|Protocol Violation|1|||
127509370|NCT02446418|458825213|FG001|Overall Study|Protocol Violation|2|||
127509371|NCT02446418|458825212|FG000|Overall Study|Lack of Efficacy|2|||
127509372|NCT02446418|458825213|FG001|Overall Study|Lack of Efficacy|0|||
127509373|NCT02446418|458825212|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
127509374|NCT02446418|458825213|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
127509375|NCT04508751|458825214|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
127509376|NCT04508751|458825215|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
127509377|NCT04508751|458825216|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
127509378|NCT02014480|458825217|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
127509379|NCT02014480|458825218|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
127509380|NCT02014480|458825219|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
127509381|NCT02014480|458825220|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
127509382|NCT02014480|458825221|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
127509383|NCT02014480|458825222|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
127509384|NCT02014480|458825217|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
127509385|NCT02014480|458825218|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
127509386|NCT02014480|458825219|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
127509387|NCT02014480|458825220|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
127509388|NCT02014480|458825221|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
127509389|NCT02014480|458825222|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
127509390|NCT02014480|458825217|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
127509391|NCT02014480|458825218|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
127509392|NCT02014480|458825219|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
127509393|NCT02014480|458825220|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
127509394|NCT02014480|458825221|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
127509395|NCT02014480|458825222|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
127509396|NCT02014480|458825217|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
127509397|NCT02014480|458825218|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
127509398|NCT02014480|458825219|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
127509399|NCT02014480|458825220|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
127509400|NCT02014480|458825221|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
127509401|NCT02014480|458825222|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
127509402|NCT02014480|458825217|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
127509403|NCT02014480|458825218|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
127509404|NCT02014480|458825219|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
127509405|NCT02014480|458825220|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
127509406|NCT02014480|458825221|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
127509407|NCT02014480|458825222|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
127509408|NCT02014480|458825217|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
127509409|NCT02014480|458825218|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
127509410|NCT02014480|458825219|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
127509411|NCT02014480|458825220|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
127509412|NCT02014480|458825221|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
127509413|NCT02014480|458825222|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
127509414|NCT02014480|458825217|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
127509415|NCT02014480|458825218|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
127509416|NCT02014480|458825219|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
127509417|NCT02014480|458825220|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
127509418|NCT02014480|458825221|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
127509419|NCT02014480|458825222|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
127509420|NCT01865812|458825225|FG000|Primary Treatment Phase|Adverse Event|2|||
127509421|NCT01865812|458825226|FG001|Primary Treatment Phase|Adverse Event|0|||
127509422|NCT01865812|458825225|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
127509423|NCT01865812|458825226|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
127509424|NCT01865812|458825225|FG000|Long-term Safety Extension Phase|Pruritus|0|||
127509425|NCT01865812|458825226|FG001|Long-term Safety Extension Phase|Pruritus|3|||
127509426|NCT01865812|458825225|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
127509427|NCT01865812|458825226|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
127509428|NCT01865812|458825225|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
127509429|NCT01865812|458825226|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
127509430|NCT01338610|458825227|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
127509431|NCT01338610|458825228|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
127509432|NCT01338610|458825229|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
127509433|NCT01338610|458825227|FG000|Overall Study|Protocol Violation|1|||
127509434|NCT01338610|458825228|FG001|Overall Study|Protocol Violation|0|||
127509435|NCT01338610|458825229|FG002|Overall Study|Protocol Violation|1|||
127509436|NCT01338610|458825227|FG000|Overall Study|Adverse Event|3|||
127509437|NCT01338610|458825228|FG001|Overall Study|Adverse Event|0|||
127509438|NCT01338610|458825229|FG002|Overall Study|Adverse Event|0|||
127509439|NCT01414205|458825232|FG000|Overall Study|Death|5|||
127509440|NCT01414205|458825233|FG001|Overall Study|Death|1|||
127509441|NCT01414205|458825232|FG000|Overall Study|Lost to Follow-up|1|||
127509442|NCT01414205|458825233|FG001|Overall Study|Lost to Follow-up|4|||
127509443|NCT01414205|458825232|FG000|Overall Study|Physician Decision|0|||
127509444|NCT01414205|458825233|FG001|Overall Study|Physician Decision|1|||
127509445|NCT01414205|458825232|FG000|Overall Study|Randomized but not Treated|1|||
127509446|NCT01414205|458825233|FG001|Overall Study|Randomized but not Treated|1|||
127509447|NCT02046226|458825234|FG000|Overall Study|Lost to Follow-up|7|||
127509448|NCT01166373|458825240|FG000|Overall Study|Lost to Follow-up|3|||
127509449|NCT01166373|458825241|FG001|Overall Study|Lost to Follow-up|2|||
127509450|NCT01166373|458825242|FG002|Overall Study|Lost to Follow-up|2|||
127509451|NCT01166373|458825243|FG003|Overall Study|Lost to Follow-up|2|||
127509452|NCT01166373|458825240|FG000|Overall Study|Withdrawal by Subject|1|||
127509453|NCT01166373|458825241|FG001|Overall Study|Withdrawal by Subject|2|||
127509454|NCT01166373|458825242|FG002|Overall Study|Withdrawal by Subject|2|||
127509455|NCT01166373|458825243|FG003|Overall Study|Withdrawal by Subject|3|||
127509456|NCT01166373|458825240|FG000|Overall Study|Physician Decision|1|||
127509457|NCT01166373|458825241|FG001|Overall Study|Physician Decision|0|||
127509458|NCT01166373|458825242|FG002|Overall Study|Physician Decision|0|||
127509459|NCT01166373|458825243|FG003|Overall Study|Physician Decision|0|||
127509460|NCT01819129|458825244|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
127509461|NCT01819129|458825245|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
127509462|NCT01819129|458825244|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
127509463|NCT01819129|458825245|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
127509464|NCT01819129|458825244|FG000|Overall Study|Other, Subject moved out of the country|0|||
127509465|NCT01819129|458825245|FG001|Overall Study|Other, Subject moved out of the country|1|||
127509466|NCT01819129|458825244|FG000|Overall Study|Withdrawal by Subject|15|||
127509467|NCT01819129|458825245|FG001|Overall Study|Withdrawal by Subject|15|||
127509468|NCT01819129|458825244|FG000|Overall Study|Lost to Follow-up|5|||
127509469|NCT01819129|458825245|FG001|Overall Study|Lost to Follow-up|2|||
127509470|NCT01819129|458825244|FG000|Overall Study|Lack of Efficacy|0|||
127509471|NCT01819129|458825245|FG001|Overall Study|Lack of Efficacy|1|||
127509472|NCT01819129|458825244|FG000|Overall Study|Adverse Event|1|||
127509473|NCT01819129|458825245|FG001|Overall Study|Adverse Event|4|||
127509474|NCT01819129|458825244|FG000|Overall Study|Death|1|||
127509475|NCT01819129|458825245|FG001|Overall Study|Death|1|||
127509476|NCT01819129|458825244|FG000|Overall Study|Withdrawal Criteria|20|||
127509477|NCT01819129|458825245|FG001|Overall Study|Withdrawal Criteria|15|||
127509478|NCT02836873|458825246|FG000|Overall Study|Protocol Violation|0|||
127509479|NCT02836873|458825247|FG001|Overall Study|Protocol Violation|1|||
127509480|NCT02836873|458825246|FG000|Overall Study|Adverse Event|1|||
127509481|NCT02836873|458825247|FG001|Overall Study|Adverse Event|4|||
127509482|NCT02836873|458825246|FG000|Overall Study|Withdrawal by Subject|2|||
127509483|NCT02836873|458825247|FG001|Overall Study|Withdrawal by Subject|2|||
127509484|NCT02836873|458825246|FG000|Overall Study|Lost to Follow-up|1|||
127509485|NCT02836873|458825247|FG001|Overall Study|Lost to Follow-up|3|||
127509486|NCT02836873|458825246|FG000|Overall Study|Physician Decision|0|||
127509487|NCT02836873|458825247|FG001|Overall Study|Physician Decision|1|||
127509488|NCT02836873|458825246|FG000|Overall Study|Other|1|||
127509489|NCT02836873|458825247|FG001|Overall Study|Other|0|||
127509490|NCT02914548|458825250|FG000|Overall Study|Adverse Event|15|||
127509491|NCT02914548|458825251|FG001|Overall Study|Adverse Event|7|||
127509492|NCT02914548|458825252|FG002|Overall Study|Adverse Event|15|||
127509493|NCT02914548|458825250|FG000|Overall Study|Physician Decision|2|||
127509494|NCT02914548|458825251|FG001|Overall Study|Physician Decision|2|||
127509495|NCT02914548|458825252|FG002|Overall Study|Physician Decision|0|||
127509496|NCT02914548|458825250|FG000|Overall Study|Protocol Violation|1|||
127509497|NCT02914548|458825251|FG001|Overall Study|Protocol Violation|0|||
127509498|NCT02914548|458825252|FG002|Overall Study|Protocol Violation|0|||
127509499|NCT02914548|458825250|FG000|Overall Study|Withdrawal by Subject|3|||
127509500|NCT02914548|458825251|FG001|Overall Study|Withdrawal by Subject|4|||
127509501|NCT02914548|458825252|FG002|Overall Study|Withdrawal by Subject|4|||
127509502|NCT02914548|458825250|FG000|Overall Study|>40% of body surface area|0|||
127509503|NCT02914548|458825251|FG001|Overall Study|>40% of body surface area|1|||
127509504|NCT02914548|458825252|FG002|Overall Study|>40% of body surface area|1|||
127509505|NCT02214225|458825253|FG000|Overall Study|Lost to Follow-up|46|||
127509506|NCT02214225|458825254|FG001|Overall Study|Lost to Follow-up|18|||
127509507|NCT02214225|458825255|FG002|Overall Study|Lost to Follow-up|18|||
127509508|NCT02214225|458825253|FG000|Overall Study|Withdrawal by Subject|2|||
127509509|NCT02214225|458825254|FG001|Overall Study|Withdrawal by Subject|0|||
127509510|NCT02214225|458825255|FG002|Overall Study|Withdrawal by Subject|2|||
127509511|NCT02214225|458825253|FG000|Overall Study|Death|5|||
127509512|NCT02214225|458825254|FG001|Overall Study|Death|0|||
127509513|NCT02214225|458825255|FG002|Overall Study|Death|1|||
127509514|NCT02214225|458825253|FG000|Overall Study|randomized in error, not vaccinated|2|||
127509515|NCT02214225|458825254|FG001|Overall Study|randomized in error, not vaccinated|1|||
127509516|NCT02214225|458825255|FG002|Overall Study|randomized in error, not vaccinated|1|||
127509517|NCT01253265|458825256|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
127509518|NCT01253265|458825257|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
127509519|NCT01253265|458825258|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
127509520|NCT01253265|458825259|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
127509521|NCT01253265|458825260|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
127509522|NCT01253265|458825256|FG000|Overall Study|Withdrawal by Subject|0|||
127509523|NCT01253265|458825257|FG001|Overall Study|Withdrawal by Subject|0|||
127509524|NCT01253265|458825258|FG002|Overall Study|Withdrawal by Subject|0|||
127509525|NCT01253265|458825259|FG003|Overall Study|Withdrawal by Subject|0|||
127509526|NCT01253265|458825260|FG004|Overall Study|Withdrawal by Subject|1|||
127509527|NCT03271047|458825261|FG000|Phase 1b: Dose Finding Period|Death|8|||
127509528|NCT03271047|458825262|FG001|Phase 1b: Dose Finding Period|Death|8|||
127509529|NCT03271047|458825263|FG002|Phase 1b: Dose Finding Period|Death|0|||
127509530|NCT03271047|458825264|FG003|Phase 1b: Dose Finding Period|Death|0|||
127509531|NCT03271047|458825261|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
127509532|NCT03271047|458825262|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
127509533|NCT03271047|458825263|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
127509534|NCT03271047|458825264|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
127509535|NCT03271047|458825261|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
127509536|NCT03271047|458825262|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
127509537|NCT03271047|458825263|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
127509538|NCT03271047|458825264|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
127509539|NCT03271047|458825261|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
127509540|NCT03271047|458825262|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
127509541|NCT03271047|458825263|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
127509542|NCT03271047|458825264|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
127509543|NCT03271047|458825261|FG000|Randomized Phase 2 Period|Other|0|||
127509544|NCT03271047|458825262|FG001|Randomized Phase 2 Period|Other|0|||
127509545|NCT03271047|458825263|FG002|Randomized Phase 2 Period|Other|0|||
127509546|NCT03271047|458825264|FG003|Randomized Phase 2 Period|Other|1|||
127509547|NCT03271047|458825261|FG000|Randomized Phase 2 Period|Death|0|||
127509548|NCT03271047|458825262|FG001|Randomized Phase 2 Period|Death|0|||
127978935|NCT01088243|460545654|FG001|Overall Study|Adverse Event|0|||
127509549|NCT03271047|458825263|FG002|Randomized Phase 2 Period|Death|20|||
127509550|NCT03271047|458825264|FG003|Randomized Phase 2 Period|Death|21|||
127509551|NCT03271047|458825261|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
127509552|NCT03271047|458825262|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
127509553|NCT03271047|458825263|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
127509554|NCT03271047|458825264|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
127509555|NCT03271047|458825261|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
127509556|NCT03271047|458825262|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
127509557|NCT03271047|458825263|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
127509558|NCT03271047|458825264|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
127509559|NCT03271047|458825261|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
127509560|NCT03271047|458825262|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
127509561|NCT03271047|458825263|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
127509562|NCT03271047|458825264|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
127509563|NCT00434759|458825265|FG000|Overall Study|Lack of Efficacy|5|||
127509564|NCT00434759|458825266|FG001|Overall Study|Lack of Efficacy|4|||
127509565|NCT00434759|458825265|FG000|Overall Study|Withdrawal by Subject|17|||
127509566|NCT00434759|458825266|FG001|Overall Study|Withdrawal by Subject|1|||
127509567|NCT00434759|458825265|FG000|Overall Study|family affairs|2|||
127509568|NCT00434759|458825266|FG001|Overall Study|family affairs|0|||
127509569|NCT00495521|458825268|FG000|Overall Study|Physician Decision|0|||
127509570|NCT00495521|458825269|FG001|Overall Study|Physician Decision|1|||
127509571|NCT02436408|458825270|FG000|Overall Study|Death|1|||
127509572|NCT02649855|458825271|FG000|Overall Study|Refused further treatment|2|||
127509573|NCT02649855|458825272|FG001|Overall Study|Refused further treatment|1|||
127509574|NCT02649855|458825273|FG002|Overall Study|Refused further treatment|1|||
127509575|NCT02649855|458825271|FG000|Overall Study|Withdrew consent|0|||
127509576|NCT02649855|458825272|FG001|Overall Study|Withdrew consent|1|||
127509577|NCT02649855|458825273|FG002|Overall Study|Withdrew consent|0|||
127509578|NCT02649855|458825271|FG000|Overall Study|Switched to alternative treatment|0|||
127509579|NCT02649855|458825272|FG001|Overall Study|Switched to alternative treatment|1|||
127509580|NCT02649855|458825273|FG002|Overall Study|Switched to alternative treatment|1|||
127509581|NCT02649855|458825271|FG000|Overall Study|Principal investigator discretion|0|||
127509582|NCT02649855|458825272|FG001|Overall Study|Principal investigator discretion|1|||
127509583|NCT02649855|458825273|FG002|Overall Study|Principal investigator discretion|1|||
127509584|NCT02649855|458825271|FG000|Overall Study|No treatment, per protocol|1|||
127509585|NCT02649855|458825272|FG001|Overall Study|No treatment, per protocol|0|||
127509586|NCT02649855|458825273|FG002|Overall Study|No treatment, per protocol|0|||
127509587|NCT02649855|458825271|FG000|Overall Study|Initiate new treatment|1|||
127509588|NCT02649855|458825272|FG001|Overall Study|Initiate new treatment|0|||
127509589|NCT02649855|458825273|FG002|Overall Study|Initiate new treatment|0|||
127509590|NCT01300819|458825274|FG000|Overall Study|Adverse Event|9|||
127509591|NCT01300819|458825275|FG001|Overall Study|Adverse Event|27|||
127509592|NCT01300819|458825274|FG000|Overall Study|Lack of Efficacy|2|||
127509593|NCT01300819|458825275|FG001|Overall Study|Lack of Efficacy|1|||
127509594|NCT01300819|458825274|FG000|Overall Study|Withdrawal by Subject|10|||
127509595|NCT01300819|458825275|FG001|Overall Study|Withdrawal by Subject|12|||
127509596|NCT01300819|458825274|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
127509597|NCT01300819|458825275|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
127509598|NCT01300819|458825274|FG000|Overall Study|Refusal to down titrate study drug|0|||
127509599|NCT01300819|458825275|FG001|Overall Study|Refusal to down titrate study drug|1|||
127509600|NCT01300819|458825274|FG000|Overall Study|Administrative reason|0|||
127509601|NCT01300819|458825275|FG001|Overall Study|Administrative reason|1|||
127509602|NCT01300819|458825274|FG000|Overall Study|Safety follow up not done by mistake|0|||
127509603|NCT01300819|458825275|FG001|Overall Study|Safety follow up not done by mistake|1|||
127509604|NCT01300819|458825274|FG000|Overall Study|Follow up call was not done|1|||
127509605|NCT01300819|458825275|FG001|Overall Study|Follow up call was not done|0|||
127509606|NCT01319721|458825279|FG000|Overall Study|Lost to Follow-up|1|||
127509607|NCT01319721|458825280|FG001|Overall Study|Lost to Follow-up|6|||
127509608|NCT00461305|458825281|FG000|Treatment|Adverse Event|26|||
127509609|NCT00461305|458825282|FG001|Treatment|Adverse Event|3|||
127509610|NCT00461305|458825281|FG000|Treatment|Lost to Follow-up|4|||
127509611|NCT00461305|458825282|FG001|Treatment|Lost to Follow-up|2|||
127509612|NCT00461305|458825281|FG000|Treatment|Protocol Violation|13|||
127509613|NCT00461305|458825282|FG001|Treatment|Protocol Violation|2|||
127509614|NCT00461305|458825281|FG000|Treatment|Withdrawal by Subject|48|||
127509615|NCT00461305|458825282|FG001|Treatment|Withdrawal by Subject|2|||
127509616|NCT00461305|458825281|FG000|Treatment|Never dispensed|5|||
127509617|NCT00461305|458825282|FG001|Treatment|Never dispensed|0|||
127509618|NCT00461305|458825281|FG000|Treatment|Study drug not taken|1|||
127509619|NCT00461305|458825282|FG001|Treatment|Study drug not taken|0|||
127509620|NCT00461305|458825281|FG000|Treatment|Partially missing diary|2|||
127509621|NCT00461305|458825282|FG001|Treatment|Partially missing diary|0|||
127509622|NCT00461305|458825281|FG000|Treatment|Other (missing drug etc)|2|||
127509623|NCT00461305|458825282|FG001|Treatment|Other (missing drug etc)|0|||
127509624|NCT00461305|458825281|FG000|Continued Treatment|Adverse Event|26|||
127509625|NCT00461305|458825282|FG001|Continued Treatment|Adverse Event|0|||
127509626|NCT00461305|458825281|FG000|Continued Treatment|Lost to Follow-up|4|||
127509627|NCT00461305|458825282|FG001|Continued Treatment|Lost to Follow-up|0|||
127509628|NCT00461305|458825281|FG000|Continued Treatment|Protocol Violation|13|||
127509629|NCT00461305|458825282|FG001|Continued Treatment|Protocol Violation|0|||
127509630|NCT00461305|458825281|FG000|Continued Treatment|Withdrawal by Subject|48|||
127509631|NCT00461305|458825282|FG001|Continued Treatment|Withdrawal by Subject|0|||
127509632|NCT00461305|458825281|FG000|Continued Treatment|Partially missing diary|2|||
127509633|NCT00461305|458825282|FG001|Continued Treatment|Partially missing diary|0|||
127509634|NCT00461305|458825281|FG000|Continued Treatment|Other (missing drug etc)|2|||
127509635|NCT00461305|458825282|FG001|Continued Treatment|Other (missing drug etc)|0|||
127509636|NCT00787930|458825287|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
127509637|NCT01896271|458825288|FG000|Overall Study|Physician Decision|10|||
127509638|NCT04030247|458827107|FG000|Overall Study|Withdrawal by Subject|4|||
127509639|NCT04030247|458827107|FG000|Overall Study|Lost to Follow-up|13|||
127509640|NCT00320255|458827108|FG000|Overall Study|Lack of Efficacy|1|||
127509641|NCT00320255|458827109|FG001|Overall Study|Lack of Efficacy|0|||
127509642|NCT00320255|458827110|FG002|Overall Study|Lack of Efficacy|0|||
127509643|NCT00320255|458827111|FG003|Overall Study|Lack of Efficacy|0|||
127509644|NCT00320255|458827112|FG004|Overall Study|Lack of Efficacy|0|||
127509645|NCT00320255|458827113|FG005|Overall Study|Lack of Efficacy|0|||
127509646|NCT00320255|458827108|FG000|Overall Study|Adverse Event|5|||
127509647|NCT00320255|458827109|FG001|Overall Study|Adverse Event|2|||
127509648|NCT00320255|458827110|FG002|Overall Study|Adverse Event|3|||
127509649|NCT00320255|458827111|FG003|Overall Study|Adverse Event|2|||
127509650|NCT00320255|458827112|FG004|Overall Study|Adverse Event|0|||
127509651|NCT00320255|458827113|FG005|Overall Study|Adverse Event|0|||
127509652|NCT00320255|458827108|FG000|Overall Study|Withdrawal by Subject|1|||
127509653|NCT00320255|458827109|FG001|Overall Study|Withdrawal by Subject|2|||
127509654|NCT00320255|458827110|FG002|Overall Study|Withdrawal by Subject|2|||
127509655|NCT00320255|458827111|FG003|Overall Study|Withdrawal by Subject|4|||
127509656|NCT00320255|458827112|FG004|Overall Study|Withdrawal by Subject|0|||
127509657|NCT00320255|458827113|FG005|Overall Study|Withdrawal by Subject|0|||
127509658|NCT00320255|458827108|FG000|Overall Study|Poor compliance/noncompliance|1|||
127509659|NCT00320255|458827109|FG001|Overall Study|Poor compliance/noncompliance|1|||
127509660|NCT00320255|458827110|FG002|Overall Study|Poor compliance/noncompliance|0|||
127509661|NCT00320255|458827111|FG003|Overall Study|Poor compliance/noncompliance|1|||
127509662|NCT00320255|458827112|FG004|Overall Study|Poor compliance/noncompliance|0|||
127509663|NCT00320255|458827113|FG005|Overall Study|Poor compliance/noncompliance|0|||
127509664|NCT00320255|458827108|FG000|Overall Study|No longer meets study criteria|0|||
127509665|NCT00320255|458827109|FG001|Overall Study|No longer meets study criteria|0|||
127509666|NCT00320255|458827110|FG002|Overall Study|No longer meets study criteria|0|||
127509667|NCT00320255|458827111|FG003|Overall Study|No longer meets study criteria|1|||
127509668|NCT00320255|458827112|FG004|Overall Study|No longer meets study criteria|0|||
127509669|NCT00320255|458827113|FG005|Overall Study|No longer meets study criteria|0|||
127509670|NCT00320255|458827108|FG000|Overall Study|Other|3|||
127509671|NCT00320255|458827109|FG001|Overall Study|Other|2|||
127509672|NCT00320255|458827110|FG002|Overall Study|Other|1|||
127509673|NCT00320255|458827111|FG003|Overall Study|Other|0|||
127509674|NCT00320255|458827112|FG004|Overall Study|Other|0|||
127509675|NCT00320255|458827113|FG005|Overall Study|Other|0|||
127509676|NCT03405935|458827114|FG000|Overall Study|Adverse Event|3|||
127509677|NCT03405935|458827114|FG000|Overall Study|Death|2|||
127509678|NCT03405935|458827114|FG000|Overall Study|Withdrawal by Subject|1|||
127509679|NCT03405935|458827114|FG000|Overall Study|Lost to Follow-up|2|||
127509680|NCT04979897|458827115|FG000|Overall Study|Death|1|||
127509681|NCT04979897|458827116|FG001|Overall Study|Death|8|||
127509682|NCT04979897|458827115|FG000|Overall Study|Lost to Follow-up|111|||
127509683|NCT04979897|458827116|FG001|Overall Study|Lost to Follow-up|56|||
127509684|NCT04979897|458827115|FG000|Overall Study|Withdrawal by Subject|7|||
127509685|NCT04979897|458827116|FG001|Overall Study|Withdrawal by Subject|2|||
127509686|NCT02435680|458827119|FG000|Overall Study|Physician Decision|3|||
127509687|NCT02435680|458827120|FG001|Overall Study|Physician Decision|0|||
127509688|NCT02435680|458827121|FG002|Overall Study|Physician Decision|0|||
127509689|NCT02435680|458827119|FG000|Overall Study|subject / guardian decision|0|||
127509690|NCT02435680|458827120|FG001|Overall Study|subject / guardian decision|3|||
127509691|NCT02435680|458827121|FG002|Overall Study|subject / guardian decision|2|||
127509692|NCT02435680|458827119|FG000|Overall Study|Adverse Event|8|||
127509693|NCT02435680|458827120|FG001|Overall Study|Adverse Event|3|||
127509694|NCT02435680|458827121|FG002|Overall Study|Adverse Event|2|||
127509695|NCT02435680|458827119|FG000|Overall Study|progressive disease|10|||
127509696|NCT02435680|458827120|FG001|Overall Study|progressive disease|7|||
127509697|NCT02435680|458827121|FG002|Overall Study|progressive disease|11|||
127509698|NCT02435680|458827119|FG000|Overall Study|not treated|0|||
127509699|NCT02435680|458827120|FG001|Overall Study|not treated|0|||
127509700|NCT02435680|458827121|FG002|Overall Study|not treated|1|||
127509701|NCT02585830|458827124|FG000|Overall Study|Withdrawal by Subject|3|||
127509702|NCT02509052|458827125|FG000|Overall Study|Non compliance|0|||
127509703|NCT02509052|458827126|FG001|Overall Study|Non compliance|0|||
127509704|NCT02509052|458827127|FG002|Overall Study|Non compliance|1|||
127509705|NCT01323270|458827130|FG000|Overall Study|Withdrawal by Subject|19|||
127509706|NCT01323270|458827131|FG001|Overall Study|Withdrawal by Subject|10|||
127509707|NCT01323270|458827130|FG000|Overall Study|Protocol Violation|9|||
127509708|NCT01323270|458827131|FG001|Overall Study|Protocol Violation|7|||
127509709|NCT01323270|458827130|FG000|Overall Study|Lost to Follow-up|4|||
127509710|NCT01323270|458827131|FG001|Overall Study|Lost to Follow-up|6|||
127509711|NCT01323270|458827130|FG000|Overall Study|Adverse Event|8|||
127509712|NCT01323270|458827131|FG001|Overall Study|Adverse Event|0|||
127509713|NCT01323270|458827130|FG000|Overall Study|Other|0|||
127509714|NCT01323270|458827131|FG001|Overall Study|Other|3|||
127509715|NCT01323270|458827130|FG000|Overall Study|Physician Decision|0|||
127509716|NCT01323270|458827131|FG001|Overall Study|Physician Decision|2|||
127509717|NCT01323270|458827130|FG000|Overall Study|Not eligible|1|||
127509718|NCT01323270|458827131|FG001|Overall Study|Not eligible|1|||
127509719|NCT01323270|458827130|FG000|Overall Study|Death|1|||
127509720|NCT01323270|458827131|FG001|Overall Study|Death|0|||
127509721|NCT01323270|458827130|FG000|Overall Study|Randomized, but not vaccinated|1|||
127509722|NCT01323270|458827131|FG001|Overall Study|Randomized, but not vaccinated|0|||
127509723|NCT03761394|458827135|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
127509724|NCT03761394|458827136|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
127509725|NCT03761394|458827137|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
127509726|NCT03761394|458827138|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
127509727|NCT03761394|458827135|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
127509728|NCT03761394|458827136|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
127509729|NCT03761394|458827137|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
127509730|NCT03761394|458827138|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
127509731|NCT03761394|458827135|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
127509732|NCT03761394|458827136|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
127509733|NCT03761394|458827137|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
127509734|NCT03761394|458827138|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
127509735|NCT03761394|458827135|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
127509736|NCT03761394|458827136|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
127509737|NCT03761394|458827137|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
127509738|NCT03761394|458827138|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
127509739|NCT03242772|458827147|FG000|Overall Study|Lost to Follow-up|2|||
127509740|NCT03242772|458827148|FG001|Overall Study|Lost to Follow-up|0|||
127509741|NCT03242772|458827147|FG000|Overall Study|Physician Decision|0|||
127509742|NCT03242772|458827148|FG001|Overall Study|Physician Decision|1|||
127509743|NCT03242772|458827147|FG000|Overall Study|Withdrawal by Subject|1|||
127509744|NCT03242772|458827148|FG001|Overall Study|Withdrawal by Subject|0|||
127509745|NCT01062841|458827152|FG000|Overall Study|Indwelling Device Removed|41|||
127509746|NCT01062841|458827153|FG001|Overall Study|Indwelling Device Removed|48|||
127509747|NCT01062841|458827152|FG000|Overall Study|Death|3|||
127509748|NCT01062841|458827153|FG001|Overall Study|Death|5|||
127509749|NCT01062841|458827152|FG000|Overall Study|Withdrawal by Subject|2|||
127509750|NCT01062841|458827153|FG001|Overall Study|Withdrawal by Subject|0|||
127509751|NCT01062841|458827152|FG000|Overall Study|Withdrawal by Study|3|||
127509752|NCT01062841|458827153|FG001|Overall Study|Withdrawal by Study|0|||
127509753|NCT01118520|458827154|FG000|Overall Study|AAA repair|9|||
127509754|NCT01118520|458827155|FG001|Overall Study|AAA repair|7|||
127509755|NCT01118520|458827156|FG002|Overall Study|AAA repair|9|||
127509756|NCT01118520|458827154|FG000|Overall Study|Adverse Event|3|||
127509757|NCT01118520|458827155|FG001|Overall Study|Adverse Event|3|||
127509758|NCT01118520|458827156|FG002|Overall Study|Adverse Event|3|||
127509759|NCT01118520|458827154|FG000|Overall Study|Withdrawal by Subject|8|||
127509760|NCT01118520|458827155|FG001|Overall Study|Withdrawal by Subject|13|||
127509761|NCT01118520|458827156|FG002|Overall Study|Withdrawal by Subject|8|||
127509762|NCT01089023|458827157|FG000|Overall Study|Lost to Follow-up|3|||
127509763|NCT01089023|458827157|FG000|Overall Study|Adverse Event|1|||
127509764|NCT01089023|458827157|FG000|Overall Study|Withdrawal by Subject|1|||
127509765|NCT01089023|458827157|FG000|Overall Study|Protocol Violation|1|||
127509766|NCT01089023|458827157|FG000|Overall Study|Lack of Efficacy|1|||
127509767|NCT03421743|458827160|FG000|Overall Study|Lack of Efficacy|1|||
127509768|NCT03421743|458827161|FG001|Overall Study|Lack of Efficacy|0|||
127509769|NCT03421743|458827160|FG000|Overall Study|Adverse Event|2|||
127509770|NCT03421743|458827161|FG001|Overall Study|Adverse Event|1|||
127509771|NCT03421743|458827160|FG000|Overall Study|Withdrawal by Subject|0|||
127509772|NCT03421743|458827161|FG001|Overall Study|Withdrawal by Subject|1|||
127509773|NCT03754582|458827165|FG000|Treatment Phase|Adverse Event|0|||
127509774|NCT03754582|458827166|FG001|Treatment Phase|Adverse Event|1|||
127509775|NCT03754582|458827167|FG002|Treatment Phase|Adverse Event|0|||
127509776|NCT03754582|458827165|FG000|Follow-up Phase|Other|0|||
127509777|NCT03754582|458827166|FG001|Follow-up Phase|Other|0|||
127509778|NCT03754582|458827167|FG002|Follow-up Phase|Other|1|||
127509779|NCT02680574|458827168|FG000|Overall Study|Death|137|||
127509780|NCT02680574|458827169|FG001|Overall Study|Death|137|||
127509781|NCT02680574|458827168|FG000|Overall Study|Withdrawal by Subject|17|||
127509782|NCT02680574|458827169|FG001|Overall Study|Withdrawal by Subject|9|||
127509783|NCT02680574|458827168|FG000|Overall Study|Lost to Follow-up|4|||
127509784|NCT02680574|458827169|FG001|Overall Study|Lost to Follow-up|6|||
127509785|NCT02847858|458827170|FG000|Overall Study|Lost to Follow-up|401|||
127509786|NCT02847858|458827171|FG001|Overall Study|Lost to Follow-up|269|||
127509787|NCT00681564|458827174|FG000|Overall Study|Lost to Follow-up|6|||
127509788|NCT00681564|458827175|FG001|Overall Study|Lost to Follow-up|6|||
127509789|NCT00681564|458827174|FG000|Overall Study|Withdrawal by Subject|0|||
127509790|NCT00681564|458827175|FG001|Overall Study|Withdrawal by Subject|1|||
127509791|NCT00681564|458827174|FG000|Overall Study|Death|0|||
127509792|NCT00681564|458827175|FG001|Overall Study|Death|1|||
127509793|NCT01009346|458827178|FG000|Overall Study|Adverse Event|4|||
127509794|NCT00541099|458827180|FG000|Overall Study|Ineligible|3|||
127509795|NCT00066469|458827182|FG000|Overall Study|Death|3|||
127509796|NCT00066469|458827182|FG000|Overall Study|Lack of Efficacy|9|||
127509797|NCT00066469|458827182|FG000|Overall Study|Lost to Follow-up|1|||
127509798|NCT00066469|458827182|FG000|Overall Study|Physician Decision|1|||
127509799|NCT00066469|458827182|FG000|Overall Study|Withdrawal by Subject|1|||
127509800|NCT00066469|458827182|FG000|Overall Study|ineligible|1|||
127509801|NCT00711802|458827183|FG000|Overall Study|Not treated (no further detail)|2|||
127509802|NCT00711802|458827184|FG001|Overall Study|Not treated (no further detail)|1|||
127509803|NCT00711802|458827185|FG002|Overall Study|Not treated (no further detail)|2|||
127509804|NCT00711802|458827186|FG003|Overall Study|Not treated (no further detail)|0|||
127509805|NCT00711802|458827187|FG004|Overall Study|Not treated (no further detail)|2|||
127509806|NCT00711802|458827188|FG005|Overall Study|Not treated (no further detail)|0|||
127509807|NCT00711802|458827189|FG006|Overall Study|Not treated (no further detail)|0|||
127509808|NCT00711802|458827190|FG007|Overall Study|Not treated (no further detail)|0|||
127509809|NCT00711802|458827183|FG000|Overall Study|Adverse Event|0|||
127509810|NCT00711802|458827184|FG001|Overall Study|Adverse Event|0|||
127509811|NCT00711802|458827185|FG002|Overall Study|Adverse Event|0|||
127509812|NCT00711802|458827186|FG003|Overall Study|Adverse Event|0|||
127509813|NCT00711802|458827187|FG004|Overall Study|Adverse Event|1|||
127509814|NCT00711802|458827188|FG005|Overall Study|Adverse Event|1|||
127509815|NCT00711802|458827189|FG006|Overall Study|Adverse Event|0|||
127509816|NCT00711802|458827190|FG007|Overall Study|Adverse Event|0|||
127509817|NCT00711802|458827183|FG000|Overall Study|Microbiological failure|0|||
127509818|NCT00711802|458827184|FG001|Overall Study|Microbiological failure|1|||
127509819|NCT00711802|458827185|FG002|Overall Study|Microbiological failure|0|||
127509820|NCT00711802|458827186|FG003|Overall Study|Microbiological failure|0|||
127509821|NCT00711802|458827187|FG004|Overall Study|Microbiological failure|0|||
127509822|NCT00711802|458827188|FG005|Overall Study|Microbiological failure|1|||
127509823|NCT00711802|458827189|FG006|Overall Study|Microbiological failure|0|||
127509824|NCT00711802|458827190|FG007|Overall Study|Microbiological failure|0|||
127509825|NCT00711802|458827183|FG000|Overall Study|Protocol Violation|0|||
127509826|NCT00711802|458827184|FG001|Overall Study|Protocol Violation|0|||
127509827|NCT00711802|458827185|FG002|Overall Study|Protocol Violation|0|||
127509828|NCT00711802|458827186|FG003|Overall Study|Protocol Violation|1|||
127509829|NCT00711802|458827187|FG004|Overall Study|Protocol Violation|0|||
127509830|NCT00711802|458827188|FG005|Overall Study|Protocol Violation|0|||
127509831|NCT00711802|458827189|FG006|Overall Study|Protocol Violation|0|||
127509832|NCT00711802|458827190|FG007|Overall Study|Protocol Violation|0|||
127509833|NCT00711802|458827183|FG000|Overall Study|Physician Decision|0|||
127509834|NCT00711802|458827184|FG001|Overall Study|Physician Decision|2|||
127509835|NCT00711802|458827185|FG002|Overall Study|Physician Decision|0|||
127509836|NCT00711802|458827186|FG003|Overall Study|Physician Decision|0|||
127509837|NCT00711802|458827187|FG004|Overall Study|Physician Decision|0|||
127509838|NCT00711802|458827188|FG005|Overall Study|Physician Decision|0|||
127509839|NCT00711802|458827189|FG006|Overall Study|Physician Decision|0|||
127509840|NCT00711802|458827190|FG007|Overall Study|Physician Decision|0|||
127509841|NCT00711802|458827183|FG000|Overall Study|Withdrawal by Subject|0|||
127509842|NCT00711802|458827184|FG001|Overall Study|Withdrawal by Subject|1|||
127509843|NCT00711802|458827185|FG002|Overall Study|Withdrawal by Subject|0|||
127509844|NCT00711802|458827186|FG003|Overall Study|Withdrawal by Subject|1|||
127509845|NCT00711802|458827187|FG004|Overall Study|Withdrawal by Subject|0|||
127509846|NCT00711802|458827188|FG005|Overall Study|Withdrawal by Subject|0|||
127509847|NCT00711802|458827189|FG006|Overall Study|Withdrawal by Subject|0|||
127509848|NCT00711802|458827190|FG007|Overall Study|Withdrawal by Subject|0|||
127509849|NCT00711802|458827183|FG000|Overall Study|Lost to Follow-up|0|||
127509850|NCT00711802|458827184|FG001|Overall Study|Lost to Follow-up|0|||
127509851|NCT00711802|458827185|FG002|Overall Study|Lost to Follow-up|3|||
127509852|NCT00711802|458827186|FG003|Overall Study|Lost to Follow-up|1|||
127509853|NCT00711802|458827187|FG004|Overall Study|Lost to Follow-up|10|||
127509854|NCT00711802|458827188|FG005|Overall Study|Lost to Follow-up|6|||
127509855|NCT00711802|458827189|FG006|Overall Study|Lost to Follow-up|4|||
127509856|NCT00711802|458827190|FG007|Overall Study|Lost to Follow-up|2|||
127509857|NCT00711802|458827183|FG000|Overall Study|Reason not reported|0|||
127509858|NCT00711802|458827184|FG001|Overall Study|Reason not reported|1|||
127509859|NCT00711802|458827185|FG002|Overall Study|Reason not reported|1|||
127509860|NCT00711802|458827186|FG003|Overall Study|Reason not reported|0|||
127509861|NCT00711802|458827187|FG004|Overall Study|Reason not reported|1|||
127509862|NCT00711802|458827188|FG005|Overall Study|Reason not reported|0|||
127509863|NCT00711802|458827189|FG006|Overall Study|Reason not reported|1|||
127509864|NCT00711802|458827190|FG007|Overall Study|Reason not reported|0|||
127978936|NCT01041976|460545655|FG000|Overall Study|Withdrawal by Subject|3|||
127509865|NCT02305849|458827192|FG000|Overall Study|Adverse Event|10|||
127509866|NCT02305849|458827193|FG001|Overall Study|Adverse Event|12|||
127509867|NCT02305849|458827194|FG002|Overall Study|Adverse Event|7|||
127509868|NCT02305849|458827195|FG003|Overall Study|Adverse Event|3|||
127509869|NCT02305849|458827192|FG000|Overall Study|Lack of Efficacy|10|||
127509870|NCT02305849|458827193|FG001|Overall Study|Lack of Efficacy|6|||
127509871|NCT02305849|458827194|FG002|Overall Study|Lack of Efficacy|3|||
127509872|NCT02305849|458827195|FG003|Overall Study|Lack of Efficacy|9|||
127509873|NCT02305849|458827192|FG000|Overall Study|Withdrawal by Subject|2|||
127509874|NCT02305849|458827193|FG001|Overall Study|Withdrawal by Subject|2|||
127509875|NCT02305849|458827194|FG002|Overall Study|Withdrawal by Subject|1|||
127509876|NCT02305849|458827195|FG003|Overall Study|Withdrawal by Subject|4|||
127509877|NCT02305849|458827192|FG000|Overall Study|Lost to Follow-up|0|||
127509878|NCT02305849|458827193|FG001|Overall Study|Lost to Follow-up|2|||
127509879|NCT02305849|458827194|FG002|Overall Study|Lost to Follow-up|0|||
127509880|NCT02305849|458827195|FG003|Overall Study|Lost to Follow-up|0|||
127509881|NCT02305849|458827192|FG000|Overall Study|Protocol Violation|3|||
127509882|NCT02305849|458827193|FG001|Overall Study|Protocol Violation|2|||
127509883|NCT02305849|458827194|FG002|Overall Study|Protocol Violation|1|||
127509884|NCT02305849|458827195|FG003|Overall Study|Protocol Violation|1|||
127509885|NCT02305849|458827192|FG000|Overall Study|Lab data met discontinuation criteria|0|||
127509886|NCT02305849|458827193|FG001|Overall Study|Lab data met discontinuation criteria|1|||
127509887|NCT02305849|458827194|FG002|Overall Study|Lab data met discontinuation criteria|2|||
127509888|NCT02305849|458827195|FG003|Overall Study|Lab data met discontinuation criteria|1|||
127509889|NCT02305849|458827192|FG000|Overall Study|Miscellaneous|1|||
127509890|NCT02305849|458827193|FG001|Overall Study|Miscellaneous|2|||
127509891|NCT02305849|458827194|FG002|Overall Study|Miscellaneous|4|||
127509892|NCT02305849|458827195|FG003|Overall Study|Miscellaneous|1|||
127509893|NCT02305849|458827192|FG000|Overall Study|Not fulfill eligibility criteria|1|||
127509894|NCT02305849|458827193|FG001|Overall Study|Not fulfill eligibility criteria|1|||
127509895|NCT02305849|458827194|FG002|Overall Study|Not fulfill eligibility criteria|0|||
127509896|NCT02305849|458827195|FG003|Overall Study|Not fulfill eligibility criteria|0|||
127509897|NCT02410824|458827200|FG000|First Intervention (One Week)|Headache|0|||
127509898|NCT02410824|458827201|FG001|First Intervention (One Week)|Headache|1|||
127509899|NCT00392808|458827202|FG000|Overall Study|Lost to Follow-up|3|||
127509900|NCT00392808|458827203|FG001|Overall Study|Lost to Follow-up|2|||
127509901|NCT00392808|458827204|FG002|Overall Study|Lost to Follow-up|1|||
127509902|NCT00392808|458827205|FG003|Overall Study|Lost to Follow-up|2|||
127509903|NCT00392808|458827202|FG000|Overall Study|Unable to withdraw blood|3|||
127509904|NCT00392808|458827203|FG001|Overall Study|Unable to withdraw blood|1|||
127509905|NCT00392808|458827204|FG002|Overall Study|Unable to withdraw blood|1|||
127509906|NCT00392808|458827205|FG003|Overall Study|Unable to withdraw blood|2|||
127509907|NCT02782325|458827206|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
127509908|NCT02782325|458827207|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
127509909|NCT02782325|458827208|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
127509910|NCT02782325|458827206|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
127509911|NCT02782325|458827207|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
127509912|NCT02782325|458827208|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
127509913|NCT02818036|458827211|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
127509914|NCT02818036|458827212|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
127978937|NCT01041976|460545656|FG001|Overall Study|Withdrawal by Subject|0|||
127978938|NCT01041976|460545655|FG000|Overall Study|Incarceration|2|||
127978939|NCT01041976|460545656|FG001|Overall Study|Incarceration|0|||
127978940|NCT01041976|460545655|FG000|Overall Study|Death|0|||
127978941|NCT01041976|460545656|FG001|Overall Study|Death|4|||
127978942|NCT02231879|460545657|FG000|Overall Study|Adverse Event|2|||
127978943|NCT02231879|460545658|FG001|Overall Study|Adverse Event|1|||
127978944|NCT02231879|460545657|FG000|Overall Study|Lack of Efficacy|0|||
127978945|NCT02231879|460545658|FG001|Overall Study|Lack of Efficacy|1|||
127978946|NCT01210495|460545659|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
127978947|NCT01210495|460545660|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
127978948|NCT01210495|460545661|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
127978949|NCT01210495|460545662|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
127978950|NCT01210495|460545659|FG000|Overall Study|Death|14|||
127978951|NCT01210495|460545660|FG001|Overall Study|Death|7|||
127978952|NCT01210495|460545661|FG002|Overall Study|Death|112|||
127978953|NCT01210495|460545662|FG003|Overall Study|Death|54|||
127978954|NCT01210495|460545659|FG000|Overall Study|Study Terminated by Sponsor|0|||
127978955|NCT01210495|460545660|FG001|Overall Study|Study Terminated by Sponsor|0|||
127978956|NCT01210495|460545661|FG002|Overall Study|Study Terminated by Sponsor|4|||
127978957|NCT01210495|460545662|FG003|Overall Study|Study Terminated by Sponsor|11|||
127978958|NCT01210495|460545659|FG000|Overall Study|Lost to Follow-up|0|||
127978959|NCT01210495|460545660|FG001|Overall Study|Lost to Follow-up|0|||
127978960|NCT01210495|460545661|FG002|Overall Study|Lost to Follow-up|1|||
127978961|NCT01210495|460545662|FG003|Overall Study|Lost to Follow-up|1|||
127978962|NCT01210495|460545659|FG000|Overall Study|Other unspecified|0|||
127978963|NCT01210495|460545660|FG001|Overall Study|Other unspecified|0|||
127978964|NCT01210495|460545661|FG002|Overall Study|Other unspecified|6|||
127978965|NCT01210495|460545662|FG003|Overall Study|Other unspecified|0|||
127978966|NCT00454818|460545665|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
127509915|NCT02818036|458827211|FG000|Overall Study|Withdrawal by Subject|1|||
127978967|NCT00454818|460545666|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
127978968|NCT00454818|460545667|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
127509916|NCT02818036|458827212|FG001|Overall Study|Withdrawal by Subject|0|||
127509917|NCT01038713|458827213|FG000|Overall Study|Patient to hospice|1|||
127509918|NCT01038713|458827214|FG001|Overall Study|Patient to hospice|1|||
127509919|NCT01038713|458827215|FG002|Overall Study|Patient to hospice|1|||
127509920|NCT01038713|458827213|FG000|Overall Study|Lost to Follow-up|3|||
127509921|NCT01038713|458827214|FG001|Overall Study|Lost to Follow-up|0|||
127509922|NCT01038713|458827215|FG002|Overall Study|Lost to Follow-up|0|||
127509923|NCT01038713|458827213|FG000|Overall Study|Neuroendocrine Tumor|0|||
127509924|NCT01038713|458827214|FG001|Overall Study|Neuroendocrine Tumor|1|||
127509925|NCT01038713|458827215|FG002|Overall Study|Neuroendocrine Tumor|0|||
127509926|NCT01038713|458827213|FG000|Overall Study|died from PEP|0|||
127509927|NCT01038713|458827214|FG001|Overall Study|died from PEP|1|||
127509928|NCT01038713|458827215|FG002|Overall Study|died from PEP|0|||
127509929|NCT01038713|458827213|FG000|Overall Study|Autoimmune Pancreatitis|1|||
127509930|NCT01038713|458827214|FG001|Overall Study|Autoimmune Pancreatitis|0|||
127509931|NCT01038713|458827215|FG002|Overall Study|Autoimmune Pancreatitis|0|||
127509932|NCT03777917|458827216|FG000|Overall Study|Withdrawal by Subject|1|||
127509933|NCT03777917|458827217|FG001|Overall Study|Withdrawal by Subject|0|||
127509934|NCT03777917|458827216|FG000|Overall Study|Physician Decision|1|||
127509935|NCT03777917|458827217|FG001|Overall Study|Physician Decision|0|||
127509936|NCT03777917|458827216|FG000|Overall Study|Lost to Follow-up|6|||
127509937|NCT03777917|458827217|FG001|Overall Study|Lost to Follow-up|2|||
127509938|NCT03777917|458827216|FG000|Overall Study|Other|1|||
127509939|NCT03777917|458827217|FG001|Overall Study|Other|0|||
127509940|NCT01154283|458827218|FG000|0-6 Weeks|Withdrawal by Subject|7|||
127509941|NCT01154283|458827219|FG001|0-6 Weeks|Withdrawal by Subject|2|||
127509942|NCT01154283|458827218|FG000|0-6 Weeks|Death|0|||
127509943|NCT01154283|458827219|FG001|0-6 Weeks|Death|1|||
127509944|NCT01154283|458827218|FG000|7-12 Weeks|Death|1|||
127509945|NCT01154283|458827219|FG001|7-12 Weeks|Death|0|||
127509946|NCT01154283|458827218|FG000|7-12 Weeks|Withdrawal by Subject|0|||
127509947|NCT01154283|458827219|FG001|7-12 Weeks|Withdrawal by Subject|1|||
127509948|NCT00042432|458827220|FG000|Overall Study|Adverse Event|4|||
127509949|NCT00042432|458827221|FG001|Overall Study|Adverse Event|1|||
127509950|NCT00042432|458827220|FG000|Overall Study|Withdrawal by Subject|1|||
127509951|NCT00042432|458827221|FG001|Overall Study|Withdrawal by Subject|3|||
127509952|NCT00042432|458827220|FG000|Overall Study|Death|0|||
127509953|NCT00042432|458827221|FG001|Overall Study|Death|2|||
127509954|NCT00042432|458827220|FG000|Overall Study|Ineligibility determined|1|||
127509955|NCT00042432|458827221|FG001|Overall Study|Ineligibility determined|0|||
127509956|NCT00042432|458827220|FG000|Overall Study|Initiation of maintenance dialysis|1|||
127509957|NCT00042432|458827221|FG001|Overall Study|Initiation of maintenance dialysis|1|||
127509958|NCT00042432|458827220|FG000|Overall Study|Other|2|||
127509959|NCT00042432|458827221|FG001|Overall Study|Other|0|||
127509960|NCT01853072|458827222|FG000|Overall Study|Adverse event prior to treatment|0|||
127509961|NCT01853072|458827223|FG001|Overall Study|Adverse event prior to treatment|1|||
127509962|NCT01853072|458827222|FG000|Overall Study|Adverse Event|0|||
127509963|NCT01853072|458827223|FG001|Overall Study|Adverse Event|3|||
127509964|NCT01853072|458827222|FG000|Overall Study|Death|1|||
127509965|NCT01853072|458827223|FG001|Overall Study|Death|4|||
127509966|NCT01853072|458827222|FG000|Overall Study|Lost to Follow-up|0|||
127509967|NCT01853072|458827223|FG001|Overall Study|Lost to Follow-up|3|||
127509968|NCT01853072|458827222|FG000|Overall Study|Non-compliance with study drug|0|||
127509969|NCT01853072|458827223|FG001|Overall Study|Non-compliance with study drug|1|||
127509970|NCT01853072|458827222|FG000|Overall Study|Physician Decision|1|||
127509971|NCT01853072|458827223|FG001|Overall Study|Physician Decision|1|||
127509972|NCT01853072|458827222|FG000|Overall Study|Withdrawal by Subject|1|||
127509973|NCT01853072|458827223|FG001|Overall Study|Withdrawal by Subject|2|||
127509974|NCT01853072|458827222|FG000|Overall Study|Reason not specified|9|||
127509975|NCT01853072|458827223|FG001|Overall Study|Reason not specified|6|||
127509976|NCT01816906|458827224|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
127509977|NCT01816906|458827225|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
127509978|NCT01816906|458827224|FG000|Six Months|Lost to Follow-up|14|||
127509979|NCT01816906|458827225|FG001|Six Months|Lost to Follow-up|16|||
127509980|NCT01816906|458827224|FG000|12 Months|Adverse Event|2|||
127509981|NCT01816906|458827225|FG001|12 Months|Adverse Event|2|||
127509982|NCT01816906|458827224|FG000|12 Months|Death|0|||
127978969|NCT00454818|460545668|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
127978970|NCT00454818|460545669|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
127509983|NCT01816906|458827225|FG001|12 Months|Death|2|||
127509984|NCT01816906|458827224|FG000|12 Months|Lost to Follow-up|2|||
127509985|NCT01816906|458827225|FG001|12 Months|Lost to Follow-up|1|||
127509986|NCT01527383|458827226|FG000|Overall Study|Adverse Event|5|||
127509987|NCT01527383|458827227|FG001|Overall Study|Adverse Event|0|||
127509988|NCT01527383|458827226|FG000|Overall Study|Lost to Follow-up|3|||
127509989|NCT01527383|458827227|FG001|Overall Study|Lost to Follow-up|0|||
127509990|NCT01527383|458827226|FG000|Overall Study|Physician Decision|2|||
127509991|NCT01527383|458827227|FG001|Overall Study|Physician Decision|0|||
127509992|NCT01527383|458827226|FG000|Overall Study|Pregnancy|1|||
127509993|NCT01527383|458827227|FG001|Overall Study|Pregnancy|0|||
127509994|NCT01527383|458827226|FG000|Overall Study|Protocol Violation|1|||
127509995|NCT01527383|458827227|FG001|Overall Study|Protocol Violation|0|||
127509996|NCT01527383|458827226|FG000|Overall Study|Screen failure|1|||
127509997|NCT01527383|458827227|FG001|Overall Study|Screen failure|0|||
127509998|NCT01527383|458827226|FG000|Overall Study|Participant moved|0|||
127509999|NCT01527383|458827227|FG001|Overall Study|Participant moved|1|||
127510000|NCT01527383|458827226|FG000|Overall Study|Withdrawal by Subject|2|||
127510001|NCT01527383|458827227|FG001|Overall Study|Withdrawal by Subject|3|||
127510002|NCT00746733|458827228|FG000|Second Intervention|Adverse Event|1|||
127510003|NCT00746733|458827229|FG001|Second Intervention|Adverse Event|0|||
127510004|NCT00746733|458827228|FG000|Third Intervention|Withdrawal by Subject|1|||
127510005|NCT00746733|458827229|FG001|Third Intervention|Withdrawal by Subject|1|||
127510006|NCT03412604|458827230|FG000|Overall Study|Withdrawal by Subject|1|||
127510007|NCT00930969|458827232|FG000|Overall Study|Death|5|||
127510008|NCT00930969|458827232|FG000|Overall Study|Lost to Follow-up|1|||
127510009|NCT00930969|458827232|FG000|Overall Study|Physician Decision|13|||
127510010|NCT00930969|458827232|FG000|Overall Study|Withdrawal by Subject|19|||
127510011|NCT01287221|458827233|FG000|Overall Study|Lack of Perceived Benefit|1|||
127510012|NCT01287221|458827234|FG001|Overall Study|Lack of Perceived Benefit|1|||
127510013|NCT01287221|458827233|FG000|Overall Study|Adverse Event|3|||
127510014|NCT01287221|458827234|FG001|Overall Study|Adverse Event|3|||
127510015|NCT01287221|458827233|FG000|Overall Study|Withdrawal by Subject|0|||
127510016|NCT01287221|458827234|FG001|Overall Study|Withdrawal by Subject|1|||
127510017|NCT00657150|458827235|FG000|Overall Study|Adverse Event|19|||
127510018|NCT00657150|458827236|FG001|Overall Study|Adverse Event|10|||
127510019|NCT00657150|458827235|FG000|Overall Study|Non-compliant with protocol|5|||
127510020|NCT00657150|458827236|FG001|Overall Study|Non-compliant with protocol|9|||
127510021|NCT00657150|458827235|FG000|Overall Study|Lost to Follow-up|2|||
127510022|NCT00657150|458827236|FG001|Overall Study|Lost to Follow-up|0|||
127510023|NCT00657150|458827235|FG000|Overall Study|Withdrawal by Subject|51|||
127510024|NCT00657150|458827236|FG001|Overall Study|Withdrawal by Subject|36|||
127510025|NCT00657150|458827235|FG000|Overall Study|Other|38|||
127510026|NCT00657150|458827236|FG001|Overall Study|Other|38|||
127510027|NCT00657150|458827235|FG000|Treatment|Adverse Event|60|||
127510028|NCT00657150|458827236|FG001|Treatment|Adverse Event|53|||
127510029|NCT00657150|458827235|FG000|Treatment|Non-compliant with protocol|10|||
127510030|NCT00657150|458827236|FG001|Treatment|Non-compliant with protocol|9|||
127510031|NCT00657150|458827235|FG000|Treatment|Lost to Follow-up|1|||
127510032|NCT00657150|458827236|FG001|Treatment|Lost to Follow-up|0|||
127510033|NCT00657150|458827235|FG000|Treatment|Withdrawal by Subject|23|||
127510034|NCT00657150|458827236|FG001|Treatment|Withdrawal by Subject|20|||
127510035|NCT00657150|458827235|FG000|Treatment|Other|13|||
127510036|NCT00657150|458827236|FG001|Treatment|Other|15|||
127510037|NCT02966795|458827237|FG000|Overall Study|Patient Left the Country|0|||
127510038|NCT02966795|458827238|FG001|Overall Study|Patient Left the Country|1|||
127510039|NCT00432744|458827239|FG000|Months 0-6|Withdrawal by Subject|4|||
127510040|NCT00432744|458827240|FG001|Months 0-6|Withdrawal by Subject|4|||
127510041|NCT00432744|458827239|FG000|Months 0-6|Too disabled to score|1|||
127510042|NCT00432744|458827240|FG001|Months 0-6|Too disabled to score|0|||
127510043|NCT00432744|458827239|FG000|Months 7 - 12|Withdrawal by Subject|1|||
127510044|NCT00432744|458827240|FG001|Months 7 - 12|Withdrawal by Subject|0|||
127510045|NCT00432744|458827239|FG000|Months 7 - 12|Too disabled to score|0|||
127510046|NCT00432744|458827240|FG001|Months 7 - 12|Too disabled to score|1|||
127510047|NCT00468845|458827254|FG000|Overall Study|Adverse Event|9|||
127510048|NCT00468845|458827255|FG001|Overall Study|Adverse Event|14|||
127510049|NCT00468845|458827256|FG002|Overall Study|Adverse Event|11|||
127510050|NCT00468845|458827254|FG000|Overall Study|Lost to Follow-up|2|||
127510051|NCT00468845|458827255|FG001|Overall Study|Lost to Follow-up|1|||
127510052|NCT00468845|458827256|FG002|Overall Study|Lost to Follow-up|2|||
127510053|NCT00468845|458827254|FG000|Overall Study|Other|4|||
127510054|NCT00468845|458827255|FG001|Overall Study|Other|9|||
127510055|NCT00468845|458827256|FG002|Overall Study|Other|5|||
127510056|NCT00468845|458827254|FG000|Overall Study|No longer willing to participate|5|||
127510057|NCT00468845|458827255|FG001|Overall Study|No longer willing to participate|6|||
127510058|NCT00468845|458827256|FG002|Overall Study|No longer willing to participate|10|||
127510059|NCT00468845|458827254|FG000|Overall Study|Randomized, not treated|1|||
127510060|NCT00468845|458827255|FG001|Overall Study|Randomized, not treated|4|||
127510061|NCT00468845|458827256|FG002|Overall Study|Randomized, not treated|2|||
127510062|NCT02395055|458827261|FG000|Overall Study|Withdrawal by Subject|7|||
127510063|NCT02395055|458827262|FG001|Overall Study|Withdrawal by Subject|3|||
127510064|NCT00509093|458829403|FG000|Overall Study|Adverse Event|10|||
127510065|NCT00509093|458829403|FG000|Overall Study|Disease Progression|9|||
127510066|NCT00509093|458829403|FG000|Overall Study|Transformed into MDS|1|||
127510067|NCT00509093|458829403|FG000|Overall Study|Withdrawal by Subject|3|||
127510068|NCT00509093|458829403|FG000|Overall Study|Physician Decision|1|||
127510069|NCT05320393|458829404|FG000|Overall Study|Withdrawal by Subject|1|||
127510070|NCT05320393|458829405|FG001|Overall Study|Withdrawal by Subject|0|||
127510071|NCT05320393|458829406|FG002|Overall Study|Withdrawal by Subject|2|||
127510072|NCT05320393|458829404|FG000|Overall Study|Lost to Follow-up|1|||
127510073|NCT05320393|458829405|FG001|Overall Study|Lost to Follow-up|2|||
127510074|NCT05320393|458829406|FG002|Overall Study|Lost to Follow-up|1|||
127510075|NCT05320393|458829404|FG000|Overall Study|Moved; too much driving|0|||
127510076|NCT05320393|458829405|FG001|Overall Study|Moved; too much driving|0|||
127510077|NCT05320393|458829406|FG002|Overall Study|Moved; too much driving|2|||
127510078|NCT05320393|458829404|FG000|Overall Study|Did not receive treatment|0|||
127510079|NCT05320393|458829405|FG001|Overall Study|Did not receive treatment|0|||
127510080|NCT05320393|458829406|FG002|Overall Study|Did not receive treatment|1|||
127510081|NCT03187834|458829410|FG000|Overall Study|Lost to Follow-up|0|||
127510082|NCT03187834|458829411|FG001|Overall Study|Lost to Follow-up|1|||
127510083|NCT03187834|458829412|FG002|Overall Study|Lost to Follow-up|2|||
127510084|NCT03187834|458829413|FG003|Overall Study|Lost to Follow-up|2|||
127510085|NCT03187834|458829410|FG000|Overall Study|Had invalid anthropometric measurements|5|||
127510086|NCT03187834|458829411|FG001|Overall Study|Had invalid anthropometric measurements|3|||
127510087|NCT03187834|458829412|FG002|Overall Study|Had invalid anthropometric measurements|4|||
127510088|NCT03187834|458829413|FG003|Overall Study|Had invalid anthropometric measurements|2|||
127510089|NCT03559699|458829414|FG000|Overall Study|Withdrawal by Subject|6|||
127510090|NCT03559699|458829414|FG000|Overall Study|Lost to Follow-up|1|||
127510091|NCT05438602|458829421|FG000|Treatment (15 Days)|Adverse Event|2|||
127510092|NCT05438602|458829422|FG001|Treatment (15 Days)|Adverse Event|1|||
127510093|NCT05438602|458829423|FG002|Treatment (15 Days)|Adverse Event|3|||
127510094|NCT05438602|458829421|FG000|Treatment (15 Days)|No longer met eligibility criteria|0|||
127510095|NCT05438602|458829422|FG001|Treatment (15 Days)|No longer met eligibility criteria|1|||
127510096|NCT05438602|458829423|FG002|Treatment (15 Days)|No longer met eligibility criteria|0|||
127510097|NCT05438602|458829421|FG000|Treatment (15 Days)|Other|0|||
127510098|NCT05438602|458829422|FG001|Treatment (15 Days)|Other|0|||
127510099|NCT05438602|458829423|FG002|Treatment (15 Days)|Other|1|||
127510100|NCT05438602|458829421|FG000|Treatment (15 Days)|Withdrawal by Subject|2|||
127510101|NCT05438602|458829422|FG001|Treatment (15 Days)|Withdrawal by Subject|1|||
127510102|NCT05438602|458829423|FG002|Treatment (15 Days)|Withdrawal by Subject|4|||
127510103|NCT05438602|458829421|FG000|Follow-up (Through Day 44)|Adverse Event|1|||
127510104|NCT05438602|458829422|FG001|Follow-up (Through Day 44)|Adverse Event|0|||
127510105|NCT05438602|458829423|FG002|Follow-up (Through Day 44)|Adverse Event|0|||
127510106|NCT05438602|458829421|FG000|Follow-up (Through Day 44)|Withdrawal by Subject|3|||
127510107|NCT05438602|458829422|FG001|Follow-up (Through Day 44)|Withdrawal by Subject|2|||
127510108|NCT05438602|458829423|FG002|Follow-up (Through Day 44)|Withdrawal by Subject|6|||
127510109|NCT05438602|458829421|FG000|Long-term Follow-up (Through Week 24)|Other|1|||
127510110|NCT05438602|458829422|FG001|Long-term Follow-up (Through Week 24)|Other|0|||
127510111|NCT05438602|458829423|FG002|Long-term Follow-up (Through Week 24)|Other|0|||
127510112|NCT05438602|458829421|FG000|Long-term Follow-up (Through Week 24)|Lost to Follow-up|1|||
127510113|NCT05438602|458829422|FG001|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
127510114|NCT05438602|458829423|FG002|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
127510115|NCT05438602|458829421|FG000|Long-term Follow-up (Through Week 24)|Death|1|||
127510116|NCT05438602|458829422|FG001|Long-term Follow-up (Through Week 24)|Death|0|||
127510117|NCT05438602|458829423|FG002|Long-term Follow-up (Through Week 24)|Death|1|||
127510118|NCT05438602|458829421|FG000|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|4|||
127510119|NCT05438602|458829422|FG001|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|5|||
127510120|NCT05438602|458829423|FG002|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|6|||
127510121|NCT01930890|458829424|FG000|Overall Study|Study Termination|14|||
127510122|NCT01930890|458829425|FG001|Overall Study|Study Termination|28|||
127510123|NCT01930890|458829426|FG002|Overall Study|Study Termination|13|||
127510124|NCT01930890|458829427|FG003|Overall Study|Study Termination|25|||
127510125|NCT01930890|458829424|FG000|Overall Study|Death|0|||
127510126|NCT01930890|458829425|FG001|Overall Study|Death|0|||
127510127|NCT01930890|458829426|FG002|Overall Study|Death|0|||
127510128|NCT01930890|458829427|FG003|Overall Study|Death|1|||
127510129|NCT01930890|458829424|FG000|Overall Study|Investigator Decision|0|||
127510130|NCT01930890|458829425|FG001|Overall Study|Investigator Decision|1|||
127510131|NCT01930890|458829426|FG002|Overall Study|Investigator Decision|0|||
127510132|NCT01930890|458829427|FG003|Overall Study|Investigator Decision|0|||
127510133|NCT01930890|458829424|FG000|Overall Study|Consent Withdrawn|0|||
127510134|NCT01930890|458829425|FG001|Overall Study|Consent Withdrawn|3|||
127510135|NCT01930890|458829426|FG002|Overall Study|Consent Withdrawn|0|||
127510136|NCT01930890|458829427|FG003|Overall Study|Consent Withdrawn|1|||
127510137|NCT01930890|458829424|FG000|Overall Study|Adverse Event|0|||
127510138|NCT01930890|458829425|FG001|Overall Study|Adverse Event|1|||
127510139|NCT01930890|458829426|FG002|Overall Study|Adverse Event|0|||
127510140|NCT01930890|458829427|FG003|Overall Study|Adverse Event|0|||
127510141|NCT02091284|458829428|FG000|Overall Study|Withdrawal by Subject|2|||
127510142|NCT02091284|458829429|FG001|Overall Study|Withdrawal by Subject|1|||
127510143|NCT02091284|458829428|FG000|Overall Study|unreliable data|1|||
127510144|NCT02091284|458829429|FG001|Overall Study|unreliable data|0|||
127510145|NCT01278407|458829430|FG000|Confirmatory Phase|Adverse Event|5|||
127978971|NCT00454818|460545665|FG000|Phase I: Open-label Dose-escalation|Death|0|||
127510146|NCT01278407|458829431|FG001|Confirmatory Phase|Adverse Event|10|||
127510147|NCT01278407|458829432|FG002|Confirmatory Phase|Adverse Event|1|||
127510148|NCT01278407|458829433|FG003|Confirmatory Phase|Adverse Event|0|||
127510149|NCT01278407|458829434|FG004|Confirmatory Phase|Adverse Event|0|||
127510150|NCT01278407|458829430|FG000|Confirmatory Phase|Participant's Choice|3|||
127510151|NCT01278407|458829431|FG001|Confirmatory Phase|Participant's Choice|5|||
127510152|NCT01278407|458829432|FG002|Confirmatory Phase|Participant's Choice|3|||
127510153|NCT01278407|458829433|FG003|Confirmatory Phase|Participant's Choice|0|||
127510154|NCT01278407|458829434|FG004|Confirmatory Phase|Participant's Choice|0|||
127510155|NCT01278407|458829430|FG000|Confirmatory Phase|Other|1|||
127510156|NCT01278407|458829431|FG001|Confirmatory Phase|Other|1|||
127510157|NCT01278407|458829432|FG002|Confirmatory Phase|Other|2|||
127510158|NCT01278407|458829433|FG003|Confirmatory Phase|Other|0|||
127510159|NCT01278407|458829434|FG004|Confirmatory Phase|Other|0|||
127510160|NCT01278407|458829430|FG000|Extension Phase|Adverse Event|0|||
127510161|NCT01278407|458829431|FG001|Extension Phase|Adverse Event|0|||
127510162|NCT01278407|458829432|FG002|Extension Phase|Adverse Event|0|||
127510163|NCT01278407|458829433|FG003|Extension Phase|Adverse Event|7|||
127510164|NCT01278407|458829434|FG004|Extension Phase|Adverse Event|16|||
127510165|NCT01278407|458829430|FG000|Extension Phase|Participant's Choice|0|||
127510166|NCT01278407|458829431|FG001|Extension Phase|Participant's Choice|0|||
127510167|NCT01278407|458829432|FG002|Extension Phase|Participant's Choice|0|||
127510168|NCT01278407|458829433|FG003|Extension Phase|Participant's Choice|4|||
127510169|NCT01278407|458829434|FG004|Extension Phase|Participant's Choice|11|||
127510170|NCT01278407|458829430|FG000|Extension Phase|Other|0|||
127510171|NCT01278407|458829431|FG001|Extension Phase|Other|0|||
127510172|NCT01278407|458829432|FG002|Extension Phase|Other|0|||
127510173|NCT01278407|458829433|FG003|Extension Phase|Other|1|||
127510174|NCT01278407|458829434|FG004|Extension Phase|Other|3|||
127510175|NCT04431713|458829437|FG000|Overall Study|Withdrawal by Subject|2|||
127510176|NCT04431713|458829438|FG001|Overall Study|Withdrawal by Subject|0|||
127510177|NCT04431713|458829437|FG000|Overall Study|Death|2|||
127510178|NCT04431713|458829438|FG001|Overall Study|Death|2|||
127510179|NCT03383783|458829441|FG000|Overall Study|Withdrawal by Subject|2|||
127510180|NCT01224821|458829445|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
127510181|NCT01224821|458829445|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
127510182|NCT01224821|458829445|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
127510183|NCT01224821|458829445|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
127510184|NCT01224821|458829445|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
127510185|NCT01224821|458829445|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
127510186|NCT01224821|458829445|FG000|Long-Term Follow-Up|Death|2|||
127510187|NCT01224821|458829445|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
127510188|NCT01340937|458829446|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
127510189|NCT01340937|458829447|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
127510190|NCT01340937|458829448|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
127510191|NCT01340937|458829449|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
127510192|NCT01340937|458829446|FG000|Period 1: Infant Series|Adverse Event|0|||
127510193|NCT01340937|458829447|FG001|Period 1: Infant Series|Adverse Event|1|||
127510194|NCT01340937|458829448|FG002|Period 1: Infant Series|Adverse Event|4|||
127510195|NCT01340937|458829449|FG003|Period 1: Infant Series|Adverse Event|0|||
127510196|NCT01340937|458829446|FG000|Period 1: Infant Series|Death|2|||
127510197|NCT01340937|458829447|FG001|Period 1: Infant Series|Death|0|||
127510198|NCT01340937|458829448|FG002|Period 1: Infant Series|Death|2|||
127510199|NCT01340937|458829449|FG003|Period 1: Infant Series|Death|0|||
127510200|NCT01340937|458829446|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
127510201|NCT01340937|458829447|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
127510202|NCT01340937|458829448|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
127510203|NCT01340937|458829449|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
127510204|NCT01340937|458829446|FG000|Period 1: Infant Series|Physician Decision|2|||
127510205|NCT01340937|458829447|FG001|Period 1: Infant Series|Physician Decision|3|||
127510206|NCT01340937|458829448|FG002|Period 1: Infant Series|Physician Decision|1|||
127510207|NCT01340937|458829449|FG003|Period 1: Infant Series|Physician Decision|0|||
127510208|NCT01340937|458829446|FG000|Period 1: Infant Series|Protocol Violation|1|||
127510209|NCT01340937|458829447|FG001|Period 1: Infant Series|Protocol Violation|4|||
127510210|NCT01340937|458829448|FG002|Period 1: Infant Series|Protocol Violation|4|||
127510211|NCT01340937|458829449|FG003|Period 1: Infant Series|Protocol Violation|3|||
127510212|NCT01340937|458829446|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
127510213|NCT01340937|458829447|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
127510214|NCT01340937|458829448|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
127510215|NCT01340937|458829449|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
127510216|NCT01340937|458829446|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
127510217|NCT01340937|458829447|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
127510218|NCT01340937|458829448|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
127510219|NCT01340937|458829449|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
127510220|NCT01340937|458829446|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
127510221|NCT01340937|458829447|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
127510222|NCT01340937|458829448|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
127510223|NCT01340937|458829449|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
127510224|NCT01340937|458829446|FG000|Period 2: Interim Period|Adverse Event|1|||
127510225|NCT01340937|458829447|FG001|Period 2: Interim Period|Adverse Event|0|||
127510226|NCT01340937|458829448|FG002|Period 2: Interim Period|Adverse Event|1|||
127510227|NCT01340937|458829449|FG003|Period 2: Interim Period|Adverse Event|0|||
127510228|NCT01340937|458829446|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
127510229|NCT01340937|458829447|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
127510230|NCT01340937|458829448|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
127510231|NCT01340937|458829449|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
127510232|NCT01340937|458829446|FG000|Period 2: Interim Period|Physician Decision|0|||
127510233|NCT01340937|458829447|FG001|Period 2: Interim Period|Physician Decision|1|||
127510234|NCT01340937|458829448|FG002|Period 2: Interim Period|Physician Decision|1|||
127510235|NCT01340937|458829449|FG003|Period 2: Interim Period|Physician Decision|0|||
127510236|NCT01340937|458829446|FG000|Period 2: Interim Period|Protocol Violation|5|||
127510237|NCT01340937|458829447|FG001|Period 2: Interim Period|Protocol Violation|3|||
127510238|NCT01340937|458829448|FG002|Period 2: Interim Period|Protocol Violation|6|||
127510239|NCT01340937|458829449|FG003|Period 2: Interim Period|Protocol Violation|3|||
127510240|NCT01340937|458829446|FG000|Period 2: Interim Period|Technical problems|4|||
127510241|NCT01340937|458829447|FG001|Period 2: Interim Period|Technical problems|4|||
127510242|NCT01340937|458829448|FG002|Period 2: Interim Period|Technical problems|6|||
127510243|NCT01340937|458829449|FG003|Period 2: Interim Period|Technical problems|3|||
127510244|NCT01340937|458829446|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
127510245|NCT01340937|458829447|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
127510246|NCT01340937|458829448|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
127510247|NCT01340937|458829449|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
127510248|NCT01340937|458829446|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
127510249|NCT01340937|458829447|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
127510250|NCT01340937|458829448|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
127510251|NCT01340937|458829449|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
127510252|NCT01340937|458829446|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
127510253|NCT01340937|458829447|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
127510254|NCT01340937|458829448|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
127510255|NCT01340937|458829449|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
127510256|NCT01340937|458829446|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
127510257|NCT01340937|458829447|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
127510258|NCT01340937|458829448|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
127510259|NCT01340937|458829449|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
127510260|NCT02469415|458829453|FG000|Overall Study|Withdrawal by Subject|1|||
127510261|NCT02469415|458829453|FG000|Overall Study|Investigational agent placed on hold|2|||
127510262|NCT00350623|458829456|FG000|Overall Study|Lost to Follow-up|8|||
127510263|NCT00350623|458829457|FG001|Overall Study|Lost to Follow-up|3|||
127510264|NCT00350623|458829458|FG002|Overall Study|Lost to Follow-up|4|||
127510265|NCT00350623|458829456|FG000|Overall Study|Withdrawal by Subject|0|||
127510266|NCT00350623|458829457|FG001|Overall Study|Withdrawal by Subject|1|||
127510267|NCT00350623|458829458|FG002|Overall Study|Withdrawal by Subject|1|||
127510268|NCT00350623|458829456|FG000|Overall Study|patient traveling outside the country|0|||
127510269|NCT00350623|458829457|FG001|Overall Study|patient traveling outside the country|0|||
127510270|NCT00350623|458829458|FG002|Overall Study|patient traveling outside the country|1|||
127510271|NCT00623545|458829459|FG000|Overall Study|Adverse Event|6|||
127510272|NCT00623545|458829459|FG000|Overall Study|Withdrawal by Subject|4|||
127510273|NCT01974752|458829462|FG000|Overall Study|Death|33|||
127510274|NCT01974752|458829463|FG001|Overall Study|Death|11|||
127510275|NCT01974752|458829462|FG000|Overall Study|Lost to Follow-up|2|||
127510276|NCT01974752|458829463|FG001|Overall Study|Lost to Follow-up|0|||
127510277|NCT01974752|458829462|FG000|Overall Study|Withdrawal by Subject|2|||
127510278|NCT01974752|458829463|FG001|Overall Study|Withdrawal by Subject|3|||
127510279|NCT01974752|458829462|FG000|Overall Study|Other Eligibility Criteria|0|||
127510280|NCT01974752|458829463|FG001|Overall Study|Other Eligibility Criteria|1|||
127510281|NCT00330928|458829467|FG000|Overall Study|Lost to Follow-up|6|||
127510282|NCT00330928|458829467|FG000|Overall Study|Physician Decision|9|||
127510283|NCT00330928|458829467|FG000|Overall Study|Death|1|||
127510284|NCT00330928|458829467|FG000|Overall Study|IVUS could not be performed.|1|||
127510285|NCT03028480|458829468|FG000|Overall Study|No revisit after the first prescription date|2|||
127510286|NCT03028480|458829468|FG000|Overall Study|Did not use the drug|1|||
127510287|NCT03028480|458829468|FG000|Overall Study|Violation of the enrollment deadline|10|||
127510288|NCT03028480|458829468|FG000|Overall Study|Case report forms were not collected|21|||
127510289|NCT02279719|458829473|FG000|Overall Study|Patients randomized but never treated|0|||
127510290|NCT02279719|458829474|FG001|Overall Study|Patients randomized but never treated|0|||
127510291|NCT02279719|458829475|FG002|Overall Study|Patients randomized but never treated|0|||
127510292|NCT02279719|458829476|FG003|Overall Study|Patients randomized but never treated|0|||
127510293|NCT02279719|458829477|FG004|Overall Study|Patients randomized but never treated|3|||
127510294|NCT02279719|458829478|FG005|Overall Study|Patients randomized but never treated|0|||
127510295|NCT02279719|458829479|FG006|Overall Study|Patients randomized but never treated|3|||
127510296|NCT03541187|458829480|FG000|Overall Study|Lost to Follow-up|2|||
127510297|NCT03541187|458829481|FG001|Overall Study|Lost to Follow-up|6|||
127510298|NCT03541187|458829480|FG000|Overall Study|Pregnancy|0|||
127510299|NCT03541187|458829481|FG001|Overall Study|Pregnancy|1|||
127510300|NCT03541187|458829480|FG000|Overall Study|Withdrawal by Subject|6|||
127510301|NCT03541187|458829481|FG001|Overall Study|Withdrawal by Subject|2|||
127510302|NCT03541187|458829480|FG000|Overall Study|Moved out of town|1|||
127510303|NCT03541187|458829481|FG001|Overall Study|Moved out of town|0|||
127510304|NCT03541187|458829480|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
127510305|NCT03541187|458829481|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
127510306|NCT03541187|458829480|FG000|Overall Study|Did not meet randomization criteria|1|||
127510307|NCT03541187|458829481|FG001|Overall Study|Did not meet randomization criteria|1|||
127510308|NCT03541187|458829480|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
127510309|NCT03541187|458829481|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
127510310|NCT03541187|458829480|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
127510311|NCT03541187|458829481|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
127510312|NCT01369680|458829484|FG000|Overall Study|Lost to Follow-up|0|||
127510313|NCT01369680|458829485|FG001|Overall Study|Lost to Follow-up|0|||
127510314|NCT01369680|458829486|FG002|Overall Study|Lost to Follow-up|1|||
127510315|NCT01369680|458829487|FG003|Overall Study|Lost to Follow-up|2|||
127510316|NCT01145053|458829490|FG000|Overall Study|Adverse Event|22|||
127510317|NCT01145053|458829490|FG000|Overall Study|Lost to Follow-up|28|||
127510318|NCT01145053|458829490|FG000|Overall Study|Withdrawal by Subject|25|||
127510319|NCT01145053|458829490|FG000|Overall Study|Other|18|||
127510320|NCT03220581|458829493|FG000|Overall Study|Withdrawal by Subject|0|||
127510321|NCT03220581|458829494|FG001|Overall Study|Withdrawal by Subject|1|||
127510322|NCT03220581|458829493|FG000|Overall Study|Lost to Follow-up|3|||
127510323|NCT03220581|458829494|FG001|Overall Study|Lost to Follow-up|6|||
127510324|NCT01484834|458829510|FG000|Overall Study|Lost to Follow-up|5|||
127510325|NCT01484834|458829511|FG001|Overall Study|Lost to Follow-up|8|||
127510326|NCT01484834|458829512|FG002|Overall Study|Lost to Follow-up|1|||
127510327|NCT01484834|458829513|FG003|Overall Study|Lost to Follow-up|4|||
127510328|NCT00747344|458829514|FG000|Controlled Period|Adverse Event|3|||
127510329|NCT00747344|458829515|FG001|Controlled Period|Adverse Event|0|||
127510330|NCT00747344|458829516|FG002|Controlled Period|Adverse Event|0|||
127510331|NCT00747344|458829517|FG003|Controlled Period|Adverse Event|0|||
127510332|NCT00747344|458829514|FG000|Controlled Period|Lack of Efficacy|2|||
127510333|NCT00747344|458829515|FG001|Controlled Period|Lack of Efficacy|1|||
127510334|NCT00747344|458829516|FG002|Controlled Period|Lack of Efficacy|0|||
127510335|NCT00747344|458829517|FG003|Controlled Period|Lack of Efficacy|0|||
127510336|NCT00747344|458829514|FG000|Controlled Period|Other|0|||
127510337|NCT00747344|458829515|FG001|Controlled Period|Other|3|||
127510338|NCT00747344|458829516|FG002|Controlled Period|Other|0|||
127510339|NCT00747344|458829517|FG003|Controlled Period|Other|0|||
127510340|NCT00747344|458829514|FG000|After Controlled Period|Adverse Event|0|||
127510341|NCT00747344|458829515|FG001|After Controlled Period|Adverse Event|0|||
127510342|NCT00747344|458829516|FG002|After Controlled Period|Adverse Event|0|||
127510343|NCT00747344|458829517|FG003|After Controlled Period|Adverse Event|1|||
127510344|NCT00765882|458829518|FG000|Overall Study|Adverse Event|10|||
127510345|NCT00765882|458829519|FG001|Overall Study|Adverse Event|21|||
127510346|NCT00765882|458829520|FG002|Overall Study|Adverse Event|20|||
127510347|NCT00765882|458829518|FG000|Overall Study|Lack of Efficacy|4|||
127978972|NCT00454818|460545666|FG001|Phase I: Open-label Dose-escalation|Death|1|||
127978973|NCT00454818|460545667|FG002|Phase I: Open-label Dose-escalation|Death|0|||
127978974|NCT00454818|460545668|FG003|Phase I: Open-label Dose-escalation|Death|0|||
127978975|NCT00454818|460545669|FG004|Phase I: Open-label Dose-escalation|Death|0|||
127978976|NCT00454818|460545665|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
127510348|NCT00765882|458829519|FG001|Overall Study|Lack of Efficacy|0|||
127510349|NCT00765882|458829520|FG002|Overall Study|Lack of Efficacy|1|||
127510350|NCT00765882|458829518|FG000|Overall Study|Protocol Violation|4|||
127510351|NCT00765882|458829519|FG001|Overall Study|Protocol Violation|3|||
127510352|NCT00765882|458829520|FG002|Overall Study|Protocol Violation|1|||
127510353|NCT00765882|458829518|FG000|Overall Study|Withdrawal by Subject|2|||
127510354|NCT00765882|458829519|FG001|Overall Study|Withdrawal by Subject|6|||
127510355|NCT00765882|458829520|FG002|Overall Study|Withdrawal by Subject|6|||
127510356|NCT00765882|458829518|FG000|Overall Study|Lost to Follow-up|1|||
127510357|NCT00765882|458829519|FG001|Overall Study|Lost to Follow-up|9|||
127510358|NCT00765882|458829520|FG002|Overall Study|Lost to Follow-up|6|||
127510359|NCT00765882|458829518|FG000|Overall Study|Other Reason|3|||
127510360|NCT00765882|458829519|FG001|Overall Study|Other Reason|1|||
127510361|NCT00765882|458829520|FG002|Overall Study|Other Reason|2|||
127510362|NCT02231762|458829521|FG000|Combination Phase|Adverse Event|10|||
127510363|NCT02231762|458829522|FG001|Combination Phase|Adverse Event|0|||
127510364|NCT02231762|458829523|FG002|Combination Phase|Adverse Event|0|||
127510365|NCT02231762|458829524|FG003|Combination Phase|Adverse Event|0|||
127510366|NCT02231762|458829521|FG000|Combination Phase|Withdrawal by Subject|2|||
127510367|NCT02231762|458829522|FG001|Combination Phase|Withdrawal by Subject|0|||
127510368|NCT02231762|458829523|FG002|Combination Phase|Withdrawal by Subject|0|||
127510369|NCT02231762|458829524|FG003|Combination Phase|Withdrawal by Subject|0|||
127510370|NCT02231762|458829521|FG000|Combination Phase|Disease Progression|6|||
127510371|NCT02231762|458829522|FG001|Combination Phase|Disease Progression|0|||
127510372|NCT02231762|458829523|FG002|Combination Phase|Disease Progression|0|||
127510373|NCT02231762|458829524|FG003|Combination Phase|Disease Progression|0|||
127510374|NCT02231762|458829521|FG000|Combination Phase|Did not meet inclusion criteria|1|||
127510375|NCT02231762|458829522|FG001|Combination Phase|Did not meet inclusion criteria|0|||
127510376|NCT02231762|458829523|FG002|Combination Phase|Did not meet inclusion criteria|0|||
127510377|NCT02231762|458829524|FG003|Combination Phase|Did not meet inclusion criteria|0|||
127510378|NCT02231762|458829521|FG000|Combination Phase|Protocol Violation|1|||
127510379|NCT02231762|458829522|FG001|Combination Phase|Protocol Violation|0|||
127510380|NCT02231762|458829523|FG002|Combination Phase|Protocol Violation|0|||
127510381|NCT02231762|458829524|FG003|Combination Phase|Protocol Violation|0|||
127510382|NCT02231762|458829521|FG000|Maintenance Phase|Disease progression|0|||
127510383|NCT02231762|458829522|FG001|Maintenance Phase|Disease progression|3|||
127510384|NCT02231762|458829523|FG002|Maintenance Phase|Disease progression|4|||
127510385|NCT02231762|458829524|FG003|Maintenance Phase|Disease progression|3|||
127510386|NCT02231762|458829521|FG000|Maintenance Phase|Adverse Event|0|||
127510387|NCT02231762|458829522|FG001|Maintenance Phase|Adverse Event|0|||
127510388|NCT02231762|458829523|FG002|Maintenance Phase|Adverse Event|1|||
127510389|NCT02231762|458829524|FG003|Maintenance Phase|Adverse Event|2|||
127510390|NCT01799239|458829525|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
127510391|NCT01799239|458829526|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
127510392|NCT01799239|458829525|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
127510393|NCT01799239|458829526|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
127510394|NCT01799239|458829525|FG000|Period 1 (7 Days)|Protocol Violation|0|||
127510395|NCT01799239|458829526|FG001|Period 1 (7 Days)|Protocol Violation|1|||
127510396|NCT01799239|458829525|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
127510397|NCT01799239|458829526|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
127510398|NCT01799239|458829525|FG000|Period 2 (7 Days)|Protocol Violation|1|||
127510399|NCT01799239|458829526|FG001|Period 2 (7 Days)|Protocol Violation|0|||
127510400|NCT02813668|458829530|FG000|Overall Study|Death|4|||
127510401|NCT02813668|458829530|FG000|Overall Study|Lost to Follow-up|509|||
127510402|NCT02813668|458829530|FG000|Overall Study|Withdrawal by Subject|148|||
127510403|NCT02813668|458829530|FG000|Overall Study|No longer at worksite|85|||
127510404|NCT02813668|458829530|FG000|Overall Study|Medical reasons not related to the study|4|||
127510405|NCT01286987|458829531|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
127510406|NCT01286987|458829532|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
127510407|NCT01286987|458829533|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
127510408|NCT01286987|458829534|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
127510409|NCT01286987|458829535|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
127510410|NCT01286987|458829536|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
127510411|NCT01286987|458829537|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
127510412|NCT01286987|458829538|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
127510413|NCT01286987|458829539|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
127510414|NCT01286987|458829540|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
127510415|NCT01286987|458829541|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
127510416|NCT01286987|458829542|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
127510417|NCT01286987|458829543|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
127510418|NCT01286987|458829544|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
127510419|NCT01286987|458829545|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
127510420|NCT01286987|458829531|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
127510421|NCT01286987|458829532|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
127510422|NCT01286987|458829533|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
127510423|NCT01286987|458829534|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
127510424|NCT01286987|458829535|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
127510425|NCT01286987|458829536|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
127510426|NCT01286987|458829537|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
127510427|NCT01286987|458829538|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
127510428|NCT01286987|458829539|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
127510429|NCT01286987|458829540|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
127510430|NCT01286987|458829541|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
127510431|NCT01286987|458829542|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
127510432|NCT01286987|458829543|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
127510433|NCT01286987|458829544|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
127510434|NCT01286987|458829545|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
127510435|NCT01286987|458829531|FG000|Part 1: Dose Escalation|Physician Decision|0|||
127510436|NCT01286987|458829532|FG001|Part 1: Dose Escalation|Physician Decision|0|||
127510437|NCT01286987|458829533|FG002|Part 1: Dose Escalation|Physician Decision|0|||
127510438|NCT01286987|458829534|FG003|Part 1: Dose Escalation|Physician Decision|0|||
127510439|NCT01286987|458829535|FG004|Part 1: Dose Escalation|Physician Decision|1|||
127510440|NCT01286987|458829536|FG005|Part 1: Dose Escalation|Physician Decision|0|||
127510441|NCT01286987|458829537|FG006|Part 1: Dose Escalation|Physician Decision|0|||
127510442|NCT01286987|458829538|FG007|Part 1: Dose Escalation|Physician Decision|0|||
127510443|NCT01286987|458829539|FG008|Part 1: Dose Escalation|Physician Decision|0|||
127510444|NCT01286987|458829540|FG009|Part 1: Dose Escalation|Physician Decision|0|||
127510445|NCT01286987|458829541|FG010|Part 1: Dose Escalation|Physician Decision|0|||
127510446|NCT01286987|458829542|FG011|Part 1: Dose Escalation|Physician Decision|0|||
127510447|NCT01286987|458829543|FG012|Part 1: Dose Escalation|Physician Decision|0|||
127510448|NCT01286987|458829544|FG013|Part 1: Dose Escalation|Physician Decision|0|||
127510449|NCT01286987|458829545|FG014|Part 1: Dose Escalation|Physician Decision|0|||
127510450|NCT01286987|458829531|FG000|Part 2: Dose Expansion|Death|0|||
127510451|NCT01286987|458829532|FG001|Part 2: Dose Expansion|Death|0|||
127510452|NCT01286987|458829533|FG002|Part 2: Dose Expansion|Death|0|||
127510453|NCT01286987|458829534|FG003|Part 2: Dose Expansion|Death|0|||
127510454|NCT01286987|458829535|FG004|Part 2: Dose Expansion|Death|0|||
127510455|NCT01286987|458829536|FG005|Part 2: Dose Expansion|Death|0|||
127510456|NCT01286987|458829537|FG006|Part 2: Dose Expansion|Death|0|||
127510457|NCT01286987|458829538|FG007|Part 2: Dose Expansion|Death|0|||
127510458|NCT01286987|458829539|FG008|Part 2: Dose Expansion|Death|0|||
127510459|NCT01286987|458829540|FG009|Part 2: Dose Expansion|Death|0|||
127510460|NCT01286987|458829541|FG010|Part 2: Dose Expansion|Death|0|||
127510461|NCT01286987|458829542|FG011|Part 2: Dose Expansion|Death|0|||
127510462|NCT01286987|458829543|FG012|Part 2: Dose Expansion|Death|1|||
127510463|NCT01286987|458829544|FG013|Part 2: Dose Expansion|Death|1|||
127510464|NCT01286987|458829545|FG014|Part 2: Dose Expansion|Death|0|||
127510465|NCT01286987|458829531|FG000|Part 2: Dose Expansion|Physician Decision|0|||
127510466|NCT01286987|458829532|FG001|Part 2: Dose Expansion|Physician Decision|0|||
127510467|NCT01286987|458829533|FG002|Part 2: Dose Expansion|Physician Decision|0|||
127510468|NCT01286987|458829534|FG003|Part 2: Dose Expansion|Physician Decision|0|||
127510469|NCT01286987|458829535|FG004|Part 2: Dose Expansion|Physician Decision|0|||
127510470|NCT01286987|458829536|FG005|Part 2: Dose Expansion|Physician Decision|0|||
127510471|NCT01286987|458829537|FG006|Part 2: Dose Expansion|Physician Decision|0|||
127510472|NCT01286987|458829538|FG007|Part 2: Dose Expansion|Physician Decision|0|||
127510473|NCT01286987|458829539|FG008|Part 2: Dose Expansion|Physician Decision|0|||
127510474|NCT01286987|458829540|FG009|Part 2: Dose Expansion|Physician Decision|0|||
127510475|NCT01286987|458829541|FG010|Part 2: Dose Expansion|Physician Decision|1|||
127510476|NCT01286987|458829542|FG011|Part 2: Dose Expansion|Physician Decision|1|||
127510477|NCT01286987|458829543|FG012|Part 2: Dose Expansion|Physician Decision|0|||
127510478|NCT01286987|458829544|FG013|Part 2: Dose Expansion|Physician Decision|1|||
127510479|NCT01286987|458829545|FG014|Part 2: Dose Expansion|Physician Decision|0|||
127510480|NCT01286987|458829531|FG000|Part 2: Dose Expansion|Other|0|||
127510481|NCT01286987|458829532|FG001|Part 2: Dose Expansion|Other|0|||
127510482|NCT01286987|458829533|FG002|Part 2: Dose Expansion|Other|0|||
127510483|NCT01286987|458829534|FG003|Part 2: Dose Expansion|Other|0|||
127510484|NCT01286987|458829535|FG004|Part 2: Dose Expansion|Other|0|||
127510485|NCT01286987|458829536|FG005|Part 2: Dose Expansion|Other|0|||
127510486|NCT01286987|458829537|FG006|Part 2: Dose Expansion|Other|0|||
127510487|NCT01286987|458829538|FG007|Part 2: Dose Expansion|Other|0|||
127510488|NCT01286987|458829539|FG008|Part 2: Dose Expansion|Other|0|||
127510489|NCT01286987|458829540|FG009|Part 2: Dose Expansion|Other|0|||
127510490|NCT01286987|458829541|FG010|Part 2: Dose Expansion|Other|0|||
127510491|NCT01286987|458829542|FG011|Part 2: Dose Expansion|Other|0|||
127510492|NCT01286987|458829543|FG012|Part 2: Dose Expansion|Other|0|||
127510493|NCT01286987|458829544|FG013|Part 2: Dose Expansion|Other|1|||
127510494|NCT01286987|458829545|FG014|Part 2: Dose Expansion|Other|0|||
127510495|NCT01286987|458829531|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
127510496|NCT01286987|458829532|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
127510497|NCT01286987|458829533|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
127510498|NCT01286987|458829534|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
127510499|NCT01286987|458829535|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
127510500|NCT01286987|458829536|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
127510501|NCT01286987|458829537|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
127510502|NCT01286987|458829538|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
127510503|NCT01286987|458829539|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
127510504|NCT01286987|458829540|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
127510505|NCT01286987|458829541|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
127510506|NCT01286987|458829542|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
127510507|NCT01286987|458829543|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
127510508|NCT01286987|458829544|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
127510509|NCT01286987|458829545|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
127510510|NCT01286987|458829531|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
127510511|NCT01286987|458829532|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
127510512|NCT01286987|458829533|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
127510513|NCT01286987|458829534|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
127510514|NCT01286987|458829535|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
127510515|NCT01286987|458829536|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
127510516|NCT01286987|458829537|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
127510517|NCT01286987|458829538|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
127510518|NCT01286987|458829539|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
127510519|NCT01286987|458829540|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
127510520|NCT01286987|458829541|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
127510521|NCT01286987|458829542|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
127510522|NCT01286987|458829543|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
127510523|NCT01286987|458829544|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
127510524|NCT01286987|458829545|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
127510525|NCT01286987|458829531|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
127510526|NCT01286987|458829532|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
127510527|NCT01286987|458829533|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
127510528|NCT01286987|458829534|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
127510529|NCT01286987|458829535|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
127510530|NCT01286987|458829536|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
127510531|NCT01286987|458829537|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
127510532|NCT01286987|458829538|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
127510533|NCT01286987|458829539|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
127510534|NCT01286987|458829540|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
127510535|NCT01286987|458829541|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
127510536|NCT01286987|458829542|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
127510537|NCT01286987|458829543|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
127510538|NCT01286987|458829544|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
127510539|NCT01286987|458829545|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
127510540|NCT02594098|458829546|FG000|Overall Study|Lack of Efficacy|17|||
127510541|NCT02594098|458829547|FG001|Overall Study|Lack of Efficacy|6|||
127510542|NCT02594098|458829546|FG000|Overall Study|Withdrawal by Subject|1|||
127510543|NCT02594098|458829547|FG001|Overall Study|Withdrawal by Subject|3|||
127510544|NCT02594098|458829546|FG000|Overall Study|Terminated participation|6|||
127510545|NCT02594098|458829547|FG001|Overall Study|Terminated participation|2|||
127510546|NCT02594098|458829546|FG000|Overall Study|Seek alternative treatment|2|||
127510547|NCT02594098|458829547|FG001|Overall Study|Seek alternative treatment|1|||
127510548|NCT02594098|458829546|FG000|Overall Study|Other|0|||
127510549|NCT02594098|458829547|FG001|Overall Study|Other|1|||
127510550|NCT00033540|458829550|FG000|Overall Study|Adverse Event|14|||
127510551|NCT00033540|458829550|FG000|Overall Study|Death|1|||
127510552|NCT00033540|458829550|FG000|Overall Study|Progression|26|||
127510553|NCT00033540|458829550|FG000|Overall Study|Withdrawal by Subject|6|||
127510554|NCT00033540|458829550|FG000|Overall Study|Other|5|||
127510555|NCT00033540|458829550|FG000|Overall Study|Ineligible|3|||
127510556|NCT00033540|458829550|FG000|Overall Study|Never received treatment|2|||
127510557|NCT03366103|458829551|FG000|Overall Study|Disease Progression|3|||
127510558|NCT03366103|458829552|FG001|Overall Study|Disease Progression|1|||
127510559|NCT03366103|458829553|FG002|Overall Study|Disease Progression|0|||
127510560|NCT03366103|458829551|FG000|Overall Study|Adverse Event|0|||
127510561|NCT03366103|458829552|FG001|Overall Study|Adverse Event|1|||
127510562|NCT03366103|458829553|FG002|Overall Study|Adverse Event|0|||
127510563|NCT01036529|458829554|FG000|Overall Study|Adverse Event|0|||
127510564|NCT01036529|458829555|FG001|Overall Study|Adverse Event|1|||
127510565|NCT01036529|458829554|FG000|Overall Study|Lost to Follow-up|0|||
127510566|NCT01036529|458829555|FG001|Overall Study|Lost to Follow-up|1|||
127510567|NCT01036529|458829554|FG000|Overall Study|Physician Decision|1|||
127510568|NCT01036529|458829555|FG001|Overall Study|Physician Decision|0|||
127510569|NCT01036529|458829554|FG000|Overall Study|Withdrawal by Subject|1|||
127510570|NCT01036529|458829555|FG001|Overall Study|Withdrawal by Subject|1|||
127510571|NCT01036529|458829554|FG000|Overall Study|Sponsor study termination|11|||
127510572|NCT01036529|458829555|FG001|Overall Study|Sponsor study termination|12|||
127510573|NCT01945775|458829556|FG000|Overall Study|Death|214|||
127510574|NCT01945775|458829557|FG001|Overall Study|Death|98|||
127510575|NCT01945775|458829556|FG000|Overall Study|Lost to Follow-up|12|||
127510576|NCT01945775|458829557|FG001|Overall Study|Lost to Follow-up|7|||
127510577|NCT01945775|458829556|FG000|Overall Study|Withdrawal by Subject|11|||
127510578|NCT01945775|458829557|FG001|Overall Study|Withdrawal by Subject|21|||
127510579|NCT01945775|458829556|FG000|Overall Study|Other|50|||
127510580|NCT01945775|458829557|FG001|Overall Study|Other|18|||
127510581|NCT02876328|458829558|FG000|Overall Study|Death|2|||
127510582|NCT02876328|458829559|FG001|Overall Study|Death|1|||
127510583|NCT02876328|458829560|FG002|Overall Study|Death|3|||
127510584|NCT02876328|458829561|FG003|Overall Study|Death|0|||
127510585|NCT02876328|458829562|FG004|Overall Study|Death|0|||
127510586|NCT02876328|458829563|FG005|Overall Study|Death|0|||
127510587|NCT02876328|458829564|FG006|Overall Study|Death|1|||
127510588|NCT02876328|458829565|FG007|Overall Study|Death|3|||
127510589|NCT02876328|458829566|FG008|Overall Study|Death|0|||
127510590|NCT02876328|458829567|FG009|Overall Study|Death|1|||
127510591|NCT02876328|458829568|FG010|Overall Study|Death|1|||
127510592|NCT02876328|458829569|FG011|Overall Study|Death|0|||
127510593|NCT02876328|458829570|FG012|Overall Study|Death|0|||
127510594|NCT02876328|458829571|FG013|Overall Study|Death|0|||
127510595|NCT02876328|458829572|FG014|Overall Study|Death|0|||
127510596|NCT02876328|458829573|FG015|Overall Study|Death|0|||
127510597|NCT02876328|458829574|FG016|Overall Study|Death|1|||
127510598|NCT02876328|458829575|FG017|Overall Study|Death|1|||
127510599|NCT02876328|458829576|FG018|Overall Study|Death|0|||
127510600|NCT02876328|458829577|FG019|Overall Study|Death|0|||
127510601|NCT02876328|458829578|FG020|Overall Study|Death|0|||
127510602|NCT02876328|458829579|FG021|Overall Study|Death|1|||
127510603|NCT02876328|458829580|FG022|Overall Study|Death|0|||
127510604|NCT02876328|458829581|FG023|Overall Study|Death|0|||
127510605|NCT02876328|458829558|FG000|Overall Study|Withdrawal by Subject|0|||
127510606|NCT02876328|458829559|FG001|Overall Study|Withdrawal by Subject|2|||
127510607|NCT02876328|458829560|FG002|Overall Study|Withdrawal by Subject|3|||
127510608|NCT02876328|458829561|FG003|Overall Study|Withdrawal by Subject|3|||
127510609|NCT02876328|458829562|FG004|Overall Study|Withdrawal by Subject|0|||
127510610|NCT02876328|458829563|FG005|Overall Study|Withdrawal by Subject|1|||
127510611|NCT02876328|458829564|FG006|Overall Study|Withdrawal by Subject|0|||
127510612|NCT02876328|458829565|FG007|Overall Study|Withdrawal by Subject|1|||
127510613|NCT02876328|458829566|FG008|Overall Study|Withdrawal by Subject|1|||
127510614|NCT02876328|458829567|FG009|Overall Study|Withdrawal by Subject|2|||
127510615|NCT02876328|458829568|FG010|Overall Study|Withdrawal by Subject|0|||
127510616|NCT02876328|458829569|FG011|Overall Study|Withdrawal by Subject|0|||
127510617|NCT02876328|458829570|FG012|Overall Study|Withdrawal by Subject|0|||
127510618|NCT02876328|458829571|FG013|Overall Study|Withdrawal by Subject|0|||
127510619|NCT02876328|458829572|FG014|Overall Study|Withdrawal by Subject|0|||
127510620|NCT02876328|458829573|FG015|Overall Study|Withdrawal by Subject|0|||
127510621|NCT02876328|458829574|FG016|Overall Study|Withdrawal by Subject|1|||
127510622|NCT02876328|458829575|FG017|Overall Study|Withdrawal by Subject|3|||
127510623|NCT02876328|458829576|FG018|Overall Study|Withdrawal by Subject|0|||
127510624|NCT02876328|458829577|FG019|Overall Study|Withdrawal by Subject|0|||
127510625|NCT02876328|458829578|FG020|Overall Study|Withdrawal by Subject|1|||
127510626|NCT02876328|458829579|FG021|Overall Study|Withdrawal by Subject|0|||
127510627|NCT02876328|458829580|FG022|Overall Study|Withdrawal by Subject|0|||
127510628|NCT02876328|458829581|FG023|Overall Study|Withdrawal by Subject|0|||
127510629|NCT02876328|458829558|FG000|Overall Study|Missed 12 Month Visit|15|||
127510630|NCT02876328|458829559|FG001|Overall Study|Missed 12 Month Visit|10|||
127510631|NCT02876328|458829560|FG002|Overall Study|Missed 12 Month Visit|11|||
127510632|NCT02876328|458829561|FG003|Overall Study|Missed 12 Month Visit|6|||
127510633|NCT02876328|458829562|FG004|Overall Study|Missed 12 Month Visit|10|||
127510634|NCT02876328|458829563|FG005|Overall Study|Missed 12 Month Visit|14|||
127510635|NCT02876328|458829564|FG006|Overall Study|Missed 12 Month Visit|3|||
127510636|NCT02876328|458829565|FG007|Overall Study|Missed 12 Month Visit|8|||
127510637|NCT02876328|458829566|FG008|Overall Study|Missed 12 Month Visit|9|||
127510638|NCT02876328|458829567|FG009|Overall Study|Missed 12 Month Visit|5|||
127510639|NCT02876328|458829568|FG010|Overall Study|Missed 12 Month Visit|4|||
127510640|NCT02876328|458829569|FG011|Overall Study|Missed 12 Month Visit|1|||
127510641|NCT02876328|458829570|FG012|Overall Study|Missed 12 Month Visit|5|||
127510642|NCT02876328|458829571|FG013|Overall Study|Missed 12 Month Visit|4|||
127510643|NCT02876328|458829572|FG014|Overall Study|Missed 12 Month Visit|4|||
127510644|NCT02876328|458829573|FG015|Overall Study|Missed 12 Month Visit|4|||
127510645|NCT02876328|458829574|FG016|Overall Study|Missed 12 Month Visit|3|||
127510646|NCT02876328|458829575|FG017|Overall Study|Missed 12 Month Visit|6|||
127510647|NCT02876328|458829576|FG018|Overall Study|Missed 12 Month Visit|2|||
127510648|NCT02876328|458829577|FG019|Overall Study|Missed 12 Month Visit|2|||
127510649|NCT02876328|458829578|FG020|Overall Study|Missed 12 Month Visit|11|||
127510650|NCT02876328|458829579|FG021|Overall Study|Missed 12 Month Visit|7|||
127510651|NCT02876328|458829580|FG022|Overall Study|Missed 12 Month Visit|1|||
127510652|NCT02876328|458829581|FG023|Overall Study|Missed 12 Month Visit|0|||
127510653|NCT02759315|458829584|FG000|Overall Study|Adverse Event|0|||
127510654|NCT02759315|458829585|FG001|Overall Study|Adverse Event|0|||
127510655|NCT02759315|458829586|FG002|Overall Study|Adverse Event|0|||
127510656|NCT02759315|458829587|FG003|Overall Study|Adverse Event|1|||
127510657|NCT02759315|458829588|FG004|Overall Study|Adverse Event|0|||
127510658|NCT02759315|458829584|FG000|Overall Study|Death|0|||
127510659|NCT02759315|458829585|FG001|Overall Study|Death|0|||
127510660|NCT02759315|458829586|FG002|Overall Study|Death|1|||
127510661|NCT02759315|458829587|FG003|Overall Study|Death|0|||
127510662|NCT02759315|458829588|FG004|Overall Study|Death|0|||
127510663|NCT02759315|458829584|FG000|Overall Study|Lost to Follow-up|2|||
127510664|NCT02759315|458829585|FG001|Overall Study|Lost to Follow-up|0|||
127510665|NCT02759315|458829586|FG002|Overall Study|Lost to Follow-up|4|||
127510666|NCT02759315|458829587|FG003|Overall Study|Lost to Follow-up|0|||
127510667|NCT02759315|458829588|FG004|Overall Study|Lost to Follow-up|0|||
127510668|NCT02759315|458829584|FG000|Overall Study|Protocol Violation|0|||
127510669|NCT02759315|458829585|FG001|Overall Study|Protocol Violation|1|||
127510670|NCT02759315|458829586|FG002|Overall Study|Protocol Violation|0|||
127510671|NCT02759315|458829587|FG003|Overall Study|Protocol Violation|0|||
127510672|NCT02759315|458829588|FG004|Overall Study|Protocol Violation|0|||
127510673|NCT02759315|458829584|FG000|Overall Study|Study terminated prior to completion|2|||
127510674|NCT02759315|458829585|FG001|Overall Study|Study terminated prior to completion|0|||
127510675|NCT02759315|458829586|FG002|Overall Study|Study terminated prior to completion|5|||
127510676|NCT02759315|458829587|FG003|Overall Study|Study terminated prior to completion|0|||
127510677|NCT02759315|458829588|FG004|Overall Study|Study terminated prior to completion|1|||
127510678|NCT00787137|458829589|FG000|Overall Study|Study Termination|0|||
127510679|NCT00787137|458829590|FG001|Overall Study|Study Termination|0|||
127510680|NCT00787137|458829591|FG002|Overall Study|Study Termination|1|||
127510681|NCT02761694|458829592|FG000|Overall Study|Lack of Efficacy|0|||
127510682|NCT02761694|458829593|FG001|Overall Study|Lack of Efficacy|0|||
127510683|NCT02761694|458829594|FG002|Overall Study|Lack of Efficacy|0|||
127510684|NCT02761694|458829595|FG003|Overall Study|Lack of Efficacy|0|||
127510685|NCT02761694|458829596|FG004|Overall Study|Lack of Efficacy|0|||
127510686|NCT02761694|458829597|FG005|Overall Study|Lack of Efficacy|0|||
127510687|NCT02761694|458829598|FG006|Overall Study|Lack of Efficacy|6|||
127510688|NCT02761694|458829599|FG007|Overall Study|Lack of Efficacy|0|||
127510689|NCT02761694|458829600|FG008|Overall Study|Lack of Efficacy|0|||
127510690|NCT02761694|458829601|FG009|Overall Study|Lack of Efficacy|1|||
127510691|NCT02761694|458829602|FG010|Overall Study|Lack of Efficacy|1|||
127510692|NCT02761694|458829603|FG011|Overall Study|Lack of Efficacy|4|||
127510693|NCT02761694|458829592|FG000|Overall Study|Death|0|||
127510694|NCT02761694|458829593|FG001|Overall Study|Death|0|||
127510695|NCT02761694|458829594|FG002|Overall Study|Death|0|||
127510696|NCT02761694|458829595|FG003|Overall Study|Death|0|||
127510697|NCT02761694|458829596|FG004|Overall Study|Death|0|||
127510698|NCT02761694|458829597|FG005|Overall Study|Death|0|||
127510699|NCT02761694|458829598|FG006|Overall Study|Death|2|||
127510700|NCT02761694|458829599|FG007|Overall Study|Death|0|||
127510701|NCT02761694|458829600|FG008|Overall Study|Death|2|||
127510702|NCT02761694|458829601|FG009|Overall Study|Death|2|||
127510703|NCT02761694|458829602|FG010|Overall Study|Death|1|||
127510704|NCT02761694|458829603|FG011|Overall Study|Death|0|||
127510705|NCT02761694|458829592|FG000|Overall Study|Physician Decision|0|||
127510706|NCT02761694|458829593|FG001|Overall Study|Physician Decision|0|||
127510707|NCT02761694|458829594|FG002|Overall Study|Physician Decision|0|||
127510708|NCT02761694|458829595|FG003|Overall Study|Physician Decision|0|||
127510709|NCT02761694|458829596|FG004|Overall Study|Physician Decision|0|||
127510710|NCT02761694|458829597|FG005|Overall Study|Physician Decision|0|||
127510711|NCT02761694|458829598|FG006|Overall Study|Physician Decision|1|||
127510712|NCT02761694|458829599|FG007|Overall Study|Physician Decision|0|||
127510713|NCT02761694|458829600|FG008|Overall Study|Physician Decision|0|||
127510714|NCT02761694|458829601|FG009|Overall Study|Physician Decision|0|||
127510715|NCT02761694|458829602|FG010|Overall Study|Physician Decision|0|||
127510716|NCT02761694|458829603|FG011|Overall Study|Physician Decision|0|||
127510717|NCT02761694|458829592|FG000|Overall Study|Withdrawal by Subject|0|||
127510718|NCT02761694|458829593|FG001|Overall Study|Withdrawal by Subject|0|||
127510719|NCT02761694|458829594|FG002|Overall Study|Withdrawal by Subject|0|||
127510720|NCT02761694|458829595|FG003|Overall Study|Withdrawal by Subject|1|||
127510721|NCT02761694|458829596|FG004|Overall Study|Withdrawal by Subject|0|||
127510722|NCT02761694|458829597|FG005|Overall Study|Withdrawal by Subject|0|||
127510723|NCT02761694|458829598|FG006|Overall Study|Withdrawal by Subject|4|||
127510724|NCT02761694|458829599|FG007|Overall Study|Withdrawal by Subject|0|||
127510725|NCT02761694|458829600|FG008|Overall Study|Withdrawal by Subject|2|||
127510726|NCT02761694|458829601|FG009|Overall Study|Withdrawal by Subject|1|||
127510727|NCT02761694|458829602|FG010|Overall Study|Withdrawal by Subject|0|||
127510728|NCT02761694|458829603|FG011|Overall Study|Withdrawal by Subject|0|||
127510729|NCT02761694|458829592|FG000|Overall Study|Lost to Follow-up|0|||
127510730|NCT02761694|458829593|FG001|Overall Study|Lost to Follow-up|0|||
127510731|NCT02761694|458829594|FG002|Overall Study|Lost to Follow-up|0|||
127510732|NCT02761694|458829595|FG003|Overall Study|Lost to Follow-up|0|||
127510733|NCT02761694|458829596|FG004|Overall Study|Lost to Follow-up|0|||
127510734|NCT02761694|458829597|FG005|Overall Study|Lost to Follow-up|0|||
127510735|NCT02761694|458829598|FG006|Overall Study|Lost to Follow-up|1|||
127510736|NCT02761694|458829599|FG007|Overall Study|Lost to Follow-up|0|||
127510737|NCT02761694|458829600|FG008|Overall Study|Lost to Follow-up|0|||
127510738|NCT02761694|458829601|FG009|Overall Study|Lost to Follow-up|0|||
127510739|NCT02761694|458829602|FG010|Overall Study|Lost to Follow-up|0|||
127510740|NCT02761694|458829603|FG011|Overall Study|Lost to Follow-up|1|||
127510741|NCT02761694|458829592|FG000|Overall Study|Adverse Event|0|||
127510742|NCT02761694|458829593|FG001|Overall Study|Adverse Event|0|||
127510743|NCT02761694|458829594|FG002|Overall Study|Adverse Event|0|||
127510744|NCT02761694|458829595|FG003|Overall Study|Adverse Event|0|||
127510745|NCT02761694|458829596|FG004|Overall Study|Adverse Event|0|||
127510746|NCT02761694|458829597|FG005|Overall Study|Adverse Event|0|||
127510747|NCT02761694|458829598|FG006|Overall Study|Adverse Event|1|||
127510748|NCT02761694|458829599|FG007|Overall Study|Adverse Event|0|||
127510749|NCT02761694|458829600|FG008|Overall Study|Adverse Event|1|||
127510750|NCT02761694|458829601|FG009|Overall Study|Adverse Event|0|||
127510751|NCT02761694|458829602|FG010|Overall Study|Adverse Event|0|||
127978977|NCT00454818|460545666|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
127978978|NCT00454818|460545667|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
127978979|NCT00454818|460545668|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
127978980|NCT00454818|460545669|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
127978981|NCT00454818|460545665|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
127978982|NCT00454818|460545666|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
127978983|NCT00454818|460545667|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
127978984|NCT00454818|460545668|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
127978985|NCT00454818|460545669|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
127978986|NCT00454818|460545665|FG000|Phase 2: Randomized Double-blind|Death|0|||
127978987|NCT00454818|460545666|FG001|Phase 2: Randomized Double-blind|Death|1|||
127978988|NCT00454818|460545667|FG002|Phase 2: Randomized Double-blind|Death|0|||
127978989|NCT00454818|460545668|FG003|Phase 2: Randomized Double-blind|Death|0|||
127978990|NCT00454818|460545669|FG004|Phase 2: Randomized Double-blind|Death|1|||
127978991|NCT00454818|460545665|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
127978992|NCT00454818|460545666|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
127978993|NCT00454818|460545667|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
127978994|NCT00454818|460545668|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
127978995|NCT00454818|460545669|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
127978996|NCT00454818|460545665|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
127978997|NCT00454818|460545666|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
127978998|NCT00454818|460545667|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
127978999|NCT00454818|460545668|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
127979000|NCT00454818|460545669|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
127979001|NCT00767039|460545672|FG000|Overall Study|Death|5|||
127979002|NCT00767039|460545673|FG001|Overall Study|Death|2|||
127979003|NCT01826370|460545674|FG000|Overall Study|Protocol Violation|6|||
127979004|NCT01826370|460545674|FG000|Overall Study|Lost to Follow-up|12|||
127979005|NCT01826370|460545674|FG000|Overall Study|Other reason not defined above|2|||
127979006|NCT04416737|460545676|FG000|Week 1 (First Injection)|Physician Decision|0|||
127979007|NCT04416737|460545677|FG001|Week 1 (First Injection)|Physician Decision|1|||
127979008|NCT03332628|460545678|FG000|Overall Study|Physician Decision|2|||
127979009|NCT01472757|460545679|FG000|Overall Study|Withdrawal by Subject|1|||
127979010|NCT01472757|460545680|FG001|Overall Study|Withdrawal by Subject|2|||
127979011|NCT01472757|460545681|FG002|Overall Study|Withdrawal by Subject|2|||
127979012|NCT01472757|460545682|FG003|Overall Study|Withdrawal by Subject|0|||
127979013|NCT01472757|460545679|FG000|Overall Study|Asthma exacerbation|4|||
127979014|NCT01472757|460545680|FG001|Overall Study|Asthma exacerbation|1|||
127979015|NCT01472757|460545681|FG002|Overall Study|Asthma exacerbation|2|||
127979016|NCT01472757|460545682|FG003|Overall Study|Asthma exacerbation|1|||
127979017|NCT01472757|460545679|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
127979018|NCT01472757|460545680|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
127979019|NCT01472757|460545681|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
127979020|NCT01472757|460545682|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
127979021|NCT01472757|460545679|FG000|Overall Study|Protocol Violation|3|||
127979022|NCT01472757|460545680|FG001|Overall Study|Protocol Violation|2|||
127979023|NCT01472757|460545681|FG002|Overall Study|Protocol Violation|4|||
127979024|NCT01472757|460545682|FG003|Overall Study|Protocol Violation|4|||
127979025|NCT01472757|460545679|FG000|Overall Study|Other reasons|1|||
127979026|NCT01472757|460545680|FG001|Overall Study|Other reasons|0|||
127979027|NCT01472757|460545681|FG002|Overall Study|Other reasons|2|||
127979028|NCT01472757|460545682|FG003|Overall Study|Other reasons|2|||
127979029|NCT00070018|460545685|FG000|Overall Study|Adverse Event|2|||
127979030|NCT00070018|460545685|FG000|Overall Study|Lack of Efficacy|1|||
127979031|NCT00070018|460545685|FG000|Overall Study|Withdrawal by Subject|1|||
127979032|NCT02939716|460545689|FG000|Overall Study|scanner failure|0|||
127979033|NCT02939716|460545690|FG001|Overall Study|scanner failure|0|||
127979034|NCT02939716|460545691|FG002|Overall Study|scanner failure|0|||
127979035|NCT02939716|460545692|FG003|Overall Study|scanner failure|1|||
127979036|NCT02939716|460545693|FG004|Overall Study|scanner failure|1|||
127979037|NCT02939716|460545694|FG005|Overall Study|scanner failure|1|||
127979038|NCT02543892|460545700|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
127979039|NCT02543892|460545701|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
127510752|NCT02761694|458829603|FG011|Overall Study|Adverse Event|1|||
127510753|NCT02761694|458829592|FG000|Overall Study|Other|4|||
127510754|NCT02761694|458829593|FG001|Overall Study|Other|4|||
127510755|NCT02761694|458829594|FG002|Overall Study|Other|1|||
127510756|NCT02761694|458829595|FG003|Overall Study|Other|2|||
127510757|NCT02761694|458829596|FG004|Overall Study|Other|3|||
127510758|NCT02761694|458829597|FG005|Overall Study|Other|3|||
127510759|NCT02761694|458829598|FG006|Overall Study|Other|18|||
127510760|NCT02761694|458829599|FG007|Overall Study|Other|8|||
127510761|NCT02761694|458829600|FG008|Overall Study|Other|0|||
127510762|NCT02761694|458829601|FG009|Overall Study|Other|1|||
127510763|NCT02761694|458829602|FG010|Overall Study|Other|1|||
127510764|NCT02761694|458829603|FG011|Overall Study|Other|0|||
127510765|NCT03464422|458829610|FG000|Overall Study|Lost to Follow-up|2|||
127510766|NCT03464422|458829610|FG000|Overall Study|Withdrawal by Subject|2|||
127510767|NCT01628367|458829616|FG000|Overall Study|Adverse Event|1|||
127510768|NCT01628367|458829617|FG001|Overall Study|Adverse Event|0|||
127510769|NCT02513823|458829618|FG000|Overall Study|Lost to Follow-up|4|||
127510770|NCT02513823|458829618|FG000|Overall Study|Physician Decision|1|||
127510771|NCT03353922|458829619|FG000|Overall Study|Withdrawal by Subject|1|||
127510772|NCT03353922|458829620|FG001|Overall Study|Withdrawal by Subject|0|||
127510773|NCT03353922|458829621|FG002|Overall Study|Withdrawal by Subject|1|||
127510774|NCT03353922|458829622|FG003|Overall Study|Withdrawal by Subject|1|||
127510775|NCT03353922|458829623|FG004|Overall Study|Withdrawal by Subject|0|||
127510776|NCT03353922|458829624|FG005|Overall Study|Withdrawal by Subject|0|||
127510777|NCT03353922|458829619|FG000|Overall Study|Adverse Event|0|||
127510778|NCT03353922|458829620|FG001|Overall Study|Adverse Event|1|||
127510779|NCT03353922|458829621|FG002|Overall Study|Adverse Event|0|||
127510780|NCT03353922|458829622|FG003|Overall Study|Adverse Event|0|||
127979040|NCT02543892|460545702|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
127979041|NCT02543892|460545703|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
127979042|NCT02543892|460545704|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
127979043|NCT02543892|460545705|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
127979044|NCT02543892|460545706|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
127979045|NCT02543892|460545707|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
127979046|NCT02543892|460545700|FG000|Received Vaccination 2|Physician Decision|0|||
127979047|NCT02543892|460545701|FG001|Received Vaccination 2|Physician Decision|0|||
127979048|NCT02543892|460545702|FG002|Received Vaccination 2|Physician Decision|0|||
127979049|NCT02543892|460545703|FG003|Received Vaccination 2|Physician Decision|0|||
127979050|NCT02543892|460545704|FG004|Received Vaccination 2|Physician Decision|0|||
127979051|NCT02543892|460545705|FG005|Received Vaccination 2|Physician Decision|1|||
127979052|NCT02543892|460545706|FG006|Received Vaccination 2|Physician Decision|0|||
127979053|NCT02543892|460545707|FG007|Received Vaccination 2|Physician Decision|0|||
127979054|NCT02543892|460545700|FG000|Received Vaccination 2|Adverse Event|0|||
127979055|NCT02543892|460545701|FG001|Received Vaccination 2|Adverse Event|1|||
127979056|NCT02543892|460545702|FG002|Received Vaccination 2|Adverse Event|0|||
127979057|NCT02543892|460545703|FG003|Received Vaccination 2|Adverse Event|0|||
127979058|NCT02543892|460545704|FG004|Received Vaccination 2|Adverse Event|0|||
127979059|NCT02543892|460545705|FG005|Received Vaccination 2|Adverse Event|0|||
127979060|NCT02543892|460545706|FG006|Received Vaccination 2|Adverse Event|0|||
127979061|NCT02543892|460545707|FG007|Received Vaccination 2|Adverse Event|0|||
127979062|NCT02543892|460545700|FG000|Had Immunology Data|Withdrawal by Subject|0|||
127979063|NCT02543892|460545701|FG001|Had Immunology Data|Withdrawal by Subject|0|||
127979064|NCT02543892|460545702|FG002|Had Immunology Data|Withdrawal by Subject|0|||
127979065|NCT02543892|460545703|FG003|Had Immunology Data|Withdrawal by Subject|0|||
127979066|NCT02543892|460545704|FG004|Had Immunology Data|Withdrawal by Subject|0|||
127979067|NCT02543892|460545705|FG005|Had Immunology Data|Withdrawal by Subject|0|||
127979068|NCT02543892|460545706|FG006|Had Immunology Data|Withdrawal by Subject|1|||
127979069|NCT02543892|460545707|FG007|Had Immunology Data|Withdrawal by Subject|0|||
127979070|NCT00785213|460545708|FG000|Quinine Sulfate Alone|Adverse Event|4|||
127979071|NCT00785213|460545708|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
127979072|NCT00844480|460545711|FG000|Overall Study|Withdrawal by Subject|2|||
127979073|NCT00844480|460545712|FG001|Overall Study|Withdrawal by Subject|3|||
127979074|NCT00979420|460545713|FG000|Overall Study|Adverse Event|1|||
127979075|NCT00979420|460545714|FG001|Overall Study|Adverse Event|0|||
127979076|NCT00979420|460545715|FG002|Overall Study|Adverse Event|0|||
127979077|NCT00979420|460545716|FG003|Overall Study|Adverse Event|0|||
127979078|NCT00979420|460545713|FG000|Overall Study|Lack of Efficacy|3|||
127979079|NCT00979420|460545714|FG001|Overall Study|Lack of Efficacy|0|||
127979080|NCT00979420|460545715|FG002|Overall Study|Lack of Efficacy|1|||
127979081|NCT00979420|460545716|FG003|Overall Study|Lack of Efficacy|1|||
127979082|NCT00979420|460545713|FG000|Overall Study|Other reasons not related to Viramune|3|||
127979083|NCT00979420|460545714|FG001|Overall Study|Other reasons not related to Viramune|0|||
127979084|NCT00979420|460545715|FG002|Overall Study|Other reasons not related to Viramune|0|||
127979085|NCT00979420|460545716|FG003|Overall Study|Other reasons not related to Viramune|1|||
127979086|NCT01259375|460545717|FG000|Overall Study|Adverse Event|1|||
127510781|NCT03353922|458829623|FG004|Overall Study|Adverse Event|0|||
127979087|NCT00478699|460545720|FG000|Overall Study|Inclusion Error|1|||
127510782|NCT03353922|458829624|FG005|Overall Study|Adverse Event|0|||
127510783|NCT00740714|458829625|FG000|Overall Study|Withdrawal by Subject|17|||
127510784|NCT00740714|458829626|FG001|Overall Study|Withdrawal by Subject|19|||
127510785|NCT00740714|458829627|FG002|Overall Study|Withdrawal by Subject|29|||
127510786|NCT02743780|458829632|FG000|Part 3 (7 Days)|Adverse Event|0|||
127510787|NCT02743780|458829633|FG001|Part 3 (7 Days)|Adverse Event|0|||
127510788|NCT02743780|458829634|FG002|Part 3 (7 Days)|Adverse Event|1|||
127510789|NCT02743780|458829635|FG003|Part 3 (7 Days)|Adverse Event|0|||
127510790|NCT02743780|458829636|FG004|Part 3 (7 Days)|Adverse Event|0|||
127979088|NCT00478699|460545721|FG001|Overall Study|Inclusion Error|7|||
127979089|NCT00478699|460545720|FG000|Overall Study|Not receive study treatment|6|||
127979090|NCT00478699|460545721|FG001|Overall Study|Not receive study treatment|30|||
127979091|NCT01043705|460545726|FG000|Overall Study|Death|28|||
127979092|NCT01043705|460545727|FG001|Overall Study|Death|60|||
127979093|NCT01043705|460545728|FG002|Overall Study|Death|26|||
127979094|NCT01043705|460545726|FG000|Overall Study|Lost to Follow-up|27|||
127979095|NCT01043705|460545727|FG001|Overall Study|Lost to Follow-up|12|||
127979096|NCT01043705|460545728|FG002|Overall Study|Lost to Follow-up|0|||
127979097|NCT01043705|460545726|FG000|Overall Study|Multiple Reasons|4|||
127979098|NCT01043705|460545727|FG001|Overall Study|Multiple Reasons|7|||
127979099|NCT01043705|460545728|FG002|Overall Study|Multiple Reasons|0|||
127979100|NCT01043705|460545726|FG000|Overall Study|Protocol Violation|2|||
127979101|NCT01043705|460545727|FG001|Overall Study|Protocol Violation|1|||
127979102|NCT01043705|460545728|FG002|Overall Study|Protocol Violation|0|||
127979103|NCT01043705|460545726|FG000|Overall Study|Withdrawal by Subject|8|||
127979104|NCT01043705|460545727|FG001|Overall Study|Withdrawal by Subject|6|||
127979105|NCT01043705|460545728|FG002|Overall Study|Withdrawal by Subject|0|||
127979106|NCT01043705|460545726|FG000|Overall Study|Site Closure|8|||
127979107|NCT01043705|460545727|FG001|Overall Study|Site Closure|0|||
127979108|NCT01043705|460545728|FG002|Overall Study|Site Closure|0|||
127979109|NCT01043705|460545726|FG000|Overall Study|Subsequent Procedure|9|||
127979110|NCT01043705|460545727|FG001|Overall Study|Subsequent Procedure|24|||
127979111|NCT01043705|460545728|FG002|Overall Study|Subsequent Procedure|29|||
127979112|NCT01043705|460545726|FG000|Overall Study|Adverse Event|0|||
127979113|NCT01043705|460545727|FG001|Overall Study|Adverse Event|2|||
127979114|NCT01043705|460545728|FG002|Overall Study|Adverse Event|0|||
127979115|NCT01043705|460545726|FG000|Overall Study|Screen Fail|21|||
127979116|NCT01043705|460545727|FG001|Overall Study|Screen Fail|0|||
127979117|NCT01043705|460545728|FG002|Overall Study|Screen Fail|0|||
127979118|NCT01043705|460545726|FG000|Overall Study|Other|0|||
127979119|NCT01043705|460545727|FG001|Overall Study|Other|19|||
127979120|NCT01043705|460545728|FG002|Overall Study|Other|25|||
127979121|NCT00581542|460545730|FG000|Overall Study|they met an exclusion criteria|2|||
127979122|NCT00581542|460545731|FG001|Overall Study|they met an exclusion criteria|2|||
127979123|NCT00581542|460545730|FG000|Overall Study|Lost to Follow-up|9|||
127979124|NCT00581542|460545731|FG001|Overall Study|Lost to Follow-up|21|||
127979125|NCT00656851|460545732|FG000|Overall Study|Withdrawal by Subject|0|||
127979126|NCT00656851|460545733|FG001|Overall Study|Withdrawal by Subject|4|||
127979127|NCT02291601|460545734|FG000|Abdomen|Did not qualify|333|||
127979128|NCT02291601|460545735|FG001|Abdomen|Did not qualify|54|||
127979129|NCT02291601|460545736|FG002|Abdomen|Did not qualify|339|||
127979130|NCT02291601|460545734|FG000|Groin|Did not qualify|183|||
127979131|NCT02291601|460545735|FG001|Groin|Did not qualify|30|||
127979132|NCT02291601|460545736|FG002|Groin|Did not qualify|177|||
127979133|NCT00347919|460545737|FG000|Overall Study|Lost to Follow-up|11|||
127979134|NCT00347919|460545738|FG001|Overall Study|Lost to Follow-up|13|||
127979135|NCT00347919|460545739|FG002|Overall Study|Lost to Follow-up|0|||
127979136|NCT00347919|460545737|FG000|Overall Study|Withdrawal by Subject|6|||
127979137|NCT00347919|460545738|FG001|Overall Study|Withdrawal by Subject|8|||
127979138|NCT00347919|460545739|FG002|Overall Study|Withdrawal by Subject|0|||
127979139|NCT00347919|460545737|FG000|Overall Study|Physician Decision|1|||
127979140|NCT00347919|460545738|FG001|Overall Study|Physician Decision|1|||
127979141|NCT00347919|460545739|FG002|Overall Study|Physician Decision|0|||
127979142|NCT00347919|460545737|FG000|Overall Study|Sponsor terminated study|15|||
127979143|NCT00347919|460545738|FG001|Overall Study|Sponsor terminated study|10|||
127979144|NCT00347919|460545739|FG002|Overall Study|Sponsor terminated study|16|||
127979145|NCT00347919|460545737|FG000|Overall Study|Death|35|||
127979146|NCT00347919|460545738|FG001|Overall Study|Death|42|||
127979147|NCT00347919|460545739|FG002|Overall Study|Death|19|||
127979148|NCT00347919|460545737|FG000|Overall Study|Par. Started Other Treatment|1|||
127979149|NCT00347919|460545738|FG001|Overall Study|Par. Started Other Treatment|1|||
127979150|NCT00347919|460545739|FG002|Overall Study|Par. Started Other Treatment|1|||
127979151|NCT00347919|460545737|FG000|Overall Study|Missing|2|||
127979152|NCT00347919|460545738|FG001|Overall Study|Missing|1|||
127979153|NCT00347919|460545739|FG002|Overall Study|Missing|2|||
127979154|NCT01597375|460545740|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
127979155|NCT01597375|460545741|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
127979156|NCT01597375|460545740|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
127979157|NCT01597375|460545741|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
127979158|NCT01597375|460545740|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
127979159|NCT01597375|460545741|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
127979160|NCT01597375|460545740|FG000|Washout (2 Weeks)|Adverse Event|1|||
127510791|NCT01367704|458829641|FG000|Overall Study|Lost to Follow-up|47|||
127510792|NCT01367704|458829642|FG001|Overall Study|Lost to Follow-up|161|||
127510793|NCT00526110|458829643|FG000|Overall Study|Adverse Event|2|||
127510794|NCT00526110|458829644|FG001|Overall Study|Adverse Event|9|||
127510795|NCT00526110|458829643|FG000|Overall Study|Disease Progression|0|||
127510796|NCT00526110|458829644|FG001|Overall Study|Disease Progression|19|||
127510797|NCT00526110|458829643|FG000|Overall Study|Maximal Response|0|||
127510798|NCT00526110|458829644|FG001|Overall Study|Maximal Response|6|||
127510799|NCT00526110|458829643|FG000|Overall Study|Withdrawal by Subject|0|||
127510800|NCT00526110|458829644|FG001|Overall Study|Withdrawal by Subject|2|||
127510801|NCT00526110|458829643|FG000|Overall Study|Poor Tolerance|0|||
127510802|NCT00526110|458829644|FG001|Overall Study|Poor Tolerance|5|||
127510803|NCT01400243|458829646|FG000|Overall Study|Protocol Violation|8|||
127510804|NCT01400243|458829647|FG001|Overall Study|Protocol Violation|11|||
127510805|NCT02193087|458829648|FG000|Overall Study|Adverse Event|2|||
127510806|NCT02193087|458829649|FG001|Overall Study|Adverse Event|0|||
127510807|NCT02193087|458829650|FG002|Overall Study|Adverse Event|0|||
127510808|NCT02193087|458829651|FG003|Overall Study|Adverse Event|11|||
127510809|NCT02193087|458829648|FG000|Overall Study|Lost to Follow-up|14|||
127510810|NCT02193087|458829649|FG001|Overall Study|Lost to Follow-up|6|||
127510811|NCT02193087|458829650|FG002|Overall Study|Lost to Follow-up|4|||
127510812|NCT02193087|458829651|FG003|Overall Study|Lost to Follow-up|37|||
127510813|NCT02193087|458829648|FG000|Overall Study|Protocol Violation|2|||
127510814|NCT02193087|458829649|FG001|Overall Study|Protocol Violation|0|||
127510815|NCT02193087|458829650|FG002|Overall Study|Protocol Violation|1|||
127510816|NCT02193087|458829651|FG003|Overall Study|Protocol Violation|2|||
127510817|NCT02193087|458829648|FG000|Overall Study|Withdrawal by Subject|10|||
127510818|NCT02193087|458829649|FG001|Overall Study|Withdrawal by Subject|3|||
127510819|NCT02193087|458829650|FG002|Overall Study|Withdrawal by Subject|1|||
127510820|NCT02193087|458829651|FG003|Overall Study|Withdrawal by Subject|19|||
127510821|NCT02193087|458829648|FG000|Overall Study|Other Reason Not Specified|7|||
127510822|NCT02193087|458829649|FG001|Overall Study|Other Reason Not Specified|2|||
127510823|NCT02193087|458829650|FG002|Overall Study|Other Reason Not Specified|1|||
127510824|NCT02193087|458829651|FG003|Overall Study|Other Reason Not Specified|9|||
127510825|NCT02193087|458829648|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
127510826|NCT02193087|458829649|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
127510827|NCT02193087|458829650|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
127510828|NCT02193087|458829651|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
127510829|NCT04096820|458829652|FG000|Overall Study|Did not return for intervention|2|||
127510830|NCT04096820|458829652|FG000|Overall Study|Death|1|||
127510831|NCT01048866|458829654|FG000|Overall Study|Adverse Event|1|||
127510832|NCT01048866|458829655|FG001|Overall Study|Adverse Event|0|||
127510833|NCT01048866|458829654|FG000|Overall Study|Protocol Violation|1|||
127510834|NCT01048866|458829655|FG001|Overall Study|Protocol Violation|0|||
127510835|NCT01048866|458829654|FG000|Overall Study|Physician Decision|1|||
127510836|NCT01048866|458829655|FG001|Overall Study|Physician Decision|0|||
127510837|NCT01048866|458829654|FG000|Overall Study|Withdrawal by Subject|0|||
127510838|NCT01048866|458829655|FG001|Overall Study|Withdrawal by Subject|2|||
127510839|NCT01048866|458829654|FG000|Overall Study|Lost to Follow-up|0|||
127510840|NCT01048866|458829655|FG001|Overall Study|Lost to Follow-up|2|||
127510841|NCT01048866|458829654|FG000|Overall Study|Other|1|||
127510842|NCT01048866|458829655|FG001|Overall Study|Other|1|||
127510843|NCT03959982|458831417|FG000|Overall Study|Withdrawal by Subject|1|||
127510844|NCT03959982|458831418|FG001|Overall Study|Withdrawal by Subject|0|||
127510845|NCT03959982|458831417|FG000|Overall Study|Physician Decision|2|||
127510846|NCT03959982|458831418|FG001|Overall Study|Physician Decision|0|||
127510847|NCT03959982|458831417|FG000|Overall Study|Lost to Follow-up|1|||
127979161|NCT01597375|460545741|FG001|Washout (2 Weeks)|Adverse Event|0|||
127979162|NCT01597375|460545740|FG000|Second Intervention|Failed to react at both Aspirin|1|||
127510848|NCT03959982|458831418|FG001|Overall Study|Lost to Follow-up|0|||
127510849|NCT00758589|458831419|FG000|Overall Study|Adverse Event|3|||
127510850|NCT00758589|458831420|FG001|Overall Study|Adverse Event|2|||
127510851|NCT00758589|458831421|FG002|Overall Study|Adverse Event|5|||
127510852|NCT00758589|458831422|FG003|Overall Study|Adverse Event|4|||
127510853|NCT00758589|458831419|FG000|Overall Study|Withdrawal by Subject|0|||
127510854|NCT00758589|458831420|FG001|Overall Study|Withdrawal by Subject|1|||
127510855|NCT00758589|458831421|FG002|Overall Study|Withdrawal by Subject|1|||
127510856|NCT00758589|458831422|FG003|Overall Study|Withdrawal by Subject|1|||
127510857|NCT00758589|458831419|FG000|Overall Study|Palm stopped to work|0|||
127510858|NCT00758589|458831420|FG001|Overall Study|Palm stopped to work|0|||
127510859|NCT00758589|458831421|FG002|Overall Study|Palm stopped to work|0|||
127510860|NCT00758589|458831422|FG003|Overall Study|Palm stopped to work|1|||
127510861|NCT02534935|458831423|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
127510862|NCT02534935|458831424|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
127510863|NCT02534935|458831425|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
127510864|NCT02534935|458831423|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
127510865|NCT02534935|458831424|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
127510866|NCT02534935|458831425|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
127510867|NCT02534935|458831423|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
127510868|NCT02534935|458831424|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
127510869|NCT02534935|458831425|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
127510870|NCT02534935|458831423|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
127510871|NCT02534935|458831424|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
127510872|NCT02534935|458831425|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
127510873|NCT02534935|458831423|FG000|Stage 1: 24 Months|Adverse Event|0|||
127510874|NCT02534935|458831424|FG001|Stage 1: 24 Months|Adverse Event|2|||
127510875|NCT02534935|458831425|FG002|Stage 1: 24 Months|Adverse Event|0|||
127510876|NCT02534935|458831423|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
127510877|NCT02534935|458831424|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
127510878|NCT02534935|458831425|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
127510879|NCT02534935|458831423|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
127510880|NCT02534935|458831424|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
127510881|NCT02534935|458831425|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
127510882|NCT01460719|458831426|FG000|Overall Study|Adverse Event|1|||
127510883|NCT01460719|458831426|FG000|Overall Study|Withdrawal by Subject|1|||
127510884|NCT02838901|458831428|FG000|Overall Study|Withdrawal by Subject|1|||
127510885|NCT02838901|458831429|FG001|Overall Study|Withdrawal by Subject|1|||
127510886|NCT02838901|458831428|FG000|Overall Study|Lost to Follow-up|1|||
127510887|NCT02838901|458831429|FG001|Overall Study|Lost to Follow-up|1|||
127510888|NCT00076336|458831430|FG000|Overall Study|Death|13|||
127510889|NCT00076336|458831431|FG001|Overall Study|Death|17|||
127510890|NCT00076336|458831430|FG000|Overall Study|Adverse Event|4|||
127510891|NCT00076336|458831431|FG001|Overall Study|Adverse Event|4|||
127510892|NCT00076336|458831430|FG000|Overall Study|Lost to Follow-up|4|||
127510893|NCT00076336|458831431|FG001|Overall Study|Lost to Follow-up|4|||
127510894|NCT00076336|458831430|FG000|Overall Study|Non-Compliance|2|||
127510895|NCT00076336|458831431|FG001|Overall Study|Non-Compliance|0|||
127510896|NCT00076336|458831430|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
127510897|NCT00076336|458831431|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
127510898|NCT00076336|458831430|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
127510899|NCT00076336|458831431|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
127510900|NCT00076336|458831430|FG000|Overall Study|Liver Transplantation|3|||
127510901|NCT00076336|458831431|FG001|Overall Study|Liver Transplantation|3|||
127510902|NCT00076336|458831430|FG000|Overall Study|Virologic Breakthrough|14|||
127510903|NCT00076336|458831431|FG001|Overall Study|Virologic Breakthrough|16|||
127510904|NCT00076336|458831430|FG000|Overall Study|Treatment failure|4|||
127510905|NCT00076336|458831431|FG001|Overall Study|Treatment failure|5|||
127510906|NCT02285114|458831432|FG000|Main Phase|Investigator's Discretion|0|||
127510907|NCT02285114|458831433|FG001|Main Phase|Investigator's Discretion|2|||
127510908|NCT02285114|458831434|FG002|Main Phase|Investigator's Discretion|0|||
127510909|NCT02285114|458831435|FG003|Main Phase|Investigator's Discretion|0|||
127510910|NCT02285114|458831436|FG004|Main Phase|Investigator's Discretion|0|||
127510911|NCT02285114|458831437|FG005|Main Phase|Investigator's Discretion|0|||
127510912|NCT02285114|458831432|FG000|Main Phase|Enrolled but Never Treated|1|||
127510913|NCT02285114|458831433|FG001|Main Phase|Enrolled but Never Treated|0|||
127510914|NCT02285114|458831434|FG002|Main Phase|Enrolled but Never Treated|0|||
127510915|NCT02285114|458831435|FG003|Main Phase|Enrolled but Never Treated|0|||
127510916|NCT02285114|458831436|FG004|Main Phase|Enrolled but Never Treated|0|||
127510917|NCT02285114|458831437|FG005|Main Phase|Enrolled but Never Treated|0|||
127510918|NCT02285114|458831432|FG000|Main Phase|Withdrew Consent|0|||
127510919|NCT02285114|458831433|FG001|Main Phase|Withdrew Consent|0|||
127510920|NCT02285114|458831434|FG002|Main Phase|Withdrew Consent|1|||
127510921|NCT02285114|458831435|FG003|Main Phase|Withdrew Consent|0|||
127510922|NCT02285114|458831436|FG004|Main Phase|Withdrew Consent|0|||
127510923|NCT02285114|458831437|FG005|Main Phase|Withdrew Consent|0|||
127510924|NCT02285114|458831432|FG000|Extension Phase|Investigator's Discretion|0|||
127510925|NCT02285114|458831433|FG001|Extension Phase|Investigator's Discretion|0|||
127510926|NCT02285114|458831434|FG002|Extension Phase|Investigator's Discretion|0|||
127510927|NCT02285114|458831435|FG003|Extension Phase|Investigator's Discretion|14|||
127510928|NCT02285114|458831436|FG004|Extension Phase|Investigator's Discretion|1|||
127510929|NCT02285114|458831437|FG005|Extension Phase|Investigator's Discretion|0|||
127510930|NCT02285114|458831432|FG000|Extension Phase|Lost to Follow-up|0|||
127510931|NCT02285114|458831433|FG001|Extension Phase|Lost to Follow-up|0|||
127510932|NCT02285114|458831434|FG002|Extension Phase|Lost to Follow-up|0|||
127510933|NCT02285114|458831435|FG003|Extension Phase|Lost to Follow-up|1|||
127510934|NCT02285114|458831436|FG004|Extension Phase|Lost to Follow-up|1|||
127510935|NCT02285114|458831437|FG005|Extension Phase|Lost to Follow-up|0|||
127510936|NCT02285114|458831432|FG000|Extension Phase|Non-compliance with Study Drug|0|||
127510937|NCT02285114|458831433|FG001|Extension Phase|Non-compliance with Study Drug|0|||
127510938|NCT02285114|458831434|FG002|Extension Phase|Non-compliance with Study Drug|0|||
127510939|NCT02285114|458831435|FG003|Extension Phase|Non-compliance with Study Drug|2|||
127979163|NCT01597375|460545741|FG001|Second Intervention|Failed to react at both Aspirin|1|||
127979164|NCT03379753|460545742|FG000|Overall Study|Withdrawal by Subject|2|||
127979165|NCT03379753|460545743|FG001|Overall Study|Withdrawal by Subject|1|||
127979166|NCT03379753|460545742|FG000|Overall Study|not having correct procedure|1|||
127979167|NCT03379753|460545743|FG001|Overall Study|not having correct procedure|2|||
127979168|NCT03379753|460545742|FG000|Overall Study|No primary outcome|12|||
127979169|NCT03379753|460545743|FG001|Overall Study|No primary outcome|22|||
127979170|NCT01032239|460545744|FG000|Overall Study|Lost to Follow-up|3|||
127979171|NCT01032239|460545745|FG001|Overall Study|Lost to Follow-up|2|||
127979172|NCT01032239|460545744|FG000|Overall Study|Withdrawal by Subject|2|||
127979173|NCT01032239|460545745|FG001|Overall Study|Withdrawal by Subject|3|||
127979174|NCT01032239|460545744|FG000|Overall Study|Death|1|||
127979175|NCT01032239|460545745|FG001|Overall Study|Death|0|||
127979176|NCT01032239|460545744|FG000|Overall Study|Protocol Violation|1|||
127979177|NCT01032239|460545745|FG001|Overall Study|Protocol Violation|0|||
127979178|NCT01940900|460545750|FG000|Overall Study|Physician Decision|4|||
127979179|NCT01940900|460545751|FG001|Overall Study|Physician Decision|0|||
127979180|NCT01940900|460545750|FG000|Overall Study|Adverse Event|10|||
127979181|NCT01940900|460545751|FG001|Overall Study|Adverse Event|15|||
127979182|NCT01940900|460545750|FG000|Overall Study|Withdrawal by Subject|11|||
127979183|NCT01940900|460545751|FG001|Overall Study|Withdrawal by Subject|15|||
127979184|NCT01940900|460545750|FG000|Overall Study|Lost to Follow-up|1|||
127979185|NCT01940900|460545751|FG001|Overall Study|Lost to Follow-up|0|||
127979186|NCT01940900|460545750|FG000|Overall Study|Sponsor Decision|1|||
127979187|NCT01940900|460545751|FG001|Overall Study|Sponsor Decision|0|||
127979188|NCT01940900|460545750|FG000|Overall Study|subject non-compliance|1|||
127979189|NCT01940900|460545751|FG001|Overall Study|subject non-compliance|1|||
127979190|NCT01940900|460545750|FG000|Overall Study|other|1|||
127979191|NCT01940900|460545751|FG001|Overall Study|other|0|||
127979192|NCT02225366|460545756|FG000|Overall Study|Lack of Efficacy|1|||
127979193|NCT02225366|460545757|FG001|Overall Study|Lack of Efficacy|0|||
127979194|NCT01797081|460545760|FG000|Overall Study|Adverse Event|1|||
127979195|NCT01797081|460545761|FG001|Overall Study|Adverse Event|0|||
127979196|NCT01797081|460545762|FG002|Overall Study|Adverse Event|1|||
127979197|NCT01797081|460545763|FG003|Overall Study|Adverse Event|0|||
127979198|NCT01797081|460545760|FG000|Overall Study|Pregnancy|1|||
127979199|NCT01797081|460545761|FG001|Overall Study|Pregnancy|0|||
127979200|NCT01797081|460545762|FG002|Overall Study|Pregnancy|0|||
127979201|NCT01797081|460545763|FG003|Overall Study|Pregnancy|0|||
127979202|NCT01797081|460545760|FG000|Overall Study|Personal Reasons|12|||
127979203|NCT01797081|460545761|FG001|Overall Study|Personal Reasons|4|||
127979204|NCT01797081|460545762|FG002|Overall Study|Personal Reasons|4|||
127979205|NCT01797081|460545763|FG003|Overall Study|Personal Reasons|8|||
127979206|NCT01797081|460545760|FG000|Overall Study|Protocol Violation|0|||
127979207|NCT01797081|460545761|FG001|Overall Study|Protocol Violation|0|||
127979208|NCT01797081|460545762|FG002|Overall Study|Protocol Violation|0|||
127979209|NCT01797081|460545763|FG003|Overall Study|Protocol Violation|1|||
127979210|NCT02375555|460545774|FG000|Induction Period|Adverse Event|7|||
127979211|NCT02375555|460545774|FG000|Induction Period|Withdrawal by Subject|2|||
127979212|NCT02375555|460545774|FG000|Induction Period|Other|1|||
127979213|NCT02375555|460545774|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
127979214|NCT02375555|460545774|FG000|Maintenance Period|Adverse Event|2|||
127979215|NCT02375555|460545774|FG000|Maintenance Period|Withdrawal by Subject|4|||
127979216|NCT02375555|460545774|FG000|Maintenance Period|Death|1|||
127979217|NCT02375555|460545774|FG000|Maintenance Period|Disease Progression|5|||
127979218|NCT02375555|460545774|FG000|Maintenance Period|Patient Non-compliance|1|||
127979219|NCT02375555|460545774|FG000|Maintenance Period|Still on maintenance|16|||
127979220|NCT01744184|460545786|FG000|Overall Study|Adverse Event|1|||
127979221|NCT01744184|460545787|FG001|Overall Study|Adverse Event|0|||
127979222|NCT01744184|460545786|FG000|Overall Study|Withdrawal by Subject|0|||
127979223|NCT01744184|460545787|FG001|Overall Study|Withdrawal by Subject|1|||
127979224|NCT01095978|460545793|FG000|Overall Study|Did not take Klacid SR|2|||
127979225|NCT01095978|460545793|FG000|Overall Study|Adverse Event|1|||
127979226|NCT02135107|460545794|FG000|Treatment Period|Withdrawal by Subject|11|||
127979227|NCT02135107|460545795|FG001|Treatment Period|Withdrawal by Subject|0|||
127979228|NCT02135107|460545796|FG002|Treatment Period|Withdrawal by Subject|0|||
127979229|NCT02135107|460545797|FG003|Treatment Period|Withdrawal by Subject|0|||
127979230|NCT02135107|460545794|FG000|Treatment Period|Adverse Event|5|||
127979231|NCT02135107|460545795|FG001|Treatment Period|Adverse Event|2|||
127979232|NCT02135107|460545796|FG002|Treatment Period|Adverse Event|0|||
127979233|NCT02135107|460545797|FG003|Treatment Period|Adverse Event|0|||
127979234|NCT02135107|460545794|FG000|Treatment Period|Pregnancy|1|||
127979235|NCT02135107|460545795|FG001|Treatment Period|Pregnancy|0|||
127979236|NCT02135107|460545796|FG002|Treatment Period|Pregnancy|0|||
127979237|NCT02135107|460545797|FG003|Treatment Period|Pregnancy|0|||
127979238|NCT02135107|460545794|FG000|Treatment Period|Other|115|||
127979239|NCT02135107|460545795|FG001|Treatment Period|Other|24|||
127979240|NCT02135107|460545796|FG002|Treatment Period|Other|0|||
127979241|NCT02135107|460545797|FG003|Treatment Period|Other|0|||
127979242|NCT02135107|460545794|FG000|Maintenance Therapy Period|Adverse Event|0|||
127510940|NCT02285114|458831436|FG004|Extension Phase|Non-compliance with Study Drug|0|||
127510941|NCT02285114|458831437|FG005|Extension Phase|Non-compliance with Study Drug|0|||
127510942|NCT02285114|458831432|FG000|Extension Phase|Pregnancy|0|||
127510943|NCT02285114|458831433|FG001|Extension Phase|Pregnancy|0|||
127510944|NCT02285114|458831434|FG002|Extension Phase|Pregnancy|0|||
127510945|NCT02285114|458831435|FG003|Extension Phase|Pregnancy|1|||
127510946|NCT02285114|458831436|FG004|Extension Phase|Pregnancy|0|||
127510947|NCT02285114|458831437|FG005|Extension Phase|Pregnancy|0|||
127510948|NCT01156389|458831443|FG000|Overall Study|Elevated liver enzymes|4|||
127510949|NCT01156389|458831444|FG001|Overall Study|Elevated liver enzymes|0|||
127510950|NCT01156389|458831443|FG000|Overall Study|Vomiting|0|||
127510951|NCT01156389|458831444|FG001|Overall Study|Vomiting|1|||
127510952|NCT04599166|458831451|FG000|Overall Study|Technological failure connecting to study app|80|||
127510953|NCT01777542|458831452|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
127510954|NCT01777542|458831453|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
127510955|NCT00953524|458831454|FG000|Overall Study|Adverse Event|2|||
127510956|NCT00953524|458831455|FG001|Overall Study|Adverse Event|0|||
127510957|NCT00953524|458831456|FG002|Overall Study|Adverse Event|1|||
127510958|NCT00953524|458831457|FG003|Overall Study|Adverse Event|2|||
127510959|NCT00953524|458831454|FG000|Overall Study|Protocol Violation|18|||
127510960|NCT00953524|458831455|FG001|Overall Study|Protocol Violation|10|||
127510961|NCT00953524|458831456|FG002|Overall Study|Protocol Violation|11|||
127510962|NCT00953524|458831457|FG003|Overall Study|Protocol Violation|6|||
127510963|NCT00953524|458831454|FG000|Overall Study|Lost to Follow-up|0|||
127510964|NCT00953524|458831455|FG001|Overall Study|Lost to Follow-up|1|||
127510965|NCT00953524|458831456|FG002|Overall Study|Lost to Follow-up|1|||
127510966|NCT00953524|458831457|FG003|Overall Study|Lost to Follow-up|0|||
127510967|NCT00953524|458831454|FG000|Overall Study|Withdrawal by Subject|2|||
127510968|NCT00953524|458831455|FG001|Overall Study|Withdrawal by Subject|4|||
127510969|NCT00953524|458831456|FG002|Overall Study|Withdrawal by Subject|1|||
127510970|NCT00953524|458831457|FG003|Overall Study|Withdrawal by Subject|0|||
127510971|NCT04639219|458831464|FG000|Overall Study|Withdrawal by Subject|8|||
127510972|NCT04639219|458831464|FG000|Overall Study|Lost to Follow-up|6|||
127510973|NCT04639219|458831464|FG000|Overall Study|Death|55|||
127510974|NCT00869050|458831465|FG000|Overall Study|Screen Failure|3|||
127510975|NCT00585221|458831471|FG000|Overall Study|Protocol Violation|8|||
127510976|NCT03554772|458831474|FG000|Overall Study|Lost to Follow-up|0|||
127510977|NCT03554772|458831475|FG001|Overall Study|Lost to Follow-up|0|||
127510978|NCT03554772|458831476|FG002|Overall Study|Lost to Follow-up|0|||
127510979|NCT03554772|458831477|FG003|Overall Study|Lost to Follow-up|2|||
127510980|NCT03276052|458831479|FG000|Overall Study|Withdrawal by Subject|5|||
127510981|NCT03276052|458831479|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
127510982|NCT01994863|458831480|FG000|Period 1|Adverse Event|4|||
127510983|NCT01994863|458831481|FG001|Period 1|Adverse Event|0|||
127510984|NCT01994863|458831480|FG000|Period 1|Withdrawal by Subject|1|||
127510985|NCT01994863|458831481|FG001|Period 1|Withdrawal by Subject|0|||
127510986|NCT01994863|458831480|FG000|Period 1|Trial stopped by sponsor|1|||
127510987|NCT01994863|458831481|FG001|Period 1|Trial stopped by sponsor|3|||
127510988|NCT01994863|458831480|FG000|Period 1|Lack of Efficacy|1|||
127510989|NCT01994863|458831481|FG001|Period 1|Lack of Efficacy|0|||
127510990|NCT01994863|458831480|FG000|Period 2|Adverse Event|0|||
127510991|NCT01994863|458831481|FG001|Period 2|Adverse Event|1|||
127510992|NCT01994863|458831480|FG000|Period 2|Lack of Efficacy|0|||
127510993|NCT01994863|458831481|FG001|Period 2|Lack of Efficacy|2|||
127510994|NCT01994863|458831480|FG000|Period 2|Withdrawal by Subject|1|||
127510995|NCT01994863|458831481|FG001|Period 2|Withdrawal by Subject|1|||
127510996|NCT05136898|458831482|FG000|Overall Study|Adverse Event|2|||
127510997|NCT03784846|458831483|FG000|Pre-COVID Study|Lost to Follow-up|3|||
127510998|NCT03784846|458831484|FG001|Pre-COVID Study|Lost to Follow-up|3|||
127510999|NCT03784846|458831485|FG002|Pre-COVID Study|Lost to Follow-up|2|||
127511000|NCT03784846|458831483|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
127511001|NCT03784846|458831484|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
127511002|NCT03784846|458831485|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
127511003|NCT03784846|458831483|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
127511004|NCT03784846|458831484|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
127511005|NCT03784846|458831485|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
127511006|NCT03784846|458831483|FG000|Post-COVID Study|Lost to Follow-up|3|||
127511007|NCT03784846|458831484|FG001|Post-COVID Study|Lost to Follow-up|5|||
127511008|NCT03784846|458831485|FG002|Post-COVID Study|Lost to Follow-up|1|||
127511009|NCT03784846|458831483|FG000|Post-COVID Study|Withdrawal by Subject|1|||
127511010|NCT03784846|458831484|FG001|Post-COVID Study|Withdrawal by Subject|2|||
127511011|NCT03784846|458831485|FG002|Post-COVID Study|Withdrawal by Subject|0|||
127511012|NCT00867087|458831486|FG000|Overall Study|Other|1|||
127511013|NCT00867087|458831486|FG000|Overall Study|Withdrawal by Subject|4|||
127511014|NCT00867087|458831486|FG000|Overall Study|Death|37|||
127511015|NCT03060512|458831487|FG000|Overall Study|Adverse Event|4|||
127511016|NCT03060512|458831488|FG001|Overall Study|Adverse Event|6|||
127511017|NCT03060512|458831487|FG000|Overall Study|Lost to Follow-up|1|||
127511018|NCT03060512|458831488|FG001|Overall Study|Lost to Follow-up|1|||
127511019|NCT03060512|458831487|FG000|Overall Study|Withdrawal by Subject|1|||
127511020|NCT03060512|458831488|FG001|Overall Study|Withdrawal by Subject|0|||
127511021|NCT03060512|458831487|FG000|Overall Study|Non-compliance with study medication|1|||
127511022|NCT03060512|458831488|FG001|Overall Study|Non-compliance with study medication|2|||
127511023|NCT03946124|458831489|FG000|Overall Study|Withdrawal by Subject|19|||
127511024|NCT00241631|458831491|FG000|Run in (2 Weeks)|Physician Decision|3|||
127511025|NCT00241631|458831492|FG001|Run in (2 Weeks)|Physician Decision|3|||
127511026|NCT00241631|458831491|FG000|Phase 1 (4 Weeks)|sore throat|1|||
127511027|NCT00241631|458831492|FG001|Phase 1 (4 Weeks)|sore throat|0|||
127511028|NCT00241631|458831491|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
127511029|NCT00241631|458831492|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
127511030|NCT00241631|458831491|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
127511031|NCT00241631|458831492|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
127511032|NCT00241631|458831491|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
127511033|NCT00241631|458831492|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
127511034|NCT00919867|458831493|FG000|First Intervention|Withdrawal by Subject|0|||
127511035|NCT00919867|458831494|FG001|First Intervention|Withdrawal by Subject|0|||
127511036|NCT00919867|458831495|FG002|First Intervention|Withdrawal by Subject|1|||
127511037|NCT00919867|458831496|FG003|First Intervention|Withdrawal by Subject|0|||
127511038|NCT00919867|458831497|FG004|First Intervention|Withdrawal by Subject|0|||
127511039|NCT00919867|458831498|FG005|First Intervention|Withdrawal by Subject|0|||
127511040|NCT00919867|458831493|FG000|First Intervention|Physician Decision|0|||
127511041|NCT00919867|458831494|FG001|First Intervention|Physician Decision|0|||
127511042|NCT00919867|458831495|FG002|First Intervention|Physician Decision|0|||
127511043|NCT00919867|458831496|FG003|First Intervention|Physician Decision|0|||
127511044|NCT00919867|458831497|FG004|First Intervention|Physician Decision|0|||
127511045|NCT00919867|458831498|FG005|First Intervention|Physician Decision|1|||
127511046|NCT03883113|458831499|FG000|Overall Study|Physician Decision|4|||
127511047|NCT03883113|458831500|FG001|Overall Study|Physician Decision|2|||
127511048|NCT03883113|458831499|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
127511049|NCT03883113|458831500|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
127511050|NCT03883113|458831499|FG000|Overall Study|Pregnancy|1|||
127511051|NCT03883113|458831500|FG001|Overall Study|Pregnancy|0|||
127511052|NCT03883113|458831499|FG000|Overall Study|Adverse Event|0|||
127511053|NCT03883113|458831500|FG001|Overall Study|Adverse Event|1|||
127511054|NCT03883113|458831499|FG000|Overall Study|Withdrawal by Subject|1|||
127511055|NCT03883113|458831500|FG001|Overall Study|Withdrawal by Subject|2|||
127511056|NCT03883113|458831499|FG000|Overall Study|Lost to Follow-up|1|||
127511057|NCT03883113|458831500|FG001|Overall Study|Lost to Follow-up|0|||
127511058|NCT01457950|458831501|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
127511059|NCT01457950|458831502|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
127511060|NCT01457950|458831503|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
127511061|NCT01457950|458831504|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
127511062|NCT01457950|458831501|FG000|Double-Blind Phase|Protocol Violation|2|||
127511063|NCT01457950|458831502|FG001|Double-Blind Phase|Protocol Violation|1|||
127511064|NCT01457950|458831503|FG002|Double-Blind Phase|Protocol Violation|0|||
127511065|NCT01457950|458831504|FG003|Double-Blind Phase|Protocol Violation|0|||
127511066|NCT01457950|458831501|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
127511067|NCT01457950|458831502|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
127511068|NCT01457950|458831503|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
127511069|NCT01457950|458831504|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
127511070|NCT01457950|458831501|FG000|Open-Label Phase|Adverse Event|0|||
127511071|NCT01457950|458831502|FG001|Open-Label Phase|Adverse Event|0|||
127511072|NCT01457950|458831503|FG002|Open-Label Phase|Adverse Event|0|||
127511073|NCT01457950|458831504|FG003|Open-Label Phase|Adverse Event|1|||
127511074|NCT01457950|458831501|FG000|Open-Label Phase|Protocol Violation|0|||
127511075|NCT01457950|458831502|FG001|Open-Label Phase|Protocol Violation|0|||
127511076|NCT01457950|458831503|FG002|Open-Label Phase|Protocol Violation|0|||
127511077|NCT01457950|458831504|FG003|Open-Label Phase|Protocol Violation|1|||
127511078|NCT01457950|458831501|FG000|Open-Label Phase|Withdrawal by Subject|0|||
127511079|NCT01457950|458831502|FG001|Open-Label Phase|Withdrawal by Subject|0|||
127511080|NCT01457950|458831503|FG002|Open-Label Phase|Withdrawal by Subject|2|||
127511081|NCT01457950|458831504|FG003|Open-Label Phase|Withdrawal by Subject|0|||
127511082|NCT00435162|458831505|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
127511083|NCT00435162|458831506|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
127511084|NCT00435162|458831507|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
127511085|NCT00435162|458831508|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
127511086|NCT00435162|458831509|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
127511087|NCT00435162|458831510|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
127511088|NCT01765426|458831513|FG000|Overall Study|Lost to Follow-up|0|||
127511089|NCT01765426|458831514|FG001|Overall Study|Lost to Follow-up|1|||
127511090|NCT01765426|458831515|FG002|Overall Study|Lost to Follow-up|0|||
127511091|NCT01765426|458831516|FG003|Overall Study|Lost to Follow-up|0|||
127511092|NCT01510184|458831517|FG000|Overall Study|Sponsor discretion|28|||
127511093|NCT01510184|458831518|FG001|Overall Study|Sponsor discretion|28|||
127511094|NCT01510184|458831517|FG000|Overall Study|Death|1|||
127511095|NCT01510184|458831518|FG001|Overall Study|Death|2|||
127511096|NCT01510184|458831517|FG000|Overall Study|Withdrawal by Subject|1|||
127511097|NCT01510184|458831518|FG001|Overall Study|Withdrawal by Subject|4|||
127511098|NCT01510184|458831517|FG000|Overall Study|Other|0|||
127511099|NCT01510184|458831518|FG001|Overall Study|Other|1|||
127511100|NCT00694096|458831521|FG000|Overall Study|Withdrawal by Subject|5|||
127511101|NCT03515941|458831522|FG000|Overall Study|Adverse Event|1|||
127511102|NCT03515941|458831523|FG001|Overall Study|Adverse Event|0|||
127511103|NCT00334282|458831526|FG000|Overall Study|Lost to Follow-up|11|||
127511104|NCT00334282|458831527|FG001|Overall Study|Lost to Follow-up|5|||
127511105|NCT00334282|458831526|FG000|Overall Study|Withdrawal by Subject|17|||
127511106|NCT00334282|458831527|FG001|Overall Study|Withdrawal by Subject|3|||
127511107|NCT00334282|458831526|FG000|Overall Study|Death|194|||
127511108|NCT00334282|458831527|FG001|Overall Study|Death|100|||
127511109|NCT03688555|458831531|FG000|Treatment Period|Adverse Event|0|||
127511110|NCT03688555|458831532|FG001|Treatment Period|Adverse Event|0|||
127511111|NCT03688555|458831533|FG002|Treatment Period|Adverse Event|1|||
127511112|NCT00886119|458831534|FG000|Period 1|Did not meet inclusion criteria|1|||
127511113|NCT00886119|458831535|FG001|Period 1|Did not meet inclusion criteria|0|||
127511114|NCT01294462|458831536|FG000|Overall Study|Lost to Follow-up|1|||
127511115|NCT01294462|458831537|FG001|Overall Study|Lost to Follow-up|0|||
127511116|NCT01294462|458831536|FG000|Overall Study|Withdrawal by Subject|65|||
127511117|NCT01294462|458831537|FG001|Overall Study|Withdrawal by Subject|63|||
127511118|NCT04342689|458831543|FG000|Overall Study|Withdrawal by Subject|32|||
127511119|NCT04342689|458831544|FG001|Overall Study|Withdrawal by Subject|33|||
127511120|NCT04342689|458831543|FG000|Overall Study|Lost to Follow-up|10|||
127511121|NCT04342689|458831544|FG001|Overall Study|Lost to Follow-up|12|||
127511122|NCT01460407|458831545|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
127511123|NCT01460407|458831546|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
127511124|NCT00844805|458831551|FG000|Treatment Phase|Adverse Event|5|||
127511125|NCT00844805|458831552|FG001|Treatment Phase|Adverse Event|1|||
127511126|NCT00844805|458831553|FG002|Treatment Phase|Adverse Event|0|||
127511127|NCT00844805|458831554|FG003|Treatment Phase|Adverse Event|0|||
127511128|NCT00844805|458831551|FG000|Treatment Phase|Withdrawal by Subject|3|||
127511129|NCT00844805|458831552|FG001|Treatment Phase|Withdrawal by Subject|4|||
127511130|NCT00844805|458831553|FG002|Treatment Phase|Withdrawal by Subject|0|||
127511131|NCT00844805|458831554|FG003|Treatment Phase|Withdrawal by Subject|0|||
127511132|NCT00844805|458831551|FG000|Treatment Phase|Noncompliance With Protocol|1|||
127511133|NCT00844805|458831552|FG001|Treatment Phase|Noncompliance With Protocol|0|||
127511134|NCT00844805|458831553|FG002|Treatment Phase|Noncompliance With Protocol|0|||
127511135|NCT00844805|458831554|FG003|Treatment Phase|Noncompliance With Protocol|0|||
127511136|NCT00844805|458831551|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
127511137|NCT00844805|458831552|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
127511138|NCT00844805|458831553|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
127511139|NCT00844805|458831554|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
127511140|NCT00844805|458831551|FG000|Follow-Up Phase|Adverse Event|0|||
127511141|NCT00844805|458831552|FG001|Follow-Up Phase|Adverse Event|0|||
127511142|NCT00844805|458831553|FG002|Follow-Up Phase|Adverse Event|1|||
127511143|NCT00844805|458831554|FG003|Follow-Up Phase|Adverse Event|0|||
127511144|NCT00844805|458831551|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
127511145|NCT00844805|458831552|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
127511146|NCT00844805|458831553|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
127511147|NCT00844805|458831554|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
127511148|NCT00844805|458831551|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
127511149|NCT00844805|458831552|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
127511150|NCT00844805|458831553|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
127511151|NCT00844805|458831554|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
127511152|NCT00844805|458831551|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
127511153|NCT00844805|458831552|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
127511154|NCT00844805|458831553|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
127511155|NCT00844805|458831554|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
127511156|NCT00844805|458831551|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
127511157|NCT00844805|458831552|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
127511158|NCT00844805|458831553|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
127511159|NCT00844805|458831554|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
127511160|NCT04070326|458831555|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
127511161|NCT04070326|458831556|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
127511162|NCT01140568|458831560|FG000|Overall Study|disease progression|31|||
127511163|NCT01140568|458831560|FG000|Overall Study|Withdrawal by Subject|1|||
127511164|NCT01140568|458831560|FG000|Overall Study|Screen Fail|4|||
127511165|NCT03618628|458831561|FG000|Overall Study|Death|1|||
127511166|NCT03618628|458831561|FG000|Overall Study|Lost to Follow-up|1|||
127511167|NCT01741532|458831563|FG000|Overall Study|Adverse Event|4|||
127511168|NCT01741532|458831564|FG001|Overall Study|Adverse Event|0|||
127511169|NCT01741532|458831563|FG000|Overall Study|Withdrawal by Subject|1|||
127511170|NCT01741532|458831564|FG001|Overall Study|Withdrawal by Subject|1|||
127979243|NCT02135107|460545795|FG001|Maintenance Therapy Period|Adverse Event|0|||
127979244|NCT02135107|460545796|FG002|Maintenance Therapy Period|Adverse Event|3|||
127979245|NCT02135107|460545797|FG003|Maintenance Therapy Period|Adverse Event|7|||
127979246|NCT02135107|460545794|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
127979247|NCT02135107|460545795|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
127979248|NCT02135107|460545796|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
127979249|NCT02135107|460545797|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
127979250|NCT02135107|460545794|FG000|Maintenance Therapy Period|Pregnancy|0|||
127979251|NCT02135107|460545795|FG001|Maintenance Therapy Period|Pregnancy|0|||
127979252|NCT02135107|460545796|FG002|Maintenance Therapy Period|Pregnancy|0|||
127979253|NCT02135107|460545797|FG003|Maintenance Therapy Period|Pregnancy|1|||
127979254|NCT02135107|460545794|FG000|Maintenance Therapy Period|Other|0|||
127979255|NCT02135107|460545795|FG001|Maintenance Therapy Period|Other|0|||
127979256|NCT02135107|460545796|FG002|Maintenance Therapy Period|Other|7|||
127979257|NCT02135107|460545797|FG003|Maintenance Therapy Period|Other|8|||
127979258|NCT00808639|460545799|FG000|Overall Study|Disease progression before surgery.|1|||
127979259|NCT03055494|460547493|FG000|Overall Study|Lost to Follow-up|6|||
127979260|NCT03055494|460547494|FG001|Overall Study|Lost to Follow-up|0|||
127979261|NCT03055494|460547493|FG000|Overall Study|Physician Decision|2|||
127979262|NCT03055494|460547494|FG001|Overall Study|Physician Decision|0|||
127511171|NCT01741532|458831563|FG000|Overall Study|Protocol Violation|0|||
127511172|NCT01741532|458831564|FG001|Overall Study|Protocol Violation|1|||
127511173|NCT01741532|458831563|FG000|Overall Study|Worsening of the disease|3|||
127511174|NCT01741532|458831564|FG001|Overall Study|Worsening of the disease|1|||
127511175|NCT01741532|458831563|FG000|Overall Study|Sponsor decision|1|||
127511176|NCT01741532|458831564|FG001|Overall Study|Sponsor decision|0|||
127511177|NCT01741532|458831563|FG000|Overall Study|Medical event|1|||
127511178|NCT01741532|458831564|FG001|Overall Study|Medical event|0|||
127511179|NCT00475865|458831565|FG000|Overall Study|Adverse Event|0|||
127511180|NCT00475865|458831566|FG001|Overall Study|Adverse Event|3|||
127511181|NCT00475865|458831567|FG002|Overall Study|Adverse Event|4|||
127511182|NCT00475865|458831565|FG000|Overall Study|Lack of Efficacy|1|||
127511183|NCT00475865|458831566|FG001|Overall Study|Lack of Efficacy|0|||
127511184|NCT00475865|458831567|FG002|Overall Study|Lack of Efficacy|0|||
127511185|NCT00475865|458831565|FG000|Overall Study|Progressive disease|0|||
127511186|NCT00475865|458831566|FG001|Overall Study|Progressive disease|1|||
127511187|NCT00475865|458831567|FG002|Overall Study|Progressive disease|2|||
127511188|NCT00475865|458831565|FG000|Overall Study|Participant did not wish to continue|1|||
127511189|NCT00475865|458831566|FG001|Overall Study|Participant did not wish to continue|0|||
127511190|NCT00475865|458831567|FG002|Overall Study|Participant did not wish to continue|0|||
127511191|NCT00475865|458831565|FG000|Overall Study|Other than above|0|||
127511192|NCT00475865|458831566|FG001|Overall Study|Other than above|1|||
127511193|NCT00475865|458831567|FG002|Overall Study|Other than above|0|||
127511194|NCT00946322|458831569|FG000|Pre-treatment|participant failure to follow up|1|||
127511195|NCT00946322|458831569|FG000|Post-treatment|participant failure to follow up|2|||
127511196|NCT01453946|458831570|FG000|Overall Study|Did not receive drug for the taper phase|1|||
127511197|NCT01453946|458831570|FG000|Overall Study|Protocol Violation|2|||
127511198|NCT01453946|458831570|FG000|Overall Study|Lack of Efficacy|3|||
127511199|NCT01453946|458831570|FG000|Overall Study|Adverse Event|3|||
127511200|NCT01822535|458831573|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
127511201|NCT01822535|458831574|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
127511202|NCT01822535|458831573|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
127511203|NCT01822535|458831574|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
127511204|NCT01822535|458831573|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
127511205|NCT01822535|458831574|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
127511206|NCT02278614|458831575|FG000|Overall Study|Withdrawal by Subject|3|||
127511207|NCT02278614|458831576|FG001|Overall Study|Withdrawal by Subject|5|||
127511208|NCT02278614|458831575|FG000|Overall Study|Adverse Event|1|||
127511209|NCT02278614|458831576|FG001|Overall Study|Adverse Event|0|||
127511210|NCT02278614|458831575|FG000|Overall Study|left eye was not eligible|1|||
127511211|NCT02278614|458831576|FG001|Overall Study|left eye was not eligible|0|||
127511212|NCT02279498|458831579|FG000|Overall Study|Adverse Event|3|||
127511213|NCT02279498|458831580|FG001|Overall Study|Adverse Event|0|||
127511214|NCT02279498|458831579|FG000|Overall Study|Lack of Efficacy|4|||
127511215|NCT02279498|458831580|FG001|Overall Study|Lack of Efficacy|0|||
127511216|NCT02279498|458831579|FG000|Overall Study|Lost to Follow-up|0|||
127511217|NCT02279498|458831580|FG001|Overall Study|Lost to Follow-up|1|||
127511218|NCT02279498|458831579|FG000|Overall Study|Withdrawal by Subject|9|||
127511219|NCT02279498|458831580|FG001|Overall Study|Withdrawal by Subject|2|||
127511220|NCT02279498|458831579|FG000|Overall Study|Undefined|2|||
127511221|NCT02279498|458831580|FG001|Overall Study|Undefined|1|||
127511222|NCT03582813|458831581|FG000|Overall Study|Lost to Follow-up|18|||
127511223|NCT03582813|458831582|FG001|Overall Study|Lost to Follow-up|21|||
127979263|NCT03055494|460547493|FG000|Overall Study|Withdrawal by Subject|1|||
127979264|NCT03055494|460547494|FG001|Overall Study|Withdrawal by Subject|0|||
127979265|NCT03055494|460547493|FG000|Overall Study|Adverse Event|0|||
127511224|NCT03582813|458831581|FG000|Overall Study|Withdrawal by Subject|1|||
127511225|NCT03582813|458831582|FG001|Overall Study|Withdrawal by Subject|0|||
127511226|NCT02366767|458831585|FG000|Overall Study|left for home after 1 day at camp|1|||
127511227|NCT02366767|458831586|FG001|Overall Study|left for home after 1 day at camp|0|||
127511228|NCT02558400|458831589|FG000|Overall Study|Adverse Event|47|||
127979266|NCT03055494|460547494|FG001|Overall Study|Adverse Event|1|||
127979267|NCT03055494|460547493|FG000|Overall Study|Non-compliance with study treatment|1|||
127979268|NCT03055494|460547494|FG001|Overall Study|Non-compliance with study treatment|0|||
127979269|NCT05079750|460547495|FG000|Overall Study|Lost to Follow-up|0|||
127979270|NCT05079750|460547496|FG001|Overall Study|Lost to Follow-up|0|||
127979271|NCT05079750|460547497|FG002|Overall Study|Lost to Follow-up|1|||
127979272|NCT05897827|460547498|FG000|Overall Study|Lost to Follow-up|33|||
127979273|NCT05897827|460547499|FG001|Overall Study|Lost to Follow-up|14|||
127979274|NCT05897827|460547498|FG000|Overall Study|Withdrawal by Subject|1|||
127979275|NCT05897827|460547499|FG001|Overall Study|Withdrawal by Subject|1|||
127979276|NCT00197002|460547500|FG000|Overall Study|Adverse Event|0|||
127979277|NCT00197002|460547501|FG001|Overall Study|Adverse Event|1|||
127979278|NCT00197002|460547502|FG002|Overall Study|Adverse Event|0|||
127979279|NCT00197002|460547500|FG000|Overall Study|Protocol Violation|1|||
127979280|NCT00197002|460547501|FG001|Overall Study|Protocol Violation|0|||
127979281|NCT00197002|460547502|FG002|Overall Study|Protocol Violation|2|||
127979282|NCT00197002|460547500|FG000|Overall Study|Withdrawal by Subject|9|||
127979283|NCT00197002|460547501|FG001|Overall Study|Withdrawal by Subject|5|||
127979284|NCT00197002|460547502|FG002|Overall Study|Withdrawal by Subject|7|||
127979285|NCT00197002|460547500|FG000|Overall Study|Migrated/moved from study area|3|||
127979286|NCT00197002|460547501|FG001|Overall Study|Migrated/moved from study area|5|||
127511229|NCT02558400|458831590|FG001|Overall Study|Adverse Event|53|||
127511230|NCT02558400|458831591|FG002|Overall Study|Adverse Event|4|||
127511231|NCT02558400|458831589|FG000|Overall Study|Withdrawal by Subject|13|||
127511232|NCT02558400|458831590|FG001|Overall Study|Withdrawal by Subject|9|||
127511233|NCT02558400|458831591|FG002|Overall Study|Withdrawal by Subject|8|||
127511234|NCT02558400|458831589|FG000|Overall Study|Non-Compliant|0|||
127511235|NCT02558400|458831590|FG001|Overall Study|Non-Compliant|1|||
127511236|NCT02558400|458831591|FG002|Overall Study|Non-Compliant|3|||
127511237|NCT02558400|458831589|FG000|Overall Study|Lost to Follow-up|5|||
127511238|NCT02558400|458831590|FG001|Overall Study|Lost to Follow-up|5|||
127511239|NCT02558400|458831591|FG002|Overall Study|Lost to Follow-up|4|||
127511240|NCT02558400|458831589|FG000|Overall Study|Lack of Efficacy|0|||
127511241|NCT02558400|458831590|FG001|Overall Study|Lack of Efficacy|13|||
127511242|NCT02558400|458831591|FG002|Overall Study|Lack of Efficacy|1|||
127511243|NCT02558400|458831589|FG000|Overall Study|Disallowed Concurrent Medication|6|||
127511244|NCT02558400|458831590|FG001|Overall Study|Disallowed Concurrent Medication|7|||
127979287|NCT00197002|460547502|FG002|Overall Study|Migrated/moved from study area|1|||
127979288|NCT00197002|460547500|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
127979289|NCT00197002|460547501|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
127979290|NCT00197002|460547502|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
127979291|NCT00197002|460547500|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
127979292|NCT00197002|460547501|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
127979293|NCT00197002|460547502|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
127979294|NCT00197002|460547500|FG000|Overall Study|Others|3|||
127979295|NCT00197002|460547501|FG001|Overall Study|Others|1|||
127979296|NCT00197002|460547502|FG002|Overall Study|Others|1|||
127979297|NCT02017717|460547503|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
127979298|NCT02017717|460547504|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
127979299|NCT02017717|460547505|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
127979300|NCT02017717|460547506|FG003|Before Treatment Period|Adverse Event unrelated to study drug|0|||
127979301|NCT02017717|460547507|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
127979302|NCT02017717|460547508|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
127979303|NCT02017717|460547509|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
127979304|NCT02017717|460547510|FG007|Before Treatment Period|Adverse Event unrelated to study drug|1|||
127979305|NCT02017717|460547511|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
127979306|NCT02017717|460547503|FG000|Before Treatment Period|Participant request to stop therapy|0|||
127979307|NCT02017717|460547504|FG001|Before Treatment Period|Participant request to stop therapy|0|||
127979308|NCT02017717|460547505|FG002|Before Treatment Period|Participant request to stop therapy|0|||
127979309|NCT02017717|460547506|FG003|Before Treatment Period|Participant request to stop therapy|0|||
127979310|NCT02017717|460547507|FG004|Before Treatment Period|Participant request to stop therapy|0|||
127979311|NCT02017717|460547508|FG005|Before Treatment Period|Participant request to stop therapy|0|||
127979312|NCT02017717|460547509|FG006|Before Treatment Period|Participant request to stop therapy|0|||
127511245|NCT02558400|458831591|FG002|Overall Study|Disallowed Concurrent Medication|5|||
127979313|NCT02017717|460547510|FG007|Before Treatment Period|Participant request to stop therapy|0|||
127979314|NCT02017717|460547511|FG008|Before Treatment Period|Participant request to stop therapy|5|||
127979315|NCT02017717|460547503|FG000|Before Treatment Period|Participant withdrew consent|0|||
127979316|NCT02017717|460547504|FG001|Before Treatment Period|Participant withdrew consent|0|||
127979317|NCT02017717|460547505|FG002|Before Treatment Period|Participant withdrew consent|0|||
127979318|NCT02017717|460547506|FG003|Before Treatment Period|Participant withdrew consent|0|||
127979319|NCT02017717|460547507|FG004|Before Treatment Period|Participant withdrew consent|0|||
127979320|NCT02017717|460547508|FG005|Before Treatment Period|Participant withdrew consent|0|||
127979321|NCT02017717|460547509|FG006|Before Treatment Period|Participant withdrew consent|2|||
127979322|NCT02017717|460547510|FG007|Before Treatment Period|Participant withdrew consent|0|||
127979323|NCT02017717|460547511|FG008|Before Treatment Period|Participant withdrew consent|11|||
127979324|NCT02017717|460547503|FG000|Before Treatment Period|Lost to Follow-up|0|||
127979325|NCT02017717|460547504|FG001|Before Treatment Period|Lost to Follow-up|0|||
127979326|NCT02017717|460547505|FG002|Before Treatment Period|Lost to Follow-up|0|||
127979327|NCT02017717|460547506|FG003|Before Treatment Period|Lost to Follow-up|0|||
127979328|NCT02017717|460547507|FG004|Before Treatment Period|Lost to Follow-up|0|||
127979329|NCT02017717|460547508|FG005|Before Treatment Period|Lost to Follow-up|0|||
127979330|NCT02017717|460547509|FG006|Before Treatment Period|Lost to Follow-up|0|||
127979331|NCT02017717|460547510|FG007|Before Treatment Period|Lost to Follow-up|0|||
127979332|NCT02017717|460547511|FG008|Before Treatment Period|Lost to Follow-up|1|||
127979333|NCT02017717|460547503|FG000|Before Treatment Period|Participant no longer met criteria|0|||
127979334|NCT02017717|460547504|FG001|Before Treatment Period|Participant no longer met criteria|0|||
127979335|NCT02017717|460547505|FG002|Before Treatment Period|Participant no longer met criteria|0|||
127979336|NCT02017717|460547506|FG003|Before Treatment Period|Participant no longer met criteria|0|||
127979337|NCT02017717|460547507|FG004|Before Treatment Period|Participant no longer met criteria|0|||
127979338|NCT02017717|460547508|FG005|Before Treatment Period|Participant no longer met criteria|1|||
127979339|NCT02017717|460547509|FG006|Before Treatment Period|Participant no longer met criteria|0|||
127979340|NCT02017717|460547510|FG007|Before Treatment Period|Participant no longer met criteria|1|||
127979341|NCT02017717|460547511|FG008|Before Treatment Period|Participant no longer met criteria|2|||
127979342|NCT02017717|460547503|FG000|Before Treatment Period|other reason|0|||
127979343|NCT02017717|460547504|FG001|Before Treatment Period|other reason|0|||
127979344|NCT02017717|460547505|FG002|Before Treatment Period|other reason|0|||
127979345|NCT02017717|460547506|FG003|Before Treatment Period|other reason|0|||
127979346|NCT02017717|460547507|FG004|Before Treatment Period|other reason|0|||
127979347|NCT02017717|460547508|FG005|Before Treatment Period|other reason|0|||
127979348|NCT02017717|460547509|FG006|Before Treatment Period|other reason|0|||
127979349|NCT02017717|460547510|FG007|Before Treatment Period|other reason|0|||
127979350|NCT02017717|460547511|FG008|Before Treatment Period|other reason|1|||
127979351|NCT02017717|460547503|FG000|Treatment Period|Disease progression|7|||
127979352|NCT02017717|460547504|FG001|Treatment Period|Disease progression|9|||
127979353|NCT02017717|460547505|FG002|Treatment Period|Disease progression|12|||
127979354|NCT02017717|460547506|FG003|Treatment Period|Disease progression|20|||
127979355|NCT02017717|460547507|FG004|Treatment Period|Disease progression|26|||
127979356|NCT02017717|460547508|FG005|Treatment Period|Disease progression|16|||
127979357|NCT02017717|460547509|FG006|Treatment Period|Disease progression|22|||
127979358|NCT02017717|460547510|FG007|Treatment Period|Disease progression|165|||
127979359|NCT02017717|460547511|FG008|Treatment Period|Disease progression|135|||
127979360|NCT02017717|460547503|FG000|Treatment Period|Study drug toxicity|3|||
127979361|NCT02017717|460547504|FG001|Treatment Period|Study drug toxicity|0|||
127979362|NCT02017717|460547505|FG002|Treatment Period|Study drug toxicity|1|||
127979363|NCT02017717|460547506|FG003|Treatment Period|Study drug toxicity|4|||
127979364|NCT02017717|460547507|FG004|Treatment Period|Study drug toxicity|4|||
127979365|NCT02017717|460547508|FG005|Treatment Period|Study drug toxicity|5|||
127979366|NCT02017717|460547509|FG006|Treatment Period|Study drug toxicity|3|||
127979367|NCT02017717|460547510|FG007|Treatment Period|Study drug toxicity|7|||
127979368|NCT02017717|460547511|FG008|Treatment Period|Study drug toxicity|11|||
127979369|NCT02017717|460547503|FG000|Treatment Period|Death|0|||
127979370|NCT02017717|460547504|FG001|Treatment Period|Death|0|||
127979371|NCT02017717|460547505|FG002|Treatment Period|Death|1|||
127979372|NCT02017717|460547506|FG003|Treatment Period|Death|0|||
127979373|NCT02017717|460547507|FG004|Treatment Period|Death|0|||
127979374|NCT02017717|460547508|FG005|Treatment Period|Death|2|||
127979375|NCT02017717|460547509|FG006|Treatment Period|Death|0|||
127979376|NCT02017717|460547510|FG007|Treatment Period|Death|0|||
127979377|NCT02017717|460547511|FG008|Treatment Period|Death|0|||
127979378|NCT02017717|460547503|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
127979379|NCT02017717|460547504|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
127979380|NCT02017717|460547505|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
127511246|NCT02558400|458831589|FG000|Overall Study|Physician Decision|2|||
127979381|NCT02017717|460547506|FG003|Treatment Period|Adverse event unrelated to study drug|0|||
127979382|NCT02017717|460547507|FG004|Treatment Period|Adverse event unrelated to study drug|0|||
127979383|NCT02017717|460547508|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
127979384|NCT02017717|460547509|FG006|Treatment Period|Adverse event unrelated to study drug|1|||
127979385|NCT02017717|460547510|FG007|Treatment Period|Adverse event unrelated to study drug|4|||
127979386|NCT02017717|460547511|FG008|Treatment Period|Adverse event unrelated to study drug|5|||
127511247|NCT02558400|458831590|FG001|Overall Study|Physician Decision|2|||
127511248|NCT02558400|458831591|FG002|Overall Study|Physician Decision|0|||
127511249|NCT02558400|458831589|FG000|Overall Study|Protocol Violation|6|||
127511250|NCT02558400|458831590|FG001|Overall Study|Protocol Violation|3|||
127511251|NCT02558400|458831591|FG002|Overall Study|Protocol Violation|8|||
127511252|NCT02558400|458831589|FG000|Overall Study|Death|0|||
127511253|NCT02558400|458831590|FG001|Overall Study|Death|1|||
127511254|NCT02558400|458831591|FG002|Overall Study|Death|0|||
127511255|NCT02558400|458831589|FG000|Overall Study|Ineligible for the study|0|||
127511256|NCT02558400|458831590|FG001|Overall Study|Ineligible for the study|2|||
127511257|NCT02558400|458831591|FG002|Overall Study|Ineligible for the study|0|||
127511258|NCT02230683|458831592|FG000|Overall Study|Adverse Event|1|||
127511259|NCT00260065|458831593|FG000|Overall Study|Progressive Disease|22|||
127511260|NCT00260065|458831593|FG000|Overall Study|Adverse Event|17|||
127511261|NCT00260065|458831593|FG000|Overall Study|Death|13|||
127511262|NCT00260065|458831593|FG000|Overall Study|Withdrawal by Subject|13|||
127511263|NCT00260065|458831593|FG000|Overall Study|Physician Decision|19|||
127511264|NCT00260065|458831593|FG000|Overall Study|Not otherwise specified|8|||
127511265|NCT00260065|458831593|FG000|Overall Study|Medication Noncompliance|1|||
127511266|NCT04068519|458831594|FG000|Dose Verification|Death|15|||
127511267|NCT04068519|458831594|FG000|Dose Verification|Withdrawal by Subject|1|||
127511268|NCT04068519|458831594|FG000|Pharmacokinetic Sub-study|Death|35|||
127511269|NCT04068519|458831594|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
127511270|NCT04068519|458831594|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
127511271|NCT04068519|458831594|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
127511272|NCT04068519|458831594|FG000|Indication Expansion|Death|152|||
127511273|NCT04068519|458831594|FG000|Indication Expansion|Withdrawal by Subject|10|||
127511274|NCT04068519|458831594|FG000|Indication Expansion|Lost to Follow-up|7|||
127511275|NCT03654885|458833123|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
127511276|NCT03654885|458833124|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
127511277|NCT03654885|458833123|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
127511278|NCT03654885|458833124|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
127511279|NCT03654885|458833123|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
127511280|NCT03654885|458833124|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
127511281|NCT03654885|458833123|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
127511282|NCT03654885|458833124|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
127511283|NCT03654885|458833123|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
127511284|NCT03654885|458833124|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
127511285|NCT03654885|458833123|FG000|Overall Study|Adverse Event in Study Eye|3|||
127511286|NCT03654885|458833124|FG001|Overall Study|Adverse Event in Study Eye|0|||
127511287|NCT03654885|458833123|FG000|Overall Study|Consent Withdrawn|1|||
127511288|NCT03654885|458833124|FG001|Overall Study|Consent Withdrawn|0|||
127511289|NCT03654885|458833123|FG000|Overall Study|Death|3|||
127511290|NCT03654885|458833124|FG001|Overall Study|Death|1|||
127511291|NCT03654885|458833123|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
127511292|NCT03654885|458833124|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
127511293|NCT03654885|458833123|FG000|Overall Study|Lost to Follow-up|3|||
127511294|NCT03654885|458833124|FG001|Overall Study|Lost to Follow-up|3|||
127511295|NCT05275582|458833125|FG000|Overall Study|Lost to Follow-up|1|||
127511296|NCT05275582|458833126|FG001|Overall Study|Lost to Follow-up|0|||
127511297|NCT05275582|458833125|FG000|Overall Study|Withdrawal by Subject|0|||
127511298|NCT05275582|458833126|FG001|Overall Study|Withdrawal by Subject|2|||
127511299|NCT05275582|458833125|FG000|Overall Study|Did not/could not complete primary care appointment for various reasons|4|||
127511300|NCT05275582|458833126|FG001|Overall Study|Did not/could not complete primary care appointment for various reasons|0|||
127511301|NCT05275582|458833125|FG000|Overall Study|Death|1|||
127511302|NCT05275582|458833126|FG001|Overall Study|Death|0|||
127511303|NCT05275582|458833125|FG000|Overall Study|Protocol Violation|1|||
127511304|NCT05275582|458833126|FG001|Overall Study|Protocol Violation|0|||
127511305|NCT00031460|458833129|FG000|Overall Study|Lost to Follow-up|0|||
127511306|NCT00031460|458833130|FG001|Overall Study|Lost to Follow-up|1|||
127511307|NCT00031460|458833129|FG000|Overall Study|Withdrawal by Subject|1|||
127511308|NCT00031460|458833130|FG001|Overall Study|Withdrawal by Subject|1|||
127511309|NCT00031460|458833129|FG000|Overall Study|Non-Compliant|1|||
127511310|NCT00031460|458833130|FG001|Overall Study|Non-Compliant|1|||
127511311|NCT00031460|458833129|FG000|Overall Study|Death|0|||
127511312|NCT00031460|458833130|FG001|Overall Study|Death|1|||
127511313|NCT00031460|458833129|FG000|Overall Study|Reactivation of Disease|5|||
127511314|NCT00031460|458833130|FG001|Overall Study|Reactivation of Disease|9|||
127511315|NCT00031460|458833129|FG000|Overall Study|Disruption of blinded drug supply|2|||
127511316|NCT00031460|458833130|FG001|Overall Study|Disruption of blinded drug supply|0|||
127511317|NCT00031460|458833129|FG000|Overall Study|Confirmed unevaluable|0|||
127511318|NCT00031460|458833130|FG001|Overall Study|Confirmed unevaluable|1|||
127511319|NCT02210832|458833131|FG000|Overall Study|Pregnancy termination .|3|||
127511320|NCT02210832|458833132|FG001|Overall Study|Pregnancy termination .|4|||
127511321|NCT02210832|458833133|FG002|Overall Study|Pregnancy termination .|1|||
127511322|NCT02210832|458833131|FG000|Overall Study|Lost to Follow-up|26|||
127511323|NCT02210832|458833132|FG001|Overall Study|Lost to Follow-up|32|||
127511324|NCT02210832|458833133|FG002|Overall Study|Lost to Follow-up|17|||
127511325|NCT02080260|458833135|FG000|Overall Study|Death|18|||
127511326|NCT02080260|458833135|FG000|Overall Study|Withdrawal by Subject|1|||
127511327|NCT00471887|458833141|FG000|Overall Study|Adverse Event|9|||
127511328|NCT01030874|458833148|FG000|Overall Study|Withdrawal by Subject|1|||
127511329|NCT01030874|458833149|FG001|Overall Study|Withdrawal by Subject|0|||
127511330|NCT01030874|458833148|FG000|Overall Study|Discharged in first 2 weeks|17|||
127511331|NCT01030874|458833149|FG001|Overall Study|Discharged in first 2 weeks|16|||
127511332|NCT02498067|458833150|FG000|Overall Study|Lost to Follow-up|22|||
127511333|NCT02498067|458833150|FG000|Overall Study|Did not meet inclusion criteria|11|||
127511334|NCT03351114|458833154|FG000|Overall Study|Withdrawal by Subject|1|||
127511335|NCT01665430|458833155|FG000|Overall Study|Adverse Event|1|||
127511336|NCT01665430|458833155|FG000|Overall Study|Withdrawal by Subject|6|||
127511337|NCT01665430|458833155|FG000|Overall Study|Other Unspecified|2|||
127511338|NCT02310230|458833156|FG000|Overall Study|Physician Decision|1|||
127511339|NCT02310230|458833157|FG001|Overall Study|Physician Decision|3|||
127511340|NCT02310230|458833156|FG000|Overall Study|monitor baseline taken after induction|2|||
127511341|NCT02310230|458833157|FG001|Overall Study|monitor baseline taken after induction|7|||
127511342|NCT02310230|458833156|FG000|Overall Study|Poor signal quality|5|||
127511343|NCT02310230|458833157|FG001|Overall Study|Poor signal quality|8|||
127511344|NCT02310230|458833156|FG000|Overall Study|Case cancelled|1|||
127511345|NCT02310230|458833157|FG001|Overall Study|Case cancelled|0|||
127511346|NCT01371643|458833162|FG000|Overall Study|Withdrawal by Subject|3|||
127511347|NCT01371643|458833163|FG001|Overall Study|Withdrawal by Subject|0|||
127511348|NCT03249935|458833164|FG000|Overall Study|Discharged from facility early|36|||
127511349|NCT03249935|458833164|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
127511350|NCT03249935|458833164|FG000|Overall Study|Protocol Violation|5|||
127511351|NCT03593681|458833167|FG000|Overall Study|Inadequate sample collected|12|||
127511352|NCT03593681|458833167|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
127511353|NCT03593681|458833167|FG000|Overall Study|Protocol Violation|3|||
127511354|NCT03593681|458833167|FG000|Overall Study|Withdrawal by Subject|3|||
127511355|NCT03593681|458833167|FG000|Overall Study|Procedure not attempted|3|||
127511356|NCT03593681|458833167|FG000|Overall Study|Adverse Event|2|||
127511357|NCT03593681|458833167|FG000|Overall Study|Physician Decision|1|||
127511358|NCT03987932|458833169|FG000|Overall Study|Lost to Follow-up|2|||
127511359|NCT03987932|458833170|FG001|Overall Study|Lost to Follow-up|1|||
127511360|NCT03987932|458833171|FG002|Overall Study|Lost to Follow-up|1|||
127511361|NCT03987932|458833169|FG000|Overall Study|Non-study related elective surgery|0|||
127511362|NCT03987932|458833170|FG001|Overall Study|Non-study related elective surgery|0|||
127511363|NCT03987932|458833171|FG002|Overall Study|Non-study related elective surgery|1|||
127511364|NCT01669421|458833175|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
127511365|NCT01669421|458833175|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
127511366|NCT01561755|458833183|FG000|Overall Study|Lost to Follow-up|0|||
127511367|NCT01561755|458833184|FG001|Overall Study|Lost to Follow-up|1|||
127511368|NCT04662073|458833186|FG000|Overall Study|Withdrawal by Subject|1|||
127511369|NCT04662073|458833187|FG001|Overall Study|Withdrawal by Subject|0|||
127511370|NCT02961790|458833188|FG000|Overall Study|Canceled|4|||
127511371|NCT02961790|458833189|FG001|Overall Study|Canceled|5|||
127511372|NCT02961790|458833190|FG002|Overall Study|Canceled|1|||
127511373|NCT02961790|458833191|FG003|Overall Study|Canceled|4|||
127511374|NCT02961790|458833188|FG000|Overall Study|without baseline data|4|||
127511375|NCT02961790|458833189|FG001|Overall Study|without baseline data|0|||
127511376|NCT02961790|458833190|FG002|Overall Study|without baseline data|1|||
127511377|NCT02961790|458833191|FG003|Overall Study|without baseline data|0|||
127511378|NCT02961790|458833188|FG000|Overall Study|without post baseline data|7|||
127511379|NCT02961790|458833189|FG001|Overall Study|without post baseline data|6|||
127511380|NCT02961790|458833190|FG002|Overall Study|without post baseline data|4|||
127511381|NCT02961790|458833191|FG003|Overall Study|without post baseline data|1|||
127511382|NCT02185014|458833192|FG000|Overall Study|Adverse Event|18|||
127511383|NCT02185014|458833192|FG000|Overall Study|Withdrew Consent|8|||
127511384|NCT02185014|458833192|FG000|Overall Study|Lost to Follow-up|4|||
127511385|NCT02185014|458833192|FG000|Overall Study|Lack of Efficacy|14|||
127511386|NCT02185014|458833192|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
127511387|NCT02185014|458833192|FG000|Overall Study|Subject Noncompliance|1|||
127511388|NCT02185014|458833192|FG000|Overall Study|Other|4|||
127511389|NCT02370641|458833199|FG000|Overall Study|dropped study|4|||
127511390|NCT02370641|458833200|FG001|Overall Study|dropped study|2|||
127511391|NCT01479595|458833201|FG000|Overall Study|Protocol deviation|0|||
127511392|NCT01479595|458833202|FG001|Overall Study|Protocol deviation|1|||
127511393|NCT01479595|458833201|FG000|Overall Study|Adverse Event|2|||
127511394|NCT01479595|458833202|FG001|Overall Study|Adverse Event|1|||
127511395|NCT02255565|458833204|FG000|Overall Study|Withdrawal by Subject|0|||
127511396|NCT02255565|458833205|FG001|Overall Study|Withdrawal by Subject|1|||
127511397|NCT02255565|458833206|FG002|Overall Study|Withdrawal by Subject|0|||
127511398|NCT02133664|458833210|FG000|Overall Study|Lost to Follow-up|2|||
127511399|NCT02133664|458833211|FG001|Overall Study|Lost to Follow-up|1|||
127511400|NCT02133664|458833210|FG000|Overall Study|Adverse Event|3|||
127511401|NCT02133664|458833211|FG001|Overall Study|Adverse Event|6|||
127511402|NCT03906656|458833212|FG000|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|1|||
127511403|NCT03906656|458833213|FG001|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|0|||
127511404|NCT03906656|458833212|FG000|Fitting/Assessment Prior to Home Use 1|Adverse Event|0|||
127511405|NCT03906656|458833213|FG001|Fitting/Assessment Prior to Home Use 1|Adverse Event|1|||
127511406|NCT03906656|458833212|FG000|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|0|||
127511407|NCT03906656|458833213|FG001|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|1|||
127511408|NCT03906656|458833212|FG000|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|0|||
127511409|NCT03906656|458833213|FG001|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|1|||
127511410|NCT03906656|458833212|FG000|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|1|||
127511411|NCT03906656|458833213|FG001|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|0|||
127511412|NCT03906656|458833212|FG000|Home Use 1 (3 Months)|Adverse Event|1|||
127511413|NCT03906656|458833213|FG001|Home Use 1 (3 Months)|Adverse Event|2|||
127511414|NCT03906656|458833212|FG000|Home Use 1 (3 Months)|Withdrawal by Subject|1|||
127511415|NCT03906656|458833213|FG001|Home Use 1 (3 Months)|Withdrawal by Subject|0|||
127511416|NCT03906656|458833212|FG000|Home Use 1 (3 Months)|Lack of Efficacy|0|||
127511417|NCT03906656|458833213|FG001|Home Use 1 (3 Months)|Lack of Efficacy|1|||
127511418|NCT03906656|458833212|FG000|Home Use 1 (3 Months)|Protocol Violation|1|||
127511419|NCT03906656|458833213|FG001|Home Use 1 (3 Months)|Protocol Violation|0|||
127511420|NCT03906656|458833212|FG000|Fitting/Assessment Prior to Home Use 2|Adverse Event|2|||
127511421|NCT03906656|458833213|FG001|Fitting/Assessment Prior to Home Use 2|Adverse Event|0|||
127511422|NCT03906656|458833212|FG000|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|1|||
127511423|NCT03906656|458833213|FG001|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|0|||
127511424|NCT03906656|458833212|FG000|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|1|||
127511425|NCT03906656|458833213|FG001|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|0|||
127511426|NCT03906656|458833212|FG000|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|1|||
127511427|NCT03906656|458833213|FG001|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|0|||
127511428|NCT03906656|458833212|FG000|Fitting/Assessment Prior to Home Use 2|Personal problems|0|||
127511429|NCT03906656|458833213|FG001|Fitting/Assessment Prior to Home Use 2|Personal problems|1|||
127511430|NCT03906656|458833212|FG000|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|1|||
127511431|NCT03906656|458833213|FG001|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|0|||
127511432|NCT03906656|458833212|FG000|Home Use 2 (3 Months)|Adverse Event|1|||
127511433|NCT03906656|458833213|FG001|Home Use 2 (3 Months)|Adverse Event|1|||
127511434|NCT03906656|458833212|FG000|Home Use 2 (3 Months)|Lost to Follow-up|2|||
127511435|NCT03906656|458833213|FG001|Home Use 2 (3 Months)|Lost to Follow-up|0|||
127511436|NCT03906656|458833212|FG000|Home Use 2 (3 Months)|Death|2|||
127511437|NCT03906656|458833213|FG001|Home Use 2 (3 Months)|Death|0|||
127511438|NCT03906656|458833212|FG000|Home Use 2 (3 Months)|Lack of Efficacy|1|||
127511439|NCT03906656|458833213|FG001|Home Use 2 (3 Months)|Lack of Efficacy|0|||
127511440|NCT03906656|458833212|FG000|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|0|||
127511441|NCT03906656|458833213|FG001|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|1|||
127511442|NCT00343915|458833220|FG000|Primary Study|Withdrawal by Subject|1|||
127511443|NCT00343915|458833221|FG001|Primary Study|Withdrawal by Subject|0|||
127511444|NCT00343915|458833220|FG000|Primary Study|Lost to Follow-up|2|||
127511445|NCT00343915|458833221|FG001|Primary Study|Lost to Follow-up|3|||
127511446|NCT00343915|458833220|FG000|Primary Study|Other|1|||
127511447|NCT00343915|458833221|FG001|Primary Study|Other|0|||
127511448|NCT00882908|458833222|FG000|Overall Study|Adverse Event|0|||
127511449|NCT00882908|458833223|FG001|Overall Study|Adverse Event|0|||
127511450|NCT00882908|458833224|FG002|Overall Study|Adverse Event|1|||
127511451|NCT00882908|458833225|FG003|Overall Study|Adverse Event|0|||
127511452|NCT00882908|458833226|FG004|Overall Study|Adverse Event|1|||
127511453|NCT00882908|458833222|FG000|Overall Study|Lost to Follow-up|3|||
127511454|NCT00882908|458833223|FG001|Overall Study|Lost to Follow-up|5|||
127511455|NCT00882908|458833224|FG002|Overall Study|Lost to Follow-up|3|||
127511456|NCT00882908|458833225|FG003|Overall Study|Lost to Follow-up|1|||
127511457|NCT00882908|458833226|FG004|Overall Study|Lost to Follow-up|2|||
127511458|NCT00882908|458833222|FG000|Overall Study|Protocol Violation|0|||
127511459|NCT00882908|458833223|FG001|Overall Study|Protocol Violation|1|||
127511460|NCT00882908|458833224|FG002|Overall Study|Protocol Violation|0|||
127511461|NCT00882908|458833225|FG003|Overall Study|Protocol Violation|0|||
127511462|NCT00882908|458833226|FG004|Overall Study|Protocol Violation|0|||
127511463|NCT00882908|458833222|FG000|Overall Study|Withdrawal by Subject|0|||
127511464|NCT00882908|458833223|FG001|Overall Study|Withdrawal by Subject|0|||
127511465|NCT00882908|458833224|FG002|Overall Study|Withdrawal by Subject|3|||
127511466|NCT00882908|458833225|FG003|Overall Study|Withdrawal by Subject|5|||
127511467|NCT00882908|458833226|FG004|Overall Study|Withdrawal by Subject|2|||
127511468|NCT00882908|458833222|FG000|Overall Study|Subject reached a virologic endpoint|0|||
127511469|NCT00882908|458833223|FG001|Overall Study|Subject reached a virologic endpoint|0|||
127511470|NCT00882908|458833224|FG002|Overall Study|Subject reached a virologic endpoint|0|||
127511471|NCT00882908|458833225|FG003|Overall Study|Subject reached a virologic endpoint|0|||
127511472|NCT00882908|458833226|FG004|Overall Study|Subject reached a virologic endpoint|1|||
127511473|NCT00882908|458833222|FG000|Overall Study|Study terminated in error|0|||
127511474|NCT00882908|458833223|FG001|Overall Study|Study terminated in error|0|||
127511475|NCT00882908|458833224|FG002|Overall Study|Study terminated in error|0|||
127511476|NCT00882908|458833225|FG003|Overall Study|Study terminated in error|1|||
127511477|NCT00882908|458833226|FG004|Overall Study|Study terminated in error|0|||
127511478|NCT05291936|458833227|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
127511479|NCT05291936|458833228|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
127511480|NCT05291936|458833227|FG000|Period 1|Withdrew Consent during study|1|||
127511481|NCT05291936|458833228|FG001|Period 1|Withdrew Consent during study|0|||
127511482|NCT05291936|458833227|FG000|Period 2|Adverse Event|0|||
127511483|NCT05291936|458833228|FG001|Period 2|Adverse Event|1|||
127511484|NCT05291936|458833227|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
127511485|NCT05291936|458833228|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
127511486|NCT02370095|458833229|FG000|Overall Study|Withdrawal by Subject|0|||
127511487|NCT02370095|458833230|FG001|Overall Study|Withdrawal by Subject|1|||
127511488|NCT00581828|458833231|FG000|Overall Study|Protocol Violation|1|||
127511489|NCT01667562|458833235|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
127511490|NCT01667562|458833236|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
127511491|NCT01667562|458833235|FG000|Erlotinib Phase|Lost to Follow-up|0|||
127511492|NCT01667562|458833236|FG001|Erlotinib Phase|Lost to Follow-up|1|||
127511493|NCT01667562|458833235|FG000|Erlotinib Phase|Adverse Event|0|||
127511494|NCT01667562|458833236|FG001|Erlotinib Phase|Adverse Event|1|||
127511495|NCT01667562|458833235|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
127511496|NCT01667562|458833236|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
127511497|NCT01129882|458833237|FG000|Overall Study|Adverse Event|39|||
127511498|NCT01129882|458833237|FG000|Overall Study|Death|6|||
127511499|NCT01129882|458833237|FG000|Overall Study|Lack of Efficacy|5|||
127511500|NCT01129882|458833237|FG000|Overall Study|Lost to Follow-up|13|||
127511501|NCT01129882|458833237|FG000|Overall Study|Physician Decision|27|||
127511502|NCT01129882|458833237|FG000|Overall Study|Protocol Deviation|3|||
127511503|NCT01129882|458833237|FG000|Overall Study|Withdrawal Criteria Met|19|||
127511504|NCT01129882|458833237|FG000|Overall Study|Trial Termination by Sponsor|6|||
127511505|NCT01129882|458833237|FG000|Overall Study|Withdrawal by Subject|160|||
127511506|NCT02130986|458833238|FG000|Overall Study|Withdrawal by Subject|4|||
127511507|NCT02130986|458833239|FG001|Overall Study|Withdrawal by Subject|4|||
127511508|NCT02130986|458833238|FG000|Overall Study|Lost to Follow-up|151|||
127511509|NCT02130986|458833239|FG001|Overall Study|Lost to Follow-up|160|||
127511510|NCT00993499|458833243|FG000|Run-in Period (8 Days)|Adverse Event|0|||
127511511|NCT00993499|458833244|FG001|Run-in Period (8 Days)|Adverse Event|1|||
127511512|NCT00993499|458833245|FG002|Run-in Period (8 Days)|Adverse Event|0|||
127511513|NCT00993499|458833246|FG003|Run-in Period (8 Days)|Adverse Event|0|||
127511514|NCT00993499|458833247|FG004|Run-in Period (8 Days)|Adverse Event|0|||
127511515|NCT00993499|458833248|FG005|Run-in Period (8 Days)|Adverse Event|0|||
127511516|NCT00993499|458833243|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
127511517|NCT00993499|458833244|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
127511518|NCT00993499|458833245|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
127511519|NCT00993499|458833246|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
127511520|NCT00993499|458833247|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
127511521|NCT00993499|458833248|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
127511522|NCT00993499|458833243|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
127511523|NCT00993499|458833244|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
127511524|NCT00993499|458833245|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
127511525|NCT00993499|458833246|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
127511526|NCT00993499|458833247|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
127511527|NCT00993499|458833248|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
127511528|NCT00993499|458833243|FG000|Run-in Period (8 Days)|Progressive disease|0|||
127511529|NCT00993499|458833244|FG001|Run-in Period (8 Days)|Progressive disease|1|||
127511530|NCT00993499|458833245|FG002|Run-in Period (8 Days)|Progressive disease|1|||
127511531|NCT00993499|458833246|FG003|Run-in Period (8 Days)|Progressive disease|0|||
127511532|NCT00993499|458833247|FG004|Run-in Period (8 Days)|Progressive disease|0|||
127511533|NCT00993499|458833248|FG005|Run-in Period (8 Days)|Progressive disease|0|||
127511534|NCT00993499|458833243|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
127511535|NCT00993499|458833244|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
127511536|NCT00993499|458833245|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
127511537|NCT00993499|458833246|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
127511538|NCT00993499|458833247|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
127511539|NCT00993499|458833248|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
127511540|NCT00993499|458833243|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
127511541|NCT00993499|458833244|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
127511542|NCT00993499|458833245|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
127511543|NCT00993499|458833246|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
127511544|NCT00993499|458833247|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
127511545|NCT00993499|458833248|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
127511546|NCT00993499|458833243|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
127511547|NCT00993499|458833244|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
127511548|NCT00993499|458833245|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
127511549|NCT00993499|458833246|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
127511550|NCT00993499|458833247|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
127511551|NCT00993499|458833248|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
127511552|NCT00993499|458833243|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
127511553|NCT00993499|458833244|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
127511554|NCT00993499|458833245|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
127511555|NCT00993499|458833246|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
127511556|NCT00993499|458833247|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
127511557|NCT00993499|458833248|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
127511558|NCT00993499|458833243|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
127511559|NCT00993499|458833244|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
127511560|NCT00993499|458833245|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
127511561|NCT00993499|458833246|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
127511562|NCT00993499|458833247|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
127511563|NCT00993499|458833248|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
127511564|NCT00993499|458833243|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
127511565|NCT00993499|458833244|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
127511566|NCT00993499|458833245|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
127511567|NCT00993499|458833246|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
127511568|NCT00993499|458833247|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
127511569|NCT00993499|458833248|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
127511570|NCT00993499|458833243|FG000|Discontinued After Starting Course 3|DLT|1|||
127511571|NCT00993499|458833244|FG001|Discontinued After Starting Course 3|DLT|0|||
127511572|NCT00993499|458833245|FG002|Discontinued After Starting Course 3|DLT|2|||
127511573|NCT00993499|458833246|FG003|Discontinued After Starting Course 3|DLT|1|||
127511574|NCT00993499|458833247|FG004|Discontinued After Starting Course 3|DLT|0|||
127511575|NCT00993499|458833248|FG005|Discontinued After Starting Course 3|DLT|0|||
127511576|NCT00993499|458833243|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
127511577|NCT00993499|458833244|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
127511578|NCT00993499|458833245|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
127511579|NCT00993499|458833246|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
127511580|NCT00993499|458833247|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
127511581|NCT00993499|458833248|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
127511582|NCT01352741|458833252|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
127979387|NCT02017717|460547503|FG000|Treatment Period|Participant request to stop therapy|0|||
127979388|NCT02017717|460547504|FG001|Treatment Period|Participant request to stop therapy|0|||
127979389|NCT02017717|460547505|FG002|Treatment Period|Participant request to stop therapy|3|||
127979390|NCT02017717|460547506|FG003|Treatment Period|Participant request to stop therapy|6|||
127979391|NCT02017717|460547507|FG004|Treatment Period|Participant request to stop therapy|0|||
127979392|NCT02017717|460547508|FG005|Treatment Period|Participant request to stop therapy|2|||
127979393|NCT02017717|460547509|FG006|Treatment Period|Participant request to stop therapy|1|||
127979394|NCT02017717|460547510|FG007|Treatment Period|Participant request to stop therapy|4|||
127979395|NCT02017717|460547511|FG008|Treatment Period|Participant request to stop therapy|7|||
127979396|NCT02017717|460547503|FG000|Treatment Period|Participant withdrew consent|0|||
127979397|NCT02017717|460547504|FG001|Treatment Period|Participant withdrew consent|0|||
127979398|NCT02017717|460547505|FG002|Treatment Period|Participant withdrew consent|1|||
127979399|NCT02017717|460547506|FG003|Treatment Period|Participant withdrew consent|0|||
127979400|NCT02017717|460547507|FG004|Treatment Period|Participant withdrew consent|0|||
127511583|NCT01352741|458833253|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
127511584|NCT01352741|458833252|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
127511585|NCT01352741|458833253|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
127511586|NCT01352741|458833252|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
127511587|NCT01352741|458833253|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
127511588|NCT01352741|458833252|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
127511589|NCT01352741|458833253|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
127511590|NCT01352741|458833252|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
127511591|NCT01352741|458833253|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
127511592|NCT01352741|458833252|FG000|Open-label Tapentadol Titration Period|Other|4|||
127511593|NCT01352741|458833253|FG001|Open-label Tapentadol Titration Period|Other|0|||
127511594|NCT01352741|458833252|FG000|Double-blind Comparative Period|Protocol Violation|2|||
127511595|NCT01352741|458833253|FG001|Double-blind Comparative Period|Protocol Violation|0|||
127511596|NCT01352741|458833252|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
127511597|NCT01352741|458833253|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
127511598|NCT01352741|458833252|FG000|Double-blind Comparative Period|Adverse Event|16|||
127511599|NCT01352741|458833253|FG001|Double-blind Comparative Period|Adverse Event|17|||
127511600|NCT01352741|458833252|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
127511601|NCT01352741|458833253|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
127511602|NCT01352741|458833252|FG000|Double-blind Comparative Period|Death|0|||
127511603|NCT01352741|458833253|FG001|Double-blind Comparative Period|Death|1|||
127511604|NCT01352741|458833252|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
127511605|NCT01352741|458833253|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
127511606|NCT01352741|458833252|FG000|Double-blind Comparative Period|Other|1|||
127511607|NCT01352741|458833253|FG001|Double-blind Comparative Period|Other|2|||
127511608|NCT01352741|458833252|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
127511609|NCT01352741|458833253|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
127511610|NCT01352741|458833252|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
127511611|NCT01352741|458833253|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
127511612|NCT01352741|458833252|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
127511613|NCT01352741|458833253|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
127511614|NCT01352741|458833252|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
127511615|NCT01352741|458833253|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
127511616|NCT00259298|458833254|FG000|Overall Study|Withdrawal by Subject|1|||
127511617|NCT00259298|458833254|FG000|Overall Study|Physician Decision|2|||
127511618|NCT00645528|458833255|FG000|Overall Study|Did not show up for Visit 2|7|||
127511619|NCT01498185|458833258|FG000|Overall Study|Adverse Event|0|||
127511620|NCT01498185|458833259|FG001|Overall Study|Adverse Event|0|||
127511621|NCT01498185|458833260|FG002|Overall Study|Adverse Event|0|||
127511622|NCT01498185|458833261|FG003|Overall Study|Adverse Event|1|||
127511623|NCT01498185|458833262|FG004|Overall Study|Adverse Event|0|||
127511624|NCT01498185|458833258|FG000|Overall Study|Withdrawal by Subject|1|||
127511625|NCT01498185|458833259|FG001|Overall Study|Withdrawal by Subject|1|||
127511626|NCT01498185|458833260|FG002|Overall Study|Withdrawal by Subject|0|||
127511627|NCT01498185|458833261|FG003|Overall Study|Withdrawal by Subject|2|||
127979401|NCT02017717|460547508|FG005|Treatment Period|Participant withdrew consent|2|||
127979402|NCT02017717|460547509|FG006|Treatment Period|Participant withdrew consent|0|||
127979403|NCT02017717|460547510|FG007|Treatment Period|Participant withdrew consent|1|||
127979404|NCT02017717|460547511|FG008|Treatment Period|Participant withdrew consent|4|||
127979405|NCT02017717|460547503|FG000|Treatment Period|Participant no longer met criteria|0|||
127979406|NCT02017717|460547504|FG001|Treatment Period|Participant no longer met criteria|0|||
127979407|NCT02017717|460547505|FG002|Treatment Period|Participant no longer met criteria|0|||
127979408|NCT02017717|460547506|FG003|Treatment Period|Participant no longer met criteria|0|||
127979409|NCT02017717|460547507|FG004|Treatment Period|Participant no longer met criteria|0|||
127979410|NCT02017717|460547508|FG005|Treatment Period|Participant no longer met criteria|0|||
127979411|NCT02017717|460547509|FG006|Treatment Period|Participant no longer met criteria|0|||
127979412|NCT02017717|460547510|FG007|Treatment Period|Participant no longer met criteria|0|||
127979413|NCT02017717|460547511|FG008|Treatment Period|Participant no longer met criteria|1|||
127979414|NCT02017717|460547503|FG000|Treatment Period|Other reasons|0|||
127979415|NCT02017717|460547504|FG001|Treatment Period|Other reasons|0|||
127979416|NCT02017717|460547505|FG002|Treatment Period|Other reasons|0|||
127979417|NCT02017717|460547506|FG003|Treatment Period|Other reasons|1|||
127979418|NCT02017717|460547507|FG004|Treatment Period|Other reasons|0|||
127979419|NCT02017717|460547508|FG005|Treatment Period|Other reasons|1|||
127979420|NCT02017717|460547509|FG006|Treatment Period|Other reasons|1|||
127979421|NCT02017717|460547510|FG007|Treatment Period|Other reasons|1|||
127979422|NCT02017717|460547511|FG008|Treatment Period|Other reasons|1|||
127979423|NCT02017717|460547503|FG000|Treatment Period|Maximum clinical benefit|0|||
127979424|NCT02017717|460547504|FG001|Treatment Period|Maximum clinical benefit|0|||
127511628|NCT01498185|458833262|FG004|Overall Study|Withdrawal by Subject|1|||
127511629|NCT01498185|458833258|FG000|Overall Study|No longer met criteria, etc|0|||
127511630|NCT01498185|458833259|FG001|Overall Study|No longer met criteria, etc|0|||
127511631|NCT01498185|458833260|FG002|Overall Study|No longer met criteria, etc|0|||
127511632|NCT01498185|458833261|FG003|Overall Study|No longer met criteria, etc|0|||
127511633|NCT01498185|458833262|FG004|Overall Study|No longer met criteria, etc|2|||
127511634|NCT02153346|458833263|FG000|Overall Study|Lost to Follow-up|11|||
127511635|NCT00846040|458833264|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
127511636|NCT00846040|458833265|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
127511637|NCT00846040|458833266|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
127511638|NCT00846040|458833264|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
127511639|NCT00846040|458833265|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
127511640|NCT00846040|458833266|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
127511641|NCT03158272|458833268|FG000|Overall Study|Disease progression|3|||
127511642|NCT03158272|458833269|FG001|Overall Study|Disease progression|3|||
127511643|NCT03158272|458833270|FG002|Overall Study|Disease progression|4|||
127511644|NCT03158272|458833271|FG003|Overall Study|Disease progression|6|||
127511645|NCT03158272|458833268|FG000|Overall Study|Death|0|||
127511646|NCT03158272|458833269|FG001|Overall Study|Death|0|||
127511647|NCT03158272|458833270|FG002|Overall Study|Death|1|||
127511648|NCT03158272|458833271|FG003|Overall Study|Death|0|||
127511649|NCT03158272|458833268|FG000|Overall Study|Other reasons|0|||
127511650|NCT03158272|458833269|FG001|Overall Study|Other reasons|0|||
127511651|NCT03158272|458833270|FG002|Overall Study|Other reasons|1|||
127511652|NCT03158272|458833271|FG003|Overall Study|Other reasons|0|||
127511653|NCT03158272|458833268|FG000|Overall Study|Adverse event unrelated to the drug|0|||
127511654|NCT03158272|458833269|FG001|Overall Study|Adverse event unrelated to the drug|1|||
127511655|NCT03158272|458833270|FG002|Overall Study|Adverse event unrelated to the drug|0|||
127511656|NCT03158272|458833271|FG003|Overall Study|Adverse event unrelated to the drug|0|||
127511657|NCT03081858|458834912|FG000|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|2|||
127511658|NCT03081858|458834913|FG001|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
127511659|NCT03081858|458834914|FG002|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
127511660|NCT03081858|458834915|FG003|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
127511661|NCT00262847|458834918|FG000|Overall Study|Disease Progression|309|||
127511662|NCT00262847|458834919|FG001|Overall Study|Disease Progression|274|||
127511663|NCT00262847|458834920|FG002|Overall Study|Disease Progression|195|||
127511664|NCT00262847|458834918|FG000|Overall Study|Patient Refusal|41|||
127511665|NCT00262847|458834919|FG001|Overall Study|Patient Refusal|52|||
127511666|NCT00262847|458834920|FG002|Overall Study|Patient Refusal|47|||
127511667|NCT00262847|458834918|FG000|Overall Study|Adverse Event|74|||
127511668|NCT00262847|458834919|FG001|Overall Study|Adverse Event|88|||
127511669|NCT00262847|458834920|FG002|Overall Study|Adverse Event|108|||
127511670|NCT00262847|458834918|FG000|Overall Study|Death|8|||
127511671|NCT00262847|458834919|FG001|Overall Study|Death|8|||
127511672|NCT00262847|458834920|FG002|Overall Study|Death|11|||
127511673|NCT00262847|458834918|FG000|Overall Study|Concomitant disease|3|||
127511674|NCT00262847|458834919|FG001|Overall Study|Concomitant disease|2|||
127511675|NCT00262847|458834920|FG002|Overall Study|Concomitant disease|4|||
127511676|NCT00262847|458834918|FG000|Overall Study|Other Reasons|79|||
127511677|NCT00262847|458834919|FG001|Overall Study|Other Reasons|88|||
127511678|NCT00262847|458834920|FG002|Overall Study|Other Reasons|27|||
127511679|NCT00262847|458834918|FG000|Overall Study|Did not receive study treatment|4|||
127511680|NCT00262847|458834919|FG001|Overall Study|Did not receive study treatment|1|||
127511681|NCT00262847|458834920|FG002|Overall Study|Did not receive study treatment|4|||
127511682|NCT03966885|458834921|FG000|Overall Study|Death|1|||
127511683|NCT03966885|458834922|FG001|Overall Study|Death|0|||
127511684|NCT03966885|458834921|FG000|Overall Study|Lost to Follow-up|1|||
127511685|NCT03966885|458834922|FG001|Overall Study|Lost to Follow-up|2|||
127511686|NCT03966885|458834921|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
127511687|NCT03966885|458834922|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
127511688|NCT03966885|458834921|FG000|Overall Study|Moved from study area.|0|||
127511689|NCT03966885|458834922|FG001|Overall Study|Moved from study area.|2|||
127511690|NCT01998893|458834943|FG000|Overall Study|Adverse Event|2|||
127511691|NCT01998893|458834943|FG000|Overall Study|Death|1|||
127979425|NCT02017717|460547505|FG002|Treatment Period|Maximum clinical benefit|0|||
127979426|NCT02017717|460547506|FG003|Treatment Period|Maximum clinical benefit|0|||
127979427|NCT02017717|460547507|FG004|Treatment Period|Maximum clinical benefit|0|||
127979428|NCT02017717|460547508|FG005|Treatment Period|Maximum clinical benefit|0|||
127979429|NCT02017717|460547509|FG006|Treatment Period|Maximum clinical benefit|0|||
127511692|NCT01998893|458834943|FG000|Overall Study|Lost to Follow-up|8|||
127511693|NCT01998893|458834943|FG000|Overall Study|Physician Decision|2|||
127511694|NCT01998893|458834943|FG000|Overall Study|Protocol Violation|2|||
127511695|NCT01998893|458834943|FG000|Overall Study|Withdrawal by Subject|1|||
127979430|NCT02017717|460547510|FG007|Treatment Period|Maximum clinical benefit|0|||
127979431|NCT02017717|460547511|FG008|Treatment Period|Maximum clinical benefit|1|||
127511696|NCT01998893|458834943|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
127511697|NCT02088073|458834945|FG000|Acute Phase|Withdrawal by Subject|5|||
127511698|NCT02088073|458834946|FG001|Acute Phase|Withdrawal by Subject|0|||
127511699|NCT02088073|458834947|FG002|Acute Phase|Withdrawal by Subject|0|||
127511700|NCT02088073|458834948|FG003|Acute Phase|Withdrawal by Subject|0|||
127511701|NCT02088073|458834949|FG004|Acute Phase|Withdrawal by Subject|0|||
127511702|NCT02088073|458834945|FG000|Acute Phase|Hyperkalemia|2|||
127511703|NCT02088073|458834946|FG001|Acute Phase|Hyperkalemia|0|||
127511704|NCT02088073|458834947|FG002|Acute Phase|Hyperkalemia|0|||
127511705|NCT02088073|458834948|FG003|Acute Phase|Hyperkalemia|0|||
127511706|NCT02088073|458834949|FG004|Acute Phase|Hyperkalemia|0|||
127511707|NCT02088073|458834945|FG000|Maintanance Phase|Withdrawal by Subject|0|||
127511708|NCT02088073|458834946|FG001|Maintanance Phase|Withdrawal by Subject|2|||
127511709|NCT02088073|458834947|FG002|Maintanance Phase|Withdrawal by Subject|0|||
127511710|NCT02088073|458834948|FG003|Maintanance Phase|Withdrawal by Subject|0|||
127511711|NCT02088073|458834949|FG004|Maintanance Phase|Withdrawal by Subject|0|||
127511712|NCT02088073|458834945|FG000|Maintanance Phase|Adverse Event|0|||
127511713|NCT02088073|458834946|FG001|Maintanance Phase|Adverse Event|0|||
127511714|NCT02088073|458834947|FG002|Maintanance Phase|Adverse Event|3|||
127511715|NCT02088073|458834948|FG003|Maintanance Phase|Adverse Event|0|||
127511716|NCT02088073|458834949|FG004|Maintanance Phase|Adverse Event|1|||
127511717|NCT02088073|458834945|FG000|Maintanance Phase|Physician Decision|0|||
127511718|NCT02088073|458834946|FG001|Maintanance Phase|Physician Decision|0|||
127511719|NCT02088073|458834947|FG002|Maintanance Phase|Physician Decision|0|||
127511720|NCT02088073|458834948|FG003|Maintanance Phase|Physician Decision|0|||
127511721|NCT02088073|458834949|FG004|Maintanance Phase|Physician Decision|1|||
127511722|NCT02088073|458834945|FG000|Maintanance Phase|Sponsor's decision|0|||
127511723|NCT02088073|458834946|FG001|Maintanance Phase|Sponsor's decision|2|||
127511724|NCT02088073|458834947|FG002|Maintanance Phase|Sponsor's decision|0|||
127511725|NCT02088073|458834948|FG003|Maintanance Phase|Sponsor's decision|2|||
127511726|NCT02088073|458834949|FG004|Maintanance Phase|Sponsor's decision|1|||
127511727|NCT02088073|458834945|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
127511728|NCT02088073|458834946|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
127511729|NCT02088073|458834947|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
127511730|NCT02088073|458834948|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
127511731|NCT02088073|458834949|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
127511732|NCT02088073|458834945|FG000|Maintanance Phase|Miscellaneous|0|||
127511733|NCT02088073|458834946|FG001|Maintanance Phase|Miscellaneous|2|||
127511734|NCT02088073|458834947|FG002|Maintanance Phase|Miscellaneous|1|||
127511735|NCT02088073|458834948|FG003|Maintanance Phase|Miscellaneous|2|||
127511736|NCT02088073|458834949|FG004|Maintanance Phase|Miscellaneous|1|||
127511737|NCT02088073|458834945|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
127511738|NCT02088073|458834946|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
127511739|NCT02088073|458834947|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
127511740|NCT02088073|458834948|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
127511741|NCT02088073|458834949|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
127511742|NCT02088073|458834945|FG000|Maintanance Phase|Subject compliance|0|||
127511743|NCT02088073|458834946|FG001|Maintanance Phase|Subject compliance|1|||
127511744|NCT02088073|458834947|FG002|Maintanance Phase|Subject compliance|0|||
127511745|NCT02088073|458834948|FG003|Maintanance Phase|Subject compliance|0|||
127511746|NCT02088073|458834949|FG004|Maintanance Phase|Subject compliance|0|||
127511747|NCT02046174|458834950|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
127511748|NCT02046174|458834951|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
127511749|NCT02118597|458834952|FG000|Overall Study|Sponsor terminated the study|14|||
127511750|NCT02118597|458834952|FG000|Overall Study|Serious Adverse Event|1|||
127511751|NCT02118597|458834952|FG000|Overall Study|Investigator's decision|1|||
127511752|NCT01891344|458834953|FG000|Overall Study|Ongoing|6|||
127511753|NCT01891344|458834954|FG001|Overall Study|Ongoing|2|||
127511754|NCT01891344|458834955|FG002|Overall Study|Ongoing|0|||
127511755|NCT01891344|458834956|FG003|Overall Study|Ongoing|1|||
127511756|NCT01891344|458834957|FG004|Overall Study|Ongoing|4|||
127511757|NCT01891344|458834958|FG005|Overall Study|Ongoing|1|||
127511758|NCT01891344|458834959|FG006|Overall Study|Ongoing|0|||
127511759|NCT01891344|458834960|FG007|Overall Study|Ongoing|0|||
127511760|NCT02969590|458834964|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
127511761|NCT02969590|458834965|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
127511762|NCT02969590|458834966|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
127511763|NCT03294135|458834967|FG000|Overall Study|Serious Adverse Event|1|||
127511764|NCT03294135|458834968|FG001|Overall Study|Serious Adverse Event|0|||
127511765|NCT03294135|458834969|FG002|Overall Study|Serious Adverse Event|0|||
127511766|NCT03294135|458834967|FG000|Overall Study|Lost to Follow-up|1|||
127511767|NCT03294135|458834968|FG001|Overall Study|Lost to Follow-up|0|||
127511768|NCT03294135|458834969|FG002|Overall Study|Lost to Follow-up|1|||
127511769|NCT03294135|458834967|FG000|Overall Study|Withdrawal by Subject|0|||
127511770|NCT03294135|458834968|FG001|Overall Study|Withdrawal by Subject|0|||
127511771|NCT03294135|458834969|FG002|Overall Study|Withdrawal by Subject|1|||
127511772|NCT03294135|458834967|FG000|Overall Study|Other|2|||
127511773|NCT03294135|458834968|FG001|Overall Study|Other|0|||
127511774|NCT03294135|458834969|FG002|Overall Study|Other|0|||
127511775|NCT00186537|458834970|FG000|Overall Study|Withdrawal by Subject|4|||
127511776|NCT00186537|458834971|FG001|Overall Study|Withdrawal by Subject|0|||
127511777|NCT00186537|458834972|FG002|Overall Study|Withdrawal by Subject|3|||
127511778|NCT00186537|458834970|FG000|Overall Study|ALT > 1.5 x ULN|3|||
127511779|NCT00186537|458834971|FG001|Overall Study|ALT > 1.5 x ULN|0|||
127511780|NCT00186537|458834972|FG002|Overall Study|ALT > 1.5 x ULN|0|||
127511781|NCT02590562|458834977|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
127511782|NCT02763254|458834978|FG000|Overall Study|Adverse Event|1|||
127511783|NCT03684304|458834979|FG000|Overall Study|Lost to Follow-up|19|||
127511784|NCT03684304|458834980|FG001|Overall Study|Lost to Follow-up|17|||
127511785|NCT00054691|458834981|FG000|Overall Study|Unmeasurable Disease|2|||
127511786|NCT00054691|458834981|FG000|Overall Study|Noncompliant|1|||
127511787|NCT02078102|458834984|FG000|Overall Study|Adverse Event|1|||
127511788|NCT02078102|458834985|FG001|Overall Study|Adverse Event|0|||
127511789|NCT02078102|458834984|FG000|Overall Study|Withdrawal by Subject|1|||
127511790|NCT02078102|458834985|FG001|Overall Study|Withdrawal by Subject|0|||
127511791|NCT02078102|458834984|FG000|Overall Study|Physician Decision|0|||
127511792|NCT02078102|458834985|FG001|Overall Study|Physician Decision|1|||
127511793|NCT00598078|458834990|FG000|Period 2 (Day 2)|Adverse Event|1|||
127511794|NCT00598078|458834991|FG001|Period 2 (Day 2)|Adverse Event|0|||
127511795|NCT02387164|458834994|FG000|Overall Study|Lost to Follow-up|2|||
127511796|NCT02387164|458834995|FG001|Overall Study|Lost to Follow-up|0|||
127511797|NCT02387164|458834994|FG000|Overall Study|Diagnosed|1|||
127511798|NCT02387164|458834995|FG001|Overall Study|Diagnosed|2|||
127511799|NCT00810901|458834996|FG000|Overall Study|Lost to Follow-up|88|||
127511800|NCT00810901|458834997|FG001|Overall Study|Lost to Follow-up|58|||
127511801|NCT02120365|458834998|FG000|Overall Study|Withdrawal by Subject|0|||
127511802|NCT02120365|458834999|FG001|Overall Study|Withdrawal by Subject|0|||
127511803|NCT02120365|458835000|FG002|Overall Study|Withdrawal by Subject|2|||
127511804|NCT02120365|458835001|FG003|Overall Study|Withdrawal by Subject|4|||
127511805|NCT02120365|458835002|FG004|Overall Study|Withdrawal by Subject|0|||
127511806|NCT02120365|458835003|FG005|Overall Study|Withdrawal by Subject|2|||
127511807|NCT01719003|458835006|FG000|Overall Study|Non compliant with protocol|1|||
127511808|NCT01719003|458835007|FG001|Overall Study|Non compliant with protocol|1|||
127511809|NCT01719003|458835008|FG002|Overall Study|Non compliant with protocol|0|||
127511810|NCT01719003|458835009|FG003|Overall Study|Non compliant with protocol|1|||
127511811|NCT01719003|458835010|FG004|Overall Study|Non compliant with protocol|2|||
127511812|NCT01719003|458835011|FG005|Overall Study|Non compliant with protocol|1|||
127511813|NCT01719003|458835012|FG006|Overall Study|Non compliant with protocol|2|||
127979432|NCT02017717|460547503|FG000|Treatment Period|Not reported|0|||
127979433|NCT02017717|460547504|FG001|Treatment Period|Not reported|1|||
127979434|NCT02017717|460547505|FG002|Treatment Period|Not reported|0|||
127979435|NCT02017717|460547506|FG003|Treatment Period|Not reported|0|||
127979436|NCT02017717|460547507|FG004|Treatment Period|Not reported|0|||
127979437|NCT02017717|460547508|FG005|Treatment Period|Not reported|0|||
127979438|NCT02017717|460547509|FG006|Treatment Period|Not reported|0|||
127979439|NCT02017717|460547510|FG007|Treatment Period|Not reported|0|||
127979440|NCT02017717|460547511|FG008|Treatment Period|Not reported|0|||
127979441|NCT04488419|460547516|FG000|Safety Population, >=1 Dose Administered|Adverse Event|10|||
127979442|NCT04488419|460547517|FG001|Safety Population, >=1 Dose Administered|Adverse Event|22|||
127979443|NCT04488419|460547518|FG002|Safety Population, >=1 Dose Administered|Adverse Event|18|||
127979444|NCT04488419|460547516|FG000|Safety Population, >=1 Dose Administered|Withdrawal by Subject|3|||
127979445|NCT04488419|460547517|FG001|Safety Population, >=1 Dose Administered|Withdrawal by Subject|6|||
127979446|NCT04488419|460547518|FG002|Safety Population, >=1 Dose Administered|Withdrawal by Subject|1|||
127979447|NCT04488419|460547516|FG000|Safety Population, >=1 Dose Administered|Lost to Follow-up|0|||
127979448|NCT04488419|460547517|FG001|Safety Population, >=1 Dose Administered|Lost to Follow-up|3|||
127979449|NCT04488419|460547518|FG002|Safety Population, >=1 Dose Administered|Lost to Follow-up|2|||
127979450|NCT04488419|460547516|FG000|Safety Population, >=1 Dose Administered|Protocol Violation|2|||
127979451|NCT04488419|460547517|FG001|Safety Population, >=1 Dose Administered|Protocol Violation|1|||
127979452|NCT04488419|460547518|FG002|Safety Population, >=1 Dose Administered|Protocol Violation|0|||
127979453|NCT04488419|460547516|FG000|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
127979454|NCT04488419|460547517|FG001|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
127979455|NCT04488419|460547518|FG002|Safety Population, >=1 Dose Administered|Lack of Efficacy|0|||
127979456|NCT04488419|460547516|FG000|Safety Population, >=1 Dose Administered|Physician Decision|0|||
127979457|NCT04488419|460547517|FG001|Safety Population, >=1 Dose Administered|Physician Decision|1|||
127979458|NCT04488419|460547518|FG002|Safety Population, >=1 Dose Administered|Physician Decision|0|||
127979459|NCT04488419|460547516|FG000|Safety Population, >=1 Dose Administered|Undetermined|15|||
127979460|NCT04488419|460547517|FG001|Safety Population, >=1 Dose Administered|Undetermined|9|||
127979461|NCT04488419|460547518|FG002|Safety Population, >=1 Dose Administered|Undetermined|5|||
127979462|NCT04488419|460547516|FG000|Safety Population, >=1 Dose Administered|>1 Reason|4|||
127979463|NCT04488419|460547517|FG001|Safety Population, >=1 Dose Administered|>1 Reason|7|||
127979464|NCT04488419|460547518|FG002|Safety Population, >=1 Dose Administered|>1 Reason|12|||
127979465|NCT04488419|460547516|FG000|Primary Analysis Population|Adverse Event|6|||
127979466|NCT04488419|460547517|FG001|Primary Analysis Population|Adverse Event|9|||
127511814|NCT01719003|458835013|FG007|Overall Study|Non compliant with protocol|3|||
127511815|NCT01719003|458835014|FG008|Overall Study|Non compliant with protocol|0|||
127511816|NCT01719003|458835006|FG000|Overall Study|Adverse Event|6|||
127511817|NCT01719003|458835007|FG001|Overall Study|Adverse Event|5|||
127511818|NCT01719003|458835008|FG002|Overall Study|Adverse Event|4|||
127511819|NCT01719003|458835009|FG003|Overall Study|Adverse Event|3|||
127511820|NCT01719003|458835010|FG004|Overall Study|Adverse Event|4|||
127511821|NCT01719003|458835011|FG005|Overall Study|Adverse Event|3|||
127511822|NCT01719003|458835012|FG006|Overall Study|Adverse Event|6|||
127979467|NCT04488419|460547518|FG002|Primary Analysis Population|Adverse Event|0|||
127979468|NCT04488419|460547516|FG000|Primary Analysis Population|Withdrawal by Subject|0|||
127979469|NCT04488419|460547517|FG001|Primary Analysis Population|Withdrawal by Subject|4|||
127979470|NCT04488419|460547518|FG002|Primary Analysis Population|Withdrawal by Subject|0|||
127979471|NCT04488419|460547516|FG000|Primary Analysis Population|Protocol Violation|1|||
127979472|NCT04488419|460547517|FG001|Primary Analysis Population|Protocol Violation|1|||
127979473|NCT04488419|460547518|FG002|Primary Analysis Population|Protocol Violation|0|||
127979474|NCT04488419|460547516|FG000|Primary Analysis Population|Undetermined|7|||
127979475|NCT04488419|460547517|FG001|Primary Analysis Population|Undetermined|3|||
127979476|NCT04488419|460547518|FG002|Primary Analysis Population|Undetermined|0|||
127979477|NCT04488419|460547516|FG000|Primary Analysis Population|>1 Reason|2|||
127979478|NCT04488419|460547517|FG001|Primary Analysis Population|>1 Reason|4|||
127979479|NCT04488419|460547518|FG002|Primary Analysis Population|>1 Reason|0|||
127979480|NCT02276053|460547521|FG000|Overall Study|Death|2|||
127979481|NCT02276053|460547521|FG000|Overall Study|Adverse Event|5|||
127979482|NCT02276053|460547521|FG000|Overall Study|Lack of Efficacy|2|||
127979483|NCT02276053|460547521|FG000|Overall Study|Withdrawal by Subject|1|||
127979484|NCT02276053|460547521|FG000|Overall Study|Patient does not meet selection criteria|3|||
127979485|NCT02276053|460547521|FG000|Overall Study|Patient needs to increase baseline AED|1|||
127979486|NCT04542499|460547524|FG000|Overall Study|Adverse Event|23|||
127979487|NCT04542499|460547525|FG001|Overall Study|Adverse Event|43|||
127979488|NCT04542499|460547524|FG000|Overall Study|Lack of Efficacy|5|||
127979489|NCT04542499|460547525|FG001|Overall Study|Lack of Efficacy|2|||
127979490|NCT04542499|460547524|FG000|Overall Study|Lost to Follow-up|3|||
127979491|NCT04542499|460547525|FG001|Overall Study|Lost to Follow-up|4|||
127979492|NCT04542499|460547524|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
127979493|NCT04542499|460547525|FG001|Overall Study|Failure to Meet Continuation Criteria|1|||
127979494|NCT04542499|460547524|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
127979495|NCT04542499|460547525|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
127979496|NCT04542499|460547524|FG000|Overall Study|Non-Compliance with Study Drug|0|||
127979497|NCT04542499|460547525|FG001|Overall Study|Non-Compliance with Study Drug|2|||
127979498|NCT04542499|460547524|FG000|Overall Study|Physician Decision|0|||
127979499|NCT04542499|460547525|FG001|Overall Study|Physician Decision|1|||
127979500|NCT04542499|460547524|FG000|Overall Study|Site Terminated by Sponsor|3|||
127979501|NCT04542499|460547525|FG001|Overall Study|Site Terminated by Sponsor|5|||
127979502|NCT04542499|460547524|FG000|Overall Study|Withdrawal by Subject|12|||
127979503|NCT04542499|460547525|FG001|Overall Study|Withdrawal by Subject|33|||
127979504|NCT04542499|460547524|FG000|Overall Study|Other|2|||
127979505|NCT04542499|460547525|FG001|Overall Study|Other|2|||
127979506|NCT03617861|460547532|FG000|Second Intervention (1 Day)|Adverse Event|0|||
127979507|NCT03617861|460547533|FG001|Second Intervention (1 Day)|Adverse Event|0|||
127979508|NCT03617861|460547534|FG002|Second Intervention (1 Day)|Adverse Event|1|||
127979509|NCT03617861|460547535|FG003|Second Intervention (1 Day)|Adverse Event|0|||
127979510|NCT01668966|460547545|FG000|Overall Study|Withdrawal by Subject|1|||
127979511|NCT01668966|460547545|FG000|Overall Study|Death|1|||
127979512|NCT01668966|460547545|FG000|Overall Study|Not treated|2|||
127979513|NCT03427268|460547546|FG000|Overall Study|Progressive disease|25|||
127979514|NCT03427268|460547546|FG000|Overall Study|Never treated|2|||
127979515|NCT03427268|460547546|FG000|Overall Study|Compassionate use|1|||
127979516|NCT03427268|460547546|FG000|Overall Study|Withdrawal by Subject|1|||
127979517|NCT03427268|460547546|FG000|Overall Study|Adverse Event|3|||
127979518|NCT00345878|460547548|FG000|Overall Study|Adverse Event|1|||
127979519|NCT00345878|460547549|FG001|Overall Study|Adverse Event|0|||
127979520|NCT00345878|460547548|FG000|Overall Study|Lost to Follow-up|2|||
127979521|NCT00345878|460547549|FG001|Overall Study|Lost to Follow-up|1|||
127979522|NCT00345878|460547548|FG000|Overall Study|Other|1|||
127979523|NCT00345878|460547549|FG001|Overall Study|Other|0|||
127979524|NCT03391232|460547550|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
127979525|NCT03391232|460547551|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
127979526|NCT03391232|460547550|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
127979527|NCT03391232|460547551|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
127979528|NCT00552032|460547552|FG000|Overall Study|Withdrawal by Subject|2|||
127979529|NCT00552032|460547553|FG001|Overall Study|Withdrawal by Subject|2|||
127979530|NCT00552032|460547552|FG000|Overall Study|Protocol Violation|7|||
127979531|NCT00552032|460547553|FG001|Overall Study|Protocol Violation|12|||
127979532|NCT00552032|460547552|FG000|Overall Study|Lost to Follow-up|8|||
127979533|NCT00552032|460547553|FG001|Overall Study|Lost to Follow-up|5|||
127979534|NCT01643798|460547554|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
127979535|NCT01643798|460547555|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
127979536|NCT01995175|460547563|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
127979537|NCT01995175|460547563|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
127979538|NCT01995175|460547563|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
127979539|NCT01995175|460547563|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
127979540|NCT01995175|460547563|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
127511823|NCT01719003|458835013|FG007|Overall Study|Adverse Event|5|||
127511824|NCT01719003|458835014|FG008|Overall Study|Adverse Event|0|||
127511825|NCT01719003|458835006|FG000|Overall Study|Lost to Follow-up|0|||
127511826|NCT01719003|458835007|FG001|Overall Study|Lost to Follow-up|6|||
127511827|NCT01719003|458835008|FG002|Overall Study|Lost to Follow-up|7|||
127511828|NCT01719003|458835009|FG003|Overall Study|Lost to Follow-up|2|||
127511829|NCT01719003|458835010|FG004|Overall Study|Lost to Follow-up|3|||
127511830|NCT01719003|458835011|FG005|Overall Study|Lost to Follow-up|4|||
127511831|NCT01719003|458835012|FG006|Overall Study|Lost to Follow-up|3|||
127511832|NCT01719003|458835013|FG007|Overall Study|Lost to Follow-up|2|||
127511833|NCT01719003|458835014|FG008|Overall Study|Lost to Follow-up|2|||
127511834|NCT01719003|458835006|FG000|Overall Study|Refusal to continue, not due to AE|2|||
127511835|NCT01719003|458835007|FG001|Overall Study|Refusal to continue, not due to AE|5|||
127511836|NCT01719003|458835008|FG002|Overall Study|Refusal to continue, not due to AE|4|||
127511837|NCT01719003|458835009|FG003|Overall Study|Refusal to continue, not due to AE|4|||
127511838|NCT01719003|458835010|FG004|Overall Study|Refusal to continue, not due to AE|4|||
127511839|NCT01719003|458835011|FG005|Overall Study|Refusal to continue, not due to AE|3|||
127511840|NCT01719003|458835012|FG006|Overall Study|Refusal to continue, not due to AE|8|||
127511841|NCT01719003|458835013|FG007|Overall Study|Refusal to continue, not due to AE|7|||
127511842|NCT01719003|458835014|FG008|Overall Study|Refusal to continue, not due to AE|1|||
127511843|NCT01719003|458835006|FG000|Overall Study|Reason other than those specified|0|||
127511844|NCT01719003|458835007|FG001|Overall Study|Reason other than those specified|0|||
127511845|NCT01719003|458835008|FG002|Overall Study|Reason other than those specified|2|||
127511846|NCT01719003|458835009|FG003|Overall Study|Reason other than those specified|3|||
127511847|NCT01719003|458835010|FG004|Overall Study|Reason other than those specified|4|||
127511848|NCT01719003|458835011|FG005|Overall Study|Reason other than those specified|1|||
127511849|NCT01719003|458835012|FG006|Overall Study|Reason other than those specified|0|||
127511850|NCT01719003|458835013|FG007|Overall Study|Reason other than those specified|3|||
127511851|NCT01719003|458835014|FG008|Overall Study|Reason other than those specified|1|||
127511852|NCT01719003|458835006|FG000|Overall Study|Lack of Efficacy|0|||
127511853|NCT01719003|458835007|FG001|Overall Study|Lack of Efficacy|0|||
127511854|NCT01719003|458835008|FG002|Overall Study|Lack of Efficacy|0|||
127511855|NCT01719003|458835009|FG003|Overall Study|Lack of Efficacy|0|||
127511856|NCT01719003|458835010|FG004|Overall Study|Lack of Efficacy|0|||
127511857|NCT01719003|458835011|FG005|Overall Study|Lack of Efficacy|0|||
127511858|NCT01719003|458835012|FG006|Overall Study|Lack of Efficacy|1|||
127511859|NCT01719003|458835013|FG007|Overall Study|Lack of Efficacy|0|||
127511860|NCT01719003|458835014|FG008|Overall Study|Lack of Efficacy|0|||
127511861|NCT00900146|458835015|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
127511862|NCT00900146|458835016|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
127511863|NCT00900146|458835017|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
127511864|NCT00900146|458835018|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
127511865|NCT00900146|458835019|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
127511866|NCT00900146|458835015|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
127511867|NCT00900146|458835016|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
127511868|NCT00900146|458835017|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
127511869|NCT00900146|458835018|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
127511870|NCT00900146|458835019|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
127511871|NCT00900146|458835015|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
127511872|NCT00900146|458835016|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
127511873|NCT00900146|458835017|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
127511874|NCT00900146|458835018|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
127511875|NCT00900146|458835019|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
127511876|NCT00900146|458835015|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
127511877|NCT00900146|458835016|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
127511878|NCT00900146|458835017|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
127511879|NCT00900146|458835018|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
127511880|NCT00900146|458835019|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
127511881|NCT00900146|458835015|FG000|Intermediate: Period III|Lost to Follow-up|2|||
127511882|NCT00900146|458835016|FG001|Intermediate: Period III|Lost to Follow-up|0|||
127511883|NCT00900146|458835017|FG002|Intermediate: Period III|Lost to Follow-up|0|||
127511884|NCT00900146|458835018|FG003|Intermediate: Period III|Lost to Follow-up|0|||
127511885|NCT00900146|458835019|FG004|Intermediate: Period III|Lost to Follow-up|1|||
127511886|NCT00900146|458835015|FG000|Intermediate: Period III|Administrative problems|85|||
127511887|NCT00900146|458835016|FG001|Intermediate: Period III|Administrative problems|92|||
127511888|NCT00900146|458835017|FG002|Intermediate: Period III|Administrative problems|84|||
127511889|NCT00900146|458835018|FG003|Intermediate: Period III|Administrative problems|90|||
127511890|NCT00900146|458835019|FG004|Intermediate: Period III|Administrative problems|163|||
127511891|NCT01133275|458835020|FG000|Overall Study|Withdrawal by Subject|1|||
127511892|NCT01133275|458835020|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
127511893|NCT00700102|458835021|FG000|Overall Study|Died|394|||
127511894|NCT00700102|458835022|FG001|Overall Study|Died|385|||
127511895|NCT00700102|458835021|FG000|Overall Study|Lost to Follow-up|8|||
127511896|NCT00700102|458835022|FG001|Overall Study|Lost to Follow-up|10|||
127511897|NCT02525939|458835027|FG000|Overall Study|Lost to Follow-up|27|||
127511898|NCT02525939|458835028|FG001|Overall Study|Lost to Follow-up|24|||
127511899|NCT02525939|458835027|FG000|Overall Study|Physician Decision|0|||
127511900|NCT02525939|458835028|FG001|Overall Study|Physician Decision|1|||
127511901|NCT02525939|458835027|FG000|Overall Study|Withdrawal by Subject|24|||
127511902|NCT02525939|458835028|FG001|Overall Study|Withdrawal by Subject|39|||
127511903|NCT02525939|458835027|FG000|Overall Study|Death|180|||
127511904|NCT02525939|458835028|FG001|Overall Study|Death|179|||
127511905|NCT01028716|458835029|FG000|Overall Study|Physician Decision|1|||
127511906|NCT05590000|458835030|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
127511907|NCT00762996|458835031|FG000|Period One|Protocol Violation|0|||
127511908|NCT00762996|458835032|FG001|Period One|Protocol Violation|0|||
127511909|NCT00762996|458835033|FG002|Period One|Protocol Violation|1|||
127511910|NCT00762996|458835034|FG003|Period One|Protocol Violation|0|||
127511911|NCT00762996|458835031|FG000|Period One|ineligible|0|||
127511912|NCT00762996|458835032|FG001|Period One|ineligible|0|||
127511913|NCT00762996|458835033|FG002|Period One|ineligible|1|||
127979541|NCT01995175|460547563|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
127979542|NCT01995175|460547563|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
127979543|NCT01995175|460547563|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
127979544|NCT01995175|460547563|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
127979545|NCT01877551|460547564|FG000|Overall Study|Physician Decision|0|||
127979546|NCT01877551|460547565|FG001|Overall Study|Physician Decision|1|||
127979547|NCT00984061|460547566|FG000|Clarithromycin Alone|Protocol Violation|1|||
127979548|NCT00614120|460547575|FG000|Overall Study|Adverse Event|9|||
127979549|NCT00614120|460547576|FG001|Overall Study|Adverse Event|22|||
127979550|NCT00614120|460547577|FG002|Overall Study|Adverse Event|30|||
127979551|NCT00614120|460547578|FG003|Overall Study|Adverse Event|3|||
127979552|NCT00614120|460547575|FG000|Overall Study|Lack of Efficacy|3|||
127979553|NCT00614120|460547576|FG001|Overall Study|Lack of Efficacy|3|||
127979554|NCT00614120|460547577|FG002|Overall Study|Lack of Efficacy|2|||
127979555|NCT00614120|460547578|FG003|Overall Study|Lack of Efficacy|2|||
127979556|NCT00614120|460547575|FG000|Overall Study|Protocol Violation|2|||
127979557|NCT00614120|460547576|FG001|Overall Study|Protocol Violation|5|||
127979558|NCT00614120|460547577|FG002|Overall Study|Protocol Violation|3|||
127979559|NCT00614120|460547578|FG003|Overall Study|Protocol Violation|1|||
127979560|NCT00614120|460547575|FG000|Overall Study|Withdrawal criteria|1|||
127979561|NCT00614120|460547576|FG001|Overall Study|Withdrawal criteria|0|||
127979562|NCT00614120|460547577|FG002|Overall Study|Withdrawal criteria|0|||
127979563|NCT00614120|460547578|FG003|Overall Study|Withdrawal criteria|0|||
127979564|NCT00614120|460547575|FG000|Overall Study|Withdrawal by Subject|9|||
127979565|NCT00614120|460547576|FG001|Overall Study|Withdrawal by Subject|10|||
127979566|NCT00614120|460547577|FG002|Overall Study|Withdrawal by Subject|16|||
127979567|NCT00614120|460547578|FG003|Overall Study|Withdrawal by Subject|3|||
127979568|NCT00614120|460547575|FG000|Overall Study|Did not meet trial criteria|0|||
127979569|NCT00614120|460547576|FG001|Overall Study|Did not meet trial criteria|1|||
127979570|NCT00614120|460547577|FG002|Overall Study|Did not meet trial criteria|1|||
127979571|NCT00614120|460547578|FG003|Overall Study|Did not meet trial criteria|1|||
127979572|NCT00614120|460547575|FG000|Overall Study|hCG positive (not pregnant)|0|||
127979573|NCT00614120|460547576|FG001|Overall Study|hCG positive (not pregnant)|0|||
127979574|NCT00614120|460547577|FG002|Overall Study|hCG positive (not pregnant)|1|||
127979575|NCT00614120|460547578|FG003|Overall Study|hCG positive (not pregnant)|0|||
127979576|NCT00614120|460547575|FG000|Overall Study|Hypoglycaemia|0|||
127979577|NCT00614120|460547576|FG001|Overall Study|Hypoglycaemia|0|||
127979578|NCT00614120|460547577|FG002|Overall Study|Hypoglycaemia|0|||
127979579|NCT00614120|460547578|FG003|Overall Study|Hypoglycaemia|1|||
127979580|NCT00614120|460547575|FG000|Overall Study|Lack of trial product|3|||
127979581|NCT00614120|460547576|FG001|Overall Study|Lack of trial product|3|||
127979582|NCT00614120|460547577|FG002|Overall Study|Lack of trial product|2|||
127979583|NCT00614120|460547578|FG003|Overall Study|Lack of trial product|0|||
127979584|NCT00614120|460547575|FG000|Overall Study|Late syphilis, latent|1|||
127979585|NCT00614120|460547576|FG001|Overall Study|Late syphilis, latent|0|||
127979586|NCT00614120|460547577|FG002|Overall Study|Late syphilis, latent|0|||
127979587|NCT00614120|460547578|FG003|Overall Study|Late syphilis, latent|0|||
127511914|NCT00762996|458835034|FG003|Period One|ineligible|1|||
127511915|NCT00762996|458835031|FG000|Period One|Adverse Event|0|||
127511916|NCT00762996|458835032|FG001|Period One|Adverse Event|0|||
127511917|NCT00762996|458835033|FG002|Period One|Adverse Event|1|||
127511918|NCT00762996|458835034|FG003|Period One|Adverse Event|0|||
127511919|NCT00762996|458835031|FG000|Period One|Withdrawal by Subject|0|||
127511920|NCT00762996|458835032|FG001|Period One|Withdrawal by Subject|0|||
127511921|NCT00762996|458835033|FG002|Period One|Withdrawal by Subject|1|||
127511922|NCT00762996|458835034|FG003|Period One|Withdrawal by Subject|0|||
127511923|NCT00536874|458835035|FG000|Overall Study|Adverse Event|1|||
127979588|NCT00614120|460547575|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
127979589|NCT00614120|460547576|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
127511924|NCT00536874|458835035|FG000|Overall Study|Death|2|||
127511925|NCT00536874|458835035|FG000|Overall Study|Withdrawal by Subject|1|||
127511926|NCT02689076|458835037|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
127511927|NCT02689076|458835038|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
127511928|NCT02689076|458835039|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
127511929|NCT02689076|458835037|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
127511930|NCT02689076|458835038|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
127511931|NCT02689076|458835039|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
127511932|NCT02689076|458835037|FG000|Overall Study|Did not have an HIE match|2|||
127511933|NCT02689076|458835038|FG001|Overall Study|Did not have an HIE match|0|||
127511934|NCT02689076|458835039|FG002|Overall Study|Did not have an HIE match|0|||
127511935|NCT02689076|458835037|FG000|Overall Study|Death during non-VA encounter|2|||
127511936|NCT02689076|458835038|FG001|Overall Study|Death during non-VA encounter|5|||
127511937|NCT02689076|458835039|FG002|Overall Study|Death during non-VA encounter|0|||
127511938|NCT02689076|458835037|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
127511939|NCT02689076|458835038|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
127511940|NCT02689076|458835039|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
127511941|NCT02689076|458835037|FG000|Overall Study|Participant no longer active in VA system|1|||
127511942|NCT02689076|458835038|FG001|Overall Study|Participant no longer active in VA system|0|||
127511943|NCT02689076|458835039|FG002|Overall Study|Participant no longer active in VA system|0|||
127511944|NCT02689076|458835037|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
127511945|NCT02689076|458835038|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
127511946|NCT02689076|458835039|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
127511947|NCT01143896|458835041|FG000|Overall Study|Did not complete Baseline Interview|5|||
127511948|NCT01143896|458835042|FG001|Overall Study|Did not complete Baseline Interview|4|||
127511949|NCT01143896|458835041|FG000|Overall Study|Lost to Follow-up|18|||
127511950|NCT01143896|458835042|FG001|Overall Study|Lost to Follow-up|13|||
127511951|NCT01143896|458835041|FG000|Overall Study|Withdrawal by Subject|13|||
127511952|NCT01143896|458835042|FG001|Overall Study|Withdrawal by Subject|5|||
127511953|NCT01143896|458835041|FG000|Overall Study|Death|6|||
127511954|NCT01143896|458835042|FG001|Overall Study|Death|3|||
127511955|NCT02084238|458835043|FG000|Overall Study|Lost to Follow-up|2|||
127511956|NCT00320372|458835044|FG000|Overall Study|Physician Decision|4|||
127511957|NCT00320372|458835045|FG001|Overall Study|Physician Decision|7|||
127511958|NCT00320372|458835044|FG000|Overall Study|Death|7|||
127511959|NCT00320372|458835045|FG001|Overall Study|Death|8|||
127511960|NCT00320372|458835044|FG000|Overall Study|Withdrawal by Subject|55|||
127511961|NCT00320372|458835045|FG001|Overall Study|Withdrawal by Subject|37|||
127511962|NCT00320372|458835044|FG000|Overall Study|Non-Compliance|40|||
127511963|NCT00320372|458835045|FG001|Overall Study|Non-Compliance|39|||
127511964|NCT00320372|458835044|FG000|Overall Study|Did not Meet (I/E)|3|||
127511965|NCT00320372|458835045|FG001|Overall Study|Did not Meet (I/E)|1|||
127511966|NCT00320372|458835044|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
127511967|NCT00320372|458835045|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
127511968|NCT00086502|458835046|FG000|Overall Study|Adverse Event|11|||
127511969|NCT00086502|458835047|FG001|Overall Study|Adverse Event|2|||
127511970|NCT00086502|458835046|FG000|Overall Study|Lack of Efficacy|0|||
127511971|NCT00086502|458835047|FG001|Overall Study|Lack of Efficacy|2|||
127511972|NCT00086502|458835046|FG000|Overall Study|Lost to Follow-up|3|||
127511973|NCT00086502|458835047|FG001|Overall Study|Lost to Follow-up|1|||
127511974|NCT00086502|458835046|FG000|Overall Study|Physician Decision|1|||
127511975|NCT00086502|458835047|FG001|Overall Study|Physician Decision|1|||
127511976|NCT00086502|458835046|FG000|Overall Study|Pregnancy|0|||
127511977|NCT00086502|458835047|FG001|Overall Study|Pregnancy|1|||
127511978|NCT00086502|458835046|FG000|Overall Study|Protocol Violation|3|||
127511979|NCT00086502|458835047|FG001|Overall Study|Protocol Violation|3|||
127511980|NCT00086502|458835046|FG000|Overall Study|Withdrawal by Subject|5|||
127511981|NCT00086502|458835047|FG001|Overall Study|Withdrawal by Subject|6|||
127511982|NCT00086502|458835046|FG000|Overall Study|Patient Moved|1|||
127511983|NCT00086502|458835047|FG001|Overall Study|Patient Moved|1|||
127511984|NCT00086502|458835046|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
127511985|NCT00086502|458835047|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
127511986|NCT00086502|458835046|FG000|Overall Study|Patient Accidentally Unblinded|1|||
127511987|NCT00086502|458835047|FG001|Overall Study|Patient Accidentally Unblinded|0|||
127511988|NCT01304329|458835048|FG000|Third Intervention (3 Days)|Adverse Event|0|||
127511989|NCT01304329|458835049|FG001|Third Intervention (3 Days)|Adverse Event|1|||
127511990|NCT01304329|458835050|FG002|Third Intervention (3 Days)|Adverse Event|0|||
127511991|NCT01304329|458835051|FG003|Third Intervention (3 Days)|Adverse Event|0|||
127511992|NCT01304329|458835052|FG004|Third Intervention (3 Days)|Adverse Event|0|||
127511993|NCT01304329|458835053|FG005|Third Intervention (3 Days)|Adverse Event|0|||
127511994|NCT02068118|458835058|FG000|18-month Comparative Study Period|Death|90|||
127511995|NCT02068118|458835059|FG001|18-month Comparative Study Period|Death|97|||
127511996|NCT02068118|458835058|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
127511997|NCT02068118|458835059|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
127511998|NCT02068118|458835058|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
127511999|NCT02068118|458835059|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
127512000|NCT02068118|458835058|FG000|18-month Comparative Study Period|Heart transplant|9|||
127512001|NCT02068118|458835059|FG001|18-month Comparative Study Period|Heart transplant|15|||
127512002|NCT02068118|458835058|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
127512003|NCT02068118|458835059|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
127512004|NCT02068118|458835058|FG000|18-month Comparative Study Period|Hemiplegia|0|||
127512005|NCT02068118|458835059|FG001|18-month Comparative Study Period|Hemiplegia|1|||
127512006|NCT02068118|458835058|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
127512007|NCT02068118|458835059|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
127512008|NCT02068118|458835058|FG000|18-month Comparative Study Period|Move|0|||
127512009|NCT02068118|458835059|FG001|18-month Comparative Study Period|Move|1|||
127512010|NCT02068118|458835058|FG000|18-month Comparative Study Period|Hearing loss|0|||
127512011|NCT02068118|458835059|FG001|18-month Comparative Study Period|Hearing loss|1|||
127512012|NCT02068118|458835058|FG000|Extension Period|Death|0|||
127979590|NCT00614120|460547577|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
127979591|NCT00614120|460547578|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
127979592|NCT00614120|460547575|FG000|Overall Study|Lost to Follow-up|1|||
127979593|NCT00614120|460547576|FG001|Overall Study|Lost to Follow-up|2|||
127979594|NCT00614120|460547577|FG002|Overall Study|Lost to Follow-up|3|||
127979595|NCT00614120|460547578|FG003|Overall Study|Lost to Follow-up|4|||
127979596|NCT03047720|460547579|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
127979597|NCT03047720|460547580|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
127979598|NCT01968707|460547584|FG000|Overall Study|Did not meet treatment day baseline|49|||
127979599|NCT01968707|460547585|FG001|Overall Study|Did not meet treatment day baseline|12|||
127979600|NCT01968707|460547586|FG002|Overall Study|Did not meet treatment day baseline|41|||
127979601|NCT01968707|460547587|FG003|Overall Study|Did not meet treatment day baseline|44|||
127979602|NCT01968707|460547588|FG004|Overall Study|Did not meet treatment day baseline|36|||
127979603|NCT01968707|460547589|FG005|Overall Study|Did not meet treatment day baseline|11|||
127979604|NCT01968707|460547590|FG006|Overall Study|Did not meet treatment day baseline|34|||
127979605|NCT01968707|460547591|FG007|Overall Study|Did not meet treatment day baseline|35|||
127979606|NCT00916344|460547592|FG000|Overall Study|Death|2|||
127979607|NCT00916344|460547592|FG000|Overall Study|ICD upgrade|1|||
127979608|NCT00916344|460547592|FG000|Overall Study|Drop-out|5|||
127979609|NCT03602391|460547601|FG000|Overall Study|COVID-19|7|||
127979610|NCT03602391|460547602|FG001|Overall Study|COVID-19|6|||
127979611|NCT03729570|460547609|FG000|Overall Study|Lost to Follow-up|16|||
127979612|NCT03729570|460547610|FG001|Overall Study|Lost to Follow-up|20|||
127979613|NCT03729570|460547609|FG000|Overall Study|Seroconversion|5|||
127979614|NCT03729570|460547610|FG001|Overall Study|Seroconversion|0|||
127979615|NCT03729570|460547609|FG000|Overall Study|Moved out of the city|1|||
127979616|NCT03729570|460547610|FG001|Overall Study|Moved out of the city|0|||
127979617|NCT03729570|460547609|FG000|Overall Study|Time Conflict|1|||
127979618|NCT03729570|460547610|FG001|Overall Study|Time Conflict|0|||
127979619|NCT03729570|460547609|FG000|Overall Study|Time Commitment|2|||
127979620|NCT03729570|460547610|FG001|Overall Study|Time Commitment|0|||
127979621|NCT03729570|460547609|FG000|Overall Study|Bad Experience|0|||
127979622|NCT03729570|460547610|FG001|Overall Study|Bad Experience|1|||
127979623|NCT03729570|460547609|FG000|Overall Study|No reason provided|2|||
127979624|NCT03729570|460547610|FG001|Overall Study|No reason provided|1|||
127979625|NCT03729570|460547609|FG000|Overall Study|Family Conflict|0|||
127979626|NCT03729570|460547610|FG001|Overall Study|Family Conflict|1|||
127979627|NCT03729570|460547609|FG000|Overall Study|Did not want to continue taking medications|0|||
127979628|NCT03729570|460547610|FG001|Overall Study|Did not want to continue taking medications|1|||
127979629|NCT03729570|460547609|FG000|Overall Study|Found another PrEP provider|1|||
127979630|NCT03729570|460547610|FG001|Overall Study|Found another PrEP provider|0|||
127979631|NCT03729570|460547609|FG000|Overall Study|Did not enjoy being in the control group|0|||
127979632|NCT03729570|460547610|FG001|Overall Study|Did not enjoy being in the control group|1|||
127979633|NCT02407457|460547613|FG000|1 Month|Death|3|||
127979634|NCT02407457|460547614|FG001|1 Month|Death|0|||
127979635|NCT02407457|460547613|FG000|1 Month|Lost to Follow-up|1|||
127979636|NCT02407457|460547614|FG001|1 Month|Lost to Follow-up|1|||
127979637|NCT02407457|460547613|FG000|1 Month|missed visit|2|||
127979638|NCT02407457|460547614|FG001|1 Month|missed visit|5|||
127979639|NCT02407457|460547613|FG000|6-Month|Death|2|||
127512013|NCT02068118|458835059|FG001|Extension Period|Death|2|||
127512014|NCT02068118|458835058|FG000|Extension Period|Withdrawal by Subject|1|||
127512015|NCT02068118|458835059|FG001|Extension Period|Withdrawal by Subject|0|||
127512016|NCT02068118|458835058|FG000|Extension Period|Heart transplant|1|||
127979640|NCT02407457|460547614|FG001|6-Month|Death|8|||
127979641|NCT02407457|460547613|FG000|6-Month|Lost to Follow-up|2|||
127512017|NCT02068118|458835059|FG001|Extension Period|Heart transplant|0|||
127979642|NCT02407457|460547614|FG001|6-Month|Lost to Follow-up|2|||
127512018|NCT02068118|458835058|FG000|Extension Period|Wrong device use|0|||
127512019|NCT02068118|458835059|FG001|Extension Period|Wrong device use|1|||
127512020|NCT00283868|458835062|FG000|Overall Study|Lost to Follow-up|7|||
127512021|NCT00283868|458835063|FG001|Overall Study|Lost to Follow-up|8|||
127512022|NCT01996592|458835069|FG000|Overall Study|no response to text/no diary entry|32|||
127512023|NCT01996592|458835069|FG000|Overall Study|change in surgical date|4|||
127512024|NCT01996592|458835069|FG000|Overall Study|Withdrawal by Subject|5|||
127512025|NCT01996592|458835069|FG000|Overall Study|change in mode of delivery|4|||
127512026|NCT01406015|458835070|FG000|Overall Study|Withdrawal by Subject|3|||
127512027|NCT01406015|458835071|FG001|Overall Study|Withdrawal by Subject|3|||
127512028|NCT00394901|458835072|FG000|Baseline Phase|Protocol Violation|0|||
127512029|NCT00394901|458835073|FG001|Baseline Phase|Protocol Violation|0|||
127512030|NCT00394901|458835074|FG002|Baseline Phase|Protocol Violation|1|||
127512031|NCT00394901|458835075|FG003|Baseline Phase|Protocol Violation|0|||
127512032|NCT00394901|458835072|FG000|Double-blind Phase|Adverse Event|5|||
127512033|NCT00394901|458835073|FG001|Double-blind Phase|Adverse Event|7|||
127979643|NCT02407457|460547613|FG000|6-Month|missed visit|16|||
127979644|NCT02407457|460547614|FG001|6-Month|missed visit|14|||
127979645|NCT02407457|460547613|FG000|6-Month|Open Repair|0|||
127979646|NCT02407457|460547614|FG001|6-Month|Open Repair|1|||
127979647|NCT02407457|460547613|FG000|1 Year|Death|6|||
127979648|NCT02407457|460547614|FG001|1 Year|Death|11|||
127979649|NCT02407457|460547613|FG000|1 Year|Lost to Follow-up|3|||
127979650|NCT02407457|460547614|FG001|1 Year|Lost to Follow-up|2|||
127979651|NCT02407457|460547613|FG000|1 Year|Missed Visit|24|||
127979652|NCT02407457|460547614|FG001|1 Year|Missed Visit|14|||
127979653|NCT02407457|460547613|FG000|1 Year|Open Repair|0|||
127979654|NCT02407457|460547614|FG001|1 Year|Open Repair|1|||
127979655|NCT02407457|460547613|FG000|2-year|Death|14|||
127979656|NCT02407457|460547614|FG001|2-year|Death|8|||
127979657|NCT02407457|460547613|FG000|2-year|Lost to Follow-up|7|||
127979658|NCT02407457|460547614|FG001|2-year|Lost to Follow-up|10|||
127979659|NCT02407457|460547613|FG000|2-year|Missed Visit|13|||
127979660|NCT02407457|460547614|FG001|2-year|Missed Visit|15|||
127979661|NCT02407457|460547613|FG000|2-year|Open Repair|0|||
127979662|NCT02407457|460547614|FG001|2-year|Open Repair|2|||
127979663|NCT02407457|460547613|FG000|3-year|Death|11|||
127979664|NCT02407457|460547614|FG001|3-year|Death|10|||
127979665|NCT02407457|460547613|FG000|3-year|Lost to Follow-up|9|||
127979666|NCT02407457|460547614|FG001|3-year|Lost to Follow-up|10|||
127979667|NCT02407457|460547613|FG000|3-year|Missed Visit|19|||
127979668|NCT02407457|460547614|FG001|3-year|Missed Visit|16|||
127979669|NCT02407457|460547613|FG000|4-year|Death|18|||
127979670|NCT02407457|460547614|FG001|4-year|Death|10|||
127979671|NCT02407457|460547613|FG000|4-year|Lost to Follow-up|10|||
127979672|NCT02407457|460547614|FG001|4-year|Lost to Follow-up|12|||
127979673|NCT02407457|460547613|FG000|4-year|Missed Visit|18|||
127979674|NCT02407457|460547614|FG001|4-year|Missed Visit|16|||
127979675|NCT02407457|460547613|FG000|5-year|Death|10|||
127979676|NCT02407457|460547614|FG001|5-year|Death|3|||
127979677|NCT02407457|460547613|FG000|5-year|Lost to Follow-up|22|||
127979678|NCT02407457|460547614|FG001|5-year|Lost to Follow-up|13|||
127979679|NCT02407457|460547613|FG000|5-year|Missed Visit|9|||
127979680|NCT02407457|460547614|FG001|5-year|Missed Visit|1|||
127979681|NCT02035748|460547615|FG000|Overall Study|Adverse Event|5|||
127979682|NCT02035748|460547615|FG000|Overall Study|Death|3|||
127979683|NCT02035748|460547615|FG000|Overall Study|Lost to Follow-up|2|||
127979684|NCT02035748|460547615|FG000|Overall Study|Physician Decision|3|||
127979685|NCT02035748|460547615|FG000|Overall Study|Withdrawal by Subject|6|||
127979686|NCT02035748|460547615|FG000|Overall Study|Progressive Disease|1|||
127979687|NCT04329091|460547616|FG000|Overall Study|Physician Decision|5|||
127979688|NCT02484651|460547617|FG000|Overall Study|Patients' data files were corrupted.|1|||
127979689|NCT02484651|460547618|FG001|Overall Study|Patients' data files were corrupted.|1|||
127979690|NCT02484651|460547617|FG000|Overall Study|BIS monitoring failed.|1|||
127979691|NCT02484651|460547618|FG001|Overall Study|BIS monitoring failed.|1|||
127979692|NCT02484651|460547617|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
127512034|NCT00394901|458835074|FG002|Double-blind Phase|Adverse Event|16|||
127512035|NCT00394901|458835075|FG003|Double-blind Phase|Adverse Event|20|||
127512036|NCT00394901|458835072|FG000|Double-blind Phase|Lack of Efficacy|6|||
127512037|NCT00394901|458835073|FG001|Double-blind Phase|Lack of Efficacy|4|||
127512038|NCT00394901|458835074|FG002|Double-blind Phase|Lack of Efficacy|1|||
127979693|NCT02484651|460547618|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
127979694|NCT01263782|460547621|FG000|Overall Study|Death|0|||
127979695|NCT01263782|460547622|FG001|Overall Study|Death|0|||
127979696|NCT01263782|460547623|FG002|Overall Study|Death|1|||
127979697|NCT01263782|460547624|FG003|Overall Study|Death|0|||
127979698|NCT01263782|460547621|FG000|Overall Study|Progressive disease|0|||
127979699|NCT01263782|460547622|FG001|Overall Study|Progressive disease|0|||
127979700|NCT01263782|460547623|FG002|Overall Study|Progressive disease|0|||
127979701|NCT01263782|460547624|FG003|Overall Study|Progressive disease|1|||
127979702|NCT01263782|460547621|FG000|Overall Study|Too early|0|||
127979703|NCT01263782|460547622|FG001|Overall Study|Too early|0|||
127979704|NCT01263782|460547623|FG002|Overall Study|Too early|1|||
127979705|NCT01263782|460547624|FG003|Overall Study|Too early|0|||
127512039|NCT00394901|458835075|FG003|Double-blind Phase|Lack of Efficacy|3|||
127512040|NCT00394901|458835072|FG000|Double-blind Phase|Withdrawal by Subject|2|||
127512041|NCT00394901|458835073|FG001|Double-blind Phase|Withdrawal by Subject|0|||
127979706|NCT01263782|460547621|FG000|Overall Study|Inevaluable|0|||
127512042|NCT00394901|458835074|FG002|Double-blind Phase|Withdrawal by Subject|0|||
127512043|NCT00394901|458835075|FG003|Double-blind Phase|Withdrawal by Subject|0|||
127512044|NCT00394901|458835072|FG000|Double-blind Phase|Lost to Follow-up|0|||
127512045|NCT00394901|458835073|FG001|Double-blind Phase|Lost to Follow-up|0|||
127979707|NCT01263782|460547622|FG001|Overall Study|Inevaluable|0|||
127979708|NCT01263782|460547623|FG002|Overall Study|Inevaluable|1|||
127979709|NCT01263782|460547624|FG003|Overall Study|Inevaluable|0|||
127979710|NCT04545567|460547625|FG000|Overall Study|tested positive for SARS-co-V2|1|||
127979711|NCT04545567|460547626|FG001|Overall Study|tested positive for SARS-co-V2|1|||
127979712|NCT04545567|460547625|FG000|Overall Study|Withdrawal by Subject|0|||
127979713|NCT04545567|460547626|FG001|Overall Study|Withdrawal by Subject|1|||
127979714|NCT02419612|460547631|FG000|Short-term Treatment Period|Adverse Event|1|||
127979715|NCT02419612|460547632|FG001|Short-term Treatment Period|Adverse Event|1|||
127979716|NCT02419612|460547631|FG000|Short-term Treatment Period|Death|0|||
127979717|NCT02419612|460547632|FG001|Short-term Treatment Period|Death|2|||
127979718|NCT02419612|460547631|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
127979719|NCT02419612|460547632|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
127979720|NCT02419612|460547631|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
127979721|NCT02419612|460547632|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
127979722|NCT02419612|460547631|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
127979723|NCT02419612|460547632|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
127979724|NCT02419612|460547631|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
127979725|NCT02419612|460547632|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
127979726|NCT02419612|460547631|FG000|Short-term Treatment Period|Worsening of liver function|0|||
127979727|NCT02419612|460547632|FG001|Short-term Treatment Period|Worsening of liver function|1|||
127979728|NCT02419612|460547631|FG000|Short-term Treatment Period|Subject moved out of state|0|||
127979729|NCT02419612|460547632|FG001|Short-term Treatment Period|Subject moved out of state|1|||
127979730|NCT02419612|460547631|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
127979731|NCT02419612|460547632|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
127979732|NCT02419612|460547631|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
127979733|NCT02419612|460547632|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
127979734|NCT02419612|460547631|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
127979735|NCT02419612|460547632|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
127979736|NCT02419612|460547631|FG000|Long-term Treatment Period|Death|0|||
127979737|NCT02419612|460547632|FG001|Long-term Treatment Period|Death|1|||
127979738|NCT02419612|460547631|FG000|Long-term Treatment Period|Adverse Event|0|||
127979739|NCT02419612|460547632|FG001|Long-term Treatment Period|Adverse Event|5|||
127979740|NCT02419612|460547631|FG000|Long-term Treatment Period|Other|4|||
127979741|NCT02419612|460547632|FG001|Long-term Treatment Period|Other|4|||
127979742|NCT02419612|460547631|FG000|Long-term Treatment Period|Subject Decision|2|||
127979743|NCT02419612|460547632|FG001|Long-term Treatment Period|Subject Decision|4|||
127979744|NCT02419612|460547631|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
127979745|NCT02419612|460547632|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
127979746|NCT00474045|460547639|FG000|Overall Study|Adverse Event|18|||
127979747|NCT00474045|460547640|FG001|Overall Study|Adverse Event|8|||
127979748|NCT00474045|460547639|FG000|Overall Study|Unclassified|1|||
127979749|NCT00474045|460547640|FG001|Overall Study|Unclassified|3|||
127979750|NCT00474045|460547639|FG000|Overall Study|Lack of Efficacy|0|||
127979751|NCT00474045|460547640|FG001|Overall Study|Lack of Efficacy|9|||
127979752|NCT00474045|460547639|FG000|Overall Study|Lost to Follow-up|1|||
127979753|NCT00474045|460547640|FG001|Overall Study|Lost to Follow-up|1|||
127979754|NCT00474045|460547639|FG000|Overall Study|Protocol Violation|10|||
127979755|NCT00474045|460547640|FG001|Overall Study|Protocol Violation|12|||
127979756|NCT00474045|460547639|FG000|Overall Study|Withdrawal by Subject|16|||
127979757|NCT00474045|460547640|FG001|Overall Study|Withdrawal by Subject|18|||
127979758|NCT00474045|460547639|FG000|Overall Study|Withdrawal criteria|60|||
127979759|NCT00474045|460547640|FG001|Overall Study|Withdrawal criteria|50|||
127979760|NCT02009397|460547641|FG000|Overall Study|Protocol Violation|6|||
127979761|NCT02009397|460547641|FG000|Overall Study|Death|8|||
127979762|NCT02009397|460547641|FG000|Overall Study|Lost to Follow-up|6|||
127512046|NCT00394901|458835074|FG002|Double-blind Phase|Lost to Follow-up|0|||
127512047|NCT00394901|458835075|FG003|Double-blind Phase|Lost to Follow-up|1|||
127512048|NCT00394901|458835072|FG000|Double-blind Phase|Protocol Violation|0|||
127512049|NCT00394901|458835073|FG001|Double-blind Phase|Protocol Violation|0|||
127512050|NCT00394901|458835074|FG002|Double-blind Phase|Protocol Violation|0|||
127512051|NCT00394901|458835075|FG003|Double-blind Phase|Protocol Violation|1|||
127512052|NCT00394901|458835072|FG000|Double-blind Phase|Death|1|||
127512053|NCT00394901|458835073|FG001|Double-blind Phase|Death|0|||
127512054|NCT00394901|458835074|FG002|Double-blind Phase|Death|0|||
127512055|NCT00394901|458835075|FG003|Double-blind Phase|Death|0|||
127512056|NCT00394901|458835072|FG000|Double-blind Phase|Subject's Personal Reason|1|||
127512057|NCT00394901|458835073|FG001|Double-blind Phase|Subject's Personal Reason|0|||
127512058|NCT00394901|458835074|FG002|Double-blind Phase|Subject's Personal Reason|0|||
127512059|NCT00394901|458835075|FG003|Double-blind Phase|Subject's Personal Reason|1|||
127512060|NCT00394901|458835072|FG000|Double-blind Phase|Lack of Compliance|0|||
127512061|NCT00394901|458835073|FG001|Double-blind Phase|Lack of Compliance|3|||
127512062|NCT00394901|458835074|FG002|Double-blind Phase|Lack of Compliance|0|||
127512063|NCT00394901|458835075|FG003|Double-blind Phase|Lack of Compliance|0|||
127512064|NCT00394901|458835072|FG000|Double-blind Phase|Entry into another study was found|0|||
127512065|NCT00394901|458835073|FG001|Double-blind Phase|Entry into another study was found|0|||
127512066|NCT00394901|458835074|FG002|Double-blind Phase|Entry into another study was found|1|||
127512067|NCT00394901|458835075|FG003|Double-blind Phase|Entry into another study was found|0|||
127512068|NCT00394901|458835072|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
127512069|NCT00394901|458835073|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
127512070|NCT00394901|458835074|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
127512071|NCT00394901|458835075|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
127512072|NCT05028517|458835076|FG000|Overall Study|Lost to Follow-up|13|||
127512073|NCT05028517|458835077|FG001|Overall Study|Lost to Follow-up|20|||
127512074|NCT05028517|458835078|FG002|Overall Study|Lost to Follow-up|12|||
127512075|NCT05028517|458835076|FG000|Overall Study|Withdrawal by Subject|0|||
127512076|NCT05028517|458835077|FG001|Overall Study|Withdrawal by Subject|0|||
127512077|NCT05028517|458835078|FG002|Overall Study|Withdrawal by Subject|1|||
127512078|NCT01886690|458835079|FG000|Overall Study|Protocol Violation|0|||
127512079|NCT01886690|458835080|FG001|Overall Study|Protocol Violation|1|||
127512080|NCT01886690|458835079|FG000|Overall Study|Personal Reasons|0|||
127512081|NCT01886690|458835080|FG001|Overall Study|Personal Reasons|1|||
127512082|NCT02360293|458835083|FG000|Overall Study|Lost to Follow-up|73|||
127512083|NCT02360293|458835084|FG001|Overall Study|Lost to Follow-up|95|||
127512084|NCT02360293|458835083|FG000|Overall Study|Withdrawal by Subject|2|||
127512085|NCT02360293|458835084|FG001|Overall Study|Withdrawal by Subject|1|||
127512086|NCT02360293|458835083|FG000|Overall Study|Excluded|1|||
127512087|NCT02360293|458835084|FG001|Overall Study|Excluded|0|||
127512088|NCT04316741|458835085|FG000|Baseline Enrollment|Lost to Follow-up|1|||
127512089|NCT04316741|458835086|FG001|Baseline Enrollment|Lost to Follow-up|1|||
127512090|NCT04316741|458835085|FG000|Immediate Post-Test|Lost to Follow-up|5|||
127512091|NCT04316741|458835086|FG001|Immediate Post-Test|Lost to Follow-up|1|||
127512092|NCT04316741|458835085|FG000|1-month Post-test|Lost to Follow-up|7|||
127512093|NCT04316741|458835086|FG001|1-month Post-test|Lost to Follow-up|2|||
127512094|NCT04316741|458835085|FG000|3-month Follow-up|Lost to Follow-up|10|||
127512095|NCT04316741|458835086|FG001|3-month Follow-up|Lost to Follow-up|2|||
127512096|NCT01510145|458835087|FG000|Overall Study|Adverse Event|6|||
127512097|NCT01510145|458835087|FG000|Overall Study|Lost to Follow-up|5|||
127512098|NCT01510145|458835087|FG000|Overall Study|Withdrawal by Subject|6|||
127512099|NCT01510145|458835087|FG000|Overall Study|Relative reported subject withdrew|1|||
127512100|NCT02725593|458835088|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
127512101|NCT02725593|458835089|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
127512102|NCT02725593|458835088|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
127512103|NCT02725593|458835089|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
127512104|NCT02725593|458835088|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
127512105|NCT02725593|458835089|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
127512106|NCT02725593|458835088|FG000|Long Term Extension|Withdrawal by Subject|1|||
127512107|NCT02725593|458835089|FG001|Long Term Extension|Withdrawal by Subject|3|||
127512108|NCT04411420|458836520|FG000|Overall Study (All Participants)|Lost to Follow-up|350|||
127512109|NCT04411420|458836521|FG001|Overall Study (All Participants)|Lost to Follow-up|469|||
127512110|NCT04411420|458836520|FG000|Survey Subset|Lost to Follow-up|134|||
127512111|NCT04411420|458836521|FG001|Survey Subset|Lost to Follow-up|120|||
127512112|NCT03899064|458836522|FG000|Overall Study|Lost to Follow-up|1|||
127512113|NCT03899064|458836522|FG000|Overall Study|Protocol Violation|2|||
127512114|NCT03899064|458836522|FG000|Overall Study|Withdrawal by Subject|2|||
127512115|NCT03899064|458836522|FG000|Overall Study|Other|2|||
127512116|NCT00289198|458836535|FG000|Overall Study|Adverse Event|0|||
127512117|NCT00289198|458836536|FG001|Overall Study|Adverse Event|2|||
127512118|NCT00289198|458836535|FG000|Overall Study|Protocol Violation|2|||
127512119|NCT00289198|458836536|FG001|Overall Study|Protocol Violation|1|||
127512120|NCT00289198|458836535|FG000|Overall Study|Withdrawal by Subject|4|||
127512121|NCT00289198|458836536|FG001|Overall Study|Withdrawal by Subject|1|||
127512122|NCT00289198|458836535|FG000|Overall Study|Lack of Efficacy|2|||
127512123|NCT00289198|458836536|FG001|Overall Study|Lack of Efficacy|0|||
127512124|NCT00289198|458836535|FG000|Overall Study|Other: Low compliance|0|||
127512125|NCT00289198|458836536|FG001|Overall Study|Other: Low compliance|1|||
127512126|NCT00289198|458836535|FG000|Overall Study|Other: Physician's decision|0|||
127512127|NCT00289198|458836536|FG001|Overall Study|Other: Physician's decision|1|||
127512128|NCT00289198|458836535|FG000|Overall Study|Other: Unable to attend on schedule|2|||
127512129|NCT00289198|458836536|FG001|Overall Study|Other: Unable to attend on schedule|1|||
127512130|NCT00289198|458836535|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
127512131|NCT00289198|458836536|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
127512132|NCT00289198|458836535|FG000|Overall Study|Other: Impossible to come on visit|0|||
127512133|NCT00289198|458836536|FG001|Overall Study|Other: Impossible to come on visit|1|||
127512134|NCT01176565|458836537|FG000|Overall Study|Lost to Follow-up|12|||
127512135|NCT01176565|458836538|FG001|Overall Study|Lost to Follow-up|16|||
127512136|NCT01176565|458836537|FG000|Overall Study|Withdrawal by Subject|7|||
127512137|NCT01176565|458836538|FG001|Overall Study|Withdrawal by Subject|1|||
127512138|NCT01176565|458836537|FG000|Overall Study|Not Analyzed (any other reason)|1|||
127512139|NCT01176565|458836538|FG001|Overall Study|Not Analyzed (any other reason)|2|||
127512140|NCT03602885|458836539|FG000|Overall Study|Lost to Follow-up|3|||
127512141|NCT03602885|458836540|FG001|Overall Study|Lost to Follow-up|0|||
127512142|NCT01062061|458836543|FG000|Overall Study|Enrolled more than once|2|||
127512143|NCT01062061|458836543|FG000|Overall Study|Investigated before study start|13|||
127512144|NCT01062061|458836543|FG000|Overall Study|Outside chief indications|10|||
127512145|NCT01062061|458836543|FG000|Overall Study|Failed to meet inclusion criteria|2|||
127512146|NCT00524589|458836544|FG000|Overall Study|Withdrawal by Subject|2|||
127512147|NCT00524589|458836544|FG000|Overall Study|Disease Progression|16|||
127512148|NCT01143051|458836550|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
127512149|NCT01143051|458836551|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
127512150|NCT01143051|458836552|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
127512151|NCT01143051|458836553|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
127512152|NCT01143051|458836554|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
127512153|NCT01143051|458836555|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
127512154|NCT01143051|458836550|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
127512155|NCT01143051|458836551|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
127512156|NCT01143051|458836552|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
127512157|NCT01143051|458836553|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
127512158|NCT01143051|458836554|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
127512159|NCT01143051|458836555|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
127512160|NCT01605227|458836557|FG000|Overall Study|Did not receive study treatment|2|||
127512161|NCT01605227|458836558|FG001|Overall Study|Did not receive study treatment|3|||
127512162|NCT01605227|458836557|FG000|Overall Study|Adverse Event|228|||
127512163|NCT01605227|458836558|FG001|Overall Study|Adverse Event|42|||
127512164|NCT01605227|458836557|FG000|Overall Study|Progressive Disease|132|||
127512165|NCT01605227|458836558|FG001|Overall Study|Progressive Disease|128|||
127512166|NCT01605227|458836557|FG000|Overall Study|Clinical Deterioration|227|||
127512167|NCT01605227|458836558|FG001|Overall Study|Clinical Deterioration|133|||
127512168|NCT01605227|458836557|FG000|Overall Study|Lost to Follow-up|1|||
127512169|NCT01605227|458836558|FG001|Overall Study|Lost to Follow-up|0|||
127512170|NCT01605227|458836557|FG000|Overall Study|Protocol Violation|1|||
127512171|NCT01605227|458836558|FG001|Overall Study|Protocol Violation|0|||
127512172|NCT01605227|458836557|FG000|Overall Study|Physician Decision|9|||
127512173|NCT01605227|458836558|FG001|Overall Study|Physician Decision|7|||
127512174|NCT01605227|458836557|FG000|Overall Study|Withdrawal by Subject|18|||
127512175|NCT01605227|458836558|FG001|Overall Study|Withdrawal by Subject|14|||
127512176|NCT01605227|458836557|FG000|Overall Study|Sponsor Decision|2|||
127512177|NCT01605227|458836558|FG001|Overall Study|Sponsor Decision|0|||
127512178|NCT01605227|458836557|FG000|Overall Study|Started New Therapy|1|||
127512179|NCT01605227|458836558|FG001|Overall Study|Started New Therapy|0|||
127512180|NCT01605227|458836557|FG000|Overall Study|Subject Decision|0|||
127512181|NCT01605227|458836558|FG001|Overall Study|Subject Decision|1|||
127512182|NCT01605227|458836557|FG000|Overall Study|Dose Held >6 weeks|0|||
127512183|NCT01605227|458836558|FG001|Overall Study|Dose Held >6 weeks|1|||
127512184|NCT03093974|458836562|FG000|Overall Study|Withdrawal by Subject|32|||
127512185|NCT03093974|458836563|FG001|Overall Study|Withdrawal by Subject|27|||
127512186|NCT03093974|458836562|FG000|Overall Study|Adverse Event|17|||
127512187|NCT03093974|458836563|FG001|Overall Study|Adverse Event|24|||
127512188|NCT03093974|458836562|FG000|Overall Study|Death|0|||
127512189|NCT03093974|458836563|FG001|Overall Study|Death|1|||
127512190|NCT03093974|458836562|FG000|Overall Study|Non-Compliance with Study Drug|1|||
127512191|NCT03093974|458836563|FG001|Overall Study|Non-Compliance with Study Drug|0|||
127512192|NCT03093974|458836562|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
127512193|NCT03093974|458836563|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
127512194|NCT03093974|458836562|FG000|Overall Study|Lost to Follow-up|0|||
127512195|NCT03093974|458836563|FG001|Overall Study|Lost to Follow-up|1|||
127512196|NCT03093974|458836562|FG000|Overall Study|Other|1|||
127512197|NCT03093974|458836563|FG001|Overall Study|Other|2|||
127512198|NCT01813721|458836564|FG000|Overall Study|Ineligibility determined|63|||
127512199|NCT01813721|458836564|FG000|Overall Study|Withdrawal by Subject|1|||
127512200|NCT01866423|458836565|FG000|Overall Study|Lack of Efficacy|3|||
127512201|NCT01866423|458836565|FG000|Overall Study|Sponsor Decision|1|||
127512202|NCT00849875|458836566|FG000|Overall Study|Death|28|||
127512203|NCT00849875|458836566|FG000|Overall Study|Ongoing (unknown completion status)|11|||
127512204|NCT00849875|458836566|FG000|Overall Study|Others|6|||
127512205|NCT00849875|458836566|FG000|Overall Study|Lost to Follow-up|2|||
127512206|NCT01515475|458836567|FG000|Overall Study|Lost to Follow-up|20|||
127512207|NCT01515475|458836568|FG001|Overall Study|Lost to Follow-up|15|||
127512208|NCT01515475|458836569|FG002|Overall Study|Lost to Follow-up|12|||
127512209|NCT01515475|458836570|FG003|Overall Study|Lost to Follow-up|12|||
127512210|NCT01420627|458836571|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
127512211|NCT00837876|458836572|FG000|Overall Study|Death|2|||
127512212|NCT00837876|458836572|FG000|Overall Study|Adverse Event|7|||
127512213|NCT00837876|458836572|FG000|Overall Study|Physician Decision|1|||
127512214|NCT00837876|458836572|FG000|Overall Study|Withdrawal by Subject|3|||
127512215|NCT00837876|458836572|FG000|Overall Study|disease progression|24|||
127512216|NCT00453973|458836573|FG000|Overall Study|Adverse Event|4|||
127512217|NCT00453973|458836574|FG001|Overall Study|Adverse Event|9|||
127512218|NCT00453973|458836573|FG000|Overall Study|Withdrawal by Subject|7|||
127512219|NCT00453973|458836574|FG001|Overall Study|Withdrawal by Subject|6|||
127512220|NCT00453973|458836573|FG000|Overall Study|PI Decision|0|||
127512221|NCT00453973|458836574|FG001|Overall Study|PI Decision|2|||
127512222|NCT00453973|458836573|FG000|Overall Study|Relocation|1|||
127512223|NCT00453973|458836574|FG001|Overall Study|Relocation|0|||
127512224|NCT00453973|458836573|FG000|Overall Study|Renal transplant|1|||
127512225|NCT00453973|458836574|FG001|Overall Study|Renal transplant|1|||
127512226|NCT00453973|458836573|FG000|Overall Study|Site closed by sponsor|3|||
127512227|NCT00453973|458836574|FG001|Overall Study|Site closed by sponsor|0|||
127512228|NCT00453973|458836573|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
127512229|NCT00453973|458836574|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
127512230|NCT00276094|458836575|FG000|Overall Study|Adverse Event|15|||
127512231|NCT00276094|458836576|FG001|Overall Study|Adverse Event|13|||
127512232|NCT00276094|458836577|FG002|Overall Study|Adverse Event|11|||
127512233|NCT00276094|458836575|FG000|Overall Study|Withdrawal by Subject|14|||
127512234|NCT00276094|458836576|FG001|Overall Study|Withdrawal by Subject|14|||
127512235|NCT00276094|458836577|FG002|Overall Study|Withdrawal by Subject|12|||
127512236|NCT00276094|458836575|FG000|Overall Study|Protocol Violation|16|||
127512237|NCT00276094|458836576|FG001|Overall Study|Protocol Violation|7|||
127512238|NCT00276094|458836577|FG002|Overall Study|Protocol Violation|10|||
127512239|NCT00276094|458836575|FG000|Overall Study|Lost to Follow-up|8|||
127512240|NCT00276094|458836576|FG001|Overall Study|Lost to Follow-up|6|||
127512241|NCT00276094|458836577|FG002|Overall Study|Lost to Follow-up|4|||
127512242|NCT00276094|458836575|FG000|Overall Study|Other-Subject moved out of country|1|||
127512243|NCT00276094|458836576|FG001|Overall Study|Other-Subject moved out of country|0|||
127512244|NCT00276094|458836577|FG002|Overall Study|Other-Subject moved out of country|0|||
127512245|NCT00276094|458836575|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
127512246|NCT00276094|458836576|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
127512247|NCT00276094|458836577|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
127512248|NCT00276094|458836575|FG000|Overall Study|Other-Lack of efficacy|1|||
127512249|NCT00276094|458836576|FG001|Overall Study|Other-Lack of efficacy|0|||
127512250|NCT00276094|458836577|FG002|Overall Study|Other-Lack of efficacy|0|||
127512251|NCT00276094|458836575|FG000|Overall Study|Other-Refused follow-up visit|1|||
127512252|NCT00276094|458836576|FG001|Overall Study|Other-Refused follow-up visit|0|||
127512253|NCT00276094|458836577|FG002|Overall Study|Other-Refused follow-up visit|0|||
127512254|NCT00276094|458836575|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
127512255|NCT00276094|458836576|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
127512256|NCT00276094|458836577|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
127512257|NCT00276094|458836575|FG000|Overall Study|Other-Relocation|0|||
127512258|NCT00276094|458836576|FG001|Overall Study|Other-Relocation|1|||
127512259|NCT00276094|458836577|FG002|Overall Study|Other-Relocation|0|||
127512260|NCT00276094|458836575|FG000|Overall Study|Other-Study medication lost|0|||
127512261|NCT00276094|458836576|FG001|Overall Study|Other-Study medication lost|0|||
127512262|NCT00276094|458836577|FG002|Overall Study|Other-Study medication lost|1|||
127512263|NCT02075632|458836582|FG000|Overall Study|Adverse Event|1|||
127512264|NCT02075632|458836583|FG001|Overall Study|Adverse Event|1|||
127979763|NCT02278120|460547643|FG000|Treatment Period|Progressive disease|234|||
127512265|NCT02075632|458836582|FG000|Overall Study|Lost to Follow-up|0|||
127512266|NCT02075632|458836583|FG001|Overall Study|Lost to Follow-up|3|||
127512267|NCT02075632|458836582|FG000|Overall Study|Withdrawal by Subject|0|||
127979764|NCT02278120|460547644|FG001|Treatment Period|Progressive disease|260|||
127979765|NCT02278120|460547643|FG000|Treatment Period|Subject/guardian decision|23|||
127512268|NCT02075632|458836583|FG001|Overall Study|Withdrawal by Subject|1|||
127512269|NCT02256267|458836584|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
127512270|NCT02256267|458836584|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
127512271|NCT01969500|458836594|FG000|Overall Study|Death|0|||
127512272|NCT01969500|458836595|FG001|Overall Study|Death|1|||
127512273|NCT01969500|458836594|FG000|Overall Study|extended hospitalization|1|||
127512274|NCT01969500|458836595|FG001|Overall Study|extended hospitalization|1|||
127512275|NCT00493636|458836596|FG000|Overall Study|Withdrawal by Subject|1|||
127512276|NCT00493636|458836597|FG001|Overall Study|Withdrawal by Subject|0|||
127512277|NCT00493636|458836596|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
127512278|NCT00493636|458836597|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
127512279|NCT00493636|458836596|FG000|Overall Study|Mis-randomization|1|||
127512280|NCT00493636|458836597|FG001|Overall Study|Mis-randomization|1|||
127512281|NCT01873729|458836604|FG000|Overall Study|Withdrawal by Subject|1|||
127512282|NCT02463032|458836605|FG000|Overall Study|Lack of Efficacy|61|||
127512283|NCT02463032|458836606|FG001|Overall Study|Lack of Efficacy|50|||
127512284|NCT02463032|458836605|FG000|Overall Study|Death|8|||
127512285|NCT02463032|458836606|FG001|Overall Study|Death|8|||
127512286|NCT02463032|458836605|FG000|Overall Study|Adverse Event|2|||
127512287|NCT02463032|458836606|FG001|Overall Study|Adverse Event|6|||
127512288|NCT01066780|458836607|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
127512289|NCT01066780|458836608|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
127512290|NCT00613080|458836609|FG000|Overall Study|Ineligible / no protocol treatment|11|||
127512291|NCT03757130|458836610|FG000|Overall Study|Lost to Follow-up|0|||
127512292|NCT03757130|458836611|FG001|Overall Study|Lost to Follow-up|0|||
127512293|NCT03757130|458836612|FG002|Overall Study|Lost to Follow-up|0|||
127512294|NCT03757130|458836613|FG003|Overall Study|Lost to Follow-up|1|||
127512295|NCT03757130|458836614|FG004|Overall Study|Lost to Follow-up|0|||
127512296|NCT03757130|458836615|FG005|Overall Study|Lost to Follow-up|0|||
127512297|NCT03757130|458836616|FG006|Overall Study|Lost to Follow-up|0|||
127512298|NCT03757130|458836617|FG007|Overall Study|Lost to Follow-up|1|||
127512299|NCT03757130|458836610|FG000|Overall Study|Withdrawal by Subject|0|||
127512300|NCT03757130|458836611|FG001|Overall Study|Withdrawal by Subject|0|||
127512301|NCT03757130|458836612|FG002|Overall Study|Withdrawal by Subject|0|||
127512302|NCT03757130|458836613|FG003|Overall Study|Withdrawal by Subject|0|||
127512303|NCT03757130|458836614|FG004|Overall Study|Withdrawal by Subject|0|||
127512304|NCT03757130|458836615|FG005|Overall Study|Withdrawal by Subject|0|||
127512305|NCT03757130|458836616|FG006|Overall Study|Withdrawal by Subject|1|||
127512306|NCT03757130|458836617|FG007|Overall Study|Withdrawal by Subject|0|||
127512307|NCT02226549|458836618|FG000|Overall Study|Randomized but Never Treated|1|||
127512308|NCT02226549|458836619|FG001|Overall Study|Randomized but Never Treated|0|||
127512309|NCT02226549|458836618|FG000|Overall Study|Lost to Follow-up|0|||
127512310|NCT02226549|458836619|FG001|Overall Study|Lost to Follow-up|1|||
127512311|NCT02726880|458836621|FG000|Overall Study|Withdrawal by Subject|2|||
127512312|NCT02726880|458836622|FG001|Overall Study|Withdrawal by Subject|0|||
127512313|NCT02726880|458836621|FG000|Overall Study|Lost to Follow-up|1|||
127512314|NCT02726880|458836622|FG001|Overall Study|Lost to Follow-up|3|||
127512315|NCT02312219|458836623|FG000|Overall Study|Withdrawal by Subject|1|||
127512316|NCT02312219|458836624|FG001|Overall Study|Withdrawal by Subject|2|||
127512317|NCT02312219|458836623|FG000|Overall Study|could not schedule imaging in time|0|||
127512318|NCT02312219|458836624|FG001|Overall Study|could not schedule imaging in time|2|||
127512319|NCT02312219|458836623|FG000|Overall Study|Other|0|||
127512320|NCT02312219|458836624|FG001|Overall Study|Other|1|||
127512321|NCT02312219|458836623|FG000|Overall Study|Not randomized. Ineligible|0|||
127512322|NCT02312219|458836624|FG001|Overall Study|Not randomized. Ineligible|1|||
127512323|NCT01269385|458836625|FG000|Overall Study|Adverse Event|1|||
127512324|NCT01269385|458836626|FG001|Overall Study|Adverse Event|1|||
127512325|NCT01269385|458836627|FG002|Overall Study|Adverse Event|0|||
127512326|NCT01269385|458836628|FG003|Overall Study|Adverse Event|0|||
127512327|NCT03553498|458836632|FG000|Overall Study|Missing primary outcome|1|||
127512328|NCT03553498|458836633|FG001|Overall Study|Missing primary outcome|2|||
127512329|NCT04941807|458836634|FG000|Overall Study|Lost to Follow-up|1|||
127512330|NCT04941807|458836635|FG001|Overall Study|Lost to Follow-up|1|||
127512331|NCT01100567|458836636|FG000|Overall Study|Withdrawal by Subject|5|||
127512332|NCT01100567|458836637|FG001|Overall Study|Withdrawal by Subject|8|||
127512333|NCT01100567|458836636|FG000|Overall Study|Early Hospital Discharge|6|||
127512334|NCT01100567|458836637|FG001|Overall Study|Early Hospital Discharge|4|||
127512335|NCT01100567|458836636|FG000|Overall Study|Lost to Follow-up|1|||
127512336|NCT01100567|458836637|FG001|Overall Study|Lost to Follow-up|2|||
127979766|NCT02278120|460547644|FG001|Treatment Period|Subject/guardian decision|20|||
127512337|NCT01100567|458836636|FG000|Overall Study|Physician Decision|0|||
127512338|NCT01100567|458836637|FG001|Overall Study|Physician Decision|1|||
127512339|NCT01100567|458836636|FG000|Overall Study|Deemed ineligible after consent|0|||
127512340|NCT01100567|458836637|FG001|Overall Study|Deemed ineligible after consent|1|||
127979767|NCT02278120|460547643|FG000|Treatment Period|Adverse Event|16|||
127512341|NCT02741570|458836638|FG000|Pre-Treatment Period|Other reasons|0|||
127512342|NCT02741570|458836639|FG001|Pre-Treatment Period|Other reasons|3|||
127512343|NCT02741570|458836638|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
127512344|NCT02741570|458836639|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
127512345|NCT02741570|458836638|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
127512346|NCT02741570|458836639|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
127512347|NCT02741570|458836638|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
127512348|NCT02741570|458836639|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
127512349|NCT02741570|458836638|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
127512350|NCT02741570|458836639|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
127512351|NCT02741570|458836638|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
127512352|NCT02741570|458836639|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
127512353|NCT02741570|458836638|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
127979768|NCT02278120|460547644|FG001|Treatment Period|Adverse Event|14|||
127512354|NCT02741570|458836639|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
127512355|NCT02741570|458836638|FG000|Pre-Treatment Period|Death|0|||
127512356|NCT02741570|458836639|FG001|Pre-Treatment Period|Death|1|||
127512357|NCT02741570|458836638|FG000|Pre-Treatment Period|Disease progression|0|||
127512358|NCT02741570|458836639|FG001|Pre-Treatment Period|Disease progression|1|||
127512359|NCT02741570|458836638|FG000|Treatment Period|Other reasons|47|||
127512360|NCT02741570|458836639|FG001|Treatment Period|Other reasons|12|||
127512361|NCT02741570|458836638|FG000|Treatment Period|Poor/non-compliance|0|||
127512362|NCT02741570|458836639|FG001|Treatment Period|Poor/non-compliance|2|||
127512363|NCT02741570|458836638|FG000|Treatment Period|Maximum clinical benefit|4|||
127512364|NCT02741570|458836639|FG001|Treatment Period|Maximum clinical benefit|6|||
127512365|NCT02741570|458836638|FG000|Treatment Period|Lost to Follow-up|1|||
127512366|NCT02741570|458836639|FG001|Treatment Period|Lost to Follow-up|3|||
127512367|NCT02741570|458836638|FG000|Treatment Period|Participant withdrew consent|9|||
127512368|NCT02741570|458836639|FG001|Treatment Period|Participant withdrew consent|13|||
127512369|NCT02741570|458836638|FG000|Treatment Period|Participant request to discontinue treatment|8|||
127512370|NCT02741570|458836639|FG001|Treatment Period|Participant request to discontinue treatment|23|||
127512371|NCT02741570|458836638|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
127512372|NCT02741570|458836639|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
127512373|NCT02741570|458836638|FG000|Treatment Period|Death|9|||
127512374|NCT02741570|458836639|FG001|Treatment Period|Death|7|||
127512375|NCT02741570|458836638|FG000|Treatment Period|Study drug toxicity|55|||
127512376|NCT02741570|458836639|FG001|Treatment Period|Study drug toxicity|47|||
127512377|NCT02741570|458836638|FG000|Treatment Period|Disease progression|294|||
127512378|NCT02741570|458836639|FG001|Treatment Period|Disease progression|301|||
127512379|NCT02741570|458836638|FG000|Treatment Period|Administrative reason by sponsor|0|||
127512380|NCT02741570|458836639|FG001|Treatment Period|Administrative reason by sponsor|1|||
127512381|NCT00160199|458836642|FG000|Overall Study|Adverse Event|5|||
127512382|NCT00160199|458836643|FG001|Overall Study|Adverse Event|14|||
127512383|NCT00160199|458836642|FG000|Overall Study|Lack of Efficacy|0|||
127512384|NCT00160199|458836643|FG001|Overall Study|Lack of Efficacy|1|||
127512385|NCT00160199|458836642|FG000|Overall Study|Lost to Follow-up|7|||
127512386|NCT00160199|458836643|FG001|Overall Study|Lost to Follow-up|7|||
127512387|NCT00160199|458836642|FG000|Overall Study|Withdrawal by Subject|4|||
127512388|NCT00160199|458836643|FG001|Overall Study|Withdrawal by Subject|6|||
127512389|NCT00160199|458836642|FG000|Overall Study|Administrative|0|||
127512390|NCT00160199|458836643|FG001|Overall Study|Administrative|1|||
127512391|NCT00160199|458836642|FG000|Overall Study|Protocol Violation|8|||
127512392|NCT00160199|458836643|FG001|Overall Study|Protocol Violation|8|||
127512393|NCT01827332|458836644|FG000|Overall Study|Lost to Follow-up|2|||
127512394|NCT01827332|458836645|FG001|Overall Study|Lost to Follow-up|1|||
127512395|NCT00546260|458836646|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
127512396|NCT00546260|458836647|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
127512397|NCT03697993|458836660|FG000|Overall Study|Became Ineligible after Enrollment|1|||
127512398|NCT03697993|458836661|FG001|Overall Study|Became Ineligible after Enrollment|3|||
127512399|NCT03697993|458836660|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
127512400|NCT03697993|458836661|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
127512401|NCT03697993|458836660|FG000|Overall Study|Lost to Follow-up|3|||
127512402|NCT03697993|458836661|FG001|Overall Study|Lost to Follow-up|0|||
127512403|NCT03697993|458836660|FG000|Overall Study|Physician Decision|4|||
127512404|NCT03697993|458836661|FG001|Overall Study|Physician Decision|0|||
127512405|NCT03697993|458836660|FG000|Overall Study|Initial Urine Culture Negative|0|||
127512406|NCT03697993|458836661|FG001|Overall Study|Initial Urine Culture Negative|1|||
127512407|NCT03759041|458836662|FG000|Overall Study|Withdrawal by Subject|4|||
127512408|NCT03759041|458836663|FG001|Overall Study|Withdrawal by Subject|10|||
127979769|NCT02278120|460547643|FG000|Treatment Period|Physician Decision|14|||
127979770|NCT02278120|460547644|FG001|Treatment Period|Physician Decision|27|||
127512409|NCT03759041|458836664|FG002|Overall Study|Withdrawal by Subject|10|||
127512410|NCT03759041|458836662|FG000|Overall Study|Adverse Event|1|||
127512411|NCT03759041|458836663|FG001|Overall Study|Adverse Event|3|||
127512412|NCT03759041|458836664|FG002|Overall Study|Adverse Event|4|||
127512413|NCT03759041|458836662|FG000|Overall Study|Lack of Efficacy|0|||
127512414|NCT03759041|458836663|FG001|Overall Study|Lack of Efficacy|0|||
127512415|NCT03759041|458836664|FG002|Overall Study|Lack of Efficacy|1|||
127512416|NCT03759041|458836662|FG000|Overall Study|Study Terminated by Sponsor|15|||
127512417|NCT03759041|458836663|FG001|Overall Study|Study Terminated by Sponsor|16|||
127512418|NCT03759041|458836664|FG002|Overall Study|Study Terminated by Sponsor|10|||
127512419|NCT03759041|458836662|FG000|Overall Study|Other reason for discontinuation|0|||
127979771|NCT02278120|460547643|FG000|Treatment Period|Death|3|||
127512420|NCT03759041|458836663|FG001|Overall Study|Other reason for discontinuation|2|||
127512421|NCT03759041|458836664|FG002|Overall Study|Other reason for discontinuation|1|||
127512422|NCT03759041|458836662|FG000|Overall Study|Lost to Follow-up|7|||
127512423|NCT03759041|458836663|FG001|Overall Study|Lost to Follow-up|2|||
127512424|NCT03759041|458836664|FG002|Overall Study|Lost to Follow-up|2|||
127512425|NCT03759041|458836662|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
127512426|NCT03759041|458836663|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
127512427|NCT03759041|458836664|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
127512428|NCT04384107|458836665|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
127512429|NCT04384107|458836666|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
127512430|NCT04384107|458836665|FG000|Overall Study|Lost to Follow-up|1|||
127512431|NCT04384107|458836666|FG001|Overall Study|Lost to Follow-up|0|||
127512432|NCT00276614|458836667|FG000|Overall Study|Progression of disease under study|3|||
127512433|NCT01522404|458836670|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
127512434|NCT01522404|458836671|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
127512435|NCT01522404|458836670|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
127512436|NCT01522404|458836671|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
127512437|NCT01522404|458836670|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
127512438|NCT01522404|458836671|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
127512439|NCT01591863|458836676|FG000|Overall Study|Adverse Event|3|||
127512440|NCT01591863|458836676|FG000|Overall Study|Withdrawal by Subject|1|||
127512441|NCT01591863|458836676|FG000|Overall Study|recurrence|9|||
127512442|NCT01591863|458836676|FG000|Overall Study|Lack of Efficacy|1|||
127512443|NCT03647267|458838251|FG000|Overall Study|Lost to Follow-up|1|||
127512444|NCT03647267|458838252|FG001|Overall Study|Lost to Follow-up|0|||
127512445|NCT01350115|458838253|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
127512446|NCT01350115|458838254|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
127512447|NCT01350115|458838253|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
127512448|NCT01350115|458838254|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
127512449|NCT01350115|458838253|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
127512450|NCT01350115|458838254|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
127512451|NCT05079477|458838255|FG000|Overall Study|Lost to Follow-up|2|||
127512452|NCT05079477|458838256|FG001|Overall Study|Lost to Follow-up|0|||
127512453|NCT05079477|458838255|FG000|Overall Study|Withdrawal by Subject|1|||
127512454|NCT05079477|458838256|FG001|Overall Study|Withdrawal by Subject|0|||
127512455|NCT05079477|458838255|FG000|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
127512456|NCT05079477|458838256|FG001|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
127512457|NCT05079477|458838255|FG000|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|0|||
127512458|NCT05079477|458838256|FG001|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|2|||
127512459|NCT05013424|458838259|FG000|Overall Study|Lost to Follow-up|1|||
127512460|NCT05013424|458838260|FG001|Overall Study|Lost to Follow-up|1|||
127512461|NCT05013424|458838261|FG002|Overall Study|Lost to Follow-up|1|||
127512462|NCT05013424|458838259|FG000|Overall Study|Withdrawal by Subject|0|||
127512463|NCT05013424|458838260|FG001|Overall Study|Withdrawal by Subject|1|||
127512464|NCT05013424|458838261|FG002|Overall Study|Withdrawal by Subject|0|||
127512465|NCT03204890|458838262|FG000|Overall Study|Withdrawal by Subject|1|||
127512466|NCT01549873|458838263|FG000|Overall Study|Physician Decision|0|||
127512467|NCT01549873|458838264|FG001|Overall Study|Physician Decision|1|||
127512468|NCT03710876|458838265|FG000|Overall Study|Death|0|||
127512469|NCT03710876|458838266|FG001|Overall Study|Death|2|||
127512470|NCT03710876|458838265|FG000|Overall Study|Withdrawal by Subject|0|||
127512471|NCT03710876|458838266|FG001|Overall Study|Withdrawal by Subject|2|||
127512472|NCT03769311|458838267|FG000|Overall Study|Withdrawal by Subject|1|||
127512473|NCT01596335|458838268|FG000|Overall Study|exacerbation of primary disease|5|||
127512474|NCT01596335|458838269|FG001|Overall Study|exacerbation of primary disease|9|||
127512475|NCT03627065|458838270|FG000|Overall Study|Study Terminated by sponsor|1|||
127512476|NCT03627065|458838270|FG000|Overall Study|Withdrawal by Subject|2|||
127512477|NCT04524455|458838272|FG000|Overall Study|Death|3|||
127512478|NCT04524455|458838273|FG001|Overall Study|Death|3|||
127512479|NCT04524455|458838272|FG000|Overall Study|Decision by Sponsor|0|||
127512480|NCT04524455|458838273|FG001|Overall Study|Decision by Sponsor|2|||
127512481|NCT04524455|458838272|FG000|Overall Study|Withdrawal of Consent From Study|1|||
127512482|NCT04524455|458838273|FG001|Overall Study|Withdrawal of Consent From Study|0|||
127512483|NCT04524455|458838272|FG000|Overall Study|Lost to Follow-up|0|||
127512484|NCT04524455|458838273|FG001|Overall Study|Lost to Follow-up|1|||
127512485|NCT02559414|458838276|FG000|Overall Study|Lost to Follow-up|0|||
127512486|NCT02559414|458838277|FG001|Overall Study|Lost to Follow-up|1|||
127512487|NCT02559414|458838278|FG002|Overall Study|Lost to Follow-up|0|||
127512488|NCT02559414|458838276|FG000|Overall Study|Withdrawal by Subject|1|||
127979772|NCT02278120|460547644|FG001|Treatment Period|Death|3|||
127979773|NCT02278120|460547643|FG000|Treatment Period|Lost to Follow-up|2|||
127512489|NCT02559414|458838277|FG001|Overall Study|Withdrawal by Subject|0|||
127512490|NCT02559414|458838278|FG002|Overall Study|Withdrawal by Subject|1|||
127512491|NCT02559414|458838276|FG000|Overall Study|Other|0|||
127512492|NCT02559414|458838277|FG001|Overall Study|Other|1|||
127512493|NCT02559414|458838278|FG002|Overall Study|Other|1|||
127512494|NCT00098722|458838279|FG000|Double Blind Phase|Adverse Event|7|||
127512495|NCT00098722|458838280|FG001|Double Blind Phase|Adverse Event|7|||
127979774|NCT02278120|460547644|FG001|Treatment Period|Lost to Follow-up|0|||
127512496|NCT00098722|458838281|FG002|Double Blind Phase|Adverse Event|3|||
127512497|NCT00098722|458838282|FG003|Double Blind Phase|Adverse Event|0|||
127512498|NCT00098722|458838283|FG004|Double Blind Phase|Adverse Event|0|||
127512499|NCT00098722|458838284|FG005|Double Blind Phase|Adverse Event|0|||
127512500|NCT00098722|458838285|FG006|Double Blind Phase|Adverse Event|0|||
127512501|NCT00098722|458838279|FG000|Double Blind Phase|Death|2|||
127512502|NCT00098722|458838280|FG001|Double Blind Phase|Death|5|||
127512503|NCT00098722|458838281|FG002|Double Blind Phase|Death|0|||
127512504|NCT00098722|458838282|FG003|Double Blind Phase|Death|0|||
127512505|NCT00098722|458838283|FG004|Double Blind Phase|Death|0|||
127512506|NCT00098722|458838284|FG005|Double Blind Phase|Death|0|||
127512507|NCT00098722|458838285|FG006|Double Blind Phase|Death|0|||
127512508|NCT00098722|458838279|FG000|Double Blind Phase|Lack of Efficacy|21|||
127512509|NCT00098722|458838280|FG001|Double Blind Phase|Lack of Efficacy|23|||
127512510|NCT00098722|458838281|FG002|Double Blind Phase|Lack of Efficacy|15|||
127512511|NCT00098722|458838282|FG003|Double Blind Phase|Lack of Efficacy|0|||
127512512|NCT00098722|458838283|FG004|Double Blind Phase|Lack of Efficacy|0|||
127512513|NCT00098722|458838284|FG005|Double Blind Phase|Lack of Efficacy|0|||
127512514|NCT00098722|458838285|FG006|Double Blind Phase|Lack of Efficacy|0|||
127512515|NCT00098722|458838279|FG000|Double Blind Phase|Participant defaulted|16|||
127512516|NCT00098722|458838280|FG001|Double Blind Phase|Participant defaulted|11|||
127512517|NCT00098722|458838281|FG002|Double Blind Phase|Participant defaulted|9|||
127512518|NCT00098722|458838282|FG003|Double Blind Phase|Participant defaulted|0|||
127512519|NCT00098722|458838283|FG004|Double Blind Phase|Participant defaulted|0|||
127512520|NCT00098722|458838284|FG005|Double Blind Phase|Participant defaulted|0|||
127512521|NCT00098722|458838285|FG006|Double Blind Phase|Participant defaulted|0|||
127512522|NCT00098722|458838279|FG000|Double Blind Phase|Pregnancy|1|||
127512523|NCT00098722|458838280|FG001|Double Blind Phase|Pregnancy|0|||
127512524|NCT00098722|458838281|FG002|Double Blind Phase|Pregnancy|0|||
127512525|NCT00098722|458838282|FG003|Double Blind Phase|Pregnancy|0|||
127512526|NCT00098722|458838283|FG004|Double Blind Phase|Pregnancy|0|||
127512527|NCT00098722|458838284|FG005|Double Blind Phase|Pregnancy|0|||
127512528|NCT00098722|458838285|FG006|Double Blind Phase|Pregnancy|0|||
127512529|NCT00098722|458838279|FG000|Double Blind Phase|Randomized, not treated|4|||
127512530|NCT00098722|458838280|FG001|Double Blind Phase|Randomized, not treated|3|||
127512531|NCT00098722|458838281|FG002|Double Blind Phase|Randomized, not treated|3|||
127512532|NCT00098722|458838282|FG003|Double Blind Phase|Randomized, not treated|0|||
127512533|NCT00098722|458838283|FG004|Double Blind Phase|Randomized, not treated|0|||
127512534|NCT00098722|458838284|FG005|Double Blind Phase|Randomized, not treated|0|||
127979775|NCT02278120|460547643|FG000|Treatment Period|Protocol deviation|0|||
127979776|NCT02278120|460547644|FG001|Treatment Period|Protocol deviation|2|||
127979777|NCT02278120|460547643|FG000|Treatment Period|Study terminated as per protocol|43|||
127979778|NCT02278120|460547644|FG001|Treatment Period|Study terminated as per protocol|11|||
127979779|NCT02278120|460547643|FG000|Post-treatment Efficacy Follow-up|Death|0|||
127512535|NCT00098722|458838285|FG006|Double Blind Phase|Randomized, not treated|0|||
127512536|NCT00098722|458838279|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
127512537|NCT00098722|458838280|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
127512538|NCT00098722|458838281|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
127512539|NCT00098722|458838282|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
127512540|NCT00098722|458838283|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
127512541|NCT00098722|458838284|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
127512542|NCT00098722|458838285|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
127512543|NCT00098722|458838279|FG000|Double Blind Phase|Other|7|||
127512544|NCT00098722|458838280|FG001|Double Blind Phase|Other|8|||
127512545|NCT00098722|458838281|FG002|Double Blind Phase|Other|7|||
127512546|NCT00098722|458838282|FG003|Double Blind Phase|Other|0|||
127512547|NCT00098722|458838283|FG004|Double Blind Phase|Other|0|||
127512548|NCT00098722|458838284|FG005|Double Blind Phase|Other|0|||
127512549|NCT00098722|458838285|FG006|Double Blind Phase|Other|0|||
127512550|NCT00098722|458838279|FG000|Open Label Phase|Adverse Event|0|||
127512551|NCT00098722|458838280|FG001|Open Label Phase|Adverse Event|0|||
127512552|NCT00098722|458838281|FG002|Open Label Phase|Adverse Event|0|||
127512553|NCT00098722|458838282|FG003|Open Label Phase|Adverse Event|5|||
127512554|NCT00098722|458838283|FG004|Open Label Phase|Adverse Event|0|||
127512555|NCT00098722|458838284|FG005|Open Label Phase|Adverse Event|0|||
127512556|NCT00098722|458838285|FG006|Open Label Phase|Adverse Event|0|||
127512557|NCT00098722|458838279|FG000|Open Label Phase|Death|0|||
127512558|NCT00098722|458838280|FG001|Open Label Phase|Death|0|||
127512559|NCT00098722|458838281|FG002|Open Label Phase|Death|0|||
127512560|NCT00098722|458838282|FG003|Open Label Phase|Death|2|||
127512561|NCT00098722|458838283|FG004|Open Label Phase|Death|0|||
127512562|NCT00098722|458838284|FG005|Open Label Phase|Death|0|||
127512563|NCT00098722|458838285|FG006|Open Label Phase|Death|0|||
127512564|NCT00098722|458838279|FG000|Open Label Phase|Lack of Efficacy|0|||
127512565|NCT00098722|458838280|FG001|Open Label Phase|Lack of Efficacy|0|||
127512566|NCT00098722|458838281|FG002|Open Label Phase|Lack of Efficacy|0|||
127512567|NCT00098722|458838282|FG003|Open Label Phase|Lack of Efficacy|8|||
127512568|NCT00098722|458838283|FG004|Open Label Phase|Lack of Efficacy|0|||
127512569|NCT00098722|458838284|FG005|Open Label Phase|Lack of Efficacy|0|||
127512570|NCT00098722|458838285|FG006|Open Label Phase|Lack of Efficacy|0|||
127512571|NCT00098722|458838279|FG000|Open Label Phase|Pregnancy|0|||
127512572|NCT00098722|458838280|FG001|Open Label Phase|Pregnancy|0|||
127512573|NCT00098722|458838281|FG002|Open Label Phase|Pregnancy|0|||
127512574|NCT00098722|458838282|FG003|Open Label Phase|Pregnancy|1|||
127512575|NCT00098722|458838283|FG004|Open Label Phase|Pregnancy|0|||
127512576|NCT00098722|458838284|FG005|Open Label Phase|Pregnancy|0|||
127512577|NCT00098722|458838285|FG006|Open Label Phase|Pregnancy|0|||
127512578|NCT00098722|458838279|FG000|Open Label Phase|Participant defaulted|0|||
127512579|NCT00098722|458838280|FG001|Open Label Phase|Participant defaulted|0|||
127512580|NCT00098722|458838281|FG002|Open Label Phase|Participant defaulted|0|||
127512581|NCT00098722|458838282|FG003|Open Label Phase|Participant defaulted|18|||
127512582|NCT00098722|458838283|FG004|Open Label Phase|Participant defaulted|0|||
127512583|NCT00098722|458838284|FG005|Open Label Phase|Participant defaulted|0|||
127512584|NCT00098722|458838285|FG006|Open Label Phase|Participant defaulted|0|||
127512585|NCT00098722|458838279|FG000|Open Label Phase|Ongoing at cut-off date|0|||
127512586|NCT00098722|458838280|FG001|Open Label Phase|Ongoing at cut-off date|0|||
127512587|NCT00098722|458838281|FG002|Open Label Phase|Ongoing at cut-off date|0|||
127512588|NCT00098722|458838282|FG003|Open Label Phase|Ongoing at cut-off date|220|||
127512589|NCT00098722|458838283|FG004|Open Label Phase|Ongoing at cut-off date|50|||
127512590|NCT00098722|458838284|FG005|Open Label Phase|Ongoing at cut-off date|0|||
127512591|NCT00098722|458838285|FG006|Open Label Phase|Ongoing at cut-off date|0|||
127512592|NCT00098722|458838279|FG000|Open Label Phase|Other|0|||
127512593|NCT00098722|458838280|FG001|Open Label Phase|Other|0|||
127512594|NCT00098722|458838281|FG002|Open Label Phase|Other|0|||
127512595|NCT00098722|458838282|FG003|Open Label Phase|Other|18|||
127512596|NCT00098722|458838283|FG004|Open Label Phase|Other|0|||
127512597|NCT00098722|458838284|FG005|Open Label Phase|Other|0|||
127512598|NCT00098722|458838285|FG006|Open Label Phase|Other|0|||
127512599|NCT00098722|458838279|FG000|Observation Phase|Death|0|||
127512600|NCT00098722|458838280|FG001|Observation Phase|Death|0|||
127512601|NCT00098722|458838281|FG002|Observation Phase|Death|0|||
127512602|NCT00098722|458838282|FG003|Observation Phase|Death|0|||
127512603|NCT00098722|458838283|FG004|Observation Phase|Death|0|||
127512604|NCT00098722|458838284|FG005|Observation Phase|Death|5|||
127512605|NCT00098722|458838285|FG006|Observation Phase|Death|3|||
127512606|NCT00098722|458838279|FG000|Observation Phase|Lack of Efficacy|0|||
127512607|NCT00098722|458838280|FG001|Observation Phase|Lack of Efficacy|0|||
127512608|NCT00098722|458838281|FG002|Observation Phase|Lack of Efficacy|0|||
127512609|NCT00098722|458838282|FG003|Observation Phase|Lack of Efficacy|0|||
127512610|NCT00098722|458838283|FG004|Observation Phase|Lack of Efficacy|0|||
127512611|NCT00098722|458838284|FG005|Observation Phase|Lack of Efficacy|2|||
127512612|NCT00098722|458838285|FG006|Observation Phase|Lack of Efficacy|0|||
127512613|NCT00098722|458838279|FG000|Observation Phase|Participant defaulted|0|||
127512614|NCT00098722|458838280|FG001|Observation Phase|Participant defaulted|0|||
127512615|NCT00098722|458838281|FG002|Observation Phase|Participant defaulted|0|||
127512616|NCT00098722|458838282|FG003|Observation Phase|Participant defaulted|0|||
127512617|NCT00098722|458838283|FG004|Observation Phase|Participant defaulted|0|||
127512618|NCT00098722|458838284|FG005|Observation Phase|Participant defaulted|17|||
127512619|NCT00098722|458838285|FG006|Observation Phase|Participant defaulted|4|||
127512620|NCT00098722|458838279|FG000|Observation Phase|Other|0|||
127512621|NCT00098722|458838280|FG001|Observation Phase|Other|0|||
127512622|NCT00098722|458838281|FG002|Observation Phase|Other|0|||
127512623|NCT00098722|458838282|FG003|Observation Phase|Other|0|||
127512624|NCT00098722|458838283|FG004|Observation Phase|Other|0|||
127512625|NCT00098722|458838284|FG005|Observation Phase|Other|21|||
127512626|NCT00098722|458838285|FG006|Observation Phase|Other|10|||
127512627|NCT02351349|458838286|FG000|Overall Study|Withdrawal by Subject|2|||
127512628|NCT02351349|458838287|FG001|Overall Study|Withdrawal by Subject|3|||
127512629|NCT00440310|458838288|FG000|Overall Study|Lost to Follow-up|4|||
127512630|NCT00440310|458838289|FG001|Overall Study|Lost to Follow-up|5|||
127512631|NCT00440310|458838288|FG000|Overall Study|Protocol Violation|0|||
127512632|NCT00440310|458838289|FG001|Overall Study|Protocol Violation|1|||
127512633|NCT00440310|458838288|FG000|Overall Study|Withdrawal by Subject|15|||
127512634|NCT00440310|458838289|FG001|Overall Study|Withdrawal by Subject|14|||
127512635|NCT00440310|458838288|FG000|Overall Study|No Reply at EOS|7|||
127512636|NCT00440310|458838289|FG001|Overall Study|No Reply at EOS|7|||
127512637|NCT00440310|458838288|FG000|Overall Study|Other|1|||
127512638|NCT00440310|458838289|FG001|Overall Study|Other|0|||
127512639|NCT00440310|458838288|FG000|Overall Study|Status Unknown|1|||
127512640|NCT00440310|458838289|FG001|Overall Study|Status Unknown|3|||
127512641|NCT01610596|458838290|FG000|Overall Study|Lost to Follow-up|0|||
127512642|NCT01610596|458838291|FG001|Overall Study|Lost to Follow-up|1|||
127512643|NCT01519674|458838292|FG000|Overall Study|Adverse Event|3|||
127512644|NCT01519674|458838293|FG001|Overall Study|Adverse Event|3|||
127512645|NCT01519674|458838294|FG002|Overall Study|Adverse Event|0|||
127512646|NCT01519674|458838292|FG000|Overall Study|Lack of Efficacy|1|||
127512647|NCT01519674|458838293|FG001|Overall Study|Lack of Efficacy|1|||
127512648|NCT01519674|458838294|FG002|Overall Study|Lack of Efficacy|1|||
127512649|NCT01519674|458838292|FG000|Overall Study|Protocol Violation|0|||
127512650|NCT01519674|458838293|FG001|Overall Study|Protocol Violation|3|||
127512651|NCT01519674|458838294|FG002|Overall Study|Protocol Violation|1|||
127512652|NCT01519674|458838292|FG000|Overall Study|Withdrawal Criteria|7|||
127512653|NCT01519674|458838293|FG001|Overall Study|Withdrawal Criteria|2|||
127512654|NCT01519674|458838294|FG002|Overall Study|Withdrawal Criteria|7|||
127512655|NCT01519674|458838292|FG000|Overall Study|Unsclassified|10|||
127512656|NCT01519674|458838293|FG001|Overall Study|Unsclassified|4|||
127512657|NCT01519674|458838294|FG002|Overall Study|Unsclassified|3|||
127512658|NCT00799591|458838301|FG000|Overall Study|De-escalation of doses|20|||
127512659|NCT00799591|458838301|FG000|Overall Study|Death|14|||
127512660|NCT00799591|458838301|FG000|Overall Study|Technical failure|12|||
127512661|NCT00799591|458838301|FG000|Overall Study|Resistant germ|11|||
127512662|NCT00799591|458838301|FG000|Overall Study|New infection|4|||
127512663|NCT00799591|458838301|FG000|Overall Study|Resistance germ and technical failure|2|||
127512664|NCT00799591|458838301|FG000|Overall Study|Persistance of fever undetermined origin|1|||
127512665|NCT00799591|458838301|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
127512666|NCT00799591|458838301|FG000|Overall Study|Infectious origin not probable|1|||
127512667|NCT03106415|458838304|FG000|Phase 1|Withdrawal by Subject|1|||
127512668|NCT03106415|458838305|FG001|Phase 1|Withdrawal by Subject|0|||
127512669|NCT03106415|458838306|FG002|Phase 1|Withdrawal by Subject|0|||
127512670|NCT03106415|458838304|FG000|Phase 1|Adverse Event|1|||
127512671|NCT03106415|458838305|FG001|Phase 1|Adverse Event|1|||
127512672|NCT03106415|458838306|FG002|Phase 1|Adverse Event|0|||
127512673|NCT03106415|458838304|FG000|Phase 1|Protocol Violation|0|||
127512674|NCT03106415|458838305|FG001|Phase 1|Protocol Violation|1|||
127512675|NCT03106415|458838306|FG002|Phase 1|Protocol Violation|0|||
127512676|NCT00293709|458838307|FG000|Overall Study|Other|47|||
127512677|NCT02785458|458838308|FG000|1 Month|Withdrawal by Subject|2|||
127512678|NCT02785458|458838309|FG001|1 Month|Withdrawal by Subject|1|||
127512679|NCT02785458|458838308|FG000|1 Month|Lost to Follow-up|38|||
127512680|NCT02785458|458838309|FG001|1 Month|Lost to Follow-up|31|||
127512681|NCT02785458|458838308|FG000|1 Month|Deemed Ineligible|1|||
127512682|NCT02785458|458838309|FG001|1 Month|Deemed Ineligible|0|||
127512683|NCT02785458|458838308|FG000|1 Month|Completed Evaluation by Baseline|42|||
127512684|NCT02785458|458838309|FG001|1 Month|Completed Evaluation by Baseline|39|||
127512685|NCT02785458|458838308|FG000|1 Month|Partial Interview|0|||
127512686|NCT02785458|458838309|FG001|1 Month|Partial Interview|4|||
127512687|NCT02785458|458838308|FG000|3 Months|Withdrawal by Subject|3|||
127512688|NCT02785458|458838309|FG001|3 Months|Withdrawal by Subject|1|||
127512689|NCT02785458|458838308|FG000|3 Months|Lost to Follow-up|25|||
127512690|NCT02785458|458838309|FG001|3 Months|Lost to Follow-up|21|||
127512691|NCT02785458|458838308|FG000|3 Months|Completed Evaluation at 1 Month|100|||
127512692|NCT02785458|458838309|FG001|3 Months|Completed Evaluation at 1 Month|89|||
127512693|NCT01804582|458838310|FG000|Overall Study|Lost to Follow-up|47|||
127512694|NCT01804582|458838311|FG001|Overall Study|Lost to Follow-up|56|||
127512695|NCT01804582|458838310|FG000|Overall Study|Physician Decision|2|||
127512696|NCT01804582|458838311|FG001|Overall Study|Physician Decision|0|||
127512697|NCT00520013|458838312|FG000|Overall Study|Withdrawal by Subject|0|||
127512698|NCT00520013|458838313|FG001|Overall Study|Withdrawal by Subject|0|||
127512699|NCT00520013|458838314|FG002|Overall Study|Withdrawal by Subject|1|||
127512700|NCT00520013|458838312|FG000|Overall Study|Adverse Event|2|||
127512701|NCT00520013|458838313|FG001|Overall Study|Adverse Event|10|||
127512702|NCT00520013|458838314|FG002|Overall Study|Adverse Event|7|||
127512703|NCT00520013|458838312|FG000|Overall Study|Progressive Disease|7|||
127512704|NCT00520013|458838313|FG001|Overall Study|Progressive Disease|3|||
127512705|NCT00520013|458838314|FG002|Overall Study|Progressive Disease|0|||
127512706|NCT00520013|458838312|FG000|Overall Study|Clinical Progression|3|||
127512707|NCT00520013|458838313|FG001|Overall Study|Clinical Progression|1|||
127512708|NCT00520013|458838314|FG002|Overall Study|Clinical Progression|0|||
127512709|NCT00520013|458838312|FG000|Overall Study|Death|0|||
127512710|NCT00520013|458838313|FG001|Overall Study|Death|1|||
127512711|NCT00520013|458838314|FG002|Overall Study|Death|0|||
127512712|NCT00520013|458838312|FG000|Overall Study|Physician Decision|0|||
127512713|NCT00520013|458838313|FG001|Overall Study|Physician Decision|0|||
127512714|NCT00520013|458838314|FG002|Overall Study|Physician Decision|3|||
127512715|NCT02677844|458838315|FG000|Period 3|Withdrawal by Subject|0|||
127512716|NCT02677844|458838316|FG001|Period 3|Withdrawal by Subject|0|||
127512717|NCT02677844|458838317|FG002|Period 3|Withdrawal by Subject|0|||
127512718|NCT02677844|458838318|FG003|Period 3|Withdrawal by Subject|1|||
127512719|NCT02677844|458838319|FG004|Period 3|Withdrawal by Subject|0|||
127512720|NCT02677844|458838320|FG005|Period 3|Withdrawal by Subject|0|||
127512721|NCT02677844|458838321|FG006|Period 3|Withdrawal by Subject|0|||
127512722|NCT01697462|458838322|FG000|Overall Study|Disease Progression|1|||
127512723|NCT01697462|458838322|FG000|Overall Study|Adverse Event|6|||
127512724|NCT01697462|458838322|FG000|Overall Study|Lost to Follow-up|21|||
127512725|NCT01697462|458838322|FG000|Overall Study|Withdrawal by Subject|12|||
127512726|NCT01697462|458838322|FG000|Overall Study|Investigator Decision|21|||
127512727|NCT01697462|458838322|FG000|Overall Study|Death|1|||
127512728|NCT01697462|458838322|FG000|Overall Study|Other|10|||
127512729|NCT01697462|458838322|FG000|Overall Study|Missing|5|||
127512730|NCT01149486|458838323|FG000|First Intervention|Adverse Event|0|||
127512731|NCT01149486|458838324|FG001|First Intervention|Adverse Event|1|||
127512732|NCT03630302|458838325|FG000|Surgery|hardware issue prevented LFP recordings|1|||
127512733|NCT03630302|458838325|FG000|3 Month Visit|Adverse Event|2|||
127512734|NCT03630302|458838325|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
127512735|NCT01135914|458838328|FG000|Overall Study|Withdrawal by Subject|1|||
127512736|NCT01135914|458838329|FG001|Overall Study|Withdrawal by Subject|3|||
127512737|NCT01135914|458838330|FG002|Overall Study|Withdrawal by Subject|6|||
127512738|NCT01135914|458838328|FG000|Overall Study|Lost to Follow-up|1|||
127512739|NCT01135914|458838329|FG001|Overall Study|Lost to Follow-up|0|||
127512740|NCT01135914|458838330|FG002|Overall Study|Lost to Follow-up|1|||
127512741|NCT01135914|458838328|FG000|Overall Study|Protocol Violation|0|||
127512742|NCT01135914|458838329|FG001|Overall Study|Protocol Violation|0|||
127512743|NCT01135914|458838330|FG002|Overall Study|Protocol Violation|3|||
127512744|NCT01135914|458838328|FG000|Overall Study|Lack of Efficacy|2|||
127512745|NCT01135914|458838329|FG001|Overall Study|Lack of Efficacy|1|||
127512746|NCT01135914|458838330|FG002|Overall Study|Lack of Efficacy|10|||
127512747|NCT01135914|458838328|FG000|Overall Study|Adverse Event|0|||
127512748|NCT01135914|458838329|FG001|Overall Study|Adverse Event|1|||
127512749|NCT01135914|458838330|FG002|Overall Study|Adverse Event|2|||
127512750|NCT03532932|458838334|FG000|Overall Study|Protocol Deviation|33|||
127512751|NCT03532932|458838335|FG001|Overall Study|Protocol Deviation|31|||
127512752|NCT03532932|458838334|FG000|Overall Study|Appearance of Exclusion Criteria|9|||
127512753|NCT03532932|458838335|FG001|Overall Study|Appearance of Exclusion Criteria|11|||
127512754|NCT03532932|458838334|FG000|Overall Study|Withdrawal by Subject|2|||
127512755|NCT03532932|458838335|FG001|Overall Study|Withdrawal by Subject|0|||
127512756|NCT03532932|458838334|FG000|Overall Study|Lost to Follow-up|15|||
127512757|NCT03532932|458838335|FG001|Overall Study|Lost to Follow-up|9|||
127512758|NCT03532932|458838334|FG000|Overall Study|Adverse Event|4|||
127512759|NCT03532932|458838335|FG001|Overall Study|Adverse Event|3|||
127512760|NCT03532932|458838334|FG000|Overall Study|Death|0|||
127512761|NCT03532932|458838335|FG001|Overall Study|Death|2|||
127512762|NCT03532932|458838334|FG000|Overall Study|Other|11|||
127512763|NCT03532932|458838335|FG001|Overall Study|Other|16|||
127512764|NCT02699450|458838336|FG000|Overall Study|Death|2|||
127512765|NCT02699450|458838337|FG001|Overall Study|Death|1|||
127512766|NCT02699450|458838338|FG002|Overall Study|Death|2|||
127512767|NCT02699450|458838336|FG000|Overall Study|Met Criteria for Study Exit|0|||
127512768|NCT02699450|458838337|FG001|Overall Study|Met Criteria for Study Exit|0|||
127512769|NCT02699450|458838338|FG002|Overall Study|Met Criteria for Study Exit|1|||
127512770|NCT02699450|458838336|FG000|Overall Study|Protocol Violation|4|||
127512771|NCT02699450|458838337|FG001|Overall Study|Protocol Violation|3|||
127512772|NCT02699450|458838338|FG002|Overall Study|Protocol Violation|5|||
127512773|NCT02699450|458838336|FG000|Overall Study|Lost to Follow-up|3|||
127512774|NCT02699450|458838337|FG001|Overall Study|Lost to Follow-up|0|||
127512775|NCT02699450|458838338|FG002|Overall Study|Lost to Follow-up|5|||
127512776|NCT02699450|458838336|FG000|Overall Study|Physician Decision|2|||
127512777|NCT02699450|458838337|FG001|Overall Study|Physician Decision|0|||
127512778|NCT02699450|458838338|FG002|Overall Study|Physician Decision|0|||
127512779|NCT02699450|458838336|FG000|Overall Study|Withdrawal by Subject|3|||
127512780|NCT02699450|458838337|FG001|Overall Study|Withdrawal by Subject|1|||
127512781|NCT02699450|458838338|FG002|Overall Study|Withdrawal by Subject|2|||
127512782|NCT02699450|458838336|FG000|Overall Study|Adverse Event|1|||
127512783|NCT02699450|458838337|FG001|Overall Study|Adverse Event|0|||
127512784|NCT02699450|458838338|FG002|Overall Study|Adverse Event|0|||
127512785|NCT01344629|458838345|FG000|Crossover Period 2|Withdrawal by Subject|0|||
127512786|NCT01344629|458838346|FG001|Crossover Period 2|Withdrawal by Subject|1|||
127512787|NCT01635764|458838347|FG000|Overall Study|Adverse Event|46|||
127512788|NCT01635764|458838347|FG000|Overall Study|Lack of Efficacy|76|||
127512789|NCT01635764|458838347|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
127512790|NCT01635764|458838347|FG000|Overall Study|Protocol Deviation|1|||
127512791|NCT01635764|458838347|FG000|Overall Study|Withdrew Consent|67|||
127512792|NCT01635764|458838347|FG000|Overall Study|Lost to Follow-up|53|||
127512793|NCT01635764|458838347|FG000|Overall Study|Other|28|||
127512794|NCT01174004|458838349|FG000|Overall Study|Adverse Event|2|||
127512795|NCT01174004|458838350|FG001|Overall Study|Adverse Event|10|||
127512796|NCT01174004|458838349|FG000|Overall Study|Withdrawal by Subject|2|||
127512797|NCT01174004|458838350|FG001|Overall Study|Withdrawal by Subject|3|||
127512798|NCT01174004|458838349|FG000|Overall Study|At Discretion of Sponsor|2|||
127512799|NCT01174004|458838350|FG001|Overall Study|At Discretion of Sponsor|2|||
127512800|NCT01174004|458838349|FG000|Overall Study|Protocol Violation|0|||
127512801|NCT01174004|458838350|FG001|Overall Study|Protocol Violation|1|||
127512802|NCT01174004|458838349|FG000|Overall Study|Physician Decision|1|||
127512803|NCT01174004|458838350|FG001|Overall Study|Physician Decision|0|||
127512804|NCT00693472|458838354|FG000|Part 1|Adverse Event|1|||
127512805|NCT00693472|458838355|FG001|Part 1|Adverse Event|1|||
127512806|NCT00693472|458838356|FG002|Part 1|Adverse Event|0|||
127512807|NCT00693472|458838357|FG003|Part 1|Adverse Event|0|||
127512808|NCT00693472|458838354|FG000|Part 1|Lost to Follow-up|0|||
127512809|NCT00693472|458838355|FG001|Part 1|Lost to Follow-up|1|||
127512810|NCT00693472|458838356|FG002|Part 1|Lost to Follow-up|0|||
127512811|NCT00693472|458838357|FG003|Part 1|Lost to Follow-up|0|||
127512812|NCT00693472|458838354|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
127512813|NCT00693472|458838355|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
127512814|NCT00693472|458838356|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
127512815|NCT00693472|458838357|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
127512816|NCT00693472|458838354|FG000|Part 2|Adverse Event|0|||
127512817|NCT00693472|458838355|FG001|Part 2|Adverse Event|0|||
127512818|NCT00693472|458838356|FG002|Part 2|Adverse Event|1|||
127512819|NCT00693472|458838357|FG003|Part 2|Adverse Event|0|||
127512820|NCT00693472|458838354|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
127512821|NCT00693472|458838355|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
127512822|NCT00693472|458838356|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
127512823|NCT00693472|458838357|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
127512824|NCT04063787|458838360|FG000|Overall Study|Inadequate Doppler data|4|||
127512825|NCT04063787|458838360|FG000|Overall Study|Lost to Follow-up|2|||
127512826|NCT04063787|458838360|FG000|Overall Study|Death|3|||
127512827|NCT05545644|458838361|FG000|Overall Study|Lost to Follow-up|4|||
127512828|NCT05545644|458838362|FG001|Overall Study|Lost to Follow-up|3|||
127512829|NCT03002623|458838370|FG000|Overall Study|Lost to Follow-up|1|||
127512830|NCT03002623|458838371|FG001|Overall Study|Lost to Follow-up|0|||
127512831|NCT03002623|458838370|FG000|Overall Study|Physician Decision|1|||
127512832|NCT03002623|458838371|FG001|Overall Study|Physician Decision|1|||
127512833|NCT03352453|458838373|FG000|Overall Study|Miscellaneous Reasons|1|||
127512834|NCT03352453|458838374|FG001|Overall Study|Miscellaneous Reasons|2|||
127512835|NCT03352453|458838373|FG000|Overall Study|Lack of Efficacy|1|||
127512836|NCT03352453|458838374|FG001|Overall Study|Lack of Efficacy|0|||
127512837|NCT03352453|458838373|FG000|Overall Study|Withdrawal by Subject|8|||
127512838|NCT03352453|458838374|FG001|Overall Study|Withdrawal by Subject|14|||
127512839|NCT03352453|458838373|FG000|Overall Study|Study Terminated by Sponsor|2|||
127512840|NCT03352453|458838374|FG001|Overall Study|Study Terminated by Sponsor|1|||
127512841|NCT03352453|458838373|FG000|Overall Study|Protocol Deviation|1|||
127512842|NCT03352453|458838374|FG001|Overall Study|Protocol Deviation|0|||
127512843|NCT03352453|458838373|FG000|Overall Study|Lost to Follow-up|7|||
127512844|NCT03352453|458838374|FG001|Overall Study|Lost to Follow-up|6|||
127512845|NCT03352453|458838373|FG000|Overall Study|Adverse Event|2|||
127512846|NCT03352453|458838374|FG001|Overall Study|Adverse Event|9|||
127512847|NCT01241760|458838377|FG000|Overall Study|Adverse Event|1|||
127512848|NCT01241760|458838378|FG001|Overall Study|Adverse Event|0|||
127512849|NCT01241760|458838377|FG000|Overall Study|Lost to Follow-up|18|||
127512850|NCT01241760|458838378|FG001|Overall Study|Lost to Follow-up|22|||
127512851|NCT01241760|458838377|FG000|Overall Study|Withdrawal by Subject|13|||
127512852|NCT01241760|458838378|FG001|Overall Study|Withdrawal by Subject|13|||
127512853|NCT01241760|458838377|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
127512854|NCT01241760|458838378|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
127512855|NCT01241760|458838377|FG000|Overall Study|Other|1|||
127512856|NCT01241760|458838378|FG001|Overall Study|Other|1|||
127512857|NCT03089944|458838379|FG000|Overall Study|Lost to Follow-up|8|||
127512858|NCT03089944|458838379|FG000|Overall Study|Withdrew Consent|2|||
127512859|NCT03089944|458838379|FG000|Overall Study|Adverse Event|1|||
127512860|NCT03089944|458838379|FG000|Overall Study|Other|1|||
127512861|NCT01636713|458838380|FG000|Overall Study|Adverse Event|16|||
127512862|NCT01636713|458838381|FG001|Overall Study|Adverse Event|16|||
127512863|NCT01636713|458838382|FG002|Overall Study|Adverse Event|7|||
127512864|NCT01636713|458838380|FG000|Overall Study|Lack of Efficacy|6|||
127512865|NCT01636713|458838381|FG001|Overall Study|Lack of Efficacy|6|||
127512866|NCT01636713|458838382|FG002|Overall Study|Lack of Efficacy|2|||
127512867|NCT01636713|458838380|FG000|Overall Study|Protocol Violation|3|||
127512868|NCT01636713|458838381|FG001|Overall Study|Protocol Violation|0|||
127512869|NCT01636713|458838382|FG002|Overall Study|Protocol Violation|1|||
127512870|NCT01636713|458838380|FG000|Overall Study|Lost to Follow-up|0|||
127512871|NCT01636713|458838381|FG001|Overall Study|Lost to Follow-up|0|||
127512872|NCT01636713|458838382|FG002|Overall Study|Lost to Follow-up|1|||
127512873|NCT01636713|458838380|FG000|Overall Study|Withdrawal by Subject|5|||
127512874|NCT01636713|458838381|FG001|Overall Study|Withdrawal by Subject|4|||
127512875|NCT01636713|458838382|FG002|Overall Study|Withdrawal by Subject|8|||
127512876|NCT01636713|458838380|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
127512877|NCT01636713|458838381|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
127512878|NCT01636713|458838382|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
127512879|NCT03780959|458838383|FG000|Part 1|Adverse Event|1|||
127512880|NCT03780959|458838384|FG001|Part 1|Adverse Event|0|||
127512881|NCT03780959|458838385|FG002|Part 1|Adverse Event|0|||
127512882|NCT03780959|458838383|FG000|Part 1|Withdrawal by Subject|1|||
127512883|NCT03780959|458838384|FG001|Part 1|Withdrawal by Subject|0|||
127512884|NCT03780959|458838385|FG002|Part 1|Withdrawal by Subject|0|||
127512885|NCT03780959|458838383|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
127512886|NCT03780959|458838384|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
127512887|NCT03780959|458838385|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
127512888|NCT03780959|458838383|FG000|Part 1|Response Status|2|||
127512889|NCT03780959|458838384|FG001|Part 1|Response Status|0|||
127512890|NCT03780959|458838385|FG002|Part 1|Response Status|0|||
127512891|NCT03780959|458838383|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
127512892|NCT03780959|458838384|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
127512893|NCT03780959|458838385|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
127512894|NCT03780959|458838383|FG000|Part 2|Response Status|0|||
127512895|NCT03780959|458838384|FG001|Part 2|Response Status|18|||
127512896|NCT03780959|458838385|FG002|Part 2|Response Status|6|||
127512897|NCT03689244|458838390|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
127512898|NCT03689244|458838391|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
127512899|NCT03689244|458838392|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
127512900|NCT03689244|458838393|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
127512901|NCT03689244|458838390|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
127512902|NCT03689244|458838391|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
127512903|NCT03689244|458838392|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
127512904|NCT03689244|458838393|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
127512905|NCT03689244|458838390|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
127512906|NCT03689244|458838391|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
127512907|NCT03689244|458838392|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
127512908|NCT03689244|458838393|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
127512909|NCT03689244|458838390|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
127512910|NCT03689244|458838391|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
127512911|NCT03689244|458838392|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
127512912|NCT03689244|458838393|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
127512913|NCT03689244|458838390|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
127512914|NCT03689244|458838391|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
127512915|NCT03689244|458838392|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
127512916|NCT03689244|458838393|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
127512917|NCT03689244|458838390|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
127512918|NCT03689244|458838391|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
127512919|NCT03689244|458838392|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
127512920|NCT03689244|458838393|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
127512921|NCT03689244|458838390|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
127512922|NCT03689244|458838391|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
127512923|NCT03689244|458838392|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
127512924|NCT03689244|458838393|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
127512925|NCT03689244|458838390|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
127512926|NCT03689244|458838391|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
127512927|NCT03689244|458838392|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
127512928|NCT03689244|458838393|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
127512929|NCT01565564|458838394|FG000|Overall Study|Lost to Follow-up|5|||
127512930|NCT01565564|458838395|FG001|Overall Study|Lost to Follow-up|1|||
127512931|NCT02698371|458838396|FG000|All Participants Flow|Lost to Follow-up|3|||
127512932|NCT02698371|458838396|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
127512933|NCT02698371|458838396|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
127512934|NCT02698371|458838396|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
127512935|NCT02698371|458838396|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
127512936|NCT02698371|458838396|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
127512937|NCT02698371|458838396|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
127512938|NCT00664326|458840102|FG000|Overall Study|Adverse Event|14|||
127512939|NCT00664326|458840102|FG000|Overall Study|Noncompliance with study medication|3|||
127512940|NCT00664326|458840102|FG000|Overall Study|Withdrawal by Subject|1|||
127512941|NCT00664326|458840102|FG000|Overall Study|Physician Decision|1|||
127512942|NCT00664326|458840102|FG000|Overall Study|Other Reasons|3|||
127512943|NCT00664326|458840102|FG000|Overall Study|Death|2|||
127512944|NCT00664326|458840102|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
127512945|NCT00387647|458840103|FG000|Overall Study|Death|18|||
127512946|NCT02032407|458840104|FG000|Overall Study|Lost to Follow-up|2|||
127512947|NCT02032407|458840104|FG000|Overall Study|Pregnancy|1|||
127512948|NCT02032407|458840104|FG000|Overall Study|Other Miscellaneous Reasons|2|||
127512949|NCT02191605|458840105|FG000|Overall Study|Lost to Follow-up|9|||
127512950|NCT02191605|458840106|FG001|Overall Study|Lost to Follow-up|4|||
127512951|NCT02191605|458840107|FG002|Overall Study|Lost to Follow-up|7|||
127512952|NCT02191605|458840108|FG003|Overall Study|Lost to Follow-up|3|||
127512953|NCT02191605|458840109|FG004|Overall Study|Lost to Follow-up|4|||
127512954|NCT01309269|458840112|FG000|Overall Study|Adverse Event|56|||
127512955|NCT01309269|458840112|FG000|Overall Study|Withdrawal by Subject|25|||
127512956|NCT01309269|458840112|FG000|Overall Study|Lack of Acceptance|15|||
127512957|NCT01309269|458840112|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
127512958|NCT01309269|458840112|FG000|Overall Study|Kidney Transplant|25|||
127512959|NCT01309269|458840112|FG000|Overall Study|Administrative Problems|141|||
127512960|NCT01309269|458840112|FG000|Overall Study|Other|256|||
127512961|NCT01309269|458840112|FG000|Overall Study|Other|1|||
127512962|NCT01309269|458840112|FG000|Overall Study|Study Completion Data Not Recorded|95|||
127512963|NCT01309269|458840112|FG000|Overall Study|Enrolled but not Treated|107|||
127512964|NCT03131596|458840115|FG000|Overall Study|Protocol Violation|3|||
127512965|NCT03131596|458840116|FG001|Overall Study|Protocol Violation|3|||
127512966|NCT03131596|458840115|FG000|Overall Study|Lost to Follow-up|3|||
127512967|NCT03131596|458840116|FG001|Overall Study|Lost to Follow-up|0|||
127512968|NCT00240110|458840118|FG000|Overall Study|Lost to Follow-up|6|||
127512969|NCT00240110|458840119|FG001|Overall Study|Lost to Follow-up|7|||
127512970|NCT00583791|458840120|FG000|Overall Study|Other|67|||
127512971|NCT00583791|458840120|FG000|Overall Study|Death|6|||
127512972|NCT03323736|458840121|FG000|Overall Study|Screen Failure|14|||
127512973|NCT03323736|458840122|FG001|Overall Study|Screen Failure|9|||
127512974|NCT03323736|458840123|FG002|Overall Study|Screen Failure|1|||
127512975|NCT03323736|458840121|FG000|Overall Study|Withdrawal Before Treatment|3|||
127512976|NCT03323736|458840122|FG001|Overall Study|Withdrawal Before Treatment|1|||
127512977|NCT03323736|458840123|FG002|Overall Study|Withdrawal Before Treatment|1|||
127512978|NCT03323736|458840121|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
127512979|NCT03323736|458840122|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
127512980|NCT03323736|458840123|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
127512981|NCT02654236|458840127|FG000|Overall Study|Withdrawal by Subject|0|||
127512982|NCT02654236|458840128|FG001|Overall Study|Withdrawal by Subject|0|||
127512983|NCT02654236|458840129|FG002|Overall Study|Withdrawal by Subject|2|||
127512984|NCT01688739|458840130|FG000|Overall Study|Administrative Decision|1|||
127512985|NCT01688739|458840131|FG001|Overall Study|Administrative Decision|0|||
127512986|NCT01688739|458840132|FG002|Overall Study|Administrative Decision|0|||
127512987|NCT01688739|458840133|FG003|Overall Study|Administrative Decision|0|||
127512988|NCT01688739|458840134|FG004|Overall Study|Administrative Decision|0|||
127512989|NCT01688739|458840135|FG005|Overall Study|Administrative Decision|0|||
127512990|NCT01688739|458840136|FG006|Overall Study|Administrative Decision|0|||
127512991|NCT01688739|458840137|FG007|Overall Study|Administrative Decision|0|||
127512992|NCT01688739|458840138|FG008|Overall Study|Administrative Decision|0|||
127512993|NCT01688739|458840139|FG009|Overall Study|Administrative Decision|0|||
127512994|NCT01266317|458840144|FG000|Overall Study|Withdrawal by Subject|2|||
127512995|NCT00490776|458840145|FG000|Overall Study|Withdrawal by Subject|1|||
127512996|NCT00490776|458840145|FG000|Overall Study|Administrative Problems|1|||
127512997|NCT00490776|458840145|FG000|Overall Study|Death|1|||
127512998|NCT00490776|458840145|FG000|Overall Study|New Cancer Therapy|1|||
127512999|NCT00490776|458840145|FG000|Overall Study|Disease Progression|5|||
127513000|NCT00046930|458840146|FG000|Overall Study|Ineligible|12|||
127513001|NCT00046930|458840147|FG001|Overall Study|Ineligible|4|||
127513002|NCT01113580|458840148|FG000|Overall Study|Protocol Violation|1|||
127513003|NCT01113580|458840149|FG001|Overall Study|Protocol Violation|0|||
127513004|NCT02317809|458840154|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
127513005|NCT02317809|458840155|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
127513006|NCT02317809|458840154|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
127513007|NCT02317809|458840155|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
127513008|NCT04912895|458840159|FG000|Overall Study|Unable to provide specimen|2|||
127513009|NCT04912895|458840160|FG001|Overall Study|Unable to provide specimen|0|||
127513010|NCT04912895|458840161|FG002|Overall Study|Unable to provide specimen|0|||
127513011|NCT00824005|458840163|FG000|Overall Study|Death|0|||
127513012|NCT00824005|458840164|FG001|Overall Study|Death|1|||
127513013|NCT00824005|458840163|FG000|Overall Study|Lost to Follow-up|0|||
127513014|NCT00824005|458840164|FG001|Overall Study|Lost to Follow-up|1|||
127513015|NCT03458702|458840165|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
127513016|NCT03458702|458840166|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
127513017|NCT03458702|458840165|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
127513018|NCT03458702|458840166|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
127513019|NCT01390779|458840167|FG000|Overall Study|Physician Decision|1|||
127513020|NCT01874275|458840168|FG000|Overall Study|Lost to Follow-up|1|||
127513021|NCT01874275|458840169|FG001|Overall Study|Lost to Follow-up|0|||
127513022|NCT00168103|458840170|FG000|Overall Study|Withdrawal by Subject|1|||
127513023|NCT00168103|458840171|FG001|Overall Study|Withdrawal by Subject|2|||
127513024|NCT00168103|458840172|FG002|Overall Study|Withdrawal by Subject|1|||
127513025|NCT00168103|458840173|FG003|Overall Study|Withdrawal by Subject|0|||
127513026|NCT00168103|458840170|FG000|Overall Study|Lost to Follow-up|1|||
127513027|NCT00168103|458840171|FG001|Overall Study|Lost to Follow-up|3|||
127513028|NCT00168103|458840172|FG002|Overall Study|Lost to Follow-up|0|||
127513029|NCT00168103|458840173|FG003|Overall Study|Lost to Follow-up|0|||
127513030|NCT00989235|458840174|FG000|Overall Study|Death|0|||
127513031|NCT00989235|458840175|FG001|Overall Study|Death|1|||
127513032|NCT00989235|458840174|FG000|Overall Study|Adverse Event|0|||
127513033|NCT00989235|458840175|FG001|Overall Study|Adverse Event|1|||
127513034|NCT00989235|458840174|FG000|Overall Study|Lack of Efficacy|1|||
127513035|NCT00989235|458840175|FG001|Overall Study|Lack of Efficacy|0|||
127513036|NCT00989235|458840174|FG000|Overall Study|Withdrawal of Consent|1|||
127513037|NCT00989235|458840175|FG001|Overall Study|Withdrawal of Consent|1|||
127513038|NCT00989235|458840174|FG000|Overall Study|Desire to Become Pregnant|1|||
127513039|NCT00989235|458840175|FG001|Overall Study|Desire to Become Pregnant|0|||
127513040|NCT00989235|458840174|FG000|Overall Study|Randomized by Mistake|0|||
127513041|NCT00989235|458840175|FG001|Overall Study|Randomized by Mistake|2|||
127513042|NCT00989235|458840174|FG000|Overall Study|Lost to Follow-up|0|||
127513043|NCT00989235|458840175|FG001|Overall Study|Lost to Follow-up|1|||
127513044|NCT00545532|458840176|FG000|Overall Study|Withdrawal by Subject|1|||
127513045|NCT00545532|458840177|FG001|Overall Study|Withdrawal by Subject|3|||
127513046|NCT00545532|458840176|FG000|Overall Study|Lost to Follow-up|5|||
127513047|NCT00545532|458840177|FG001|Overall Study|Lost to Follow-up|6|||
127513048|NCT00545532|458840176|FG000|Overall Study|Death|0|||
127513049|NCT00545532|458840177|FG001|Overall Study|Death|1|||
127513050|NCT00933244|458840180|FG000|Overall Study|Withdrawal by Subject|5|||
127513051|NCT00933244|458840181|FG001|Overall Study|Withdrawal by Subject|1|||
127513052|NCT00933244|458840182|FG002|Overall Study|Withdrawal by Subject|3|||
127513053|NCT02266875|458840183|FG000|Overall Study|Withdrawal by Subject|9|||
127513054|NCT02266875|458840184|FG001|Overall Study|Withdrawal by Subject|0|||
127513055|NCT02266875|458840183|FG000|Overall Study|Lost to Follow-up|2|||
127513056|NCT02266875|458840184|FG001|Overall Study|Lost to Follow-up|0|||
127513057|NCT00875056|458840188|FG000|Overall Study|Adverse Event|6|||
127513058|NCT00875056|458840189|FG001|Overall Study|Adverse Event|1|||
127513059|NCT00875056|458840190|FG002|Overall Study|Adverse Event|2|||
127513060|NCT00875056|458840188|FG000|Overall Study|Progressive Disease|14|||
127513061|NCT00875056|458840189|FG001|Overall Study|Progressive Disease|8|||
127513062|NCT00875056|458840190|FG002|Overall Study|Progressive Disease|3|||
127513063|NCT00875056|458840188|FG000|Overall Study|Withdrawal by Subject|3|||
127513064|NCT00875056|458840189|FG001|Overall Study|Withdrawal by Subject|0|||
127513065|NCT00875056|458840190|FG002|Overall Study|Withdrawal by Subject|1|||
127513066|NCT02956850|458840191|FG000|Overall Study|Withdrawal by Subject|0|||
127513067|NCT02956850|458840192|FG001|Overall Study|Withdrawal by Subject|0|||
127513068|NCT02956850|458840193|FG002|Overall Study|Withdrawal by Subject|0|||
127513069|NCT02956850|458840194|FG003|Overall Study|Withdrawal by Subject|0|||
127513070|NCT02956850|458840195|FG004|Overall Study|Withdrawal by Subject|0|||
127513071|NCT02956850|458840196|FG005|Overall Study|Withdrawal by Subject|0|||
127513072|NCT02956850|458840197|FG006|Overall Study|Withdrawal by Subject|0|||
127513073|NCT02956850|458840198|FG007|Overall Study|Withdrawal by Subject|0|||
127513074|NCT02956850|458840199|FG008|Overall Study|Withdrawal by Subject|0|||
127513075|NCT02956850|458840200|FG009|Overall Study|Withdrawal by Subject|0|||
127513076|NCT02956850|458840201|FG010|Overall Study|Withdrawal by Subject|0|||
127513077|NCT02956850|458840202|FG011|Overall Study|Withdrawal by Subject|0|||
127513078|NCT02956850|458840203|FG012|Overall Study|Withdrawal by Subject|0|||
127513079|NCT02956850|458840204|FG013|Overall Study|Withdrawal by Subject|0|||
127513080|NCT02956850|458840205|FG014|Overall Study|Withdrawal by Subject|0|||
127513081|NCT02956850|458840206|FG015|Overall Study|Withdrawal by Subject|0|||
127513082|NCT02956850|458840207|FG016|Overall Study|Withdrawal by Subject|0|||
127513083|NCT02956850|458840208|FG017|Overall Study|Withdrawal by Subject|1|||
127513084|NCT00391391|458840211|FG000|Overall Study|Adverse Event|0|||
127513085|NCT00391391|458840212|FG001|Overall Study|Adverse Event|0|||
127513086|NCT00391391|458840213|FG002|Overall Study|Adverse Event|0|||
127513087|NCT00391391|458840214|FG003|Overall Study|Adverse Event|1|||
127513088|NCT00391391|458840211|FG000|Overall Study|Lost to Follow-up|1|||
127513089|NCT00391391|458840212|FG001|Overall Study|Lost to Follow-up|3|||
127513090|NCT00391391|458840213|FG002|Overall Study|Lost to Follow-up|7|||
127513091|NCT00391391|458840214|FG003|Overall Study|Lost to Follow-up|4|||
127513092|NCT00391391|458840211|FG000|Overall Study|Protocol Violation|2|||
127513093|NCT00391391|458840212|FG001|Overall Study|Protocol Violation|3|||
127513094|NCT00391391|458840213|FG002|Overall Study|Protocol Violation|6|||
127513095|NCT00391391|458840214|FG003|Overall Study|Protocol Violation|7|||
127513096|NCT00391391|458840211|FG000|Overall Study|Withdrawal by Subject|6|||
127513097|NCT00391391|458840212|FG001|Overall Study|Withdrawal by Subject|4|||
127513098|NCT00391391|458840213|FG002|Overall Study|Withdrawal by Subject|10|||
127513099|NCT00391391|458840214|FG003|Overall Study|Withdrawal by Subject|7|||
127513100|NCT01920152|458840215|FG000|Overall Study|Withdrawal by Subject|1|||
127513101|NCT01920152|458840216|FG001|Overall Study|Withdrawal by Subject|2|||
127513102|NCT04375397|458840219|FG000|Overall Study|Death|1|||
127513103|NCT04375397|458840220|FG001|Overall Study|Death|1|||
127513104|NCT04375397|458840219|FG000|Overall Study|Withdrew consent|2|||
127513105|NCT04375397|458840220|FG001|Overall Study|Withdrew consent|0|||
127513106|NCT04375397|458840219|FG000|Overall Study|Lost to Follow-up|6|||
127513107|NCT04375397|458840220|FG001|Overall Study|Lost to Follow-up|4|||
127513108|NCT04375397|458840219|FG000|Overall Study|Other, not specified|0|||
127513109|NCT04375397|458840220|FG001|Overall Study|Other, not specified|1|||
127513110|NCT00610441|458840224|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
127513111|NCT00610441|458840225|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
127513112|NCT00610441|458840226|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
127513113|NCT00610441|458840227|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
127513114|NCT00610441|458840224|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
127513115|NCT00610441|458840225|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
127513116|NCT00610441|458840226|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
127513117|NCT00610441|458840227|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
127513118|NCT00610441|458840224|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
127513119|NCT00610441|458840225|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
127513120|NCT00610441|458840226|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
127513121|NCT00610441|458840227|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
127513122|NCT00610441|458840224|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
127513123|NCT00610441|458840225|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
127513124|NCT00610441|458840226|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
127513125|NCT00610441|458840227|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
127513126|NCT00610441|458840224|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
127513127|NCT00610441|458840225|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
127513128|NCT00610441|458840226|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
127513129|NCT00610441|458840227|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
127513130|NCT00610441|458840224|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
127513131|NCT00610441|458840225|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
127513132|NCT00610441|458840226|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
127513133|NCT00610441|458840227|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
127513134|NCT00610441|458840224|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
127513135|NCT00610441|458840225|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
127513136|NCT00610441|458840226|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
127513137|NCT00610441|458840227|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
127513138|NCT00610441|458840224|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
127513139|NCT00610441|458840225|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
127513140|NCT00610441|458840226|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
127513141|NCT00610441|458840227|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
127513142|NCT00610441|458840224|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
127513143|NCT00610441|458840225|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
127513144|NCT00610441|458840226|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
127513145|NCT00610441|458840227|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
127513146|NCT00554099|458840228|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
127513147|NCT00554099|458840229|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
127513148|NCT00554099|458840230|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
127513149|NCT00554099|458840228|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
127513150|NCT00554099|458840229|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
127513151|NCT00554099|458840230|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
127513152|NCT00554099|458840228|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
127513153|NCT00554099|458840229|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
127513154|NCT00554099|458840230|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
127513155|NCT00554099|458840228|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
127513156|NCT00554099|458840229|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
127513157|NCT00554099|458840230|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
127513158|NCT00554099|458840228|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
127513159|NCT00554099|458840229|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
127513160|NCT00554099|458840230|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
127513161|NCT00554099|458840228|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
127513162|NCT00554099|458840229|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
127513163|NCT00554099|458840230|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
127513164|NCT00554099|458840228|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
127513165|NCT00554099|458840229|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
127513166|NCT00554099|458840230|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
127979780|NCT02278120|460547644|FG001|Post-treatment Efficacy Follow-up|Death|1|||
127979781|NCT02278120|460547643|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
127513167|NCT00554099|458840228|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
127513168|NCT00554099|458840229|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
127513169|NCT00554099|458840230|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
127513170|NCT00554099|458840228|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
127513171|NCT00554099|458840229|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
127513172|NCT00554099|458840230|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
127513173|NCT01011933|458840231|FG000|Overall Study|Wrong cell type|1|||
127513174|NCT01011933|458840231|FG000|Overall Study|Improper pre-protocol Rx|1|||
127513175|NCT01011933|458840231|FG000|Overall Study|Inadequate pathology|1|||
127513176|NCT01011933|458840231|FG000|Overall Study|Never treated|1|||
127513177|NCT01439074|458840232|FG000|Overall Study|Lost to Follow-up|3|||
127513178|NCT01439074|458840233|FG001|Overall Study|Lost to Follow-up|4|||
127513179|NCT01439074|458840232|FG000|Overall Study|Subject shedding|1|||
127513180|NCT01439074|458840233|FG001|Overall Study|Subject shedding|0|||
127979782|NCT02278120|460547644|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
127979783|NCT02278120|460547643|FG000|Post-treatment Efficacy Follow-up|Study terminated as per protocol|8|||
127513181|NCT01439074|458840232|FG000|Overall Study|Withdrawal by Subject|1|||
127513182|NCT01439074|458840233|FG001|Overall Study|Withdrawal by Subject|5|||
127513183|NCT01439074|458840232|FG000|Overall Study|Other|4|||
127513184|NCT01439074|458840233|FG001|Overall Study|Other|4|||
127513185|NCT02639338|458840234|FG000|Overall Study|Lost to Follow-up|2|||
127513186|NCT02639338|458840235|FG001|Overall Study|Lost to Follow-up|2|||
127513187|NCT02639338|458840234|FG000|Overall Study|Withdrew Consent|1|||
127513188|NCT02639338|458840235|FG001|Overall Study|Withdrew Consent|2|||
127513189|NCT02639338|458840234|FG000|Overall Study|Death|1|||
127513190|NCT02639338|458840235|FG001|Overall Study|Death|0|||
127513191|NCT02639338|458840234|FG000|Overall Study|Randomized but Not Treated|0|||
127513192|NCT02639338|458840235|FG001|Overall Study|Randomized but Not Treated|1|||
127513193|NCT00612508|458840236|FG000|Overall Study|Withdrawal by Subject|3|||
127513194|NCT00612508|458840237|FG001|Overall Study|Withdrawal by Subject|4|||
127513195|NCT02012686|458840238|FG000|Overall Study|muscle contraction|0|||
127513196|NCT02012686|458840239|FG001|Overall Study|muscle contraction|1|||
127513197|NCT02012686|458840238|FG000|Overall Study|electrocardiography monitoring noise|0|||
127513198|NCT02012686|458840239|FG001|Overall Study|electrocardiography monitoring noise|1|||
127513199|NCT02008357|458840240|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
127513200|NCT02008357|458840241|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
127513201|NCT02008357|458840240|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
127513202|NCT02008357|458840241|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
127513203|NCT02008357|458840240|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
127513204|NCT02008357|458840241|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
127513205|NCT02008357|458840240|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
127513206|NCT02008357|458840241|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
127513207|NCT02008357|458840240|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
127513208|NCT02008357|458840241|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
127513209|NCT02008357|458840240|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
127513210|NCT02008357|458840241|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
127513211|NCT02008357|458840240|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
127513212|NCT02008357|458840241|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
127513213|NCT02008357|458840240|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
127513214|NCT02008357|458840241|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
127513215|NCT02008357|458840240|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
127513216|NCT02008357|458840241|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
127513217|NCT02008357|458840240|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
127513218|NCT02008357|458840241|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
127513219|NCT02008357|458840240|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
127513220|NCT02008357|458840241|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
127513221|NCT02008357|458840240|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
127513222|NCT02008357|458840241|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
127513223|NCT02008357|458840240|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
127513224|NCT02008357|458840241|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
127513225|NCT02008357|458840240|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
127513226|NCT02008357|458840241|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
127513227|NCT02008357|458840240|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
127513228|NCT02008357|458840241|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
127513229|NCT02008357|458840240|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
127513230|NCT02008357|458840241|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
127513231|NCT02008357|458840240|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
127513232|NCT02008357|458840241|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
127513233|NCT02008357|458840240|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
127513234|NCT02008357|458840241|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
127513235|NCT02008357|458840240|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
127513236|NCT02008357|458840241|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
127513237|NCT02008357|458840240|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
127513238|NCT02008357|458840241|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
127513239|NCT02008357|458840240|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
127513240|NCT02008357|458840241|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
127513241|NCT02008357|458840240|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
127513242|NCT02008357|458840241|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
127513243|NCT02008357|458840240|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
127513244|NCT02008357|458840241|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
127513245|NCT02008357|458840240|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
127513246|NCT02008357|458840241|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
127513247|NCT02008357|458840240|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
127513248|NCT02008357|458840241|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
127513249|NCT02008357|458840240|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
127513250|NCT02008357|458840241|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
127513251|NCT02008357|458840240|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
127513252|NCT02008357|458840241|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
127513253|NCT02008357|458840240|FG000|Open-label Extension Period|Adverse Event|8|||
127513254|NCT02008357|458840241|FG001|Open-label Extension Period|Adverse Event|7|||
127513255|NCT02008357|458840240|FG000|Open-label Extension Period|Death|7|||
127513256|NCT02008357|458840241|FG001|Open-label Extension Period|Death|4|||
127513257|NCT02008357|458840240|FG000|Open-label Extension Period|Lack of Efficacy|9|||
127513258|NCT02008357|458840241|FG001|Open-label Extension Period|Lack of Efficacy|5|||
127513259|NCT02008357|458840240|FG000|Open-label Extension Period|Lost to Follow-up|2|||
127513260|NCT02008357|458840241|FG001|Open-label Extension Period|Lost to Follow-up|2|||
127513261|NCT02008357|458840240|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
127513262|NCT02008357|458840241|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
127513263|NCT02008357|458840240|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
127513264|NCT02008357|458840241|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
127513265|NCT02008357|458840240|FG000|Open-label Extension Period|Safety Risk|2|||
127513266|NCT02008357|458840241|FG001|Open-label Extension Period|Safety Risk|1|||
127513267|NCT02008357|458840240|FG000|Open-label Extension Period|Non-Compliance|0|||
127513268|NCT02008357|458840241|FG001|Open-label Extension Period|Non-Compliance|1|||
127513269|NCT02008357|458840240|FG000|Open-label Extension Period|Investigator Recommendation|0|||
127513270|NCT02008357|458840241|FG001|Open-label Extension Period|Investigator Recommendation|1|||
127513271|NCT02008357|458840240|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
127513272|NCT02008357|458840241|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
127513273|NCT02008357|458840240|FG000|Open-label Extension Period|Coordinating Center Request|2|||
127513274|NCT02008357|458840241|FG001|Open-label Extension Period|Coordinating Center Request|4|||
127513275|NCT02008357|458840240|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
127513276|NCT02008357|458840241|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
127513277|NCT02008357|458840240|FG000|Open-label Extension Period|Study Ended|20|||
127513278|NCT02008357|458840241|FG001|Open-label Extension Period|Study Ended|25|||
127513279|NCT02008357|458840240|FG000|Open-label Extension Period|Personal Reasons|0|||
127513280|NCT02008357|458840241|FG001|Open-label Extension Period|Personal Reasons|1|||
127513281|NCT02008357|458840240|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
127513282|NCT02008357|458840241|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
127513283|NCT02008357|458840240|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
127513284|NCT02008357|458840241|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
127513285|NCT02008357|458840240|FG000|Open-label Extension Period|Other|2|||
127513286|NCT02008357|458840241|FG001|Open-label Extension Period|Other|0|||
127513287|NCT00787202|458840242|FG000|Overall Study|Adverse Event|3|||
127513288|NCT00787202|458840243|FG001|Overall Study|Adverse Event|2|||
127513289|NCT00787202|458840244|FG002|Overall Study|Adverse Event|0|||
127513290|NCT00787202|458840245|FG003|Overall Study|Adverse Event|0|||
127513291|NCT00787202|458840246|FG004|Overall Study|Adverse Event|2|||
127513292|NCT00787202|458840242|FG000|Overall Study|Lack of Efficacy|5|||
127513293|NCT00787202|458840243|FG001|Overall Study|Lack of Efficacy|6|||
127513294|NCT00787202|458840244|FG002|Overall Study|Lack of Efficacy|5|||
127513295|NCT00787202|458840245|FG003|Overall Study|Lack of Efficacy|2|||
127513296|NCT00787202|458840246|FG004|Overall Study|Lack of Efficacy|1|||
127513297|NCT00787202|458840242|FG000|Overall Study|Lost to Follow-up|1|||
127513298|NCT00787202|458840243|FG001|Overall Study|Lost to Follow-up|0|||
127513299|NCT00787202|458840244|FG002|Overall Study|Lost to Follow-up|0|||
127513300|NCT00787202|458840245|FG003|Overall Study|Lost to Follow-up|0|||
127513301|NCT00787202|458840246|FG004|Overall Study|Lost to Follow-up|0|||
127513302|NCT00787202|458840242|FG000|Overall Study|Withdrawal by Subject|2|||
127979784|NCT02278120|460547644|FG001|Post-treatment Efficacy Follow-up|Study terminated as per protocol|3|||
127513303|NCT00787202|458840243|FG001|Overall Study|Withdrawal by Subject|2|||
127513304|NCT00787202|458840244|FG002|Overall Study|Withdrawal by Subject|2|||
127513305|NCT00787202|458840245|FG003|Overall Study|Withdrawal by Subject|0|||
127513306|NCT00787202|458840246|FG004|Overall Study|Withdrawal by Subject|0|||
127513307|NCT00787202|458840242|FG000|Overall Study|Protocol Violation|2|||
127513308|NCT00787202|458840243|FG001|Overall Study|Protocol Violation|1|||
127513309|NCT00787202|458840244|FG002|Overall Study|Protocol Violation|0|||
127513310|NCT00787202|458840245|FG003|Overall Study|Protocol Violation|0|||
127513311|NCT00787202|458840246|FG004|Overall Study|Protocol Violation|1|||
127979785|NCT02278120|460547643|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
127513312|NCT00787202|458840242|FG000|Overall Study|Randomized, not treated|1|||
127513313|NCT00787202|458840243|FG001|Overall Study|Randomized, not treated|0|||
127513314|NCT00787202|458840244|FG002|Overall Study|Randomized, not treated|0|||
127513315|NCT00787202|458840245|FG003|Overall Study|Randomized, not treated|0|||
127513316|NCT00787202|458840246|FG004|Overall Study|Randomized, not treated|0|||
127513317|NCT01442064|458840247|FG000|Overall Study|Adverse Event|2|||
127513318|NCT01442064|458840248|FG001|Overall Study|Adverse Event|2|||
127513319|NCT01442064|458840249|FG002|Overall Study|Adverse Event|2|||
127513320|NCT01442064|458840250|FG003|Overall Study|Adverse Event|1|||
127513321|NCT01442064|458840251|FG004|Overall Study|Adverse Event|2|||
127513322|NCT01442064|458840252|FG005|Overall Study|Adverse Event|0|||
127513323|NCT01442064|458840247|FG000|Overall Study|Death|0|||
127513324|NCT01442064|458840248|FG001|Overall Study|Death|1|||
127513325|NCT01442064|458840249|FG002|Overall Study|Death|3|||
127513326|NCT01442064|458840250|FG003|Overall Study|Death|3|||
127513327|NCT01442064|458840251|FG004|Overall Study|Death|1|||
127513328|NCT01442064|458840252|FG005|Overall Study|Death|3|||
127513329|NCT01442064|458840247|FG000|Overall Study|Lost to Follow-up|5|||
127513330|NCT01442064|458840248|FG001|Overall Study|Lost to Follow-up|5|||
127513331|NCT01442064|458840249|FG002|Overall Study|Lost to Follow-up|1|||
127513332|NCT01442064|458840250|FG003|Overall Study|Lost to Follow-up|1|||
127513333|NCT01442064|458840251|FG004|Overall Study|Lost to Follow-up|3|||
127513334|NCT01442064|458840252|FG005|Overall Study|Lost to Follow-up|3|||
127513335|NCT01442064|458840247|FG000|Overall Study|Physician Decision|1|||
127513336|NCT01442064|458840248|FG001|Overall Study|Physician Decision|1|||
127513337|NCT01442064|458840249|FG002|Overall Study|Physician Decision|2|||
127513338|NCT01442064|458840250|FG003|Overall Study|Physician Decision|3|||
127513339|NCT01442064|458840251|FG004|Overall Study|Physician Decision|3|||
127513340|NCT01442064|458840252|FG005|Overall Study|Physician Decision|1|||
127513341|NCT01442064|458840247|FG000|Overall Study|Withdrawal by Subject|6|||
127513342|NCT01442064|458840248|FG001|Overall Study|Withdrawal by Subject|3|||
127513343|NCT01442064|458840249|FG002|Overall Study|Withdrawal by Subject|2|||
127513344|NCT01442064|458840250|FG003|Overall Study|Withdrawal by Subject|2|||
127513345|NCT01442064|458840251|FG004|Overall Study|Withdrawal by Subject|2|||
127513346|NCT01442064|458840252|FG005|Overall Study|Withdrawal by Subject|1|||
127513347|NCT01442064|458840247|FG000|Overall Study|Sponsor decision|82|||
127513348|NCT01442064|458840248|FG001|Overall Study|Sponsor decision|88|||
127513349|NCT01442064|458840249|FG002|Overall Study|Sponsor decision|92|||
127513350|NCT01442064|458840250|FG003|Overall Study|Sponsor decision|88|||
127513351|NCT01442064|458840251|FG004|Overall Study|Sponsor decision|95|||
127513352|NCT01442064|458840252|FG005|Overall Study|Sponsor decision|87|||
127513353|NCT01442064|458840247|FG000|Overall Study|Subject non-compliance|0|||
127513354|NCT01442064|458840248|FG001|Overall Study|Subject non-compliance|0|||
127513355|NCT01442064|458840249|FG002|Overall Study|Subject non-compliance|0|||
127513356|NCT01442064|458840250|FG003|Overall Study|Subject non-compliance|0|||
127513357|NCT01442064|458840251|FG004|Overall Study|Subject non-compliance|0|||
127513358|NCT01442064|458840252|FG005|Overall Study|Subject non-compliance|2|||
127513359|NCT01442064|458840247|FG000|Overall Study|Condition mandated other intervention|1|||
127513360|NCT01442064|458840248|FG001|Overall Study|Condition mandated other intervention|1|||
127513361|NCT01442064|458840249|FG002|Overall Study|Condition mandated other intervention|2|||
127513362|NCT01442064|458840250|FG003|Overall Study|Condition mandated other intervention|0|||
127513363|NCT01442064|458840251|FG004|Overall Study|Condition mandated other intervention|0|||
127513364|NCT01442064|458840252|FG005|Overall Study|Condition mandated other intervention|2|||
127513365|NCT00514020|458840255|FG000|Overall Study|Adverse Event|6|||
127513366|NCT00514020|458840255|FG000|Overall Study|Withdrawal by Subject|3|||
127513367|NCT00514020|458840255|FG000|Overall Study|Physician Decision|1|||
127513368|NCT00514020|458840255|FG000|Overall Study|disease progression|9|||
127513369|NCT00514020|458840255|FG000|Overall Study|other complicating disease|2|||
127513370|NCT00514020|458840255|FG000|Overall Study|patient went to radiation treatment|1|||
127513371|NCT00514020|458840255|FG000|Overall Study|"patients moved to the no tx group"|6|||
127513372|NCT01688921|458840256|FG000|Overall Study|Lost to Follow-up|7|||
127513373|NCT01688921|458840257|FG001|Overall Study|Lost to Follow-up|13|||
127513374|NCT01688921|458840256|FG000|Overall Study|Physician Decision|6|||
127513375|NCT01688921|458840257|FG001|Overall Study|Physician Decision|1|||
127513376|NCT01688921|458840256|FG000|Overall Study|Protocol Violation|0|||
127513377|NCT01688921|458840257|FG001|Overall Study|Protocol Violation|1|||
127513378|NCT01688921|458840256|FG000|Overall Study|informed consent|3|||
127513379|NCT01688921|458840257|FG001|Overall Study|informed consent|0|||
127513380|NCT00969436|458840259|FG000|Overall Study|Protocol Violation|1|||
127513381|NCT00969436|458840260|FG001|Overall Study|Protocol Violation|3|||
127513382|NCT00969436|458840261|FG002|Overall Study|Protocol Violation|0|||
127513383|NCT00969436|458840259|FG000|Overall Study|Migrated/moved from study area|12|||
127513384|NCT00969436|458840260|FG001|Overall Study|Migrated/moved from study area|10|||
127513385|NCT00969436|458840261|FG002|Overall Study|Migrated/moved from study area|2|||
127513386|NCT00969436|458840259|FG000|Overall Study|Father - serious health problem|0|||
127513387|NCT00969436|458840260|FG001|Overall Study|Father - serious health problem|0|||
127513388|NCT00969436|458840261|FG002|Overall Study|Father - serious health problem|1|||
127513389|NCT00969436|458840259|FG000|Overall Study|Parents personal problem|0|||
127513390|NCT00969436|458840260|FG001|Overall Study|Parents personal problem|0|||
127513391|NCT00969436|458840261|FG002|Overall Study|Parents personal problem|1|||
127513392|NCT00969436|458840259|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
127513393|NCT00969436|458840260|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
127513394|NCT00969436|458840261|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
127513395|NCT00969436|458840259|FG000|Overall Study|Withdrawal by Subject|3|||
127513396|NCT00969436|458840260|FG001|Overall Study|Withdrawal by Subject|0|||
127513397|NCT00969436|458840261|FG002|Overall Study|Withdrawal by Subject|2|||
127513398|NCT00969436|458840259|FG000|Overall Study|Lost to Follow-up|8|||
127513399|NCT00969436|458840260|FG001|Overall Study|Lost to Follow-up|8|||
127513400|NCT00969436|458840261|FG002|Overall Study|Lost to Follow-up|5|||
127513401|NCT00831701|458840266|FG000|Overall Study|Withdrawal by Subject|2|||
127513402|NCT00831701|458840267|FG001|Overall Study|Withdrawal by Subject|0|||
127513403|NCT00831701|458840266|FG000|Overall Study|Stone expulsion before first medication|2|||
127513404|NCT00831701|458840267|FG001|Overall Study|Stone expulsion before first medication|2|||
127513405|NCT00831701|458840266|FG000|Overall Study|Lost to Follow-up|1|||
127513406|NCT00831701|458840267|FG001|Overall Study|Lost to Follow-up|3|||
127513407|NCT00459537|458840273|FG000|Overall Study|Adverse Event|1|||
127513408|NCT00459537|458840274|FG001|Overall Study|Adverse Event|6|||
127513409|NCT00459537|458840273|FG000|Overall Study|Lack of Efficacy|10|||
127513410|NCT00459537|458840274|FG001|Overall Study|Lack of Efficacy|11|||
127513411|NCT00459537|458840273|FG000|Overall Study|Withdrawal by Subject|20|||
127513412|NCT00459537|458840274|FG001|Overall Study|Withdrawal by Subject|26|||
127513413|NCT00459537|458840273|FG000|Overall Study|Lost to Follow-up|27|||
127513414|NCT00459537|458840274|FG001|Overall Study|Lost to Follow-up|30|||
127513415|NCT00459537|458840273|FG000|Overall Study|Administrative problems|3|||
127513416|NCT00459537|458840274|FG001|Overall Study|Administrative problems|0|||
127513417|NCT00459537|458840273|FG000|Overall Study|Protocol Violation|4|||
127513418|NCT00459537|458840274|FG001|Overall Study|Protocol Violation|3|||
127513419|NCT00459537|458840273|FG000|Overall Study|Missing|1|||
127513420|NCT00459537|458840274|FG001|Overall Study|Missing|0|||
127513421|NCT03159104|458840275|FG000|Overall Study|Violation of inclusion criteria|1|||
127513422|NCT03159104|458840276|FG001|Overall Study|Violation of inclusion criteria|2|||
127513423|NCT00456599|458840277|FG000|Overall Study|Non-compliance|1|||
127513424|NCT00456599|458840277|FG000|Overall Study|Withdrawal by Subject|2|||
127513425|NCT01999218|458840278|FG000|Overall Study|Hyperglycemia|18|||
127513426|NCT01999218|458840279|FG001|Overall Study|Hyperglycemia|17|||
127513427|NCT01999218|458840280|FG002|Overall Study|Hyperglycemia|17|||
127513428|NCT01999218|458840278|FG000|Overall Study|Lack of Efficacy|1|||
127513429|NCT01999218|458840279|FG001|Overall Study|Lack of Efficacy|0|||
127513430|NCT01999218|458840280|FG002|Overall Study|Lack of Efficacy|1|||
127513431|NCT01999218|458840278|FG000|Overall Study|Lost to Follow-up|22|||
127513432|NCT01999218|458840279|FG001|Overall Study|Lost to Follow-up|17|||
127513433|NCT01999218|458840280|FG002|Overall Study|Lost to Follow-up|18|||
127513434|NCT01999218|458840278|FG000|Overall Study|Non-Compliance With Study Drug|6|||
127513435|NCT01999218|458840279|FG001|Overall Study|Non-Compliance With Study Drug|4|||
127513436|NCT01999218|458840280|FG002|Overall Study|Non-Compliance With Study Drug|1|||
127513437|NCT01999218|458840278|FG000|Overall Study|Physician Decision|1|||
127513438|NCT01999218|458840279|FG001|Overall Study|Physician Decision|4|||
127513439|NCT01999218|458840280|FG002|Overall Study|Physician Decision|6|||
127513440|NCT01999218|458840278|FG000|Overall Study|Protocol Violation|4|||
127513441|NCT01999218|458840279|FG001|Overall Study|Protocol Violation|5|||
127513442|NCT01999218|458840280|FG002|Overall Study|Protocol Violation|4|||
127513443|NCT01999218|458840278|FG000|Overall Study|Screen failure|0|||
127513444|NCT01999218|458840279|FG001|Overall Study|Screen failure|1|||
127513445|NCT01999218|458840280|FG002|Overall Study|Screen failure|0|||
127513446|NCT01999218|458840278|FG000|Overall Study|Study Terminated By Sponsor|7|||
127513447|NCT01999218|458840279|FG001|Overall Study|Study Terminated By Sponsor|5|||
127513448|NCT01999218|458840280|FG002|Overall Study|Study Terminated By Sponsor|12|||
127513449|NCT01999218|458840278|FG000|Overall Study|Participant moves|2|||
127513450|NCT01999218|458840279|FG001|Overall Study|Participant moves|5|||
127513451|NCT01999218|458840280|FG002|Overall Study|Participant moves|3|||
127513452|NCT01999218|458840278|FG000|Overall Study|Withdrawal by Subject|28|||
127513453|NCT01999218|458840279|FG001|Overall Study|Withdrawal by Subject|29|||
127513454|NCT01999218|458840280|FG002|Overall Study|Withdrawal by Subject|34|||
127513455|NCT01999218|458840278|FG000|Overall Study|Creatinine/eGFR|0|||
127513456|NCT01999218|458840279|FG001|Overall Study|Creatinine/eGFR|0|||
127513457|NCT01999218|458840280|FG002|Overall Study|Creatinine/eGFR|1|||
127513458|NCT01999218|458840278|FG000|Overall Study|Death|7|||
127513459|NCT01999218|458840279|FG001|Overall Study|Death|1|||
127513460|NCT01999218|458840280|FG002|Overall Study|Death|2|||
127513461|NCT01999218|458840278|FG000|Overall Study|Excluded Medication|1|||
127513462|NCT01999218|458840279|FG001|Overall Study|Excluded Medication|1|||
127513463|NCT01999218|458840280|FG002|Overall Study|Excluded Medication|2|||
127513464|NCT01999218|458840278|FG000|Overall Study|Adverse Event|9|||
127513465|NCT01999218|458840279|FG001|Overall Study|Adverse Event|7|||
127513466|NCT01999218|458840280|FG002|Overall Study|Adverse Event|7|||
127513467|NCT01999218|458840278|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
127513468|NCT01999218|458840279|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
127513469|NCT01999218|458840280|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
127513470|NCT00734071|458842000|FG000|Overall Study|Adverse Event|4|||
127513471|NCT00734071|458842001|FG001|Overall Study|Adverse Event|3|||
127513472|NCT00734071|458842000|FG000|Overall Study|Lack of Efficacy|3|||
127513473|NCT00734071|458842001|FG001|Overall Study|Lack of Efficacy|1|||
127513474|NCT00734071|458842000|FG000|Overall Study|Noncompliance|2|||
127513475|NCT00734071|458842001|FG001|Overall Study|Noncompliance|2|||
127513476|NCT00734071|458842000|FG000|Overall Study|Protocol Deviations|3|||
127513477|NCT00734071|458842001|FG001|Overall Study|Protocol Deviations|4|||
127513478|NCT00734071|458842000|FG000|Overall Study|Voluntary Withdrawal|9|||
127513479|NCT00734071|458842001|FG001|Overall Study|Voluntary Withdrawal|7|||
127513480|NCT00734071|458842000|FG000|Overall Study|Lost to Follow-up|16|||
127513481|NCT00734071|458842001|FG001|Overall Study|Lost to Follow-up|8|||
127513482|NCT00734071|458842000|FG000|Overall Study|Other|1|||
127513483|NCT00734071|458842001|FG001|Overall Study|Other|2|||
127513484|NCT00151372|458842002|FG000|Overall Study|Death|12|||
127513485|NCT00151372|458842003|FG001|Overall Study|Death|11|||
127513486|NCT00151372|458842002|FG000|Overall Study|Lost to Follow-up|5|||
127513487|NCT00151372|458842003|FG001|Overall Study|Lost to Follow-up|5|||
127513488|NCT00151372|458842002|FG000|Overall Study|Too sick medically to continue|5|||
127513489|NCT00151372|458842003|FG001|Overall Study|Too sick medically to continue|6|||
127513490|NCT00151372|458842002|FG000|Overall Study|Withdrawal by Subject|7|||
127513491|NCT00151372|458842003|FG001|Overall Study|Withdrawal by Subject|7|||
127513492|NCT00541346|458842004|FG000|Follow-up|Adverse Event|1|||
127513493|NCT04732949|458842005|FG000|Overall Study|Withdrawal by Subject|23|||
127513494|NCT04732949|458842006|FG001|Overall Study|Withdrawal by Subject|27|||
127513495|NCT04732949|458842005|FG000|Overall Study|Protocol Violation|0|||
127513496|NCT04732949|458842006|FG001|Overall Study|Protocol Violation|1|||
127513497|NCT04732949|458842005|FG000|Overall Study|Non-compliance|0|||
127513498|NCT04732949|458842006|FG001|Overall Study|Non-compliance|2|||
127513499|NCT04732949|458842005|FG000|Overall Study|Physician Decision|2|||
127513500|NCT04732949|458842006|FG001|Overall Study|Physician Decision|1|||
127513501|NCT04732949|458842005|FG000|Overall Study|Serious adverse event (Fatal)|16|||
127513502|NCT04732949|458842006|FG001|Overall Study|Serious adverse event (Fatal)|18|||
127513503|NCT04732949|458842005|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
127513504|NCT04732949|458842006|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
127513505|NCT04732949|458842005|FG000|Overall Study|Non-serious adverse event|1|||
127513506|NCT04732949|458842006|FG001|Overall Study|Non-serious adverse event|3|||
127513507|NCT04732949|458842005|FG000|Overall Study|Lost to Follow-up|26|||
127513508|NCT04732949|458842006|FG001|Overall Study|Lost to Follow-up|27|||
127513509|NCT04732949|458842005|FG000|Overall Study|Other|6|||
127513510|NCT04732949|458842006|FG001|Overall Study|Other|3|||
127513511|NCT02853435|458842009|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
127513512|NCT02853435|458842010|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
127513513|NCT02853435|458842011|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
127513514|NCT02853435|458842012|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
127513515|NCT02853435|458842013|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
127513516|NCT02853435|458842014|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
127513517|NCT03747120|458842015|FG000|Overall Study|treatment related toxicity|3|||
127513518|NCT03747120|458842016|FG001|Overall Study|treatment related toxicity|0|||
127513519|NCT03747120|458842017|FG002|Overall Study|treatment related toxicity|0|||
127513520|NCT03747120|458842015|FG000|Overall Study|Withdrawal by Subject|0|||
127513521|NCT03747120|458842016|FG001|Overall Study|Withdrawal by Subject|1|||
127513522|NCT03747120|458842017|FG002|Overall Study|Withdrawal by Subject|2|||
127513523|NCT00996801|458842018|FG000|Overall Study|Adverse Event|6|||
127513524|NCT00996801|458842019|FG001|Overall Study|Adverse Event|4|||
127513525|NCT00996801|458842020|FG002|Overall Study|Adverse Event|12|||
127513526|NCT00996801|458842021|FG003|Overall Study|Adverse Event|17|||
127513527|NCT00996801|458842022|FG004|Overall Study|Adverse Event|31|||
127513528|NCT00996801|458842023|FG005|Overall Study|Adverse Event|3|||
127513529|NCT00996801|458842018|FG000|Overall Study|Lack of Efficacy|3|||
127513530|NCT00996801|458842019|FG001|Overall Study|Lack of Efficacy|0|||
127513531|NCT00996801|458842020|FG002|Overall Study|Lack of Efficacy|1|||
127513532|NCT00996801|458842021|FG003|Overall Study|Lack of Efficacy|3|||
127513533|NCT00996801|458842022|FG004|Overall Study|Lack of Efficacy|0|||
127513534|NCT00996801|458842023|FG005|Overall Study|Lack of Efficacy|1|||
127513535|NCT00996801|458842018|FG000|Overall Study|Lost to Follow-up|0|||
127513536|NCT00996801|458842019|FG001|Overall Study|Lost to Follow-up|0|||
127513537|NCT00996801|458842020|FG002|Overall Study|Lost to Follow-up|0|||
127513538|NCT00996801|458842021|FG003|Overall Study|Lost to Follow-up|3|||
127513539|NCT00996801|458842022|FG004|Overall Study|Lost to Follow-up|3|||
127513540|NCT00996801|458842023|FG005|Overall Study|Lost to Follow-up|2|||
127513541|NCT00996801|458842018|FG000|Overall Study|Physician Decision|0|||
127513542|NCT00996801|458842019|FG001|Overall Study|Physician Decision|0|||
127513543|NCT00996801|458842020|FG002|Overall Study|Physician Decision|0|||
127513544|NCT00996801|458842021|FG003|Overall Study|Physician Decision|1|||
127513545|NCT00996801|458842022|FG004|Overall Study|Physician Decision|0|||
127513546|NCT00996801|458842023|FG005|Overall Study|Physician Decision|0|||
127513547|NCT00996801|458842018|FG000|Overall Study|Progressive Disease|0|||
127513548|NCT00996801|458842019|FG001|Overall Study|Progressive Disease|1|||
127513549|NCT00996801|458842020|FG002|Overall Study|Progressive Disease|0|||
127513550|NCT00996801|458842021|FG003|Overall Study|Progressive Disease|0|||
127513551|NCT00996801|458842022|FG004|Overall Study|Progressive Disease|0|||
127513552|NCT00996801|458842023|FG005|Overall Study|Progressive Disease|0|||
127513553|NCT00996801|458842018|FG000|Overall Study|Protocol Violation|3|||
127513554|NCT00996801|458842019|FG001|Overall Study|Protocol Violation|4|||
127513555|NCT00996801|458842020|FG002|Overall Study|Protocol Violation|1|||
127513556|NCT00996801|458842021|FG003|Overall Study|Protocol Violation|2|||
127513557|NCT00996801|458842022|FG004|Overall Study|Protocol Violation|3|||
127513558|NCT00996801|458842023|FG005|Overall Study|Protocol Violation|4|||
127513559|NCT00996801|458842018|FG000|Overall Study|Study Terminated by Sponsor|0|||
127513560|NCT00996801|458842019|FG001|Overall Study|Study Terminated by Sponsor|1|||
127513561|NCT00996801|458842020|FG002|Overall Study|Study Terminated by Sponsor|0|||
127513562|NCT00996801|458842021|FG003|Overall Study|Study Terminated by Sponsor|0|||
127513563|NCT00996801|458842022|FG004|Overall Study|Study Terminated by Sponsor|46|||
127513564|NCT00996801|458842023|FG005|Overall Study|Study Terminated by Sponsor|0|||
127513565|NCT00996801|458842018|FG000|Overall Study|Withdrawal by Subject|8|||
127513566|NCT00996801|458842019|FG001|Overall Study|Withdrawal by Subject|6|||
127513567|NCT00996801|458842020|FG002|Overall Study|Withdrawal by Subject|9|||
127513568|NCT00996801|458842021|FG003|Overall Study|Withdrawal by Subject|5|||
127513569|NCT00996801|458842022|FG004|Overall Study|Withdrawal by Subject|5|||
127513570|NCT00996801|458842023|FG005|Overall Study|Withdrawal by Subject|9|||
127513571|NCT02804750|458842025|FG000|Period 1|Adverse Event|0|||
127513572|NCT02804750|458842026|FG001|Period 1|Adverse Event|2|||
127513573|NCT02804750|458842025|FG000|Period 1|Withdrawal by Subject|0|||
127513574|NCT02804750|458842026|FG001|Period 1|Withdrawal by Subject|1|||
127513575|NCT02804750|458842025|FG000|Period 2|Adverse Event|1|||
127513576|NCT02804750|458842026|FG001|Period 2|Adverse Event|0|||
127513577|NCT02804750|458842025|FG000|Period 3|Adverse Event|0|||
127513578|NCT02804750|458842026|FG001|Period 3|Adverse Event|2|||
127513579|NCT02804750|458842025|FG000|Period 4|Adverse Event|0|||
127513580|NCT02804750|458842026|FG001|Period 4|Adverse Event|5|||
127513581|NCT03369431|458842028|FG000|Overall Study|Lost to Follow-up|1|||
127513582|NCT03369431|458842029|FG001|Overall Study|Lost to Follow-up|3|||
127513583|NCT03369431|458842028|FG000|Overall Study|Withdrawal by Subject|2|||
127513584|NCT03369431|458842029|FG001|Overall Study|Withdrawal by Subject|3|||
127513585|NCT03369431|458842028|FG000|Overall Study|Protocol Violation|1|||
127513586|NCT03369431|458842029|FG001|Overall Study|Protocol Violation|1|||
127513587|NCT04271475|458842037|FG000|DB Period: Day 1 up to EODBT|Death|1|||
127513588|NCT04271475|458842038|FG001|DB Period: Day 1 up to EODBT|Death|0|||
127513589|NCT04271475|458842039|FG002|DB Period: Day 1 up to EODBT|Death|0|||
127513590|NCT04271475|458842040|FG003|DB Period: Day 1 up to EODBT|Death|0|||
127513591|NCT04271475|458842037|FG000|DB Period: Day 1 up to EODBT|Physician Decision|8|||
127513592|NCT04271475|458842038|FG001|DB Period: Day 1 up to EODBT|Physician Decision|1|||
127513593|NCT04271475|458842039|FG002|DB Period: Day 1 up to EODBT|Physician Decision|0|||
127513594|NCT04271475|458842040|FG003|DB Period: Day 1 up to EODBT|Physician Decision|0|||
127513595|NCT04271475|458842037|FG000|DB Period: Day 1 up to EODBT|Withdrawal by Subject|5|||
127513596|NCT04271475|458842038|FG001|DB Period: Day 1 up to EODBT|Withdrawal by Subject|4|||
127513597|NCT04271475|458842039|FG002|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
127513598|NCT04271475|458842040|FG003|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
127513599|NCT04271475|458842037|FG000|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|41|||
127513600|NCT04271475|458842038|FG001|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|52|||
127513601|NCT04271475|458842039|FG002|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
127513602|NCT04271475|458842040|FG003|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
127513603|NCT04271475|458842037|FG000|DB Period: Day 1 up to EODBT|Other|8|||
127513604|NCT04271475|458842038|FG001|DB Period: Day 1 up to EODBT|Other|5|||
127513605|NCT04271475|458842039|FG002|DB Period: Day 1 up to EODBT|Other|0|||
127513606|NCT04271475|458842040|FG003|DB Period: Day 1 up to EODBT|Other|0|||
127513607|NCT04271475|458842037|FG000|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
127513608|NCT04271475|458842038|FG001|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
127513609|NCT04271475|458842039|FG002|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|1|||
127513610|NCT04271475|458842040|FG003|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|5|||
127513611|NCT04271475|458842037|FG000|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
127513612|NCT04271475|458842038|FG001|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
127513613|NCT04271475|458842039|FG002|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
127513614|NCT04271475|458842040|FG003|OL Period:Day 1 Upto End of OL Treatment|Other|1|||
127513615|NCT00159913|458842041|FG000|Overall Study|Adverse Event|1|||
127513616|NCT00159913|458842042|FG001|Overall Study|Adverse Event|0|||
127513617|NCT00159913|458842043|FG002|Overall Study|Adverse Event|1|||
127513618|NCT00159913|458842044|FG003|Overall Study|Adverse Event|0|||
127513619|NCT00159913|458842041|FG000|Overall Study|Withdrawal by Subject|0|||
127513620|NCT00159913|458842042|FG001|Overall Study|Withdrawal by Subject|0|||
127513621|NCT00159913|458842043|FG002|Overall Study|Withdrawal by Subject|0|||
127513622|NCT00159913|458842044|FG003|Overall Study|Withdrawal by Subject|1|||
127513623|NCT00159913|458842041|FG000|Overall Study|Lost to Follow-up|0|||
127513624|NCT00159913|458842042|FG001|Overall Study|Lost to Follow-up|0|||
127513625|NCT00159913|458842043|FG002|Overall Study|Lost to Follow-up|0|||
127513626|NCT00159913|458842044|FG003|Overall Study|Lost to Follow-up|1|||
127513627|NCT00159913|458842041|FG000|Overall Study|Protocol Violation|1|||
127513628|NCT00159913|458842042|FG001|Overall Study|Protocol Violation|0|||
127513629|NCT00159913|458842043|FG002|Overall Study|Protocol Violation|1|||
127513630|NCT00159913|458842044|FG003|Overall Study|Protocol Violation|0|||
127513631|NCT00931801|458842047|FG000|Overall Study|Adverse Event|0|||
127513632|NCT00931801|458842048|FG001|Overall Study|Adverse Event|0|||
127513633|NCT00931801|458842049|FG002|Overall Study|Adverse Event|1|||
127513634|NCT00931801|458842047|FG000|Overall Study|Lost to Follow-up|0|||
127513635|NCT00931801|458842048|FG001|Overall Study|Lost to Follow-up|1|||
127513636|NCT00931801|458842049|FG002|Overall Study|Lost to Follow-up|0|||
127513637|NCT00931801|458842047|FG000|Overall Study|Withdrawal by Subject|1|||
127513638|NCT00931801|458842048|FG001|Overall Study|Withdrawal by Subject|0|||
127513639|NCT00931801|458842049|FG002|Overall Study|Withdrawal by Subject|0|||
127513640|NCT00931801|458842047|FG000|Overall Study|Confirmed Virologic Failure|0|||
127513641|NCT00931801|458842048|FG001|Overall Study|Confirmed Virologic Failure|0|||
127513642|NCT00931801|458842049|FG002|Overall Study|Confirmed Virologic Failure|3|||
127513643|NCT01318070|458842050|FG000|Overall Study|Adverse Event|1|||
127513644|NCT01318070|458842051|FG001|Overall Study|Adverse Event|1|||
127513645|NCT01318070|458842052|FG002|Overall Study|Adverse Event|5|||
127513646|NCT01318070|458842050|FG000|Overall Study|Withdrawal by Subject|0|||
127513647|NCT01318070|458842051|FG001|Overall Study|Withdrawal by Subject|1|||
127513648|NCT01318070|458842052|FG002|Overall Study|Withdrawal by Subject|1|||
127513649|NCT01318070|458842050|FG000|Overall Study|Lack of Efficacy|0|||
127513650|NCT01318070|458842051|FG001|Overall Study|Lack of Efficacy|0|||
127513651|NCT01318070|458842052|FG002|Overall Study|Lack of Efficacy|1|||
127513652|NCT01318070|458842050|FG000|Overall Study|Principal Investigator Discretion|1|||
127513653|NCT01318070|458842051|FG001|Overall Study|Principal Investigator Discretion|0|||
127513654|NCT01318070|458842052|FG002|Overall Study|Principal Investigator Discretion|0|||
127513655|NCT01995552|458842055|FG000|Overall Study|Protocol Violation|1|||
127513656|NCT01995552|458842055|FG000|Overall Study|Lack of Efficacy|15|||
127513657|NCT01995552|458842055|FG000|Overall Study|Death|1|||
127513658|NCT00870194|458842058|FG000|Overall Study|Adverse Event|10|||
127513659|NCT00870194|458842059|FG001|Overall Study|Adverse Event|5|||
127513660|NCT00870194|458842058|FG000|Overall Study|Lack of Efficacy|0|||
127513661|NCT00870194|458842059|FG001|Overall Study|Lack of Efficacy|1|||
127513662|NCT00870194|458842058|FG000|Overall Study|Lost to Follow-up|2|||
127513663|NCT00870194|458842059|FG001|Overall Study|Lost to Follow-up|0|||
127513664|NCT00870194|458842058|FG000|Overall Study|Physician Decision|3|||
127513665|NCT00870194|458842059|FG001|Overall Study|Physician Decision|1|||
127513666|NCT00870194|458842058|FG000|Overall Study|Protocol Violation|3|||
127513667|NCT00870194|458842059|FG001|Overall Study|Protocol Violation|3|||
127513668|NCT00870194|458842058|FG000|Overall Study|Entry Criteria Not Met|1|||
127513669|NCT00870194|458842059|FG001|Overall Study|Entry Criteria Not Met|2|||
127513670|NCT00870194|458842058|FG000|Overall Study|Subject Decision|7|||
127513671|NCT00870194|458842059|FG001|Overall Study|Subject Decision|2|||
127513672|NCT02322190|458842060|FG000|Overall Study|Death on study|1|||
127513673|NCT02322190|458842061|FG001|Overall Study|Death on study|0|||
127513674|NCT01685983|458842065|FG000|Overall Study|Adverse Event|7|||
127513675|NCT01685983|458842065|FG000|Overall Study|Death|1|||
127513676|NCT01685983|458842065|FG000|Overall Study|Withdrawal by Subject|19|||
127513677|NCT01685983|458842065|FG000|Overall Study|Protocol Violation|2|||
127513678|NCT01685983|458842065|FG000|Overall Study|Physician Decision|13|||
127513679|NCT01685983|458842065|FG000|Overall Study|Other|7|||
127513680|NCT01685983|458842065|FG000|Overall Study|Progressive Disease|32|||
127513681|NCT01685983|458842065|FG000|Overall Study|Noncompliance with Study Drug|1|||
127513682|NCT01443130|458842066|FG000|Overall Study|Lost to Follow-up|44|||
127513683|NCT01443130|458842067|FG001|Overall Study|Lost to Follow-up|42|||
127513684|NCT01443130|458842068|FG002|Overall Study|Lost to Follow-up|50|||
127513685|NCT01443130|458842069|FG003|Overall Study|Lost to Follow-up|23|||
127513686|NCT01443130|458842070|FG004|Overall Study|Lost to Follow-up|25|||
127513687|NCT01443130|458842071|FG005|Overall Study|Lost to Follow-up|21|||
127513688|NCT01443130|458842066|FG000|Overall Study|Death|0|||
127513689|NCT01443130|458842067|FG001|Overall Study|Death|1|||
127513690|NCT01443130|458842068|FG002|Overall Study|Death|0|||
127513691|NCT01443130|458842069|FG003|Overall Study|Death|7|||
127513692|NCT01443130|458842070|FG004|Overall Study|Death|10|||
127513693|NCT01443130|458842071|FG005|Overall Study|Death|8|||
127513694|NCT01443130|458842066|FG000|Overall Study|Adverse Event|2|||
127513695|NCT01443130|458842067|FG001|Overall Study|Adverse Event|1|||
127513696|NCT01443130|458842068|FG002|Overall Study|Adverse Event|1|||
127513697|NCT01443130|458842069|FG003|Overall Study|Adverse Event|0|||
127513698|NCT01443130|458842070|FG004|Overall Study|Adverse Event|0|||
127513699|NCT01443130|458842071|FG005|Overall Study|Adverse Event|0|||
127513700|NCT01443130|458842066|FG000|Overall Study|Protocol Violation|2|||
127513701|NCT01443130|458842067|FG001|Overall Study|Protocol Violation|1|||
127513702|NCT01443130|458842068|FG002|Overall Study|Protocol Violation|3|||
127513703|NCT01443130|458842069|FG003|Overall Study|Protocol Violation|2|||
127513704|NCT01443130|458842070|FG004|Overall Study|Protocol Violation|2|||
127513705|NCT01443130|458842071|FG005|Overall Study|Protocol Violation|3|||
127513706|NCT01443130|458842066|FG000|Overall Study|Withdrawal by Subject|15|||
127513707|NCT01443130|458842067|FG001|Overall Study|Withdrawal by Subject|14|||
127513708|NCT01443130|458842068|FG002|Overall Study|Withdrawal by Subject|12|||
127513709|NCT01443130|458842069|FG003|Overall Study|Withdrawal by Subject|7|||
127513710|NCT01443130|458842070|FG004|Overall Study|Withdrawal by Subject|7|||
127513711|NCT01443130|458842071|FG005|Overall Study|Withdrawal by Subject|2|||
127513712|NCT01443130|458842066|FG000|Overall Study|Death of Subject's Infant|5|||
127513713|NCT01443130|458842067|FG001|Overall Study|Death of Subject's Infant|10|||
127513714|NCT01443130|458842068|FG002|Overall Study|Death of Subject's Infant|11|||
127513715|NCT01443130|458842069|FG003|Overall Study|Death of Subject's Infant|0|||
127513716|NCT01443130|458842070|FG004|Overall Study|Death of Subject's Infant|0|||
127513717|NCT01443130|458842071|FG005|Overall Study|Death of Subject's Infant|0|||
127513718|NCT01167907|458842073|FG000|Overall Study|Protocol Violation|1|||
127513719|NCT01167907|458842074|FG001|Overall Study|Protocol Violation|0|||
127513720|NCT01167907|458842073|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
127513721|NCT01167907|458842074|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
127513722|NCT03077698|458842075|FG000|Progestin Monotherapy|Stable Disease|8|||
127513723|NCT03077698|458842076|FG001|Progestin Monotherapy|Stable Disease|0|||
127513724|NCT03077698|458842075|FG000|Progestin Monotherapy|Adverse Event|1|||
127513725|NCT03077698|458842076|FG001|Progestin Monotherapy|Adverse Event|0|||
127513726|NCT03077698|458842075|FG000|Progestin Monotherapy|Death|1|||
127513727|NCT03077698|458842076|FG001|Progestin Monotherapy|Death|0|||
127513728|NCT03077698|458842075|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
127513729|NCT03077698|458842076|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
127513730|NCT03077698|458842075|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
127513731|NCT03077698|458842076|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
127513732|NCT03077698|458842075|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
127513733|NCT03077698|458842076|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
127513734|NCT03077698|458842075|FG000|Safety Follow Up|Withdrawal by Subject|2|||
127513735|NCT03077698|458842076|FG001|Safety Follow Up|Withdrawal by Subject|1|||
127513736|NCT03077698|458842075|FG000|Safety Follow Up|Transfer of care to hospice|1|||
127513737|NCT03077698|458842076|FG001|Safety Follow Up|Transfer of care to hospice|0|||
127513738|NCT03461406|458842077|FG000|Overall Study|Death|1|||
127513739|NCT03461406|458842078|FG001|Overall Study|Death|2|||
127513740|NCT03461406|458842077|FG000|Overall Study|Consent Withdrawn by Participant|0|||
127513741|NCT03461406|458842078|FG001|Overall Study|Consent Withdrawn by Participant|1|||
127513742|NCT03461406|458842077|FG000|Overall Study|Screen Failure|3|||
127513743|NCT03461406|458842078|FG001|Overall Study|Screen Failure|1|||
127513744|NCT03461406|458842077|FG000|Overall Study|Reason not Specified|1|||
127513745|NCT03461406|458842078|FG001|Overall Study|Reason not Specified|3|||
127513746|NCT03461406|458842077|FG000|Overall Study|Lost to Follow-up|3|||
127513747|NCT03461406|458842078|FG001|Overall Study|Lost to Follow-up|0|||
127513748|NCT00973102|458842081|FG000|Overall Study|Protocol Violation|1|||
127513749|NCT00973102|458842082|FG001|Overall Study|Protocol Violation|0|||
127513750|NCT00973102|458842081|FG000|Overall Study|Prisoner|0|||
127513751|NCT00973102|458842082|FG001|Overall Study|Prisoner|1|||
127513752|NCT01710527|458842085|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
127513753|NCT01710527|458842086|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
127513754|NCT02635347|458842089|FG000|Overall Study|Failed screening|20|||
127513755|NCT02635347|458842090|FG001|Overall Study|Failed screening|7|||
127513756|NCT02124772|458842092|FG000|Overall Study|Lack of Efficacy|2|||
127513757|NCT02124772|458842093|FG001|Overall Study|Lack of Efficacy|0|||
127513758|NCT02124772|458842094|FG002|Overall Study|Lack of Efficacy|0|||
127513759|NCT02124772|458842095|FG003|Overall Study|Lack of Efficacy|1|||
127513760|NCT02124772|458842096|FG004|Overall Study|Lack of Efficacy|2|||
127513761|NCT02124772|458842097|FG005|Overall Study|Lack of Efficacy|3|||
127513762|NCT02124772|458842098|FG006|Overall Study|Lack of Efficacy|0|||
127513763|NCT02124772|458842099|FG007|Overall Study|Lack of Efficacy|2|||
127513764|NCT02124772|458842100|FG008|Overall Study|Lack of Efficacy|0|||
127513765|NCT02124772|458842101|FG009|Overall Study|Lack of Efficacy|1|||
127513766|NCT02124772|458842102|FG010|Overall Study|Lack of Efficacy|0|||
127513767|NCT02124772|458842103|FG011|Overall Study|Lack of Efficacy|0|||
127513768|NCT02124772|458842104|FG012|Overall Study|Lack of Efficacy|1|||
127513769|NCT02124772|458842092|FG000|Overall Study|Adverse Event|1|||
127513770|NCT02124772|458842093|FG001|Overall Study|Adverse Event|4|||
127513771|NCT02124772|458842094|FG002|Overall Study|Adverse Event|1|||
127513772|NCT02124772|458842095|FG003|Overall Study|Adverse Event|5|||
127513773|NCT02124772|458842096|FG004|Overall Study|Adverse Event|2|||
127513774|NCT02124772|458842097|FG005|Overall Study|Adverse Event|1|||
127513775|NCT02124772|458842098|FG006|Overall Study|Adverse Event|1|||
127513776|NCT02124772|458842099|FG007|Overall Study|Adverse Event|5|||
127513777|NCT02124772|458842100|FG008|Overall Study|Adverse Event|0|||
127979786|NCT02278120|460547644|FG001|Post-treatment Efficacy Follow-up|Progressive disease|7|||
127979787|NCT02278120|460547643|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
127979788|NCT02278120|460547644|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
127979789|NCT01966068|460547648|FG000|Overall Study|Withdrawal by Subject|57|||
127979790|NCT01966068|460547648|FG000|Overall Study|Lost to Follow-up|81|||
127979791|NCT00191282|460547653|FG000|Overall Study|Adverse Event|5|||
127979792|NCT00191282|460547654|FG001|Overall Study|Adverse Event|6|||
127979793|NCT00191282|460547653|FG000|Overall Study|Death|51|||
127979794|NCT00191282|460547654|FG001|Overall Study|Death|51|||
127979795|NCT00191282|460547653|FG000|Overall Study|Lack of Efficacy|11|||
127979796|NCT00191282|460547654|FG001|Overall Study|Lack of Efficacy|6|||
127979797|NCT00191282|460547653|FG000|Overall Study|Noncompliance|14|||
127979798|NCT00191282|460547654|FG001|Overall Study|Noncompliance|17|||
127979799|NCT00191282|460547653|FG000|Overall Study|Patient moved|11|||
127979800|NCT00191282|460547654|FG001|Overall Study|Patient moved|14|||
127979801|NCT00191282|460547653|FG000|Overall Study|Withdrawal by Subject|59|||
127979802|NCT00191282|460547654|FG001|Overall Study|Withdrawal by Subject|44|||
127979803|NCT00191282|460547653|FG000|Overall Study|Physician Decision|18|||
127979804|NCT00191282|460547654|FG001|Overall Study|Physician Decision|15|||
127979805|NCT00191282|460547653|FG000|Overall Study|Protocol entry criteria not met|14|||
127979806|NCT00191282|460547654|FG001|Overall Study|Protocol entry criteria not met|9|||
127979807|NCT00191282|460547653|FG000|Overall Study|Protocol Violation|9|||
127979808|NCT00191282|460547654|FG001|Overall Study|Protocol Violation|12|||
127979809|NCT00191282|460547653|FG000|Overall Study|Severity of outcome|2|||
127979810|NCT00191282|460547654|FG001|Overall Study|Severity of outcome|5|||
127979811|NCT00191282|460547653|FG000|Overall Study|Sponsor's decision|2|||
127979812|NCT00191282|460547654|FG001|Overall Study|Sponsor's decision|2|||
127979813|NCT00191282|460547653|FG000|Overall Study|Lost to Follow-up|24|||
127979814|NCT00191282|460547654|FG001|Overall Study|Lost to Follow-up|31|||
127979815|NCT00102531|460547655|FG000|Overall Study|Adverse Event|0|||
127979816|NCT00102531|460547656|FG001|Overall Study|Adverse Event|1|||
127979817|NCT00102531|460547655|FG000|Overall Study|Disease Progression|5|||
127979818|NCT00102531|460547656|FG001|Overall Study|Disease Progression|9|||
127979819|NCT00102531|460547655|FG000|Overall Study|Physician Decision|0|||
127979820|NCT00102531|460547656|FG001|Overall Study|Physician Decision|1|||
127979821|NCT04756154|460547657|FG000|Overall Study|Did not meet treatment day baseline|30|||
127513778|NCT02124772|458842101|FG009|Overall Study|Adverse Event|3|||
127513779|NCT02124772|458842102|FG010|Overall Study|Adverse Event|1|||
127513780|NCT02124772|458842103|FG011|Overall Study|Adverse Event|3|||
127513781|NCT02124772|458842104|FG012|Overall Study|Adverse Event|1|||
127513782|NCT02124772|458842092|FG000|Overall Study|Withdrawal consent|0|||
127513783|NCT02124772|458842093|FG001|Overall Study|Withdrawal consent|1|||
127513784|NCT02124772|458842094|FG002|Overall Study|Withdrawal consent|1|||
127513785|NCT02124772|458842095|FG003|Overall Study|Withdrawal consent|1|||
127513786|NCT02124772|458842096|FG004|Overall Study|Withdrawal consent|0|||
127513787|NCT02124772|458842097|FG005|Overall Study|Withdrawal consent|1|||
127513788|NCT02124772|458842098|FG006|Overall Study|Withdrawal consent|1|||
127513789|NCT02124772|458842099|FG007|Overall Study|Withdrawal consent|0|||
127513790|NCT02124772|458842100|FG008|Overall Study|Withdrawal consent|0|||
127513791|NCT02124772|458842101|FG009|Overall Study|Withdrawal consent|1|||
127513792|NCT02124772|458842102|FG010|Overall Study|Withdrawal consent|0|||
127513793|NCT02124772|458842103|FG011|Overall Study|Withdrawal consent|1|||
127513794|NCT02124772|458842104|FG012|Overall Study|Withdrawal consent|0|||
127513795|NCT02124772|458842092|FG000|Overall Study|Investigator discretion|0|||
127513796|NCT02124772|458842093|FG001|Overall Study|Investigator discretion|2|||
127979822|NCT04756154|460547658|FG001|Overall Study|Did not meet treatment day baseline|28|||
127979823|NCT04756154|460547659|FG002|Overall Study|Did not meet treatment day baseline|7|||
127979824|NCT04756154|460547657|FG000|Overall Study|Did not return for final sample collection|1|||
127979825|NCT04756154|460547658|FG001|Overall Study|Did not return for final sample collection|1|||
127979826|NCT04756154|460547659|FG002|Overall Study|Did not return for final sample collection|0|||
127979827|NCT01790828|460547661|FG000|Overall Study|Other|34|||
127979828|NCT03721835|460547662|FG000|Overall Study|Participant not able to return|1|||
127979829|NCT03721835|460547662|FG000|Overall Study|Lost to Follow-up|1|||
127513797|NCT02124772|458842094|FG002|Overall Study|Investigator discretion|2|||
127513798|NCT02124772|458842095|FG003|Overall Study|Investigator discretion|1|||
127513799|NCT02124772|458842096|FG004|Overall Study|Investigator discretion|1|||
127513800|NCT02124772|458842097|FG005|Overall Study|Investigator discretion|0|||
127513801|NCT02124772|458842098|FG006|Overall Study|Investigator discretion|1|||
127513802|NCT02124772|458842099|FG007|Overall Study|Investigator discretion|0|||
127979830|NCT03721835|460547662|FG000|Overall Study|Revision of the components of the study device|2|||
127979831|NCT03721835|460547662|FG000|Overall Study|Sponsor terminated study|6|||
127979832|NCT03721835|460547662|FG000|Overall Study|Death|1|||
127979833|NCT03721835|460547662|FG000|Overall Study|Sponsor decision|1|||
127979834|NCT01390428|460549102|FG000|Overall Study|Elective Surgery|0|||
127979835|NCT01390428|460549103|FG001|Overall Study|Elective Surgery|0|||
127979836|NCT01390428|460549104|FG002|Overall Study|Elective Surgery|0|||
127513803|NCT02124772|458842100|FG008|Overall Study|Investigator discretion|0|||
127979837|NCT01390428|460549105|FG003|Overall Study|Elective Surgery|0|||
127979838|NCT01390428|460549106|FG004|Overall Study|Elective Surgery|1|||
127979839|NCT01390428|460549107|FG005|Overall Study|Elective Surgery|0|||
127979840|NCT01390428|460549102|FG000|Overall Study|Withdrawal by Subject|0|||
127979841|NCT01390428|460549103|FG001|Overall Study|Withdrawal by Subject|0|||
127979842|NCT01390428|460549104|FG002|Overall Study|Withdrawal by Subject|1|||
127979843|NCT01390428|460549105|FG003|Overall Study|Withdrawal by Subject|0|||
127979844|NCT01390428|460549106|FG004|Overall Study|Withdrawal by Subject|0|||
127513804|NCT02124772|458842101|FG009|Overall Study|Investigator discretion|1|||
127513805|NCT02124772|458842102|FG010|Overall Study|Investigator discretion|0|||
127513806|NCT02124772|458842103|FG011|Overall Study|Investigator discretion|1|||
127513807|NCT02124772|458842104|FG012|Overall Study|Investigator discretion|0|||
127513808|NCT02124772|458842092|FG000|Overall Study|Progressive disease|0|||
127513809|NCT02124772|458842093|FG001|Overall Study|Progressive disease|0|||
127513810|NCT02124772|458842094|FG002|Overall Study|Progressive disease|0|||
127513811|NCT02124772|458842095|FG003|Overall Study|Progressive disease|0|||
127513812|NCT02124772|458842096|FG004|Overall Study|Progressive disease|0|||
127513813|NCT02124772|458842097|FG005|Overall Study|Progressive disease|0|||
127513814|NCT02124772|458842098|FG006|Overall Study|Progressive disease|1|||
127513815|NCT02124772|458842099|FG007|Overall Study|Progressive disease|1|||
127979845|NCT01390428|460549107|FG005|Overall Study|Withdrawal by Subject|0|||
127979846|NCT04322539|460549110|FG000|Overall Study|Adverse Event|2|||
127513816|NCT02124772|458842100|FG008|Overall Study|Progressive disease|0|||
127513817|NCT02124772|458842101|FG009|Overall Study|Progressive disease|0|||
127513818|NCT02124772|458842102|FG010|Overall Study|Progressive disease|0|||
127513819|NCT02124772|458842103|FG011|Overall Study|Progressive disease|0|||
127513820|NCT02124772|458842104|FG012|Overall Study|Progressive disease|0|||
127513821|NCT02124772|458842092|FG000|Overall Study|Other|0|||
127513822|NCT02124772|458842093|FG001|Overall Study|Other|7|||
127513823|NCT02124772|458842094|FG002|Overall Study|Other|2|||
127513824|NCT02124772|458842095|FG003|Overall Study|Other|5|||
127513825|NCT02124772|458842096|FG004|Overall Study|Other|4|||
127513826|NCT02124772|458842097|FG005|Overall Study|Other|3|||
127513827|NCT02124772|458842098|FG006|Overall Study|Other|4|||
127513828|NCT02124772|458842099|FG007|Overall Study|Other|1|||
127513829|NCT02124772|458842100|FG008|Overall Study|Other|1|||
127979847|NCT04322539|460549111|FG001|Overall Study|Adverse Event|0|||
127979848|NCT04322539|460549110|FG000|Overall Study|Death|411|||
127979849|NCT04322539|460549111|FG001|Overall Study|Death|203|||
127979850|NCT04322539|460549110|FG000|Overall Study|Lost to Follow-up|3|||
127979851|NCT04322539|460549111|FG001|Overall Study|Lost to Follow-up|1|||
127979852|NCT04322539|460549110|FG000|Overall Study|Withdrawal of consent|14|||
127979853|NCT04322539|460549111|FG001|Overall Study|Withdrawal of consent|8|||
127979854|NCT04322539|460549110|FG000|Overall Study|Radiological Disease Progression|6|||
127979855|NCT04322539|460549111|FG001|Overall Study|Radiological Disease Progression|0|||
127979856|NCT04322539|460549110|FG000|Overall Study|Sponsor Decision|19|||
127979857|NCT04322539|460549111|FG001|Overall Study|Sponsor Decision|14|||
127979858|NCT04322539|460549110|FG000|Overall Study|Other|6|||
127979859|NCT04322539|460549111|FG001|Overall Study|Other|4|||
127979860|NCT01702532|460549112|FG000|Overall Study|Adverse Event|0|||
127979861|NCT01702532|460549113|FG001|Overall Study|Adverse Event|1|||
127979862|NCT01846221|460549114|FG000|Overall Study|Catheter Failure|2|||
127979863|NCT01846221|460549115|FG001|Overall Study|Catheter Failure|0|||
127979864|NCT01846221|460549114|FG000|Overall Study|Age Exclusion|1|||
127979865|NCT01846221|460549115|FG001|Overall Study|Age Exclusion|0|||
127979866|NCT02879994|460549116|FG000|Overall Study|off treatment early|7|||
127979867|NCT02879994|460549116|FG000|Overall Study|Adverse Event|2|||
127979868|NCT02879994|460549116|FG000|Overall Study|Death|2|||
127979869|NCT01097421|460549117|FG000|Overall Study|Adverse Event|8|||
127979870|NCT01097421|460549117|FG000|Overall Study|Protocol Violation|2|||
127979871|NCT01097421|460549117|FG000|Overall Study|Lost to Follow-up|1|||
127979872|NCT01097421|460549117|FG000|Overall Study|Withdrawal by Subject|3|||
127513830|NCT02124772|458842101|FG009|Overall Study|Other|1|||
127979873|NCT04495816|460549125|FG000|Overall Study|Lost to Follow-up|10|||
127979874|NCT04495816|460549126|FG001|Overall Study|Lost to Follow-up|4|||
127979875|NCT04495816|460549125|FG000|Overall Study|Withdrawal by Subject|3|||
127513831|NCT02124772|458842102|FG010|Overall Study|Other|1|||
127979876|NCT04495816|460549126|FG001|Overall Study|Withdrawal by Subject|5|||
127979877|NCT02052596|460549127|FG000|Active Phase|Adverse Event|3|||
127979878|NCT02052596|460549128|FG001|Active Phase|Adverse Event|2|||
127979879|NCT02052596|460549127|FG000|Active Phase|Lost to Follow-up|8|||
127979880|NCT02052596|460549128|FG001|Active Phase|Lost to Follow-up|11|||
127979881|NCT02052596|460549127|FG000|Active Phase|Protocol Violation|1|||
127979882|NCT02052596|460549128|FG001|Active Phase|Protocol Violation|2|||
127513832|NCT02124772|458842103|FG011|Overall Study|Other|1|||
127513833|NCT02124772|458842104|FG012|Overall Study|Other|0|||
127513834|NCT00780273|458842105|FG000|Overall Study|Death|1|||
127979883|NCT02052596|460549127|FG000|Active Phase|Withdrawal by Subject|3|||
127513835|NCT00780273|458842105|FG000|Overall Study|Lost to Follow-up|1|||
127513836|NCT02358044|458842106|FG000|Overall Study|Adverse Event|0|||
127513837|NCT02358044|458842107|FG001|Overall Study|Adverse Event|1|||
127979884|NCT02052596|460549128|FG001|Active Phase|Withdrawal by Subject|4|||
127979885|NCT02052596|460549127|FG000|Active Phase|Enrolled in error|1|||
127979886|NCT02052596|460549128|FG001|Active Phase|Enrolled in error|0|||
127979887|NCT02052596|460549127|FG000|Active Phase|Lost due to Crohn's disease|0|||
127979888|NCT02052596|460549128|FG001|Active Phase|Lost due to Crohn's disease|1|||
127979889|NCT02052596|460549127|FG000|Safety Phase|Adverse Event|6|||
127979890|NCT02052596|460549128|FG001|Safety Phase|Adverse Event|3|||
127979891|NCT02052596|460549127|FG000|Safety Phase|Lost to Follow-up|11|||
127979892|NCT02052596|460549128|FG001|Safety Phase|Lost to Follow-up|18|||
127979893|NCT02052596|460549127|FG000|Safety Phase|Protocol Violation|1|||
127979894|NCT02052596|460549128|FG001|Safety Phase|Protocol Violation|2|||
127979895|NCT02052596|460549127|FG000|Safety Phase|Withdrawal by Subject|8|||
127979896|NCT02052596|460549128|FG001|Safety Phase|Withdrawal by Subject|11|||
127979897|NCT02052596|460549127|FG000|Safety Phase|Enrolled in error|1|||
127979898|NCT02052596|460549128|FG001|Safety Phase|Enrolled in error|0|||
127979899|NCT02052596|460549127|FG000|Safety Phase|Lost due to Crohn's disease|0|||
127979900|NCT02052596|460549128|FG001|Safety Phase|Lost due to Crohn's disease|1|||
127979901|NCT00558896|460549129|FG000|Overall Study|Adverse Event|1|||
127979902|NCT00558896|460549130|FG001|Overall Study|Adverse Event|1|||
127979903|NCT00558896|460549131|FG002|Overall Study|Adverse Event|1|||
127979904|NCT00558896|460549132|FG003|Overall Study|Adverse Event|3|||
127979905|NCT00558896|460549133|FG004|Overall Study|Adverse Event|4|||
127979906|NCT00558896|460549134|FG005|Overall Study|Adverse Event|10|||
127979907|NCT00558896|460549135|FG006|Overall Study|Adverse Event|3|||
127979908|NCT00558896|460549129|FG000|Overall Study|Death|3|||
127979909|NCT00558896|460549130|FG001|Overall Study|Death|0|||
127979910|NCT00558896|460549131|FG002|Overall Study|Death|2|||
127979911|NCT00558896|460549132|FG003|Overall Study|Death|3|||
127979912|NCT00558896|460549133|FG004|Overall Study|Death|2|||
127979913|NCT00558896|460549134|FG005|Overall Study|Death|2|||
127979914|NCT00558896|460549135|FG006|Overall Study|Death|6|||
127979915|NCT00558896|460549129|FG000|Overall Study|Withdrawal by Subject|2|||
127979916|NCT00558896|460549130|FG001|Overall Study|Withdrawal by Subject|1|||
127979917|NCT00558896|460549131|FG002|Overall Study|Withdrawal by Subject|1|||
127979918|NCT00558896|460549132|FG003|Overall Study|Withdrawal by Subject|1|||
127979919|NCT00558896|460549133|FG004|Overall Study|Withdrawal by Subject|1|||
127979920|NCT00558896|460549134|FG005|Overall Study|Withdrawal by Subject|5|||
127979921|NCT00558896|460549135|FG006|Overall Study|Withdrawal by Subject|5|||
127979922|NCT00558896|460549129|FG000|Overall Study|Alternative Treatment|2|||
127979923|NCT00558896|460549130|FG001|Overall Study|Alternative Treatment|2|||
127979924|NCT00558896|460549131|FG002|Overall Study|Alternative Treatment|0|||
127979925|NCT00558896|460549132|FG003|Overall Study|Alternative Treatment|2|||
127979926|NCT00558896|460549133|FG004|Overall Study|Alternative Treatment|6|||
127979927|NCT00558896|460549134|FG005|Overall Study|Alternative Treatment|7|||
127979928|NCT00558896|460549135|FG006|Overall Study|Alternative Treatment|1|||
127979929|NCT00558896|460549129|FG000|Overall Study|Physician discretion|3|||
127979930|NCT00558896|460549130|FG001|Overall Study|Physician discretion|2|||
127979931|NCT00558896|460549131|FG002|Overall Study|Physician discretion|1|||
127979932|NCT00558896|460549132|FG003|Overall Study|Physician discretion|2|||
127979933|NCT00558896|460549133|FG004|Overall Study|Physician discretion|1|||
127979934|NCT00558896|460549134|FG005|Overall Study|Physician discretion|3|||
127979935|NCT00558896|460549135|FG006|Overall Study|Physician discretion|3|||
127979936|NCT00558896|460549129|FG000|Overall Study|Continues on treatment|10|||
127513838|NCT02358044|458842106|FG000|Overall Study|Lost to Follow-up|2|||
127513839|NCT02358044|458842107|FG001|Overall Study|Lost to Follow-up|1|||
127513840|NCT02358044|458842106|FG000|Overall Study|Physician Decision|0|||
127513841|NCT02358044|458842107|FG001|Overall Study|Physician Decision|1|||
127979937|NCT00558896|460549130|FG001|Overall Study|Continues on treatment|1|||
127979938|NCT00558896|460549131|FG002|Overall Study|Continues on treatment|0|||
127979939|NCT00558896|460549132|FG003|Overall Study|Continues on treatment|1|||
127979940|NCT00558896|460549133|FG004|Overall Study|Continues on treatment|9|||
127979941|NCT00558896|460549134|FG005|Overall Study|Continues on treatment|25|||
127979942|NCT00558896|460549135|FG006|Overall Study|Continues on treatment|6|||
127979943|NCT00705718|460549136|FG000|Overall Study|Death|6|||
127979944|NCT00705718|460549137|FG001|Overall Study|Death|6|||
127979945|NCT00705718|460549136|FG000|Overall Study|Not due for Visit|0|||
127979946|NCT00705718|460549137|FG001|Overall Study|Not due for Visit|12|||
127979947|NCT00705718|460549136|FG000|Overall Study|Follow up not done|1|||
127979948|NCT00705718|460549137|FG001|Overall Study|Follow up not done|4|||
127979949|NCT06137703|460549139|FG000|Overall Study|Other|0|||
127979950|NCT06137703|460549140|FG001|Overall Study|Other|1|||
127979951|NCT06137703|460549141|FG002|Overall Study|Other|0|||
127513842|NCT02358044|458842106|FG000|Overall Study|Withdrawal by Subject|0|||
127513843|NCT02358044|458842107|FG001|Overall Study|Withdrawal by Subject|4|||
127979952|NCT06137703|460549142|FG003|Overall Study|Other|0|||
127979953|NCT06137703|460549139|FG000|Overall Study|Adverse Event|0|||
127513844|NCT01739803|458842108|FG000|Overall Study|Lost to Follow-up|9|||
127979954|NCT06137703|460549140|FG001|Overall Study|Adverse Event|0|||
127979955|NCT06137703|460549141|FG002|Overall Study|Adverse Event|1|||
127979956|NCT06137703|460549142|FG003|Overall Study|Adverse Event|0|||
127979957|NCT01527487|460549147|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
127979958|NCT01527487|460549148|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
127979959|NCT01527487|460549147|FG000|Overall Study|Disease Progression|4|||
127979960|NCT01527487|460549148|FG001|Overall Study|Disease Progression|1|||
127979961|NCT01527487|460549147|FG000|Overall Study|Adverse Event|1|||
127979962|NCT01527487|460549148|FG001|Overall Study|Adverse Event|1|||
127979963|NCT01527487|460549147|FG000|Overall Study|Death|0|||
127979964|NCT01527487|460549148|FG001|Overall Study|Death|1|||
127979965|NCT03181503|460549149|FG000|Overall Study|Adverse Event|2|||
127979966|NCT03181503|460549150|FG001|Overall Study|Adverse Event|2|||
127979967|NCT03181503|460549149|FG000|Overall Study|Protocol Violation|1|||
127979968|NCT03181503|460549150|FG001|Overall Study|Protocol Violation|0|||
127979969|NCT03181503|460549149|FG000|Overall Study|Withdrawal by Subject|3|||
127979970|NCT03181503|460549150|FG001|Overall Study|Withdrawal by Subject|0|||
127979971|NCT03181503|460549149|FG000|Overall Study|Lost to Follow-up|1|||
127979972|NCT03181503|460549150|FG001|Overall Study|Lost to Follow-up|1|||
127979973|NCT02505334|460549158|FG000|Main Treatment Period|Adverse Event|3|||
127979974|NCT02505334|460549159|FG001|Main Treatment Period|Adverse Event|3|||
127979975|NCT02505334|460549158|FG000|Main Treatment Period|Lack of Efficacy|7|||
127979976|NCT02505334|460549159|FG001|Main Treatment Period|Lack of Efficacy|17|||
127979977|NCT02505334|460549158|FG000|Main Treatment Period|Protocol Violation|0|||
127979978|NCT02505334|460549159|FG001|Main Treatment Period|Protocol Violation|1|||
127979979|NCT02505334|460549158|FG000|Main Treatment Period|Withdrawal by Subject|1|||
127979980|NCT02505334|460549159|FG001|Main Treatment Period|Withdrawal by Subject|8|||
127979981|NCT02505334|460549158|FG000|Main Treatment Period|Unclassified|4|||
127979982|NCT02505334|460549159|FG001|Main Treatment Period|Unclassified|10|||
127979983|NCT02505334|460549158|FG000|Extension Treatment Period|Adverse Event|5|||
127979984|NCT02505334|460549159|FG001|Extension Treatment Period|Adverse Event|0|||
127979985|NCT02505334|460549158|FG000|Extension Treatment Period|Lack of Efficacy|4|||
127979986|NCT02505334|460549159|FG001|Extension Treatment Period|Lack of Efficacy|0|||
127979987|NCT02505334|460549158|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
127979988|NCT02505334|460549159|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
127979989|NCT02505334|460549158|FG000|Extension Treatment Period|Unclassified|3|||
127979990|NCT02505334|460549159|FG001|Extension Treatment Period|Unclassified|0|||
127979991|NCT03199612|460549160|FG000|Overall Study|Adverse Event|1|||
127979992|NCT03199612|460549161|FG001|Overall Study|Adverse Event|0|||
127979993|NCT00081731|460549166|FG000|Overall Study|scientific integrity issue|8|||
127979994|NCT00081731|460549167|FG001|Overall Study|scientific integrity issue|8|||
127979995|NCT02386345|460549171|FG000|Overall Study|Not treated|14|||
127979996|NCT02386345|460549171|FG000|Overall Study|Lost to Follow-up|1|||
127979997|NCT02386345|460549171|FG000|Overall Study|Adverse Event|5|||
127979998|NCT02386345|460549171|FG000|Overall Study|Repeat Procedure|10|||
127979999|NCT02386345|460549171|FG000|Overall Study|Did not complete 12-month follow-up|72|||
127513845|NCT01739803|458842109|FG001|Overall Study|Lost to Follow-up|6|||
127513846|NCT02525094|458842117|FG000|Overall Study|Lost to Follow-up|2|||
127513847|NCT02525094|458842118|FG001|Overall Study|Lost to Follow-up|1|||
127513848|NCT02525094|458842117|FG000|Overall Study|Withdrawal by Subject|5|||
127513849|NCT02525094|458842118|FG001|Overall Study|Withdrawal by Subject|6|||
127513850|NCT02525094|458842117|FG000|Overall Study|Not Treated|1|||
127513851|NCT02525094|458842118|FG001|Overall Study|Not Treated|1|||
127513852|NCT01751776|458842120|FG000|Overall Study|Adverse Event|0|||
127513853|NCT01751776|458842121|FG001|Overall Study|Adverse Event|0|||
127513854|NCT01751776|458842122|FG002|Overall Study|Adverse Event|0|||
127513855|NCT01751776|458842123|FG003|Overall Study|Adverse Event|0|||
127513856|NCT01751776|458842124|FG004|Overall Study|Adverse Event|0|||
127513857|NCT01751776|458842125|FG005|Overall Study|Adverse Event|0|||
127513858|NCT01751776|458842126|FG006|Overall Study|Adverse Event|4|||
127513859|NCT01751776|458842127|FG007|Overall Study|Adverse Event|2|||
127513860|NCT01751776|458842120|FG000|Overall Study|Consent withdrawn|0|||
127980000|NCT02258542|460549172|FG000|Overall Study|eg. not made to the visit|7|||
127980001|NCT02258542|460549173|FG001|Overall Study|eg. not made to the visit|4|||
127980002|NCT02258542|460549174|FG002|Overall Study|eg. not made to the visit|0|||
127980003|NCT02258542|460549175|FG003|Overall Study|eg. not made to the visit|1|||
127980004|NCT02258542|460549172|FG000|Overall Study|study specific discount. criteria|1|||
127513861|NCT01751776|458842121|FG001|Overall Study|Consent withdrawn|0|||
127980005|NCT02258542|460549173|FG001|Overall Study|study specific discount. criteria|1|||
127980006|NCT02258542|460549174|FG002|Overall Study|study specific discount. criteria|0|||
127513862|NCT01751776|458842122|FG002|Overall Study|Consent withdrawn|0|||
127980007|NCT02258542|460549175|FG003|Overall Study|study specific discount. criteria|0|||
127980008|NCT02258542|460549172|FG000|Overall Study|Withdrawal by Subject|20|||
127980009|NCT02258542|460549173|FG001|Overall Study|Withdrawal by Subject|20|||
127980010|NCT02258542|460549174|FG002|Overall Study|Withdrawal by Subject|7|||
127513863|NCT01751776|458842123|FG003|Overall Study|Consent withdrawn|0|||
127513864|NCT01751776|458842124|FG004|Overall Study|Consent withdrawn|0|||
127513865|NCT01751776|458842125|FG005|Overall Study|Consent withdrawn|0|||
127513866|NCT01751776|458842126|FG006|Overall Study|Consent withdrawn|0|||
127513867|NCT01751776|458842127|FG007|Overall Study|Consent withdrawn|1|||
127513868|NCT01751776|458842120|FG000|Overall Study|Other reason not specified above|0|||
127513869|NCT01751776|458842121|FG001|Overall Study|Other reason not specified above|0|||
127513870|NCT01751776|458842122|FG002|Overall Study|Other reason not specified above|0|||
127513871|NCT01751776|458842123|FG003|Overall Study|Other reason not specified above|0|||
127513872|NCT01751776|458842124|FG004|Overall Study|Other reason not specified above|0|||
127513873|NCT01751776|458842125|FG005|Overall Study|Other reason not specified above|0|||
127513874|NCT01751776|458842126|FG006|Overall Study|Other reason not specified above|0|||
127513875|NCT01751776|458842127|FG007|Overall Study|Other reason not specified above|1|||
127513876|NCT01831817|458842132|FG000|Overall Study|Lost to Follow-up|1|||
127513877|NCT01831817|458842133|FG001|Overall Study|Lost to Follow-up|0|||
127513878|NCT01831817|458842134|FG002|Overall Study|Lost to Follow-up|0|||
127513879|NCT01831817|458842135|FG003|Overall Study|Lost to Follow-up|0|||
127513880|NCT01831817|458842132|FG000|Overall Study|Withdrawl of Consent|3|||
127513881|NCT01831817|458842133|FG001|Overall Study|Withdrawl of Consent|0|||
127513882|NCT01831817|458842134|FG002|Overall Study|Withdrawl of Consent|0|||
127513883|NCT01831817|458842135|FG003|Overall Study|Withdrawl of Consent|0|||
127513884|NCT02198235|458842137|FG000|Overall Study|Lost to Follow-up|3|||
127513885|NCT02198235|458842138|FG001|Overall Study|Lost to Follow-up|2|||
127513886|NCT02198235|458842139|FG002|Overall Study|Lost to Follow-up|2|||
127513887|NCT00203021|458843316|FG000|Overall Study|Death|4|||
127513888|NCT00203021|458843317|FG001|Overall Study|Death|1|||
127513889|NCT00203021|458843316|FG000|Overall Study|Adverse Event|10|||
127513890|NCT00203021|458843317|FG001|Overall Study|Adverse Event|5|||
127513891|NCT00203021|458843316|FG000|Overall Study|Withdrawal by Subject|45|||
127513892|NCT00203021|458843317|FG001|Overall Study|Withdrawal by Subject|48|||
127513893|NCT00203021|458843316|FG000|Overall Study|Lost to Follow-up|9|||
127513894|NCT00203021|458843317|FG001|Overall Study|Lost to Follow-up|7|||
127513895|NCT00203021|458843316|FG000|Overall Study|Other than specified|11|||
127513896|NCT00203021|458843317|FG001|Overall Study|Other than specified|16|||
127513897|NCT01657760|458843330|FG000|Overall Study|Withdrawal by Subject|0|||
127513898|NCT01657760|458843331|FG001|Overall Study|Withdrawal by Subject|0|||
127513899|NCT01657760|458843332|FG002|Overall Study|Withdrawal by Subject|0|||
127513900|NCT01657760|458843333|FG003|Overall Study|Withdrawal by Subject|1|||
127513901|NCT01657760|458843330|FG000|Overall Study|Physician Decision|1|||
127513902|NCT01657760|458843331|FG001|Overall Study|Physician Decision|1|||
127513903|NCT01657760|458843332|FG002|Overall Study|Physician Decision|1|||
127513904|NCT01657760|458843333|FG003|Overall Study|Physician Decision|2|||
127513905|NCT00940485|458843341|FG000|Overall Study|HBeAb positive at Baseline|3|||
127513906|NCT00940485|458843342|FG001|Overall Study|HBeAb positive at Baseline|2|||
127513907|NCT00940485|458843341|FG000|Overall Study|Lost to Follow-up|2|||
127513908|NCT00940485|458843342|FG001|Overall Study|Lost to Follow-up|3|||
127513909|NCT00940485|458843341|FG000|Overall Study|Adverse Event|8|||
127513910|NCT00940485|458843342|FG001|Overall Study|Adverse Event|0|||
127513911|NCT00940485|458843341|FG000|Overall Study|Withdrawal by Subject|1|||
127513912|NCT00940485|458843342|FG001|Overall Study|Withdrawal by Subject|1|||
127513913|NCT00940485|458843341|FG000|Overall Study|Others|1|||
127513914|NCT00940485|458843342|FG001|Overall Study|Others|1|||
127513915|NCT06250738|458843348|FG000|Overall Study|Lost to Follow-up|1|||
127513916|NCT02936284|458843350|FG000|Overall Study|Withdrawal by Subject|3|||
127513917|NCT02936284|458843351|FG001|Overall Study|Withdrawal by Subject|1|||
127513918|NCT02936284|458843350|FG000|Overall Study|Lost to Follow-up|7|||
127513919|NCT02936284|458843351|FG001|Overall Study|Lost to Follow-up|8|||
127513920|NCT01068249|458843352|FG000|Overall Study|Death|1|||
127513921|NCT01068249|458843352|FG000|Overall Study|Withdrawal by Subject|3|||
127513922|NCT03921554|458843356|FG000|Overall Study|Adverse Event|2|||
127513923|NCT03921554|458843356|FG000|Overall Study|Withdrawal by Subject|1|||
127513924|NCT03921554|458843356|FG000|Overall Study|Death|3|||
127513925|NCT03283150|458843363|FG000|Overall Study|Withdrawal by Subject|6|||
127513926|NCT03283150|458843364|FG001|Overall Study|Withdrawal by Subject|0|||
127513927|NCT03283150|458843365|FG002|Overall Study|Withdrawal by Subject|0|||
127513928|NCT01842581|458843369|FG000|Overall Study|Adverse Event|6|||
127513929|NCT01842581|458843370|FG001|Overall Study|Adverse Event|4|||
127513930|NCT01842581|458843369|FG000|Overall Study|HE breakthrough|26|||
127513931|NCT01842581|458843370|FG001|Overall Study|HE breakthrough|13|||
127513932|NCT01842581|458843369|FG000|Overall Study|Liver transplant|2|||
127513933|NCT01842581|458843370|FG001|Overall Study|Liver transplant|0|||
127513934|NCT01842581|458843369|FG000|Overall Study|Lost to Follow-up|2|||
127513935|NCT01842581|458843370|FG001|Overall Study|Lost to Follow-up|5|||
127513936|NCT01842581|458843369|FG000|Overall Study|Withdrawal by Subject|5|||
127513937|NCT01842581|458843370|FG001|Overall Study|Withdrawal by Subject|7|||
127513938|NCT01842581|458843369|FG000|Overall Study|Other than specified|3|||
127513939|NCT01842581|458843370|FG001|Overall Study|Other than specified|1|||
127513940|NCT01287195|458843373|FG000|Overall Study|Withdrawal by Subject|2|||
127513941|NCT00353873|458843376|FG000|Overall Study|Protocol Violation|1|||
127513942|NCT00353873|458843377|FG001|Overall Study|Protocol Violation|2|||
127513943|NCT00353873|458843376|FG000|Overall Study|Exacerbation|1|||
127513944|NCT00353873|458843377|FG001|Overall Study|Exacerbation|0|||
127980011|NCT02258542|460549175|FG003|Overall Study|Withdrawal by Subject|1|||
127980012|NCT02258542|460549172|FG000|Overall Study|Lost to Follow-up|5|||
127980013|NCT02258542|460549173|FG001|Overall Study|Lost to Follow-up|12|||
127980014|NCT02258542|460549174|FG002|Overall Study|Lost to Follow-up|1|||
127980015|NCT02258542|460549175|FG003|Overall Study|Lost to Follow-up|2|||
127980016|NCT02258542|460549172|FG000|Overall Study|Death|5|||
127980017|NCT02258542|460549173|FG001|Overall Study|Death|4|||
127980018|NCT02258542|460549174|FG002|Overall Study|Death|0|||
127980019|NCT02258542|460549175|FG003|Overall Study|Death|1|||
127980020|NCT02258542|460549172|FG000|Overall Study|Adverse Event|3|||
127980021|NCT02258542|460549173|FG001|Overall Study|Adverse Event|4|||
127980022|NCT02258542|460549174|FG002|Overall Study|Adverse Event|0|||
127980023|NCT02258542|460549175|FG003|Overall Study|Adverse Event|0|||
127980024|NCT02258542|460549172|FG000|Overall Study|Protocol Violation|1|||
127980025|NCT02258542|460549173|FG001|Overall Study|Protocol Violation|2|||
127980026|NCT02258542|460549174|FG002|Overall Study|Protocol Violation|0|||
127980027|NCT02258542|460549175|FG003|Overall Study|Protocol Violation|0|||
127980028|NCT02258542|460549172|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
127980029|NCT02258542|460549173|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
127980030|NCT02258542|460549174|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
127980031|NCT02258542|460549175|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
127980032|NCT04442269|460549179|FG000|Overall Study|Adverse Event|1|||
127980033|NCT04442269|460549180|FG001|Overall Study|Adverse Event|0|||
127980034|NCT04442269|460549179|FG000|Overall Study|Death|0|||
127980035|NCT04442269|460549180|FG001|Overall Study|Death|1|||
127980036|NCT04442269|460549179|FG000|Overall Study|Decision by the Investigator/Sponsor|1|||
127980037|NCT04442269|460549180|FG001|Overall Study|Decision by the Investigator/Sponsor|1|||
127980038|NCT04442269|460549179|FG000|Overall Study|Lost to Follow-up|1|||
127980039|NCT04442269|460549180|FG001|Overall Study|Lost to Follow-up|0|||
127980040|NCT04442269|460549179|FG000|Overall Study|Withdrawal by Subject|3|||
127980041|NCT04442269|460549180|FG001|Overall Study|Withdrawal by Subject|2|||
127980042|NCT04442269|460549179|FG000|Overall Study|Protocol Deviation|0|||
127980043|NCT04442269|460549180|FG001|Overall Study|Protocol Deviation|1|||
127980044|NCT04442269|460549179|FG000|Overall Study|Travel Limitations|1|||
127980045|NCT04442269|460549180|FG001|Overall Study|Travel Limitations|1|||
127980046|NCT01793688|460549181|FG000|Overall Study|Protocol Violation|2|||
127980047|NCT04972968|460549182|FG000|Overall Study|Adverse Event|3|||
127980048|NCT04972968|460549183|FG001|Overall Study|Adverse Event|1|||
127980049|NCT04972968|460549184|FG002|Overall Study|Adverse Event|1|||
127980050|NCT04972968|460549185|FG003|Overall Study|Adverse Event|7|||
127980051|NCT04972968|460549182|FG000|Overall Study|Lack of Efficacy|2|||
127980052|NCT04972968|460549183|FG001|Overall Study|Lack of Efficacy|1|||
127980053|NCT04972968|460549184|FG002|Overall Study|Lack of Efficacy|0|||
127980054|NCT04972968|460549185|FG003|Overall Study|Lack of Efficacy|0|||
127980055|NCT04972968|460549182|FG000|Overall Study|Withdrawal by Subject|7|||
127980056|NCT04972968|460549183|FG001|Overall Study|Withdrawal by Subject|4|||
127980057|NCT04972968|460549184|FG002|Overall Study|Withdrawal by Subject|3|||
127980058|NCT04972968|460549185|FG003|Overall Study|Withdrawal by Subject|2|||
127980059|NCT04972968|460549182|FG000|Overall Study|Study Terminated by Sponsor|25|||
127980060|NCT04972968|460549183|FG001|Overall Study|Study Terminated by Sponsor|28|||
127980061|NCT04972968|460549184|FG002|Overall Study|Study Terminated by Sponsor|32|||
127980062|NCT04972968|460549185|FG003|Overall Study|Study Terminated by Sponsor|27|||
127980063|NCT04972968|460549182|FG000|Overall Study|Other|1|||
127980064|NCT04972968|460549183|FG001|Overall Study|Other|0|||
127980065|NCT04972968|460549184|FG002|Overall Study|Other|1|||
127980066|NCT04972968|460549185|FG003|Overall Study|Other|1|||
127980067|NCT01698879|460549186|FG000|Overall Study|Withdrawal by Subject|1|||
127980068|NCT01698879|460549187|FG001|Overall Study|Withdrawal by Subject|0|||
127980069|NCT01698879|460549188|FG002|Overall Study|Withdrawal by Subject|0|||
127980070|NCT03589976|460549196|FG000|Overall Study|Death|5|||
127980071|NCT03589976|460549197|FG001|Overall Study|Death|1|||
127980072|NCT03589976|460549196|FG000|Overall Study|Adverse Event|5|||
127980073|NCT03589976|460549197|FG001|Overall Study|Adverse Event|1|||
127980074|NCT03589976|460549196|FG000|Overall Study|Withdrawal by Subject|4|||
127980075|NCT03589976|460549197|FG001|Overall Study|Withdrawal by Subject|1|||
127980076|NCT03589976|460549196|FG000|Overall Study|Lost to Follow-up|1|||
127980077|NCT03589976|460549197|FG001|Overall Study|Lost to Follow-up|0|||
127980078|NCT03589976|460549196|FG000|Overall Study|Other|4|||
127980079|NCT03589976|460549197|FG001|Overall Study|Other|3|||
127980080|NCT00514904|460549201|FG000|Overall Study|Withdrawal by Subject|3|||
127980081|NCT00514904|460549202|FG001|Overall Study|Withdrawal by Subject|2|||
127980082|NCT00514904|460549201|FG000|Overall Study|Lost to Follow-up|21|||
127980083|NCT00514904|460549202|FG001|Overall Study|Lost to Follow-up|3|||
127980084|NCT03430895|460549203|FG000|Overall Study|Not Treated|2|||
127980085|NCT01317797|460549204|FG000|Overall Study|Other|0|||
127980086|NCT01317797|460549205|FG001|Overall Study|Other|1|||
127980087|NCT01317797|460549206|FG002|Overall Study|Other|0|||
127980088|NCT01317797|460549204|FG000|Overall Study|Withdrawal of Patient|0|||
127980089|NCT01317797|460549205|FG001|Overall Study|Withdrawal of Patient|0|||
127980090|NCT01317797|460549206|FG002|Overall Study|Withdrawal of Patient|1|||
127980091|NCT03026530|460549212|FG000|Overall Study|Lost to Follow-up|19|||
127980092|NCT03026530|460549213|FG001|Overall Study|Lost to Follow-up|24|||
127980093|NCT03026530|460549212|FG000|Overall Study|Protocol Violation|2|||
127980094|NCT03026530|460549213|FG001|Overall Study|Protocol Violation|5|||
127980095|NCT00138073|460549214|FG000|Overall Study|lack of resources|55|||
127980096|NCT05072964|460549218|FG000|Overall Study|Withdrawal by Subject|4|||
127980097|NCT05072964|460549218|FG000|Overall Study|Death|1|||
127980098|NCT03197467|460550567|FG000|Overall Study|Withdrawal by Subject|1|||
127980099|NCT03666533|460550569|FG000|Overall Study|Lost to Follow-up|2|||
127980100|NCT03666533|460550570|FG001|Overall Study|Lost to Follow-up|2|||
127980101|NCT04392167|460550588|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
127980102|NCT04063657|460550589|FG000|Overall Study|Lost to Follow-up|1|||
127980103|NCT04063657|460550590|FG001|Overall Study|Lost to Follow-up|0|||
127980104|NCT03408444|460550591|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
127980105|NCT03408444|460550592|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
127980106|NCT03408444|460550593|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
127980107|NCT03408444|460550594|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
127980108|NCT03408444|460550591|FG000|Overall Study|Lens Discomfort|0|||
127980109|NCT03408444|460550592|FG001|Overall Study|Lens Discomfort|1|||
127980110|NCT03408444|460550593|FG002|Overall Study|Lens Discomfort|0|||
127980111|NCT03408444|460550594|FG003|Overall Study|Lens Discomfort|0|||
127980112|NCT03408444|460550591|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
127980113|NCT03408444|460550592|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
127980114|NCT03408444|460550593|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
127980115|NCT03408444|460550594|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
127980116|NCT03408444|460550591|FG000|Overall Study|Withdrawal by Subject|0|||
127980117|NCT03408444|460550592|FG001|Overall Study|Withdrawal by Subject|2|||
127980118|NCT03408444|460550593|FG002|Overall Study|Withdrawal by Subject|3|||
127980119|NCT03408444|460550594|FG003|Overall Study|Withdrawal by Subject|0|||
127980120|NCT03408444|460550591|FG000|Overall Study|Lost to Follow-up|0|||
127980121|NCT03408444|460550592|FG001|Overall Study|Lost to Follow-up|0|||
127980122|NCT03408444|460550593|FG002|Overall Study|Lost to Follow-up|1|||
127980123|NCT03408444|460550594|FG003|Overall Study|Lost to Follow-up|0|||
127980124|NCT03408444|460550591|FG000|Overall Study|Adverse Event|0|||
127980125|NCT03408444|460550592|FG001|Overall Study|Adverse Event|0|||
127980126|NCT03408444|460550593|FG002|Overall Study|Adverse Event|0|||
127980127|NCT03408444|460550594|FG003|Overall Study|Adverse Event|1|||
127980128|NCT03408444|460550591|FG000|Overall Study|Lens Handling Difficulties|0|||
127980129|NCT03408444|460550592|FG001|Overall Study|Lens Handling Difficulties|0|||
127980130|NCT03408444|460550593|FG002|Overall Study|Lens Handling Difficulties|1|||
127980131|NCT03408444|460550594|FG003|Overall Study|Lens Handling Difficulties|0|||
127980132|NCT03408444|460550591|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
127980133|NCT03408444|460550592|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
127513945|NCT00353873|458843376|FG000|Overall Study|Adverse Event|1|||
127513946|NCT00353873|458843377|FG001|Overall Study|Adverse Event|0|||
127513947|NCT00353873|458843376|FG000|Overall Study|Physician Decision|2|||
127513948|NCT00353873|458843377|FG001|Overall Study|Physician Decision|0|||
127513949|NCT00353873|458843376|FG000|Overall Study|Withdrawal by Subject|1|||
127513950|NCT00353873|458843377|FG001|Overall Study|Withdrawal by Subject|1|||
127513951|NCT02717130|458843378|FG000|Overall Study|Withdrawal by Subject|1|||
127513952|NCT02717130|458843378|FG000|Overall Study|Adverse Event|1|||
127513953|NCT02717130|458843378|FG000|Overall Study|Physician Decision|1|||
127513954|NCT02717130|458843378|FG000|Overall Study|Study Closure|4|||
127980134|NCT03408444|460550593|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
127980135|NCT03408444|460550594|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
127980136|NCT04984681|460550595|FG000|Overall Study|Lost to Follow-up|3|||
127980137|NCT04984681|460550596|FG001|Overall Study|Lost to Follow-up|1|||
127980138|NCT01473394|460550599|FG000|Overall Study|Adverse Event|13|||
127980139|NCT01473394|460550600|FG001|Overall Study|Adverse Event|16|||
127980140|NCT01473394|460550599|FG000|Overall Study|Insufficient Therapeutic Response|4|||
127980141|NCT01473394|460550600|FG001|Overall Study|Insufficient Therapeutic Response|1|||
127980142|NCT01473394|460550599|FG000|Overall Study|Protocol Violation|7|||
127980143|NCT01473394|460550600|FG001|Overall Study|Protocol Violation|5|||
127980144|NCT01473394|460550599|FG000|Overall Study|Withdrew Consent|12|||
127513955|NCT00106691|458843379|FG000|Overall Study|Adverse Event|60|||
127980145|NCT01473394|460550600|FG001|Overall Study|Withdrew Consent|10|||
127980146|NCT01473394|460550599|FG000|Overall Study|Lost to Follow-up|9|||
127980147|NCT01473394|460550600|FG001|Overall Study|Lost to Follow-up|11|||
127980148|NCT01482962|460550603|FG000|Overall Study|Progressive Disease|65|||
127513956|NCT00106691|458843380|FG001|Overall Study|Adverse Event|64|||
127980149|NCT01482962|460550604|FG001|Overall Study|Progressive Disease|53|||
127980150|NCT01482962|460550603|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
127513957|NCT00106691|458843379|FG000|Overall Study|Lost to Follow-up|23|||
127980151|NCT01482962|460550604|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
127980152|NCT01482962|460550603|FG000|Overall Study|Adverse Event|18|||
127980153|NCT01482962|460550604|FG001|Overall Study|Adverse Event|22|||
127980154|NCT01482962|460550603|FG000|Overall Study|Withdrawal by Participant|8|||
127980155|NCT01482962|460550604|FG001|Overall Study|Withdrawal by Participant|13|||
127980156|NCT01482962|460550603|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
127980157|NCT01482962|460550604|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
127980158|NCT01482962|460550603|FG000|Overall Study|Other Reason|1|||
127980159|NCT01482962|460550604|FG001|Overall Study|Other Reason|5|||
127980160|NCT01482962|460550603|FG000|Overall Study|Study Terminated by Sponsor|5|||
127980161|NCT01482962|460550604|FG001|Overall Study|Study Terminated by Sponsor|2|||
127980162|NCT01482962|460550603|FG000|Overall Study|Did not Receive Study Drug|1|||
127980163|NCT01482962|460550604|FG001|Overall Study|Did not Receive Study Drug|6|||
127980164|NCT00741091|460550609|FG000|Overall Study|Death|13|||
127980165|NCT00741091|460550609|FG000|Overall Study|Lost to Follow-up|16|||
127980166|NCT00741091|460550609|FG000|Overall Study|Withdrawal by Subject|6|||
127980167|NCT00741091|460550609|FG000|Overall Study|Missed Visit|22|||
127980168|NCT01801358|460550610|FG000|Overall Study|Adverse Event|0|||
127980169|NCT01801358|460550611|FG001|Overall Study|Adverse Event|2|||
127980170|NCT01801358|460550612|FG002|Overall Study|Adverse Event|1|||
127980171|NCT01801358|460550613|FG003|Overall Study|Adverse Event|0|||
127980172|NCT01801358|460550614|FG004|Overall Study|Adverse Event|0|||
127980173|NCT01801358|460550615|FG005|Overall Study|Adverse Event|1|||
127980174|NCT01801358|460550610|FG000|Overall Study|Physician Decision|0|||
127980175|NCT01801358|460550611|FG001|Overall Study|Physician Decision|0|||
127980176|NCT01801358|460550612|FG002|Overall Study|Physician Decision|1|||
127980177|NCT01801358|460550613|FG003|Overall Study|Physician Decision|0|||
127980178|NCT01801358|460550614|FG004|Overall Study|Physician Decision|0|||
127980179|NCT01801358|460550615|FG005|Overall Study|Physician Decision|0|||
127980180|NCT01801358|460550610|FG000|Overall Study|Progressive Disease|6|||
127980181|NCT01801358|460550611|FG001|Overall Study|Progressive Disease|4|||
127980182|NCT01801358|460550612|FG002|Overall Study|Progressive Disease|4|||
127980183|NCT01801358|460550613|FG003|Overall Study|Progressive Disease|5|||
127980184|NCT01801358|460550614|FG004|Overall Study|Progressive Disease|6|||
127980185|NCT01801358|460550615|FG005|Overall Study|Progressive Disease|5|||
127980186|NCT01801358|460550610|FG000|Overall Study|Withdrawal by Subject|0|||
127980187|NCT01801358|460550611|FG001|Overall Study|Withdrawal by Subject|0|||
127980188|NCT01801358|460550612|FG002|Overall Study|Withdrawal by Subject|0|||
127980189|NCT01801358|460550613|FG003|Overall Study|Withdrawal by Subject|1|||
127980190|NCT01801358|460550614|FG004|Overall Study|Withdrawal by Subject|0|||
127980191|NCT01801358|460550615|FG005|Overall Study|Withdrawal by Subject|2|||
127980192|NCT00723190|460550617|FG000|Overall Study|Withdrawal by Subject|45|||
127980193|NCT00723190|460550617|FG000|Overall Study|Lost to Follow-up|37|||
127980194|NCT00723190|460550617|FG000|Overall Study|Adverse Event|18|||
127980195|NCT00723190|460550617|FG000|Overall Study|Lack of Efficacy|16|||
127980196|NCT00723190|460550617|FG000|Overall Study|Protocol Violation|15|||
127980197|NCT00723190|460550617|FG000|Overall Study|Other-Premature Discontinuation|9|||
127980198|NCT00723190|460550617|FG000|Overall Study|Other-Not included in safety population|2|||
127980199|NCT01549041|460550623|FG000|Overall Study|Lack of Efficacy|2|||
127980200|NCT01549041|460550624|FG001|Overall Study|Lack of Efficacy|4|||
127980201|NCT01549041|460550623|FG000|Overall Study|Adverse Event|0|||
127980202|NCT01549041|460550624|FG001|Overall Study|Adverse Event|4|||
127980203|NCT00597506|460550625|FG000|Overall Study|Subject is being followed for survival|1|||
127980204|NCT03077659|460550629|FG000|Overall Study|Withdrawal by Subject|0|||
127980205|NCT03077659|460550630|FG001|Overall Study|Withdrawal by Subject|0|||
127980206|NCT03077659|460550631|FG002|Overall Study|Withdrawal by Subject|1|||
127980207|NCT00986986|460550632|FG000|Overall Study|Lost to Follow-up|0|||
127980208|NCT00986986|460550633|FG001|Overall Study|Lost to Follow-up|1|||
127980209|NCT04050124|460550634|FG000|Overall Study|Death|1|||
127980210|NCT04050124|460550635|FG001|Overall Study|Death|0|||
127980211|NCT01537068|460550643|FG000|Overall Study|Lost to Follow-up|2|||
127980212|NCT01537068|460550644|FG001|Overall Study|Lost to Follow-up|1|||
127980213|NCT01537068|460550643|FG000|Overall Study|Adverse Event|0|||
127980214|NCT01537068|460550644|FG001|Overall Study|Adverse Event|1|||
127980215|NCT01537068|460550643|FG000|Overall Study|Withdrawal by Subject|1|||
127980216|NCT01537068|460550644|FG001|Overall Study|Withdrawal by Subject|1|||
127513958|NCT00106691|458843380|FG001|Overall Study|Lost to Follow-up|18|||
127513959|NCT00106691|458843379|FG000|Overall Study|Physician Decision|18|||
127980217|NCT01537068|460550643|FG000|Overall Study|Lack of Efficacy|1|||
127513960|NCT00106691|458843380|FG001|Overall Study|Physician Decision|21|||
127980218|NCT01537068|460550644|FG001|Overall Study|Lack of Efficacy|0|||
127980219|NCT00483704|460550645|FG000|Randomization|Withdrawal by Subject|19|||
127980220|NCT00483704|460550646|FG001|Randomization|Withdrawal by Subject|28|||
127980221|NCT00483704|460550647|FG002|Randomization|Withdrawal by Subject|18|||
127980222|NCT00483704|460550645|FG000|Randomization|Protocol Violation|14|||
127980223|NCT00483704|460550646|FG001|Randomization|Protocol Violation|25|||
127980224|NCT00483704|460550647|FG002|Randomization|Protocol Violation|22|||
127980225|NCT00483704|460550645|FG000|Randomization|Lost to Follow-up|14|||
127980226|NCT00483704|460550646|FG001|Randomization|Lost to Follow-up|14|||
127980227|NCT00483704|460550647|FG002|Randomization|Lost to Follow-up|19|||
127980228|NCT00483704|460550645|FG000|Randomization|Pregnancy|1|||
127980229|NCT00483704|460550646|FG001|Randomization|Pregnancy|0|||
127980230|NCT00483704|460550647|FG002|Randomization|Pregnancy|0|||
127980231|NCT00483704|460550645|FG000|Randomization|Physician Decision|2|||
127980232|NCT00483704|460550646|FG001|Randomization|Physician Decision|4|||
127980233|NCT00483704|460550647|FG002|Randomization|Physician Decision|0|||
127980234|NCT00483704|460550645|FG000|Randomization|Progressive disease|0|||
127980235|NCT00483704|460550646|FG001|Randomization|Progressive disease|0|||
127980236|NCT00483704|460550647|FG002|Randomization|Progressive disease|1|||
127980237|NCT00483704|460550645|FG000|Randomization|Lack of qualifying migraines|21|||
127980238|NCT00483704|460550646|FG001|Randomization|Lack of qualifying migraines|25|||
127980239|NCT00483704|460550647|FG002|Randomization|Lack of qualifying migraines|31|||
127980240|NCT00483704|460550645|FG000|Treatment|Lack of qualifying migraines|101|||
127980241|NCT00483704|460550646|FG001|Treatment|Lack of qualifying migraines|99|||
127980242|NCT00483704|460550647|FG002|Treatment|Lack of qualifying migraines|116|||
127980243|NCT00483704|460550645|FG000|Treatment|Adverse Event|3|||
127980244|NCT00483704|460550646|FG001|Treatment|Adverse Event|5|||
127980245|NCT00483704|460550647|FG002|Treatment|Adverse Event|4|||
127980246|NCT00483704|460550645|FG000|Treatment|Withdrawal by Subject|16|||
127980247|NCT00483704|460550646|FG001|Treatment|Withdrawal by Subject|12|||
127980248|NCT00483704|460550647|FG002|Treatment|Withdrawal by Subject|21|||
127980249|NCT00483704|460550645|FG000|Treatment|Protocol Violation|6|||
127980250|NCT00483704|460550646|FG001|Treatment|Protocol Violation|3|||
127980251|NCT00483704|460550647|FG002|Treatment|Protocol Violation|5|||
127980252|NCT00483704|460550645|FG000|Treatment|Lost to Follow-up|2|||
127980253|NCT00483704|460550646|FG001|Treatment|Lost to Follow-up|7|||
127980254|NCT00483704|460550647|FG002|Treatment|Lost to Follow-up|5|||
127980255|NCT00483704|460550645|FG000|Treatment|Lack of Efficacy|1|||
127980256|NCT00483704|460550646|FG001|Treatment|Lack of Efficacy|1|||
127980257|NCT00483704|460550647|FG002|Treatment|Lack of Efficacy|1|||
127980258|NCT00483704|460550645|FG000|Treatment|Pregnancy|0|||
127980259|NCT00483704|460550646|FG001|Treatment|Pregnancy|1|||
127980260|NCT00483704|460550647|FG002|Treatment|Pregnancy|0|||
127980261|NCT00483704|460550645|FG000|Treatment|Physician Decision|0|||
127980262|NCT00483704|460550646|FG001|Treatment|Physician Decision|1|||
127980263|NCT00483704|460550647|FG002|Treatment|Physician Decision|4|||
127980264|NCT00819780|460550648|FG000|Overall Study|Did not receive study drug|3|||
127980265|NCT00819780|460550649|FG001|Overall Study|Did not receive study drug|4|||
127980266|NCT00819780|460550648|FG000|Overall Study|Still in treatment|25|||
127980267|NCT00819780|460550649|FG001|Overall Study|Still in treatment|17|||
127980268|NCT00150800|460550652|FG000|Overall Study|Adverse Event|89|||
127980269|NCT00150800|460550652|FG000|Overall Study|Death|18|||
127980270|NCT00150800|460550652|FG000|Overall Study|Lack of Efficacy|166|||
127980271|NCT00150800|460550652|FG000|Overall Study|Lost to Follow-up|58|||
127980272|NCT00150800|460550652|FG000|Overall Study|Subject's choice|90|||
127980273|NCT00150800|460550652|FG000|Overall Study|No compliance|18|||
127980274|NCT00150800|460550652|FG000|Overall Study|IP misshandling|1|||
127980275|NCT00150800|460550652|FG000|Overall Study|Site closure|24|||
127980276|NCT00150800|460550652|FG000|Overall Study|Protocol non-adherence|2|||
127980277|NCT00150800|460550652|FG000|Overall Study|Nobody to accompany patient|1|||
127980278|NCT00150800|460550652|FG000|Overall Study|Distance too long for patient|1|||
127980279|NCT00150800|460550652|FG000|Overall Study|Neurosurgery|2|||
127980280|NCT00150800|460550652|FG000|Overall Study|BRV monotherapy|1|||
127980281|NCT00150800|460550652|FG000|Overall Study|Visit refusal|3|||
127980282|NCT00150800|460550652|FG000|Overall Study|Sponsor's request|2|||
127980283|NCT00150800|460550652|FG000|Overall Study|Generalized Epilepsy|1|||
127980284|NCT00150800|460550652|FG000|Overall Study|Moved from area/country|8|||
127980285|NCT00150800|460550652|FG000|Overall Study|PI retiring|2|||
127980286|NCT00150800|460550652|FG000|Overall Study|PI leaving site|2|||
127980287|NCT00150800|460550652|FG000|Overall Study|Patient insurance|1|||
127980288|NCT00150800|460550652|FG000|Overall Study|Surgical intervention|4|||
127980289|NCT00150800|460550652|FG000|Overall Study|Pregnancy planned|1|||
127980290|NCT00150800|460550652|FG000|Overall Study|PI discontinuation request|1|||
127980291|NCT04450407|460550653|FG000|Overall Study|Withdrawal by Subject|10|||
127980292|NCT04450407|460550654|FG001|Overall Study|Withdrawal by Subject|1|||
127980293|NCT04450407|460550655|FG002|Overall Study|Withdrawal by Subject|4|||
127980294|NCT04450407|460550653|FG000|Overall Study|Adverse Event|0|||
127980295|NCT04450407|460550654|FG001|Overall Study|Adverse Event|0|||
127980296|NCT04450407|460550655|FG002|Overall Study|Adverse Event|1|||
127980297|NCT04450407|460550653|FG000|Overall Study|Lost to Follow-up|1|||
127980298|NCT04450407|460550654|FG001|Overall Study|Lost to Follow-up|0|||
127980299|NCT04450407|460550655|FG002|Overall Study|Lost to Follow-up|0|||
127980300|NCT04450407|460550653|FG000|Overall Study|Physician Decision|0|||
127980301|NCT04450407|460550654|FG001|Overall Study|Physician Decision|0|||
127980302|NCT04450407|460550655|FG002|Overall Study|Physician Decision|1|||
127980303|NCT04450407|460550653|FG000|Overall Study|Pregnancy|1|||
127980304|NCT04450407|460550654|FG001|Overall Study|Pregnancy|0|||
127980305|NCT04450407|460550655|FG002|Overall Study|Pregnancy|0|||
127980306|NCT04450407|460550653|FG000|Overall Study|Protocol Violation|2|||
127980307|NCT04450407|460550654|FG001|Overall Study|Protocol Violation|0|||
127980308|NCT04450407|460550655|FG002|Overall Study|Protocol Violation|0|||
127980309|NCT04450407|460550653|FG000|Overall Study|Investigational site terminated by sponsor|3|||
127980310|NCT04450407|460550654|FG001|Overall Study|Investigational site terminated by sponsor|0|||
127980311|NCT04450407|460550655|FG002|Overall Study|Investigational site terminated by sponsor|2|||
127980312|NCT02089334|460550656|FG000|Overall Study|Withdrawal by Subject|0|||
127980313|NCT02089334|460550657|FG001|Overall Study|Withdrawal by Subject|0|||
127980314|NCT02089334|460550658|FG002|Overall Study|Withdrawal by Subject|0|||
127980315|NCT02089334|460550659|FG003|Overall Study|Withdrawal by Subject|2|||
127980316|NCT02089334|460550656|FG000|Overall Study|Adverse Event|0|||
127980317|NCT02089334|460550657|FG001|Overall Study|Adverse Event|0|||
127980318|NCT02089334|460550658|FG002|Overall Study|Adverse Event|0|||
127980319|NCT02089334|460550659|FG003|Overall Study|Adverse Event|2|||
127980320|NCT02089334|460550656|FG000|Overall Study|Progressive disease|0|||
127980321|NCT02089334|460550657|FG001|Overall Study|Progressive disease|0|||
127980322|NCT02089334|460550658|FG002|Overall Study|Progressive disease|0|||
127980323|NCT02089334|460550659|FG003|Overall Study|Progressive disease|2|||
127980324|NCT02089334|460550656|FG000|Overall Study|Physician Decision|0|||
127980325|NCT02089334|460550657|FG001|Overall Study|Physician Decision|0|||
127980326|NCT02089334|460550658|FG002|Overall Study|Physician Decision|1|||
127980327|NCT02089334|460550659|FG003|Overall Study|Physician Decision|1|||
127980328|NCT02832375|460550660|FG000|Overall Study|Lost to Follow-up|1|||
127980329|NCT02832375|460550661|FG001|Overall Study|Lost to Follow-up|0|||
127980330|NCT02832375|460550660|FG000|Overall Study|Withdrawal of Consent|1|||
127980331|NCT02832375|460550661|FG001|Overall Study|Withdrawal of Consent|0|||
127980332|NCT00084318|460550664|FG000|Overall Study|Withdrawal by Subject|5|||
127980333|NCT00084318|460550665|FG001|Overall Study|Withdrawal by Subject|2|||
127980334|NCT00084318|460550664|FG000|Overall Study|Protocol Violation|15|||
127980335|NCT00084318|460550665|FG001|Overall Study|Protocol Violation|11|||
127980336|NCT00084318|460550664|FG000|Overall Study|No protocol treatment|2|||
127980337|NCT00084318|460550665|FG001|Overall Study|No protocol treatment|0|||
127980338|NCT01645891|460550669|FG000|Overall Study|Adverse Event|6|||
127980339|NCT01645891|460550670|FG001|Overall Study|Adverse Event|10|||
127980340|NCT01645891|460550669|FG000|Overall Study|Adverse Event Unrelated to Wound|5|||
127980341|NCT01645891|460550670|FG001|Overall Study|Adverse Event Unrelated to Wound|3|||
127980342|NCT01645891|460550669|FG000|Overall Study|Withdrawal by Subject|3|||
127980343|NCT01645891|460550670|FG001|Overall Study|Withdrawal by Subject|3|||
127980344|NCT01645891|460550669|FG000|Overall Study|Protocol Violation|4|||
127980345|NCT01645891|460550670|FG001|Overall Study|Protocol Violation|0|||
127980346|NCT01645891|460550669|FG000|Overall Study|Lost to Follow-up|4|||
127980347|NCT01645891|460550670|FG001|Overall Study|Lost to Follow-up|1|||
127980348|NCT01645891|460550669|FG000|Overall Study|Death|0|||
127980349|NCT01645891|460550670|FG001|Overall Study|Death|2|||
127980350|NCT03301740|460550671|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
127980351|NCT03301740|460550672|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
127980352|NCT03301740|460550671|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
127980353|NCT03301740|460550672|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
127980354|NCT01037127|460550673|FG000|Overall Study|Lost to Follow-up|2|||
127980355|NCT01037127|460550674|FG001|Overall Study|Lost to Follow-up|4|||
127980356|NCT01037127|460550673|FG000|Overall Study|Physician Decision|1|||
127980357|NCT01037127|460550674|FG001|Overall Study|Physician Decision|0|||
127980358|NCT01037127|460550673|FG000|Overall Study|Study Closed Terminated|2|||
127980359|NCT01037127|460550674|FG001|Overall Study|Study Closed Terminated|17|||
127980360|NCT02637713|460550681|FG000|Overall Study|Screen Failure|2|||
127980361|NCT01173055|460550682|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
127980362|NCT01173055|460550683|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
127980363|NCT01173055|460550682|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
127980364|NCT01173055|460550683|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
127980365|NCT04325698|460550684|FG000|Overall Study|Study Terminated By Sponsor|1|||
127980366|NCT04325698|460550685|FG001|Overall Study|Study Terminated By Sponsor|1|||
127980367|NCT04325698|460550684|FG000|Overall Study|Withdrawal by Subject|0|||
127980368|NCT04325698|460550685|FG001|Overall Study|Withdrawal by Subject|2|||
127980369|NCT04253782|460550686|FG000|Overall Study|Death|2|||
127980370|NCT04253782|460550687|FG001|Overall Study|Death|0|||
127980371|NCT00962091|460550688|FG000|Overall Study|Withdrawal by Subject|1|||
127980372|NCT00962091|460550689|FG001|Overall Study|Withdrawal by Subject|2|||
127980373|NCT00962091|460550690|FG002|Overall Study|Withdrawal by Subject|1|||
127980374|NCT00962091|460550691|FG003|Overall Study|Withdrawal by Subject|1|||
127980375|NCT00962091|460550692|FG004|Overall Study|Withdrawal by Subject|0|||
127980376|NCT00962091|460550693|FG005|Overall Study|Withdrawal by Subject|1|||
127980377|NCT00962091|460550694|FG006|Overall Study|Withdrawal by Subject|0|||
127980378|NCT00962091|460550688|FG000|Overall Study|Adverse Event|0|||
127980379|NCT00962091|460550689|FG001|Overall Study|Adverse Event|0|||
127980380|NCT00962091|460550690|FG002|Overall Study|Adverse Event|0|||
127980381|NCT00962091|460550691|FG003|Overall Study|Adverse Event|0|||
127980382|NCT00962091|460550692|FG004|Overall Study|Adverse Event|0|||
127980383|NCT00962091|460550693|FG005|Overall Study|Adverse Event|0|||
127980384|NCT00962091|460550694|FG006|Overall Study|Adverse Event|1|||
127980385|NCT03191864|460550699|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
127980386|NCT03191864|460550700|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
127980387|NCT03191864|460550701|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
127980388|NCT03191864|460550702|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
127980389|NCT03191864|460550703|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
127980390|NCT03191864|460550704|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
127980391|NCT03191864|460550699|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
127980392|NCT03191864|460550700|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
127980393|NCT03191864|460550701|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
127980394|NCT03191864|460550702|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
127980395|NCT03191864|460550703|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
127980396|NCT03191864|460550704|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
127980397|NCT03191864|460550699|FG000|Baseline Symptom Assessment|Adverse Event|0|||
127980398|NCT03191864|460550700|FG001|Baseline Symptom Assessment|Adverse Event|0|||
127980399|NCT03191864|460550701|FG002|Baseline Symptom Assessment|Adverse Event|0|||
127980400|NCT03191864|460550702|FG003|Baseline Symptom Assessment|Adverse Event|0|||
127980401|NCT03191864|460550703|FG004|Baseline Symptom Assessment|Adverse Event|0|||
127980402|NCT03191864|460550704|FG005|Baseline Symptom Assessment|Adverse Event|2|||
127980403|NCT03191864|460550699|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
127980404|NCT03191864|460550700|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
127980405|NCT03191864|460550701|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
127980406|NCT03191864|460550702|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
127980407|NCT03191864|460550703|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
127980408|NCT03191864|460550704|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
127980409|NCT03191864|460550699|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
127980410|NCT03191864|460550700|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
127980411|NCT03191864|460550701|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
127980412|NCT03191864|460550702|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
127980413|NCT03191864|460550703|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
127980414|NCT03191864|460550704|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
127980415|NCT03191864|460550699|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
127980416|NCT03191864|460550700|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
127980417|NCT03191864|460550701|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
127980418|NCT03191864|460550702|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
127980419|NCT03191864|460550703|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
127980420|NCT03191864|460550704|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
127980421|NCT03191864|460550699|FG000|Part 1 - Induction|Adverse Event|0|||
127980422|NCT03191864|460550700|FG001|Part 1 - Induction|Adverse Event|2|||
127980423|NCT03191864|460550701|FG002|Part 1 - Induction|Adverse Event|0|||
127980424|NCT03191864|460550702|FG003|Part 1 - Induction|Adverse Event|1|||
127980425|NCT03191864|460550703|FG004|Part 1 - Induction|Adverse Event|0|||
127980426|NCT03191864|460550704|FG005|Part 1 - Induction|Adverse Event|2|||
127980427|NCT03191864|460550699|FG000|Part 1 - Induction|Randomized but never dosed|0|||
127980428|NCT03191864|460550700|FG001|Part 1 - Induction|Randomized but never dosed|0|||
127980429|NCT03191864|460550701|FG002|Part 1 - Induction|Randomized but never dosed|1|||
127980430|NCT03191864|460550702|FG003|Part 1 - Induction|Randomized but never dosed|0|||
127980431|NCT03191864|460550703|FG004|Part 1 - Induction|Randomized but never dosed|0|||
127980432|NCT03191864|460550704|FG005|Part 1 - Induction|Randomized but never dosed|0|||
127980433|NCT03191864|460550699|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
127980434|NCT03191864|460550700|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
127980435|NCT03191864|460550701|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
127980436|NCT03191864|460550702|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
127980437|NCT03191864|460550703|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
127980438|NCT03191864|460550704|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
127980439|NCT03191864|460550699|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
127980440|NCT03191864|460550700|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
127980441|NCT03191864|460550701|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
127980442|NCT03191864|460550702|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
127980443|NCT03191864|460550703|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
127980444|NCT03191864|460550704|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
127980445|NCT03191864|460550699|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
127980446|NCT03191864|460550700|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
127980447|NCT03191864|460550701|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
127980448|NCT03191864|460550702|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
127980449|NCT03191864|460550703|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
127980450|NCT03191864|460550704|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
127513961|NCT00106691|458843379|FG000|Overall Study|Protocol Violation|13|||
127980451|NCT03191864|460550699|FG000|Part 2 - Maintenance|Physician Decision|1|||
127513962|NCT00106691|458843380|FG001|Overall Study|Protocol Violation|18|||
127980452|NCT03191864|460550700|FG001|Part 2 - Maintenance|Physician Decision|0|||
127980453|NCT03191864|460550701|FG002|Part 2 - Maintenance|Physician Decision|0|||
127980454|NCT03191864|460550702|FG003|Part 2 - Maintenance|Physician Decision|0|||
127980455|NCT03191864|460550703|FG004|Part 2 - Maintenance|Physician Decision|0|||
127980456|NCT03191864|460550704|FG005|Part 2 - Maintenance|Physician Decision|0|||
127980457|NCT03191864|460550699|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
127980458|NCT03191864|460550700|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
127980459|NCT03191864|460550701|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
127980460|NCT03191864|460550702|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
127980461|NCT03191864|460550703|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
127980462|NCT03191864|460550704|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
127980463|NCT03191864|460550699|FG000|Part 2 - Maintenance|Adverse Event|0|||
127980464|NCT03191864|460550700|FG001|Part 2 - Maintenance|Adverse Event|0|||
127980465|NCT03191864|460550701|FG002|Part 2 - Maintenance|Adverse Event|0|||
127980466|NCT03191864|460550702|FG003|Part 2 - Maintenance|Adverse Event|0|||
127980467|NCT03191864|460550703|FG004|Part 2 - Maintenance|Adverse Event|1|||
127980468|NCT03191864|460550704|FG005|Part 2 - Maintenance|Adverse Event|0|||
127980469|NCT03191864|460550699|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
127980470|NCT03191864|460550700|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
127980471|NCT03191864|460550701|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
127980472|NCT03191864|460550702|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
127980473|NCT03191864|460550703|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
127980474|NCT03191864|460550704|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
127980475|NCT03191864|460550699|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
127980476|NCT03191864|460550700|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
127980477|NCT03191864|460550701|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
127980478|NCT03191864|460550702|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
127980479|NCT03191864|460550703|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
127980480|NCT03191864|460550704|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
127980481|NCT02342548|460550707|FG000|Overall Study|Adverse Event|12|||
127980482|NCT02342548|460550708|FG001|Overall Study|Adverse Event|17|||
127980483|NCT02342548|460550709|FG002|Overall Study|Adverse Event|13|||
127980484|NCT02342548|460550707|FG000|Overall Study|Lost to Follow-up|0|||
127980485|NCT02342548|460550708|FG001|Overall Study|Lost to Follow-up|1|||
127980486|NCT02342548|460550709|FG002|Overall Study|Lost to Follow-up|0|||
127980487|NCT02342548|460550707|FG000|Overall Study|Study terminated by sponsor|20|||
127980488|NCT02342548|460550708|FG001|Overall Study|Study terminated by sponsor|39|||
127980489|NCT02342548|460550709|FG002|Overall Study|Study terminated by sponsor|25|||
127980490|NCT02342548|460550707|FG000|Overall Study|Protocol Violation|0|||
127980491|NCT02342548|460550708|FG001|Overall Study|Protocol Violation|1|||
127980492|NCT02342548|460550709|FG002|Overall Study|Protocol Violation|0|||
127980493|NCT02342548|460550707|FG000|Overall Study|Withdrawal by Subject|1|||
127980494|NCT02342548|460550708|FG001|Overall Study|Withdrawal by Subject|3|||
127980495|NCT02342548|460550709|FG002|Overall Study|Withdrawal by Subject|4|||
127980496|NCT02342548|460550707|FG000|Overall Study|Other|1|||
127980497|NCT02342548|460550708|FG001|Overall Study|Other|1|||
127980498|NCT02342548|460550709|FG002|Overall Study|Other|1|||
127980499|NCT01047332|460550710|FG000|Overall Study|SEMS Obstruction|11|||
127980500|NCT01047332|460550711|FG001|Overall Study|SEMS Obstruction|20|||
127980501|NCT01047332|460550710|FG000|Overall Study|Died Unobstructed|38|||
127980502|NCT01047332|460550711|FG001|Overall Study|Died Unobstructed|41|||
127980503|NCT01047332|460550710|FG000|Overall Study|Lost to Follow-up|8|||
127980504|NCT01047332|460550711|FG001|Overall Study|Lost to Follow-up|3|||
127980505|NCT02417961|460552125|FG000|Overall Study|Adverse Event|1|||
127980506|NCT02417961|460552125|FG000|Overall Study|Lost to Follow-up|1|||
127980507|NCT02417961|460552125|FG000|Overall Study|Withdrawal by Subject|2|||
127980508|NCT04743804|460552128|FG000|Overall Study|Other|1|||
127980509|NCT04743804|460552129|FG001|Overall Study|Other|0|||
127980510|NCT04743804|460552128|FG000|Overall Study|Withdrawal by Subject|0|||
127980511|NCT04743804|460552129|FG001|Overall Study|Withdrawal by Subject|1|||
127980512|NCT04743804|460552128|FG000|Overall Study|Study Terminated by Sponsor|1|||
127980513|NCT04743804|460552129|FG001|Overall Study|Study Terminated by Sponsor|4|||
127980514|NCT04743804|460552128|FG000|Overall Study|Physician Decision|0|||
127513963|NCT00106691|458843379|FG000|Overall Study|Withdrawal by Subject|75|||
127513964|NCT00106691|458843380|FG001|Overall Study|Withdrawal by Subject|70|||
127980515|NCT04743804|460552129|FG001|Overall Study|Physician Decision|1|||
127980516|NCT04743804|460552128|FG000|Overall Study|Death|3|||
127980517|NCT04743804|460552129|FG001|Overall Study|Death|0|||
127980518|NCT02059434|460552133|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
127980519|NCT02059434|460552134|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
127980520|NCT02059434|460552135|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
127980521|NCT02059434|460552136|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
127980522|NCT02059434|460552137|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
127980523|NCT02059434|460552138|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
127980524|NCT02059434|460552139|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
127980525|NCT02059434|460552140|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
127980526|NCT02059434|460552141|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
127980527|NCT02059434|460552133|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
127980528|NCT02059434|460552134|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
127980529|NCT02059434|460552135|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
127980530|NCT02059434|460552136|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
127980531|NCT02059434|460552137|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
127980532|NCT02059434|460552138|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
127980533|NCT02059434|460552139|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
127980534|NCT02059434|460552140|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
127980535|NCT02059434|460552141|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
127980536|NCT02059434|460552133|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
127980537|NCT02059434|460552134|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
127980538|NCT02059434|460552135|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
127980539|NCT02059434|460552136|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
127980540|NCT02059434|460552137|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
127980541|NCT02059434|460552138|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
127980542|NCT02059434|460552139|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
127980543|NCT02059434|460552140|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
127980544|NCT02059434|460552141|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
127980545|NCT02059434|460552133|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
127980546|NCT02059434|460552134|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
127980547|NCT02059434|460552135|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
127980548|NCT02059434|460552136|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
127980549|NCT02059434|460552137|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
127980550|NCT02059434|460552138|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
127980551|NCT02059434|460552139|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
127980552|NCT02059434|460552140|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
127980553|NCT02059434|460552141|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
127980554|NCT02059434|460552133|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
127980555|NCT02059434|460552134|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
127980556|NCT02059434|460552135|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
127980557|NCT02059434|460552136|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
127980558|NCT02059434|460552137|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
127980559|NCT02059434|460552138|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
127980560|NCT02059434|460552139|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
127980561|NCT02059434|460552140|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
127980562|NCT02059434|460552141|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
127980563|NCT01004406|460552146|FG000|Overall Study|Withdrawal by Subject|2|||
127980564|NCT01004406|460552147|FG001|Overall Study|Withdrawal by Subject|0|||
127980565|NCT01004406|460552146|FG000|Overall Study|Lost to Follow-up|1|||
127980566|NCT01004406|460552147|FG001|Overall Study|Lost to Follow-up|0|||
127980567|NCT02928770|460552148|FG000|Overall Study|Withdrawal by Subject|2|||
127980568|NCT03201874|460552151|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
127980569|NCT03201874|460552152|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
127980570|NCT03201874|460552151|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
127980571|NCT03201874|460552152|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
127980572|NCT02907593|460552153|FG000|Overall Study|Withdrawal by Subject|0|||
127980573|NCT02907593|460552154|FG001|Overall Study|Withdrawal by Subject|0|||
127980574|NCT02907593|460552155|FG002|Overall Study|Withdrawal by Subject|1|||
127980575|NCT02907593|460552156|FG003|Overall Study|Withdrawal by Subject|0|||
127980576|NCT04618471|460552157|FG000|Overall Study|Screen Failure|62|||
127980577|NCT04618471|460552157|FG000|Overall Study|Withdrawal by Subject|6|||
127980578|NCT04618471|460552157|FG000|Overall Study|Physician Decision|2|||
127980579|NCT04618471|460552157|FG000|Overall Study|Lost to Follow-up|1|||
127980580|NCT04618471|460552157|FG000|Overall Study|Various other reasons|2|||
127980581|NCT04618471|460552157|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
127980582|NCT01752634|460552158|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
127980583|NCT01752634|460552159|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
127980584|NCT01752634|460552160|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
127980585|NCT01752634|460552161|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
127980586|NCT01752634|460552162|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
127980587|NCT01752634|460552163|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
127980588|NCT01752634|460552158|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
127980589|NCT01752634|460552159|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
127980590|NCT01752634|460552160|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
127980591|NCT01752634|460552161|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
127980592|NCT01752634|460552162|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
127980593|NCT01752634|460552163|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
127980594|NCT01752634|460552158|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
127980595|NCT01752634|460552159|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
127980596|NCT01752634|460552160|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
127980597|NCT01752634|460552161|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
127980598|NCT01752634|460552162|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
127980599|NCT01752634|460552163|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
127980600|NCT01752634|460552158|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
127980601|NCT01752634|460552159|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
127980602|NCT01752634|460552160|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
127980603|NCT01752634|460552161|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
127980604|NCT01752634|460552162|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
127980605|NCT01752634|460552163|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
127980606|NCT01752634|460552158|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
127980607|NCT01752634|460552159|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
127980608|NCT01752634|460552160|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
127980609|NCT01752634|460552161|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
127980610|NCT01752634|460552162|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
127980611|NCT01752634|460552163|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
127980612|NCT01752634|460552158|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
127980613|NCT01752634|460552159|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
127980614|NCT01752634|460552160|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
127980615|NCT01752634|460552161|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
127980616|NCT01752634|460552162|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
127980617|NCT01752634|460552163|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
127980618|NCT01752634|460552158|FG000|Week 24 to Week 260|Physician Decision|1|||
127980619|NCT01752634|460552159|FG001|Week 24 to Week 260|Physician Decision|2|||
127980620|NCT01752634|460552160|FG002|Week 24 to Week 260|Physician Decision|4|||
127980621|NCT01752634|460552161|FG003|Week 24 to Week 260|Physician Decision|2|||
127980622|NCT01752634|460552162|FG004|Week 24 to Week 260|Physician Decision|1|||
127980623|NCT01752634|460552163|FG005|Week 24 to Week 260|Physician Decision|0|||
127980624|NCT01752634|460552158|FG000|Week 24 to Week 260|Death|0|||
127980625|NCT01752634|460552159|FG001|Week 24 to Week 260|Death|1|||
127980626|NCT01752634|460552160|FG002|Week 24 to Week 260|Death|0|||
127980627|NCT01752634|460552161|FG003|Week 24 to Week 260|Death|0|||
127980628|NCT01752634|460552162|FG004|Week 24 to Week 260|Death|0|||
127980629|NCT01752634|460552163|FG005|Week 24 to Week 260|Death|0|||
127980630|NCT01752634|460552158|FG000|Week 24 to Week 260|Pregnancy|0|||
127980631|NCT01752634|460552159|FG001|Week 24 to Week 260|Pregnancy|0|||
127980632|NCT01752634|460552160|FG002|Week 24 to Week 260|Pregnancy|1|||
127980633|NCT01752634|460552161|FG003|Week 24 to Week 260|Pregnancy|0|||
127980634|NCT01752634|460552162|FG004|Week 24 to Week 260|Pregnancy|0|||
127980635|NCT01752634|460552163|FG005|Week 24 to Week 260|Pregnancy|0|||
127980636|NCT01752634|460552158|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
127980637|NCT01752634|460552159|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
127980638|NCT01752634|460552160|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
127980639|NCT01752634|460552161|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
127980640|NCT01752634|460552162|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
127980641|NCT01752634|460552163|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
127980642|NCT01752634|460552158|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
127980643|NCT01752634|460552159|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
127980644|NCT01752634|460552160|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
127980645|NCT01752634|460552161|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
127980646|NCT01752634|460552162|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
127980647|NCT01752634|460552163|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
127980648|NCT01752634|460552158|FG000|Week 24 to Week 260|Adverse Event|4|||
127980649|NCT01752634|460552159|FG001|Week 24 to Week 260|Adverse Event|8|||
127980650|NCT01752634|460552160|FG002|Week 24 to Week 260|Adverse Event|8|||
127980651|NCT01752634|460552161|FG003|Week 24 to Week 260|Adverse Event|4|||
127980652|NCT01752634|460552162|FG004|Week 24 to Week 260|Adverse Event|2|||
127980653|NCT01752634|460552163|FG005|Week 24 to Week 260|Adverse Event|0|||
127980654|NCT01451164|460552171|FG000|Overall Study|Adverse Event|19|||
127980655|NCT01451164|460552172|FG001|Overall Study|Adverse Event|12|||
127980656|NCT01451164|460552173|FG002|Overall Study|Adverse Event|18|||
127980657|NCT01451164|460552174|FG003|Overall Study|Adverse Event|21|||
127980658|NCT01451164|460552171|FG000|Overall Study|Withdrawal Criteria|1|||
127980659|NCT01451164|460552172|FG001|Overall Study|Withdrawal Criteria|1|||
127980660|NCT01451164|460552173|FG002|Overall Study|Withdrawal Criteria|1|||
127980661|NCT01451164|460552174|FG003|Overall Study|Withdrawal Criteria|1|||
127980662|NCT01451164|460552171|FG000|Overall Study|Physician Decision|2|||
127980663|NCT01451164|460552172|FG001|Overall Study|Physician Decision|0|||
127980664|NCT01451164|460552173|FG002|Overall Study|Physician Decision|1|||
127980665|NCT01451164|460552174|FG003|Overall Study|Physician Decision|0|||
127980666|NCT01451164|460552171|FG000|Overall Study|Withdrawal by Subject|14|||
127980667|NCT01451164|460552172|FG001|Overall Study|Withdrawal by Subject|11|||
127980668|NCT01451164|460552173|FG002|Overall Study|Withdrawal by Subject|16|||
127980669|NCT01451164|460552174|FG003|Overall Study|Withdrawal by Subject|17|||
127980670|NCT01451164|460552171|FG000|Overall Study|Protocol Violation|0|||
127980671|NCT01451164|460552172|FG001|Overall Study|Protocol Violation|1|||
127980672|NCT01451164|460552173|FG002|Overall Study|Protocol Violation|0|||
127980673|NCT01451164|460552174|FG003|Overall Study|Protocol Violation|0|||
127980674|NCT01451164|460552171|FG000|Overall Study|Lack of Efficacy|7|||
127980675|NCT01451164|460552172|FG001|Overall Study|Lack of Efficacy|9|||
127980676|NCT01451164|460552173|FG002|Overall Study|Lack of Efficacy|9|||
127980677|NCT01451164|460552174|FG003|Overall Study|Lack of Efficacy|7|||
127980678|NCT04599933|460552175|FG000|Overall Study|Adverse Event|4|||
127980679|NCT04599933|460552176|FG001|Overall Study|Adverse Event|1|||
127980680|NCT04599933|460552175|FG000|Overall Study|Withdrawal by Subject|4|||
127980681|NCT04599933|460552176|FG001|Overall Study|Withdrawal by Subject|2|||
127980682|NCT04599933|460552175|FG000|Overall Study|Lost to Follow-up|0|||
127980683|NCT04599933|460552176|FG001|Overall Study|Lost to Follow-up|1|||
127980684|NCT04599933|460552175|FG000|Overall Study|Physician Decision|0|||
127980685|NCT04599933|460552176|FG001|Overall Study|Physician Decision|1|||
127980686|NCT04599933|460552175|FG000|Overall Study|Screen Failure|1|||
127980687|NCT04599933|460552176|FG001|Overall Study|Screen Failure|2|||
127980688|NCT03226678|460552179|FG000|Part A (Core Study Phase)|Adverse Event|0|||
127980689|NCT03226678|460552180|FG001|Part A (Core Study Phase)|Adverse Event|1|||
127980690|NCT03226678|460552181|FG002|Part A (Core Study Phase)|Adverse Event|0|||
127980691|NCT03226678|460552182|FG003|Part A (Core Study Phase)|Adverse Event|0|||
127980692|NCT03226678|460552183|FG004|Part A (Core Study Phase)|Adverse Event|0|||
127980693|NCT03226678|460552184|FG005|Part A (Core Study Phase)|Adverse Event|0|||
127980694|NCT03226678|460552179|FG000|Part A (Core Study Phase)|Death|0|||
127980695|NCT03226678|460552180|FG001|Part A (Core Study Phase)|Death|0|||
127980696|NCT03226678|460552181|FG002|Part A (Core Study Phase)|Death|1|||
127980697|NCT03226678|460552182|FG003|Part A (Core Study Phase)|Death|0|||
127980698|NCT03226678|460552183|FG004|Part A (Core Study Phase)|Death|0|||
127980699|NCT03226678|460552184|FG005|Part A (Core Study Phase)|Death|0|||
127980700|NCT03226678|460552179|FG000|Part A (Core Study Phase)|Lack of Efficacy|0|||
127980701|NCT03226678|460552180|FG001|Part A (Core Study Phase)|Lack of Efficacy|1|||
127980702|NCT03226678|460552181|FG002|Part A (Core Study Phase)|Lack of Efficacy|0|||
127980703|NCT03226678|460552182|FG003|Part A (Core Study Phase)|Lack of Efficacy|0|||
127980704|NCT03226678|460552183|FG004|Part A (Core Study Phase)|Lack of Efficacy|0|||
127980705|NCT03226678|460552184|FG005|Part A (Core Study Phase)|Lack of Efficacy|0|||
127980706|NCT03226678|460552179|FG000|Part A (Core Study Phase)|Non-compliance with study drug|0|||
127980707|NCT03226678|460552180|FG001|Part A (Core Study Phase)|Non-compliance with study drug|0|||
127980708|NCT03226678|460552181|FG002|Part A (Core Study Phase)|Non-compliance with study drug|1|||
127980709|NCT03226678|460552182|FG003|Part A (Core Study Phase)|Non-compliance with study drug|0|||
127980710|NCT03226678|460552183|FG004|Part A (Core Study Phase)|Non-compliance with study drug|0|||
127980711|NCT03226678|460552184|FG005|Part A (Core Study Phase)|Non-compliance with study drug|0|||
127980712|NCT03226678|460552179|FG000|Part A (Core Study Phase)|Withdrawal by Subject|0|||
127980713|NCT03226678|460552180|FG001|Part A (Core Study Phase)|Withdrawal by Subject|0|||
127980714|NCT03226678|460552181|FG002|Part A (Core Study Phase)|Withdrawal by Subject|0|||
127980715|NCT03226678|460552182|FG003|Part A (Core Study Phase)|Withdrawal by Subject|1|||
127980716|NCT03226678|460552183|FG004|Part A (Core Study Phase)|Withdrawal by Subject|0|||
127980717|NCT03226678|460552184|FG005|Part A (Core Study Phase)|Withdrawal by Subject|0|||
127980718|NCT03226678|460552179|FG000|Part A (Core Study Phase)|Withdrew, per Investigator|2|||
127980719|NCT03226678|460552180|FG001|Part A (Core Study Phase)|Withdrew, per Investigator|1|||
127980720|NCT03226678|460552181|FG002|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
127980721|NCT03226678|460552182|FG003|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
127980722|NCT03226678|460552183|FG004|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
127980723|NCT03226678|460552184|FG005|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
127980724|NCT03226678|460552179|FG000|Part B (Long-Term Extension Phase)|Adverse Event|0|||
127980725|NCT03226678|460552180|FG001|Part B (Long-Term Extension Phase)|Adverse Event|0|||
127513965|NCT00106691|458843379|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
127513966|NCT00106691|458843380|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
127980726|NCT03226678|460552181|FG002|Part B (Long-Term Extension Phase)|Adverse Event|0|||
127980727|NCT03226678|460552182|FG003|Part B (Long-Term Extension Phase)|Adverse Event|0|||
127980728|NCT03226678|460552183|FG004|Part B (Long-Term Extension Phase)|Adverse Event|2|||
127980729|NCT03226678|460552184|FG005|Part B (Long-Term Extension Phase)|Adverse Event|1|||
127980730|NCT03226678|460552179|FG000|Part B (Long-Term Extension Phase)|Death|0|||
127980731|NCT03226678|460552180|FG001|Part B (Long-Term Extension Phase)|Death|0|||
127980732|NCT03226678|460552181|FG002|Part B (Long-Term Extension Phase)|Death|0|||
127980733|NCT03226678|460552182|FG003|Part B (Long-Term Extension Phase)|Death|0|||
127980734|NCT03226678|460552183|FG004|Part B (Long-Term Extension Phase)|Death|0|||
127980735|NCT03226678|460552184|FG005|Part B (Long-Term Extension Phase)|Death|1|||
127980736|NCT03226678|460552179|FG000|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
127980737|NCT03226678|460552180|FG001|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
127980738|NCT03226678|460552181|FG002|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
127980739|NCT03226678|460552182|FG003|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
127980740|NCT03226678|460552183|FG004|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
127980741|NCT03226678|460552184|FG005|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|1|||
127980742|NCT03226678|460552179|FG000|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
127980743|NCT03226678|460552180|FG001|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
127980744|NCT03226678|460552181|FG002|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
127980745|NCT03226678|460552182|FG003|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
127980746|NCT03226678|460552183|FG004|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|3|||
127980747|NCT03226678|460552184|FG005|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|5|||
127980748|NCT03226678|460552179|FG000|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
127980749|NCT03226678|460552180|FG001|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
127980750|NCT03226678|460552181|FG002|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
127980751|NCT03226678|460552182|FG003|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
127980752|NCT03226678|460552183|FG004|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
127980753|NCT03226678|460552184|FG005|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|1|||
127980754|NCT03117881|460552185|FG000|Baseline|Withdrawal by Subject|21|||
127980755|NCT03117881|460552186|FG001|Baseline|Withdrawal by Subject|10|||
127980756|NCT03117881|460552187|FG002|Baseline|Withdrawal by Subject|0|||
127980757|NCT03117881|460552185|FG000|Baseline|Lost to Follow-up|22|||
127980758|NCT03117881|460552186|FG001|Baseline|Lost to Follow-up|25|||
127980759|NCT03117881|460552187|FG002|Baseline|Lost to Follow-up|0|||
127980760|NCT03117881|460552185|FG000|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|26|||
127980761|NCT03117881|460552186|FG001|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|21|||
127980762|NCT03117881|460552187|FG002|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|1|||
127980763|NCT03117881|460552185|FG000|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|34|||
127980764|NCT03117881|460552186|FG001|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|38|||
127980765|NCT03117881|460552187|FG002|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|4|||
127980766|NCT03117881|460552185|FG000|Post-Intervention Follow-Up (3 Months)|Did not complete test|33|||
127980767|NCT03117881|460552186|FG001|Post-Intervention Follow-Up (3 Months)|Did not complete test|22|||
127980768|NCT03117881|460552187|FG002|Post-Intervention Follow-Up (3 Months)|Did not complete test|2|||
127980769|NCT03117881|460552185|FG000|6-Month Follow-Up|Withdrawal by Subject|4|||
127980770|NCT03117881|460552186|FG001|6-Month Follow-Up|Withdrawal by Subject|8|||
127980771|NCT03117881|460552187|FG002|6-Month Follow-Up|Withdrawal by Subject|0|||
127980772|NCT03117881|460552185|FG000|6-Month Follow-Up|Lost to Follow-up|18|||
127980773|NCT03117881|460552186|FG001|6-Month Follow-Up|Lost to Follow-up|8|||
127980774|NCT03117881|460552187|FG002|6-Month Follow-Up|Lost to Follow-up|2|||
127980775|NCT03117881|460552185|FG000|6-Month Follow-Up|Did not complete test|53|||
127980776|NCT03117881|460552186|FG001|6-Month Follow-Up|Did not complete test|25|||
127980777|NCT03117881|460552187|FG002|6-Month Follow-Up|Did not complete test|7|||
127980778|NCT03117881|460552185|FG000|12-Month Follow-Up|Withdrawal by Subject|3|||
127980779|NCT03117881|460552186|FG001|12-Month Follow-Up|Withdrawal by Subject|2|||
127980780|NCT03117881|460552187|FG002|12-Month Follow-Up|Withdrawal by Subject|0|||
127980781|NCT03117881|460552185|FG000|12-Month Follow-Up|Lost to Follow-up|18|||
127980782|NCT03117881|460552186|FG001|12-Month Follow-Up|Lost to Follow-up|22|||
127980783|NCT03117881|460552187|FG002|12-Month Follow-Up|Lost to Follow-up|0|||
127980784|NCT03117881|460552185|FG000|12-Month Follow-Up|Did not complete test|40|||
127980785|NCT03117881|460552186|FG001|12-Month Follow-Up|Did not complete test|0|||
127980786|NCT03117881|460552187|FG002|12-Month Follow-Up|Did not complete test|0|||
127980787|NCT01027897|460552188|FG000|Overall Study|Protocol Violation|1|||
127980788|NCT01027897|460552188|FG000|Overall Study|Withdrawal by Subject|1|||
127980789|NCT02045732|460552191|FG000|Overall Study|At the discretion of the investigator|1|||
127980790|NCT02045732|460552192|FG001|Overall Study|At the discretion of the investigator|1|||
127980791|NCT00473824|460552193|FG000|Overall Study|Virologic Breakthrough|1|||
127980792|NCT00473824|460552194|FG001|Overall Study|Virologic Breakthrough|0|||
127980793|NCT00473824|460552193|FG000|Overall Study|Adverse Event|1|||
127980794|NCT00473824|460552194|FG001|Overall Study|Adverse Event|0|||
127980795|NCT00473824|460552193|FG000|Overall Study|Death|1|||
127980796|NCT00473824|460552194|FG001|Overall Study|Death|0|||
127513967|NCT00106691|458843379|FG000|Overall Study|QTc>480|3|||
127513968|NCT00106691|458843380|FG001|Overall Study|QTc>480|1|||
127980797|NCT00473824|460552193|FG000|Overall Study|Lost to Follow-up|1|||
127980798|NCT00473824|460552194|FG001|Overall Study|Lost to Follow-up|0|||
127980799|NCT00473824|460552193|FG000|Overall Study|Withdrawal by physician|1|||
127980800|NCT00473824|460552194|FG001|Overall Study|Withdrawal by physician|0|||
127980801|NCT02560623|460552195|FG000|Overall Study|Unable to swallow sponge|0|||
127980802|NCT02560623|460552196|FG001|Overall Study|Unable to swallow sponge|1|||
127980803|NCT02560623|460552197|FG002|Overall Study|Unable to swallow sponge|0|||
127513969|NCT00106691|458843379|FG000|Overall Study|mililtary deployment|2|||
127513970|NCT00106691|458843380|FG001|Overall Study|mililtary deployment|0|||
127980804|NCT02560623|460552198|FG003|Overall Study|Unable to swallow sponge|0|||
127980805|NCT02560623|460552195|FG000|Overall Study|Intervention prior to sponge administration|0|||
127980806|NCT02560623|460552196|FG001|Overall Study|Intervention prior to sponge administration|1|||
127980807|NCT02560623|460552197|FG002|Overall Study|Intervention prior to sponge administration|0|||
127980808|NCT02560623|460552198|FG003|Overall Study|Intervention prior to sponge administration|0|||
127980809|NCT05014815|460552199|FG000|Overall Study|Death|63|||
127980810|NCT05014815|460552200|FG001|Overall Study|Death|70|||
127980811|NCT05014815|460552199|FG000|Overall Study|Withdrawal by Subject|10|||
127980812|NCT05014815|460552200|FG001|Overall Study|Withdrawal by Subject|10|||
127980813|NCT05014815|460552199|FG000|Overall Study|Lost to Follow-up|4|||
127980814|NCT05014815|460552200|FG001|Overall Study|Lost to Follow-up|2|||
127980815|NCT05014815|460552199|FG000|Overall Study|Physician Decision|2|||
127980816|NCT05014815|460552200|FG001|Overall Study|Physician Decision|4|||
127980817|NCT04247880|460552201|FG000|Overall Study|Lost to Follow-up|24|||
127980818|NCT04247880|460552202|FG001|Overall Study|Lost to Follow-up|17|||
127980819|NCT04247880|460552201|FG000|Overall Study|Withdrawal by Subject|3|||
127980820|NCT04247880|460552202|FG001|Overall Study|Withdrawal by Subject|0|||
127980821|NCT06303167|460552203|FG000|Overall Study|Ineligible|1|||
127980822|NCT06303167|460552203|FG000|Overall Study|Never start protocol therapy|2|||
127980823|NCT06303167|460552203|FG000|Overall Study|Disease progression|16|||
127980824|NCT02453282|460552204|FG000|Overall Study|Death|275|||
127980825|NCT02453282|460552205|FG001|Overall Study|Death|277|||
127980826|NCT02453282|460552206|FG002|Overall Study|Death|296|||
127980827|NCT02453282|460552204|FG000|Overall Study|Lost to Follow-up|1|||
127980828|NCT02453282|460552205|FG001|Overall Study|Lost to Follow-up|0|||
127980829|NCT02453282|460552206|FG002|Overall Study|Lost to Follow-up|2|||
127980830|NCT02453282|460552204|FG000|Overall Study|Withdrawal by Subject|12|||
127980831|NCT02453282|460552205|FG001|Overall Study|Withdrawal by Subject|10|||
127980832|NCT02453282|460552206|FG002|Overall Study|Withdrawal by Subject|11|||
127980833|NCT02453282|460552204|FG000|Overall Study|Participants ongoing at data cut-off|85|||
127980834|NCT02453282|460552205|FG001|Overall Study|Participants ongoing at data cut-off|84|||
127980835|NCT02453282|460552206|FG002|Overall Study|Participants ongoing at data cut-off|62|||
127980836|NCT02453282|460552204|FG000|Overall Study|Other|1|||
127980837|NCT02453282|460552205|FG001|Overall Study|Other|1|||
127980838|NCT02453282|460552206|FG002|Overall Study|Other|1|||
127980839|NCT01661933|460552207|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
127980840|NCT01661933|460552207|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
127980841|NCT01120249|460552208|FG000|Overall Study|No protocol treatment received|21|||
127980842|NCT01120249|460552209|FG001|Overall Study|No protocol treatment received|15|||
127980843|NCT01120249|460552208|FG000|Overall Study|Disease recurrence|107|||
127980844|NCT01120249|460552209|FG001|Overall Study|Disease recurrence|57|||
127980845|NCT01120249|460552208|FG000|Overall Study|Death|1|||
127980846|NCT01120249|460552209|FG001|Overall Study|Death|0|||
127980847|NCT01120249|460552208|FG000|Overall Study|Adverse Event|40|||
127980848|NCT01120249|460552209|FG001|Overall Study|Adverse Event|276|||
127980849|NCT01120249|460552208|FG000|Overall Study|Participant refusal|34|||
127980850|NCT01120249|460552209|FG001|Overall Study|Participant refusal|42|||
127980851|NCT01120249|460552208|FG000|Overall Study|Other reasons, not protocol specified|29|||
127980852|NCT01120249|460552209|FG001|Overall Study|Other reasons, not protocol specified|22|||
127980853|NCT01447446|460552210|FG000|Overall Study|Death|6|||
127980854|NCT01447446|460552211|FG001|Overall Study|Death|3|||
127980855|NCT01447446|460552212|FG002|Overall Study|Death|2|||
127980856|NCT01447446|460552213|FG003|Overall Study|Death|1|||
127980857|NCT01447446|460552214|FG004|Overall Study|Death|7|||
127980858|NCT01447446|460552215|FG005|Overall Study|Death|0|||
127980859|NCT01447446|460552210|FG000|Overall Study|Adverse Event|3|||
127980860|NCT01447446|460552211|FG001|Overall Study|Adverse Event|0|||
127980861|NCT01447446|460552212|FG002|Overall Study|Adverse Event|1|||
127980862|NCT01447446|460552213|FG003|Overall Study|Adverse Event|0|||
127980863|NCT01447446|460552214|FG004|Overall Study|Adverse Event|2|||
127980864|NCT01447446|460552215|FG005|Overall Study|Adverse Event|0|||
127980865|NCT01447446|460552210|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
127980866|NCT01447446|460552211|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
127980867|NCT01447446|460552212|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
127980868|NCT01447446|460552213|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
127980869|NCT01447446|460552214|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
127980870|NCT01447446|460552215|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
127980871|NCT01447446|460552210|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
127513971|NCT00106691|458843379|FG000|Overall Study|Study Site Closing/PI Moved|1|||
127513972|NCT00106691|458843380|FG001|Overall Study|Study Site Closing/PI Moved|2|||
127980872|NCT01447446|460552211|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
127980873|NCT01447446|460552212|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
127980874|NCT01447446|460552213|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
127980875|NCT01447446|460552214|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
127980876|NCT01447446|460552215|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
127980877|NCT01447446|460552210|FG000|Overall Study|Administrative/Other|34|||
127980878|NCT01447446|460552211|FG001|Overall Study|Administrative/Other|9|||
127980879|NCT01447446|460552212|FG002|Overall Study|Administrative/Other|10|||
127980880|NCT01447446|460552213|FG003|Overall Study|Administrative/Other|2|||
127980881|NCT01447446|460552214|FG004|Overall Study|Administrative/Other|33|||
127980882|NCT01447446|460552215|FG005|Overall Study|Administrative/Other|4|||
127980883|NCT01447446|460552210|FG000|Overall Study|SVR12 Assessment|13|||
127980884|NCT01447446|460552211|FG001|Overall Study|SVR12 Assessment|1|||
127980885|NCT01447446|460552212|FG002|Overall Study|SVR12 Assessment|2|||
127980886|NCT01447446|460552213|FG003|Overall Study|SVR12 Assessment|1|||
127980887|NCT01447446|460552214|FG004|Overall Study|SVR12 Assessment|5|||
127980888|NCT01447446|460552215|FG005|Overall Study|SVR12 Assessment|5|||
127980889|NCT01447446|460552210|FG000|Overall Study|New Treatment Started|8|||
127980890|NCT01447446|460552211|FG001|Overall Study|New Treatment Started|2|||
127980891|NCT01447446|460552212|FG002|Overall Study|New Treatment Started|1|||
127980892|NCT01447446|460552213|FG003|Overall Study|New Treatment Started|0|||
127980893|NCT01447446|460552214|FG004|Overall Study|New Treatment Started|2|||
127980894|NCT01447446|460552215|FG005|Overall Study|New Treatment Started|0|||
127980895|NCT01447446|460552210|FG000|Overall Study|Reason not Specified|1|||
127980896|NCT01447446|460552211|FG001|Overall Study|Reason not Specified|1|||
127980897|NCT01447446|460552212|FG002|Overall Study|Reason not Specified|1|||
127980898|NCT01447446|460552213|FG003|Overall Study|Reason not Specified|1|||
127980899|NCT01447446|460552214|FG004|Overall Study|Reason not Specified|1|||
127980900|NCT01447446|460552215|FG005|Overall Study|Reason not Specified|0|||
127980901|NCT03536949|460552226|FG000|Overall Study|Adverse Event|4|||
127980902|NCT03536949|460552227|FG001|Overall Study|Adverse Event|0|||
127980903|NCT03536949|460552226|FG000|Overall Study|Lost to Follow-up|2|||
127980904|NCT03536949|460552227|FG001|Overall Study|Lost to Follow-up|1|||
127980905|NCT03536949|460552226|FG000|Overall Study|Withdrawal by Subject|6|||
127980906|NCT03536949|460552227|FG001|Overall Study|Withdrawal by Subject|0|||
127980907|NCT03536949|460552226|FG000|Overall Study|Non-compliance|2|||
127980908|NCT03536949|460552227|FG001|Overall Study|Non-compliance|1|||
127980909|NCT00250458|460552233|FG000|Overall Study|Lost to Follow-up|4|||
127980910|NCT00250458|460552234|FG001|Overall Study|Lost to Follow-up|2|||
127980911|NCT00250458|460552233|FG000|Overall Study|Protocol Violation|0|||
127980912|NCT00250458|460552234|FG001|Overall Study|Protocol Violation|1|||
127980913|NCT00250458|460552233|FG000|Overall Study|Withdrawal by Subject|4|||
127980914|NCT00250458|460552234|FG001|Overall Study|Withdrawal by Subject|2|||
127980915|NCT00250458|460552233|FG000|Overall Study|Lack of Migraine Attack|20|||
127980916|NCT00250458|460552234|FG001|Overall Study|Lack of Migraine Attack|9|||
127980917|NCT00250458|460552233|FG000|Overall Study|Qualifying migraine but did not treat|3|||
127980918|NCT00250458|460552234|FG001|Overall Study|Qualifying migraine but did not treat|3|||
127980919|NCT00250458|460552233|FG000|Overall Study|Other|1|||
127980920|NCT00250458|460552234|FG001|Overall Study|Other|0|||
127980921|NCT01892085|460552237|FG000|Overall Study|Death|4|||
127980922|NCT01892085|460552238|FG001|Overall Study|Death|1|||
127980923|NCT01892085|460552239|FG002|Overall Study|Death|3|||
127980924|NCT01892085|460552237|FG000|Overall Study|Withdrawal by Subject|2|||
127980925|NCT01892085|460552238|FG001|Overall Study|Withdrawal by Subject|0|||
127980926|NCT01892085|460552239|FG002|Overall Study|Withdrawal by Subject|2|||
127980927|NCT01629823|460552240|FG000|Trial Period|Missed visit|11|||
127980928|NCT01629823|460552241|FG001|Trial Period|Missed visit|9|||
127980929|NCT01629823|460552242|FG002|Trial Period|Missed visit|8|||
127980930|NCT01629823|460552240|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
127980931|NCT01629823|460552241|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
127980932|NCT01629823|460552242|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
127980933|NCT01629823|460552240|FG000|Trial Period|Pregnancy|1|||
127513973|NCT00106691|458843379|FG000|Overall Study|Cardiologist recommendation|1|||
127980934|NCT01629823|460552241|FG001|Trial Period|Pregnancy|0|||
127980935|NCT01629823|460552242|FG002|Trial Period|Pregnancy|0|||
127980936|NCT01629823|460552240|FG000|Trial Period|Adverse Event|0|||
127980937|NCT01629823|460552241|FG001|Trial Period|Adverse Event|1|||
127980938|NCT01629823|460552242|FG002|Trial Period|Adverse Event|0|||
127980939|NCT01629823|460552240|FG000|Trial Period|Out-of-window visit|0|||
127980940|NCT01629823|460552241|FG001|Trial Period|Out-of-window visit|2|||
127980941|NCT01629823|460552242|FG002|Trial Period|Out-of-window visit|0|||
127513974|NCT00106691|458843380|FG001|Overall Study|Cardiologist recommendation|0|||
127513975|NCT00106691|458843379|FG000|Overall Study|Pt. moved to another state|1|||
127513976|NCT00106691|458843380|FG001|Overall Study|Pt. moved to another state|0|||
127980942|NCT01629823|460552240|FG000|Trial Period|Failed to hold medication|0|||
127980943|NCT01629823|460552241|FG001|Trial Period|Failed to hold medication|0|||
127980944|NCT01629823|460552242|FG002|Trial Period|Failed to hold medication|1|||
127513977|NCT00106691|458843379|FG000|Overall Study|Taking exclusionary avodart|1|||
127980945|NCT01629823|460552240|FG000|Washout Period|Safety|2|||
127980946|NCT01629823|460552241|FG001|Washout Period|Safety|5|||
127513978|NCT00106691|458843380|FG001|Overall Study|Taking exclusionary avodart|0|||
127980947|NCT01629823|460552242|FG002|Washout Period|Safety|0|||
127980948|NCT01629823|460552240|FG000|Washout Period|Pregnancy|1|||
127980949|NCT01629823|460552241|FG001|Washout Period|Pregnancy|0|||
127980950|NCT01629823|460552242|FG002|Washout Period|Pregnancy|0|||
127980951|NCT01629823|460552240|FG000|Washout Period|Protocol Violation|0|||
127980952|NCT01629823|460552241|FG001|Washout Period|Protocol Violation|1|||
127980953|NCT01629823|460552242|FG002|Washout Period|Protocol Violation|0|||
127980954|NCT02609724|460552243|FG000|Overall Study|Death|2|||
127980955|NCT02609724|460552244|FG001|Overall Study|Death|0|||
127980956|NCT02609724|460552245|FG002|Overall Study|Death|1|||
127980957|NCT02609724|460552243|FG000|Overall Study|Withdrawal by Subject|1|||
127980958|NCT02609724|460552244|FG001|Overall Study|Withdrawal by Subject|2|||
127980959|NCT02609724|460552245|FG002|Overall Study|Withdrawal by Subject|3|||
127980960|NCT02609724|460552243|FG000|Overall Study|Illness|2|||
127980961|NCT02609724|460552244|FG001|Overall Study|Illness|1|||
127980962|NCT02609724|460552245|FG002|Overall Study|Illness|0|||
127980963|NCT02844907|460552246|FG000|With Dexamethasone|No IV access|1|||
127980964|NCT02003963|460552251|FG000|Overall Study|Lost to Follow-up|2|||
127980965|NCT02003963|460552252|FG001|Overall Study|Lost to Follow-up|1|||
127980966|NCT03589326|460552255|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
127980967|NCT03589326|460552256|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
127980968|NCT03589326|460552255|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
127980969|NCT03589326|460552256|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
127980970|NCT03589326|460552255|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
127980971|NCT03589326|460552256|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
127980972|NCT03589326|460552255|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
127980973|NCT03589326|460552256|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
127980974|NCT03589326|460552255|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
127980975|NCT03589326|460552256|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
127980976|NCT02847182|460552259|FG000|Overall Study|Withdrawal by Subject|0|||
127980977|NCT02847182|460552260|FG001|Overall Study|Withdrawal by Subject|1|||
127980978|NCT02345889|460552261|FG000|Overall Study|Inadequate Bowel Prep|17|||
127980979|NCT02345889|460552262|FG001|Overall Study|Inadequate Bowel Prep|16|||
127980980|NCT02345889|460552263|FG002|Overall Study|Inadequate Bowel Prep|18|||
127980981|NCT02345889|460552264|FG003|Overall Study|Inadequate Bowel Prep|14|||
127980982|NCT02345889|460552261|FG000|Overall Study|Polyposis identified during procedure|1|||
127980983|NCT02345889|460552262|FG001|Overall Study|Polyposis identified during procedure|1|||
127980984|NCT02345889|460552263|FG002|Overall Study|Polyposis identified during procedure|0|||
127980985|NCT02345889|460552264|FG003|Overall Study|Polyposis identified during procedure|1|||
127980986|NCT02345889|460552261|FG000|Overall Study|Recognized ineligible post-randomization|1|||
127980987|NCT02345889|460552262|FG001|Overall Study|Recognized ineligible post-randomization|0|||
127980988|NCT02345889|460552263|FG002|Overall Study|Recognized ineligible post-randomization|2|||
127980989|NCT02345889|460552264|FG003|Overall Study|Recognized ineligible post-randomization|1|||
127980990|NCT02345889|460552261|FG000|Overall Study|Ulcerative Colitis identified|1|||
127980991|NCT02345889|460552262|FG001|Overall Study|Ulcerative Colitis identified|0|||
127980992|NCT02345889|460552263|FG002|Overall Study|Ulcerative Colitis identified|0|||
127980993|NCT02345889|460552264|FG003|Overall Study|Ulcerative Colitis identified|0|||
127980994|NCT02345889|460552261|FG000|Overall Study|Cecum not intubated|1|||
127980995|NCT02345889|460552262|FG001|Overall Study|Cecum not intubated|0|||
127980996|NCT02345889|460552263|FG002|Overall Study|Cecum not intubated|0|||
127980997|NCT02345889|460552264|FG003|Overall Study|Cecum not intubated|0|||
127980998|NCT04216589|460552266|FG000|Overall Study|Withdrawal by Subject|2|||
127980999|NCT04216589|460552266|FG000|Overall Study|Protocol Violation|1|||
127981000|NCT04216589|460552266|FG000|Overall Study|Incarceration|1|||
127981001|NCT02326298|460552268|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
127981002|NCT02326298|460552269|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
127981003|NCT02326298|460552270|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
127981004|NCT02326298|460552271|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
127981005|NCT02326298|460552272|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
127981006|NCT02326298|460552273|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
127981007|NCT02326298|460552274|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
127981008|NCT02326298|460552275|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
127981009|NCT02326298|460552276|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
127981010|NCT02326298|460552277|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
127981011|NCT02326298|460552278|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
127981012|NCT02326298|460552279|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
127981013|NCT02326298|460552280|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
127981014|NCT02326298|460552281|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
127981015|NCT02326298|460552268|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
127981016|NCT02326298|460552269|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
127981017|NCT02326298|460552270|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
127981018|NCT02326298|460552271|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
127981019|NCT02326298|460552272|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
127981020|NCT02326298|460552273|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
127981021|NCT02326298|460552274|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
127981022|NCT02326298|460552275|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
127981023|NCT02326298|460552276|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
127981024|NCT02326298|460552277|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
127981025|NCT02326298|460552278|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
127981026|NCT02326298|460552279|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
127981027|NCT02326298|460552280|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
127981028|NCT02326298|460552281|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
127981029|NCT02326298|460552268|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
127981030|NCT02326298|460552269|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
127981031|NCT02326298|460552270|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
127981032|NCT02326298|460552271|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
127981033|NCT02326298|460552272|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
127981034|NCT02326298|460552273|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
127981035|NCT02326298|460552274|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
127981036|NCT02326298|460552275|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
127981037|NCT02326298|460552276|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
127981038|NCT02326298|460552277|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
127981039|NCT02326298|460552278|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
127981040|NCT02326298|460552279|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
127981041|NCT02326298|460552280|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
127981042|NCT02326298|460552281|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
127981043|NCT02326298|460552268|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
127981044|NCT02326298|460552269|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
127981045|NCT02326298|460552270|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
127981046|NCT02326298|460552271|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
127981047|NCT02326298|460552272|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
127981048|NCT02326298|460552273|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
127981049|NCT02326298|460552274|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
127981050|NCT02326298|460552275|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
127981051|NCT02326298|460552276|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
127981052|NCT02326298|460552277|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
127981053|NCT02326298|460552278|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
127981054|NCT02326298|460552279|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
127981055|NCT02326298|460552280|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
127981056|NCT02326298|460552281|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
127981057|NCT02326298|460552268|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
127981058|NCT02326298|460552269|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
127981059|NCT02326298|460552270|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
127981060|NCT02326298|460552271|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
127981061|NCT02326298|460552272|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
127981062|NCT02326298|460552273|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
127981063|NCT02326298|460552274|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
127981064|NCT02326298|460552275|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
127981065|NCT02326298|460552276|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
127981066|NCT02326298|460552277|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
127981067|NCT02326298|460552278|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
127981068|NCT02326298|460552279|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
127981069|NCT02326298|460552280|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
127981070|NCT02326298|460552281|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
127981071|NCT02326298|460552268|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
127981072|NCT02326298|460552269|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
127981073|NCT02326298|460552270|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
127981074|NCT02326298|460552271|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
127981075|NCT02326298|460552272|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
127981076|NCT02326298|460552273|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
127981077|NCT02326298|460552274|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
127981078|NCT02326298|460552275|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
127981079|NCT02326298|460552276|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
127981080|NCT02326298|460552277|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
127981081|NCT02326298|460552278|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
127981082|NCT02326298|460552279|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
127981083|NCT02326298|460552280|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
127981084|NCT02326298|460552281|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
127981085|NCT02326298|460552268|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
127981086|NCT02326298|460552269|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
127981087|NCT02326298|460552270|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
127981088|NCT02326298|460552271|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
127981089|NCT02326298|460552272|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
127981090|NCT02326298|460552273|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
127981091|NCT02326298|460552274|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
127981092|NCT02326298|460552275|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
127981093|NCT02326298|460552276|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
127981094|NCT02326298|460552277|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
127981095|NCT02326298|460552278|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
127981096|NCT02326298|460552279|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
127981097|NCT02326298|460552280|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
127981098|NCT02326298|460552281|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
127981099|NCT02326298|460552268|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
127981100|NCT02326298|460552269|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
127981101|NCT02326298|460552270|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
127981102|NCT02326298|460552271|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
127981103|NCT02326298|460552272|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
127981104|NCT02326298|460552273|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
127981105|NCT02326298|460552274|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
127981106|NCT02326298|460552275|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
127981107|NCT02326298|460552276|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
127981108|NCT02326298|460552277|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
127981109|NCT02326298|460552278|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
127981110|NCT02326298|460552279|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
127981111|NCT02326298|460552280|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
127981112|NCT02326298|460552281|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
127981113|NCT02326298|460552268|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
127981114|NCT02326298|460552269|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
127981115|NCT02326298|460552270|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
127981116|NCT02326298|460552271|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
127981117|NCT02326298|460552272|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
127981118|NCT02326298|460552273|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
127981119|NCT02326298|460552274|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
127981120|NCT02326298|460552275|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
127981121|NCT02326298|460552276|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
127981122|NCT02326298|460552277|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
127981123|NCT02326298|460552278|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
127981124|NCT02326298|460552279|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
127981125|NCT02326298|460552280|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
127981126|NCT02326298|460552281|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
127981127|NCT02326298|460552268|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
127981128|NCT02326298|460552269|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
127981129|NCT02326298|460552270|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
127981130|NCT02326298|460552271|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
127981131|NCT02326298|460552272|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
127981132|NCT02326298|460552273|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
127981133|NCT02326298|460552274|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
127981134|NCT02326298|460552275|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
127981135|NCT02326298|460552276|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
127981136|NCT02326298|460552277|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
127981137|NCT02326298|460552278|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
127981138|NCT02326298|460552279|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
127981139|NCT02326298|460552280|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
127981140|NCT02326298|460552281|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
127981141|NCT02326298|460552268|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127981142|NCT02326298|460552269|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127513979|NCT00106691|458843379|FG000|Overall Study|Not able to discontinue plavix|0|||
127513980|NCT00106691|458843380|FG001|Overall Study|Not able to discontinue plavix|1|||
127981143|NCT02326298|460552270|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127981144|NCT02326298|460552271|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127981145|NCT02326298|460552272|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127981146|NCT02326298|460552273|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127981147|NCT02326298|460552274|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
127981148|NCT02326298|460552275|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
127981149|NCT02326298|460552276|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127981150|NCT02326298|460552277|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127981151|NCT02326298|460552278|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127981152|NCT02326298|460552279|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127981153|NCT02326298|460552280|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127981154|NCT02326298|460552281|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
127981155|NCT02326298|460552268|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
127981156|NCT02326298|460552269|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
127981157|NCT02326298|460552270|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
127981158|NCT02326298|460552271|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
127981159|NCT02326298|460552272|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
127981160|NCT02326298|460552273|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
127981161|NCT02326298|460552274|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
127981162|NCT02326298|460552275|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
127981163|NCT02326298|460552276|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
127981164|NCT02326298|460552277|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
127981165|NCT02326298|460552278|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
127981166|NCT02326298|460552279|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
127981167|NCT02326298|460552280|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
127981168|NCT02326298|460552281|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
127981169|NCT02326298|460552268|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
127981170|NCT02326298|460552269|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
127513981|NCT00530920|458843381|FG000|Overall Study|Randomized but not treated|0|||
127513982|NCT00530920|458843382|FG001|Overall Study|Randomized but not treated|2|||
127513983|NCT00530920|458843383|FG002|Overall Study|Randomized but not treated|0|||
127513984|NCT00530920|458843381|FG000|Overall Study|Adverse Event|0|||
127513985|NCT00530920|458843382|FG001|Overall Study|Adverse Event|0|||
127513986|NCT00530920|458843383|FG002|Overall Study|Adverse Event|3|||
127513987|NCT00530920|458843381|FG000|Overall Study|Withdrawal by Subject|0|||
127513988|NCT00530920|458843382|FG001|Overall Study|Withdrawal by Subject|0|||
127513989|NCT00530920|458843383|FG002|Overall Study|Withdrawal by Subject|1|||
127513990|NCT04957758|458843385|FG000|Overall Study|Adverse Event|1|||
127513991|NCT04957758|458843386|FG001|Overall Study|Adverse Event|0|||
127513992|NCT04957758|458843385|FG000|Overall Study|Lost to Follow-up|0|||
127513993|NCT04957758|458843386|FG001|Overall Study|Lost to Follow-up|2|||
127513994|NCT04957758|458843385|FG000|Overall Study|Withdrawal by Subject|4|||
127513995|NCT04957758|458843386|FG001|Overall Study|Withdrawal by Subject|2|||
127513996|NCT04957758|458843385|FG000|Overall Study|Protocol Violation|0|||
127513997|NCT04957758|458843386|FG001|Overall Study|Protocol Violation|1|||
127513998|NCT00707746|458843387|FG000|Treatment Period|Adverse Event|2|||
127513999|NCT00707746|458843388|FG001|Treatment Period|Adverse Event|4|||
127514000|NCT00707746|458843387|FG000|Treatment Period|Ineligibility|0|||
127514001|NCT00707746|458843388|FG001|Treatment Period|Ineligibility|1|||
127514002|NCT00685373|458843392|FG000|Overall Study|Adverse Event|3|||
127514003|NCT00685373|458843392|FG000|Overall Study|Withdrawal by Subject|5|||
127514004|NCT00685373|458843392|FG000|Overall Study|Lack of Efficacy|3|||
127514005|NCT00685373|458843392|FG000|Overall Study|Condition no longer requires study drug|1|||
127514006|NCT00685373|458843392|FG000|Overall Study|Lost to Follow-up|2|||
127514007|NCT00685373|458843392|FG000|Overall Study|Protocol Violation|1|||
127514008|NCT02642965|458843394|FG000|Overall Study|Lack of Efficacy|4|||
127514009|NCT02642965|458843394|FG000|Overall Study|Physician Decision|9|||
127514010|NCT03099148|458843399|FG000|Wash-out|scheduling conflict|0|||
127514011|NCT03099148|458843400|FG001|Wash-out|scheduling conflict|1|||
127514012|NCT03099148|458843401|FG002|Wash-out|scheduling conflict|0|||
127514013|NCT03099148|458843402|FG003|Wash-out|scheduling conflict|0|||
127514014|NCT03099148|458843399|FG000|Wash-out|Adverse Event|0|||
127514015|NCT03099148|458843400|FG001|Wash-out|Adverse Event|1|||
127514016|NCT03099148|458843401|FG002|Wash-out|Adverse Event|0|||
127514017|NCT03099148|458843402|FG003|Wash-out|Adverse Event|0|||
127514018|NCT00966719|458843403|FG000|Overall Study|Lost to Follow-up|6|||
127514019|NCT00966719|458843404|FG001|Overall Study|Lost to Follow-up|11|||
127514020|NCT01703065|458843405|FG000|Overall Study|Lack of Efficacy|1|||
127514021|NCT01703065|458843406|FG001|Overall Study|Lack of Efficacy|0|||
127514022|NCT01439126|458843407|FG000|Overall Study|Adverse Event|2|||
127514023|NCT01439126|458843408|FG001|Overall Study|Adverse Event|0|||
127514024|NCT01439126|458843407|FG000|Overall Study|Withdrawal by Subject|5|||
127514025|NCT01439126|458843408|FG001|Overall Study|Withdrawal by Subject|21|||
127514026|NCT01439126|458843407|FG000|Overall Study|Protocol Violation|6|||
127514027|NCT01439126|458843408|FG001|Overall Study|Protocol Violation|4|||
127514028|NCT01439126|458843407|FG000|Overall Study|Lost to Follow-up|6|||
127514029|NCT01439126|458843408|FG001|Overall Study|Lost to Follow-up|3|||
127514030|NCT01439126|458843407|FG000|Overall Study|Other-Use of prohibited treatment|0|||
127514031|NCT01439126|458843408|FG001|Overall Study|Other-Use of prohibited treatment|2|||
127514032|NCT01439126|458843407|FG000|Overall Study|Other-Miscellaneous|12|||
127514033|NCT01439126|458843408|FG001|Overall Study|Other-Miscellaneous|12|||
127514034|NCT01617447|458843409|FG000|Overall Study|Adverse Event|0|||
127514035|NCT01617447|458843410|FG001|Overall Study|Adverse Event|1|||
127514036|NCT01617447|458843409|FG000|Overall Study|Physician Decision|0|||
127514037|NCT01617447|458843410|FG001|Overall Study|Physician Decision|2|||
127514038|NCT02713529|458843412|FG000|Overall Study|Withdrawal by Subject|3|||
127514039|NCT02713529|458843413|FG001|Overall Study|Withdrawal by Subject|1|||
127514040|NCT02713529|458843414|FG002|Overall Study|Withdrawal by Subject|4|||
127514041|NCT02713529|458843415|FG003|Overall Study|Withdrawal by Subject|2|||
127514042|NCT02713529|458843416|FG004|Overall Study|Withdrawal by Subject|0|||
127514043|NCT02713529|458843417|FG005|Overall Study|Withdrawal by Subject|1|||
127514044|NCT02713529|458843418|FG006|Overall Study|Withdrawal by Subject|1|||
127514045|NCT02713529|458843412|FG000|Overall Study|Lost to Follow-up|1|||
127514046|NCT02713529|458843413|FG001|Overall Study|Lost to Follow-up|0|||
127514047|NCT02713529|458843414|FG002|Overall Study|Lost to Follow-up|1|||
127514048|NCT02713529|458843415|FG003|Overall Study|Lost to Follow-up|0|||
127514049|NCT02713529|458843416|FG004|Overall Study|Lost to Follow-up|0|||
127514050|NCT02713529|458843417|FG005|Overall Study|Lost to Follow-up|0|||
127514051|NCT02713529|458843418|FG006|Overall Study|Lost to Follow-up|0|||
127514052|NCT02713529|458843412|FG000|Overall Study|Death|3|||
127514053|NCT02713529|458843413|FG001|Overall Study|Death|3|||
127514054|NCT02713529|458843414|FG002|Overall Study|Death|26|||
127514055|NCT02713529|458843415|FG003|Overall Study|Death|27|||
127514056|NCT02713529|458843416|FG004|Overall Study|Death|3|||
127514057|NCT02713529|458843417|FG005|Overall Study|Death|13|||
127514058|NCT02713529|458843418|FG006|Overall Study|Death|3|||
127514059|NCT02827500|458843419|FG000|Overall Study|Death|7|||
127514060|NCT02827500|458843420|FG001|Overall Study|Death|3|||
127514061|NCT02827500|458843419|FG000|Overall Study|Lost to Follow-up|1|||
127514062|NCT02827500|458843420|FG001|Overall Study|Lost to Follow-up|1|||
127514063|NCT02827500|458843419|FG000|Overall Study|Withdrawal by Subject|3|||
127514064|NCT02827500|458843420|FG001|Overall Study|Withdrawal by Subject|1|||
127514065|NCT02827500|458843419|FG000|Overall Study|Missing primary endpoint data|3|||
127514066|NCT02827500|458843420|FG001|Overall Study|Missing primary endpoint data|1|||
127514067|NCT02827500|458843419|FG000|Overall Study|Other|5|||
127514068|NCT02827500|458843420|FG001|Overall Study|Other|1|||
127514069|NCT02308488|458843423|FG000|Overall Study|Withdrawal by Subject|2|||
127514070|NCT02242981|458843424|FG000|Overall Study|Withdrawal by Subject|1|||
127514071|NCT03474081|458843425|FG000|Overall Study|Adverse Event|6|||
127514072|NCT03474081|458843426|FG001|Overall Study|Adverse Event|3|||
127514073|NCT03474081|458843425|FG000|Overall Study|Lost to Follow-up|2|||
127514074|NCT03474081|458843426|FG001|Overall Study|Lost to Follow-up|1|||
127514075|NCT03474081|458843425|FG000|Overall Study|Physician Decision|3|||
127514076|NCT03474081|458843426|FG001|Overall Study|Physician Decision|2|||
127514077|NCT03474081|458843425|FG000|Overall Study|Withdrawal by Subject|5|||
127514078|NCT03474081|458843426|FG001|Overall Study|Withdrawal by Subject|7|||
127514079|NCT03474081|458843425|FG000|Overall Study|Investigator site closed|1|||
127514080|NCT03474081|458843426|FG001|Overall Study|Investigator site closed|0|||
127514081|NCT02210091|458843429|FG000|Overall Study|Physician Decision|0|||
127514082|NCT02210091|458843430|FG001|Overall Study|Physician Decision|1|||
127514083|NCT02210091|458843429|FG000|Overall Study|Withdrawal by Sponsor|0|||
127514084|NCT02210091|458843430|FG001|Overall Study|Withdrawal by Sponsor|1|||
127514085|NCT02290938|458843431|FG000|Overall Study|Lost to Follow-up|14|||
127514086|NCT02290938|458843432|FG001|Overall Study|Lost to Follow-up|43|||
127514087|NCT05160766|458845264|FG000|Overall Study|Adverse Event|0|||
127514088|NCT05160766|458845265|FG001|Overall Study|Adverse Event|1|||
127514089|NCT05160766|458845266|FG002|Overall Study|Adverse Event|0|||
127514090|NCT05160766|458845267|FG003|Overall Study|Adverse Event|0|||
127514091|NCT05160766|458845264|FG000|Overall Study|COVID-19 infection|0|||
127514092|NCT05160766|458845265|FG001|Overall Study|COVID-19 infection|1|||
127514093|NCT05160766|458845266|FG002|Overall Study|COVID-19 infection|0|||
127514094|NCT05160766|458845267|FG003|Overall Study|COVID-19 infection|0|||
127514095|NCT05160766|458845264|FG000|Overall Study|travel time|1|||
127514096|NCT05160766|458845265|FG001|Overall Study|travel time|0|||
127514097|NCT05160766|458845266|FG002|Overall Study|travel time|0|||
127514098|NCT05160766|458845267|FG003|Overall Study|travel time|1|||
127514099|NCT05160766|458845264|FG000|Overall Study|Withdrawal by Subject|3|||
127514100|NCT05160766|458845265|FG001|Overall Study|Withdrawal by Subject|5|||
127514101|NCT05160766|458845266|FG002|Overall Study|Withdrawal by Subject|4|||
127514102|NCT05160766|458845267|FG003|Overall Study|Withdrawal by Subject|2|||
127514103|NCT05160766|458845264|FG000|Overall Study|Death|0|||
127514104|NCT05160766|458845265|FG001|Overall Study|Death|0|||
127514105|NCT05160766|458845266|FG002|Overall Study|Death|2|||
127514106|NCT05160766|458845267|FG003|Overall Study|Death|5|||
127514107|NCT05160766|458845264|FG000|Overall Study|Lost to Follow-up|0|||
127514108|NCT05160766|458845265|FG001|Overall Study|Lost to Follow-up|0|||
127514109|NCT05160766|458845266|FG002|Overall Study|Lost to Follow-up|1|||
127514110|NCT05160766|458845267|FG003|Overall Study|Lost to Follow-up|2|||
127514111|NCT05160766|458845264|FG000|Overall Study|No show|0|||
127514112|NCT05160766|458845265|FG001|Overall Study|No show|0|||
127514113|NCT05160766|458845266|FG002|Overall Study|No show|1|||
127514114|NCT05160766|458845267|FG003|Overall Study|No show|1|||
127514115|NCT05160766|458845264|FG000|Overall Study|Physician Decision|0|||
127514116|NCT05160766|458845265|FG001|Overall Study|Physician Decision|0|||
127514117|NCT05160766|458845266|FG002|Overall Study|Physician Decision|0|||
127514118|NCT05160766|458845267|FG003|Overall Study|Physician Decision|1|||
127514119|NCT05160766|458845264|FG000|Overall Study|Protocol Violation|0|||
127514120|NCT05160766|458845265|FG001|Overall Study|Protocol Violation|0|||
127514121|NCT05160766|458845266|FG002|Overall Study|Protocol Violation|1|||
127514122|NCT05160766|458845267|FG003|Overall Study|Protocol Violation|0|||
127514123|NCT04284813|458845270|FG000|Overall Study|Withdrawal by Subject|1|||
127514124|NCT01146652|458845275|FG000|Overall Study|Adverse Event|506|||
127514125|NCT01146652|458845276|FG001|Overall Study|Adverse Event|15|||
127514126|NCT01146652|458845275|FG000|Overall Study|Lack of Efficacy|91|||
127514127|NCT01146652|458845276|FG001|Overall Study|Lack of Efficacy|7|||
127514128|NCT01146652|458845275|FG000|Overall Study|Poor compliance to protocol|38|||
127514129|NCT01146652|458845276|FG001|Overall Study|Poor compliance to protocol|1|||
127514130|NCT01146652|458845275|FG000|Overall Study|Other unspecified reasons|314|||
127514131|NCT01146652|458845276|FG001|Overall Study|Other unspecified reasons|22|||
127514132|NCT01146652|458845275|FG000|Overall Study|Enrolled but not treated|2|||
127514133|NCT01146652|458845276|FG001|Overall Study|Enrolled but not treated|0|||
127514134|NCT00431951|458845280|FG000|Overall Study|Inability to follow study procedures|1|||
127514135|NCT00431951|458845281|FG001|Overall Study|Inability to follow study procedures|0|||
127514136|NCT00431951|458845282|FG002|Overall Study|Inability to follow study procedures|1|||
127514137|NCT00431951|458845283|FG003|Overall Study|Inability to follow study procedures|2|||
127514138|NCT00431951|458845280|FG000|Overall Study|Lost to Follow-up|0|||
127514139|NCT00431951|458845281|FG001|Overall Study|Lost to Follow-up|1|||
127514140|NCT00431951|458845282|FG002|Overall Study|Lost to Follow-up|0|||
127514141|NCT00431951|458845283|FG003|Overall Study|Lost to Follow-up|0|||
127514142|NCT00431951|458845280|FG000|Overall Study|Withdrawal by Subject|0|||
127514143|NCT00431951|458845281|FG001|Overall Study|Withdrawal by Subject|1|||
127514144|NCT00431951|458845282|FG002|Overall Study|Withdrawal by Subject|0|||
127514145|NCT00431951|458845283|FG003|Overall Study|Withdrawal by Subject|0|||
127514146|NCT00431951|458845280|FG000|Overall Study|Adverse Event|0|||
127514147|NCT00431951|458845281|FG001|Overall Study|Adverse Event|0|||
127514148|NCT00431951|458845282|FG002|Overall Study|Adverse Event|1|||
127514149|NCT00431951|458845283|FG003|Overall Study|Adverse Event|0|||
127514150|NCT03455829|458845284|FG000|Overall Study|Death|2|||
127514151|NCT03455829|458845285|FG001|Overall Study|Death|3|||
127514152|NCT03455829|458845286|FG002|Overall Study|Death|2|||
127514153|NCT03455829|458845287|FG003|Overall Study|Death|4|||
127514154|NCT03455829|458845288|FG004|Overall Study|Death|2|||
127514155|NCT03455829|458845284|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
127514156|NCT03455829|458845285|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
127514157|NCT03455829|458845286|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
127514158|NCT03455829|458845287|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
127514159|NCT03455829|458845288|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
127514160|NCT03455829|458845284|FG000|Overall Study|Disease progression|0|||
127514161|NCT03455829|458845285|FG001|Overall Study|Disease progression|0|||
127514162|NCT03455829|458845286|FG002|Overall Study|Disease progression|0|||
127514163|NCT03455829|458845287|FG003|Overall Study|Disease progression|1|||
127514164|NCT03455829|458845288|FG004|Overall Study|Disease progression|1|||
127514165|NCT05824936|458845292|FG000|Overall Study|Lost to Follow-up|1|||
127514166|NCT00673881|458845293|FG000|Overall Study|Withdrawal by Subject|1|||
127514167|NCT00096018|458845294|FG000|Overall Study|Became Ineligible (not treated)|0|||
127514168|NCT00096018|458845295|FG001|Overall Study|Became Ineligible (not treated)|3|||
127514169|NCT00096018|458845294|FG000|Overall Study|Miscellaneous (not treated)|0|||
127514170|NCT00096018|458845295|FG001|Overall Study|Miscellaneous (not treated)|2|||
127514171|NCT00096018|458845294|FG000|Overall Study|Adverse Event|0|||
127514172|NCT00096018|458845295|FG001|Overall Study|Adverse Event|5|||
127514173|NCT00096018|458845294|FG000|Overall Study|Death|0|||
127514174|NCT00096018|458845295|FG001|Overall Study|Death|1|||
127514175|NCT00096018|458845294|FG000|Overall Study|Withdrawal by Subject|0|||
127514176|NCT00096018|458845295|FG001|Overall Study|Withdrawal by Subject|2|||
127514177|NCT00096018|458845294|FG000|Overall Study|Miscellaneous|2|||
127514178|NCT00096018|458845295|FG001|Overall Study|Miscellaneous|1|||
127514179|NCT03689712|458845296|FG000|Overall Study|Adverse Event|1|||
127514180|NCT03689712|458845297|FG001|Overall Study|Adverse Event|0|||
127514181|NCT03689712|458845296|FG000|Overall Study|Death|20|||
127514182|NCT03689712|458845297|FG001|Overall Study|Death|10|||
127514183|NCT03689712|458845296|FG000|Overall Study|Lost to Follow-up|6|||
127514184|NCT03689712|458845297|FG001|Overall Study|Lost to Follow-up|6|||
127514185|NCT03689712|458845296|FG000|Overall Study|Other|1|||
127514186|NCT03689712|458845297|FG001|Overall Study|Other|0|||
127514187|NCT03689712|458845296|FG000|Overall Study|Patient Non-Compliance|0|||
127514188|NCT03689712|458845297|FG001|Overall Study|Patient Non-Compliance|1|||
127514189|NCT03689712|458845296|FG000|Overall Study|Withdrawal by Subject|20|||
127514190|NCT03689712|458845297|FG001|Overall Study|Withdrawal by Subject|4|||
127514191|NCT03689712|458845296|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
127514192|NCT03689712|458845297|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
127514193|NCT03689712|458845296|FG000|Overall Study|Randomized but not Treated|13|||
127514194|NCT03689712|458845297|FG001|Overall Study|Randomized but not Treated|7|||
127514195|NCT03689712|458845296|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
127514196|NCT03689712|458845297|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
127514197|NCT00689793|458845298|FG000|Overall Study|Lost to Follow-up|4|||
127514198|NCT00689793|458845299|FG001|Overall Study|Lost to Follow-up|5|||
127514199|NCT01100528|458845302|FG000|Overall Study|Death|1|||
127514200|NCT01100528|458845302|FG000|Overall Study|Withdrawal by Subject|2|||
127514201|NCT03968159|458845303|FG000|Overall Study|Adverse Event|4|||
127514202|NCT03968159|458845304|FG001|Overall Study|Adverse Event|4|||
127514203|NCT03968159|458845303|FG000|Overall Study|Lost to Follow-up|1|||
127514204|NCT03968159|458845304|FG001|Overall Study|Lost to Follow-up|1|||
127514205|NCT03968159|458845303|FG000|Overall Study|Use of prohibited medication|0|||
127514206|NCT03968159|458845304|FG001|Overall Study|Use of prohibited medication|1|||
127514207|NCT03968159|458845303|FG000|Overall Study|Protocol Violation|2|||
127514208|NCT03968159|458845304|FG001|Overall Study|Protocol Violation|2|||
127514209|NCT03968159|458845303|FG000|Overall Study|Withdrawal by Subject|4|||
127514210|NCT03968159|458845304|FG001|Overall Study|Withdrawal by Subject|6|||
127514211|NCT03968159|458845303|FG000|Overall Study|Lack of Efficacy|0|||
127514212|NCT03968159|458845304|FG001|Overall Study|Lack of Efficacy|1|||
127514213|NCT03968159|458845303|FG000|Overall Study|Not further specified|2|||
127514214|NCT03968159|458845304|FG001|Overall Study|Not further specified|0|||
127514215|NCT01299571|458845309|FG000|Overall Study|Protocol Violation|107|||
127514216|NCT00864851|458845310|FG000|Overall Study|Withdrawal by Subject|0|||
127514217|NCT00864851|458845311|FG001|Overall Study|Withdrawal by Subject|1|||
127514218|NCT00864851|458845312|FG002|Overall Study|Withdrawal by Subject|0|||
127514219|NCT00864851|458845310|FG000|Overall Study|Physician Decision|1|||
127514220|NCT00864851|458845311|FG001|Overall Study|Physician Decision|0|||
127514221|NCT00864851|458845312|FG002|Overall Study|Physician Decision|0|||
127514222|NCT00864851|458845310|FG000|Overall Study|Death|1|||
127514223|NCT00864851|458845311|FG001|Overall Study|Death|0|||
127514224|NCT00864851|458845312|FG002|Overall Study|Death|0|||
127514225|NCT00864851|458845310|FG000|Overall Study|Patient uncooperative|1|||
127514226|NCT00864851|458845311|FG001|Overall Study|Patient uncooperative|0|||
127514227|NCT00864851|458845312|FG002|Overall Study|Patient uncooperative|0|||
127514228|NCT02006069|458845313|FG000|Overall Study|MPP other programming|239|||
127514229|NCT02006069|458845314|FG001|Overall Study|MPP other programming|0|||
127514230|NCT02006069|458845313|FG000|Overall Study|RV only pacing|0|||
127514231|NCT02006069|458845314|FG001|Overall Study|RV only pacing|3|||
127514232|NCT02066129|458845315|FG000|Overall Study|Lost to Follow-up|13|||
127514233|NCT02066129|458845316|FG001|Overall Study|Lost to Follow-up|12|||
127514234|NCT02066129|458845315|FG000|Overall Study|Withdrawal by Subject|7|||
127514235|NCT02066129|458845316|FG001|Overall Study|Withdrawal by Subject|10|||
127514236|NCT02066129|458845315|FG000|Overall Study|Lack of Efficacy|8|||
127514237|NCT02066129|458845316|FG001|Overall Study|Lack of Efficacy|10|||
127514238|NCT02066129|458845315|FG000|Overall Study|Physician Decision|1|||
127514239|NCT02066129|458845316|FG001|Overall Study|Physician Decision|1|||
127514240|NCT00316888|458845320|FG000|Overall Study|Adverse Event|4|||
127514241|NCT00316888|458845321|FG001|Overall Study|Adverse Event|5|||
127514242|NCT00316888|458845320|FG000|Overall Study|Withdrawal by Subject|2|||
127514243|NCT00316888|458845321|FG001|Overall Study|Withdrawal by Subject|2|||
127514244|NCT00316888|458845320|FG000|Overall Study|Not start protocol therapy|0|||
127514245|NCT00316888|458845321|FG001|Overall Study|Not start protocol therapy|1|||
127514246|NCT00857948|458845322|FG000|Overall Study|Withdrawal by Subject|2|||
127514247|NCT00857948|458845323|FG001|Overall Study|Withdrawal by Subject|0|||
127514248|NCT00857948|458845324|FG002|Overall Study|Withdrawal by Subject|0|||
127514249|NCT00857948|458845325|FG003|Overall Study|Withdrawal by Subject|0|||
127514250|NCT00857948|458845322|FG000|Overall Study|Protocol Violation|1|||
127514251|NCT00857948|458845323|FG001|Overall Study|Protocol Violation|0|||
127514252|NCT00857948|458845324|FG002|Overall Study|Protocol Violation|1|||
127514253|NCT00857948|458845325|FG003|Overall Study|Protocol Violation|0|||
127514254|NCT00815191|458845326|FG000|Overall Study|Protocol Violation|1|||
127514255|NCT00815191|458845327|FG001|Overall Study|Protocol Violation|1|||
127514256|NCT01814670|458845330|FG000|Overall Study|Protocol Violation|12|||
127514257|NCT03443427|458845331|FG000|Overall Study|Adverse Event|2|||
127514258|NCT03443427|458845332|FG001|Overall Study|Adverse Event|3|||
127514259|NCT03443427|458845331|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
127514260|NCT03443427|458845332|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
127514261|NCT03443427|458845331|FG000|Overall Study|Other|4|||
127514262|NCT03443427|458845332|FG001|Overall Study|Other|6|||
127514263|NCT02576860|458845333|FG000|Overall Study|Adverse Event|6|||
127514264|NCT02576860|458845334|FG001|Overall Study|Adverse Event|6|||
127514265|NCT02576860|458845333|FG000|Overall Study|Lost to Follow-up|5|||
127514266|NCT02576860|458845334|FG001|Overall Study|Lost to Follow-up|7|||
127514267|NCT02576860|458845333|FG000|Overall Study|Physician Decision|0|||
127514268|NCT02576860|458845334|FG001|Overall Study|Physician Decision|1|||
127514269|NCT02576860|458845333|FG000|Overall Study|Protocol Violation|0|||
127514270|NCT02576860|458845334|FG001|Overall Study|Protocol Violation|2|||
127514271|NCT02576860|458845333|FG000|Overall Study|Withdrawal by Subject|13|||
127514272|NCT02576860|458845334|FG001|Overall Study|Withdrawal by Subject|8|||
127514273|NCT02576860|458845333|FG000|Overall Study|Disallowed medication|1|||
127514274|NCT02576860|458845334|FG001|Overall Study|Disallowed medication|0|||
127514275|NCT01541917|458845335|FG000|Overall Study|Lost to Follow-up|2|||
127514276|NCT01541917|458845336|FG001|Overall Study|Lost to Follow-up|2|||
127514277|NCT01541917|458845335|FG000|Overall Study|Withdrawal by Subject|13|||
127514278|NCT01541917|458845336|FG001|Overall Study|Withdrawal by Subject|7|||
127514279|NCT00094107|458845341|FG000|Overall Study|Lack of Efficacy|23|||
127514280|NCT00094107|458845341|FG000|Overall Study|Death|5|||
127514281|NCT00094107|458845341|FG000|Overall Study|Adverse Event|3|||
127514282|NCT00094107|458845341|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
127514283|NCT00525824|458845342|FG000|Overall Study|Adverse Event|7|||
127514284|NCT00525824|458845343|FG001|Overall Study|Adverse Event|11|||
127514285|NCT00525824|458845344|FG002|Overall Study|Adverse Event|6|||
127514286|NCT00525824|458845345|FG003|Overall Study|Adverse Event|7|||
127514287|NCT00525824|458845342|FG000|Overall Study|Withdrawal by Subject|5|||
127514288|NCT00525824|458845343|FG001|Overall Study|Withdrawal by Subject|9|||
127514289|NCT00525824|458845344|FG002|Overall Study|Withdrawal by Subject|3|||
127514290|NCT00525824|458845345|FG003|Overall Study|Withdrawal by Subject|4|||
127514291|NCT00525824|458845342|FG000|Overall Study|Lost to Follow-up|4|||
127514292|NCT00525824|458845343|FG001|Overall Study|Lost to Follow-up|2|||
127514293|NCT00525824|458845344|FG002|Overall Study|Lost to Follow-up|4|||
127514294|NCT00525824|458845345|FG003|Overall Study|Lost to Follow-up|0|||
127514295|NCT00525824|458845342|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
127514296|NCT00525824|458845343|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
127514297|NCT00525824|458845344|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
127514298|NCT00525824|458845345|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
127514299|NCT00525824|458845342|FG000|Overall Study|Severe non-compliance|0|||
127514300|NCT00525824|458845343|FG001|Overall Study|Severe non-compliance|1|||
127514301|NCT00525824|458845344|FG002|Overall Study|Severe non-compliance|1|||
127514302|NCT00525824|458845345|FG003|Overall Study|Severe non-compliance|1|||
127514303|NCT00525824|458845342|FG000|Overall Study|Safety reasons|1|||
127514304|NCT00525824|458845343|FG001|Overall Study|Safety reasons|0|||
127514305|NCT00525824|458845344|FG002|Overall Study|Safety reasons|1|||
127514306|NCT00525824|458845345|FG003|Overall Study|Safety reasons|0|||
127514307|NCT00525824|458845342|FG000|Overall Study|Other|1|||
127514308|NCT00525824|458845343|FG001|Overall Study|Other|3|||
127514309|NCT00525824|458845344|FG002|Overall Study|Other|3|||
127514310|NCT00525824|458845345|FG003|Overall Study|Other|1|||
127514311|NCT01378429|458845356|FG000|Overall Study|Noncompliance with study drug|1|||
127514312|NCT01378429|458845357|FG001|Overall Study|Noncompliance with study drug|0|||
127514313|NCT01490294|458845360|FG000|Overall Study|Prematurely discontinuation|4|||
127514314|NCT01490294|458845361|FG001|Overall Study|Prematurely discontinuation|0|||
127514315|NCT01490294|458845362|FG002|Overall Study|Prematurely discontinuation|1|||
127514316|NCT01490294|458845363|FG003|Overall Study|Prematurely discontinuation|1|||
127514317|NCT01490294|458845360|FG000|Overall Study|Adverse Event|1|||
127514318|NCT01490294|458845361|FG001|Overall Study|Adverse Event|0|||
127514319|NCT01490294|458845362|FG002|Overall Study|Adverse Event|0|||
127514320|NCT01490294|458845363|FG003|Overall Study|Adverse Event|0|||
127514321|NCT05219669|458845364|FG000|Period 1 (1 Day)|Withdrawal by Subject|0|||
127514322|NCT05219669|458845365|FG001|Period 1 (1 Day)|Withdrawal by Subject|0|||
127514323|NCT05219669|458845366|FG002|Period 1 (1 Day)|Withdrawal by Subject|1|||
127514324|NCT05219669|458845367|FG003|Period 1 (1 Day)|Withdrawal by Subject|0|||
127514325|NCT05219669|458845368|FG004|Period 1 (1 Day)|Withdrawal by Subject|0|||
127514326|NCT05219669|458845369|FG005|Period 1 (1 Day)|Withdrawal by Subject|0|||
127514327|NCT02404649|458845370|FG000|Overall Study|Adverse Event|1|||
127514328|NCT02404649|458845371|FG001|Overall Study|Adverse Event|2|||
127514329|NCT00330668|458845375|FG000|BID Dosing Period|Adverse Event|1|||
127514330|NCT00330668|458845375|FG000|BID Dosing Period|Lost to Follow-up|7|||
127514331|NCT00330668|458845375|FG000|BID Dosing Period|Non-Compliance|5|||
127514332|NCT00330668|458845375|FG000|BID Dosing Period|Withdrawal by Subject|19|||
127514333|NCT00330668|458845375|FG000|BID Dosing Period|Sponsor's decision|1|||
127514334|NCT00330668|458845375|FG000|BID Dosing Period|Other|3|||
127514335|NCT00330668|458845375|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
127514336|NCT00330668|458845375|FG000|QD Dosing Period|Other|1|||
127514337|NCT00330668|458845375|FG000|QD Dosing Period|Withdrawal by Subject|1|||
127514338|NCT00330668|458845375|FG000|QD Dosing Period|Lost to Follow-up|2|||
127514339|NCT01839656|458845376|FG000|Overall Study|Withdrawal by Subject|1|||
127514340|NCT01839656|458845377|FG001|Overall Study|Withdrawal by Subject|1|||
127514341|NCT01839656|458845376|FG000|Overall Study|Adverse event, serious fatal|1|||
127514342|NCT01839656|458845377|FG001|Overall Study|Adverse event, serious fatal|4|||
127514343|NCT01839656|458845376|FG000|Overall Study|Early study closure|0|||
127514344|NCT01839656|458845377|FG001|Overall Study|Early study closure|11|||
127514345|NCT01839656|458845376|FG000|Overall Study|Adverse Event|1|||
127514346|NCT01839656|458845377|FG001|Overall Study|Adverse Event|0|||
127514347|NCT01595581|458845378|FG000|Overall Study|Withdrawal by Subject|1|||
127514348|NCT01595581|458845379|FG001|Overall Study|Withdrawal by Subject|0|||
127514349|NCT02621073|458845389|FG000|Overall Study|Lost to Follow-up|0|||
127514350|NCT02621073|458845390|FG001|Overall Study|Lost to Follow-up|1|||
127514351|NCT02621073|458845389|FG000|Overall Study|Physician Decision|3|||
127514352|NCT02621073|458845390|FG001|Overall Study|Physician Decision|2|||
127514353|NCT01440881|458845391|FG000|Overall Study|Death|0|||
127514354|NCT01440881|458845392|FG001|Overall Study|Death|1|||
127514355|NCT02920957|458845397|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
127514356|NCT02920957|458845398|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
127514357|NCT02920957|458845397|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
127514358|NCT02920957|458845398|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
127514359|NCT02920957|458845397|FG000|First Intervention : 1 Month|Adverse Event|1|||
127514360|NCT02920957|458845398|FG001|First Intervention : 1 Month|Adverse Event|0|||
127514361|NCT02920957|458845397|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
127514362|NCT02920957|458845398|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
127514363|NCT02644356|458845400|FG000|Overall Study|Withdrawal by Subject|2|||
127514364|NCT02739321|458845407|FG000|Overall Study|Lack of Efficacy|1|||
127514365|NCT02739321|458845408|FG001|Overall Study|Lack of Efficacy|1|||
127514366|NCT02739321|458845407|FG000|Overall Study|Lost to Follow-up|1|||
127514367|NCT02739321|458845408|FG001|Overall Study|Lost to Follow-up|1|||
127514368|NCT02739321|458845407|FG000|Overall Study|Withdrawal by Subject|1|||
127514369|NCT02739321|458845408|FG001|Overall Study|Withdrawal by Subject|2|||
127514370|NCT01711866|458845409|FG000|Overall Study|Noncompliant|3|||
127514371|NCT01711866|458845409|FG000|Overall Study|Withdrawal by Subject|3|||
127514372|NCT01711866|458845409|FG000|Overall Study|Adverse Event|2|||
127514373|NCT01345682|458845410|FG000|Overall Study|Progressive disease per RECIST|226|||
127514374|NCT01345682|458845411|FG001|Overall Study|Progressive disease per RECIST|93|||
127514375|NCT01345682|458845410|FG000|Overall Study|Worsening of underlying cancer disease|23|||
127514376|NCT01345682|458845411|FG001|Overall Study|Worsening of underlying cancer disease|12|||
127514377|NCT01345682|458845410|FG000|Overall Study|Adverse Event|51|||
127514378|NCT01345682|458845411|FG001|Overall Study|Adverse Event|41|||
127514379|NCT01345682|458845410|FG000|Overall Study|Non-compliance with protocol|0|||
127514380|NCT01345682|458845411|FG001|Overall Study|Non-compliance with protocol|1|||
127514381|NCT01345682|458845410|FG000|Overall Study|Lost to Follow-up|0|||
127514382|NCT01345682|458845411|FG001|Overall Study|Lost to Follow-up|1|||
127514383|NCT01345682|458845410|FG000|Overall Study|Refused to continue trial medication|16|||
127514384|NCT01345682|458845411|FG001|Overall Study|Refused to continue trial medication|9|||
127514385|NCT01345682|458845410|FG000|Overall Study|Not treated|2|||
127514386|NCT01345682|458845411|FG001|Overall Study|Not treated|1|||
127514387|NCT01345682|458845410|FG000|Overall Study|Reason other than those specified above|4|||
127514388|NCT01345682|458845411|FG001|Overall Study|Reason other than those specified above|3|||
127514389|NCT00897390|458845414|FG000|Overall Study|Adverse Event|2|||
127514390|NCT00897390|458845414|FG000|Overall Study|No Longer Met Study Criteria|1|||
127514391|NCT00897390|458845414|FG000|Overall Study|Personal Reasons|1|||
127514392|NCT00897390|458845414|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
127514393|NCT00958217|458845418|FG000|Overall Study|Death|2|||
127514394|NCT00958217|458845419|FG001|Overall Study|Death|1|||
127514395|NCT00958217|458845418|FG000|Overall Study|Withdrawal by Subject|4|||
127514396|NCT00958217|458845419|FG001|Overall Study|Withdrawal by Subject|3|||
127514397|NCT00958217|458845418|FG000|Overall Study|Lost to Follow-up|17|||
127514398|NCT00958217|458845419|FG001|Overall Study|Lost to Follow-up|19|||
127514399|NCT00958217|458845418|FG000|Overall Study|Moved out of area|1|||
127514400|NCT00958217|458845419|FG001|Overall Study|Moved out of area|1|||
127514401|NCT00958217|458845418|FG000|Overall Study|Inpatient hospitalization|0|||
127514402|NCT00958217|458845419|FG001|Overall Study|Inpatient hospitalization|1|||
127514403|NCT01075984|458845422|FG000|Treatment Phase|Adverse Event|0|||
127514404|NCT01075984|458845423|FG001|Treatment Phase|Adverse Event|1|||
127514405|NCT01075984|458845424|FG002|Treatment Phase|Adverse Event|3|||
127514406|NCT01075984|458845425|FG003|Treatment Phase|Adverse Event|7|||
127514407|NCT01075984|458845426|FG004|Treatment Phase|Adverse Event|35|||
127514408|NCT01075984|458845422|FG000|Treatment Phase|Protocol Violation|0|||
127514409|NCT01075984|458845423|FG001|Treatment Phase|Protocol Violation|0|||
127514410|NCT01075984|458845424|FG002|Treatment Phase|Protocol Violation|1|||
127514411|NCT01075984|458845425|FG003|Treatment Phase|Protocol Violation|0|||
127514412|NCT01075984|458845426|FG004|Treatment Phase|Protocol Violation|3|||
127514413|NCT01075984|458845422|FG000|Treatment Phase|Withdrawal by Subject|0|||
127514414|NCT01075984|458845423|FG001|Treatment Phase|Withdrawal by Subject|0|||
127514415|NCT01075984|458845424|FG002|Treatment Phase|Withdrawal by Subject|2|||
127514416|NCT01075984|458845425|FG003|Treatment Phase|Withdrawal by Subject|0|||
127514417|NCT01075984|458845426|FG004|Treatment Phase|Withdrawal by Subject|15|||
127514418|NCT01075984|458845422|FG000|Treatment Phase|Treatment Failure|0|||
127514419|NCT01075984|458845423|FG001|Treatment Phase|Treatment Failure|0|||
127514420|NCT01075984|458845424|FG002|Treatment Phase|Treatment Failure|1|||
127514421|NCT01075984|458845425|FG003|Treatment Phase|Treatment Failure|0|||
127514422|NCT01075984|458845426|FG004|Treatment Phase|Treatment Failure|5|||
127514423|NCT01075984|458845422|FG000|Treatment Phase|Progression of disease|0|||
127514424|NCT01075984|458845423|FG001|Treatment Phase|Progression of disease|0|||
127514425|NCT01075984|458845424|FG002|Treatment Phase|Progression of disease|0|||
127514426|NCT01075984|458845425|FG003|Treatment Phase|Progression of disease|0|||
127514427|NCT01075984|458845426|FG004|Treatment Phase|Progression of disease|2|||
127514428|NCT01075984|458845422|FG000|Follow-up Phase|Protocol Violation|0|||
127514429|NCT01075984|458845423|FG001|Follow-up Phase|Protocol Violation|0|||
127514430|NCT01075984|458845424|FG002|Follow-up Phase|Protocol Violation|1|||
127514431|NCT01075984|458845425|FG003|Follow-up Phase|Protocol Violation|0|||
127514432|NCT01075984|458845426|FG004|Follow-up Phase|Protocol Violation|3|||
127514433|NCT01075984|458845422|FG000|Follow-up Phase|Adverse Event|0|||
127514434|NCT01075984|458845423|FG001|Follow-up Phase|Adverse Event|0|||
127514435|NCT01075984|458845424|FG002|Follow-up Phase|Adverse Event|0|||
127514436|NCT01075984|458845425|FG003|Follow-up Phase|Adverse Event|2|||
127514437|NCT01075984|458845426|FG004|Follow-up Phase|Adverse Event|27|||
127514438|NCT01075984|458845422|FG000|Follow-up Phase|Administrative|0|||
127514439|NCT01075984|458845423|FG001|Follow-up Phase|Administrative|0|||
127514440|NCT01075984|458845424|FG002|Follow-up Phase|Administrative|0|||
127514441|NCT01075984|458845425|FG003|Follow-up Phase|Administrative|0|||
127514442|NCT01075984|458845426|FG004|Follow-up Phase|Administrative|1|||
127514443|NCT01075984|458845422|FG000|Follow-up Phase|Withdrawal by Subject|0|||
127514444|NCT01075984|458845423|FG001|Follow-up Phase|Withdrawal by Subject|0|||
127514445|NCT01075984|458845424|FG002|Follow-up Phase|Withdrawal by Subject|0|||
127514446|NCT01075984|458845425|FG003|Follow-up Phase|Withdrawal by Subject|0|||
127514447|NCT01075984|458845426|FG004|Follow-up Phase|Withdrawal by Subject|10|||
127514448|NCT01075984|458845422|FG000|Follow-up Phase|Progression of disease|0|||
127514449|NCT01075984|458845423|FG001|Follow-up Phase|Progression of disease|0|||
127514450|NCT01075984|458845424|FG002|Follow-up Phase|Progression of disease|0|||
127514451|NCT01075984|458845425|FG003|Follow-up Phase|Progression of disease|0|||
127514452|NCT01075984|458845426|FG004|Follow-up Phase|Progression of disease|2|||
127514453|NCT01075984|458845422|FG000|Follow-up Phase|Treatment failure|0|||
127514454|NCT01075984|458845423|FG001|Follow-up Phase|Treatment failure|0|||
127514455|NCT01075984|458845424|FG002|Follow-up Phase|Treatment failure|0|||
127514456|NCT01075984|458845425|FG003|Follow-up Phase|Treatment failure|0|||
127514457|NCT01075984|458845426|FG004|Follow-up Phase|Treatment failure|4|||
127514458|NCT02440789|458845428|FG000|Overall Study|Withdrawal by Subject|3|||
127514459|NCT02440789|458845428|FG000|Overall Study|Not willing to adhere to reqs|1|||
127514460|NCT04573881|458845430|FG000|Overall Study|Participant in active follow-up at 30 days|24|||
127514461|NCT02564978|458845433|FG000|Overall Study|Adverse Event|8|||
127514462|NCT02564978|458845433|FG000|Overall Study|Death|1|||
127514463|NCT02564978|458845433|FG000|Overall Study|Lost to Follow-up|1|||
127514464|NCT02564978|458845433|FG000|Overall Study|Withdrawal by Subject|15|||
127514465|NCT02564978|458845433|FG000|Overall Study|Early Study Closure|2|||
127514466|NCT02564978|458845433|FG000|Overall Study|Other Reason|5|||
127514467|NCT03684694|458845434|FG000|Phase 1|Withdrawal by Subject|1|||
127514468|NCT03684694|458845435|FG001|Phase 1|Withdrawal by Subject|0|||
127514469|NCT03684694|458845436|FG002|Phase 1|Withdrawal by Subject|0|||
127514470|NCT03684694|458845437|FG003|Phase 1|Withdrawal by Subject|0|||
127514471|NCT03684694|458845438|FG004|Phase 1|Withdrawal by Subject|0|||
127514472|NCT03684694|458845439|FG005|Phase 1|Withdrawal by Subject|0|||
127514473|NCT03684694|458845434|FG000|Phase 1|Investigator/Sponsor Decision|12|||
127514474|NCT03684694|458845435|FG001|Phase 1|Investigator/Sponsor Decision|2|||
127514475|NCT03684694|458845436|FG002|Phase 1|Investigator/Sponsor Decision|1|||
127514476|NCT03684694|458845437|FG003|Phase 1|Investigator/Sponsor Decision|0|||
127514477|NCT03684694|458845438|FG004|Phase 1|Investigator/Sponsor Decision|0|||
127514478|NCT03684694|458845439|FG005|Phase 1|Investigator/Sponsor Decision|0|||
127514479|NCT03684694|458845434|FG000|Phase 1|Death|24|||
127514480|NCT03684694|458845435|FG001|Phase 1|Death|0|||
127514481|NCT03684694|458845436|FG002|Phase 1|Death|3|||
127514482|NCT03684694|458845437|FG003|Phase 1|Death|0|||
127514483|NCT03684694|458845438|FG004|Phase 1|Death|0|||
127514484|NCT03684694|458845439|FG005|Phase 1|Death|0|||
127514485|NCT03684694|458845434|FG000|Phase 1|Lost to Follow-up|0|||
127514486|NCT03684694|458845435|FG001|Phase 1|Lost to Follow-up|0|||
127514487|NCT03684694|458845436|FG002|Phase 1|Lost to Follow-up|1|||
127514488|NCT03684694|458845437|FG003|Phase 1|Lost to Follow-up|0|||
127514489|NCT03684694|458845438|FG004|Phase 1|Lost to Follow-up|0|||
127514490|NCT03684694|458845439|FG005|Phase 1|Lost to Follow-up|0|||
127514491|NCT03684694|458845434|FG000|Phase 1|Miscellaneous|0|||
127514492|NCT03684694|458845435|FG001|Phase 1|Miscellaneous|1|||
127514493|NCT03684694|458845436|FG002|Phase 1|Miscellaneous|0|||
127514494|NCT03684694|458845437|FG003|Phase 1|Miscellaneous|0|||
127514495|NCT03684694|458845438|FG004|Phase 1|Miscellaneous|0|||
127514496|NCT03684694|458845439|FG005|Phase 1|Miscellaneous|0|||
127514497|NCT03684694|458845434|FG000|Phase 2|Withdrawal by Subject|0|||
127514498|NCT03684694|458845435|FG001|Phase 2|Withdrawal by Subject|0|||
127514499|NCT03684694|458845436|FG002|Phase 2|Withdrawal by Subject|0|||
127514500|NCT03684694|458845437|FG003|Phase 2|Withdrawal by Subject|0|||
127514501|NCT03684694|458845438|FG004|Phase 2|Withdrawal by Subject|0|||
127514502|NCT03684694|458845439|FG005|Phase 2|Withdrawal by Subject|1|||
127514503|NCT03684694|458845434|FG000|Phase 2|Investigator/Sponsor Decision|0|||
127514504|NCT03684694|458845435|FG001|Phase 2|Investigator/Sponsor Decision|0|||
127514505|NCT03684694|458845436|FG002|Phase 2|Investigator/Sponsor Decision|0|||
127514506|NCT03684694|458845437|FG003|Phase 2|Investigator/Sponsor Decision|17|||
127514507|NCT03684694|458845438|FG004|Phase 2|Investigator/Sponsor Decision|16|||
127514508|NCT03684694|458845439|FG005|Phase 2|Investigator/Sponsor Decision|6|||
127514509|NCT03684694|458845434|FG000|Phase 2|Death|0|||
127514510|NCT03684694|458845435|FG001|Phase 2|Death|0|||
127514511|NCT03684694|458845436|FG002|Phase 2|Death|0|||
127514512|NCT03684694|458845437|FG003|Phase 2|Death|28|||
127514513|NCT03684694|458845438|FG004|Phase 2|Death|14|||
127514514|NCT03684694|458845439|FG005|Phase 2|Death|3|||
127514515|NCT03684694|458845434|FG000|Phase 2|Lost to Follow-up|0|||
127514516|NCT03684694|458845435|FG001|Phase 2|Lost to Follow-up|0|||
127514517|NCT03684694|458845436|FG002|Phase 2|Lost to Follow-up|0|||
127514518|NCT03684694|458845437|FG003|Phase 2|Lost to Follow-up|1|||
127514519|NCT03684694|458845438|FG004|Phase 2|Lost to Follow-up|0|||
127514520|NCT03684694|458845439|FG005|Phase 2|Lost to Follow-up|0|||
127514521|NCT03684694|458845434|FG000|Phase 2|Miscellaneous|0|||
127514522|NCT03684694|458845435|FG001|Phase 2|Miscellaneous|0|||
127514523|NCT03684694|458845436|FG002|Phase 2|Miscellaneous|0|||
127514524|NCT03684694|458845437|FG003|Phase 2|Miscellaneous|3|||
127514525|NCT03684694|458845438|FG004|Phase 2|Miscellaneous|0|||
127514526|NCT03684694|458845439|FG005|Phase 2|Miscellaneous|0|||
127514527|NCT01825941|458846935|FG000|Overall Study|Lost to Follow-up|4|||
127514528|NCT01825941|458846936|FG001|Overall Study|Lost to Follow-up|1|||
127514529|NCT00528996|458846937|FG000|Overall Study|Other reasons than listing|6|||
127514530|NCT00528996|458846938|FG001|Overall Study|Other reasons than listing|7|||
127514531|NCT00528996|458846939|FG002|Overall Study|Other reasons than listing|14|||
127514532|NCT00528996|458846940|FG003|Overall Study|Other reasons than listing|11|||
127514533|NCT00528996|458846941|FG004|Overall Study|Other reasons than listing|5|||
127514534|NCT00528996|458846937|FG000|Overall Study|Refused continue medication|16|||
127514535|NCT00528996|458846938|FG001|Overall Study|Refused continue medication|0|||
127514536|NCT00528996|458846939|FG002|Overall Study|Refused continue medication|3|||
127514537|NCT00528996|458846940|FG003|Overall Study|Refused continue medication|3|||
127514538|NCT00528996|458846941|FG004|Overall Study|Refused continue medication|6|||
127514539|NCT00528996|458846937|FG000|Overall Study|Lost to Follow-up|2|||
127514540|NCT00528996|458846938|FG001|Overall Study|Lost to Follow-up|0|||
127514541|NCT00528996|458846939|FG002|Overall Study|Lost to Follow-up|4|||
127514542|NCT00528996|458846940|FG003|Overall Study|Lost to Follow-up|1|||
127514543|NCT00528996|458846941|FG004|Overall Study|Lost to Follow-up|3|||
127514544|NCT00528996|458846937|FG000|Overall Study|Protocol Violation|1|||
127514545|NCT00528996|458846938|FG001|Overall Study|Protocol Violation|2|||
127514546|NCT00528996|458846939|FG002|Overall Study|Protocol Violation|3|||
127514547|NCT00528996|458846940|FG003|Overall Study|Protocol Violation|3|||
127514548|NCT00528996|458846941|FG004|Overall Study|Protocol Violation|2|||
127514549|NCT00528996|458846937|FG000|Overall Study|Lack of Efficacy|7|||
127514550|NCT00528996|458846938|FG001|Overall Study|Lack of Efficacy|2|||
127514551|NCT00528996|458846939|FG002|Overall Study|Lack of Efficacy|1|||
127514552|NCT00528996|458846940|FG003|Overall Study|Lack of Efficacy|3|||
127514553|NCT00528996|458846941|FG004|Overall Study|Lack of Efficacy|3|||
127514554|NCT00528996|458846937|FG000|Overall Study|Adverse Event|32|||
127514555|NCT00528996|458846938|FG001|Overall Study|Adverse Event|13|||
127514556|NCT00528996|458846939|FG002|Overall Study|Adverse Event|18|||
127514557|NCT00528996|458846940|FG003|Overall Study|Adverse Event|29|||
127514558|NCT00528996|458846941|FG004|Overall Study|Adverse Event|18|||
127514559|NCT05065190|458846948|FG000|Overall Study|Other than listed|2|||
127514560|NCT05065190|458846949|FG001|Overall Study|Other than listed|12|||
127514561|NCT05065190|458846948|FG000|Overall Study|Lack of Efficacy|4|||
127514562|NCT05065190|458846949|FG001|Overall Study|Lack of Efficacy|0|||
127514563|NCT05065190|458846948|FG000|Overall Study|Adverse Event|1|||
127514564|NCT05065190|458846949|FG001|Overall Study|Adverse Event|10|||
127514565|NCT05565937|458846950|FG000|Overall Study|Adverse Event|0|||
127514566|NCT05565937|458846951|FG001|Overall Study|Adverse Event|1|||
127514567|NCT05565937|458846950|FG000|Overall Study|Persistent study-related symptoms /complaints|1|||
127514568|NCT05565937|458846951|FG001|Overall Study|Persistent study-related symptoms /complaints|1|||
127514569|NCT05565937|458846950|FG000|Overall Study|Lost to Follow-up|2|||
127514570|NCT05565937|458846951|FG001|Overall Study|Lost to Follow-up|0|||
127514571|NCT05565937|458846950|FG000|Overall Study|Pregnancy|0|||
127514572|NCT05565937|458846951|FG001|Overall Study|Pregnancy|2|||
127514573|NCT05565937|458846950|FG000|Overall Study|Anisometropia|0|||
127514574|NCT05565937|458846951|FG001|Overall Study|Anisometropia|1|||
127514575|NCT01022424|458846952|FG000|Overall Study|Adverse Event|1|||
127514576|NCT01022424|458846952|FG000|Overall Study|Physician Decision|1|||
127514577|NCT01022424|458846952|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
127514578|NCT02783170|458846955|FG000|Overall Study|Randomized but not Vaccinated|1|||
127514579|NCT02783170|458846956|FG001|Overall Study|Randomized but not Vaccinated|0|||
127514580|NCT04938037|458846959|FG000|Overall Study|Lost to Follow-up|4|||
127514581|NCT04938037|458846960|FG001|Overall Study|Lost to Follow-up|3|||
127514582|NCT03320330|458846961|FG000|Overall Study|Lack of Efficacy|5|||
127514583|NCT03320330|458846962|FG001|Overall Study|Lack of Efficacy|5|||
127514584|NCT03320330|458846963|FG002|Overall Study|Lack of Efficacy|14|||
127514585|NCT03320330|458846961|FG000|Overall Study|Physician Decision|1|||
127514586|NCT03320330|458846962|FG001|Overall Study|Physician Decision|0|||
127514587|NCT03320330|458846963|FG002|Overall Study|Physician Decision|0|||
127514588|NCT01806064|458846964|FG000|Overall Study|Randomized Not Enrolled|0|||
127514589|NCT01806064|458846965|FG001|Overall Study|Randomized Not Enrolled|0|||
127514590|NCT01806064|458846966|FG002|Overall Study|Randomized Not Enrolled|0|||
127514591|NCT01806064|458846967|FG003|Overall Study|Randomized Not Enrolled|1|||
127514592|NCT01806064|458846968|FG004|Overall Study|Randomized Not Enrolled|2|||
127514593|NCT01282294|458846973|FG000|Overall Study|Lost to Follow-up|14|||
127514594|NCT01282294|458846973|FG000|Overall Study|Screening failure|1|||
127514595|NCT01282294|458846973|FG000|Overall Study|Adverse Event|1|||
127514596|NCT01282294|458846973|FG000|Overall Study|Patient non-compliance|2|||
127514597|NCT01282294|458846973|FG000|Overall Study|Physician Decision|1|||
127514598|NCT02943915|458846974|FG000|Overall Study|Withdrawal by Subject|2|||
127514599|NCT02943915|458846975|FG001|Overall Study|Withdrawal by Subject|1|||
127514600|NCT02943915|458846976|FG002|Overall Study|Withdrawal by Subject|0|||
127514601|NCT02943915|458846977|FG003|Overall Study|Withdrawal by Subject|0|||
127514602|NCT02943915|458846974|FG000|Overall Study|Lost to Follow-up|3|||
127514603|NCT02943915|458846975|FG001|Overall Study|Lost to Follow-up|1|||
127514604|NCT02943915|458846976|FG002|Overall Study|Lost to Follow-up|0|||
127514605|NCT02943915|458846977|FG003|Overall Study|Lost to Follow-up|0|||
127514606|NCT02943915|458846974|FG000|Overall Study|excluded|0|||
127514607|NCT02943915|458846975|FG001|Overall Study|excluded|1|||
127514608|NCT02943915|458846976|FG002|Overall Study|excluded|0|||
127514609|NCT02943915|458846977|FG003|Overall Study|excluded|0|||
127514610|NCT00004445|458846979|FG000|Overall Study|Physician Decision|2|||
127514611|NCT00004445|458846979|FG000|Overall Study|Withdrawal by Subject|1|||
127514612|NCT04692077|458846980|FG000|Cabotegravir Long Acting Injection Phase|Withdrawal by Subject|1|||
127514613|NCT02753127|458846987|FG000|Overall Study|Lost to Follow-up|13|||
127514614|NCT02753127|458846988|FG001|Overall Study|Lost to Follow-up|11|||
127514615|NCT02753127|458846987|FG000|Overall Study|Withdrawal by Subject|37|||
127514616|NCT02753127|458846988|FG001|Overall Study|Withdrawal by Subject|47|||
127514617|NCT02753127|458846987|FG000|Overall Study|Other|3|||
127514618|NCT02753127|458846988|FG001|Overall Study|Other|8|||
127514619|NCT02753127|458846987|FG000|Overall Study|Hospice|0|||
127514620|NCT02753127|458846988|FG001|Overall Study|Hospice|2|||
127514621|NCT03826342|458846989|FG000|Overall Study|Withdrawal by Subject|8|||
127514622|NCT03826342|458846990|FG001|Overall Study|Withdrawal by Subject|1|||
127514623|NCT03826342|458846989|FG000|Overall Study|Lost to Follow-up|7|||
127514624|NCT03826342|458846990|FG001|Overall Study|Lost to Follow-up|7|||
127514625|NCT03826342|458846989|FG000|Overall Study|Miscarriage - Loss of Eligibility to Participate|1|||
127514626|NCT03826342|458846990|FG001|Overall Study|Miscarriage - Loss of Eligibility to Participate|3|||
127514627|NCT01818284|458846991|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
127514628|NCT01818284|458846992|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
127514629|NCT01818284|458846991|FG000|Overall Study|Death|0|||
127514630|NCT01818284|458846992|FG001|Overall Study|Death|2|||
127514631|NCT03681678|458846993|FG000|Overall Study|Lost to Follow-up|20|||
127514632|NCT01114360|458846996|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
127514633|NCT01114360|458846997|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
127514634|NCT03007745|458846998|FG000|Overall Study|Sleep test negative for OSA|53|||
127514635|NCT03007745|458846999|FG001|Overall Study|Sleep test negative for OSA|49|||
127514636|NCT03007745|458846998|FG000|Overall Study|Physician Decision|6|||
127514637|NCT03007745|458846999|FG001|Overall Study|Physician Decision|9|||
127514638|NCT03007745|458846998|FG000|Overall Study|Withdrawal by Subject|38|||
127514639|NCT03007745|458846999|FG001|Overall Study|Withdrawal by Subject|16|||
127514640|NCT03007745|458846998|FG000|Overall Study|Lost to Follow-up|19|||
127514641|NCT03007745|458846999|FG001|Overall Study|Lost to Follow-up|25|||
127514642|NCT03007745|458846998|FG000|Overall Study|Unable to login to website|17|||
127514643|NCT03007745|458846999|FG001|Overall Study|Unable to login to website|4|||
127514644|NCT01300351|458847000|FG000|Overall Study|Did not receive treatment|2|||
127514645|NCT01300351|458847001|FG001|Overall Study|Did not receive treatment|0|||
127514646|NCT01300351|458847000|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
127514647|NCT01300351|458847001|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
127514648|NCT01300351|458847000|FG000|Overall Study|Lost to Follow-up|0|||
127514649|NCT01300351|458847001|FG001|Overall Study|Lost to Follow-up|1|||
127514650|NCT01300351|458847000|FG000|Overall Study|Adverse Event|0|||
127514651|NCT01300351|458847001|FG001|Overall Study|Adverse Event|4|||
127514652|NCT01300351|458847000|FG000|Overall Study|Withdrawal by Subject|7|||
127514653|NCT01300351|458847001|FG001|Overall Study|Withdrawal by Subject|10|||
127514654|NCT01146288|458847003|FG000|First Intervention(1 Day)|Adverse Event|0|||
127514655|NCT01146288|458847004|FG001|First Intervention(1 Day)|Adverse Event|1|||
127514656|NCT00385723|458847005|FG000|Overall Study|Lost to Follow-up|1|||
127514657|NCT00385723|458847006|FG001|Overall Study|Lost to Follow-up|1|||
127514658|NCT00385723|458847007|FG002|Overall Study|Lost to Follow-up|0|||
127514659|NCT00385723|458847005|FG000|Overall Study|Withdrawal by Subject|1|||
127514660|NCT00385723|458847006|FG001|Overall Study|Withdrawal by Subject|0|||
127514661|NCT00385723|458847007|FG002|Overall Study|Withdrawal by Subject|2|||
127514662|NCT00413010|458847008|FG000|Overall Study|Adverse Event|8|||
127514663|NCT00413010|458847009|FG001|Overall Study|Adverse Event|4|||
127514664|NCT00413010|458847008|FG000|Overall Study|Laboratory abnormality|0|||
127514665|NCT00413010|458847009|FG001|Overall Study|Laboratory abnormality|2|||
127514666|NCT00413010|458847008|FG000|Overall Study|Lack of Efficacy|0|||
127514667|NCT00413010|458847009|FG001|Overall Study|Lack of Efficacy|3|||
127514668|NCT00413010|458847008|FG000|Overall Study|Lost to Follow-up|3|||
127514669|NCT00413010|458847009|FG001|Overall Study|Lost to Follow-up|0|||
127514670|NCT00413010|458847008|FG000|Overall Study|Withdrawal by Subject|7|||
127514671|NCT00413010|458847009|FG001|Overall Study|Withdrawal by Subject|2|||
127514672|NCT00413010|458847008|FG000|Overall Study|Due to termination of the study|54|||
127514673|NCT00413010|458847009|FG001|Overall Study|Due to termination of the study|52|||
127514674|NCT00708734|458847012|FG000|Overall Study|scheduling conflict|2|||
127514675|NCT00708734|458847012|FG000|Overall Study|moved|1|||
127514676|NCT00708734|458847012|FG000|Overall Study|leg injury|1|||
127514677|NCT00708734|458847012|FG000|Overall Study|knee replacement|1|||
127514678|NCT00708734|458847012|FG000|Overall Study|vertigo|1|||
127514679|NCT00708734|458847012|FG000|Overall Study|leg fracture|1|||
127514680|NCT01533922|458847014|FG000|Overall Study|Adverse Event|5|||
127514681|NCT01533922|458847015|FG001|Overall Study|Adverse Event|8|||
127514682|NCT01533922|458847016|FG002|Overall Study|Adverse Event|6|||
127514683|NCT01533922|458847017|FG003|Overall Study|Adverse Event|3|||
127514684|NCT01533922|458847018|FG004|Overall Study|Adverse Event|4|||
127514685|NCT01533922|458847014|FG000|Overall Study|Lack of Efficacy|0|||
127514686|NCT01533922|458847015|FG001|Overall Study|Lack of Efficacy|0|||
127514687|NCT01533922|458847016|FG002|Overall Study|Lack of Efficacy|1|||
127514688|NCT01533922|458847017|FG003|Overall Study|Lack of Efficacy|0|||
127514689|NCT01533922|458847018|FG004|Overall Study|Lack of Efficacy|0|||
127514690|NCT01533922|458847014|FG000|Overall Study|Protocol Violation|0|||
127514691|NCT01533922|458847015|FG001|Overall Study|Protocol Violation|3|||
127514692|NCT01533922|458847016|FG002|Overall Study|Protocol Violation|0|||
127514693|NCT01533922|458847017|FG003|Overall Study|Protocol Violation|0|||
127514694|NCT01533922|458847018|FG004|Overall Study|Protocol Violation|1|||
127514695|NCT01533922|458847014|FG000|Overall Study|Withdrawal by Subject|3|||
127514696|NCT01533922|458847015|FG001|Overall Study|Withdrawal by Subject|1|||
127514697|NCT01533922|458847016|FG002|Overall Study|Withdrawal by Subject|2|||
127514698|NCT01533922|458847017|FG003|Overall Study|Withdrawal by Subject|2|||
127514699|NCT01533922|458847018|FG004|Overall Study|Withdrawal by Subject|1|||
127514700|NCT01533922|458847014|FG000|Overall Study|Other reason not defined above|2|||
127514701|NCT01533922|458847015|FG001|Overall Study|Other reason not defined above|0|||
127514702|NCT01533922|458847016|FG002|Overall Study|Other reason not defined above|1|||
127514703|NCT01533922|458847017|FG003|Overall Study|Other reason not defined above|0|||
127514704|NCT01533922|458847018|FG004|Overall Study|Other reason not defined above|0|||
127514705|NCT02634606|458847019|FG000|Overall Study|unable to obtain the drug at start|13|||
127514706|NCT00286221|458847020|FG000|Overall Study|Protocol Violation|2|||
127514707|NCT00286221|458847021|FG001|Overall Study|Protocol Violation|1|||
127514708|NCT00286221|458847022|FG002|Overall Study|Protocol Violation|6|||
127514709|NCT00286221|458847023|FG003|Overall Study|Protocol Violation|4|||
127514710|NCT00286221|458847020|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
127514711|NCT00286221|458847021|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
127514712|NCT00286221|458847022|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
127514713|NCT00286221|458847023|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
127514714|NCT00286221|458847020|FG000|Overall Study|Inability to trigger PCA|2|||
127514715|NCT00286221|458847021|FG001|Overall Study|Inability to trigger PCA|0|||
127514716|NCT00286221|458847022|FG002|Overall Study|Inability to trigger PCA|0|||
127514717|NCT00286221|458847023|FG003|Overall Study|Inability to trigger PCA|0|||
127514718|NCT00286221|458847020|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
127514719|NCT00286221|458847021|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
127514720|NCT00286221|458847022|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
127514721|NCT00286221|458847023|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
127514722|NCT02553538|458847025|FG000|Overall Study|Could Not Reach by Telephone|133|||
127514723|NCT02553538|458847026|FG001|Overall Study|Could Not Reach by Telephone|0|||
127514724|NCT02553538|458847025|FG000|Overall Study|Died or Left Network|54|||
127514725|NCT02553538|458847026|FG001|Overall Study|Died or Left Network|56|||
127514726|NCT02276547|458847027|FG000|Overall Study|Death|2|||
127514727|NCT02276547|458847027|FG000|Overall Study|Explant|2|||
127514728|NCT01754194|458847028|FG000|Overall Study|Lost to Follow-up|39|||
127514729|NCT01754194|458847029|FG001|Overall Study|Lost to Follow-up|14|||
127514730|NCT01754194|458847028|FG000|Overall Study|Withdrawal by Subject|4|||
127514731|NCT01754194|458847029|FG001|Overall Study|Withdrawal by Subject|5|||
127514732|NCT01754194|458847028|FG000|Overall Study|Other|9|||
127514733|NCT01754194|458847029|FG001|Overall Study|Other|8|||
127514734|NCT00357656|458847031|FG000|Overall Study|Other, No surgery performed|0|||
127514735|NCT00357656|458847032|FG001|Overall Study|Other, No surgery performed|3|||
127514736|NCT01565941|458847033|FG000|Overall Study|Withdrawn by parent/guardian|3|||
127514737|NCT01565941|458847034|FG001|Overall Study|Withdrawn by parent/guardian|2|||
127514738|NCT01565941|458847033|FG000|Overall Study|Randomized; did not receive intevention|8|||
127514739|NCT01565941|458847034|FG001|Overall Study|Randomized; did not receive intevention|2|||
127514740|NCT02365285|458847035|FG000|Overall Study|Physician Decision|0|||
127514741|NCT02365285|458847036|FG001|Overall Study|Physician Decision|1|||
127514742|NCT02365285|458847037|FG002|Overall Study|Physician Decision|1|||
127514743|NCT02365285|458847038|FG003|Overall Study|Physician Decision|0|||
127514744|NCT02365285|458847035|FG000|Overall Study|Adverse Event|0|||
127514745|NCT02365285|458847036|FG001|Overall Study|Adverse Event|0|||
127514746|NCT02365285|458847037|FG002|Overall Study|Adverse Event|0|||
127514747|NCT02365285|458847038|FG003|Overall Study|Adverse Event|2|||
127514748|NCT03262116|458847039|FG000|Overall Study|Physician Decision|0|||
127514749|NCT03262116|458847040|FG001|Overall Study|Physician Decision|2|||
127514750|NCT03262116|458847041|FG002|Overall Study|Physician Decision|1|||
127514751|NCT03262116|458847042|FG003|Overall Study|Physician Decision|1|||
127514752|NCT03262116|458847043|FG004|Overall Study|Physician Decision|1|||
127514753|NCT03262116|458847044|FG005|Overall Study|Physician Decision|2|||
127514754|NCT00121641|458847045|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
127514755|NCT00121641|458847046|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
127514756|NCT00121641|458847047|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
127514757|NCT00121641|458847048|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
127514758|NCT00121641|458847049|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
127514759|NCT00121641|458847045|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
127514760|NCT00121641|458847046|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
127514761|NCT00121641|458847047|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
127514762|NCT00121641|458847048|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
127514763|NCT00121641|458847049|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
127514764|NCT00121641|458847045|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
127514765|NCT00121641|458847046|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
127514766|NCT00121641|458847047|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
127514767|NCT00121641|458847048|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
127514768|NCT00121641|458847049|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
127514769|NCT00121641|458847045|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
127514770|NCT00121641|458847046|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
127514771|NCT00121641|458847047|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
127514772|NCT00121641|458847048|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
127514773|NCT00121641|458847049|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
127514774|NCT00121641|458847045|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
127514775|NCT00121641|458847046|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
127514776|NCT00121641|458847047|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
127514777|NCT00121641|458847048|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
127514778|NCT00121641|458847049|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
127514779|NCT00121641|458847045|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
127514780|NCT00121641|458847046|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
127514781|NCT00121641|458847047|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
127514782|NCT00121641|458847048|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
127514783|NCT00121641|458847049|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
127514784|NCT00121641|458847045|FG000|24-week Short-term Treatment Period|Other Reason|1|||
127514785|NCT00121641|458847046|FG001|24-week Short-term Treatment Period|Other Reason|0|||
127514786|NCT00121641|458847047|FG002|24-week Short-term Treatment Period|Other Reason|0|||
127514787|NCT00121641|458847048|FG003|24-week Short-term Treatment Period|Other Reason|0|||
127514788|NCT00121641|458847049|FG004|24-week Short-term Treatment Period|Other Reason|0|||
127514789|NCT00121641|458847045|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
127514790|NCT00121641|458847046|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
127514791|NCT00121641|458847047|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
127514792|NCT00121641|458847048|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
127514793|NCT00121641|458847049|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
127514794|NCT00121641|458847045|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
127514795|NCT00121641|458847046|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
127514796|NCT00121641|458847047|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
127514797|NCT00121641|458847048|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
127514798|NCT00121641|458847049|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
127514799|NCT00121641|458847045|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
127514800|NCT00121641|458847046|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
127514801|NCT00121641|458847047|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
127514802|NCT00121641|458847048|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
127514803|NCT00121641|458847049|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
127514804|NCT00121641|458847045|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
127514805|NCT00121641|458847046|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
127514806|NCT00121641|458847047|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
127514807|NCT00121641|458847048|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
127514808|NCT00121641|458847049|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
127514809|NCT00121641|458847045|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
127514810|NCT00121641|458847046|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
127514811|NCT00121641|458847047|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
127514812|NCT00121641|458847048|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
127514813|NCT00121641|458847049|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
127514814|NCT00121641|458847045|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
127514815|NCT00121641|458847046|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
127514816|NCT00121641|458847047|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
127514817|NCT00121641|458847048|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
127514818|NCT00121641|458847049|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
127514819|NCT00121641|458847045|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
127514820|NCT00121641|458847046|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
127514821|NCT00121641|458847047|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
127514822|NCT00121641|458847048|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
127514823|NCT00121641|458847049|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
127514824|NCT00121641|458847045|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
127514825|NCT00121641|458847046|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
127514826|NCT00121641|458847047|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
127514827|NCT00121641|458847048|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
127514828|NCT00121641|458847049|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
127514829|NCT00121641|458847045|FG000|48-month Short Term + Long Term Period|Death|0|||
127514830|NCT00121641|458847046|FG001|48-month Short Term + Long Term Period|Death|0|||
127514831|NCT00121641|458847047|FG002|48-month Short Term + Long Term Period|Death|0|||
127514832|NCT00121641|458847048|FG003|48-month Short Term + Long Term Period|Death|1|||
127514833|NCT00121641|458847049|FG004|48-month Short Term + Long Term Period|Death|0|||
127514834|NCT00121641|458847045|FG000|48-month Short Term + Long Term Period|Missing|0|||
127514835|NCT00121641|458847046|FG001|48-month Short Term + Long Term Period|Missing|0|||
127514836|NCT00121641|458847047|FG002|48-month Short Term + Long Term Period|Missing|1|||
127514837|NCT00121641|458847048|FG003|48-month Short Term + Long Term Period|Missing|0|||
127514838|NCT00121641|458847049|FG004|48-month Short Term + Long Term Period|Missing|0|||
127514839|NCT00121641|458847045|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
127514840|NCT00121641|458847046|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
127514841|NCT00121641|458847047|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
127514842|NCT00121641|458847048|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
127514843|NCT00121641|458847049|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
127514844|NCT00249613|458847052|FG000|12 Month Follow-up|Death|1|||
127514845|NCT00249613|458847053|FG001|12 Month Follow-up|Death|1|||
127514846|NCT00249613|458847052|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
127514847|NCT00249613|458847053|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
127514848|NCT00249613|458847052|FG000|12 Month Follow-up|Lost to Follow-up|10|||
127514849|NCT00249613|458847053|FG001|12 Month Follow-up|Lost to Follow-up|8|||
127514850|NCT00806442|458847063|FG000|Overall Study|Lost to Follow-up|3|||
127514851|NCT00806442|458847064|FG001|Overall Study|Lost to Follow-up|2|||
127514852|NCT00806442|458847063|FG000|Overall Study|Withdrawal by Subject|1|||
127514853|NCT00806442|458847064|FG001|Overall Study|Withdrawal by Subject|5|||
127514854|NCT01264770|458847072|FG000|Overall Study|Not reported|0|||
127514855|NCT01264770|458847073|FG001|Overall Study|Not reported|0|||
127514856|NCT01264770|458847074|FG002|Overall Study|Not reported|1|||
127514857|NCT01264770|458847075|FG003|Overall Study|Not reported|0|||
127514858|NCT01264770|458847076|FG004|Overall Study|Not reported|0|||
127514859|NCT01264770|458847077|FG005|Overall Study|Not reported|0|||
127514860|NCT01264770|458847072|FG000|Overall Study|e.g., change in circumstances|8|||
127514861|NCT01264770|458847073|FG001|Overall Study|e.g., change in circumstances|3|||
127514862|NCT01264770|458847074|FG002|Overall Study|e.g., change in circumstances|3|||
127514863|NCT01264770|458847075|FG003|Overall Study|e.g., change in circumstances|3|||
127514864|NCT01264770|458847076|FG004|Overall Study|e.g., change in circumstances|4|||
127514865|NCT01264770|458847077|FG005|Overall Study|e.g., change in circumstances|4|||
127514866|NCT01264770|458847072|FG000|Overall Study|Severe non-compliance to protocol|0|||
127514867|NCT01264770|458847073|FG001|Overall Study|Severe non-compliance to protocol|0|||
127514868|NCT01264770|458847074|FG002|Overall Study|Severe non-compliance to protocol|1|||
127514869|NCT01264770|458847075|FG003|Overall Study|Severe non-compliance to protocol|1|||
127514870|NCT01264770|458847076|FG004|Overall Study|Severe non-compliance to protocol|0|||
127514871|NCT01264770|458847077|FG005|Overall Study|Severe non-compliance to protocol|0|||
127514872|NCT01264770|458847072|FG000|Overall Study|Lack of therapeutic response|1|||
127514873|NCT01264770|458847073|FG001|Overall Study|Lack of therapeutic response|0|||
127514874|NCT01264770|458847074|FG002|Overall Study|Lack of therapeutic response|2|||
127514875|NCT01264770|458847075|FG003|Overall Study|Lack of therapeutic response|1|||
127514876|NCT01264770|458847076|FG004|Overall Study|Lack of therapeutic response|1|||
127514877|NCT01264770|458847077|FG005|Overall Study|Lack of therapeutic response|0|||
127514878|NCT01264770|458847072|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
127514879|NCT01264770|458847073|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
127514880|NCT01264770|458847074|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
127514881|NCT01264770|458847075|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
127514882|NCT01264770|458847076|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
127514883|NCT01264770|458847077|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
127514884|NCT01264770|458847072|FG000|Overall Study|Lost to Follow-up|0|||
127514885|NCT01264770|458847073|FG001|Overall Study|Lost to Follow-up|0|||
127514886|NCT01264770|458847074|FG002|Overall Study|Lost to Follow-up|1|||
127514887|NCT01264770|458847075|FG003|Overall Study|Lost to Follow-up|1|||
127514888|NCT01264770|458847076|FG004|Overall Study|Lost to Follow-up|0|||
127514889|NCT01264770|458847077|FG005|Overall Study|Lost to Follow-up|0|||
127514890|NCT01264770|458847072|FG000|Overall Study|Adverse Event|7|||
127514891|NCT01264770|458847073|FG001|Overall Study|Adverse Event|7|||
127514892|NCT01264770|458847074|FG002|Overall Study|Adverse Event|8|||
127514893|NCT01264770|458847075|FG003|Overall Study|Adverse Event|0|||
127514894|NCT01264770|458847076|FG004|Overall Study|Adverse Event|2|||
127514895|NCT01264770|458847077|FG005|Overall Study|Adverse Event|1|||
127514896|NCT00424190|458847079|FG000|Overall Study|Withdrew consent|3|||
127514897|NCT00424190|458847080|FG001|Overall Study|Withdrew consent|4|||
127514898|NCT00424190|458847079|FG000|Overall Study|Death|3|||
127514899|NCT00424190|458847080|FG001|Overall Study|Death|0|||
127514900|NCT00424190|458847079|FG000|Overall Study|Noncompliance|1|||
127514901|NCT00424190|458847080|FG001|Overall Study|Noncompliance|2|||
127514902|NCT00424190|458847079|FG000|Overall Study|Request of sponsor or investigator|0|||
127514903|NCT00424190|458847080|FG001|Overall Study|Request of sponsor or investigator|2|||
127514904|NCT00424190|458847079|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
127514905|NCT00424190|458847080|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
127514906|NCT00424190|458847079|FG000|Overall Study|Other|15|||
127514907|NCT00424190|458847080|FG001|Overall Study|Other|21|||
127514908|NCT01672866|458847081|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
127514909|NCT01672866|458847082|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
127514910|NCT01672866|458847083|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
127514911|NCT01672866|458847081|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
127514912|NCT01672866|458847082|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
127514913|NCT01672866|458847083|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
127514914|NCT01672866|458847081|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
127514915|NCT01672866|458847082|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
127514916|NCT01672866|458847083|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
127514917|NCT01672866|458847081|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
127514918|NCT01672866|458847082|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
127514919|NCT01672866|458847083|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
127514920|NCT01672866|458847081|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
127514921|NCT01672866|458847082|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
127514922|NCT01672866|458847083|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
127514923|NCT01672866|458847081|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
127514924|NCT01672866|458847082|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
127514925|NCT01672866|458847083|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
127514926|NCT01672866|458847081|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
127514927|NCT01672866|458847082|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
127514928|NCT01672866|458847083|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
127514929|NCT01672866|458847081|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
127514930|NCT01672866|458847082|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
127514931|NCT01672866|458847083|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
127514932|NCT01672866|458847081|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
127514933|NCT01672866|458847082|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
127514934|NCT01672866|458847083|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
127514935|NCT01672866|458847081|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
127514936|NCT01672866|458847082|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
127514937|NCT01672866|458847083|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
127514938|NCT01672866|458847081|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
127514939|NCT01672866|458847082|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
127514940|NCT01672866|458847083|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
127514941|NCT01672866|458847081|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
127514942|NCT01672866|458847082|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
127514943|NCT01672866|458847083|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
127514944|NCT01672866|458847081|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
127514945|NCT01672866|458847082|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
127514946|NCT01672866|458847083|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
127514947|NCT02241187|458847084|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
127514948|NCT02356887|458847085|FG000|Overall Study|poor compliance|2|||
127514949|NCT00199888|458847086|FG000|Overall Study|Lost to Follow-up|1|||
127514950|NCT00160654|458847093|FG000|Overall Study|Adverse Event|14|||
127514951|NCT00160654|458847093|FG000|Overall Study|Lack of Efficacy|4|||
127514952|NCT00160654|458847093|FG000|Overall Study|Lost to Follow-up|2|||
127514953|NCT00160654|458847093|FG000|Overall Study|Intake of expired drug|7|||
127514954|NCT00160654|458847093|FG000|Overall Study|Psychological trauma|1|||
127514955|NCT00160654|458847093|FG000|Overall Study|Sponsor decision|1|||
127514956|NCT00160654|458847093|FG000|Overall Study|Patient met exclusion criteria|1|||
127514957|NCT00160654|458847093|FG000|Overall Study|Patient decision|1|||
127514958|NCT00160654|458847093|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
127514959|NCT00160654|458847093|FG000|Overall Study|Met exclusion criteria|1|||
127514960|NCT02544373|458847095|FG000|Overall Study|Lost to Follow-up|5|||
127514961|NCT02544373|458847096|FG001|Overall Study|Lost to Follow-up|3|||
127514962|NCT02544373|458847095|FG000|Overall Study|Withdrawal by Subject|8|||
127514963|NCT02544373|458847096|FG001|Overall Study|Withdrawal by Subject|2|||
127514964|NCT03172130|458848366|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
127514965|NCT03172130|458848367|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
127514966|NCT02831933|458848371|FG000|Overall Study|Physician Decision|11|||
127514967|NCT04544683|458848373|FG000|Overall Study|Lost to Follow-up|2|||
127514968|NCT04544683|458848373|FG000|Overall Study|Underwent cervical spine surgery|6|||
127514969|NCT02046070|458848384|FG000|Overall Study|Progressive Disease|18|||
127514970|NCT02046070|458848385|FG001|Overall Study|Progressive Disease|11|||
127514971|NCT02046070|458848386|FG002|Overall Study|Progressive Disease|40|||
127514972|NCT02046070|458848384|FG000|Overall Study|Adverse Event|8|||
127514973|NCT02046070|458848385|FG001|Overall Study|Adverse Event|10|||
127514974|NCT02046070|458848386|FG002|Overall Study|Adverse Event|17|||
127514975|NCT02046070|458848384|FG000|Overall Study|Withdrawal by Subject|1|||
127514976|NCT02046070|458848385|FG001|Overall Study|Withdrawal by Subject|2|||
127514977|NCT02046070|458848386|FG002|Overall Study|Withdrawal by Subject|6|||
127514978|NCT02046070|458848384|FG000|Overall Study|Study Terminated by Sponsor|1|||
127514979|NCT02046070|458848385|FG001|Overall Study|Study Terminated by Sponsor|1|||
127514980|NCT02046070|458848386|FG002|Overall Study|Study Terminated by Sponsor|1|||
127514981|NCT02046070|458848384|FG000|Overall Study|Reason not Specified|4|||
127514982|NCT02046070|458848385|FG001|Overall Study|Reason not Specified|4|||
127514983|NCT02046070|458848386|FG002|Overall Study|Reason not Specified|6|||
127514984|NCT04619004|458848387|FG000|Overall Study|Death|114|||
127514985|NCT04619004|458848388|FG001|Overall Study|Death|28|||
127514986|NCT04619004|458848387|FG000|Overall Study|Lost to Follow-up|1|||
127514987|NCT04619004|458848388|FG001|Overall Study|Lost to Follow-up|1|||
127514988|NCT04619004|458848387|FG000|Overall Study|Withdrawal by Subject|24|||
127514989|NCT04619004|458848388|FG001|Overall Study|Withdrawal by Subject|7|||
127514990|NCT04619004|458848387|FG000|Overall Study|Other - Not specified|0|||
127514991|NCT04619004|458848388|FG001|Overall Study|Other - Not specified|1|||
127514992|NCT04030962|458848389|FG000|Stage 2|Adverse Event|0|||
127514993|NCT04030962|458848390|FG001|Stage 2|Adverse Event|0|||
127514994|NCT04030962|458848391|FG002|Stage 2|Adverse Event|0|||
127514995|NCT04030962|458848392|FG003|Stage 2|Adverse Event|0|||
127514996|NCT04030962|458848393|FG004|Stage 2|Adverse Event|0|||
127514997|NCT04030962|458848394|FG005|Stage 2|Adverse Event|0|||
127514998|NCT04030962|458848395|FG006|Stage 2|Adverse Event|0|||
127514999|NCT04030962|458848396|FG007|Stage 2|Adverse Event|0|||
127515000|NCT04030962|458848397|FG008|Stage 2|Adverse Event|1|||
127515001|NCT04030962|458848398|FG009|Stage 2|Adverse Event|0|||
127515002|NCT04030962|458848399|FG010|Stage 2|Adverse Event|1|||
127515003|NCT04030962|458848400|FG011|Stage 2|Adverse Event|1|||
127515004|NCT04030962|458848401|FG012|Stage 2|Adverse Event|1|||
127515005|NCT04030962|458848389|FG000|Stage 2|Withdrawal by Subject|0|||
127515006|NCT04030962|458848390|FG001|Stage 2|Withdrawal by Subject|0|||
127515007|NCT04030962|458848391|FG002|Stage 2|Withdrawal by Subject|0|||
127515008|NCT04030962|458848392|FG003|Stage 2|Withdrawal by Subject|0|||
127515009|NCT04030962|458848393|FG004|Stage 2|Withdrawal by Subject|0|||
127515010|NCT04030962|458848394|FG005|Stage 2|Withdrawal by Subject|0|||
127515011|NCT04030962|458848395|FG006|Stage 2|Withdrawal by Subject|0|||
127515012|NCT04030962|458848396|FG007|Stage 2|Withdrawal by Subject|0|||
127515013|NCT04030962|458848397|FG008|Stage 2|Withdrawal by Subject|1|||
127515014|NCT04030962|458848398|FG009|Stage 2|Withdrawal by Subject|0|||
127515015|NCT04030962|458848399|FG010|Stage 2|Withdrawal by Subject|0|||
127515016|NCT04030962|458848400|FG011|Stage 2|Withdrawal by Subject|2|||
127515017|NCT04030962|458848401|FG012|Stage 2|Withdrawal by Subject|1|||
127515018|NCT04030962|458848389|FG000|Stage 2|Lost to Follow-up|0|||
127515019|NCT04030962|458848390|FG001|Stage 2|Lost to Follow-up|0|||
127515020|NCT04030962|458848391|FG002|Stage 2|Lost to Follow-up|0|||
127515021|NCT04030962|458848392|FG003|Stage 2|Lost to Follow-up|0|||
127515022|NCT04030962|458848393|FG004|Stage 2|Lost to Follow-up|0|||
127515023|NCT04030962|458848394|FG005|Stage 2|Lost to Follow-up|0|||
127515024|NCT04030962|458848395|FG006|Stage 2|Lost to Follow-up|0|||
127515025|NCT04030962|458848396|FG007|Stage 2|Lost to Follow-up|0|||
127515026|NCT04030962|458848397|FG008|Stage 2|Lost to Follow-up|1|||
127515027|NCT04030962|458848398|FG009|Stage 2|Lost to Follow-up|0|||
127515028|NCT04030962|458848399|FG010|Stage 2|Lost to Follow-up|0|||
127515029|NCT04030962|458848400|FG011|Stage 2|Lost to Follow-up|0|||
127515030|NCT04030962|458848401|FG012|Stage 2|Lost to Follow-up|0|||
127515031|NCT04030962|458848389|FG000|Stage 2|Technical Problems|0|||
127515032|NCT04030962|458848390|FG001|Stage 2|Technical Problems|0|||
127515033|NCT04030962|458848391|FG002|Stage 2|Technical Problems|0|||
127515034|NCT04030962|458848392|FG003|Stage 2|Technical Problems|0|||
127515035|NCT04030962|458848393|FG004|Stage 2|Technical Problems|0|||
127515036|NCT04030962|458848394|FG005|Stage 2|Technical Problems|0|||
127515037|NCT04030962|458848395|FG006|Stage 2|Technical Problems|0|||
127515038|NCT04030962|458848396|FG007|Stage 2|Technical Problems|0|||
127515039|NCT04030962|458848397|FG008|Stage 2|Technical Problems|0|||
127515040|NCT04030962|458848398|FG009|Stage 2|Technical Problems|0|||
127515041|NCT04030962|458848399|FG010|Stage 2|Technical Problems|0|||
127515042|NCT04030962|458848400|FG011|Stage 2|Technical Problems|1|||
127515043|NCT04030962|458848401|FG012|Stage 2|Technical Problems|0|||
127515044|NCT05601102|458848404|FG000|Overall Study|Death|1|||
127515045|NCT05601102|458848405|FG001|Overall Study|Death|2|||
127515046|NCT05601102|458848404|FG000|Overall Study|Withdrawal by Subject|1|||
127515047|NCT05601102|458848405|FG001|Overall Study|Withdrawal by Subject|1|||
127515048|NCT05601102|458848404|FG000|Overall Study|Lost to Follow-up|0|||
127515049|NCT05601102|458848405|FG001|Overall Study|Lost to Follow-up|2|||
127515050|NCT05288166|458848406|FG000|Overall Study|Adverse Event|1|||
127515051|NCT05288166|458848407|FG001|Overall Study|Adverse Event|0|||
127515052|NCT05288166|458848406|FG000|Overall Study|Lost to Follow-up|2|||
127515053|NCT05288166|458848407|FG001|Overall Study|Lost to Follow-up|0|||
127515054|NCT05288166|458848406|FG000|Overall Study|Physician Decision|0|||
127515055|NCT05288166|458848407|FG001|Overall Study|Physician Decision|2|||
127515056|NCT05288166|458848406|FG000|Overall Study|Screen Failure|1|||
127515057|NCT05288166|458848407|FG001|Overall Study|Screen Failure|1|||
127515058|NCT05288166|458848406|FG000|Overall Study|Withdrawal by Subject|4|||
127515059|NCT05288166|458848407|FG001|Overall Study|Withdrawal by Subject|2|||
127515060|NCT05288166|458848406|FG000|Overall Study|On Study Treatment|408|||
127515061|NCT05288166|458848407|FG001|Overall Study|On Study Treatment|418|||
127515062|NCT02981524|458848409|FG000|Overall Study|Progressive Disease|14|||
127515063|NCT02981524|458848409|FG000|Overall Study|Death (unrelated)|1|||
127515064|NCT02981524|458848409|FG000|Overall Study|Treatment Related Toxicity|1|||
127515065|NCT02981524|458848409|FG000|Overall Study|Withdrawal by Subject|1|||
127515066|NCT00483041|458848410|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
127515067|NCT00483041|458848411|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
127515068|NCT02258529|458848414|FG000|Overall Study|Study Terminated by Sponsor|9|||
127515069|NCT02258529|458848414|FG000|Overall Study|Adverse Event|1|||
127515070|NCT05432167|458848418|FG000|Overall Study|Adverse Event|0|||
127515071|NCT05432167|458848419|FG001|Overall Study|Adverse Event|2|||
127515072|NCT05432167|458848420|FG002|Overall Study|Adverse Event|1|||
127515073|NCT05432167|458848418|FG000|Overall Study|Lost to Follow-up|3|||
127515074|NCT05432167|458848419|FG001|Overall Study|Lost to Follow-up|3|||
127515075|NCT05432167|458848420|FG002|Overall Study|Lost to Follow-up|2|||
127515076|NCT05432167|458848418|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
127515077|NCT05432167|458848419|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
127515078|NCT05432167|458848420|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
127515079|NCT05432167|458848418|FG000|Overall Study|Physician Decision|1|||
127515080|NCT05432167|458848419|FG001|Overall Study|Physician Decision|0|||
127515081|NCT05432167|458848420|FG002|Overall Study|Physician Decision|0|||
127515082|NCT05432167|458848418|FG000|Overall Study|Withdrawal by Subject|7|||
127515083|NCT05432167|458848419|FG001|Overall Study|Withdrawal by Subject|4|||
127515084|NCT05432167|458848420|FG002|Overall Study|Withdrawal by Subject|11|||
127515085|NCT05432167|458848418|FG000|Overall Study|Other|0|||
127515086|NCT05432167|458848419|FG001|Overall Study|Other|0|||
127515087|NCT05432167|458848420|FG002|Overall Study|Other|1|||
127515088|NCT01267175|458848421|FG000|Overall Study|Withdrawal by Subject|1|||
127515089|NCT01267175|458848421|FG000|Overall Study|Lost to Follow-up|1|||
127515090|NCT00895661|458848423|FG000|Overall Study|Death|1|||
127515091|NCT00895661|458848423|FG000|Overall Study|reason unknown|2|||
127515092|NCT04094584|458848426|FG000|Overall Study|No interest in study|88|||
127515093|NCT04094584|458848426|FG000|Overall Study|Unwilling to undergo screening tests|36|||
127515094|NCT04094584|458848426|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
127515095|NCT04094584|458848426|FG000|Overall Study|Opioid use|7|||
127515096|NCT04094584|458848426|FG000|Overall Study|Need for major surgery in study period|4|||
127515097|NCT04094584|458848426|FG000|Overall Study|eligible but declined enrollment|4|||
127515098|NCT04094584|458848426|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
127515099|NCT04094584|458848426|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
127515100|NCT04094584|458848426|FG000|Overall Study|Lost to Follow-up|3|||
127515101|NCT04094584|458848426|FG000|Overall Study|Withdrawal by Subject|2|||
127515102|NCT02690649|458848427|FG000|Overall Study|Withdrawal by Subject|1|||
127515103|NCT02690649|458848428|FG001|Overall Study|Withdrawal by Subject|1|||
127515104|NCT02690649|458848427|FG000|Overall Study|Protocol Violation|0|||
127515105|NCT02690649|458848428|FG001|Overall Study|Protocol Violation|3|||
127515106|NCT00907296|458848429|FG000|Overall Study|Ineligibility Determined|1|||
127515107|NCT00907296|458848430|FG001|Overall Study|Ineligibility Determined|0|||
127515108|NCT00907296|458848431|FG002|Overall Study|Ineligibility Determined|0|||
127515109|NCT00907296|458848432|FG003|Overall Study|Ineligibility Determined|1|||
127515110|NCT00907296|458848433|FG004|Overall Study|Ineligibility Determined|0|||
127515111|NCT00907296|458848434|FG005|Overall Study|Ineligibility Determined|0|||
127515112|NCT00907296|458848435|FG006|Overall Study|Ineligibility Determined|0|||
127515113|NCT00907296|458848436|FG007|Overall Study|Ineligibility Determined|1|||
127515114|NCT00907296|458848437|FG008|Overall Study|Ineligibility Determined|0|||
127515115|NCT00907296|458848438|FG009|Overall Study|Ineligibility Determined|0|||
127515116|NCT00907296|458848429|FG000|Overall Study|Protocol Deviation|0|||
127515117|NCT00907296|458848430|FG001|Overall Study|Protocol Deviation|1|||
127515118|NCT00907296|458848431|FG002|Overall Study|Protocol Deviation|0|||
127515119|NCT00907296|458848432|FG003|Overall Study|Protocol Deviation|0|||
127515120|NCT00907296|458848433|FG004|Overall Study|Protocol Deviation|0|||
127515121|NCT00907296|458848434|FG005|Overall Study|Protocol Deviation|0|||
127515122|NCT00907296|458848435|FG006|Overall Study|Protocol Deviation|0|||
127515123|NCT00907296|458848436|FG007|Overall Study|Protocol Deviation|0|||
127515124|NCT00907296|458848437|FG008|Overall Study|Protocol Deviation|0|||
127515125|NCT00907296|458848438|FG009|Overall Study|Protocol Deviation|0|||
127515126|NCT00907296|458848429|FG000|Overall Study|Noncompliance|1|||
127515127|NCT00907296|458848430|FG001|Overall Study|Noncompliance|1|||
127515128|NCT00907296|458848431|FG002|Overall Study|Noncompliance|1|||
127515129|NCT00907296|458848432|FG003|Overall Study|Noncompliance|0|||
127515130|NCT00907296|458848433|FG004|Overall Study|Noncompliance|0|||
127515131|NCT00907296|458848434|FG005|Overall Study|Noncompliance|1|||
127515132|NCT00907296|458848435|FG006|Overall Study|Noncompliance|0|||
127515133|NCT00907296|458848436|FG007|Overall Study|Noncompliance|2|||
127515134|NCT00907296|458848437|FG008|Overall Study|Noncompliance|0|||
127515135|NCT00907296|458848438|FG009|Overall Study|Noncompliance|0|||
127515136|NCT00907296|458848429|FG000|Overall Study|Adverse Event|2|||
127515137|NCT00907296|458848430|FG001|Overall Study|Adverse Event|0|||
127515138|NCT00907296|458848431|FG002|Overall Study|Adverse Event|0|||
127515139|NCT00907296|458848432|FG003|Overall Study|Adverse Event|0|||
127515140|NCT00907296|458848433|FG004|Overall Study|Adverse Event|0|||
127515141|NCT00907296|458848434|FG005|Overall Study|Adverse Event|0|||
127515142|NCT00907296|458848435|FG006|Overall Study|Adverse Event|1|||
127515143|NCT00907296|458848436|FG007|Overall Study|Adverse Event|0|||
127515144|NCT00907296|458848437|FG008|Overall Study|Adverse Event|0|||
127515145|NCT00907296|458848438|FG009|Overall Study|Adverse Event|1|||
127515146|NCT00907296|458848429|FG000|Overall Study|Withdrawal by Subject|7|||
127515147|NCT00907296|458848430|FG001|Overall Study|Withdrawal by Subject|2|||
127515148|NCT00907296|458848431|FG002|Overall Study|Withdrawal by Subject|1|||
127515149|NCT00907296|458848432|FG003|Overall Study|Withdrawal by Subject|1|||
127515150|NCT00907296|458848433|FG004|Overall Study|Withdrawal by Subject|1|||
127515151|NCT00907296|458848434|FG005|Overall Study|Withdrawal by Subject|5|||
127515152|NCT00907296|458848435|FG006|Overall Study|Withdrawal by Subject|3|||
127515153|NCT00907296|458848436|FG007|Overall Study|Withdrawal by Subject|2|||
127515154|NCT00907296|458848437|FG008|Overall Study|Withdrawal by Subject|4|||
127515155|NCT00907296|458848438|FG009|Overall Study|Withdrawal by Subject|2|||
127515156|NCT00907296|458848429|FG000|Overall Study|Lost to Follow-up|9|||
127515157|NCT00907296|458848430|FG001|Overall Study|Lost to Follow-up|1|||
127515158|NCT00907296|458848431|FG002|Overall Study|Lost to Follow-up|0|||
127515159|NCT00907296|458848432|FG003|Overall Study|Lost to Follow-up|2|||
127515160|NCT00907296|458848433|FG004|Overall Study|Lost to Follow-up|0|||
127515161|NCT00907296|458848434|FG005|Overall Study|Lost to Follow-up|3|||
127515162|NCT00907296|458848435|FG006|Overall Study|Lost to Follow-up|2|||
127515163|NCT00907296|458848436|FG007|Overall Study|Lost to Follow-up|2|||
127515164|NCT00907296|458848437|FG008|Overall Study|Lost to Follow-up|0|||
127515165|NCT00907296|458848438|FG009|Overall Study|Lost to Follow-up|4|||
127515166|NCT00791557|458848439|FG000|Overall Study|Adverse Event|1|||
127515167|NCT03344640|458848442|FG000|Overall Study|Adverse Event|1|||
127515168|NCT03344640|458848443|FG001|Overall Study|Adverse Event|0|||
127515169|NCT03344640|458848442|FG000|Overall Study|Physician Decision|1|||
127515170|NCT03344640|458848443|FG001|Overall Study|Physician Decision|1|||
127515171|NCT03344640|458848442|FG000|Overall Study|Withdrawal by Subject|1|||
127515172|NCT03344640|458848443|FG001|Overall Study|Withdrawal by Subject|2|||
127515173|NCT03344640|458848442|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
127515174|NCT03344640|458848443|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
127515175|NCT02573246|458848444|FG000|Overall Study|Lost to Follow-up|2|||
127515176|NCT02573246|458848445|FG001|Overall Study|Lost to Follow-up|0|||
127515177|NCT02573246|458848446|FG002|Overall Study|Lost to Follow-up|0|||
127515178|NCT02573246|458848447|FG003|Overall Study|Lost to Follow-up|0|||
127515179|NCT02573246|458848448|FG004|Overall Study|Lost to Follow-up|1|||
127515180|NCT02573246|458848444|FG000|Overall Study|Withdrawal by Subject|0|||
127515181|NCT02573246|458848445|FG001|Overall Study|Withdrawal by Subject|0|||
127515182|NCT02573246|458848446|FG002|Overall Study|Withdrawal by Subject|0|||
127515183|NCT02573246|458848447|FG003|Overall Study|Withdrawal by Subject|0|||
127515184|NCT02573246|458848448|FG004|Overall Study|Withdrawal by Subject|1|||
127515185|NCT02573246|458848444|FG000|Overall Study|Physician Decision|1|||
127515186|NCT02573246|458848445|FG001|Overall Study|Physician Decision|1|||
127515187|NCT02573246|458848446|FG002|Overall Study|Physician Decision|3|||
127515188|NCT02573246|458848447|FG003|Overall Study|Physician Decision|2|||
127515189|NCT02573246|458848448|FG004|Overall Study|Physician Decision|2|||
127515190|NCT01219933|458848449|FG000|Overall Study|Adverse Event|8|||
127515191|NCT01219933|458848449|FG000|Overall Study|No LDA reached|5|||
127515192|NCT01219933|458848449|FG000|Overall Study|No LDA maintained|7|||
127515193|NCT01219933|458848449|FG000|Overall Study|Lost to Follow-up|3|||
127515194|NCT01219933|458848449|FG000|Overall Study|GC free|1|||
127515195|NCT01219933|458848449|FG000|Overall Study|Withdrawal by Subject|5|||
127515196|NCT01219933|458848449|FG000|Overall Study|Protocol Violation|8|||
127515197|NCT01219933|458848449|FG000|Overall Study|Lack of Efficacy|1|||
127515198|NCT01902888|458848450|FG000|Overall Study|Study Terminated|3|||
127515199|NCT03149003|458848451|FG000|Overall Study|Randomized but not treated|0|||
127515200|NCT03149003|458848452|FG001|Overall Study|Randomized but not treated|1|||
127515201|NCT03149003|458848453|FG002|Overall Study|Randomized but not treated|18|||
127515202|NCT04047420|458848454|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
127515203|NCT04047420|458848454|FG000|Washout Period|Refused Participation|2|||
127515204|NCT02608450|458848457|FG000|Overall Study|Lost to Follow-up|39|||
127515205|NCT02608450|458848458|FG001|Overall Study|Lost to Follow-up|32|||
127515206|NCT02608450|458848457|FG000|Overall Study|Withdrawal by Subject|21|||
127515207|NCT02608450|458848458|FG001|Overall Study|Withdrawal by Subject|15|||
127515208|NCT02608450|458848457|FG000|Overall Study|Adverse Event|3|||
127515209|NCT02608450|458848458|FG001|Overall Study|Adverse Event|6|||
127515210|NCT02608450|458848457|FG000|Overall Study|Withdrawal by parent|2|||
127515211|NCT02608450|458848458|FG001|Overall Study|Withdrawal by parent|3|||
127515212|NCT02608450|458848457|FG000|Overall Study|Lack of Efficacy|0|||
127515213|NCT02608450|458848458|FG001|Overall Study|Lack of Efficacy|3|||
127515214|NCT02608450|458848457|FG000|Overall Study|Noncompliance with study drug|0|||
127515215|NCT02608450|458848458|FG001|Overall Study|Noncompliance with study drug|2|||
127515216|NCT02608450|458848457|FG000|Overall Study|Physician Decision|0|||
127515217|NCT02608450|458848458|FG001|Overall Study|Physician Decision|1|||
127515218|NCT02608450|458848457|FG000|Overall Study|Pregnancy|0|||
127515219|NCT02608450|458848458|FG001|Overall Study|Pregnancy|1|||
127515220|NCT02608450|458848457|FG000|Overall Study|Progressive disease|1|||
127515221|NCT02608450|458848458|FG001|Overall Study|Progressive disease|0|||
127515222|NCT02608450|458848457|FG000|Overall Study|Multiple reasons|0|||
127515223|NCT02608450|458848458|FG001|Overall Study|Multiple reasons|2|||
127515224|NCT02636946|458848459|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
127515225|NCT02636946|458848460|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
127515226|NCT02636946|458848459|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
127515227|NCT02636946|458848460|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
127515228|NCT02636946|458848459|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
127515229|NCT02636946|458848460|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
127515230|NCT02636946|458848459|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
127515231|NCT02636946|458848460|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
127515232|NCT02636946|458848459|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
127515233|NCT02636946|458848460|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
127515234|NCT02636946|458848459|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
127515235|NCT02636946|458848460|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
127515236|NCT00477269|458848461|FG000|Core Study|Adverse Event|6|||
127515237|NCT00477269|458848462|FG001|Core Study|Adverse Event|4|||
127515238|NCT00477269|458848463|FG002|Core Study|Adverse Event|0|||
127515239|NCT00477269|458848461|FG000|Core Study|Death|3|||
127515240|NCT00477269|458848462|FG001|Core Study|Death|3|||
127515241|NCT00477269|458848463|FG002|Core Study|Death|0|||
127515242|NCT00477269|458848461|FG000|Core Study|Withdrawn Consent|0|||
127515243|NCT00477269|458848462|FG001|Core Study|Withdrawn Consent|1|||
127515244|NCT00477269|458848463|FG002|Core Study|Withdrawn Consent|0|||
127515245|NCT00477269|458848461|FG000|Open Label Extension|Adverse Event|0|||
127515246|NCT00477269|458848462|FG001|Open Label Extension|Adverse Event|0|||
127515247|NCT00477269|458848463|FG002|Open Label Extension|Adverse Event|4|||
127515248|NCT00477269|458848461|FG000|Open Label Extension|Abnormal laboratory values|0|||
127515249|NCT00477269|458848462|FG001|Open Label Extension|Abnormal laboratory values|0|||
127515250|NCT00477269|458848463|FG002|Open Label Extension|Abnormal laboratory values|1|||
127515251|NCT00477269|458848461|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
127515252|NCT00477269|458848462|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
127515253|NCT00477269|458848463|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
127515254|NCT00477269|458848461|FG000|Open Label Extension|Adminiatrative problems|0|||
127515255|NCT00477269|458848462|FG001|Open Label Extension|Adminiatrative problems|0|||
127515256|NCT00477269|458848463|FG002|Open Label Extension|Adminiatrative problems|2|||
127515257|NCT00477269|458848461|FG000|Open Label Extension|Death|0|||
127515258|NCT00477269|458848462|FG001|Open Label Extension|Death|0|||
127515259|NCT00477269|458848463|FG002|Open Label Extension|Death|4|||
127515260|NCT01792518|458848464|FG000|Overall Study|Adverse Event|3|||
127515261|NCT01792518|458848465|FG001|Overall Study|Adverse Event|4|||
127515262|NCT01792518|458848464|FG000|Overall Study|Protocol Violation|0|||
127515263|NCT01792518|458848465|FG001|Overall Study|Protocol Violation|1|||
127515264|NCT01792518|458848464|FG000|Overall Study|Lost to Follow-up|3|||
127515265|NCT01792518|458848465|FG001|Overall Study|Lost to Follow-up|1|||
127515266|NCT01792518|458848464|FG000|Overall Study|Withdrawal by Subject|2|||
127515267|NCT01792518|458848465|FG001|Overall Study|Withdrawal by Subject|0|||
127515268|NCT01792518|458848464|FG000|Overall Study|Other Reason|0|||
127515269|NCT01792518|458848465|FG001|Overall Study|Other Reason|1|||
127515270|NCT00654004|458848492|FG000|Overall Study|Lost to Follow-up|1|||
127515271|NCT00654004|458848493|FG001|Overall Study|Lost to Follow-up|0|||
127515272|NCT00351273|458848494|FG000|Overall Study|Lost to Follow-up|1|||
127515273|NCT00351273|458848495|FG001|Overall Study|Lost to Follow-up|2|||
127515274|NCT00351273|458848496|FG002|Overall Study|Lost to Follow-up|5|||
127515275|NCT02383433|458848499|FG000|Overall Study|Disease progression|2|||
127515276|NCT02535416|458848500|FG000|Overall Study|Family bereavement overseas|1|||
127515277|NCT02535416|458848501|FG001|Overall Study|Family bereavement overseas|0|||
127515278|NCT02535416|458848502|FG002|Overall Study|Family bereavement overseas|0|||
127515279|NCT02535416|458848503|FG003|Overall Study|Family bereavement overseas|0|||
127515280|NCT02535416|458848504|FG004|Overall Study|Family bereavement overseas|0|||
127515281|NCT02535416|458848505|FG005|Overall Study|Family bereavement overseas|0|||
127515282|NCT02535416|458848506|FG006|Overall Study|Family bereavement overseas|0|||
127515283|NCT02535416|458848507|FG007|Overall Study|Family bereavement overseas|0|||
127515284|NCT02535416|458848508|FG008|Overall Study|Family bereavement overseas|0|||
127515285|NCT01977690|458848509|FG000|Overall Study|Withdrawal by Subject|0|||
127515286|NCT01977690|458848510|FG001|Overall Study|Withdrawal by Subject|4|||
127515287|NCT00447122|458848511|FG000|Overall Study|worsening medical condition -came off|0|||
127515288|NCT00447122|458848512|FG001|Overall Study|worsening medical condition -came off|1|||
127515289|NCT00447122|458848513|FG002|Overall Study|worsening medical condition -came off|0|||
127515290|NCT00447122|458848514|FG003|Overall Study|worsening medical condition -came off|0|||
127515291|NCT01174173|458848519|FG000|Overall Study|drug-drug interaction|1|||
127515292|NCT03938324|458849725|FG000|Overall Study|Lost to Follow-up|42|||
127515293|NCT03938324|458849726|FG001|Overall Study|Lost to Follow-up|21|||
127515294|NCT03938324|458849725|FG000|Overall Study|Withdrawal by Subject|6|||
127515295|NCT03938324|458849726|FG001|Overall Study|Withdrawal by Subject|1|||
127515296|NCT02769962|458849727|FG000|Overall Study|Physician Decision|0|||
127515297|NCT02769962|458849728|FG001|Overall Study|Physician Decision|0|||
127515298|NCT02769962|458849729|FG002|Overall Study|Physician Decision|0|||
127515299|NCT02769962|458849730|FG003|Overall Study|Physician Decision|0|||
127515300|NCT02769962|458849731|FG004|Overall Study|Physician Decision|0|||
127515301|NCT02769962|458849732|FG005|Overall Study|Physician Decision|1|||
127515302|NCT02769962|458849733|FG006|Overall Study|Physician Decision|0|||
127515303|NCT02769962|458849734|FG007|Overall Study|Physician Decision|1|||
127515304|NCT02769962|458849727|FG000|Overall Study|Refused further treatment|0|||
127515305|NCT02769962|458849728|FG001|Overall Study|Refused further treatment|0|||
127515306|NCT02769962|458849729|FG002|Overall Study|Refused further treatment|0|||
127515307|NCT02769962|458849730|FG003|Overall Study|Refused further treatment|0|||
127515308|NCT02769962|458849731|FG004|Overall Study|Refused further treatment|0|||
127515309|NCT02769962|458849732|FG005|Overall Study|Refused further treatment|1|||
127515310|NCT02769962|458849733|FG006|Overall Study|Refused further treatment|1|||
127515311|NCT02769962|458849734|FG007|Overall Study|Refused further treatment|0|||
127515312|NCT00837759|458849735|FG000|Overall Study|Protocol Violation|3|||
127515313|NCT00837759|458849735|FG000|Overall Study|Lost to Follow-up|1|||
127515314|NCT01073930|458849736|FG000|Overall Study|Withdrawal by Subject|3|||
127515315|NCT01073930|458849737|FG001|Overall Study|Withdrawal by Subject|2|||
127515316|NCT01073930|458849736|FG000|Overall Study|Lost to Follow-up|0|||
127515317|NCT01073930|458849737|FG001|Overall Study|Lost to Follow-up|1|||
127515318|NCT01073930|458849736|FG000|Overall Study|Adverse Event|0|||
127515319|NCT01073930|458849737|FG001|Overall Study|Adverse Event|1|||
127515320|NCT01073930|458849736|FG000|Overall Study|Noncompliance with study drug|0|||
127515321|NCT01073930|458849737|FG001|Overall Study|Noncompliance with study drug|1|||
127515322|NCT01073930|458849736|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
127515323|NCT01073930|458849737|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
127515324|NCT02081599|458849738|FG000|Period 1：Double-blind Period|Adverse Event|3|||
127515325|NCT02081599|458849739|FG001|Period 1：Double-blind Period|Adverse Event|0|||
127515326|NCT02081599|458849738|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
127515327|NCT02081599|458849739|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
127515328|NCT02081599|458849738|FG000|Period 1：Double-blind Period|Physician Decision|1|||
127515329|NCT02081599|458849739|FG001|Period 1：Double-blind Period|Physician Decision|0|||
127515330|NCT02081599|458849738|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
127515331|NCT02081599|458849739|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
127515332|NCT02081599|458849738|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
127515333|NCT02081599|458849739|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
127515334|NCT02081599|458849738|FG000|Period 1：Double-blind Period|stopping criteria|1|||
127515335|NCT02081599|458849739|FG001|Period 1：Double-blind Period|stopping criteria|0|||
127515336|NCT02081599|458849738|FG000|Period 2：Open-label Period|Adverse Event|1|||
127515337|NCT02081599|458849739|FG001|Period 2：Open-label Period|Adverse Event|0|||
127515338|NCT02081599|458849738|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
127515339|NCT02081599|458849739|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
127515340|NCT02081599|458849738|FG000|Period 2：Open-label Period|Physician Decision|1|||
127515341|NCT02081599|458849739|FG001|Period 2：Open-label Period|Physician Decision|0|||
127515342|NCT02081599|458849738|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
127515343|NCT02081599|458849739|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
127515344|NCT01266590|458849740|FG000|Overall Study|Adverse Event|3|||
127515345|NCT01266590|458849740|FG000|Overall Study|Lost to Follow-up|1|||
127515346|NCT01266590|458849740|FG000|Overall Study|Withdrawal by Subject|1|||
127515347|NCT01266590|458849740|FG000|Overall Study|Physician Decision|1|||
127515348|NCT00720343|458849743|FG000|Overall Study|Lost to Follow-up|1|||
127515349|NCT00720343|458849744|FG001|Overall Study|Lost to Follow-up|0|||
127515350|NCT00720343|458849743|FG000|Overall Study|Protocol Violation|0|||
127515351|NCT00720343|458849744|FG001|Overall Study|Protocol Violation|2|||
127515352|NCT02008773|458849745|FG000|Overall Study|Adverse Event|3|||
127515353|NCT02008773|458849746|FG001|Overall Study|Adverse Event|3|||
127515354|NCT02008773|458849747|FG002|Overall Study|Adverse Event|1|||
127515355|NCT02008773|458849748|FG003|Overall Study|Adverse Event|2|||
127515356|NCT02008773|458849745|FG000|Overall Study|Medication Non-compliance|2|||
127515357|NCT02008773|458849746|FG001|Overall Study|Medication Non-compliance|1|||
127515358|NCT02008773|458849747|FG002|Overall Study|Medication Non-compliance|3|||
127515359|NCT02008773|458849748|FG003|Overall Study|Medication Non-compliance|2|||
127515360|NCT02008773|458849745|FG000|Overall Study|Withdrawal by Subject|8|||
127515361|NCT02008773|458849746|FG001|Overall Study|Withdrawal by Subject|4|||
127515362|NCT02008773|458849747|FG002|Overall Study|Withdrawal by Subject|7|||
127515363|NCT02008773|458849748|FG003|Overall Study|Withdrawal by Subject|6|||
127515364|NCT02008773|458849745|FG000|Overall Study|Lost to Follow-up|0|||
127515365|NCT02008773|458849746|FG001|Overall Study|Lost to Follow-up|1|||
127515366|NCT02008773|458849747|FG002|Overall Study|Lost to Follow-up|3|||
127515367|NCT02008773|458849748|FG003|Overall Study|Lost to Follow-up|2|||
127515368|NCT02198794|458849749|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
127515369|NCT02198794|458849750|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
127515370|NCT02198794|458849751|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
127515371|NCT02198794|458849752|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
127515372|NCT02198794|458849749|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
127515373|NCT02198794|458849750|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
127515374|NCT02198794|458849751|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
127515375|NCT02198794|458849752|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
127515376|NCT02198794|458849749|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
127515377|NCT02198794|458849750|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
127515378|NCT02198794|458849751|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
127515379|NCT02198794|458849752|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
127515380|NCT02198794|458849749|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
127515381|NCT02198794|458849750|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
127515382|NCT02198794|458849751|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
127515383|NCT02198794|458849752|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
127515384|NCT02198794|458849749|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
127515385|NCT02198794|458849750|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
127515386|NCT02198794|458849751|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
127515387|NCT02198794|458849752|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
127515388|NCT02198794|458849749|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
127515389|NCT02198794|458849750|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
127515390|NCT02198794|458849751|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
127515391|NCT02198794|458849752|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
127515392|NCT02198794|458849749|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
127515393|NCT02198794|458849750|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
127515394|NCT02198794|458849751|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
127515395|NCT02198794|458849752|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
127515396|NCT02198794|458849749|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
127515397|NCT02198794|458849750|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
127515398|NCT02198794|458849751|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
127515399|NCT02198794|458849752|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
127515400|NCT02198794|458849749|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
127515401|NCT02198794|458849750|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
127515402|NCT02198794|458849751|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
127515403|NCT02198794|458849752|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
127515404|NCT02198794|458849749|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
127515405|NCT02198794|458849750|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
127515406|NCT02198794|458849751|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
127515407|NCT02198794|458849752|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
127515408|NCT02198794|458849749|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
127515409|NCT02198794|458849750|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
127515410|NCT02198794|458849751|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
127515411|NCT02198794|458849752|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
127515412|NCT02198794|458849749|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
127515413|NCT02198794|458849750|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
127515414|NCT02198794|458849751|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
127515415|NCT02198794|458849752|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
127515416|NCT02198794|458849749|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
127515417|NCT02198794|458849750|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
127515418|NCT02198794|458849751|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
127515419|NCT02198794|458849752|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
127515420|NCT02198794|458849749|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
127515421|NCT02198794|458849750|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
127515422|NCT02198794|458849751|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
127515423|NCT02198794|458849752|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
127515424|NCT02198794|458849749|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
127515425|NCT02198794|458849750|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
127515426|NCT02198794|458849751|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
127515427|NCT02198794|458849752|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
127515428|NCT01918332|458849753|FG000|Overall Study|Adverse Event|0|||
127515429|NCT01918332|458849754|FG001|Overall Study|Adverse Event|0|||
127515430|NCT01918332|458849755|FG002|Overall Study|Adverse Event|0|||
127515431|NCT01918332|458849756|FG003|Overall Study|Adverse Event|1|||
127515432|NCT01918332|458849753|FG000|Overall Study|Withdrawal by Subject|2|||
127515433|NCT01918332|458849754|FG001|Overall Study|Withdrawal by Subject|3|||
127515434|NCT01918332|458849755|FG002|Overall Study|Withdrawal by Subject|2|||
127515435|NCT01918332|458849756|FG003|Overall Study|Withdrawal by Subject|3|||
127515436|NCT01918332|458849753|FG000|Overall Study|Protocol Violation|6|||
127515437|NCT01918332|458849754|FG001|Overall Study|Protocol Violation|2|||
127515438|NCT01918332|458849755|FG002|Overall Study|Protocol Violation|6|||
127515439|NCT01918332|458849756|FG003|Overall Study|Protocol Violation|3|||
127515440|NCT01918332|458849753|FG000|Overall Study|lipid result by central lab did not meet|0|||
127515441|NCT01918332|458849754|FG001|Overall Study|lipid result by central lab did not meet|0|||
127515442|NCT01918332|458849755|FG002|Overall Study|lipid result by central lab did not meet|1|||
127515443|NCT01918332|458849756|FG003|Overall Study|lipid result by central lab did not meet|0|||
127515444|NCT02408523|458849757|FG000|Overall Study|Adverse Event|4|||
127515445|NCT02408523|458849758|FG001|Overall Study|Adverse Event|10|||
127515446|NCT02408523|458849757|FG000|Overall Study|Lack of Efficacy|0|||
127515447|NCT02408523|458849758|FG001|Overall Study|Lack of Efficacy|1|||
127515448|NCT02408523|458849757|FG000|Overall Study|Protocol Violation|1|||
127515449|NCT02408523|458849758|FG001|Overall Study|Protocol Violation|2|||
127515450|NCT02408523|458849757|FG000|Overall Study|Lost to Follow-up|2|||
127515451|NCT02408523|458849758|FG001|Overall Study|Lost to Follow-up|3|||
127515452|NCT02408523|458849757|FG000|Overall Study|Withdrawal by Subject|3|||
127515453|NCT02408523|458849758|FG001|Overall Study|Withdrawal by Subject|1|||
127515454|NCT02408523|458849757|FG000|Overall Study|Sponsor request|1|||
127515455|NCT02408523|458849758|FG001|Overall Study|Sponsor request|0|||
127515456|NCT02408523|458849757|FG000|Overall Study|Did not satisfy extension conditions|0|||
127515457|NCT02408523|458849758|FG001|Overall Study|Did not satisfy extension conditions|1|||
127515458|NCT00701805|458849759|FG000|Overall Study|Withdrawal by Subject|3|||
127515459|NCT00701805|458849760|FG001|Overall Study|Withdrawal by Subject|1|||
127515460|NCT00701805|458849761|FG002|Overall Study|Withdrawal by Subject|4|||
127515461|NCT00701805|458849762|FG003|Overall Study|Withdrawal by Subject|3|||
127515462|NCT00701805|458849759|FG000|Overall Study|Adverse Event|0|||
127515463|NCT00701805|458849760|FG001|Overall Study|Adverse Event|1|||
127515464|NCT00701805|458849761|FG002|Overall Study|Adverse Event|1|||
127515465|NCT00701805|458849762|FG003|Overall Study|Adverse Event|0|||
127515466|NCT00701805|458849759|FG000|Overall Study|Missed 7 consecutive doses|0|||
127515467|NCT00701805|458849760|FG001|Overall Study|Missed 7 consecutive doses|1|||
127515468|NCT00701805|458849761|FG002|Overall Study|Missed 7 consecutive doses|0|||
127515469|NCT00701805|458849762|FG003|Overall Study|Missed 7 consecutive doses|0|||
127515470|NCT00701805|458849759|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
127515471|NCT00701805|458849760|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
127515472|NCT00701805|458849761|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
127515473|NCT00701805|458849762|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
127515474|NCT00701805|458849759|FG000|Overall Study|Physician decision, change of therapy|0|||
127515475|NCT00701805|458849760|FG001|Overall Study|Physician decision, change of therapy|0|||
127515476|NCT00701805|458849761|FG002|Overall Study|Physician decision, change of therapy|0|||
127515477|NCT00701805|458849762|FG003|Overall Study|Physician decision, change of therapy|1|||
127515478|NCT00701805|458849759|FG000|Overall Study|Difficult to travel to dialysis site|0|||
127515479|NCT00701805|458849760|FG001|Overall Study|Difficult to travel to dialysis site|0|||
127515480|NCT00701805|458849761|FG002|Overall Study|Difficult to travel to dialysis site|1|||
127515481|NCT00701805|458849762|FG003|Overall Study|Difficult to travel to dialysis site|0|||
127515482|NCT00701805|458849759|FG000|Overall Study|Resumption criteria were not met|0|||
127515483|NCT00701805|458849760|FG001|Overall Study|Resumption criteria were not met|1|||
127515484|NCT00701805|458849761|FG002|Overall Study|Resumption criteria were not met|0|||
127515485|NCT00701805|458849762|FG003|Overall Study|Resumption criteria were not met|0|||
127515486|NCT02252965|458849764|FG000|Overall Study|Adverse Event|9|||
127515487|NCT02252965|458849765|FG001|Overall Study|Adverse Event|14|||
127515488|NCT02252965|458849764|FG000|Overall Study|Lost to Follow-up|16|||
127515489|NCT02252965|458849765|FG001|Overall Study|Lost to Follow-up|8|||
127515490|NCT02252965|458849764|FG000|Overall Study|Protocol Violation|4|||
127515491|NCT02252965|458849765|FG001|Overall Study|Protocol Violation|5|||
127515492|NCT02252965|458849764|FG000|Overall Study|Lack of Efficacy|0|||
127515493|NCT02252965|458849765|FG001|Overall Study|Lack of Efficacy|2|||
127515494|NCT02252965|458849764|FG000|Overall Study|Withdrawal by Subject|7|||
127515495|NCT02252965|458849765|FG001|Overall Study|Withdrawal by Subject|9|||
127515496|NCT02252965|458849764|FG000|Overall Study|Other|4|||
127515497|NCT02252965|458849765|FG001|Overall Study|Other|5|||
127515498|NCT02797184|458849771|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
127515499|NCT02797184|458849772|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
127515500|NCT05149313|458849773|FG000|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
127515501|NCT05149313|458849774|FG001|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
127515502|NCT05149313|458849775|FG002|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
127515503|NCT05149313|458849776|FG003|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
127515504|NCT05149313|458849773|FG000|Double-blind Induction Period (16-weeks)|Lost to Follow-up|2|||
127515505|NCT05149313|458849774|FG001|Double-blind Induction Period (16-weeks)|Lost to Follow-up|3|||
127515506|NCT05149313|458849775|FG002|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
127515507|NCT05149313|458849776|FG003|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
127515508|NCT05149313|458849773|FG000|Double-blind Induction Period (16-weeks)|Pregnancy|1|||
127515509|NCT05149313|458849774|FG001|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
127515510|NCT05149313|458849775|FG002|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
127515511|NCT05149313|458849776|FG003|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
127515512|NCT05149313|458849773|FG000|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|2|||
127515513|NCT05149313|458849774|FG001|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|5|||
127515514|NCT05149313|458849775|FG002|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
127515515|NCT05149313|458849776|FG003|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
127515516|NCT05149313|458849773|FG000|Double-blind Induction Period (16-weeks)|Physician Decision|1|||
127515517|NCT05149313|458849774|FG001|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
127515518|NCT05149313|458849775|FG002|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
127515519|NCT05149313|458849776|FG003|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
127515520|NCT05149313|458849773|FG000|Double-blind Induction Period (16-weeks)|Other|0|||
127515521|NCT05149313|458849774|FG001|Double-blind Induction Period (16-weeks)|Other|1|||
127515522|NCT05149313|458849775|FG002|Double-blind Induction Period (16-weeks)|Other|0|||
127515523|NCT05149313|458849776|FG003|Double-blind Induction Period (16-weeks)|Other|0|||
127515524|NCT05149313|458849773|FG000|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
127515525|NCT05149313|458849774|FG001|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
127515526|NCT05149313|458849775|FG002|Open-label Maintenance Period (36 Weeks)|Adverse Event|7|||
127515527|NCT05149313|458849776|FG003|Open-label Maintenance Period (36 Weeks)|Adverse Event|1|||
127515528|NCT05149313|458849773|FG000|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
127515529|NCT05149313|458849774|FG001|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
127515530|NCT05149313|458849775|FG002|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|14|||
127515531|NCT05149313|458849776|FG003|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|7|||
127515532|NCT05149313|458849773|FG000|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
127515533|NCT05149313|458849774|FG001|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
127515534|NCT05149313|458849775|FG002|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|6|||
127515535|NCT05149313|458849776|FG003|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|5|||
127515536|NCT05149313|458849773|FG000|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
127515537|NCT05149313|458849774|FG001|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
127515538|NCT05149313|458849775|FG002|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|4|||
127515539|NCT05149313|458849776|FG003|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
127515540|NCT05149313|458849773|FG000|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
127515541|NCT05149313|458849774|FG001|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
127515542|NCT05149313|458849775|FG002|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|1|||
127515543|NCT05149313|458849776|FG003|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
127515544|NCT03199391|458849781|FG000|Overall Study|Death|1|||
127515545|NCT03199391|458849781|FG000|Overall Study|Lost to Follow-up|3|||
127515546|NCT03199391|458849781|FG000|Overall Study|Adverse Event|2|||
127515547|NCT03199391|458849781|FG000|Overall Study|Withdrawal by Subject|10|||
127515548|NCT01867086|458849782|FG000|Overall Study|Disease Progression|1|||
127515549|NCT02616393|458849792|FG000|Overall Study|Death|5|||
127515550|NCT02616393|458849793|FG001|Overall Study|Death|12|||
127515551|NCT02616393|458849794|FG002|Overall Study|Death|1|||
127515552|NCT02616393|458849792|FG000|Overall Study|Termination by Sponsor|4|||
127515553|NCT02616393|458849793|FG001|Overall Study|Termination by Sponsor|5|||
127515554|NCT02616393|458849794|FG002|Overall Study|Termination by Sponsor|2|||
127515555|NCT02616393|458849792|FG000|Overall Study|Other|3|||
127515556|NCT02616393|458849793|FG001|Overall Study|Other|0|||
127515557|NCT02616393|458849794|FG002|Overall Study|Other|0|||
127515558|NCT02616393|458849792|FG000|Overall Study|Withdrawal by Subject|1|||
127515559|NCT02616393|458849793|FG001|Overall Study|Withdrawal by Subject|1|||
127515560|NCT02616393|458849794|FG002|Overall Study|Withdrawal by Subject|0|||
127515561|NCT02616393|458849792|FG000|Overall Study|Lost to Follow-up|0|||
127515562|NCT02616393|458849793|FG001|Overall Study|Lost to Follow-up|2|||
127515563|NCT02616393|458849794|FG002|Overall Study|Lost to Follow-up|0|||
127515564|NCT02758301|458849796|FG000|Overall Study|Death|12|||
127515565|NCT02758301|458849797|FG001|Overall Study|Death|0|||
127515566|NCT02758301|458849796|FG000|Overall Study|Physician Decision|10|||
127515567|NCT02758301|458849797|FG001|Overall Study|Physician Decision|1|||
127515568|NCT02758301|458849796|FG000|Overall Study|Withdrawal by Subject|5|||
127515569|NCT02758301|458849797|FG001|Overall Study|Withdrawal by Subject|6|||
127515570|NCT02758301|458849796|FG000|Overall Study|Lost to Follow-up|7|||
127515571|NCT02758301|458849797|FG001|Overall Study|Lost to Follow-up|0|||
127515572|NCT02758301|458849796|FG000|Overall Study|Protocol Violation|0|||
127515573|NCT02758301|458849797|FG001|Overall Study|Protocol Violation|1|||
127515574|NCT00582738|458849798|FG000|Overall Study|Administrative Problems|7|||
127515575|NCT00582738|458849799|FG001|Overall Study|Administrative Problems|8|||
127515576|NCT00582738|458849798|FG000|Overall Study|Adverse Event|0|||
127515577|NCT00582738|458849799|FG001|Overall Study|Adverse Event|5|||
127515578|NCT00582738|458849798|FG000|Overall Study|Graft Lost|0|||
127515579|NCT00582738|458849799|FG001|Overall Study|Graft Lost|1|||
127515580|NCT00582738|458849798|FG000|Overall Study|Other|1|||
127515581|NCT00582738|458849799|FG001|Overall Study|Other|0|||
127515582|NCT00582738|458849798|FG000|Overall Study|Protocol Violation|1|||
127515583|NCT00582738|458849799|FG001|Overall Study|Protocol Violation|1|||
127515584|NCT00582738|458849798|FG000|Overall Study|Withdrawal by Subject|0|||
127515585|NCT00582738|458849799|FG001|Overall Study|Withdrawal by Subject|3|||
127515586|NCT00364533|458849800|FG000|Overall Study|Adverse Event|8|||
127515587|NCT00364533|458849801|FG001|Overall Study|Adverse Event|7|||
127515588|NCT00364533|458849802|FG002|Overall Study|Adverse Event|15|||
127515589|NCT00364533|458849803|FG003|Overall Study|Adverse Event|5|||
127515590|NCT00364533|458849804|FG004|Overall Study|Adverse Event|2|||
127515591|NCT00364533|458849800|FG000|Overall Study|Withdrawal by Subject|4|||
127515592|NCT00364533|458849801|FG001|Overall Study|Withdrawal by Subject|8|||
127515593|NCT00364533|458849802|FG002|Overall Study|Withdrawal by Subject|6|||
127515594|NCT00364533|458849803|FG003|Overall Study|Withdrawal by Subject|6|||
127515595|NCT00364533|458849804|FG004|Overall Study|Withdrawal by Subject|6|||
127515596|NCT00364533|458849800|FG000|Overall Study|Lack of Efficacy|22|||
127515597|NCT00364533|458849801|FG001|Overall Study|Lack of Efficacy|22|||
127515598|NCT00364533|458849802|FG002|Overall Study|Lack of Efficacy|21|||
127515599|NCT00364533|458849803|FG003|Overall Study|Lack of Efficacy|17|||
127515600|NCT00364533|458849804|FG004|Overall Study|Lack of Efficacy|42|||
127515601|NCT00364533|458849800|FG000|Overall Study|Subject discharged from hospital|4|||
127515602|NCT00364533|458849801|FG001|Overall Study|Subject discharged from hospital|1|||
127515603|NCT00364533|458849802|FG002|Overall Study|Subject discharged from hospital|2|||
127515604|NCT00364533|458849803|FG003|Overall Study|Subject discharged from hospital|3|||
127515605|NCT00364533|458849804|FG004|Overall Study|Subject discharged from hospital|1|||
127515606|NCT00364533|458849800|FG000|Overall Study|Variations in drug compliance|2|||
127515607|NCT00364533|458849801|FG001|Overall Study|Variations in drug compliance|1|||
127515608|NCT00364533|458849802|FG002|Overall Study|Variations in drug compliance|1|||
127515609|NCT00364533|458849803|FG003|Overall Study|Variations in drug compliance|0|||
127515610|NCT00364533|458849804|FG004|Overall Study|Variations in drug compliance|0|||
127515611|NCT00364533|458849800|FG000|Overall Study|Non-compliance|1|||
127515612|NCT00364533|458849801|FG001|Overall Study|Non-compliance|0|||
127515613|NCT00364533|458849802|FG002|Overall Study|Non-compliance|0|||
127515614|NCT00364533|458849803|FG003|Overall Study|Non-compliance|0|||
127515615|NCT00364533|458849804|FG004|Overall Study|Non-compliance|0|||
127515616|NCT00364533|458849800|FG000|Overall Study|Protocol Violation|1|||
127515617|NCT00364533|458849801|FG001|Overall Study|Protocol Violation|1|||
127515618|NCT00364533|458849802|FG002|Overall Study|Protocol Violation|0|||
127515619|NCT00364533|458849803|FG003|Overall Study|Protocol Violation|0|||
127515620|NCT00364533|458849804|FG004|Overall Study|Protocol Violation|0|||
127515621|NCT00652899|458849805|FG000|Overall Study|Death|1|||
127515622|NCT00652899|458849805|FG000|Overall Study|Treating physician decision|1|||
127515623|NCT04135859|458849808|FG000|Overall Study|Withdrawal by Subject|1|||
127515624|NCT04135859|458849809|FG001|Overall Study|Withdrawal by Subject|0|||
127515625|NCT04135859|458849808|FG000|Overall Study|Withdrawal due to screening failure|1|||
127515626|NCT04135859|458849809|FG001|Overall Study|Withdrawal due to screening failure|2|||
127515627|NCT04135859|458849808|FG000|Overall Study|Did not complete stress test|3|||
127515628|NCT04135859|458849809|FG001|Overall Study|Did not complete stress test|3|||
127515629|NCT04135859|458849808|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
127515630|NCT04135859|458849809|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
127515631|NCT02900170|458849810|FG000|Overall Study|Lost to Follow-up|8|||
127515632|NCT00551291|458849811|FG000|Overall Study|Physician Decision|1|||
127515633|NCT01943552|458849812|FG000|Overall Study|Adverse Event|3|||
127515634|NCT01943552|458849813|FG001|Overall Study|Adverse Event|2|||
127515635|NCT01943552|458849812|FG000|Overall Study|Withdrawal by Subject|6|||
127515636|NCT01943552|458849813|FG001|Overall Study|Withdrawal by Subject|6|||
127515637|NCT01943552|458849812|FG000|Overall Study|Other Reasons|16|||
127515638|NCT01943552|458849813|FG001|Overall Study|Other Reasons|17|||
127515639|NCT01600053|458849814|FG000|Overall Study|Adverse Event|2|||
127515640|NCT01600053|458849814|FG000|Overall Study|trial will not meet the interim endpoint|9|||
127515641|NCT02445573|458849815|FG000|Overall Study|Withdrawal by Subject|1|||
127515642|NCT02445573|458849816|FG001|Overall Study|Withdrawal by Subject|1|||
127515643|NCT02445573|458849815|FG000|Overall Study|Lost to Follow-up|0|||
127515644|NCT02445573|458849816|FG001|Overall Study|Lost to Follow-up|1|||
127515645|NCT02855944|458849817|FG000|Period 1: Treatment|Ongoing|14|||
127515646|NCT02855944|458849818|FG001|Period 1: Treatment|Ongoing|0|||
127515647|NCT02855944|458849817|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
127515648|NCT02855944|458849818|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
127515649|NCT02855944|458849817|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
127515650|NCT02855944|458849818|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
127515651|NCT03242018|458849828|FG000|Overall Study|Adverse Event|7|||
127515652|NCT03242018|458849829|FG001|Overall Study|Adverse Event|7|||
127515653|NCT03242018|458849830|FG002|Overall Study|Adverse Event|6|||
127515654|NCT03242018|458849828|FG000|Overall Study|Lost to Follow-up|2|||
127515655|NCT03242018|458849829|FG001|Overall Study|Lost to Follow-up|2|||
127515656|NCT03242018|458849830|FG002|Overall Study|Lost to Follow-up|2|||
127515657|NCT03242018|458849828|FG000|Overall Study|At the Participant's Own Request|5|||
127515658|NCT03242018|458849829|FG001|Overall Study|At the Participant's Own Request|1|||
127515659|NCT03242018|458849830|FG002|Overall Study|At the Participant's Own Request|4|||
127515660|NCT03242018|458849828|FG000|Overall Study|Reason Not Specified|3|||
127515661|NCT03242018|458849829|FG001|Overall Study|Reason Not Specified|4|||
127515662|NCT03242018|458849830|FG002|Overall Study|Reason Not Specified|1|||
127515663|NCT03242018|458849828|FG000|Overall Study|Study Terminated by Sponsor|1|||
127515664|NCT03242018|458849829|FG001|Overall Study|Study Terminated by Sponsor|0|||
127515665|NCT03242018|458849830|FG002|Overall Study|Study Terminated by Sponsor|1|||
127515666|NCT01475162|458849832|FG000|Overall Study|Physician Decision|1|||
127515667|NCT01475162|458849832|FG000|Overall Study|Death|10|||
127515668|NCT01475162|458849832|FG000|Overall Study|Study closed for safety|3|||
127515669|NCT00490022|458849833|FG000|Overall Study|Adverse Event|0|||
127515670|NCT00490022|458849834|FG001|Overall Study|Adverse Event|2|||
127515671|NCT00490022|458849833|FG000|Overall Study|Withdrawal by Subject|1|||
127515672|NCT00490022|458849834|FG001|Overall Study|Withdrawal by Subject|0|||
127515673|NCT00490022|458849833|FG000|Overall Study|Subject failed to disclose concommitant|0|||
127515674|NCT00490022|458849834|FG001|Overall Study|Subject failed to disclose concommitant|1|||
127515675|NCT01283542|458849835|FG000|Main Phase|Acute or progressive vision loss|1|||
127515676|NCT01283542|458849835|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
127515677|NCT01283542|458849835|FG000|Main Phase|abnormal laboratory values|5|||
127515678|NCT01283542|458849835|FG000|Extension Phase|Physician Decision|1|||
127515679|NCT01283542|458849835|FG000|Extension Phase|Adverse Event|1|||
127515680|NCT01283542|458849835|FG000|Extension Phase|Administrative problems|1|||
127515681|NCT03263780|458849839|FG000|Overall Study|Withdrawal by Subject|3|||
127515682|NCT03263780|458849839|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
127515683|NCT01504204|458849842|FG000|Overall Study|Lost to Follow-up|1|||
127515684|NCT01504204|458849843|FG001|Overall Study|Lost to Follow-up|1|||
127515685|NCT00903331|458849844|FG000|Overall Study|Death|4|||
127515686|NCT00903331|458849845|FG001|Overall Study|Death|8|||
127515687|NCT00903331|458849844|FG000|Overall Study|Withdrawal of consent|1|||
127515688|NCT00903331|458849845|FG001|Overall Study|Withdrawal of consent|8|||
127515689|NCT00903331|458849844|FG000|Overall Study|Lung transplant|0|||
127515690|NCT00903331|458849845|FG001|Overall Study|Lung transplant|2|||
127515691|NCT02723175|458849846|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
127515692|NCT02723175|458849847|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
127515693|NCT02723175|458849846|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
127515694|NCT02723175|458849847|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
127515695|NCT00257660|458849850|FG000|Overall Study|Lack of Efficacy|5|||
127515696|NCT00257660|458849851|FG001|Overall Study|Lack of Efficacy|23|||
127515697|NCT00257660|458849850|FG000|Overall Study|Withdrawal by Subject|2|||
127515698|NCT00257660|458849851|FG001|Overall Study|Withdrawal by Subject|0|||
127515699|NCT00257660|458849850|FG000|Overall Study|Lost to Follow-up|1|||
127515700|NCT00257660|458849851|FG001|Overall Study|Lost to Follow-up|0|||
127515701|NCT00257660|458849850|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
127515702|NCT00257660|458849851|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
127515703|NCT00257660|458849850|FG000|Overall Study|No longer wanted to do blood draws|1|||
127515704|NCT00257660|458849851|FG001|Overall Study|No longer wanted to do blood draws|0|||
127515705|NCT02449018|458849856|FG000|Overall Study|Abnormal laboratory value|0|||
127515706|NCT02449018|458849857|FG001|Overall Study|Abnormal laboratory value|1|||
127515707|NCT02449018|458849856|FG000|Overall Study|Administrative problems|1|||
127515708|NCT02449018|458849857|FG001|Overall Study|Administrative problems|0|||
127515709|NCT02449018|458849856|FG000|Overall Study|Adverse Event|5|||
127515710|NCT02449018|458849857|FG001|Overall Study|Adverse Event|1|||
127515711|NCT02449018|458849856|FG000|Overall Study|Protocol deviation|4|||
127515712|NCT02449018|458849857|FG001|Overall Study|Protocol deviation|0|||
127515713|NCT02449018|458849856|FG000|Overall Study|Patient decision|2|||
127515714|NCT02449018|458849857|FG001|Overall Study|Patient decision|0|||
127515715|NCT03995355|458849858|FG000|Overall Study|Adverse Event|1|||
127515716|NCT03995355|458849859|FG001|Overall Study|Adverse Event|0|||
127515717|NCT03995355|458849858|FG000|Overall Study|Withdrawal by Subject|1|||
127515718|NCT03995355|458849859|FG001|Overall Study|Withdrawal by Subject|0|||
127515719|NCT03995355|458849858|FG000|Overall Study|Scheduling Issues|0|||
127515720|NCT03995355|458849859|FG001|Overall Study|Scheduling Issues|1|||
127515721|NCT03426631|458849860|FG000|Overall Study|Lost to Follow-up|0|||
127515722|NCT03426631|458849861|FG001|Overall Study|Lost to Follow-up|1|||
127515723|NCT05063539|458851259|FG000|Overall Study|Adverse Event|1|||
127515724|NCT05063539|458851260|FG001|Overall Study|Adverse Event|2|||
127515725|NCT05063539|458851261|FG002|Overall Study|Adverse Event|1|||
127515726|NCT05063539|458851259|FG000|Overall Study|Death|0|||
127515727|NCT05063539|458851260|FG001|Overall Study|Death|1|||
127515728|NCT05063539|458851261|FG002|Overall Study|Death|1|||
127515729|NCT05063539|458851259|FG000|Overall Study|Lost to Follow-up|0|||
127515730|NCT05063539|458851260|FG001|Overall Study|Lost to Follow-up|1|||
127515731|NCT05063539|458851261|FG002|Overall Study|Lost to Follow-up|0|||
127515732|NCT05063539|458851259|FG000|Overall Study|Physician Decision|4|||
127515733|NCT05063539|458851260|FG001|Overall Study|Physician Decision|3|||
127515734|NCT05063539|458851261|FG002|Overall Study|Physician Decision|1|||
127515735|NCT05063539|458851259|FG000|Overall Study|Progressive Disease|0|||
127515736|NCT05063539|458851260|FG001|Overall Study|Progressive Disease|2|||
127515737|NCT05063539|458851261|FG002|Overall Study|Progressive Disease|0|||
127515738|NCT05063539|458851259|FG000|Overall Study|Withdrawal by Subject|17|||
127515739|NCT05063539|458851260|FG001|Overall Study|Withdrawal by Subject|26|||
127515740|NCT05063539|458851261|FG002|Overall Study|Withdrawal by Subject|14|||
127515741|NCT05063539|458851259|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
127515742|NCT05063539|458851260|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
127515743|NCT05063539|458851261|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|0|||
127515744|NCT05063539|458851259|FG000|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|1|||
127515745|NCT05063539|458851260|FG001|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
127515746|NCT05063539|458851261|FG002|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
127515747|NCT05063539|458851259|FG000|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
127515748|NCT05063539|458851260|FG001|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
127515749|NCT05063539|458851261|FG002|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|1|||
127515750|NCT05063539|458851259|FG000|Overall Study|Discontinued due to Common Close Design|0|||
127515751|NCT05063539|458851260|FG001|Overall Study|Discontinued due to Common Close Design|1|||
127515752|NCT05063539|458851261|FG002|Overall Study|Discontinued due to Common Close Design|0|||
127515753|NCT05063539|458851259|FG000|Overall Study|Participant not co-operative|0|||
127515754|NCT05063539|458851260|FG001|Overall Study|Participant not co-operative|1|||
127515755|NCT05063539|458851261|FG002|Overall Study|Participant not co-operative|0|||
127515756|NCT05063539|458851259|FG000|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
127515757|NCT05063539|458851260|FG001|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
127515758|NCT05063539|458851261|FG002|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|1|||
127515759|NCT05063539|458851259|FG000|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
127515760|NCT05063539|458851260|FG001|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|1|||
127515761|NCT05063539|458851261|FG002|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
127515762|NCT04256512|458851262|FG000|Overall Study|Withdrawal by Subject|1|||
127515763|NCT04435600|458851266|FG000|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
127515764|NCT04435600|458851267|FG001|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
127515765|NCT04435600|458851268|FG002|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|1|||
127515766|NCT04435600|458851269|FG003|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
127515767|NCT04435600|458851270|FG004|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
127515768|NCT04435600|458851271|FG005|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
127515769|NCT04435600|458851272|FG006|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
127515770|NCT04435600|458851273|FG007|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
127515771|NCT04435600|458851274|FG008|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
127515772|NCT04435600|458851275|FG009|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
127515773|NCT04435600|458851266|FG000|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
127515774|NCT04435600|458851267|FG001|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
127515775|NCT04435600|458851268|FG002|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
127515776|NCT04435600|458851269|FG003|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
127515777|NCT04435600|458851270|FG004|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
127515778|NCT04435600|458851271|FG005|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
127515779|NCT04435600|458851272|FG006|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
127515780|NCT04435600|458851273|FG007|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
127515781|NCT04435600|458851274|FG008|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
127515782|NCT04435600|458851275|FG009|Part 4 (Baseline to Week 52)|Withdrawal by Subject|1|||
127515783|NCT04435600|458851266|FG000|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
127515784|NCT04435600|458851267|FG001|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
127515785|NCT04435600|458851268|FG002|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
127515786|NCT04435600|458851269|FG003|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
127515787|NCT04435600|458851270|FG004|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
127515788|NCT04435600|458851271|FG005|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
127515789|NCT04435600|458851272|FG006|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
127515790|NCT04435600|458851273|FG007|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
127515791|NCT04435600|458851274|FG008|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
127515792|NCT04435600|458851275|FG009|Part 4 (Baseline to Week 52)|Lost to Follow-up|1|||
127515793|NCT04435600|458851266|FG000|Part 4 (Baseline to Week 52)|Other than specified|0|||
127515794|NCT04435600|458851267|FG001|Part 4 (Baseline to Week 52)|Other than specified|0|||
127515795|NCT04435600|458851268|FG002|Part 4 (Baseline to Week 52)|Other than specified|0|||
127515796|NCT04435600|458851269|FG003|Part 4 (Baseline to Week 52)|Other than specified|0|||
127515797|NCT04435600|458851270|FG004|Part 4 (Baseline to Week 52)|Other than specified|0|||
127515798|NCT04435600|458851271|FG005|Part 4 (Baseline to Week 52)|Other than specified|0|||
127515799|NCT04435600|458851272|FG006|Part 4 (Baseline to Week 52)|Other than specified|0|||
127515800|NCT04435600|458851273|FG007|Part 4 (Baseline to Week 52)|Other than specified|0|||
127515801|NCT04435600|458851274|FG008|Part 4 (Baseline to Week 52)|Other than specified|0|||
127515802|NCT04435600|458851275|FG009|Part 4 (Baseline to Week 52)|Other than specified|1|||
127515803|NCT01751139|458851276|FG000|Overall Study|Other|135|||
127515804|NCT01751139|458851276|FG000|Overall Study|Sponsor study termination|1609|||
127515805|NCT01751139|458851276|FG000|Overall Study|Lost to Follow-up|240|||
127515806|NCT01751139|458851276|FG000|Overall Study|Withdrawal by Subject|251|||
127515807|NCT01751139|458851276|FG000|Overall Study|Adverse Event|1|||
127515808|NCT01751139|458851276|FG000|Overall Study|Death|31|||
127515809|NCT04736628|458851277|FG000|Overall Study|Not treated|0|||
127515810|NCT04736628|458851278|FG001|Overall Study|Not treated|0|||
127515811|NCT04736628|458851279|FG002|Overall Study|Not treated|0|||
127515812|NCT04736628|458851280|FG003|Overall Study|Not treated|2|||
127515813|NCT04736628|458851277|FG000|Overall Study|Other reason than listed|1|||
127515814|NCT04736628|458851278|FG001|Overall Study|Other reason than listed|2|||
127515815|NCT04736628|458851279|FG002|Overall Study|Other reason than listed|2|||
127515816|NCT04736628|458851280|FG003|Overall Study|Other reason than listed|3|||
127515817|NCT04736628|458851277|FG000|Overall Study|Protocol deviation|0|||
127515818|NCT04736628|458851278|FG001|Overall Study|Protocol deviation|0|||
127515819|NCT04736628|458851279|FG002|Overall Study|Protocol deviation|0|||
127515820|NCT04736628|458851280|FG003|Overall Study|Protocol deviation|1|||
127515821|NCT04736628|458851277|FG000|Overall Study|Burden of study procedures|1|||
127515822|NCT04736628|458851278|FG001|Overall Study|Burden of study procedures|0|||
127515823|NCT04736628|458851279|FG002|Overall Study|Burden of study procedures|0|||
127515824|NCT04736628|458851280|FG003|Overall Study|Burden of study procedures|1|||
127515825|NCT04736628|458851277|FG000|Overall Study|Change of residence|0|||
127515826|NCT04736628|458851278|FG001|Overall Study|Change of residence|1|||
127515827|NCT04736628|458851279|FG002|Overall Study|Change of residence|0|||
127515828|NCT04736628|458851280|FG003|Overall Study|Change of residence|0|||
127515829|NCT04736628|458851277|FG000|Overall Study|Perceived lack of efficacy|1|||
127515830|NCT04736628|458851278|FG001|Overall Study|Perceived lack of efficacy|0|||
127515831|NCT04736628|458851279|FG002|Overall Study|Perceived lack of efficacy|0|||
127515832|NCT04736628|458851280|FG003|Overall Study|Perceived lack of efficacy|1|||
127515833|NCT04736628|458851277|FG000|Overall Study|Adverse Event|3|||
127515834|NCT04736628|458851278|FG001|Overall Study|Adverse Event|2|||
127515835|NCT04736628|458851279|FG002|Overall Study|Adverse Event|4|||
127515836|NCT04736628|458851280|FG003|Overall Study|Adverse Event|3|||
127515837|NCT04279613|458851281|FG000|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
127515838|NCT04279613|458851282|FG001|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
127515839|NCT04279613|458851283|FG002|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
127515840|NCT04279613|458851284|FG003|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
127515841|NCT04279613|458851285|FG004|Cohort 1: Dose Level 1 mg|Protocol Violation|1|||
127515842|NCT04279613|458851281|FG000|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
127515843|NCT04279613|458851282|FG001|Cohort 2: Dose Level 5 mg|Adverse Event|1|||
127515844|NCT04279613|458851283|FG002|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
127515845|NCT04279613|458851284|FG003|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
127515846|NCT04279613|458851285|FG004|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
127515847|NCT04279613|458851281|FG000|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
127515848|NCT04279613|458851282|FG001|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
127515849|NCT04279613|458851283|FG002|Cohort 3: Dose Level 12.5 mg|Protocol Violation|1|||
127515850|NCT04279613|458851284|FG003|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
127515851|NCT04279613|458851285|FG004|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
127515852|NCT04279613|458851281|FG000|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
127515853|NCT04279613|458851282|FG001|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
127515854|NCT04279613|458851283|FG002|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
127515855|NCT04279613|458851284|FG003|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
127515856|NCT04279613|458851285|FG004|Cohort 4: Dose Level 25 mg|Adverse Event|1|||
127515857|NCT04279613|458851281|FG000|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
127515858|NCT04279613|458851282|FG001|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
127515859|NCT04279613|458851283|FG002|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
127515860|NCT04279613|458851284|FG003|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|1|||
127515861|NCT04279613|458851285|FG004|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
127515862|NCT04428151|458851286|FG000|Overall Study|Death|100|||
127515863|NCT04428151|458851287|FG001|Overall Study|Death|86|||
127515864|NCT04428151|458851288|FG002|Overall Study|Death|57|||
127515865|NCT04428151|458851286|FG000|Overall Study|Lost to Follow-up|1|||
127515866|NCT04428151|458851287|FG001|Overall Study|Lost to Follow-up|1|||
127515867|NCT04428151|458851288|FG002|Overall Study|Lost to Follow-up|0|||
127515868|NCT04428151|458851286|FG000|Overall Study|Withdrawal by Subject|2|||
127515869|NCT04428151|458851287|FG001|Overall Study|Withdrawal by Subject|2|||
127515870|NCT04428151|458851288|FG002|Overall Study|Withdrawal by Subject|3|||
127515871|NCT04428151|458851286|FG000|Overall Study|Participant Ongoing in Study|41|||
127515872|NCT04428151|458851287|FG001|Overall Study|Participant Ongoing in Study|53|||
127515873|NCT04428151|458851288|FG002|Overall Study|Participant Ongoing in Study|28|||
127515874|NCT02704689|458851289|FG000|Overall Study|Physician Decision|1|||
127515875|NCT02704689|458851289|FG000|Overall Study|Study device not implanted|2|||
127515876|NCT02212678|458851292|FG000|Overall Study|Adverse Event|1|||
127515877|NCT02337634|458851293|FG000|Overall Study|Protocol Violation|3|||
127515878|NCT02337634|458851294|FG001|Overall Study|Protocol Violation|1|||
127515879|NCT02337634|458851293|FG000|Overall Study|Lost to Follow-up|1|||
127515880|NCT02337634|458851294|FG001|Overall Study|Lost to Follow-up|0|||
127515881|NCT04068610|458851295|FG000|Overall Study|Death|4|||
127515882|NCT04068610|458851296|FG001|Overall Study|Death|8|||
127515883|NCT04068610|458851297|FG002|Overall Study|Death|13|||
127515884|NCT04068610|458851295|FG000|Overall Study|Lost to Follow-up|0|||
127515885|NCT04068610|458851296|FG001|Overall Study|Lost to Follow-up|2|||
127515886|NCT04068610|458851297|FG002|Overall Study|Lost to Follow-up|0|||
127515887|NCT04068610|458851295|FG000|Overall Study|Withdrawal by Subject|0|||
127515888|NCT04068610|458851296|FG001|Overall Study|Withdrawal by Subject|4|||
127515889|NCT04068610|458851297|FG002|Overall Study|Withdrawal by Subject|2|||
127515890|NCT04068610|458851295|FG000|Overall Study|Other|3|||
127515891|NCT04068610|458851296|FG001|Overall Study|Other|12|||
127515892|NCT04068610|458851297|FG002|Overall Study|Other|11|||
127515893|NCT02428205|458851298|FG000|Overall Study|Lack of Efficacy|1|||
127515894|NCT02428205|458851299|FG001|Overall Study|Lack of Efficacy|0|||
127515895|NCT02428205|458851298|FG000|Overall Study|Lost to Follow-up|1|||
127515896|NCT02428205|458851299|FG001|Overall Study|Lost to Follow-up|1|||
127515897|NCT02428205|458851298|FG000|Overall Study|Worse behavior|0|||
127515898|NCT02428205|458851299|FG001|Overall Study|Worse behavior|1|||
127515899|NCT00527319|458851300|FG000|Overall Study|Withdrawal by Subject|5|||
127515900|NCT00527319|458851301|FG001|Overall Study|Withdrawal by Subject|0|||
127515901|NCT00527319|458851302|FG002|Overall Study|Withdrawal by Subject|1|||
127515902|NCT00527319|458851300|FG000|Overall Study|Lost to Follow-up|1|||
127515903|NCT00527319|458851301|FG001|Overall Study|Lost to Follow-up|0|||
127515904|NCT00527319|458851302|FG002|Overall Study|Lost to Follow-up|0|||
127515905|NCT00527319|458851300|FG000|Overall Study|Death|0|||
127515906|NCT00527319|458851301|FG001|Overall Study|Death|3|||
127515907|NCT00527319|458851302|FG002|Overall Study|Death|1|||
127515908|NCT00527319|458851300|FG000|Overall Study|Intercurrent Medical Illness|0|||
127515909|NCT00527319|458851301|FG001|Overall Study|Intercurrent Medical Illness|1|||
127515910|NCT00527319|458851302|FG002|Overall Study|Intercurrent Medical Illness|3|||
127515911|NCT00527319|458851300|FG000|Overall Study|Adverse Event|0|||
127515912|NCT00527319|458851301|FG001|Overall Study|Adverse Event|0|||
127515913|NCT00527319|458851302|FG002|Overall Study|Adverse Event|1|||
127515914|NCT00680368|458851308|FG000|Overall Study|not supervised, not eligible|15|||
127515915|NCT00443781|458851313|FG000|Overall Study|Lost to Follow-up|10|||
127515916|NCT00443781|458851313|FG000|Overall Study|Physician Decision|2|||
127515917|NCT00443781|458851313|FG000|Overall Study|Protocol Violation|1|||
127515918|NCT00443781|458851313|FG000|Overall Study|Withdrawal by Subject|6|||
127515919|NCT00443781|458851313|FG000|Overall Study|Unable to comply with study follow up|2|||
127515920|NCT00443781|458851313|FG000|Overall Study|Investigator terminated participation|1|||
127515921|NCT00443781|458851313|FG000|Overall Study|Insurance not covered|2|||
127515922|NCT00443781|458851313|FG000|Overall Study|PD/FAD not done|1|||
127515923|NCT02066415|458851314|FG000|Overall Study|Decision by Sponsor|5|||
127515924|NCT02066415|458851315|FG001|Overall Study|Decision by Sponsor|4|||
127515925|NCT02066415|458851316|FG002|Overall Study|Decision by Sponsor|2|||
127515926|NCT02066415|458851314|FG000|Overall Study|Withdrawal by Subject|9|||
127515927|NCT02066415|458851315|FG001|Overall Study|Withdrawal by Subject|1|||
127515928|NCT02066415|458851316|FG002|Overall Study|Withdrawal by Subject|4|||
127515929|NCT02066415|458851314|FG000|Overall Study|Lost to Follow-up|7|||
127515930|NCT02066415|458851315|FG001|Overall Study|Lost to Follow-up|2|||
127515931|NCT02066415|458851316|FG002|Overall Study|Lost to Follow-up|2|||
127515932|NCT00430937|458851317|FG000|Overall Study|Adverse Event|3|||
127515933|NCT00430937|458851318|FG001|Overall Study|Adverse Event|8|||
127515934|NCT00430937|458851317|FG000|Overall Study|Death|0|||
127515935|NCT00430937|458851318|FG001|Overall Study|Death|1|||
127515936|NCT00430937|458851317|FG000|Overall Study|Lost to Follow-up|6|||
127515937|NCT00430937|458851318|FG001|Overall Study|Lost to Follow-up|6|||
127515938|NCT00430937|458851317|FG000|Overall Study|Withdrawal by Subject|5|||
127515939|NCT00430937|458851318|FG001|Overall Study|Withdrawal by Subject|2|||
127515940|NCT00430937|458851317|FG000|Overall Study|Protocol Violation|3|||
127515941|NCT00430937|458851318|FG001|Overall Study|Protocol Violation|2|||
127515942|NCT00430937|458851317|FG000|Overall Study|Lack of Efficacy|6|||
127515943|NCT00430937|458851318|FG001|Overall Study|Lack of Efficacy|5|||
127515944|NCT00430937|458851317|FG000|Overall Study|Inappropriate enrollment|2|||
127515945|NCT00430937|458851318|FG001|Overall Study|Inappropriate enrollment|1|||
127515946|NCT00430937|458851317|FG000|Overall Study|Administrative reasons|1|||
127515947|NCT00430937|458851318|FG001|Overall Study|Administrative reasons|0|||
127515948|NCT00430937|458851317|FG000|Overall Study|Protocol discontinuation criteria met|1|||
127515949|NCT00430937|458851318|FG001|Overall Study|Protocol discontinuation criteria met|2|||
127515950|NCT00430937|458851317|FG000|Overall Study|Unable to classify|0|||
127515951|NCT00430937|458851318|FG001|Overall Study|Unable to classify|1|||
127515952|NCT00657371|458851319|FG000|Overall Study|Poor bowel preparation|15|||
127515953|NCT00657371|458851319|FG000|Overall Study|Unable to intubate the cecum|5|||
127515954|NCT00657371|458851319|FG000|Overall Study|Protocol Violation|2|||
127515955|NCT00657371|458851319|FG000|Overall Study|Device- related reasons|13|||
127515956|NCT00657371|458851319|FG000|Overall Study|Pre-existing medical condition|4|||
127515957|NCT01639755|458851320|FG000|Overall Study|Study Ongoing|15|||
127515958|NCT01639755|458851320|FG000|Overall Study|Patient had device explantation|4|||
127515959|NCT05059977|458851322|FG000|Overall Study|Withdrawal by Subject|0|||
127515960|NCT05059977|458851323|FG001|Overall Study|Withdrawal by Subject|0|||
127515961|NCT05059977|458851324|FG002|Overall Study|Withdrawal by Subject|1|||
127515962|NCT00576472|458851325|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
127515963|NCT00576472|458851326|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
127515964|NCT00576472|458851327|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
127515965|NCT00576472|458851328|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
127515966|NCT00576472|458851329|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
127515967|NCT00576472|458851330|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
127515968|NCT00576472|458851331|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
127515969|NCT00576472|458851332|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
127515970|NCT00576472|458851333|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
127515971|NCT00576472|458851334|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
127515972|NCT00576472|458851335|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
127515973|NCT00576472|458851336|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
127515974|NCT00576472|458851337|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
127515975|NCT00576472|458851338|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
127515976|NCT00576472|458851339|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
127515977|NCT00576472|458851325|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
127515978|NCT00576472|458851326|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
127515979|NCT00576472|458851327|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
127515980|NCT00576472|458851328|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
127515981|NCT00576472|458851329|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
127515982|NCT00576472|458851330|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
127515983|NCT00576472|458851331|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
127515984|NCT00576472|458851332|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
127515985|NCT00576472|458851333|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
127515986|NCT00576472|458851334|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
127515987|NCT00576472|458851335|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
127515988|NCT00576472|458851336|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
127515989|NCT00576472|458851337|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
127515990|NCT00576472|458851338|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
127515991|NCT00576472|458851339|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
127515992|NCT00576472|458851325|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
127515993|NCT00576472|458851326|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
127515994|NCT00576472|458851327|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
127515995|NCT00576472|458851328|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
127515996|NCT00576472|458851329|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
127515997|NCT00576472|458851330|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
127515998|NCT00576472|458851331|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
127515999|NCT00576472|458851332|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
127516000|NCT00576472|458851333|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
127516001|NCT00576472|458851334|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
127516002|NCT00576472|458851335|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
127516003|NCT00576472|458851336|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
127516004|NCT00576472|458851337|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
127516005|NCT00576472|458851338|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
127516006|NCT00576472|458851339|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
127516007|NCT00576472|458851325|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
127516008|NCT00576472|458851326|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
127516009|NCT00576472|458851327|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
127516010|NCT00576472|458851328|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
127516011|NCT00576472|458851329|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
127516012|NCT00576472|458851330|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
127516013|NCT00576472|458851331|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
127516014|NCT00576472|458851332|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
127516015|NCT00576472|458851333|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
127516016|NCT00576472|458851334|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
127516017|NCT00576472|458851335|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
127516018|NCT00576472|458851336|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
127516019|NCT00576472|458851337|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
127516020|NCT00576472|458851338|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
127516021|NCT00576472|458851339|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
127516022|NCT00576472|458851325|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
127516023|NCT00576472|458851326|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
127516024|NCT00576472|458851327|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
127516025|NCT00576472|458851328|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
127516026|NCT00576472|458851329|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
127516027|NCT00576472|458851330|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
127516028|NCT00576472|458851331|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
127516029|NCT00576472|458851332|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
127516030|NCT00576472|458851333|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
127516031|NCT00576472|458851334|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
127516032|NCT00576472|458851335|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
127516033|NCT00576472|458851336|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
127516034|NCT00576472|458851337|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
127516035|NCT00576472|458851338|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
127516036|NCT00576472|458851339|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
127516037|NCT00576472|458851325|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
127516038|NCT00576472|458851326|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
127516039|NCT00576472|458851327|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
127516040|NCT00576472|458851328|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
127516041|NCT00576472|458851329|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
127516042|NCT00576472|458851330|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
127516043|NCT00576472|458851331|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
127516044|NCT00576472|458851332|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
127516045|NCT00576472|458851333|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
127516046|NCT00576472|458851334|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
127516047|NCT00576472|458851335|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
127516048|NCT00576472|458851336|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
127516049|NCT00576472|458851337|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
127516050|NCT00576472|458851338|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
127516051|NCT00576472|458851339|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
127516052|NCT00576472|458851325|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
127516053|NCT00576472|458851326|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
127516054|NCT00576472|458851327|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
127516055|NCT00576472|458851328|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
127516056|NCT00576472|458851329|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
127516057|NCT00576472|458851330|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
127516058|NCT00576472|458851331|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
127516059|NCT00576472|458851332|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
127516060|NCT00576472|458851333|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
127516061|NCT00576472|458851334|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
127516062|NCT00576472|458851335|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
127516063|NCT00576472|458851336|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
127516064|NCT00576472|458851337|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
127516065|NCT00576472|458851338|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
127516066|NCT00576472|458851339|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
127516067|NCT00576472|458851325|FG000|MPH Cross Over Phase|Physician Decision|0|||
127516068|NCT00576472|458851326|FG001|MPH Cross Over Phase|Physician Decision|0|||
127516069|NCT00576472|458851327|FG002|MPH Cross Over Phase|Physician Decision|0|||
127516070|NCT00576472|458851328|FG003|MPH Cross Over Phase|Physician Decision|0|||
127516071|NCT00576472|458851329|FG004|MPH Cross Over Phase|Physician Decision|0|||
127516072|NCT00576472|458851330|FG005|MPH Cross Over Phase|Physician Decision|0|||
127516073|NCT00576472|458851331|FG006|MPH Cross Over Phase|Physician Decision|4|||
127516074|NCT00576472|458851332|FG007|MPH Cross Over Phase|Physician Decision|0|||
127516075|NCT00576472|458851333|FG008|MPH Cross Over Phase|Physician Decision|0|||
127516076|NCT00576472|458851334|FG009|MPH Cross Over Phase|Physician Decision|0|||
127516077|NCT00576472|458851335|FG010|MPH Cross Over Phase|Physician Decision|0|||
127516078|NCT00576472|458851336|FG011|MPH Cross Over Phase|Physician Decision|0|||
127516079|NCT00576472|458851337|FG012|MPH Cross Over Phase|Physician Decision|0|||
127516080|NCT00576472|458851338|FG013|MPH Cross Over Phase|Physician Decision|0|||
127516081|NCT00576472|458851339|FG014|MPH Cross Over Phase|Physician Decision|0|||
127516082|NCT00576472|458851325|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
127516083|NCT00576472|458851326|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
127516084|NCT00576472|458851327|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
127516085|NCT00576472|458851328|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
127516086|NCT00576472|458851329|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
127516087|NCT00576472|458851330|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
127516088|NCT00576472|458851331|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
127516089|NCT00576472|458851332|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
127516090|NCT00576472|458851333|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
127516091|NCT00576472|458851334|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
127516092|NCT00576472|458851335|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
127516093|NCT00576472|458851336|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
127516094|NCT00576472|458851337|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
127516095|NCT00576472|458851338|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
127516096|NCT00576472|458851339|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
127516097|NCT00576472|458851325|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
127516098|NCT00576472|458851326|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
127516099|NCT00576472|458851327|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
127516100|NCT00576472|458851328|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
127516101|NCT00576472|458851329|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
127516102|NCT00576472|458851330|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
127516103|NCT00576472|458851331|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
127516104|NCT00576472|458851332|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
127516105|NCT00576472|458851333|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
127516106|NCT00576472|458851334|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
127516107|NCT00576472|458851335|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
127516108|NCT00576472|458851336|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
127516109|NCT00576472|458851337|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
127516110|NCT00576472|458851338|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
127516111|NCT00576472|458851339|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
127516112|NCT00576472|458851325|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
127516113|NCT00576472|458851326|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
127516114|NCT00576472|458851327|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
127516115|NCT00576472|458851328|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
127516116|NCT00576472|458851329|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
127516117|NCT00576472|458851330|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
127516118|NCT00576472|458851331|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
127516119|NCT00576472|458851332|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
127516120|NCT00576472|458851333|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
127516121|NCT00576472|458851334|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
127516122|NCT00576472|458851335|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
127516123|NCT00576472|458851336|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
127516124|NCT00576472|458851337|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
127516125|NCT00576472|458851338|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
127516126|NCT00576472|458851339|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
127516127|NCT00576472|458851325|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
127516128|NCT00576472|458851326|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
127516129|NCT00576472|458851327|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
127516130|NCT00576472|458851328|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
127516131|NCT00576472|458851329|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
127516132|NCT00576472|458851330|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
127516133|NCT00576472|458851331|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
127516134|NCT00576472|458851332|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
127516135|NCT00576472|458851333|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
127516136|NCT00576472|458851334|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
127516137|NCT00576472|458851335|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
127516138|NCT00576472|458851336|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
127516139|NCT00576472|458851337|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
127516140|NCT00576472|458851338|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
127516141|NCT00576472|458851339|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
127516142|NCT00576472|458851325|FG000|MPH Home Maintenance Phase|Side effects|0|||
127516143|NCT00576472|458851326|FG001|MPH Home Maintenance Phase|Side effects|0|||
127516144|NCT00576472|458851327|FG002|MPH Home Maintenance Phase|Side effects|0|||
127516145|NCT00576472|458851328|FG003|MPH Home Maintenance Phase|Side effects|0|||
127516146|NCT00576472|458851329|FG004|MPH Home Maintenance Phase|Side effects|0|||
127516147|NCT00576472|458851330|FG005|MPH Home Maintenance Phase|Side effects|0|||
127516148|NCT00576472|458851331|FG006|MPH Home Maintenance Phase|Side effects|0|||
127516149|NCT00576472|458851332|FG007|MPH Home Maintenance Phase|Side effects|0|||
127516150|NCT00576472|458851333|FG008|MPH Home Maintenance Phase|Side effects|0|||
127516151|NCT00576472|458851334|FG009|MPH Home Maintenance Phase|Side effects|0|||
127516152|NCT00576472|458851335|FG010|MPH Home Maintenance Phase|Side effects|0|||
127516153|NCT00576472|458851336|FG011|MPH Home Maintenance Phase|Side effects|0|||
127516154|NCT00576472|458851337|FG012|MPH Home Maintenance Phase|Side effects|0|||
127516155|NCT00576472|458851338|FG013|MPH Home Maintenance Phase|Side effects|0|||
127516156|NCT00576472|458851339|FG014|MPH Home Maintenance Phase|Side effects|8|||
127516157|NCT00576472|458851325|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
127516158|NCT00576472|458851326|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
127516159|NCT00576472|458851327|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
127516160|NCT00576472|458851328|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
127516161|NCT00576472|458851329|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
127516162|NCT00576472|458851330|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
127516163|NCT00576472|458851331|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
127516164|NCT00576472|458851332|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
127516165|NCT00576472|458851333|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
127516166|NCT00576472|458851334|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
127516167|NCT00576472|458851335|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
127516168|NCT00576472|458851336|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
127516169|NCT00576472|458851337|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
127516170|NCT00576472|458851338|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
127516171|NCT00576472|458851339|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
127516172|NCT00576472|458851325|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
127516173|NCT00576472|458851326|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
127516174|NCT00576472|458851327|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
127516175|NCT00576472|458851328|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
127516176|NCT00576472|458851329|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
127516177|NCT00576472|458851330|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
127516178|NCT00576472|458851331|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
127516179|NCT00576472|458851332|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
127516180|NCT00576472|458851333|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
127516181|NCT00576472|458851334|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
127516182|NCT00576472|458851335|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
127516183|NCT00576472|458851336|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
127516184|NCT00576472|458851337|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
127516185|NCT00576472|458851338|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
127516186|NCT00576472|458851339|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
127516187|NCT00576472|458851325|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
127516188|NCT00576472|458851326|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
127516189|NCT00576472|458851327|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
127516190|NCT00576472|458851328|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
127516191|NCT00576472|458851329|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
127516192|NCT00576472|458851330|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
127516193|NCT00576472|458851331|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
127516194|NCT00576472|458851332|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
127516195|NCT00576472|458851333|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
127516196|NCT00576472|458851334|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
127516197|NCT00576472|458851335|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
127516198|NCT00576472|458851336|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
127516199|NCT00576472|458851337|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
127516200|NCT00576472|458851338|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
127516201|NCT00576472|458851339|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
127516202|NCT03691779|458851359|FG000|Part B (24 Weeks)|Adverse Event|0|||
127516203|NCT03691779|458851360|FG001|Part B (24 Weeks)|Adverse Event|1|||
127516204|NCT03691779|458851359|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
127516205|NCT03691779|458851360|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
127516206|NCT00267150|458851361|FG000|Overall Study|Adverse Event|1|||
127516207|NCT01561963|458851362|FG000|Overall Study|Adverse Event|1|||
127516208|NCT03134183|458851365|FG000|Overall Study|Withdrawal by Subject|1|||
127516209|NCT03134183|458851366|FG001|Overall Study|Withdrawal by Subject|1|||
127516210|NCT02299076|458851367|FG000|Overall Study|Fraudulent Entries|20|||
127516211|NCT02299076|458851368|FG001|Overall Study|Fraudulent Entries|14|||
127516212|NCT00162266|458851369|FG000|Double-Blind Period|Adverse Event|5|||
127516213|NCT00162266|458851370|FG001|Double-Blind Period|Adverse Event|9|||
127516214|NCT00162266|458851371|FG002|Double-Blind Period|Adverse Event|11|||
127516215|NCT00162266|458851372|FG003|Double-Blind Period|Adverse Event|0|||
127516216|NCT00162266|458851369|FG000|Double-Blind Period|Death|0|||
127516217|NCT00162266|458851370|FG001|Double-Blind Period|Death|1|||
127516218|NCT00162266|458851371|FG002|Double-Blind Period|Death|0|||
127516219|NCT00162266|458851372|FG003|Double-Blind Period|Death|0|||
127516220|NCT00162266|458851369|FG000|Double-Blind Period|Lost to Follow-up|1|||
127516221|NCT00162266|458851370|FG001|Double-Blind Period|Lost to Follow-up|2|||
127516222|NCT00162266|458851371|FG002|Double-Blind Period|Lost to Follow-up|0|||
127516223|NCT00162266|458851372|FG003|Double-Blind Period|Lost to Follow-up|0|||
127516224|NCT00162266|458851369|FG000|Double-Blind Period|Other Reason|1|||
127516225|NCT00162266|458851370|FG001|Double-Blind Period|Other Reason|0|||
127516226|NCT00162266|458851371|FG002|Double-Blind Period|Other Reason|1|||
127516227|NCT00162266|458851372|FG003|Double-Blind Period|Other Reason|0|||
127516228|NCT00162266|458851369|FG000|Double-Blind Period|Lack of Efficacy|13|||
127516229|NCT00162266|458851370|FG001|Double-Blind Period|Lack of Efficacy|17|||
127516230|NCT00162266|458851371|FG002|Double-Blind Period|Lack of Efficacy|30|||
127516231|NCT00162266|458851372|FG003|Double-Blind Period|Lack of Efficacy|0|||
127516232|NCT00162266|458851369|FG000|Double-Blind Period|Withdrawal by Subject|5|||
127516233|NCT00162266|458851370|FG001|Double-Blind Period|Withdrawal by Subject|2|||
127516234|NCT00162266|458851371|FG002|Double-Blind Period|Withdrawal by Subject|6|||
127516235|NCT00162266|458851372|FG003|Double-Blind Period|Withdrawal by Subject|0|||
127516236|NCT00162266|458851369|FG000|Open-Label Period|Death|0|||
127516237|NCT00162266|458851370|FG001|Open-Label Period|Death|0|||
127516238|NCT00162266|458851371|FG002|Open-Label Period|Death|0|||
127516239|NCT00162266|458851372|FG003|Open-Label Period|Death|7|||
127516240|NCT00162266|458851369|FG000|Open-Label Period|Adverse Event|0|||
127516241|NCT00162266|458851370|FG001|Open-Label Period|Adverse Event|0|||
127516242|NCT00162266|458851371|FG002|Open-Label Period|Adverse Event|0|||
127516243|NCT00162266|458851372|FG003|Open-Label Period|Adverse Event|46|||
127516244|NCT00162266|458851369|FG000|Open-Label Period|Lack of Efficacy|0|||
127516245|NCT00162266|458851370|FG001|Open-Label Period|Lack of Efficacy|0|||
127516246|NCT00162266|458851371|FG002|Open-Label Period|Lack of Efficacy|0|||
127516247|NCT00162266|458851372|FG003|Open-Label Period|Lack of Efficacy|26|||
127516248|NCT00162266|458851369|FG000|Open-Label Period|Lost to Follow-up|0|||
127516249|NCT00162266|458851370|FG001|Open-Label Period|Lost to Follow-up|0|||
127516250|NCT00162266|458851371|FG002|Open-Label Period|Lost to Follow-up|0|||
127516251|NCT00162266|458851372|FG003|Open-Label Period|Lost to Follow-up|3|||
127516252|NCT00162266|458851369|FG000|Open-Label Period|Withdrawal by Subject|0|||
127516253|NCT00162266|458851370|FG001|Open-Label Period|Withdrawal by Subject|0|||
127516254|NCT00162266|458851371|FG002|Open-Label Period|Withdrawal by Subject|0|||
127516255|NCT00162266|458851372|FG003|Open-Label Period|Withdrawal by Subject|31|||
127516256|NCT00162266|458851369|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
127516257|NCT00162266|458851370|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
127516258|NCT00162266|458851371|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
127516259|NCT00162266|458851372|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
127516260|NCT00162266|458851369|FG000|Open-Label Period|Other Reasons|0|||
127516261|NCT00162266|458851370|FG001|Open-Label Period|Other Reasons|0|||
127516262|NCT00162266|458851371|FG002|Open-Label Period|Other Reasons|0|||
127516263|NCT00162266|458851372|FG003|Open-Label Period|Other Reasons|15|||
127516264|NCT04208087|458851373|FG000|Overall Study|Adverse Event|1|||
127516265|NCT04208087|458851374|FG001|Overall Study|Adverse Event|0|||
127516266|NCT04208087|458851375|FG002|Overall Study|Adverse Event|0|||
127516267|NCT04208087|458851376|FG003|Overall Study|Adverse Event|0|||
127516268|NCT04208087|458851377|FG004|Overall Study|Adverse Event|0|||
127516269|NCT04208087|458851373|FG000|Overall Study|Withdrawal by Subject|0|||
127516270|NCT04208087|458851374|FG001|Overall Study|Withdrawal by Subject|0|||
127516271|NCT04208087|458851375|FG002|Overall Study|Withdrawal by Subject|1|||
127516272|NCT04208087|458851376|FG003|Overall Study|Withdrawal by Subject|0|||
127516273|NCT04208087|458851377|FG004|Overall Study|Withdrawal by Subject|0|||
127516274|NCT04208087|458851373|FG000|Overall Study|Other|0|||
127516275|NCT04208087|458851374|FG001|Overall Study|Other|0|||
127516276|NCT04208087|458851375|FG002|Overall Study|Other|0|||
127516277|NCT04208087|458851376|FG003|Overall Study|Other|0|||
127516278|NCT04208087|458851377|FG004|Overall Study|Other|1|||
127516279|NCT02117349|458851379|FG000|Overall Study|Withdrawal by Subject|1|||
127516280|NCT02117349|458851380|FG001|Overall Study|Withdrawal by Subject|0|||
127516281|NCT02117349|458851379|FG000|Overall Study|Lost to Follow-up|1|||
127516282|NCT02117349|458851380|FG001|Overall Study|Lost to Follow-up|1|||
127516283|NCT02117349|458851379|FG000|Overall Study|Death|1|||
127516284|NCT02117349|458851380|FG001|Overall Study|Death|0|||
127516285|NCT00495755|458851381|FG000|Overall Study|Adverse Event|3|||
127516286|NCT01012323|458851382|FG000|Overall Study|Investigator Judgment|1|||
127516287|NCT02265796|458851383|FG000|Overall Study|Death|1|||
127516288|NCT02265796|458851384|FG001|Overall Study|Death|0|||
127516289|NCT02265796|458851383|FG000|Overall Study|started on excluded medication|1|||
127516290|NCT02265796|458851384|FG001|Overall Study|started on excluded medication|0|||
127516291|NCT02265796|458851383|FG000|Overall Study|Withdrawal by Subject|1|||
127516292|NCT02265796|458851384|FG001|Overall Study|Withdrawal by Subject|1|||
127516293|NCT02477553|458851385|FG000|Overall Study|Screening up-to-date|12|||
127516294|NCT02477553|458851386|FG001|Overall Study|Screening up-to-date|13|||
127516295|NCT02477553|458851385|FG000|Overall Study|No MD visit|1|||
127516296|NCT02477553|458851386|FG001|Overall Study|No MD visit|1|||
127516297|NCT02477553|458851385|FG000|Overall Study|Workup consistent w/CRC|1|||
127516298|NCT02477553|458851386|FG001|Overall Study|Workup consistent w/CRC|1|||
127516299|NCT02477553|458851385|FG000|Overall Study|Technical issues with intervention|2|||
127516300|NCT02477553|458851386|FG001|Overall Study|Technical issues with intervention|0|||
127516301|NCT02477553|458851385|FG000|Overall Study|Elevated risk for CRC|2|||
127516302|NCT02477553|458851386|FG001|Overall Study|Elevated risk for CRC|2|||
127516303|NCT02477553|458851385|FG000|Overall Study|MD advised against screening|1|||
127516304|NCT02477553|458851386|FG001|Overall Study|MD advised against screening|3|||
127516305|NCT02477553|458851385|FG000|Overall Study|patient deceased|1|||
127516306|NCT02477553|458851386|FG001|Overall Study|patient deceased|0|||
127516307|NCT04023682|458851387|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
127516308|NCT02963701|458851389|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
127516309|NCT02963701|458851390|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
127516310|NCT00637572|458851393|FG000|Overall Study|Adverse Event|1|||
127516311|NCT00637572|458851394|FG001|Overall Study|Adverse Event|2|||
127516312|NCT00637572|458851393|FG000|Overall Study|Death|0|||
127516313|NCT00637572|458851394|FG001|Overall Study|Death|1|||
127516314|NCT00637572|458851393|FG000|Overall Study|Lost to Follow-up|0|||
127516315|NCT00637572|458851394|FG001|Overall Study|Lost to Follow-up|1|||
127516316|NCT00637572|458851393|FG000|Overall Study|Physician Decision|1|||
127516317|NCT00637572|458851394|FG001|Overall Study|Physician Decision|1|||
127516318|NCT00637572|458851393|FG000|Overall Study|Withdrawal by Subject|0|||
127516319|NCT00637572|458851394|FG001|Overall Study|Withdrawal by Subject|2|||
127516320|NCT00637572|458851393|FG000|Overall Study|Illicit Drug Use|1|||
127516321|NCT00637572|458851394|FG001|Overall Study|Illicit Drug Use|0|||
127516322|NCT00896649|458851395|FG000|Overall Study|Physician Decision|1|||
127516323|NCT00896649|458851395|FG000|Overall Study|Pregnancy|1|||
127516324|NCT00896649|458851395|FG000|Overall Study|missing documentation|1|||
127516325|NCT00896649|458851395|FG000|Overall Study|technical difficulties|2|||
127516326|NCT03652675|458851398|FG000|Overall Study|Lost to Follow-up|4|||
127516327|NCT03652675|458851399|FG001|Overall Study|Lost to Follow-up|4|||
127516328|NCT01638559|458851400|FG000|Overall Study|Lost to Follow-up|1|||
127516329|NCT01638559|458851400|FG000|Overall Study|Withdrawal by Subject|1|||
127516330|NCT01638559|458851400|FG000|Overall Study|Subject declined to travel for biopsy|1|||
127516331|NCT00483002|458851403|FG000|Overall Study|Adverse Event|68|||
127516332|NCT00483002|458851403|FG000|Overall Study|Lack of Efficacy|555|||
127516333|NCT00483002|458851403|FG000|Overall Study|Lost to Follow-up|962|||
127516334|NCT00483002|458851403|FG000|Overall Study|Other|2|||
127516335|NCT00483002|458851403|FG000|Overall Study|Other|967|||
127516336|NCT03442296|458851409|FG000|3 Month Follow-up|Death|3|||
127516337|NCT03442296|458851410|FG001|3 Month Follow-up|Death|1|||
127516338|NCT03442296|458851409|FG000|3 Month Follow-up|Lost to Follow-up|1|||
127516339|NCT03442296|458851410|FG001|3 Month Follow-up|Lost to Follow-up|1|||
127516340|NCT03442296|458851409|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
127516341|NCT03442296|458851410|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
127516342|NCT03442296|458851409|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
127516343|NCT03442296|458851410|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
127516344|NCT03442296|458851409|FG000|12 Month Follow-up|Incomplete measurement|1|||
127516345|NCT03442296|458851410|FG001|12 Month Follow-up|Incomplete measurement|1|||
127516346|NCT01895309|458851411|FG000|Overall Study|Adverse Event|13|||
127516347|NCT01895309|458851412|FG001|Overall Study|Adverse Event|17|||
127516348|NCT01895309|458851411|FG000|Overall Study|Protocol Violation|1|||
127516349|NCT01895309|458851412|FG001|Overall Study|Protocol Violation|0|||
127516350|NCT01895309|458851411|FG000|Overall Study|Lack of Efficacy|1|||
127516351|NCT01895309|458851412|FG001|Overall Study|Lack of Efficacy|3|||
127516352|NCT01895309|458851411|FG000|Overall Study|Lost to Follow-up|1|||
127516353|NCT01895309|458851412|FG001|Overall Study|Lost to Follow-up|3|||
127516354|NCT01895309|458851411|FG000|Overall Study|Physician Decision|15|||
127516355|NCT01895309|458851412|FG001|Overall Study|Physician Decision|10|||
127516356|NCT01895309|458851411|FG000|Overall Study|Withdrawal by Subject|9|||
127516357|NCT01895309|458851412|FG001|Overall Study|Withdrawal by Subject|18|||
127516358|NCT04268745|458851413|FG000|Overall Study|Lost to Follow-up|2|||
127516359|NCT04268745|458851414|FG001|Overall Study|Lost to Follow-up|3|||
127516360|NCT04268745|458851413|FG000|Overall Study|Withdrawal by Subject|4|||
127516361|NCT04268745|458851414|FG001|Overall Study|Withdrawal by Subject|2|||
127516362|NCT04268745|458851413|FG000|Overall Study|Death in the family|1|||
127516363|NCT04268745|458851414|FG001|Overall Study|Death in the family|0|||
127516364|NCT01286077|458853120|FG000|Overall Study|Adverse Event|2|||
127516365|NCT01286077|458853121|FG001|Overall Study|Adverse Event|0|||
127516366|NCT01286077|458853120|FG000|Overall Study|Death|1|||
127516367|NCT01286077|458853121|FG001|Overall Study|Death|0|||
127516368|NCT01286077|458853120|FG000|Overall Study|Protocol Violation|1|||
127516369|NCT01286077|458853121|FG001|Overall Study|Protocol Violation|1|||
127516370|NCT01286077|458853120|FG000|Overall Study|Withdrawal by Subject|0|||
127516371|NCT01286077|458853121|FG001|Overall Study|Withdrawal by Subject|2|||
127516372|NCT01286077|458853120|FG000|Overall Study|Intercurrent illness|1|||
127516373|NCT01286077|458853121|FG001|Overall Study|Intercurrent illness|0|||
127516374|NCT01286077|458853120|FG000|Overall Study|Non-compliance|1|||
127516375|NCT01286077|458853121|FG001|Overall Study|Non-compliance|0|||
127516376|NCT01286077|458853120|FG000|Overall Study|The subject starts with alternative MMY|0|||
127516377|NCT01286077|458853121|FG001|Overall Study|The subject starts with alternative MMY|3|||
127516378|NCT01286077|458853120|FG000|Overall Study|Patient's decision to stop treatment|3|||
127516379|NCT01286077|458853121|FG001|Overall Study|Patient's decision to stop treatment|0|||
127516380|NCT01286077|458853120|FG000|Overall Study|Progression of disease|0|||
127516381|NCT01286077|458853121|FG001|Overall Study|Progression of disease|1|||
127516382|NCT01286077|458853120|FG000|Overall Study|refill medication not received in time|1|||
127516383|NCT01286077|458853121|FG001|Overall Study|refill medication not received in time|0|||
127516384|NCT03344172|458853122|FG000|Overall Study|Received <1 dose of treatment|1|||
127516385|NCT03344172|458853123|FG001|Overall Study|Received <1 dose of treatment|0|||
127516386|NCT01646203|458853124|FG000|Overall Study|Adverse Event|2|||
127516387|NCT01646203|458853125|FG001|Overall Study|Adverse Event|0|||
127516388|NCT01646203|458853126|FG002|Overall Study|Adverse Event|1|||
127516389|NCT01646203|458853124|FG000|Overall Study|Withdrawal by Subject|0|||
127516390|NCT01646203|458853125|FG001|Overall Study|Withdrawal by Subject|1|||
127516391|NCT01646203|458853126|FG002|Overall Study|Withdrawal by Subject|0|||
127516392|NCT01646203|458853124|FG000|Overall Study|Physician's Decision|0|||
127516393|NCT01646203|458853125|FG001|Overall Study|Physician's Decision|1|||
127516394|NCT01646203|458853126|FG002|Overall Study|Physician's Decision|0|||
127516395|NCT03242252|458853128|FG000|Overall Study|At the Participant's own Request|18|||
127516396|NCT03242252|458853129|FG001|Overall Study|At the Participant's own Request|10|||
127516397|NCT03242252|458853130|FG002|Overall Study|At the Participant's own Request|15|||
127516398|NCT03242252|458853128|FG000|Overall Study|Adverse Event|8|||
127516399|NCT03242252|458853129|FG001|Overall Study|Adverse Event|6|||
127516400|NCT03242252|458853130|FG002|Overall Study|Adverse Event|9|||
127516401|NCT03242252|458853128|FG000|Overall Study|Poor Compliance to Protocol|0|||
127516402|NCT03242252|458853129|FG001|Overall Study|Poor Compliance to Protocol|2|||
127516403|NCT03242252|458853130|FG002|Overall Study|Poor Compliance to Protocol|3|||
127516404|NCT03242252|458853128|FG000|Overall Study|Study Terminated by Sponsor|1|||
127516405|NCT03242252|458853129|FG001|Overall Study|Study Terminated by Sponsor|0|||
127516406|NCT03242252|458853130|FG002|Overall Study|Study Terminated by Sponsor|0|||
127516407|NCT03242252|458853128|FG000|Overall Study|Reason not Specified|4|||
127516408|NCT03242252|458853129|FG001|Overall Study|Reason not Specified|4|||
127516409|NCT03242252|458853130|FG002|Overall Study|Reason not Specified|1|||
127516410|NCT03242252|458853128|FG000|Overall Study|Lost to Follow-up|5|||
127516411|NCT03242252|458853129|FG001|Overall Study|Lost to Follow-up|1|||
127516412|NCT03242252|458853130|FG002|Overall Study|Lost to Follow-up|4|||
127516413|NCT01659255|458853131|FG000|Overall Study|Adverse Event|0|||
127516414|NCT01659255|458853132|FG001|Overall Study|Adverse Event|0|||
127516415|NCT01659255|458853133|FG002|Overall Study|Adverse Event|0|||
127516416|NCT01659255|458853134|FG003|Overall Study|Adverse Event|0|||
127516417|NCT01659255|458853135|FG004|Overall Study|Adverse Event|0|||
127516418|NCT01659255|458853136|FG005|Overall Study|Adverse Event|1|||
127516419|NCT01659255|458853137|FG006|Overall Study|Adverse Event|1|||
127516420|NCT01659255|458853138|FG007|Overall Study|Adverse Event|0|||
127516421|NCT01659255|458853139|FG008|Overall Study|Adverse Event|0|||
127516422|NCT01659255|458853140|FG009|Overall Study|Adverse Event|1|||
127516423|NCT01659255|458853141|FG010|Overall Study|Adverse Event|0|||
127516424|NCT01659255|458853142|FG011|Overall Study|Adverse Event|1|||
127516425|NCT01659255|458853143|FG012|Overall Study|Adverse Event|0|||
127516426|NCT01659255|458853144|FG013|Overall Study|Adverse Event|2|||
127516427|NCT01659255|458853145|FG014|Overall Study|Adverse Event|0|||
127516428|NCT01659255|458853146|FG015|Overall Study|Adverse Event|1|||
127516429|NCT01659255|458853147|FG016|Overall Study|Adverse Event|0|||
127516430|NCT01659255|458853131|FG000|Overall Study|Death|0|||
127516431|NCT01659255|458853132|FG001|Overall Study|Death|1|||
127516432|NCT01659255|458853133|FG002|Overall Study|Death|0|||
127516433|NCT01659255|458853134|FG003|Overall Study|Death|0|||
127516434|NCT01659255|458853135|FG004|Overall Study|Death|0|||
127516435|NCT01659255|458853136|FG005|Overall Study|Death|0|||
127516436|NCT01659255|458853137|FG006|Overall Study|Death|0|||
127516437|NCT01659255|458853138|FG007|Overall Study|Death|1|||
127516438|NCT01659255|458853139|FG008|Overall Study|Death|1|||
127516439|NCT01659255|458853140|FG009|Overall Study|Death|0|||
127516440|NCT01659255|458853141|FG010|Overall Study|Death|0|||
127516441|NCT01659255|458853142|FG011|Overall Study|Death|0|||
127516442|NCT01659255|458853143|FG012|Overall Study|Death|1|||
127516443|NCT01659255|458853144|FG013|Overall Study|Death|1|||
127516444|NCT01659255|458853145|FG014|Overall Study|Death|2|||
127516445|NCT01659255|458853146|FG015|Overall Study|Death|1|||
127516446|NCT01659255|458853147|FG016|Overall Study|Death|0|||
127516447|NCT01659255|458853131|FG000|Overall Study|Progressive Disease|2|||
127516448|NCT01659255|458853132|FG001|Overall Study|Progressive Disease|0|||
127516449|NCT01659255|458853133|FG002|Overall Study|Progressive Disease|0|||
127516450|NCT01659255|458853134|FG003|Overall Study|Progressive Disease|0|||
127516451|NCT01659255|458853135|FG004|Overall Study|Progressive Disease|0|||
127516452|NCT01659255|458853136|FG005|Overall Study|Progressive Disease|0|||
127516453|NCT01659255|458853137|FG006|Overall Study|Progressive Disease|0|||
127516454|NCT01659255|458853138|FG007|Overall Study|Progressive Disease|1|||
127516455|NCT01659255|458853139|FG008|Overall Study|Progressive Disease|0|||
127516456|NCT01659255|458853140|FG009|Overall Study|Progressive Disease|2|||
127516457|NCT01659255|458853141|FG010|Overall Study|Progressive Disease|2|||
127516458|NCT01659255|458853142|FG011|Overall Study|Progressive Disease|3|||
127516459|NCT01659255|458853143|FG012|Overall Study|Progressive Disease|5|||
127516460|NCT01659255|458853144|FG013|Overall Study|Progressive Disease|13|||
127516461|NCT01659255|458853145|FG014|Overall Study|Progressive Disease|6|||
127516462|NCT01659255|458853146|FG015|Overall Study|Progressive Disease|2|||
127516463|NCT01659255|458853147|FG016|Overall Study|Progressive Disease|3|||
127516464|NCT01659255|458853131|FG000|Overall Study|Withdrew Consent|0|||
127516465|NCT01659255|458853132|FG001|Overall Study|Withdrew Consent|0|||
127516466|NCT01659255|458853133|FG002|Overall Study|Withdrew Consent|0|||
127516467|NCT01659255|458853134|FG003|Overall Study|Withdrew Consent|0|||
127516468|NCT01659255|458853135|FG004|Overall Study|Withdrew Consent|0|||
127516469|NCT01659255|458853136|FG005|Overall Study|Withdrew Consent|0|||
127516470|NCT01659255|458853137|FG006|Overall Study|Withdrew Consent|0|||
127516471|NCT01659255|458853138|FG007|Overall Study|Withdrew Consent|0|||
127516472|NCT01659255|458853139|FG008|Overall Study|Withdrew Consent|0|||
127516473|NCT01659255|458853140|FG009|Overall Study|Withdrew Consent|0|||
127516474|NCT01659255|458853141|FG010|Overall Study|Withdrew Consent|1|||
127516475|NCT01659255|458853142|FG011|Overall Study|Withdrew Consent|0|||
127516476|NCT01659255|458853143|FG012|Overall Study|Withdrew Consent|0|||
127516477|NCT01659255|458853144|FG013|Overall Study|Withdrew Consent|1|||
127516478|NCT01659255|458853145|FG014|Overall Study|Withdrew Consent|0|||
127516479|NCT01659255|458853146|FG015|Overall Study|Withdrew Consent|0|||
127516480|NCT01659255|458853147|FG016|Overall Study|Withdrew Consent|0|||
127516481|NCT01659255|458853131|FG000|Overall Study|Investigator Decision|0|||
127516482|NCT01659255|458853132|FG001|Overall Study|Investigator Decision|0|||
127516483|NCT01659255|458853133|FG002|Overall Study|Investigator Decision|0|||
127516484|NCT01659255|458853134|FG003|Overall Study|Investigator Decision|0|||
127516485|NCT01659255|458853135|FG004|Overall Study|Investigator Decision|0|||
127516486|NCT01659255|458853136|FG005|Overall Study|Investigator Decision|0|||
127516487|NCT01659255|458853137|FG006|Overall Study|Investigator Decision|0|||
127516488|NCT01659255|458853138|FG007|Overall Study|Investigator Decision|0|||
127516489|NCT01659255|458853139|FG008|Overall Study|Investigator Decision|0|||
127516490|NCT01659255|458853140|FG009|Overall Study|Investigator Decision|0|||
127516491|NCT01659255|458853141|FG010|Overall Study|Investigator Decision|0|||
127516492|NCT01659255|458853142|FG011|Overall Study|Investigator Decision|0|||
127516493|NCT01659255|458853143|FG012|Overall Study|Investigator Decision|1|||
127516494|NCT01659255|458853144|FG013|Overall Study|Investigator Decision|1|||
127516495|NCT01659255|458853145|FG014|Overall Study|Investigator Decision|0|||
127516496|NCT01659255|458853146|FG015|Overall Study|Investigator Decision|0|||
127516497|NCT01659255|458853147|FG016|Overall Study|Investigator Decision|0|||
127516498|NCT01659255|458853131|FG000|Overall Study|Sponsor's Decision|0|||
127516499|NCT01659255|458853132|FG001|Overall Study|Sponsor's Decision|0|||
127516500|NCT01659255|458853133|FG002|Overall Study|Sponsor's Decision|0|||
127516501|NCT01659255|458853134|FG003|Overall Study|Sponsor's Decision|0|||
127516502|NCT01659255|458853135|FG004|Overall Study|Sponsor's Decision|0|||
127516503|NCT01659255|458853136|FG005|Overall Study|Sponsor's Decision|0|||
127516504|NCT01659255|458853137|FG006|Overall Study|Sponsor's Decision|1|||
127516505|NCT01659255|458853138|FG007|Overall Study|Sponsor's Decision|0|||
127516506|NCT01659255|458853139|FG008|Overall Study|Sponsor's Decision|0|||
127516507|NCT01659255|458853140|FG009|Overall Study|Sponsor's Decision|0|||
127516508|NCT01659255|458853141|FG010|Overall Study|Sponsor's Decision|0|||
127516509|NCT01659255|458853142|FG011|Overall Study|Sponsor's Decision|0|||
127516510|NCT01659255|458853143|FG012|Overall Study|Sponsor's Decision|0|||
127516511|NCT01659255|458853144|FG013|Overall Study|Sponsor's Decision|0|||
127516512|NCT01659255|458853145|FG014|Overall Study|Sponsor's Decision|0|||
127516513|NCT01659255|458853146|FG015|Overall Study|Sponsor's Decision|0|||
127516514|NCT01659255|458853147|FG016|Overall Study|Sponsor's Decision|0|||
127516515|NCT01659255|458853131|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
127516516|NCT01659255|458853132|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
127516517|NCT01659255|458853133|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
127516518|NCT01659255|458853134|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
127516519|NCT01659255|458853135|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
127516520|NCT01659255|458853136|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
127516521|NCT01659255|458853137|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
127516522|NCT01659255|458853138|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
127516523|NCT01659255|458853139|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
127516524|NCT01659255|458853140|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
127516525|NCT01659255|458853141|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
127516526|NCT01659255|458853142|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
127516527|NCT01659255|458853143|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
127516528|NCT01659255|458853144|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
127516529|NCT01659255|458853145|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
127516530|NCT01659255|458853146|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
127516531|NCT01659255|458853147|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
127516532|NCT01659255|458853131|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
127516533|NCT01659255|458853132|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
127516534|NCT01659255|458853133|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
127516535|NCT01659255|458853134|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
127516536|NCT01659255|458853135|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
127516537|NCT01659255|458853136|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
127516538|NCT01659255|458853137|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
127516539|NCT01659255|458853138|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
127516540|NCT01659255|458853139|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
127516541|NCT01659255|458853140|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
127516542|NCT01659255|458853141|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
127516543|NCT01659255|458853142|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
127516544|NCT01659255|458853143|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
127516545|NCT01659255|458853144|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
127516546|NCT01659255|458853145|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
127516547|NCT01659255|458853146|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
127516548|NCT01659255|458853147|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
127516549|NCT01116427|458853148|FG000|Core Phase|Adverse Event|0|||
127516550|NCT01116427|458853149|FG001|Core Phase|Adverse Event|1|||
127516551|NCT01116427|458853148|FG000|Core Phase|Lost to Follow-up|1|||
127516552|NCT01116427|458853149|FG001|Core Phase|Lost to Follow-up|0|||
127516553|NCT01116427|458853148|FG000|Core Phase|Withdrawal by Subject|3|||
127516554|NCT01116427|458853149|FG001|Core Phase|Withdrawal by Subject|0|||
127516555|NCT01116427|458853148|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
127516556|NCT01116427|458853149|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
127516557|NCT01116427|458853148|FG000|Extension Phase|Adverse Event|1|||
127516558|NCT01116427|458853149|FG001|Extension Phase|Adverse Event|1|||
127516559|NCT01116427|458853148|FG000|Extension Phase|Lost to Follow-up|2|||
127516560|NCT01116427|458853149|FG001|Extension Phase|Lost to Follow-up|0|||
127516561|NCT01116427|458853148|FG000|Extension Phase|Withdrawal by Subject|5|||
127516562|NCT01116427|458853149|FG001|Extension Phase|Withdrawal by Subject|1|||
127516563|NCT01116427|458853148|FG000|Extension Phase|Not using appropriate birth control|1|||
127516564|NCT01116427|458853149|FG001|Extension Phase|Not using appropriate birth control|0|||
127516565|NCT02989805|458853150|FG000|Overall Study|invalid consent|6|||
127516566|NCT02989805|458853151|FG001|Overall Study|invalid consent|4|||
127516567|NCT02648217|458853154|FG000|Overall Study|Adverse Event|0|||
127516568|NCT02648217|458853155|FG001|Overall Study|Adverse Event|1|||
127516569|NCT02648217|458853154|FG000|Overall Study|Lost to Follow-up|1|||
127516570|NCT02648217|458853155|FG001|Overall Study|Lost to Follow-up|1|||
127516571|NCT02648217|458853154|FG000|Overall Study|Withdrawal by Subject|4|||
127516572|NCT02648217|458853155|FG001|Overall Study|Withdrawal by Subject|3|||
127516573|NCT02648217|458853154|FG000|Overall Study|Unclassified|5|||
127516574|NCT02648217|458853155|FG001|Overall Study|Unclassified|0|||
127516575|NCT03316950|458853156|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
127516576|NCT03316950|458853157|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
127516577|NCT03316950|458853158|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
127516578|NCT03316950|458853159|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
127516579|NCT03316950|458853156|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
127516580|NCT03316950|458853157|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
127516581|NCT03316950|458853158|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
127516582|NCT03316950|458853159|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
127516583|NCT03316950|458853156|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
127516584|NCT03316950|458853157|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
127516585|NCT03316950|458853158|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
127516586|NCT03316950|458853159|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
127516587|NCT02392403|458853160|FG000|Overall Study|Adverse Event|1|||
127516588|NCT02392403|458853160|FG000|Overall Study|Death|1|||
127516589|NCT02392403|458853160|FG000|Overall Study|Withdrawal by Subject|1|||
127516590|NCT02335424|458853164|FG000|Overall Study|Withdrawal by Subject|19|||
127516591|NCT02335424|458853164|FG000|Overall Study|Adverse Event|25|||
127516592|NCT02335424|458853164|FG000|Overall Study|Death|273|||
127516593|NCT02335424|458853164|FG000|Overall Study|Lost to Follow-up|3|||
127516594|NCT02335424|458853164|FG000|Overall Study|Physician Decision|13|||
127516595|NCT02335424|458853164|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
127516596|NCT02335424|458853164|FG000|Overall Study|Protocol Violation|1|||
127516597|NCT02335424|458853164|FG000|Overall Study|Screen failure|1|||
127516598|NCT02776033|458853167|FG000|Overall Study|Withdrawal by Subject|0|||
127516599|NCT02776033|458853168|FG001|Overall Study|Withdrawal by Subject|0|||
127516600|NCT02776033|458853169|FG002|Overall Study|Withdrawal by Subject|2|||
127516601|NCT02776033|458853167|FG000|Overall Study|Physician Decision|2|||
127516602|NCT02776033|458853168|FG001|Overall Study|Physician Decision|0|||
127516603|NCT02776033|458853169|FG002|Overall Study|Physician Decision|0|||
127516604|NCT02776033|458853167|FG000|Overall Study|Lost to Follow-up|1|||
127516605|NCT02776033|458853168|FG001|Overall Study|Lost to Follow-up|0|||
127516606|NCT02776033|458853169|FG002|Overall Study|Lost to Follow-up|0|||
127516607|NCT02776033|458853167|FG000|Overall Study|Adverse Event|1|||
127516608|NCT02776033|458853168|FG001|Overall Study|Adverse Event|2|||
127516609|NCT02776033|458853169|FG002|Overall Study|Adverse Event|0|||
127516610|NCT02712424|458853170|FG000|Overall Study|Lost to Follow-up|34|||
127516611|NCT02712424|458853171|FG001|Overall Study|Lost to Follow-up|32|||
127516612|NCT02713867|458853177|FG000|Randomization|Other Reason|2|||
127516613|NCT02713867|458853178|FG001|Randomization|Other Reason|1|||
127516614|NCT02713867|458853177|FG000|Randomization|Participant Withdrew consent|0|||
127516615|NCT02713867|458853178|FG001|Randomization|Participant Withdrew consent|2|||
127516616|NCT02713867|458853177|FG000|Treatment Period|Other Reasons|22|||
127516617|NCT02713867|458853178|FG001|Treatment Period|Other Reasons|28|||
127516618|NCT02713867|458853177|FG000|Treatment Period|Administrative reason by sponsor|21|||
127516619|NCT02713867|458853178|FG001|Treatment Period|Administrative reason by sponsor|16|||
127516620|NCT02713867|458853177|FG000|Treatment Period|No longer meets study criteria|2|||
127516621|NCT02713867|458853178|FG001|Treatment Period|No longer meets study criteria|1|||
127516622|NCT02713867|458853177|FG000|Treatment Period|Poor/Non Compliance|1|||
127516623|NCT02713867|458853178|FG001|Treatment Period|Poor/Non Compliance|0|||
127516624|NCT02713867|458853177|FG000|Treatment Period|Maximum Clinical Benefit|5|||
127516625|NCT02713867|458853178|FG001|Treatment Period|Maximum Clinical Benefit|6|||
127516626|NCT02713867|458853177|FG000|Treatment Period|Withdrew consent|3|||
127516627|NCT02713867|458853178|FG001|Treatment Period|Withdrew consent|6|||
127516628|NCT02713867|458853177|FG000|Treatment Period|Requested to Discontinue|8|||
127516629|NCT02713867|458853178|FG001|Treatment Period|Requested to Discontinue|8|||
127516630|NCT02713867|458853177|FG000|Treatment Period|AE unrelated to Study Drug|11|||
127516631|NCT02713867|458853178|FG001|Treatment Period|AE unrelated to Study Drug|10|||
127516632|NCT02713867|458853177|FG000|Treatment Period|Death|7|||
127516633|NCT02713867|458853178|FG001|Treatment Period|Death|3|||
127516634|NCT02713867|458853177|FG000|Treatment Period|Study Drug Toxicity|16|||
127516635|NCT02713867|458853178|FG001|Treatment Period|Study Drug Toxicity|19|||
127516636|NCT02713867|458853177|FG000|Treatment Period|Disease Progression|82|||
127516637|NCT02713867|458853178|FG001|Treatment Period|Disease Progression|83|||
127516638|NCT02715726|458853182|FG000|Overall Study|Adverse Event|2|||
127516639|NCT02715726|458853183|FG001|Overall Study|Adverse Event|6|||
127516640|NCT02715726|458853182|FG000|Overall Study|Protocol Violation|1|||
127516641|NCT02715726|458853183|FG001|Overall Study|Protocol Violation|0|||
127516642|NCT02715726|458853182|FG000|Overall Study|Death|2|||
127516643|NCT02715726|458853183|FG001|Overall Study|Death|1|||
127516644|NCT02715726|458853182|FG000|Overall Study|Participant moved|1|||
127516645|NCT02715726|458853183|FG001|Overall Study|Participant moved|3|||
127516646|NCT02715726|458853182|FG000|Overall Study|Other than specified above|11|||
127516647|NCT02715726|458853183|FG001|Overall Study|Other than specified above|15|||
127516648|NCT02715726|458853182|FG000|Overall Study|Randomized but not treated|1|||
127516649|NCT02715726|458853183|FG001|Overall Study|Randomized but not treated|2|||
127516650|NCT03230292|458853184|FG000|Overall Study|Adverse Event|1|||
127516651|NCT03230292|458853184|FG000|Overall Study|Protocol Violation|1|||
127516652|NCT03230292|458853184|FG000|Overall Study|Lost to Follow-up|1|||
127516653|NCT03230292|458853184|FG000|Overall Study|Withdrawal by Subject|3|||
127516654|NCT03629912|458853185|FG000|Overall Study|Lost to Follow-up|19|||
127516655|NCT03629912|458853186|FG001|Overall Study|Lost to Follow-up|7|||
127516656|NCT03629912|458853187|FG002|Overall Study|Lost to Follow-up|5|||
127516657|NCT03629912|458853188|FG003|Overall Study|Lost to Follow-up|1|||
127516658|NCT03629912|458853185|FG000|Overall Study|Withdrawal by Subject|6|||
127516659|NCT03629912|458853186|FG001|Overall Study|Withdrawal by Subject|0|||
127516660|NCT03629912|458853187|FG002|Overall Study|Withdrawal by Subject|1|||
127516661|NCT03629912|458853188|FG003|Overall Study|Withdrawal by Subject|2|||
127516662|NCT03629912|458853185|FG000|Overall Study|Illness or Injury Unrelated to Research Study|3|||
127516663|NCT03629912|458853186|FG001|Overall Study|Illness or Injury Unrelated to Research Study|6|||
127516664|NCT03629912|458853187|FG002|Overall Study|Illness or Injury Unrelated to Research Study|3|||
127516665|NCT03629912|458853188|FG003|Overall Study|Illness or Injury Unrelated to Research Study|1|||
127516666|NCT03629912|458853185|FG000|Overall Study|Death|1|||
127516667|NCT03629912|458853186|FG001|Overall Study|Death|0|||
127516668|NCT03629912|458853187|FG002|Overall Study|Death|0|||
127516669|NCT03629912|458853188|FG003|Overall Study|Death|0|||
127516670|NCT04405245|458853189|FG000|Overall Study|Adverse Event|0|||
127516671|NCT04405245|458853190|FG001|Overall Study|Adverse Event|1|||
127516672|NCT04405245|458853191|FG002|Overall Study|Adverse Event|0|||
127516673|NCT02391961|458853192|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
127516674|NCT02391961|458853193|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
127516675|NCT02391961|458853192|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
127516676|NCT02391961|458853193|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
127516677|NCT02391961|458853192|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
127516678|NCT02391961|458853193|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
127516679|NCT00491608|458853197|FG000|Overall Study|Death|2|||
127516680|NCT00491608|458853197|FG000|Overall Study|Withdrawal by Subject|1|||
127516681|NCT04109976|458853198|FG000|Overall Study|Withdrawal by Subject|1|||
127516682|NCT04109976|458853199|FG001|Overall Study|Withdrawal by Subject|0|||
127516683|NCT00413374|458853200|FG000|Overall Study|Ineligible due to screening criteria.|3|||
127516684|NCT00413374|458853201|FG001|Overall Study|Ineligible due to screening criteria.|0|||
127516685|NCT00413374|458853200|FG000|Overall Study|Adverse Event|1|||
127516686|NCT00413374|458853201|FG001|Overall Study|Adverse Event|0|||
127516687|NCT00413374|458853200|FG000|Overall Study|Lost to Follow-up|1|||
127516688|NCT00413374|458853201|FG001|Overall Study|Lost to Follow-up|0|||
127516689|NCT00413374|458853200|FG000|Overall Study|Surgery|1|||
127516690|NCT00413374|458853201|FG001|Overall Study|Surgery|0|||
127516691|NCT00552760|458853202|FG000|Overall Study|Adverse Event|3|||
127516692|NCT00552760|458853203|FG001|Overall Study|Adverse Event|5|||
127516693|NCT00552760|458853202|FG000|Overall Study|Relapsed- Depressed Event|10|||
127516694|NCT00552760|458853203|FG001|Overall Study|Relapsed- Depressed Event|16|||
127516695|NCT00552760|458853202|FG000|Overall Study|Relapse- Manic Event|3|||
127516696|NCT00552760|458853203|FG001|Overall Study|Relapse- Manic Event|3|||
127516697|NCT00552760|458853202|FG000|Overall Study|Relapsed- Mixed Event|3|||
127516698|NCT00552760|458853203|FG001|Overall Study|Relapsed- Mixed Event|5|||
127516699|NCT00552760|458853202|FG000|Overall Study|Protocol Violation|0|||
127516700|NCT00552760|458853203|FG001|Overall Study|Protocol Violation|1|||
127516701|NCT00552760|458853202|FG000|Overall Study|Lost to Follow-up|1|||
127516702|NCT00552760|458853203|FG001|Overall Study|Lost to Follow-up|1|||
127516703|NCT00552760|458853202|FG000|Overall Study|Non-compliance|1|||
127516704|NCT00552760|458853203|FG001|Overall Study|Non-compliance|1|||
127516705|NCT00552760|458853202|FG000|Overall Study|Medical Condition|1|||
127516706|NCT00552760|458853203|FG001|Overall Study|Medical Condition|1|||
127516707|NCT00552760|458853202|FG000|Overall Study|Withdrawal by Subject|3|||
127516708|NCT00552760|458853203|FG001|Overall Study|Withdrawal by Subject|0|||
127516709|NCT00552760|458853202|FG000|Overall Study|Medication Change|1|||
127516710|NCT00552760|458853203|FG001|Overall Study|Medication Change|0|||
127516711|NCT00924404|458853207|FG000|Overall Study|Lost to Follow-up|6|||
127516712|NCT00924404|458853208|FG001|Overall Study|Lost to Follow-up|4|||
127516713|NCT03831945|458853209|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
127516714|NCT03831945|458853210|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
127516715|NCT03831945|458853209|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
127516716|NCT03831945|458853210|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
127516717|NCT03831945|458853209|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
127516718|NCT03831945|458853210|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
127516719|NCT02613169|458853211|FG000|Overall Study|Withdrawal by Subject|4|||
127516720|NCT02613169|458853212|FG001|Overall Study|Withdrawal by Subject|1|||
127516721|NCT02613169|458853211|FG000|Overall Study|Lost to Follow-up|0|||
127516722|NCT02613169|458853212|FG001|Overall Study|Lost to Follow-up|5|||
127516723|NCT02613169|458853211|FG000|Overall Study|HIV|0|||
127516724|NCT02613169|458853212|FG001|Overall Study|HIV|2|||
127516725|NCT02613169|458853211|FG000|Overall Study|No TB infection endpoint|14|||
127516726|NCT02613169|458853212|FG001|Overall Study|No TB infection endpoint|9|||
127516727|NCT00343382|458853213|FG000|Overall Study|Adverse Event|2|||
127516728|NCT00343382|458853214|FG001|Overall Study|Adverse Event|10|||
127516729|NCT00343382|458853215|FG002|Overall Study|Adverse Event|7|||
127516730|NCT00343382|458853213|FG000|Overall Study|Withdrawal by Subject|1|||
127516731|NCT00343382|458853214|FG001|Overall Study|Withdrawal by Subject|2|||
127516732|NCT00343382|458853215|FG002|Overall Study|Withdrawal by Subject|6|||
127516733|NCT00343382|458853213|FG000|Overall Study|Other Reason Not Specified|1|||
127516734|NCT00343382|458853214|FG001|Overall Study|Other Reason Not Specified|2|||
127516735|NCT00343382|458853215|FG002|Overall Study|Other Reason Not Specified|4|||
127516736|NCT00710385|458853221|FG000|Overall Study|Did not qualify|1|||
127516737|NCT00710385|458853221|FG000|Overall Study|Withdrawal by Subject|1|||
127516738|NCT00710385|458853221|FG000|Overall Study|Undisclosed back pain|1|||
127516739|NCT00710385|458853221|FG000|Overall Study|Physician Decision|1|||
127516740|NCT00710385|458853221|FG000|Overall Study|Undisclosed excessive methadone use|1|||
127516741|NCT02976103|458853222|FG000|Overall Study|Withdrawal by Subject|1|||
127516742|NCT02976103|458853223|FG001|Overall Study|Withdrawal by Subject|0|||
127516743|NCT02976103|458853222|FG000|Overall Study|Lost to Follow-up|12|||
127516744|NCT02976103|458853223|FG001|Overall Study|Lost to Follow-up|8|||
127516745|NCT01985360|458853224|FG000|Overall Study|Withdrawal by Subject|4|||
127516746|NCT01985360|458853225|FG001|Overall Study|Withdrawal by Subject|0|||
127516747|NCT01985360|458853224|FG000|Overall Study|Lost to Follow-up|5|||
127516748|NCT01985360|458853225|FG001|Overall Study|Lost to Follow-up|3|||
127516749|NCT02914561|458853226|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
127516750|NCT02914561|458853227|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
127516751|NCT02914561|458853228|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
127516752|NCT02914561|458853229|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
127516753|NCT02914561|458853230|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
127516754|NCT02914561|458853231|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
127516755|NCT02914561|458853232|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
127516756|NCT02914561|458853233|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
127516757|NCT02914561|458853234|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
127516758|NCT02914561|458853235|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
127516759|NCT02914561|458853236|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
127516760|NCT02914561|458853226|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
127516761|NCT02914561|458853227|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
127516762|NCT02914561|458853228|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
127516763|NCT02914561|458853229|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
127516764|NCT02914561|458853230|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
127516765|NCT02914561|458853231|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
127516766|NCT02914561|458853232|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
127516767|NCT02914561|458853233|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
127516768|NCT02914561|458853234|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
127516769|NCT02914561|458853235|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
127516770|NCT02914561|458853236|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
127516771|NCT02914561|458853226|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
127516772|NCT02914561|458853227|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
127516773|NCT02914561|458853228|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
127516774|NCT02914561|458853229|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
127516775|NCT02914561|458853230|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
127516776|NCT02914561|458853231|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
127516777|NCT02914561|458853232|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
127516778|NCT02914561|458853233|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
127516779|NCT02914561|458853234|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
127516780|NCT02914561|458853235|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
127516781|NCT02914561|458853236|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
127516782|NCT02914561|458853226|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
127516783|NCT02914561|458853227|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
127516784|NCT02914561|458853228|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
127516785|NCT02914561|458853229|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
127516786|NCT02914561|458853230|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
127516787|NCT02914561|458853231|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
127516788|NCT02914561|458853232|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
127516789|NCT02914561|458853233|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
127516790|NCT02914561|458853234|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
127516791|NCT02914561|458853235|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
127516792|NCT02914561|458853236|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
127516793|NCT02914561|458853226|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
127516794|NCT02914561|458853227|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
127516795|NCT02914561|458853228|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
127516796|NCT02914561|458853229|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
127516797|NCT02914561|458853230|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
127516798|NCT02914561|458853231|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
127516799|NCT02914561|458853232|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
127516800|NCT02914561|458853233|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
127516801|NCT02914561|458853234|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
127516802|NCT02914561|458853235|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
127516803|NCT02914561|458853236|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
127516804|NCT02914561|458853226|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
127516805|NCT02914561|458853227|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
127516806|NCT02914561|458853228|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
127516807|NCT02914561|458853229|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
127516808|NCT02914561|458853230|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
127516809|NCT02914561|458853231|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
127516810|NCT02914561|458853232|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
127516811|NCT02914561|458853233|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
127516812|NCT02914561|458853234|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
127516813|NCT02914561|458853235|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
127516814|NCT02914561|458853236|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
127516815|NCT02914561|458853226|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
127516816|NCT02914561|458853227|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
127516817|NCT02914561|458853228|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
127516818|NCT02914561|458853229|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
127516819|NCT02914561|458853230|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
127516820|NCT02914561|458853231|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
127516821|NCT02914561|458853232|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
127516822|NCT02914561|458853233|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
127516823|NCT02914561|458853234|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
127516824|NCT02914561|458853235|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
127516825|NCT02914561|458853236|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
127516826|NCT02914561|458853226|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
127516827|NCT02914561|458853227|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
127516828|NCT02914561|458853228|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
127516829|NCT02914561|458853229|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
127516830|NCT02914561|458853230|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
127516831|NCT02914561|458853231|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
127516832|NCT02914561|458853232|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
127516833|NCT02914561|458853233|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
127516834|NCT02914561|458853234|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
127516835|NCT02914561|458853235|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
127516836|NCT02914561|458853236|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
127516837|NCT02914561|458853226|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
127516838|NCT02914561|458853227|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
127516839|NCT02914561|458853228|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
127516840|NCT02914561|458853229|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
127516841|NCT02914561|458853230|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
127516842|NCT02914561|458853231|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
127516843|NCT02914561|458853232|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
127516844|NCT02914561|458853233|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
127516845|NCT02914561|458853234|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
127516846|NCT02914561|458853235|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
127516847|NCT02914561|458853236|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
127516848|NCT02914561|458853226|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
127516849|NCT02914561|458853227|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
127516850|NCT02914561|458853228|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
127516851|NCT02914561|458853229|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
127516852|NCT02914561|458853230|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
127516853|NCT02914561|458853231|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
127516854|NCT02914561|458853232|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
127516855|NCT02914561|458853233|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
127516856|NCT02914561|458853234|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
127516857|NCT02914561|458853235|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
127516858|NCT02914561|458853236|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
127516859|NCT02914561|458853226|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
127516860|NCT02914561|458853227|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
127516861|NCT02914561|458853228|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
127516862|NCT02914561|458853229|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
127516863|NCT02914561|458853230|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
127516864|NCT02914561|458853231|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
127516865|NCT02914561|458853232|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
127516866|NCT02914561|458853233|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
127516867|NCT02914561|458853234|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
127516868|NCT02914561|458853235|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
127516869|NCT02914561|458853236|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
127516870|NCT02914561|458853226|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
127516871|NCT02914561|458853227|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
127516872|NCT02914561|458853228|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
127516873|NCT02914561|458853229|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
127516874|NCT02914561|458853230|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
127516875|NCT02914561|458853231|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
127516876|NCT02914561|458853232|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
127516877|NCT02914561|458853233|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
127516878|NCT02914561|458853234|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
127516879|NCT02914561|458853235|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
127516880|NCT02914561|458853236|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
127516881|NCT02914561|458853226|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
127516882|NCT02914561|458853227|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
127516883|NCT02914561|458853228|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
127516884|NCT02914561|458853229|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
127516885|NCT02914561|458853230|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
127516886|NCT02914561|458853231|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
127516887|NCT02914561|458853232|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
127516888|NCT02914561|458853233|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
127516889|NCT02914561|458853234|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
127516890|NCT02914561|458853235|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
127516891|NCT02914561|458853236|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
127516892|NCT02914561|458853226|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
127516893|NCT02914561|458853227|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
127516894|NCT02914561|458853228|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
127516895|NCT02914561|458853229|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
127516896|NCT02914561|458853230|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
127516897|NCT02914561|458853231|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
127516898|NCT02914561|458853232|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
127516899|NCT02914561|458853233|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
127516900|NCT02914561|458853234|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
127516901|NCT02914561|458853235|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
127516902|NCT02914561|458853236|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
127516903|NCT02914561|458853226|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
127516904|NCT02914561|458853227|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
127516905|NCT02914561|458853228|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
127516906|NCT02914561|458853229|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
127516907|NCT02914561|458853230|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
127516908|NCT02914561|458853231|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
127516909|NCT02914561|458853232|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
127516910|NCT02914561|458853233|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
127516911|NCT02914561|458853234|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
127516912|NCT02914561|458853235|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
127516913|NCT02914561|458853236|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
127516914|NCT02914561|458853226|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
127516915|NCT02914561|458853227|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
127516916|NCT02914561|458853228|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
127516917|NCT02914561|458853229|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
127516918|NCT02914561|458853230|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
127516919|NCT02914561|458853231|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
127516920|NCT02914561|458853232|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
127516921|NCT02914561|458853233|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
127516922|NCT02914561|458853234|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
127516923|NCT02914561|458853235|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
127516924|NCT02914561|458853236|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
127516925|NCT02914561|458853226|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
127516926|NCT02914561|458853227|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
127516927|NCT02914561|458853228|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
127516928|NCT02914561|458853229|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
127516929|NCT02914561|458853230|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
127516930|NCT02914561|458853231|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
127516931|NCT02914561|458853232|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
127516932|NCT02914561|458853233|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
127516933|NCT02914561|458853234|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
127516934|NCT02914561|458853235|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
127516935|NCT02914561|458853236|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
127516936|NCT00521222|458853240|FG000|Overall Study|Lost to Follow-up|0|||
127516937|NCT00521222|458853241|FG001|Overall Study|Lost to Follow-up|0|||
127516938|NCT00521222|458853242|FG002|Overall Study|Lost to Follow-up|1|||
127516939|NCT00521222|458853243|FG003|Overall Study|Lost to Follow-up|1|||
127516940|NCT00521222|458853240|FG000|Overall Study|Withdrawal by Subject|0|||
127516941|NCT00521222|458853241|FG001|Overall Study|Withdrawal by Subject|0|||
127516942|NCT00521222|458853242|FG002|Overall Study|Withdrawal by Subject|2|||
127516943|NCT00521222|458853243|FG003|Overall Study|Withdrawal by Subject|0|||
127516944|NCT00521222|458853240|FG000|Overall Study|Physician Decision|0|||
127516945|NCT00521222|458853241|FG001|Overall Study|Physician Decision|1|||
127516946|NCT00521222|458853242|FG002|Overall Study|Physician Decision|0|||
127516947|NCT00521222|458853243|FG003|Overall Study|Physician Decision|1|||
127516948|NCT03332160|458853246|FG000|Overall Study|Withdrawal by Subject|1|||
127516949|NCT03332160|458853247|FG001|Overall Study|Withdrawal by Subject|1|||
127516950|NCT03332160|458853246|FG000|Overall Study|Adverse Event|0|||
127516951|NCT03332160|458853247|FG001|Overall Study|Adverse Event|1|||
127516952|NCT03332160|458853246|FG000|Overall Study|Developed Exclusion Criteria|0|||
127516953|NCT03332160|458853247|FG001|Overall Study|Developed Exclusion Criteria|1|||
127516954|NCT03332160|458853246|FG000|Overall Study|Non-adherence to treatment|0|||
127516955|NCT03332160|458853247|FG001|Overall Study|Non-adherence to treatment|2|||
127516956|NCT03869333|458853252|FG000|Overall Study|Lost to Follow-up|1|||
127516957|NCT03869333|458853253|FG001|Overall Study|Lost to Follow-up|0|||
127516958|NCT03869333|458853254|FG002|Overall Study|Lost to Follow-up|0|||
127516959|NCT03869333|458853255|FG003|Overall Study|Lost to Follow-up|0|||
127516960|NCT03869333|458853252|FG000|Overall Study|Pregnancy|1|||
127516961|NCT03869333|458853253|FG001|Overall Study|Pregnancy|0|||
127516962|NCT03869333|458853254|FG002|Overall Study|Pregnancy|0|||
127516963|NCT03869333|458853255|FG003|Overall Study|Pregnancy|0|||
127516964|NCT03869333|458853252|FG000|Overall Study|Physician Decision|0|||
127516965|NCT03869333|458853253|FG001|Overall Study|Physician Decision|1|||
127516966|NCT03869333|458853254|FG002|Overall Study|Physician Decision|0|||
127516967|NCT03869333|458853255|FG003|Overall Study|Physician Decision|0|||
127516968|NCT01927055|458853256|FG000|Open-label|Adverse Event|6|||
127516969|NCT01927055|458853257|FG001|Open-label|Adverse Event|0|||
127516970|NCT01927055|458853258|FG002|Open-label|Adverse Event|0|||
127516971|NCT01927055|458853256|FG000|Open-label|Withdrawal by Subject|1|||
127516972|NCT01927055|458853257|FG001|Open-label|Withdrawal by Subject|0|||
127516973|NCT01927055|458853258|FG002|Open-label|Withdrawal by Subject|0|||
127516974|NCT01927055|458853256|FG000|Open-label|Study Stopped|4|||
127516975|NCT01927055|458853257|FG001|Open-label|Study Stopped|0|||
127516976|NCT01927055|458853258|FG002|Open-label|Study Stopped|0|||
127516977|NCT01927055|458853256|FG000|Open-label|Supine Hypertension|4|||
127516978|NCT01927055|458853257|FG001|Open-label|Supine Hypertension|0|||
127516979|NCT01927055|458853258|FG002|Open-label|Supine Hypertension|0|||
127516980|NCT01927055|458853256|FG000|Open-label|Difficulty attending study visits|1|||
127516981|NCT01927055|458853257|FG001|Open-label|Difficulty attending study visits|0|||
127516982|NCT01927055|458853258|FG002|Open-label|Difficulty attending study visits|0|||
127516983|NCT01927055|458853256|FG000|Double-Blind|Adverse Event|0|||
127516984|NCT01927055|458853257|FG001|Double-Blind|Adverse Event|1|||
127516985|NCT01927055|458853258|FG002|Double-Blind|Adverse Event|1|||
127516986|NCT01927055|458853256|FG000|Double-Blind|Protocol Violation|0|||
127516987|NCT01927055|458853257|FG001|Double-Blind|Protocol Violation|0|||
127516988|NCT01927055|458853258|FG002|Double-Blind|Protocol Violation|1|||
127516989|NCT01927055|458853256|FG000|Double-Blind|Withdrawal by Subject|0|||
127516990|NCT01927055|458853257|FG001|Double-Blind|Withdrawal by Subject|2|||
127516991|NCT01927055|458853258|FG002|Double-Blind|Withdrawal by Subject|3|||
127516992|NCT01927055|458853256|FG000|Double-Blind|Study Stopped|0|||
127516993|NCT01927055|458853257|FG001|Double-Blind|Study Stopped|7|||
127516994|NCT01927055|458853258|FG002|Double-Blind|Study Stopped|7|||
127516995|NCT01927055|458853256|FG000|Double-Blind|Supine Hypertension|0|||
127516996|NCT01927055|458853257|FG001|Double-Blind|Supine Hypertension|0|||
127516997|NCT01927055|458853258|FG002|Double-Blind|Supine Hypertension|1|||
127516998|NCT01927055|458853256|FG000|Double-Blind|Extended Vacation|0|||
127516999|NCT01927055|458853257|FG001|Double-Blind|Extended Vacation|1|||
127517000|NCT01927055|458853258|FG002|Double-Blind|Extended Vacation|0|||
127517001|NCT02598128|458853259|FG000|Period A: Days -7 to -1|Adverse Event|1|||
127517002|NCT02598128|458853260|FG001|Period A: Days -7 to -1|Adverse Event|0|||
127517003|NCT02598128|458853261|FG002|Period A: Days -7 to -1|Adverse Event|0|||
127517004|NCT02598128|458853262|FG003|Period A: Days -7 to -1|Adverse Event|0|||
127517005|NCT01459913|458853264|FG000|Overall Study|Adverse Event|0|||
127517006|NCT01459913|458853265|FG001|Overall Study|Adverse Event|0|||
127517007|NCT01459913|458853266|FG002|Overall Study|Adverse Event|0|||
127517008|NCT01459913|458853267|FG003|Overall Study|Adverse Event|3|||
127517009|NCT01459913|458853264|FG000|Overall Study|Withdrawal by Subject|4|||
127517010|NCT01459913|458853265|FG001|Overall Study|Withdrawal by Subject|0|||
127517011|NCT01459913|458853266|FG002|Overall Study|Withdrawal by Subject|0|||
127517012|NCT01459913|458853267|FG003|Overall Study|Withdrawal by Subject|5|||
127517013|NCT01459913|458853264|FG000|Overall Study|Lost to Follow-up|7|||
127517014|NCT01459913|458853265|FG001|Overall Study|Lost to Follow-up|4|||
127517015|NCT01459913|458853266|FG002|Overall Study|Lost to Follow-up|1|||
127517016|NCT01459913|458853267|FG003|Overall Study|Lost to Follow-up|8|||
127517017|NCT01459913|458853264|FG000|Overall Study|Death|0|||
127517018|NCT01459913|458853265|FG001|Overall Study|Death|0|||
127517019|NCT01459913|458853266|FG002|Overall Study|Death|0|||
127517020|NCT01459913|458853267|FG003|Overall Study|Death|1|||
127517021|NCT01459913|458853264|FG000|Overall Study|Non- Compliance|0|||
127517022|NCT01459913|458853265|FG001|Overall Study|Non- Compliance|0|||
127517023|NCT01459913|458853266|FG002|Overall Study|Non- Compliance|0|||
127517024|NCT01459913|458853267|FG003|Overall Study|Non- Compliance|3|||
127517025|NCT01459913|458853264|FG000|Overall Study|Physician Decision|0|||
127517026|NCT01459913|458853265|FG001|Overall Study|Physician Decision|1|||
127517027|NCT01459913|458853266|FG002|Overall Study|Physician Decision|0|||
127517028|NCT01459913|458853267|FG003|Overall Study|Physician Decision|0|||
127517029|NCT01459913|458853264|FG000|Overall Study|Study Terminated by Sponsor|30|||
127517030|NCT01459913|458853265|FG001|Overall Study|Study Terminated by Sponsor|15|||
127517031|NCT01459913|458853266|FG002|Overall Study|Study Terminated by Sponsor|9|||
127517032|NCT01459913|458853267|FG003|Overall Study|Study Terminated by Sponsor|11|||
127517033|NCT01459913|458853264|FG000|Overall Study|Other|0|||
127517034|NCT01459913|458853265|FG001|Overall Study|Other|0|||
127517035|NCT01459913|458853266|FG002|Overall Study|Other|3|||
127517036|NCT01459913|458853267|FG003|Overall Study|Other|1|||
127517037|NCT01459913|458853264|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
127517038|NCT01459913|458853265|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
127517039|NCT01459913|458853266|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
127517040|NCT01459913|458853267|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
127517041|NCT01064687|458853270|FG000|Overall Study|Adverse Event|9|||
127517042|NCT01064687|458853271|FG001|Overall Study|Adverse Event|4|||
127517043|NCT01064687|458853272|FG002|Overall Study|Adverse Event|10|||
127517044|NCT01064687|458853273|FG003|Overall Study|Adverse Event|3|||
127517045|NCT01064687|458853270|FG000|Overall Study|Death|1|||
127517046|NCT01064687|458853271|FG001|Overall Study|Death|1|||
127517047|NCT01064687|458853272|FG002|Overall Study|Death|0|||
127517048|NCT01064687|458853273|FG003|Overall Study|Death|0|||
127517049|NCT01064687|458853270|FG000|Overall Study|Entry Criteria Not Met|3|||
127517050|NCT01064687|458853271|FG001|Overall Study|Entry Criteria Not Met|0|||
127517051|NCT01064687|458853272|FG002|Overall Study|Entry Criteria Not Met|0|||
127517052|NCT01064687|458853273|FG003|Overall Study|Entry Criteria Not Met|0|||
127517053|NCT01064687|458853270|FG000|Overall Study|Lack of Efficacy|1|||
127517054|NCT01064687|458853271|FG001|Overall Study|Lack of Efficacy|0|||
127517055|NCT01064687|458853272|FG002|Overall Study|Lack of Efficacy|2|||
127517056|NCT01064687|458853273|FG003|Overall Study|Lack of Efficacy|3|||
127517057|NCT01064687|458853270|FG000|Overall Study|Lost to Follow-up|7|||
127517058|NCT01064687|458853271|FG001|Overall Study|Lost to Follow-up|10|||
127517059|NCT01064687|458853272|FG002|Overall Study|Lost to Follow-up|13|||
127517060|NCT01064687|458853273|FG003|Overall Study|Lost to Follow-up|5|||
127517061|NCT01064687|458853270|FG000|Overall Study|Physician Decision|2|||
127517062|NCT01064687|458853271|FG001|Overall Study|Physician Decision|2|||
127517063|NCT01064687|458853272|FG002|Overall Study|Physician Decision|0|||
127517064|NCT01064687|458853273|FG003|Overall Study|Physician Decision|0|||
127517065|NCT01064687|458853270|FG000|Overall Study|Protocol Violation|1|||
127517066|NCT01064687|458853271|FG001|Overall Study|Protocol Violation|1|||
127517067|NCT01064687|458853272|FG002|Overall Study|Protocol Violation|0|||
127517068|NCT01064687|458853273|FG003|Overall Study|Protocol Violation|1|||
127517069|NCT01064687|458853270|FG000|Overall Study|Sponsor Decision|0|||
127517070|NCT01064687|458853271|FG001|Overall Study|Sponsor Decision|0|||
127517071|NCT01064687|458853272|FG002|Overall Study|Sponsor Decision|3|||
127517072|NCT01064687|458853273|FG003|Overall Study|Sponsor Decision|0|||
127517073|NCT01064687|458853270|FG000|Overall Study|Withdrawal by Subject|9|||
127517074|NCT01064687|458853271|FG001|Overall Study|Withdrawal by Subject|7|||
127517075|NCT01064687|458853272|FG002|Overall Study|Withdrawal by Subject|12|||
127517076|NCT01064687|458853273|FG003|Overall Study|Withdrawal by Subject|5|||
127517077|NCT01064687|458853270|FG000|Overall Study|Treatment Noncompliance|1|||
127517078|NCT01064687|458853271|FG001|Overall Study|Treatment Noncompliance|1|||
127517079|NCT01064687|458853272|FG002|Overall Study|Treatment Noncompliance|1|||
127517080|NCT01064687|458853273|FG003|Overall Study|Treatment Noncompliance|0|||
127517081|NCT00845065|458853276|FG000|Overall Study|Adverse Event|3|||
127517082|NCT00845065|458853277|FG001|Overall Study|Adverse Event|23|||
127517083|NCT00845065|458853276|FG000|Overall Study|Lack of Efficacy|43|||
127517084|NCT00845065|458853277|FG001|Overall Study|Lack of Efficacy|21|||
127517085|NCT00845065|458853276|FG000|Overall Study|Non-Medical Reasons|1|||
127517086|NCT00845065|458853277|FG001|Overall Study|Non-Medical Reasons|11|||
127517087|NCT01969721|458853278|FG000|Overall Study|Adverse Event|3|||
127517088|NCT01969721|458853279|FG001|Overall Study|Adverse Event|8|||
127517089|NCT01969721|458853280|FG002|Overall Study|Adverse Event|3|||
127517090|NCT01969721|458853281|FG003|Overall Study|Adverse Event|2|||
127517091|NCT01969721|458853278|FG000|Overall Study|Lack of Efficacy|0|||
127517092|NCT01969721|458853279|FG001|Overall Study|Lack of Efficacy|0|||
127517093|NCT01969721|458853280|FG002|Overall Study|Lack of Efficacy|1|||
127517094|NCT01969721|458853281|FG003|Overall Study|Lack of Efficacy|0|||
127517095|NCT01969721|458853278|FG000|Overall Study|Non compliant with protocol|1|||
127517096|NCT01969721|458853279|FG001|Overall Study|Non compliant with protocol|1|||
127517097|NCT01969721|458853280|FG002|Overall Study|Non compliant with protocol|0|||
127517098|NCT01969721|458853281|FG003|Overall Study|Non compliant with protocol|2|||
127517099|NCT01969721|458853278|FG000|Overall Study|Other not defined above|0|||
127517100|NCT01969721|458853279|FG001|Overall Study|Other not defined above|2|||
127517101|NCT01969721|458853280|FG002|Overall Study|Other not defined above|0|||
127517102|NCT01969721|458853281|FG003|Overall Study|Other not defined above|0|||
127517103|NCT01969721|458853278|FG000|Overall Study|Discontinued during washout periods.|0|||
127517104|NCT01969721|458853279|FG001|Overall Study|Discontinued during washout periods.|1|||
127517105|NCT01969721|458853280|FG002|Overall Study|Discontinued during washout periods.|1|||
127517106|NCT01969721|458853281|FG003|Overall Study|Discontinued during washout periods.|2|||
127517107|NCT00952614|458853282|FG000|Overall Study|Death|3|||
127517108|NCT00952614|458853282|FG000|Overall Study|Lost to Follow-up|3|||
127517109|NCT00952614|458853282|FG000|Overall Study|other reason|1|||
127517110|NCT01403116|458853283|FG000|Overall Study|Adverse Event|7|||
127517111|NCT01403116|458853284|FG001|Overall Study|Adverse Event|4|||
127517112|NCT01403116|458853283|FG000|Overall Study|Lost to Follow-up|7|||
127517113|NCT01403116|458853284|FG001|Overall Study|Lost to Follow-up|5|||
127517114|NCT01403116|458853283|FG000|Overall Study|Withdrawal by Subject|12|||
127517115|NCT01403116|458853284|FG001|Overall Study|Withdrawal by Subject|15|||
127517116|NCT01403116|458853283|FG000|Overall Study|Non-compliance of study drug|3|||
127517117|NCT01403116|458853284|FG001|Overall Study|Non-compliance of study drug|0|||
127517118|NCT01403116|458853283|FG000|Overall Study|Protocol Violation|0|||
127517119|NCT01403116|458853284|FG001|Overall Study|Protocol Violation|1|||
127517120|NCT01403116|458853283|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
127517121|NCT01403116|458853284|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
127517122|NCT01403116|458853283|FG000|Overall Study|Hct >54%|2|||
127517123|NCT01403116|458853284|FG001|Overall Study|Hct >54%|0|||
127517124|NCT01403116|458853283|FG000|Overall Study|unable to keep appointments|0|||
127517125|NCT01403116|458853284|FG001|Overall Study|unable to keep appointments|2|||
127517126|NCT02540291|458853285|FG000|Overall Study|Death|7|||
127517127|NCT02540291|458853286|FG001|Overall Study|Death|7|||
127517128|NCT02540291|458853287|FG002|Overall Study|Death|5|||
127517129|NCT02540291|458853288|FG003|Overall Study|Death|7|||
127517130|NCT02540291|458853285|FG000|Overall Study|Lost to Follow-up|0|||
127517131|NCT02540291|458853286|FG001|Overall Study|Lost to Follow-up|0|||
127517132|NCT02540291|458853287|FG002|Overall Study|Lost to Follow-up|1|||
127517133|NCT02540291|458853288|FG003|Overall Study|Lost to Follow-up|0|||
127517134|NCT02540291|458853285|FG000|Overall Study|Withdrawal Of Consent|0|||
127517135|NCT02540291|458853286|FG001|Overall Study|Withdrawal Of Consent|1|||
127517136|NCT02540291|458853287|FG002|Overall Study|Withdrawal Of Consent|0|||
127517137|NCT02540291|458853288|FG003|Overall Study|Withdrawal Of Consent|0|||
127517138|NCT02540291|458853285|FG000|Overall Study|Study Terminated By Sponsor|1|||
127517139|NCT02540291|458853286|FG001|Overall Study|Study Terminated By Sponsor|0|||
127517140|NCT02540291|458853287|FG002|Overall Study|Study Terminated By Sponsor|0|||
127517141|NCT02540291|458853288|FG003|Overall Study|Study Terminated By Sponsor|0|||
127517142|NCT02540291|458853285|FG000|Overall Study|Other|0|||
127517143|NCT02540291|458853286|FG001|Overall Study|Other|0|||
127517144|NCT02540291|458853287|FG002|Overall Study|Other|1|||
127517145|NCT02540291|458853288|FG003|Overall Study|Other|0|||
127517146|NCT00707954|458854924|FG000|Overall Study|Physician Decision|0|||
127517147|NCT00707954|458854925|FG001|Overall Study|Physician Decision|0|||
127517148|NCT00707954|458854926|FG002|Overall Study|Physician Decision|0|||
127517149|NCT00707954|458854927|FG003|Overall Study|Physician Decision|0|||
127517150|NCT00707954|458854928|FG004|Overall Study|Physician Decision|1|||
127517151|NCT01306656|458854929|FG000|Overall Study|Lost to Follow-up|1|||
127517152|NCT01306656|458854930|FG001|Overall Study|Lost to Follow-up|0|||
127517153|NCT01571232|458854931|FG000|Overall Study|Lost to Follow-up|0|||
127517154|NCT01571232|458854932|FG001|Overall Study|Lost to Follow-up|1|||
127517155|NCT01571232|458854931|FG000|Overall Study|Withdrawal by Subject|1|||
127517156|NCT01571232|458854932|FG001|Overall Study|Withdrawal by Subject|0|||
127517157|NCT03517969|458854934|FG000|Overall Study|Never started protocol treatment|3|||
127517158|NCT03517969|458854935|FG001|Overall Study|Never started protocol treatment|5|||
127517159|NCT03517969|458854934|FG000|Overall Study|Disease progression|11|||
127517160|NCT03517969|458854935|FG001|Overall Study|Disease progression|16|||
127517161|NCT03517969|458854934|FG000|Overall Study|PSA progression|8|||
127517162|NCT03517969|458854935|FG001|Overall Study|PSA progression|1|||
127517163|NCT03517969|458854934|FG000|Overall Study|Clinical progression|4|||
127517164|NCT03517969|458854935|FG001|Overall Study|Clinical progression|2|||
127517165|NCT03517969|458854934|FG000|Overall Study|Adverse Event|5|||
127517166|NCT03517969|458854935|FG001|Overall Study|Adverse Event|4|||
127517167|NCT03517969|458854934|FG000|Overall Study|Intercurrent illness|1|||
127517168|NCT03517969|458854935|FG001|Overall Study|Intercurrent illness|2|||
127517169|NCT03517969|458854934|FG000|Overall Study|Death|1|||
127517170|NCT03517969|458854935|FG001|Overall Study|Death|1|||
127517171|NCT03517969|458854934|FG000|Overall Study|Withdrawal by Subject|1|||
127517172|NCT03517969|458854935|FG001|Overall Study|Withdrawal by Subject|2|||
127517173|NCT03517969|458854934|FG000|Overall Study|Physician Decision|1|||
127517174|NCT03517969|458854935|FG001|Overall Study|Physician Decision|1|||
127517175|NCT03517969|458854934|FG000|Overall Study|No clinical benefit|1|||
127517176|NCT03517969|458854935|FG001|Overall Study|No clinical benefit|0|||
127517177|NCT03517969|458854934|FG000|Overall Study|Delayed treatment for dental treatment|1|||
127517178|NCT03517969|458854935|FG001|Overall Study|Delayed treatment for dental treatment|0|||
127517179|NCT03517969|458854934|FG000|Overall Study|Difficult to maintain appointment|0|||
127517180|NCT03517969|458854935|FG001|Overall Study|Difficult to maintain appointment|1|||
127517181|NCT03517969|458854934|FG000|Overall Study|Protocol Violation|0|||
127517182|NCT03517969|458854935|FG001|Overall Study|Protocol Violation|1|||
127517183|NCT04051827|458854940|FG000|Overall Study|Death|1|||
127517184|NCT04051827|458854940|FG000|Overall Study|Withdrawal by Subject|4|||
127517185|NCT04051827|458854940|FG000|Overall Study|Progressive disease|16|||
127517186|NCT04051827|458854940|FG000|Overall Study|Physician Decision|1|||
127517187|NCT04051827|458854940|FG000|Overall Study|Other|4|||
127517188|NCT03779503|458854943|FG000|First Intervention|Adverse Event|0|||
127517189|NCT03779503|458854944|FG001|First Intervention|Adverse Event|1|||
127517190|NCT03779503|458854943|FG000|First Intervention|Withdrawal by Subject|1|||
127517191|NCT03779503|458854944|FG001|First Intervention|Withdrawal by Subject|0|||
127517192|NCT02211313|458854947|FG000|Overall Study|Treatment Failure|5|||
127517193|NCT02211313|458854948|FG001|Overall Study|Treatment Failure|2|||
127517194|NCT02211313|458854947|FG000|Overall Study|No Follow up Questionnaires|1|||
127517195|NCT02211313|458854948|FG001|Overall Study|No Follow up Questionnaires|1|||
127517196|NCT03743064|458854949|FG000|Overall Study|Adverse Event|7|||
127517197|NCT03743064|458854950|FG001|Overall Study|Adverse Event|9|||
127517198|NCT03743064|458854949|FG000|Overall Study|Death|25|||
127517199|NCT03743064|458854950|FG001|Overall Study|Death|28|||
127517200|NCT03743064|458854949|FG000|Overall Study|Lost to Follow-up|3|||
127517201|NCT03743064|458854950|FG001|Overall Study|Lost to Follow-up|6|||
127517202|NCT03743064|458854949|FG000|Overall Study|Withdrawal by Subject|28|||
127517203|NCT03743064|458854950|FG001|Overall Study|Withdrawal by Subject|25|||
127517204|NCT03743064|458854949|FG000|Overall Study|Physician Decision|2|||
127517205|NCT03743064|458854950|FG001|Overall Study|Physician Decision|4|||
127517206|NCT03743064|458854949|FG000|Overall Study|"Reported as Other in Clinical Study Report"|6|||
127517207|NCT03743064|458854950|FG001|Overall Study|"Reported as Other in Clinical Study Report"|2|||
127517208|NCT02771626|458854953|FG000|Overall Study|Adverse Event|1|||
127517209|NCT02771626|458854954|FG001|Overall Study|Adverse Event|5|||
127517210|NCT02771626|458854955|FG002|Overall Study|Adverse Event|3|||
127517211|NCT02771626|458854956|FG003|Overall Study|Adverse Event|0|||
127517212|NCT02771626|458854957|FG004|Overall Study|Adverse Event|1|||
127517213|NCT02771626|458854958|FG005|Overall Study|Adverse Event|1|||
127517214|NCT02771626|458854953|FG000|Overall Study|Radiologic Disease Progression|6|||
127517215|NCT02771626|458854954|FG001|Overall Study|Radiologic Disease Progression|13|||
127517216|NCT02771626|458854955|FG002|Overall Study|Radiologic Disease Progression|10|||
127517217|NCT02771626|458854956|FG003|Overall Study|Radiologic Disease Progression|7|||
127517218|NCT02771626|458854957|FG004|Overall Study|Radiologic Disease Progression|28|||
127517219|NCT02771626|458854958|FG005|Overall Study|Radiologic Disease Progression|15|||
127517220|NCT02771626|458854953|FG000|Overall Study|Symptomatic Deterioration|0|||
127517221|NCT02771626|458854954|FG001|Overall Study|Symptomatic Deterioration|4|||
127517222|NCT02771626|458854955|FG002|Overall Study|Symptomatic Deterioration|2|||
127517223|NCT02771626|458854956|FG003|Overall Study|Symptomatic Deterioration|0|||
127517224|NCT02771626|458854957|FG004|Overall Study|Symptomatic Deterioration|5|||
127517225|NCT02771626|458854958|FG005|Overall Study|Symptomatic Deterioration|2|||
127517226|NCT02771626|458854953|FG000|Overall Study|Participant Request|0|||
127517227|NCT02771626|458854954|FG001|Overall Study|Participant Request|1|||
127517228|NCT02771626|458854955|FG002|Overall Study|Participant Request|0|||
127517229|NCT02771626|458854956|FG003|Overall Study|Participant Request|2|||
127517230|NCT02771626|458854957|FG004|Overall Study|Participant Request|0|||
127517231|NCT02771626|458854958|FG005|Overall Study|Participant Request|1|||
127517232|NCT02771626|458854953|FG000|Overall Study|Investigator Decision|0|||
127517233|NCT02771626|458854954|FG001|Overall Study|Investigator Decision|1|||
127517234|NCT02771626|458854955|FG002|Overall Study|Investigator Decision|0|||
127517235|NCT02771626|458854956|FG003|Overall Study|Investigator Decision|0|||
127517236|NCT02771626|458854957|FG004|Overall Study|Investigator Decision|1|||
127517237|NCT02771626|458854958|FG005|Overall Study|Investigator Decision|0|||
127517238|NCT02771626|458854953|FG000|Overall Study|Study Termination by Sponsor|0|||
127517239|NCT02771626|458854954|FG001|Overall Study|Study Termination by Sponsor|2|||
127517240|NCT02771626|458854955|FG002|Overall Study|Study Termination by Sponsor|1|||
127517241|NCT02771626|458854956|FG003|Overall Study|Study Termination by Sponsor|0|||
127517242|NCT02771626|458854957|FG004|Overall Study|Study Termination by Sponsor|1|||
127517243|NCT02771626|458854958|FG005|Overall Study|Study Termination by Sponsor|0|||
127517244|NCT02771626|458854953|FG000|Overall Study|Informed Consent Withdrawn|0|||
127517245|NCT02771626|458854954|FG001|Overall Study|Informed Consent Withdrawn|0|||
127517246|NCT02771626|458854955|FG002|Overall Study|Informed Consent Withdrawn|1|||
127517247|NCT02771626|458854956|FG003|Overall Study|Informed Consent Withdrawn|0|||
127517248|NCT02771626|458854957|FG004|Overall Study|Informed Consent Withdrawn|1|||
127517249|NCT02771626|458854958|FG005|Overall Study|Informed Consent Withdrawn|1|||
127517250|NCT02771626|458854953|FG000|Overall Study|Other, Not Specified|1|||
127517251|NCT02771626|458854954|FG001|Overall Study|Other, Not Specified|0|||
127517252|NCT02771626|458854955|FG002|Overall Study|Other, Not Specified|0|||
127517253|NCT02771626|458854956|FG003|Overall Study|Other, Not Specified|0|||
127517254|NCT02771626|458854957|FG004|Overall Study|Other, Not Specified|0|||
127517255|NCT02771626|458854958|FG005|Overall Study|Other, Not Specified|1|||
127517256|NCT01302054|458854959|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
127517257|NCT01302054|458854960|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
127517258|NCT01302054|458854961|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
127517259|NCT01302054|458854959|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
127517260|NCT01302054|458854960|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
127517261|NCT01302054|458854961|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
127517262|NCT01302054|458854959|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
127517263|NCT01302054|458854960|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
127517264|NCT01302054|458854961|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
127517265|NCT01302054|458854959|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
127517266|NCT01302054|458854960|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
127517267|NCT01302054|458854961|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
127517268|NCT01302054|458854959|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
127517269|NCT01302054|458854960|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
127517270|NCT01302054|458854961|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
127517271|NCT01302054|458854959|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
127517272|NCT01302054|458854960|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
127517273|NCT01302054|458854961|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
127517274|NCT01302054|458854959|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
127517275|NCT01302054|458854960|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
127517276|NCT01302054|458854961|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
127517277|NCT01302054|458854959|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
127517278|NCT01302054|458854960|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
127517279|NCT01302054|458854961|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
127517280|NCT01302054|458854959|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
127517281|NCT01302054|458854960|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
127517282|NCT01302054|458854961|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
127517283|NCT01302054|458854959|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
127517284|NCT01302054|458854960|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
127517285|NCT01302054|458854961|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
127517286|NCT01302054|458854959|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
127517287|NCT01302054|458854960|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
127517288|NCT01302054|458854961|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
127517289|NCT01302054|458854959|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
127517290|NCT01302054|458854960|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
127517291|NCT01302054|458854961|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
127517292|NCT01302054|458854959|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
127517293|NCT01302054|458854960|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
127517294|NCT01302054|458854961|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
127517295|NCT01302054|458854959|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
127517296|NCT01302054|458854960|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
127517297|NCT01302054|458854961|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
127517298|NCT01302054|458854959|FG000|Double-Blind Treatment Phase|Other|0|||
127517299|NCT01302054|458854960|FG001|Double-Blind Treatment Phase|Other|4|||
127517300|NCT01302054|458854961|FG002|Double-Blind Treatment Phase|Other|9|||
127517301|NCT02809053|458854962|FG000|Overall Study|Death|0|||
127517302|NCT02809053|458854963|FG001|Overall Study|Death|1|||
127517303|NCT02809053|458854962|FG000|Overall Study|Lost to Follow-up|3|||
127517304|NCT02809053|458854963|FG001|Overall Study|Lost to Follow-up|1|||
127517305|NCT02809053|458854962|FG000|Overall Study|Withdrawal by Subject|2|||
127517306|NCT02809053|458854963|FG001|Overall Study|Withdrawal by Subject|3|||
127517307|NCT02809053|458854962|FG000|Overall Study|Disease Progression|2|||
127517308|NCT02809053|458854963|FG001|Overall Study|Disease Progression|1|||
127517309|NCT01177969|458854966|FG000|Overall Study|Protocol Violation|2|||
127517310|NCT01177969|458854967|FG001|Overall Study|Protocol Violation|1|||
127517311|NCT01177969|458854966|FG000|Overall Study|Withdrawal by Subject|1|||
127517312|NCT01177969|458854967|FG001|Overall Study|Withdrawal by Subject|2|||
127517313|NCT00687609|458854968|FG000|Overall Study|Physician Decision|1|||
127517314|NCT00687609|458854968|FG000|Overall Study|Withdrawal by Subject|2|||
127517315|NCT00908037|458854970|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
127517316|NCT00908037|458854971|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
127517317|NCT00908037|458854972|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
127517318|NCT00908037|458854973|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
127517319|NCT00908037|458854974|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
127517320|NCT00908037|458854975|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
127517321|NCT00908037|458854976|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
127517322|NCT00908037|458854977|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
127517323|NCT00908037|458854978|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
127517324|NCT00908037|458854979|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
127517325|NCT00908037|458854980|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
127517326|NCT00908037|458854981|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
127517327|NCT00908037|458854970|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
127517328|NCT00908037|458854971|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
127517329|NCT00908037|458854972|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
127517330|NCT00908037|458854973|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
127517331|NCT00908037|458854974|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
127517332|NCT00908037|458854975|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
127517333|NCT00908037|458854976|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
127517334|NCT00908037|458854977|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
127517335|NCT00908037|458854978|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
127517336|NCT00908037|458854979|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
127517337|NCT00908037|458854980|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
127517338|NCT00908037|458854981|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
127517339|NCT00908037|458854970|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
127517340|NCT00908037|458854971|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
127517341|NCT00908037|458854972|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
127517342|NCT00908037|458854973|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
127517343|NCT00908037|458854974|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
127517344|NCT00908037|458854975|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
127517345|NCT00908037|458854976|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
127517346|NCT00908037|458854977|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
127517347|NCT00908037|458854978|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
127517348|NCT00908037|458854979|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
127517349|NCT00908037|458854980|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
127517350|NCT00908037|458854981|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
127517351|NCT00908037|458854970|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
127517352|NCT00908037|458854971|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
127517353|NCT00908037|458854972|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
127517354|NCT00908037|458854973|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
127517355|NCT00908037|458854974|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
127517356|NCT00908037|458854975|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
127517357|NCT00908037|458854976|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
127517358|NCT00908037|458854977|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
127517359|NCT00908037|458854978|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
127517360|NCT00908037|458854979|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
127517361|NCT00908037|458854980|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
127517362|NCT00908037|458854981|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
127517363|NCT00908037|458854970|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
127517364|NCT00908037|458854971|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
127517365|NCT00908037|458854972|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
127517366|NCT00908037|458854973|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
127517367|NCT00908037|458854974|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
127517368|NCT00908037|458854975|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
127517369|NCT00908037|458854976|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
127517370|NCT00908037|458854977|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
127517371|NCT00908037|458854978|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
127517372|NCT00908037|458854979|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
127517373|NCT00908037|458854980|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
127517374|NCT00908037|458854981|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
127517375|NCT00908037|458854970|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
127517376|NCT00908037|458854971|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
127517377|NCT00908037|458854972|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
127517378|NCT00908037|458854973|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
127517379|NCT00908037|458854974|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
127517380|NCT00908037|458854975|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
127517381|NCT00908037|458854976|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
127517382|NCT00908037|458854977|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
127517383|NCT00908037|458854978|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
127517384|NCT00908037|458854979|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
127517385|NCT00908037|458854980|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
127517386|NCT00908037|458854981|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
127517387|NCT00908037|458854970|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
127517388|NCT00908037|458854971|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
127517389|NCT00908037|458854972|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
127517390|NCT00908037|458854973|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
127517391|NCT00908037|458854974|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
127517392|NCT00908037|458854975|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
127517393|NCT00908037|458854976|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
127517394|NCT00908037|458854977|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
127517395|NCT00908037|458854978|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
127517396|NCT00908037|458854979|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
127517397|NCT00908037|458854980|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
127517398|NCT00908037|458854981|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
127517399|NCT00908037|458854970|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
127517400|NCT00908037|458854971|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
127517401|NCT00908037|458854972|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
127517402|NCT00908037|458854973|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
127517403|NCT00908037|458854974|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
127517404|NCT00908037|458854975|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
127517405|NCT00908037|458854976|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
127517406|NCT00908037|458854977|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
127517407|NCT00908037|458854978|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
127517408|NCT00908037|458854979|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
127517409|NCT00908037|458854980|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
127517410|NCT00908037|458854981|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
127517411|NCT00908037|458854970|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
127517412|NCT00908037|458854971|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
127517413|NCT00908037|458854972|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
127517414|NCT00908037|458854973|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
127517415|NCT00908037|458854974|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
127517416|NCT00908037|458854975|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
127517417|NCT00908037|458854976|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
127517418|NCT00908037|458854977|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
127517419|NCT00908037|458854978|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
127517420|NCT00908037|458854979|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
127517421|NCT00908037|458854980|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
127517422|NCT00908037|458854981|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
127517423|NCT02565810|458854983|FG000|Overall Study|Withdrawal by Subject|1|||
127517424|NCT00635089|458854984|FG000|Overall Study|Adverse Event|7|||
127517425|NCT00635089|458854984|FG000|Overall Study|Lack of Efficacy|28|||
127517426|NCT00635089|458854984|FG000|Overall Study|Protocol Deviation|4|||
127517427|NCT00635089|458854984|FG000|Overall Study|Lost to Follow-up|8|||
127517428|NCT00635089|458854984|FG000|Overall Study|Other|31|||
127517429|NCT00869401|458854989|FG000|Overall Study|Withdrawal by Subject|0|||
127517430|NCT00869401|458854990|FG001|Overall Study|Withdrawal by Subject|0|||
127517431|NCT00869401|458854991|FG002|Overall Study|Withdrawal by Subject|0|||
127517432|NCT00869401|458854992|FG003|Overall Study|Withdrawal by Subject|5|||
127517433|NCT00869401|458854993|FG004|Overall Study|Withdrawal by Subject|3|||
127517434|NCT01147900|458854994|FG000|At Year 10|Lost to Follow-up|0|||
127517435|NCT01147900|458854995|FG001|At Year 10|Lost to Follow-up|1|||
127517436|NCT01147900|458854996|FG002|At Year 10|Lost to Follow-up|0|||
127517437|NCT00581360|458854999|FG000|Overall Study|Withdrawal by Subject|1|||
127517438|NCT00025155|458855000|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
127517439|NCT00025155|458855000|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
127517440|NCT01455220|458855003|FG000|Overall Study|screen fail|30|||
127517441|NCT04881747|458855004|FG000|Period 2 Washout|Adverse Event|1|||
127517442|NCT04881747|458855005|FG001|Period 2 Washout|Adverse Event|0|||
127517443|NCT04881747|458855006|FG002|Period 2 Washout|Adverse Event|0|||
127517444|NCT04881747|458855007|FG003|Period 2 Washout|Adverse Event|0|||
127517445|NCT04881747|458855008|FG004|Period 2 Washout|Adverse Event|1|||
127517446|NCT04881747|458855009|FG005|Period 2 Washout|Adverse Event|0|||
127517447|NCT04881747|458855004|FG000|Period 2 Washout|Withdrawal by Subject|1|||
127517448|NCT04881747|458855005|FG001|Period 2 Washout|Withdrawal by Subject|0|||
127517449|NCT04881747|458855006|FG002|Period 2 Washout|Withdrawal by Subject|0|||
127517450|NCT04881747|458855007|FG003|Period 2 Washout|Withdrawal by Subject|1|||
127517451|NCT04881747|458855008|FG004|Period 2 Washout|Withdrawal by Subject|0|||
127517452|NCT04881747|458855009|FG005|Period 2 Washout|Withdrawal by Subject|0|||
127517453|NCT04598269|458855010|FG000|Overall Study|Adverse Event|0|||
127517454|NCT04598269|458855011|FG001|Overall Study|Adverse Event|3|||
127517455|NCT04598269|458855010|FG000|Overall Study|Withdrawal by Subject|1|||
127517456|NCT04598269|458855011|FG001|Overall Study|Withdrawal by Subject|4|||
127517457|NCT04598269|458855010|FG000|Overall Study|Lost to Follow-up|1|||
127517458|NCT04598269|458855011|FG001|Overall Study|Lost to Follow-up|0|||
127517459|NCT04598269|458855010|FG000|Overall Study|Not Treated|2|||
127517460|NCT04598269|458855011|FG001|Overall Study|Not Treated|0|||
127517461|NCT00619489|458855013|FG000|Overall Study|Adverse Event|0|||
127517462|NCT00619489|458855014|FG001|Overall Study|Adverse Event|7|||
127517463|NCT00619489|458855013|FG000|Overall Study|Withdrawal by Subject|1|||
127517464|NCT00619489|458855014|FG001|Overall Study|Withdrawal by Subject|1|||
127517465|NCT00619489|458855013|FG000|Overall Study|Lack of Efficacy|0|||
127517466|NCT00619489|458855014|FG001|Overall Study|Lack of Efficacy|11|||
127517467|NCT00619489|458855013|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
127517468|NCT00619489|458855014|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
127517469|NCT02966015|458855015|FG000|Inclusion Visit|did not answer questionnaire|8|||
127517470|NCT02966015|458855016|FG001|Inclusion Visit|did not answer questionnaire|3|||
127517471|NCT01198509|458855023|FG000|Overall Study|Withdrawal by Subject|1|||
127517472|NCT01198509|458855024|FG001|Overall Study|Withdrawal by Subject|0|||
127517473|NCT01198509|458855025|FG002|Overall Study|Withdrawal by Subject|0|||
127517474|NCT01198509|458855026|FG003|Overall Study|Withdrawal by Subject|0|||
127517475|NCT01198509|458855027|FG004|Overall Study|Withdrawal by Subject|0|||
127517476|NCT01198509|458855028|FG005|Overall Study|Withdrawal by Subject|0|||
127517477|NCT00499746|458855029|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
127517478|NCT00499746|458855029|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
127517479|NCT00499746|458855029|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
127517480|NCT00499746|458855029|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
127517481|NCT02745535|458855031|FG000|Overall Study|Death|1|||
127517482|NCT02745535|458855031|FG000|Overall Study|Adverse Event|3|||
127517483|NCT02745535|458855031|FG000|Overall Study|Lost to Follow-up|2|||
127517484|NCT01291277|458855032|FG000|Overall Study|Death|2|||
127517485|NCT01291277|458855033|FG001|Overall Study|Death|2|||
127517486|NCT01291277|458855032|FG000|Overall Study|Lost to Follow-up|3|||
127517487|NCT01291277|458855033|FG001|Overall Study|Lost to Follow-up|1|||
127517488|NCT00849108|458855034|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
127517489|NCT00849108|458855035|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
127517490|NCT00849108|458855034|FG000|Cohort 2 Efficacy|Adverse Event|0|||
127517491|NCT00849108|458855035|FG001|Cohort 2 Efficacy|Adverse Event|1|||
127517492|NCT00849108|458855034|FG000|Cohort 2 Efficacy|Other|0|||
127517493|NCT00849108|458855035|FG001|Cohort 2 Efficacy|Other|9|||
127517494|NCT03480009|458855036|FG000|Overall Study|Lost to Follow-up|4|||
127517495|NCT03480009|458855037|FG001|Overall Study|Lost to Follow-up|5|||
127517496|NCT03480009|458855038|FG002|Overall Study|Lost to Follow-up|4|||
127517497|NCT03480009|458855039|FG003|Overall Study|Lost to Follow-up|0|||
127517498|NCT01563172|458855040|FG000|Overall Study|Adverse Event|5|||
127517499|NCT01563172|458855040|FG000|Overall Study|Lost to Follow-up|2|||
127517500|NCT01563172|458855040|FG000|Overall Study|Other (Protocol deviation)|5|||
127517501|NCT01563172|458855040|FG000|Overall Study|Other (Not specified)|1|||
127517502|NCT01105377|458855041|FG000|Overall Study|Withdrawal by Subject|0|||
127517503|NCT01105377|458855042|FG001|Overall Study|Withdrawal by Subject|1|||
127517504|NCT02014584|458855050|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
127517505|NCT02014584|458855051|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
127517506|NCT02014584|458855052|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
127517507|NCT02014584|458855053|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
127517508|NCT02014584|458855054|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
127517509|NCT02014584|458855055|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
127517510|NCT02014584|458855050|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
127517511|NCT02014584|458855051|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
127517512|NCT02014584|458855052|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
127517513|NCT02014584|458855053|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
127517514|NCT02014584|458855054|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
127517515|NCT02014584|458855055|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
127517516|NCT02014584|458855050|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
127517517|NCT02014584|458855051|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
127517518|NCT02014584|458855052|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
127517519|NCT02014584|458855053|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
127517520|NCT02014584|458855054|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
127517521|NCT02014584|458855055|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
127517522|NCT02014584|458855050|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
127517523|NCT02014584|458855051|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
127517524|NCT02014584|458855052|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
127517525|NCT02014584|458855053|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
127517526|NCT02014584|458855054|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
127517527|NCT02014584|458855055|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
127517528|NCT02014584|458855050|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
127517529|NCT02014584|458855051|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
127517530|NCT02014584|458855052|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
127517531|NCT02014584|458855053|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
127517532|NCT02014584|458855054|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
127517533|NCT02014584|458855055|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
127517534|NCT00772109|458855056|FG000|Overall Study|Serious adverse event|1|||
127517535|NCT00772109|458855057|FG001|Overall Study|Serious adverse event|0|||
127517536|NCT00772109|458855058|FG002|Overall Study|Serious adverse event|1|||
127517537|NCT00772109|458855059|FG003|Overall Study|Serious adverse event|0|||
127517538|NCT00772109|458855056|FG000|Overall Study|Protocol Violation|5|||
127517539|NCT00772109|458855057|FG001|Overall Study|Protocol Violation|8|||
127517540|NCT00772109|458855058|FG002|Overall Study|Protocol Violation|7|||
127517541|NCT00772109|458855059|FG003|Overall Study|Protocol Violation|6|||
127517542|NCT00772109|458855056|FG000|Overall Study|Lost to Follow-up|7|||
127517543|NCT00772109|458855057|FG001|Overall Study|Lost to Follow-up|3|||
127517544|NCT00772109|458855058|FG002|Overall Study|Lost to Follow-up|5|||
127517545|NCT00772109|458855059|FG003|Overall Study|Lost to Follow-up|9|||
127517546|NCT00772109|458855056|FG000|Overall Study|Withdrawal by Subject|8|||
127517547|NCT00772109|458855057|FG001|Overall Study|Withdrawal by Subject|8|||
127517548|NCT00772109|458855058|FG002|Overall Study|Withdrawal by Subject|6|||
127517549|NCT00772109|458855059|FG003|Overall Study|Withdrawal by Subject|16|||
127517550|NCT01624090|458855060|FG000|Overall Study|DLT, taken off therapy|0|||
127517551|NCT01624090|458855061|FG001|Overall Study|DLT, taken off therapy|1|||
127517552|NCT01624090|458855062|FG002|Overall Study|DLT, taken off therapy|0|||
127517553|NCT01624090|458855063|FG003|Overall Study|DLT, taken off therapy|0|||
127517554|NCT01624090|458855060|FG000|Overall Study|Withdrew prior to treatment|0|||
127517555|NCT01624090|458855061|FG001|Overall Study|Withdrew prior to treatment|1|||
127517556|NCT01624090|458855062|FG002|Overall Study|Withdrew prior to treatment|0|||
127517557|NCT01624090|458855063|FG003|Overall Study|Withdrew prior to treatment|0|||
127517558|NCT01624090|458855060|FG000|Overall Study|Died on study|0|||
127517559|NCT01624090|458855061|FG001|Overall Study|Died on study|0|||
127517560|NCT01624090|458855062|FG002|Overall Study|Died on study|2|||
127517561|NCT01624090|458855063|FG003|Overall Study|Died on study|0|||
127517562|NCT01624090|458855060|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
127517563|NCT01624090|458855061|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
127517564|NCT01624090|458855062|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
127517565|NCT01624090|458855063|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
127517566|NCT01624090|458855060|FG000|Overall Study|Dose escalated|0|||
127517567|NCT01624090|458855061|FG001|Overall Study|Dose escalated|0|||
127517568|NCT01624090|458855062|FG002|Overall Study|Dose escalated|3|||
127517569|NCT01624090|458855063|FG003|Overall Study|Dose escalated|0|||
127517570|NCT00752726|458855064|FG000|Overall Study|Lost to Follow-up|2|||
127517571|NCT00752726|458855065|FG001|Overall Study|Lost to Follow-up|1|||
127517572|NCT00752726|458855064|FG000|Overall Study|Adverse Event|3|||
127517573|NCT00752726|458855065|FG001|Overall Study|Adverse Event|0|||
127517574|NCT00752726|458855064|FG000|Overall Study|Withdrawal by Subject|5|||
127517575|NCT00752726|458855065|FG001|Overall Study|Withdrawal by Subject|10|||
127517576|NCT00752726|458855064|FG000|Overall Study|Other Reason|1|||
127517577|NCT00752726|458855065|FG001|Overall Study|Other Reason|2|||
127517578|NCT00042666|458855066|FG000|Overall Study|Adverse Event|2|||
127517579|NCT00042666|458855066|FG000|Overall Study|Death|4|||
127517580|NCT00042666|458855066|FG000|Overall Study|Protocol Violation|1|||
127517581|NCT00042666|458855066|FG000|Overall Study|Participant/Physician Perception|1|||
127517582|NCT00042666|458855066|FG000|Overall Study|Progressive Disease|41|||
127517583|NCT00042666|458855066|FG000|Overall Study|Other|1|||
127517584|NCT00042666|458855066|FG000|Overall Study|Other|4|||
127517585|NCT04232215|458855067|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
127517586|NCT04232215|458855068|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
127517587|NCT01555125|458855071|FG000|Induction Period|Lost to Follow-up|0|||
127517588|NCT01555125|458855072|FG001|Induction Period|Lost to Follow-up|2|||
127517589|NCT01555125|458855073|FG002|Induction Period|Lost to Follow-up|0|||
127517590|NCT01555125|458855074|FG003|Induction Period|Lost to Follow-up|0|||
127517591|NCT01555125|458855075|FG004|Induction Period|Lost to Follow-up|0|||
127517592|NCT01555125|458855071|FG000|Induction Period|Adverse Event|0|||
127517593|NCT01555125|458855072|FG001|Induction Period|Adverse Event|1|||
127517594|NCT01555125|458855073|FG002|Induction Period|Adverse Event|0|||
127517595|NCT01555125|458855074|FG003|Induction Period|Adverse Event|0|||
127517596|NCT01555125|458855075|FG004|Induction Period|Adverse Event|1|||
127517597|NCT01555125|458855071|FG000|Induction Period|Subject / guardian decision|0|||
127517598|NCT01555125|458855072|FG001|Induction Period|Subject / guardian decision|0|||
127517599|NCT01555125|458855073|FG002|Induction Period|Subject / guardian decision|0|||
127517600|NCT01555125|458855074|FG003|Induction Period|Subject / guardian decision|0|||
127517601|NCT01555125|458855075|FG004|Induction Period|Subject / guardian decision|2|||
127517602|NCT01555125|458855071|FG000|Induction Period|Death|1|||
127517603|NCT01555125|458855072|FG001|Induction Period|Death|0|||
127517604|NCT01555125|458855073|FG002|Induction Period|Death|0|||
127517605|NCT01555125|458855074|FG003|Induction Period|Death|0|||
127517606|NCT01555125|458855075|FG004|Induction Period|Death|0|||
127517607|NCT01555125|458855071|FG000|Maintenance Period|Adverse Event|1|||
127517608|NCT01555125|458855072|FG001|Maintenance Period|Adverse Event|1|||
127517609|NCT01555125|458855073|FG002|Maintenance Period|Adverse Event|0|||
127517610|NCT01555125|458855074|FG003|Maintenance Period|Adverse Event|0|||
127517611|NCT01555125|458855075|FG004|Maintenance Period|Adverse Event|0|||
127517612|NCT01555125|458855071|FG000|Maintenance Period|Subject / guardian decision|1|||
127517613|NCT01555125|458855072|FG001|Maintenance Period|Subject / guardian decision|2|||
127517614|NCT01555125|458855073|FG002|Maintenance Period|Subject / guardian decision|0|||
127517615|NCT01555125|458855074|FG003|Maintenance Period|Subject / guardian decision|0|||
127517616|NCT01555125|458855075|FG004|Maintenance Period|Subject / guardian decision|0|||
127517617|NCT01555125|458855071|FG000|Maintenance Period|Lost to Follow-up|2|||
127517618|NCT01555125|458855072|FG001|Maintenance Period|Lost to Follow-up|0|||
127517619|NCT01555125|458855073|FG002|Maintenance Period|Lost to Follow-up|0|||
127517620|NCT01555125|458855074|FG003|Maintenance Period|Lost to Follow-up|1|||
127517621|NCT01555125|458855075|FG004|Maintenance Period|Lost to Follow-up|0|||
127517622|NCT01555125|458855071|FG000|Maintenance Period|Lack of Efficacy|6|||
127517623|NCT01555125|458855072|FG001|Maintenance Period|Lack of Efficacy|1|||
127517624|NCT01555125|458855073|FG002|Maintenance Period|Lack of Efficacy|3|||
127517625|NCT01555125|458855074|FG003|Maintenance Period|Lack of Efficacy|0|||
127517626|NCT01555125|458855075|FG004|Maintenance Period|Lack of Efficacy|0|||
127517627|NCT01555125|458855071|FG000|Maintenance Period|Physician Decision|0|||
127517628|NCT01555125|458855072|FG001|Maintenance Period|Physician Decision|0|||
127517629|NCT01555125|458855073|FG002|Maintenance Period|Physician Decision|1|||
127517630|NCT01555125|458855074|FG003|Maintenance Period|Physician Decision|0|||
127517631|NCT01555125|458855075|FG004|Maintenance Period|Physician Decision|0|||
127517632|NCT01555125|458855071|FG000|Maintenance Period|Death|0|||
127517633|NCT01555125|458855072|FG001|Maintenance Period|Death|0|||
127517634|NCT01555125|458855073|FG002|Maintenance Period|Death|0|||
127517635|NCT01555125|458855074|FG003|Maintenance Period|Death|1|||
127517636|NCT01555125|458855075|FG004|Maintenance Period|Death|0|||
127517637|NCT01555125|458855071|FG000|Extension|Adverse Event|1|||
127517638|NCT01555125|458855072|FG001|Extension|Adverse Event|2|||
127517639|NCT01555125|458855073|FG002|Extension|Adverse Event|1|||
127517640|NCT01555125|458855074|FG003|Extension|Adverse Event|1|||
127517641|NCT01555125|458855075|FG004|Extension|Adverse Event|0|||
127517642|NCT01555125|458855071|FG000|Extension|Protocol deviation|1|||
127517643|NCT01555125|458855072|FG001|Extension|Protocol deviation|0|||
127517644|NCT01555125|458855073|FG002|Extension|Protocol deviation|0|||
127517645|NCT01555125|458855074|FG003|Extension|Protocol deviation|0|||
127517646|NCT01555125|458855075|FG004|Extension|Protocol deviation|0|||
127517647|NCT01555125|458855071|FG000|Extension|Lack of Efficacy|7|||
127517648|NCT01555125|458855072|FG001|Extension|Lack of Efficacy|6|||
127517649|NCT01555125|458855073|FG002|Extension|Lack of Efficacy|3|||
127517650|NCT01555125|458855074|FG003|Extension|Lack of Efficacy|0|||
127517651|NCT01555125|458855075|FG004|Extension|Lack of Efficacy|0|||
127517652|NCT01555125|458855071|FG000|Extension|Lost to Follow-up|2|||
127517653|NCT01555125|458855072|FG001|Extension|Lost to Follow-up|1|||
127517654|NCT01555125|458855073|FG002|Extension|Lost to Follow-up|2|||
127517655|NCT01555125|458855074|FG003|Extension|Lost to Follow-up|0|||
127517656|NCT01555125|458855075|FG004|Extension|Lost to Follow-up|0|||
127517657|NCT01555125|458855071|FG000|Extension|Study terminated by sponsor|32|||
127517658|NCT01555125|458855072|FG001|Extension|Study terminated by sponsor|33|||
127517659|NCT01555125|458855073|FG002|Extension|Study terminated by sponsor|16|||
127517660|NCT01555125|458855074|FG003|Extension|Study terminated by sponsor|20|||
127517661|NCT01555125|458855075|FG004|Extension|Study terminated by sponsor|0|||
127517662|NCT01555125|458855071|FG000|Extension|Subject/guardian decision|1|||
127517663|NCT01555125|458855072|FG001|Extension|Subject/guardian decision|9|||
127517664|NCT01555125|458855073|FG002|Extension|Subject/guardian decision|1|||
127517665|NCT01555125|458855074|FG003|Extension|Subject/guardian decision|0|||
127517666|NCT01555125|458855075|FG004|Extension|Subject/guardian decision|0|||
127517667|NCT01555125|458855071|FG000|Extension|Technical Problems|1|||
127517668|NCT01555125|458855072|FG001|Extension|Technical Problems|0|||
127517669|NCT01555125|458855073|FG002|Extension|Technical Problems|0|||
127517670|NCT01555125|458855074|FG003|Extension|Technical Problems|1|||
127517671|NCT01555125|458855075|FG004|Extension|Technical Problems|0|||
127517672|NCT01555125|458855071|FG000|Follow-Up Period|Lost to Follow-up|1|||
127517673|NCT01555125|458855072|FG001|Follow-Up Period|Lost to Follow-up|0|||
127517674|NCT01555125|458855073|FG002|Follow-Up Period|Lost to Follow-up|0|||
127517675|NCT01555125|458855074|FG003|Follow-Up Period|Lost to Follow-up|0|||
127517676|NCT01555125|458855075|FG004|Follow-Up Period|Lost to Follow-up|0|||
127517677|NCT01555125|458855071|FG000|Follow-Up Period|Subject / guardian decision|3|||
127517678|NCT01555125|458855072|FG001|Follow-Up Period|Subject / guardian decision|1|||
127517679|NCT01555125|458855073|FG002|Follow-Up Period|Subject / guardian decision|1|||
127517680|NCT01555125|458855074|FG003|Follow-Up Period|Subject / guardian decision|1|||
127517681|NCT01555125|458855075|FG004|Follow-Up Period|Subject / guardian decision|0|||
127517682|NCT02651220|458855076|FG000|Overall Study|Adverse Event|1|||
127517683|NCT02651220|458855077|FG001|Overall Study|Adverse Event|5|||
127517684|NCT02651220|458855078|FG002|Overall Study|Adverse Event|1|||
127517685|NCT02651220|458855076|FG000|Overall Study|Lost to Follow-up|8|||
127517686|NCT02651220|458855077|FG001|Overall Study|Lost to Follow-up|14|||
127517687|NCT02651220|458855078|FG002|Overall Study|Lost to Follow-up|14|||
127517688|NCT02651220|458855076|FG000|Overall Study|Non-Compliance with Study Drug|4|||
127517689|NCT02651220|458855077|FG001|Overall Study|Non-Compliance with Study Drug|0|||
127517690|NCT02651220|458855078|FG002|Overall Study|Non-Compliance with Study Drug|1|||
127517691|NCT02651220|458855076|FG000|Overall Study|Pregnancy|1|||
127517692|NCT02651220|458855077|FG001|Overall Study|Pregnancy|0|||
127517693|NCT02651220|458855078|FG002|Overall Study|Pregnancy|1|||
127517694|NCT02651220|458855076|FG000|Overall Study|Protocol Violation|0|||
127517695|NCT02651220|458855077|FG001|Overall Study|Protocol Violation|0|||
127517696|NCT02651220|458855078|FG002|Overall Study|Protocol Violation|1|||
127517697|NCT02651220|458855076|FG000|Overall Study|Withdrawal by Subject|5|||
127517698|NCT02651220|458855077|FG001|Overall Study|Withdrawal by Subject|6|||
127517699|NCT02651220|458855078|FG002|Overall Study|Withdrawal by Subject|8|||
127517700|NCT02651220|458855076|FG000|Overall Study|Miscellaneous|4|||
127517701|NCT02651220|458855077|FG001|Overall Study|Miscellaneous|1|||
127517702|NCT02651220|458855078|FG002|Overall Study|Miscellaneous|2|||
127517703|NCT02651220|458855076|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
127517704|NCT02651220|458855077|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
127517705|NCT02651220|458855078|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
127517706|NCT04046250|458855096|FG000|Overall Study|Death|0|||
127517707|NCT04046250|458855097|FG001|Overall Study|Death|1|||
127517708|NCT04046250|458855096|FG000|Overall Study|Withdrawal by Subject|3|||
127517709|NCT04046250|458855097|FG001|Overall Study|Withdrawal by Subject|3|||
127517710|NCT04576897|458855102|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
127517711|NCT00527332|458855103|FG000|Overall Study|Protocol Violation|4|||
127517712|NCT00527332|458855104|FG001|Overall Study|Protocol Violation|8|||
127517713|NCT00527332|458855103|FG000|Overall Study|Withdrew consent|5|||
127517714|NCT00527332|458855104|FG001|Overall Study|Withdrew consent|1|||
127517715|NCT02666105|458855105|FG000|Overall Study|Death|1|||
127517716|NCT01078168|458855106|FG000|Overall Study|Physician Decision|0|||
127517717|NCT01078168|458855107|FG001|Overall Study|Physician Decision|1|||
127517718|NCT01264419|458855109|FG000|Overall Study|Lost to Follow-up|3|||
127517719|NCT02720692|458857309|FG000|Overall Study|Withdrawal by Subject|3|||
127517720|NCT02720692|458857310|FG001|Overall Study|Withdrawal by Subject|0|||
127517721|NCT02720692|458857309|FG000|Overall Study|Physician Decision|1|||
127517722|NCT02720692|458857310|FG001|Overall Study|Physician Decision|0|||
127517723|NCT02720692|458857309|FG000|Overall Study|Lost to Follow-up|8|||
127517724|NCT02720692|458857310|FG001|Overall Study|Lost to Follow-up|3|||
127517725|NCT02720692|458857309|FG000|Overall Study|Subject unable to return for visit|1|||
127517726|NCT02720692|458857310|FG001|Overall Study|Subject unable to return for visit|0|||
127517727|NCT05011513|458857311|FG000|Overall Study|Death|0|||
127517728|NCT05011513|458857312|FG001|Overall Study|Death|1|||
127517729|NCT05011513|458857311|FG000|Overall Study|Lost to Follow-up|4|||
127517730|NCT05011513|458857312|FG001|Overall Study|Lost to Follow-up|0|||
127517731|NCT05011513|458857311|FG000|Overall Study|Withdrawal by Subject|18|||
127517732|NCT05011513|458857312|FG001|Overall Study|Withdrawal by Subject|17|||
127517733|NCT05011513|458857311|FG000|Overall Study|Other|4|||
127517734|NCT05011513|458857312|FG001|Overall Study|Other|2|||
127517735|NCT03878758|458857313|FG000|Overall Study|Withdrawal by Subject|1|||
127517736|NCT03878758|458857313|FG000|Overall Study|Protocol defined|2|||
127517737|NCT03878758|458857313|FG000|Overall Study|Improper consent documentation|1|||
127517738|NCT02315560|458857314|FG000|Overall Study|noncompliance by subjects|3|||
127517739|NCT00358436|458857316|FG000|Overall Study|Adverse Event|29|||
127517740|NCT00358436|458857317|FG001|Overall Study|Adverse Event|13|||
127517741|NCT00358436|458857316|FG000|Overall Study|Lack of Efficacy|34|||
127517742|NCT00358436|458857317|FG001|Overall Study|Lack of Efficacy|36|||
127517743|NCT00358436|458857316|FG000|Overall Study|Lost to Follow-up|11|||
127517744|NCT00358436|458857317|FG001|Overall Study|Lost to Follow-up|6|||
127517745|NCT00358436|458857316|FG000|Overall Study|Protocol Violation|8|||
127517746|NCT00358436|458857317|FG001|Overall Study|Protocol Violation|3|||
127517747|NCT00358436|458857316|FG000|Overall Study|Withdrawal by Subject|40|||
127517748|NCT00358436|458857317|FG001|Overall Study|Withdrawal by Subject|17|||
127517749|NCT00358436|458857316|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
127517750|NCT00358436|458857317|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
127517751|NCT00358436|458857316|FG000|Overall Study|COPD exacerbation|22|||
127517752|NCT00358436|458857317|FG001|Overall Study|COPD exacerbation|10|||
127517753|NCT00358436|458857316|FG000|Overall Study|Other|6|||
127517754|NCT00358436|458857317|FG001|Overall Study|Other|1|||
127517755|NCT02100969|458857319|FG000|Overall Study|Did not pass screening phase|1|||
127517756|NCT01629953|458857320|FG000|Overall Study|Death|3|||
127517757|NCT01629953|458857321|FG001|Overall Study|Death|1|||
127517758|NCT01629953|458857320|FG000|Overall Study|Lost to Follow-up|10|||
127517759|NCT01629953|458857321|FG001|Overall Study|Lost to Follow-up|14|||
127517760|NCT06359080|458857322|FG000|Overall Study|Withdrawal by Subject|3|||
127517761|NCT00306527|458857325|FG000|Overall Study|Lost to Follow-up|3|||
127517762|NCT00306527|458857326|FG001|Overall Study|Lost to Follow-up|4|||
127517763|NCT00306527|458857327|FG002|Overall Study|Lost to Follow-up|3|||
127517764|NCT00306527|458857328|FG003|Overall Study|Lost to Follow-up|0|||
127517765|NCT00306527|458857325|FG000|Overall Study|Withdrawal by Subject|2|||
127517766|NCT00306527|458857326|FG001|Overall Study|Withdrawal by Subject|3|||
127517767|NCT00306527|458857327|FG002|Overall Study|Withdrawal by Subject|0|||
127517768|NCT00306527|458857328|FG003|Overall Study|Withdrawal by Subject|3|||
127517769|NCT00306527|458857325|FG000|Overall Study|Adverse Event|0|||
127517770|NCT00306527|458857326|FG001|Overall Study|Adverse Event|0|||
127517771|NCT00306527|458857327|FG002|Overall Study|Adverse Event|1|||
127517772|NCT00306527|458857328|FG003|Overall Study|Adverse Event|1|||
127517773|NCT00306527|458857325|FG000|Overall Study|Death|1|||
127517774|NCT00306527|458857326|FG001|Overall Study|Death|0|||
127517775|NCT00306527|458857327|FG002|Overall Study|Death|1|||
127517776|NCT00306527|458857328|FG003|Overall Study|Death|2|||
127517777|NCT04037254|458857329|FG000|Overall Study|Protocol Violation|1|||
127517778|NCT04037254|458857330|FG001|Overall Study|Protocol Violation|0|||
127517779|NCT04037254|458857331|FG002|Overall Study|Protocol Violation|0|||
127517780|NCT04037254|458857332|FG003|Overall Study|Protocol Violation|0|||
127517781|NCT04037254|458857333|FG004|Overall Study|Protocol Violation|0|||
127517782|NCT04037254|458857329|FG000|Overall Study|Withdrawal by Subject|0|||
127517783|NCT04037254|458857330|FG001|Overall Study|Withdrawal by Subject|0|||
127517784|NCT04037254|458857331|FG002|Overall Study|Withdrawal by Subject|1|||
127517785|NCT04037254|458857332|FG003|Overall Study|Withdrawal by Subject|0|||
127517786|NCT04037254|458857333|FG004|Overall Study|Withdrawal by Subject|0|||
127517787|NCT04037254|458857329|FG000|Overall Study|Delayed or incomplete treatment|0|||
127517788|NCT04037254|458857330|FG001|Overall Study|Delayed or incomplete treatment|2|||
127517789|NCT04037254|458857331|FG002|Overall Study|Delayed or incomplete treatment|1|||
127517790|NCT04037254|458857332|FG003|Overall Study|Delayed or incomplete treatment|0|||
127517791|NCT04037254|458857333|FG004|Overall Study|Delayed or incomplete treatment|0|||
127517792|NCT00477152|458857334|FG000|Overall Study|Parent withdrew consent|2|||
127517793|NCT00477152|458857334|FG000|Overall Study|Adverse Event|1|||
127517794|NCT02504580|458857335|FG000|Overall Study|Other|1|||
127517795|NCT02504580|458857336|FG001|Overall Study|Other|0|||
127517796|NCT02504580|458857337|FG002|Overall Study|Other|0|||
127517797|NCT02504580|458857338|FG003|Overall Study|Other|2|||
127517798|NCT02504580|458857339|FG004|Overall Study|Other|1|||
127517799|NCT02504580|458857340|FG005|Overall Study|Other|1|||
127517800|NCT02504580|458857341|FG006|Overall Study|Other|1|||
127517801|NCT02504580|458857342|FG007|Overall Study|Other|2|||
127517802|NCT02504580|458857343|FG008|Overall Study|Other|0|||
127517803|NCT02504580|458857344|FG009|Overall Study|Other|0|||
127517804|NCT02504580|458857345|FG010|Overall Study|Other|0|||
127517805|NCT02504580|458857346|FG011|Overall Study|Other|2|||
127517806|NCT02504580|458857335|FG000|Overall Study|Subject refusal to continue|0|||
127517807|NCT02504580|458857336|FG001|Overall Study|Subject refusal to continue|1|||
127517808|NCT02504580|458857337|FG002|Overall Study|Subject refusal to continue|0|||
127517809|NCT02504580|458857338|FG003|Overall Study|Subject refusal to continue|0|||
127517810|NCT02504580|458857339|FG004|Overall Study|Subject refusal to continue|0|||
127517811|NCT02504580|458857340|FG005|Overall Study|Subject refusal to continue|0|||
127517812|NCT02504580|458857341|FG006|Overall Study|Subject refusal to continue|0|||
127517813|NCT02504580|458857342|FG007|Overall Study|Subject refusal to continue|0|||
127517814|NCT02504580|458857343|FG008|Overall Study|Subject refusal to continue|0|||
127517815|NCT02504580|458857344|FG009|Overall Study|Subject refusal to continue|0|||
127517816|NCT02504580|458857345|FG010|Overall Study|Subject refusal to continue|0|||
127517817|NCT02504580|458857346|FG011|Overall Study|Subject refusal to continue|0|||
127517818|NCT00448747|458857348|FG000|Overall Study|collapsed veins|1|||
127517819|NCT00448747|458857349|FG001|Overall Study|collapsed veins|0|||
127517820|NCT02905006|458857350|FG000|Overall Study|Adverse Event|1|||
127517821|NCT02905006|458857351|FG001|Overall Study|Adverse Event|1|||
127517822|NCT02905006|458857352|FG002|Overall Study|Adverse Event|1|||
127517823|NCT02905006|458857353|FG003|Overall Study|Adverse Event|1|||
127517824|NCT02905006|458857354|FG004|Overall Study|Adverse Event|0|||
127517825|NCT02905006|458857355|FG005|Overall Study|Adverse Event|1|||
127517826|NCT02905006|458857350|FG000|Overall Study|Lack of Efficacy|1|||
127517827|NCT02905006|458857351|FG001|Overall Study|Lack of Efficacy|0|||
127517828|NCT02905006|458857352|FG002|Overall Study|Lack of Efficacy|0|||
127517829|NCT02905006|458857353|FG003|Overall Study|Lack of Efficacy|0|||
127517830|NCT02905006|458857354|FG004|Overall Study|Lack of Efficacy|0|||
127517831|NCT02905006|458857355|FG005|Overall Study|Lack of Efficacy|0|||
127517832|NCT02905006|458857350|FG000|Overall Study|Protocol Violation|2|||
127517833|NCT02905006|458857351|FG001|Overall Study|Protocol Violation|0|||
127517834|NCT02905006|458857352|FG002|Overall Study|Protocol Violation|0|||
127517835|NCT02905006|458857353|FG003|Overall Study|Protocol Violation|0|||
127517836|NCT02905006|458857354|FG004|Overall Study|Protocol Violation|0|||
127517837|NCT02905006|458857355|FG005|Overall Study|Protocol Violation|0|||
127517838|NCT02905006|458857350|FG000|Overall Study|Lost to Follow-up|0|||
127517839|NCT02905006|458857351|FG001|Overall Study|Lost to Follow-up|0|||
127517840|NCT02905006|458857352|FG002|Overall Study|Lost to Follow-up|0|||
127517841|NCT02905006|458857353|FG003|Overall Study|Lost to Follow-up|1|||
127517842|NCT02905006|458857354|FG004|Overall Study|Lost to Follow-up|1|||
127517843|NCT02905006|458857355|FG005|Overall Study|Lost to Follow-up|0|||
127517844|NCT02905006|458857350|FG000|Overall Study|Withdrawal by Subject|0|||
127517845|NCT02905006|458857351|FG001|Overall Study|Withdrawal by Subject|0|||
127517846|NCT02905006|458857352|FG002|Overall Study|Withdrawal by Subject|1|||
127517847|NCT02905006|458857353|FG003|Overall Study|Withdrawal by Subject|1|||
127517848|NCT02905006|458857354|FG004|Overall Study|Withdrawal by Subject|0|||
127517849|NCT02905006|458857355|FG005|Overall Study|Withdrawal by Subject|1|||
127517850|NCT02905006|458857350|FG000|Overall Study|Screening exclusion criteria met|1|||
127517851|NCT02905006|458857351|FG001|Overall Study|Screening exclusion criteria met|0|||
127517852|NCT02905006|458857352|FG002|Overall Study|Screening exclusion criteria met|0|||
127517853|NCT02905006|458857353|FG003|Overall Study|Screening exclusion criteria met|0|||
127517854|NCT02905006|458857354|FG004|Overall Study|Screening exclusion criteria met|0|||
127517855|NCT02905006|458857355|FG005|Overall Study|Screening exclusion criteria met|0|||
127517856|NCT02905006|458857350|FG000|Overall Study|Lab withdrawal criterion met|0|||
127517857|NCT02905006|458857351|FG001|Overall Study|Lab withdrawal criterion met|1|||
127517858|NCT02905006|458857352|FG002|Overall Study|Lab withdrawal criterion met|2|||
127517859|NCT02905006|458857353|FG003|Overall Study|Lab withdrawal criterion met|2|||
127517860|NCT02905006|458857354|FG004|Overall Study|Lab withdrawal criterion met|2|||
127517861|NCT02905006|458857355|FG005|Overall Study|Lab withdrawal criterion met|1|||
127517862|NCT02905006|458857350|FG000|Overall Study|Positive for Tuberculosis|0|||
127517863|NCT02905006|458857351|FG001|Overall Study|Positive for Tuberculosis|1|||
127517864|NCT02905006|458857352|FG002|Overall Study|Positive for Tuberculosis|0|||
127517865|NCT02905006|458857353|FG003|Overall Study|Positive for Tuberculosis|0|||
127517866|NCT02905006|458857354|FG004|Overall Study|Positive for Tuberculosis|0|||
127517867|NCT02905006|458857355|FG005|Overall Study|Positive for Tuberculosis|0|||
127517868|NCT02905006|458857350|FG000|Overall Study|Subject positive for Hep B|0|||
127517869|NCT02905006|458857351|FG001|Overall Study|Subject positive for Hep B|0|||
127517870|NCT02905006|458857352|FG002|Overall Study|Subject positive for Hep B|1|||
127517871|NCT02905006|458857353|FG003|Overall Study|Subject positive for Hep B|0|||
127517872|NCT02905006|458857354|FG004|Overall Study|Subject positive for Hep B|0|||
127517873|NCT02905006|458857355|FG005|Overall Study|Subject positive for Hep B|0|||
127517874|NCT02905006|458857350|FG000|Overall Study|Patient moved abroad|0|||
127517875|NCT02905006|458857351|FG001|Overall Study|Patient moved abroad|0|||
127517876|NCT02905006|458857352|FG002|Overall Study|Patient moved abroad|0|||
127517877|NCT02905006|458857353|FG003|Overall Study|Patient moved abroad|1|||
127517878|NCT02905006|458857354|FG004|Overall Study|Patient moved abroad|0|||
127517879|NCT02905006|458857355|FG005|Overall Study|Patient moved abroad|0|||
127517880|NCT02905006|458857350|FG000|Overall Study|Patient randomized by mistake|0|||
127517881|NCT02905006|458857351|FG001|Overall Study|Patient randomized by mistake|0|||
127517882|NCT02905006|458857352|FG002|Overall Study|Patient randomized by mistake|0|||
127517883|NCT02905006|458857353|FG003|Overall Study|Patient randomized by mistake|0|||
127517884|NCT02905006|458857354|FG004|Overall Study|Patient randomized by mistake|0|||
127517885|NCT02905006|458857355|FG005|Overall Study|Patient randomized by mistake|1|||
127517886|NCT02429791|458857360|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
127517887|NCT02429791|458857361|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
127517888|NCT02429791|458857360|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
127517889|NCT02429791|458857361|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
127517890|NCT02429791|458857360|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
127517891|NCT02429791|458857361|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
127517892|NCT02429791|458857360|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
127517893|NCT02429791|458857361|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
127517894|NCT02429791|458857360|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
127517895|NCT02429791|458857361|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
127517896|NCT02429791|458857360|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
127517897|NCT02429791|458857361|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
127517898|NCT02429791|458857360|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
127517899|NCT02429791|458857361|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
127517900|NCT02429791|458857360|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
127517901|NCT02429791|458857361|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
127517902|NCT02429791|458857360|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
127517903|NCT02429791|458857361|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
127517904|NCT02429791|458857360|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
127517905|NCT02429791|458857361|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
127517906|NCT02429791|458857360|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
127517907|NCT02429791|458857361|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
127517908|NCT02429791|458857360|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
127517909|NCT02429791|458857361|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
127517910|NCT02429791|458857360|FG000|Continuation Phase(Week 148 to Week 411)|Adverse Event|3|||
127517911|NCT02429791|458857361|FG001|Continuation Phase(Week 148 to Week 411)|Adverse Event|1|||
127517912|NCT02429791|458857360|FG000|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|1|||
127517913|NCT02429791|458857361|FG001|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|0|||
127517914|NCT02429791|458857360|FG000|Continuation Phase(Week 148 to Week 411)|Protocol Violation|1|||
127517915|NCT02429791|458857361|FG001|Continuation Phase(Week 148 to Week 411)|Protocol Violation|0|||
127517916|NCT02429791|458857360|FG000|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
127517917|NCT02429791|458857361|FG001|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
127517918|NCT02429791|458857360|FG000|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
127517919|NCT02429791|458857361|FG001|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
127517920|NCT02429791|458857360|FG000|Continuation Phase(Week 148 to Week 411)|Investigator discretion|0|||
127517921|NCT02429791|458857361|FG001|Continuation Phase(Week 148 to Week 411)|Investigator discretion|2|||
127517922|NCT04201093|458857362|FG000|Overall Study|Adverse Event|6|||
127517923|NCT04201093|458857363|FG001|Overall Study|Adverse Event|29|||
127517924|NCT04201093|458857364|FG002|Overall Study|Adverse Event|35|||
127517925|NCT04201093|458857362|FG000|Overall Study|Death|2|||
127517926|NCT04201093|458857363|FG001|Overall Study|Death|1|||
127517927|NCT04201093|458857364|FG002|Overall Study|Death|0|||
127517928|NCT04201093|458857362|FG000|Overall Study|Lack of Efficacy|5|||
127517929|NCT04201093|458857363|FG001|Overall Study|Lack of Efficacy|1|||
127517930|NCT04201093|458857364|FG002|Overall Study|Lack of Efficacy|2|||
127517931|NCT04201093|458857362|FG000|Overall Study|Lost to Follow-up|0|||
127517932|NCT04201093|458857363|FG001|Overall Study|Lost to Follow-up|0|||
127517933|NCT04201093|458857364|FG002|Overall Study|Lost to Follow-up|1|||
127517934|NCT04201093|458857362|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
127517935|NCT04201093|458857363|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
127517936|NCT04201093|458857364|FG002|Overall Study|Failure to Meet Continuation Criteria|1|||
127517937|NCT04201093|458857362|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
127517938|NCT04201093|458857363|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
127517939|NCT04201093|458857364|FG002|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
127517940|NCT04201093|458857362|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
127517941|NCT04201093|458857363|FG001|Overall Study|Non-Compliance with Study Schedule|0|||
127517942|NCT04201093|458857364|FG002|Overall Study|Non-Compliance with Study Schedule|1|||
127517943|NCT04201093|458857362|FG000|Overall Study|Physician Decision|1|||
127517944|NCT04201093|458857363|FG001|Overall Study|Physician Decision|0|||
127517945|NCT04201093|458857364|FG002|Overall Study|Physician Decision|0|||
127517946|NCT04201093|458857362|FG000|Overall Study|Protocol Deviation|1|||
127517947|NCT04201093|458857363|FG001|Overall Study|Protocol Deviation|0|||
127517948|NCT04201093|458857364|FG002|Overall Study|Protocol Deviation|0|||
127517949|NCT04201093|458857362|FG000|Overall Study|Site Terminated by Sponsor|5|||
127517950|NCT04201093|458857363|FG001|Overall Study|Site Terminated by Sponsor|3|||
127517951|NCT04201093|458857364|FG002|Overall Study|Site Terminated by Sponsor|1|||
127517952|NCT04201093|458857362|FG000|Overall Study|Withdrawal by Subject|7|||
127517953|NCT04201093|458857363|FG001|Overall Study|Withdrawal by Subject|8|||
127517954|NCT04201093|458857364|FG002|Overall Study|Withdrawal by Subject|15|||
127517955|NCT04201093|458857362|FG000|Overall Study|Other|0|||
127517956|NCT04201093|458857363|FG001|Overall Study|Other|1|||
127517957|NCT04201093|458857364|FG002|Overall Study|Other|2|||
127517958|NCT00881504|458857365|FG000|Overall Study|Withdrawal by Subject|1|||
127517959|NCT00007020|458857366|FG000|Overall Study|Death|16|||
127517960|NCT00007020|458857366|FG000|Overall Study|Lost to Follow-up|13|||
127517961|NCT00007020|458857366|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
127517962|NCT00007020|458857366|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
127517963|NCT00007020|458857366|FG000|Overall Study|Pt cared for by outside physician|4|||
127517964|NCT00007020|458857366|FG000|Overall Study|No evidence of treatment|6|||
127517965|NCT01276223|458857367|FG000|Overall Study|Adverse Event|7|||
127517966|NCT01276223|458857368|FG001|Overall Study|Adverse Event|4|||
127517967|NCT01276223|458857369|FG002|Overall Study|Adverse Event|1|||
127517968|NCT01276223|458857367|FG000|Overall Study|Lost to Follow-up|0|||
127517969|NCT01276223|458857368|FG001|Overall Study|Lost to Follow-up|0|||
127517970|NCT01276223|458857369|FG002|Overall Study|Lost to Follow-up|1|||
127517971|NCT01276223|458857367|FG000|Overall Study|Other|0|||
127517972|NCT01276223|458857368|FG001|Overall Study|Other|0|||
127517973|NCT01276223|458857369|FG002|Overall Study|Other|1|||
127517974|NCT01276223|458857367|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
127517975|NCT01276223|458857368|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
127517976|NCT01276223|458857369|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
127517977|NCT01276223|458857367|FG000|Overall Study|Protocol Violation|1|||
127517978|NCT01276223|458857368|FG001|Overall Study|Protocol Violation|0|||
127517979|NCT01276223|458857369|FG002|Overall Study|Protocol Violation|0|||
127517980|NCT05856227|458857370|FG000|Overall Study|Adverse Event|0|||
127517981|NCT05856227|458857371|FG001|Overall Study|Adverse Event|1|||
127517982|NCT05856227|458857370|FG000|Overall Study|Due to Investigator absence|1|||
127517983|NCT05856227|458857371|FG001|Overall Study|Due to Investigator absence|0|||
127517984|NCT05856227|458857370|FG000|Overall Study|Cerebrospinal fluid test positive for S. aureus|1|||
127517985|NCT05856227|458857371|FG001|Overall Study|Cerebrospinal fluid test positive for S. aureus|0|||
127517986|NCT00771615|458857373|FG000|Overall Study|Withdrawal by Subject|0|||
127517987|NCT00771615|458857374|FG001|Overall Study|Withdrawal by Subject|1|||
127517988|NCT00771615|458857375|FG002|Overall Study|Withdrawal by Subject|0|||
127517989|NCT00771615|458857376|FG003|Overall Study|Withdrawal by Subject|0|||
127517990|NCT00771615|458857377|FG004|Overall Study|Withdrawal by Subject|0|||
127517991|NCT00771615|458857378|FG005|Overall Study|Withdrawal by Subject|0|||
127517992|NCT00771615|458857379|FG006|Overall Study|Withdrawal by Subject|0|||
127517993|NCT00771615|458857380|FG007|Overall Study|Withdrawal by Subject|1|||
127517994|NCT00771615|458857381|FG008|Overall Study|Withdrawal by Subject|0|||
127517995|NCT00771615|458857373|FG000|Overall Study|Lost to Follow-up|1|||
127517996|NCT00771615|458857374|FG001|Overall Study|Lost to Follow-up|1|||
127517997|NCT00771615|458857375|FG002|Overall Study|Lost to Follow-up|1|||
127517998|NCT00771615|458857376|FG003|Overall Study|Lost to Follow-up|1|||
127517999|NCT00771615|458857377|FG004|Overall Study|Lost to Follow-up|0|||
127518000|NCT00771615|458857378|FG005|Overall Study|Lost to Follow-up|1|||
127518001|NCT00771615|458857379|FG006|Overall Study|Lost to Follow-up|1|||
127518002|NCT00771615|458857380|FG007|Overall Study|Lost to Follow-up|0|||
127518003|NCT00771615|458857381|FG008|Overall Study|Lost to Follow-up|0|||
127518004|NCT02455076|458857382|FG000|Inpatient|Withdrawal by Subject|1|||
127518005|NCT02455076|458857383|FG001|Inpatient|Withdrawal by Subject|0|||
127518006|NCT02455076|458857384|FG002|Inpatient|Withdrawal by Subject|0|||
127518007|NCT02455076|458857385|FG003|Inpatient|Withdrawal by Subject|0|||
127518008|NCT02455076|458857386|FG004|Inpatient|Withdrawal by Subject|0|||
127518009|NCT02455076|458857382|FG000|Inpatient|Discharged <24 h after admission|0|||
127518010|NCT02455076|458857383|FG001|Inpatient|Discharged <24 h after admission|1|||
127518011|NCT02455076|458857384|FG002|Inpatient|Discharged <24 h after admission|0|||
127518012|NCT02455076|458857385|FG003|Inpatient|Discharged <24 h after admission|0|||
127518013|NCT02455076|458857386|FG004|Inpatient|Discharged <24 h after admission|0|||
127518014|NCT02455076|458857382|FG000|Inpatient|Adverse Event|3|||
127518015|NCT02455076|458857383|FG001|Inpatient|Adverse Event|0|||
127518016|NCT02455076|458857384|FG002|Inpatient|Adverse Event|0|||
127518017|NCT02455076|458857385|FG003|Inpatient|Adverse Event|0|||
127518018|NCT02455076|458857386|FG004|Inpatient|Adverse Event|0|||
127518019|NCT02455076|458857382|FG000|Outpatient|Adverse Event|0|||
127518020|NCT02455076|458857383|FG001|Outpatient|Adverse Event|0|||
127518021|NCT02455076|458857384|FG002|Outpatient|Adverse Event|0|||
127518022|NCT02455076|458857385|FG003|Outpatient|Adverse Event|5|||
127518023|NCT02455076|458857386|FG004|Outpatient|Adverse Event|0|||
127518024|NCT02455076|458857382|FG000|Outpatient|Lost to Follow-up|0|||
127518025|NCT02455076|458857383|FG001|Outpatient|Lost to Follow-up|0|||
127518026|NCT02455076|458857384|FG002|Outpatient|Lost to Follow-up|0|||
127518027|NCT02455076|458857385|FG003|Outpatient|Lost to Follow-up|1|||
127518028|NCT02455076|458857386|FG004|Outpatient|Lost to Follow-up|12|||
127518029|NCT01424566|458857387|FG000|Single-blind Treatment|Adverse Event|71|||
127518030|NCT01424566|458857388|FG001|Single-blind Treatment|Adverse Event|0|||
127518031|NCT01424566|458857389|FG002|Single-blind Treatment|Adverse Event|0|||
127518032|NCT01424566|458857387|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
127518033|NCT01424566|458857388|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
127518034|NCT01424566|458857389|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
127518035|NCT01424566|458857387|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
127518036|NCT01424566|458857388|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
127518037|NCT01424566|458857389|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
127518038|NCT01424566|458857387|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
127518039|NCT01424566|458857388|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
127518040|NCT01424566|458857389|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
127518041|NCT01424566|458857387|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
127518042|NCT01424566|458857388|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
127518043|NCT01424566|458857389|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
127518044|NCT01424566|458857387|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
127518045|NCT01424566|458857388|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
127518046|NCT01424566|458857389|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
127518047|NCT01424566|458857387|FG000|Double-blind Treatment|Adverse Event|0|||
127518048|NCT01424566|458857388|FG001|Double-blind Treatment|Adverse Event|21|||
127518049|NCT01424566|458857389|FG002|Double-blind Treatment|Adverse Event|13|||
127518050|NCT01424566|458857387|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
127518051|NCT01424566|458857388|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
127518052|NCT01424566|458857389|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
127518053|NCT01424566|458857387|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
127518054|NCT01424566|458857388|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
127518055|NCT01424566|458857389|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
127518056|NCT01424566|458857387|FG000|Double-blind Treatment|Lack of Efficacy|0|||
127518057|NCT01424566|458857388|FG001|Double-blind Treatment|Lack of Efficacy|1|||
127518058|NCT01424566|458857389|FG002|Double-blind Treatment|Lack of Efficacy|1|||
127518059|NCT05147662|458857402|FG000|Overall Study|Withdrawal by parent/guardian|3|||
127518060|NCT05147662|458857402|FG000|Overall Study|Assigned to treatment but never treated|1|||
127518061|NCT04676867|458857405|FG000|Overall Study|Screen failure|0|||
127518062|NCT04676867|458857406|FG001|Overall Study|Screen failure|0|||
127518063|NCT04676867|458857407|FG002|Overall Study|Screen failure|6|||
127518064|NCT04676867|458857408|FG003|Overall Study|Screen failure|2|||
127518065|NCT04676867|458857405|FG000|Overall Study|Death|0|||
127518066|NCT04676867|458857406|FG001|Overall Study|Death|0|||
127518067|NCT04676867|458857407|FG002|Overall Study|Death|1|||
127518068|NCT04676867|458857408|FG003|Overall Study|Death|0|||
127518069|NCT04676867|458857405|FG000|Overall Study|Withdrawal by Subject|2|||
127518070|NCT04676867|458857406|FG001|Overall Study|Withdrawal by Subject|2|||
127518071|NCT04676867|458857407|FG002|Overall Study|Withdrawal by Subject|4|||
127518072|NCT04676867|458857408|FG003|Overall Study|Withdrawal by Subject|4|||
127518073|NCT04676867|458857405|FG000|Overall Study|Lost to Follow-up|1|||
127518074|NCT04676867|458857406|FG001|Overall Study|Lost to Follow-up|0|||
127518075|NCT04676867|458857407|FG002|Overall Study|Lost to Follow-up|0|||
127518076|NCT04676867|458857408|FG003|Overall Study|Lost to Follow-up|0|||
127518077|NCT01732913|458857409|FG000|Overall Study|Study Terminated by Sponsor|105|||
127518078|NCT01732913|458857410|FG001|Overall Study|Study Terminated by Sponsor|55|||
127518079|NCT01732913|458857409|FG000|Overall Study|Withdrawal by Subject|27|||
127518080|NCT01732913|458857410|FG001|Overall Study|Withdrawal by Subject|4|||
127518081|NCT01732913|458857409|FG000|Overall Study|Physician Decision|14|||
127518082|NCT01732913|458857410|FG001|Overall Study|Physician Decision|7|||
127518083|NCT01732913|458857409|FG000|Overall Study|Other|7|||
127518084|NCT01732913|458857410|FG001|Overall Study|Other|1|||
127518085|NCT01732913|458857409|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
127518086|NCT01732913|458857410|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
127518087|NCT00444067|458857411|FG000|Overall Study|Lost to Follow-up|0|||
127518088|NCT00444067|458857412|FG001|Overall Study|Lost to Follow-up|1|||
127518089|NCT01300455|458857413|FG000|Washout|Withdrawal by Subject|1|||
127518090|NCT01300455|458857414|FG001|Washout|Withdrawal by Subject|0|||
127518091|NCT00084487|458857415|FG000|Overall Study|Death|1|||
127518092|NCT02528357|458857416|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
127518093|NCT02528357|458857417|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
127518094|NCT02528357|458857418|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
127518095|NCT02528357|458857419|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
127518096|NCT02528357|458857420|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
127518097|NCT02528357|458857421|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
127518098|NCT02528357|458857422|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
127518099|NCT02528357|458857423|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
127518100|NCT02528357|458857424|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
127518101|NCT02528357|458857425|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
127518102|NCT02528357|458857426|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
127518103|NCT02528357|458857427|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
127518104|NCT02528357|458857428|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
127518105|NCT02528357|458857429|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
127518106|NCT02528357|458857430|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
127518107|NCT02528357|458857431|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
127518108|NCT02528357|458857432|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
127518109|NCT02528357|458857433|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
127518110|NCT02528357|458857434|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
127518111|NCT02528357|458857416|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
127518112|NCT02528357|458857417|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
127518113|NCT02528357|458857418|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
127518114|NCT02528357|458857419|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
127518115|NCT02528357|458857420|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
127518116|NCT02528357|458857421|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
127518117|NCT02528357|458857422|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
127518118|NCT02528357|458857423|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
127518119|NCT02528357|458857424|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
127518120|NCT02528357|458857425|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
127518121|NCT02528357|458857426|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
127518122|NCT02528357|458857427|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
127518123|NCT02528357|458857428|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
127518124|NCT02528357|458857429|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
127518125|NCT02528357|458857430|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
127518126|NCT02528357|458857431|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
127518127|NCT02528357|458857432|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
127518128|NCT02528357|458857433|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
127518129|NCT02528357|458857434|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
127518130|NCT02528357|458857416|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
127518131|NCT02528357|458857417|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
127518132|NCT02528357|458857418|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
127518133|NCT02528357|458857419|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
127518134|NCT02528357|458857420|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
127518135|NCT02528357|458857421|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
127518136|NCT02528357|458857422|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
127518137|NCT02528357|458857423|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
127518138|NCT02528357|458857424|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
127518139|NCT02528357|458857425|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
127518140|NCT02528357|458857426|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
127518141|NCT02528357|458857427|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
127518142|NCT02528357|458857428|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
127518143|NCT02528357|458857429|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
127518144|NCT02528357|458857430|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
127518145|NCT02528357|458857431|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
127518146|NCT02528357|458857432|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
127518147|NCT02528357|458857433|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
127518148|NCT02528357|458857434|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
127518149|NCT02528357|458857416|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127518150|NCT02528357|458857417|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127518151|NCT02528357|458857418|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127518152|NCT02528357|458857419|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127518153|NCT02528357|458857420|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
127518154|NCT02528357|458857421|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127518155|NCT02528357|458857422|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127518156|NCT02528357|458857423|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127518157|NCT02528357|458857424|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127518158|NCT02528357|458857425|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127518159|NCT02528357|458857426|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127518160|NCT02528357|458857427|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127518161|NCT02528357|458857428|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127518162|NCT02528357|458857429|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127518163|NCT02528357|458857430|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127518164|NCT02528357|458857431|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127518165|NCT02528357|458857432|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127518166|NCT02528357|458857433|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127518167|NCT02528357|458857434|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127518168|NCT02528357|458857416|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
127518169|NCT02528357|458857417|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
127518170|NCT02528357|458857418|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
127518171|NCT02528357|458857419|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
127518172|NCT02528357|458857420|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
127518173|NCT02528357|458857421|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
127518174|NCT02528357|458857422|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
127518175|NCT02528357|458857423|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
127518176|NCT02528357|458857424|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
127518177|NCT02528357|458857425|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
127518178|NCT02528357|458857426|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
127518179|NCT02528357|458857427|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
127518180|NCT02528357|458857428|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
127518181|NCT02528357|458857429|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
127518182|NCT02528357|458857430|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
127518183|NCT02528357|458857431|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
127518184|NCT02528357|458857432|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
127518185|NCT02528357|458857433|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
127518186|NCT02528357|458857434|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
127518187|NCT02528357|458857416|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
127518188|NCT02528357|458857417|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
127518189|NCT02528357|458857418|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
127518190|NCT02528357|458857419|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
127518191|NCT02528357|458857420|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
127518192|NCT02528357|458857421|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
127518193|NCT02528357|458857422|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
127518194|NCT02528357|458857423|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
127518195|NCT02528357|458857424|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
127518196|NCT02528357|458857425|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
127518197|NCT02528357|458857426|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
127518198|NCT02528357|458857427|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
127518199|NCT02528357|458857428|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
127518200|NCT02528357|458857429|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
127518201|NCT02528357|458857430|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
127518202|NCT02528357|458857431|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
127518203|NCT02528357|458857432|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
127518204|NCT02528357|458857433|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
127518205|NCT02528357|458857434|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
127518206|NCT02528357|458857416|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
127518207|NCT02528357|458857417|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
127518208|NCT02528357|458857418|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
127518209|NCT02528357|458857419|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
127518210|NCT02528357|458857420|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
127518211|NCT02528357|458857421|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
127518212|NCT02528357|458857422|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
127518213|NCT02528357|458857423|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
127518214|NCT02528357|458857424|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
127518215|NCT02528357|458857425|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
127518216|NCT02528357|458857426|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
127518217|NCT02528357|458857427|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
127518218|NCT02528357|458857428|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
127518219|NCT02528357|458857429|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
127518220|NCT02528357|458857430|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
127518221|NCT02528357|458857431|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
127518222|NCT02528357|458857432|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
127518223|NCT02528357|458857433|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
127518224|NCT02528357|458857434|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
127518225|NCT02528357|458857416|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127518226|NCT02528357|458857417|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127518227|NCT02528357|458857418|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127868987|NCT05602818|460137447|FG005|Qualification Phase (3 Days)|Other|0|||
127518228|NCT02528357|458857419|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127518229|NCT02528357|458857420|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127518230|NCT02528357|458857421|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127518231|NCT02528357|458857422|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127518232|NCT02528357|458857423|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127518233|NCT02528357|458857424|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
127518234|NCT02528357|458857425|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
127518235|NCT02528357|458857426|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127518236|NCT02528357|458857427|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
127518237|NCT02528357|458857428|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
127518238|NCT02528357|458857429|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
127518239|NCT02528357|458857430|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
127518240|NCT02528357|458857431|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127518241|NCT02528357|458857432|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127518242|NCT02528357|458857433|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127518243|NCT02528357|458857434|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127518244|NCT02528357|458857416|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
127518245|NCT02528357|458857417|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
127518246|NCT02528357|458857418|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
127518247|NCT02528357|458857419|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
127518248|NCT02528357|458857420|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
127518249|NCT02528357|458857421|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
127518250|NCT02528357|458857422|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
127518251|NCT02528357|458857423|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
127518252|NCT02528357|458857424|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
127518253|NCT02528357|458857425|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
127518254|NCT02528357|458857426|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
127518255|NCT02528357|458857427|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
127518256|NCT02528357|458857428|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
127518257|NCT02528357|458857429|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
127518258|NCT02528357|458857430|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
127518259|NCT02528357|458857431|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
127518260|NCT02528357|458857432|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
127518261|NCT02528357|458857433|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
127518262|NCT02528357|458857434|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
127518263|NCT02528357|458857416|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127518264|NCT02528357|458857417|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127518265|NCT02528357|458857418|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127518266|NCT02528357|458857419|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127518267|NCT02528357|458857420|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127518268|NCT02528357|458857421|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127518269|NCT02528357|458857422|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127518270|NCT02528357|458857423|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127518271|NCT02528357|458857424|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127518272|NCT02528357|458857425|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127518273|NCT02528357|458857426|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127518274|NCT02528357|458857427|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127518275|NCT02528357|458857428|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127518276|NCT02528357|458857429|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127518277|NCT02528357|458857430|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127518278|NCT02528357|458857431|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
127518279|NCT02528357|458857432|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
127518280|NCT02528357|458857433|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
127518281|NCT02528357|458857434|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
127518282|NCT02438813|458857440|FG000|Overall Study|Patient Decision|59|||
127518283|NCT02438813|458857440|FG000|Overall Study|Patient Lost to Follow-Up|137|||
127518284|NCT02438813|458857440|FG000|Overall Study|Study Ended by Sponsor|80|||
127518285|NCT02438813|458857440|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
127518286|NCT03040986|458857442|FG000|Overall Study|Hospice|1|||
127518287|NCT03040986|458857443|FG001|Overall Study|Hospice|0|||
127518288|NCT03040986|458857442|FG000|Overall Study|Adverse Event|2|||
127518289|NCT03040986|458857443|FG001|Overall Study|Adverse Event|1|||
127518290|NCT03040986|458857442|FG000|Overall Study|Disease progression on study|3|||
127518291|NCT03040986|458857443|FG001|Overall Study|Disease progression on study|1|||
127518292|NCT01183468|458857446|FG000|Overall Study|Lost to Follow-up|2|||
127518293|NCT01183468|458857447|FG001|Overall Study|Lost to Follow-up|1|||
127518294|NCT01183468|458857448|FG002|Overall Study|Lost to Follow-up|0|||
127518295|NCT01183468|458857449|FG003|Overall Study|Lost to Follow-up|0|||
127518296|NCT01183468|458857446|FG000|Overall Study|Physician Decision|1|||
127518297|NCT01183468|458857447|FG001|Overall Study|Physician Decision|0|||
127518298|NCT01183468|458857448|FG002|Overall Study|Physician Decision|0|||
127518299|NCT01183468|458857449|FG003|Overall Study|Physician Decision|0|||
127518300|NCT01183468|458857446|FG000|Overall Study|Withdrawal by Subject|0|||
127518301|NCT01183468|458857447|FG001|Overall Study|Withdrawal by Subject|1|||
127518302|NCT01183468|458857448|FG002|Overall Study|Withdrawal by Subject|0|||
127518303|NCT01183468|458857449|FG003|Overall Study|Withdrawal by Subject|0|||
127518304|NCT02228096|458857458|FG000|Overall Study|Study terminated by Sponsor|24|||
127518305|NCT02228096|458857458|FG000|Overall Study|Lack of Efficacy|18|||
127518306|NCT02228096|458857458|FG000|Overall Study|Death|12|||
127518307|NCT02228096|458857458|FG000|Overall Study|Physician Decision|3|||
127518308|NCT02228096|458857458|FG000|Overall Study|Subject/guardian decision|2|||
127518309|NCT02228096|458857458|FG000|Overall Study|New therapy for study indication|1|||
127518310|NCT02228096|458857458|FG000|Overall Study|Enrolled, not infused|11|||
127518311|NCT02273960|458857459|FG000|Short Term Period|Lost to Follow-up|1|||
127518312|NCT02273960|458857460|FG001|Short Term Period|Lost to Follow-up|0|||
127518313|NCT02273960|458857461|FG002|Short Term Period|Lost to Follow-up|0|||
127518314|NCT02273960|458857462|FG003|Short Term Period|Lost to Follow-up|0|||
127518315|NCT02273960|458857459|FG000|Short Term Period|Lack of Efficacy|0|||
127518316|NCT02273960|458857460|FG001|Short Term Period|Lack of Efficacy|0|||
127518317|NCT02273960|458857461|FG002|Short Term Period|Lack of Efficacy|0|||
127518318|NCT02273960|458857462|FG003|Short Term Period|Lack of Efficacy|1|||
127518319|NCT02273960|458857459|FG000|Short Term Period|ST complete, not entering LTE|4|||
127518320|NCT02273960|458857460|FG001|Short Term Period|ST complete, not entering LTE|6|||
127518321|NCT02273960|458857461|FG002|Short Term Period|ST complete, not entering LTE|4|||
127518322|NCT02273960|458857462|FG003|Short Term Period|ST complete, not entering LTE|5|||
127518323|NCT02273960|458857459|FG000|Long Term Extension|Death|0|||
127518324|NCT02273960|458857460|FG001|Long Term Extension|Death|0|||
127518325|NCT02273960|458857461|FG002|Long Term Extension|Death|0|||
127518326|NCT02273960|458857462|FG003|Long Term Extension|Death|1|||
127518327|NCT00558272|458857463|FG000|Overall Study|Adverse Event|10|||
127518328|NCT00558272|458857464|FG001|Overall Study|Adverse Event|0|||
127518329|NCT00558272|458857463|FG000|Overall Study|Death|1|||
127518330|NCT00558272|458857464|FG001|Overall Study|Death|0|||
127518331|NCT00558272|458857463|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
127518332|NCT00558272|458857464|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
127518333|NCT00558272|458857463|FG000|Overall Study|AZ study team decision|0|||
127518334|NCT00558272|458857464|FG001|Overall Study|AZ study team decision|1|||
127518335|NCT00558272|458857463|FG000|Overall Study|Incorrectly enrolled|1|||
127518336|NCT00558272|458857464|FG001|Overall Study|Incorrectly enrolled|0|||
127518337|NCT00558272|458857463|FG000|Overall Study|Withdrawal by Subject|0|||
127518338|NCT00558272|458857464|FG001|Overall Study|Withdrawal by Subject|1|||
127518339|NCT00454649|458857465|FG000|Overall Study|Lack of Efficacy|2|||
127518340|NCT00454649|458857466|FG001|Overall Study|Lack of Efficacy|2|||
127518341|NCT00454649|458857467|FG002|Overall Study|Lack of Efficacy|10|||
127518342|NCT00454649|458857468|FG003|Overall Study|Lack of Efficacy|3|||
127518343|NCT00454649|458857469|FG004|Overall Study|Lack of Efficacy|0|||
127518344|NCT00454649|458857470|FG005|Overall Study|Lack of Efficacy|4|||
127518345|NCT00454649|458857471|FG006|Overall Study|Lack of Efficacy|5|||
127518346|NCT00454649|458857472|FG007|Overall Study|Lack of Efficacy|13|||
127518347|NCT00454649|458857473|FG008|Overall Study|Lack of Efficacy|10|||
127518348|NCT00454649|458857474|FG009|Overall Study|Lack of Efficacy|2|||
127518349|NCT00454649|458857465|FG000|Overall Study|Adverse Event|0|||
127518350|NCT00454649|458857466|FG001|Overall Study|Adverse Event|1|||
127518351|NCT00454649|458857467|FG002|Overall Study|Adverse Event|3|||
127518352|NCT00454649|458857468|FG003|Overall Study|Adverse Event|0|||
127518353|NCT00454649|458857469|FG004|Overall Study|Adverse Event|1|||
127518354|NCT00454649|458857470|FG005|Overall Study|Adverse Event|2|||
127518355|NCT00454649|458857471|FG006|Overall Study|Adverse Event|3|||
127518356|NCT00454649|458857472|FG007|Overall Study|Adverse Event|4|||
127518357|NCT00454649|458857473|FG008|Overall Study|Adverse Event|6|||
127518358|NCT00454649|458857474|FG009|Overall Study|Adverse Event|2|||
127518359|NCT00454649|458857465|FG000|Overall Study|Lost to Follow-up|0|||
127518360|NCT00454649|458857466|FG001|Overall Study|Lost to Follow-up|0|||
127518361|NCT00454649|458857467|FG002|Overall Study|Lost to Follow-up|1|||
127518362|NCT00454649|458857468|FG003|Overall Study|Lost to Follow-up|0|||
127518363|NCT00454649|458857469|FG004|Overall Study|Lost to Follow-up|0|||
127518364|NCT00454649|458857470|FG005|Overall Study|Lost to Follow-up|0|||
127518365|NCT00454649|458857471|FG006|Overall Study|Lost to Follow-up|1|||
127518366|NCT00454649|458857472|FG007|Overall Study|Lost to Follow-up|0|||
127518367|NCT00454649|458857473|FG008|Overall Study|Lost to Follow-up|0|||
127518368|NCT00454649|458857474|FG009|Overall Study|Lost to Follow-up|0|||
127518369|NCT00454649|458857465|FG000|Overall Study|Other|1|||
127518370|NCT00454649|458857466|FG001|Overall Study|Other|1|||
127518371|NCT00454649|458857467|FG002|Overall Study|Other|5|||
127518372|NCT00454649|458857468|FG003|Overall Study|Other|3|||
127518373|NCT00454649|458857469|FG004|Overall Study|Other|0|||
127518374|NCT00454649|458857470|FG005|Overall Study|Other|0|||
127518375|NCT00454649|458857471|FG006|Overall Study|Other|0|||
127518376|NCT00454649|458857472|FG007|Overall Study|Other|0|||
127518377|NCT00454649|458857473|FG008|Overall Study|Other|3|||
127518378|NCT00454649|458857474|FG009|Overall Study|Other|1|||
127518379|NCT00454649|458857465|FG000|Overall Study|Withdrawal by Subject|0|||
127518380|NCT00454649|458857466|FG001|Overall Study|Withdrawal by Subject|0|||
127518381|NCT00454649|458857467|FG002|Overall Study|Withdrawal by Subject|0|||
127518382|NCT00454649|458857468|FG003|Overall Study|Withdrawal by Subject|0|||
127518383|NCT00454649|458857469|FG004|Overall Study|Withdrawal by Subject|0|||
127518384|NCT00454649|458857470|FG005|Overall Study|Withdrawal by Subject|1|||
127518385|NCT00454649|458857471|FG006|Overall Study|Withdrawal by Subject|0|||
127518386|NCT00454649|458857472|FG007|Overall Study|Withdrawal by Subject|2|||
127518387|NCT00454649|458857473|FG008|Overall Study|Withdrawal by Subject|1|||
127518388|NCT00454649|458857474|FG009|Overall Study|Withdrawal by Subject|0|||
127518389|NCT01789606|458857475|FG000|Overall Study|Participant not Purchased the Product|0|||
127518390|NCT01789606|458857476|FG001|Overall Study|Participant not Purchased the Product|20|||
127518391|NCT01789606|458857475|FG000|Overall Study|Withdrawal by Subject|0|||
127518392|NCT01789606|458857476|FG001|Overall Study|Withdrawal by Subject|1|||
127518393|NCT01789606|458857475|FG000|Overall Study|Ineligible|6|||
127518394|NCT01789606|458857476|FG001|Overall Study|Ineligible|2|||
127518395|NCT01789606|458857475|FG000|Overall Study|Administrative Reasons|17|||
127518396|NCT01789606|458857476|FG001|Overall Study|Administrative Reasons|6|||
127518397|NCT01789606|458857475|FG000|Overall Study|No Study Medication Taken|0|||
127518398|NCT01789606|458857476|FG001|Overall Study|No Study Medication Taken|1|||
127518399|NCT01789606|458857475|FG000|Overall Study|Protocol Violation|0|||
127518400|NCT01789606|458857476|FG001|Overall Study|Protocol Violation|55|||
127518401|NCT01789606|458857475|FG000|Overall Study|Adverse Event|0|||
127518402|NCT01789606|458857476|FG001|Overall Study|Adverse Event|3|||
127518403|NCT01789606|458857475|FG000|Overall Study|Lost to Follow-up|0|||
127518404|NCT01789606|458857476|FG001|Overall Study|Lost to Follow-up|14|||
127518405|NCT01789606|458857475|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
127518406|NCT01789606|458857476|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
127518407|NCT00417963|458858941|FG000|Overall Study|Lost to Follow-up|3|||
127518408|NCT00417963|458858941|FG000|Overall Study|Withdrawal by Subject|18|||
127518409|NCT00417963|458858941|FG000|Overall Study|Death|17|||
127518410|NCT00417963|458858941|FG000|Overall Study|Study device could not be deployed|3|||
127518411|NCT01023672|458858955|FG000|Overall Study|Worsening disease|2|||
127518412|NCT01023672|458858955|FG000|Overall Study|Death|1|||
127518413|NCT02166463|458858958|FG000|Overall Study|Lost to Follow-up|0|||
127518414|NCT02166463|458858959|FG001|Overall Study|Lost to Follow-up|1|||
127518415|NCT02166463|458858958|FG000|Overall Study|Physician Decision|10|||
127518416|NCT02166463|458858959|FG001|Overall Study|Physician Decision|10|||
127518417|NCT02166463|458858958|FG000|Overall Study|Ineligible|11|||
127518418|NCT02166463|458858959|FG001|Overall Study|Ineligible|2|||
127518419|NCT02166463|458858958|FG000|Overall Study|Progressive Disease|9|||
127518420|NCT02166463|458858959|FG001|Overall Study|Progressive Disease|6|||
127518421|NCT02166463|458858958|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
127518422|NCT02166463|458858959|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
127518423|NCT02166463|458858958|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
127518424|NCT02166463|458858959|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
127518425|NCT02166463|458858958|FG000|Overall Study|Refusal of further protocol therapy|5|||
127518426|NCT02166463|458858959|FG001|Overall Study|Refusal of further protocol therapy|6|||
127518427|NCT02478164|458858960|FG000|Overall Study|Lack of Efficacy|13|||
127518428|NCT02478164|458858960|FG000|Overall Study|Adverse Event|1|||
127518429|NCT02478164|458858960|FG000|Overall Study|Withdrawal by Subject|1|||
127518430|NCT04588389|458858961|FG000|Overall Study|Issues with anesthesia during surgery|2|||
127518431|NCT04588389|458858962|FG001|Overall Study|Issues with anesthesia during surgery|0|||
127518432|NCT04588389|458858963|FG002|Overall Study|Issues with anesthesia during surgery|0|||
127518433|NCT02911142|458858964|FG000|Phase I - Safety & Tolerability|Did not complete last cycle of EPOCH-R2 due to progressive disease.|1|||
127518434|NCT02911142|458858964|FG000|Phase II - Recommended Phase 2 Dose|Refused further treatment|1|||
127518435|NCT02911142|458858964|FG000|Phase II - Recommended Phase 2 Dose|Physician Decision|2|||
127518436|NCT02911142|458858964|FG000|Phase II - Recommended Phase 2 Dose|Death|1|||
127518437|NCT05779007|458858965|FG000|Overall Study|not meeting eligibility criteria|3517|||
127518438|NCT05779007|458858966|FG001|Overall Study|not meeting eligibility criteria|2009|||
127518439|NCT01638546|458858967|FG000|Overall Study|Adverse Event|1|||
127518440|NCT01638546|458858968|FG001|Overall Study|Adverse Event|3|||
127518441|NCT00549770|458858971|FG000|Overall Study|Protocol deviation|1|||
127518442|NCT00549770|458858972|FG001|Overall Study|Protocol deviation|1|||
127518443|NCT00549770|458858973|FG002|Overall Study|Protocol deviation|1|||
127518444|NCT00549770|458858974|FG003|Overall Study|Protocol deviation|2|||
127518445|NCT00549770|458858975|FG004|Overall Study|Protocol deviation|2|||
127518446|NCT00549770|458858976|FG005|Overall Study|Protocol deviation|2|||
127518447|NCT00549770|458858977|FG006|Overall Study|Protocol deviation|1|||
127518448|NCT00549770|458858978|FG007|Overall Study|Protocol deviation|2|||
127518449|NCT00549770|458858971|FG000|Overall Study|Administrative problems|0|||
127518450|NCT00549770|458858972|FG001|Overall Study|Administrative problems|1|||
127518451|NCT00549770|458858973|FG002|Overall Study|Administrative problems|0|||
127518452|NCT00549770|458858974|FG003|Overall Study|Administrative problems|0|||
127518453|NCT00549770|458858975|FG004|Overall Study|Administrative problems|0|||
127518454|NCT00549770|458858976|FG005|Overall Study|Administrative problems|0|||
127518455|NCT00549770|458858977|FG006|Overall Study|Administrative problems|0|||
127518456|NCT00549770|458858978|FG007|Overall Study|Administrative problems|1|||
127518457|NCT00549770|458858971|FG000|Overall Study|Lost to Follow-up|0|||
127518458|NCT00549770|458858972|FG001|Overall Study|Lost to Follow-up|0|||
127518459|NCT00549770|458858973|FG002|Overall Study|Lost to Follow-up|2|||
127518460|NCT00549770|458858974|FG003|Overall Study|Lost to Follow-up|2|||
127518461|NCT00549770|458858975|FG004|Overall Study|Lost to Follow-up|3|||
127518462|NCT00549770|458858976|FG005|Overall Study|Lost to Follow-up|2|||
127518463|NCT00549770|458858977|FG006|Overall Study|Lost to Follow-up|0|||
127518464|NCT00549770|458858978|FG007|Overall Study|Lost to Follow-up|0|||
127518465|NCT00549770|458858971|FG000|Overall Study|Withdrawal by Subject|4|||
127518466|NCT00549770|458858972|FG001|Overall Study|Withdrawal by Subject|6|||
127518467|NCT00549770|458858973|FG002|Overall Study|Withdrawal by Subject|4|||
127518468|NCT00549770|458858974|FG003|Overall Study|Withdrawal by Subject|5|||
127518469|NCT00549770|458858975|FG004|Overall Study|Withdrawal by Subject|6|||
127518470|NCT00549770|458858976|FG005|Overall Study|Withdrawal by Subject|6|||
127518471|NCT00549770|458858977|FG006|Overall Study|Withdrawal by Subject|4|||
127518472|NCT00549770|458858978|FG007|Overall Study|Withdrawal by Subject|9|||
127518473|NCT00549770|458858971|FG000|Overall Study|Lack of Efficacy|1|||
127518474|NCT00549770|458858972|FG001|Overall Study|Lack of Efficacy|0|||
127518475|NCT00549770|458858973|FG002|Overall Study|Lack of Efficacy|2|||
127518476|NCT00549770|458858974|FG003|Overall Study|Lack of Efficacy|3|||
127518477|NCT00549770|458858975|FG004|Overall Study|Lack of Efficacy|5|||
127518478|NCT00549770|458858976|FG005|Overall Study|Lack of Efficacy|1|||
127518479|NCT00549770|458858977|FG006|Overall Study|Lack of Efficacy|3|||
127518480|NCT00549770|458858978|FG007|Overall Study|Lack of Efficacy|8|||
127518481|NCT00549770|458858971|FG000|Overall Study|Abnormal test procedure results|0|||
127518482|NCT00549770|458858972|FG001|Overall Study|Abnormal test procedure results|0|||
127518483|NCT00549770|458858973|FG002|Overall Study|Abnormal test procedure results|0|||
127518484|NCT00549770|458858974|FG003|Overall Study|Abnormal test procedure results|2|||
127518485|NCT00549770|458858975|FG004|Overall Study|Abnormal test procedure results|0|||
127518486|NCT00549770|458858976|FG005|Overall Study|Abnormal test procedure results|1|||
127518487|NCT00549770|458858977|FG006|Overall Study|Abnormal test procedure results|1|||
127518488|NCT00549770|458858978|FG007|Overall Study|Abnormal test procedure results|1|||
127518489|NCT00549770|458858971|FG000|Overall Study|Abnormal laboratory values|0|||
127518490|NCT00549770|458858972|FG001|Overall Study|Abnormal laboratory values|0|||
127518491|NCT00549770|458858973|FG002|Overall Study|Abnormal laboratory values|0|||
127518492|NCT00549770|458858974|FG003|Overall Study|Abnormal laboratory values|0|||
127518493|NCT00549770|458858975|FG004|Overall Study|Abnormal laboratory values|0|||
127518494|NCT00549770|458858976|FG005|Overall Study|Abnormal laboratory values|1|||
127518495|NCT00549770|458858977|FG006|Overall Study|Abnormal laboratory values|0|||
127518496|NCT00549770|458858978|FG007|Overall Study|Abnormal laboratory values|0|||
127518497|NCT00549770|458858971|FG000|Overall Study|Adverse Event|1|||
127518498|NCT00549770|458858972|FG001|Overall Study|Adverse Event|3|||
127518499|NCT00549770|458858973|FG002|Overall Study|Adverse Event|1|||
127518500|NCT00549770|458858974|FG003|Overall Study|Adverse Event|2|||
127518501|NCT00549770|458858975|FG004|Overall Study|Adverse Event|1|||
127518502|NCT00549770|458858976|FG005|Overall Study|Adverse Event|0|||
127518503|NCT00549770|458858977|FG006|Overall Study|Adverse Event|5|||
127518504|NCT00549770|458858978|FG007|Overall Study|Adverse Event|4|||
127518505|NCT01079936|458858979|FG000|Phase I: MTD|First Remission Status|2|||
127518506|NCT01079936|458858980|FG001|Phase I: MTD|First Remission Status|0|||
127518507|NCT01079936|458858981|FG002|Phase I: MTD|First Remission Status|0|||
127518508|NCT01079936|458858982|FG003|Phase I: MTD|First Remission Status|0|||
127518509|NCT01079936|458858983|FG004|Phase I: MTD|First Remission Status|0|||
127518510|NCT01079936|458858979|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
127518511|NCT01079936|458858980|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
127518512|NCT01079936|458858981|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
127518513|NCT01079936|458858982|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
127518514|NCT01079936|458858983|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
127518515|NCT01079936|458858979|FG000|Phase II|Adverse Event|0|||
127518516|NCT01079936|458858980|FG001|Phase II|Adverse Event|0|||
127518517|NCT01079936|458858981|FG002|Phase II|Adverse Event|1|||
127518518|NCT01079936|458858982|FG003|Phase II|Adverse Event|0|||
127518519|NCT01079936|458858983|FG004|Phase II|Adverse Event|0|||
127518520|NCT01079936|458858979|FG000|Phase II|Insurance Issue|0|||
127518521|NCT01079936|458858980|FG001|Phase II|Insurance Issue|0|||
127518522|NCT01079936|458858981|FG002|Phase II|Insurance Issue|0|||
127518523|NCT01079936|458858982|FG003|Phase II|Insurance Issue|0|||
127518524|NCT01079936|458858983|FG004|Phase II|Insurance Issue|1|||
127518525|NCT02294734|458858984|FG000|Overall Study|Adverse Event|5|||
127518526|NCT02294734|458858985|FG001|Overall Study|Adverse Event|5|||
127518527|NCT02294734|458858984|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
127518528|NCT02294734|458858985|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
127518529|NCT02294734|458858984|FG000|Overall Study|Lost to Follow-up|2|||
127518530|NCT02294734|458858985|FG001|Overall Study|Lost to Follow-up|0|||
127518531|NCT02294734|458858984|FG000|Overall Study|Physician Decision|2|||
127518532|NCT02294734|458858985|FG001|Overall Study|Physician Decision|1|||
127518533|NCT02294734|458858984|FG000|Overall Study|Withdrawal by Subject|4|||
127518534|NCT02294734|458858985|FG001|Overall Study|Withdrawal by Subject|2|||
127518535|NCT00548717|458858986|FG000|Overall Study|Death|5|||
127518536|NCT00548717|458858987|FG001|Overall Study|Death|2|||
127518537|NCT00548717|458858986|FG000|Overall Study|Relapse|3|||
127518538|NCT00548717|458858987|FG001|Overall Study|Relapse|0|||
127518539|NCT00548717|458858986|FG000|Overall Study|Alternative treatment for GVHD|1|||
127518540|NCT00548717|458858987|FG001|Overall Study|Alternative treatment for GVHD|0|||
127518541|NCT03157583|458858988|FG000|Overall Study|Other (did not meet study criteria)|1|||
127518542|NCT00847015|458858992|FG000|Overall Study|Withdrawal by Subject|1|||
127518543|NCT00847015|458858992|FG000|Overall Study|declined any surgery|1|||
127518544|NCT00847015|458858992|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
127518545|NCT01141478|458858993|FG000|Overall Study|Withdrawal by Subject|1|||
127518546|NCT01141478|458858994|FG001|Overall Study|Withdrawal by Subject|1|||
127518547|NCT03847909|458859004|FG000|Overall Study|Withdrawal by Subject|1|||
127518548|NCT03847909|458859005|FG001|Overall Study|Withdrawal by Subject|1|||
127518549|NCT00975143|458859006|FG000|Overall Study|Adverse Event|19|||
127518550|NCT00975143|458859007|FG001|Overall Study|Adverse Event|15|||
127518551|NCT00975143|458859006|FG000|Overall Study|Withdrawal by Subject|15|||
127518552|NCT00975143|458859007|FG001|Overall Study|Withdrawal by Subject|15|||
127518553|NCT00975143|458859006|FG000|Overall Study|Lost to Follow-up|20|||
127518554|NCT00975143|458859007|FG001|Overall Study|Lost to Follow-up|16|||
127518555|NCT00975143|458859006|FG000|Overall Study|Non-compliance|5|||
127518556|NCT00975143|458859007|FG001|Overall Study|Non-compliance|8|||
127518557|NCT00975143|458859006|FG000|Overall Study|Physician Decision|1|||
127518558|NCT00975143|458859007|FG001|Overall Study|Physician Decision|2|||
127518559|NCT00975143|458859006|FG000|Overall Study|Details not available|10|||
127518560|NCT00975143|458859007|FG001|Overall Study|Details not available|4|||
127518561|NCT01375608|458859008|FG000|Overall Study|Withdrawal by Subject|2|||
127518562|NCT01953913|458859009|FG000|Overall Study|Disease Progression|349|||
127518563|NCT01953913|458859009|FG000|Overall Study|Worsening of underlying cancer|22|||
127518564|NCT01953913|458859009|FG000|Overall Study|Adverse Event|20|||
127518565|NCT01953913|458859009|FG000|Overall Study|Protocol Violation|6|||
127518566|NCT01953913|458859009|FG000|Overall Study|Lost to Follow-up|4|||
127518567|NCT01953913|458859009|FG000|Overall Study|Withdrawal by Subject|32|||
127518568|NCT01953913|458859009|FG000|Overall Study|Other than listed|108|||
127518569|NCT01953913|458859009|FG000|Overall Study|Not Treated|1|||
127518570|NCT02925741|458859012|FG000|Overall Study|Withdrawal by Subject|11|||
127518571|NCT02925741|458859013|FG001|Overall Study|Withdrawal by Subject|0|||
127518572|NCT05086510|458859014|FG000|Overall Study|Lost to Follow-up|0|||
127518573|NCT05086510|458859015|FG001|Overall Study|Lost to Follow-up|2|||
127518574|NCT05086510|458859014|FG000|Overall Study|Death|0|||
127518575|NCT05086510|458859015|FG001|Overall Study|Death|2|||
127518576|NCT03022981|458859016|FG000|Overall Study|Adverse Event|0|||
127518577|NCT03022981|458859017|FG001|Overall Study|Adverse Event|1|||
127518578|NCT03022981|458859018|FG002|Overall Study|Adverse Event|0|||
127518579|NCT03022981|458859016|FG000|Overall Study|Investigator's Discretion|0|||
127518580|NCT03022981|458859017|FG001|Overall Study|Investigator's Discretion|1|||
127518581|NCT03022981|458859018|FG002|Overall Study|Investigator's Discretion|2|||
127518582|NCT03022981|458859016|FG000|Overall Study|Lost to Follow-up|6|||
127518583|NCT03022981|458859017|FG001|Overall Study|Lost to Follow-up|2|||
127518584|NCT03022981|458859018|FG002|Overall Study|Lost to Follow-up|1|||
127518585|NCT03022981|458859016|FG000|Overall Study|Non-Compliance With Study Drug|0|||
127518586|NCT03022981|458859017|FG001|Overall Study|Non-Compliance With Study Drug|0|||
127518587|NCT03022981|458859018|FG002|Overall Study|Non-Compliance With Study Drug|2|||
127518588|NCT03022981|458859016|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
127518589|NCT03022981|458859017|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
127518590|NCT03022981|458859018|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
127518591|NCT00295932|458859019|FG000|Overall Study|Not Treated|0|||
127518592|NCT00295932|458859020|FG001|Overall Study|Not Treated|0|||
127518593|NCT00295932|458859021|FG002|Overall Study|Not Treated|0|||
127518594|NCT00295932|458859022|FG003|Overall Study|Not Treated|0|||
127518595|NCT00295932|458859023|FG004|Overall Study|Not Treated|0|||
127518596|NCT00295932|458859024|FG005|Overall Study|Not Treated|0|||
127518597|NCT00295932|458859025|FG006|Overall Study|Not Treated|0|||
127518598|NCT00295932|458859026|FG007|Overall Study|Not Treated|0|||
127518599|NCT00295932|458859027|FG008|Overall Study|Not Treated|0|||
127518600|NCT00295932|458859028|FG009|Overall Study|Not Treated|0|||
127518601|NCT00295932|458859029|FG010|Overall Study|Not Treated|1|||
127518602|NCT00109577|458859030|FG000|Overall Study|Withdrawal by Subject|3|||
127518603|NCT00109577|458859031|FG001|Overall Study|Withdrawal by Subject|3|||
127518604|NCT03322423|458859032|FG000|Period 1|Subject no longer eligible|0|||
127518605|NCT03322423|458859033|FG001|Period 1|Subject no longer eligible|1|||
127518606|NCT03322423|458859032|FG000|Period 1|Withdrawal by Subject|0|||
127518607|NCT03322423|458859033|FG001|Period 1|Withdrawal by Subject|1|||
127518608|NCT03322423|458859032|FG000|Period 1|Incorrect Lens Dispensed|1|||
127518609|NCT03322423|458859033|FG001|Period 1|Incorrect Lens Dispensed|0|||
127518610|NCT03322423|458859032|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
127518611|NCT03322423|458859033|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
127518612|NCT03322423|458859032|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
127518613|NCT03322423|458859033|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
127518614|NCT03322423|458859032|FG000|Period 2|Protocol Violation|1|||
127518615|NCT03322423|458859033|FG001|Period 2|Protocol Violation|0|||
127518616|NCT03322423|458859032|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
127518617|NCT03322423|458859033|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
127518618|NCT02337725|458859034|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
127518619|NCT02337725|458859035|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
127518620|NCT02337725|458859034|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
127518621|NCT02337725|458859035|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
127518622|NCT02337725|458859034|FG000|Overall Study|Major Protocol Deviation|0|||
127518623|NCT02337725|458859035|FG001|Overall Study|Major Protocol Deviation|1|||
127518624|NCT02337725|458859034|FG000|Overall Study|Voluntary Withdrawal|14|||
127518625|NCT02337725|458859035|FG001|Overall Study|Voluntary Withdrawal|3|||
127518626|NCT02337725|458859034|FG000|Overall Study|Lack of Efficacy|4|||
127518627|NCT02337725|458859035|FG001|Overall Study|Lack of Efficacy|0|||
127518628|NCT04891107|458859036|FG000|Overall Study|Physician Decision|1|||
127518629|NCT04891107|458859036|FG000|Overall Study|Withdrawal by Subject|1|||
127518630|NCT04891107|458859036|FG000|Overall Study|Screen failure after consent|1|||
127518631|NCT01571453|458859037|FG000|Overall Study|Adverse Event|14|||
127518632|NCT01571453|458859038|FG001|Overall Study|Adverse Event|32|||
127518633|NCT01571453|458859037|FG000|Overall Study|Lack of Efficacy|8|||
127518634|NCT01571453|458859038|FG001|Overall Study|Lack of Efficacy|3|||
127518635|NCT01571453|458859037|FG000|Overall Study|Non-compliance|2|||
127518636|NCT01571453|458859038|FG001|Overall Study|Non-compliance|4|||
127518637|NCT01571453|458859037|FG000|Overall Study|Protocol Violation|1|||
127518638|NCT01571453|458859038|FG001|Overall Study|Protocol Violation|5|||
127518639|NCT01571453|458859037|FG000|Overall Study|Withdrawal of consent|5|||
127518640|NCT01571453|458859038|FG001|Overall Study|Withdrawal of consent|13|||
127518641|NCT01571453|458859037|FG000|Overall Study|Lost to Follow-up|4|||
127518642|NCT01571453|458859038|FG001|Overall Study|Lost to Follow-up|2|||
127518643|NCT01571453|458859037|FG000|Overall Study|Administrative or other reason(s)|4|||
127518644|NCT01571453|458859038|FG001|Overall Study|Administrative or other reason(s)|3|||
127518645|NCT00500760|458859046|FG000|Overall Study|Death|32|||
127518646|NCT00500760|458859047|FG001|Overall Study|Death|15|||
127518647|NCT00500760|458859046|FG000|Overall Study|Withdrawal by Subject|5|||
127518648|NCT00500760|458859047|FG001|Overall Study|Withdrawal by Subject|7|||
127518649|NCT00500760|458859046|FG000|Overall Study|Administrative decision|2|||
127518650|NCT00500760|458859047|FG001|Overall Study|Administrative decision|0|||
127518651|NCT00500760|458859046|FG000|Overall Study|Lost to Follow-up|3|||
127518652|NCT00500760|458859047|FG001|Overall Study|Lost to Follow-up|0|||
127518653|NCT00500760|458859046|FG000|Overall Study|Other|1|||
127518654|NCT00500760|458859047|FG001|Overall Study|Other|2|||
127518655|NCT03178669|458859048|FG000|Overall Study|Adverse Event|4|||
127518656|NCT03178669|458859049|FG001|Overall Study|Adverse Event|1|||
127518657|NCT03178669|458859050|FG002|Overall Study|Adverse Event|4|||
127518658|NCT03178669|458859051|FG003|Overall Study|Adverse Event|2|||
127518659|NCT03178669|458859052|FG004|Overall Study|Adverse Event|2|||
127518660|NCT03178669|458859048|FG000|Overall Study|Lack of Efficacy|0|||
127518661|NCT03178669|458859049|FG001|Overall Study|Lack of Efficacy|0|||
127518662|NCT03178669|458859050|FG002|Overall Study|Lack of Efficacy|2|||
127518663|NCT03178669|458859051|FG003|Overall Study|Lack of Efficacy|0|||
127518664|NCT03178669|458859052|FG004|Overall Study|Lack of Efficacy|1|||
127518665|NCT03178669|458859048|FG000|Overall Study|Physician Decision|0|||
127518666|NCT03178669|458859049|FG001|Overall Study|Physician Decision|0|||
127518667|NCT03178669|458859050|FG002|Overall Study|Physician Decision|0|||
127518668|NCT03178669|458859051|FG003|Overall Study|Physician Decision|0|||
127518669|NCT03178669|458859052|FG004|Overall Study|Physician Decision|1|||
127518670|NCT03178669|458859048|FG000|Overall Study|Withdrawal by Subject|1|||
127518671|NCT03178669|458859049|FG001|Overall Study|Withdrawal by Subject|0|||
127518672|NCT03178669|458859050|FG002|Overall Study|Withdrawal by Subject|1|||
127518673|NCT03178669|458859051|FG003|Overall Study|Withdrawal by Subject|1|||
127518674|NCT03178669|458859052|FG004|Overall Study|Withdrawal by Subject|0|||
127518675|NCT03178669|458859048|FG000|Overall Study|Lost to Follow-up|0|||
127518676|NCT03178669|458859049|FG001|Overall Study|Lost to Follow-up|0|||
127518677|NCT03178669|458859050|FG002|Overall Study|Lost to Follow-up|0|||
127518678|NCT03178669|458859051|FG003|Overall Study|Lost to Follow-up|1|||
127518679|NCT03178669|458859052|FG004|Overall Study|Lost to Follow-up|0|||
127518680|NCT01600092|458859053|FG000|Overall Study|Adverse Event|2|||
127518681|NCT01600092|458859054|FG001|Overall Study|Adverse Event|0|||
127518682|NCT01600092|458859053|FG000|Overall Study|Lost to Follow-up|4|||
127518683|NCT01600092|458859054|FG001|Overall Study|Lost to Follow-up|6|||
127518684|NCT01600092|458859053|FG000|Overall Study|Withdrawal by parent/guardian|8|||
127518685|NCT01600092|458859054|FG001|Overall Study|Withdrawal by parent/guardian|6|||
127518686|NCT01600092|458859053|FG000|Overall Study|Physician Decision|1|||
127518687|NCT01600092|458859054|FG001|Overall Study|Physician Decision|1|||
127518688|NCT01600092|458859053|FG000|Overall Study|Randomized but not vaccinated|3|||
127518689|NCT01600092|458859054|FG001|Overall Study|Randomized but not vaccinated|3|||
127518690|NCT00079677|458859055|FG000|Overall Study|Adverse Event|5|||
127518691|NCT00079677|458859056|FG001|Overall Study|Adverse Event|6|||
127518692|NCT00079677|458859055|FG000|Overall Study|Lack of Efficacy|1|||
127518693|NCT00079677|458859056|FG001|Overall Study|Lack of Efficacy|0|||
127518694|NCT00079677|458859055|FG000|Overall Study|Lost to Follow-up|2|||
127518695|NCT00079677|458859056|FG001|Overall Study|Lost to Follow-up|2|||
127518696|NCT00079677|458859055|FG000|Overall Study|Physician Decision|3|||
127518697|NCT00079677|458859056|FG001|Overall Study|Physician Decision|0|||
127518698|NCT00079677|458859055|FG000|Overall Study|Protocol Violation|2|||
127518699|NCT00079677|458859056|FG001|Overall Study|Protocol Violation|3|||
127518700|NCT00079677|458859055|FG000|Overall Study|Withdrawal by Subject|5|||
127518701|NCT00079677|458859056|FG001|Overall Study|Withdrawal by Subject|3|||
127518702|NCT00079677|458859055|FG000|Overall Study|Miscellaneous|2|||
127518703|NCT00079677|458859056|FG001|Overall Study|Miscellaneous|0|||
127518704|NCT00565136|458859057|FG000|Overall Study|Lost to Follow-up|1|||
127518705|NCT00565136|458859057|FG000|Overall Study|Withdrawal by Subject|1|||
127518706|NCT00565136|458859057|FG000|Overall Study|Protocol Violation|1|||
127518707|NCT04284774|458859059|FG000|Overall Study|Progressive disease|5|||
127518708|NCT02879578|458859060|FG000|Overall Study|Adverse Event|1|||
127518709|NCT02879578|458859061|FG001|Overall Study|Adverse Event|2|||
127518710|NCT02879578|458859062|FG002|Overall Study|Adverse Event|14|||
127518711|NCT02879578|458859060|FG000|Overall Study|Protocol Violation|0|||
127518712|NCT02879578|458859061|FG001|Overall Study|Protocol Violation|1|||
127518713|NCT02879578|458859062|FG002|Overall Study|Protocol Violation|1|||
127518714|NCT02879578|458859060|FG000|Overall Study|Withdrawal by Subject|8|||
127518715|NCT02879578|458859061|FG001|Overall Study|Withdrawal by Subject|6|||
127518716|NCT02879578|458859062|FG002|Overall Study|Withdrawal by Subject|9|||
127518717|NCT02879578|458859060|FG000|Overall Study|Lost to Follow-up|1|||
127518718|NCT02879578|458859061|FG001|Overall Study|Lost to Follow-up|0|||
127518719|NCT02879578|458859062|FG002|Overall Study|Lost to Follow-up|4|||
127518720|NCT02879578|458859060|FG000|Overall Study|Physician Decision|0|||
127518721|NCT02879578|458859061|FG001|Overall Study|Physician Decision|0|||
127518722|NCT02879578|458859062|FG002|Overall Study|Physician Decision|4|||
127518723|NCT00279812|458859067|FG000|Overall Study|Protocol Violation|1|||
127518724|NCT00279812|458859068|FG001|Overall Study|Protocol Violation|1|||
127518725|NCT00279812|458859069|FG002|Overall Study|Protocol Violation|0|||
127518726|NCT00279812|458859070|FG003|Overall Study|Protocol Violation|0|||
127518727|NCT00279812|458859071|FG004|Overall Study|Protocol Violation|1|||
127518728|NCT00279812|458859072|FG005|Overall Study|Protocol Violation|0|||
127518729|NCT00279812|458859067|FG000|Overall Study|Withdrawal by Subject|0|||
127518730|NCT00279812|458859068|FG001|Overall Study|Withdrawal by Subject|4|||
127518731|NCT00279812|458859069|FG002|Overall Study|Withdrawal by Subject|2|||
127518732|NCT00279812|458859070|FG003|Overall Study|Withdrawal by Subject|0|||
127518733|NCT00279812|458859071|FG004|Overall Study|Withdrawal by Subject|0|||
127518734|NCT00279812|458859072|FG005|Overall Study|Withdrawal by Subject|0|||
127518735|NCT00279812|458859067|FG000|Overall Study|Adverse Event|0|||
127518736|NCT00279812|458859068|FG001|Overall Study|Adverse Event|1|||
127518737|NCT00279812|458859069|FG002|Overall Study|Adverse Event|1|||
127518738|NCT00279812|458859070|FG003|Overall Study|Adverse Event|0|||
127518739|NCT00279812|458859071|FG004|Overall Study|Adverse Event|2|||
127518740|NCT00279812|458859072|FG005|Overall Study|Adverse Event|1|||
127518741|NCT01274429|458859073|FG000|Overall Study|Study closed do to lack of funding|5|||
127518742|NCT01879072|458859081|FG000|Overall Study|Withdrawal by Subject|121|||
127518743|NCT01879072|458859081|FG000|Overall Study|Not Transplanted|30|||
127518744|NCT05327361|458859082|FG000|Overall Study|Lost to Follow-up|4|||
127518745|NCT01439373|458859092|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
127518746|NCT01439373|458859093|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
127518747|NCT01439373|458859092|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
127518748|NCT01439373|458859093|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
127518749|NCT03281304|458859094|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
127518750|NCT03281304|458859095|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
127518751|NCT03281304|458859094|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
127518752|NCT03281304|458859095|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
127518753|NCT03281304|458859094|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
127518754|NCT03281304|458859095|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
127518755|NCT03281304|458859094|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
127518756|NCT03281304|458859095|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
127518757|NCT03281304|458859094|FG000|Treatment Phase (up to 42 Months)|Death|0|||
127518758|NCT03281304|458859095|FG001|Treatment Phase (up to 42 Months)|Death|1|||
127518759|NCT03281304|458859094|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
127518760|NCT03281304|458859095|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
127518761|NCT03281304|458859094|FG000|Treatment Phase (up to 42 Months)|Other|0|||
127518762|NCT03281304|458859095|FG001|Treatment Phase (up to 42 Months)|Other|2|||
127518763|NCT03281304|458859094|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
127518764|NCT03281304|458859095|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
127518765|NCT00626405|458859096|FG000|Overall Study|Deemed Ineligible|1|||
127518766|NCT00626405|458859097|FG001|Overall Study|Deemed Ineligible|0|||
127518767|NCT00626405|458859096|FG000|Overall Study|Withdrawal by Subject|0|||
127518768|NCT00626405|458859097|FG001|Overall Study|Withdrawal by Subject|1|||
127518769|NCT03834220|458859098|FG000|Overall Study|Adverse Event|1|||
127518770|NCT03834220|458859099|FG001|Overall Study|Adverse Event|0|||
127518771|NCT03834220|458859100|FG002|Overall Study|Adverse Event|0|||
127518772|NCT03834220|458859098|FG000|Overall Study|Death|8|||
127518773|NCT03834220|458859099|FG001|Overall Study|Death|1|||
127518774|NCT03834220|458859100|FG002|Overall Study|Death|17|||
127518775|NCT03834220|458859098|FG000|Overall Study|Reason not Specified|9|||
127518776|NCT03834220|458859099|FG001|Overall Study|Reason not Specified|0|||
127518777|NCT03834220|458859100|FG002|Overall Study|Reason not Specified|6|||
127518778|NCT03834220|458859098|FG000|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|10|||
127518779|NCT03834220|458859099|FG001|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|1|||
127518780|NCT03834220|458859100|FG002|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|4|||
127518781|NCT03834220|458859098|FG000|Overall Study|Withdrawal of Consent|2|||
127518782|NCT03834220|458859099|FG001|Overall Study|Withdrawal of Consent|2|||
127518783|NCT03834220|458859100|FG002|Overall Study|Withdrawal of Consent|2|||
127518784|NCT02593318|458859101|FG000|Overall Study|Withdrawal by Subject|1|||
127518785|NCT02593318|458859102|FG001|Overall Study|Withdrawal by Subject|1|||
127518786|NCT01740401|458861616|FG000|Overall Study|Progression of disease|6|||
127518787|NCT01740401|458861616|FG000|Overall Study|Adverse Event|2|||
127518788|NCT01740401|458861616|FG000|Overall Study|Did not reach primary endpoint|2|||
127518789|NCT03667690|458861617|FG000|Overall Study|Adverse Event|0|||
127518790|NCT03667690|458861618|FG001|Overall Study|Adverse Event|3|||
127518791|NCT03667690|458861617|FG000|Overall Study|Death|22|||
127518792|NCT03667690|458861618|FG001|Overall Study|Death|21|||
127518793|NCT03667690|458861617|FG000|Overall Study|Lost to Follow-up|4|||
127518794|NCT03667690|458861618|FG001|Overall Study|Lost to Follow-up|5|||
127518795|NCT03667690|458861617|FG000|Overall Study|Withdrawal by Subject|7|||
127518796|NCT03667690|458861618|FG001|Overall Study|Withdrawal by Subject|8|||
127518797|NCT03667690|458861617|FG000|Overall Study|Subject could not return for additional investigational product|1|||
127518798|NCT03667690|458861618|FG001|Overall Study|Subject could not return for additional investigational product|0|||
127518799|NCT03667690|458861617|FG000|Overall Study|Subject discharged to hospice care|2|||
127518800|NCT03667690|458861618|FG001|Overall Study|Subject discharged to hospice care|0|||
127518801|NCT03667690|458861617|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
127518802|NCT03667690|458861618|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
127518803|NCT03667690|458861617|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
127518804|NCT03667690|458861618|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
127518805|NCT03667690|458861617|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
127518806|NCT03667690|458861618|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
127518807|NCT03667690|458861617|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
127518808|NCT03667690|458861618|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
127518809|NCT03667690|458861617|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
127518810|NCT03667690|458861618|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
127518811|NCT03495102|458861619|FG000|Overall Study|Adverse Event|5|||
127518812|NCT03495102|458861620|FG001|Overall Study|Adverse Event|7|||
127518813|NCT03495102|458861621|FG002|Overall Study|Adverse Event|10|||
127518814|NCT03495102|458861619|FG000|Overall Study|Death|3|||
127518815|NCT03495102|458861620|FG001|Overall Study|Death|4|||
127518816|NCT03495102|458861621|FG002|Overall Study|Death|4|||
127518817|NCT03495102|458861619|FG000|Overall Study|Lost to Follow-up|15|||
127518818|NCT03495102|458861620|FG001|Overall Study|Lost to Follow-up|16|||
127518819|NCT03495102|458861621|FG002|Overall Study|Lost to Follow-up|17|||
127518820|NCT03495102|458861619|FG000|Overall Study|Physician Decision|2|||
127518821|NCT03495102|458861620|FG001|Overall Study|Physician Decision|0|||
127518822|NCT03495102|458861621|FG002|Overall Study|Physician Decision|2|||
127518823|NCT03495102|458861619|FG000|Overall Study|Withdrawal by Subject|25|||
127518824|NCT03495102|458861620|FG001|Overall Study|Withdrawal by Subject|36|||
127518825|NCT03495102|458861621|FG002|Overall Study|Withdrawal by Subject|18|||
127518826|NCT03495102|458861619|FG000|Overall Study|Protocol Violation|1|||
127518827|NCT03495102|458861620|FG001|Overall Study|Protocol Violation|1|||
127518828|NCT03495102|458861621|FG002|Overall Study|Protocol Violation|0|||
127518829|NCT03495102|458861619|FG000|Overall Study|Site Closure|3|||
127518830|NCT03495102|458861620|FG001|Overall Study|Site Closure|1|||
127518831|NCT03495102|458861621|FG002|Overall Study|Site Closure|2|||
127518832|NCT03495102|458861619|FG000|Overall Study|Non-compliance|1|||
127518833|NCT03495102|458861620|FG001|Overall Study|Non-compliance|0|||
127518834|NCT03495102|458861621|FG002|Overall Study|Non-compliance|0|||
127518835|NCT03495102|458861619|FG000|Overall Study|Participant Duplicated at Another Site|0|||
127518836|NCT03495102|458861620|FG001|Overall Study|Participant Duplicated at Another Site|0|||
127518837|NCT03495102|458861621|FG002|Overall Study|Participant Duplicated at Another Site|1|||
127518838|NCT03495102|458861619|FG000|Overall Study|Primary Care Physician Recommendation|0|||
127518839|NCT03495102|458861620|FG001|Overall Study|Primary Care Physician Recommendation|1|||
127518840|NCT03495102|458861621|FG002|Overall Study|Primary Care Physician Recommendation|0|||
127518841|NCT03495102|458861619|FG000|Overall Study|Relocated to Another Country|0|||
127518842|NCT03495102|458861620|FG001|Overall Study|Relocated to Another Country|1|||
127518843|NCT03495102|458861621|FG002|Overall Study|Relocated to Another Country|0|||
127518844|NCT03495102|458861619|FG000|Overall Study|Participant was in Rehabilitation|1|||
127518845|NCT03495102|458861620|FG001|Overall Study|Participant was in Rehabilitation|0|||
127518846|NCT03495102|458861621|FG002|Overall Study|Participant was in Rehabilitation|0|||
127518847|NCT01161537|458861623|FG000|Part B|Withdrawal by Subject|2|||
127518848|NCT00321464|458861626|FG000|Overall Study|Death|169|||
127518849|NCT00321464|458861627|FG001|Overall Study|Death|174|||
127518850|NCT00321464|458861626|FG000|Overall Study|Disease progression|124|||
127518851|NCT00321464|458861627|FG001|Overall Study|Disease progression|124|||
127518852|NCT00321464|458861626|FG000|Overall Study|Withdrawal by Subject|117|||
127518853|NCT00321464|458861627|FG001|Overall Study|Withdrawal by Subject|118|||
127518854|NCT00321464|458861626|FG000|Overall Study|Participant request|57|||
127518855|NCT00321464|458861627|FG001|Overall Study|Participant request|61|||
127518856|NCT00321464|458861626|FG000|Overall Study|Adverse Event|43|||
127518857|NCT00321464|458861627|FG001|Overall Study|Adverse Event|28|||
127518858|NCT00321464|458861626|FG000|Overall Study|Physician Decision|15|||
127518859|NCT00321464|458861627|FG001|Overall Study|Physician Decision|14|||
127518860|NCT00321464|458861626|FG000|Overall Study|Noncompliance|4|||
127518861|NCT00321464|458861627|FG001|Overall Study|Noncompliance|10|||
127518862|NCT00321464|458861626|FG000|Overall Study|Lost to Follow-up|7|||
127518863|NCT00321464|458861627|FG001|Overall Study|Lost to Follow-up|8|||
127518864|NCT00321464|458861626|FG000|Overall Study|Protocol deviation|0|||
127518865|NCT00321464|458861627|FG001|Overall Study|Protocol deviation|2|||
127518866|NCT00321464|458861626|FG000|Overall Study|Ineligibility determined|2|||
127518867|NCT00321464|458861627|FG001|Overall Study|Ineligibility determined|1|||
127518868|NCT00321464|458861626|FG000|Overall Study|Other|21|||
127518869|NCT00321464|458861627|FG001|Overall Study|Other|18|||
127518870|NCT04327024|458861628|FG000|Overall Study|Death|1|||
127518871|NCT04327024|458861629|FG001|Overall Study|Death|2|||
127518872|NCT04327024|458861630|FG002|Overall Study|Death|1|||
127518873|NCT04327024|458861628|FG000|Overall Study|Non-compliance with study drug|0|||
127518874|NCT04327024|458861629|FG001|Overall Study|Non-compliance with study drug|1|||
127518875|NCT04327024|458861630|FG002|Overall Study|Non-compliance with study drug|0|||
127518876|NCT04327024|458861628|FG000|Overall Study|Withdrawal by Subject|1|||
127518877|NCT04327024|458861629|FG001|Overall Study|Withdrawal by Subject|1|||
127518878|NCT04327024|458861630|FG002|Overall Study|Withdrawal by Subject|2|||
127518879|NCT01192568|458861634|FG000|Open Label Pre-Amendment 3|Adverse Event|0|||
127518880|NCT01192568|458861635|FG001|Open Label Pre-Amendment 3|Adverse Event|0|||
127518881|NCT01192568|458861636|FG002|Open Label Pre-Amendment 3|Adverse Event|1|||
127518882|NCT01192568|458861637|FG003|Open Label Pre-Amendment 3|Adverse Event|0|||
127518883|NCT01192568|458861634|FG000|Open Label Post-Amendment 3|Adverse Event|0|||
127518884|NCT01192568|458861635|FG001|Open Label Post-Amendment 3|Adverse Event|0|||
127518885|NCT01192568|458861636|FG002|Open Label Post-Amendment 3|Adverse Event|0|||
127518886|NCT01192568|458861637|FG003|Open Label Post-Amendment 3|Adverse Event|1|||
127518887|NCT00652951|458861638|FG000|Booster Phase|Adverse event, non-fatal|0|||
127518888|NCT00652951|458861639|FG001|Booster Phase|Adverse event, non-fatal|1|||
127518889|NCT00652951|458861640|FG002|Booster Phase|Adverse event, non-fatal|0|||
127518890|NCT00652951|458861638|FG000|Booster Phase|Other|1|||
127518891|NCT00652951|458861639|FG001|Booster Phase|Other|0|||
127518892|NCT00652951|458861640|FG002|Booster Phase|Other|0|||
127518893|NCT02593825|458861641|FG000|Intervention|Lost to Follow-up|10|||
127518894|NCT02593825|458861642|FG001|Intervention|Lost to Follow-up|12|||
127518895|NCT01206582|458861643|FG000|Overall Study|Withdrew prior to study|1|||
127518896|NCT01206582|458861644|FG001|Overall Study|Withdrew prior to study|0|||
127518897|NCT01206582|458861643|FG000|Overall Study|Discontinued intervention before week 8|1|||
127518898|NCT01206582|458861644|FG001|Overall Study|Discontinued intervention before week 8|2|||
127518899|NCT02522325|458861645|FG000|Overall Study|Adverse Event|0|||
127518900|NCT02522325|458861646|FG001|Overall Study|Adverse Event|1|||
127518901|NCT01209078|458861647|FG000|Overall Study|Adverse Event|5|||
127518902|NCT01209078|458861648|FG001|Overall Study|Adverse Event|0|||
127518903|NCT01209078|458861647|FG000|Overall Study|Lost to Follow-up|4|||
127518904|NCT01209078|458861648|FG001|Overall Study|Lost to Follow-up|0|||
127518905|NCT01209078|458861647|FG000|Overall Study|Physician Decision|5|||
127518906|NCT01209078|458861648|FG001|Overall Study|Physician Decision|2|||
127518907|NCT01209078|458861647|FG000|Overall Study|Withdrawal by Subject|2|||
127518908|NCT01209078|458861648|FG001|Overall Study|Withdrawal by Subject|1|||
127518909|NCT00924508|458861649|FG000|Overall Study|Withdrawal by Subject|3|||
127518910|NCT00511134|458861653|FG000|Overall Study|Withdrawal by Subject|0|||
127518911|NCT00511134|458861654|FG001|Overall Study|Withdrawal by Subject|2|||
127518912|NCT01949090|458861655|FG000|Overall Study|Serious Adverse Event|0|||
127518913|NCT01949090|458861656|FG001|Overall Study|Serious Adverse Event|1|||
127518914|NCT01949090|458861657|FG002|Overall Study|Serious Adverse Event|2|||
127518915|NCT01949090|458861658|FG003|Overall Study|Serious Adverse Event|0|||
127518916|NCT01949090|458861659|FG004|Overall Study|Serious Adverse Event|1|||
127518917|NCT01949090|458861655|FG000|Overall Study|Withdrawal by Subject|2|||
127518918|NCT01949090|458861656|FG001|Overall Study|Withdrawal by Subject|0|||
127518919|NCT01949090|458861657|FG002|Overall Study|Withdrawal by Subject|0|||
127518920|NCT01949090|458861658|FG003|Overall Study|Withdrawal by Subject|0|||
127518921|NCT01949090|458861659|FG004|Overall Study|Withdrawal by Subject|1|||
127518922|NCT01949090|458861655|FG000|Overall Study|Protocol non-compliance|0|||
127518923|NCT01949090|458861656|FG001|Overall Study|Protocol non-compliance|0|||
127518924|NCT01949090|458861657|FG002|Overall Study|Protocol non-compliance|0|||
127518925|NCT01949090|458861658|FG003|Overall Study|Protocol non-compliance|0|||
127518926|NCT01949090|458861659|FG004|Overall Study|Protocol non-compliance|1|||
127518927|NCT01949090|458861655|FG000|Overall Study|Lost to Follow-up|2|||
127518928|NCT01949090|458861656|FG001|Overall Study|Lost to Follow-up|1|||
127518929|NCT01949090|458861657|FG002|Overall Study|Lost to Follow-up|0|||
127518930|NCT01949090|458861658|FG003|Overall Study|Lost to Follow-up|1|||
127518931|NCT01949090|458861659|FG004|Overall Study|Lost to Follow-up|1|||
127518932|NCT03459365|458861660|FG000|Overall Study|Withdrawal by Subject|6|||
127518933|NCT03459365|458861660|FG000|Overall Study|Protocol Violation|8|||
127518934|NCT02207491|458861662|FG000|Overall Study|Adverse Event|20|||
127518935|NCT02207491|458861663|FG001|Overall Study|Adverse Event|4|||
127518936|NCT02207491|458861662|FG000|Overall Study|Withdrawal by Subject|3|||
127518937|NCT02207491|458861663|FG001|Overall Study|Withdrawal by Subject|2|||
127518938|NCT02207491|458861662|FG000|Overall Study|Non-compliant|0|||
127518939|NCT02207491|458861663|FG001|Overall Study|Non-compliant|1|||
127518940|NCT02207491|458861662|FG000|Overall Study|Lost to Follow-up|0|||
127518941|NCT02207491|458861663|FG001|Overall Study|Lost to Follow-up|1|||
127518942|NCT02207491|458861662|FG000|Overall Study|Lack of Efficacy|3|||
127518943|NCT02207491|458861663|FG001|Overall Study|Lack of Efficacy|0|||
127518944|NCT02207491|458861662|FG000|Overall Study|Physician Decision|2|||
127518945|NCT02207491|458861663|FG001|Overall Study|Physician Decision|0|||
127518946|NCT02207491|458861662|FG000|Overall Study|Protocol Violation|3|||
127518947|NCT02207491|458861663|FG001|Overall Study|Protocol Violation|5|||
127518948|NCT00387725|458861664|FG000|Overall Study|Adverse Event|0|||
127518949|NCT00387725|458861665|FG001|Overall Study|Adverse Event|0|||
127518950|NCT00387725|458861666|FG002|Overall Study|Adverse Event|0|||
127518951|NCT00387725|458861667|FG003|Overall Study|Adverse Event|1|||
127518952|NCT00387725|458861664|FG000|Overall Study|Protocol Violation|0|||
127518953|NCT00387725|458861665|FG001|Overall Study|Protocol Violation|1|||
127518954|NCT00387725|458861666|FG002|Overall Study|Protocol Violation|0|||
127518955|NCT00387725|458861667|FG003|Overall Study|Protocol Violation|0|||
127518956|NCT00387725|458861664|FG000|Overall Study|Withdrawal by Subject|1|||
127518957|NCT00387725|458861665|FG001|Overall Study|Withdrawal by Subject|0|||
127518958|NCT00387725|458861666|FG002|Overall Study|Withdrawal by Subject|1|||
127518959|NCT00387725|458861667|FG003|Overall Study|Withdrawal by Subject|0|||
127518960|NCT00387725|458861664|FG000|Overall Study|Parent/legal guardian request|0|||
127518961|NCT00387725|458861665|FG001|Overall Study|Parent/legal guardian request|0|||
127518962|NCT00387725|458861666|FG002|Overall Study|Parent/legal guardian request|1|||
127518963|NCT00387725|458861667|FG003|Overall Study|Parent/legal guardian request|1|||
127518964|NCT02017522|458861668|FG000|Overall Study|Withdrawal by Subject|1|||
127518965|NCT01272869|458861669|FG000|Period 2 (14 Days)|Adverse Event|1|||
127518966|NCT01272869|458861670|FG001|Period 2 (14 Days)|Adverse Event|0|||
127518967|NCT00859937|458861671|FG000|Overall Study|Protocol Violation|1|||
127518968|NCT00859937|458861672|FG001|Overall Study|Protocol Violation|0|||
127518969|NCT00615030|458861673|FG000|Period I|Administrative problem|0|||
127518970|NCT00615030|458861674|FG001|Period I|Administrative problem|0|||
127518971|NCT00615030|458861675|FG002|Period I|Administrative problem|0|||
127518972|NCT00615030|458861676|FG003|Period I|Administrative problem|0|||
127518973|NCT00615030|458861677|FG004|Period I|Administrative problem|1|||
127518974|NCT00615030|458861678|FG005|Period I|Administrative problem|0|||
127518975|NCT00615030|458861679|FG006|Period I|Administrative problem|0|||
127518976|NCT00615030|458861680|FG007|Period I|Administrative problem|0|||
127518977|NCT00615030|458861681|FG008|Period I|Administrative problem|0|||
127518978|NCT00615030|458861682|FG009|Period I|Administrative problem|0|||
127518979|NCT00615030|458861683|FG010|Period I|Administrative problem|0|||
127518980|NCT00615030|458861684|FG011|Period I|Administrative problem|0|||
127518981|NCT00615030|458861673|FG000|Period I|Protocol deviation|1|||
127518982|NCT00615030|458861674|FG001|Period I|Protocol deviation|0|||
127518983|NCT00615030|458861675|FG002|Period I|Protocol deviation|0|||
127518984|NCT00615030|458861676|FG003|Period I|Protocol deviation|0|||
127518985|NCT00615030|458861677|FG004|Period I|Protocol deviation|0|||
127518986|NCT00615030|458861678|FG005|Period I|Protocol deviation|0|||
127518987|NCT00615030|458861679|FG006|Period I|Protocol deviation|0|||
127518988|NCT00615030|458861680|FG007|Period I|Protocol deviation|0|||
127518989|NCT00615030|458861681|FG008|Period I|Protocol deviation|0|||
127518990|NCT00615030|458861682|FG009|Period I|Protocol deviation|0|||
127518991|NCT00615030|458861683|FG010|Period I|Protocol deviation|0|||
127518992|NCT00615030|458861684|FG011|Period I|Protocol deviation|0|||
127518993|NCT00615030|458861673|FG000|Period I|Subject withdrew consent|0|||
127518994|NCT00615030|458861674|FG001|Period I|Subject withdrew consent|0|||
127518995|NCT00615030|458861675|FG002|Period I|Subject withdrew consent|0|||
127518996|NCT00615030|458861676|FG003|Period I|Subject withdrew consent|0|||
127518997|NCT00615030|458861677|FG004|Period I|Subject withdrew consent|0|||
127518998|NCT00615030|458861678|FG005|Period I|Subject withdrew consent|0|||
127518999|NCT00615030|458861679|FG006|Period I|Subject withdrew consent|0|||
127519000|NCT00615030|458861680|FG007|Period I|Subject withdrew consent|0|||
127519001|NCT00615030|458861681|FG008|Period I|Subject withdrew consent|1|||
127519002|NCT00615030|458861682|FG009|Period I|Subject withdrew consent|0|||
127519003|NCT00615030|458861683|FG010|Period I|Subject withdrew consent|1|||
127519004|NCT00615030|458861684|FG011|Period I|Subject withdrew consent|1|||
127519005|NCT00615030|458861673|FG000|Period I|Abnormal laboratory value(s)|0|||
127519006|NCT00615030|458861674|FG001|Period I|Abnormal laboratory value(s)|0|||
127519007|NCT00615030|458861675|FG002|Period I|Abnormal laboratory value(s)|0|||
127519008|NCT00615030|458861676|FG003|Period I|Abnormal laboratory value(s)|0|||
127519009|NCT00615030|458861677|FG004|Period I|Abnormal laboratory value(s)|0|||
127519010|NCT00615030|458861678|FG005|Period I|Abnormal laboratory value(s)|1|||
127519011|NCT00615030|458861679|FG006|Period I|Abnormal laboratory value(s)|0|||
127519012|NCT00615030|458861680|FG007|Period I|Abnormal laboratory value(s)|0|||
127519013|NCT00615030|458861681|FG008|Period I|Abnormal laboratory value(s)|0|||
127519014|NCT00615030|458861682|FG009|Period I|Abnormal laboratory value(s)|0|||
127519015|NCT00615030|458861683|FG010|Period I|Abnormal laboratory value(s)|0|||
127519016|NCT00615030|458861684|FG011|Period I|Abnormal laboratory value(s)|0|||
127519017|NCT00615030|458861673|FG000|Period II|Adverse Event|0|||
127519018|NCT00615030|458861674|FG001|Period II|Adverse Event|0|||
127519019|NCT00615030|458861675|FG002|Period II|Adverse Event|1|||
127519020|NCT00615030|458861676|FG003|Period II|Adverse Event|0|||
127519021|NCT00615030|458861677|FG004|Period II|Adverse Event|0|||
127519022|NCT00615030|458861678|FG005|Period II|Adverse Event|0|||
127519023|NCT00615030|458861679|FG006|Period II|Adverse Event|0|||
127519024|NCT00615030|458861680|FG007|Period II|Adverse Event|0|||
127519025|NCT00615030|458861681|FG008|Period II|Adverse Event|1|||
127519026|NCT00615030|458861682|FG009|Period II|Adverse Event|0|||
127519027|NCT00615030|458861683|FG010|Period II|Adverse Event|0|||
127519028|NCT00615030|458861684|FG011|Period II|Adverse Event|0|||
127519029|NCT00615030|458861673|FG000|Period II|Subject withdrew consent|0|||
127519030|NCT00615030|458861674|FG001|Period II|Subject withdrew consent|0|||
127519031|NCT00615030|458861675|FG002|Period II|Subject withdrew consent|0|||
127519032|NCT00615030|458861676|FG003|Period II|Subject withdrew consent|1|||
127519033|NCT00615030|458861677|FG004|Period II|Subject withdrew consent|0|||
127519034|NCT00615030|458861678|FG005|Period II|Subject withdrew consent|0|||
127519035|NCT00615030|458861679|FG006|Period II|Subject withdrew consent|1|||
127519036|NCT00615030|458861680|FG007|Period II|Subject withdrew consent|0|||
127519037|NCT00615030|458861681|FG008|Period II|Subject withdrew consent|0|||
127519038|NCT00615030|458861682|FG009|Period II|Subject withdrew consent|0|||
127519039|NCT00615030|458861683|FG010|Period II|Subject withdrew consent|0|||
127519040|NCT00615030|458861684|FG011|Period II|Subject withdrew consent|0|||
127519041|NCT00615030|458861673|FG000|Period III|Administrative problems|1|||
127519042|NCT00615030|458861674|FG001|Period III|Administrative problems|0|||
127519043|NCT00615030|458861675|FG002|Period III|Administrative problems|0|||
127519044|NCT00615030|458861676|FG003|Period III|Administrative problems|1|||
127519045|NCT00615030|458861677|FG004|Period III|Administrative problems|0|||
127519046|NCT00615030|458861678|FG005|Period III|Administrative problems|0|||
127519047|NCT00615030|458861679|FG006|Period III|Administrative problems|0|||
127519048|NCT00615030|458861680|FG007|Period III|Administrative problems|0|||
127519049|NCT00615030|458861681|FG008|Period III|Administrative problems|0|||
127519050|NCT00615030|458861682|FG009|Period III|Administrative problems|0|||
127519051|NCT00615030|458861683|FG010|Period III|Administrative problems|0|||
127519052|NCT00615030|458861684|FG011|Period III|Administrative problems|0|||
127519053|NCT03908476|458861685|FG000|Overall Study|Death|3|||
127519054|NCT03908476|458861686|FG001|Overall Study|Death|0|||
127519055|NCT03908476|458861685|FG000|Overall Study|Lost to Follow-up|3|||
127519056|NCT03908476|458861686|FG001|Overall Study|Lost to Follow-up|1|||
127519057|NCT03908476|458861685|FG000|Overall Study|Withdrawal by Subject|7|||
127519058|NCT03908476|458861686|FG001|Overall Study|Withdrawal by Subject|1|||
127519059|NCT03908476|458861685|FG000|Overall Study|Physician Decision|2|||
127519060|NCT03908476|458861686|FG001|Overall Study|Physician Decision|0|||
127519061|NCT03908476|458861685|FG000|Overall Study|System Explanted and not Replaced|4|||
127519062|NCT03908476|458861686|FG001|Overall Study|System Explanted and not Replaced|0|||
127519063|NCT03908476|458861685|FG000|Overall Study|Intrathecal Pump|1|||
127519064|NCT03908476|458861686|FG001|Overall Study|Intrathecal Pump|0|||
127519065|NCT03908476|458861685|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
127519066|NCT03908476|458861686|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
127519067|NCT05194267|458861687|FG000|Overall Study|Withdrawal by Subject|2|||
127519068|NCT00802893|458861688|FG000|Overall Study|study terminated|3|||
127519069|NCT02868229|458861689|FG000|Overall Study|Adverse Event|1|||
127519070|NCT02868229|458861690|FG001|Overall Study|Adverse Event|0|||
127519071|NCT02868229|458861691|FG002|Overall Study|Adverse Event|0|||
127519072|NCT02868229|458861692|FG003|Overall Study|Adverse Event|1|||
127519073|NCT02868229|458861689|FG000|Overall Study|Death|0|||
127519074|NCT02868229|458861690|FG001|Overall Study|Death|0|||
127519075|NCT02868229|458861691|FG002|Overall Study|Death|1|||
127519076|NCT02868229|458861692|FG003|Overall Study|Death|1|||
127519077|NCT02868229|458861689|FG000|Overall Study|Missed dose|0|||
127519078|NCT02868229|458861690|FG001|Overall Study|Missed dose|0|||
127519079|NCT02868229|458861691|FG002|Overall Study|Missed dose|0|||
127519080|NCT02868229|458861692|FG003|Overall Study|Missed dose|3|||
127519081|NCT06151288|458861693|FG000|Overall Study|Lost to Follow-up|4|||
127519082|NCT06151288|458861694|FG001|Overall Study|Lost to Follow-up|2|||
127519083|NCT06151288|458861695|FG002|Overall Study|Lost to Follow-up|4|||
127519084|NCT06151288|458861696|FG003|Overall Study|Lost to Follow-up|3|||
127519085|NCT06151288|458861693|FG000|Overall Study|Withdrawal by Subject|4|||
127519086|NCT06151288|458861694|FG001|Overall Study|Withdrawal by Subject|5|||
127519087|NCT06151288|458861695|FG002|Overall Study|Withdrawal by Subject|1|||
127519088|NCT06151288|458861696|FG003|Overall Study|Withdrawal by Subject|1|||
127519089|NCT00026312|458861697|FG000|Overall Study|Adverse Event|0|||
127519090|NCT00026312|458861698|FG001|Overall Study|Adverse Event|32|||
127519091|NCT00026312|458861697|FG000|Overall Study|Death|1|||
127519092|NCT00026312|458861698|FG001|Overall Study|Death|7|||
127519093|NCT00026312|458861697|FG000|Overall Study|Lack of Efficacy|19|||
127519094|NCT00026312|458861698|FG001|Overall Study|Lack of Efficacy|114|||
127519095|NCT00026312|458861697|FG000|Overall Study|Lost to Follow-up|0|||
127519096|NCT00026312|458861698|FG001|Overall Study|Lost to Follow-up|5|||
127519097|NCT00026312|458861697|FG000|Overall Study|Physician Decision|1|||
127519098|NCT00026312|458861698|FG001|Overall Study|Physician Decision|37|||
127519099|NCT00026312|458861697|FG000|Overall Study|Protocol Violation|0|||
127519100|NCT00026312|458861698|FG001|Overall Study|Protocol Violation|3|||
127519101|NCT00026312|458861697|FG000|Overall Study|Withdrawal by Subject|1|||
127519102|NCT00026312|458861698|FG001|Overall Study|Withdrawal by Subject|6|||
127519103|NCT00026312|458861697|FG000|Overall Study|Ineligible|4|||
127519104|NCT00026312|458861698|FG001|Overall Study|Ineligible|5|||
127519105|NCT00026312|458861697|FG000|Overall Study|Entry onto another COG study|0|||
127519106|NCT00026312|458861698|FG001|Overall Study|Entry onto another COG study|1|||
127519107|NCT00026312|458861697|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
127519108|NCT00026312|458861698|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
127519109|NCT03194438|458861701|FG000|Overall Study|Withdrawal by Subject|2|||
127519110|NCT00231413|458861702|FG000|Overall Study|Non-serious AE|0|||
127519111|NCT00231413|458861703|FG001|Overall Study|Non-serious AE|0|||
127519112|NCT00231413|458861704|FG002|Overall Study|Non-serious AE|1|||
127519113|NCT00231413|458861705|FG003|Overall Study|Non-serious AE|0|||
127519114|NCT00231413|458861706|FG004|Overall Study|Non-serious AE|0|||
127519115|NCT00231413|458861707|FG005|Overall Study|Non-serious AE|0|||
127519116|NCT00231413|458861708|FG006|Overall Study|Non-serious AE|1|||
127519117|NCT00231413|458861702|FG000|Overall Study|Withdrawal by Subject|3|||
127519118|NCT00231413|458861703|FG001|Overall Study|Withdrawal by Subject|1|||
127519119|NCT00231413|458861704|FG002|Overall Study|Withdrawal by Subject|4|||
127519120|NCT00231413|458861705|FG003|Overall Study|Withdrawal by Subject|2|||
127519121|NCT00231413|458861706|FG004|Overall Study|Withdrawal by Subject|2|||
127519122|NCT00231413|458861707|FG005|Overall Study|Withdrawal by Subject|0|||
127519123|NCT00231413|458861708|FG006|Overall Study|Withdrawal by Subject|3|||
127519124|NCT00231413|458861702|FG000|Overall Study|Migrated/moved from study area|0|||
127519125|NCT00231413|458861703|FG001|Overall Study|Migrated/moved from study area|0|||
127519126|NCT00231413|458861704|FG002|Overall Study|Migrated/moved from study area|1|||
127519127|NCT00231413|458861705|FG003|Overall Study|Migrated/moved from study area|0|||
127519128|NCT00231413|458861706|FG004|Overall Study|Migrated/moved from study area|0|||
127519129|NCT00231413|458861707|FG005|Overall Study|Migrated/moved from study area|1|||
127519130|NCT00231413|458861708|FG006|Overall Study|Migrated/moved from study area|0|||
127519131|NCT00231413|458861702|FG000|Overall Study|Lost to Follow-up|4|||
127519132|NCT00231413|458861703|FG001|Overall Study|Lost to Follow-up|4|||
127519133|NCT00231413|458861704|FG002|Overall Study|Lost to Follow-up|1|||
127519134|NCT00231413|458861705|FG003|Overall Study|Lost to Follow-up|1|||
127519135|NCT00231413|458861706|FG004|Overall Study|Lost to Follow-up|1|||
127519136|NCT00231413|458861707|FG005|Overall Study|Lost to Follow-up|4|||
127519137|NCT00231413|458861708|FG006|Overall Study|Lost to Follow-up|0|||
127519138|NCT00231413|458861702|FG000|Overall Study|Pregnancy|1|||
127519139|NCT00231413|458861703|FG001|Overall Study|Pregnancy|0|||
127519140|NCT00231413|458861704|FG002|Overall Study|Pregnancy|0|||
127519141|NCT00231413|458861705|FG003|Overall Study|Pregnancy|0|||
127519142|NCT00231413|458861706|FG004|Overall Study|Pregnancy|0|||
127519143|NCT00231413|458861707|FG005|Overall Study|Pregnancy|0|||
127519144|NCT00231413|458861708|FG006|Overall Study|Pregnancy|0|||
127519145|NCT02250664|458861709|FG000|Overall Study|Lost to Follow-up|18|||
127519146|NCT02250664|458861710|FG001|Overall Study|Lost to Follow-up|28|||
127519147|NCT02250664|458861711|FG002|Overall Study|Lost to Follow-up|33|||
127519148|NCT02250664|458861709|FG000|Overall Study|Personal Reasons|7|||
127519149|NCT02250664|458861710|FG001|Overall Study|Personal Reasons|8|||
127519150|NCT02250664|458861711|FG002|Overall Study|Personal Reasons|14|||
127519151|NCT02250664|458861709|FG000|Overall Study|Adverse Event|6|||
127519152|NCT02250664|458861710|FG001|Overall Study|Adverse Event|3|||
127519153|NCT02250664|458861711|FG002|Overall Study|Adverse Event|8|||
127519154|NCT02250664|458861709|FG000|Overall Study|Incarcerated|2|||
127519155|NCT02250664|458861710|FG001|Overall Study|Incarcerated|1|||
127519156|NCT02250664|458861711|FG002|Overall Study|Incarcerated|2|||
127519157|NCT02250664|458861709|FG000|Overall Study|Withdrawal by Subject|0|||
127519158|NCT02250664|458861710|FG001|Overall Study|Withdrawal by Subject|1|||
127519159|NCT02250664|458861711|FG002|Overall Study|Withdrawal by Subject|2|||
127519160|NCT02250664|458861709|FG000|Overall Study|Death|0|||
127519161|NCT02250664|458861710|FG001|Overall Study|Death|1|||
127519162|NCT02250664|458861711|FG002|Overall Study|Death|1|||
127519163|NCT02250664|458861709|FG000|Overall Study|Physician Decision|1|||
127519164|NCT02250664|458861710|FG001|Overall Study|Physician Decision|3|||
127519165|NCT02250664|458861711|FG002|Overall Study|Physician Decision|1|||
127519166|NCT02250664|458861709|FG000|Overall Study|Protocol Violation|1|||
127519167|NCT02250664|458861710|FG001|Overall Study|Protocol Violation|0|||
127519168|NCT02250664|458861711|FG002|Overall Study|Protocol Violation|1|||
127519169|NCT02250664|458861709|FG000|Overall Study|Reason unknown|1|||
127519170|NCT02250664|458861710|FG001|Overall Study|Reason unknown|0|||
127519171|NCT02250664|458861711|FG002|Overall Study|Reason unknown|0|||
127519172|NCT00117793|458861712|FG000|Overall Study|Withdrawal by Subject|12|||
127519173|NCT04268173|458861713|FG000|Overall Study|Lost to Follow-up|75|||
127519174|NCT04268173|458861714|FG001|Overall Study|Lost to Follow-up|108|||
127519175|NCT00545103|458861715|FG000|Overall Study|Lack of Efficacy|48|||
127519176|NCT00545103|458861716|FG001|Overall Study|Lack of Efficacy|45|||
127519177|NCT00545103|458861717|FG002|Overall Study|Lack of Efficacy|31|||
127519178|NCT00545103|458861718|FG003|Overall Study|Lack of Efficacy|27|||
127519179|NCT00545103|458861715|FG000|Overall Study|Withdrawal by Subject|6|||
127519180|NCT00545103|458861716|FG001|Overall Study|Withdrawal by Subject|10|||
127519181|NCT00545103|458861717|FG002|Overall Study|Withdrawal by Subject|18|||
127519182|NCT00545103|458861718|FG003|Overall Study|Withdrawal by Subject|22|||
127519183|NCT00545103|458861715|FG000|Overall Study|Adverse Event|11|||
127519184|NCT00545103|458861716|FG001|Overall Study|Adverse Event|12|||
127519185|NCT00545103|458861717|FG002|Overall Study|Adverse Event|17|||
127519186|NCT00545103|458861718|FG003|Overall Study|Adverse Event|10|||
127519187|NCT00545103|458861715|FG000|Overall Study|Lost to Follow-up|4|||
127519188|NCT00545103|458861716|FG001|Overall Study|Lost to Follow-up|6|||
127519189|NCT00545103|458861717|FG002|Overall Study|Lost to Follow-up|3|||
127519190|NCT00545103|458861718|FG003|Overall Study|Lost to Follow-up|4|||
127519191|NCT00545103|458861715|FG000|Overall Study|Protocol Violation|1|||
127519192|NCT00545103|458861716|FG001|Overall Study|Protocol Violation|2|||
127519193|NCT00545103|458861717|FG002|Overall Study|Protocol Violation|3|||
127519194|NCT00545103|458861718|FG003|Overall Study|Protocol Violation|0|||
127519195|NCT00545103|458861715|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
127519196|NCT00545103|458861716|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
127519197|NCT00545103|458861717|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
127519198|NCT00545103|458861718|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
127519199|NCT00545103|458861715|FG000|Overall Study|Difficult to open package|0|||
127519200|NCT00545103|458861716|FG001|Overall Study|Difficult to open package|0|||
127519201|NCT00545103|458861717|FG002|Overall Study|Difficult to open package|0|||
127519202|NCT00545103|458861718|FG003|Overall Study|Difficult to open package|1|||
127519203|NCT00545103|458861715|FG000|Overall Study|Investigational product not taken|1|||
127519204|NCT00545103|458861716|FG001|Overall Study|Investigational product not taken|0|||
127519205|NCT00545103|458861717|FG002|Overall Study|Investigational product not taken|0|||
127519206|NCT00545103|458861718|FG003|Overall Study|Investigational product not taken|1|||
127519207|NCT00545103|458861715|FG000|Overall Study|Wish to start a family|0|||
127519208|NCT00545103|458861716|FG001|Overall Study|Wish to start a family|0|||
127519209|NCT00545103|458861717|FG002|Overall Study|Wish to start a family|0|||
127519210|NCT00545103|458861718|FG003|Overall Study|Wish to start a family|1|||
127519211|NCT00545103|458861715|FG000|Overall Study|Diverticulitis crisis|0|||
127519212|NCT00545103|458861716|FG001|Overall Study|Diverticulitis crisis|0|||
127519213|NCT00545103|458861717|FG002|Overall Study|Diverticulitis crisis|0|||
127519214|NCT00545103|458861718|FG003|Overall Study|Diverticulitis crisis|1|||
127519215|NCT00545103|458861715|FG000|Overall Study|Personal reasons|1|||
127519216|NCT00545103|458861716|FG001|Overall Study|Personal reasons|0|||
127519217|NCT00545103|458861717|FG002|Overall Study|Personal reasons|0|||
127519218|NCT00545103|458861718|FG003|Overall Study|Personal reasons|0|||
127519219|NCT00545103|458861715|FG000|Overall Study|Subject's decision|1|||
127519220|NCT00545103|458861716|FG001|Overall Study|Subject's decision|0|||
127519221|NCT00545103|458861717|FG002|Overall Study|Subject's decision|0|||
127519222|NCT00545103|458861718|FG003|Overall Study|Subject's decision|0|||
127519223|NCT00545103|458861715|FG000|Overall Study|Noncompliance|0|||
127519224|NCT00545103|458861716|FG001|Overall Study|Noncompliance|1|||
127519225|NCT00545103|458861717|FG002|Overall Study|Noncompliance|0|||
127519226|NCT00545103|458861718|FG003|Overall Study|Noncompliance|0|||
127519227|NCT00545103|458861715|FG000|Overall Study|Investigator decision|0|||
127519228|NCT00545103|458861716|FG001|Overall Study|Investigator decision|0|||
127519229|NCT00545103|458861717|FG002|Overall Study|Investigator decision|1|||
127519230|NCT00545103|458861718|FG003|Overall Study|Investigator decision|0|||
127519231|NCT00545103|458861715|FG000|Overall Study|Subject moved|0|||
127519232|NCT00545103|458861716|FG001|Overall Study|Subject moved|1|||
127519233|NCT00545103|458861717|FG002|Overall Study|Subject moved|0|||
127519234|NCT00545103|458861718|FG003|Overall Study|Subject moved|0|||
127519235|NCT00545103|458861715|FG000|Overall Study|Use of prohibited medication|0|||
127519236|NCT00545103|458861716|FG001|Overall Study|Use of prohibited medication|0|||
127519237|NCT00545103|458861717|FG002|Overall Study|Use of prohibited medication|1|||
127519238|NCT00545103|458861718|FG003|Overall Study|Use of prohibited medication|0|||
127519239|NCT00545103|458861715|FG000|Overall Study|Does not want to take study drug anymore|1|||
127519240|NCT00545103|458861716|FG001|Overall Study|Does not want to take study drug anymore|0|||
127519241|NCT00545103|458861717|FG002|Overall Study|Does not want to take study drug anymore|1|||
127519242|NCT00545103|458861718|FG003|Overall Study|Does not want to take study drug anymore|0|||
127519243|NCT00545103|458861715|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
127519244|NCT00545103|458861716|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
127519245|NCT00545103|458861717|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
127519246|NCT00545103|458861718|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
127519247|NCT00545103|458861715|FG000|Overall Study|Death|0|||
127519248|NCT00545103|458861716|FG001|Overall Study|Death|1|||
127519249|NCT00545103|458861717|FG002|Overall Study|Death|0|||
127519250|NCT00545103|458861718|FG003|Overall Study|Death|0|||
127519251|NCT00082381|458861719|FG000|Overall Study|Adverse Event|27|||
127519252|NCT00082381|458861720|FG001|Overall Study|Adverse Event|2|||
127519253|NCT00082381|458861719|FG000|Overall Study|Lost to Follow-up|5|||
127519254|NCT00082381|458861720|FG001|Overall Study|Lost to Follow-up|7|||
127519255|NCT00082381|458861719|FG000|Overall Study|Patient Decision|8|||
127519256|NCT00082381|458861720|FG001|Overall Study|Patient Decision|4|||
127519257|NCT00082381|458861719|FG000|Overall Study|Physician Decision|1|||
127519258|NCT00082381|458861720|FG001|Overall Study|Physician Decision|2|||
127519259|NCT00082381|458861719|FG000|Overall Study|Protocol Violation|10|||
127519260|NCT00082381|458861720|FG001|Overall Study|Protocol Violation|11|||
127519261|NCT00082381|458861719|FG000|Overall Study|Loss of Glucose Control|4|||
127519262|NCT00082381|458861720|FG001|Overall Study|Loss of Glucose Control|0|||
127519263|NCT02049138|458861721|FG000|Overall Study|Adverse Event|46|||
127519264|NCT02049138|458861722|FG001|Overall Study|Adverse Event|25|||
127519265|NCT02049138|458861723|FG002|Overall Study|Adverse Event|1|||
127519266|NCT02049138|458861721|FG000|Overall Study|Withdrawal by Subject|57|||
127519267|NCT02049138|458861722|FG001|Overall Study|Withdrawal by Subject|21|||
127519268|NCT02049138|458861723|FG002|Overall Study|Withdrawal by Subject|5|||
127519269|NCT02049138|458861721|FG000|Overall Study|Lost to Follow-up|18|||
127519270|NCT02049138|458861722|FG001|Overall Study|Lost to Follow-up|5|||
127519271|NCT02049138|458861723|FG002|Overall Study|Lost to Follow-up|1|||
127519272|NCT02049138|458861721|FG000|Overall Study|Lack of Efficacy|10|||
127519273|NCT02049138|458861722|FG001|Overall Study|Lack of Efficacy|26|||
127519274|NCT02049138|458861723|FG002|Overall Study|Lack of Efficacy|1|||
127519275|NCT02049138|458861721|FG000|Overall Study|Non-Compliance|15|||
127519276|NCT02049138|458861722|FG001|Overall Study|Non-Compliance|6|||
127519277|NCT02049138|458861723|FG002|Overall Study|Non-Compliance|0|||
127519278|NCT02049138|458861721|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
127519279|NCT02049138|458861722|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
127519280|NCT02049138|458861723|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
127519281|NCT02049138|458861721|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
127519282|NCT02049138|458861722|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
127519283|NCT02049138|458861723|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
127519284|NCT02049138|458861721|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
127519285|NCT02049138|458861722|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
127519286|NCT02049138|458861723|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
127519287|NCT02049138|458861721|FG000|Overall Study|Other|15|||
127519288|NCT02049138|458861722|FG001|Overall Study|Other|13|||
127519289|NCT02049138|458861723|FG002|Overall Study|Other|0|||
127519290|NCT02049138|458861721|FG000|Overall Study|Missing|0|||
127519291|NCT02049138|458861722|FG001|Overall Study|Missing|1|||
127519292|NCT02049138|458861723|FG002|Overall Study|Missing|0|||
127519293|NCT00884832|458861724|FG000|Overall Study|Withdrawal by Subject|0|||
127519294|NCT00884832|458861725|FG001|Overall Study|Withdrawal by Subject|1|||
127519295|NCT02096263|458861726|FG000|Overall Study|Adverse Event|1|||
127519296|NCT02096263|458861727|FG001|Overall Study|Adverse Event|0|||
127519297|NCT02096263|458861728|FG002|Overall Study|Adverse Event|1|||
127519298|NCT02096263|458861726|FG000|Overall Study|Lost to Follow-up|14|||
127519299|NCT02096263|458861727|FG001|Overall Study|Lost to Follow-up|18|||
127519300|NCT02096263|458861728|FG002|Overall Study|Lost to Follow-up|15|||
127519301|NCT02096263|458861726|FG000|Overall Study|Other|7|||
127519302|NCT02096263|458861727|FG001|Overall Study|Other|9|||
127519303|NCT02096263|458861728|FG002|Overall Study|Other|6|||
127519304|NCT02096263|458861726|FG000|Overall Study|Sponsor study termination|0|||
127519305|NCT02096263|458861727|FG001|Overall Study|Sponsor study termination|0|||
127519306|NCT02096263|458861728|FG002|Overall Study|Sponsor study termination|1|||
127519307|NCT02096263|458861726|FG000|Overall Study|Protocol Violation|7|||
127519308|NCT02096263|458861727|FG001|Overall Study|Protocol Violation|2|||
127519309|NCT02096263|458861728|FG002|Overall Study|Protocol Violation|8|||
127519310|NCT02096263|458861726|FG000|Overall Study|Withdrawal by Subject|5|||
127519311|NCT02096263|458861727|FG001|Overall Study|Withdrawal by Subject|7|||
127519312|NCT02096263|458861728|FG002|Overall Study|Withdrawal by Subject|8|||
127519313|NCT02453555|458861729|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
127519314|NCT02453555|458861730|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
127519315|NCT02453555|458861731|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
127519316|NCT02453555|458861732|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
127519317|NCT02453555|458861733|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
127519318|NCT02453555|458861734|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
127519319|NCT02453555|458861729|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
127519320|NCT02453555|458861730|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
127519321|NCT02453555|458861731|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
127519322|NCT02453555|458861732|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
127519323|NCT02453555|458861733|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
127519324|NCT02453555|458861734|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
127519325|NCT02453555|458861729|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
127519326|NCT02453555|458861730|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
127519327|NCT02453555|458861731|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
127519328|NCT02453555|458861732|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
127519329|NCT02453555|458861733|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
127519330|NCT02453555|458861734|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
127519331|NCT02453555|458861729|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
127519332|NCT02453555|458861730|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
127519333|NCT02453555|458861731|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
127519334|NCT02453555|458861732|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
127519335|NCT02453555|458861733|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
127519336|NCT02453555|458861734|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
127519337|NCT02453555|458861729|FG000|Extension Period|Adverse Event|0|||
127519338|NCT02453555|458861730|FG001|Extension Period|Adverse Event|0|||
127519339|NCT02453555|458861731|FG002|Extension Period|Adverse Event|1|||
127519340|NCT02453555|458861732|FG003|Extension Period|Adverse Event|2|||
127519341|NCT02453555|458861733|FG004|Extension Period|Adverse Event|1|||
127519342|NCT02453555|458861734|FG005|Extension Period|Adverse Event|1|||
127519343|NCT02453555|458861729|FG000|Extension Period|Protocol Violation|0|||
127519344|NCT02453555|458861730|FG001|Extension Period|Protocol Violation|0|||
127519345|NCT02453555|458861731|FG002|Extension Period|Protocol Violation|1|||
127519346|NCT02453555|458861732|FG003|Extension Period|Protocol Violation|0|||
127519347|NCT02453555|458861733|FG004|Extension Period|Protocol Violation|0|||
127519348|NCT02453555|458861734|FG005|Extension Period|Protocol Violation|0|||
127519349|NCT02453555|458861729|FG000|Extension Period|Withdrawal by Subject|0|||
127519350|NCT02453555|458861730|FG001|Extension Period|Withdrawal by Subject|0|||
127519351|NCT02453555|458861731|FG002|Extension Period|Withdrawal by Subject|1|||
127519352|NCT02453555|458861732|FG003|Extension Period|Withdrawal by Subject|0|||
127519353|NCT02453555|458861733|FG004|Extension Period|Withdrawal by Subject|0|||
127519354|NCT02453555|458861734|FG005|Extension Period|Withdrawal by Subject|0|||
127519355|NCT00129961|458861735|FG000|Overall Study|Adverse Event|1|||
127519356|NCT00129961|458861736|FG001|Overall Study|Adverse Event|0|||
127519357|NCT00129961|458861735|FG000|Overall Study|Death|1|||
127519358|NCT00129961|458861736|FG001|Overall Study|Death|1|||
127519359|NCT00129961|458861735|FG000|Overall Study|Withdrawal by Sponsor|14|||
127519360|NCT00129961|458861736|FG001|Overall Study|Withdrawal by Sponsor|20|||
127519361|NCT00129961|458861735|FG000|Overall Study|Physician Decision|1|||
127519362|NCT00129961|458861736|FG001|Overall Study|Physician Decision|0|||
127519363|NCT00129961|458861735|FG000|Overall Study|Withdrawal by Subject|2|||
127519364|NCT00129961|458861736|FG001|Overall Study|Withdrawal by Subject|1|||
127519365|NCT00129961|458861735|FG000|Overall Study|Missing Record|0|||
127519366|NCT00129961|458861736|FG001|Overall Study|Missing Record|1|||
127519367|NCT01270256|458861737|FG000|Overall Study|Withdrawal by Subject|1|||
127519368|NCT01270256|458861738|FG001|Overall Study|Withdrawal by Subject|0|||
127519369|NCT02925728|458861740|FG000|Overall Study|Death|3|||
127519370|NCT02925728|458861741|FG001|Overall Study|Death|5|||
127519371|NCT02925728|458861740|FG000|Overall Study|Physician Decision|1|||
127519372|NCT02925728|458861741|FG001|Overall Study|Physician Decision|0|||
127519373|NCT02925728|458861740|FG000|Overall Study|Withdrawal by Subject|1|||
127519374|NCT02925728|458861741|FG001|Overall Study|Withdrawal by Subject|0|||
127519375|NCT04033068|458861742|FG000|Overall Study|Withdrawal by Subject|0|||
127519376|NCT04033068|458861743|FG001|Overall Study|Withdrawal by Subject|0|||
127519377|NCT04033068|458861744|FG002|Overall Study|Withdrawal by Subject|1|||
127519378|NCT04033068|458861745|FG003|Overall Study|Withdrawal by Subject|0|||
127519379|NCT04033068|458861742|FG000|Overall Study|Lost to Follow-up|0|||
127519380|NCT04033068|458861743|FG001|Overall Study|Lost to Follow-up|1|||
127519381|NCT04033068|458861744|FG002|Overall Study|Lost to Follow-up|0|||
127519382|NCT04033068|458861745|FG003|Overall Study|Lost to Follow-up|0|||
127519383|NCT04033068|458861742|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
127519384|NCT04033068|458861743|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
127519385|NCT04033068|458861744|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
127519386|NCT04033068|458861745|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
127519387|NCT02986854|458861747|FG000|Overall Study|Withdrawal by Subject|0|||
127519388|NCT02986854|458861748|FG001|Overall Study|Withdrawal by Subject|1|||
127519389|NCT02986854|458861749|FG002|Overall Study|Withdrawal by Subject|1|||
127519390|NCT02986854|458861747|FG000|Overall Study|Lost to Follow-up|3|||
127519391|NCT02986854|458861748|FG001|Overall Study|Lost to Follow-up|11|||
127519392|NCT02986854|458861749|FG002|Overall Study|Lost to Follow-up|2|||
127519393|NCT00324233|458861752|FG000|First Period|unable to insert catheter|1|||
127519394|NCT00324233|458861753|FG001|First Period|unable to insert catheter|0|||
127519395|NCT00324233|458861752|FG000|Second Period|unable to insert catheter|1|||
127519396|NCT00324233|458861753|FG001|Second Period|unable to insert catheter|1|||
127519397|NCT00324233|458861752|FG000|Second Period|Protocol Violation|4|||
127519398|NCT00324233|458861753|FG001|Second Period|Protocol Violation|6|||
127519399|NCT00086411|458861761|FG000|Overall Study|Lost to Follow-up|11|||
127519400|NCT00086411|458861762|FG001|Overall Study|Lost to Follow-up|11|||
127519401|NCT00086411|458861763|FG002|Overall Study|Lost to Follow-up|13|||
127519402|NCT00086411|458861764|FG003|Overall Study|Lost to Follow-up|12|||
127519403|NCT02039856|458861765|FG000|Overall Study|Death|5|||
127519404|NCT02039856|458861766|FG001|Overall Study|Death|3|||
127519405|NCT02039856|458861765|FG000|Overall Study|Partial survey completion|61|||
127519406|NCT02039856|458861766|FG001|Overall Study|Partial survey completion|26|||
127519407|NCT02039856|458861765|FG000|Overall Study|Lost to Follow-up|388|||
127519408|NCT02039856|458861766|FG001|Overall Study|Lost to Follow-up|206|||
127519409|NCT02039856|458861765|FG000|Overall Study|Withdrawal by Subject|1573|||
127519410|NCT02039856|458861766|FG001|Overall Study|Withdrawal by Subject|618|||
127519411|NCT02409342|458861769|FG000|Overall Study|Death|211|||
127519412|NCT02409342|458861770|FG001|Overall Study|Death|201|||
127519413|NCT02409342|458861769|FG000|Overall Study|Withdrawal by Subject|24|||
127519414|NCT02409342|458861770|FG001|Overall Study|Withdrawal by Subject|17|||
127519415|NCT02409342|458861769|FG000|Overall Study|Study Terminated By Sponsor|48|||
127519416|NCT02409342|458861770|FG001|Overall Study|Study Terminated By Sponsor|59|||
127519417|NCT02409342|458861769|FG000|Overall Study|Lost to Follow-up|3|||
127519418|NCT02409342|458861770|FG001|Overall Study|Lost to Follow-up|5|||
127519419|NCT02409342|458861769|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
127519420|NCT02409342|458861770|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
127519421|NCT02409342|458861769|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
127519422|NCT02409342|458861770|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
127519423|NCT02409342|458861769|FG000|Overall Study|Sponsor Decision|1|||
127519424|NCT02409342|458861770|FG001|Overall Study|Sponsor Decision|0|||
127519425|NCT03908970|458861771|FG000|Overall Study|Adverse Event|7|||
127519426|NCT03908970|458861772|FG001|Overall Study|Adverse Event|21|||
127519427|NCT03908970|458861771|FG000|Overall Study|Physician Decision|1|||
127519428|NCT03908970|458861772|FG001|Overall Study|Physician Decision|4|||
127519429|NCT03908970|458861771|FG000|Overall Study|Withdrawal by Subject|9|||
127519430|NCT03908970|458861772|FG001|Overall Study|Withdrawal by Subject|22|||
127519431|NCT00495625|458863563|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
127519432|NCT01912339|458863564|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
127519433|NCT01912339|458863565|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
127519434|NCT01912339|458863566|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
127519435|NCT01912339|458863564|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
127519436|NCT01912339|458863565|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
127519437|NCT01912339|458863566|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
127519438|NCT01912339|458863564|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
127519439|NCT01912339|458863565|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
127519440|NCT01912339|458863566|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
127519441|NCT01912339|458863564|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
127519442|NCT01912339|458863565|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
127519443|NCT01912339|458863566|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
127519444|NCT01912339|458863564|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
127519445|NCT01912339|458863565|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
127519446|NCT01912339|458863566|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
127519447|NCT01912339|458863564|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
127519448|NCT01912339|458863565|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
127519449|NCT01912339|458863566|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
127519450|NCT01912339|458863564|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
127519451|NCT01912339|458863565|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
127519452|NCT01912339|458863566|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
127519453|NCT01912339|458863564|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
127519454|NCT01912339|458863565|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
127519455|NCT01912339|458863566|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
127519456|NCT01912339|458863564|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
127519457|NCT01912339|458863565|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
127519458|NCT01912339|458863566|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
127519459|NCT01912339|458863564|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
127519460|NCT01912339|458863565|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
127519461|NCT01912339|458863566|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
127519462|NCT01912339|458863564|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
127519463|NCT01912339|458863565|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
127519464|NCT01912339|458863566|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
127519465|NCT01912339|458863564|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
127519466|NCT01912339|458863565|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
127519467|NCT01912339|458863566|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
127519468|NCT01912339|458863564|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
127519469|NCT01912339|458863565|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
127519470|NCT01912339|458863566|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
127519471|NCT03464019|458863567|FG000|NODE-301 Part 1|Withdrawal by Subject|0|||
127519472|NCT03464019|458863568|FG001|NODE-301 Part 1|Withdrawal by Subject|0|||
127519473|NCT03464019|458863569|FG002|NODE-301 Part 1|Withdrawal by Subject|18|||
127519474|NCT03464019|458863567|FG000|NODE-301 Part 1|Ablation|0|||
127519475|NCT03464019|458863568|FG001|NODE-301 Part 1|Ablation|0|||
127519476|NCT03464019|458863569|FG002|NODE-301 Part 1|Ablation|16|||
127519477|NCT03464019|458863567|FG000|NODE-301 Part 1|Test Dose Failure|0|||
127519478|NCT03464019|458863568|FG001|NODE-301 Part 1|Test Dose Failure|0|||
127519479|NCT03464019|458863569|FG002|NODE-301 Part 1|Test Dose Failure|8|||
127519480|NCT03464019|458863567|FG000|NODE-301 Part 1|Adverse Event|0|||
127519481|NCT03464019|458863568|FG001|NODE-301 Part 1|Adverse Event|0|||
127519482|NCT03464019|458863569|FG002|NODE-301 Part 1|Adverse Event|5|||
127519483|NCT03464019|458863567|FG000|NODE-301 Part 1|Physician Decision|0|||
127519484|NCT03464019|458863568|FG001|NODE-301 Part 1|Physician Decision|0|||
127519485|NCT03464019|458863569|FG002|NODE-301 Part 1|Physician Decision|4|||
127519486|NCT03464019|458863567|FG000|NODE-301 Part 1|Lost to Follow-up|0|||
127519487|NCT03464019|458863568|FG001|NODE-301 Part 1|Lost to Follow-up|0|||
127519488|NCT03464019|458863569|FG002|NODE-301 Part 1|Lost to Follow-up|3|||
127519489|NCT03464019|458863567|FG000|NODE-301 Part 1|Protocol Violation|0|||
127519490|NCT03464019|458863568|FG001|NODE-301 Part 1|Protocol Violation|0|||
127519491|NCT03464019|458863569|FG002|NODE-301 Part 1|Protocol Violation|2|||
127519492|NCT03464019|458863567|FG000|NODE-301 Part 1|Reason was not provided by the participant|0|||
127519493|NCT03464019|458863568|FG001|NODE-301 Part 1|Reason was not provided by the participant|0|||
127519494|NCT03464019|458863569|FG002|NODE-301 Part 1|Reason was not provided by the participant|15|||
127519495|NCT03464019|458863567|FG000|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
127519496|NCT03464019|458863568|FG001|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
127519497|NCT03464019|458863569|FG002|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|82|||
127519498|NCT03464019|458863567|FG000|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
127519499|NCT03464019|458863568|FG001|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
127519500|NCT03464019|458863569|FG002|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|80|||
127519501|NCT03464019|458863567|FG000|NODE-301 Part 2 and Part 3|Withdrawal by Subject|5|||
127519502|NCT03464019|458863568|FG001|NODE-301 Part 2 and Part 3|Withdrawal by Subject|1|||
127519503|NCT03464019|458863569|FG002|NODE-301 Part 2 and Part 3|Withdrawal by Subject|32|||
127519504|NCT03464019|458863567|FG000|NODE-301 Part 2 and Part 3|Ablation|8|||
127519505|NCT03464019|458863568|FG001|NODE-301 Part 2 and Part 3|Ablation|11|||
127519506|NCT03464019|458863569|FG002|NODE-301 Part 2 and Part 3|Ablation|46|||
127519507|NCT03464019|458863567|FG000|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
127519508|NCT03464019|458863568|FG001|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
127519509|NCT03464019|458863569|FG002|NODE-301 Part 2 and Part 3|Test Dose failure|8|||
127519510|NCT03464019|458863567|FG000|NODE-301 Part 2 and Part 3|Adverse Event|1|||
127519511|NCT03464019|458863568|FG001|NODE-301 Part 2 and Part 3|Adverse Event|3|||
127519512|NCT03464019|458863569|FG002|NODE-301 Part 2 and Part 3|Adverse Event|14|||
127519513|NCT03464019|458863567|FG000|NODE-301 Part 2 and Part 3|Physician Decision|0|||
127519514|NCT03464019|458863568|FG001|NODE-301 Part 2 and Part 3|Physician Decision|0|||
127519515|NCT03464019|458863569|FG002|NODE-301 Part 2 and Part 3|Physician Decision|2|||
127519516|NCT03464019|458863567|FG000|NODE-301 Part 2 and Part 3|Lost to Follow-up|1|||
127519517|NCT03464019|458863568|FG001|NODE-301 Part 2 and Part 3|Lost to Follow-up|0|||
127519518|NCT03464019|458863569|FG002|NODE-301 Part 2 and Part 3|Lost to Follow-up|7|||
127519519|NCT03464019|458863567|FG000|NODE-301 Part 2 and Part 3|Protocol Violation|0|||
127519520|NCT03464019|458863568|FG001|NODE-301 Part 2 and Part 3|Protocol Violation|1|||
127519521|NCT03464019|458863569|FG002|NODE-301 Part 2 and Part 3|Protocol Violation|2|||
127519522|NCT03464019|458863567|FG000|NODE-301 Part 2 and Part 3|Pregnancy|0|||
127519523|NCT03464019|458863568|FG001|NODE-301 Part 2 and Part 3|Pregnancy|0|||
127519524|NCT03464019|458863569|FG002|NODE-301 Part 2 and Part 3|Pregnancy|1|||
127519525|NCT03464019|458863567|FG000|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
127519526|NCT03464019|458863568|FG001|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
127519527|NCT03464019|458863569|FG002|NODE-301 Part 2 and Part 3|Prohibited Medication|4|||
127519528|NCT03464019|458863567|FG000|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|46|||
127519529|NCT03464019|458863568|FG001|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|61|||
127519530|NCT03464019|458863569|FG002|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|314|||
127519531|NCT03464019|458863567|FG000|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|5|||
127519532|NCT03464019|458863568|FG001|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|1|||
127519533|NCT03464019|458863569|FG002|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|15|||
127519534|NCT01754493|458863570|FG000|Overall Study|Adverse Event|1|||
127519535|NCT01754493|458863570|FG000|Overall Study|Lost to Follow-up|3|||
127519536|NCT01754493|458863570|FG000|Overall Study|Withdrawal by Subject|1|||
127519537|NCT01754493|458863570|FG000|Overall Study|Moved out of town|1|||
127519538|NCT01754493|458863570|FG000|Overall Study|Scheduling conflict|1|||
127519539|NCT01543776|458863571|FG000|Overall Study|Withdrawal by Subject|2|||
127519540|NCT01543776|458863572|FG001|Overall Study|Withdrawal by Subject|2|||
127519541|NCT00785980|458863575|FG000|7 Day Washout Period|Protocol Violation|3|||
127519542|NCT03055013|458863576|FG000|Overall Study|Adverse Event|78|||
127519543|NCT03055013|458863577|FG001|Overall Study|Adverse Event|0|||
127519544|NCT03055013|458863576|FG000|Overall Study|Death|6|||
127519545|NCT03055013|458863577|FG001|Overall Study|Death|0|||
127519546|NCT03055013|458863576|FG000|Overall Study|Disease relapse|33|||
127519547|NCT03055013|458863577|FG001|Overall Study|Disease relapse|0|||
127519548|NCT03055013|458863576|FG000|Overall Study|Withdrawal by Subject|28|||
127519549|NCT03055013|458863577|FG001|Overall Study|Withdrawal by Subject|0|||
127519550|NCT03055013|458863576|FG000|Overall Study|Other complicating disease|5|||
127519551|NCT03055013|458863577|FG001|Overall Study|Other complicating disease|0|||
127519552|NCT03055013|458863576|FG000|Overall Study|Physician Decision|1|||
127519553|NCT03055013|458863577|FG001|Overall Study|Physician Decision|0|||
127519554|NCT03055013|458863576|FG000|Overall Study|Benign mass/non-RCC|4|||
127519555|NCT03055013|458863577|FG001|Overall Study|Benign mass/non-RCC|0|||
127519556|NCT03055013|458863576|FG000|Overall Study|Enrolled in another trial|1|||
127519557|NCT03055013|458863577|FG001|Overall Study|Enrolled in another trial|0|||
127519558|NCT03055013|458863576|FG000|Overall Study|Non-protocol therapy|1|||
127519559|NCT03055013|458863577|FG001|Overall Study|Non-protocol therapy|0|||
127519560|NCT03055013|458863576|FG000|Overall Study|Incompliance|1|||
127519561|NCT03055013|458863577|FG001|Overall Study|Incompliance|0|||
127519562|NCT03055013|458863576|FG000|Overall Study|Insurance issues|1|||
127519563|NCT03055013|458863577|FG001|Overall Study|Insurance issues|0|||
127519564|NCT03055013|458863576|FG000|Overall Study|Did not receive nivolumab and surgery|38|||
127519565|NCT03055013|458863577|FG001|Overall Study|Did not receive nivolumab and surgery|0|||
127519566|NCT03055013|458863576|FG000|Overall Study|Did not receive nivolumab|10|||
127519567|NCT03055013|458863577|FG001|Overall Study|Did not receive nivolumab|0|||
127519568|NCT03055013|458863576|FG000|Overall Study|Did not receive surgery|0|||
127519569|NCT03055013|458863577|FG001|Overall Study|Did not receive surgery|28|||
127519570|NCT00528801|458863578|FG000|Overall Study|Withdrawal by Subject|1|||
127519571|NCT00528801|458863579|FG001|Overall Study|Withdrawal by Subject|1|||
127519572|NCT00528801|458863578|FG000|Overall Study|Protocol Violation|11|||
127519573|NCT00528801|458863579|FG001|Overall Study|Protocol Violation|5|||
127519574|NCT00528801|458863578|FG000|Overall Study|Lost to Follow-up|15|||
127519575|NCT00528801|458863579|FG001|Overall Study|Lost to Follow-up|4|||
127519576|NCT00528801|458863578|FG000|Overall Study|Administrative Reasons|0|||
127519577|NCT00528801|458863579|FG001|Overall Study|Administrative Reasons|1|||
127519578|NCT00344500|458863580|FG000|Overall Study|Adverse Event|6|||
127519579|NCT00344500|458863581|FG001|Overall Study|Adverse Event|2|||
127519580|NCT00344500|458863582|FG002|Overall Study|Adverse Event|0|||
127519581|NCT00344500|458863580|FG000|Overall Study|Lost to Follow-up|5|||
127519582|NCT00344500|458863581|FG001|Overall Study|Lost to Follow-up|13|||
127519583|NCT00344500|458863582|FG002|Overall Study|Lost to Follow-up|1|||
127519584|NCT00344500|458863580|FG000|Overall Study|Withdrawal by Subject|7|||
127519585|NCT00344500|458863581|FG001|Overall Study|Withdrawal by Subject|10|||
127519586|NCT00344500|458863582|FG002|Overall Study|Withdrawal by Subject|0|||
127519587|NCT00344500|458863580|FG000|Overall Study|Protocol Violation|4|||
127519588|NCT00344500|458863581|FG001|Overall Study|Protocol Violation|7|||
127519589|NCT00344500|458863582|FG002|Overall Study|Protocol Violation|1|||
127519590|NCT00344500|458863580|FG000|Overall Study|Not Noted|1|||
127519591|NCT00344500|458863581|FG001|Overall Study|Not Noted|3|||
127519592|NCT00344500|458863582|FG002|Overall Study|Not Noted|0|||
127519593|NCT00126776|458863583|FG000|Overall Study|follow up complete on all patients|0|||
127519594|NCT00126776|458863584|FG001|Overall Study|follow up complete on all patients|0|||
127519595|NCT00599755|458863585|FG000|Overall Study|Adverse Event|11|||
127519596|NCT00599755|458863585|FG000|Overall Study|Withdrawal by Subject|2|||
127519597|NCT00599755|458863585|FG000|Overall Study|Progression of Disease|3|||
127519598|NCT00599755|458863585|FG000|Overall Study|Other Reason|2|||
127519599|NCT00599755|458863585|FG000|Overall Study|No data available|1|||
127519600|NCT00568126|458863590|FG000|Overall Study|Adverse Event|3|||
127519601|NCT00568126|458863591|FG001|Overall Study|Adverse Event|0|||
127519602|NCT00568126|458863590|FG000|Overall Study|Withdrawal by Subject|2|||
127519603|NCT00568126|458863591|FG001|Overall Study|Withdrawal by Subject|3|||
127519604|NCT00568126|458863590|FG000|Overall Study|Lost to Follow-up|4|||
127519605|NCT00568126|458863591|FG001|Overall Study|Lost to Follow-up|3|||
127519606|NCT00568126|458863590|FG000|Overall Study|Lack of Efficacy|0|||
127519607|NCT00568126|458863591|FG001|Overall Study|Lack of Efficacy|1|||
127519608|NCT00568126|458863590|FG000|Overall Study|Physician Decision|2|||
127519609|NCT00568126|458863591|FG001|Overall Study|Physician Decision|2|||
127519610|NCT01939366|458863592|FG000|Overall Study|Adverse Event|8|||
127519611|NCT01939366|458863593|FG001|Overall Study|Adverse Event|17|||
127519612|NCT01939366|458863594|FG002|Overall Study|Adverse Event|30|||
127519613|NCT01939366|458863595|FG003|Overall Study|Adverse Event|8|||
127519614|NCT01939366|458863596|FG004|Overall Study|Adverse Event|5|||
127519615|NCT01939366|458863592|FG000|Overall Study|Lack of Efficacy|2|||
127519616|NCT01939366|458863593|FG001|Overall Study|Lack of Efficacy|1|||
127519617|NCT01939366|458863594|FG002|Overall Study|Lack of Efficacy|1|||
127519618|NCT01939366|458863595|FG003|Overall Study|Lack of Efficacy|1|||
127519619|NCT01939366|458863596|FG004|Overall Study|Lack of Efficacy|3|||
127519620|NCT01939366|458863592|FG000|Overall Study|Lost to Follow-up|1|||
127519621|NCT01939366|458863593|FG001|Overall Study|Lost to Follow-up|1|||
127519622|NCT01939366|458863594|FG002|Overall Study|Lost to Follow-up|0|||
127519623|NCT01939366|458863595|FG003|Overall Study|Lost to Follow-up|0|||
127519624|NCT01939366|458863596|FG004|Overall Study|Lost to Follow-up|0|||
127519625|NCT01939366|458863592|FG000|Overall Study|Withdrawal by Subject|1|||
127519626|NCT01939366|458863593|FG001|Overall Study|Withdrawal by Subject|0|||
127519627|NCT01939366|458863594|FG002|Overall Study|Withdrawal by Subject|2|||
127519628|NCT01939366|458863595|FG003|Overall Study|Withdrawal by Subject|2|||
127519629|NCT01939366|458863596|FG004|Overall Study|Withdrawal by Subject|3|||
127519630|NCT01939366|458863592|FG000|Overall Study|Inclusion criteria not met|0|||
127519631|NCT01939366|458863593|FG001|Overall Study|Inclusion criteria not met|1|||
127519632|NCT01939366|458863594|FG002|Overall Study|Inclusion criteria not met|1|||
127519633|NCT01939366|458863595|FG003|Overall Study|Inclusion criteria not met|0|||
127519634|NCT01939366|458863596|FG004|Overall Study|Inclusion criteria not met|1|||
127519635|NCT01939366|458863592|FG000|Overall Study|Other|0|||
127519636|NCT01939366|458863593|FG001|Overall Study|Other|0|||
127519637|NCT01939366|458863594|FG002|Overall Study|Other|2|||
127519638|NCT01939366|458863595|FG003|Overall Study|Other|2|||
127519639|NCT01939366|458863596|FG004|Overall Study|Other|1|||
127519640|NCT01939366|458863592|FG000|Overall Study|Protocol Violation|0|||
127519641|NCT01939366|458863593|FG001|Overall Study|Protocol Violation|0|||
127519642|NCT01939366|458863594|FG002|Overall Study|Protocol Violation|0|||
127519643|NCT01939366|458863595|FG003|Overall Study|Protocol Violation|1|||
127519644|NCT01939366|458863596|FG004|Overall Study|Protocol Violation|0|||
127519645|NCT01939366|458863592|FG000|Overall Study|Sponsor decision|0|||
127519646|NCT01939366|458863593|FG001|Overall Study|Sponsor decision|0|||
127519647|NCT01939366|458863594|FG002|Overall Study|Sponsor decision|0|||
127519648|NCT01939366|458863595|FG003|Overall Study|Sponsor decision|0|||
127519649|NCT01939366|458863596|FG004|Overall Study|Sponsor decision|2|||
127519650|NCT01939366|458863592|FG000|Overall Study|GCP non-compliance at site|2|||
127519651|NCT01939366|458863593|FG001|Overall Study|GCP non-compliance at site|3|||
127519652|NCT01939366|458863594|FG002|Overall Study|GCP non-compliance at site|2|||
127519653|NCT01939366|458863595|FG003|Overall Study|GCP non-compliance at site|3|||
127519654|NCT01939366|458863596|FG004|Overall Study|GCP non-compliance at site|3|||
127519655|NCT04680975|458863601|FG000|Overall Study|Adverse Event|3|||
127519656|NCT04680975|458863601|FG000|Overall Study|Death|1|||
127519657|NCT04680975|458863601|FG000|Overall Study|Progressive Disease|1|||
127519658|NCT04680975|458863601|FG000|Overall Study|Withdrawal by Subject|1|||
127519659|NCT03909152|458863602|FG000|Overall Study|Adverse Event|14|||
127519660|NCT03909152|458863603|FG001|Overall Study|Adverse Event|5|||
127519661|NCT03909152|458863604|FG002|Overall Study|Adverse Event|1|||
127519662|NCT03909152|458863605|FG003|Overall Study|Adverse Event|14|||
127519663|NCT02615691|458863606|FG000|Part A: Main Study (5 Years)|Adverse Event|3|||
127519664|NCT02615691|458863606|FG000|Part A: Main Study (5 Years)|Physician Decision|2|||
127519665|NCT02615691|458863606|FG000|Part A: Main Study (5 Years)|Withdrawal by Subject|7|||
127519666|NCT02615691|458863606|FG000|Part A: Main Study (5 Years)|Reason Not Specified|2|||
127519667|NCT02702414|458863607|FG000|Overall Study|Death|96|||
127519668|NCT02702414|458863608|FG001|Overall Study|Death|42|||
127519669|NCT02702414|458863607|FG000|Overall Study|Lost to Follow-up|0|||
127519670|NCT02702414|458863608|FG001|Overall Study|Lost to Follow-up|1|||
127519671|NCT02702414|458863607|FG000|Overall Study|Withdrawal by Subject|0|||
127519672|NCT02702414|458863608|FG001|Overall Study|Withdrawal by Subject|1|||
127519673|NCT02702414|458863607|FG000|Overall Study|Protocol Violation|1|||
127519674|NCT02702414|458863608|FG001|Overall Study|Protocol Violation|0|||
127519675|NCT02702414|458863607|FG000|Overall Study|Sponsor Decision|8|||
127519676|NCT02702414|458863608|FG001|Overall Study|Sponsor Decision|7|||
127519677|NCT02596230|458863609|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
127519678|NCT02596230|458863610|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
127519679|NCT02596230|458863611|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
127519680|NCT02596230|458863612|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
127519681|NCT02596230|458863613|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
127519682|NCT02596230|458863609|FG000|Objective 2, One Year|Lost to Follow-up|0|||
127519683|NCT02596230|458863610|FG001|Objective 2, One Year|Lost to Follow-up|41|||
127519684|NCT02596230|458863611|FG002|Objective 2, One Year|Lost to Follow-up|41|||
127519685|NCT02596230|458863612|FG003|Objective 2, One Year|Lost to Follow-up|32|||
127519686|NCT02596230|458863613|FG004|Objective 2, One Year|Lost to Follow-up|46|||
127519687|NCT02596230|458863609|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
127519688|NCT02596230|458863610|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
127519689|NCT02596230|458863611|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
127519690|NCT02596230|458863612|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
127519691|NCT02596230|458863613|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
127519692|NCT02596230|458863609|FG000|Objective 2, One Year|Adverse drug reaction|0|||
127519693|NCT02596230|458863610|FG001|Objective 2, One Year|Adverse drug reaction|1|||
127519694|NCT02596230|458863611|FG002|Objective 2, One Year|Adverse drug reaction|0|||
127519695|NCT02596230|458863612|FG003|Objective 2, One Year|Adverse drug reaction|0|||
127519696|NCT02596230|458863613|FG004|Objective 2, One Year|Adverse drug reaction|0|||
127519697|NCT02596230|458863609|FG000|Objective 2, One Year|Death|0|||
127519698|NCT02596230|458863610|FG001|Objective 2, One Year|Death|12|||
127519699|NCT02596230|458863611|FG002|Objective 2, One Year|Death|41|||
127519700|NCT02596230|458863612|FG003|Objective 2, One Year|Death|21|||
127519701|NCT02596230|458863613|FG004|Objective 2, One Year|Death|30|||
127519702|NCT02596230|458863609|FG000|Objective 2, One Year|Other|0|||
127519703|NCT02596230|458863610|FG001|Objective 2, One Year|Other|3|||
127519704|NCT02596230|458863611|FG002|Objective 2, One Year|Other|2|||
127519705|NCT02596230|458863612|FG003|Objective 2, One Year|Other|0|||
127519706|NCT02596230|458863613|FG004|Objective 2, One Year|Other|0|||
127519707|NCT02271945|458863614|FG000|Overall Study|Death|3|||
127519708|NCT02271945|458863615|FG001|Overall Study|Death|3|||
127519709|NCT02271945|458863614|FG000|Overall Study|Withdrawal by Subject|1|||
127519710|NCT02271945|458863615|FG001|Overall Study|Withdrawal by Subject|1|||
127519711|NCT02271945|458863614|FG000|Overall Study|Other|1|||
127519712|NCT02271945|458863615|FG001|Overall Study|Other|1|||
127519713|NCT00151476|458863617|FG000|FAP Identified Subjects|Protocol Violation|0|||
127519714|NCT00151476|458863618|FG001|FAP Identified Subjects|Protocol Violation|1|||
127519715|NCT00151476|458863617|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
127519716|NCT00151476|458863618|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
127519717|NCT00151476|458863617|FG000|FAP Analyzed Subjects|Other study participation|0|||
127519718|NCT00151476|458863618|FG001|FAP Analyzed Subjects|Other study participation|1|||
127519719|NCT03446456|458863619|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
127519720|NCT03446456|458863620|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
127519721|NCT03446456|458863619|FG000|Overall Study|Lost to Follow-up|1|||
127519722|NCT03446456|458863620|FG001|Overall Study|Lost to Follow-up|3|||
127519723|NCT03446456|458863619|FG000|Overall Study|Participant failed the toxicology test|1|||
127519724|NCT03446456|458863620|FG001|Overall Study|Participant failed the toxicology test|0|||
127519725|NCT03446456|458863619|FG000|Overall Study|Break down of the experimental equipment|1|||
127519726|NCT03446456|458863620|FG001|Overall Study|Break down of the experimental equipment|0|||
127519727|NCT04099511|458863627|FG000|Overall Study|Lost to Follow-up|2|||
127519728|NCT04099511|458863628|FG001|Overall Study|Lost to Follow-up|2|||
127519729|NCT04099511|458863627|FG000|Overall Study|Withdrawal by Subject|8|||
127519730|NCT04099511|458863628|FG001|Overall Study|Withdrawal by Subject|4|||
127519731|NCT03002311|458863633|FG000|Overall Study|Lost to Follow-up|13|||
127519732|NCT03002311|458863634|FG001|Overall Study|Lost to Follow-up|26|||
127519733|NCT03002311|458863633|FG000|Overall Study|Referral provider called to schedule app|3|||
127519734|NCT03002311|458863634|FG001|Overall Study|Referral provider called to schedule app|3|||
127519735|NCT03002311|458863633|FG000|Overall Study|Physician Decision|3|||
127519736|NCT03002311|458863634|FG001|Overall Study|Physician Decision|1|||
127519737|NCT00320424|458863635|FG000|Overall Study|Adverse Event|3|||
127519738|NCT00320424|458863635|FG000|Overall Study|Other|3|||
127519739|NCT00658814|458863636|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
127519740|NCT00658814|458863637|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
127519741|NCT00658814|458863636|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
127519742|NCT00658814|458863637|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
127519743|NCT00658814|458863636|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
127519744|NCT00658814|458863637|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
127519745|NCT00658814|458863636|FG000|Remission Induction Chemotherapy|Death|1|||
127519746|NCT00658814|458863637|FG001|Remission Induction Chemotherapy|Death|4|||
127519747|NCT00658814|458863636|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
127519748|NCT00658814|458863637|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
127519749|NCT00658814|458863636|FG000|Remission Induction Chemotherapy|Not eligible|1|||
127519750|NCT00658814|458863637|FG001|Remission Induction Chemotherapy|Not eligible|2|||
127519751|NCT00658814|458863636|FG000|Consolidation Therapy|Not protocol specified|0|||
127519752|NCT00658814|458863637|FG001|Consolidation Therapy|Not protocol specified|1|||
127519753|NCT00658814|458863636|FG000|Consolidation Therapy|Not eligible|2|||
127519754|NCT00658814|458863637|FG001|Consolidation Therapy|Not eligible|2|||
127519755|NCT00658814|458863636|FG000|Maintenance Therapy|Adverse Event|1|||
127519756|NCT00658814|458863637|FG001|Maintenance Therapy|Adverse Event|1|||
127519757|NCT00658814|458863636|FG000|Maintenance Therapy|Not protocol specified|1|||
127519758|NCT00658814|458863637|FG001|Maintenance Therapy|Not protocol specified|0|||
127519759|NCT00658814|458863636|FG000|Maintenance Therapy|Not eligible|1|||
127519760|NCT00658814|458863637|FG001|Maintenance Therapy|Not eligible|0|||
127519761|NCT02540668|458863638|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
127519762|NCT02540668|458863639|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
127519763|NCT03270891|458863640|FG000|Overall Study|Lost to Follow-up|3|||
127519764|NCT03270891|458863641|FG001|Overall Study|Lost to Follow-up|6|||
127519765|NCT03270891|458863642|FG002|Overall Study|Lost to Follow-up|0|||
127519766|NCT03270891|458863640|FG000|Overall Study|Withdrawal by Subject|1|||
127519767|NCT03270891|458863641|FG001|Overall Study|Withdrawal by Subject|0|||
127519768|NCT03270891|458863642|FG002|Overall Study|Withdrawal by Subject|0|||
127519769|NCT03270891|458863640|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
127519770|NCT03270891|458863641|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
127519771|NCT03270891|458863642|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
127519772|NCT02883062|458863644|FG000|Overall Study|Withdrawal by Subject|6|||
127519773|NCT02883062|458863645|FG001|Overall Study|Withdrawal by Subject|0|||
127519774|NCT02888743|458863646|FG000|Overall Study|Withdrawal by Subject|1|||
127519775|NCT02888743|458863647|FG001|Overall Study|Withdrawal by Subject|2|||
127519776|NCT02888743|458863648|FG002|Overall Study|Withdrawal by Subject|2|||
127519777|NCT02888743|458863649|FG003|Overall Study|Withdrawal by Subject|0|||
127519778|NCT02888743|458863650|FG004|Overall Study|Withdrawal by Subject|1|||
127519779|NCT02888743|458863646|FG000|Overall Study|Disease progression before treatment|2|||
127519780|NCT02888743|458863647|FG001|Overall Study|Disease progression before treatment|0|||
127519781|NCT02888743|458863648|FG002|Overall Study|Disease progression before treatment|2|||
127519782|NCT02888743|458863649|FG003|Overall Study|Disease progression before treatment|0|||
127519783|NCT02888743|458863650|FG004|Overall Study|Disease progression before treatment|0|||
127519784|NCT02888743|458863646|FG000|Overall Study|Patient ineligible|1|||
127519785|NCT02888743|458863647|FG001|Overall Study|Patient ineligible|2|||
127519786|NCT02888743|458863648|FG002|Overall Study|Patient ineligible|0|||
127519787|NCT02888743|458863649|FG003|Overall Study|Patient ineligible|0|||
127519788|NCT02888743|458863650|FG004|Overall Study|Patient ineligible|0|||
127519789|NCT04816721|458863658|FG000|Overall Study|Withdrawal by Subject|0|||
127519790|NCT04816721|458863659|FG001|Overall Study|Withdrawal by Subject|2|||
127519791|NCT04816721|458863660|FG002|Overall Study|Withdrawal by Subject|0|||
127519792|NCT04816721|458863661|FG003|Overall Study|Withdrawal by Subject|1|||
127519793|NCT04816721|458863662|FG004|Overall Study|Withdrawal by Subject|1|||
127519794|NCT04816721|458863663|FG005|Overall Study|Withdrawal by Subject|0|||
127519795|NCT04816721|458863664|FG006|Overall Study|Withdrawal by Subject|0|||
127519796|NCT04816721|458863665|FG007|Overall Study|Withdrawal by Subject|0|||
127519797|NCT04816721|458863658|FG000|Overall Study|Miscellaneous|0|||
127519798|NCT04816721|458863659|FG001|Overall Study|Miscellaneous|0|||
127519799|NCT04816721|458863660|FG002|Overall Study|Miscellaneous|0|||
127519800|NCT04816721|458863661|FG003|Overall Study|Miscellaneous|0|||
127519801|NCT04816721|458863662|FG004|Overall Study|Miscellaneous|0|||
127519802|NCT04816721|458863663|FG005|Overall Study|Miscellaneous|1|||
127519803|NCT04816721|458863664|FG006|Overall Study|Miscellaneous|0|||
127519804|NCT04816721|458863665|FG007|Overall Study|Miscellaneous|0|||
127519805|NCT04816721|458863658|FG000|Overall Study|Lost to Follow-up|0|||
127519806|NCT04816721|458863659|FG001|Overall Study|Lost to Follow-up|0|||
127519807|NCT04816721|458863660|FG002|Overall Study|Lost to Follow-up|0|||
127519808|NCT04816721|458863661|FG003|Overall Study|Lost to Follow-up|1|||
127519809|NCT04816721|458863662|FG004|Overall Study|Lost to Follow-up|0|||
127519810|NCT04816721|458863663|FG005|Overall Study|Lost to Follow-up|0|||
127519811|NCT04816721|458863664|FG006|Overall Study|Lost to Follow-up|0|||
127519812|NCT04816721|458863665|FG007|Overall Study|Lost to Follow-up|0|||
127519813|NCT02708485|458863666|FG000|Overall Study|Withdrawal by Subject|3|||
127519814|NCT02708485|458863667|FG001|Overall Study|Withdrawal by Subject|2|||
127519815|NCT03266172|458863668|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
127519816|NCT03266172|458863669|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
127519817|NCT03266172|458863670|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
127519818|NCT03266172|458863668|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
127519819|NCT03266172|458863669|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
127519820|NCT03266172|458863670|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
127519821|NCT03266172|458863668|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
127519822|NCT03266172|458863669|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
127519823|NCT03266172|458863670|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
127519824|NCT03266172|458863668|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
127519825|NCT03266172|458863669|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
127519826|NCT03266172|458863670|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
127519827|NCT03266172|458863668|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
127519828|NCT03266172|458863669|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
127519829|NCT03266172|458863670|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
127519830|NCT03266172|458863668|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
127519831|NCT03266172|458863669|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
127519832|NCT03266172|458863670|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
127519833|NCT01554514|458863673|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
127519834|NCT01554514|458863673|FG000|Overall Study|Physician Decision|1|||
127519835|NCT05222555|458863674|FG000|Overall Study|Ongoing|2|||
127519836|NCT05222555|458863675|FG001|Overall Study|Ongoing|18|||
127519837|NCT05222555|458863674|FG000|Overall Study|Adverse Event|1|||
127519838|NCT05222555|458863675|FG001|Overall Study|Adverse Event|1|||
127519839|NCT05222555|458863674|FG000|Overall Study|Death|0|||
127519840|NCT05222555|458863675|FG001|Overall Study|Death|6|||
127519841|NCT05222555|458863674|FG000|Overall Study|Withdrawal by Subject|0|||
127519842|NCT05222555|458863675|FG001|Overall Study|Withdrawal by Subject|11|||
127519843|NCT00300365|458863676|FG000|Overall Study|Lost to Follow-up|1|||
127519844|NCT00300365|458863677|FG001|Overall Study|Lost to Follow-up|0|||
127519845|NCT00300365|458863676|FG000|Overall Study|Physician Decision|2|||
127519846|NCT00300365|458863677|FG001|Overall Study|Physician Decision|0|||
127519847|NCT00300365|458863676|FG000|Overall Study|Withdrawal by Subject|1|||
127519848|NCT00300365|458863677|FG001|Overall Study|Withdrawal by Subject|0|||
127519849|NCT00300365|458863676|FG000|Overall Study|Adverse Event|0|||
127519850|NCT00300365|458863677|FG001|Overall Study|Adverse Event|2|||
127519851|NCT01422824|458863678|FG000|Overall Study|Case record form not evaluated|1|||
127519852|NCT01422824|458863678|FG000|Overall Study|Lost to Follow-up|37|||
127519853|NCT01581619|458863679|FG000|Overall Study|Withdrawal by Subject|1|||
127519854|NCT01581619|458863679|FG000|Overall Study|Lost to Follow-up|1|||
127519855|NCT00290498|458863680|FG000|Overall Study|Death|2|||
127519856|NCT00290498|458863681|FG001|Overall Study|Death|0|||
127519857|NCT00290498|458863680|FG000|Overall Study|Physician Decision|1|||
127519858|NCT00290498|458863681|FG001|Overall Study|Physician Decision|0|||
127519859|NCT00290498|458863680|FG000|Overall Study|Withdrawal by Subject|1|||
127519860|NCT00290498|458863681|FG001|Overall Study|Withdrawal by Subject|0|||
127519861|NCT00290498|458863680|FG000|Overall Study|Ineligible|3|||
127519862|NCT00290498|458863681|FG001|Overall Study|Ineligible|0|||
127519863|NCT00290498|458863680|FG000|Overall Study|Non-Compliance|1|||
127519864|NCT00290498|458863681|FG001|Overall Study|Non-Compliance|0|||
127519865|NCT01716104|458863683|FG000|Overall Study|Do not meet inclusion criteria|6|||
127519866|NCT01716104|458863684|FG001|Overall Study|Do not meet inclusion criteria|7|||
127519867|NCT01753401|458863687|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
127519868|NCT01753401|458863688|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
127519869|NCT01753401|458863689|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
127519870|NCT01753401|458863690|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
127519871|NCT01753401|458863687|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
127519872|NCT01753401|458863688|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
127519873|NCT01753401|458863689|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
127519874|NCT01753401|458863690|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
127519875|NCT01753401|458863687|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
127519876|NCT01753401|458863688|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
127519877|NCT01753401|458863689|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
127519878|NCT01753401|458863690|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
127519879|NCT01753401|458863687|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
127519880|NCT01753401|458863688|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
127519881|NCT01753401|458863689|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
127519882|NCT01753401|458863690|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
127519883|NCT01753401|458863687|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
127519884|NCT01753401|458863688|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
127519885|NCT01753401|458863689|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
127519886|NCT01753401|458863690|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
127519887|NCT01753401|458863687|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
127519888|NCT01753401|458863688|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
127519889|NCT01753401|458863689|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
127519890|NCT01753401|458863690|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
127519891|NCT01753401|458863687|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
127519892|NCT01753401|458863688|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
127519893|NCT01753401|458863689|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
127519894|NCT01753401|458863690|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
127519895|NCT03129360|458863691|FG000|Overall Study|Did not meet entry criteria|0|||
127519896|NCT03129360|458863692|FG001|Overall Study|Did not meet entry criteria|2|||
127519897|NCT03129360|458863693|FG002|Overall Study|Did not meet entry criteria|1|||
127519898|NCT03129360|458863691|FG000|Overall Study|Excluded due to motion in scanner|1|||
127519899|NCT03129360|458863692|FG001|Overall Study|Excluded due to motion in scanner|0|||
127519900|NCT03129360|458863693|FG002|Overall Study|Excluded due to motion in scanner|0|||
127519901|NCT05026853|458863694|FG000|Overall Study|Cancelled appointment|1|||
127519902|NCT05026853|458863695|FG001|Overall Study|Cancelled appointment|0|||
127519903|NCT05026853|458863694|FG000|Overall Study|Excluded due to technical difficulties with generating scorecard|8|||
127519904|NCT05026853|458863695|FG001|Overall Study|Excluded due to technical difficulties with generating scorecard|0|||
127519905|NCT05026853|458863694|FG000|Overall Study|Did not complete 12-week survey|16|||
127519906|NCT05026853|458863695|FG001|Overall Study|Did not complete 12-week survey|16|||
127519907|NCT03006887|458863696|FG000|Overall Study|Adverse Event|1|||
127519908|NCT00494507|458863697|FG000|Double-Blind Phase|Adverse Event|2|||
127519909|NCT00494507|458863698|FG001|Double-Blind Phase|Adverse Event|0|||
127519910|NCT00494507|458863699|FG002|Double-Blind Phase|Adverse Event|1|||
127519911|NCT00494507|458863700|FG003|Double-Blind Phase|Adverse Event|0|||
127519912|NCT00494507|458863697|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
127519913|NCT00494507|458863698|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
127519914|NCT00494507|458863699|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
127519915|NCT00494507|458863700|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
127519916|NCT00494507|458863697|FG000|Double-Blind Phase|Subject Non-compliance|0|||
127519917|NCT00494507|458863698|FG001|Double-Blind Phase|Subject Non-compliance|0|||
127519918|NCT00494507|458863699|FG002|Double-Blind Phase|Subject Non-compliance|1|||
127519919|NCT00494507|458863700|FG003|Double-Blind Phase|Subject Non-compliance|0|||
127519920|NCT00494507|458863697|FG000|Double-Blind Phase|Negative DNA test|0|||
127519921|NCT00494507|458863698|FG001|Double-Blind Phase|Negative DNA test|0|||
127519922|NCT00494507|458863699|FG002|Double-Blind Phase|Negative DNA test|0|||
127519923|NCT00494507|458863700|FG003|Double-Blind Phase|Negative DNA test|1|||
127519924|NCT00494507|458863697|FG000|Open-Label Phase|Adverse Event|0|||
127519925|NCT00494507|458863698|FG001|Open-Label Phase|Adverse Event|1|||
127519926|NCT00494507|458863699|FG002|Open-Label Phase|Adverse Event|5|||
127519927|NCT00494507|458863700|FG003|Open-Label Phase|Adverse Event|3|||
127519928|NCT00494507|458863697|FG000|Open-Label Phase|Worsening Disease|0|||
127519929|NCT00494507|458863698|FG001|Open-Label Phase|Worsening Disease|0|||
127519930|NCT00494507|458863699|FG002|Open-Label Phase|Worsening Disease|0|||
127519931|NCT00494507|458863700|FG003|Open-Label Phase|Worsening Disease|2|||
127519932|NCT03615066|458863701|FG000|Main Study|Withdrew Consent|0|||
127519933|NCT03615066|458863702|FG001|Main Study|Withdrew Consent|1|||
127519934|NCT03615066|458863703|FG002|Main Study|Withdrew Consent|1|||
127519935|NCT03615066|458863701|FG000|Main Study|Lost to Follow-up|0|||
127519936|NCT03615066|458863702|FG001|Main Study|Lost to Follow-up|0|||
127519937|NCT03615066|458863703|FG002|Main Study|Lost to Follow-up|1|||
127519938|NCT03615066|458863701|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
127519939|NCT03615066|458863702|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
127519940|NCT03615066|458863703|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
127519941|NCT03615066|458863701|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
127519942|NCT03615066|458863702|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
127519943|NCT03615066|458863703|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
127519944|NCT03615066|458863701|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
127519945|NCT03615066|458863702|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
127519946|NCT03615066|458863703|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
127519947|NCT02437084|458863705|FG000|Overall Study|Withdrawal by Subject|2|||
127519948|NCT02437084|458863705|FG000|Overall Study|Physician Decision|1|||
127519949|NCT00587847|458863706|FG000|Overall Study|Lack of Efficacy|5|||
127519950|NCT00587847|458863706|FG000|Overall Study|Adverse Event|2|||
127519951|NCT00694304|458863710|FG000|Overall Study|Adverse Event|42|||
127519952|NCT00694304|458863710|FG000|Overall Study|Lack of Efficacy|35|||
127519953|NCT00694304|458863710|FG000|Overall Study|Non-compliance With Study Product|16|||
127519954|NCT00694304|458863710|FG000|Overall Study|Protocol Violation|6|||
127519955|NCT00694304|458863710|FG000|Overall Study|Withdrawal of Consent|61|||
127519956|NCT00694304|458863710|FG000|Overall Study|Lost to Follow-up|15|||
127519957|NCT00694304|458863710|FG000|Overall Study|Administrative or Other Reasons|32|||
127519958|NCT03203291|458863715|FG000|Overall Study|Withdrawal by Subject|1|||
127519959|NCT05098509|458863717|FG000|Overall Study|Withdrawal by Subject|0|||
127519960|NCT05098509|458863718|FG001|Overall Study|Withdrawal by Subject|0|||
127519961|NCT05098509|458863719|FG002|Overall Study|Withdrawal by Subject|1|||
127519962|NCT05098509|458863720|FG003|Overall Study|Withdrawal by Subject|0|||
127519963|NCT05098509|458863717|FG000|Overall Study|Early study termination|1|||
127519964|NCT05098509|458863718|FG001|Overall Study|Early study termination|1|||
127519965|NCT05098509|458863719|FG002|Overall Study|Early study termination|1|||
127519966|NCT05098509|458863720|FG003|Overall Study|Early study termination|0|||
127519967|NCT01972789|458863723|FG000|Overall Study|Adverse Event|11|||
127519968|NCT01972789|458863724|FG001|Overall Study|Adverse Event|4|||
127519969|NCT01972789|458863723|FG000|Overall Study|Subject withdrew consent|14|||
127519970|NCT01972789|458863724|FG001|Overall Study|Subject withdrew consent|12|||
127519971|NCT01972789|458863723|FG000|Overall Study|Lost to Follow-up|4|||
127519972|NCT01972789|458863724|FG001|Overall Study|Lost to Follow-up|7|||
127519973|NCT01972789|458863723|FG000|Overall Study|Death|7|||
127519974|NCT01972789|458863724|FG001|Overall Study|Death|5|||
127519975|NCT01972789|458863723|FG000|Overall Study|Protocol deviation|1|||
127519976|NCT01972789|458863724|FG001|Overall Study|Protocol deviation|0|||
127519977|NCT01972789|458863723|FG000|Overall Study|Physician Decision|3|||
127519978|NCT01972789|458863724|FG001|Overall Study|Physician Decision|2|||
127519979|NCT04407234|458863731|FG000|Overall Study|Adverse Event|3|||
127519980|NCT04407234|458863732|FG001|Overall Study|Adverse Event|3|||
127519981|NCT00727558|458863733|FG000|Overall Study|Lens issue|0|||
127519982|NCT00727558|458863734|FG001|Overall Study|Lens issue|1|||
127519983|NCT00727558|458863733|FG000|Overall Study|Adverse Event|0|||
127519984|NCT00727558|458863734|FG001|Overall Study|Adverse Event|1|||
127519985|NCT00727558|458863733|FG000|Overall Study|Subject unable to return for follow-up|1|||
127519986|NCT00727558|458863734|FG001|Overall Study|Subject unable to return for follow-up|1|||
127519987|NCT00727558|458863733|FG000|Overall Study|Lost to Follow-up|1|||
127519988|NCT00727558|458863734|FG001|Overall Study|Lost to Follow-up|0|||
127519989|NCT03268941|458865401|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
127519990|NCT03268941|458865402|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
127519991|NCT03268941|458865403|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
127519992|NCT03268941|458865404|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
127519993|NCT03268941|458865405|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
127519994|NCT03268941|458865406|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
127519995|NCT03268941|458865407|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
127519996|NCT03268941|458865401|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
127519997|NCT03268941|458865402|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
127519998|NCT03268941|458865403|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
127519999|NCT03268941|458865404|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
127520000|NCT03268941|458865405|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
127520001|NCT03268941|458865406|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
127520002|NCT03268941|458865407|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
127520003|NCT03268941|458865401|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
127520004|NCT03268941|458865402|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
127520005|NCT03268941|458865403|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
127520006|NCT03268941|458865404|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
127520007|NCT03268941|458865405|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
127520008|NCT03268941|458865406|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
127520009|NCT03268941|458865407|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
127520010|NCT03268941|458865401|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
127520011|NCT03268941|458865402|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
127520012|NCT03268941|458865403|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
127520013|NCT03268941|458865404|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
127520014|NCT03268941|458865405|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
127520015|NCT03268941|458865406|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
127520016|NCT03268941|458865407|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
127520017|NCT03268941|458865401|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
127520018|NCT03268941|458865402|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
127520019|NCT03268941|458865403|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
127520020|NCT03268941|458865404|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
127520021|NCT03268941|458865405|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
127520022|NCT03268941|458865406|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
127520023|NCT03268941|458865407|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
127520024|NCT01216683|458865408|FG000|Induction|Never started treatment|0|||
127520025|NCT01216683|458865409|FG001|Induction|Never started treatment|6|||
127520026|NCT01216683|458865410|FG002|Induction|Never started treatment|3|||
127520027|NCT01216683|458865408|FG000|Induction|Lack of Efficacy|4|||
127520028|NCT01216683|458865409|FG001|Induction|Lack of Efficacy|3|||
127520029|NCT01216683|458865410|FG002|Induction|Lack of Efficacy|7|||
127520030|NCT01216683|458865408|FG000|Induction|Adverse Event|0|||
127520031|NCT01216683|458865409|FG001|Induction|Adverse Event|5|||
127520032|NCT01216683|458865410|FG002|Induction|Adverse Event|5|||
127520033|NCT01216683|458865408|FG000|Induction|Death|0|||
127520034|NCT01216683|458865409|FG001|Induction|Death|0|||
127520035|NCT01216683|458865410|FG002|Induction|Death|2|||
127520036|NCT01216683|458865408|FG000|Induction|Withdrawal by Subject|0|||
127520037|NCT01216683|458865409|FG001|Induction|Withdrawal by Subject|4|||
127520038|NCT01216683|458865410|FG002|Induction|Withdrawal by Subject|2|||
127520039|NCT01216683|458865408|FG000|Induction|Other disease|0|||
127520040|NCT01216683|458865409|FG001|Induction|Other disease|1|||
127520041|NCT01216683|458865410|FG002|Induction|Other disease|2|||
127520042|NCT01216683|458865408|FG000|Continuation|Lack of Efficacy|3|||
127520043|NCT01216683|458865409|FG001|Continuation|Lack of Efficacy|2|||
127520044|NCT01216683|458865410|FG002|Continuation|Lack of Efficacy|7|||
127520045|NCT01216683|458865408|FG000|Continuation|Adverse Event|5|||
127520046|NCT01216683|458865409|FG001|Continuation|Adverse Event|3|||
127520047|NCT01216683|458865410|FG002|Continuation|Adverse Event|16|||
127520048|NCT01216683|458865408|FG000|Continuation|Death|1|||
127520049|NCT01216683|458865409|FG001|Continuation|Death|0|||
127520050|NCT01216683|458865410|FG002|Continuation|Death|2|||
127520051|NCT01216683|458865408|FG000|Continuation|Withdrawal by Subject|4|||
127520052|NCT01216683|458865409|FG001|Continuation|Withdrawal by Subject|5|||
127520053|NCT01216683|458865410|FG002|Continuation|Withdrawal by Subject|9|||
127520054|NCT01216683|458865408|FG000|Continuation|Other diseases|0|||
127520055|NCT01216683|458865409|FG001|Continuation|Other diseases|2|||
127520056|NCT01216683|458865410|FG002|Continuation|Other diseases|1|||
127520057|NCT01216683|458865408|FG000|Continuation|Physician Decision|1|||
127520058|NCT01216683|458865409|FG001|Continuation|Physician Decision|0|||
127520059|NCT01216683|458865410|FG002|Continuation|Physician Decision|1|||
127520060|NCT01216683|458865408|FG000|Continuation|Non-compliance|1|||
127520061|NCT01216683|458865409|FG001|Continuation|Non-compliance|0|||
127520062|NCT01216683|458865410|FG002|Continuation|Non-compliance|1|||
127520063|NCT01216683|458865408|FG000|Continuation|Insurance change|0|||
127520064|NCT01216683|458865409|FG001|Continuation|Insurance change|1|||
127520065|NCT01216683|458865410|FG002|Continuation|Insurance change|0|||
127520066|NCT01216683|458865408|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
127520067|NCT01216683|458865409|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
127520068|NCT01216683|458865410|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
127520069|NCT01216683|458865408|FG000|Continuation|Not reported|0|||
127520070|NCT01216683|458865409|FG001|Continuation|Not reported|0|||
127520071|NCT01216683|458865410|FG002|Continuation|Not reported|1|||
127520072|NCT01216683|458865408|FG000|Continuation|Never started treatment|0|||
127520073|NCT01216683|458865409|FG001|Continuation|Never started treatment|1|||
127520074|NCT01216683|458865410|FG002|Continuation|Never started treatment|5|||
127520075|NCT02503501|458865414|FG000|Overall Study|Physician Decision|1|||
127520076|NCT02503501|458865415|FG001|Overall Study|Physician Decision|0|||
127520077|NCT02503501|458865414|FG000|Overall Study|Protocol Violation|0|||
127520078|NCT02503501|458865415|FG001|Overall Study|Protocol Violation|1|||
127520079|NCT02503501|458865414|FG000|Overall Study|Withdrawal by Subject|0|||
127520080|NCT02503501|458865415|FG001|Overall Study|Withdrawal by Subject|2|||
127520081|NCT02806960|458865416|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
127520082|NCT02806960|458865417|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
127520083|NCT02806960|458865418|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
127520084|NCT02806960|458865419|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
127520085|NCT00765063|458865425|FG000|Overall Study|Lack of Efficacy|5|||
127520086|NCT00765063|458865425|FG000|Overall Study|Withdrawal by Subject|1|||
127520087|NCT00765063|458865425|FG000|Overall Study|Other|16|||
127520088|NCT00765063|458865425|FG000|Overall Study|Protocol Violation|6|||
127520089|NCT00765063|458865425|FG000|Overall Study|Adverse Event|4|||
127520090|NCT01041287|458865426|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
127520091|NCT01041287|458865427|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
127520092|NCT01041287|458865426|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
127520093|NCT01041287|458865427|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
127520094|NCT02702180|458865428|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
127520095|NCT02702180|458865429|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
127520096|NCT02702180|458865430|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
127520097|NCT02702180|458865428|FG000|Double-blind Treatment Period|Adverse Event|0|||
127520098|NCT02702180|458865429|FG001|Double-blind Treatment Period|Adverse Event|0|||
127520099|NCT02702180|458865430|FG002|Double-blind Treatment Period|Adverse Event|1|||
127520100|NCT02702180|458865428|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
127520101|NCT02702180|458865429|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
127520102|NCT02702180|458865430|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
127520103|NCT02702180|458865428|FG000|Double-blind Treatment Period|Protocol Violation|0|||
127520104|NCT02702180|458865429|FG001|Double-blind Treatment Period|Protocol Violation|0|||
127520105|NCT02702180|458865430|FG002|Double-blind Treatment Period|Protocol Violation|2|||
127520106|NCT02702180|458865428|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
127520107|NCT02702180|458865429|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
127520108|NCT02702180|458865430|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
127520109|NCT02702180|458865428|FG000|Open-label Treatment Period|Withdrawn in error|0|||
127520110|NCT02702180|458865429|FG001|Open-label Treatment Period|Withdrawn in error|0|||
127520111|NCT02702180|458865430|FG002|Open-label Treatment Period|Withdrawn in error|1|||
127520112|NCT00567359|458865431|FG000|Overall Study|Withdrawal by Subject|1|||
127520113|NCT03626545|458865433|FG000|Overall Study|Progressive disease|3|||
127520114|NCT03626545|458865434|FG001|Overall Study|Progressive disease|82|||
127520115|NCT03626545|458865435|FG002|Overall Study|Progressive disease|85|||
127520116|NCT03626545|458865433|FG000|Overall Study|Adverse Event|3|||
127520117|NCT03626545|458865434|FG001|Overall Study|Adverse Event|13|||
127520118|NCT03626545|458865435|FG002|Overall Study|Adverse Event|10|||
127520119|NCT03626545|458865433|FG000|Overall Study|Physician Decision|1|||
127520120|NCT03626545|458865434|FG001|Overall Study|Physician Decision|18|||
127520121|NCT03626545|458865435|FG002|Overall Study|Physician Decision|14|||
127520122|NCT03626545|458865433|FG000|Overall Study|Subject Decision|0|||
127520123|NCT03626545|458865434|FG001|Overall Study|Subject Decision|5|||
127520124|NCT03626545|458865435|FG002|Overall Study|Subject Decision|5|||
127520125|NCT03626545|458865433|FG000|Overall Study|Death|1|||
127520126|NCT03626545|458865434|FG001|Overall Study|Death|1|||
127520127|NCT03626545|458865435|FG002|Overall Study|Death|1|||
127520128|NCT03626545|458865433|FG000|Overall Study|Protocol Deviation|0|||
127520129|NCT03626545|458865434|FG001|Overall Study|Protocol Deviation|1|||
127520130|NCT03626545|458865435|FG002|Overall Study|Protocol Deviation|1|||
127520131|NCT03626545|458865433|FG000|Overall Study|Guardian Decision|0|||
127520132|NCT03626545|458865434|FG001|Overall Study|Guardian Decision|0|||
127520133|NCT03626545|458865435|FG002|Overall Study|Guardian Decision|1|||
127520134|NCT01452919|458865436|FG000|Open-Label Treatment|Adverse Event|5|||
127520135|NCT01452919|458865437|FG001|Open-Label Treatment|Adverse Event|0|||
127520136|NCT01452919|458865438|FG002|Open-Label Treatment|Adverse Event|0|||
127520137|NCT01452919|458865436|FG000|Open-Label Treatment|Lost to Follow-up|4|||
127520138|NCT01452919|458865437|FG001|Open-Label Treatment|Lost to Follow-up|0|||
127520139|NCT01452919|458865438|FG002|Open-Label Treatment|Lost to Follow-up|0|||
127520140|NCT01452919|458865436|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
127520141|NCT01452919|458865437|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
127520142|NCT01452919|458865438|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
127520143|NCT01452919|458865436|FG000|Open-Label Treatment|Protocol Violation|4|||
127520144|NCT01452919|458865437|FG001|Open-Label Treatment|Protocol Violation|0|||
127520145|NCT01452919|458865438|FG002|Open-Label Treatment|Protocol Violation|0|||
127520146|NCT01452919|458865436|FG000|Open-Label Treatment|Sponsor Decision|1|||
127520147|NCT01452919|458865437|FG001|Open-Label Treatment|Sponsor Decision|0|||
127520148|NCT01452919|458865438|FG002|Open-Label Treatment|Sponsor Decision|0|||
127520149|NCT01452919|458865436|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
127520150|NCT01452919|458865437|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
127520151|NCT01452919|458865438|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
127520152|NCT01452919|458865436|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
127520153|NCT01452919|458865437|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
127520154|NCT01452919|458865438|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
127520155|NCT01452919|458865436|FG000|Randomization Treatment|Adverse Event|0|||
127520156|NCT01452919|458865437|FG001|Randomization Treatment|Adverse Event|0|||
127520157|NCT01452919|458865438|FG002|Randomization Treatment|Adverse Event|2|||
127520158|NCT01452919|458865436|FG000|Randomization Treatment|Sponsor Decision|0|||
127520159|NCT01452919|458865437|FG001|Randomization Treatment|Sponsor Decision|1|||
127520160|NCT01452919|458865438|FG002|Randomization Treatment|Sponsor Decision|0|||
127520161|NCT01452919|458865436|FG000|Randomization Treatment|Withdrawal by Subject|0|||
127520162|NCT01452919|458865437|FG001|Randomization Treatment|Withdrawal by Subject|1|||
127520163|NCT01452919|458865438|FG002|Randomization Treatment|Withdrawal by Subject|0|||
127520164|NCT01452919|458865436|FG000|Randomization Treatment|Subject is moving or has moved|0|||
127520165|NCT01452919|458865437|FG001|Randomization Treatment|Subject is moving or has moved|1|||
127520166|NCT01452919|458865438|FG002|Randomization Treatment|Subject is moving or has moved|0|||
127520167|NCT02421588|458865439|FG000|Overall Study|Non-treatment-related AE|8|||
127520168|NCT02421588|458865440|FG001|Overall Study|Non-treatment-related AE|8|||
127520169|NCT02421588|458865439|FG000|Overall Study|Progressive disease|152|||
127520170|NCT02421588|458865440|FG001|Overall Study|Progressive disease|135|||
127520171|NCT02421588|458865439|FG000|Overall Study|Death|11|||
127520172|NCT02421588|458865440|FG001|Overall Study|Death|3|||
127520173|NCT02421588|458865439|FG000|Overall Study|Physician Decision|8|||
127520174|NCT02421588|458865440|FG001|Overall Study|Physician Decision|17|||
127520175|NCT02421588|458865439|FG000|Overall Study|Other reason not specified|3|||
127520176|NCT02421588|458865440|FG001|Overall Study|Other reason not specified|1|||
127520177|NCT02421588|458865439|FG000|Overall Study|Symptomatic deterioration|13|||
127520178|NCT02421588|458865440|FG001|Overall Study|Symptomatic deterioration|19|||
127520179|NCT02421588|458865439|FG000|Overall Study|Treatment-related AE|10|||
127520180|NCT02421588|458865440|FG001|Overall Study|Treatment-related AE|14|||
127520181|NCT02421588|458865439|FG000|Overall Study|Withdrawal by Subject|14|||
127520182|NCT02421588|458865440|FG001|Overall Study|Withdrawal by Subject|16|||
127520183|NCT02421588|458865439|FG000|Overall Study|Not treated|2|||
127520184|NCT02421588|458865440|FG001|Overall Study|Not treated|8|||
127520185|NCT01359943|458865441|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
127520186|NCT01359943|458865442|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
127520187|NCT01359943|458865443|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
127520188|NCT01359943|458865441|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
127520189|NCT01359943|458865442|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
127520190|NCT01359943|458865443|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
127520191|NCT01359943|458865441|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
127520192|NCT01359943|458865442|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
127520193|NCT01359943|458865443|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
127520194|NCT01359943|458865441|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
127520195|NCT01359943|458865442|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
127520196|NCT01359943|458865443|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
127520197|NCT01359943|458865441|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
127520198|NCT01359943|458865442|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
127520199|NCT01359943|458865443|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
127520200|NCT01359943|458865441|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
127520201|NCT01359943|458865442|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
127520202|NCT01359943|458865443|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
127520203|NCT01359943|458865441|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
127520204|NCT01359943|458865442|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
127520205|NCT01359943|458865443|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
127520206|NCT01359943|458865441|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
127520207|NCT01359943|458865442|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
127520208|NCT01359943|458865443|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
127520209|NCT01359943|458865441|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
127520210|NCT01359943|458865442|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
127520211|NCT01359943|458865443|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
127520212|NCT01359943|458865441|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
127520213|NCT01359943|458865442|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
127520214|NCT01359943|458865443|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
127520215|NCT01359943|458865441|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
127520216|NCT01359943|458865442|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
127520217|NCT01359943|458865443|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
127520218|NCT01359943|458865441|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
127520219|NCT01359943|458865442|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
127520220|NCT01359943|458865443|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
127520221|NCT01359943|458865441|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
127520222|NCT01359943|458865442|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
127520223|NCT01359943|458865443|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
127520224|NCT01359943|458865441|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
127520225|NCT01359943|458865442|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
127520226|NCT01359943|458865443|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
127520227|NCT01359943|458865441|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
127520228|NCT01359943|458865442|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
127520229|NCT01359943|458865443|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
127520230|NCT03194646|458865453|FG000|Overall Study|Adverse Event|24|||
127520231|NCT03194646|458865454|FG001|Overall Study|Adverse Event|25|||
127520232|NCT03194646|458865455|FG002|Overall Study|Adverse Event|14|||
127520233|NCT03194646|458865456|FG003|Overall Study|Adverse Event|17|||
127520234|NCT03194646|458865453|FG000|Overall Study|Lack of Efficacy|4|||
127520235|NCT03194646|458865454|FG001|Overall Study|Lack of Efficacy|2|||
127520236|NCT03194646|458865455|FG002|Overall Study|Lack of Efficacy|2|||
127520237|NCT03194646|458865456|FG003|Overall Study|Lack of Efficacy|12|||
127520238|NCT03194646|458865453|FG000|Overall Study|Lost to Follow-up|30|||
127520239|NCT03194646|458865454|FG001|Overall Study|Lost to Follow-up|22|||
127520240|NCT03194646|458865455|FG002|Overall Study|Lost to Follow-up|12|||
127520241|NCT03194646|458865456|FG003|Overall Study|Lost to Follow-up|35|||
127520242|NCT03194646|458865453|FG000|Overall Study|Non-compliance with study drug|4|||
127520243|NCT03194646|458865454|FG001|Overall Study|Non-compliance with study drug|0|||
127520244|NCT03194646|458865455|FG002|Overall Study|Non-compliance with study drug|1|||
127520245|NCT03194646|458865456|FG003|Overall Study|Non-compliance with study drug|1|||
127520246|NCT03194646|458865453|FG000|Overall Study|Other|89|||
127520247|NCT03194646|458865454|FG001|Overall Study|Other|68|||
127520248|NCT03194646|458865455|FG002|Overall Study|Other|34|||
127520249|NCT03194646|458865456|FG003|Overall Study|Other|31|||
127520250|NCT03194646|458865453|FG000|Overall Study|Physician Decision|7|||
127520251|NCT03194646|458865454|FG001|Overall Study|Physician Decision|9|||
127520252|NCT03194646|458865455|FG002|Overall Study|Physician Decision|5|||
127520253|NCT03194646|458865456|FG003|Overall Study|Physician Decision|4|||
127520254|NCT03194646|458865453|FG000|Overall Study|Pregnancy|4|||
127520255|NCT03194646|458865454|FG001|Overall Study|Pregnancy|5|||
127520256|NCT03194646|458865455|FG002|Overall Study|Pregnancy|1|||
127520257|NCT03194646|458865456|FG003|Overall Study|Pregnancy|2|||
127520258|NCT03194646|458865453|FG000|Overall Study|Protocol Violation|4|||
127520259|NCT03194646|458865454|FG001|Overall Study|Protocol Violation|2|||
127520260|NCT03194646|458865455|FG002|Overall Study|Protocol Violation|1|||
127520261|NCT03194646|458865456|FG003|Overall Study|Protocol Violation|1|||
127520262|NCT03194646|458865453|FG000|Overall Study|Site terminated by sponsor|0|||
127520263|NCT03194646|458865454|FG001|Overall Study|Site terminated by sponsor|0|||
127520264|NCT03194646|458865455|FG002|Overall Study|Site terminated by sponsor|2|||
127520265|NCT03194646|458865456|FG003|Overall Study|Site terminated by sponsor|0|||
127520266|NCT03194646|458865453|FG000|Overall Study|Study terminated by sponsor|62|||
127520267|NCT03194646|458865454|FG001|Overall Study|Study terminated by sponsor|61|||
127520268|NCT03194646|458865455|FG002|Overall Study|Study terminated by sponsor|30|||
127520269|NCT03194646|458865456|FG003|Overall Study|Study terminated by sponsor|34|||
127520270|NCT03194646|458865453|FG000|Overall Study|Withdrawal by Subject|75|||
127520271|NCT03194646|458865454|FG001|Overall Study|Withdrawal by Subject|74|||
127520272|NCT03194646|458865455|FG002|Overall Study|Withdrawal by Subject|36|||
127520273|NCT03194646|458865456|FG003|Overall Study|Withdrawal by Subject|131|||
127520274|NCT03194646|458865453|FG000|Overall Study|Missing|1|||
127520275|NCT03194646|458865454|FG001|Overall Study|Missing|0|||
127520276|NCT03194646|458865455|FG002|Overall Study|Missing|1|||
127520277|NCT03194646|458865456|FG003|Overall Study|Missing|12|||
127520278|NCT02649894|458865457|FG000|Overall Study|Adverse Event|1|||
127520279|NCT02649894|458865458|FG001|Overall Study|Adverse Event|0|||
127520280|NCT02649894|458865457|FG000|Overall Study|Physician Decision|0|||
127520281|NCT02649894|458865458|FG001|Overall Study|Physician Decision|1|||
127520282|NCT02649894|458865457|FG000|Overall Study|Withdrawal by Subject|5|||
127520283|NCT02649894|458865458|FG001|Overall Study|Withdrawal by Subject|2|||
127520284|NCT02649894|458865457|FG000|Overall Study|Lost to Follow-up|2|||
127520285|NCT02649894|458865458|FG001|Overall Study|Lost to Follow-up|1|||
127520286|NCT02649894|458865457|FG000|Overall Study|Death|30|||
127520287|NCT02649894|458865458|FG001|Overall Study|Death|7|||
127520288|NCT02649894|458865457|FG000|Overall Study|Other, not specified|6|||
127520289|NCT02649894|458865458|FG001|Overall Study|Other, not specified|0|||
127520290|NCT00719680|458865459|FG000|Overall Study|Adverse Event|1|||
127520291|NCT00719680|458865459|FG000|Overall Study|Lost to Follow-up|1|||
127520292|NCT00719680|458865459|FG000|Overall Study|Withdrawal by Subject|3|||
127520293|NCT01110382|458865461|FG000|Overall Study|Withdrawal by Subject|0|||
127520294|NCT01110382|458865462|FG001|Overall Study|Withdrawal by Subject|1|||
127520295|NCT01110382|458865461|FG000|Overall Study|Protocol Violation|0|||
127520296|NCT01110382|458865462|FG001|Overall Study|Protocol Violation|1|||
127520297|NCT00902174|458865463|FG000|Overall Study|Adverse Event|27|||
127520298|NCT00902174|458865464|FG001|Overall Study|Adverse Event|7|||
127520299|NCT00902174|458865463|FG000|Overall Study|Lack of Efficacy|1|||
127520300|NCT00902174|458865464|FG001|Overall Study|Lack of Efficacy|5|||
127520301|NCT00902174|458865463|FG000|Overall Study|Death|2|||
127520302|NCT00902174|458865464|FG001|Overall Study|Death|2|||
127520303|NCT00902174|458865463|FG000|Overall Study|Withdrawal by Subject|2|||
127520304|NCT00902174|458865464|FG001|Overall Study|Withdrawal by Subject|1|||
127520305|NCT00902174|458865463|FG000|Overall Study|Abnormal labs|1|||
127520306|NCT00902174|458865464|FG001|Overall Study|Abnormal labs|1|||
127520307|NCT00902174|458865463|FG000|Overall Study|Protocol Violation|1|||
127520308|NCT00902174|458865464|FG001|Overall Study|Protocol Violation|1|||
127520309|NCT00902174|458865463|FG000|Overall Study|Administration problem|0|||
127520310|NCT00902174|458865464|FG001|Overall Study|Administration problem|1|||
127520311|NCT03836677|458865465|FG000|Period 1|Adverse Event|0|||
127520312|NCT03836677|458865466|FG001|Period 1|Adverse Event|1|||
127520313|NCT03836677|458865465|FG000|Period 2|Severe non-compliance to protocol|1|||
127520314|NCT03836677|458865466|FG001|Period 2|Severe non-compliance to protocol|0|||
127520315|NCT01353911|458865467|FG000|Overall Study|Lost to Follow-up|2|||
127520316|NCT01353911|458865468|FG001|Overall Study|Lost to Follow-up|6|||
127520317|NCT01353911|458865469|FG002|Overall Study|Lost to Follow-up|4|||
127520318|NCT01353911|458865470|FG003|Overall Study|Lost to Follow-up|0|||
127520319|NCT01353911|458865471|FG004|Overall Study|Lost to Follow-up|4|||
127520320|NCT01353911|458865472|FG005|Overall Study|Lost to Follow-up|4|||
127520321|NCT01353911|458865473|FG006|Overall Study|Lost to Follow-up|3|||
127520322|NCT01353911|458865474|FG007|Overall Study|Lost to Follow-up|6|||
127520323|NCT01353911|458865467|FG000|Overall Study|Withdrawal by Subject|2|||
127520324|NCT01353911|458865468|FG001|Overall Study|Withdrawal by Subject|3|||
127520325|NCT01353911|458865469|FG002|Overall Study|Withdrawal by Subject|4|||
127520326|NCT01353911|458865470|FG003|Overall Study|Withdrawal by Subject|2|||
127520327|NCT01353911|458865471|FG004|Overall Study|Withdrawal by Subject|2|||
127520328|NCT01353911|458865472|FG005|Overall Study|Withdrawal by Subject|3|||
127520329|NCT01353911|458865473|FG006|Overall Study|Withdrawal by Subject|3|||
127520330|NCT01353911|458865474|FG007|Overall Study|Withdrawal by Subject|9|||
127520331|NCT01353911|458865467|FG000|Overall Study|Status Not Recorded|4|||
127520332|NCT01353911|458865468|FG001|Overall Study|Status Not Recorded|0|||
127520333|NCT01353911|458865469|FG002|Overall Study|Status Not Recorded|1|||
127520334|NCT01353911|458865470|FG003|Overall Study|Status Not Recorded|0|||
127520335|NCT01353911|458865471|FG004|Overall Study|Status Not Recorded|0|||
127520336|NCT01353911|458865472|FG005|Overall Study|Status Not Recorded|0|||
127520337|NCT01353911|458865473|FG006|Overall Study|Status Not Recorded|0|||
127520338|NCT01353911|458865474|FG007|Overall Study|Status Not Recorded|0|||
127520339|NCT00462748|458865479|FG000|Overall Study|Adverse Event|7|||
127520340|NCT00462748|458865480|FG001|Overall Study|Adverse Event|5|||
127520341|NCT00462748|458865481|FG002|Overall Study|Adverse Event|9|||
127520342|NCT00462748|458865479|FG000|Overall Study|Protocol Violation|0|||
127520343|NCT00462748|458865480|FG001|Overall Study|Protocol Violation|2|||
127520344|NCT00462748|458865481|FG002|Overall Study|Protocol Violation|1|||
127520345|NCT00462748|458865479|FG000|Overall Study|Withdrew consent|3|||
127520346|NCT00462748|458865480|FG001|Overall Study|Withdrew consent|3|||
127520347|NCT00462748|458865481|FG002|Overall Study|Withdrew consent|0|||
127520348|NCT00462748|458865479|FG000|Overall Study|Lost to Follow-up|1|||
127520349|NCT00462748|458865480|FG001|Overall Study|Lost to Follow-up|1|||
127520350|NCT00462748|458865481|FG002|Overall Study|Lost to Follow-up|1|||
127520351|NCT00462748|458865479|FG000|Overall Study|Discontinued after 41 days Rx|1|||
127520352|NCT00462748|458865480|FG001|Overall Study|Discontinued after 41 days Rx|0|||
127520353|NCT00462748|458865481|FG002|Overall Study|Discontinued after 41 days Rx|0|||
127520354|NCT03233438|458865482|FG000|Overall Study|Lost to Follow-up|4|||
127520355|NCT03233438|458865483|FG001|Overall Study|Lost to Follow-up|9|||
127520356|NCT03233438|458865482|FG000|Overall Study|Withdrawal by Subject|2|||
127520357|NCT03233438|458865483|FG001|Overall Study|Withdrawal by Subject|1|||
127520358|NCT03233438|458865482|FG000|Overall Study|No recording of dalbavancin|0|||
127520359|NCT03233438|458865483|FG001|Overall Study|No recording of dalbavancin|1|||
127520360|NCT03429543|458865484|FG000|Overall Study|Adverse Event|1|||
127520361|NCT03429543|458865485|FG001|Overall Study|Adverse Event|1|||
127520362|NCT03429543|458865486|FG002|Overall Study|Adverse Event|0|||
127520363|NCT03429543|458865487|FG003|Overall Study|Adverse Event|0|||
127520364|NCT03429543|458865488|FG004|Overall Study|Adverse Event|0|||
127520365|NCT03429543|458865489|FG005|Overall Study|Adverse Event|2|||
127520366|NCT03429543|458865490|FG006|Overall Study|Adverse Event|0|||
127520367|NCT03429543|458865484|FG000|Overall Study|Lost to Follow-up|1|||
127520368|NCT03429543|458865485|FG001|Overall Study|Lost to Follow-up|0|||
127520369|NCT03429543|458865486|FG002|Overall Study|Lost to Follow-up|0|||
127520370|NCT03429543|458865487|FG003|Overall Study|Lost to Follow-up|0|||
127520371|NCT03429543|458865488|FG004|Overall Study|Lost to Follow-up|1|||
127520372|NCT03429543|458865489|FG005|Overall Study|Lost to Follow-up|0|||
127520373|NCT03429543|458865490|FG006|Overall Study|Lost to Follow-up|0|||
127520374|NCT03429543|458865484|FG000|Overall Study|Withdrawal by Subject|5|||
127520375|NCT03429543|458865485|FG001|Overall Study|Withdrawal by Subject|0|||
127520376|NCT03429543|458865486|FG002|Overall Study|Withdrawal by Subject|1|||
127520377|NCT03429543|458865487|FG003|Overall Study|Withdrawal by Subject|2|||
127520378|NCT03429543|458865488|FG004|Overall Study|Withdrawal by Subject|6|||
127520379|NCT03429543|458865489|FG005|Overall Study|Withdrawal by Subject|3|||
127520380|NCT03429543|458865490|FG006|Overall Study|Withdrawal by Subject|1|||
127520381|NCT03429543|458865484|FG000|Overall Study|Other reason than listed|0|||
127520382|NCT03429543|458865485|FG001|Overall Study|Other reason than listed|1|||
127520383|NCT03429543|458865486|FG002|Overall Study|Other reason than listed|0|||
127520384|NCT03429543|458865487|FG003|Overall Study|Other reason than listed|0|||
127520385|NCT03429543|458865488|FG004|Overall Study|Other reason than listed|4|||
127520386|NCT03429543|458865489|FG005|Overall Study|Other reason than listed|4|||
127520387|NCT03429543|458865490|FG006|Overall Study|Other reason than listed|0|||
127520388|NCT03429543|458865484|FG000|Overall Study|Not treated|0|||
127520389|NCT03429543|458865485|FG001|Overall Study|Not treated|0|||
127520390|NCT03429543|458865486|FG002|Overall Study|Not treated|0|||
127520391|NCT03429543|458865487|FG003|Overall Study|Not treated|0|||
127520392|NCT03429543|458865488|FG004|Overall Study|Not treated|1|||
127520393|NCT03429543|458865489|FG005|Overall Study|Not treated|0|||
127520394|NCT03429543|458865490|FG006|Overall Study|Not treated|0|||
127520395|NCT01818492|458865491|FG000|Overall Study|Adverse Event|2|||
127520396|NCT01818492|458865491|FG000|Overall Study|Death|3|||
127520397|NCT01818492|458865491|FG000|Overall Study|Withdrawal by Subject|1|||
127520398|NCT01818492|458865491|FG000|Overall Study|Additional therapy when not allowed PP|4|||
127520399|NCT01729208|458865492|FG000|Baseline|Physician Decision|5|||
127520400|NCT01729208|458865493|FG001|Baseline|Physician Decision|4|||
127520401|NCT01729208|458865492|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
127520402|NCT01729208|458865493|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
127520403|NCT01729208|458865492|FG000|12 Months Follow-up|Lost to Follow-up|3|||
127520404|NCT01729208|458865493|FG001|12 Months Follow-up|Lost to Follow-up|3|||
127520405|NCT01729208|458865492|FG000|24 Months Follow-up|Lost to Follow-up|3|||
127520406|NCT01729208|458865493|FG001|24 Months Follow-up|Lost to Follow-up|0|||
127520407|NCT01729208|458865492|FG000|36 Months Follow-up|Physician Decision|1|||
127520408|NCT01729208|458865493|FG001|36 Months Follow-up|Physician Decision|0|||
127520409|NCT01729208|458865492|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
127520410|NCT01729208|458865493|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
127520411|NCT02428413|458865495|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
127520412|NCT02428413|458865496|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
127520413|NCT02428413|458865495|FG000|Overall Study|Protocol Violation|1|||
127520414|NCT02428413|458865496|FG001|Overall Study|Protocol Violation|2|||
127520415|NCT02428413|458865495|FG000|Overall Study|Case Cancelled|2|||
127520416|NCT02428413|458865496|FG001|Overall Study|Case Cancelled|0|||
127520417|NCT02428413|458865495|FG000|Overall Study|Missed Cases|1|||
127520418|NCT02428413|458865496|FG001|Overall Study|Missed Cases|2|||
127520419|NCT02428413|458865495|FG000|Overall Study|Nurse Refusal|1|||
127520420|NCT02428413|458865496|FG001|Overall Study|Nurse Refusal|0|||
127520421|NCT02345330|458865499|FG000|Overall Study|Death|1|||
127520422|NCT02345330|458865499|FG000|Overall Study|Progressive Disease|2|||
127520423|NCT03688100|458865502|FG000|Overall Study|Lost to Follow-up|21|||
127520424|NCT03688100|458865503|FG001|Overall Study|Lost to Follow-up|15|||
127520425|NCT03688100|458865504|FG002|Overall Study|Lost to Follow-up|15|||
127520426|NCT03688100|458865505|FG003|Overall Study|Lost to Follow-up|18|||
127520427|NCT03688100|458865502|FG000|Overall Study|Withdrawal by Subject|19|||
127520428|NCT03688100|458865503|FG001|Overall Study|Withdrawal by Subject|16|||
127520429|NCT03688100|458865504|FG002|Overall Study|Withdrawal by Subject|0|||
127520430|NCT03688100|458865505|FG003|Overall Study|Withdrawal by Subject|0|||
127520431|NCT03688100|458865502|FG000|Overall Study|Death|36|||
127520432|NCT03688100|458865503|FG001|Overall Study|Death|27|||
127520433|NCT03688100|458865504|FG002|Overall Study|Death|0|||
127520434|NCT03688100|458865505|FG003|Overall Study|Death|0|||
127520435|NCT03729245|458865506|FG000|Overall Study|Lost to Follow-up|5|||
127520436|NCT03729245|458865507|FG001|Overall Study|Lost to Follow-up|6|||
127520437|NCT03729245|458865506|FG000|Overall Study|Withdrawal by Subject|16|||
127520438|NCT03729245|458865507|FG001|Overall Study|Withdrawal by Subject|19|||
127520439|NCT03729245|458865506|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
127520440|NCT03729245|458865507|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
127520441|NCT00989781|458865514|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
127520442|NCT00989781|458865515|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
127520443|NCT04311463|458865520|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
127520444|NCT04311463|458865521|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
127520445|NCT04311463|458865520|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
127520446|NCT04311463|458865521|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
127520447|NCT04311463|458865520|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
127520448|NCT04311463|458865521|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
127520449|NCT00737633|458865522|FG000|Overall Study|Study terminated by sponsor|44|||
127520450|NCT00737633|458865523|FG001|Overall Study|Study terminated by sponsor|55|||
127520451|NCT00737633|458865522|FG000|Overall Study|Lost to Follow-up|0|||
127520452|NCT00737633|458865523|FG001|Overall Study|Lost to Follow-up|1|||
127520453|NCT00737633|458865522|FG000|Overall Study|protocol non-compliance|0|||
127520454|NCT00737633|458865523|FG001|Overall Study|protocol non-compliance|1|||
127520455|NCT01300260|458865528|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
127520456|NCT01300260|458865529|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
127520457|NCT01300260|458865528|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
127520458|NCT01300260|458865529|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
127520459|NCT01300260|458865528|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
127520460|NCT01300260|458865529|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
127520461|NCT00377364|458865530|FG000|Overall Study|Lost to Follow-up|1|||
127520462|NCT00377364|458865531|FG001|Overall Study|Lost to Follow-up|0|||
127520463|NCT00377364|458865530|FG000|Overall Study|Withdrawal by Subject|1|||
127520464|NCT00377364|458865531|FG001|Overall Study|Withdrawal by Subject|0|||
127520465|NCT02540265|458865537|FG000|Overall Study|Lost to Follow-up|0|||
127520466|NCT02540265|458865538|FG001|Overall Study|Lost to Follow-up|0|||
127520467|NCT02540265|458865539|FG002|Overall Study|Lost to Follow-up|1|||
127520468|NCT03157037|458865542|FG000|Overall Study|Death|1|||
127520469|NCT02102399|458865546|FG000|Overall Study|Withdrawal by Subject|6|||
127520470|NCT02102399|458865547|FG001|Overall Study|Withdrawal by Subject|4|||
127520471|NCT03101085|458865548|FG000|Overall Study|Lost to Follow-up|0|||
127520472|NCT03101085|458865549|FG001|Overall Study|Lost to Follow-up|1|||
127520473|NCT00718770|458865550|FG000|Overall Study|Adverse Event|1|||
127520474|NCT00718770|458865550|FG000|Overall Study|Lack of Efficacy|1|||
127520475|NCT00718770|458865550|FG000|Overall Study|Lack of Efficacy|1|||
127520476|NCT00718770|458865550|FG000|Overall Study|Adverse Event|1|||
127520477|NCT00718770|458865550|FG000|Overall Study|Lack of Efficacy|1|||
127520478|NCT00718770|458865550|FG000|Overall Study|Adverse Event|1|||
127520479|NCT00718770|458865550|FG000|Overall Study|Lack of Efficacy|1|||
127520480|NCT00718770|458865550|FG000|Overall Study|Adverse Event|1|||
127520481|NCT01704456|458865551|FG000|Overall Study|Lost to Follow-up|8|||
127520482|NCT01704456|458865552|FG001|Overall Study|Lost to Follow-up|14|||
127520483|NCT00695864|458865553|FG000|Placebo|Withdrawal by Subject|1|||
127520484|NCT00695864|458865553|FG000|Placebo|Physician Decision|4|||
127520485|NCT00498355|458865554|FG000|Overall Study|Lost to Follow-up|1|||
127520486|NCT04583956|458865555|FG000|Overall Study|Death|9|||
127520487|NCT04583956|458865556|FG001|Overall Study|Death|11|||
127520488|NCT04583956|458865555|FG000|Overall Study|Lost to Follow-up|7|||
127520489|NCT04583956|458865556|FG001|Overall Study|Lost to Follow-up|9|||
127520490|NCT04583956|458865555|FG000|Overall Study|Protocol Violation|2|||
127520491|NCT04583956|458865556|FG001|Overall Study|Protocol Violation|0|||
127520492|NCT04583956|458865555|FG000|Overall Study|Withdrawal by Subject|0|||
127520493|NCT04583956|458865556|FG001|Overall Study|Withdrawal by Subject|2|||
127520494|NCT04583956|458865555|FG000|Overall Study|Randomized but not dosed|2|||
127520495|NCT04583956|458865556|FG001|Overall Study|Randomized but not dosed|3|||
127520496|NCT04583956|458865555|FG000|Overall Study|Withdrawal of consent before product administration|1|||
127520497|NCT04583956|458865556|FG001|Overall Study|Withdrawal of consent before product administration|0|||
127520498|NCT02100475|458867362|FG000|Overall Study|Unclassified|1|||
127520499|NCT02100475|458867363|FG001|Overall Study|Unclassified|2|||
127520500|NCT02100475|458867362|FG000|Overall Study|Withdrawal criteria|1|||
127520501|NCT02100475|458867363|FG001|Overall Study|Withdrawal criteria|0|||
127520502|NCT04599465|458867364|FG000|Overall Study|Physician Decision|1|||
127520503|NCT04599465|458867364|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
127520504|NCT03614325|458867367|FG000|Overall Study|Withdrawal by Subject|0|||
127520505|NCT03614325|458867368|FG001|Overall Study|Withdrawal by Subject|2|||
127520506|NCT03614325|458867367|FG000|Overall Study|Surgery Cancelled|2|||
127520507|NCT03614325|458867368|FG001|Overall Study|Surgery Cancelled|1|||
127520508|NCT03614325|458867367|FG000|Overall Study|Lost to Follow-up|2|||
127520509|NCT03614325|458867368|FG001|Overall Study|Lost to Follow-up|1|||
127520510|NCT03614325|458867367|FG000|Overall Study|Surgery never scheduled|1|||
127520511|NCT03614325|458867368|FG001|Overall Study|Surgery never scheduled|0|||
127520512|NCT02814175|458867369|FG000|Part 1|Adverse Event|2|||
127520513|NCT02814175|458867370|FG001|Part 1|Adverse Event|3|||
127520514|NCT02814175|458867371|FG002|Part 1|Adverse Event|0|||
127520515|NCT02814175|458867372|FG003|Part 1|Adverse Event|0|||
127520516|NCT02814175|458867373|FG004|Part 1|Adverse Event|0|||
127520517|NCT02814175|458867374|FG005|Part 1|Adverse Event|0|||
127520518|NCT02814175|458867369|FG000|Part 1|Withdrawal Consent|8|||
127520519|NCT02814175|458867370|FG001|Part 1|Withdrawal Consent|1|||
127520520|NCT02814175|458867371|FG002|Part 1|Withdrawal Consent|0|||
127520521|NCT02814175|458867372|FG003|Part 1|Withdrawal Consent|0|||
127520522|NCT02814175|458867373|FG004|Part 1|Withdrawal Consent|0|||
127520523|NCT02814175|458867374|FG005|Part 1|Withdrawal Consent|0|||
127520524|NCT02814175|458867369|FG000|Part 1|Lost to Follow-up|1|||
127520525|NCT02814175|458867370|FG001|Part 1|Lost to Follow-up|0|||
127520526|NCT02814175|458867371|FG002|Part 1|Lost to Follow-up|0|||
127520527|NCT02814175|458867372|FG003|Part 1|Lost to Follow-up|0|||
127520528|NCT02814175|458867373|FG004|Part 1|Lost to Follow-up|0|||
127520529|NCT02814175|458867374|FG005|Part 1|Lost to Follow-up|0|||
127520530|NCT02814175|458867369|FG000|Part 1|Lack of Efficacy|1|||
127520531|NCT02814175|458867370|FG001|Part 1|Lack of Efficacy|2|||
127520532|NCT02814175|458867371|FG002|Part 1|Lack of Efficacy|0|||
127520533|NCT02814175|458867372|FG003|Part 1|Lack of Efficacy|0|||
127520534|NCT02814175|458867373|FG004|Part 1|Lack of Efficacy|0|||
127520535|NCT02814175|458867374|FG005|Part 1|Lack of Efficacy|0|||
127520536|NCT02814175|458867369|FG000|Part 2|Adverse Event|0|||
127520537|NCT02814175|458867370|FG001|Part 2|Adverse Event|0|||
127520538|NCT02814175|458867371|FG002|Part 2|Adverse Event|0|||
127520539|NCT02814175|458867372|FG003|Part 2|Adverse Event|1|||
127520540|NCT02814175|458867373|FG004|Part 2|Adverse Event|1|||
127520541|NCT02814175|458867374|FG005|Part 2|Adverse Event|2|||
127520542|NCT02814175|458867369|FG000|Part 2|Withdrawal Consent|0|||
127520543|NCT02814175|458867370|FG001|Part 2|Withdrawal Consent|0|||
127520544|NCT02814175|458867371|FG002|Part 2|Withdrawal Consent|0|||
127520545|NCT02814175|458867372|FG003|Part 2|Withdrawal Consent|2|||
127520546|NCT02814175|458867373|FG004|Part 2|Withdrawal Consent|1|||
127520547|NCT02814175|458867374|FG005|Part 2|Withdrawal Consent|1|||
127520548|NCT02814175|458867369|FG000|Part 2|Lost to Follow-up|0|||
127520549|NCT02814175|458867370|FG001|Part 2|Lost to Follow-up|0|||
127520550|NCT02814175|458867371|FG002|Part 2|Lost to Follow-up|0|||
127520551|NCT02814175|458867372|FG003|Part 2|Lost to Follow-up|1|||
127520552|NCT02814175|458867373|FG004|Part 2|Lost to Follow-up|0|||
127520553|NCT02814175|458867374|FG005|Part 2|Lost to Follow-up|0|||
127520554|NCT02814175|458867369|FG000|Part 2|Lack of Efficacy|0|||
127520555|NCT02814175|458867370|FG001|Part 2|Lack of Efficacy|0|||
127520556|NCT02814175|458867371|FG002|Part 2|Lack of Efficacy|0|||
127520557|NCT02814175|458867372|FG003|Part 2|Lack of Efficacy|0|||
127520558|NCT02814175|458867373|FG004|Part 2|Lack of Efficacy|0|||
127520559|NCT02814175|458867374|FG005|Part 2|Lack of Efficacy|3|||
127520560|NCT01673620|458867380|FG000|Overall Study|Adverse Event|1|||
127520561|NCT01673620|458867381|FG001|Overall Study|Adverse Event|0|||
127520562|NCT01597635|458867383|FG000|Part A|Adverse Event|3|||
127520563|NCT01597635|458867384|FG001|Part A|Adverse Event|0|||
127520564|NCT01597635|458867385|FG002|Part A|Adverse Event|0|||
127520565|NCT01597635|458867383|FG000|Part B|Adverse Event|0|||
127520566|NCT01597635|458867384|FG001|Part B|Adverse Event|0|||
127520567|NCT01597635|458867385|FG002|Part B|Adverse Event|1|||
127520568|NCT01597635|458867383|FG000|Part B|Protocol Violation|0|||
127520569|NCT01597635|458867384|FG001|Part B|Protocol Violation|1|||
127520570|NCT01597635|458867385|FG002|Part B|Protocol Violation|0|||
127520571|NCT01597635|458867383|FG000|Part B|Protocol-defined stopping criteria|0|||
127520572|NCT01597635|458867384|FG001|Part B|Protocol-defined stopping criteria|4|||
127520573|NCT01597635|458867385|FG002|Part B|Protocol-defined stopping criteria|3|||
127520574|NCT01597635|458867383|FG000|Part B|Withdrawal by Subject|0|||
127520575|NCT01597635|458867384|FG001|Part B|Withdrawal by Subject|1|||
127520576|NCT01597635|458867385|FG002|Part B|Withdrawal by Subject|0|||
127520577|NCT01363661|458867386|FG000|Overall Study|Adverse Event|9|||
127520578|NCT01363661|458867387|FG001|Overall Study|Adverse Event|2|||
127520579|NCT01363661|458867386|FG000|Overall Study|Withdrawal by Subject|1|||
127520580|NCT01363661|458867387|FG001|Overall Study|Withdrawal by Subject|1|||
127520581|NCT01363661|458867386|FG000|Overall Study|Protocol Violation|1|||
127520582|NCT01363661|458867387|FG001|Overall Study|Protocol Violation|0|||
127520583|NCT01363661|458867386|FG000|Overall Study|Lost to Follow-up|3|||
127520584|NCT01363661|458867387|FG001|Overall Study|Lost to Follow-up|1|||
127520585|NCT01971008|458867388|FG000|Overall Study|Protocol Violation|2|||
127520586|NCT01971008|458867389|FG001|Overall Study|Protocol Violation|1|||
127520587|NCT03416127|458867390|FG000|Overall Study|Withdrawal by Subject|0|||
127520588|NCT03416127|458867391|FG001|Overall Study|Withdrawal by Subject|1|||
127520589|NCT03416127|458867392|FG002|Overall Study|Withdrawal by Subject|1|||
127520590|NCT00767806|458867395|FG000|Overall Study|Adverse Event|30|||
127520591|NCT00767806|458867396|FG001|Overall Study|Adverse Event|11|||
127520592|NCT00767806|458867395|FG000|Overall Study|Withdrawal by Subject|8|||
127520593|NCT00767806|458867396|FG001|Overall Study|Withdrawal by Subject|13|||
127520594|NCT00767806|458867395|FG000|Overall Study|Protocol Violation|6|||
127520595|NCT00767806|458867396|FG001|Overall Study|Protocol Violation|5|||
127520596|NCT00767806|458867395|FG000|Overall Study|Lack of Efficacy|1|||
127520597|NCT00767806|458867396|FG001|Overall Study|Lack of Efficacy|9|||
127520598|NCT00767806|458867395|FG000|Overall Study|Physician Decision|4|||
127520599|NCT00767806|458867396|FG001|Overall Study|Physician Decision|3|||
127520600|NCT00767806|458867395|FG000|Overall Study|Lost to Follow-up|1|||
127520601|NCT00767806|458867396|FG001|Overall Study|Lost to Follow-up|4|||
127520602|NCT00767806|458867395|FG000|Overall Study|Entry Criteria Not Met|1|||
127520603|NCT00767806|458867396|FG001|Overall Study|Entry Criteria Not Met|1|||
127520604|NCT00767806|458867395|FG000|Overall Study|Sponsor Decision|0|||
127520605|NCT00767806|458867396|FG001|Overall Study|Sponsor Decision|1|||
127520606|NCT02489942|458867397|FG000|Overall Study|Request by patient|602|||
127520607|NCT02489942|458867397|FG000|Overall Study|Improvement/remission|157|||
127520608|NCT02489942|458867397|FG000|Overall Study|No change/Progressive disease|263|||
127520609|NCT02489942|458867397|FG000|Overall Study|Adverse Event|522|||
127520610|NCT02489942|458867397|FG000|Overall Study|Other personal reasons|1218|||
127520611|NCT02489942|458867397|FG000|Overall Study|Lost to Follow-up|456|||
127520612|NCT02489942|458867397|FG000|Overall Study|Not continuously investigated|7|||
127520613|NCT02489942|458867397|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
127520614|NCT02489942|458867397|FG000|Overall Study|Multiple registration|1|||
127520615|NCT02489942|458867397|FG000|Overall Study|No patient visit after entry|100|||
127520616|NCT02489942|458867397|FG000|Overall Study|No treatment with Jardiance|2|||
127520617|NCT02489942|458867397|FG000|Overall Study|Patient received Jardiance before registration|1|||
127520618|NCT02489942|458867397|FG000|Overall Study|No CRF collected|86|||
127520619|NCT00858208|458867398|FG000|Overall Study|Adverse Event|3|||
127520620|NCT00858208|458867398|FG000|Overall Study|Lost to Follow-up|26|||
127520621|NCT00858208|458867398|FG000|Overall Study|Participant refused|40|||
127520622|NCT00858208|458867398|FG000|Overall Study|Other|10|||
127520623|NCT02397057|458867399|FG000|Overall Study|Withdrawal by Subject|6|||
127520624|NCT02397057|458867400|FG001|Overall Study|Withdrawal by Subject|7|||
127520625|NCT02397057|458867399|FG000|Overall Study|Lost to Follow-up|4|||
127520626|NCT02397057|458867400|FG001|Overall Study|Lost to Follow-up|3|||
127520627|NCT02397057|458867399|FG000|Overall Study|Death|1|||
127520628|NCT02397057|458867400|FG001|Overall Study|Death|0|||
127520629|NCT02397057|458867399|FG000|Overall Study|Adverse Event|0|||
127520630|NCT02397057|458867400|FG001|Overall Study|Adverse Event|1|||
127520631|NCT02397057|458867399|FG000|Overall Study|Physician Decision|0|||
127520632|NCT02397057|458867400|FG001|Overall Study|Physician Decision|1|||
127520633|NCT02397057|458867399|FG000|Overall Study|Subject did not receive study drug|0|||
127520634|NCT02397057|458867400|FG001|Overall Study|Subject did not receive study drug|1|||
127520635|NCT01393639|458867401|FG000|Overall Study|Protocol Violation|0|||
127520636|NCT01393639|458867402|FG001|Overall Study|Protocol Violation|0|||
127520637|NCT01393639|458867403|FG002|Overall Study|Protocol Violation|0|||
127520638|NCT01393639|458867404|FG003|Overall Study|Protocol Violation|1|||
127520639|NCT01393639|458867405|FG004|Overall Study|Protocol Violation|0|||
127520640|NCT01393639|458867406|FG005|Overall Study|Protocol Violation|0|||
127520641|NCT01393639|458867407|FG006|Overall Study|Protocol Violation|0|||
127520642|NCT01393639|458867401|FG000|Overall Study|Other|0|||
127520643|NCT01393639|458867402|FG001|Overall Study|Other|2|||
127520644|NCT01393639|458867403|FG002|Overall Study|Other|0|||
127520645|NCT01393639|458867404|FG003|Overall Study|Other|2|||
127520646|NCT01393639|458867405|FG004|Overall Study|Other|1|||
127520647|NCT01393639|458867406|FG005|Overall Study|Other|0|||
127520648|NCT01393639|458867407|FG006|Overall Study|Other|1|||
127520649|NCT01393639|458867401|FG000|Overall Study|Withdrawal by Subject|1|||
127520650|NCT01393639|458867402|FG001|Overall Study|Withdrawal by Subject|1|||
127520651|NCT01393639|458867403|FG002|Overall Study|Withdrawal by Subject|0|||
127520652|NCT01393639|458867404|FG003|Overall Study|Withdrawal by Subject|0|||
127520653|NCT01393639|458867405|FG004|Overall Study|Withdrawal by Subject|0|||
127520654|NCT01393639|458867406|FG005|Overall Study|Withdrawal by Subject|0|||
127520655|NCT01393639|458867407|FG006|Overall Study|Withdrawal by Subject|1|||
127520656|NCT01393639|458867401|FG000|Overall Study|Medication error without associated AE|0|||
127520657|NCT01393639|458867402|FG001|Overall Study|Medication error without associated AE|0|||
127520658|NCT01393639|458867403|FG002|Overall Study|Medication error without associated AE|0|||
127520659|NCT01393639|458867404|FG003|Overall Study|Medication error without associated AE|0|||
127520660|NCT01393639|458867405|FG004|Overall Study|Medication error without associated AE|0|||
127520661|NCT01393639|458867406|FG005|Overall Study|Medication error without associated AE|0|||
127520662|NCT01393639|458867407|FG006|Overall Study|Medication error without associated AE|1|||
127520663|NCT01393639|458867401|FG000|Overall Study|Lost to Follow-up|0|||
127520664|NCT01393639|458867402|FG001|Overall Study|Lost to Follow-up|1|||
127520665|NCT01393639|458867403|FG002|Overall Study|Lost to Follow-up|0|||
127520666|NCT01393639|458867404|FG003|Overall Study|Lost to Follow-up|0|||
127520667|NCT01393639|458867405|FG004|Overall Study|Lost to Follow-up|0|||
127520668|NCT01393639|458867406|FG005|Overall Study|Lost to Follow-up|0|||
127520669|NCT01393639|458867407|FG006|Overall Study|Lost to Follow-up|1|||
127520670|NCT01393639|458867401|FG000|Overall Study|Lack of Efficacy|0|||
127520671|NCT01393639|458867402|FG001|Overall Study|Lack of Efficacy|0|||
127520672|NCT01393639|458867403|FG002|Overall Study|Lack of Efficacy|0|||
127520673|NCT01393639|458867404|FG003|Overall Study|Lack of Efficacy|0|||
127520674|NCT01393639|458867405|FG004|Overall Study|Lack of Efficacy|0|||
127520675|NCT01393639|458867406|FG005|Overall Study|Lack of Efficacy|0|||
127520676|NCT01393639|458867407|FG006|Overall Study|Lack of Efficacy|1|||
127520677|NCT01393639|458867401|FG000|Overall Study|Adverse Event|2|||
127520678|NCT01393639|458867402|FG001|Overall Study|Adverse Event|3|||
127520679|NCT01393639|458867403|FG002|Overall Study|Adverse Event|1|||
127520680|NCT01393639|458867404|FG003|Overall Study|Adverse Event|2|||
127520681|NCT01393639|458867405|FG004|Overall Study|Adverse Event|0|||
127520682|NCT01393639|458867406|FG005|Overall Study|Adverse Event|2|||
127520683|NCT01393639|458867407|FG006|Overall Study|Adverse Event|3|||
127520684|NCT00679172|458867408|FG000|Overall Study|Non-compliance|1|||
127520685|NCT00679172|458867409|FG001|Overall Study|Non-compliance|1|||
127520686|NCT00679172|458867410|FG002|Overall Study|Non-compliance|0|||
127520687|NCT00679172|458867411|FG003|Overall Study|Non-compliance|1|||
127520688|NCT00679172|458867412|FG004|Overall Study|Non-compliance|0|||
127520689|NCT00679172|458867408|FG000|Overall Study|Other not specified|0|||
127520690|NCT00679172|458867409|FG001|Overall Study|Other not specified|0|||
127520691|NCT00679172|458867410|FG002|Overall Study|Other not specified|1|||
127520692|NCT00679172|458867411|FG003|Overall Study|Other not specified|0|||
127520693|NCT00679172|458867412|FG004|Overall Study|Other not specified|0|||
127520694|NCT00793325|458867413|FG000|Overall Study|Protocol Violation|18|||
127520695|NCT00793325|458867413|FG000|Overall Study|Lost to Follow-up|1|||
127520696|NCT01815840|458867414|FG000|Overall Study|Missing|1|||
127520697|NCT01815840|458867415|FG001|Overall Study|Missing|0|||
127520698|NCT01815840|458867414|FG000|Overall Study|Withdrew Consent|31|||
127520699|NCT01815840|458867415|FG001|Overall Study|Withdrew Consent|30|||
127520700|NCT01815840|458867414|FG000|Overall Study|Administrative/Other|1|||
127520701|NCT01815840|458867415|FG001|Overall Study|Administrative/Other|3|||
127520702|NCT01815840|458867414|FG000|Overall Study|Adverse Event|10|||
127520703|NCT01815840|458867415|FG001|Overall Study|Adverse Event|16|||
127520704|NCT01815840|458867414|FG000|Overall Study|Death|2|||
127520705|NCT01815840|458867415|FG001|Overall Study|Death|2|||
127520706|NCT01815840|458867414|FG000|Overall Study|Disease progression|3|||
127520707|NCT01815840|458867415|FG001|Overall Study|Disease progression|2|||
127520708|NCT01815840|458867414|FG000|Overall Study|Investigators Decision|2|||
127520709|NCT01815840|458867415|FG001|Overall Study|Investigators Decision|3|||
127520710|NCT01815840|458867414|FG000|Overall Study|Lost to Follow-up|3|||
127520711|NCT01815840|458867415|FG001|Overall Study|Lost to Follow-up|6|||
127520712|NCT01815840|458867414|FG000|Overall Study|Refused Treatment|5|||
127520713|NCT01815840|458867415|FG001|Overall Study|Refused Treatment|1|||
127520714|NCT01815840|458867414|FG000|Overall Study|Sponsor Termination Treatment|1|||
127520715|NCT01815840|458867415|FG001|Overall Study|Sponsor Termination Treatment|0|||
127520716|NCT00434642|458867416|FG000|Blinded Treatment Phase|Adverse Event|12|||
127520717|NCT00434642|458867417|FG001|Blinded Treatment Phase|Adverse Event|58|||
127520718|NCT00434642|458867416|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
127520719|NCT00434642|458867417|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
127520720|NCT00434642|458867416|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
127520721|NCT00434642|458867417|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
127520722|NCT00434642|458867416|FG000|Blinded Treatment Phase|Physician Decision|19|||
127520723|NCT00434642|458867417|FG001|Blinded Treatment Phase|Physician Decision|27|||
127520724|NCT00434642|458867416|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
127520725|NCT00434642|458867417|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
127520726|NCT00434642|458867416|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
127520727|NCT00434642|458867417|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
127520728|NCT00434642|458867416|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
127520729|NCT00434642|458867417|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
127520730|NCT00434642|458867416|FG000|Open-label Treatment Phase|Adverse Event|0|||
127520731|NCT00434642|458867417|FG001|Open-label Treatment Phase|Adverse Event|5|||
127520732|NCT00434642|458867416|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
127520733|NCT00434642|458867417|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
127520734|NCT04512976|458867422|FG000|Overall Study|Unable to complete the exercise protocols in the study.|0|||
127520735|NCT04512976|458867423|FG001|Overall Study|Unable to complete the exercise protocols in the study.|0|||
127520736|NCT04512976|458867424|FG002|Overall Study|Unable to complete the exercise protocols in the study.|0|||
127520737|NCT04512976|458867425|FG003|Overall Study|Unable to complete the exercise protocols in the study.|0|||
127520738|NCT04512976|458867426|FG004|Overall Study|Unable to complete the exercise protocols in the study.|0|||
127520739|NCT04512976|458867427|FG005|Overall Study|Unable to complete the exercise protocols in the study.|3|||
127520740|NCT00527982|458867428|FG000|Overall Study|Physician Decision|1|||
127520741|NCT00527982|458867429|FG001|Overall Study|Physician Decision|0|||
127520742|NCT02241343|458867438|FG000|Overall Study|Adverse Event|1|||
127520743|NCT00753454|458867439|FG000|Overall Study|Adverse Event|4|||
127520744|NCT00753454|458867439|FG000|Overall Study|Lack of Efficacy|1|||
127520745|NCT00753454|458867439|FG000|Overall Study|Lost to Follow-up|3|||
127520746|NCT00753454|458867439|FG000|Overall Study|Withdrawal by Subject|5|||
127520747|NCT00753454|458867439|FG000|Overall Study|Investigator Decision|1|||
127520748|NCT03927144|458867440|FG000|Core Phase|Adverse Event|9|||
127520749|NCT03927144|458867441|FG001|Core Phase|Adverse Event|5|||
127520750|NCT03927144|458867440|FG000|Core Phase|Lost to Follow-up|3|||
127520751|NCT03927144|458867441|FG001|Core Phase|Lost to Follow-up|2|||
127520752|NCT03927144|458867440|FG000|Core Phase|New Therapy for Study Indication|0|||
127520753|NCT03927144|458867441|FG001|Core Phase|New Therapy for Study Indication|1|||
127520754|NCT03927144|458867440|FG000|Core Phase|No Longer Clinically Benefiting|4|||
127520755|NCT03927144|458867441|FG001|Core Phase|No Longer Clinically Benefiting|4|||
127520756|NCT03927144|458867440|FG000|Core Phase|Physician Decision|2|||
127520757|NCT03927144|458867441|FG001|Core Phase|Physician Decision|8|||
127520758|NCT03927144|458867440|FG000|Core Phase|Protocol Violation|2|||
127520759|NCT03927144|458867441|FG001|Core Phase|Protocol Violation|2|||
127520760|NCT03927144|458867440|FG000|Core Phase|Withdrawal by Subject|16|||
127520761|NCT03927144|458867441|FG001|Core Phase|Withdrawal by Subject|40|||
127520762|NCT03927144|458867440|FG000|Extension Phase|Adverse Event|2|||
127520763|NCT03927144|458867441|FG001|Extension Phase|Adverse Event|1|||
127520764|NCT03927144|458867440|FG000|Extension Phase|No longer clinically benefiting|4|||
127520765|NCT03927144|458867441|FG001|Extension Phase|No longer clinically benefiting|5|||
127520766|NCT03927144|458867440|FG000|Extension Phase|Pregnancy|1|||
127520767|NCT03927144|458867441|FG001|Extension Phase|Pregnancy|0|||
127520768|NCT03927144|458867440|FG000|Extension Phase|Protocol Violation|0|||
127520769|NCT03927144|458867441|FG001|Extension Phase|Protocol Violation|1|||
127520770|NCT03927144|458867440|FG000|Extension Phase|Withdrawal by Subject|8|||
127520771|NCT03927144|458867441|FG001|Extension Phase|Withdrawal by Subject|3|||
127520772|NCT04541628|458867446|FG000|Overall Study|Study Terminated|1|||
127520773|NCT04541628|458867447|FG001|Overall Study|Study Terminated|1|||
127520774|NCT04541628|458867448|FG002|Overall Study|Study Terminated|1|||
127520775|NCT05011058|458867452|FG000|Overall Study|Sponsor Decision|2|||
127520776|NCT05011058|458867453|FG001|Overall Study|Sponsor Decision|0|||
127520777|NCT05011058|458867454|FG002|Overall Study|Sponsor Decision|14|||
127520778|NCT05011058|458867455|FG003|Overall Study|Sponsor Decision|0|||
127520779|NCT05011058|458867456|FG004|Overall Study|Sponsor Decision|0|||
127520780|NCT05011058|458867457|FG005|Overall Study|Sponsor Decision|1|||
127520781|NCT05011058|458867458|FG006|Overall Study|Sponsor Decision|0|||
127520782|NCT05011058|458867459|FG007|Overall Study|Sponsor Decision|5|||
127520783|NCT01192412|458867460|FG000|Overall Study|Lost to Follow-up|2|||
127520784|NCT01192412|458867461|FG001|Overall Study|Lost to Follow-up|1|||
127520785|NCT01192412|458867460|FG000|Overall Study|Withdrawal by Subject|2|||
127520786|NCT01192412|458867461|FG001|Overall Study|Withdrawal by Subject|1|||
127520787|NCT00308074|458867467|FG000|Overall Study|Withdrawal by Subject|1|||
127520788|NCT02141360|458867472|FG000|Overall Study|Withdrawal by Subject|6|||
127520789|NCT02141360|458867473|FG001|Overall Study|Withdrawal by Subject|0|||
127520790|NCT02141360|458867474|FG002|Overall Study|Withdrawal by Subject|0|||
127520791|NCT02141360|458867472|FG000|Overall Study|Study Terminated before Visit|1|||
127520792|NCT02141360|458867473|FG001|Overall Study|Study Terminated before Visit|0|||
127520793|NCT02141360|458867474|FG002|Overall Study|Study Terminated before Visit|0|||
127520794|NCT04071158|458867475|FG000|Overall Study|Lost to Follow-up|1|||
127520795|NCT04071158|458867476|FG001|Overall Study|Lost to Follow-up|2|||
127520796|NCT04071158|458867477|FG002|Overall Study|Lost to Follow-up|3|||
127520797|NCT04071158|458867478|FG003|Overall Study|Lost to Follow-up|3|||
127520798|NCT04071158|458867479|FG004|Overall Study|Lost to Follow-up|5|||
127520799|NCT04071158|458867475|FG000|Overall Study|Randomized but not treated|2|||
127520800|NCT04071158|458867476|FG001|Overall Study|Randomized but not treated|2|||
127520801|NCT04071158|458867477|FG002|Overall Study|Randomized but not treated|0|||
127520802|NCT04071158|458867478|FG003|Overall Study|Randomized but not treated|0|||
127520803|NCT04071158|458867479|FG004|Overall Study|Randomized but not treated|0|||
127520804|NCT01178099|458867480|FG000|Overall Study|Physician Decision|0|||
127520805|NCT01178099|458867481|FG001|Overall Study|Physician Decision|1|||
127520806|NCT02516592|458867482|FG000|Overall Study|Patient withdrew consent|5|||
127520807|NCT02516592|458867483|FG001|Overall Study|Patient withdrew consent|2|||
127520808|NCT02516592|458867482|FG000|Overall Study|Protocol deviation|4|||
127520809|NCT02516592|458867483|FG001|Overall Study|Protocol deviation|4|||
127520810|NCT02516592|458867482|FG000|Overall Study|Lost to Follow-up|2|||
127520811|NCT02516592|458867483|FG001|Overall Study|Lost to Follow-up|3|||
127520812|NCT02516592|458867482|FG000|Overall Study|Patient/guardian decision|2|||
127520813|NCT02516592|458867483|FG001|Overall Study|Patient/guardian decision|1|||
127520814|NCT02516592|458867482|FG000|Overall Study|Adverse Event|1|||
127520815|NCT02516592|458867483|FG001|Overall Study|Adverse Event|2|||
127520816|NCT02516592|458867482|FG000|Overall Study|Abnormal test procedure result|1|||
127520817|NCT02516592|458867483|FG001|Overall Study|Abnormal test procedure result|0|||
127520818|NCT02516592|458867482|FG000|Overall Study|Death|1|||
127520819|NCT02516592|458867483|FG001|Overall Study|Death|1|||
127520820|NCT01286740|458867484|FG000|Overall Study|Enrolled but not treated|1|||
127520821|NCT01286740|458867484|FG000|Overall Study|Protocol Violation|1|||
127520822|NCT00576576|458867491|FG000|Overall Study|Lost to Follow-up|6|||
127520823|NCT00576576|458867491|FG000|Overall Study|Protocol Violation|1|||
127520824|NCT01805037|458867497|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
127520825|NCT01805037|458867498|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
127520826|NCT01805037|458867497|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
127520827|NCT01805037|458867498|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
127520828|NCT01805037|458867497|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
127520829|NCT01805037|458867498|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
127520830|NCT01805037|458867497|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
127520831|NCT01805037|458867498|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
127520832|NCT01805037|458867497|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
127520833|NCT01805037|458867498|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
127520834|NCT01805037|458867497|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
127520835|NCT01805037|458867498|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
127520836|NCT01805037|458867497|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
127520837|NCT01805037|458867498|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
127520838|NCT01805037|458867497|FG000|Follow Up (up to 3 Years)|Death|0|||
127520839|NCT01805037|458867498|FG001|Follow Up (up to 3 Years)|Death|2|||
127520840|NCT01805037|458867497|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
127520841|NCT01805037|458867498|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
127520842|NCT01805037|458867497|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
127520843|NCT01805037|458867498|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
127520844|NCT02177838|458867502|FG000|Overall Study|Withdrawal by Subject|1|||
127520845|NCT02177838|458867502|FG000|Overall Study|Physician Decision|1|||
127520846|NCT02177838|458867502|FG000|Overall Study|Death|1|||
127520847|NCT03517566|458867503|FG000|Overall Study|Adverse Event|5|||
127520848|NCT03517566|458867504|FG001|Overall Study|Adverse Event|2|||
127520849|NCT03517566|458867505|FG002|Overall Study|Adverse Event|2|||
127520850|NCT03517566|458867506|FG003|Overall Study|Adverse Event|8|||
127520851|NCT03517566|458867507|FG004|Overall Study|Adverse Event|7|||
127520852|NCT03517566|458867503|FG000|Overall Study|Lack of Efficacy|3|||
127520853|NCT03517566|458867504|FG001|Overall Study|Lack of Efficacy|2|||
127520854|NCT03517566|458867505|FG002|Overall Study|Lack of Efficacy|1|||
127520855|NCT03517566|458867506|FG003|Overall Study|Lack of Efficacy|1|||
127520856|NCT03517566|458867507|FG004|Overall Study|Lack of Efficacy|4|||
127520857|NCT03517566|458867503|FG000|Overall Study|Lost to Follow-up|3|||
127520858|NCT03517566|458867504|FG001|Overall Study|Lost to Follow-up|1|||
127520859|NCT03517566|458867505|FG002|Overall Study|Lost to Follow-up|1|||
127520860|NCT03517566|458867506|FG003|Overall Study|Lost to Follow-up|1|||
127520861|NCT03517566|458867507|FG004|Overall Study|Lost to Follow-up|0|||
127520862|NCT03517566|458867503|FG000|Overall Study|Physician Decision|1|||
127520863|NCT03517566|458867504|FG001|Overall Study|Physician Decision|1|||
127520864|NCT03517566|458867505|FG002|Overall Study|Physician Decision|0|||
127520865|NCT03517566|458867506|FG003|Overall Study|Physician Decision|1|||
127520866|NCT03517566|458867507|FG004|Overall Study|Physician Decision|0|||
127520867|NCT03517566|458867503|FG000|Overall Study|Pregnancy|0|||
127520868|NCT03517566|458867504|FG001|Overall Study|Pregnancy|1|||
127520869|NCT03517566|458867505|FG002|Overall Study|Pregnancy|0|||
127520870|NCT03517566|458867506|FG003|Overall Study|Pregnancy|0|||
127520871|NCT03517566|458867507|FG004|Overall Study|Pregnancy|0|||
127520872|NCT03517566|458867503|FG000|Overall Study|Protocol Deviation|0|||
127520873|NCT03517566|458867504|FG001|Overall Study|Protocol Deviation|1|||
127520874|NCT03517566|458867505|FG002|Overall Study|Protocol Deviation|0|||
127520875|NCT03517566|458867506|FG003|Overall Study|Protocol Deviation|1|||
127520876|NCT03517566|458867507|FG004|Overall Study|Protocol Deviation|1|||
127520877|NCT03517566|458867503|FG000|Overall Study|Study terminated by Sponsor|11|||
127520878|NCT03517566|458867504|FG001|Overall Study|Study terminated by Sponsor|5|||
127520879|NCT03517566|458867505|FG002|Overall Study|Study terminated by Sponsor|6|||
127520880|NCT03517566|458867506|FG003|Overall Study|Study terminated by Sponsor|14|||
127520881|NCT03517566|458867507|FG004|Overall Study|Study terminated by Sponsor|12|||
127520882|NCT03517566|458867503|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
127520883|NCT03517566|458867504|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
127520884|NCT03517566|458867505|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
127520885|NCT03517566|458867506|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
127520886|NCT03517566|458867507|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
127520887|NCT04566692|458867511|FG000|Overall Study|Adverse Event|2|||
127520888|NCT04566692|458867512|FG001|Overall Study|Adverse Event|0|||
127520889|NCT04566692|458867511|FG000|Overall Study|Withdrawal by Subject|1|||
127520890|NCT04566692|458867512|FG001|Overall Study|Withdrawal by Subject|1|||
127520891|NCT00671437|458867513|FG000|Overall Study|Progressive disease before C1 week 8|8|||
127520892|NCT00671437|458867513|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
127520893|NCT00671437|458867513|FG000|Overall Study|Adverse Event|3|||
127520894|NCT00671437|458867513|FG000|Overall Study|Ineligible post-hoc|1|||
127520895|NCT03927404|458867515|FG000|Overall Study|Withdrawal by Subject|1|||
127520896|NCT00293020|458867517|FG000|Overall Study|Withdrawal by Subject|34|||
127520897|NCT00293020|458867517|FG000|Overall Study|Adverse Event|30|||
127520898|NCT00293020|458867517|FG000|Overall Study|Death|32|||
127520899|NCT00293020|458867517|FG000|Overall Study|Lack of Efficacy|12|||
127520900|NCT00293020|458867517|FG000|Overall Study|Lost to Follow-up|4|||
127520901|NCT00293020|458867517|FG000|Overall Study|Protocol Violation|6|||
127520902|NCT00293020|458867517|FG000|Overall Study|Physician Decision|21|||
127520903|NCT00293020|458867517|FG000|Overall Study|Other Reason|22|||
127520904|NCT00293020|458867517|FG000|Overall Study|No dose taken|1|||
127520905|NCT01147848|458867520|FG000|Run-in Period|Screen Failure|623|||
127520906|NCT01147848|458867521|FG001|Run-in Period|Screen Failure|0|||
127520907|NCT01147848|458867522|FG002|Run-in Period|Screen Failure|0|||
127520908|NCT01147848|458867520|FG000|Run-in Period|Run-in Failure|135|||
127520909|NCT01147848|458867521|FG001|Run-in Period|Run-in Failure|0|||
127520910|NCT01147848|458867522|FG002|Run-in Period|Run-in Failure|0|||
127520911|NCT01147848|458867520|FG000|Randomized Phase|Adverse Event|0|||
127520912|NCT01147848|458867521|FG001|Randomized Phase|Adverse Event|6|||
127520913|NCT01147848|458867522|FG002|Randomized Phase|Adverse Event|8|||
127520914|NCT01147848|458867520|FG000|Randomized Phase|Lack of Efficacy|0|||
127520915|NCT01147848|458867521|FG001|Randomized Phase|Lack of Efficacy|20|||
127520916|NCT01147848|458867522|FG002|Randomized Phase|Lack of Efficacy|11|||
127520917|NCT01147848|458867520|FG000|Randomized Phase|Protocol Violation|0|||
127520918|NCT01147848|458867521|FG001|Randomized Phase|Protocol Violation|7|||
127520919|NCT01147848|458867522|FG002|Randomized Phase|Protocol Violation|10|||
127520920|NCT01147848|458867520|FG000|Randomized Phase|Lost to Follow-up|0|||
127520921|NCT01147848|458867521|FG001|Randomized Phase|Lost to Follow-up|5|||
127520922|NCT01147848|458867522|FG002|Randomized Phase|Lost to Follow-up|7|||
127520923|NCT01147848|458867520|FG000|Randomized Phase|Physician Decision|0|||
127520924|NCT01147848|458867521|FG001|Randomized Phase|Physician Decision|0|||
127520925|NCT01147848|458867522|FG002|Randomized Phase|Physician Decision|1|||
127520926|NCT01147848|458867520|FG000|Randomized Phase|Withdrawal by Subject|0|||
127520927|NCT01147848|458867521|FG001|Randomized Phase|Withdrawal by Subject|7|||
127520928|NCT01147848|458867522|FG002|Randomized Phase|Withdrawal by Subject|9|||
127520929|NCT03180307|458867523|FG000|Overall Study|Lost to Follow-up|2|||
127520930|NCT03180307|458867524|FG001|Overall Study|Lost to Follow-up|0|||
127520931|NCT03180307|458867523|FG000|Overall Study|Death|1|||
127520932|NCT03180307|458867524|FG001|Overall Study|Death|0|||
127520933|NCT03180307|458867523|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
127520934|NCT03180307|458867524|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
127520935|NCT00742417|458869417|FG000|Randomized|Withdrawal by legal representative|0|||
127520936|NCT00742417|458869418|FG001|Randomized|Withdrawal by legal representative|1|||
127520937|NCT00742417|458869417|FG000|Randomized|Withdrawal by Subject|1|||
127520938|NCT00742417|458869418|FG001|Randomized|Withdrawal by Subject|0|||
127520939|NCT00742417|458869417|FG000|Randomized|Physician Decision|1|||
127520940|NCT00742417|458869418|FG001|Randomized|Physician Decision|0|||
127520941|NCT00742417|458869417|FG000|Intensive Period|Withdrawal by Subject|1|||
127520942|NCT00742417|458869418|FG001|Intensive Period|Withdrawal by Subject|1|||
127520943|NCT00742417|458869417|FG000|Intensive Period|Adverse Event|2|||
127520944|NCT00742417|458869418|FG001|Intensive Period|Adverse Event|0|||
127520945|NCT03775512|458869419|FG000|Overall Study|Death|1|||
127520946|NCT03775512|458869420|FG001|Overall Study|Death|1|||
127520947|NCT03775512|458869419|FG000|Overall Study|Withdrawal by Subject|7|||
127520948|NCT03775512|458869420|FG001|Overall Study|Withdrawal by Subject|4|||
127520949|NCT03775512|458869419|FG000|Overall Study|Lost to Follow-up|5|||
127520950|NCT03775512|458869420|FG001|Overall Study|Lost to Follow-up|5|||
127520951|NCT03775512|458869419|FG000|Overall Study|Excluded before Catheter insertion|14|||
127520952|NCT03775512|458869420|FG001|Overall Study|Excluded before Catheter insertion|5|||
127520953|NCT03775512|458869419|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
127520954|NCT03775512|458869420|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
127520955|NCT03775512|458869419|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
127520956|NCT03775512|458869420|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
127520957|NCT01378325|458869423|FG000|Overall Study|Protocol Violation|0|||
127520958|NCT01378325|458869424|FG001|Overall Study|Protocol Violation|1|||
127520959|NCT00372697|458869425|FG000|Overall Study|Protocol Violation|1|||
127520960|NCT00372697|458869426|FG001|Overall Study|Protocol Violation|1|||
127520961|NCT03221842|458869427|FG000|Period 1 (Open-label)|Adverse Event|4|||
127520962|NCT03221842|458869428|FG001|Period 1 (Open-label)|Adverse Event|0|||
127520963|NCT03221842|458869427|FG000|Period 1 (Open-label)|Physician Decision|2|||
127520964|NCT03221842|458869428|FG001|Period 1 (Open-label)|Physician Decision|0|||
127520965|NCT03221842|458869427|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
127520966|NCT03221842|458869428|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
127520967|NCT03221842|458869427|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
127520968|NCT03221842|458869428|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
127520969|NCT03221842|458869427|FG000|Period 1 (Open-label)|Other|2|||
127520970|NCT03221842|458869428|FG001|Period 1 (Open-label)|Other|0|||
127520971|NCT03221842|458869427|FG000|Period 2 (Randomized, Blinded)|Death|0|||
127520972|NCT03221842|458869428|FG001|Period 2 (Randomized, Blinded)|Death|1|||
127520973|NCT03221842|458869427|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
127520974|NCT03221842|458869428|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
127520975|NCT00704288|458869430|FG000|Overall Treatment Period|Adverse Event|11|||
127520976|NCT00704288|458869431|FG001|Overall Treatment Period|Adverse Event|8|||
127520977|NCT00704288|458869432|FG002|Overall Treatment Period|Adverse Event|22|||
127520978|NCT00704288|458869430|FG000|Overall Treatment Period|Death|0|||
127520979|NCT00704288|458869431|FG001|Overall Treatment Period|Death|0|||
127520980|NCT00704288|458869432|FG002|Overall Treatment Period|Death|1|||
127520981|NCT00704288|458869430|FG000|Overall Treatment Period|Physician Decision|0|||
127520982|NCT00704288|458869431|FG001|Overall Treatment Period|Physician Decision|2|||
127520983|NCT00704288|458869432|FG002|Overall Treatment Period|Physician Decision|0|||
127520984|NCT00704288|458869430|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
127520985|NCT00704288|458869431|FG001|Overall Treatment Period|Withdrawal by Subject|1|||
127520986|NCT00704288|458869432|FG002|Overall Treatment Period|Withdrawal by Subject|3|||
127520987|NCT00704288|458869430|FG000|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|30|||
127520988|NCT00704288|458869431|FG001|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
127520989|NCT00704288|458869432|FG002|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
127520990|NCT00704288|458869430|FG000|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|0|||
127520991|NCT00704288|458869431|FG001|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|42|||
127520992|NCT00704288|458869432|FG002|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|76|||
127520993|NCT00704288|458869430|FG000|Overall Treatment Period|Disease Progression--Clinical Deterioration|3|||
127520994|NCT00704288|458869431|FG001|Overall Treatment Period|Disease Progression--Clinical Deterioration|6|||
127520995|NCT00704288|458869432|FG002|Overall Treatment Period|Disease Progression--Clinical Deterioration|11|||
127520996|NCT00704288|458869430|FG000|Overall Treatment Period|Roll-over to another study|1|||
127520997|NCT00704288|458869431|FG001|Overall Treatment Period|Roll-over to another study|0|||
127520998|NCT00704288|458869432|FG002|Overall Treatment Period|Roll-over to another study|4|||
127520999|NCT00704288|458869430|FG000|Overall Treatment Period|Other--Subject had intracranial hemorrhage|1|||
127521000|NCT00704288|458869431|FG001|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
127521001|NCT00704288|458869432|FG002|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
127521002|NCT00704288|458869430|FG000|Extended Post Treatment Follow Up Period|Death|41|||
127521003|NCT00704288|458869431|FG001|Extended Post Treatment Follow Up Period|Death|50|||
127521004|NCT00704288|458869432|FG002|Extended Post Treatment Follow Up Period|Death|93|||
127521005|NCT00704288|458869430|FG000|Extended Post Treatment Follow Up Period|Lost to Follow-up|0|||
127521006|NCT00704288|458869431|FG001|Extended Post Treatment Follow Up Period|Lost to Follow-up|2|||
127521007|NCT00704288|458869432|FG002|Extended Post Treatment Follow Up Period|Lost to Follow-up|1|||
127521008|NCT00704288|458869430|FG000|Extended Post Treatment Follow Up Period|Withdrawal by Subject|0|||
127521009|NCT00704288|458869431|FG001|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
127521010|NCT00704288|458869432|FG002|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
127521011|NCT00704288|458869430|FG000|Extended Post Treatment Follow Up Period|Various reasons|5|||
127521012|NCT00704288|458869431|FG001|Extended Post Treatment Follow Up Period|Various reasons|5|||
127521013|NCT00704288|458869432|FG002|Extended Post Treatment Follow Up Period|Various reasons|21|||
127521014|NCT04395690|458869433|FG000|Overall Study|Lost to Follow-up|1|||
127521015|NCT04395690|458869434|FG001|Overall Study|Lost to Follow-up|1|||
127521016|NCT03387020|458869436|FG000|Overall Study|Adverse Event|0|||
127521017|NCT03387020|458869437|FG001|Overall Study|Adverse Event|2|||
127521018|NCT03387020|458869438|FG002|Overall Study|Adverse Event|0|||
127521019|NCT03387020|458869436|FG000|Overall Study|Withdrawal by Subject|2|||
127521020|NCT03387020|458869437|FG001|Overall Study|Withdrawal by Subject|0|||
127521021|NCT03387020|458869438|FG002|Overall Study|Withdrawal by Subject|0|||
127521022|NCT01329939|458869439|FG000|Overall Study|Lost to Follow-up|3|||
127521023|NCT01329939|458869440|FG001|Overall Study|Lost to Follow-up|0|||
127521024|NCT01329939|458869441|FG002|Overall Study|Lost to Follow-up|1|||
127521025|NCT01329939|458869442|FG003|Overall Study|Lost to Follow-up|2|||
127521026|NCT01329939|458869439|FG000|Overall Study|Withdrawal by Subject|0|||
127521027|NCT01329939|458869440|FG001|Overall Study|Withdrawal by Subject|1|||
127521028|NCT01329939|458869441|FG002|Overall Study|Withdrawal by Subject|0|||
127521029|NCT01329939|458869442|FG003|Overall Study|Withdrawal by Subject|0|||
127521030|NCT01329939|458869439|FG000|Overall Study|Adverse Event|0|||
127521031|NCT01329939|458869440|FG001|Overall Study|Adverse Event|0|||
127521032|NCT01329939|458869441|FG002|Overall Study|Adverse Event|0|||
127521033|NCT01329939|458869442|FG003|Overall Study|Adverse Event|3|||
127521034|NCT03722524|458869443|FG000|Overall Study|Protocol Violation|86|||
127521035|NCT03722524|458869443|FG000|Overall Study|Adverse Event|7|||
127521036|NCT03722524|458869443|FG000|Overall Study|Lost to Follow-up|1|||
127521037|NCT03722524|458869443|FG000|Overall Study|Reason is not stated|1|||
127521038|NCT03722524|458869443|FG000|Overall Study|Physician Decision|1|||
127521039|NCT03722524|458869443|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
127521040|NCT02942485|458869444|FG000|Overall Study|Lost to Follow-up|1|||
127521041|NCT02942485|458869445|FG001|Overall Study|Lost to Follow-up|0|||
127521042|NCT04369950|458869447|FG000|Overall Study|Protocol Violation|2|||
127521043|NCT04369950|458869448|FG001|Overall Study|Protocol Violation|2|||
127521044|NCT00989963|458869449|FG000|Overall Study|Adverse Event|1|||
127521045|NCT00989963|458869450|FG001|Overall Study|Adverse Event|1|||
127521046|NCT00989963|458869451|FG002|Overall Study|Adverse Event|1|||
127521047|NCT01240200|458869452|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
127521048|NCT01240200|458869453|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
127521049|NCT01529034|458869456|FG000|Overall Study|Discontinued prior to study treatment|14|||
127521050|NCT01529034|458869456|FG000|Overall Study|Site closure|62|||
127521051|NCT01529034|458869456|FG000|Overall Study|Study termination|29|||
127521052|NCT01529034|458869456|FG000|Overall Study|Withdrawal by Subject|25|||
127521053|NCT01529034|458869456|FG000|Overall Study|No treated SCs within protocol window|13|||
127521054|NCT01529034|458869456|FG000|Overall Study|Noncompliance|8|||
127521055|NCT01529034|458869456|FG000|Overall Study|Caregiver no longer available|7|||
127521056|NCT01529034|458869456|FG000|Overall Study|Adverse Event|4|||
127521057|NCT01529034|458869456|FG000|Overall Study|Protocol Violation|4|||
127521058|NCT01529034|458869456|FG000|Overall Study|Lack of Efficacy|4|||
127521059|NCT01529034|458869456|FG000|Overall Study|Investigator no longer available|2|||
127521060|NCT01529034|458869456|FG000|Overall Study|Study drug not available|2|||
127521061|NCT00646399|458869458|FG000|Overall Study|Death|63|||
127521062|NCT00646399|458869459|FG001|Overall Study|Death|53|||
127521063|NCT00646399|458869458|FG000|Overall Study|Withdrawal by Subject|9|||
127521064|NCT00646399|458869459|FG001|Overall Study|Withdrawal by Subject|10|||
127521065|NCT00646399|458869458|FG000|Overall Study|Other Reason|11|||
127521066|NCT00646399|458869459|FG001|Overall Study|Other Reason|11|||
127521067|NCT02473367|458869462|FG000|Wait 1|Withdrawal by Subject|1|||
127521068|NCT02473367|458869462|FG000|Period 4|Lost to Follow-up|1|||
127521069|NCT02678923|458869463|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
127521070|NCT02678923|458869464|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
127521071|NCT02678923|458869463|FG000|Overall Study|Withdrawal by Subject|3|||
127521072|NCT02678923|458869464|FG001|Overall Study|Withdrawal by Subject|2|||
127521073|NCT02678923|458869463|FG000|Overall Study|Lost to Follow-up|1|||
127521074|NCT02678923|458869464|FG001|Overall Study|Lost to Follow-up|0|||
127521075|NCT02678923|458869463|FG000|Overall Study|Did Not Return for Study Visits|1|||
127521076|NCT02678923|458869464|FG001|Overall Study|Did Not Return for Study Visits|0|||
127521077|NCT00455143|458869465|FG000|Overall Study|Physician Decision|1|||
127521078|NCT00455143|458869465|FG000|Overall Study|Withdrawal by Subject|1|||
127521079|NCT00455143|458869465|FG000|Overall Study|Staff was not avail to follow patient|2|||
127521080|NCT00455143|458869465|FG000|Overall Study|No longer met Inclusion Criteria|1|||
127521081|NCT00455143|458869465|FG000|Overall Study|Surgical time, staff not available|1|||
127521082|NCT01641822|458869468|FG000|Run-in Phase|Noncompliance with study drug|1|||
127521083|NCT01641822|458869469|FG001|Run-in Phase|Noncompliance with study drug|0|||
127521084|NCT01641822|458869470|FG002|Run-in Phase|Noncompliance with study drug|0|||
127521085|NCT01641822|458869468|FG000|Run-in Phase|Adverse Event|3|||
127521086|NCT01641822|458869469|FG001|Run-in Phase|Adverse Event|0|||
127521087|NCT01641822|458869470|FG002|Run-in Phase|Adverse Event|0|||
127521088|NCT01641822|458869468|FG000|Run-in Phase|Withdrew consent|1|||
127521089|NCT01641822|458869469|FG001|Run-in Phase|Withdrew consent|0|||
127521090|NCT01641822|458869470|FG002|Run-in Phase|Withdrew consent|0|||
127521091|NCT01641822|458869468|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
127521092|NCT01641822|458869469|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
127521093|NCT01641822|458869470|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
127521094|NCT01641822|458869468|FG000|Comparative Phase|Noncompliance with study drug|0|||
127521095|NCT01641822|458869469|FG001|Comparative Phase|Noncompliance with study drug|1|||
127521096|NCT01641822|458869470|FG002|Comparative Phase|Noncompliance with study drug|0|||
127521097|NCT01641822|458869468|FG000|Comparative Phase|Investigator's discretion|0|||
127521098|NCT01641822|458869469|FG001|Comparative Phase|Investigator's discretion|0|||
127521099|NCT01641822|458869470|FG002|Comparative Phase|Investigator's discretion|1|||
127521100|NCT01641822|458869468|FG000|Comparative Phase|Pregnancy|0|||
127521101|NCT01641822|458869469|FG001|Comparative Phase|Pregnancy|0|||
127521102|NCT01641822|458869470|FG002|Comparative Phase|Pregnancy|1|||
127521103|NCT01641822|458869468|FG000|Comparative Phase|Adverse event, serious fatal|0|||
127521104|NCT01641822|458869469|FG001|Comparative Phase|Adverse event, serious fatal|1|||
127521105|NCT01641822|458869470|FG002|Comparative Phase|Adverse event, serious fatal|0|||
127521106|NCT01641822|458869468|FG000|Comparative Phase|Withdrew consent|0|||
127521107|NCT01641822|458869469|FG001|Comparative Phase|Withdrew consent|3|||
127521108|NCT01641822|458869470|FG002|Comparative Phase|Withdrew consent|7|||
127521109|NCT01641822|458869468|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
127521110|NCT01641822|458869469|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
127521111|NCT01641822|458869470|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
127521112|NCT00454584|458869471|FG000|Controlled Period|Adverse Event|5|||
127521113|NCT00454584|458869472|FG001|Controlled Period|Adverse Event|2|||
127521114|NCT00454584|458869473|FG002|Controlled Period|Adverse Event|1|||
127521115|NCT00454584|458869474|FG003|Controlled Period|Adverse Event|0|||
127521116|NCT00454584|458869475|FG004|Controlled Period|Adverse Event|0|||
127521117|NCT00454584|458869476|FG005|Controlled Period|Adverse Event|0|||
127521118|NCT00454584|458869471|FG000|Controlled Period|Lost to Follow-up|1|||
127521119|NCT00454584|458869472|FG001|Controlled Period|Lost to Follow-up|2|||
127521120|NCT00454584|458869473|FG002|Controlled Period|Lost to Follow-up|2|||
127521121|NCT00454584|458869474|FG003|Controlled Period|Lost to Follow-up|0|||
127521122|NCT00454584|458869475|FG004|Controlled Period|Lost to Follow-up|0|||
127521123|NCT00454584|458869476|FG005|Controlled Period|Lost to Follow-up|0|||
127521124|NCT00454584|458869471|FG000|Controlled Period|Other|5|||
127521125|NCT00454584|458869472|FG001|Controlled Period|Other|4|||
127521126|NCT00454584|458869473|FG002|Controlled Period|Other|2|||
127521127|NCT00454584|458869474|FG003|Controlled Period|Other|0|||
127521128|NCT00454584|458869475|FG004|Controlled Period|Other|0|||
127521129|NCT00454584|458869476|FG005|Controlled Period|Other|0|||
127521130|NCT00454584|458869471|FG000|After Controlled Period|Adverse Event|0|||
127521131|NCT00454584|458869472|FG001|After Controlled Period|Adverse Event|0|||
127521132|NCT00454584|458869473|FG002|After Controlled Period|Adverse Event|0|||
127521133|NCT00454584|458869474|FG003|After Controlled Period|Adverse Event|9|||
127521134|NCT00454584|458869475|FG004|After Controlled Period|Adverse Event|3|||
127521135|NCT00454584|458869476|FG005|After Controlled Period|Adverse Event|9|||
127521136|NCT00454584|458869471|FG000|After Controlled Period|Lack of Efficacy|0|||
127521137|NCT00454584|458869472|FG001|After Controlled Period|Lack of Efficacy|0|||
127521138|NCT00454584|458869473|FG002|After Controlled Period|Lack of Efficacy|0|||
127521139|NCT00454584|458869474|FG003|After Controlled Period|Lack of Efficacy|1|||
127521140|NCT00454584|458869475|FG004|After Controlled Period|Lack of Efficacy|0|||
127521141|NCT00454584|458869476|FG005|After Controlled Period|Lack of Efficacy|0|||
127521142|NCT00454584|458869471|FG000|After Controlled Period|Lost to Follow-up|0|||
127521143|NCT00454584|458869472|FG001|After Controlled Period|Lost to Follow-up|0|||
127521144|NCT00454584|458869473|FG002|After Controlled Period|Lost to Follow-up|0|||
127521145|NCT00454584|458869474|FG003|After Controlled Period|Lost to Follow-up|2|||
127521146|NCT00454584|458869475|FG004|After Controlled Period|Lost to Follow-up|4|||
127521147|NCT00454584|458869476|FG005|After Controlled Period|Lost to Follow-up|6|||
127521148|NCT00454584|458869471|FG000|After Controlled Period|Other|0|||
127521149|NCT00454584|458869472|FG001|After Controlled Period|Other|0|||
127521150|NCT00454584|458869473|FG002|After Controlled Period|Other|0|||
127521151|NCT00454584|458869474|FG003|After Controlled Period|Other|1|||
127521152|NCT00454584|458869475|FG004|After Controlled Period|Other|0|||
127521153|NCT00454584|458869476|FG005|After Controlled Period|Other|0|||
127521154|NCT00454584|458869471|FG000|After Controlled Period|Other|0|||
127521155|NCT00454584|458869472|FG001|After Controlled Period|Other|0|||
127521156|NCT00454584|458869473|FG002|After Controlled Period|Other|0|||
127521157|NCT00454584|458869474|FG003|After Controlled Period|Other|13|||
127521158|NCT00454584|458869475|FG004|After Controlled Period|Other|5|||
127521159|NCT00454584|458869476|FG005|After Controlled Period|Other|17|||
127521160|NCT00470418|458869477|FG000|Overall Study|Withdrawal by Subject|1|||
127521161|NCT00470418|458869478|FG001|Overall Study|Withdrawal by Subject|0|||
127521162|NCT00599638|458869479|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
127521163|NCT00599638|458869480|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
127521164|NCT00599638|458869481|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
127521165|NCT00599638|458869482|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
127521166|NCT00599638|458869479|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
127521167|NCT00599638|458869480|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
127521168|NCT00599638|458869481|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
127521169|NCT00599638|458869482|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
127521170|NCT00599638|458869479|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
127521171|NCT00599638|458869480|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
127521172|NCT00599638|458869481|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
127521173|NCT00599638|458869482|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
127521174|NCT00599638|458869479|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
127521175|NCT00599638|458869480|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
127521176|NCT00599638|458869481|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
127521177|NCT00599638|458869482|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
127521178|NCT00599638|458869479|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
127521179|NCT00599638|458869480|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
127521180|NCT00599638|458869481|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
127521181|NCT00599638|458869482|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
127521182|NCT00599638|458869479|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
127521183|NCT00599638|458869480|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
127521184|NCT00599638|458869481|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
127521185|NCT00599638|458869482|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
127521186|NCT00599638|458869479|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
127521187|NCT00599638|458869480|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
127521188|NCT00599638|458869481|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
127521189|NCT00599638|458869482|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
127521190|NCT00599638|458869479|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
127521191|NCT00599638|458869480|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
127521192|NCT00599638|458869481|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
127521193|NCT00599638|458869482|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
127521194|NCT00599638|458869479|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
127521195|NCT00599638|458869480|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
127521196|NCT00599638|458869481|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
127521197|NCT00599638|458869482|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
127521198|NCT04032080|458869488|FG000|Overall Study|Death|6|||
127521199|NCT03689855|458869496|FG000|Overall Study|Adverse Event|3|||
127521200|NCT03689855|458869496|FG000|Overall Study|Withdrawal by Subject|1|||
127521201|NCT02409719|458869497|FG000|Overall Study|Lost to Follow-up|3|||
127521202|NCT02409719|458869498|FG001|Overall Study|Lost to Follow-up|3|||
127521203|NCT02479139|458869499|FG000|Overall Study|Lost to Follow-up|2|||
127521204|NCT02479139|458869500|FG001|Overall Study|Lost to Follow-up|4|||
127521205|NCT02479139|458869501|FG002|Overall Study|Lost to Follow-up|4|||
127521206|NCT02479139|458869502|FG003|Overall Study|Lost to Follow-up|2|||
127521207|NCT02479139|458869503|FG004|Overall Study|Lost to Follow-up|3|||
127521208|NCT02479139|458869504|FG005|Overall Study|Lost to Follow-up|5|||
127521209|NCT02479139|458869499|FG000|Overall Study|Withdrew Consent|5|||
127521210|NCT02479139|458869500|FG001|Overall Study|Withdrew Consent|6|||
127521211|NCT02479139|458869501|FG002|Overall Study|Withdrew Consent|1|||
127521212|NCT02479139|458869502|FG003|Overall Study|Withdrew Consent|4|||
127521213|NCT02479139|458869503|FG004|Overall Study|Withdrew Consent|1|||
127521214|NCT02479139|458869504|FG005|Overall Study|Withdrew Consent|1|||
127521215|NCT02479139|458869499|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
127521216|NCT02479139|458869500|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
127521217|NCT02479139|458869501|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
127521218|NCT02479139|458869502|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
127521219|NCT02479139|458869503|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
127521220|NCT02479139|458869504|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
127521221|NCT02479139|458869499|FG000|Overall Study|Other Miscellaneous Reasons|1|||
127521222|NCT02479139|458869500|FG001|Overall Study|Other Miscellaneous Reasons|0|||
127521223|NCT02479139|458869501|FG002|Overall Study|Other Miscellaneous Reasons|1|||
127521224|NCT02479139|458869502|FG003|Overall Study|Other Miscellaneous Reasons|1|||
127521225|NCT02479139|458869503|FG004|Overall Study|Other Miscellaneous Reasons|1|||
127521226|NCT02479139|458869504|FG005|Overall Study|Other Miscellaneous Reasons|0|||
127521227|NCT00764673|458869505|FG000|Overall Study|Death|1|||
127521228|NCT00764673|458869505|FG000|Overall Study|Lost to Follow-up|3|||
127521229|NCT00764673|458869505|FG000|Overall Study|Withdrawal by Subject|6|||
127521230|NCT00764673|458869505|FG000|Overall Study|Revision of Device|2|||
127521231|NCT01438177|458869506|FG000|Overall Study|Withdrawal by Subject|1|||
127521232|NCT01438177|458869506|FG000|Overall Study|Initiation of new therapy|1|||
127521233|NCT01727336|458869507|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
127521234|NCT01727336|458869508|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
127521235|NCT01727336|458869509|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
127521236|NCT01727336|458869510|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
127521237|NCT01727336|458869511|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
127521238|NCT01727336|458869512|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
127521239|NCT01727336|458869507|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
127521240|NCT01727336|458869508|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
127521241|NCT01727336|458869509|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
127521242|NCT01727336|458869510|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
127521243|NCT01727336|458869511|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
127521244|NCT01727336|458869512|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
127521245|NCT01727336|458869507|FG000|Part 2 Blinded|Death|0|||
127521246|NCT01727336|458869508|FG001|Part 2 Blinded|Death|0|||
127521247|NCT01727336|458869509|FG002|Part 2 Blinded|Death|0|||
127521248|NCT01727336|458869510|FG003|Part 2 Blinded|Death|0|||
127521249|NCT01727336|458869511|FG004|Part 2 Blinded|Death|20|||
127521250|NCT01727336|458869512|FG005|Part 2 Blinded|Death|16|||
127521251|NCT01727336|458869507|FG000|Part 2 Blinded|Lack of Efficacy|0|||
127521252|NCT01727336|458869508|FG001|Part 2 Blinded|Lack of Efficacy|0|||
127521253|NCT01727336|458869509|FG002|Part 2 Blinded|Lack of Efficacy|0|||
127521254|NCT01727336|458869510|FG003|Part 2 Blinded|Lack of Efficacy|0|||
127521255|NCT01727336|458869511|FG004|Part 2 Blinded|Lack of Efficacy|42|||
127521256|NCT01727336|458869512|FG005|Part 2 Blinded|Lack of Efficacy|44|||
127521257|NCT01727336|458869507|FG000|Part 2 Blinded|Lost to Follow-up|0|||
127521258|NCT01727336|458869508|FG001|Part 2 Blinded|Lost to Follow-up|0|||
127521259|NCT01727336|458869509|FG002|Part 2 Blinded|Lost to Follow-up|0|||
127521260|NCT01727336|458869510|FG003|Part 2 Blinded|Lost to Follow-up|0|||
127521261|NCT01727336|458869511|FG004|Part 2 Blinded|Lost to Follow-up|0|||
127521262|NCT01727336|458869512|FG005|Part 2 Blinded|Lost to Follow-up|1|||
127521263|NCT01727336|458869507|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
127521264|NCT01727336|458869508|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
127521265|NCT01727336|458869509|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
127521266|NCT01727336|458869510|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
127521267|NCT01727336|458869511|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
127521268|NCT01727336|458869512|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
127521269|NCT01727336|458869507|FG000|Part 2 Blinded|use of prohibited medications|0|||
127521270|NCT01727336|458869508|FG001|Part 2 Blinded|use of prohibited medications|0|||
127521271|NCT01727336|458869509|FG002|Part 2 Blinded|use of prohibited medications|0|||
127521272|NCT01727336|458869510|FG003|Part 2 Blinded|use of prohibited medications|0|||
127521273|NCT01727336|458869511|FG004|Part 2 Blinded|use of prohibited medications|1|||
127521274|NCT01727336|458869512|FG005|Part 2 Blinded|use of prohibited medications|3|||
127521275|NCT00129467|458869515|FG000|Received Intervention|Death|1|||
127521276|NCT00129467|458869516|FG001|Received Intervention|Death|1|||
127521277|NCT00129467|458869515|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
127521278|NCT00129467|458869516|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
127521279|NCT00129467|458869515|FG000|Received Intervention|Delirium|2|||
127521280|NCT00129467|458869516|FG001|Received Intervention|Delirium|0|||
127521281|NCT00129467|458869515|FG000|Received Intervention|Withdrawal by Subject|1|||
127521282|NCT00129467|458869516|FG001|Received Intervention|Withdrawal by Subject|0|||
127521283|NCT00129467|458869515|FG000|Received Intervention|Nausea|1|||
127521284|NCT00129467|458869516|FG001|Received Intervention|Nausea|0|||
127521285|NCT00129467|458869515|FG000|Received Intervention|Intolerance to citalopram|0|||
127521286|NCT00129467|458869516|FG001|Received Intervention|Intolerance to citalopram|1|||
127521287|NCT00129467|458869515|FG000|Received Intervention|Dizzyness, fatigue|0|||
127521288|NCT00129467|458869516|FG001|Received Intervention|Dizzyness, fatigue|1|||
127521289|NCT00129467|458869515|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
127521290|NCT00129467|458869516|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
127521291|NCT00129467|458869515|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
127521292|NCT00129467|458869516|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
127521293|NCT01532869|458869517|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
127521294|NCT01532869|458869518|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
127521295|NCT01532869|458869517|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
127521296|NCT01532869|458869518|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
127521297|NCT01532869|458869517|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
127521298|NCT01532869|458869518|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
127521299|NCT01532869|458869517|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
127521300|NCT01532869|458869518|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
127521301|NCT01532869|458869517|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
127521302|NCT01532869|458869518|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
127521303|NCT01532869|458869517|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
127521304|NCT01532869|458869518|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
127521305|NCT01532869|458869517|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
127521306|NCT01532869|458869518|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
127521307|NCT01532869|458869517|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
127521308|NCT01532869|458869518|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
127521309|NCT01532869|458869517|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
127521310|NCT01532869|458869518|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
127521311|NCT01532869|458869517|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
127521312|NCT01532869|458869518|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
127521313|NCT01532869|458869517|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
127521314|NCT01532869|458869518|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
127521315|NCT01532869|458869517|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
127521316|NCT01532869|458869518|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
127521317|NCT01532869|458869517|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
127521318|NCT01532869|458869518|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
127521319|NCT01532869|458869517|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
127521320|NCT01532869|458869518|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
127521321|NCT01532869|458869517|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
127521322|NCT01532869|458869518|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
127521323|NCT01532869|458869517|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
127521324|NCT01532869|458869518|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
127521325|NCT01532869|458869517|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
127521326|NCT01532869|458869518|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
127521327|NCT01424228|458869519|FG000|Overall Study|Withdrawal by Subject|27|||
127521328|NCT01424228|458869520|FG001|Overall Study|Withdrawal by Subject|11|||
127521329|NCT01424228|458869519|FG000|Overall Study|Adverse Event|10|||
127521330|NCT01424228|458869520|FG001|Overall Study|Adverse Event|14|||
127521331|NCT01424228|458869519|FG000|Overall Study|Sponsor's decision|9|||
127521332|NCT01424228|458869520|FG001|Overall Study|Sponsor's decision|12|||
127521333|NCT01424228|458869519|FG000|Overall Study|Lack of Efficacy|5|||
127521334|NCT01424228|458869520|FG001|Overall Study|Lack of Efficacy|7|||
127521335|NCT01424228|458869519|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
127521336|NCT01424228|458869520|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
127521337|NCT01424228|458869519|FG000|Overall Study|Non-compliance|2|||
127521338|NCT01424228|458869520|FG001|Overall Study|Non-compliance|0|||
127521339|NCT01424228|458869519|FG000|Overall Study|Worsening of symptoms|1|||
127521340|NCT01424228|458869520|FG001|Overall Study|Worsening of symptoms|0|||
127521341|NCT01424228|458869519|FG000|Overall Study|Unplanned journey|0|||
127521342|NCT01424228|458869520|FG001|Overall Study|Unplanned journey|1|||
127521343|NCT01229449|458869521|FG000|Overall Study|Withdrawal by Subject|0|||
127521344|NCT01229449|458869522|FG001|Overall Study|Withdrawal by Subject|3|||
127521345|NCT01229449|458869523|FG002|Overall Study|Withdrawal by Subject|0|||
127521346|NCT01229449|458869524|FG003|Overall Study|Withdrawal by Subject|1|||
127521347|NCT01229449|458869525|FG004|Overall Study|Withdrawal by Subject|1|||
127521348|NCT01229449|458869521|FG000|Overall Study|Lost to Follow-up|1|||
127521349|NCT01229449|458869522|FG001|Overall Study|Lost to Follow-up|1|||
127521350|NCT01229449|458869523|FG002|Overall Study|Lost to Follow-up|1|||
127521351|NCT01229449|458869524|FG003|Overall Study|Lost to Follow-up|0|||
127521352|NCT01229449|458869525|FG004|Overall Study|Lost to Follow-up|0|||
127521353|NCT01229449|458869521|FG000|Overall Study|Physician Decision|0|||
127521354|NCT01229449|458869522|FG001|Overall Study|Physician Decision|0|||
127521355|NCT01229449|458869523|FG002|Overall Study|Physician Decision|1|||
127521356|NCT01229449|458869524|FG003|Overall Study|Physician Decision|0|||
127521357|NCT01229449|458869525|FG004|Overall Study|Physician Decision|0|||
127521358|NCT04349033|458869526|FG000|Overall Study|Lost to Follow-up|3|||
127521359|NCT04349033|458869527|FG001|Overall Study|Lost to Follow-up|1|||
127521360|NCT04349033|458869528|FG002|Overall Study|Lost to Follow-up|1|||
127521361|NCT03596450|458869538|FG000|Overall Study|Death|9|||
127521362|NCT03596450|458869539|FG001|Overall Study|Death|9|||
127521363|NCT03596450|458869538|FG000|Overall Study|Protocol Violation|18|||
127521364|NCT03596450|458869539|FG001|Overall Study|Protocol Violation|26|||
127521365|NCT03596450|458869538|FG000|Overall Study|Lost to Follow-up|50|||
127521366|NCT03596450|458869539|FG001|Overall Study|Lost to Follow-up|56|||
127521367|NCT03596450|458869538|FG000|Overall Study|Adverse Event|14|||
127521368|NCT03596450|458869539|FG001|Overall Study|Adverse Event|7|||
127521369|NCT03596450|458869538|FG000|Overall Study|Withdrawal by Subject|38|||
127521370|NCT03596450|458869539|FG001|Overall Study|Withdrawal by Subject|36|||
127521371|NCT03596450|458869538|FG000|Overall Study|Accidentally Randomized|2|||
127521372|NCT03596450|458869539|FG001|Overall Study|Accidentally Randomized|0|||
127521373|NCT03596450|458869538|FG000|Overall Study|Other reasons|48|||
127521374|NCT03596450|458869539|FG001|Overall Study|Other reasons|53|||
127521375|NCT03596450|458869538|FG000|Overall Study|Pregnancy|2|||
127521376|NCT03596450|458869539|FG001|Overall Study|Pregnancy|0|||
127521377|NCT01894022|458869542|FG000|Overall Study|Death|1|||
127521378|NCT01894022|458869543|FG001|Overall Study|Death|0|||
127521379|NCT01894022|458869542|FG000|Overall Study|Adverse Event, non-fatal|1|||
127521380|NCT01894022|458869543|FG001|Overall Study|Adverse Event, non-fatal|0|||
127521381|NCT01894022|458869542|FG000|Overall Study|Study Closed/terminated|7|||
127521382|NCT01894022|458869543|FG001|Overall Study|Study Closed/terminated|10|||
127521383|NCT00410605|458869544|FG000|Overall Study|Adverse Event|12|||
127521384|NCT00410605|458869544|FG000|Overall Study|Physician Decision|3|||
127521385|NCT00410605|458869544|FG000|Overall Study|Withdrawal by Subject|5|||
127521386|NCT00410605|458869544|FG000|Overall Study|Started Non-Protocol Therapy|3|||
127521387|NCT00410605|458869544|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
127521388|NCT00410605|458869544|FG000|Overall Study|Transferred to another Institution|1|||
127521389|NCT04058886|458869545|FG000|Overall Study|Withdrawal by Subject|4|||
127521390|NCT04058886|458869545|FG000|Overall Study|Inadequate deafness interpreter service|1|||
127521391|NCT02332291|458869546|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
127521392|NCT02332291|458869547|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
127521393|NCT02332291|458869546|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
127521394|NCT02332291|458869547|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
127521395|NCT02332291|458869546|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
127521396|NCT02332291|458869547|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
127521397|NCT02332291|458869546|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
127521398|NCT02332291|458869547|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
127521399|NCT02332291|458869546|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
127521400|NCT02332291|458869547|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
127521401|NCT02332291|458869546|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
127521402|NCT02332291|458869547|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
127521403|NCT02220712|458869551|FG000|Overall Study|Adverse Event|1|||
127521404|NCT02220712|458869551|FG000|Overall Study|Withdrawal by Subject|2|||
127521405|NCT02220712|458869551|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
127521406|NCT00760838|458869552|FG000|Overall Study|Adverse Event|1|||
127521407|NCT00760838|458869553|FG001|Overall Study|Adverse Event|1|||
127521408|NCT00760838|458869552|FG000|Overall Study|Lack of Efficacy|1|||
127521409|NCT00760838|458869553|FG001|Overall Study|Lack of Efficacy|0|||
127521410|NCT00760838|458869552|FG000|Overall Study|Lost to Follow-up|2|||
127521411|NCT00760838|458869553|FG001|Overall Study|Lost to Follow-up|0|||
127521412|NCT00760838|458869552|FG000|Overall Study|Withdrawal by Subject|1|||
127521413|NCT00760838|458869553|FG001|Overall Study|Withdrawal by Subject|1|||
127521414|NCT03624127|458869554|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
127521415|NCT03624127|458869555|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
127521416|NCT03624127|458869556|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
127521417|NCT03624127|458869554|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
127521418|NCT03624127|458869555|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
127521419|NCT03624127|458869556|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
127521420|NCT03624127|458869554|FG000|Treatment Week 0 - Week 16|Death|0|||
127521421|NCT03624127|458869555|FG001|Treatment Week 0 - Week 16|Death|1|||
127521422|NCT03624127|458869556|FG002|Treatment Week 0 - Week 16|Death|0|||
127521423|NCT03624127|458869554|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
127521424|NCT03624127|458869555|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
127521425|NCT03624127|458869556|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
127521426|NCT03624127|458869554|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
127521427|NCT03624127|458869555|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
127521428|NCT03624127|458869556|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
127521429|NCT03624127|458869554|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
127521430|NCT03624127|458869555|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
127521431|NCT03624127|458869556|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
127521432|NCT03624127|458869554|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
127521433|NCT03624127|458869555|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
127521434|NCT03624127|458869556|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
127521435|NCT03624127|458869554|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
127521436|NCT03624127|458869555|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
127521437|NCT03624127|458869556|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
127521438|NCT03624127|458869554|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
127521439|NCT03624127|458869555|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
127521440|NCT03624127|458869556|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
127521441|NCT03624127|458869554|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
127521442|NCT03624127|458869555|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
127521443|NCT03624127|458869556|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
127521444|NCT03624127|458869554|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
127521445|NCT03624127|458869555|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
127521446|NCT03624127|458869556|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
127521447|NCT03624127|458869554|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
127521448|NCT03624127|458869555|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
127521449|NCT03624127|458869556|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
127521450|NCT03624127|458869554|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
127521451|NCT03624127|458869555|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
127521452|NCT03624127|458869556|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
127521453|NCT03624127|458869554|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
127521454|NCT03624127|458869555|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
127521455|NCT03624127|458869556|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
127521456|NCT03624127|458869554|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
127521457|NCT03624127|458869555|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
127521458|NCT03624127|458869556|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
127521459|NCT03624127|458869554|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
127521460|NCT03624127|458869555|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
127521461|NCT03624127|458869556|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
127521462|NCT03624127|458869554|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
127521463|NCT03624127|458869555|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
127521464|NCT03624127|458869556|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
127521465|NCT03624127|458869554|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
127521466|NCT03624127|458869555|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
127521467|NCT03624127|458869556|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
127521468|NCT03624127|458869554|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
127521469|NCT03624127|458869555|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
127521470|NCT03624127|458869556|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
127521471|NCT03624127|458869554|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
127521472|NCT03624127|458869555|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
127521473|NCT03624127|458869556|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
127521474|NCT03624127|458869554|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
127521475|NCT03624127|458869555|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
127521476|NCT03624127|458869556|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
127521477|NCT02607228|458869557|FG000|Overall Study|Progressive Disease|4|||
127521478|NCT02607228|458869558|FG001|Overall Study|Progressive Disease|3|||
127521479|NCT02607228|458869559|FG002|Overall Study|Progressive Disease|1|||
127521480|NCT02607228|458869560|FG003|Overall Study|Progressive Disease|5|||
127521481|NCT02607228|458869561|FG004|Overall Study|Progressive Disease|4|||
127521482|NCT02607228|458869562|FG005|Overall Study|Progressive Disease|3|||
127521483|NCT02607228|458869563|FG006|Overall Study|Progressive Disease|1|||
127521484|NCT02607228|458869557|FG000|Overall Study|Adverse Event|1|||
127521485|NCT02607228|458869558|FG001|Overall Study|Adverse Event|0|||
127521486|NCT02607228|458869559|FG002|Overall Study|Adverse Event|1|||
127521487|NCT02607228|458869560|FG003|Overall Study|Adverse Event|0|||
127521488|NCT02607228|458869561|FG004|Overall Study|Adverse Event|1|||
127521489|NCT02607228|458869562|FG005|Overall Study|Adverse Event|1|||
127521490|NCT02607228|458869563|FG006|Overall Study|Adverse Event|1|||
127521491|NCT02607228|458869557|FG000|Overall Study|Investigator's Discretion|0|||
127521492|NCT02607228|458869558|FG001|Overall Study|Investigator's Discretion|0|||
127521493|NCT02607228|458869559|FG002|Overall Study|Investigator's Discretion|1|||
127521494|NCT02607228|458869560|FG003|Overall Study|Investigator's Discretion|0|||
127521495|NCT02607228|458869561|FG004|Overall Study|Investigator's Discretion|0|||
127521496|NCT02607228|458869562|FG005|Overall Study|Investigator's Discretion|1|||
127521497|NCT02607228|458869563|FG006|Overall Study|Investigator's Discretion|0|||
127521498|NCT02607228|458869557|FG000|Overall Study|Withdrew Consent|0|||
127521499|NCT02607228|458869558|FG001|Overall Study|Withdrew Consent|1|||
127521500|NCT02607228|458869559|FG002|Overall Study|Withdrew Consent|0|||
127521501|NCT02607228|458869560|FG003|Overall Study|Withdrew Consent|0|||
127521502|NCT02607228|458869561|FG004|Overall Study|Withdrew Consent|0|||
127521503|NCT02607228|458869562|FG005|Overall Study|Withdrew Consent|1|||
127521504|NCT02607228|458869563|FG006|Overall Study|Withdrew Consent|0|||
127521505|NCT02607228|458869557|FG000|Overall Study|Study Terminated by Sponsor|0|||
127521506|NCT02607228|458869558|FG001|Overall Study|Study Terminated by Sponsor|0|||
127521507|NCT02607228|458869559|FG002|Overall Study|Study Terminated by Sponsor|0|||
127521508|NCT02607228|458869560|FG003|Overall Study|Study Terminated by Sponsor|1|||
127521509|NCT02607228|458869561|FG004|Overall Study|Study Terminated by Sponsor|0|||
127521510|NCT02607228|458869562|FG005|Overall Study|Study Terminated by Sponsor|0|||
127521511|NCT02607228|458869563|FG006|Overall Study|Study Terminated by Sponsor|0|||
127521512|NCT04356040|458869564|FG000|Overall Study|Death|2|||
127521513|NCT04356040|458869565|FG001|Overall Study|Death|0|||
127521514|NCT04356040|458869564|FG000|Overall Study|Lost to Follow-up|1|||
127521515|NCT04356040|458869565|FG001|Overall Study|Lost to Follow-up|0|||
127521516|NCT04356040|458869564|FG000|Overall Study|Physician Decision|0|||
127521517|NCT04356040|458869565|FG001|Overall Study|Physician Decision|1|||
127521518|NCT04356040|458869564|FG000|Overall Study|Withdrawal by Subject|13|||
127521519|NCT04356040|458869565|FG001|Overall Study|Withdrawal by Subject|1|||
127521520|NCT04356040|458869564|FG000|Overall Study|Enrollment Pause|10|||
127521521|NCT04356040|458869565|FG001|Overall Study|Enrollment Pause|0|||
127521522|NCT04356040|458869564|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
127521523|NCT04356040|458869565|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
127521524|NCT04356040|458869564|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
127521525|NCT04356040|458869565|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
127521526|NCT04356040|458869564|FG000|Overall Study|PI left institution|3|||
127521527|NCT04356040|458869565|FG001|Overall Study|PI left institution|0|||
127521528|NCT01990859|458869566|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
127521529|NCT01990859|458869566|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
127521530|NCT02262754|458869568|FG000|Overall Study|Adverse Event|3|||
127521531|NCT02262754|458869569|FG001|Overall Study|Adverse Event|4|||
127521532|NCT02262754|458869570|FG002|Overall Study|Adverse Event|0|||
127521533|NCT02262754|458869568|FG000|Overall Study|Lack of Efficacy|2|||
127521534|NCT02262754|458869569|FG001|Overall Study|Lack of Efficacy|0|||
127521535|NCT02262754|458869570|FG002|Overall Study|Lack of Efficacy|1|||
127521536|NCT02262754|458869568|FG000|Overall Study|Lost to Follow-up|0|||
127521537|NCT02262754|458869569|FG001|Overall Study|Lost to Follow-up|0|||
127521538|NCT02262754|458869570|FG002|Overall Study|Lost to Follow-up|1|||
127521539|NCT02262754|458869568|FG000|Overall Study|No longer meets eligibility criteria|0|||
127521540|NCT02262754|458869569|FG001|Overall Study|No longer meets eligibility criteria|1|||
127521541|NCT02262754|458869570|FG002|Overall Study|No longer meets eligibility criteria|0|||
127521542|NCT02262754|458869568|FG000|Overall Study|Study terminated by sponsor|5|||
127521543|NCT02262754|458869569|FG001|Overall Study|Study terminated by sponsor|4|||
127521544|NCT02262754|458869570|FG002|Overall Study|Study terminated by sponsor|4|||
127521545|NCT02262754|458869568|FG000|Overall Study|Protocol Violation|1|||
127521546|NCT02262754|458869569|FG001|Overall Study|Protocol Violation|0|||
127521547|NCT02262754|458869570|FG002|Overall Study|Protocol Violation|0|||
127521548|NCT02262754|458869568|FG000|Overall Study|Withdrawal by Subject|1|||
127521549|NCT02262754|458869569|FG001|Overall Study|Withdrawal by Subject|0|||
127521550|NCT02262754|458869570|FG002|Overall Study|Withdrawal by Subject|1|||
127521551|NCT02262754|458869568|FG000|Overall Study|Other|4|||
127521552|NCT02262754|458869569|FG001|Overall Study|Other|0|||
127521553|NCT02262754|458869570|FG002|Overall Study|Other|2|||
127521554|NCT02577016|458869575|FG000|Overall Study|Adverse Event|2|||
127521555|NCT02577016|458869576|FG001|Overall Study|Adverse Event|1|||
127521556|NCT02577016|458869575|FG000|Overall Study|Physician Decision|0|||
127521557|NCT02577016|458869576|FG001|Overall Study|Physician Decision|1|||
127521558|NCT02126839|458869577|FG000|Overall Study|Adverse Event|0|||
127521559|NCT02126839|458869578|FG001|Overall Study|Adverse Event|1|||
127521560|NCT02126839|458869577|FG000|Overall Study|Withdrawal by Subject|1|||
127521561|NCT02126839|458869578|FG001|Overall Study|Withdrawal by Subject|0|||
127521562|NCT02126839|458869577|FG000|Overall Study|Withdrawal by parent/guardian|1|||
127521563|NCT02126839|458869578|FG001|Overall Study|Withdrawal by parent/guardian|0|||
127521564|NCT02126839|458869577|FG000|Overall Study|Protocol Violation|2|||
127521565|NCT02126839|458869578|FG001|Overall Study|Protocol Violation|3|||
127521566|NCT02126839|458869577|FG000|Overall Study|Sponsor request|0|||
127521567|NCT02126839|458869578|FG001|Overall Study|Sponsor request|1|||
127521568|NCT02126839|458869577|FG000|Overall Study|Lost to Follow-up|1|||
127521569|NCT02126839|458869578|FG001|Overall Study|Lost to Follow-up|4|||
127521570|NCT02126839|458869577|FG000|Overall Study|Other|5|||
127521571|NCT02126839|458869578|FG001|Overall Study|Other|5|||
127521572|NCT00812565|458869581|FG000|Overall Study|Did Not Receive Study Medication|1|||
127521573|NCT00812565|458869582|FG001|Overall Study|Did Not Receive Study Medication|1|||
127521574|NCT00812565|458869583|FG002|Overall Study|Did Not Receive Study Medication|0|||
127521575|NCT00812565|458869584|FG003|Overall Study|Did Not Receive Study Medication|0|||
127521576|NCT00812565|458869585|FG004|Overall Study|Did Not Receive Study Medication|0|||
127521577|NCT00812565|458869586|FG005|Overall Study|Did Not Receive Study Medication|0|||
127521578|NCT00812565|458869587|FG006|Overall Study|Did Not Receive Study Medication|0|||
127521579|NCT00812565|458869588|FG007|Overall Study|Did Not Receive Study Medication|0|||
127521580|NCT00812565|458869581|FG000|Overall Study|Adverse Event|0|||
127521581|NCT00812565|458869582|FG001|Overall Study|Adverse Event|0|||
127521582|NCT00812565|458869583|FG002|Overall Study|Adverse Event|0|||
127521583|NCT00812565|458869584|FG003|Overall Study|Adverse Event|2|||
127521584|NCT00812565|458869585|FG004|Overall Study|Adverse Event|0|||
127521585|NCT00812565|458869586|FG005|Overall Study|Adverse Event|0|||
127521586|NCT00812565|458869587|FG006|Overall Study|Adverse Event|0|||
127521587|NCT00812565|458869588|FG007|Overall Study|Adverse Event|1|||
127521588|NCT00812565|458869581|FG000|Overall Study|Did Not Come to Study Visit|1|||
127521589|NCT00812565|458869582|FG001|Overall Study|Did Not Come to Study Visit|0|||
127521590|NCT00812565|458869583|FG002|Overall Study|Did Not Come to Study Visit|0|||
127521591|NCT00812565|458869584|FG003|Overall Study|Did Not Come to Study Visit|0|||
127521592|NCT00812565|458869585|FG004|Overall Study|Did Not Come to Study Visit|0|||
127521593|NCT00812565|458869586|FG005|Overall Study|Did Not Come to Study Visit|0|||
127521594|NCT00812565|458869587|FG006|Overall Study|Did Not Come to Study Visit|0|||
127521595|NCT00812565|458869588|FG007|Overall Study|Did Not Come to Study Visit|0|||
127521596|NCT00812565|458869581|FG000|Overall Study|Withdrawal of Consent|1|||
127521597|NCT00812565|458869582|FG001|Overall Study|Withdrawal of Consent|0|||
127521598|NCT00812565|458869583|FG002|Overall Study|Withdrawal of Consent|0|||
127521599|NCT00812565|458869584|FG003|Overall Study|Withdrawal of Consent|0|||
127521600|NCT00812565|458869585|FG004|Overall Study|Withdrawal of Consent|1|||
127521601|NCT00812565|458869586|FG005|Overall Study|Withdrawal of Consent|0|||
127521602|NCT00812565|458869587|FG006|Overall Study|Withdrawal of Consent|0|||
127521603|NCT00812565|458869588|FG007|Overall Study|Withdrawal of Consent|0|||
127521604|NCT00812565|458869581|FG000|Overall Study|Reason Not Specified|0|||
127521605|NCT00812565|458869582|FG001|Overall Study|Reason Not Specified|0|||
127521606|NCT00812565|458869583|FG002|Overall Study|Reason Not Specified|0|||
127521607|NCT00812565|458869584|FG003|Overall Study|Reason Not Specified|0|||
127521608|NCT00812565|458869585|FG004|Overall Study|Reason Not Specified|0|||
127521609|NCT00812565|458869586|FG005|Overall Study|Reason Not Specified|1|||
127521610|NCT00812565|458869587|FG006|Overall Study|Reason Not Specified|0|||
127521611|NCT00812565|458869588|FG007|Overall Study|Reason Not Specified|0|||
127521612|NCT00422383|458869589|FG000|Overall Study|Adverse Event|5|||
127521613|NCT00422383|458869590|FG001|Overall Study|Adverse Event|3|||
127521614|NCT00422383|458869591|FG002|Overall Study|Adverse Event|1|||
127521615|NCT00422383|458869592|FG003|Overall Study|Adverse Event|1|||
127521616|NCT00422383|458869593|FG004|Overall Study|Adverse Event|0|||
127521617|NCT00422383|458869589|FG000|Overall Study|Lack of Efficacy|4|||
127521618|NCT00422383|458869590|FG001|Overall Study|Lack of Efficacy|4|||
127521619|NCT00422383|458869591|FG002|Overall Study|Lack of Efficacy|2|||
127521620|NCT00422383|458869592|FG003|Overall Study|Lack of Efficacy|1|||
127521621|NCT00422383|458869593|FG004|Overall Study|Lack of Efficacy|1|||
127521622|NCT00422383|458869589|FG000|Overall Study|Lost to Follow-up|0|||
127521623|NCT00422383|458869590|FG001|Overall Study|Lost to Follow-up|1|||
127521624|NCT00422383|458869591|FG002|Overall Study|Lost to Follow-up|0|||
127521625|NCT00422383|458869592|FG003|Overall Study|Lost to Follow-up|0|||
127521626|NCT00422383|458869593|FG004|Overall Study|Lost to Follow-up|1|||
127521627|NCT00422383|458869589|FG000|Overall Study|Protocol Violation|1|||
127521628|NCT00422383|458869590|FG001|Overall Study|Protocol Violation|1|||
127521629|NCT00422383|458869591|FG002|Overall Study|Protocol Violation|1|||
127521630|NCT00422383|458869592|FG003|Overall Study|Protocol Violation|0|||
127521631|NCT00422383|458869593|FG004|Overall Study|Protocol Violation|0|||
127521632|NCT00422383|458869589|FG000|Overall Study|Withdrawal by Subject|5|||
127521633|NCT00422383|458869590|FG001|Overall Study|Withdrawal by Subject|5|||
127521634|NCT00422383|458869591|FG002|Overall Study|Withdrawal by Subject|0|||
127521635|NCT00422383|458869592|FG003|Overall Study|Withdrawal by Subject|0|||
127521636|NCT00422383|458869593|FG004|Overall Study|Withdrawal by Subject|1|||
127521637|NCT05066165|458871463|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
127521638|NCT05066165|458871464|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
127521639|NCT05066165|458871463|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
127521640|NCT05066165|458871464|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
127521641|NCT03738618|458871465|FG000|Overall Study|Protocol deviation|23|||
127521642|NCT03738618|458871466|FG001|Overall Study|Protocol deviation|0|||
127521643|NCT03738618|458871465|FG000|Overall Study|Adverse Event|4|||
127521644|NCT03738618|458871466|FG001|Overall Study|Adverse Event|0|||
127521645|NCT03738618|458871465|FG000|Overall Study|Lost to Follow-up|2|||
127521646|NCT03738618|458871466|FG001|Overall Study|Lost to Follow-up|0|||
127521647|NCT03738618|458871465|FG000|Overall Study|Randomization failure|1|||
127521648|NCT03738618|458871466|FG001|Overall Study|Randomization failure|0|||
127521649|NCT03738618|458871465|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
127521650|NCT03738618|458871466|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
127521651|NCT03738618|458871465|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
127521652|NCT03738618|458871466|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
127521653|NCT00649428|458871467|FG000|Overall Study|Adverse Event|2|||
127521654|NCT00649428|458871468|FG001|Overall Study|Adverse Event|2|||
127521655|NCT00649428|458871467|FG000|Overall Study|Withdrawal by Subject|6|||
127521656|NCT00649428|458871468|FG001|Overall Study|Withdrawal by Subject|6|||
127521657|NCT00649428|458871467|FG000|Overall Study|Lost to Follow-up|1|||
127521658|NCT00649428|458871468|FG001|Overall Study|Lost to Follow-up|3|||
127521659|NCT00649428|458871467|FG000|Overall Study|Insufficient manufacturing yield|5|||
127521660|NCT00649428|458871468|FG001|Overall Study|Insufficient manufacturing yield|1|||
127521661|NCT00649428|458871467|FG000|Overall Study|Protocol Violation|6|||
127521662|NCT00649428|458871468|FG001|Overall Study|Protocol Violation|2|||
127521663|NCT00649428|458871467|FG000|Overall Study|Physician Decision|0|||
127521664|NCT00649428|458871468|FG001|Overall Study|Physician Decision|1|||
127521665|NCT04566601|458871473|FG000|Overall Study|Other than listed|13|||
127521666|NCT04566601|458871474|FG001|Overall Study|Other than listed|4|||
127521667|NCT04566601|458871475|FG002|Overall Study|Other than listed|2|||
127521668|NCT04566601|458871476|FG003|Overall Study|Other than listed|1|||
127521669|NCT04566601|458871477|FG004|Overall Study|Other than listed|4|||
127521670|NCT04566601|458871473|FG000|Overall Study|Protocol deviation|3|||
127521671|NCT04566601|458871474|FG001|Overall Study|Protocol deviation|0|||
127521672|NCT04566601|458871475|FG002|Overall Study|Protocol deviation|1|||
127521673|NCT04566601|458871476|FG003|Overall Study|Protocol deviation|1|||
127521674|NCT04566601|458871477|FG004|Overall Study|Protocol deviation|1|||
127521675|NCT04566601|458871473|FG000|Overall Study|Technical problems|0|||
127521676|NCT04566601|458871474|FG001|Overall Study|Technical problems|0|||
127521677|NCT04566601|458871475|FG002|Overall Study|Technical problems|1|||
127521678|NCT04566601|458871476|FG003|Overall Study|Technical problems|0|||
127521679|NCT04566601|458871477|FG004|Overall Study|Technical problems|0|||
127521680|NCT04566601|458871473|FG000|Overall Study|No reason available|3|||
127521681|NCT04566601|458871474|FG001|Overall Study|No reason available|2|||
127521682|NCT04566601|458871475|FG002|Overall Study|No reason available|7|||
127521683|NCT04566601|458871476|FG003|Overall Study|No reason available|1|||
127521684|NCT04566601|458871477|FG004|Overall Study|No reason available|5|||
127521685|NCT04566601|458871473|FG000|Overall Study|Burden of study procedures|3|||
127521686|NCT04566601|458871474|FG001|Overall Study|Burden of study procedures|0|||
127521687|NCT04566601|458871475|FG002|Overall Study|Burden of study procedures|0|||
127521688|NCT04566601|458871476|FG003|Overall Study|Burden of study procedures|3|||
127521689|NCT04566601|458871477|FG004|Overall Study|Burden of study procedures|1|||
127521690|NCT04566601|458871473|FG000|Overall Study|Change of residence|2|||
127521691|NCT04566601|458871474|FG001|Overall Study|Change of residence|2|||
127521692|NCT04566601|458871475|FG002|Overall Study|Change of residence|0|||
127521693|NCT04566601|458871476|FG003|Overall Study|Change of residence|1|||
127521694|NCT04566601|458871477|FG004|Overall Study|Change of residence|2|||
127521695|NCT04566601|458871473|FG000|Overall Study|Perceived lack of efficacy|2|||
127521696|NCT04566601|458871474|FG001|Overall Study|Perceived lack of efficacy|0|||
127521697|NCT04566601|458871475|FG002|Overall Study|Perceived lack of efficacy|1|||
127521698|NCT04566601|458871476|FG003|Overall Study|Perceived lack of efficacy|1|||
127521699|NCT04566601|458871477|FG004|Overall Study|Perceived lack of efficacy|2|||
127521700|NCT04566601|458871473|FG000|Overall Study|Adverse Event|7|||
127521701|NCT04566601|458871474|FG001|Overall Study|Adverse Event|4|||
127521702|NCT04566601|458871475|FG002|Overall Study|Adverse Event|6|||
127521703|NCT04566601|458871476|FG003|Overall Study|Adverse Event|5|||
127521704|NCT04566601|458871477|FG004|Overall Study|Adverse Event|12|||
127521705|NCT01450098|458871478|FG000|Period 3|Protocol Violation|0|||
127521706|NCT01450098|458871479|FG001|Period 3|Protocol Violation|1|||
127521707|NCT01450098|458871478|FG000|Period 3|Withdrawal by Subject|0|||
127521708|NCT01450098|458871479|FG001|Period 3|Withdrawal by Subject|2|||
127521709|NCT01272635|458871480|FG000|Overall Study|Lost to Follow-up|31|||
127521710|NCT01272635|458871481|FG001|Overall Study|Lost to Follow-up|20|||
127521711|NCT01272635|458871482|FG002|Overall Study|Lost to Follow-up|31|||
127521712|NCT01272635|458871483|FG003|Overall Study|Lost to Follow-up|23|||
127521713|NCT01832155|458871486|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
127521714|NCT01832155|458871487|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
127521715|NCT01832155|458871486|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
127521716|NCT01832155|458871487|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
127521717|NCT01055314|458871488|FG000|Overall Study|Adverse Event|7|||
127521718|NCT01055314|458871489|FG001|Overall Study|Adverse Event|4|||
127521719|NCT01055314|458871488|FG000|Overall Study|Death|2|||
127521720|NCT01055314|458871489|FG001|Overall Study|Death|1|||
127521721|NCT01055314|458871488|FG000|Overall Study|Lack of Efficacy|11|||
127521722|NCT01055314|458871489|FG001|Overall Study|Lack of Efficacy|19|||
127521723|NCT01055314|458871488|FG000|Overall Study|Physician Decision|10|||
127521724|NCT01055314|458871489|FG001|Overall Study|Physician Decision|5|||
127521725|NCT01055314|458871488|FG000|Overall Study|Withdrawal by Subject|1|||
127521726|NCT01055314|458871489|FG001|Overall Study|Withdrawal by Subject|0|||
127521727|NCT01055314|458871488|FG000|Overall Study|Ineligible|3|||
127521728|NCT01055314|458871489|FG001|Overall Study|Ineligible|5|||
127521729|NCT01055314|458871488|FG000|Overall Study|Refusal of further protocol therapy|10|||
127521730|NCT01055314|458871489|FG001|Overall Study|Refusal of further protocol therapy|4|||
127521731|NCT01055314|458871488|FG000|Overall Study|No treatment|1|||
127521732|NCT01055314|458871489|FG001|Overall Study|No treatment|0|||
127521733|NCT01279616|458871490|FG000|Overall Study|donor could not be located|5|||
127521734|NCT01279616|458871490|FG000|Overall Study|no signs of sickle cell disease|2|||
127521735|NCT02462720|458871491|FG000|Part 2|Withdrawal by Subject|1|||
127521736|NCT02462720|458871492|FG001|Part 2|Withdrawal by Subject|0|||
127521737|NCT02462720|458871491|FG000|Part 2|Protocol Violation|0|||
127521738|NCT02462720|458871492|FG001|Part 2|Protocol Violation|1|||
127521739|NCT00183625|458871495|FG000|Overall Study|Withdrawal by Subject|18|||
127521740|NCT00183625|458871496|FG001|Overall Study|Withdrawal by Subject|18|||
127521741|NCT00183625|458871497|FG002|Overall Study|Withdrawal by Subject|19|||
127521742|NCT00183625|458871498|FG003|Overall Study|Withdrawal by Subject|14|||
127521743|NCT05249569|458871501|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
127521744|NCT01423916|458871504|FG000|Overall Study|Adverse Event|5|||
127521745|NCT01423916|458871505|FG001|Overall Study|Adverse Event|9|||
127521746|NCT01423916|458871506|FG002|Overall Study|Adverse Event|2|||
127521747|NCT01423916|458871504|FG000|Overall Study|Met Withdrawal Criteria|1|||
127521748|NCT01423916|458871505|FG001|Overall Study|Met Withdrawal Criteria|1|||
127521749|NCT01423916|458871506|FG002|Overall Study|Met Withdrawal Criteria|1|||
127521750|NCT01423916|458871504|FG000|Overall Study|Physician Decision|1|||
127521751|NCT01423916|458871505|FG001|Overall Study|Physician Decision|0|||
127521752|NCT01423916|458871506|FG002|Overall Study|Physician Decision|1|||
127521753|NCT01423916|458871504|FG000|Overall Study|Withdrawal by Subject|3|||
127521754|NCT01423916|458871505|FG001|Overall Study|Withdrawal by Subject|10|||
127521755|NCT01423916|458871506|FG002|Overall Study|Withdrawal by Subject|3|||
127521756|NCT01423916|458871504|FG000|Overall Study|Protocol Deviation|1|||
127521757|NCT01423916|458871505|FG001|Overall Study|Protocol Deviation|0|||
127521758|NCT01423916|458871506|FG002|Overall Study|Protocol Deviation|0|||
127521759|NCT01966445|458871507|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
127521760|NCT01966445|458871508|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
127521761|NCT01966445|458871509|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
127521762|NCT01966445|458871510|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
127521763|NCT01966445|458871511|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
127521764|NCT01966445|458871512|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
127521765|NCT01966445|458871513|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
127521766|NCT01966445|458871507|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
127521767|NCT01966445|458871508|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
127521768|NCT01966445|458871509|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
127521769|NCT01966445|458871510|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
127521770|NCT01966445|458871511|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
127521771|NCT01966445|458871512|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
127521772|NCT01966445|458871513|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
127521773|NCT01966445|458871507|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
127521774|NCT01966445|458871508|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
127521775|NCT01966445|458871509|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
127521776|NCT01966445|458871510|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
127521777|NCT01966445|458871511|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
127521778|NCT01966445|458871512|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
127521779|NCT01966445|458871513|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
127521780|NCT01966445|458871507|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
127521781|NCT01966445|458871508|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
127521782|NCT01966445|458871509|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
127521783|NCT01966445|458871510|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
127521784|NCT01966445|458871511|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
127521785|NCT01966445|458871512|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
127521786|NCT01966445|458871513|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
127521787|NCT01966445|458871507|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
127521788|NCT01966445|458871508|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
127521789|NCT01966445|458871509|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
127521790|NCT01966445|458871510|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
127521791|NCT01966445|458871511|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
127521792|NCT01966445|458871512|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
127521793|NCT01966445|458871513|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
127521794|NCT01374178|458871516|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
127521795|NCT01374178|458871517|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
127521796|NCT01374178|458871516|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
127521797|NCT01374178|458871517|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
127521798|NCT04856904|458871520|FG000|Overall Study|Physician Decision|1|||
127521799|NCT04856904|458871521|FG001|Overall Study|Physician Decision|1|||
127521800|NCT04856904|458871520|FG000|Overall Study|Withdrawal by Subject|13|||
127521801|NCT04856904|458871521|FG001|Overall Study|Withdrawal by Subject|13|||
127521802|NCT04856904|458871520|FG000|Overall Study|Adverse Event|1|||
127521803|NCT04856904|458871521|FG001|Overall Study|Adverse Event|1|||
127521804|NCT04856904|458871520|FG000|Overall Study|Non-compliance with study drug|1|||
127521805|NCT04856904|458871521|FG001|Overall Study|Non-compliance with study drug|1|||
127521806|NCT04856904|458871520|FG000|Overall Study|Lost to Follow-up|4|||
127521807|NCT04856904|458871521|FG001|Overall Study|Lost to Follow-up|4|||
127521808|NCT04856904|458871520|FG000|Overall Study|Withdrawal by Subject|1|||
127521809|NCT04856904|458871521|FG001|Overall Study|Withdrawal by Subject|1|||
127521810|NCT04856904|458871520|FG000|Overall Study|Protocol Violation|1|||
127521811|NCT04856904|458871521|FG001|Overall Study|Protocol Violation|1|||
127521812|NCT00077649|458871522|FG000|Overall Study|Adverse Event|5|||
127521813|NCT00077649|458871523|FG001|Overall Study|Adverse Event|1|||
127521814|NCT00077649|458871524|FG002|Overall Study|Adverse Event|7|||
127521815|NCT00077649|458871525|FG003|Overall Study|Adverse Event|9|||
127521816|NCT00077649|458871522|FG000|Overall Study|Lack of Efficacy|5|||
127521817|NCT00077649|458871523|FG001|Overall Study|Lack of Efficacy|3|||
127521818|NCT00077649|458871524|FG002|Overall Study|Lack of Efficacy|3|||
127521819|NCT00077649|458871525|FG003|Overall Study|Lack of Efficacy|2|||
127521820|NCT00077649|458871522|FG000|Overall Study|Withdrawal by Subject|0|||
127521821|NCT00077649|458871523|FG001|Overall Study|Withdrawal by Subject|1|||
127521822|NCT00077649|458871524|FG002|Overall Study|Withdrawal by Subject|1|||
127521823|NCT00077649|458871525|FG003|Overall Study|Withdrawal by Subject|2|||
127521824|NCT00077649|458871522|FG000|Overall Study|Lost to Follow-up|2|||
127521825|NCT00077649|458871523|FG001|Overall Study|Lost to Follow-up|2|||
127521826|NCT00077649|458871524|FG002|Overall Study|Lost to Follow-up|3|||
127521827|NCT00077649|458871525|FG003|Overall Study|Lost to Follow-up|2|||
127521828|NCT00077649|458871522|FG000|Overall Study|Abnormality of Laboratory Test|1|||
127521829|NCT00077649|458871523|FG001|Overall Study|Abnormality of Laboratory Test|2|||
127521830|NCT00077649|458871524|FG002|Overall Study|Abnormality of Laboratory Test|1|||
127521831|NCT00077649|458871525|FG003|Overall Study|Abnormality of Laboratory Test|2|||
127521832|NCT00077649|458871522|FG000|Overall Study|Randomized but never dosed|1|||
127521833|NCT00077649|458871523|FG001|Overall Study|Randomized but never dosed|0|||
127521834|NCT00077649|458871524|FG002|Overall Study|Randomized but never dosed|0|||
127521835|NCT00077649|458871525|FG003|Overall Study|Randomized but never dosed|0|||
127521836|NCT02421601|458871526|FG000|Overall Study|Adverse Event|4|||
127521837|NCT02421601|458871526|FG000|Overall Study|Lack of Efficacy|5|||
127521838|NCT02421601|458871526|FG000|Overall Study|Physician Decision|1|||
127521839|NCT02421601|458871526|FG000|Overall Study|Withdrawal by Subject|31|||
127521840|NCT02421601|458871526|FG000|Overall Study|Others|41|||
127521841|NCT02895945|458871527|FG000|Overall Study|Physician Decision|2|||
127521842|NCT02895945|458871528|FG001|Overall Study|Physician Decision|1|||
127521843|NCT00454181|458871530|FG000|Overall Study|Adverse Event|1|||
127521844|NCT00454181|458871531|FG001|Overall Study|Adverse Event|1|||
127521845|NCT00454181|458871530|FG000|Overall Study|Lost to Follow-up|11|||
127521846|NCT00454181|458871531|FG001|Overall Study|Lost to Follow-up|1|||
127521847|NCT00454181|458871530|FG000|Overall Study|Protocol Violation|1|||
127521848|NCT00454181|458871531|FG001|Overall Study|Protocol Violation|1|||
127521849|NCT00454181|458871530|FG000|Overall Study|Withdrawal by Subject|2|||
127521850|NCT00454181|458871531|FG001|Overall Study|Withdrawal by Subject|0|||
127521851|NCT00619099|458871536|FG000|Overall Study|Progressive Disease|7|||
127521852|NCT00619099|458871537|FG001|Overall Study|Progressive Disease|5|||
127521853|NCT00619099|458871536|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
127521854|NCT00619099|458871537|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
127521855|NCT00619099|458871536|FG000|Overall Study|Adverse Event|4|||
127521856|NCT00619099|458871537|FG001|Overall Study|Adverse Event|3|||
127521857|NCT00619099|458871536|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
127521858|NCT00619099|458871537|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
127521859|NCT00619099|458871536|FG000|Overall Study|Withdrawal by Subject|10|||
127521860|NCT00619099|458871537|FG001|Overall Study|Withdrawal by Subject|2|||
127521861|NCT00619099|458871536|FG000|Overall Study|Physician Decision|9|||
127521862|NCT00619099|458871537|FG001|Overall Study|Physician Decision|6|||
127521863|NCT00885482|458871538|FG000|Overall Study|Pregnancy|1|||
127521864|NCT00885482|458871538|FG000|Overall Study|Lack of Efficacy|1|||
127521865|NCT00885482|458871538|FG000|Overall Study|Death|1|||
127521866|NCT00885482|458871538|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
127521867|NCT00084656|458871539|FG000|Overall Study|Other reasons|0|||
127521868|NCT00084656|458871540|FG001|Overall Study|Other reasons|12|||
127521869|NCT00084656|458871541|FG002|Overall Study|Other reasons|11|||
127521870|NCT00084656|458871539|FG000|Overall Study|Withdrawal by Subject|15|||
127521871|NCT00084656|458871540|FG001|Overall Study|Withdrawal by Subject|4|||
127521872|NCT00084656|458871541|FG002|Overall Study|Withdrawal by Subject|4|||
127521873|NCT00084656|458871539|FG000|Overall Study|Disease relapse|0|||
127521874|NCT00084656|458871540|FG001|Overall Study|Disease relapse|9|||
127521875|NCT00084656|458871541|FG002|Overall Study|Disease relapse|10|||
127521876|NCT00084656|458871539|FG000|Overall Study|Disease progression|9|||
127521877|NCT00084656|458871540|FG001|Overall Study|Disease progression|0|||
127521878|NCT00084656|458871541|FG002|Overall Study|Disease progression|0|||
127521879|NCT00084656|458871539|FG000|Overall Study|Lost to Follow-up|1|||
127521880|NCT00084656|458871540|FG001|Overall Study|Lost to Follow-up|0|||
127521881|NCT00084656|458871541|FG002|Overall Study|Lost to Follow-up|1|||
127521882|NCT02772978|458871542|FG000|Overall Study|Withdrawal by Subject|1|||
127521883|NCT02772978|458871543|FG001|Overall Study|Withdrawal by Subject|1|||
127521884|NCT01331291|458871544|FG000|Overall Study|Lack of Efficacy|2|||
127521885|NCT01331291|458871545|FG001|Overall Study|Lack of Efficacy|8|||
127521886|NCT01331291|458871544|FG000|Overall Study|Death|0|||
127521887|NCT01331291|458871545|FG001|Overall Study|Death|1|||
127521888|NCT01026220|458871546|FG000|Induction|Death|1|||
127521889|NCT01026220|458871547|FG001|Induction|Death|0|||
127521890|NCT01026220|458871548|FG002|Induction|Death|0|||
127521891|NCT01026220|458871546|FG000|Induction|Lack of Efficacy|2|||
127521892|NCT01026220|458871547|FG001|Induction|Lack of Efficacy|0|||
127521893|NCT01026220|458871548|FG002|Induction|Lack of Efficacy|0|||
127521894|NCT01026220|458871546|FG000|Induction|Physician Decision|12|||
127521895|NCT01026220|458871547|FG001|Induction|Physician Decision|0|||
127521896|NCT01026220|458871548|FG002|Induction|Physician Decision|0|||
127521897|NCT01026220|458871546|FG000|Induction|Withdrawal by Subject|9|||
127521898|NCT01026220|458871547|FG001|Induction|Withdrawal by Subject|0|||
127521899|NCT01026220|458871548|FG002|Induction|Withdrawal by Subject|0|||
127521900|NCT01026220|458871546|FG000|Induction|Ineligible|1|||
127521901|NCT01026220|458871547|FG001|Induction|Ineligible|0|||
127521902|NCT01026220|458871548|FG002|Induction|Ineligible|0|||
127521903|NCT01026220|458871546|FG000|Consolidation Maintenance|Death|0|||
127521904|NCT01026220|458871547|FG001|Consolidation Maintenance|Death|1|||
127521905|NCT01026220|458871548|FG002|Consolidation Maintenance|Death|0|||
127521906|NCT01026220|458871546|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
127521907|NCT01026220|458871547|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
127521908|NCT01026220|458871548|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
127521909|NCT01026220|458871546|FG000|Consolidation Maintenance|Physician Decision|0|||
127521910|NCT01026220|458871547|FG001|Consolidation Maintenance|Physician Decision|2|||
127521911|NCT01026220|458871548|FG002|Consolidation Maintenance|Physician Decision|7|||
127521912|NCT01026220|458871546|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
127521913|NCT01026220|458871547|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
127521914|NCT01026220|458871548|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
127521915|NCT00778895|458871549|FG000|Active Phase|Adverse Event|3|||
127521916|NCT00778895|458871550|FG001|Active Phase|Adverse Event|1|||
127521917|NCT00778895|458871551|FG002|Active Phase|Adverse Event|0|||
127521918|NCT00778895|458871549|FG000|Active Phase|Withdrawal by Subject|1|||
127521919|NCT00778895|458871550|FG001|Active Phase|Withdrawal by Subject|4|||
127521920|NCT00778895|458871551|FG002|Active Phase|Withdrawal by Subject|0|||
127521921|NCT00778895|458871549|FG000|Active Phase|Lost to Follow-up|1|||
127521922|NCT00778895|458871550|FG001|Active Phase|Lost to Follow-up|1|||
127521923|NCT00778895|458871551|FG002|Active Phase|Lost to Follow-up|0|||
127521924|NCT00778895|458871549|FG000|Active Phase|Other|2|||
127521925|NCT00778895|458871550|FG001|Active Phase|Other|0|||
127521926|NCT00778895|458871551|FG002|Active Phase|Other|0|||
127521927|NCT00778895|458871549|FG000|ESFU Phase|Adverse Event|2|||
127521928|NCT00778895|458871550|FG001|ESFU Phase|Adverse Event|1|||
127521929|NCT00778895|458871551|FG002|ESFU Phase|Adverse Event|0|||
127521930|NCT00778895|458871549|FG000|ESFU Phase|Withdrawal by Subject|1|||
127521931|NCT00778895|458871550|FG001|ESFU Phase|Withdrawal by Subject|4|||
127521932|NCT00778895|458871551|FG002|ESFU Phase|Withdrawal by Subject|0|||
127521933|NCT00778895|458871549|FG000|ESFU Phase|Lost to Follow-up|6|||
127521934|NCT00778895|458871550|FG001|ESFU Phase|Lost to Follow-up|7|||
127521935|NCT00778895|458871551|FG002|ESFU Phase|Lost to Follow-up|2|||
127521936|NCT00778895|458871549|FG000|ESFU Phase|Other|2|||
127521937|NCT00778895|458871550|FG001|ESFU Phase|Other|0|||
127521938|NCT00778895|458871551|FG002|ESFU Phase|Other|0|||
127521939|NCT02540993|458871553|FG000|Overall Study|Lost to Follow-up|5|||
127521940|NCT02540993|458871554|FG001|Overall Study|Lost to Follow-up|3|||
127521941|NCT02540993|458871553|FG000|Overall Study|Withdrawal by Subject|4|||
127521942|NCT02540993|458871554|FG001|Overall Study|Withdrawal by Subject|6|||
127521943|NCT02540993|458871553|FG000|Overall Study|GCP violations|33|||
127521944|NCT02540993|458871554|FG001|Overall Study|GCP violations|27|||
127521945|NCT00409344|458871555|FG000|Overall Study|no enrollment|0|||
127521946|NCT00409344|458871556|FG001|Overall Study|no enrollment|0|||
127521947|NCT03550404|458871557|FG000|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|3|||
127521948|NCT03550404|458871558|FG001|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
127521949|NCT03550404|458871559|FG002|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
127521950|NCT03550404|458871557|FG000|Phase 2|Vacated position|1|||
127521951|NCT03550404|458871558|FG001|Phase 2|Vacated position|0|||
127521952|NCT03550404|458871559|FG002|Phase 2|Vacated position|0|||
127521953|NCT01009086|458871561|FG000|Overall Study|Lack of Efficacy|16|||
127521954|NCT01009086|458871562|FG001|Overall Study|Lack of Efficacy|15|||
127521955|NCT01009086|458871563|FG002|Overall Study|Lack of Efficacy|9|||
127521956|NCT01009086|458871561|FG000|Overall Study|Lost to Follow-up|4|||
127521957|NCT01009086|458871562|FG001|Overall Study|Lost to Follow-up|5|||
127521958|NCT01009086|458871563|FG002|Overall Study|Lost to Follow-up|3|||
127521959|NCT01009086|458871561|FG000|Overall Study|Adverse Event|12|||
127521960|NCT01009086|458871562|FG001|Overall Study|Adverse Event|11|||
127521961|NCT01009086|458871563|FG002|Overall Study|Adverse Event|8|||
127521962|NCT01009086|458871561|FG000|Overall Study|Withdrawal by Subject|9|||
127521963|NCT01009086|458871562|FG001|Overall Study|Withdrawal by Subject|11|||
127521964|NCT01009086|458871563|FG002|Overall Study|Withdrawal by Subject|13|||
127521965|NCT01009086|458871561|FG000|Overall Study|Other|3|||
127521966|NCT01009086|458871562|FG001|Overall Study|Other|5|||
127521967|NCT01009086|458871563|FG002|Overall Study|Other|1|||
127521968|NCT01389323|458871564|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
127521969|NCT01389323|458871564|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
127521970|NCT01389323|458871564|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
127521971|NCT01389323|458871564|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
127521972|NCT01389323|458871564|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
127521973|NCT01389323|458871564|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
127521974|NCT01389323|458871564|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
127521975|NCT01389323|458871564|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
127521976|NCT01389323|458871564|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
127521977|NCT01389323|458871564|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
127521978|NCT01389323|458871564|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
127521979|NCT00590577|458871566|FG000|Overall Study|Lack of Efficacy|31|||
127521980|NCT00590577|458871567|FG001|Overall Study|Lack of Efficacy|28|||
127521981|NCT00590577|458871568|FG002|Overall Study|Lack of Efficacy|23|||
127521982|NCT00590577|458871569|FG003|Overall Study|Lack of Efficacy|45|||
127521983|NCT00590577|458871566|FG000|Overall Study|Withdrawal by Subject|23|||
127521984|NCT00590577|458871567|FG001|Overall Study|Withdrawal by Subject|28|||
127521985|NCT00590577|458871568|FG002|Overall Study|Withdrawal by Subject|30|||
127521986|NCT00590577|458871569|FG003|Overall Study|Withdrawal by Subject|26|||
127521987|NCT00590577|458871566|FG000|Overall Study|Adverse Event|10|||
127521988|NCT00590577|458871567|FG001|Overall Study|Adverse Event|10|||
127521989|NCT00590577|458871568|FG002|Overall Study|Adverse Event|13|||
127521990|NCT00590577|458871569|FG003|Overall Study|Adverse Event|11|||
127521991|NCT00590577|458871566|FG000|Overall Study|Lost to Follow-up|12|||
127521992|NCT00590577|458871567|FG001|Overall Study|Lost to Follow-up|6|||
127521993|NCT00590577|458871568|FG002|Overall Study|Lost to Follow-up|6|||
127521994|NCT00590577|458871569|FG003|Overall Study|Lost to Follow-up|9|||
127521995|NCT00590577|458871566|FG000|Overall Study|Pregnancy|0|||
127521996|NCT00590577|458871567|FG001|Overall Study|Pregnancy|1|||
127521997|NCT00590577|458871568|FG002|Overall Study|Pregnancy|0|||
127521998|NCT00590577|458871569|FG003|Overall Study|Pregnancy|0|||
127521999|NCT00590577|458871566|FG000|Overall Study|Various reasons|1|||
127522000|NCT00590577|458871567|FG001|Overall Study|Various reasons|3|||
127522001|NCT00590577|458871568|FG002|Overall Study|Various reasons|1|||
127522002|NCT00590577|458871569|FG003|Overall Study|Various reasons|2|||
127522003|NCT00844558|458871570|FG000|Overall Study|Withdrawal by Subject|9|||
127522004|NCT00844558|458871571|FG001|Overall Study|Withdrawal by Subject|2|||
127522005|NCT00844558|458871570|FG000|Overall Study|Death|1|||
127522006|NCT00844558|458871571|FG001|Overall Study|Death|0|||
127522007|NCT00844558|458871570|FG000|Overall Study|Protocol Violation|1|||
127522008|NCT00844558|458871571|FG001|Overall Study|Protocol Violation|1|||
127522009|NCT00844558|458871570|FG000|Overall Study|Lost to Follow-up|0|||
127522010|NCT00844558|458871571|FG001|Overall Study|Lost to Follow-up|1|||
127522011|NCT00844558|458871570|FG000|Overall Study|Physician Decision|1|||
127522012|NCT00844558|458871571|FG001|Overall Study|Physician Decision|0|||
127522013|NCT04496453|458871585|FG000|Overall Study|Lost to Follow-up|6|||
127522014|NCT01887353|458871599|FG000|Overall Study|Study stopped early|4|||
127522015|NCT01887353|458871600|FG001|Overall Study|Study stopped early|3|||
127522016|NCT00699335|458871601|FG000|Overall Study|Combination of multiple reasons|176|||
127522017|NCT00699335|458871601|FG000|Overall Study|Missing data|52|||
127522018|NCT01069705|458871602|FG000|Overall Study|Adverse Event|1|||
127522019|NCT01069705|458871602|FG000|Overall Study|Withdrawal by Subject|2|||
127522020|NCT02726022|458871603|FG000|Overall Study|Adverse Event|14|||
127522021|NCT02726022|458871603|FG000|Overall Study|Treatment Failure|8|||
127522022|NCT02726022|458871603|FG000|Overall Study|Poor Compliance|13|||
127522023|NCT02726022|458871603|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
127522024|NCT02999633|458871604|FG000|Overall Study|Adverse Event|2|||
127522025|NCT02999633|458871604|FG000|Overall Study|Progressive disease|12|||
127522026|NCT03262441|458871605|FG000|Overall Study|Withdrawal by Subject|1|||
127522027|NCT01545050|458871606|FG000|Overall Study|Lack of Efficacy|0|||
127522028|NCT01545050|458871607|FG001|Overall Study|Lack of Efficacy|0|||
127522029|NCT01545050|458871608|FG002|Overall Study|Lack of Efficacy|0|||
127522030|NCT01545050|458871609|FG003|Overall Study|Lack of Efficacy|3|||
127522031|NCT01545050|458871610|FG004|Overall Study|Lack of Efficacy|2|||
127522032|NCT01545050|458871606|FG000|Overall Study|Adverse Event|1|||
127522033|NCT01545050|458871607|FG001|Overall Study|Adverse Event|1|||
127522034|NCT01545050|458871608|FG002|Overall Study|Adverse Event|2|||
127522035|NCT01545050|458871609|FG003|Overall Study|Adverse Event|2|||
127522036|NCT01545050|458871610|FG004|Overall Study|Adverse Event|0|||
127522037|NCT01545050|458871606|FG000|Overall Study|Discontinued study treatment|1|||
127522038|NCT01545050|458871607|FG001|Overall Study|Discontinued study treatment|0|||
127522039|NCT01545050|458871608|FG002|Overall Study|Discontinued study treatment|0|||
127522040|NCT01545050|458871609|FG003|Overall Study|Discontinued study treatment|0|||
127522041|NCT01545050|458871610|FG004|Overall Study|Discontinued study treatment|0|||
127522042|NCT01545050|458871606|FG000|Overall Study|Withdrawal by Subject|1|||
127522043|NCT01545050|458871607|FG001|Overall Study|Withdrawal by Subject|0|||
127522044|NCT01545050|458871608|FG002|Overall Study|Withdrawal by Subject|0|||
127522045|NCT01545050|458871609|FG003|Overall Study|Withdrawal by Subject|2|||
127522046|NCT01545050|458871610|FG004|Overall Study|Withdrawal by Subject|1|||
127522047|NCT01545050|458871606|FG000|Overall Study|Participant no longer meets study criteria|0|||
127522048|NCT01545050|458871607|FG001|Overall Study|Participant no longer meets study criteria|2|||
127522049|NCT01545050|458871608|FG002|Overall Study|Participant no longer meets study criteria|0|||
127522050|NCT01545050|458871609|FG003|Overall Study|Participant no longer meets study criteria|0|||
127522051|NCT01545050|458871610|FG004|Overall Study|Participant no longer meets study criteria|1|||
127522052|NCT01545050|458871606|FG000|Overall Study|Administrative reason by sponsor|4|||
127522053|NCT01545050|458871607|FG001|Overall Study|Administrative reason by sponsor|2|||
127522054|NCT01545050|458871608|FG002|Overall Study|Administrative reason by sponsor|3|||
127522055|NCT01545050|458871609|FG003|Overall Study|Administrative reason by sponsor|5|||
127522056|NCT01545050|458871610|FG004|Overall Study|Administrative reason by sponsor|5|||
127522057|NCT03235089|458871611|FG000|Overall Study|Lost to Follow-up|1|||
127522058|NCT03235089|458871612|FG001|Overall Study|Lost to Follow-up|1|||
127522059|NCT03235089|458871611|FG000|Overall Study|Physician Decision|2|||
127522060|NCT03235089|458871612|FG001|Overall Study|Physician Decision|2|||
127522061|NCT03238924|458871616|FG000|Overall Study|Withdrawal by Subject|2|||
127522062|NCT03238924|458871617|FG001|Overall Study|Withdrawal by Subject|2|||
127522063|NCT03576716|458871618|FG000|Overall Study|Withdrawal by Subject|0|||
127522064|NCT03576716|458871619|FG001|Overall Study|Withdrawal by Subject|1|||
127522065|NCT00559988|458871620|FG000|Overall Study|Death|147|||
127522066|NCT00559988|458871621|FG001|Overall Study|Death|140|||
127522067|NCT00559988|458871620|FG000|Overall Study|Withdrawal by Subject|152|||
127522068|NCT00559988|458871621|FG001|Overall Study|Withdrawal by Subject|139|||
127522069|NCT00559988|458871620|FG000|Overall Study|Lost to Follow-up|42|||
127522070|NCT00559988|458871621|FG001|Overall Study|Lost to Follow-up|56|||
127522071|NCT00559988|458871620|FG000|Overall Study|ICD device explanted|10|||
127522072|NCT00559988|458871621|FG001|Overall Study|ICD device explanted|17|||
127522073|NCT01455194|458871622|FG000|Overall Study|Screen Failure|20|||
127522074|NCT01455194|458871623|FG001|Overall Study|Screen Failure|0|||
127522075|NCT01455194|458871624|FG002|Overall Study|Screen Failure|0|||
127522076|NCT01455194|458871625|FG003|Overall Study|Screen Failure|0|||
127522077|NCT01455194|458871622|FG000|Overall Study|Randomisation Failure|90|||
127522078|NCT01455194|458871623|FG001|Overall Study|Randomisation Failure|0|||
127522079|NCT01455194|458871624|FG002|Overall Study|Randomisation Failure|0|||
127522080|NCT01455194|458871625|FG003|Overall Study|Randomisation Failure|0|||
127522081|NCT01455194|458871622|FG000|Overall Study|Deterioration in asthma|12|||
127522082|NCT01455194|458871623|FG001|Overall Study|Deterioration in asthma|6|||
127522083|NCT01455194|458871624|FG002|Overall Study|Deterioration in asthma|14|||
127522084|NCT01455194|458871625|FG003|Overall Study|Deterioration in asthma|9|||
127522085|NCT01455194|458871622|FG000|Overall Study|Adverse Event|1|||
127522086|NCT01455194|458871623|FG001|Overall Study|Adverse Event|1|||
127522087|NCT01455194|458871624|FG002|Overall Study|Adverse Event|1|||
127522088|NCT01455194|458871625|FG003|Overall Study|Adverse Event|3|||
127522089|NCT01455194|458871622|FG000|Overall Study|Withdrawal by Subject|21|||
127522090|NCT01455194|458871623|FG001|Overall Study|Withdrawal by Subject|16|||
127522091|NCT01455194|458871624|FG002|Overall Study|Withdrawal by Subject|12|||
127522092|NCT01455194|458871625|FG003|Overall Study|Withdrawal by Subject|9|||
127522093|NCT01455194|458871622|FG000|Overall Study|Lost to Follow-up|2|||
127522094|NCT01455194|458871623|FG001|Overall Study|Lost to Follow-up|0|||
127522095|NCT01455194|458871624|FG002|Overall Study|Lost to Follow-up|1|||
127522096|NCT01455194|458871625|FG003|Overall Study|Lost to Follow-up|1|||
127522097|NCT01455194|458871622|FG000|Overall Study|Pregnancy|0|||
127522098|NCT01455194|458871623|FG001|Overall Study|Pregnancy|1|||
127522099|NCT01455194|458871624|FG002|Overall Study|Pregnancy|1|||
127522100|NCT01455194|458871625|FG003|Overall Study|Pregnancy|0|||
127522101|NCT01455194|458871622|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
127522102|NCT01455194|458871623|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
127522103|NCT01455194|458871624|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
127522104|NCT01455194|458871625|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
127522105|NCT01455194|458871622|FG000|Overall Study|Miscellaneous|4|||
127522106|NCT01455194|458871623|FG001|Overall Study|Miscellaneous|5|||
127522107|NCT01455194|458871624|FG002|Overall Study|Miscellaneous|1|||
127522108|NCT01455194|458871625|FG003|Overall Study|Miscellaneous|4|||
127522109|NCT02249182|458871626|FG000|Treatment Phase|Lost to Follow-up|4|||
127522110|NCT02249182|458871627|FG001|Treatment Phase|Lost to Follow-up|0|||
127522111|NCT02249182|458871628|FG002|Treatment Phase|Lost to Follow-up|0|||
127522112|NCT02249182|458871629|FG003|Treatment Phase|Lost to Follow-up|0|||
127522113|NCT02249182|458871630|FG004|Treatment Phase|Lost to Follow-up|0|||
127522114|NCT00788710|458871633|FG000|Overall Study|Adverse Event|1|||
127522115|NCT00788710|458871634|FG001|Overall Study|Adverse Event|3|||
127522116|NCT00788710|458871635|FG002|Overall Study|Adverse Event|4|||
127522117|NCT00788710|458871633|FG000|Overall Study|Lack of Efficacy|0|||
127522118|NCT00788710|458871634|FG001|Overall Study|Lack of Efficacy|0|||
127522119|NCT00788710|458871635|FG002|Overall Study|Lack of Efficacy|1|||
127522120|NCT00788710|458871633|FG000|Overall Study|Lost to Follow-up|0|||
127522121|NCT00788710|458871634|FG001|Overall Study|Lost to Follow-up|1|||
127522122|NCT00788710|458871635|FG002|Overall Study|Lost to Follow-up|0|||
127522123|NCT00788710|458871633|FG000|Overall Study|Physician Decision|2|||
127522124|NCT00788710|458871634|FG001|Overall Study|Physician Decision|1|||
127522125|NCT00788710|458871635|FG002|Overall Study|Physician Decision|0|||
127522126|NCT00788710|458871633|FG000|Overall Study|Protocol Violation|0|||
127522127|NCT00788710|458871634|FG001|Overall Study|Protocol Violation|1|||
127522128|NCT00788710|458871635|FG002|Overall Study|Protocol Violation|1|||
127522129|NCT00788710|458871633|FG000|Overall Study|Withdrawal by Subject|2|||
127522130|NCT00788710|458871634|FG001|Overall Study|Withdrawal by Subject|2|||
127522131|NCT00788710|458871635|FG002|Overall Study|Withdrawal by Subject|0|||
127522132|NCT01717326|458871636|FG000|Overall Study|Death|0|||
127522133|NCT01717326|458871637|FG001|Overall Study|Death|0|||
127522134|NCT01717326|458871638|FG002|Overall Study|Death|0|||
127522135|NCT01717326|458871639|FG003|Overall Study|Death|0|||
127522136|NCT01717326|458871640|FG004|Overall Study|Death|0|||
127522137|NCT01717326|458871641|FG005|Overall Study|Death|0|||
127522138|NCT01717326|458871642|FG006|Overall Study|Death|0|||
127522139|NCT01717326|458871643|FG007|Overall Study|Death|0|||
127522140|NCT01717326|458871644|FG008|Overall Study|Death|0|||
127522141|NCT01717326|458871645|FG009|Overall Study|Death|0|||
127522142|NCT01717326|458871646|FG010|Overall Study|Death|1|||
127522143|NCT01717326|458871647|FG011|Overall Study|Death|0|||
127522144|NCT01717326|458871648|FG012|Overall Study|Death|0|||
127522145|NCT01717326|458871649|FG013|Overall Study|Death|0|||
127522146|NCT01717326|458871650|FG014|Overall Study|Death|0|||
127522147|NCT01717326|458871651|FG015|Overall Study|Death|0|||
127522148|NCT01717326|458871652|FG016|Overall Study|Death|0|||
127522149|NCT01717326|458871653|FG017|Overall Study|Death|0|||
127522150|NCT01717326|458871654|FG018|Overall Study|Death|0|||
127522151|NCT01717326|458871655|FG019|Overall Study|Death|0|||
127522152|NCT01717326|458871636|FG000|Overall Study|Lost to Follow-up|3|||
127522153|NCT01717326|458871637|FG001|Overall Study|Lost to Follow-up|0|||
127522154|NCT01717326|458871638|FG002|Overall Study|Lost to Follow-up|0|||
127522155|NCT01717326|458871639|FG003|Overall Study|Lost to Follow-up|2|||
127522156|NCT01717326|458871640|FG004|Overall Study|Lost to Follow-up|1|||
127522157|NCT01717326|458871641|FG005|Overall Study|Lost to Follow-up|0|||
127522158|NCT01717326|458871642|FG006|Overall Study|Lost to Follow-up|1|||
127522159|NCT01717326|458871643|FG007|Overall Study|Lost to Follow-up|0|||
127522160|NCT01717326|458871644|FG008|Overall Study|Lost to Follow-up|0|||
127522161|NCT01717326|458871645|FG009|Overall Study|Lost to Follow-up|0|||
127522162|NCT01717326|458871646|FG010|Overall Study|Lost to Follow-up|1|||
127522163|NCT01717326|458871647|FG011|Overall Study|Lost to Follow-up|0|||
127522164|NCT01717326|458871648|FG012|Overall Study|Lost to Follow-up|0|||
127522165|NCT01717326|458871649|FG013|Overall Study|Lost to Follow-up|0|||
127522166|NCT01717326|458871650|FG014|Overall Study|Lost to Follow-up|0|||
127522167|NCT01717326|458871651|FG015|Overall Study|Lost to Follow-up|2|||
127522168|NCT01717326|458871652|FG016|Overall Study|Lost to Follow-up|1|||
127522169|NCT01717326|458871653|FG017|Overall Study|Lost to Follow-up|0|||
127522170|NCT01717326|458871654|FG018|Overall Study|Lost to Follow-up|2|||
127522171|NCT01717326|458871655|FG019|Overall Study|Lost to Follow-up|3|||
127522172|NCT01717326|458871636|FG000|Overall Study|Physician Decision|0|||
127522173|NCT01717326|458871637|FG001|Overall Study|Physician Decision|0|||
127522174|NCT01717326|458871638|FG002|Overall Study|Physician Decision|0|||
127522175|NCT01717326|458871639|FG003|Overall Study|Physician Decision|0|||
127522176|NCT01717326|458871640|FG004|Overall Study|Physician Decision|0|||
127522177|NCT01717326|458871641|FG005|Overall Study|Physician Decision|0|||
127522178|NCT01717326|458871642|FG006|Overall Study|Physician Decision|0|||
127522179|NCT01717326|458871643|FG007|Overall Study|Physician Decision|0|||
127522180|NCT01717326|458871644|FG008|Overall Study|Physician Decision|0|||
127522181|NCT01717326|458871645|FG009|Overall Study|Physician Decision|1|||
127522182|NCT01717326|458871646|FG010|Overall Study|Physician Decision|0|||
127522183|NCT01717326|458871647|FG011|Overall Study|Physician Decision|0|||
127522184|NCT01717326|458871648|FG012|Overall Study|Physician Decision|0|||
127522185|NCT01717326|458871649|FG013|Overall Study|Physician Decision|0|||
127522186|NCT01717326|458871650|FG014|Overall Study|Physician Decision|0|||
127522187|NCT01717326|458871651|FG015|Overall Study|Physician Decision|0|||
127522188|NCT01717326|458871652|FG016|Overall Study|Physician Decision|0|||
127522189|NCT01717326|458871653|FG017|Overall Study|Physician Decision|0|||
127522190|NCT01717326|458871654|FG018|Overall Study|Physician Decision|0|||
127522191|NCT01717326|458871655|FG019|Overall Study|Physician Decision|0|||
127522192|NCT01717326|458871636|FG000|Overall Study|Protocol Violation|0|||
127522193|NCT01717326|458871637|FG001|Overall Study|Protocol Violation|0|||
127522194|NCT01717326|458871638|FG002|Overall Study|Protocol Violation|0|||
127522195|NCT01717326|458871639|FG003|Overall Study|Protocol Violation|0|||
127522196|NCT01717326|458871640|FG004|Overall Study|Protocol Violation|1|||
127522197|NCT01717326|458871641|FG005|Overall Study|Protocol Violation|0|||
127522198|NCT01717326|458871642|FG006|Overall Study|Protocol Violation|0|||
127522199|NCT01717326|458871643|FG007|Overall Study|Protocol Violation|0|||
127522200|NCT01717326|458871644|FG008|Overall Study|Protocol Violation|0|||
127522201|NCT01717326|458871645|FG009|Overall Study|Protocol Violation|0|||
127522202|NCT01717326|458871646|FG010|Overall Study|Protocol Violation|0|||
127522203|NCT01717326|458871647|FG011|Overall Study|Protocol Violation|0|||
127522204|NCT01717326|458871648|FG012|Overall Study|Protocol Violation|0|||
127522205|NCT01717326|458871649|FG013|Overall Study|Protocol Violation|0|||
127522206|NCT01717326|458871650|FG014|Overall Study|Protocol Violation|0|||
127522207|NCT01717326|458871651|FG015|Overall Study|Protocol Violation|0|||
127522208|NCT01717326|458871652|FG016|Overall Study|Protocol Violation|0|||
127522209|NCT01717326|458871653|FG017|Overall Study|Protocol Violation|0|||
127522210|NCT01717326|458871654|FG018|Overall Study|Protocol Violation|0|||
127522211|NCT01717326|458871655|FG019|Overall Study|Protocol Violation|0|||
127522212|NCT01717326|458871636|FG000|Overall Study|Withdrawal by Subject|0|||
127522213|NCT01717326|458871637|FG001|Overall Study|Withdrawal by Subject|1|||
127522214|NCT01717326|458871638|FG002|Overall Study|Withdrawal by Subject|0|||
127522215|NCT01717326|458871639|FG003|Overall Study|Withdrawal by Subject|0|||
127522216|NCT01717326|458871640|FG004|Overall Study|Withdrawal by Subject|0|||
127522217|NCT01717326|458871641|FG005|Overall Study|Withdrawal by Subject|0|||
127522218|NCT01717326|458871642|FG006|Overall Study|Withdrawal by Subject|0|||
127522219|NCT01717326|458871643|FG007|Overall Study|Withdrawal by Subject|0|||
127522220|NCT01717326|458871644|FG008|Overall Study|Withdrawal by Subject|0|||
127522221|NCT01717326|458871645|FG009|Overall Study|Withdrawal by Subject|1|||
127522222|NCT01717326|458871646|FG010|Overall Study|Withdrawal by Subject|0|||
127522223|NCT01717326|458871647|FG011|Overall Study|Withdrawal by Subject|0|||
127522224|NCT01717326|458871648|FG012|Overall Study|Withdrawal by Subject|1|||
127522225|NCT01717326|458871649|FG013|Overall Study|Withdrawal by Subject|0|||
127522226|NCT01717326|458871650|FG014|Overall Study|Withdrawal by Subject|0|||
127522227|NCT01717326|458871651|FG015|Overall Study|Withdrawal by Subject|1|||
127522228|NCT01717326|458871652|FG016|Overall Study|Withdrawal by Subject|0|||
127522229|NCT01717326|458871653|FG017|Overall Study|Withdrawal by Subject|0|||
127522230|NCT01717326|458871654|FG018|Overall Study|Withdrawal by Subject|2|||
127522231|NCT01717326|458871655|FG019|Overall Study|Withdrawal by Subject|3|||
127522232|NCT00605345|458871656|FG000|Overall Study|Withdrawal by Subject|1|||
127522233|NCT00605345|458871657|FG001|Overall Study|Withdrawal by Subject|0|||
127522234|NCT00605345|458871656|FG000|Overall Study|Adverse Event|0|||
127522235|NCT00605345|458871657|FG001|Overall Study|Adverse Event|1|||
127522236|NCT00605345|458871656|FG000|Overall Study|Protocol Violation|0|||
127522237|NCT00605345|458871657|FG001|Overall Study|Protocol Violation|2|||
127522238|NCT02596945|458871658|FG000|Overall Study|No documentation of study drug dosing|3|||
127522239|NCT02596945|458871658|FG000|Overall Study|Other|32|||
127522240|NCT02596945|458871658|FG000|Overall Study|Change to hemodialysis|15|||
127522241|NCT02596945|458871658|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
127522242|NCT02596945|458871658|FG000|Overall Study|Withdrawal by Subject|1|||
127522243|NCT02596945|458871658|FG000|Overall Study|Missing|1|||
127522244|NCT01769196|458873806|FG000|Overall Study|Adverse Event|24|||
127522245|NCT01769196|458873807|FG001|Overall Study|Adverse Event|20|||
127522246|NCT01769196|458873806|FG000|Overall Study|Death|21|||
127522247|NCT01769196|458873807|FG001|Overall Study|Death|26|||
127522248|NCT01769196|458873806|FG000|Overall Study|Investigator Discretion|7|||
127522249|NCT01769196|458873807|FG001|Overall Study|Investigator Discretion|3|||
127522250|NCT01769196|458873806|FG000|Overall Study|Lack of Efficacy|3|||
127522251|NCT01769196|458873807|FG001|Overall Study|Lack of Efficacy|2|||
127522252|NCT01769196|458873806|FG000|Overall Study|Progressive disease|11|||
127522253|NCT01769196|458873807|FG001|Overall Study|Progressive disease|6|||
127522254|NCT01769196|458873806|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
127522255|NCT01769196|458873807|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
127522256|NCT01769196|458873806|FG000|Overall Study|Protocol Violation|0|||
127522257|NCT01769196|458873807|FG001|Overall Study|Protocol Violation|3|||
127522258|NCT01769196|458873806|FG000|Overall Study|Study terminated by sponsor|160|||
127522259|NCT01769196|458873807|FG001|Overall Study|Study terminated by sponsor|161|||
127522260|NCT01769196|458873806|FG000|Overall Study|Participant never dosed with study drug|1|||
127522261|NCT01769196|458873807|FG001|Overall Study|Participant never dosed with study drug|0|||
127522262|NCT01769196|458873806|FG000|Overall Study|Withdrew consent|36|||
127522263|NCT01769196|458873807|FG001|Overall Study|Withdrew consent|40|||
127522264|NCT00655629|458873810|FG000|Overall Study|Adverse Event|4|||
127522265|NCT00655629|458873811|FG001|Overall Study|Adverse Event|1|||
127522266|NCT00655629|458873810|FG000|Overall Study|Lack of Efficacy|2|||
127522267|NCT00655629|458873811|FG001|Overall Study|Lack of Efficacy|12|||
127522268|NCT00655629|458873810|FG000|Overall Study|Lost to Follow-up|4|||
127522269|NCT00655629|458873811|FG001|Overall Study|Lost to Follow-up|3|||
127522270|NCT00655629|458873810|FG000|Overall Study|Protocol Violation|5|||
127522271|NCT00655629|458873811|FG001|Overall Study|Protocol Violation|3|||
127522272|NCT00655629|458873810|FG000|Overall Study|consent withdrawn|6|||
127522273|NCT00655629|458873811|FG001|Overall Study|consent withdrawn|4|||
127522274|NCT00705367|458873812|FG000|Long-term Extension Period|Adverse Event|2|||
127522275|NCT00705367|458873813|FG001|Long-term Extension Period|Adverse Event|0|||
127522276|NCT00705367|458873812|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
127522277|NCT00705367|458873813|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
127522278|NCT00705367|458873812|FG000|Long-term Extension Period|Lack of Efficacy|1|||
127522279|NCT00705367|458873813|FG001|Long-term Extension Period|Lack of Efficacy|0|||
127522280|NCT00705367|458873812|FG000|Long-term Extension Period|No longer met study criteria|1|||
127522281|NCT00705367|458873813|FG001|Long-term Extension Period|No longer met study criteria|0|||
127522282|NCT00705367|458873812|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
127522283|NCT00705367|458873813|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
127522284|NCT00098306|458873818|FG000|Double Blind|Randomized, not treated|9|||
127522285|NCT00098306|458873819|FG001|Double Blind|Randomized, not treated|5|||
127522286|NCT00098306|458873820|FG002|Double Blind|Randomized, not treated|2|||
127522287|NCT00098306|458873821|FG003|Double Blind|Randomized, not treated|0|||
127522288|NCT00098306|458873822|FG004|Double Blind|Randomized, not treated|0|||
127522289|NCT00098306|458873823|FG005|Double Blind|Randomized, not treated|0|||
127522290|NCT00098306|458873824|FG006|Double Blind|Randomized, not treated|0|||
127522291|NCT00098306|458873818|FG000|Double Blind|Ongoing at cut-off date|151|||
127522292|NCT00098306|458873819|FG001|Double Blind|Ongoing at cut-off date|166|||
127522293|NCT00098306|458873820|FG002|Double Blind|Ongoing at cut-off date|72|||
127522294|NCT00098306|458873821|FG003|Double Blind|Ongoing at cut-off date|0|||
127522295|NCT00098306|458873822|FG004|Double Blind|Ongoing at cut-off date|0|||
127522296|NCT00098306|458873823|FG005|Double Blind|Ongoing at cut-off date|0|||
127522297|NCT00098306|458873824|FG006|Double Blind|Ongoing at cut-off date|0|||
127522298|NCT00098306|458873818|FG000|Double Blind|Adverse Event|11|||
127522299|NCT00098306|458873819|FG001|Double Blind|Adverse Event|10|||
127522300|NCT00098306|458873820|FG002|Double Blind|Adverse Event|6|||
127522301|NCT00098306|458873821|FG003|Double Blind|Adverse Event|0|||
127522302|NCT00098306|458873822|FG004|Double Blind|Adverse Event|0|||
127522303|NCT00098306|458873823|FG005|Double Blind|Adverse Event|0|||
127522304|NCT00098306|458873824|FG006|Double Blind|Adverse Event|0|||
127522305|NCT00098306|458873818|FG000|Double Blind|Lack of Efficacy|43|||
127522306|NCT00098306|458873819|FG001|Double Blind|Lack of Efficacy|34|||
127522307|NCT00098306|458873820|FG002|Double Blind|Lack of Efficacy|17|||
127522308|NCT00098306|458873821|FG003|Double Blind|Lack of Efficacy|0|||
127522309|NCT00098306|458873822|FG004|Double Blind|Lack of Efficacy|0|||
127522310|NCT00098306|458873823|FG005|Double Blind|Lack of Efficacy|0|||
127522311|NCT00098306|458873824|FG006|Double Blind|Lack of Efficacy|0|||
127522312|NCT00098306|458873818|FG000|Double Blind|Death|1|||
127522313|NCT00098306|458873819|FG001|Double Blind|Death|4|||
127522314|NCT00098306|458873820|FG002|Double Blind|Death|1|||
127522315|NCT00098306|458873821|FG003|Double Blind|Death|0|||
127522316|NCT00098306|458873822|FG004|Double Blind|Death|0|||
127522317|NCT00098306|458873823|FG005|Double Blind|Death|0|||
127522318|NCT00098306|458873824|FG006|Double Blind|Death|0|||
127522319|NCT00098306|458873818|FG000|Double Blind|Participant defaulted|19|||
127522320|NCT00098306|458873819|FG001|Double Blind|Participant defaulted|18|||
127522321|NCT00098306|458873820|FG002|Double Blind|Participant defaulted|11|||
127522322|NCT00098306|458873821|FG003|Double Blind|Participant defaulted|0|||
127522323|NCT00098306|458873822|FG004|Double Blind|Participant defaulted|0|||
127522324|NCT00098306|458873823|FG005|Double Blind|Participant defaulted|0|||
127522325|NCT00098306|458873824|FG006|Double Blind|Participant defaulted|0|||
127522326|NCT00098306|458873818|FG000|Double Blind|Un-specified|7|||
127522327|NCT00098306|458873819|FG001|Double Blind|Un-specified|3|||
127522328|NCT00098306|458873820|FG002|Double Blind|Un-specified|11|||
127522329|NCT00098306|458873821|FG003|Double Blind|Un-specified|0|||
127522330|NCT00098306|458873822|FG004|Double Blind|Un-specified|0|||
127522331|NCT00098306|458873823|FG005|Double Blind|Un-specified|0|||
127522332|NCT00098306|458873824|FG006|Double Blind|Un-specified|0|||
127522333|NCT00098306|458873818|FG000|Open Label|Lack of Efficacy|0|||
127522334|NCT00098306|458873819|FG001|Open Label|Lack of Efficacy|0|||
127522335|NCT00098306|458873820|FG002|Open Label|Lack of Efficacy|0|||
127522336|NCT00098306|458873821|FG003|Open Label|Lack of Efficacy|13|||
127522337|NCT00098306|458873822|FG004|Open Label|Lack of Efficacy|0|||
127522338|NCT00098306|458873823|FG005|Open Label|Lack of Efficacy|0|||
127522339|NCT00098306|458873824|FG006|Open Label|Lack of Efficacy|0|||
127522340|NCT00098306|458873818|FG000|Open Label|Adverse Event|0|||
127522341|NCT00098306|458873819|FG001|Open Label|Adverse Event|0|||
127522342|NCT00098306|458873820|FG002|Open Label|Adverse Event|0|||
127522343|NCT00098306|458873821|FG003|Open Label|Adverse Event|2|||
127522344|NCT00098306|458873822|FG004|Open Label|Adverse Event|0|||
127522345|NCT00098306|458873823|FG005|Open Label|Adverse Event|0|||
127522346|NCT00098306|458873824|FG006|Open Label|Adverse Event|0|||
127522347|NCT00098306|458873818|FG000|Open Label|Death|0|||
127522348|NCT00098306|458873819|FG001|Open Label|Death|0|||
127522349|NCT00098306|458873820|FG002|Open Label|Death|0|||
127522350|NCT00098306|458873821|FG003|Open Label|Death|4|||
127522351|NCT00098306|458873822|FG004|Open Label|Death|0|||
127522352|NCT00098306|458873823|FG005|Open Label|Death|0|||
127522353|NCT00098306|458873824|FG006|Open Label|Death|0|||
127522354|NCT00098306|458873818|FG000|Open Label|Participant defaulted|0|||
127522355|NCT00098306|458873819|FG001|Open Label|Participant defaulted|0|||
127522356|NCT00098306|458873820|FG002|Open Label|Participant defaulted|0|||
127522357|NCT00098306|458873821|FG003|Open Label|Participant defaulted|24|||
127522358|NCT00098306|458873822|FG004|Open Label|Participant defaulted|0|||
127522359|NCT00098306|458873823|FG005|Open Label|Participant defaulted|0|||
127522360|NCT00098306|458873824|FG006|Open Label|Participant defaulted|0|||
127522361|NCT00098306|458873818|FG000|Open Label|Un-specified|0|||
127522362|NCT00098306|458873819|FG001|Open Label|Un-specified|0|||
127522363|NCT00098306|458873820|FG002|Open Label|Un-specified|0|||
127522364|NCT00098306|458873821|FG003|Open Label|Un-specified|15|||
127522365|NCT00098306|458873822|FG004|Open Label|Un-specified|0|||
127522366|NCT00098306|458873823|FG005|Open Label|Un-specified|0|||
127522367|NCT00098306|458873824|FG006|Open Label|Un-specified|0|||
127522368|NCT00098306|458873818|FG000|Open Label|Ongoing at cut-off date|0|||
127522369|NCT00098306|458873819|FG001|Open Label|Ongoing at cut-off date|0|||
127522370|NCT00098306|458873820|FG002|Open Label|Ongoing at cut-off date|0|||
127522371|NCT00098306|458873821|FG003|Open Label|Ongoing at cut-off date|269|||
127522372|NCT00098306|458873822|FG004|Open Label|Ongoing at cut-off date|62|||
127522373|NCT00098306|458873823|FG005|Open Label|Ongoing at cut-off date|0|||
127522374|NCT00098306|458873824|FG006|Open Label|Ongoing at cut-off date|0|||
127522375|NCT00098306|458873818|FG000|Observational Phase|Death|0|||
127522376|NCT00098306|458873819|FG001|Observational Phase|Death|0|||
127522377|NCT00098306|458873820|FG002|Observational Phase|Death|0|||
127522378|NCT00098306|458873821|FG003|Observational Phase|Death|0|||
127522379|NCT00098306|458873822|FG004|Observational Phase|Death|0|||
127522380|NCT00098306|458873823|FG005|Observational Phase|Death|5|||
127522381|NCT00098306|458873824|FG006|Observational Phase|Death|4|||
127522382|NCT00098306|458873818|FG000|Observational Phase|Participant defaulted|0|||
127522383|NCT00098306|458873819|FG001|Observational Phase|Participant defaulted|0|||
127522384|NCT00098306|458873820|FG002|Observational Phase|Participant defaulted|0|||
127522385|NCT00098306|458873821|FG003|Observational Phase|Participant defaulted|0|||
127522386|NCT00098306|458873822|FG004|Observational Phase|Participant defaulted|0|||
127522387|NCT00098306|458873823|FG005|Observational Phase|Participant defaulted|34|||
127522388|NCT00098306|458873824|FG006|Observational Phase|Participant defaulted|18|||
127522389|NCT00098306|458873818|FG000|Observational Phase|Un-specified|0|||
127522390|NCT00098306|458873819|FG001|Observational Phase|Un-specified|0|||
127522391|NCT00098306|458873820|FG002|Observational Phase|Un-specified|0|||
127522392|NCT00098306|458873821|FG003|Observational Phase|Un-specified|0|||
127522393|NCT00098306|458873822|FG004|Observational Phase|Un-specified|0|||
127522394|NCT00098306|458873823|FG005|Observational Phase|Un-specified|7|||
127522395|NCT00098306|458873824|FG006|Observational Phase|Un-specified|4|||
127522396|NCT02760810|458873825|FG000|Overall Study|Protocol Violation|1|||
127522397|NCT05096312|458873826|FG000|Overall Study|Lost to Follow-up|2|||
127522398|NCT05096312|458873827|FG001|Overall Study|Lost to Follow-up|4|||
127522399|NCT05096312|458873826|FG000|Overall Study|Adverse Event|1|||
127522400|NCT05096312|458873827|FG001|Overall Study|Adverse Event|0|||
127522401|NCT03135210|458873828|FG000|Overall Study|Death|0|||
127522402|NCT03135210|458873829|FG001|Overall Study|Death|1|||
127522403|NCT00820222|458873831|FG000|Overall Study|Lost to Follow-up|10|||
127522404|NCT00820222|458873832|FG001|Overall Study|Lost to Follow-up|9|||
127522405|NCT00820222|458873831|FG000|Overall Study|Withdrawal by Subject|19|||
127522406|NCT00820222|458873832|FG001|Overall Study|Withdrawal by Subject|21|||
127522407|NCT00820222|458873831|FG000|Overall Study|Physician Decision|93|||
127522408|NCT00820222|458873832|FG001|Overall Study|Physician Decision|88|||
127522409|NCT00820222|458873831|FG000|Overall Study|Sponsor Terminated Study|43|||
127522410|NCT00820222|458873832|FG001|Overall Study|Sponsor Terminated Study|65|||
127522411|NCT00820222|458873831|FG000|Overall Study|Unkown|11|||
127522412|NCT00820222|458873832|FG001|Overall Study|Unkown|7|||
127522413|NCT00932165|458873833|FG000|Overall Study|Lost to Follow-up|1|||
127522414|NCT00588094|458873834|FG000|Overall Study|Adverse Event|3|||
127522415|NCT00588094|458873834|FG000|Overall Study|Progression of Disease|2|||
127522416|NCT01336023|458873835|FG000|Week 0 to Week 26|Adverse Event|8|||
127522417|NCT01336023|458873836|FG001|Week 0 to Week 26|Adverse Event|10|||
127522418|NCT01336023|458873837|FG002|Week 0 to Week 26|Adverse Event|24|||
127522419|NCT01336023|458873835|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
127522420|NCT01336023|458873836|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
127522421|NCT01336023|458873837|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
127522422|NCT01336023|458873835|FG000|Week 0 to Week 26|Protocol Violation|1|||
127522423|NCT01336023|458873836|FG001|Week 0 to Week 26|Protocol Violation|2|||
127522424|NCT01336023|458873837|FG002|Week 0 to Week 26|Protocol Violation|0|||
127522425|NCT01336023|458873835|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
127522426|NCT01336023|458873836|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
127522427|NCT01336023|458873837|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
127522428|NCT01336023|458873835|FG000|Week 0 to Week 26|Unclassified|5|||
127522429|NCT01336023|458873836|FG001|Week 0 to Week 26|Unclassified|16|||
127522430|NCT01336023|458873837|FG002|Week 0 to Week 26|Unclassified|9|||
127522431|NCT01336023|458873835|FG000|Week 27 to 52|Adverse Event|1|||
127522432|NCT01336023|458873836|FG001|Week 27 to 52|Adverse Event|5|||
127522433|NCT01336023|458873837|FG002|Week 27 to 52|Adverse Event|2|||
127522434|NCT01336023|458873835|FG000|Week 27 to 52|Protocol Violation|0|||
127522435|NCT01336023|458873836|FG001|Week 27 to 52|Protocol Violation|2|||
127522436|NCT01336023|458873837|FG002|Week 27 to 52|Protocol Violation|1|||
127522437|NCT01336023|458873835|FG000|Week 27 to 52|Withdrawal Criteria|14|||
127522438|NCT01336023|458873836|FG001|Week 27 to 52|Withdrawal Criteria|19|||
127522439|NCT01336023|458873837|FG002|Week 27 to 52|Withdrawal Criteria|16|||
127522440|NCT01336023|458873835|FG000|Week 27 to 52|Unclassified|13|||
127522441|NCT01336023|458873836|FG001|Week 27 to 52|Unclassified|18|||
127522442|NCT01336023|458873837|FG002|Week 27 to 52|Unclassified|9|||
127522443|NCT00391625|458873843|FG000|Month 14|Withdrawal by Subject|1|||
127522444|NCT00391625|458873843|FG000|Month 50|Physician Decision|1|||
127522445|NCT03997825|458873844|FG000|Overall Study|Death|3|||
127522446|NCT03997825|458873844|FG000|Overall Study|Lost to Follow-up|10|||
127522447|NCT03997825|458873844|FG000|Overall Study|Withdrawal by Subject|3|||
127522448|NCT03997825|458873844|FG000|Overall Study|Refused participation|1|||
127522449|NCT01361178|458873845|FG000|Overall Study|Death|13|||
127522450|NCT01361178|458873846|FG001|Overall Study|Death|0|||
127522451|NCT00383162|458873847|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
127522452|NCT00383162|458873848|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
127522453|NCT00383162|458873847|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
127522454|NCT00383162|458873848|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
127522455|NCT00383162|458873847|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
127522456|NCT00383162|458873848|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
127522457|NCT00383162|458873847|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
127522458|NCT00383162|458873848|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
127522459|NCT00383162|458873847|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
127522460|NCT00383162|458873848|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
127522461|NCT00383162|458873847|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
127522462|NCT00383162|458873848|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
127522463|NCT00383162|458873847|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
127522464|NCT00383162|458873848|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
127522465|NCT00383162|458873847|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
127522466|NCT00383162|458873848|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
127522467|NCT00383162|458873847|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
127522468|NCT00383162|458873848|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
127522469|NCT00767819|458873849|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
127522470|NCT00767819|458873850|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
127522471|NCT00767819|458873851|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
127522472|NCT00767819|458873849|FG000|Overall Study|Withdrawal by Subject|1|||
127522473|NCT00767819|458873850|FG001|Overall Study|Withdrawal by Subject|1|||
127522474|NCT00767819|458873851|FG002|Overall Study|Withdrawal by Subject|0|||
127522475|NCT00767819|458873849|FG000|Overall Study|Administrative problems|0|||
127522476|NCT00767819|458873850|FG001|Overall Study|Administrative problems|1|||
127522477|NCT00767819|458873851|FG002|Overall Study|Administrative problems|0|||
127522478|NCT00767819|458873849|FG000|Overall Study|Death|2|||
127522479|NCT00767819|458873850|FG001|Overall Study|Death|3|||
127522480|NCT00767819|458873851|FG002|Overall Study|Death|0|||
127522481|NCT00767819|458873849|FG000|Overall Study|Adverse Event|2|||
127522482|NCT00767819|458873850|FG001|Overall Study|Adverse Event|0|||
127522483|NCT00767819|458873851|FG002|Overall Study|Adverse Event|0|||
127522484|NCT00767819|458873849|FG000|Overall Study|Abnormal lab values|1|||
127522485|NCT00767819|458873850|FG001|Overall Study|Abnormal lab values|0|||
127522486|NCT00767819|458873851|FG002|Overall Study|Abnormal lab values|0|||
127522487|NCT00767819|458873849|FG000|Overall Study|Lost to Follow-up|1|||
127522488|NCT00767819|458873850|FG001|Overall Study|Lost to Follow-up|0|||
127522489|NCT00767819|458873851|FG002|Overall Study|Lost to Follow-up|0|||
127522490|NCT05392803|458873852|FG000|Overall Study|Lost to Follow-up|0|||
127522491|NCT05392803|458873853|FG001|Overall Study|Lost to Follow-up|2|||
127522492|NCT04294147|458873854|FG000|Overall Study|Protocol Violation|2|||
127522493|NCT04294147|458873855|FG001|Overall Study|Protocol Violation|0|||
127522494|NCT00915551|458873856|FG000|Overall Study|Withdrawal by Subject|0|||
127522495|NCT00915551|458873857|FG001|Overall Study|Withdrawal by Subject|1|||
127522496|NCT00235716|458873858|FG000|Overall Study|Death|26|||
127522497|NCT00235716|458873859|FG001|Overall Study|Death|39|||
127522498|NCT00235716|458873860|FG002|Overall Study|Death|32|||
127522499|NCT00235716|458873861|FG003|Overall Study|Death|31|||
127522500|NCT00235716|458873858|FG000|Overall Study|Withdrawal by Subject|23|||
127522501|NCT00235716|458873859|FG001|Overall Study|Withdrawal by Subject|19|||
127522502|NCT00235716|458873860|FG002|Overall Study|Withdrawal by Subject|17|||
127522503|NCT00235716|458873861|FG003|Overall Study|Withdrawal by Subject|18|||
127522504|NCT00235716|458873858|FG000|Overall Study|Lost to Follow-up|12|||
127522505|NCT00235716|458873859|FG001|Overall Study|Lost to Follow-up|7|||
127522506|NCT00235716|458873860|FG002|Overall Study|Lost to Follow-up|14|||
127522507|NCT00235716|458873861|FG003|Overall Study|Lost to Follow-up|10|||
127522508|NCT00235716|458873858|FG000|Overall Study|Adverse Event|1|||
127522509|NCT00235716|458873859|FG001|Overall Study|Adverse Event|1|||
127522510|NCT00235716|458873860|FG002|Overall Study|Adverse Event|1|||
127522511|NCT00235716|458873861|FG003|Overall Study|Adverse Event|0|||
127522512|NCT00235716|458873858|FG000|Overall Study|Physician Decision|0|||
127522513|NCT00235716|458873859|FG001|Overall Study|Physician Decision|1|||
127522514|NCT00235716|458873860|FG002|Overall Study|Physician Decision|1|||
127522515|NCT00235716|458873861|FG003|Overall Study|Physician Decision|3|||
127522516|NCT04390841|458873862|FG000|Overall Study|Withdrawal by Subject|2|||
127522517|NCT02188849|458873873|FG000|Overall Study|Lost to Follow-up|3|||
127522518|NCT02188849|458873874|FG001|Overall Study|Lost to Follow-up|8|||
127522519|NCT02516228|458873877|FG000|Overall Study|Lost to Follow-up|1|||
127522520|NCT02516228|458873877|FG000|Overall Study|Withdrawal by Subject|1|||
127522521|NCT02516228|458873877|FG000|Overall Study|Physician Decision|1|||
127522522|NCT03916484|458873880|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
127522523|NCT03916484|458873881|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
127522524|NCT03916484|458873882|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
127522525|NCT03916484|458873883|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
127522526|NCT03916484|458873880|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
127522527|NCT03916484|458873881|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
127522528|NCT03916484|458873882|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
127522529|NCT03916484|458873883|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
127522530|NCT00504894|458873890|FG000|Overall Study|fMRI technical problems|1|||
127522531|NCT00504894|458873891|FG001|Overall Study|fMRI technical problems|1|||
127522532|NCT00504894|458873892|FG002|Overall Study|fMRI technical problems|0|||
127522533|NCT00504894|458873890|FG000|Overall Study|Withdrawal by Subject|0|||
127522534|NCT00504894|458873891|FG001|Overall Study|Withdrawal by Subject|1|||
127522535|NCT00504894|458873892|FG002|Overall Study|Withdrawal by Subject|0|||
127522536|NCT00504894|458873890|FG000|Overall Study|Infusion technical problems|0|||
127522537|NCT00504894|458873891|FG001|Overall Study|Infusion technical problems|1|||
127522538|NCT00504894|458873892|FG002|Overall Study|Infusion technical problems|0|||
127522539|NCT00504894|458873890|FG000|Overall Study|poor subject data|2|||
127522540|NCT00504894|458873891|FG001|Overall Study|poor subject data|0|||
127522541|NCT00504894|458873892|FG002|Overall Study|poor subject data|0|||
127522542|NCT01196416|458873893|FG000|Overall Study|Withdrawal by Subject|2|||
127522543|NCT02673684|458873894|FG000|Overall Study|Study not completed d/t loss of funding|9|||
127522544|NCT02673684|458873895|FG001|Overall Study|Study not completed d/t loss of funding|8|||
127522545|NCT01092663|458873896|FG000|Overall Study|Withdrawal by Subject|3|||
127522546|NCT01092663|458873897|FG001|Overall Study|Withdrawal by Subject|2|||
127522547|NCT01092663|458873896|FG000|Overall Study|Glucose >300mg/dL|1|||
127522548|NCT01092663|458873897|FG001|Overall Study|Glucose >300mg/dL|0|||
127522549|NCT01092663|458873896|FG000|Overall Study|High fasting triglyceride|2|||
127522550|NCT01092663|458873897|FG001|Overall Study|High fasting triglyceride|0|||
127522551|NCT01092663|458873896|FG000|Overall Study|Adverse Event|1|||
127522552|NCT01092663|458873897|FG001|Overall Study|Adverse Event|1|||
127522553|NCT01092663|458873896|FG000|Overall Study|Protocol Violation|0|||
127522554|NCT01092663|458873897|FG001|Overall Study|Protocol Violation|1|||
127522555|NCT03688620|458873898|FG000|Overall Study|Other|0|||
127522556|NCT03688620|458873899|FG001|Overall Study|Other|0|||
127522557|NCT03688620|458873900|FG002|Overall Study|Other|1|||
127522558|NCT03688620|458873898|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
127522559|NCT03688620|458873899|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
127522560|NCT03688620|458873900|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
127522561|NCT03688620|458873898|FG000|Overall Study|Lost to Follow-up|16|||
127522562|NCT03688620|458873899|FG001|Overall Study|Lost to Follow-up|0|||
127522563|NCT03688620|458873900|FG002|Overall Study|Lost to Follow-up|1|||
127522564|NCT03688620|458873898|FG000|Overall Study|Withdrawal by Subject|0|||
127522565|NCT03688620|458873899|FG001|Overall Study|Withdrawal by Subject|0|||
127522566|NCT03688620|458873900|FG002|Overall Study|Withdrawal by Subject|6|||
127522567|NCT01008904|458873901|FG000|Overall Study|Lost to Follow-up|1|||
127522568|NCT01008904|458873901|FG000|Overall Study|Adverse Event|2|||
127522569|NCT01008904|458873901|FG000|Overall Study|unexpected unrelated surgery|1|||
127522570|NCT01183065|458873902|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
127522571|NCT02456857|458873903|FG000|Overall Study|Disease Progression|4|||
127522572|NCT00781859|458873904|FG000|Overall Study|Adverse Event|2|||
127522573|NCT00781859|458873905|FG001|Overall Study|Adverse Event|2|||
127522574|NCT00781859|458873904|FG000|Overall Study|Withdrawal by Subject|8|||
127522575|NCT00781859|458873905|FG001|Overall Study|Withdrawal by Subject|4|||
127522576|NCT00781859|458873904|FG000|Overall Study|Lost to Follow-up|6|||
127522577|NCT00781859|458873905|FG001|Overall Study|Lost to Follow-up|3|||
127522578|NCT00781859|458873904|FG000|Overall Study|Death|3|||
127522579|NCT00781859|458873905|FG001|Overall Study|Death|0|||
127522580|NCT01983774|458873909|FG000|Overall Study|Lung Transplant|0|||
127522581|NCT01983774|458873910|FG001|Overall Study|Lung Transplant|1|||
127522582|NCT01983774|458873909|FG000|Overall Study|Lost to Follow-up|1|||
127522583|NCT01983774|458873910|FG001|Overall Study|Lost to Follow-up|0|||
127522584|NCT01008449|458873911|FG000|Overall Study|Lost to Follow-up|29|||
127522585|NCT01008449|458873912|FG001|Overall Study|Lost to Follow-up|19|||
127522586|NCT01220180|458873913|FG000|Overall Study|Lost to Follow-up|76|||
127522587|NCT01220180|458873913|FG000|Overall Study|Other|72|||
127522588|NCT01220180|458873913|FG000|Overall Study|Adverse Event|35|||
127522589|NCT01220180|458873913|FG000|Overall Study|Lack of Efficacy|22|||
127522590|NCT01220180|458873913|FG000|Overall Study|Death|1|||
127522591|NCT01220180|458873913|FG000|Overall Study|Randomized but not treated|1|||
127522592|NCT01067469|458873918|FG000|Overall Study|Withdrawal by Subject|0|||
127522593|NCT01067469|458873919|FG001|Overall Study|Withdrawal by Subject|1|||
127522594|NCT01067469|458873918|FG000|Overall Study|Disease Progression|0|||
127522595|NCT01067469|458873919|FG001|Overall Study|Disease Progression|1|||
127522596|NCT01299116|458873922|FG000|Overall Study|Lost to Follow-up|65|||
127522597|NCT01299116|458873923|FG001|Overall Study|Lost to Follow-up|9|||
127522598|NCT01299116|458873924|FG002|Overall Study|Lost to Follow-up|11|||
127522599|NCT01123707|458873926|FG000|Overall Study|Lost to Follow-up|3|||
127522600|NCT01123707|458873927|FG001|Overall Study|Lost to Follow-up|1|||
127522601|NCT01123707|458873928|FG002|Overall Study|Lost to Follow-up|3|||
127522602|NCT01123707|458873929|FG003|Overall Study|Lost to Follow-up|2|||
127522603|NCT01123707|458873926|FG000|Overall Study|Adverse Event|5|||
127522604|NCT01123707|458873927|FG001|Overall Study|Adverse Event|7|||
127522605|NCT01123707|458873928|FG002|Overall Study|Adverse Event|5|||
127522606|NCT01123707|458873929|FG003|Overall Study|Adverse Event|3|||
127522607|NCT01123707|458873926|FG000|Overall Study|Sponsor Discontinued Study|30|||
127522608|NCT01123707|458873927|FG001|Overall Study|Sponsor Discontinued Study|24|||
127522609|NCT01123707|458873928|FG002|Overall Study|Sponsor Discontinued Study|25|||
127522610|NCT01123707|458873929|FG003|Overall Study|Sponsor Discontinued Study|40|||
127522611|NCT01123707|458873926|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
127522612|NCT01123707|458873927|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
127522613|NCT01123707|458873928|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
127522614|NCT01123707|458873929|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
127522615|NCT01123707|458873926|FG000|Overall Study|Investigator Withdrew Participant|0|||
127522616|NCT01123707|458873927|FG001|Overall Study|Investigator Withdrew Participant|1|||
127522617|NCT01123707|458873928|FG002|Overall Study|Investigator Withdrew Participant|1|||
127522618|NCT01123707|458873929|FG003|Overall Study|Investigator Withdrew Participant|1|||
127522619|NCT01123707|458873926|FG000|Overall Study|Subject Withdrew Consent|4|||
127522620|NCT01123707|458873927|FG001|Overall Study|Subject Withdrew Consent|5|||
127522621|NCT01123707|458873928|FG002|Overall Study|Subject Withdrew Consent|1|||
127522622|NCT01123707|458873929|FG003|Overall Study|Subject Withdrew Consent|2|||
127522623|NCT01123707|458873926|FG000|Overall Study|Lack of Efficacy|1|||
127522624|NCT01123707|458873927|FG001|Overall Study|Lack of Efficacy|2|||
127522625|NCT01123707|458873928|FG002|Overall Study|Lack of Efficacy|1|||
127522626|NCT01123707|458873929|FG003|Overall Study|Lack of Efficacy|0|||
127522627|NCT01123707|458873926|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
127522628|NCT01123707|458873927|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
127522629|NCT01123707|458873928|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
127522630|NCT01123707|458873929|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
127522631|NCT04378114|458873930|FG000|Overall Study|Withdrawal by Subject|5|||
127522632|NCT01959243|458873935|FG000|Overall Study|Investigator Decision|3|||
127522633|NCT01959243|458873936|FG001|Overall Study|Investigator Decision|0|||
127522634|NCT01959243|458873935|FG000|Overall Study|Adverse Event|5|||
127522635|NCT01959243|458873936|FG001|Overall Study|Adverse Event|2|||
127522636|NCT01959243|458873935|FG000|Overall Study|Administrative reasons|2|||
127522637|NCT01959243|458873936|FG001|Overall Study|Administrative reasons|1|||
127522638|NCT01959243|458873935|FG000|Overall Study|Lost to Follow-up|3|||
127522639|NCT01959243|458873936|FG001|Overall Study|Lost to Follow-up|1|||
127522640|NCT00629798|458873937|FG000|Overall Study|Not Treated|4|||
127522641|NCT02554981|458873938|FG000|Overall Study|Adverse Event|1|||
127522642|NCT02554981|458873938|FG000|Overall Study|Administrative Reasons|1|||
127522643|NCT02554981|458873938|FG000|Overall Study|Other Miscellaneous Reasons|3|||
127522644|NCT01114438|458873939|FG000|Overall Study|Adverse Event|10|||
127522645|NCT01114438|458873939|FG000|Overall Study|concomitant medication|1|||
127522646|NCT01114438|458873939|FG000|Overall Study|Physician Decision|1|||
127522647|NCT01114438|458873939|FG000|Overall Study|Withdrawal by Subject|2|||
127522648|NCT00428844|458873942|FG000|Completed Study Drug Treatment|Adverse Event|2|||
127522649|NCT00428844|458873943|FG001|Completed Study Drug Treatment|Adverse Event|4|||
127522650|NCT00428844|458873944|FG002|Completed Study Drug Treatment|Adverse Event|4|||
127522651|NCT00428844|458873942|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
127522652|NCT00428844|458873943|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
127522653|NCT00428844|458873944|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
127522654|NCT00428844|458873942|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
127522655|NCT00428844|458873943|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
127522656|NCT00428844|458873944|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
127522657|NCT00428844|458873942|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
127522658|NCT00428844|458873943|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
127522659|NCT00428844|458873944|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
127522660|NCT00428844|458873942|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
127522661|NCT00428844|458873943|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
127522662|NCT00428844|458873944|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
127522663|NCT00428844|458873942|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
127522664|NCT00428844|458873943|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
127522665|NCT00428844|458873944|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
127522666|NCT00428844|458873942|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
127522667|NCT00428844|458873943|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
127522668|NCT00428844|458873944|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
127522669|NCT00428844|458873942|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
127522670|NCT00428844|458873943|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
127522671|NCT00428844|458873944|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
127522672|NCT00428844|458873942|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
127522673|NCT00428844|458873943|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
127522674|NCT00428844|458873944|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
127522675|NCT00488826|458873945|FG000|Overall Study|Withdrawal by Subject|40|||
127522676|NCT00488826|458873946|FG001|Overall Study|Withdrawal by Subject|35|||
127522677|NCT00488826|458873947|FG002|Overall Study|Withdrawal by Subject|19|||
127522678|NCT00488826|458873945|FG000|Overall Study|Protocol Violation|0|||
127522679|NCT00488826|458873946|FG001|Overall Study|Protocol Violation|0|||
127522680|NCT00488826|458873947|FG002|Overall Study|Protocol Violation|2|||
127522681|NCT00488826|458873945|FG000|Overall Study|Adverse Event|9|||
127522682|NCT00488826|458873946|FG001|Overall Study|Adverse Event|15|||
127522683|NCT00488826|458873947|FG002|Overall Study|Adverse Event|4|||
127522684|NCT00488826|458873945|FG000|Overall Study|Lost to Follow-up|5|||
127522685|NCT00488826|458873946|FG001|Overall Study|Lost to Follow-up|1|||
127522686|NCT00488826|458873947|FG002|Overall Study|Lost to Follow-up|0|||
127522687|NCT00488826|458873945|FG000|Overall Study|Protocol Deviations|2|||
127522688|NCT00488826|458873946|FG001|Overall Study|Protocol Deviations|1|||
127522689|NCT00488826|458873947|FG002|Overall Study|Protocol Deviations|1|||
127522690|NCT02292706|458873948|FG000|Overall Study|Lost to Follow-up|20|||
127522691|NCT02292706|458873949|FG001|Overall Study|Lost to Follow-up|44|||
127522692|NCT02292706|458873950|FG002|Overall Study|Lost to Follow-up|24|||
127522693|NCT02292706|458873951|FG003|Overall Study|Lost to Follow-up|61|||
127522694|NCT02292706|458873952|FG004|Overall Study|Lost to Follow-up|21|||
127522695|NCT02292706|458873953|FG005|Overall Study|Lost to Follow-up|52|||
127522696|NCT02292706|458873954|FG006|Overall Study|Lost to Follow-up|25|||
127522697|NCT02292706|458873955|FG007|Overall Study|Lost to Follow-up|0|||
127522698|NCT02292706|458873948|FG000|Overall Study|Withdrew consent|15|||
127522699|NCT02292706|458873949|FG001|Overall Study|Withdrew consent|56|||
127522700|NCT02292706|458873950|FG002|Overall Study|Withdrew consent|43|||
127522701|NCT02292706|458873951|FG003|Overall Study|Withdrew consent|36|||
127522702|NCT02292706|458873952|FG004|Overall Study|Withdrew consent|13|||
127522703|NCT02292706|458873953|FG005|Overall Study|Withdrew consent|51|||
127522704|NCT02292706|458873954|FG006|Overall Study|Withdrew consent|20|||
127522705|NCT02292706|458873955|FG007|Overall Study|Withdrew consent|0|||
127522706|NCT02292706|458873948|FG000|Overall Study|Death|3|||
127522707|NCT02292706|458873949|FG001|Overall Study|Death|11|||
127522708|NCT02292706|458873950|FG002|Overall Study|Death|16|||
127522709|NCT02292706|458873951|FG003|Overall Study|Death|22|||
127522710|NCT02292706|458873952|FG004|Overall Study|Death|8|||
127522711|NCT02292706|458873953|FG005|Overall Study|Death|17|||
127522712|NCT02292706|458873954|FG006|Overall Study|Death|3|||
127522713|NCT02292706|458873955|FG007|Overall Study|Death|0|||
127522714|NCT02292706|458873948|FG000|Overall Study|Study terminated by sponsor|0|||
127522715|NCT02292706|458873949|FG001|Overall Study|Study terminated by sponsor|9|||
127522716|NCT02292706|458873950|FG002|Overall Study|Study terminated by sponsor|4|||
127522717|NCT02292706|458873951|FG003|Overall Study|Study terminated by sponsor|21|||
127522718|NCT02292706|458873952|FG004|Overall Study|Study terminated by sponsor|11|||
127522719|NCT02292706|458873953|FG005|Overall Study|Study terminated by sponsor|13|||
127522720|NCT02292706|458873954|FG006|Overall Study|Study terminated by sponsor|3|||
127522721|NCT02292706|458873955|FG007|Overall Study|Study terminated by sponsor|0|||
127522722|NCT02292706|458873948|FG000|Overall Study|Investigator's discretion|4|||
127522723|NCT02292706|458873949|FG001|Overall Study|Investigator's discretion|9|||
127522724|NCT02292706|458873950|FG002|Overall Study|Investigator's discretion|7|||
127522725|NCT02292706|458873951|FG003|Overall Study|Investigator's discretion|11|||
127522726|NCT02292706|458873952|FG004|Overall Study|Investigator's discretion|4|||
127522727|NCT02292706|458873953|FG005|Overall Study|Investigator's discretion|10|||
127522728|NCT02292706|458873954|FG006|Overall Study|Investigator's discretion|1|||
127522729|NCT02292706|458873955|FG007|Overall Study|Investigator's discretion|0|||
127522730|NCT02292706|458873948|FG000|Overall Study|Liver transplant|1|||
127522731|NCT02292706|458873949|FG001|Overall Study|Liver transplant|1|||
127522732|NCT02292706|458873950|FG002|Overall Study|Liver transplant|11|||
127522733|NCT02292706|458873951|FG003|Overall Study|Liver transplant|16|||
127522734|NCT02292706|458873952|FG004|Overall Study|Liver transplant|5|||
127522735|NCT02292706|458873953|FG005|Overall Study|Liver transplant|6|||
127522736|NCT02292706|458873954|FG006|Overall Study|Liver transplant|5|||
127522737|NCT02292706|458873955|FG007|Overall Study|Liver transplant|0|||
127522738|NCT02292706|458873948|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
127522739|NCT02292706|458873949|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
127522740|NCT02292706|458873950|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
127522741|NCT02292706|458873951|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
127522742|NCT02292706|458873952|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
127522743|NCT02292706|458873953|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
127522744|NCT02292706|458873954|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
127522745|NCT02292706|458873955|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
127522746|NCT02292706|458873948|FG000|Overall Study|Subject terminated by sponsor|1|||
127522747|NCT02292706|458873949|FG001|Overall Study|Subject terminated by sponsor|0|||
127522748|NCT02292706|458873950|FG002|Overall Study|Subject terminated by sponsor|0|||
127522749|NCT02292706|458873951|FG003|Overall Study|Subject terminated by sponsor|2|||
127522750|NCT02292706|458873952|FG004|Overall Study|Subject terminated by sponsor|1|||
127522751|NCT02292706|458873953|FG005|Overall Study|Subject terminated by sponsor|0|||
127522752|NCT02292706|458873954|FG006|Overall Study|Subject terminated by sponsor|0|||
127522753|NCT02292706|458873955|FG007|Overall Study|Subject terminated by sponsor|0|||
127522754|NCT02292706|458873948|FG000|Overall Study|Missing|0|||
127522755|NCT02292706|458873949|FG001|Overall Study|Missing|0|||
127522756|NCT02292706|458873950|FG002|Overall Study|Missing|1|||
127522757|NCT02292706|458873951|FG003|Overall Study|Missing|1|||
127522758|NCT02292706|458873952|FG004|Overall Study|Missing|0|||
127522759|NCT02292706|458873953|FG005|Overall Study|Missing|1|||
127522760|NCT02292706|458873954|FG006|Overall Study|Missing|0|||
127522761|NCT02292706|458873955|FG007|Overall Study|Missing|0|||
127522762|NCT02292706|458873948|FG000|Overall Study|Virologic relapse or reinfection|1|||
127522763|NCT02292706|458873949|FG001|Overall Study|Virologic relapse or reinfection|0|||
127522764|NCT02292706|458873950|FG002|Overall Study|Virologic relapse or reinfection|0|||
127522765|NCT02292706|458873951|FG003|Overall Study|Virologic relapse or reinfection|1|||
127522766|NCT02292706|458873952|FG004|Overall Study|Virologic relapse or reinfection|0|||
127522767|NCT02292706|458873953|FG005|Overall Study|Virologic relapse or reinfection|1|||
127522768|NCT02292706|458873954|FG006|Overall Study|Virologic relapse or reinfection|0|||
127522769|NCT02292706|458873955|FG007|Overall Study|Virologic relapse or reinfection|0|||
127522770|NCT02725866|458873958|FG000|Overall Study|Failure to return|6|||
127522771|NCT02725866|458873958|FG000|Overall Study|Withdrew consent|3|||
127522772|NCT02725866|458873958|FG000|Overall Study|Insufficient virological response|1|||
127522773|NCT02725866|458873958|FG000|Overall Study|Other, not specified|4|||
127522774|NCT04667104|458873965|FG000|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
127522775|NCT04667104|458873966|FG001|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
127522776|NCT04667104|458873967|FG002|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|1|||
127522777|NCT03043651|458873968|FG000|Overall Study|Death|1|||
127522778|NCT03043651|458873968|FG000|Overall Study|Progressive Disease|2|||
127522779|NCT03043651|458873968|FG000|Overall Study|Adverse Event|2|||
127522780|NCT03043651|458873968|FG000|Overall Study|Withdrawal by Subject|4|||
127522781|NCT03043651|458873968|FG000|Overall Study|Study Terminated by Sponsor|39|||
127522782|NCT01630889|458873969|FG000|Overall Study|Death|2|||
127522783|NCT01630889|458873969|FG000|Overall Study|Withdrawal by Subject|1|||
127522784|NCT01630889|458873969|FG000|Overall Study|Other than Specified|2|||
127522785|NCT01630889|458873969|FG000|Overall Study|Lost to Follow-up|4|||
127522786|NCT01630889|458873969|FG000|Overall Study|Other|1|||
127522787|NCT03208088|458873974|FG000|Period 2|Withdrawal by Subject|0|||
127522788|NCT03208088|458873975|FG001|Period 2|Withdrawal by Subject|0|||
127522789|NCT03208088|458873976|FG002|Period 2|Withdrawal by Subject|0|||
127522790|NCT03208088|458873977|FG003|Period 2|Withdrawal by Subject|0|||
127522791|NCT03208088|458873978|FG004|Period 2|Withdrawal by Subject|0|||
127522792|NCT03208088|458873979|FG005|Period 2|Withdrawal by Subject|0|||
127522793|NCT03208088|458873980|FG006|Period 2|Withdrawal by Subject|0|||
127522794|NCT03208088|458873981|FG007|Period 2|Withdrawal by Subject|0|||
127522795|NCT03208088|458873982|FG008|Period 2|Withdrawal by Subject|1|||
127522796|NCT03208088|458873983|FG009|Period 2|Withdrawal by Subject|0|||
127522797|NCT03208088|458873974|FG000|Period 3|Unsatisfactory Test Article|0|||
127522798|NCT03208088|458873975|FG001|Period 3|Unsatisfactory Test Article|0|||
127522799|NCT03208088|458873976|FG002|Period 3|Unsatisfactory Test Article|0|||
127522800|NCT03208088|458873977|FG003|Period 3|Unsatisfactory Test Article|1|||
127522801|NCT03208088|458873978|FG004|Period 3|Unsatisfactory Test Article|0|||
127522802|NCT03208088|458873979|FG005|Period 3|Unsatisfactory Test Article|0|||
127522803|NCT03208088|458873980|FG006|Period 3|Unsatisfactory Test Article|0|||
127522804|NCT03208088|458873981|FG007|Period 3|Unsatisfactory Test Article|0|||
127522805|NCT03208088|458873982|FG008|Period 3|Unsatisfactory Test Article|0|||
127522806|NCT03208088|458873983|FG009|Period 3|Unsatisfactory Test Article|0|||
127522807|NCT03208088|458873974|FG000|Period 4|Unsatisfactory Test Article|0|||
127522808|NCT03208088|458873975|FG001|Period 4|Unsatisfactory Test Article|0|||
127522809|NCT03208088|458873976|FG002|Period 4|Unsatisfactory Test Article|0|||
127522810|NCT03208088|458873977|FG003|Period 4|Unsatisfactory Test Article|1|||
127522811|NCT03208088|458873978|FG004|Period 4|Unsatisfactory Test Article|0|||
127522812|NCT03208088|458873979|FG005|Period 4|Unsatisfactory Test Article|0|||
127522813|NCT03208088|458873980|FG006|Period 4|Unsatisfactory Test Article|0|||
127522814|NCT03208088|458873981|FG007|Period 4|Unsatisfactory Test Article|0|||
127522815|NCT03208088|458873982|FG008|Period 4|Unsatisfactory Test Article|0|||
127522816|NCT03208088|458873983|FG009|Period 4|Unsatisfactory Test Article|0|||
127522817|NCT00566254|458873984|FG000|Overall Study|Adverse Event|3|||
127522818|NCT00566254|458873985|FG001|Overall Study|Adverse Event|1|||
127522819|NCT00566254|458873984|FG000|Overall Study|Protocol Violation|1|||
127522820|NCT00566254|458873985|FG001|Overall Study|Protocol Violation|3|||
127522821|NCT00566254|458873984|FG000|Overall Study|Withdrawal by Subject|1|||
127522822|NCT00566254|458873985|FG001|Overall Study|Withdrawal by Subject|2|||
127522823|NCT00566254|458873984|FG000|Overall Study|Lack of Efficacy|5|||
127522824|NCT00566254|458873985|FG001|Overall Study|Lack of Efficacy|6|||
127522825|NCT00566254|458873984|FG000|Overall Study|Other|0|||
127522826|NCT00566254|458873985|FG001|Overall Study|Other|2|||
127522827|NCT00238238|458873986|FG000|Overall Study|Withdrawal by Subject|0|||
127522828|NCT00238238|458873987|FG001|Overall Study|Withdrawal by Subject|3|||
127522829|NCT00238238|458873988|FG002|Overall Study|Withdrawal by Subject|0|||
127522830|NCT01345669|458873989|FG000|Overall Study|Primary tumour recurrence|53|||
127522831|NCT01345669|458873990|FG001|Overall Study|Primary tumour recurrence|32|||
127522832|NCT01345669|458873989|FG000|Overall Study|Second primary tumour|4|||
127522833|NCT01345669|458873990|FG001|Overall Study|Second primary tumour|3|||
127522834|NCT01345669|458873989|FG000|Overall Study|Adverse Event|63|||
127522835|NCT01345669|458873990|FG001|Overall Study|Adverse Event|9|||
127522836|NCT01345669|458873989|FG000|Overall Study|Protocol Violation|3|||
127522837|NCT01345669|458873990|FG001|Overall Study|Protocol Violation|1|||
127522838|NCT01345669|458873989|FG000|Overall Study|Lost to Follow-up|1|||
127522839|NCT01345669|458873990|FG001|Overall Study|Lost to Follow-up|1|||
127522840|NCT01345669|458873989|FG000|Overall Study|Withdrawal by Subject|52|||
127522841|NCT01345669|458873990|FG001|Overall Study|Withdrawal by Subject|13|||
127522842|NCT01345669|458873989|FG000|Overall Study|Other Reasons|111|||
127522843|NCT01345669|458873990|FG001|Overall Study|Other Reasons|60|||
127522844|NCT01793883|458873991|FG000|Overall Study|Withdrawal by Subject|3|||
127522845|NCT01793883|458873992|FG001|Overall Study|Withdrawal by Subject|7|||
127522846|NCT01793883|458873993|FG002|Overall Study|Withdrawal by Subject|3|||
127522847|NCT01793883|458873991|FG000|Overall Study|Subject noncompliance|0|||
127522848|NCT01793883|458873992|FG001|Overall Study|Subject noncompliance|1|||
127522849|NCT01793883|458873993|FG002|Overall Study|Subject noncompliance|1|||
127522850|NCT01793883|458873991|FG000|Overall Study|Lost to Follow-up|5|||
127522851|NCT01793883|458873992|FG001|Overall Study|Lost to Follow-up|1|||
127522852|NCT01793883|458873993|FG002|Overall Study|Lost to Follow-up|3|||
127522853|NCT01793883|458873991|FG000|Overall Study|Randomized in error|1|||
127522854|NCT01793883|458873992|FG001|Overall Study|Randomized in error|0|||
127522855|NCT01793883|458873993|FG002|Overall Study|Randomized in error|0|||
127522856|NCT01793883|458873991|FG000|Overall Study|Unable to complete spriometry|1|||
127522857|NCT01793883|458873992|FG001|Overall Study|Unable to complete spriometry|0|||
127522858|NCT01793883|458873993|FG002|Overall Study|Unable to complete spriometry|0|||
127522859|NCT01793883|458873991|FG000|Overall Study|Unable to complete measurements|1|||
127522860|NCT01793883|458873992|FG001|Overall Study|Unable to complete measurements|0|||
127522861|NCT01793883|458873993|FG002|Overall Study|Unable to complete measurements|0|||
127522862|NCT01793883|458873991|FG000|Overall Study|Met exclusion criteria|1|||
127522863|NCT01793883|458873992|FG001|Overall Study|Met exclusion criteria|0|||
127522864|NCT01793883|458873993|FG002|Overall Study|Met exclusion criteria|0|||
127522865|NCT01793883|458873991|FG000|Overall Study|Dosing error|0|||
127522866|NCT01793883|458873992|FG001|Overall Study|Dosing error|1|||
127522867|NCT01793883|458873993|FG002|Overall Study|Dosing error|0|||
127522868|NCT01793883|458873991|FG000|Overall Study|Respiratory distress during spirometry|0|||
127522869|NCT01793883|458873992|FG001|Overall Study|Respiratory distress during spirometry|0|||
127522870|NCT01793883|458873993|FG002|Overall Study|Respiratory distress during spirometry|1|||
127522871|NCT02478255|458873994|FG000|Overall Study|Physician Decision|6|||
127522872|NCT02478255|458873995|FG001|Overall Study|Physician Decision|0|||
127522873|NCT02478255|458873994|FG000|Overall Study|Withdrawal by Subject|2|||
127522874|NCT02478255|458873995|FG001|Overall Study|Withdrawal by Subject|0|||
127522875|NCT00761527|458873997|FG000|Overall Study|Adverse Event|3|||
127522876|NCT00761527|458873997|FG000|Overall Study|Poor Compliance|8|||
127522877|NCT00761527|458873997|FG000|Overall Study|Lost to Follow-up|9|||
127522878|NCT00761527|458873997|FG000|Overall Study|Unknown reason|2|||
127522879|NCT01730586|458873998|FG000|Overall Study|Progressive Disease|2|||
127522880|NCT01730586|458873998|FG000|Overall Study|Inadequate Trial|8|||
127522881|NCT01730586|458873998|FG000|Overall Study|Adverse Event|2|||
127522882|NCT01730586|458873998|FG000|Overall Study|Hospice|1|||
127522883|NCT00061633|458873999|FG000|Overall Study|Adverse Event|1|||
127522884|NCT00061633|458874000|FG001|Overall Study|Adverse Event|2|||
127522885|NCT00061633|458873999|FG000|Overall Study|Withdrawal by Subject|2|||
127522886|NCT00061633|458874000|FG001|Overall Study|Withdrawal by Subject|2|||
127522887|NCT00061633|458873999|FG000|Overall Study|Lost to Follow-up|1|||
127522888|NCT00061633|458874000|FG001|Overall Study|Lost to Follow-up|4|||
127522889|NCT00061633|458873999|FG000|Overall Study|Other|1|||
127522890|NCT00061633|458874000|FG001|Overall Study|Other|1|||
127522891|NCT00061633|458873999|FG000|Overall Study|Never received study treatment|0|||
127522892|NCT00061633|458874000|FG001|Overall Study|Never received study treatment|2|||
127522893|NCT01431963|458874001|FG000|Overall Study|Adverse Event|18|||
127522894|NCT01431963|458874001|FG000|Overall Study|Lack of Efficacy|7|||
127522895|NCT01431963|458874001|FG000|Overall Study|Protocol Violation|1|||
127522896|NCT01431963|458874001|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
127522897|NCT01431963|458874001|FG000|Overall Study|Physician Decision|4|||
127522898|NCT01431963|458874001|FG000|Overall Study|Withdrawal by Subject|3|||
127522899|NCT03109184|458875739|FG000|Overall Study|Lost to Follow-up|6|||
127522900|NCT03109184|458875740|FG001|Overall Study|Lost to Follow-up|6|||
127522901|NCT03109184|458875739|FG000|Overall Study|Withdrawal by Subject|1|||
127522902|NCT03109184|458875740|FG001|Overall Study|Withdrawal by Subject|1|||
127522903|NCT00602420|458875741|FG000|Overall Study|Death|1|||
127522904|NCT00602420|458875742|FG001|Overall Study|Death|4|||
127522905|NCT00602420|458875741|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
127522906|NCT00602420|458875742|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
127522907|NCT00602420|458875741|FG000|Overall Study|Withdrawal by Subject|18|||
127522908|NCT00602420|458875742|FG001|Overall Study|Withdrawal by Subject|17|||
127522909|NCT00602420|458875741|FG000|Overall Study|Adverse Event|1|||
127522910|NCT00602420|458875742|FG001|Overall Study|Adverse Event|0|||
127522911|NCT00703924|458875745|FG000|Overall Study|Withdrawal by Subject|1|||
127522912|NCT00703924|458875746|FG001|Overall Study|Withdrawal by Subject|1|||
127522913|NCT03592368|458875747|FG000|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
127522914|NCT03592368|458875748|FG001|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|1|||
127522915|NCT03592368|458875749|FG002|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
127522916|NCT03592368|458875750|FG003|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
127522917|NCT03592368|458875747|FG000|Overall Study|Adverse Event|0|||
127522918|NCT03592368|458875748|FG001|Overall Study|Adverse Event|0|||
127522919|NCT03592368|458875749|FG002|Overall Study|Adverse Event|0|||
127522920|NCT03592368|458875750|FG003|Overall Study|Adverse Event|1|||
127522921|NCT03592368|458875747|FG000|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
127522922|NCT03592368|458875748|FG001|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
127522923|NCT03592368|458875749|FG002|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
127522924|NCT03592368|458875750|FG003|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
127522925|NCT02008227|458875752|FG000|Overall Study|Lost to Follow-up|7|||
127522926|NCT02008227|458875753|FG001|Overall Study|Lost to Follow-up|9|||
127522927|NCT02008227|458875752|FG000|Overall Study|Death|494|||
127522928|NCT02008227|458875753|FG001|Overall Study|Death|485|||
127522929|NCT02008227|458875752|FG000|Overall Study|Withdrawal by Subject|67|||
127522930|NCT02008227|458875753|FG001|Overall Study|Withdrawal by Subject|36|||
127522931|NCT02008227|458875752|FG000|Overall Study|Study Terminated By Sponsor|44|||
127522932|NCT02008227|458875753|FG001|Overall Study|Study Terminated By Sponsor|83|||
127522933|NCT03499314|458875754|FG000|Overall Study|Time Commitment|1|||
127522934|NCT03499314|458875755|FG001|Overall Study|Time Commitment|2|||
127522935|NCT03499314|458875754|FG000|Overall Study|Medical issue unrelated to research study|1|||
127522936|NCT03499314|458875755|FG001|Overall Study|Medical issue unrelated to research study|1|||
127522937|NCT01271725|458875756|FG000|Part A|Progressive disease according to RECIST|8|||
127522938|NCT01271725|458875757|FG001|Part A|Progressive disease according to RECIST|0|||
127522939|NCT01271725|458875756|FG000|Part A|Clinical signs/symptoms of progression|2|||
127522940|NCT01271725|458875757|FG001|Part A|Clinical signs/symptoms of progression|0|||
127522941|NCT01271725|458875756|FG000|Part A|Other Adverse Event|8|||
127522942|NCT01271725|458875757|FG001|Part A|Other Adverse Event|0|||
127522943|NCT01271725|458875756|FG000|Part A|Lost to Follow-up|1|||
127522944|NCT01271725|458875757|FG001|Part A|Lost to Follow-up|0|||
127522945|NCT01271725|458875756|FG000|Part A|Withdrawal by Subject|12|||
127522946|NCT01271725|458875757|FG001|Part A|Withdrawal by Subject|0|||
127522947|NCT01271725|458875756|FG000|Part A|Other than specified|3|||
127522948|NCT01271725|458875757|FG001|Part A|Other than specified|0|||
127522949|NCT01271725|458875756|FG000|Part A|Protocol Violation|1|||
127522950|NCT01271725|458875757|FG001|Part A|Protocol Violation|0|||
127522951|NCT01271725|458875756|FG000|Part B|Other than specified|0|||
127522952|NCT01271725|458875757|FG001|Part B|Other than specified|2|||
127522953|NCT01271725|458875756|FG000|Part B|Clinical signs/symptoms of progression|0|||
127522954|NCT01271725|458875757|FG001|Part B|Clinical signs/symptoms of progression|2|||
127522955|NCT01271725|458875756|FG000|Part B|Other Adverse Event|0|||
127522956|NCT01271725|458875757|FG001|Part B|Other Adverse Event|1|||
127522957|NCT01271725|458875756|FG000|Part B|Protocol Violation|0|||
127522958|NCT01271725|458875757|FG001|Part B|Protocol Violation|1|||
127522959|NCT01271725|458875756|FG000|Part B|Withdrawal by Subject|0|||
127522960|NCT01271725|458875757|FG001|Part B|Withdrawal by Subject|6|||
127522961|NCT01702025|458875758|FG000|Overall Study|Equipment failure|1|||
127522962|NCT01702025|458875759|FG001|Overall Study|Equipment failure|0|||
127522963|NCT01702025|458875760|FG002|Overall Study|Equipment failure|0|||
127522964|NCT01702025|458875761|FG003|Overall Study|Equipment failure|0|||
127522965|NCT01702025|458875758|FG000|Overall Study|Adverse Event|1|||
127522966|NCT01702025|458875759|FG001|Overall Study|Adverse Event|1|||
127522967|NCT01702025|458875760|FG002|Overall Study|Adverse Event|1|||
127522968|NCT01702025|458875761|FG003|Overall Study|Adverse Event|0|||
127522969|NCT03354273|458875762|FG000|Overall Study|Adverse Event|5|||
127522970|NCT03354273|458875762|FG000|Overall Study|Screen Failure|21|||
127522971|NCT03354273|458875762|FG000|Overall Study|Withdrawal by Subject|34|||
127522972|NCT03354273|458875762|FG000|Overall Study|Technical Problems|30|||
127522973|NCT03354273|458875762|FG000|Overall Study|Lost to Follow-up|4|||
127522974|NCT03354273|458875762|FG000|Overall Study|Investigator Decision|3|||
127522975|NCT03354273|458875762|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
127522976|NCT03354273|458875762|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
127522977|NCT03354273|458875762|FG000|Overall Study|COVID-19 Restrictions|9|||
127522978|NCT03354273|458875762|FG000|Overall Study|Other|5|||
127522979|NCT03149055|458875769|FG000|Overall Study|Not treated|4|||
127522980|NCT04440813|458875770|FG000|Overall Study|Lost to Follow-up|5|||
127522981|NCT04440813|458875771|FG001|Overall Study|Lost to Follow-up|5|||
127522982|NCT02629822|458875772|FG000|Base Study|Lost to Follow-up|2|||
127522983|NCT02629822|458875772|FG000|Base Study|Non-Compliance With Study Drug|1|||
127522984|NCT02629822|458875772|FG000|Extension Study|Adverse Event|1|||
127522985|NCT02629822|458875772|FG000|Extension Study|Lost to Follow-up|1|||
127522986|NCT00741013|458875773|FG000|Overall Study|Adverse Event|1|||
127522987|NCT00741013|458875774|FG001|Overall Study|Adverse Event|0|||
127522988|NCT00741013|458875775|FG002|Overall Study|Adverse Event|0|||
127522989|NCT00741013|458875773|FG000|Overall Study|Withdrawal by Subject|0|||
127522990|NCT00741013|458875774|FG001|Overall Study|Withdrawal by Subject|0|||
127522991|NCT00741013|458875775|FG002|Overall Study|Withdrawal by Subject|1|||
127522992|NCT00741013|458875773|FG000|Overall Study|Discovered failed screen after enrolled|0|||
127522993|NCT00741013|458875774|FG001|Overall Study|Discovered failed screen after enrolled|2|||
127522994|NCT00741013|458875775|FG002|Overall Study|Discovered failed screen after enrolled|0|||
127522995|NCT00193180|458875779|FG000|Overall Study|Lack of Efficacy|1|||
127522996|NCT00193180|458875779|FG000|Overall Study|Adverse Event|8|||
127522997|NCT00193180|458875779|FG000|Overall Study|Protocol Violation|1|||
127522998|NCT01357551|458875780|FG000|Overall Study|Withdrawal by Subject|6|||
127522999|NCT01357551|458875781|FG001|Overall Study|Withdrawal by Subject|4|||
127523000|NCT01357551|458875780|FG000|Overall Study|Death|0|||
127523001|NCT01357551|458875781|FG001|Overall Study|Death|1|||
127523002|NCT01357551|458875780|FG000|Overall Study|Lost to Follow-up|16|||
127523003|NCT01357551|458875781|FG001|Overall Study|Lost to Follow-up|6|||
127523004|NCT00539305|458875782|FG000|Overall Study|Adverse Event|1|||
127523005|NCT00539305|458875783|FG001|Overall Study|Adverse Event|0|||
127523006|NCT00539305|458875782|FG000|Overall Study|Substance Use|0|||
127523007|NCT00539305|458875783|FG001|Overall Study|Substance Use|1|||
127523008|NCT00539305|458875782|FG000|Overall Study|Withdrawal by Subject|0|||
127523009|NCT00539305|458875783|FG001|Overall Study|Withdrawal by Subject|1|||
127523010|NCT00413036|458875789|FG000|Overall Study|Adverse Event|44|||
127523011|NCT00413036|458875789|FG000|Overall Study|Lack of Efficacy|129|||
127523012|NCT00413036|458875789|FG000|Overall Study|Withdrawal by Subject|7|||
127523013|NCT00413036|458875789|FG000|Overall Study|Death|9|||
127523014|NCT00413036|458875789|FG000|Overall Study|Other|26|||
127523015|NCT00413036|458875789|FG000|Overall Study|Missing|2|||
127523016|NCT01369641|458875790|FG000|Overall Study|Withdrawal by Subject|1|||
127523017|NCT00842543|458875791|FG000|Overall Study|Withdrawal by Subject|2|||
127523018|NCT00842543|458875792|FG001|Overall Study|Withdrawal by Subject|0|||
127523019|NCT00842543|458875793|FG002|Overall Study|Withdrawal by Subject|3|||
127523020|NCT00842543|458875794|FG003|Overall Study|Withdrawal by Subject|4|||
127523021|NCT01483183|458875799|FG000|Overall Study|Physician Decision|0|||
127523022|NCT01483183|458875800|FG001|Overall Study|Physician Decision|0|||
127523023|NCT01483183|458875801|FG002|Overall Study|Physician Decision|0|||
127523024|NCT01483183|458875802|FG003|Overall Study|Physician Decision|0|||
127523025|NCT01483183|458875803|FG004|Overall Study|Physician Decision|0|||
127523026|NCT01483183|458875804|FG005|Overall Study|Physician Decision|0|||
127523027|NCT01483183|458875805|FG006|Overall Study|Physician Decision|2|||
127523028|NCT01483183|458875806|FG007|Overall Study|Physician Decision|0|||
127523029|NCT01483183|458875807|FG008|Overall Study|Physician Decision|0|||
127523030|NCT01483183|458875808|FG009|Overall Study|Physician Decision|0|||
127523031|NCT01483183|458875799|FG000|Overall Study|Withdrawal by Subject|0|||
127523032|NCT01483183|458875800|FG001|Overall Study|Withdrawal by Subject|0|||
127523033|NCT01483183|458875801|FG002|Overall Study|Withdrawal by Subject|0|||
127523034|NCT01483183|458875802|FG003|Overall Study|Withdrawal by Subject|0|||
127523035|NCT01483183|458875803|FG004|Overall Study|Withdrawal by Subject|0|||
127523036|NCT01483183|458875804|FG005|Overall Study|Withdrawal by Subject|0|||
127523037|NCT01483183|458875805|FG006|Overall Study|Withdrawal by Subject|0|||
127523038|NCT01483183|458875806|FG007|Overall Study|Withdrawal by Subject|0|||
127523039|NCT01483183|458875807|FG008|Overall Study|Withdrawal by Subject|0|||
127523040|NCT01483183|458875808|FG009|Overall Study|Withdrawal by Subject|1|||
127523041|NCT00239928|458875809|FG000|Overall Study|Lack of Efficacy|1|||
127523042|NCT00239928|458875809|FG000|Overall Study|Adverse Event|4|||
127523043|NCT00239928|458875809|FG000|Overall Study|Not need to continue study|3|||
127523044|NCT00239928|458875809|FG000|Overall Study|Withdrawal by Subject|2|||
127523045|NCT03100058|458875811|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
127523046|NCT03100058|458875812|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
127523047|NCT03100058|458875813|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
127523048|NCT03100058|458875814|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
127523049|NCT03100058|458875815|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
127523050|NCT03100058|458875816|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
127523051|NCT03100058|458875817|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
127523052|NCT03100058|458875818|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
127523053|NCT03100058|458875819|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
127523054|NCT03100058|458875820|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
127523055|NCT03100058|458875821|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
127523056|NCT03100058|458875822|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
127523057|NCT03100058|458875823|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
127523058|NCT03100058|458875811|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
127523059|NCT03100058|458875812|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
127523060|NCT03100058|458875813|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
127523061|NCT03100058|458875814|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
127523062|NCT03100058|458875815|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
127523063|NCT03100058|458875816|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
127523064|NCT03100058|458875817|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
127523065|NCT03100058|458875818|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
127523066|NCT03100058|458875819|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
127523067|NCT03100058|458875820|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
127523068|NCT03100058|458875821|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
127523069|NCT03100058|458875822|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
127523070|NCT03100058|458875823|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
127523071|NCT03100058|458875811|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
127523072|NCT03100058|458875812|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
127523073|NCT03100058|458875813|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
127523074|NCT03100058|458875814|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
127523075|NCT03100058|458875815|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
127523076|NCT03100058|458875816|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
127523077|NCT03100058|458875817|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
127523078|NCT03100058|458875818|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
127523079|NCT03100058|458875819|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
127523080|NCT03100058|458875820|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
127523081|NCT03100058|458875821|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
127523082|NCT03100058|458875822|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
127523083|NCT03100058|458875823|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
127523084|NCT03100058|458875811|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
127523085|NCT03100058|458875812|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
127523086|NCT03100058|458875813|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
127523087|NCT03100058|458875814|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
127523088|NCT03100058|458875815|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
127523089|NCT03100058|458875816|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
127523090|NCT03100058|458875817|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
127523091|NCT03100058|458875818|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
127523092|NCT03100058|458875819|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
127523093|NCT03100058|458875820|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
127523094|NCT03100058|458875821|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
127523095|NCT03100058|458875822|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
127523096|NCT03100058|458875823|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
127523097|NCT03100058|458875811|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
127523098|NCT03100058|458875812|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
127523099|NCT03100058|458875813|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
127523100|NCT03100058|458875814|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
127523101|NCT03100058|458875815|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
127523102|NCT03100058|458875816|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
127523103|NCT03100058|458875817|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
127523104|NCT03100058|458875818|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
127523105|NCT03100058|458875819|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
127523106|NCT03100058|458875820|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
127523107|NCT03100058|458875821|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
127523108|NCT03100058|458875822|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
127523109|NCT03100058|458875823|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
127523110|NCT03100058|458875811|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
127523111|NCT03100058|458875812|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
127523112|NCT03100058|458875813|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
127523113|NCT03100058|458875814|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
127523114|NCT03100058|458875815|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
127523115|NCT03100058|458875816|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
127523116|NCT03100058|458875817|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
127523117|NCT03100058|458875818|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
127523118|NCT03100058|458875819|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
127523119|NCT03100058|458875820|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
127523120|NCT03100058|458875821|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
127523121|NCT03100058|458875822|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
127523122|NCT03100058|458875823|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
127523123|NCT03100058|458875811|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
127523124|NCT03100058|458875812|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
127523125|NCT03100058|458875813|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
127523126|NCT03100058|458875814|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
127523127|NCT03100058|458875815|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
127523128|NCT03100058|458875816|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
127523129|NCT03100058|458875817|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
127523130|NCT03100058|458875818|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
127523131|NCT03100058|458875819|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
127523132|NCT03100058|458875820|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
127523133|NCT03100058|458875821|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
127523134|NCT03100058|458875822|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
127523135|NCT03100058|458875823|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
127523136|NCT03100058|458875811|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
127523137|NCT03100058|458875812|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
127523138|NCT03100058|458875813|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
127523139|NCT03100058|458875814|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
127523140|NCT03100058|458875815|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
127523141|NCT03100058|458875816|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
127523142|NCT03100058|458875817|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
127523143|NCT03100058|458875818|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
127523144|NCT03100058|458875819|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
127523145|NCT03100058|458875820|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
127523146|NCT03100058|458875821|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
127523147|NCT03100058|458875822|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
127523148|NCT03100058|458875823|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
127523149|NCT03100058|458875811|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
127523150|NCT03100058|458875812|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
127523151|NCT03100058|458875813|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
127523152|NCT03100058|458875814|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
127523153|NCT03100058|458875815|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
127523154|NCT03100058|458875816|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
127523155|NCT03100058|458875817|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
127523156|NCT03100058|458875818|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
127523157|NCT03100058|458875819|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
127523158|NCT03100058|458875820|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
127523159|NCT03100058|458875821|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
127523160|NCT03100058|458875822|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
127523161|NCT03100058|458875823|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
127523162|NCT03100058|458875811|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
127523163|NCT03100058|458875812|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
127523164|NCT03100058|458875813|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
127523165|NCT03100058|458875814|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
127523166|NCT03100058|458875815|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
127523167|NCT03100058|458875816|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
127523168|NCT03100058|458875817|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
127523169|NCT03100058|458875818|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
127523170|NCT03100058|458875819|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
127523171|NCT03100058|458875820|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
127523172|NCT03100058|458875821|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
127523173|NCT03100058|458875822|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
127523174|NCT03100058|458875823|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
127523175|NCT03100058|458875811|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
127523176|NCT03100058|458875812|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
127523177|NCT03100058|458875813|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
127523178|NCT03100058|458875814|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
127523179|NCT03100058|458875815|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
127523180|NCT03100058|458875816|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
127523181|NCT03100058|458875817|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
127523182|NCT03100058|458875818|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
127523183|NCT03100058|458875819|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
127523184|NCT03100058|458875820|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
127523185|NCT03100058|458875821|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
127523186|NCT03100058|458875822|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
127523187|NCT03100058|458875823|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
127523188|NCT03100058|458875811|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
127523189|NCT03100058|458875812|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
127523190|NCT03100058|458875813|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
127523191|NCT03100058|458875814|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
127523192|NCT03100058|458875815|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
127523193|NCT03100058|458875816|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
127523194|NCT03100058|458875817|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
127523195|NCT03100058|458875818|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
127523196|NCT03100058|458875819|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
127523197|NCT03100058|458875820|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
127523198|NCT03100058|458875821|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
127523199|NCT03100058|458875822|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
127523200|NCT03100058|458875823|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
127523201|NCT03100058|458875811|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
127523202|NCT03100058|458875812|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
127523203|NCT03100058|458875813|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
127523204|NCT03100058|458875814|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
127523205|NCT03100058|458875815|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
127523206|NCT03100058|458875816|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
127523207|NCT03100058|458875817|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
127523208|NCT03100058|458875818|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
127523209|NCT03100058|458875819|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
127523210|NCT03100058|458875820|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
127523211|NCT03100058|458875821|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
127523212|NCT03100058|458875822|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
127523213|NCT03100058|458875823|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
127523214|NCT03100058|458875811|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
127523215|NCT03100058|458875812|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
127523216|NCT03100058|458875813|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
127523217|NCT03100058|458875814|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
127523218|NCT03100058|458875815|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
127523219|NCT03100058|458875816|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
127523220|NCT03100058|458875817|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
127523221|NCT03100058|458875818|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
127523222|NCT03100058|458875819|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
127523223|NCT03100058|458875820|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
127523224|NCT03100058|458875821|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
127523225|NCT03100058|458875822|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
127523226|NCT03100058|458875823|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
127523227|NCT03100058|458875811|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
127523228|NCT03100058|458875812|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
127523229|NCT03100058|458875813|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
127523230|NCT03100058|458875814|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
127523231|NCT03100058|458875815|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
127523232|NCT03100058|458875816|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
127523233|NCT03100058|458875817|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
127523234|NCT03100058|458875818|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
127523235|NCT03100058|458875819|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
127523236|NCT03100058|458875820|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
127523237|NCT03100058|458875821|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
127523238|NCT03100058|458875822|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
127523239|NCT03100058|458875823|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
127523240|NCT00774800|458875827|FG000|Intervention 4|Withdrawal by Subject|1|||
127523241|NCT01331109|458875832|FG000|Overall Study|Adverse Event|6|||
127523242|NCT01331109|458875832|FG000|Overall Study|Lack of Efficacy|2|||
127523243|NCT01331109|458875832|FG000|Overall Study|Protocol Violation|3|||
127523244|NCT01331109|458875832|FG000|Overall Study|Withdrawal by Subject|7|||
127523245|NCT01331109|458875832|FG000|Overall Study|Lost to Follow-up|1|||
127523246|NCT01331109|458875832|FG000|Overall Study|Study Terminated by Sponsor|38|||
127523247|NCT00479856|458875833|FG000|Overall Study|Adverse Event|1|||
127523248|NCT00479856|458875833|FG000|Overall Study|Withdrawal by Subject|1|||
127523249|NCT00479856|458875833|FG000|Overall Study|Physician Decision|1|||
127523250|NCT00661622|458875836|FG000|Overall Study|Protocol Violation|1|||
127523251|NCT00661622|458875837|FG001|Overall Study|Protocol Violation|0|||
127523252|NCT03068754|458875841|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
127523253|NCT03068754|458875842|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
127523254|NCT03068754|458875843|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
127523255|NCT03068754|458875844|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
127523256|NCT03068754|458875841|FG000|Randomized Treatment Period (RTP)|Death|2|||
127523257|NCT03068754|458875842|FG001|Randomized Treatment Period (RTP)|Death|2|||
127523258|NCT03068754|458875843|FG002|Randomized Treatment Period (RTP)|Death|0|||
127523259|NCT03068754|458875844|FG003|Randomized Treatment Period (RTP)|Death|0|||
127523260|NCT03068754|458875841|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
127523261|NCT03068754|458875842|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
127523262|NCT03068754|458875843|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
127523263|NCT03068754|458875844|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
127523264|NCT03068754|458875841|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
127523265|NCT03068754|458875842|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
127523266|NCT03068754|458875843|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
127523267|NCT03068754|458875844|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
127523268|NCT03068754|458875841|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
127523269|NCT03068754|458875842|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
127523270|NCT03068754|458875843|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
127523271|NCT03068754|458875844|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
127523272|NCT03068754|458875841|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
127523273|NCT03068754|458875842|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
127523274|NCT03068754|458875843|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
127523275|NCT03068754|458875844|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
127523276|NCT03068754|458875841|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
127523277|NCT03068754|458875842|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
127523278|NCT03068754|458875843|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
127523279|NCT03068754|458875844|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
127523280|NCT03068754|458875841|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
127523281|NCT03068754|458875842|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
127523282|NCT03068754|458875843|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
127523283|NCT03068754|458875844|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
127523284|NCT03068754|458875841|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
127523285|NCT03068754|458875842|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
127523286|NCT03068754|458875843|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
127523287|NCT03068754|458875844|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
127523288|NCT03068754|458875841|FG000|Open Label Extension Period (OLE)|Death|0|||
127523289|NCT03068754|458875842|FG001|Open Label Extension Period (OLE)|Death|0|||
127523290|NCT03068754|458875843|FG002|Open Label Extension Period (OLE)|Death|0|||
127523291|NCT03068754|458875844|FG003|Open Label Extension Period (OLE)|Death|1|||
127523292|NCT03068754|458875841|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
127523293|NCT03068754|458875842|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
127523294|NCT03068754|458875843|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
127523295|NCT03068754|458875844|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
127523296|NCT03068754|458875841|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
127523297|NCT03068754|458875842|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
127523298|NCT03068754|458875843|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
127523299|NCT03068754|458875844|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
127523300|NCT03068754|458875841|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
127523301|NCT03068754|458875842|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
127523302|NCT03068754|458875843|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
127523303|NCT03068754|458875844|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
127523304|NCT03068754|458875841|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
127523305|NCT03068754|458875842|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
127523306|NCT03068754|458875843|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
127523307|NCT03068754|458875844|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
127523308|NCT00666965|458875845|FG000|Overall Study|Adverse Event|0|||
127523309|NCT00666965|458875846|FG001|Overall Study|Adverse Event|2|||
127523310|NCT00666965|458875847|FG002|Overall Study|Adverse Event|1|||
127523311|NCT00666965|458875848|FG003|Overall Study|Adverse Event|9|||
127523312|NCT00666965|458875845|FG000|Overall Study|Lack of Efficacy|1|||
127523313|NCT00666965|458875846|FG001|Overall Study|Lack of Efficacy|1|||
127523314|NCT00666965|458875847|FG002|Overall Study|Lack of Efficacy|0|||
127523315|NCT00666965|458875848|FG003|Overall Study|Lack of Efficacy|0|||
127523316|NCT00666965|458875845|FG000|Overall Study|Protocol Violation|0|||
127523317|NCT00666965|458875846|FG001|Overall Study|Protocol Violation|0|||
127523318|NCT00666965|458875847|FG002|Overall Study|Protocol Violation|0|||
127523319|NCT00666965|458875848|FG003|Overall Study|Protocol Violation|2|||
127523320|NCT00666965|458875845|FG000|Overall Study|Discontinuation criteria|2|||
127523321|NCT00666965|458875846|FG001|Overall Study|Discontinuation criteria|1|||
127523322|NCT00666965|458875847|FG002|Overall Study|Discontinuation criteria|1|||
127523323|NCT00666965|458875848|FG003|Overall Study|Discontinuation criteria|2|||
127523324|NCT00666965|458875845|FG000|Overall Study|Withdrawal by Subject|0|||
127523325|NCT00666965|458875846|FG001|Overall Study|Withdrawal by Subject|0|||
127523326|NCT00666965|458875847|FG002|Overall Study|Withdrawal by Subject|0|||
127523327|NCT00666965|458875848|FG003|Overall Study|Withdrawal by Subject|2|||
127523328|NCT02891382|458875854|FG000|Overall Study|Lost to Follow-up|3|||
127523329|NCT02891382|458875855|FG001|Overall Study|Lost to Follow-up|4|||
127523330|NCT02891382|458875856|FG002|Overall Study|Lost to Follow-up|5|||
127523331|NCT02891382|458875857|FG003|Overall Study|Lost to Follow-up|3|||
127523332|NCT02891382|458875858|FG004|Overall Study|Lost to Follow-up|4|||
127523333|NCT05090852|458875861|FG000|Overall Study|Physician Decision|5|||
127523334|NCT00148941|458875863|FG000|Overall Study|Lost to Follow-up|17|||
127523335|NCT00148941|458875864|FG001|Overall Study|Lost to Follow-up|24|||
127523336|NCT00148941|458875865|FG002|Overall Study|Lost to Follow-up|18|||
127523337|NCT00148941|458875866|FG003|Overall Study|Lost to Follow-up|22|||
127523338|NCT00148941|458875863|FG000|Overall Study|Withdrawal by Subject|1|||
127523339|NCT00148941|458875864|FG001|Overall Study|Withdrawal by Subject|0|||
127523340|NCT00148941|458875865|FG002|Overall Study|Withdrawal by Subject|1|||
127523341|NCT00148941|458875866|FG003|Overall Study|Withdrawal by Subject|0|||
127523342|NCT00148941|458875863|FG000|Overall Study|Other|0|||
127523343|NCT00148941|458875864|FG001|Overall Study|Other|0|||
127523344|NCT00148941|458875865|FG002|Overall Study|Other|1|||
127523345|NCT00148941|458875866|FG003|Overall Study|Other|2|||
127523346|NCT03244826|458875867|FG000|Overall Study|Withdrawal by Subject|2|||
127523347|NCT03244826|458875868|FG001|Overall Study|Withdrawal by Subject|0|||
127523348|NCT03244826|458875867|FG000|Overall Study|Transplant delayed or withdrawn|12|||
127523349|NCT03244826|458875868|FG001|Overall Study|Transplant delayed or withdrawn|10|||
127523350|NCT00416455|458875873|FG000|Overall Study|PET / CT not done|3|||
127523351|NCT00416455|458875874|FG001|Overall Study|PET / CT not done|5|||
127523352|NCT00416455|458875873|FG000|Overall Study|PET / CT poor quality|2|||
127523353|NCT00416455|458875874|FG001|Overall Study|PET / CT poor quality|1|||
127523354|NCT00416455|458875873|FG000|Overall Study|Inadequate pathology|11|||
127523355|NCT00416455|458875874|FG001|Overall Study|Inadequate pathology|2|||
127523356|NCT01620944|458875875|FG000|Overall Study|Early termination of Study|2|||
127523357|NCT01620944|458875876|FG001|Overall Study|Early termination of Study|1|||
127523358|NCT04079114|458875877|FG000|Overall Study|Study prematuely terminated.|166|||
127523359|NCT01364389|458875878|FG000|Overall Study|Withdrawal by Subject|0|||
127523360|NCT01364389|458875879|FG001|Overall Study|Withdrawal by Subject|1|||
127523361|NCT01364389|458875880|FG002|Overall Study|Withdrawal by Subject|0|||
127523362|NCT01364389|458875878|FG000|Overall Study|Protocol deviation|0|||
127523363|NCT01364389|458875879|FG001|Overall Study|Protocol deviation|0|||
127523364|NCT01364389|458875880|FG002|Overall Study|Protocol deviation|1|||
127523365|NCT01364389|458875878|FG000|Overall Study|Administrative problems|1|||
127523366|NCT01364389|458875879|FG001|Overall Study|Administrative problems|0|||
127523367|NCT01364389|458875880|FG002|Overall Study|Administrative problems|0|||
127523368|NCT01364389|458875878|FG000|Overall Study|Adverse Event|1|||
127523369|NCT01364389|458875879|FG001|Overall Study|Adverse Event|0|||
127523370|NCT01364389|458875880|FG002|Overall Study|Adverse Event|0|||
127523371|NCT02160145|458875885|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
127523372|NCT02160145|458875886|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
127523373|NCT02160145|458875887|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
127523374|NCT02160145|458875885|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
127523375|NCT02160145|458875886|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
127523376|NCT02160145|458875887|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
127523377|NCT02160145|458875885|FG000|Randomized Double-blind Period|Subject decision|0|||
127523378|NCT02160145|458875886|FG001|Randomized Double-blind Period|Subject decision|21|||
127523379|NCT02160145|458875887|FG002|Randomized Double-blind Period|Subject decision|20|||
127523380|NCT02160145|458875885|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
127523381|NCT02160145|458875886|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
127523382|NCT02160145|458875887|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
127523383|NCT02160145|458875885|FG000|Randomized Double-blind Period|Physician Decision|0|||
127523384|NCT02160145|458875886|FG001|Randomized Double-blind Period|Physician Decision|7|||
127523385|NCT02160145|458875887|FG002|Randomized Double-blind Period|Physician Decision|5|||
127523386|NCT03597061|458875888|FG000|Overall Study|Lost to Follow-up|1|||
127523387|NCT03597061|458875889|FG001|Overall Study|Lost to Follow-up|0|||
127523388|NCT03597061|458875888|FG000|Overall Study|Protocol Violation|0|||
127523389|NCT03597061|458875889|FG001|Overall Study|Protocol Violation|1|||
127523390|NCT02921087|458875892|FG000|Overall Study|Withdrawal by Subject|0|||
127523391|NCT02921087|458875893|FG001|Overall Study|Withdrawal by Subject|1|||
127523392|NCT00687531|458875894|FG000|Overall Study|Did not meet protocol eligibility|104|||
127523393|NCT00687531|458875894|FG000|Overall Study|Adverse Event|5|||
127523394|NCT00687531|458875894|FG000|Overall Study|Lost to Follow-up|26|||
127523395|NCT03848949|458875895|FG000|Overall Study|Lost to Follow-up|5|||
127523396|NCT03848949|458875896|FG001|Overall Study|Lost to Follow-up|7|||
127523397|NCT02353728|458875899|FG000|Overall Study|Subject non-compliance|1|||
127523398|NCT02301624|458875900|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
127523399|NCT02301624|458875901|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
127523400|NCT02301624|458875900|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
127523401|NCT02301624|458875901|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
127523402|NCT02301624|458875900|FG000|Open-label Maintenance Phase|Adverse Event|2|||
127523403|NCT02301624|458875901|FG001|Open-label Maintenance Phase|Adverse Event|5|||
127523404|NCT02301624|458875900|FG000|Open-label Maintenance Phase|Physician Decision|3|||
127523405|NCT02301624|458875901|FG001|Open-label Maintenance Phase|Physician Decision|3|||
127523406|NCT02301624|458875900|FG000|Open-label Maintenance Phase|Death|2|||
127523407|NCT02301624|458875901|FG001|Open-label Maintenance Phase|Death|1|||
127523408|NCT02301624|458875900|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
127523409|NCT02301624|458875901|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
127523410|NCT00895310|458875902|FG000|Overall Study|Withdrawal by Subject|1|||
127523411|NCT00619307|458875903|FG000|Overall Study|Adverse Event|0|||
127523412|NCT00619307|458875904|FG001|Overall Study|Adverse Event|1|||
127523413|NCT00619307|458875903|FG000|Overall Study|Lost to Follow-up|0|||
127523414|NCT00619307|458875904|FG001|Overall Study|Lost to Follow-up|1|||
127523415|NCT00619307|458875903|FG000|Overall Study|Protocol Violation|3|||
127523416|NCT00619307|458875904|FG001|Overall Study|Protocol Violation|0|||
127523417|NCT00619307|458875903|FG000|Overall Study|Withdrew consent|1|||
127523418|NCT00619307|458875904|FG001|Overall Study|Withdrew consent|0|||
127523419|NCT00619307|458875903|FG000|Overall Study|Severe migraine|0|||
127523420|NCT00619307|458875904|FG001|Overall Study|Severe migraine|1|||
127523421|NCT00619307|458875903|FG000|Overall Study|MS attack plus steroids|0|||
127523422|NCT00619307|458875904|FG001|Overall Study|MS attack plus steroids|1|||
127523423|NCT00547521|458875905|FG000|Short Term Study (4 Months)|Adverse Event|1|||
127523424|NCT00547521|458875906|FG001|Short Term Study (4 Months)|Adverse Event|0|||
127523425|NCT00547521|458875905|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
127523426|NCT00547521|458875906|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
127523427|NCT00547521|458875905|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
127523428|NCT00547521|458875906|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
127523429|NCT00547521|458875905|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
127523430|NCT00547521|458875906|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
127523431|NCT00547521|458875905|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
127523432|NCT00547521|458875906|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
127523433|NCT00547521|458875905|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
127523434|NCT00547521|458875906|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
127523435|NCT00547521|458875905|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
127523436|NCT00547521|458875906|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
127523437|NCT00547521|458875905|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
127523438|NCT00547521|458875906|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
127523439|NCT00547521|458875905|FG000|Long Term Extension (LTE) Study|Other|0|||
127523440|NCT00547521|458875906|FG001|Long Term Extension (LTE) Study|Other|2|||
127523441|NCT00547521|458875905|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
127523442|NCT00547521|458875906|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
127523443|NCT03210961|458877724|FG000|Overall Study|Adverse Event|0|||
127523444|NCT03210961|458877725|FG001|Overall Study|Adverse Event|0|||
127523445|NCT03210961|458877726|FG002|Overall Study|Adverse Event|0|||
127523446|NCT03210961|458877727|FG003|Overall Study|Adverse Event|0|||
127523447|NCT03210961|458877728|FG004|Overall Study|Adverse Event|0|||
127523448|NCT03210961|458877729|FG005|Overall Study|Adverse Event|0|||
127523449|NCT03210961|458877730|FG006|Overall Study|Adverse Event|0|||
127523450|NCT03210961|458877731|FG007|Overall Study|Adverse Event|0|||
127523451|NCT03210961|458877732|FG008|Overall Study|Adverse Event|0|||
127523452|NCT03210961|458877733|FG009|Overall Study|Adverse Event|0|||
127523453|NCT03210961|458877734|FG010|Overall Study|Adverse Event|0|||
127523454|NCT03210961|458877735|FG011|Overall Study|Adverse Event|0|||
127523455|NCT03210961|458877736|FG012|Overall Study|Adverse Event|0|||
127523456|NCT03210961|458877737|FG013|Overall Study|Adverse Event|1|||
127523457|NCT03210961|458877738|FG014|Overall Study|Adverse Event|0|||
127523458|NCT03210961|458877724|FG000|Overall Study|Lost to Follow-up|0|||
127523459|NCT03210961|458877725|FG001|Overall Study|Lost to Follow-up|0|||
127523460|NCT03210961|458877726|FG002|Overall Study|Lost to Follow-up|0|||
127523461|NCT03210961|458877727|FG003|Overall Study|Lost to Follow-up|0|||
127523462|NCT03210961|458877728|FG004|Overall Study|Lost to Follow-up|0|||
127523463|NCT03210961|458877729|FG005|Overall Study|Lost to Follow-up|0|||
127523464|NCT03210961|458877730|FG006|Overall Study|Lost to Follow-up|0|||
127523465|NCT03210961|458877731|FG007|Overall Study|Lost to Follow-up|0|||
127523466|NCT03210961|458877732|FG008|Overall Study|Lost to Follow-up|0|||
127523467|NCT03210961|458877733|FG009|Overall Study|Lost to Follow-up|0|||
127523468|NCT03210961|458877734|FG010|Overall Study|Lost to Follow-up|0|||
127523469|NCT03210961|458877735|FG011|Overall Study|Lost to Follow-up|0|||
127523470|NCT03210961|458877736|FG012|Overall Study|Lost to Follow-up|0|||
127523471|NCT03210961|458877737|FG013|Overall Study|Lost to Follow-up|0|||
127523472|NCT03210961|458877738|FG014|Overall Study|Lost to Follow-up|1|||
127523473|NCT03210961|458877724|FG000|Overall Study|Withdrawal by Subject|0|||
127523474|NCT03210961|458877725|FG001|Overall Study|Withdrawal by Subject|0|||
127523475|NCT03210961|458877726|FG002|Overall Study|Withdrawal by Subject|0|||
127523476|NCT03210961|458877727|FG003|Overall Study|Withdrawal by Subject|0|||
127523477|NCT03210961|458877728|FG004|Overall Study|Withdrawal by Subject|0|||
127523478|NCT03210961|458877729|FG005|Overall Study|Withdrawal by Subject|0|||
127523479|NCT03210961|458877730|FG006|Overall Study|Withdrawal by Subject|0|||
127523480|NCT03210961|458877731|FG007|Overall Study|Withdrawal by Subject|0|||
127523481|NCT03210961|458877732|FG008|Overall Study|Withdrawal by Subject|0|||
127523482|NCT03210961|458877733|FG009|Overall Study|Withdrawal by Subject|0|||
127523483|NCT03210961|458877734|FG010|Overall Study|Withdrawal by Subject|0|||
127523484|NCT03210961|458877735|FG011|Overall Study|Withdrawal by Subject|0|||
127523485|NCT03210961|458877736|FG012|Overall Study|Withdrawal by Subject|0|||
127523486|NCT03210961|458877737|FG013|Overall Study|Withdrawal by Subject|0|||
127523487|NCT03210961|458877738|FG014|Overall Study|Withdrawal by Subject|1|||
127523488|NCT03210961|458877724|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
127523489|NCT03210961|458877725|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
127523490|NCT03210961|458877726|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
127523491|NCT03210961|458877727|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
127523492|NCT03210961|458877728|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
127523493|NCT03210961|458877729|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
127523494|NCT03210961|458877730|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
127523495|NCT03210961|458877731|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
127523496|NCT03210961|458877732|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
127523497|NCT03210961|458877733|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
127523498|NCT03210961|458877734|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
127523499|NCT03210961|458877735|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
127523500|NCT03210961|458877736|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
127523501|NCT03210961|458877737|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
127523502|NCT03210961|458877738|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
127523503|NCT03210961|458877724|FG000|Overall Study|Other|0|||
127523504|NCT03210961|458877725|FG001|Overall Study|Other|0|||
127523505|NCT03210961|458877726|FG002|Overall Study|Other|0|||
127523506|NCT03210961|458877727|FG003|Overall Study|Other|1|||
127523507|NCT03210961|458877728|FG004|Overall Study|Other|0|||
127523508|NCT03210961|458877729|FG005|Overall Study|Other|0|||
127523509|NCT03210961|458877730|FG006|Overall Study|Other|1|||
127523510|NCT03210961|458877731|FG007|Overall Study|Other|0|||
127523511|NCT03210961|458877732|FG008|Overall Study|Other|0|||
127523512|NCT03210961|458877733|FG009|Overall Study|Other|0|||
127523513|NCT03210961|458877734|FG010|Overall Study|Other|1|||
127523514|NCT03210961|458877735|FG011|Overall Study|Other|0|||
127523515|NCT03210961|458877736|FG012|Overall Study|Other|2|||
127523516|NCT03210961|458877737|FG013|Overall Study|Other|2|||
127523517|NCT03210961|458877738|FG014|Overall Study|Other|0|||
127523518|NCT03077919|458877745|FG000|Overall Study|Lost to Follow-up|4|||
127523519|NCT03077919|458877746|FG001|Overall Study|Lost to Follow-up|1|||
127523520|NCT01031979|458877749|FG000|Overall Study|Lost to Follow-up|5|||
127523521|NCT01031979|458877750|FG001|Overall Study|Lost to Follow-up|4|||
127523522|NCT03831100|458877752|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
127523523|NCT03831100|458877753|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
127523524|NCT01487265|458877758|FG000|Overall Study|Adverse Event|8|||
127523525|NCT01487265|458877758|FG000|Overall Study|Withdrawal by Subject|5|||
127523526|NCT01487265|458877758|FG000|Overall Study|Disease Progression|21|||
127523527|NCT01487265|458877758|FG000|Overall Study|Death|2|||
127523528|NCT01487265|458877758|FG000|Overall Study|Still on Treatment|1|||
127523529|NCT01618695|458877760|FG000|Core Phase|Adverse Event|4|||
127523530|NCT01618695|458877761|FG001|Core Phase|Adverse Event|5|||
127523531|NCT01618695|458877762|FG002|Core Phase|Adverse Event|15|||
127523532|NCT01618695|458877763|FG003|Core Phase|Adverse Event|20|||
127523533|NCT01618695|458877760|FG000|Core Phase|Lost to Follow-up|0|||
127523534|NCT01618695|458877761|FG001|Core Phase|Lost to Follow-up|0|||
127523535|NCT01618695|458877762|FG002|Core Phase|Lost to Follow-up|1|||
127523536|NCT01618695|458877763|FG003|Core Phase|Lost to Follow-up|0|||
127523537|NCT01618695|458877760|FG000|Core Phase|Withdrawal by Subject|16|||
127523538|NCT01618695|458877761|FG001|Core Phase|Withdrawal by Subject|11|||
127523539|NCT01618695|458877762|FG002|Core Phase|Withdrawal by Subject|9|||
127523540|NCT01618695|458877763|FG003|Core Phase|Withdrawal by Subject|13|||
127523541|NCT01618695|458877760|FG000|Core Phase|Pregnancy|2|||
127523542|NCT01618695|458877761|FG001|Core Phase|Pregnancy|0|||
127523543|NCT01618695|458877762|FG002|Core Phase|Pregnancy|0|||
127523544|NCT01618695|458877763|FG003|Core Phase|Pregnancy|0|||
127523545|NCT01618695|458877760|FG000|Core Phase|Lack of Efficacy|1|||
127523546|NCT01618695|458877761|FG001|Core Phase|Lack of Efficacy|2|||
127523547|NCT01618695|458877762|FG002|Core Phase|Lack of Efficacy|1|||
127523548|NCT01618695|458877763|FG003|Core Phase|Lack of Efficacy|1|||
127523549|NCT01618695|458877760|FG000|Core Phase|Other than specified|1|||
127523550|NCT01618695|458877761|FG001|Core Phase|Other than specified|2|||
127523551|NCT01618695|458877762|FG002|Core Phase|Other than specified|2|||
127523552|NCT01618695|458877763|FG003|Core Phase|Other than specified|2|||
127523553|NCT01618695|458877760|FG000|Core Phase|Not treated|1|||
127523554|NCT01618695|458877761|FG001|Core Phase|Not treated|0|||
127523555|NCT01618695|458877762|FG002|Core Phase|Not treated|2|||
127523556|NCT01618695|458877763|FG003|Core Phase|Not treated|0|||
127523557|NCT01618695|458877760|FG000|Extension Phase|Lack of Efficacy|17|||
127523558|NCT01618695|458877761|FG001|Extension Phase|Lack of Efficacy|33|||
127523559|NCT01618695|458877762|FG002|Extension Phase|Lack of Efficacy|26|||
127523560|NCT01618695|458877763|FG003|Extension Phase|Lack of Efficacy|24|||
127523561|NCT01618695|458877760|FG000|Extension Phase|Pregnancy|2|||
127523562|NCT01618695|458877761|FG001|Extension Phase|Pregnancy|0|||
127523563|NCT01618695|458877762|FG002|Extension Phase|Pregnancy|1|||
127523564|NCT01618695|458877763|FG003|Extension Phase|Pregnancy|1|||
127523565|NCT01618695|458877760|FG000|Extension Phase|Withdrawal by Subject|43|||
127523566|NCT01618695|458877761|FG001|Extension Phase|Withdrawal by Subject|48|||
127523567|NCT01618695|458877762|FG002|Extension Phase|Withdrawal by Subject|42|||
127523568|NCT01618695|458877763|FG003|Extension Phase|Withdrawal by Subject|33|||
127523569|NCT01618695|458877760|FG000|Extension Phase|Adverse Event|18|||
127523570|NCT01618695|458877761|FG001|Extension Phase|Adverse Event|16|||
127523571|NCT01618695|458877762|FG002|Extension Phase|Adverse Event|9|||
127523572|NCT01618695|458877763|FG003|Extension Phase|Adverse Event|20|||
127523573|NCT01618695|458877760|FG000|Extension Phase|Lost to Follow-up|2|||
127523574|NCT01618695|458877761|FG001|Extension Phase|Lost to Follow-up|1|||
127523575|NCT01618695|458877762|FG002|Extension Phase|Lost to Follow-up|1|||
127523576|NCT01618695|458877763|FG003|Extension Phase|Lost to Follow-up|1|||
127523577|NCT01618695|458877760|FG000|Extension Phase|Other than specified|13|||
127523578|NCT01618695|458877761|FG001|Extension Phase|Other than specified|18|||
127523579|NCT01618695|458877762|FG002|Extension Phase|Other than specified|13|||
127523580|NCT01618695|458877763|FG003|Extension Phase|Other than specified|18|||
127523581|NCT02454478|458877766|FG000|Overall Study|Incomplete DLT Evaluation|1|||
127523582|NCT03229109|458877774|FG000|Overall Study|Withdrawal by Subject|0|||
127523583|NCT03229109|458877775|FG001|Overall Study|Withdrawal by Subject|0|||
127523584|NCT03229109|458877776|FG002|Overall Study|Withdrawal by Subject|0|||
127523585|NCT03229109|458877777|FG003|Overall Study|Withdrawal by Subject|1|||
127523586|NCT04207749|458877778|FG000|Overall Study|Lost to Follow-up|0|||
127523587|NCT04207749|458877779|FG001|Overall Study|Lost to Follow-up|2|||
127523588|NCT04207749|458877778|FG000|Overall Study|Protocol Violation|0|||
127523589|NCT04207749|458877779|FG001|Overall Study|Protocol Violation|1|||
127523590|NCT04207749|458877778|FG000|Overall Study|Withdrawal by Subject|3|||
127523591|NCT04207749|458877779|FG001|Overall Study|Withdrawal by Subject|0|||
127523592|NCT04207749|458877778|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
127523593|NCT04207749|458877779|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
127523594|NCT01835223|458877780|FG000|Overall Study|Adverse Event|1|||
127523595|NCT01835223|458877781|FG001|Overall Study|Adverse Event|0|||
127523596|NCT01835223|458877780|FG000|Overall Study|Withdrawal by Subject|2|||
127523597|NCT01835223|458877781|FG001|Overall Study|Withdrawal by Subject|0|||
127523598|NCT01835223|458877780|FG000|Overall Study|Disease progression|2|||
127523599|NCT01835223|458877781|FG001|Overall Study|Disease progression|1|||
127523600|NCT01835223|458877780|FG000|Overall Study|Became Inelligible|4|||
127523601|NCT01835223|458877781|FG001|Overall Study|Became Inelligible|0|||
127523602|NCT01504841|458877782|FG000|Overall Study|Withdrawal by Subject|1|||
127523603|NCT01504841|458877783|FG001|Overall Study|Withdrawal by Subject|1|||
127523604|NCT01504841|458877784|FG002|Overall Study|Withdrawal by Subject|0|||
127523605|NCT03679624|458877785|FG000|Overall Study|Adverse Event|1|||
127523606|NCT03679624|458877786|FG001|Overall Study|Adverse Event|0|||
127523607|NCT01610336|458877787|FG000|Overall Study|Progressive Disease|4|||
127523608|NCT01610336|458877788|FG001|Overall Study|Progressive Disease|6|||
127523609|NCT01610336|458877789|FG002|Overall Study|Progressive Disease|6|||
127523610|NCT01610336|458877790|FG003|Overall Study|Progressive Disease|5|||
127523611|NCT01610336|458877791|FG004|Overall Study|Progressive Disease|3|||
127523612|NCT01610336|458877792|FG005|Overall Study|Progressive Disease|10|||
127523613|NCT01610336|458877793|FG006|Overall Study|Progressive Disease|1|||
127523614|NCT01610336|458877794|FG007|Overall Study|Progressive Disease|6|||
127523615|NCT01610336|458877795|FG008|Overall Study|Progressive Disease|6|||
127523616|NCT01610336|458877796|FG009|Overall Study|Progressive Disease|40|||
127523617|NCT01610336|458877797|FG010|Overall Study|Progressive Disease|36|||
127523618|NCT01610336|458877787|FG000|Overall Study|Adverse Event|0|||
127523619|NCT01610336|458877788|FG001|Overall Study|Adverse Event|0|||
127523620|NCT01610336|458877789|FG002|Overall Study|Adverse Event|0|||
127523621|NCT01610336|458877790|FG003|Overall Study|Adverse Event|1|||
127523622|NCT01610336|458877791|FG004|Overall Study|Adverse Event|1|||
127523623|NCT01610336|458877792|FG005|Overall Study|Adverse Event|1|||
127523624|NCT01610336|458877793|FG006|Overall Study|Adverse Event|0|||
127523625|NCT01610336|458877794|FG007|Overall Study|Adverse Event|0|||
127523626|NCT01610336|458877795|FG008|Overall Study|Adverse Event|2|||
127523627|NCT01610336|458877796|FG009|Overall Study|Adverse Event|8|||
127523628|NCT01610336|458877797|FG010|Overall Study|Adverse Event|6|||
127523629|NCT01610336|458877787|FG000|Overall Study|Subject/Guardian decision|1|||
127523630|NCT01610336|458877788|FG001|Overall Study|Subject/Guardian decision|1|||
127523631|NCT01610336|458877789|FG002|Overall Study|Subject/Guardian decision|0|||
127523632|NCT01610336|458877790|FG003|Overall Study|Subject/Guardian decision|1|||
127523633|NCT01610336|458877791|FG004|Overall Study|Subject/Guardian decision|0|||
127523634|NCT01610336|458877792|FG005|Overall Study|Subject/Guardian decision|0|||
127523635|NCT01610336|458877793|FG006|Overall Study|Subject/Guardian decision|0|||
127523636|NCT01610336|458877794|FG007|Overall Study|Subject/Guardian decision|1|||
127523637|NCT01610336|458877795|FG008|Overall Study|Subject/Guardian decision|0|||
127523638|NCT01610336|458877796|FG009|Overall Study|Subject/Guardian decision|2|||
127523639|NCT01610336|458877797|FG010|Overall Study|Subject/Guardian decision|2|||
127523640|NCT01610336|458877787|FG000|Overall Study|Death|0|||
127523641|NCT01610336|458877788|FG001|Overall Study|Death|0|||
127523642|NCT01610336|458877789|FG002|Overall Study|Death|0|||
127523643|NCT01610336|458877790|FG003|Overall Study|Death|0|||
127523644|NCT01610336|458877791|FG004|Overall Study|Death|0|||
127523645|NCT01610336|458877792|FG005|Overall Study|Death|1|||
127523646|NCT01610336|458877793|FG006|Overall Study|Death|3|||
127523647|NCT01610336|458877794|FG007|Overall Study|Death|0|||
127523648|NCT01610336|458877795|FG008|Overall Study|Death|0|||
127523649|NCT01610336|458877796|FG009|Overall Study|Death|1|||
127523650|NCT01610336|458877797|FG010|Overall Study|Death|2|||
127523651|NCT01610336|458877787|FG000|Overall Study|Non-Compliance with study treatment|0|||
127523652|NCT01610336|458877788|FG001|Overall Study|Non-Compliance with study treatment|0|||
127523653|NCT01610336|458877789|FG002|Overall Study|Non-Compliance with study treatment|0|||
127523654|NCT01610336|458877790|FG003|Overall Study|Non-Compliance with study treatment|0|||
127523655|NCT01610336|458877791|FG004|Overall Study|Non-Compliance with study treatment|0|||
127523656|NCT01610336|458877792|FG005|Overall Study|Non-Compliance with study treatment|0|||
127523657|NCT01610336|458877793|FG006|Overall Study|Non-Compliance with study treatment|0|||
127523658|NCT01610336|458877794|FG007|Overall Study|Non-Compliance with study treatment|0|||
127523659|NCT01610336|458877795|FG008|Overall Study|Non-Compliance with study treatment|0|||
127523660|NCT01610336|458877796|FG009|Overall Study|Non-Compliance with study treatment|1|||
127523661|NCT01610336|458877797|FG010|Overall Study|Non-Compliance with study treatment|0|||
127523662|NCT01610336|458877787|FG000|Overall Study|Physician Decision|0|||
127523663|NCT01610336|458877788|FG001|Overall Study|Physician Decision|0|||
127523664|NCT01610336|458877789|FG002|Overall Study|Physician Decision|0|||
127523665|NCT01610336|458877790|FG003|Overall Study|Physician Decision|0|||
127523666|NCT01610336|458877791|FG004|Overall Study|Physician Decision|0|||
127523667|NCT01610336|458877792|FG005|Overall Study|Physician Decision|0|||
127523668|NCT01610336|458877793|FG006|Overall Study|Physician Decision|1|||
127523669|NCT01610336|458877794|FG007|Overall Study|Physician Decision|0|||
127523670|NCT01610336|458877795|FG008|Overall Study|Physician Decision|0|||
127523671|NCT01610336|458877796|FG009|Overall Study|Physician Decision|0|||
127523672|NCT01610336|458877797|FG010|Overall Study|Physician Decision|0|||
127523673|NCT01610336|458877787|FG000|Overall Study|Protocol Deviation|0|||
127523674|NCT01610336|458877788|FG001|Overall Study|Protocol Deviation|0|||
127523675|NCT01610336|458877789|FG002|Overall Study|Protocol Deviation|0|||
127523676|NCT01610336|458877790|FG003|Overall Study|Protocol Deviation|0|||
127523677|NCT01610336|458877791|FG004|Overall Study|Protocol Deviation|0|||
127523678|NCT01610336|458877792|FG005|Overall Study|Protocol Deviation|0|||
127523679|NCT01610336|458877793|FG006|Overall Study|Protocol Deviation|0|||
127523680|NCT01610336|458877794|FG007|Overall Study|Protocol Deviation|0|||
127523681|NCT01610336|458877795|FG008|Overall Study|Protocol Deviation|0|||
127523682|NCT01610336|458877796|FG009|Overall Study|Protocol Deviation|1|||
127523683|NCT01610336|458877797|FG010|Overall Study|Protocol Deviation|0|||
127523684|NCT01610336|458877787|FG000|Overall Study|Transfer to another trial|0|||
127523685|NCT01610336|458877788|FG001|Overall Study|Transfer to another trial|0|||
127523686|NCT01610336|458877789|FG002|Overall Study|Transfer to another trial|0|||
127523687|NCT01610336|458877790|FG003|Overall Study|Transfer to another trial|0|||
127523688|NCT01610336|458877791|FG004|Overall Study|Transfer to another trial|0|||
127523689|NCT01610336|458877792|FG005|Overall Study|Transfer to another trial|0|||
127523690|NCT01610336|458877793|FG006|Overall Study|Transfer to another trial|0|||
127523691|NCT01610336|458877794|FG007|Overall Study|Transfer to another trial|0|||
127523692|NCT01610336|458877795|FG008|Overall Study|Transfer to another trial|0|||
127523693|NCT01610336|458877796|FG009|Overall Study|Transfer to another trial|0|||
127523694|NCT01610336|458877797|FG010|Overall Study|Transfer to another trial|1|||
127523695|NCT01559675|458877800|FG000|Overall Study|Protocol Violation|1|||
127523696|NCT01559675|458877801|FG001|Overall Study|Protocol Violation|2|||
127523697|NCT01559675|458877800|FG000|Overall Study|2nd operation on same patient excluded|14|||
127523698|NCT01559675|458877801|FG001|Overall Study|2nd operation on same patient excluded|12|||
127523699|NCT00291018|458877802|FG000|Overall Study|Not Consented or Declined PAS|12|||
127523700|NCT00291018|458877803|FG001|Overall Study|Not Consented or Declined PAS|15|||
127523701|NCT00291018|458877804|FG002|Overall Study|Not Consented or Declined PAS|15|||
127523702|NCT00291018|458877802|FG000|Overall Study|Death|3|||
127523703|NCT00291018|458877803|FG001|Overall Study|Death|3|||
127523704|NCT00291018|458877804|FG002|Overall Study|Death|4|||
127523705|NCT00291018|458877802|FG000|Overall Study|Withdrawal by Subject|2|||
127523706|NCT00291018|458877803|FG001|Overall Study|Withdrawal by Subject|8|||
127523707|NCT00291018|458877804|FG002|Overall Study|Withdrawal by Subject|1|||
127523708|NCT00291018|458877802|FG000|Overall Study|Failures|5|||
127523709|NCT00291018|458877803|FG001|Overall Study|Failures|12|||
127523710|NCT00291018|458877804|FG002|Overall Study|Failures|5|||
127523711|NCT00291018|458877802|FG000|Overall Study|Lost to Follow-up|3|||
127523712|NCT00291018|458877803|FG001|Overall Study|Lost to Follow-up|4|||
127523713|NCT00291018|458877804|FG002|Overall Study|Lost to Follow-up|18|||
127523714|NCT01496469|458877805|FG000|Overall Study|Adverse Event|1|||
127523715|NCT01496469|458877806|FG001|Overall Study|Adverse Event|0|||
127523716|NCT01496469|458877805|FG000|Overall Study|Protocol Violation|2|||
127523717|NCT01496469|458877806|FG001|Overall Study|Protocol Violation|0|||
127523718|NCT01496469|458877805|FG000|Overall Study|Lost to Follow-up|1|||
127523719|NCT01496469|458877806|FG001|Overall Study|Lost to Follow-up|1|||
127523720|NCT01496469|458877805|FG000|Overall Study|Withdrawal by Subject|4|||
127523721|NCT01496469|458877806|FG001|Overall Study|Withdrawal by Subject|4|||
127523722|NCT01496469|458877805|FG000|Overall Study|BP exceeds protocol limits|1|||
127523723|NCT01496469|458877806|FG001|Overall Study|BP exceeds protocol limits|2|||
127523724|NCT01496469|458877805|FG000|Overall Study|Other|1|||
127523725|NCT01496469|458877806|FG001|Overall Study|Other|1|||
127523726|NCT02202538|458877807|FG000|Overall Study|Withdrawal by Subject|5|||
127523727|NCT02202538|458877807|FG000|Overall Study|Did not meet all inclusion criteria|2|||
127523728|NCT02202538|458877807|FG000|Overall Study|Investigator Decision|1|||
127523729|NCT01853878|458877808|FG000|Overall Study|Recurrence|2|||
127523730|NCT01853878|458877809|FG001|Overall Study|Recurrence|0|||
127523731|NCT01853878|458877808|FG000|Overall Study|Adverse Event|2|||
127523732|NCT01853878|458877809|FG001|Overall Study|Adverse Event|0|||
127523733|NCT01853878|458877808|FG000|Overall Study|Withdrawal by Subject|3|||
127523734|NCT01853878|458877809|FG001|Overall Study|Withdrawal by Subject|1|||
127523735|NCT01853878|458877808|FG000|Overall Study|Migrated/moved from the study area|1|||
127523736|NCT01853878|458877809|FG001|Overall Study|Migrated/moved from the study area|0|||
127523737|NCT01853878|458877808|FG000|Overall Study|Other|55|||
127523738|NCT01853878|458877809|FG001|Overall Study|Other|43|||
127523739|NCT00465647|458877814|FG000|Overall Study|Administrative|2|||
127523740|NCT00465647|458877815|FG001|Overall Study|Administrative|2|||
127523741|NCT00465647|458877816|FG002|Overall Study|Administrative|3|||
127523742|NCT00465647|458877817|FG003|Overall Study|Administrative|2|||
127523743|NCT00465647|458877814|FG000|Overall Study|Adverse Event|2|||
127523744|NCT00465647|458877815|FG001|Overall Study|Adverse Event|0|||
127523745|NCT00465647|458877816|FG002|Overall Study|Adverse Event|3|||
127523746|NCT00465647|458877817|FG003|Overall Study|Adverse Event|2|||
127523747|NCT00465647|458877814|FG000|Overall Study|Withdrawal by Subject|1|||
127523748|NCT00465647|458877815|FG001|Overall Study|Withdrawal by Subject|2|||
127523749|NCT00465647|458877816|FG002|Overall Study|Withdrawal by Subject|2|||
127523750|NCT00465647|458877817|FG003|Overall Study|Withdrawal by Subject|7|||
127523751|NCT00465647|458877814|FG000|Overall Study|"The other reasons included loss of IV"|8|||
127523752|NCT00465647|458877815|FG001|Overall Study|"The other reasons included loss of IV"|4|||
127523753|NCT00465647|458877816|FG002|Overall Study|"The other reasons included loss of IV"|3|||
127523754|NCT00465647|458877817|FG003|Overall Study|"The other reasons included loss of IV"|2|||
127523755|NCT03916081|458877818|FG000|Overall Study|Adverse Event|1|||
127523756|NCT03916081|458877819|FG001|Overall Study|Adverse Event|0|||
127523757|NCT03916081|458877820|FG002|Overall Study|Adverse Event|0|||
127523758|NCT03916081|458877818|FG000|Overall Study|Physician Decision|0|||
127523759|NCT03916081|458877819|FG001|Overall Study|Physician Decision|0|||
127523760|NCT03916081|458877820|FG002|Overall Study|Physician Decision|1|||
127523761|NCT03916081|458877818|FG000|Overall Study|Lost to Follow-up|0|||
127523762|NCT03916081|458877819|FG001|Overall Study|Lost to Follow-up|1|||
127523763|NCT03916081|458877820|FG002|Overall Study|Lost to Follow-up|0|||
127523764|NCT03916081|458877818|FG000|Overall Study|Withdrawal by Subject|3|||
127523765|NCT03916081|458877819|FG001|Overall Study|Withdrawal by Subject|0|||
127523766|NCT03916081|458877820|FG002|Overall Study|Withdrawal by Subject|1|||
127523767|NCT03916081|458877818|FG000|Overall Study|Worsening of AD|0|||
127523768|NCT03916081|458877819|FG001|Overall Study|Worsening of AD|0|||
127523769|NCT03916081|458877820|FG002|Overall Study|Worsening of AD|1|||
127523770|NCT02828020|458877825|FG000|Treatment Period|Adverse Event|3|||
127523771|NCT02828020|458877826|FG001|Treatment Period|Adverse Event|1|||
127523772|NCT02828020|458877827|FG002|Treatment Period|Adverse Event|1|||
127523773|NCT02828020|458877825|FG000|Treatment Period|Withdrawal of Consent|10|||
127523774|NCT02828020|458877826|FG001|Treatment Period|Withdrawal of Consent|14|||
127523775|NCT02828020|458877827|FG002|Treatment Period|Withdrawal of Consent|9|||
127523776|NCT02828020|458877825|FG000|Treatment Period|Lost to Follow-up|21|||
127523777|NCT02828020|458877826|FG001|Treatment Period|Lost to Follow-up|24|||
127523778|NCT02828020|458877827|FG002|Treatment Period|Lost to Follow-up|18|||
127523779|NCT02828020|458877825|FG000|Treatment Period|Lack of Qualifying Event|44|||
127523780|NCT02828020|458877826|FG001|Treatment Period|Lack of Qualifying Event|53|||
127523781|NCT02828020|458877827|FG002|Treatment Period|Lack of Qualifying Event|43|||
127523782|NCT02828020|458877825|FG000|Treatment Period|Pregnancy|0|||
127523783|NCT02828020|458877826|FG001|Treatment Period|Pregnancy|2|||
127523784|NCT02828020|458877827|FG002|Treatment Period|Pregnancy|0|||
127523785|NCT02828020|458877825|FG000|Treatment Period|Protocol Violation|2|||
127523786|NCT02828020|458877826|FG001|Treatment Period|Protocol Violation|4|||
127523787|NCT02828020|458877827|FG002|Treatment Period|Protocol Violation|7|||
127523788|NCT02828020|458877825|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
127523789|NCT02828020|458877826|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
127523790|NCT02828020|458877827|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
127523791|NCT02828020|458877825|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
127523792|NCT02828020|458877826|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
127523793|NCT02828020|458877827|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
127523794|NCT02828020|458877825|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
127523795|NCT02828020|458877826|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
127523796|NCT02828020|458877827|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
127523797|NCT02828020|458877825|FG000|Safety Follow-up Period|Protocol Violation|0|||
127523798|NCT02828020|458877826|FG001|Safety Follow-up Period|Protocol Violation|2|||
127523799|NCT02828020|458877827|FG002|Safety Follow-up Period|Protocol Violation|1|||
127523800|NCT02828020|458877825|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
127523801|NCT02828020|458877826|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
127523802|NCT02828020|458877827|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
127523803|NCT01339897|458877828|FG000|Overall Study|Adverse Event|1|||
127523804|NCT01339897|458877829|FG001|Overall Study|Adverse Event|0|||
127523805|NCT01339897|458877830|FG002|Overall Study|Adverse Event|0|||
127523806|NCT01339897|458877831|FG003|Overall Study|Adverse Event|1|||
127523807|NCT01138501|458877832|FG000|Overall Study|Protocol Violation|2|||
127523808|NCT01138501|458877832|FG000|Overall Study|Withdrawal by Subject|3|||
127523809|NCT00847197|458877835|FG000|Overall Study|Adverse Event|21|||
127523810|NCT00847197|458877836|FG001|Overall Study|Adverse Event|3|||
127523811|NCT00847197|458877835|FG000|Overall Study|Protocol Violation|0|||
127523812|NCT00847197|458877836|FG001|Overall Study|Protocol Violation|1|||
127523813|NCT00847197|458877835|FG000|Overall Study|Withdrawal by Subject|3|||
127523814|NCT00847197|458877836|FG001|Overall Study|Withdrawal by Subject|1|||
127523815|NCT00348309|458877837|FG000|Overall Study|Adverse Event|56|||
127523816|NCT00348309|458877838|FG001|Overall Study|Adverse Event|28|||
127523817|NCT00348309|458877839|FG002|Overall Study|Adverse Event|63|||
127523818|NCT00348309|458877837|FG000|Overall Study|Lost to Follow-up|6|||
127523819|NCT00348309|458877838|FG001|Overall Study|Lost to Follow-up|7|||
127523820|NCT00348309|458877839|FG002|Overall Study|Lost to Follow-up|4|||
127523821|NCT00348309|458877837|FG000|Overall Study|Protocol Violation|7|||
127523822|NCT00348309|458877838|FG001|Overall Study|Protocol Violation|12|||
127523823|NCT00348309|458877839|FG002|Overall Study|Protocol Violation|7|||
127523824|NCT00348309|458877837|FG000|Overall Study|Withdrawal by Subject|33|||
127523825|NCT00348309|458877838|FG001|Overall Study|Withdrawal by Subject|37|||
127523826|NCT00348309|458877839|FG002|Overall Study|Withdrawal by Subject|40|||
127523827|NCT00348309|458877837|FG000|Overall Study|Non-compliance|8|||
127523828|NCT00348309|458877838|FG001|Overall Study|Non-compliance|6|||
127523829|NCT00348309|458877839|FG002|Overall Study|Non-compliance|8|||
127523830|NCT00348309|458877837|FG000|Overall Study|Death of caregiver|1|||
127523831|NCT00348309|458877838|FG001|Overall Study|Death of caregiver|0|||
127523832|NCT00348309|458877839|FG002|Overall Study|Death of caregiver|1|||
127523833|NCT00348309|458877837|FG000|Overall Study|Lack of insight, dementia|1|||
127523834|NCT00348309|458877838|FG001|Overall Study|Lack of insight, dementia|0|||
127523835|NCT00348309|458877839|FG002|Overall Study|Lack of insight, dementia|0|||
127523836|NCT00348309|458877837|FG000|Overall Study|Wrong bottle allocated|1|||
127523837|NCT00348309|458877838|FG001|Overall Study|Wrong bottle allocated|0|||
127523838|NCT00348309|458877839|FG002|Overall Study|Wrong bottle allocated|0|||
127523839|NCT00348309|458877837|FG000|Overall Study|Caregiver sick|1|||
127523840|NCT00348309|458877838|FG001|Overall Study|Caregiver sick|0|||
127523841|NCT00348309|458877839|FG002|Overall Study|Caregiver sick|0|||
127523842|NCT00348309|458877837|FG000|Overall Study|Use of prohibited medication|5|||
127523843|NCT00348309|458877838|FG001|Overall Study|Use of prohibited medication|2|||
127523844|NCT00348309|458877839|FG002|Overall Study|Use of prohibited medication|2|||
127523845|NCT00348309|458877837|FG000|Overall Study|Caregiver withdrawal|3|||
127523846|NCT00348309|458877838|FG001|Overall Study|Caregiver withdrawal|0|||
127523847|NCT00348309|458877839|FG002|Overall Study|Caregiver withdrawal|7|||
127523848|NCT00348309|458877837|FG000|Overall Study|Unable to complete ET visit|1|||
127523849|NCT00348309|458877838|FG001|Overall Study|Unable to complete ET visit|0|||
127523850|NCT00348309|458877839|FG002|Overall Study|Unable to complete ET visit|0|||
127523851|NCT00348309|458877837|FG000|Overall Study|PI closing medical practice|1|||
127523852|NCT00348309|458877838|FG001|Overall Study|PI closing medical practice|0|||
127523853|NCT00348309|458877839|FG002|Overall Study|PI closing medical practice|0|||
127523854|NCT00348309|458877837|FG000|Overall Study|Principal investigator's decision|1|||
127523855|NCT00348309|458877838|FG001|Overall Study|Principal investigator's decision|0|||
127523856|NCT00348309|458877839|FG002|Overall Study|Principal investigator's decision|0|||
127523857|NCT00348309|458877837|FG000|Overall Study|No disponibility of medication|1|||
127523858|NCT00348309|458877838|FG001|Overall Study|No disponibility of medication|0|||
127523859|NCT00348309|458877839|FG002|Overall Study|No disponibility of medication|0|||
127523860|NCT00348309|458877837|FG000|Overall Study|Worsened neurodegenerative disease|1|||
127523861|NCT00348309|458877838|FG001|Overall Study|Worsened neurodegenerative disease|0|||
127523862|NCT00348309|458877839|FG002|Overall Study|Worsened neurodegenerative disease|0|||
127523863|NCT00348309|458877837|FG000|Overall Study|Cognitive and behaviour worsening|2|||
127523864|NCT00348309|458877838|FG001|Overall Study|Cognitive and behaviour worsening|0|||
127523865|NCT00348309|458877839|FG002|Overall Study|Cognitive and behaviour worsening|0|||
127523866|NCT00348309|458877837|FG000|Overall Study|Worsening of alzheimer|1|||
127523867|NCT00348309|458877838|FG001|Overall Study|Worsening of alzheimer|0|||
127523868|NCT00348309|458877839|FG002|Overall Study|Worsening of alzheimer|1|||
127523869|NCT00348309|458877837|FG000|Overall Study|Did not appear in time for Visit 3|1|||
127523870|NCT00348309|458877838|FG001|Overall Study|Did not appear in time for Visit 3|0|||
127523871|NCT00348309|458877839|FG002|Overall Study|Did not appear in time for Visit 3|0|||
127523872|NCT00348309|458877837|FG000|Overall Study|Participant died|2|||
127523873|NCT00348309|458877838|FG001|Overall Study|Participant died|1|||
127523874|NCT00348309|458877839|FG002|Overall Study|Participant died|1|||
127523875|NCT00348309|458877837|FG000|Overall Study|Decision of sponsor|1|||
127523876|NCT00348309|458877838|FG001|Overall Study|Decision of sponsor|0|||
127523877|NCT00348309|458877839|FG002|Overall Study|Decision of sponsor|0|||
127523878|NCT00348309|458877837|FG000|Overall Study|Ineffectiveness of treatment|0|||
127523879|NCT00348309|458877838|FG001|Overall Study|Ineffectiveness of treatment|1|||
127523880|NCT00348309|458877839|FG002|Overall Study|Ineffectiveness of treatment|0|||
127523881|NCT00348309|458877837|FG000|Overall Study|A foul of exclusion criteria|0|||
127523882|NCT00348309|458877838|FG001|Overall Study|A foul of exclusion criteria|1|||
127523883|NCT00348309|458877839|FG002|Overall Study|A foul of exclusion criteria|0|||
127523884|NCT00348309|458877837|FG000|Overall Study|Participant was hospitalized|0|||
127523885|NCT00348309|458877838|FG001|Overall Study|Participant was hospitalized|1|||
127523886|NCT00348309|458877839|FG002|Overall Study|Participant was hospitalized|0|||
127523887|NCT00348309|458877837|FG000|Overall Study|Sponsor refuseal|0|||
127523888|NCT00348309|458877838|FG001|Overall Study|Sponsor refuseal|1|||
127523889|NCT00348309|458877839|FG002|Overall Study|Sponsor refuseal|1|||
127523890|NCT00348309|458877837|FG000|Overall Study|Forgot often medication|0|||
127523891|NCT00348309|458877838|FG001|Overall Study|Forgot often medication|1|||
127523892|NCT00348309|458877839|FG002|Overall Study|Forgot often medication|0|||
127523893|NCT00348309|458877837|FG000|Overall Study|Medical Monitor decision|0|||
127523894|NCT00348309|458877838|FG001|Overall Study|Medical Monitor decision|0|||
127523895|NCT00348309|458877839|FG002|Overall Study|Medical Monitor decision|1|||
127523896|NCT00348309|458877837|FG000|Overall Study|Increased dose of Aricept|0|||
127523897|NCT00348309|458877838|FG001|Overall Study|Increased dose of Aricept|0|||
127523898|NCT00348309|458877839|FG002|Overall Study|Increased dose of Aricept|1|||
127523899|NCT00348309|458877837|FG000|Overall Study|Site closure|0|||
127523900|NCT00348309|458877838|FG001|Overall Study|Site closure|0|||
127523901|NCT00348309|458877839|FG002|Overall Study|Site closure|1|||
127523902|NCT00348309|458877837|FG000|Overall Study|Adverse event not attended|0|||
127523903|NCT00348309|458877838|FG001|Overall Study|Adverse event not attended|0|||
127523904|NCT00348309|458877839|FG002|Overall Study|Adverse event not attended|1|||
127523905|NCT00348309|458877837|FG000|Overall Study|ECG abnormal|0|||
127523906|NCT00348309|458877838|FG001|Overall Study|ECG abnormal|0|||
127523907|NCT00348309|458877839|FG002|Overall Study|ECG abnormal|2|||
127523908|NCT00348309|458877837|FG000|Overall Study|Cardiologist recommendations|0|||
127523909|NCT00348309|458877838|FG001|Overall Study|Cardiologist recommendations|0|||
127523910|NCT00348309|458877839|FG002|Overall Study|Cardiologist recommendations|1|||
127523911|NCT00348309|458877837|FG000|Overall Study|HCV career|0|||
127523912|NCT00348309|458877838|FG001|Overall Study|HCV career|0|||
127523913|NCT00348309|458877839|FG002|Overall Study|HCV career|1|||
127523914|NCT00622388|458877840|FG000|Overall Study|Disease Progression|47|||
127523915|NCT00622388|458877840|FG000|Overall Study|Adverse Event|6|||
127523916|NCT00622388|458877840|FG000|Overall Study|Protocol Violation|3|||
127523917|NCT00622388|458877840|FG000|Overall Study|Participant Refusal|1|||
127523918|NCT00622388|458877840|FG000|Overall Study|Death|3|||
127523919|NCT00622388|458877840|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
127523920|NCT00622388|458877840|FG000|Overall Study|Took Prohibited Medication|2|||
127523921|NCT00622388|458877840|FG000|Overall Study|Withdrew Consent|1|||
127523922|NCT00622388|458877840|FG000|Overall Study|Insurance Expired|1|||
127523923|NCT01743040|458877841|FG000|Overall Study|Death|1|||
127523924|NCT01743040|458877841|FG000|Overall Study|Lost to Follow-up|66|||
127523925|NCT01743040|458877841|FG000|Overall Study|Physician Decision|40|||
127523926|NCT01743040|458877841|FG000|Overall Study|Protocol Violation|1|||
127523927|NCT01743040|458877841|FG000|Overall Study|Withdrawal by Subject|121|||
127523928|NCT01894243|458877842|FG000|Overall Study|Adverse Event|0|||
127523929|NCT01894243|458877843|FG001|Overall Study|Adverse Event|1|||
127523930|NCT01894243|458877844|FG002|Overall Study|Adverse Event|2|||
127523931|NCT01894243|458877842|FG000|Overall Study|Death|0|||
127523932|NCT01894243|458877843|FG001|Overall Study|Death|0|||
127523933|NCT01894243|458877844|FG002|Overall Study|Death|3|||
127523934|NCT01894243|458877842|FG000|Overall Study|Lack of Efficacy|3|||
127523935|NCT01894243|458877843|FG001|Overall Study|Lack of Efficacy|3|||
127523936|NCT01894243|458877844|FG002|Overall Study|Lack of Efficacy|1|||
127523937|NCT01894243|458877842|FG000|Overall Study|Condition under investigation worsened|8|||
127523938|NCT01894243|458877843|FG001|Overall Study|Condition under investigation worsened|6|||
127523939|NCT01894243|458877844|FG002|Overall Study|Condition under investigation worsened|2|||
127523940|NCT01894243|458877842|FG000|Overall Study|Subject decision|1|||
127523941|NCT01894243|458877843|FG001|Overall Study|Subject decision|0|||
127523942|NCT01894243|458877844|FG002|Overall Study|Subject decision|0|||
127523943|NCT01894243|458877842|FG000|Overall Study|Other|1|||
127523944|NCT01894243|458877843|FG001|Overall Study|Other|0|||
127523945|NCT01894243|458877844|FG002|Overall Study|Other|0|||
127523946|NCT00828750|458877845|FG000|Overall Study|Lack of Efficacy|3|||
127523947|NCT00828750|458877845|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
127523948|NCT00830180|458877849|FG000|Overall Study|Adverse Event|6|||
127523949|NCT00830180|458877849|FG000|Overall Study|Death|11|||
127523950|NCT00830180|458877849|FG000|Overall Study|Insufficient clinical response|1|||
127523951|NCT00830180|458877849|FG000|Overall Study|Withdrawal by Subject|5|||
127523952|NCT00830180|458877849|FG000|Overall Study|Progressive disease|2|||
127523953|NCT00830180|458877849|FG000|Overall Study|Other - Unspecified|1|||
127523954|NCT01832532|458877850|FG000|Overall Study|Withdrawal by Subject|5|||
127523955|NCT01832532|458877851|FG001|Overall Study|Withdrawal by Subject|2|||
127523956|NCT02687581|458877853|FG000|Overall Study|Withdrawal by Subject|1|||
127523957|NCT02687581|458877854|FG001|Overall Study|Withdrawal by Subject|0|||
127523958|NCT02687581|458877855|FG002|Overall Study|Withdrawal by Subject|0|||
127523959|NCT02687581|458877856|FG003|Overall Study|Withdrawal by Subject|1|||
127523960|NCT02687581|458877853|FG000|Overall Study|Lost to Follow-up|2|||
127523961|NCT02687581|458877854|FG001|Overall Study|Lost to Follow-up|2|||
127523962|NCT02687581|458877855|FG002|Overall Study|Lost to Follow-up|0|||
127523963|NCT02687581|458877856|FG003|Overall Study|Lost to Follow-up|0|||
127523964|NCT02687581|458877853|FG000|Overall Study|the device is too small for the patient.|1|||
127523965|NCT02687581|458877854|FG001|Overall Study|the device is too small for the patient.|0|||
127523966|NCT02687581|458877855|FG002|Overall Study|the device is too small for the patient.|0|||
127523967|NCT02687581|458877856|FG003|Overall Study|the device is too small for the patient.|0|||
127523968|NCT01990612|458877859|FG000|Overall Study|Lost to Follow-up|2|||
127523969|NCT01990612|458877860|FG001|Overall Study|Lost to Follow-up|1|||
127523970|NCT01990612|458877859|FG000|Overall Study|Withdrawal by Subject|5|||
127523971|NCT01990612|458877860|FG001|Overall Study|Withdrawal by Subject|2|||
127523972|NCT02974842|458877861|FG000|Overall Study|Withdrawal by Subject|4|||
127523973|NCT02974842|458877861|FG000|Overall Study|Screen failures|4|||
127523974|NCT01068158|458877869|FG000|Overall Study|Withdrawal by Subject|1|||
127523975|NCT01068158|458877870|FG001|Overall Study|Withdrawal by Subject|2|||
127523976|NCT01068158|458877869|FG000|Overall Study|Lost to Follow-up|7|||
127523977|NCT01068158|458877870|FG001|Overall Study|Lost to Follow-up|0|||
127523978|NCT01068158|458877869|FG000|Overall Study|Protocol Violation|0|||
127523979|NCT01068158|458877870|FG001|Overall Study|Protocol Violation|2|||
127523980|NCT00991406|458877877|FG000|Overall Study|One participant did not respond to FES.|1|||
127523981|NCT01300572|458877878|FG000|Overall Study|HAMA + post dosimetry|1|||
127523982|NCT00375518|458877880|FG000|Overall Study|Withdrawal by Subject|2|||
127523983|NCT00375518|458877881|FG001|Overall Study|Withdrawal by Subject|10|||
127523984|NCT00375518|458877880|FG000|Overall Study|Patient Not Treated|6|||
127523985|NCT00375518|458877881|FG001|Overall Study|Patient Not Treated|6|||
127523986|NCT00375518|458877880|FG000|Overall Study|Death|0|||
127523987|NCT00375518|458877881|FG001|Overall Study|Death|1|||
127523988|NCT00411632|458877882|FG000|Overall Study|Death|1|||
127523989|NCT01108523|458877883|FG000|Overall Study|Protocol Violation|4|||
127523990|NCT03755661|458877891|FG000|Overall Study|Lost to Follow-up|1|||
127523991|NCT03755661|458877892|FG001|Overall Study|Lost to Follow-up|0|||
127523992|NCT02277119|458877893|FG000|Overall Study|Lack of Efficacy|1|||
127523993|NCT02277119|458877894|FG001|Overall Study|Lack of Efficacy|1|||
127523994|NCT02277119|458877895|FG002|Overall Study|Lack of Efficacy|1|||
127523995|NCT02277119|458877893|FG000|Overall Study|Protocol Violation|2|||
127523996|NCT02277119|458877894|FG001|Overall Study|Protocol Violation|3|||
127523997|NCT02277119|458877895|FG002|Overall Study|Protocol Violation|7|||
127523998|NCT04699461|458877896|FG000|Overall Study|Withdrawal by Subject|1|||
127523999|NCT04699461|458877897|FG001|Overall Study|Withdrawal by Subject|0|||
127524000|NCT04699461|458877896|FG000|Overall Study|Study termination by sponsor|2|||
127524001|NCT04699461|458877897|FG001|Overall Study|Study termination by sponsor|1|||
127524002|NCT04699461|458877896|FG000|Overall Study|Death|1|||
127524003|NCT04699461|458877897|FG001|Overall Study|Death|0|||
127524004|NCT04699461|458877896|FG000|Overall Study|Radiographic progression|0|||
127524005|NCT04699461|458877897|FG001|Overall Study|Radiographic progression|1|||
127524006|NCT03068767|458877900|FG000|Overall Study|Lost to Follow-up|7|||
127524007|NCT03068767|458877901|FG001|Overall Study|Lost to Follow-up|3|||
127524008|NCT03068767|458877900|FG000|Overall Study|Protocol Violation|3|||
127524009|NCT03068767|458877901|FG001|Overall Study|Protocol Violation|0|||
127524010|NCT00659230|458877906|FG000|Overall Study|Lost to Follow-up|2|||
127524011|NCT00659230|458877907|FG001|Overall Study|Lost to Follow-up|5|||
127524012|NCT00659230|458877906|FG000|Overall Study|Lost source documentation|5|||
127524013|NCT00659230|458877907|FG001|Overall Study|Lost source documentation|4|||
127524014|NCT00659230|458877906|FG000|Overall Study|Did not return post-randomization|2|||
127524015|NCT00659230|458877907|FG001|Overall Study|Did not return post-randomization|3|||
127524016|NCT02467582|458880452|FG000|Allocation|Withdrawal by Subject|1|||
127524017|NCT02467582|458880453|FG001|Allocation|Withdrawal by Subject|0|||
127524018|NCT02467582|458880452|FG000|Follow-up|Death|5|||
127524019|NCT02467582|458880453|FG001|Follow-up|Death|4|||
127524020|NCT02467582|458880452|FG000|Follow-up|Lost to Follow-up|6|||
127524021|NCT02467582|458880453|FG001|Follow-up|Lost to Follow-up|5|||
127524022|NCT01370265|458880454|FG000|First Intervention|Adverse Event|1|||
127524023|NCT01370265|458880455|FG001|First Intervention|Adverse Event|1|||
127524024|NCT02291419|458880456|FG000|Overall Study|Early study termination|1|||
127524025|NCT02291419|458880457|FG001|Overall Study|Early study termination|5|||
127524026|NCT00965575|458880461|FG000|Overall Study|subject unwillingness to swallow study c|1|||
127524027|NCT00965575|458880462|FG001|Overall Study|subject unwillingness to swallow study c|0|||
127524028|NCT01732770|458880467|FG000|Overall Study|Lost to Follow-up|2|||
127524029|NCT01732770|458880468|FG001|Overall Study|Lost to Follow-up|3|||
127524030|NCT01732770|458880467|FG000|Overall Study|Withdrawal by Subject|5|||
127524031|NCT01732770|458880468|FG001|Overall Study|Withdrawal by Subject|3|||
127524032|NCT01732770|458880467|FG000|Overall Study|Decision by Sponsor|2|||
127524033|NCT01732770|458880468|FG001|Overall Study|Decision by Sponsor|2|||
127524034|NCT01732770|458880467|FG000|Overall Study|Death|1|||
127524035|NCT01732770|458880468|FG001|Overall Study|Death|0|||
127524036|NCT03047031|458880474|FG000|Overall Study|Other than listed|1|||
127524037|NCT03047031|458880475|FG001|Overall Study|Other than listed|0|||
127524038|NCT03047031|458880476|FG002|Overall Study|Other than listed|0|||
127524039|NCT03047031|458880474|FG000|Overall Study|Lost to Follow-up|4|||
127524040|NCT03047031|458880475|FG001|Overall Study|Lost to Follow-up|0|||
127524041|NCT03047031|458880476|FG002|Overall Study|Lost to Follow-up|0|||
127524042|NCT03047031|458880474|FG000|Overall Study|Patient refusal to continue taking trial medication|2|||
127524043|NCT03047031|458880475|FG001|Overall Study|Patient refusal to continue taking trial medication|0|||
127524044|NCT03047031|458880476|FG002|Overall Study|Patient refusal to continue taking trial medication|0|||
127524045|NCT03047031|458880474|FG000|Overall Study|Adverse Event|1|||
127524046|NCT03047031|458880475|FG001|Overall Study|Adverse Event|0|||
127524047|NCT03047031|458880476|FG002|Overall Study|Adverse Event|0|||
127524048|NCT03047031|458880474|FG000|Overall Study|Withdrawal by Subject|2|||
127524049|NCT03047031|458880475|FG001|Overall Study|Withdrawal by Subject|0|||
127524050|NCT03047031|458880476|FG002|Overall Study|Withdrawal by Subject|0|||
127524051|NCT03047031|458880474|FG000|Overall Study|Change to other medication|2|||
127524052|NCT03047031|458880475|FG001|Overall Study|Change to other medication|0|||
127524053|NCT03047031|458880476|FG002|Overall Study|Change to other medication|0|||
127524054|NCT03047031|458880474|FG000|Overall Study|Patients were not followed as planned in the protocol|0|||
127524055|NCT03047031|458880475|FG001|Overall Study|Patients were not followed as planned in the protocol|4|||
127524056|NCT03047031|458880476|FG002|Overall Study|Patients were not followed as planned in the protocol|3|||
127524057|NCT01959841|458880477|FG000|Overall Study|Adverse Event|1|||
127524058|NCT01959841|458880478|FG001|Overall Study|Adverse Event|3|||
127524059|NCT01959841|458880479|FG002|Overall Study|Adverse Event|2|||
127524060|NCT01959841|458880477|FG000|Overall Study|Lack of Efficacy|5|||
127524061|NCT01959841|458880478|FG001|Overall Study|Lack of Efficacy|0|||
127524062|NCT01959841|458880479|FG002|Overall Study|Lack of Efficacy|0|||
127524063|NCT01959841|458880477|FG000|Overall Study|Lost to Follow-up|1|||
127524064|NCT01959841|458880478|FG001|Overall Study|Lost to Follow-up|1|||
127524065|NCT01959841|458880479|FG002|Overall Study|Lost to Follow-up|0|||
127524066|NCT01959841|458880477|FG000|Overall Study|Physician Decision|0|||
127524067|NCT01959841|458880478|FG001|Overall Study|Physician Decision|2|||
127524068|NCT01959841|458880479|FG002|Overall Study|Physician Decision|3|||
127524069|NCT01959841|458880477|FG000|Overall Study|Protocol Violation|16|||
127524070|NCT01959841|458880478|FG001|Overall Study|Protocol Violation|23|||
127524071|NCT01959841|458880479|FG002|Overall Study|Protocol Violation|16|||
127524072|NCT01959841|458880477|FG000|Overall Study|Withdrawal by Subject|7|||
127524073|NCT01959841|458880478|FG001|Overall Study|Withdrawal by Subject|7|||
127524074|NCT01959841|458880479|FG002|Overall Study|Withdrawal by Subject|5|||
127524075|NCT01959841|458880477|FG000|Overall Study|Clinical laboratory value|2|||
127524076|NCT01959841|458880478|FG001|Overall Study|Clinical laboratory value|6|||
127524077|NCT01959841|458880479|FG002|Overall Study|Clinical laboratory value|6|||
127524078|NCT01959841|458880477|FG000|Overall Study|Platelet count below on day1 or 4|11|||
127524079|NCT01959841|458880478|FG001|Overall Study|Platelet count below on day1 or 4|15|||
127524080|NCT01959841|458880479|FG002|Overall Study|Platelet count below on day1 or 4|11|||
127524081|NCT00780416|458880480|FG000|Overall Study|Physician Decision|3|||
127524082|NCT00780416|458880481|FG001|Overall Study|Physician Decision|3|||
127524083|NCT00780416|458880480|FG000|Overall Study|Protocol Violation|1|||
127524084|NCT00780416|458880481|FG001|Overall Study|Protocol Violation|0|||
127524085|NCT00780416|458880480|FG000|Overall Study|Withdrawal by Subject|8|||
127524086|NCT00780416|458880481|FG001|Overall Study|Withdrawal by Subject|6|||
127524087|NCT00666224|458880484|FG000|Double-Blind|Adverse Event|15|||
127524088|NCT00666224|458880485|FG001|Double-Blind|Adverse Event|5|||
127524089|NCT00666224|458880484|FG000|Double-Blind|Lost to Follow-up|2|||
127524090|NCT00666224|458880485|FG001|Double-Blind|Lost to Follow-up|2|||
127524091|NCT00666224|458880484|FG000|Double-Blind|Withdrawal by Subject|18|||
127524092|NCT00666224|458880485|FG001|Double-Blind|Withdrawal by Subject|14|||
127524093|NCT00666224|458880484|FG000|Double-Blind|Physician Decision|0|||
127524094|NCT00666224|458880485|FG001|Double-Blind|Physician Decision|3|||
127524095|NCT00666224|458880484|FG000|Double-Blind|Sponsor decision|1|||
127524096|NCT00666224|458880485|FG001|Double-Blind|Sponsor decision|0|||
127524097|NCT00666224|458880484|FG000|Double-Blind|Pregnancy|3|||
127524098|NCT00666224|458880485|FG001|Double-Blind|Pregnancy|2|||
127524099|NCT00666224|458880484|FG000|Double-Blind|Noncompliance|1|||
127524100|NCT00666224|458880485|FG001|Double-Blind|Noncompliance|0|||
127524101|NCT00666224|458880484|FG000|Double-Blind|Death|1|||
127524102|NCT00666224|458880485|FG001|Double-Blind|Death|0|||
127524103|NCT00666224|458880484|FG000|Double-Blind|Undefined/Unknown|4|||
127524104|NCT00666224|458880485|FG001|Double-Blind|Undefined/Unknown|1|||
127524105|NCT00666224|458880484|FG000|Open-Label|Adverse Event|8|||
127524106|NCT00666224|458880485|FG001|Open-Label|Adverse Event|43|||
127524107|NCT00666224|458880484|FG000|Open-Label|Lost to Follow-up|4|||
127524108|NCT00666224|458880485|FG001|Open-Label|Lost to Follow-up|5|||
127524109|NCT00666224|458880484|FG000|Open-Label|Withdrawal by Subject|12|||
127524110|NCT00666224|458880485|FG001|Open-Label|Withdrawal by Subject|25|||
127524111|NCT00666224|458880484|FG000|Open-Label|Physician Decision|7|||
127524112|NCT00666224|458880485|FG001|Open-Label|Physician Decision|5|||
127524113|NCT00666224|458880484|FG000|Open-Label|Pregnancy|1|||
127524114|NCT00666224|458880485|FG001|Open-Label|Pregnancy|5|||
127524115|NCT00666224|458880484|FG000|Open-Label|Noncompliance|2|||
127524116|NCT00666224|458880485|FG001|Open-Label|Noncompliance|1|||
127524117|NCT00666224|458880484|FG000|Open-Label|Undefined/Unknown|1|||
127524118|NCT00666224|458880485|FG001|Open-Label|Undefined/Unknown|1|||
127524119|NCT03521141|458880486|FG000|Overall Study|Death|1|||
127524120|NCT03521141|458880487|FG001|Overall Study|Death|0|||
127524121|NCT03521141|458880488|FG002|Overall Study|Death|1|||
127524122|NCT02950480|458880494|FG000|Overall Study|Withdrawal by Subject|1|||
127524123|NCT02950480|458880495|FG001|Overall Study|Withdrawal by Subject|0|||
127524124|NCT01959139|458880505|FG000|Phase II|Disease progression|0|||
127524125|NCT01959139|458880506|FG001|Phase II|Disease progression|0|||
127524126|NCT01959139|458880507|FG002|Phase II|Disease progression|26|||
127524127|NCT01959139|458880508|FG003|Phase II|Disease progression|34|||
127524128|NCT01959139|458880505|FG000|Phase II|Adverse Event|0|||
127524129|NCT01959139|458880506|FG001|Phase II|Adverse Event|0|||
127524130|NCT01959139|458880507|FG002|Phase II|Adverse Event|10|||
127524131|NCT01959139|458880508|FG003|Phase II|Adverse Event|11|||
127524132|NCT01959139|458880505|FG000|Phase II|Patient Refusal|0|||
127524133|NCT01959139|458880506|FG001|Phase II|Patient Refusal|0|||
127524134|NCT01959139|458880507|FG002|Phase II|Patient Refusal|5|||
127524135|NCT01959139|458880508|FG003|Phase II|Patient Refusal|4|||
127524136|NCT01959139|458880505|FG000|Phase II|Death|0|||
127524137|NCT01959139|458880506|FG001|Phase II|Death|0|||
127524138|NCT01959139|458880507|FG002|Phase II|Death|3|||
127524139|NCT01959139|458880508|FG003|Phase II|Death|1|||
127524140|NCT01959139|458880505|FG000|Phase II|Other/Unknown|0|||
127524141|NCT01959139|458880506|FG001|Phase II|Other/Unknown|0|||
127524142|NCT01959139|458880507|FG002|Phase II|Other/Unknown|8|||
127524143|NCT01959139|458880508|FG003|Phase II|Other/Unknown|5|||
127524144|NCT01959139|458880505|FG000|Phase II|On treatment|0|||
127524145|NCT01959139|458880506|FG001|Phase II|On treatment|0|||
127524146|NCT01959139|458880507|FG002|Phase II|On treatment|4|||
127524147|NCT01959139|458880508|FG003|Phase II|On treatment|0|||
127524148|NCT00630344|458880511|FG000|Overall Study|Adverse Event|5|||
127524149|NCT00630344|458880511|FG000|Overall Study|Progressive Disease|19|||
127524150|NCT00630344|458880511|FG000|Overall Study|Physician Decision|9|||
127524151|NCT00630344|458880511|FG000|Overall Study|Withdrawal by Subject|1|||
127524152|NCT00630344|458880511|FG000|Overall Study|Intercurrent Illness|1|||
127524153|NCT00630344|458880511|FG000|Overall Study|Other|1|||
127524154|NCT05362058|458880512|FG000|Treatment Period|Adverse Event|3|||
127524155|NCT05362058|458880513|FG001|Treatment Period|Adverse Event|3|||
127524156|NCT05362058|458880512|FG000|Treatment Period|Assigned treatment by mistake|3|||
127524157|NCT05362058|458880513|FG001|Treatment Period|Assigned treatment by mistake|4|||
127524158|NCT05362058|458880512|FG000|Treatment Period|Death|1|||
127524159|NCT05362058|458880513|FG001|Treatment Period|Death|1|||
127524160|NCT05362058|458880512|FG000|Treatment Period|Lost to Follow-up|6|||
127524161|NCT05362058|458880513|FG001|Treatment Period|Lost to Follow-up|3|||
127524162|NCT05362058|458880512|FG000|Treatment Period|Non-compliance with study drug|0|||
127524163|NCT05362058|458880513|FG001|Treatment Period|Non-compliance with study drug|1|||
127524164|NCT05362058|458880512|FG000|Treatment Period|Physician Decision|1|||
127524165|NCT05362058|458880513|FG001|Treatment Period|Physician Decision|0|||
127524166|NCT05362058|458880512|FG000|Treatment Period|Protocol deviation|1|||
127524167|NCT05362058|458880513|FG001|Treatment Period|Protocol deviation|0|||
127524168|NCT05362058|458880512|FG000|Treatment Period|Withdrawal by Subject|10|||
127524169|NCT05362058|458880513|FG001|Treatment Period|Withdrawal by Subject|11|||
127524170|NCT05362058|458880512|FG000|Follow-Up Period|Death|1|||
127524171|NCT05362058|458880513|FG001|Follow-Up Period|Death|0|||
127524172|NCT05362058|458880512|FG000|Follow-Up Period|Lost to Follow-up|2|||
127524173|NCT05362058|458880513|FG001|Follow-Up Period|Lost to Follow-up|1|||
127524174|NCT05362058|458880512|FG000|Follow-Up Period|Protocol deviation|1|||
127524175|NCT05362058|458880513|FG001|Follow-Up Period|Protocol deviation|1|||
127524176|NCT05362058|458880512|FG000|Follow-Up Period|Withdrawal by Subject|0|||
127524177|NCT05362058|458880513|FG001|Follow-Up Period|Withdrawal by Subject|3|||
127524178|NCT01964963|458880516|FG000|Overall Study|Case Report Forms Uncollected|888|||
127524179|NCT01964963|458880516|FG000|Overall Study|Protocol Deviation|50|||
127524180|NCT01964963|458880516|FG000|Overall Study|Data Reliability was not Assured|5|||
127524181|NCT00930553|458880517|FG000|Overall Study|Adverse Event|1|||
127524182|NCT00930553|458880517|FG000|Overall Study|Lack of Efficacy|7|||
127524183|NCT00930553|458880517|FG000|Overall Study|Physician Decision|39|||
127524184|NCT00930553|458880517|FG000|Overall Study|Protocol Violation|1|||
127524185|NCT00930553|458880517|FG000|Overall Study|Pregnancy|1|||
127524186|NCT00930553|458880517|FG000|Overall Study|Withdrawal by Subject|88|||
127524187|NCT00930553|458880517|FG000|Overall Study|Lost to Follow-up|25|||
127524188|NCT00930553|458880517|FG000|Overall Study|Death|9|||
127524189|NCT00930553|458880517|FG000|Overall Study|Study terminated by sponsor|24|||
127524190|NCT00930553|458880517|FG000|Overall Study|Other than specified above|28|||
127524191|NCT01235234|458880518|FG000|Overall Study|Adverse Event|2|||
127524192|NCT01235234|458880519|FG001|Overall Study|Adverse Event|2|||
127524193|NCT01235234|458880520|FG002|Overall Study|Adverse Event|1|||
127524194|NCT02352753|458880521|FG000|6-Month Dosing Period|Decision by sponsor|2|||
127524195|NCT02352753|458880521|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
127524196|NCT02352753|458880521|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
127524197|NCT02352753|458880521|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
127524198|NCT02352753|458880521|FG000|3-Month Dosing Period|Decision by sponsor|14|||
127524199|NCT02352753|458880521|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
127524200|NCT04042909|458880522|FG000|Overall Study|Withdrawal by Subject|1|||
127524201|NCT04042909|458880523|FG001|Overall Study|Withdrawal by Subject|0|||
127524202|NCT04042909|458880524|FG002|Overall Study|Withdrawal by Subject|0|||
127524203|NCT04042909|458880522|FG000|Overall Study|duplicate cases|2|||
127524204|NCT04042909|458880523|FG001|Overall Study|duplicate cases|0|||
127524205|NCT04042909|458880524|FG002|Overall Study|duplicate cases|0|||
127524206|NCT04042909|458880522|FG000|Overall Study|technical problem|0|||
127524207|NCT04042909|458880523|FG001|Overall Study|technical problem|1|||
127524208|NCT04042909|458880524|FG002|Overall Study|technical problem|0|||
127524209|NCT00286494|458880529|FG000|Overall Study|Hyperglycemic rescue|12|||
127524210|NCT00286494|458880530|FG001|Overall Study|Hyperglycemic rescue|19|||
127524211|NCT00286494|458880531|FG002|Overall Study|Hyperglycemic rescue|18|||
127524212|NCT00286494|458880529|FG000|Overall Study|Withdrawal by Subject|2|||
127524213|NCT00286494|458880530|FG001|Overall Study|Withdrawal by Subject|10|||
127524214|NCT00286494|458880531|FG002|Overall Study|Withdrawal by Subject|9|||
127524215|NCT00286494|458880529|FG000|Overall Study|Adverse Event|3|||
127524216|NCT00286494|458880530|FG001|Overall Study|Adverse Event|8|||
127524217|NCT00286494|458880531|FG002|Overall Study|Adverse Event|6|||
127524218|NCT00286494|458880529|FG000|Overall Study|Physician Decision|5|||
127524219|NCT00286494|458880530|FG001|Overall Study|Physician Decision|5|||
127524220|NCT00286494|458880531|FG002|Overall Study|Physician Decision|1|||
127524221|NCT00286494|458880529|FG000|Overall Study|Lost to Follow-up|3|||
127524222|NCT00286494|458880530|FG001|Overall Study|Lost to Follow-up|1|||
127524223|NCT00286494|458880531|FG002|Overall Study|Lost to Follow-up|3|||
127524224|NCT00286494|458880529|FG000|Overall Study|Protocol Violation|1|||
127524225|NCT00286494|458880530|FG001|Overall Study|Protocol Violation|1|||
127524226|NCT00286494|458880531|FG002|Overall Study|Protocol Violation|2|||
127524227|NCT04776317|458880532|FG000|Overall Study|Physician Decision|0|||
127524228|NCT04776317|458880533|FG001|Overall Study|Physician Decision|1|||
127524229|NCT04776317|458880534|FG002|Overall Study|Physician Decision|0|||
127524230|NCT04776317|458880535|FG003|Overall Study|Physician Decision|0|||
127524231|NCT04776317|458880536|FG004|Overall Study|Physician Decision|0|||
127524232|NCT04776317|458880537|FG005|Overall Study|Physician Decision|0|||
127524233|NCT04776317|458880538|FG006|Overall Study|Physician Decision|0|||
127524234|NCT04776317|458880539|FG007|Overall Study|Physician Decision|0|||
127524235|NCT04776317|458880540|FG008|Overall Study|Physician Decision|0|||
127524236|NCT04776317|458880541|FG009|Overall Study|Physician Decision|0|||
127524237|NCT04776317|458880542|FG010|Overall Study|Physician Decision|0|||
127524238|NCT04776317|458880543|FG011|Overall Study|Physician Decision|0|||
127524239|NCT04776317|458880544|FG012|Overall Study|Physician Decision|0|||
127524240|NCT04776317|458880545|FG013|Overall Study|Physician Decision|0|||
127524241|NCT04776317|458880546|FG014|Overall Study|Physician Decision|0|||
127524242|NCT04776317|458880532|FG000|Overall Study|Protocol Violation|0|||
127524243|NCT04776317|458880533|FG001|Overall Study|Protocol Violation|0|||
127524244|NCT04776317|458880534|FG002|Overall Study|Protocol Violation|1|||
127524245|NCT04776317|458880535|FG003|Overall Study|Protocol Violation|0|||
127524246|NCT04776317|458880536|FG004|Overall Study|Protocol Violation|0|||
127524247|NCT04776317|458880537|FG005|Overall Study|Protocol Violation|0|||
127524248|NCT04776317|458880538|FG006|Overall Study|Protocol Violation|0|||
127524249|NCT04776317|458880539|FG007|Overall Study|Protocol Violation|0|||
127524250|NCT04776317|458880540|FG008|Overall Study|Protocol Violation|0|||
127524251|NCT04776317|458880541|FG009|Overall Study|Protocol Violation|0|||
127524252|NCT04776317|458880542|FG010|Overall Study|Protocol Violation|0|||
127524253|NCT04776317|458880543|FG011|Overall Study|Protocol Violation|0|||
127524254|NCT04776317|458880544|FG012|Overall Study|Protocol Violation|0|||
127524255|NCT04776317|458880545|FG013|Overall Study|Protocol Violation|0|||
127524256|NCT04776317|458880546|FG014|Overall Study|Protocol Violation|0|||
127524257|NCT04776317|458880532|FG000|Overall Study|Withdrawal by Subject|0|||
127524258|NCT04776317|458880533|FG001|Overall Study|Withdrawal by Subject|0|||
127524259|NCT04776317|458880534|FG002|Overall Study|Withdrawal by Subject|0|||
127524260|NCT04776317|458880535|FG003|Overall Study|Withdrawal by Subject|0|||
127524261|NCT04776317|458880536|FG004|Overall Study|Withdrawal by Subject|1|||
127524262|NCT04776317|458880537|FG005|Overall Study|Withdrawal by Subject|0|||
127524263|NCT04776317|458880538|FG006|Overall Study|Withdrawal by Subject|0|||
127524264|NCT04776317|458880539|FG007|Overall Study|Withdrawal by Subject|0|||
127524265|NCT04776317|458880540|FG008|Overall Study|Withdrawal by Subject|0|||
127524266|NCT04776317|458880541|FG009|Overall Study|Withdrawal by Subject|0|||
127524267|NCT04776317|458880542|FG010|Overall Study|Withdrawal by Subject|0|||
127524268|NCT04776317|458880543|FG011|Overall Study|Withdrawal by Subject|0|||
127524269|NCT04776317|458880544|FG012|Overall Study|Withdrawal by Subject|0|||
127524270|NCT04776317|458880545|FG013|Overall Study|Withdrawal by Subject|0|||
127524271|NCT04776317|458880546|FG014|Overall Study|Withdrawal by Subject|0|||
127524272|NCT04207060|458880547|FG000|Overall Study|Lost to Follow-up|2|||
127524273|NCT04207060|458880548|FG001|Overall Study|Lost to Follow-up|0|||
127524274|NCT02524158|458880549|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
127524275|NCT02524158|458880550|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
127524276|NCT02524158|458880549|FG000|12-weeks Assessment|Lost to Follow-up|18|||
127524277|NCT02524158|458880550|FG001|12-weeks Assessment|Lost to Follow-up|12|||
127524278|NCT02524158|458880549|FG000|6-month Assessment|Withdrawal by Subject|1|||
127524279|NCT02524158|458880550|FG001|6-month Assessment|Withdrawal by Subject|1|||
127524280|NCT02524158|458880549|FG000|6-month Assessment|Lost to Follow-up|21|||
127524281|NCT02524158|458880550|FG001|6-month Assessment|Lost to Follow-up|20|||
127524282|NCT03671304|458880551|FG000|Overall Study|study terminated|7|||
127524283|NCT02718716|458880553|FG000|Overall Study|Lack of Efficacy|1|||
127524284|NCT02718716|458880554|FG001|Overall Study|Lack of Efficacy|0|||
127524285|NCT02718716|458880555|FG002|Overall Study|Lack of Efficacy|0|||
127524286|NCT02718716|458880556|FG003|Overall Study|Lack of Efficacy|0|||
127524287|NCT02718716|458880557|FG004|Overall Study|Lack of Efficacy|0|||
127524288|NCT00296140|458880561|FG000|Overall Study|Lost to Follow-up|1|||
127524289|NCT00296140|458880562|FG001|Overall Study|Lost to Follow-up|0|||
127524290|NCT00296140|458880561|FG000|Overall Study|Withdrawal by Subject|1|||
127524291|NCT00296140|458880562|FG001|Overall Study|Withdrawal by Subject|0|||
127524292|NCT00296140|458880561|FG000|Overall Study|Discharge to Nursing Home|1|||
127524293|NCT00296140|458880562|FG001|Overall Study|Discharge to Nursing Home|0|||
127524294|NCT01856582|458880563|FG000|Overall Study|Died prior to Boost infusion|1|||
127524295|NCT00596830|458880564|FG000|Overall Study|Death|258|||
127524296|NCT00596830|458880565|FG001|Overall Study|Death|247|||
127524297|NCT00596830|458880564|FG000|Overall Study|Lost to Follow-up|7|||
127524298|NCT00596830|458880565|FG001|Overall Study|Lost to Follow-up|11|||
127524299|NCT00596830|458880564|FG000|Overall Study|Withdrawal by Subject|22|||
127524300|NCT00596830|458880565|FG001|Overall Study|Withdrawal by Subject|12|||
127524301|NCT00596830|458880564|FG000|Overall Study|Study terminated by sponsor|51|||
127524302|NCT00596830|458880565|FG001|Overall Study|Study terminated by sponsor|62|||
127524303|NCT00596830|458880564|FG000|Overall Study|Follow-up was discontinued|1|||
127524304|NCT00596830|458880565|FG001|Overall Study|Follow-up was discontinued|0|||
127524305|NCT00596830|458880564|FG000|Overall Study|Randomized but not treated|3|||
127524306|NCT00596830|458880565|FG001|Overall Study|Randomized but not treated|7|||
127524307|NCT01919801|458880566|FG000|Overall Study|Withdrawal by Subject|1|||
127524308|NCT01919801|458880567|FG001|Overall Study|Withdrawal by Subject|0|||
127524309|NCT01919801|458880566|FG000|Overall Study|Physician Decision|0|||
127524310|NCT01919801|458880567|FG001|Overall Study|Physician Decision|1|||
127524311|NCT01919801|458880566|FG000|Overall Study|Lost to Follow-up|0|||
127524312|NCT01919801|458880567|FG001|Overall Study|Lost to Follow-up|1|||
127524313|NCT01919801|458880566|FG000|Overall Study|Other|0|||
127524314|NCT01919801|458880567|FG001|Overall Study|Other|1|||
127524315|NCT01843062|458880568|FG000|Overall Study|Protocol Violation|1|||
127524316|NCT01843062|458880569|FG001|Overall Study|Protocol Violation|0|||
127524317|NCT01843062|458880568|FG000|Overall Study|New treatment following progression|2|||
127524318|NCT01843062|458880569|FG001|Overall Study|New treatment following progression|0|||
127524319|NCT01843062|458880568|FG000|Overall Study|Pregnancy|1|||
127524320|NCT01843062|458880569|FG001|Overall Study|Pregnancy|0|||
127524321|NCT01843062|458880568|FG000|Overall Study|Adverse Event|2|||
127524322|NCT01843062|458880569|FG001|Overall Study|Adverse Event|0|||
127524323|NCT01843062|458880568|FG000|Overall Study|Incorrect randomisation|1|||
127524324|NCT01843062|458880569|FG001|Overall Study|Incorrect randomisation|0|||
127524325|NCT01843062|458880568|FG000|Overall Study|Withdrawal by Subject|12|||
127524326|NCT01843062|458880569|FG001|Overall Study|Withdrawal by Subject|3|||
127524327|NCT01843062|458880568|FG000|Overall Study|Death|1|||
127524328|NCT01843062|458880569|FG001|Overall Study|Death|2|||
127524329|NCT01843062|458880568|FG000|Overall Study|Lost to Follow-up|2|||
127524330|NCT01843062|458880569|FG001|Overall Study|Lost to Follow-up|4|||
127524331|NCT01677858|458880570|FG000|Overall Study|Adverse Event|0|||
127524332|NCT01677858|458880571|FG001|Overall Study|Adverse Event|0|||
127524333|NCT01677858|458880572|FG002|Overall Study|Adverse Event|2|||
127524334|NCT01677858|458880573|FG003|Overall Study|Adverse Event|3|||
127524335|NCT01677858|458880574|FG004|Overall Study|Adverse Event|13|||
127524336|NCT01677858|458880570|FG000|Overall Study|Death|0|||
127524337|NCT01677858|458880571|FG001|Overall Study|Death|0|||
127524338|NCT01677858|458880572|FG002|Overall Study|Death|0|||
127524339|NCT01677858|458880573|FG003|Overall Study|Death|0|||
127524340|NCT01677858|458880574|FG004|Overall Study|Death|1|||
127524341|NCT01677858|458880570|FG000|Overall Study|Physician Decision|1|||
127524342|NCT01677858|458880571|FG001|Overall Study|Physician Decision|0|||
127524343|NCT01677858|458880572|FG002|Overall Study|Physician Decision|2|||
127524344|NCT01677858|458880573|FG003|Overall Study|Physician Decision|0|||
127524345|NCT01677858|458880574|FG004|Overall Study|Physician Decision|12|||
127524346|NCT01677858|458880570|FG000|Overall Study|Progressive Disease|2|||
127524347|NCT01677858|458880571|FG001|Overall Study|Progressive Disease|1|||
127524348|NCT01677858|458880572|FG002|Overall Study|Progressive Disease|9|||
127524349|NCT01677858|458880573|FG003|Overall Study|Progressive Disease|3|||
127524350|NCT01677858|458880574|FG004|Overall Study|Progressive Disease|43|||
127524351|NCT01677858|458880570|FG000|Overall Study|Withdrawal by Subject|0|||
127524352|NCT01677858|458880571|FG001|Overall Study|Withdrawal by Subject|1|||
127524353|NCT01677858|458880572|FG002|Overall Study|Withdrawal by Subject|1|||
127524354|NCT01677858|458880573|FG003|Overall Study|Withdrawal by Subject|0|||
127524355|NCT01677858|458880574|FG004|Overall Study|Withdrawal by Subject|15|||
127524356|NCT01677858|458880570|FG000|Overall Study|Lost to Follow-up|0|||
127524357|NCT01677858|458880571|FG001|Overall Study|Lost to Follow-up|0|||
127524358|NCT01677858|458880572|FG002|Overall Study|Lost to Follow-up|0|||
127524359|NCT01677858|458880573|FG003|Overall Study|Lost to Follow-up|0|||
127524360|NCT01677858|458880574|FG004|Overall Study|Lost to Follow-up|1|||
127524361|NCT02669212|458880575|FG000|Overall Study|Lost to Follow-up|1|||
127524362|NCT02669212|458880576|FG001|Overall Study|Lost to Follow-up|0|||
127524363|NCT02669212|458880575|FG000|Overall Study|Medical Condition|3|||
127524364|NCT02669212|458880576|FG001|Overall Study|Medical Condition|4|||
127524365|NCT02669212|458880575|FG000|Overall Study|Withdrawal by Subject|0|||
127524366|NCT02669212|458880576|FG001|Overall Study|Withdrawal by Subject|2|||
127524367|NCT02669212|458880575|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
127524368|NCT02669212|458880576|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
127524369|NCT03549104|458880577|FG000|Overall Study|Withdrawal by Subject|5|||
127524370|NCT03549104|458880578|FG001|Overall Study|Withdrawal by Subject|2|||
127524371|NCT03549104|458880577|FG000|Overall Study|Covid shelter in place|1|||
127524372|NCT03549104|458880578|FG001|Overall Study|Covid shelter in place|2|||
127524373|NCT02690714|458880582|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
127524374|NCT02690714|458880582|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
127524375|NCT01457846|458880583|FG000|Overall Study|Death before treatment|1|||
127524376|NCT01457846|458880584|FG001|Overall Study|Death before treatment|2|||
127524377|NCT01457846|458880583|FG000|Overall Study|Did not receive treatment|0|||
127524378|NCT01457846|458880584|FG001|Overall Study|Did not receive treatment|1|||
127524379|NCT01457846|458880583|FG000|Overall Study|Death|27|||
127524380|NCT01457846|458880584|FG001|Overall Study|Death|16|||
127524381|NCT01457846|458880583|FG000|Overall Study|Unclassified reason for not completed|11|||
127524382|NCT01457846|458880584|FG001|Overall Study|Unclassified reason for not completed|10|||
127524383|NCT01457846|458880583|FG000|Overall Study|Withdrawal by Subject|1|||
127524384|NCT01457846|458880584|FG001|Overall Study|Withdrawal by Subject|1|||
127524385|NCT01457846|458880583|FG000|Overall Study|Lost to Follow-up|1|||
127524386|NCT01457846|458880584|FG001|Overall Study|Lost to Follow-up|0|||
127524387|NCT02161757|458880585|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
127524388|NCT02161757|458880586|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
127524389|NCT02161757|458880587|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
127524390|NCT02161757|458880585|FG000|Treatment Through Study Completion|Adverse Event|1|||
127524391|NCT02161757|458880586|FG001|Treatment Through Study Completion|Adverse Event|1|||
127524392|NCT02161757|458880587|FG002|Treatment Through Study Completion|Adverse Event|0|||
127524393|NCT02161757|458880585|FG000|Treatment Through Study Completion|Protocol Violation|0|||
127524394|NCT02161757|458880586|FG001|Treatment Through Study Completion|Protocol Violation|1|||
127524395|NCT02161757|458880587|FG002|Treatment Through Study Completion|Protocol Violation|2|||
127524396|NCT02161757|458880585|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
127524397|NCT02161757|458880586|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
127524398|NCT02161757|458880587|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
127524399|NCT02161757|458880585|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
127524400|NCT02161757|458880586|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
127524401|NCT02161757|458880587|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
127524402|NCT02161757|458880585|FG000|Treatment Through Study Completion|Other|20|||
127524403|NCT02161757|458880586|FG001|Treatment Through Study Completion|Other|19|||
127524404|NCT02161757|458880587|FG002|Treatment Through Study Completion|Other|12|||
127524405|NCT02161757|458880585|FG000|Treatment Through Study Completion|Death|2|||
127524406|NCT02161757|458880586|FG001|Treatment Through Study Completion|Death|1|||
127524407|NCT02161757|458880587|FG002|Treatment Through Study Completion|Death|1|||
127524408|NCT01240135|458880588|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
127524409|NCT01240135|458880589|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
127524410|NCT01240135|458880588|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
127524411|NCT01240135|458880589|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
127524412|NCT01371305|458880590|FG000|Overall Study|Adverse Event|0|||
127524413|NCT01371305|458880591|FG001|Overall Study|Adverse Event|0|||
127524414|NCT01371305|458880592|FG002|Overall Study|Adverse Event|0|||
127524415|NCT01371305|458880593|FG003|Overall Study|Adverse Event|2|||
127524416|NCT01371305|458880594|FG004|Overall Study|Adverse Event|1|||
127524417|NCT01371305|458880595|FG005|Overall Study|Adverse Event|0|||
127524418|NCT01371305|458880590|FG000|Overall Study|Study terminated by sponsor|0|||
127524419|NCT01371305|458880591|FG001|Overall Study|Study terminated by sponsor|0|||
127524420|NCT01371305|458880592|FG002|Overall Study|Study terminated by sponsor|0|||
127524421|NCT01371305|458880593|FG003|Overall Study|Study terminated by sponsor|0|||
127524422|NCT01371305|458880594|FG004|Overall Study|Study terminated by sponsor|3|||
127524423|NCT01371305|458880595|FG005|Overall Study|Study terminated by sponsor|1|||
127524424|NCT01371305|458880590|FG000|Overall Study|Subject request|0|||
127524425|NCT01371305|458880591|FG001|Overall Study|Subject request|0|||
127524426|NCT01371305|458880592|FG002|Overall Study|Subject request|0|||
127524427|NCT01371305|458880593|FG003|Overall Study|Subject request|0|||
127524428|NCT01371305|458880594|FG004|Overall Study|Subject request|0|||
127524429|NCT01371305|458880595|FG005|Overall Study|Subject request|1|||
127524430|NCT01628965|458880596|FG000|Overall Study|Adverse Event|30|||
127524431|NCT01628965|458880596|FG000|Overall Study|Lack of Efficacy|7|||
127524432|NCT01628965|458880596|FG000|Overall Study|Withdrawal by Subject|3|||
127524433|NCT01628965|458880596|FG000|Overall Study|Lost to Follow-up|1|||
127524434|NCT01628965|458880596|FG000|Overall Study|Discontinuation criteria|8|||
127524435|NCT04356352|458880597|FG000|Overall Study|PIV in location that was excluded, surgery cancelled|2|||
127524436|NCT04356352|458880598|FG001|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
127524437|NCT04356352|458880599|FG002|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
127524438|NCT04356352|458880597|FG000|Overall Study|Protocol Violation|0|||
127524439|NCT04356352|458880598|FG001|Overall Study|Protocol Violation|3|||
127524440|NCT04356352|458880599|FG002|Overall Study|Protocol Violation|1|||
127524441|NCT03170193|458880602|FG000|Overall Study|Withdrawal by Subject|0|||
127524442|NCT03170193|458880603|FG001|Overall Study|Withdrawal by Subject|0|||
127524443|NCT03170193|458880604|FG002|Overall Study|Withdrawal by Subject|0|||
127524444|NCT03170193|458880605|FG003|Overall Study|Withdrawal by Subject|1|||
127524445|NCT03170193|458880606|FG004|Overall Study|Withdrawal by Subject|0|||
127524446|NCT03170193|458880607|FG005|Overall Study|Withdrawal by Subject|0|||
127524447|NCT03170193|458880608|FG006|Overall Study|Withdrawal by Subject|0|||
127524448|NCT03170193|458880602|FG000|Overall Study|Lost to Follow-up|1|||
127524449|NCT03170193|458880603|FG001|Overall Study|Lost to Follow-up|1|||
127524450|NCT03170193|458880604|FG002|Overall Study|Lost to Follow-up|0|||
127524451|NCT03170193|458880605|FG003|Overall Study|Lost to Follow-up|0|||
127524452|NCT03170193|458880606|FG004|Overall Study|Lost to Follow-up|0|||
127524453|NCT03170193|458880607|FG005|Overall Study|Lost to Follow-up|0|||
127524454|NCT03170193|458880608|FG006|Overall Study|Lost to Follow-up|0|||
127524455|NCT01368081|458880609|FG000|Overall Study|Adverse Event|4|||
127524456|NCT01368081|458880610|FG001|Overall Study|Adverse Event|4|||
127524457|NCT01368081|458880611|FG002|Overall Study|Adverse Event|3|||
127524458|NCT01368081|458880612|FG003|Overall Study|Adverse Event|2|||
127524459|NCT01368081|458880613|FG004|Overall Study|Adverse Event|2|||
127524460|NCT01368081|458880614|FG005|Overall Study|Adverse Event|5|||
127524461|NCT01368081|458880615|FG006|Overall Study|Adverse Event|6|||
127524462|NCT01368081|458880616|FG007|Overall Study|Adverse Event|2|||
127524463|NCT01368081|458880617|FG008|Overall Study|Adverse Event|3|||
127524464|NCT01368081|458880618|FG009|Overall Study|Adverse Event|5|||
127524465|NCT01368081|458880619|FG010|Overall Study|Adverse Event|6|||
127524466|NCT01368081|458880620|FG011|Overall Study|Adverse Event|1|||
127524467|NCT01368081|458880621|FG012|Overall Study|Adverse Event|3|||
127524468|NCT01368081|458880609|FG000|Overall Study|Lack of Efficacy|0|||
127524469|NCT01368081|458880610|FG001|Overall Study|Lack of Efficacy|1|||
127524470|NCT01368081|458880611|FG002|Overall Study|Lack of Efficacy|0|||
127524471|NCT01368081|458880612|FG003|Overall Study|Lack of Efficacy|1|||
127524472|NCT01368081|458880613|FG004|Overall Study|Lack of Efficacy|0|||
127524473|NCT01368081|458880614|FG005|Overall Study|Lack of Efficacy|0|||
127524474|NCT01368081|458880615|FG006|Overall Study|Lack of Efficacy|0|||
127524475|NCT01368081|458880616|FG007|Overall Study|Lack of Efficacy|2|||
127524476|NCT01368081|458880617|FG008|Overall Study|Lack of Efficacy|0|||
127524477|NCT01368081|458880618|FG009|Overall Study|Lack of Efficacy|0|||
127524478|NCT01368081|458880619|FG010|Overall Study|Lack of Efficacy|0|||
127524479|NCT01368081|458880620|FG011|Overall Study|Lack of Efficacy|0|||
127524480|NCT01368081|458880621|FG012|Overall Study|Lack of Efficacy|0|||
127524481|NCT01368081|458880609|FG000|Overall Study|Protocol Violation|0|||
127524482|NCT01368081|458880610|FG001|Overall Study|Protocol Violation|0|||
127524483|NCT01368081|458880611|FG002|Overall Study|Protocol Violation|0|||
127524484|NCT01368081|458880612|FG003|Overall Study|Protocol Violation|0|||
127524485|NCT01368081|458880613|FG004|Overall Study|Protocol Violation|0|||
127524486|NCT01368081|458880614|FG005|Overall Study|Protocol Violation|1|||
127524487|NCT01368081|458880615|FG006|Overall Study|Protocol Violation|0|||
127524488|NCT01368081|458880616|FG007|Overall Study|Protocol Violation|1|||
127524489|NCT01368081|458880617|FG008|Overall Study|Protocol Violation|0|||
127524490|NCT01368081|458880618|FG009|Overall Study|Protocol Violation|0|||
127524491|NCT01368081|458880619|FG010|Overall Study|Protocol Violation|0|||
127524492|NCT01368081|458880620|FG011|Overall Study|Protocol Violation|0|||
127524493|NCT01368081|458880621|FG012|Overall Study|Protocol Violation|0|||
127524494|NCT01368081|458880609|FG000|Overall Study|Lost to Follow-up|0|||
127524495|NCT01368081|458880610|FG001|Overall Study|Lost to Follow-up|0|||
127524496|NCT01368081|458880611|FG002|Overall Study|Lost to Follow-up|0|||
127524497|NCT01368081|458880612|FG003|Overall Study|Lost to Follow-up|0|||
127524498|NCT01368081|458880613|FG004|Overall Study|Lost to Follow-up|0|||
127524499|NCT01368081|458880614|FG005|Overall Study|Lost to Follow-up|0|||
127524500|NCT01368081|458880615|FG006|Overall Study|Lost to Follow-up|0|||
127524501|NCT01368081|458880616|FG007|Overall Study|Lost to Follow-up|0|||
127524502|NCT01368081|458880617|FG008|Overall Study|Lost to Follow-up|0|||
127524503|NCT01368081|458880618|FG009|Overall Study|Lost to Follow-up|0|||
127524504|NCT01368081|458880619|FG010|Overall Study|Lost to Follow-up|0|||
127524505|NCT01368081|458880620|FG011|Overall Study|Lost to Follow-up|0|||
127524506|NCT01368081|458880621|FG012|Overall Study|Lost to Follow-up|1|||
127524507|NCT01368081|458880609|FG000|Overall Study|Withdrawal by Subject|4|||
127524508|NCT01368081|458880610|FG001|Overall Study|Withdrawal by Subject|4|||
127524509|NCT01368081|458880611|FG002|Overall Study|Withdrawal by Subject|1|||
127524510|NCT01368081|458880612|FG003|Overall Study|Withdrawal by Subject|1|||
127524511|NCT01368081|458880613|FG004|Overall Study|Withdrawal by Subject|0|||
127524512|NCT01368081|458880614|FG005|Overall Study|Withdrawal by Subject|3|||
127524513|NCT01368081|458880615|FG006|Overall Study|Withdrawal by Subject|4|||
127524514|NCT01368081|458880616|FG007|Overall Study|Withdrawal by Subject|2|||
127524515|NCT01368081|458880617|FG008|Overall Study|Withdrawal by Subject|5|||
127524516|NCT01368081|458880618|FG009|Overall Study|Withdrawal by Subject|4|||
127524517|NCT01368081|458880619|FG010|Overall Study|Withdrawal by Subject|3|||
127524518|NCT01368081|458880620|FG011|Overall Study|Withdrawal by Subject|2|||
127524519|NCT01368081|458880621|FG012|Overall Study|Withdrawal by Subject|0|||
127524520|NCT01368081|458880609|FG000|Overall Study|Other reason not defined above|2|||
127524521|NCT01368081|458880610|FG001|Overall Study|Other reason not defined above|0|||
127524522|NCT01368081|458880611|FG002|Overall Study|Other reason not defined above|0|||
127524523|NCT01368081|458880612|FG003|Overall Study|Other reason not defined above|1|||
127524524|NCT01368081|458880613|FG004|Overall Study|Other reason not defined above|0|||
127524525|NCT01368081|458880614|FG005|Overall Study|Other reason not defined above|1|||
127524526|NCT01368081|458880615|FG006|Overall Study|Other reason not defined above|2|||
127524527|NCT01368081|458880616|FG007|Overall Study|Other reason not defined above|0|||
127524528|NCT01368081|458880617|FG008|Overall Study|Other reason not defined above|0|||
127524529|NCT01368081|458880618|FG009|Overall Study|Other reason not defined above|1|||
127524530|NCT01368081|458880619|FG010|Overall Study|Other reason not defined above|0|||
127524531|NCT01368081|458880620|FG011|Overall Study|Other reason not defined above|0|||
127524532|NCT01368081|458880621|FG012|Overall Study|Other reason not defined above|3|||
127524533|NCT01007838|458880622|FG000|Overall Study|Withdrawal by Subject|1|||
127524534|NCT01007838|458880623|FG001|Overall Study|Withdrawal by Subject|0|||
127524535|NCT01007838|458880624|FG002|Overall Study|Withdrawal by Subject|0|||
127524536|NCT01007838|458880625|FG003|Overall Study|Withdrawal by Subject|0|||
127524537|NCT01007838|458880622|FG000|Overall Study|Physician Decision|1|||
127524538|NCT01007838|458880623|FG001|Overall Study|Physician Decision|0|||
127524539|NCT01007838|458880624|FG002|Overall Study|Physician Decision|0|||
127524540|NCT01007838|458880625|FG003|Overall Study|Physician Decision|0|||
127524541|NCT01007838|458880622|FG000|Overall Study|Started home haemodialysis|1|||
127524542|NCT01007838|458880623|FG001|Overall Study|Started home haemodialysis|0|||
127524543|NCT01007838|458880624|FG002|Overall Study|Started home haemodialysis|0|||
127524544|NCT01007838|458880625|FG003|Overall Study|Started home haemodialysis|0|||
127524545|NCT04167137|458880626|FG000|Overall Study|Disease progression|1|||
127524546|NCT04167137|458880627|FG001|Overall Study|Disease progression|1|||
127524547|NCT04167137|458880628|FG002|Overall Study|Disease progression|3|||
127524548|NCT04167137|458880629|FG003|Overall Study|Disease progression|3|||
127524549|NCT04167137|458880630|FG004|Overall Study|Disease progression|2|||
127524550|NCT04167137|458880631|FG005|Overall Study|Disease progression|3|||
127524551|NCT04167137|458880632|FG006|Overall Study|Disease progression|2|||
127524552|NCT04167137|458880633|FG007|Overall Study|Disease progression|2|||
127524553|NCT04167137|458880626|FG000|Overall Study|Withdrawal by Subject|1|||
127524554|NCT04167137|458880627|FG001|Overall Study|Withdrawal by Subject|0|||
127524555|NCT04167137|458880628|FG002|Overall Study|Withdrawal by Subject|0|||
127524556|NCT04167137|458880629|FG003|Overall Study|Withdrawal by Subject|1|||
127524557|NCT04167137|458880630|FG004|Overall Study|Withdrawal by Subject|0|||
127524558|NCT04167137|458880631|FG005|Overall Study|Withdrawal by Subject|2|||
127524559|NCT04167137|458880632|FG006|Overall Study|Withdrawal by Subject|1|||
127524560|NCT04167137|458880633|FG007|Overall Study|Withdrawal by Subject|0|||
127524561|NCT04167137|458880626|FG000|Overall Study|Adverse Event|0|||
127524562|NCT04167137|458880627|FG001|Overall Study|Adverse Event|0|||
127524563|NCT04167137|458880628|FG002|Overall Study|Adverse Event|0|||
127524564|NCT04167137|458880629|FG003|Overall Study|Adverse Event|0|||
127524565|NCT04167137|458880630|FG004|Overall Study|Adverse Event|0|||
127524566|NCT04167137|458880631|FG005|Overall Study|Adverse Event|1|||
127524567|NCT04167137|458880632|FG006|Overall Study|Adverse Event|0|||
127524568|NCT04167137|458880633|FG007|Overall Study|Adverse Event|1|||
127524569|NCT04167137|458880626|FG000|Overall Study|Physician Decision|0|||
127524570|NCT04167137|458880627|FG001|Overall Study|Physician Decision|0|||
127524571|NCT04167137|458880628|FG002|Overall Study|Physician Decision|0|||
127524572|NCT04167137|458880629|FG003|Overall Study|Physician Decision|1|||
127524573|NCT04167137|458880630|FG004|Overall Study|Physician Decision|0|||
127524574|NCT04167137|458880631|FG005|Overall Study|Physician Decision|0|||
127524575|NCT04167137|458880632|FG006|Overall Study|Physician Decision|1|||
127524576|NCT04167137|458880633|FG007|Overall Study|Physician Decision|0|||
127524577|NCT04167137|458880626|FG000|Overall Study|Death|0|||
127524578|NCT04167137|458880627|FG001|Overall Study|Death|1|||
127524579|NCT04167137|458880628|FG002|Overall Study|Death|0|||
127524580|NCT04167137|458880629|FG003|Overall Study|Death|0|||
127524581|NCT04167137|458880630|FG004|Overall Study|Death|0|||
127524582|NCT04167137|458880631|FG005|Overall Study|Death|0|||
127524583|NCT04167137|458880632|FG006|Overall Study|Death|0|||
127524584|NCT04167137|458880633|FG007|Overall Study|Death|0|||
127524585|NCT04167137|458880626|FG000|Overall Study|Study terminated by Sponsor|0|||
127524586|NCT04167137|458880627|FG001|Overall Study|Study terminated by Sponsor|0|||
127524587|NCT04167137|458880628|FG002|Overall Study|Study terminated by Sponsor|0|||
127524588|NCT04167137|458880629|FG003|Overall Study|Study terminated by Sponsor|0|||
127524589|NCT04167137|458880630|FG004|Overall Study|Study terminated by Sponsor|0|||
127524590|NCT04167137|458880631|FG005|Overall Study|Study terminated by Sponsor|0|||
127524591|NCT04167137|458880632|FG006|Overall Study|Study terminated by Sponsor|0|||
127524592|NCT04167137|458880633|FG007|Overall Study|Study terminated by Sponsor|1|||
127524593|NCT01748825|458880638|FG000|Dose Escalation|Refused further treatment|2|||
127524594|NCT01748825|458880639|FG001|Dose Escalation|Refused further treatment|2|||
127524595|NCT01748825|458880640|FG002|Dose Escalation|Refused further treatment|0|||
127524596|NCT01748825|458880641|FG003|Dose Escalation|Refused further treatment|0|||
127524597|NCT01748825|458880642|FG004|Dose Escalation|Refused further treatment|1|||
127524598|NCT01748825|458880643|FG005|Dose Escalation|Refused further treatment|2|||
127524599|NCT01748825|458880644|FG006|Dose Escalation|Refused further treatment|0|||
127524600|NCT01748825|458880645|FG007|Dose Escalation|Refused further treatment|0|||
127524601|NCT01748825|458880646|FG008|Dose Escalation|Refused further treatment|0|||
127524602|NCT01748825|458880647|FG009|Dose Escalation|Refused further treatment|0|||
127524603|NCT01748825|458880638|FG000|Dose Escalation|Switched to alternative treatment|0|||
127524604|NCT01748825|458880639|FG001|Dose Escalation|Switched to alternative treatment|0|||
127524605|NCT01748825|458880640|FG002|Dose Escalation|Switched to alternative treatment|0|||
127524606|NCT01748825|458880641|FG003|Dose Escalation|Switched to alternative treatment|1|||
127524607|NCT01748825|458880642|FG004|Dose Escalation|Switched to alternative treatment|0|||
127524608|NCT01748825|458880643|FG005|Dose Escalation|Switched to alternative treatment|0|||
127524609|NCT01748825|458880644|FG006|Dose Escalation|Switched to alternative treatment|0|||
127524610|NCT01748825|458880645|FG007|Dose Escalation|Switched to alternative treatment|0|||
127524611|NCT01748825|458880646|FG008|Dose Escalation|Switched to alternative treatment|0|||
127524612|NCT01748825|458880647|FG009|Dose Escalation|Switched to alternative treatment|0|||
127524613|NCT01748825|458880638|FG000|Dose Escalation|Adverse Event|0|||
127524614|NCT01748825|458880639|FG001|Dose Escalation|Adverse Event|0|||
127524615|NCT01748825|458880640|FG002|Dose Escalation|Adverse Event|0|||
127524616|NCT01748825|458880641|FG003|Dose Escalation|Adverse Event|0|||
127524617|NCT01748825|458880642|FG004|Dose Escalation|Adverse Event|0|||
127524618|NCT01748825|458880643|FG005|Dose Escalation|Adverse Event|0|||
127524619|NCT01748825|458880644|FG006|Dose Escalation|Adverse Event|1|||
127524620|NCT01748825|458880645|FG007|Dose Escalation|Adverse Event|0|||
127524621|NCT01748825|458880646|FG008|Dose Escalation|Adverse Event|0|||
127524622|NCT01748825|458880647|FG009|Dose Escalation|Adverse Event|0|||
127524623|NCT01748825|458880638|FG000|Dose Expansion|Refused further treatment|0|||
127524624|NCT01748825|458880639|FG001|Dose Expansion|Refused further treatment|0|||
127524625|NCT01748825|458880640|FG002|Dose Expansion|Refused further treatment|0|||
127524626|NCT01748825|458880641|FG003|Dose Expansion|Refused further treatment|0|||
127524627|NCT01748825|458880642|FG004|Dose Expansion|Refused further treatment|0|||
127524628|NCT01748825|458880643|FG005|Dose Expansion|Refused further treatment|0|||
127524629|NCT01748825|458880644|FG006|Dose Expansion|Refused further treatment|0|||
127524630|NCT01748825|458880645|FG007|Dose Expansion|Refused further treatment|0|||
127524631|NCT01748825|458880646|FG008|Dose Expansion|Refused further treatment|1|||
127524632|NCT01748825|458880647|FG009|Dose Expansion|Refused further treatment|1|||
127524633|NCT01748825|458880638|FG000|Dose Expansion|Switched to alternative treatment|0|||
127524634|NCT01748825|458880639|FG001|Dose Expansion|Switched to alternative treatment|0|||
127524635|NCT01748825|458880640|FG002|Dose Expansion|Switched to alternative treatment|0|||
127524636|NCT01748825|458880641|FG003|Dose Expansion|Switched to alternative treatment|0|||
127524637|NCT01748825|458880642|FG004|Dose Expansion|Switched to alternative treatment|0|||
127524638|NCT01748825|458880643|FG005|Dose Expansion|Switched to alternative treatment|0|||
127524639|NCT01748825|458880644|FG006|Dose Expansion|Switched to alternative treatment|0|||
127524640|NCT01748825|458880645|FG007|Dose Expansion|Switched to alternative treatment|0|||
127524641|NCT01748825|458880646|FG008|Dose Expansion|Switched to alternative treatment|0|||
127524642|NCT01748825|458880647|FG009|Dose Expansion|Switched to alternative treatment|1|||
127524643|NCT01748825|458880638|FG000|Dose Expansion|Adverse Event|0|||
127524644|NCT01748825|458880639|FG001|Dose Expansion|Adverse Event|0|||
127524645|NCT01748825|458880640|FG002|Dose Expansion|Adverse Event|0|||
127524646|NCT01748825|458880641|FG003|Dose Expansion|Adverse Event|0|||
127524647|NCT01748825|458880642|FG004|Dose Expansion|Adverse Event|0|||
127524648|NCT01748825|458880643|FG005|Dose Expansion|Adverse Event|0|||
127524649|NCT01748825|458880644|FG006|Dose Expansion|Adverse Event|0|||
127524650|NCT01748825|458880645|FG007|Dose Expansion|Adverse Event|0|||
127524651|NCT01748825|458880646|FG008|Dose Expansion|Adverse Event|0|||
127524652|NCT01748825|458880647|FG009|Dose Expansion|Adverse Event|3|||
127524653|NCT01748825|458880638|FG000|Dose Expansion|Physician Decision|0|||
127524654|NCT01748825|458880639|FG001|Dose Expansion|Physician Decision|0|||
127524655|NCT01748825|458880640|FG002|Dose Expansion|Physician Decision|0|||
127524656|NCT01748825|458880641|FG003|Dose Expansion|Physician Decision|0|||
127524657|NCT01748825|458880642|FG004|Dose Expansion|Physician Decision|0|||
127524658|NCT01748825|458880643|FG005|Dose Expansion|Physician Decision|0|||
127524659|NCT01748825|458880644|FG006|Dose Expansion|Physician Decision|0|||
127524660|NCT01748825|458880645|FG007|Dose Expansion|Physician Decision|0|||
127524661|NCT01748825|458880646|FG008|Dose Expansion|Physician Decision|1|||
127524662|NCT01748825|458880647|FG009|Dose Expansion|Physician Decision|0|||
127524663|NCT00852241|458880649|FG000|Overall Study|Physician Decision|18|||
127524664|NCT00118430|458880651|FG000|Overall Study|Withdrawal by Subject|6|||
127524665|NCT00118430|458880652|FG001|Overall Study|Withdrawal by Subject|2|||
127524666|NCT00118430|458880653|FG002|Overall Study|Withdrawal by Subject|0|||
127524667|NCT00118430|458880651|FG000|Overall Study|Lost to Follow-up|15|||
127524668|NCT00118430|458880652|FG001|Overall Study|Lost to Follow-up|22|||
127524669|NCT00118430|458880653|FG002|Overall Study|Lost to Follow-up|28|||
127524670|NCT02147288|458880654|FG000|Overall Study|post-operative hematoma|1|||
127524671|NCT02147288|458880655|FG001|Overall Study|post-operative hematoma|1|||
127524672|NCT02147288|458880656|FG002|Overall Study|post-operative hematoma|0|||
127524673|NCT02147288|458880657|FG003|Overall Study|post-operative hematoma|0|||
127524674|NCT02147288|458880658|FG004|Overall Study|post-operative hematoma|0|||
127524675|NCT02147288|458880659|FG005|Overall Study|post-operative hematoma|0|||
127524676|NCT02147288|458880660|FG006|Overall Study|post-operative hematoma|0|||
127524677|NCT02147288|458880661|FG007|Overall Study|post-operative hematoma|0|||
127524678|NCT02147288|458880662|FG008|Overall Study|post-operative hematoma|0|||
127524679|NCT02147288|458880663|FG009|Overall Study|post-operative hematoma|0|||
127524680|NCT02147288|458880654|FG000|Overall Study|complications from concurrent hernia rep|0|||
127524681|NCT02147288|458880655|FG001|Overall Study|complications from concurrent hernia rep|1|||
127524682|NCT02147288|458880656|FG002|Overall Study|complications from concurrent hernia rep|0|||
127524683|NCT02147288|458880657|FG003|Overall Study|complications from concurrent hernia rep|0|||
127524684|NCT02147288|458880658|FG004|Overall Study|complications from concurrent hernia rep|0|||
127524685|NCT02147288|458880659|FG005|Overall Study|complications from concurrent hernia rep|0|||
127524686|NCT02147288|458880660|FG006|Overall Study|complications from concurrent hernia rep|0|||
127524687|NCT02147288|458880661|FG007|Overall Study|complications from concurrent hernia rep|0|||
127524688|NCT02147288|458880662|FG008|Overall Study|complications from concurrent hernia rep|0|||
127524689|NCT02147288|458880663|FG009|Overall Study|complications from concurrent hernia rep|0|||
127524690|NCT02069392|458880666|FG000|Overall Study|Withdrawal by Subject|4|||
127524691|NCT02069392|458880667|FG001|Overall Study|Withdrawal by Subject|2|||
127524692|NCT00269633|458880668|FG000|Overall Study|Withdrawal by Subject|1|||
127524693|NCT00269633|458880669|FG001|Overall Study|Withdrawal by Subject|0|||
127524694|NCT04412707|458880670|FG000|Cycle 1|Death|0|||
127524695|NCT04412707|458880671|FG001|Cycle 1|Death|3|||
127524696|NCT04412707|458880670|FG000|Cycle 1|Disease progression|1|||
127524697|NCT04412707|458880671|FG001|Cycle 1|Disease progression|2|||
127524698|NCT04412707|458880670|FG000|Cycle 2|Death|0|||
127524699|NCT04412707|458880671|FG001|Cycle 2|Death|1|||
127524700|NCT04412707|458880670|FG000|Cycle 2|Disease progression|3|||
127524701|NCT04412707|458880671|FG001|Cycle 2|Disease progression|0|||
127524702|NCT04412707|458880670|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
127524703|NCT04412707|458880671|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
127524704|NCT04412707|458880670|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
127524705|NCT04412707|458880671|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
127524706|NCT04412707|458880670|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
127524707|NCT04412707|458880671|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
127524708|NCT04412707|458880670|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
127524709|NCT04412707|458880671|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
127524710|NCT02476006|458880672|FG000|Overall Study|Death|4|||
127524711|NCT02476006|458880672|FG000|Overall Study|Lack of treatment efficacy|2|||
127524712|NCT02476006|458880672|FG000|Overall Study|Pregnancy|1|||
127524713|NCT02476006|458880672|FG000|Overall Study|Participant did not wish to continue|39|||
127524714|NCT02476006|458880672|FG000|Overall Study|Adverse Event|41|||
127524715|NCT02476006|458880672|FG000|Overall Study|Poor compliance to study protocol|3|||
127524716|NCT02476006|458880672|FG000|Overall Study|Sponsor decision|6|||
127524717|NCT02476006|458880672|FG000|Overall Study|Lost to Follow-up|5|||
127524718|NCT02476006|458880672|FG000|Overall Study|Physician Decision|5|||
127524719|NCT02476006|458880672|FG000|Overall Study|Study ended treatment not available|4|||
127524720|NCT02476006|458880672|FG000|Overall Study|Switched to commercial drug|4|||
127524721|NCT02476006|458880672|FG000|Overall Study|Excluded from study|1|||
127524722|NCT02476006|458880672|FG000|Overall Study|Protocol Violation|1|||
127524723|NCT02476006|458880672|FG000|Overall Study|Enrolled but not treated|4|||
127524724|NCT00871338|458882801|FG000|Prior to Booster|Withdrawal by Subject|1|||
127524725|NCT00871338|458882802|FG001|Prior to Booster|Withdrawal by Subject|3|||
127524726|NCT00871338|458882801|FG000|Prior to Booster|Lost to Follow-up|1|||
127524727|NCT00871338|458882802|FG001|Prior to Booster|Lost to Follow-up|0|||
127524728|NCT02391363|458882803|FG000|Overall Study|Lost to Follow-up|5|||
127524729|NCT02391363|458882804|FG001|Overall Study|Lost to Follow-up|5|||
127524730|NCT02391363|458882803|FG000|Overall Study|Withdrawal by Subject|6|||
127524731|NCT02391363|458882804|FG001|Overall Study|Withdrawal by Subject|3|||
127524732|NCT02510001|458882807|FG000|Overall Study|Early disease progression|0|||
127524733|NCT02510001|458882808|FG001|Overall Study|Early disease progression|0|||
127524734|NCT02510001|458882809|FG002|Overall Study|Early disease progression|0|||
127524735|NCT02510001|458882810|FG003|Overall Study|Early disease progression|1|||
127524736|NCT02510001|458882811|FG004|Overall Study|Early disease progression|1|||
127524737|NCT02510001|458882812|FG005|Overall Study|Early disease progression|1|||
127524738|NCT02510001|458882813|FG006|Overall Study|Early disease progression|0|||
127524739|NCT02510001|458882814|FG007|Overall Study|Early disease progression|0|||
127524740|NCT02510001|458882807|FG000|Overall Study|Adverse Event|0|||
127524741|NCT02510001|458882808|FG001|Overall Study|Adverse Event|0|||
127524742|NCT02510001|458882809|FG002|Overall Study|Adverse Event|0|||
127524743|NCT02510001|458882810|FG003|Overall Study|Adverse Event|1|||
127524744|NCT02510001|458882811|FG004|Overall Study|Adverse Event|2|||
127524745|NCT02510001|458882812|FG005|Overall Study|Adverse Event|1|||
127524746|NCT02510001|458882813|FG006|Overall Study|Adverse Event|2|||
127524747|NCT02510001|458882814|FG007|Overall Study|Adverse Event|5|||
127524748|NCT02510001|458882807|FG000|Overall Study|Physician Decision|0|||
127524749|NCT02510001|458882808|FG001|Overall Study|Physician Decision|0|||
127524750|NCT02510001|458882809|FG002|Overall Study|Physician Decision|0|||
127524751|NCT02510001|458882810|FG003|Overall Study|Physician Decision|0|||
127524752|NCT02510001|458882811|FG004|Overall Study|Physician Decision|1|||
127524753|NCT02510001|458882812|FG005|Overall Study|Physician Decision|0|||
127524754|NCT02510001|458882813|FG006|Overall Study|Physician Decision|0|||
127524755|NCT02510001|458882814|FG007|Overall Study|Physician Decision|0|||
127524756|NCT02510001|458882807|FG000|Overall Study|Withdrawal by Subject|0|||
127524757|NCT02510001|458882808|FG001|Overall Study|Withdrawal by Subject|0|||
127524758|NCT02510001|458882809|FG002|Overall Study|Withdrawal by Subject|0|||
127524759|NCT02510001|458882810|FG003|Overall Study|Withdrawal by Subject|0|||
127524760|NCT02510001|458882811|FG004|Overall Study|Withdrawal by Subject|0|||
127524761|NCT02510001|458882812|FG005|Overall Study|Withdrawal by Subject|0|||
127524762|NCT02510001|458882813|FG006|Overall Study|Withdrawal by Subject|0|||
127524763|NCT02510001|458882814|FG007|Overall Study|Withdrawal by Subject|2|||
127524764|NCT01440816|458882830|FG000|Overall Study|Disease Progression|0|||
127524765|NCT01440816|458882831|FG001|Overall Study|Disease Progression|9|||
127524766|NCT01440816|458882830|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
127524767|NCT01440816|458882831|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
127524768|NCT00856544|458882832|FG000|Overall Study|Randomized but not treated|3|||
127524769|NCT00856544|458882833|FG001|Overall Study|Randomized but not treated|0|||
127524770|NCT00856544|458882834|FG002|Overall Study|Randomized but not treated|0|||
127524771|NCT00856544|458882835|FG003|Overall Study|Randomized but not treated|0|||
127524772|NCT00856544|458882832|FG000|Overall Study|Death|0|||
127524773|NCT00856544|458882833|FG001|Overall Study|Death|2|||
127524774|NCT00856544|458882834|FG002|Overall Study|Death|0|||
127524775|NCT00856544|458882835|FG003|Overall Study|Death|0|||
127524776|NCT00856544|458882832|FG000|Overall Study|Adverse Event|20|||
127524777|NCT00856544|458882833|FG001|Overall Study|Adverse Event|29|||
127524778|NCT00856544|458882834|FG002|Overall Study|Adverse Event|2|||
127524779|NCT00856544|458882835|FG003|Overall Study|Adverse Event|3|||
127524780|NCT00856544|458882832|FG000|Overall Study|Lack of Efficacy|16|||
127524781|NCT00856544|458882833|FG001|Overall Study|Lack of Efficacy|12|||
127524782|NCT00856544|458882834|FG002|Overall Study|Lack of Efficacy|3|||
127524783|NCT00856544|458882835|FG003|Overall Study|Lack of Efficacy|3|||
127524784|NCT00856544|458882832|FG000|Overall Study|Other|9|||
127524785|NCT00856544|458882833|FG001|Overall Study|Other|16|||
127524786|NCT00856544|458882834|FG002|Overall Study|Other|1|||
127524787|NCT00856544|458882835|FG003|Overall Study|Other|6|||
127524788|NCT00856544|458882832|FG000|Overall Study|Lost to Follow-up|1|||
127524789|NCT00856544|458882833|FG001|Overall Study|Lost to Follow-up|2|||
127524790|NCT00856544|458882834|FG002|Overall Study|Lost to Follow-up|2|||
127524791|NCT00856544|458882835|FG003|Overall Study|Lost to Follow-up|0|||
127524792|NCT00856544|458882832|FG000|Overall Study|Withdrawal by Subject|8|||
127524793|NCT00856544|458882833|FG001|Overall Study|Withdrawal by Subject|5|||
127524794|NCT00856544|458882834|FG002|Overall Study|Withdrawal by Subject|0|||
127524795|NCT00856544|458882835|FG003|Overall Study|Withdrawal by Subject|1|||
127524796|NCT00787189|458882836|FG000|Overall Study|Lost to Follow-up|2|||
127524797|NCT00787189|458882837|FG001|Overall Study|Lost to Follow-up|2|||
127524798|NCT01687101|458882838|FG000|Overall Study|Lost to Follow-up|7|||
127524799|NCT03920254|458882842|FG000|Overall Study|Adverse Event|1|||
127524800|NCT03920254|458882843|FG001|Overall Study|Adverse Event|0|||
127524801|NCT03920254|458882844|FG002|Overall Study|Adverse Event|0|||
127524802|NCT03920254|458882842|FG000|Overall Study|Physician Decision|0|||
127524803|NCT03920254|458882843|FG001|Overall Study|Physician Decision|1|||
127524804|NCT03920254|458882844|FG002|Overall Study|Physician Decision|2|||
127524805|NCT03920254|458882842|FG000|Overall Study|Study Terminated By Sponsor|12|||
127524806|NCT03920254|458882843|FG001|Overall Study|Study Terminated By Sponsor|17|||
127524807|NCT03920254|458882844|FG002|Overall Study|Study Terminated By Sponsor|12|||
127524808|NCT03920254|458882842|FG000|Overall Study|Withdrawal by Subject|0|||
127524809|NCT03920254|458882843|FG001|Overall Study|Withdrawal by Subject|0|||
127524810|NCT03920254|458882844|FG002|Overall Study|Withdrawal by Subject|1|||
127524811|NCT03250182|458882845|FG000|Overall Study|Withdrawal by Subject|1|||
127524812|NCT05274269|458882846|FG000|Overall Study|Adverse Event|0|||
127524813|NCT05274269|458882847|FG001|Overall Study|Adverse Event|3|||
127524814|NCT05274269|458882846|FG000|Overall Study|Death|0|||
127524815|NCT05274269|458882847|FG001|Overall Study|Death|1|||
127524816|NCT05274269|458882846|FG000|Overall Study|Other|0|||
127524817|NCT05274269|458882847|FG001|Overall Study|Other|2|||
127524818|NCT05274269|458882846|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
127524819|NCT05274269|458882847|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
127524820|NCT01858740|458882848|FG000|Overall Study|Death|4|||
127524821|NCT00894361|458882851|FG000|Overall Study|deaths and less than 2 years followup|24|||
127524822|NCT00894361|458882852|FG001|Overall Study|deaths and less than 2 years followup|64|||
127524823|NCT02097030|458882860|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
127524824|NCT02097030|458882861|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
127524825|NCT02097030|458882860|FG000|First Intervention (3 Days)|Visual Acuity|0|||
127524826|NCT02097030|458882861|FG001|First Intervention (3 Days)|Visual Acuity|1|||
127524827|NCT00773747|458882862|FG000|Overall Study|Lack of Efficacy|112|||
127524828|NCT00773747|458882863|FG001|Overall Study|Lack of Efficacy|144|||
127524829|NCT00773747|458882862|FG000|Overall Study|Physician Decision|26|||
127524830|NCT00773747|458882863|FG001|Overall Study|Physician Decision|18|||
127524831|NCT00773747|458882862|FG000|Overall Study|Lost to Follow-up|0|||
127524832|NCT00773747|458882863|FG001|Overall Study|Lost to Follow-up|1|||
127524833|NCT00773747|458882862|FG000|Overall Study|Protocol Violation|2|||
127524834|NCT00773747|458882863|FG001|Overall Study|Protocol Violation|2|||
127524835|NCT00773747|458882862|FG000|Overall Study|Withdrawal by Subject|89|||
127524836|NCT00773747|458882863|FG001|Overall Study|Withdrawal by Subject|61|||
127524837|NCT00773747|458882862|FG000|Overall Study|Adverse Event|61|||
127524838|NCT00773747|458882863|FG001|Overall Study|Adverse Event|62|||
127524839|NCT00773747|458882862|FG000|Overall Study|Death|5|||
127524840|NCT00773747|458882863|FG001|Overall Study|Death|8|||
127524841|NCT00773747|458882862|FG000|Overall Study|Not Treated|2|||
127524842|NCT00773747|458882863|FG001|Overall Study|Not Treated|0|||
127524843|NCT00391027|458882866|FG000|Overall Study|Adverse Event|8|||
127524844|NCT00391027|458882867|FG001|Overall Study|Adverse Event|8|||
127524845|NCT00391027|458882866|FG000|Overall Study|Lack of Efficacy|3|||
127524846|NCT00391027|458882867|FG001|Overall Study|Lack of Efficacy|0|||
127524847|NCT00391027|458882866|FG000|Overall Study|Withdrawal by Subject|10|||
127524848|NCT00391027|458882867|FG001|Overall Study|Withdrawal by Subject|1|||
127524849|NCT00391027|458882866|FG000|Overall Study|Other|4|||
127524850|NCT00391027|458882867|FG001|Overall Study|Other|3|||
127524851|NCT04869358|458882872|FG000|Overall Study|Wish to have children.|1|||
127524852|NCT04869358|458882873|FG001|Overall Study|Wish to have children.|0|||
127524853|NCT04869358|458882874|FG002|Overall Study|Wish to have children.|0|||
127524854|NCT04869358|458882875|FG003|Overall Study|Wish to have children.|0|||
127524855|NCT04164732|458882876|FG000|Treatment run-in Period|Adverse Event|4|||
127524856|NCT04164732|458882877|FG001|Treatment run-in Period|Adverse Event|0|||
127524857|NCT04164732|458882878|FG002|Treatment run-in Period|Adverse Event|0|||
127524858|NCT04164732|458882876|FG000|Treatment run-in Period|Physician Decision|1|||
127524859|NCT04164732|458882877|FG001|Treatment run-in Period|Physician Decision|0|||
127524860|NCT04164732|458882878|FG002|Treatment run-in Period|Physician Decision|0|||
127524861|NCT04164732|458882876|FG000|Treatment run-in Period|Screen Failure|1|||
127524862|NCT04164732|458882877|FG001|Treatment run-in Period|Screen Failure|0|||
127524863|NCT04164732|458882878|FG002|Treatment run-in Period|Screen Failure|0|||
127524864|NCT04164732|458882876|FG000|Randomized Treatment Period|Adverse Event|0|||
127524865|NCT04164732|458882877|FG001|Randomized Treatment Period|Adverse Event|1|||
127524866|NCT04164732|458882878|FG002|Randomized Treatment Period|Adverse Event|0|||
127524867|NCT04164732|458882876|FG000|Randomized Treatment Period|Protocol Deviation|0|||
127524868|NCT04164732|458882877|FG001|Randomized Treatment Period|Protocol Deviation|1|||
127524869|NCT04164732|458882878|FG002|Randomized Treatment Period|Protocol Deviation|1|||
127524870|NCT04164732|458882876|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
127524871|NCT04164732|458882877|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
127524872|NCT04164732|458882878|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
127524873|NCT04302545|458882879|FG000|Overall Study|Lost to Follow-up|3|||
127524874|NCT04302545|458882880|FG001|Overall Study|Lost to Follow-up|4|||
127524875|NCT01636986|458882884|FG000|Overall Study|Withdrawal by Subject|0|||
127524876|NCT01636986|458882885|FG001|Overall Study|Withdrawal by Subject|1|||
127524877|NCT01636986|458882884|FG000|Overall Study|Corneal Staining|0|||
127524878|NCT01636986|458882885|FG001|Overall Study|Corneal Staining|1|||
127524879|NCT01844778|458882891|FG000|Overall Study|Protocol deviation|0|||
127524880|NCT01844778|458882892|FG001|Overall Study|Protocol deviation|1|||
127524881|NCT01844778|458882893|FG002|Overall Study|Protocol deviation|2|||
127524882|NCT01844778|458882891|FG000|Overall Study|Withdrawal by Subject|2|||
127524883|NCT01844778|458882892|FG001|Overall Study|Withdrawal by Subject|0|||
127524884|NCT01844778|458882893|FG002|Overall Study|Withdrawal by Subject|0|||
127524885|NCT01844778|458882891|FG000|Overall Study|Adverse Event|0|||
127524886|NCT01844778|458882892|FG001|Overall Study|Adverse Event|2|||
127524887|NCT01844778|458882893|FG002|Overall Study|Adverse Event|2|||
127524888|NCT02951429|458882899|FG000|Overall Study|Adverse Event|3|||
127524889|NCT02951429|458882900|FG001|Overall Study|Adverse Event|7|||
127524890|NCT02951429|458882899|FG000|Overall Study|Death|28|||
127524891|NCT02951429|458882900|FG001|Overall Study|Death|36|||
127524892|NCT02951429|458882899|FG000|Overall Study|Lack of Efficacy|0|||
127524893|NCT02951429|458882900|FG001|Overall Study|Lack of Efficacy|1|||
127524894|NCT02951429|458882899|FG000|Overall Study|Lost to Follow-up|0|||
127524895|NCT02951429|458882900|FG001|Overall Study|Lost to Follow-up|1|||
127524896|NCT02951429|458882899|FG000|Overall Study|Lung Transplantation|9|||
127524897|NCT02951429|458882900|FG001|Overall Study|Lung Transplantation|6|||
127524898|NCT02951429|458882899|FG000|Overall Study|Other|1|||
127524899|NCT02951429|458882900|FG001|Overall Study|Other|3|||
127524900|NCT02951429|458882899|FG000|Overall Study|Progressive Disease|1|||
127524901|NCT02951429|458882900|FG001|Overall Study|Progressive Disease|1|||
127524902|NCT02951429|458882899|FG000|Overall Study|Withdrawal by Subject|7|||
127524903|NCT02951429|458882900|FG001|Overall Study|Withdrawal by Subject|11|||
127524904|NCT02951429|458882899|FG000|Overall Study|Participant ongoing in the study|23|||
127524905|NCT02951429|458882900|FG001|Overall Study|Participant ongoing in the study|17|||
127524906|NCT01620528|458882901|FG000|Treatment Period|Did Not Receive Study Drug|0|||
127524907|NCT01620528|458882902|FG001|Treatment Period|Did Not Receive Study Drug|0|||
127524908|NCT01620528|458882903|FG002|Treatment Period|Did Not Receive Study Drug|1|||
127524909|NCT01620528|458882901|FG000|Treatment Period|Withdrawal by Subject|35|||
127524910|NCT01620528|458882902|FG001|Treatment Period|Withdrawal by Subject|21|||
127524911|NCT01620528|458882903|FG002|Treatment Period|Withdrawal by Subject|16|||
127524912|NCT01620528|458882901|FG000|Treatment Period|Adverse Event|17|||
127524913|NCT01620528|458882902|FG001|Treatment Period|Adverse Event|13|||
127524914|NCT01620528|458882903|FG002|Treatment Period|Adverse Event|21|||
127524915|NCT01620528|458882901|FG000|Treatment Period|Lost to Follow-up|16|||
127524916|NCT01620528|458882902|FG001|Treatment Period|Lost to Follow-up|8|||
127524917|NCT01620528|458882903|FG002|Treatment Period|Lost to Follow-up|14|||
127524918|NCT01620528|458882901|FG000|Treatment Period|Other|9|||
127524919|NCT01620528|458882902|FG001|Treatment Period|Other|5|||
127524920|NCT01620528|458882903|FG002|Treatment Period|Other|7|||
127524921|NCT01620528|458882901|FG000|Treatment Period|Subject Noncompliant|11|||
127524922|NCT01620528|458882902|FG001|Treatment Period|Subject Noncompliant|2|||
127524923|NCT01620528|458882903|FG002|Treatment Period|Subject Noncompliant|2|||
127524924|NCT01620528|458882901|FG000|Treatment Period|Pregnancy|7|||
127524925|NCT01620528|458882902|FG001|Treatment Period|Pregnancy|2|||
127524926|NCT01620528|458882903|FG002|Treatment Period|Pregnancy|2|||
127524927|NCT01620528|458882901|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
127524928|NCT01620528|458882902|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
127524929|NCT01620528|458882903|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
127524930|NCT01620528|458882901|FG000|Treatment Period|Exclusionary Medication Received|0|||
127524931|NCT01620528|458882902|FG001|Treatment Period|Exclusionary Medication Received|1|||
127524932|NCT01620528|458882903|FG002|Treatment Period|Exclusionary Medication Received|0|||
127524933|NCT01620528|458882901|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
127524934|NCT01620528|458882902|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
127524935|NCT01620528|458882903|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
127524936|NCT01620528|458882901|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
127524937|NCT01620528|458882902|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
127524938|NCT01620528|458882903|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
127524939|NCT01620528|458882901|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
127524940|NCT01620528|458882902|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
127524941|NCT01620528|458882903|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
127524942|NCT01620528|458882901|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
127524943|NCT01620528|458882902|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
127524944|NCT01620528|458882903|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
127524945|NCT01620528|458882901|FG000|Post-Treatment Follow-Up Period|Other|6|||
127524946|NCT01620528|458882902|FG001|Post-Treatment Follow-Up Period|Other|4|||
127524947|NCT01620528|458882903|FG002|Post-Treatment Follow-Up Period|Other|2|||
127524948|NCT02106403|458882907|FG000|Follow-Up Visit 3|Other Reason|0|||
127524949|NCT02106403|458882908|FG001|Follow-Up Visit 3|Other Reason|0|||
127524950|NCT02106403|458882909|FG002|Follow-Up Visit 3|Other Reason|0|||
127524951|NCT02106403|458882910|FG003|Follow-Up Visit 3|Other Reason|0|||
127524952|NCT02106403|458882911|FG004|Follow-Up Visit 3|Other Reason|0|||
127524953|NCT02106403|458882912|FG005|Follow-Up Visit 3|Other Reason|1|||
127524954|NCT01496846|458882913|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
127524955|NCT01496846|458882914|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
127524956|NCT01496846|458882915|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
127524957|NCT01496846|458882916|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
127524958|NCT01496846|458882917|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
127524959|NCT01496846|458882918|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
127524960|NCT01772576|458882919|FG000|Overall Study|Death|15|||
127524961|NCT01772576|458882919|FG000|Overall Study|Protocol Violation|1|||
127524962|NCT01772576|458882919|FG000|Overall Study|Lost to Follow-up|3|||
127524963|NCT01772576|458882919|FG000|Overall Study|Study device not used|3|||
127524964|NCT01772576|458882919|FG000|Overall Study|Adverse Event|6|||
127524965|NCT01772576|458882919|FG000|Overall Study|Withdrawal by Subject|6|||
127524966|NCT01128946|458882932|FG000|Period I|Protocol Violation|0|||
127524967|NCT01128946|458882933|FG001|Period I|Protocol Violation|1|||
127524968|NCT01128946|458882934|FG002|Period I|Protocol Violation|0|||
127524969|NCT01128946|458882935|FG003|Period I|Protocol Violation|0|||
127524970|NCT01128946|458882932|FG000|Period I|Withdrawal by Subject|0|||
127524971|NCT01128946|458882933|FG001|Period I|Withdrawal by Subject|0|||
127524972|NCT01128946|458882934|FG002|Period I|Withdrawal by Subject|1|||
127524973|NCT01128946|458882935|FG003|Period I|Withdrawal by Subject|1|||
127524974|NCT01128946|458882932|FG000|Period II|Protocol Violation|0|||
127524975|NCT01128946|458882933|FG001|Period II|Protocol Violation|1|||
127524976|NCT01128946|458882934|FG002|Period II|Protocol Violation|0|||
127524977|NCT01128946|458882935|FG003|Period II|Protocol Violation|0|||
127524978|NCT01128946|458882932|FG000|Period II|Withdrawal by Subject|0|||
127524979|NCT01128946|458882933|FG001|Period II|Withdrawal by Subject|0|||
127524980|NCT01128946|458882934|FG002|Period II|Withdrawal by Subject|0|||
127524981|NCT01128946|458882935|FG003|Period II|Withdrawal by Subject|1|||
127524982|NCT01128946|458882932|FG000|Period III|Protocol Violation|1|||
127524983|NCT01128946|458882933|FG001|Period III|Protocol Violation|0|||
127524984|NCT01128946|458882934|FG002|Period III|Protocol Violation|0|||
127524985|NCT01128946|458882935|FG003|Period III|Protocol Violation|0|||
127524986|NCT00379912|458882936|FG000|Overall Study|Lack of Efficacy|1|||
127524987|NCT00379912|458882937|FG001|Overall Study|Lack of Efficacy|0|||
127524988|NCT00621140|458882938|FG000|Overall Study|Adverse Event|4|||
127524989|NCT00621140|458882939|FG001|Overall Study|Adverse Event|5|||
127524990|NCT00621140|458882938|FG000|Overall Study|Lost to Follow-up|1|||
127524991|NCT00621140|458882939|FG001|Overall Study|Lost to Follow-up|2|||
127524992|NCT00621140|458882938|FG000|Overall Study|Withdrawal by Subject|4|||
127524993|NCT00621140|458882939|FG001|Overall Study|Withdrawal by Subject|6|||
127524994|NCT00621140|458882938|FG000|Overall Study|Other incl. lack of efficacy|6|||
127524995|NCT00621140|458882939|FG001|Overall Study|Other incl. lack of efficacy|5|||
127524996|NCT01371734|458882940|FG000|Overall Study|Other|2|||
127524997|NCT01371734|458882941|FG001|Overall Study|Other|1|||
127524998|NCT01371734|458882942|FG002|Overall Study|Other|2|||
127524999|NCT01371734|458882940|FG000|Overall Study|Withdrawal by Subject|3|||
127525000|NCT01371734|458882941|FG001|Overall Study|Withdrawal by Subject|4|||
127525001|NCT01371734|458882942|FG002|Overall Study|Withdrawal by Subject|9|||
127525002|NCT01371734|458882940|FG000|Overall Study|Lost to Follow-up|5|||
127525003|NCT01371734|458882941|FG001|Overall Study|Lost to Follow-up|3|||
127525004|NCT01371734|458882942|FG002|Overall Study|Lost to Follow-up|1|||
127525005|NCT01371734|458882940|FG000|Overall Study|Protocol Violation|3|||
127525006|NCT01371734|458882941|FG001|Overall Study|Protocol Violation|1|||
127525007|NCT01371734|458882942|FG002|Overall Study|Protocol Violation|2|||
127525008|NCT01371734|458882940|FG000|Overall Study|Adverse Event|8|||
127525009|NCT01371734|458882941|FG001|Overall Study|Adverse Event|8|||
127525010|NCT01371734|458882942|FG002|Overall Study|Adverse Event|3|||
127525011|NCT01371734|458882940|FG000|Overall Study|Lack of Efficacy|2|||
127525012|NCT01371734|458882941|FG001|Overall Study|Lack of Efficacy|2|||
127525013|NCT01371734|458882942|FG002|Overall Study|Lack of Efficacy|0|||
127525014|NCT00360568|458882943|FG000|Overall Study|Adverse Event|1|||
127525015|NCT00360568|458882944|FG001|Overall Study|Adverse Event|2|||
127525016|NCT00360568|458882943|FG000|Overall Study|Lack of Efficacy|1|||
127525017|NCT00360568|458882944|FG001|Overall Study|Lack of Efficacy|0|||
127525018|NCT00360568|458882943|FG000|Overall Study|Withdrawal by Subject|0|||
127525019|NCT00360568|458882944|FG001|Overall Study|Withdrawal by Subject|3|||
127525020|NCT03565237|458882945|FG000|Overall Study|Non-compliance of Investigational Product|1|||
127525021|NCT03565237|458882945|FG000|Overall Study|Physician Decision|1|||
127525022|NCT02873338|458882949|FG000|Overall Study|Adverse Event|0|||
127525023|NCT02873338|458882950|FG001|Overall Study|Adverse Event|2|||
127525024|NCT02873338|458882951|FG002|Overall Study|Adverse Event|1|||
127525025|NCT02873338|458882949|FG000|Overall Study|Death|2|||
127525026|NCT02873338|458882950|FG001|Overall Study|Death|1|||
127525027|NCT02873338|458882951|FG002|Overall Study|Death|1|||
127525028|NCT02873338|458882949|FG000|Overall Study|Withdrawal by Subject|2|||
127525029|NCT02873338|458882950|FG001|Overall Study|Withdrawal by Subject|1|||
127525030|NCT02873338|458882951|FG002|Overall Study|Withdrawal by Subject|3|||
127525031|NCT02873338|458882949|FG000|Overall Study|Lack of Efficacy|0|||
127525032|NCT02873338|458882950|FG001|Overall Study|Lack of Efficacy|2|||
127525033|NCT02873338|458882951|FG002|Overall Study|Lack of Efficacy|0|||
127525034|NCT02873338|458882949|FG000|Overall Study|Other or Missing|14|||
127525035|NCT02873338|458882950|FG001|Overall Study|Other or Missing|15|||
127525036|NCT02873338|458882951|FG002|Overall Study|Other or Missing|13|||
127525037|NCT03657095|458882952|FG000|Overall Study|Withdrawal by Subject|1|||
127525038|NCT03657095|458882953|FG001|Overall Study|Withdrawal by Subject|1|||
127525039|NCT03657095|458882952|FG000|Overall Study|Adverse Event|0|||
127525040|NCT03657095|458882953|FG001|Overall Study|Adverse Event|3|||
127525041|NCT03657095|458882952|FG000|Overall Study|Study Terminated by Sponsor|58|||
127525042|NCT03657095|458882953|FG001|Overall Study|Study Terminated by Sponsor|49|||
127525043|NCT04006392|458882954|FG000|Overall Study|Lost to Follow-up|0|||
127525044|NCT04006392|458882955|FG001|Overall Study|Lost to Follow-up|1|||
127525045|NCT03824587|458882956|FG000|Run-in Period|Screen Failure|0|||
127525046|NCT03824587|458882957|FG001|Run-in Period|Screen Failure|275|||
127525047|NCT03824587|458882956|FG000|Treatment Period|Adverse Event|4|||
127525048|NCT03824587|458882957|FG001|Treatment Period|Adverse Event|1|||
127525049|NCT03824587|458882956|FG000|Treatment Period|Withdrawal by Subject|0|||
127525050|NCT03824587|458882957|FG001|Treatment Period|Withdrawal by Subject|1|||
127525051|NCT03824587|458882956|FG000|Treatment Period|Kidney Transplant|1|||
127525052|NCT03824587|458882957|FG001|Treatment Period|Kidney Transplant|1|||
127525053|NCT00986362|458882958|FG000|Overall Study|Death|2|||
127525054|NCT00986362|458882959|FG001|Overall Study|Death|0|||
127525055|NCT00986362|458882958|FG000|Overall Study|Lost to Follow-up|0|||
127525056|NCT00986362|458882959|FG001|Overall Study|Lost to Follow-up|1|||
127525057|NCT00384332|458882960|FG000|Overall Study|Lost to Follow-up|4|||
127525058|NCT00384332|458882961|FG001|Overall Study|Lost to Follow-up|0|||
127525059|NCT02006979|458882962|FG000|Overall Study|Withdrawal by Subject|1|||
127525060|NCT02006979|458882963|FG001|Overall Study|Withdrawal by Subject|1|||
127525061|NCT02006979|458882962|FG000|Overall Study|Protocol Violation|0|||
127525062|NCT02006979|458882963|FG001|Overall Study|Protocol Violation|1|||
127525063|NCT02560012|458882964|FG000|Overall Study|Study Terminated|2|||
127525064|NCT02611817|458884806|FG000|Open-label Induction Phase|Reason not Specified|9|||
127525065|NCT02611817|458884807|FG001|Open-label Induction Phase|Reason not Specified|0|||
127525066|NCT02611817|458884808|FG002|Open-label Induction Phase|Reason not Specified|0|||
127525067|NCT02611817|458884806|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
127525068|NCT02611817|458884807|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
127525069|NCT02611817|458884808|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
127525070|NCT02611817|458884806|FG000|Open-label Induction Phase|Pregnancy|1|||
127525071|NCT02611817|458884807|FG001|Open-label Induction Phase|Pregnancy|0|||
127525072|NCT02611817|458884808|FG002|Open-label Induction Phase|Pregnancy|0|||
127525073|NCT02611817|458884806|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
127525074|NCT02611817|458884807|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
127525075|NCT02611817|458884808|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
127525076|NCT02611817|458884806|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
127525077|NCT02611817|458884807|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
127525078|NCT02611817|458884808|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
127525079|NCT02611817|458884806|FG000|Open-label Induction Phase|Protocol Violation|5|||
127525080|NCT02611817|458884807|FG001|Open-label Induction Phase|Protocol Violation|0|||
127525081|NCT02611817|458884808|FG002|Open-label Induction Phase|Protocol Violation|0|||
127525082|NCT02611817|458884806|FG000|Open-label Induction Phase|Adverse Event|16|||
127525083|NCT02611817|458884807|FG001|Open-label Induction Phase|Adverse Event|0|||
127525084|NCT02611817|458884808|FG002|Open-label Induction Phase|Adverse Event|0|||
127525085|NCT02611817|458884806|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
127525086|NCT02611817|458884807|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
127525087|NCT02611817|458884808|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
127525088|NCT02611817|458884806|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
127525089|NCT02611817|458884807|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
127525090|NCT02611817|458884808|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
127525091|NCT02611817|458884806|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
127525092|NCT02611817|458884807|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
127525093|NCT02611817|458884808|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
127525094|NCT02611817|458884806|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
127525095|NCT02611817|458884807|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
127525096|NCT02611817|458884808|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
127525097|NCT02611817|458884806|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
127525098|NCT02611817|458884807|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
127525099|NCT02611817|458884808|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
127525100|NCT02611817|458884806|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
127525101|NCT02611817|458884807|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
127525102|NCT02611817|458884808|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
127525103|NCT02611817|458884806|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
127525104|NCT02611817|458884807|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
127525105|NCT02611817|458884808|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
127525106|NCT00931606|458884809|FG000|Overall Study|Death|1|||
127525107|NCT00931606|458884810|FG001|Overall Study|Death|3|||
127525108|NCT00931606|458884811|FG002|Overall Study|Death|2|||
127525109|NCT00931606|458884812|FG003|Overall Study|Death|0|||
127525110|NCT00931606|458884809|FG000|Overall Study|Lost to Follow-up|0|||
127525111|NCT00931606|458884810|FG001|Overall Study|Lost to Follow-up|1|||
127525112|NCT00931606|458884811|FG002|Overall Study|Lost to Follow-up|0|||
127525113|NCT00931606|458884812|FG003|Overall Study|Lost to Follow-up|0|||
127525114|NCT00931606|458884809|FG000|Overall Study|Physician Decision|0|||
127525115|NCT00931606|458884810|FG001|Overall Study|Physician Decision|0|||
127525116|NCT00931606|458884811|FG002|Overall Study|Physician Decision|3|||
127525117|NCT00931606|458884812|FG003|Overall Study|Physician Decision|0|||
127525118|NCT00931606|458884809|FG000|Overall Study|Sponsor Decision|1|||
127525119|NCT00931606|458884810|FG001|Overall Study|Sponsor Decision|4|||
127525120|NCT00931606|458884811|FG002|Overall Study|Sponsor Decision|0|||
127525121|NCT00931606|458884812|FG003|Overall Study|Sponsor Decision|2|||
127525122|NCT00931606|458884809|FG000|Overall Study|Withdrawal by Subject|3|||
127525123|NCT00931606|458884810|FG001|Overall Study|Withdrawal by Subject|1|||
127525124|NCT00931606|458884811|FG002|Overall Study|Withdrawal by Subject|1|||
127525125|NCT00931606|458884812|FG003|Overall Study|Withdrawal by Subject|1|||
127525126|NCT03412812|458884820|FG000|Level 1|Death|3|||
127525127|NCT03412812|458884821|FG001|Level 1|Death|0|||
127525128|NCT03412812|458884820|FG000|Level 1|Adverse Event|0|||
127525129|NCT03412812|458884821|FG001|Level 1|Adverse Event|1|||
127525130|NCT03828617|458884827|FG000|Overall Study|Lost to Follow-up|22|||
127525131|NCT03828617|458884828|FG001|Overall Study|Lost to Follow-up|12|||
127525132|NCT03828617|458884829|FG002|Overall Study|Lost to Follow-up|23|||
127525133|NCT03828617|458884830|FG003|Overall Study|Lost to Follow-up|7|||
127525134|NCT03828617|458884827|FG000|Overall Study|No longer met eligibility criteria|0|||
127525135|NCT03828617|458884828|FG001|Overall Study|No longer met eligibility criteria|1|||
127525136|NCT03828617|458884829|FG002|Overall Study|No longer met eligibility criteria|1|||
127525137|NCT03828617|458884830|FG003|Overall Study|No longer met eligibility criteria|3|||
127525138|NCT03828617|458884827|FG000|Overall Study|Protocol Violation|0|||
127525139|NCT03828617|458884828|FG001|Overall Study|Protocol Violation|2|||
127525140|NCT03828617|458884829|FG002|Overall Study|Protocol Violation|0|||
127525141|NCT03828617|458884830|FG003|Overall Study|Protocol Violation|0|||
127525142|NCT03828617|458884827|FG000|Overall Study|Withdrawal by Subject|2|||
127525143|NCT03828617|458884828|FG001|Overall Study|Withdrawal by Subject|0|||
127525144|NCT03828617|458884829|FG002|Overall Study|Withdrawal by Subject|2|||
127525145|NCT03828617|458884830|FG003|Overall Study|Withdrawal by Subject|0|||
127525146|NCT04794270|458884831|FG000|Period 1|Non Compliance|1|||
127525147|NCT04794270|458884832|FG001|Period 1|Non Compliance|0|||
127525148|NCT04794270|458884831|FG000|Period 1|Adverse Event|1|||
127525149|NCT04794270|458884832|FG001|Period 1|Adverse Event|0|||
127525150|NCT04794270|458884831|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
127525151|NCT04794270|458884832|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
127525152|NCT00265317|458884835|FG000|Lead-In|Objective progression or relapse|6|||
127525153|NCT00265317|458884836|FG001|Lead-In|Objective progression or relapse|11|||
127525154|NCT00265317|458884837|FG002|Lead-In|Objective progression or relapse|0|||
127525155|NCT00265317|458884838|FG003|Lead-In|Objective progression or relapse|0|||
127525156|NCT00265317|458884835|FG000|Lead-In|Adverse Event|2|||
127525157|NCT00265317|458884836|FG001|Lead-In|Adverse Event|1|||
127525158|NCT00265317|458884837|FG002|Lead-In|Adverse Event|0|||
127525159|NCT00265317|458884838|FG003|Lead-In|Adverse Event|0|||
127525160|NCT00265317|458884835|FG000|Lead-In|Death|3|||
127525161|NCT00265317|458884836|FG001|Lead-In|Death|5|||
127525162|NCT00265317|458884837|FG002|Lead-In|Death|0|||
127525163|NCT00265317|458884838|FG003|Lead-In|Death|0|||
127525164|NCT00265317|458884835|FG000|Lead-In|Withdrawal/other than adverse event|1|||
127525165|NCT00265317|458884836|FG001|Lead-In|Withdrawal/other than adverse event|0|||
127525166|NCT00265317|458884837|FG002|Lead-In|Withdrawal/other than adverse event|0|||
127525167|NCT00265317|458884838|FG003|Lead-In|Withdrawal/other than adverse event|0|||
127525168|NCT00265317|458884835|FG000|Phase 2|Objective progression or relapse|0|||
127525169|NCT00265317|458884836|FG001|Phase 2|Objective progression or relapse|0|||
127525170|NCT00265317|458884837|FG002|Phase 2|Objective progression or relapse|37|||
127525171|NCT00265317|458884838|FG003|Phase 2|Objective progression or relapse|38|||
127525172|NCT00265317|458884835|FG000|Phase 2|Global deterioration of health status|0|||
127525173|NCT00265317|458884836|FG001|Phase 2|Global deterioration of health status|0|||
127525174|NCT00265317|458884837|FG002|Phase 2|Global deterioration of health status|3|||
127525175|NCT00265317|458884838|FG003|Phase 2|Global deterioration of health status|0|||
127525176|NCT00265317|458884835|FG000|Phase 2|Adverse Event|0|||
127525177|NCT00265317|458884836|FG001|Phase 2|Adverse Event|0|||
127525178|NCT00265317|458884837|FG002|Phase 2|Adverse Event|7|||
127525179|NCT00265317|458884838|FG003|Phase 2|Adverse Event|5|||
127525180|NCT00265317|458884835|FG000|Phase 2|Death|0|||
127525181|NCT00265317|458884836|FG001|Phase 2|Death|0|||
127525182|NCT00265317|458884837|FG002|Phase 2|Death|12|||
127525183|NCT00265317|458884838|FG003|Phase 2|Death|15|||
127525184|NCT00265317|458884835|FG000|Phase 2|Protocol Violation|0|||
127525185|NCT00265317|458884836|FG001|Phase 2|Protocol Violation|0|||
127525186|NCT00265317|458884837|FG002|Phase 2|Protocol Violation|1|||
127525187|NCT00265317|458884838|FG003|Phase 2|Protocol Violation|4|||
127525188|NCT00265317|458884835|FG000|Phase 2|Lost to Follow-up|0|||
127525189|NCT00265317|458884836|FG001|Phase 2|Lost to Follow-up|0|||
127525190|NCT00265317|458884837|FG002|Phase 2|Lost to Follow-up|0|||
127525191|NCT00265317|458884838|FG003|Phase 2|Lost to Follow-up|1|||
127525192|NCT00265317|458884835|FG000|Phase 2|Withdrawal/other than adverse event|0|||
127525193|NCT00265317|458884836|FG001|Phase 2|Withdrawal/other than adverse event|0|||
127525194|NCT00265317|458884837|FG002|Phase 2|Withdrawal/other than adverse event|2|||
127525195|NCT00265317|458884838|FG003|Phase 2|Withdrawal/other than adverse event|1|||
127525196|NCT00265317|458884835|FG000|Phase 2|Study terminated by sponsor|0|||
127525197|NCT00265317|458884836|FG001|Phase 2|Study terminated by sponsor|0|||
127525198|NCT00265317|458884837|FG002|Phase 2|Study terminated by sponsor|1|||
127525199|NCT00265317|458884838|FG003|Phase 2|Study terminated by sponsor|0|||
127525200|NCT00265317|458884835|FG000|Phase 2|Other|0|||
127525201|NCT00265317|458884836|FG001|Phase 2|Other|0|||
127525202|NCT00265317|458884837|FG002|Phase 2|Other|1|||
127525203|NCT00265317|458884838|FG003|Phase 2|Other|1|||
127525204|NCT03826186|458884839|FG000|Overall Study|Protocol Violation|2|||
127525205|NCT03826186|458884840|FG001|Overall Study|Protocol Violation|0|||
127525206|NCT03826186|458884839|FG000|Overall Study|Withdrawal by Subject|1|||
127525207|NCT03826186|458884840|FG001|Overall Study|Withdrawal by Subject|0|||
127525208|NCT00303485|458884854|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
127525209|NCT00303485|458884855|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
127525210|NCT00303485|458884854|FG000|Overall Study|Failure to return|0|||
127525211|NCT00303485|458884855|FG001|Overall Study|Failure to return|1|||
127525212|NCT00303485|458884854|FG000|Overall Study|Withdrawal by Subject|1|||
127525213|NCT00303485|458884855|FG001|Overall Study|Withdrawal by Subject|0|||
127525214|NCT00082407|458884862|FG000|Overall Study|Adverse Event|20|||
127525215|NCT00082407|458884863|FG001|Overall Study|Adverse Event|0|||
127525216|NCT00082407|458884862|FG000|Overall Study|Protocol Violation|14|||
127525217|NCT00082407|458884863|FG001|Overall Study|Protocol Violation|12|||
127525218|NCT00082407|458884862|FG000|Overall Study|Patient Decision|13|||
127525219|NCT00082407|458884863|FG001|Overall Study|Patient Decision|6|||
127525220|NCT00082407|458884862|FG000|Overall Study|Physician Decision|5|||
127525221|NCT00082407|458884863|FG001|Overall Study|Physician Decision|3|||
127525222|NCT00082407|458884862|FG000|Overall Study|Loss of Glucose Control|2|||
127525223|NCT00082407|458884863|FG001|Overall Study|Loss of Glucose Control|2|||
127525224|NCT00082407|458884862|FG000|Overall Study|Death|2|||
127525225|NCT00082407|458884863|FG001|Overall Study|Death|1|||
127525226|NCT00082407|458884862|FG000|Overall Study|Lost to Follow-up|0|||
127525227|NCT00082407|458884863|FG001|Overall Study|Lost to Follow-up|3|||
127525228|NCT00891228|458884865|FG000|Overall Study|Adverse Event|0|||
127525229|NCT00891228|458884866|FG001|Overall Study|Adverse Event|2|||
127525230|NCT00891228|458884867|FG002|Overall Study|Adverse Event|3|||
127525231|NCT00891228|458884865|FG000|Overall Study|Withdrawal by Subject|2|||
127525232|NCT00891228|458884866|FG001|Overall Study|Withdrawal by Subject|4|||
127525233|NCT00891228|458884867|FG002|Overall Study|Withdrawal by Subject|5|||
127525234|NCT00891228|458884865|FG000|Overall Study|Protocol Violation|3|||
127525235|NCT00891228|458884866|FG001|Overall Study|Protocol Violation|1|||
127525236|NCT00891228|458884867|FG002|Overall Study|Protocol Violation|2|||
127525237|NCT00891228|458884865|FG000|Overall Study|Physician Decision|2|||
127525238|NCT00891228|458884866|FG001|Overall Study|Physician Decision|1|||
127525239|NCT00891228|458884867|FG002|Overall Study|Physician Decision|0|||
127525240|NCT00891228|458884865|FG000|Overall Study|Lost to Follow-up|4|||
127525241|NCT00891228|458884866|FG001|Overall Study|Lost to Follow-up|4|||
127525242|NCT00891228|458884867|FG002|Overall Study|Lost to Follow-up|5|||
127525243|NCT00891228|458884865|FG000|Overall Study|Pregnancy|0|||
127525244|NCT00891228|458884866|FG001|Overall Study|Pregnancy|1|||
127525245|NCT00891228|458884867|FG002|Overall Study|Pregnancy|0|||
127525246|NCT02688985|458884870|FG000|Overall Study|Adverse Event|1|||
127525247|NCT02688985|458884871|FG001|Overall Study|Adverse Event|2|||
127525248|NCT02688985|458884872|FG002|Overall Study|Adverse Event|2|||
127525249|NCT02688985|458884873|FG003|Overall Study|Adverse Event|0|||
127525250|NCT02688985|458884874|FG004|Overall Study|Adverse Event|0|||
127525251|NCT02688985|458884870|FG000|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
127525252|NCT02688985|458884871|FG001|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
127525253|NCT02688985|458884872|FG002|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
127525254|NCT02688985|458884873|FG003|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
127525255|NCT02688985|458884874|FG004|Overall Study|Continued Onto Commercially Available Ocrelizumab|21|||
127525256|NCT02688985|458884870|FG000|Overall Study|Death|0|||
127525257|NCT02688985|458884871|FG001|Overall Study|Death|0|||
127525258|NCT02688985|458884872|FG002|Overall Study|Death|0|||
127525259|NCT02688985|458884873|FG003|Overall Study|Death|0|||
127525260|NCT02688985|458884874|FG004|Overall Study|Death|1|||
127525261|NCT02688985|458884870|FG000|Overall Study|Lack of Efficacy|0|||
127525262|NCT02688985|458884871|FG001|Overall Study|Lack of Efficacy|0|||
127525263|NCT02688985|458884872|FG002|Overall Study|Lack of Efficacy|0|||
127525264|NCT02688985|458884873|FG003|Overall Study|Lack of Efficacy|0|||
127525265|NCT02688985|458884874|FG004|Overall Study|Lack of Efficacy|1|||
127525266|NCT02688985|458884870|FG000|Overall Study|Lost to Follow-up|2|||
127525267|NCT02688985|458884871|FG001|Overall Study|Lost to Follow-up|0|||
127525268|NCT02688985|458884872|FG002|Overall Study|Lost to Follow-up|1|||
127525269|NCT02688985|458884873|FG003|Overall Study|Lost to Follow-up|1|||
127525270|NCT02688985|458884874|FG004|Overall Study|Lost to Follow-up|1|||
127525271|NCT02688985|458884870|FG000|Overall Study|Non-Compliance With Study Drug|1|||
127525272|NCT02688985|458884871|FG001|Overall Study|Non-Compliance With Study Drug|3|||
127525273|NCT02688985|458884872|FG002|Overall Study|Non-Compliance With Study Drug|1|||
127525274|NCT02688985|458884873|FG003|Overall Study|Non-Compliance With Study Drug|0|||
127525275|NCT02688985|458884874|FG004|Overall Study|Non-Compliance With Study Drug|1|||
127525276|NCT02688985|458884870|FG000|Overall Study|Other|3|||
127525277|NCT02688985|458884871|FG001|Overall Study|Other|4|||
127525278|NCT02688985|458884872|FG002|Overall Study|Other|1|||
127525279|NCT02688985|458884873|FG003|Overall Study|Other|0|||
127525280|NCT02688985|458884874|FG004|Overall Study|Other|0|||
127525281|NCT02688985|458884870|FG000|Overall Study|Physician Decision|2|||
127525282|NCT02688985|458884871|FG001|Overall Study|Physician Decision|2|||
127525283|NCT02688985|458884872|FG002|Overall Study|Physician Decision|0|||
127525284|NCT02688985|458884873|FG003|Overall Study|Physician Decision|0|||
127525285|NCT02688985|458884874|FG004|Overall Study|Physician Decision|1|||
127525286|NCT02688985|458884870|FG000|Overall Study|Pregnancy|0|||
127525287|NCT02688985|458884871|FG001|Overall Study|Pregnancy|0|||
127525288|NCT02688985|458884872|FG002|Overall Study|Pregnancy|2|||
127525289|NCT02688985|458884873|FG003|Overall Study|Pregnancy|1|||
127525290|NCT02688985|458884874|FG004|Overall Study|Pregnancy|0|||
127525291|NCT02688985|458884870|FG000|Overall Study|Study Terminated By Sponsor|0|||
127525292|NCT02688985|458884871|FG001|Overall Study|Study Terminated By Sponsor|0|||
127525293|NCT02688985|458884872|FG002|Overall Study|Study Terminated By Sponsor|0|||
127525294|NCT02688985|458884873|FG003|Overall Study|Study Terminated By Sponsor|1|||
127525295|NCT02688985|458884874|FG004|Overall Study|Study Terminated By Sponsor|0|||
127525296|NCT02688985|458884870|FG000|Overall Study|Withdrawal by Subject|2|||
127525297|NCT02688985|458884871|FG001|Overall Study|Withdrawal by Subject|8|||
127525298|NCT02688985|458884872|FG002|Overall Study|Withdrawal by Subject|7|||
127525299|NCT02688985|458884873|FG003|Overall Study|Withdrawal by Subject|1|||
127525300|NCT02688985|458884874|FG004|Overall Study|Withdrawal by Subject|4|||
127525301|NCT01726582|458884877|FG000|Overall Study|Physician Decision|99|||
127525302|NCT01726582|458884877|FG000|Overall Study|Death|85|||
127525303|NCT00711971|458884878|FG000|Overall Study|Lost to Follow-up|3|||
127525304|NCT00711971|458884879|FG001|Overall Study|Lost to Follow-up|4|||
127525305|NCT00711971|458884880|FG002|Overall Study|Lost to Follow-up|1|||
127525306|NCT01363908|458884881|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
127525307|NCT01363908|458884882|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
127525308|NCT01363908|458884881|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
127525309|NCT01363908|458884882|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
127525310|NCT01363908|458884881|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
127525311|NCT01363908|458884882|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
127525312|NCT01363908|458884881|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
127525313|NCT01363908|458884882|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
127525314|NCT02644343|458884883|FG000|Overall Study|Withdrawal by Subject|1|||
127525315|NCT03437577|458884884|FG000|Pre-Randomization|Withdrawal by Subject|0|||
127525316|NCT03437577|458884885|FG001|Pre-Randomization|Withdrawal by Subject|0|||
127525317|NCT03437577|458884886|FG002|Pre-Randomization|Withdrawal by Subject|10|||
127525318|NCT03437577|458884884|FG000|Post-Randomization|Physician Decision|0|||
127525319|NCT03437577|458884885|FG001|Post-Randomization|Physician Decision|2|||
127525320|NCT03437577|458884886|FG002|Post-Randomization|Physician Decision|0|||
127525321|NCT00536471|458884887|FG000|Overall Study|Lost to Follow-up|48|||
127525322|NCT00536471|458884888|FG001|Overall Study|Lost to Follow-up|23|||
127525323|NCT00536471|458884889|FG002|Overall Study|Lost to Follow-up|48|||
127525324|NCT00536471|458884890|FG003|Overall Study|Lost to Follow-up|22|||
127525325|NCT00536471|458884887|FG000|Overall Study|Adverse Event|32|||
127525326|NCT00536471|458884888|FG001|Overall Study|Adverse Event|16|||
127525327|NCT00536471|458884889|FG002|Overall Study|Adverse Event|28|||
127525328|NCT00536471|458884890|FG003|Overall Study|Adverse Event|13|||
127525329|NCT00536471|458884887|FG000|Overall Study|Withdrawal by Subject|40|||
127525330|NCT00536471|458884888|FG001|Overall Study|Withdrawal by Subject|24|||
127525331|NCT00536471|458884889|FG002|Overall Study|Withdrawal by Subject|43|||
127525332|NCT00536471|458884890|FG003|Overall Study|Withdrawal by Subject|21|||
127525333|NCT00536471|458884887|FG000|Overall Study|Lack of Efficacy|17|||
127525334|NCT00536471|458884888|FG001|Overall Study|Lack of Efficacy|18|||
127525335|NCT00536471|458884889|FG002|Overall Study|Lack of Efficacy|11|||
127525336|NCT00536471|458884890|FG003|Overall Study|Lack of Efficacy|9|||
127525337|NCT00536471|458884887|FG000|Overall Study|Protocol Violation|8|||
127525338|NCT00536471|458884888|FG001|Overall Study|Protocol Violation|1|||
127525339|NCT00536471|458884889|FG002|Overall Study|Protocol Violation|2|||
127525340|NCT00536471|458884890|FG003|Overall Study|Protocol Violation|3|||
127525341|NCT00536471|458884887|FG000|Overall Study|Physician Decision|11|||
127525342|NCT00536471|458884888|FG001|Overall Study|Physician Decision|1|||
127525343|NCT00536471|458884889|FG002|Overall Study|Physician Decision|3|||
127525344|NCT00536471|458884890|FG003|Overall Study|Physician Decision|2|||
127525345|NCT00536471|458884887|FG000|Overall Study|Death|0|||
127525346|NCT00536471|458884888|FG001|Overall Study|Death|0|||
127525347|NCT00536471|458884889|FG002|Overall Study|Death|1|||
127525348|NCT00536471|458884890|FG003|Overall Study|Death|2|||
127525349|NCT00536471|458884887|FG000|Overall Study|Sponsor Decision|0|||
127525350|NCT00536471|458884888|FG001|Overall Study|Sponsor Decision|1|||
127525351|NCT00536471|458884889|FG002|Overall Study|Sponsor Decision|3|||
127525352|NCT00536471|458884890|FG003|Overall Study|Sponsor Decision|2|||
127525353|NCT03704688|458884891|FG000|Overall Study|Adverse Event|0|||
127525354|NCT03704688|458884892|FG001|Overall Study|Adverse Event|0|||
127525355|NCT03704688|458884893|FG002|Overall Study|Adverse Event|0|||
127525356|NCT03704688|458884894|FG003|Overall Study|Adverse Event|4|||
127525357|NCT03704688|458884895|FG004|Overall Study|Adverse Event|1|||
127525358|NCT03704688|458884896|FG005|Overall Study|Adverse Event|0|||
127525359|NCT03704688|458884891|FG000|Overall Study|Disease Progression|0|||
127525360|NCT03704688|458884892|FG001|Overall Study|Disease Progression|0|||
127525361|NCT03704688|458884893|FG002|Overall Study|Disease Progression|0|||
127525362|NCT03704688|458884894|FG003|Overall Study|Disease Progression|3|||
127525363|NCT03704688|458884895|FG004|Overall Study|Disease Progression|1|||
127525364|NCT03704688|458884896|FG005|Overall Study|Disease Progression|0|||
127525365|NCT03704688|458884891|FG000|Overall Study|Death|0|||
127525366|NCT03704688|458884892|FG001|Overall Study|Death|0|||
127525367|NCT03704688|458884893|FG002|Overall Study|Death|0|||
127525368|NCT03704688|458884894|FG003|Overall Study|Death|0|||
127525369|NCT03704688|458884895|FG004|Overall Study|Death|3|||
127525370|NCT03704688|458884896|FG005|Overall Study|Death|0|||
127525371|NCT04878211|458884897|FG000|Overall Study|Lost to Follow-up|0|||
127525372|NCT04878211|458884898|FG001|Overall Study|Lost to Follow-up|0|||
127525373|NCT04878211|458884899|FG002|Overall Study|Lost to Follow-up|0|||
127525374|NCT04878211|458884900|FG003|Overall Study|Lost to Follow-up|1|||
127525375|NCT04878211|458884901|FG004|Overall Study|Lost to Follow-up|0|||
127525376|NCT04878211|458884902|FG005|Overall Study|Lost to Follow-up|1|||
127525377|NCT04878211|458884897|FG000|Overall Study|Protocol deviation|1|||
127525378|NCT04878211|458884898|FG001|Overall Study|Protocol deviation|0|||
127525379|NCT04878211|458884899|FG002|Overall Study|Protocol deviation|0|||
127525380|NCT04878211|458884900|FG003|Overall Study|Protocol deviation|0|||
127525381|NCT04878211|458884901|FG004|Overall Study|Protocol deviation|0|||
127525382|NCT04878211|458884902|FG005|Overall Study|Protocol deviation|0|||
127525383|NCT04878211|458884897|FG000|Overall Study|Study terminated by sponsor|0|||
127525384|NCT04878211|458884898|FG001|Overall Study|Study terminated by sponsor|0|||
127525385|NCT04878211|458884899|FG002|Overall Study|Study terminated by sponsor|0|||
127525386|NCT04878211|458884900|FG003|Overall Study|Study terminated by sponsor|0|||
127525387|NCT04878211|458884901|FG004|Overall Study|Study terminated by sponsor|9|||
127525388|NCT04878211|458884902|FG005|Overall Study|Study terminated by sponsor|4|||
127525389|NCT04878211|458884897|FG000|Overall Study|Subject decision|0|||
127525390|NCT04878211|458884898|FG001|Overall Study|Subject decision|0|||
127525391|NCT04878211|458884899|FG002|Overall Study|Subject decision|0|||
127525392|NCT04878211|458884900|FG003|Overall Study|Subject decision|0|||
127525393|NCT04878211|458884901|FG004|Overall Study|Subject decision|1|||
127525394|NCT04878211|458884902|FG005|Overall Study|Subject decision|0|||
127525395|NCT04774926|458884909|FG000|Overall Study|Adverse Event|15|||
127525396|NCT04774926|458884909|FG000|Overall Study|Lost to Follow-up|3|||
127525397|NCT04774926|458884909|FG000|Overall Study|Physician Decision|6|||
127525398|NCT04774926|458884909|FG000|Overall Study|Withdrawal by Subject|3|||
127525399|NCT04774926|458884909|FG000|Overall Study|The original PI resigned and a new one could not be appointed|4|||
127525400|NCT02783599|458884910|FG000|Overall Study|Progressive disease|23|||
127525401|NCT02783599|458884910|FG000|Overall Study|Surgical Resection|10|||
127525402|NCT02783599|458884910|FG000|Overall Study|Adverse Event|4|||
127525403|NCT02783599|458884910|FG000|Overall Study|Physician Decision|2|||
127525404|NCT02783599|458884910|FG000|Overall Study|Death|1|||
127525405|NCT00847886|458884911|FG000|Overall Study|Adverse Event|0|||
127525406|NCT00847886|458884912|FG001|Overall Study|Adverse Event|1|||
127525407|NCT05173012|458884917|FG000|Overall Study|Adverse Event|2|||
127525408|NCT05173012|458884918|FG001|Overall Study|Adverse Event|3|||
127525409|NCT05173012|458884919|FG002|Overall Study|Adverse Event|4|||
127525410|NCT05173012|458884920|FG003|Overall Study|Adverse Event|13|||
127525411|NCT05173012|458884921|FG004|Overall Study|Adverse Event|0|||
127525412|NCT05173012|458884922|FG005|Overall Study|Adverse Event|0|||
127525413|NCT05173012|458884923|FG006|Overall Study|Adverse Event|2|||
127525414|NCT05173012|458884924|FG007|Overall Study|Adverse Event|4|||
127525415|NCT05173012|458884917|FG000|Overall Study|Lost to Follow-up|0|||
127525416|NCT05173012|458884918|FG001|Overall Study|Lost to Follow-up|0|||
127525417|NCT05173012|458884919|FG002|Overall Study|Lost to Follow-up|0|||
127525418|NCT05173012|458884920|FG003|Overall Study|Lost to Follow-up|1|||
127525419|NCT05173012|458884921|FG004|Overall Study|Lost to Follow-up|0|||
127525420|NCT05173012|458884922|FG005|Overall Study|Lost to Follow-up|0|||
127525421|NCT05173012|458884923|FG006|Overall Study|Lost to Follow-up|0|||
127525422|NCT05173012|458884924|FG007|Overall Study|Lost to Follow-up|0|||
127525423|NCT05173012|458884917|FG000|Overall Study|Withdrawal by Subject|1|||
127525424|NCT05173012|458884918|FG001|Overall Study|Withdrawal by Subject|0|||
127525425|NCT05173012|458884919|FG002|Overall Study|Withdrawal by Subject|1|||
127525426|NCT05173012|458884920|FG003|Overall Study|Withdrawal by Subject|3|||
127525427|NCT05173012|458884921|FG004|Overall Study|Withdrawal by Subject|1|||
127525428|NCT05173012|458884922|FG005|Overall Study|Withdrawal by Subject|0|||
127525429|NCT05173012|458884923|FG006|Overall Study|Withdrawal by Subject|1|||
127525430|NCT05173012|458884924|FG007|Overall Study|Withdrawal by Subject|0|||
127525431|NCT05173012|458884917|FG000|Overall Study|Protocol Deviation|0|||
127525432|NCT05173012|458884918|FG001|Overall Study|Protocol Deviation|0|||
127525433|NCT05173012|458884919|FG002|Overall Study|Protocol Deviation|0|||
127525434|NCT05173012|458884920|FG003|Overall Study|Protocol Deviation|1|||
127525435|NCT05173012|458884921|FG004|Overall Study|Protocol Deviation|0|||
127525436|NCT05173012|458884922|FG005|Overall Study|Protocol Deviation|0|||
127525437|NCT05173012|458884923|FG006|Overall Study|Protocol Deviation|0|||
127525438|NCT05173012|458884924|FG007|Overall Study|Protocol Deviation|0|||
127525439|NCT05173012|458884917|FG000|Overall Study|Other|0|||
127525440|NCT05173012|458884918|FG001|Overall Study|Other|0|||
127525441|NCT05173012|458884919|FG002|Overall Study|Other|0|||
127525442|NCT05173012|458884920|FG003|Overall Study|Other|2|||
127525443|NCT05173012|458884921|FG004|Overall Study|Other|0|||
127525444|NCT05173012|458884922|FG005|Overall Study|Other|0|||
127525445|NCT05173012|458884923|FG006|Overall Study|Other|0|||
127525446|NCT05173012|458884924|FG007|Overall Study|Other|0|||
127525447|NCT03668613|458884925|FG000|Overall Study|Adverse Event|1|||
127525448|NCT03668613|458884926|FG001|Overall Study|Adverse Event|2|||
127525449|NCT03668613|458884925|FG000|Overall Study|Lack of Efficacy|5|||
127525450|NCT03668613|458884926|FG001|Overall Study|Lack of Efficacy|1|||
127525451|NCT03668613|458884925|FG000|Overall Study|Pregnancy|0|||
127525452|NCT03668613|458884926|FG001|Overall Study|Pregnancy|2|||
127525453|NCT03668613|458884925|FG000|Overall Study|Protocol Violation|1|||
127525454|NCT03668613|458884926|FG001|Overall Study|Protocol Violation|0|||
127525455|NCT03668613|458884925|FG000|Overall Study|Physician Decision|1|||
127525456|NCT03668613|458884926|FG001|Overall Study|Physician Decision|0|||
127525457|NCT03668613|458884925|FG000|Overall Study|Withdrawal by Subject|2|||
127525458|NCT03668613|458884926|FG001|Overall Study|Withdrawal by Subject|1|||
127525459|NCT03668613|458884925|FG000|Overall Study|Guardian decision|1|||
127525460|NCT03668613|458884926|FG001|Overall Study|Guardian decision|0|||
127525461|NCT01068769|458884929|FG000|Overall Study|Ineligible|1|||
127525462|NCT00709618|458884930|FG000|Overall Study|Withdrawal by Subject|4|||
127525463|NCT00709618|458884930|FG000|Overall Study|Lost to Follow-up|1|||
127525464|NCT00709618|458884930|FG000|Overall Study|Study Closed/Terminated|25|||
127525465|NCT01948063|458884931|FG000|Overall Study|Boston MCI halted research protocol|0|||
127525466|NCT01948063|458884932|FG001|Overall Study|Boston MCI halted research protocol|1|||
127525467|NCT01948063|458884931|FG000|Overall Study|Discovered an enrollment in other study|0|||
127525468|NCT01948063|458884932|FG001|Overall Study|Discovered an enrollment in other study|1|||
127525469|NCT01948063|458884931|FG000|Overall Study|Blood samples were accidentally thawed|1|||
127525470|NCT01948063|458884932|FG001|Overall Study|Blood samples were accidentally thawed|0|||
127525471|NCT03245398|458884937|FG000|Overall Study|Travelled to another island|1|||
127525472|NCT03245398|458884938|FG001|Overall Study|Travelled to another island|0|||
127525473|NCT00887926|458884939|FG000|Overall Study|Withdrawal by Subject|0|||
127525474|NCT00887926|458884940|FG001|Overall Study|Withdrawal by Subject|1|||
127525475|NCT00887926|458884941|FG002|Overall Study|Withdrawal by Subject|0|||
127525476|NCT00887926|458884942|FG003|Overall Study|Withdrawal by Subject|0|||
127525477|NCT00880191|458884943|FG000|Overall Study|Refused further treatment|4|||
127525478|NCT00880191|458884944|FG001|Overall Study|Refused further treatment|1|||
127525479|NCT00880191|458884943|FG000|Overall Study|Adverse Event|8|||
127525480|NCT00880191|458884944|FG001|Overall Study|Adverse Event|6|||
127525481|NCT00880191|458884943|FG000|Overall Study|Hospitalization/efficacy|1|||
127525482|NCT00880191|458884944|FG001|Overall Study|Hospitalization/efficacy|1|||
127525483|NCT03078855|458884945|FG000|Overall Study|Lack of Efficacy|62|||
127525484|NCT03078855|458884946|FG001|Overall Study|Lack of Efficacy|31|||
127525485|NCT03078855|458884945|FG000|Overall Study|Death|1|||
127525486|NCT03078855|458884946|FG001|Overall Study|Death|0|||
127525487|NCT03078855|458884945|FG000|Overall Study|Withdrawal by Subject|12|||
127525488|NCT03078855|458884946|FG001|Overall Study|Withdrawal by Subject|6|||
127525489|NCT03078855|458884945|FG000|Overall Study|Physician Decision|3|||
127525490|NCT03078855|458884946|FG001|Overall Study|Physician Decision|2|||
127525491|NCT03078855|458884945|FG000|Overall Study|Second Malignancy|4|||
127525492|NCT03078855|458884946|FG001|Overall Study|Second Malignancy|0|||
127525493|NCT03078855|458884945|FG000|Overall Study|Ineligible|2|||
127525494|NCT03078855|458884946|FG001|Overall Study|Ineligible|0|||
127525495|NCT03078855|458884945|FG000|Overall Study|Withdrew before day 1 treatment|2|||
127525496|NCT03078855|458884946|FG001|Overall Study|Withdrew before day 1 treatment|1|||
127525497|NCT04124705|458884948|FG000|Titration Period|Adverse Event|9|||
127525498|NCT04124705|458884949|FG001|Titration Period|Adverse Event|5|||
127525499|NCT04124705|458884948|FG000|Titration Period|Withdrawal by Subject|6|||
127525500|NCT04124705|458884949|FG001|Titration Period|Withdrawal by Subject|3|||
127525501|NCT04124705|458884948|FG000|Titration Period|Lost to Follow-up|0|||
127525502|NCT04124705|458884949|FG001|Titration Period|Lost to Follow-up|1|||
127525503|NCT04124705|458884948|FG000|Titration Period|Death|1|||
127525504|NCT04124705|458884949|FG001|Titration Period|Death|1|||
127525505|NCT04124705|458884948|FG000|Titration Period|Lack of Efficacy|2|||
127525506|NCT04124705|458884949|FG001|Titration Period|Lack of Efficacy|0|||
127525507|NCT04124705|458884948|FG000|Titration Period|Physician Decision|2|||
127525508|NCT04124705|458884949|FG001|Titration Period|Physician Decision|0|||
127525509|NCT04124705|458884948|FG000|Titration Period|Non-compliance with Study Drug|2|||
127525510|NCT04124705|458884949|FG001|Titration Period|Non-compliance with Study Drug|0|||
127525511|NCT04124705|458884948|FG000|Titration Period|Other|4|||
127525512|NCT04124705|458884949|FG001|Titration Period|Other|9|||
127525513|NCT04124705|458884948|FG000|Stabilization Period|Adverse Event|4|||
127525514|NCT04124705|458884949|FG001|Stabilization Period|Adverse Event|2|||
127525515|NCT04124705|458884948|FG000|Stabilization Period|Withdrawal by Subject|1|||
127525516|NCT04124705|458884949|FG001|Stabilization Period|Withdrawal by Subject|1|||
127525517|NCT04124705|458884948|FG000|Stabilization Period|Lost to Follow-up|0|||
127525518|NCT04124705|458884949|FG001|Stabilization Period|Lost to Follow-up|1|||
127525519|NCT04124705|458884948|FG000|Stabilization Period|Lack of Efficacy|4|||
127525520|NCT04124705|458884949|FG001|Stabilization Period|Lack of Efficacy|2|||
127525521|NCT04124705|458884948|FG000|Stabilization Period|Protocol Deviation|0|||
127525522|NCT04124705|458884949|FG001|Stabilization Period|Protocol Deviation|2|||
127525523|NCT04124705|458884948|FG000|Stabilization Period|Other|2|||
127525524|NCT04124705|458884949|FG001|Stabilization Period|Other|2|||
127525525|NCT01973998|458884950|FG000|Overall Study|Death|2|||
127525526|NCT01973998|458884951|FG001|Overall Study|Death|2|||
127525527|NCT04038567|458884954|FG000|Overall Study|Lost to Follow-up|6|||
127525528|NCT04038567|458884955|FG001|Overall Study|Lost to Follow-up|4|||
127525529|NCT04038567|458884956|FG002|Overall Study|Lost to Follow-up|5|||
127525530|NCT04038567|458884957|FG003|Overall Study|Lost to Follow-up|4|||
127525531|NCT04038567|458884958|FG004|Overall Study|Lost to Follow-up|6|||
127525532|NCT04038567|458884959|FG005|Overall Study|Lost to Follow-up|4|||
127525533|NCT04038567|458884960|FG006|Overall Study|Lost to Follow-up|4|||
127525534|NCT04038567|458884961|FG007|Overall Study|Lost to Follow-up|1|||
127525535|NCT04038567|458884954|FG000|Overall Study|Withdrawal by Subject|2|||
127525536|NCT04038567|458884955|FG001|Overall Study|Withdrawal by Subject|1|||
127525537|NCT04038567|458884956|FG002|Overall Study|Withdrawal by Subject|1|||
127525538|NCT04038567|458884957|FG003|Overall Study|Withdrawal by Subject|1|||
127525539|NCT04038567|458884958|FG004|Overall Study|Withdrawal by Subject|4|||
127525540|NCT04038567|458884959|FG005|Overall Study|Withdrawal by Subject|1|||
127525541|NCT04038567|458884960|FG006|Overall Study|Withdrawal by Subject|1|||
127525542|NCT04038567|458884961|FG007|Overall Study|Withdrawal by Subject|1|||
127525543|NCT04038567|458884954|FG000|Overall Study|missed survey window|1|||
127525544|NCT04038567|458884955|FG001|Overall Study|missed survey window|2|||
127525545|NCT04038567|458884956|FG002|Overall Study|missed survey window|0|||
127525546|NCT04038567|458884957|FG003|Overall Study|missed survey window|0|||
127525547|NCT04038567|458884958|FG004|Overall Study|missed survey window|1|||
127525548|NCT04038567|458884959|FG005|Overall Study|missed survey window|1|||
127525549|NCT04038567|458884960|FG006|Overall Study|missed survey window|2|||
127525550|NCT04038567|458884961|FG007|Overall Study|missed survey window|2|||
127525551|NCT04038567|458884954|FG000|Overall Study|technical issues|0|||
127525552|NCT04038567|458884955|FG001|Overall Study|technical issues|0|||
127525553|NCT04038567|458884956|FG002|Overall Study|technical issues|0|||
127525554|NCT04038567|458884957|FG003|Overall Study|technical issues|0|||
127525555|NCT04038567|458884958|FG004|Overall Study|technical issues|0|||
127525556|NCT04038567|458884959|FG005|Overall Study|technical issues|0|||
127525557|NCT04038567|458884960|FG006|Overall Study|technical issues|1|||
127525558|NCT04038567|458884961|FG007|Overall Study|technical issues|0|||
127525559|NCT04038567|458884954|FG000|Overall Study|Medical issues (i.e., illness)|0|||
127525560|NCT04038567|458884955|FG001|Overall Study|Medical issues (i.e., illness)|1|||
127525561|NCT04038567|458884956|FG002|Overall Study|Medical issues (i.e., illness)|2|||
127525562|NCT04038567|458884957|FG003|Overall Study|Medical issues (i.e., illness)|1|||
127525563|NCT04038567|458884958|FG004|Overall Study|Medical issues (i.e., illness)|1|||
127525564|NCT04038567|458884959|FG005|Overall Study|Medical issues (i.e., illness)|1|||
127525565|NCT04038567|458884960|FG006|Overall Study|Medical issues (i.e., illness)|0|||
127525566|NCT04038567|458884961|FG007|Overall Study|Medical issues (i.e., illness)|0|||
127525567|NCT04038567|458884954|FG000|Overall Study|Death|0|||
127525568|NCT04038567|458884955|FG001|Overall Study|Death|0|||
127525569|NCT04038567|458884956|FG002|Overall Study|Death|0|||
127525570|NCT04038567|458884957|FG003|Overall Study|Death|1|||
127525571|NCT04038567|458884958|FG004|Overall Study|Death|1|||
127525572|NCT04038567|458884959|FG005|Overall Study|Death|0|||
127525573|NCT04038567|458884960|FG006|Overall Study|Death|0|||
127525574|NCT04038567|458884961|FG007|Overall Study|Death|1|||
127525575|NCT03052816|458884964|FG000|Overall Study|Withdrawal by Subject|1|||
127525576|NCT03052816|458884965|FG001|Overall Study|Withdrawal by Subject|0|||
127525577|NCT03052816|458884964|FG000|Overall Study|Desired opioids|2|||
127525578|NCT03052816|458884965|FG001|Overall Study|Desired opioids|0|||
127525579|NCT01278797|458884966|FG000|Period 1|Adverse Event|0|||
127525580|NCT01278797|458884967|FG001|Period 1|Adverse Event|1|||
127525581|NCT01278797|458884966|FG000|Period 1|Protocol Violation|1|||
127525582|NCT01278797|458884967|FG001|Period 1|Protocol Violation|0|||
127525583|NCT00895453|458884968|FG000|Overall Study|Lost to Follow-up|25|||
127525584|NCT00895453|458884969|FG001|Overall Study|Lost to Follow-up|25|||
127525585|NCT00895453|458884970|FG002|Overall Study|Lost to Follow-up|23|||
127525586|NCT01736618|458884972|FG000|Overall Study|Death|294|||
127525587|NCT01736618|458884972|FG000|Overall Study|Lost to Follow-up|193|||
127525588|NCT01736618|458884972|FG000|Overall Study|Withdrawal by Subject|54|||
127525589|NCT01736618|458884972|FG000|Overall Study|Subject unable to be followed at study location|223|||
127525590|NCT01736618|458884972|FG000|Overall Study|Physician Decision|33|||
127525591|NCT01736618|458884972|FG000|Overall Study|Transplant or removal of target organ|19|||
127525592|NCT01736618|458884972|FG000|Overall Study|Change in indication or condition|78|||
127525593|NCT01736618|458884972|FG000|Overall Study|Study device explant|103|||
127525594|NCT01736618|458884972|FG000|Overall Study|Unable to complete implant|2|||
127525595|NCT00400569|458884977|FG000|Overall Study|Death|1|||
127525596|NCT00620113|458884980|FG000|Overall Study|Adverse Event|3|||
127525597|NCT00620113|458884981|FG001|Overall Study|Adverse Event|2|||
127525598|NCT00620113|458884982|FG002|Overall Study|Adverse Event|2|||
127525599|NCT00620113|458884983|FG003|Overall Study|Adverse Event|1|||
127525600|NCT00620113|458884980|FG000|Overall Study|Lack of Efficacy|2|||
127525601|NCT00620113|458884981|FG001|Overall Study|Lack of Efficacy|3|||
127525602|NCT00620113|458884982|FG002|Overall Study|Lack of Efficacy|0|||
127525603|NCT00620113|458884983|FG003|Overall Study|Lack of Efficacy|2|||
127525604|NCT00620113|458884980|FG000|Overall Study|Physician Decision|1|||
127525605|NCT00620113|458884981|FG001|Overall Study|Physician Decision|0|||
127525606|NCT00620113|458884982|FG002|Overall Study|Physician Decision|0|||
127525607|NCT00620113|458884983|FG003|Overall Study|Physician Decision|2|||
127525608|NCT00620113|458884980|FG000|Overall Study|Protocol Violation|2|||
127525609|NCT00620113|458884981|FG001|Overall Study|Protocol Violation|1|||
127525610|NCT00620113|458884982|FG002|Overall Study|Protocol Violation|0|||
127525611|NCT00620113|458884983|FG003|Overall Study|Protocol Violation|0|||
127525612|NCT00620113|458884980|FG000|Overall Study|Withdrawal by Subject|5|||
127525613|NCT00620113|458884981|FG001|Overall Study|Withdrawal by Subject|1|||
127525614|NCT00620113|458884982|FG002|Overall Study|Withdrawal by Subject|3|||
127525615|NCT00620113|458884983|FG003|Overall Study|Withdrawal by Subject|5|||
127525616|NCT02461745|458884988|FG000|Overall Study|Lack of Efficacy|9|||
127525617|NCT02461745|458884989|FG001|Overall Study|Lack of Efficacy|1|||
127525618|NCT02461745|458884988|FG000|Overall Study|Lost to Follow-up|2|||
127525619|NCT02461745|458884989|FG001|Overall Study|Lost to Follow-up|2|||
127525620|NCT02461745|458884988|FG000|Overall Study|Withdrawal by Subject|3|||
127525621|NCT02461745|458884989|FG001|Overall Study|Withdrawal by Subject|1|||
127525622|NCT00211887|458884990|FG000|Overall Study|Adverse Event|8|||
127525623|NCT00211887|458884991|FG001|Overall Study|Adverse Event|4|||
127525624|NCT00211887|458884992|FG002|Overall Study|Adverse Event|6|||
127525625|NCT00211887|458884990|FG000|Overall Study|Death|1|||
127525626|NCT00211887|458884991|FG001|Overall Study|Death|1|||
127525627|NCT00211887|458884992|FG002|Overall Study|Death|1|||
127525628|NCT00211887|458884990|FG000|Overall Study|Lost to Follow-up|28|||
127525629|NCT00211887|458884991|FG001|Overall Study|Lost to Follow-up|13|||
127525630|NCT00211887|458884992|FG002|Overall Study|Lost to Follow-up|9|||
127525631|NCT00211887|458884990|FG000|Overall Study|Non-medical reason|31|||
127525632|NCT00211887|458884991|FG001|Overall Study|Non-medical reason|14|||
127525633|NCT00211887|458884992|FG002|Overall Study|Non-medical reason|8|||
127525634|NCT00211887|458884990|FG000|Overall Study|Other medical reason|15|||
127525635|NCT00211887|458884991|FG001|Overall Study|Other medical reason|11|||
127525636|NCT00211887|458884992|FG002|Overall Study|Other medical reason|7|||
127525637|NCT00211887|458884990|FG000|Overall Study|Side effects|19|||
127525638|NCT00211887|458884991|FG001|Overall Study|Side effects|13|||
127525639|NCT00211887|458884992|FG002|Overall Study|Side effects|5|||
127525640|NCT00965419|458884996|FG000|Open Label Treatment for Responders|Adverse Event|33|||
127525641|NCT00965419|458884996|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
127525642|NCT00965419|458884996|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
127525643|NCT00965419|458884996|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
127525644|NCT00965419|458884996|FG000|Open Label Treatment for Responders|Physician Decision|6|||
127525645|NCT00965419|458884996|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
127525646|NCT00965419|458884996|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
127525647|NCT00965419|458884996|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
127525648|NCT00965419|458884996|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
127525649|NCT00965419|458884996|FG000|Follow-up Phase|Adverse Event|9|||
127525650|NCT00965419|458884996|FG000|Follow-up Phase|Protocol Violation|4|||
127525651|NCT00965419|458884996|FG000|Follow-up Phase|Withdrawal by Subject|8|||
127525652|NCT00965419|458884996|FG000|Follow-up Phase|Physician Decision|4|||
127525653|NCT00965419|458884996|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
127525654|NCT00965419|458884996|FG000|Follow-up Phase|Lack of Efficacy|28|||
127525655|NCT02927938|458884997|FG000|Overall Study|Death|0|||
127525656|NCT02927938|458884998|FG001|Overall Study|Death|1|||
127525657|NCT02927938|458884999|FG002|Overall Study|Death|0|||
127525658|NCT02927938|458885000|FG003|Overall Study|Death|4|||
127525659|NCT02927938|458884997|FG000|Overall Study|Early Study Termination|1|||
127525660|NCT02927938|458884998|FG001|Overall Study|Early Study Termination|5|||
127525661|NCT02927938|458884999|FG002|Overall Study|Early Study Termination|4|||
127525662|NCT02927938|458885000|FG003|Overall Study|Early Study Termination|3|||
127525663|NCT00826618|458886741|FG000|Overall Study|Withdrawal by Subject|1|||
127525664|NCT03712787|458886742|FG000|Overall Study|Adverse Event|2|||
127525665|NCT03712787|458886743|FG001|Overall Study|Adverse Event|3|||
127525666|NCT03712787|458886744|FG002|Overall Study|Adverse Event|0|||
127525667|NCT03712787|458886745|FG003|Overall Study|Adverse Event|4|||
127525668|NCT03712787|458886742|FG000|Overall Study|Withdrawal by Subject|4|||
127525669|NCT03712787|458886743|FG001|Overall Study|Withdrawal by Subject|14|||
127525670|NCT03712787|458886744|FG002|Overall Study|Withdrawal by Subject|12|||
127525671|NCT03712787|458886745|FG003|Overall Study|Withdrawal by Subject|8|||
127525672|NCT03712787|458886742|FG000|Overall Study|Lost to Follow-up|1|||
127525673|NCT03712787|458886743|FG001|Overall Study|Lost to Follow-up|1|||
127525674|NCT03712787|458886744|FG002|Overall Study|Lost to Follow-up|2|||
127525675|NCT03712787|458886745|FG003|Overall Study|Lost to Follow-up|1|||
127525676|NCT03712787|458886742|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
127525677|NCT03712787|458886743|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
127525678|NCT03712787|458886744|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
127525679|NCT03712787|458886745|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
127525680|NCT03712787|458886742|FG000|Overall Study|COVID-19 Infection|0|||
127525681|NCT03712787|458886743|FG001|Overall Study|COVID-19 Infection|1|||
127525682|NCT03712787|458886744|FG002|Overall Study|COVID-19 Infection|0|||
127525683|NCT03712787|458886745|FG003|Overall Study|COVID-19 Infection|0|||
127525684|NCT03712787|458886742|FG000|Overall Study|Other, Not Specified|79|||
127525685|NCT03712787|458886743|FG001|Overall Study|Other, Not Specified|77|||
127525686|NCT03712787|458886744|FG002|Overall Study|Other, Not Specified|74|||
127525687|NCT03712787|458886745|FG003|Overall Study|Other, Not Specified|78|||
127525688|NCT00732875|458886746|FG000|Overall Study|Adverse Event|16|||
127525689|NCT00732875|458886746|FG000|Overall Study|Withdrawal by Subject|6|||
127525690|NCT00732875|458886746|FG000|Overall Study|Lack of Efficacy|13|||
127525691|NCT02630472|458886748|FG000|Overall Study|Physician Decision|10|||
127525692|NCT02630472|458886749|FG001|Overall Study|Physician Decision|0|||
127525693|NCT03517228|458886752|FG000|Overall Study|Withdrawal by Subject|2|||
127525694|NCT03517228|458886752|FG000|Overall Study|Hard drive issues, abandoned prior to surgery|2|||
127525695|NCT03517228|458886752|FG000|Overall Study|Anatomy issue - abandoned prior to surgery|1|||
127525696|NCT03517228|458886752|FG000|Overall Study|Surgery was at MAIN, could not change location to JOSIE|1|||
127525697|NCT03517228|458886752|FG000|Overall Study|Canceled due to device being updated|1|||
127525698|NCT03517228|458886752|FG000|Overall Study|No V Cares in stock|1|||
127525699|NCT03517228|458886752|FG000|Overall Study|Service issue, use of device cancelled prior to surgery|2|||
127525700|NCT03781414|458886755|FG000|Overall Study|Study terminated by sponsor|39|||
127525701|NCT03781414|458886756|FG001|Overall Study|Study terminated by sponsor|34|||
127525702|NCT03781414|458886757|FG002|Overall Study|Study terminated by sponsor|25|||
127525703|NCT03781414|458886755|FG000|Overall Study|Adverse Event|3|||
127525704|NCT03781414|458886756|FG001|Overall Study|Adverse Event|6|||
127525705|NCT03781414|458886757|FG002|Overall Study|Adverse Event|3|||
127525706|NCT03781414|458886755|FG000|Overall Study|Physician Decision|2|||
127525707|NCT03781414|458886756|FG001|Overall Study|Physician Decision|0|||
127525708|NCT03781414|458886757|FG002|Overall Study|Physician Decision|1|||
127525709|NCT03781414|458886755|FG000|Overall Study|Withdrawal by Subject|2|||
127525710|NCT03781414|458886756|FG001|Overall Study|Withdrawal by Subject|3|||
127525711|NCT03781414|458886757|FG002|Overall Study|Withdrawal by Subject|3|||
127525712|NCT03781414|458886755|FG000|Overall Study|Death|1|||
127525713|NCT03781414|458886756|FG001|Overall Study|Death|4|||
127525714|NCT03781414|458886757|FG002|Overall Study|Death|0|||
127525715|NCT03781414|458886755|FG000|Overall Study|Lost to Follow-up|1|||
127525716|NCT03781414|458886756|FG001|Overall Study|Lost to Follow-up|1|||
127525717|NCT03781414|458886757|FG002|Overall Study|Lost to Follow-up|0|||
127525718|NCT04752358|458886761|FG000|Overall Study|Death|2|||
127525719|NCT04752358|458886762|FG001|Overall Study|Death|1|||
127525720|NCT00719355|458886765|FG000|Overall Study|Death|0|||
127525721|NCT00719355|458886766|FG001|Overall Study|Death|1|||
127525722|NCT00719355|458886765|FG000|Overall Study|Medical|14|||
127525723|NCT00719355|458886766|FG001|Overall Study|Medical|5|||
127525724|NCT00719355|458886765|FG000|Overall Study|Compliance|4|||
127525725|NCT00719355|458886766|FG001|Overall Study|Compliance|6|||
127525726|NCT00719355|458886765|FG000|Overall Study|Moved|0|||
127525727|NCT00719355|458886766|FG001|Overall Study|Moved|1|||
127525728|NCT01835158|458886767|FG000|Overall Study|Withdrawal by Subject|1|||
127525729|NCT01835158|458886768|FG001|Overall Study|Withdrawal by Subject|6|||
127525730|NCT03364738|458886770|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
127525731|NCT03364738|458886770|FG000|Overall Study|Withdrawal by Subject|1|||
127525732|NCT03364738|458886770|FG000|Overall Study|Adverse Event|1|||
127525733|NCT00988091|458886780|FG000|Double-blind Period|Withdrawal by Subject|15|||
127525734|NCT00988091|458886781|FG001|Double-blind Period|Withdrawal by Subject|13|||
127525735|NCT00988091|458886780|FG000|Double-blind Period|Lost to Follow-up|12|||
127525736|NCT00988091|458886781|FG001|Double-blind Period|Lost to Follow-up|14|||
127525737|NCT00988091|458886780|FG000|Double-blind Period|Other|8|||
127525738|NCT00988091|458886781|FG001|Double-blind Period|Other|8|||
127525739|NCT00988091|458886780|FG000|Double-blind Period|Adverse Event|6|||
127525740|NCT00988091|458886781|FG001|Double-blind Period|Adverse Event|9|||
127525741|NCT00988091|458886780|FG000|Double-blind Period|Use of exclusionary medication|2|||
127525742|NCT00988091|458886781|FG001|Double-blind Period|Use of exclusionary medication|3|||
127525743|NCT00988091|458886780|FG000|Open-label Period|Adverse Event|4|||
127525744|NCT00988091|458886781|FG001|Open-label Period|Adverse Event|7|||
127525745|NCT00988091|458886780|FG000|Open-label Period|Use of exclusionary medication|1|||
127525746|NCT00988091|458886781|FG001|Open-label Period|Use of exclusionary medication|1|||
127525747|NCT00988091|458886780|FG000|Open-label Period|Protocol Violation|1|||
127525748|NCT00988091|458886781|FG001|Open-label Period|Protocol Violation|1|||
127525749|NCT00988091|458886780|FG000|Open-label Period|Withdrawal by Subject|10|||
127525750|NCT00988091|458886781|FG001|Open-label Period|Withdrawal by Subject|16|||
127525751|NCT00988091|458886780|FG000|Open-label Period|Lost to Follow-up|3|||
127525752|NCT00988091|458886781|FG001|Open-label Period|Lost to Follow-up|5|||
127525753|NCT00988091|458886780|FG000|Open-label Period|Other|2|||
127525754|NCT00988091|458886781|FG001|Open-label Period|Other|3|||
127525755|NCT00994422|458886782|FG000|Overall Study|Lost to Follow-up|7|||
127525756|NCT00994422|458886783|FG001|Overall Study|Lost to Follow-up|1|||
127525757|NCT03422536|458886787|FG000|Randomized|Physician Decision|1|||
127525758|NCT03422536|458886788|FG001|Randomized|Physician Decision|1|||
127525759|NCT03422536|458886787|FG000|Allocation - Received Intervention|Disease progression|19|||
127525760|NCT03422536|458886788|FG001|Allocation - Received Intervention|Disease progression|25|||
127525761|NCT03422536|458886787|FG000|Allocation - Received Intervention|Death|1|||
127525762|NCT03422536|458886788|FG001|Allocation - Received Intervention|Death|3|||
127525763|NCT03422536|458886787|FG000|Allocation - Received Intervention|Adverse Event|1|||
127525764|NCT03422536|458886788|FG001|Allocation - Received Intervention|Adverse Event|0|||
127525765|NCT03422536|458886787|FG000|Allocation - Received Intervention|Physician Decision|1|||
127525766|NCT03422536|458886788|FG001|Allocation - Received Intervention|Physician Decision|1|||
127525767|NCT03422536|458886787|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
127525768|NCT03422536|458886788|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
127525769|NCT03422536|458886787|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
127525770|NCT03422536|458886788|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
127525771|NCT02023996|458886789|FG000|Overall Study|Protocol Violation|6|||
127525772|NCT00395850|458886798|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
127525773|NCT00395850|458886799|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
127525774|NCT00395850|458886800|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
127525775|NCT00395850|458886801|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
127525776|NCT00395850|458886798|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
127525777|NCT00395850|458886799|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
127525778|NCT00395850|458886800|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
127525779|NCT00395850|458886801|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
127525780|NCT00395850|458886798|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
127525781|NCT00395850|458886799|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
127525782|NCT00395850|458886800|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
127525783|NCT00395850|458886801|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
127525784|NCT00395850|458886798|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
127525785|NCT00395850|458886799|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
127525786|NCT00395850|458886800|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
127525787|NCT00395850|458886801|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
127525788|NCT00395850|458886798|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
127525789|NCT00395850|458886799|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
127525790|NCT00395850|458886800|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
127525791|NCT00395850|458886801|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
127525792|NCT00395850|458886798|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
127525793|NCT00395850|458886799|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
127525794|NCT00395850|458886800|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
127525795|NCT00395850|458886801|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
127525796|NCT00395850|458886798|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
127525797|NCT00395850|458886799|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
127525798|NCT00395850|458886800|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
127525799|NCT00395850|458886801|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
127525800|NCT01846741|458886803|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
127525801|NCT03664765|458886804|FG000|Overall Study|Withdrawal by Subject|4|||
127525802|NCT03664765|458886805|FG001|Overall Study|Withdrawal by Subject|1|||
127525803|NCT03664765|458886804|FG000|Overall Study|Lost to Follow-up|0|||
127525804|NCT03664765|458886805|FG001|Overall Study|Lost to Follow-up|1|||
127525805|NCT01153698|458886806|FG000|Overall Study|Adverse Event|12|||
127525806|NCT01153698|458886806|FG000|Overall Study|Lost to Follow-up|4|||
127525807|NCT01153698|458886806|FG000|Overall Study|Withdrawal by Subject|2|||
127525808|NCT01153698|458886806|FG000|Overall Study|Switch to other anticoagulants|4|||
127525809|NCT01153698|458886806|FG000|Overall Study|Other|2|||
127525810|NCT01153698|458886806|FG000|Overall Study|Not treated with Pradaxa|5|||
127525811|NCT01090063|458886807|FG000|Screen|Screen Failed|4|||
127525812|NCT01090063|458886807|FG000|Treatment|Withdrawal by Subject|4|||
127525813|NCT01817959|458886811|FG000|Overall Study|Graft loss|1|||
127525814|NCT01817959|458886812|FG001|Overall Study|Graft loss|1|||
127525815|NCT01817959|458886811|FG000|Overall Study|forbidden medication|1|||
127525816|NCT01817959|458886812|FG001|Overall Study|forbidden medication|1|||
127525817|NCT01817959|458886811|FG000|Overall Study|Adverse Event|1|||
127525818|NCT01817959|458886812|FG001|Overall Study|Adverse Event|0|||
127525819|NCT01817959|458886811|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
127525820|NCT01817959|458886812|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
127525821|NCT00923845|458886815|FG000|Induction Therapy|Poor performance status|0|||
127525822|NCT00923845|458886816|FG001|Induction Therapy|Poor performance status|2|||
127525823|NCT00330681|458886821|FG000|Overall Study|Adverse Event|3|||
127525824|NCT00330681|458886822|FG001|Overall Study|Adverse Event|6|||
127525825|NCT00330681|458886821|FG000|Overall Study|Protocol Violation|0|||
127525826|NCT00330681|458886822|FG001|Overall Study|Protocol Violation|1|||
127525827|NCT00330681|458886821|FG000|Overall Study|Withdrawal by Subject|5|||
127525828|NCT00330681|458886822|FG001|Overall Study|Withdrawal by Subject|5|||
127525829|NCT00330681|458886821|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
127525830|NCT00330681|458886822|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
127525831|NCT01140061|458886823|FG000|Part I|Adverse Event|1|||
127525832|NCT01140061|458886824|FG001|Part I|Adverse Event|0|||
127525833|NCT01140061|458886825|FG002|Part I|Adverse Event|0|||
127525834|NCT01140061|458886826|FG003|Part I|Adverse Event|0|||
127525835|NCT01140061|458886827|FG004|Part I|Adverse Event|0|||
127525836|NCT01140061|458886828|FG005|Part I|Adverse Event|0|||
127525837|NCT01140061|458886829|FG006|Part I|Adverse Event|0|||
127525838|NCT01140061|458886830|FG007|Part I|Adverse Event|0|||
127525839|NCT01140061|458886831|FG008|Part I|Adverse Event|0|||
127525840|NCT01140061|458886832|FG009|Part I|Adverse Event|0|||
127525841|NCT01140061|458886823|FG000|Extension|Laboratory Adverse Event|0|||
127525842|NCT01140061|458886824|FG001|Extension|Laboratory Adverse Event|0|||
127525843|NCT01140061|458886825|FG002|Extension|Laboratory Adverse Event|0|||
127525844|NCT01140061|458886826|FG003|Extension|Laboratory Adverse Event|0|||
127525845|NCT01140061|458886827|FG004|Extension|Laboratory Adverse Event|0|||
127525846|NCT01140061|458886828|FG005|Extension|Laboratory Adverse Event|0|||
127525847|NCT01140061|458886829|FG006|Extension|Laboratory Adverse Event|0|||
127525848|NCT01140061|458886830|FG007|Extension|Laboratory Adverse Event|0|||
127525849|NCT01140061|458886831|FG008|Extension|Laboratory Adverse Event|0|||
127525850|NCT01140061|458886832|FG009|Extension|Laboratory Adverse Event|1|||
127525851|NCT01534195|458886833|FG000|Overall Study|Withdrawal by Subject|1|||
127525852|NCT01534195|458886834|FG001|Overall Study|Withdrawal by Subject|1|||
127525853|NCT02669121|458886835|FG000|Overall Study|Adverse Event|4|||
127525854|NCT02669121|458886836|FG001|Overall Study|Adverse Event|5|||
127525855|NCT02669121|458886835|FG000|Overall Study|Lost to Follow-up|15|||
127525856|NCT02669121|458886836|FG001|Overall Study|Lost to Follow-up|27|||
127525857|NCT02669121|458886835|FG000|Overall Study|Withdrawal by Subject|132|||
127525858|NCT02669121|458886836|FG001|Overall Study|Withdrawal by Subject|140|||
127525859|NCT02669121|458886835|FG000|Overall Study|Pregnancy|0|||
127525860|NCT02669121|458886836|FG001|Overall Study|Pregnancy|1|||
127525861|NCT02669121|458886835|FG000|Overall Study|Discharged from US Military Active Service|117|||
127525862|NCT02669121|458886836|FG001|Overall Study|Discharged from US Military Active Service|91|||
127525863|NCT02669121|458886835|FG000|Overall Study|Reason not Specified|22|||
127525864|NCT02669121|458886836|FG001|Overall Study|Reason not Specified|18|||
127525865|NCT03216746|458886837|FG000|Overall Study|Lost to Follow-up|6|||
127525866|NCT03216746|458886838|FG001|Overall Study|Lost to Follow-up|8|||
127525867|NCT03216746|458886839|FG002|Overall Study|Lost to Follow-up|5|||
127525868|NCT03216746|458886840|FG003|Overall Study|Lost to Follow-up|6|||
127525869|NCT04384523|458886841|FG000|Overall Study|Lost to Follow-up|0|||
127525870|NCT04384523|458886842|FG001|Overall Study|Lost to Follow-up|0|||
127525871|NCT04384523|458886843|FG002|Overall Study|Lost to Follow-up|0|||
127525872|NCT04384523|458886844|FG003|Overall Study|Lost to Follow-up|0|||
127525873|NCT04384523|458886845|FG004|Overall Study|Lost to Follow-up|0|||
127525874|NCT04384523|458886846|FG005|Overall Study|Lost to Follow-up|1|||
127525875|NCT04384523|458886841|FG000|Overall Study|Protocol Violation|0|||
127525876|NCT04384523|458886842|FG001|Overall Study|Protocol Violation|1|||
127525877|NCT04384523|458886843|FG002|Overall Study|Protocol Violation|0|||
127525878|NCT04384523|458886844|FG003|Overall Study|Protocol Violation|0|||
127525879|NCT04384523|458886845|FG004|Overall Study|Protocol Violation|0|||
127525880|NCT04384523|458886846|FG005|Overall Study|Protocol Violation|0|||
127525881|NCT04384523|458886841|FG000|Overall Study|Withdrawal by Subject|1|||
127525882|NCT04384523|458886842|FG001|Overall Study|Withdrawal by Subject|0|||
127525883|NCT04384523|458886843|FG002|Overall Study|Withdrawal by Subject|0|||
127525884|NCT04384523|458886844|FG003|Overall Study|Withdrawal by Subject|0|||
127525885|NCT04384523|458886845|FG004|Overall Study|Withdrawal by Subject|0|||
127525886|NCT04384523|458886846|FG005|Overall Study|Withdrawal by Subject|0|||
127525887|NCT04405076|458886847|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
127525888|NCT04405076|458886848|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
127525889|NCT04405076|458886849|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
127525890|NCT04405076|458886850|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
127525891|NCT04405076|458886851|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
127525892|NCT04405076|458886852|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
127525893|NCT04405076|458886853|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
127525894|NCT04405076|458886854|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
127525895|NCT04405076|458886855|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
127525896|NCT04405076|458886847|FG000|Part A (Blinded Phase)|Physician Decision|1|||
127525897|NCT04405076|458886848|FG001|Part A (Blinded Phase)|Physician Decision|2|||
127525898|NCT04405076|458886849|FG002|Part A (Blinded Phase)|Physician Decision|0|||
127525899|NCT04405076|458886850|FG003|Part A (Blinded Phase)|Physician Decision|0|||
127525900|NCT04405076|458886851|FG004|Part A (Blinded Phase)|Physician Decision|0|||
127525901|NCT04405076|458886852|FG005|Part A (Blinded Phase)|Physician Decision|0|||
127525902|NCT04405076|458886853|FG006|Part A (Blinded Phase)|Physician Decision|0|||
127525903|NCT04405076|458886854|FG007|Part A (Blinded Phase)|Physician Decision|0|||
127525904|NCT04405076|458886855|FG008|Part A (Blinded Phase)|Physician Decision|0|||
127525905|NCT04405076|458886847|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
127525906|NCT04405076|458886848|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
127525907|NCT04405076|458886849|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
127525908|NCT04405076|458886850|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
127525909|NCT04405076|458886851|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
127525910|NCT04405076|458886852|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
127525911|NCT04405076|458886853|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
127525912|NCT04405076|458886854|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
127525913|NCT04405076|458886855|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
127525914|NCT04405076|458886847|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
127525915|NCT04405076|458886848|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
127525916|NCT04405076|458886849|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
127525917|NCT04405076|458886850|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
127525918|NCT04405076|458886851|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
127525919|NCT04405076|458886852|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
127525920|NCT04405076|458886853|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
127525921|NCT04405076|458886854|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
127525922|NCT04405076|458886855|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
127525923|NCT04405076|458886847|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
127525924|NCT04405076|458886848|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
127525925|NCT04405076|458886849|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
127525926|NCT04405076|458886850|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
127525927|NCT04405076|458886851|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
127525928|NCT04405076|458886852|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
127525929|NCT04405076|458886853|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
127525930|NCT04405076|458886854|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
127525931|NCT04405076|458886855|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
127525932|NCT04405076|458886847|FG000|Part A (Blinded Phase)|Other than Specified|0|||
127525933|NCT04405076|458886848|FG001|Part A (Blinded Phase)|Other than Specified|0|||
127525934|NCT04405076|458886849|FG002|Part A (Blinded Phase)|Other than Specified|3|||
127525935|NCT04405076|458886850|FG003|Part A (Blinded Phase)|Other than Specified|0|||
127525936|NCT04405076|458886851|FG004|Part A (Blinded Phase)|Other than Specified|0|||
127525937|NCT04405076|458886852|FG005|Part A (Blinded Phase)|Other than Specified|0|||
127525938|NCT04405076|458886853|FG006|Part A (Blinded Phase)|Other than Specified|0|||
127525939|NCT04405076|458886854|FG007|Part A (Blinded Phase)|Other than Specified|0|||
127525940|NCT04405076|458886855|FG008|Part A (Blinded Phase)|Other than Specified|0|||
127525941|NCT04405076|458886847|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
127525942|NCT04405076|458886848|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
127525943|NCT04405076|458886849|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
127525944|NCT04405076|458886850|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
127525945|NCT04405076|458886851|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
127525946|NCT04405076|458886852|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
127525947|NCT04405076|458886853|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
127525948|NCT04405076|458886854|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
127525949|NCT04405076|458886855|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
127525950|NCT04405076|458886847|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
127525951|NCT04405076|458886848|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
127525952|NCT04405076|458886849|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
127525953|NCT04405076|458886850|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
127525954|NCT04405076|458886851|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
127525955|NCT04405076|458886852|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
127525956|NCT04405076|458886853|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
127525957|NCT04405076|458886854|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
127525958|NCT04405076|458886855|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
127525959|NCT04405076|458886847|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
127525960|NCT04405076|458886848|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
127525961|NCT04405076|458886849|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
127525962|NCT04405076|458886850|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
127525963|NCT04405076|458886851|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
127525964|NCT04405076|458886852|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
127525965|NCT04405076|458886853|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
127525966|NCT04405076|458886854|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
127525967|NCT04405076|458886855|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
127525968|NCT04405076|458886847|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
127525969|NCT04405076|458886848|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
127525970|NCT04405076|458886849|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
127525971|NCT04405076|458886850|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
127525972|NCT04405076|458886851|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
127525973|NCT04405076|458886852|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
127525974|NCT04405076|458886853|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
127525975|NCT04405076|458886854|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
127525976|NCT04405076|458886855|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
127525977|NCT04405076|458886847|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
127525978|NCT04405076|458886848|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
127525979|NCT04405076|458886849|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
127525980|NCT04405076|458886850|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
127525981|NCT04405076|458886851|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
127525982|NCT04405076|458886852|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
127525983|NCT04405076|458886853|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
127525984|NCT04405076|458886854|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
127525985|NCT04405076|458886855|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
127525986|NCT00392990|458886858|FG000|Treatment on Study|Adverse Event|3|||
127525987|NCT00392990|458886859|FG001|Treatment on Study|Adverse Event|1|||
127525988|NCT00392990|458886858|FG000|Follow up for 2 Years|Death|4|||
127525989|NCT00392990|458886859|FG001|Follow up for 2 Years|Death|0|||
127525990|NCT02980133|458886862|FG000|Overall Study|Other than specified|1|||
127525991|NCT02980133|458886863|FG001|Overall Study|Other than specified|1|||
127525992|NCT02980133|458886864|FG002|Overall Study|Other than specified|2|||
127525993|NCT02980133|458886865|FG003|Overall Study|Other than specified|2|||
127525994|NCT02980133|458886862|FG000|Overall Study|Lost to Follow-up|0|||
127525995|NCT02980133|458886863|FG001|Overall Study|Lost to Follow-up|0|||
127525996|NCT02980133|458886864|FG002|Overall Study|Lost to Follow-up|1|||
127525997|NCT02980133|458886865|FG003|Overall Study|Lost to Follow-up|3|||
127525998|NCT02980133|458886862|FG000|Overall Study|Protocol Violation|0|||
127525999|NCT02980133|458886863|FG001|Overall Study|Protocol Violation|1|||
127526000|NCT02980133|458886864|FG002|Overall Study|Protocol Violation|0|||
127526001|NCT02980133|458886865|FG003|Overall Study|Protocol Violation|0|||
127526002|NCT02980133|458886862|FG000|Overall Study|Withdrawal by parent/guardian|6|||
127526003|NCT02980133|458886863|FG001|Overall Study|Withdrawal by parent/guardian|3|||
127526004|NCT02980133|458886864|FG002|Overall Study|Withdrawal by parent/guardian|3|||
127526005|NCT02980133|458886865|FG003|Overall Study|Withdrawal by parent/guardian|1|||
127526006|NCT02980133|458886862|FG000|Overall Study|Withdrawal by Subject|0|||
127526007|NCT02980133|458886863|FG001|Overall Study|Withdrawal by Subject|0|||
127526008|NCT02980133|458886864|FG002|Overall Study|Withdrawal by Subject|1|||
127526009|NCT02980133|458886865|FG003|Overall Study|Withdrawal by Subject|0|||
127526010|NCT00825812|458886866|FG000|Overall Study|Never entered follow up|0|||
127526011|NCT00825812|458886867|FG001|Overall Study|Never entered follow up|0|||
127526012|NCT00825812|458886868|FG002|Overall Study|Never entered follow up|0|||
127526013|NCT00825812|458886869|FG003|Overall Study|Never entered follow up|1|||
127526014|NCT00825812|458886866|FG000|Overall Study|Adverse Event|0|||
127526015|NCT00825812|458886867|FG001|Overall Study|Adverse Event|0|||
127526016|NCT00825812|458886868|FG002|Overall Study|Adverse Event|0|||
127526017|NCT00825812|458886869|FG003|Overall Study|Adverse Event|1|||
127526018|NCT00825812|458886866|FG000|Overall Study|Subject withdrew consent|0|||
127526019|NCT00825812|458886867|FG001|Overall Study|Subject withdrew consent|0|||
127526020|NCT00825812|458886868|FG002|Overall Study|Subject withdrew consent|3|||
127526021|NCT00825812|458886869|FG003|Overall Study|Subject withdrew consent|2|||
127526022|NCT00825812|458886866|FG000|Overall Study|Non-compliance with protocol|0|||
127526023|NCT00825812|458886867|FG001|Overall Study|Non-compliance with protocol|0|||
127526024|NCT00825812|458886868|FG002|Overall Study|Non-compliance with protocol|0|||
127526025|NCT00825812|458886869|FG003|Overall Study|Non-compliance with protocol|1|||
127526026|NCT00825812|458886866|FG000|Overall Study|Administrative|0|||
127526027|NCT00825812|458886867|FG001|Overall Study|Administrative|1|||
127526028|NCT00825812|458886868|FG002|Overall Study|Administrative|3|||
127526029|NCT00825812|458886869|FG003|Overall Study|Administrative|5|||
127526030|NCT00408434|458886870|FG000|Overall Study|Adverse Event|0|||
127526031|NCT00408434|458886871|FG001|Overall Study|Adverse Event|0|||
127526032|NCT00408434|458886872|FG002|Overall Study|Adverse Event|1|||
127526033|NCT00408434|458886873|FG003|Overall Study|Adverse Event|0|||
127526034|NCT00408434|458886874|FG004|Overall Study|Adverse Event|0|||
127526035|NCT00408434|458886875|FG005|Overall Study|Adverse Event|0|||
127526036|NCT00408434|458886876|FG006|Overall Study|Adverse Event|0|||
127526037|NCT00408434|458886870|FG000|Overall Study|Progressive disease|6|||
127526038|NCT00408434|458886871|FG001|Overall Study|Progressive disease|3|||
127526039|NCT00408434|458886872|FG002|Overall Study|Progressive disease|4|||
127526040|NCT00408434|458886873|FG003|Overall Study|Progressive disease|3|||
127526041|NCT00408434|458886874|FG004|Overall Study|Progressive disease|3|||
127526042|NCT00408434|458886875|FG005|Overall Study|Progressive disease|1|||
127526043|NCT00408434|458886876|FG006|Overall Study|Progressive disease|4|||
127526044|NCT00408434|458886870|FG000|Overall Study|Other|0|||
127526045|NCT00408434|458886871|FG001|Overall Study|Other|0|||
127526046|NCT00408434|458886872|FG002|Overall Study|Other|1|||
127526047|NCT00408434|458886873|FG003|Overall Study|Other|0|||
127526048|NCT00408434|458886874|FG004|Overall Study|Other|2|||
127526049|NCT00408434|458886875|FG005|Overall Study|Other|1|||
127526050|NCT00408434|458886876|FG006|Overall Study|Other|0|||
127526051|NCT00408434|458886870|FG000|Overall Study|Terminated by Investigator|0|||
127526052|NCT00408434|458886871|FG001|Overall Study|Terminated by Investigator|0|||
127526053|NCT00408434|458886872|FG002|Overall Study|Terminated by Investigator|0|||
127526054|NCT00408434|458886873|FG003|Overall Study|Terminated by Investigator|0|||
127526055|NCT00408434|458886874|FG004|Overall Study|Terminated by Investigator|1|||
127526056|NCT00408434|458886875|FG005|Overall Study|Terminated by Investigator|1|||
127526057|NCT00408434|458886876|FG006|Overall Study|Terminated by Investigator|0|||
127526058|NCT00588354|458886877|FG000|Baseline to 2 Weeks|Adverse Event|1|||
127526059|NCT00588354|458886878|FG001|Baseline to 2 Weeks|Adverse Event|0|||
127526060|NCT00588354|458886877|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
127526061|NCT00588354|458886878|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
127526062|NCT00588354|458886877|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
127526063|NCT00588354|458886878|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
127526064|NCT04000581|458886879|FG000|Overall Study|Withdrawal by Subject|0|||
127526065|NCT04000581|458886880|FG001|Overall Study|Withdrawal by Subject|1|||
127526066|NCT03477838|458886881|FG000|Overall Study|Lost to Follow-up|14|||
127526067|NCT02519595|458886885|FG000|Overall Study|Protocol Violation|8|||
127526068|NCT02519595|458886886|FG001|Overall Study|Protocol Violation|22|||
127526069|NCT02519595|458886887|FG002|Overall Study|Protocol Violation|16|||
127526070|NCT03188510|458886895|FG000|Overall Study|Inappropriate behavior with site staff|0|||
127526071|NCT03188510|458886896|FG001|Overall Study|Inappropriate behavior with site staff|1|||
127526072|NCT03188510|458886897|FG002|Overall Study|Inappropriate behavior with site staff|0|||
127526073|NCT03052049|458886899|FG000|Overall Study|Withdrawal by Subject|2|||
127526074|NCT00999518|458886900|FG000|Overall Study|Adverse Event|1|||
127526075|NCT00999518|458886901|FG001|Overall Study|Adverse Event|6|||
127526076|NCT00999518|458886902|FG002|Overall Study|Adverse Event|3|||
127526077|NCT00999518|458886903|FG003|Overall Study|Adverse Event|1|||
127526078|NCT00999518|458886904|FG004|Overall Study|Adverse Event|2|||
127526079|NCT00999518|458886900|FG000|Overall Study|Lack of Efficacy|2|||
127526080|NCT00999518|458886901|FG001|Overall Study|Lack of Efficacy|0|||
127526081|NCT00999518|458886902|FG002|Overall Study|Lack of Efficacy|0|||
127526082|NCT00999518|458886903|FG003|Overall Study|Lack of Efficacy|2|||
127526083|NCT00999518|458886904|FG004|Overall Study|Lack of Efficacy|2|||
127526084|NCT00999518|458886900|FG000|Overall Study|Lost to Follow-up|0|||
127526085|NCT00999518|458886901|FG001|Overall Study|Lost to Follow-up|0|||
127526086|NCT00999518|458886902|FG002|Overall Study|Lost to Follow-up|0|||
127526087|NCT00999518|458886903|FG003|Overall Study|Lost to Follow-up|4|||
127526088|NCT00999518|458886904|FG004|Overall Study|Lost to Follow-up|1|||
127526089|NCT00999518|458886900|FG000|Overall Study|Did not meet entrance criteria|0|||
127526090|NCT00999518|458886901|FG001|Overall Study|Did not meet entrance criteria|0|||
127526091|NCT00999518|458886902|FG002|Overall Study|Did not meet entrance criteria|0|||
127526092|NCT00999518|458886903|FG003|Overall Study|Did not meet entrance criteria|0|||
127526093|NCT00999518|458886904|FG004|Overall Study|Did not meet entrance criteria|1|||
127526094|NCT00999518|458886900|FG000|Overall Study|Study terminated by sponsor|10|||
127526095|NCT00999518|458886901|FG001|Overall Study|Study terminated by sponsor|6|||
127526096|NCT00999518|458886902|FG002|Overall Study|Study terminated by sponsor|5|||
127526097|NCT00999518|458886903|FG003|Overall Study|Study terminated by sponsor|5|||
127526098|NCT00999518|458886904|FG004|Overall Study|Study terminated by sponsor|9|||
127526099|NCT00999518|458886900|FG000|Overall Study|Pregnancy|0|||
127526100|NCT00999518|458886901|FG001|Overall Study|Pregnancy|0|||
127526101|NCT00999518|458886902|FG002|Overall Study|Pregnancy|1|||
127526102|NCT00999518|458886903|FG003|Overall Study|Pregnancy|0|||
127526103|NCT00999518|458886904|FG004|Overall Study|Pregnancy|0|||
127526104|NCT00999518|458886900|FG000|Overall Study|Protocol Violation|0|||
127526105|NCT00999518|458886901|FG001|Overall Study|Protocol Violation|1|||
127526106|NCT00999518|458886902|FG002|Overall Study|Protocol Violation|0|||
127526107|NCT00999518|458886903|FG003|Overall Study|Protocol Violation|0|||
127526108|NCT00999518|458886904|FG004|Overall Study|Protocol Violation|2|||
127526109|NCT00999518|458886900|FG000|Overall Study|Withdrawal by Subject|5|||
127526110|NCT00999518|458886901|FG001|Overall Study|Withdrawal by Subject|4|||
127526111|NCT00999518|458886902|FG002|Overall Study|Withdrawal by Subject|10|||
127526112|NCT00999518|458886903|FG003|Overall Study|Withdrawal by Subject|6|||
127526113|NCT00999518|458886904|FG004|Overall Study|Withdrawal by Subject|1|||
127526114|NCT00999518|458886900|FG000|Overall Study|Other|5|||
127526115|NCT00999518|458886901|FG001|Overall Study|Other|7|||
127526116|NCT00999518|458886902|FG002|Overall Study|Other|1|||
127526117|NCT00999518|458886903|FG003|Overall Study|Other|4|||
127526118|NCT00999518|458886904|FG004|Overall Study|Other|5|||
127526119|NCT00999518|458886900|FG000|Overall Study|Randomized but not Treated|1|||
127526120|NCT00999518|458886901|FG001|Overall Study|Randomized but not Treated|1|||
127526121|NCT00999518|458886902|FG002|Overall Study|Randomized but not Treated|2|||
127526122|NCT00999518|458886903|FG003|Overall Study|Randomized but not Treated|0|||
127526123|NCT00999518|458886904|FG004|Overall Study|Randomized but not Treated|1|||
127526124|NCT01088399|458886908|FG000|Overall Study|Adverse Event|211|||
127526125|NCT01088399|458886909|FG001|Overall Study|Adverse Event|16|||
127526126|NCT01088399|458886910|FG002|Overall Study|Adverse Event|0|||
127526127|NCT01088399|458886908|FG000|Overall Study|Death|204|||
127526128|NCT01088399|458886909|FG001|Overall Study|Death|45|||
127526129|NCT01088399|458886910|FG002|Overall Study|Death|0|||
127526130|NCT01088399|458886908|FG000|Overall Study|Lack of Efficacy|298|||
127526131|NCT01088399|458886909|FG001|Overall Study|Lack of Efficacy|7|||
127526132|NCT01088399|458886910|FG002|Overall Study|Lack of Efficacy|5|||
127526133|NCT01088399|458886908|FG000|Overall Study|Lost to Follow-up|1070|||
127526134|NCT01088399|458886909|FG001|Overall Study|Lost to Follow-up|278|||
127526135|NCT01088399|458886910|FG002|Overall Study|Lost to Follow-up|58|||
127526136|NCT01088399|458886908|FG000|Overall Study|Physician Decision|531|||
127526137|NCT01088399|458886909|FG001|Overall Study|Physician Decision|88|||
127526138|NCT01088399|458886910|FG002|Overall Study|Physician Decision|16|||
127526139|NCT01088399|458886908|FG000|Overall Study|Withdrawal by Subject|544|||
127526140|NCT01088399|458886909|FG001|Overall Study|Withdrawal by Subject|195|||
127526141|NCT01088399|458886910|FG002|Overall Study|Withdrawal by Subject|33|||
127526142|NCT01088399|458886908|FG000|Overall Study|Change to or start of somatropin therapy|234|||
127526143|NCT01088399|458886909|FG001|Overall Study|Change to or start of somatropin therapy|17|||
127526144|NCT01088399|458886910|FG002|Overall Study|Change to or start of somatropin therapy|12|||
127526145|NCT01088399|458886908|FG000|Overall Study|Sponsor decision|1573|||
127526146|NCT01088399|458886909|FG001|Overall Study|Sponsor decision|298|||
127526147|NCT01088399|458886910|FG002|Overall Study|Sponsor decision|7|||
127526148|NCT01088399|458886908|FG000|Overall Study|Protocol Violation|10|||
127526149|NCT01088399|458886909|FG001|Overall Study|Protocol Violation|1|||
127526150|NCT01088399|458886910|FG002|Overall Study|Protocol Violation|0|||
127526151|NCT01088399|458886908|FG000|Overall Study|Enrollment criteria not met|48|||
127526152|NCT01088399|458886909|FG001|Overall Study|Enrollment criteria not met|119|||
127526153|NCT01088399|458886910|FG002|Overall Study|Enrollment criteria not met|70|||
127526154|NCT01088399|458886908|FG000|Overall Study|Study summary visit not completed|2398|||
127526155|NCT01088399|458886909|FG001|Overall Study|Study summary visit not completed|283|||
127526156|NCT01088399|458886910|FG002|Overall Study|Study summary visit not completed|80|||
127526157|NCT00782483|458886911|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
127526158|NCT02475278|458888523|FG000|Overall Study|Lost to Follow-up|1|||
127526159|NCT02475278|458888523|FG000|Overall Study|Reason Not Specified|1|||
127526160|NCT03688074|458888526|FG000|Overall Study|Adverse Event|0|||
127526161|NCT03688074|458888527|FG001|Overall Study|Adverse Event|1|||
127526162|NCT03688074|458888526|FG000|Overall Study|Other|1|||
127526163|NCT03688074|458888527|FG001|Overall Study|Other|0|||
127526164|NCT01128244|458888530|FG000|Overall Study|Adverse Event|1|||
127526165|NCT01128244|458888530|FG000|Overall Study|Scheduling conflict|2|||
127526166|NCT02219334|458888531|FG000|Overall Study|Withdrawal by Subject|1|||
127526167|NCT02219334|458888532|FG001|Overall Study|Withdrawal by Subject|0|||
127526168|NCT02219334|458888531|FG000|Overall Study|Protocol Violation|7|||
127526169|NCT02219334|458888532|FG001|Overall Study|Protocol Violation|3|||
127526170|NCT02206035|458888536|FG000|Overall Study|Physician Decision|10|||
127526171|NCT02206035|458888537|FG001|Overall Study|Physician Decision|0|||
127526172|NCT02206035|458888538|FG002|Overall Study|Physician Decision|175|||
127526173|NCT01934010|458888539|FG000|Overall Study|Adverse Event|1|||
127526174|NCT01934010|458888540|FG001|Overall Study|Adverse Event|1|||
127526175|NCT01934010|458888541|FG002|Overall Study|Adverse Event|0|||
127526176|NCT01934010|458888539|FG000|Overall Study|Withdrawal by Subject|15|||
127526177|NCT01934010|458888540|FG001|Overall Study|Withdrawal by Subject|6|||
127526178|NCT01934010|458888541|FG002|Overall Study|Withdrawal by Subject|2|||
127526179|NCT01934010|458888539|FG000|Overall Study|Lost to Follow-up|7|||
127526180|NCT01934010|458888540|FG001|Overall Study|Lost to Follow-up|4|||
127526181|NCT01934010|458888541|FG002|Overall Study|Lost to Follow-up|0|||
127526182|NCT01393821|458888542|FG000|Overall Study|Cancel|1|||
127526183|NCT01393821|458888543|FG001|Overall Study|Cancel|1|||
127526184|NCT01393821|458888542|FG000|Overall Study|not evaluable for primary endpoint|4|||
127526185|NCT01393821|458888543|FG001|Overall Study|not evaluable for primary endpoint|2|||
127526186|NCT01858766|458888546|FG000|Overall Study|Randomized but Never Treated|0|||
127526187|NCT01858766|458888547|FG001|Overall Study|Randomized but Never Treated|0|||
127526188|NCT01858766|458888548|FG002|Overall Study|Randomized but Never Treated|0|||
127526189|NCT01858766|458888549|FG003|Overall Study|Randomized but Never Treated|0|||
127526190|NCT01858766|458888550|FG004|Overall Study|Randomized but Never Treated|0|||
127526191|NCT01858766|458888551|FG005|Overall Study|Randomized but Never Treated|1|||
127526192|NCT01858766|458888552|FG006|Overall Study|Randomized but Never Treated|0|||
127526193|NCT01858766|458888553|FG007|Overall Study|Randomized but Never Treated|0|||
127526194|NCT01858766|458888554|FG008|Overall Study|Randomized but Never Treated|0|||
127526195|NCT01858766|458888555|FG009|Overall Study|Randomized but Never Treated|0|||
127526196|NCT01858766|458888556|FG010|Overall Study|Randomized but Never Treated|0|||
127526197|NCT01858766|458888557|FG011|Overall Study|Randomized but Never Treated|0|||
127526198|NCT01858766|458888558|FG012|Overall Study|Randomized but Never Treated|0|||
127526199|NCT01858766|458888559|FG013|Overall Study|Randomized but Never Treated|0|||
127526200|NCT01858766|458888560|FG014|Overall Study|Randomized but Never Treated|0|||
127526201|NCT01858766|458888561|FG015|Overall Study|Randomized but Never Treated|0|||
127526202|NCT01858766|458888562|FG016|Overall Study|Randomized but Never Treated|0|||
127526203|NCT01858766|458888563|FG017|Overall Study|Randomized but Never Treated|1|||
127526204|NCT01858766|458888564|FG018|Overall Study|Randomized but Never Treated|0|||
127526205|NCT01858766|458888546|FG000|Overall Study|Death|0|||
127526206|NCT01858766|458888547|FG001|Overall Study|Death|0|||
127526207|NCT01858766|458888548|FG002|Overall Study|Death|1|||
127526208|NCT01858766|458888549|FG003|Overall Study|Death|0|||
127526209|NCT01858766|458888550|FG004|Overall Study|Death|0|||
127526210|NCT01858766|458888551|FG005|Overall Study|Death|0|||
127526211|NCT01858766|458888552|FG006|Overall Study|Death|0|||
127526212|NCT01858766|458888553|FG007|Overall Study|Death|0|||
127526213|NCT01858766|458888554|FG008|Overall Study|Death|0|||
127526214|NCT01858766|458888555|FG009|Overall Study|Death|0|||
127526215|NCT01858766|458888556|FG010|Overall Study|Death|0|||
127526216|NCT01858766|458888557|FG011|Overall Study|Death|0|||
127526217|NCT01858766|458888558|FG012|Overall Study|Death|0|||
127526218|NCT01858766|458888559|FG013|Overall Study|Death|0|||
127526219|NCT01858766|458888560|FG014|Overall Study|Death|0|||
127526220|NCT01858766|458888561|FG015|Overall Study|Death|0|||
127526221|NCT01858766|458888562|FG016|Overall Study|Death|0|||
127526222|NCT01858766|458888563|FG017|Overall Study|Death|0|||
127526223|NCT01858766|458888564|FG018|Overall Study|Death|0|||
127526224|NCT01858766|458888546|FG000|Overall Study|Lack of Efficacy|1|||
127526225|NCT01858766|458888547|FG001|Overall Study|Lack of Efficacy|0|||
127526226|NCT01858766|458888548|FG002|Overall Study|Lack of Efficacy|0|||
127526227|NCT01858766|458888549|FG003|Overall Study|Lack of Efficacy|0|||
127526228|NCT01858766|458888550|FG004|Overall Study|Lack of Efficacy|1|||
127526229|NCT01858766|458888551|FG005|Overall Study|Lack of Efficacy|2|||
127526230|NCT01858766|458888552|FG006|Overall Study|Lack of Efficacy|0|||
127526231|NCT01858766|458888553|FG007|Overall Study|Lack of Efficacy|0|||
127526232|NCT01858766|458888554|FG008|Overall Study|Lack of Efficacy|0|||
127526233|NCT01858766|458888555|FG009|Overall Study|Lack of Efficacy|0|||
127526234|NCT01858766|458888556|FG010|Overall Study|Lack of Efficacy|0|||
127526235|NCT01858766|458888557|FG011|Overall Study|Lack of Efficacy|3|||
127526236|NCT01858766|458888558|FG012|Overall Study|Lack of Efficacy|5|||
127526237|NCT01858766|458888559|FG013|Overall Study|Lack of Efficacy|3|||
127526238|NCT01858766|458888560|FG014|Overall Study|Lack of Efficacy|5|||
127526239|NCT01858766|458888561|FG015|Overall Study|Lack of Efficacy|5|||
127526240|NCT01858766|458888562|FG016|Overall Study|Lack of Efficacy|2|||
127526241|NCT01858766|458888563|FG017|Overall Study|Lack of Efficacy|3|||
127526242|NCT01858766|458888564|FG018|Overall Study|Lack of Efficacy|3|||
127526243|NCT01858766|458888546|FG000|Overall Study|Lost to Follow-up|0|||
127526244|NCT01858766|458888547|FG001|Overall Study|Lost to Follow-up|0|||
127526245|NCT01858766|458888548|FG002|Overall Study|Lost to Follow-up|0|||
127526246|NCT01858766|458888549|FG003|Overall Study|Lost to Follow-up|0|||
127526247|NCT01858766|458888550|FG004|Overall Study|Lost to Follow-up|0|||
127526248|NCT01858766|458888551|FG005|Overall Study|Lost to Follow-up|1|||
127526249|NCT01858766|458888552|FG006|Overall Study|Lost to Follow-up|0|||
127526250|NCT01858766|458888553|FG007|Overall Study|Lost to Follow-up|2|||
127526251|NCT01858766|458888554|FG008|Overall Study|Lost to Follow-up|0|||
127526252|NCT01858766|458888555|FG009|Overall Study|Lost to Follow-up|0|||
127526253|NCT01858766|458888556|FG010|Overall Study|Lost to Follow-up|0|||
127526254|NCT01858766|458888557|FG011|Overall Study|Lost to Follow-up|1|||
127526255|NCT01858766|458888558|FG012|Overall Study|Lost to Follow-up|0|||
127526256|NCT01858766|458888559|FG013|Overall Study|Lost to Follow-up|0|||
127526257|NCT01858766|458888560|FG014|Overall Study|Lost to Follow-up|3|||
127526258|NCT01858766|458888561|FG015|Overall Study|Lost to Follow-up|1|||
127526259|NCT01858766|458888562|FG016|Overall Study|Lost to Follow-up|1|||
127526260|NCT01858766|458888563|FG017|Overall Study|Lost to Follow-up|0|||
127526261|NCT01858766|458888564|FG018|Overall Study|Lost to Follow-up|1|||
127526262|NCT01858766|458888546|FG000|Overall Study|Withdrew Consent|0|||
127526263|NCT01858766|458888547|FG001|Overall Study|Withdrew Consent|0|||
127526264|NCT01858766|458888548|FG002|Overall Study|Withdrew Consent|0|||
127526265|NCT01858766|458888549|FG003|Overall Study|Withdrew Consent|0|||
127526266|NCT01858766|458888550|FG004|Overall Study|Withdrew Consent|0|||
127526267|NCT01858766|458888551|FG005|Overall Study|Withdrew Consent|0|||
127526268|NCT01858766|458888552|FG006|Overall Study|Withdrew Consent|0|||
127526269|NCT01858766|458888553|FG007|Overall Study|Withdrew Consent|0|||
127526270|NCT01858766|458888554|FG008|Overall Study|Withdrew Consent|0|||
127526271|NCT01858766|458888555|FG009|Overall Study|Withdrew Consent|0|||
127526272|NCT01858766|458888556|FG010|Overall Study|Withdrew Consent|0|||
127526273|NCT01858766|458888557|FG011|Overall Study|Withdrew Consent|1|||
127526274|NCT01858766|458888558|FG012|Overall Study|Withdrew Consent|0|||
127526275|NCT01858766|458888559|FG013|Overall Study|Withdrew Consent|0|||
127526276|NCT01858766|458888560|FG014|Overall Study|Withdrew Consent|0|||
127526277|NCT01858766|458888561|FG015|Overall Study|Withdrew Consent|0|||
127526278|NCT01858766|458888562|FG016|Overall Study|Withdrew Consent|0|||
127526279|NCT01858766|458888563|FG017|Overall Study|Withdrew Consent|0|||
127526280|NCT01858766|458888564|FG018|Overall Study|Withdrew Consent|0|||
127526281|NCT00836186|458888572|FG000|Overall Study|Blood could not be drawn|1|||
127526282|NCT00532298|458888573|FG000|Overall Study|Adverse Event|1|||
127526283|NCT00532298|458888574|FG001|Overall Study|Adverse Event|0|||
127526284|NCT00532298|458888575|FG002|Overall Study|Adverse Event|0|||
127526285|NCT00532298|458888576|FG003|Overall Study|Adverse Event|0|||
127526286|NCT00532298|458888577|FG004|Overall Study|Adverse Event|1|||
127526287|NCT00532298|458888578|FG005|Overall Study|Adverse Event|1|||
127526288|NCT00532298|458888573|FG000|Overall Study|Lost to Follow-up|1|||
127526289|NCT00532298|458888574|FG001|Overall Study|Lost to Follow-up|1|||
127526290|NCT00532298|458888575|FG002|Overall Study|Lost to Follow-up|1|||
127526291|NCT00532298|458888576|FG003|Overall Study|Lost to Follow-up|0|||
127526292|NCT00532298|458888577|FG004|Overall Study|Lost to Follow-up|0|||
127526293|NCT00532298|458888578|FG005|Overall Study|Lost to Follow-up|1|||
127526294|NCT04531241|458888579|FG000|Period 1|Withdrawal by Subject|2|||
127526295|NCT04531241|458888580|FG001|Period 1|Withdrawal by Subject|0|||
127526296|NCT04531241|458888579|FG000|Period 1|Dispesed incorrect lens power|1|||
127526297|NCT04531241|458888580|FG001|Period 1|Dispesed incorrect lens power|0|||
127526298|NCT04531241|458888579|FG000|Period 1|Protocol Violation|1|||
127526299|NCT04531241|458888580|FG001|Period 1|Protocol Violation|0|||
127526300|NCT04531241|458888579|FG000|Period 1|No longer eligible|0|||
127526301|NCT04531241|458888580|FG001|Period 1|No longer eligible|1|||
127526302|NCT04531241|458888579|FG000|Period 1|Lens Discomfort|0|||
127526303|NCT04531241|458888580|FG001|Period 1|Lens Discomfort|1|||
127526304|NCT04531241|458888579|FG000|Period 2|Covid-19 Related|1|||
127526305|NCT04531241|458888580|FG001|Period 2|Covid-19 Related|1|||
127526306|NCT04929249|458888581|FG000|Overall Study|Adverse Event|2|||
127526307|NCT04929249|458888582|FG001|Overall Study|Adverse Event|1|||
127526308|NCT04929249|458888581|FG000|Overall Study|Death|2|||
127526309|NCT04929249|458888582|FG001|Overall Study|Death|1|||
127526310|NCT04929249|458888581|FG000|Overall Study|Lost to Follow-up|3|||
127526311|NCT04929249|458888582|FG001|Overall Study|Lost to Follow-up|11|||
127526312|NCT04929249|458888581|FG000|Overall Study|Technical problems|0|||
127526313|NCT04929249|458888582|FG001|Overall Study|Technical problems|1|||
127526314|NCT04929249|458888581|FG000|Overall Study|Subject decision|6|||
127526315|NCT04929249|458888582|FG001|Overall Study|Subject decision|8|||
127526316|NCT04929249|458888581|FG000|Overall Study|Withdrew consent|0|||
127526317|NCT04929249|458888582|FG001|Overall Study|Withdrew consent|8|||
127526318|NCT01620762|458888589|FG000|Overall Study|Protocol Violation|1|||
127526319|NCT01620762|458888590|FG001|Overall Study|Protocol Violation|1|||
127526320|NCT01620762|458888591|FG002|Overall Study|Protocol Violation|1|||
127526321|NCT01620762|458888589|FG000|Overall Study|Adverse Event|9|||
127526322|NCT01620762|458888590|FG001|Overall Study|Adverse Event|5|||
127526323|NCT01620762|458888591|FG002|Overall Study|Adverse Event|2|||
127526324|NCT01620762|458888589|FG000|Overall Study|Withdrawal by Subject|23|||
127526325|NCT01620762|458888590|FG001|Overall Study|Withdrawal by Subject|26|||
127526326|NCT01620762|458888591|FG002|Overall Study|Withdrawal by Subject|27|||
127526327|NCT01620762|458888589|FG000|Overall Study|Lost to Follow-up|11|||
127526328|NCT01620762|458888590|FG001|Overall Study|Lost to Follow-up|17|||
127526329|NCT01620762|458888591|FG002|Overall Study|Lost to Follow-up|10|||
127526330|NCT01620762|458888589|FG000|Overall Study|Protocol deviation|1|||
127526331|NCT01620762|458888590|FG001|Overall Study|Protocol deviation|1|||
127526332|NCT01620762|458888591|FG002|Overall Study|Protocol deviation|6|||
127526333|NCT01620762|458888589|FG000|Overall Study|Subject deterioration|0|||
127526334|NCT01620762|458888590|FG001|Overall Study|Subject deterioration|1|||
127526335|NCT01620762|458888591|FG002|Overall Study|Subject deterioration|1|||
127526336|NCT01620762|458888589|FG000|Overall Study|Non-specified|3|||
127526337|NCT01620762|458888590|FG001|Overall Study|Non-specified|6|||
127526338|NCT01620762|458888591|FG002|Overall Study|Non-specified|5|||
127526339|NCT01620762|458888589|FG000|Overall Study|Use of prohibted therapies|0|||
127526340|NCT01620762|458888590|FG001|Overall Study|Use of prohibted therapies|1|||
127526341|NCT01620762|458888591|FG002|Overall Study|Use of prohibted therapies|1|||
127526342|NCT00705146|458888596|FG000|Overall Study|Lost to Follow-up|1|||
127526343|NCT00705146|458888597|FG001|Overall Study|Lost to Follow-up|1|||
127526344|NCT00095173|458888600|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
127526345|NCT00095173|458888601|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
127526346|NCT00095173|458888602|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
127526347|NCT00095173|458888603|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
127526348|NCT00095173|458888604|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
127526349|NCT00095173|458888605|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
127526350|NCT00095173|458888600|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
127526351|NCT00095173|458888601|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
127526352|NCT00095173|458888602|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
127526353|NCT00095173|458888603|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
127526354|NCT00095173|458888604|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
127526355|NCT00095173|458888605|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
127526356|NCT00095173|458888600|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
127526357|NCT00095173|458888601|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
127526358|NCT00095173|458888602|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
127526359|NCT00095173|458888603|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
127526360|NCT00095173|458888604|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
127526361|NCT00095173|458888605|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
127526362|NCT00095173|458888600|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
127526363|NCT00095173|458888601|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
127526364|NCT00095173|458888602|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
127526365|NCT00095173|458888603|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
127526366|NCT00095173|458888604|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
127526367|NCT00095173|458888605|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
127526368|NCT00095173|458888600|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
127526369|NCT00095173|458888601|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
127526370|NCT00095173|458888602|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
127526371|NCT00095173|458888603|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
127526372|NCT00095173|458888604|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
127526373|NCT00095173|458888605|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
127526374|NCT00095173|458888600|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
127526375|NCT00095173|458888601|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
127526376|NCT00095173|458888602|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
127526377|NCT00095173|458888603|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
127526378|NCT00095173|458888604|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
127526379|NCT00095173|458888605|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
127526380|NCT00095173|458888600|FG000|Open-Label Extension Phase (Period C)|Death|0|||
127526381|NCT00095173|458888601|FG001|Open-Label Extension Phase (Period C)|Death|0|||
127526382|NCT00095173|458888602|FG002|Open-Label Extension Phase (Period C)|Death|0|||
127526383|NCT00095173|458888603|FG003|Open-Label Extension Phase (Period C)|Death|0|||
127526384|NCT00095173|458888604|FG004|Open-Label Extension Phase (Period C)|Death|0|||
127526385|NCT00095173|458888605|FG005|Open-Label Extension Phase (Period C)|Death|1|||
127526386|NCT00095173|458888600|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
127526387|NCT00095173|458888601|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
127526388|NCT00095173|458888602|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
127526389|NCT00095173|458888603|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
127526390|NCT00095173|458888604|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
127526391|NCT00095173|458888605|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
127526392|NCT00095173|458888600|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
127526393|NCT00095173|458888601|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
127526394|NCT00095173|458888602|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
127526395|NCT00095173|458888603|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
127526396|NCT00095173|458888604|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
127526397|NCT00095173|458888605|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
127526398|NCT00095173|458888600|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
127526399|NCT00095173|458888601|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
127526400|NCT00095173|458888602|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
127526401|NCT00095173|458888603|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
127526402|NCT00095173|458888604|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
127526403|NCT00095173|458888605|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
127526404|NCT00095173|458888600|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
127526405|NCT00095173|458888601|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
127526406|NCT00095173|458888602|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
127526407|NCT00095173|458888603|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
127526408|NCT00095173|458888604|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
127526409|NCT00095173|458888605|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
127526410|NCT00095173|458888600|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
127526411|NCT00095173|458888601|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
127526412|NCT00095173|458888602|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
127526413|NCT00095173|458888603|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
127526414|NCT00095173|458888604|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
127526415|NCT00095173|458888605|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
127526416|NCT00095173|458888600|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
127526417|NCT00095173|458888601|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
127526418|NCT00095173|458888602|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
127526419|NCT00095173|458888603|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
127526420|NCT00095173|458888604|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
127526421|NCT00095173|458888605|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
127526422|NCT00095173|458888600|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
127526423|NCT00095173|458888601|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
127526424|NCT00095173|458888602|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
127526425|NCT00095173|458888603|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
127526426|NCT00095173|458888604|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
127526427|NCT00095173|458888605|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
127526428|NCT00095173|458888600|FG000|Open-Label Extension Phase (Period C)|Other|0|||
127526429|NCT00095173|458888601|FG001|Open-Label Extension Phase (Period C)|Other|0|||
127526430|NCT00095173|458888602|FG002|Open-Label Extension Phase (Period C)|Other|0|||
127526431|NCT00095173|458888603|FG003|Open-Label Extension Phase (Period C)|Other|4|||
127526432|NCT00095173|458888604|FG004|Open-Label Extension Phase (Period C)|Other|6|||
127526433|NCT00095173|458888605|FG005|Open-Label Extension Phase (Period C)|Other|8|||
127526434|NCT04698993|458888610|FG000|Overall Study|PCR results not accessible|2|||
127526435|NCT04698993|458888611|FG001|Overall Study|PCR results not accessible|7|||
127526436|NCT04698993|458888610|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
127526437|NCT04698993|458888611|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
127526438|NCT02578186|458888612|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
127526439|NCT02578186|458888613|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
127526440|NCT02578186|458888612|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
127526441|NCT02578186|458888613|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
127526442|NCT00527904|458888614|FG000|Overall Study|Adverse Event|45|||
127526443|NCT00527904|458888614|FG000|Overall Study|Withdrawal by Subject|21|||
127526444|NCT00527904|458888614|FG000|Overall Study|Lost to Follow-up|8|||
127526445|NCT00527904|458888614|FG000|Overall Study|misc|22|||
127526446|NCT00428389|458888616|FG000|Core Phase|Adverse Event|6|||
127526447|NCT00428389|458888617|FG001|Core Phase|Adverse Event|4|||
127526448|NCT00428389|458888616|FG000|Core Phase|Lack of Efficacy|2|||
127526449|NCT00428389|458888617|FG001|Core Phase|Lack of Efficacy|0|||
127526450|NCT00428389|458888616|FG000|Core Phase|Abnormal test procedure result(s)|0|||
127526451|NCT00428389|458888617|FG001|Core Phase|Abnormal test procedure result(s)|1|||
127526452|NCT00428389|458888616|FG000|Core Phase|Withdrawal by Subject|3|||
127526453|NCT00428389|458888617|FG001|Core Phase|Withdrawal by Subject|4|||
127526454|NCT00428389|458888616|FG000|Core Phase|Protocol deviation|0|||
127526455|NCT00428389|458888617|FG001|Core Phase|Protocol deviation|2|||
127526456|NCT00428389|458888616|FG000|Extension Phase|Adverse Event|17|||
127526457|NCT00428389|458888617|FG001|Extension Phase|Adverse Event|11|||
127526458|NCT00428389|458888616|FG000|Extension Phase|Lack of Efficacy|4|||
127526459|NCT00428389|458888617|FG001|Extension Phase|Lack of Efficacy|3|||
127526460|NCT00428389|458888616|FG000|Extension Phase|Withdrawal by Subject|6|||
127526461|NCT00428389|458888617|FG001|Extension Phase|Withdrawal by Subject|6|||
127526462|NCT00428389|458888616|FG000|Extension Phase|Lost to Follow-up|0|||
127526463|NCT00428389|458888617|FG001|Extension Phase|Lost to Follow-up|3|||
127526464|NCT00428389|458888616|FG000|Extension Phase|Death|1|||
127526465|NCT00428389|458888617|FG001|Extension Phase|Death|0|||
127526466|NCT00428389|458888616|FG000|Extension Phase|Protocol Violation|3|||
127526467|NCT00428389|458888617|FG001|Extension Phase|Protocol Violation|2|||
127526468|NCT00428389|458888616|FG000|Extension Phase|Administrative problems|1|||
127526469|NCT00428389|458888617|FG001|Extension Phase|Administrative problems|1|||
127526470|NCT02708355|458888618|FG000|Overall Study|Adverse Event|1|||
127526471|NCT02708355|458888619|FG001|Overall Study|Adverse Event|0|||
127526472|NCT02708355|458888620|FG002|Overall Study|Adverse Event|0|||
127526473|NCT01320202|458888621|FG000|Overall Study|Adverse Event|5|||
127526474|NCT01320202|458888622|FG001|Overall Study|Adverse Event|5|||
127526475|NCT01320202|458888621|FG000|Overall Study|Death|5|||
127526476|NCT01320202|458888622|FG001|Overall Study|Death|3|||
127526477|NCT01320202|458888621|FG000|Overall Study|Lost to Follow-up|1|||
127526478|NCT01320202|458888622|FG001|Overall Study|Lost to Follow-up|0|||
127526479|NCT01320202|458888621|FG000|Overall Study|Physician Decision|3|||
127526480|NCT01320202|458888622|FG001|Overall Study|Physician Decision|1|||
127526481|NCT01320202|458888621|FG000|Overall Study|Protocol Violation|2|||
127526482|NCT01320202|458888622|FG001|Overall Study|Protocol Violation|1|||
127526483|NCT01320202|458888621|FG000|Overall Study|Withdrawal by Subject|10|||
127526484|NCT01320202|458888622|FG001|Overall Study|Withdrawal by Subject|3|||
127526485|NCT01320202|458888621|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
127526486|NCT01320202|458888622|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
127526487|NCT01320202|458888621|FG000|Overall Study|kidney transplant|1|||
127526488|NCT01320202|458888622|FG001|Overall Study|kidney transplant|2|||
127526489|NCT01320202|458888621|FG000|Overall Study|blood transfusion|1|||
127526490|NCT01320202|458888622|FG001|Overall Study|blood transfusion|7|||
127526491|NCT01320202|458888621|FG000|Overall Study|moved/changed dialysis|5|||
127526492|NCT01320202|458888622|FG001|Overall Study|moved/changed dialysis|2|||
127526493|NCT01320202|458888621|FG000|Overall Study|sponsor request|2|||
127526494|NCT01320202|458888622|FG001|Overall Study|sponsor request|0|||
127526495|NCT01320202|458888621|FG000|Overall Study|ineligible|3|||
127526496|NCT01320202|458888622|FG001|Overall Study|ineligible|0|||
127526497|NCT01320202|458888621|FG000|Overall Study|regained renal function|1|||
127526498|NCT01320202|458888622|FG001|Overall Study|regained renal function|0|||
127526499|NCT00635882|458888623|FG000|Overall Study|Protocol Violation|1|||
127526500|NCT00635882|458888624|FG001|Overall Study|Protocol Violation|0|||
127526501|NCT00635882|458888625|FG002|Overall Study|Protocol Violation|0|||
127526502|NCT00635882|458888626|FG003|Overall Study|Protocol Violation|0|||
127526503|NCT00635882|458888627|FG004|Overall Study|Protocol Violation|0|||
127526504|NCT00635882|458888628|FG005|Overall Study|Protocol Violation|0|||
127526505|NCT00835341|458888629|FG000|Overall Study|Lost to Follow-up|3|||
127526506|NCT00835341|458888630|FG001|Overall Study|Lost to Follow-up|12|||
127526507|NCT00172042|458888635|FG000|Overall Study|Adverse Event|27|||
127526508|NCT00172042|458888636|FG001|Overall Study|Adverse Event|13|||
127526509|NCT00172042|458888635|FG000|Overall Study|Abnormal laboratory value(s)|5|||
127526510|NCT00172042|458888636|FG001|Overall Study|Abnormal laboratory value(s)|1|||
127526511|NCT00172042|458888635|FG000|Overall Study|Abnormal test procedure(s)|0|||
127526512|NCT00172042|458888636|FG001|Overall Study|Abnormal test procedure(s)|3|||
127526513|NCT00172042|458888635|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
127526514|NCT00172042|458888636|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
127526515|NCT00172042|458888635|FG000|Overall Study|Patient no longer requires study drug|10|||
127526516|NCT00172042|458888636|FG001|Overall Study|Patient no longer requires study drug|8|||
127526517|NCT00172042|458888635|FG000|Overall Study|Protocol Violation|8|||
127526518|NCT00172042|458888636|FG001|Overall Study|Protocol Violation|7|||
127526519|NCT00172042|458888635|FG000|Overall Study|Withdrawal by Subject|37|||
127526520|NCT00172042|458888636|FG001|Overall Study|Withdrawal by Subject|25|||
127526521|NCT00172042|458888635|FG000|Overall Study|Lost to Follow-up|3|||
127526522|NCT00172042|458888636|FG001|Overall Study|Lost to Follow-up|5|||
127526523|NCT00172042|458888635|FG000|Overall Study|Administrative problems|13|||
127526524|NCT00172042|458888636|FG001|Overall Study|Administrative problems|10|||
127526525|NCT00172042|458888635|FG000|Overall Study|Death|42|||
127526526|NCT00172042|458888636|FG001|Overall Study|Death|42|||
127526527|NCT01771250|458888637|FG000|Period 1|Met exclusion criteria|1|||
127526528|NCT01771250|458888638|FG001|Period 1|Met exclusion criteria|0|||
127526529|NCT00483938|458888639|FG000|Overall Study|Protocol Violation|0|||
127526530|NCT00483938|458888640|FG001|Overall Study|Protocol Violation|0|||
127526531|NCT00483938|458888641|FG002|Overall Study|Protocol Violation|0|||
127526532|NCT00483938|458888642|FG003|Overall Study|Protocol Violation|0|||
127526533|NCT00483938|458888643|FG004|Overall Study|Protocol Violation|0|||
127526534|NCT00483938|458888644|FG005|Overall Study|Protocol Violation|0|||
127526535|NCT00483938|458888645|FG006|Overall Study|Protocol Violation|3|||
127526536|NCT00483938|458888639|FG000|Overall Study|Withdrawal by Subject|1|||
127526537|NCT00483938|458888640|FG001|Overall Study|Withdrawal by Subject|6|||
127526538|NCT00483938|458888641|FG002|Overall Study|Withdrawal by Subject|0|||
127526539|NCT00483938|458888642|FG003|Overall Study|Withdrawal by Subject|0|||
127526540|NCT00483938|458888643|FG004|Overall Study|Withdrawal by Subject|1|||
127526541|NCT00483938|458888644|FG005|Overall Study|Withdrawal by Subject|3|||
127526542|NCT00483938|458888645|FG006|Overall Study|Withdrawal by Subject|2|||
127526543|NCT00483938|458888639|FG000|Overall Study|Lost to Follow-up|1|||
127526544|NCT00483938|458888640|FG001|Overall Study|Lost to Follow-up|2|||
127526545|NCT00483938|458888641|FG002|Overall Study|Lost to Follow-up|0|||
127526546|NCT00483938|458888642|FG003|Overall Study|Lost to Follow-up|2|||
127526547|NCT00483938|458888643|FG004|Overall Study|Lost to Follow-up|1|||
127526548|NCT00483938|458888644|FG005|Overall Study|Lost to Follow-up|1|||
127526549|NCT00483938|458888645|FG006|Overall Study|Lost to Follow-up|3|||
127526550|NCT00483938|458888639|FG000|Overall Study|Death|0|||
127526551|NCT00483938|458888640|FG001|Overall Study|Death|2|||
127526552|NCT00483938|458888641|FG002|Overall Study|Death|0|||
127526553|NCT00483938|458888642|FG003|Overall Study|Death|0|||
127526554|NCT00483938|458888643|FG004|Overall Study|Death|0|||
127526555|NCT00483938|458888644|FG005|Overall Study|Death|0|||
127526556|NCT00483938|458888645|FG006|Overall Study|Death|0|||
127526557|NCT00483938|458888639|FG000|Overall Study|Other|3|||
127526558|NCT00483938|458888640|FG001|Overall Study|Other|9|||
127526559|NCT00483938|458888641|FG002|Overall Study|Other|0|||
127526560|NCT00483938|458888642|FG003|Overall Study|Other|4|||
127526561|NCT00483938|458888643|FG004|Overall Study|Other|0|||
127526562|NCT00483938|458888644|FG005|Overall Study|Other|4|||
127526563|NCT00483938|458888645|FG006|Overall Study|Other|32|||
127526564|NCT02218008|458888646|FG000|Stage 1 (S1)|Adverse Event|6|||
127526565|NCT02218008|458888647|FG001|Stage 1 (S1)|Adverse Event|5|||
127526566|NCT02218008|458888648|FG002|Stage 1 (S1)|Adverse Event|11|||
127526567|NCT02218008|458888649|FG003|Stage 1 (S1)|Adverse Event|0|||
127526568|NCT02218008|458888650|FG004|Stage 1 (S1)|Adverse Event|0|||
127526569|NCT02218008|458888651|FG005|Stage 1 (S1)|Adverse Event|0|||
127526570|NCT02218008|458888646|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
127526571|NCT02218008|458888647|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
127526572|NCT02218008|458888648|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
127526573|NCT02218008|458888649|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
127526574|NCT02218008|458888650|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
127526575|NCT02218008|458888651|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
127526576|NCT02218008|458888646|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
127526577|NCT02218008|458888647|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
127526578|NCT02218008|458888648|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
127526579|NCT02218008|458888649|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
127526580|NCT02218008|458888650|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
127526581|NCT02218008|458888651|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
127526582|NCT02218008|458888646|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
127526583|NCT02218008|458888647|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
127526584|NCT02218008|458888648|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
127526585|NCT02218008|458888649|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
127526586|NCT02218008|458888650|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
127526587|NCT02218008|458888651|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
127526588|NCT02218008|458888646|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
127526589|NCT02218008|458888647|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
127526590|NCT02218008|458888648|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
127526591|NCT02218008|458888649|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
127526592|NCT02218008|458888650|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
127526593|NCT02218008|458888651|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
127526594|NCT02218008|458888646|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
127526595|NCT02218008|458888647|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
127526596|NCT02218008|458888648|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
127526597|NCT02218008|458888649|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
127526598|NCT02218008|458888650|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
127526599|NCT02218008|458888651|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
127526600|NCT02218008|458888646|FG000|Stage 1 (S1)|Pregnancy|0|||
127526601|NCT02218008|458888647|FG001|Stage 1 (S1)|Pregnancy|0|||
127526602|NCT02218008|458888648|FG002|Stage 1 (S1)|Pregnancy|1|||
127526603|NCT02218008|458888649|FG003|Stage 1 (S1)|Pregnancy|0|||
127526604|NCT02218008|458888650|FG004|Stage 1 (S1)|Pregnancy|0|||
127526605|NCT02218008|458888651|FG005|Stage 1 (S1)|Pregnancy|0|||
127526606|NCT02218008|458888646|FG000|Stage 1 (S1)|Protocol Violation|0|||
127526607|NCT02218008|458888647|FG001|Stage 1 (S1)|Protocol Violation|0|||
127526608|NCT02218008|458888648|FG002|Stage 1 (S1)|Protocol Violation|1|||
127526609|NCT02218008|458888649|FG003|Stage 1 (S1)|Protocol Violation|0|||
127526610|NCT02218008|458888650|FG004|Stage 1 (S1)|Protocol Violation|0|||
127526611|NCT02218008|458888651|FG005|Stage 1 (S1)|Protocol Violation|0|||
127526612|NCT02218008|458888646|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
127526613|NCT02218008|458888647|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
127526614|NCT02218008|458888648|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
127526615|NCT02218008|458888649|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
127526616|NCT02218008|458888650|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
127526617|NCT02218008|458888651|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
127526618|NCT02218008|458888646|FG000|Stage 2 (S2)|Adverse Event|0|||
127526619|NCT02218008|458888647|FG001|Stage 2 (S2)|Adverse Event|0|||
127526620|NCT02218008|458888648|FG002|Stage 2 (S2)|Adverse Event|0|||
127526621|NCT02218008|458888649|FG003|Stage 2 (S2)|Adverse Event|2|||
127526622|NCT02218008|458888650|FG004|Stage 2 (S2)|Adverse Event|3|||
127526623|NCT02218008|458888651|FG005|Stage 2 (S2)|Adverse Event|3|||
127526624|NCT02218008|458888646|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
127526625|NCT02218008|458888647|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
127526626|NCT02218008|458888648|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
127526627|NCT02218008|458888649|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
127526628|NCT02218008|458888650|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
127526629|NCT02218008|458888651|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
127526630|NCT02218008|458888646|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
127526631|NCT02218008|458888647|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
127526632|NCT02218008|458888648|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
127526633|NCT02218008|458888649|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
127526634|NCT02218008|458888650|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
127526635|NCT02218008|458888651|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
127526636|NCT02218008|458888646|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
127526637|NCT02218008|458888647|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
127526638|NCT02218008|458888648|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
127526639|NCT02218008|458888649|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
127526640|NCT02218008|458888650|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
127526641|NCT02218008|458888651|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
127526642|NCT02218008|458888646|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
127526643|NCT02218008|458888647|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
127526644|NCT02218008|458888648|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
127526645|NCT02218008|458888649|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
127526646|NCT02218008|458888650|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
127526647|NCT02218008|458888651|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
127526648|NCT02038075|458888652|FG000|Overall Study|Withdrawal by Subject|3|||
127526649|NCT02038075|458888653|FG001|Overall Study|Withdrawal by Subject|0|||
127526650|NCT00106353|458888654|FG000|Part 1|Disease progression|3|||
127526651|NCT00106353|458888655|FG001|Part 1|Disease progression|4|||
127526652|NCT00106353|458888656|FG002|Part 1|Disease progression|1|||
127526653|NCT00106353|458888657|FG003|Part 1|Disease progression|3|||
127526654|NCT00106353|458888658|FG004|Part 1|Disease progression|0|||
127526655|NCT00106353|458888659|FG005|Part 1|Disease progression|0|||
127526656|NCT00106353|458888660|FG006|Part 1|Disease progression|0|||
127526657|NCT00106353|458888654|FG000|Part 1|Withdrawal by Subject|0|||
127526658|NCT00106353|458888655|FG001|Part 1|Withdrawal by Subject|0|||
127526659|NCT00106353|458888656|FG002|Part 1|Withdrawal by Subject|1|||
127526660|NCT00106353|458888657|FG003|Part 1|Withdrawal by Subject|2|||
127526661|NCT00106353|458888658|FG004|Part 1|Withdrawal by Subject|0|||
127526662|NCT00106353|458888659|FG005|Part 1|Withdrawal by Subject|0|||
127526663|NCT00106353|458888660|FG006|Part 1|Withdrawal by Subject|0|||
127526664|NCT00106353|458888654|FG000|Part 1|Symptomatic deterioration|0|||
127526665|NCT00106353|458888655|FG001|Part 1|Symptomatic deterioration|0|||
127526666|NCT00106353|458888656|FG002|Part 1|Symptomatic deterioration|1|||
127526667|NCT00106353|458888657|FG003|Part 1|Symptomatic deterioration|0|||
127526668|NCT00106353|458888658|FG004|Part 1|Symptomatic deterioration|0|||
127526669|NCT00106353|458888659|FG005|Part 1|Symptomatic deterioration|0|||
127526670|NCT00106353|458888660|FG006|Part 1|Symptomatic deterioration|0|||
127526671|NCT00106353|458888654|FG000|Part 1|Entered follow-up phase|1|||
127526672|NCT00106353|458888655|FG001|Part 1|Entered follow-up phase|1|||
127526673|NCT00106353|458888656|FG002|Part 1|Entered follow-up phase|0|||
127526674|NCT00106353|458888657|FG003|Part 1|Entered follow-up phase|1|||
127526675|NCT00106353|458888658|FG004|Part 1|Entered follow-up phase|0|||
127526676|NCT00106353|458888659|FG005|Part 1|Entered follow-up phase|0|||
127526677|NCT00106353|458888660|FG006|Part 1|Entered follow-up phase|0|||
127526678|NCT00106353|458888654|FG000|Part 1|Adverse Event|0|||
127526679|NCT00106353|458888655|FG001|Part 1|Adverse Event|0|||
127526680|NCT00106353|458888656|FG002|Part 1|Adverse Event|0|||
127526681|NCT00106353|458888657|FG003|Part 1|Adverse Event|1|||
127526682|NCT00106353|458888658|FG004|Part 1|Adverse Event|0|||
127526683|NCT00106353|458888659|FG005|Part 1|Adverse Event|0|||
127526684|NCT00106353|458888660|FG006|Part 1|Adverse Event|0|||
127526685|NCT00106353|458888654|FG000|Part 2|Disease progression|0|||
127526686|NCT00106353|458888655|FG001|Part 2|Disease progression|0|||
127526687|NCT00106353|458888656|FG002|Part 2|Disease progression|0|||
127526688|NCT00106353|458888657|FG003|Part 2|Disease progression|0|||
127526689|NCT00106353|458888658|FG004|Part 2|Disease progression|8|||
127526690|NCT00106353|458888659|FG005|Part 2|Disease progression|14|||
127526691|NCT00106353|458888660|FG006|Part 2|Disease progression|13|||
127526692|NCT00106353|458888654|FG000|Part 2|Death|0|||
127526693|NCT00106353|458888655|FG001|Part 2|Death|0|||
127526694|NCT00106353|458888656|FG002|Part 2|Death|0|||
127526695|NCT00106353|458888657|FG003|Part 2|Death|0|||
127526696|NCT00106353|458888658|FG004|Part 2|Death|3|||
127526697|NCT00106353|458888659|FG005|Part 2|Death|0|||
127526698|NCT00106353|458888660|FG006|Part 2|Death|1|||
127526699|NCT00106353|458888654|FG000|Part 2|Symptomatic deterioration|0|||
127526700|NCT00106353|458888655|FG001|Part 2|Symptomatic deterioration|0|||
127526701|NCT00106353|458888656|FG002|Part 2|Symptomatic deterioration|0|||
127526702|NCT00106353|458888657|FG003|Part 2|Symptomatic deterioration|0|||
127526703|NCT00106353|458888658|FG004|Part 2|Symptomatic deterioration|3|||
127526704|NCT00106353|458888659|FG005|Part 2|Symptomatic deterioration|0|||
127526705|NCT00106353|458888660|FG006|Part 2|Symptomatic deterioration|0|||
127526706|NCT00106353|458888654|FG000|Part 2|Adverse Event|0|||
127526707|NCT00106353|458888655|FG001|Part 2|Adverse Event|0|||
127526708|NCT00106353|458888656|FG002|Part 2|Adverse Event|0|||
127526709|NCT00106353|458888657|FG003|Part 2|Adverse Event|0|||
127526710|NCT00106353|458888658|FG004|Part 2|Adverse Event|0|||
127526711|NCT00106353|458888659|FG005|Part 2|Adverse Event|2|||
127526712|NCT00106353|458888660|FG006|Part 2|Adverse Event|1|||
127526713|NCT00106353|458888654|FG000|Part 2|Other|0|||
127526714|NCT00106353|458888655|FG001|Part 2|Other|0|||
127526715|NCT00106353|458888656|FG002|Part 2|Other|0|||
127526716|NCT00106353|458888657|FG003|Part 2|Other|0|||
127526717|NCT00106353|458888658|FG004|Part 2|Other|1|||
127526718|NCT00106353|458888659|FG005|Part 2|Other|1|||
127526719|NCT00106353|458888660|FG006|Part 2|Other|1|||
127526720|NCT00106353|458888654|FG000|Part 2|Withdrawal by Subject|0|||
127526721|NCT00106353|458888655|FG001|Part 2|Withdrawal by Subject|0|||
127526722|NCT00106353|458888656|FG002|Part 2|Withdrawal by Subject|0|||
127526723|NCT00106353|458888657|FG003|Part 2|Withdrawal by Subject|0|||
127526724|NCT00106353|458888658|FG004|Part 2|Withdrawal by Subject|1|||
127526725|NCT00106353|458888659|FG005|Part 2|Withdrawal by Subject|0|||
127526726|NCT00106353|458888660|FG006|Part 2|Withdrawal by Subject|0|||
127526727|NCT00106353|458888654|FG000|Part 2|Physician Decision|0|||
127526728|NCT00106353|458888655|FG001|Part 2|Physician Decision|0|||
127526729|NCT00106353|458888656|FG002|Part 2|Physician Decision|0|||
127526730|NCT00106353|458888657|FG003|Part 2|Physician Decision|0|||
127526731|NCT00106353|458888658|FG004|Part 2|Physician Decision|0|||
127526732|NCT00106353|458888659|FG005|Part 2|Physician Decision|1|||
127526733|NCT00106353|458888660|FG006|Part 2|Physician Decision|0|||
127526734|NCT00850538|458888661|FG000|Overall Study|unable/unwilling to complete MRI|13|||
127526735|NCT00850538|458888661|FG000|Overall Study|specimen missed due to scheduling error|14|||
127526736|NCT00850538|458888661|FG000|Overall Study|specimen unusable|7|||
127526737|NCT00850538|458888661|FG000|Overall Study|Withdrawal by Subject|3|||
127526738|NCT00850538|458888661|FG000|Overall Study|radiology error|2|||
127526739|NCT00850538|458888661|FG000|Overall Study|Protocol Violation|2|||
127526740|NCT02328027|458888662|FG000|Overall Study|Withdrawal by Subject|0|||
127526741|NCT02328027|458888663|FG001|Overall Study|Withdrawal by Subject|1|||
127526742|NCT03319212|458888664|FG000|Overall Study|Discontinued as moving out of local area|0|||
127526743|NCT03319212|458888665|FG001|Overall Study|Discontinued as moving out of local area|1|||
127526744|NCT03319212|458888664|FG000|Overall Study|Adverse Event|2|||
127526745|NCT03319212|458888665|FG001|Overall Study|Adverse Event|2|||
127526746|NCT03319212|458888664|FG000|Overall Study|Withdrawal by Subject|0|||
127526747|NCT03319212|458888665|FG001|Overall Study|Withdrawal by Subject|1|||
127526748|NCT03319212|458888664|FG000|Overall Study|Lost to Follow-up|0|||
127526749|NCT03319212|458888665|FG001|Overall Study|Lost to Follow-up|1|||
127526750|NCT03319212|458888664|FG000|Overall Study|Physician Decision|1|||
127526751|NCT03319212|458888665|FG001|Overall Study|Physician Decision|0|||
127526752|NCT00250276|458888666|FG000|Overall Study|Serious Adverse Event|0|||
127526753|NCT00250276|458888667|FG001|Overall Study|Serious Adverse Event|0|||
127526754|NCT00250276|458888668|FG002|Overall Study|Serious Adverse Event|1|||
127526755|NCT00250276|458888669|FG003|Overall Study|Serious Adverse Event|0|||
127526756|NCT00250276|458888666|FG000|Overall Study|Non-serious Adverse Event|2|||
127526757|NCT00250276|458888667|FG001|Overall Study|Non-serious Adverse Event|0|||
127526758|NCT00250276|458888668|FG002|Overall Study|Non-serious Adverse Event|0|||
127526759|NCT00250276|458888669|FG003|Overall Study|Non-serious Adverse Event|2|||
127526760|NCT00250276|458888666|FG000|Overall Study|Protocol Violation|0|||
127526761|NCT00250276|458888667|FG001|Overall Study|Protocol Violation|1|||
127526762|NCT00250276|458888668|FG002|Overall Study|Protocol Violation|0|||
127526763|NCT00250276|458888669|FG003|Overall Study|Protocol Violation|0|||
127526764|NCT00250276|458888666|FG000|Overall Study|Withdrawal by Subject|1|||
127526765|NCT00250276|458888667|FG001|Overall Study|Withdrawal by Subject|2|||
127526766|NCT00250276|458888668|FG002|Overall Study|Withdrawal by Subject|3|||
127526767|NCT00250276|458888669|FG003|Overall Study|Withdrawal by Subject|2|||
127526768|NCT00250276|458888666|FG000|Overall Study|Migrated/moved from study area|3|||
127526769|NCT00250276|458888667|FG001|Overall Study|Migrated/moved from study area|0|||
127526770|NCT00250276|458888668|FG002|Overall Study|Migrated/moved from study area|2|||
127526771|NCT00250276|458888669|FG003|Overall Study|Migrated/moved from study area|7|||
127526772|NCT00250276|458888666|FG000|Overall Study|Lost to Follow-up|11|||
127526773|NCT00250276|458888667|FG001|Overall Study|Lost to Follow-up|18|||
127526774|NCT00250276|458888668|FG002|Overall Study|Lost to Follow-up|13|||
127526775|NCT00250276|458888669|FG003|Overall Study|Lost to Follow-up|8|||
127526776|NCT01811186|458888670|FG000|Overall Study|Adverse Event|54|||
127526777|NCT01811186|458888671|FG001|Overall Study|Adverse Event|38|||
127526778|NCT01811186|458888670|FG000|Overall Study|Protocol Violation|5|||
127526779|NCT01811186|458888671|FG001|Overall Study|Protocol Violation|6|||
127526780|NCT01811186|458888670|FG000|Overall Study|Withdrawal by Subject|5|||
127526781|NCT01811186|458888671|FG001|Overall Study|Withdrawal by Subject|10|||
127526782|NCT01811186|458888670|FG000|Overall Study|Lack of Efficacy|3|||
127526783|NCT01811186|458888671|FG001|Overall Study|Lack of Efficacy|6|||
127526784|NCT01811186|458888670|FG000|Overall Study|Lost to Follow-up|4|||
127526785|NCT01811186|458888671|FG001|Overall Study|Lost to Follow-up|2|||
127526786|NCT03369236|458888672|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
127526787|NCT03369236|458888673|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
127526788|NCT03369236|458888672|FG000|Open-label Extension Period|Lack of Efficacy|2|||
127526789|NCT03369236|458888673|FG001|Open-label Extension Period|Lack of Efficacy|1|||
127526790|NCT03369236|458888672|FG000|Open-label Extension Period|Adverse Event|0|||
127526791|NCT03369236|458888673|FG001|Open-label Extension Period|Adverse Event|1|||
127526792|NCT03369236|458888672|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
127526793|NCT03369236|458888673|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
127526794|NCT01153724|458888680|FG000|Treatment Period 1|Withdrawal by Subject|1|||
127526795|NCT01153724|458888680|FG000|Treatment Period 2|Adverse Event|1|||
127526796|NCT01153724|458888680|FG000|Treatment Period 2|Other reason not defined above|1|||
127526797|NCT02508428|458888687|FG000|Overall Study|Death|32|||
127526798|NCT02508428|458888688|FG001|Overall Study|Death|33|||
127526799|NCT02508428|458888687|FG000|Overall Study|Liner revised|3|||
127526800|NCT02508428|458888688|FG001|Overall Study|Liner revised|19|||
127526801|NCT02508428|458888687|FG000|Overall Study|Incomplete follow-up|17|||
127526802|NCT02508428|458888688|FG001|Overall Study|Incomplete follow-up|15|||
127526803|NCT00534976|458888693|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
127526804|NCT00534976|458888694|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
127526805|NCT00534976|458888693|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
127526806|NCT00534976|458888694|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
127526807|NCT00534976|458888693|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
127526808|NCT00534976|458888694|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
127526809|NCT02834247|458888695|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
127526810|NCT02834247|458888696|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
127526811|NCT02834247|458888697|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
127526812|NCT02834247|458888698|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
127526813|NCT02834247|458888695|FG000|Dose Escalation Phase|Death|5|||
127526814|NCT02834247|458888696|FG001|Dose Escalation Phase|Death|6|||
127526815|NCT02834247|458888697|FG002|Dose Escalation Phase|Death|5|||
127526816|NCT02834247|458888698|FG003|Dose Escalation Phase|Death|0|||
127526817|NCT02834247|458888695|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
127526818|NCT02834247|458888696|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
127526819|NCT02834247|458888697|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
127526820|NCT02834247|458888698|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
127526821|NCT02834247|458888695|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
127526822|NCT02834247|458888696|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
127526823|NCT02834247|458888697|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
127526824|NCT02834247|458888698|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
127526825|NCT02834247|458888695|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
127526826|NCT02834247|458888696|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
127526827|NCT02834247|458888697|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
127526828|NCT02834247|458888698|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
127526829|NCT02834247|458888695|FG000|Dose Expansion Phase|Death|0|||
127526830|NCT02834247|458888696|FG001|Dose Expansion Phase|Death|0|||
127526831|NCT02834247|458888697|FG002|Dose Expansion Phase|Death|0|||
127526832|NCT02834247|458888698|FG003|Dose Expansion Phase|Death|8|||
127526833|NCT02834247|458888695|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
127526834|NCT02834247|458888696|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
127526835|NCT02834247|458888697|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
127526836|NCT02834247|458888698|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
127526837|NCT02834247|458888695|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
127526838|NCT02834247|458888696|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
127526839|NCT02834247|458888697|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
127526840|NCT02834247|458888698|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
127526841|NCT03343626|458890979|FG000|Overall Study|Lost to Follow-up|4|||
127526842|NCT03343626|458890980|FG001|Overall Study|Lost to Follow-up|3|||
127526843|NCT03343626|458890981|FG002|Overall Study|Lost to Follow-up|2|||
127526844|NCT03343626|458890982|FG003|Overall Study|Lost to Follow-up|5|||
127526845|NCT03343626|458890983|FG004|Overall Study|Lost to Follow-up|4|||
127526846|NCT03343626|458890984|FG005|Overall Study|Lost to Follow-up|4|||
127526847|NCT03343626|458890985|FG006|Overall Study|Lost to Follow-up|4|||
127526848|NCT03343626|458890986|FG007|Overall Study|Lost to Follow-up|7|||
127526849|NCT03343626|458890979|FG000|Overall Study|Withdrawal of Consent|2|||
127526850|NCT03343626|458890980|FG001|Overall Study|Withdrawal of Consent|1|||
127526851|NCT03343626|458890981|FG002|Overall Study|Withdrawal of Consent|0|||
127526852|NCT03343626|458890982|FG003|Overall Study|Withdrawal of Consent|3|||
127526853|NCT03343626|458890983|FG004|Overall Study|Withdrawal of Consent|3|||
127526854|NCT03343626|458890984|FG005|Overall Study|Withdrawal of Consent|1|||
127526855|NCT03343626|458890985|FG006|Overall Study|Withdrawal of Consent|1|||
127526856|NCT03343626|458890986|FG007|Overall Study|Withdrawal of Consent|2|||
127526857|NCT03343626|458890979|FG000|Overall Study|Reason not Specified|0|||
127526858|NCT03343626|458890980|FG001|Overall Study|Reason not Specified|1|||
127526859|NCT03343626|458890981|FG002|Overall Study|Reason not Specified|0|||
127526860|NCT03343626|458890982|FG003|Overall Study|Reason not Specified|0|||
127526861|NCT03343626|458890983|FG004|Overall Study|Reason not Specified|0|||
127526862|NCT03343626|458890984|FG005|Overall Study|Reason not Specified|0|||
127526863|NCT03343626|458890985|FG006|Overall Study|Reason not Specified|0|||
127526864|NCT03343626|458890986|FG007|Overall Study|Reason not Specified|1|||
127526865|NCT03343626|458890979|FG000|Overall Study|Data Entry Error|0|||
127526866|NCT03343626|458890980|FG001|Overall Study|Data Entry Error|0|||
127526867|NCT03343626|458890981|FG002|Overall Study|Data Entry Error|0|||
127526868|NCT03343626|458890982|FG003|Overall Study|Data Entry Error|0|||
127526869|NCT03343626|458890983|FG004|Overall Study|Data Entry Error|0|||
127526870|NCT03343626|458890984|FG005|Overall Study|Data Entry Error|0|||
127526871|NCT03343626|458890985|FG006|Overall Study|Data Entry Error|0|||
127526872|NCT03343626|458890986|FG007|Overall Study|Data Entry Error|1|||
127526873|NCT01865448|458890987|FG000|Overall Study|Adverse Event|1|||
127526874|NCT01865448|458890988|FG001|Overall Study|Adverse Event|1|||
127526875|NCT01865448|458890987|FG000|Overall Study|Pregnancy|0|||
127526876|NCT01865448|458890988|FG001|Overall Study|Pregnancy|1|||
127526877|NCT01865448|458890987|FG000|Overall Study|dropout unrelated to study|1|||
127526878|NCT01865448|458890988|FG001|Overall Study|dropout unrelated to study|1|||
127526879|NCT05111249|458890992|FG000|Overall Study|Lost to Follow-up|0|||
127526880|NCT05111249|458890993|FG001|Overall Study|Lost to Follow-up|2|||
127526881|NCT05111249|458890992|FG000|Overall Study|Physician Decision|0|||
127526882|NCT05111249|458890993|FG001|Overall Study|Physician Decision|1|||
127526883|NCT05111249|458890992|FG000|Overall Study|Participant decision|1|||
127526884|NCT05111249|458890993|FG001|Overall Study|Participant decision|5|||
127526885|NCT05128578|458890994|FG000|Overall Study|Withdrawal by Subject|9|||
127526886|NCT05128578|458890994|FG000|Overall Study|Lost to Follow-up|5|||
127526887|NCT02610777|458890997|FG000|Overall Study|Lost to Follow-up|1|||
127526888|NCT02610777|458890998|FG001|Overall Study|Lost to Follow-up|0|||
127526889|NCT02610777|458890997|FG000|Overall Study|Site Terminated by Sponsor|9|||
127526890|NCT02610777|458890998|FG001|Overall Study|Site Terminated by Sponsor|8|||
127526891|NCT02610777|458890997|FG000|Overall Study|Withdrawal by Subject|2|||
127526892|NCT02610777|458890998|FG001|Overall Study|Withdrawal by Subject|2|||
127526893|NCT02610777|458890997|FG000|Overall Study|Reason not Specified|0|||
127526894|NCT02610777|458890998|FG001|Overall Study|Reason not Specified|1|||
127526895|NCT02610777|458890997|FG000|Overall Study|Death|50|||
127526896|NCT02610777|458890998|FG001|Overall Study|Death|47|||
127526897|NCT02451917|458890999|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
127526898|NCT02451917|458891000|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
127526899|NCT02451917|458890999|FG000|First Intervention (24 Weeks)|Death|0|||
127526900|NCT02451917|458891000|FG001|First Intervention (24 Weeks)|Death|1|||
127526901|NCT02451917|458890999|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
127526902|NCT02451917|458891000|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
127526903|NCT02300259|458891005|FG000|Period 1|Adverse Event|0|||
127526904|NCT02300259|458891006|FG001|Period 1|Adverse Event|0|||
127526905|NCT02300259|458891007|FG002|Period 1|Adverse Event|1|||
127526906|NCT02300259|458891005|FG000|Period 1|Withdrawal by Subject|0|||
127526907|NCT02300259|458891006|FG001|Period 1|Withdrawal by Subject|0|||
127526908|NCT02300259|458891007|FG002|Period 1|Withdrawal by Subject|1|||
127526909|NCT02300259|458891005|FG000|Period 2|Adverse Event|1|||
127526910|NCT02300259|458891006|FG001|Period 2|Adverse Event|0|||
127526911|NCT02300259|458891007|FG002|Period 2|Adverse Event|0|||
127526912|NCT02300259|458891005|FG000|Period 2|Withdrawal by Subject|0|||
127526913|NCT02300259|458891006|FG001|Period 2|Withdrawal by Subject|0|||
127526914|NCT02300259|458891007|FG002|Period 2|Withdrawal by Subject|1|||
127526915|NCT04737278|458891008|FG000|Overall Study|Lost to Follow-up|1|||
127526916|NCT04737278|458891009|FG001|Overall Study|Lost to Follow-up|1|||
127526917|NCT04737278|458891008|FG000|Overall Study|Withdrawal by Subject|1|||
127526918|NCT04737278|458891009|FG001|Overall Study|Withdrawal by Subject|0|||
127526919|NCT04737278|458891008|FG000|Overall Study|Protocol Violation|1|||
127526920|NCT04737278|458891009|FG001|Overall Study|Protocol Violation|1|||
127526921|NCT04737278|458891008|FG000|Overall Study|failure to complete questionnaire|1|||
127526922|NCT04737278|458891009|FG001|Overall Study|failure to complete questionnaire|1|||
127526923|NCT02737475|458891010|FG000|Overall Study|Other reasons|0|||
127526924|NCT02737475|458891011|FG001|Overall Study|Other reasons|0|||
127526925|NCT02737475|458891012|FG002|Overall Study|Other reasons|0|||
127526926|NCT02737475|458891013|FG003|Overall Study|Other reasons|0|||
127526927|NCT02737475|458891014|FG004|Overall Study|Other reasons|1|||
127526928|NCT02737475|458891015|FG005|Overall Study|Other reasons|1|||
127526929|NCT02737475|458891016|FG006|Overall Study|Other reasons|0|||
127526930|NCT02737475|458891017|FG007|Overall Study|Other reasons|0|||
127526931|NCT02737475|458891018|FG008|Overall Study|Other reasons|1|||
127526932|NCT02737475|458891019|FG009|Overall Study|Other reasons|0|||
127526933|NCT02737475|458891020|FG010|Overall Study|Other reasons|1|||
127526934|NCT02737475|458891021|FG011|Overall Study|Other reasons|0|||
127526935|NCT02737475|458891022|FG012|Overall Study|Other reasons|0|||
127526936|NCT02737475|458891023|FG013|Overall Study|Other reasons|0|||
127526937|NCT02737475|458891024|FG014|Overall Study|Other reasons|0|||
127526938|NCT02737475|458891025|FG015|Overall Study|Other reasons|0|||
127526939|NCT02737475|458891026|FG016|Overall Study|Other reasons|0|||
127526940|NCT02737475|458891027|FG017|Overall Study|Other reasons|0|||
127526941|NCT02737475|458891028|FG018|Overall Study|Other reasons|0|||
127526942|NCT02737475|458891029|FG019|Overall Study|Other reasons|0|||
127526943|NCT02737475|458891030|FG020|Overall Study|Other reasons|0|||
127526944|NCT02737475|458891031|FG021|Overall Study|Other reasons|1|||
127526945|NCT02737475|458891032|FG022|Overall Study|Other reasons|0|||
127526946|NCT02737475|458891033|FG023|Overall Study|Other reasons|1|||
127526947|NCT02737475|458891034|FG024|Overall Study|Other reasons|1|||
127526948|NCT02737475|458891035|FG025|Overall Study|Other reasons|1|||
127526949|NCT02737475|458891036|FG026|Overall Study|Other reasons|0|||
127526950|NCT02737475|458891010|FG000|Overall Study|Death|1|||
127526951|NCT02737475|458891011|FG001|Overall Study|Death|0|||
127526952|NCT02737475|458891012|FG002|Overall Study|Death|0|||
127526953|NCT02737475|458891013|FG003|Overall Study|Death|1|||
127526954|NCT02737475|458891014|FG004|Overall Study|Death|0|||
127526955|NCT02737475|458891015|FG005|Overall Study|Death|0|||
127526956|NCT02737475|458891016|FG006|Overall Study|Death|0|||
127526957|NCT02737475|458891017|FG007|Overall Study|Death|2|||
127526958|NCT02737475|458891018|FG008|Overall Study|Death|0|||
127526959|NCT02737475|458891019|FG009|Overall Study|Death|0|||
127526960|NCT02737475|458891020|FG010|Overall Study|Death|0|||
127526961|NCT02737475|458891021|FG011|Overall Study|Death|4|||
127526962|NCT02737475|458891022|FG012|Overall Study|Death|2|||
127526963|NCT02737475|458891023|FG013|Overall Study|Death|2|||
127526964|NCT02737475|458891024|FG014|Overall Study|Death|0|||
127526965|NCT02737475|458891025|FG015|Overall Study|Death|2|||
127526966|NCT02737475|458891026|FG016|Overall Study|Death|2|||
127526967|NCT02737475|458891027|FG017|Overall Study|Death|2|||
127526968|NCT02737475|458891028|FG018|Overall Study|Death|1|||
127526969|NCT02737475|458891029|FG019|Overall Study|Death|0|||
127526970|NCT02737475|458891030|FG020|Overall Study|Death|0|||
127526971|NCT02737475|458891031|FG021|Overall Study|Death|0|||
127526972|NCT02737475|458891032|FG022|Overall Study|Death|0|||
127526973|NCT02737475|458891033|FG023|Overall Study|Death|0|||
127526974|NCT02737475|458891034|FG024|Overall Study|Death|0|||
127526975|NCT02737475|458891035|FG025|Overall Study|Death|0|||
127526976|NCT02737475|458891036|FG026|Overall Study|Death|0|||
127526977|NCT02737475|458891010|FG000|Overall Study|Participant withdrew consent|0|||
127526978|NCT02737475|458891011|FG001|Overall Study|Participant withdrew consent|0|||
127526979|NCT02737475|458891012|FG002|Overall Study|Participant withdrew consent|0|||
127526980|NCT02737475|458891013|FG003|Overall Study|Participant withdrew consent|0|||
127526981|NCT02737475|458891014|FG004|Overall Study|Participant withdrew consent|0|||
127526982|NCT02737475|458891015|FG005|Overall Study|Participant withdrew consent|2|||
127526983|NCT02737475|458891016|FG006|Overall Study|Participant withdrew consent|0|||
127526984|NCT02737475|458891017|FG007|Overall Study|Participant withdrew consent|0|||
127526985|NCT02737475|458891018|FG008|Overall Study|Participant withdrew consent|0|||
127526986|NCT02737475|458891019|FG009|Overall Study|Participant withdrew consent|0|||
127526987|NCT02737475|458891020|FG010|Overall Study|Participant withdrew consent|0|||
127526988|NCT02737475|458891021|FG011|Overall Study|Participant withdrew consent|0|||
127526989|NCT02737475|458891022|FG012|Overall Study|Participant withdrew consent|0|||
127526990|NCT02737475|458891023|FG013|Overall Study|Participant withdrew consent|0|||
127526991|NCT02737475|458891024|FG014|Overall Study|Participant withdrew consent|1|||
127526992|NCT02737475|458891025|FG015|Overall Study|Participant withdrew consent|0|||
127526993|NCT02737475|458891026|FG016|Overall Study|Participant withdrew consent|0|||
127526994|NCT02737475|458891027|FG017|Overall Study|Participant withdrew consent|2|||
127526995|NCT02737475|458891028|FG018|Overall Study|Participant withdrew consent|1|||
127526996|NCT02737475|458891029|FG019|Overall Study|Participant withdrew consent|0|||
127526997|NCT02737475|458891030|FG020|Overall Study|Participant withdrew consent|2|||
127526998|NCT02737475|458891031|FG021|Overall Study|Participant withdrew consent|0|||
127526999|NCT02737475|458891032|FG022|Overall Study|Participant withdrew consent|0|||
127527000|NCT02737475|458891033|FG023|Overall Study|Participant withdrew consent|0|||
127527001|NCT02737475|458891034|FG024|Overall Study|Participant withdrew consent|0|||
127527002|NCT02737475|458891035|FG025|Overall Study|Participant withdrew consent|0|||
127527003|NCT02737475|458891036|FG026|Overall Study|Participant withdrew consent|0|||
127527004|NCT02737475|458891010|FG000|Overall Study|Lost to Follow-up|0|||
127527005|NCT02737475|458891011|FG001|Overall Study|Lost to Follow-up|0|||
127527006|NCT02737475|458891012|FG002|Overall Study|Lost to Follow-up|0|||
127527007|NCT02737475|458891013|FG003|Overall Study|Lost to Follow-up|0|||
127527008|NCT02737475|458891014|FG004|Overall Study|Lost to Follow-up|0|||
127527009|NCT02737475|458891015|FG005|Overall Study|Lost to Follow-up|0|||
127527010|NCT02737475|458891016|FG006|Overall Study|Lost to Follow-up|0|||
127527011|NCT02737475|458891017|FG007|Overall Study|Lost to Follow-up|0|||
127527012|NCT02737475|458891018|FG008|Overall Study|Lost to Follow-up|0|||
127527013|NCT02737475|458891019|FG009|Overall Study|Lost to Follow-up|0|||
127527014|NCT02737475|458891020|FG010|Overall Study|Lost to Follow-up|0|||
127527015|NCT02737475|458891021|FG011|Overall Study|Lost to Follow-up|0|||
127527016|NCT02737475|458891022|FG012|Overall Study|Lost to Follow-up|0|||
127527017|NCT02737475|458891023|FG013|Overall Study|Lost to Follow-up|0|||
127527018|NCT02737475|458891024|FG014|Overall Study|Lost to Follow-up|0|||
127527019|NCT02737475|458891025|FG015|Overall Study|Lost to Follow-up|1|||
127527020|NCT02737475|458891026|FG016|Overall Study|Lost to Follow-up|0|||
127527021|NCT02737475|458891027|FG017|Overall Study|Lost to Follow-up|0|||
127527022|NCT02737475|458891028|FG018|Overall Study|Lost to Follow-up|0|||
127527023|NCT02737475|458891029|FG019|Overall Study|Lost to Follow-up|0|||
127527024|NCT02737475|458891030|FG020|Overall Study|Lost to Follow-up|0|||
127527025|NCT02737475|458891031|FG021|Overall Study|Lost to Follow-up|0|||
127527026|NCT02737475|458891032|FG022|Overall Study|Lost to Follow-up|0|||
127527027|NCT02737475|458891033|FG023|Overall Study|Lost to Follow-up|0|||
127527028|NCT02737475|458891034|FG024|Overall Study|Lost to Follow-up|0|||
127527029|NCT02737475|458891035|FG025|Overall Study|Lost to Follow-up|0|||
127527030|NCT02737475|458891036|FG026|Overall Study|Lost to Follow-up|0|||
127527031|NCT02737475|458891010|FG000|Overall Study|Disease Progression|0|||
127527032|NCT02737475|458891011|FG001|Overall Study|Disease Progression|0|||
127527033|NCT02737475|458891012|FG002|Overall Study|Disease Progression|0|||
127527034|NCT02737475|458891013|FG003|Overall Study|Disease Progression|0|||
127527035|NCT02737475|458891014|FG004|Overall Study|Disease Progression|0|||
127527036|NCT02737475|458891015|FG005|Overall Study|Disease Progression|0|||
127527037|NCT02737475|458891016|FG006|Overall Study|Disease Progression|0|||
127527038|NCT02737475|458891017|FG007|Overall Study|Disease Progression|0|||
127527039|NCT02737475|458891018|FG008|Overall Study|Disease Progression|0|||
127527040|NCT02737475|458891019|FG009|Overall Study|Disease Progression|0|||
127527041|NCT02737475|458891020|FG010|Overall Study|Disease Progression|0|||
127527042|NCT02737475|458891021|FG011|Overall Study|Disease Progression|0|||
127527043|NCT02737475|458891022|FG012|Overall Study|Disease Progression|0|||
127527044|NCT02737475|458891023|FG013|Overall Study|Disease Progression|0|||
127527045|NCT02737475|458891024|FG014|Overall Study|Disease Progression|0|||
127527046|NCT02737475|458891025|FG015|Overall Study|Disease Progression|0|||
127527047|NCT02737475|458891026|FG016|Overall Study|Disease Progression|0|||
127527048|NCT02737475|458891027|FG017|Overall Study|Disease Progression|0|||
127527049|NCT02737475|458891028|FG018|Overall Study|Disease Progression|0|||
127527050|NCT02737475|458891029|FG019|Overall Study|Disease Progression|0|||
127527051|NCT02737475|458891030|FG020|Overall Study|Disease Progression|0|||
127527052|NCT02737475|458891031|FG021|Overall Study|Disease Progression|0|||
127527053|NCT02737475|458891032|FG022|Overall Study|Disease Progression|0|||
127527054|NCT02737475|458891033|FG023|Overall Study|Disease Progression|0|||
127527055|NCT02737475|458891034|FG024|Overall Study|Disease Progression|0|||
127527056|NCT02737475|458891035|FG025|Overall Study|Disease Progression|0|||
127527057|NCT02737475|458891036|FG026|Overall Study|Disease Progression|1|||
127527058|NCT00546000|458891037|FG000|Overall Study|Adverse Event|1|||
127527059|NCT00546000|458891037|FG000|Overall Study|Lost to Follow-up|1|||
127527060|NCT00546000|458891037|FG000|Overall Study|Baseline HPA Axis Supression|2|||
127527061|NCT02255461|458891038|FG000|Overall Study|Adverse Event|0|||
127527062|NCT02255461|458891039|FG001|Overall Study|Adverse Event|1|||
127527063|NCT02255461|458891040|FG002|Overall Study|Adverse Event|0|||
127527064|NCT02255461|458891041|FG003|Overall Study|Adverse Event|0|||
127527065|NCT02255461|458891042|FG004|Overall Study|Adverse Event|1|||
127527066|NCT02255461|458891038|FG000|Overall Study|Withdrawal by Subject|0|||
127527067|NCT02255461|458891039|FG001|Overall Study|Withdrawal by Subject|0|||
127527068|NCT02255461|458891040|FG002|Overall Study|Withdrawal by Subject|1|||
127527069|NCT02255461|458891041|FG003|Overall Study|Withdrawal by Subject|0|||
127527070|NCT02255461|458891042|FG004|Overall Study|Withdrawal by Subject|1|||
127527071|NCT02255461|458891038|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
127527072|NCT02255461|458891039|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
127527073|NCT02255461|458891040|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
127527074|NCT02255461|458891041|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
127527075|NCT02255461|458891042|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
127527076|NCT03056339|458891045|FG000|Overall Study|Failed Requirements|0|||
127527077|NCT03056339|458891046|FG001|Overall Study|Failed Requirements|2|||
127527078|NCT03056339|458891047|FG002|Overall Study|Failed Requirements|7|||
127527079|NCT03056339|458891048|FG003|Overall Study|Failed Requirements|1|||
127527080|NCT01504412|458891051|FG000|Overall Study|Adverse Event|1|||
127527081|NCT01504412|458891052|FG001|Overall Study|Adverse Event|8|||
127527082|NCT01504412|458891053|FG002|Overall Study|Adverse Event|1|||
127527083|NCT01504412|458891054|FG003|Overall Study|Adverse Event|7|||
127527084|NCT01504412|458891055|FG004|Overall Study|Adverse Event|10|||
127527085|NCT01504412|458891051|FG000|Overall Study|Withdrawal by Subject|2|||
127527086|NCT01504412|458891052|FG001|Overall Study|Withdrawal by Subject|1|||
127527087|NCT01504412|458891053|FG002|Overall Study|Withdrawal by Subject|1|||
127527088|NCT01504412|458891054|FG003|Overall Study|Withdrawal by Subject|5|||
127527089|NCT01504412|458891055|FG004|Overall Study|Withdrawal by Subject|1|||
127527090|NCT01504412|458891051|FG000|Overall Study|Other|2|||
127527091|NCT01504412|458891052|FG001|Overall Study|Other|1|||
127527092|NCT01504412|458891053|FG002|Overall Study|Other|1|||
127527093|NCT01504412|458891054|FG003|Overall Study|Other|6|||
127527094|NCT01504412|458891055|FG004|Overall Study|Other|1|||
127527095|NCT01504412|458891051|FG000|Overall Study|Lost to Follow-up|0|||
127527096|NCT01504412|458891052|FG001|Overall Study|Lost to Follow-up|2|||
127527097|NCT01504412|458891053|FG002|Overall Study|Lost to Follow-up|0|||
127527098|NCT01504412|458891054|FG003|Overall Study|Lost to Follow-up|0|||
127527099|NCT01504412|458891055|FG004|Overall Study|Lost to Follow-up|0|||
127527100|NCT01504412|458891051|FG000|Overall Study|Lack of Efficacy|0|||
127527101|NCT01504412|458891052|FG001|Overall Study|Lack of Efficacy|0|||
127527102|NCT01504412|458891053|FG002|Overall Study|Lack of Efficacy|1|||
127527103|NCT01504412|458891054|FG003|Overall Study|Lack of Efficacy|0|||
127527104|NCT01504412|458891055|FG004|Overall Study|Lack of Efficacy|1|||
127527105|NCT01504412|458891051|FG000|Overall Study|Death|0|||
127527106|NCT01504412|458891052|FG001|Overall Study|Death|0|||
127527107|NCT01504412|458891053|FG002|Overall Study|Death|0|||
127527108|NCT01504412|458891054|FG003|Overall Study|Death|1|||
127527109|NCT01504412|458891055|FG004|Overall Study|Death|0|||
127527110|NCT04171219|458891060|FG000|Overall Study|Adverse Event|1|||
127527111|NCT04171219|458891061|FG001|Overall Study|Adverse Event|0|||
127527112|NCT04171219|458891060|FG000|Overall Study|Death|0|||
127527113|NCT04171219|458891061|FG001|Overall Study|Death|1|||
127527114|NCT04171219|458891060|FG000|Overall Study|Lack of Efficacy|9|||
127527115|NCT04171219|458891061|FG001|Overall Study|Lack of Efficacy|13|||
127527116|NCT04171219|458891060|FG000|Overall Study|Withdrawal by Subject|1|||
127527117|NCT04171219|458891061|FG001|Overall Study|Withdrawal by Subject|2|||
127527118|NCT04171219|458891060|FG000|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
127527119|NCT04171219|458891061|FG001|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
127527120|NCT04171219|458891060|FG000|Overall Study|Clinical PD/Patient choice|1|||
127527121|NCT04171219|458891061|FG001|Overall Study|Clinical PD/Patient choice|0|||
127527122|NCT04171219|458891060|FG000|Overall Study|Toxicity/ Patient choice|1|||
127527123|NCT04171219|458891061|FG001|Overall Study|Toxicity/ Patient choice|0|||
127527124|NCT04809285|458891062|FG000|Phase 1|Lost to Follow-up|6|||
127527125|NCT04809285|458891062|FG000|Phase 1|Protocol Violation|2|||
127527126|NCT04809285|458891062|FG000|Phase 1|Physician Decision|3|||
127527127|NCT04809285|458891062|FG000|Phase 1|Withdrawal by Subject|29|||
127527128|NCT04809285|458891062|FG000|Phase 2|Protocol Violation|3|||
127527129|NCT04809285|458891062|FG000|Phase 2|Withdrawal by Subject|4|||
127868988|NCT05602818|460137448|FG006|Qualification Phase (3 Days)|Other|0|||
127868989|NCT05602818|460137449|FG007|Qualification Phase (3 Days)|Other|0|||
127868990|NCT05602818|460137450|FG008|Qualification Phase (3 Days)|Other|0|||
127868991|NCT05602818|460137451|FG009|Qualification Phase (3 Days)|Other|0|||
127868992|NCT05602818|460137452|FG010|Qualification Phase (3 Days)|Other|0|||
127527135|NCT01449006|458891068|FG000|Overall Study|Lost to Follow-up|1|||
127527136|NCT01449006|458891069|FG001|Overall Study|Lost to Follow-up|0|||
127527137|NCT01449006|458891068|FG000|Overall Study|Withdrawal by Subject|1|||
127527138|NCT01449006|458891069|FG001|Overall Study|Withdrawal by Subject|0|||
127527139|NCT01449006|458891068|FG000|Overall Study|Protocol Violation|1|||
127527140|NCT01449006|458891069|FG001|Overall Study|Protocol Violation|0|||
127527141|NCT03350815|458891070|FG000|Period 1|Adverse Event|10|||
127527142|NCT03350815|458891071|FG001|Period 1|Adverse Event|0|||
127527143|NCT03350815|458891072|FG002|Period 1|Adverse Event|0|||
127527144|NCT03350815|458891073|FG003|Period 1|Adverse Event|0|||
127527145|NCT03350815|458891070|FG000|Period 1|Technical problems|1|||
127527146|NCT03350815|458891071|FG001|Period 1|Technical problems|0|||
127527147|NCT03350815|458891072|FG002|Period 1|Technical problems|0|||
127527148|NCT03350815|458891073|FG003|Period 1|Technical problems|0|||
127527149|NCT03350815|458891070|FG000|Period 1|Lost to Follow-up|3|||
127527150|NCT03350815|458891071|FG001|Period 1|Lost to Follow-up|0|||
127527151|NCT03350815|458891072|FG002|Period 1|Lost to Follow-up|0|||
127527152|NCT03350815|458891073|FG003|Period 1|Lost to Follow-up|0|||
127527153|NCT03350815|458891070|FG000|Period 1|Physician Decision|1|||
127527154|NCT03350815|458891071|FG001|Period 1|Physician Decision|0|||
127527155|NCT03350815|458891072|FG002|Period 1|Physician Decision|0|||
127527156|NCT03350815|458891073|FG003|Period 1|Physician Decision|0|||
127527157|NCT03350815|458891070|FG000|Period 1|Withdrawal by Subject|8|||
127527158|NCT03350815|458891071|FG001|Period 1|Withdrawal by Subject|0|||
127527159|NCT03350815|458891072|FG002|Period 1|Withdrawal by Subject|0|||
127527160|NCT03350815|458891073|FG003|Period 1|Withdrawal by Subject|0|||
127527161|NCT03350815|458891070|FG000|Period 1|Lack of Efficacy|15|||
127527162|NCT03350815|458891071|FG001|Period 1|Lack of Efficacy|0|||
127527163|NCT03350815|458891072|FG002|Period 1|Lack of Efficacy|0|||
127527164|NCT03350815|458891073|FG003|Period 1|Lack of Efficacy|0|||
127527165|NCT03350815|458891070|FG000|Period 1|Non-compliance with study treatment|2|||
127527166|NCT03350815|458891071|FG001|Period 1|Non-compliance with study treatment|0|||
127527167|NCT03350815|458891072|FG002|Period 1|Non-compliance with study treatment|0|||
127527168|NCT03350815|458891073|FG003|Period 1|Non-compliance with study treatment|0|||
127527169|NCT03350815|458891070|FG000|Period 1|Protocol Violation|3|||
127527170|NCT03350815|458891071|FG001|Period 1|Protocol Violation|0|||
127527171|NCT03350815|458891072|FG002|Period 1|Protocol Violation|0|||
127527172|NCT03350815|458891073|FG003|Period 1|Protocol Violation|0|||
127527173|NCT03350815|458891070|FG000|Period 2|Adverse Event|0|||
127527174|NCT03350815|458891071|FG001|Period 2|Adverse Event|3|||
127527175|NCT03350815|458891072|FG002|Period 2|Adverse Event|5|||
127527176|NCT03350815|458891073|FG003|Period 2|Adverse Event|0|||
127527177|NCT03350815|458891070|FG000|Period 2|Technical problem|0|||
127527178|NCT03350815|458891071|FG001|Period 2|Technical problem|1|||
127527179|NCT03350815|458891072|FG002|Period 2|Technical problem|0|||
127527180|NCT03350815|458891073|FG003|Period 2|Technical problem|0|||
127527181|NCT03350815|458891070|FG000|Period 2|Lost to Follow-up|0|||
127527182|NCT03350815|458891071|FG001|Period 2|Lost to Follow-up|3|||
127527183|NCT03350815|458891072|FG002|Period 2|Lost to Follow-up|3|||
127527184|NCT03350815|458891073|FG003|Period 2|Lost to Follow-up|0|||
127527185|NCT03350815|458891070|FG000|Period 2|Physician Decision|0|||
127527186|NCT03350815|458891071|FG001|Period 2|Physician Decision|0|||
127527187|NCT03350815|458891072|FG002|Period 2|Physician Decision|1|||
127527188|NCT03350815|458891073|FG003|Period 2|Physician Decision|0|||
127527189|NCT03350815|458891070|FG000|Period 2|Withdrawal by Subject|0|||
127527190|NCT03350815|458891071|FG001|Period 2|Withdrawal by Subject|3|||
127527191|NCT03350815|458891072|FG002|Period 2|Withdrawal by Subject|4|||
127527192|NCT03350815|458891073|FG003|Period 2|Withdrawal by Subject|0|||
127527193|NCT03350815|458891070|FG000|Period 2|Lack of Efficacy|0|||
127527194|NCT03350815|458891071|FG001|Period 2|Lack of Efficacy|6|||
127527195|NCT03350815|458891072|FG002|Period 2|Lack of Efficacy|2|||
127527196|NCT03350815|458891073|FG003|Period 2|Lack of Efficacy|0|||
127527197|NCT03350815|458891070|FG000|Period 2|Protocol Violation|0|||
127527198|NCT03350815|458891071|FG001|Period 2|Protocol Violation|0|||
127527199|NCT03350815|458891072|FG002|Period 2|Protocol Violation|1|||
127527200|NCT03350815|458891073|FG003|Period 2|Protocol Violation|0|||
127527201|NCT03350815|458891070|FG000|Period 2|New therapy for study indication|0|||
127527202|NCT03350815|458891071|FG001|Period 2|New therapy for study indication|0|||
127527203|NCT03350815|458891072|FG002|Period 2|New therapy for study indication|1|||
127527204|NCT03350815|458891073|FG003|Period 2|New therapy for study indication|0|||
127527205|NCT03040674|458891078|FG000|Overall Study|Lost to Follow-up|225|||
127527206|NCT03040674|458891078|FG000|Overall Study|Death|23|||
127527207|NCT02936843|458891079|FG000|Overall Study|Lost to Follow-up|3|||
127527208|NCT02936843|458891080|FG001|Overall Study|Lost to Follow-up|1|||
127527209|NCT02936843|458891079|FG000|Overall Study|Withdrawal by Subject|1|||
127527210|NCT02936843|458891080|FG001|Overall Study|Withdrawal by Subject|1|||
127527211|NCT03386487|458891081|FG000|Overall Study|Lost to Follow-up|5|||
127527212|NCT03386487|458891082|FG001|Overall Study|Lost to Follow-up|6|||
127527213|NCT03386487|458891081|FG000|Overall Study|Withdrawal by Subject|11|||
127527214|NCT03386487|458891082|FG001|Overall Study|Withdrawal by Subject|7|||
127527215|NCT03386487|458891081|FG000|Overall Study|Physician Decision|11|||
127527216|NCT03386487|458891082|FG001|Overall Study|Physician Decision|8|||
127527217|NCT02703324|458891083|FG000|Period Two|Withdrawal by Subject|0|||
127527218|NCT02703324|458891084|FG001|Period Two|Withdrawal by Subject|0|||
127527219|NCT02703324|458891085|FG002|Period Two|Withdrawal by Subject|1|||
127527220|NCT02703324|458891086|FG003|Period Two|Withdrawal by Subject|0|||
127527221|NCT02703324|458891087|FG004|Period Two|Withdrawal by Subject|0|||
127527222|NCT02703324|458891088|FG005|Period Two|Withdrawal by Subject|0|||
127527223|NCT04303572|458891089|FG000|Overall Study|Study closed due to poor enrollment|1|||
127527224|NCT06312592|458891090|FG000|Overall Study|Lost to Follow-up|29|||
127527225|NCT06312592|458891091|FG001|Overall Study|Lost to Follow-up|13|||
127527226|NCT01979952|458891092|FG000|Overall Study|Adverse Event|4|||
127527227|NCT01979952|458891093|FG001|Overall Study|Adverse Event|5|||
127527228|NCT01979952|458891092|FG000|Overall Study|Protocol Violation|1|||
127527229|NCT01979952|458891093|FG001|Overall Study|Protocol Violation|0|||
127527230|NCT01979952|458891092|FG000|Overall Study|Withdrawal by Subject|2|||
127527231|NCT01979952|458891093|FG001|Overall Study|Withdrawal by Subject|1|||
127527232|NCT01979952|458891092|FG000|Overall Study|Other than specified above|1|||
127527233|NCT01979952|458891093|FG001|Overall Study|Other than specified above|0|||
127527234|NCT05438576|458891094|FG000|Overall Study|Death|1|||
127527235|NCT05438576|458891095|FG001|Overall Study|Death|1|||
127527236|NCT05438576|458891094|FG000|Overall Study|Withdrawal by Subject|4|||
127527237|NCT05438576|458891095|FG001|Overall Study|Withdrawal by Subject|2|||
127527238|NCT05438576|458891094|FG000|Overall Study|Not Eligible|2|||
127527239|NCT05438576|458891095|FG001|Overall Study|Not Eligible|1|||
127527240|NCT05438576|458891094|FG000|Overall Study|Did not complete baseline testing|22|||
127527241|NCT05438576|458891095|FG001|Overall Study|Did not complete baseline testing|4|||
127527242|NCT01067144|458891101|FG000|Treatment|Did not receive allocated intervention|4|||
127527243|NCT01067144|458891102|FG001|Treatment|Did not receive allocated intervention|7|||
127527244|NCT01067144|458891101|FG000|Follow-up|Lost to Follow-up|22|||
127527245|NCT01067144|458891102|FG001|Follow-up|Lost to Follow-up|12|||
127527246|NCT01067144|458891101|FG000|Follow-up|Censored owing to second surgery|19|||
127527247|NCT01067144|458891102|FG001|Follow-up|Censored owing to second surgery|28|||
127527248|NCT01067144|458891101|FG000|Follow-up|Withdrawal by Subject|18|||
127527249|NCT01067144|458891102|FG001|Follow-up|Withdrawal by Subject|14|||
127527250|NCT01067144|458891101|FG000|Follow-up|Surgery cancelled|0|||
127527251|NCT01067144|458891102|FG001|Follow-up|Surgery cancelled|1|||
127527252|NCT01067144|458891101|FG000|Follow-up|Death|0|||
127527253|NCT01067144|458891102|FG001|Follow-up|Death|1|||
127527254|NCT00475709|458891103|FG000|Overall Study|Did not meet eligibility criteria|8|||
127527255|NCT00475709|458891103|FG000|Overall Study|Death|41|||
127527256|NCT00475709|458891103|FG000|Overall Study|Device Explant|6|||
127527257|NCT00475709|458891103|FG000|Overall Study|Lost to Follow-up|21|||
127527258|NCT00555672|458891104|FG000|Overall Study|Death|0|||
127527259|NCT00555672|458891105|FG001|Overall Study|Death|2|||
127527260|NCT00555672|458891104|FG000|Overall Study|Adverse Event|8|||
127527261|NCT00555672|458891105|FG001|Overall Study|Adverse Event|2|||
127527262|NCT00555672|458891104|FG000|Overall Study|Objective progression or relapse|11|||
127527263|NCT00555672|458891105|FG001|Overall Study|Objective progression or relapse|5|||
127527264|NCT00555672|458891104|FG000|Overall Study|Other|3|||
127527265|NCT00555672|458891105|FG001|Overall Study|Other|1|||
127527266|NCT00555672|458891104|FG000|Overall Study|Participant refused|2|||
127527267|NCT00555672|458891105|FG001|Overall Study|Participant refused|0|||
127527268|NCT01415401|458891110|FG000|Overall Study|Adverse Event|5|||
127527269|NCT01415401|458891110|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
127527270|NCT01415401|458891110|FG000|Overall Study|Terminated by Sponsor|1|||
127527271|NCT04765202|458891124|FG000|Overall Study|Lost to Follow-up|1|||
127527272|NCT04765202|458891125|FG001|Overall Study|Lost to Follow-up|1|||
127527273|NCT04765202|458891126|FG002|Overall Study|Lost to Follow-up|2|||
127527274|NCT04765202|458891127|FG003|Overall Study|Lost to Follow-up|2|||
127527275|NCT04765202|458891124|FG000|Overall Study|Physician Decision|0|||
127527276|NCT04765202|458891125|FG001|Overall Study|Physician Decision|0|||
127527277|NCT04765202|458891126|FG002|Overall Study|Physician Decision|1|||
127527278|NCT04765202|458891127|FG003|Overall Study|Physician Decision|1|||
127527279|NCT02305238|458891129|FG000|Overall Study|Death|2|||
127527280|NCT02305238|458891130|FG001|Overall Study|Death|1|||
127527281|NCT02305238|458891131|FG002|Overall Study|Death|0|||
127527282|NCT02305238|458891129|FG000|Overall Study|Progressive disease|4|||
127527283|NCT02305238|458891130|FG001|Overall Study|Progressive disease|4|||
127527284|NCT02305238|458891131|FG002|Overall Study|Progressive disease|0|||
127527285|NCT02305238|458891129|FG000|Overall Study|Logistical difficulties|1|||
127527286|NCT02305238|458891130|FG001|Overall Study|Logistical difficulties|3|||
127527287|NCT02305238|458891131|FG002|Overall Study|Logistical difficulties|0|||
127527288|NCT02305238|458891129|FG000|Overall Study|Protocol Violation|0|||
127527289|NCT02305238|458891130|FG001|Overall Study|Protocol Violation|3|||
127527290|NCT02305238|458891131|FG002|Overall Study|Protocol Violation|0|||
127527291|NCT02305238|458891129|FG000|Overall Study|Physician Decision|2|||
127527292|NCT02305238|458891130|FG001|Overall Study|Physician Decision|1|||
127527293|NCT02305238|458891131|FG002|Overall Study|Physician Decision|0|||
127527294|NCT02305238|458891129|FG000|Overall Study|Adverse Event|4|||
127527295|NCT02305238|458891130|FG001|Overall Study|Adverse Event|2|||
127527296|NCT02305238|458891131|FG002|Overall Study|Adverse Event|0|||
127527297|NCT02305238|458891129|FG000|Overall Study|Withdrawal by Subject|3|||
127527298|NCT02305238|458891130|FG001|Overall Study|Withdrawal by Subject|4|||
127527299|NCT02305238|458891131|FG002|Overall Study|Withdrawal by Subject|0|||
127527300|NCT02305238|458891129|FG000|Overall Study|Randomized failure|0|||
127527301|NCT02305238|458891130|FG001|Overall Study|Randomized failure|0|||
127527302|NCT02305238|458891131|FG002|Overall Study|Randomized failure|8|||
127527303|NCT02305238|458891129|FG000|Overall Study|Required procedure failed|0|||
127527304|NCT02305238|458891130|FG001|Overall Study|Required procedure failed|1|||
127527305|NCT02305238|458891131|FG002|Overall Study|Required procedure failed|0|||
127527306|NCT01019369|458891132|FG000|Overall Study|Lost to Follow-up|10|||
127527307|NCT01019369|458891133|FG001|Overall Study|Lost to Follow-up|6|||
127527308|NCT01019369|458891132|FG000|Overall Study|Withdrawal by Subject|0|||
127527309|NCT01019369|458891133|FG001|Overall Study|Withdrawal by Subject|1|||
127527310|NCT02513472|458891134|FG000|Overall Study|Radiological Disease Progression|45|||
127527311|NCT02513472|458891135|FG001|Overall Study|Radiological Disease Progression|57|||
127527312|NCT02513472|458891134|FG000|Overall Study|Clinical Disease Progression|5|||
127527313|NCT02513472|458891135|FG001|Overall Study|Clinical Disease Progression|13|||
127527314|NCT02513472|458891134|FG000|Overall Study|Adverse Event|8|||
127527315|NCT02513472|458891135|FG001|Overall Study|Adverse Event|11|||
127527316|NCT02513472|458891134|FG000|Overall Study|Withdrawal by Subject|0|||
127527317|NCT02513472|458891135|FG001|Overall Study|Withdrawal by Subject|4|||
127527318|NCT02513472|458891134|FG000|Overall Study|Subject Choice|2|||
127527319|NCT02513472|458891135|FG001|Overall Study|Subject Choice|7|||
127527320|NCT02513472|458891134|FG000|Overall Study|Treatment Completed as per Protocol|3|||
127527321|NCT02513472|458891135|FG001|Overall Study|Treatment Completed as per Protocol|3|||
127527322|NCT02513472|458891134|FG000|Overall Study|Other|3|||
127527323|NCT02513472|458891135|FG001|Overall Study|Other|6|||
127527324|NCT01380834|458891136|FG000|Overall Study|Physician Decision|1|||
127527325|NCT01380834|458891137|FG001|Overall Study|Physician Decision|0|||
127527326|NCT04310566|458891138|FG000|Period 1|Study Termination due to COVID-19|15|||
127527327|NCT04310566|458891139|FG001|Period 1|Study Termination due to COVID-19|17|||
127527328|NCT04310566|458891138|FG000|Period 1|Protocol Violation|0|||
127527329|NCT04310566|458891139|FG001|Period 1|Protocol Violation|1|||
127527330|NCT04310566|458891138|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
127527331|NCT04310566|458891139|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
127527332|NCT04310566|458891138|FG000|Period 1|Lost to Follow-up|1|||
127527333|NCT04310566|458891139|FG001|Period 1|Lost to Follow-up|0|||
127527334|NCT04310566|458891138|FG000|Period 1|Withdrawal by Subject|0|||
127527335|NCT04310566|458891139|FG001|Period 1|Withdrawal by Subject|1|||
127527336|NCT04310566|458891138|FG000|Period 2|Study Termination|7|||
127527337|NCT04310566|458891139|FG001|Period 2|Study Termination|5|||
127527338|NCT04565951|458891140|FG000|Overall Study|Lost to Follow-up|66|||
127527339|NCT04565951|458891141|FG001|Overall Study|Lost to Follow-up|38|||
127527340|NCT04565951|458891140|FG000|Overall Study|Withdrawal by Subject|14|||
127527341|NCT04565951|458891141|FG001|Overall Study|Withdrawal by Subject|7|||
127527342|NCT04565951|458891140|FG000|Overall Study|Death|0|||
127527343|NCT04565951|458891141|FG001|Overall Study|Death|1|||
127527344|NCT04677504|458891143|FG000|Overall Study|Death|51|||
127527345|NCT04677504|458891144|FG001|Overall Study|Death|49|||
127527346|NCT04677504|458891143|FG000|Overall Study|Progressive Disease|1|||
127527347|NCT04677504|458891144|FG001|Overall Study|Progressive Disease|0|||
127527348|NCT04677504|458891143|FG000|Overall Study|Symptomatic Deterioration|1|||
127527349|NCT04677504|458891144|FG001|Overall Study|Symptomatic Deterioration|0|||
127527350|NCT04677504|458891143|FG000|Overall Study|Withdrawal by Subject|2|||
127527351|NCT04677504|458891144|FG001|Overall Study|Withdrawal by Subject|5|||
127527352|NCT04677504|458891143|FG000|Overall Study|Study Terminated By Sponsor|28|||
127527353|NCT04677504|458891144|FG001|Overall Study|Study Terminated By Sponsor|24|||
127527354|NCT04677504|458891143|FG000|Overall Study|Adverse Event|0|||
127527355|NCT04677504|458891144|FG001|Overall Study|Adverse Event|1|||
127527356|NCT01711645|458891152|FG000|Overall Study|Withdrawal by Subject|8|||
127527357|NCT01711645|458891152|FG000|Overall Study|Lost to Follow-up|6|||
127527358|NCT01711645|458891152|FG000|Overall Study|Physician Decision|5|||
127527359|NCT01746173|458891158|FG000|Overall Study|Disease Progression|2|||
127527360|NCT01371552|458891160|FG000|Part 1, First 3 Days|Inconvenience|0|||
127527361|NCT01371552|458891161|FG001|Part 1, First 3 Days|Inconvenience|0|||
127527362|NCT01371552|458891162|FG002|Part 1, First 3 Days|Inconvenience|1|||
127527363|NCT01371552|458891163|FG003|Part 1, First 3 Days|Inconvenience|0|||
127527364|NCT01371552|458891164|FG004|Part 1, First 3 Days|Inconvenience|0|||
127527365|NCT01371552|458891165|FG005|Part 1, First 3 Days|Inconvenience|0|||
127527366|NCT01016600|458892687|FG000|Overall Study|Did not start treatment|1|||
127527367|NCT01016600|458892688|FG001|Overall Study|Did not start treatment|0|||
127527368|NCT01016600|458892689|FG002|Overall Study|Did not start treatment|0|||
127527369|NCT01016600|458892690|FG003|Overall Study|Did not start treatment|0|||
127527370|NCT00872599|458892691|FG000|Second Washout Period|Adverse Event|1|||
127527371|NCT00872599|458892692|FG001|Second Washout Period|Adverse Event|1|||
127527372|NCT02679755|458892693|FG000|Overall Study|Death|0|||
127527373|NCT02679755|458892694|FG001|Overall Study|Death|3|||
127527374|NCT02679755|458892693|FG000|Overall Study|Global deterioration of health status|1|||
127527375|NCT02679755|458892694|FG001|Overall Study|Global deterioration of health status|8|||
127527376|NCT02679755|458892693|FG000|Overall Study|Lost to Follow-up|1|||
127527377|NCT02679755|458892694|FG001|Overall Study|Lost to Follow-up|0|||
127527378|NCT02679755|458892693|FG000|Overall Study|Objective progression or relapse|24|||
127527379|NCT02679755|458892694|FG001|Overall Study|Objective progression or relapse|83|||
127527380|NCT02679755|458892693|FG000|Overall Study|Not defined|0|||
127527381|NCT02679755|458892694|FG001|Overall Study|Not defined|2|||
127527382|NCT02679755|458892693|FG000|Overall Study|Withdrawal by participant|6|||
127527383|NCT02679755|458892694|FG001|Overall Study|Withdrawal by participant|3|||
127527384|NCT02679755|458892693|FG000|Overall Study|Adverse Event|1|||
127527385|NCT02679755|458892694|FG001|Overall Study|Adverse Event|4|||
127527386|NCT02679755|458892693|FG000|Overall Study|Adverse events not related to study drug|1|||
127527387|NCT02679755|458892694|FG001|Overall Study|Adverse events not related to study drug|2|||
127527388|NCT00801229|458892695|FG000|Signed Consent|Withdrawal by Subject|2|||
127527389|NCT00801229|458892696|FG001|Signed Consent|Withdrawal by Subject|2|||
127527390|NCT00801229|458892695|FG000|Signed Consent|Found Ineligible|1|||
127527391|NCT00801229|458892696|FG001|Signed Consent|Found Ineligible|1|||
127527392|NCT00801229|458892695|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
127527393|NCT00801229|458892696|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
127527394|NCT00801229|458892695|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
127527395|NCT00801229|458892696|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
127527396|NCT00801229|458892695|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
127527397|NCT00801229|458892696|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
127527398|NCT00801229|458892695|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
127527399|NCT00801229|458892696|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
127527400|NCT00801229|458892695|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
127527401|NCT00801229|458892696|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
127527402|NCT00801229|458892695|FG000|Received Study Drug/Placebo|Adverse Event|1|||
127527403|NCT00801229|458892696|FG001|Received Study Drug/Placebo|Adverse Event|1|||
127527404|NCT00660179|458892700|FG000|Overall Study|Death|44|||
127527405|NCT00660179|458892701|FG001|Overall Study|Death|47|||
127527406|NCT00660179|458892702|FG002|Overall Study|Death|34|||
127527407|NCT00660179|458892700|FG000|Overall Study|Withdrawal of consent|4|||
127527408|NCT00660179|458892701|FG001|Overall Study|Withdrawal of consent|6|||
127527409|NCT00660179|458892702|FG002|Overall Study|Withdrawal of consent|4|||
127527410|NCT00660179|458892700|FG000|Overall Study|Lost to Follow-up|7|||
127527411|NCT00660179|458892701|FG001|Overall Study|Lost to Follow-up|5|||
127527412|NCT00660179|458892702|FG002|Overall Study|Lost to Follow-up|2|||
127527413|NCT00660179|458892700|FG000|Overall Study|Administrative reason|0|||
127527414|NCT00660179|458892701|FG001|Overall Study|Administrative reason|0|||
127527415|NCT00660179|458892702|FG002|Overall Study|Administrative reason|1|||
127527416|NCT00660179|458892700|FG000|Overall Study|Incorrect randomization|1|||
127527417|NCT00660179|458892701|FG001|Overall Study|Incorrect randomization|0|||
127527418|NCT00660179|458892702|FG002|Overall Study|Incorrect randomization|0|||
127527419|NCT02974257|458892703|FG000|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|1|||
127527420|NCT02974257|458892704|FG001|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|0|||
127527421|NCT02974257|458892703|FG000|Overall Study|Clinical indication for thiamine|1|||
127527422|NCT02974257|458892704|FG001|Overall Study|Clinical indication for thiamine|0|||
127527423|NCT02974257|458892703|FG000|Overall Study|Already on thiamine|1|||
127527424|NCT02974257|458892704|FG001|Overall Study|Already on thiamine|0|||
127527425|NCT02974257|458892703|FG000|Overall Study|Extubated prior to study drug|0|||
127527426|NCT02974257|458892704|FG001|Overall Study|Extubated prior to study drug|1|||
127527427|NCT02974257|458892703|FG000|Overall Study|Death|0|||
127527428|NCT02974257|458892704|FG001|Overall Study|Death|1|||
127527429|NCT00398567|458892705|FG000|Overall Study|Disease Progression|3|||
127527430|NCT00398567|458892706|FG001|Overall Study|Disease Progression|4|||
127527431|NCT00398567|458892707|FG002|Overall Study|Disease Progression|27|||
127527432|NCT00398567|458892705|FG000|Overall Study|Withdrawal by Subject|1|||
127527433|NCT00398567|458892706|FG001|Overall Study|Withdrawal by Subject|0|||
127527434|NCT00398567|458892707|FG002|Overall Study|Withdrawal by Subject|4|||
127527435|NCT00398567|458892705|FG000|Overall Study|Adverse Event|0|||
127527436|NCT00398567|458892706|FG001|Overall Study|Adverse Event|0|||
127527437|NCT00398567|458892707|FG002|Overall Study|Adverse Event|2|||
127527438|NCT00398567|458892705|FG000|Overall Study|Protocol Violation|0|||
127527439|NCT00398567|458892706|FG001|Overall Study|Protocol Violation|0|||
127527440|NCT00398567|458892707|FG002|Overall Study|Protocol Violation|1|||
127527441|NCT02837029|458892708|FG000|Screening|Failed to meet screening requirements.|7|||
127527442|NCT02837029|458892709|FG001|Screening|Failed to meet screening requirements.|3|||
127527443|NCT02837029|458892710|FG002|Screening|Failed to meet screening requirements.|0|||
127527444|NCT02837029|458892708|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
127527445|NCT02837029|458892709|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
127527446|NCT02837029|458892710|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
127527447|NCT02837029|458892708|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
127527448|NCT02837029|458892709|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
127527449|NCT02837029|458892710|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
127527450|NCT02837029|458892708|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
127527451|NCT02837029|458892709|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
127527452|NCT02837029|458892710|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
127527453|NCT02837029|458892708|FG000|Cycle 2 and Beyond|Adverse Event|1|||
127527454|NCT02837029|458892709|FG001|Cycle 2 and Beyond|Adverse Event|0|||
127527455|NCT02837029|458892710|FG002|Cycle 2 and Beyond|Adverse Event|0|||
127527456|NCT02837029|458892708|FG000|2 Year Follow-up|Death|6|||
127527457|NCT02837029|458892709|FG001|2 Year Follow-up|Death|7|||
127527458|NCT02837029|458892710|FG002|2 Year Follow-up|Death|0|||
127527459|NCT02034877|458892711|FG000|Overall Study|Lost to Follow-up|0|||
127527460|NCT02034877|458892712|FG001|Overall Study|Lost to Follow-up|3|||
127527461|NCT02034877|458892711|FG000|Overall Study|No Longer Willing to Participate|0|||
127527462|NCT02034877|458892712|FG001|Overall Study|No Longer Willing to Participate|3|||
127527463|NCT03906071|458892715|FG000|Overall Study|Death|180|||
127527464|NCT03906071|458892716|FG001|Overall Study|Death|185|||
127527465|NCT03906071|458892715|FG000|Overall Study|Lost to Follow-up|3|||
127527466|NCT03906071|458892716|FG001|Overall Study|Lost to Follow-up|3|||
127527467|NCT03906071|458892715|FG000|Overall Study|Withdrawal by Subject|15|||
127527468|NCT03906071|458892716|FG001|Overall Study|Withdrawal by Subject|27|||
127527469|NCT03906071|458892715|FG000|Overall Study|Other|2|||
127527470|NCT03906071|458892716|FG001|Overall Study|Other|1|||
127527471|NCT01564732|458892728|FG000|Overall Study|Early termination by the study sponsor|6|||
127527472|NCT01564732|458892729|FG001|Overall Study|Early termination by the study sponsor|5|||
127527473|NCT01036321|458892732|FG000|Overall Study|Ineligible after randomization|0|||
127527474|NCT01036321|458892733|FG001|Overall Study|Ineligible after randomization|1|||
127527475|NCT01036321|458892732|FG000|Overall Study|Withdrawal by Subject|3|||
127527476|NCT01036321|458892733|FG001|Overall Study|Withdrawal by Subject|2|||
127527477|NCT01036321|458892732|FG000|Overall Study|Adverse Event|2|||
127527478|NCT01036321|458892733|FG001|Overall Study|Adverse Event|1|||
127527479|NCT00381693|458892736|FG000|Overall Study|Death|1|||
127527480|NCT00381693|458892736|FG000|Overall Study|Adverse Event|4|||
127527481|NCT00381693|458892736|FG000|Overall Study|Patient Choice|1|||
127527482|NCT00381693|458892736|FG000|Overall Study|Progression|2|||
127527483|NCT02598297|458892737|FG000|Overall Study|Study terminated by Sponsor|21|||
127527484|NCT02598297|458892738|FG001|Overall Study|Study terminated by Sponsor|23|||
127527485|NCT02598297|458892737|FG000|Overall Study|Adverse Event|1|||
127527486|NCT02598297|458892738|FG001|Overall Study|Adverse Event|1|||
127527487|NCT02598297|458892737|FG000|Overall Study|Physician Decision|1|||
127527488|NCT02598297|458892738|FG001|Overall Study|Physician Decision|0|||
127527489|NCT02598297|458892737|FG000|Overall Study|Subject/guardian decision|1|||
127527490|NCT02598297|458892738|FG001|Overall Study|Subject/guardian decision|0|||
127527491|NCT02598297|458892737|FG000|Overall Study|Followed for survival|1|||
127527492|NCT02598297|458892738|FG001|Overall Study|Followed for survival|0|||
127527493|NCT00394706|458892749|FG000|Overall Study|Withdrawal by Subject|2|||
127527494|NCT00394706|458892750|FG001|Overall Study|Withdrawal by Subject|0|||
127527495|NCT00394706|458892751|FG002|Overall Study|Withdrawal by Subject|1|||
127527496|NCT00394706|458892752|FG003|Overall Study|Withdrawal by Subject|0|||
127527497|NCT00394706|458892753|FG004|Overall Study|Withdrawal by Subject|0|||
127527498|NCT00394706|458892754|FG005|Overall Study|Withdrawal by Subject|2|||
127527499|NCT00394706|458892755|FG006|Overall Study|Withdrawal by Subject|1|||
127527500|NCT00394706|458892756|FG007|Overall Study|Withdrawal by Subject|0|||
127527501|NCT00394706|458892749|FG000|Overall Study|Lost to Follow-up|2|||
127527502|NCT00394706|458892750|FG001|Overall Study|Lost to Follow-up|2|||
127527503|NCT00394706|458892751|FG002|Overall Study|Lost to Follow-up|8|||
127527504|NCT00394706|458892752|FG003|Overall Study|Lost to Follow-up|1|||
127527505|NCT00394706|458892753|FG004|Overall Study|Lost to Follow-up|2|||
127527506|NCT00394706|458892754|FG005|Overall Study|Lost to Follow-up|5|||
127527507|NCT00394706|458892755|FG006|Overall Study|Lost to Follow-up|2|||
127527508|NCT00394706|458892756|FG007|Overall Study|Lost to Follow-up|0|||
127527509|NCT02003534|458892759|FG000|Overall Study|Lost to Follow-up|47|||
127527510|NCT02506192|458892762|FG000|Overall Study|Withdrawal by Subject|1|||
127527511|NCT02506192|458892763|FG001|Overall Study|Withdrawal by Subject|1|||
127527512|NCT05292131|458892764|FG000|Overall Study|Lost to Follow-up|1|||
127527513|NCT05292131|458892765|FG001|Overall Study|Lost to Follow-up|1|||
127527514|NCT05292131|458892764|FG000|Overall Study|Withdrawal by Subject|0|||
127527515|NCT05292131|458892765|FG001|Overall Study|Withdrawal by Subject|1|||
127527516|NCT02557542|458892767|FG000|Overall Study|Poor recruitment|3|||
127527517|NCT02557542|458892768|FG001|Overall Study|Poor recruitment|0|||
127527518|NCT06136897|458892769|FG000|Overall Study|Ineligible|3|||
127527519|NCT06136897|458892769|FG000|Overall Study|Mutation status not confirmed|7|||
127527520|NCT06136897|458892769|FG000|Overall Study|Adverse Event|2|||
127527521|NCT06136897|458892769|FG000|Overall Study|Death|1|||
127527522|NCT06136897|458892769|FG000|Overall Study|Disease progression|18|||
127527523|NCT06136897|458892769|FG000|Overall Study|Other complicating disease|1|||
127527524|NCT06136897|458892769|FG000|Overall Study|Withdrawal by Subject|1|||
127527525|NCT06136897|458892769|FG000|Overall Study|Still on treatment|1|||
127527526|NCT06136897|458892769|FG000|Overall Study|Lost to Follow-up|1|||
127527527|NCT03705559|458892770|FG000|Overall Study|COVID Shut down|1|||
127527528|NCT00203424|458892772|FG000|Treatment Period|Withdrawal by Subject|4|||
127527529|NCT00203424|458892772|FG000|Treatment Period|Adverse Event|5|||
127527530|NCT00203424|458892772|FG000|Treatment Period|progressive disease|2|||
127527531|NCT00203424|458892772|FG000|Follow-up Period|Withdrawal by Subject|1|||
127527532|NCT00203424|458892772|FG000|Follow-up Period|progressive disease|4|||
127527533|NCT00203424|458892772|FG000|Follow-up Period|Lost to Follow-up|1|||
127527534|NCT01053988|458892773|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
127527535|NCT01053988|458892774|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
127527536|NCT01053988|458892775|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
127527537|NCT01053988|458892776|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
127527538|NCT01053988|458892777|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
127527539|NCT01053988|458892778|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
127527540|NCT01053988|458892773|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
127527541|NCT01053988|458892774|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
127527542|NCT01053988|458892775|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
127527543|NCT01053988|458892776|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
127527544|NCT01053988|458892777|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
127527545|NCT01053988|458892778|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
127527546|NCT01053988|458892773|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
127527547|NCT01053988|458892774|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
127527548|NCT01053988|458892775|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
127527549|NCT01053988|458892776|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
127527550|NCT01053988|458892777|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
127527551|NCT01053988|458892778|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
127527552|NCT01053988|458892773|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
127527553|NCT01053988|458892774|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
127527554|NCT01053988|458892775|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
127527555|NCT01053988|458892776|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
127527556|NCT01053988|458892777|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
127527557|NCT01053988|458892778|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
127527558|NCT01053988|458892773|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
127527559|NCT01053988|458892774|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
127527560|NCT01053988|458892775|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
127527561|NCT01053988|458892776|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
127527562|NCT01053988|458892777|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
127527563|NCT01053988|458892778|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
127527564|NCT01053988|458892773|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
127527565|NCT01053988|458892774|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
127527566|NCT01053988|458892775|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
127527567|NCT01053988|458892776|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
127527568|NCT01053988|458892777|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
127527569|NCT01053988|458892778|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
127527570|NCT01053988|458892773|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
127527571|NCT01053988|458892774|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
127527572|NCT01053988|458892775|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
127527573|NCT01053988|458892776|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
127527574|NCT01053988|458892777|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
127527575|NCT01053988|458892778|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
127527576|NCT01053988|458892773|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
127527577|NCT01053988|458892774|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
127527578|NCT01053988|458892775|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
127527579|NCT01053988|458892776|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
127527580|NCT01053988|458892777|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
127527581|NCT01053988|458892778|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
127527582|NCT01053988|458892773|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
127527583|NCT01053988|458892774|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
127527584|NCT01053988|458892775|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
127527585|NCT01053988|458892776|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
127527586|NCT01053988|458892777|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
127527587|NCT01053988|458892778|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
127527588|NCT01053988|458892773|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
127527589|NCT01053988|458892774|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
127527590|NCT01053988|458892775|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
127527591|NCT01053988|458892776|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
127527592|NCT01053988|458892777|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
127527593|NCT01053988|458892778|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
127527594|NCT01053988|458892773|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
127527595|NCT01053988|458892774|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
127527596|NCT01053988|458892775|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
127527597|NCT01053988|458892776|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
127527598|NCT01053988|458892777|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
127527599|NCT01053988|458892778|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
127527600|NCT01053988|458892773|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
127527601|NCT01053988|458892774|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
127527602|NCT01053988|458892775|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
127527603|NCT01053988|458892776|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
127527604|NCT01053988|458892777|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
127527605|NCT01053988|458892778|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
127527606|NCT01053988|458892773|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
127527607|NCT01053988|458892774|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
127527608|NCT01053988|458892775|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
127527609|NCT01053988|458892776|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
127527610|NCT01053988|458892777|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
127527611|NCT01053988|458892778|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
127527612|NCT01053988|458892773|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
127527613|NCT01053988|458892774|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
127527614|NCT01053988|458892775|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
127527615|NCT01053988|458892776|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
127527616|NCT01053988|458892777|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
127527617|NCT01053988|458892778|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
127527618|NCT01824355|458892779|FG000|Overall Study|Adverse Event|2|||
127527619|NCT01824355|458892779|FG000|Overall Study|unevaluable reference method results per|1|||
127527620|NCT02576795|458892781|FG000|Overall Study|Lost to Follow-up|0|||
127527621|NCT02576795|458892782|FG001|Overall Study|Lost to Follow-up|0|||
127527622|NCT02576795|458892783|FG002|Overall Study|Lost to Follow-up|1|||
127527623|NCT02576795|458892784|FG003|Overall Study|Lost to Follow-up|0|||
127527624|NCT04427072|458892785|FG000|Randomized Treatment Phase|Progressive disease|9|||
127527625|NCT04427072|458892786|FG001|Randomized Treatment Phase|Progressive disease|4|||
127527626|NCT04427072|458892785|FG000|Randomized Treatment Phase|Adverse Event|3|||
127527627|NCT04427072|458892786|FG001|Randomized Treatment Phase|Adverse Event|1|||
127527628|NCT04427072|458892785|FG000|Randomized Treatment Phase|Study terminated by sponsor|3|||
127527629|NCT04427072|458892786|FG001|Randomized Treatment Phase|Study terminated by sponsor|0|||
127527630|NCT04427072|458892785|FG000|Randomized Treatment Phase|Death|0|||
127527631|NCT04427072|458892786|FG001|Randomized Treatment Phase|Death|1|||
127527632|NCT04427072|458892785|FG000|Randomized Treatment Phase|Not treated (participant decision)|0|||
127527633|NCT04427072|458892786|FG001|Randomized Treatment Phase|Not treated (participant decision)|1|||
127527634|NCT04427072|458892785|FG000|Extension Treatment Phase|Progressive disease|0|||
127527635|NCT04427072|458892786|FG001|Extension Treatment Phase|Progressive disease|5|||
127527636|NCT05232864|458892787|FG000|Overall Study|Adverse Event|0|||
127527637|NCT05232864|458892788|FG001|Overall Study|Adverse Event|1|||
127527638|NCT05232864|458892787|FG000|Overall Study|Study terminated by sponsor|16|||
127527639|NCT05232864|458892788|FG001|Overall Study|Study terminated by sponsor|14|||
127527640|NCT00465452|458892792|FG000|Overall Study|Adverse Event|1|||
127527641|NCT02104947|458892798|FG000|Overall Study|Withdrawal by Subject|10|||
127527642|NCT02104947|458892799|FG001|Overall Study|Withdrawal by Subject|3|||
127527643|NCT02104947|458892798|FG000|Overall Study|Lost to Follow-up|4|||
127527644|NCT02104947|458892799|FG001|Overall Study|Lost to Follow-up|4|||
127527645|NCT02104947|458892798|FG000|Overall Study|Protocol Violation|6|||
127527646|NCT02104947|458892799|FG001|Overall Study|Protocol Violation|8|||
127527647|NCT02104947|458892798|FG000|Overall Study|Adverse Event|57|||
127527648|NCT02104947|458892799|FG001|Overall Study|Adverse Event|38|||
127527649|NCT02104947|458892798|FG000|Overall Study|Other than stated above|2|||
127527650|NCT02104947|458892799|FG001|Overall Study|Other than stated above|3|||
127527651|NCT00145574|458892800|FG000|Double Blind|Adverse Event|0|||
127527652|NCT00145574|458892801|FG001|Double Blind|Adverse Event|3|||
127527653|NCT00145574|458892802|FG002|Double Blind|Adverse Event|1|||
127527654|NCT00145574|458892800|FG000|Double Blind|Withdrawal by Subject|1|||
127527655|NCT00145574|458892801|FG001|Double Blind|Withdrawal by Subject|1|||
127527656|NCT00145574|458892802|FG002|Double Blind|Withdrawal by Subject|1|||
127527657|NCT00145574|458892800|FG000|Double Blind|required restricted medicine|0|||
127527658|NCT00145574|458892801|FG001|Double Blind|required restricted medicine|1|||
127527659|NCT00145574|458892802|FG002|Double Blind|required restricted medicine|0|||
127527660|NCT00145574|458892800|FG000|Open Label Long-term Extension|Adverse Event|0|||
127527661|NCT00145574|458892801|FG001|Open Label Long-term Extension|Adverse Event|0|||
127527662|NCT00145574|458892802|FG002|Open Label Long-term Extension|Adverse Event|5|||
127527663|NCT00145574|458892800|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
127527664|NCT00145574|458892801|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
127527665|NCT00145574|458892802|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
127527666|NCT00145574|458892800|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
127527667|NCT00145574|458892801|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
127527668|NCT00145574|458892802|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
127527669|NCT00145574|458892800|FG000|Open Label Long-term Extension|required restricted medicine|0|||
127527670|NCT00145574|458892801|FG001|Open Label Long-term Extension|required restricted medicine|0|||
127527671|NCT00145574|458892802|FG002|Open Label Long-term Extension|required restricted medicine|1|||
127527672|NCT00858637|458892806|FG000|Active Comparison Phase|Adverse Event|14|||
127527673|NCT00858637|458892807|FG001|Active Comparison Phase|Adverse Event|0|||
127527674|NCT00858637|458892808|FG002|Active Comparison Phase|Adverse Event|0|||
127527675|NCT00858637|458892809|FG003|Active Comparison Phase|Adverse Event|9|||
127527676|NCT00858637|458892810|FG004|Active Comparison Phase|Adverse Event|0|||
127527677|NCT00858637|458892811|FG005|Active Comparison Phase|Adverse Event|0|||
127527678|NCT00858637|458892806|FG000|Active Comparison Phase|Death|1|||
127527679|NCT00858637|458892807|FG001|Active Comparison Phase|Death|0|||
127527680|NCT00858637|458892808|FG002|Active Comparison Phase|Death|0|||
127527681|NCT00858637|458892809|FG003|Active Comparison Phase|Death|1|||
127527682|NCT00858637|458892810|FG004|Active Comparison Phase|Death|0|||
127527683|NCT00858637|458892811|FG005|Active Comparison Phase|Death|0|||
127527684|NCT00858637|458892806|FG000|Active Comparison Phase|Physician Decision|1|||
127527685|NCT00858637|458892807|FG001|Active Comparison Phase|Physician Decision|0|||
127527686|NCT00858637|458892808|FG002|Active Comparison Phase|Physician Decision|0|||
127527687|NCT00858637|458892809|FG003|Active Comparison Phase|Physician Decision|1|||
127527688|NCT00858637|458892810|FG004|Active Comparison Phase|Physician Decision|0|||
127527689|NCT00858637|458892811|FG005|Active Comparison Phase|Physician Decision|0|||
127527690|NCT00858637|458892806|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
127527691|NCT00858637|458892807|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
127527692|NCT00858637|458892808|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
127527693|NCT00858637|458892809|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
127527694|NCT00858637|458892810|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
127527695|NCT00858637|458892811|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
127527696|NCT00858637|458892806|FG000|Active Comparison Phase|Other Reasons|1|||
127527697|NCT00858637|458892807|FG001|Active Comparison Phase|Other Reasons|0|||
127527698|NCT00858637|458892808|FG002|Active Comparison Phase|Other Reasons|0|||
127527699|NCT00858637|458892809|FG003|Active Comparison Phase|Other Reasons|1|||
127527700|NCT00858637|458892810|FG004|Active Comparison Phase|Other Reasons|0|||
127527701|NCT00858637|458892811|FG005|Active Comparison Phase|Other Reasons|0|||
127527702|NCT00858637|458892806|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
127527703|NCT00858637|458892807|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
127527704|NCT00858637|458892808|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
127527705|NCT00858637|458892809|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
127527706|NCT00858637|458892810|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
127527707|NCT00858637|458892811|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
127527708|NCT00858637|458892806|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
127527709|NCT00858637|458892807|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
127527710|NCT00858637|458892808|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
127527711|NCT00858637|458892809|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
127527712|NCT00858637|458892810|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
127527713|NCT00858637|458892811|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
127527714|NCT03543137|458892816|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
127527715|NCT03543137|458892817|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
127527716|NCT03543137|458892816|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
127527717|NCT03543137|458892817|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
127527718|NCT03543137|458892816|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
127527719|NCT03543137|458892817|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
127527720|NCT03193736|458892818|FG000|Overall Study|Death|2|||
127527721|NCT03193736|458892818|FG000|Overall Study|Withdrawal by Subject|1|||
127527722|NCT03193736|458892818|FG000|Overall Study|Lost to Follow-up|1|||
127527723|NCT03193736|458892818|FG000|Overall Study|implant not received|1|||
127527724|NCT00423449|458892819|FG000|Overall Study|Clinical Adverse Event|1|||
127527725|NCT00423449|458892820|FG001|Overall Study|Clinical Adverse Event|0|||
127527726|NCT00423449|458892821|FG002|Overall Study|Clinical Adverse Event|1|||
127527727|NCT00423449|458892822|FG003|Overall Study|Clinical Adverse Event|8|||
127527728|NCT00423449|458892823|FG004|Overall Study|Clinical Adverse Event|2|||
127527729|NCT00423449|458892819|FG000|Overall Study|Death|1|||
127527730|NCT00423449|458892820|FG001|Overall Study|Death|0|||
127527731|NCT00423449|458892821|FG002|Overall Study|Death|2|||
127527732|NCT00423449|458892822|FG003|Overall Study|Death|1|||
127527733|NCT00423449|458892823|FG004|Overall Study|Death|1|||
127527734|NCT00423449|458892819|FG000|Overall Study|Progressive Disease|1|||
127527735|NCT00423449|458892820|FG001|Overall Study|Progressive Disease|3|||
127527736|NCT00423449|458892821|FG002|Overall Study|Progressive Disease|8|||
127527737|NCT00423449|458892822|FG003|Overall Study|Progressive Disease|11|||
127527738|NCT00423449|458892823|FG004|Overall Study|Progressive Disease|4|||
127527739|NCT00423449|458892819|FG000|Overall Study|Laboratory Adverse Event|0|||
127527740|NCT00423449|458892820|FG001|Overall Study|Laboratory Adverse Event|1|||
127527741|NCT00423449|458892821|FG002|Overall Study|Laboratory Adverse Event|2|||
127527742|NCT00423449|458892822|FG003|Overall Study|Laboratory Adverse Event|0|||
127527743|NCT00423449|458892823|FG004|Overall Study|Laboratory Adverse Event|0|||
127527744|NCT00423449|458892819|FG000|Overall Study|Other|0|||
127527745|NCT00423449|458892820|FG001|Overall Study|Other|0|||
127527746|NCT00423449|458892821|FG002|Overall Study|Other|0|||
127527747|NCT00423449|458892822|FG003|Overall Study|Other|1|||
127527748|NCT00423449|458892823|FG004|Overall Study|Other|0|||
127527749|NCT00423449|458892819|FG000|Overall Study|Protocol Violation|0|||
127527750|NCT00423449|458892820|FG001|Overall Study|Protocol Violation|0|||
127527751|NCT00423449|458892821|FG002|Overall Study|Protocol Violation|2|||
127527752|NCT00423449|458892822|FG003|Overall Study|Protocol Violation|1|||
127527753|NCT00423449|458892823|FG004|Overall Study|Protocol Violation|0|||
127527754|NCT04230213|458892824|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
127527755|NCT04230213|458892825|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
127527756|NCT04230213|458892826|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
127527757|NCT04230213|458892824|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
127527758|NCT04230213|458892825|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
127527759|NCT04230213|458892826|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
127527760|NCT04230213|458892824|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
127527761|NCT04230213|458892825|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
127527762|NCT04230213|458892826|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
127527763|NCT04230213|458892824|FG000|TP2: Week 10 to Week 16|Other|0|||
127527764|NCT04230213|458892825|FG001|TP2: Week 10 to Week 16|Other|2|||
127527765|NCT04230213|458892826|FG002|TP2: Week 10 to Week 16|Other|1|||
127527766|NCT04230213|458892824|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
127527767|NCT04230213|458892825|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
127527768|NCT04230213|458892826|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
127527769|NCT04230213|458892824|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
127527770|NCT04230213|458892825|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
127527771|NCT04230213|458892826|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
127527772|NCT04230213|458892824|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
127527773|NCT04230213|458892825|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
127527774|NCT04230213|458892826|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
127527775|NCT04230213|458892824|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
127527776|NCT04230213|458892825|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
127527777|NCT04230213|458892826|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
127527778|NCT04230213|458892824|FG000|TP3: Week 16 to Week 22|Other|0|||
127527779|NCT04230213|458892825|FG001|TP3: Week 16 to Week 22|Other|1|||
127527780|NCT04230213|458892826|FG002|TP3: Week 16 to Week 22|Other|3|||
127527781|NCT04230213|458892824|FG000|TP4: Week 22 to Week 32|Other|0|||
127527782|NCT04230213|458892825|FG001|TP4: Week 22 to Week 32|Other|5|||
127527783|NCT04230213|458892826|FG002|TP4: Week 22 to Week 32|Other|5|||
127527784|NCT04230213|458892824|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
127527785|NCT04230213|458892825|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
127527786|NCT04230213|458892826|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
127527787|NCT04230213|458892824|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
127527788|NCT04230213|458892825|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
127527789|NCT04230213|458892826|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
127527790|NCT04230213|458892824|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
127527791|NCT04230213|458892825|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
127527792|NCT04230213|458892826|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
127527793|NCT04230213|458892824|FG000|Follow up: Week 32 to Week 36|Other|0|||
127527794|NCT04230213|458892825|FG001|Follow up: Week 32 to Week 36|Other|1|||
127527795|NCT04230213|458892826|FG002|Follow up: Week 32 to Week 36|Other|1|||
127527796|NCT00861471|458892829|FG000|Overall Study|Withdrawal by Subject|1|||
127527797|NCT00861471|458892829|FG000|Overall Study|Adverse Event|2|||
127527798|NCT00861471|458892829|FG000|Overall Study|Lack of Efficacy|3|||
127527799|NCT00861471|458892829|FG000|Overall Study|treatment for lumbar laminectomy|1|||
127527800|NCT00861471|458892829|FG000|Overall Study|Physician Decision|2|||
127527801|NCT01445080|458892830|FG000|Overall Study|Adverse Event|5|||
127527802|NCT01445080|458892831|FG001|Overall Study|Adverse Event|3|||
127527803|NCT01445080|458892832|FG002|Overall Study|Adverse Event|11|||
127527804|NCT01445080|458892833|FG003|Overall Study|Adverse Event|6|||
127527805|NCT01445080|458892834|FG004|Overall Study|Adverse Event|2|||
127527806|NCT01445080|458892835|FG005|Overall Study|Adverse Event|3|||
127527807|NCT01445080|458892836|FG006|Overall Study|Adverse Event|0|||
127527808|NCT01445080|458892837|FG007|Overall Study|Adverse Event|3|||
127527809|NCT01445080|458892838|FG008|Overall Study|Adverse Event|10|||
127527810|NCT01445080|458892830|FG000|Overall Study|Physician Decision|0|||
127527811|NCT01445080|458892831|FG001|Overall Study|Physician Decision|0|||
127527812|NCT01445080|458892832|FG002|Overall Study|Physician Decision|1|||
127527813|NCT01445080|458892833|FG003|Overall Study|Physician Decision|0|||
127527814|NCT01445080|458892834|FG004|Overall Study|Physician Decision|0|||
127527815|NCT01445080|458892835|FG005|Overall Study|Physician Decision|3|||
127527816|NCT01445080|458892836|FG006|Overall Study|Physician Decision|2|||
127527817|NCT01445080|458892837|FG007|Overall Study|Physician Decision|2|||
127527818|NCT01445080|458892838|FG008|Overall Study|Physician Decision|0|||
127527819|NCT01445080|458892830|FG000|Overall Study|Withdrawal by Subject|1|||
127527820|NCT01445080|458892831|FG001|Overall Study|Withdrawal by Subject|0|||
127527821|NCT01445080|458892832|FG002|Overall Study|Withdrawal by Subject|0|||
127527822|NCT01445080|458892833|FG003|Overall Study|Withdrawal by Subject|1|||
127527823|NCT01445080|458892834|FG004|Overall Study|Withdrawal by Subject|0|||
127527824|NCT01445080|458892835|FG005|Overall Study|Withdrawal by Subject|0|||
127527825|NCT01445080|458892836|FG006|Overall Study|Withdrawal by Subject|0|||
127527826|NCT01445080|458892837|FG007|Overall Study|Withdrawal by Subject|0|||
127527827|NCT01445080|458892838|FG008|Overall Study|Withdrawal by Subject|2|||
127527828|NCT01445080|458892830|FG000|Overall Study|Ineligible/Inevaluable|1|||
127527829|NCT01445080|458892831|FG001|Overall Study|Ineligible/Inevaluable|2|||
127527830|NCT01445080|458892832|FG002|Overall Study|Ineligible/Inevaluable|0|||
127527831|NCT01445080|458892833|FG003|Overall Study|Ineligible/Inevaluable|1|||
127527832|NCT01445080|458892834|FG004|Overall Study|Ineligible/Inevaluable|2|||
127527833|NCT01445080|458892835|FG005|Overall Study|Ineligible/Inevaluable|3|||
127527834|NCT01445080|458892836|FG006|Overall Study|Ineligible/Inevaluable|0|||
127527835|NCT01445080|458892837|FG007|Overall Study|Ineligible/Inevaluable|0|||
127527836|NCT01445080|458892838|FG008|Overall Study|Ineligible/Inevaluable|6|||
127527837|NCT03857542|458892839|FG000|Overall Study|Adverse Event|1|||
127527838|NCT03857542|458892840|FG001|Overall Study|Adverse Event|3|||
127527839|NCT03857542|458892839|FG000|Overall Study|Withdrawal by Subject|2|||
127527840|NCT03857542|458892840|FG001|Overall Study|Withdrawal by Subject|1|||
127527841|NCT03857542|458892839|FG000|Overall Study|Lost to Follow-up|2|||
127527842|NCT03857542|458892840|FG001|Overall Study|Lost to Follow-up|1|||
127527843|NCT03857542|458892839|FG000|Overall Study|Reason not Specified|1|||
127527844|NCT03857542|458892840|FG001|Overall Study|Reason not Specified|0|||
127527845|NCT02123576|458892841|FG000|Overall Study|Adverse Event|1|||
127527846|NCT02123576|458892842|FG001|Overall Study|Adverse Event|0|||
127527847|NCT00934128|458892843|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
127527848|NCT00934128|458892844|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
127527849|NCT00934128|458892843|FG000|First Intervention (2 Hours)|Adverse Event|4|||
127527850|NCT00934128|458892844|FG001|First Intervention (2 Hours)|Adverse Event|1|||
127527851|NCT00934128|458892843|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
127527852|NCT00934128|458892844|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
127527853|NCT00934128|458892843|FG000|Washout Period (1 Hour)|Patient preference|1|||
127527854|NCT00934128|458892844|FG001|Washout Period (1 Hour)|Patient preference|3|||
127527855|NCT00934128|458892843|FG000|Washout Period (1 Hour)|Pain|1|||
127527856|NCT00934128|458892844|FG001|Washout Period (1 Hour)|Pain|0|||
127527857|NCT00934128|458892843|FG000|Washout Period (1 Hour)|Too tired|1|||
127527858|NCT00934128|458892844|FG001|Washout Period (1 Hour)|Too tired|0|||
127527859|NCT00934128|458892843|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
127527860|NCT00934128|458892844|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
127527861|NCT00934128|458892843|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
127527862|NCT00934128|458892844|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
127527863|NCT01946152|458894530|FG000|Overall Study|Adverse Event|1|||
127527864|NCT01946152|458894531|FG001|Overall Study|Adverse Event|0|||
127527865|NCT01946152|458894532|FG002|Overall Study|Adverse Event|0|||
127527866|NCT01946152|458894533|FG003|Overall Study|Adverse Event|0|||
127527867|NCT01946152|458894530|FG000|Overall Study|Withdrawal by Subject|0|||
127527868|NCT01946152|458894531|FG001|Overall Study|Withdrawal by Subject|2|||
127527869|NCT01946152|458894532|FG002|Overall Study|Withdrawal by Subject|0|||
127527870|NCT01946152|458894533|FG003|Overall Study|Withdrawal by Subject|0|||
127527871|NCT01946152|458894530|FG000|Overall Study|Progression|0|||
127527872|NCT01946152|458894531|FG001|Overall Study|Progression|1|||
127527873|NCT01946152|458894532|FG002|Overall Study|Progression|4|||
127527874|NCT01946152|458894533|FG003|Overall Study|Progression|7|||
127527875|NCT01946152|458894530|FG000|Overall Study|Physician Decision|0|||
127527876|NCT01946152|458894531|FG001|Overall Study|Physician Decision|0|||
127527877|NCT01946152|458894532|FG002|Overall Study|Physician Decision|1|||
127527878|NCT01946152|458894533|FG003|Overall Study|Physician Decision|0|||
127527879|NCT01946152|458894530|FG000|Overall Study|Second malignancy|0|||
127527880|NCT01946152|458894531|FG001|Overall Study|Second malignancy|0|||
127527881|NCT01946152|458894532|FG002|Overall Study|Second malignancy|1|||
127527882|NCT01946152|458894533|FG003|Overall Study|Second malignancy|0|||
127527883|NCT01946152|458894530|FG000|Overall Study|Adverse Event|0|||
127527884|NCT01946152|458894531|FG001|Overall Study|Adverse Event|0|||
127527885|NCT01946152|458894532|FG002|Overall Study|Adverse Event|0|||
127527886|NCT01946152|458894533|FG003|Overall Study|Adverse Event|1|||
127527887|NCT01698814|458894534|FG000|Overall Study|Adverse Event|0|||
127527888|NCT01698814|458894535|FG001|Overall Study|Adverse Event|2|||
127527889|NCT01698814|458894534|FG000|Overall Study|Lost to Follow-up|0|||
127527890|NCT01698814|458894535|FG001|Overall Study|Lost to Follow-up|1|||
127527891|NCT01698814|458894534|FG000|Overall Study|Pregnancy|1|||
127527892|NCT01698814|458894535|FG001|Overall Study|Pregnancy|0|||
127527893|NCT01698814|458894534|FG000|Overall Study|Randomized in error|1|||
127527894|NCT01698814|458894535|FG001|Overall Study|Randomized in error|0|||
127527895|NCT00799266|458894542|FG000|Overall Study|Adverse Event|0|||
127527896|NCT00799266|458894543|FG001|Overall Study|Adverse Event|1|||
127527897|NCT00799266|458894542|FG000|Overall Study|Subject withdrew consent|3|||
127527898|NCT00799266|458894543|FG001|Overall Study|Subject withdrew consent|0|||
127527899|NCT01061359|458894545|FG000|Overall Study|Death|32|||
127527900|NCT01061359|458894545|FG000|Overall Study|Lost to Follow-up|1072|||
127527901|NCT01061359|458894545|FG000|Overall Study|Relapse|187|||
127527902|NCT01061359|458894545|FG000|Overall Study|Secondary neoplasm|11|||
127527903|NCT04014062|458894546|FG000|Period I: Dosing|Medical Grounds|4|||
127527904|NCT04014062|458894547|FG001|Period I: Dosing|Medical Grounds|5|||
127527905|NCT04014062|458894546|FG000|Period I: Dosing|Withdrawal by Subject|3|||
127527906|NCT04014062|458894547|FG001|Period I: Dosing|Withdrawal by Subject|1|||
127527907|NCT03038126|458894549|FG000|Overall Study|Death|1|||
127527908|NCT03038126|458894550|FG001|Overall Study|Death|1|||
127527909|NCT03038126|458894549|FG000|Overall Study|Withdrawal by Subject|5|||
127527910|NCT03038126|458894550|FG001|Overall Study|Withdrawal by Subject|0|||
127527911|NCT03038126|458894549|FG000|Overall Study|Lost to Follow-up|0|||
127527912|NCT03038126|458894550|FG001|Overall Study|Lost to Follow-up|1|||
127527913|NCT03038126|458894549|FG000|Overall Study|Long Term Hospitalization|2|||
127527914|NCT03038126|458894550|FG001|Overall Study|Long Term Hospitalization|0|||
127527915|NCT03038126|458894549|FG000|Overall Study|Too Ill to Participate|1|||
127527916|NCT03038126|458894550|FG001|Overall Study|Too Ill to Participate|2|||
127527917|NCT01724866|458894551|FG000|Overall Study|Adverse Event|0|||
127527918|NCT01724866|458894552|FG001|Overall Study|Adverse Event|0|||
127527919|NCT01724866|458894553|FG002|Overall Study|Adverse Event|1|||
127527920|NCT01724866|458894554|FG003|Overall Study|Adverse Event|1|||
127527921|NCT01724866|458894551|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
127527922|NCT01724866|458894552|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
127527923|NCT01724866|458894553|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
127527924|NCT01724866|458894554|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
127527925|NCT01724866|458894551|FG000|Overall Study|Investigator's Discretion|0|||
127527926|NCT01724866|458894552|FG001|Overall Study|Investigator's Discretion|1|||
127527927|NCT01724866|458894553|FG002|Overall Study|Investigator's Discretion|1|||
127527928|NCT01724866|458894554|FG003|Overall Study|Investigator's Discretion|0|||
127527929|NCT01724866|458894551|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
127527930|NCT01724866|458894552|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
127527931|NCT01724866|458894553|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
127527932|NCT01724866|458894554|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
127527933|NCT01724866|458894551|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
127527934|NCT01724866|458894552|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
127527935|NCT01724866|458894553|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
127527936|NCT01724866|458894554|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
127527937|NCT01424501|458894555|FG000|Overall Study|Withdrawal by Subject|1|||
127527938|NCT01424501|458894556|FG001|Overall Study|Withdrawal by Subject|0|||
127527939|NCT01424501|458894557|FG002|Overall Study|Withdrawal by Subject|1|||
127527940|NCT01424501|458894558|FG003|Overall Study|Withdrawal by Subject|0|||
127527941|NCT01424501|458894559|FG004|Overall Study|Withdrawal by Subject|0|||
127527942|NCT01424501|458894560|FG005|Overall Study|Withdrawal by Subject|0|||
127527943|NCT01424501|458894555|FG000|Overall Study|Lost to Follow-up|0|||
127527944|NCT01424501|458894556|FG001|Overall Study|Lost to Follow-up|1|||
127527945|NCT01424501|458894557|FG002|Overall Study|Lost to Follow-up|1|||
127527946|NCT01424501|458894558|FG003|Overall Study|Lost to Follow-up|0|||
127527947|NCT01424501|458894559|FG004|Overall Study|Lost to Follow-up|0|||
127527948|NCT01424501|458894560|FG005|Overall Study|Lost to Follow-up|0|||
127527949|NCT01980095|458894561|FG000|Overall Study|Lost to Follow-up|6|||
127527950|NCT01980095|458894562|FG001|Overall Study|Lost to Follow-up|7|||
127527951|NCT01980095|458894561|FG000|Overall Study|Withdrawal by Subject|2|||
127527952|NCT01980095|458894562|FG001|Overall Study|Withdrawal by Subject|3|||
127527953|NCT01980095|458894561|FG000|Overall Study|Poor compliance|5|||
127527954|NCT01980095|458894562|FG001|Overall Study|Poor compliance|0|||
127527955|NCT01980095|458894561|FG000|Overall Study|Safety issue|0|||
127527956|NCT01980095|458894562|FG001|Overall Study|Safety issue|1|||
127527957|NCT01980095|458894561|FG000|Overall Study|Study drug discontinued|1|||
127527958|NCT01980095|458894562|FG001|Overall Study|Study drug discontinued|0|||
127527959|NCT01980095|458894561|FG000|Overall Study|Randomized by mistake|1|||
127527960|NCT01980095|458894562|FG001|Overall Study|Randomized by mistake|0|||
127527961|NCT01136408|458894573|FG000|Overall Study|Adverse Event|4|||
127527962|NCT01136408|458894574|FG001|Overall Study|Adverse Event|8|||
127527963|NCT01136408|458894575|FG002|Overall Study|Adverse Event|4|||
127527964|NCT01136408|458894573|FG000|Overall Study|Protocol Violation|1|||
127527965|NCT01136408|458894574|FG001|Overall Study|Protocol Violation|1|||
127527966|NCT01136408|458894575|FG002|Overall Study|Protocol Violation|1|||
127527967|NCT02828436|458894576|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
127527968|NCT02828436|458894577|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
127527969|NCT02828436|458894576|FG000|Period 1|Lost to Follow-up|0|||
127527970|NCT02828436|458894577|FG001|Period 1|Lost to Follow-up|1|||
127527971|NCT02828436|458894576|FG000|Period 2|Withdrawal by Subject|4|||
127527972|NCT02828436|458894577|FG001|Period 2|Withdrawal by Subject|0|||
127527973|NCT02828436|458894576|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
127527974|NCT02828436|458894577|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
127527975|NCT02828436|458894576|FG000|Period 2|Lost to Follow-up|1|||
127527976|NCT02828436|458894577|FG001|Period 2|Lost to Follow-up|0|||
127527977|NCT04273893|458894578|FG000|Overall Study|Withdrawal by Subject|0|||
127527978|NCT04273893|458894579|FG001|Overall Study|Withdrawal by Subject|2|||
127527979|NCT04273893|458894578|FG000|Overall Study|Treatment of Disease Progression|0|||
127527980|NCT04273893|458894579|FG001|Overall Study|Treatment of Disease Progression|2|||
127527981|NCT04273893|458894578|FG000|Overall Study|Death|1|||
127527982|NCT04273893|458894579|FG001|Overall Study|Death|2|||
127527983|NCT04273893|458894578|FG000|Overall Study|Lost to Follow-up|0|||
127527984|NCT04273893|458894579|FG001|Overall Study|Lost to Follow-up|2|||
127527985|NCT04273893|458894578|FG000|Overall Study|Physician Decision|1|||
127527986|NCT04273893|458894579|FG001|Overall Study|Physician Decision|0|||
127527987|NCT01957202|458894581|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
127527988|NCT01957202|458894582|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
127527989|NCT01957202|458894583|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
127527990|NCT01957202|458894584|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
127527991|NCT01957202|458894585|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
127527992|NCT01957202|458894586|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
127527993|NCT01957202|458894587|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
127527994|NCT01957202|458894588|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
127527995|NCT01957202|458894589|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
127527996|NCT01957202|458894590|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
127527997|NCT01957202|458894591|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
127527998|NCT01957202|458894592|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
127527999|NCT01957202|458894593|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
127528000|NCT01957202|458894594|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
127528001|NCT01957202|458894595|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
127528002|NCT01957202|458894596|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
127528003|NCT01957202|458894597|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
127528004|NCT01957202|458894598|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
127528005|NCT01957202|458894581|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
127528006|NCT01957202|458894582|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
127528007|NCT01957202|458894583|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
127528008|NCT01957202|458894584|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
127528009|NCT01957202|458894585|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
127528010|NCT01957202|458894586|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
127528011|NCT01957202|458894587|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
127528012|NCT01957202|458894588|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
127528013|NCT01957202|458894589|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
127528014|NCT01957202|458894590|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
127528015|NCT01957202|458894591|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
127528016|NCT01957202|458894592|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
127528017|NCT01957202|458894593|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
127528018|NCT01957202|458894594|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
127528019|NCT01957202|458894595|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
127528020|NCT01957202|458894596|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
127528021|NCT01957202|458894597|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
127528022|NCT01957202|458894598|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
127528023|NCT02221674|458894607|FG000|Overall Study|Lost to Follow-up|1|||
127528024|NCT02221674|458894608|FG001|Overall Study|Lost to Follow-up|0|||
127528025|NCT02221674|458894609|FG002|Overall Study|Lost to Follow-up|0|||
127528026|NCT04390880|458894610|FG000|Overall Study|Withdrawal by Subject|1|||
127528027|NCT03785405|458894611|FG000|Overall Study|Adverse Event|16|||
127528028|NCT03785405|458894612|FG001|Overall Study|Adverse Event|1|||
127528029|NCT03785405|458894611|FG000|Overall Study|Death|6|||
127528030|NCT03785405|458894612|FG001|Overall Study|Death|4|||
127528031|NCT03785405|458894611|FG000|Overall Study|Guardian decision|4|||
127528032|NCT03785405|458894612|FG001|Overall Study|Guardian decision|1|||
127528033|NCT03785405|458894611|FG000|Overall Study|Lost to Follow-up|1|||
127528034|NCT03785405|458894612|FG001|Overall Study|Lost to Follow-up|0|||
127528035|NCT03785405|458894611|FG000|Overall Study|Physician Decision|8|||
127528036|NCT03785405|458894612|FG001|Overall Study|Physician Decision|5|||
127528037|NCT03785405|458894611|FG000|Overall Study|Participant decision|2|||
127528038|NCT03785405|458894612|FG001|Overall Study|Participant decision|0|||
127528039|NCT03785405|458894611|FG000|Overall Study|Other|1|||
127528040|NCT03785405|458894612|FG001|Overall Study|Other|0|||
127528041|NCT03785405|458894611|FG000|Overall Study|No treatment was received|0|||
127528042|NCT03785405|458894612|FG001|Overall Study|No treatment was received|1|||
127528043|NCT02881762|458894615|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
127528044|NCT02881762|458894616|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
127528045|NCT01922271|458894619|FG000|WASHOUT Period|Withdrawal by Subject|1|||
127528046|NCT01922271|458894620|FG001|WASHOUT Period|Withdrawal by Subject|0|||
127528047|NCT01635855|458894625|FG000|Overall Study|Withdrawal by Subject|4|||
127528048|NCT03828019|458894626|FG000|Overall Study|Withdrawal by Subject|3|||
127528049|NCT03828019|458894627|FG001|Overall Study|Withdrawal by Subject|8|||
127528050|NCT03828019|458894626|FG000|Overall Study|Lost to Follow-up|1|||
127528051|NCT03828019|458894627|FG001|Overall Study|Lost to Follow-up|6|||
127528052|NCT03828019|458894626|FG000|Overall Study|Incarcerated|1|||
127528053|NCT03828019|458894627|FG001|Overall Study|Incarcerated|0|||
127528054|NCT03828019|458894626|FG000|Overall Study|Adverse Event|0|||
127528055|NCT03828019|458894627|FG001|Overall Study|Adverse Event|1|||
127528056|NCT03400176|458894628|FG000|Dose Escalation|Progressive disease|1|||
127528057|NCT03400176|458894629|FG001|Dose Escalation|Progressive disease|1|||
127528058|NCT03400176|458894630|FG002|Dose Escalation|Progressive disease|0|||
127528059|NCT03400176|458894631|FG003|Dose Escalation|Progressive disease|0|||
127528060|NCT03400176|458894632|FG004|Dose Escalation|Progressive disease|1|||
127528061|NCT03400176|458894628|FG000|Dose Escalation|Patient decision|0|||
127528062|NCT03400176|458894629|FG001|Dose Escalation|Patient decision|0|||
127528063|NCT03400176|458894630|FG002|Dose Escalation|Patient decision|0|||
127528064|NCT03400176|458894631|FG003|Dose Escalation|Patient decision|0|||
127528065|NCT03400176|458894632|FG004|Dose Escalation|Patient decision|1|||
127528066|NCT03400176|458894628|FG000|Dose Expansion|Patient decision|0|||
127528067|NCT03400176|458894629|FG001|Dose Expansion|Patient decision|0|||
127528068|NCT03400176|458894630|FG002|Dose Expansion|Patient decision|0|||
127528069|NCT03400176|458894631|FG003|Dose Expansion|Patient decision|1|||
127528070|NCT03400176|458894632|FG004|Dose Expansion|Patient decision|0|||
127528071|NCT03400176|458894628|FG000|Dose Expansion|Adverse Event|0|||
127528072|NCT03400176|458894629|FG001|Dose Expansion|Adverse Event|0|||
127528073|NCT03400176|458894630|FG002|Dose Expansion|Adverse Event|0|||
127528074|NCT03400176|458894631|FG003|Dose Expansion|Adverse Event|1|||
127528075|NCT03400176|458894632|FG004|Dose Expansion|Adverse Event|0|||
127528076|NCT03400176|458894628|FG000|Dose Expansion|Physician Decision|0|||
127528077|NCT03400176|458894629|FG001|Dose Expansion|Physician Decision|0|||
127528078|NCT03400176|458894630|FG002|Dose Expansion|Physician Decision|0|||
127528079|NCT03400176|458894631|FG003|Dose Expansion|Physician Decision|1|||
127528080|NCT03400176|458894632|FG004|Dose Expansion|Physician Decision|0|||
127528081|NCT03400176|458894628|FG000|Dose Expansion|Progressive disease|0|||
127528082|NCT03400176|458894629|FG001|Dose Expansion|Progressive disease|0|||
127528083|NCT03400176|458894630|FG002|Dose Expansion|Progressive disease|1|||
127528084|NCT03400176|458894631|FG003|Dose Expansion|Progressive disease|1|||
127528085|NCT03400176|458894632|FG004|Dose Expansion|Progressive disease|0|||
127528086|NCT00206440|458894633|FG000|Overall Study|Protocol Violation|1|||
127528087|NCT00206440|458894634|FG001|Overall Study|Protocol Violation|2|||
127528088|NCT00206440|458894633|FG000|Overall Study|Adverse Event|4|||
127528089|NCT00206440|458894634|FG001|Overall Study|Adverse Event|2|||
127528090|NCT01298765|458894635|FG000|Titration Period|Adverse Event|26|||
127528091|NCT01298765|458894635|FG000|Titration Period|Death|1|||
127528092|NCT01298765|458894635|FG000|Titration Period|Lack of Efficacy|21|||
127528093|NCT01298765|458894635|FG000|Titration Period|Lost to Follow-up|9|||
127528094|NCT01298765|458894635|FG000|Titration Period|Physician Decision|1|||
127528095|NCT01298765|458894635|FG000|Titration Period|Withdrawal by Subject|10|||
127528096|NCT01298765|458894635|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
127528097|NCT01298765|458894635|FG000|Long-Term Treatment Period|Adverse Event|19|||
127528098|NCT01298765|458894635|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
127528099|NCT01298765|458894635|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
127528100|NCT01298765|458894635|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
127528101|NCT01298765|458894635|FG000|Long-Term Treatment Period|Physician Decision|1|||
127528102|NCT01298765|458894635|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
127528103|NCT03302247|458894638|FG000|Overall Study|the study has closed prematurely|2|||
127528104|NCT03302247|458894638|FG000|Overall Study|Death|1|||
127528105|NCT04090242|458894639|FG000|Overall Study|Withdrawal by Subject|1|||
127528106|NCT04090242|458894640|FG001|Overall Study|Withdrawal by Subject|0|||
127528107|NCT03214406|458894641|FG000|Overall Study|did not meet enrollment criteria|9|||
127528108|NCT03214406|458894642|FG001|Overall Study|did not meet enrollment criteria|13|||
127528109|NCT03214406|458894641|FG000|Overall Study|Withdrawal by Subject|1|||
127528110|NCT03214406|458894642|FG001|Overall Study|Withdrawal by Subject|0|||
127528111|NCT03214406|458894641|FG000|Overall Study|Lost to Follow-up|0|||
127528112|NCT03214406|458894642|FG001|Overall Study|Lost to Follow-up|2|||
127528113|NCT01098305|458894646|FG000|Overall Study|Lost to Follow-up|31|||
127528114|NCT01098305|458894647|FG001|Overall Study|Lost to Follow-up|33|||
127528115|NCT03182907|458894650|FG000|Overall Study|Death|3|||
127528116|NCT03182907|458894651|FG001|Overall Study|Death|0|||
127528117|NCT03182907|458894650|FG000|Overall Study|Protocol Violation|4|||
127528118|NCT03182907|458894651|FG001|Overall Study|Protocol Violation|0|||
127528119|NCT03182907|458894650|FG000|Overall Study|Lost to Follow-up|1|||
127528120|NCT03182907|458894651|FG001|Overall Study|Lost to Follow-up|0|||
127528121|NCT03182907|458894650|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
127528122|NCT03182907|458894651|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
127528123|NCT00429169|458894652|FG000|Overall Study|Lost to Follow-up|0|||
127528124|NCT00429169|458894653|FG001|Overall Study|Lost to Follow-up|1|||
127528125|NCT00429169|458894652|FG000|Overall Study|Ineligibility discovered after entry|2|||
127528126|NCT00429169|458894653|FG001|Overall Study|Ineligibility discovered after entry|1|||
127528127|NCT01180296|458894658|FG000|Overall Study|Protocol Violation|1|||
127528128|NCT01180296|458894659|FG001|Overall Study|Protocol Violation|2|||
127528129|NCT03364309|458894664|FG000|Induction Period|Adverse Event|4|||
127528130|NCT03364309|458894665|FG001|Induction Period|Adverse Event|0|||
127528131|NCT03364309|458894666|FG002|Induction Period|Adverse Event|1|||
127528132|NCT03364309|458894667|FG003|Induction Period|Adverse Event|0|||
127528133|NCT03364309|458894668|FG004|Induction Period|Adverse Event|0|||
127528134|NCT03364309|458894669|FG005|Induction Period|Adverse Event|0|||
127528135|NCT03364309|458894670|FG006|Induction Period|Adverse Event|0|||
127528136|NCT03364309|458894671|FG007|Induction Period|Adverse Event|0|||
127528137|NCT03364309|458894672|FG008|Induction Period|Adverse Event|0|||
127528138|NCT03364309|458894673|FG009|Induction Period|Adverse Event|0|||
127528139|NCT03364309|458894674|FG010|Induction Period|Adverse Event|0|||
127528140|NCT03364309|458894675|FG011|Induction Period|Adverse Event|0|||
127528141|NCT03364309|458894676|FG012|Induction Period|Adverse Event|0|||
127528142|NCT03364309|458894677|FG013|Induction Period|Adverse Event|0|||
127528143|NCT03364309|458894678|FG014|Induction Period|Adverse Event|0|||
127528144|NCT03364309|458894679|FG015|Induction Period|Adverse Event|0|||
127528145|NCT03364309|458894680|FG016|Induction Period|Adverse Event|0|||
127528146|NCT03364309|458894681|FG017|Induction Period|Adverse Event|0|||
127528147|NCT03364309|458894682|FG018|Induction Period|Adverse Event|0|||
127528148|NCT03364309|458894664|FG000|Induction Period|Withdrawal by Subject|1|||
127528149|NCT03364309|458894665|FG001|Induction Period|Withdrawal by Subject|3|||
127528150|NCT03364309|458894666|FG002|Induction Period|Withdrawal by Subject|0|||
127528151|NCT03364309|458894667|FG003|Induction Period|Withdrawal by Subject|0|||
127528152|NCT03364309|458894668|FG004|Induction Period|Withdrawal by Subject|0|||
127528153|NCT03364309|458894669|FG005|Induction Period|Withdrawal by Subject|0|||
127528154|NCT03364309|458894670|FG006|Induction Period|Withdrawal by Subject|0|||
127528155|NCT03364309|458894671|FG007|Induction Period|Withdrawal by Subject|0|||
127528156|NCT03364309|458894672|FG008|Induction Period|Withdrawal by Subject|0|||
127528157|NCT03364309|458894673|FG009|Induction Period|Withdrawal by Subject|0|||
127528158|NCT03364309|458894674|FG010|Induction Period|Withdrawal by Subject|0|||
127528159|NCT03364309|458894675|FG011|Induction Period|Withdrawal by Subject|0|||
127528160|NCT03364309|458894676|FG012|Induction Period|Withdrawal by Subject|0|||
127528161|NCT03364309|458894677|FG013|Induction Period|Withdrawal by Subject|0|||
127528162|NCT03364309|458894678|FG014|Induction Period|Withdrawal by Subject|0|||
127528163|NCT03364309|458894679|FG015|Induction Period|Withdrawal by Subject|0|||
127528164|NCT03364309|458894680|FG016|Induction Period|Withdrawal by Subject|0|||
127528165|NCT03364309|458894681|FG017|Induction Period|Withdrawal by Subject|0|||
127528166|NCT03364309|458894682|FG018|Induction Period|Withdrawal by Subject|0|||
127528167|NCT03364309|458894664|FG000|Induction Period|Lost to Follow-up|1|||
127528168|NCT03364309|458894665|FG001|Induction Period|Lost to Follow-up|0|||
127528169|NCT03364309|458894666|FG002|Induction Period|Lost to Follow-up|0|||
127528170|NCT03364309|458894667|FG003|Induction Period|Lost to Follow-up|0|||
127528171|NCT03364309|458894668|FG004|Induction Period|Lost to Follow-up|0|||
127528172|NCT03364309|458894669|FG005|Induction Period|Lost to Follow-up|0|||
127528173|NCT03364309|458894670|FG006|Induction Period|Lost to Follow-up|0|||
127528174|NCT03364309|458894671|FG007|Induction Period|Lost to Follow-up|0|||
127528175|NCT03364309|458894672|FG008|Induction Period|Lost to Follow-up|0|||
127528176|NCT03364309|458894673|FG009|Induction Period|Lost to Follow-up|0|||
127528177|NCT03364309|458894674|FG010|Induction Period|Lost to Follow-up|0|||
127528178|NCT03364309|458894675|FG011|Induction Period|Lost to Follow-up|0|||
127528179|NCT03364309|458894676|FG012|Induction Period|Lost to Follow-up|0|||
127528180|NCT03364309|458894677|FG013|Induction Period|Lost to Follow-up|0|||
127528181|NCT03364309|458894678|FG014|Induction Period|Lost to Follow-up|0|||
127528182|NCT03364309|458894679|FG015|Induction Period|Lost to Follow-up|0|||
127528183|NCT03364309|458894680|FG016|Induction Period|Lost to Follow-up|0|||
127528184|NCT03364309|458894681|FG017|Induction Period|Lost to Follow-up|0|||
127528185|NCT03364309|458894682|FG018|Induction Period|Lost to Follow-up|0|||
127528186|NCT03364309|458894664|FG000|Induction Period|Physician Decision|0|||
127528187|NCT03364309|458894665|FG001|Induction Period|Physician Decision|1|||
127528188|NCT03364309|458894666|FG002|Induction Period|Physician Decision|0|||
127528189|NCT03364309|458894667|FG003|Induction Period|Physician Decision|0|||
127528190|NCT03364309|458894668|FG004|Induction Period|Physician Decision|0|||
127528191|NCT03364309|458894669|FG005|Induction Period|Physician Decision|0|||
127528192|NCT03364309|458894670|FG006|Induction Period|Physician Decision|0|||
127528193|NCT03364309|458894671|FG007|Induction Period|Physician Decision|0|||
127528194|NCT03364309|458894672|FG008|Induction Period|Physician Decision|0|||
127528195|NCT03364309|458894673|FG009|Induction Period|Physician Decision|0|||
127528196|NCT03364309|458894674|FG010|Induction Period|Physician Decision|0|||
127528197|NCT03364309|458894675|FG011|Induction Period|Physician Decision|0|||
127528198|NCT03364309|458894676|FG012|Induction Period|Physician Decision|0|||
127528199|NCT03364309|458894677|FG013|Induction Period|Physician Decision|0|||
127528200|NCT03364309|458894678|FG014|Induction Period|Physician Decision|0|||
127528201|NCT03364309|458894679|FG015|Induction Period|Physician Decision|0|||
127528202|NCT03364309|458894680|FG016|Induction Period|Physician Decision|0|||
127528203|NCT03364309|458894681|FG017|Induction Period|Physician Decision|0|||
127528204|NCT03364309|458894682|FG018|Induction Period|Physician Decision|0|||
127528205|NCT03364309|458894664|FG000|Maintenance Period|Withdrawal by Subject|0|||
127528206|NCT03364309|458894665|FG001|Maintenance Period|Withdrawal by Subject|0|||
127528207|NCT03364309|458894666|FG002|Maintenance Period|Withdrawal by Subject|0|||
127528208|NCT03364309|458894667|FG003|Maintenance Period|Withdrawal by Subject|1|||
127528209|NCT03364309|458894668|FG004|Maintenance Period|Withdrawal by Subject|3|||
127528210|NCT03364309|458894669|FG005|Maintenance Period|Withdrawal by Subject|1|||
127528211|NCT03364309|458894670|FG006|Maintenance Period|Withdrawal by Subject|3|||
127528212|NCT03364309|458894671|FG007|Maintenance Period|Withdrawal by Subject|0|||
127528213|NCT03364309|458894672|FG008|Maintenance Period|Withdrawal by Subject|1|||
127528214|NCT03364309|458894673|FG009|Maintenance Period|Withdrawal by Subject|1|||
127528215|NCT03364309|458894674|FG010|Maintenance Period|Withdrawal by Subject|2|||
127528216|NCT03364309|458894675|FG011|Maintenance Period|Withdrawal by Subject|0|||
127528217|NCT03364309|458894676|FG012|Maintenance Period|Withdrawal by Subject|0|||
127528218|NCT03364309|458894677|FG013|Maintenance Period|Withdrawal by Subject|0|||
127528219|NCT03364309|458894678|FG014|Maintenance Period|Withdrawal by Subject|0|||
127528220|NCT03364309|458894679|FG015|Maintenance Period|Withdrawal by Subject|0|||
127528221|NCT03364309|458894680|FG016|Maintenance Period|Withdrawal by Subject|0|||
127528222|NCT03364309|458894681|FG017|Maintenance Period|Withdrawal by Subject|0|||
127528223|NCT03364309|458894682|FG018|Maintenance Period|Withdrawal by Subject|0|||
127528224|NCT03364309|458894664|FG000|Maintenance Period|Adverse Event|0|||
127528225|NCT03364309|458894665|FG001|Maintenance Period|Adverse Event|0|||
127528226|NCT03364309|458894666|FG002|Maintenance Period|Adverse Event|0|||
127528227|NCT03364309|458894667|FG003|Maintenance Period|Adverse Event|0|||
127528228|NCT03364309|458894668|FG004|Maintenance Period|Adverse Event|2|||
127528229|NCT03364309|458894669|FG005|Maintenance Period|Adverse Event|0|||
127528230|NCT03364309|458894670|FG006|Maintenance Period|Adverse Event|3|||
127528231|NCT03364309|458894671|FG007|Maintenance Period|Adverse Event|0|||
127528232|NCT03364309|458894672|FG008|Maintenance Period|Adverse Event|1|||
127528233|NCT03364309|458894673|FG009|Maintenance Period|Adverse Event|0|||
127528234|NCT03364309|458894674|FG010|Maintenance Period|Adverse Event|2|||
127528235|NCT03364309|458894675|FG011|Maintenance Period|Adverse Event|0|||
127528236|NCT03364309|458894676|FG012|Maintenance Period|Adverse Event|0|||
127528237|NCT03364309|458894677|FG013|Maintenance Period|Adverse Event|0|||
127528238|NCT03364309|458894678|FG014|Maintenance Period|Adverse Event|0|||
127528239|NCT03364309|458894679|FG015|Maintenance Period|Adverse Event|0|||
127528240|NCT03364309|458894680|FG016|Maintenance Period|Adverse Event|0|||
127528241|NCT03364309|458894681|FG017|Maintenance Period|Adverse Event|0|||
127528242|NCT03364309|458894682|FG018|Maintenance Period|Adverse Event|0|||
127528243|NCT03364309|458894664|FG000|Maintenance Period|Relapsed|0|||
127528244|NCT03364309|458894665|FG001|Maintenance Period|Relapsed|0|||
127528245|NCT03364309|458894666|FG002|Maintenance Period|Relapsed|0|||
127528246|NCT03364309|458894667|FG003|Maintenance Period|Relapsed|43|||
127528247|NCT03364309|458894668|FG004|Maintenance Period|Relapsed|7|||
127528248|NCT03364309|458894669|FG005|Maintenance Period|Relapsed|45|||
127528249|NCT03364309|458894670|FG006|Maintenance Period|Relapsed|10|||
127528250|NCT03364309|458894671|FG007|Maintenance Period|Relapsed|2|||
127528251|NCT03364309|458894672|FG008|Maintenance Period|Relapsed|0|||
127528252|NCT03364309|458894673|FG009|Maintenance Period|Relapsed|0|||
127528253|NCT03364309|458894674|FG010|Maintenance Period|Relapsed|0|||
127528254|NCT03364309|458894675|FG011|Maintenance Period|Relapsed|0|||
127528255|NCT03364309|458894676|FG012|Maintenance Period|Relapsed|0|||
127528256|NCT03364309|458894677|FG013|Maintenance Period|Relapsed|0|||
127528257|NCT03364309|458894678|FG014|Maintenance Period|Relapsed|0|||
127528258|NCT03364309|458894679|FG015|Maintenance Period|Relapsed|0|||
127528259|NCT03364309|458894680|FG016|Maintenance Period|Relapsed|0|||
127528260|NCT03364309|458894681|FG017|Maintenance Period|Relapsed|0|||
127528261|NCT03364309|458894682|FG018|Maintenance Period|Relapsed|0|||
127528262|NCT03364309|458894664|FG000|Maintenance Period|Lack of Efficacy|0|||
127528263|NCT03364309|458894665|FG001|Maintenance Period|Lack of Efficacy|0|||
127528264|NCT03364309|458894666|FG002|Maintenance Period|Lack of Efficacy|0|||
127528265|NCT03364309|458894667|FG003|Maintenance Period|Lack of Efficacy|0|||
127528266|NCT03364309|458894668|FG004|Maintenance Period|Lack of Efficacy|0|||
127528267|NCT03364309|458894669|FG005|Maintenance Period|Lack of Efficacy|0|||
127528268|NCT03364309|458894670|FG006|Maintenance Period|Lack of Efficacy|0|||
127528269|NCT03364309|458894671|FG007|Maintenance Period|Lack of Efficacy|0|||
127528270|NCT03364309|458894672|FG008|Maintenance Period|Lack of Efficacy|1|||
127528271|NCT03364309|458894673|FG009|Maintenance Period|Lack of Efficacy|3|||
127528272|NCT03364309|458894674|FG010|Maintenance Period|Lack of Efficacy|2|||
127528273|NCT03364309|458894675|FG011|Maintenance Period|Lack of Efficacy|0|||
127528274|NCT03364309|458894676|FG012|Maintenance Period|Lack of Efficacy|0|||
127528275|NCT03364309|458894677|FG013|Maintenance Period|Lack of Efficacy|0|||
127528276|NCT03364309|458894678|FG014|Maintenance Period|Lack of Efficacy|0|||
127528277|NCT03364309|458894679|FG015|Maintenance Period|Lack of Efficacy|0|||
127528278|NCT03364309|458894680|FG016|Maintenance Period|Lack of Efficacy|0|||
127528279|NCT03364309|458894681|FG017|Maintenance Period|Lack of Efficacy|0|||
127528280|NCT03364309|458894682|FG018|Maintenance Period|Lack of Efficacy|0|||
127528281|NCT03364309|458894664|FG000|Maintenance Period|Death|0|||
127528282|NCT03364309|458894665|FG001|Maintenance Period|Death|0|||
127528283|NCT03364309|458894666|FG002|Maintenance Period|Death|0|||
127528284|NCT03364309|458894667|FG003|Maintenance Period|Death|0|||
127528285|NCT03364309|458894668|FG004|Maintenance Period|Death|0|||
127528286|NCT03364309|458894669|FG005|Maintenance Period|Death|0|||
127528287|NCT03364309|458894670|FG006|Maintenance Period|Death|0|||
127528288|NCT03364309|458894671|FG007|Maintenance Period|Death|0|||
127528289|NCT03364309|458894672|FG008|Maintenance Period|Death|1|||
127528290|NCT03364309|458894673|FG009|Maintenance Period|Death|0|||
127528291|NCT03364309|458894674|FG010|Maintenance Period|Death|0|||
127528292|NCT03364309|458894675|FG011|Maintenance Period|Death|0|||
127528293|NCT03364309|458894676|FG012|Maintenance Period|Death|0|||
127528294|NCT03364309|458894677|FG013|Maintenance Period|Death|0|||
127528295|NCT03364309|458894678|FG014|Maintenance Period|Death|0|||
127528296|NCT03364309|458894679|FG015|Maintenance Period|Death|0|||
127528297|NCT03364309|458894680|FG016|Maintenance Period|Death|0|||
127528298|NCT03364309|458894681|FG017|Maintenance Period|Death|0|||
127528299|NCT03364309|458894682|FG018|Maintenance Period|Death|0|||
127528300|NCT03364309|458894664|FG000|Maintenance Period|Lost to Follow-up|0|||
127528301|NCT03364309|458894665|FG001|Maintenance Period|Lost to Follow-up|0|||
127528302|NCT03364309|458894666|FG002|Maintenance Period|Lost to Follow-up|0|||
127528303|NCT03364309|458894667|FG003|Maintenance Period|Lost to Follow-up|0|||
127528304|NCT03364309|458894668|FG004|Maintenance Period|Lost to Follow-up|0|||
127528305|NCT03364309|458894669|FG005|Maintenance Period|Lost to Follow-up|0|||
127528306|NCT03364309|458894670|FG006|Maintenance Period|Lost to Follow-up|0|||
127528307|NCT03364309|458894671|FG007|Maintenance Period|Lost to Follow-up|0|||
127528308|NCT03364309|458894672|FG008|Maintenance Period|Lost to Follow-up|1|||
127528309|NCT03364309|458894673|FG009|Maintenance Period|Lost to Follow-up|0|||
127528310|NCT03364309|458894674|FG010|Maintenance Period|Lost to Follow-up|0|||
127528311|NCT03364309|458894675|FG011|Maintenance Period|Lost to Follow-up|0|||
127528312|NCT03364309|458894676|FG012|Maintenance Period|Lost to Follow-up|0|||
127528313|NCT03364309|458894677|FG013|Maintenance Period|Lost to Follow-up|0|||
127528314|NCT03364309|458894678|FG014|Maintenance Period|Lost to Follow-up|0|||
127528315|NCT03364309|458894679|FG015|Maintenance Period|Lost to Follow-up|0|||
127528316|NCT03364309|458894680|FG016|Maintenance Period|Lost to Follow-up|0|||
127528317|NCT03364309|458894681|FG017|Maintenance Period|Lost to Follow-up|0|||
127528318|NCT03364309|458894682|FG018|Maintenance Period|Lost to Follow-up|0|||
127528319|NCT03364309|458894664|FG000|Maintenance Period|Miscellaneous|0|||
127528320|NCT03364309|458894665|FG001|Maintenance Period|Miscellaneous|0|||
127528321|NCT03364309|458894666|FG002|Maintenance Period|Miscellaneous|0|||
127528322|NCT03364309|458894667|FG003|Maintenance Period|Miscellaneous|0|||
127528323|NCT03364309|458894668|FG004|Maintenance Period|Miscellaneous|0|||
127528324|NCT03364309|458894669|FG005|Maintenance Period|Miscellaneous|0|||
127528325|NCT03364309|458894670|FG006|Maintenance Period|Miscellaneous|0|||
127528326|NCT03364309|458894671|FG007|Maintenance Period|Miscellaneous|0|||
127528327|NCT03364309|458894672|FG008|Maintenance Period|Miscellaneous|1|||
127528328|NCT03364309|458894673|FG009|Maintenance Period|Miscellaneous|0|||
127528329|NCT03364309|458894674|FG010|Maintenance Period|Miscellaneous|0|||
127528330|NCT03364309|458894675|FG011|Maintenance Period|Miscellaneous|0|||
127528331|NCT03364309|458894676|FG012|Maintenance Period|Miscellaneous|0|||
127528332|NCT03364309|458894677|FG013|Maintenance Period|Miscellaneous|0|||
127528333|NCT03364309|458894678|FG014|Maintenance Period|Miscellaneous|0|||
127528334|NCT03364309|458894679|FG015|Maintenance Period|Miscellaneous|0|||
127528335|NCT03364309|458894680|FG016|Maintenance Period|Miscellaneous|0|||
127528336|NCT03364309|458894681|FG017|Maintenance Period|Miscellaneous|0|||
127528337|NCT03364309|458894682|FG018|Maintenance Period|Miscellaneous|0|||
127528338|NCT03364309|458894664|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
127528339|NCT03364309|458894665|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
127528340|NCT03364309|458894666|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
127528341|NCT03364309|458894667|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
127528342|NCT03364309|458894668|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
127528343|NCT03364309|458894669|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
127528344|NCT03364309|458894670|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
127528345|NCT03364309|458894671|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
127528346|NCT03364309|458894672|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
127528347|NCT03364309|458894673|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
127528348|NCT03364309|458894674|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
127528349|NCT03364309|458894675|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
127528350|NCT03364309|458894676|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
127528351|NCT03364309|458894677|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
127528352|NCT03364309|458894678|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
127528353|NCT03364309|458894679|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
127528354|NCT03364309|458894680|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
127528355|NCT03364309|458894681|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
127528356|NCT03364309|458894682|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
127528357|NCT03364309|458894664|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
127528358|NCT03364309|458894665|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
127528359|NCT03364309|458894666|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
127528360|NCT03364309|458894667|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
127528361|NCT03364309|458894668|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
127528362|NCT03364309|458894669|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
127528363|NCT03364309|458894670|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
127528364|NCT03364309|458894671|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
127528365|NCT03364309|458894672|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
127528366|NCT03364309|458894673|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
127528367|NCT03364309|458894674|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
127528368|NCT03364309|458894675|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
127528369|NCT03364309|458894676|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
127528370|NCT03364309|458894677|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
127528371|NCT03364309|458894678|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
127528372|NCT03364309|458894679|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
127528373|NCT03364309|458894680|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
127528374|NCT03364309|458894681|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
127528375|NCT03364309|458894682|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
127528376|NCT03364309|458894664|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
127528377|NCT03364309|458894665|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
127528378|NCT03364309|458894666|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
127528379|NCT03364309|458894667|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
127528380|NCT03364309|458894668|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
127528381|NCT03364309|458894669|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
127528382|NCT03364309|458894670|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
127528383|NCT03364309|458894671|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
127528384|NCT03364309|458894672|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
127528385|NCT03364309|458894673|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
127528386|NCT03364309|458894674|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
127528387|NCT03364309|458894675|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
127528388|NCT03364309|458894676|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
127528389|NCT03364309|458894677|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
127528390|NCT03364309|458894678|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
127528391|NCT03364309|458894679|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
127528392|NCT03364309|458894680|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
127528393|NCT03364309|458894681|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
127528394|NCT03364309|458894682|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
127528395|NCT03364309|458894664|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
127528396|NCT03364309|458894665|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
127528397|NCT03364309|458894666|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
127528398|NCT03364309|458894667|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
127528399|NCT03364309|458894668|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
127528400|NCT03364309|458894669|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
127528401|NCT03364309|458894670|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
127528402|NCT03364309|458894671|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
127528403|NCT03364309|458894672|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
127528404|NCT03364309|458894673|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
127528405|NCT03364309|458894674|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
127528406|NCT03364309|458894675|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
127528407|NCT03364309|458894676|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
127528408|NCT03364309|458894677|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
127528409|NCT03364309|458894678|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
127528410|NCT03364309|458894679|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
127528411|NCT03364309|458894680|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
127528412|NCT03364309|458894681|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
127528413|NCT03364309|458894682|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
127528414|NCT03364309|458894664|FG000|Post-Treatment Followup Period|Adverse Event|0|||
127528415|NCT03364309|458894665|FG001|Post-Treatment Followup Period|Adverse Event|0|||
127528416|NCT03364309|458894666|FG002|Post-Treatment Followup Period|Adverse Event|0|||
127528417|NCT03364309|458894667|FG003|Post-Treatment Followup Period|Adverse Event|0|||
127528418|NCT03364309|458894668|FG004|Post-Treatment Followup Period|Adverse Event|0|||
127528419|NCT03364309|458894669|FG005|Post-Treatment Followup Period|Adverse Event|0|||
127528420|NCT03364309|458894670|FG006|Post-Treatment Followup Period|Adverse Event|0|||
127528421|NCT03364309|458894671|FG007|Post-Treatment Followup Period|Adverse Event|0|||
127528422|NCT03364309|458894672|FG008|Post-Treatment Followup Period|Adverse Event|0|||
127528423|NCT03364309|458894673|FG009|Post-Treatment Followup Period|Adverse Event|0|||
127528424|NCT03364309|458894674|FG010|Post-Treatment Followup Period|Adverse Event|0|||
127528425|NCT03364309|458894675|FG011|Post-Treatment Followup Period|Adverse Event|0|||
127528426|NCT03364309|458894676|FG012|Post-Treatment Followup Period|Adverse Event|0|||
127528427|NCT03364309|458894677|FG013|Post-Treatment Followup Period|Adverse Event|0|||
127528428|NCT03364309|458894678|FG014|Post-Treatment Followup Period|Adverse Event|0|||
127528429|NCT03364309|458894679|FG015|Post-Treatment Followup Period|Adverse Event|0|||
127528430|NCT03364309|458894680|FG016|Post-Treatment Followup Period|Adverse Event|2|||
127528431|NCT03364309|458894681|FG017|Post-Treatment Followup Period|Adverse Event|6|||
127528432|NCT03364309|458894682|FG018|Post-Treatment Followup Period|Adverse Event|1|||
127528433|NCT03364309|458894664|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
127528434|NCT03364309|458894665|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
127528435|NCT03364309|458894666|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
127528436|NCT03364309|458894667|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
127528437|NCT03364309|458894668|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
127528438|NCT03364309|458894669|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
127528439|NCT03364309|458894670|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
127528440|NCT03364309|458894671|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
127528441|NCT03364309|458894672|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
127528442|NCT03364309|458894673|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
127528443|NCT03364309|458894674|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
127528444|NCT03364309|458894675|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
127528445|NCT03364309|458894676|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
127528446|NCT03364309|458894677|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
127528447|NCT03364309|458894678|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
127528448|NCT03364309|458894679|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
127528449|NCT03364309|458894680|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
127528450|NCT03364309|458894681|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
127528451|NCT03364309|458894682|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
127528452|NCT03364309|458894664|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
127528453|NCT03364309|458894665|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
127528454|NCT03364309|458894666|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
127528455|NCT03364309|458894667|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
127528456|NCT03364309|458894668|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
127528457|NCT03364309|458894669|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
127528458|NCT03364309|458894670|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
127528459|NCT03364309|458894671|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
127528460|NCT03364309|458894672|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
127528461|NCT03364309|458894673|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
127528462|NCT03364309|458894674|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
127528463|NCT03364309|458894675|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
127528464|NCT03364309|458894676|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
127528465|NCT03364309|458894677|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
127528466|NCT03364309|458894678|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
127528467|NCT03364309|458894679|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
127528468|NCT03364309|458894680|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
127528469|NCT03364309|458894681|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
127528470|NCT03364309|458894682|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
127528471|NCT00167310|458894683|FG000|Overall Study|Protocol Violation|5|||
127528472|NCT00167310|458894684|FG001|Overall Study|Protocol Violation|3|||
127528473|NCT00167310|458894683|FG000|Overall Study|Withdrawal by Subject|3|||
127528474|NCT00167310|458894684|FG001|Overall Study|Withdrawal by Subject|7|||
127528475|NCT03304873|458894685|FG000|Overall Study|Lost to Follow-up|1|||
127528476|NCT03304873|458894686|FG001|Overall Study|Lost to Follow-up|8|||
127528477|NCT01546688|458894687|FG000|Overall Study|Adverse Event|0|||
127528478|NCT01546688|458894688|FG001|Overall Study|Adverse Event|4|||
127528479|NCT01546688|458894687|FG000|Overall Study|Withdrawal by Subject|2|||
127528480|NCT01546688|458894688|FG001|Overall Study|Withdrawal by Subject|1|||
127528481|NCT01546688|458894687|FG000|Overall Study|Lack of Efficacy|1|||
127528482|NCT01546688|458894688|FG001|Overall Study|Lack of Efficacy|0|||
127528483|NCT01052077|458894692|FG000|Phase A|Lost to Follow-up|22|||
127528484|NCT01052077|458894693|FG001|Phase A|Lost to Follow-up|0|||
127528485|NCT01052077|458894694|FG002|Phase A|Lost to Follow-up|0|||
127528486|NCT01052077|458894695|FG003|Phase A|Lost to Follow-up|0|||
127528487|NCT01052077|458894692|FG000|Phase A|Adverse Event|32|||
127528488|NCT01052077|458894693|FG001|Phase A|Adverse Event|0|||
127528489|NCT01052077|458894694|FG002|Phase A|Adverse Event|0|||
127528490|NCT01052077|458894695|FG003|Phase A|Adverse Event|0|||
127528491|NCT01052077|458894692|FG000|Phase A|Met Withdrawal Criteria|26|||
127528492|NCT01052077|458894693|FG001|Phase A|Met Withdrawal Criteria|0|||
127528493|NCT01052077|458894694|FG002|Phase A|Met Withdrawal Criteria|0|||
127528494|NCT01052077|458894695|FG003|Phase A|Met Withdrawal Criteria|0|||
127528495|NCT01052077|458894692|FG000|Phase A|Physician Decision|10|||
127528496|NCT01052077|458894693|FG001|Phase A|Physician Decision|0|||
127528497|NCT01052077|458894694|FG002|Phase A|Physician Decision|0|||
127528498|NCT01052077|458894695|FG003|Phase A|Physician Decision|0|||
127528499|NCT01052077|458894692|FG000|Phase A|Withdrawal by Subject|29|||
127528500|NCT01052077|458894693|FG001|Phase A|Withdrawal by Subject|0|||
127528501|NCT01052077|458894694|FG002|Phase A|Withdrawal by Subject|0|||
127528502|NCT01052077|458894695|FG003|Phase A|Withdrawal by Subject|0|||
127528503|NCT01052077|458894692|FG000|Phase A|Protocol Deviation|27|||
127528504|NCT01052077|458894693|FG001|Phase A|Protocol Deviation|0|||
127528505|NCT01052077|458894694|FG002|Phase A|Protocol Deviation|0|||
127528506|NCT01052077|458894695|FG003|Phase A|Protocol Deviation|0|||
127528507|NCT01052077|458894692|FG000|Phase B|Lost to Follow-up|0|||
127528508|NCT01052077|458894693|FG001|Phase B|Lost to Follow-up|2|||
127528509|NCT01052077|458894694|FG002|Phase B|Lost to Follow-up|3|||
127528510|NCT01052077|458894695|FG003|Phase B|Lost to Follow-up|0|||
127528511|NCT01052077|458894692|FG000|Phase B|Adverse Event|0|||
127528512|NCT01052077|458894693|FG001|Phase B|Adverse Event|9|||
127528513|NCT01052077|458894694|FG002|Phase B|Adverse Event|2|||
127528514|NCT01052077|458894695|FG003|Phase B|Adverse Event|0|||
127528515|NCT01052077|458894692|FG000|Phase B|Met Withdrawal Criteria|0|||
127528516|NCT01052077|458894693|FG001|Phase B|Met Withdrawal Criteria|2|||
127528517|NCT01052077|458894694|FG002|Phase B|Met Withdrawal Criteria|1|||
127528518|NCT01052077|458894695|FG003|Phase B|Met Withdrawal Criteria|0|||
127528519|NCT01052077|458894692|FG000|Phase B|Physician Decision|0|||
127528520|NCT01052077|458894693|FG001|Phase B|Physician Decision|1|||
127528521|NCT01052077|458894694|FG002|Phase B|Physician Decision|1|||
127528522|NCT01052077|458894695|FG003|Phase B|Physician Decision|0|||
127528523|NCT01052077|458894692|FG000|Phase B|Withdrawal by Subject|0|||
127528524|NCT01052077|458894693|FG001|Phase B|Withdrawal by Subject|0|||
127528525|NCT01052077|458894694|FG002|Phase B|Withdrawal by Subject|5|||
127528526|NCT01052077|458894695|FG003|Phase B|Withdrawal by Subject|0|||
127528527|NCT01052077|458894692|FG000|Phase B|Protocol Deviation|0|||
127528528|NCT01052077|458894693|FG001|Phase B|Protocol Deviation|3|||
127528529|NCT01052077|458894694|FG002|Phase B|Protocol Deviation|4|||
127528530|NCT01052077|458894695|FG003|Phase B|Protocol Deviation|0|||
127528531|NCT01052077|458894692|FG000|Phase B|Lack of Efficacy|0|||
127528532|NCT01052077|458894693|FG001|Phase B|Lack of Efficacy|1|||
127528533|NCT01052077|458894694|FG002|Phase B|Lack of Efficacy|0|||
127528534|NCT01052077|458894695|FG003|Phase B|Lack of Efficacy|0|||
127528535|NCT01052077|458894692|FG000|Phase A+|Lost to Follow-up|0|||
127528536|NCT01052077|458894693|FG001|Phase A+|Lost to Follow-up|0|||
127528537|NCT01052077|458894694|FG002|Phase A+|Lost to Follow-up|0|||
127528538|NCT01052077|458894695|FG003|Phase A+|Lost to Follow-up|8|||
127528539|NCT01052077|458894692|FG000|Phase A+|Adverse Event|0|||
127528540|NCT01052077|458894693|FG001|Phase A+|Adverse Event|0|||
127528541|NCT01052077|458894694|FG002|Phase A+|Adverse Event|0|||
127528542|NCT01052077|458894695|FG003|Phase A+|Adverse Event|4|||
127528543|NCT01052077|458894692|FG000|Phase A+|Met Withdrawal Criteria|0|||
127528544|NCT01052077|458894693|FG001|Phase A+|Met Withdrawal Criteria|0|||
127528545|NCT01052077|458894694|FG002|Phase A+|Met Withdrawal Criteria|0|||
127528546|NCT01052077|458894695|FG003|Phase A+|Met Withdrawal Criteria|2|||
127528547|NCT01052077|458894692|FG000|Phase A+|Withdrawal by Subject|0|||
127528548|NCT01052077|458894693|FG001|Phase A+|Withdrawal by Subject|0|||
127528549|NCT01052077|458894694|FG002|Phase A+|Withdrawal by Subject|0|||
127528550|NCT01052077|458894695|FG003|Phase A+|Withdrawal by Subject|7|||
127528551|NCT02465203|458894696|FG000|Overall Study|Protocol Violation|1|||
127528552|NCT02465203|458894697|FG001|Overall Study|Protocol Violation|1|||
127528553|NCT02465203|458894698|FG002|Overall Study|Protocol Violation|1|||
127528554|NCT02465203|458894696|FG000|Overall Study|Study terminated by sponsor|50|||
127528555|NCT02465203|458894697|FG001|Overall Study|Study terminated by sponsor|34|||
127528556|NCT02465203|458894698|FG002|Overall Study|Study terminated by sponsor|11|||
127528557|NCT02465203|458894696|FG000|Overall Study|New therapy for study indication|4|||
127528558|NCT02465203|458894697|FG001|Overall Study|New therapy for study indication|0|||
127528559|NCT02465203|458894698|FG002|Overall Study|New therapy for study indication|0|||
127528560|NCT02465203|458894696|FG000|Overall Study|Patient/guardian decision|1|||
127528561|NCT02465203|458894697|FG001|Overall Study|Patient/guardian decision|1|||
127528562|NCT02465203|458894698|FG002|Overall Study|Patient/guardian decision|1|||
127528563|NCT00042991|458894699|FG000|Overall Study|Adverse Event|1|||
127528564|NCT00042991|458894700|FG001|Overall Study|Adverse Event|4|||
127528565|NCT00042991|458894701|FG002|Overall Study|Adverse Event|2|||
127528566|NCT00042991|458894702|FG003|Overall Study|Adverse Event|0|||
127528567|NCT00042991|458894703|FG004|Overall Study|Adverse Event|0|||
127528568|NCT00042991|458894704|FG005|Overall Study|Adverse Event|1|||
127528569|NCT00042991|458894705|FG006|Overall Study|Adverse Event|0|||
127528570|NCT00042991|458894699|FG000|Overall Study|Withdrawal by Subject|0|||
127528571|NCT00042991|458894700|FG001|Overall Study|Withdrawal by Subject|7|||
127528572|NCT00042991|458894701|FG002|Overall Study|Withdrawal by Subject|2|||
127528573|NCT00042991|458894702|FG003|Overall Study|Withdrawal by Subject|0|||
127528574|NCT00042991|458894703|FG004|Overall Study|Withdrawal by Subject|1|||
127528575|NCT00042991|458894704|FG005|Overall Study|Withdrawal by Subject|0|||
127528576|NCT00042991|458894705|FG006|Overall Study|Withdrawal by Subject|0|||
127528577|NCT00042991|458894699|FG000|Overall Study|Disease Progression|5|||
127528578|NCT00042991|458894700|FG001|Overall Study|Disease Progression|29|||
127528579|NCT00042991|458894701|FG002|Overall Study|Disease Progression|2|||
127528580|NCT00042991|458894702|FG003|Overall Study|Disease Progression|2|||
127528581|NCT00042991|458894703|FG004|Overall Study|Disease Progression|1|||
127528582|NCT00042991|458894704|FG005|Overall Study|Disease Progression|4|||
127528583|NCT00042991|458894705|FG006|Overall Study|Disease Progression|2|||
127528584|NCT00042991|458894699|FG000|Overall Study|Alternative Therapy|0|||
127528585|NCT00042991|458894700|FG001|Overall Study|Alternative Therapy|0|||
127528586|NCT00042991|458894701|FG002|Overall Study|Alternative Therapy|0|||
127528587|NCT00042991|458894702|FG003|Overall Study|Alternative Therapy|0|||
127528588|NCT00042991|458894703|FG004|Overall Study|Alternative Therapy|1|||
127528589|NCT00042991|458894704|FG005|Overall Study|Alternative Therapy|0|||
127528590|NCT00042991|458894705|FG006|Overall Study|Alternative Therapy|0|||
127528591|NCT04072887|458894706|FG000|Overall Study|Withdrawal by Subject|3|||
127528592|NCT04072887|458894707|FG001|Overall Study|Withdrawal by Subject|8|||
127528593|NCT04072887|458894708|FG002|Overall Study|Withdrawal by Subject|1|||
127528594|NCT04072887|458894709|FG003|Overall Study|Withdrawal by Subject|3|||
127528595|NCT04072887|458894710|FG004|Overall Study|Withdrawal by Subject|3|||
127528596|NCT04072887|458894711|FG005|Overall Study|Withdrawal by Subject|13|||
127528597|NCT04072887|458894706|FG000|Overall Study|Adverse Event|2|||
127528598|NCT04072887|458894707|FG001|Overall Study|Adverse Event|4|||
127528599|NCT04072887|458894708|FG002|Overall Study|Adverse Event|1|||
127528600|NCT04072887|458894709|FG003|Overall Study|Adverse Event|4|||
127528601|NCT04072887|458894710|FG004|Overall Study|Adverse Event|0|||
127528602|NCT04072887|458894711|FG005|Overall Study|Adverse Event|1|||
127528603|NCT04072887|458894706|FG000|Overall Study|Physician Decision|2|||
127528604|NCT04072887|458894707|FG001|Overall Study|Physician Decision|0|||
127528605|NCT04072887|458894708|FG002|Overall Study|Physician Decision|0|||
127528606|NCT04072887|458894709|FG003|Overall Study|Physician Decision|0|||
127528607|NCT04072887|458894710|FG004|Overall Study|Physician Decision|0|||
127528608|NCT04072887|458894711|FG005|Overall Study|Physician Decision|1|||
127528609|NCT04072887|458894706|FG000|Overall Study|Lost to Follow-up|1|||
127528610|NCT04072887|458894707|FG001|Overall Study|Lost to Follow-up|3|||
127528611|NCT04072887|458894708|FG002|Overall Study|Lost to Follow-up|0|||
127528612|NCT04072887|458894709|FG003|Overall Study|Lost to Follow-up|0|||
127528613|NCT04072887|458894710|FG004|Overall Study|Lost to Follow-up|0|||
127528614|NCT04072887|458894711|FG005|Overall Study|Lost to Follow-up|0|||
127528615|NCT04072887|458894706|FG000|Overall Study|Death|0|||
127528616|NCT04072887|458894707|FG001|Overall Study|Death|2|||
127528617|NCT04072887|458894708|FG002|Overall Study|Death|0|||
127528618|NCT04072887|458894709|FG003|Overall Study|Death|2|||
127528619|NCT04072887|458894710|FG004|Overall Study|Death|3|||
127528620|NCT04072887|458894711|FG005|Overall Study|Death|0|||
127528621|NCT02697435|458894712|FG000|Overall Study|Withdrawal by Subject|1|||
127528622|NCT02697435|458894713|FG001|Overall Study|Withdrawal by Subject|0|||
127528623|NCT02697435|458894712|FG000|Overall Study|Physician Decision|0|||
127528624|NCT02697435|458894713|FG001|Overall Study|Physician Decision|4|||
127528625|NCT04371666|458894714|FG000|DB Treatment Period (52 Weeks)|Adverse Event|3|||
127528626|NCT04371666|458894715|FG001|DB Treatment Period (52 Weeks)|Adverse Event|1|||
127528627|NCT04371666|458894714|FG000|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|1|||
127528628|NCT04371666|458894715|FG001|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
127528629|NCT04371666|458894714|FG000|DB Treatment Period (52 Weeks)|Other than specified|1|||
127528630|NCT04371666|458894715|FG001|DB Treatment Period (52 Weeks)|Other than specified|0|||
127528631|NCT04371666|458894714|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
127528632|NCT04371666|458894715|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
127528633|NCT04371666|458894714|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|40|||
127528634|NCT04371666|458894715|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|41|||
127528635|NCT04371666|458894714|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|1|||
127528636|NCT04371666|458894715|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|0|||
127981171|NCT02326298|460552270|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
127981172|NCT02326298|460552271|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
127528637|NCT00445770|458894722|FG000|Overall Study|Adverse Event|9|||
127528638|NCT00445770|458894723|FG001|Overall Study|Adverse Event|15|||
127528639|NCT00445770|458894724|FG002|Overall Study|Adverse Event|19|||
127528640|NCT00445770|458894722|FG000|Overall Study|Lack of Efficacy|38|||
127528641|NCT00445770|458894723|FG001|Overall Study|Lack of Efficacy|13|||
127528642|NCT00445770|458894724|FG002|Overall Study|Lack of Efficacy|6|||
127528643|NCT00445770|458894722|FG000|Overall Study|Lost to Follow-up|0|||
127528644|NCT00445770|458894723|FG001|Overall Study|Lost to Follow-up|2|||
127528645|NCT00445770|458894724|FG002|Overall Study|Lost to Follow-up|0|||
127528646|NCT00445770|458894722|FG000|Overall Study|Other|6|||
127528647|NCT00445770|458894723|FG001|Overall Study|Other|5|||
127528648|NCT00445770|458894724|FG002|Overall Study|Other|6|||
127528649|NCT03058692|458896799|FG000|Overall Study|Lost to Follow-up|2|||
127528650|NCT03058692|458896800|FG001|Overall Study|Lost to Follow-up|1|||
127528651|NCT03058692|458896799|FG000|Overall Study|Withdrawal by Subject|1|||
127528652|NCT03058692|458896800|FG001|Overall Study|Withdrawal by Subject|1|||
127528653|NCT01392547|458896801|FG000|Overall Study|Adverse Event|2|||
127528654|NCT01392547|458896801|FG000|Overall Study|Non-compliance|2|||
127528655|NCT01392547|458896801|FG000|Overall Study|Withdrawal criteria|3|||
127528656|NCT01392547|458896801|FG000|Overall Study|Unclassified|1|||
127528657|NCT04421482|458896806|FG000|Overall Study|Physician Decision|1|||
127528658|NCT03329092|458896807|FG000|Overall Study|Other|2|||
127528659|NCT03329092|458896808|FG001|Overall Study|Other|2|||
127528660|NCT03329092|458896807|FG000|Overall Study|Withdrawal by Subject|16|||
127528661|NCT03329092|458896808|FG001|Overall Study|Withdrawal by Subject|3|||
127528662|NCT03329092|458896807|FG000|Overall Study|Physician Decision|1|||
127528663|NCT03329092|458896808|FG001|Overall Study|Physician Decision|0|||
127528664|NCT03329092|458896807|FG000|Overall Study|Death|17|||
127528665|NCT03329092|458896808|FG001|Overall Study|Death|11|||
127528666|NCT03329092|458896807|FG000|Overall Study|Adverse Event|3|||
127528667|NCT03329092|458896808|FG001|Overall Study|Adverse Event|1|||
127528668|NCT03329092|458896807|FG000|Overall Study|Lost to Follow-up|1|||
127528669|NCT03329092|458896808|FG001|Overall Study|Lost to Follow-up|1|||
127528670|NCT05786508|458896809|FG000|Overall Study|Withdrawal by Subject|2|||
127528671|NCT05786508|458896810|FG001|Overall Study|Withdrawal by Subject|0|||
127528672|NCT04426318|458896811|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
127528673|NCT04426318|458896812|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
127528674|NCT02652156|458896814|FG000|Overall Study|Physician Decision|1|||
127528675|NCT02652156|458896815|FG001|Overall Study|Physician Decision|0|||
127528676|NCT02652156|458896816|FG002|Overall Study|Physician Decision|0|||
127528677|NCT02342223|458896818|FG000|Overall Study|Lost to Follow-up|1|||
127528678|NCT01200368|458896825|FG000|Infant Series|Adverse Event|2|||
127528679|NCT01200368|458896826|FG001|Infant Series|Adverse Event|2|||
127528680|NCT01200368|458896827|FG002|Infant Series|Adverse Event|3|||
127528681|NCT01200368|458896825|FG000|Infant Series|Withdrawal by Subject|0|||
127528682|NCT01200368|458896826|FG001|Infant Series|Withdrawal by Subject|2|||
127528683|NCT01200368|458896827|FG002|Infant Series|Withdrawal by Subject|2|||
127528684|NCT01200368|458896825|FG000|Infant Series|Did not meet entrance criteria|0|||
127528685|NCT01200368|458896826|FG001|Infant Series|Did not meet entrance criteria|1|||
127528686|NCT01200368|458896827|FG002|Infant Series|Did not meet entrance criteria|0|||
127528687|NCT01200368|458896825|FG000|Infant Series|Randomized, not vaccinated|0|||
127528688|NCT01200368|458896826|FG001|Infant Series|Randomized, not vaccinated|1|||
127528689|NCT01200368|458896827|FG002|Infant Series|Randomized, not vaccinated|1|||
127528690|NCT01200368|458896825|FG000|Infant Series|Other|1|||
127528691|NCT01200368|458896826|FG001|Infant Series|Other|0|||
127528692|NCT01200368|458896827|FG002|Infant Series|Other|0|||
127528693|NCT01200368|458896825|FG000|After Infant Series|Adverse Event|6|||
127528694|NCT01200368|458896826|FG001|After Infant Series|Adverse Event|6|||
127528695|NCT01200368|458896827|FG002|After Infant Series|Adverse Event|3|||
127528696|NCT01200368|458896825|FG000|After Infant Series|Withdrawal by Subject|10|||
127528697|NCT01200368|458896826|FG001|After Infant Series|Withdrawal by Subject|8|||
127528698|NCT01200368|458896827|FG002|After Infant Series|Withdrawal by Subject|4|||
127528699|NCT01200368|458896825|FG000|After Infant Series|Lost to Follow-up|1|||
127528700|NCT01200368|458896826|FG001|After Infant Series|Lost to Follow-up|0|||
127528701|NCT01200368|458896827|FG002|After Infant Series|Lost to Follow-up|0|||
127528702|NCT01200368|458896825|FG000|After Infant Series|Other|1|||
127528703|NCT01200368|458896826|FG001|After Infant Series|Other|2|||
127528704|NCT01200368|458896827|FG002|After Infant Series|Other|2|||
127528705|NCT01200368|458896825|FG000|Toddler Dose|Adverse Event|0|||
127528706|NCT01200368|458896826|FG001|Toddler Dose|Adverse Event|3|||
127528707|NCT01200368|458896827|FG002|Toddler Dose|Adverse Event|1|||
127528708|NCT00108862|458896828|FG000|Overall Study|Death|31|||
127528709|NCT00108862|458896829|FG001|Overall Study|Death|37|||
127528710|NCT00108862|458896828|FG000|Overall Study|Withdrawal by Subject|10|||
127528711|NCT00108862|458896829|FG001|Overall Study|Withdrawal by Subject|6|||
127528712|NCT00108862|458896828|FG000|Overall Study|Lost to Follow-up|27|||
127528713|NCT00108862|458896829|FG001|Overall Study|Lost to Follow-up|19|||
127528714|NCT03534141|458896830|FG000|Overall Study|Enrolled in other clinical trial|1|||
127528715|NCT03534141|458896831|FG001|Overall Study|Enrolled in other clinical trial|0|||
127528716|NCT03534141|458896830|FG000|Overall Study|Liver transplant aborted after randomization|0|||
127528717|NCT03534141|458896831|FG001|Overall Study|Liver transplant aborted after randomization|2|||
127528718|NCT03534141|458896830|FG000|Overall Study|Liver graft explanted due to surgical issue|0|||
127528719|NCT03534141|458896831|FG001|Overall Study|Liver graft explanted due to surgical issue|1|||
127528720|NCT00566852|458896834|FG000|Overall Study|Protocol Violation|22|||
127528721|NCT00566852|458896835|FG001|Overall Study|Protocol Violation|24|||
127528722|NCT00566852|458896834|FG000|Overall Study|Death|95|||
127528723|NCT00566852|458896835|FG001|Overall Study|Death|78|||
127528724|NCT00566852|458896834|FG000|Overall Study|Withdrawal by Subject|30|||
127528725|NCT00566852|458896835|FG001|Overall Study|Withdrawal by Subject|25|||
127528726|NCT00566852|458896834|FG000|Overall Study|Patient refusal|37|||
127528727|NCT00566852|458896835|FG001|Overall Study|Patient refusal|37|||
127528728|NCT00566852|458896834|FG000|Overall Study|Not tested due to disability|6|||
127528729|NCT00566852|458896835|FG001|Overall Study|Not tested due to disability|12|||
127528730|NCT00566852|458896834|FG000|Overall Study|Missing reason not specified|1|||
127528731|NCT00566852|458896835|FG001|Overall Study|Missing reason not specified|2|||
127528732|NCT00566852|458896834|FG000|Overall Study|Missing reason not reported|16|||
127528733|NCT00566852|458896835|FG001|Overall Study|Missing reason not reported|20|||
127528734|NCT00577824|458896838|FG000|Overall Study|Adverse Event|6|||
127528735|NCT00577824|458896839|FG001|Overall Study|Adverse Event|18|||
127528736|NCT00577824|458896840|FG002|Overall Study|Adverse Event|1|||
127528737|NCT00577824|458896838|FG000|Overall Study|Patient decision|0|||
127528738|NCT00577824|458896839|FG001|Overall Study|Patient decision|1|||
127528739|NCT00577824|458896840|FG002|Overall Study|Patient decision|1|||
127528740|NCT00577824|458896838|FG000|Overall Study|Protocol Violation|1|||
127528741|NCT00577824|458896839|FG001|Overall Study|Protocol Violation|1|||
127528742|NCT00577824|458896840|FG002|Overall Study|Protocol Violation|0|||
127528743|NCT04079816|458896841|FG000|Overall Study|Request of Subject|2|||
127528744|NCT04079816|458896841|FG000|Overall Study|Unable to draw samples|1|||
127528745|NCT04137731|458896842|FG000|Overall Study|Surgery Cancellation|1|||
127528746|NCT04137731|458896843|FG001|Overall Study|Surgery Cancellation|2|||
127528747|NCT04137731|458896842|FG000|Overall Study|Withdrawal by Subject|2|||
127528748|NCT04137731|458896843|FG001|Overall Study|Withdrawal by Subject|0|||
127528749|NCT04137731|458896842|FG000|Overall Study|Protocol Violation|0|||
127528750|NCT04137731|458896843|FG001|Overall Study|Protocol Violation|1|||
127528751|NCT00310817|458896844|FG000|Overall Study|AE or Death|3|||
127528752|NCT00310817|458896845|FG001|Overall Study|AE or Death|1|||
127528753|NCT00310817|458896846|FG002|Overall Study|AE or Death|0|||
127528754|NCT00310817|458896847|FG003|Overall Study|AE or Death|0|||
127528755|NCT00310817|458896844|FG000|Overall Study|Withdrawal by Subject|1|||
127528756|NCT00310817|458896845|FG001|Overall Study|Withdrawal by Subject|4|||
127528757|NCT00310817|458896846|FG002|Overall Study|Withdrawal by Subject|6|||
127528758|NCT00310817|458896847|FG003|Overall Study|Withdrawal by Subject|7|||
127528759|NCT00310817|458896844|FG000|Overall Study|Lost to Follow-up|2|||
127528760|NCT00310817|458896845|FG001|Overall Study|Lost to Follow-up|1|||
127528761|NCT00310817|458896846|FG002|Overall Study|Lost to Follow-up|0|||
127528762|NCT00310817|458896847|FG003|Overall Study|Lost to Follow-up|0|||
127528763|NCT00310817|458896844|FG000|Overall Study|Inappropriate Enrollment|1|||
127528764|NCT00310817|458896845|FG001|Overall Study|Inappropriate Enrollment|0|||
127528765|NCT00310817|458896846|FG002|Overall Study|Inappropriate Enrollment|1|||
127528766|NCT00310817|458896847|FG003|Overall Study|Inappropriate Enrollment|0|||
127528767|NCT00310817|458896844|FG000|Overall Study|Protocol Violation|1|||
127528768|NCT00310817|458896845|FG001|Overall Study|Protocol Violation|1|||
127528769|NCT00310817|458896846|FG002|Overall Study|Protocol Violation|1|||
127528770|NCT00310817|458896847|FG003|Overall Study|Protocol Violation|1|||
127528771|NCT00310817|458896844|FG000|Overall Study|Unable to classify|3|||
127528772|NCT00310817|458896845|FG001|Overall Study|Unable to classify|1|||
127528773|NCT00310817|458896846|FG002|Overall Study|Unable to classify|0|||
127528774|NCT00310817|458896847|FG003|Overall Study|Unable to classify|0|||
127528775|NCT01702246|458896848|FG000|Overall Study|Lost to Follow-up|2|||
127528776|NCT01702246|458896848|FG000|Overall Study|Withdrawal by Subject|2|||
127528777|NCT01702246|458896848|FG000|Overall Study|Physician Decision|1|||
127528778|NCT01587040|458896849|FG000|Overall Study|Protocol Violation|0|||
127528779|NCT01587040|458896850|FG001|Overall Study|Protocol Violation|0|||
127528780|NCT01587040|458896851|FG002|Overall Study|Protocol Violation|1|||
127528781|NCT01587040|458896852|FG003|Overall Study|Protocol Violation|0|||
127528782|NCT01587040|458896849|FG000|Overall Study|Adverse Event|0|||
127528783|NCT01587040|458896850|FG001|Overall Study|Adverse Event|1|||
127528784|NCT01587040|458896851|FG002|Overall Study|Adverse Event|10|||
127528785|NCT01587040|458896852|FG003|Overall Study|Adverse Event|0|||
127528786|NCT01587040|458896849|FG000|Overall Study|Disease progression|12|||
127528787|NCT01587040|458896850|FG001|Overall Study|Disease progression|1|||
127528788|NCT01587040|458896851|FG002|Overall Study|Disease progression|15|||
127528789|NCT01587040|458896852|FG003|Overall Study|Disease progression|3|||
127528790|NCT01587040|458896849|FG000|Overall Study|Other than specified|5|||
127528791|NCT01587040|458896850|FG001|Overall Study|Other than specified|1|||
127528792|NCT01587040|458896851|FG002|Overall Study|Other than specified|11|||
127528793|NCT01587040|458896852|FG003|Overall Study|Other than specified|1|||
127528794|NCT03724890|458896855|FG000|Overall Study|Death|2|||
127528795|NCT03724890|458896856|FG001|Overall Study|Death|6|||
127528796|NCT03724890|458896857|FG002|Overall Study|Death|3|||
127528797|NCT03724890|458896858|FG003|Overall Study|Death|5|||
127528798|NCT03724890|458896859|FG004|Overall Study|Death|2|||
127528799|NCT03724890|458896860|FG005|Overall Study|Death|0|||
127528800|NCT03724890|458896861|FG006|Overall Study|Death|2|||
127528801|NCT03724890|458896862|FG007|Overall Study|Death|3|||
127528802|NCT03724890|458896863|FG008|Overall Study|Death|4|||
127528803|NCT03724890|458896864|FG009|Overall Study|Death|2|||
127528804|NCT03724890|458896865|FG010|Overall Study|Death|2|||
127528805|NCT03724890|458896855|FG000|Overall Study|Lost to Follow-up|0|||
127528806|NCT03724890|458896856|FG001|Overall Study|Lost to Follow-up|3|||
127528807|NCT03724890|458896857|FG002|Overall Study|Lost to Follow-up|0|||
127528808|NCT03724890|458896858|FG003|Overall Study|Lost to Follow-up|1|||
127528809|NCT03724890|458896859|FG004|Overall Study|Lost to Follow-up|2|||
127528810|NCT03724890|458896860|FG005|Overall Study|Lost to Follow-up|2|||
127528811|NCT03724890|458896861|FG006|Overall Study|Lost to Follow-up|1|||
127528812|NCT03724890|458896862|FG007|Overall Study|Lost to Follow-up|0|||
127528813|NCT03724890|458896863|FG008|Overall Study|Lost to Follow-up|2|||
127528814|NCT03724890|458896864|FG009|Overall Study|Lost to Follow-up|0|||
127528815|NCT03724890|458896865|FG010|Overall Study|Lost to Follow-up|0|||
127528816|NCT03724890|458896855|FG000|Overall Study|Withdrawal by Subject|1|||
127528817|NCT03724890|458896856|FG001|Overall Study|Withdrawal by Subject|2|||
127528818|NCT03724890|458896857|FG002|Overall Study|Withdrawal by Subject|1|||
127528819|NCT03724890|458896858|FG003|Overall Study|Withdrawal by Subject|0|||
127528820|NCT03724890|458896859|FG004|Overall Study|Withdrawal by Subject|0|||
127528821|NCT03724890|458896860|FG005|Overall Study|Withdrawal by Subject|1|||
127528822|NCT03724890|458896861|FG006|Overall Study|Withdrawal by Subject|0|||
127528823|NCT03724890|458896862|FG007|Overall Study|Withdrawal by Subject|0|||
127528824|NCT03724890|458896863|FG008|Overall Study|Withdrawal by Subject|2|||
127528825|NCT03724890|458896864|FG009|Overall Study|Withdrawal by Subject|2|||
127528826|NCT03724890|458896865|FG010|Overall Study|Withdrawal by Subject|1|||
127528827|NCT03724890|458896855|FG000|Overall Study|Other|1|||
127528828|NCT03724890|458896856|FG001|Overall Study|Other|0|||
127528829|NCT03724890|458896857|FG002|Overall Study|Other|0|||
127528830|NCT03724890|458896858|FG003|Overall Study|Other|0|||
127528831|NCT03724890|458896859|FG004|Overall Study|Other|0|||
127528832|NCT03724890|458896860|FG005|Overall Study|Other|0|||
127528833|NCT03724890|458896861|FG006|Overall Study|Other|0|||
127528834|NCT03724890|458896862|FG007|Overall Study|Other|1|||
127528835|NCT03724890|458896863|FG008|Overall Study|Other|1|||
127528836|NCT03724890|458896864|FG009|Overall Study|Other|0|||
127528837|NCT03724890|458896865|FG010|Overall Study|Other|2|||
127528838|NCT04607837|458896868|FG000|Overall Study|Adverse Event|8|||
127528839|NCT04607837|458896869|FG001|Overall Study|Adverse Event|2|||
127528840|NCT04607837|458896868|FG000|Overall Study|Withdrawal by Subject|8|||
127528841|NCT04607837|458896869|FG001|Overall Study|Withdrawal by Subject|7|||
127528842|NCT04607837|458896868|FG000|Overall Study|Physician Decision|2|||
127528843|NCT04607837|458896869|FG001|Overall Study|Physician Decision|0|||
127528844|NCT04607837|458896868|FG000|Overall Study|Lack of Efficacy|2|||
127528845|NCT04607837|458896869|FG001|Overall Study|Lack of Efficacy|0|||
127528846|NCT04607837|458896868|FG000|Overall Study|Participant terminated by sponsor|1|||
127528847|NCT04607837|458896869|FG001|Overall Study|Participant terminated by sponsor|0|||
127528848|NCT04607837|458896868|FG000|Overall Study|Disease worsening|36|||
127528849|NCT04607837|458896869|FG001|Overall Study|Disease worsening|36|||
127528850|NCT04607837|458896868|FG000|Overall Study|Other|1|||
127528851|NCT04607837|458896869|FG001|Overall Study|Other|0|||
127528852|NCT02123823|458896871|FG000|Overall Study|Lack of Efficacy|0|||
127528853|NCT02123823|458896872|FG001|Overall Study|Lack of Efficacy|2|||
127528854|NCT02123823|458896873|FG002|Overall Study|Lack of Efficacy|8|||
127528855|NCT02123823|458896874|FG003|Overall Study|Lack of Efficacy|10|||
127528856|NCT02123823|458896871|FG000|Overall Study|Progressive disease|3|||
127528857|NCT02123823|458896872|FG001|Overall Study|Progressive disease|19|||
127528858|NCT02123823|458896873|FG002|Overall Study|Progressive disease|52|||
127528859|NCT02123823|458896874|FG003|Overall Study|Progressive disease|53|||
127528860|NCT02123823|458896871|FG000|Overall Study|Withdrawal by Subject|0|||
127528861|NCT02123823|458896872|FG001|Overall Study|Withdrawal by Subject|0|||
127528862|NCT02123823|458896873|FG002|Overall Study|Withdrawal by Subject|7|||
127528863|NCT02123823|458896874|FG003|Overall Study|Withdrawal by Subject|2|||
127528864|NCT02123823|458896871|FG000|Overall Study|Adverse Event|0|||
127528865|NCT02123823|458896872|FG001|Overall Study|Adverse Event|0|||
127528866|NCT02123823|458896873|FG002|Overall Study|Adverse Event|3|||
127528867|NCT02123823|458896874|FG003|Overall Study|Adverse Event|5|||
127528868|NCT04346654|458896876|FG000|Overall Study|Adverse Event|2|||
127528869|NCT04346654|458896877|FG001|Overall Study|Adverse Event|0|||
127528870|NCT04346654|458896876|FG000|Overall Study|Non-response|1|||
127528871|NCT04346654|458896877|FG001|Overall Study|Non-response|1|||
127528872|NCT04346654|458896876|FG000|Overall Study|Withdrawal by Subject|2|||
127528873|NCT04346654|458896877|FG001|Overall Study|Withdrawal by Subject|0|||
127528874|NCT04346654|458896876|FG000|Overall Study|Lost to Follow-up|0|||
127528875|NCT04346654|458896877|FG001|Overall Study|Lost to Follow-up|1|||
127528876|NCT04346654|458896876|FG000|Overall Study|Pregnancy|0|||
127528877|NCT04346654|458896877|FG001|Overall Study|Pregnancy|1|||
127528878|NCT05870865|458896882|FG000|Randomized|Did not receive study treatment|2|||
127528879|NCT05870865|458896883|FG001|Randomized|Did not receive study treatment|4|||
127528880|NCT05870865|458896884|FG002|Randomized|Did not receive study treatment|4|||
127528881|NCT05870865|458896885|FG003|Randomized|Did not receive study treatment|3|||
127528882|NCT05870865|458896882|FG000|Treatment Period|Adverse Event|1|||
127528883|NCT05870865|458896883|FG001|Treatment Period|Adverse Event|1|||
127528884|NCT05870865|458896884|FG002|Treatment Period|Adverse Event|1|||
127528885|NCT05870865|458896885|FG003|Treatment Period|Adverse Event|1|||
127528886|NCT05870865|458896882|FG000|Treatment Period|Lost to Follow-up|0|||
127528887|NCT05870865|458896883|FG001|Treatment Period|Lost to Follow-up|1|||
127528888|NCT05870865|458896884|FG002|Treatment Period|Lost to Follow-up|2|||
127528889|NCT05870865|458896885|FG003|Treatment Period|Lost to Follow-up|0|||
127528890|NCT05870865|458896882|FG000|Treatment Period|Protocol Violation|0|||
127528891|NCT05870865|458896883|FG001|Treatment Period|Protocol Violation|0|||
127528892|NCT05870865|458896884|FG002|Treatment Period|Protocol Violation|0|||
127528893|NCT05870865|458896885|FG003|Treatment Period|Protocol Violation|1|||
127528894|NCT05870865|458896882|FG000|Treatment Period|Withdrawal by Subject|0|||
127528895|NCT05870865|458896883|FG001|Treatment Period|Withdrawal by Subject|1|||
127528896|NCT05870865|458896884|FG002|Treatment Period|Withdrawal by Subject|1|||
127528897|NCT05870865|458896885|FG003|Treatment Period|Withdrawal by Subject|1|||
127528898|NCT05715242|458896886|FG000|Overall Study|Lost to Follow-up|0|||
127528899|NCT05715242|458896887|FG001|Overall Study|Lost to Follow-up|0|||
127528900|NCT05715242|458896888|FG002|Overall Study|Lost to Follow-up|1|||
127528901|NCT05715242|458896889|FG003|Overall Study|Lost to Follow-up|0|||
127528902|NCT05715242|458896890|FG004|Overall Study|Lost to Follow-up|0|||
127528903|NCT05715242|458896891|FG005|Overall Study|Lost to Follow-up|1|||
127528904|NCT05715242|458896892|FG006|Overall Study|Lost to Follow-up|0|||
127528905|NCT05715242|458896893|FG007|Overall Study|Lost to Follow-up|0|||
127528906|NCT05715242|458896894|FG008|Overall Study|Lost to Follow-up|0|||
127528907|NCT05715242|458896895|FG009|Overall Study|Lost to Follow-up|0|||
127528908|NCT05715242|458896896|FG010|Overall Study|Lost to Follow-up|0|||
127528909|NCT05715242|458896897|FG011|Overall Study|Lost to Follow-up|0|||
127528910|NCT05715242|458896898|FG012|Overall Study|Lost to Follow-up|0|||
127528911|NCT05715242|458896899|FG013|Overall Study|Lost to Follow-up|0|||
127528912|NCT05715242|458896900|FG014|Overall Study|Lost to Follow-up|0|||
127528913|NCT05715242|458896901|FG015|Overall Study|Lost to Follow-up|0|||
127528914|NCT02915978|458896902|FG000|Overall Study|Adverse Event|2|||
127528915|NCT02915978|458896903|FG001|Overall Study|Adverse Event|1|||
127528916|NCT02915978|458896904|FG002|Overall Study|Adverse Event|0|||
127528917|NCT02343406|458896910|FG000|Overall Study|Progressive disease|72|||
127528918|NCT02343406|458896911|FG001|Overall Study|Progressive disease|70|||
127528919|NCT02343406|458896912|FG002|Overall Study|Progressive disease|43|||
127528920|NCT02343406|458896913|FG003|Overall Study|Progressive disease|15|||
127528921|NCT02343406|458896914|FG004|Overall Study|Progressive disease|5|||
127528922|NCT02343406|458896910|FG000|Overall Study|Adverse Event|6|||
127528923|NCT02343406|458896911|FG001|Overall Study|Adverse Event|8|||
127528924|NCT02343406|458896912|FG002|Overall Study|Adverse Event|6|||
127528925|NCT02343406|458896913|FG003|Overall Study|Adverse Event|3|||
127528926|NCT02343406|458896914|FG004|Overall Study|Adverse Event|0|||
127528927|NCT02343406|458896910|FG000|Overall Study|Withdrawal by Subject|6|||
127528928|NCT02343406|458896911|FG001|Overall Study|Withdrawal by Subject|4|||
127528929|NCT02343406|458896912|FG002|Overall Study|Withdrawal by Subject|8|||
127528930|NCT02343406|458896913|FG003|Overall Study|Withdrawal by Subject|3|||
127528931|NCT02343406|458896914|FG004|Overall Study|Withdrawal by Subject|0|||
127528932|NCT02343406|458896910|FG000|Overall Study|Death|2|||
127528933|NCT02343406|458896911|FG001|Overall Study|Death|1|||
127528934|NCT02343406|458896912|FG002|Overall Study|Death|0|||
127528935|NCT02343406|458896913|FG003|Overall Study|Death|0|||
127528936|NCT02343406|458896914|FG004|Overall Study|Death|0|||
127528937|NCT02343406|458896910|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
127528938|NCT02343406|458896911|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
127528939|NCT02343406|458896912|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
127528940|NCT02343406|458896913|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
127528941|NCT02343406|458896914|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
127528942|NCT02343406|458896910|FG000|Overall Study|Other primary malignancy|0|||
127528943|NCT02343406|458896911|FG001|Overall Study|Other primary malignancy|1|||
127528944|NCT02343406|458896912|FG002|Overall Study|Other primary malignancy|0|||
127528945|NCT02343406|458896913|FG003|Overall Study|Other primary malignancy|0|||
127528946|NCT02343406|458896914|FG004|Overall Study|Other primary malignancy|0|||
127528947|NCT02343406|458896910|FG000|Overall Study|Other, not specified|2|||
127528948|NCT02343406|458896911|FG001|Overall Study|Other, not specified|1|||
127528949|NCT02343406|458896912|FG002|Overall Study|Other, not specified|1|||
127528950|NCT02343406|458896913|FG003|Overall Study|Other, not specified|4|||
127528951|NCT02343406|458896914|FG004|Overall Study|Other, not specified|0|||
127528952|NCT02451124|458896915|FG000|Overall Study|Withdrawal by Subject|1|||
127528953|NCT00958165|458896916|FG000|Overall Study|Lost to Follow-up|5|||
127528954|NCT00958165|458896916|FG000|Overall Study|Not eligible|9|||
127528955|NCT00766051|458896918|FG000|Overall Study|Withdrawal by Subject|2|||
127528956|NCT00766051|458896919|FG001|Overall Study|Withdrawal by Subject|0|||
127528957|NCT00195663|458896920|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
127528958|NCT00195663|458896921|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
127528959|NCT00195663|458896922|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
127528960|NCT00195663|458896920|FG000|2-year Double-blind Treatment Period|Death|0|||
127528961|NCT00195663|458896921|FG001|2-year Double-blind Treatment Period|Death|2|||
127528962|NCT00195663|458896922|FG002|2-year Double-blind Treatment Period|Death|0|||
127528963|NCT00195663|458896920|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
127528964|NCT00195663|458896921|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
127528965|NCT00195663|458896922|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
127528966|NCT00195663|458896920|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
127528967|NCT00195663|458896921|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
127528968|NCT00195663|458896922|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
127528969|NCT00195663|458896920|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
127528970|NCT00195663|458896921|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
127528971|NCT00195663|458896922|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
127528972|NCT00195663|458896920|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
127528973|NCT00195663|458896921|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
127528974|NCT00195663|458896922|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
127528975|NCT00195663|458896920|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
127528976|NCT00195663|458896921|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
127528977|NCT00195663|458896922|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
127528978|NCT00195663|458896920|FG000|2-year Double-blind Treatment Period|Recovery|1|||
127528979|NCT00195663|458896921|FG001|2-year Double-blind Treatment Period|Recovery|0|||
127528980|NCT00195663|458896922|FG002|2-year Double-blind Treatment Period|Recovery|1|||
127528981|NCT00195663|458896920|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
127528982|NCT00195663|458896921|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
127528983|NCT00195663|458896922|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
127528984|NCT00195663|458896920|FG000|Open-Label Extension Period|Adverse Event|21|||
127528985|NCT00195663|458896921|FG001|Open-Label Extension Period|Adverse Event|32|||
127528986|NCT00195663|458896922|FG002|Open-Label Extension Period|Adverse Event|36|||
127528987|NCT00195663|458896920|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
127528988|NCT00195663|458896921|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
127528989|NCT00195663|458896922|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
127528990|NCT00195663|458896920|FG000|Open-Label Extension Period|Recovery|0|||
127528991|NCT00195663|458896921|FG001|Open-Label Extension Period|Recovery|2|||
127528992|NCT00195663|458896922|FG002|Open-Label Extension Period|Recovery|2|||
127528993|NCT00195663|458896920|FG000|Open-Label Extension Period|Protocol Violation|3|||
127528994|NCT00195663|458896921|FG001|Open-Label Extension Period|Protocol Violation|4|||
127528995|NCT00195663|458896922|FG002|Open-Label Extension Period|Protocol Violation|4|||
127528996|NCT00195663|458896920|FG000|Open-Label Extension Period|Death|2|||
127528997|NCT00195663|458896921|FG001|Open-Label Extension Period|Death|2|||
127528998|NCT00195663|458896922|FG002|Open-Label Extension Period|Death|2|||
127528999|NCT00195663|458896920|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
127529000|NCT00195663|458896921|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
127529001|NCT00195663|458896922|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
127529002|NCT00195663|458896920|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
127529003|NCT00195663|458896921|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
127529004|NCT00195663|458896922|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
127529005|NCT00195663|458896920|FG000|Open-Label Extension Period|Administrative reasons|11|||
127529006|NCT00195663|458896921|FG001|Open-Label Extension Period|Administrative reasons|11|||
127529007|NCT00195663|458896922|FG002|Open-Label Extension Period|Administrative reasons|13|||
127529008|NCT00604695|458896923|FG000|Overall Study|Did not receive first bolus.|0|||
127529009|NCT00604695|458896924|FG001|Overall Study|Did not receive first bolus.|4|||
127529010|NCT02058563|458896928|FG000|Overall Study|Lost to Follow-up|26|||
127529011|NCT02058563|458896929|FG001|Overall Study|Lost to Follow-up|22|||
127529012|NCT02058563|458896928|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
127529013|NCT02058563|458896929|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
127529014|NCT02058563|458896928|FG000|Overall Study|Consent Withdrawal|1|||
127529015|NCT02058563|458896929|FG001|Overall Study|Consent Withdrawal|1|||
127529016|NCT02058563|458896928|FG000|Overall Study|Other (patient incarcerated)|0|||
127529017|NCT02058563|458896929|FG001|Overall Study|Other (patient incarcerated)|1|||
127529018|NCT00166439|458896930|FG000|Overall Study|Ineligible|5|||
127529019|NCT04039217|458896931|FG000|Overall Study|Lost to Follow-up|1|||
127529020|NCT00615992|458896932|FG000|Overall Study|Protocol Violation|67|||
127529021|NCT01868477|458896933|FG000|Overall Study|Adverse Event|2|||
127529022|NCT01868477|458896934|FG001|Overall Study|Adverse Event|4|||
127529023|NCT01868477|458896933|FG000|Overall Study|Disease progression|1|||
127529024|NCT01868477|458896934|FG001|Overall Study|Disease progression|1|||
127529025|NCT01868477|458896933|FG000|Overall Study|Withdrawal by Subject|1|||
127529026|NCT01868477|458896934|FG001|Overall Study|Withdrawal by Subject|0|||
127529027|NCT00856297|458896940|FG000|Overall Study|Unable to classify|2|||
127529028|NCT00856297|458896941|FG001|Overall Study|Unable to classify|0|||
127529029|NCT00856297|458896942|FG002|Overall Study|Unable to classify|0|||
127529030|NCT00856297|458896943|FG003|Overall Study|Unable to classify|0|||
127529031|NCT00856297|458896944|FG004|Overall Study|Unable to classify|0|||
127529032|NCT00811174|458896953|FG000|Overall Study|Protocol Violation|2|||
127529033|NCT00811174|458896953|FG000|Overall Study|Sponsors Decision|1|||
127529034|NCT01362608|458898454|FG000|Overall Study|Protocol Violation|0|||
127529035|NCT01362608|458898455|FG001|Overall Study|Protocol Violation|1|||
127529036|NCT01362608|458898454|FG000|Overall Study|Lost to Follow-up|3|||
127529037|NCT01362608|458898455|FG001|Overall Study|Lost to Follow-up|1|||
127529038|NCT01362608|458898454|FG000|Overall Study|Withdrawal by Subject|1|||
127529039|NCT01362608|458898455|FG001|Overall Study|Withdrawal by Subject|2|||
127529040|NCT01362608|458898454|FG000|Overall Study|Lack of Efficacy|0|||
127529041|NCT01362608|458898455|FG001|Overall Study|Lack of Efficacy|2|||
127529042|NCT01362608|458898454|FG000|Overall Study|Adverse Event|0|||
127529043|NCT01362608|458898455|FG001|Overall Study|Adverse Event|2|||
127529044|NCT04506502|458898458|FG000|Overall Study|Withdrawal by Subject|1|||
127529045|NCT04506502|458898458|FG000|Overall Study|Illness and subsequent quarantine requirements related to SARS-CoV-2 local guidelines|1|||
127529046|NCT03526146|458898459|FG000|Overall Study|Lost to Follow-up|5|||
127529047|NCT03526146|458898459|FG000|Overall Study|Withdrawal by Subject|6|||
127529048|NCT03526146|458898459|FG000|Overall Study|class canceled due to COVID-19|4|||
127529049|NCT02517541|458898462|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
127529050|NCT02517541|458898462|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
127529051|NCT02517541|458898462|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
127529052|NCT02517541|458898462|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
127529053|NCT02517541|458898462|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
127529054|NCT02517541|458898462|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
127529055|NCT00699608|458898463|FG000|First Intervention|Withdrawal by Subject|0|||
127529056|NCT00699608|458898464|FG001|First Intervention|Withdrawal by Subject|0|||
127529057|NCT00699608|458898465|FG002|First Intervention|Withdrawal by Subject|1|||
127529058|NCT00699608|458898466|FG003|First Intervention|Withdrawal by Subject|0|||
127529059|NCT00699608|458898467|FG004|First Intervention|Withdrawal by Subject|0|||
127529060|NCT00699608|458898468|FG005|First Intervention|Withdrawal by Subject|0|||
127529061|NCT00699608|458898463|FG000|First Intervention|Protocol Violation|0|||
127529062|NCT00699608|458898464|FG001|First Intervention|Protocol Violation|0|||
127529063|NCT00699608|458898465|FG002|First Intervention|Protocol Violation|0|||
127529064|NCT00699608|458898466|FG003|First Intervention|Protocol Violation|0|||
127529065|NCT00699608|458898467|FG004|First Intervention|Protocol Violation|1|||
127529066|NCT00699608|458898468|FG005|First Intervention|Protocol Violation|0|||
127529067|NCT00699608|458898463|FG000|Second Intervention|Adverse Event|0|||
127529068|NCT00699608|458898464|FG001|Second Intervention|Adverse Event|0|||
127529069|NCT00699608|458898465|FG002|Second Intervention|Adverse Event|1|||
127529070|NCT00699608|458898466|FG003|Second Intervention|Adverse Event|0|||
127529071|NCT00699608|458898467|FG004|Second Intervention|Adverse Event|0|||
127529072|NCT00699608|458898468|FG005|Second Intervention|Adverse Event|0|||
127529073|NCT00699608|458898463|FG000|Second Intervention|Withdrawal by Subject|0|||
127529074|NCT00699608|458898464|FG001|Second Intervention|Withdrawal by Subject|0|||
127529075|NCT00699608|458898465|FG002|Second Intervention|Withdrawal by Subject|0|||
127529076|NCT00699608|458898466|FG003|Second Intervention|Withdrawal by Subject|1|||
127529077|NCT00699608|458898467|FG004|Second Intervention|Withdrawal by Subject|0|||
127529078|NCT00699608|458898468|FG005|Second Intervention|Withdrawal by Subject|0|||
127529079|NCT01510158|458898469|FG000|Overall Study|Adverse Event|7|||
127529080|NCT01510158|458898470|FG001|Overall Study|Adverse Event|8|||
127529081|NCT01510158|458898471|FG002|Overall Study|Adverse Event|5|||
127529082|NCT01510158|458898469|FG000|Overall Study|Gout flare|1|||
127529083|NCT01510158|458898470|FG001|Overall Study|Gout flare|0|||
127529084|NCT01510158|458898471|FG002|Overall Study|Gout flare|0|||
127529085|NCT01510158|458898469|FG000|Overall Study|Protocol Violation|17|||
127529086|NCT01510158|458898470|FG001|Overall Study|Protocol Violation|16|||
127529087|NCT01510158|458898471|FG002|Overall Study|Protocol Violation|24|||
127529088|NCT01510158|458898469|FG000|Overall Study|Sponsor terminated study.|2|||
127529089|NCT01510158|458898470|FG001|Overall Study|Sponsor terminated study.|0|||
127529090|NCT01510158|458898471|FG002|Overall Study|Sponsor terminated study.|2|||
127529091|NCT01510158|458898469|FG000|Overall Study|Lost to Follow-up|13|||
127529092|NCT01510158|458898470|FG001|Overall Study|Lost to Follow-up|16|||
127529093|NCT01510158|458898471|FG002|Overall Study|Lost to Follow-up|9|||
127529094|NCT01510158|458898469|FG000|Overall Study|Withdrawal by Subject|10|||
127529095|NCT01510158|458898470|FG001|Overall Study|Withdrawal by Subject|13|||
127529096|NCT01510158|458898471|FG002|Overall Study|Withdrawal by Subject|10|||
127529097|NCT01510158|458898469|FG000|Overall Study|Death|1|||
127529098|NCT01510158|458898470|FG001|Overall Study|Death|0|||
127529099|NCT01510158|458898471|FG002|Overall Study|Death|0|||
127529100|NCT03010319|458898477|FG000|Overall Study|Adverse Event|15|||
127529101|NCT03010319|458898478|FG001|Overall Study|Adverse Event|9|||
127529102|NCT03010319|458898477|FG000|Overall Study|Withdrawal by Subject|1|||
127529103|NCT03010319|458898478|FG001|Overall Study|Withdrawal by Subject|6|||
127529104|NCT03010319|458898477|FG000|Overall Study|Physician Decision|2|||
127529105|NCT03010319|458898478|FG001|Overall Study|Physician Decision|4|||
127529106|NCT03010319|458898477|FG000|Overall Study|Sponsor requested withdrawal|2|||
127529107|NCT03010319|458898478|FG001|Overall Study|Sponsor requested withdrawal|2|||
127529108|NCT03010319|458898477|FG000|Overall Study|Death|1|||
127529109|NCT03010319|458898478|FG001|Overall Study|Death|0|||
127529110|NCT03010319|458898477|FG000|Overall Study|Lost to Follow-up|0|||
127529111|NCT03010319|458898478|FG001|Overall Study|Lost to Follow-up|1|||
127529112|NCT03010319|458898477|FG000|Overall Study|Other Reason|5|||
127529113|NCT03010319|458898478|FG001|Overall Study|Other Reason|7|||
127529114|NCT02128724|458898479|FG000|Overall Study|Death|1|||
127529115|NCT02128724|458898480|FG001|Overall Study|Death|0|||
127529116|NCT02128724|458898481|FG002|Overall Study|Death|0|||
127529117|NCT02128724|458898482|FG003|Overall Study|Death|0|||
127529118|NCT02128724|458898479|FG000|Overall Study|Adverse Event|0|||
127529119|NCT02128724|458898480|FG001|Overall Study|Adverse Event|1|||
127529120|NCT02128724|458898481|FG002|Overall Study|Adverse Event|0|||
127529121|NCT02128724|458898482|FG003|Overall Study|Adverse Event|0|||
127529122|NCT02128724|458898479|FG000|Overall Study|Physician Decision|0|||
127529123|NCT02128724|458898480|FG001|Overall Study|Physician Decision|0|||
127529124|NCT02128724|458898481|FG002|Overall Study|Physician Decision|0|||
127529125|NCT02128724|458898482|FG003|Overall Study|Physician Decision|2|||
127529126|NCT02128724|458898479|FG000|Overall Study|Withdrawal by Subject|0|||
127529127|NCT02128724|458898480|FG001|Overall Study|Withdrawal by Subject|0|||
127529128|NCT02128724|458898481|FG002|Overall Study|Withdrawal by Subject|0|||
127529129|NCT02128724|458898482|FG003|Overall Study|Withdrawal by Subject|1|||
127529130|NCT04720417|458898483|FG000|Overall Study|one subject did not initiate treatment due to rapid disease progression|1|||
127529131|NCT03574779|458898484|FG000|Overall Study|Screening failure|13|||
127529132|NCT03574779|458898485|FG001|Overall Study|Screening failure|83|||
127529133|NCT02588261|458898488|FG000|Overall Study|Study Terminated by Sponsor|157|||
127529134|NCT02588261|458898489|FG001|Overall Study|Study Terminated by Sponsor|142|||
127529135|NCT02588261|458898488|FG000|Overall Study|Protocol Deviation|1|||
127529136|NCT02588261|458898489|FG001|Overall Study|Protocol Deviation|0|||
127529137|NCT02588261|458898488|FG000|Overall Study|Death|1|||
127529138|NCT02588261|458898489|FG001|Overall Study|Death|2|||
127529139|NCT02588261|458898488|FG000|Overall Study|Withdrawal by Subject|12|||
127529140|NCT02588261|458898489|FG001|Overall Study|Withdrawal by Subject|8|||
127529141|NCT02588261|458898488|FG000|Overall Study|Noncompliance with Study Drug|0|||
127529142|NCT02588261|458898489|FG001|Overall Study|Noncompliance with Study Drug|1|||
127529143|NCT02588261|458898488|FG000|Overall Study|Miscellaneous|5|||
127529144|NCT02588261|458898489|FG001|Overall Study|Miscellaneous|4|||
127529145|NCT02588261|458898488|FG000|Overall Study|Progressive Disease|61|||
127529146|NCT02588261|458898489|FG001|Overall Study|Progressive Disease|82|||
127529147|NCT02588261|458898488|FG000|Overall Study|Adverse Event|29|||
127529148|NCT02588261|458898489|FG001|Overall Study|Adverse Event|24|||
127529149|NCT02588261|458898488|FG000|Overall Study|Lost to Follow-up|1|||
127529150|NCT02588261|458898489|FG001|Overall Study|Lost to Follow-up|0|||
127529151|NCT02287467|458898490|FG000|Overall Study|Protocol Violation|12|||
127529152|NCT02287467|458898491|FG001|Overall Study|Protocol Violation|9|||
127529153|NCT03781778|458898492|FG000|Overall Study|Withdrawal by Subject|2|||
127529154|NCT03781778|458898493|FG001|Overall Study|Withdrawal by Subject|2|||
127529155|NCT01456169|458898494|FG000|Overall Study|Adverse Event|1|||
127529156|NCT01456169|458898495|FG001|Overall Study|Adverse Event|2|||
127529157|NCT01456169|458898496|FG002|Overall Study|Adverse Event|7|||
127529158|NCT01456169|458898494|FG000|Overall Study|Major Protocol Deviation|3|||
127529159|NCT01456169|458898495|FG001|Overall Study|Major Protocol Deviation|2|||
127529160|NCT01456169|458898496|FG002|Overall Study|Major Protocol Deviation|3|||
127529161|NCT01456169|458898494|FG000|Overall Study|Voluntary Withdrawal|3|||
127529162|NCT01456169|458898495|FG001|Overall Study|Voluntary Withdrawal|0|||
127529163|NCT01456169|458898496|FG002|Overall Study|Voluntary Withdrawal|2|||
127529164|NCT01456169|458898494|FG000|Overall Study|Lack of Efficacy|2|||
127529165|NCT01456169|458898495|FG001|Overall Study|Lack of Efficacy|0|||
127529166|NCT01456169|458898496|FG002|Overall Study|Lack of Efficacy|0|||
127529167|NCT01456169|458898494|FG000|Overall Study|Other|1|||
127529168|NCT01456169|458898495|FG001|Overall Study|Other|1|||
127529169|NCT01456169|458898496|FG002|Overall Study|Other|0|||
127529170|NCT00496080|458898498|FG000|Overall Study|Lost to Follow-up|9|||
127529171|NCT00496080|458898498|FG000|Overall Study|Surgical re-intervention|7|||
127529172|NCT00496080|458898498|FG000|Overall Study|Withdrawal by Subject|5|||
127529173|NCT00496080|458898498|FG000|Overall Study|Physician Decision|6|||
127529174|NCT00570310|458898499|FG000|Overall Study|Adverse Event|1|||
127529175|NCT00570310|458898500|FG001|Overall Study|Adverse Event|2|||
127529176|NCT00570310|458898499|FG000|Overall Study|Lack of Efficacy|1|||
127529177|NCT00570310|458898500|FG001|Overall Study|Lack of Efficacy|4|||
127529178|NCT03472950|458898503|FG000|Overall Study|Lost to Follow-up|0|||
127529179|NCT03472950|458898504|FG001|Overall Study|Lost to Follow-up|1|||
127529180|NCT03472950|458898503|FG000|Overall Study|Adverse Event|0|||
127529181|NCT03472950|458898504|FG001|Overall Study|Adverse Event|3|||
127529182|NCT00517361|458898509|FG000|Overall Study|Death|6|||
127529183|NCT00517361|458898509|FG000|Overall Study|The study was terminated|5|||
127529184|NCT00195091|458898510|FG000|Overall Study|Study terminated and PI has left MSKCC|16|||
127529185|NCT00245037|458898516|FG000|Overall Study|Death|17|||
127529186|NCT06964165|458898521|FG000|Overall Study|Withdrawal by Subject|0|||
127529187|NCT06964165|458898522|FG001|Overall Study|Withdrawal by Subject|1|||
127529188|NCT06964165|458898521|FG000|Overall Study|Ongoing at the time of analysis|15|||
127529189|NCT06964165|458898522|FG001|Overall Study|Ongoing at the time of analysis|14|||
127529190|NCT06964165|458898521|FG000|Overall Study|Participant discontinued due to relocation to a long-term care facility|0|||
127529191|NCT06964165|458898522|FG001|Overall Study|Participant discontinued due to relocation to a long-term care facility|1|||
127529192|NCT06964165|458898521|FG000|Overall Study|Participant removed due to non-compliance|0|||
127529193|NCT06964165|458898522|FG001|Overall Study|Participant removed due to non-compliance|1|||
127529194|NCT01514201|458898536|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
127529195|NCT01514201|458898537|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
127529196|NCT01514201|458898538|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
127529197|NCT01514201|458898539|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
127529198|NCT01514201|458898536|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
127529199|NCT01514201|458898537|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
127529200|NCT01514201|458898538|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
127529201|NCT01514201|458898539|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
127529202|NCT01514201|458898536|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
127529203|NCT01514201|458898537|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
127529204|NCT01514201|458898538|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
127529205|NCT01514201|458898539|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
127529206|NCT01514201|458898536|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
127529207|NCT01514201|458898537|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
127529208|NCT01514201|458898538|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
127529209|NCT01514201|458898539|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
127529210|NCT01514201|458898536|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
127529211|NCT01514201|458898537|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
127529212|NCT01514201|458898538|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
127529213|NCT01514201|458898539|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
127529214|NCT01514201|458898536|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
127529215|NCT01514201|458898537|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
127529216|NCT01514201|458898538|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
127529217|NCT01514201|458898539|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
127529218|NCT01514201|458898536|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
127529219|NCT01514201|458898537|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
127529220|NCT01514201|458898538|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
127529221|NCT01514201|458898539|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
127529222|NCT01514201|458898536|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
127529223|NCT01514201|458898537|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
127529224|NCT01514201|458898538|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
127529225|NCT01514201|458898539|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
127529226|NCT01514201|458898536|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
127529227|NCT01514201|458898537|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
127529228|NCT01514201|458898538|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
127529229|NCT01514201|458898539|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
127529230|NCT01514201|458898536|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
127529231|NCT01514201|458898537|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
127529232|NCT01514201|458898538|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
127529233|NCT01514201|458898539|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
127529234|NCT01514201|458898536|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
127529235|NCT01514201|458898537|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
127529236|NCT01514201|458898538|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
127529237|NCT01514201|458898539|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
127529238|NCT01514201|458898536|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
127529239|NCT01514201|458898537|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
127529240|NCT01514201|458898538|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
127529241|NCT01514201|458898539|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
127529242|NCT05888181|458898540|FG000|Overall Study|Lost to Follow-up|1|||
127529243|NCT05888181|458898541|FG001|Overall Study|Lost to Follow-up|1|||
127529244|NCT05888181|458898542|FG002|Overall Study|Lost to Follow-up|0|||
127529245|NCT02534909|458898548|FG000|Treatment Period 1 to 3 (up to Week 312)|Withdrawal by Subject|1|||
127529246|NCT01625000|458898549|FG000|Overall Study|Physician Decision|15|||
127529247|NCT01625000|458898550|FG001|Overall Study|Physician Decision|7|||
127529248|NCT01625000|458898551|FG002|Overall Study|Physician Decision|7|||
127529249|NCT01625000|458898552|FG003|Overall Study|Physician Decision|2|||
127529250|NCT01625000|458898553|FG004|Overall Study|Physician Decision|15|||
127529251|NCT01625000|458898549|FG000|Overall Study|Protocol Violation|3|||
127529252|NCT01625000|458898550|FG001|Overall Study|Protocol Violation|10|||
127529253|NCT01625000|458898551|FG002|Overall Study|Protocol Violation|4|||
127529254|NCT01625000|458898552|FG003|Overall Study|Protocol Violation|1|||
127529255|NCT01625000|458898553|FG004|Overall Study|Protocol Violation|2|||
127529256|NCT01625000|458898549|FG000|Overall Study|Withdrawal by Subject|19|||
127529257|NCT01625000|458898550|FG001|Overall Study|Withdrawal by Subject|16|||
127529258|NCT01625000|458898551|FG002|Overall Study|Withdrawal by Subject|11|||
127529259|NCT01625000|458898552|FG003|Overall Study|Withdrawal by Subject|9|||
127529260|NCT01625000|458898553|FG004|Overall Study|Withdrawal by Subject|17|||
127529261|NCT01625000|458898549|FG000|Overall Study|Adverse Event (including Death)|15|||
127529262|NCT01625000|458898550|FG001|Overall Study|Adverse Event (including Death)|19|||
127529263|NCT01625000|458898551|FG002|Overall Study|Adverse Event (including Death)|11|||
127529264|NCT01625000|458898552|FG003|Overall Study|Adverse Event (including Death)|7|||
127529265|NCT01625000|458898553|FG004|Overall Study|Adverse Event (including Death)|21|||
127529266|NCT00362648|458898554|FG000|Overall Study|Adverse Event|12|||
127529267|NCT00362648|458898555|FG001|Overall Study|Adverse Event|21|||
127529268|NCT00362648|458898556|FG002|Overall Study|Adverse Event|1|||
127529269|NCT00362648|458898557|FG003|Overall Study|Adverse Event|0|||
127529270|NCT00362648|458898554|FG000|Overall Study|Lost to Follow-up|62|||
127529271|NCT00362648|458898555|FG001|Overall Study|Lost to Follow-up|69|||
127529272|NCT00362648|458898556|FG002|Overall Study|Lost to Follow-up|4|||
127529273|NCT00362648|458898557|FG003|Overall Study|Lost to Follow-up|3|||
127529274|NCT00362648|458898554|FG000|Overall Study|Protocol Violation|4|||
127529275|NCT00362648|458898555|FG001|Overall Study|Protocol Violation|2|||
127529276|NCT00362648|458898556|FG002|Overall Study|Protocol Violation|2|||
127529277|NCT00362648|458898557|FG003|Overall Study|Protocol Violation|2|||
127529278|NCT00362648|458898554|FG000|Overall Study|Withdrawal by Subject|48|||
127529279|NCT00362648|458898555|FG001|Overall Study|Withdrawal by Subject|42|||
127529280|NCT00362648|458898556|FG002|Overall Study|Withdrawal by Subject|2|||
127529281|NCT00362648|458898557|FG003|Overall Study|Withdrawal by Subject|6|||
127529282|NCT03983304|458898558|FG000|Overall Study|Withdrawal by Subject|5|||
127529283|NCT03983304|458898558|FG000|Overall Study|Lost to Follow-up|2|||
127529284|NCT01518374|458898561|FG000|Overall Study|Withdrawal by Subject|2|||
127529285|NCT01518374|458898561|FG000|Overall Study|Protocol Violation|3|||
127529286|NCT01518374|458898561|FG000|Overall Study|Lost to Follow-up|2|||
127529287|NCT04300309|458898562|FG000|Overall Study|Lost to Follow-up|1|||
127529288|NCT04300309|458898563|FG001|Overall Study|Lost to Follow-up|0|||
127529289|NCT02362464|458898566|FG000|Overall Study|Switched to alternative therapy|1|||
127529290|NCT02362464|458898566|FG000|Overall Study|Refused further treatment|1|||
127529291|NCT02362464|458898566|FG000|Overall Study|Physician Decision|4|||
127529292|NCT04752332|458898570|FG000|Overall Study|Adverse Event|3|||
127529293|NCT04752332|458898571|FG001|Overall Study|Adverse Event|1|||
127529294|NCT04752332|458898570|FG000|Overall Study|Disease Relapse|1|||
127529295|NCT04752332|458898571|FG001|Overall Study|Disease Relapse|0|||
127529296|NCT04752332|458898570|FG000|Overall Study|Non-compliance With Study Drug|2|||
127529297|NCT04752332|458898571|FG001|Overall Study|Non-compliance With Study Drug|0|||
127529298|NCT04752332|458898570|FG000|Overall Study|Physician Decision|2|||
127529299|NCT04752332|458898571|FG001|Overall Study|Physician Decision|1|||
127529300|NCT04752332|458898570|FG000|Overall Study|Protocol Violation|1|||
127529301|NCT04752332|458898571|FG001|Overall Study|Protocol Violation|1|||
127529302|NCT04752332|458898570|FG000|Overall Study|Study Terminated by IRB/ERB|0|||
127529303|NCT04752332|458898571|FG001|Overall Study|Study Terminated by IRB/ERB|2|||
127529304|NCT04752332|458898570|FG000|Overall Study|Study Terminated by Sponsor|10|||
127529305|NCT04752332|458898571|FG001|Overall Study|Study Terminated by Sponsor|48|||
127529306|NCT04752332|458898570|FG000|Overall Study|Withdrawal by Subject|11|||
127529307|NCT04752332|458898571|FG001|Overall Study|Withdrawal by Subject|3|||
127529308|NCT00048347|458898572|FG000|Overall Study|Screen failure|2|||
127529309|NCT04522141|458898573|FG000|Overall Study|Withdrawal by Subject|1|||
127529310|NCT04522141|458898574|FG001|Overall Study|Withdrawal by Subject|0|||
127529311|NCT03508609|458898575|FG000|Overall Study|Withdrawal by Subject|1|||
127529312|NCT00555217|458898576|FG000|Overall Study|Withdrawal by Subject|35|||
127529313|NCT00555217|458898577|FG001|Overall Study|Withdrawal by Subject|31|||
127529314|NCT00555217|458898576|FG000|Overall Study|Lost to Follow-up|19|||
127529315|NCT00555217|458898577|FG001|Overall Study|Lost to Follow-up|20|||
127529316|NCT00555217|458898576|FG000|Overall Study|close out sites|21|||
127529317|NCT00555217|458898577|FG001|Overall Study|close out sites|17|||
127529318|NCT00367835|458898579|FG000|Overall Study|Adverse Event|14|||
127529319|NCT00367835|458898580|FG001|Overall Study|Adverse Event|1|||
127529320|NCT00367835|458898579|FG000|Overall Study|Protocol Violation|1|||
127529321|NCT00367835|458898580|FG001|Overall Study|Protocol Violation|7|||
127529322|NCT00367835|458898579|FG000|Overall Study|Withdrawal by Subject|7|||
127529323|NCT00367835|458898580|FG001|Overall Study|Withdrawal by Subject|6|||
127529324|NCT00367835|458898579|FG000|Overall Study|Lost to Follow-up|1|||
127529325|NCT00367835|458898580|FG001|Overall Study|Lost to Follow-up|4|||
127529326|NCT00367835|458898579|FG000|Overall Study|Lack of Efficacy|3|||
127529327|NCT00367835|458898580|FG001|Overall Study|Lack of Efficacy|12|||
127529328|NCT00367835|458898579|FG000|Overall Study|Subject in juvenile detention center|1|||
127529329|NCT00367835|458898580|FG001|Overall Study|Subject in juvenile detention center|0|||
127529330|NCT00367835|458898579|FG000|Overall Study|refused blood collection|1|||
127529331|NCT00367835|458898580|FG001|Overall Study|refused blood collection|0|||
127529332|NCT00367835|458898579|FG000|Overall Study|Did not respond to calls|1|||
127529333|NCT00367835|458898580|FG001|Overall Study|Did not respond to calls|0|||
127529334|NCT00367835|458898579|FG000|Overall Study|History of lead poisoning|0|||
127529335|NCT00367835|458898580|FG001|Overall Study|History of lead poisoning|1|||
127529336|NCT03761810|458898584|FG000|Overall Study|Adverse Event|12|||
127529337|NCT03761810|458898585|FG001|Overall Study|Adverse Event|0|||
127529338|NCT03761810|458898584|FG000|Overall Study|Lost to Follow-up|15|||
127529339|NCT03761810|458898585|FG001|Overall Study|Lost to Follow-up|7|||
127529340|NCT03761810|458898584|FG000|Overall Study|Pregnancy|1|||
127529341|NCT03761810|458898585|FG001|Overall Study|Pregnancy|0|||
127529342|NCT03761810|458898584|FG000|Overall Study|Withdrawal by Subject|14|||
127529343|NCT03761810|458898585|FG001|Overall Study|Withdrawal by Subject|5|||
127529344|NCT03761810|458898584|FG000|Overall Study|Physician Decision|1|||
127529345|NCT03761810|458898585|FG001|Overall Study|Physician Decision|0|||
127529346|NCT03761810|458898584|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
127529347|NCT03761810|458898585|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
127529348|NCT03761810|458898584|FG000|Overall Study|Other Than Specified|1|||
127529349|NCT03761810|458898585|FG001|Overall Study|Other Than Specified|0|||
127529350|NCT01574651|458898586|FG000|Overall Study|Lost to Follow-up|2|||
127529351|NCT01574651|458898587|FG001|Overall Study|Lost to Follow-up|4|||
127529352|NCT01574651|458898586|FG000|Overall Study|Administrative problems|0|||
127529353|NCT01574651|458898587|FG001|Overall Study|Administrative problems|1|||
127529354|NCT01574651|458898586|FG000|Overall Study|Death|3|||
127529355|NCT01574651|458898587|FG001|Overall Study|Death|3|||
127529356|NCT01574651|458898586|FG000|Overall Study|Patient's inability to use the device|0|||
127529357|NCT01574651|458898587|FG001|Overall Study|Patient's inability to use the device|1|||
127529358|NCT01574651|458898586|FG000|Overall Study|Adverse Event|36|||
127529359|NCT01574651|458898587|FG001|Overall Study|Adverse Event|27|||
127529360|NCT01574651|458898586|FG000|Overall Study|Abnormal laboratory value(s)|1|||
127529361|NCT01574651|458898587|FG001|Overall Study|Abnormal laboratory value(s)|0|||
127529362|NCT01574651|458898586|FG000|Overall Study|Abnormal test procedure result(s)|1|||
127529363|NCT01574651|458898587|FG001|Overall Study|Abnormal test procedure result(s)|1|||
127529364|NCT01574651|458898586|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
127529365|NCT01574651|458898587|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
127529366|NCT01574651|458898586|FG000|Overall Study|Protocol Violation|3|||
127529367|NCT01574651|458898587|FG001|Overall Study|Protocol Violation|5|||
127529368|NCT01574651|458898586|FG000|Overall Study|Withdrawal by Subject|9|||
127529369|NCT01574651|458898587|FG001|Overall Study|Withdrawal by Subject|10|||
127529370|NCT03887221|458898588|FG000|Overall Study|Protocol Violation|1|||
127529371|NCT03887221|458898589|FG001|Overall Study|Protocol Violation|0|||
127529372|NCT02487030|458898590|FG000|Overall Study|Lack of Efficacy|2|||
127529373|NCT02487030|458898591|FG001|Overall Study|Lack of Efficacy|4|||
127529374|NCT02487030|458898592|FG002|Overall Study|Lack of Efficacy|1|||
127529375|NCT02487030|458898593|FG003|Overall Study|Lack of Efficacy|0|||
127529376|NCT02487030|458898594|FG004|Overall Study|Lack of Efficacy|1|||
127529377|NCT02487030|458898595|FG005|Overall Study|Lack of Efficacy|0|||
127529378|NCT02487030|458898596|FG006|Overall Study|Lack of Efficacy|0|||
127529379|NCT02487030|458898590|FG000|Overall Study|Lost to Follow-up|0|||
127529380|NCT02487030|458898591|FG001|Overall Study|Lost to Follow-up|0|||
127529381|NCT02487030|458898592|FG002|Overall Study|Lost to Follow-up|1|||
127529382|NCT02487030|458898593|FG003|Overall Study|Lost to Follow-up|1|||
127529383|NCT02487030|458898594|FG004|Overall Study|Lost to Follow-up|0|||
127529384|NCT02487030|458898595|FG005|Overall Study|Lost to Follow-up|1|||
127529385|NCT02487030|458898596|FG006|Overall Study|Lost to Follow-up|0|||
127529386|NCT02487030|458898590|FG000|Overall Study|Adverse Event|0|||
127529387|NCT02487030|458898591|FG001|Overall Study|Adverse Event|0|||
127529388|NCT02487030|458898592|FG002|Overall Study|Adverse Event|0|||
127529389|NCT02487030|458898593|FG003|Overall Study|Adverse Event|1|||
127529390|NCT02487030|458898594|FG004|Overall Study|Adverse Event|0|||
127529391|NCT02487030|458898595|FG005|Overall Study|Adverse Event|0|||
127529392|NCT02487030|458898596|FG006|Overall Study|Adverse Event|0|||
127529393|NCT02487030|458898590|FG000|Overall Study|Death|0|||
127529394|NCT02487030|458898591|FG001|Overall Study|Death|0|||
127529395|NCT02487030|458898592|FG002|Overall Study|Death|0|||
127529396|NCT02487030|458898593|FG003|Overall Study|Death|0|||
127529397|NCT02487030|458898594|FG004|Overall Study|Death|1|||
127529398|NCT02487030|458898595|FG005|Overall Study|Death|0|||
127529399|NCT02487030|458898596|FG006|Overall Study|Death|0|||
127529400|NCT02092025|458898597|FG000|Overall Study|Case Report Forms Uncollected|44|||
127529401|NCT02092025|458898597|FG000|Overall Study|Protocol Deviation|24|||
127529402|NCT00264537|458898598|FG000|Overall Study|Death|0|||
127529403|NCT00264537|458898599|FG001|Overall Study|Death|3|||
127529404|NCT00264537|458898600|FG002|Overall Study|Death|3|||
127529405|NCT00264537|458898601|FG003|Overall Study|Death|2|||
127529406|NCT00264537|458898598|FG000|Overall Study|Lost to Follow-up|3|||
127529407|NCT00264537|458898599|FG001|Overall Study|Lost to Follow-up|4|||
127529408|NCT00264537|458898600|FG002|Overall Study|Lost to Follow-up|7|||
127529409|NCT00264537|458898601|FG003|Overall Study|Lost to Follow-up|6|||
127529410|NCT00264537|458898598|FG000|Overall Study|Adverse Event|21|||
127529411|NCT00264537|458898599|FG001|Overall Study|Adverse Event|32|||
127529412|NCT00264537|458898600|FG002|Overall Study|Adverse Event|24|||
127529413|NCT00264537|458898601|FG003|Overall Study|Adverse Event|34|||
127529414|NCT00264537|458898598|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
127529415|NCT00264537|458898599|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
127529416|NCT00264537|458898600|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
127529417|NCT00264537|458898601|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
127529418|NCT00264537|458898598|FG000|Overall Study|Other|21|||
127529419|NCT00264537|458898599|FG001|Overall Study|Other|11|||
127529420|NCT00264537|458898600|FG002|Overall Study|Other|10|||
127529421|NCT00264537|458898601|FG003|Overall Study|Other|11|||
127529422|NCT00264537|458898598|FG000|Overall Study|Not treated|0|||
127529423|NCT00264537|458898599|FG001|Overall Study|Not treated|2|||
127529424|NCT00264537|458898600|FG002|Overall Study|Not treated|1|||
127529425|NCT00264537|458898601|FG003|Overall Study|Not treated|0|||
127529426|NCT03228212|458898603|FG000|Period 1|Adverse Event|1|||
127529427|NCT03228212|458898604|FG001|Period 1|Adverse Event|0|||
127529428|NCT03228212|458898603|FG000|Period 1|no longer meets eligibility criteria|0|||
127529429|NCT03228212|458898604|FG001|Period 1|no longer meets eligibility criteria|1|||
127529430|NCT03228212|458898603|FG000|Period 2|Lost to Follow-up|1|||
127529431|NCT03228212|458898604|FG001|Period 2|Lost to Follow-up|0|||
127529432|NCT01807299|458898605|FG000|Overall Study|Protocol Violation|3|||
127529433|NCT01807299|458898606|FG001|Overall Study|Protocol Violation|1|||
127529434|NCT01807299|458898607|FG002|Overall Study|Protocol Violation|0|||
127529435|NCT01807299|458898608|FG003|Overall Study|Protocol Violation|2|||
127529436|NCT04864639|458899865|FG000|Overall Study|Death|1|||
127529437|NCT04864639|458899865|FG000|Overall Study|Lost to Follow-up|1|||
127529438|NCT00615017|458899866|FG000|Overall Study|Adverse Event|0|||
127529439|NCT00615017|458899867|FG001|Overall Study|Adverse Event|1|||
127529440|NCT00615017|458899868|FG002|Overall Study|Adverse Event|2|||
127529441|NCT00615017|458899869|FG003|Overall Study|Adverse Event|0|||
127529442|NCT00615017|458899870|FG004|Overall Study|Adverse Event|0|||
127529443|NCT00615017|458899871|FG005|Overall Study|Adverse Event|1|||
127529444|NCT00615017|458899866|FG000|Overall Study|Death|0|||
127529445|NCT00615017|458899867|FG001|Overall Study|Death|0|||
127529446|NCT00615017|458899868|FG002|Overall Study|Death|2|||
127529447|NCT00615017|458899869|FG003|Overall Study|Death|0|||
127529448|NCT00615017|458899870|FG004|Overall Study|Death|1|||
127529449|NCT00615017|458899871|FG005|Overall Study|Death|1|||
127529450|NCT00615017|458899866|FG000|Overall Study|Sepsis resolved|0|||
127529451|NCT00615017|458899867|FG001|Overall Study|Sepsis resolved|0|||
127529452|NCT00615017|458899868|FG002|Overall Study|Sepsis resolved|1|||
127529453|NCT00615017|458899869|FG003|Overall Study|Sepsis resolved|0|||
127529454|NCT00615017|458899870|FG004|Overall Study|Sepsis resolved|0|||
127529455|NCT00615017|458899871|FG005|Overall Study|Sepsis resolved|0|||
127529456|NCT00615017|458899866|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
127529457|NCT00615017|458899867|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
127529458|NCT00615017|458899868|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
127529459|NCT00615017|458899869|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
127529460|NCT00615017|458899870|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
127529461|NCT00615017|458899871|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
127529462|NCT00615017|458899866|FG000|Overall Study|Physician discontinued drug|0|||
127529463|NCT00615017|458899867|FG001|Overall Study|Physician discontinued drug|0|||
127529464|NCT00615017|458899868|FG002|Overall Study|Physician discontinued drug|0|||
127529465|NCT00615017|458899869|FG003|Overall Study|Physician discontinued drug|0|||
127529466|NCT00615017|458899870|FG004|Overall Study|Physician discontinued drug|0|||
127529467|NCT00615017|458899871|FG005|Overall Study|Physician discontinued drug|1|||
127529468|NCT00806988|458899872|FG000|Overall Study|Death|15|||
127529469|NCT00806988|458899873|FG001|Overall Study|Death|16|||
127529470|NCT00806988|458899872|FG000|Overall Study|Withdrawal by Subject|8|||
127529471|NCT00806988|458899873|FG001|Overall Study|Withdrawal by Subject|8|||
127529472|NCT00806988|458899872|FG000|Overall Study|Lost to Follow-up|4|||
127529473|NCT00806988|458899873|FG001|Overall Study|Lost to Follow-up|19|||
127529474|NCT04775953|458899874|FG000|Overall Study|Lost to Follow-up|6|||
127529475|NCT04775953|458899875|FG001|Overall Study|Lost to Follow-up|11|||
127529476|NCT04775953|458899874|FG000|Overall Study|Death|5|||
127529477|NCT04775953|458899875|FG001|Overall Study|Death|4|||
127529478|NCT04775953|458899874|FG000|Overall Study|Withdrawal by Subject|3|||
127529479|NCT04775953|458899875|FG001|Overall Study|Withdrawal by Subject|3|||
127529480|NCT04775953|458899874|FG000|Overall Study|Protocol Violation|2|||
127529481|NCT04775953|458899875|FG001|Overall Study|Protocol Violation|0|||
127529482|NCT04775953|458899874|FG000|Overall Study|Participant non-compliance|0|||
127529483|NCT04775953|458899875|FG001|Overall Study|Participant non-compliance|1|||
127529484|NCT00855959|458899876|FG000|Overall Study|Adverse Event|2|||
127529485|NCT00855959|458899876|FG000|Overall Study|Lost to Follow-up|2|||
127529486|NCT00855959|458899876|FG000|Overall Study|Withdrawal by Subject|3|||
127529487|NCT00855959|458899876|FG000|Overall Study|Pregnancy|1|||
127529488|NCT00855959|458899876|FG000|Overall Study|Incorrect enrolment|1|||
127529489|NCT02813889|458899877|FG000|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|7|||
127529490|NCT02813889|458899878|FG001|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|0|||
127529491|NCT00368641|458899879|FG000|Overall Study|Adverse Event|2|||
127529492|NCT00368641|458899880|FG001|Overall Study|Adverse Event|1|||
127529493|NCT00368641|458899879|FG000|Overall Study|Death|1|||
127529494|NCT00368641|458899880|FG001|Overall Study|Death|0|||
127529495|NCT00368641|458899879|FG000|Overall Study|Withdrawal by Subject|1|||
127529496|NCT00368641|458899880|FG001|Overall Study|Withdrawal by Subject|0|||
127529497|NCT00368641|458899879|FG000|Overall Study|Sponsor decision to terminate study|2|||
127529498|NCT00368641|458899880|FG001|Overall Study|Sponsor decision to terminate study|5|||
127529499|NCT03078556|458899886|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
127529500|NCT03078556|458899887|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
127529501|NCT03078556|458899888|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
127529502|NCT03078556|458899889|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
127529503|NCT03078556|458899886|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
127529504|NCT03078556|458899887|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
127529505|NCT03078556|458899888|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
127529506|NCT03078556|458899889|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
127529507|NCT03078556|458899886|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
127529508|NCT03078556|458899887|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
127529509|NCT03078556|458899888|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
127529510|NCT03078556|458899889|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
127529511|NCT03078556|458899886|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
127529512|NCT03078556|458899887|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
127529513|NCT03078556|458899888|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
127529514|NCT03078556|458899889|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
127529515|NCT03314987|458899890|FG000|Overall Study|Lost to Follow-up|13|||
127529516|NCT03314987|458899891|FG001|Overall Study|Lost to Follow-up|13|||
127529517|NCT02751580|458899892|FG000|Overall Study|Lost to Follow-up|4|||
127529518|NCT02751580|458899892|FG000|Overall Study|Death|2|||
127529519|NCT02292446|458899899|FG000|Overall Study|Adverse Event|12|||
127529520|NCT02292446|458899899|FG000|Overall Study|Death|1|||
127529521|NCT02292446|458899899|FG000|Overall Study|Disease progression|2|||
127529522|NCT02292446|458899899|FG000|Overall Study|Subject/guardian decision|2|||
127529523|NCT02292446|458899899|FG000|Overall Study|Withdrawal by Subject|3|||
127529524|NCT01290757|458899902|FG000|Overall Study|Adverse Event|1|||
127529525|NCT01290757|458899903|FG001|Overall Study|Adverse Event|0|||
127529526|NCT01290757|458899902|FG000|Overall Study|Protocol Violation|1|||
127529527|NCT01290757|458899903|FG001|Overall Study|Protocol Violation|1|||
127529528|NCT01290757|458899902|FG000|Overall Study|Other|0|||
127529529|NCT01290757|458899903|FG001|Overall Study|Other|1|||
127529530|NCT00887549|458899904|FG000|Induction Therapy|Adverse Event|8|||
127529531|NCT00887549|458899904|FG000|Induction Therapy|Physician Decision|1|||
127529532|NCT00887549|458899904|FG000|Induction Therapy|Progressive Disease|13|||
127529533|NCT00887549|458899904|FG000|Induction Therapy|Death due to Study Disease|4|||
127529534|NCT00887549|458899904|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
127529535|NCT00887549|458899904|FG000|Maintenance Therapy|Adverse Event|16|||
127529536|NCT00887549|458899904|FG000|Maintenance Therapy|Physician Decision|1|||
127529537|NCT00887549|458899904|FG000|Maintenance Therapy|Progressive Disease|25|||
127529538|NCT00887549|458899904|FG000|Maintenance Therapy|Death due to adverse event|1|||
127529539|NCT03329846|458899907|FG000|Overall Study|Disease progression|4|||
127529540|NCT03329846|458899908|FG001|Overall Study|Disease progression|6|||
127529541|NCT03329846|458899907|FG000|Overall Study|Study drug toxicity|1|||
127529542|NCT03329846|458899908|FG001|Overall Study|Study drug toxicity|0|||
127529543|NCT03329846|458899907|FG000|Overall Study|Participant request to discontinue treatment|0|||
127529544|NCT03329846|458899908|FG001|Overall Study|Participant request to discontinue treatment|1|||
127529545|NCT03329846|458899907|FG000|Overall Study|Participant withdrew consent|1|||
127529546|NCT03329846|458899908|FG001|Overall Study|Participant withdrew consent|0|||
127529547|NCT03329846|458899907|FG000|Overall Study|Other reasons|2|||
127529548|NCT03329846|458899908|FG001|Overall Study|Other reasons|2|||
127529549|NCT00479336|458899909|FG000|Overall Study|Adverse Event|1|||
127529550|NCT00479336|458899910|FG001|Overall Study|Adverse Event|1|||
127529551|NCT00479336|458899911|FG002|Overall Study|Adverse Event|1|||
127529552|NCT00479336|458899912|FG003|Overall Study|Adverse Event|3|||
127529553|NCT00479336|458899909|FG000|Overall Study|Lack of Efficacy|1|||
127529554|NCT00479336|458899910|FG001|Overall Study|Lack of Efficacy|0|||
127529555|NCT00479336|458899911|FG002|Overall Study|Lack of Efficacy|0|||
127529556|NCT00479336|458899912|FG003|Overall Study|Lack of Efficacy|0|||
127529557|NCT00479336|458899909|FG000|Overall Study|Protocol Violation|0|||
127529558|NCT00479336|458899910|FG001|Overall Study|Protocol Violation|1|||
127529559|NCT00479336|458899911|FG002|Overall Study|Protocol Violation|0|||
127529560|NCT00479336|458899912|FG003|Overall Study|Protocol Violation|0|||
127529561|NCT00479336|458899909|FG000|Overall Study|Withdrawal by Subject|1|||
127529562|NCT00479336|458899910|FG001|Overall Study|Withdrawal by Subject|2|||
127529563|NCT00479336|458899911|FG002|Overall Study|Withdrawal by Subject|0|||
127529564|NCT00479336|458899912|FG003|Overall Study|Withdrawal by Subject|0|||
127529565|NCT00479336|458899909|FG000|Overall Study|Physician Decision|0|||
127529566|NCT00479336|458899910|FG001|Overall Study|Physician Decision|1|||
127529567|NCT00479336|458899911|FG002|Overall Study|Physician Decision|0|||
127529568|NCT00479336|458899912|FG003|Overall Study|Physician Decision|2|||
127529569|NCT00479336|458899909|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
127529570|NCT00479336|458899910|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
127529571|NCT00479336|458899911|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
127529572|NCT00479336|458899912|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
127529573|NCT03066193|458899913|FG000|Overall Study|Withdrawal by Subject|1|||
127529574|NCT02021643|458899914|FG000|Overall Study|Enrolled but Never Treated|1|||
127529575|NCT02021643|458899915|FG001|Overall Study|Enrolled but Never Treated|0|||
127529576|NCT02021643|458899916|FG002|Overall Study|Enrolled but Never Treated|0|||
127529577|NCT02021643|458899917|FG003|Overall Study|Enrolled but Never Treated|0|||
127529578|NCT02021643|458899914|FG000|Overall Study|Adverse Event|0|||
127529579|NCT02021643|458899915|FG001|Overall Study|Adverse Event|1|||
127529580|NCT02021643|458899916|FG002|Overall Study|Adverse Event|0|||
127529581|NCT02021643|458899917|FG003|Overall Study|Adverse Event|0|||
127529582|NCT02021643|458899914|FG000|Overall Study|Death|0|||
127529583|NCT02021643|458899915|FG001|Overall Study|Death|1|||
127529584|NCT02021643|458899916|FG002|Overall Study|Death|0|||
127529585|NCT02021643|458899917|FG003|Overall Study|Death|0|||
127529586|NCT02021643|458899914|FG000|Overall Study|Investigator's Discretion|1|||
127529587|NCT02021643|458899915|FG001|Overall Study|Investigator's Discretion|0|||
127529588|NCT02021643|458899916|FG002|Overall Study|Investigator's Discretion|0|||
127529589|NCT02021643|458899917|FG003|Overall Study|Investigator's Discretion|0|||
127529590|NCT02021643|458899914|FG000|Overall Study|Lack of Efficacy|7|||
127529591|NCT02021643|458899915|FG001|Overall Study|Lack of Efficacy|6|||
127529592|NCT02021643|458899916|FG002|Overall Study|Lack of Efficacy|0|||
127529593|NCT02021643|458899917|FG003|Overall Study|Lack of Efficacy|12|||
127529594|NCT02021643|458899914|FG000|Overall Study|Lost to Follow-up|0|||
127529595|NCT02021643|458899915|FG001|Overall Study|Lost to Follow-up|1|||
127529596|NCT02021643|458899916|FG002|Overall Study|Lost to Follow-up|0|||
127529597|NCT02021643|458899917|FG003|Overall Study|Lost to Follow-up|0|||
127529598|NCT02021643|458899914|FG000|Overall Study|Withdrew Consent|0|||
127529599|NCT02021643|458899915|FG001|Overall Study|Withdrew Consent|1|||
127529600|NCT02021643|458899916|FG002|Overall Study|Withdrew Consent|0|||
127529601|NCT02021643|458899917|FG003|Overall Study|Withdrew Consent|0|||
127529602|NCT04854551|458899918|FG000|Overall Study|Withdrawal by Subject|1|||
127529603|NCT04854551|458899919|FG001|Overall Study|Withdrawal by Subject|1|||
127529604|NCT02631551|458899920|FG000|Overall Study|Adverse Event|1|||
127529605|NCT02631551|458899921|FG001|Overall Study|Adverse Event|2|||
127529606|NCT02631551|458899922|FG002|Overall Study|Adverse Event|4|||
127529607|NCT02631551|458899923|FG003|Overall Study|Adverse Event|0|||
127529608|NCT02631551|458899920|FG000|Overall Study|Lack of Efficacy|0|||
127529609|NCT02631551|458899921|FG001|Overall Study|Lack of Efficacy|0|||
127529610|NCT02631551|458899922|FG002|Overall Study|Lack of Efficacy|1|||
127529611|NCT02631551|458899923|FG003|Overall Study|Lack of Efficacy|0|||
127529612|NCT02631551|458899920|FG000|Overall Study|Lost to Follow-up|1|||
127529613|NCT02631551|458899921|FG001|Overall Study|Lost to Follow-up|2|||
127529614|NCT02631551|458899922|FG002|Overall Study|Lost to Follow-up|0|||
127529615|NCT02631551|458899923|FG003|Overall Study|Lost to Follow-up|3|||
127529616|NCT02631551|458899920|FG000|Overall Study|Withdrawal by Subject|2|||
127529617|NCT02631551|458899921|FG001|Overall Study|Withdrawal by Subject|2|||
127529618|NCT02631551|458899922|FG002|Overall Study|Withdrawal by Subject|0|||
127529619|NCT02631551|458899923|FG003|Overall Study|Withdrawal by Subject|5|||
127529620|NCT02631551|458899920|FG000|Overall Study|Protocol deviation|3|||
127529621|NCT02631551|458899921|FG001|Overall Study|Protocol deviation|6|||
127529622|NCT02631551|458899922|FG002|Overall Study|Protocol deviation|3|||
127529623|NCT02631551|458899923|FG003|Overall Study|Protocol deviation|0|||
127529624|NCT02631551|458899920|FG000|Overall Study|Non-compliance with study procedures|0|||
127529625|NCT02631551|458899921|FG001|Overall Study|Non-compliance with study procedures|0|||
127529626|NCT02631551|458899922|FG002|Overall Study|Non-compliance with study procedures|1|||
127529627|NCT02631551|458899923|FG003|Overall Study|Non-compliance with study procedures|1|||
127529628|NCT02631551|458899920|FG000|Overall Study|Non-compliance with study drug|1|||
127529629|NCT02631551|458899921|FG001|Overall Study|Non-compliance with study drug|0|||
127529630|NCT02631551|458899922|FG002|Overall Study|Non-compliance with study drug|0|||
127529631|NCT02631551|458899923|FG003|Overall Study|Non-compliance with study drug|0|||
127529632|NCT02631551|458899920|FG000|Overall Study|Other, specific reasons not collected|5|||
127529633|NCT02631551|458899921|FG001|Overall Study|Other, specific reasons not collected|7|||
127529634|NCT02631551|458899922|FG002|Overall Study|Other, specific reasons not collected|2|||
127529635|NCT02631551|458899923|FG003|Overall Study|Other, specific reasons not collected|2|||
127529636|NCT04112303|458899924|FG000|Overall Study|Death|1|||
127529637|NCT00377858|458899933|FG000|Overall Study|Withdrawal by Subject|12|||
127529638|NCT00377858|458899934|FG001|Overall Study|Withdrawal by Subject|11|||
127529639|NCT00377858|458899933|FG000|Overall Study|Lost to Follow-up|6|||
127529640|NCT00377858|458899934|FG001|Overall Study|Lost to Follow-up|1|||
127529641|NCT00377858|458899933|FG000|Overall Study|Physician Decision|5|||
127529642|NCT00377858|458899934|FG001|Overall Study|Physician Decision|5|||
127529643|NCT00377858|458899933|FG000|Overall Study|Protocol Violation|3|||
127529644|NCT00377858|458899934|FG001|Overall Study|Protocol Violation|4|||
127529645|NCT00377858|458899933|FG000|Overall Study|Adverse Event|2|||
127529646|NCT00377858|458899934|FG001|Overall Study|Adverse Event|1|||
127529647|NCT00377858|458899933|FG000|Overall Study|Entry Criteria Not Met|2|||
127529648|NCT00377858|458899934|FG001|Overall Study|Entry Criteria Not Met|0|||
127529649|NCT00377858|458899933|FG000|Overall Study|Sponsor Decision|1|||
127529650|NCT00377858|458899934|FG001|Overall Study|Sponsor Decision|2|||
127529651|NCT00377858|458899933|FG000|Overall Study|Death|0|||
127529652|NCT00377858|458899934|FG001|Overall Study|Death|3|||
127529653|NCT05636852|458899935|FG000|Overall Study|Withdrawal by Subject|1|||
127529654|NCT05636852|458899935|FG000|Overall Study|Other than specified|1|||
127529655|NCT01685697|458899936|FG000|Overall Study|Protocol Violation|3|||
127529656|NCT01685697|458899937|FG001|Overall Study|Protocol Violation|3|||
127529657|NCT01076036|458899938|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
127529658|NCT00726232|458899939|FG000|Initial Phase (Dose-finding)|Death|0|||
127529659|NCT00726232|458899940|FG001|Initial Phase (Dose-finding)|Death|0|||
127529660|NCT00726232|458899941|FG002|Initial Phase (Dose-finding)|Death|0|||
127529661|NCT00726232|458899942|FG003|Initial Phase (Dose-finding)|Death|0|||
127529662|NCT00726232|458899943|FG004|Initial Phase (Dose-finding)|Death|1|||
127529663|NCT00726232|458899944|FG005|Initial Phase (Dose-finding)|Death|0|||
127529664|NCT00726232|458899945|FG006|Initial Phase (Dose-finding)|Death|0|||
127529665|NCT00726232|458899946|FG007|Initial Phase (Dose-finding)|Death|0|||
127529666|NCT00726232|458899939|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
127529667|NCT00726232|458899940|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
127529668|NCT00726232|458899941|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
127529669|NCT00726232|458899942|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
127529670|NCT00726232|458899943|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
127529671|NCT00726232|458899944|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
127529672|NCT00726232|458899945|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
127529673|NCT00726232|458899946|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
127529674|NCT00726232|458899939|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
127529675|NCT00726232|458899940|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
127529676|NCT00726232|458899941|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
127529677|NCT00726232|458899942|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
127529678|NCT00726232|458899943|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
127529679|NCT00726232|458899944|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
127529680|NCT00726232|458899945|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
127529681|NCT00726232|458899946|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
127529682|NCT00726232|458899939|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
127529683|NCT00726232|458899940|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
127529684|NCT00726232|458899941|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
127529685|NCT00726232|458899942|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
127529686|NCT00726232|458899943|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
127529687|NCT00726232|458899944|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
127529688|NCT00726232|458899945|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
127529689|NCT00726232|458899946|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
127529690|NCT00726232|458899939|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
127529691|NCT00726232|458899940|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
127529692|NCT00726232|458899941|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
127529693|NCT00726232|458899942|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
127529694|NCT00726232|458899943|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
127529695|NCT00726232|458899944|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
127529696|NCT00726232|458899945|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
127529697|NCT00726232|458899946|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
127529698|NCT00726232|458899939|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
127529699|NCT00726232|458899940|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
127529700|NCT00726232|458899941|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
127529701|NCT00726232|458899942|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
127529702|NCT00726232|458899943|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
127529703|NCT00726232|458899944|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
127529704|NCT00726232|458899945|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
127529705|NCT00726232|458899946|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
127529706|NCT00726232|458899939|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
127529707|NCT00726232|458899940|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
127529708|NCT00726232|458899941|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
127529709|NCT00726232|458899942|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
127529710|NCT00726232|458899943|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
127529711|NCT00726232|458899944|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
127529712|NCT00726232|458899945|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
127529713|NCT00726232|458899946|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
127529714|NCT00726232|458899939|FG000|Expansion Phase|Death|0|||
127529715|NCT00726232|458899940|FG001|Expansion Phase|Death|0|||
127529716|NCT00726232|458899941|FG002|Expansion Phase|Death|0|||
127529717|NCT00726232|458899942|FG003|Expansion Phase|Death|0|||
127529718|NCT00726232|458899943|FG004|Expansion Phase|Death|0|||
127529719|NCT00726232|458899944|FG005|Expansion Phase|Death|0|||
127529720|NCT00726232|458899945|FG006|Expansion Phase|Death|0|||
127529721|NCT00726232|458899946|FG007|Expansion Phase|Death|1|||
127529722|NCT00726232|458899939|FG000|Expansion Phase|Adverse Event|0|||
127529723|NCT00726232|458899940|FG001|Expansion Phase|Adverse Event|0|||
127529724|NCT00726232|458899941|FG002|Expansion Phase|Adverse Event|0|||
127529725|NCT00726232|458899942|FG003|Expansion Phase|Adverse Event|0|||
127529726|NCT00726232|458899943|FG004|Expansion Phase|Adverse Event|0|||
127529727|NCT00726232|458899944|FG005|Expansion Phase|Adverse Event|0|||
127529728|NCT00726232|458899945|FG006|Expansion Phase|Adverse Event|6|||
127529729|NCT00726232|458899946|FG007|Expansion Phase|Adverse Event|11|||
127529730|NCT00726232|458899939|FG000|Expansion Phase|Withdrawal by Subject|0|||
127529731|NCT00726232|458899940|FG001|Expansion Phase|Withdrawal by Subject|0|||
127529732|NCT00726232|458899941|FG002|Expansion Phase|Withdrawal by Subject|0|||
127529733|NCT00726232|458899942|FG003|Expansion Phase|Withdrawal by Subject|0|||
127529734|NCT00726232|458899943|FG004|Expansion Phase|Withdrawal by Subject|0|||
127529735|NCT00726232|458899944|FG005|Expansion Phase|Withdrawal by Subject|0|||
127529736|NCT00726232|458899945|FG006|Expansion Phase|Withdrawal by Subject|2|||
127529737|NCT00726232|458899946|FG007|Expansion Phase|Withdrawal by Subject|3|||
127529738|NCT00726232|458899939|FG000|Expansion Phase|Disease progression|0|||
127529739|NCT00726232|458899940|FG001|Expansion Phase|Disease progression|0|||
127529740|NCT00726232|458899941|FG002|Expansion Phase|Disease progression|0|||
127529741|NCT00726232|458899942|FG003|Expansion Phase|Disease progression|0|||
127529742|NCT00726232|458899943|FG004|Expansion Phase|Disease progression|0|||
127529743|NCT00726232|458899944|FG005|Expansion Phase|Disease progression|0|||
127529744|NCT00726232|458899945|FG006|Expansion Phase|Disease progression|4|||
127529745|NCT00726232|458899946|FG007|Expansion Phase|Disease progression|0|||
127529746|NCT00726232|458899939|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
127529747|NCT00726232|458899940|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
127529748|NCT00726232|458899941|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
127529749|NCT00726232|458899942|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
127529750|NCT00726232|458899943|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
127529751|NCT00726232|458899944|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
127529752|NCT00726232|458899945|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
127529753|NCT00726232|458899946|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
127529754|NCT00726232|458899939|FG000|Expansion Phase|Per Investigator: lack of response|0|||
127529755|NCT00726232|458899940|FG001|Expansion Phase|Per Investigator: lack of response|0|||
127529756|NCT00726232|458899941|FG002|Expansion Phase|Per Investigator: lack of response|0|||
127529757|NCT00726232|458899942|FG003|Expansion Phase|Per Investigator: lack of response|0|||
127529758|NCT00726232|458899943|FG004|Expansion Phase|Per Investigator: lack of response|0|||
127529759|NCT00726232|458899944|FG005|Expansion Phase|Per Investigator: lack of response|0|||
127529760|NCT00726232|458899945|FG006|Expansion Phase|Per Investigator: lack of response|1|||
127529761|NCT00726232|458899946|FG007|Expansion Phase|Per Investigator: lack of response|7|||
127529762|NCT00726232|458899939|FG000|Expansion Phase|Unspecified reason|0|||
127529763|NCT00726232|458899940|FG001|Expansion Phase|Unspecified reason|0|||
127529764|NCT00726232|458899941|FG002|Expansion Phase|Unspecified reason|0|||
127529765|NCT00726232|458899942|FG003|Expansion Phase|Unspecified reason|0|||
127529766|NCT00726232|458899943|FG004|Expansion Phase|Unspecified reason|0|||
127529767|NCT00726232|458899944|FG005|Expansion Phase|Unspecified reason|0|||
127529768|NCT00726232|458899945|FG006|Expansion Phase|Unspecified reason|1|||
127529769|NCT00726232|458899946|FG007|Expansion Phase|Unspecified reason|0|||
127529770|NCT04034004|458899951|FG000|Overall Study|Withdrawal by Subject|1|||
127529771|NCT04034004|458899952|FG001|Overall Study|Withdrawal by Subject|2|||
127529772|NCT04034004|458899953|FG002|Overall Study|Withdrawal by Subject|2|||
127529773|NCT04034004|458899954|FG003|Overall Study|Withdrawal by Subject|3|||
127529774|NCT04034004|458899951|FG000|Overall Study|could not find vein to administer IV|2|||
127529775|NCT04034004|458899952|FG001|Overall Study|could not find vein to administer IV|1|||
127529776|NCT04034004|458899953|FG002|Overall Study|could not find vein to administer IV|0|||
127529777|NCT04034004|458899954|FG003|Overall Study|could not find vein to administer IV|0|||
127529778|NCT04034004|458899951|FG000|Overall Study|nurse accidentally unblinded subject|0|||
127529779|NCT04034004|458899952|FG001|Overall Study|nurse accidentally unblinded subject|0|||
127529780|NCT04034004|458899953|FG002|Overall Study|nurse accidentally unblinded subject|0|||
127529781|NCT04034004|458899954|FG003|Overall Study|nurse accidentally unblinded subject|1|||
127529782|NCT03088917|458899955|FG000|Overall Study|In care/cured elsewhere|15|||
127529783|NCT03088917|458899955|FG000|Overall Study|Refuse re-evaluation|13|||
127529784|NCT03088917|458899955|FG000|Overall Study|Contact not established|13|||
127529785|NCT03088917|458899955|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
127529786|NCT03088917|458899955|FG000|Overall Study|Moved outside study region|50|||
127529787|NCT01345188|458899956|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
127529788|NCT01345188|458899956|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
127529789|NCT05447663|458899958|FG000|Overall Study|Study terminated by Sponsor|5|||
127529790|NCT05447663|458899958|FG000|Overall Study|Death|2|||
127529791|NCT05447663|458899958|FG000|Overall Study|Withdrawal by Subject|1|||
127529792|NCT01397461|458899959|FG000|Overall Study|Withdrawal by Subject|2|||
127529793|NCT01397461|458899960|FG001|Overall Study|Withdrawal by Subject|1|||
127529794|NCT01397461|458899961|FG002|Overall Study|Withdrawal by Subject|0|||
127529795|NCT01397461|458899959|FG000|Overall Study|Lost to Follow-up|0|||
127529796|NCT01397461|458899960|FG001|Overall Study|Lost to Follow-up|2|||
127529797|NCT01397461|458899961|FG002|Overall Study|Lost to Follow-up|1|||
127529798|NCT01397461|458899959|FG000|Overall Study|Lack of Efficacy|0|||
127529799|NCT01397461|458899960|FG001|Overall Study|Lack of Efficacy|3|||
127529800|NCT01397461|458899961|FG002|Overall Study|Lack of Efficacy|0|||
127529801|NCT01397461|458899959|FG000|Overall Study|Not treated|0|||
127529802|NCT01397461|458899960|FG001|Overall Study|Not treated|0|||
127529803|NCT01397461|458899961|FG002|Overall Study|Not treated|1|||
127529804|NCT05729568|458899978|FG000|Overall Study|Still on Study|52|||
127529805|NCT05729568|458899979|FG001|Overall Study|Still on Study|26|||
127529806|NCT05729568|458899978|FG000|Overall Study|Randomized but Never Treated|3|||
127529807|NCT05729568|458899979|FG001|Overall Study|Randomized but Never Treated|0|||
127529808|NCT05729568|458899978|FG000|Overall Study|Adverse Event|0|||
127529809|NCT05729568|458899979|FG001|Overall Study|Adverse Event|1|||
127529810|NCT05729568|458899978|FG000|Overall Study|Investigator's Discretion|1|||
127529811|NCT05729568|458899979|FG001|Overall Study|Investigator's Discretion|0|||
127529812|NCT04181762|458899980|FG000|Overall Study|Adverse Event|1|||
127529813|NCT04181762|458899981|FG001|Overall Study|Adverse Event|3|||
127529814|NCT04181762|458899980|FG000|Overall Study|Lost to Follow-up|1|||
127529815|NCT04181762|458899981|FG001|Overall Study|Lost to Follow-up|1|||
127529816|NCT04181762|458899980|FG000|Overall Study|Physician Decision|1|||
127529817|NCT04181762|458899981|FG001|Overall Study|Physician Decision|3|||
127529818|NCT04181762|458899980|FG000|Overall Study|Pregnancy|0|||
127529819|NCT04181762|458899981|FG001|Overall Study|Pregnancy|1|||
127529820|NCT04181762|458899980|FG000|Overall Study|Lack of Efficacy|2|||
127529821|NCT04181762|458899981|FG001|Overall Study|Lack of Efficacy|2|||
127529822|NCT04181762|458899980|FG000|Overall Study|Study terminated by sponsor|95|||
127529823|NCT04181762|458899981|FG001|Overall Study|Study terminated by sponsor|97|||
127529824|NCT04181762|458899980|FG000|Overall Study|Subject decision|11|||
127529825|NCT04181762|458899981|FG001|Overall Study|Subject decision|4|||
127529826|NCT04181762|458899980|FG000|Overall Study|Death|1|||
127529827|NCT04181762|458899981|FG001|Overall Study|Death|1|||
127529828|NCT04181762|458899980|FG000|Overall Study|Protocol deviation|1|||
127529829|NCT04181762|458899981|FG001|Overall Study|Protocol deviation|0|||
127529830|NCT04181762|458899980|FG000|Overall Study|Withdrawal of informed consent|1|||
127529831|NCT04181762|458899981|FG001|Overall Study|Withdrawal of informed consent|3|||
127529832|NCT06041919|458899982|FG000|Overall Study|Lost to Follow-up|1|||
127529833|NCT06041919|458899983|FG001|Overall Study|Lost to Follow-up|0|||
127529834|NCT06041919|458899984|FG002|Overall Study|Lost to Follow-up|0|||
127529835|NCT06041919|458899985|FG003|Overall Study|Lost to Follow-up|0|||
127529836|NCT06041919|458899986|FG004|Overall Study|Lost to Follow-up|0|||
127529837|NCT06041919|458899982|FG000|Overall Study|At the request of the investigator or the sponsor|0|||
127529838|NCT06041919|458899983|FG001|Overall Study|At the request of the investigator or the sponsor|1|||
127529839|NCT06041919|458899984|FG002|Overall Study|At the request of the investigator or the sponsor|0|||
127529840|NCT06041919|458899985|FG003|Overall Study|At the request of the investigator or the sponsor|0|||
127529841|NCT06041919|458899986|FG004|Overall Study|At the request of the investigator or the sponsor|0|||
127529842|NCT04526145|458899987|FG000|Overall Study|Withdrawal by Subject|5|||
127529843|NCT01502228|458899988|FG000|Overall Study|Death|1|||
127529844|NCT01221350|458899994|FG000|Overall Study|Discontinued intervention (GERD)|1|||
127529845|NCT01221350|458899995|FG001|Overall Study|Discontinued intervention (GERD)|0|||
127529846|NCT01221350|458899994|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
127529847|NCT01221350|458899995|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
127529848|NCT01221350|458899994|FG000|Overall Study|Withdrawal by Subject|4|||
127529849|NCT01221350|458899995|FG001|Overall Study|Withdrawal by Subject|2|||
127529850|NCT02735343|458900001|FG000|Overall Study|screen fail|0|||
127529851|NCT02735343|458900002|FG001|Overall Study|screen fail|2|||
127529852|NCT00637416|458900003|FG000|Overall Study|Lost to Follow-up|1|||
127529853|NCT00637416|458900004|FG001|Overall Study|Lost to Follow-up|1|||
127529854|NCT00637416|458900003|FG000|Overall Study|Unable to take study drug|0|||
127529855|NCT00637416|458900004|FG001|Overall Study|Unable to take study drug|1|||
127529856|NCT02204072|458900010|FG000|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|1|||
127529857|NCT02204072|458900011|FG001|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|0|||
127529858|NCT02204072|458900012|FG002|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|2|||
127529859|NCT02204072|458900013|FG003|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|9|||
127529860|NCT02204072|458900014|FG004|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|6|||
127529861|NCT02204072|458900010|FG000|Overall Study|Discontinued Enzalutamide due to adverse events|0|||
127529862|NCT02204072|458900011|FG001|Overall Study|Discontinued Enzalutamide due to adverse events|3|||
127529863|NCT02204072|458900012|FG002|Overall Study|Discontinued Enzalutamide due to adverse events|1|||
127529864|NCT02204072|458900013|FG003|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
127529865|NCT02204072|458900014|FG004|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
127529866|NCT02204072|458900010|FG000|Overall Study|Discontinued Enzalutamide due to progressive disease|2|||
127529867|NCT02204072|458900011|FG001|Overall Study|Discontinued Enzalutamide due to progressive disease|4|||
127529868|NCT02204072|458900012|FG002|Overall Study|Discontinued Enzalutamide due to progressive disease|19|||
127529869|NCT02204072|458900013|FG003|Overall Study|Discontinued Enzalutamide due to progressive disease|26|||
127529870|NCT02204072|458900014|FG004|Overall Study|Discontinued Enzalutamide due to progressive disease|31|||
127529871|NCT02204072|458900010|FG000|Overall Study|Discontinued Enzalutamide due to other reason|0|||
127529872|NCT02204072|458900011|FG001|Overall Study|Discontinued Enzalutamide due to other reason|0|||
127529873|NCT02204072|458900012|FG002|Overall Study|Discontinued Enzalutamide due to other reason|2|||
127529874|NCT02204072|458900013|FG003|Overall Study|Discontinued Enzalutamide due to other reason|0|||
127529875|NCT02204072|458900014|FG004|Overall Study|Discontinued Enzalutamide due to other reason|0|||
127529876|NCT00999544|458901769|FG000|Overall Study|Withdrawal by Subject|1|||
127529877|NCT02407223|458901771|FG000|Overall Study|Adverse Event|1|||
127529878|NCT02407223|458901772|FG001|Overall Study|Adverse Event|0|||
127529879|NCT02407223|458901773|FG002|Overall Study|Adverse Event|1|||
127529880|NCT02407223|458901771|FG000|Overall Study|Lack of Efficacy|6|||
127529881|NCT02407223|458901772|FG001|Overall Study|Lack of Efficacy|6|||
127529882|NCT02407223|458901773|FG002|Overall Study|Lack of Efficacy|4|||
127529883|NCT02407223|458901771|FG000|Overall Study|Lost to Follow-up|1|||
127529884|NCT02407223|458901772|FG001|Overall Study|Lost to Follow-up|0|||
127529885|NCT02407223|458901773|FG002|Overall Study|Lost to Follow-up|2|||
127529886|NCT02407223|458901771|FG000|Overall Study|Withdrawal by Subject|2|||
127529887|NCT02407223|458901772|FG001|Overall Study|Withdrawal by Subject|4|||
127529888|NCT02407223|458901773|FG002|Overall Study|Withdrawal by Subject|4|||
127529889|NCT02407223|458901771|FG000|Overall Study|Study Terminated by Sponsor|77|||
127529890|NCT02407223|458901772|FG001|Overall Study|Study Terminated by Sponsor|80|||
127529891|NCT02407223|458901773|FG002|Overall Study|Study Terminated by Sponsor|86|||
127529892|NCT02407223|458901771|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
127529893|NCT02407223|458901772|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
127529894|NCT02407223|458901773|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
127529895|NCT02407223|458901771|FG000|Overall Study|Other|29|||
127529896|NCT02407223|458901772|FG001|Overall Study|Other|27|||
127529897|NCT02407223|458901773|FG002|Overall Study|Other|25|||
127529898|NCT01478971|458901782|FG000|Standard of Care Period|Adverse Event|1|||
127529899|NCT01478971|458901782|FG000|Standard of Care Period|Withdrawal by Subject|3|||
127529900|NCT01478971|458901782|FG000|Standard of Care Period|Death|8|||
127529901|NCT01478971|458901782|FG000|Standard of Care Period|Lost to Follow-up|9|||
127529902|NCT01478971|458901782|FG000|Standard of Care Period|Other|4|||
127529903|NCT01478971|458901782|FG000|Peginesatide Treatment Period|Adverse Event|1|||
127529904|NCT01478971|458901782|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
127529905|NCT01478971|458901782|FG000|Peginesatide Treatment Period|Death|4|||
127529906|NCT01478971|458901782|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
127529907|NCT01478971|458901782|FG000|Peginesatide Treatment Period|Other|4|||
127529908|NCT00584012|458901783|FG000|Overall Study|Withdrawal by Subject|1|||
127529909|NCT01525615|458901784|FG000|Overall Study|Adverse Event|11|||
127529910|NCT01525615|458901785|FG001|Overall Study|Adverse Event|7|||
127529911|NCT01525615|458901786|FG002|Overall Study|Adverse Event|5|||
127529912|NCT01525615|458901784|FG000|Overall Study|Lost to Follow-up|1|||
127529913|NCT01525615|458901785|FG001|Overall Study|Lost to Follow-up|0|||
127529914|NCT01525615|458901786|FG002|Overall Study|Lost to Follow-up|0|||
127529915|NCT01525615|458901784|FG000|Overall Study|Withdrawal by Subject|1|||
127529916|NCT01525615|458901785|FG001|Overall Study|Withdrawal by Subject|0|||
127529917|NCT01525615|458901786|FG002|Overall Study|Withdrawal by Subject|0|||
127529918|NCT01525615|458901784|FG000|Overall Study|Other reason not described above|1|||
127529919|NCT01525615|458901785|FG001|Overall Study|Other reason not described above|0|||
127529920|NCT01525615|458901786|FG002|Overall Study|Other reason not described above|1|||
127529921|NCT04050618|458901787|FG000|First Intervention|Withdrawal by Subject|2|||
127529922|NCT04050618|458901788|FG001|First Intervention|Withdrawal by Subject|0|||
127529923|NCT04050618|458901787|FG000|Second Intervention|Withdrawal by Subject|1|||
127529924|NCT04050618|458901788|FG001|Second Intervention|Withdrawal by Subject|0|||
127529925|NCT04404556|458901789|FG000|Intervention|Withdrawal by Subject|15|||
127529926|NCT04404556|458901790|FG001|Intervention|Withdrawal by Subject|3|||
127529927|NCT04404556|458901789|FG000|Intervention|Did not complete all intervention sessions|2|||
127529928|NCT04404556|458901790|FG001|Intervention|Did not complete all intervention sessions|1|||
127529929|NCT04404556|458901789|FG000|Post-Intervention|Missing Data|1|||
127529930|NCT04404556|458901790|FG001|Post-Intervention|Missing Data|2|||
127529931|NCT04404556|458901789|FG000|Follow-up 1|Withdrawal by Subject|5|||
127529932|NCT04404556|458901790|FG001|Follow-up 1|Withdrawal by Subject|1|||
127529933|NCT04404556|458901789|FG000|Follow-up 1|Missing Data|4|||
127529934|NCT04404556|458901790|FG001|Follow-up 1|Missing Data|7|||
127529935|NCT04404556|458901789|FG000|Follow-up 2|Withdrawal by Subject|1|||
127529936|NCT04404556|458901790|FG001|Follow-up 2|Withdrawal by Subject|1|||
127529937|NCT04404556|458901789|FG000|Follow-up 2|Missing Data|6|||
127529938|NCT04404556|458901790|FG001|Follow-up 2|Missing Data|5|||
127529939|NCT03777059|458901791|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
127529940|NCT03777059|458901792|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
127529941|NCT03777059|458901793|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
127529942|NCT03777059|458901794|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
127529943|NCT03777059|458901791|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
127529944|NCT03777059|458901792|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
127529945|NCT03777059|458901793|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
127529946|NCT03777059|458901794|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
127529947|NCT03777059|458901791|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
127529948|NCT03777059|458901792|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
127529949|NCT03777059|458901793|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
127529950|NCT03777059|458901794|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
127529951|NCT03777059|458901791|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
127529952|NCT03777059|458901792|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
127529953|NCT03777059|458901793|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
127529954|NCT03777059|458901794|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
127529955|NCT03777059|458901791|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
127529956|NCT03777059|458901792|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
127529957|NCT03777059|458901793|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
127529958|NCT03777059|458901794|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
127529959|NCT03777059|458901791|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
127529960|NCT03777059|458901792|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
127529961|NCT03777059|458901793|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
127529962|NCT03777059|458901794|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
127529963|NCT03777059|458901791|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
127529964|NCT03777059|458901792|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
127529965|NCT03777059|458901793|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
127529966|NCT03777059|458901794|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
127529967|NCT03777059|458901791|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
127529968|NCT03777059|458901792|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
127529969|NCT03777059|458901793|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
127529970|NCT03777059|458901794|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
127529971|NCT03777059|458901791|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
127529972|NCT03777059|458901792|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
127529973|NCT03777059|458901793|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
127529974|NCT03777059|458901794|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
127529975|NCT03777059|458901791|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
127529976|NCT03777059|458901792|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
127529977|NCT03777059|458901793|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
127529978|NCT03777059|458901794|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
127529979|NCT03777059|458901791|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
127529980|NCT03777059|458901792|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
127529981|NCT03777059|458901793|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
127981173|NCT02326298|460552272|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
127529982|NCT03777059|458901794|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
127529983|NCT02451943|458901801|FG000|Overall Study|Withdrawal by Subject|13|||
127529984|NCT02451943|458901802|FG001|Overall Study|Withdrawal by Subject|16|||
127529985|NCT02451943|458901801|FG000|Overall Study|Lost to Follow-up|3|||
127529986|NCT02451943|458901802|FG001|Overall Study|Lost to Follow-up|4|||
127529987|NCT02451943|458901801|FG000|Overall Study|Sponsor Decision|0|||
127529988|NCT02451943|458901802|FG001|Overall Study|Sponsor Decision|4|||
127529989|NCT01101035|458901804|FG000|Overall Study|Adverse Event|191|||
127529990|NCT01101035|458901805|FG001|Overall Study|Adverse Event|172|||
127529991|NCT01101035|458901804|FG000|Overall Study|Major Protocol Deviation|52|||
127529992|NCT01101035|458901805|FG001|Overall Study|Major Protocol Deviation|46|||
127529993|NCT01101035|458901804|FG000|Overall Study|Lost to Follow-up|226|||
127529994|NCT01101035|458901805|FG001|Overall Study|Lost to Follow-up|223|||
127529995|NCT01101035|458901804|FG000|Overall Study|Voluntary Withdrawal|595|||
127529996|NCT01101035|458901805|FG001|Overall Study|Voluntary Withdrawal|587|||
127529997|NCT01101035|458901804|FG000|Overall Study|Reason not Specified|333|||
127529998|NCT01101035|458901805|FG001|Overall Study|Reason not Specified|363|||
127529999|NCT00763386|458901806|FG000|Overall Study|Adverse Event|43|||
127530000|NCT00763386|458901807|FG001|Overall Study|Adverse Event|33|||
127530001|NCT00763386|458901806|FG000|Overall Study|Death|1|||
127530002|NCT00763386|458901807|FG001|Overall Study|Death|2|||
127530003|NCT00763386|458901806|FG000|Overall Study|Lost to Follow-up|3|||
127530004|NCT00763386|458901807|FG001|Overall Study|Lost to Follow-up|3|||
127530005|NCT00763386|458901806|FG000|Overall Study|Withdrawal by Subject|0|||
127530006|NCT00763386|458901807|FG001|Overall Study|Withdrawal by Subject|1|||
127530007|NCT00763386|458901806|FG000|Overall Study|CRF missing|0|||
127530008|NCT00763386|458901807|FG001|Overall Study|CRF missing|1|||
127530009|NCT00763386|458901806|FG000|Overall Study|Study Prosthesis Removed|1|||
127530010|NCT00763386|458901807|FG001|Overall Study|Study Prosthesis Removed|0|||
127530011|NCT00681629|458901810|FG000|Overall Study|Study termination|4|||
127530012|NCT00681629|458901811|FG001|Overall Study|Study termination|2|||
127530013|NCT00681629|458901810|FG000|Overall Study|Adverse Event|1|||
127530014|NCT00681629|458901811|FG001|Overall Study|Adverse Event|0|||
127530015|NCT00411671|458901814|FG000|Overall Study|Adverse Event|15|||
127530016|NCT00411671|458901814|FG000|Overall Study|Death|2|||
127530017|NCT00411671|458901814|FG000|Overall Study|Lost to Follow-up|3|||
127530018|NCT01173601|458901816|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
127530019|NCT01173601|458901817|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
127530020|NCT01173601|458901818|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
127530021|NCT01173601|458901819|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
127530022|NCT01173601|458901820|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
127530023|NCT01173601|458901816|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
127530024|NCT01173601|458901817|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
127530025|NCT01173601|458901818|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
127530026|NCT01173601|458901819|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
127530027|NCT01173601|458901820|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
127530028|NCT01173601|458901816|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
127530029|NCT01173601|458901817|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
127530030|NCT01173601|458901818|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
127530031|NCT01173601|458901819|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
127530032|NCT01173601|458901820|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
127530033|NCT01173601|458901816|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
127530034|NCT01173601|458901817|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
127530035|NCT01173601|458901818|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
127530036|NCT01173601|458901819|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
127530037|NCT01173601|458901820|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
127530038|NCT01173601|458901816|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
127530039|NCT01173601|458901817|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
127530040|NCT01173601|458901818|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
127530041|NCT01173601|458901819|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
127530042|NCT01173601|458901820|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
127530043|NCT01173601|458901816|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
127530044|NCT01173601|458901817|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
127530045|NCT01173601|458901818|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
127530046|NCT01173601|458901819|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
127530047|NCT01173601|458901820|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
127530048|NCT01173601|458901816|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
127530049|NCT01173601|458901817|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
127530050|NCT01173601|458901818|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
127530051|NCT01173601|458901819|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
127530052|NCT01173601|458901820|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
127530053|NCT01173601|458901816|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
127530054|NCT01173601|458901817|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
127530055|NCT01173601|458901818|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
127530056|NCT01173601|458901819|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
127530057|NCT01173601|458901820|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
127530058|NCT01173601|458901816|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
127530059|NCT01173601|458901817|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
127530060|NCT01173601|458901818|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
127530061|NCT01173601|458901819|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
127530062|NCT01173601|458901820|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
127530063|NCT01173601|458901816|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
127530064|NCT01173601|458901817|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
127530065|NCT01173601|458901818|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
127530066|NCT01173601|458901819|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
127530067|NCT01173601|458901820|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
127530068|NCT01173601|458901816|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
127530069|NCT01173601|458901817|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
127530070|NCT01173601|458901818|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
127530071|NCT01173601|458901819|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
127530072|NCT01173601|458901820|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
127530073|NCT01173601|458901816|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
127530074|NCT01173601|458901817|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
127530075|NCT01173601|458901818|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
127530076|NCT01173601|458901819|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
127530077|NCT01173601|458901820|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
127530078|NCT01173601|458901816|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
127530079|NCT01173601|458901817|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
127530080|NCT01173601|458901818|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
127530081|NCT01173601|458901819|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
127530082|NCT01173601|458901820|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
127530083|NCT01173601|458901816|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
127530084|NCT01173601|458901817|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
127530085|NCT01173601|458901818|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
127530086|NCT01173601|458901819|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
127530087|NCT01173601|458901820|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
127530088|NCT03951077|458901821|FG000|Overall Study|Adverse Event|1|||
127530089|NCT03951077|458901822|FG001|Overall Study|Adverse Event|0|||
127530090|NCT03951077|458901823|FG002|Overall Study|Adverse Event|0|||
127530091|NCT03951077|458901824|FG003|Overall Study|Adverse Event|0|||
127530092|NCT03951077|458901825|FG004|Overall Study|Adverse Event|0|||
127530093|NCT03951077|458901826|FG005|Overall Study|Adverse Event|0|||
127530094|NCT03951077|458901821|FG000|Overall Study|Withdrawal by Subject|3|||
127530095|NCT03951077|458901822|FG001|Overall Study|Withdrawal by Subject|3|||
127530096|NCT03951077|458901823|FG002|Overall Study|Withdrawal by Subject|0|||
127530097|NCT03951077|458901824|FG003|Overall Study|Withdrawal by Subject|3|||
127530098|NCT03951077|458901825|FG004|Overall Study|Withdrawal by Subject|3|||
127530099|NCT03951077|458901826|FG005|Overall Study|Withdrawal by Subject|2|||
127530100|NCT03951077|458901821|FG000|Overall Study|Lost to Follow-up|1|||
127530101|NCT03951077|458901822|FG001|Overall Study|Lost to Follow-up|1|||
127530102|NCT03951077|458901823|FG002|Overall Study|Lost to Follow-up|2|||
127530103|NCT03951077|458901824|FG003|Overall Study|Lost to Follow-up|3|||
127530104|NCT03951077|458901825|FG004|Overall Study|Lost to Follow-up|2|||
127530105|NCT03951077|458901826|FG005|Overall Study|Lost to Follow-up|3|||
127530106|NCT03951077|458901821|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
127530107|NCT03951077|458901822|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
127530108|NCT03951077|458901823|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
127530109|NCT03951077|458901824|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
127530110|NCT03951077|458901825|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
127530111|NCT03951077|458901826|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
127530112|NCT03951077|458901821|FG000|Overall Study|Other, Not Specified|12|||
127530113|NCT03951077|458901822|FG001|Overall Study|Other, Not Specified|10|||
127530114|NCT03951077|458901823|FG002|Overall Study|Other, Not Specified|10|||
127530115|NCT03951077|458901824|FG003|Overall Study|Other, Not Specified|5|||
127530116|NCT03951077|458901825|FG004|Overall Study|Other, Not Specified|9|||
127530117|NCT03951077|458901826|FG005|Overall Study|Other, Not Specified|6|||
127530118|NCT03951077|458901821|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
127530119|NCT03951077|458901822|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
127530120|NCT03951077|458901823|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
127530121|NCT03951077|458901824|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
127530122|NCT03951077|458901825|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
127530123|NCT03951077|458901826|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
127530124|NCT01395901|458901829|FG000|Overall Study|Lost to Follow-up|4|||
127530125|NCT01395901|458901830|FG001|Overall Study|Lost to Follow-up|0|||
127530126|NCT01395901|458901829|FG000|Overall Study|Randomized but not received study drug|5|||
127530127|NCT01395901|458901830|FG001|Overall Study|Randomized but not received study drug|4|||
127530128|NCT01395901|458901829|FG000|Overall Study|Adverse Event|0|||
127530129|NCT01395901|458901830|FG001|Overall Study|Adverse Event|1|||
127530130|NCT01395901|458901829|FG000|Overall Study|Withdrawal of consent|1|||
127530131|NCT01395901|458901830|FG001|Overall Study|Withdrawal of consent|0|||
127530132|NCT00713544|458901836|FG000|Overall Study|Adverse Event|5|||
127530133|NCT00713544|458901837|FG001|Overall Study|Adverse Event|3|||
127530134|NCT00713544|458901838|FG002|Overall Study|Adverse Event|7|||
127530135|NCT00713544|458901839|FG003|Overall Study|Adverse Event|7|||
127530136|NCT00713544|458901840|FG004|Overall Study|Adverse Event|3|||
127530137|NCT00713544|458901841|FG005|Overall Study|Adverse Event|5|||
127530138|NCT00713544|458901836|FG000|Overall Study|Withdrawal by Subject|2|||
127530139|NCT00713544|458901837|FG001|Overall Study|Withdrawal by Subject|0|||
127530140|NCT00713544|458901838|FG002|Overall Study|Withdrawal by Subject|3|||
127530141|NCT00713544|458901839|FG003|Overall Study|Withdrawal by Subject|2|||
127530142|NCT00713544|458901840|FG004|Overall Study|Withdrawal by Subject|3|||
127530143|NCT00713544|458901841|FG005|Overall Study|Withdrawal by Subject|1|||
127530144|NCT00713544|458901836|FG000|Overall Study|Protocol Violation|0|||
127530145|NCT00713544|458901837|FG001|Overall Study|Protocol Violation|0|||
127530146|NCT00713544|458901838|FG002|Overall Study|Protocol Violation|0|||
127530147|NCT00713544|458901839|FG003|Overall Study|Protocol Violation|0|||
127530148|NCT00713544|458901840|FG004|Overall Study|Protocol Violation|0|||
127530149|NCT00713544|458901841|FG005|Overall Study|Protocol Violation|1|||
127530150|NCT00713544|458901836|FG000|Overall Study|Physician Decision|0|||
127530151|NCT00713544|458901837|FG001|Overall Study|Physician Decision|0|||
127530152|NCT00713544|458901838|FG002|Overall Study|Physician Decision|0|||
127530153|NCT00713544|458901839|FG003|Overall Study|Physician Decision|0|||
127530154|NCT00713544|458901840|FG004|Overall Study|Physician Decision|0|||
127530155|NCT00713544|458901841|FG005|Overall Study|Physician Decision|2|||
127530156|NCT00713544|458901836|FG000|Overall Study|Lack of Efficacy|0|||
127530157|NCT00713544|458901837|FG001|Overall Study|Lack of Efficacy|1|||
127530158|NCT00713544|458901838|FG002|Overall Study|Lack of Efficacy|0|||
127530159|NCT00713544|458901839|FG003|Overall Study|Lack of Efficacy|1|||
127530160|NCT00713544|458901840|FG004|Overall Study|Lack of Efficacy|1|||
127530161|NCT00713544|458901841|FG005|Overall Study|Lack of Efficacy|0|||
127530162|NCT00713544|458901836|FG000|Overall Study|Lost to Follow-up|0|||
127530163|NCT00713544|458901837|FG001|Overall Study|Lost to Follow-up|0|||
127530164|NCT00713544|458901838|FG002|Overall Study|Lost to Follow-up|1|||
127530165|NCT00713544|458901839|FG003|Overall Study|Lost to Follow-up|0|||
127530166|NCT00713544|458901840|FG004|Overall Study|Lost to Follow-up|0|||
127530167|NCT00713544|458901841|FG005|Overall Study|Lost to Follow-up|0|||
127530168|NCT00713544|458901836|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
127530169|NCT00713544|458901837|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
127530170|NCT00713544|458901838|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
127530171|NCT00713544|458901839|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
127530172|NCT00713544|458901840|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
127530173|NCT00713544|458901841|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
127530174|NCT00713544|458901836|FG000|Overall Study|Incorrect enrollment|0|||
127530175|NCT00713544|458901837|FG001|Overall Study|Incorrect enrollment|1|||
127530176|NCT00713544|458901838|FG002|Overall Study|Incorrect enrollment|0|||
127530177|NCT00713544|458901839|FG003|Overall Study|Incorrect enrollment|0|||
127530178|NCT00713544|458901840|FG004|Overall Study|Incorrect enrollment|0|||
127530179|NCT00713544|458901841|FG005|Overall Study|Incorrect enrollment|0|||
127530180|NCT00713544|458901836|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
127530181|NCT00713544|458901837|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
127530182|NCT00713544|458901838|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
127530183|NCT00713544|458901839|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
127530184|NCT00713544|458901840|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
127530185|NCT00713544|458901841|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
127530186|NCT02380287|458901842|FG000|Overall Study|Adverse Event|0|||
127530187|NCT02380287|458901843|FG001|Overall Study|Adverse Event|0|||
127530188|NCT02380287|458901844|FG002|Overall Study|Adverse Event|1|||
127530189|NCT02380287|458901845|FG003|Overall Study|Adverse Event|0|||
127530190|NCT02380287|458901846|FG004|Overall Study|Adverse Event|0|||
127530191|NCT02380287|458901847|FG005|Overall Study|Adverse Event|0|||
127530192|NCT02380287|458901848|FG006|Overall Study|Adverse Event|0|||
127530193|NCT02380287|458901849|FG007|Overall Study|Adverse Event|0|||
127530194|NCT01641601|458901850|FG000|Overall Study|Study discontinued.|3|||
127530195|NCT01641601|458901851|FG001|Overall Study|Study discontinued.|5|||
127530196|NCT00950846|458901854|FG000|Overall Study|Death|6|||
127530197|NCT00950846|458901854|FG000|Overall Study|Lost to Follow-up|3|||
127530198|NCT00950846|458901854|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
127530199|NCT01799226|458901855|FG000|Overall Study|Withdrawal by Subject|1|||
127530200|NCT01799226|458901856|FG001|Overall Study|Withdrawal by Subject|0|||
127530201|NCT01799226|458901855|FG000|Overall Study|Disqualified at Day 14|1|||
127530202|NCT01799226|458901856|FG001|Overall Study|Disqualified at Day 14|0|||
127530203|NCT02178995|458901857|FG000|Double Blind|Adverse Event|0|||
127530204|NCT02178995|458901858|FG001|Double Blind|Adverse Event|0|||
127530205|NCT02178995|458901859|FG002|Double Blind|Adverse Event|0|||
127530206|NCT02178995|458901860|FG003|Double Blind|Adverse Event|0|||
127530207|NCT02178995|458901861|FG004|Double Blind|Adverse Event|0|||
127530208|NCT02178995|458901862|FG005|Double Blind|Adverse Event|1|||
127530209|NCT02178995|458901863|FG006|Double Blind|Adverse Event|0|||
127530210|NCT02178995|458901864|FG007|Double Blind|Adverse Event|1|||
127530211|NCT02178995|458901865|FG008|Double Blind|Adverse Event|1|||
127530212|NCT02178995|458901857|FG000|Double Blind|Lost to Follow-up|0|||
127530213|NCT02178995|458901858|FG001|Double Blind|Lost to Follow-up|1|||
127530214|NCT02178995|458901859|FG002|Double Blind|Lost to Follow-up|0|||
127530215|NCT02178995|458901860|FG003|Double Blind|Lost to Follow-up|0|||
127530216|NCT02178995|458901861|FG004|Double Blind|Lost to Follow-up|0|||
127530217|NCT02178995|458901862|FG005|Double Blind|Lost to Follow-up|0|||
127530218|NCT02178995|458901863|FG006|Double Blind|Lost to Follow-up|0|||
127530219|NCT02178995|458901864|FG007|Double Blind|Lost to Follow-up|1|||
127530220|NCT02178995|458901865|FG008|Double Blind|Lost to Follow-up|0|||
127530221|NCT02178995|458901857|FG000|Open Label|Adverse Event|2|||
127530222|NCT02178995|458901858|FG001|Open Label|Adverse Event|0|||
127530223|NCT02178995|458901859|FG002|Open Label|Adverse Event|0|||
127530224|NCT02178995|458901860|FG003|Open Label|Adverse Event|0|||
127530225|NCT02178995|458901861|FG004|Open Label|Adverse Event|0|||
127530226|NCT02178995|458901862|FG005|Open Label|Adverse Event|0|||
127530227|NCT02178995|458901863|FG006|Open Label|Adverse Event|0|||
127530228|NCT02178995|458901864|FG007|Open Label|Adverse Event|0|||
127530229|NCT02178995|458901865|FG008|Open Label|Adverse Event|0|||
127530230|NCT02274792|458901866|FG000|Overall Study|Withdrawal by Subject|13|||
127530231|NCT02274792|458901866|FG000|Overall Study|Lost to Follow-up|8|||
127530232|NCT02274792|458901866|FG000|Overall Study|Protocol Specified Criteria|2|||
127530233|NCT02274792|458901866|FG000|Overall Study|Sponsor Decision|2|||
127530234|NCT05258149|458901873|FG000|Period 1|Protocol Deviation|1|||
127530235|NCT05258149|458901874|FG001|Period 1|Protocol Deviation|0|||
127530236|NCT05258149|458901873|FG000|Period 1|Adverse Event|0|||
127530237|NCT05258149|458901874|FG001|Period 1|Adverse Event|1|||
127530238|NCT05258149|458901873|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
127530239|NCT05258149|458901874|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
127530240|NCT05258149|458901873|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
127530241|NCT05258149|458901874|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
127530242|NCT05258149|458901873|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
127530243|NCT05258149|458901874|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
127530244|NCT00832416|458901877|FG000|Overall Study|Lack of Efficacy|17|||
127530245|NCT00832416|458901878|FG001|Overall Study|Lack of Efficacy|15|||
127530246|NCT00832416|458901879|FG002|Overall Study|Lack of Efficacy|13|||
127530247|NCT00832416|458901880|FG003|Overall Study|Lack of Efficacy|52|||
127530248|NCT00832416|458901877|FG000|Overall Study|Withdrawal by Subject|5|||
127530249|NCT00832416|458901878|FG001|Overall Study|Withdrawal by Subject|7|||
127530250|NCT00832416|458901879|FG002|Overall Study|Withdrawal by Subject|2|||
127530251|NCT00832416|458901880|FG003|Overall Study|Withdrawal by Subject|10|||
127530252|NCT00832416|458901877|FG000|Overall Study|Physician Decision|2|||
127530253|NCT00832416|458901878|FG001|Overall Study|Physician Decision|12|||
127530254|NCT00832416|458901879|FG002|Overall Study|Physician Decision|5|||
127530255|NCT00832416|458901880|FG003|Overall Study|Physician Decision|10|||
127530256|NCT00832416|458901877|FG000|Overall Study|Administrative|0|||
127530257|NCT00832416|458901878|FG001|Overall Study|Administrative|0|||
127530258|NCT00832416|458901879|FG002|Overall Study|Administrative|0|||
127530259|NCT00832416|458901880|FG003|Overall Study|Administrative|1|||
127530260|NCT00832416|458901877|FG000|Overall Study|Adverse Event|21|||
127530261|NCT00832416|458901878|FG001|Overall Study|Adverse Event|19|||
127530262|NCT00832416|458901879|FG002|Overall Study|Adverse Event|41|||
127530263|NCT00832416|458901880|FG003|Overall Study|Adverse Event|10|||
127530264|NCT00832416|458901877|FG000|Overall Study|Death|1|||
127530265|NCT00832416|458901878|FG001|Overall Study|Death|0|||
127530266|NCT00832416|458901879|FG002|Overall Study|Death|0|||
127530267|NCT00832416|458901880|FG003|Overall Study|Death|0|||
127530268|NCT01442714|458901881|FG000|Overall Study|Death|11|||
127530269|NCT01442714|458901881|FG000|Overall Study|Withdrawal by Subject|1|||
127530270|NCT04306510|458901882|FG000|Overall Study|Voluntarily withdrawal|1|||
127530271|NCT04306510|458901882|FG000|Overall Study|Enrolled but Not Treated|1|||
127530272|NCT04829916|458901892|FG000|Overall Study|Withdrawal by Subject|1|||
127530273|NCT04829916|458901893|FG001|Overall Study|Withdrawal by Subject|0|||
127530274|NCT02152761|458901894|FG000|Epoch: Treatment Epoch|Technical problems|0|||
127530275|NCT02152761|458901895|FG001|Epoch: Treatment Epoch|Technical problems|0|||
127530276|NCT02152761|458901896|FG002|Epoch: Treatment Epoch|Technical problems|0|||
127530277|NCT02152761|458901897|FG003|Epoch: Treatment Epoch|Technical problems|1|||
127530278|NCT02152761|458901894|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
127530279|NCT02152761|458901895|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
127530280|NCT02152761|458901896|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
127530281|NCT02152761|458901897|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
127530282|NCT02152761|458901894|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
127530283|NCT02152761|458901895|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
127530284|NCT02152761|458901896|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
127530285|NCT02152761|458901897|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
127530286|NCT02152761|458901894|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
127530287|NCT02152761|458901895|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
127530288|NCT02152761|458901896|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
127530289|NCT02152761|458901897|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
127530290|NCT02152761|458901894|FG000|Epoch: Treatment Epoch|Death|0|||
127530291|NCT02152761|458901895|FG001|Epoch: Treatment Epoch|Death|3|||
127530292|NCT02152761|458901896|FG002|Epoch: Treatment Epoch|Death|1|||
127530293|NCT02152761|458901897|FG003|Epoch: Treatment Epoch|Death|0|||
127530294|NCT02152761|458901894|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
127530295|NCT02152761|458901895|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
127530296|NCT02152761|458901896|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
127530297|NCT02152761|458901897|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
127530298|NCT02152761|458901894|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
127530299|NCT02152761|458901895|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
127530300|NCT02152761|458901896|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
127530301|NCT02152761|458901897|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
127530302|NCT02152761|458901894|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
127530303|NCT02152761|458901895|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
127530304|NCT02152761|458901896|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
127530305|NCT02152761|458901897|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
127530306|NCT02152761|458901894|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
127530307|NCT02152761|458901895|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
127530308|NCT02152761|458901896|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
127530309|NCT02152761|458901897|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
127530310|NCT02152761|458901894|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
127530311|NCT02152761|458901895|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
127530312|NCT02152761|458901896|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
127530313|NCT02152761|458901897|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
127530314|NCT04343755|458901898|FG000|Overall Study|Death|11|||
127530315|NCT04343755|458901898|FG000|Overall Study|Screen Failure|1|||
127530316|NCT03755882|458901899|FG000|Period 1|Protocol Violation|1|||
127530317|NCT03755882|458901900|FG001|Period 1|Protocol Violation|0|||
127530318|NCT03755882|458901899|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
127530319|NCT03755882|458901900|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
127530320|NCT02859246|458901903|FG000|Overall Study|Screen fails|3|||
127530321|NCT02859246|458901903|FG000|Overall Study|Adverse Event|1|||
127530322|NCT02859246|458901903|FG000|Overall Study|Withdrawal by Subject|1|||
127530323|NCT01746368|458901904|FG000|Overall Study|Lost to Follow-up|2|||
127530324|NCT01746368|458901905|FG001|Overall Study|Lost to Follow-up|0|||
127530325|NCT01746368|458901904|FG000|Overall Study|Withdrawal by Subject|0|||
127530326|NCT01746368|458901905|FG001|Overall Study|Withdrawal by Subject|1|||
127530327|NCT05280717|458901906|FG000|Part A (Up to Week 35)|Withdrawal by Subject|1|||
127530328|NCT05280717|458901907|FG001|Part A (Up to Week 35)|Withdrawal by Subject|3|||
127530329|NCT05280717|458901908|FG002|Part A (Up to Week 35)|Withdrawal by Subject|2|||
127530330|NCT05280717|458901909|FG003|Part A (Up to Week 35)|Withdrawal by Subject|0|||
127530331|NCT05280717|458901910|FG004|Part A (Up to Week 35)|Withdrawal by Subject|0|||
127530332|NCT05280717|458901911|FG005|Part A (Up to Week 35)|Withdrawal by Subject|0|||
127530333|NCT05280717|458901912|FG006|Part A (Up to Week 35)|Withdrawal by Subject|0|||
127530334|NCT05280717|458901906|FG000|Part A (Up to Week 35)|Randomized but not received treatment|1|||
127530335|NCT05280717|458901907|FG001|Part A (Up to Week 35)|Randomized but not received treatment|0|||
127530336|NCT05280717|458901908|FG002|Part A (Up to Week 35)|Randomized but not received treatment|0|||
127530337|NCT05280717|458901909|FG003|Part A (Up to Week 35)|Randomized but not received treatment|0|||
127530338|NCT05280717|458901910|FG004|Part A (Up to Week 35)|Randomized but not received treatment|0|||
127530339|NCT05280717|458901911|FG005|Part A (Up to Week 35)|Randomized but not received treatment|0|||
127530340|NCT05280717|458901912|FG006|Part A (Up to Week 35)|Randomized but not received treatment|0|||
127530341|NCT05280717|458901906|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
127530342|NCT05280717|458901907|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|1|||
127530343|NCT05280717|458901908|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
127530344|NCT05280717|458901909|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
127530345|NCT05280717|458901910|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
127530346|NCT05280717|458901911|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
127530347|NCT05280717|458901912|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
127530348|NCT05280717|458901906|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
127530349|NCT05280717|458901907|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
127530350|NCT05280717|458901908|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|1|||
127530351|NCT05280717|458901909|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
127530352|NCT05280717|458901910|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
127530353|NCT05280717|458901911|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
127530354|NCT05280717|458901912|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
127530355|NCT05280717|458901906|FG000|Part C (Up to Week 35)|Withdrawal by Subject|0|||
127530356|NCT05280717|458901907|FG001|Part C (Up to Week 35)|Withdrawal by Subject|0|||
127530357|NCT05280717|458901908|FG002|Part C (Up to Week 35)|Withdrawal by Subject|0|||
127530358|NCT05280717|458901909|FG003|Part C (Up to Week 35)|Withdrawal by Subject|0|||
127530359|NCT05280717|458901910|FG004|Part C (Up to Week 35)|Withdrawal by Subject|0|||
127530360|NCT05280717|458901911|FG005|Part C (Up to Week 35)|Withdrawal by Subject|2|||
127530361|NCT05280717|458901912|FG006|Part C (Up to Week 35)|Withdrawal by Subject|0|||
127530362|NCT05280717|458901906|FG000|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
127530363|NCT05280717|458901907|FG001|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
127530364|NCT05280717|458901908|FG002|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
127530365|NCT05280717|458901909|FG003|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
127530366|NCT05280717|458901910|FG004|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
127530367|NCT05280717|458901911|FG005|Part C (Up to Week 35)|Enrolled but not received treatment|2|||
127530368|NCT05280717|458901912|FG006|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
127530369|NCT04209205|458901915|FG000|Overall Study|Adverse Event|2|||
127530370|NCT04209205|458901916|FG001|Overall Study|Adverse Event|3|||
127530371|NCT04209205|458901915|FG000|Overall Study|Lost to Follow-up|3|||
127530372|NCT04209205|458901916|FG001|Overall Study|Lost to Follow-up|1|||
127530373|NCT04209205|458901915|FG000|Overall Study|Physician Decision|1|||
127530374|NCT04209205|458901916|FG001|Overall Study|Physician Decision|1|||
127530375|NCT04209205|458901915|FG000|Overall Study|Subject decision|10|||
127530376|NCT04209205|458901916|FG001|Overall Study|Subject decision|10|||
127530377|NCT04209205|458901915|FG000|Overall Study|Progressive disease|1|||
127530378|NCT04209205|458901916|FG001|Overall Study|Progressive disease|0|||
127530379|NCT04209205|458901915|FG000|Overall Study|Protocol deviation|0|||
127530380|NCT04209205|458901916|FG001|Overall Study|Protocol deviation|1|||
127530381|NCT04209205|458901915|FG000|Overall Study|New therapy for study indication|1|||
127530382|NCT04209205|458901916|FG001|Overall Study|New therapy for study indication|0|||
127530383|NCT04209205|458901915|FG000|Overall Study|Adverse event - placebo not switched|0|||
127530384|NCT04209205|458901916|FG001|Overall Study|Adverse event - placebo not switched|1|||
127530385|NCT04209205|458901915|FG000|Overall Study|Subject decision - placebo not switched|0|||
127530386|NCT04209205|458901916|FG001|Overall Study|Subject decision - placebo not switched|5|||
127530387|NCT04209205|458901915|FG000|Overall Study|Death - placebo not switched|0|||
127530388|NCT04209205|458901916|FG001|Overall Study|Death - placebo not switched|1|||
127530389|NCT05236257|458901949|FG000|Overall Study|Ongoing with study treatment|29|||
127530390|NCT05236257|458901950|FG001|Overall Study|Ongoing with study treatment|1|||
127530391|NCT05236257|458901949|FG000|Overall Study|Discontinued study treatment|22|||
127530392|NCT05236257|458901950|FG001|Overall Study|Discontinued study treatment|41|||
127530393|NCT00924443|458901953|FG000|Overall Study|Physician Decision|2|||
127530394|NCT00924443|458901953|FG000|Overall Study|Protocol Violation|1|||
127530395|NCT00874848|458901954|FG000|Overall Study|Adverse Event|13|||
127530396|NCT00874848|458901955|FG001|Overall Study|Adverse Event|2|||
127530397|NCT00874848|458901954|FG000|Overall Study|Progressive neoplastic disease|38|||
127530398|NCT00874848|458901955|FG001|Overall Study|Progressive neoplastic disease|18|||
127530399|NCT00874848|458901954|FG000|Overall Study|Withdrawal by Subject|7|||
127530400|NCT00874848|458901955|FG001|Overall Study|Withdrawal by Subject|4|||
127530401|NCT00874848|458901954|FG000|Overall Study|Noncompliance|1|||
127530402|NCT00874848|458901955|FG001|Overall Study|Noncompliance|1|||
127530403|NCT00874848|458901954|FG000|Overall Study|Failure to comply with protocol|0|||
127530404|NCT00874848|458901955|FG001|Overall Study|Failure to comply with protocol|1|||
127530405|NCT00874848|458901954|FG000|Overall Study|Physician Decision|0|||
127530406|NCT00874848|458901955|FG001|Overall Study|Physician Decision|2|||
127530407|NCT03405818|458901962|FG000|Overall Study|Withdrawal by Subject|4|||
127530408|NCT03405818|458901962|FG000|Overall Study|Lost to Follow-up|4|||
127530409|NCT03197376|458901963|FG000|Primary and Booster Phase|Adverse Event|0|||
127530410|NCT03197376|458901964|FG001|Primary and Booster Phase|Adverse Event|0|||
127530411|NCT03197376|458901965|FG002|Primary and Booster Phase|Adverse Event|0|||
127530412|NCT03197376|458901966|FG003|Primary and Booster Phase|Adverse Event|1|||
127530413|NCT03197376|458901963|FG000|Primary and Booster Phase|Death|1|||
127530414|NCT03197376|458901964|FG001|Primary and Booster Phase|Death|0|||
127530415|NCT03197376|458901965|FG002|Primary and Booster Phase|Death|0|||
127530416|NCT03197376|458901966|FG003|Primary and Booster Phase|Death|2|||
127530417|NCT03197376|458901963|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
127530418|NCT03197376|458901964|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
127530419|NCT03197376|458901965|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
127530420|NCT03197376|458901966|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
127530421|NCT03197376|458901963|FG000|Primary and Booster Phase|Physician Decision|1|||
127530422|NCT03197376|458901964|FG001|Primary and Booster Phase|Physician Decision|0|||
127530423|NCT03197376|458901965|FG002|Primary and Booster Phase|Physician Decision|1|||
127530424|NCT03197376|458901966|FG003|Primary and Booster Phase|Physician Decision|3|||
127530425|NCT03197376|458901963|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
127530426|NCT03197376|458901964|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
127530427|NCT03197376|458901965|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
127530428|NCT03197376|458901966|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
127530429|NCT03197376|458901963|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
127530430|NCT03197376|458901964|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
127530431|NCT03197376|458901965|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
127530432|NCT03197376|458901966|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
127530433|NCT03197376|458901963|FG000|Primary and Booster Phase|Not vaccine related|1|||
127530434|NCT03197376|458901964|FG001|Primary and Booster Phase|Not vaccine related|2|||
127530435|NCT03197376|458901965|FG002|Primary and Booster Phase|Not vaccine related|0|||
127530436|NCT03197376|458901966|FG003|Primary and Booster Phase|Not vaccine related|6|||
127530437|NCT03197376|458901963|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
127530438|NCT03197376|458901964|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
127530439|NCT03197376|458901965|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
127530440|NCT03197376|458901966|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
127530441|NCT03197376|458901963|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
127530442|NCT03197376|458901964|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
127530443|NCT03197376|458901965|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
127530444|NCT03197376|458901966|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
127530445|NCT03197376|458901963|FG000|Immune Persistence Phase|Not vaccine related|1|||
127530446|NCT03197376|458901964|FG001|Immune Persistence Phase|Not vaccine related|0|||
127530447|NCT03197376|458901965|FG002|Immune Persistence Phase|Not vaccine related|1|||
127530448|NCT03197376|458901966|FG003|Immune Persistence Phase|Not vaccine related|1|||
127530449|NCT00003199|458901967|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
127530450|NCT00003199|458901967|FG000|Overall Study|Lack of insurance clearance|2|||
127530451|NCT00003199|458901967|FG000|Overall Study|Screen fail|15|||
127530452|NCT01223183|458901969|FG000|Imaging Day 1|Physician Decision|0|||
127530453|NCT01223183|458901970|FG001|Imaging Day 1|Physician Decision|1|||
127530454|NCT01223183|458901969|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
127530455|NCT01223183|458901970|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
127530456|NCT01223183|458901969|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
127530457|NCT01223183|458901970|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
127530458|NCT00502671|458903518|FG000|Overall Study|Disease Progression|13|||
127530459|NCT00502671|458903518|FG000|Overall Study|Personal Reasons|22|||
127530460|NCT00502671|458903518|FG000|Overall Study|Lost to Follow-up|7|||
127530461|NCT00502671|458903518|FG000|Overall Study|Protocol Violation|16|||
127530462|NCT00502671|458903518|FG000|Overall Study|Adverse Event|19|||
127530463|NCT00412893|458903521|FG000|Overall Study|Adverse Event|31|||
127530464|NCT00412893|458903522|FG001|Overall Study|Adverse Event|53|||
127530465|NCT00412893|458903521|FG000|Overall Study|Death|17|||
127530466|NCT00412893|458903522|FG001|Overall Study|Death|21|||
127530467|NCT00412893|458903521|FG000|Overall Study|Insufficient Therapeutic Response|39|||
127530468|NCT00412893|458903522|FG001|Overall Study|Insufficient Therapeutic Response|23|||
127530469|NCT00412893|458903521|FG000|Overall Study|Lost to Follow-up|2|||
127530470|NCT00412893|458903522|FG001|Overall Study|Lost to Follow-up|1|||
127530471|NCT00412893|458903521|FG000|Overall Study|Violation of Selection at Entry|17|||
127530472|NCT00412893|458903522|FG001|Overall Study|Violation of Selection at Entry|10|||
127530473|NCT00412893|458903521|FG000|Overall Study|Other Protocol Violation|10|||
127530474|NCT00412893|458903522|FG001|Overall Study|Other Protocol Violation|6|||
127530475|NCT00412893|458903521|FG000|Overall Study|Did Not Cooperate|12|||
127530476|NCT00412893|458903522|FG001|Overall Study|Did Not Cooperate|9|||
127530477|NCT00412893|458903521|FG000|Overall Study|Administrative Reason|12|||
127530478|NCT00412893|458903522|FG001|Overall Study|Administrative Reason|15|||
127530479|NCT00412893|458903521|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
127530480|NCT00412893|458903522|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
127530481|NCT04473963|458903523|FG000|Overall Study|Withdrawal by Subject|1|||
127530482|NCT04473963|458903524|FG001|Overall Study|Withdrawal by Subject|1|||
127530483|NCT04473963|458903525|FG002|Overall Study|Withdrawal by Subject|0|||
127530484|NCT04473963|458903523|FG000|Overall Study|Not inducible in AF|0|||
127530485|NCT04473963|458903524|FG001|Overall Study|Not inducible in AF|0|||
127530486|NCT04473963|458903525|FG002|Overall Study|Not inducible in AF|2|||
127530487|NCT00587158|458903529|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
127530488|NCT00587158|458903530|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
127530489|NCT00587158|458903529|FG000|Overall Study|Physician Decision|0|||
127530490|NCT00587158|458903530|FG001|Overall Study|Physician Decision|1|||
127530491|NCT00587158|458903529|FG000|Overall Study|Lost to Follow-up|1|||
127530492|NCT00587158|458903530|FG001|Overall Study|Lost to Follow-up|2|||
127530493|NCT00587158|458903529|FG000|Overall Study|Death|0|||
127530494|NCT00587158|458903530|FG001|Overall Study|Death|1|||
127530495|NCT00587158|458903529|FG000|Overall Study|Subject did not want to take study med|0|||
127530496|NCT00587158|458903530|FG001|Overall Study|Subject did not want to take study med|1|||
127530497|NCT02114606|458903531|FG000|Overall Study|Unable to swallow Cytosponge|6|||
127530498|NCT00981461|458903532|FG000|Overall Study|Lost to Follow-up|5|||
127530499|NCT00981461|458903533|FG001|Overall Study|Lost to Follow-up|2|||
127530500|NCT03361293|458903542|FG000|Overall Study|Lost to Follow-up|0|||
127530501|NCT03361293|458903543|FG001|Overall Study|Lost to Follow-up|2|||
127530502|NCT03361293|458903542|FG000|Overall Study|Withdrawal by Subject|1|||
127530503|NCT03361293|458903543|FG001|Overall Study|Withdrawal by Subject|3|||
127530504|NCT01910402|458903546|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
127530505|NCT01910402|458903547|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
127530506|NCT01910402|458903548|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
127530507|NCT01910402|458903546|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
127530508|NCT01910402|458903547|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
127530509|NCT01910402|458903548|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
127530510|NCT01910402|458903546|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
127530511|NCT01910402|458903547|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
127530512|NCT01910402|458903548|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
127530513|NCT01910402|458903546|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
127530514|NCT01910402|458903547|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
127530515|NCT01910402|458903548|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
127530516|NCT01910402|458903546|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
127530517|NCT01910402|458903547|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
127530518|NCT01910402|458903548|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
127530519|NCT01910402|458903546|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
127530520|NCT01910402|458903547|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
127530521|NCT01910402|458903548|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
127530522|NCT01910402|458903546|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
127530523|NCT01910402|458903547|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
127530524|NCT01910402|458903548|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
127530525|NCT01910402|458903546|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
127530526|NCT01910402|458903547|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
127530527|NCT01910402|458903548|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
127530528|NCT01910402|458903546|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
127530529|NCT01910402|458903547|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
127530530|NCT01910402|458903548|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
127530531|NCT01910402|458903546|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
127530532|NCT01910402|458903547|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
127530533|NCT01910402|458903548|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
127530534|NCT01910402|458903546|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
127530535|NCT01910402|458903547|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
127530536|NCT01910402|458903548|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
127530537|NCT01910402|458903546|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
127530538|NCT01910402|458903547|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
127530539|NCT01910402|458903548|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
127530540|NCT01910402|458903546|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
127530541|NCT01910402|458903547|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
127530542|NCT01910402|458903548|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
127530543|NCT00483405|458903549|FG000|Overall Study|Adverse Event|8|||
127530544|NCT00483405|458903549|FG000|Overall Study|Lack of Efficacy|14|||
127530545|NCT00483405|458903549|FG000|Overall Study|Death|3|||
127530546|NCT00483405|458903549|FG000|Overall Study|Withdrawal by Subject|2|||
127530547|NCT00483405|458903549|FG000|Overall Study|Other complicating disease|1|||
127530548|NCT00571038|458903550|FG000|Overall Study|Lost to Follow-up|1|||
127530549|NCT00571038|458903551|FG001|Overall Study|Lost to Follow-up|4|||
127530550|NCT00571038|458903550|FG000|Overall Study|Death|7|||
127530551|NCT00571038|458903551|FG001|Overall Study|Death|5|||
127530552|NCT00571038|458903550|FG000|Overall Study|Withdrawal by Subject|1|||
127530553|NCT00571038|458903551|FG001|Overall Study|Withdrawal by Subject|3|||
127530554|NCT00571038|458903550|FG000|Overall Study|Moved out of state|2|||
127530555|NCT00571038|458903551|FG001|Overall Study|Moved out of state|2|||
127530556|NCT01550757|458903552|FG000|Overall Study|Lost to Follow-up|21|||
127530557|NCT01550757|458903553|FG001|Overall Study|Lost to Follow-up|14|||
127530558|NCT01550757|458903554|FG002|Overall Study|Lost to Follow-up|42|||
127530559|NCT01550757|458903555|FG003|Overall Study|Lost to Follow-up|53|||
127530560|NCT01550757|458903552|FG000|Overall Study|Withdrawal by Subject|2|||
127530561|NCT01550757|458903553|FG001|Overall Study|Withdrawal by Subject|0|||
127530562|NCT01550757|458903554|FG002|Overall Study|Withdrawal by Subject|3|||
127530563|NCT01550757|458903555|FG003|Overall Study|Withdrawal by Subject|1|||
127530564|NCT04098809|458903557|FG000|Overall Study|Withdrawal by Subject|1|||
127530565|NCT04098809|458903558|FG001|Overall Study|Withdrawal by Subject|3|||
127530566|NCT04098809|458903557|FG000|Overall Study|Physician Decision|2|||
127530567|NCT04098809|458903558|FG001|Overall Study|Physician Decision|1|||
127530568|NCT00193206|458903559|FG000|Preoperative Therapy|Lack of Efficacy|2|||
127530569|NCT00193206|458903559|FG000|Preoperative Therapy|Adverse Event|2|||
127530570|NCT00193206|458903559|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
127530571|NCT00193206|458903559|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
127530572|NCT00193206|458903559|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
127530573|NCT00193206|458903559|FG000|Postoperative Therapy|Physician Decision|3|||
127530574|NCT00193206|458903559|FG000|Postoperative Therapy|Intercurrent Illness|2|||
127530575|NCT00193206|458903559|FG000|Postoperative Therapy|Lack of Efficacy|1|||
127530576|NCT00193206|458903559|FG000|Postoperative Therapy|Protocol Violation|1|||
127530577|NCT02741596|458903560|FG000|Overall Study|Adverse Event|1|||
127530578|NCT02741596|458903561|FG001|Overall Study|Adverse Event|5|||
127530579|NCT02741596|458903560|FG000|Overall Study|Lost to Follow-up|1|||
127530580|NCT02741596|458903561|FG001|Overall Study|Lost to Follow-up|1|||
127530581|NCT02741596|458903560|FG000|Overall Study|Physician Decision|2|||
127530582|NCT02741596|458903561|FG001|Overall Study|Physician Decision|1|||
127530583|NCT02741596|458903560|FG000|Overall Study|Pregnancy|3|||
127530584|NCT02741596|458903561|FG001|Overall Study|Pregnancy|1|||
127530585|NCT02741596|458903560|FG000|Overall Study|Other (Unspecified)|0|||
127530586|NCT02741596|458903561|FG001|Overall Study|Other (Unspecified)|3|||
127530587|NCT02741596|458903560|FG000|Overall Study|Subject withdrawn-Other|17|||
127530588|NCT02741596|458903561|FG001|Overall Study|Subject withdrawn-Other|4|||
127530589|NCT02741596|458903560|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
127530590|NCT02741596|458903561|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
127530591|NCT01426958|458903562|FG000|Overall Study|Adverse Event|2|||
127530592|NCT00100789|458903563|FG000|Overall Study|Adverse Event|10|||
127530593|NCT00100789|458903563|FG000|Overall Study|Withdrawal by Subject|1|||
127530594|NCT00100789|458903563|FG000|Overall Study|Progression/relapse|42|||
127530595|NCT00100789|458903563|FG000|Overall Study|Death|2|||
127530596|NCT00100789|458903563|FG000|Overall Study|Not protocol specified|5|||
127530597|NCT00100789|458903563|FG000|Overall Study|Ineligible|3|||
127530598|NCT00100789|458903563|FG000|Overall Study|Never received treatment|1|||
127530599|NCT00080301|458903564|FG000|Overall Study|Randomized but Never Treated|5|||
127530600|NCT00080301|458903565|FG001|Overall Study|Randomized but Never Treated|10|||
127530601|NCT00080301|458903564|FG000|Overall Study|Still on Treatment as of CSR date|0|||
127530602|NCT00080301|458903565|FG001|Overall Study|Still on Treatment as of CSR date|1|||
127530603|NCT02518971|458903566|FG000|Overall Study|Lost to Follow-up|0|||
127530604|NCT02518971|458903567|FG001|Overall Study|Lost to Follow-up|1|||
127530605|NCT02518971|458903566|FG000|Overall Study|Physician Decision|6|||
127530606|NCT02518971|458903567|FG001|Overall Study|Physician Decision|6|||
127530607|NCT02518971|458903566|FG000|Overall Study|Protocol Violation|6|||
127530608|NCT02518971|458903567|FG001|Overall Study|Protocol Violation|4|||
127530609|NCT02518971|458903566|FG000|Overall Study|Withdrawal by Subject|4|||
127530610|NCT02518971|458903567|FG001|Overall Study|Withdrawal by Subject|5|||
127530611|NCT02518971|458903566|FG000|Overall Study|Side effects|1|||
127530612|NCT02518971|458903567|FG001|Overall Study|Side effects|0|||
127530613|NCT02518971|458903566|FG000|Overall Study|medication lost in mail|0|||
127530614|NCT02518971|458903567|FG001|Overall Study|medication lost in mail|1|||
127530615|NCT02518971|458903566|FG000|Overall Study|eligibility criteria no longer met|6|||
127530616|NCT02518971|458903567|FG001|Overall Study|eligibility criteria no longer met|3|||
127530617|NCT02336230|458903568|FG000|Overall Study|Adverse Event|1|||
127530618|NCT02336230|458903568|FG000|Overall Study|Withdrawal of consent|1|||
127530619|NCT02336230|458903568|FG000|Overall Study|Death|9|||
127530620|NCT02336230|458903568|FG000|Overall Study|Dose not received due to shipping delay|1|||
127530621|NCT02336230|458903568|FG000|Overall Study|Discontinuation of MSC infusion|1|||
127530622|NCT02524171|458903569|FG000|6-month Follow-up|Lost to Follow-up|53|||
127530623|NCT02524171|458903570|FG001|6-month Follow-up|Lost to Follow-up|45|||
127530624|NCT02524171|458903569|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
127530625|NCT02524171|458903570|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
127530626|NCT00757237|458903573|FG000|Overall Study|Lost to Follow-up|0|||
127530627|NCT00757237|458903574|FG001|Overall Study|Lost to Follow-up|1|||
127530628|NCT00757237|458903573|FG000|Overall Study|Protocol Violation|0|||
127530629|NCT00757237|458903574|FG001|Overall Study|Protocol Violation|2|||
127530630|NCT00757237|458903573|FG000|Overall Study|Physician Decision|2|||
127530631|NCT00757237|458903574|FG001|Overall Study|Physician Decision|3|||
127530632|NCT00757237|458903573|FG000|Overall Study|Withdrawal by Subject|8|||
127530633|NCT00757237|458903574|FG001|Overall Study|Withdrawal by Subject|12|||
127530634|NCT00757237|458903573|FG000|Overall Study|Safety or Tolerability|3|||
127530635|NCT00757237|458903574|FG001|Overall Study|Safety or Tolerability|5|||
127530636|NCT00757237|458903573|FG000|Overall Study|Other|0|||
127530637|NCT00757237|458903574|FG001|Overall Study|Other|2|||
127530638|NCT05150990|458903575|FG000|Overall Study|Decline in health of older adult (unrelated to the intervention)|5|||
127530639|NCT05150990|458903576|FG001|Overall Study|Decline in health of older adult (unrelated to the intervention)|2|||
127530640|NCT05150990|458903575|FG000|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|6|||
127530641|NCT05150990|458903576|FG001|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|2|||
127530642|NCT05150990|458903575|FG000|Overall Study|Adverse response to the intervention - social strain|0|||
127530643|NCT05150990|458903576|FG001|Overall Study|Adverse response to the intervention - social strain|2|||
127530644|NCT05150990|458903575|FG000|Overall Study|Adverse response to the intervention - discomfort using technology|0|||
127530645|NCT05150990|458903576|FG001|Overall Study|Adverse response to the intervention - discomfort using technology|1|||
127530646|NCT05150990|458903575|FG000|Overall Study|External circumstances (family emergency, loss of Wifi)|0|||
127530647|NCT05150990|458903576|FG001|Overall Study|External circumstances (family emergency, loss of Wifi)|2|||
127530648|NCT05150990|458903575|FG000|Overall Study|Participant no longer eligible due to history of seizures not previously reported|0|||
127530649|NCT05150990|458903576|FG001|Overall Study|Participant no longer eligible due to history of seizures not previously reported|1|||
127530650|NCT05150990|458903575|FG000|Overall Study|Death (unrelated to the intervention)|1|||
127530651|NCT05150990|458903576|FG001|Overall Study|Death (unrelated to the intervention)|2|||
127530652|NCT00466921|458903577|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
127530653|NCT00466921|458903577|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
127530654|NCT00466921|458903577|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
127530655|NCT00466921|458903577|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
127530656|NCT00466921|458903577|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
127530657|NCT00466921|458903577|FG000|Follow up for a Minimum of 1 Year|Death|6|||
127530658|NCT01100320|458903578|FG000|Period 1|Withdrawal by Subject|2|||
127530659|NCT01100320|458903579|FG001|Period 1|Withdrawal by Subject|4|||
127530660|NCT01100320|458903578|FG000|Period 1|Positive Drug Screen|1|||
127530661|NCT01100320|458903579|FG001|Period 1|Positive Drug Screen|1|||
127530662|NCT01100320|458903578|FG000|Period 1|Adverse Event|2|||
127530663|NCT01100320|458903579|FG001|Period 1|Adverse Event|2|||
127530664|NCT01100320|458903578|FG000|Period 2|Withdrawal by Subject|1|||
127530665|NCT01100320|458903579|FG001|Period 2|Withdrawal by Subject|1|||
127530666|NCT03797586|458903580|FG000|Overall Study|Lost to Follow-up|3|||
127530667|NCT03797586|458903581|FG001|Overall Study|Lost to Follow-up|6|||
127530668|NCT03797586|458903580|FG000|Overall Study|Death|1|||
127530669|NCT03797586|458903581|FG001|Overall Study|Death|1|||
127530670|NCT03797586|458903580|FG000|Overall Study|Adverse Event|0|||
127530671|NCT03797586|458903581|FG001|Overall Study|Adverse Event|2|||
127530672|NCT01147055|458903584|FG000|First Intervention Period|Lost to Follow-up|1|||
127530673|NCT01147055|458903585|FG001|First Intervention Period|Lost to Follow-up|0|||
127530674|NCT01870726|458903590|FG000|Overall Study|Withdrawal of informed consent|0|||
127530675|NCT01870726|458903591|FG001|Overall Study|Withdrawal of informed consent|0|||
127530676|NCT01870726|458903592|FG002|Overall Study|Withdrawal of informed consent|0|||
127530677|NCT01870726|458903593|FG003|Overall Study|Withdrawal of informed consent|1|||
127530678|NCT01870726|458903594|FG004|Overall Study|Withdrawal of informed consent|0|||
127530679|NCT01870726|458903595|FG005|Overall Study|Withdrawal of informed consent|0|||
127530680|NCT01870726|458903596|FG006|Overall Study|Withdrawal of informed consent|0|||
127530681|NCT01870726|458903590|FG000|Overall Study|Withdrawal by Subject|0|||
127530682|NCT01870726|458903591|FG001|Overall Study|Withdrawal by Subject|1|||
127530683|NCT01870726|458903592|FG002|Overall Study|Withdrawal by Subject|0|||
127530684|NCT01870726|458903593|FG003|Overall Study|Withdrawal by Subject|0|||
127530685|NCT01870726|458903594|FG004|Overall Study|Withdrawal by Subject|0|||
127530686|NCT01870726|458903595|FG005|Overall Study|Withdrawal by Subject|0|||
127530687|NCT01870726|458903596|FG006|Overall Study|Withdrawal by Subject|0|||
127530688|NCT01870726|458903590|FG000|Overall Study|Adverse Event|0|||
127530689|NCT01870726|458903591|FG001|Overall Study|Adverse Event|0|||
127530690|NCT01870726|458903592|FG002|Overall Study|Adverse Event|0|||
127530691|NCT01870726|458903593|FG003|Overall Study|Adverse Event|0|||
127530692|NCT01870726|458903594|FG004|Overall Study|Adverse Event|1|||
127530693|NCT01870726|458903595|FG005|Overall Study|Adverse Event|1|||
127530694|NCT01870726|458903596|FG006|Overall Study|Adverse Event|0|||
127530695|NCT01870726|458903590|FG000|Overall Study|Progressive disease|5|||
127530696|NCT01870726|458903591|FG001|Overall Study|Progressive disease|5|||
127530697|NCT01870726|458903592|FG002|Overall Study|Progressive disease|4|||
127530698|NCT01870726|458903593|FG003|Overall Study|Progressive disease|5|||
127530699|NCT01870726|458903594|FG004|Overall Study|Progressive disease|6|||
127530700|NCT01870726|458903595|FG005|Overall Study|Progressive disease|4|||
127530701|NCT01870726|458903596|FG006|Overall Study|Progressive disease|10|||
127530702|NCT01746225|458903597|FG000|Overall Study|Death|1|||
127530703|NCT01746225|458903598|FG001|Overall Study|Death|0|||
127530704|NCT01746225|458903599|FG002|Overall Study|Death|1|||
127530705|NCT01746225|458903597|FG000|Overall Study|Withdrawal by Subject|5|||
127530706|NCT01746225|458903598|FG001|Overall Study|Withdrawal by Subject|15|||
127530707|NCT01746225|458903599|FG002|Overall Study|Withdrawal by Subject|19|||
127530708|NCT01746225|458903597|FG000|Overall Study|Physician Decision|14|||
127530709|NCT01746225|458903598|FG001|Overall Study|Physician Decision|11|||
127530710|NCT01746225|458903599|FG002|Overall Study|Physician Decision|3|||
127530711|NCT01746225|458903597|FG000|Overall Study|Adverse Event|15|||
127530712|NCT01746225|458903598|FG001|Overall Study|Adverse Event|12|||
127530713|NCT01746225|458903599|FG002|Overall Study|Adverse Event|17|||
127530714|NCT01746225|458903597|FG000|Overall Study|Continuing Treatment|5|||
127530715|NCT01746225|458903598|FG001|Overall Study|Continuing Treatment|8|||
127530716|NCT01746225|458903599|FG002|Overall Study|Continuing Treatment|3|||
127530717|NCT00595478|458903600|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
127530718|NCT00595478|458903601|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
127530719|NCT00595478|458903600|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
127530720|NCT00595478|458903601|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
127530721|NCT01123395|458903606|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
127530722|NCT01123395|458903607|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
127530723|NCT03691571|458903608|FG000|Overall Study|Withdrawal by Subject|9|||
127530724|NCT03691571|458903609|FG001|Overall Study|Withdrawal by Subject|2|||
127530725|NCT00186901|458903612|FG000|Overall Study|Pregnancy|6|||
127530726|NCT00186901|458903613|FG001|Overall Study|Pregnancy|3|||
127530727|NCT00186901|458903614|FG002|Overall Study|Pregnancy|0|||
127530728|NCT00186901|458903612|FG000|Overall Study|Lost to Follow-up|6|||
127530729|NCT00186901|458903613|FG001|Overall Study|Lost to Follow-up|3|||
127530730|NCT00186901|458903614|FG002|Overall Study|Lost to Follow-up|0|||
127530731|NCT00186901|458903612|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
127530732|NCT00186901|458903613|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
127530733|NCT00186901|458903614|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
127530734|NCT00186901|458903612|FG000|Overall Study|ALL relapse or second malignancy|1|||
127530735|NCT00186901|458903613|FG001|Overall Study|ALL relapse or second malignancy|2|||
127530736|NCT00186901|458903614|FG002|Overall Study|ALL relapse or second malignancy|0|||
127530737|NCT00186901|458903612|FG000|Overall Study|Withdrawal by Subject|4|||
127530738|NCT00186901|458903613|FG001|Overall Study|Withdrawal by Subject|5|||
127530739|NCT00186901|458903614|FG002|Overall Study|Withdrawal by Subject|0|||
127530740|NCT00186901|458903612|FG000|Overall Study|Open label|3|||
127530741|NCT00186901|458903613|FG001|Overall Study|Open label|2|||
127530742|NCT00186901|458903614|FG002|Overall Study|Open label|0|||
127530743|NCT00186901|458903612|FG000|Overall Study|Limited adherence to study requirements|20|||
127530744|NCT00186901|458903613|FG001|Overall Study|Limited adherence to study requirements|23|||
127530745|NCT00186901|458903614|FG002|Overall Study|Limited adherence to study requirements|0|||
127530746|NCT00186901|458903612|FG000|Overall Study|Bone Mineral Density > 0|0|||
127530747|NCT00186901|458903613|FG001|Overall Study|Bone Mineral Density > 0|0|||
127530748|NCT00186901|458903614|FG002|Overall Study|Bone Mineral Density > 0|149|||
127530749|NCT00291486|458903620|FG000|Overall Study|Adverse Event|0|||
127530750|NCT00291486|458903621|FG001|Overall Study|Adverse Event|3|||
127530751|NCT00291486|458903622|FG002|Overall Study|Adverse Event|0|||
127530752|NCT00291486|458903623|FG003|Overall Study|Adverse Event|1|||
127530753|NCT00291486|458903624|FG004|Overall Study|Adverse Event|0|||
127530754|NCT00291486|458903620|FG000|Overall Study|Withdrawal by Subject|0|||
127530755|NCT00291486|458903621|FG001|Overall Study|Withdrawal by Subject|0|||
127530756|NCT00291486|458903622|FG002|Overall Study|Withdrawal by Subject|0|||
127530757|NCT00291486|458903623|FG003|Overall Study|Withdrawal by Subject|0|||
127530758|NCT00291486|458903624|FG004|Overall Study|Withdrawal by Subject|1|||
127530759|NCT00291486|458903620|FG000|Overall Study|Disease progression|1|||
127530760|NCT00291486|458903621|FG001|Overall Study|Disease progression|0|||
127530761|NCT00291486|458903622|FG002|Overall Study|Disease progression|1|||
127530762|NCT00291486|458903623|FG003|Overall Study|Disease progression|0|||
127530763|NCT00291486|458903624|FG004|Overall Study|Disease progression|0|||
127530764|NCT01099397|458903627|FG000|Overall Study|Lost to Follow-up|4|||
127530765|NCT01099397|458903627|FG000|Overall Study|Protocol Violation|4|||
127530766|NCT01099397|458903627|FG000|Overall Study|Withdrawal by Subject|5|||
127530767|NCT02363959|458903628|FG000|Overall Study|Medical instability|1|||
127530768|NCT02363959|458903629|FG001|Overall Study|Medical instability|0|||
127530769|NCT00950248|458903632|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
127530770|NCT00950248|458903633|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
127530771|NCT00950248|458903634|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
127530772|NCT00950248|458903632|FG000|Year 1: Baseline|worsening of symptoms|2|||
127530773|NCT00950248|458903633|FG001|Year 1: Baseline|worsening of symptoms|0|||
127530774|NCT00950248|458903634|FG002|Year 1: Baseline|worsening of symptoms|0|||
127530775|NCT00950248|458903632|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
127530776|NCT00950248|458903633|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
127530777|NCT00950248|458903634|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
127530778|NCT00950248|458903632|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
127530779|NCT00950248|458903633|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
127530780|NCT00950248|458903634|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
127530781|NCT00950248|458903632|FG000|Year 2&3 Treatment Randomization|Death|0|||
127530782|NCT00950248|458903633|FG001|Year 2&3 Treatment Randomization|Death|0|||
127530783|NCT00950248|458903634|FG002|Year 2&3 Treatment Randomization|Death|1|||
127530784|NCT00950248|458903632|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
127530785|NCT00950248|458903633|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
127530786|NCT00950248|458903634|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
127530787|NCT01900652|458903636|FG000|Overall Study|Progressive Disease|1|||
127530788|NCT01900652|458903637|FG001|Overall Study|Progressive Disease|0|||
127530789|NCT01900652|458903636|FG000|Overall Study|Consent withdrawn by subject|1|||
127530790|NCT01900652|458903637|FG001|Overall Study|Consent withdrawn by subject|1|||
127530791|NCT01900652|458903636|FG000|Overall Study|Death|3|||
127530792|NCT01900652|458903637|FG001|Overall Study|Death|0|||
127530793|NCT01900652|458903636|FG000|Overall Study|Adverse Event|2|||
127530794|NCT01900652|458903637|FG001|Overall Study|Adverse Event|1|||
127530795|NCT01900652|458903636|FG000|Overall Study|Physician Decision|1|||
127530796|NCT01900652|458903637|FG001|Overall Study|Physician Decision|1|||
127530797|NCT00869518|458903640|FG000|Overall Study|Lost to Follow-up|1|||
127530798|NCT00869518|458903641|FG001|Overall Study|Lost to Follow-up|1|||
127530799|NCT00947115|458903642|FG000|Overall Study|Missed reporting interval|3|||
127530800|NCT00947115|458903643|FG001|Overall Study|Missed reporting interval|4|||
127530801|NCT00947115|458903644|FG002|Overall Study|Missed reporting interval|2|||
127530802|NCT00947115|458903642|FG000|Overall Study|Physician Decision|0|||
127530803|NCT00947115|458903643|FG001|Overall Study|Physician Decision|2|||
127530804|NCT00947115|458903644|FG002|Overall Study|Physician Decision|0|||
127530805|NCT00947115|458903642|FG000|Overall Study|Death|0|||
127530806|NCT00947115|458903643|FG001|Overall Study|Death|1|||
127530807|NCT00947115|458903644|FG002|Overall Study|Death|1|||
127530808|NCT00947115|458903642|FG000|Overall Study|Migrated from study area|2|||
127530809|NCT00947115|458903643|FG001|Overall Study|Migrated from study area|0|||
127530810|NCT00947115|458903644|FG002|Overall Study|Migrated from study area|0|||
127530811|NCT00947115|458903642|FG000|Overall Study|Withdrawal by Subject|1|||
127530812|NCT00947115|458903643|FG001|Overall Study|Withdrawal by Subject|3|||
127530813|NCT00947115|458903644|FG002|Overall Study|Withdrawal by Subject|4|||
127530814|NCT00947115|458903642|FG000|Overall Study|Lost to Follow-up|11|||
127530815|NCT00947115|458903643|FG001|Overall Study|Lost to Follow-up|12|||
127530816|NCT00947115|458903644|FG002|Overall Study|Lost to Follow-up|8|||
127530817|NCT00900029|458903647|FG000|Overall Study|Lost to Follow-up|0|||
127530818|NCT00900029|458903648|FG001|Overall Study|Lost to Follow-up|2|||
127530819|NCT00900029|458903649|FG002|Overall Study|Lost to Follow-up|1|||
127530820|NCT00900029|458903650|FG003|Overall Study|Lost to Follow-up|4|||
127530821|NCT00900029|458903651|FG004|Overall Study|Lost to Follow-up|4|||
127530822|NCT00900029|458903647|FG000|Overall Study|Withdrawal by Subject|2|||
127530823|NCT00900029|458903648|FG001|Overall Study|Withdrawal by Subject|2|||
127530824|NCT00900029|458903649|FG002|Overall Study|Withdrawal by Subject|1|||
127530825|NCT00900029|458903650|FG003|Overall Study|Withdrawal by Subject|1|||
127530826|NCT00900029|458903651|FG004|Overall Study|Withdrawal by Subject|1|||
127530827|NCT00900029|458903647|FG000|Overall Study|Adverse Event|0|||
127530828|NCT00900029|458903648|FG001|Overall Study|Adverse Event|0|||
127530829|NCT00900029|458903649|FG002|Overall Study|Adverse Event|1|||
127530830|NCT00900029|458903650|FG003|Overall Study|Adverse Event|1|||
127530831|NCT00900029|458903651|FG004|Overall Study|Adverse Event|1|||
127530832|NCT00900029|458903647|FG000|Overall Study|Death|1|||
127530833|NCT00900029|458903648|FG001|Overall Study|Death|0|||
127530834|NCT00900029|458903649|FG002|Overall Study|Death|0|||
127530835|NCT00900029|458903650|FG003|Overall Study|Death|1|||
127530836|NCT00900029|458903651|FG004|Overall Study|Death|0|||
127530837|NCT00511238|458903652|FG000|Overall Study|Adverse Event|13|||
127530838|NCT00511238|458903653|FG001|Overall Study|Adverse Event|33|||
127530839|NCT00511238|458903652|FG000|Overall Study|Withdrawal by Subject|2|||
127530840|NCT00511238|458903653|FG001|Overall Study|Withdrawal by Subject|22|||
127530841|NCT00511238|458903652|FG000|Overall Study|Progressive Disease|23|||
127530842|NCT00511238|458903653|FG001|Overall Study|Progressive Disease|157|||
127530843|NCT00511238|458903652|FG000|Overall Study|various reasons|4|||
127530844|NCT00511238|458903653|FG001|Overall Study|various reasons|14|||
127530845|NCT00163020|458903656|FG000|Overall Study|Lost to Follow-up|0|||
127530846|NCT00163020|458903657|FG001|Overall Study|Lost to Follow-up|2|||
127530847|NCT03772665|458903658|FG000|Overall Study|Protocol Violation|1|||
127530848|NCT03772665|458903659|FG001|Overall Study|Protocol Violation|0|||
127530849|NCT00447226|458905256|FG000|12-Week Open-label Phase|Adverse Event|0|||
127530850|NCT00447226|458905257|FG001|12-Week Open-label Phase|Adverse Event|3|||
127530851|NCT00447226|458905256|FG000|12-Week Open-label Phase|Protocol Violation|0|||
127530852|NCT00447226|458905257|FG001|12-Week Open-label Phase|Protocol Violation|1|||
127530853|NCT00447226|458905256|FG000|12-Week Open-label Phase|Disease Progression|0|||
127530854|NCT00447226|458905257|FG001|12-Week Open-label Phase|Disease Progression|20|||
127530855|NCT00447226|458905256|FG000|12-Week Open-label Phase|Physician Decision|0|||
127530856|NCT00447226|458905257|FG001|12-Week Open-label Phase|Physician Decision|1|||
127530857|NCT00447226|458905256|FG000|Double-blind Phase|Disease Progression|4|||
127530858|NCT00447226|458905257|FG001|Double-blind Phase|Disease Progression|3|||
127530859|NCT02871635|458905271|FG000|Overall Study|Primary lack of efficacy|4|||
127530860|NCT02871635|458905272|FG001|Overall Study|Primary lack of efficacy|4|||
127530861|NCT02871635|458905271|FG000|Overall Study|Protocol Violation|3|||
127530862|NCT02871635|458905272|FG001|Overall Study|Protocol Violation|1|||
127530863|NCT02871635|458905271|FG000|Overall Study|Lost to Follow-up|1|||
127530864|NCT02871635|458905272|FG001|Overall Study|Lost to Follow-up|2|||
127530865|NCT02871635|458905271|FG000|Overall Study|Pregnancy|0|||
127530866|NCT02871635|458905272|FG001|Overall Study|Pregnancy|2|||
127530867|NCT02871635|458905271|FG000|Overall Study|Physician Decision|1|||
127530868|NCT02871635|458905272|FG001|Overall Study|Physician Decision|1|||
127530869|NCT02871635|458905271|FG000|Overall Study|Withdrawal by Subject|3|||
127530870|NCT02871635|458905272|FG001|Overall Study|Withdrawal by Subject|4|||
127530871|NCT02871635|458905271|FG000|Overall Study|Adverse Event|4|||
127530872|NCT02871635|458905272|FG001|Overall Study|Adverse Event|4|||
127530873|NCT02871635|458905271|FG000|Overall Study|Secondary lack of efficacy|2|||
127530874|NCT02871635|458905272|FG001|Overall Study|Secondary lack of efficacy|1|||
127530875|NCT02420379|458905273|FG000|Overall Study|Withdrawal by Subject|0|||
127530876|NCT02420379|458905274|FG001|Overall Study|Withdrawal by Subject|3|||
127530877|NCT02420379|458905273|FG000|Overall Study|Unable to complete due to schooling|0|||
127530878|NCT02420379|458905274|FG001|Overall Study|Unable to complete due to schooling|1|||
127530879|NCT02420379|458905273|FG000|Overall Study|Transitioned to commercial drug|1|||
127530880|NCT02420379|458905274|FG001|Overall Study|Transitioned to commercial drug|0|||
127530881|NCT00991939|458905277|FG000|Overall Study|Lost to Follow-up|0|||
127530882|NCT00991939|458905278|FG001|Overall Study|Lost to Follow-up|1|||
127530883|NCT00991939|458905277|FG000|Overall Study|Withdrawal by Subject|1|||
127530884|NCT00991939|458905278|FG001|Overall Study|Withdrawal by Subject|0|||
127530885|NCT00991939|458905277|FG000|Overall Study|Entire study terminated|4|||
127530886|NCT00991939|458905278|FG001|Overall Study|Entire study terminated|1|||
127530887|NCT00714415|458905279|FG000|Overall Study|Lack of Efficacy|1|||
127530888|NCT00714415|458905280|FG001|Overall Study|Lack of Efficacy|0|||
127530889|NCT00714415|458905279|FG000|Overall Study|Death|1|||
127530890|NCT00714415|458905280|FG001|Overall Study|Death|0|||
127530891|NCT00740584|458905283|FG000|Overall Study|Withdrawal by Subject|1|||
127530892|NCT02073682|458905293|FG000|Overall Study|Low Creatinine Clearance|1|||
127530893|NCT02073682|458905294|FG001|Overall Study|Low Creatinine Clearance|2|||
127530894|NCT02073682|458905293|FG000|Overall Study|Death|86|||
127530895|NCT02073682|458905294|FG001|Overall Study|Death|100|||
127530896|NCT02073682|458905293|FG000|Overall Study|Cancer Cured|10|||
127530897|NCT02073682|458905294|FG001|Overall Study|Cancer Cured|15|||
127530898|NCT02073682|458905293|FG000|Overall Study|ID: Patient Noncompliance|1|||
127530899|NCT02073682|458905294|FG001|Overall Study|ID: Patient Noncompliance|2|||
127530900|NCT02073682|458905293|FG000|Overall Study|ID: Palliative Treatment Only|10|||
127530901|NCT02073682|458905294|FG001|Overall Study|ID: Palliative Treatment Only|7|||
127530902|NCT02073682|458905293|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
127530903|NCT02073682|458905294|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
127530904|NCT02073682|458905293|FG000|Overall Study|Platelet Count <50,000/mL|1|||
127530905|NCT02073682|458905294|FG001|Overall Study|Platelet Count <50,000/mL|2|||
127530906|NCT02073682|458905293|FG000|Overall Study|Surgery/Medical Procedure|3|||
127530907|NCT02073682|458905294|FG001|Overall Study|Surgery/Medical Procedure|1|||
127530908|NCT02073682|458905293|FG000|Overall Study|Withdrawal by Subject|6|||
127530909|NCT02073682|458905294|FG001|Overall Study|Withdrawal by Subject|8|||
127530910|NCT02073682|458905293|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
127530911|NCT02073682|458905294|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
127530912|NCT02073682|458905293|FG000|Overall Study|Cancer Progression|53|||
127530913|NCT02073682|458905294|FG001|Overall Study|Cancer Progression|33|||
127530914|NCT02073682|458905293|FG000|Overall Study|Protocol Violation|1|||
127530915|NCT02073682|458905294|FG001|Overall Study|Protocol Violation|0|||
127530916|NCT02073682|458905293|FG000|Overall Study|Adverse Event|79|||
127530917|NCT02073682|458905294|FG001|Overall Study|Adverse Event|62|||
127530918|NCT02073682|458905293|FG000|Overall Study|No reason provided|11|||
127530919|NCT02073682|458905294|FG001|Overall Study|No reason provided|9|||
127530920|NCT02073682|458905293|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
127530921|NCT02073682|458905294|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
127530922|NCT02073682|458905293|FG000|Overall Study|Lost to Follow-up|1|||
127530923|NCT02073682|458905294|FG001|Overall Study|Lost to Follow-up|1|||
127530924|NCT02073682|458905293|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
127530925|NCT02073682|458905294|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
127530926|NCT03461146|458905295|FG000|Overall Study|Adverse Event|2|||
127530927|NCT03461146|458905295|FG000|Overall Study|Physician Decision|1|||
127530928|NCT00181766|458905296|FG000|Overall Study|Lost to Follow-up|6|||
127530929|NCT00181766|458905296|FG000|Overall Study|Adverse Event|4|||
127530930|NCT00181766|458905296|FG000|Overall Study|non-compliance|2|||
127530931|NCT00855816|458905297|FG000|Overall Study|Withdrawal by Subject|22|||
127530932|NCT00855816|458905298|FG001|Overall Study|Withdrawal by Subject|15|||
127530933|NCT00855816|458905297|FG000|Overall Study|Lost to Follow-up|3|||
127530934|NCT00855816|458905298|FG001|Overall Study|Lost to Follow-up|5|||
127530935|NCT00855816|458905297|FG000|Overall Study|Death|1|||
127530936|NCT00855816|458905298|FG001|Overall Study|Death|0|||
127530937|NCT00855816|458905297|FG000|Overall Study|Became ineligible|0|||
127530938|NCT00855816|458905298|FG001|Overall Study|Became ineligible|1|||
127530939|NCT01965704|458905302|FG000|Overall Study|Withdrawal by Subject|2|||
127530940|NCT01965704|458905303|FG001|Overall Study|Withdrawal by Subject|2|||
127530941|NCT01965704|458905304|FG002|Overall Study|Withdrawal by Subject|1|||
127530942|NCT01965704|458905305|FG003|Overall Study|Withdrawal by Subject|1|||
127530943|NCT01965704|458905302|FG000|Overall Study|Delivered at home|1|||
127530944|NCT01965704|458905303|FG001|Overall Study|Delivered at home|1|||
127530945|NCT01965704|458905304|FG002|Overall Study|Delivered at home|0|||
127530946|NCT01965704|458905305|FG003|Overall Study|Delivered at home|0|||
127530947|NCT01965704|458905302|FG000|Overall Study|Experienced complications|0|||
127530948|NCT01965704|458905303|FG001|Overall Study|Experienced complications|0|||
127530949|NCT01965704|458905304|FG002|Overall Study|Experienced complications|2|||
127530950|NCT01965704|458905305|FG003|Overall Study|Experienced complications|2|||
127530951|NCT01965704|458905302|FG000|Overall Study|Adverse Event|0|||
127530952|NCT01965704|458905303|FG001|Overall Study|Adverse Event|0|||
127530953|NCT01965704|458905304|FG002|Overall Study|Adverse Event|1|||
127530954|NCT01965704|458905305|FG003|Overall Study|Adverse Event|1|||
127530955|NCT01965704|458905302|FG000|Overall Study|Did not meet inclusion criteria|0|||
127530956|NCT01965704|458905303|FG001|Overall Study|Did not meet inclusion criteria|0|||
127530957|NCT01965704|458905304|FG002|Overall Study|Did not meet inclusion criteria|1|||
127530958|NCT01965704|458905305|FG003|Overall Study|Did not meet inclusion criteria|1|||
127530959|NCT00687804|458905313|FG000|Core Study|Adverse Event|5|||
127530960|NCT00687804|458905314|FG001|Core Study|Adverse Event|3|||
127530961|NCT00687804|458905315|FG002|Core Study|Adverse Event|3|||
127530962|NCT00687804|458905313|FG000|Core Study|Abnormal laboratory value(s)|1|||
127530963|NCT00687804|458905314|FG001|Core Study|Abnormal laboratory value(s)|0|||
127530964|NCT00687804|458905315|FG002|Core Study|Abnormal laboratory value(s)|0|||
127530965|NCT00687804|458905313|FG000|Core Study|Lack of Efficacy|1|||
127530966|NCT00687804|458905314|FG001|Core Study|Lack of Efficacy|1|||
127530967|NCT00687804|458905315|FG002|Core Study|Lack of Efficacy|1|||
127530968|NCT00687804|458905313|FG000|Core Study|Withdrawal by Subject|4|||
127530969|NCT00687804|458905314|FG001|Core Study|Withdrawal by Subject|7|||
127530970|NCT00687804|458905315|FG002|Core Study|Withdrawal by Subject|7|||
127530971|NCT00687804|458905313|FG000|Core Study|Lost to Follow-up|0|||
127530972|NCT00687804|458905314|FG001|Core Study|Lost to Follow-up|1|||
127530973|NCT00687804|458905315|FG002|Core Study|Lost to Follow-up|0|||
127530974|NCT00687804|458905313|FG000|Core Study|Death|2|||
127530975|NCT00687804|458905314|FG001|Core Study|Death|2|||
127530976|NCT00687804|458905315|FG002|Core Study|Death|2|||
127530977|NCT00687804|458905313|FG000|Core Study|Protocol Violation|1|||
127530978|NCT00687804|458905314|FG001|Core Study|Protocol Violation|1|||
127530979|NCT00687804|458905315|FG002|Core Study|Protocol Violation|0|||
127530980|NCT00687804|458905313|FG000|Open-Label Extension Study|Adverse Event|2|||
127530981|NCT00687804|458905314|FG001|Open-Label Extension Study|Adverse Event|2|||
127530982|NCT00687804|458905315|FG002|Open-Label Extension Study|Adverse Event|2|||
127530983|NCT00687804|458905313|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
127530984|NCT00687804|458905314|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
127530985|NCT00687804|458905315|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
127530986|NCT00687804|458905313|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
127530987|NCT00687804|458905314|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
127530988|NCT00687804|458905315|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
127530989|NCT00687804|458905313|FG000|Open-Label Extension Study|Administrative problems|1|||
127530990|NCT00687804|458905314|FG001|Open-Label Extension Study|Administrative problems|1|||
127530991|NCT00687804|458905315|FG002|Open-Label Extension Study|Administrative problems|0|||
127530992|NCT00687804|458905313|FG000|Open-Label Extension Study|Death|2|||
127530993|NCT00687804|458905314|FG001|Open-Label Extension Study|Death|3|||
127530994|NCT00687804|458905315|FG002|Open-Label Extension Study|Death|3|||
127530995|NCT04390243|458905316|FG000|Overall Study|Death|1|||
127530996|NCT04390243|458905316|FG000|Overall Study|Disease Progression|4|||
127530997|NCT04390243|458905316|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
127530998|NCT00413218|458905320|FG000|Overall Study|Randomized but didn't receive study drug|2|||
127530999|NCT00413218|458905321|FG001|Overall Study|Randomized but didn't receive study drug|8|||
127531000|NCT00413218|458905320|FG000|Overall Study|Death|57|||
127531001|NCT00413218|458905321|FG001|Overall Study|Death|56|||
127531002|NCT00413218|458905320|FG000|Overall Study|Lost to Follow-up|14|||
127531003|NCT00413218|458905321|FG001|Overall Study|Lost to Follow-up|17|||
127531004|NCT00413218|458905320|FG000|Overall Study|Admin|20|||
127531005|NCT00413218|458905321|FG001|Overall Study|Admin|14|||
127531006|NCT00413218|458905320|FG000|Overall Study|Missing|1|||
127531007|NCT00413218|458905321|FG001|Overall Study|Missing|0|||
127531008|NCT00413218|458905320|FG000|Overall Study|Withdrawal by Subject|9|||
127531009|NCT00413218|458905321|FG001|Overall Study|Withdrawal by Subject|1|||
127531010|NCT01196026|458905323|FG000|Overall Study|Withdrawal by Subject|1|||
127531011|NCT01196026|458905324|FG001|Overall Study|Withdrawal by Subject|4|||
127531012|NCT01196026|458905325|FG002|Overall Study|Withdrawal by Subject|0|||
127531013|NCT01196026|458905326|FG003|Overall Study|Withdrawal by Subject|0|||
127531014|NCT01196026|458905327|FG004|Overall Study|Withdrawal by Subject|0|||
127531015|NCT01196026|458905328|FG005|Overall Study|Withdrawal by Subject|0|||
127531016|NCT01196026|458905323|FG000|Overall Study|Lost to Follow-up|0|||
127531017|NCT01196026|458905324|FG001|Overall Study|Lost to Follow-up|3|||
127531018|NCT01196026|458905325|FG002|Overall Study|Lost to Follow-up|0|||
127531019|NCT01196026|458905326|FG003|Overall Study|Lost to Follow-up|0|||
127531020|NCT01196026|458905327|FG004|Overall Study|Lost to Follow-up|1|||
127531021|NCT01196026|458905328|FG005|Overall Study|Lost to Follow-up|0|||
127531022|NCT01196026|458905323|FG000|Overall Study|Other|0|||
127531023|NCT01196026|458905324|FG001|Overall Study|Other|1|||
127531024|NCT01196026|458905325|FG002|Overall Study|Other|0|||
127531025|NCT01196026|458905326|FG003|Overall Study|Other|0|||
127531026|NCT01196026|458905327|FG004|Overall Study|Other|0|||
127531027|NCT01196026|458905328|FG005|Overall Study|Other|0|||
127531028|NCT01687296|458905329|FG000|Overall Study|Lack of Efficacy|1|||
127531029|NCT01687296|458905330|FG001|Overall Study|Lack of Efficacy|1|||
127531030|NCT01687296|458905329|FG000|Overall Study|Protocol Violation|0|||
127531031|NCT01687296|458905330|FG001|Overall Study|Protocol Violation|1|||
127531032|NCT01687296|458905329|FG000|Overall Study|Withdrawal by Subject|6|||
127531033|NCT01687296|458905330|FG001|Overall Study|Withdrawal by Subject|3|||
127531034|NCT03672292|458905334|FG000|Overall Study|Adverse Event|3|||
127531035|NCT03672292|458905335|FG001|Overall Study|Adverse Event|1|||
127531036|NCT03672292|458905334|FG000|Overall Study|Physician Decision|0|||
127531037|NCT03672292|458905335|FG001|Overall Study|Physician Decision|1|||
127531038|NCT03672292|458905334|FG000|Overall Study|Withdrawal by Subject|1|||
127531039|NCT03672292|458905335|FG001|Overall Study|Withdrawal by Subject|2|||
127531040|NCT00799903|458905336|FG000|Overall Study|Investigator Site Closed|25|||
127531041|NCT00799903|458905337|FG001|Overall Study|Investigator Site Closed|23|||
127531042|NCT00799903|458905336|FG000|Overall Study|Withdrawal by Subject|179|||
127531043|NCT00799903|458905337|FG001|Overall Study|Withdrawal by Subject|175|||
127531044|NCT00799903|458905336|FG000|Overall Study|Lost to Follow-up|69|||
127531045|NCT00799903|458905337|FG001|Overall Study|Lost to Follow-up|80|||
127531046|NCT02864901|458905338|FG000|Overall Study|Withdrawal by Subject|1|||
127531047|NCT02864901|458905339|FG001|Overall Study|Withdrawal by Subject|0|||
127531048|NCT05730387|458905340|FG000|Overall Study|Stillbirth|0|||
127531049|NCT05730387|458905341|FG001|Overall Study|Stillbirth|262|||
127531050|NCT05730387|458905340|FG000|Overall Study|Died during or after delivery|2|||
127531051|NCT05730387|458905341|FG001|Overall Study|Died during or after delivery|85|||
127531052|NCT05730387|458905340|FG000|Overall Study|Died after being admitted|0|||
127531053|NCT05730387|458905341|FG001|Overall Study|Died after being admitted|44|||
127531054|NCT05730387|458905340|FG000|Overall Study|Lost to Follow-up|69|||
127531055|NCT05730387|458905341|FG001|Overall Study|Lost to Follow-up|77|||
127531056|NCT01219985|458905342|FG000|Overall Study|Physician Decision|20|||
127531057|NCT00596752|458905343|FG000|Overall Study|Other Reason|44|||
127531058|NCT00596752|458905344|FG001|Overall Study|Other Reason|49|||
127531059|NCT00596752|458905343|FG000|Overall Study|Adverse Event|34|||
127531060|NCT00596752|458905344|FG001|Overall Study|Adverse Event|34|||
127531061|NCT00596752|458905343|FG000|Overall Study|Lost to Follow-up|22|||
127531062|NCT00596752|458905344|FG001|Overall Study|Lost to Follow-up|38|||
127531063|NCT00596752|458905343|FG000|Overall Study|Withdrawal by Subject|12|||
127531064|NCT00596752|458905344|FG001|Overall Study|Withdrawal by Subject|9|||
127531065|NCT00596752|458905343|FG000|Overall Study|Unsatisfactory Compliance|9|||
127531066|NCT00596752|458905344|FG001|Overall Study|Unsatisfactory Compliance|6|||
127531067|NCT00596752|458905343|FG000|Overall Study|Lack of Efficacy|4|||
127531068|NCT00596752|458905344|FG001|Overall Study|Lack of Efficacy|7|||
127531069|NCT00596752|458905343|FG000|Overall Study|Protocol Violation|1|||
127531070|NCT00596752|458905344|FG001|Overall Study|Protocol Violation|0|||
127531071|NCT04797780|458905345|FG000|Overall Study|Lost to Follow-up|1|||
127531072|NCT04797780|458905346|FG001|Overall Study|Lost to Follow-up|1|||
127531073|NCT04797780|458905345|FG000|Overall Study|Withdrawal by Subject|14|||
127531074|NCT04797780|458905346|FG001|Overall Study|Withdrawal by Subject|9|||
127531075|NCT04797780|458905345|FG000|Overall Study|Death|49|||
127531076|NCT04797780|458905346|FG001|Overall Study|Death|20|||
127531077|NCT04669301|458905347|FG000|Overall Study|Lost to Follow-up|0|||
127531078|NCT04669301|458905348|FG001|Overall Study|Lost to Follow-up|1|||
127531079|NCT04669301|458905349|FG002|Overall Study|Lost to Follow-up|0|||
127531080|NCT04669301|458905347|FG000|Overall Study|Withdrawal by Subject|3|||
127531081|NCT04669301|458905348|FG001|Overall Study|Withdrawal by Subject|2|||
127531082|NCT04669301|458905349|FG002|Overall Study|Withdrawal by Subject|0|||
127531083|NCT02940496|458905350|FG000|Overall Study|Adverse Event|1|||
127531084|NCT02940496|458905351|FG001|Overall Study|Adverse Event|0|||
127531085|NCT02940496|458905350|FG000|Overall Study|Death|2|||
127531086|NCT02940496|458905351|FG001|Overall Study|Death|0|||
127531087|NCT02940496|458905350|FG000|Overall Study|Hospice Care|1|||
127531088|NCT02940496|458905351|FG001|Overall Study|Hospice Care|0|||
127531089|NCT02940496|458905350|FG000|Overall Study|No MRE Done|1|||
127531090|NCT02940496|458905351|FG001|Overall Study|No MRE Done|0|||
127531091|NCT02940496|458905350|FG000|Overall Study|MRE Failure|1|||
127531092|NCT02940496|458905351|FG001|Overall Study|MRE Failure|0|||
127531093|NCT05973006|458905352|FG000|Overall Study|Early termination|3|||
127531094|NCT05973006|458905353|FG001|Overall Study|Early termination|9|||
127531095|NCT00132808|458905359|FG000|Stratum I|Adverse Event|2|||
127531096|NCT00132808|458905360|FG001|Stratum I|Adverse Event|1|||
127531097|NCT00132808|458905361|FG002|Stratum I|Adverse Event|0|||
127531098|NCT00132808|458905359|FG000|Stratum I|Lost to Follow-up|3|||
127531099|NCT00132808|458905360|FG001|Stratum I|Lost to Follow-up|4|||
127531100|NCT00132808|458905361|FG002|Stratum I|Lost to Follow-up|1|||
127531101|NCT00132808|458905359|FG000|Stratum I|Withdrawal by Subject|4|||
127531102|NCT00132808|458905360|FG001|Stratum I|Withdrawal by Subject|7|||
127531103|NCT00132808|458905361|FG002|Stratum I|Withdrawal by Subject|3|||
127531104|NCT00132808|458905359|FG000|Stratum I|Abnormal test procedure result (s)|0|||
127531105|NCT00132808|458905360|FG001|Stratum I|Abnormal test procedure result (s)|0|||
127531106|NCT00132808|458905361|FG002|Stratum I|Abnormal test procedure result (s)|1|||
127531107|NCT00132808|458905359|FG000|Stratum II|Adverse Event|1|||
127531108|NCT00132808|458905360|FG001|Stratum II|Adverse Event|2|||
127531109|NCT00132808|458905361|FG002|Stratum II|Adverse Event|1|||
127531110|NCT00132808|458905359|FG000|Stratum II|Death|1|||
127531111|NCT00132808|458905360|FG001|Stratum II|Death|0|||
127531112|NCT00132808|458905361|FG002|Stratum II|Death|0|||
127531113|NCT00132808|458905359|FG000|Stratum II|Lost to Follow-up|2|||
127531114|NCT00132808|458905360|FG001|Stratum II|Lost to Follow-up|2|||
127531115|NCT00132808|458905361|FG002|Stratum II|Lost to Follow-up|1|||
127531116|NCT00132808|458905359|FG000|Stratum II|Protocol Violation|0|||
127531117|NCT00132808|458905360|FG001|Stratum II|Protocol Violation|2|||
127531118|NCT00132808|458905361|FG002|Stratum II|Protocol Violation|1|||
127531119|NCT00132808|458905359|FG000|Stratum II|Withdrawal by Subject|4|||
127531120|NCT00132808|458905360|FG001|Stratum II|Withdrawal by Subject|9|||
127531121|NCT00132808|458905361|FG002|Stratum II|Withdrawal by Subject|6|||
127531122|NCT00548145|458905369|FG000|Overall Study|Death|0|||
127531123|NCT00548145|458905370|FG001|Overall Study|Death|1|||
127531124|NCT00548145|458905369|FG000|Overall Study|Withdrawal by Subject|0|||
127531125|NCT00548145|458905370|FG001|Overall Study|Withdrawal by Subject|2|||
127531126|NCT00548145|458905369|FG000|Overall Study|Physician Decision|1|||
127531127|NCT00548145|458905370|FG001|Overall Study|Physician Decision|1|||
127531128|NCT02119663|458905372|FG000|Overall Study|Disease progression|26|||
127531129|NCT02119663|458905373|FG001|Overall Study|Disease progression|27|||
127531130|NCT02119663|458905372|FG000|Overall Study|Adverse Event|5|||
127531131|NCT02119663|458905373|FG001|Overall Study|Adverse Event|5|||
127531132|NCT02119663|458905372|FG000|Overall Study|Death|3|||
127531133|NCT02119663|458905373|FG001|Overall Study|Death|2|||
127531134|NCT02119663|458905372|FG000|Overall Study|Physician Decision|1|||
127531135|NCT02119663|458905373|FG001|Overall Study|Physician Decision|2|||
127531136|NCT02119663|458905372|FG000|Overall Study|Other unspecified|2|||
127531137|NCT02119663|458905373|FG001|Overall Study|Other unspecified|0|||
127531138|NCT02119663|458905372|FG000|Overall Study|Subject decision|0|||
127531139|NCT02119663|458905373|FG001|Overall Study|Subject decision|1|||
127531140|NCT02119663|458905372|FG000|Overall Study|Study Terminated by the Sponsor|3|||
127531141|NCT02119663|458905373|FG001|Overall Study|Study Terminated by the Sponsor|4|||
127531142|NCT02863328|458905374|FG000|Overall Study|Lost to Follow-up|4|||
127531143|NCT02863328|458905375|FG001|Overall Study|Lost to Follow-up|10|||
127531144|NCT02863328|458905374|FG000|Overall Study|Withdrawal by Subject|7|||
127531145|NCT02863328|458905375|FG001|Overall Study|Withdrawal by Subject|12|||
127531146|NCT02863328|458905374|FG000|Overall Study|Died|0|||
127531147|NCT02863328|458905375|FG001|Overall Study|Died|1|||
127531148|NCT00699660|458905376|FG000|Overall Study|Lost to Follow-up|4|||
127531149|NCT00699660|458905377|FG001|Overall Study|Lost to Follow-up|2|||
127531150|NCT00699660|458905376|FG000|Overall Study|missing reports and recording failures|10|||
127531151|NCT00699660|458905377|FG001|Overall Study|missing reports and recording failures|6|||
127531152|NCT00398320|458905378|FG000|Overall Study|Death|1|||
127531153|NCT00398320|458905378|FG000|Overall Study|Adverse Event|4|||
127531154|NCT00398320|458905378|FG000|Overall Study|Physician Decision|1|||
127531155|NCT00064792|458905379|FG000|Overall Study|Withdrawal by Subject|2|||
127531156|NCT00064792|458905380|FG001|Overall Study|Withdrawal by Subject|0|||
127531157|NCT00064792|458905379|FG000|Overall Study|Adverse Event|3|||
127531158|NCT00064792|458905380|FG001|Overall Study|Adverse Event|0|||
127531159|NCT03301350|458905381|FG000|Overall Study|Withdrawal by Subject|4|||
127531160|NCT03301350|458905381|FG000|Overall Study|Adverse Event|1|||
127531161|NCT03301350|458905381|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
127531162|NCT03301350|458905381|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
127531163|NCT03301350|458905381|FG000|Overall Study|no detail provided|1|||
127531164|NCT01248949|458905384|FG000|Overall Study|Lost to Follow-up|2|||
127531165|NCT01248949|458905385|FG001|Overall Study|Lost to Follow-up|2|||
127531166|NCT01248949|458905386|FG002|Overall Study|Lost to Follow-up|2|||
127531167|NCT01248949|458905387|FG003|Overall Study|Lost to Follow-up|1|||
127531168|NCT01248949|458905388|FG004|Overall Study|Lost to Follow-up|0|||
127531169|NCT01248949|458905384|FG000|Overall Study|Withdrawal by Subject|5|||
127531170|NCT01248949|458905385|FG001|Overall Study|Withdrawal by Subject|3|||
127531171|NCT01248949|458905386|FG002|Overall Study|Withdrawal by Subject|11|||
127531172|NCT01248949|458905387|FG003|Overall Study|Withdrawal by Subject|3|||
127531173|NCT01248949|458905388|FG004|Overall Study|Withdrawal by Subject|1|||
127531174|NCT01248949|458905384|FG000|Overall Study|Death|22|||
127531175|NCT01248949|458905385|FG001|Overall Study|Death|7|||
127531176|NCT01248949|458905386|FG002|Overall Study|Death|21|||
127531177|NCT01248949|458905387|FG003|Overall Study|Death|6|||
127531178|NCT01248949|458905388|FG004|Overall Study|Death|2|||
127531179|NCT01248949|458905384|FG000|Overall Study|Alternative Therapy|1|||
127531180|NCT01248949|458905385|FG001|Overall Study|Alternative Therapy|0|||
127531181|NCT01248949|458905386|FG002|Overall Study|Alternative Therapy|0|||
127531182|NCT01248949|458905387|FG003|Overall Study|Alternative Therapy|0|||
127531183|NCT01248949|458905388|FG004|Overall Study|Alternative Therapy|0|||
127531184|NCT01248949|458905384|FG000|Overall Study|Alternative Therapy.|1|||
127531185|NCT01248949|458905385|FG001|Overall Study|Alternative Therapy.|0|||
127531186|NCT01248949|458905386|FG002|Overall Study|Alternative Therapy.|0|||
127531187|NCT01248949|458905387|FG003|Overall Study|Alternative Therapy.|0|||
127531188|NCT01248949|458905388|FG004|Overall Study|Alternative Therapy.|0|||
127531189|NCT01248949|458905384|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
127531190|NCT01248949|458905385|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
127531191|NCT01248949|458905386|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
127531192|NCT01248949|458905387|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
127531193|NCT01248949|458905388|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
127531194|NCT01248949|458905384|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
127531195|NCT01248949|458905385|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
127531196|NCT01248949|458905386|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
127531197|NCT01248949|458905387|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
127531198|NCT01248949|458905388|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
127531199|NCT01248949|458905384|FG000|Overall Study|Participant Went To Hospice|0|||
127531200|NCT01248949|458905385|FG001|Overall Study|Participant Went To Hospice|0|||
127531201|NCT01248949|458905386|FG002|Overall Study|Participant Went To Hospice|1|||
127531202|NCT01248949|458905387|FG003|Overall Study|Participant Went To Hospice|0|||
127531203|NCT01248949|458905388|FG004|Overall Study|Participant Went To Hospice|0|||
127531204|NCT01248949|458905384|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
127531205|NCT01248949|458905385|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
127531206|NCT01248949|458905386|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
127531207|NCT01248949|458905387|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
127531208|NCT01248949|458905388|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
127531209|NCT01248949|458905384|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
127531210|NCT01248949|458905385|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
127531211|NCT01248949|458905386|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
127531212|NCT01248949|458905387|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
127531213|NCT01248949|458905388|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
127531214|NCT01248949|458905384|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
127531215|NCT01248949|458905385|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
127531216|NCT01248949|458905386|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
127531217|NCT01248949|458905387|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
127531218|NCT01248949|458905388|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
127531219|NCT01248949|458905384|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
127531220|NCT01248949|458905385|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
127531221|NCT01248949|458905386|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
127531222|NCT01248949|458905387|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
127531223|NCT01248949|458905388|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
127531224|NCT00286429|458905389|FG000|Overall Study|Adverse Event|4|||
127531225|NCT00286429|458905390|FG001|Overall Study|Adverse Event|1|||
127531226|NCT00286429|458905391|FG002|Overall Study|Adverse Event|6|||
127531227|NCT00286429|458905389|FG000|Overall Study|Lack of Efficacy|52|||
127531228|NCT00286429|458905390|FG001|Overall Study|Lack of Efficacy|27|||
127531229|NCT00286429|458905391|FG002|Overall Study|Lack of Efficacy|25|||
127531230|NCT00286429|458905389|FG000|Overall Study|Lost to Follow-up|2|||
127531231|NCT00286429|458905390|FG001|Overall Study|Lost to Follow-up|4|||
127531232|NCT00286429|458905391|FG002|Overall Study|Lost to Follow-up|3|||
127531233|NCT00286429|458905389|FG000|Overall Study|Physician Decision|10|||
127531234|NCT00286429|458905390|FG001|Overall Study|Physician Decision|7|||
127531235|NCT00286429|458905391|FG002|Overall Study|Physician Decision|7|||
127531236|NCT00286429|458905389|FG000|Overall Study|Protocol Violation|3|||
127531237|NCT00286429|458905390|FG001|Overall Study|Protocol Violation|5|||
127531238|NCT00286429|458905391|FG002|Overall Study|Protocol Violation|4|||
127531239|NCT00286429|458905389|FG000|Overall Study|Withdrawal by Subject|3|||
127531240|NCT00286429|458905390|FG001|Overall Study|Withdrawal by Subject|2|||
127531241|NCT00286429|458905391|FG002|Overall Study|Withdrawal by Subject|6|||
127531242|NCT00286429|458905389|FG000|Overall Study|Administrative Error|1|||
127531243|NCT00286429|458905390|FG001|Overall Study|Administrative Error|1|||
127531244|NCT00286429|458905391|FG002|Overall Study|Administrative Error|1|||
127531245|NCT00286429|458905389|FG000|Overall Study|Administrative Decision|0|||
127531246|NCT00286429|458905390|FG001|Overall Study|Administrative Decision|1|||
127531247|NCT00286429|458905391|FG002|Overall Study|Administrative Decision|0|||
127531248|NCT03915470|458905394|FG000|Overall Study|Death|3|||
127531249|NCT03915470|458905395|FG001|Overall Study|Death|1|||
127531250|NCT03915470|458905394|FG000|Overall Study|Adverse Event|1|||
127531251|NCT03915470|458905395|FG001|Overall Study|Adverse Event|0|||
127531252|NCT03915470|458905394|FG000|Overall Study|Physician Decision|1|||
127531253|NCT03915470|458905395|FG001|Overall Study|Physician Decision|0|||
127531254|NCT03915470|458905394|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
127531255|NCT03915470|458905395|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
127531256|NCT03160898|458905396|FG000|Overall Study|Adverse Event|4|||
127531257|NCT03160898|458905397|FG001|Overall Study|Adverse Event|8|||
127531258|NCT03160898|458905398|FG002|Overall Study|Adverse Event|7|||
127531259|NCT03160898|458905399|FG003|Overall Study|Adverse Event|10|||
127531260|NCT03160898|458905396|FG000|Overall Study|Death|1|||
127531261|NCT03160898|458905397|FG001|Overall Study|Death|0|||
127531262|NCT03160898|458905398|FG002|Overall Study|Death|0|||
127531263|NCT03160898|458905399|FG003|Overall Study|Death|1|||
127531264|NCT03160898|458905396|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
127531265|NCT03160898|458905397|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
127531266|NCT03160898|458905398|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
127531267|NCT03160898|458905399|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
127531268|NCT03160898|458905396|FG000|Overall Study|Lost to Follow-up|1|||
127531269|NCT03160898|458905397|FG001|Overall Study|Lost to Follow-up|1|||
127531270|NCT03160898|458905398|FG002|Overall Study|Lost to Follow-up|1|||
127531271|NCT03160898|458905399|FG003|Overall Study|Lost to Follow-up|2|||
127531272|NCT03160898|458905396|FG000|Overall Study|Physician Decision|1|||
127531273|NCT03160898|458905397|FG001|Overall Study|Physician Decision|0|||
127531274|NCT03160898|458905398|FG002|Overall Study|Physician Decision|0|||
127531275|NCT03160898|458905399|FG003|Overall Study|Physician Decision|1|||
127531276|NCT03160898|458905396|FG000|Overall Study|Progressive Disease|4|||
127531277|NCT03160898|458905397|FG001|Overall Study|Progressive Disease|1|||
127531278|NCT03160898|458905398|FG002|Overall Study|Progressive Disease|2|||
127531279|NCT03160898|458905399|FG003|Overall Study|Progressive Disease|1|||
127531280|NCT03160898|458905396|FG000|Overall Study|Protocol Violation|1|||
127531281|NCT03160898|458905397|FG001|Overall Study|Protocol Violation|0|||
127531282|NCT03160898|458905398|FG002|Overall Study|Protocol Violation|2|||
127531283|NCT03160898|458905399|FG003|Overall Study|Protocol Violation|0|||
127531284|NCT03160898|458905396|FG000|Overall Study|Sponsor Discretion|2|||
127531285|NCT03160898|458905397|FG001|Overall Study|Sponsor Discretion|0|||
127531286|NCT03160898|458905398|FG002|Overall Study|Sponsor Discretion|0|||
127531287|NCT03160898|458905399|FG003|Overall Study|Sponsor Discretion|0|||
127531288|NCT03160898|458905396|FG000|Overall Study|Withdrawal by Subject|1|||
127531289|NCT03160898|458905397|FG001|Overall Study|Withdrawal by Subject|3|||
127531290|NCT03160898|458905398|FG002|Overall Study|Withdrawal by Subject|2|||
127531291|NCT03160898|458905399|FG003|Overall Study|Withdrawal by Subject|1|||
127531292|NCT03160898|458905396|FG000|Overall Study|Other|2|||
127531293|NCT03160898|458905397|FG001|Overall Study|Other|0|||
127531294|NCT03160898|458905398|FG002|Overall Study|Other|2|||
127531295|NCT03160898|458905399|FG003|Overall Study|Other|2|||
127531296|NCT03245775|458905402|FG000|Overall Study|Lost to Follow-up|25|||
127531297|NCT03245775|458905403|FG001|Overall Study|Lost to Follow-up|26|||
127531298|NCT03245775|458905404|FG002|Overall Study|Lost to Follow-up|16|||
127531299|NCT03245775|458905405|FG003|Overall Study|Lost to Follow-up|16|||
127531300|NCT02713828|458905406|FG000|Overall Study|Death|2|||
127531301|NCT02713828|458905407|FG001|Overall Study|Death|0|||
127531302|NCT02713828|458905406|FG000|Overall Study|Withdrawal by Subject|1|||
127531303|NCT02713828|458905407|FG001|Overall Study|Withdrawal by Subject|0|||
127531304|NCT02713828|458905406|FG000|Overall Study|study terminated but patient allowed to|2|||
127531305|NCT02713828|458905407|FG001|Overall Study|study terminated but patient allowed to|0|||
127531306|NCT02663622|458905413|FG000|Overall Study|Death|3|||
127531307|NCT02663622|458905414|FG001|Overall Study|Death|1|||
127531308|NCT02663622|458905415|FG002|Overall Study|Death|1|||
127531309|NCT02663622|458905416|FG003|Overall Study|Death|8|||
127531310|NCT02663622|458905413|FG000|Overall Study|Protocol Violation|0|||
127531311|NCT02663622|458905414|FG001|Overall Study|Protocol Violation|0|||
127531312|NCT02663622|458905415|FG002|Overall Study|Protocol Violation|0|||
127531313|NCT02663622|458905416|FG003|Overall Study|Protocol Violation|1|||
127531314|NCT02587819|458905417|FG000|Overall Study|Adverse Event|1|||
127531315|NCT02587819|458905417|FG000|Overall Study|Lost to Follow-up|1|||
127531316|NCT02936635|458908019|FG000|Overall Study|Adverse Event|43|||
127531317|NCT02936635|458908020|FG001|Overall Study|Adverse Event|25|||
127531318|NCT02936635|458908019|FG000|Overall Study|Progressive Disease|10|||
127531319|NCT02936635|458908020|FG001|Overall Study|Progressive Disease|18|||
127531320|NCT02936635|458908019|FG000|Overall Study|Sponsor Discretion|10|||
127531321|NCT02936635|458908020|FG001|Overall Study|Sponsor Discretion|16|||
127531322|NCT02936635|458908019|FG000|Overall Study|Death|9|||
127531323|NCT02936635|458908020|FG001|Overall Study|Death|15|||
127531324|NCT02936635|458908019|FG000|Overall Study|Withdrawal by Subject|8|||
127531325|NCT02936635|458908020|FG001|Overall Study|Withdrawal by Subject|15|||
127531326|NCT02936635|458908019|FG000|Overall Study|Physician Decision|2|||
127531327|NCT02936635|458908020|FG001|Overall Study|Physician Decision|9|||
127531328|NCT02936635|458908019|FG000|Overall Study|Lost to Follow-up|1|||
127531329|NCT02936635|458908020|FG001|Overall Study|Lost to Follow-up|2|||
127531330|NCT02936635|458908019|FG000|Overall Study|Protocol Violation|1|||
127531331|NCT02936635|458908020|FG001|Overall Study|Protocol Violation|0|||
127531332|NCT02936635|458908019|FG000|Overall Study|Lack of effect/Entry into other study|31|||
127531333|NCT02936635|458908020|FG001|Overall Study|Lack of effect/Entry into other study|65|||
127531334|NCT03553758|458908021|FG000|Overall Study|Lost to Follow-up|1|||
127531335|NCT01473732|458908036|FG000|Overall Study|Adverse Event|1|||
127531336|NCT01473732|458908037|FG001|Overall Study|Adverse Event|0|||
127531337|NCT01473732|458908036|FG000|Overall Study|Death|1|||
127531338|NCT01473732|458908037|FG001|Overall Study|Death|0|||
127531339|NCT01217944|458908043|FG000|Overall Study|Protocol Violation|1|||
127531340|NCT01217944|458908044|FG001|Overall Study|Protocol Violation|1|||
127531341|NCT01217944|458908045|FG002|Overall Study|Protocol Violation|0|||
127531342|NCT01217944|458908043|FG000|Overall Study|Lost to Follow-up|3|||
127531343|NCT01217944|458908044|FG001|Overall Study|Lost to Follow-up|1|||
127531344|NCT01217944|458908045|FG002|Overall Study|Lost to Follow-up|0|||
127531345|NCT01217944|458908043|FG000|Overall Study|Withdrawal by Subject|1|||
127531346|NCT01217944|458908044|FG001|Overall Study|Withdrawal by Subject|2|||
127531347|NCT01217944|458908045|FG002|Overall Study|Withdrawal by Subject|0|||
127531348|NCT01217944|458908043|FG000|Overall Study|Lack of Efficacy|1|||
127531349|NCT01217944|458908044|FG001|Overall Study|Lack of Efficacy|0|||
127531350|NCT01217944|458908045|FG002|Overall Study|Lack of Efficacy|0|||
127531351|NCT03579940|458908046|FG000|Period 2|Withdrawal by Subject|0|||
127531352|NCT03579940|458908047|FG001|Period 2|Withdrawal by Subject|0|||
127531353|NCT03579940|458908048|FG002|Period 2|Withdrawal by Subject|1|||
127531354|NCT03579940|458908049|FG003|Period 2|Withdrawal by Subject|0|||
127531355|NCT03579940|458908050|FG004|Period 2|Withdrawal by Subject|0|||
127531356|NCT03579940|458908051|FG005|Period 2|Withdrawal by Subject|0|||
127531357|NCT03579940|458908052|FG006|Period 2|Withdrawal by Subject|0|||
127531358|NCT03579940|458908053|FG007|Period 2|Withdrawal by Subject|0|||
127531359|NCT03579940|458908054|FG008|Period 2|Withdrawal by Subject|0|||
127531360|NCT03579940|458908055|FG009|Period 2|Withdrawal by Subject|0|||
127531361|NCT03579940|458908056|FG010|Period 2|Withdrawal by Subject|0|||
127531362|NCT00671034|458908057|FG000|Overall Study|Adverse Event|5|||
127531363|NCT00671034|458908058|FG001|Overall Study|Adverse Event|7|||
127531364|NCT00671034|458908059|FG002|Overall Study|Adverse Event|1|||
127531365|NCT00671034|458908057|FG000|Overall Study|Death|3|||
127531366|NCT00671034|458908058|FG001|Overall Study|Death|2|||
127531367|NCT00671034|458908059|FG002|Overall Study|Death|1|||
127531368|NCT00671034|458908057|FG000|Overall Study|Physician Decision|12|||
127531369|NCT00671034|458908058|FG001|Overall Study|Physician Decision|4|||
127531370|NCT00671034|458908059|FG002|Overall Study|Physician Decision|5|||
127531371|NCT00671034|458908057|FG000|Overall Study|VHR ALL feature|8|||
127531372|NCT00671034|458908058|FG001|Overall Study|VHR ALL feature|3|||
127531373|NCT00671034|458908059|FG002|Overall Study|VHR ALL feature|5|||
127531374|NCT00671034|458908057|FG000|Overall Study|Refusal|5|||
127531375|NCT00671034|458908058|FG001|Overall Study|Refusal|3|||
127531376|NCT00671034|458908059|FG002|Overall Study|Refusal|5|||
127531377|NCT00671034|458908057|FG000|Overall Study|includes Alternative therapy, etc.|6|||
127531378|NCT00671034|458908058|FG001|Overall Study|includes Alternative therapy, etc.|1|||
127531379|NCT00671034|458908059|FG002|Overall Study|includes Alternative therapy, etc.|7|||
127531380|NCT00853151|458908060|FG000|Overall Study|Adverse Event|1|||
127531381|NCT00853151|458908061|FG001|Overall Study|Adverse Event|4|||
127531382|NCT00853151|458908062|FG002|Overall Study|Adverse Event|2|||
127531383|NCT00853151|458908063|FG003|Overall Study|Adverse Event|0|||
127531384|NCT00853151|458908060|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
127531385|NCT00853151|458908061|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
127531386|NCT00853151|458908062|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
127531387|NCT00853151|458908063|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
127531388|NCT00853151|458908060|FG000|Overall Study|Lost to Follow-up|2|||
127531389|NCT00853151|458908061|FG001|Overall Study|Lost to Follow-up|0|||
127531390|NCT00853151|458908062|FG002|Overall Study|Lost to Follow-up|3|||
127531391|NCT00853151|458908063|FG003|Overall Study|Lost to Follow-up|0|||
127531392|NCT00853151|458908060|FG000|Overall Study|Death|1|||
127531393|NCT00853151|458908061|FG001|Overall Study|Death|0|||
127531394|NCT00853151|458908062|FG002|Overall Study|Death|0|||
127531395|NCT00853151|458908063|FG003|Overall Study|Death|1|||
127531396|NCT00853151|458908060|FG000|Overall Study|Protocol Violation|0|||
127531397|NCT00853151|458908061|FG001|Overall Study|Protocol Violation|0|||
127531398|NCT00853151|458908062|FG002|Overall Study|Protocol Violation|0|||
127531399|NCT00853151|458908063|FG003|Overall Study|Protocol Violation|1|||
127531400|NCT00853151|458908060|FG000|Overall Study|Withdrawal by Subject|5|||
127531401|NCT00853151|458908061|FG001|Overall Study|Withdrawal by Subject|4|||
127531402|NCT00853151|458908062|FG002|Overall Study|Withdrawal by Subject|2|||
127531403|NCT00853151|458908063|FG003|Overall Study|Withdrawal by Subject|1|||
127531404|NCT00853151|458908060|FG000|Overall Study|Physician Decision|0|||
127531405|NCT00853151|458908061|FG001|Overall Study|Physician Decision|2|||
127531406|NCT00853151|458908062|FG002|Overall Study|Physician Decision|1|||
127531407|NCT00853151|458908063|FG003|Overall Study|Physician Decision|0|||
127531408|NCT00853151|458908060|FG000|Overall Study|Sponsor Decision|0|||
127531409|NCT00853151|458908061|FG001|Overall Study|Sponsor Decision|3|||
127531410|NCT00853151|458908062|FG002|Overall Study|Sponsor Decision|0|||
127531411|NCT00853151|458908063|FG003|Overall Study|Sponsor Decision|0|||
127531412|NCT00269919|458908064|FG000|Overall Study|Other|26|||
127531413|NCT00269919|458908064|FG000|Overall Study|Started but not treated|1|||
127531414|NCT01751984|458908067|FG000|Overall Study|Adverse Event|5|||
127531415|NCT01751984|458908068|FG001|Overall Study|Adverse Event|3|||
127531416|NCT01751984|458908067|FG000|Overall Study|Withdrawal by Subject|0|||
127531417|NCT01751984|458908068|FG001|Overall Study|Withdrawal by Subject|1|||
127531418|NCT01751984|458908067|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
127531419|NCT01751984|458908068|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
127531420|NCT01388907|458908069|FG000|Overall Study|Adverse Event|2|||
127531421|NCT01388907|458908070|FG001|Overall Study|Adverse Event|0|||
127531422|NCT03187132|458908071|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
127531423|NCT03187132|458908072|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
127531424|NCT03187132|458908071|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
127531425|NCT03187132|458908072|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
127531426|NCT03187132|458908071|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
127531427|NCT03187132|458908072|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
127531428|NCT03187132|458908071|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
127531429|NCT03187132|458908072|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
127531430|NCT03187132|458908071|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
127531431|NCT03187132|458908072|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
127531432|NCT03187132|458908071|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
127531433|NCT03187132|458908072|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
127531434|NCT03187132|458908071|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
127531435|NCT03187132|458908072|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
127531436|NCT03187132|458908071|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
127531437|NCT03187132|458908072|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
127531438|NCT03187132|458908071|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
127531439|NCT03187132|458908072|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
127531440|NCT03187132|458908071|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
127531441|NCT03187132|458908072|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
127531442|NCT03187132|458908071|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
127531443|NCT03187132|458908072|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
127531444|NCT01797263|458908073|FG000|Overall Study|Withdrawal by Subject|21|||
127531445|NCT01797263|458908074|FG001|Overall Study|Withdrawal by Subject|25|||
127531446|NCT01797263|458908073|FG000|Overall Study|Death|1|||
127531447|NCT01797263|458908074|FG001|Overall Study|Death|0|||
127531448|NCT01797263|458908073|FG000|Overall Study|Lost to Follow-up|15|||
127531449|NCT01797263|458908074|FG001|Overall Study|Lost to Follow-up|15|||
127531450|NCT02045095|458908075|FG000|Overall Study|Other|0|||
127531451|NCT02045095|458908076|FG001|Overall Study|Other|0|||
127531452|NCT02045095|458908077|FG002|Overall Study|Other|1|||
127531453|NCT02045095|458908078|FG003|Overall Study|Other|0|||
127531454|NCT02045095|458908079|FG004|Overall Study|Other|0|||
127531455|NCT02045095|458908080|FG005|Overall Study|Other|2|||
127531456|NCT02045095|458908081|FG006|Overall Study|Other|0|||
127531457|NCT02045095|458908075|FG000|Overall Study|Progressive Disease|3|||
127531458|NCT02045095|458908076|FG001|Overall Study|Progressive Disease|3|||
127531459|NCT02045095|458908077|FG002|Overall Study|Progressive Disease|2|||
127531460|NCT02045095|458908078|FG003|Overall Study|Progressive Disease|4|||
127531461|NCT02045095|458908079|FG004|Overall Study|Progressive Disease|2|||
127531462|NCT02045095|458908080|FG005|Overall Study|Progressive Disease|4|||
127531463|NCT02045095|458908081|FG006|Overall Study|Progressive Disease|1|||
127531464|NCT02045095|458908075|FG000|Overall Study|Withdrawal by Subject|0|||
127531465|NCT02045095|458908076|FG001|Overall Study|Withdrawal by Subject|0|||
127531466|NCT02045095|458908077|FG002|Overall Study|Withdrawal by Subject|0|||
127531467|NCT02045095|458908078|FG003|Overall Study|Withdrawal by Subject|0|||
127531468|NCT02045095|458908079|FG004|Overall Study|Withdrawal by Subject|3|||
127531469|NCT02045095|458908080|FG005|Overall Study|Withdrawal by Subject|0|||
127531470|NCT02045095|458908081|FG006|Overall Study|Withdrawal by Subject|0|||
127531471|NCT02045095|458908075|FG000|Overall Study|Adverse Event|0|||
127531472|NCT02045095|458908076|FG001|Overall Study|Adverse Event|1|||
127531473|NCT02045095|458908077|FG002|Overall Study|Adverse Event|1|||
127531474|NCT02045095|458908078|FG003|Overall Study|Adverse Event|0|||
127531475|NCT02045095|458908079|FG004|Overall Study|Adverse Event|0|||
127531476|NCT02045095|458908080|FG005|Overall Study|Adverse Event|2|||
127531477|NCT02045095|458908081|FG006|Overall Study|Adverse Event|0|||
127531478|NCT03594773|458908082|FG000|Overall Study|Withdrawal by Subject|3|||
127531479|NCT03594773|458908083|FG001|Overall Study|Withdrawal by Subject|2|||
127531480|NCT03594773|458908082|FG000|Overall Study|Lost to Follow-up|3|||
127531481|NCT03594773|458908083|FG001|Overall Study|Lost to Follow-up|4|||
127531482|NCT01461707|458908087|FG000|Overall Study|Withdrawal by Subject|1|||
127531483|NCT01461707|458908088|FG001|Overall Study|Withdrawal by Subject|0|||
127531484|NCT01450761|458908089|FG000|Randomization|Subject no longer meets study criteria|1|||
127531485|NCT01450761|458908090|FG001|Randomization|Subject no longer meets study criteria|2|||
127531486|NCT01450761|458908089|FG000|Randomization|Withdrawal by Subject|2|||
127531487|NCT01450761|458908090|FG001|Randomization|Withdrawal by Subject|0|||
127531488|NCT01450761|458908089|FG000|Randomization|Disease progression|0|||
127531489|NCT01450761|458908090|FG001|Randomization|Disease progression|2|||
127531490|NCT01450761|458908089|FG000|Randomization|Adverse Event unrelated to study drug|1|||
127531491|NCT01450761|458908090|FG001|Randomization|Adverse Event unrelated to study drug|0|||
127531492|NCT01450761|458908089|FG000|Randomization|Other|0|||
127531493|NCT01450761|458908090|FG001|Randomization|Other|1|||
127531494|NCT01450761|458908089|FG000|Lead-in Chemotherapy|Disease progression|33|||
127531495|NCT01450761|458908090|FG001|Lead-in Chemotherapy|Disease progression|32|||
127531496|NCT01450761|458908089|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
127531497|NCT01450761|458908090|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
127531498|NCT01450761|458908089|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
127531499|NCT01450761|458908090|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
127531500|NCT01450761|458908089|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
127531501|NCT01450761|458908090|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
127531502|NCT01450761|458908089|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
127531503|NCT01450761|458908090|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
127531504|NCT01450761|458908089|FG000|Lead-in Chemotherapy|Death|3|||
127531505|NCT01450761|458908090|FG001|Lead-in Chemotherapy|Death|3|||
127531506|NCT01450761|458908089|FG000|Lead-in Chemotherapy|Other|2|||
127531507|NCT01450761|458908090|FG001|Lead-in Chemotherapy|Other|2|||
127531508|NCT01450761|458908089|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
127531509|NCT01450761|458908090|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
127531510|NCT01450761|458908089|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
127531511|NCT01450761|458908090|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
127531512|NCT01450761|458908089|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
127531513|NCT01450761|458908090|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
127531514|NCT01450761|458908089|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
127531515|NCT01450761|458908090|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
127531516|NCT01450761|458908089|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
127531517|NCT01450761|458908090|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
127531518|NCT01450761|458908089|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
127531519|NCT01450761|458908090|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
127531520|NCT01450761|458908089|FG000|Treatment With Blinded Study Therapy|Death|5|||
127531521|NCT01450761|458908090|FG001|Treatment With Blinded Study Therapy|Death|6|||
127531522|NCT01450761|458908089|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
127531523|NCT01450761|458908090|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
127531524|NCT01450761|458908089|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
127531525|NCT01450761|458908090|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
127531526|NCT01450761|458908089|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
127531527|NCT01450761|458908090|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
127531528|NCT01450761|458908089|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
127531529|NCT01450761|458908090|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
127531530|NCT01450761|458908089|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
127531531|NCT01450761|458908090|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
127531532|NCT01450761|458908089|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
127531533|NCT01450761|458908090|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
127531534|NCT01450761|458908089|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
127531535|NCT01450761|458908090|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
127531536|NCT00337207|458908103|FG000|Overall Study|Withdrawal by Subject|3|||
127531537|NCT01338818|458908107|FG000|Overall Study|Adverse Event|8|||
127531538|NCT01338818|458908107|FG000|Overall Study|Lack of Efficacy|5|||
127531539|NCT01338818|458908107|FG000|Overall Study|no longer require study drug|1|||
127531540|NCT01338818|458908107|FG000|Overall Study|Withdrawal by Subject|11|||
127531541|NCT01338818|458908107|FG000|Overall Study|Lost to Follow-up|4|||
127531542|NCT01338818|458908107|FG000|Overall Study|Administrative problems|3|||
127531543|NCT01338818|458908107|FG000|Overall Study|Protocol Deviation|4|||
127531544|NCT00556998|458908112|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
127531545|NCT00556998|458908112|FG000|Voriconazole Intravenous (IV)|Other|4|||
127531546|NCT00556998|458908112|FG000|Voriconazole Oral|Adverse Event|1|||
127531547|NCT00556998|458908112|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
127531548|NCT00216671|458908121|FG000|Overall Study|Adverse Event|4|||
127531549|NCT00216671|458908122|FG001|Overall Study|Adverse Event|9|||
127531550|NCT00216671|458908121|FG000|Overall Study|Pregnancy|0|||
127531551|NCT00216671|458908122|FG001|Overall Study|Pregnancy|1|||
127531552|NCT00216671|458908121|FG000|Overall Study|Withdrawal by Subject|4|||
127531553|NCT00216671|458908122|FG001|Overall Study|Withdrawal by Subject|2|||
127531554|NCT00216671|458908121|FG000|Overall Study|Refused Injections|3|||
127531555|NCT00216671|458908122|FG001|Overall Study|Refused Injections|13|||
127531556|NCT00216671|458908121|FG000|Overall Study|No Need to Continue Medication|1|||
127531557|NCT00216671|458908122|FG001|Overall Study|No Need to Continue Medication|1|||
127531558|NCT00216671|458908121|FG000|Overall Study|Insufficient Response|9|||
127531559|NCT00216671|458908122|FG001|Overall Study|Insufficient Response|4|||
127531560|NCT00216671|458908121|FG000|Overall Study|Lost to Follow-up|3|||
127531561|NCT00216671|458908122|FG001|Overall Study|Lost to Follow-up|5|||
127531562|NCT00216671|458908121|FG000|Overall Study|Non compliant|2|||
127531563|NCT00216671|458908122|FG001|Overall Study|Non compliant|2|||
127531564|NCT00216671|458908121|FG000|Overall Study|Ineligible|0|||
127531565|NCT00216671|458908122|FG001|Overall Study|Ineligible|2|||
127531566|NCT00216671|458908121|FG000|Overall Study|Physician Decision|1|||
127531567|NCT00216671|458908122|FG001|Overall Study|Physician Decision|1|||
127531568|NCT00216671|458908121|FG000|Overall Study|Protocol Violation|3|||
127531569|NCT00216671|458908122|FG001|Overall Study|Protocol Violation|5|||
127531570|NCT00216671|458908121|FG000|Overall Study|Relapse|1|||
127531571|NCT00216671|458908122|FG001|Overall Study|Relapse|0|||
127531572|NCT00216671|458908121|FG000|Overall Study|Investigator Illness|0|||
127531573|NCT00216671|458908122|FG001|Overall Study|Investigator Illness|1|||
127531574|NCT00216671|458908121|FG000|Overall Study|Patient Moved|0|||
127531575|NCT00216671|458908122|FG001|Overall Study|Patient Moved|1|||
127531576|NCT00216671|458908121|FG000|Overall Study|Ineligible, no efficacy data|2|||
127531577|NCT00216671|458908122|FG001|Overall Study|Ineligible, no efficacy data|2|||
127531578|NCT00216671|458908121|FG000|Overall Study|Insufficient Response Adverse Event|2|||
127531579|NCT00216671|458908122|FG001|Overall Study|Insufficient Response Adverse Event|1|||
127531580|NCT04961541|458908123|FG000|Overall Study|Adverse Event|0|||
127531581|NCT04961541|458908124|FG001|Overall Study|Adverse Event|0|||
127531582|NCT04961541|458908125|FG002|Overall Study|Adverse Event|0|||
127531583|NCT04961541|458908126|FG003|Overall Study|Adverse Event|0|||
127531584|NCT04961541|458908127|FG004|Overall Study|Adverse Event|0|||
127531585|NCT04961541|458908128|FG005|Overall Study|Adverse Event|1|||
127531586|NCT04961541|458908129|FG006|Overall Study|Adverse Event|0|||
127531587|NCT04961541|458908130|FG007|Overall Study|Adverse Event|0|||
127531588|NCT04961541|458908131|FG008|Overall Study|Adverse Event|0|||
127531589|NCT04961541|458908132|FG009|Overall Study|Adverse Event|0|||
127531590|NCT04961541|458908133|FG010|Overall Study|Adverse Event|0|||
127531591|NCT04961541|458908134|FG011|Overall Study|Adverse Event|0|||
127531592|NCT04961541|458908135|FG012|Overall Study|Adverse Event|0|||
127531593|NCT04961541|458908136|FG013|Overall Study|Adverse Event|0|||
127531594|NCT04961541|458908123|FG000|Overall Study|Lost to Follow-up|0|||
127531595|NCT04961541|458908124|FG001|Overall Study|Lost to Follow-up|0|||
127531596|NCT04961541|458908125|FG002|Overall Study|Lost to Follow-up|3|||
127531597|NCT04961541|458908126|FG003|Overall Study|Lost to Follow-up|0|||
127531598|NCT04961541|458908127|FG004|Overall Study|Lost to Follow-up|0|||
127531599|NCT04961541|458908128|FG005|Overall Study|Lost to Follow-up|0|||
127531600|NCT04961541|458908129|FG006|Overall Study|Lost to Follow-up|1|||
127531601|NCT04961541|458908130|FG007|Overall Study|Lost to Follow-up|1|||
127531602|NCT04961541|458908131|FG008|Overall Study|Lost to Follow-up|0|||
127531603|NCT04961541|458908132|FG009|Overall Study|Lost to Follow-up|1|||
127531604|NCT04961541|458908133|FG010|Overall Study|Lost to Follow-up|0|||
127531605|NCT04961541|458908134|FG011|Overall Study|Lost to Follow-up|0|||
127531606|NCT04961541|458908135|FG012|Overall Study|Lost to Follow-up|1|||
127531607|NCT04961541|458908136|FG013|Overall Study|Lost to Follow-up|0|||
127531608|NCT04961541|458908123|FG000|Overall Study|Withdrawal by Subject|0|||
127531609|NCT04961541|458908124|FG001|Overall Study|Withdrawal by Subject|0|||
127531610|NCT04961541|458908125|FG002|Overall Study|Withdrawal by Subject|1|||
127531611|NCT04961541|458908126|FG003|Overall Study|Withdrawal by Subject|1|||
127531612|NCT04961541|458908127|FG004|Overall Study|Withdrawal by Subject|0|||
127531613|NCT04961541|458908128|FG005|Overall Study|Withdrawal by Subject|0|||
127531614|NCT04961541|458908129|FG006|Overall Study|Withdrawal by Subject|0|||
127531615|NCT04961541|458908130|FG007|Overall Study|Withdrawal by Subject|0|||
127531616|NCT04961541|458908131|FG008|Overall Study|Withdrawal by Subject|0|||
127531617|NCT04961541|458908132|FG009|Overall Study|Withdrawal by Subject|1|||
127531618|NCT04961541|458908133|FG010|Overall Study|Withdrawal by Subject|0|||
127531619|NCT04961541|458908134|FG011|Overall Study|Withdrawal by Subject|0|||
127531620|NCT04961541|458908135|FG012|Overall Study|Withdrawal by Subject|0|||
127531621|NCT04961541|458908136|FG013|Overall Study|Withdrawal by Subject|0|||
127531622|NCT01843023|458908138|FG000|Overall Study|Death|1|||
127531623|NCT01843023|458908139|FG001|Overall Study|Death|0|||
127531624|NCT01843023|458908138|FG000|Overall Study|Lost to Follow-up|24|||
127531625|NCT01843023|458908139|FG001|Overall Study|Lost to Follow-up|29|||
127531626|NCT01843023|458908138|FG000|Overall Study|Withdrawal by Subject|8|||
127531627|NCT01843023|458908139|FG001|Overall Study|Withdrawal by Subject|6|||
127531628|NCT03305770|458908140|FG000|Overall Study|Physician Decision - prior to dispense|0|||
127531629|NCT03305770|458908141|FG001|Overall Study|Physician Decision - prior to dispense|1|||
127531630|NCT03305770|458908140|FG000|Overall Study|Subject moved|1|||
127531631|NCT03305770|458908141|FG001|Overall Study|Subject moved|0|||
127531632|NCT03539601|458908142|FG000|Overall Study|Withdraw by parent/guardian|1|||
127531633|NCT03539601|458908143|FG001|Overall Study|Withdraw by parent/guardian|0|||
127531634|NCT03539601|458908144|FG002|Overall Study|Withdraw by parent/guardian|1|||
127531635|NCT03539601|458908145|FG003|Overall Study|Withdraw by parent/guardian|0|||
127531636|NCT03539601|458908142|FG000|Overall Study|Adverse Event|0|||
127531637|NCT03539601|458908143|FG001|Overall Study|Adverse Event|2|||
127531638|NCT03539601|458908144|FG002|Overall Study|Adverse Event|0|||
127531639|NCT03539601|458908145|FG003|Overall Study|Adverse Event|0|||
127531640|NCT03539601|458908142|FG000|Overall Study|Lost to Follow-up|2|||
127531641|NCT03539601|458908143|FG001|Overall Study|Lost to Follow-up|4|||
127531642|NCT03539601|458908144|FG002|Overall Study|Lost to Follow-up|5|||
127531643|NCT03539601|458908145|FG003|Overall Study|Lost to Follow-up|0|||
127531644|NCT03539601|458908142|FG000|Overall Study|Withdrawal by Subject|2|||
127531645|NCT03539601|458908143|FG001|Overall Study|Withdrawal by Subject|0|||
127531646|NCT03539601|458908144|FG002|Overall Study|Withdrawal by Subject|0|||
127531647|NCT03539601|458908145|FG003|Overall Study|Withdrawal by Subject|1|||
127531648|NCT03539601|458908142|FG000|Overall Study|Randomized but not treated|1|||
127531649|NCT03539601|458908143|FG001|Overall Study|Randomized but not treated|1|||
127531650|NCT03539601|458908144|FG002|Overall Study|Randomized but not treated|0|||
127531651|NCT03539601|458908145|FG003|Overall Study|Randomized but not treated|0|||
127531652|NCT01970306|458908146|FG000|Overall Study|Not eligible|3|||
127531653|NCT01970306|458908146|FG000|Overall Study|Not able to be treated|9|||
127531654|NCT00226811|458908147|FG000|Overall Study|Death|8|||
127531655|NCT00226811|458908147|FG000|Overall Study|Adverse Event|11|||
127531656|NCT00226811|458908147|FG000|Overall Study|Lack of Efficacy|55|||
127531657|NCT00226811|458908147|FG000|Overall Study|Withdrawal by Subject|2|||
127531658|NCT03081884|458908148|FG000|Overall Study|deferred prostate cancer treatment|1|||
127531659|NCT03081884|458908148|FG000|Overall Study|metastasis managed with systemic therapy|3|||
127531660|NCT03948334|458908150|FG000|Overall Study|Adverse Event|1|||
127531661|NCT03948334|458908151|FG001|Overall Study|Adverse Event|4|||
127531662|NCT03948334|458908150|FG000|Overall Study|Lack of Efficacy|2|||
127531663|NCT03948334|458908151|FG001|Overall Study|Lack of Efficacy|0|||
127531664|NCT03948334|458908150|FG000|Overall Study|Lost to Follow-up|1|||
127531665|NCT03948334|458908151|FG001|Overall Study|Lost to Follow-up|0|||
127531666|NCT03948334|458908150|FG000|Overall Study|Physician Decision|1|||
127531667|NCT03948334|458908151|FG001|Overall Study|Physician Decision|0|||
127531668|NCT03948334|458908150|FG000|Overall Study|Pregnancy|0|||
127531669|NCT03948334|458908151|FG001|Overall Study|Pregnancy|1|||
127531670|NCT03948334|458908150|FG000|Overall Study|Protocol Deviation|1|||
127531671|NCT03948334|458908151|FG001|Overall Study|Protocol Deviation|0|||
127531672|NCT03948334|458908150|FG000|Overall Study|Study terminated by Sponsor|50|||
127531673|NCT03948334|458908151|FG001|Overall Study|Study terminated by Sponsor|51|||
127531674|NCT03948334|458908150|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
127531675|NCT03948334|458908151|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
127531676|NCT00700713|458908152|FG000|Overall Study|Protocol Violation|1|||
127531677|NCT00700713|458908153|FG001|Overall Study|Protocol Violation|0|||
127531678|NCT00700713|458908154|FG002|Overall Study|Protocol Violation|1|||
127531679|NCT00700713|458908152|FG000|Overall Study|Withdrawal by Subject|0|||
127531680|NCT00700713|458908153|FG001|Overall Study|Withdrawal by Subject|0|||
127531681|NCT00700713|458908154|FG002|Overall Study|Withdrawal by Subject|1|||
127531682|NCT00550953|458908157|FG000|Overall Study|Adverse Event|4|||
127531683|NCT00550953|458908158|FG001|Overall Study|Adverse Event|3|||
127531684|NCT00550953|458908157|FG000|Overall Study|Not able to visit the site|2|||
127531685|NCT00550953|458908158|FG001|Overall Study|Not able to visit the site|3|||
127531686|NCT04980612|458908159|FG000|Overall Study|Withdrawal by Subject|7|||
127531687|NCT04980612|458908160|FG001|Overall Study|Withdrawal by Subject|5|||
127531688|NCT02446717|458908161|FG000|Overall Study|Adverse Event|0|||
127531689|NCT02446717|458908162|FG001|Overall Study|Adverse Event|0|||
127531690|NCT02446717|458908163|FG002|Overall Study|Adverse Event|1|||
127531691|NCT02446717|458908164|FG003|Overall Study|Adverse Event|0|||
127531692|NCT02446717|458908165|FG004|Overall Study|Adverse Event|0|||
127531693|NCT02446717|458908161|FG000|Overall Study|Lost to Follow-up|0|||
127531694|NCT02446717|458908162|FG001|Overall Study|Lost to Follow-up|1|||
127531695|NCT02446717|458908163|FG002|Overall Study|Lost to Follow-up|1|||
127531696|NCT02446717|458908164|FG003|Overall Study|Lost to Follow-up|0|||
127531697|NCT02446717|458908165|FG004|Overall Study|Lost to Follow-up|1|||
127531698|NCT02446717|458908161|FG000|Overall Study|Withdrew consent|0|||
127531699|NCT02446717|458908162|FG001|Overall Study|Withdrew consent|0|||
127531700|NCT02446717|458908163|FG002|Overall Study|Withdrew consent|0|||
127531701|NCT02446717|458908164|FG003|Overall Study|Withdrew consent|1|||
127531702|NCT02446717|458908165|FG004|Overall Study|Withdrew consent|0|||
127531703|NCT02680665|458908166|FG000|Overall Study|No visit after the first prescription|5|||
127531704|NCT01327599|458908167|FG000|Overall Study|Adverse Event|1|||
127531705|NCT01327599|458908167|FG000|Overall Study|Could Not Attend Visit|1|||
127531706|NCT01327599|458908167|FG000|Overall Study|Withdrawal of Consent|1|||
127531707|NCT00892775|458908168|FG000|Overall Study|Protocol Violation|1|||
127531708|NCT00892775|458908169|FG001|Overall Study|Protocol Violation|0|||
127531709|NCT00892775|458908168|FG000|Overall Study|Subject difficulties with blood drawing|1|||
127531710|NCT00892775|458908169|FG001|Overall Study|Subject difficulties with blood drawing|0|||
127531711|NCT00892775|458908168|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
127531712|NCT00892775|458908169|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
127531713|NCT00892775|458908168|FG000|Overall Study|Migrated/ moved from study area|1|||
127531714|NCT00892775|458908169|FG001|Overall Study|Migrated/ moved from study area|0|||
127531715|NCT00892775|458908168|FG000|Overall Study|Withdrawal by Subject|0|||
127531716|NCT00892775|458908169|FG001|Overall Study|Withdrawal by Subject|1|||
127531717|NCT00892775|458908168|FG000|Overall Study|Lost to Follow-up|1|||
127531718|NCT00892775|458908169|FG001|Overall Study|Lost to Follow-up|0|||
127531719|NCT00434109|458908170|FG000|Overall Study|Physician Decision|9|||
127531720|NCT00434109|458908170|FG000|Overall Study|Adverse Event|5|||
127531721|NCT00434109|458908170|FG000|Overall Study|Protocol Violation|1|||
127531722|NCT00434109|458908170|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
127531723|NCT02978833|458908173|FG000|Overall Study|Study terminated|1|||
127531724|NCT02978833|458908174|FG001|Overall Study|Study terminated|1|||
127531725|NCT00103740|458908175|FG000|Period 1 - Core|Adverse Event|1|||
127531726|NCT00103740|458908176|FG001|Period 1 - Core|Adverse Event|0|||
127531727|NCT00103740|458908175|FG000|Period 1 - Core|Protocol Violation|3|||
127531728|NCT00103740|458908176|FG001|Period 1 - Core|Protocol Violation|2|||
127531729|NCT00103740|458908175|FG000|Period 1 - Core|Patient withdrew consent|3|||
127531730|NCT00103740|458908176|FG001|Period 1 - Core|Patient withdrew consent|2|||
127531731|NCT00103740|458908175|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
127531732|NCT00103740|458908176|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
127531733|NCT00103740|458908175|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
127531734|NCT00103740|458908176|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
127531735|NCT00103740|458908175|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
127531736|NCT00103740|458908176|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
127531737|NCT00103740|458908175|FG000|Period 2 - Extended Observation Period|Death|6|||
127531738|NCT00103740|458908176|FG001|Period 2 - Extended Observation Period|Death|2|||
127531739|NCT00103740|458908175|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
127531740|NCT00103740|458908176|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
127531741|NCT01594931|458910360|FG000|Overall Study|Adverse Event|3|||
127531742|NCT01594931|458910361|FG001|Overall Study|Adverse Event|1|||
127531743|NCT01594931|458910362|FG002|Overall Study|Adverse Event|1|||
127531744|NCT01594931|458910360|FG000|Overall Study|Withdrawal by Subject|2|||
127531745|NCT01594931|458910361|FG001|Overall Study|Withdrawal by Subject|1|||
127531746|NCT01594931|458910362|FG002|Overall Study|Withdrawal by Subject|1|||
127531747|NCT01594931|458910360|FG000|Overall Study|Lack of Efficacy|7|||
127531748|NCT01594931|458910361|FG001|Overall Study|Lack of Efficacy|2|||
127531749|NCT01594931|458910362|FG002|Overall Study|Lack of Efficacy|2|||
127531750|NCT01594931|458910360|FG000|Overall Study|Lost to Follow-up|4|||
127531751|NCT01594931|458910361|FG001|Overall Study|Lost to Follow-up|3|||
127531752|NCT01594931|458910362|FG002|Overall Study|Lost to Follow-up|3|||
127531753|NCT01594931|458910360|FG000|Overall Study|Protocol Violation|2|||
127531754|NCT01594931|458910361|FG001|Overall Study|Protocol Violation|1|||
127531755|NCT01594931|458910362|FG002|Overall Study|Protocol Violation|0|||
127531756|NCT01594931|458910360|FG000|Overall Study|No defiined|11|||
127531757|NCT01594931|458910361|FG001|Overall Study|No defiined|4|||
127531758|NCT01594931|458910362|FG002|Overall Study|No defiined|7|||
127531759|NCT01633788|458910368|FG000|Overall Study|Adverse Event|1|||
127531760|NCT01633788|458910369|FG001|Overall Study|Adverse Event|3|||
127531761|NCT01633788|458910370|FG002|Overall Study|Adverse Event|3|||
127531762|NCT01633788|458910371|FG003|Overall Study|Adverse Event|3|||
127531763|NCT01633788|458910368|FG000|Overall Study|Lost to Follow-up|2|||
127531764|NCT01633788|458910369|FG001|Overall Study|Lost to Follow-up|2|||
127531765|NCT01633788|458910370|FG002|Overall Study|Lost to Follow-up|2|||
127531766|NCT01633788|458910371|FG003|Overall Study|Lost to Follow-up|0|||
127531767|NCT01633788|458910368|FG000|Overall Study|Personal Reasons|3|||
127531768|NCT01633788|458910369|FG001|Overall Study|Personal Reasons|1|||
127531769|NCT01633788|458910370|FG002|Overall Study|Personal Reasons|1|||
127531770|NCT01633788|458910371|FG003|Overall Study|Personal Reasons|3|||
127531771|NCT01633788|458910368|FG000|Overall Study|Protocol Violation|1|||
127531772|NCT01633788|458910369|FG001|Overall Study|Protocol Violation|0|||
127531773|NCT01633788|458910370|FG002|Overall Study|Protocol Violation|1|||
127531774|NCT01633788|458910371|FG003|Overall Study|Protocol Violation|0|||
127531775|NCT01633788|458910368|FG000|Overall Study|Other Reasons|0|||
127531776|NCT01633788|458910369|FG001|Overall Study|Other Reasons|2|||
127531777|NCT01633788|458910370|FG002|Overall Study|Other Reasons|3|||
127531778|NCT01633788|458910371|FG003|Overall Study|Other Reasons|7|||
127531779|NCT01929226|458910372|FG000|Overall Study|Lost to Follow-up|4|||
127531780|NCT01929226|458910373|FG001|Overall Study|Lost to Follow-up|0|||
127531781|NCT01929226|458910372|FG000|Overall Study|Withdrawal by Subject|1|||
127531782|NCT01929226|458910373|FG001|Overall Study|Withdrawal by Subject|1|||
127531783|NCT01467505|458910376|FG000|Overall Study|Adverse Event|1|||
127531784|NCT01467505|458910377|FG001|Overall Study|Adverse Event|0|||
127531785|NCT01467505|458910376|FG000|Overall Study|Withdrawal by Subject|4|||
127531786|NCT01467505|458910377|FG001|Overall Study|Withdrawal by Subject|0|||
127531787|NCT01467505|458910376|FG000|Overall Study|Study Terminated by Sponsor|28|||
127531788|NCT01467505|458910377|FG001|Overall Study|Study Terminated by Sponsor|3|||
127531789|NCT03449758|458910378|FG000|Overall Study|Major protocol deviation|1|||
127531790|NCT03449758|458910378|FG000|Overall Study|Treatment inefficacy|5|||
127531791|NCT03449758|458910378|FG000|Overall Study|Adverse Event|9|||
127531792|NCT03449758|458910378|FG000|Overall Study|Consent withdrawal|1|||
127531793|NCT03449758|458910378|FG000|Overall Study|Other unspecified reason|3|||
127531794|NCT00922623|458910383|FG000|Overall Study|Other|4|||
127531795|NCT00922623|458910383|FG000|Overall Study|Lost to Follow-up|1|||
127531796|NCT01402817|458910384|FG000|Overall Study|Withdrawal by Subject|3|||
127531797|NCT01402817|458910384|FG000|Overall Study|Study Suspended by FDA|8|||
127531798|NCT00086047|458910385|FG000|Overall Study|Lost to Follow-up|7|||
127531799|NCT00086047|458910386|FG001|Overall Study|Lost to Follow-up|6|||
127531800|NCT00086047|458910385|FG000|Overall Study|Physician Decision|0|||
127531801|NCT00086047|458910386|FG001|Overall Study|Physician Decision|1|||
127531802|NCT02471014|458910388|FG000|Overall Study|Lost to Follow-up|2|||
127531803|NCT02471014|458910389|FG001|Overall Study|Lost to Follow-up|2|||
127531804|NCT01172535|458910390|FG000|Overall Study|Death|3|||
127531805|NCT01172535|458910390|FG000|Overall Study|Withdrawal by Subject|2|||
127531806|NCT01172535|458910390|FG000|Overall Study|Lost to Follow-up|1|||
127531807|NCT01172535|458910390|FG000|Overall Study|Ineligible at study entry|1|||
127531808|NCT01172535|458910390|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
127531809|NCT00988598|458910391|FG000|Overall Study|Withdrawal by Subject|2|||
127531810|NCT00988598|458910392|FG001|Overall Study|Withdrawal by Subject|0|||
127531811|NCT03573323|458910395|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
127531812|NCT03573323|458910396|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
127531813|NCT03573323|458910395|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
127531814|NCT03573323|458910396|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
127531815|NCT03573323|458910395|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
127531816|NCT03573323|458910396|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
127531817|NCT03573323|458910395|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
127531818|NCT03573323|458910396|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
127531819|NCT03573323|458910395|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
127531820|NCT03573323|458910396|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
127531821|NCT03573323|458910395|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
127531822|NCT03573323|458910396|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
127531823|NCT03573323|458910395|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
127531824|NCT03573323|458910396|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
127531825|NCT03573323|458910395|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
127531826|NCT03573323|458910396|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
127531827|NCT03573323|458910395|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
127531828|NCT03573323|458910396|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
127531829|NCT03573323|458910395|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
127531830|NCT03573323|458910396|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
127531831|NCT03573323|458910395|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
127531832|NCT03573323|458910396|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
127531833|NCT03573323|458910395|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
127531834|NCT03573323|458910396|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
127531835|NCT03573323|458910395|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
127531836|NCT03573323|458910396|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
127531837|NCT03573323|458910395|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
127531838|NCT03573323|458910396|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
127531839|NCT03573323|458910395|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
127531840|NCT03573323|458910396|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
127531841|NCT03573323|458910395|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
127531842|NCT03573323|458910396|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
127531843|NCT03573323|458910395|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
127531844|NCT03573323|458910396|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
127531845|NCT03573323|458910395|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
127531846|NCT03573323|458910396|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
127531847|NCT03573323|458910395|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
127531848|NCT03573323|458910396|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
127531849|NCT00837213|458910400|FG000|Overall Study|Lost to Follow-up|3|||
127531850|NCT00837213|458910401|FG001|Overall Study|Lost to Follow-up|2|||
127531851|NCT00837213|458910400|FG000|Overall Study|Withdrawal by Subject|2|||
127531852|NCT00837213|458910401|FG001|Overall Study|Withdrawal by Subject|2|||
127531853|NCT00837213|458910400|FG000|Overall Study|not stated|1|||
127531854|NCT00837213|458910401|FG001|Overall Study|not stated|1|||
127531855|NCT02698826|458910405|FG000|Overall Study|Death|13|||
127531856|NCT02698826|458910405|FG000|Overall Study|Adverse Event|1|||
127531857|NCT01618669|458910409|FG000|Overall Study|Lost to Follow-up|1|||
127531858|NCT01618669|458910410|FG001|Overall Study|Lost to Follow-up|1|||
127531859|NCT01618669|458910409|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
127531860|NCT01618669|458910410|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
127531861|NCT01618669|458910409|FG000|Overall Study|Adverse Event|16|||
127531862|NCT01618669|458910410|FG001|Overall Study|Adverse Event|7|||
127531863|NCT01618669|458910409|FG000|Overall Study|Protocol Violation|5|||
127531864|NCT01618669|458910410|FG001|Overall Study|Protocol Violation|3|||
127531865|NCT01618669|458910409|FG000|Overall Study|Withdrawal by Subject|9|||
127531866|NCT01618669|458910410|FG001|Overall Study|Withdrawal by Subject|9|||
127531867|NCT01618669|458910409|FG000|Overall Study|Miscellaneous Reason|0|||
127531868|NCT01618669|458910410|FG001|Overall Study|Miscellaneous Reason|1|||
127531869|NCT04317040|458910413|FG000|Overall Study|Lost to Follow-up|2|||
127531870|NCT04317040|458910414|FG001|Overall Study|Lost to Follow-up|0|||
127531871|NCT04317040|458910413|FG000|Overall Study|Death|16|||
127531872|NCT04317040|458910414|FG001|Overall Study|Death|18|||
127531873|NCT04317040|458910413|FG000|Overall Study|Withdrawal by Subject|0|||
127531874|NCT04317040|458910414|FG001|Overall Study|Withdrawal by Subject|1|||
127531875|NCT04317040|458910413|FG000|Overall Study|Incomplete assessments|0|||
127531876|NCT04317040|458910414|FG001|Overall Study|Incomplete assessments|1|||
127531877|NCT01177007|458910417|FG000|Overall Study|Lost to Follow-up|2|||
127531878|NCT01177007|458910417|FG000|Overall Study|Death|4|||
127531879|NCT01177007|458910417|FG000|Overall Study|Entered hospice care|5|||
127531880|NCT01177007|458910417|FG000|Overall Study|Required additional Y90 treatment|6|||
127531881|NCT01177007|458910417|FG000|Overall Study|Change in treatment modality|21|||
127531882|NCT01702558|458910419|FG000|Overall Study|Withdrawal by Subject|0|||
127531883|NCT01702558|458910420|FG001|Overall Study|Withdrawal by Subject|0|||
127531884|NCT01702558|458910421|FG002|Overall Study|Withdrawal by Subject|0|||
127531885|NCT01702558|458910422|FG003|Overall Study|Withdrawal by Subject|12|||
127531886|NCT01702558|458910423|FG004|Overall Study|Withdrawal by Subject|4|||
127531887|NCT01702558|458910419|FG000|Overall Study|Lost to Follow-up|0|||
127531888|NCT01702558|458910420|FG001|Overall Study|Lost to Follow-up|0|||
127531889|NCT01702558|458910421|FG002|Overall Study|Lost to Follow-up|0|||
127531890|NCT01702558|458910422|FG003|Overall Study|Lost to Follow-up|3|||
127531891|NCT01702558|458910423|FG004|Overall Study|Lost to Follow-up|0|||
127531892|NCT01702558|458910419|FG000|Overall Study|Death|4|||
127531893|NCT01702558|458910420|FG001|Overall Study|Death|3|||
127531894|NCT01702558|458910421|FG002|Overall Study|Death|3|||
127531895|NCT01702558|458910422|FG003|Overall Study|Death|16|||
127531896|NCT01702558|458910423|FG004|Overall Study|Death|20|||
127531897|NCT01702558|458910419|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
127531898|NCT01702558|458910420|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
127531899|NCT01702558|458910421|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
127531900|NCT01702558|458910422|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
127531901|NCT01702558|458910423|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
127531902|NCT01702558|458910419|FG000|Overall Study|Study Terminated by Sponsor|0|||
127531903|NCT01702558|458910420|FG001|Overall Study|Study Terminated by Sponsor|1|||
127531904|NCT01702558|458910421|FG002|Overall Study|Study Terminated by Sponsor|0|||
127531905|NCT01702558|458910422|FG003|Overall Study|Study Terminated by Sponsor|0|||
127531906|NCT01702558|458910423|FG004|Overall Study|Study Terminated by Sponsor|1|||
127531907|NCT01702558|458910419|FG000|Overall Study|Other|0|||
127531908|NCT01702558|458910420|FG001|Overall Study|Other|0|||
127531909|NCT01702558|458910421|FG002|Overall Study|Other|0|||
127531910|NCT01702558|458910422|FG003|Overall Study|Other|16|||
127531911|NCT01702558|458910423|FG004|Overall Study|Other|17|||
127531912|NCT03259087|458910428|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
127531913|NCT03259087|458910429|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
127531914|NCT03259087|458910430|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
127531915|NCT03259087|458910431|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
127531916|NCT03259087|458910432|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
127531917|NCT03259087|458910428|FG000|Period 2 of Part 2|Adverse Event|0|||
127531918|NCT03259087|458910429|FG001|Period 2 of Part 2|Adverse Event|0|||
127531919|NCT03259087|458910430|FG002|Period 2 of Part 2|Adverse Event|0|||
127531920|NCT03259087|458910431|FG003|Period 2 of Part 2|Adverse Event|0|||
127531921|NCT03259087|458910432|FG004|Period 2 of Part 2|Adverse Event|1|||
127531922|NCT04950465|458910433|FG000|Overall Study|Lost to Follow-up|1|||
127531923|NCT04950465|458910434|FG001|Overall Study|Lost to Follow-up|0|||
127531924|NCT04950465|458910435|FG002|Overall Study|Lost to Follow-up|0|||
127531925|NCT02366195|458910439|FG000|Overall Study|Protocol-specified criteria|3|||
127531926|NCT02366195|458910439|FG000|Overall Study|Withdrawal by Subject|9|||
127531927|NCT02366195|458910439|FG000|Overall Study|Lost to Follow-up|1|||
127531928|NCT02366195|458910439|FG000|Overall Study|Death|41|||
127531929|NCT02741635|458910440|FG000|Overall Study|Withdrawal by Subject|1|||
127531930|NCT01427933|458910441|FG000|Overall Study|Withdrawal by Subject|5|||
127531931|NCT01427933|458910442|FG001|Overall Study|Withdrawal by Subject|8|||
127531932|NCT01427933|458910441|FG000|Overall Study|Lost to Follow-up|1|||
127531933|NCT01427933|458910442|FG001|Overall Study|Lost to Follow-up|5|||
127531934|NCT01427933|458910441|FG000|Overall Study|Other|1|||
127531935|NCT01427933|458910442|FG001|Overall Study|Other|0|||
127531936|NCT01427933|458910441|FG000|Overall Study|Investigator's Decision|1|||
127531937|NCT01427933|458910442|FG001|Overall Study|Investigator's Decision|0|||
127531938|NCT01633541|458910445|FG000|Overall Study|Death|1|||
127531939|NCT01633541|458910446|FG001|Overall Study|Death|0|||
127531940|NCT03472326|458910447|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
127531941|NCT03472326|458910448|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
127531942|NCT03472326|458910449|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
127531943|NCT03472326|458910450|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
127531944|NCT03472326|458910447|FG000|Part 2: Combination Therapy|Pregnancy|0|||
127531945|NCT03472326|458910448|FG001|Part 2: Combination Therapy|Pregnancy|0|||
127531946|NCT03472326|458910449|FG002|Part 2: Combination Therapy|Pregnancy|0|||
127531947|NCT03472326|458910450|FG003|Part 2: Combination Therapy|Pregnancy|1|||
127531948|NCT01010971|458910451|FG000|Overall Study|Adverse Event|2|||
127531949|NCT01010971|458910452|FG001|Overall Study|Adverse Event|4|||
127531950|NCT01010971|458910453|FG002|Overall Study|Adverse Event|3|||
127531951|NCT01010971|458910451|FG000|Overall Study|Withdrawal by Subject|0|||
127531952|NCT01010971|458910452|FG001|Overall Study|Withdrawal by Subject|2|||
127531953|NCT01010971|458910453|FG002|Overall Study|Withdrawal by Subject|5|||
127531954|NCT01010971|458910451|FG000|Overall Study|Lost to Follow-up|0|||
127531955|NCT01010971|458910452|FG001|Overall Study|Lost to Follow-up|2|||
127531956|NCT01010971|458910453|FG002|Overall Study|Lost to Follow-up|3|||
127531957|NCT01010971|458910451|FG000|Overall Study|Other|1|||
127531958|NCT01010971|458910452|FG001|Overall Study|Other|0|||
127531959|NCT01010971|458910453|FG002|Overall Study|Other|2|||
127531960|NCT03386721|458910454|FG000|Overall Study|Death|12|||
127531961|NCT03386721|458910455|FG001|Overall Study|Death|21|||
127531962|NCT03386721|458910456|FG002|Overall Study|Death|2|||
127531963|NCT03386721|458910457|FG003|Overall Study|Death|5|||
127531964|NCT03386721|458910458|FG004|Overall Study|Death|1|||
127531965|NCT03386721|458910459|FG005|Overall Study|Death|12|||
127531966|NCT03386721|458910460|FG006|Overall Study|Death|1|||
127531967|NCT03386721|458910461|FG007|Overall Study|Death|1|||
127531968|NCT03386721|458910462|FG008|Overall Study|Death|12|||
127531969|NCT03386721|458910463|FG009|Overall Study|Death|20|||
127531970|NCT03386721|458910464|FG010|Overall Study|Death|21|||
127531971|NCT03386721|458910465|FG011|Overall Study|Death|21|||
127531972|NCT03386721|458910466|FG012|Overall Study|Death|14|||
127531973|NCT03386721|458910467|FG013|Overall Study|Death|2|||
127531974|NCT03386721|458910468|FG014|Overall Study|Death|1|||
127531975|NCT03386721|458910454|FG000|Overall Study|Lost to Follow-up|1|||
127531976|NCT03386721|458910455|FG001|Overall Study|Lost to Follow-up|3|||
127531977|NCT03386721|458910456|FG002|Overall Study|Lost to Follow-up|0|||
127531978|NCT03386721|458910457|FG003|Overall Study|Lost to Follow-up|0|||
127531979|NCT03386721|458910458|FG004|Overall Study|Lost to Follow-up|0|||
127531980|NCT03386721|458910459|FG005|Overall Study|Lost to Follow-up|2|||
127531981|NCT03386721|458910460|FG006|Overall Study|Lost to Follow-up|1|||
127531982|NCT03386721|458910461|FG007|Overall Study|Lost to Follow-up|0|||
127531983|NCT03386721|458910462|FG008|Overall Study|Lost to Follow-up|1|||
127531984|NCT03386721|458910463|FG009|Overall Study|Lost to Follow-up|2|||
127531985|NCT03386721|458910464|FG010|Overall Study|Lost to Follow-up|1|||
127531986|NCT03386721|458910465|FG011|Overall Study|Lost to Follow-up|0|||
127531987|NCT03386721|458910466|FG012|Overall Study|Lost to Follow-up|0|||
127531988|NCT03386721|458910467|FG013|Overall Study|Lost to Follow-up|0|||
127531989|NCT03386721|458910468|FG014|Overall Study|Lost to Follow-up|0|||
127531990|NCT03386721|458910454|FG000|Overall Study|Reason not specified|3|||
127531991|NCT03386721|458910455|FG001|Overall Study|Reason not specified|0|||
127531992|NCT03386721|458910456|FG002|Overall Study|Reason not specified|0|||
127531993|NCT03386721|458910457|FG003|Overall Study|Reason not specified|0|||
127531994|NCT03386721|458910458|FG004|Overall Study|Reason not specified|0|||
127531995|NCT03386721|458910459|FG005|Overall Study|Reason not specified|3|||
127531996|NCT03386721|458910460|FG006|Overall Study|Reason not specified|1|||
127531997|NCT03386721|458910461|FG007|Overall Study|Reason not specified|0|||
127531998|NCT03386721|458910462|FG008|Overall Study|Reason not specified|0|||
127531999|NCT03386721|458910463|FG009|Overall Study|Reason not specified|1|||
127532000|NCT03386721|458910464|FG010|Overall Study|Reason not specified|2|||
127532001|NCT03386721|458910465|FG011|Overall Study|Reason not specified|6|||
127532002|NCT03386721|458910466|FG012|Overall Study|Reason not specified|1|||
127532003|NCT03386721|458910467|FG013|Overall Study|Reason not specified|0|||
127532004|NCT03386721|458910468|FG014|Overall Study|Reason not specified|0|||
127532005|NCT03386721|458910454|FG000|Overall Study|Progressive Disease|0|||
127532006|NCT03386721|458910455|FG001|Overall Study|Progressive Disease|0|||
127532007|NCT03386721|458910456|FG002|Overall Study|Progressive Disease|1|||
127532008|NCT03386721|458910457|FG003|Overall Study|Progressive Disease|0|||
127532009|NCT03386721|458910458|FG004|Overall Study|Progressive Disease|0|||
127532010|NCT03386721|458910459|FG005|Overall Study|Progressive Disease|1|||
127532011|NCT03386721|458910460|FG006|Overall Study|Progressive Disease|0|||
127532012|NCT03386721|458910461|FG007|Overall Study|Progressive Disease|0|||
127532013|NCT03386721|458910462|FG008|Overall Study|Progressive Disease|2|||
127532014|NCT03386721|458910463|FG009|Overall Study|Progressive Disease|1|||
127532015|NCT03386721|458910464|FG010|Overall Study|Progressive Disease|1|||
127532016|NCT03386721|458910465|FG011|Overall Study|Progressive Disease|0|||
127532017|NCT03386721|458910466|FG012|Overall Study|Progressive Disease|1|||
127532018|NCT03386721|458910467|FG013|Overall Study|Progressive Disease|0|||
127532019|NCT03386721|458910468|FG014|Overall Study|Progressive Disease|0|||
127532020|NCT03386721|458910454|FG000|Overall Study|Site Terminated by Sponsor|5|||
127532021|NCT03386721|458910455|FG001|Overall Study|Site Terminated by Sponsor|5|||
127532022|NCT03386721|458910456|FG002|Overall Study|Site Terminated by Sponsor|0|||
127532023|NCT03386721|458910457|FG003|Overall Study|Site Terminated by Sponsor|0|||
127532024|NCT03386721|458910458|FG004|Overall Study|Site Terminated by Sponsor|1|||
127532025|NCT03386721|458910459|FG005|Overall Study|Site Terminated by Sponsor|3|||
127532026|NCT03386721|458910460|FG006|Overall Study|Site Terminated by Sponsor|0|||
127532027|NCT03386721|458910461|FG007|Overall Study|Site Terminated by Sponsor|1|||
127532028|NCT03386721|458910462|FG008|Overall Study|Site Terminated by Sponsor|4|||
127532029|NCT03386721|458910463|FG009|Overall Study|Site Terminated by Sponsor|5|||
127532030|NCT03386721|458910464|FG010|Overall Study|Site Terminated by Sponsor|3|||
127532031|NCT03386721|458910465|FG011|Overall Study|Site Terminated by Sponsor|11|||
127532032|NCT03386721|458910466|FG012|Overall Study|Site Terminated by Sponsor|6|||
127532033|NCT03386721|458910467|FG013|Overall Study|Site Terminated by Sponsor|0|||
127532034|NCT03386721|458910468|FG014|Overall Study|Site Terminated by Sponsor|0|||
127532035|NCT03386721|458910454|FG000|Overall Study|Symptomatic Deterioration|0|||
127532036|NCT03386721|458910455|FG001|Overall Study|Symptomatic Deterioration|0|||
127532037|NCT03386721|458910456|FG002|Overall Study|Symptomatic Deterioration|0|||
127532038|NCT03386721|458910457|FG003|Overall Study|Symptomatic Deterioration|0|||
127532039|NCT03386721|458910458|FG004|Overall Study|Symptomatic Deterioration|0|||
127532040|NCT03386721|458910459|FG005|Overall Study|Symptomatic Deterioration|0|||
127532041|NCT03386721|458910460|FG006|Overall Study|Symptomatic Deterioration|0|||
127532042|NCT03386721|458910461|FG007|Overall Study|Symptomatic Deterioration|0|||
127532043|NCT03386721|458910462|FG008|Overall Study|Symptomatic Deterioration|1|||
127532044|NCT03386721|458910463|FG009|Overall Study|Symptomatic Deterioration|0|||
127532045|NCT03386721|458910464|FG010|Overall Study|Symptomatic Deterioration|0|||
127532046|NCT03386721|458910465|FG011|Overall Study|Symptomatic Deterioration|1|||
127532047|NCT03386721|458910466|FG012|Overall Study|Symptomatic Deterioration|0|||
127532048|NCT03386721|458910467|FG013|Overall Study|Symptomatic Deterioration|0|||
127532049|NCT03386721|458910468|FG014|Overall Study|Symptomatic Deterioration|0|||
127532050|NCT03386721|458910454|FG000|Overall Study|Withdrawal by Subject|1|||
127532051|NCT03386721|458910455|FG001|Overall Study|Withdrawal by Subject|2|||
127532052|NCT03386721|458910456|FG002|Overall Study|Withdrawal by Subject|0|||
127532053|NCT03386721|458910457|FG003|Overall Study|Withdrawal by Subject|0|||
127532054|NCT03386721|458910458|FG004|Overall Study|Withdrawal by Subject|0|||
127532055|NCT03386721|458910459|FG005|Overall Study|Withdrawal by Subject|0|||
127532056|NCT03386721|458910460|FG006|Overall Study|Withdrawal by Subject|0|||
127532057|NCT03386721|458910461|FG007|Overall Study|Withdrawal by Subject|0|||
127532058|NCT03386721|458910462|FG008|Overall Study|Withdrawal by Subject|2|||
127532059|NCT03386721|458910463|FG009|Overall Study|Withdrawal by Subject|1|||
127532060|NCT03386721|458910464|FG010|Overall Study|Withdrawal by Subject|3|||
127532061|NCT03386721|458910465|FG011|Overall Study|Withdrawal by Subject|2|||
127532062|NCT03386721|458910466|FG012|Overall Study|Withdrawal by Subject|3|||
127532063|NCT03386721|458910467|FG013|Overall Study|Withdrawal by Subject|0|||
127532064|NCT03386721|458910468|FG014|Overall Study|Withdrawal by Subject|0|||
127532065|NCT05114473|458910469|FG000|Overall Study|Lost to Follow-up|2|||
127532066|NCT05114473|458910470|FG001|Overall Study|Lost to Follow-up|2|||
127532067|NCT05114473|458910471|FG002|Overall Study|Lost to Follow-up|0|||
127532068|NCT01369784|458910474|FG000|Overall Study|Protocol Violation|12|||
127532069|NCT02905266|458910475|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
127532070|NCT02905266|458910476|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
127532071|NCT02905266|458910475|FG000|Treatment Phase Part 1|Disease Progression|6|||
127532072|NCT02905266|458910476|FG001|Treatment Phase Part 1|Disease Progression|7|||
127532073|NCT02905266|458910475|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
127532074|NCT02905266|458910476|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
127532075|NCT02905266|458910475|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
127532076|NCT02905266|458910476|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
127532077|NCT02905266|458910475|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
127532078|NCT02905266|458910476|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
127532079|NCT02905266|458910475|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
127532080|NCT02905266|458910476|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
127532081|NCT02905266|458910475|FG000|Transition From Part 1 to Part 2|Death|0|||
127532082|NCT02905266|458910476|FG001|Transition From Part 1 to Part 2|Death|1|||
127532083|NCT02905266|458910475|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
127532084|NCT02905266|458910476|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
127532085|NCT02905266|458910475|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
127532086|NCT02905266|458910476|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
127532087|NCT02905266|458910475|FG000|Maintenance Phase Part 2|Disease Progression|9|||
127532088|NCT02905266|458910476|FG001|Maintenance Phase Part 2|Disease Progression|2|||
127532089|NCT02905266|458910475|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
127532090|NCT02905266|458910476|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
127532091|NCT02905266|458910475|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
127532092|NCT02905266|458910476|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
127532093|NCT04378270|458910483|FG000|Overall Study|Lack of Efficacy|1|||
127532094|NCT04378270|458910483|FG000|Overall Study|Withdrawal by Subject|1|||
127532095|NCT04378270|458910483|FG000|Overall Study|Screen Failure|1|||
127532096|NCT04378270|458910483|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
127532097|NCT01132313|458910484|FG000|Overall Study|Lack of Efficacy|1|||
127532098|NCT01132313|458910485|FG001|Overall Study|Lack of Efficacy|0|||
127532099|NCT01132313|458910486|FG002|Overall Study|Lack of Efficacy|0|||
127532100|NCT01132313|458910487|FG003|Overall Study|Lack of Efficacy|0|||
127532101|NCT01132313|458910488|FG004|Overall Study|Lack of Efficacy|0|||
127532102|NCT01132313|458910489|FG005|Overall Study|Lack of Efficacy|0|||
127532103|NCT01132313|458910490|FG006|Overall Study|Lack of Efficacy|0|||
127532104|NCT01132313|458910491|FG007|Overall Study|Lack of Efficacy|3|||
127532105|NCT01132313|458910492|FG008|Overall Study|Lack of Efficacy|14|||
127532106|NCT01132313|458910493|FG009|Overall Study|Lack of Efficacy|16|||
127532107|NCT01132313|458910494|FG010|Overall Study|Lack of Efficacy|0|||
127532108|NCT01132313|458910495|FG011|Overall Study|Lack of Efficacy|0|||
127532109|NCT01132313|458910484|FG000|Overall Study|Not treated|2|||
127532110|NCT01132313|458910485|FG001|Overall Study|Not treated|0|||
127532111|NCT01132313|458910486|FG002|Overall Study|Not treated|0|||
127532112|NCT01132313|458910487|FG003|Overall Study|Not treated|0|||
127532113|NCT01132313|458910488|FG004|Overall Study|Not treated|2|||
127532114|NCT01132313|458910489|FG005|Overall Study|Not treated|1|||
127532115|NCT01132313|458910490|FG006|Overall Study|Not treated|3|||
127532116|NCT01132313|458910491|FG007|Overall Study|Not treated|0|||
127532117|NCT01132313|458910492|FG008|Overall Study|Not treated|0|||
127532118|NCT01132313|458910493|FG009|Overall Study|Not treated|0|||
127532119|NCT01132313|458910494|FG010|Overall Study|Not treated|0|||
127532120|NCT01132313|458910495|FG011|Overall Study|Not treated|0|||
127532121|NCT01132313|458910484|FG000|Overall Study|Adverse Event|0|||
127532122|NCT01132313|458910485|FG001|Overall Study|Adverse Event|0|||
127532123|NCT01132313|458910486|FG002|Overall Study|Adverse Event|4|||
127532124|NCT01132313|458910487|FG003|Overall Study|Adverse Event|10|||
127532125|NCT01132313|458910488|FG004|Overall Study|Adverse Event|19|||
127532126|NCT01132313|458910489|FG005|Overall Study|Adverse Event|6|||
127532127|NCT01132313|458910490|FG006|Overall Study|Adverse Event|5|||
127532128|NCT01132313|458910491|FG007|Overall Study|Adverse Event|3|||
127532129|NCT01132313|458910492|FG008|Overall Study|Adverse Event|7|||
127532130|NCT01132313|458910493|FG009|Overall Study|Adverse Event|2|||
127532131|NCT01132313|458910494|FG010|Overall Study|Adverse Event|0|||
127532132|NCT01132313|458910495|FG011|Overall Study|Adverse Event|0|||
127532133|NCT01132313|458910484|FG000|Overall Study|Protocol Violation|0|||
127532134|NCT01132313|458910485|FG001|Overall Study|Protocol Violation|0|||
127532135|NCT01132313|458910486|FG002|Overall Study|Protocol Violation|0|||
127532136|NCT01132313|458910487|FG003|Overall Study|Protocol Violation|1|||
127532137|NCT01132313|458910488|FG004|Overall Study|Protocol Violation|0|||
127532138|NCT01132313|458910489|FG005|Overall Study|Protocol Violation|0|||
127532139|NCT01132313|458910490|FG006|Overall Study|Protocol Violation|0|||
127532140|NCT01132313|458910491|FG007|Overall Study|Protocol Violation|0|||
127532141|NCT01132313|458910492|FG008|Overall Study|Protocol Violation|0|||
127532142|NCT01132313|458910493|FG009|Overall Study|Protocol Violation|0|||
127532143|NCT01132313|458910494|FG010|Overall Study|Protocol Violation|0|||
127532144|NCT01132313|458910495|FG011|Overall Study|Protocol Violation|0|||
127532145|NCT01132313|458910484|FG000|Overall Study|Lost to Follow-up|0|||
127532146|NCT01132313|458910485|FG001|Overall Study|Lost to Follow-up|0|||
127532147|NCT01132313|458910486|FG002|Overall Study|Lost to Follow-up|1|||
127532148|NCT01132313|458910487|FG003|Overall Study|Lost to Follow-up|0|||
127532149|NCT01132313|458910488|FG004|Overall Study|Lost to Follow-up|0|||
127532150|NCT01132313|458910489|FG005|Overall Study|Lost to Follow-up|0|||
127532151|NCT01132313|458910490|FG006|Overall Study|Lost to Follow-up|0|||
127532152|NCT01132313|458910491|FG007|Overall Study|Lost to Follow-up|1|||
127532153|NCT01132313|458910492|FG008|Overall Study|Lost to Follow-up|0|||
127532154|NCT01132313|458910493|FG009|Overall Study|Lost to Follow-up|0|||
127532155|NCT01132313|458910494|FG010|Overall Study|Lost to Follow-up|0|||
127532156|NCT01132313|458910495|FG011|Overall Study|Lost to Follow-up|0|||
127532157|NCT01132313|458910484|FG000|Overall Study|Withdrawal by Subject|0|||
127532158|NCT01132313|458910485|FG001|Overall Study|Withdrawal by Subject|0|||
127532159|NCT01132313|458910486|FG002|Overall Study|Withdrawal by Subject|3|||
127532160|NCT01132313|458910487|FG003|Overall Study|Withdrawal by Subject|3|||
127532161|NCT01132313|458910488|FG004|Overall Study|Withdrawal by Subject|6|||
127532162|NCT01132313|458910489|FG005|Overall Study|Withdrawal by Subject|0|||
127532163|NCT01132313|458910490|FG006|Overall Study|Withdrawal by Subject|1|||
127532164|NCT01132313|458910491|FG007|Overall Study|Withdrawal by Subject|0|||
127532165|NCT01132313|458910492|FG008|Overall Study|Withdrawal by Subject|0|||
127532166|NCT01132313|458910493|FG009|Overall Study|Withdrawal by Subject|2|||
127532167|NCT01132313|458910494|FG010|Overall Study|Withdrawal by Subject|0|||
127532168|NCT01132313|458910495|FG011|Overall Study|Withdrawal by Subject|0|||
127532169|NCT01132313|458910484|FG000|Overall Study|Lack of antiviral response|0|||
127532170|NCT01132313|458910485|FG001|Overall Study|Lack of antiviral response|0|||
127532171|NCT01132313|458910486|FG002|Overall Study|Lack of antiviral response|12|||
127532172|NCT01132313|458910487|FG003|Overall Study|Lack of antiviral response|18|||
127532173|NCT01132313|458910488|FG004|Overall Study|Lack of antiviral response|18|||
127532174|NCT01132313|458910489|FG005|Overall Study|Lack of antiviral response|18|||
127532175|NCT01132313|458910490|FG006|Overall Study|Lack of antiviral response|21|||
127532176|NCT01132313|458910491|FG007|Overall Study|Lack of antiviral response|0|||
127532177|NCT01132313|458910492|FG008|Overall Study|Lack of antiviral response|0|||
127532178|NCT01132313|458910493|FG009|Overall Study|Lack of antiviral response|0|||
127532179|NCT01132313|458910494|FG010|Overall Study|Lack of antiviral response|1|||
127532180|NCT01132313|458910495|FG011|Overall Study|Lack of antiviral response|0|||
127532181|NCT01132313|458910484|FG000|Overall Study|Other reason not defined above|0|||
127532182|NCT01132313|458910485|FG001|Overall Study|Other reason not defined above|0|||
127532183|NCT01132313|458910486|FG002|Overall Study|Other reason not defined above|0|||
127532184|NCT01132313|458910487|FG003|Overall Study|Other reason not defined above|0|||
127532185|NCT01132313|458910488|FG004|Overall Study|Other reason not defined above|0|||
127532186|NCT01132313|458910489|FG005|Overall Study|Other reason not defined above|0|||
127532187|NCT01132313|458910490|FG006|Overall Study|Other reason not defined above|0|||
127532188|NCT01132313|458910491|FG007|Overall Study|Other reason not defined above|1|||
127532189|NCT01132313|458910492|FG008|Overall Study|Other reason not defined above|0|||
127532190|NCT01132313|458910493|FG009|Overall Study|Other reason not defined above|0|||
127532191|NCT01132313|458910494|FG010|Overall Study|Other reason not defined above|0|||
127532192|NCT01132313|458910495|FG011|Overall Study|Other reason not defined above|0|||
127532193|NCT02715609|458910497|FG000|Overall Study|Patient only completed pre-operative treatment|1|||
127532194|NCT02715609|458910498|FG001|Overall Study|Patient only completed pre-operative treatment|0|||
127532195|NCT02715609|458910499|FG002|Overall Study|Patient only completed pre-operative treatment|0|||
127532196|NCT02715609|458910497|FG000|Overall Study|Withdrawal by Subject|0|||
127532197|NCT02715609|458910498|FG001|Overall Study|Withdrawal by Subject|0|||
127532198|NCT02715609|458910499|FG002|Overall Study|Withdrawal by Subject|1|||
127532199|NCT03201419|458910500|FG000|Overall Study|Adverse Event|3|||
127532200|NCT03201419|458910501|FG001|Overall Study|Adverse Event|1|||
127532201|NCT03201419|458910502|FG002|Overall Study|Adverse Event|0|||
127532202|NCT03201419|458910503|FG003|Overall Study|Adverse Event|0|||
127532203|NCT03201419|458910504|FG004|Overall Study|Adverse Event|1|||
127532204|NCT03201419|458910505|FG005|Overall Study|Adverse Event|1|||
127532205|NCT03201419|458910506|FG006|Overall Study|Adverse Event|5|||
127532206|NCT03201419|458910507|FG007|Overall Study|Adverse Event|0|||
127532207|NCT03201419|458910508|FG008|Overall Study|Adverse Event|0|||
127532208|NCT03201419|458910500|FG000|Overall Study|Lost to Follow-up|1|||
127532209|NCT03201419|458910501|FG001|Overall Study|Lost to Follow-up|0|||
127532210|NCT03201419|458910502|FG002|Overall Study|Lost to Follow-up|0|||
127532211|NCT03201419|458910503|FG003|Overall Study|Lost to Follow-up|0|||
127532212|NCT03201419|458910504|FG004|Overall Study|Lost to Follow-up|0|||
127532213|NCT03201419|458910505|FG005|Overall Study|Lost to Follow-up|0|||
127532214|NCT03201419|458910506|FG006|Overall Study|Lost to Follow-up|0|||
127532215|NCT03201419|458910507|FG007|Overall Study|Lost to Follow-up|0|||
127532216|NCT03201419|458910508|FG008|Overall Study|Lost to Follow-up|0|||
127532217|NCT03201419|458910500|FG000|Overall Study|Protocol Deviation|0|||
127532218|NCT03201419|458910501|FG001|Overall Study|Protocol Deviation|0|||
127532219|NCT03201419|458910502|FG002|Overall Study|Protocol Deviation|0|||
127532220|NCT03201419|458910503|FG003|Overall Study|Protocol Deviation|0|||
127532221|NCT03201419|458910504|FG004|Overall Study|Protocol Deviation|0|||
127532222|NCT03201419|458910505|FG005|Overall Study|Protocol Deviation|0|||
127532223|NCT03201419|458910506|FG006|Overall Study|Protocol Deviation|1|||
127532224|NCT03201419|458910507|FG007|Overall Study|Protocol Deviation|0|||
127532225|NCT03201419|458910508|FG008|Overall Study|Protocol Deviation|0|||
127532226|NCT03201419|458910500|FG000|Overall Study|Withdrawal by Subject|4|||
127532227|NCT03201419|458910501|FG001|Overall Study|Withdrawal by Subject|2|||
127532228|NCT03201419|458910502|FG002|Overall Study|Withdrawal by Subject|1|||
127532229|NCT03201419|458910503|FG003|Overall Study|Withdrawal by Subject|0|||
127532230|NCT03201419|458910504|FG004|Overall Study|Withdrawal by Subject|0|||
127532231|NCT03201419|458910505|FG005|Overall Study|Withdrawal by Subject|0|||
127532232|NCT03201419|458910506|FG006|Overall Study|Withdrawal by Subject|0|||
127532233|NCT03201419|458910507|FG007|Overall Study|Withdrawal by Subject|1|||
127532234|NCT03201419|458910508|FG008|Overall Study|Withdrawal by Subject|2|||
127532235|NCT03201419|458910500|FG000|Overall Study|Other|0|||
127532236|NCT03201419|458910501|FG001|Overall Study|Other|0|||
127532237|NCT03201419|458910502|FG002|Overall Study|Other|1|||
127532238|NCT03201419|458910503|FG003|Overall Study|Other|0|||
127532239|NCT03201419|458910504|FG004|Overall Study|Other|0|||
127532240|NCT03201419|458910505|FG005|Overall Study|Other|0|||
127532241|NCT03201419|458910506|FG006|Overall Study|Other|0|||
127532242|NCT03201419|458910507|FG007|Overall Study|Other|0|||
127532243|NCT03201419|458910508|FG008|Overall Study|Other|0|||
127532244|NCT05907395|458910511|FG000|Period 1|No longer met eligibility criteria|0|||
127532245|NCT05907395|458910512|FG001|Period 1|No longer met eligibility criteria|1|||
127532246|NCT05907395|458910513|FG002|Period 1|No longer met eligibility criteria|0|||
127532247|NCT05907395|458910514|FG003|Period 1|No longer met eligibility criteria|0|||
127532248|NCT05907395|458910515|FG004|Period 1|No longer met eligibility criteria|0|||
127532249|NCT05907395|458910516|FG005|Period 1|No longer met eligibility criteria|1|||
127532250|NCT05907395|458910517|FG006|Period 1|No longer met eligibility criteria|1|||
127532251|NCT05907395|458910518|FG007|Period 1|No longer met eligibility criteria|0|||
127532252|NCT05907395|458910519|FG008|Period 1|No longer met eligibility criteria|0|||
127532253|NCT05907395|458910520|FG009|Period 1|No longer met eligibility criteria|0|||
127532254|NCT05907395|458910521|FG010|Period 1|No longer met eligibility criteria|0|||
127532255|NCT05907395|458910522|FG011|Period 1|No longer met eligibility criteria|0|||
127532256|NCT05907395|458910511|FG000|Period 2|Adverse Event|0|||
127532257|NCT05907395|458910512|FG001|Period 2|Adverse Event|0|||
127532258|NCT05907395|458910513|FG002|Period 2|Adverse Event|0|||
127532259|NCT05907395|458910514|FG003|Period 2|Adverse Event|1|||
127532260|NCT05907395|458910515|FG004|Period 2|Adverse Event|0|||
127532261|NCT05907395|458910516|FG005|Period 2|Adverse Event|0|||
127532262|NCT05907395|458910517|FG006|Period 2|Adverse Event|0|||
127532263|NCT05907395|458910518|FG007|Period 2|Adverse Event|1|||
127532264|NCT05907395|458910519|FG008|Period 2|Adverse Event|0|||
127532265|NCT05907395|458910520|FG009|Period 2|Adverse Event|0|||
127532266|NCT05907395|458910521|FG010|Period 2|Adverse Event|0|||
127532267|NCT05907395|458910522|FG011|Period 2|Adverse Event|0|||
127532268|NCT05907395|458910511|FG000|Period 2|Personal reason|0|||
127532269|NCT05907395|458910512|FG001|Period 2|Personal reason|0|||
127532270|NCT05907395|458910513|FG002|Period 2|Personal reason|0|||
127532271|NCT05907395|458910514|FG003|Period 2|Personal reason|0|||
127532272|NCT05907395|458910515|FG004|Period 2|Personal reason|0|||
127532273|NCT05907395|458910516|FG005|Period 2|Personal reason|0|||
127532274|NCT05907395|458910517|FG006|Period 2|Personal reason|0|||
127532275|NCT05907395|458910518|FG007|Period 2|Personal reason|0|||
127532276|NCT05907395|458910519|FG008|Period 2|Personal reason|0|||
127532277|NCT05907395|458910520|FG009|Period 2|Personal reason|1|||
127532278|NCT05907395|458910521|FG010|Period 2|Personal reason|0|||
127532279|NCT05907395|458910522|FG011|Period 2|Personal reason|0|||
127532280|NCT05907395|458910511|FG000|Period 3|Adverse Event|0|||
127532281|NCT05907395|458910512|FG001|Period 3|Adverse Event|0|||
127532282|NCT05907395|458910513|FG002|Period 3|Adverse Event|0|||
127532283|NCT05907395|458910514|FG003|Period 3|Adverse Event|0|||
127532284|NCT05907395|458910515|FG004|Period 3|Adverse Event|1|||
127532285|NCT05907395|458910516|FG005|Period 3|Adverse Event|0|||
127532286|NCT05907395|458910517|FG006|Period 3|Adverse Event|0|||
127532287|NCT05907395|458910518|FG007|Period 3|Adverse Event|0|||
127532288|NCT05907395|458910519|FG008|Period 3|Adverse Event|0|||
127532289|NCT05907395|458910520|FG009|Period 3|Adverse Event|0|||
127532290|NCT05907395|458910521|FG010|Period 3|Adverse Event|0|||
127532291|NCT05907395|458910522|FG011|Period 3|Adverse Event|0|||
127532292|NCT04544956|458910523|FG000|Overall Study|Withdrawal by Subject|1|||
127532293|NCT04896593|458910524|FG000|Overall Study|Withdrawal by Subject|2|||
127532294|NCT04896593|458910524|FG000|Overall Study|Lost to Follow-up|1|||
127532295|NCT04896593|458910524|FG000|Overall Study|Did not complete onboarding|2|||
127532296|NCT02777827|458910525|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
127532297|NCT02777827|458910526|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
127532298|NCT02777827|458910527|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
127532299|NCT02777827|458910528|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
127532300|NCT02777827|458910529|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
127532301|NCT02777827|458910530|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
127532302|NCT04178720|458910531|FG000|Overall Study|Withdrawal by Subject|2|||
127532303|NCT04178720|458910532|FG001|Overall Study|Withdrawal by Subject|0|||
127532304|NCT04178720|458910531|FG000|Overall Study|Relocation|0|||
127532305|NCT04178720|458910532|FG001|Overall Study|Relocation|1|||
127532306|NCT01792115|458910533|FG000|Overall Study|Lost to Follow-up|0|||
127532307|NCT01792115|458910534|FG001|Overall Study|Lost to Follow-up|1|||
127532308|NCT01792115|458910535|FG002|Overall Study|Lost to Follow-up|0|||
127532309|NCT03191630|458912530|FG000|Overall Study|Lost to Follow-up|7|||
127532310|NCT03191630|458912531|FG001|Overall Study|Lost to Follow-up|7|||
127532311|NCT01367834|458912538|FG000|Overall Study|Withdrawal by Subject|2|||
127532312|NCT01367834|458912539|FG001|Overall Study|Withdrawal by Subject|2|||
127532313|NCT01367834|458912538|FG000|Overall Study|Study was ended.|0|||
127532314|NCT01367834|458912539|FG001|Overall Study|Study was ended.|1|||
127532315|NCT01818596|458912547|FG000|Overall Study|Enrolled but Not Treated|4|||
127532316|NCT01818596|458912548|FG001|Overall Study|Enrolled but Not Treated|0|||
127532317|NCT01818596|458912547|FG000|Overall Study|Adverse Event|7|||
127532318|NCT01818596|458912548|FG001|Overall Study|Adverse Event|0|||
127532319|NCT01818596|458912547|FG000|Overall Study|Death|3|||
127532320|NCT01818596|458912548|FG001|Overall Study|Death|0|||
127532321|NCT01818596|458912547|FG000|Overall Study|Investigator's Discretion|4|||
127532322|NCT01818596|458912548|FG001|Overall Study|Investigator's Discretion|0|||
127532323|NCT01818596|458912547|FG000|Overall Study|Protocol Violation|1|||
127532324|NCT01818596|458912548|FG001|Overall Study|Protocol Violation|0|||
127532325|NCT01818596|458912547|FG000|Overall Study|Withdrew Consent|5|||
127532326|NCT01818596|458912548|FG001|Overall Study|Withdrew Consent|0|||
127532327|NCT01818596|458912547|FG000|Overall Study|Lost to Follow-up|7|||
127532328|NCT01818596|458912548|FG001|Overall Study|Lost to Follow-up|0|||
127532329|NCT03801174|458912549|FG000|Overall Study|Withdrawal by Subject|14|||
127532330|NCT03801174|458912550|FG001|Overall Study|Withdrawal by Subject|15|||
127532331|NCT03801174|458912549|FG000|Overall Study|Death|1|||
127532332|NCT03801174|458912550|FG001|Overall Study|Death|0|||
127532333|NCT03801174|458912549|FG000|Overall Study|Pregnancy|2|||
127532334|NCT03801174|458912550|FG001|Overall Study|Pregnancy|2|||
127532335|NCT03801174|458912549|FG000|Overall Study|Lost to Follow-up|19|||
127532336|NCT03801174|458912550|FG001|Overall Study|Lost to Follow-up|10|||
127532337|NCT03801174|458912549|FG000|Overall Study|Other|4|||
127532338|NCT03801174|458912550|FG001|Overall Study|Other|3|||
127532339|NCT03801174|458912549|FG000|Overall Study|Lack of Efficacy|4|||
127532340|NCT03801174|458912550|FG001|Overall Study|Lack of Efficacy|0|||
127532341|NCT03801174|458912549|FG000|Overall Study|Unwilling to complete activities|5|||
127532342|NCT03801174|458912550|FG001|Overall Study|Unwilling to complete activities|6|||
127532343|NCT03801174|458912549|FG000|Overall Study|Moved out of area|3|||
127532344|NCT03801174|458912550|FG001|Overall Study|Moved out of area|0|||
127532345|NCT02915263|458912561|FG000|Overall Study|Covid|3|||
127532346|NCT02915263|458912562|FG001|Overall Study|Covid|2|||
127532347|NCT01879683|458912563|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
127532348|NCT01788566|458912564|FG000|Overall Study|Death|4|||
127532349|NCT01788566|458912564|FG000|Overall Study|Adverse Event|1|||
127532350|NCT01788566|458912564|FG000|Overall Study|Clinical Progressive Disease|3|||
127532351|NCT01620086|458912567|FG000|Overall Study|Withdrawal by Subject|3|||
127532352|NCT01620086|458912568|FG001|Overall Study|Withdrawal by Subject|3|||
127532353|NCT01620086|458912569|FG002|Overall Study|Withdrawal by Subject|0|||
127532354|NCT01620086|458912567|FG000|Overall Study|failed study criteria|1|||
127532355|NCT01620086|458912568|FG001|Overall Study|failed study criteria|4|||
127532356|NCT01620086|458912569|FG002|Overall Study|failed study criteria|0|||
127532357|NCT01620086|458912567|FG000|Overall Study|Physician Decision|1|||
127532358|NCT01620086|458912568|FG001|Overall Study|Physician Decision|0|||
127532359|NCT01620086|458912569|FG002|Overall Study|Physician Decision|0|||
127532360|NCT01695135|458912570|FG000|Double-blind Treatment Phase|Progressive disease|50|||
127532361|NCT01695135|458912571|FG001|Double-blind Treatment Phase|Progressive disease|110|||
127532362|NCT01695135|458912572|FG002|Double-blind Treatment Phase|Progressive disease|0|||
127532363|NCT01695135|458912573|FG003|Double-blind Treatment Phase|Progressive disease|0|||
127532364|NCT01695135|458912570|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
127532365|NCT01695135|458912571|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
127532366|NCT01695135|458912572|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
127532367|NCT01695135|458912573|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
127532368|NCT01695135|458912570|FG000|Double-blind Treatment Phase|Adverse Event|7|||
127532369|NCT01695135|458912571|FG001|Double-blind Treatment Phase|Adverse Event|7|||
127532370|NCT01695135|458912572|FG002|Double-blind Treatment Phase|Adverse Event|0|||
127532371|NCT01695135|458912573|FG003|Double-blind Treatment Phase|Adverse Event|0|||
127532372|NCT01695135|458912570|FG000|Double-blind Treatment Phase|Other|1|||
127532373|NCT01695135|458912571|FG001|Double-blind Treatment Phase|Other|3|||
127532374|NCT01695135|458912572|FG002|Double-blind Treatment Phase|Other|0|||
127532375|NCT01695135|458912573|FG003|Double-blind Treatment Phase|Other|0|||
127532376|NCT01695135|458912570|FG000|Double-blind Treatment Phase|Physician Decision|6|||
127532377|NCT01695135|458912571|FG001|Double-blind Treatment Phase|Physician Decision|3|||
127532378|NCT01695135|458912572|FG002|Double-blind Treatment Phase|Physician Decision|0|||
127532379|NCT01695135|458912573|FG003|Double-blind Treatment Phase|Physician Decision|0|||
127532380|NCT01695135|458912570|FG000|Double-blind Treatment Phase|Death|1|||
127532381|NCT01695135|458912571|FG001|Double-blind Treatment Phase|Death|1|||
127532382|NCT01695135|458912572|FG002|Double-blind Treatment Phase|Death|0|||
127532383|NCT01695135|458912573|FG003|Double-blind Treatment Phase|Death|0|||
127532384|NCT01695135|458912570|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
127532385|NCT01695135|458912571|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
127532386|NCT01695135|458912572|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
127532387|NCT01695135|458912573|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
127532388|NCT01695135|458912570|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
127532389|NCT01695135|458912571|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
127532390|NCT01695135|458912572|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
127532391|NCT01695135|458912573|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
127532392|NCT01695135|458912570|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
127532393|NCT01695135|458912571|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
127532394|NCT01695135|458912572|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
127532395|NCT01695135|458912573|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
127532396|NCT01695135|458912570|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
127532397|NCT01695135|458912571|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
127532398|NCT01695135|458912572|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
127532399|NCT01695135|458912573|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
127532400|NCT01695135|458912570|FG000|Open Label Extension Treatment Phase|Other|0|||
127532401|NCT01695135|458912571|FG001|Open Label Extension Treatment Phase|Other|0|||
127532402|NCT01695135|458912572|FG002|Open Label Extension Treatment Phase|Other|4|||
127532403|NCT01695135|458912573|FG003|Open Label Extension Treatment Phase|Other|7|||
127532404|NCT01695135|458912570|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
127532405|NCT01695135|458912571|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
127532406|NCT01695135|458912572|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
127532407|NCT01695135|458912573|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
127532408|NCT01695135|458912570|FG000|Open Label Extension Treatment Phase|Death|0|||
127532409|NCT01695135|458912571|FG001|Open Label Extension Treatment Phase|Death|0|||
127532410|NCT01695135|458912572|FG002|Open Label Extension Treatment Phase|Death|2|||
127532411|NCT01695135|458912573|FG003|Open Label Extension Treatment Phase|Death|7|||
127532412|NCT01695135|458912570|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
127532413|NCT01695135|458912571|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
127532414|NCT01695135|458912572|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
127532415|NCT01695135|458912573|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
127532416|NCT02562716|458912574|FG000|Overall Study|Adverse Event|7|||
127532417|NCT02562716|458912575|FG001|Overall Study|Adverse Event|14|||
127532418|NCT02562716|458912574|FG000|Overall Study|Withdrawal unrelated to AE|7|||
127532419|NCT02562716|458912575|FG001|Overall Study|Withdrawal unrelated to AE|1|||
127532420|NCT02562716|458912574|FG000|Overall Study|Progression|8|||
127532421|NCT02562716|458912575|FG001|Overall Study|Progression|10|||
127532422|NCT02562716|458912574|FG000|Overall Study|Death|2|||
127532423|NCT02562716|458912575|FG001|Overall Study|Death|1|||
127532424|NCT02562716|458912574|FG000|Overall Study|Not protocol specified|4|||
127532425|NCT02562716|458912575|FG001|Overall Study|Not protocol specified|2|||
127532426|NCT00684996|458912576|FG000|Overall Study|Adverse Event|1|||
127532427|NCT00684996|458912576|FG000|Overall Study|Refusal unrelated to adverse event|1|||
127532428|NCT00684996|458912576|FG000|Overall Study|Progression/relapse|2|||
127532429|NCT00684996|458912576|FG000|Overall Study|Other reasons not protocol specified|1|||
127532430|NCT03030417|458912579|FG000|Dose Expansion|Disease progression before treatment|0|||
127532431|NCT03030417|458912580|FG001|Dose Expansion|Disease progression before treatment|0|||
127532432|NCT03030417|458912581|FG002|Dose Expansion|Disease progression before treatment|0|||
127532433|NCT03030417|458912582|FG003|Dose Expansion|Disease progression before treatment|0|||
127532434|NCT03030417|458912583|FG004|Dose Expansion|Disease progression before treatment|0|||
127532435|NCT03030417|458912584|FG005|Dose Expansion|Disease progression before treatment|0|||
127532436|NCT03030417|458912585|FG006|Dose Expansion|Disease progression before treatment|0|||
127532437|NCT03030417|458912586|FG007|Dose Expansion|Disease progression before treatment|0|||
127532438|NCT03030417|458912587|FG008|Dose Expansion|Disease progression before treatment|0|||
127532439|NCT03030417|458912588|FG009|Dose Expansion|Disease progression before treatment|0|||
127532440|NCT03030417|458912589|FG010|Dose Expansion|Disease progression before treatment|0|||
127532441|NCT03030417|458912590|FG011|Dose Expansion|Disease progression before treatment|0|||
127532442|NCT03030417|458912591|FG012|Dose Expansion|Disease progression before treatment|1|||
127532443|NCT01076959|458912592|FG000|Overall Study|Adverse Event|767|||
127532444|NCT01076959|458912592|FG000|Overall Study|Lack of Efficacy|849|||
127532445|NCT01076959|458912592|FG000|Overall Study|Non-compliance|274|||
127532446|NCT01076959|458912592|FG000|Overall Study|Lost to Follow-up|241|||
127532447|NCT01076959|458912592|FG000|Overall Study|Other|119|||
127532448|NCT01078441|458912593|FG000|Overall Study|Withdrawal by Subject|1|||
127532449|NCT01425801|458912594|FG000|Period 1|Withdrawal by Subject|0|||
127532450|NCT01425801|458912595|FG001|Period 1|Withdrawal by Subject|0|||
127532451|NCT01425801|458912596|FG002|Period 1|Withdrawal by Subject|0|||
127532452|NCT01425801|458912597|FG003|Period 1|Withdrawal by Subject|0|||
127532453|NCT01425801|458912598|FG004|Period 1|Withdrawal by Subject|1|||
127532454|NCT01425801|458912599|FG005|Period 1|Withdrawal by Subject|0|||
127532455|NCT01425801|458912594|FG000|Period 2|Withdrawal by Subject|0|||
127532456|NCT01425801|458912595|FG001|Period 2|Withdrawal by Subject|0|||
127532457|NCT01425801|458912596|FG002|Period 2|Withdrawal by Subject|0|||
127532458|NCT01425801|458912597|FG003|Period 2|Withdrawal by Subject|0|||
127532459|NCT01425801|458912598|FG004|Period 2|Withdrawal by Subject|1|||
127532460|NCT01425801|458912599|FG005|Period 2|Withdrawal by Subject|0|||
127532461|NCT01425801|458912594|FG000|Period 3|Stability criteria not fullfilled|0|||
127532462|NCT01425801|458912595|FG001|Period 3|Stability criteria not fullfilled|0|||
127532463|NCT01425801|458912596|FG002|Period 3|Stability criteria not fullfilled|1|||
127532464|NCT01425801|458912597|FG003|Period 3|Stability criteria not fullfilled|0|||
127532465|NCT01425801|458912598|FG004|Period 3|Stability criteria not fullfilled|0|||
127532466|NCT01425801|458912599|FG005|Period 3|Stability criteria not fullfilled|0|||
127532467|NCT01425801|458912594|FG000|Period 4|Not able to maintain visit schedule|0|||
127532468|NCT01425801|458912595|FG001|Period 4|Not able to maintain visit schedule|0|||
127532469|NCT01425801|458912596|FG002|Period 4|Not able to maintain visit schedule|1|||
127532470|NCT01425801|458912597|FG003|Period 4|Not able to maintain visit schedule|0|||
127532471|NCT01425801|458912598|FG004|Period 4|Not able to maintain visit schedule|0|||
127532472|NCT01425801|458912599|FG005|Period 4|Not able to maintain visit schedule|0|||
127532473|NCT02868554|458912600|FG000|Overall Study|Lost to Follow-up|3|||
127532474|NCT02868554|458912601|FG001|Overall Study|Lost to Follow-up|0|||
127532475|NCT02868554|458912602|FG002|Overall Study|Lost to Follow-up|1|||
127532476|NCT02175017|458912603|FG000|Overall Study|Did not receive the investigational product|1|||
127532477|NCT02175017|458912604|FG001|Overall Study|Did not receive the investigational product|2|||
127532478|NCT02175017|458912603|FG000|Overall Study|Withdrawal by Subject|6|||
127532479|NCT02175017|458912604|FG001|Overall Study|Withdrawal by Subject|3|||
127532480|NCT02175017|458912603|FG000|Overall Study|Met an exclusion criteria|0|||
127532481|NCT02175017|458912604|FG001|Overall Study|Met an exclusion criteria|1|||
127532482|NCT02175017|458912603|FG000|Overall Study|Adverse Event|3|||
127532483|NCT02175017|458912604|FG001|Overall Study|Adverse Event|10|||
127532484|NCT02175017|458912603|FG000|Overall Study|Disease progression|20|||
127532485|NCT02175017|458912604|FG001|Overall Study|Disease progression|27|||
127532486|NCT02175017|458912603|FG000|Overall Study|Other than above reasons|3|||
127532487|NCT02175017|458912604|FG001|Overall Study|Other than above reasons|0|||
127532488|NCT02491983|458912605|FG000|Overall Study|Physician Decision|1|||
127532489|NCT02491983|458912606|FG001|Overall Study|Physician Decision|0|||
127532490|NCT02491983|458912605|FG000|Overall Study|Not meet selection criteria|1|||
127532491|NCT02491983|458912606|FG001|Overall Study|Not meet selection criteria|0|||
127532492|NCT02491983|458912605|FG000|Overall Study|Withdrawal by Subject|0|||
127532493|NCT02491983|458912606|FG001|Overall Study|Withdrawal by Subject|1|||
127532494|NCT02714569|458912607|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
127532495|NCT02714569|458912608|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
127532496|NCT02714569|458912609|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
127532497|NCT02714569|458912610|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
127532498|NCT02714569|458912611|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
127532499|NCT02714569|458912612|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
127532500|NCT02714569|458912613|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
127532501|NCT02714569|458912614|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
127532502|NCT02714569|458912615|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
127532503|NCT02714569|458912616|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
127532504|NCT02714569|458912617|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
127532505|NCT02714569|458912607|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
127532506|NCT02714569|458912608|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
127532507|NCT02714569|458912609|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
127532508|NCT02714569|458912610|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
127532509|NCT02714569|458912611|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
127532510|NCT02714569|458912612|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
127532511|NCT02714569|458912613|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
127532512|NCT02714569|458912614|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
127532513|NCT02714569|458912615|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
127532514|NCT02714569|458912616|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
127532515|NCT02714569|458912617|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
127532516|NCT02714569|458912607|FG000|Part A Third Intervention|Adverse Event|0|||
127532517|NCT02714569|458912608|FG001|Part A Third Intervention|Adverse Event|0|||
127532518|NCT02714569|458912609|FG002|Part A Third Intervention|Adverse Event|1|||
127532519|NCT02714569|458912610|FG003|Part A Third Intervention|Adverse Event|0|||
127532520|NCT02714569|458912611|FG004|Part A Third Intervention|Adverse Event|0|||
127532521|NCT02714569|458912612|FG005|Part A Third Intervention|Adverse Event|0|||
127532522|NCT02714569|458912613|FG006|Part A Third Intervention|Adverse Event|0|||
127532523|NCT02714569|458912614|FG007|Part A Third Intervention|Adverse Event|0|||
127532524|NCT02714569|458912615|FG008|Part A Third Intervention|Adverse Event|0|||
127532525|NCT02714569|458912616|FG009|Part A Third Intervention|Adverse Event|0|||
127532526|NCT02714569|458912617|FG010|Part A Third Intervention|Adverse Event|0|||
127532527|NCT02714569|458912607|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
127532528|NCT02714569|458912608|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
127532529|NCT02714569|458912609|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
127532530|NCT02714569|458912610|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
127532531|NCT02714569|458912611|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
127532532|NCT02714569|458912612|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
127532533|NCT02714569|458912613|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
127532534|NCT02714569|458912614|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
127532535|NCT02714569|458912615|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
127532536|NCT02714569|458912616|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
127532537|NCT02714569|458912617|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
127532538|NCT02714569|458912607|FG000|Part B (Overall)|Lost to Follow-up|0|||
127532539|NCT02714569|458912608|FG001|Part B (Overall)|Lost to Follow-up|0|||
127532540|NCT02714569|458912609|FG002|Part B (Overall)|Lost to Follow-up|0|||
127532541|NCT02714569|458912610|FG003|Part B (Overall)|Lost to Follow-up|0|||
127532542|NCT02714569|458912611|FG004|Part B (Overall)|Lost to Follow-up|0|||
127532543|NCT02714569|458912612|FG005|Part B (Overall)|Lost to Follow-up|0|||
127532544|NCT02714569|458912613|FG006|Part B (Overall)|Lost to Follow-up|1|||
127532545|NCT02714569|458912614|FG007|Part B (Overall)|Lost to Follow-up|0|||
127532546|NCT02714569|458912615|FG008|Part B (Overall)|Lost to Follow-up|0|||
127532547|NCT02714569|458912616|FG009|Part B (Overall)|Lost to Follow-up|0|||
127532548|NCT02714569|458912617|FG010|Part B (Overall)|Lost to Follow-up|0|||
127532549|NCT02714569|458912607|FG000|Part B (Overall)|Withdrawal by Subject|0|||
127532550|NCT02714569|458912608|FG001|Part B (Overall)|Withdrawal by Subject|0|||
127532551|NCT02714569|458912609|FG002|Part B (Overall)|Withdrawal by Subject|0|||
127532552|NCT02714569|458912610|FG003|Part B (Overall)|Withdrawal by Subject|0|||
127532553|NCT02714569|458912611|FG004|Part B (Overall)|Withdrawal by Subject|0|||
127532554|NCT02714569|458912612|FG005|Part B (Overall)|Withdrawal by Subject|0|||
127532555|NCT02714569|458912613|FG006|Part B (Overall)|Withdrawal by Subject|0|||
127532556|NCT02714569|458912614|FG007|Part B (Overall)|Withdrawal by Subject|1|||
127532557|NCT02714569|458912615|FG008|Part B (Overall)|Withdrawal by Subject|0|||
127532558|NCT02714569|458912616|FG009|Part B (Overall)|Withdrawal by Subject|1|||
127532559|NCT02714569|458912617|FG010|Part B (Overall)|Withdrawal by Subject|0|||
127532560|NCT02714569|458912607|FG000|Part B (Overall)|Adverse Event|0|||
127532561|NCT02714569|458912608|FG001|Part B (Overall)|Adverse Event|0|||
127532562|NCT02714569|458912609|FG002|Part B (Overall)|Adverse Event|0|||
127532563|NCT02714569|458912610|FG003|Part B (Overall)|Adverse Event|0|||
127532564|NCT02714569|458912611|FG004|Part B (Overall)|Adverse Event|0|||
127532565|NCT02714569|458912612|FG005|Part B (Overall)|Adverse Event|0|||
127532566|NCT02714569|458912613|FG006|Part B (Overall)|Adverse Event|0|||
127532567|NCT02714569|458912614|FG007|Part B (Overall)|Adverse Event|0|||
127532568|NCT02714569|458912615|FG008|Part B (Overall)|Adverse Event|0|||
127532569|NCT02714569|458912616|FG009|Part B (Overall)|Adverse Event|1|||
127532570|NCT02714569|458912617|FG010|Part B (Overall)|Adverse Event|0|||
127532571|NCT04915729|458912618|FG000|Overall Study|Lost to Follow-up|20|||
127532572|NCT04915729|458912619|FG001|Overall Study|Lost to Follow-up|10|||
127532573|NCT04915729|458912618|FG000|Overall Study|Withdrawal by Subject|12|||
127532574|NCT04915729|458912619|FG001|Overall Study|Withdrawal by Subject|5|||
127532575|NCT04915729|458912618|FG000|Overall Study|Death|34|||
127532576|NCT04915729|458912619|FG001|Overall Study|Death|44|||
127532577|NCT04915729|458912618|FG000|Overall Study|not treated|3|||
127532578|NCT04915729|458912619|FG001|Overall Study|not treated|6|||
127532579|NCT04915729|458912618|FG000|Overall Study|Investigator removed subject|1|||
127532580|NCT04915729|458912619|FG001|Overall Study|Investigator removed subject|2|||
127532581|NCT04915729|458912618|FG000|Overall Study|questionnaire result not evaluated|1|||
127532582|NCT04915729|458912619|FG001|Overall Study|questionnaire result not evaluated|0|||
127532583|NCT04915729|458912618|FG000|Overall Study|refuse of hospital visit|1|||
127532584|NCT04915729|458912619|FG001|Overall Study|refuse of hospital visit|3|||
127532585|NCT04915729|458912618|FG000|Overall Study|Subject withdrew|1|||
127532586|NCT04915729|458912619|FG001|Overall Study|Subject withdrew|0|||
127532587|NCT01684202|458912620|FG000|Dose-escalation Period|Adverse Event|0|||
127532588|NCT01684202|458912621|FG001|Dose-escalation Period|Adverse Event|1|||
127532589|NCT01684202|458912622|FG002|Dose-escalation Period|Adverse Event|0|||
127532590|NCT01684202|458912623|FG003|Dose-escalation Period|Adverse Event|0|||
127532591|NCT01684202|458912620|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
127532592|NCT01684202|458912621|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
127532593|NCT01684202|458912622|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
127532594|NCT01684202|458912623|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
127532595|NCT01684202|458912620|FG000|Maintenance Period|Adverse Event|1|||
127532596|NCT01684202|458912621|FG001|Maintenance Period|Adverse Event|1|||
127532597|NCT01684202|458912622|FG002|Maintenance Period|Adverse Event|1|||
127532598|NCT01684202|458912623|FG003|Maintenance Period|Adverse Event|1|||
127532599|NCT01684202|458912620|FG000|Maintenance Period|Physician Decision|0|||
127532600|NCT01684202|458912621|FG001|Maintenance Period|Physician Decision|1|||
127532601|NCT01684202|458912622|FG002|Maintenance Period|Physician Decision|0|||
127532602|NCT01684202|458912623|FG003|Maintenance Period|Physician Decision|0|||
127532603|NCT01684202|458912620|FG000|Maintenance Period|Withdrawal by Subject|0|||
127532604|NCT01684202|458912621|FG001|Maintenance Period|Withdrawal by Subject|1|||
127532605|NCT01684202|458912622|FG002|Maintenance Period|Withdrawal by Subject|0|||
127532606|NCT01684202|458912623|FG003|Maintenance Period|Withdrawal by Subject|0|||
127532607|NCT00191308|458912624|FG000|Overall Study|Adverse Event|1|||
127532608|NCT00779025|458912625|FG000|Overall Study|Withdrawal by Subject|1|||
127532609|NCT03710642|458912629|FG000|Overall Study|Adverse Event|5|||
127532610|NCT03710642|458912630|FG001|Overall Study|Adverse Event|1|||
127532611|NCT03710642|458912629|FG000|Overall Study|non-site physician recommendation|1|||
127532612|NCT03710642|458912630|FG001|Overall Study|non-site physician recommendation|0|||
127532613|NCT03710642|458912629|FG000|Overall Study|Participant unwilling or unable to participate|1|||
127532614|NCT03710642|458912630|FG001|Overall Study|Participant unwilling or unable to participate|1|||
127532615|NCT03710642|458912629|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
127532616|NCT03710642|458912630|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
127532617|NCT03710642|458912629|FG000|Overall Study|NA-no code provided|1|||
127532618|NCT03710642|458912630|FG001|Overall Study|NA-no code provided|0|||
127532619|NCT03710642|458912629|FG000|Overall Study|Withdrawal by Subject|1|||
127532620|NCT03710642|458912630|FG001|Overall Study|Withdrawal by Subject|0|||
127532621|NCT00782717|458912636|FG000|Overall Study|Adverse Event|2|||
127532622|NCT00782717|458912637|FG001|Overall Study|Adverse Event|5|||
127532623|NCT00782717|458912636|FG000|Overall Study|Patient decision unrelated to AE|6|||
127532624|NCT00782717|458912637|FG001|Overall Study|Patient decision unrelated to AE|3|||
127532625|NCT00782717|458912636|FG000|Overall Study|Noncompliance|2|||
127532626|NCT00782717|458912637|FG001|Overall Study|Noncompliance|1|||
127532627|NCT00782717|458912636|FG000|Overall Study|Treatment failure|3|||
127532628|NCT00782717|458912637|FG001|Overall Study|Treatment failure|14|||
127532629|NCT00782717|458912636|FG000|Overall Study|Enrollment close prior to surgery|1|||
127532630|NCT00782717|458912637|FG001|Overall Study|Enrollment close prior to surgery|0|||
127532631|NCT00782717|458912636|FG000|Overall Study|Did not meet entrance criteria|1|||
127532632|NCT00782717|458912637|FG001|Overall Study|Did not meet entrance criteria|3|||
127532633|NCT00782717|458912636|FG000|Overall Study|Exited in error|0|||
127532634|NCT00782717|458912637|FG001|Overall Study|Exited in error|2|||
127532635|NCT02292719|458912638|FG000|Overall Study|Withdrawal by Subject|0|||
127532636|NCT02292719|458912639|FG001|Overall Study|Withdrawal by Subject|0|||
127532637|NCT02292719|458912640|FG002|Overall Study|Withdrawal by Subject|0|||
127532638|NCT02292719|458912641|FG003|Overall Study|Withdrawal by Subject|1|||
127532639|NCT02292719|458912642|FG004|Overall Study|Withdrawal by Subject|1|||
127532640|NCT02292719|458912643|FG005|Overall Study|Withdrawal by Subject|0|||
127532641|NCT02292719|458912638|FG000|Overall Study|Subject enrolled in new study.|0|||
127532642|NCT02292719|458912639|FG001|Overall Study|Subject enrolled in new study.|0|||
127532643|NCT02292719|458912640|FG002|Overall Study|Subject enrolled in new study.|1|||
127532644|NCT02292719|458912641|FG003|Overall Study|Subject enrolled in new study.|0|||
127532645|NCT02292719|458912642|FG004|Overall Study|Subject enrolled in new study.|0|||
127532646|NCT02292719|458912643|FG005|Overall Study|Subject enrolled in new study.|0|||
127532647|NCT02586727|458912649|FG000|Overall Study|Lost to Follow-up|1|||
127532648|NCT02586727|458912650|FG001|Overall Study|Lost to Follow-up|0|||
127532649|NCT00731679|458912651|FG000|Overall Study|Adverse Event|7|||
127532650|NCT00731679|458912652|FG001|Overall Study|Adverse Event|8|||
127532651|NCT00731679|458912651|FG000|Overall Study|Withdrawal by Subject|8|||
127532652|NCT00731679|458912652|FG001|Overall Study|Withdrawal by Subject|8|||
127532653|NCT00731679|458912651|FG000|Overall Study|Lost to Follow-up|7|||
127532654|NCT00731679|458912652|FG001|Overall Study|Lost to Follow-up|8|||
127532655|NCT00731679|458912651|FG000|Overall Study|Noncompliance|0|||
127532656|NCT00731679|458912652|FG001|Overall Study|Noncompliance|1|||
127532657|NCT00731679|458912651|FG000|Overall Study|Pregnancy|0|||
127532658|NCT00731679|458912652|FG001|Overall Study|Pregnancy|1|||
127532659|NCT02488005|458912655|FG000|Overall Study|Lost to Follow-up|2|||
127532660|NCT02326597|458912662|FG000|Overall Study|Lost to Follow-up|42|||
127532661|NCT02326597|458912663|FG001|Overall Study|Lost to Follow-up|32|||
127532662|NCT04089761|458912666|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
127532663|NCT04089761|458912666|FG000|"Run In Phase"|Lost to Follow-up|1|||
127532664|NCT04089761|458912666|FG000|"Treatment Phase"|No evaluable data|5|||
127532665|NCT04089761|458912666|FG000|"Treatment Phase"|Lost to Follow-up|1|||
127532666|NCT04628780|458912667|FG000|Overall Study|Death|0|||
127532667|NCT04628780|458912668|FG001|Overall Study|Death|1|||
127532668|NCT04628780|458912669|FG002|Overall Study|Death|0|||
127532669|NCT04628780|458912670|FG003|Overall Study|Death|0|||
127532670|NCT04628780|458912671|FG004|Overall Study|Death|1|||
127532671|NCT04628780|458912672|FG005|Overall Study|Death|0|||
127532672|NCT04628780|458912667|FG000|Overall Study|Physician Decision|2|||
127532673|NCT04628780|458912668|FG001|Overall Study|Physician Decision|0|||
127532674|NCT04628780|458912669|FG002|Overall Study|Physician Decision|0|||
127532675|NCT04628780|458912670|FG003|Overall Study|Physician Decision|0|||
127532676|NCT04628780|458912671|FG004|Overall Study|Physician Decision|2|||
127532677|NCT04628780|458912672|FG005|Overall Study|Physician Decision|0|||
127532678|NCT04628780|458912667|FG000|Overall Study|Progressive disease|2|||
127532679|NCT04628780|458912668|FG001|Overall Study|Progressive disease|2|||
127532680|NCT04628780|458912669|FG002|Overall Study|Progressive disease|2|||
127532681|NCT04628780|458912670|FG003|Overall Study|Progressive disease|3|||
127532682|NCT04628780|458912671|FG004|Overall Study|Progressive disease|9|||
127532683|NCT04628780|458912672|FG005|Overall Study|Progressive disease|4|||
127532684|NCT04628780|458912667|FG000|Overall Study|Withdrawal by Subject|0|||
127532685|NCT04628780|458912668|FG001|Overall Study|Withdrawal by Subject|1|||
127532686|NCT04628780|458912669|FG002|Overall Study|Withdrawal by Subject|2|||
127532687|NCT04628780|458912670|FG003|Overall Study|Withdrawal by Subject|0|||
127532688|NCT04628780|458912671|FG004|Overall Study|Withdrawal by Subject|3|||
127532689|NCT04628780|458912672|FG005|Overall Study|Withdrawal by Subject|1|||
127532690|NCT04628780|458912667|FG000|Overall Study|Global deterioration of health status|0|||
127532691|NCT04628780|458912668|FG001|Overall Study|Global deterioration of health status|0|||
127532692|NCT04628780|458912669|FG002|Overall Study|Global deterioration of health status|0|||
127532693|NCT04628780|458912670|FG003|Overall Study|Global deterioration of health status|0|||
127532694|NCT04628780|458912671|FG004|Overall Study|Global deterioration of health status|1|||
127532695|NCT04628780|458912672|FG005|Overall Study|Global deterioration of health status|1|||
127532696|NCT03622814|458912674|FG000|Overall Study|Lost to Follow-up|8|||
127532697|NCT03622814|458912675|FG001|Overall Study|Lost to Follow-up|14|||
127532698|NCT01156714|458912678|FG000|Overall Study|Withdrawal by Subject|9|||
127532699|NCT01156714|458912679|FG001|Overall Study|Withdrawal by Subject|4|||
127532700|NCT01156714|458912680|FG002|Overall Study|Withdrawal by Subject|3|||
127532701|NCT00369577|458912686|FG000|Overall Study|Withdrawal by Subject|0|||
127532702|NCT00369577|458912687|FG001|Overall Study|Withdrawal by Subject|0|||
127532703|NCT00369577|458912688|FG002|Overall Study|Withdrawal by Subject|1|||
127532704|NCT01059318|458912699|FG000|Core Study (26 Week)|Adverse Event|3|||
127532705|NCT01059318|458912699|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
127532706|NCT01059318|458912699|FG000|Extension (36 Week)|Adverse Event|3|||
127532707|NCT00176462|458912700|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
127532708|NCT00176462|458912701|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
127532709|NCT00176462|458912700|FG000|Induction (4 Weeks)|Death|1|||
127532710|NCT00176462|458912701|FG001|Induction (4 Weeks)|Death|2|||
127532711|NCT00176462|458912700|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
127532712|NCT00176462|458912701|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
127532713|NCT00176462|458912700|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
127532714|NCT00176462|458912701|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
127532715|NCT00176462|458912700|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
127532716|NCT00176462|458912701|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
127532717|NCT00176462|458912700|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
127532718|NCT00176462|458912701|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
127532719|NCT00176462|458912700|FG000|Consolidation (12 Weeks)|Not documented|0|||
127532720|NCT00176462|458912701|FG001|Consolidation (12 Weeks)|Not documented|1|||
127532721|NCT00176462|458912700|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
127532722|NCT00176462|458912701|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
127532723|NCT00176462|458912700|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
127532724|NCT00176462|458912701|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
127532725|NCT01408459|458912702|FG000|Overall Study|Withdrawal by Subject|1|||
127532726|NCT01408459|458912703|FG001|Overall Study|Withdrawal by Subject|1|||
127532727|NCT01657292|458912709|FG000|Overall Study|Adverse Event|6|||
127532728|NCT01657292|458912709|FG000|Overall Study|Withdrawal by Subject|2|||
127532729|NCT01657292|458912709|FG000|Overall Study|Violation of eligibility criteria|1|||
127532730|NCT01657292|458912709|FG000|Overall Study|Change of therapy|1|||
127532731|NCT00650845|458912710|FG000|Overall Study|Withdrawal by Subject|5|||
127532732|NCT00650845|458912711|FG001|Overall Study|Withdrawal by Subject|0|||
127532733|NCT00650845|458912710|FG000|Overall Study|Protocol Violation|0|||
127532734|NCT00650845|458912711|FG001|Overall Study|Protocol Violation|13|||
127532735|NCT01301833|458912712|FG000|Overall Study|Adverse Event|7|||
127532736|NCT01301833|458912713|FG001|Overall Study|Adverse Event|5|||
127532737|NCT01301833|458912714|FG002|Overall Study|Adverse Event|5|||
127532738|NCT01301833|458912715|FG003|Overall Study|Adverse Event|5|||
127532739|NCT01301833|458912712|FG000|Overall Study|Lack of Efficacy|1|||
127532740|NCT01301833|458912713|FG001|Overall Study|Lack of Efficacy|1|||
127532741|NCT01301833|458912714|FG002|Overall Study|Lack of Efficacy|0|||
127532742|NCT01301833|458912715|FG003|Overall Study|Lack of Efficacy|0|||
127532743|NCT01301833|458912712|FG000|Overall Study|Physician Decision|3|||
127532744|NCT01301833|458912713|FG001|Overall Study|Physician Decision|1|||
127532745|NCT01301833|458912714|FG002|Overall Study|Physician Decision|1|||
127532746|NCT01301833|458912715|FG003|Overall Study|Physician Decision|0|||
127532747|NCT01301833|458912712|FG000|Overall Study|Withdrawal by Subject|3|||
127532748|NCT01301833|458912713|FG001|Overall Study|Withdrawal by Subject|1|||
127532749|NCT01301833|458912714|FG002|Overall Study|Withdrawal by Subject|1|||
127532750|NCT01301833|458912715|FG003|Overall Study|Withdrawal by Subject|2|||
127532751|NCT01301833|458912712|FG000|Overall Study|Personal matter|1|||
127532752|NCT01301833|458912713|FG001|Overall Study|Personal matter|0|||
127532753|NCT01301833|458912714|FG002|Overall Study|Personal matter|0|||
127532754|NCT01301833|458912715|FG003|Overall Study|Personal matter|0|||
127532755|NCT03922620|458912716|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
127532756|NCT03922620|458912717|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
127532757|NCT00983385|458912718|FG000|Observation Period|Not eligible to be dosed|20|||
127532758|NCT00983385|458912718|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
127532759|NCT04177212|458912720|FG000|Overall Study|Withdrawal by Subject|9|||
127532760|NCT04177212|458912721|FG001|Overall Study|Withdrawal by Subject|7|||
127532761|NCT04177212|458912720|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
127532762|NCT04177212|458912721|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
127532763|NCT04177212|458912720|FG000|Overall Study|Physician Decision|1|||
127532764|NCT04177212|458912721|FG001|Overall Study|Physician Decision|0|||
127532765|NCT04177212|458912720|FG000|Overall Study|Lost to Follow-up|0|||
127532766|NCT04177212|458912721|FG001|Overall Study|Lost to Follow-up|3|||
127532767|NCT04177212|458912720|FG000|Overall Study|Adverse Event|0|||
127532768|NCT04177212|458912721|FG001|Overall Study|Adverse Event|1|||
127532769|NCT04177212|458912720|FG000|Overall Study|Other|1|||
127532770|NCT04177212|458912721|FG001|Overall Study|Other|2|||
127532771|NCT04725500|458912722|FG000|Screening|Screen Failure|26|||
127532772|NCT04725500|458912722|FG000|Screening|Withdrawal by Subject|1|||
127532773|NCT04725500|458912722|FG000|2 Week Take Home|Screen Fail|5|||
127532774|NCT04618744|458912724|FG000|Overall Study|Adverse Event|0|||
127532775|NCT04618744|458912725|FG001|Overall Study|Adverse Event|1|||
127532776|NCT04618744|458912724|FG000|Overall Study|Withdrawal by Subject|0|||
127532777|NCT04618744|458912725|FG001|Overall Study|Withdrawal by Subject|1|||
127532778|NCT00930930|458912726|FG000|Overall Study|Death|1|||
127532779|NCT00930930|458912727|FG001|Overall Study|Death|0|||
127532780|NCT00930930|458912726|FG000|Overall Study|Physician Decision|1|||
127532781|NCT00930930|458912727|FG001|Overall Study|Physician Decision|0|||
127532782|NCT00930930|458912726|FG000|Overall Study|Adverse Event|13|||
127532783|NCT00930930|458912727|FG001|Overall Study|Adverse Event|3|||
127532784|NCT00930930|458912726|FG000|Overall Study|Withdrawal by Subject|3|||
127532785|NCT00930930|458912727|FG001|Overall Study|Withdrawal by Subject|1|||
127532786|NCT00930930|458912726|FG000|Overall Study|Disease progression|2|||
127532787|NCT00930930|458912727|FG001|Overall Study|Disease progression|3|||
127532788|NCT00930930|458912726|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
127532789|NCT00930930|458912727|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
127532790|NCT00930930|458912726|FG000|Overall Study|patients not compliant|1|||
127532791|NCT00930930|458912727|FG001|Overall Study|patients not compliant|1|||
127532792|NCT02709330|458912728|FG000|Overall Study|Death|5|||
127532793|NCT02709330|458912729|FG001|Overall Study|Death|0|||
127532794|NCT02709330|458912728|FG000|Overall Study|Lost to Follow-up|2|||
127532795|NCT02709330|458912729|FG001|Overall Study|Lost to Follow-up|0|||
127532796|NCT02709330|458912728|FG000|Overall Study|Physician Decision|2|||
127532797|NCT02709330|458912729|FG001|Overall Study|Physician Decision|0|||
127532798|NCT02709330|458912728|FG000|Overall Study|Withdrawal by Subject|4|||
127532799|NCT02709330|458912729|FG001|Overall Study|Withdrawal by Subject|0|||
127532800|NCT01279681|458912730|FG000|Overall Study|Disease Progression|9|||
127532801|NCT01279681|458912731|FG001|Overall Study|Disease Progression|6|||
127532802|NCT01279681|458912730|FG000|Overall Study|Withdrawal by Subject|3|||
127532803|NCT01279681|458912731|FG001|Overall Study|Withdrawal by Subject|4|||
127532804|NCT01279681|458912730|FG000|Overall Study|Adverse Event|2|||
127532805|NCT01279681|458912731|FG001|Overall Study|Adverse Event|3|||
127532806|NCT01279681|458912730|FG000|Overall Study|Death|0|||
127532807|NCT01279681|458912731|FG001|Overall Study|Death|1|||
127532808|NCT01279681|458912730|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
127532809|NCT01279681|458912731|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
127532810|NCT01279681|458912730|FG000|Overall Study|Physician Decision|1|||
127532811|NCT01279681|458912731|FG001|Overall Study|Physician Decision|0|||
127532812|NCT01279681|458912730|FG000|Overall Study|Other Reason|0|||
127532813|NCT01279681|458912731|FG001|Overall Study|Other Reason|2|||
127532814|NCT02807623|458914478|FG000|Overall Study|Lost to Follow-up|23|||
127532815|NCT02807623|458914479|FG001|Overall Study|Lost to Follow-up|18|||
127532816|NCT02807623|458914480|FG002|Overall Study|Lost to Follow-up|22|||
127532817|NCT02807623|458914478|FG000|Overall Study|Drug intolerance|0|||
127532818|NCT02807623|458914479|FG001|Overall Study|Drug intolerance|1|||
127532819|NCT02807623|458914480|FG002|Overall Study|Drug intolerance|0|||
127532820|NCT02807623|458914478|FG000|Overall Study|incomplete blood draw|0|||
127532821|NCT02807623|458914479|FG001|Overall Study|incomplete blood draw|2|||
127532822|NCT02807623|458914480|FG002|Overall Study|incomplete blood draw|1|||
127532823|NCT03310723|458914482|FG000|Overall Study|Withdrawal by Subject|0|||
127532824|NCT03310723|458914483|FG001|Overall Study|Withdrawal by Subject|1|||
127532825|NCT03310723|458914482|FG000|Overall Study|Protocol Violation|0|||
127532826|NCT03310723|458914483|FG001|Overall Study|Protocol Violation|2|||
127532827|NCT02098746|458914484|FG000|Overall Study|Changes of Investigator|2|||
127532828|NCT02098746|458914484|FG000|Overall Study|Other Miscellaneous Reasons|1|||
127532829|NCT02098746|458914484|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
127532830|NCT02098746|458914484|FG000|Overall Study|Data Not Available After Treatment|1|||
127532831|NCT01410890|458914485|FG000|Overall Study|Withdrawal by Subject|0|||
127532832|NCT01410890|458914486|FG001|Overall Study|Withdrawal by Subject|1|||
127532833|NCT00217425|458914487|FG000|Overall Study|Never started treatment|2|||
127532834|NCT00217425|458914487|FG000|Overall Study|Patient ineligible|5|||
127532835|NCT00217425|458914487|FG000|Overall Study|Lack of Efficacy|13|||
127532836|NCT00217425|458914487|FG000|Overall Study|Adverse Event|8|||
127532837|NCT00217425|458914487|FG000|Overall Study|Withdrawal by Subject|4|||
127532838|NCT00217425|458914487|FG000|Overall Study|Other complicating disease|1|||
127532839|NCT00217425|458914487|FG000|Overall Study|Other|4|||
127532840|NCT01121146|458914488|FG000|Overall Study|Death|17|||
127532841|NCT01121146|458914489|FG001|Overall Study|Death|15|||
127532842|NCT01121146|458914488|FG000|Overall Study|Adverse Event|2|||
127532843|NCT01121146|458914489|FG001|Overall Study|Adverse Event|11|||
127532844|NCT01121146|458914488|FG000|Overall Study|Lost to Follow-up|7|||
127532845|NCT01121146|458914489|FG001|Overall Study|Lost to Follow-up|16|||
127532846|NCT00330759|458914492|FG000|Overall Study|Death|316|||
127532847|NCT00330759|458914493|FG001|Overall Study|Death|310|||
127532848|NCT00330759|458914492|FG000|Overall Study|Disease progression|104|||
127532849|NCT00330759|458914493|FG001|Overall Study|Disease progression|126|||
127532850|NCT00330759|458914492|FG000|Overall Study|Withdrawal by Subject|143|||
127532851|NCT00330759|458914493|FG001|Overall Study|Withdrawal by Subject|124|||
127532852|NCT00330759|458914492|FG000|Overall Study|Adverse Event|48|||
127532853|NCT00330759|458914493|FG001|Overall Study|Adverse Event|36|||
127532854|NCT00330759|458914492|FG000|Overall Study|Participant request|31|||
127532855|NCT00330759|458914493|FG001|Overall Study|Participant request|22|||
127532856|NCT00330759|458914492|FG000|Overall Study|Lost to Follow-up|16|||
127532857|NCT00330759|458914493|FG001|Overall Study|Lost to Follow-up|22|||
127532858|NCT00330759|458914492|FG000|Overall Study|Noncompliance|15|||
127532859|NCT00330759|458914493|FG001|Overall Study|Noncompliance|17|||
127532860|NCT00330759|458914492|FG000|Overall Study|Physician Decision|1|||
127532861|NCT00330759|458914493|FG001|Overall Study|Physician Decision|2|||
127532862|NCT00330759|458914492|FG000|Overall Study|Protocol deviation|0|||
127532863|NCT00330759|458914493|FG001|Overall Study|Protocol deviation|2|||
127532864|NCT00330759|458914492|FG000|Overall Study|Ineligibility determined|2|||
127532865|NCT00330759|458914493|FG001|Overall Study|Ineligibility determined|1|||
127532866|NCT00330759|458914492|FG000|Overall Study|Other|36|||
127532867|NCT00330759|458914493|FG001|Overall Study|Other|44|||
127532868|NCT00997035|458914494|FG000|3-week Followup Visit|Lost to Follow-up|9|||
127532869|NCT00997035|458914495|FG001|3-week Followup Visit|Lost to Follow-up|6|||
127532870|NCT00997035|458914494|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
127532871|NCT00997035|458914495|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
127532872|NCT03654690|458914498|FG000|Overall Study|Withdrawal by Subject|1|||
127532873|NCT03654690|458914499|FG001|Overall Study|Withdrawal by Subject|0|||
127532874|NCT03654690|458914500|FG002|Overall Study|Withdrawal by Subject|0|||
127532875|NCT02544503|458914502|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
127532876|NCT02544503|458914503|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
127532877|NCT02544503|458914502|FG000|Overall Study|Lost to Follow-up|9|||
127532878|NCT02544503|458914503|FG001|Overall Study|Lost to Follow-up|0|||
127532879|NCT02544503|458914502|FG000|Overall Study|Withdrawal by Subject|1|||
127532880|NCT02544503|458914503|FG001|Overall Study|Withdrawal by Subject|0|||
127532881|NCT03922581|458914509|FG000|Overall Study|Lost to Follow-up|20|||
127532882|NCT03922581|458914510|FG001|Overall Study|Lost to Follow-up|9|||
127532883|NCT03922581|458914509|FG000|Overall Study|Physician Decision|1|||
127532884|NCT03922581|458914510|FG001|Overall Study|Physician Decision|1|||
127532885|NCT03922581|458914509|FG000|Overall Study|Withdrawal by Subject|1|||
127532886|NCT03922581|458914510|FG001|Overall Study|Withdrawal by Subject|0|||
127532887|NCT04685798|458914513|FG000|Overall Study|Did not have standard of care FDG PET/CT|2|||
127532888|NCT04640311|458914514|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
127532889|NCT04640311|458914515|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
127532890|NCT04640311|458914516|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
127532891|NCT04640311|458914517|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
127532892|NCT04640311|458914518|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
127532893|NCT04640311|458914519|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
127532894|NCT04640311|458914520|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
127532895|NCT04640311|458914521|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
127532896|NCT04640311|458914522|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
127532897|NCT04640311|458914523|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
127532898|NCT04640311|458914524|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
127532899|NCT04640311|458914525|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
127532900|NCT04640311|458914526|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
127532901|NCT04640311|458914514|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
127532902|NCT04640311|458914515|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
127532903|NCT04640311|458914516|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
127532904|NCT04640311|458914517|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
127532905|NCT04640311|458914518|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
127532906|NCT04640311|458914519|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
127532907|NCT04640311|458914520|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
127532908|NCT04640311|458914521|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
127532909|NCT04640311|458914522|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
127532910|NCT04640311|458914523|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
127532911|NCT04640311|458914524|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
127532912|NCT04640311|458914525|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
127532913|NCT04640311|458914526|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
127532914|NCT04640311|458914514|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
127532915|NCT04640311|458914515|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
127532916|NCT04640311|458914516|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
127532917|NCT04640311|458914517|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
127532918|NCT04640311|458914518|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
127532919|NCT04640311|458914519|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
127532920|NCT04640311|458914520|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
127532921|NCT04640311|458914521|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
127532922|NCT04640311|458914522|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
127532923|NCT04640311|458914523|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
127532924|NCT04640311|458914524|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
127532925|NCT04640311|458914525|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
127532926|NCT04640311|458914526|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
127532927|NCT04640311|458914514|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
127532928|NCT04640311|458914515|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
127532929|NCT04640311|458914516|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
127532930|NCT04640311|458914517|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
127532931|NCT04640311|458914518|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
127532932|NCT04640311|458914519|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
127532933|NCT04640311|458914520|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
127532934|NCT04640311|458914521|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
127532935|NCT04640311|458914522|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
127532936|NCT04640311|458914523|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
127532937|NCT04640311|458914524|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
127532938|NCT04640311|458914525|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
127532939|NCT04640311|458914526|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
127532940|NCT04640311|458914514|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
127532941|NCT04640311|458914515|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
127532942|NCT04640311|458914516|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
127532943|NCT04640311|458914517|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
127532944|NCT04640311|458914518|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
127532945|NCT04640311|458914519|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
127532946|NCT04640311|458914520|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
127532947|NCT04640311|458914521|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
127532948|NCT04640311|458914522|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
127532949|NCT04640311|458914523|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
127532950|NCT04640311|458914524|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
127532951|NCT04640311|458914525|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
127532952|NCT04640311|458914526|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
127532953|NCT04640311|458914514|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
127532954|NCT04640311|458914515|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
127532955|NCT04640311|458914516|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
127532956|NCT04640311|458914517|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
127532957|NCT04640311|458914518|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
127532958|NCT04640311|458914519|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
127532959|NCT04640311|458914520|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
127532960|NCT04640311|458914521|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
127532961|NCT04640311|458914522|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
127532962|NCT04640311|458914523|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
127532963|NCT04640311|458914524|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
127532964|NCT04640311|458914525|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
127532965|NCT04640311|458914526|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
127532966|NCT04640311|458914514|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
127532967|NCT04640311|458914515|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
127532968|NCT04640311|458914516|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
127532969|NCT04640311|458914517|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
127532970|NCT04640311|458914518|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
127532971|NCT04640311|458914519|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
127532972|NCT04640311|458914520|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
127532973|NCT04640311|458914521|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
127532974|NCT04640311|458914522|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
127532975|NCT04640311|458914523|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
127532976|NCT04640311|458914524|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
127532977|NCT04640311|458914525|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
127532978|NCT04640311|458914526|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
127532979|NCT04640311|458914514|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
127532980|NCT04640311|458914515|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
127532981|NCT04640311|458914516|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
127532982|NCT04640311|458914517|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
127532983|NCT04640311|458914518|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
127532984|NCT04640311|458914519|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
127532985|NCT04640311|458914520|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
127532986|NCT04640311|458914521|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
127532987|NCT04640311|458914522|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
127532988|NCT04640311|458914523|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
127532989|NCT04640311|458914524|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
127532990|NCT04640311|458914525|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
127532991|NCT04640311|458914526|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
127532992|NCT04640311|458914514|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
127532993|NCT04640311|458914515|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
127532994|NCT04640311|458914516|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
127532995|NCT04640311|458914517|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
127532996|NCT04640311|458914518|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
127532997|NCT04640311|458914519|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
127532998|NCT04640311|458914520|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
127532999|NCT04640311|458914521|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
127533000|NCT04640311|458914522|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
127533001|NCT04640311|458914523|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
127533002|NCT04640311|458914524|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
127533003|NCT04640311|458914525|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
127533004|NCT04640311|458914526|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
127533005|NCT03956550|458914527|FG000|Overall Study|Sponsor decision|65|||
127533006|NCT03956550|458914528|FG001|Overall Study|Sponsor decision|66|||
127533007|NCT03956550|458914529|FG002|Overall Study|Sponsor decision|64|||
127533008|NCT03956550|458914527|FG000|Overall Study|Adverse Event|0|||
127533009|NCT03956550|458914528|FG001|Overall Study|Adverse Event|1|||
127533010|NCT03956550|458914529|FG002|Overall Study|Adverse Event|0|||
127533011|NCT03956550|458914527|FG000|Overall Study|Withdrawal by Subject|5|||
127533012|NCT03956550|458914528|FG001|Overall Study|Withdrawal by Subject|5|||
127533013|NCT03956550|458914529|FG002|Overall Study|Withdrawal by Subject|6|||
127533014|NCT00592904|458914532|FG000|Overall Study|Adverse Event|15|||
127533015|NCT00592904|458914533|FG001|Overall Study|Adverse Event|25|||
127533016|NCT00592904|458914534|FG002|Overall Study|Adverse Event|13|||
127533017|NCT00592904|458914535|FG003|Overall Study|Adverse Event|5|||
127533018|NCT00592904|458914532|FG000|Overall Study|Protocol Violation|1|||
127533019|NCT00592904|458914533|FG001|Overall Study|Protocol Violation|1|||
127533020|NCT00592904|458914534|FG002|Overall Study|Protocol Violation|0|||
127533021|NCT00592904|458914535|FG003|Overall Study|Protocol Violation|1|||
127533022|NCT00592904|458914532|FG000|Overall Study|Withdrawal by Subject|4|||
127533023|NCT00592904|458914533|FG001|Overall Study|Withdrawal by Subject|16|||
127533024|NCT00592904|458914534|FG002|Overall Study|Withdrawal by Subject|1|||
127533025|NCT00592904|458914535|FG003|Overall Study|Withdrawal by Subject|2|||
127533026|NCT00592904|458914532|FG000|Overall Study|Lack of Efficacy|2|||
127533027|NCT00592904|458914533|FG001|Overall Study|Lack of Efficacy|7|||
127533028|NCT00592904|458914534|FG002|Overall Study|Lack of Efficacy|2|||
127533029|NCT00592904|458914535|FG003|Overall Study|Lack of Efficacy|3|||
127533030|NCT00592904|458914532|FG000|Overall Study|Physician Decision|0|||
127533031|NCT00592904|458914533|FG001|Overall Study|Physician Decision|3|||
127533032|NCT00592904|458914534|FG002|Overall Study|Physician Decision|1|||
127533033|NCT00592904|458914535|FG003|Overall Study|Physician Decision|0|||
127533034|NCT00592904|458914532|FG000|Overall Study|Other|3|||
127533035|NCT00592904|458914533|FG001|Overall Study|Other|3|||
127533036|NCT00592904|458914534|FG002|Overall Study|Other|0|||
127533037|NCT00592904|458914535|FG003|Overall Study|Other|0|||
127533038|NCT03369418|458914537|FG000|Overall Study|Withdrawal by Subject|3|||
127533039|NCT03369418|458914538|FG001|Overall Study|Withdrawal by Subject|3|||
127533040|NCT01485094|458914539|FG000|Overall Study|Adverse Event|1|||
127533041|NCT01485094|458914540|FG001|Overall Study|Adverse Event|1|||
127533042|NCT01485094|458914541|FG002|Overall Study|Adverse Event|1|||
127533043|NCT01485094|458914539|FG000|Overall Study|Lost to Follow-up|1|||
127533044|NCT01485094|458914540|FG001|Overall Study|Lost to Follow-up|0|||
127533045|NCT01485094|458914541|FG002|Overall Study|Lost to Follow-up|0|||
127533046|NCT01485094|458914539|FG000|Overall Study|Withdrawal by Subject|1|||
127533047|NCT01485094|458914540|FG001|Overall Study|Withdrawal by Subject|1|||
127533048|NCT01485094|458914541|FG002|Overall Study|Withdrawal by Subject|0|||
127533049|NCT01020786|458914546|FG000|Induction Period|Entry Criteria Not Met|2|||
127533050|NCT01020786|458914546|FG000|Induction Period|Adverse Event|10|||
127533051|NCT01020786|458914546|FG000|Induction Period|Progressive Disease|31|||
127533052|NCT01020786|458914546|FG000|Induction Period|Investigator Decision|3|||
127533053|NCT01020786|458914546|FG000|Induction Period|Withdrawal by Subject|3|||
127533054|NCT01020786|458914546|FG000|Maintenance Period|Adverse Event|8|||
127533055|NCT01020786|458914546|FG000|Maintenance Period|Progressive Disease|43|||
127533056|NCT01020786|458914546|FG000|Maintenance Period|Withdrawal by Subject|8|||
127533057|NCT01020786|458914546|FG000|Maintenance Period|Sponsor Decision|1|||
127533058|NCT02753946|458914563|FG000|Overall Study|Adverse Event|7|||
127533059|NCT02753946|458914564|FG001|Overall Study|Adverse Event|6|||
127533060|NCT02753946|458914563|FG000|Overall Study|Withdrawal by Subject|6|||
127533061|NCT02753946|458914564|FG001|Overall Study|Withdrawal by Subject|1|||
127533062|NCT02753946|458914563|FG000|Overall Study|Lack of Efficacy|1|||
127533063|NCT02753946|458914564|FG001|Overall Study|Lack of Efficacy|0|||
127533064|NCT02753946|458914563|FG000|Overall Study|Physician Decision|0|||
127533065|NCT02753946|458914564|FG001|Overall Study|Physician Decision|2|||
127533066|NCT02519439|458914565|FG000|Overall Study|Study Termination|19|||
127533067|NCT02519439|458914565|FG000|Overall Study|Withdrawal by Subject|1|||
127533068|NCT02519439|458914565|FG000|Overall Study|Adverse Event|1|||
127533069|NCT01539759|458914569|FG000|Overall Study|Lost to Follow-up|6|||
127533070|NCT01539759|458914570|FG001|Overall Study|Lost to Follow-up|8|||
127533071|NCT03901144|458914571|FG000|Overall Study|Lost to Follow-up|1|||
127533072|NCT03901144|458914572|FG001|Overall Study|Lost to Follow-up|1|||
127533073|NCT03901144|458914573|FG002|Overall Study|Lost to Follow-up|1|||
127533074|NCT03901144|458914574|FG003|Overall Study|Lost to Follow-up|1|||
127533075|NCT03575403|458914575|FG000|Overall Study|Adverse Event|1|||
127533076|NCT03575403|458914576|FG001|Overall Study|Adverse Event|0|||
127533077|NCT03575403|458914577|FG002|Overall Study|Adverse Event|0|||
127533078|NCT03575403|458914575|FG000|Overall Study|One subject left due to personal reasons unrelated to study-procedures|1|||
127533079|NCT03575403|458914576|FG001|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
127533080|NCT03575403|458914577|FG002|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
127533081|NCT02330055|458914578|FG000|Overall Study|technical issues|2|||
127533082|NCT02330055|458914579|FG001|Overall Study|technical issues|0|||
127533083|NCT02330055|458914578|FG000|Overall Study|participant forgot to wear device|5|||
127533084|NCT02330055|458914579|FG001|Overall Study|participant forgot to wear device|5|||
127533085|NCT02330055|458914578|FG000|Overall Study|data for less than 60 minutes|3|||
127533086|NCT02330055|458914579|FG001|Overall Study|data for less than 60 minutes|3|||
127533087|NCT02330055|458914578|FG000|Overall Study|participant did not sleep|0|||
127533088|NCT02330055|458914579|FG001|Overall Study|participant did not sleep|1|||
127533089|NCT02728089|458914581|FG000|Overall Study|Physician Decision|2|||
127533090|NCT02728089|458914581|FG000|Overall Study|Withdrawal by Subject|1|||
127533091|NCT03359174|458914584|FG000|Overall Study|Adverse Event|1|||
127533092|NCT01332994|458914588|FG000|Overall Study|Adverse Event|34|||
127533093|NCT01332994|458914588|FG000|Overall Study|Death|1|||
127533094|NCT01332994|458914588|FG000|Overall Study|Lack of Efficacy|1|||
127533095|NCT01332994|458914588|FG000|Overall Study|Lost to Follow-up|4|||
127533096|NCT01332994|458914588|FG000|Overall Study|Protocol Violation|6|||
127533097|NCT01332994|458914588|FG000|Overall Study|Withdrawal by Subject|15|||
127533098|NCT01332994|458914588|FG000|Overall Study|Administrative Problem|2|||
127533099|NCT01332994|458914588|FG000|Overall Study|Other|8|||
127533100|NCT02800863|458914589|FG000|Overall Study|Adverse Event|14|||
127533101|NCT02800863|458914589|FG000|Overall Study|Another Device Implanted|1|||
127533102|NCT02800863|458914589|FG000|Overall Study|Device Explanted|1|||
127533103|NCT02800863|458914589|FG000|Overall Study|Device Has Been Turned Off Since Jan 2019|1|||
127533104|NCT02800863|458914589|FG000|Overall Study|Health Issues|1|||
127533105|NCT02800863|458914589|FG000|Overall Study|Insurance Denial|8|||
127533106|NCT02800863|458914589|FG000|Overall Study|No Perm Implant, Active Pain Pump Implanted|1|||
127533107|NCT02800863|458914589|FG000|Overall Study|Patient Did not Obtain at Least 50% Pain Relief|1|||
127533108|NCT02800863|458914589|FG000|Overall Study|Screen Failure|1|||
127533109|NCT02800863|458914589|FG000|Overall Study|Sponsor Request|6|||
127533110|NCT02800863|458914589|FG000|Overall Study|Death|3|||
127533111|NCT02800863|458914589|FG000|Overall Study|Subject Implant at Another Facility|1|||
127533112|NCT02800863|458914589|FG000|Overall Study|Lost to Follow-up|26|||
127533113|NCT02800863|458914589|FG000|Overall Study|Subject Participation Terminated by Investigator|17|||
127533114|NCT02800863|458914589|FG000|Overall Study|Subject and/or Family Request|64|||
127533115|NCT02800863|458914589|FG000|Overall Study|Trial Failure|81|||
127533116|NCT02800863|458914589|FG000|Overall Study|Used Different Battery not Approved for Study at Time of Perm|1|||
127533117|NCT00279916|458914590|FG000|Overall Study|Withdrawal by Subject|4|||
127533118|NCT00279916|458914591|FG001|Overall Study|Withdrawal by Subject|3|||
127533119|NCT00279916|458914590|FG000|Overall Study|Lost to Follow-up|3|||
127533120|NCT00279916|458914591|FG001|Overall Study|Lost to Follow-up|2|||
127533121|NCT02717494|458914593|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
127533122|NCT02717494|458914594|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
127533123|NCT02717494|458914595|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
127533124|NCT02717494|458914593|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
127533125|NCT02717494|458914594|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
127533126|NCT02717494|458914595|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
127533127|NCT02717494|458914593|FG000|First Intervention (Step 1)|Death|0|||
127533128|NCT02717494|458914594|FG001|First Intervention (Step 1)|Death|0|||
127533129|NCT02717494|458914595|FG002|First Intervention (Step 1)|Death|1|||
127533130|NCT02717494|458914593|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
127533131|NCT02717494|458914594|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
127533132|NCT02717494|458914595|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
127533133|NCT04739436|458914597|FG000|Overall Study|Lost to Follow-up|21|||
127533134|NCT04739436|458914598|FG001|Overall Study|Lost to Follow-up|23|||
127533135|NCT04739436|458914597|FG000|Overall Study|Withdrawal by Subject|4|||
127533136|NCT04739436|458914598|FG001|Overall Study|Withdrawal by Subject|6|||
127533137|NCT04739436|458914597|FG000|Overall Study|not randomized properly|1|||
127533138|NCT04739436|458914598|FG001|Overall Study|not randomized properly|0|||
127533139|NCT00428948|458914600|FG000|Overall Study|Lost to Follow-up|15|||
127533140|NCT00428948|458914601|FG001|Overall Study|Lost to Follow-up|8|||
127533141|NCT00428948|458914600|FG000|Overall Study|Adverse Event|148|||
127533142|NCT00428948|458914601|FG001|Overall Study|Adverse Event|24|||
127533143|NCT00428948|458914600|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
127533144|NCT00428948|458914601|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
127533145|NCT00428948|458914600|FG000|Overall Study|Investigator Withdrew Subject|3|||
127533146|NCT00428948|458914601|FG001|Overall Study|Investigator Withdrew Subject|4|||
127533147|NCT00428948|458914600|FG000|Overall Study|Subject Withdrew Consent|50|||
127533148|NCT00428948|458914601|FG001|Overall Study|Subject Withdrew Consent|30|||
127533149|NCT00428948|458914600|FG000|Overall Study|Protocol Deviation|1|||
127533150|NCT00428948|458914601|FG001|Overall Study|Protocol Deviation|1|||
127533151|NCT01288989|458914602|FG000|Overall Study|Death|0|||
127533152|NCT01288989|458914603|FG001|Overall Study|Death|0|||
127533153|NCT01288989|458914604|FG002|Overall Study|Death|0|||
127533154|NCT01288989|458914605|FG003|Overall Study|Death|1|||
127533155|NCT01288989|458914606|FG004|Overall Study|Death|0|||
127533156|NCT01288989|458914602|FG000|Overall Study|Dose limiting toxicity|1|||
127533157|NCT01288989|458914603|FG001|Overall Study|Dose limiting toxicity|0|||
127533158|NCT01288989|458914604|FG002|Overall Study|Dose limiting toxicity|0|||
127533159|NCT01288989|458914605|FG003|Overall Study|Dose limiting toxicity|0|||
127533160|NCT01288989|458914606|FG004|Overall Study|Dose limiting toxicity|0|||
127533161|NCT01288989|458914602|FG000|Overall Study|Adverse Event|0|||
127533162|NCT01288989|458914603|FG001|Overall Study|Adverse Event|0|||
127533163|NCT01288989|458914604|FG002|Overall Study|Adverse Event|0|||
127533164|NCT01288989|458914605|FG003|Overall Study|Adverse Event|0|||
127533165|NCT01288989|458914606|FG004|Overall Study|Adverse Event|2|||
127533166|NCT01288989|458914602|FG000|Overall Study|Physician Decision|0|||
127533167|NCT01288989|458914603|FG001|Overall Study|Physician Decision|0|||
127533168|NCT01288989|458914604|FG002|Overall Study|Physician Decision|0|||
127533169|NCT01288989|458914605|FG003|Overall Study|Physician Decision|0|||
127533170|NCT01288989|458914606|FG004|Overall Study|Physician Decision|1|||
127533171|NCT01288989|458914602|FG000|Overall Study|Withdrawal by Subject|0|||
127533172|NCT01288989|458914603|FG001|Overall Study|Withdrawal by Subject|0|||
127533173|NCT01288989|458914604|FG002|Overall Study|Withdrawal by Subject|0|||
127533174|NCT01288989|458914605|FG003|Overall Study|Withdrawal by Subject|0|||
127533175|NCT01288989|458914606|FG004|Overall Study|Withdrawal by Subject|3|||
127533176|NCT00165672|458914608|FG000|Overall Study|Adverse Event|0|||
127533177|NCT00165672|458914609|FG001|Overall Study|Adverse Event|1|||
127533178|NCT04965688|458914615|FG000|Overall Study|Withdrawal by Subject|2|||
127533179|NCT05864586|458914616|FG000|Overall Study|Ineligible|4|||
127533180|NCT05864586|458914617|FG001|Overall Study|Ineligible|12|||
127533181|NCT05864586|458914616|FG000|Overall Study|Pregnancy|0|||
127533182|NCT05864586|458914617|FG001|Overall Study|Pregnancy|1|||
127533183|NCT05864586|458914616|FG000|Overall Study|Withdrawal by Subject|0|||
127533184|NCT05864586|458914617|FG001|Overall Study|Withdrawal by Subject|1|||
127533185|NCT00319254|458914622|FG000|Overall Study|Withdrawal by Subject|4|||
127533186|NCT00319254|458914622|FG000|Overall Study|Death|46|||
127533187|NCT00319254|458914622|FG000|Overall Study|Lost to Follow-up|2|||
127533188|NCT00319254|458914622|FG000|Overall Study|Enrolled, Not Treated|2|||
127533189|NCT01505374|458914623|FG000|Overall Study|Lost to Follow-up|1|||
127533190|NCT01505374|458914624|FG001|Overall Study|Lost to Follow-up|0|||
127533191|NCT02360228|458914625|FG000|Overall Study|Withdrawal by Subject|1|||
127533192|NCT02360228|458914626|FG001|Overall Study|Withdrawal by Subject|0|||
127533193|NCT02360228|458914627|FG002|Overall Study|Withdrawal by Subject|0|||
127533194|NCT02360228|458914625|FG000|Overall Study|Self-discontinued medication|0|||
127533195|NCT02360228|458914626|FG001|Overall Study|Self-discontinued medication|1|||
127533196|NCT02360228|458914627|FG002|Overall Study|Self-discontinued medication|0|||
127533197|NCT02360228|458914625|FG000|Overall Study|Unstable symptoms during screening|0|||
127533198|NCT02360228|458914626|FG001|Overall Study|Unstable symptoms during screening|0|||
127533199|NCT02360228|458914627|FG002|Overall Study|Unstable symptoms during screening|1|||
127533200|NCT02452424|458914628|FG000|Overall Study|Death|2|||
127533201|NCT02452424|458914629|FG001|Overall Study|Death|2|||
127533202|NCT02452424|458914630|FG002|Overall Study|Death|2|||
127533203|NCT02452424|458914631|FG003|Overall Study|Death|6|||
127533204|NCT02452424|458914632|FG004|Overall Study|Death|2|||
127533205|NCT02452424|458914633|FG005|Overall Study|Death|0|||
127533206|NCT02452424|458914634|FG006|Overall Study|Death|5|||
127533207|NCT02452424|458914635|FG007|Overall Study|Death|1|||
127533208|NCT02452424|458914636|FG008|Overall Study|Death|3|||
127533209|NCT02452424|458914637|FG009|Overall Study|Death|1|||
127533210|NCT02452424|458914638|FG010|Overall Study|Death|0|||
127533211|NCT02452424|458914628|FG000|Overall Study|Lost to Follow-up|0|||
127533212|NCT02452424|458914629|FG001|Overall Study|Lost to Follow-up|1|||
127533213|NCT02452424|458914630|FG002|Overall Study|Lost to Follow-up|1|||
127533214|NCT02452424|458914631|FG003|Overall Study|Lost to Follow-up|0|||
127533215|NCT02452424|458914632|FG004|Overall Study|Lost to Follow-up|0|||
127533216|NCT02452424|458914633|FG005|Overall Study|Lost to Follow-up|0|||
127533217|NCT02452424|458914634|FG006|Overall Study|Lost to Follow-up|0|||
127533218|NCT02452424|458914635|FG007|Overall Study|Lost to Follow-up|0|||
127533219|NCT02452424|458914636|FG008|Overall Study|Lost to Follow-up|0|||
127533220|NCT02452424|458914637|FG009|Overall Study|Lost to Follow-up|0|||
127533221|NCT02452424|458914638|FG010|Overall Study|Lost to Follow-up|0|||
127533222|NCT02452424|458914628|FG000|Overall Study|Withdrawal by Subject|0|||
127533223|NCT02452424|458914629|FG001|Overall Study|Withdrawal by Subject|0|||
127533224|NCT02452424|458914630|FG002|Overall Study|Withdrawal by Subject|3|||
127533225|NCT02452424|458914631|FG003|Overall Study|Withdrawal by Subject|2|||
127533226|NCT02452424|458914632|FG004|Overall Study|Withdrawal by Subject|0|||
127533227|NCT02452424|458914633|FG005|Overall Study|Withdrawal by Subject|0|||
127533228|NCT02452424|458914634|FG006|Overall Study|Withdrawal by Subject|1|||
127533229|NCT02452424|458914635|FG007|Overall Study|Withdrawal by Subject|0|||
127533230|NCT02452424|458914636|FG008|Overall Study|Withdrawal by Subject|1|||
127533231|NCT02452424|458914637|FG009|Overall Study|Withdrawal by Subject|1|||
127533232|NCT02452424|458914638|FG010|Overall Study|Withdrawal by Subject|0|||
127533233|NCT02452424|458914628|FG000|Overall Study|Other|0|||
127533234|NCT02452424|458914629|FG001|Overall Study|Other|0|||
127533235|NCT02452424|458914630|FG002|Overall Study|Other|1|||
127533236|NCT02452424|458914631|FG003|Overall Study|Other|0|||
127533237|NCT02452424|458914632|FG004|Overall Study|Other|0|||
127533238|NCT02452424|458914633|FG005|Overall Study|Other|1|||
127533239|NCT02452424|458914634|FG006|Overall Study|Other|4|||
127533240|NCT02452424|458914635|FG007|Overall Study|Other|3|||
127533241|NCT02452424|458914636|FG008|Overall Study|Other|0|||
127533242|NCT02452424|458914637|FG009|Overall Study|Other|0|||
127533243|NCT02452424|458914638|FG010|Overall Study|Other|1|||
127533244|NCT02452424|458914628|FG000|Overall Study|Progressive disease (per RECIST)|0|||
127533245|NCT02452424|458914629|FG001|Overall Study|Progressive disease (per RECIST)|0|||
127533246|NCT02452424|458914630|FG002|Overall Study|Progressive disease (per RECIST)|0|||
127533247|NCT02452424|458914631|FG003|Overall Study|Progressive disease (per RECIST)|0|||
127533248|NCT02452424|458914632|FG004|Overall Study|Progressive disease (per RECIST)|0|||
127533249|NCT02452424|458914633|FG005|Overall Study|Progressive disease (per RECIST)|0|||
127533250|NCT02452424|458914634|FG006|Overall Study|Progressive disease (per RECIST)|0|||
127533251|NCT02452424|458914635|FG007|Overall Study|Progressive disease (per RECIST)|0|||
127533252|NCT02452424|458914636|FG008|Overall Study|Progressive disease (per RECIST)|2|||
127533253|NCT02452424|458914637|FG009|Overall Study|Progressive disease (per RECIST)|0|||
127533254|NCT02452424|458914638|FG010|Overall Study|Progressive disease (per RECIST)|0|||
127533255|NCT02452424|458914628|FG000|Overall Study|Adverse Event|0|||
127533256|NCT02452424|458914629|FG001|Overall Study|Adverse Event|0|||
127533257|NCT02452424|458914630|FG002|Overall Study|Adverse Event|0|||
127533258|NCT02452424|458914631|FG003|Overall Study|Adverse Event|0|||
127533259|NCT02452424|458914632|FG004|Overall Study|Adverse Event|0|||
127533260|NCT02452424|458914633|FG005|Overall Study|Adverse Event|0|||
127533261|NCT02452424|458914634|FG006|Overall Study|Adverse Event|0|||
127533262|NCT02452424|458914635|FG007|Overall Study|Adverse Event|0|||
127533263|NCT02452424|458914636|FG008|Overall Study|Adverse Event|0|||
127533264|NCT02452424|458914637|FG009|Overall Study|Adverse Event|0|||
127533265|NCT02452424|458914638|FG010|Overall Study|Adverse Event|1|||
127533266|NCT03790917|458914641|FG000|Overall Study|Death|1|||
127533267|NCT04186871|458914642|FG000|Overall Study|Lack of Efficacy|0|||
127533268|NCT04186871|458914643|FG001|Overall Study|Lack of Efficacy|1|||
127533269|NCT04186871|458914644|FG002|Overall Study|Lack of Efficacy|0|||
127533270|NCT04186871|458914645|FG003|Overall Study|Lack of Efficacy|0|||
127533271|NCT04186871|458914646|FG004|Overall Study|Lack of Efficacy|1|||
127533272|NCT04186871|458914647|FG005|Overall Study|Lack of Efficacy|1|||
127533273|NCT04186871|458914642|FG000|Overall Study|Adverse Event|1|||
127533274|NCT04186871|458914643|FG001|Overall Study|Adverse Event|1|||
127533275|NCT04186871|458914644|FG002|Overall Study|Adverse Event|0|||
127533276|NCT04186871|458914645|FG003|Overall Study|Adverse Event|0|||
127533277|NCT04186871|458914646|FG004|Overall Study|Adverse Event|0|||
127533278|NCT04186871|458914647|FG005|Overall Study|Adverse Event|2|||
127533279|NCT04186871|458914642|FG000|Overall Study|Study terminated by sponsor|1|||
127533280|NCT04186871|458914643|FG001|Overall Study|Study terminated by sponsor|2|||
127533281|NCT04186871|458914644|FG002|Overall Study|Study terminated by sponsor|0|||
127533282|NCT04186871|458914645|FG003|Overall Study|Study terminated by sponsor|1|||
127533283|NCT04186871|458914646|FG004|Overall Study|Study terminated by sponsor|0|||
127533284|NCT04186871|458914647|FG005|Overall Study|Study terminated by sponsor|0|||
127533285|NCT04186871|458914642|FG000|Overall Study|Other reasons|0|||
127533286|NCT04186871|458914643|FG001|Overall Study|Other reasons|0|||
127533287|NCT04186871|458914644|FG002|Overall Study|Other reasons|0|||
127533288|NCT04186871|458914645|FG003|Overall Study|Other reasons|0|||
127533289|NCT04186871|458914646|FG004|Overall Study|Other reasons|0|||
127533290|NCT04186871|458914647|FG005|Overall Study|Other reasons|1|||
127533291|NCT04186871|458914642|FG000|Overall Study|Withdrawal by Subject|0|||
127533292|NCT04186871|458914643|FG001|Overall Study|Withdrawal by Subject|0|||
127533293|NCT04186871|458914644|FG002|Overall Study|Withdrawal by Subject|0|||
127533294|NCT04186871|458914645|FG003|Overall Study|Withdrawal by Subject|0|||
127533295|NCT04186871|458914646|FG004|Overall Study|Withdrawal by Subject|0|||
127533296|NCT04186871|458914647|FG005|Overall Study|Withdrawal by Subject|1|||
127533297|NCT04186871|458914642|FG000|Overall Study|Lost to Follow-up|0|||
127533298|NCT04186871|458914643|FG001|Overall Study|Lost to Follow-up|0|||
127533299|NCT04186871|458914644|FG002|Overall Study|Lost to Follow-up|0|||
127533300|NCT04186871|458914645|FG003|Overall Study|Lost to Follow-up|0|||
127533301|NCT04186871|458914646|FG004|Overall Study|Lost to Follow-up|0|||
127533302|NCT04186871|458914647|FG005|Overall Study|Lost to Follow-up|1|||
127533303|NCT02464410|458914648|FG000|Overall Study|Death|3|||
127533304|NCT02464410|458914649|FG001|Overall Study|Death|4|||
127533305|NCT02464410|458914648|FG000|Overall Study|Lost to Follow-up|7|||
127533306|NCT02464410|458914649|FG001|Overall Study|Lost to Follow-up|9|||
127533307|NCT02464410|458914648|FG000|Overall Study|Withdrawal by Subject|12|||
127533308|NCT02464410|458914649|FG001|Overall Study|Withdrawal by Subject|3|||
127533309|NCT00543387|458914657|FG000|Panel 1 + Panel 2|Adverse Event|0|||
127533310|NCT00543387|458914658|FG001|Panel 1 + Panel 2|Adverse Event|1|||
127533311|NCT00543387|458914659|FG002|Panel 1 + Panel 2|Adverse Event|0|||
127533312|NCT00543387|458914660|FG003|Panel 1 + Panel 2|Adverse Event|0|||
127533313|NCT00543387|458914661|FG004|Panel 1 + Panel 2|Adverse Event|0|||
127533314|NCT00543387|458914662|FG005|Panel 1 + Panel 2|Adverse Event|0|||
127533315|NCT00543387|458914663|FG006|Panel 1 + Panel 2|Adverse Event|0|||
127533316|NCT00543387|458914664|FG007|Panel 1 + Panel 2|Adverse Event|1|||
127533317|NCT00543387|458914665|FG008|Panel 1 + Panel 2|Adverse Event|1|||
127533318|NCT00543387|458914666|FG009|Panel 1 + Panel 2|Adverse Event|0|||
127533319|NCT00543387|458914667|FG010|Panel 1 + Panel 2|Adverse Event|0|||
127533320|NCT00543387|458914657|FG000|Panel 1 + Panel 2|Physician Decision|0|||
127533321|NCT00543387|458914658|FG001|Panel 1 + Panel 2|Physician Decision|0|||
127533322|NCT00543387|458914659|FG002|Panel 1 + Panel 2|Physician Decision|1|||
127533323|NCT00543387|458914660|FG003|Panel 1 + Panel 2|Physician Decision|0|||
127533324|NCT00543387|458914661|FG004|Panel 1 + Panel 2|Physician Decision|0|||
127533325|NCT00543387|458914662|FG005|Panel 1 + Panel 2|Physician Decision|0|||
127533326|NCT00543387|458914663|FG006|Panel 1 + Panel 2|Physician Decision|0|||
127533327|NCT00543387|458914664|FG007|Panel 1 + Panel 2|Physician Decision|1|||
127533328|NCT00543387|458914665|FG008|Panel 1 + Panel 2|Physician Decision|0|||
127533329|NCT00543387|458914666|FG009|Panel 1 + Panel 2|Physician Decision|0|||
127533330|NCT00543387|458914667|FG010|Panel 1 + Panel 2|Physician Decision|0|||
127533331|NCT00543387|458914657|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
127533332|NCT00543387|458914658|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
127533333|NCT00543387|458914659|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
127533334|NCT00543387|458914660|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
127533335|NCT00543387|458914661|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
127533336|NCT00543387|458914662|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
127533337|NCT00543387|458914663|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
127533338|NCT00543387|458914664|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
127533339|NCT00543387|458914665|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
127533340|NCT00543387|458914666|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
127533341|NCT00543387|458914667|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
127533342|NCT00543387|458914657|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
127533343|NCT00543387|458914658|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
127533344|NCT00543387|458914659|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
127533345|NCT00543387|458914660|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
127533346|NCT00543387|458914661|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
127533347|NCT00543387|458914662|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
127533348|NCT00543387|458914663|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
127533349|NCT00543387|458914664|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
127533350|NCT00543387|458914665|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
127533351|NCT00543387|458914666|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
127533352|NCT00543387|458914667|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
127533353|NCT00543387|458914657|FG000|Crossover Participants|Progressive Disease|0|||
127533354|NCT00543387|458914658|FG001|Crossover Participants|Progressive Disease|0|||
127533355|NCT00543387|458914659|FG002|Crossover Participants|Progressive Disease|0|||
127533356|NCT00543387|458914660|FG003|Crossover Participants|Progressive Disease|0|||
127533357|NCT00543387|458914661|FG004|Crossover Participants|Progressive Disease|0|||
127533358|NCT00543387|458914662|FG005|Crossover Participants|Progressive Disease|0|||
127533359|NCT00543387|458914663|FG006|Crossover Participants|Progressive Disease|0|||
127533360|NCT00543387|458914664|FG007|Crossover Participants|Progressive Disease|0|||
127533361|NCT00543387|458914665|FG008|Crossover Participants|Progressive Disease|0|||
127533362|NCT00543387|458914666|FG009|Crossover Participants|Progressive Disease|1|||
127533363|NCT00543387|458914667|FG010|Crossover Participants|Progressive Disease|2|||
127533364|NCT00543387|458914657|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
127533365|NCT00543387|458914658|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
127533366|NCT00543387|458914659|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
127533367|NCT00543387|458914660|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
127533368|NCT00543387|458914661|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
127533369|NCT00543387|458914662|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
127533370|NCT00543387|458914663|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
127533371|NCT00543387|458914664|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
127533372|NCT00543387|458914665|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
127533373|NCT00543387|458914666|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
127533374|NCT00543387|458914667|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
127533375|NCT00940498|458914668|FG000|Overall Study|Death|2|||
127533376|NCT00940498|458914669|FG001|Overall Study|Death|0|||
127533377|NCT00940498|458914670|FG002|Overall Study|Death|0|||
127533378|NCT00940498|458914671|FG003|Overall Study|Death|1|||
127533379|NCT00940498|458914672|FG004|Overall Study|Death|5|||
127533380|NCT00940498|458914673|FG005|Overall Study|Death|0|||
127533381|NCT00940498|458914674|FG006|Overall Study|Death|1|||
127533382|NCT00940498|458914675|FG007|Overall Study|Death|0|||
127533383|NCT00940498|458914668|FG000|Overall Study|Lost to Follow-up|1|||
127533384|NCT00940498|458914669|FG001|Overall Study|Lost to Follow-up|1|||
127533385|NCT00940498|458914670|FG002|Overall Study|Lost to Follow-up|2|||
127533386|NCT00940498|458914671|FG003|Overall Study|Lost to Follow-up|0|||
127533387|NCT00940498|458914672|FG004|Overall Study|Lost to Follow-up|1|||
127533388|NCT00940498|458914673|FG005|Overall Study|Lost to Follow-up|0|||
127533389|NCT00940498|458914674|FG006|Overall Study|Lost to Follow-up|0|||
127533390|NCT00940498|458914675|FG007|Overall Study|Lost to Follow-up|1|||
127533391|NCT00940498|458914668|FG000|Overall Study|Disease Progression|0|||
127533392|NCT00940498|458914669|FG001|Overall Study|Disease Progression|0|||
127533393|NCT00940498|458914670|FG002|Overall Study|Disease Progression|1|||
127533394|NCT00940498|458914671|FG003|Overall Study|Disease Progression|1|||
127533395|NCT00940498|458914672|FG004|Overall Study|Disease Progression|0|||
127533396|NCT00940498|458914673|FG005|Overall Study|Disease Progression|1|||
127533397|NCT00940498|458914674|FG006|Overall Study|Disease Progression|0|||
127533398|NCT00940498|458914675|FG007|Overall Study|Disease Progression|0|||
127533399|NCT00940498|458914668|FG000|Overall Study|Physician Decision|0|||
127533400|NCT00940498|458914669|FG001|Overall Study|Physician Decision|0|||
127533401|NCT00940498|458914670|FG002|Overall Study|Physician Decision|0|||
127533402|NCT00940498|458914671|FG003|Overall Study|Physician Decision|0|||
127533403|NCT00940498|458914672|FG004|Overall Study|Physician Decision|2|||
127533404|NCT00940498|458914673|FG005|Overall Study|Physician Decision|0|||
127533405|NCT00940498|458914674|FG006|Overall Study|Physician Decision|0|||
127533406|NCT00940498|458914675|FG007|Overall Study|Physician Decision|0|||
127533407|NCT00940498|458914668|FG000|Overall Study|Not treated due to disease related pain|0|||
127533408|NCT00940498|458914669|FG001|Overall Study|Not treated due to disease related pain|0|||
127533409|NCT00940498|458914670|FG002|Overall Study|Not treated due to disease related pain|0|||
127533410|NCT00940498|458914671|FG003|Overall Study|Not treated due to disease related pain|0|||
127533411|NCT00940498|458914672|FG004|Overall Study|Not treated due to disease related pain|1|||
127533412|NCT00940498|458914673|FG005|Overall Study|Not treated due to disease related pain|0|||
127533413|NCT00940498|458914674|FG006|Overall Study|Not treated due to disease related pain|0|||
127533414|NCT00940498|458914675|FG007|Overall Study|Not treated due to disease related pain|0|||
127533415|NCT03932760|458914676|FG000|Overall Study|Became Ineligible|2|||
127533416|NCT03932760|458914677|FG001|Overall Study|Became Ineligible|5|||
127533417|NCT03932760|458914676|FG000|Overall Study|Withdrawal by Subject|6|||
127533418|NCT03932760|458914677|FG001|Overall Study|Withdrawal by Subject|6|||
127533419|NCT03566082|458914678|FG000|Overall Study|Death|7|||
127533420|NCT03566082|458914678|FG000|Overall Study|Failures (revision required)|2|||
127533421|NCT03566082|458914678|FG000|Overall Study|Lost to Follow-up|8|||
127533422|NCT00859547|458916229|FG000|Overall Study|Lost to Follow-up|1|||
127533423|NCT00859547|458916229|FG000|Overall Study|Parent withdrew consent|1|||
127533424|NCT01276639|458916239|FG000|Week 0 to 16|Death|1|||
127533425|NCT01276639|458916240|FG001|Week 0 to 16|Death|0|||
127533426|NCT01276639|458916241|FG002|Week 0 to 16|Death|0|||
127533427|NCT01276639|458916242|FG003|Week 0 to 16|Death|0|||
127533428|NCT01276639|458916243|FG004|Week 0 to 16|Death|0|||
127533429|NCT01276639|458916239|FG000|Week 0 to 16|Adverse Event|11|||
127533430|NCT01276639|458916240|FG001|Week 0 to 16|Adverse Event|8|||
127533431|NCT01276639|458916241|FG002|Week 0 to 16|Adverse Event|11|||
127533432|NCT01276639|458916242|FG003|Week 0 to 16|Adverse Event|0|||
127533433|NCT01276639|458916243|FG004|Week 0 to 16|Adverse Event|0|||
127533434|NCT01276639|458916239|FG000|Week 0 to 16|Lack of Efficacy|20|||
127533435|NCT01276639|458916240|FG001|Week 0 to 16|Lack of Efficacy|15|||
127533436|NCT01276639|458916241|FG002|Week 0 to 16|Lack of Efficacy|25|||
127533437|NCT01276639|458916242|FG003|Week 0 to 16|Lack of Efficacy|0|||
127533438|NCT01276639|458916243|FG004|Week 0 to 16|Lack of Efficacy|0|||
127533439|NCT01276639|458916239|FG000|Week 0 to 16|Lost to Follow-up|3|||
127533440|NCT01276639|458916240|FG001|Week 0 to 16|Lost to Follow-up|5|||
127533441|NCT01276639|458916241|FG002|Week 0 to 16|Lost to Follow-up|3|||
127533442|NCT01276639|458916242|FG003|Week 0 to 16|Lost to Follow-up|0|||
127533443|NCT01276639|458916243|FG004|Week 0 to 16|Lost to Follow-up|0|||
127533444|NCT01276639|458916239|FG000|Week 0 to 16|Withdrawal by Subject|8|||
127533445|NCT01276639|458916240|FG001|Week 0 to 16|Withdrawal by Subject|5|||
127533446|NCT01276639|458916241|FG002|Week 0 to 16|Withdrawal by Subject|4|||
127533447|NCT01276639|458916242|FG003|Week 0 to 16|Withdrawal by Subject|0|||
127533448|NCT01276639|458916243|FG004|Week 0 to 16|Withdrawal by Subject|0|||
127533449|NCT01276639|458916239|FG000|Week 0 to 16|Other|7|||
127533450|NCT01276639|458916240|FG001|Week 0 to 16|Other|7|||
127533451|NCT01276639|458916241|FG002|Week 0 to 16|Other|2|||
127533452|NCT01276639|458916242|FG003|Week 0 to 16|Other|0|||
127533453|NCT01276639|458916243|FG004|Week 0 to 16|Other|0|||
127533454|NCT01276639|458916239|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
127533455|NCT01276639|458916240|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
127533456|NCT01276639|458916241|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
127533457|NCT01276639|458916242|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
127533458|NCT01276639|458916243|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
127533459|NCT01276639|458916239|FG000|Week 16 to 52|Death|1|||
127533460|NCT01276639|458916240|FG001|Week 16 to 52|Death|0|||
127533461|NCT01276639|458916241|FG002|Week 16 to 52|Death|0|||
127533462|NCT01276639|458916242|FG003|Week 16 to 52|Death|0|||
127533463|NCT01276639|458916243|FG004|Week 16 to 52|Death|0|||
127533464|NCT01276639|458916239|FG000|Week 16 to 52|Adverse Event|10|||
127533465|NCT01276639|458916240|FG001|Week 16 to 52|Adverse Event|13|||
127533466|NCT01276639|458916241|FG002|Week 16 to 52|Adverse Event|0|||
127533467|NCT01276639|458916242|FG003|Week 16 to 52|Adverse Event|1|||
127533468|NCT01276639|458916243|FG004|Week 16 to 52|Adverse Event|3|||
127533469|NCT01276639|458916239|FG000|Week 16 to 52|Lack of Efficacy|99|||
127533470|NCT01276639|458916240|FG001|Week 16 to 52|Lack of Efficacy|71|||
127533471|NCT01276639|458916241|FG002|Week 16 to 52|Lack of Efficacy|0|||
127533472|NCT01276639|458916242|FG003|Week 16 to 52|Lack of Efficacy|14|||
127533473|NCT01276639|458916243|FG004|Week 16 to 52|Lack of Efficacy|13|||
127533474|NCT01276639|458916239|FG000|Week 16 to 52|Lost to Follow-up|3|||
127533475|NCT01276639|458916240|FG001|Week 16 to 52|Lost to Follow-up|1|||
127533476|NCT01276639|458916241|FG002|Week 16 to 52|Lost to Follow-up|0|||
127533477|NCT01276639|458916242|FG003|Week 16 to 52|Lost to Follow-up|0|||
127533478|NCT01276639|458916243|FG004|Week 16 to 52|Lost to Follow-up|1|||
127533479|NCT01276639|458916239|FG000|Week 16 to 52|Withdrawal by Subject|4|||
127533480|NCT01276639|458916240|FG001|Week 16 to 52|Withdrawal by Subject|4|||
127533481|NCT01276639|458916241|FG002|Week 16 to 52|Withdrawal by Subject|0|||
127533482|NCT01276639|458916242|FG003|Week 16 to 52|Withdrawal by Subject|0|||
127533483|NCT01276639|458916243|FG004|Week 16 to 52|Withdrawal by Subject|1|||
127533484|NCT01276639|458916239|FG000|Week 16 to 52|Other|10|||
127533485|NCT01276639|458916240|FG001|Week 16 to 52|Other|12|||
127533486|NCT01276639|458916241|FG002|Week 16 to 52|Other|0|||
127533487|NCT01276639|458916242|FG003|Week 16 to 52|Other|1|||
127533488|NCT01276639|458916243|FG004|Week 16 to 52|Other|3|||
127533489|NCT01380769|458916248|FG000|Overall Study|Withdrawal by Subject|7|||
127533490|NCT01380769|458916249|FG001|Overall Study|Withdrawal by Subject|11|||
127533491|NCT01380769|458916248|FG000|Overall Study|Physician Decision|1|||
127533492|NCT01380769|458916249|FG001|Overall Study|Physician Decision|1|||
127533493|NCT01380769|458916248|FG000|Overall Study|Adverse Event|1|||
127533494|NCT01380769|458916249|FG001|Overall Study|Adverse Event|1|||
127533495|NCT01380769|458916248|FG000|Overall Study|Protocol Violation|0|||
127533496|NCT01380769|458916249|FG001|Overall Study|Protocol Violation|1|||
127533497|NCT00742183|458916252|FG000|Overall Study|Adverse Event|2|||
127533498|NCT00742183|458916253|FG001|Overall Study|Adverse Event|2|||
127533499|NCT00742183|458916252|FG000|Overall Study|Death|1|||
127533500|NCT00742183|458916253|FG001|Overall Study|Death|0|||
127533501|NCT00742183|458916252|FG000|Overall Study|Physician Decision|0|||
127533502|NCT00742183|458916253|FG001|Overall Study|Physician Decision|2|||
127533503|NCT00742183|458916252|FG000|Overall Study|Lost to Follow-up|4|||
127533504|NCT00742183|458916253|FG001|Overall Study|Lost to Follow-up|4|||
127533505|NCT00742183|458916252|FG000|Overall Study|Required skin-graft|1|||
127533506|NCT00742183|458916253|FG001|Overall Study|Required skin-graft|1|||
127533507|NCT00742183|458916252|FG000|Overall Study|Withdrawal by Subject|1|||
127533508|NCT00742183|458916253|FG001|Overall Study|Withdrawal by Subject|0|||
127533509|NCT00742183|458916252|FG000|Overall Study|Lack of Efficacy|0|||
127533510|NCT00742183|458916253|FG001|Overall Study|Lack of Efficacy|3|||
127533511|NCT00786799|458916256|FG000|Overall Study|Lost to Follow-up|1|||
127533512|NCT00786799|458916257|FG001|Overall Study|Lost to Follow-up|1|||
127533513|NCT01080807|458916258|FG000|Overall Study|Adverse Event|9|||
127533514|NCT01080807|458916259|FG001|Overall Study|Adverse Event|1|||
127533515|NCT01080807|458916258|FG000|Overall Study|Lack of Efficacy|0|||
127533516|NCT01080807|458916259|FG001|Overall Study|Lack of Efficacy|1|||
127533517|NCT01080807|458916258|FG000|Overall Study|Withdrawal by Subject|7|||
127533518|NCT01080807|458916259|FG001|Overall Study|Withdrawal by Subject|2|||
127533519|NCT01080807|458916258|FG000|Overall Study|Protocol Violation|7|||
127533520|NCT01080807|458916259|FG001|Overall Study|Protocol Violation|6|||
127533521|NCT01080807|458916258|FG000|Overall Study|Lost to Follow-up|6|||
127533522|NCT01080807|458916259|FG001|Overall Study|Lost to Follow-up|4|||
127533523|NCT01080807|458916258|FG000|Overall Study|Noncompliance with drug administration|1|||
127533524|NCT01080807|458916259|FG001|Overall Study|Noncompliance with drug administration|1|||
127533525|NCT01080807|458916258|FG000|Overall Study|Noncompliance to study procedures|1|||
127533526|NCT01080807|458916259|FG001|Overall Study|Noncompliance to study procedures|1|||
127533527|NCT01080807|458916258|FG000|Overall Study|Began working day shift|0|||
127533528|NCT01080807|458916259|FG001|Overall Study|Began working day shift|2|||
127533529|NCT01080807|458916258|FG000|Overall Study|Laid off or terminated from job|1|||
127533530|NCT01080807|458916259|FG001|Overall Study|Laid off or terminated from job|2|||
127533531|NCT01080807|458916258|FG000|Overall Study|Stopped working consistent night shifts|0|||
127533532|NCT01080807|458916259|FG001|Overall Study|Stopped working consistent night shifts|1|||
127533533|NCT01080807|458916258|FG000|Overall Study|Work schedule changing|1|||
127533534|NCT01080807|458916259|FG001|Overall Study|Work schedule changing|1|||
127533535|NCT01080807|458916258|FG000|Overall Study|Work schedule and travel|0|||
127533536|NCT01080807|458916259|FG001|Overall Study|Work schedule and travel|1|||
127533537|NCT01080807|458916258|FG000|Overall Study|Switched to first shift|1|||
127533538|NCT01080807|458916259|FG001|Overall Study|Switched to first shift|0|||
127533539|NCT01080807|458916258|FG000|Overall Study|Moved away without notifying center|1|||
127533540|NCT01080807|458916259|FG001|Overall Study|Moved away without notifying center|0|||
127533541|NCT02223715|458916263|FG000|Overall Study|Death|31|||
127533542|NCT02223715|458916263|FG000|Overall Study|Lost to Follow-up|73|||
127533543|NCT01745367|458916264|FG000|Overall Study|Death|1|||
127533544|NCT01745367|458916265|FG001|Overall Study|Death|0|||
127533545|NCT01745367|458916264|FG000|Overall Study|Withdrawal by Subject|1|||
127533546|NCT01745367|458916265|FG001|Overall Study|Withdrawal by Subject|2|||
127533547|NCT01745367|458916264|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
127533548|NCT01745367|458916265|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
127533549|NCT01745367|458916264|FG000|Overall Study|Other Reasons Unspecified|0|||
127533550|NCT01745367|458916265|FG001|Overall Study|Other Reasons Unspecified|2|||
127533551|NCT00824473|458916267|FG000|Overall Study|Adverse Event|4|||
127533552|NCT00824473|458916268|FG001|Overall Study|Adverse Event|5|||
127533553|NCT00824473|458916267|FG000|Overall Study|Lack of Efficacy|2|||
127533554|NCT00824473|458916268|FG001|Overall Study|Lack of Efficacy|2|||
127533555|NCT00824473|458916267|FG000|Overall Study|Protocol Violation|2|||
127533556|NCT00824473|458916268|FG001|Overall Study|Protocol Violation|0|||
127533557|NCT00824473|458916267|FG000|Overall Study|Non-Compliance|4|||
127533558|NCT00824473|458916268|FG001|Overall Study|Non-Compliance|2|||
127533559|NCT00824473|458916267|FG000|Overall Study|Withdrawal by Subject|2|||
127533560|NCT00824473|458916268|FG001|Overall Study|Withdrawal by Subject|3|||
127533561|NCT00824473|458916267|FG000|Overall Study|Other|1|||
127533562|NCT00824473|458916268|FG001|Overall Study|Other|1|||
127533563|NCT01359904|458916269|FG000|Overall Study|Withdrawal by Subject|1|||
127533564|NCT01359904|458916270|FG001|Overall Study|Withdrawal by Subject|0|||
127533565|NCT02640547|458916271|FG000|Overall Study|Failure to Return|1|||
127533566|NCT02640547|458916271|FG000|Overall Study|Withdrawal by Subject|1|||
127533567|NCT02640547|458916271|FG000|Overall Study|Death|6|||
127533568|NCT02640547|458916271|FG000|Overall Study|Miscellaneous|3|||
127533569|NCT02525588|458916272|FG000|Overall Study|Death|3|||
127533570|NCT02525588|458916273|FG001|Overall Study|Death|1|||
127533571|NCT02525588|458916272|FG000|Overall Study|Lost to Follow-up|2|||
127533572|NCT02525588|458916273|FG001|Overall Study|Lost to Follow-up|0|||
127533573|NCT02525588|458916272|FG000|Overall Study|Withdrawal by Subject|1|||
127533574|NCT02525588|458916273|FG001|Overall Study|Withdrawal by Subject|1|||
127533575|NCT02525588|458916272|FG000|Overall Study|Adverse Event|0|||
127533576|NCT02525588|458916273|FG001|Overall Study|Adverse Event|1|||
127533577|NCT02478463|458916274|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
127533578|NCT02478463|458916274|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
127533579|NCT02478463|458916274|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
127533580|NCT01358825|458916277|FG000|Overall Study|Blood sample not drawn|0|||
127533581|NCT01358825|458916278|FG001|Overall Study|Blood sample not drawn|1|||
127533582|NCT01479868|458916279|FG000|Overall Study|Adverse Event|1|||
127533583|NCT01479868|458916279|FG000|Overall Study|Lost to Follow-up|4|||
127533584|NCT01479868|458916279|FG000|Overall Study|Protocol Violation|1|||
127533585|NCT01479868|458916279|FG000|Overall Study|Withdrawal by Subject|1|||
127533586|NCT01479868|458916279|FG000|Overall Study|Sponsor's Decision|1|||
127533587|NCT01479868|458916279|FG000|Overall Study|Initiation of new HCV Therapy|1|||
127533588|NCT01508169|458916280|FG000|Overall Study|Adverse Event|1|||
127533589|NCT01508169|458916281|FG001|Overall Study|Adverse Event|0|||
127533590|NCT01508169|458916280|FG000|Overall Study|Withdrawal by Subject|1|||
127533591|NCT01508169|458916281|FG001|Overall Study|Withdrawal by Subject|0|||
127533592|NCT01508169|458916280|FG000|Overall Study|Lost to Follow-up|1|||
127533593|NCT01508169|458916281|FG001|Overall Study|Lost to Follow-up|2|||
127533594|NCT01814527|458916288|FG000|Overall Study|RTP greater than 30 days|6|||
127533595|NCT01814527|458916289|FG001|Overall Study|RTP greater than 30 days|1|||
127533596|NCT04524858|458916290|FG000|Overall Study|Adverse Event|1|||
127533597|NCT01363700|458916293|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
127533598|NCT01363700|458916294|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
127533599|NCT01363700|458916295|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
127533600|NCT01363700|458916296|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
127533601|NCT01363700|458916297|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
127533602|NCT00113841|458916302|FG000|Overall Study|Disease progression|0|||
127533603|NCT00113841|458916303|FG001|Overall Study|Disease progression|2|||
127533604|NCT00113841|458916302|FG000|Overall Study|Non-compliant|1|||
127533605|NCT00113841|458916303|FG001|Overall Study|Non-compliant|0|||
127533606|NCT00104650|458916308|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
127533607|NCT00104650|458916309|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
127533608|NCT00104650|458916310|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
127533609|NCT00104650|458916308|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
127533610|NCT00104650|458916309|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
127533611|NCT00104650|458916310|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
127533612|NCT00104650|458916308|FG000|Treatment Period (25 Weeks)|Death|7|||
127533613|NCT00104650|458916309|FG001|Treatment Period (25 Weeks)|Death|5|||
127533614|NCT00104650|458916310|FG002|Treatment Period (25 Weeks)|Death|6|||
127533615|NCT00104650|458916308|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
127533616|NCT00104650|458916309|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
127533617|NCT00104650|458916310|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
127533618|NCT00104650|458916308|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
127533619|NCT00104650|458916309|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
127533620|NCT00104650|458916310|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
127533621|NCT00104650|458916308|FG000|Treatment Period (25 Weeks)|Other|1|||
127533622|NCT00104650|458916309|FG001|Treatment Period (25 Weeks)|Other|0|||
127533623|NCT00104650|458916310|FG002|Treatment Period (25 Weeks)|Other|0|||
127533624|NCT00104650|458916308|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
127533625|NCT00104650|458916309|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
127533626|NCT00104650|458916310|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
127533627|NCT00104650|458916308|FG000|Follow-up Period|Physician Decision|1|||
127533628|NCT00104650|458916309|FG001|Follow-up Period|Physician Decision|1|||
127533629|NCT00104650|458916310|FG002|Follow-up Period|Physician Decision|0|||
127533630|NCT00104650|458916308|FG000|Follow-up Period|Adverse Event|1|||
127533631|NCT00104650|458916309|FG001|Follow-up Period|Adverse Event|0|||
127533632|NCT00104650|458916310|FG002|Follow-up Period|Adverse Event|1|||
127533633|NCT00104650|458916308|FG000|Follow-up Period|Withdrawal by Subject|0|||
127533634|NCT00104650|458916309|FG001|Follow-up Period|Withdrawal by Subject|3|||
127533635|NCT00104650|458916310|FG002|Follow-up Period|Withdrawal by Subject|3|||
127533636|NCT00104650|458916308|FG000|Follow-up Period|Death|6|||
127533637|NCT00104650|458916309|FG001|Follow-up Period|Death|6|||
127533638|NCT00104650|458916310|FG002|Follow-up Period|Death|4|||
127533639|NCT00104650|458916308|FG000|Follow-up Period|Disease progression|3|||
127533640|NCT00104650|458916309|FG001|Follow-up Period|Disease progression|1|||
127533641|NCT00104650|458916310|FG002|Follow-up Period|Disease progression|0|||
127533642|NCT00104650|458916308|FG000|Follow-up Period|Lost to Follow-up|0|||
127533643|NCT00104650|458916309|FG001|Follow-up Period|Lost to Follow-up|1|||
127533644|NCT00104650|458916310|FG002|Follow-up Period|Lost to Follow-up|2|||
127533645|NCT00104650|458916308|FG000|Follow-up Period|Other|0|||
127533646|NCT00104650|458916309|FG001|Follow-up Period|Other|1|||
127533647|NCT00104650|458916310|FG002|Follow-up Period|Other|0|||
127533648|NCT02294058|458916311|FG000|Overall Study|Adverse Event|16|||
127533649|NCT02294058|458916312|FG001|Overall Study|Adverse Event|7|||
127533650|NCT02294058|458916313|FG002|Overall Study|Adverse Event|13|||
127533651|NCT02294058|458916311|FG000|Overall Study|Lack of Efficacy|3|||
127533652|NCT02294058|458916312|FG001|Overall Study|Lack of Efficacy|3|||
127533653|NCT02294058|458916313|FG002|Overall Study|Lack of Efficacy|0|||
127533654|NCT02294058|458916311|FG000|Overall Study|Lost to Follow-up|1|||
127533655|NCT02294058|458916312|FG001|Overall Study|Lost to Follow-up|0|||
127533656|NCT02294058|458916313|FG002|Overall Study|Lost to Follow-up|2|||
127533657|NCT02294058|458916311|FG000|Overall Study|Withdrawal by Subject|10|||
127533658|NCT02294058|458916312|FG001|Overall Study|Withdrawal by Subject|14|||
127533659|NCT02294058|458916313|FG002|Overall Study|Withdrawal by Subject|13|||
127533660|NCT02294058|458916311|FG000|Overall Study|Physician Decision|2|||
127533661|NCT02294058|458916312|FG001|Overall Study|Physician Decision|1|||
127533662|NCT02294058|458916313|FG002|Overall Study|Physician Decision|0|||
127533663|NCT02294058|458916311|FG000|Overall Study|Miscellaneous|4|||
127533664|NCT02294058|458916312|FG001|Overall Study|Miscellaneous|1|||
127533665|NCT02294058|458916313|FG002|Overall Study|Miscellaneous|1|||
127533666|NCT01807598|458916315|FG000|Overall Study|Withdrawal by Subject|4|||
127533667|NCT01807598|458916315|FG000|Overall Study|Adverse Event|1|||
127533668|NCT01807598|458916315|FG000|Overall Study|Other Physician Decision|1|||
127533669|NCT03384940|458916320|FG000|Overall Study|Progressive disease|36|||
127533670|NCT03384940|458916321|FG001|Overall Study|Progressive disease|11|||
127533671|NCT03384940|458916322|FG002|Overall Study|Progressive disease|13|||
127533672|NCT03384940|458916320|FG000|Overall Study|Clinical progression|4|||
127533673|NCT03384940|458916321|FG001|Overall Study|Clinical progression|0|||
127533674|NCT03384940|458916322|FG002|Overall Study|Clinical progression|3|||
127533675|NCT03384940|458916320|FG000|Overall Study|Adverse Event|7|||
127533676|NCT03384940|458916321|FG001|Overall Study|Adverse Event|1|||
127533677|NCT03384940|458916322|FG002|Overall Study|Adverse Event|1|||
127533678|NCT03384940|458916320|FG000|Overall Study|Withdrawal by Subject|3|||
127533679|NCT03384940|458916321|FG001|Overall Study|Withdrawal by Subject|1|||
127533680|NCT03384940|458916322|FG002|Overall Study|Withdrawal by Subject|0|||
127533681|NCT03384940|458916320|FG000|Overall Study|Physician Decision|1|||
127533682|NCT03384940|458916321|FG001|Overall Study|Physician Decision|1|||
127533683|NCT03384940|458916322|FG002|Overall Study|Physician Decision|0|||
127533684|NCT03384940|458916320|FG000|Overall Study|Death|2|||
127533685|NCT03384940|458916321|FG001|Overall Study|Death|1|||
127533686|NCT03384940|458916322|FG002|Overall Study|Death|0|||
127533687|NCT03384940|458916320|FG000|Overall Study|Other|0|||
127533688|NCT03384940|458916321|FG001|Overall Study|Other|0|||
127533689|NCT03384940|458916322|FG002|Overall Study|Other|1|||
127533690|NCT03089580|458916328|FG000|Overall Study|Lost to Follow-up|2|||
127533691|NCT03087513|458916329|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
127533692|NCT00770601|458916330|FG000|Overall Study|Withdrawal by Subject|1|||
127533693|NCT04417361|458916332|FG000|Overall Study|Withdrawal by Subject|1|||
127533694|NCT04417361|458916333|FG001|Overall Study|Withdrawal by Subject|0|||
127533695|NCT04417361|458916332|FG000|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|0|||
127533696|NCT04417361|458916333|FG001|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|1|||
127533697|NCT00801216|458916334|FG000|Overall Study|Screening Failure|2|||
127533698|NCT05481359|458916335|FG000|Overall Study|Lost to Follow-up|3|||
127533699|NCT05481359|458916335|FG000|Overall Study|Withdrawal by Subject|1|||
127533700|NCT01712204|458916336|FG000|Overall Study|Adverse Event|3|||
127533701|NCT01712204|458916337|FG001|Overall Study|Adverse Event|1|||
127533702|NCT01712204|458916336|FG000|Overall Study|Withdrawal by Subject|3|||
127533703|NCT01712204|458916337|FG001|Overall Study|Withdrawal by Subject|3|||
127533704|NCT01712204|458916336|FG000|Overall Study|Lost to Follow-up|1|||
127533705|NCT01712204|458916337|FG001|Overall Study|Lost to Follow-up|0|||
127533706|NCT01712204|458916336|FG000|Overall Study|Protocol Violation|1|||
127533707|NCT01712204|458916337|FG001|Overall Study|Protocol Violation|1|||
127533708|NCT01463306|458916340|FG000|Overall Study|Adverse Event|6|||
127533709|NCT01463306|458916341|FG001|Overall Study|Adverse Event|9|||
127533710|NCT01463306|458916342|FG002|Overall Study|Adverse Event|3|||
127533711|NCT01463306|458916340|FG000|Overall Study|Death|3|||
127533712|NCT01463306|458916341|FG001|Overall Study|Death|3|||
127533713|NCT01463306|458916342|FG002|Overall Study|Death|0|||
127533714|NCT01463306|458916340|FG000|Overall Study|Lack of Efficacy|22|||
127533715|NCT01463306|458916341|FG001|Overall Study|Lack of Efficacy|16|||
127533716|NCT01463306|458916342|FG002|Overall Study|Lack of Efficacy|1|||
127533717|NCT01463306|458916340|FG000|Overall Study|Lost to Follow-up|5|||
127533718|NCT01463306|458916341|FG001|Overall Study|Lost to Follow-up|2|||
127533719|NCT01463306|458916342|FG002|Overall Study|Lost to Follow-up|0|||
127533720|NCT01463306|458916340|FG000|Overall Study|Protocol Violation|4|||
127533721|NCT01463306|458916341|FG001|Overall Study|Protocol Violation|0|||
127533722|NCT01463306|458916342|FG002|Overall Study|Protocol Violation|0|||
127533723|NCT01463306|458916340|FG000|Overall Study|Withdrawal by Subject|19|||
127533724|NCT01463306|458916341|FG001|Overall Study|Withdrawal by Subject|9|||
127533725|NCT01463306|458916342|FG002|Overall Study|Withdrawal by Subject|1|||
127533726|NCT01463306|458916340|FG000|Overall Study|Other|26|||
127533727|NCT01463306|458916341|FG001|Overall Study|Other|13|||
127533728|NCT01463306|458916342|FG002|Overall Study|Other|0|||
127533729|NCT01463306|458916340|FG000|Overall Study|Approval expiry at site|1|||
127533730|NCT01463306|458916341|FG001|Overall Study|Approval expiry at site|0|||
127533731|NCT01463306|458916342|FG002|Overall Study|Approval expiry at site|0|||
127533732|NCT02679287|458916350|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
127533733|NCT02679287|458916351|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
127533734|NCT02679287|458916350|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
127533735|NCT02679287|458916351|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
127533736|NCT02679287|458916350|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
127533737|NCT02679287|458916351|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
127533738|NCT02679287|458916350|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
127533739|NCT02679287|458916351|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
127533740|NCT02679287|458916350|FG000|Period 2|Work/Scheduling Conflict|1|||
127533741|NCT02679287|458916351|FG001|Period 2|Work/Scheduling Conflict|0|||
127533742|NCT02679287|458916350|FG000|Period 2|Disliked Mobile System|2|||
127533743|NCT02679287|458916351|FG001|Period 2|Disliked Mobile System|0|||
127533744|NCT02679287|458916350|FG000|Period 3|Work/Scheduling Conflict|0|||
127533745|NCT02679287|458916351|FG001|Period 3|Work/Scheduling Conflict|1|||
127533746|NCT00992459|458916356|FG000|Overall Study|Withdrawal by Subject|0|||
127533747|NCT00992459|458916357|FG001|Overall Study|Withdrawal by Subject|1|||
127533748|NCT00992459|458916356|FG000|Overall Study|Adverse Event|1|||
127533749|NCT00992459|458916357|FG001|Overall Study|Adverse Event|0|||
127533750|NCT00227721|458917496|FG000|Overall Study|On study, but never treated.|1|||
127533751|NCT01389882|458917505|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
127533752|NCT01389882|458917506|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
127533753|NCT01389882|458917505|FG000|Overall Study|Withdrawal by Subject|0|||
127533754|NCT01389882|458917506|FG001|Overall Study|Withdrawal by Subject|1|||
127533755|NCT03018691|458917528|FG000|Overall Study|Adverse Event|1|||
127533756|NCT03018691|458917529|FG001|Overall Study|Adverse Event|1|||
127533757|NCT03018691|458917530|FG002|Overall Study|Adverse Event|4|||
127533758|NCT03018691|458917528|FG000|Overall Study|Lack of Efficacy|0|||
127533759|NCT03018691|458917529|FG001|Overall Study|Lack of Efficacy|0|||
127533760|NCT03018691|458917530|FG002|Overall Study|Lack of Efficacy|1|||
127533761|NCT03018691|458917528|FG000|Overall Study|Withdrawal by Subject|0|||
127533762|NCT03018691|458917529|FG001|Overall Study|Withdrawal by Subject|0|||
127533763|NCT03018691|458917530|FG002|Overall Study|Withdrawal by Subject|1|||
127533764|NCT03018691|458917528|FG000|Overall Study|Withdrawal by parent/guardian|1|||
127533765|NCT03018691|458917529|FG001|Overall Study|Withdrawal by parent/guardian|0|||
127533766|NCT03018691|458917530|FG002|Overall Study|Withdrawal by parent/guardian|1|||
127533767|NCT00796666|458917532|FG000|Overall Study|Death|2|||
127533768|NCT00796666|458917533|FG001|Overall Study|Death|4|||
127533769|NCT00796666|458917532|FG000|Overall Study|Withdrawal by Subject|2|||
127533770|NCT00796666|458917533|FG001|Overall Study|Withdrawal by Subject|0|||
127533771|NCT00796666|458917532|FG000|Overall Study|Adverse Event|7|||
127533772|NCT00796666|458917533|FG001|Overall Study|Adverse Event|5|||
127533773|NCT00796666|458917532|FG000|Overall Study|Protocol Violation|1|||
127533774|NCT00796666|458917533|FG001|Overall Study|Protocol Violation|0|||
127533775|NCT00796666|458917532|FG000|Overall Study|Other|1|||
127533776|NCT00796666|458917533|FG001|Overall Study|Other|0|||
127533777|NCT00796666|458917532|FG000|Overall Study|Terminated by sponsor|53|||
127533778|NCT00796666|458917533|FG001|Overall Study|Terminated by sponsor|55|||
127533779|NCT00796666|458917532|FG000|Overall Study|Randomized and not treated|1|||
127533780|NCT00796666|458917533|FG001|Overall Study|Randomized and not treated|0|||
127533781|NCT02576639|458917534|FG000|Overall Study|Withdrawal by Subject|1|||
127533782|NCT02576639|458917535|FG001|Overall Study|Withdrawal by Subject|2|||
127533783|NCT02576639|458917536|FG002|Overall Study|Withdrawal by Subject|1|||
127533784|NCT02576639|458917537|FG003|Overall Study|Withdrawal by Subject|0|||
127533785|NCT02576639|458917538|FG004|Overall Study|Withdrawal by Subject|1|||
127533786|NCT02576639|458917534|FG000|Overall Study|Adverse Event|1|||
127533787|NCT02576639|458917535|FG001|Overall Study|Adverse Event|0|||
127533788|NCT02576639|458917536|FG002|Overall Study|Adverse Event|1|||
127533789|NCT02576639|458917537|FG003|Overall Study|Adverse Event|1|||
127533790|NCT02576639|458917538|FG004|Overall Study|Adverse Event|2|||
127533791|NCT02576639|458917534|FG000|Overall Study|Physician Decision|0|||
127533792|NCT02576639|458917535|FG001|Overall Study|Physician Decision|0|||
127533793|NCT02576639|458917536|FG002|Overall Study|Physician Decision|0|||
127533794|NCT02576639|458917537|FG003|Overall Study|Physician Decision|0|||
127533795|NCT02576639|458917538|FG004|Overall Study|Physician Decision|1|||
127533796|NCT00057863|458917540|FG000|Overall Study|Death|1|||
127533797|NCT00057863|458917540|FG000|Overall Study|Withdrawal by Subject|2|||
127533798|NCT01521507|458917541|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
127533799|NCT01521507|458917542|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
127533800|NCT01521507|458917541|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
127533801|NCT01521507|458917542|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
127533802|NCT01521507|458917541|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
127533803|NCT01521507|458917542|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
127533804|NCT01521507|458917541|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
127533805|NCT01521507|458917542|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
127533806|NCT01521507|458917541|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
127533807|NCT01521507|458917542|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
127533808|NCT01521507|458917541|FG000|Stage 2: Observational Design|Physician Decision|1|||
127533809|NCT01521507|458917542|FG001|Stage 2: Observational Design|Physician Decision|0|||
127533810|NCT02079038|458917543|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
127533811|NCT02079038|458917544|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
127533812|NCT02079038|458917543|FG000|Modified Intent to Treat Population|Death|1|||
127533813|NCT02079038|458917544|FG001|Modified Intent to Treat Population|Death|0|||
127533814|NCT02079038|458917543|FG000|Completed 6 Months|Lost to Follow-up|2|||
127533815|NCT02079038|458917544|FG001|Completed 6 Months|Lost to Follow-up|1|||
127533816|NCT00580723|458917548|FG000|Overall Study|Did not want to participate in extension|3|||
127533817|NCT00580723|458917548|FG000|Overall Study|Lost to Follow-up|5|||
127533818|NCT00148759|458917549|FG000|Overall Study|Withdrawal by Subject|1|||
127533819|NCT00148759|458917550|FG001|Overall Study|Withdrawal by Subject|1|||
127533820|NCT00148759|458917549|FG000|Overall Study|Lost to Follow-up|1|||
127533821|NCT00148759|458917550|FG001|Overall Study|Lost to Follow-up|0|||
127533822|NCT05202418|458917551|FG000|Overall Study|Withdrawal by Subject|2|||
127533823|NCT05202418|458917552|FG001|Overall Study|Withdrawal by Subject|1|||
127533824|NCT05202418|458917551|FG000|Overall Study|Lost to Follow-up|1|||
127533825|NCT05202418|458917552|FG001|Overall Study|Lost to Follow-up|1|||
127533826|NCT01454596|458917553|FG000|Overall Study|Death|0|||
127533827|NCT01454596|458917554|FG001|Overall Study|Death|0|||
127533828|NCT01454596|458917555|FG002|Overall Study|Death|0|||
127533829|NCT01454596|458917556|FG003|Overall Study|Death|0|||
127533830|NCT01454596|458917557|FG004|Overall Study|Death|0|||
127533831|NCT01454596|458917558|FG005|Overall Study|Death|0|||
127533832|NCT01454596|458917559|FG006|Overall Study|Death|0|||
127533833|NCT01454596|458917560|FG007|Overall Study|Death|0|||
127533834|NCT01454596|458917561|FG008|Overall Study|Death|0|||
127533835|NCT01454596|458917562|FG009|Overall Study|Death|1|||
127533836|NCT01454596|458917563|FG010|Overall Study|Death|1|||
127533837|NCT01454596|458917564|FG011|Overall Study|Death|0|||
127533838|NCT02721875|458917566|FG000|Overall Study|Progressive disease/relapse|1|||
127533839|NCT02721875|458917567|FG001|Overall Study|Progressive disease/relapse|0|||
127533840|NCT00430716|458917570|FG000|Double Blind Phase|Death|1|||
127533841|NCT00430716|458917571|FG001|Double Blind Phase|Death|0|||
127533842|NCT00430716|458917572|FG002|Double Blind Phase|Death|0|||
127533843|NCT00430716|458917570|FG000|Double Blind Phase|No longer willing to participate|2|||
127533844|NCT00430716|458917571|FG001|Double Blind Phase|No longer willing to participate|1|||
127533845|NCT00430716|458917572|FG002|Double Blind Phase|No longer willing to participate|1|||
127533846|NCT00430716|458917570|FG000|Double Blind Phase|Other|0|||
127533847|NCT00430716|458917571|FG001|Double Blind Phase|Other|2|||
127533848|NCT00430716|458917572|FG002|Double Blind Phase|Other|0|||
127533849|NCT00430716|458917570|FG000|Double Blind Phase|Study terminated by sponsor|1|||
127533850|NCT00430716|458917571|FG001|Double Blind Phase|Study terminated by sponsor|1|||
127533851|NCT00430716|458917572|FG002|Double Blind Phase|Study terminated by sponsor|2|||
127533852|NCT00430716|458917570|FG000|Double Blind Phase|Adverse Event|1|||
127533853|NCT00430716|458917571|FG001|Double Blind Phase|Adverse Event|1|||
127533854|NCT00430716|458917572|FG002|Double Blind Phase|Adverse Event|3|||
127533855|NCT00430716|458917570|FG000|Double Blind Phase|Not treated|1|||
127533856|NCT00430716|458917571|FG001|Double Blind Phase|Not treated|0|||
127533857|NCT00430716|458917572|FG002|Double Blind Phase|Not treated|0|||
127533858|NCT00430716|458917570|FG000|Open Label Phase|Lost to Follow-up|1|||
127533859|NCT00430716|458917571|FG001|Open Label Phase|Lost to Follow-up|0|||
127533860|NCT00430716|458917572|FG002|Open Label Phase|Lost to Follow-up|1|||
127533861|NCT00430716|458917570|FG000|Open Label Phase|No longer willing to participate|0|||
127533862|NCT00430716|458917571|FG001|Open Label Phase|No longer willing to participate|1|||
127533863|NCT00430716|458917572|FG002|Open Label Phase|No longer willing to participate|1|||
127533864|NCT00430716|458917570|FG000|Open Label Phase|Other|3|||
127533865|NCT00430716|458917571|FG001|Open Label Phase|Other|1|||
127533866|NCT00430716|458917572|FG002|Open Label Phase|Other|1|||
127533867|NCT00430716|458917570|FG000|Open Label Phase|Protocol Violation|1|||
127533868|NCT00430716|458917571|FG001|Open Label Phase|Protocol Violation|0|||
127533869|NCT00430716|458917572|FG002|Open Label Phase|Protocol Violation|0|||
127533870|NCT00430716|458917570|FG000|Open Label Phase|Study terminated by sponsor|4|||
127533871|NCT00430716|458917571|FG001|Open Label Phase|Study terminated by sponsor|5|||
127533872|NCT00430716|458917572|FG002|Open Label Phase|Study terminated by sponsor|4|||
127533873|NCT01329978|458917576|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
127533874|NCT01329978|458917577|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
127533875|NCT01329978|458917578|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
127533876|NCT01329978|458917579|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
127533877|NCT01329978|458917580|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
127533878|NCT01329978|458917576|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
127533879|NCT01329978|458917577|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
127533880|NCT01329978|458917578|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
127533881|NCT01329978|458917579|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
127533882|NCT01329978|458917580|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
127533883|NCT01329978|458917576|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
127533884|NCT01329978|458917577|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
127533885|NCT01329978|458917578|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
127533886|NCT01329978|458917579|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
127533887|NCT01329978|458917580|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
127533888|NCT01329978|458917576|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
127533889|NCT01329978|458917577|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
127533890|NCT01329978|458917578|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
127533891|NCT01329978|458917579|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
127533892|NCT01329978|458917580|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
127533893|NCT01329978|458917576|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
127533894|NCT01329978|458917577|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
127533895|NCT01329978|458917578|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
127533896|NCT01329978|458917579|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
127533897|NCT01329978|458917580|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
127533898|NCT01329978|458917576|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
127533899|NCT01329978|458917577|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
127533900|NCT01329978|458917578|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
127533901|NCT01329978|458917579|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
127533902|NCT01329978|458917580|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
127533903|NCT01329978|458917576|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
127533904|NCT01329978|458917577|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
127533905|NCT01329978|458917578|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
127533906|NCT01329978|458917579|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
127533907|NCT01329978|458917580|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
127533908|NCT00773513|458917585|FG000|Overall Study|Renal Transplant|254|||
127533909|NCT00773513|458917586|FG001|Overall Study|Renal Transplant|263|||
127533910|NCT00773513|458917585|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
127533911|NCT00773513|458917586|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
127533912|NCT00773513|458917585|FG000|Overall Study|Withdrew Consent|68|||
127533913|NCT00773513|458917586|FG001|Overall Study|Withdrew Consent|69|||
127533914|NCT00773513|458917585|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
127533915|NCT00773513|458917586|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
127533916|NCT00773513|458917585|FG000|Overall Study|Failure to Return|22|||
127533917|NCT00773513|458917586|FG001|Overall Study|Failure to Return|8|||
127533918|NCT00773513|458917585|FG000|Overall Study|Insufficient Therapeutic Response|1|||
127533919|NCT00773513|458917586|FG001|Overall Study|Insufficient Therapeutic Response|18|||
127533920|NCT00773513|458917585|FG000|Overall Study|Reason Not Specified|159|||
127533921|NCT00773513|458917586|FG001|Overall Study|Reason Not Specified|126|||
127533922|NCT00773513|458917585|FG000|Overall Study|Death|531|||
127533923|NCT00773513|458917586|FG001|Overall Study|Death|545|||
127533924|NCT04170543|458917589|FG000|Overall Study|Death|1|||
127533925|NCT04170543|458917590|FG001|Overall Study|Death|1|||
127533926|NCT04170543|458917591|FG002|Overall Study|Death|1|||
127533927|NCT04170543|458917592|FG003|Overall Study|Death|1|||
127533928|NCT04170543|458917593|FG004|Overall Study|Death|1|||
127533929|NCT04170543|458917589|FG000|Overall Study|Lost to Follow-up|3|||
127533930|NCT04170543|458917590|FG001|Overall Study|Lost to Follow-up|3|||
127533931|NCT04170543|458917591|FG002|Overall Study|Lost to Follow-up|0|||
127533932|NCT04170543|458917592|FG003|Overall Study|Lost to Follow-up|3|||
127533933|NCT04170543|458917593|FG004|Overall Study|Lost to Follow-up|1|||
127533934|NCT04170543|458917589|FG000|Overall Study|Withdrawal by Subject|13|||
127533935|NCT04170543|458917590|FG001|Overall Study|Withdrawal by Subject|6|||
127533936|NCT04170543|458917591|FG002|Overall Study|Withdrawal by Subject|5|||
127533937|NCT04170543|458917592|FG003|Overall Study|Withdrawal by Subject|4|||
127533938|NCT04170543|458917593|FG004|Overall Study|Withdrawal by Subject|9|||
127533939|NCT04170543|458917589|FG000|Overall Study|Not able to transition to phase 2b|8|||
127533940|NCT04170543|458917590|FG001|Overall Study|Not able to transition to phase 2b|0|||
127533941|NCT04170543|458917591|FG002|Overall Study|Not able to transition to phase 2b|10|||
127533942|NCT04170543|458917592|FG003|Overall Study|Not able to transition to phase 2b|0|||
127533943|NCT04170543|458917593|FG004|Overall Study|Not able to transition to phase 2b|6|||
127533944|NCT04170543|458917589|FG000|Overall Study|Enrolled in Site with GCP Breach|6|||
127533945|NCT04170543|458917590|FG001|Overall Study|Enrolled in Site with GCP Breach|1|||
127533946|NCT04170543|458917591|FG002|Overall Study|Enrolled in Site with GCP Breach|2|||
127533947|NCT04170543|458917592|FG003|Overall Study|Enrolled in Site with GCP Breach|2|||
127533948|NCT04170543|458917593|FG004|Overall Study|Enrolled in Site with GCP Breach|4|||
127533949|NCT04170543|458917589|FG000|Overall Study|Not Treated|0|||
127533950|NCT04170543|458917590|FG001|Overall Study|Not Treated|0|||
127533951|NCT04170543|458917591|FG002|Overall Study|Not Treated|0|||
127533952|NCT04170543|458917592|FG003|Overall Study|Not Treated|0|||
127533953|NCT04170543|458917593|FG004|Overall Study|Not Treated|2|||
127533954|NCT04170543|458917589|FG000|Overall Study|(CRF)|16|||
127533955|NCT04170543|458917590|FG001|Overall Study|(CRF)|15|||
127533956|NCT04170543|458917591|FG002|Overall Study|(CRF)|12|||
127533957|NCT04170543|458917592|FG003|Overall Study|(CRF)|17|||
127533958|NCT04170543|458917593|FG004|Overall Study|(CRF)|17|||
127533959|NCT04170543|458917589|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
127533960|NCT04170543|458917590|FG001|Overall Study|Due to COVID-19 Pandemic|0|||
127533961|NCT04170543|458917591|FG002|Overall Study|Due to COVID-19 Pandemic|1|||
127533962|NCT04170543|458917592|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
127533963|NCT04170543|458917593|FG004|Overall Study|Due to COVID-19 Pandemic|0|||
127533964|NCT03116685|458917600|FG000|Overall Study|Physician Decision|0|||
127533965|NCT03116685|458917601|FG001|Overall Study|Physician Decision|1|||
127533966|NCT00452790|458917604|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
127533967|NCT00452790|458917605|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
127533968|NCT00452790|458917604|FG000|Infant Series|Parent/legal guardian request|8|||
127533969|NCT00452790|458917605|FG001|Infant Series|Parent/legal guardian request|6|||
127533970|NCT00452790|458917604|FG000|Infant Series|Failed to return|4|||
127533971|NCT00452790|458917605|FG001|Infant Series|Failed to return|1|||
127533972|NCT00452790|458917604|FG000|Infant Series|Protocol Violation|1|||
127533973|NCT00452790|458917605|FG001|Infant Series|Protocol Violation|3|||
127533974|NCT00452790|458917604|FG000|Infant Series|Lost to Follow-up|2|||
127533975|NCT00452790|458917605|FG001|Infant Series|Lost to Follow-up|2|||
127533976|NCT00452790|458917604|FG000|Infant Series|Adverse Event|1|||
127533977|NCT00452790|458917605|FG001|Infant Series|Adverse Event|2|||
127533978|NCT00452790|458917604|FG000|Infant Series|Other reasons|1|||
127533979|NCT00452790|458917605|FG001|Infant Series|Other reasons|2|||
127533980|NCT00452790|458917604|FG000|Infant Series|Investigator request|0|||
127533981|NCT00452790|458917605|FG001|Infant Series|Investigator request|1|||
127533982|NCT00452790|458917604|FG000|Infant Series|Death|0|||
127533983|NCT00452790|458917605|FG001|Infant Series|Death|1|||
127533984|NCT00452790|458917604|FG000|After Infant Series|Investigator request|10|||
127533985|NCT00452790|458917605|FG001|After Infant Series|Investigator request|10|||
127533986|NCT00452790|458917604|FG000|After Infant Series|Adverse Event|4|||
127533987|NCT00452790|458917605|FG001|After Infant Series|Adverse Event|1|||
127533988|NCT00452790|458917604|FG000|After Infant Series|Parent/legal guardian request|1|||
127533989|NCT00452790|458917605|FG001|After Infant Series|Parent/legal guardian request|3|||
127533990|NCT00452790|458917604|FG000|After Infant Series|Lost to Follow-up|4|||
127533991|NCT00452790|458917605|FG001|After Infant Series|Lost to Follow-up|0|||
127533992|NCT00452790|458917604|FG000|After Infant Series|Failed to return|1|||
127533993|NCT00452790|458917605|FG001|After Infant Series|Failed to return|0|||
127533994|NCT00452790|458917604|FG000|After Infant Series|Other reasons|1|||
127533995|NCT00452790|458917605|FG001|After Infant Series|Other reasons|0|||
127533996|NCT00452790|458917604|FG000|Toddler Dose|Failed to return|0|||
127533997|NCT00452790|458917605|FG001|Toddler Dose|Failed to return|1|||
127533998|NCT00452790|458917604|FG000|Toddler Dose|Parent/legal guardian request|0|||
127533999|NCT00452790|458917605|FG001|Toddler Dose|Parent/legal guardian request|1|||
127534000|NCT01045694|458917618|FG000|Overall Study|Withdrawal by Subject|2|||
127534001|NCT01150097|458917619|FG000|Months 24 to 36 Post-transplantation|Death|2|||
127534002|NCT01150097|458917620|FG001|Months 24 to 36 Post-transplantation|Death|0|||
127534003|NCT01150097|458917621|FG002|Months 24 to 36 Post-transplantation|Death|0|||
127534004|NCT01150097|458917619|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
127534005|NCT01150097|458917620|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
127534006|NCT01150097|458917621|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
127534007|NCT01150097|458917619|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
127534008|NCT01150097|458917620|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
127534009|NCT01150097|458917621|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
127534010|NCT01150097|458917619|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
127534011|NCT01150097|458917620|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
127534012|NCT01150097|458917621|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
127534013|NCT01150097|458917619|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
127534014|NCT01150097|458917620|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
127534015|NCT01150097|458917621|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
127534016|NCT01150097|458917619|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
127534017|NCT01150097|458917620|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
127534018|NCT01150097|458917621|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
127534019|NCT01150097|458917619|FG000|Months 24 to 48 Post-transplantation|Death|2|||
127534020|NCT01150097|458917620|FG001|Months 24 to 48 Post-transplantation|Death|0|||
127534021|NCT01150097|458917621|FG002|Months 24 to 48 Post-transplantation|Death|0|||
127534022|NCT01114828|458917624|FG000|Overall Study|Adverse Event|1|||
127534023|NCT01114828|458917625|FG001|Overall Study|Adverse Event|1|||
127534024|NCT01114828|458917624|FG000|Overall Study|Lack of Efficacy|0|||
127534025|NCT01114828|458917625|FG001|Overall Study|Lack of Efficacy|2|||
127534026|NCT01114828|458917624|FG000|Overall Study|Protocol Violation|2|||
127534027|NCT01114828|458917625|FG001|Overall Study|Protocol Violation|0|||
127534028|NCT01114828|458917624|FG000|Overall Study|Withdrawal by Subject|0|||
127534029|NCT01114828|458917625|FG001|Overall Study|Withdrawal by Subject|1|||
127534030|NCT00549445|458917626|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
127534031|NCT00549445|458917627|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
127534032|NCT01943591|458917628|FG000|Overall Study|Lost to Follow-up|3|||
127534033|NCT01943591|458917629|FG001|Overall Study|Lost to Follow-up|4|||
127534034|NCT01943591|458917628|FG000|Overall Study|Death|2|||
127534035|NCT01943591|458917629|FG001|Overall Study|Death|7|||
127534036|NCT02719171|458918785|FG000|Overall Study|Adverse Event|1|||
127534037|NCT02719171|458918786|FG001|Overall Study|Adverse Event|2|||
127534038|NCT02719171|458918787|FG002|Overall Study|Adverse Event|0|||
127534039|NCT02719171|458918788|FG003|Overall Study|Adverse Event|0|||
127534040|NCT02719171|458918789|FG004|Overall Study|Adverse Event|2|||
127534041|NCT02719171|458918785|FG000|Overall Study|Lost to Follow-up|0|||
127534042|NCT02719171|458918786|FG001|Overall Study|Lost to Follow-up|0|||
127534043|NCT02719171|458918787|FG002|Overall Study|Lost to Follow-up|1|||
127534044|NCT02719171|458918788|FG003|Overall Study|Lost to Follow-up|0|||
127534045|NCT02719171|458918789|FG004|Overall Study|Lost to Follow-up|0|||
127534046|NCT02719171|458918785|FG000|Overall Study|Subject Withdrawal|0|||
127534047|NCT02719171|458918786|FG001|Overall Study|Subject Withdrawal|2|||
127534048|NCT02719171|458918787|FG002|Overall Study|Subject Withdrawal|2|||
127534049|NCT02719171|458918788|FG003|Overall Study|Subject Withdrawal|1|||
127534050|NCT02719171|458918789|FG004|Overall Study|Subject Withdrawal|0|||
127534051|NCT02719171|458918785|FG000|Overall Study|Other|0|||
127534052|NCT02719171|458918786|FG001|Overall Study|Other|0|||
127534053|NCT02719171|458918787|FG002|Overall Study|Other|0|||
127534054|NCT02719171|458918788|FG003|Overall Study|Other|1|||
127534055|NCT02719171|458918789|FG004|Overall Study|Other|0|||
127534056|NCT02614729|458918790|FG000|Overall Study|Withdrawal by Subject|1|||
127534057|NCT02614729|458918791|FG001|Overall Study|Withdrawal by Subject|0|||
127534058|NCT02796677|458918792|FG000|Overall Study|Adverse Event|11|||
127534059|NCT02796677|458918793|FG001|Overall Study|Adverse Event|22|||
127534060|NCT02796677|458918794|FG002|Overall Study|Adverse Event|14|||
127534061|NCT02796677|458918795|FG003|Overall Study|Adverse Event|14|||
127534062|NCT02796677|458918792|FG000|Overall Study|Protocol Violation|7|||
127534063|NCT02796677|458918793|FG001|Overall Study|Protocol Violation|5|||
127534064|NCT02796677|458918794|FG002|Overall Study|Protocol Violation|4|||
127534065|NCT02796677|458918795|FG003|Overall Study|Protocol Violation|8|||
127534066|NCT02796677|458918792|FG000|Overall Study|Lost to Follow-up|1|||
127534067|NCT02796677|458918793|FG001|Overall Study|Lost to Follow-up|5|||
127534068|NCT02796677|458918794|FG002|Overall Study|Lost to Follow-up|2|||
127534069|NCT02796677|458918795|FG003|Overall Study|Lost to Follow-up|2|||
127534070|NCT02796677|458918792|FG000|Overall Study|Lack of Efficacy|7|||
127534071|NCT02796677|458918793|FG001|Overall Study|Lack of Efficacy|9|||
127534072|NCT02796677|458918794|FG002|Overall Study|Lack of Efficacy|14|||
127534073|NCT02796677|458918795|FG003|Overall Study|Lack of Efficacy|20|||
127534074|NCT02796677|458918792|FG000|Overall Study|Withdrawal by Subject|4|||
127534075|NCT02796677|458918793|FG001|Overall Study|Withdrawal by Subject|14|||
127534076|NCT02796677|458918794|FG002|Overall Study|Withdrawal by Subject|6|||
127534077|NCT02796677|458918795|FG003|Overall Study|Withdrawal by Subject|7|||
127534078|NCT02796677|458918792|FG000|Overall Study|Progressive disease|6|||
127534079|NCT02796677|458918793|FG001|Overall Study|Progressive disease|15|||
127534080|NCT02796677|458918794|FG002|Overall Study|Progressive disease|13|||
127534081|NCT02796677|458918795|FG003|Overall Study|Progressive disease|18|||
127534082|NCT02796677|458918792|FG000|Overall Study|Reason not mentioned|2|||
127534083|NCT02796677|458918793|FG001|Overall Study|Reason not mentioned|3|||
127534084|NCT02796677|458918794|FG002|Overall Study|Reason not mentioned|0|||
127534085|NCT02796677|458918795|FG003|Overall Study|Reason not mentioned|5|||
127534086|NCT00961181|458918796|FG000|Overall Study|Death|2|||
127534087|NCT00961181|458918796|FG000|Overall Study|Withdrawal by Subject|2|||
127534088|NCT00961181|458918796|FG000|Overall Study|Lost to Follow-up|1|||
127534089|NCT03811340|458918797|FG000|Overall Study|subjects did not complete the survey.|90|||
127534090|NCT01045967|458918798|FG000|Second Intervention|Protocol Violation|0|||
127534091|NCT01045967|458918799|FG001|Second Intervention|Protocol Violation|1|||
127534092|NCT01132807|458918806|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
127534093|NCT01132807|458918807|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
127534094|NCT01132807|458918808|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
127534095|NCT01132807|458918806|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
127534096|NCT01132807|458918807|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
127534097|NCT01132807|458918808|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
127534098|NCT01544920|458918812|FG000|Overall Study|Adverse Event|0|||
127534099|NCT01544920|458918813|FG001|Overall Study|Adverse Event|3|||
127534100|NCT01544920|458918812|FG000|Overall Study|Death|0|||
127534101|NCT01544920|458918813|FG001|Overall Study|Death|1|||
127534102|NCT01544920|458918812|FG000|Overall Study|Lost to Follow-up|11|||
127534103|NCT01544920|458918813|FG001|Overall Study|Lost to Follow-up|12|||
127534104|NCT01544920|458918812|FG000|Overall Study|Protocol Violation|0|||
127534105|NCT01544920|458918813|FG001|Overall Study|Protocol Violation|2|||
127534106|NCT01544920|458918812|FG000|Overall Study|Physician Decision|4|||
127534107|NCT01544920|458918813|FG001|Overall Study|Physician Decision|1|||
127534108|NCT01544920|458918812|FG000|Overall Study|Withdrawal by Subject|4|||
127534109|NCT01544920|458918813|FG001|Overall Study|Withdrawal by Subject|4|||
127534110|NCT00466440|458918814|FG000|Overall Study|Adverse Event|0|||
127534111|NCT00466440|458918815|FG001|Overall Study|Adverse Event|3|||
127534112|NCT00466440|458918816|FG002|Overall Study|Adverse Event|1|||
127534113|NCT00466440|458918814|FG000|Overall Study|Death|1|||
127534114|NCT00466440|458918815|FG001|Overall Study|Death|1|||
127534115|NCT00466440|458918816|FG002|Overall Study|Death|0|||
127534116|NCT00466440|458918814|FG000|Overall Study|Progressive disease|13|||
127534117|NCT00466440|458918815|FG001|Overall Study|Progressive disease|5|||
127534118|NCT00466440|458918816|FG002|Overall Study|Progressive disease|4|||
127534119|NCT00466440|458918814|FG000|Overall Study|Lost to Follow-up|0|||
127534120|NCT00466440|458918815|FG001|Overall Study|Lost to Follow-up|1|||
127534121|NCT00466440|458918816|FG002|Overall Study|Lost to Follow-up|0|||
127534122|NCT00466440|458918814|FG000|Overall Study|Physician Decision|0|||
127534123|NCT00466440|458918815|FG001|Overall Study|Physician Decision|1|||
127534124|NCT00466440|458918816|FG002|Overall Study|Physician Decision|2|||
127534125|NCT00466440|458918814|FG000|Overall Study|Protocol entry criteria not met|0|||
127534126|NCT00466440|458918815|FG001|Overall Study|Protocol entry criteria not met|0|||
127534127|NCT00466440|458918816|FG002|Overall Study|Protocol entry criteria not met|4|||
127534128|NCT00466440|458918814|FG000|Overall Study|Withdrawal by Subject|0|||
127534129|NCT00466440|458918815|FG001|Overall Study|Withdrawal by Subject|1|||
127534130|NCT00466440|458918816|FG002|Overall Study|Withdrawal by Subject|0|||
127534131|NCT00466440|458918814|FG000|Overall Study|Sponsor decision|0|||
127534132|NCT00466440|458918815|FG001|Overall Study|Sponsor decision|0|||
127534133|NCT00466440|458918816|FG002|Overall Study|Sponsor decision|1|||
127534134|NCT00965081|458918817|FG000|Overall Study|Adverse Event|14|||
127534135|NCT00965081|458918818|FG001|Overall Study|Adverse Event|9|||
127534136|NCT00965081|458918817|FG000|Overall Study|Lack of Efficacy|2|||
127534137|NCT00965081|458918818|FG001|Overall Study|Lack of Efficacy|5|||
127534138|NCT00965081|458918817|FG000|Overall Study|Lost to Follow-up|4|||
127534139|NCT00965081|458918818|FG001|Overall Study|Lost to Follow-up|5|||
127534140|NCT00965081|458918817|FG000|Overall Study|Physician Decision|2|||
127534141|NCT00965081|458918818|FG001|Overall Study|Physician Decision|0|||
127534142|NCT00965081|458918817|FG000|Overall Study|Protocol Violation|2|||
127534143|NCT00965081|458918818|FG001|Overall Study|Protocol Violation|5|||
127534144|NCT00965081|458918817|FG000|Overall Study|Sponsor Decision|1|||
127534145|NCT00965081|458918818|FG001|Overall Study|Sponsor Decision|0|||
127534146|NCT00965081|458918817|FG000|Overall Study|Withdrawal by Subject|4|||
127534147|NCT00965081|458918818|FG001|Overall Study|Withdrawal by Subject|7|||
127534148|NCT00965081|458918817|FG000|Overall Study|Switched to Rescue Arm|5|||
127534149|NCT00965081|458918818|FG001|Overall Study|Switched to Rescue Arm|12|||
127534150|NCT00256724|458918825|FG000|Overall Study|Physician Decision|2|||
127534151|NCT00256724|458918826|FG001|Overall Study|Physician Decision|5|||
127534152|NCT00256724|458918825|FG000|Overall Study|Protocol Violation|3|||
127534153|NCT00256724|458918826|FG001|Overall Study|Protocol Violation|3|||
127534154|NCT01217463|458918827|FG000|Overall Study|Adverse Event|8|||
127534155|NCT01217463|458918828|FG001|Overall Study|Adverse Event|5|||
127534156|NCT01217463|458918827|FG000|Overall Study|Physician Decision|0|||
127534157|NCT01217463|458918828|FG001|Overall Study|Physician Decision|1|||
127534158|NCT01217463|458918827|FG000|Overall Study|Withdrawal by Subject|3|||
127534159|NCT01217463|458918828|FG001|Overall Study|Withdrawal by Subject|0|||
127534160|NCT01217463|458918827|FG000|Overall Study|Surgery on the Target Limb|0|||
127534161|NCT01217463|458918828|FG001|Overall Study|Surgery on the Target Limb|1|||
127534162|NCT01217463|458918827|FG000|Overall Study|Patient Non-compliant|1|||
127534163|NCT01217463|458918828|FG001|Overall Study|Patient Non-compliant|0|||
127534164|NCT01217463|458918827|FG000|Overall Study|Other|1|||
127534165|NCT01217463|458918828|FG001|Overall Study|Other|1|||
127534166|NCT01569841|458918837|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
127534167|NCT01569841|458918838|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
127534168|NCT00764361|458918841|FG000|Overall Study|Withdrawal by Subject|2|||
127534169|NCT00764361|458918842|FG001|Overall Study|Withdrawal by Subject|3|||
127534170|NCT00764361|458918841|FG000|Overall Study|Adverse Event|0|||
127534171|NCT00764361|458918842|FG001|Overall Study|Adverse Event|1|||
127534172|NCT02090426|458918843|FG000|Overall Study|Lost to Follow-up|12|||
127534173|NCT02090426|458918844|FG001|Overall Study|Lost to Follow-up|6|||
127534174|NCT01141712|458918848|FG000|Overall Study|Disease progression|3|||
127534175|NCT01308736|458918849|FG000|Overall Study|Did not attend a single session|6|||
127534176|NCT01308736|458918850|FG001|Overall Study|Did not attend a single session|5|||
127534177|NCT00296816|458918851|FG000|Overall Study|Disease Progression|37|||
127534178|NCT00296816|458918851|FG000|Overall Study|Adverse Event|18|||
127534179|NCT00296816|458918851|FG000|Overall Study|Investigator/Participant request|5|||
127534180|NCT00296816|458918851|FG000|Overall Study|Non-compliance|1|||
127534181|NCT00296816|458918851|FG000|Overall Study|Missing for end of treatment|4|||
127534182|NCT00296816|458918851|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
127534183|NCT00296816|458918851|FG000|Overall Study|Poor performance status|1|||
127534184|NCT00296816|458918851|FG000|Overall Study|Relocation to Florida|1|||
127534185|NCT00296816|458918851|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
127534186|NCT00296816|458918851|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
127534187|NCT00296816|458918851|FG000|Overall Study|Neuropathy/patient preference|1|||
127534188|NCT00296816|458918851|FG000|Overall Study|Proteinuria|1|||
127534189|NCT00296816|458918851|FG000|Overall Study|ineligibility due to radiation treatment|1|||
127534190|NCT00985465|458918855|FG000|Overall Study|Withdrawal by Subject|1|||
127534191|NCT00985465|458918856|FG001|Overall Study|Withdrawal by Subject|2|||
127534192|NCT00985465|458918855|FG000|Overall Study|Considered to be part of the other group|0|||
127534193|NCT00985465|458918856|FG001|Overall Study|Considered to be part of the other group|1|||
127534194|NCT04701333|458918859|FG000|Overall Study|Lost to Follow-up|3|||
127534195|NCT04701333|458918860|FG001|Overall Study|Lost to Follow-up|7|||
127534196|NCT04701333|458918859|FG000|Overall Study|Withdrawal by Subject|0|||
127534197|NCT04701333|458918860|FG001|Overall Study|Withdrawal by Subject|1|||
127534198|NCT01012258|458918861|FG000|Overall Study|Death|14|||
127534199|NCT01012258|458918861|FG000|Overall Study|Lost to Follow-up|1|||
127534200|NCT01012258|458918861|FG000|Overall Study|Adverse Event|1|||
127534201|NCT01012258|458918861|FG000|Overall Study|Progressive Disease (PD)|18|||
127534202|NCT01012258|458918861|FG000|Overall Study|Symptomatic Deterioration|1|||
127534203|NCT01012258|458918861|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
127534204|NCT01012258|458918861|FG000|Overall Study|Another Tumor Discovered|1|||
127534205|NCT01012258|458918861|FG000|Overall Study|Ongoing|29|||
127534206|NCT01292187|458918862|FG000|Overall Study|Adverse Event|10|||
127534207|NCT01292187|458918863|FG001|Overall Study|Adverse Event|5|||
127534208|NCT01292187|458918862|FG000|Overall Study|Withdrawal by Subject|6|||
127534209|NCT01292187|458918863|FG001|Overall Study|Withdrawal by Subject|5|||
127534210|NCT01292187|458918862|FG000|Overall Study|All other reasons|1|||
127534211|NCT01292187|458918863|FG001|Overall Study|All other reasons|3|||
127534212|NCT03600740|458918864|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
127534213|NCT03571204|458918865|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
127534214|NCT03571204|458918866|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
127534215|NCT03571204|458918867|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
127534216|NCT03571204|458918865|FG000|Overall Study|Physician Decision|0|||
127534217|NCT03571204|458918866|FG001|Overall Study|Physician Decision|1|||
127534218|NCT03571204|458918867|FG002|Overall Study|Physician Decision|0|||
127534219|NCT02396212|458918868|FG000|Overall Study|Adverse Event|1|||
127534220|NCT02396212|458918868|FG000|Overall Study|Lack of Efficacy|2|||
127534221|NCT01623115|458918869|FG000|Overall Study|Randomized but not treated|0|||
127534222|NCT01623115|458918870|FG001|Overall Study|Randomized but not treated|1|||
127534223|NCT01623115|458918869|FG000|Overall Study|Physician Decision|1|||
127534224|NCT01623115|458918870|FG001|Overall Study|Physician Decision|0|||
127534225|NCT01623115|458918869|FG000|Overall Study|Participants moved|1|||
127534226|NCT01623115|458918870|FG001|Overall Study|Participants moved|5|||
127534227|NCT01623115|458918869|FG000|Overall Study|Adverse Event|10|||
127534228|NCT01623115|458918870|FG001|Overall Study|Adverse Event|13|||
127534229|NCT01623115|458918869|FG000|Overall Study|Poor compliance to protocol|4|||
127534230|NCT01623115|458918870|FG001|Overall Study|Poor compliance to protocol|10|||
127534231|NCT01623115|458918869|FG000|Overall Study|Consent withdrawn by participant|2|||
127534232|NCT01623115|458918870|FG001|Overall Study|Consent withdrawn by participant|6|||
127534233|NCT01623115|458918869|FG000|Overall Study|Related to study drug administration|0|||
127534234|NCT01623115|458918870|FG001|Overall Study|Related to study drug administration|2|||
127534235|NCT01623115|458918869|FG000|Overall Study|Last visit outside protocol visit window|14|||
127534236|NCT01623115|458918870|FG001|Overall Study|Last visit outside protocol visit window|26|||
127534237|NCT01623115|458918869|FG000|Overall Study|Site closure|1|||
127534238|NCT01623115|458918870|FG001|Overall Study|Site closure|7|||
127534239|NCT01623115|458918869|FG000|Overall Study|Death|0|||
127534240|NCT01623115|458918870|FG001|Overall Study|Death|4|||
127534241|NCT01623115|458918869|FG000|Overall Study|Other than specified above|0|||
127534242|NCT01623115|458918870|FG001|Overall Study|Other than specified above|3|||
127534243|NCT00857285|458918875|FG000|Overall Study|Adverse Event|4|||
127534244|NCT00857285|458918876|FG001|Overall Study|Adverse Event|2|||
127534245|NCT00857285|458918875|FG000|Overall Study|Lack of Efficacy|0|||
127534246|NCT00857285|458918876|FG001|Overall Study|Lack of Efficacy|2|||
127534247|NCT00857285|458918875|FG000|Overall Study|Protocol Violation|3|||
127534248|NCT00857285|458918876|FG001|Overall Study|Protocol Violation|1|||
127534249|NCT00857285|458918875|FG000|Overall Study|Withdrawal by Subject|4|||
127534250|NCT00857285|458918876|FG001|Overall Study|Withdrawal by Subject|0|||
127534251|NCT00857285|458918875|FG000|Overall Study|Randomization criteria not met|1|||
127534252|NCT00857285|458918876|FG001|Overall Study|Randomization criteria not met|1|||
127534253|NCT01433172|458918877|FG000|Overall Study|Withdrawal by Subject|0|||
127534254|NCT01433172|458918878|FG001|Overall Study|Withdrawal by Subject|1|||
127534255|NCT01433172|458918879|FG002|Overall Study|Withdrawal by Subject|0|||
127534256|NCT01433172|458918877|FG000|Overall Study|Disease Progression|0|||
127534257|NCT01433172|458918878|FG001|Overall Study|Disease Progression|0|||
127534258|NCT01433172|458918879|FG002|Overall Study|Disease Progression|1|||
127534259|NCT01433172|458918877|FG000|Overall Study|Death|0|||
127534260|NCT01433172|458918878|FG001|Overall Study|Death|2|||
127534261|NCT01433172|458918879|FG002|Overall Study|Death|0|||
127534262|NCT01987102|458918883|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
127534263|NCT01987102|458918884|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
127534264|NCT01987102|458918883|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
127534265|NCT01987102|458918884|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
127534266|NCT01987102|458918883|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
127534267|NCT01987102|458918884|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
127534268|NCT01987102|458918883|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
127534269|NCT01987102|458918884|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
127534270|NCT01987102|458918883|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
127534271|NCT01987102|458918884|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
127534272|NCT01987102|458918883|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
127534273|NCT01987102|458918884|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
127534274|NCT01236521|458918885|FG000|Overall Study|Withdrawal by Subject|12|||
127534275|NCT01236521|458918886|FG001|Overall Study|Withdrawal by Subject|17|||
127534276|NCT01236521|458918885|FG000|Overall Study|Death|2|||
127534277|NCT01236521|458918886|FG001|Overall Study|Death|1|||
127534278|NCT01236521|458918885|FG000|Overall Study|Lost to Follow-up|9|||
127534279|NCT01236521|458918886|FG001|Overall Study|Lost to Follow-up|7|||
127534280|NCT03446313|458918887|FG000|Overall Study|Lost to Follow-up|1|||
127534281|NCT03446313|458918888|FG001|Overall Study|Lost to Follow-up|2|||
127534282|NCT03446313|458918887|FG000|Overall Study|Failed primary screening|3|||
127534283|NCT03446313|458918888|FG001|Overall Study|Failed primary screening|0|||
127534284|NCT03446313|458918887|FG000|Overall Study|Diagnosed with terminal cancer|1|||
127534285|NCT03446313|458918888|FG001|Overall Study|Diagnosed with terminal cancer|0|||
127534286|NCT03446313|458918887|FG000|Overall Study|Excluded from analysis|1|||
127534287|NCT03446313|458918888|FG001|Overall Study|Excluded from analysis|1|||
127534288|NCT04491136|458918893|FG000|Overall Study|Patient withdraw informed consent|9|||
127534289|NCT04491136|458918893|FG000|Overall Study|Adverse Event|2|||
127534290|NCT04491136|458918893|FG000|Overall Study|Death|3|||
127534291|NCT04491136|458918893|FG000|Overall Study|Lost to Follow-up|3|||
127534292|NCT04491136|458918893|FG000|Overall Study|Physician Decision|45|||
127534293|NCT04491136|458918893|FG000|Overall Study|sponsor terminated the study early|16|||
127534294|NCT04491136|458918893|FG000|Overall Study|Patient/guardian's decision|1|||
127534295|NCT01611194|458918894|FG000|Overall Study|Lost to Follow-up|0|||
127534296|NCT01611194|458918895|FG001|Overall Study|Lost to Follow-up|1|||
127534297|NCT01611194|458918894|FG000|Overall Study|Withdrawal by Subject|0|||
127534298|NCT01611194|458918895|FG001|Overall Study|Withdrawal by Subject|1|||
127534299|NCT01611194|458918894|FG000|Overall Study|drug use|0|||
127534300|NCT01611194|458918895|FG001|Overall Study|drug use|1|||
127534301|NCT00348673|458918896|FG000|Stage 1|Randomized but not Treated|0|||
127534302|NCT00348673|458918897|FG001|Stage 1|Randomized but not Treated|0|||
127534303|NCT00348673|458918898|FG002|Stage 1|Randomized but not Treated|1|||
127534304|NCT00348673|458918899|FG003|Stage 1|Randomized but not Treated|0|||
127534305|NCT00348673|458918900|FG004|Stage 1|Randomized but not Treated|0|||
127534306|NCT00348673|458918901|FG005|Stage 1|Randomized but not Treated|0|||
127534307|NCT00348673|458918902|FG006|Stage 1|Randomized but not Treated|0|||
127534308|NCT00348673|458918903|FG007|Stage 1|Randomized but not Treated|0|||
127534309|NCT00348673|458918904|FG008|Stage 1|Randomized but not Treated|0|||
127534310|NCT03790111|458920917|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
127534311|NCT03798717|458920922|FG000|Overall Study|Failed Screening|0|||
127534312|NCT03798717|458920923|FG001|Overall Study|Failed Screening|0|||
127534313|NCT03798717|458920924|FG002|Overall Study|Failed Screening|0|||
127534314|NCT03798717|458920925|FG003|Overall Study|Failed Screening|0|||
127534315|NCT03798717|458920926|FG004|Overall Study|Failed Screening|0|||
127534316|NCT03798717|458920927|FG005|Overall Study|Failed Screening|1|||
127534317|NCT03798717|458920922|FG000|Overall Study|Physician Decision|1|||
127534318|NCT03798717|458920923|FG001|Overall Study|Physician Decision|0|||
127534319|NCT03798717|458920924|FG002|Overall Study|Physician Decision|1|||
127534320|NCT03798717|458920925|FG003|Overall Study|Physician Decision|0|||
127534321|NCT03798717|458920926|FG004|Overall Study|Physician Decision|0|||
127534322|NCT03798717|458920927|FG005|Overall Study|Physician Decision|0|||
127534323|NCT03798717|458920922|FG000|Overall Study|Withdrawal by Subject|0|||
127534324|NCT03798717|458920923|FG001|Overall Study|Withdrawal by Subject|0|||
127534325|NCT03798717|458920924|FG002|Overall Study|Withdrawal by Subject|0|||
127534326|NCT03798717|458920925|FG003|Overall Study|Withdrawal by Subject|1|||
127534327|NCT03798717|458920926|FG004|Overall Study|Withdrawal by Subject|0|||
127534328|NCT03798717|458920927|FG005|Overall Study|Withdrawal by Subject|0|||
127534329|NCT03798717|458920922|FG000|Overall Study|Lost to Follow-up|1|||
127534330|NCT03798717|458920923|FG001|Overall Study|Lost to Follow-up|0|||
127534331|NCT03798717|458920924|FG002|Overall Study|Lost to Follow-up|0|||
127534332|NCT03798717|458920925|FG003|Overall Study|Lost to Follow-up|1|||
127534333|NCT03798717|458920926|FG004|Overall Study|Lost to Follow-up|0|||
127534334|NCT03798717|458920927|FG005|Overall Study|Lost to Follow-up|0|||
127534335|NCT03798717|458920922|FG000|Overall Study|Adverse Event|0|||
127534336|NCT03798717|458920923|FG001|Overall Study|Adverse Event|1|||
127534337|NCT03798717|458920924|FG002|Overall Study|Adverse Event|0|||
127534338|NCT03798717|458920925|FG003|Overall Study|Adverse Event|0|||
127534339|NCT03798717|458920926|FG004|Overall Study|Adverse Event|0|||
127534340|NCT03798717|458920927|FG005|Overall Study|Adverse Event|0|||
127534341|NCT03798717|458920922|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
127534342|NCT03798717|458920923|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
127534343|NCT03798717|458920924|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
127534344|NCT03798717|458920925|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
127534345|NCT03798717|458920926|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
127534346|NCT03798717|458920927|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
127534347|NCT01777308|458920931|FG000|Overall Study|Withdrawal by Subject|5|||
127534348|NCT01777308|458920932|FG001|Overall Study|Withdrawal by Subject|1|||
127534349|NCT01777308|458920931|FG000|Overall Study|Migrated/moved from study area|1|||
127534350|NCT01777308|458920932|FG001|Overall Study|Migrated/moved from study area|0|||
127534351|NCT01777308|458920931|FG000|Overall Study|Lost to Follow-up|7|||
127534352|NCT01777308|458920932|FG001|Overall Study|Lost to Follow-up|2|||
127534353|NCT01777308|458920931|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
127534354|NCT01777308|458920932|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
127534355|NCT03212326|458920934|FG000|Overall Study|Physician Decision|4|||
127534356|NCT00985673|458920946|FG000|Overall Study|Lost to Follow-up|6|||
127534357|NCT00985673|458920947|FG001|Overall Study|Lost to Follow-up|7|||
127534358|NCT00985673|458920948|FG002|Overall Study|Lost to Follow-up|6|||
127534359|NCT00985673|458920949|FG003|Overall Study|Lost to Follow-up|10|||
127534360|NCT00985673|458920950|FG004|Overall Study|Lost to Follow-up|5|||
127534361|NCT00985673|458920951|FG005|Overall Study|Lost to Follow-up|3|||
127534362|NCT00985673|458920946|FG000|Overall Study|Withdrawal by Subject|0|||
127534363|NCT00985673|458920947|FG001|Overall Study|Withdrawal by Subject|4|||
127534364|NCT00985673|458920948|FG002|Overall Study|Withdrawal by Subject|5|||
127534365|NCT00985673|458920949|FG003|Overall Study|Withdrawal by Subject|2|||
127534366|NCT00985673|458920950|FG004|Overall Study|Withdrawal by Subject|2|||
127534367|NCT00985673|458920951|FG005|Overall Study|Withdrawal by Subject|3|||
127534368|NCT00985673|458920946|FG000|Overall Study|Other|1|||
127534369|NCT00985673|458920947|FG001|Overall Study|Other|0|||
127534370|NCT00985673|458920948|FG002|Overall Study|Other|1|||
127534371|NCT00985673|458920949|FG003|Overall Study|Other|0|||
127534372|NCT00985673|458920950|FG004|Overall Study|Other|1|||
127534373|NCT00985673|458920951|FG005|Overall Study|Other|0|||
127534374|NCT02252146|458920952|FG000|Overall Study|Lack of Efficacy|4|||
127534375|NCT02252146|458920952|FG000|Overall Study|Entered hospice care|1|||
127534376|NCT02252146|458920952|FG000|Overall Study|Inability to travel to study site|1|||
127534377|NCT00531284|458920955|FG000|Overall Study|Progressive Disease|1|||
127534378|NCT00531284|458920956|FG001|Overall Study|Progressive Disease|3|||
127534379|NCT00531284|458920957|FG002|Overall Study|Progressive Disease|5|||
127534380|NCT00531284|458920958|FG003|Overall Study|Progressive Disease|42|||
127534381|NCT00531284|458920959|FG004|Overall Study|Progressive Disease|4|||
127534382|NCT00531284|458920960|FG005|Overall Study|Progressive Disease|4|||
127534383|NCT00531284|458920961|FG006|Overall Study|Progressive Disease|3|||
127534384|NCT00531284|458920962|FG007|Overall Study|Progressive Disease|8|||
127534385|NCT00531284|458920963|FG008|Overall Study|Progressive Disease|6|||
127534386|NCT00531284|458920964|FG009|Overall Study|Progressive Disease|3|||
127534387|NCT00531284|458920965|FG010|Overall Study|Progressive Disease|3|||
127534388|NCT00531284|458920966|FG011|Overall Study|Progressive Disease|14|||
127534389|NCT00531284|458920967|FG012|Overall Study|Progressive Disease|2|||
127534390|NCT00531284|458920968|FG013|Overall Study|Progressive Disease|1|||
127534391|NCT00531284|458920969|FG014|Overall Study|Progressive Disease|2|||
127534392|NCT00531284|458920970|FG015|Overall Study|Progressive Disease|11|||
127534393|NCT00531284|458920971|FG016|Overall Study|Progressive Disease|5|||
127534394|NCT00531284|458920955|FG000|Overall Study|Adverse Event|0|||
127534395|NCT00531284|458920956|FG001|Overall Study|Adverse Event|1|||
127534396|NCT00531284|458920957|FG002|Overall Study|Adverse Event|1|||
127534397|NCT00531284|458920958|FG003|Overall Study|Adverse Event|7|||
127534398|NCT00531284|458920959|FG004|Overall Study|Adverse Event|0|||
127534399|NCT00531284|458920960|FG005|Overall Study|Adverse Event|2|||
127534400|NCT00531284|458920961|FG006|Overall Study|Adverse Event|3|||
127534401|NCT00531284|458920962|FG007|Overall Study|Adverse Event|2|||
127534402|NCT00531284|458920963|FG008|Overall Study|Adverse Event|3|||
127534403|NCT00531284|458920964|FG009|Overall Study|Adverse Event|0|||
127534404|NCT00531284|458920965|FG010|Overall Study|Adverse Event|0|||
127534405|NCT00531284|458920966|FG011|Overall Study|Adverse Event|5|||
127534406|NCT00531284|458920967|FG012|Overall Study|Adverse Event|0|||
127534407|NCT00531284|458920968|FG013|Overall Study|Adverse Event|1|||
127534408|NCT00531284|458920969|FG014|Overall Study|Adverse Event|1|||
127534409|NCT00531284|458920970|FG015|Overall Study|Adverse Event|0|||
127534410|NCT00531284|458920971|FG016|Overall Study|Adverse Event|2|||
127534411|NCT00531284|458920955|FG000|Overall Study|Withdrawal by Subject|1|||
127534412|NCT00531284|458920956|FG001|Overall Study|Withdrawal by Subject|0|||
127534413|NCT00531284|458920957|FG002|Overall Study|Withdrawal by Subject|0|||
127534414|NCT00531284|458920958|FG003|Overall Study|Withdrawal by Subject|4|||
127534415|NCT00531284|458920959|FG004|Overall Study|Withdrawal by Subject|0|||
127534416|NCT00531284|458920960|FG005|Overall Study|Withdrawal by Subject|0|||
127534417|NCT00531284|458920961|FG006|Overall Study|Withdrawal by Subject|0|||
127534418|NCT00531284|458920962|FG007|Overall Study|Withdrawal by Subject|0|||
127534419|NCT00531284|458920963|FG008|Overall Study|Withdrawal by Subject|0|||
127534420|NCT00531284|458920964|FG009|Overall Study|Withdrawal by Subject|0|||
127534421|NCT00531284|458920965|FG010|Overall Study|Withdrawal by Subject|0|||
127534422|NCT00531284|458920966|FG011|Overall Study|Withdrawal by Subject|3|||
127534423|NCT00531284|458920967|FG012|Overall Study|Withdrawal by Subject|0|||
127534424|NCT00531284|458920968|FG013|Overall Study|Withdrawal by Subject|1|||
127534425|NCT00531284|458920969|FG014|Overall Study|Withdrawal by Subject|0|||
127534426|NCT00531284|458920970|FG015|Overall Study|Withdrawal by Subject|1|||
127534427|NCT00531284|458920971|FG016|Overall Study|Withdrawal by Subject|1|||
127534428|NCT00531284|458920955|FG000|Overall Study|Other|1|||
127534429|NCT00531284|458920956|FG001|Overall Study|Other|0|||
127534430|NCT00531284|458920957|FG002|Overall Study|Other|0|||
127534431|NCT00531284|458920958|FG003|Overall Study|Other|10|||
127534432|NCT00531284|458920959|FG004|Overall Study|Other|2|||
127534433|NCT00531284|458920960|FG005|Overall Study|Other|1|||
127534434|NCT00531284|458920961|FG006|Overall Study|Other|0|||
127534435|NCT00531284|458920962|FG007|Overall Study|Other|0|||
127534436|NCT00531284|458920963|FG008|Overall Study|Other|2|||
127534437|NCT00531284|458920964|FG009|Overall Study|Other|1|||
127534438|NCT00531284|458920965|FG010|Overall Study|Other|0|||
127534439|NCT00531284|458920966|FG011|Overall Study|Other|2|||
127534440|NCT00531284|458920967|FG012|Overall Study|Other|0|||
127534441|NCT00531284|458920968|FG013|Overall Study|Other|0|||
127534442|NCT00531284|458920969|FG014|Overall Study|Other|1|||
127534443|NCT00531284|458920970|FG015|Overall Study|Other|0|||
127534444|NCT00531284|458920971|FG016|Overall Study|Other|0|||
127534445|NCT02219464|458920973|FG000|Overall Study|Withdrawal by Subject|1|||
127534446|NCT02219464|458920974|FG001|Overall Study|Withdrawal by Subject|0|||
127534447|NCT02219464|458920973|FG000|Overall Study|case cancelled|1|||
127534448|NCT02219464|458920974|FG001|Overall Study|case cancelled|0|||
127534449|NCT02219464|458920973|FG000|Overall Study|catheter malfunction|1|||
127534450|NCT02219464|458920974|FG001|Overall Study|catheter malfunction|0|||
127534451|NCT00984256|458920975|FG000|Overall Study|Withdrawal by Subject|0|||
127534452|NCT00984256|458920976|FG001|Overall Study|Withdrawal by Subject|1|||
127534453|NCT03057496|458920977|FG000|Overall Study|Withdrawal by Subject|8|||
127534454|NCT03057496|458920977|FG000|Overall Study|Lost to Follow-up|5|||
127534455|NCT03057496|458920977|FG000|Overall Study|Did not use device during home trial|3|||
127534456|NCT03057496|458920977|FG000|Overall Study|Device failure|2|||
127534457|NCT00280917|458920985|FG000|Overall Study|Adverse Event|1|||
127534458|NCT00280917|458920986|FG001|Overall Study|Adverse Event|1|||
127534459|NCT00280917|458920987|FG002|Overall Study|Adverse Event|4|||
127534460|NCT00280917|458920988|FG003|Overall Study|Adverse Event|1|||
127534461|NCT00280917|458920985|FG000|Overall Study|Change Therapy|1|||
127534462|NCT00280917|458920986|FG001|Overall Study|Change Therapy|2|||
127534463|NCT00280917|458920987|FG002|Overall Study|Change Therapy|0|||
127534464|NCT00280917|458920988|FG003|Overall Study|Change Therapy|0|||
127534465|NCT00280917|458920985|FG000|Overall Study|Withdrawal by Subject|0|||
127534466|NCT00280917|458920986|FG001|Overall Study|Withdrawal by Subject|2|||
127534467|NCT00280917|458920987|FG002|Overall Study|Withdrawal by Subject|0|||
127534468|NCT00280917|458920988|FG003|Overall Study|Withdrawal by Subject|1|||
127534469|NCT00280917|458920985|FG000|Overall Study|Noncompliance|0|||
127534470|NCT00280917|458920986|FG001|Overall Study|Noncompliance|1|||
127534471|NCT00280917|458920987|FG002|Overall Study|Noncompliance|2|||
127534472|NCT00280917|458920988|FG003|Overall Study|Noncompliance|0|||
127534473|NCT02544321|458920993|FG000|Overall Study|Withdrawal by Subject|1|||
127534474|NCT02544321|458920994|FG001|Overall Study|Withdrawal by Subject|2|||
127534475|NCT02544321|458920993|FG000|Overall Study|Adverse Event|1|||
127534476|NCT02544321|458920994|FG001|Overall Study|Adverse Event|1|||
127534477|NCT02544321|458920993|FG000|Overall Study|Protocol Violation|0|||
127534478|NCT02544321|458920994|FG001|Overall Study|Protocol Violation|1|||
127534479|NCT01584232|458920995|FG000|Overall Study|Adverse Event|3|||
127534480|NCT01584232|458920996|FG001|Overall Study|Adverse Event|1|||
127534481|NCT01584232|458920995|FG000|Overall Study|Withdrawal by Subject|2|||
127534482|NCT01584232|458920996|FG001|Overall Study|Withdrawal by Subject|1|||
127534483|NCT01584232|458920995|FG000|Overall Study|Physician Decision|2|||
127534484|NCT01584232|458920996|FG001|Overall Study|Physician Decision|1|||
127534485|NCT01584232|458920995|FG000|Overall Study|Lost to Follow-up|1|||
127534486|NCT01584232|458920996|FG001|Overall Study|Lost to Follow-up|0|||
127534487|NCT01731912|458920999|FG000|Overall Study|noncompliance|2|||
127534488|NCT02043938|458921000|FG000|Overall Study|Withdrawal by Subject|7|||
127534489|NCT02043938|458921000|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
127534490|NCT02043938|458921000|FG000|Overall Study|No show by subject|1|||
127534491|NCT02043938|458921000|FG000|Overall Study|Investigator decision|1|||
127534492|NCT02222558|458921001|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
127534493|NCT02222558|458921002|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
127534494|NCT02222558|458921003|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
127534495|NCT02222558|458921004|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
127534496|NCT02222558|458921005|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
127534497|NCT02222558|458921006|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
127534498|NCT02222558|458921001|FG000|Period 3|Withdrawal by Subject|0|||
127534499|NCT02222558|458921002|FG001|Period 3|Withdrawal by Subject|0|||
127534500|NCT02222558|458921003|FG002|Period 3|Withdrawal by Subject|0|||
127534501|NCT02222558|458921004|FG003|Period 3|Withdrawal by Subject|0|||
127534502|NCT02222558|458921005|FG004|Period 3|Withdrawal by Subject|0|||
127534503|NCT02222558|458921006|FG005|Period 3|Withdrawal by Subject|1|||
127534504|NCT03400852|458921007|FG000|Blinded Treatment Period|Physician Decision|0|||
127534505|NCT03400852|458921008|FG001|Blinded Treatment Period|Physician Decision|1|||
127534506|NCT03400852|458921009|FG002|Blinded Treatment Period|Physician Decision|0|||
127534507|NCT03400852|458921007|FG000|Blinded Treatment Period|Adverse Event|1|||
127534508|NCT03400852|458921008|FG001|Blinded Treatment Period|Adverse Event|1|||
127534509|NCT03400852|458921009|FG002|Blinded Treatment Period|Adverse Event|0|||
127534510|NCT03400852|458921007|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
127534511|NCT03400852|458921008|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
127534512|NCT03400852|458921009|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
127534513|NCT03400852|458921007|FG000|Open Label Period|Physician Decision|0|||
127534514|NCT03400852|458921008|FG001|Open Label Period|Physician Decision|0|||
127534515|NCT03400852|458921009|FG002|Open Label Period|Physician Decision|1|||
127534516|NCT03400852|458921007|FG000|Open Label Period|Study terminated by sponsor|0|||
127534517|NCT03400852|458921008|FG001|Open Label Period|Study terminated by sponsor|0|||
127534518|NCT03400852|458921009|FG002|Open Label Period|Study terminated by sponsor|21|||
127534519|NCT00936702|458921010|FG000|Overall Study|Disease progression|34|||
127534520|NCT00936702|458921010|FG000|Overall Study|Adverse Event|8|||
127534521|NCT00936702|458921010|FG000|Overall Study|Withdrawal by Subject|2|||
127534522|NCT00936702|458921010|FG000|Overall Study|Alternative Treatment|1|||
127534523|NCT00936702|458921010|FG000|Overall Study|Other|1|||
127534524|NCT02532465|458921011|FG000|Overall Study|Protocol Violation|1|||
127534525|NCT02532465|458921012|FG001|Overall Study|Protocol Violation|0|||
127534526|NCT02532465|458921011|FG000|Overall Study|Lack of Efficacy|0|||
127534527|NCT02532465|458921012|FG001|Overall Study|Lack of Efficacy|1|||
127534528|NCT00354679|458921018|FG000|Overall Study|Patient Not Treated|1|||
127534529|NCT00622505|458921019|FG000|Overall Study|Adverse Event|9|||
127534530|NCT00622505|458921020|FG001|Overall Study|Adverse Event|7|||
127534531|NCT00622505|458921019|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
127534532|NCT00622505|458921020|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
127534533|NCT00622505|458921019|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
127534534|NCT00622505|458921020|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
127534535|NCT00622505|458921019|FG000|Overall Study|Withdrawal by Subject|12|||
127534536|NCT00622505|458921020|FG001|Overall Study|Withdrawal by Subject|5|||
127534537|NCT00622505|458921019|FG000|Overall Study|Administrative Problems|2|||
127534538|NCT00622505|458921020|FG001|Overall Study|Administrative Problems|4|||
127534539|NCT00622505|458921019|FG000|Overall Study|Death|2|||
127534540|NCT00622505|458921020|FG001|Overall Study|Death|2|||
127534541|NCT02420093|458921023|FG000|Overall Study|Withdrawal by Subject|1|||
127534542|NCT02420093|458921024|FG001|Overall Study|Withdrawal by Subject|1|||
127534543|NCT03244917|458921027|FG000|Overall Study|Lost to Follow-up|2|||
127534544|NCT03244917|458921028|FG001|Overall Study|Lost to Follow-up|2|||
127534545|NCT02159066|458921031|FG000|Part I|Adverse Event|7|||
127534546|NCT02159066|458921032|FG001|Part I|Adverse Event|5|||
127534547|NCT02159066|458921033|FG002|Part I|Adverse Event|0|||
127534548|NCT02159066|458921034|FG003|Part I|Adverse Event|0|||
127534549|NCT02159066|458921035|FG004|Part I|Adverse Event|0|||
127534550|NCT02159066|458921036|FG005|Part I|Adverse Event|0|||
127534551|NCT02159066|458921031|FG000|Part I|Death|11|||
127534552|NCT02159066|458921032|FG001|Part I|Death|9|||
127534553|NCT02159066|458921033|FG002|Part I|Death|0|||
127534554|NCT02159066|458921034|FG003|Part I|Death|0|||
127534555|NCT02159066|458921035|FG004|Part I|Death|0|||
127534556|NCT02159066|458921036|FG005|Part I|Death|0|||
127534557|NCT02159066|458921031|FG000|Part I|Progressive Disease|37|||
127534558|NCT02159066|458921032|FG001|Part I|Progressive Disease|46|||
127534559|NCT02159066|458921033|FG002|Part I|Progressive Disease|0|||
127534560|NCT02159066|458921034|FG003|Part I|Progressive Disease|0|||
127534561|NCT02159066|458921035|FG004|Part I|Progressive Disease|0|||
127534562|NCT02159066|458921036|FG005|Part I|Progressive Disease|0|||
127534563|NCT02159066|458921031|FG000|Part I|New Therapy for Study Indication|5|||
127534564|NCT02159066|458921032|FG001|Part I|New Therapy for Study Indication|4|||
127534565|NCT02159066|458921033|FG002|Part I|New Therapy for Study Indication|0|||
127534566|NCT02159066|458921034|FG003|Part I|New Therapy for Study Indication|0|||
127534567|NCT02159066|458921035|FG004|Part I|New Therapy for Study Indication|0|||
127534568|NCT02159066|458921036|FG005|Part I|New Therapy for Study Indication|0|||
127534569|NCT02159066|458921031|FG000|Part I|Termination of participants from the study|3|||
127534570|NCT02159066|458921032|FG001|Part I|Termination of participants from the study|3|||
127534571|NCT02159066|458921033|FG002|Part I|Termination of participants from the study|0|||
127534572|NCT02159066|458921034|FG003|Part I|Termination of participants from the study|0|||
127534573|NCT02159066|458921035|FG004|Part I|Termination of participants from the study|0|||
127534574|NCT02159066|458921036|FG005|Part I|Termination of participants from the study|0|||
127534575|NCT02159066|458921031|FG000|Part I|Physician Decision|2|||
127534576|NCT02159066|458921032|FG001|Part I|Physician Decision|9|||
127534577|NCT02159066|458921033|FG002|Part I|Physician Decision|0|||
127534578|NCT02159066|458921034|FG003|Part I|Physician Decision|0|||
127534579|NCT02159066|458921035|FG004|Part I|Physician Decision|0|||
127534580|NCT02159066|458921036|FG005|Part I|Physician Decision|0|||
127534581|NCT02159066|458921031|FG000|Part I|Participant/Guardian Decision|9|||
127534582|NCT02159066|458921032|FG001|Part I|Participant/Guardian Decision|3|||
127534583|NCT02159066|458921033|FG002|Part I|Participant/Guardian Decision|0|||
127534584|NCT02159066|458921034|FG003|Part I|Participant/Guardian Decision|0|||
127534585|NCT02159066|458921035|FG004|Part I|Participant/Guardian Decision|0|||
127534586|NCT02159066|458921036|FG005|Part I|Participant/Guardian Decision|0|||
127534587|NCT02159066|458921031|FG000|Part I|Missing Data|1|||
127534588|NCT02159066|458921032|FG001|Part I|Missing Data|0|||
127534589|NCT02159066|458921033|FG002|Part I|Missing Data|0|||
127534590|NCT02159066|458921034|FG003|Part I|Missing Data|0|||
127534591|NCT02159066|458921035|FG004|Part I|Missing Data|0|||
127534592|NCT02159066|458921036|FG005|Part I|Missing Data|0|||
127534593|NCT02159066|458921031|FG000|Part II|Adverse Event|0|||
127534594|NCT02159066|458921032|FG001|Part II|Adverse Event|0|||
127534595|NCT02159066|458921033|FG002|Part II|Adverse Event|1|||
127534596|NCT02159066|458921034|FG003|Part II|Adverse Event|0|||
127534597|NCT02159066|458921035|FG004|Part II|Adverse Event|1|||
127534598|NCT02159066|458921036|FG005|Part II|Adverse Event|1|||
127534599|NCT02159066|458921031|FG000|Part II|Death|0|||
127534600|NCT02159066|458921032|FG001|Part II|Death|0|||
127534601|NCT02159066|458921033|FG002|Part II|Death|1|||
127534602|NCT02159066|458921034|FG003|Part II|Death|0|||
127534603|NCT02159066|458921035|FG004|Part II|Death|2|||
127534604|NCT02159066|458921036|FG005|Part II|Death|1|||
127534605|NCT02159066|458921031|FG000|Part II|Progressive Disease|0|||
127534606|NCT02159066|458921032|FG001|Part II|Progressive Disease|0|||
127534607|NCT02159066|458921033|FG002|Part II|Progressive Disease|35|||
127534608|NCT02159066|458921034|FG003|Part II|Progressive Disease|1|||
127534609|NCT02159066|458921035|FG004|Part II|Progressive Disease|7|||
127534610|NCT02159066|458921036|FG005|Part II|Progressive Disease|4|||
127534611|NCT02159066|458921031|FG000|Part II|New Therapy for Study Indication|0|||
127534612|NCT02159066|458921032|FG001|Part II|New Therapy for Study Indication|0|||
127534613|NCT02159066|458921033|FG002|Part II|New Therapy for Study Indication|0|||
127534614|NCT02159066|458921034|FG003|Part II|New Therapy for Study Indication|0|||
127534615|NCT02159066|458921035|FG004|Part II|New Therapy for Study Indication|1|||
127534616|NCT02159066|458921036|FG005|Part II|New Therapy for Study Indication|0|||
127534617|NCT02159066|458921031|FG000|Part II|Physician Decision|0|||
127534618|NCT02159066|458921032|FG001|Part II|Physician Decision|0|||
127534619|NCT02159066|458921033|FG002|Part II|Physician Decision|1|||
127534620|NCT02159066|458921034|FG003|Part II|Physician Decision|0|||
127534621|NCT02159066|458921035|FG004|Part II|Physician Decision|0|||
127534622|NCT02159066|458921036|FG005|Part II|Physician Decision|0|||
127534623|NCT02159066|458921031|FG000|Part II|Participant/Guardian Decision|0|||
127534624|NCT02159066|458921032|FG001|Part II|Participant/Guardian Decision|0|||
127534625|NCT02159066|458921033|FG002|Part II|Participant/Guardian Decision|0|||
127534626|NCT02159066|458921034|FG003|Part II|Participant/Guardian Decision|0|||
127534627|NCT02159066|458921035|FG004|Part II|Participant/Guardian Decision|2|||
127534628|NCT02159066|458921036|FG005|Part II|Participant/Guardian Decision|0|||
127534629|NCT01147666|458921037|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
127534630|NCT01147666|458921038|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
127534631|NCT01147666|458921039|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
127534632|NCT01147666|458921040|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
127534633|NCT01147666|458921041|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
127534634|NCT01147666|458921042|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
127534635|NCT01147666|458921043|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
127534636|NCT01147666|458921044|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
127534637|NCT01147666|458921045|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
127534638|NCT01147666|458921046|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
127534639|NCT01147666|458921047|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
127534640|NCT01147666|458921048|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
127534641|NCT01147666|458921049|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
127534642|NCT01147666|458921050|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
127534643|NCT01147666|458921051|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
127534644|NCT01147666|458921037|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
127534645|NCT01147666|458921038|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
127534646|NCT01147666|458921039|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
127534647|NCT01147666|458921040|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
127534648|NCT01147666|458921041|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
127534649|NCT01147666|458921042|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
127534650|NCT01147666|458921043|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
127534651|NCT01147666|458921044|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
127534652|NCT01147666|458921045|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
127534653|NCT01147666|458921046|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
127534654|NCT01147666|458921047|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
127534655|NCT01147666|458921048|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
127534656|NCT01147666|458921049|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
127534657|NCT01147666|458921050|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
127534658|NCT01147666|458921051|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
127534659|NCT01147666|458921037|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
127534660|NCT01147666|458921038|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
127534661|NCT01147666|458921039|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
127534662|NCT01147666|458921040|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
127534663|NCT01147666|458921041|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
127534664|NCT01147666|458921042|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
127534665|NCT01147666|458921043|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
127534666|NCT01147666|458921044|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
127534667|NCT01147666|458921045|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
127534668|NCT01147666|458921046|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
127534669|NCT01147666|458921047|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
127534670|NCT01147666|458921048|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
127534671|NCT01147666|458921049|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
127534672|NCT01147666|458921050|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
127534673|NCT01147666|458921051|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
127534674|NCT01147666|458921037|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
127534675|NCT01147666|458921038|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
127534676|NCT01147666|458921039|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
127534677|NCT01147666|458921040|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
127534678|NCT01147666|458921041|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
127534679|NCT01147666|458921042|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
127534680|NCT01147666|458921043|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
127534681|NCT01147666|458921044|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
127534682|NCT01147666|458921045|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
127534683|NCT01147666|458921046|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
127534684|NCT01147666|458921047|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
127534685|NCT01147666|458921048|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
127534686|NCT01147666|458921049|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
127534687|NCT01147666|458921050|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
127534688|NCT01147666|458921051|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
127534689|NCT01147666|458921037|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
127534690|NCT01147666|458921038|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
127534691|NCT01147666|458921039|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
127534692|NCT01147666|458921040|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
127534693|NCT01147666|458921041|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
127534694|NCT01147666|458921042|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
127534695|NCT01147666|458921043|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
127534696|NCT01147666|458921044|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
127534697|NCT01147666|458921045|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
127534698|NCT01147666|458921046|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
127534699|NCT01147666|458921047|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
127534700|NCT01147666|458921048|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
127534701|NCT01147666|458921049|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
127534702|NCT01147666|458921050|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
127534703|NCT01147666|458921051|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
127534704|NCT01147666|458921037|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
127534705|NCT01147666|458921038|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
127534706|NCT01147666|458921039|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
127534707|NCT01147666|458921040|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
127534708|NCT01147666|458921041|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
127534709|NCT01147666|458921042|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
127534710|NCT01147666|458921043|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
127534711|NCT01147666|458921044|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
127534712|NCT01147666|458921045|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
127534713|NCT01147666|458921046|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
127534714|NCT01147666|458921047|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
127534715|NCT01147666|458921048|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
127534716|NCT01147666|458921049|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
127534717|NCT01147666|458921050|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
127534718|NCT01147666|458921051|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
127534719|NCT01147666|458921037|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
127534720|NCT01147666|458921038|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
127534721|NCT01147666|458921039|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
127534722|NCT01147666|458921040|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
127534723|NCT01147666|458921041|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
127534724|NCT01147666|458921042|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
127534725|NCT01147666|458921043|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
127534726|NCT01147666|458921044|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
127534727|NCT01147666|458921045|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
127534728|NCT01147666|458921046|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
127534729|NCT01147666|458921047|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
127534730|NCT01147666|458921048|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
127534731|NCT01147666|458921049|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
127534732|NCT01147666|458921050|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
127534733|NCT01147666|458921051|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
127534734|NCT01147666|458921037|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
127534735|NCT01147666|458921038|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
127534736|NCT01147666|458921039|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
127534737|NCT01147666|458921040|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
127534738|NCT01147666|458921041|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
127534739|NCT01147666|458921042|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
127534740|NCT01147666|458921043|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
127534741|NCT01147666|458921044|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
127534742|NCT01147666|458921045|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
127534743|NCT01147666|458921046|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
127534744|NCT01147666|458921047|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
127534745|NCT01147666|458921048|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
127534746|NCT01147666|458921049|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
127534747|NCT01147666|458921050|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
127534748|NCT01147666|458921051|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
127534749|NCT01147666|458921037|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
127534750|NCT01147666|458921038|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
127534751|NCT01147666|458921039|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
127534752|NCT01147666|458921040|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
127534753|NCT01147666|458921041|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
127534754|NCT01147666|458921042|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
127534755|NCT01147666|458921043|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
127534756|NCT01147666|458921044|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
127534757|NCT01147666|458921045|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
127534758|NCT01147666|458921046|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
127534759|NCT01147666|458921047|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
127534760|NCT01147666|458921048|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
127534761|NCT01147666|458921049|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
127534762|NCT01147666|458921050|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
127534763|NCT01147666|458921051|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
127534764|NCT01147666|458921037|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
127534765|NCT01147666|458921038|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
127534766|NCT01147666|458921039|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
127534767|NCT01147666|458921040|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
127534768|NCT01147666|458921041|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
127534769|NCT01147666|458921042|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
127534770|NCT01147666|458921043|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
127534771|NCT01147666|458921044|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
127534772|NCT01147666|458921045|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
127534773|NCT01147666|458921046|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
127534774|NCT01147666|458921047|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
127534775|NCT01147666|458921048|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
127534776|NCT01147666|458921049|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
127534777|NCT01147666|458921050|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
127534778|NCT01147666|458921051|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
127534779|NCT01147666|458921037|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
127534780|NCT01147666|458921038|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
127534781|NCT01147666|458921039|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
127534782|NCT01147666|458921040|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
127534783|NCT01147666|458921041|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
127534784|NCT01147666|458921042|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
127534785|NCT01147666|458921043|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
127534786|NCT01147666|458921044|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
127534787|NCT01147666|458921045|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
127534788|NCT01147666|458921046|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
127534789|NCT01147666|458921047|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
127534790|NCT01147666|458921048|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
127534791|NCT01147666|458921049|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
127534792|NCT01147666|458921050|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
127534793|NCT01147666|458921051|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
127534794|NCT01147666|458921037|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
127534795|NCT01147666|458921038|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
127534796|NCT01147666|458921039|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
127534797|NCT01147666|458921040|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
127534798|NCT01147666|458921041|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
127534799|NCT01147666|458921042|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
127534800|NCT01147666|458921043|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
127534801|NCT01147666|458921044|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
127534802|NCT01147666|458921045|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
127534803|NCT01147666|458921046|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
127534804|NCT01147666|458921047|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
127534805|NCT01147666|458921048|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
127534806|NCT01147666|458921049|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
127534807|NCT01147666|458921050|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
127534808|NCT01147666|458921051|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
127534809|NCT01147666|458921037|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
127534810|NCT01147666|458921038|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
127534811|NCT01147666|458921039|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
127534812|NCT01147666|458921040|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
127534813|NCT01147666|458921041|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
127534814|NCT01147666|458921042|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
127534815|NCT01147666|458921043|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
127534816|NCT01147666|458921044|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
127534817|NCT01147666|458921045|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
127534818|NCT01147666|458921046|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
127534819|NCT01147666|458921047|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
127534820|NCT01147666|458921048|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
127534821|NCT01147666|458921049|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
127534822|NCT01147666|458921050|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
127534823|NCT01147666|458921051|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
127534824|NCT01147666|458921037|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
127534825|NCT01147666|458921038|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
127534826|NCT01147666|458921039|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
127534827|NCT01147666|458921040|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
127534828|NCT01147666|458921041|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
127534829|NCT01147666|458921042|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
127534830|NCT01147666|458921043|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
127534831|NCT01147666|458921044|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
127534832|NCT01147666|458921045|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
127534833|NCT01147666|458921046|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
127534834|NCT01147666|458921047|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
127534835|NCT01147666|458921048|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
127534836|NCT01147666|458921049|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
127534837|NCT01147666|458921050|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
127534838|NCT01147666|458921051|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
127534839|NCT00474955|458921053|FG000|Overall Study|Adverse Event|2|||
127534840|NCT00474955|458921053|FG000|Overall Study|Drug unavailability|1|||
127534841|NCT00474955|458921053|FG000|Overall Study|Personal reasons|5|||
127534842|NCT01135134|458921054|FG000|Overall Study|Adverse Event|1|||
127534843|NCT01135134|458921055|FG001|Overall Study|Adverse Event|1|||
127534844|NCT01135134|458921054|FG000|Overall Study|Did not meet protocol eligibility|1|||
127534845|NCT01135134|458921055|FG001|Overall Study|Did not meet protocol eligibility|0|||
127534846|NCT00255190|458921058|FG000|Overall Study|Adverse Event|17|||
127534847|NCT00255190|458921059|FG001|Overall Study|Adverse Event|36|||
127534848|NCT00255190|458921058|FG000|Overall Study|Protocol Violation|2|||
127534849|NCT00255190|458921059|FG001|Overall Study|Protocol Violation|2|||
127534850|NCT00255190|458921058|FG000|Overall Study|Lost to Follow-up|10|||
127534851|NCT00255190|458921059|FG001|Overall Study|Lost to Follow-up|27|||
127534852|NCT00255190|458921058|FG000|Overall Study|Withdrew Consent|17|||
127534853|NCT00255190|458921059|FG001|Overall Study|Withdrew Consent|48|||
127534854|NCT00255190|458921058|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
127534855|NCT00255190|458921059|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
127534856|NCT00255190|458921058|FG000|Overall Study|Erosive esophagitis not healed|0|||
127534857|NCT00255190|458921059|FG001|Overall Study|Erosive esophagitis not healed|20|||
127534858|NCT00255190|458921058|FG000|Overall Study|Various|4|||
127534859|NCT00255190|458921059|FG001|Overall Study|Various|23|||
127534860|NCT01859923|458921064|FG000|Overall Study|Adverse Event|0|||
127534861|NCT01859923|458921065|FG001|Overall Study|Adverse Event|0|||
127534862|NCT01859923|458921066|FG002|Overall Study|Adverse Event|1|||
127534863|NCT01859923|458921067|FG003|Overall Study|Adverse Event|1|||
127534864|NCT03634085|458921071|FG000|Overall Study|Adverse Event|1|||
127534865|NCT03634085|458921072|FG001|Overall Study|Adverse Event|0|||
127534866|NCT03634085|458921071|FG000|Overall Study|Withdrawal by Subject|0|||
127534867|NCT03634085|458921072|FG001|Overall Study|Withdrawal by Subject|2|||
127534868|NCT01216202|458921075|FG000|Overall Study|Withdrawal by Subject|8|||
127534869|NCT01216202|458921076|FG001|Overall Study|Withdrawal by Subject|0|||
127534870|NCT01216202|458921075|FG000|Overall Study|Death|0|||
127534871|NCT01216202|458921076|FG001|Overall Study|Death|2|||
127534872|NCT01216202|458921075|FG000|Overall Study|Lost to Follow-up|14|||
127534873|NCT01216202|458921076|FG001|Overall Study|Lost to Follow-up|0|||
127534874|NCT04303559|458921090|FG000|Overall Study|Study closed due to poor enrollment.|1|||
127534875|NCT04037891|458921091|FG000|Open-label Period|Withdrawal by Subject|1|||
127534876|NCT04037891|458921092|FG001|Open-label Period|Withdrawal by Subject|0|||
127534877|NCT04037891|458921093|FG002|Open-label Period|Withdrawal by Subject|0|||
127534878|NCT04037891|458921091|FG000|Randomized, Double-blind Period|Withdrawal by Subject|0|||
127534879|NCT04037891|458921092|FG001|Randomized, Double-blind Period|Withdrawal by Subject|1|||
127534880|NCT04037891|458921093|FG002|Randomized, Double-blind Period|Withdrawal by Subject|0|||
127534881|NCT05274958|458921094|FG000|Overall Study|Only completed 1 set of PROMs|22|||
127534882|NCT05274958|458921095|FG001|Overall Study|Only completed 1 set of PROMs|35|||
127868993|NCT05602818|460137453|FG011|Qualification Phase (3 Days)|Other|0|||
127868994|NCT05602818|460137442|FG000|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
127868995|NCT05602818|460137443|FG001|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|1|||
127868996|NCT05602818|460137444|FG002|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
127868997|NCT05602818|460137445|FG003|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
127868998|NCT05602818|460137446|FG004|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
127868999|NCT05602818|460137447|FG005|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
127869000|NCT05602818|460137448|FG006|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
127869001|NCT05602818|460137449|FG007|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
127869002|NCT05602818|460137450|FG008|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
127869003|NCT05602818|460137451|FG009|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
127869004|NCT05602818|460137452|FG010|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
127869005|NCT05602818|460137453|FG011|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
127869006|NCT05602818|460137442|FG000|Treatment Phase (29 Days)|Protocol Violation|0|||
127869007|NCT05602818|460137443|FG001|Treatment Phase (29 Days)|Protocol Violation|0|||
127869008|NCT05602818|460137444|FG002|Treatment Phase (29 Days)|Protocol Violation|2|||
127869009|NCT05602818|460137445|FG003|Treatment Phase (29 Days)|Protocol Violation|1|||
127869010|NCT05602818|460137446|FG004|Treatment Phase (29 Days)|Protocol Violation|1|||
127869011|NCT05602818|460137447|FG005|Treatment Phase (29 Days)|Protocol Violation|1|||
127869012|NCT05602818|460137448|FG006|Treatment Phase (29 Days)|Protocol Violation|2|||
127869013|NCT05602818|460137449|FG007|Treatment Phase (29 Days)|Protocol Violation|2|||
127869014|NCT05602818|460137450|FG008|Treatment Phase (29 Days)|Protocol Violation|1|||
127869015|NCT05602818|460137451|FG009|Treatment Phase (29 Days)|Protocol Violation|1|||
127869016|NCT05602818|460137452|FG010|Treatment Phase (29 Days)|Protocol Violation|2|||
127869017|NCT05602818|460137453|FG011|Treatment Phase (29 Days)|Protocol Violation|1|||
127869018|NCT05602818|460137442|FG000|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
127869019|NCT05602818|460137443|FG001|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
127869020|NCT05602818|460137444|FG002|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
127869021|NCT05602818|460137445|FG003|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
127869022|NCT05602818|460137446|FG004|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
127869023|NCT05602818|460137447|FG005|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
127869024|NCT05602818|460137448|FG006|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
127869025|NCT05602818|460137449|FG007|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
127869026|NCT05602818|460137450|FG008|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
127869027|NCT05602818|460137451|FG009|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
127869028|NCT05602818|460137452|FG010|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
127869029|NCT05602818|460137453|FG011|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
127869030|NCT05602818|460137442|FG000|Treatment Phase (29 Days)|Physician Decision|0|||
127869031|NCT05602818|460137443|FG001|Treatment Phase (29 Days)|Physician Decision|0|||
127869032|NCT05602818|460137444|FG002|Treatment Phase (29 Days)|Physician Decision|1|||
127869033|NCT05602818|460137445|FG003|Treatment Phase (29 Days)|Physician Decision|0|||
127869034|NCT05602818|460137446|FG004|Treatment Phase (29 Days)|Physician Decision|0|||
127869035|NCT05602818|460137447|FG005|Treatment Phase (29 Days)|Physician Decision|0|||
127869036|NCT05602818|460137448|FG006|Treatment Phase (29 Days)|Physician Decision|1|||
127869037|NCT05602818|460137449|FG007|Treatment Phase (29 Days)|Physician Decision|0|||
127869038|NCT05602818|460137450|FG008|Treatment Phase (29 Days)|Physician Decision|0|||
127869039|NCT05602818|460137451|FG009|Treatment Phase (29 Days)|Physician Decision|0|||
127869040|NCT05602818|460137452|FG010|Treatment Phase (29 Days)|Physician Decision|1|||
127869041|NCT05602818|460137453|FG011|Treatment Phase (29 Days)|Physician Decision|0|||
127869042|NCT04594213|460137458|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
127869043|NCT04594213|460137459|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|6|||
127869044|NCT04594213|460137460|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
127869045|NCT04594213|460137461|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
127869046|NCT04594213|460137462|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
127869047|NCT04594213|460137463|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
127869048|NCT04594213|460137458|FG000|Main Period (Up to 22 Weeks)|Physician Decision|0|||
127869049|NCT04594213|460137459|FG001|Main Period (Up to 22 Weeks)|Physician Decision|1|||
127869050|NCT04594213|460137460|FG002|Main Period (Up to 22 Weeks)|Physician Decision|0|||
127869051|NCT04594213|460137461|FG003|Main Period (Up to 22 Weeks)|Physician Decision|0|||
127869052|NCT04594213|460137462|FG004|Main Period (Up to 22 Weeks)|Physician Decision|0|||
127869053|NCT04594213|460137463|FG005|Main Period (Up to 22 Weeks)|Physician Decision|0|||
127869054|NCT04594213|460137458|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
127869055|NCT04594213|460137459|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
127869056|NCT04594213|460137460|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
127869057|NCT04594213|460137461|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
127869058|NCT04594213|460137462|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
127869059|NCT04594213|460137463|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
127869060|NCT04594213|460137458|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
127869061|NCT04594213|460137459|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
127869062|NCT04594213|460137460|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
127869063|NCT04594213|460137461|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
127869064|NCT04594213|460137462|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|2|||
127869065|NCT04594213|460137463|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
127869066|NCT04594213|460137458|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
127869067|NCT04594213|460137459|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
127869068|NCT04594213|460137460|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
127869069|NCT04594213|460137461|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|4|||
127869070|NCT04594213|460137462|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|6|||
127869071|NCT04594213|460137463|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
127869072|NCT04594213|460137458|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
127869073|NCT04594213|460137459|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
127869074|NCT04594213|460137460|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
127869075|NCT04594213|460137461|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
127869076|NCT04594213|460137462|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
127869077|NCT04594213|460137463|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
127869078|NCT04594213|460137458|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
127869079|NCT04594213|460137459|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
127869080|NCT04594213|460137460|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
127869081|NCT04594213|460137461|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
127869082|NCT04594213|460137462|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
127869083|NCT04594213|460137463|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
127869084|NCT04594213|460137458|FG000|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
127869085|NCT04594213|460137459|FG001|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
127869086|NCT04594213|460137460|FG002|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
127869087|NCT04594213|460137461|FG003|OLEX Period (Up to 39 Weeks)|Protocol Violation|1|||
127869088|NCT04594213|460137462|FG004|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
127869089|NCT04594213|460137463|FG005|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
127869090|NCT04594213|460137458|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
127869091|NCT04594213|460137459|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
127869092|NCT04594213|460137460|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
127869093|NCT04594213|460137461|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|6|||
127869094|NCT04594213|460137462|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|11|||
127869095|NCT04594213|460137463|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
127869096|NCT04594213|460137458|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
127869097|NCT04594213|460137459|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
127869098|NCT04594213|460137460|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
127869099|NCT04594213|460137461|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|7|||
127869100|NCT04594213|460137462|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|22|||
127869101|NCT04594213|460137463|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|5|||
127869102|NCT04594213|460137458|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
127869103|NCT04594213|460137459|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
127869104|NCT04594213|460137460|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
127869105|NCT04594213|460137461|FG003|OLEX Period (Up to 39 Weeks)|Other|1|||
127869106|NCT04594213|460137462|FG004|OLEX Period (Up to 39 Weeks)|Other|3|||
127869107|NCT04594213|460137463|FG005|OLEX Period (Up to 39 Weeks)|Other|1|||
127869108|NCT03814499|460137465|FG000|Overall Study|Lost to Follow-up|3|||
127869109|NCT01589185|460137466|FG000|Overall Study|Death|1|||
127869110|NCT01589185|460137467|FG001|Overall Study|Death|2|||
127869111|NCT01589185|460137468|FG002|Overall Study|Death|2|||
127869112|NCT01589185|460137469|FG003|Overall Study|Death|0|||
127869113|NCT01589185|460137470|FG004|Overall Study|Death|1|||
127869114|NCT01589185|460137466|FG000|Overall Study|Lost to Follow-up|1|||
127869115|NCT01589185|460137467|FG001|Overall Study|Lost to Follow-up|0|||
127869116|NCT01589185|460137468|FG002|Overall Study|Lost to Follow-up|2|||
127869117|NCT01589185|460137469|FG003|Overall Study|Lost to Follow-up|3|||
127869118|NCT01589185|460137470|FG004|Overall Study|Lost to Follow-up|0|||
127869119|NCT02046993|460137471|FG000|Overall Study|Withdrawal by Subject|2|||
127869120|NCT02046993|460137472|FG001|Overall Study|Withdrawal by Subject|10|||
127869121|NCT02046993|460137471|FG000|Overall Study|Lost to Follow-up|1|||
127869122|NCT02046993|460137472|FG001|Overall Study|Lost to Follow-up|1|||
127869123|NCT00598442|460137475|FG000|Overall Study|Adverse Event|3|||
127869124|NCT00598442|460137476|FG001|Overall Study|Adverse Event|0|||
127869125|NCT00598442|460137477|FG002|Overall Study|Adverse Event|0|||
127869126|NCT00598442|460137475|FG000|Overall Study|Death|19|||
127869127|NCT00598442|460137476|FG001|Overall Study|Death|11|||
127869128|NCT00598442|460137477|FG002|Overall Study|Death|11|||
127869129|NCT00598442|460137475|FG000|Overall Study|Lost to Follow-up|4|||
127869130|NCT00598442|460137476|FG001|Overall Study|Lost to Follow-up|3|||
127869131|NCT00598442|460137477|FG002|Overall Study|Lost to Follow-up|3|||
127869132|NCT00598442|460137475|FG000|Overall Study|Physician Decision|2|||
127869133|NCT00598442|460137476|FG001|Overall Study|Physician Decision|1|||
127869134|NCT00598442|460137477|FG002|Overall Study|Physician Decision|1|||
127869135|NCT00598442|460137475|FG000|Overall Study|Withdrawal by Subject|8|||
127869136|NCT00598442|460137476|FG001|Overall Study|Withdrawal by Subject|16|||
127869137|NCT00598442|460137477|FG002|Overall Study|Withdrawal by Subject|6|||
127869138|NCT00598442|460137475|FG000|Overall Study|Noncompliance|0|||
127869139|NCT00598442|460137476|FG001|Overall Study|Noncompliance|2|||
127869140|NCT00598442|460137477|FG002|Overall Study|Noncompliance|1|||
127869141|NCT00598442|460137475|FG000|Overall Study|Relocation|1|||
127869142|NCT00598442|460137476|FG001|Overall Study|Relocation|4|||
127869143|NCT00598442|460137477|FG002|Overall Study|Relocation|0|||
127869144|NCT00598442|460137475|FG000|Overall Study|Renal transplant|0|||
127869145|NCT00598442|460137476|FG001|Overall Study|Renal transplant|0|||
127869146|NCT00598442|460137477|FG002|Overall Study|Renal transplant|1|||
127869147|NCT00598442|460137475|FG000|Overall Study|Site closed by sponsor|5|||
127869148|NCT00598442|460137476|FG001|Overall Study|Site closed by sponsor|2|||
127869149|NCT00598442|460137477|FG002|Overall Study|Site closed by sponsor|1|||
127869150|NCT00598442|460137475|FG000|Overall Study|Started dialysis|1|||
127869151|NCT00598442|460137476|FG001|Overall Study|Started dialysis|0|||
127869152|NCT00598442|460137477|FG002|Overall Study|Started dialysis|0|||
127869153|NCT00697255|460137478|FG000|Stage 1a|Insufficient ovarian response|1|||
127869154|NCT00697255|460137479|FG001|Stage 1a|Insufficient ovarian response|0|||
127869155|NCT00697255|460137478|FG000|Stage 1a|Multifollicular growth|1|||
127869156|NCT00697255|460137479|FG001|Stage 1a|Multifollicular growth|0|||
127869157|NCT00697255|460137478|FG000|Stage 1a|Not growing of dominant follicle|1|||
127869158|NCT00697255|460137479|FG001|Stage 1a|Not growing of dominant follicle|0|||
127869159|NCT00697255|460137478|FG000|Stage 1b|Not growing of dominant follicle|0|||
127869160|NCT00697255|460137479|FG001|Stage 1b|Not growing of dominant follicle|1|||
127869161|NCT00697255|460137478|FG000|Stage 1b|Insufficient ovarian response|0|||
127869162|NCT00697255|460137479|FG001|Stage 1b|Insufficient ovarian response|1|||
127869163|NCT01005875|460137489|FG000|Overall Study|Death|3|||
127869164|NCT00911508|460139522|FG000|Overall Study|Lost to Follow-up|27|||
127869165|NCT00911508|460139523|FG001|Overall Study|Lost to Follow-up|18|||
127869166|NCT00911508|460139522|FG000|Overall Study|Withdrawal by Subject|79|||
127869167|NCT00911508|460139523|FG001|Overall Study|Withdrawal by Subject|112|||
127869168|NCT01409382|460139524|FG000|Overall Study|Lost to Follow-up|1|||
127869169|NCT01409382|460139525|FG001|Overall Study|Lost to Follow-up|1|||
127869170|NCT01409382|460139524|FG000|Overall Study|Protocol Violation|0|||
127869171|NCT01409382|460139525|FG001|Overall Study|Protocol Violation|3|||
127869172|NCT01409382|460139524|FG000|Overall Study|Multiple pregnancy|2|||
127869173|NCT01409382|460139525|FG001|Overall Study|Multiple pregnancy|4|||
127869174|NCT01409382|460139524|FG000|Overall Study|Still pregnant when study ended|13|||
127869175|NCT01409382|460139525|FG001|Overall Study|Still pregnant when study ended|2|||
127869176|NCT01409382|460139524|FG000|Overall Study|Did not manage to get pregnant|64|||
127869177|NCT01409382|460139525|FG001|Overall Study|Did not manage to get pregnant|70|||
127869178|NCT01409382|460139524|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
127869179|NCT01409382|460139525|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
127869180|NCT01233076|460139526|FG000|Period 2, One Week|Lost to Follow-up|1|||
127869181|NCT01233076|460139527|FG001|Period 2, One Week|Lost to Follow-up|0|||
127869182|NCT01336647|460139528|FG000|Overall Study|Lost to Follow-up|4|||
127869183|NCT01336647|460139529|FG001|Overall Study|Lost to Follow-up|1|||
127869184|NCT01336647|460139530|FG002|Overall Study|Lost to Follow-up|3|||
127869185|NCT01004822|460139531|FG000|Overall Study|Objective progression or relapse|3|||
127869186|NCT01004822|460139532|FG001|Overall Study|Objective progression or relapse|3|||
127869187|NCT01004822|460139533|FG002|Overall Study|Objective progression or relapse|0|||
127869188|NCT01004822|460139534|FG003|Overall Study|Objective progression or relapse|1|||
127869189|NCT01004822|460139535|FG004|Overall Study|Objective progression or relapse|2|||
127869190|NCT01004822|460139536|FG005|Overall Study|Objective progression or relapse|2|||
127869191|NCT01004822|460139537|FG006|Overall Study|Objective progression or relapse|1|||
127869192|NCT01004822|460139538|FG007|Overall Study|Objective progression or relapse|4|||
127869193|NCT01004822|460139531|FG000|Overall Study|Global deterioration of health status|0|||
127869194|NCT01004822|460139532|FG001|Overall Study|Global deterioration of health status|0|||
127869195|NCT01004822|460139533|FG002|Overall Study|Global deterioration of health status|0|||
127869196|NCT01004822|460139534|FG003|Overall Study|Global deterioration of health status|1|||
127869197|NCT01004822|460139535|FG004|Overall Study|Global deterioration of health status|0|||
127869198|NCT01004822|460139536|FG005|Overall Study|Global deterioration of health status|0|||
127869199|NCT01004822|460139537|FG006|Overall Study|Global deterioration of health status|1|||
127869200|NCT01004822|460139538|FG007|Overall Study|Global deterioration of health status|0|||
127869201|NCT01004822|460139531|FG000|Overall Study|No longer willing to continue|0|||
127869202|NCT01004822|460139532|FG001|Overall Study|No longer willing to continue|0|||
127869203|NCT01004822|460139533|FG002|Overall Study|No longer willing to continue|0|||
127869204|NCT01004822|460139534|FG003|Overall Study|No longer willing to continue|1|||
127869205|NCT01004822|460139535|FG004|Overall Study|No longer willing to continue|2|||
127869206|NCT01004822|460139536|FG005|Overall Study|No longer willing to continue|1|||
127869207|NCT01004822|460139537|FG006|Overall Study|No longer willing to continue|1|||
127869208|NCT01004822|460139538|FG007|Overall Study|No longer willing to continue|0|||
127869209|NCT01004822|460139531|FG000|Overall Study|Adverse Event|0|||
127869210|NCT01004822|460139532|FG001|Overall Study|Adverse Event|0|||
127869211|NCT01004822|460139533|FG002|Overall Study|Adverse Event|0|||
127869212|NCT01004822|460139534|FG003|Overall Study|Adverse Event|0|||
127869213|NCT01004822|460139535|FG004|Overall Study|Adverse Event|0|||
127869214|NCT01004822|460139536|FG005|Overall Study|Adverse Event|0|||
127869215|NCT01004822|460139537|FG006|Overall Study|Adverse Event|1|||
127869216|NCT01004822|460139538|FG007|Overall Study|Adverse Event|1|||
127869217|NCT01004822|460139531|FG000|Overall Study|Other|0|||
127869218|NCT01004822|460139532|FG001|Overall Study|Other|0|||
127869219|NCT01004822|460139533|FG002|Overall Study|Other|4|||
127869220|NCT01004822|460139534|FG003|Overall Study|Other|1|||
127869221|NCT01004822|460139535|FG004|Overall Study|Other|0|||
127869222|NCT01004822|460139536|FG005|Overall Study|Other|1|||
127869223|NCT01004822|460139537|FG006|Overall Study|Other|0|||
127869224|NCT01004822|460139538|FG007|Overall Study|Other|0|||
127869225|NCT01858701|460139539|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
127869226|NCT01858701|460139540|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
127869227|NCT01858701|460139539|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
127869228|NCT01858701|460139540|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
127869229|NCT01858701|460139539|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
127869230|NCT01858701|460139540|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
127869231|NCT01858701|460139539|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
127869232|NCT01858701|460139540|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
127869233|NCT00501969|460139547|FG000|Overall Study|Major Protocol Violation|4|||
127869234|NCT00501969|460139547|FG000|Overall Study|Lack of Efficacy|29|||
127869235|NCT00501969|460139547|FG000|Overall Study|Adverse Event|76|||
127869236|NCT00501969|460139547|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
127869237|NCT00501969|460139547|FG000|Overall Study|Subject withdrew consent|51|||
127869238|NCT00501969|460139547|FG000|Overall Study|Lost to Follow-up|4|||
127869239|NCT00501969|460139547|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
127869240|NCT00501969|460139547|FG000|Overall Study|Other: Sponsors Request|10|||
127869241|NCT00501969|460139547|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
127869242|NCT00501969|460139547|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
127869243|NCT00501969|460139547|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
127869244|NCT00501969|460139547|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
127869245|NCT00501969|460139547|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
127869246|NCT00501969|460139547|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
127869247|NCT00501969|460139547|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
127869248|NCT00501969|460139547|FG000|Overall Study|Other: As Required by Local EC|2|||
127869249|NCT00501969|460139547|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
127869250|NCT00501969|460139547|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
127869251|NCT00665366|460139548|FG000|Overall Study|Lack of Efficacy|11|||
127869252|NCT00665366|460139549|FG001|Overall Study|Lack of Efficacy|10|||
127869253|NCT00665366|460139548|FG000|Overall Study|Adverse Event|25|||
127869254|NCT00665366|460139549|FG001|Overall Study|Adverse Event|23|||
127869255|NCT00665366|460139548|FG000|Overall Study|Withdrawal by Subject|11|||
127869256|NCT00665366|460139549|FG001|Overall Study|Withdrawal by Subject|14|||
127869257|NCT00665366|460139548|FG000|Overall Study|Lost to Follow-up|3|||
127869258|NCT00665366|460139549|FG001|Overall Study|Lost to Follow-up|5|||
127869259|NCT00665366|460139548|FG000|Overall Study|Poor compliance/noncompliance|3|||
127869260|NCT00665366|460139549|FG001|Overall Study|Poor compliance/noncompliance|5|||
127869261|NCT00665366|460139548|FG000|Overall Study|Pregnancy|1|||
127869262|NCT00665366|460139549|FG001|Overall Study|Pregnancy|0|||
127869263|NCT00665366|460139548|FG000|Overall Study|No longer meets study criteria|0|||
127869264|NCT00665366|460139549|FG001|Overall Study|No longer meets study criteria|1|||
127869265|NCT00665366|460139548|FG000|Overall Study|Other reasons|4|||
127869266|NCT00665366|460139549|FG001|Overall Study|Other reasons|1|||
127869267|NCT04177862|460139553|FG000|Overall Study|Protocol Violation|2|||
127869268|NCT04177862|460139554|FG001|Overall Study|Protocol Violation|7|||
127869269|NCT05111548|460139555|FG000|Overall Study|Withdrawal by Subject|2|||
127869270|NCT05111548|460139556|FG001|Overall Study|Withdrawal by Subject|1|||
127869271|NCT05111548|460139555|FG000|Overall Study|Adverse Event|1|||
127869272|NCT05111548|460139556|FG001|Overall Study|Adverse Event|0|||
127869273|NCT00379639|460139557|FG000|Overall Study|Disease Progression|3|||
127869274|NCT00379639|460139558|FG001|Overall Study|Disease Progression|3|||
127869275|NCT00379639|460139559|FG002|Overall Study|Disease Progression|3|||
127869276|NCT00379639|460139560|FG003|Overall Study|Disease Progression|4|||
127869277|NCT00379639|460139561|FG004|Overall Study|Disease Progression|4|||
127869278|NCT00379639|460139557|FG000|Overall Study|Physician Decision|0|||
127869279|NCT00379639|460139558|FG001|Overall Study|Physician Decision|2|||
127869280|NCT00379639|460139559|FG002|Overall Study|Physician Decision|1|||
127869281|NCT00379639|460139560|FG003|Overall Study|Physician Decision|1|||
127869282|NCT00379639|460139561|FG004|Overall Study|Physician Decision|0|||
127869283|NCT00379639|460139557|FG000|Overall Study|Symptomatic Deterioration|0|||
127869284|NCT00379639|460139558|FG001|Overall Study|Symptomatic Deterioration|0|||
127869285|NCT00379639|460139559|FG002|Overall Study|Symptomatic Deterioration|1|||
127869286|NCT00379639|460139560|FG003|Overall Study|Symptomatic Deterioration|0|||
127869287|NCT00379639|460139561|FG004|Overall Study|Symptomatic Deterioration|1|||
127869288|NCT00379639|460139557|FG000|Overall Study|Adverse Event|0|||
127869289|NCT00379639|460139558|FG001|Overall Study|Adverse Event|0|||
127869290|NCT00379639|460139559|FG002|Overall Study|Adverse Event|1|||
127869291|NCT00379639|460139560|FG003|Overall Study|Adverse Event|0|||
127869292|NCT00379639|460139561|FG004|Overall Study|Adverse Event|1|||
127869293|NCT00379639|460139557|FG000|Overall Study|Lost to Follow-up|0|||
127869294|NCT00379639|460139558|FG001|Overall Study|Lost to Follow-up|0|||
127869295|NCT00379639|460139559|FG002|Overall Study|Lost to Follow-up|0|||
127869296|NCT00379639|460139560|FG003|Overall Study|Lost to Follow-up|1|||
127869297|NCT00379639|460139561|FG004|Overall Study|Lost to Follow-up|0|||
127869298|NCT00379639|460139557|FG000|Overall Study|Other|0|||
127869299|NCT00379639|460139558|FG001|Overall Study|Other|0|||
127869300|NCT00379639|460139559|FG002|Overall Study|Other|3|||
127869301|NCT00379639|460139560|FG003|Overall Study|Other|0|||
127869302|NCT00379639|460139561|FG004|Overall Study|Other|0|||
127869303|NCT00594958|460139562|FG000|Overall Study|Withdrawal by Subject|1|||
127869304|NCT00594958|460139563|FG001|Overall Study|Withdrawal by Subject|0|||
127869305|NCT00594958|460139564|FG002|Overall Study|Withdrawal by Subject|1|||
127869306|NCT00594958|460139562|FG000|Overall Study|Adverse Event|4|||
127869307|NCT00594958|460139563|FG001|Overall Study|Adverse Event|1|||
127869308|NCT00594958|460139564|FG002|Overall Study|Adverse Event|2|||
127869309|NCT00594958|460139562|FG000|Overall Study|Pregnancy|0|||
127869310|NCT00594958|460139563|FG001|Overall Study|Pregnancy|2|||
127869311|NCT00594958|460139564|FG002|Overall Study|Pregnancy|0|||
127869312|NCT00594958|460139562|FG000|Overall Study|Protocol Violation|1|||
127869313|NCT00594958|460139563|FG001|Overall Study|Protocol Violation|0|||
127869314|NCT00594958|460139564|FG002|Overall Study|Protocol Violation|2|||
127869315|NCT00594958|460139562|FG000|Overall Study|Lost to Follow-up|5|||
127869316|NCT00594958|460139563|FG001|Overall Study|Lost to Follow-up|0|||
127869317|NCT00594958|460139564|FG002|Overall Study|Lost to Follow-up|3|||
127869318|NCT00594958|460139562|FG000|Overall Study|administrative|3|||
127869319|NCT00594958|460139563|FG001|Overall Study|administrative|0|||
127869320|NCT00594958|460139564|FG002|Overall Study|administrative|2|||
127869321|NCT03233009|460139575|FG000|Overall Study|Lost to Follow-up|1|||
127869322|NCT00151775|460139576|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
127869323|NCT00151775|460139577|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
127869324|NCT00151775|460139578|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
127869325|NCT00151775|460139579|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
127869326|NCT00151775|460139580|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
127869327|NCT00151775|460139581|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
127869328|NCT00151775|460139582|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
127869329|NCT00151775|460139583|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
127869330|NCT00151775|460139584|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
127869331|NCT00151775|460139585|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
127869332|NCT00151775|460139586|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
127869333|NCT00151775|460139587|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
127869334|NCT00151775|460139576|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
127869335|NCT00151775|460139577|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
127869336|NCT00151775|460139578|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
127869337|NCT00151775|460139579|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
127869338|NCT00151775|460139580|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
127869339|NCT00151775|460139581|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
127869340|NCT00151775|460139582|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
127869341|NCT00151775|460139583|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
127869342|NCT00151775|460139584|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
127869343|NCT00151775|460139585|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
127869344|NCT00151775|460139586|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
127869345|NCT00151775|460139587|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
127869346|NCT00151775|460139576|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
127869347|NCT00151775|460139577|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
127869348|NCT00151775|460139578|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
127869349|NCT00151775|460139579|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
127869350|NCT00151775|460139580|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
127869351|NCT00151775|460139581|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
127869352|NCT00151775|460139582|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
127869353|NCT00151775|460139583|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
127869354|NCT00151775|460139584|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
127869355|NCT00151775|460139585|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
127869356|NCT00151775|460139586|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
127869357|NCT00151775|460139587|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
127869358|NCT00151775|460139576|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
127869359|NCT00151775|460139577|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
127869360|NCT00151775|460139578|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
127869361|NCT00151775|460139579|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
127869362|NCT00151775|460139580|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
127869363|NCT00151775|460139581|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
127869364|NCT00151775|460139582|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
127869365|NCT00151775|460139583|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
127869366|NCT00151775|460139584|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
127869367|NCT00151775|460139585|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
127869368|NCT00151775|460139586|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
127869369|NCT00151775|460139587|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
127869370|NCT00151775|460139576|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
127869371|NCT00151775|460139577|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
127869372|NCT00151775|460139578|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
127869373|NCT00151775|460139579|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
127869374|NCT00151775|460139580|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
127869375|NCT00151775|460139581|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
127869376|NCT00151775|460139582|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
127869377|NCT00151775|460139583|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
127869378|NCT00151775|460139584|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
127869379|NCT00151775|460139585|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
127869380|NCT00151775|460139586|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
127869381|NCT00151775|460139587|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
127869382|NCT00151775|460139576|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
127869383|NCT00151775|460139577|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
127869384|NCT00151775|460139578|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
127869385|NCT00151775|460139579|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
127869386|NCT00151775|460139580|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
127869387|NCT00151775|460139581|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
127869388|NCT00151775|460139582|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
127869389|NCT00151775|460139583|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
127869390|NCT00151775|460139584|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
127869391|NCT00151775|460139585|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
127869392|NCT00151775|460139586|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
127869393|NCT00151775|460139587|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
127869394|NCT00151775|460139576|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
127869395|NCT00151775|460139577|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
127869396|NCT00151775|460139578|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
127869397|NCT00151775|460139579|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
127869398|NCT00151775|460139580|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
127869399|NCT00151775|460139581|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
127869400|NCT00151775|460139582|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
127869401|NCT00151775|460139583|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
127869402|NCT00151775|460139584|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
127869403|NCT00151775|460139585|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
127869404|NCT00151775|460139586|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
127869405|NCT00151775|460139587|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
127869406|NCT00151775|460139576|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
127869407|NCT00151775|460139577|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
127869408|NCT00151775|460139578|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
127869409|NCT00151775|460139579|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
127869410|NCT00151775|460139580|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
127869411|NCT00151775|460139581|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
127869412|NCT00151775|460139582|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
127869413|NCT00151775|460139583|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
127869414|NCT00151775|460139584|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
127869415|NCT00151775|460139585|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
127869416|NCT00151775|460139586|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
127869417|NCT00151775|460139587|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
127869418|NCT00151775|460139576|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
127869419|NCT00151775|460139577|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
127869420|NCT00151775|460139578|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
127869421|NCT00151775|460139579|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
127869422|NCT00151775|460139580|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
127869423|NCT00151775|460139581|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
127869424|NCT00151775|460139582|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
127869425|NCT00151775|460139583|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
127869426|NCT00151775|460139584|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
127869427|NCT00151775|460139585|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
127869428|NCT00151775|460139586|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
127869429|NCT00151775|460139587|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
127869430|NCT00151775|460139576|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
127869431|NCT00151775|460139577|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
127869432|NCT00151775|460139578|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
127869433|NCT00151775|460139579|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
127869434|NCT00151775|460139580|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
127869435|NCT00151775|460139581|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
127869436|NCT00151775|460139582|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
127869437|NCT00151775|460139583|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
127869438|NCT00151775|460139584|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
127869439|NCT00151775|460139585|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
127869440|NCT00151775|460139586|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
127869441|NCT00151775|460139587|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
127869442|NCT00151775|460139576|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
127869443|NCT00151775|460139577|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
127869444|NCT00151775|460139578|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
127869445|NCT00151775|460139579|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
127869446|NCT00151775|460139580|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
127869447|NCT00151775|460139581|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
127869448|NCT00151775|460139582|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
127869449|NCT00151775|460139583|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
127869450|NCT00151775|460139584|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
127869451|NCT00151775|460139585|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
127869452|NCT00151775|460139586|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
127869453|NCT00151775|460139587|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
127869454|NCT00151775|460139576|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
127869455|NCT00151775|460139577|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
127869456|NCT00151775|460139578|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
127869457|NCT00151775|460139579|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
127869458|NCT00151775|460139580|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
127869459|NCT00151775|460139581|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
127869460|NCT00151775|460139582|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
127869461|NCT00151775|460139583|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
127869462|NCT00151775|460139584|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
127869463|NCT00151775|460139585|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
127869464|NCT00151775|460139586|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
127869465|NCT00151775|460139587|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
127869466|NCT00151775|460139576|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
127869467|NCT00151775|460139577|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
127869468|NCT00151775|460139578|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
127869469|NCT00151775|460139579|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
127869470|NCT00151775|460139580|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
127869471|NCT00151775|460139581|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
127869472|NCT00151775|460139582|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
127869473|NCT00151775|460139583|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
127869474|NCT00151775|460139584|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
127869475|NCT00151775|460139585|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
127869476|NCT00151775|460139586|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
127869477|NCT00151775|460139587|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
127869478|NCT00151775|460139576|FG000|Period 4: Open Label|Increased blood pressure|0|||
127869479|NCT00151775|460139577|FG001|Period 4: Open Label|Increased blood pressure|0|||
127869480|NCT00151775|460139578|FG002|Period 4: Open Label|Increased blood pressure|0|||
127869481|NCT00151775|460139579|FG003|Period 4: Open Label|Increased blood pressure|0|||
127869482|NCT00151775|460139580|FG004|Period 4: Open Label|Increased blood pressure|1|||
127869483|NCT00151775|460139581|FG005|Period 4: Open Label|Increased blood pressure|0|||
127869484|NCT00151775|460139582|FG006|Period 4: Open Label|Increased blood pressure|0|||
127869485|NCT00151775|460139583|FG007|Period 4: Open Label|Increased blood pressure|0|||
127869486|NCT00151775|460139584|FG008|Period 4: Open Label|Increased blood pressure|0|||
127869487|NCT00151775|460139585|FG009|Period 4: Open Label|Increased blood pressure|1|||
127869488|NCT00151775|460139586|FG010|Period 4: Open Label|Increased blood pressure|0|||
127869489|NCT00151775|460139587|FG011|Period 4: Open Label|Increased blood pressure|0|||
127869490|NCT00151775|460139576|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
127869491|NCT00151775|460139577|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
127869492|NCT00151775|460139578|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
127869493|NCT00151775|460139579|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
127869494|NCT00151775|460139580|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
127869495|NCT00151775|460139581|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
127869496|NCT00151775|460139582|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
127869497|NCT00151775|460139583|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
127869498|NCT00151775|460139584|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
127869499|NCT00151775|460139585|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
127869500|NCT00151775|460139586|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
127869501|NCT00151775|460139587|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
127869502|NCT00151775|460139576|FG000|Period 4: Open Label|Adverse Event|0|||
127869503|NCT00151775|460139577|FG001|Period 4: Open Label|Adverse Event|0|||
127869504|NCT00151775|460139578|FG002|Period 4: Open Label|Adverse Event|0|||
127869505|NCT00151775|460139579|FG003|Period 4: Open Label|Adverse Event|0|||
127869506|NCT00151775|460139580|FG004|Period 4: Open Label|Adverse Event|1|||
127869507|NCT00151775|460139581|FG005|Period 4: Open Label|Adverse Event|0|||
127869508|NCT00151775|460139582|FG006|Period 4: Open Label|Adverse Event|0|||
127869509|NCT00151775|460139583|FG007|Period 4: Open Label|Adverse Event|0|||
127869510|NCT00151775|460139584|FG008|Period 4: Open Label|Adverse Event|0|||
127869511|NCT00151775|460139585|FG009|Period 4: Open Label|Adverse Event|2|||
127869512|NCT00151775|460139586|FG010|Period 4: Open Label|Adverse Event|0|||
127869513|NCT00151775|460139587|FG011|Period 4: Open Label|Adverse Event|0|||
127869514|NCT00151775|460139576|FG000|Period 4: Open Label|Lost to Follow-up|0|||
127869515|NCT00151775|460139577|FG001|Period 4: Open Label|Lost to Follow-up|0|||
127869516|NCT00151775|460139578|FG002|Period 4: Open Label|Lost to Follow-up|0|||
127869517|NCT00151775|460139579|FG003|Period 4: Open Label|Lost to Follow-up|0|||
127869518|NCT00151775|460139580|FG004|Period 4: Open Label|Lost to Follow-up|17|||
127869519|NCT00151775|460139581|FG005|Period 4: Open Label|Lost to Follow-up|0|||
127869520|NCT00151775|460139582|FG006|Period 4: Open Label|Lost to Follow-up|0|||
127869521|NCT00151775|460139583|FG007|Period 4: Open Label|Lost to Follow-up|0|||
127869522|NCT00151775|460139584|FG008|Period 4: Open Label|Lost to Follow-up|0|||
127869523|NCT00151775|460139585|FG009|Period 4: Open Label|Lost to Follow-up|7|||
127869524|NCT00151775|460139586|FG010|Period 4: Open Label|Lost to Follow-up|0|||
127869525|NCT00151775|460139587|FG011|Period 4: Open Label|Lost to Follow-up|0|||
127869526|NCT00151775|460139576|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
127869527|NCT00151775|460139577|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
127869528|NCT00151775|460139578|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
127869529|NCT00151775|460139579|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
127869530|NCT00151775|460139580|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
127869531|NCT00151775|460139581|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
127981174|NCT02326298|460552273|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
127869532|NCT00151775|460139582|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
127869533|NCT00151775|460139583|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
127869534|NCT00151775|460139584|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
127869535|NCT00151775|460139585|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
127869536|NCT00151775|460139586|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
127869537|NCT00151775|460139587|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
127869538|NCT00151775|460139576|FG000|Period 4: Open Label|Other|0|||
127869539|NCT00151775|460139577|FG001|Period 4: Open Label|Other|0|||
127869540|NCT00151775|460139578|FG002|Period 4: Open Label|Other|0|||
127869541|NCT00151775|460139579|FG003|Period 4: Open Label|Other|0|||
127869542|NCT00151775|460139580|FG004|Period 4: Open Label|Other|1|||
127869543|NCT00151775|460139581|FG005|Period 4: Open Label|Other|0|||
127869544|NCT00151775|460139582|FG006|Period 4: Open Label|Other|0|||
127869545|NCT00151775|460139583|FG007|Period 4: Open Label|Other|0|||
127869546|NCT00151775|460139584|FG008|Period 4: Open Label|Other|0|||
127869547|NCT00151775|460139585|FG009|Period 4: Open Label|Other|3|||
127869548|NCT00151775|460139586|FG010|Period 4: Open Label|Other|0|||
127869549|NCT00151775|460139587|FG011|Period 4: Open Label|Other|0|||
127869550|NCT00151775|460139576|FG000|Period 4: Open Label|Physician Decision|0|||
127869551|NCT00151775|460139577|FG001|Period 4: Open Label|Physician Decision|0|||
127869552|NCT00151775|460139578|FG002|Period 4: Open Label|Physician Decision|0|||
127869553|NCT00151775|460139579|FG003|Period 4: Open Label|Physician Decision|0|||
127869554|NCT00151775|460139580|FG004|Period 4: Open Label|Physician Decision|0|||
127869555|NCT00151775|460139581|FG005|Period 4: Open Label|Physician Decision|0|||
127869556|NCT00151775|460139582|FG006|Period 4: Open Label|Physician Decision|0|||
127869557|NCT00151775|460139583|FG007|Period 4: Open Label|Physician Decision|0|||
127869558|NCT00151775|460139584|FG008|Period 4: Open Label|Physician Decision|0|||
127869559|NCT00151775|460139585|FG009|Period 4: Open Label|Physician Decision|2|||
127869560|NCT00151775|460139586|FG010|Period 4: Open Label|Physician Decision|0|||
127869561|NCT00151775|460139587|FG011|Period 4: Open Label|Physician Decision|0|||
127869562|NCT00151775|460139576|FG000|Period 4: Open Label|Protocol Violation|0|||
127869563|NCT00151775|460139577|FG001|Period 4: Open Label|Protocol Violation|0|||
127869564|NCT00151775|460139578|FG002|Period 4: Open Label|Protocol Violation|0|||
127869565|NCT00151775|460139579|FG003|Period 4: Open Label|Protocol Violation|0|||
127869566|NCT00151775|460139580|FG004|Period 4: Open Label|Protocol Violation|1|||
127869567|NCT00151775|460139581|FG005|Period 4: Open Label|Protocol Violation|0|||
127869568|NCT00151775|460139582|FG006|Period 4: Open Label|Protocol Violation|0|||
127869569|NCT00151775|460139583|FG007|Period 4: Open Label|Protocol Violation|0|||
127869570|NCT00151775|460139584|FG008|Period 4: Open Label|Protocol Violation|0|||
127869571|NCT00151775|460139585|FG009|Period 4: Open Label|Protocol Violation|0|||
127869572|NCT00151775|460139586|FG010|Period 4: Open Label|Protocol Violation|0|||
127869573|NCT00151775|460139587|FG011|Period 4: Open Label|Protocol Violation|0|||
127869574|NCT00474994|460139597|FG000|Overall Study|Patient Not treated|1|||
127869575|NCT00474994|460139597|FG000|Overall Study|Patient evaluable for toxicity only|3|||
127869576|NCT00474994|460139597|FG000|Overall Study|Patient found to be ineligible|1|||
127869577|NCT00278473|460139598|FG000|Overall Study|drop out|4|||
127869578|NCT00278473|460139599|FG001|Overall Study|drop out|3|||
127869579|NCT04516291|460139600|FG000|Treatment Period (24 Weeks)|Other|1|||
127869580|NCT04516291|460139601|FG001|Treatment Period (24 Weeks)|Other|0|||
127869581|NCT04516291|460139602|FG002|Treatment Period (24 Weeks)|Other|0|||
127869582|NCT04516291|460139603|FG003|Treatment Period (24 Weeks)|Other|2|||
127869583|NCT04516291|460139604|FG004|Treatment Period (24 Weeks)|Other|2|||
127869584|NCT04516291|460139605|FG005|Treatment Period (24 Weeks)|Other|4|||
127869585|NCT04516291|460139606|FG006|Treatment Period (24 Weeks)|Other|2|||
127869586|NCT04516291|460139607|FG007|Treatment Period (24 Weeks)|Other|0|||
127869587|NCT04516291|460139600|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
127869588|NCT04516291|460139601|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
127869589|NCT04516291|460139602|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
127869590|NCT04516291|460139603|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
127869591|NCT04516291|460139604|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
127869592|NCT04516291|460139605|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
127869593|NCT04516291|460139606|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
127981175|NCT02326298|460552274|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
127981176|NCT02326298|460552275|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
127981177|NCT02326298|460552276|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
127981178|NCT02326298|460552277|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
127981179|NCT02326298|460552278|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
127981180|NCT02326298|460552279|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
127981181|NCT02326298|460552280|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
127981182|NCT02326298|460552281|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
127981183|NCT02326298|460552268|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
127981184|NCT02326298|460552269|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
127981185|NCT02326298|460552270|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
127981186|NCT02326298|460552271|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
127981187|NCT02326298|460552272|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
127981188|NCT02326298|460552273|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
127981189|NCT02326298|460552274|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
127981190|NCT02326298|460552275|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
127981191|NCT02326298|460552276|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
127981192|NCT02326298|460552277|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
127981193|NCT02326298|460552278|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
127981194|NCT02326298|460552279|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
127981195|NCT02326298|460552280|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
127981196|NCT02326298|460552281|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
127981197|NCT02326298|460552268|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
127981198|NCT02326298|460552269|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
127981199|NCT02326298|460552270|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
127981200|NCT02326298|460552271|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
127981201|NCT02326298|460552272|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
127981202|NCT02326298|460552273|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
127981203|NCT02326298|460552274|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
127981204|NCT02326298|460552275|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
127981205|NCT02326298|460552276|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
127981206|NCT02326298|460552277|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
127981207|NCT02326298|460552278|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
127981208|NCT02326298|460552279|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
127981209|NCT02326298|460552280|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
127981210|NCT02326298|460552281|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
127981211|NCT02326298|460552268|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127981212|NCT02326298|460552269|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127981213|NCT02326298|460552270|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127981214|NCT02326298|460552271|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127981215|NCT02326298|460552272|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127981216|NCT02326298|460552273|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127981217|NCT02326298|460552274|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127981218|NCT02326298|460552275|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127981219|NCT02326298|460552276|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127981220|NCT02326298|460552277|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127981221|NCT02326298|460552278|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127981222|NCT02326298|460552279|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
127981223|NCT02326298|460552280|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
127981224|NCT02326298|460552281|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
127981225|NCT02326298|460552268|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
127981226|NCT02326298|460552269|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
127981227|NCT02326298|460552270|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
127981228|NCT02326298|460552271|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
127981229|NCT02326298|460552272|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
127981230|NCT02326298|460552273|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
127981231|NCT02326298|460552274|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
127981232|NCT02326298|460552275|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
127981233|NCT02326298|460552276|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
127981234|NCT02326298|460552277|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
127981235|NCT02326298|460552278|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
127981236|NCT02326298|460552279|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
127981237|NCT02326298|460552280|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
127981238|NCT02326298|460552281|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
127981239|NCT02326298|460552268|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
127981240|NCT02326298|460552269|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
127981241|NCT02326298|460552270|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
127981242|NCT02326298|460552271|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
127981243|NCT02326298|460552272|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
127981244|NCT02326298|460552273|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
127981245|NCT02326298|460552274|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
127981246|NCT02326298|460552275|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
127981247|NCT02326298|460552276|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
127981248|NCT02326298|460552277|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
127981249|NCT02326298|460552278|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
127981250|NCT02326298|460552279|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
127981251|NCT02326298|460552280|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
127981252|NCT02326298|460552281|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
127981253|NCT02326298|460552268|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
127981254|NCT02326298|460552269|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
127981255|NCT02326298|460552270|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
127981256|NCT02326298|460552271|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
127981257|NCT02326298|460552272|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
127981258|NCT02326298|460552273|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
127981259|NCT02326298|460552274|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
127981260|NCT02326298|460552275|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
127981261|NCT02326298|460552276|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
127981262|NCT02326298|460552277|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
127981263|NCT02326298|460552278|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
127981264|NCT02326298|460552279|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
127981265|NCT02326298|460552280|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
127981266|NCT02326298|460552281|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
127981267|NCT02326298|460552268|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
127981268|NCT02326298|460552269|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
127981269|NCT02326298|460552270|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
127981270|NCT02326298|460552271|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
127981271|NCT02326298|460552272|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
127981272|NCT02326298|460552273|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
127981273|NCT02326298|460552274|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
127981274|NCT02326298|460552275|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
127981275|NCT02326298|460552276|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
127981276|NCT02326298|460552277|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
127981277|NCT02326298|460552278|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
127981278|NCT02326298|460552279|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
127981279|NCT02326298|460552280|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
127981280|NCT02326298|460552281|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
127981281|NCT03521817|460552283|FG000|Overall Study|Protocol Violation|0|||
127981282|NCT03521817|460552284|FG001|Overall Study|Protocol Violation|1|||
127869594|NCT04516291|460139607|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
127869595|NCT04516291|460139600|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
127869596|NCT04516291|460139601|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
127869597|NCT04516291|460139602|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
127869598|NCT04516291|460139603|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
127869599|NCT04516291|460139604|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
127869600|NCT04516291|460139605|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
127869601|NCT04516291|460139606|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
127869602|NCT04516291|460139607|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
127869603|NCT04516291|460139600|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
127869604|NCT04516291|460139601|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
127869605|NCT04516291|460139602|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
127869606|NCT04516291|460139603|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
127869607|NCT04516291|460139604|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
127869608|NCT04516291|460139605|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
127869609|NCT04516291|460139606|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
127869610|NCT04516291|460139607|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
127869611|NCT04516291|460139600|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
127869612|NCT04516291|460139601|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
127869613|NCT04516291|460139602|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
127869614|NCT04516291|460139603|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
127869615|NCT04516291|460139604|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
127869616|NCT04516291|460139605|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
127869617|NCT04516291|460139606|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
127869618|NCT04516291|460139607|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
127869619|NCT04516291|460139600|FG000|Follow-up Period (12 Weeks)|Other|0|||
127869620|NCT04516291|460139601|FG001|Follow-up Period (12 Weeks)|Other|1|||
127869621|NCT04516291|460139602|FG002|Follow-up Period (12 Weeks)|Other|0|||
127869622|NCT04516291|460139603|FG003|Follow-up Period (12 Weeks)|Other|2|||
127869623|NCT04516291|460139604|FG004|Follow-up Period (12 Weeks)|Other|0|||
127869624|NCT04516291|460139605|FG005|Follow-up Period (12 Weeks)|Other|0|||
127869625|NCT04516291|460139606|FG006|Follow-up Period (12 Weeks)|Other|0|||
127869626|NCT04516291|460139607|FG007|Follow-up Period (12 Weeks)|Other|0|||
127869627|NCT04516291|460139600|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
127869628|NCT04516291|460139601|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
127869629|NCT04516291|460139602|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
127869630|NCT04516291|460139603|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
127869631|NCT04516291|460139604|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
127869632|NCT04516291|460139605|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
127869633|NCT04516291|460139606|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
127869634|NCT04516291|460139607|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
127869635|NCT04516291|460139600|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
127869636|NCT04516291|460139601|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
127869637|NCT04516291|460139602|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
127869638|NCT04516291|460139603|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
127869639|NCT04516291|460139604|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
127869640|NCT04516291|460139605|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
127869641|NCT04516291|460139606|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
127869642|NCT04516291|460139607|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
127869643|NCT02322866|460139609|FG000|Overall Study|Adverse Event|6|||
127869644|NCT02322866|460139610|FG001|Overall Study|Adverse Event|11|||
127869645|NCT02322866|460139609|FG000|Overall Study|Withdrawal of Consent|16|||
127869646|NCT02322866|460139610|FG001|Overall Study|Withdrawal of Consent|25|||
127869647|NCT02322866|460139609|FG000|Overall Study|Lost to Follow-up|36|||
127869648|NCT02322866|460139610|FG001|Overall Study|Lost to Follow-up|39|||
127869649|NCT02322866|460139609|FG000|Overall Study|Protocol Violation|1|||
127869650|NCT02322866|460139610|FG001|Overall Study|Protocol Violation|0|||
127869651|NCT02322866|460139609|FG000|Overall Study|Noncompliance with Treatment|3|||
127869652|NCT02322866|460139610|FG001|Overall Study|Noncompliance with Treatment|4|||
127869653|NCT02322866|460139609|FG000|Overall Study|Lack of Efficacy|3|||
127869654|NCT02322866|460139610|FG001|Overall Study|Lack of Efficacy|1|||
127869655|NCT02322866|460139609|FG000|Overall Study|Other Miscellaneous Reasons|6|||
127869656|NCT02322866|460139610|FG001|Overall Study|Other Miscellaneous Reasons|6|||
127869657|NCT02181634|460139613|FG000|Overall Study|Lack of Efficacy|33|||
127869658|NCT02181634|460139613|FG000|Overall Study|Adverse Event|17|||
127869659|NCT02181634|460139613|FG000|Overall Study|Physician Decision|8|||
127869660|NCT02181634|460139613|FG000|Overall Study|Withdrawal by Subject|5|||
127869661|NCT02181634|460139613|FG000|Overall Study|Death|2|||
127869662|NCT02181634|460139613|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
127869663|NCT02181634|460139613|FG000|Overall Study|Ineligible|1|||
127869664|NCT02181634|460139613|FG000|Overall Study|Max number of dose reduction|1|||
127869665|NCT02181634|460139613|FG000|Overall Study|Symptomatic progression|1|||
127869666|NCT02181634|460139613|FG000|Overall Study|Patient opted to proceed to surgery|1|||
127869667|NCT01928758|460139629|FG000|Overall Study|Lost to Follow-up|14|||
127869668|NCT01928758|460139630|FG001|Overall Study|Lost to Follow-up|9|||
127869669|NCT01928758|460139629|FG000|Overall Study|Withdrawal by Subject|5|||
127869670|NCT01928758|460139630|FG001|Overall Study|Withdrawal by Subject|2|||
127869671|NCT01928758|460139629|FG000|Overall Study|Adverse Event|3|||
127869672|NCT01928758|460139630|FG001|Overall Study|Adverse Event|5|||
127869673|NCT01928758|460139629|FG000|Overall Study|Protocol Violation|3|||
127869674|NCT01928758|460139630|FG001|Overall Study|Protocol Violation|4|||
127869675|NCT00719706|460139631|FG000|Overall Study|Adverse Event|5|||
127869676|NCT00719706|460139632|FG001|Overall Study|Adverse Event|4|||
127869677|NCT00719706|460139631|FG000|Overall Study|Withdrawal by Subject|1|||
127869678|NCT00719706|460139632|FG001|Overall Study|Withdrawal by Subject|2|||
127869679|NCT00719706|460139631|FG000|Overall Study|Protocol Violation|3|||
127869680|NCT00719706|460139632|FG001|Overall Study|Protocol Violation|0|||
127869681|NCT00649220|460139633|FG000|Overall Study|Adverse Event|2|||
127869682|NCT00649220|460139633|FG000|Overall Study|Withdrawal by Subject|1|||
127869683|NCT02557308|460139634|FG000|Overall Study|Withdrawal by Subject|11|||
127869684|NCT02557308|460139635|FG001|Overall Study|Withdrawal by Subject|3|||
127869685|NCT02557308|460139636|FG002|Overall Study|Withdrawal by Subject|2|||
127869686|NCT02557308|460139637|FG003|Overall Study|Withdrawal by Subject|0|||
127869687|NCT02557308|460139638|FG004|Overall Study|Withdrawal by Subject|1|||
127869688|NCT02557308|460139639|FG005|Overall Study|Withdrawal by Subject|0|||
127869689|NCT02557308|460139640|FG006|Overall Study|Withdrawal by Subject|10|||
127869690|NCT02557308|460139641|FG007|Overall Study|Withdrawal by Subject|1|||
127869691|NCT02557308|460139634|FG000|Overall Study|Disease Progression|0|||
127869692|NCT02557308|460139635|FG001|Overall Study|Disease Progression|1|||
127869693|NCT02557308|460139636|FG002|Overall Study|Disease Progression|0|||
127869694|NCT02557308|460139637|FG003|Overall Study|Disease Progression|0|||
127869695|NCT02557308|460139638|FG004|Overall Study|Disease Progression|0|||
127869696|NCT02557308|460139639|FG005|Overall Study|Disease Progression|0|||
127869697|NCT02557308|460139640|FG006|Overall Study|Disease Progression|0|||
127869698|NCT02557308|460139641|FG007|Overall Study|Disease Progression|0|||
127869699|NCT02557308|460139634|FG000|Overall Study|Lack of Efficacy|3|||
127869700|NCT02557308|460139635|FG001|Overall Study|Lack of Efficacy|0|||
127869701|NCT02557308|460139636|FG002|Overall Study|Lack of Efficacy|0|||
127869702|NCT02557308|460139637|FG003|Overall Study|Lack of Efficacy|0|||
127869703|NCT02557308|460139638|FG004|Overall Study|Lack of Efficacy|0|||
127869704|NCT02557308|460139639|FG005|Overall Study|Lack of Efficacy|0|||
127869705|NCT02557308|460139640|FG006|Overall Study|Lack of Efficacy|1|||
127869706|NCT02557308|460139641|FG007|Overall Study|Lack of Efficacy|0|||
127869707|NCT02557308|460139634|FG000|Overall Study|Adverse Event|4|||
127869708|NCT02557308|460139635|FG001|Overall Study|Adverse Event|1|||
127869709|NCT02557308|460139636|FG002|Overall Study|Adverse Event|2|||
127869710|NCT02557308|460139637|FG003|Overall Study|Adverse Event|0|||
127869711|NCT02557308|460139638|FG004|Overall Study|Adverse Event|0|||
127869712|NCT02557308|460139639|FG005|Overall Study|Adverse Event|0|||
127869713|NCT02557308|460139640|FG006|Overall Study|Adverse Event|4|||
127869714|NCT02557308|460139641|FG007|Overall Study|Adverse Event|1|||
127869715|NCT02557308|460139634|FG000|Overall Study|Lost to Follow-up|2|||
127869716|NCT02557308|460139635|FG001|Overall Study|Lost to Follow-up|0|||
127869717|NCT02557308|460139636|FG002|Overall Study|Lost to Follow-up|1|||
127869718|NCT02557308|460139637|FG003|Overall Study|Lost to Follow-up|0|||
127869719|NCT02557308|460139638|FG004|Overall Study|Lost to Follow-up|0|||
127869720|NCT02557308|460139639|FG005|Overall Study|Lost to Follow-up|0|||
127869721|NCT02557308|460139640|FG006|Overall Study|Lost to Follow-up|2|||
127869722|NCT02557308|460139641|FG007|Overall Study|Lost to Follow-up|0|||
127869723|NCT02557308|460139634|FG000|Overall Study|Death|1|||
127869724|NCT02557308|460139635|FG001|Overall Study|Death|0|||
127869725|NCT02557308|460139636|FG002|Overall Study|Death|0|||
127869726|NCT02557308|460139637|FG003|Overall Study|Death|0|||
127869727|NCT02557308|460139638|FG004|Overall Study|Death|0|||
127869728|NCT02557308|460139639|FG005|Overall Study|Death|0|||
127869729|NCT02557308|460139640|FG006|Overall Study|Death|0|||
127869730|NCT02557308|460139641|FG007|Overall Study|Death|0|||
127869786|NCT00808665|460139659|FG000|Overall Study|required an additional procedure|0|||
127869787|NCT00808665|460139660|FG001|Overall Study|required an additional procedure|1|||
127869788|NCT00808665|460139659|FG000|Overall Study|Physician Decision|3|||
127869789|NCT00808665|460139660|FG001|Overall Study|Physician Decision|1|||
127869790|NCT00808665|460139659|FG000|Overall Study|Medication stopped by resident|0|||
127869791|NCT00808665|460139660|FG001|Overall Study|Medication stopped by resident|1|||
127869792|NCT03319160|460139661|FG000|Overall Study|Data not available.|7|||
127869793|NCT00665002|460139662|FG000|Overall Study|Progression/relapse during treatment|11|||
127869794|NCT00665002|460139662|FG000|Overall Study|Cytogenetic resistance|1|||
127869795|NCT01303159|460139670|FG000|Overall Study|Death|16|||
127869796|NCT01303159|460139670|FG000|Overall Study|Study Termination|7|||
127869797|NCT00242658|460139671|FG000|Overall Study|Lost to Follow-up|22|||
127869798|NCT00242658|460139672|FG001|Overall Study|Lost to Follow-up|19|||
127869799|NCT01815099|460139673|FG000|Overall Study|Lack of Efficacy|1|||
127869800|NCT01815099|460139673|FG000|Overall Study|unable to attend study visits|1|||
127869801|NCT00643851|460139674|FG000|Overall Study|Death|0|||
127869802|NCT00643851|460139675|FG001|Overall Study|Death|1|||
127869803|NCT00643851|460139676|FG002|Overall Study|Death|0|||
127869804|NCT00643851|460139674|FG000|Overall Study|Lack of Efficacy|0|||
127869805|NCT00643851|460139675|FG001|Overall Study|Lack of Efficacy|1|||
127869806|NCT00643851|460139676|FG002|Overall Study|Lack of Efficacy|0|||
127869807|NCT00643851|460139674|FG000|Overall Study|Adverse Event|2|||
127869808|NCT00643851|460139675|FG001|Overall Study|Adverse Event|6|||
127869809|NCT00643851|460139676|FG002|Overall Study|Adverse Event|6|||
127869810|NCT00643851|460139674|FG000|Overall Study|Lost to Follow-up|4|||
127869811|NCT00643851|460139675|FG001|Overall Study|Lost to Follow-up|6|||
127869812|NCT00643851|460139676|FG002|Overall Study|Lost to Follow-up|9|||
127869813|NCT00643851|460139674|FG000|Overall Study|Withdrawal by Subject|8|||
127869814|NCT00643851|460139675|FG001|Overall Study|Withdrawal by Subject|15|||
127869815|NCT00643851|460139676|FG002|Overall Study|Withdrawal by Subject|9|||
127869816|NCT00643851|460139674|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
127869817|NCT00643851|460139675|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
127869818|NCT00643851|460139676|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
127869819|NCT04806334|460139679|FG000|Overall Study|Withdrawal by Subject|1|||
127869820|NCT04557189|460139680|FG000|Overall Study|Adverse Event|0|||
127869821|NCT04557189|460139681|FG001|Overall Study|Adverse Event|1|||
127869822|NCT04557189|460139680|FG000|Overall Study|Lost to Follow-up|1|||
127869823|NCT04557189|460139681|FG001|Overall Study|Lost to Follow-up|1|||
127869824|NCT04557189|460139680|FG000|Overall Study|Withdrawal by Subject|2|||
127869825|NCT04557189|460139681|FG001|Overall Study|Withdrawal by Subject|1|||
127869826|NCT04557189|460139680|FG000|Overall Study|Reason not Specified|3|||
127869827|NCT04557189|460139681|FG001|Overall Study|Reason not Specified|6|||
127869828|NCT01731600|460139684|FG000|Overall Study|Adverse Event|2|||
127869829|NCT01731600|460139685|FG001|Overall Study|Adverse Event|0|||
127869830|NCT01731600|460139684|FG000|Overall Study|Withdrawal criteria|1|||
127869831|NCT01731600|460139685|FG001|Overall Study|Withdrawal criteria|0|||
127869832|NCT01731600|460139684|FG000|Overall Study|Other reasons|3|||
127869833|NCT01731600|460139685|FG001|Overall Study|Other reasons|0|||
127869834|NCT00465894|460139686|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
127869835|NCT00465894|460139687|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
127869836|NCT00465894|460139686|FG000|Treatment For 12 Weeks|Family Issues|1|||
127869837|NCT00465894|460139687|FG001|Treatment For 12 Weeks|Family Issues|1|||
127869838|NCT00465894|460139686|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
127869839|NCT00465894|460139687|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
127869840|NCT01636076|460139688|FG000|Overall Study|Terminated by sponsor|1|||
127869841|NCT01636076|460139689|FG001|Overall Study|Terminated by sponsor|1|||
127869842|NCT01636076|460139688|FG000|Overall Study|Lack of Efficacy|0|||
127869843|NCT01636076|460139689|FG001|Overall Study|Lack of Efficacy|1|||
127869844|NCT01636076|460139688|FG000|Overall Study|Lost to Follow-up|1|||
127869845|NCT01636076|460139689|FG001|Overall Study|Lost to Follow-up|0|||
127869846|NCT01636076|460139688|FG000|Overall Study|Physician Decision|1|||
127869847|NCT01636076|460139689|FG001|Overall Study|Physician Decision|1|||
127869848|NCT01636076|460139688|FG000|Overall Study|Non-compliance with study treatment|1|||
127869849|NCT01636076|460139689|FG001|Overall Study|Non-compliance with study treatment|1|||
127869850|NCT01636076|460139688|FG000|Overall Study|Adverse Event|6|||
127869851|NCT01636076|460139689|FG001|Overall Study|Adverse Event|11|||
127869852|NCT01636076|460139688|FG000|Overall Study|Withdrawal by Subject|7|||
127869853|NCT01636076|460139689|FG001|Overall Study|Withdrawal by Subject|10|||
127869854|NCT02173158|460139691|FG000|Efficacy Phase|Adverse Event|1|||
127869855|NCT01728454|460139703|FG000|Stage 1 and 2|Pregnancy|1|||
127869856|NCT01728454|460139704|FG001|Stage 1 and 2|Pregnancy|0|||
127869857|NCT01728454|460139705|FG002|Stage 1 and 2|Pregnancy|0|||
127869858|NCT01728454|460139703|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
127869859|NCT01728454|460139704|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
127869860|NCT01728454|460139705|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
127869861|NCT01728454|460139703|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
127869862|NCT01728454|460139704|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
127869863|NCT01728454|460139705|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
127869864|NCT01728454|460139703|FG000|Stage 1 and 2|Lost to Follow-up|1|||
127869865|NCT01728454|460139704|FG001|Stage 1 and 2|Lost to Follow-up|1|||
127869866|NCT01728454|460139705|FG002|Stage 1 and 2|Lost to Follow-up|0|||
127869867|NCT01728454|460139703|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
127869868|NCT01728454|460139704|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
127869869|NCT01728454|460139705|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
127869870|NCT01728454|460139703|FG000|Stage 3|Reason Missing|0|||
127869871|NCT01728454|460139704|FG001|Stage 3|Reason Missing|0|||
127869872|NCT01728454|460139705|FG002|Stage 3|Reason Missing|1|||
127869873|NCT01728454|460139703|FG000|Stage 3|Subject Required Other Treatment|0|||
127869874|NCT01728454|460139704|FG001|Stage 3|Subject Required Other Treatment|1|||
127869875|NCT01728454|460139705|FG002|Stage 3|Subject Required Other Treatment|0|||
127869876|NCT01728454|460139703|FG000|Stage 3|Pregnancy|1|||
127869877|NCT01728454|460139704|FG001|Stage 3|Pregnancy|0|||
127869878|NCT01728454|460139705|FG002|Stage 3|Pregnancy|0|||
127869879|NCT01728454|460139703|FG000|Stage 3|Withdrew Consent|1|||
127869880|NCT01728454|460139704|FG001|Stage 3|Withdrew Consent|0|||
127869881|NCT01728454|460139705|FG002|Stage 3|Withdrew Consent|1|||
127869882|NCT01728454|460139703|FG000|Stage 3|Non-compliance with Protocol|0|||
127869883|NCT01728454|460139704|FG001|Stage 3|Non-compliance with Protocol|0|||
127869884|NCT01728454|460139705|FG002|Stage 3|Non-compliance with Protocol|1|||
127869885|NCT01728454|460139703|FG000|Stage 3|Lost to Follow-up|0|||
127869886|NCT01728454|460139704|FG001|Stage 3|Lost to Follow-up|3|||
127869887|NCT01728454|460139705|FG002|Stage 3|Lost to Follow-up|1|||
127869888|NCT01728454|460139703|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
127869889|NCT01728454|460139704|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
127869890|NCT01728454|460139705|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
127869891|NCT01190839|460139706|FG000|Overall Study|Adverse Event|32|||
127869892|NCT01190839|460139707|FG001|Overall Study|Adverse Event|41|||
127869893|NCT01190839|460139706|FG000|Overall Study|Protocol Violation|2|||
127869894|NCT01190839|460139707|FG001|Overall Study|Protocol Violation|2|||
127869895|NCT01190839|460139706|FG000|Overall Study|Lost to Follow-up|7|||
127869896|NCT01190839|460139707|FG001|Overall Study|Lost to Follow-up|1|||
127869897|NCT01190839|460139706|FG000|Overall Study|Death|1|||
127869898|NCT01190839|460139707|FG001|Overall Study|Death|0|||
127869899|NCT01190839|460139706|FG000|Overall Study|Trial stopped by Sponsor|71|||
127869900|NCT01190839|460139707|FG001|Overall Study|Trial stopped by Sponsor|68|||
127869901|NCT01190839|460139706|FG000|Overall Study|Undefined|35|||
127869902|NCT01190839|460139707|FG001|Overall Study|Undefined|31|||
127869903|NCT01190839|460139706|FG000|Overall Study|Randomized but not treated|2|||
127869904|NCT01190839|460139707|FG001|Overall Study|Randomized but not treated|4|||
127869905|NCT03077646|460139711|FG000|Overall Study|Lost to Follow-up|29|||
127869906|NCT03077646|460139712|FG001|Overall Study|Lost to Follow-up|30|||
127869907|NCT03077646|460139713|FG002|Overall Study|Lost to Follow-up|31|||
127869908|NCT00765726|460139714|FG000|Overall Study|Withdrawal by Subject|1|||
127869909|NCT00765726|460139714|FG000|Overall Study|Discontinuation of study by sponsor|8|||
127869910|NCT02058966|460139715|FG000|Open-Label Methamphetamine|Adverse Event|1|||
127869911|NCT02058966|460139715|FG000|First Intervention|Withdrawal by Subject|1|||
127869912|NCT01265511|460139716|FG000|Overall Study|Lack of Efficacy|2|||
127869913|NCT01265511|460139717|FG001|Overall Study|Lack of Efficacy|1|||
127869914|NCT01265511|460139716|FG000|Overall Study|Met stopping rules|0|||
127869915|NCT01265511|460139717|FG001|Overall Study|Met stopping rules|2|||
127869916|NCT00323479|460139718|FG000|Overall Study|Adverse Event|2|||
127869917|NCT00323479|460139718|FG000|Overall Study|Withdrawal by Subject|2|||
127869918|NCT00323479|460139718|FG000|Overall Study|Protocol Violation|3|||
127869919|NCT00323479|460139718|FG000|Overall Study|house moving|1|||
127869920|NCT01362062|460139719|FG000|Overall Study|Adverse Event|1|||
127869921|NCT01362062|460139720|FG001|Overall Study|Adverse Event|0|||
127869922|NCT01362062|460139719|FG000|Overall Study|Lost to Follow-up|11|||
127869923|NCT01362062|460139720|FG001|Overall Study|Lost to Follow-up|0|||
127869924|NCT01362062|460139719|FG000|Overall Study|Withdrawal by Subject|2|||
127869925|NCT01362062|460139720|FG001|Overall Study|Withdrawal by Subject|0|||
127869926|NCT01362062|460139719|FG000|Overall Study|Non-compliant participant|2|||
127869927|NCT01362062|460139720|FG001|Overall Study|Non-compliant participant|0|||
127869928|NCT01362062|460139719|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
127869929|NCT01362062|460139720|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
127869930|NCT01362062|460139719|FG000|Overall Study|Had significant improvement|9|||
127869931|NCT01362062|460139720|FG001|Overall Study|Had significant improvement|0|||
127869932|NCT00967343|460139721|FG000|Overall Study|Study termination by sponsor|12|||
127869933|NCT00967343|460139721|FG000|Overall Study|Death|24|||
127869934|NCT00967343|460139721|FG000|Overall Study|Relapse|1|||
127869935|NCT00967343|460139721|FG000|Overall Study|Lost to Follow-up|1|||
127869936|NCT00950755|460139722|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
127869937|NCT00950755|460139722|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
127869938|NCT00950755|460139722|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
127869939|NCT00950755|460139722|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
127869940|NCT00950755|460139722|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
127869941|NCT00950755|460139722|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
127869942|NCT00950755|460139722|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
127869943|NCT00950755|460139722|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
127869944|NCT00950755|460139722|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
127869945|NCT00950755|460139722|FG000|Long-Term Follow-Up|Death|8|||
